Functional	O
interactions	O
of	O
transforming	B-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
with	O
IkappaB	B-Gene_or_gene_product
kinases	I-Gene_or_gene_product
to	O
stimulate	O
NF	O
-	O
kappaB	O
activation	O
.	O
<EOS>	B-X
This	B-X
review	B-X
provides	B-X
insight	B-X
to	B-X
stimulate	B-X
interest	B-X
in	B-X
and	B-X
support	B-X
future	B-X
research	B-X
into	B-X
understanding	B-X
this	B-X
signaling	B-X
axis	B-X
in	B-X
cardiovascular	B-X
and	B-X
metabolic	B-X
tissues	B-X
and	B-X
diseases	B-X
.	B-X
Several	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinases	B-X
play	B-X
critical	B-X
roles	B-X
in	B-X
nuclear	B-X
factor-kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
activation	B-X
.	B-X
We	B-X
recently	B-X
reported	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
transforming	B-X
growth	B-X
factor-beta-activated	B-X
kinase	B-X
1	B-X
(	B-X
TAK1	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinase	B-X
family	B-X
,	B-X
together	B-X
with	B-X
its	B-X
activator	B-X
TAK1-binding	B-X
protein	B-X
1	B-X
(	B-X
TAB1	B-X
)	B-X
stimulates	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanism	B-X
of	B-X
TAK1-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Dominant	B-X
negative	B-X
mutants	B-X
of	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
alpha	B-X
and	B-X
IKKbeta	B-X
inhibited	B-X
TAK1-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
TAK1	B-X
activated	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
TAB1	B-X
.	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
were	B-X
coimmunoprecipitated	B-X
with	B-X
TAK1	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
TAB1	B-X
.	B-X
TAB1-induced	B-X
TAK1	B-X
activation	B-X
promoted	B-X
the	B-X
dissociation	B-X
of	B-X
active	B-X
forms	B-X
of	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
from	B-X
active	B-X
TAK1	B-X
,	B-X
whereas	B-X
the	B-X
IKK	B-X
mutants	B-X
remained	B-X
to	B-X
interact	B-X
with	B-X
active	B-X
TAK1	B-X
.	B-X
Furthermore	B-X
,	B-X
tumor	B-X
necrosis	B-X
factor-alpha	B-X
activated	B-X
endogenous	B-X
TAK1	B-X
,	B-X
and	B-X
the	B-X
kinase-negative	B-X
TAK1	B-X
acted	B-X
as	B-X
a	B-X
dominant	B-X
negative	B-X
inhibitor	B-X
against	B-X
tumor	B-X
necrosis	B-X
factor-alpha-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
These	B-X
results	B-X
demonstrated	B-X
a	B-X
novel	B-X
signaling	B-X
pathway	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
through	B-X
TAK1	B-X
in	B-X
which	B-X
TAK1	B-X
may	B-X
act	B-X
as	B-X
a	B-X
regulatory	B-X
kinase	B-X
of	B-X
IKKs	B-X
.	B-X

Several	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
play	O
critical	O
roles	O
in	O
nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
activation	O
.	O
<EOS>	B-X
Neutrophils	B-X
play	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
the	B-X
host	B-X
defense	B-X
against	B-X
bacterial	B-X
and	B-X
fungal	B-X
infections	B-X
,	B-X
but	B-X
their	B-X
inappropriate	B-X
activation	B-X
also	B-X
contributes	B-X
to	B-X
tissue	B-X
damage	B-X
during	B-X
autoimmune	B-X
and	B-X
inflammatory	B-X
diseases	B-X
.	B-X
Those	B-X
include	B-X
G-protein-coupled	B-X
chemokine	B-X
and	B-X
chemoattractant	B-X
receptors	B-X
,	B-X
Fc-receptors	B-X
,	B-X
adhesion	B-X
receptors	B-X
such	B-X
as	B-X
selectins/selectin	B-X
ligands	B-X
and	B-X
integrins	B-X
,	B-X
various	B-X
cytokine	B-X
receptors	B-X
,	B-X
as	B-X
well	B-X
as	B-X
innate	B-X
immune	B-X
receptors	B-X
such	B-X
as	B-X
Toll-like	B-X
receptors	B-X
and	B-X
C-type	B-X
lectins	B-X
.	B-X
The	B-X
various	B-X
cell	B-X
surface	B-X
receptors	B-X
trigger	B-X
very	B-X
diverse	B-X
signal	B-X
transduction	B-X
pathways	B-X
including	B-X
activation	B-X
of	B-X
heterotrimeric	B-X
and	B-X
monomeric	B-X
G-proteins	B-X
,	B-X
receptor-induced	B-X
and	B-X
store-operated	B-X
Ca	B-X
(	B-X
2+	B-X
)	B-X
signals	B-X
,	B-X
protein	B-X
and	B-X
lipid	B-X
kinases	B-X
,	B-X
adapter	B-X
proteins	B-X
and	B-X
cytoskeletal	B-X
rearrangement	B-X
.	B-X
Here	B-X
we	B-X
provide	B-X
an	B-X
overview	B-X
of	B-X
the	B-X
receptors	B-X
involved	B-X
in	B-X
neutrophil	B-X
activation	B-X
and	B-X
the	B-X
intracellular	B-X
signal	B-X
transduction	B-X
processes	B-X
they	B-X
trigger	B-X
.	B-X

We	O
recently	O
reported	O
that	O
the	O
overexpression	O
of	O
transforming	B-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
TAK1	B-Gene_or_gene_product
)	O
,	O
a	O
member	O
of	O
the	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
family	I-Gene_or_gene_product
,	O
together	O
with	O
its	O
activator	O
TAK1	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
TAB1	B-Gene_or_gene_product
)	O
stimulates	O
NF	O
-	O
kappaB	O
activation	O
.	O
<EOS>	B-X
Several	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinases	B-X
play	B-X
critical	B-X
roles	B-X
in	B-X
nuclear	B-X
factor-kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
activation	B-X
.	B-X
We	B-X
recently	B-X
reported	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
transforming	B-X
growth	B-X
factor-beta-activated	B-X
kinase	B-X
1	B-X
(	B-X
TAK1	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinase	B-X
family	B-X
,	B-X
together	B-X
with	B-X
its	B-X
activator	B-X
TAK1-binding	B-X
protein	B-X
1	B-X
(	B-X
TAB1	B-X
)	B-X
stimulates	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanism	B-X
of	B-X
TAK1-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Dominant	B-X
negative	B-X
mutants	B-X
of	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
alpha	B-X
and	B-X
IKKbeta	B-X
inhibited	B-X
TAK1-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
TAK1	B-X
activated	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
TAB1	B-X
.	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
were	B-X
coimmunoprecipitated	B-X
with	B-X
TAK1	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
TAB1	B-X
.	B-X
TAB1-induced	B-X
TAK1	B-X
activation	B-X
promoted	B-X
the	B-X
dissociation	B-X
of	B-X
active	B-X
forms	B-X
of	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
from	B-X
active	B-X
TAK1	B-X
,	B-X
whereas	B-X
the	B-X
IKK	B-X
mutants	B-X
remained	B-X
to	B-X
interact	B-X
with	B-X
active	B-X
TAK1	B-X
.	B-X
Furthermore	B-X
,	B-X
tumor	B-X
necrosis	B-X
factor-alpha	B-X
activated	B-X
endogenous	B-X
TAK1	B-X
,	B-X
and	B-X
the	B-X
kinase-negative	B-X
TAK1	B-X
acted	B-X
as	B-X
a	B-X
dominant	B-X
negative	B-X
inhibitor	B-X
against	B-X
tumor	B-X
necrosis	B-X
factor-alpha-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
These	B-X
results	B-X
demonstrated	B-X
a	B-X
novel	B-X
signaling	B-X
pathway	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
through	B-X
TAK1	B-X
in	B-X
which	B-X
TAK1	B-X
may	B-X
act	B-X
as	B-X
a	B-X
regulatory	B-X
kinase	B-X
of	B-X
IKKs	B-X
.	B-X

Here	O
we	O
investigated	O
the	O
molecular	O
mechanism	O
of	O
TAK1	B-Gene_or_gene_product
-	O
induced	O
NF	O
-	O
kappaB	O
activation	O
.	O
<EOS>	B-X
However	B-X
,	B-X
it	B-X
remains	B-X
unknown	B-X
whether	B-X
and	B-X
how	B-X
the	B-X
macrophage	B-X
Notch1	B-X
may	B-X
control	B-X
the	B-X
innate	B-X
immune	B-X
signaling	B-X
TAK1	B-X
,	B-X
and	B-X
RIPK3-mediated	B-X
hepatocyte	B-X
necroptosis	B-X
in	B-X
liver	B-X
ischemia	B-X
and	B-X
reperfusion	B-X
injury	B-X
(	B-X
IRI	B-X
)	B-X
.	B-X
This	B-X
study	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanisms	B-X
of	B-X
macrophage	B-X
Notch1	B-X
in	B-X
modulating	B-X
TAK1-mediated	B-X
innate	B-X
immune	B-X
responses	B-X
and	B-X
RIPK3	B-X
functions	B-X
in	B-X
liver	B-X
IRI	B-X
.	B-X
As	B-X
an	B-X
important	B-X
effector	B-X
in	B-X
response	B-X
to	B-X
various	B-X
intracellular	B-X
or	B-X
extracellular	B-X
stimuli	B-X
,	B-X
the	B-X
NF-κB	B-X
family	B-X
extensively	B-X
participates	B-X
in	B-X
a	B-X
wide	B-X
spectrum	B-X
of	B-X
biological	B-X
events	B-X
,	B-X
and	B-X
its	B-X
dysregulation	B-X
may	B-X
result	B-X
in	B-X
many	B-X
pathological	B-X
conditions	B-X
,	B-X
such	B-X
as	B-X
microbial	B-X
infection	B-X
,	B-X
tumor	B-X
progression	B-X
,	B-X
and	B-X
neurodegenerative	B-X
disorders	B-X
.	B-X
Previous	B-X
investigations	B-X
showed	B-X
that	B-X
multiple	B-X
types	B-X
of	B-X
ubiquitination	B-X
play	B-X
critical	B-X
roles	B-X
in	B-X
the	B-X
modulation	B-X
of	B-X
the	B-X
NF-κB	B-X
signaling	B-X
pathway	B-X
,	B-X
yet	B-X
the	B-X
molecular	B-X
mechanisms	B-X
are	B-X
still	B-X
poorly	B-X
understood	B-X
.	B-X
In	B-X
the	B-X
current	B-X
study	B-X
,	B-X
we	B-X
identified	B-X
TRIM25	B-X
,	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
,	B-X
as	B-X
a	B-X
novel	B-X
positive	B-X
regulator	B-X
in	B-X
mediating	B-X
NF-κB	B-X
activation	B-X
in	B-X
human	B-X
embryonic	B-X
kidney	B-X
293T	B-X
(	B-X
HEK293T	B-X
)	B-X
,	B-X
HeLa	B-X
cells	B-X
,	B-X
THP-1	B-X
cells	B-X
,	B-X
and	B-X
PBMCs	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
TRIM25	B-X
promoted	B-X
TNF-α-induced	B-X
NF-κB	B-X
signaling	B-X
,	B-X
whereas	B-X
the	B-X
knockdown	B-X
had	B-X
the	B-X
opposite	B-X
effect	B-X
.	B-X
Moreover	B-X
,	B-X
TRIM25	B-X
bridged	B-X
the	B-X
interaction	B-X
of	B-X
TRAF2	B-X
and	B-X
TAK1	B-X
or	B-X
IKKβ	B-X
.	B-X
To	B-X
our	B-X
knowledge	B-X
,	B-X
our	B-X
study	B-X
has	B-X
identified	B-X
a	B-X
previously	B-X
unrecognized	B-X
role	B-X
for	B-X
TRIM25	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
NF-κB	B-X
activation	B-X
by	B-X
enhancing	B-X
the	B-X
K63-linked	B-X
ubiquitination	B-X
of	B-X
TRAF2	B-X
.	B-X

Dominant	O
negative	O
mutants	O
of	O
IkappaB	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	I-Gene_or_gene_product
IKK	I-Gene_or_gene_product
)	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
IKKbeta	B-Gene_or_gene_product
inhibited	O
TAK1	B-Gene_or_gene_product
-	O
induced	O
NF	O
-	O
kappaB	O
activation	O
.	O
<EOS>	B-X
The	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
regulated	B-X
by	B-X
multiple	B-X
phosphorylations	B-X
of	B-X
IkappaBs	B-X
and	B-X
the	B-X
NF-kappaB	B-X
p65	B-X
subunit	B-X
.	B-X
The	B-X
Ser-536	B-X
of	B-X
endogenous	B-X
p65	B-X
was	B-X
rapidly	B-X
phosphorylated	B-X
in	B-X
response	B-X
to	B-X
a	B-X
wide	B-X
variety	B-X
of	B-X
NF-kappaB	B-X
stimulants	B-X
including	B-X
TNF-alpha	B-X
in	B-X
the	B-X
cytoplasm	B-X
and	B-X
rapidly	B-X
dephosphorylated	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X
The	B-X
TNF-alpha-but	B-X
not	B-X
IL-1beta-induced	B-X
Ser-536	B-X
phosphorylation	B-X
was	B-X
severely	B-X
impaired	B-X
in	B-X
murine	B-X
embryonic	B-X
fibroblasts	B-X
derived	B-X
from	B-X
traf2-/-traf5-/-	B-X
mice	B-X
.	B-X
Bay	B-X
11-7082	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
IkappaB	B-X
phosphorylation	B-X
,	B-X
inhibited	B-X
the	B-X
TNF-alpha-induced	B-X
phosphorylation	B-X
in	B-X
vivo	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
overexpression	B-X
of	B-X
TGF-beta-activated	B-X
kinase	B-X
1	B-X
(	B-X
TAK1	B-X
)	B-X
,	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
stimulated	B-X
the	B-X
phosphorylation	B-X
,	B-X
and	B-X
their	B-X
dominant	B-X
negative	B-X
mutants	B-X
blocked	B-X
the	B-X
TNF-alpha-induced	B-X
phosphorylation	B-X
.	B-X
Moreover	B-X
,	B-X
small	B-X
interfering	B-X
RNAs	B-X
(	B-X
siRNAs	B-X
)	B-X
against	B-X
TAK1	B-X
,	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
blocked	B-X
the	B-X
phosphorylation	B-X
of	B-X
endogenous	B-X
p65	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
similar	B-X
signaling	B-X
pathways	B-X
were	B-X
utilized	B-X
for	B-X
the	B-X
phosphorylations	B-X
of	B-X
IkappaBalpha	B-X
and	B-X
p65	B-X
,	B-X
which	B-X
further	B-X
support	B-X
the	B-X
idea	B-X
that	B-X
both	B-X
IkappaB	B-X
and	B-X
NF-kappaB	B-X
are	B-X
substrates	B-X
for	B-X
the	B-X
IKK	B-X
complex	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
.	B-X

TAK1	B-Gene_or_gene_product
activated	O
IKKalpha	B-Gene_or_gene_product
and	O
IKKbeta	B-Gene_or_gene_product
in	O
the	O
presence	O
of	O
TAB1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Several	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinases	B-X
play	B-X
critical	B-X
roles	B-X
in	B-X
nuclear	B-X
factor-kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
activation	B-X
.	B-X
We	B-X
recently	B-X
reported	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
transforming	B-X
growth	B-X
factor-beta-activated	B-X
kinase	B-X
1	B-X
(	B-X
TAK1	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinase	B-X
family	B-X
,	B-X
together	B-X
with	B-X
its	B-X
activator	B-X
TAK1-binding	B-X
protein	B-X
1	B-X
(	B-X
TAB1	B-X
)	B-X
stimulates	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanism	B-X
of	B-X
TAK1-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Dominant	B-X
negative	B-X
mutants	B-X
of	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
alpha	B-X
and	B-X
IKKbeta	B-X
inhibited	B-X
TAK1-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
TAK1	B-X
activated	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
TAB1	B-X
.	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
were	B-X
coimmunoprecipitated	B-X
with	B-X
TAK1	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
TAB1	B-X
.	B-X
TAB1-induced	B-X
TAK1	B-X
activation	B-X
promoted	B-X
the	B-X
dissociation	B-X
of	B-X
active	B-X
forms	B-X
of	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
from	B-X
active	B-X
TAK1	B-X
,	B-X
whereas	B-X
the	B-X
IKK	B-X
mutants	B-X
remained	B-X
to	B-X
interact	B-X
with	B-X
active	B-X
TAK1	B-X
.	B-X
Furthermore	B-X
,	B-X
tumor	B-X
necrosis	B-X
factor-alpha	B-X
activated	B-X
endogenous	B-X
TAK1	B-X
,	B-X
and	B-X
the	B-X
kinase-negative	B-X
TAK1	B-X
acted	B-X
as	B-X
a	B-X
dominant	B-X
negative	B-X
inhibitor	B-X
against	B-X
tumor	B-X
necrosis	B-X
factor-alpha-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
These	B-X
results	B-X
demonstrated	B-X
a	B-X
novel	B-X
signaling	B-X
pathway	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
through	B-X
TAK1	B-X
in	B-X
which	B-X
TAK1	B-X
may	B-X
act	B-X
as	B-X
a	B-X
regulatory	B-X
kinase	B-X
of	B-X
IKKs	B-X
.	B-X

IKKalpha	B-Gene_or_gene_product
and	O
IKKbeta	B-Gene_or_gene_product
were	O
coimmunoprecipitated	O
with	O
TAK1	B-Gene_or_gene_product
in	O
the	O
absence	O
of	O
TAB1	B-Gene_or_gene_product
.	O
<EOS>	B-X
We	B-X
recently	B-X
reported	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
transforming	B-X
growth	B-X
factor-beta-activated	B-X
kinase	B-X
1	B-X
(	B-X
TAK1	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinase	B-X
family	B-X
,	B-X
together	B-X
with	B-X
its	B-X
activator	B-X
TAK1-binding	B-X
protein	B-X
1	B-X
(	B-X
TAB1	B-X
)	B-X
stimulates	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanism	B-X
of	B-X
TAK1-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Dominant	B-X
negative	B-X
mutants	B-X
of	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
alpha	B-X
and	B-X
IKKbeta	B-X
inhibited	B-X
TAK1-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
TAK1	B-X
activated	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
TAB1	B-X
.	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
were	B-X
coimmunoprecipitated	B-X
with	B-X
TAK1	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
TAB1	B-X
.	B-X
TAB1-induced	B-X
TAK1	B-X
activation	B-X
promoted	B-X
the	B-X
dissociation	B-X
of	B-X
active	B-X
forms	B-X
of	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
from	B-X
active	B-X
TAK1	B-X
,	B-X
whereas	B-X
the	B-X
IKK	B-X
mutants	B-X
remained	B-X
to	B-X
interact	B-X
with	B-X
active	B-X
TAK1	B-X
.	B-X
Furthermore	B-X
,	B-X
tumor	B-X
necrosis	B-X
factor-alpha	B-X
activated	B-X
endogenous	B-X
TAK1	B-X
,	B-X
and	B-X
the	B-X
kinase-negative	B-X
TAK1	B-X
acted	B-X
as	B-X
a	B-X
dominant	B-X
negative	B-X
inhibitor	B-X
against	B-X
tumor	B-X
necrosis	B-X
factor-alpha-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
These	B-X
results	B-X
demonstrated	B-X
a	B-X
novel	B-X
signaling	B-X
pathway	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
through	B-X
TAK1	B-X
in	B-X
which	B-X
TAK1	B-X
may	B-X
act	B-X
as	B-X
a	B-X
regulatory	B-X
kinase	B-X
of	B-X
IKKs	B-X
.	B-X

TAB1	B-Gene_or_gene_product
-	O
induced	O
TAK1	B-Gene_or_gene_product
activation	O
promoted	O
the	O
dissociation	O
of	O
active	O
forms	O
of	O
IKKalpha	B-Gene_or_gene_product
and	O
IKKbeta	B-Gene_or_gene_product
from	O
active	O
TAK1	B-Gene_or_gene_product
,	O
whereas	O
the	O
IKK	B-Gene_or_gene_product
mutants	O
remained	O
to	O
interact	O
with	O
active	O
TAK1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Several	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinases	B-X
play	B-X
critical	B-X
roles	B-X
in	B-X
nuclear	B-X
factor-kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
activation	B-X
.	B-X
We	B-X
recently	B-X
reported	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
transforming	B-X
growth	B-X
factor-beta-activated	B-X
kinase	B-X
1	B-X
(	B-X
TAK1	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinase	B-X
family	B-X
,	B-X
together	B-X
with	B-X
its	B-X
activator	B-X
TAK1-binding	B-X
protein	B-X
1	B-X
(	B-X
TAB1	B-X
)	B-X
stimulates	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanism	B-X
of	B-X
TAK1-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Dominant	B-X
negative	B-X
mutants	B-X
of	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
alpha	B-X
and	B-X
IKKbeta	B-X
inhibited	B-X
TAK1-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
TAK1	B-X
activated	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
TAB1	B-X
.	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
were	B-X
coimmunoprecipitated	B-X
with	B-X
TAK1	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
TAB1	B-X
.	B-X
TAB1-induced	B-X
TAK1	B-X
activation	B-X
promoted	B-X
the	B-X
dissociation	B-X
of	B-X
active	B-X
forms	B-X
of	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
from	B-X
active	B-X
TAK1	B-X
,	B-X
whereas	B-X
the	B-X
IKK	B-X
mutants	B-X
remained	B-X
to	B-X
interact	B-X
with	B-X
active	B-X
TAK1	B-X
.	B-X
Furthermore	B-X
,	B-X
tumor	B-X
necrosis	B-X
factor-alpha	B-X
activated	B-X
endogenous	B-X
TAK1	B-X
,	B-X
and	B-X
the	B-X
kinase-negative	B-X
TAK1	B-X
acted	B-X
as	B-X
a	B-X
dominant	B-X
negative	B-X
inhibitor	B-X
against	B-X
tumor	B-X
necrosis	B-X
factor-alpha-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
These	B-X
results	B-X
demonstrated	B-X
a	B-X
novel	B-X
signaling	B-X
pathway	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
through	B-X
TAK1	B-X
in	B-X
which	B-X
TAK1	B-X
may	B-X
act	B-X
as	B-X
a	B-X
regulatory	B-X
kinase	B-X
of	B-X
IKKs	B-X
.	B-X

Furthermore	O
,	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
activated	O
endogenous	O
TAK1	B-Gene_or_gene_product
,	O
and	O
the	O
kinase	O
-	O
negative	O
TAK1	B-Gene_or_gene_product
acted	O
as	O
a	O
dominant	O
negative	O
inhibitor	O
against	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
-	O
induced	O
NF	O
-	O
kappaB	O
activation	O
.	O
<EOS>	B-X
Several	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinases	B-X
play	B-X
critical	B-X
roles	B-X
in	B-X
nuclear	B-X
factor-kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
activation	B-X
.	B-X
We	B-X
recently	B-X
reported	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
transforming	B-X
growth	B-X
factor-beta-activated	B-X
kinase	B-X
1	B-X
(	B-X
TAK1	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinase	B-X
family	B-X
,	B-X
together	B-X
with	B-X
its	B-X
activator	B-X
TAK1-binding	B-X
protein	B-X
1	B-X
(	B-X
TAB1	B-X
)	B-X
stimulates	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanism	B-X
of	B-X
TAK1-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Dominant	B-X
negative	B-X
mutants	B-X
of	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
alpha	B-X
and	B-X
IKKbeta	B-X
inhibited	B-X
TAK1-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
TAK1	B-X
activated	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
TAB1	B-X
.	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
were	B-X
coimmunoprecipitated	B-X
with	B-X
TAK1	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
TAB1	B-X
.	B-X
TAB1-induced	B-X
TAK1	B-X
activation	B-X
promoted	B-X
the	B-X
dissociation	B-X
of	B-X
active	B-X
forms	B-X
of	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
from	B-X
active	B-X
TAK1	B-X
,	B-X
whereas	B-X
the	B-X
IKK	B-X
mutants	B-X
remained	B-X
to	B-X
interact	B-X
with	B-X
active	B-X
TAK1	B-X
.	B-X
Furthermore	B-X
,	B-X
tumor	B-X
necrosis	B-X
factor-alpha	B-X
activated	B-X
endogenous	B-X
TAK1	B-X
,	B-X
and	B-X
the	B-X
kinase-negative	B-X
TAK1	B-X
acted	B-X
as	B-X
a	B-X
dominant	B-X
negative	B-X
inhibitor	B-X
against	B-X
tumor	B-X
necrosis	B-X
factor-alpha-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
These	B-X
results	B-X
demonstrated	B-X
a	B-X
novel	B-X
signaling	B-X
pathway	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
through	B-X
TAK1	B-X
in	B-X
which	B-X
TAK1	B-X
may	B-X
act	B-X
as	B-X
a	B-X
regulatory	B-X
kinase	B-X
of	B-X
IKKs	B-X
.	B-X

These	O
results	O
demonstrated	O
a	O
novel	O
signaling	O
pathway	O
to	O
NF	O
-	O
kappaB	O
activation	O
through	O
TAK1	B-Gene_or_gene_product
in	O
which	O
TAK1	B-Gene_or_gene_product
may	O
act	O
as	O
a	O
regulatory	O
kinase	O
of	O
IKKs	B-Gene_or_gene_product
.	O
<EOS>	B-X
Several	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinases	B-X
play	B-X
critical	B-X
roles	B-X
in	B-X
nuclear	B-X
factor-kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
activation	B-X
.	B-X
We	B-X
recently	B-X
reported	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
transforming	B-X
growth	B-X
factor-beta-activated	B-X
kinase	B-X
1	B-X
(	B-X
TAK1	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinase	B-X
family	B-X
,	B-X
together	B-X
with	B-X
its	B-X
activator	B-X
TAK1-binding	B-X
protein	B-X
1	B-X
(	B-X
TAB1	B-X
)	B-X
stimulates	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanism	B-X
of	B-X
TAK1-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Dominant	B-X
negative	B-X
mutants	B-X
of	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
alpha	B-X
and	B-X
IKKbeta	B-X
inhibited	B-X
TAK1-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
TAK1	B-X
activated	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
TAB1	B-X
.	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
were	B-X
coimmunoprecipitated	B-X
with	B-X
TAK1	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
TAB1	B-X
.	B-X
TAB1-induced	B-X
TAK1	B-X
activation	B-X
promoted	B-X
the	B-X
dissociation	B-X
of	B-X
active	B-X
forms	B-X
of	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
from	B-X
active	B-X
TAK1	B-X
,	B-X
whereas	B-X
the	B-X
IKK	B-X
mutants	B-X
remained	B-X
to	B-X
interact	B-X
with	B-X
active	B-X
TAK1	B-X
.	B-X
Furthermore	B-X
,	B-X
tumor	B-X
necrosis	B-X
factor-alpha	B-X
activated	B-X
endogenous	B-X
TAK1	B-X
,	B-X
and	B-X
the	B-X
kinase-negative	B-X
TAK1	B-X
acted	B-X
as	B-X
a	B-X
dominant	B-X
negative	B-X
inhibitor	B-X
against	B-X
tumor	B-X
necrosis	B-X
factor-alpha-induced	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
These	B-X
results	B-X
demonstrated	B-X
a	B-X
novel	B-X
signaling	B-X
pathway	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
through	B-X
TAK1	B-X
in	B-X
which	B-X
TAK1	B-X
may	B-X
act	B-X
as	B-X
a	B-X
regulatory	B-X
kinase	B-X
of	B-X
IKKs	B-X
.	B-X

Phosphorylation	O
of	O
axin	B-Gene_or_gene_product
,	O
a	O
Wnt	B-Gene_or_gene_product
signal	O
negative	O
regulator	O
,	O
by	O
glycogen	B-Gene_or_gene_product
synthase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
regulates	O
its	O
stability	O
.	O
<EOS>	B-X
Axin	B-X
forms	B-X
a	B-X
complex	B-X
with	B-X
glycogen	B-X
synthase	B-X
kinase-3beta	B-X
(	B-X
GSK-3beta	B-X
)	B-X
and	B-X
beta-catenin	B-X
and	B-X
promotes	B-X
GSK-3beta-dependent	B-X
phosphorylation	B-X
of	B-X
beta-catenin	B-X
,	B-X
thereby	B-X
stimulating	B-X
the	B-X
degradation	B-X
of	B-X
beta-catenin	B-X
.	B-X
Because	B-X
GSK-3beta	B-X
also	B-X
phosphorylates	B-X
Axin	B-X
in	B-X
the	B-X
complex	B-X
,	B-X
the	B-X
physiological	B-X
significance	B-X
of	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
was	B-X
examined	B-X
.	B-X
Treatment	B-X
of	B-X
COS	B-X
cells	B-X
with	B-X
LiCl	B-X
,	B-X
a	B-X
GSK-3beta	B-X
inhibitor	B-X
,	B-X
and	B-X
okadaic	B-X
acid	B-X
,	B-X
a	B-X
protein	B-X
phosphatase	B-X
inhibitor	B-X
,	B-X
decreased	B-X
and	B-X
increased	B-X
,	B-X
respectively	B-X
,	B-X
the	B-X
cellular	B-X
protein	B-X
level	B-X
of	B-X
Axin	B-X
.	B-X
Pulse-chase	B-X
analyses	B-X
showed	B-X
that	B-X
the	B-X
phosphorylated	B-X
form	B-X
of	B-X
Axin	B-X
was	B-X
more	B-X
stable	B-X
than	B-X
the	B-X
unphosphorylated	B-X
form	B-X
and	B-X
that	B-X
an	B-X
Axin	B-X
mutant	B-X
,	B-X
in	B-X
which	B-X
the	B-X
possible	B-X
phosphorylation	B-X
sites	B-X
for	B-X
GSK-3beta	B-X
were	B-X
mutated	B-X
,	B-X
exhibited	B-X
a	B-X
shorter	B-X
half-life	B-X
than	B-X
wild	B-X
type	B-X
Axin	B-X
.	B-X
Dvl-1	B-X
,	B-X
which	B-X
was	B-X
genetically	B-X
shown	B-X
to	B-X
function	B-X
upstream	B-X
of	B-X
GSK-3beta	B-X
,	B-X
inhibited	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
by	B-X
GSK-3beta	B-X
in	B-X
vitro	B-X
.	B-X
Furthermore	B-X
,	B-X
Wnt-3a-containing	B-X
conditioned	B-X
medium	B-X
down-regulated	B-X
Axin	B-X
and	B-X
accumulated	B-X
beta-catenin	B-X
in	B-X
L	B-X
cells	B-X
and	B-X
expression	B-X
of	B-X
Dvl-1	B-X
(	B-X
DeltaPDZ	B-X
)	B-X
,	B-X
in	B-X
which	B-X
the	B-X
PDZ	B-X
domain	B-X
was	B-X
deleted	B-X
,	B-X
suppressed	B-X
this	B-X
action	B-X
of	B-X
Wnt-3a	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
is	B-X
important	B-X
for	B-X
the	B-X
regulation	B-X
of	B-X
its	B-X
stability	B-X
and	B-X
that	B-X
Wnt	B-X
down-regulates	B-X
Axin	B-X
through	B-X
Dvl	B-X
.	B-X

Axin	B-Gene_or_gene_product
forms	O
a	O
complex	O
with	O
glycogen	B-Gene_or_gene_product
synthase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
(	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
)	O
and	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
and	O
promotes	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
-	O
dependent	O
phosphorylation	O
of	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
,	O
thereby	O
stimulating	O
the	O
degradation	O
of	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
.	O
<EOS>	B-X
Axin	B-X
forms	B-X
a	B-X
complex	B-X
with	B-X
glycogen	B-X
synthase	B-X
kinase-3beta	B-X
(	B-X
GSK-3beta	B-X
)	B-X
and	B-X
beta-catenin	B-X
and	B-X
promotes	B-X
GSK-3beta-dependent	B-X
phosphorylation	B-X
of	B-X
beta-catenin	B-X
,	B-X
thereby	B-X
stimulating	B-X
the	B-X
degradation	B-X
of	B-X
beta-catenin	B-X
.	B-X
Because	B-X
GSK-3beta	B-X
also	B-X
phosphorylates	B-X
Axin	B-X
in	B-X
the	B-X
complex	B-X
,	B-X
the	B-X
physiological	B-X
significance	B-X
of	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
was	B-X
examined	B-X
.	B-X
Treatment	B-X
of	B-X
COS	B-X
cells	B-X
with	B-X
LiCl	B-X
,	B-X
a	B-X
GSK-3beta	B-X
inhibitor	B-X
,	B-X
and	B-X
okadaic	B-X
acid	B-X
,	B-X
a	B-X
protein	B-X
phosphatase	B-X
inhibitor	B-X
,	B-X
decreased	B-X
and	B-X
increased	B-X
,	B-X
respectively	B-X
,	B-X
the	B-X
cellular	B-X
protein	B-X
level	B-X
of	B-X
Axin	B-X
.	B-X
Pulse-chase	B-X
analyses	B-X
showed	B-X
that	B-X
the	B-X
phosphorylated	B-X
form	B-X
of	B-X
Axin	B-X
was	B-X
more	B-X
stable	B-X
than	B-X
the	B-X
unphosphorylated	B-X
form	B-X
and	B-X
that	B-X
an	B-X
Axin	B-X
mutant	B-X
,	B-X
in	B-X
which	B-X
the	B-X
possible	B-X
phosphorylation	B-X
sites	B-X
for	B-X
GSK-3beta	B-X
were	B-X
mutated	B-X
,	B-X
exhibited	B-X
a	B-X
shorter	B-X
half-life	B-X
than	B-X
wild	B-X
type	B-X
Axin	B-X
.	B-X
Dvl-1	B-X
,	B-X
which	B-X
was	B-X
genetically	B-X
shown	B-X
to	B-X
function	B-X
upstream	B-X
of	B-X
GSK-3beta	B-X
,	B-X
inhibited	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
by	B-X
GSK-3beta	B-X
in	B-X
vitro	B-X
.	B-X
Furthermore	B-X
,	B-X
Wnt-3a-containing	B-X
conditioned	B-X
medium	B-X
down-regulated	B-X
Axin	B-X
and	B-X
accumulated	B-X
beta-catenin	B-X
in	B-X
L	B-X
cells	B-X
and	B-X
expression	B-X
of	B-X
Dvl-1	B-X
(	B-X
DeltaPDZ	B-X
)	B-X
,	B-X
in	B-X
which	B-X
the	B-X
PDZ	B-X
domain	B-X
was	B-X
deleted	B-X
,	B-X
suppressed	B-X
this	B-X
action	B-X
of	B-X
Wnt-3a	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
is	B-X
important	B-X
for	B-X
the	B-X
regulation	B-X
of	B-X
its	B-X
stability	B-X
and	B-X
that	B-X
Wnt	B-X
down-regulates	B-X
Axin	B-X
through	B-X
Dvl	B-X
.	B-X

Because	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
also	O
phosphorylates	O
Axin	B-Gene_or_gene_product
in	O
the	O
complex	O
,	O
the	O
physiological	O
significance	O
of	O
the	O
phosphorylation	O
of	O
Axin	B-Gene_or_gene_product
was	O
examined	O
.	O
<EOS>	B-X
Axin	B-X
forms	B-X
a	B-X
complex	B-X
with	B-X
glycogen	B-X
synthase	B-X
kinase-3beta	B-X
(	B-X
GSK-3beta	B-X
)	B-X
and	B-X
beta-catenin	B-X
and	B-X
promotes	B-X
GSK-3beta-dependent	B-X
phosphorylation	B-X
of	B-X
beta-catenin	B-X
,	B-X
thereby	B-X
stimulating	B-X
the	B-X
degradation	B-X
of	B-X
beta-catenin	B-X
.	B-X
Because	B-X
GSK-3beta	B-X
also	B-X
phosphorylates	B-X
Axin	B-X
in	B-X
the	B-X
complex	B-X
,	B-X
the	B-X
physiological	B-X
significance	B-X
of	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
was	B-X
examined	B-X
.	B-X
Treatment	B-X
of	B-X
COS	B-X
cells	B-X
with	B-X
LiCl	B-X
,	B-X
a	B-X
GSK-3beta	B-X
inhibitor	B-X
,	B-X
and	B-X
okadaic	B-X
acid	B-X
,	B-X
a	B-X
protein	B-X
phosphatase	B-X
inhibitor	B-X
,	B-X
decreased	B-X
and	B-X
increased	B-X
,	B-X
respectively	B-X
,	B-X
the	B-X
cellular	B-X
protein	B-X
level	B-X
of	B-X
Axin	B-X
.	B-X
Pulse-chase	B-X
analyses	B-X
showed	B-X
that	B-X
the	B-X
phosphorylated	B-X
form	B-X
of	B-X
Axin	B-X
was	B-X
more	B-X
stable	B-X
than	B-X
the	B-X
unphosphorylated	B-X
form	B-X
and	B-X
that	B-X
an	B-X
Axin	B-X
mutant	B-X
,	B-X
in	B-X
which	B-X
the	B-X
possible	B-X
phosphorylation	B-X
sites	B-X
for	B-X
GSK-3beta	B-X
were	B-X
mutated	B-X
,	B-X
exhibited	B-X
a	B-X
shorter	B-X
half-life	B-X
than	B-X
wild	B-X
type	B-X
Axin	B-X
.	B-X
Dvl-1	B-X
,	B-X
which	B-X
was	B-X
genetically	B-X
shown	B-X
to	B-X
function	B-X
upstream	B-X
of	B-X
GSK-3beta	B-X
,	B-X
inhibited	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
by	B-X
GSK-3beta	B-X
in	B-X
vitro	B-X
.	B-X
Furthermore	B-X
,	B-X
Wnt-3a-containing	B-X
conditioned	B-X
medium	B-X
down-regulated	B-X
Axin	B-X
and	B-X
accumulated	B-X
beta-catenin	B-X
in	B-X
L	B-X
cells	B-X
and	B-X
expression	B-X
of	B-X
Dvl-1	B-X
(	B-X
DeltaPDZ	B-X
)	B-X
,	B-X
in	B-X
which	B-X
the	B-X
PDZ	B-X
domain	B-X
was	B-X
deleted	B-X
,	B-X
suppressed	B-X
this	B-X
action	B-X
of	B-X
Wnt-3a	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
is	B-X
important	B-X
for	B-X
the	B-X
regulation	B-X
of	B-X
its	B-X
stability	B-X
and	B-X
that	B-X
Wnt	B-X
down-regulates	B-X
Axin	B-X
through	B-X
Dvl	B-X
.	B-X

Treatment	O
of	O
COS	O
cells	O
with	O
LiCl	O
,	O
a	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
inhibitor	O
,	O
and	O
okadaic	O
acid	O
,	O
a	O
protein	O
phosphatase	O
inhibitor	O
,	O
decreased	O
and	O
increased	O
,	O
respectively	O
,	O
the	O
cellular	O
protein	O
level	O
of	O
Axin	B-Gene_or_gene_product
.	O
<EOS>	B-X
Axin	B-X
forms	B-X
a	B-X
complex	B-X
with	B-X
glycogen	B-X
synthase	B-X
kinase-3beta	B-X
(	B-X
GSK-3beta	B-X
)	B-X
and	B-X
beta-catenin	B-X
and	B-X
promotes	B-X
GSK-3beta-dependent	B-X
phosphorylation	B-X
of	B-X
beta-catenin	B-X
,	B-X
thereby	B-X
stimulating	B-X
the	B-X
degradation	B-X
of	B-X
beta-catenin	B-X
.	B-X
Because	B-X
GSK-3beta	B-X
also	B-X
phosphorylates	B-X
Axin	B-X
in	B-X
the	B-X
complex	B-X
,	B-X
the	B-X
physiological	B-X
significance	B-X
of	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
was	B-X
examined	B-X
.	B-X
Treatment	B-X
of	B-X
COS	B-X
cells	B-X
with	B-X
LiCl	B-X
,	B-X
a	B-X
GSK-3beta	B-X
inhibitor	B-X
,	B-X
and	B-X
okadaic	B-X
acid	B-X
,	B-X
a	B-X
protein	B-X
phosphatase	B-X
inhibitor	B-X
,	B-X
decreased	B-X
and	B-X
increased	B-X
,	B-X
respectively	B-X
,	B-X
the	B-X
cellular	B-X
protein	B-X
level	B-X
of	B-X
Axin	B-X
.	B-X
Pulse-chase	B-X
analyses	B-X
showed	B-X
that	B-X
the	B-X
phosphorylated	B-X
form	B-X
of	B-X
Axin	B-X
was	B-X
more	B-X
stable	B-X
than	B-X
the	B-X
unphosphorylated	B-X
form	B-X
and	B-X
that	B-X
an	B-X
Axin	B-X
mutant	B-X
,	B-X
in	B-X
which	B-X
the	B-X
possible	B-X
phosphorylation	B-X
sites	B-X
for	B-X
GSK-3beta	B-X
were	B-X
mutated	B-X
,	B-X
exhibited	B-X
a	B-X
shorter	B-X
half-life	B-X
than	B-X
wild	B-X
type	B-X
Axin	B-X
.	B-X
Dvl-1	B-X
,	B-X
which	B-X
was	B-X
genetically	B-X
shown	B-X
to	B-X
function	B-X
upstream	B-X
of	B-X
GSK-3beta	B-X
,	B-X
inhibited	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
by	B-X
GSK-3beta	B-X
in	B-X
vitro	B-X
.	B-X
Furthermore	B-X
,	B-X
Wnt-3a-containing	B-X
conditioned	B-X
medium	B-X
down-regulated	B-X
Axin	B-X
and	B-X
accumulated	B-X
beta-catenin	B-X
in	B-X
L	B-X
cells	B-X
and	B-X
expression	B-X
of	B-X
Dvl-1	B-X
(	B-X
DeltaPDZ	B-X
)	B-X
,	B-X
in	B-X
which	B-X
the	B-X
PDZ	B-X
domain	B-X
was	B-X
deleted	B-X
,	B-X
suppressed	B-X
this	B-X
action	B-X
of	B-X
Wnt-3a	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
is	B-X
important	B-X
for	B-X
the	B-X
regulation	B-X
of	B-X
its	B-X
stability	B-X
and	B-X
that	B-X
Wnt	B-X
down-regulates	B-X
Axin	B-X
through	B-X
Dvl	B-X
.	B-X

Pulse	O
-	O
chase	O
analyses	O
showed	O
that	O
the	O
phosphorylated	O
form	O
of	O
Axin	B-Gene_or_gene_product
was	O
more	O
stable	O
than	O
the	O
unphosphorylated	O
form	O
and	O
that	O
an	O
Axin	B-Gene_or_gene_product
mutant	O
,	O
in	O
which	O
the	O
possible	O
phosphorylation	O
sites	O
for	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
were	O
mutated	O
,	O
exhibited	O
a	O
shorter	O
half	O
-	O
life	O
than	O
wild	O
type	O
Axin	B-Gene_or_gene_product
.	O

Dvl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
which	O
was	O
genetically	O
shown	O
to	O
function	O
upstream	O
of	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
,	O
inhibited	O
the	O
phosphorylation	O
of	O
Axin	B-Gene_or_gene_product
by	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
in	O
vitro	O
.	O
<EOS>	B-X
Axin	B-X
forms	B-X
a	B-X
complex	B-X
with	B-X
glycogen	B-X
synthase	B-X
kinase-3beta	B-X
(	B-X
GSK-3beta	B-X
)	B-X
and	B-X
beta-catenin	B-X
and	B-X
promotes	B-X
GSK-3beta-dependent	B-X
phosphorylation	B-X
of	B-X
beta-catenin	B-X
,	B-X
thereby	B-X
stimulating	B-X
the	B-X
degradation	B-X
of	B-X
beta-catenin	B-X
.	B-X
Because	B-X
GSK-3beta	B-X
also	B-X
phosphorylates	B-X
Axin	B-X
in	B-X
the	B-X
complex	B-X
,	B-X
the	B-X
physiological	B-X
significance	B-X
of	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
was	B-X
examined	B-X
.	B-X
Treatment	B-X
of	B-X
COS	B-X
cells	B-X
with	B-X
LiCl	B-X
,	B-X
a	B-X
GSK-3beta	B-X
inhibitor	B-X
,	B-X
and	B-X
okadaic	B-X
acid	B-X
,	B-X
a	B-X
protein	B-X
phosphatase	B-X
inhibitor	B-X
,	B-X
decreased	B-X
and	B-X
increased	B-X
,	B-X
respectively	B-X
,	B-X
the	B-X
cellular	B-X
protein	B-X
level	B-X
of	B-X
Axin	B-X
.	B-X
Pulse-chase	B-X
analyses	B-X
showed	B-X
that	B-X
the	B-X
phosphorylated	B-X
form	B-X
of	B-X
Axin	B-X
was	B-X
more	B-X
stable	B-X
than	B-X
the	B-X
unphosphorylated	B-X
form	B-X
and	B-X
that	B-X
an	B-X
Axin	B-X
mutant	B-X
,	B-X
in	B-X
which	B-X
the	B-X
possible	B-X
phosphorylation	B-X
sites	B-X
for	B-X
GSK-3beta	B-X
were	B-X
mutated	B-X
,	B-X
exhibited	B-X
a	B-X
shorter	B-X
half-life	B-X
than	B-X
wild	B-X
type	B-X
Axin	B-X
.	B-X
Dvl-1	B-X
,	B-X
which	B-X
was	B-X
genetically	B-X
shown	B-X
to	B-X
function	B-X
upstream	B-X
of	B-X
GSK-3beta	B-X
,	B-X
inhibited	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
by	B-X
GSK-3beta	B-X
in	B-X
vitro	B-X
.	B-X
Furthermore	B-X
,	B-X
Wnt-3a-containing	B-X
conditioned	B-X
medium	B-X
down-regulated	B-X
Axin	B-X
and	B-X
accumulated	B-X
beta-catenin	B-X
in	B-X
L	B-X
cells	B-X
and	B-X
expression	B-X
of	B-X
Dvl-1	B-X
(	B-X
DeltaPDZ	B-X
)	B-X
,	B-X
in	B-X
which	B-X
the	B-X
PDZ	B-X
domain	B-X
was	B-X
deleted	B-X
,	B-X
suppressed	B-X
this	B-X
action	B-X
of	B-X
Wnt-3a	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
is	B-X
important	B-X
for	B-X
the	B-X
regulation	B-X
of	B-X
its	B-X
stability	B-X
and	B-X
that	B-X
Wnt	B-X
down-regulates	B-X
Axin	B-X
through	B-X
Dvl	B-X
.	B-X

Furthermore	O
,	O
Wnt	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3a	I-Gene_or_gene_product
-	O
containing	O
conditioned	O
medium	O
down	O
-	O
regulated	O
Axin	B-Gene_or_gene_product
and	O
accumulated	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
in	O
L	O
cells	O
and	O
expression	O
of	O
Dvl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	I-Gene_or_gene_product
DeltaPDZ	I-Gene_or_gene_product
)	I-Gene_or_gene_product
,	O
in	O
which	O
the	O
PDZ	O
domain	O
was	O
deleted	O
,	O
suppressed	O
this	O
action	O
of	O
Wnt	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3a	I-Gene_or_gene_product
.	O

These	O
results	O
suggest	O
that	O
the	O
phosphorylation	O
of	O
Axin	B-Gene_or_gene_product
is	O
important	O
for	O
the	O
regulation	O
of	O
its	O
stability	O
and	O
that	O
Wnt	B-Gene_or_gene_product
down	O
-	O
regulates	O
Axin	B-Gene_or_gene_product
through	O
Dvl	B-Gene_or_gene_product
.	O
<EOS>	B-X
Axin	B-X
forms	B-X
a	B-X
complex	B-X
with	B-X
glycogen	B-X
synthase	B-X
kinase-3beta	B-X
(	B-X
GSK-3beta	B-X
)	B-X
and	B-X
beta-catenin	B-X
and	B-X
promotes	B-X
GSK-3beta-dependent	B-X
phosphorylation	B-X
of	B-X
beta-catenin	B-X
,	B-X
thereby	B-X
stimulating	B-X
the	B-X
degradation	B-X
of	B-X
beta-catenin	B-X
.	B-X
Because	B-X
GSK-3beta	B-X
also	B-X
phosphorylates	B-X
Axin	B-X
in	B-X
the	B-X
complex	B-X
,	B-X
the	B-X
physiological	B-X
significance	B-X
of	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
was	B-X
examined	B-X
.	B-X
Treatment	B-X
of	B-X
COS	B-X
cells	B-X
with	B-X
LiCl	B-X
,	B-X
a	B-X
GSK-3beta	B-X
inhibitor	B-X
,	B-X
and	B-X
okadaic	B-X
acid	B-X
,	B-X
a	B-X
protein	B-X
phosphatase	B-X
inhibitor	B-X
,	B-X
decreased	B-X
and	B-X
increased	B-X
,	B-X
respectively	B-X
,	B-X
the	B-X
cellular	B-X
protein	B-X
level	B-X
of	B-X
Axin	B-X
.	B-X
Pulse-chase	B-X
analyses	B-X
showed	B-X
that	B-X
the	B-X
phosphorylated	B-X
form	B-X
of	B-X
Axin	B-X
was	B-X
more	B-X
stable	B-X
than	B-X
the	B-X
unphosphorylated	B-X
form	B-X
and	B-X
that	B-X
an	B-X
Axin	B-X
mutant	B-X
,	B-X
in	B-X
which	B-X
the	B-X
possible	B-X
phosphorylation	B-X
sites	B-X
for	B-X
GSK-3beta	B-X
were	B-X
mutated	B-X
,	B-X
exhibited	B-X
a	B-X
shorter	B-X
half-life	B-X
than	B-X
wild	B-X
type	B-X
Axin	B-X
.	B-X
Dvl-1	B-X
,	B-X
which	B-X
was	B-X
genetically	B-X
shown	B-X
to	B-X
function	B-X
upstream	B-X
of	B-X
GSK-3beta	B-X
,	B-X
inhibited	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
by	B-X
GSK-3beta	B-X
in	B-X
vitro	B-X
.	B-X
Furthermore	B-X
,	B-X
Wnt-3a-containing	B-X
conditioned	B-X
medium	B-X
down-regulated	B-X
Axin	B-X
and	B-X
accumulated	B-X
beta-catenin	B-X
in	B-X
L	B-X
cells	B-X
and	B-X
expression	B-X
of	B-X
Dvl-1	B-X
(	B-X
DeltaPDZ	B-X
)	B-X
,	B-X
in	B-X
which	B-X
the	B-X
PDZ	B-X
domain	B-X
was	B-X
deleted	B-X
,	B-X
suppressed	B-X
this	B-X
action	B-X
of	B-X
Wnt-3a	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
phosphorylation	B-X
of	B-X
Axin	B-X
is	B-X
important	B-X
for	B-X
the	B-X
regulation	B-X
of	B-X
its	B-X
stability	B-X
and	B-X
that	B-X
Wnt	B-X
down-regulates	B-X
Axin	B-X
through	B-X
Dvl	B-X
.	B-X

Activation	O
of	O
p53	B-Gene_or_gene_product
and	O
its	O
target	O
genes	O
p21	B-Gene_or_gene_product
(	O
WAF1	B-Gene_or_gene_product
/	O
Cip1	B-Gene_or_gene_product
)	O
and	O
PAG608	B-Gene_or_gene_product
/	O
Wig	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
in	O
ischemic	O
preconditioning	O
.	O
<EOS>	B-X
A	B-X
brief	B-X
,	B-X
3	B-X
min	B-X
period	B-X
of	B-X
global	B-X
forebrain	B-X
ischemia	B-X
in	B-X
the	B-X
rat	B-X
,	B-X
induced	B-X
by	B-X
bilateral	B-X
common	B-X
carotid	B-X
occlusion	B-X
combined	B-X
with	B-X
hypotension	B-X
,	B-X
confers	B-X
resistance	B-X
to	B-X
hippocampal	B-X
pyramidal	B-X
neurons	B-X
against	B-X
a	B-X
subsequent	B-X
10	B-X
min	B-X
ischemia	B-X
,	B-X
which	B-X
is	B-X
normally	B-X
lethal	B-X
to	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
molecular	B-X
mechanisms	B-X
underlying	B-X
this	B-X
ischemic	B-X
preconditioning	B-X
,	B-X
or	B-X
tolerance	B-X
,	B-X
are	B-X
poorly	B-X
understood	B-X
.	B-X
The	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
a	B-X
transcription	B-X
factor	B-X
implicated	B-X
in	B-X
neuronal	B-X
death	B-X
following	B-X
various	B-X
insults	B-X
,	B-X
including	B-X
cerebral	B-X
ischemia	B-X
.	B-X
p53	B-X
is	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
cellular	B-X
stress	B-X
,	B-X
e.g	B-X
.	B-X
Using	B-X
in	B-X
situ	B-X
hybridization	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
hippocampal	B-X
mRNA	B-X
expression	B-X
of	B-X
p53	B-X
,	B-X
and	B-X
two	B-X
of	B-X
its	B-X
target	B-X
genes	B-X
,	B-X
p21	B-X
(	B-X
WAF1/Cip1	B-X
)	B-X
and	B-X
the	B-X
recently	B-X
cloned	B-X
PAG608/Wig-1	B-X
,	B-X
in	B-X
a	B-X
two-vessel	B-X
occlusion	B-X
model	B-X
of	B-X
ischemic	B-X
preconditioning	B-X
.	B-X
We	B-X
also	B-X
evaluated	B-X
changes	B-X
in	B-X
the	B-X
protein	B-X
levels	B-X
of	B-X
p53	B-X
and	B-X
PAG608/Wig-1	B-X
using	B-X
immunohistochemistry	B-X
.	B-X
The	B-X
mRNA	B-X
levels	B-X
of	B-X
all	B-X
three	B-X
genes	B-X
increased	B-X
in	B-X
the	B-X
ischemia	B-X
sensitive	B-X
CA1	B-X
region	B-X
both	B-X
following	B-X
3	B-X
min	B-X
(	B-X
non-lethal	B-X
)	B-X
preconditioning	B-X
and	B-X
10	B-X
min	B-X
of	B-X
(	B-X
lethal	B-X
)	B-X
nonconditioned	B-X
ischemia	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
after	B-X
10	B-X
min	B-X
of	B-X
ischemia	B-X
preconditioned	B-X
by	B-X
a	B-X
3	B-X
min	B-X
ischemic	B-X
insult	B-X
48	B-X
h	B-X
earlier	B-X
,	B-X
no	B-X
upregulation	B-X
of	B-X
these	B-X
genes	B-X
was	B-X
detected	B-X
in	B-X
the	B-X
CA1	B-X
.	B-X
Following	B-X
10	B-X
min	B-X
of	B-X
nonconditioned	B-X
ischemia	B-X
,	B-X
increased	B-X
neuronal	B-X
immunostaining	B-X
of	B-X
p53	B-X
and	B-X
PAG608/Wig-1	B-X
was	B-X
observed	B-X
in	B-X
the	B-X
hippocampus	B-X
,	B-X
which	B-X
was	B-X
less	B-X
pronounced	B-X
following	B-X
3	B-X
min	B-X
of	B-X
preconditioning	B-X
ischemia	B-X
and	B-X
10	B-X
min	B-X
of	B-X
preconditioned	B-X
ischemia	B-X
.	B-X
Our	B-X
results	B-X
demonstrate	B-X
that	B-X
activation	B-X
of	B-X
p53	B-X
and	B-X
its	B-X
response	B-X
genes	B-X
p21	B-X
(	B-X
WAF1/Cip1	B-X
)	B-X
and	B-X
PAG608/Wig-1	B-X
occurs	B-X
in	B-X
the	B-X
brain	B-X
following	B-X
lethal	B-X
as	B-X
well	B-X
as	B-X
non-lethal	B-X
ischemic	B-X
insults	B-X
,	B-X
and	B-X
that	B-X
ischemic	B-X
preconditioning	B-X
markedly	B-X
diminishes	B-X
this	B-X
activation	B-X
.	B-X

A	O
brief	O
,	O
3	O
min	O
period	O
of	O
global	O
forebrain	O
ischemia	O
in	O
the	O
rat	O
,	O
induced	O
by	O
bilateral	O
common	O
carotid	O
occlusion	O
combined	O
with	O
hypotension	O
,	O
confers	O
resistance	O
to	O
hippocampal	O
pyramidal	O
neurons	O
against	O
a	O
subsequent	O
10	O
min	O
ischemia	O
,	O
which	O
is	O
normally	O
lethal	O
to	O
these	O
cells	O
.	O
<EOS>	B-X
A	B-X
brief	B-X
,	B-X
3	B-X
min	B-X
period	B-X
of	B-X
global	B-X
forebrain	B-X
ischemia	B-X
in	B-X
the	B-X
rat	B-X
,	B-X
induced	B-X
by	B-X
bilateral	B-X
common	B-X
carotid	B-X
occlusion	B-X
combined	B-X
with	B-X
hypotension	B-X
,	B-X
confers	B-X
resistance	B-X
to	B-X
hippocampal	B-X
pyramidal	B-X
neurons	B-X
against	B-X
a	B-X
subsequent	B-X
10	B-X
min	B-X
ischemia	B-X
,	B-X
which	B-X
is	B-X
normally	B-X
lethal	B-X
to	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
a	B-X
transcription	B-X
factor	B-X
implicated	B-X
in	B-X
neuronal	B-X
death	B-X
following	B-X
various	B-X
insults	B-X
,	B-X
including	B-X
cerebral	B-X
ischemia	B-X
.	B-X
p53	B-X
is	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
cellular	B-X
stress	B-X
,	B-X
e.g	B-X
.	B-X
Using	B-X
in	B-X
situ	B-X
hybridization	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
hippocampal	B-X
mRNA	B-X
expression	B-X
of	B-X
p53	B-X
,	B-X
and	B-X
two	B-X
of	B-X
its	B-X
target	B-X
genes	B-X
,	B-X
p21	B-X
(	B-X
WAF1/Cip1	B-X
)	B-X
and	B-X
the	B-X
recently	B-X
cloned	B-X
PAG608/Wig-1	B-X
,	B-X
in	B-X
a	B-X
two-vessel	B-X
occlusion	B-X
model	B-X
of	B-X
ischemic	B-X
preconditioning	B-X
.	B-X
We	B-X
also	B-X
evaluated	B-X
changes	B-X
in	B-X
the	B-X
protein	B-X
levels	B-X
of	B-X
p53	B-X
and	B-X
PAG608/Wig-1	B-X
using	B-X
immunohistochemistry	B-X
.	B-X
The	B-X
mRNA	B-X
levels	B-X
of	B-X
all	B-X
three	B-X
genes	B-X
increased	B-X
in	B-X
the	B-X
ischemia	B-X
sensitive	B-X
CA1	B-X
region	B-X
both	B-X
following	B-X
3	B-X
min	B-X
(	B-X
non-lethal	B-X
)	B-X
preconditioning	B-X
and	B-X
10	B-X
min	B-X
of	B-X
(	B-X
lethal	B-X
)	B-X
nonconditioned	B-X
ischemia	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
after	B-X
10	B-X
min	B-X
of	B-X
ischemia	B-X
preconditioned	B-X
by	B-X
a	B-X
3	B-X
min	B-X
ischemic	B-X
insult	B-X
48	B-X
h	B-X
earlier	B-X
,	B-X
no	B-X
upregulation	B-X
of	B-X
these	B-X
genes	B-X
was	B-X
detected	B-X
in	B-X
the	B-X
CA1	B-X
.	B-X
Following	B-X
10	B-X
min	B-X
of	B-X
nonconditioned	B-X
ischemia	B-X
,	B-X
increased	B-X
neuronal	B-X
immunostaining	B-X
of	B-X
p53	B-X
and	B-X
PAG608/Wig-1	B-X
was	B-X
observed	B-X
in	B-X
the	B-X
hippocampus	B-X
,	B-X
which	B-X
was	B-X
less	B-X
pronounced	B-X
following	B-X
3	B-X
min	B-X
of	B-X
preconditioning	B-X
ischemia	B-X
and	B-X
10	B-X
min	B-X
of	B-X
preconditioned	B-X
ischemia	B-X
.	B-X
Our	B-X
results	B-X
demonstrate	B-X
that	B-X
activation	B-X
of	B-X
p53	B-X
and	B-X
its	B-X
response	B-X
genes	B-X
p21	B-X
(	B-X
WAF1/Cip1	B-X
)	B-X
and	B-X
PAG608/Wig-1	B-X
occurs	B-X
in	B-X
the	B-X
brain	B-X
following	B-X
lethal	B-X
as	B-X
well	B-X
as	B-X
non-lethal	B-X
ischemic	B-X
insults	B-X
,	B-X
and	B-X
that	B-X
ischemic	B-X
preconditioning	B-X
markedly	B-X
diminishes	B-X
this	B-X
activation	B-X
.	B-X

The	O
molecular	O
mechanisms	O
underlying	O
this	O
ischemic	O
preconditioning	O
,	O
or	O
tolerance	O
,	O
are	O
poorly	O
understood	O
.	O
<EOS>	B-X
Although	B-X
it	B-X
is	B-X
now	B-X
accepted	B-X
that	B-X
the	B-X
central	B-X
nervous	B-X
system	B-X
undergoes	B-X
constant	B-X
immune	B-X
surveillance	B-X
that	B-X
takes	B-X
place	B-X
within	B-X
the	B-X
meningeal	B-X
compartment	B-X
,	B-X
the	B-X
mechanisms	B-X
governing	B-X
the	B-X
entrance	B-X
and	B-X
exit	B-X
of	B-X
immune	B-X
cells	B-X
from	B-X
the	B-X
central	B-X
nervous	B-X
system	B-X
remain	B-X
poorly	B-X
understood	B-X
.	B-X
These	B-X
structures	B-X
express	B-X
all	B-X
of	B-X
the	B-X
molecular	B-X
hallmarks	B-X
of	B-X
lymphatic	B-X
endothelial	B-X
cells	B-X
,	B-X
are	B-X
able	B-X
to	B-X
carry	B-X
both	B-X
fluid	B-X
and	B-X
immune	B-X
cells	B-X
from	B-X
the	B-X
cerebrospinal	B-X
fluid	B-X
,	B-X
and	B-X
are	B-X
connected	B-X
to	B-X
the	B-X
deep	B-X
cervical	B-X
lymph	B-X
nodes	B-X
.	B-X
To	B-X
summarize	B-X
the	B-X
literature	B-X
on	B-X
immunomodulatory	B-X
effects	B-X
of	B-X
breast	B-X
milk	B-X
on	B-X
sensitization	B-X
and	B-X
possible	B-X
mechanisms	B-X
of	B-X
action	B-X
.	B-X
The	B-X
molecular	B-X
basis	B-X
of	B-X
this	B-X
dichotomy	B-X
is	B-X
poorly	B-X
understood	B-X
.	B-X
Genomic	B-X
analysis	B-X
of	B-X
dysfunctional	B-X
HBV-specific	B-X
CD8+	B-X
T	B-X
cells	B-X
in	B-X
CHB	B-X
patients	B-X
and	B-X
various	B-X
mouse	B-X
models	B-X
suggest	B-X
that	B-X
multifaceted	B-X
mechanisms	B-X
including	B-X
negative	B-X
signaling	B-X
and	B-X
metabolic	B-X
abnormalities	B-X
cooperatively	B-X
establish	B-X
CD8+	B-X
T	B-X
cell	B-X
dysfunction	B-X
.	B-X

The	O
tumor	O
suppressor	O
p53	B-Gene_or_gene_product
is	O
a	O
transcription	O
factor	O
implicated	O
in	O
neuronal	O
death	O
following	O
various	O
insults	O
,	O
including	O
cerebral	O
ischemia	O
.	O
<EOS>	B-X
A	B-X
brief	B-X
,	B-X
3	B-X
min	B-X
period	B-X
of	B-X
global	B-X
forebrain	B-X
ischemia	B-X
in	B-X
the	B-X
rat	B-X
,	B-X
induced	B-X
by	B-X
bilateral	B-X
common	B-X
carotid	B-X
occlusion	B-X
combined	B-X
with	B-X
hypotension	B-X
,	B-X
confers	B-X
resistance	B-X
to	B-X
hippocampal	B-X
pyramidal	B-X
neurons	B-X
against	B-X
a	B-X
subsequent	B-X
10	B-X
min	B-X
ischemia	B-X
,	B-X
which	B-X
is	B-X
normally	B-X
lethal	B-X
to	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
a	B-X
transcription	B-X
factor	B-X
implicated	B-X
in	B-X
neuronal	B-X
death	B-X
following	B-X
various	B-X
insults	B-X
,	B-X
including	B-X
cerebral	B-X
ischemia	B-X
.	B-X
p53	B-X
is	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
cellular	B-X
stress	B-X
,	B-X
e.g	B-X
.	B-X
Using	B-X
in	B-X
situ	B-X
hybridization	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
hippocampal	B-X
mRNA	B-X
expression	B-X
of	B-X
p53	B-X
,	B-X
and	B-X
two	B-X
of	B-X
its	B-X
target	B-X
genes	B-X
,	B-X
p21	B-X
(	B-X
WAF1/Cip1	B-X
)	B-X
and	B-X
the	B-X
recently	B-X
cloned	B-X
PAG608/Wig-1	B-X
,	B-X
in	B-X
a	B-X
two-vessel	B-X
occlusion	B-X
model	B-X
of	B-X
ischemic	B-X
preconditioning	B-X
.	B-X
We	B-X
also	B-X
evaluated	B-X
changes	B-X
in	B-X
the	B-X
protein	B-X
levels	B-X
of	B-X
p53	B-X
and	B-X
PAG608/Wig-1	B-X
using	B-X
immunohistochemistry	B-X
.	B-X
The	B-X
mRNA	B-X
levels	B-X
of	B-X
all	B-X
three	B-X
genes	B-X
increased	B-X
in	B-X
the	B-X
ischemia	B-X
sensitive	B-X
CA1	B-X
region	B-X
both	B-X
following	B-X
3	B-X
min	B-X
(	B-X
non-lethal	B-X
)	B-X
preconditioning	B-X
and	B-X
10	B-X
min	B-X
of	B-X
(	B-X
lethal	B-X
)	B-X
nonconditioned	B-X
ischemia	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
after	B-X
10	B-X
min	B-X
of	B-X
ischemia	B-X
preconditioned	B-X
by	B-X
a	B-X
3	B-X
min	B-X
ischemic	B-X
insult	B-X
48	B-X
h	B-X
earlier	B-X
,	B-X
no	B-X
upregulation	B-X
of	B-X
these	B-X
genes	B-X
was	B-X
detected	B-X
in	B-X
the	B-X
CA1	B-X
.	B-X
Following	B-X
10	B-X
min	B-X
of	B-X
nonconditioned	B-X
ischemia	B-X
,	B-X
increased	B-X
neuronal	B-X
immunostaining	B-X
of	B-X
p53	B-X
and	B-X
PAG608/Wig-1	B-X
was	B-X
observed	B-X
in	B-X
the	B-X
hippocampus	B-X
,	B-X
which	B-X
was	B-X
less	B-X
pronounced	B-X
following	B-X
3	B-X
min	B-X
of	B-X
preconditioning	B-X
ischemia	B-X
and	B-X
10	B-X
min	B-X
of	B-X
preconditioned	B-X
ischemia	B-X
.	B-X
Our	B-X
results	B-X
demonstrate	B-X
that	B-X
activation	B-X
of	B-X
p53	B-X
and	B-X
its	B-X
response	B-X
genes	B-X
p21	B-X
(	B-X
WAF1/Cip1	B-X
)	B-X
and	B-X
PAG608/Wig-1	B-X
occurs	B-X
in	B-X
the	B-X
brain	B-X
following	B-X
lethal	B-X
as	B-X
well	B-X
as	B-X
non-lethal	B-X
ischemic	B-X
insults	B-X
,	B-X
and	B-X
that	B-X
ischemic	B-X
preconditioning	B-X
markedly	B-X
diminishes	B-X
this	B-X
activation	B-X
.	B-X

p53	B-Gene_or_gene_product
is	O
activated	O
in	O
response	O
to	O
cellular	O
stress	O
,	O
e	O
.	O
g	O
.	O
hypoxia	O
and	O
DNA	O
damage	O
.	O

Using	O
in	O
situ	O
hybridization	O
,	O
we	O
investigated	O
the	O
hippocampal	O
mRNA	O
expression	O
of	O
p53	B-Gene_or_gene_product
,	O
and	O
two	O
of	O
its	O
target	O
genes	O
,	O
p21	B-Gene_or_gene_product
(	O
WAF1	B-Gene_or_gene_product
/	O
Cip1	B-Gene_or_gene_product
)	O
and	O
the	O
recently	O
cloned	O
PAG608	B-Gene_or_gene_product
/	O
Wig	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
in	O
a	O
two	O
-	O
vessel	O
occlusion	O
model	O
of	O
ischemic	O
preconditioning	O
.	O

We	O
also	O
evaluated	O
changes	O
in	O
the	O
protein	O
levels	O
of	O
p53	B-Gene_or_gene_product
and	O
PAG608	B-Gene_or_gene_product
/	O
Wig	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
using	O
immunohistochemistry	O
.	O
<EOS>	B-X
A	B-X
brief	B-X
,	B-X
3	B-X
min	B-X
period	B-X
of	B-X
global	B-X
forebrain	B-X
ischemia	B-X
in	B-X
the	B-X
rat	B-X
,	B-X
induced	B-X
by	B-X
bilateral	B-X
common	B-X
carotid	B-X
occlusion	B-X
combined	B-X
with	B-X
hypotension	B-X
,	B-X
confers	B-X
resistance	B-X
to	B-X
hippocampal	B-X
pyramidal	B-X
neurons	B-X
against	B-X
a	B-X
subsequent	B-X
10	B-X
min	B-X
ischemia	B-X
,	B-X
which	B-X
is	B-X
normally	B-X
lethal	B-X
to	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
a	B-X
transcription	B-X
factor	B-X
implicated	B-X
in	B-X
neuronal	B-X
death	B-X
following	B-X
various	B-X
insults	B-X
,	B-X
including	B-X
cerebral	B-X
ischemia	B-X
.	B-X
p53	B-X
is	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
cellular	B-X
stress	B-X
,	B-X
e.g	B-X
.	B-X
Using	B-X
in	B-X
situ	B-X
hybridization	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
hippocampal	B-X
mRNA	B-X
expression	B-X
of	B-X
p53	B-X
,	B-X
and	B-X
two	B-X
of	B-X
its	B-X
target	B-X
genes	B-X
,	B-X
p21	B-X
(	B-X
WAF1/Cip1	B-X
)	B-X
and	B-X
the	B-X
recently	B-X
cloned	B-X
PAG608/Wig-1	B-X
,	B-X
in	B-X
a	B-X
two-vessel	B-X
occlusion	B-X
model	B-X
of	B-X
ischemic	B-X
preconditioning	B-X
.	B-X
We	B-X
also	B-X
evaluated	B-X
changes	B-X
in	B-X
the	B-X
protein	B-X
levels	B-X
of	B-X
p53	B-X
and	B-X
PAG608/Wig-1	B-X
using	B-X
immunohistochemistry	B-X
.	B-X
The	B-X
mRNA	B-X
levels	B-X
of	B-X
all	B-X
three	B-X
genes	B-X
increased	B-X
in	B-X
the	B-X
ischemia	B-X
sensitive	B-X
CA1	B-X
region	B-X
both	B-X
following	B-X
3	B-X
min	B-X
(	B-X
non-lethal	B-X
)	B-X
preconditioning	B-X
and	B-X
10	B-X
min	B-X
of	B-X
(	B-X
lethal	B-X
)	B-X
nonconditioned	B-X
ischemia	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
after	B-X
10	B-X
min	B-X
of	B-X
ischemia	B-X
preconditioned	B-X
by	B-X
a	B-X
3	B-X
min	B-X
ischemic	B-X
insult	B-X
48	B-X
h	B-X
earlier	B-X
,	B-X
no	B-X
upregulation	B-X
of	B-X
these	B-X
genes	B-X
was	B-X
detected	B-X
in	B-X
the	B-X
CA1	B-X
.	B-X
Following	B-X
10	B-X
min	B-X
of	B-X
nonconditioned	B-X
ischemia	B-X
,	B-X
increased	B-X
neuronal	B-X
immunostaining	B-X
of	B-X
p53	B-X
and	B-X
PAG608/Wig-1	B-X
was	B-X
observed	B-X
in	B-X
the	B-X
hippocampus	B-X
,	B-X
which	B-X
was	B-X
less	B-X
pronounced	B-X
following	B-X
3	B-X
min	B-X
of	B-X
preconditioning	B-X
ischemia	B-X
and	B-X
10	B-X
min	B-X
of	B-X
preconditioned	B-X
ischemia	B-X
.	B-X
Our	B-X
results	B-X
demonstrate	B-X
that	B-X
activation	B-X
of	B-X
p53	B-X
and	B-X
its	B-X
response	B-X
genes	B-X
p21	B-X
(	B-X
WAF1/Cip1	B-X
)	B-X
and	B-X
PAG608/Wig-1	B-X
occurs	B-X
in	B-X
the	B-X
brain	B-X
following	B-X
lethal	B-X
as	B-X
well	B-X
as	B-X
non-lethal	B-X
ischemic	B-X
insults	B-X
,	B-X
and	B-X
that	B-X
ischemic	B-X
preconditioning	B-X
markedly	B-X
diminishes	B-X
this	B-X
activation	B-X
.	B-X

The	O
mRNA	O
levels	O
of	O
all	O
three	O
genes	O
increased	O
in	O
the	O
ischemia	O
sensitive	O
CA1	O
region	O
both	O
following	O
3	O
min	O
(	O
non	O
-	O
lethal	O
)	O
preconditioning	O
and	O
10	O
min	O
of	O
(	O
lethal	O
)	O
nonconditioned	O
ischemia	O
.	O
<EOS>	B-X
A	B-X
brief	B-X
,	B-X
3	B-X
min	B-X
period	B-X
of	B-X
global	B-X
forebrain	B-X
ischemia	B-X
in	B-X
the	B-X
rat	B-X
,	B-X
induced	B-X
by	B-X
bilateral	B-X
common	B-X
carotid	B-X
occlusion	B-X
combined	B-X
with	B-X
hypotension	B-X
,	B-X
confers	B-X
resistance	B-X
to	B-X
hippocampal	B-X
pyramidal	B-X
neurons	B-X
against	B-X
a	B-X
subsequent	B-X
10	B-X
min	B-X
ischemia	B-X
,	B-X
which	B-X
is	B-X
normally	B-X
lethal	B-X
to	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
molecular	B-X
mechanisms	B-X
underlying	B-X
this	B-X
ischemic	B-X
preconditioning	B-X
,	B-X
or	B-X
tolerance	B-X
,	B-X
are	B-X
poorly	B-X
understood	B-X
.	B-X
The	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
a	B-X
transcription	B-X
factor	B-X
implicated	B-X
in	B-X
neuronal	B-X
death	B-X
following	B-X
various	B-X
insults	B-X
,	B-X
including	B-X
cerebral	B-X
ischemia	B-X
.	B-X
p53	B-X
is	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
cellular	B-X
stress	B-X
,	B-X
e.g	B-X
.	B-X
Using	B-X
in	B-X
situ	B-X
hybridization	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
hippocampal	B-X
mRNA	B-X
expression	B-X
of	B-X
p53	B-X
,	B-X
and	B-X
two	B-X
of	B-X
its	B-X
target	B-X
genes	B-X
,	B-X
p21	B-X
(	B-X
WAF1/Cip1	B-X
)	B-X
and	B-X
the	B-X
recently	B-X
cloned	B-X
PAG608/Wig-1	B-X
,	B-X
in	B-X
a	B-X
two-vessel	B-X
occlusion	B-X
model	B-X
of	B-X
ischemic	B-X
preconditioning	B-X
.	B-X
We	B-X
also	B-X
evaluated	B-X
changes	B-X
in	B-X
the	B-X
protein	B-X
levels	B-X
of	B-X
p53	B-X
and	B-X
PAG608/Wig-1	B-X
using	B-X
immunohistochemistry	B-X
.	B-X
The	B-X
mRNA	B-X
levels	B-X
of	B-X
all	B-X
three	B-X
genes	B-X
increased	B-X
in	B-X
the	B-X
ischemia	B-X
sensitive	B-X
CA1	B-X
region	B-X
both	B-X
following	B-X
3	B-X
min	B-X
(	B-X
non-lethal	B-X
)	B-X
preconditioning	B-X
and	B-X
10	B-X
min	B-X
of	B-X
(	B-X
lethal	B-X
)	B-X
nonconditioned	B-X
ischemia	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
after	B-X
10	B-X
min	B-X
of	B-X
ischemia	B-X
preconditioned	B-X
by	B-X
a	B-X
3	B-X
min	B-X
ischemic	B-X
insult	B-X
48	B-X
h	B-X
earlier	B-X
,	B-X
no	B-X
upregulation	B-X
of	B-X
these	B-X
genes	B-X
was	B-X
detected	B-X
in	B-X
the	B-X
CA1	B-X
.	B-X
Following	B-X
10	B-X
min	B-X
of	B-X
nonconditioned	B-X
ischemia	B-X
,	B-X
increased	B-X
neuronal	B-X
immunostaining	B-X
of	B-X
p53	B-X
and	B-X
PAG608/Wig-1	B-X
was	B-X
observed	B-X
in	B-X
the	B-X
hippocampus	B-X
,	B-X
which	B-X
was	B-X
less	B-X
pronounced	B-X
following	B-X
3	B-X
min	B-X
of	B-X
preconditioning	B-X
ischemia	B-X
and	B-X
10	B-X
min	B-X
of	B-X
preconditioned	B-X
ischemia	B-X
.	B-X
Our	B-X
results	B-X
demonstrate	B-X
that	B-X
activation	B-X
of	B-X
p53	B-X
and	B-X
its	B-X
response	B-X
genes	B-X
p21	B-X
(	B-X
WAF1/Cip1	B-X
)	B-X
and	B-X
PAG608/Wig-1	B-X
occurs	B-X
in	B-X
the	B-X
brain	B-X
following	B-X
lethal	B-X
as	B-X
well	B-X
as	B-X
non-lethal	B-X
ischemic	B-X
insults	B-X
,	B-X
and	B-X
that	B-X
ischemic	B-X
preconditioning	B-X
markedly	B-X
diminishes	B-X
this	B-X
activation	B-X
.	B-X

In	O
contrast	O
,	O
after	O
10	O
min	O
of	O
ischemia	O
preconditioned	O
by	O
a	O
3	O
min	O
ischemic	O
insult	O
48	O
h	O
earlier	O
,	O
no	O
upregulation	O
of	O
these	O
genes	O
was	O
detected	O
in	O
the	O
CA1	O
.	O
<EOS>	B-X
A	B-X
brief	B-X
,	B-X
3	B-X
min	B-X
period	B-X
of	B-X
global	B-X
forebrain	B-X
ischemia	B-X
in	B-X
the	B-X
rat	B-X
,	B-X
induced	B-X
by	B-X
bilateral	B-X
common	B-X
carotid	B-X
occlusion	B-X
combined	B-X
with	B-X
hypotension	B-X
,	B-X
confers	B-X
resistance	B-X
to	B-X
hippocampal	B-X
pyramidal	B-X
neurons	B-X
against	B-X
a	B-X
subsequent	B-X
10	B-X
min	B-X
ischemia	B-X
,	B-X
which	B-X
is	B-X
normally	B-X
lethal	B-X
to	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
molecular	B-X
mechanisms	B-X
underlying	B-X
this	B-X
ischemic	B-X
preconditioning	B-X
,	B-X
or	B-X
tolerance	B-X
,	B-X
are	B-X
poorly	B-X
understood	B-X
.	B-X
The	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
a	B-X
transcription	B-X
factor	B-X
implicated	B-X
in	B-X
neuronal	B-X
death	B-X
following	B-X
various	B-X
insults	B-X
,	B-X
including	B-X
cerebral	B-X
ischemia	B-X
.	B-X
p53	B-X
is	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
cellular	B-X
stress	B-X
,	B-X
e.g	B-X
.	B-X
hypoxia	B-X
and	B-X
DNA	B-X
damage	B-X
.	B-X
Using	B-X
in	B-X
situ	B-X
hybridization	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
hippocampal	B-X
mRNA	B-X
expression	B-X
of	B-X
p53	B-X
,	B-X
and	B-X
two	B-X
of	B-X
its	B-X
target	B-X
genes	B-X
,	B-X
p21	B-X
(	B-X
WAF1/Cip1	B-X
)	B-X
and	B-X
the	B-X
recently	B-X
cloned	B-X
PAG608/Wig-1	B-X
,	B-X
in	B-X
a	B-X
two-vessel	B-X
occlusion	B-X
model	B-X
of	B-X
ischemic	B-X
preconditioning	B-X
.	B-X
We	B-X
also	B-X
evaluated	B-X
changes	B-X
in	B-X
the	B-X
protein	B-X
levels	B-X
of	B-X
p53	B-X
and	B-X
PAG608/Wig-1	B-X
using	B-X
immunohistochemistry	B-X
.	B-X
The	B-X
mRNA	B-X
levels	B-X
of	B-X
all	B-X
three	B-X
genes	B-X
increased	B-X
in	B-X
the	B-X
ischemia	B-X
sensitive	B-X
CA1	B-X
region	B-X
both	B-X
following	B-X
3	B-X
min	B-X
(	B-X
non-lethal	B-X
)	B-X
preconditioning	B-X
and	B-X
10	B-X
min	B-X
of	B-X
(	B-X
lethal	B-X
)	B-X
nonconditioned	B-X
ischemia	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
after	B-X
10	B-X
min	B-X
of	B-X
ischemia	B-X
preconditioned	B-X
by	B-X
a	B-X
3	B-X
min	B-X
ischemic	B-X
insult	B-X
48	B-X
h	B-X
earlier	B-X
,	B-X
no	B-X
upregulation	B-X
of	B-X
these	B-X
genes	B-X
was	B-X
detected	B-X
in	B-X
the	B-X
CA1	B-X
.	B-X
Following	B-X
10	B-X
min	B-X
of	B-X
nonconditioned	B-X
ischemia	B-X
,	B-X
increased	B-X
neuronal	B-X
immunostaining	B-X
of	B-X
p53	B-X
and	B-X
PAG608/Wig-1	B-X
was	B-X
observed	B-X
in	B-X
the	B-X
hippocampus	B-X
,	B-X
which	B-X
was	B-X
less	B-X
pronounced	B-X
following	B-X
3	B-X
min	B-X
of	B-X
preconditioning	B-X
ischemia	B-X
and	B-X
10	B-X
min	B-X
of	B-X
preconditioned	B-X
ischemia	B-X
.	B-X
Our	B-X
results	B-X
demonstrate	B-X
that	B-X
activation	B-X
of	B-X
p53	B-X
and	B-X
its	B-X
response	B-X
genes	B-X
p21	B-X
(	B-X
WAF1/Cip1	B-X
)	B-X
and	B-X
PAG608/Wig-1	B-X
occurs	B-X
in	B-X
the	B-X
brain	B-X
following	B-X
lethal	B-X
as	B-X
well	B-X
as	B-X
non-lethal	B-X
ischemic	B-X
insults	B-X
,	B-X
and	B-X
that	B-X
ischemic	B-X
preconditioning	B-X
markedly	B-X
diminishes	B-X
this	B-X
activation	B-X
.	B-X

Following	O
10	O
min	O
of	O
nonconditioned	O
ischemia	O
,	O
increased	O
neuronal	O
immunostaining	O
of	O
p53	B-Gene_or_gene_product
and	O
PAG608	B-Gene_or_gene_product
/	O
Wig	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
was	O
observed	O
in	O
the	O
hippocampus	O
,	O
which	O
was	O
less	O
pronounced	O
following	O
3	O
min	O
of	O
preconditioning	O
ischemia	O
and	O
10	O
min	O
of	O
preconditioned	O
ischemia	O
.	O
<EOS>	B-X
A	B-X
brief	B-X
,	B-X
3	B-X
min	B-X
period	B-X
of	B-X
global	B-X
forebrain	B-X
ischemia	B-X
in	B-X
the	B-X
rat	B-X
,	B-X
induced	B-X
by	B-X
bilateral	B-X
common	B-X
carotid	B-X
occlusion	B-X
combined	B-X
with	B-X
hypotension	B-X
,	B-X
confers	B-X
resistance	B-X
to	B-X
hippocampal	B-X
pyramidal	B-X
neurons	B-X
against	B-X
a	B-X
subsequent	B-X
10	B-X
min	B-X
ischemia	B-X
,	B-X
which	B-X
is	B-X
normally	B-X
lethal	B-X
to	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
molecular	B-X
mechanisms	B-X
underlying	B-X
this	B-X
ischemic	B-X
preconditioning	B-X
,	B-X
or	B-X
tolerance	B-X
,	B-X
are	B-X
poorly	B-X
understood	B-X
.	B-X
The	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
a	B-X
transcription	B-X
factor	B-X
implicated	B-X
in	B-X
neuronal	B-X
death	B-X
following	B-X
various	B-X
insults	B-X
,	B-X
including	B-X
cerebral	B-X
ischemia	B-X
.	B-X
p53	B-X
is	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
cellular	B-X
stress	B-X
,	B-X
e.g	B-X
.	B-X
Using	B-X
in	B-X
situ	B-X
hybridization	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
hippocampal	B-X
mRNA	B-X
expression	B-X
of	B-X
p53	B-X
,	B-X
and	B-X
two	B-X
of	B-X
its	B-X
target	B-X
genes	B-X
,	B-X
p21	B-X
(	B-X
WAF1/Cip1	B-X
)	B-X
and	B-X
the	B-X
recently	B-X
cloned	B-X
PAG608/Wig-1	B-X
,	B-X
in	B-X
a	B-X
two-vessel	B-X
occlusion	B-X
model	B-X
of	B-X
ischemic	B-X
preconditioning	B-X
.	B-X
We	B-X
also	B-X
evaluated	B-X
changes	B-X
in	B-X
the	B-X
protein	B-X
levels	B-X
of	B-X
p53	B-X
and	B-X
PAG608/Wig-1	B-X
using	B-X
immunohistochemistry	B-X
.	B-X
The	B-X
mRNA	B-X
levels	B-X
of	B-X
all	B-X
three	B-X
genes	B-X
increased	B-X
in	B-X
the	B-X
ischemia	B-X
sensitive	B-X
CA1	B-X
region	B-X
both	B-X
following	B-X
3	B-X
min	B-X
(	B-X
non-lethal	B-X
)	B-X
preconditioning	B-X
and	B-X
10	B-X
min	B-X
of	B-X
(	B-X
lethal	B-X
)	B-X
nonconditioned	B-X
ischemia	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
after	B-X
10	B-X
min	B-X
of	B-X
ischemia	B-X
preconditioned	B-X
by	B-X
a	B-X
3	B-X
min	B-X
ischemic	B-X
insult	B-X
48	B-X
h	B-X
earlier	B-X
,	B-X
no	B-X
upregulation	B-X
of	B-X
these	B-X
genes	B-X
was	B-X
detected	B-X
in	B-X
the	B-X
CA1	B-X
.	B-X
Following	B-X
10	B-X
min	B-X
of	B-X
nonconditioned	B-X
ischemia	B-X
,	B-X
increased	B-X
neuronal	B-X
immunostaining	B-X
of	B-X
p53	B-X
and	B-X
PAG608/Wig-1	B-X
was	B-X
observed	B-X
in	B-X
the	B-X
hippocampus	B-X
,	B-X
which	B-X
was	B-X
less	B-X
pronounced	B-X
following	B-X
3	B-X
min	B-X
of	B-X
preconditioning	B-X
ischemia	B-X
and	B-X
10	B-X
min	B-X
of	B-X
preconditioned	B-X
ischemia	B-X
.	B-X
Our	B-X
results	B-X
demonstrate	B-X
that	B-X
activation	B-X
of	B-X
p53	B-X
and	B-X
its	B-X
response	B-X
genes	B-X
p21	B-X
(	B-X
WAF1/Cip1	B-X
)	B-X
and	B-X
PAG608/Wig-1	B-X
occurs	B-X
in	B-X
the	B-X
brain	B-X
following	B-X
lethal	B-X
as	B-X
well	B-X
as	B-X
non-lethal	B-X
ischemic	B-X
insults	B-X
,	B-X
and	B-X
that	B-X
ischemic	B-X
preconditioning	B-X
markedly	B-X
diminishes	B-X
this	B-X
activation	B-X
.	B-X

Our	O
results	O
demonstrate	O
that	O
activation	O
of	O
p53	B-Gene_or_gene_product
and	O
its	O
response	O
genes	O
p21	B-Gene_or_gene_product
(	O
WAF1	B-Gene_or_gene_product
/	O
Cip1	B-Gene_or_gene_product
)	O
and	O
PAG608	B-Gene_or_gene_product
/	O
Wig	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
occurs	O
in	O
the	O
brain	O
following	O
lethal	O
as	O
well	O
as	O
non	O
-	O
lethal	O
ischemic	O
insults	O
,	O
and	O
that	O
ischemic	O
preconditioning	O
markedly	O
diminishes	O
this	O
activation	O
.	O
<EOS>	B-X
A	B-X
brief	B-X
,	B-X
3	B-X
min	B-X
period	B-X
of	B-X
global	B-X
forebrain	B-X
ischemia	B-X
in	B-X
the	B-X
rat	B-X
,	B-X
induced	B-X
by	B-X
bilateral	B-X
common	B-X
carotid	B-X
occlusion	B-X
combined	B-X
with	B-X
hypotension	B-X
,	B-X
confers	B-X
resistance	B-X
to	B-X
hippocampal	B-X
pyramidal	B-X
neurons	B-X
against	B-X
a	B-X
subsequent	B-X
10	B-X
min	B-X
ischemia	B-X
,	B-X
which	B-X
is	B-X
normally	B-X
lethal	B-X
to	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
molecular	B-X
mechanisms	B-X
underlying	B-X
this	B-X
ischemic	B-X
preconditioning	B-X
,	B-X
or	B-X
tolerance	B-X
,	B-X
are	B-X
poorly	B-X
understood	B-X
.	B-X
The	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
a	B-X
transcription	B-X
factor	B-X
implicated	B-X
in	B-X
neuronal	B-X
death	B-X
following	B-X
various	B-X
insults	B-X
,	B-X
including	B-X
cerebral	B-X
ischemia	B-X
.	B-X
p53	B-X
is	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
cellular	B-X
stress	B-X
,	B-X
e.g	B-X
.	B-X
Using	B-X
in	B-X
situ	B-X
hybridization	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
hippocampal	B-X
mRNA	B-X
expression	B-X
of	B-X
p53	B-X
,	B-X
and	B-X
two	B-X
of	B-X
its	B-X
target	B-X
genes	B-X
,	B-X
p21	B-X
(	B-X
WAF1/Cip1	B-X
)	B-X
and	B-X
the	B-X
recently	B-X
cloned	B-X
PAG608/Wig-1	B-X
,	B-X
in	B-X
a	B-X
two-vessel	B-X
occlusion	B-X
model	B-X
of	B-X
ischemic	B-X
preconditioning	B-X
.	B-X
We	B-X
also	B-X
evaluated	B-X
changes	B-X
in	B-X
the	B-X
protein	B-X
levels	B-X
of	B-X
p53	B-X
and	B-X
PAG608/Wig-1	B-X
using	B-X
immunohistochemistry	B-X
.	B-X
The	B-X
mRNA	B-X
levels	B-X
of	B-X
all	B-X
three	B-X
genes	B-X
increased	B-X
in	B-X
the	B-X
ischemia	B-X
sensitive	B-X
CA1	B-X
region	B-X
both	B-X
following	B-X
3	B-X
min	B-X
(	B-X
non-lethal	B-X
)	B-X
preconditioning	B-X
and	B-X
10	B-X
min	B-X
of	B-X
(	B-X
lethal	B-X
)	B-X
nonconditioned	B-X
ischemia	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
after	B-X
10	B-X
min	B-X
of	B-X
ischemia	B-X
preconditioned	B-X
by	B-X
a	B-X
3	B-X
min	B-X
ischemic	B-X
insult	B-X
48	B-X
h	B-X
earlier	B-X
,	B-X
no	B-X
upregulation	B-X
of	B-X
these	B-X
genes	B-X
was	B-X
detected	B-X
in	B-X
the	B-X
CA1	B-X
.	B-X
Following	B-X
10	B-X
min	B-X
of	B-X
nonconditioned	B-X
ischemia	B-X
,	B-X
increased	B-X
neuronal	B-X
immunostaining	B-X
of	B-X
p53	B-X
and	B-X
PAG608/Wig-1	B-X
was	B-X
observed	B-X
in	B-X
the	B-X
hippocampus	B-X
,	B-X
which	B-X
was	B-X
less	B-X
pronounced	B-X
following	B-X
3	B-X
min	B-X
of	B-X
preconditioning	B-X
ischemia	B-X
and	B-X
10	B-X
min	B-X
of	B-X
preconditioned	B-X
ischemia	B-X
.	B-X
Our	B-X
results	B-X
demonstrate	B-X
that	B-X
activation	B-X
of	B-X
p53	B-X
and	B-X
its	B-X
response	B-X
genes	B-X
p21	B-X
(	B-X
WAF1/Cip1	B-X
)	B-X
and	B-X
PAG608/Wig-1	B-X
occurs	B-X
in	B-X
the	B-X
brain	B-X
following	B-X
lethal	B-X
as	B-X
well	B-X
as	B-X
non-lethal	B-X
ischemic	B-X
insults	B-X
,	B-X
and	B-X
that	B-X
ischemic	B-X
preconditioning	B-X
markedly	B-X
diminishes	B-X
this	B-X
activation	B-X
.	B-X

A	O
GSK3beta	B-Gene_or_gene_product
phosphorylation	O
site	O
in	O
axin	B-Gene_or_gene_product
modulates	O
interaction	O
with	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
and	O
Tcf	B-Gene_or_gene_product
-	O
mediated	O
gene	O
expression	O
.	O
<EOS>	B-X
Upon	B-X
binding	B-X
of	B-X
a	B-X
Wnt	B-X
to	B-X
its	B-X
receptor	B-X
,	B-X
GSK3beta	B-X
is	B-X
inhibited	B-X
through	B-X
an	B-X
unknown	B-X
mechanism	B-X
involving	B-X
Dishevelled	B-X
(	B-X
Dsh	B-X
)	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
dephosphorylation	B-X
and	B-X
stabilization	B-X
of	B-X
beta-catenin	B-X
,	B-X
which	B-X
translocates	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
interacts	B-X
with	B-X
Lef/Tcf	B-X
transcription	B-X
factors	B-X
to	B-X
activate	B-X
target	B-X
gene	B-X
expression	B-X
.	B-X
Axin	B-X
is	B-X
a	B-X
scaffold	B-X
protein	B-X
which	B-X
binds	B-X
beta-catenin	B-X
and	B-X
GSK3beta	B-X
(	B-X
as	B-X
well	B-X
as	B-X
several	B-X
other	B-X
proteins	B-X
)	B-X
and	B-X
thus	B-X
promotes	B-X
the	B-X
phosphorylation	B-X
of	B-X
beta-catenin	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
Axin	B-X
is	B-X
phosphorylated	B-X
on	B-X
Ser	B-X
and	B-X
Thr	B-X
residues	B-X
in	B-X
several	B-X
regions	B-X
in	B-X
vivo	B-X
,	B-X
while	B-X
only	B-X
one	B-X
region	B-X
(	B-X
amino	B-X
acids	B-X
600-672	B-X
)	B-X
is	B-X
efficiently	B-X
phosphorylated	B-X
by	B-X
GSK3beta	B-X
in	B-X
vitro	B-X
.	B-X
Site-directed	B-X
mutagenesis	B-X
,	B-X
together	B-X
with	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
assays	B-X
,	B-X
demonstrates	B-X
that	B-X
Axin	B-X
residues	B-X
T609	B-X
and	B-X
S614	B-X
are	B-X
physiological	B-X
GSK3beta	B-X
targets	B-X
.	B-X
Substitutions	B-X
for	B-X
one	B-X
or	B-X
more	B-X
of	B-X
these	B-X
residues	B-X
,	B-X
which	B-X
lie	B-X
within	B-X
a	B-X
beta-catenin	B-X
binding	B-X
site	B-X
,	B-X
reduce	B-X
the	B-X
ability	B-X
of	B-X
Axin	B-X
to	B-X
modulate	B-X
Wnt-induced	B-X
signaling	B-X
in	B-X
a	B-X
Lef/Tcf	B-X
reporter	B-X
assay	B-X
.	B-X
These	B-X
amino	B-X
acid	B-X
substitutions	B-X
also	B-X
reduce	B-X
the	B-X
binding	B-X
between	B-X
Axin	B-X
and	B-X
beta-catenin	B-X
.	B-X
We	B-X
propose	B-X
a	B-X
model	B-X
in	B-X
which	B-X
inhibition	B-X
of	B-X
GSK3beta	B-X
activity	B-X
upon	B-X
Wnt	B-X
signaling	B-X
leads	B-X
to	B-X
the	B-X
dephosphorylation	B-X
of	B-X
GSK3beta	B-X
sites	B-X
in	B-X
Axin	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
release	B-X
of	B-X
beta-catenin	B-X
from	B-X
the	B-X
phosphorylation	B-X
complex	B-X
.	B-X

Upon	O
binding	O
of	O
a	O
Wnt	B-Gene_or_gene_product
to	O
its	O
receptor	O
,	O
GSK3beta	B-Gene_or_gene_product
is	O
inhibited	O
through	O
an	O
unknown	O
mechanism	O
involving	O
Dishevelled	B-Gene_or_gene_product
(	O
Dsh	B-Gene_or_gene_product
)	O
,	O
resulting	O
in	O
the	O
dephosphorylation	O
and	O
stabilization	O
of	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
,	O
which	O
translocates	O
to	O
the	O
nucleus	O
and	O
interacts	O
with	O
Lef	B-Gene_or_gene_product
/	O
Tcf	B-Gene_or_gene_product
transcription	O
factors	O
to	O
activate	O
target	O
gene	O
expression	O
.	O

Axin	B-Gene_or_gene_product
is	O
a	O
scaffold	O
protein	O
which	O
binds	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
and	O
GSK3beta	B-Gene_or_gene_product
(	O
as	O
well	O
as	O
several	O
other	O
proteins	O
)	O
and	O
thus	O
promotes	O
the	O
phosphorylation	O
of	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
.	O
<EOS>	B-X
Upon	B-X
binding	B-X
of	B-X
a	B-X
Wnt	B-X
to	B-X
its	B-X
receptor	B-X
,	B-X
GSK3beta	B-X
is	B-X
inhibited	B-X
through	B-X
an	B-X
unknown	B-X
mechanism	B-X
involving	B-X
Dishevelled	B-X
(	B-X
Dsh	B-X
)	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
dephosphorylation	B-X
and	B-X
stabilization	B-X
of	B-X
beta-catenin	B-X
,	B-X
which	B-X
translocates	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
interacts	B-X
with	B-X
Lef/Tcf	B-X
transcription	B-X
factors	B-X
to	B-X
activate	B-X
target	B-X
gene	B-X
expression	B-X
.	B-X
Axin	B-X
is	B-X
a	B-X
scaffold	B-X
protein	B-X
which	B-X
binds	B-X
beta-catenin	B-X
and	B-X
GSK3beta	B-X
(	B-X
as	B-X
well	B-X
as	B-X
several	B-X
other	B-X
proteins	B-X
)	B-X
and	B-X
thus	B-X
promotes	B-X
the	B-X
phosphorylation	B-X
of	B-X
beta-catenin	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
Axin	B-X
is	B-X
phosphorylated	B-X
on	B-X
Ser	B-X
and	B-X
Thr	B-X
residues	B-X
in	B-X
several	B-X
regions	B-X
in	B-X
vivo	B-X
,	B-X
while	B-X
only	B-X
one	B-X
region	B-X
(	B-X
amino	B-X
acids	B-X
600-672	B-X
)	B-X
is	B-X
efficiently	B-X
phosphorylated	B-X
by	B-X
GSK3beta	B-X
in	B-X
vitro	B-X
.	B-X
Site-directed	B-X
mutagenesis	B-X
,	B-X
together	B-X
with	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
assays	B-X
,	B-X
demonstrates	B-X
that	B-X
Axin	B-X
residues	B-X
T609	B-X
and	B-X
S614	B-X
are	B-X
physiological	B-X
GSK3beta	B-X
targets	B-X
.	B-X
Substitutions	B-X
for	B-X
one	B-X
or	B-X
more	B-X
of	B-X
these	B-X
residues	B-X
,	B-X
which	B-X
lie	B-X
within	B-X
a	B-X
beta-catenin	B-X
binding	B-X
site	B-X
,	B-X
reduce	B-X
the	B-X
ability	B-X
of	B-X
Axin	B-X
to	B-X
modulate	B-X
Wnt-induced	B-X
signaling	B-X
in	B-X
a	B-X
Lef/Tcf	B-X
reporter	B-X
assay	B-X
.	B-X
These	B-X
amino	B-X
acid	B-X
substitutions	B-X
also	B-X
reduce	B-X
the	B-X
binding	B-X
between	B-X
Axin	B-X
and	B-X
beta-catenin	B-X
.	B-X
We	B-X
propose	B-X
a	B-X
model	B-X
in	B-X
which	B-X
inhibition	B-X
of	B-X
GSK3beta	B-X
activity	B-X
upon	B-X
Wnt	B-X
signaling	B-X
leads	B-X
to	B-X
the	B-X
dephosphorylation	B-X
of	B-X
GSK3beta	B-X
sites	B-X
in	B-X
Axin	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
release	B-X
of	B-X
beta-catenin	B-X
from	B-X
the	B-X
phosphorylation	B-X
complex	B-X
.	B-X

Here	O
we	O
report	O
that	O
Axin	B-Gene_or_gene_product
is	O
phosphorylated	O
on	O
Ser	O
and	O
Thr	O
residues	O
in	O
several	O
regions	O
in	O
vivo	O
,	O
while	O
only	O
one	O
region	O
(	O
amino	O
acids	O
600	O
-	O
672	O
)	O
is	O
efficiently	O
phosphorylated	O
by	O
GSK3beta	B-Gene_or_gene_product
in	O
vitro	O
.	O
<EOS>	B-X
Upon	B-X
binding	B-X
of	B-X
a	B-X
Wnt	B-X
to	B-X
its	B-X
receptor	B-X
,	B-X
GSK3beta	B-X
is	B-X
inhibited	B-X
through	B-X
an	B-X
unknown	B-X
mechanism	B-X
involving	B-X
Dishevelled	B-X
(	B-X
Dsh	B-X
)	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
dephosphorylation	B-X
and	B-X
stabilization	B-X
of	B-X
beta-catenin	B-X
,	B-X
which	B-X
translocates	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
interacts	B-X
with	B-X
Lef/Tcf	B-X
transcription	B-X
factors	B-X
to	B-X
activate	B-X
target	B-X
gene	B-X
expression	B-X
.	B-X
Axin	B-X
is	B-X
a	B-X
scaffold	B-X
protein	B-X
which	B-X
binds	B-X
beta-catenin	B-X
and	B-X
GSK3beta	B-X
(	B-X
as	B-X
well	B-X
as	B-X
several	B-X
other	B-X
proteins	B-X
)	B-X
and	B-X
thus	B-X
promotes	B-X
the	B-X
phosphorylation	B-X
of	B-X
beta-catenin	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
Axin	B-X
is	B-X
phosphorylated	B-X
on	B-X
Ser	B-X
and	B-X
Thr	B-X
residues	B-X
in	B-X
several	B-X
regions	B-X
in	B-X
vivo	B-X
,	B-X
while	B-X
only	B-X
one	B-X
region	B-X
(	B-X
amino	B-X
acids	B-X
600-672	B-X
)	B-X
is	B-X
efficiently	B-X
phosphorylated	B-X
by	B-X
GSK3beta	B-X
in	B-X
vitro	B-X
.	B-X
Site-directed	B-X
mutagenesis	B-X
,	B-X
together	B-X
with	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
assays	B-X
,	B-X
demonstrates	B-X
that	B-X
Axin	B-X
residues	B-X
T609	B-X
and	B-X
S614	B-X
are	B-X
physiological	B-X
GSK3beta	B-X
targets	B-X
.	B-X
Substitutions	B-X
for	B-X
one	B-X
or	B-X
more	B-X
of	B-X
these	B-X
residues	B-X
,	B-X
which	B-X
lie	B-X
within	B-X
a	B-X
beta-catenin	B-X
binding	B-X
site	B-X
,	B-X
reduce	B-X
the	B-X
ability	B-X
of	B-X
Axin	B-X
to	B-X
modulate	B-X
Wnt-induced	B-X
signaling	B-X
in	B-X
a	B-X
Lef/Tcf	B-X
reporter	B-X
assay	B-X
.	B-X
These	B-X
amino	B-X
acid	B-X
substitutions	B-X
also	B-X
reduce	B-X
the	B-X
binding	B-X
between	B-X
Axin	B-X
and	B-X
beta-catenin	B-X
.	B-X
We	B-X
propose	B-X
a	B-X
model	B-X
in	B-X
which	B-X
inhibition	B-X
of	B-X
GSK3beta	B-X
activity	B-X
upon	B-X
Wnt	B-X
signaling	B-X
leads	B-X
to	B-X
the	B-X
dephosphorylation	B-X
of	B-X
GSK3beta	B-X
sites	B-X
in	B-X
Axin	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
release	B-X
of	B-X
beta-catenin	B-X
from	B-X
the	B-X
phosphorylation	B-X
complex	B-X
.	B-X

Site	O
-	O
directed	O
mutagenesis	O
,	O
together	O
with	O
in	O
vitro	O
and	O
in	O
vivo	O
phosphorylation	O
assays	O
,	O
demonstrates	O
that	O
Axin	B-Gene_or_gene_product
residues	O
T609	O
and	O
S614	O
are	O
physiological	O
GSK3beta	B-Gene_or_gene_product
targets	O
.	O
<EOS>	B-X
Upon	B-X
binding	B-X
of	B-X
a	B-X
Wnt	B-X
to	B-X
its	B-X
receptor	B-X
,	B-X
GSK3beta	B-X
is	B-X
inhibited	B-X
through	B-X
an	B-X
unknown	B-X
mechanism	B-X
involving	B-X
Dishevelled	B-X
(	B-X
Dsh	B-X
)	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
dephosphorylation	B-X
and	B-X
stabilization	B-X
of	B-X
beta-catenin	B-X
,	B-X
which	B-X
translocates	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
interacts	B-X
with	B-X
Lef/Tcf	B-X
transcription	B-X
factors	B-X
to	B-X
activate	B-X
target	B-X
gene	B-X
expression	B-X
.	B-X
Axin	B-X
is	B-X
a	B-X
scaffold	B-X
protein	B-X
which	B-X
binds	B-X
beta-catenin	B-X
and	B-X
GSK3beta	B-X
(	B-X
as	B-X
well	B-X
as	B-X
several	B-X
other	B-X
proteins	B-X
)	B-X
and	B-X
thus	B-X
promotes	B-X
the	B-X
phosphorylation	B-X
of	B-X
beta-catenin	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
Axin	B-X
is	B-X
phosphorylated	B-X
on	B-X
Ser	B-X
and	B-X
Thr	B-X
residues	B-X
in	B-X
several	B-X
regions	B-X
in	B-X
vivo	B-X
,	B-X
while	B-X
only	B-X
one	B-X
region	B-X
(	B-X
amino	B-X
acids	B-X
600-672	B-X
)	B-X
is	B-X
efficiently	B-X
phosphorylated	B-X
by	B-X
GSK3beta	B-X
in	B-X
vitro	B-X
.	B-X
Site-directed	B-X
mutagenesis	B-X
,	B-X
together	B-X
with	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
assays	B-X
,	B-X
demonstrates	B-X
that	B-X
Axin	B-X
residues	B-X
T609	B-X
and	B-X
S614	B-X
are	B-X
physiological	B-X
GSK3beta	B-X
targets	B-X
.	B-X
Substitutions	B-X
for	B-X
one	B-X
or	B-X
more	B-X
of	B-X
these	B-X
residues	B-X
,	B-X
which	B-X
lie	B-X
within	B-X
a	B-X
beta-catenin	B-X
binding	B-X
site	B-X
,	B-X
reduce	B-X
the	B-X
ability	B-X
of	B-X
Axin	B-X
to	B-X
modulate	B-X
Wnt-induced	B-X
signaling	B-X
in	B-X
a	B-X
Lef/Tcf	B-X
reporter	B-X
assay	B-X
.	B-X
These	B-X
amino	B-X
acid	B-X
substitutions	B-X
also	B-X
reduce	B-X
the	B-X
binding	B-X
between	B-X
Axin	B-X
and	B-X
beta-catenin	B-X
.	B-X
We	B-X
propose	B-X
a	B-X
model	B-X
in	B-X
which	B-X
inhibition	B-X
of	B-X
GSK3beta	B-X
activity	B-X
upon	B-X
Wnt	B-X
signaling	B-X
leads	B-X
to	B-X
the	B-X
dephosphorylation	B-X
of	B-X
GSK3beta	B-X
sites	B-X
in	B-X
Axin	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
release	B-X
of	B-X
beta-catenin	B-X
from	B-X
the	B-X
phosphorylation	B-X
complex	B-X
.	B-X

Substitutions	O
for	O
one	O
or	O
more	O
of	O
these	O
residues	O
,	O
which	O
lie	O
within	O
a	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
binding	O
site	O
,	O
reduce	O
the	O
ability	O
of	O
Axin	B-Gene_or_gene_product
to	O
modulate	O
Wnt	B-Gene_or_gene_product
-	O
induced	O
signaling	O
in	O
a	O
Lef	B-Gene_or_gene_product
/	O
Tcf	B-Gene_or_gene_product
reporter	O
assay	O
.	O
<EOS>	B-X
After	B-X
tooth	B-X
loss	B-X
,	B-X
bone	B-X
resorption	B-X
is	B-X
irreversible	B-X
,	B-X
leaving	B-X
the	B-X
area	B-X
without	B-X
adequate	B-X
bone	B-X
volume	B-X
for	B-X
successful	B-X
implant	B-X
treatment	B-X
.	B-X
Bone	B-X
grafting	B-X
is	B-X
the	B-X
only	B-X
solution	B-X
to	B-X
reverse	B-X
dental	B-X
bone	B-X
loss	B-X
and	B-X
is	B-X
a	B-X
well-accepted	B-X
procedure	B-X
required	B-X
in	B-X
one	B-X
in	B-X
every	B-X
four	B-X
dental	B-X
implants	B-X
.	B-X
This	B-X
review	B-X
will	B-X
critically	B-X
present	B-X
the	B-X
various	B-X
dental	B-X
bone	B-X
graft	B-X
and	B-X
substitute	B-X
materials	B-X
that	B-X
have	B-X
been	B-X
used	B-X
to	B-X
achieve	B-X
a	B-X
successful	B-X
dental	B-X
implant	B-X
.	B-X
The	B-X
article	B-X
also	B-X
reviews	B-X
the	B-X
properties	B-X
of	B-X
dental	B-X
bone	B-X
grafts	B-X
and	B-X
various	B-X
dental	B-X
bone	B-X
substitutes	B-X
that	B-X
have	B-X
been	B-X
studied	B-X
or	B-X
are	B-X
currently	B-X
available	B-X
commercially	B-X
.	B-X
The	B-X
various	B-X
classifications	B-X
of	B-X
bone	B-X
grafts	B-X
and	B-X
substitutes	B-X
,	B-X
including	B-X
natural	B-X
and	B-X
synthetic	B-X
materials	B-X
,	B-X
are	B-X
critically	B-X
presented	B-X
,	B-X
and	B-X
available	B-X
commercial	B-X
products	B-X
in	B-X
each	B-X
category	B-X
are	B-X
discussed	B-X
.	B-X
Different	B-X
bone	B-X
substitute	B-X
materials	B-X
,	B-X
including	B-X
metals	B-X
,	B-X
ceramics	B-X
,	B-X
polymers	B-X
,	B-X
or	B-X
their	B-X
combinations	B-X
,	B-X
and	B-X
their	B-X
chemical	B-X
,	B-X
physical	B-X
,	B-X
and	B-X
biocompatibility	B-X
properties	B-X
are	B-X
explored	B-X
.	B-X
Tissue	B-X
engineering	B-X
hybrid	B-X
constructions	B-X
with	B-X
enhanced	B-X
bone	B-X
regeneration	B-X
ability	B-X
,	B-X
such	B-X
as	B-X
cell-based	B-X
or	B-X
growth	B-X
factor-based	B-X
bone	B-X
substitutes	B-X
,	B-X
are	B-X
discussed	B-X
as	B-X
an	B-X
emerging	B-X
area	B-X
of	B-X
development	B-X
.	B-X

These	O
amino	O
acid	O
substitutions	O
also	O
reduce	O
the	O
binding	O
between	O
Axin	B-Gene_or_gene_product
and	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
.	O
<EOS>	B-X
Upon	B-X
binding	B-X
of	B-X
a	B-X
Wnt	B-X
to	B-X
its	B-X
receptor	B-X
,	B-X
GSK3beta	B-X
is	B-X
inhibited	B-X
through	B-X
an	B-X
unknown	B-X
mechanism	B-X
involving	B-X
Dishevelled	B-X
(	B-X
Dsh	B-X
)	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
dephosphorylation	B-X
and	B-X
stabilization	B-X
of	B-X
beta-catenin	B-X
,	B-X
which	B-X
translocates	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
interacts	B-X
with	B-X
Lef/Tcf	B-X
transcription	B-X
factors	B-X
to	B-X
activate	B-X
target	B-X
gene	B-X
expression	B-X
.	B-X
Axin	B-X
is	B-X
a	B-X
scaffold	B-X
protein	B-X
which	B-X
binds	B-X
beta-catenin	B-X
and	B-X
GSK3beta	B-X
(	B-X
as	B-X
well	B-X
as	B-X
several	B-X
other	B-X
proteins	B-X
)	B-X
and	B-X
thus	B-X
promotes	B-X
the	B-X
phosphorylation	B-X
of	B-X
beta-catenin	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
Axin	B-X
is	B-X
phosphorylated	B-X
on	B-X
Ser	B-X
and	B-X
Thr	B-X
residues	B-X
in	B-X
several	B-X
regions	B-X
in	B-X
vivo	B-X
,	B-X
while	B-X
only	B-X
one	B-X
region	B-X
(	B-X
amino	B-X
acids	B-X
600-672	B-X
)	B-X
is	B-X
efficiently	B-X
phosphorylated	B-X
by	B-X
GSK3beta	B-X
in	B-X
vitro	B-X
.	B-X
Site-directed	B-X
mutagenesis	B-X
,	B-X
together	B-X
with	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
assays	B-X
,	B-X
demonstrates	B-X
that	B-X
Axin	B-X
residues	B-X
T609	B-X
and	B-X
S614	B-X
are	B-X
physiological	B-X
GSK3beta	B-X
targets	B-X
.	B-X
Substitutions	B-X
for	B-X
one	B-X
or	B-X
more	B-X
of	B-X
these	B-X
residues	B-X
,	B-X
which	B-X
lie	B-X
within	B-X
a	B-X
beta-catenin	B-X
binding	B-X
site	B-X
,	B-X
reduce	B-X
the	B-X
ability	B-X
of	B-X
Axin	B-X
to	B-X
modulate	B-X
Wnt-induced	B-X
signaling	B-X
in	B-X
a	B-X
Lef/Tcf	B-X
reporter	B-X
assay	B-X
.	B-X
These	B-X
amino	B-X
acid	B-X
substitutions	B-X
also	B-X
reduce	B-X
the	B-X
binding	B-X
between	B-X
Axin	B-X
and	B-X
beta-catenin	B-X
.	B-X
We	B-X
propose	B-X
a	B-X
model	B-X
in	B-X
which	B-X
inhibition	B-X
of	B-X
GSK3beta	B-X
activity	B-X
upon	B-X
Wnt	B-X
signaling	B-X
leads	B-X
to	B-X
the	B-X
dephosphorylation	B-X
of	B-X
GSK3beta	B-X
sites	B-X
in	B-X
Axin	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
release	B-X
of	B-X
beta-catenin	B-X
from	B-X
the	B-X
phosphorylation	B-X
complex	B-X
.	B-X

We	O
propose	O
a	O
model	O
in	O
which	O
inhibition	O
of	O
GSK3beta	B-Gene_or_gene_product
activity	O
upon	O
Wnt	B-Gene_or_gene_product
signaling	O
leads	O
to	O
the	O
dephosphorylation	O
of	O
GSK3beta	B-Gene_or_gene_product
sites	O
in	O
Axin	B-Gene_or_gene_product
,	O
resulting	O
in	O
the	O
release	O
of	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
from	O
the	O
phosphorylation	O
complex	O
.	O

Novel	O
inositol	B-Gene_or_gene_product
polyphosphate	I-Gene_or_gene_product
5	I-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
localizes	O
at	O
membrane	O
ruffles	O
.	O
<EOS>	B-X
We	B-X
have	B-X
cloned	B-X
a	B-X
novel	B-X
inositol	B-X
polyphosphate	B-X
5-phosphatase	B-X
from	B-X
the	B-X
rat	B-X
brain	B-X
cDNA	B-X
library	B-X
.	B-X
It	B-X
contains	B-X
two	B-X
highly	B-X
conserved	B-X
5-phosphatase	B-X
motifs	B-X
,	B-X
both	B-X
of	B-X
which	B-X
are	B-X
essential	B-X
for	B-X
its	B-X
enzymatic	B-X
activity	B-X
.	B-X
This	B-X
enzyme	B-X
hydrolyzed	B-X
phosphate	B-X
at	B-X
the	B-X
D-5	B-X
position	B-X
of	B-X
inositol	B-X
1,4,5-trisphosphate	B-X
,	B-X
inositol	B-X
1,3,4	B-X
,	B-X
5-tetrakisphosphate	B-X
,	B-X
and	B-X
phosphatidylinositol	B-X
4,5-bisphosphate	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
substrate	B-X
specificity	B-X
of	B-X
type	B-X
II	B-X
5-phosphatase	B-X
,	B-X
OCRL	B-X
,	B-X
synaptojanin	B-X
and	B-X
synaptojanin	B-X
2	B-X
,	B-X
already	B-X
characterized	B-X
5-phosphatases	B-X
.	B-X
When	B-X
the	B-X
Myc-epitope-tagged	B-X
enzyme	B-X
was	B-X
expressed	B-X
in	B-X
COS-7	B-X
cells	B-X
and	B-X
stained	B-X
with	B-X
anti-Myc	B-X
polyclonal	B-X
antibody	B-X
,	B-X
a	B-X
signal	B-X
was	B-X
observed	B-X
at	B-X
ruffling	B-X
membranes	B-X
and	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
We	B-X
prepared	B-X
several	B-X
deletion	B-X
mutants	B-X
and	B-X
demonstrated	B-X
that	B-X
the	B-X
123	B-X
N-terminal	B-X
amino	B-X
acids	B-X
(	B-X
311-433	B-X
)	B-X
and	B-X
a	B-X
C-terminal	B-X
proline-rich	B-X
region	B-X
containing	B-X
277	B-X
amino	B-X
acids	B-X
(	B-X
725-1001	B-X
)	B-X
were	B-X
essential	B-X
for	B-X
its	B-X
localization	B-X
to	B-X
ruffling	B-X
membranes	B-X
.	B-X
This	B-X
enzyme	B-X
might	B-X
regulate	B-X
the	B-X
level	B-X
of	B-X
inositol	B-X
and	B-X
phosphatidylinositol	B-X
polyphosphates	B-X
at	B-X
membrane	B-X
ruffles	B-X
.	B-X

We	O
have	O
cloned	O
a	O
novel	O
inositol	B-Gene_or_gene_product
polyphosphate	I-Gene_or_gene_product
5	I-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
from	O
the	O
rat	O
brain	O
cDNA	O
library	O
.	O
<EOS>	B-X
We	B-X
have	B-X
cloned	B-X
a	B-X
novel	B-X
inositol	B-X
polyphosphate	B-X
5-phosphatase	B-X
from	B-X
the	B-X
rat	B-X
brain	B-X
cDNA	B-X
library	B-X
.	B-X
It	B-X
contains	B-X
two	B-X
highly	B-X
conserved	B-X
5-phosphatase	B-X
motifs	B-X
,	B-X
both	B-X
of	B-X
which	B-X
are	B-X
essential	B-X
for	B-X
its	B-X
enzymatic	B-X
activity	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
proline	B-X
content	B-X
of	B-X
this	B-X
protein	B-X
is	B-X
high	B-X
and	B-X
concentrated	B-X
in	B-X
its	B-X
N-	B-X
and	B-X
C-terminal	B-X
regions	B-X
.	B-X
This	B-X
enzyme	B-X
hydrolyzed	B-X
phosphate	B-X
at	B-X
the	B-X
D-5	B-X
position	B-X
of	B-X
inositol	B-X
1,4,5-trisphosphate	B-X
,	B-X
inositol	B-X
1,3,4	B-X
,	B-X
5-tetrakisphosphate	B-X
,	B-X
and	B-X
phosphatidylinositol	B-X
4,5-bisphosphate	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
substrate	B-X
specificity	B-X
of	B-X
type	B-X
II	B-X
5-phosphatase	B-X
,	B-X
OCRL	B-X
,	B-X
synaptojanin	B-X
and	B-X
synaptojanin	B-X
2	B-X
,	B-X
already	B-X
characterized	B-X
5-phosphatases	B-X
.	B-X
We	B-X
prepared	B-X
several	B-X
deletion	B-X
mutants	B-X
and	B-X
demonstrated	B-X
that	B-X
the	B-X
123	B-X
N-terminal	B-X
amino	B-X
acids	B-X
(	B-X
311-433	B-X
)	B-X
and	B-X
a	B-X
C-terminal	B-X
proline-rich	B-X
region	B-X
containing	B-X
277	B-X
amino	B-X
acids	B-X
(	B-X
725-1001	B-X
)	B-X
were	B-X
essential	B-X
for	B-X
its	B-X
localization	B-X
to	B-X
ruffling	B-X
membranes	B-X
.	B-X
This	B-X
enzyme	B-X
might	B-X
regulate	B-X
the	B-X
level	B-X
of	B-X
inositol	B-X
and	B-X
phosphatidylinositol	B-X
polyphosphates	B-X
at	B-X
membrane	B-X
ruffles	B-X
.	B-X

It	O
contains	O
two	O
highly	O
conserved	O
5	B-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
motifs	O
,	O
both	O
of	O
which	O
are	O
essential	O
for	O
its	O
enzymatic	O
activity	O
.	O
<EOS>	B-X
We	B-X
have	B-X
cloned	B-X
a	B-X
novel	B-X
inositol	B-X
polyphosphate	B-X
5-phosphatase	B-X
from	B-X
the	B-X
rat	B-X
brain	B-X
cDNA	B-X
library	B-X
.	B-X
It	B-X
contains	B-X
two	B-X
highly	B-X
conserved	B-X
5-phosphatase	B-X
motifs	B-X
,	B-X
both	B-X
of	B-X
which	B-X
are	B-X
essential	B-X
for	B-X
its	B-X
enzymatic	B-X
activity	B-X
.	B-X
One	B-X
putative	B-X
SH3-binding	B-X
motif	B-X
and	B-X
six	B-X
14-3-3	B-X
zeta-binding	B-X
motifs	B-X
were	B-X
found	B-X
in	B-X
the	B-X
amino	B-X
acid	B-X
sequence	B-X
.	B-X
This	B-X
enzyme	B-X
hydrolyzed	B-X
phosphate	B-X
at	B-X
the	B-X
D-5	B-X
position	B-X
of	B-X
inositol	B-X
1,4,5-trisphosphate	B-X
,	B-X
inositol	B-X
1,3,4	B-X
,	B-X
5-tetrakisphosphate	B-X
,	B-X
and	B-X
phosphatidylinositol	B-X
4,5-bisphosphate	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
substrate	B-X
specificity	B-X
of	B-X
type	B-X
II	B-X
5-phosphatase	B-X
,	B-X
OCRL	B-X
,	B-X
synaptojanin	B-X
and	B-X
synaptojanin	B-X
2	B-X
,	B-X
already	B-X
characterized	B-X
5-phosphatases	B-X
.	B-X
We	B-X
prepared	B-X
several	B-X
deletion	B-X
mutants	B-X
and	B-X
demonstrated	B-X
that	B-X
the	B-X
123	B-X
N-terminal	B-X
amino	B-X
acids	B-X
(	B-X
311-433	B-X
)	B-X
and	B-X
a	B-X
C-terminal	B-X
proline-rich	B-X
region	B-X
containing	B-X
277	B-X
amino	B-X
acids	B-X
(	B-X
725-1001	B-X
)	B-X
were	B-X
essential	B-X
for	B-X
its	B-X
localization	B-X
to	B-X
ruffling	B-X
membranes	B-X
.	B-X

Interestingly	O
,	O
the	O
proline	O
content	O
of	O
this	O
protein	O
is	O
high	O
and	O
concentrated	O
in	O
its	O
N	O
-	O
and	O
C	O
-	O
terminal	O
regions	O
.	O

One	O
putative	O
SH3	O
-	O
binding	O
motif	O
and	O
six	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
zeta	I-Gene_or_gene_product
-	O
binding	O
motifs	O
were	O
found	O
in	O
the	O
amino	O
acid	O
sequence	O
.	O
<EOS>	B-X
It	B-X
contains	B-X
two	B-X
highly	B-X
conserved	B-X
5-phosphatase	B-X
motifs	B-X
,	B-X
both	B-X
of	B-X
which	B-X
are	B-X
essential	B-X
for	B-X
its	B-X
enzymatic	B-X
activity	B-X
.	B-X
One	B-X
putative	B-X
SH3-binding	B-X
motif	B-X
and	B-X
six	B-X
14-3-3	B-X
zeta-binding	B-X
motifs	B-X
were	B-X
found	B-X
in	B-X
the	B-X
amino	B-X
acid	B-X
sequence	B-X
.	B-X
This	B-X
enzyme	B-X
hydrolyzed	B-X
phosphate	B-X
at	B-X
the	B-X
D-5	B-X
position	B-X
of	B-X
inositol	B-X
1,4,5-trisphosphate	B-X
,	B-X
inositol	B-X
1,3,4	B-X
,	B-X
5-tetrakisphosphate	B-X
,	B-X
and	B-X
phosphatidylinositol	B-X
4,5-bisphosphate	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
substrate	B-X
specificity	B-X
of	B-X
type	B-X
II	B-X
5-phosphatase	B-X
,	B-X
OCRL	B-X
,	B-X
synaptojanin	B-X
and	B-X
synaptojanin	B-X
2	B-X
,	B-X
already	B-X
characterized	B-X
5-phosphatases	B-X
.	B-X
We	B-X
prepared	B-X
several	B-X
deletion	B-X
mutants	B-X
and	B-X
demonstrated	B-X
that	B-X
the	B-X
123	B-X
N-terminal	B-X
amino	B-X
acids	B-X
(	B-X
311-433	B-X
)	B-X
and	B-X
a	B-X
C-terminal	B-X
proline-rich	B-X
region	B-X
containing	B-X
277	B-X
amino	B-X
acids	B-X
(	B-X
725-1001	B-X
)	B-X
were	B-X
essential	B-X
for	B-X
its	B-X
localization	B-X
to	B-X
ruffling	B-X
membranes	B-X
.	B-X

This	O
enzyme	O
hydrolyzed	O
phosphate	O
at	O
the	O
D	O
-	O
5	O
position	O
of	O
inositol	O
1	O
,	O
4	O
,	O
5	O
-	O
trisphosphate	O
,	O
inositol	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
-	O
tetrakisphosphate	O
,	O
and	O
phosphatidylinositol	O
4	O
,	O
5	O
-	O
bisphosphate	O
,	O
consistent	O
with	O
the	O
substrate	O
specificity	O
of	O
type	B-Gene_or_gene_product
II	I-Gene_or_gene_product
5	I-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
,	O
OCRL	B-Gene_or_gene_product
,	O
synaptojanin	B-Gene_or_gene_product
and	O
synaptojanin	B-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
already	O
characterized	O
5	B-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphatases	I-Gene_or_gene_product
.	O

When	O
the	O
Myc	B-Gene_or_gene_product
-	O
epitope	O
-	O
tagged	O
enzyme	O
was	O
expressed	O
in	O
COS	O
-	O
7	O
cells	O
and	O
stained	O
with	O
anti	O
-	O
Myc	B-Gene_or_gene_product
polyclonal	O
antibody	O
,	O
a	O
signal	O
was	O
observed	O
at	O
ruffling	O
membranes	O
and	O
in	O
the	O
cytoplasm	O
.	O
<EOS>	B-X
This	B-X
enzyme	B-X
hydrolyzed	B-X
phosphate	B-X
at	B-X
the	B-X
D-5	B-X
position	B-X
of	B-X
inositol	B-X
1,4,5-trisphosphate	B-X
,	B-X
inositol	B-X
1,3,4	B-X
,	B-X
5-tetrakisphosphate	B-X
,	B-X
and	B-X
phosphatidylinositol	B-X
4,5-bisphosphate	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
substrate	B-X
specificity	B-X
of	B-X
type	B-X
II	B-X
5-phosphatase	B-X
,	B-X
OCRL	B-X
,	B-X
synaptojanin	B-X
and	B-X
synaptojanin	B-X
2	B-X
,	B-X
already	B-X
characterized	B-X
5-phosphatases	B-X
.	B-X
When	B-X
the	B-X
Myc-epitope-tagged	B-X
enzyme	B-X
was	B-X
expressed	B-X
in	B-X
COS-7	B-X
cells	B-X
and	B-X
stained	B-X
with	B-X
anti-Myc	B-X
polyclonal	B-X
antibody	B-X
,	B-X
a	B-X
signal	B-X
was	B-X
observed	B-X
at	B-X
ruffling	B-X
membranes	B-X
and	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
We	B-X
prepared	B-X
several	B-X
deletion	B-X
mutants	B-X
and	B-X
demonstrated	B-X
that	B-X
the	B-X
123	B-X
N-terminal	B-X
amino	B-X
acids	B-X
(	B-X
311-433	B-X
)	B-X
and	B-X
a	B-X
C-terminal	B-X
proline-rich	B-X
region	B-X
containing	B-X
277	B-X
amino	B-X
acids	B-X
(	B-X
725-1001	B-X
)	B-X
were	B-X
essential	B-X
for	B-X
its	B-X
localization	B-X
to	B-X
ruffling	B-X
membranes	B-X
.	B-X
This	B-X
enzyme	B-X
might	B-X
regulate	B-X
the	B-X
level	B-X
of	B-X
inositol	B-X
and	B-X
phosphatidylinositol	B-X
polyphosphates	B-X
at	B-X
membrane	B-X
ruffles	B-X
.	B-X

We	O
prepared	O
several	O
deletion	O
mutants	O
and	O
demonstrated	O
that	O
the	O
123	O
N	O
-	O
terminal	O
amino	O
acids	O
(	O
311	O
-	O
433	O
)	O
and	O
a	O
C	O
-	O
terminal	O
proline	O
-	O
rich	O
region	O
containing	O
277	O
amino	O
acids	O
(	O
725	O
-	O
1001	O
)	O
were	O
essential	O
for	O
its	O
localization	O
to	O
ruffling	O
membranes	O
.	O

This	O
enzyme	O
might	O
regulate	O
the	O
level	O
of	O
inositol	O
and	O
phosphatidylinositol	O
polyphosphates	O
at	O
membrane	O
ruffles	O
.	O
<EOS>	B-X
We	B-X
have	B-X
cloned	B-X
a	B-X
novel	B-X
inositol	B-X
polyphosphate	B-X
5-phosphatase	B-X
from	B-X
the	B-X
rat	B-X
brain	B-X
cDNA	B-X
library	B-X
.	B-X
This	B-X
enzyme	B-X
hydrolyzed	B-X
phosphate	B-X
at	B-X
the	B-X
D-5	B-X
position	B-X
of	B-X
inositol	B-X
1,4,5-trisphosphate	B-X
,	B-X
inositol	B-X
1,3,4	B-X
,	B-X
5-tetrakisphosphate	B-X
,	B-X
and	B-X
phosphatidylinositol	B-X
4,5-bisphosphate	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
substrate	B-X
specificity	B-X
of	B-X
type	B-X
II	B-X
5-phosphatase	B-X
,	B-X
OCRL	B-X
,	B-X
synaptojanin	B-X
and	B-X
synaptojanin	B-X
2	B-X
,	B-X
already	B-X
characterized	B-X
5-phosphatases	B-X
.	B-X
When	B-X
the	B-X
Myc-epitope-tagged	B-X
enzyme	B-X
was	B-X
expressed	B-X
in	B-X
COS-7	B-X
cells	B-X
and	B-X
stained	B-X
with	B-X
anti-Myc	B-X
polyclonal	B-X
antibody	B-X
,	B-X
a	B-X
signal	B-X
was	B-X
observed	B-X
at	B-X
ruffling	B-X
membranes	B-X
and	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
We	B-X
prepared	B-X
several	B-X
deletion	B-X
mutants	B-X
and	B-X
demonstrated	B-X
that	B-X
the	B-X
123	B-X
N-terminal	B-X
amino	B-X
acids	B-X
(	B-X
311-433	B-X
)	B-X
and	B-X
a	B-X
C-terminal	B-X
proline-rich	B-X
region	B-X
containing	B-X
277	B-X
amino	B-X
acids	B-X
(	B-X
725-1001	B-X
)	B-X
were	B-X
essential	B-X
for	B-X
its	B-X
localization	B-X
to	B-X
ruffling	B-X
membranes	B-X
.	B-X
This	B-X
enzyme	B-X
might	B-X
regulate	B-X
the	B-X
level	B-X
of	B-X
inositol	B-X
and	B-X
phosphatidylinositol	B-X
polyphosphates	B-X
at	B-X
membrane	B-X
ruffles	B-X
.	B-X

The	O
I	O
kappa	O
B	O
kinase	O
(	O
IKK	O
)	O
and	O
NF	O
-	O
kappa	O
B	O
:	O
key	O
elements	O
of	O
proinflammatory	O
signalling	O
.	O
<EOS>	B-X
NF-kappa	B-X
B	B-X
is	B-X
a	B-X
heterodimeric	B-X
transcription	B-X
factor	B-X
that	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
inflammatory	B-X
and	B-X
immune	B-X
responses	B-X
.	B-X
In	B-X
nonstimulated	B-X
cells	B-X
,	B-X
NF-kappa	B-X
B	B-X
dimers	B-X
are	B-X
maintained	B-X
in	B-X
the	B-X
cytoplasm	B-X
through	B-X
interaction	B-X
with	B-X
inhibitory	B-X
proteins	B-X
,	B-X
the	B-X
I	B-X
kappa	B-X
Bs	B-X
.	B-X
In	B-X
response	B-X
to	B-X
cell	B-X
stimulation	B-X
,	B-X
mainly	B-X
by	B-X
proinflammatory	B-X
cytokines	B-X
,	B-X
a	B-X
multisubunit	B-X
protein	B-X
kinase	B-X
,	B-X
the	B-X
I	B-X
kappa	B-X
B	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
,	B-X
is	B-X
rapidly	B-X
activated	B-X
and	B-X
phosphorylates	B-X
two	B-X
critical	B-X
serines	B-X
in	B-X
the	B-X
N-terminal	B-X
regulatory	B-X
domain	B-X
of	B-X
the	B-X
I	B-X
kappa	B-X
Bs	B-X
.	B-X
Phosphorylated	B-X
I	B-X
kappa	B-X
Bs	B-X
are	B-X
recognized	B-X
by	B-X
a	B-X
specific	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
and	B-X
undergo	B-X
polyubiquitination	B-X
which	B-X
targets	B-X
them	B-X
for	B-X
rapid	B-X
degradation	B-X
by	B-X
the	B-X
26S	B-X
proteasome	B-X
.	B-X
NF-kappa	B-X
B	B-X
dimers	B-X
,	B-X
which	B-X
are	B-X
spared	B-X
from	B-X
degradation	B-X
,	B-X
translocate	B-X
to	B-X
the	B-X
nucleus	B-X
to	B-X
activate	B-X
gene	B-X
transcription	B-X
.	B-X
There	B-X
is	B-X
strong	B-X
biochemical	B-X
and	B-X
genetic	B-X
evidence	B-X
that	B-X
the	B-X
IKK	B-X
complex	B-X
,	B-X
which	B-X
consists	B-X
of	B-X
two	B-X
catalytic	B-X
subunits	B-X
,	B-X
IKK	B-X
alpha	B-X
and	B-X
IKK	B-X
beta	B-X
,	B-X
and	B-X
a	B-X
regulatory	B-X
subunit	B-X
,	B-X
IKK	B-X
gamma	B-X
,	B-X
is	B-X
the	B-X
master	B-X
regulator	B-X
of	B-X
NF-kappa	B-X
B-mediated	B-X
innate	B-X
immune	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
IKK	B-X
gamma	B-X
,	B-X
which	B-X
normally	B-X
connects	B-X
IKK	B-X
to	B-X
upstream	B-X
activators	B-X
,	B-X
no	B-X
IKK	B-X
or	B-X
NF-kappa	B-X
B	B-X
activation	B-X
can	B-X
occur	B-X
.	B-X
Surprisingly	B-X
,	B-X
however	B-X
,	B-X
of	B-X
the	B-X
two	B-X
catalytic	B-X
subunits	B-X
,	B-X
only	B-X
IKK	B-X
beta	B-X
is	B-X
essential	B-X
for	B-X
NF-kappa	B-X
B	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
proinflammatory	B-X
stimuli	B-X
.	B-X
The	B-X
second	B-X
catalytic	B-X
subunit	B-X
,	B-X
IKK	B-X
alpha	B-X
,	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
developmental	B-X
processes	B-X
,	B-X
in	B-X
particular	B-X
formation	B-X
and	B-X
differentiation	B-X
of	B-X
the	B-X
epidermis	B-X
.	B-X

NF	O
-	O
kappa	O
B	O
is	O
a	O
heterodimeric	O
transcription	O
factor	O
that	O
plays	O
a	O
key	O
role	O
in	O
inflammatory	O
and	O
immune	O
responses	O
.	O

In	O
nonstimulated	O
cells	O
,	O
NF	O
-	O
kappa	O
B	O
dimers	O
are	O
maintained	O
in	O
the	O
cytoplasm	O
through	O
interaction	O
with	O
inhibitory	O
proteins	O
,	O
the	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
Bs	I-Gene_or_gene_product
.	O
<EOS>	B-X
NF-kappa	B-X
B	B-X
is	B-X
a	B-X
heterodimeric	B-X
transcription	B-X
factor	B-X
that	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
inflammatory	B-X
and	B-X
immune	B-X
responses	B-X
.	B-X
In	B-X
nonstimulated	B-X
cells	B-X
,	B-X
NF-kappa	B-X
B	B-X
dimers	B-X
are	B-X
maintained	B-X
in	B-X
the	B-X
cytoplasm	B-X
through	B-X
interaction	B-X
with	B-X
inhibitory	B-X
proteins	B-X
,	B-X
the	B-X
I	B-X
kappa	B-X
Bs	B-X
.	B-X
In	B-X
response	B-X
to	B-X
cell	B-X
stimulation	B-X
,	B-X
mainly	B-X
by	B-X
proinflammatory	B-X
cytokines	B-X
,	B-X
a	B-X
multisubunit	B-X
protein	B-X
kinase	B-X
,	B-X
the	B-X
I	B-X
kappa	B-X
B	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
,	B-X
is	B-X
rapidly	B-X
activated	B-X
and	B-X
phosphorylates	B-X
two	B-X
critical	B-X
serines	B-X
in	B-X
the	B-X
N-terminal	B-X
regulatory	B-X
domain	B-X
of	B-X
the	B-X
I	B-X
kappa	B-X
Bs	B-X
.	B-X
Phosphorylated	B-X
I	B-X
kappa	B-X
Bs	B-X
are	B-X
recognized	B-X
by	B-X
a	B-X
specific	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
and	B-X
undergo	B-X
polyubiquitination	B-X
which	B-X
targets	B-X
them	B-X
for	B-X
rapid	B-X
degradation	B-X
by	B-X
the	B-X
26S	B-X
proteasome	B-X
.	B-X
NF-kappa	B-X
B	B-X
dimers	B-X
,	B-X
which	B-X
are	B-X
spared	B-X
from	B-X
degradation	B-X
,	B-X
translocate	B-X
to	B-X
the	B-X
nucleus	B-X
to	B-X
activate	B-X
gene	B-X
transcription	B-X
.	B-X
There	B-X
is	B-X
strong	B-X
biochemical	B-X
and	B-X
genetic	B-X
evidence	B-X
that	B-X
the	B-X
IKK	B-X
complex	B-X
,	B-X
which	B-X
consists	B-X
of	B-X
two	B-X
catalytic	B-X
subunits	B-X
,	B-X
IKK	B-X
alpha	B-X
and	B-X
IKK	B-X
beta	B-X
,	B-X
and	B-X
a	B-X
regulatory	B-X
subunit	B-X
,	B-X
IKK	B-X
gamma	B-X
,	B-X
is	B-X
the	B-X
master	B-X
regulator	B-X
of	B-X
NF-kappa	B-X
B-mediated	B-X
innate	B-X
immune	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
IKK	B-X
gamma	B-X
,	B-X
which	B-X
normally	B-X
connects	B-X
IKK	B-X
to	B-X
upstream	B-X
activators	B-X
,	B-X
no	B-X
IKK	B-X
or	B-X
NF-kappa	B-X
B	B-X
activation	B-X
can	B-X
occur	B-X
.	B-X
Surprisingly	B-X
,	B-X
however	B-X
,	B-X
of	B-X
the	B-X
two	B-X
catalytic	B-X
subunits	B-X
,	B-X
only	B-X
IKK	B-X
beta	B-X
is	B-X
essential	B-X
for	B-X
NF-kappa	B-X
B	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
proinflammatory	B-X
stimuli	B-X
.	B-X

In	O
response	O
to	O
cell	O
stimulation	O
,	O
mainly	O
by	O
proinflammatory	O
cytokines	O
,	O
a	O
multisubunit	O
protein	O
kinase	O
,	O
the	O
I	O
kappa	O
B	O
kinase	O
(	O
IKK	O
)	O
,	O
is	O
rapidly	O
activated	O
and	O
phosphorylates	O
two	O
critical	O
serines	O
in	O
the	O
N	O
-	O
terminal	O
regulatory	O
domain	O
of	O
the	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
Bs	I-Gene_or_gene_product
.	O

Phosphorylated	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
Bs	I-Gene_or_gene_product
are	O
recognized	O
by	O
a	O
specific	O
E3	O
ubiquitin	B-Gene_or_gene_product
ligase	O
complex	O
and	O
undergo	O
polyubiquitination	O
which	O
targets	O
them	O
for	O
rapid	O
degradation	O
by	O
the	O
26S	O
proteasome	O
.	O
<EOS>	B-X
NF-kappa	B-X
B	B-X
is	B-X
a	B-X
heterodimeric	B-X
transcription	B-X
factor	B-X
that	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
inflammatory	B-X
and	B-X
immune	B-X
responses	B-X
.	B-X
In	B-X
nonstimulated	B-X
cells	B-X
,	B-X
NF-kappa	B-X
B	B-X
dimers	B-X
are	B-X
maintained	B-X
in	B-X
the	B-X
cytoplasm	B-X
through	B-X
interaction	B-X
with	B-X
inhibitory	B-X
proteins	B-X
,	B-X
the	B-X
I	B-X
kappa	B-X
Bs	B-X
.	B-X
In	B-X
response	B-X
to	B-X
cell	B-X
stimulation	B-X
,	B-X
mainly	B-X
by	B-X
proinflammatory	B-X
cytokines	B-X
,	B-X
a	B-X
multisubunit	B-X
protein	B-X
kinase	B-X
,	B-X
the	B-X
I	B-X
kappa	B-X
B	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
,	B-X
is	B-X
rapidly	B-X
activated	B-X
and	B-X
phosphorylates	B-X
two	B-X
critical	B-X
serines	B-X
in	B-X
the	B-X
N-terminal	B-X
regulatory	B-X
domain	B-X
of	B-X
the	B-X
I	B-X
kappa	B-X
Bs	B-X
.	B-X
Phosphorylated	B-X
I	B-X
kappa	B-X
Bs	B-X
are	B-X
recognized	B-X
by	B-X
a	B-X
specific	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
and	B-X
undergo	B-X
polyubiquitination	B-X
which	B-X
targets	B-X
them	B-X
for	B-X
rapid	B-X
degradation	B-X
by	B-X
the	B-X
26S	B-X
proteasome	B-X
.	B-X
NF-kappa	B-X
B	B-X
dimers	B-X
,	B-X
which	B-X
are	B-X
spared	B-X
from	B-X
degradation	B-X
,	B-X
translocate	B-X
to	B-X
the	B-X
nucleus	B-X
to	B-X
activate	B-X
gene	B-X
transcription	B-X
.	B-X
There	B-X
is	B-X
strong	B-X
biochemical	B-X
and	B-X
genetic	B-X
evidence	B-X
that	B-X
the	B-X
IKK	B-X
complex	B-X
,	B-X
which	B-X
consists	B-X
of	B-X
two	B-X
catalytic	B-X
subunits	B-X
,	B-X
IKK	B-X
alpha	B-X
and	B-X
IKK	B-X
beta	B-X
,	B-X
and	B-X
a	B-X
regulatory	B-X
subunit	B-X
,	B-X
IKK	B-X
gamma	B-X
,	B-X
is	B-X
the	B-X
master	B-X
regulator	B-X
of	B-X
NF-kappa	B-X
B-mediated	B-X
innate	B-X
immune	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
IKK	B-X
gamma	B-X
,	B-X
which	B-X
normally	B-X
connects	B-X
IKK	B-X
to	B-X
upstream	B-X
activators	B-X
,	B-X
no	B-X
IKK	B-X
or	B-X
NF-kappa	B-X
B	B-X
activation	B-X
can	B-X
occur	B-X
.	B-X
Surprisingly	B-X
,	B-X
however	B-X
,	B-X
of	B-X
the	B-X
two	B-X
catalytic	B-X
subunits	B-X
,	B-X
only	B-X
IKK	B-X
beta	B-X
is	B-X
essential	B-X
for	B-X
NF-kappa	B-X
B	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
proinflammatory	B-X
stimuli	B-X
.	B-X

NF	O
-	O
kappa	O
B	O
dimers	O
,	O
which	O
are	O
spared	O
from	O
degradation	O
,	O
translocate	O
to	O
the	O
nucleus	O
to	O
activate	O
gene	O
transcription	O
.	O

There	O
is	O
strong	O
biochemical	O
and	O
genetic	O
evidence	O
that	O
the	O
IKK	O
complex	O
,	O
which	O
consists	O
of	O
two	O
catalytic	O
subunits	O
,	O
IKK	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
IKK	B-Gene_or_gene_product
beta	I-Gene_or_gene_product
,	O
and	O
a	O
regulatory	O
subunit	O
,	O
IKK	B-Gene_or_gene_product
gamma	I-Gene_or_gene_product
,	O
is	O
the	O
master	O
regulator	O
of	O
NF	O
-	O
kappa	O
B	O
-	O
mediated	O
innate	O
immune	O
and	O
inflammatory	O
responses	O
.	O

In	O
the	O
absence	O
of	O
IKK	B-Gene_or_gene_product
gamma	I-Gene_or_gene_product
,	O
which	O
normally	O
connects	O
IKK	O
to	O
upstream	O
activators	O
,	O
no	O
IKK	O
or	O
NF	O
-	O
kappa	O
B	O
activation	O
can	O
occur	O
.	O
<EOS>	B-X
NF-κB	B-X
pathway	B-X
consists	B-X
of	B-X
canonical	B-X
and	B-X
non-canonical	B-X
pathways	B-X
.	B-X
The	B-X
canonical	B-X
NF-κB	B-X
is	B-X
activated	B-X
by	B-X
various	B-X
stimuli	B-X
,	B-X
transducing	B-X
a	B-X
quick	B-X
but	B-X
transient	B-X
transcriptional	B-X
activity	B-X
,	B-X
to	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
various	B-X
proinflammatory	B-X
genes	B-X
and	B-X
also	B-X
serve	B-X
as	B-X
the	B-X
critical	B-X
mediator	B-X
for	B-X
inflammatory	B-X
response	B-X
.	B-X
Meanwhile	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
non-canonical	B-X
NF-κB	B-X
pathway	B-X
occurs	B-X
through	B-X
a	B-X
handful	B-X
of	B-X
TNF	B-X
receptor	B-X
superfamily	B-X
members	B-X
.	B-X
Since	B-X
the	B-X
activation	B-X
of	B-X
this	B-X
pathway	B-X
involves	B-X
protein	B-X
synthesis	B-X
,	B-X
the	B-X
kinetics	B-X
of	B-X
non-canonical	B-X
NF-κB	B-X
activation	B-X
is	B-X
slow	B-X
but	B-X
persistent	B-X
,	B-X
in	B-X
concordance	B-X
with	B-X
its	B-X
biological	B-X
functions	B-X
in	B-X
the	B-X
development	B-X
of	B-X
immune	B-X
cell	B-X
and	B-X
lymphoid	B-X
organ	B-X
,	B-X
immune	B-X
homeostasis	B-X
and	B-X
immune	B-X
response	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
the	B-X
canonical	B-X
and	B-X
non-canonical	B-X
NF-κB	B-X
pathway	B-X
is	B-X
tightly	B-X
controlled	B-X
,	B-X
highlighting	B-X
the	B-X
vital	B-X
roles	B-X
of	B-X
ubiquitination	B-X
in	B-X
these	B-X
pathways	B-X
.	B-X
Emerging	B-X
studies	B-X
indicate	B-X
that	B-X
dysregulated	B-X
NF-κB	B-X
activity	B-X
causes	B-X
inflammation-related	B-X
diseases	B-X
as	B-X
well	B-X
as	B-X
cancers	B-X
,	B-X
and	B-X
NF-κB	B-X
has	B-X
been	B-X
long	B-X
proposed	B-X
as	B-X
the	B-X
potential	B-X
target	B-X
for	B-X
therapy	B-X
of	B-X
diseases	B-X
.	B-X
This	B-X
review	B-X
attempts	B-X
to	B-X
summarize	B-X
our	B-X
current	B-X
knowledge	B-X
and	B-X
updates	B-X
on	B-X
the	B-X
mechanisms	B-X
of	B-X
NF-κB	B-X
pathway	B-X
regulation	B-X
and	B-X
the	B-X
potential	B-X
therapeutic	B-X
application	B-X
of	B-X
inhibition	B-X
of	B-X
NF-κB	B-X
signaling	B-X
in	B-X
cancer	B-X
and	B-X
inflammatory	B-X
diseases	B-X
.	B-X

Surprisingly	O
,	O
however	O
,	O
of	O
the	O
two	O
catalytic	O
subunits	O
,	O
only	O
IKK	B-Gene_or_gene_product
beta	I-Gene_or_gene_product
is	O
essential	O
for	O
NF	O
-	O
kappa	O
B	O
activation	O
in	O
response	O
to	O
proinflammatory	O
stimuli	O
.	O
<EOS>	B-X
NF-kappa	B-X
B	B-X
is	B-X
a	B-X
heterodimeric	B-X
transcription	B-X
factor	B-X
that	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
inflammatory	B-X
and	B-X
immune	B-X
responses	B-X
.	B-X
In	B-X
nonstimulated	B-X
cells	B-X
,	B-X
NF-kappa	B-X
B	B-X
dimers	B-X
are	B-X
maintained	B-X
in	B-X
the	B-X
cytoplasm	B-X
through	B-X
interaction	B-X
with	B-X
inhibitory	B-X
proteins	B-X
,	B-X
the	B-X
I	B-X
kappa	B-X
Bs	B-X
.	B-X
In	B-X
response	B-X
to	B-X
cell	B-X
stimulation	B-X
,	B-X
mainly	B-X
by	B-X
proinflammatory	B-X
cytokines	B-X
,	B-X
a	B-X
multisubunit	B-X
protein	B-X
kinase	B-X
,	B-X
the	B-X
I	B-X
kappa	B-X
B	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
,	B-X
is	B-X
rapidly	B-X
activated	B-X
and	B-X
phosphorylates	B-X
two	B-X
critical	B-X
serines	B-X
in	B-X
the	B-X
N-terminal	B-X
regulatory	B-X
domain	B-X
of	B-X
the	B-X
I	B-X
kappa	B-X
Bs	B-X
.	B-X
Phosphorylated	B-X
I	B-X
kappa	B-X
Bs	B-X
are	B-X
recognized	B-X
by	B-X
a	B-X
specific	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
and	B-X
undergo	B-X
polyubiquitination	B-X
which	B-X
targets	B-X
them	B-X
for	B-X
rapid	B-X
degradation	B-X
by	B-X
the	B-X
26S	B-X
proteasome	B-X
.	B-X
NF-kappa	B-X
B	B-X
dimers	B-X
,	B-X
which	B-X
are	B-X
spared	B-X
from	B-X
degradation	B-X
,	B-X
translocate	B-X
to	B-X
the	B-X
nucleus	B-X
to	B-X
activate	B-X
gene	B-X
transcription	B-X
.	B-X
There	B-X
is	B-X
strong	B-X
biochemical	B-X
and	B-X
genetic	B-X
evidence	B-X
that	B-X
the	B-X
IKK	B-X
complex	B-X
,	B-X
which	B-X
consists	B-X
of	B-X
two	B-X
catalytic	B-X
subunits	B-X
,	B-X
IKK	B-X
alpha	B-X
and	B-X
IKK	B-X
beta	B-X
,	B-X
and	B-X
a	B-X
regulatory	B-X
subunit	B-X
,	B-X
IKK	B-X
gamma	B-X
,	B-X
is	B-X
the	B-X
master	B-X
regulator	B-X
of	B-X
NF-kappa	B-X
B-mediated	B-X
innate	B-X
immune	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
IKK	B-X
gamma	B-X
,	B-X
which	B-X
normally	B-X
connects	B-X
IKK	B-X
to	B-X
upstream	B-X
activators	B-X
,	B-X
no	B-X
IKK	B-X
or	B-X
NF-kappa	B-X
B	B-X
activation	B-X
can	B-X
occur	B-X
.	B-X
Surprisingly	B-X
,	B-X
however	B-X
,	B-X
of	B-X
the	B-X
two	B-X
catalytic	B-X
subunits	B-X
,	B-X
only	B-X
IKK	B-X
beta	B-X
is	B-X
essential	B-X
for	B-X
NF-kappa	B-X
B	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
proinflammatory	B-X
stimuli	B-X
.	B-X
The	B-X
second	B-X
catalytic	B-X
subunit	B-X
,	B-X
IKK	B-X
alpha	B-X
,	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
developmental	B-X
processes	B-X
,	B-X
in	B-X
particular	B-X
formation	B-X
and	B-X
differentiation	B-X
of	B-X
the	B-X
epidermis	B-X
.	B-X

The	O
second	O
catalytic	O
subunit	O
,	O
IKK	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
,	O
plays	O
a	O
critical	O
role	O
in	O
developmental	O
processes	O
,	O
in	O
particular	O
formation	O
and	O
differentiation	O
of	O
the	O
epidermis	O
.	O

Forkhead	B-Gene_or_gene_product
genes	O
in	O
transcriptional	O
silencing	O
,	O
cell	O
morphology	O
and	O
the	O
cell	O
cycle	O
.	O
<EOS>	B-X
The	B-X
SIR1	B-X
gene	B-X
is	B-X
one	B-X
of	B-X
four	B-X
specialized	B-X
genes	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
required	B-X
for	B-X
repressing	B-X
transcription	B-X
at	B-X
the	B-X
silent	B-X
mating-type	B-X
cassettes	B-X
,	B-X
HMLalpha	B-X
and	B-X
HMRa	B-X
,	B-X
by	B-X
a	B-X
mechanism	B-X
known	B-X
as	B-X
silencing	B-X
.	B-X
FKH1	B-X
was	B-X
isolated	B-X
as	B-X
a	B-X
gene	B-X
that	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
multiple	B-X
copies	B-X
,	B-X
could	B-X
substitute	B-X
for	B-X
the	B-X
function	B-X
of	B-X
SIR1	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
FKH1	B-X
(	B-X
Forkhead	B-X
Homologue	B-X
One	B-X
)	B-X
was	B-X
named	B-X
for	B-X
its	B-X
homology	B-X
to	B-X
the	B-X
forkhead	B-X
family	B-X
of	B-X
eukaryotic	B-X
transcription	B-X
factors	B-X
classified	B-X
on	B-X
the	B-X
basis	B-X
of	B-X
a	B-X
conserved	B-X
DNA	B-X
binding	B-X
domain	B-X
.	B-X
Deletion	B-X
of	B-X
FKH1	B-X
caused	B-X
a	B-X
defect	B-X
in	B-X
silencing	B-X
HMRa	B-X
,	B-X
indicating	B-X
that	B-X
FKH1	B-X
has	B-X
a	B-X
positive	B-X
role	B-X
in	B-X
silencing	B-X
.	B-X
Significantly	B-X
,	B-X
deletion	B-X
of	B-X
both	B-X
FKH1	B-X
and	B-X
its	B-X
closest	B-X
homologue	B-X
in	B-X
yeast	B-X
,	B-X
FKH2	B-X
,	B-X
caused	B-X
a	B-X
form	B-X
of	B-X
yeast	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
redundant	B-X
functions	B-X
in	B-X
controlling	B-X
yeast	B-X
cell	B-X
morphology	B-X
.	B-X
Although	B-X
FKH2	B-X
is	B-X
redundant	B-X
with	B-X
FKH1	B-X
in	B-X
controlling	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
different	B-X
functions	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
High-copy	B-X
expression	B-X
of	B-X
CLB2	B-X
,	B-X
a	B-X
G2/M-phase	B-X
cyclin	B-X
,	B-X
prevented	B-X
fkh1Delta	B-X
fkh2Delta-induced	B-X
pseudohyphal	B-X
growth	B-X
and	B-X
modulated	B-X
some	B-X
of	B-X
the	B-X
fkhDelta-induced	B-X
silencing	B-X
phenotypes	B-X
.	B-X
Interestingly	B-X
,	B-X
deletions	B-X
in	B-X
either	B-X
FKH1	B-X
or	B-X
FKH2	B-X
alone	B-X
caused	B-X
subtle	B-X
but	B-X
opposite	B-X
effects	B-X
on	B-X
cell-cycle	B-X
progression	B-X
and	B-X
CLB2	B-X
mRNA	B-X
expression	B-X
,	B-X
consistent	B-X
with	B-X
a	B-X
role	B-X
for	B-X
each	B-X
of	B-X
these	B-X
genes	B-X
in	B-X
modulating	B-X
the	B-X
cell	B-X
cycle	B-X
and	B-X
having	B-X
opposing	B-X
effects	B-X
on	B-X
silencing	B-X
.	B-X

Overlapping	O
and	O
distinct	O
functions	O
for	O
FKH1	B-Gene_or_gene_product
and	O
FKH2	B-Gene_or_gene_product
in	O
Saccharomyces	O
cerevisiae	O
.	O
<EOS>	B-X
The	B-X
SIR1	B-X
gene	B-X
is	B-X
one	B-X
of	B-X
four	B-X
specialized	B-X
genes	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
required	B-X
for	B-X
repressing	B-X
transcription	B-X
at	B-X
the	B-X
silent	B-X
mating-type	B-X
cassettes	B-X
,	B-X
HMLalpha	B-X
and	B-X
HMRa	B-X
,	B-X
by	B-X
a	B-X
mechanism	B-X
known	B-X
as	B-X
silencing	B-X
.	B-X
FKH1	B-X
was	B-X
isolated	B-X
as	B-X
a	B-X
gene	B-X
that	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
multiple	B-X
copies	B-X
,	B-X
could	B-X
substitute	B-X
for	B-X
the	B-X
function	B-X
of	B-X
SIR1	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
FKH1	B-X
(	B-X
Forkhead	B-X
Homologue	B-X
One	B-X
)	B-X
was	B-X
named	B-X
for	B-X
its	B-X
homology	B-X
to	B-X
the	B-X
forkhead	B-X
family	B-X
of	B-X
eukaryotic	B-X
transcription	B-X
factors	B-X
classified	B-X
on	B-X
the	B-X
basis	B-X
of	B-X
a	B-X
conserved	B-X
DNA	B-X
binding	B-X
domain	B-X
.	B-X
Deletion	B-X
of	B-X
FKH1	B-X
caused	B-X
a	B-X
defect	B-X
in	B-X
silencing	B-X
HMRa	B-X
,	B-X
indicating	B-X
that	B-X
FKH1	B-X
has	B-X
a	B-X
positive	B-X
role	B-X
in	B-X
silencing	B-X
.	B-X
Significantly	B-X
,	B-X
deletion	B-X
of	B-X
both	B-X
FKH1	B-X
and	B-X
its	B-X
closest	B-X
homologue	B-X
in	B-X
yeast	B-X
,	B-X
FKH2	B-X
,	B-X
caused	B-X
a	B-X
form	B-X
of	B-X
yeast	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
redundant	B-X
functions	B-X
in	B-X
controlling	B-X
yeast	B-X
cell	B-X
morphology	B-X
.	B-X
By	B-X
several	B-X
criteria	B-X
,	B-X
fkh1Delta	B-X
fkh2Delta-induced	B-X
pseudohyphal	B-X
growth	B-X
was	B-X
distinct	B-X
from	B-X
the	B-X
nutritionally	B-X
induced	B-X
form	B-X
of	B-X
pseudohyphal	B-X
growth	B-X
observed	B-X
in	B-X
some	B-X
strains	B-X
of	B-X
S.	B-X
cerevisiae	B-X
.	B-X
Although	B-X
FKH2	B-X
is	B-X
redundant	B-X
with	B-X
FKH1	B-X
in	B-X
controlling	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
different	B-X
functions	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
Interestingly	B-X
,	B-X
deletions	B-X
in	B-X
either	B-X
FKH1	B-X
or	B-X
FKH2	B-X
alone	B-X
caused	B-X
subtle	B-X
but	B-X
opposite	B-X
effects	B-X
on	B-X
cell-cycle	B-X
progression	B-X
and	B-X
CLB2	B-X
mRNA	B-X
expression	B-X
,	B-X
consistent	B-X
with	B-X
a	B-X
role	B-X
for	B-X
each	B-X
of	B-X
these	B-X
genes	B-X
in	B-X
modulating	B-X
the	B-X
cell	B-X
cycle	B-X
and	B-X
having	B-X
opposing	B-X
effects	B-X
on	B-X
silencing	B-X
.	B-X

The	O
SIR1	B-Gene_or_gene_product
gene	O
is	O
one	O
of	O
four	O
specialized	O
genes	O
in	O
Saccharomyces	O
cerevisiae	O
required	O
for	O
repressing	O
transcription	O
at	O
the	O
silent	O
mating	O
-	O
type	O
cassettes	O
,	O
HMLalpha	B-Gene_or_gene_product
and	O
HMRa	B-Gene_or_gene_product
,	O
by	O
a	O
mechanism	O
known	O
as	O
silencing	O
.	O
<EOS>	B-X
The	B-X
SIR1	B-X
gene	B-X
is	B-X
one	B-X
of	B-X
four	B-X
specialized	B-X
genes	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
required	B-X
for	B-X
repressing	B-X
transcription	B-X
at	B-X
the	B-X
silent	B-X
mating-type	B-X
cassettes	B-X
,	B-X
HMLalpha	B-X
and	B-X
HMRa	B-X
,	B-X
by	B-X
a	B-X
mechanism	B-X
known	B-X
as	B-X
silencing	B-X
.	B-X
Silencing	B-X
requires	B-X
the	B-X
assembly	B-X
of	B-X
a	B-X
specialized	B-X
chromatin	B-X
structure	B-X
analogous	B-X
to	B-X
heterochromatin	B-X
.	B-X
FKH1	B-X
was	B-X
isolated	B-X
as	B-X
a	B-X
gene	B-X
that	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
multiple	B-X
copies	B-X
,	B-X
could	B-X
substitute	B-X
for	B-X
the	B-X
function	B-X
of	B-X
SIR1	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
FKH1	B-X
(	B-X
Forkhead	B-X
Homologue	B-X
One	B-X
)	B-X
was	B-X
named	B-X
for	B-X
its	B-X
homology	B-X
to	B-X
the	B-X
forkhead	B-X
family	B-X
of	B-X
eukaryotic	B-X
transcription	B-X
factors	B-X
classified	B-X
on	B-X
the	B-X
basis	B-X
of	B-X
a	B-X
conserved	B-X
DNA	B-X
binding	B-X
domain	B-X
.	B-X
Deletion	B-X
of	B-X
FKH1	B-X
caused	B-X
a	B-X
defect	B-X
in	B-X
silencing	B-X
HMRa	B-X
,	B-X
indicating	B-X
that	B-X
FKH1	B-X
has	B-X
a	B-X
positive	B-X
role	B-X
in	B-X
silencing	B-X
.	B-X
Significantly	B-X
,	B-X
deletion	B-X
of	B-X
both	B-X
FKH1	B-X
and	B-X
its	B-X
closest	B-X
homologue	B-X
in	B-X
yeast	B-X
,	B-X
FKH2	B-X
,	B-X
caused	B-X
a	B-X
form	B-X
of	B-X
yeast	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
redundant	B-X
functions	B-X
in	B-X
controlling	B-X
yeast	B-X
cell	B-X
morphology	B-X
.	B-X
By	B-X
several	B-X
criteria	B-X
,	B-X
fkh1Delta	B-X
fkh2Delta-induced	B-X
pseudohyphal	B-X
growth	B-X
was	B-X
distinct	B-X
from	B-X
the	B-X
nutritionally	B-X
induced	B-X
form	B-X
of	B-X
pseudohyphal	B-X
growth	B-X
observed	B-X
in	B-X
some	B-X
strains	B-X
of	B-X
S.	B-X
cerevisiae	B-X
.	B-X
Although	B-X
FKH2	B-X
is	B-X
redundant	B-X
with	B-X
FKH1	B-X
in	B-X
controlling	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
different	B-X
functions	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
High-copy	B-X
expression	B-X
of	B-X
CLB2	B-X
,	B-X
a	B-X
G2/M-phase	B-X
cyclin	B-X
,	B-X
prevented	B-X
fkh1Delta	B-X
fkh2Delta-induced	B-X
pseudohyphal	B-X
growth	B-X
and	B-X
modulated	B-X
some	B-X
of	B-X
the	B-X
fkhDelta-induced	B-X
silencing	B-X
phenotypes	B-X
.	B-X
Interestingly	B-X
,	B-X
deletions	B-X
in	B-X
either	B-X
FKH1	B-X
or	B-X
FKH2	B-X
alone	B-X
caused	B-X
subtle	B-X
but	B-X
opposite	B-X
effects	B-X
on	B-X
cell-cycle	B-X
progression	B-X
and	B-X
CLB2	B-X
mRNA	B-X
expression	B-X
,	B-X
consistent	B-X
with	B-X
a	B-X
role	B-X
for	B-X
each	B-X
of	B-X
these	B-X
genes	B-X
in	B-X
modulating	B-X
the	B-X
cell	B-X
cycle	B-X
and	B-X
having	B-X
opposing	B-X
effects	B-X
on	B-X
silencing	B-X
.	B-X

Silencing	O
requires	O
the	O
assembly	O
of	O
a	O
specialized	O
chromatin	O
structure	O
analogous	O
to	O
heterochromatin	O
.	O
<EOS>	B-X
The	B-X
SIR1	B-X
gene	B-X
is	B-X
one	B-X
of	B-X
four	B-X
specialized	B-X
genes	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
required	B-X
for	B-X
repressing	B-X
transcription	B-X
at	B-X
the	B-X
silent	B-X
mating-type	B-X
cassettes	B-X
,	B-X
HMLalpha	B-X
and	B-X
HMRa	B-X
,	B-X
by	B-X
a	B-X
mechanism	B-X
known	B-X
as	B-X
silencing	B-X
.	B-X
Silencing	B-X
requires	B-X
the	B-X
assembly	B-X
of	B-X
a	B-X
specialized	B-X
chromatin	B-X
structure	B-X
analogous	B-X
to	B-X
heterochromatin	B-X
.	B-X

FKH1	B-Gene_or_gene_product
was	O
isolated	O
as	O
a	O
gene	O
that	O
,	O
when	O
expressed	O
in	O
multiple	O
copies	O
,	O
could	O
substitute	O
for	O
the	O
function	O
of	O
SIR1	B-Gene_or_gene_product
in	O
silencing	O
HMRa	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
SIR1	B-X
gene	B-X
is	B-X
one	B-X
of	B-X
four	B-X
specialized	B-X
genes	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
required	B-X
for	B-X
repressing	B-X
transcription	B-X
at	B-X
the	B-X
silent	B-X
mating-type	B-X
cassettes	B-X
,	B-X
HMLalpha	B-X
and	B-X
HMRa	B-X
,	B-X
by	B-X
a	B-X
mechanism	B-X
known	B-X
as	B-X
silencing	B-X
.	B-X
FKH1	B-X
was	B-X
isolated	B-X
as	B-X
a	B-X
gene	B-X
that	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
multiple	B-X
copies	B-X
,	B-X
could	B-X
substitute	B-X
for	B-X
the	B-X
function	B-X
of	B-X
SIR1	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
FKH1	B-X
(	B-X
Forkhead	B-X
Homologue	B-X
One	B-X
)	B-X
was	B-X
named	B-X
for	B-X
its	B-X
homology	B-X
to	B-X
the	B-X
forkhead	B-X
family	B-X
of	B-X
eukaryotic	B-X
transcription	B-X
factors	B-X
classified	B-X
on	B-X
the	B-X
basis	B-X
of	B-X
a	B-X
conserved	B-X
DNA	B-X
binding	B-X
domain	B-X
.	B-X
Deletion	B-X
of	B-X
FKH1	B-X
caused	B-X
a	B-X
defect	B-X
in	B-X
silencing	B-X
HMRa	B-X
,	B-X
indicating	B-X
that	B-X
FKH1	B-X
has	B-X
a	B-X
positive	B-X
role	B-X
in	B-X
silencing	B-X
.	B-X
Significantly	B-X
,	B-X
deletion	B-X
of	B-X
both	B-X
FKH1	B-X
and	B-X
its	B-X
closest	B-X
homologue	B-X
in	B-X
yeast	B-X
,	B-X
FKH2	B-X
,	B-X
caused	B-X
a	B-X
form	B-X
of	B-X
yeast	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
redundant	B-X
functions	B-X
in	B-X
controlling	B-X
yeast	B-X
cell	B-X
morphology	B-X
.	B-X
Although	B-X
FKH2	B-X
is	B-X
redundant	B-X
with	B-X
FKH1	B-X
in	B-X
controlling	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
different	B-X
functions	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
High-copy	B-X
expression	B-X
of	B-X
CLB2	B-X
,	B-X
a	B-X
G2/M-phase	B-X
cyclin	B-X
,	B-X
prevented	B-X
fkh1Delta	B-X
fkh2Delta-induced	B-X
pseudohyphal	B-X
growth	B-X
and	B-X
modulated	B-X
some	B-X
of	B-X
the	B-X
fkhDelta-induced	B-X
silencing	B-X
phenotypes	B-X
.	B-X
Interestingly	B-X
,	B-X
deletions	B-X
in	B-X
either	B-X
FKH1	B-X
or	B-X
FKH2	B-X
alone	B-X
caused	B-X
subtle	B-X
but	B-X
opposite	B-X
effects	B-X
on	B-X
cell-cycle	B-X
progression	B-X
and	B-X
CLB2	B-X
mRNA	B-X
expression	B-X
,	B-X
consistent	B-X
with	B-X
a	B-X
role	B-X
for	B-X
each	B-X
of	B-X
these	B-X
genes	B-X
in	B-X
modulating	B-X
the	B-X
cell	B-X
cycle	B-X
and	B-X
having	B-X
opposing	B-X
effects	B-X
on	B-X
silencing	B-X
.	B-X

FKH1	B-Gene_or_gene_product
(	O
Forkhead	B-Gene_or_gene_product
Homologue	I-Gene_or_gene_product
One	I-Gene_or_gene_product
)	O
was	O
named	O
for	O
its	O
homology	O
to	O
the	O
forkhead	O
family	O
of	O
eukaryotic	O
transcription	O
factors	O
classified	O
on	O
the	O
basis	O
of	O
a	O
conserved	O
DNA	O
binding	O
domain	O
.	O

Deletion	O
of	O
FKH1	B-Gene_or_gene_product
caused	O
a	O
defect	O
in	O
silencing	O
HMRa	B-Gene_or_gene_product
,	O
indicating	O
that	O
FKH1	B-Gene_or_gene_product
has	O
a	O
positive	O
role	O
in	O
silencing	O
.	O

Significantly	O
,	O
deletion	O
of	O
both	O
FKH1	B-Gene_or_gene_product
and	O
its	O
closest	O
homologue	O
in	O
yeast	O
,	O
FKH2	B-Gene_or_gene_product
,	O
caused	O
a	O
form	O
of	O
yeast	O
pseudohyphal	O
growth	O
,	O
indicating	O
that	O
the	O
two	O
genes	O
have	O
redundant	O
functions	O
in	O
controlling	O
yeast	O
cell	O
morphology	O
.	O
<EOS>	B-X
The	B-X
SIR1	B-X
gene	B-X
is	B-X
one	B-X
of	B-X
four	B-X
specialized	B-X
genes	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
required	B-X
for	B-X
repressing	B-X
transcription	B-X
at	B-X
the	B-X
silent	B-X
mating-type	B-X
cassettes	B-X
,	B-X
HMLalpha	B-X
and	B-X
HMRa	B-X
,	B-X
by	B-X
a	B-X
mechanism	B-X
known	B-X
as	B-X
silencing	B-X
.	B-X
FKH1	B-X
was	B-X
isolated	B-X
as	B-X
a	B-X
gene	B-X
that	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
multiple	B-X
copies	B-X
,	B-X
could	B-X
substitute	B-X
for	B-X
the	B-X
function	B-X
of	B-X
SIR1	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
FKH1	B-X
(	B-X
Forkhead	B-X
Homologue	B-X
One	B-X
)	B-X
was	B-X
named	B-X
for	B-X
its	B-X
homology	B-X
to	B-X
the	B-X
forkhead	B-X
family	B-X
of	B-X
eukaryotic	B-X
transcription	B-X
factors	B-X
classified	B-X
on	B-X
the	B-X
basis	B-X
of	B-X
a	B-X
conserved	B-X
DNA	B-X
binding	B-X
domain	B-X
.	B-X
Deletion	B-X
of	B-X
FKH1	B-X
caused	B-X
a	B-X
defect	B-X
in	B-X
silencing	B-X
HMRa	B-X
,	B-X
indicating	B-X
that	B-X
FKH1	B-X
has	B-X
a	B-X
positive	B-X
role	B-X
in	B-X
silencing	B-X
.	B-X
Significantly	B-X
,	B-X
deletion	B-X
of	B-X
both	B-X
FKH1	B-X
and	B-X
its	B-X
closest	B-X
homologue	B-X
in	B-X
yeast	B-X
,	B-X
FKH2	B-X
,	B-X
caused	B-X
a	B-X
form	B-X
of	B-X
yeast	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
redundant	B-X
functions	B-X
in	B-X
controlling	B-X
yeast	B-X
cell	B-X
morphology	B-X
.	B-X
By	B-X
several	B-X
criteria	B-X
,	B-X
fkh1Delta	B-X
fkh2Delta-induced	B-X
pseudohyphal	B-X
growth	B-X
was	B-X
distinct	B-X
from	B-X
the	B-X
nutritionally	B-X
induced	B-X
form	B-X
of	B-X
pseudohyphal	B-X
growth	B-X
observed	B-X
in	B-X
some	B-X
strains	B-X
of	B-X
S.	B-X
cerevisiae	B-X
.	B-X
Although	B-X
FKH2	B-X
is	B-X
redundant	B-X
with	B-X
FKH1	B-X
in	B-X
controlling	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
different	B-X
functions	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
High-copy	B-X
expression	B-X
of	B-X
CLB2	B-X
,	B-X
a	B-X
G2/M-phase	B-X
cyclin	B-X
,	B-X
prevented	B-X
fkh1Delta	B-X
fkh2Delta-induced	B-X
pseudohyphal	B-X
growth	B-X
and	B-X
modulated	B-X
some	B-X
of	B-X
the	B-X
fkhDelta-induced	B-X
silencing	B-X
phenotypes	B-X
.	B-X
Interestingly	B-X
,	B-X
deletions	B-X
in	B-X
either	B-X
FKH1	B-X
or	B-X
FKH2	B-X
alone	B-X
caused	B-X
subtle	B-X
but	B-X
opposite	B-X
effects	B-X
on	B-X
cell-cycle	B-X
progression	B-X
and	B-X
CLB2	B-X
mRNA	B-X
expression	B-X
,	B-X
consistent	B-X
with	B-X
a	B-X
role	B-X
for	B-X
each	B-X
of	B-X
these	B-X
genes	B-X
in	B-X
modulating	B-X
the	B-X
cell	B-X
cycle	B-X
and	B-X
having	B-X
opposing	B-X
effects	B-X
on	B-X
silencing	B-X
.	B-X

By	O
several	O
criteria	O
,	O
fkh1Delta	B-Gene_or_gene_product
fkh2Delta	B-Gene_or_gene_product
-	O
induced	O
pseudohyphal	O
growth	O
was	O
distinct	O
from	O
the	O
nutritionally	O
induced	O
form	O
of	O
pseudohyphal	O
growth	O
observed	O
in	O
some	O
strains	O
of	O
S	O
.	O
cerevisiae	O
.	O
<EOS>	B-X
The	B-X
SIR1	B-X
gene	B-X
is	B-X
one	B-X
of	B-X
four	B-X
specialized	B-X
genes	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
required	B-X
for	B-X
repressing	B-X
transcription	B-X
at	B-X
the	B-X
silent	B-X
mating-type	B-X
cassettes	B-X
,	B-X
HMLalpha	B-X
and	B-X
HMRa	B-X
,	B-X
by	B-X
a	B-X
mechanism	B-X
known	B-X
as	B-X
silencing	B-X
.	B-X
Significantly	B-X
,	B-X
deletion	B-X
of	B-X
both	B-X
FKH1	B-X
and	B-X
its	B-X
closest	B-X
homologue	B-X
in	B-X
yeast	B-X
,	B-X
FKH2	B-X
,	B-X
caused	B-X
a	B-X
form	B-X
of	B-X
yeast	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
redundant	B-X
functions	B-X
in	B-X
controlling	B-X
yeast	B-X
cell	B-X
morphology	B-X
.	B-X
By	B-X
several	B-X
criteria	B-X
,	B-X
fkh1Delta	B-X
fkh2Delta-induced	B-X
pseudohyphal	B-X
growth	B-X
was	B-X
distinct	B-X
from	B-X
the	B-X
nutritionally	B-X
induced	B-X
form	B-X
of	B-X
pseudohyphal	B-X
growth	B-X
observed	B-X
in	B-X
some	B-X
strains	B-X
of	B-X
S.	B-X
cerevisiae	B-X
.	B-X
Although	B-X
FKH2	B-X
is	B-X
redundant	B-X
with	B-X
FKH1	B-X
in	B-X
controlling	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
different	B-X
functions	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
High-copy	B-X
expression	B-X
of	B-X
CLB2	B-X
,	B-X
a	B-X
G2/M-phase	B-X
cyclin	B-X
,	B-X
prevented	B-X
fkh1Delta	B-X
fkh2Delta-induced	B-X
pseudohyphal	B-X
growth	B-X
and	B-X
modulated	B-X
some	B-X
of	B-X
the	B-X
fkhDelta-induced	B-X
silencing	B-X
phenotypes	B-X
.	B-X

Although	O
FKH2	B-Gene_or_gene_product
is	O
redundant	O
with	O
FKH1	B-Gene_or_gene_product
in	O
controlling	O
pseudohyphal	O
growth	O
,	O
the	O
two	O
genes	O
have	O
different	O
functions	O
in	O
silencing	O
HMRa	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
SIR1	B-X
gene	B-X
is	B-X
one	B-X
of	B-X
four	B-X
specialized	B-X
genes	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
required	B-X
for	B-X
repressing	B-X
transcription	B-X
at	B-X
the	B-X
silent	B-X
mating-type	B-X
cassettes	B-X
,	B-X
HMLalpha	B-X
and	B-X
HMRa	B-X
,	B-X
by	B-X
a	B-X
mechanism	B-X
known	B-X
as	B-X
silencing	B-X
.	B-X
FKH1	B-X
was	B-X
isolated	B-X
as	B-X
a	B-X
gene	B-X
that	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
multiple	B-X
copies	B-X
,	B-X
could	B-X
substitute	B-X
for	B-X
the	B-X
function	B-X
of	B-X
SIR1	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
FKH1	B-X
(	B-X
Forkhead	B-X
Homologue	B-X
One	B-X
)	B-X
was	B-X
named	B-X
for	B-X
its	B-X
homology	B-X
to	B-X
the	B-X
forkhead	B-X
family	B-X
of	B-X
eukaryotic	B-X
transcription	B-X
factors	B-X
classified	B-X
on	B-X
the	B-X
basis	B-X
of	B-X
a	B-X
conserved	B-X
DNA	B-X
binding	B-X
domain	B-X
.	B-X
Deletion	B-X
of	B-X
FKH1	B-X
caused	B-X
a	B-X
defect	B-X
in	B-X
silencing	B-X
HMRa	B-X
,	B-X
indicating	B-X
that	B-X
FKH1	B-X
has	B-X
a	B-X
positive	B-X
role	B-X
in	B-X
silencing	B-X
.	B-X
Significantly	B-X
,	B-X
deletion	B-X
of	B-X
both	B-X
FKH1	B-X
and	B-X
its	B-X
closest	B-X
homologue	B-X
in	B-X
yeast	B-X
,	B-X
FKH2	B-X
,	B-X
caused	B-X
a	B-X
form	B-X
of	B-X
yeast	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
redundant	B-X
functions	B-X
in	B-X
controlling	B-X
yeast	B-X
cell	B-X
morphology	B-X
.	B-X
By	B-X
several	B-X
criteria	B-X
,	B-X
fkh1Delta	B-X
fkh2Delta-induced	B-X
pseudohyphal	B-X
growth	B-X
was	B-X
distinct	B-X
from	B-X
the	B-X
nutritionally	B-X
induced	B-X
form	B-X
of	B-X
pseudohyphal	B-X
growth	B-X
observed	B-X
in	B-X
some	B-X
strains	B-X
of	B-X
S.	B-X
cerevisiae	B-X
.	B-X
Although	B-X
FKH2	B-X
is	B-X
redundant	B-X
with	B-X
FKH1	B-X
in	B-X
controlling	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
different	B-X
functions	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
High-copy	B-X
expression	B-X
of	B-X
CLB2	B-X
,	B-X
a	B-X
G2/M-phase	B-X
cyclin	B-X
,	B-X
prevented	B-X
fkh1Delta	B-X
fkh2Delta-induced	B-X
pseudohyphal	B-X
growth	B-X
and	B-X
modulated	B-X
some	B-X
of	B-X
the	B-X
fkhDelta-induced	B-X
silencing	B-X
phenotypes	B-X
.	B-X
Interestingly	B-X
,	B-X
deletions	B-X
in	B-X
either	B-X
FKH1	B-X
or	B-X
FKH2	B-X
alone	B-X
caused	B-X
subtle	B-X
but	B-X
opposite	B-X
effects	B-X
on	B-X
cell-cycle	B-X
progression	B-X
and	B-X
CLB2	B-X
mRNA	B-X
expression	B-X
,	B-X
consistent	B-X
with	B-X
a	B-X
role	B-X
for	B-X
each	B-X
of	B-X
these	B-X
genes	B-X
in	B-X
modulating	B-X
the	B-X
cell	B-X
cycle	B-X
and	B-X
having	B-X
opposing	B-X
effects	B-X
on	B-X
silencing	B-X
.	B-X

High	O
-	O
copy	O
expression	O
of	O
CLB2	B-Gene_or_gene_product
,	O
a	O
G2	O
/	O
M	O
-	O
phase	O
cyclin	B-Gene_or_gene_product
,	O
prevented	O
fkh1Delta	B-Gene_or_gene_product
fkh2Delta	B-Gene_or_gene_product
-	O
induced	O
pseudohyphal	O
growth	O
and	O
modulated	O
some	O
of	O
the	O
fkhDelta	B-Gene_or_gene_product
-	O
induced	O
silencing	O
phenotypes	O
.	O
<EOS>	B-X
The	B-X
SIR1	B-X
gene	B-X
is	B-X
one	B-X
of	B-X
four	B-X
specialized	B-X
genes	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
required	B-X
for	B-X
repressing	B-X
transcription	B-X
at	B-X
the	B-X
silent	B-X
mating-type	B-X
cassettes	B-X
,	B-X
HMLalpha	B-X
and	B-X
HMRa	B-X
,	B-X
by	B-X
a	B-X
mechanism	B-X
known	B-X
as	B-X
silencing	B-X
.	B-X
FKH1	B-X
was	B-X
isolated	B-X
as	B-X
a	B-X
gene	B-X
that	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
multiple	B-X
copies	B-X
,	B-X
could	B-X
substitute	B-X
for	B-X
the	B-X
function	B-X
of	B-X
SIR1	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
Deletion	B-X
of	B-X
FKH1	B-X
caused	B-X
a	B-X
defect	B-X
in	B-X
silencing	B-X
HMRa	B-X
,	B-X
indicating	B-X
that	B-X
FKH1	B-X
has	B-X
a	B-X
positive	B-X
role	B-X
in	B-X
silencing	B-X
.	B-X
Significantly	B-X
,	B-X
deletion	B-X
of	B-X
both	B-X
FKH1	B-X
and	B-X
its	B-X
closest	B-X
homologue	B-X
in	B-X
yeast	B-X
,	B-X
FKH2	B-X
,	B-X
caused	B-X
a	B-X
form	B-X
of	B-X
yeast	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
redundant	B-X
functions	B-X
in	B-X
controlling	B-X
yeast	B-X
cell	B-X
morphology	B-X
.	B-X
By	B-X
several	B-X
criteria	B-X
,	B-X
fkh1Delta	B-X
fkh2Delta-induced	B-X
pseudohyphal	B-X
growth	B-X
was	B-X
distinct	B-X
from	B-X
the	B-X
nutritionally	B-X
induced	B-X
form	B-X
of	B-X
pseudohyphal	B-X
growth	B-X
observed	B-X
in	B-X
some	B-X
strains	B-X
of	B-X
S.	B-X
cerevisiae	B-X
.	B-X
Although	B-X
FKH2	B-X
is	B-X
redundant	B-X
with	B-X
FKH1	B-X
in	B-X
controlling	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
different	B-X
functions	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
High-copy	B-X
expression	B-X
of	B-X
CLB2	B-X
,	B-X
a	B-X
G2/M-phase	B-X
cyclin	B-X
,	B-X
prevented	B-X
fkh1Delta	B-X
fkh2Delta-induced	B-X
pseudohyphal	B-X
growth	B-X
and	B-X
modulated	B-X
some	B-X
of	B-X
the	B-X
fkhDelta-induced	B-X
silencing	B-X
phenotypes	B-X
.	B-X
Interestingly	B-X
,	B-X
deletions	B-X
in	B-X
either	B-X
FKH1	B-X
or	B-X
FKH2	B-X
alone	B-X
caused	B-X
subtle	B-X
but	B-X
opposite	B-X
effects	B-X
on	B-X
cell-cycle	B-X
progression	B-X
and	B-X
CLB2	B-X
mRNA	B-X
expression	B-X
,	B-X
consistent	B-X
with	B-X
a	B-X
role	B-X
for	B-X
each	B-X
of	B-X
these	B-X
genes	B-X
in	B-X
modulating	B-X
the	B-X
cell	B-X
cycle	B-X
and	B-X
having	B-X
opposing	B-X
effects	B-X
on	B-X
silencing	B-X
.	B-X

Interestingly	O
,	O
deletions	O
in	O
either	O
FKH1	B-Gene_or_gene_product
or	O
FKH2	B-Gene_or_gene_product
alone	O
caused	O
subtle	O
but	O
opposite	O
effects	O
on	O
cell	O
-	O
cycle	O
progression	O
and	O
CLB2	B-Gene_or_gene_product
mRNA	O
expression	O
,	O
consistent	O
with	O
a	O
role	O
for	O
each	O
of	O
these	O
genes	O
in	O
modulating	O
the	O
cell	O
cycle	O
and	O
having	O
opposing	O
effects	O
on	O
silencing	O
.	O
<EOS>	B-X
The	B-X
SIR1	B-X
gene	B-X
is	B-X
one	B-X
of	B-X
four	B-X
specialized	B-X
genes	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
required	B-X
for	B-X
repressing	B-X
transcription	B-X
at	B-X
the	B-X
silent	B-X
mating-type	B-X
cassettes	B-X
,	B-X
HMLalpha	B-X
and	B-X
HMRa	B-X
,	B-X
by	B-X
a	B-X
mechanism	B-X
known	B-X
as	B-X
silencing	B-X
.	B-X
FKH1	B-X
was	B-X
isolated	B-X
as	B-X
a	B-X
gene	B-X
that	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
multiple	B-X
copies	B-X
,	B-X
could	B-X
substitute	B-X
for	B-X
the	B-X
function	B-X
of	B-X
SIR1	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
FKH1	B-X
(	B-X
Forkhead	B-X
Homologue	B-X
One	B-X
)	B-X
was	B-X
named	B-X
for	B-X
its	B-X
homology	B-X
to	B-X
the	B-X
forkhead	B-X
family	B-X
of	B-X
eukaryotic	B-X
transcription	B-X
factors	B-X
classified	B-X
on	B-X
the	B-X
basis	B-X
of	B-X
a	B-X
conserved	B-X
DNA	B-X
binding	B-X
domain	B-X
.	B-X
Deletion	B-X
of	B-X
FKH1	B-X
caused	B-X
a	B-X
defect	B-X
in	B-X
silencing	B-X
HMRa	B-X
,	B-X
indicating	B-X
that	B-X
FKH1	B-X
has	B-X
a	B-X
positive	B-X
role	B-X
in	B-X
silencing	B-X
.	B-X
Significantly	B-X
,	B-X
deletion	B-X
of	B-X
both	B-X
FKH1	B-X
and	B-X
its	B-X
closest	B-X
homologue	B-X
in	B-X
yeast	B-X
,	B-X
FKH2	B-X
,	B-X
caused	B-X
a	B-X
form	B-X
of	B-X
yeast	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
redundant	B-X
functions	B-X
in	B-X
controlling	B-X
yeast	B-X
cell	B-X
morphology	B-X
.	B-X
Although	B-X
FKH2	B-X
is	B-X
redundant	B-X
with	B-X
FKH1	B-X
in	B-X
controlling	B-X
pseudohyphal	B-X
growth	B-X
,	B-X
the	B-X
two	B-X
genes	B-X
have	B-X
different	B-X
functions	B-X
in	B-X
silencing	B-X
HMRa	B-X
.	B-X
High-copy	B-X
expression	B-X
of	B-X
CLB2	B-X
,	B-X
a	B-X
G2/M-phase	B-X
cyclin	B-X
,	B-X
prevented	B-X
fkh1Delta	B-X
fkh2Delta-induced	B-X
pseudohyphal	B-X
growth	B-X
and	B-X
modulated	B-X
some	B-X
of	B-X
the	B-X
fkhDelta-induced	B-X
silencing	B-X
phenotypes	B-X
.	B-X
Interestingly	B-X
,	B-X
deletions	B-X
in	B-X
either	B-X
FKH1	B-X
or	B-X
FKH2	B-X
alone	B-X
caused	B-X
subtle	B-X
but	B-X
opposite	B-X
effects	B-X
on	B-X
cell-cycle	B-X
progression	B-X
and	B-X
CLB2	B-X
mRNA	B-X
expression	B-X
,	B-X
consistent	B-X
with	B-X
a	B-X
role	B-X
for	B-X
each	B-X
of	B-X
these	B-X
genes	B-X
in	B-X
modulating	B-X
the	B-X
cell	B-X
cycle	B-X
and	B-X
having	B-X
opposing	B-X
effects	B-X
on	B-X
silencing	B-X
.	B-X

The	O
differences	O
between	O
Fkh1p	B-Gene_or_gene_product
and	O
Fkh2p	B-Gene_or_gene_product
in	O
vivo	O
were	O
not	O
attributable	O
to	O
differences	O
in	O
their	O
DNA	O
binding	O
domains	O
.	O
<EOS>	B-X
The	B-X
roles	B-X
of	B-X
DNA	B-X
and	B-X
Mcm1p	B-X
interactions	B-X
in	B-X
determining	B-X
the	B-X
overlapping	B-X
and	B-X
distinct	B-X
functions	B-X
of	B-X
the	B-X
yeast	B-X
cell	B-X
cycle	B-X
regulatory	B-X
transcription	B-X
factors	B-X
Fkh1p	B-X
and	B-X
Fkh2p	B-X
were	B-X
examined	B-X
.	B-X
Full-length	B-X
recombinant	B-X
Fkh1p	B-X
and	B-X
Fkh2p	B-X
were	B-X
purified	B-X
and	B-X
their	B-X
binding	B-X
to	B-X
bona	B-X
fide	B-X
promoters	B-X
examined	B-X
in	B-X
vitro	B-X
.	B-X
Each	B-X
protein	B-X
bound	B-X
a	B-X
variety	B-X
of	B-X
target	B-X
promoters	B-X
with	B-X
similar	B-X
specificity	B-X
in	B-X
vitro	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
observation	B-X
that	B-X
these	B-X
proteins	B-X
bind	B-X
common	B-X
promoters	B-X
in	B-X
vivo	B-X
.	B-X
However	B-X
,	B-X
in	B-X
vivo	B-X
,	B-X
the	B-X
Fkh1p	B-X
and	B-X
Fkh2p	B-X
occupied	B-X
different	B-X
target	B-X
promoters	B-X
to	B-X
different	B-X
extents	B-X
,	B-X
suggesting	B-X
that	B-X
each	B-X
was	B-X
primarily	B-X
responsible	B-X
for	B-X
controlling	B-X
a	B-X
different	B-X
set	B-X
of	B-X
genes	B-X
.	B-X
Specifically	B-X
,	B-X
the	B-X
Fkh2p	B-X
,	B-X
but	B-X
not	B-X
the	B-X
Fkh1p	B-X
,	B-X
was	B-X
capable	B-X
of	B-X
binding	B-X
cooperatively	B-X
with	B-X
Mcm1p	B-X
.	B-X
The	B-X
Mcm1p-Fkh2p	B-X
cooperative	B-X
binding	B-X
was	B-X
enhanced	B-X
by	B-X
,	B-X
but	B-X
did	B-X
not	B-X
require	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
Mcm1p-binding	B-X
site	B-X
within	B-X
a	B-X
target	B-X
promoter	B-X
.	B-X
Consistent	B-X
with	B-X
these	B-X
data	B-X
,	B-X
Mcm1p	B-X
was	B-X
present	B-X
at	B-X
Fkh-controlled	B-X
promoters	B-X
in	B-X
vivo	B-X
regardless	B-X
of	B-X
whether	B-X
they	B-X
contained	B-X
Mcm1p-binding	B-X
sites	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
Mcm1p	B-X
at	B-X
promoters	B-X
not	B-X
thought	B-X
previously	B-X
to	B-X
be	B-X
under	B-X
Mcm1p	B-X
control	B-X
.	B-X
Analysis	B-X
of	B-X
Fkh1p	B-X
and	B-X
Fkh2p	B-X
binding	B-X
to	B-X
promoter	B-X
targets	B-X
in	B-X
vivo	B-X
by	B-X
use	B-X
of	B-X
mutant	B-X
strains	B-X
indicated	B-X
that	B-X
the	B-X
two	B-X
proteins	B-X
compete	B-X
for	B-X
promoter-occupancy	B-X
at	B-X
a	B-X
number	B-X
of	B-X
target	B-X
promoters	B-X
.	B-X
We	B-X
postulate	B-X
that	B-X
Fkh1p	B-X
and	B-X
a	B-X
stable	B-X
Fkh2p/Mcm1p	B-X
complex	B-X
compete	B-X
for	B-X
binding	B-X
to	B-X
target	B-X
promoters	B-X
and	B-X
that	B-X
the	B-X
levels	B-X
and/or	B-X
binding	B-X
activity	B-X
of	B-X
Fkh1p	B-X
,	B-X
but	B-X
not	B-X
Fkh2p	B-X
,	B-X
are	B-X
most	B-X
limiting	B-X
for	B-X
promoter-occupancy	B-X
in	B-X
vivo	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
in	B-X
vitro	B-X
DNA-binding	B-X
assays	B-X
,	B-X
using	B-X
a	B-X
variety	B-X
of	B-X
promoter	B-X
targets	B-X
,	B-X
revealed	B-X
that	B-X
bona	B-X
fide	B-X
Fkh	B-X
target	B-X
promoters	B-X
contained	B-X
two	B-X
or	B-X
more	B-X
Fkh-binding	B-X
sites	B-X
that	B-X
allowed	B-X
the	B-X
Fkh1p	B-X
and	B-X
Fkh2p	B-X
proteins	B-X
to	B-X
form	B-X
multiple	B-X
protein-DNA	B-X
complexes	B-X
in	B-X
vitro	B-X
.	B-X
Multiple	B-X
Fkh-binding	B-X
sites	B-X
may	B-X
be	B-X
a	B-X
distinguishing	B-X
feature	B-X
of	B-X
bona	B-X
fide	B-X
Fkh	B-X
promoters	B-X
in	B-X
yeast	B-X
and	B-X
other	B-X
organisms	B-X
.	B-X

Analysis	O
of	O
promoter	O
binding	O
by	O
the	O
E2F	B-Gene_or_gene_product
and	O
pRB	B-Gene_or_gene_product
families	O
in	O
vivo	O
:	O
distinct	O
E2F	B-Gene_or_gene_product
proteins	O
mediate	O
activation	O
and	O
repression	O
.	O
<EOS>	B-X
The	B-X
E2F	B-X
transcription	B-X
factor	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
timely	B-X
activation	B-X
of	B-X
gene	B-X
expression	B-X
during	B-X
mammalian	B-X
cell	B-X
cycle	B-X
progression	B-X
,	B-X
whereas	B-X
pRB	B-X
and	B-X
related	B-X
proteins	B-X
control	B-X
cell	B-X
growth	B-X
in	B-X
part	B-X
through	B-X
the	B-X
ability	B-X
to	B-X
block	B-X
the	B-X
action	B-X
of	B-X
E2F	B-X
.	B-X
To	B-X
identify	B-X
physiologically	B-X
important	B-X
E2F-responsive	B-X
promoters	B-X
and	B-X
to	B-X
study	B-X
their	B-X
occupancy	B-X
and	B-X
histone	B-X
acetylation	B-X
state	B-X
in	B-X
vivo	B-X
,	B-X
we	B-X
have	B-X
taken	B-X
advantage	B-X
of	B-X
a	B-X
cross-linking	B-X
approach	B-X
in	B-X
synchronized	B-X
,	B-X
living	B-X
cells	B-X
.	B-X
We	B-X
find	B-X
that	B-X
the	B-X
pattern	B-X
of	B-X
E2F	B-X
and	B-X
pRB-related	B-X
polypeptides	B-X
recruited	B-X
to	B-X
these	B-X
promoters	B-X
changes	B-X
in	B-X
a	B-X
strikingly	B-X
dynamic	B-X
fashion	B-X
as	B-X
cells	B-X
progress	B-X
from	B-X
quiescence	B-X
into	B-X
G	B-X
(	B-X
1	B-X
)	B-X
and	B-X
S	B-X
phase	B-X
:	B-X
Repression	B-X
of	B-X
each	B-X
promoter	B-X
in	B-X
quiescent	B-X
cells	B-X
is	B-X
associated	B-X
with	B-X
recruitment	B-X
of	B-X
E2F-4	B-X
and	B-X
p130	B-X
and	B-X
low	B-X
levels	B-X
of	B-X
histone	B-X
acetylation	B-X
,	B-X
but	B-X
by	B-X
late	B-X
G	B-X
(	B-X
1	B-X
)	B-X
,	B-X
these	B-X
proteins	B-X
are	B-X
replaced	B-X
largely	B-X
by	B-X
E2F-1	B-X
and	B-X
E2F-3	B-X
,	B-X
in	B-X
concert	B-X
with	B-X
acetylation	B-X
of	B-X
histones	B-X
H3	B-X
and	B-X
H4	B-X
and	B-X
gene	B-X
activation	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
that	B-X
repression	B-X
and	B-X
activation	B-X
of	B-X
E2F-responsive	B-X
genes	B-X
may	B-X
occur	B-X
through	B-X
distinct	B-X
E2F	B-X
heterodimers	B-X
that	B-X
direct	B-X
the	B-X
sequential	B-X
recruitment	B-X
of	B-X
enzymes	B-X
able	B-X
to	B-X
deacetylate	B-X
and	B-X
then	B-X
acetylate	B-X
core	B-X
histones	B-X
.	B-X

The	O
E2F	B-Gene_or_gene_product
transcription	O
factor	O
plays	O
a	O
pivotal	O
role	O
in	O
the	O
timely	O
activation	O
of	O
gene	O
expression	O
during	O
mammalian	O
cell	O
cycle	O
progression	O
,	O
whereas	O
pRB	B-Gene_or_gene_product
and	O
related	O
proteins	O
control	O
cell	O
growth	O
in	O
part	O
through	O
the	O
ability	O
to	O
block	O
the	O
action	O
of	O
E2F	B-Gene_or_gene_product
.	O

To	O
identify	O
physiologically	O
important	O
E2F	B-Gene_or_gene_product
-	O
responsive	O
promoters	O
and	O
to	O
study	O
their	O
occupancy	O
and	O
histone	B-Gene_or_gene_product
acetylation	O
state	O
in	O
vivo	O
,	O
we	O
have	O
taken	O
advantage	O
of	O
a	O
cross	O
-	O
linking	O
approach	O
in	O
synchronized	O
,	O
living	O
cells	O
.	O

We	O
find	O
that	O
the	O
pattern	O
of	O
E2F	B-Gene_or_gene_product
and	O
pRB	B-Gene_or_gene_product
-	O
related	O
polypeptides	O
recruited	O
to	O
these	O
promoters	O
changes	O
in	O
a	O
strikingly	O
dynamic	O
fashion	O
as	O
cells	O
progress	O
from	O
quiescence	O
into	O
G	O
(	O
1	O
)	O
and	O
S	O
phase	O
:	O
Repression	O
of	O
each	O
promoter	O
in	O
quiescent	O
cells	O
is	O
associated	O
with	O
recruitment	O
of	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
and	O
p130	B-Gene_or_gene_product
and	O
low	O
levels	O
of	O
histone	B-Gene_or_gene_product
acetylation	O
,	O
but	O
by	O
late	O
G	O
(	O
1	O
)	O
,	O
these	O
proteins	O
are	O
replaced	O
largely	O
by	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
,	O
in	O
concert	O
with	O
acetylation	O
of	O
histones	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
and	O
H4	B-Gene_or_gene_product
and	O
gene	O
activation	O
.	O

These	O
findings	O
suggest	O
that	O
repression	O
and	O
activation	O
of	O
E2F	B-Gene_or_gene_product
-	O
responsive	O
genes	O
may	O
occur	O
through	O
distinct	O
E2F	O
heterodimers	O
that	O
direct	O
the	O
sequential	O
recruitment	O
of	O
enzymes	O
able	O
to	O
deacetylate	O
and	O
then	O
acetylate	O
core	O
histones	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
E2F	B-X
transcription	B-X
factor	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
timely	B-X
activation	B-X
of	B-X
gene	B-X
expression	B-X
during	B-X
mammalian	B-X
cell	B-X
cycle	B-X
progression	B-X
,	B-X
whereas	B-X
pRB	B-X
and	B-X
related	B-X
proteins	B-X
control	B-X
cell	B-X
growth	B-X
in	B-X
part	B-X
through	B-X
the	B-X
ability	B-X
to	B-X
block	B-X
the	B-X
action	B-X
of	B-X
E2F	B-X
.	B-X
To	B-X
identify	B-X
physiologically	B-X
important	B-X
E2F-responsive	B-X
promoters	B-X
and	B-X
to	B-X
study	B-X
their	B-X
occupancy	B-X
and	B-X
histone	B-X
acetylation	B-X
state	B-X
in	B-X
vivo	B-X
,	B-X
we	B-X
have	B-X
taken	B-X
advantage	B-X
of	B-X
a	B-X
cross-linking	B-X
approach	B-X
in	B-X
synchronized	B-X
,	B-X
living	B-X
cells	B-X
.	B-X
We	B-X
find	B-X
that	B-X
the	B-X
pattern	B-X
of	B-X
E2F	B-X
and	B-X
pRB-related	B-X
polypeptides	B-X
recruited	B-X
to	B-X
these	B-X
promoters	B-X
changes	B-X
in	B-X
a	B-X
strikingly	B-X
dynamic	B-X
fashion	B-X
as	B-X
cells	B-X
progress	B-X
from	B-X
quiescence	B-X
into	B-X
G	B-X
(	B-X
1	B-X
)	B-X
and	B-X
S	B-X
phase	B-X
:	B-X
Repression	B-X
of	B-X
each	B-X
promoter	B-X
in	B-X
quiescent	B-X
cells	B-X
is	B-X
associated	B-X
with	B-X
recruitment	B-X
of	B-X
E2F-4	B-X
and	B-X
p130	B-X
and	B-X
low	B-X
levels	B-X
of	B-X
histone	B-X
acetylation	B-X
,	B-X
but	B-X
by	B-X
late	B-X
G	B-X
(	B-X
1	B-X
)	B-X
,	B-X
these	B-X
proteins	B-X
are	B-X
replaced	B-X
largely	B-X
by	B-X
E2F-1	B-X
and	B-X
E2F-3	B-X
,	B-X
in	B-X
concert	B-X
with	B-X
acetylation	B-X
of	B-X
histones	B-X
H3	B-X
and	B-X
H4	B-X
and	B-X
gene	B-X
activation	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
that	B-X
repression	B-X
and	B-X
activation	B-X
of	B-X
E2F-responsive	B-X
genes	B-X
may	B-X
occur	B-X
through	B-X
distinct	B-X
E2F	B-X
heterodimers	B-X
that	B-X
direct	B-X
the	B-X
sequential	B-X
recruitment	B-X
of	B-X
enzymes	B-X
able	B-X
to	B-X
deacetylate	B-X
and	B-X
then	B-X
acetylate	B-X
core	B-X
histones	B-X
.	B-X

Analysis	O
of	O
p73	B-Gene_or_gene_product
in	O
human	O
borderline	O
and	O
invasive	O
ovarian	O
tumor	O
.	O
<EOS>	B-X
p73	B-X
is	B-X
a	B-X
novel	B-X
gene	B-X
that	B-X
has	B-X
high	B-X
sequence	B-X
homology	B-X
and	B-X
similar	B-X
gene	B-X
structure	B-X
to	B-X
the	B-X
tumor	B-X
suppressor	B-X
gene	B-X
p53	B-X
.	B-X
We	B-X
analysed	B-X
p73	B-X
in	B-X
seven	B-X
ovarian	B-X
carcinoma	B-X
cell	B-X
lines	B-X
and	B-X
a	B-X
total	B-X
of	B-X
63	B-X
human	B-X
borderline	B-X
and	B-X
invasive	B-X
ovarian	B-X
tumor	B-X
samples	B-X
.	B-X
Loss	B-X
of	B-X
heterozygosity	B-X
at	B-X
this	B-X
locus	B-X
was	B-X
observed	B-X
in	B-X
50	B-X
%	B-X
of	B-X
invasive	B-X
tumors	B-X
but	B-X
in	B-X
none	B-X
of	B-X
the	B-X
borderline	B-X
tumors	B-X
.	B-X
Biallelic	B-X
expression	B-X
of	B-X
the	B-X
gene	B-X
was	B-X
observed	B-X
in	B-X
the	B-X
heterozygous	B-X
tumor	B-X
tissues	B-X
.	B-X
Direct	B-X
sequencing	B-X
and	B-X
single-strand	B-X
conformation	B-X
polymorphism	B-X
analyses	B-X
of	B-X
the	B-X
p73	B-X
cDNA	B-X
sequence	B-X
homologous	B-X
to	B-X
the	B-X
highly	B-X
mutatable	B-X
region	B-X
of	B-X
p53	B-X
did	B-X
not	B-X
reveal	B-X
any	B-X
mutations	B-X
.	B-X
When	B-X
compared	B-X
to	B-X
the	B-X
primary	B-X
cultures	B-X
of	B-X
normal	B-X
human	B-X
ovarian	B-X
surface	B-X
epithelial	B-X
cells	B-X
and	B-X
immortalized	B-X
cell	B-X
lines	B-X
,	B-X
four	B-X
of	B-X
the	B-X
seven	B-X
ovarian	B-X
carcinoma	B-X
cell	B-X
lines	B-X
,	B-X
71	B-X
%	B-X
of	B-X
the	B-X
invasive	B-X
tumors	B-X
,	B-X
and	B-X
92	B-X
%	B-X
of	B-X
the	B-X
borderline	B-X
tumor	B-X
tissues	B-X
express	B-X
elevated	B-X
levels	B-X
of	B-X
p73	B-X
transcript	B-X
.	B-X
Except	B-X
for	B-X
the	B-X
OVCA3	B-X
cell	B-X
line	B-X
,	B-X
Western	B-X
blot	B-X
analysis	B-X
of	B-X
the	B-X
nuclear	B-X
extracts	B-X
prepared	B-X
from	B-X
the	B-X
cell	B-X
lines	B-X
showed	B-X
concordant	B-X
levels	B-X
of	B-X
p73	B-X
protein	B-X
.	B-X
Our	B-X
analysis	B-X
also	B-X
demonstrated	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
spliced	B-X
variant	B-X
of	B-X
p73	B-X
transcript	B-X
with	B-X
the	B-X
omission	B-X
of	B-X
exon	B-X
2	B-X
solely	B-X
in	B-X
the	B-X
cancer	B-X
cell	B-X
lines	B-X
and	B-X
invasive	B-X
tumor	B-X
tissues	B-X
.	B-X
This	B-X
exon	B-X
2-spliced	B-X
transcript	B-X
would	B-X
give	B-X
rise	B-X
to	B-X
a	B-X
truncated	B-X
p73	B-X
protein	B-X
without	B-X
the	B-X
N-terminal	B-X
transactivation	B-X
domain	B-X
.	B-X
In	B-X
reminiscence	B-X
of	B-X
the	B-X
dominant	B-X
negative	B-X
phenotype	B-X
of	B-X
the	B-X
N-terminal	B-X
truncated	B-X
variants	B-X
of	B-X
another	B-X
p53-related	B-X
gene	B-X
,	B-X
p63	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
truncated	B-X
p73	B-X
variant	B-X
form	B-X
in	B-X
ovarian	B-X
tumors	B-X
may	B-X
play	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
ovarian	B-X
cancer	B-X
.	B-X

p73	B-Gene_or_gene_product
is	O
a	O
novel	O
gene	O
that	O
has	O
high	O
sequence	O
homology	O
and	O
similar	O
gene	O
structure	O
to	O
the	O
tumor	O
suppressor	O
gene	O
p53	B-Gene_or_gene_product
.	O

We	O
analysed	O
p73	B-Gene_or_gene_product
in	O
seven	O
ovarian	O
carcinoma	O
cell	O
lines	O
and	O
a	O
total	O
of	O
63	O
human	O
borderline	O
and	O
invasive	O
ovarian	O
tumor	O
samples	O
.	O

Loss	O
of	O
heterozygosity	O
at	O
this	O
locus	O
was	O
observed	O
in	O
50	O
%	O
of	O
invasive	O
tumors	O
but	O
in	O
none	O
of	O
the	O
borderline	O
tumors	O
.	O
<EOS>	B-X
We	B-X
analysed	B-X
p73	B-X
in	B-X
seven	B-X
ovarian	B-X
carcinoma	B-X
cell	B-X
lines	B-X
and	B-X
a	B-X
total	B-X
of	B-X
63	B-X
human	B-X
borderline	B-X
and	B-X
invasive	B-X
ovarian	B-X
tumor	B-X
samples	B-X
.	B-X
Loss	B-X
of	B-X
heterozygosity	B-X
at	B-X
this	B-X
locus	B-X
was	B-X
observed	B-X
in	B-X
50	B-X
%	B-X
of	B-X
invasive	B-X
tumors	B-X
but	B-X
in	B-X
none	B-X
of	B-X
the	B-X
borderline	B-X
tumors	B-X
.	B-X
Biallelic	B-X
expression	B-X
of	B-X
the	B-X
gene	B-X
was	B-X
observed	B-X
in	B-X
the	B-X
heterozygous	B-X
tumor	B-X
tissues	B-X
.	B-X
When	B-X
compared	B-X
to	B-X
the	B-X
primary	B-X
cultures	B-X
of	B-X
normal	B-X
human	B-X
ovarian	B-X
surface	B-X
epithelial	B-X
cells	B-X
and	B-X
immortalized	B-X
cell	B-X
lines	B-X
,	B-X
four	B-X
of	B-X
the	B-X
seven	B-X
ovarian	B-X
carcinoma	B-X
cell	B-X
lines	B-X
,	B-X
71	B-X
%	B-X
of	B-X
the	B-X
invasive	B-X
tumors	B-X
,	B-X
and	B-X
92	B-X
%	B-X
of	B-X
the	B-X
borderline	B-X
tumor	B-X
tissues	B-X
express	B-X
elevated	B-X
levels	B-X
of	B-X
p73	B-X
transcript	B-X
.	B-X
Our	B-X
analysis	B-X
also	B-X
demonstrated	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
spliced	B-X
variant	B-X
of	B-X
p73	B-X
transcript	B-X
with	B-X
the	B-X
omission	B-X
of	B-X
exon	B-X
2	B-X
solely	B-X
in	B-X
the	B-X
cancer	B-X
cell	B-X
lines	B-X
and	B-X
invasive	B-X
tumor	B-X
tissues	B-X
.	B-X
In	B-X
reminiscence	B-X
of	B-X
the	B-X
dominant	B-X
negative	B-X
phenotype	B-X
of	B-X
the	B-X
N-terminal	B-X
truncated	B-X
variants	B-X
of	B-X
another	B-X
p53-related	B-X
gene	B-X
,	B-X
p63	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
truncated	B-X
p73	B-X
variant	B-X
form	B-X
in	B-X
ovarian	B-X
tumors	B-X
may	B-X
play	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
ovarian	B-X
cancer	B-X
.	B-X

Biallelic	O
expression	O
of	O
the	O
gene	O
was	O
observed	O
in	O
the	O
heterozygous	O
tumor	O
tissues	O
.	O
<EOS>	B-X
The	B-X
human	B-X
IGF2	B-X
gene	B-X
,	B-X
which	B-X
encodes	B-X
a	B-X
mitogenic	B-X
peptide	B-X
required	B-X
for	B-X
normal	B-X
fetal	B-X
development	B-X
,	B-X
is	B-X
overexpressed	B-X
in	B-X
many	B-X
types	B-X
of	B-X
tumors	B-X
.	B-X
IGF2	B-X
is	B-X
transcribed	B-X
from	B-X
four	B-X
promoters	B-X
(	B-X
P1-P4	B-X
)	B-X
,	B-X
and	B-X
in	B-X
most	B-X
tissues	B-X
,	B-X
the	B-X
gene	B-X
is	B-X
imprinted	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
have	B-X
analyzed	B-X
IGF2	B-X
promoter	B-X
usage	B-X
and	B-X
determined	B-X
the	B-X
allelic	B-X
expression	B-X
from	B-X
each	B-X
promoter	B-X
in	B-X
19	B-X
ApaI-	B-X
and	B-X
22	B-X
AluI-heterozygous	B-X
Wilms	B-X
'	B-X
tumors	B-X
.	B-X
Loss	B-X
of	B-X
IGF2	B-X
imprinting	B-X
(	B-X
LOI	B-X
)	B-X
was	B-X
observed	B-X
in	B-X
8	B-X
ApaI-informative	B-X
tumors	B-X
.	B-X
In	B-X
these	B-X
tumors	B-X
,	B-X
each	B-X
parental	B-X
allele	B-X
was	B-X
expressed	B-X
in	B-X
equal	B-X
abundance	B-X
,	B-X
indicating	B-X
that	B-X
there	B-X
was	B-X
complete	B-X
relaxation	B-X
of	B-X
IGF2	B-X
imprinting	B-X
.	B-X
In	B-X
each	B-X
LOI	B-X
tumor	B-X
,	B-X
expression	B-X
from	B-X
promoter	B-X
P1	B-X
as	B-X
well	B-X
as	B-X
from	B-X
the	B-X
normally	B-X
imprinted	B-X
promoters	B-X
P2-P4	B-X
was	B-X
biallelic	B-X
.	B-X
In	B-X
the	B-X
11	B-X
ApaI-informative	B-X
tumors	B-X
which	B-X
maintained	B-X
IGF2	B-X
imprinting	B-X
(	B-X
maintenance	B-X
of	B-X
imprinting	B-X
)	B-X
,	B-X
transcription	B-X
from	B-X
promoters	B-X
P2-P4	B-X
was	B-X
always	B-X
monoallelic	B-X
,	B-X
while	B-X
transcripts	B-X
from	B-X
P1	B-X
were	B-X
derived	B-X
from	B-X
either	B-X
one	B-X
or	B-X
both	B-X
alleles	B-X
.	B-X
The	B-X
lack	B-X
of	B-X
consistency	B-X
of	B-X
IGF2	B-X
imprinting	B-X
of	B-X
promoter	B-X
P1	B-X
in	B-X
maintenance	B-X
of	B-X
imprinting	B-X
tumors	B-X
was	B-X
also	B-X
observed	B-X
in	B-X
normal	B-X
fetal	B-X
tissues	B-X
of	B-X
6	B-X
12	B-X
weeks	B-X
gestation	B-X
,	B-X
suggesting	B-X
a	B-X
similarity	B-X
in	B-X
IGF2	B-X
regulation	B-X
between	B-X
Wilms	B-X
'	B-X
tumors	B-X
and	B-X
embryonic	B-X
tissue	B-X
development	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
the	B-X
increased	B-X
expression	B-X
of	B-X
IGF2	B-X
in	B-X
Wilms	B-X
'	B-X
tumor	B-X
may	B-X
be	B-X
caused	B-X
either	B-X
by	B-X
biallelic	B-X
gene	B-X
expression	B-X
in	B-X
LOI	B-X
tumors	B-X
from	B-X
promoters	B-X
P2-P4	B-X
and/or	B-X
by	B-X
a	B-X
reversion	B-X
to	B-X
an	B-X
earlier	B-X
stage	B-X
of	B-X
development	B-X
which	B-X
is	B-X
characterized	B-X
by	B-X
increased	B-X
synthesis	B-X
of	B-X
this	B-X
fetal	B-X
growth	B-X
factor	B-X
.	B-X

Direct	O
sequencing	O
and	O
single	O
-	O
strand	O
conformation	O
polymorphism	O
analyses	O
of	O
the	O
p73	B-Gene_or_gene_product
cDNA	O
sequence	O
homologous	O
to	O
the	O
highly	O
mutatable	O
region	O
of	O
p53	B-Gene_or_gene_product
did	O
not	O
reveal	O
any	O
mutations	O
.	O

When	O
compared	O
to	O
the	O
primary	O
cultures	O
of	O
normal	O
human	O
ovarian	O
surface	O
epithelial	O
cells	O
and	O
immortalized	O
cell	O
lines	O
,	O
four	O
of	O
the	O
seven	O
ovarian	O
carcinoma	O
cell	O
lines	O
,	O
71	O
%	O
of	O
the	O
invasive	O
tumors	O
,	O
and	O
92	O
%	O
of	O
the	O
borderline	O
tumor	O
tissues	O
express	O
elevated	O
levels	O
of	O
p73	B-Gene_or_gene_product
transcript	O
.	O

Except	O
for	O
the	O
OVCA3	O
cell	O
line	O
,	O
Western	O
blot	O
analysis	O
of	O
the	O
nuclear	O
extracts	O
prepared	O
from	O
the	O
cell	O
lines	O
showed	O
concordant	O
levels	O
of	O
p73	B-Gene_or_gene_product
protein	O
.	O
<EOS>	B-X
p73	B-X
is	B-X
a	B-X
novel	B-X
gene	B-X
that	B-X
has	B-X
high	B-X
sequence	B-X
homology	B-X
and	B-X
similar	B-X
gene	B-X
structure	B-X
to	B-X
the	B-X
tumor	B-X
suppressor	B-X
gene	B-X
p53	B-X
.	B-X
We	B-X
analysed	B-X
p73	B-X
in	B-X
seven	B-X
ovarian	B-X
carcinoma	B-X
cell	B-X
lines	B-X
and	B-X
a	B-X
total	B-X
of	B-X
63	B-X
human	B-X
borderline	B-X
and	B-X
invasive	B-X
ovarian	B-X
tumor	B-X
samples	B-X
.	B-X
Loss	B-X
of	B-X
heterozygosity	B-X
at	B-X
this	B-X
locus	B-X
was	B-X
observed	B-X
in	B-X
50	B-X
%	B-X
of	B-X
invasive	B-X
tumors	B-X
but	B-X
in	B-X
none	B-X
of	B-X
the	B-X
borderline	B-X
tumors	B-X
.	B-X
Direct	B-X
sequencing	B-X
and	B-X
single-strand	B-X
conformation	B-X
polymorphism	B-X
analyses	B-X
of	B-X
the	B-X
p73	B-X
cDNA	B-X
sequence	B-X
homologous	B-X
to	B-X
the	B-X
highly	B-X
mutatable	B-X
region	B-X
of	B-X
p53	B-X
did	B-X
not	B-X
reveal	B-X
any	B-X
mutations	B-X
.	B-X
When	B-X
compared	B-X
to	B-X
the	B-X
primary	B-X
cultures	B-X
of	B-X
normal	B-X
human	B-X
ovarian	B-X
surface	B-X
epithelial	B-X
cells	B-X
and	B-X
immortalized	B-X
cell	B-X
lines	B-X
,	B-X
four	B-X
of	B-X
the	B-X
seven	B-X
ovarian	B-X
carcinoma	B-X
cell	B-X
lines	B-X
,	B-X
71	B-X
%	B-X
of	B-X
the	B-X
invasive	B-X
tumors	B-X
,	B-X
and	B-X
92	B-X
%	B-X
of	B-X
the	B-X
borderline	B-X
tumor	B-X
tissues	B-X
express	B-X
elevated	B-X
levels	B-X
of	B-X
p73	B-X
transcript	B-X
.	B-X
Except	B-X
for	B-X
the	B-X
OVCA3	B-X
cell	B-X
line	B-X
,	B-X
Western	B-X
blot	B-X
analysis	B-X
of	B-X
the	B-X
nuclear	B-X
extracts	B-X
prepared	B-X
from	B-X
the	B-X
cell	B-X
lines	B-X
showed	B-X
concordant	B-X
levels	B-X
of	B-X
p73	B-X
protein	B-X
.	B-X
Our	B-X
analysis	B-X
also	B-X
demonstrated	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
spliced	B-X
variant	B-X
of	B-X
p73	B-X
transcript	B-X
with	B-X
the	B-X
omission	B-X
of	B-X
exon	B-X
2	B-X
solely	B-X
in	B-X
the	B-X
cancer	B-X
cell	B-X
lines	B-X
and	B-X
invasive	B-X
tumor	B-X
tissues	B-X
.	B-X
This	B-X
exon	B-X
2-spliced	B-X
transcript	B-X
would	B-X
give	B-X
rise	B-X
to	B-X
a	B-X
truncated	B-X
p73	B-X
protein	B-X
without	B-X
the	B-X
N-terminal	B-X
transactivation	B-X
domain	B-X
.	B-X
In	B-X
reminiscence	B-X
of	B-X
the	B-X
dominant	B-X
negative	B-X
phenotype	B-X
of	B-X
the	B-X
N-terminal	B-X
truncated	B-X
variants	B-X
of	B-X
another	B-X
p53-related	B-X
gene	B-X
,	B-X
p63	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
truncated	B-X
p73	B-X
variant	B-X
form	B-X
in	B-X
ovarian	B-X
tumors	B-X
may	B-X
play	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
ovarian	B-X
cancer	B-X
.	B-X

Our	O
analysis	O
also	O
demonstrated	O
the	O
expression	O
of	O
a	O
spliced	O
variant	O
of	O
p73	B-Gene_or_gene_product
transcript	O
with	O
the	O
omission	O
of	O
exon	O
2	O
solely	O
in	O
the	O
cancer	O
cell	O
lines	O
and	O
invasive	O
tumor	O
tissues	O
.	O
<EOS>	B-X
p73	B-X
is	B-X
a	B-X
novel	B-X
gene	B-X
that	B-X
has	B-X
high	B-X
sequence	B-X
homology	B-X
and	B-X
similar	B-X
gene	B-X
structure	B-X
to	B-X
the	B-X
tumor	B-X
suppressor	B-X
gene	B-X
p53	B-X
.	B-X
We	B-X
analysed	B-X
p73	B-X
in	B-X
seven	B-X
ovarian	B-X
carcinoma	B-X
cell	B-X
lines	B-X
and	B-X
a	B-X
total	B-X
of	B-X
63	B-X
human	B-X
borderline	B-X
and	B-X
invasive	B-X
ovarian	B-X
tumor	B-X
samples	B-X
.	B-X
Loss	B-X
of	B-X
heterozygosity	B-X
at	B-X
this	B-X
locus	B-X
was	B-X
observed	B-X
in	B-X
50	B-X
%	B-X
of	B-X
invasive	B-X
tumors	B-X
but	B-X
in	B-X
none	B-X
of	B-X
the	B-X
borderline	B-X
tumors	B-X
.	B-X
Biallelic	B-X
expression	B-X
of	B-X
the	B-X
gene	B-X
was	B-X
observed	B-X
in	B-X
the	B-X
heterozygous	B-X
tumor	B-X
tissues	B-X
.	B-X
Direct	B-X
sequencing	B-X
and	B-X
single-strand	B-X
conformation	B-X
polymorphism	B-X
analyses	B-X
of	B-X
the	B-X
p73	B-X
cDNA	B-X
sequence	B-X
homologous	B-X
to	B-X
the	B-X
highly	B-X
mutatable	B-X
region	B-X
of	B-X
p53	B-X
did	B-X
not	B-X
reveal	B-X
any	B-X
mutations	B-X
.	B-X
When	B-X
compared	B-X
to	B-X
the	B-X
primary	B-X
cultures	B-X
of	B-X
normal	B-X
human	B-X
ovarian	B-X
surface	B-X
epithelial	B-X
cells	B-X
and	B-X
immortalized	B-X
cell	B-X
lines	B-X
,	B-X
four	B-X
of	B-X
the	B-X
seven	B-X
ovarian	B-X
carcinoma	B-X
cell	B-X
lines	B-X
,	B-X
71	B-X
%	B-X
of	B-X
the	B-X
invasive	B-X
tumors	B-X
,	B-X
and	B-X
92	B-X
%	B-X
of	B-X
the	B-X
borderline	B-X
tumor	B-X
tissues	B-X
express	B-X
elevated	B-X
levels	B-X
of	B-X
p73	B-X
transcript	B-X
.	B-X
Except	B-X
for	B-X
the	B-X
OVCA3	B-X
cell	B-X
line	B-X
,	B-X
Western	B-X
blot	B-X
analysis	B-X
of	B-X
the	B-X
nuclear	B-X
extracts	B-X
prepared	B-X
from	B-X
the	B-X
cell	B-X
lines	B-X
showed	B-X
concordant	B-X
levels	B-X
of	B-X
p73	B-X
protein	B-X
.	B-X
Our	B-X
analysis	B-X
also	B-X
demonstrated	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
spliced	B-X
variant	B-X
of	B-X
p73	B-X
transcript	B-X
with	B-X
the	B-X
omission	B-X
of	B-X
exon	B-X
2	B-X
solely	B-X
in	B-X
the	B-X
cancer	B-X
cell	B-X
lines	B-X
and	B-X
invasive	B-X
tumor	B-X
tissues	B-X
.	B-X
This	B-X
exon	B-X
2-spliced	B-X
transcript	B-X
would	B-X
give	B-X
rise	B-X
to	B-X
a	B-X
truncated	B-X
p73	B-X
protein	B-X
without	B-X
the	B-X
N-terminal	B-X
transactivation	B-X
domain	B-X
.	B-X
In	B-X
reminiscence	B-X
of	B-X
the	B-X
dominant	B-X
negative	B-X
phenotype	B-X
of	B-X
the	B-X
N-terminal	B-X
truncated	B-X
variants	B-X
of	B-X
another	B-X
p53-related	B-X
gene	B-X
,	B-X
p63	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
truncated	B-X
p73	B-X
variant	B-X
form	B-X
in	B-X
ovarian	B-X
tumors	B-X
may	B-X
play	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
ovarian	B-X
cancer	B-X
.	B-X

This	O
exon	O
2	O
-	O
spliced	O
transcript	O
would	O
give	O
rise	O
to	O
a	O
truncated	O
p73	B-Gene_or_gene_product
protein	O
without	O
the	O
N	O
-	O
terminal	O
transactivation	O
domain	O
.	O

In	O
reminiscence	O
of	O
the	O
dominant	O
negative	O
phenotype	O
of	O
the	O
N	O
-	O
terminal	O
truncated	O
variants	O
of	O
another	O
p53	B-Gene_or_gene_product
-	O
related	O
gene	O
,	O
p63	B-Gene_or_gene_product
,	O
the	O
expression	O
of	O
the	O
truncated	O
p73	B-Gene_or_gene_product
variant	O
form	O
in	O
ovarian	O
tumors	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
ovarian	O
cancer	O
.	O

Phosphorylation	O
of	O
the	O
MEKK	B-Gene_or_gene_product
Ste11p	B-Gene_or_gene_product
by	O
the	O
PAK	B-Gene_or_gene_product
-	O
like	O
kinase	O
Ste20p	B-Gene_or_gene_product
is	O
required	O
for	O
MAP	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
signaling	O
in	O
vivo	O
.	O
<EOS>	B-X
Many	B-X
signals	B-X
are	B-X
transduced	B-X
from	B-X
the	B-X
cell	B-X
surface	B-X
to	B-X
the	B-X
nucleus	B-X
through	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
cascades	B-X
.	B-X
Activation	B-X
of	B-X
MAP	B-X
kinase	B-X
requires	B-X
phosphorylation	B-X
by	B-X
MEK	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
is	B-X
controlled	B-X
by	B-X
Raf	B-X
,	B-X
Mos	B-X
or	B-X
a	B-X
group	B-X
of	B-X
structurally	B-X
related	B-X
kinases	B-X
termed	B-X
MEKKs	B-X
.	B-X
It	B-X
is	B-X
not	B-X
understood	B-X
how	B-X
MEKKs	B-X
are	B-X
regulated	B-X
by	B-X
extracellular	B-X
signals	B-X
.	B-X
In	B-X
yeast	B-X
,	B-X
the	B-X
MEKK	B-X
Ste11p	B-X
functions	B-X
in	B-X
multiple	B-X
MAP	B-X
kinase	B-X
cascades	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
pheromones	B-X
,	B-X
high	B-X
osmolarity	B-X
and	B-X
nutrient	B-X
starvation	B-X
.	B-X
Genetic	B-X
evidence	B-X
suggests	B-X
that	B-X
the	B-X
p21-activated	B-X
protein	B-X
kinase	B-X
(	B-X
PAK	B-X
)	B-X
Ste20p	B-X
functions	B-X
upstream	B-X
of	B-X
Ste11p	B-X
,	B-X
and	B-X
Ste20p	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
phosphorylate	B-X
Ste11p	B-X
in	B-X
vitro	B-X
.	B-X

BACKGROUND	O
:	O
Many	O
signals	O
are	O
transduced	O
from	O
the	O
cell	O
surface	O
to	O
the	O
nucleus	O
through	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	I-Gene_or_gene_product
MAP	I-Gene_or_gene_product
)	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
cascades	O
.	O

Activation	O
of	O
MAP	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
requires	O
phosphorylation	O
by	O
MEK	B-Gene_or_gene_product
,	O
which	O
in	O
turn	O
is	O
controlled	O
by	O
Raf	B-Gene_or_gene_product
,	O
Mos	B-Gene_or_gene_product
or	O
a	O
group	O
of	O
structurally	O
related	O
kinases	O
termed	O
MEKKs	B-Gene_or_gene_product
.	O
<EOS>	B-X
Despite	B-X
being	B-X
successful	B-X
in	B-X
controlling	B-X
the	B-X
disease	B-X
in	B-X
the	B-X
majority	B-X
of	B-X
men	B-X
,	B-X
the	B-X
high	B-X
frequency	B-X
of	B-X
disease	B-X
progression	B-X
to	B-X
aggressive	B-X
and	B-X
therapy	B-X
resistant	B-X
stages	B-X
(	B-X
termed	B-X
castrate	B-X
resistant	B-X
prostate	B-X
cancer	B-X
)	B-X
has	B-X
led	B-X
to	B-X
the	B-X
search	B-X
for	B-X
new	B-X
therapeutic	B-X
targets	B-X
.	B-X
The	B-X
p90	B-X
ribosomal	B-X
S6	B-X
kinase	B-X
(	B-X
RSK1-4	B-X
)	B-X
family	B-X
is	B-X
a	B-X
group	B-X
of	B-X
highly	B-X
conserved	B-X
Ser/Thr	B-X
kinases	B-X
that	B-X
holds	B-X
promise	B-X
as	B-X
a	B-X
novel	B-X
target	B-X
.	B-X
RSKs	B-X
are	B-X
effector	B-X
kinases	B-X
that	B-X
lay	B-X
downstream	B-X
of	B-X
the	B-X
Ras/Raf/MEK/ERK	B-X
signaling	B-X
pathway	B-X
,	B-X
and	B-X
aberrant	B-X
activation	B-X
or	B-X
expression	B-X
of	B-X
RSKs	B-X
has	B-X
been	B-X
reported	B-X
in	B-X
several	B-X
malignancies	B-X
,	B-X
including	B-X
PCa	B-X
.	B-X
This	B-X
resting	B-X
state	B-X
can	B-X
be	B-X
stable	B-X
for	B-X
many	B-X
hours	B-X
and	B-X
depends	B-X
on	B-X
a	B-X
cytoplasmic	B-X
activity	B-X
termed	B-X
cytostatic	B-X
factor	B-X
(	B-X
CSF	B-X
)	B-X
.	B-X
Initially	B-X
,	B-X
Xenopus	B-X
early	B-X
mitotic	B-X
inhibitor	B-X
1	B-X
(	B-X
Emi1	B-X
)	B-X
was	B-X
proposed	B-X
to	B-X
be	B-X
a	B-X
component	B-X
of	B-X
CSF	B-X
,	B-X
but	B-X
newer	B-X
work	B-X
suggests	B-X
that	B-X
a	B-X
structural	B-X
relative	B-X
,	B-X
Emi-related	B-X
protein	B-X
1	B-X
(	B-X
Erp1/Emi2	B-X
)	B-X
,	B-X
is	B-X
essential	B-X
for	B-X
maintenance	B-X
of	B-X
CSF	B-X
arrest	B-X
in	B-X
Xenopus	B-X
.	B-X
Most	B-X
importantly	B-X
,	B-X
studies	B-X
on	B-X
Erp1/Emi2	B-X
regulation	B-X
have	B-X
led	B-X
to	B-X
a	B-X
detailed	B-X
molecular	B-X
understanding	B-X
of	B-X
the	B-X
Ca2+-mediated	B-X
release	B-X
from	B-X
CSF	B-X
arrest	B-X
that	B-X
occurs	B-X
upon	B-X
fertilization	B-X
.	B-X

It	O
is	O
not	O
understood	O
how	O
MEKKs	B-Gene_or_gene_product
are	O
regulated	O
by	O
extracellular	O
signals	O
.	O

In	O
yeast	O
,	O
the	O
MEKK	B-Gene_or_gene_product
Ste11p	B-Gene_or_gene_product
functions	O
in	O
multiple	O
MAP	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
cascades	O
activated	O
in	O
response	O
to	O
pheromones	O
,	O
high	O
osmolarity	O
and	O
nutrient	O
starvation	O
.	O
<EOS>	B-X
Many	B-X
signals	B-X
are	B-X
transduced	B-X
from	B-X
the	B-X
cell	B-X
surface	B-X
to	B-X
the	B-X
nucleus	B-X
through	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
cascades	B-X
.	B-X
Activation	B-X
of	B-X
MAP	B-X
kinase	B-X
requires	B-X
phosphorylation	B-X
by	B-X
MEK	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
is	B-X
controlled	B-X
by	B-X
Raf	B-X
,	B-X
Mos	B-X
or	B-X
a	B-X
group	B-X
of	B-X
structurally	B-X
related	B-X
kinases	B-X
termed	B-X
MEKKs	B-X
.	B-X
It	B-X
is	B-X
not	B-X
understood	B-X
how	B-X
MEKKs	B-X
are	B-X
regulated	B-X
by	B-X
extracellular	B-X
signals	B-X
.	B-X
In	B-X
yeast	B-X
,	B-X
the	B-X
MEKK	B-X
Ste11p	B-X
functions	B-X
in	B-X
multiple	B-X
MAP	B-X
kinase	B-X
cascades	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
pheromones	B-X
,	B-X
high	B-X
osmolarity	B-X
and	B-X
nutrient	B-X
starvation	B-X
.	B-X
Genetic	B-X
evidence	B-X
suggests	B-X
that	B-X
the	B-X
p21-activated	B-X
protein	B-X
kinase	B-X
(	B-X
PAK	B-X
)	B-X
Ste20p	B-X
functions	B-X
upstream	B-X
of	B-X
Ste11p	B-X
,	B-X
and	B-X
Ste20p	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
phosphorylate	B-X
Ste11p	B-X
in	B-X
vitro	B-X
.	B-X

Genetic	O
evidence	O
suggests	O
that	O
the	O
p21	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
PAK	B-Gene_or_gene_product
)	O
Ste20p	B-Gene_or_gene_product
functions	O
upstream	O
of	O
Ste11p	B-Gene_or_gene_product
,	O
and	O
Ste20p	B-Gene_or_gene_product
has	O
been	O
shown	O
to	O
phosphorylate	O
Ste11p	B-Gene_or_gene_product
in	O
vitro	O
.	O
<EOS>	B-X
Many	B-X
signals	B-X
are	B-X
transduced	B-X
from	B-X
the	B-X
cell	B-X
surface	B-X
to	B-X
the	B-X
nucleus	B-X
through	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
cascades	B-X
.	B-X
Activation	B-X
of	B-X
MAP	B-X
kinase	B-X
requires	B-X
phosphorylation	B-X
by	B-X
MEK	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
is	B-X
controlled	B-X
by	B-X
Raf	B-X
,	B-X
Mos	B-X
or	B-X
a	B-X
group	B-X
of	B-X
structurally	B-X
related	B-X
kinases	B-X
termed	B-X
MEKKs	B-X
.	B-X
In	B-X
yeast	B-X
,	B-X
the	B-X
MEKK	B-X
Ste11p	B-X
functions	B-X
in	B-X
multiple	B-X
MAP	B-X
kinase	B-X
cascades	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
pheromones	B-X
,	B-X
high	B-X
osmolarity	B-X
and	B-X
nutrient	B-X
starvation	B-X
.	B-X
Genetic	B-X
evidence	B-X
suggests	B-X
that	B-X
the	B-X
p21-activated	B-X
protein	B-X
kinase	B-X
(	B-X
PAK	B-X
)	B-X
Ste20p	B-X
functions	B-X
upstream	B-X
of	B-X
Ste11p	B-X
,	B-X
and	B-X
Ste20p	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
phosphorylate	B-X
Ste11p	B-X
in	B-X
vitro	B-X
.	B-X

RESULTS	O
:	O
Ste20p	B-Gene_or_gene_product
phosphorylated	O
Ste11p	B-Gene_or_gene_product
on	O
Ser302	O
and	O
/	O
or	O
Ser306	O
and	O
Thr307	O
in	O
yeast	O
,	O
residues	O
that	O
are	O
conserved	O
in	O
MEKKs	B-Gene_or_gene_product
of	O
other	O
organisms	O
.	O
<EOS>	B-X
Activation	B-X
of	B-X
MAP	B-X
kinase	B-X
requires	B-X
phosphorylation	B-X
by	B-X
MEK	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
is	B-X
controlled	B-X
by	B-X
Raf	B-X
,	B-X
Mos	B-X
or	B-X
a	B-X
group	B-X
of	B-X
structurally	B-X
related	B-X
kinases	B-X
termed	B-X
MEKKs	B-X
.	B-X
It	B-X
is	B-X
not	B-X
understood	B-X
how	B-X
MEKKs	B-X
are	B-X
regulated	B-X
by	B-X
extracellular	B-X
signals	B-X
.	B-X
In	B-X
yeast	B-X
,	B-X
the	B-X
MEKK	B-X
Ste11p	B-X
functions	B-X
in	B-X
multiple	B-X
MAP	B-X
kinase	B-X
cascades	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
pheromones	B-X
,	B-X
high	B-X
osmolarity	B-X
and	B-X
nutrient	B-X
starvation	B-X
.	B-X
Genetic	B-X
evidence	B-X
suggests	B-X
that	B-X
the	B-X
p21-activated	B-X
protein	B-X
kinase	B-X
(	B-X
PAK	B-X
)	B-X
Ste20p	B-X
functions	B-X
upstream	B-X
of	B-X
Ste11p	B-X
,	B-X
and	B-X
Ste20p	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
phosphorylate	B-X
Ste11p	B-X
in	B-X
vitro	B-X
.	B-X

Mutating	O
these	O
sites	O
to	O
non	O
-	O
phosphorylatable	O
residues	O
abolished	O
Ste11p	B-Gene_or_gene_product
function	O
,	O
whereas	O
changing	O
them	O
to	O
aspartic	O
acid	O
to	O
mimic	O
the	O
phosphorylated	O
form	O
constitutively	O
activated	O
Ste11p	B-Gene_or_gene_product
in	O
vivo	O
in	O
a	O
Ste20p	B-Gene_or_gene_product
-	O
independent	O
manner	O
.	O

The	O
amino	O
-	O
terminal	O
regulatory	O
domain	O
of	O
Ste11p	B-Gene_or_gene_product
interacted	O
with	O
its	O
catalytic	O
domain	O
,	O
and	O
overexpression	O
of	O
a	O
small	O
amino	O
-	O
terminal	O
fragment	O
of	O
Ste11p	B-Gene_or_gene_product
was	O
able	O
to	O
inhibit	O
signaling	O
in	O
response	O
to	O
pheromones	O
.	O
<EOS>	B-X
In	B-X
yeast	B-X
,	B-X
the	B-X
MEKK	B-X
Ste11p	B-X
functions	B-X
in	B-X
multiple	B-X
MAP	B-X
kinase	B-X
cascades	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
pheromones	B-X
,	B-X
high	B-X
osmolarity	B-X
and	B-X
nutrient	B-X
starvation	B-X
.	B-X
Genetic	B-X
evidence	B-X
suggests	B-X
that	B-X
the	B-X
p21-activated	B-X
protein	B-X
kinase	B-X
(	B-X
PAK	B-X
)	B-X
Ste20p	B-X
functions	B-X
upstream	B-X
of	B-X
Ste11p	B-X
,	B-X
and	B-X
Ste20p	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
phosphorylate	B-X
Ste11p	B-X
in	B-X
vitro	B-X
.	B-X

Mutational	O
analysis	O
suggested	O
that	O
this	O
interaction	O
was	O
regulated	O
by	O
phosphorylation	O
and	O
dependent	O
on	O
Thr596	O
,	O
which	O
is	O
located	O
in	O
the	O
substrate	O
cleft	O
of	O
the	O
catalytic	O
domain	O
.	O
<EOS>	B-X
Activation	B-X
of	B-X
MAP	B-X
kinase	B-X
requires	B-X
phosphorylation	B-X
by	B-X
MEK	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
is	B-X
controlled	B-X
by	B-X
Raf	B-X
,	B-X
Mos	B-X
or	B-X
a	B-X
group	B-X
of	B-X
structurally	B-X
related	B-X
kinases	B-X
termed	B-X
MEKKs	B-X
.	B-X
It	B-X
is	B-X
not	B-X
understood	B-X
how	B-X
MEKKs	B-X
are	B-X
regulated	B-X
by	B-X
extracellular	B-X
signals	B-X
.	B-X

CONCLUSIONS	O
:	O
Our	O
results	O
suggest	O
that	O
,	O
in	O
response	O
to	O
multiple	O
extracellular	O
signals	O
,	O
phosphorylation	O
of	O
Ste11p	B-Gene_or_gene_product
by	O
Ste20p	B-Gene_or_gene_product
removes	O
an	O
amino	O
-	O
terminal	O
inhibitory	O
domain	O
,	O
leading	O
to	O
activation	O
of	O
the	O
Ste11	B-Gene_or_gene_product
protein	O
kinase	O
.	O
<EOS>	B-X
Many	B-X
signals	B-X
are	B-X
transduced	B-X
from	B-X
the	B-X
cell	B-X
surface	B-X
to	B-X
the	B-X
nucleus	B-X
through	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
cascades	B-X
.	B-X
Activation	B-X
of	B-X
MAP	B-X
kinase	B-X
requires	B-X
phosphorylation	B-X
by	B-X
MEK	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
is	B-X
controlled	B-X
by	B-X
Raf	B-X
,	B-X
Mos	B-X
or	B-X
a	B-X
group	B-X
of	B-X
structurally	B-X
related	B-X
kinases	B-X
termed	B-X
MEKKs	B-X
.	B-X
It	B-X
is	B-X
not	B-X
understood	B-X
how	B-X
MEKKs	B-X
are	B-X
regulated	B-X
by	B-X
extracellular	B-X
signals	B-X
.	B-X
In	B-X
yeast	B-X
,	B-X
the	B-X
MEKK	B-X
Ste11p	B-X
functions	B-X
in	B-X
multiple	B-X
MAP	B-X
kinase	B-X
cascades	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
pheromones	B-X
,	B-X
high	B-X
osmolarity	B-X
and	B-X
nutrient	B-X
starvation	B-X
.	B-X
Genetic	B-X
evidence	B-X
suggests	B-X
that	B-X
the	B-X
p21-activated	B-X
protein	B-X
kinase	B-X
(	B-X
PAK	B-X
)	B-X
Ste20p	B-X
functions	B-X
upstream	B-X
of	B-X
Ste11p	B-X
,	B-X
and	B-X
Ste20p	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
phosphorylate	B-X
Ste11p	B-X
in	B-X
vitro	B-X
.	B-X

This	O
mechanism	O
may	O
serve	O
as	O
a	O
paradigm	O
for	O
the	O
activation	O
of	O
mammalian	O
MEKKs	B-Gene_or_gene_product
.	O
<EOS>	B-X
Activation	B-X
of	B-X
MAP	B-X
kinase	B-X
requires	B-X
phosphorylation	B-X
by	B-X
MEK	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
is	B-X
controlled	B-X
by	B-X
Raf	B-X
,	B-X
Mos	B-X
or	B-X
a	B-X
group	B-X
of	B-X
structurally	B-X
related	B-X
kinases	B-X
termed	B-X
MEKKs	B-X
.	B-X
It	B-X
is	B-X
not	B-X
understood	B-X
how	B-X
MEKKs	B-X
are	B-X
regulated	B-X
by	B-X
extracellular	B-X
signals	B-X
.	B-X
Small	B-X
G	B-X
proteins	B-X
serve	B-X
as	B-X
critical	B-X
control	B-X
points	B-X
in	B-X
signal	B-X
transduction	B-X
,	B-X
integrating	B-X
a	B-X
wide	B-X
range	B-X
of	B-X
stimuli	B-X
to	B-X
dictate	B-X
discrete	B-X
cellular	B-X
outcomes	B-X
.	B-X
Because	B-X
Rap1	B-X
can	B-X
regulate	B-X
cell	B-X
proliferation	B-X
,	B-X
differentiation	B-X
,	B-X
and	B-X
adhesion	B-X
through	B-X
distinct	B-X
mechanisms	B-X
,	B-X
it	B-X
serves	B-X
as	B-X
a	B-X
paradigm	B-X
for	B-X
the	B-X
need	B-X
for	B-X
tight	B-X
cellular	B-X
control	B-X
of	B-X
small	B-X
G-protein	B-X
function	B-X
.	B-X
Rap1	B-X
may	B-X
also	B-X
regulate	B-X
cellular	B-X
differentiation	B-X
and	B-X
proliferation	B-X
via	B-X
pathways	B-X
that	B-X
are	B-X
distinct	B-X
from	B-X
those	B-X
mediating	B-X
adhesion	B-X
,	B-X
and	B-X
involve	B-X
regulation	B-X
of	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
or	B-X
ERK	B-X
(	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
)	B-X
cascade	B-X
.	B-X
Recent	B-X
studies	B-X
implicating	B-X
Rap1	B-X
in	B-X
the	B-X
maturation	B-X
of	B-X
megakaryocytes	B-X
,	B-X
the	B-X
pathogenesis	B-X
of	B-X
chronic	B-X
myelogenous	B-X
leukemia	B-X
(	B-X
CML	B-X
)	B-X
,	B-X
and	B-X
activation	B-X
of	B-X
peripheral	B-X
T	B-X
cells	B-X
will	B-X
receive	B-X
particular	B-X
attention	B-X
.	B-X

GLUT8	B-Gene_or_gene_product
is	O
a	O
glucose	O
transporter	O
responsible	O
for	O
insulin	B-Gene_or_gene_product
-	O
stimulated	O
glucose	O
uptake	O
in	O
the	O
blastocyst	O
.	O
<EOS>	B-X
Mammalian	B-X
preimplantation	B-X
blastocysts	B-X
exhibit	B-X
insulin-stimulated	B-X
glucose	B-X
uptake	B-X
despite	B-X
the	B-X
absence	B-X
of	B-X
the	B-X
only	B-X
known	B-X
insulin-regulated	B-X
transporter	B-X
,	B-X
GLUT4	B-X
.	B-X
Insulin	B-X
induces	B-X
a	B-X
change	B-X
in	B-X
the	B-X
intracellular	B-X
localization	B-X
of	B-X
this	B-X
protein	B-X
,	B-X
which	B-X
translates	B-X
into	B-X
increased	B-X
glucose	B-X
uptake	B-X
into	B-X
the	B-X
blastocyst	B-X
,	B-X
a	B-X
process	B-X
that	B-X
is	B-X
inhibited	B-X
by	B-X
antisense	B-X
oligoprobes	B-X
.	B-X
Presence	B-X
of	B-X
this	B-X
transporter	B-X
may	B-X
be	B-X
necessary	B-X
for	B-X
successful	B-X
blastocyst	B-X
development	B-X
,	B-X
fuel	B-X
metabolism	B-X
,	B-X
and	B-X
subsequent	B-X
implantation	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
existence	B-X
of	B-X
an	B-X
alternative	B-X
transporter	B-X
may	B-X
explain	B-X
examples	B-X
in	B-X
other	B-X
tissues	B-X
of	B-X
insulin-regulated	B-X
glucose	B-X
transport	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
GLUT4	B-X
.	B-X

Mammalian	O
preimplantation	O
blastocysts	O
exhibit	O
insulin	B-Gene_or_gene_product
-	O
stimulated	O
glucose	O
uptake	O
despite	O
the	O
absence	O
of	O
the	O
only	O
known	O
insulin	B-Gene_or_gene_product
-	O
regulated	O
transporter	O
,	O
GLUT4	B-Gene_or_gene_product
.	O
<EOS>	B-X
Mammalian	B-X
preimplantation	B-X
blastocysts	B-X
exhibit	B-X
insulin-stimulated	B-X
glucose	B-X
uptake	B-X
despite	B-X
the	B-X
absence	B-X
of	B-X
the	B-X
only	B-X
known	B-X
insulin-regulated	B-X
transporter	B-X
,	B-X
GLUT4	B-X
.	B-X
We	B-X
describe	B-X
a	B-X
previously	B-X
unidentified	B-X
member	B-X
of	B-X
the	B-X
mammalian	B-X
facilitative	B-X
GLUT	B-X
superfamily	B-X
that	B-X
exhibits	B-X
approximately	B-X
20-25	B-X
%	B-X
identity	B-X
with	B-X
other	B-X
murine	B-X
facilitative	B-X
GLUTs	B-X
.	B-X
Insulin	B-X
induces	B-X
a	B-X
change	B-X
in	B-X
the	B-X
intracellular	B-X
localization	B-X
of	B-X
this	B-X
protein	B-X
,	B-X
which	B-X
translates	B-X
into	B-X
increased	B-X
glucose	B-X
uptake	B-X
into	B-X
the	B-X
blastocyst	B-X
,	B-X
a	B-X
process	B-X
that	B-X
is	B-X
inhibited	B-X
by	B-X
antisense	B-X
oligoprobes	B-X
.	B-X
Presence	B-X
of	B-X
this	B-X
transporter	B-X
may	B-X
be	B-X
necessary	B-X
for	B-X
successful	B-X
blastocyst	B-X
development	B-X
,	B-X
fuel	B-X
metabolism	B-X
,	B-X
and	B-X
subsequent	B-X
implantation	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
existence	B-X
of	B-X
an	B-X
alternative	B-X
transporter	B-X
may	B-X
explain	B-X
examples	B-X
in	B-X
other	B-X
tissues	B-X
of	B-X
insulin-regulated	B-X
glucose	B-X
transport	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
GLUT4	B-X
.	B-X

We	O
describe	O
a	O
previously	O
unidentified	O
member	O
of	O
the	O
mammalian	O
facilitative	O
GLUT	B-Gene_or_gene_product
superfamily	O
that	O
exhibits	O
approximately	O
20	O
-	O
25	O
%	O
identity	O
with	O
other	O
murine	O
facilitative	O
GLUTs	B-Gene_or_gene_product
.	O
<EOS>	B-X
Mammalian	B-X
preimplantation	B-X
blastocysts	B-X
exhibit	B-X
insulin-stimulated	B-X
glucose	B-X
uptake	B-X
despite	B-X
the	B-X
absence	B-X
of	B-X
the	B-X
only	B-X
known	B-X
insulin-regulated	B-X
transporter	B-X
,	B-X
GLUT4	B-X
.	B-X
We	B-X
describe	B-X
a	B-X
previously	B-X
unidentified	B-X
member	B-X
of	B-X
the	B-X
mammalian	B-X
facilitative	B-X
GLUT	B-X
superfamily	B-X
that	B-X
exhibits	B-X
approximately	B-X
20-25	B-X
%	B-X
identity	B-X
with	B-X
other	B-X
murine	B-X
facilitative	B-X
GLUTs	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
existence	B-X
of	B-X
an	B-X
alternative	B-X
transporter	B-X
may	B-X
explain	B-X
examples	B-X
in	B-X
other	B-X
tissues	B-X
of	B-X
insulin-regulated	B-X
glucose	B-X
transport	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
GLUT4	B-X
.	B-X

Insulin	B-Gene_or_gene_product
induces	O
a	O
change	O
in	O
the	O
intracellular	O
localization	O
of	O
this	O
protein	O
,	O
which	O
translates	O
into	O
increased	O
glucose	O
uptake	O
into	O
the	O
blastocyst	O
,	O
a	O
process	O
that	O
is	O
inhibited	O
by	O
antisense	O
oligoprobes	O
.	O
<EOS>	B-X
Mammalian	B-X
preimplantation	B-X
blastocysts	B-X
exhibit	B-X
insulin-stimulated	B-X
glucose	B-X
uptake	B-X
despite	B-X
the	B-X
absence	B-X
of	B-X
the	B-X
only	B-X
known	B-X
insulin-regulated	B-X
transporter	B-X
,	B-X
GLUT4	B-X
.	B-X
Insulin	B-X
induces	B-X
a	B-X
change	B-X
in	B-X
the	B-X
intracellular	B-X
localization	B-X
of	B-X
this	B-X
protein	B-X
,	B-X
which	B-X
translates	B-X
into	B-X
increased	B-X
glucose	B-X
uptake	B-X
into	B-X
the	B-X
blastocyst	B-X
,	B-X
a	B-X
process	B-X
that	B-X
is	B-X
inhibited	B-X
by	B-X
antisense	B-X
oligoprobes	B-X
.	B-X
Presence	B-X
of	B-X
this	B-X
transporter	B-X
may	B-X
be	B-X
necessary	B-X
for	B-X
successful	B-X
blastocyst	B-X
development	B-X
,	B-X
fuel	B-X
metabolism	B-X
,	B-X
and	B-X
subsequent	B-X
implantation	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
existence	B-X
of	B-X
an	B-X
alternative	B-X
transporter	B-X
may	B-X
explain	B-X
examples	B-X
in	B-X
other	B-X
tissues	B-X
of	B-X
insulin-regulated	B-X
glucose	B-X
transport	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
GLUT4	B-X
.	B-X

Presence	O
of	O
this	O
transporter	O
may	O
be	O
necessary	O
for	O
successful	O
blastocyst	O
development	O
,	O
fuel	O
metabolism	O
,	O
and	O
subsequent	O
implantation	O
.	O
<EOS>	B-X
Mammalian	B-X
preimplantation	B-X
blastocysts	B-X
exhibit	B-X
insulin-stimulated	B-X
glucose	B-X
uptake	B-X
despite	B-X
the	B-X
absence	B-X
of	B-X
the	B-X
only	B-X
known	B-X
insulin-regulated	B-X
transporter	B-X
,	B-X
GLUT4	B-X
.	B-X
Insulin	B-X
induces	B-X
a	B-X
change	B-X
in	B-X
the	B-X
intracellular	B-X
localization	B-X
of	B-X
this	B-X
protein	B-X
,	B-X
which	B-X
translates	B-X
into	B-X
increased	B-X
glucose	B-X
uptake	B-X
into	B-X
the	B-X
blastocyst	B-X
,	B-X
a	B-X
process	B-X
that	B-X
is	B-X
inhibited	B-X
by	B-X
antisense	B-X
oligoprobes	B-X
.	B-X
Presence	B-X
of	B-X
this	B-X
transporter	B-X
may	B-X
be	B-X
necessary	B-X
for	B-X
successful	B-X
blastocyst	B-X
development	B-X
,	B-X
fuel	B-X
metabolism	B-X
,	B-X
and	B-X
subsequent	B-X
implantation	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
existence	B-X
of	B-X
an	B-X
alternative	B-X
transporter	B-X
may	B-X
explain	B-X
examples	B-X
in	B-X
other	B-X
tissues	B-X
of	B-X
insulin-regulated	B-X
glucose	B-X
transport	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
GLUT4	B-X
.	B-X

Moreover	O
,	O
the	O
existence	O
of	O
an	O
alternative	O
transporter	O
may	O
explain	O
examples	O
in	O
other	O
tissues	O
of	O
insulin	B-Gene_or_gene_product
-	O
regulated	O
glucose	O
transport	O
in	O
the	O
absence	O
of	O
GLUT4	B-Gene_or_gene_product
.	O
<EOS>	B-X
Mammalian	B-X
preimplantation	B-X
blastocysts	B-X
exhibit	B-X
insulin-stimulated	B-X
glucose	B-X
uptake	B-X
despite	B-X
the	B-X
absence	B-X
of	B-X
the	B-X
only	B-X
known	B-X
insulin-regulated	B-X
transporter	B-X
,	B-X
GLUT4	B-X
.	B-X
Insulin	B-X
induces	B-X
a	B-X
change	B-X
in	B-X
the	B-X
intracellular	B-X
localization	B-X
of	B-X
this	B-X
protein	B-X
,	B-X
which	B-X
translates	B-X
into	B-X
increased	B-X
glucose	B-X
uptake	B-X
into	B-X
the	B-X
blastocyst	B-X
,	B-X
a	B-X
process	B-X
that	B-X
is	B-X
inhibited	B-X
by	B-X
antisense	B-X
oligoprobes	B-X
.	B-X
Presence	B-X
of	B-X
this	B-X
transporter	B-X
may	B-X
be	B-X
necessary	B-X
for	B-X
successful	B-X
blastocyst	B-X
development	B-X
,	B-X
fuel	B-X
metabolism	B-X
,	B-X
and	B-X
subsequent	B-X
implantation	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
existence	B-X
of	B-X
an	B-X
alternative	B-X
transporter	B-X
may	B-X
explain	B-X
examples	B-X
in	B-X
other	B-X
tissues	B-X
of	B-X
insulin-regulated	B-X
glucose	B-X
transport	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
GLUT4	B-X
.	B-X

Regulation	O
of	O
the	O
yeast	O
transcriptional	O
factor	O
PHO2	B-Gene_or_gene_product
activity	O
by	O
phosphorylation	O
.	O
<EOS>	B-X
The	B-X
induction	B-X
of	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
gene	B-X
PHO5	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
transcriptional	B-X
factors	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
We	B-X
report	B-X
here	B-X
that	B-X
PHO2	B-X
can	B-X
also	B-X
be	B-X
phosphorylated	B-X
.	B-X
A	B-X
Ser-230	B-X
to	B-X
Ala	B-X
mutation	B-X
in	B-X
the	B-X
consensus	B-X
sequence	B-X
(	B-X
SPIK	B-X
)	B-X
recognized	B-X
by	B-X
cdc2/CDC28-related	B-X
kinase	B-X
in	B-X
PHO2	B-X
protein	B-X
led	B-X
to	B-X
complete	B-X
loss	B-X
of	B-X
its	B-X
ability	B-X
to	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Further	B-X
investigation	B-X
showed	B-X
that	B-X
the	B-X
Pro-231	B-X
to	B-X
Ser	B-X
mutation	B-X
inactivated	B-X
PHO2	B-X
protein	B-X
as	B-X
well	B-X
,	B-X
whereas	B-X
the	B-X
Ser-230	B-X
to	B-X
Asp	B-X
mutation	B-X
did	B-X
not	B-X
affect	B-X
PHO2	B-X
activity	B-X
.	B-X
Since	B-X
the	B-X
PHO2	B-X
Asp-230	B-X
mutant	B-X
mimics	B-X
Ser-230-phosphorylated	B-X
PHO2	B-X
,	B-X
we	B-X
postulate	B-X
that	B-X
only	B-X
phosphorylated	B-X
PHO2	B-X
protein	B-X
could	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Two	B-X
hybrid	B-X
assays	B-X
showed	B-X
that	B-X
yeast	B-X
CDC28	B-X
could	B-X
interact	B-X
with	B-X
PHO2	B-X
.	B-X
CDC28	B-X
immunoprecipitate	B-X
derived	B-X
from	B-X
the	B-X
YPH499	B-X
strain	B-X
grown	B-X
under	B-X
low	B-X
phosphate	B-X
conditions	B-X
phosphorylated	B-X
GST-PHO2	B-X
in	B-X
vitro	B-X
.	B-X
A	B-X
phosphate	B-X
switch	B-X
regulates	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
,	B-X
and	B-X
mutations	B-X
of	B-X
the	B-X
(	B-X
SPIK	B-X
)	B-X
site	B-X
affect	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
and	B-X
the	B-X
interaction	B-X
between	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
BIAcore	B-X
(	B-X
R	B-X
)	B-X
analysis	B-X
indicated	B-X
that	B-X
the	B-X
negative	B-X
charge	B-X
in	B-X
residue	B-X
230	B-X
of	B-X
PHO2	B-X
was	B-X
sufficient	B-X
to	B-X
help	B-X
PHO2	B-X
interact	B-X
with	B-X
PHO4	B-X
in	B-X
vitro	B-X
.	B-X

The	O
induction	O
of	O
yeast	O
Saccharomyces	O
cerevisiae	O
gene	O
PHO5	B-Gene_or_gene_product
expression	O
is	O
mediated	O
by	O
transcriptional	O
factors	O
PHO2	B-Gene_or_gene_product
and	O
PHO4	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
induction	B-X
of	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
gene	B-X
PHO5	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
transcriptional	B-X
factors	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
PHO4	B-X
protein	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
be	B-X
phosphorylated	B-X
and	B-X
inactivated	B-X
by	B-X
a	B-X
cyclin-CDK	B-X
(	B-X
cyclin-dependent	B-X
kinase	B-X
)	B-X
complex	B-X
,	B-X
PHO80-PHO85	B-X
.	B-X
We	B-X
report	B-X
here	B-X
that	B-X
PHO2	B-X
can	B-X
also	B-X
be	B-X
phosphorylated	B-X
.	B-X
A	B-X
Ser-230	B-X
to	B-X
Ala	B-X
mutation	B-X
in	B-X
the	B-X
consensus	B-X
sequence	B-X
(	B-X
SPIK	B-X
)	B-X
recognized	B-X
by	B-X
cdc2/CDC28-related	B-X
kinase	B-X
in	B-X
PHO2	B-X
protein	B-X
led	B-X
to	B-X
complete	B-X
loss	B-X
of	B-X
its	B-X
ability	B-X
to	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Further	B-X
investigation	B-X
showed	B-X
that	B-X
the	B-X
Pro-231	B-X
to	B-X
Ser	B-X
mutation	B-X
inactivated	B-X
PHO2	B-X
protein	B-X
as	B-X
well	B-X
,	B-X
whereas	B-X
the	B-X
Ser-230	B-X
to	B-X
Asp	B-X
mutation	B-X
did	B-X
not	B-X
affect	B-X
PHO2	B-X
activity	B-X
.	B-X
Since	B-X
the	B-X
PHO2	B-X
Asp-230	B-X
mutant	B-X
mimics	B-X
Ser-230-phosphorylated	B-X
PHO2	B-X
,	B-X
we	B-X
postulate	B-X
that	B-X
only	B-X
phosphorylated	B-X
PHO2	B-X
protein	B-X
could	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Two	B-X
hybrid	B-X
assays	B-X
showed	B-X
that	B-X
yeast	B-X
CDC28	B-X
could	B-X
interact	B-X
with	B-X
PHO2	B-X
.	B-X
CDC28	B-X
immunoprecipitate	B-X
derived	B-X
from	B-X
the	B-X
YPH499	B-X
strain	B-X
grown	B-X
under	B-X
low	B-X
phosphate	B-X
conditions	B-X
phosphorylated	B-X
GST-PHO2	B-X
in	B-X
vitro	B-X
.	B-X
A	B-X
phosphate	B-X
switch	B-X
regulates	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
,	B-X
and	B-X
mutations	B-X
of	B-X
the	B-X
(	B-X
SPIK	B-X
)	B-X
site	B-X
affect	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
and	B-X
the	B-X
interaction	B-X
between	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
BIAcore	B-X
(	B-X
R	B-X
)	B-X
analysis	B-X
indicated	B-X
that	B-X
the	B-X
negative	B-X
charge	B-X
in	B-X
residue	B-X
230	B-X
of	B-X
PHO2	B-X
was	B-X
sufficient	B-X
to	B-X
help	B-X
PHO2	B-X
interact	B-X
with	B-X
PHO4	B-X
in	B-X
vitro	B-X
.	B-X

PHO4	B-Gene_or_gene_product
protein	O
has	O
been	O
reported	O
to	O
be	O
phosphorylated	O
and	O
inactivated	O
by	O
a	O
cyclin	O
-	O
CDK	O
(	O
cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
)	O
complex	O
,	O
PHO80	O
-	O
PHO85	O
.	O
<EOS>	B-X
Induction	B-X
of	B-X
the	B-X
yeast	B-X
gene	B-X
PHO5	B-X
is	B-X
mediated	B-X
by	B-X
the	B-X
transcription	B-X
factors	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
PHO5	B-X
transcription	B-X
is	B-X
not	B-X
detectable	B-X
in	B-X
high	B-X
phosphate	B-X
;	B-X
it	B-X
is	B-X
thought	B-X
that	B-X
the	B-X
negative	B-X
regulators	B-X
PHO80	B-X
and	B-X
PHO85	B-X
inactivate	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
Here	B-X
it	B-X
is	B-X
reported	B-X
that	B-X
PHO80	B-X
has	B-X
homology	B-X
to	B-X
yeast	B-X
cyclins	B-X
and	B-X
interacts	B-X
with	B-X
PHO85	B-X
,	B-X
a	B-X
p34cdc2/CDC28-related	B-X
protein	B-X
kinase	B-X
.	B-X
The	B-X
PHO80-PHO85	B-X
complex	B-X
phosphorylates	B-X
PHO4	B-X
;	B-X
this	B-X
phosphorylation	B-X
is	B-X
correlated	B-X
with	B-X
negative	B-X
regulation	B-X
of	B-X
PHO5	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
the	B-X
existence	B-X
of	B-X
a	B-X
cyclin-cdk	B-X
complex	B-X
that	B-X
is	B-X
used	B-X
for	B-X
a	B-X
regulatory	B-X
process	B-X
other	B-X
than	B-X
cell-cycle	B-X
control	B-X
and	B-X
identify	B-X
a	B-X
physiologically	B-X
relevant	B-X
substrate	B-X
for	B-X
this	B-X
complex	B-X
.	B-X

We	O
report	O
here	O
that	O
PHO2	B-Gene_or_gene_product
can	O
also	O
be	O
phosphorylated	O
.	O
<EOS>	B-X
The	B-X
induction	B-X
of	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
gene	B-X
PHO5	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
transcriptional	B-X
factors	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
PHO4	B-X
protein	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
be	B-X
phosphorylated	B-X
and	B-X
inactivated	B-X
by	B-X
a	B-X
cyclin-CDK	B-X
(	B-X
cyclin-dependent	B-X
kinase	B-X
)	B-X
complex	B-X
,	B-X
PHO80-PHO85	B-X
.	B-X
We	B-X
report	B-X
here	B-X
that	B-X
PHO2	B-X
can	B-X
also	B-X
be	B-X
phosphorylated	B-X
.	B-X
A	B-X
Ser-230	B-X
to	B-X
Ala	B-X
mutation	B-X
in	B-X
the	B-X
consensus	B-X
sequence	B-X
(	B-X
SPIK	B-X
)	B-X
recognized	B-X
by	B-X
cdc2/CDC28-related	B-X
kinase	B-X
in	B-X
PHO2	B-X
protein	B-X
led	B-X
to	B-X
complete	B-X
loss	B-X
of	B-X
its	B-X
ability	B-X
to	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Further	B-X
investigation	B-X
showed	B-X
that	B-X
the	B-X
Pro-231	B-X
to	B-X
Ser	B-X
mutation	B-X
inactivated	B-X
PHO2	B-X
protein	B-X
as	B-X
well	B-X
,	B-X
whereas	B-X
the	B-X
Ser-230	B-X
to	B-X
Asp	B-X
mutation	B-X
did	B-X
not	B-X
affect	B-X
PHO2	B-X
activity	B-X
.	B-X
Since	B-X
the	B-X
PHO2	B-X
Asp-230	B-X
mutant	B-X
mimics	B-X
Ser-230-phosphorylated	B-X
PHO2	B-X
,	B-X
we	B-X
postulate	B-X
that	B-X
only	B-X
phosphorylated	B-X
PHO2	B-X
protein	B-X
could	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Two	B-X
hybrid	B-X
assays	B-X
showed	B-X
that	B-X
yeast	B-X
CDC28	B-X
could	B-X
interact	B-X
with	B-X
PHO2	B-X
.	B-X
CDC28	B-X
immunoprecipitate	B-X
derived	B-X
from	B-X
the	B-X
YPH499	B-X
strain	B-X
grown	B-X
under	B-X
low	B-X
phosphate	B-X
conditions	B-X
phosphorylated	B-X
GST-PHO2	B-X
in	B-X
vitro	B-X
.	B-X
A	B-X
phosphate	B-X
switch	B-X
regulates	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
,	B-X
and	B-X
mutations	B-X
of	B-X
the	B-X
(	B-X
SPIK	B-X
)	B-X
site	B-X
affect	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
and	B-X
the	B-X
interaction	B-X
between	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
BIAcore	B-X
(	B-X
R	B-X
)	B-X
analysis	B-X
indicated	B-X
that	B-X
the	B-X
negative	B-X
charge	B-X
in	B-X
residue	B-X
230	B-X
of	B-X
PHO2	B-X
was	B-X
sufficient	B-X
to	B-X
help	B-X
PHO2	B-X
interact	B-X
with	B-X
PHO4	B-X
in	B-X
vitro	B-X
.	B-X

A	O
Ser	O
-	O
230	O
to	O
Ala	O
mutation	O
in	O
the	O
consensus	O
sequence	O
(	O
SPIK	O
)	O
recognized	O
by	O
cdc2	B-Gene_or_gene_product
/	I-Gene_or_gene_product
CDC28	I-Gene_or_gene_product
-	I-Gene_or_gene_product
related	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
in	O
PHO2	B-Gene_or_gene_product
protein	O
led	O
to	O
complete	O
loss	O
of	O
its	O
ability	O
to	O
activate	O
the	O
transcription	O
of	O
PHO5	B-Gene_or_gene_product
gene	O
.	O
<EOS>	B-X
The	B-X
induction	B-X
of	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
gene	B-X
PHO5	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
transcriptional	B-X
factors	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
PHO4	B-X
protein	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
be	B-X
phosphorylated	B-X
and	B-X
inactivated	B-X
by	B-X
a	B-X
cyclin-CDK	B-X
(	B-X
cyclin-dependent	B-X
kinase	B-X
)	B-X
complex	B-X
,	B-X
PHO80-PHO85	B-X
.	B-X
We	B-X
report	B-X
here	B-X
that	B-X
PHO2	B-X
can	B-X
also	B-X
be	B-X
phosphorylated	B-X
.	B-X
A	B-X
Ser-230	B-X
to	B-X
Ala	B-X
mutation	B-X
in	B-X
the	B-X
consensus	B-X
sequence	B-X
(	B-X
SPIK	B-X
)	B-X
recognized	B-X
by	B-X
cdc2/CDC28-related	B-X
kinase	B-X
in	B-X
PHO2	B-X
protein	B-X
led	B-X
to	B-X
complete	B-X
loss	B-X
of	B-X
its	B-X
ability	B-X
to	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Further	B-X
investigation	B-X
showed	B-X
that	B-X
the	B-X
Pro-231	B-X
to	B-X
Ser	B-X
mutation	B-X
inactivated	B-X
PHO2	B-X
protein	B-X
as	B-X
well	B-X
,	B-X
whereas	B-X
the	B-X
Ser-230	B-X
to	B-X
Asp	B-X
mutation	B-X
did	B-X
not	B-X
affect	B-X
PHO2	B-X
activity	B-X
.	B-X
Since	B-X
the	B-X
PHO2	B-X
Asp-230	B-X
mutant	B-X
mimics	B-X
Ser-230-phosphorylated	B-X
PHO2	B-X
,	B-X
we	B-X
postulate	B-X
that	B-X
only	B-X
phosphorylated	B-X
PHO2	B-X
protein	B-X
could	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Two	B-X
hybrid	B-X
assays	B-X
showed	B-X
that	B-X
yeast	B-X
CDC28	B-X
could	B-X
interact	B-X
with	B-X
PHO2	B-X
.	B-X
CDC28	B-X
immunoprecipitate	B-X
derived	B-X
from	B-X
the	B-X
YPH499	B-X
strain	B-X
grown	B-X
under	B-X
low	B-X
phosphate	B-X
conditions	B-X
phosphorylated	B-X
GST-PHO2	B-X
in	B-X
vitro	B-X
.	B-X
A	B-X
phosphate	B-X
switch	B-X
regulates	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
,	B-X
and	B-X
mutations	B-X
of	B-X
the	B-X
(	B-X
SPIK	B-X
)	B-X
site	B-X
affect	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
and	B-X
the	B-X
interaction	B-X
between	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
BIAcore	B-X
(	B-X
R	B-X
)	B-X
analysis	B-X
indicated	B-X
that	B-X
the	B-X
negative	B-X
charge	B-X
in	B-X
residue	B-X
230	B-X
of	B-X
PHO2	B-X
was	B-X
sufficient	B-X
to	B-X
help	B-X
PHO2	B-X
interact	B-X
with	B-X
PHO4	B-X
in	B-X
vitro	B-X
.	B-X

Further	O
investigation	O
showed	O
that	O
the	O
Pro	O
-	O
231	O
to	O
Ser	O
mutation	O
inactivated	O
PHO2	B-Gene_or_gene_product
protein	O
as	O
well	O
,	O
whereas	O
the	O
Ser	O
-	O
230	O
to	O
Asp	O
mutation	O
did	O
not	O
affect	O
PHO2	B-Gene_or_gene_product
activity	O
.	O

Since	O
the	O
PHO2	B-Gene_or_gene_product
Asp	O
-	O
230	O
mutant	O
mimics	O
Ser	O
-	O
230	O
-	O
phosphorylated	O
PHO2	B-Gene_or_gene_product
,	O
we	O
postulate	O
that	O
only	O
phosphorylated	O
PHO2	B-Gene_or_gene_product
protein	O
could	O
activate	O
the	O
transcription	O
of	O
PHO5	B-Gene_or_gene_product
gene	O
.	O
<EOS>	B-X
The	B-X
induction	B-X
of	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
gene	B-X
PHO5	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
transcriptional	B-X
factors	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
PHO4	B-X
protein	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
be	B-X
phosphorylated	B-X
and	B-X
inactivated	B-X
by	B-X
a	B-X
cyclin-CDK	B-X
(	B-X
cyclin-dependent	B-X
kinase	B-X
)	B-X
complex	B-X
,	B-X
PHO80-PHO85	B-X
.	B-X
We	B-X
report	B-X
here	B-X
that	B-X
PHO2	B-X
can	B-X
also	B-X
be	B-X
phosphorylated	B-X
.	B-X
A	B-X
Ser-230	B-X
to	B-X
Ala	B-X
mutation	B-X
in	B-X
the	B-X
consensus	B-X
sequence	B-X
(	B-X
SPIK	B-X
)	B-X
recognized	B-X
by	B-X
cdc2/CDC28-related	B-X
kinase	B-X
in	B-X
PHO2	B-X
protein	B-X
led	B-X
to	B-X
complete	B-X
loss	B-X
of	B-X
its	B-X
ability	B-X
to	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Further	B-X
investigation	B-X
showed	B-X
that	B-X
the	B-X
Pro-231	B-X
to	B-X
Ser	B-X
mutation	B-X
inactivated	B-X
PHO2	B-X
protein	B-X
as	B-X
well	B-X
,	B-X
whereas	B-X
the	B-X
Ser-230	B-X
to	B-X
Asp	B-X
mutation	B-X
did	B-X
not	B-X
affect	B-X
PHO2	B-X
activity	B-X
.	B-X
Since	B-X
the	B-X
PHO2	B-X
Asp-230	B-X
mutant	B-X
mimics	B-X
Ser-230-phosphorylated	B-X
PHO2	B-X
,	B-X
we	B-X
postulate	B-X
that	B-X
only	B-X
phosphorylated	B-X
PHO2	B-X
protein	B-X
could	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Two	B-X
hybrid	B-X
assays	B-X
showed	B-X
that	B-X
yeast	B-X
CDC28	B-X
could	B-X
interact	B-X
with	B-X
PHO2	B-X
.	B-X
CDC28	B-X
immunoprecipitate	B-X
derived	B-X
from	B-X
the	B-X
YPH499	B-X
strain	B-X
grown	B-X
under	B-X
low	B-X
phosphate	B-X
conditions	B-X
phosphorylated	B-X
GST-PHO2	B-X
in	B-X
vitro	B-X
.	B-X
A	B-X
phosphate	B-X
switch	B-X
regulates	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
,	B-X
and	B-X
mutations	B-X
of	B-X
the	B-X
(	B-X
SPIK	B-X
)	B-X
site	B-X
affect	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
and	B-X
the	B-X
interaction	B-X
between	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
BIAcore	B-X
(	B-X
R	B-X
)	B-X
analysis	B-X
indicated	B-X
that	B-X
the	B-X
negative	B-X
charge	B-X
in	B-X
residue	B-X
230	B-X
of	B-X
PHO2	B-X
was	B-X
sufficient	B-X
to	B-X
help	B-X
PHO2	B-X
interact	B-X
with	B-X
PHO4	B-X
in	B-X
vitro	B-X
.	B-X

Two	O
hybrid	O
assays	O
showed	O
that	O
yeast	O
CDC28	B-Gene_or_gene_product
could	O
interact	O
with	O
PHO2	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
induction	B-X
of	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
gene	B-X
PHO5	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
transcriptional	B-X
factors	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
We	B-X
report	B-X
here	B-X
that	B-X
PHO2	B-X
can	B-X
also	B-X
be	B-X
phosphorylated	B-X
.	B-X
A	B-X
Ser-230	B-X
to	B-X
Ala	B-X
mutation	B-X
in	B-X
the	B-X
consensus	B-X
sequence	B-X
(	B-X
SPIK	B-X
)	B-X
recognized	B-X
by	B-X
cdc2/CDC28-related	B-X
kinase	B-X
in	B-X
PHO2	B-X
protein	B-X
led	B-X
to	B-X
complete	B-X
loss	B-X
of	B-X
its	B-X
ability	B-X
to	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Further	B-X
investigation	B-X
showed	B-X
that	B-X
the	B-X
Pro-231	B-X
to	B-X
Ser	B-X
mutation	B-X
inactivated	B-X
PHO2	B-X
protein	B-X
as	B-X
well	B-X
,	B-X
whereas	B-X
the	B-X
Ser-230	B-X
to	B-X
Asp	B-X
mutation	B-X
did	B-X
not	B-X
affect	B-X
PHO2	B-X
activity	B-X
.	B-X
Since	B-X
the	B-X
PHO2	B-X
Asp-230	B-X
mutant	B-X
mimics	B-X
Ser-230-phosphorylated	B-X
PHO2	B-X
,	B-X
we	B-X
postulate	B-X
that	B-X
only	B-X
phosphorylated	B-X
PHO2	B-X
protein	B-X
could	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Two	B-X
hybrid	B-X
assays	B-X
showed	B-X
that	B-X
yeast	B-X
CDC28	B-X
could	B-X
interact	B-X
with	B-X
PHO2	B-X
.	B-X
CDC28	B-X
immunoprecipitate	B-X
derived	B-X
from	B-X
the	B-X
YPH499	B-X
strain	B-X
grown	B-X
under	B-X
low	B-X
phosphate	B-X
conditions	B-X
phosphorylated	B-X
GST-PHO2	B-X
in	B-X
vitro	B-X
.	B-X
A	B-X
phosphate	B-X
switch	B-X
regulates	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
,	B-X
and	B-X
mutations	B-X
of	B-X
the	B-X
(	B-X
SPIK	B-X
)	B-X
site	B-X
affect	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
and	B-X
the	B-X
interaction	B-X
between	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
BIAcore	B-X
(	B-X
R	B-X
)	B-X
analysis	B-X
indicated	B-X
that	B-X
the	B-X
negative	B-X
charge	B-X
in	B-X
residue	B-X
230	B-X
of	B-X
PHO2	B-X
was	B-X
sufficient	B-X
to	B-X
help	B-X
PHO2	B-X
interact	B-X
with	B-X
PHO4	B-X
in	B-X
vitro	B-X
.	B-X

CDC28	B-Gene_or_gene_product
immunoprecipitate	O
derived	O
from	O
the	O
YPH499	O
strain	O
grown	O
under	O
low	O
phosphate	O
conditions	O
phosphorylated	O
GST	B-Gene_or_gene_product
-	I-Gene_or_gene_product
PHO2	I-Gene_or_gene_product
in	O
vitro	O
.	O
<EOS>	B-X
The	B-X
induction	B-X
of	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
gene	B-X
PHO5	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
transcriptional	B-X
factors	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
PHO4	B-X
protein	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
be	B-X
phosphorylated	B-X
and	B-X
inactivated	B-X
by	B-X
a	B-X
cyclin-CDK	B-X
(	B-X
cyclin-dependent	B-X
kinase	B-X
)	B-X
complex	B-X
,	B-X
PHO80-PHO85	B-X
.	B-X
We	B-X
report	B-X
here	B-X
that	B-X
PHO2	B-X
can	B-X
also	B-X
be	B-X
phosphorylated	B-X
.	B-X
A	B-X
Ser-230	B-X
to	B-X
Ala	B-X
mutation	B-X
in	B-X
the	B-X
consensus	B-X
sequence	B-X
(	B-X
SPIK	B-X
)	B-X
recognized	B-X
by	B-X
cdc2/CDC28-related	B-X
kinase	B-X
in	B-X
PHO2	B-X
protein	B-X
led	B-X
to	B-X
complete	B-X
loss	B-X
of	B-X
its	B-X
ability	B-X
to	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Further	B-X
investigation	B-X
showed	B-X
that	B-X
the	B-X
Pro-231	B-X
to	B-X
Ser	B-X
mutation	B-X
inactivated	B-X
PHO2	B-X
protein	B-X
as	B-X
well	B-X
,	B-X
whereas	B-X
the	B-X
Ser-230	B-X
to	B-X
Asp	B-X
mutation	B-X
did	B-X
not	B-X
affect	B-X
PHO2	B-X
activity	B-X
.	B-X
Since	B-X
the	B-X
PHO2	B-X
Asp-230	B-X
mutant	B-X
mimics	B-X
Ser-230-phosphorylated	B-X
PHO2	B-X
,	B-X
we	B-X
postulate	B-X
that	B-X
only	B-X
phosphorylated	B-X
PHO2	B-X
protein	B-X
could	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Two	B-X
hybrid	B-X
assays	B-X
showed	B-X
that	B-X
yeast	B-X
CDC28	B-X
could	B-X
interact	B-X
with	B-X
PHO2	B-X
.	B-X
CDC28	B-X
immunoprecipitate	B-X
derived	B-X
from	B-X
the	B-X
YPH499	B-X
strain	B-X
grown	B-X
under	B-X
low	B-X
phosphate	B-X
conditions	B-X
phosphorylated	B-X
GST-PHO2	B-X
in	B-X
vitro	B-X
.	B-X
A	B-X
phosphate	B-X
switch	B-X
regulates	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
,	B-X
and	B-X
mutations	B-X
of	B-X
the	B-X
(	B-X
SPIK	B-X
)	B-X
site	B-X
affect	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
and	B-X
the	B-X
interaction	B-X
between	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
BIAcore	B-X
(	B-X
R	B-X
)	B-X
analysis	B-X
indicated	B-X
that	B-X
the	B-X
negative	B-X
charge	B-X
in	B-X
residue	B-X
230	B-X
of	B-X
PHO2	B-X
was	B-X
sufficient	B-X
to	B-X
help	B-X
PHO2	B-X
interact	B-X
with	B-X
PHO4	B-X
in	B-X
vitro	B-X
.	B-X

A	O
phosphate	O
switch	O
regulates	O
the	O
transcriptional	O
activation	O
activity	O
of	O
PHO2	B-Gene_or_gene_product
,	O
and	O
mutations	O
of	O
the	O
(	O
SPIK	O
)	O
site	O
affect	O
the	O
transcriptional	O
activation	O
activity	O
of	O
PHO2	B-Gene_or_gene_product
and	O
the	O
interaction	O
between	O
PHO2	B-Gene_or_gene_product
and	O
PHO4	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
induction	B-X
of	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
gene	B-X
PHO5	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
transcriptional	B-X
factors	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
PHO4	B-X
protein	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
be	B-X
phosphorylated	B-X
and	B-X
inactivated	B-X
by	B-X
a	B-X
cyclin-CDK	B-X
(	B-X
cyclin-dependent	B-X
kinase	B-X
)	B-X
complex	B-X
,	B-X
PHO80-PHO85	B-X
.	B-X
We	B-X
report	B-X
here	B-X
that	B-X
PHO2	B-X
can	B-X
also	B-X
be	B-X
phosphorylated	B-X
.	B-X
A	B-X
Ser-230	B-X
to	B-X
Ala	B-X
mutation	B-X
in	B-X
the	B-X
consensus	B-X
sequence	B-X
(	B-X
SPIK	B-X
)	B-X
recognized	B-X
by	B-X
cdc2/CDC28-related	B-X
kinase	B-X
in	B-X
PHO2	B-X
protein	B-X
led	B-X
to	B-X
complete	B-X
loss	B-X
of	B-X
its	B-X
ability	B-X
to	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Further	B-X
investigation	B-X
showed	B-X
that	B-X
the	B-X
Pro-231	B-X
to	B-X
Ser	B-X
mutation	B-X
inactivated	B-X
PHO2	B-X
protein	B-X
as	B-X
well	B-X
,	B-X
whereas	B-X
the	B-X
Ser-230	B-X
to	B-X
Asp	B-X
mutation	B-X
did	B-X
not	B-X
affect	B-X
PHO2	B-X
activity	B-X
.	B-X
Since	B-X
the	B-X
PHO2	B-X
Asp-230	B-X
mutant	B-X
mimics	B-X
Ser-230-phosphorylated	B-X
PHO2	B-X
,	B-X
we	B-X
postulate	B-X
that	B-X
only	B-X
phosphorylated	B-X
PHO2	B-X
protein	B-X
could	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Two	B-X
hybrid	B-X
assays	B-X
showed	B-X
that	B-X
yeast	B-X
CDC28	B-X
could	B-X
interact	B-X
with	B-X
PHO2	B-X
.	B-X
CDC28	B-X
immunoprecipitate	B-X
derived	B-X
from	B-X
the	B-X
YPH499	B-X
strain	B-X
grown	B-X
under	B-X
low	B-X
phosphate	B-X
conditions	B-X
phosphorylated	B-X
GST-PHO2	B-X
in	B-X
vitro	B-X
.	B-X
A	B-X
phosphate	B-X
switch	B-X
regulates	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
,	B-X
and	B-X
mutations	B-X
of	B-X
the	B-X
(	B-X
SPIK	B-X
)	B-X
site	B-X
affect	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
and	B-X
the	B-X
interaction	B-X
between	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
BIAcore	B-X
(	B-X
R	B-X
)	B-X
analysis	B-X
indicated	B-X
that	B-X
the	B-X
negative	B-X
charge	B-X
in	B-X
residue	B-X
230	B-X
of	B-X
PHO2	B-X
was	B-X
sufficient	B-X
to	B-X
help	B-X
PHO2	B-X
interact	B-X
with	B-X
PHO4	B-X
in	B-X
vitro	B-X
.	B-X

BIAcore	O
(	O
R	O
)	O
analysis	O
indicated	O
that	O
the	O
negative	O
charge	O
in	O
residue	O
230	O
of	O
PHO2	B-Gene_or_gene_product
was	O
sufficient	O
to	O
help	O
PHO2	B-Gene_or_gene_product
interact	O
with	O
PHO4	B-Gene_or_gene_product
in	O
vitro	O
.	O
<EOS>	B-X
The	B-X
induction	B-X
of	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
gene	B-X
PHO5	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
transcriptional	B-X
factors	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
PHO4	B-X
protein	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
be	B-X
phosphorylated	B-X
and	B-X
inactivated	B-X
by	B-X
a	B-X
cyclin-CDK	B-X
(	B-X
cyclin-dependent	B-X
kinase	B-X
)	B-X
complex	B-X
,	B-X
PHO80-PHO85	B-X
.	B-X
We	B-X
report	B-X
here	B-X
that	B-X
PHO2	B-X
can	B-X
also	B-X
be	B-X
phosphorylated	B-X
.	B-X
A	B-X
Ser-230	B-X
to	B-X
Ala	B-X
mutation	B-X
in	B-X
the	B-X
consensus	B-X
sequence	B-X
(	B-X
SPIK	B-X
)	B-X
recognized	B-X
by	B-X
cdc2/CDC28-related	B-X
kinase	B-X
in	B-X
PHO2	B-X
protein	B-X
led	B-X
to	B-X
complete	B-X
loss	B-X
of	B-X
its	B-X
ability	B-X
to	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Further	B-X
investigation	B-X
showed	B-X
that	B-X
the	B-X
Pro-231	B-X
to	B-X
Ser	B-X
mutation	B-X
inactivated	B-X
PHO2	B-X
protein	B-X
as	B-X
well	B-X
,	B-X
whereas	B-X
the	B-X
Ser-230	B-X
to	B-X
Asp	B-X
mutation	B-X
did	B-X
not	B-X
affect	B-X
PHO2	B-X
activity	B-X
.	B-X
Since	B-X
the	B-X
PHO2	B-X
Asp-230	B-X
mutant	B-X
mimics	B-X
Ser-230-phosphorylated	B-X
PHO2	B-X
,	B-X
we	B-X
postulate	B-X
that	B-X
only	B-X
phosphorylated	B-X
PHO2	B-X
protein	B-X
could	B-X
activate	B-X
the	B-X
transcription	B-X
of	B-X
PHO5	B-X
gene	B-X
.	B-X
Two	B-X
hybrid	B-X
assays	B-X
showed	B-X
that	B-X
yeast	B-X
CDC28	B-X
could	B-X
interact	B-X
with	B-X
PHO2	B-X
.	B-X
CDC28	B-X
immunoprecipitate	B-X
derived	B-X
from	B-X
the	B-X
YPH499	B-X
strain	B-X
grown	B-X
under	B-X
low	B-X
phosphate	B-X
conditions	B-X
phosphorylated	B-X
GST-PHO2	B-X
in	B-X
vitro	B-X
.	B-X
A	B-X
phosphate	B-X
switch	B-X
regulates	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
,	B-X
and	B-X
mutations	B-X
of	B-X
the	B-X
(	B-X
SPIK	B-X
)	B-X
site	B-X
affect	B-X
the	B-X
transcriptional	B-X
activation	B-X
activity	B-X
of	B-X
PHO2	B-X
and	B-X
the	B-X
interaction	B-X
between	B-X
PHO2	B-X
and	B-X
PHO4	B-X
.	B-X
BIAcore	B-X
(	B-X
R	B-X
)	B-X
analysis	B-X
indicated	B-X
that	B-X
the	B-X
negative	B-X
charge	B-X
in	B-X
residue	B-X
230	B-X
of	B-X
PHO2	B-X
was	B-X
sufficient	B-X
to	B-X
help	B-X
PHO2	B-X
interact	B-X
with	B-X
PHO4	B-X
in	B-X
vitro	B-X
.	B-X

Requirement	O
for	O
glycogen	B-Gene_or_gene_product
synthase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
in	O
cell	O
survival	O
and	O
NF	O
-	O
kappaB	O
activation	O
.	O
<EOS>	B-X
Glycogen	B-X
synthase	B-X
kinase-3	B-X
(	B-X
GSK-3	B-X
)	B-X
-alpha	B-X
and	B-X
-beta	B-X
are	B-X
closely	B-X
related	B-X
protein-serine	B-X
kinases	B-X
,	B-X
which	B-X
act	B-X
as	B-X
inhibitory	B-X
components	B-X
of	B-X
Wnt	B-X
signalling	B-X
during	B-X
embryonic	B-X
development	B-X
and	B-X
cell	B-X
proliferation	B-X
in	B-X
adult	B-X
tissues	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
disruption	B-X
of	B-X
the	B-X
murine	B-X
GSK-3beta	B-X
gene	B-X
results	B-X
in	B-X
embryonic	B-X
lethality	B-X
caused	B-X
by	B-X
severe	B-X
liver	B-X
degeneration	B-X
during	B-X
mid-gestation	B-X
,	B-X
a	B-X
phenotype	B-X
consistent	B-X
with	B-X
excessive	B-X
tumour	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
toxicity	B-X
,	B-X
as	B-X
observed	B-X
in	B-X
mice	B-X
lacking	B-X
genes	B-X
involved	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
activation	B-X
NF-kappaB	B-X
.	B-X
GSK-3beta-deficient	B-X
embryos	B-X
were	B-X
rescued	B-X
by	B-X
inhibition	B-X
of	B-X
TNF	B-X
using	B-X
an	B-X
anti-TNF-alpha	B-X
antibody	B-X
.	B-X
Fibroblasts	B-X
from	B-X
GSK-3beta-deficient	B-X
embryos	B-X
were	B-X
hypersensitive	B-X
to	B-X
TNF-alpha	B-X
and	B-X
showed	B-X
reduced	B-X
NF-kappaB	B-X
function	B-X
.	B-X
Lithium	B-X
treatment	B-X
(	B-X
which	B-X
inhibits	B-X
GSK-3	B-X
;	B-X
refs	B-X
8	B-X
,	B-X
9	B-X
)	B-X
sensitized	B-X
wild-type	B-X
fibroblasts	B-X
to	B-X
TNF	B-X
and	B-X
inhibited	B-X
transactivation	B-X
of	B-X
NF-kappaB	B-X
.	B-X
The	B-X
early	B-X
steps	B-X
leading	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
(	B-X
degradation	B-X
of	B-X
I-kappaB	B-X
and	B-X
translocation	B-X
of	B-X
NF-kappaB	B-X
to	B-X
the	B-X
nucleus	B-X
)	B-X
were	B-X
unaffected	B-X
by	B-X
the	B-X
loss	B-X
of	B-X
GSK-3beta	B-X
,	B-X
indicating	B-X
that	B-X
NF-kappaB	B-X
is	B-X
regulated	B-X
by	B-X
GSK-3beta	B-X
at	B-X
the	B-X
level	B-X
of	B-X
the	B-X
transcriptional	B-X
complex	B-X
.	B-X
Thus	B-X
,	B-X
GSK-3beta	B-X
facilitates	B-X
NF-kappaB	B-X
function	B-X
.	B-X

Glycogen	B-Gene_or_gene_product
synthase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
(	I-Gene_or_gene_product
GSK	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
)	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
-	B-Gene_or_gene_product
beta	I-Gene_or_gene_product
are	O
closely	O
related	O
protein	O
-	O
serine	O
kinases	O
,	O
which	O
act	O
as	O
inhibitory	O
components	O
of	O
Wnt	B-Gene_or_gene_product
signalling	O
during	O
embryonic	O
development	O
and	O
cell	O
proliferation	O
in	O
adult	O
tissues	O
.	O
<EOS>	B-X
Glycogen	B-X
synthase	B-X
kinase-3	B-X
(	B-X
GSK-3	B-X
)	B-X
-alpha	B-X
and	B-X
-beta	B-X
are	B-X
closely	B-X
related	B-X
protein-serine	B-X
kinases	B-X
,	B-X
which	B-X
act	B-X
as	B-X
inhibitory	B-X
components	B-X
of	B-X
Wnt	B-X
signalling	B-X
during	B-X
embryonic	B-X
development	B-X
and	B-X
cell	B-X
proliferation	B-X
in	B-X
adult	B-X
tissues	B-X
.	B-X
Insight	B-X
into	B-X
the	B-X
physiological	B-X
function	B-X
of	B-X
GSK-3	B-X
has	B-X
emerged	B-X
from	B-X
genetic	B-X
analysis	B-X
in	B-X
Drosophila	B-X
,	B-X
Dictyostelium	B-X
and	B-X
yeast	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
disruption	B-X
of	B-X
the	B-X
murine	B-X
GSK-3beta	B-X
gene	B-X
results	B-X
in	B-X
embryonic	B-X
lethality	B-X
caused	B-X
by	B-X
severe	B-X
liver	B-X
degeneration	B-X
during	B-X
mid-gestation	B-X
,	B-X
a	B-X
phenotype	B-X
consistent	B-X
with	B-X
excessive	B-X
tumour	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
toxicity	B-X
,	B-X
as	B-X
observed	B-X
in	B-X
mice	B-X
lacking	B-X
genes	B-X
involved	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
activation	B-X
NF-kappaB	B-X
.	B-X
GSK-3beta-deficient	B-X
embryos	B-X
were	B-X
rescued	B-X
by	B-X
inhibition	B-X
of	B-X
TNF	B-X
using	B-X
an	B-X
anti-TNF-alpha	B-X
antibody	B-X
.	B-X
Fibroblasts	B-X
from	B-X
GSK-3beta-deficient	B-X
embryos	B-X
were	B-X
hypersensitive	B-X
to	B-X
TNF-alpha	B-X
and	B-X
showed	B-X
reduced	B-X
NF-kappaB	B-X
function	B-X
.	B-X
Lithium	B-X
treatment	B-X
(	B-X
which	B-X
inhibits	B-X
GSK-3	B-X
;	B-X
refs	B-X
8	B-X
,	B-X
9	B-X
)	B-X
sensitized	B-X
wild-type	B-X
fibroblasts	B-X
to	B-X
TNF	B-X
and	B-X
inhibited	B-X
transactivation	B-X
of	B-X
NF-kappaB	B-X
.	B-X
The	B-X
early	B-X
steps	B-X
leading	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
(	B-X
degradation	B-X
of	B-X
I-kappaB	B-X
and	B-X
translocation	B-X
of	B-X
NF-kappaB	B-X
to	B-X
the	B-X
nucleus	B-X
)	B-X
were	B-X
unaffected	B-X
by	B-X
the	B-X
loss	B-X
of	B-X
GSK-3beta	B-X
,	B-X
indicating	B-X
that	B-X
NF-kappaB	B-X
is	B-X
regulated	B-X
by	B-X
GSK-3beta	B-X
at	B-X
the	B-X
level	B-X
of	B-X
the	B-X
transcriptional	B-X
complex	B-X
.	B-X
Thus	B-X
,	B-X
GSK-3beta	B-X
facilitates	B-X
NF-kappaB	B-X
function	B-X
.	B-X

Insight	O
into	O
the	O
physiological	O
function	O
of	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
has	O
emerged	O
from	O
genetic	O
analysis	O
in	O
Drosophila	O
,	O
Dictyostelium	O
and	O
yeast	O
.	O
<EOS>	B-X
Glycogen	B-X
synthase	B-X
kinase-3	B-X
(	B-X
GSK-3	B-X
)	B-X
-alpha	B-X
and	B-X
-beta	B-X
are	B-X
closely	B-X
related	B-X
protein-serine	B-X
kinases	B-X
,	B-X
which	B-X
act	B-X
as	B-X
inhibitory	B-X
components	B-X
of	B-X
Wnt	B-X
signalling	B-X
during	B-X
embryonic	B-X
development	B-X
and	B-X
cell	B-X
proliferation	B-X
in	B-X
adult	B-X
tissues	B-X
.	B-X
Insight	B-X
into	B-X
the	B-X
physiological	B-X
function	B-X
of	B-X
GSK-3	B-X
has	B-X
emerged	B-X
from	B-X
genetic	B-X
analysis	B-X
in	B-X
Drosophila	B-X
,	B-X
Dictyostelium	B-X
and	B-X
yeast	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
disruption	B-X
of	B-X
the	B-X
murine	B-X
GSK-3beta	B-X
gene	B-X
results	B-X
in	B-X
embryonic	B-X
lethality	B-X
caused	B-X
by	B-X
severe	B-X
liver	B-X
degeneration	B-X
during	B-X
mid-gestation	B-X
,	B-X
a	B-X
phenotype	B-X
consistent	B-X
with	B-X
excessive	B-X
tumour	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
toxicity	B-X
,	B-X
as	B-X
observed	B-X
in	B-X
mice	B-X
lacking	B-X
genes	B-X
involved	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
activation	B-X
NF-kappaB	B-X
.	B-X
GSK-3beta-deficient	B-X
embryos	B-X
were	B-X
rescued	B-X
by	B-X
inhibition	B-X
of	B-X
TNF	B-X
using	B-X
an	B-X
anti-TNF-alpha	B-X
antibody	B-X
.	B-X
Fibroblasts	B-X
from	B-X
GSK-3beta-deficient	B-X
embryos	B-X
were	B-X
hypersensitive	B-X
to	B-X
TNF-alpha	B-X
and	B-X
showed	B-X
reduced	B-X
NF-kappaB	B-X
function	B-X
.	B-X
Lithium	B-X
treatment	B-X
(	B-X
which	B-X
inhibits	B-X
GSK-3	B-X
;	B-X
refs	B-X
8	B-X
,	B-X
9	B-X
)	B-X
sensitized	B-X
wild-type	B-X
fibroblasts	B-X
to	B-X
TNF	B-X
and	B-X
inhibited	B-X
transactivation	B-X
of	B-X
NF-kappaB	B-X
.	B-X
The	B-X
early	B-X
steps	B-X
leading	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
(	B-X
degradation	B-X
of	B-X
I-kappaB	B-X
and	B-X
translocation	B-X
of	B-X
NF-kappaB	B-X
to	B-X
the	B-X
nucleus	B-X
)	B-X
were	B-X
unaffected	B-X
by	B-X
the	B-X
loss	B-X
of	B-X
GSK-3beta	B-X
,	B-X
indicating	B-X
that	B-X
NF-kappaB	B-X
is	B-X
regulated	B-X
by	B-X
GSK-3beta	B-X
at	B-X
the	B-X
level	B-X
of	B-X
the	B-X
transcriptional	B-X
complex	B-X
.	B-X
Thus	B-X
,	B-X
GSK-3beta	B-X
facilitates	B-X
NF-kappaB	B-X
function	B-X
.	B-X

Here	O
we	O
show	O
that	O
disruption	O
of	O
the	O
murine	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
gene	O
results	O
in	O
embryonic	O
lethality	O
caused	O
by	O
severe	O
liver	O
degeneration	O
during	O
mid	O
-	O
gestation	O
,	O
a	O
phenotype	O
consistent	O
with	O
excessive	O
tumour	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
TNF	B-Gene_or_gene_product
)	O
toxicity	O
,	O
as	O
observed	O
in	O
mice	O
lacking	O
genes	O
involved	O
in	O
the	O
activation	O
of	O
the	O
transcription	O
factor	O
activation	O
NF	O
-	O
kappaB	O
.	O
<EOS>	B-X
Glycogen	B-X
synthase	B-X
kinase-3	B-X
(	B-X
GSK-3	B-X
)	B-X
-alpha	B-X
and	B-X
-beta	B-X
are	B-X
closely	B-X
related	B-X
protein-serine	B-X
kinases	B-X
,	B-X
which	B-X
act	B-X
as	B-X
inhibitory	B-X
components	B-X
of	B-X
Wnt	B-X
signalling	B-X
during	B-X
embryonic	B-X
development	B-X
and	B-X
cell	B-X
proliferation	B-X
in	B-X
adult	B-X
tissues	B-X
.	B-X
Insight	B-X
into	B-X
the	B-X
physiological	B-X
function	B-X
of	B-X
GSK-3	B-X
has	B-X
emerged	B-X
from	B-X
genetic	B-X
analysis	B-X
in	B-X
Drosophila	B-X
,	B-X
Dictyostelium	B-X
and	B-X
yeast	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
disruption	B-X
of	B-X
the	B-X
murine	B-X
GSK-3beta	B-X
gene	B-X
results	B-X
in	B-X
embryonic	B-X
lethality	B-X
caused	B-X
by	B-X
severe	B-X
liver	B-X
degeneration	B-X
during	B-X
mid-gestation	B-X
,	B-X
a	B-X
phenotype	B-X
consistent	B-X
with	B-X
excessive	B-X
tumour	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
toxicity	B-X
,	B-X
as	B-X
observed	B-X
in	B-X
mice	B-X
lacking	B-X
genes	B-X
involved	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
activation	B-X
NF-kappaB	B-X
.	B-X
GSK-3beta-deficient	B-X
embryos	B-X
were	B-X
rescued	B-X
by	B-X
inhibition	B-X
of	B-X
TNF	B-X
using	B-X
an	B-X
anti-TNF-alpha	B-X
antibody	B-X
.	B-X
Fibroblasts	B-X
from	B-X
GSK-3beta-deficient	B-X
embryos	B-X
were	B-X
hypersensitive	B-X
to	B-X
TNF-alpha	B-X
and	B-X
showed	B-X
reduced	B-X
NF-kappaB	B-X
function	B-X
.	B-X
Lithium	B-X
treatment	B-X
(	B-X
which	B-X
inhibits	B-X
GSK-3	B-X
;	B-X
refs	B-X
8	B-X
,	B-X
9	B-X
)	B-X
sensitized	B-X
wild-type	B-X
fibroblasts	B-X
to	B-X
TNF	B-X
and	B-X
inhibited	B-X
transactivation	B-X
of	B-X
NF-kappaB	B-X
.	B-X
The	B-X
early	B-X
steps	B-X
leading	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
(	B-X
degradation	B-X
of	B-X
I-kappaB	B-X
and	B-X
translocation	B-X
of	B-X
NF-kappaB	B-X
to	B-X
the	B-X
nucleus	B-X
)	B-X
were	B-X
unaffected	B-X
by	B-X
the	B-X
loss	B-X
of	B-X
GSK-3beta	B-X
,	B-X
indicating	B-X
that	B-X
NF-kappaB	B-X
is	B-X
regulated	B-X
by	B-X
GSK-3beta	B-X
at	B-X
the	B-X
level	B-X
of	B-X
the	B-X
transcriptional	B-X
complex	B-X
.	B-X
Thus	B-X
,	B-X
GSK-3beta	B-X
facilitates	B-X
NF-kappaB	B-X
function	B-X
.	B-X

GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
-	O
deficient	O
embryos	O
were	O
rescued	O
by	O
inhibition	O
of	O
TNF	B-Gene_or_gene_product
using	O
an	O
anti	O
-	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
antibody	O
.	O
<EOS>	B-X
Glycogen	B-X
synthase	B-X
kinase-3	B-X
(	B-X
GSK-3	B-X
)	B-X
-alpha	B-X
and	B-X
-beta	B-X
are	B-X
closely	B-X
related	B-X
protein-serine	B-X
kinases	B-X
,	B-X
which	B-X
act	B-X
as	B-X
inhibitory	B-X
components	B-X
of	B-X
Wnt	B-X
signalling	B-X
during	B-X
embryonic	B-X
development	B-X
and	B-X
cell	B-X
proliferation	B-X
in	B-X
adult	B-X
tissues	B-X
.	B-X
Insight	B-X
into	B-X
the	B-X
physiological	B-X
function	B-X
of	B-X
GSK-3	B-X
has	B-X
emerged	B-X
from	B-X
genetic	B-X
analysis	B-X
in	B-X
Drosophila	B-X
,	B-X
Dictyostelium	B-X
and	B-X
yeast	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
disruption	B-X
of	B-X
the	B-X
murine	B-X
GSK-3beta	B-X
gene	B-X
results	B-X
in	B-X
embryonic	B-X
lethality	B-X
caused	B-X
by	B-X
severe	B-X
liver	B-X
degeneration	B-X
during	B-X
mid-gestation	B-X
,	B-X
a	B-X
phenotype	B-X
consistent	B-X
with	B-X
excessive	B-X
tumour	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
toxicity	B-X
,	B-X
as	B-X
observed	B-X
in	B-X
mice	B-X
lacking	B-X
genes	B-X
involved	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
activation	B-X
NF-kappaB	B-X
.	B-X
GSK-3beta-deficient	B-X
embryos	B-X
were	B-X
rescued	B-X
by	B-X
inhibition	B-X
of	B-X
TNF	B-X
using	B-X
an	B-X
anti-TNF-alpha	B-X
antibody	B-X
.	B-X
Fibroblasts	B-X
from	B-X
GSK-3beta-deficient	B-X
embryos	B-X
were	B-X
hypersensitive	B-X
to	B-X
TNF-alpha	B-X
and	B-X
showed	B-X
reduced	B-X
NF-kappaB	B-X
function	B-X
.	B-X
Lithium	B-X
treatment	B-X
(	B-X
which	B-X
inhibits	B-X
GSK-3	B-X
;	B-X
refs	B-X
8	B-X
,	B-X
9	B-X
)	B-X
sensitized	B-X
wild-type	B-X
fibroblasts	B-X
to	B-X
TNF	B-X
and	B-X
inhibited	B-X
transactivation	B-X
of	B-X
NF-kappaB	B-X
.	B-X
The	B-X
early	B-X
steps	B-X
leading	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
(	B-X
degradation	B-X
of	B-X
I-kappaB	B-X
and	B-X
translocation	B-X
of	B-X
NF-kappaB	B-X
to	B-X
the	B-X
nucleus	B-X
)	B-X
were	B-X
unaffected	B-X
by	B-X
the	B-X
loss	B-X
of	B-X
GSK-3beta	B-X
,	B-X
indicating	B-X
that	B-X
NF-kappaB	B-X
is	B-X
regulated	B-X
by	B-X
GSK-3beta	B-X
at	B-X
the	B-X
level	B-X
of	B-X
the	B-X
transcriptional	B-X
complex	B-X
.	B-X
Thus	B-X
,	B-X
GSK-3beta	B-X
facilitates	B-X
NF-kappaB	B-X
function	B-X
.	B-X

Fibroblasts	O
from	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
-	O
deficient	O
embryos	O
were	O
hypersensitive	O
to	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
showed	O
reduced	O
NF	O
-	O
kappaB	O
function	O
.	O

Lithium	O
treatment	O
(	O
which	O
inhibits	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
;	O
refs	O
8	O
,	O
9	O
)	O
sensitized	O
wild	O
-	O
type	O
fibroblasts	O
to	O
TNF	B-Gene_or_gene_product
and	O
inhibited	O
transactivation	O
of	O
NF	O
-	O
kappaB	O
.	O
<EOS>	B-X
Lithium	B-X
has	B-X
been	B-X
used	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
bipolar	B-X
disorder	B-X
(	B-X
BD	B-X
)	B-X
for	B-X
the	B-X
last	B-X
sixty	B-X
or	B-X
more	B-X
years	B-X
,	B-X
and	B-X
recent	B-X
studies	B-X
with	B-X
more	B-X
reliable	B-X
designs	B-X
and	B-X
updated	B-X
guidelines	B-X
have	B-X
recommended	B-X
lithium	B-X
to	B-X
be	B-X
the	B-X
treatment	B-X
of	B-X
choice	B-X
for	B-X
acute	B-X
manic	B-X
,	B-X
mixed	B-X
and	B-X
depressive	B-X
episodes	B-X
of	B-X
BD	B-X
,	B-X
along	B-X
with	B-X
long-term	B-X
prophylaxis	B-X
.	B-X
Lithium	B-X
's	B-X
specific	B-X
mechanism	B-X
of	B-X
action	B-X
in	B-X
mood	B-X
regulation	B-X
is	B-X
progressively	B-X
being	B-X
clarified	B-X
,	B-X
such	B-X
as	B-X
the	B-X
direct	B-X
inhibition	B-X
on	B-X
glycogen	B-X
synthase	B-X
kinase	B-X
3β	B-X
,	B-X
and	B-X
its	B-X
various	B-X
effects	B-X
on	B-X
neurotrophic	B-X
factors	B-X
,	B-X
neurotransmitters	B-X
,	B-X
oxidative	B-X
metabolism	B-X
,	B-X
apoptosis	B-X
,	B-X
second	B-X
messenger	B-X
systems	B-X
,	B-X
and	B-X
biological	B-X
systems	B-X
are	B-X
also	B-X
being	B-X
revealed	B-X
.	B-X
Furthermore	B-X
,	B-X
lithium	B-X
has	B-X
been	B-X
proposed	B-X
to	B-X
exert	B-X
its	B-X
treatment	B-X
effects	B-X
through	B-X
mechanisms	B-X
associated	B-X
with	B-X
neuronal	B-X
plasticity	B-X
.	B-X
Lithium	B-X
acts	B-X
through	B-X
multiple	B-X
pathways	B-X
to	B-X
inhibit	B-X
glycogen	B-X
synthetase	B-X
kinase-3beta	B-X
(	B-X
GSK3	B-X
beta	B-X
)	B-X
.	B-X
This	B-X
enzyme	B-X
phosphorylates	B-X
and	B-X
inhibits	B-X
nuclear	B-X
factors	B-X
that	B-X
turn	B-X
on	B-X
cell	B-X
growth	B-X
and	B-X
protection	B-X
programs	B-X
,	B-X
including	B-X
the	B-X
nuclear	B-X
factor	B-X
of	B-X
activated	B-X
T	B-X
cells	B-X
(	B-X
NFAT	B-X
)	B-X
and	B-X
WNT/beta-catenin	B-X
.	B-X
In	B-X
animals	B-X
,	B-X
lithium	B-X
upregulates	B-X
neurotrophins	B-X
,	B-X
including	B-X
brain-derived	B-X
neurotrophic	B-X
factor	B-X
(	B-X
BDNF	B-X
)	B-X
,	B-X
nerve	B-X
growth	B-X
factor	B-X
,	B-X
neurotrophin-3	B-X
(	B-X
NT3	B-X
)	B-X
,	B-X
as	B-X
well	B-X
as	B-X
receptors	B-X
to	B-X
these	B-X
growth	B-X
factors	B-X
in	B-X
brain	B-X
.	B-X
Lithium	B-X
also	B-X
stimulates	B-X
proliferation	B-X
of	B-X
stem	B-X
cells	B-X
,	B-X
including	B-X
bone	B-X
marrow	B-X
and	B-X
neural	B-X
stem	B-X
cells	B-X
in	B-X
the	B-X
subventricular	B-X
zone	B-X
,	B-X
striatum	B-X
,	B-X
and	B-X
forebrain	B-X
.	B-X
Lithium	B-X
also	B-X
increases	B-X
brain	B-X
concentrations	B-X
of	B-X
the	B-X
neuronal	B-X
markers	B-X
n-acetyl-aspartate	B-X
and	B-X
myoinositol	B-X
.	B-X
Lithium	B-X
also	B-X
remarkably	B-X
protects	B-X
neurons	B-X
against	B-X
glutamate	B-X
,	B-X
seizures	B-X
,	B-X
and	B-X
apoptosis	B-X
due	B-X
to	B-X
a	B-X
wide	B-X
variety	B-X
of	B-X
neurotoxins	B-X
.	B-X
Lithium	B-X
has	B-X
low	B-X
mutagenic	B-X
and	B-X
carcinogenic	B-X
risk	B-X
.	B-X
Lithium	B-X
is	B-X
still	B-X
the	B-X
most	B-X
effective	B-X
therapy	B-X
for	B-X
depression	B-X
.	B-X
Lithium	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
be	B-X
beneficial	B-X
in	B-X
animal	B-X
models	B-X
of	B-X
brain	B-X
injury	B-X
,	B-X
stroke	B-X
,	B-X
Alzheimer	B-X
's	B-X
,	B-X
Huntington	B-X
's	B-X
,	B-X
and	B-X
Parkinson	B-X
's	B-X
diseases	B-X
,	B-X
amyotrophic	B-X
lateral	B-X
sclerosis	B-X
(	B-X
ALS	B-X
)	B-X
,	B-X
spinal	B-X
cord	B-X
injury	B-X
,	B-X
and	B-X
other	B-X
conditions	B-X
.	B-X

The	O
early	O
steps	O
leading	O
to	O
NF	O
-	O
kappaB	O
activation	O
(	O
degradation	O
of	O
I	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
and	O
translocation	O
of	O
NF	O
-	O
kappaB	O
to	O
the	O
nucleus	O
)	O
were	O
unaffected	O
by	O
the	O
loss	O
of	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
,	O
indicating	O
that	O
NF	O
-	O
kappaB	O
is	O
regulated	O
by	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
at	O
the	O
level	O
of	O
the	O
transcriptional	O
complex	O
.	O

Thus	O
,	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
facilitates	O
NF	O
-	O
kappaB	O
function	O
.	O
<EOS>	B-X
The	B-X
NF-κB	B-X
pathway	B-X
is	B-X
central	B-X
pathway	B-X
for	B-X
inflammatory	B-X
and	B-X
immune	B-X
responses	B-X
,	B-X
and	B-X
IKKγ/NEMO	B-X
is	B-X
essential	B-X
for	B-X
NF-κB	B-X
activation	B-X
.	B-X
In	B-X
a	B-X
previous	B-X
report	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
role	B-X
of	B-X
glycogen	B-X
synthase	B-X
kinase-3β	B-X
(	B-X
GSK-3β	B-X
)	B-X
in	B-X
NF-κB	B-X
activation	B-X
by	B-X
regulating	B-X
IKKγ/NEMO	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
NEMO	B-X
phosphorylation	B-X
by	B-X
GSK-3β	B-X
leads	B-X
to	B-X
NEMO	B-X
localization	B-X
into	B-X
multivesicular	B-X
bodies	B-X
(	B-X
MVBs	B-X
)	B-X
.	B-X
Using	B-X
siRNA	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
AAA-ATPase	B-X
Vps4A	B-X
,	B-X
which	B-X
is	B-X
involved	B-X
in	B-X
recycling	B-X
the	B-X
ESCRT	B-X
machinery	B-X
by	B-X
facilitating	B-X
its	B-X
dissociation	B-X
from	B-X
endosomal	B-X
membranes	B-X
,	B-X
which	B-X
is	B-X
necessary	B-X
for	B-X
NEMO	B-X
stability	B-X
and	B-X
NF-κB	B-X
activation	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
overexpression	B-X
of	B-X
the	B-X
mutated	B-X
form	B-X
of	B-X
Vps4A	B-X
led	B-X
to	B-X
increased	B-X
NF-κB	B-X
activation	B-X
.	B-X
The	B-X
treatment	B-X
of	B-X
cells	B-X
with	B-X
the	B-X
pharmacologic	B-X
V-ATPase	B-X
inhibitor	B-X
bafilomycin	B-X
A	B-X
led	B-X
to	B-X
a	B-X
dramatic	B-X
downregulation	B-X
of	B-X
NEMO	B-X
and	B-X
,	B-X
in	B-X
this	B-X
way	B-X
,	B-X
inhibited	B-X
NF-κB	B-X
signal	B-X
transduction	B-X
.	B-X
These	B-X
results	B-X
reveal	B-X
an	B-X
unexpected	B-X
role	B-X
for	B-X
GSK-3β	B-X
and	B-X
V-ATPase	B-X
in	B-X
NF-κB	B-X
signaling	B-X
activation	B-X
.	B-X

Marathon	O
running	O
transiently	O
increases	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
NH2	I-Gene_or_gene_product
-	I-Gene_or_gene_product
terminal	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
and	O
p38	B-Gene_or_gene_product
activities	O
in	O
human	O
skeletal	O
muscle	O
.	O
<EOS>	B-X
We	B-X
examined	B-X
the	B-X
pattern	B-X
of	B-X
activation	B-X
and	B-X
deactivation	B-X
of	B-X
the	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
signalling	B-X
molecules	B-X
c-Jun	B-X
NH2-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
and	B-X
p38	B-X
kinase	B-X
in	B-X
skeletal	B-X
muscle	B-X
in	B-X
response	B-X
to	B-X
prolonged	B-X
strenuous	B-X
running	B-X
exercise	B-X
in	B-X
human	B-X
subjects	B-X
.	B-X
Male	B-X
subjects	B-X
(	B-X
n	B-X
=	B-X
14	B-X
;	B-X
age	B-X
32	B-X
+/-	B-X
2	B-X
years	B-X
;	B-X
VO2	B-X
,	B-X
max	B-X
60	B-X
+/-	B-X
2	B-X
ml	B-X
kg-1	B-X
min-1	B-X
)	B-X
completed	B-X
a	B-X
42.2	B-X
km	B-X
marathon	B-X
(	B-X
mean	B-X
race	B-X
time	B-X
3	B-X
h	B-X
35	B-X
min	B-X
)	B-X
.	B-X
Muscle	B-X
biopsies	B-X
were	B-X
obtained	B-X
10	B-X
days	B-X
prior	B-X
to	B-X
the	B-X
marathon	B-X
,	B-X
immediately	B-X
following	B-X
the	B-X
race	B-X
,	B-X
and	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
after	B-X
the	B-X
race	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
JNK	B-X
and	B-X
p38	B-X
,	B-X
including	B-X
both	B-X
p38alpha	B-X
and	B-X
p38gamma	B-X
,	B-X
was	B-X
measured	B-X
with	B-X
immune	B-X
complex	B-X
assays	B-X
.	B-X
The	B-X
phosphorylation	B-X
state	B-X
of	B-X
p38	B-X
(	B-X
alpha	B-X
and	B-X
gamma	B-X
)	B-X
and	B-X
the	B-X
upstream	B-X
regulators	B-X
of	B-X
JNK	B-X
and	B-X
p38	B-X
,	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
4	B-X
(	B-X
MKK4	B-X
)	B-X
and	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
6	B-X
(	B-X
MKK6	B-X
)	B-X
,	B-X
were	B-X
assessed	B-X
using	B-X
phosphospecific	B-X
antibodies	B-X
.	B-X
JNK	B-X
activity	B-X
increased	B-X
7-fold	B-X
over	B-X
basal	B-X
level	B-X
immediately	B-X
post-exercise	B-X
,	B-X
but	B-X
decreased	B-X
back	B-X
to	B-X
basal	B-X
levels	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
after	B-X
the	B-X
exercise	B-X
.	B-X
p38gamma	B-X
phosphorylation	B-X
(	B-X
4-fold	B-X
)	B-X
and	B-X
activity	B-X
(	B-X
1.5-fold	B-X
)	B-X
increased	B-X
immediately	B-X
post-exercise	B-X
and	B-X
returned	B-X
to	B-X
basal	B-X
levels	B-X
at	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
following	B-X
exercise	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
p38alpha	B-X
phosphorylation	B-X
and	B-X
activity	B-X
did	B-X
not	B-X
change	B-X
over	B-X
the	B-X
time	B-X
course	B-X
studied	B-X
.	B-X
MKK4	B-X
and	B-X
MKK6	B-X
phosphorylation	B-X
increased	B-X
and	B-X
decreased	B-X
in	B-X
a	B-X
trend	B-X
similar	B-X
to	B-X
that	B-X
observed	B-X
with	B-X
JNK	B-X
activity	B-X
and	B-X
p38gamma	B-X
phosphorylation	B-X
.	B-X
Prolonged	B-X
running	B-X
exercise	B-X
did	B-X
not	B-X
affect	B-X
JNK	B-X
,	B-X
p38alpha	B-X
,	B-X
or	B-X
p38gamma	B-X
protein	B-X
expression	B-X
in	B-X
the	B-X
days	B-X
following	B-X
the	B-X
race	B-X
.	B-X
This	B-X
study	B-X
demonstrates	B-X
that	B-X
both	B-X
JNK	B-X
and	B-X
p38	B-X
intracellular	B-X
signalling	B-X
cascades	B-X
are	B-X
robustly	B-X
,	B-X
yet	B-X
transiently	B-X
increased	B-X
following	B-X
prolonged	B-X
running	B-X
exercise	B-X
.	B-X
The	B-X
differential	B-X
activation	B-X
of	B-X
the	B-X
p38	B-X
isoforms	B-X
with	B-X
exercise	B-X
in	B-X
human	B-X
skeletal	B-X
muscle	B-X
indicates	B-X
that	B-X
these	B-X
proteins	B-X
may	B-X
have	B-X
distinct	B-X
functions	B-X
in	B-X
vivo	B-X
.	B-X

We	O
examined	O
the	O
pattern	O
of	O
activation	O
and	O
deactivation	O
of	O
the	O
stress	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
signalling	O
molecules	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
NH2	I-Gene_or_gene_product
-	I-Gene_or_gene_product
terminal	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
JNK	B-Gene_or_gene_product
)	O
and	O
p38	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
in	O
skeletal	O
muscle	O
in	O
response	O
to	O
prolonged	O
strenuous	O
running	O
exercise	O
in	O
human	O
subjects	O
.	O
<EOS>	B-X
We	B-X
examined	B-X
the	B-X
pattern	B-X
of	B-X
activation	B-X
and	B-X
deactivation	B-X
of	B-X
the	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
signalling	B-X
molecules	B-X
c-Jun	B-X
NH2-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
and	B-X
p38	B-X
kinase	B-X
in	B-X
skeletal	B-X
muscle	B-X
in	B-X
response	B-X
to	B-X
prolonged	B-X
strenuous	B-X
running	B-X
exercise	B-X
in	B-X
human	B-X
subjects	B-X
.	B-X
Male	B-X
subjects	B-X
(	B-X
n	B-X
=	B-X
14	B-X
;	B-X
age	B-X
32	B-X
+/-	B-X
2	B-X
years	B-X
;	B-X
VO2	B-X
,	B-X
max	B-X
60	B-X
+/-	B-X
2	B-X
ml	B-X
kg-1	B-X
min-1	B-X
)	B-X
completed	B-X
a	B-X
42.2	B-X
km	B-X
marathon	B-X
(	B-X
mean	B-X
race	B-X
time	B-X
3	B-X
h	B-X
35	B-X
min	B-X
)	B-X
.	B-X
Muscle	B-X
biopsies	B-X
were	B-X
obtained	B-X
10	B-X
days	B-X
prior	B-X
to	B-X
the	B-X
marathon	B-X
,	B-X
immediately	B-X
following	B-X
the	B-X
race	B-X
,	B-X
and	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
after	B-X
the	B-X
race	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
JNK	B-X
and	B-X
p38	B-X
,	B-X
including	B-X
both	B-X
p38alpha	B-X
and	B-X
p38gamma	B-X
,	B-X
was	B-X
measured	B-X
with	B-X
immune	B-X
complex	B-X
assays	B-X
.	B-X
The	B-X
phosphorylation	B-X
state	B-X
of	B-X
p38	B-X
(	B-X
alpha	B-X
and	B-X
gamma	B-X
)	B-X
and	B-X
the	B-X
upstream	B-X
regulators	B-X
of	B-X
JNK	B-X
and	B-X
p38	B-X
,	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
4	B-X
(	B-X
MKK4	B-X
)	B-X
and	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
6	B-X
(	B-X
MKK6	B-X
)	B-X
,	B-X
were	B-X
assessed	B-X
using	B-X
phosphospecific	B-X
antibodies	B-X
.	B-X
JNK	B-X
activity	B-X
increased	B-X
7-fold	B-X
over	B-X
basal	B-X
level	B-X
immediately	B-X
post-exercise	B-X
,	B-X
but	B-X
decreased	B-X
back	B-X
to	B-X
basal	B-X
levels	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
after	B-X
the	B-X
exercise	B-X
.	B-X
p38gamma	B-X
phosphorylation	B-X
(	B-X
4-fold	B-X
)	B-X
and	B-X
activity	B-X
(	B-X
1.5-fold	B-X
)	B-X
increased	B-X
immediately	B-X
post-exercise	B-X
and	B-X
returned	B-X
to	B-X
basal	B-X
levels	B-X
at	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
following	B-X
exercise	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
p38alpha	B-X
phosphorylation	B-X
and	B-X
activity	B-X
did	B-X
not	B-X
change	B-X
over	B-X
the	B-X
time	B-X
course	B-X
studied	B-X
.	B-X
MKK4	B-X
and	B-X
MKK6	B-X
phosphorylation	B-X
increased	B-X
and	B-X
decreased	B-X
in	B-X
a	B-X
trend	B-X
similar	B-X
to	B-X
that	B-X
observed	B-X
with	B-X
JNK	B-X
activity	B-X
and	B-X
p38gamma	B-X
phosphorylation	B-X
.	B-X
Prolonged	B-X
running	B-X
exercise	B-X
did	B-X
not	B-X
affect	B-X
JNK	B-X
,	B-X
p38alpha	B-X
,	B-X
or	B-X
p38gamma	B-X
protein	B-X
expression	B-X
in	B-X
the	B-X
days	B-X
following	B-X
the	B-X
race	B-X
.	B-X
This	B-X
study	B-X
demonstrates	B-X
that	B-X
both	B-X
JNK	B-X
and	B-X
p38	B-X
intracellular	B-X
signalling	B-X
cascades	B-X
are	B-X
robustly	B-X
,	B-X
yet	B-X
transiently	B-X
increased	B-X
following	B-X
prolonged	B-X
running	B-X
exercise	B-X
.	B-X
The	B-X
differential	B-X
activation	B-X
of	B-X
the	B-X
p38	B-X
isoforms	B-X
with	B-X
exercise	B-X
in	B-X
human	B-X
skeletal	B-X
muscle	B-X
indicates	B-X
that	B-X
these	B-X
proteins	B-X
may	B-X
have	B-X
distinct	B-X
functions	B-X
in	B-X
vivo	B-X
.	B-X

Male	O
subjects	O
(	O
n	O
=	O
14	O
;	O
age	O
32	O
+	O
/	O
-	O
2	O
years	O
;	O
VO2	O
,	O
max	O
60	O
+	O
/	O
-	O
2	O
ml	O
kg	O
-	O
1	O
min	O
-	O
1	O
)	O
completed	O
a	O
42	O
.	O
2	O
km	O
marathon	O
(	O
mean	O
race	O
time	O
3	O
h	O
35	O
min	O
)	O
.	O
<EOS>	B-X
This	B-X
study	B-X
investigated	B-X
plasma	B-X
biomarkers	B-X
for	B-X
neuroinflammation	B-X
associated	B-X
with	B-X
Alzheimer	B-X
's	B-X
disease	B-X
(	B-X
AD	B-X
)	B-X
in	B-X
subjects	B-X
with	B-X
preclinical	B-X
AD	B-X
compared	B-X
to	B-X
healthy	B-X
elderly	B-X
.	B-X
How	B-X
these	B-X
biomarkers	B-X
behave	B-X
in	B-X
patients	B-X
with	B-X
AD	B-X
,	B-X
compared	B-X
to	B-X
healthy	B-X
elderly	B-X
is	B-X
well	B-X
known	B-X
,	B-X
but	B-X
determining	B-X
these	B-X
in	B-X
subjects	B-X
with	B-X
preclinical	B-X
AD	B-X
is	B-X
not	B-X
and	B-X
will	B-X
add	B-X
information	B-X
related	B-X
to	B-X
the	B-X
onset	B-X
of	B-X
AD	B-X
.	B-X
When	B-X
found	B-X
to	B-X
be	B-X
different	B-X
in	B-X
preclinical	B-X
AD	B-X
,	B-X
these	B-X
inflammatory	B-X
biomarkers	B-X
may	B-X
be	B-X
used	B-X
to	B-X
select	B-X
preclinical	B-X
AD	B-X
subjects	B-X
who	B-X
are	B-X
most	B-X
likely	B-X
to	B-X
develop	B-X
AD	B-X
,	B-X
to	B-X
participate	B-X
in	B-X
clinical	B-X
trials	B-X
with	B-X
new	B-X
disease-modifying	B-X
drugs	B-X
.	B-X
Pharmacologic	B-X
treatment	B-X
is	B-X
a	B-X
mainstay	B-X
of	B-X
allergy	B-X
therapy	B-X
and	B-X
many	B-X
caregivers	B-X
use	B-X
over-the-counter	B-X
antihistamines	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
seasonal	B-X
allergic	B-X
rhinitis	B-X
(	B-X
SAR	B-X
)	B-X
symptoms	B-X
in	B-X
children	B-X
.	B-X

Muscle	O
biopsies	O
were	O
obtained	O
10	O
days	O
prior	O
to	O
the	O
marathon	O
,	O
immediately	O
following	O
the	O
race	O
,	O
and	O
1	O
,	O
3	O
and	O
5	O
days	O
after	O
the	O
race	O
.	O

The	O
activation	O
of	O
JNK	B-Gene_or_gene_product
and	O
p38	B-Gene_or_gene_product
,	O
including	O
both	O
p38alpha	B-Gene_or_gene_product
and	O
p38gamma	B-Gene_or_gene_product
,	O
was	O
measured	O
with	O
immune	O
complex	O
assays	O
.	O
<EOS>	B-X
We	B-X
examined	B-X
the	B-X
pattern	B-X
of	B-X
activation	B-X
and	B-X
deactivation	B-X
of	B-X
the	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
signalling	B-X
molecules	B-X
c-Jun	B-X
NH2-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
and	B-X
p38	B-X
kinase	B-X
in	B-X
skeletal	B-X
muscle	B-X
in	B-X
response	B-X
to	B-X
prolonged	B-X
strenuous	B-X
running	B-X
exercise	B-X
in	B-X
human	B-X
subjects	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
JNK	B-X
and	B-X
p38	B-X
,	B-X
including	B-X
both	B-X
p38alpha	B-X
and	B-X
p38gamma	B-X
,	B-X
was	B-X
measured	B-X
with	B-X
immune	B-X
complex	B-X
assays	B-X
.	B-X
The	B-X
phosphorylation	B-X
state	B-X
of	B-X
p38	B-X
(	B-X
alpha	B-X
and	B-X
gamma	B-X
)	B-X
and	B-X
the	B-X
upstream	B-X
regulators	B-X
of	B-X
JNK	B-X
and	B-X
p38	B-X
,	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
4	B-X
(	B-X
MKK4	B-X
)	B-X
and	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
6	B-X
(	B-X
MKK6	B-X
)	B-X
,	B-X
were	B-X
assessed	B-X
using	B-X
phosphospecific	B-X
antibodies	B-X
.	B-X
JNK	B-X
activity	B-X
increased	B-X
7-fold	B-X
over	B-X
basal	B-X
level	B-X
immediately	B-X
post-exercise	B-X
,	B-X
but	B-X
decreased	B-X
back	B-X
to	B-X
basal	B-X
levels	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
after	B-X
the	B-X
exercise	B-X
.	B-X
p38gamma	B-X
phosphorylation	B-X
(	B-X
4-fold	B-X
)	B-X
and	B-X
activity	B-X
(	B-X
1.5-fold	B-X
)	B-X
increased	B-X
immediately	B-X
post-exercise	B-X
and	B-X
returned	B-X
to	B-X
basal	B-X
levels	B-X
at	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
following	B-X
exercise	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
p38alpha	B-X
phosphorylation	B-X
and	B-X
activity	B-X
did	B-X
not	B-X
change	B-X
over	B-X
the	B-X
time	B-X
course	B-X
studied	B-X
.	B-X
MKK4	B-X
and	B-X
MKK6	B-X
phosphorylation	B-X
increased	B-X
and	B-X
decreased	B-X
in	B-X
a	B-X
trend	B-X
similar	B-X
to	B-X
that	B-X
observed	B-X
with	B-X
JNK	B-X
activity	B-X
and	B-X
p38gamma	B-X
phosphorylation	B-X
.	B-X
Prolonged	B-X
running	B-X
exercise	B-X
did	B-X
not	B-X
affect	B-X
JNK	B-X
,	B-X
p38alpha	B-X
,	B-X
or	B-X
p38gamma	B-X
protein	B-X
expression	B-X
in	B-X
the	B-X
days	B-X
following	B-X
the	B-X
race	B-X
.	B-X
This	B-X
study	B-X
demonstrates	B-X
that	B-X
both	B-X
JNK	B-X
and	B-X
p38	B-X
intracellular	B-X
signalling	B-X
cascades	B-X
are	B-X
robustly	B-X
,	B-X
yet	B-X
transiently	B-X
increased	B-X
following	B-X
prolonged	B-X
running	B-X
exercise	B-X
.	B-X
The	B-X
differential	B-X
activation	B-X
of	B-X
the	B-X
p38	B-X
isoforms	B-X
with	B-X
exercise	B-X
in	B-X
human	B-X
skeletal	B-X
muscle	B-X
indicates	B-X
that	B-X
these	B-X
proteins	B-X
may	B-X
have	B-X
distinct	B-X
functions	B-X
in	B-X
vivo	B-X
.	B-X

The	O
phosphorylation	O
state	O
of	O
p38	B-Gene_or_gene_product
(	O
alpha	B-Gene_or_gene_product
and	O
gamma	B-Gene_or_gene_product
)	O
and	O
the	O
upstream	O
regulators	O
of	O
JNK	B-Gene_or_gene_product
and	O
p38	B-Gene_or_gene_product
,	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
4	I-Gene_or_gene_product
(	O
MKK4	B-Gene_or_gene_product
)	O
and	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
6	I-Gene_or_gene_product
(	O
MKK6	B-Gene_or_gene_product
)	O
,	O
were	O
assessed	O
using	O
phosphospecific	O
antibodies	O
.	O
<EOS>	B-X
We	B-X
examined	B-X
the	B-X
pattern	B-X
of	B-X
activation	B-X
and	B-X
deactivation	B-X
of	B-X
the	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
signalling	B-X
molecules	B-X
c-Jun	B-X
NH2-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
and	B-X
p38	B-X
kinase	B-X
in	B-X
skeletal	B-X
muscle	B-X
in	B-X
response	B-X
to	B-X
prolonged	B-X
strenuous	B-X
running	B-X
exercise	B-X
in	B-X
human	B-X
subjects	B-X
.	B-X
Male	B-X
subjects	B-X
(	B-X
n	B-X
=	B-X
14	B-X
;	B-X
age	B-X
32	B-X
+/-	B-X
2	B-X
years	B-X
;	B-X
VO2	B-X
,	B-X
max	B-X
60	B-X
+/-	B-X
2	B-X
ml	B-X
kg-1	B-X
min-1	B-X
)	B-X
completed	B-X
a	B-X
42.2	B-X
km	B-X
marathon	B-X
(	B-X
mean	B-X
race	B-X
time	B-X
3	B-X
h	B-X
35	B-X
min	B-X
)	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
JNK	B-X
and	B-X
p38	B-X
,	B-X
including	B-X
both	B-X
p38alpha	B-X
and	B-X
p38gamma	B-X
,	B-X
was	B-X
measured	B-X
with	B-X
immune	B-X
complex	B-X
assays	B-X
.	B-X
The	B-X
phosphorylation	B-X
state	B-X
of	B-X
p38	B-X
(	B-X
alpha	B-X
and	B-X
gamma	B-X
)	B-X
and	B-X
the	B-X
upstream	B-X
regulators	B-X
of	B-X
JNK	B-X
and	B-X
p38	B-X
,	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
4	B-X
(	B-X
MKK4	B-X
)	B-X
and	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
6	B-X
(	B-X
MKK6	B-X
)	B-X
,	B-X
were	B-X
assessed	B-X
using	B-X
phosphospecific	B-X
antibodies	B-X
.	B-X
JNK	B-X
activity	B-X
increased	B-X
7-fold	B-X
over	B-X
basal	B-X
level	B-X
immediately	B-X
post-exercise	B-X
,	B-X
but	B-X
decreased	B-X
back	B-X
to	B-X
basal	B-X
levels	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
after	B-X
the	B-X
exercise	B-X
.	B-X
p38gamma	B-X
phosphorylation	B-X
(	B-X
4-fold	B-X
)	B-X
and	B-X
activity	B-X
(	B-X
1.5-fold	B-X
)	B-X
increased	B-X
immediately	B-X
post-exercise	B-X
and	B-X
returned	B-X
to	B-X
basal	B-X
levels	B-X
at	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
following	B-X
exercise	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
p38alpha	B-X
phosphorylation	B-X
and	B-X
activity	B-X
did	B-X
not	B-X
change	B-X
over	B-X
the	B-X
time	B-X
course	B-X
studied	B-X
.	B-X
MKK4	B-X
and	B-X
MKK6	B-X
phosphorylation	B-X
increased	B-X
and	B-X
decreased	B-X
in	B-X
a	B-X
trend	B-X
similar	B-X
to	B-X
that	B-X
observed	B-X
with	B-X
JNK	B-X
activity	B-X
and	B-X
p38gamma	B-X
phosphorylation	B-X
.	B-X
Prolonged	B-X
running	B-X
exercise	B-X
did	B-X
not	B-X
affect	B-X
JNK	B-X
,	B-X
p38alpha	B-X
,	B-X
or	B-X
p38gamma	B-X
protein	B-X
expression	B-X
in	B-X
the	B-X
days	B-X
following	B-X
the	B-X
race	B-X
.	B-X
This	B-X
study	B-X
demonstrates	B-X
that	B-X
both	B-X
JNK	B-X
and	B-X
p38	B-X
intracellular	B-X
signalling	B-X
cascades	B-X
are	B-X
robustly	B-X
,	B-X
yet	B-X
transiently	B-X
increased	B-X
following	B-X
prolonged	B-X
running	B-X
exercise	B-X
.	B-X
The	B-X
differential	B-X
activation	B-X
of	B-X
the	B-X
p38	B-X
isoforms	B-X
with	B-X
exercise	B-X
in	B-X
human	B-X
skeletal	B-X
muscle	B-X
indicates	B-X
that	B-X
these	B-X
proteins	B-X
may	B-X
have	B-X
distinct	B-X
functions	B-X
in	B-X
vivo	B-X
.	B-X

JNK	B-Gene_or_gene_product
activity	O
increased	O
7	O
-	O
fold	O
over	O
basal	O
level	O
immediately	O
post	O
-	O
exercise	O
,	O
but	O
decreased	O
back	O
to	O
basal	O
levels	O
1	O
,	O
3	O
and	O
5	O
days	O
after	O
the	O
exercise	O
.	O
<EOS>	B-X
We	B-X
examined	B-X
the	B-X
pattern	B-X
of	B-X
activation	B-X
and	B-X
deactivation	B-X
of	B-X
the	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
signalling	B-X
molecules	B-X
c-Jun	B-X
NH2-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
and	B-X
p38	B-X
kinase	B-X
in	B-X
skeletal	B-X
muscle	B-X
in	B-X
response	B-X
to	B-X
prolonged	B-X
strenuous	B-X
running	B-X
exercise	B-X
in	B-X
human	B-X
subjects	B-X
.	B-X
Male	B-X
subjects	B-X
(	B-X
n	B-X
=	B-X
14	B-X
;	B-X
age	B-X
32	B-X
+/-	B-X
2	B-X
years	B-X
;	B-X
VO2	B-X
,	B-X
max	B-X
60	B-X
+/-	B-X
2	B-X
ml	B-X
kg-1	B-X
min-1	B-X
)	B-X
completed	B-X
a	B-X
42.2	B-X
km	B-X
marathon	B-X
(	B-X
mean	B-X
race	B-X
time	B-X
3	B-X
h	B-X
35	B-X
min	B-X
)	B-X
.	B-X
Muscle	B-X
biopsies	B-X
were	B-X
obtained	B-X
10	B-X
days	B-X
prior	B-X
to	B-X
the	B-X
marathon	B-X
,	B-X
immediately	B-X
following	B-X
the	B-X
race	B-X
,	B-X
and	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
after	B-X
the	B-X
race	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
JNK	B-X
and	B-X
p38	B-X
,	B-X
including	B-X
both	B-X
p38alpha	B-X
and	B-X
p38gamma	B-X
,	B-X
was	B-X
measured	B-X
with	B-X
immune	B-X
complex	B-X
assays	B-X
.	B-X
The	B-X
phosphorylation	B-X
state	B-X
of	B-X
p38	B-X
(	B-X
alpha	B-X
and	B-X
gamma	B-X
)	B-X
and	B-X
the	B-X
upstream	B-X
regulators	B-X
of	B-X
JNK	B-X
and	B-X
p38	B-X
,	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
4	B-X
(	B-X
MKK4	B-X
)	B-X
and	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
6	B-X
(	B-X
MKK6	B-X
)	B-X
,	B-X
were	B-X
assessed	B-X
using	B-X
phosphospecific	B-X
antibodies	B-X
.	B-X
JNK	B-X
activity	B-X
increased	B-X
7-fold	B-X
over	B-X
basal	B-X
level	B-X
immediately	B-X
post-exercise	B-X
,	B-X
but	B-X
decreased	B-X
back	B-X
to	B-X
basal	B-X
levels	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
after	B-X
the	B-X
exercise	B-X
.	B-X
p38gamma	B-X
phosphorylation	B-X
(	B-X
4-fold	B-X
)	B-X
and	B-X
activity	B-X
(	B-X
1.5-fold	B-X
)	B-X
increased	B-X
immediately	B-X
post-exercise	B-X
and	B-X
returned	B-X
to	B-X
basal	B-X
levels	B-X
at	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
following	B-X
exercise	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
p38alpha	B-X
phosphorylation	B-X
and	B-X
activity	B-X
did	B-X
not	B-X
change	B-X
over	B-X
the	B-X
time	B-X
course	B-X
studied	B-X
.	B-X
MKK4	B-X
and	B-X
MKK6	B-X
phosphorylation	B-X
increased	B-X
and	B-X
decreased	B-X
in	B-X
a	B-X
trend	B-X
similar	B-X
to	B-X
that	B-X
observed	B-X
with	B-X
JNK	B-X
activity	B-X
and	B-X
p38gamma	B-X
phosphorylation	B-X
.	B-X
Prolonged	B-X
running	B-X
exercise	B-X
did	B-X
not	B-X
affect	B-X
JNK	B-X
,	B-X
p38alpha	B-X
,	B-X
or	B-X
p38gamma	B-X
protein	B-X
expression	B-X
in	B-X
the	B-X
days	B-X
following	B-X
the	B-X
race	B-X
.	B-X
This	B-X
study	B-X
demonstrates	B-X
that	B-X
both	B-X
JNK	B-X
and	B-X
p38	B-X
intracellular	B-X
signalling	B-X
cascades	B-X
are	B-X
robustly	B-X
,	B-X
yet	B-X
transiently	B-X
increased	B-X
following	B-X
prolonged	B-X
running	B-X
exercise	B-X
.	B-X
The	B-X
differential	B-X
activation	B-X
of	B-X
the	B-X
p38	B-X
isoforms	B-X
with	B-X
exercise	B-X
in	B-X
human	B-X
skeletal	B-X
muscle	B-X
indicates	B-X
that	B-X
these	B-X
proteins	B-X
may	B-X
have	B-X
distinct	B-X
functions	B-X
in	B-X
vivo	B-X
.	B-X

p38gamma	B-Gene_or_gene_product
phosphorylation	O
(	O
4	O
-	O
fold	O
)	O
and	O
activity	O
(	O
1	O
.	O
5	O
-	O
fold	O
)	O
increased	O
immediately	O
post	O
-	O
exercise	O
and	O
returned	O
to	O
basal	O
levels	O
at	O
1	O
,	O
3	O
and	O
5	O
days	O
following	O
exercise	O
.	O
<EOS>	B-X
We	B-X
examined	B-X
the	B-X
pattern	B-X
of	B-X
activation	B-X
and	B-X
deactivation	B-X
of	B-X
the	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
signalling	B-X
molecules	B-X
c-Jun	B-X
NH2-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
and	B-X
p38	B-X
kinase	B-X
in	B-X
skeletal	B-X
muscle	B-X
in	B-X
response	B-X
to	B-X
prolonged	B-X
strenuous	B-X
running	B-X
exercise	B-X
in	B-X
human	B-X
subjects	B-X
.	B-X
Male	B-X
subjects	B-X
(	B-X
n	B-X
=	B-X
14	B-X
;	B-X
age	B-X
32	B-X
+/-	B-X
2	B-X
years	B-X
;	B-X
VO2	B-X
,	B-X
max	B-X
60	B-X
+/-	B-X
2	B-X
ml	B-X
kg-1	B-X
min-1	B-X
)	B-X
completed	B-X
a	B-X
42.2	B-X
km	B-X
marathon	B-X
(	B-X
mean	B-X
race	B-X
time	B-X
3	B-X
h	B-X
35	B-X
min	B-X
)	B-X
.	B-X
Muscle	B-X
biopsies	B-X
were	B-X
obtained	B-X
10	B-X
days	B-X
prior	B-X
to	B-X
the	B-X
marathon	B-X
,	B-X
immediately	B-X
following	B-X
the	B-X
race	B-X
,	B-X
and	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
after	B-X
the	B-X
race	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
JNK	B-X
and	B-X
p38	B-X
,	B-X
including	B-X
both	B-X
p38alpha	B-X
and	B-X
p38gamma	B-X
,	B-X
was	B-X
measured	B-X
with	B-X
immune	B-X
complex	B-X
assays	B-X
.	B-X
The	B-X
phosphorylation	B-X
state	B-X
of	B-X
p38	B-X
(	B-X
alpha	B-X
and	B-X
gamma	B-X
)	B-X
and	B-X
the	B-X
upstream	B-X
regulators	B-X
of	B-X
JNK	B-X
and	B-X
p38	B-X
,	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
4	B-X
(	B-X
MKK4	B-X
)	B-X
and	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
6	B-X
(	B-X
MKK6	B-X
)	B-X
,	B-X
were	B-X
assessed	B-X
using	B-X
phosphospecific	B-X
antibodies	B-X
.	B-X
JNK	B-X
activity	B-X
increased	B-X
7-fold	B-X
over	B-X
basal	B-X
level	B-X
immediately	B-X
post-exercise	B-X
,	B-X
but	B-X
decreased	B-X
back	B-X
to	B-X
basal	B-X
levels	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
after	B-X
the	B-X
exercise	B-X
.	B-X
p38gamma	B-X
phosphorylation	B-X
(	B-X
4-fold	B-X
)	B-X
and	B-X
activity	B-X
(	B-X
1.5-fold	B-X
)	B-X
increased	B-X
immediately	B-X
post-exercise	B-X
and	B-X
returned	B-X
to	B-X
basal	B-X
levels	B-X
at	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
following	B-X
exercise	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
p38alpha	B-X
phosphorylation	B-X
and	B-X
activity	B-X
did	B-X
not	B-X
change	B-X
over	B-X
the	B-X
time	B-X
course	B-X
studied	B-X
.	B-X
MKK4	B-X
and	B-X
MKK6	B-X
phosphorylation	B-X
increased	B-X
and	B-X
decreased	B-X
in	B-X
a	B-X
trend	B-X
similar	B-X
to	B-X
that	B-X
observed	B-X
with	B-X
JNK	B-X
activity	B-X
and	B-X
p38gamma	B-X
phosphorylation	B-X
.	B-X
Prolonged	B-X
running	B-X
exercise	B-X
did	B-X
not	B-X
affect	B-X
JNK	B-X
,	B-X
p38alpha	B-X
,	B-X
or	B-X
p38gamma	B-X
protein	B-X
expression	B-X
in	B-X
the	B-X
days	B-X
following	B-X
the	B-X
race	B-X
.	B-X
This	B-X
study	B-X
demonstrates	B-X
that	B-X
both	B-X
JNK	B-X
and	B-X
p38	B-X
intracellular	B-X
signalling	B-X
cascades	B-X
are	B-X
robustly	B-X
,	B-X
yet	B-X
transiently	B-X
increased	B-X
following	B-X
prolonged	B-X
running	B-X
exercise	B-X
.	B-X
The	B-X
differential	B-X
activation	B-X
of	B-X
the	B-X
p38	B-X
isoforms	B-X
with	B-X
exercise	B-X
in	B-X
human	B-X
skeletal	B-X
muscle	B-X
indicates	B-X
that	B-X
these	B-X
proteins	B-X
may	B-X
have	B-X
distinct	B-X
functions	B-X
in	B-X
vivo	B-X
.	B-X

In	O
contrast	O
,	O
p38alpha	B-Gene_or_gene_product
phosphorylation	O
and	O
activity	O
did	O
not	O
change	O
over	O
the	O
time	O
course	O
studied	O
.	O
<EOS>	B-X
This	B-X
increased	B-X
invasiveness	B-X
correlated	B-X
with	B-X
enhanced	B-X
phosphorylation	B-X
of	B-X
p38α	B-X
,	B-X
AKT	B-X
and	B-X
glycogen	B-X
synthase	B-X
kinase	B-X
3β	B-X
(	B-X
GSK3β	B-X
)	B-X
,	B-X
and	B-X
activation	B-X
of	B-X
serum	B-X
response-	B-X
and	B-X
Smad-dependent	B-X
gene	B-X
promoters	B-X
by	B-X
Rac1	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
Rac1b	B-X
solely	B-X
activated	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
JNK2	B-X
,	B-X
together	B-X
with	B-X
TCF/LEF1-	B-X
and	B-X
nuclear	B-X
factor	B-X
kappa	B-X
B	B-X
(	B-X
NFκB	B-X
)	B-X
-responsive	B-X
gene	B-X
reporters	B-X
.	B-X
The	B-X
IL-1β-dependent	B-X
activation	B-X
of	B-X
the	B-X
TAB1-TAK1	B-X
heterodimer	B-X
in	B-X
TAB2/3	B-X
DKO	B-X
cells	B-X
is	B-X
required	B-X
for	B-X
the	B-X
expression	B-X
and	B-X
E3	B-X
ligase	B-X
activity	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
receptor-associated	B-X
factor	B-X
6	B-X
(	B-X
TRAF6	B-X
)	B-X
and	B-X
is	B-X
reduced	B-X
by	B-X
the	B-X
small	B-X
interfering	B-X
RNA	B-X
(	B-X
siRNA	B-X
)	B-X
knockdown	B-X
of	B-X
ubiquitin	B-X
conjugating	B-X
13	B-X
(	B-X
Ubc13	B-X
)	B-X
,	B-X
an	B-X
E2-conjugating	B-X
enzyme	B-X
that	B-X
directs	B-X
the	B-X
formation	B-X
of	B-X
K63-Ub	B-X
chains	B-X
.	B-X
However	B-X
,	B-X
in	B-X
contrast	B-X
with	B-X
TAB2/3-expressing	B-X
cells	B-X
,	B-X
IL-1β	B-X
signaling	B-X
was	B-X
transient	B-X
in	B-X
TAB2/3	B-X
DKO	B-X
cells	B-X
,	B-X
and	B-X
the	B-X
activation	B-X
of	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
1	B-X
(	B-X
JNK1	B-X
)	B-X
,	B-X
JNK2	B-X
and	B-X
p38γ	B-X
was	B-X
greatly	B-X
reduced	B-X
at	B-X
all	B-X
times	B-X
.	B-X

MKK4	B-Gene_or_gene_product
and	O
MKK6	B-Gene_or_gene_product
phosphorylation	O
increased	O
and	O
decreased	O
in	O
a	O
trend	O
similar	O
to	O
that	O
observed	O
with	O
JNK	B-Gene_or_gene_product
activity	O
and	O
p38gamma	B-Gene_or_gene_product
phosphorylation	O
.	O

Prolonged	O
running	O
exercise	O
did	O
not	O
affect	O
JNK	B-Gene_or_gene_product
,	O
p38alpha	B-Gene_or_gene_product
,	O
or	O
p38gamma	B-Gene_or_gene_product
protein	O
expression	O
in	O
the	O
days	O
following	O
the	O
race	O
.	O
<EOS>	B-X
where	B-X
players	B-X
perform	B-X
repeated	B-X
bouts	B-X
of	B-X
brief	B-X
high-intensity	B-X
exercise	B-X
punctuated	B-X
by	B-X
lower	B-X
intensity	B-X
activity	B-X
.	B-X
Prolonged	B-X
periods	B-X
of	B-X
multiple	B-X
sprints	B-X
drain	B-X
muscle	B-X
glycogen	B-X
stores	B-X
,	B-X
leading	B-X
to	B-X
a	B-X
decrease	B-X
in	B-X
power	B-X
output	B-X
and	B-X
a	B-X
reduction	B-X
in	B-X
general	B-X
work	B-X
rate	B-X
during	B-X
training	B-X
and	B-X
competition	B-X
.	B-X
The	B-X
impact	B-X
of	B-X
dietary	B-X
carbohydrate	B-X
interventions	B-X
on	B-X
team	B-X
sport	B-X
performance	B-X
have	B-X
been	B-X
typically	B-X
assessed	B-X
using	B-X
intermittent	B-X
variable-speed	B-X
shuttle	B-X
running	B-X
over	B-X
a	B-X
distance	B-X
of	B-X
20	B-X
m.	B-X
This	B-X
method	B-X
has	B-X
evolved	B-X
to	B-X
include	B-X
specific	B-X
work	B-X
to	B-X
rest	B-X
ratios	B-X
and	B-X
skills	B-X
specific	B-X
to	B-X
team	B-X
sports	B-X
such	B-X
as	B-X
soccer	B-X
,	B-X
rugby	B-X
and	B-X
basketball	B-X
.	B-X
Increasing	B-X
liver	B-X
and	B-X
muscle	B-X
carbohydrate	B-X
stores	B-X
before	B-X
sports	B-X
helps	B-X
delay	B-X
the	B-X
onset	B-X
of	B-X
fatigue	B-X
during	B-X
prolonged	B-X
intermittent	B-X
variable-speed	B-X
running	B-X
.	B-X
Carbohydrate	B-X
intake	B-X
during	B-X
exercise	B-X
,	B-X
typically	B-X
ingested	B-X
as	B-X
carbohydrate-electrolyte	B-X
solutions	B-X
,	B-X
is	B-X
also	B-X
associated	B-X
with	B-X
improved	B-X
performance	B-X
.	B-X
Variable-speed	B-X
running	B-X
in	B-X
hot	B-X
environments	B-X
is	B-X
limited	B-X
by	B-X
the	B-X
degree	B-X
of	B-X
hyperthermia	B-X
before	B-X
muscle	B-X
glycogen	B-X
availability	B-X
becomes	B-X
a	B-X
significant	B-X
contributor	B-X
to	B-X
the	B-X
onset	B-X
of	B-X
fatigue	B-X
.	B-X

This	O
study	O
demonstrates	O
that	O
both	O
JNK	B-Gene_or_gene_product
and	O
p38	B-Gene_or_gene_product
intracellular	O
signalling	O
cascades	O
are	O
robustly	O
,	O
yet	O
transiently	O
increased	O
following	O
prolonged	O
running	O
exercise	O
.	O
<EOS>	B-X
We	B-X
examined	B-X
the	B-X
pattern	B-X
of	B-X
activation	B-X
and	B-X
deactivation	B-X
of	B-X
the	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
signalling	B-X
molecules	B-X
c-Jun	B-X
NH2-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
and	B-X
p38	B-X
kinase	B-X
in	B-X
skeletal	B-X
muscle	B-X
in	B-X
response	B-X
to	B-X
prolonged	B-X
strenuous	B-X
running	B-X
exercise	B-X
in	B-X
human	B-X
subjects	B-X
.	B-X
Muscle	B-X
biopsies	B-X
were	B-X
obtained	B-X
10	B-X
days	B-X
prior	B-X
to	B-X
the	B-X
marathon	B-X
,	B-X
immediately	B-X
following	B-X
the	B-X
race	B-X
,	B-X
and	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
after	B-X
the	B-X
race	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
JNK	B-X
and	B-X
p38	B-X
,	B-X
including	B-X
both	B-X
p38alpha	B-X
and	B-X
p38gamma	B-X
,	B-X
was	B-X
measured	B-X
with	B-X
immune	B-X
complex	B-X
assays	B-X
.	B-X
The	B-X
phosphorylation	B-X
state	B-X
of	B-X
p38	B-X
(	B-X
alpha	B-X
and	B-X
gamma	B-X
)	B-X
and	B-X
the	B-X
upstream	B-X
regulators	B-X
of	B-X
JNK	B-X
and	B-X
p38	B-X
,	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
4	B-X
(	B-X
MKK4	B-X
)	B-X
and	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
6	B-X
(	B-X
MKK6	B-X
)	B-X
,	B-X
were	B-X
assessed	B-X
using	B-X
phosphospecific	B-X
antibodies	B-X
.	B-X
JNK	B-X
activity	B-X
increased	B-X
7-fold	B-X
over	B-X
basal	B-X
level	B-X
immediately	B-X
post-exercise	B-X
,	B-X
but	B-X
decreased	B-X
back	B-X
to	B-X
basal	B-X
levels	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
after	B-X
the	B-X
exercise	B-X
.	B-X
p38gamma	B-X
phosphorylation	B-X
(	B-X
4-fold	B-X
)	B-X
and	B-X
activity	B-X
(	B-X
1.5-fold	B-X
)	B-X
increased	B-X
immediately	B-X
post-exercise	B-X
and	B-X
returned	B-X
to	B-X
basal	B-X
levels	B-X
at	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
following	B-X
exercise	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
p38alpha	B-X
phosphorylation	B-X
and	B-X
activity	B-X
did	B-X
not	B-X
change	B-X
over	B-X
the	B-X
time	B-X
course	B-X
studied	B-X
.	B-X
MKK4	B-X
and	B-X
MKK6	B-X
phosphorylation	B-X
increased	B-X
and	B-X
decreased	B-X
in	B-X
a	B-X
trend	B-X
similar	B-X
to	B-X
that	B-X
observed	B-X
with	B-X
JNK	B-X
activity	B-X
and	B-X
p38gamma	B-X
phosphorylation	B-X
.	B-X
Prolonged	B-X
running	B-X
exercise	B-X
did	B-X
not	B-X
affect	B-X
JNK	B-X
,	B-X
p38alpha	B-X
,	B-X
or	B-X
p38gamma	B-X
protein	B-X
expression	B-X
in	B-X
the	B-X
days	B-X
following	B-X
the	B-X
race	B-X
.	B-X
This	B-X
study	B-X
demonstrates	B-X
that	B-X
both	B-X
JNK	B-X
and	B-X
p38	B-X
intracellular	B-X
signalling	B-X
cascades	B-X
are	B-X
robustly	B-X
,	B-X
yet	B-X
transiently	B-X
increased	B-X
following	B-X
prolonged	B-X
running	B-X
exercise	B-X
.	B-X
The	B-X
differential	B-X
activation	B-X
of	B-X
the	B-X
p38	B-X
isoforms	B-X
with	B-X
exercise	B-X
in	B-X
human	B-X
skeletal	B-X
muscle	B-X
indicates	B-X
that	B-X
these	B-X
proteins	B-X
may	B-X
have	B-X
distinct	B-X
functions	B-X
in	B-X
vivo	B-X
.	B-X

The	O
differential	O
activation	O
of	O
the	O
p38	B-Gene_or_gene_product
isoforms	O
with	O
exercise	O
in	O
human	O
skeletal	O
muscle	O
indicates	O
that	O
these	O
proteins	O
may	O
have	O
distinct	O
functions	O
in	O
vivo	O
.	O
<EOS>	B-X
We	B-X
examined	B-X
the	B-X
pattern	B-X
of	B-X
activation	B-X
and	B-X
deactivation	B-X
of	B-X
the	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
signalling	B-X
molecules	B-X
c-Jun	B-X
NH2-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
and	B-X
p38	B-X
kinase	B-X
in	B-X
skeletal	B-X
muscle	B-X
in	B-X
response	B-X
to	B-X
prolonged	B-X
strenuous	B-X
running	B-X
exercise	B-X
in	B-X
human	B-X
subjects	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
JNK	B-X
and	B-X
p38	B-X
,	B-X
including	B-X
both	B-X
p38alpha	B-X
and	B-X
p38gamma	B-X
,	B-X
was	B-X
measured	B-X
with	B-X
immune	B-X
complex	B-X
assays	B-X
.	B-X
The	B-X
phosphorylation	B-X
state	B-X
of	B-X
p38	B-X
(	B-X
alpha	B-X
and	B-X
gamma	B-X
)	B-X
and	B-X
the	B-X
upstream	B-X
regulators	B-X
of	B-X
JNK	B-X
and	B-X
p38	B-X
,	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
4	B-X
(	B-X
MKK4	B-X
)	B-X
and	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
6	B-X
(	B-X
MKK6	B-X
)	B-X
,	B-X
were	B-X
assessed	B-X
using	B-X
phosphospecific	B-X
antibodies	B-X
.	B-X
JNK	B-X
activity	B-X
increased	B-X
7-fold	B-X
over	B-X
basal	B-X
level	B-X
immediately	B-X
post-exercise	B-X
,	B-X
but	B-X
decreased	B-X
back	B-X
to	B-X
basal	B-X
levels	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
after	B-X
the	B-X
exercise	B-X
.	B-X
p38gamma	B-X
phosphorylation	B-X
(	B-X
4-fold	B-X
)	B-X
and	B-X
activity	B-X
(	B-X
1.5-fold	B-X
)	B-X
increased	B-X
immediately	B-X
post-exercise	B-X
and	B-X
returned	B-X
to	B-X
basal	B-X
levels	B-X
at	B-X
1	B-X
,	B-X
3	B-X
and	B-X
5	B-X
days	B-X
following	B-X
exercise	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
p38alpha	B-X
phosphorylation	B-X
and	B-X
activity	B-X
did	B-X
not	B-X
change	B-X
over	B-X
the	B-X
time	B-X
course	B-X
studied	B-X
.	B-X
MKK4	B-X
and	B-X
MKK6	B-X
phosphorylation	B-X
increased	B-X
and	B-X
decreased	B-X
in	B-X
a	B-X
trend	B-X
similar	B-X
to	B-X
that	B-X
observed	B-X
with	B-X
JNK	B-X
activity	B-X
and	B-X
p38gamma	B-X
phosphorylation	B-X
.	B-X
Prolonged	B-X
running	B-X
exercise	B-X
did	B-X
not	B-X
affect	B-X
JNK	B-X
,	B-X
p38alpha	B-X
,	B-X
or	B-X
p38gamma	B-X
protein	B-X
expression	B-X
in	B-X
the	B-X
days	B-X
following	B-X
the	B-X
race	B-X
.	B-X
This	B-X
study	B-X
demonstrates	B-X
that	B-X
both	B-X
JNK	B-X
and	B-X
p38	B-X
intracellular	B-X
signalling	B-X
cascades	B-X
are	B-X
robustly	B-X
,	B-X
yet	B-X
transiently	B-X
increased	B-X
following	B-X
prolonged	B-X
running	B-X
exercise	B-X
.	B-X
The	B-X
differential	B-X
activation	B-X
of	B-X
the	B-X
p38	B-X
isoforms	B-X
with	B-X
exercise	B-X
in	B-X
human	B-X
skeletal	B-X
muscle	B-X
indicates	B-X
that	B-X
these	B-X
proteins	B-X
may	B-X
have	B-X
distinct	B-X
functions	B-X
in	B-X
vivo	B-X
.	B-X

Ataxia	B-Gene_or_gene_product
telangiectasia	I-Gene_or_gene_product
-	I-Gene_or_gene_product
mutated	I-Gene_or_gene_product
phosphorylates	O
Chk2	B-Gene_or_gene_product
in	O
vivo	O
and	O
in	O
vitro	O
.	O
<EOS>	B-X
The	B-X
protein	B-X
kinase	B-X
Chk2	B-X
,	B-X
the	B-X
mammalian	B-X
homolog	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Rad53	B-X
and	B-X
fission	B-X
yeast	B-X
Cds1	B-X
checkpoint	B-X
kinases	B-X
,	B-X
is	B-X
phosphorylated	B-X
and	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
by	B-X
ionizing	B-X
radiation	B-X
(	B-X
IR	B-X
)	B-X
,	B-X
UV	B-X
irradiation	B-X
,	B-X
and	B-X
replication	B-X
blocks	B-X
by	B-X
hydroxyurea	B-X
(	B-X
HU	B-X
)	B-X
.	B-X
Phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Chk2	B-X
are	B-X
ataxia	B-X
telangiectasia-mutated	B-X
(	B-X
ATM	B-X
)	B-X
dependent	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
,	B-X
whereas	B-X
Chk2	B-X
phosphorylation	B-X
is	B-X
ATM-independent	B-X
when	B-X
cells	B-X
are	B-X
exposed	B-X
to	B-X
UV	B-X
or	B-X
HU	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
in	B-X
vitro	B-X
,	B-X
ATM	B-X
phosphorylates	B-X
the	B-X
Ser-Gln/Thr-Gln	B-X
(	B-X
SQ/TQ	B-X
)	B-X
cluster	B-X
domain	B-X
(	B-X
SCD	B-X
)	B-X
on	B-X
Chk2	B-X
,	B-X
which	B-X
contains	B-X
seven	B-X
SQ/TQ	B-X
motifs	B-X
,	B-X
and	B-X
Thr68	B-X
is	B-X
the	B-X
major	B-X
in	B-X
vitro	B-X
phosphorylation	B-X
site	B-X
by	B-X
ATM	B-X
.	B-X
ATM-	B-X
and	B-X
Rad3-related	B-X
also	B-X
phosphorylates	B-X
Thr68	B-X
in	B-X
addition	B-X
to	B-X
Thr26	B-X
and	B-X
Ser50	B-X
,	B-X
which	B-X
are	B-X
not	B-X
phosphorylated	B-X
to	B-X
a	B-X
significant	B-X
extent	B-X
by	B-X
ATM	B-X
in	B-X
vitro	B-X
.	B-X
In	B-X
vivo	B-X
,	B-X
Thr68	B-X
is	B-X
phosphorylated	B-X
in	B-X
an	B-X
ATM-dependent	B-X
manner	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
,	B-X
but	B-X
not	B-X
in	B-X
response	B-X
to	B-X
UV	B-X
or	B-X
HU	B-X
.	B-X
Substitution	B-X
of	B-X
Thr68	B-X
with	B-X
Ala	B-X
reduced	B-X
the	B-X
extent	B-X
of	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Chk2	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
all	B-X
seven	B-X
SQ/TQ	B-X
motifs	B-X
blocked	B-X
all	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Chk2	B-X
after	B-X
IR	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
in	B-X
vivo	B-X
,	B-X
Chk2	B-X
is	B-X
directly	B-X
phosphorylated	B-X
by	B-X
ATM	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
and	B-X
that	B-X
Chk2	B-X
is	B-X
regulated	B-X
by	B-X
phosphorylation	B-X
of	B-X
the	B-X
SCD	B-X
.	B-X

The	O
protein	O
kinase	O
Chk2	B-Gene_or_gene_product
,	O
the	O
mammalian	O
homolog	O
of	O
the	O
budding	O
yeast	O
Rad53	B-Gene_or_gene_product
and	O
fission	O
yeast	O
Cds1	B-Gene_or_gene_product
checkpoint	O
kinases	O
,	O
is	O
phosphorylated	O
and	O
activated	O
in	O
response	O
to	O
DNA	O
damage	O
by	O
ionizing	O
radiation	O
(	O
IR	O
)	O
,	O
UV	O
irradiation	O
,	O
and	O
replication	O
blocks	O
by	O
hydroxyurea	O
(	O
HU	O
)	O
.	O
<EOS>	B-X
The	B-X
protein	B-X
kinase	B-X
Chk2	B-X
,	B-X
the	B-X
mammalian	B-X
homolog	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Rad53	B-X
and	B-X
fission	B-X
yeast	B-X
Cds1	B-X
checkpoint	B-X
kinases	B-X
,	B-X
is	B-X
phosphorylated	B-X
and	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
by	B-X
ionizing	B-X
radiation	B-X
(	B-X
IR	B-X
)	B-X
,	B-X
UV	B-X
irradiation	B-X
,	B-X
and	B-X
replication	B-X
blocks	B-X
by	B-X
hydroxyurea	B-X
(	B-X
HU	B-X
)	B-X
.	B-X
Phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Chk2	B-X
are	B-X
ataxia	B-X
telangiectasia-mutated	B-X
(	B-X
ATM	B-X
)	B-X
dependent	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
,	B-X
whereas	B-X
Chk2	B-X
phosphorylation	B-X
is	B-X
ATM-independent	B-X
when	B-X
cells	B-X
are	B-X
exposed	B-X
to	B-X
UV	B-X
or	B-X
HU	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
in	B-X
vitro	B-X
,	B-X
ATM	B-X
phosphorylates	B-X
the	B-X
Ser-Gln/Thr-Gln	B-X
(	B-X
SQ/TQ	B-X
)	B-X
cluster	B-X
domain	B-X
(	B-X
SCD	B-X
)	B-X
on	B-X
Chk2	B-X
,	B-X
which	B-X
contains	B-X
seven	B-X
SQ/TQ	B-X
motifs	B-X
,	B-X
and	B-X
Thr68	B-X
is	B-X
the	B-X
major	B-X
in	B-X
vitro	B-X
phosphorylation	B-X
site	B-X
by	B-X
ATM	B-X
.	B-X
ATM-	B-X
and	B-X
Rad3-related	B-X
also	B-X
phosphorylates	B-X
Thr68	B-X
in	B-X
addition	B-X
to	B-X
Thr26	B-X
and	B-X
Ser50	B-X
,	B-X
which	B-X
are	B-X
not	B-X
phosphorylated	B-X
to	B-X
a	B-X
significant	B-X
extent	B-X
by	B-X
ATM	B-X
in	B-X
vitro	B-X
.	B-X
In	B-X
vivo	B-X
,	B-X
Thr68	B-X
is	B-X
phosphorylated	B-X
in	B-X
an	B-X
ATM-dependent	B-X
manner	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
,	B-X
but	B-X
not	B-X
in	B-X
response	B-X
to	B-X
UV	B-X
or	B-X
HU	B-X
.	B-X
Substitution	B-X
of	B-X
Thr68	B-X
with	B-X
Ala	B-X
reduced	B-X
the	B-X
extent	B-X
of	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Chk2	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
all	B-X
seven	B-X
SQ/TQ	B-X
motifs	B-X
blocked	B-X
all	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Chk2	B-X
after	B-X
IR	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
in	B-X
vivo	B-X
,	B-X
Chk2	B-X
is	B-X
directly	B-X
phosphorylated	B-X
by	B-X
ATM	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
and	B-X
that	B-X
Chk2	B-X
is	B-X
regulated	B-X
by	B-X
phosphorylation	B-X
of	B-X
the	B-X
SCD	B-X
.	B-X

Phosphorylation	O
and	O
activation	O
of	O
Chk2	B-Gene_or_gene_product
are	O
ataxia	B-Gene_or_gene_product
telangiectasia	I-Gene_or_gene_product
-	I-Gene_or_gene_product
mutated	I-Gene_or_gene_product
(	O
ATM	B-Gene_or_gene_product
)	O
dependent	O
in	O
response	O
to	O
IR	O
,	O
whereas	O
Chk2	B-Gene_or_gene_product
phosphorylation	O
is	O
ATM	B-Gene_or_gene_product
-	O
independent	O
when	O
cells	O
are	O
exposed	O
to	O
UV	O
or	O
HU	O
.	O
<EOS>	B-X
Hyperuricaemia	B-X
(	B-X
HU	B-X
)	B-X
caused	B-X
by	B-X
disorders	B-X
of	B-X
purine	B-X
metabolism	B-X
is	B-X
a	B-X
metabolic	B-X
disease	B-X
.	B-X
A	B-X
number	B-X
of	B-X
epidemiological	B-X
reports	B-X
have	B-X
confirmed	B-X
that	B-X
HU	B-X
is	B-X
correlated	B-X
with	B-X
multiple	B-X
disorders	B-X
,	B-X
such	B-X
as	B-X
chronic	B-X
kidney	B-X
diseases	B-X
,	B-X
cardiovascular	B-X
disease	B-X
and	B-X
gout	B-X
.	B-X
Recent	B-X
studies	B-X
showed	B-X
that	B-X
the	B-X
expression	B-X
and	B-X
functional	B-X
changes	B-X
of	B-X
uric	B-X
acid	B-X
transporters	B-X
,	B-X
including	B-X
URAT1	B-X
,	B-X
GLUT9	B-X
and	B-X
ABCG2	B-X
,	B-X
were	B-X
associated	B-X
with	B-X
HU	B-X
.	B-X
Moreover	B-X
,	B-X
a	B-X
large	B-X
number	B-X
of	B-X
genome-wide	B-X
association	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
these	B-X
transporters	B-X
'	B-X
dysfunction	B-X
leads	B-X
to	B-X
HU	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
describe	B-X
the	B-X
recent	B-X
progress	B-X
of	B-X
aetiology	B-X
and	B-X
related	B-X
transporters	B-X
of	B-X
HU	B-X
,	B-X
and	B-X
we	B-X
also	B-X
summarise	B-X
the	B-X
common	B-X
co-morbidities	B-X
possible	B-X
mechanisms	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
potential	B-X
pharmacological	B-X
and	B-X
non-pharmacological	B-X
treatment	B-X
methods	B-X
for	B-X
HU	B-X
,	B-X
aiming	B-X
to	B-X
provide	B-X
new	B-X
ideas	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
HU	B-X
.	B-X

Here	O
we	O
show	O
that	O
in	O
vitro	O
,	O
ATM	B-Gene_or_gene_product
phosphorylates	O
the	O
Ser	O
-	O
Gln	O
/	O
Thr	O
-	O
Gln	O
(	O
SQ	O
/	O
TQ	O
)	O
cluster	O
domain	O
(	O
SCD	O
)	O
on	O
Chk2	B-Gene_or_gene_product
,	O
which	O
contains	O
seven	O
SQ	O
/	O
TQ	O
motifs	O
,	O
and	O
Thr68	O
is	O
the	O
major	O
in	O
vitro	O
phosphorylation	O
site	O
by	O
ATM	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
protein	B-X
kinase	B-X
Chk2	B-X
,	B-X
the	B-X
mammalian	B-X
homolog	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Rad53	B-X
and	B-X
fission	B-X
yeast	B-X
Cds1	B-X
checkpoint	B-X
kinases	B-X
,	B-X
is	B-X
phosphorylated	B-X
and	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
by	B-X
ionizing	B-X
radiation	B-X
(	B-X
IR	B-X
)	B-X
,	B-X
UV	B-X
irradiation	B-X
,	B-X
and	B-X
replication	B-X
blocks	B-X
by	B-X
hydroxyurea	B-X
(	B-X
HU	B-X
)	B-X
.	B-X
Phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Chk2	B-X
are	B-X
ataxia	B-X
telangiectasia-mutated	B-X
(	B-X
ATM	B-X
)	B-X
dependent	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
,	B-X
whereas	B-X
Chk2	B-X
phosphorylation	B-X
is	B-X
ATM-independent	B-X
when	B-X
cells	B-X
are	B-X
exposed	B-X
to	B-X
UV	B-X
or	B-X
HU	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
in	B-X
vitro	B-X
,	B-X
ATM	B-X
phosphorylates	B-X
the	B-X
Ser-Gln/Thr-Gln	B-X
(	B-X
SQ/TQ	B-X
)	B-X
cluster	B-X
domain	B-X
(	B-X
SCD	B-X
)	B-X
on	B-X
Chk2	B-X
,	B-X
which	B-X
contains	B-X
seven	B-X
SQ/TQ	B-X
motifs	B-X
,	B-X
and	B-X
Thr68	B-X
is	B-X
the	B-X
major	B-X
in	B-X
vitro	B-X
phosphorylation	B-X
site	B-X
by	B-X
ATM	B-X
.	B-X
ATM-	B-X
and	B-X
Rad3-related	B-X
also	B-X
phosphorylates	B-X
Thr68	B-X
in	B-X
addition	B-X
to	B-X
Thr26	B-X
and	B-X
Ser50	B-X
,	B-X
which	B-X
are	B-X
not	B-X
phosphorylated	B-X
to	B-X
a	B-X
significant	B-X
extent	B-X
by	B-X
ATM	B-X
in	B-X
vitro	B-X
.	B-X
In	B-X
vivo	B-X
,	B-X
Thr68	B-X
is	B-X
phosphorylated	B-X
in	B-X
an	B-X
ATM-dependent	B-X
manner	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
,	B-X
but	B-X
not	B-X
in	B-X
response	B-X
to	B-X
UV	B-X
or	B-X
HU	B-X
.	B-X
Substitution	B-X
of	B-X
Thr68	B-X
with	B-X
Ala	B-X
reduced	B-X
the	B-X
extent	B-X
of	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Chk2	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
all	B-X
seven	B-X
SQ/TQ	B-X
motifs	B-X
blocked	B-X
all	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Chk2	B-X
after	B-X
IR	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
in	B-X
vivo	B-X
,	B-X
Chk2	B-X
is	B-X
directly	B-X
phosphorylated	B-X
by	B-X
ATM	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
and	B-X
that	B-X
Chk2	B-X
is	B-X
regulated	B-X
by	B-X
phosphorylation	B-X
of	B-X
the	B-X
SCD	B-X
.	B-X

ATM	B-Gene_or_gene_product
-	I-Gene_or_gene_product
and	I-Gene_or_gene_product
Rad3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
related	I-Gene_or_gene_product
also	O
phosphorylates	O
Thr68	O
in	O
addition	O
to	O
Thr26	O
and	O
Ser50	O
,	O
which	O
are	O
not	O
phosphorylated	O
to	O
a	O
significant	O
extent	O
by	O
ATM	B-Gene_or_gene_product
in	O
vitro	O
.	O

In	O
vivo	O
,	O
Thr68	O
is	O
phosphorylated	O
in	O
an	O
ATM	B-Gene_or_gene_product
-	O
dependent	O
manner	O
in	O
response	O
to	O
IR	O
,	O
but	O
not	O
in	O
response	O
to	O
UV	O
or	O
HU	O
.	O
<EOS>	B-X
Hydroxyurea	B-X
(	B-X
HU	B-X
)	B-X
is	B-X
a	B-X
drug	B-X
that	B-X
induces	B-X
fetal	B-X
hemoglobin	B-X
production	B-X
.	B-X
As	B-X
a	B-X
result	B-X
,	B-X
HU	B-X
is	B-X
widely	B-X
used	B-X
to	B-X
treat	B-X
β-thalassemia	B-X
(	B-X
β-thal	B-X
)	B-X
patients	B-X
.	B-X
However	B-X
,	B-X
the	B-X
response	B-X
of	B-X
these	B-X
patients	B-X
to	B-X
HU	B-X
varies	B-X
.	B-X
HU	B-X
has	B-X
a	B-X
number	B-X
of	B-X
side-effects	B-X
and	B-X
therefore	B-X
its	B-X
targeted	B-X
prescription	B-X
is	B-X
beneficial	B-X
.	B-X
Hence	B-X
,	B-X
identifying	B-X
the	B-X
genetic	B-X
determinants	B-X
which	B-X
lead	B-X
to	B-X
the	B-X
differential	B-X
HU	B-X
response	B-X
is	B-X
important	B-X
.	B-X
These	B-X
findings	B-X
have	B-X
helped	B-X
identify	B-X
several	B-X
single	B-X
nucleotide	B-X
polymorphisms	B-X
which	B-X
associate	B-X
with	B-X
the	B-X
response	B-X
to	B-X
HU	B-X
in	B-X
both	B-X
β-thal	B-X
and	B-X
sickle	B-X
cell	B-X
disease	B-X
patients	B-X
.	B-X

Substitution	O
of	O
Thr68	O
with	O
Ala	O
reduced	O
the	O
extent	O
of	O
phosphorylation	O
and	O
activation	O
of	O
Chk2	B-Gene_or_gene_product
in	O
response	O
to	O
IR	O
,	O
and	O
mutation	O
of	O
all	O
seven	O
SQ	O
/	O
TQ	O
motifs	O
blocked	O
all	O
phosphorylation	O
and	O
activation	O
of	O
Chk2	B-Gene_or_gene_product
after	O
IR	O
.	O
<EOS>	B-X
The	B-X
protein	B-X
kinase	B-X
Chk2	B-X
,	B-X
the	B-X
mammalian	B-X
homolog	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Rad53	B-X
and	B-X
fission	B-X
yeast	B-X
Cds1	B-X
checkpoint	B-X
kinases	B-X
,	B-X
is	B-X
phosphorylated	B-X
and	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
by	B-X
ionizing	B-X
radiation	B-X
(	B-X
IR	B-X
)	B-X
,	B-X
UV	B-X
irradiation	B-X
,	B-X
and	B-X
replication	B-X
blocks	B-X
by	B-X
hydroxyurea	B-X
(	B-X
HU	B-X
)	B-X
.	B-X
Phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Chk2	B-X
are	B-X
ataxia	B-X
telangiectasia-mutated	B-X
(	B-X
ATM	B-X
)	B-X
dependent	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
,	B-X
whereas	B-X
Chk2	B-X
phosphorylation	B-X
is	B-X
ATM-independent	B-X
when	B-X
cells	B-X
are	B-X
exposed	B-X
to	B-X
UV	B-X
or	B-X
HU	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
in	B-X
vitro	B-X
,	B-X
ATM	B-X
phosphorylates	B-X
the	B-X
Ser-Gln/Thr-Gln	B-X
(	B-X
SQ/TQ	B-X
)	B-X
cluster	B-X
domain	B-X
(	B-X
SCD	B-X
)	B-X
on	B-X
Chk2	B-X
,	B-X
which	B-X
contains	B-X
seven	B-X
SQ/TQ	B-X
motifs	B-X
,	B-X
and	B-X
Thr68	B-X
is	B-X
the	B-X
major	B-X
in	B-X
vitro	B-X
phosphorylation	B-X
site	B-X
by	B-X
ATM	B-X
.	B-X
ATM-	B-X
and	B-X
Rad3-related	B-X
also	B-X
phosphorylates	B-X
Thr68	B-X
in	B-X
addition	B-X
to	B-X
Thr26	B-X
and	B-X
Ser50	B-X
,	B-X
which	B-X
are	B-X
not	B-X
phosphorylated	B-X
to	B-X
a	B-X
significant	B-X
extent	B-X
by	B-X
ATM	B-X
in	B-X
vitro	B-X
.	B-X
In	B-X
vivo	B-X
,	B-X
Thr68	B-X
is	B-X
phosphorylated	B-X
in	B-X
an	B-X
ATM-dependent	B-X
manner	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
,	B-X
but	B-X
not	B-X
in	B-X
response	B-X
to	B-X
UV	B-X
or	B-X
HU	B-X
.	B-X
Substitution	B-X
of	B-X
Thr68	B-X
with	B-X
Ala	B-X
reduced	B-X
the	B-X
extent	B-X
of	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Chk2	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
all	B-X
seven	B-X
SQ/TQ	B-X
motifs	B-X
blocked	B-X
all	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Chk2	B-X
after	B-X
IR	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
in	B-X
vivo	B-X
,	B-X
Chk2	B-X
is	B-X
directly	B-X
phosphorylated	B-X
by	B-X
ATM	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
and	B-X
that	B-X
Chk2	B-X
is	B-X
regulated	B-X
by	B-X
phosphorylation	B-X
of	B-X
the	B-X
SCD	B-X
.	B-X

These	O
results	O
suggest	O
that	O
in	O
vivo	O
,	O
Chk2	B-Gene_or_gene_product
is	O
directly	O
phosphorylated	O
by	O
ATM	B-Gene_or_gene_product
in	O
response	O
to	O
IR	O
and	O
that	O
Chk2	B-Gene_or_gene_product
is	O
regulated	O
by	O
phosphorylation	O
of	O
the	O
SCD	O
.	O
<EOS>	B-X
The	B-X
protein	B-X
kinase	B-X
Chk2	B-X
,	B-X
the	B-X
mammalian	B-X
homolog	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Rad53	B-X
and	B-X
fission	B-X
yeast	B-X
Cds1	B-X
checkpoint	B-X
kinases	B-X
,	B-X
is	B-X
phosphorylated	B-X
and	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
by	B-X
ionizing	B-X
radiation	B-X
(	B-X
IR	B-X
)	B-X
,	B-X
UV	B-X
irradiation	B-X
,	B-X
and	B-X
replication	B-X
blocks	B-X
by	B-X
hydroxyurea	B-X
(	B-X
HU	B-X
)	B-X
.	B-X
Phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Chk2	B-X
are	B-X
ataxia	B-X
telangiectasia-mutated	B-X
(	B-X
ATM	B-X
)	B-X
dependent	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
,	B-X
whereas	B-X
Chk2	B-X
phosphorylation	B-X
is	B-X
ATM-independent	B-X
when	B-X
cells	B-X
are	B-X
exposed	B-X
to	B-X
UV	B-X
or	B-X
HU	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
in	B-X
vitro	B-X
,	B-X
ATM	B-X
phosphorylates	B-X
the	B-X
Ser-Gln/Thr-Gln	B-X
(	B-X
SQ/TQ	B-X
)	B-X
cluster	B-X
domain	B-X
(	B-X
SCD	B-X
)	B-X
on	B-X
Chk2	B-X
,	B-X
which	B-X
contains	B-X
seven	B-X
SQ/TQ	B-X
motifs	B-X
,	B-X
and	B-X
Thr68	B-X
is	B-X
the	B-X
major	B-X
in	B-X
vitro	B-X
phosphorylation	B-X
site	B-X
by	B-X
ATM	B-X
.	B-X
ATM-	B-X
and	B-X
Rad3-related	B-X
also	B-X
phosphorylates	B-X
Thr68	B-X
in	B-X
addition	B-X
to	B-X
Thr26	B-X
and	B-X
Ser50	B-X
,	B-X
which	B-X
are	B-X
not	B-X
phosphorylated	B-X
to	B-X
a	B-X
significant	B-X
extent	B-X
by	B-X
ATM	B-X
in	B-X
vitro	B-X
.	B-X
In	B-X
vivo	B-X
,	B-X
Thr68	B-X
is	B-X
phosphorylated	B-X
in	B-X
an	B-X
ATM-dependent	B-X
manner	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
,	B-X
but	B-X
not	B-X
in	B-X
response	B-X
to	B-X
UV	B-X
or	B-X
HU	B-X
.	B-X
Substitution	B-X
of	B-X
Thr68	B-X
with	B-X
Ala	B-X
reduced	B-X
the	B-X
extent	B-X
of	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Chk2	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
all	B-X
seven	B-X
SQ/TQ	B-X
motifs	B-X
blocked	B-X
all	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Chk2	B-X
after	B-X
IR	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
in	B-X
vivo	B-X
,	B-X
Chk2	B-X
is	B-X
directly	B-X
phosphorylated	B-X
by	B-X
ATM	B-X
in	B-X
response	B-X
to	B-X
IR	B-X
and	B-X
that	B-X
Chk2	B-X
is	B-X
regulated	B-X
by	B-X
phosphorylation	B-X
of	B-X
the	B-X
SCD	B-X
.	B-X

Structure	O
of	O
PAK1	B-Gene_or_gene_product
in	O
an	O
autoinhibited	O
conformation	O
reveals	O
a	O
multistage	O
activation	O
switch	O
.	O

The	O
p21	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
(	O
PAKs	B-Gene_or_gene_product
)	O
,	O
stimulated	O
by	O
binding	O
with	O
GTP	O
-	O
liganded	O
forms	O
of	O
Cdc42	B-Gene_or_gene_product
or	O
Rac	B-Gene_or_gene_product
,	O
modulate	O
cytoskeletal	O
actin	B-Gene_or_gene_product
assembly	O
and	O
activate	O
MAP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
pathways	O
.	O
<EOS>	B-X
The	B-X
p21-activated	B-X
kinases	B-X
(	B-X
PAKs	B-X
)	B-X
,	B-X
stimulated	B-X
by	B-X
binding	B-X
with	B-X
GTP-liganded	B-X
forms	B-X
of	B-X
Cdc42	B-X
or	B-X
Rac	B-X
,	B-X
modulate	B-X
cytoskeletal	B-X
actin	B-X
assembly	B-X
and	B-X
activate	B-X
MAP-kinase	B-X
pathways	B-X
.	B-X
The	B-X
2.3	B-X
A	B-X
resolution	B-X
crystal	B-X
structure	B-X
of	B-X
a	B-X
complex	B-X
between	B-X
the	B-X
N-terminal	B-X
autoregulatory	B-X
fragment	B-X
and	B-X
the	B-X
C-terminal	B-X
kinase	B-X
domain	B-X
of	B-X
PAK1	B-X
shows	B-X
that	B-X
GTPase	B-X
binding	B-X
will	B-X
trigger	B-X
a	B-X
series	B-X
of	B-X
conformational	B-X
changes	B-X
,	B-X
beginning	B-X
with	B-X
disruption	B-X
of	B-X
a	B-X
PAK1	B-X
dimer	B-X
and	B-X
ending	B-X
with	B-X
rearrangement	B-X
of	B-X
the	B-X
kinase	B-X
active	B-X
site	B-X
into	B-X
a	B-X
catalytically	B-X
competent	B-X
state	B-X
.	B-X
An	B-X
inhibitory	B-X
switch	B-X
(	B-X
IS	B-X
)	B-X
domain	B-X
,	B-X
which	B-X
overlaps	B-X
the	B-X
GTPase	B-X
binding	B-X
region	B-X
of	B-X
PAK1	B-X
,	B-X
positions	B-X
a	B-X
polypeptide	B-X
segment	B-X
across	B-X
the	B-X
kinase	B-X
cleft	B-X
.	B-X
GTPase	B-X
binding	B-X
will	B-X
refold	B-X
part	B-X
of	B-X
the	B-X
IS	B-X
domain	B-X
and	B-X
unfold	B-X
the	B-X
rest	B-X
.	B-X

The	O
2	O
.	O
3	O
A	O
resolution	O
crystal	O
structure	O
of	O
a	O
complex	O
between	O
the	O
N	O
-	O
terminal	O
autoregulatory	O
fragment	O
and	O
the	O
C	O
-	O
terminal	O
kinase	O
domain	O
of	O
PAK1	B-Gene_or_gene_product
shows	O
that	O
GTPase	O
binding	O
will	O
trigger	O
a	O
series	O
of	O
conformational	O
changes	O
,	O
beginning	O
with	O
disruption	O
of	O
a	O
PAK1	O
dimer	O
and	O
ending	O
with	O
rearrangement	O
of	O
the	O
kinase	O
active	O
site	O
into	O
a	O
catalytically	O
competent	O
state	O
.	O

An	O
inhibitory	O
switch	O
(	O
IS	O
)	O
domain	O
,	O
which	O
overlaps	O
the	O
GTPase	O
binding	O
region	O
of	O
PAK1	B-Gene_or_gene_product
,	O
positions	O
a	O
polypeptide	O
segment	O
across	O
the	O
kinase	O
cleft	O
.	O
<EOS>	B-X
The	B-X
p21-activated	B-X
kinases	B-X
(	B-X
PAKs	B-X
)	B-X
,	B-X
stimulated	B-X
by	B-X
binding	B-X
with	B-X
GTP-liganded	B-X
forms	B-X
of	B-X
Cdc42	B-X
or	B-X
Rac	B-X
,	B-X
modulate	B-X
cytoskeletal	B-X
actin	B-X
assembly	B-X
and	B-X
activate	B-X
MAP-kinase	B-X
pathways	B-X
.	B-X
The	B-X
2.3	B-X
A	B-X
resolution	B-X
crystal	B-X
structure	B-X
of	B-X
a	B-X
complex	B-X
between	B-X
the	B-X
N-terminal	B-X
autoregulatory	B-X
fragment	B-X
and	B-X
the	B-X
C-terminal	B-X
kinase	B-X
domain	B-X
of	B-X
PAK1	B-X
shows	B-X
that	B-X
GTPase	B-X
binding	B-X
will	B-X
trigger	B-X
a	B-X
series	B-X
of	B-X
conformational	B-X
changes	B-X
,	B-X
beginning	B-X
with	B-X
disruption	B-X
of	B-X
a	B-X
PAK1	B-X
dimer	B-X
and	B-X
ending	B-X
with	B-X
rearrangement	B-X
of	B-X
the	B-X
kinase	B-X
active	B-X
site	B-X
into	B-X
a	B-X
catalytically	B-X
competent	B-X
state	B-X
.	B-X
An	B-X
inhibitory	B-X
switch	B-X
(	B-X
IS	B-X
)	B-X
domain	B-X
,	B-X
which	B-X
overlaps	B-X
the	B-X
GTPase	B-X
binding	B-X
region	B-X
of	B-X
PAK1	B-X
,	B-X
positions	B-X
a	B-X
polypeptide	B-X
segment	B-X
across	B-X
the	B-X
kinase	B-X
cleft	B-X
.	B-X
GTPase	B-X
binding	B-X
will	B-X
refold	B-X
part	B-X
of	B-X
the	B-X
IS	B-X
domain	B-X
and	B-X
unfold	B-X
the	B-X
rest	B-X
.	B-X
A	B-X
related	B-X
switch	B-X
has	B-X
been	B-X
seen	B-X
in	B-X
the	B-X
Wiskott-Aldrich	B-X
syndrome	B-X
protein	B-X
(	B-X
WASP	B-X
)	B-X
.	B-X

GTPase	O
binding	O
will	O
refold	O
part	O
of	O
the	O
IS	O
domain	O
and	O
unfold	O
the	O
rest	O
.	O

A	O
related	O
switch	O
has	O
been	O
seen	O
in	O
the	O
Wiskott	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Aldrich	I-Gene_or_gene_product
syndrome	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
WASP	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
The	B-X
Rho-family	B-X
GTP-hydrolysing	B-X
proteins	B-X
(	B-X
GTPases	B-X
)	B-X
,	B-X
Cdc42	B-X
,	B-X
Rac	B-X
and	B-X
Rho	B-X
,	B-X
act	B-X
as	B-X
molecular	B-X
switches	B-X
in	B-X
signalling	B-X
pathways	B-X
that	B-X
regulate	B-X
cytoskeletal	B-X
architecture	B-X
,	B-X
gene	B-X
expression	B-X
and	B-X
progression	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Cdc42	B-X
and	B-X
Rac	B-X
transmit	B-X
many	B-X
signals	B-X
through	B-X
GTP-dependent	B-X
binding	B-X
to	B-X
effector	B-X
proteins	B-X
containing	B-X
a	B-X
Cdc42/Rac-interactive-binding	B-X
(	B-X
CRIB	B-X
)	B-X
motif	B-X
.	B-X
One	B-X
such	B-X
effector	B-X
,	B-X
the	B-X
Wiskott-Aldrich	B-X
syndrome	B-X
protein	B-X
(	B-X
WASP	B-X
)	B-X
,	B-X
is	B-X
postulated	B-X
to	B-X
link	B-X
activation	B-X
of	B-X
Cdc42	B-X
directly	B-X
to	B-X
the	B-X
rearrangement	B-X
of	B-X
actin	B-X
.	B-X
Human	B-X
mutations	B-X
in	B-X
WASP	B-X
cause	B-X
severe	B-X
defects	B-X
in	B-X
haematopoletic	B-X
cell	B-X
function	B-X
,	B-X
leading	B-X
to	B-X
clinical	B-X
symptoms	B-X
of	B-X
thrombocytopenia	B-X
,	B-X
immunodeficiency	B-X
and	B-X
eczema	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
solution	B-X
structure	B-X
of	B-X
a	B-X
complex	B-X
between	B-X
activated	B-X
Cdc42	B-X
and	B-X
a	B-X
minimal	B-X
GTPase-binding	B-X
domain	B-X
(	B-X
GBD	B-X
)	B-X
from	B-X
WASP	B-X
.	B-X
An	B-X
extended	B-X
amino-terminal	B-X
GBD	B-X
peptide	B-X
that	B-X
includes	B-X
the	B-X
CRIB	B-X
motif	B-X
contacts	B-X
the	B-X
switch	B-X
I	B-X
,	B-X
beta2	B-X
and	B-X
alpha5	B-X
regions	B-X
of	B-X
Cdc42	B-X
.	B-X
A	B-X
carboxy-terminal	B-X
beta-hairpin	B-X
and	B-X
alpha-helix	B-X
pack	B-X
against	B-X
switch	B-X
II	B-X
.	B-X
The	B-X
Phe-X-His-X2-His	B-X
portion	B-X
of	B-X
the	B-X
CRIB	B-X
motif	B-X
and	B-X
the	B-X
alpha-helix	B-X
appear	B-X
to	B-X
mediate	B-X
sensitivity	B-X
to	B-X
the	B-X
nucleotide	B-X
switch	B-X
through	B-X
contacts	B-X
to	B-X
residues	B-X
36-40	B-X
of	B-X
Cdc42	B-X
.	B-X
Discrimination	B-X
between	B-X
the	B-X
Rho-family	B-X
members	B-X
is	B-X
likely	B-X
to	B-X
be	B-X
governed	B-X
by	B-X
GBD	B-X
contacts	B-X
to	B-X
the	B-X
switch	B-X
I	B-X
and	B-X
alpha5	B-X
regions	B-X
of	B-X
the	B-X
GTPases	B-X
.	B-X

Activation	O
of	O
the	O
IkappaB	O
kinase	O
complex	O
by	O
TRAF6	B-Gene_or_gene_product
requires	O
a	O
dimeric	O
ubiquitin	B-Gene_or_gene_product
-	O
conjugating	O
enzyme	O
complex	O
and	O
a	O
unique	O
polyubiquitin	B-Gene_or_gene_product
chain	O
.	O

TRAF6	B-Gene_or_gene_product
is	O
a	O
signal	O
transducer	O
in	O
the	O
NF	O
-	O
kappaB	O
pathway	O
that	O
activates	O
IkappaB	O
kinase	O
(	O
IKK	O
)	O
in	O
response	O
to	O
proinflammatory	O
cytokines	O
.	O
<EOS>	B-X
RNA	B-X
virus	B-X
infections	B-X
are	B-X
detected	B-X
by	B-X
the	B-X
RIG-I	B-X
family	B-X
of	B-X
receptors	B-X
,	B-X
which	B-X
signal	B-X
through	B-X
the	B-X
adaptor	B-X
molecule	B-X
mitochondrial	B-X
antiviral	B-X
signaling	B-X
(	B-X
MAVS	B-X
)	B-X
.	B-X
MAVS	B-X
then	B-X
recruits	B-X
the	B-X
adaptor	B-X
's	B-X
tumor	B-X
necrosis	B-X
factor	B-X
receptor-associated	B-X
factor	B-X
(	B-X
TRAF	B-X
)	B-X
3	B-X
and	B-X
TRAF6	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
activate	B-X
IRF3	B-X
and	B-X
NF-κB	B-X
,	B-X
respectively	B-X
,	B-X
to	B-X
induce	B-X
interferons	B-X
(	B-X
IFNs	B-X
)	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
the	B-X
biotin-containing	B-X
enzyme	B-X
methylcrotonoyl-CoA	B-X
carboxylase	B-X
1	B-X
(	B-X
MCCC1	B-X
)	B-X
enhances	B-X
virus-induced	B-X
,	B-X
MAVS-mediated	B-X
IFN	B-X
and	B-X
inflammatory	B-X
cytokine	B-X
expression	B-X
through	B-X
the	B-X
NF-κB	B-X
signaling	B-X
pathway	B-X
.	B-X
MCCC1	B-X
knockdown	B-X
strongly	B-X
inhibits	B-X
induction	B-X
of	B-X
IFNs	B-X
and	B-X
inflammatory	B-X
cytokines	B-X
.	B-X
MCCC1	B-X
interacts	B-X
with	B-X
MAVS	B-X
and	B-X
components	B-X
of	B-X
the	B-X
MAVS	B-X
signalosome	B-X
and	B-X
contributes	B-X
to	B-X
enhanced	B-X
production	B-X
of	B-X
type	B-X
I	B-X
IFNs	B-X
and	B-X
pro-inflammatory	B-X
cytokines	B-X
by	B-X
promoting	B-X
phosphorylation	B-X
of	B-X
the	B-X
IκB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
and	B-X
NF-κB	B-X
inhibitor-α	B-X
(	B-X
IκBα	B-X
)	B-X
,	B-X
as	B-X
well	B-X
as	B-X
NF-κB	B-X
nuclear	B-X
translocation	B-X
.	B-X
This	B-X
process	B-X
leads	B-X
to	B-X
activation	B-X
of	B-X
IFNs	B-X
and	B-X
cytokine	B-X
expression	B-X
and	B-X
subsequent	B-X
activation	B-X
of	B-X
IFN-stimulated	B-X
genes	B-X
,	B-X
including	B-X
double-stranded	B-X
RNA-dependent	B-X
protein	B-X
kinase	B-X
PKR	B-X
and	B-X
myxovirus	B-X
resistance	B-X
protein	B-X
1	B-X
.	B-X
These	B-X
findings	B-X
demonstrate	B-X
that	B-X
MCCC1	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
virus-triggered	B-X
,	B-X
MAVS-mediated	B-X
activation	B-X
of	B-X
NF-κB	B-X
signaling	B-X
.	B-X

We	O
have	O
purified	O
a	O
heterodimeric	O
protein	O
complex	O
that	O
links	O
TRAF6	B-Gene_or_gene_product
to	O
IKK	O
activation	O
.	O
<EOS>	B-X
TRAF6	B-X
is	B-X
a	B-X
signal	B-X
transducer	B-X
in	B-X
the	B-X
NF-kappaB	B-X
pathway	B-X
that	B-X
activates	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
in	B-X
response	B-X
to	B-X
proinflammatory	B-X
cytokines	B-X
.	B-X
We	B-X
have	B-X
purified	B-X
a	B-X
heterodimeric	B-X
protein	B-X
complex	B-X
that	B-X
links	B-X
TRAF6	B-X
to	B-X
IKK	B-X
activation	B-X
.	B-X
Peptide	B-X
mass	B-X
fingerprinting	B-X
analysis	B-X
reveals	B-X
that	B-X
this	B-X
complex	B-X
is	B-X
composed	B-X
of	B-X
the	B-X
ubiquitin	B-X
conjugating	B-X
enzyme	B-X
Ubc13	B-X
and	B-X
the	B-X
Ubc-like	B-X
protein	B-X
Uev1A	B-X
.	B-X
We	B-X
find	B-X
that	B-X
TRAF6	B-X
,	B-X
a	B-X
RING	B-X
domain	B-X
protein	B-X
,	B-X
functions	B-X
together	B-X
with	B-X
Ubc13/Uev1A	B-X
to	B-X
catalyze	B-X
the	B-X
synthesis	B-X
of	B-X
unique	B-X
polyubiquitin	B-X
chains	B-X
linked	B-X
through	B-X
lysine-63	B-X
(	B-X
K63	B-X
)	B-X
of	B-X
ubiquitin	B-X
.	B-X
Blockade	B-X
of	B-X
this	B-X
polyubiquitin	B-X
chain	B-X
synthesis	B-X
,	B-X
but	B-X
not	B-X
inhibition	B-X
of	B-X
the	B-X
proteasome	B-X
,	B-X
prevents	B-X
the	B-X
activation	B-X
of	B-X
IKK	B-X
by	B-X
TRAF6	B-X
.	B-X
These	B-X
results	B-X
unveil	B-X
a	B-X
new	B-X
regulatory	B-X
function	B-X
for	B-X
ubiquitin	B-X
,	B-X
in	B-X
which	B-X
IKK	B-X
is	B-X
activated	B-X
through	B-X
the	B-X
assembly	B-X
of	B-X
K63-linked	B-X
polyubiquitin	B-X
chains	B-X
.	B-X

Peptide	O
mass	O
fingerprinting	O
analysis	O
reveals	O
that	O
this	O
complex	O
is	O
composed	O
of	O
the	O
ubiquitin	B-Gene_or_gene_product
conjugating	O
enzyme	O
Ubc13	B-Gene_or_gene_product
and	O
the	O
Ubc	B-Gene_or_gene_product
-	O
like	O
protein	O
Uev1A	B-Gene_or_gene_product
.	O
<EOS>	B-X
We	B-X
have	B-X
purified	B-X
a	B-X
heterodimeric	B-X
protein	B-X
complex	B-X
that	B-X
links	B-X
TRAF6	B-X
to	B-X
IKK	B-X
activation	B-X
.	B-X
Peptide	B-X
mass	B-X
fingerprinting	B-X
analysis	B-X
reveals	B-X
that	B-X
this	B-X
complex	B-X
is	B-X
composed	B-X
of	B-X
the	B-X
ubiquitin	B-X
conjugating	B-X
enzyme	B-X
Ubc13	B-X
and	B-X
the	B-X
Ubc-like	B-X
protein	B-X
Uev1A	B-X
.	B-X
We	B-X
find	B-X
that	B-X
TRAF6	B-X
,	B-X
a	B-X
RING	B-X
domain	B-X
protein	B-X
,	B-X
functions	B-X
together	B-X
with	B-X
Ubc13/Uev1A	B-X
to	B-X
catalyze	B-X
the	B-X
synthesis	B-X
of	B-X
unique	B-X
polyubiquitin	B-X
chains	B-X
linked	B-X
through	B-X
lysine-63	B-X
(	B-X
K63	B-X
)	B-X
of	B-X
ubiquitin	B-X
.	B-X
Blockade	B-X
of	B-X
this	B-X
polyubiquitin	B-X
chain	B-X
synthesis	B-X
,	B-X
but	B-X
not	B-X
inhibition	B-X
of	B-X
the	B-X
proteasome	B-X
,	B-X
prevents	B-X
the	B-X
activation	B-X
of	B-X
IKK	B-X
by	B-X
TRAF6	B-X
.	B-X
These	B-X
results	B-X
unveil	B-X
a	B-X
new	B-X
regulatory	B-X
function	B-X
for	B-X
ubiquitin	B-X
,	B-X
in	B-X
which	B-X
IKK	B-X
is	B-X
activated	B-X
through	B-X
the	B-X
assembly	B-X
of	B-X
K63-linked	B-X
polyubiquitin	B-X
chains	B-X
.	B-X

We	O
find	O
that	O
TRAF6	B-Gene_or_gene_product
,	O
a	O
RING	O
domain	O
protein	O
,	O
functions	O
together	O
with	O
Ubc13	B-Gene_or_gene_product
/	O
Uev1A	B-Gene_or_gene_product
to	O
catalyze	O
the	O
synthesis	O
of	O
unique	O
polyubiquitin	B-Gene_or_gene_product
chains	O
linked	O
through	O
lysine	O
-	O
63	O
(	O
K63	O
)	O
of	O
ubiquitin	B-Gene_or_gene_product
.	O
<EOS>	B-X
TRAF6	B-X
is	B-X
a	B-X
signal	B-X
transducer	B-X
in	B-X
the	B-X
NF-kappaB	B-X
pathway	B-X
that	B-X
activates	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
in	B-X
response	B-X
to	B-X
proinflammatory	B-X
cytokines	B-X
.	B-X
We	B-X
have	B-X
purified	B-X
a	B-X
heterodimeric	B-X
protein	B-X
complex	B-X
that	B-X
links	B-X
TRAF6	B-X
to	B-X
IKK	B-X
activation	B-X
.	B-X
Peptide	B-X
mass	B-X
fingerprinting	B-X
analysis	B-X
reveals	B-X
that	B-X
this	B-X
complex	B-X
is	B-X
composed	B-X
of	B-X
the	B-X
ubiquitin	B-X
conjugating	B-X
enzyme	B-X
Ubc13	B-X
and	B-X
the	B-X
Ubc-like	B-X
protein	B-X
Uev1A	B-X
.	B-X
We	B-X
find	B-X
that	B-X
TRAF6	B-X
,	B-X
a	B-X
RING	B-X
domain	B-X
protein	B-X
,	B-X
functions	B-X
together	B-X
with	B-X
Ubc13/Uev1A	B-X
to	B-X
catalyze	B-X
the	B-X
synthesis	B-X
of	B-X
unique	B-X
polyubiquitin	B-X
chains	B-X
linked	B-X
through	B-X
lysine-63	B-X
(	B-X
K63	B-X
)	B-X
of	B-X
ubiquitin	B-X
.	B-X
Blockade	B-X
of	B-X
this	B-X
polyubiquitin	B-X
chain	B-X
synthesis	B-X
,	B-X
but	B-X
not	B-X
inhibition	B-X
of	B-X
the	B-X
proteasome	B-X
,	B-X
prevents	B-X
the	B-X
activation	B-X
of	B-X
IKK	B-X
by	B-X
TRAF6	B-X
.	B-X
These	B-X
results	B-X
unveil	B-X
a	B-X
new	B-X
regulatory	B-X
function	B-X
for	B-X
ubiquitin	B-X
,	B-X
in	B-X
which	B-X
IKK	B-X
is	B-X
activated	B-X
through	B-X
the	B-X
assembly	B-X
of	B-X
K63-linked	B-X
polyubiquitin	B-X
chains	B-X
.	B-X

Blockade	O
of	O
this	O
polyubiquitin	B-Gene_or_gene_product
chain	O
synthesis	O
,	O
but	O
not	O
inhibition	O
of	O
the	O
proteasome	O
,	O
prevents	O
the	O
activation	O
of	O
IKK	O
by	O
TRAF6	B-Gene_or_gene_product
.	O
<EOS>	B-X
Adult	B-X
Sprague-Dawley	B-X
rats	B-X
and	B-X
YFP-Mito-DAn	B-X
mice	B-X
with	B-X
fluorescent	B-X
mitochondria	B-X
in	B-X
dopaminergic	B-X
neurons	B-X
were	B-X
injected	B-X
in	B-X
the	B-X
lateral	B-X
ventricles	B-X
with	B-X
6-hydroxydopamine	B-X
,	B-X
a	B-X
toxic	B-X
that	B-X
inhibits	B-X
the	B-X
mitochondrial	B-X
chain	B-X
of	B-X
dopaminergic	B-X
neurons	B-X
and	B-X
blockades	B-X
the	B-X
axonal	B-X
transport	B-X
.	B-X
Damaged	B-X
mitochondria	B-X
accumulated	B-X
in	B-X
spheroids	B-X
initiated	B-X
(	B-X
showing	B-X
high	B-X
Pink1	B-X
,	B-X
parkin	B-X
,	B-X
ubiquitin	B-X
,	B-X
p-S65-Ubi	B-X
,	B-X
AMBRA1	B-X
,	B-X
and	B-X
BCL2L13	B-X
immunoreactivity	B-X
and	B-X
developing	B-X
autophagosomes	B-X
)	B-X
but	B-X
did	B-X
not	B-X
complete	B-X
(	B-X
mitochondria	B-X
were	B-X
not	B-X
polyubiquitinated	B-X
,	B-X
autophagosomes	B-X
had	B-X
no	B-X
STX17	B-X
,	B-X
and	B-X
no	B-X
lysosomes	B-X
were	B-X
found	B-X
in	B-X
spheroids	B-X
)	B-X
the	B-X
mitophagy	B-X
process	B-X
.	B-X
Then	B-X
,	B-X
spheroids	B-X
were	B-X
penetrated	B-X
by	B-X
astrocytic	B-X
processes	B-X
and	B-X
DAergic	B-X
mitochondria	B-X
were	B-X
transferred	B-X
to	B-X
astrocytes	B-X
where	B-X
they	B-X
were	B-X
polyubiquitinated	B-X
(	B-X
UbiK63+	B-X
)	B-X
and	B-X
linked	B-X
to	B-X
mature	B-X
autophagosomes	B-X
(	B-X
STX17+	B-X
)	B-X
which	B-X
became	B-X
autophagolysosomes	B-X
(	B-X
Lamp1/Lamp2	B-X
which	B-X
co-localized	B-X
with	B-X
LC3	B-X
)	B-X
.	B-X
The	B-X
ubiquitin-proteasome	B-X
pathway	B-X
is	B-X
crucial	B-X
for	B-X
protein	B-X
turnover	B-X
.	B-X
Expression	B-X
of	B-X
other	B-X
members	B-X
of	B-X
the	B-X
ubiquitin-proteasome	B-X
pathway	B-X
studied	B-X
after	B-X
culturing	B-X
islets	B-X
at	B-X
high	B-X
glucose	B-X
concentrations	B-X
revealed	B-X
little	B-X
change	B-X
except	B-X
for	B-X
modest	B-X
declines	B-X
in	B-X
parkin	B-X
,	B-X
human	B-X
ubiquitin-conjugating	B-X
enzyme	B-X
5	B-X
(	B-X
UbcH5	B-X
)	B-X
,	B-X
and	B-X
beta-TRCP	B-X
(	B-X
transducin	B-X
repeat-containing	B-X
protein	B-X
)	B-X
.	B-X
With	B-X
the	B-X
pancreatectomy	B-X
model	B-X
,	B-X
expression	B-X
of	B-X
polyubiquitin-B	B-X
and	B-X
c-Cbl	B-X
were	B-X
increased	B-X
and	B-X
E6-associated	B-X
protein	B-X
was	B-X
reduced	B-X
.	B-X
Further	B-X
insight	B-X
about	B-X
the	B-X
proteasome	B-X
pathway	B-X
was	B-X
obtained	B-X
with	B-X
the	B-X
proteasome	B-X
inhibitor	B-X
lactacystin	B-X
,	B-X
which	B-X
in	B-X
short-term	B-X
2-h	B-X
experiments	B-X
enhanced	B-X
glucose-induced	B-X
insulin	B-X
secretion	B-X
.	B-X
An	B-X
important	B-X
role	B-X
for	B-X
the	B-X
ubiquitin-proteasome	B-X
pathways	B-X
in	B-X
beta-cells	B-X
is	B-X
suggested	B-X
by	B-X
the	B-X
findings	B-X
that	B-X
changes	B-X
in	B-X
glucose	B-X
concentration	B-X
influence	B-X
expression	B-X
of	B-X
genes	B-X
in	B-X
the	B-X
pathway	B-X
and	B-X
that	B-X
blockade	B-X
of	B-X
the	B-X
proteasome	B-X
degradation	B-X
machinery	B-X
enhances	B-X
glucose-stimulated	B-X
insulin	B-X
secretion	B-X
.	B-X

These	O
results	O
unveil	O
a	O
new	O
regulatory	O
function	O
for	O
ubiquitin	B-Gene_or_gene_product
,	O
in	O
which	O
IKK	O
is	O
activated	O
through	O
the	O
assembly	O
of	O
K63	O
-	O
linked	O
polyubiquitin	B-Gene_or_gene_product
chains	O
.	O
<EOS>	B-X
TRAF6	B-X
is	B-X
a	B-X
signal	B-X
transducer	B-X
in	B-X
the	B-X
NF-kappaB	B-X
pathway	B-X
that	B-X
activates	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
in	B-X
response	B-X
to	B-X
proinflammatory	B-X
cytokines	B-X
.	B-X
We	B-X
have	B-X
purified	B-X
a	B-X
heterodimeric	B-X
protein	B-X
complex	B-X
that	B-X
links	B-X
TRAF6	B-X
to	B-X
IKK	B-X
activation	B-X
.	B-X
Peptide	B-X
mass	B-X
fingerprinting	B-X
analysis	B-X
reveals	B-X
that	B-X
this	B-X
complex	B-X
is	B-X
composed	B-X
of	B-X
the	B-X
ubiquitin	B-X
conjugating	B-X
enzyme	B-X
Ubc13	B-X
and	B-X
the	B-X
Ubc-like	B-X
protein	B-X
Uev1A	B-X
.	B-X
We	B-X
find	B-X
that	B-X
TRAF6	B-X
,	B-X
a	B-X
RING	B-X
domain	B-X
protein	B-X
,	B-X
functions	B-X
together	B-X
with	B-X
Ubc13/Uev1A	B-X
to	B-X
catalyze	B-X
the	B-X
synthesis	B-X
of	B-X
unique	B-X
polyubiquitin	B-X
chains	B-X
linked	B-X
through	B-X
lysine-63	B-X
(	B-X
K63	B-X
)	B-X
of	B-X
ubiquitin	B-X
.	B-X
Blockade	B-X
of	B-X
this	B-X
polyubiquitin	B-X
chain	B-X
synthesis	B-X
,	B-X
but	B-X
not	B-X
inhibition	B-X
of	B-X
the	B-X
proteasome	B-X
,	B-X
prevents	B-X
the	B-X
activation	B-X
of	B-X
IKK	B-X
by	B-X
TRAF6	B-X
.	B-X
These	B-X
results	B-X
unveil	B-X
a	B-X
new	B-X
regulatory	B-X
function	B-X
for	B-X
ubiquitin	B-X
,	B-X
in	B-X
which	B-X
IKK	B-X
is	B-X
activated	B-X
through	B-X
the	B-X
assembly	B-X
of	B-X
K63-linked	B-X
polyubiquitin	B-X
chains	B-X
.	B-X

TAK1	B-Gene_or_gene_product
regulates	O
multiple	O
protein	O
kinase	O
cascades	O
activated	O
by	O
bacterial	O
lipopolysaccharide	O
.	O
<EOS>	B-X
During	B-X
inflammation	B-X
the	B-X
balance	B-X
between	B-X
cell	B-X
activation	B-X
and	B-X
cell	B-X
death	B-X
is	B-X
determined	B-X
by	B-X
the	B-X
tight	B-X
regulation	B-X
of	B-X
multiple	B-X
intracellular	B-X
enzyme	B-X
cascades	B-X
.	B-X
Key	B-X
regulatory	B-X
steps	B-X
often	B-X
involve	B-X
protein	B-X
kinases	B-X
.	B-X
We	B-X
show	B-X
that	B-X
the	B-X
prototypical	B-X
pro-inflammatory	B-X
molecule	B-X
,	B-X
bacterial	B-X
lipopolysaccharide	B-X
,	B-X
activates	B-X
multiple	B-X
protein	B-X
kinases	B-X
such	B-X
as	B-X
p38	B-X
,	B-X
JNK	B-X
,	B-X
IKK-beta	B-X
,	B-X
and	B-X
PKB/Akt	B-X
via	B-X
transforming	B-X
growth	B-X
factor	B-X
beta-activated	B-X
kinase-1	B-X
(	B-X
TAK1	B-X
)	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
TAK1	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
similar	B-X
activation	B-X
pathways	B-X
triggered	B-X
by	B-X
interleukin-1	B-X
.	B-X
Thus	B-X
TAK1	B-X
must	B-X
be	B-X
considered	B-X
as	B-X
an	B-X
important	B-X
component	B-X
of	B-X
intracellular	B-X
pathways	B-X
in	B-X
cells	B-X
involved	B-X
in	B-X
host	B-X
responses	B-X
to	B-X
physiological	B-X
and/or	B-X
environmental	B-X
stress	B-X
signals	B-X
during	B-X
inflammation	B-X
.	B-X

During	O
inflammation	O
the	O
balance	O
between	O
cell	O
activation	O
and	O
cell	O
death	O
is	O
determined	O
by	O
the	O
tight	O
regulation	O
of	O
multiple	O
intracellular	O
enzyme	O
cascades	O
.	O
<EOS>	B-X
During	B-X
inflammation	B-X
the	B-X
balance	B-X
between	B-X
cell	B-X
activation	B-X
and	B-X
cell	B-X
death	B-X
is	B-X
determined	B-X
by	B-X
the	B-X
tight	B-X
regulation	B-X
of	B-X
multiple	B-X
intracellular	B-X
enzyme	B-X
cascades	B-X
.	B-X
We	B-X
show	B-X
that	B-X
the	B-X
prototypical	B-X
pro-inflammatory	B-X
molecule	B-X
,	B-X
bacterial	B-X
lipopolysaccharide	B-X
,	B-X
activates	B-X
multiple	B-X
protein	B-X
kinases	B-X
such	B-X
as	B-X
p38	B-X
,	B-X
JNK	B-X
,	B-X
IKK-beta	B-X
,	B-X
and	B-X
PKB/Akt	B-X
via	B-X
transforming	B-X
growth	B-X
factor	B-X
beta-activated	B-X
kinase-1	B-X
(	B-X
TAK1	B-X
)	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
TAK1	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
similar	B-X
activation	B-X
pathways	B-X
triggered	B-X
by	B-X
interleukin-1	B-X
.	B-X
Thus	B-X
TAK1	B-X
must	B-X
be	B-X
considered	B-X
as	B-X
an	B-X
important	B-X
component	B-X
of	B-X
intracellular	B-X
pathways	B-X
in	B-X
cells	B-X
involved	B-X
in	B-X
host	B-X
responses	B-X
to	B-X
physiological	B-X
and/or	B-X
environmental	B-X
stress	B-X
signals	B-X
during	B-X
inflammation	B-X
.	B-X

Key	O
regulatory	O
steps	O
often	O
involve	O
protein	O
kinases	O
.	O
<EOS>	B-X
Viral	B-X
replication	B-X
is	B-X
a	B-X
complex	B-X
process	B-X
relying	B-X
on	B-X
a	B-X
network	B-X
of	B-X
interacting	B-X
viral	B-X
and	B-X
cellular	B-X
proteins	B-X
,	B-X
in	B-X
which	B-X
particularly	B-X
protein	B-X
kinases	B-X
play	B-X
an	B-X
important	B-X
regulatory	B-X
role	B-X
.	B-X
The	B-X
specific	B-X
phosphorylation	B-X
of	B-X
substrate	B-X
proteins	B-X
induces	B-X
activation	B-X
,	B-X
inactivation	B-X
,	B-X
or	B-X
other	B-X
functional	B-X
modification	B-X
and	B-X
thus	B-X
determines	B-X
virus-host	B-X
cell	B-X
interregulation	B-X
.	B-X
During	B-X
herpesviral	B-X
infections	B-X
,	B-X
both	B-X
viral	B-X
and	B-X
cellular	B-X
protein	B-X
kinases	B-X
are	B-X
expressed	B-X
and	B-X
provide	B-X
activities	B-X
crucial	B-X
for	B-X
the	B-X
efficiency	B-X
of	B-X
virus	B-X
replication	B-X
.	B-X
The	B-X
protein	B-X
kinase	B-X
pUL97	B-X
encoded	B-X
by	B-X
human	B-X
cytomegalovirus	B-X
(	B-X
HCMV	B-X
)	B-X
is	B-X
a	B-X
multifunctional	B-X
regulatory	B-X
enzyme	B-X
which	B-X
exerts	B-X
strong	B-X
regulatory	B-X
effects	B-X
on	B-X
early	B-X
and	B-X
late	B-X
steps	B-X
of	B-X
the	B-X
viral	B-X
replication	B-X
cycle	B-X
.	B-X
A	B-X
number	B-X
of	B-X
interacting	B-X
proteins	B-X
and	B-X
substrates	B-X
of	B-X
pUL97	B-X
have	B-X
been	B-X
described	B-X
,	B-X
including	B-X
retinoblastoma	B-X
(	B-X
Rb	B-X
)	B-X
protein	B-X
,	B-X
nuclear	B-X
lamins	B-X
and	B-X
viral	B-X
pUL69	B-X
.	B-X
Recently	B-X
,	B-X
it	B-X
was	B-X
demonstrated	B-X
that	B-X
pUL97	B-X
has	B-X
structural	B-X
and	B-X
functional	B-X
resemblance	B-X
to	B-X
cyclin-dependent	B-X
protein	B-X
kinases	B-X
(	B-X
CDKs	B-X
)	B-X
and	B-X
thus	B-X
represents	B-X
a	B-X
CDK	B-X
ortholog	B-X
.	B-X
On	B-X
the	B-X
basis	B-X
of	B-X
very	B-X
recent	B-X
findings	B-X
,	B-X
it	B-X
is	B-X
becoming	B-X
increasingly	B-X
clear	B-X
that	B-X
pUL97	B-X
is	B-X
a	B-X
component	B-X
of	B-X
a	B-X
multiprotein	B-X
nuclear	B-X
egress	B-X
complex	B-X
(	B-X
NEC	B-X
)	B-X
.	B-X
The	B-X
NEC	B-X
contains	B-X
a	B-X
small	B-X
number	B-X
of	B-X
egress	B-X
proteins	B-X
involved	B-X
in	B-X
the	B-X
recruitment	B-X
of	B-X
protein	B-X
kinases	B-X
,	B-X
such	B-X
as	B-X
pUL97	B-X
and	B-X
cellular	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
,	B-X
to	B-X
specific	B-X
sites	B-X
of	B-X
the	B-X
nuclear	B-X
lamina	B-X
.	B-X
Current	B-X
information	B-X
about	B-X
the	B-X
composition	B-X
,	B-X
function	B-X
,	B-X
and	B-X
regulatory	B-X
complexity	B-X
of	B-X
the	B-X
NEC	B-X
leads	B-X
to	B-X
a	B-X
mechanistic	B-X
concept	B-X
which	B-X
may	B-X
set	B-X
the	B-X
key	B-X
features	B-X
of	B-X
HCMV	B-X
nuclear	B-X
egress	B-X
in	B-X
a	B-X
new	B-X
light	B-X
.	B-X

We	O
show	O
that	O
the	O
prototypical	O
pro	O
-	O
inflammatory	O
molecule	O
,	O
bacterial	O
lipopolysaccharide	O
,	O
activates	O
multiple	O
protein	O
kinases	O
such	O
as	O
p38	B-Gene_or_gene_product
,	O
JNK	B-Gene_or_gene_product
,	O
IKK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
,	O
and	O
PKB	B-Gene_or_gene_product
/	O
Akt	B-Gene_or_gene_product
via	O
transforming	B-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
TAK1	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
During	B-X
inflammation	B-X
the	B-X
balance	B-X
between	B-X
cell	B-X
activation	B-X
and	B-X
cell	B-X
death	B-X
is	B-X
determined	B-X
by	B-X
the	B-X
tight	B-X
regulation	B-X
of	B-X
multiple	B-X
intracellular	B-X
enzyme	B-X
cascades	B-X
.	B-X
Key	B-X
regulatory	B-X
steps	B-X
often	B-X
involve	B-X
protein	B-X
kinases	B-X
.	B-X
We	B-X
show	B-X
that	B-X
the	B-X
prototypical	B-X
pro-inflammatory	B-X
molecule	B-X
,	B-X
bacterial	B-X
lipopolysaccharide	B-X
,	B-X
activates	B-X
multiple	B-X
protein	B-X
kinases	B-X
such	B-X
as	B-X
p38	B-X
,	B-X
JNK	B-X
,	B-X
IKK-beta	B-X
,	B-X
and	B-X
PKB/Akt	B-X
via	B-X
transforming	B-X
growth	B-X
factor	B-X
beta-activated	B-X
kinase-1	B-X
(	B-X
TAK1	B-X
)	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
TAK1	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
similar	B-X
activation	B-X
pathways	B-X
triggered	B-X
by	B-X
interleukin-1	B-X
.	B-X
Thus	B-X
TAK1	B-X
must	B-X
be	B-X
considered	B-X
as	B-X
an	B-X
important	B-X
component	B-X
of	B-X
intracellular	B-X
pathways	B-X
in	B-X
cells	B-X
involved	B-X
in	B-X
host	B-X
responses	B-X
to	B-X
physiological	B-X
and/or	B-X
environmental	B-X
stress	B-X
signals	B-X
during	B-X
inflammation	B-X
.	B-X

We	O
also	O
show	O
that	O
TAK1	B-Gene_or_gene_product
plays	O
an	O
important	O
role	O
in	O
similar	O
activation	O
pathways	O
triggered	O
by	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O
<EOS>	B-X
During	B-X
inflammation	B-X
the	B-X
balance	B-X
between	B-X
cell	B-X
activation	B-X
and	B-X
cell	B-X
death	B-X
is	B-X
determined	B-X
by	B-X
the	B-X
tight	B-X
regulation	B-X
of	B-X
multiple	B-X
intracellular	B-X
enzyme	B-X
cascades	B-X
.	B-X
We	B-X
show	B-X
that	B-X
the	B-X
prototypical	B-X
pro-inflammatory	B-X
molecule	B-X
,	B-X
bacterial	B-X
lipopolysaccharide	B-X
,	B-X
activates	B-X
multiple	B-X
protein	B-X
kinases	B-X
such	B-X
as	B-X
p38	B-X
,	B-X
JNK	B-X
,	B-X
IKK-beta	B-X
,	B-X
and	B-X
PKB/Akt	B-X
via	B-X
transforming	B-X
growth	B-X
factor	B-X
beta-activated	B-X
kinase-1	B-X
(	B-X
TAK1	B-X
)	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
TAK1	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
similar	B-X
activation	B-X
pathways	B-X
triggered	B-X
by	B-X
interleukin-1	B-X
.	B-X
Thus	B-X
TAK1	B-X
must	B-X
be	B-X
considered	B-X
as	B-X
an	B-X
important	B-X
component	B-X
of	B-X
intracellular	B-X
pathways	B-X
in	B-X
cells	B-X
involved	B-X
in	B-X
host	B-X
responses	B-X
to	B-X
physiological	B-X
and/or	B-X
environmental	B-X
stress	B-X
signals	B-X
during	B-X
inflammation	B-X
.	B-X

Thus	O
TAK1	B-Gene_or_gene_product
must	O
be	O
considered	O
as	O
an	O
important	O
component	O
of	O
intracellular	O
pathways	O
in	O
cells	O
involved	O
in	O
host	O
responses	O
to	O
physiological	O
and	O
/	O
or	O
environmental	O
stress	O
signals	O
during	O
inflammation	O
.	O
<EOS>	B-X
Persistent	B-X
inflammation	B-X
within	B-X
the	B-X
respiratory	B-X
tract	B-X
underlies	B-X
the	B-X
pathogenesis	B-X
of	B-X
numerous	B-X
chronic	B-X
pulmonary	B-X
diseases	B-X
including	B-X
chronic	B-X
obstructive	B-X
pulmonary	B-X
disease	B-X
,	B-X
asthma	B-X
and	B-X
pulmonary	B-X
fibrosis	B-X
.	B-X
Chronic	B-X
inflammation	B-X
in	B-X
the	B-X
lung	B-X
may	B-X
arise	B-X
from	B-X
a	B-X
combination	B-X
of	B-X
genetic	B-X
susceptibility	B-X
and	B-X
environmental	B-X
influences	B-X
,	B-X
including	B-X
exposure	B-X
to	B-X
microbes	B-X
,	B-X
particles	B-X
from	B-X
the	B-X
atmosphere	B-X
,	B-X
irritants	B-X
,	B-X
pollutants	B-X
,	B-X
allergens	B-X
,	B-X
and	B-X
toxic	B-X
molecules	B-X
.	B-X
Macroautophagy/autophagy	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
the	B-X
inflammatory	B-X
response	B-X
of	B-X
the	B-X
lung	B-X
to	B-X
infection	B-X
and	B-X
stress	B-X
.	B-X
At	B-X
baseline	B-X
,	B-X
autophagy	B-X
may	B-X
be	B-X
critical	B-X
for	B-X
inhibiting	B-X
spontaneous	B-X
pulmonary	B-X
inflammation	B-X
and	B-X
fundamental	B-X
for	B-X
the	B-X
response	B-X
of	B-X
pulmonary	B-X
leukocytes	B-X
to	B-X
infection	B-X
;	B-X
however	B-X
,	B-X
when	B-X
not	B-X
regulated	B-X
,	B-X
persistent	B-X
or	B-X
inefficient	B-X
autophagy	B-X
may	B-X
be	B-X
detrimental	B-X
to	B-X
lung	B-X
epithelial	B-X
cells	B-X
,	B-X
promoting	B-X
lung	B-X
injury	B-X
.	B-X
This	B-X
perspective	B-X
will	B-X
discuss	B-X
the	B-X
role	B-X
of	B-X
autophagy	B-X
in	B-X
driving	B-X
and	B-X
regulating	B-X
inflammatory	B-X
responses	B-X
of	B-X
the	B-X
lung	B-X
in	B-X
chronic	B-X
lung	B-X
diseases	B-X
with	B-X
a	B-X
focus	B-X
on	B-X
potential	B-X
avenues	B-X
for	B-X
therapeutic	B-X
targeting	B-X
.	B-X

Cloning	O
,	O
Golgi	O
localization	O
,	O
and	O
enzyme	O
activity	O
of	O
the	O
full	O
-	O
length	O
heparin	O
/	O
heparan	O
sulfate	O
-	O
glucuronic	O
acid	O
C5	B-Gene_or_gene_product
-	I-Gene_or_gene_product
epimerase	I-Gene_or_gene_product
.	O
<EOS>	B-X
While	B-X
studying	B-X
the	B-X
cellular	B-X
localization	B-X
and	B-X
activity	B-X
of	B-X
enzymes	B-X
involved	B-X
in	B-X
heparan	B-X
sulfate	B-X
biosynthesis	B-X
,	B-X
we	B-X
discovered	B-X
that	B-X
the	B-X
published	B-X
sequence	B-X
for	B-X
the	B-X
glucuronic	B-X
acid	B-X
C5-epimerase	B-X
responsible	B-X
for	B-X
the	B-X
interconversion	B-X
of	B-X
d-glucuronic	B-X
acid	B-X
and	B-X
l-iduronic	B-X
acid	B-X
residues	B-X
encodes	B-X
a	B-X
truncated	B-X
protein	B-X
.	B-X
Genome	B-X
analysis	B-X
and	B-X
5'-rapid	B-X
amplification	B-X
of	B-X
cDNA	B-X
ends	B-X
was	B-X
used	B-X
to	B-X
clone	B-X
the	B-X
full-length	B-X
cDNA	B-X
from	B-X
a	B-X
mouse	B-X
mastocytoma	B-X
cell	B-X
line	B-X
.	B-X
The	B-X
extended	B-X
cDNA	B-X
encodes	B-X
for	B-X
an	B-X
additional	B-X
174	B-X
amino	B-X
acids	B-X
at	B-X
the	B-X
amino	B-X
terminus	B-X
of	B-X
the	B-X
protein	B-X
.	B-X
The	B-X
murine	B-X
sequence	B-X
is	B-X
95	B-X
%	B-X
identical	B-X
to	B-X
the	B-X
human	B-X
epimerase	B-X
identified	B-X
from	B-X
genomic	B-X
sequences	B-X
and	B-X
fits	B-X
with	B-X
the	B-X
general	B-X
size	B-X
and	B-X
structure	B-X
of	B-X
the	B-X
gene	B-X
from	B-X
Drosophila	B-X
melanogaster	B-X
and	B-X
Caenorhabditis	B-X
elegans	B-X
.	B-X
Full-length	B-X
epimerase	B-X
is	B-X
predicted	B-X
to	B-X
have	B-X
a	B-X
type	B-X
II	B-X
transmembrane	B-X
topology	B-X
with	B-X
a	B-X
17-amino	B-X
acid	B-X
transmembrane	B-X
domain	B-X
and	B-X
an	B-X
11-amino	B-X
acid	B-X
cytoplasmic	B-X
tail	B-X
.	B-X
An	B-X
assay	B-X
with	B-X
increased	B-X
sensitivity	B-X
was	B-X
devised	B-X
that	B-X
detects	B-X
enzyme	B-X
activity	B-X
in	B-X
extracts	B-X
prepared	B-X
from	B-X
cultured	B-X
cells	B-X
and	B-X
in	B-X
recombinant	B-X
proteins	B-X
.	B-X
Unlike	B-X
other	B-X
enzymes	B-X
involved	B-X
in	B-X
glycosaminoglycan	B-X
biosynthesis	B-X
,	B-X
the	B-X
addition	B-X
of	B-X
a	B-X
c-myc	B-X
tag	B-X
or	B-X
green	B-X
fluorescent	B-X
protein	B-X
to	B-X
the	B-X
highly	B-X
conserved	B-X
COOH-terminal	B-X
portion	B-X
of	B-X
the	B-X
protein	B-X
inhibits	B-X
its	B-X
activity	B-X
.	B-X
The	B-X
amino-terminally	B-X
truncated	B-X
epimerase	B-X
does	B-X
not	B-X
localize	B-X
to	B-X
any	B-X
cellular	B-X
compartment	B-X
,	B-X
whereas	B-X
the	B-X
full-length	B-X
enzyme	B-X
is	B-X
in	B-X
the	B-X
Golgi	B-X
,	B-X
where	B-X
heparan	B-X
sulfate	B-X
synthesis	B-X
is	B-X
thought	B-X
to	B-X
occur	B-X
.	B-X

While	O
studying	O
the	O
cellular	O
localization	O
and	O
activity	O
of	O
enzymes	O
involved	O
in	O
heparan	O
sulfate	O
biosynthesis	O
,	O
we	O
discovered	O
that	O
the	O
published	O
sequence	O
for	O
the	O
glucuronic	O
acid	O
C5	B-Gene_or_gene_product
-	I-Gene_or_gene_product
epimerase	I-Gene_or_gene_product
responsible	O
for	O
the	O
interconversion	O
of	O
d	O
-	O
glucuronic	O
acid	O
and	O
l	O
-	O
iduronic	O
acid	O
residues	O
encodes	O
a	O
truncated	O
protein	O
.	O
<EOS>	B-X
While	B-X
studying	B-X
the	B-X
cellular	B-X
localization	B-X
and	B-X
activity	B-X
of	B-X
enzymes	B-X
involved	B-X
in	B-X
heparan	B-X
sulfate	B-X
biosynthesis	B-X
,	B-X
we	B-X
discovered	B-X
that	B-X
the	B-X
published	B-X
sequence	B-X
for	B-X
the	B-X
glucuronic	B-X
acid	B-X
C5-epimerase	B-X
responsible	B-X
for	B-X
the	B-X
interconversion	B-X
of	B-X
d-glucuronic	B-X
acid	B-X
and	B-X
l-iduronic	B-X
acid	B-X
residues	B-X
encodes	B-X
a	B-X
truncated	B-X
protein	B-X
.	B-X
Genome	B-X
analysis	B-X
and	B-X
5'-rapid	B-X
amplification	B-X
of	B-X
cDNA	B-X
ends	B-X
was	B-X
used	B-X
to	B-X
clone	B-X
the	B-X
full-length	B-X
cDNA	B-X
from	B-X
a	B-X
mouse	B-X
mastocytoma	B-X
cell	B-X
line	B-X
.	B-X
The	B-X
extended	B-X
cDNA	B-X
encodes	B-X
for	B-X
an	B-X
additional	B-X
174	B-X
amino	B-X
acids	B-X
at	B-X
the	B-X
amino	B-X
terminus	B-X
of	B-X
the	B-X
protein	B-X
.	B-X
The	B-X
murine	B-X
sequence	B-X
is	B-X
95	B-X
%	B-X
identical	B-X
to	B-X
the	B-X
human	B-X
epimerase	B-X
identified	B-X
from	B-X
genomic	B-X
sequences	B-X
and	B-X
fits	B-X
with	B-X
the	B-X
general	B-X
size	B-X
and	B-X
structure	B-X
of	B-X
the	B-X
gene	B-X
from	B-X
Drosophila	B-X
melanogaster	B-X
and	B-X
Caenorhabditis	B-X
elegans	B-X
.	B-X
Full-length	B-X
epimerase	B-X
is	B-X
predicted	B-X
to	B-X
have	B-X
a	B-X
type	B-X
II	B-X
transmembrane	B-X
topology	B-X
with	B-X
a	B-X
17-amino	B-X
acid	B-X
transmembrane	B-X
domain	B-X
and	B-X
an	B-X
11-amino	B-X
acid	B-X
cytoplasmic	B-X
tail	B-X
.	B-X
An	B-X
assay	B-X
with	B-X
increased	B-X
sensitivity	B-X
was	B-X
devised	B-X
that	B-X
detects	B-X
enzyme	B-X
activity	B-X
in	B-X
extracts	B-X
prepared	B-X
from	B-X
cultured	B-X
cells	B-X
and	B-X
in	B-X
recombinant	B-X
proteins	B-X
.	B-X
Unlike	B-X
other	B-X
enzymes	B-X
involved	B-X
in	B-X
glycosaminoglycan	B-X
biosynthesis	B-X
,	B-X
the	B-X
addition	B-X
of	B-X
a	B-X
c-myc	B-X
tag	B-X
or	B-X
green	B-X
fluorescent	B-X
protein	B-X
to	B-X
the	B-X
highly	B-X
conserved	B-X
COOH-terminal	B-X
portion	B-X
of	B-X
the	B-X
protein	B-X
inhibits	B-X
its	B-X
activity	B-X
.	B-X
The	B-X
amino-terminally	B-X
truncated	B-X
epimerase	B-X
does	B-X
not	B-X
localize	B-X
to	B-X
any	B-X
cellular	B-X
compartment	B-X
,	B-X
whereas	B-X
the	B-X
full-length	B-X
enzyme	B-X
is	B-X
in	B-X
the	B-X
Golgi	B-X
,	B-X
where	B-X
heparan	B-X
sulfate	B-X
synthesis	B-X
is	B-X
thought	B-X
to	B-X
occur	B-X
.	B-X

Genome	O
analysis	O
and	O
5	O
'	O
-	O
rapid	O
amplification	O
of	O
cDNA	O
ends	O
was	O
used	O
to	O
clone	O
the	O
full	O
-	O
length	O
cDNA	O
from	O
a	O
mouse	O
mastocytoma	O
cell	O
line	O
.	O
<EOS>	B-X
While	B-X
studying	B-X
the	B-X
cellular	B-X
localization	B-X
and	B-X
activity	B-X
of	B-X
enzymes	B-X
involved	B-X
in	B-X
heparan	B-X
sulfate	B-X
biosynthesis	B-X
,	B-X
we	B-X
discovered	B-X
that	B-X
the	B-X
published	B-X
sequence	B-X
for	B-X
the	B-X
glucuronic	B-X
acid	B-X
C5-epimerase	B-X
responsible	B-X
for	B-X
the	B-X
interconversion	B-X
of	B-X
d-glucuronic	B-X
acid	B-X
and	B-X
l-iduronic	B-X
acid	B-X
residues	B-X
encodes	B-X
a	B-X
truncated	B-X
protein	B-X
.	B-X
Genome	B-X
analysis	B-X
and	B-X
5'-rapid	B-X
amplification	B-X
of	B-X
cDNA	B-X
ends	B-X
was	B-X
used	B-X
to	B-X
clone	B-X
the	B-X
full-length	B-X
cDNA	B-X
from	B-X
a	B-X
mouse	B-X
mastocytoma	B-X
cell	B-X
line	B-X
.	B-X
The	B-X
extended	B-X
cDNA	B-X
encodes	B-X
for	B-X
an	B-X
additional	B-X
174	B-X
amino	B-X
acids	B-X
at	B-X
the	B-X
amino	B-X
terminus	B-X
of	B-X
the	B-X
protein	B-X
.	B-X
The	B-X
murine	B-X
sequence	B-X
is	B-X
95	B-X
%	B-X
identical	B-X
to	B-X
the	B-X
human	B-X
epimerase	B-X
identified	B-X
from	B-X
genomic	B-X
sequences	B-X
and	B-X
fits	B-X
with	B-X
the	B-X
general	B-X
size	B-X
and	B-X
structure	B-X
of	B-X
the	B-X
gene	B-X
from	B-X
Drosophila	B-X
melanogaster	B-X
and	B-X
Caenorhabditis	B-X
elegans	B-X
.	B-X
Full-length	B-X
epimerase	B-X
is	B-X
predicted	B-X
to	B-X
have	B-X
a	B-X
type	B-X
II	B-X
transmembrane	B-X
topology	B-X
with	B-X
a	B-X
17-amino	B-X
acid	B-X
transmembrane	B-X
domain	B-X
and	B-X
an	B-X
11-amino	B-X
acid	B-X
cytoplasmic	B-X
tail	B-X
.	B-X
An	B-X
assay	B-X
with	B-X
increased	B-X
sensitivity	B-X
was	B-X
devised	B-X
that	B-X
detects	B-X
enzyme	B-X
activity	B-X
in	B-X
extracts	B-X
prepared	B-X
from	B-X
cultured	B-X
cells	B-X
and	B-X
in	B-X
recombinant	B-X
proteins	B-X
.	B-X
The	B-X
amino-terminally	B-X
truncated	B-X
epimerase	B-X
does	B-X
not	B-X
localize	B-X
to	B-X
any	B-X
cellular	B-X
compartment	B-X
,	B-X
whereas	B-X
the	B-X
full-length	B-X
enzyme	B-X
is	B-X
in	B-X
the	B-X
Golgi	B-X
,	B-X
where	B-X
heparan	B-X
sulfate	B-X
synthesis	B-X
is	B-X
thought	B-X
to	B-X
occur	B-X
.	B-X

The	O
extended	O
cDNA	O
encodes	O
for	O
an	O
additional	O
174	O
amino	O
acids	O
at	O
the	O
amino	O
terminus	O
of	O
the	O
protein	O
.	O
<EOS>	B-X
While	B-X
studying	B-X
the	B-X
cellular	B-X
localization	B-X
and	B-X
activity	B-X
of	B-X
enzymes	B-X
involved	B-X
in	B-X
heparan	B-X
sulfate	B-X
biosynthesis	B-X
,	B-X
we	B-X
discovered	B-X
that	B-X
the	B-X
published	B-X
sequence	B-X
for	B-X
the	B-X
glucuronic	B-X
acid	B-X
C5-epimerase	B-X
responsible	B-X
for	B-X
the	B-X
interconversion	B-X
of	B-X
d-glucuronic	B-X
acid	B-X
and	B-X
l-iduronic	B-X
acid	B-X
residues	B-X
encodes	B-X
a	B-X
truncated	B-X
protein	B-X
.	B-X
Genome	B-X
analysis	B-X
and	B-X
5'-rapid	B-X
amplification	B-X
of	B-X
cDNA	B-X
ends	B-X
was	B-X
used	B-X
to	B-X
clone	B-X
the	B-X
full-length	B-X
cDNA	B-X
from	B-X
a	B-X
mouse	B-X
mastocytoma	B-X
cell	B-X
line	B-X
.	B-X
The	B-X
extended	B-X
cDNA	B-X
encodes	B-X
for	B-X
an	B-X
additional	B-X
174	B-X
amino	B-X
acids	B-X
at	B-X
the	B-X
amino	B-X
terminus	B-X
of	B-X
the	B-X
protein	B-X
.	B-X
Full-length	B-X
epimerase	B-X
is	B-X
predicted	B-X
to	B-X
have	B-X
a	B-X
type	B-X
II	B-X
transmembrane	B-X
topology	B-X
with	B-X
a	B-X
17-amino	B-X
acid	B-X
transmembrane	B-X
domain	B-X
and	B-X
an	B-X
11-amino	B-X
acid	B-X
cytoplasmic	B-X
tail	B-X
.	B-X
An	B-X
assay	B-X
with	B-X
increased	B-X
sensitivity	B-X
was	B-X
devised	B-X
that	B-X
detects	B-X
enzyme	B-X
activity	B-X
in	B-X
extracts	B-X
prepared	B-X
from	B-X
cultured	B-X
cells	B-X
and	B-X
in	B-X
recombinant	B-X
proteins	B-X
.	B-X
Unlike	B-X
other	B-X
enzymes	B-X
involved	B-X
in	B-X
glycosaminoglycan	B-X
biosynthesis	B-X
,	B-X
the	B-X
addition	B-X
of	B-X
a	B-X
c-myc	B-X
tag	B-X
or	B-X
green	B-X
fluorescent	B-X
protein	B-X
to	B-X
the	B-X
highly	B-X
conserved	B-X
COOH-terminal	B-X
portion	B-X
of	B-X
the	B-X
protein	B-X
inhibits	B-X
its	B-X
activity	B-X
.	B-X
The	B-X
amino-terminally	B-X
truncated	B-X
epimerase	B-X
does	B-X
not	B-X
localize	B-X
to	B-X
any	B-X
cellular	B-X
compartment	B-X
,	B-X
whereas	B-X
the	B-X
full-length	B-X
enzyme	B-X
is	B-X
in	B-X
the	B-X
Golgi	B-X
,	B-X
where	B-X
heparan	B-X
sulfate	B-X
synthesis	B-X
is	B-X
thought	B-X
to	B-X
occur	B-X
.	B-X

The	O
murine	O
sequence	O
is	O
95	O
%	O
identical	O
to	O
the	O
human	O
epimerase	B-Gene_or_gene_product
identified	O
from	O
genomic	O
sequences	O
and	O
fits	O
with	O
the	O
general	O
size	O
and	O
structure	O
of	O
the	O
gene	O
from	O
Drosophila	O
melanogaster	O
and	O
Caenorhabditis	O
elegans	O
.	O

Full	O
-	O
length	O
epimerase	B-Gene_or_gene_product
is	O
predicted	O
to	O
have	O
a	O
type	O
II	O
transmembrane	O
topology	O
with	O
a	O
17	O
-	O
amino	O
acid	O
transmembrane	O
domain	O
and	O
an	O
11	O
-	O
amino	O
acid	O
cytoplasmic	O
tail	O
.	O

An	O
assay	O
with	O
increased	O
sensitivity	O
was	O
devised	O
that	O
detects	O
enzyme	O
activity	O
in	O
extracts	O
prepared	O
from	O
cultured	O
cells	O
and	O
in	O
recombinant	O
proteins	O
.	O
<EOS>	B-X
While	B-X
studying	B-X
the	B-X
cellular	B-X
localization	B-X
and	B-X
activity	B-X
of	B-X
enzymes	B-X
involved	B-X
in	B-X
heparan	B-X
sulfate	B-X
biosynthesis	B-X
,	B-X
we	B-X
discovered	B-X
that	B-X
the	B-X
published	B-X
sequence	B-X
for	B-X
the	B-X
glucuronic	B-X
acid	B-X
C5-epimerase	B-X
responsible	B-X
for	B-X
the	B-X
interconversion	B-X
of	B-X
d-glucuronic	B-X
acid	B-X
and	B-X
l-iduronic	B-X
acid	B-X
residues	B-X
encodes	B-X
a	B-X
truncated	B-X
protein	B-X
.	B-X
An	B-X
assay	B-X
with	B-X
increased	B-X
sensitivity	B-X
was	B-X
devised	B-X
that	B-X
detects	B-X
enzyme	B-X
activity	B-X
in	B-X
extracts	B-X
prepared	B-X
from	B-X
cultured	B-X
cells	B-X
and	B-X
in	B-X
recombinant	B-X
proteins	B-X
.	B-X
Unlike	B-X
other	B-X
enzymes	B-X
involved	B-X
in	B-X
glycosaminoglycan	B-X
biosynthesis	B-X
,	B-X
the	B-X
addition	B-X
of	B-X
a	B-X
c-myc	B-X
tag	B-X
or	B-X
green	B-X
fluorescent	B-X
protein	B-X
to	B-X
the	B-X
highly	B-X
conserved	B-X
COOH-terminal	B-X
portion	B-X
of	B-X
the	B-X
protein	B-X
inhibits	B-X
its	B-X
activity	B-X
.	B-X
The	B-X
amino-terminally	B-X
truncated	B-X
epimerase	B-X
does	B-X
not	B-X
localize	B-X
to	B-X
any	B-X
cellular	B-X
compartment	B-X
,	B-X
whereas	B-X
the	B-X
full-length	B-X
enzyme	B-X
is	B-X
in	B-X
the	B-X
Golgi	B-X
,	B-X
where	B-X
heparan	B-X
sulfate	B-X
synthesis	B-X
is	B-X
thought	B-X
to	B-X
occur	B-X
.	B-X

Unlike	O
other	O
enzymes	O
involved	O
in	O
glycosaminoglycan	O
biosynthesis	O
,	O
the	O
addition	O
of	O
a	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
myc	I-Gene_or_gene_product
tag	O
or	O
green	B-Gene_or_gene_product
fluorescent	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
to	O
the	O
highly	O
conserved	O
COOH	O
-	O
terminal	O
portion	O
of	O
the	O
protein	O
inhibits	O
its	O
activity	O
.	O

The	O
amino	O
-	O
terminally	O
truncated	O
epimerase	B-Gene_or_gene_product
does	O
not	O
localize	O
to	O
any	O
cellular	O
compartment	O
,	O
whereas	O
the	O
full	O
-	O
length	O
enzyme	O
is	O
in	O
the	O
Golgi	O
,	O
where	O
heparan	O
sulfate	O
synthesis	O
is	O
thought	O
to	O
occur	O
.	O
<EOS>	B-X
An	B-X
important	B-X
part	B-X
of	B-X
the	B-X
biosynthesis	B-X
of	B-X
proteoglycans	B-X
is	B-X
the	B-X
epimerization	B-X
of	B-X
glycosaminoglycan	B-X
chains	B-X
.	B-X
As	B-X
a	B-X
consequence	B-X
of	B-X
the	B-X
conversion	B-X
of	B-X
chondroitin	B-X
sulfate	B-X
(	B-X
CS	B-X
)	B-X
to	B-X
dermatan	B-X
sulfate	B-X
(	B-X
DS	B-X
)	B-X
,	B-X
the	B-X
glycosaminoglycans	B-X
become	B-X
more	B-X
flexible	B-X
and	B-X
enable	B-X
DS	B-X
to	B-X
perform	B-X
more	B-X
sophisticated	B-X
signaling	B-X
functions	B-X
.	B-X
In	B-X
a	B-X
recent	B-X
study	B-X
,	B-X
we	B-X
generated	B-X
a	B-X
chimera	B-X
(	B-X
S222A	B-X
)	B-X
composed	B-X
of	B-X
a	B-X
truncated	B-X
form	B-X
of	B-X
a	B-X
DS	B-X
(	B-X
decorin	B-X
)	B-X
and	B-X
CS	B-X
(	B-X
CSF-1	B-X
)	B-X
containing	B-X
proteoglycan	B-X
and	B-X
analyzed	B-X
the	B-X
influence	B-X
of	B-X
the	B-X
core	B-X
protein	B-X
on	B-X
the	B-X
extent	B-X
of	B-X
epimerization	B-X
.	B-X
C-terminal	B-X
truncation	B-X
constructs	B-X
from	B-X
S222A	B-X
enabled	B-X
us	B-X
to	B-X
identify	B-X
an	B-X
amino	B-X
acid	B-X
segment	B-X
that	B-X
lies	B-X
within	B-X
the	B-X
CSF-1	B-X
part	B-X
which	B-X
prevents	B-X
DS	B-X
synthesis	B-X
.	B-X
Co-localization	B-X
experiments	B-X
using	B-X
S222A-HA	B-X
and	B-X
DCN-Flag	B-X
showed	B-X
different	B-X
intracellular	B-X
localizations	B-X
for	B-X
the	B-X
proteoglycans	B-X
during	B-X
biosynthesis	B-X
.	B-X
Co-localization	B-X
with	B-X
an	B-X
ER-marker	B-X
demonstrated	B-X
that	B-X
the	B-X
biosynthesis	B-X
of	B-X
recombinant	B-X
decorin	B-X
is	B-X
similar	B-X
to	B-X
the	B-X
chimera	B-X
S222A	B-X
and	B-X
S222A	B-X
(	B-X
W216L	B-X
)	B-X
in	B-X
HEK293	B-X
cells	B-X
.	B-X
Co-staining	B-X
of	B-X
S222A-HA	B-X
and	B-X
S222A	B-X
(	B-X
W216L	B-X
)	B-X
-Flag	B-X
showed	B-X
different	B-X
intracellular	B-X
localizations	B-X
for	B-X
the	B-X
proteoglycans	B-X
.	B-X
A	B-X
more	B-X
detailed	B-X
analysis	B-X
of	B-X
the	B-X
glycosaminoglycans	B-X
reflects	B-X
a	B-X
similar	B-X
total	B-X
sulfate	B-X
content	B-X
for	B-X
S222A	B-X
and	B-X
S222A	B-X
(	B-X
W216L	B-X
)	B-X
.	B-X
These	B-X
results	B-X
are	B-X
consistent	B-X
with	B-X
the	B-X
model	B-X
in	B-X
which	B-X
the	B-X
core	B-X
protein	B-X
,	B-X
via	B-X
the	B-X
amino	B-X
acid	B-X
tryptophan	B-X
,	B-X
is	B-X
responsible	B-X
for	B-X
routing	B-X
to	B-X
subcellular	B-X
compartments	B-X
with	B-X
or	B-X
without	B-X
sufficient	B-X
access	B-X
to	B-X
chondroitin-glucuronate	B-X
5-epimerase	B-X
.	B-X

Human	O
immunodeficiency	O
virus	O
type	O
1	O
Tat	B-Gene_or_gene_product
protein	O
decreases	O
cyclic	O
AMP	O
synthesis	O
in	O
rat	O
microglia	O
cultures	O
.	O
<EOS>	B-X
We	B-X
have	B-X
studied	B-X
the	B-X
modulation	B-X
of	B-X
cyclic	B-X
AMP	B-X
(	B-X
cAMP	B-X
)	B-X
accumulation	B-X
by	B-X
the	B-X
human	B-X
immunodeficiency	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HIV	B-X
1	B-X
)	B-X
protein	B-X
Tat	B-X
in	B-X
microglia	B-X
and	B-X
astrocyte	B-X
cultures	B-X
obtained	B-X
from	B-X
neonatal	B-X
rat	B-X
brain	B-X
.	B-X
Pretreatment	B-X
of	B-X
microglia	B-X
with	B-X
recombinant	B-X
Tat	B-X
resulted	B-X
in	B-X
a	B-X
dose-	B-X
and	B-X
time-dependent	B-X
decrease	B-X
of	B-X
cAMP	B-X
accumulation	B-X
induced	B-X
by	B-X
subsequent	B-X
exposure	B-X
to	B-X
isoproterenol	B-X
(	B-X
1	B-X
microM	B-X
)	B-X
.	B-X
The	B-X
inhibitory	B-X
action	B-X
of	B-X
100	B-X
ng/mL	B-X
Tat	B-X
approached	B-X
50	B-X
%	B-X
after	B-X
4	B-X
h	B-X
of	B-X
preincubation	B-X
and	B-X
reached	B-X
a	B-X
maximum	B-X
of	B-X
70	B-X
%	B-X
after	B-X
24	B-X
h.	B-X
The	B-X
Tat-induced	B-X
time-	B-X
and	B-X
dose-dependent	B-X
decrease	B-X
of	B-X
cAMP	B-X
accumulation	B-X
was	B-X
observed	B-X
also	B-X
when	B-X
microglial	B-X
cultures	B-X
were	B-X
stimulated	B-X
with	B-X
the	B-X
adenylyl	B-X
cyclase	B-X
activator	B-X
forskolin	B-X
(	B-X
100	B-X
microM	B-X
)	B-X
.	B-X
In	B-X
both	B-X
cases	B-X
,	B-X
Tat	B-X
inhibitory	B-X
action	B-X
was	B-X
70	B-X
%	B-X
reverted	B-X
by	B-X
a	B-X
specific	B-X
monoclonal	B-X
anti-Tat	B-X
antibody	B-X
,	B-X
but	B-X
was	B-X
not	B-X
prevented	B-X
either	B-X
by	B-X
the	B-X
phosphodiesterase	B-X
inhibitor	B-X
3-isobutyl-1-methyl-xantine	B-X
(	B-X
100	B-X
microM	B-X
)	B-X
or	B-X
by	B-X
a	B-X
16-h	B-X
pretreatment	B-X
of	B-X
microglial	B-X
cultures	B-X
with	B-X
the	B-X
Gi	B-X
protein	B-X
inhibitor	B-X
pertussis	B-X
toxin	B-X
(	B-X
10	B-X
ng/mL	B-X
)	B-X
.	B-X
All	B-X
these	B-X
results	B-X
suggested	B-X
that	B-X
the	B-X
viral	B-X
protein	B-X
acts	B-X
at	B-X
a	B-X
step	B-X
of	B-X
the	B-X
cAMP	B-X
transduction	B-X
pathway	B-X
other	B-X
than	B-X
receptors	B-X
,	B-X
G	B-X
proteins	B-X
and	B-X
phosphodiesterases	B-X
.	B-X
The	B-X
target	B-X
of	B-X
Tat	B-X
appeared	B-X
to	B-X
be	B-X
adenylyl	B-X
cyclase	B-X
,	B-X
whose	B-X
activity	B-X
was	B-X
markedly	B-X
reduced	B-X
(	B-X
up	B-X
to	B-X
60	B-X
%	B-X
)	B-X
in	B-X
membranes	B-X
prepared	B-X
from	B-X
Tat-treated	B-X
microglial	B-X
cells	B-X
,	B-X
both	B-X
in	B-X
basal	B-X
conditions	B-X
and	B-X
after	B-X
stimulation	B-X
with	B-X
isoproterenol	B-X
and	B-X
forskolin	B-X
.	B-X
The	B-X
inability	B-X
of	B-X
the	B-X
competitive	B-X
inhibitor	B-X
of	B-X
nitric	B-X
oxide	B-X
synthase	B-X
N	B-X
(	B-X
G	B-X
)	B-X
-monometyl-	B-X
L-arginine	B-X
(	B-X
20	B-X
and	B-X
200	B-X
microM	B-X
)	B-X
to	B-X
revert	B-X
Tat	B-X
action	B-X
on	B-X
forskolin-induced	B-X
cAMP	B-X
accumulation	B-X
,	B-X
and	B-X
of	B-X
two	B-X
potent	B-X
nitric	B-X
oxide	B-X
donors	B-X
,	B-X
PAPA	B-X
and	B-X
DETA	B-X
(	B-X
0.1-2	B-X
m	B-X
M	B-X
)	B-X
,	B-X
to	B-X
alter	B-X
forskolin-induced	B-X
cAMP	B-X
accumulation	B-X
,	B-X
excluded	B-X
an	B-X
involvement	B-X
of	B-X
nitric	B-X
oxide	B-X
in	B-X
Tat-induced	B-X
adenylyl	B-X
cyclase	B-X
inhibition	B-X
.	B-X
On	B-X
the	B-X
contrary	B-X
,	B-X
two	B-X
inhibitors	B-X
of	B-X
nuclear	B-X
factor	B-X
kappaB	B-X
activation	B-X
,	B-X
N-tosyl-	B-X
(	B-X
L	B-X
)	B-X
-phenylalanine	B-X
chloromethyl	B-X
ketone	B-X
(	B-X
10	B-X
microM	B-X
)	B-X
and	B-X
SN50	B-X
(	B-X
25	B-X
microM	B-X
)	B-X
,	B-X
markedly	B-X
prevented	B-X
the	B-X
reduction	B-X
of	B-X
forskolin-evoked	B-X
cAMP	B-X
accumulation	B-X
by	B-X
Tat	B-X
,	B-X
suggesting	B-X
a	B-X
possible	B-X
role	B-X
for	B-X
this	B-X
nuclear	B-X
transcriptional	B-X
factor	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
by	B-X
Tat	B-X
in	B-X
microglia	B-X
.	B-X
This	B-X
assumption	B-X
was	B-X
strengthened	B-X
by	B-X
the	B-X
ability	B-X
of	B-X
lipopolysaccharide	B-X
(	B-X
100	B-X
ng/mL	B-X
,	B-X
4	B-X
h	B-X
)	B-X
to	B-X
mimic	B-X
the	B-X
inhibitory	B-X
effect	B-X
of	B-X
the	B-X
viral	B-X
protein	B-X
.	B-X
Conversely	B-X
,	B-X
astrocyte	B-X
cAMP	B-X
accumulation	B-X
was	B-X
unaffected	B-X
by	B-X
the	B-X
viral	B-X
protein	B-X
,	B-X
as	B-X
tested	B-X
at	B-X
various	B-X
concentrations	B-X
and	B-X
time	B-X
points	B-X
.	B-X
Finally	B-X
,	B-X
Tat	B-X
inhibition	B-X
of	B-X
microglial	B-X
adenylyl	B-X
cyclase	B-X
was	B-X
not	B-X
due	B-X
to	B-X
non-specific	B-X
cytotoxicity	B-X
.	B-X
As	B-X
cAMP	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
exert	B-X
a	B-X
neuroprotective	B-X
role	B-X
in	B-X
several	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
models	B-X
of	B-X
brain	B-X
pathologies	B-X
,	B-X
and	B-X
microglia	B-X
is	B-X
believed	B-X
to	B-X
mediate	B-X
Tat-induced	B-X
neurotoxicity	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
Tat	B-X
to	B-X
inhibit	B-X
cAMP	B-X
synthesis	B-X
in	B-X
microglia	B-X
may	B-X
contribute	B-X
to	B-X
neuronal	B-X
degeneration	B-X
and	B-X
cell	B-X
death	B-X
associated	B-X
with	B-X
HIV	B-X
infection	B-X
.	B-X

We	O
have	O
studied	O
the	O
modulation	O
of	O
cyclic	O
AMP	O
(	O
cAMP	O
)	O
accumulation	O
by	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV	O
1	O
)	O
protein	O
Tat	B-Gene_or_gene_product
in	O
microglia	O
and	O
astrocyte	O
cultures	O
obtained	O
from	O
neonatal	O
rat	O
brain	O
.	O
<EOS>	B-X
We	B-X
have	B-X
studied	B-X
the	B-X
modulation	B-X
of	B-X
cyclic	B-X
AMP	B-X
(	B-X
cAMP	B-X
)	B-X
accumulation	B-X
by	B-X
the	B-X
human	B-X
immunodeficiency	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HIV	B-X
1	B-X
)	B-X
protein	B-X
Tat	B-X
in	B-X
microglia	B-X
and	B-X
astrocyte	B-X
cultures	B-X
obtained	B-X
from	B-X
neonatal	B-X
rat	B-X
brain	B-X
.	B-X
Pretreatment	B-X
of	B-X
microglia	B-X
with	B-X
recombinant	B-X
Tat	B-X
resulted	B-X
in	B-X
a	B-X
dose-	B-X
and	B-X
time-dependent	B-X
decrease	B-X
of	B-X
cAMP	B-X
accumulation	B-X
induced	B-X
by	B-X
subsequent	B-X
exposure	B-X
to	B-X
isoproterenol	B-X
(	B-X
1	B-X
microM	B-X
)	B-X
.	B-X
The	B-X
inhibitory	B-X
action	B-X
of	B-X
100	B-X
ng/mL	B-X
Tat	B-X
approached	B-X
50	B-X
%	B-X
after	B-X
4	B-X
h	B-X
of	B-X
preincubation	B-X
and	B-X
reached	B-X
a	B-X
maximum	B-X
of	B-X
70	B-X
%	B-X
after	B-X
24	B-X
h.	B-X
The	B-X
Tat-induced	B-X
time-	B-X
and	B-X
dose-dependent	B-X
decrease	B-X
of	B-X
cAMP	B-X
accumulation	B-X
was	B-X
observed	B-X
also	B-X
when	B-X
microglial	B-X
cultures	B-X
were	B-X
stimulated	B-X
with	B-X
the	B-X
adenylyl	B-X
cyclase	B-X
activator	B-X
forskolin	B-X
(	B-X
100	B-X
microM	B-X
)	B-X
.	B-X
In	B-X
both	B-X
cases	B-X
,	B-X
Tat	B-X
inhibitory	B-X
action	B-X
was	B-X
70	B-X
%	B-X
reverted	B-X
by	B-X
a	B-X
specific	B-X
monoclonal	B-X
anti-Tat	B-X
antibody	B-X
,	B-X
but	B-X
was	B-X
not	B-X
prevented	B-X
either	B-X
by	B-X
the	B-X
phosphodiesterase	B-X
inhibitor	B-X
3-isobutyl-1-methyl-xantine	B-X
(	B-X
100	B-X
microM	B-X
)	B-X
or	B-X
by	B-X
a	B-X
16-h	B-X
pretreatment	B-X
of	B-X
microglial	B-X
cultures	B-X
with	B-X
the	B-X
Gi	B-X
protein	B-X
inhibitor	B-X
pertussis	B-X
toxin	B-X
(	B-X
10	B-X
ng/mL	B-X
)	B-X
.	B-X
All	B-X
these	B-X
results	B-X
suggested	B-X
that	B-X
the	B-X
viral	B-X
protein	B-X
acts	B-X
at	B-X
a	B-X
step	B-X
of	B-X
the	B-X
cAMP	B-X
transduction	B-X
pathway	B-X
other	B-X
than	B-X
receptors	B-X
,	B-X
G	B-X
proteins	B-X
and	B-X
phosphodiesterases	B-X
.	B-X
The	B-X
target	B-X
of	B-X
Tat	B-X
appeared	B-X
to	B-X
be	B-X
adenylyl	B-X
cyclase	B-X
,	B-X
whose	B-X
activity	B-X
was	B-X
markedly	B-X
reduced	B-X
(	B-X
up	B-X
to	B-X
60	B-X
%	B-X
)	B-X
in	B-X
membranes	B-X
prepared	B-X
from	B-X
Tat-treated	B-X
microglial	B-X
cells	B-X
,	B-X
both	B-X
in	B-X
basal	B-X
conditions	B-X
and	B-X
after	B-X
stimulation	B-X
with	B-X
isoproterenol	B-X
and	B-X
forskolin	B-X
.	B-X
The	B-X
inability	B-X
of	B-X
the	B-X
competitive	B-X
inhibitor	B-X
of	B-X
nitric	B-X
oxide	B-X
synthase	B-X
N	B-X
(	B-X
G	B-X
)	B-X
-monometyl-	B-X
L-arginine	B-X
(	B-X
20	B-X
and	B-X
200	B-X
microM	B-X
)	B-X
to	B-X
revert	B-X
Tat	B-X
action	B-X
on	B-X
forskolin-induced	B-X
cAMP	B-X
accumulation	B-X
,	B-X
and	B-X
of	B-X
two	B-X
potent	B-X
nitric	B-X
oxide	B-X
donors	B-X
,	B-X
PAPA	B-X
and	B-X
DETA	B-X
(	B-X
0.1-2	B-X
m	B-X
M	B-X
)	B-X
,	B-X
to	B-X
alter	B-X
forskolin-induced	B-X
cAMP	B-X
accumulation	B-X
,	B-X
excluded	B-X
an	B-X
involvement	B-X
of	B-X
nitric	B-X
oxide	B-X
in	B-X
Tat-induced	B-X
adenylyl	B-X
cyclase	B-X
inhibition	B-X
.	B-X
On	B-X
the	B-X
contrary	B-X
,	B-X
two	B-X
inhibitors	B-X
of	B-X
nuclear	B-X
factor	B-X
kappaB	B-X
activation	B-X
,	B-X
N-tosyl-	B-X
(	B-X
L	B-X
)	B-X
-phenylalanine	B-X
chloromethyl	B-X
ketone	B-X
(	B-X
10	B-X
microM	B-X
)	B-X
and	B-X
SN50	B-X
(	B-X
25	B-X
microM	B-X
)	B-X
,	B-X
markedly	B-X
prevented	B-X
the	B-X
reduction	B-X
of	B-X
forskolin-evoked	B-X
cAMP	B-X
accumulation	B-X
by	B-X
Tat	B-X
,	B-X
suggesting	B-X
a	B-X
possible	B-X
role	B-X
for	B-X
this	B-X
nuclear	B-X
transcriptional	B-X
factor	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
by	B-X
Tat	B-X
in	B-X
microglia	B-X
.	B-X
This	B-X
assumption	B-X
was	B-X
strengthened	B-X
by	B-X
the	B-X
ability	B-X
of	B-X
lipopolysaccharide	B-X
(	B-X
100	B-X
ng/mL	B-X
,	B-X
4	B-X
h	B-X
)	B-X
to	B-X
mimic	B-X
the	B-X
inhibitory	B-X
effect	B-X
of	B-X
the	B-X
viral	B-X
protein	B-X
.	B-X
Conversely	B-X
,	B-X
astrocyte	B-X
cAMP	B-X
accumulation	B-X
was	B-X
unaffected	B-X
by	B-X
the	B-X
viral	B-X
protein	B-X
,	B-X
as	B-X
tested	B-X
at	B-X
various	B-X
concentrations	B-X
and	B-X
time	B-X
points	B-X
.	B-X
Finally	B-X
,	B-X
Tat	B-X
inhibition	B-X
of	B-X
microglial	B-X
adenylyl	B-X
cyclase	B-X
was	B-X
not	B-X
due	B-X
to	B-X
non-specific	B-X
cytotoxicity	B-X
.	B-X
As	B-X
cAMP	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
exert	B-X
a	B-X
neuroprotective	B-X
role	B-X
in	B-X
several	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
models	B-X
of	B-X
brain	B-X
pathologies	B-X
,	B-X
and	B-X
microglia	B-X
is	B-X
believed	B-X
to	B-X
mediate	B-X
Tat-induced	B-X
neurotoxicity	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
Tat	B-X
to	B-X
inhibit	B-X
cAMP	B-X
synthesis	B-X
in	B-X
microglia	B-X
may	B-X
contribute	B-X
to	B-X
neuronal	B-X
degeneration	B-X
and	B-X
cell	B-X
death	B-X
associated	B-X
with	B-X
HIV	B-X
infection	B-X
.	B-X

Pretreatment	O
of	O
microglia	O
with	O
recombinant	O
Tat	B-Gene_or_gene_product
resulted	O
in	O
a	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
decrease	O
of	O
cAMP	O
accumulation	O
induced	O
by	O
subsequent	O
exposure	O
to	O
isoproterenol	O
(	O
1	O
microM	O
)	O
.	O

The	O
inhibitory	O
action	O
of	O
100	O
ng	O
/	O
mL	O
Tat	B-Gene_or_gene_product
approached	O
50	O
%	O
after	O
4	O
h	O
of	O
preincubation	O
and	O
reached	O
a	O
maximum	O
of	O
70	O
%	O
after	O
24	O
h	O
.	O

The	O
Tat	B-Gene_or_gene_product
-	O
induced	O
time	O
-	O
and	O
dose	O
-	O
dependent	O
decrease	O
of	O
cAMP	O
accumulation	O
was	O
observed	O
also	O
when	O
microglial	O
cultures	O
were	O
stimulated	O
with	O
the	O
adenylyl	B-Gene_or_gene_product
cyclase	I-Gene_or_gene_product
activator	O
forskolin	O
(	O
100	O
microM	O
)	O
.	O
<EOS>	B-X
We	B-X
have	B-X
studied	B-X
the	B-X
modulation	B-X
of	B-X
cyclic	B-X
AMP	B-X
(	B-X
cAMP	B-X
)	B-X
accumulation	B-X
by	B-X
the	B-X
human	B-X
immunodeficiency	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HIV	B-X
1	B-X
)	B-X
protein	B-X
Tat	B-X
in	B-X
microglia	B-X
and	B-X
astrocyte	B-X
cultures	B-X
obtained	B-X
from	B-X
neonatal	B-X
rat	B-X
brain	B-X
.	B-X
Pretreatment	B-X
of	B-X
microglia	B-X
with	B-X
recombinant	B-X
Tat	B-X
resulted	B-X
in	B-X
a	B-X
dose-	B-X
and	B-X
time-dependent	B-X
decrease	B-X
of	B-X
cAMP	B-X
accumulation	B-X
induced	B-X
by	B-X
subsequent	B-X
exposure	B-X
to	B-X
isoproterenol	B-X
(	B-X
1	B-X
microM	B-X
)	B-X
.	B-X
The	B-X
inhibitory	B-X
action	B-X
of	B-X
100	B-X
ng/mL	B-X
Tat	B-X
approached	B-X
50	B-X
%	B-X
after	B-X
4	B-X
h	B-X
of	B-X
preincubation	B-X
and	B-X
reached	B-X
a	B-X
maximum	B-X
of	B-X
70	B-X
%	B-X
after	B-X
24	B-X
h.	B-X
The	B-X
Tat-induced	B-X
time-	B-X
and	B-X
dose-dependent	B-X
decrease	B-X
of	B-X
cAMP	B-X
accumulation	B-X
was	B-X
observed	B-X
also	B-X
when	B-X
microglial	B-X
cultures	B-X
were	B-X
stimulated	B-X
with	B-X
the	B-X
adenylyl	B-X
cyclase	B-X
activator	B-X
forskolin	B-X
(	B-X
100	B-X
microM	B-X
)	B-X
.	B-X
In	B-X
both	B-X
cases	B-X
,	B-X
Tat	B-X
inhibitory	B-X
action	B-X
was	B-X
70	B-X
%	B-X
reverted	B-X
by	B-X
a	B-X
specific	B-X
monoclonal	B-X
anti-Tat	B-X
antibody	B-X
,	B-X
but	B-X
was	B-X
not	B-X
prevented	B-X
either	B-X
by	B-X
the	B-X
phosphodiesterase	B-X
inhibitor	B-X
3-isobutyl-1-methyl-xantine	B-X
(	B-X
100	B-X
microM	B-X
)	B-X
or	B-X
by	B-X
a	B-X
16-h	B-X
pretreatment	B-X
of	B-X
microglial	B-X
cultures	B-X
with	B-X
the	B-X
Gi	B-X
protein	B-X
inhibitor	B-X
pertussis	B-X
toxin	B-X
(	B-X
10	B-X
ng/mL	B-X
)	B-X
.	B-X
All	B-X
these	B-X
results	B-X
suggested	B-X
that	B-X
the	B-X
viral	B-X
protein	B-X
acts	B-X
at	B-X
a	B-X
step	B-X
of	B-X
the	B-X
cAMP	B-X
transduction	B-X
pathway	B-X
other	B-X
than	B-X
receptors	B-X
,	B-X
G	B-X
proteins	B-X
and	B-X
phosphodiesterases	B-X
.	B-X
The	B-X
target	B-X
of	B-X
Tat	B-X
appeared	B-X
to	B-X
be	B-X
adenylyl	B-X
cyclase	B-X
,	B-X
whose	B-X
activity	B-X
was	B-X
markedly	B-X
reduced	B-X
(	B-X
up	B-X
to	B-X
60	B-X
%	B-X
)	B-X
in	B-X
membranes	B-X
prepared	B-X
from	B-X
Tat-treated	B-X
microglial	B-X
cells	B-X
,	B-X
both	B-X
in	B-X
basal	B-X
conditions	B-X
and	B-X
after	B-X
stimulation	B-X
with	B-X
isoproterenol	B-X
and	B-X
forskolin	B-X
.	B-X
The	B-X
inability	B-X
of	B-X
the	B-X
competitive	B-X
inhibitor	B-X
of	B-X
nitric	B-X
oxide	B-X
synthase	B-X
N	B-X
(	B-X
G	B-X
)	B-X
-monometyl-	B-X
L-arginine	B-X
(	B-X
20	B-X
and	B-X
200	B-X
microM	B-X
)	B-X
to	B-X
revert	B-X
Tat	B-X
action	B-X
on	B-X
forskolin-induced	B-X
cAMP	B-X
accumulation	B-X
,	B-X
and	B-X
of	B-X
two	B-X
potent	B-X
nitric	B-X
oxide	B-X
donors	B-X
,	B-X
PAPA	B-X
and	B-X
DETA	B-X
(	B-X
0.1-2	B-X
m	B-X
M	B-X
)	B-X
,	B-X
to	B-X
alter	B-X
forskolin-induced	B-X
cAMP	B-X
accumulation	B-X
,	B-X
excluded	B-X
an	B-X
involvement	B-X
of	B-X
nitric	B-X
oxide	B-X
in	B-X
Tat-induced	B-X
adenylyl	B-X
cyclase	B-X
inhibition	B-X
.	B-X
On	B-X
the	B-X
contrary	B-X
,	B-X
two	B-X
inhibitors	B-X
of	B-X
nuclear	B-X
factor	B-X
kappaB	B-X
activation	B-X
,	B-X
N-tosyl-	B-X
(	B-X
L	B-X
)	B-X
-phenylalanine	B-X
chloromethyl	B-X
ketone	B-X
(	B-X
10	B-X
microM	B-X
)	B-X
and	B-X
SN50	B-X
(	B-X
25	B-X
microM	B-X
)	B-X
,	B-X
markedly	B-X
prevented	B-X
the	B-X
reduction	B-X
of	B-X
forskolin-evoked	B-X
cAMP	B-X
accumulation	B-X
by	B-X
Tat	B-X
,	B-X
suggesting	B-X
a	B-X
possible	B-X
role	B-X
for	B-X
this	B-X
nuclear	B-X
transcriptional	B-X
factor	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
by	B-X
Tat	B-X
in	B-X
microglia	B-X
.	B-X
This	B-X
assumption	B-X
was	B-X
strengthened	B-X
by	B-X
the	B-X
ability	B-X
of	B-X
lipopolysaccharide	B-X
(	B-X
100	B-X
ng/mL	B-X
,	B-X
4	B-X
h	B-X
)	B-X
to	B-X
mimic	B-X
the	B-X
inhibitory	B-X
effect	B-X
of	B-X
the	B-X
viral	B-X
protein	B-X
.	B-X
Conversely	B-X
,	B-X
astrocyte	B-X
cAMP	B-X
accumulation	B-X
was	B-X
unaffected	B-X
by	B-X
the	B-X
viral	B-X
protein	B-X
,	B-X
as	B-X
tested	B-X
at	B-X
various	B-X
concentrations	B-X
and	B-X
time	B-X
points	B-X
.	B-X
Finally	B-X
,	B-X
Tat	B-X
inhibition	B-X
of	B-X
microglial	B-X
adenylyl	B-X
cyclase	B-X
was	B-X
not	B-X
due	B-X
to	B-X
non-specific	B-X
cytotoxicity	B-X
.	B-X
As	B-X
cAMP	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
exert	B-X
a	B-X
neuroprotective	B-X
role	B-X
in	B-X
several	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
models	B-X
of	B-X
brain	B-X
pathologies	B-X
,	B-X
and	B-X
microglia	B-X
is	B-X
believed	B-X
to	B-X
mediate	B-X
Tat-induced	B-X
neurotoxicity	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
Tat	B-X
to	B-X
inhibit	B-X
cAMP	B-X
synthesis	B-X
in	B-X
microglia	B-X
may	B-X
contribute	B-X
to	B-X
neuronal	B-X
degeneration	B-X
and	B-X
cell	B-X
death	B-X
associated	B-X
with	B-X
HIV	B-X
infection	B-X
.	B-X

In	O
both	O
cases	O
,	O
Tat	B-Gene_or_gene_product
inhibitory	O
action	O
was	O
70	O
%	O
reverted	O
by	O
a	O
specific	O
monoclonal	O
anti	O
-	O
Tat	B-Gene_or_gene_product
antibody	O
,	O
but	O
was	O
not	O
prevented	O
either	O
by	O
the	O
phosphodiesterase	B-Gene_or_gene_product
inhibitor	O
3	O
-	O
isobutyl	O
-	O
1	O
-	O
methyl	O
-	O
xantine	O
(	O
100	O
microM	O
)	O
or	O
by	O
a	O
16	O
-	O
h	O
pretreatment	O
of	O
microglial	O
cultures	O
with	O
the	O
Gi	B-Gene_or_gene_product
protein	O
inhibitor	O
pertussis	O
toxin	O
(	O
10	O
ng	O
/	O
mL	O
)	O
.	O

All	O
these	O
results	O
suggested	O
that	O
the	O
viral	O
protein	O
acts	O
at	O
a	O
step	O
of	O
the	O
cAMP	O
transduction	O
pathway	O
other	O
than	O
receptors	O
,	O
G	O
proteins	O
and	O
phosphodiesterases	O
.	O

The	O
target	O
of	O
Tat	B-Gene_or_gene_product
appeared	O
to	O
be	O
adenylyl	B-Gene_or_gene_product
cyclase	I-Gene_or_gene_product
,	O
whose	O
activity	O
was	O
markedly	O
reduced	O
(	O
up	O
to	O
60	O
%	O
)	O
in	O
membranes	O
prepared	O
from	O
Tat	B-Gene_or_gene_product
-	O
treated	O
microglial	O
cells	O
,	O
both	O
in	O
basal	O
conditions	O
and	O
after	O
stimulation	O
with	O
isoproterenol	O
and	O
forskolin	O
.	O
<EOS>	B-X
We	B-X
have	B-X
studied	B-X
the	B-X
modulation	B-X
of	B-X
cyclic	B-X
AMP	B-X
(	B-X
cAMP	B-X
)	B-X
accumulation	B-X
by	B-X
the	B-X
human	B-X
immunodeficiency	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HIV	B-X
1	B-X
)	B-X
protein	B-X
Tat	B-X
in	B-X
microglia	B-X
and	B-X
astrocyte	B-X
cultures	B-X
obtained	B-X
from	B-X
neonatal	B-X
rat	B-X
brain	B-X
.	B-X
Pretreatment	B-X
of	B-X
microglia	B-X
with	B-X
recombinant	B-X
Tat	B-X
resulted	B-X
in	B-X
a	B-X
dose-	B-X
and	B-X
time-dependent	B-X
decrease	B-X
of	B-X
cAMP	B-X
accumulation	B-X
induced	B-X
by	B-X
subsequent	B-X
exposure	B-X
to	B-X
isoproterenol	B-X
(	B-X
1	B-X
microM	B-X
)	B-X
.	B-X
The	B-X
inhibitory	B-X
action	B-X
of	B-X
100	B-X
ng/mL	B-X
Tat	B-X
approached	B-X
50	B-X
%	B-X
after	B-X
4	B-X
h	B-X
of	B-X
preincubation	B-X
and	B-X
reached	B-X
a	B-X
maximum	B-X
of	B-X
70	B-X
%	B-X
after	B-X
24	B-X
h.	B-X
The	B-X
Tat-induced	B-X
time-	B-X
and	B-X
dose-dependent	B-X
decrease	B-X
of	B-X
cAMP	B-X
accumulation	B-X
was	B-X
observed	B-X
also	B-X
when	B-X
microglial	B-X
cultures	B-X
were	B-X
stimulated	B-X
with	B-X
the	B-X
adenylyl	B-X
cyclase	B-X
activator	B-X
forskolin	B-X
(	B-X
100	B-X
microM	B-X
)	B-X
.	B-X
In	B-X
both	B-X
cases	B-X
,	B-X
Tat	B-X
inhibitory	B-X
action	B-X
was	B-X
70	B-X
%	B-X
reverted	B-X
by	B-X
a	B-X
specific	B-X
monoclonal	B-X
anti-Tat	B-X
antibody	B-X
,	B-X
but	B-X
was	B-X
not	B-X
prevented	B-X
either	B-X
by	B-X
the	B-X
phosphodiesterase	B-X
inhibitor	B-X
3-isobutyl-1-methyl-xantine	B-X
(	B-X
100	B-X
microM	B-X
)	B-X
or	B-X
by	B-X
a	B-X
16-h	B-X
pretreatment	B-X
of	B-X
microglial	B-X
cultures	B-X
with	B-X
the	B-X
Gi	B-X
protein	B-X
inhibitor	B-X
pertussis	B-X
toxin	B-X
(	B-X
10	B-X
ng/mL	B-X
)	B-X
.	B-X
The	B-X
target	B-X
of	B-X
Tat	B-X
appeared	B-X
to	B-X
be	B-X
adenylyl	B-X
cyclase	B-X
,	B-X
whose	B-X
activity	B-X
was	B-X
markedly	B-X
reduced	B-X
(	B-X
up	B-X
to	B-X
60	B-X
%	B-X
)	B-X
in	B-X
membranes	B-X
prepared	B-X
from	B-X
Tat-treated	B-X
microglial	B-X
cells	B-X
,	B-X
both	B-X
in	B-X
basal	B-X
conditions	B-X
and	B-X
after	B-X
stimulation	B-X
with	B-X
isoproterenol	B-X
and	B-X
forskolin	B-X
.	B-X
The	B-X
inability	B-X
of	B-X
the	B-X
competitive	B-X
inhibitor	B-X
of	B-X
nitric	B-X
oxide	B-X
synthase	B-X
N	B-X
(	B-X
G	B-X
)	B-X
-monometyl-	B-X
L-arginine	B-X
(	B-X
20	B-X
and	B-X
200	B-X
microM	B-X
)	B-X
to	B-X
revert	B-X
Tat	B-X
action	B-X
on	B-X
forskolin-induced	B-X
cAMP	B-X
accumulation	B-X
,	B-X
and	B-X
of	B-X
two	B-X
potent	B-X
nitric	B-X
oxide	B-X
donors	B-X
,	B-X
PAPA	B-X
and	B-X
DETA	B-X
(	B-X
0.1-2	B-X
m	B-X
M	B-X
)	B-X
,	B-X
to	B-X
alter	B-X
forskolin-induced	B-X
cAMP	B-X
accumulation	B-X
,	B-X
excluded	B-X
an	B-X
involvement	B-X
of	B-X
nitric	B-X
oxide	B-X
in	B-X
Tat-induced	B-X
adenylyl	B-X
cyclase	B-X
inhibition	B-X
.	B-X
On	B-X
the	B-X
contrary	B-X
,	B-X
two	B-X
inhibitors	B-X
of	B-X
nuclear	B-X
factor	B-X
kappaB	B-X
activation	B-X
,	B-X
N-tosyl-	B-X
(	B-X
L	B-X
)	B-X
-phenylalanine	B-X
chloromethyl	B-X
ketone	B-X
(	B-X
10	B-X
microM	B-X
)	B-X
and	B-X
SN50	B-X
(	B-X
25	B-X
microM	B-X
)	B-X
,	B-X
markedly	B-X
prevented	B-X
the	B-X
reduction	B-X
of	B-X
forskolin-evoked	B-X
cAMP	B-X
accumulation	B-X
by	B-X
Tat	B-X
,	B-X
suggesting	B-X
a	B-X
possible	B-X
role	B-X
for	B-X
this	B-X
nuclear	B-X
transcriptional	B-X
factor	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
by	B-X
Tat	B-X
in	B-X
microglia	B-X
.	B-X
Finally	B-X
,	B-X
Tat	B-X
inhibition	B-X
of	B-X
microglial	B-X
adenylyl	B-X
cyclase	B-X
was	B-X
not	B-X
due	B-X
to	B-X
non-specific	B-X
cytotoxicity	B-X
.	B-X
As	B-X
cAMP	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
exert	B-X
a	B-X
neuroprotective	B-X
role	B-X
in	B-X
several	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
models	B-X
of	B-X
brain	B-X
pathologies	B-X
,	B-X
and	B-X
microglia	B-X
is	B-X
believed	B-X
to	B-X
mediate	B-X
Tat-induced	B-X
neurotoxicity	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
Tat	B-X
to	B-X
inhibit	B-X
cAMP	B-X
synthesis	B-X
in	B-X
microglia	B-X
may	B-X
contribute	B-X
to	B-X
neuronal	B-X
degeneration	B-X
and	B-X
cell	B-X
death	B-X
associated	B-X
with	B-X
HIV	B-X
infection	B-X
.	B-X

The	O
inability	O
of	O
the	O
competitive	O
inhibitor	O
of	O
nitric	B-Gene_or_gene_product
oxide	I-Gene_or_gene_product
synthase	I-Gene_or_gene_product
N	O
(	O
G	O
)	O
-	O
monometyl	O
-	O
L	O
-	O
arginine	O
(	O
20	O
and	O
200	O
microM	O
)	O
to	O
revert	O
Tat	B-Gene_or_gene_product
action	O
on	O
forskolin	O
-	O
induced	O
cAMP	O
accumulation	O
,	O
and	O
of	O
two	O
potent	O
nitric	O
oxide	O
donors	O
,	O
PAPA	O
and	O
DETA	O
(	O
0	O
.	O
1	O
-	O
2	O
m	O
M	O
)	O
,	O
to	O
alter	O
forskolin	O
-	O
induced	O
cAMP	O
accumulation	O
,	O
excluded	O
an	O
involvement	O
of	O
nitric	O
oxide	O
in	O
Tat	B-Gene_or_gene_product
-	O
induced	O
adenylyl	B-Gene_or_gene_product
cyclase	I-Gene_or_gene_product
inhibition	O
.	O

On	O
the	O
contrary	O
,	O
two	O
inhibitors	O
of	O
nuclear	O
factor	O
kappaB	O
activation	O
,	O
N	O
-	O
tosyl	O
-	O
(	O
L	O
)	O
-	O
phenylalanine	O
chloromethyl	O
ketone	O
(	O
10	O
microM	O
)	O
and	O
SN50	O
(	O
25	O
microM	O
)	O
,	O
markedly	O
prevented	O
the	O
reduction	O
of	O
forskolin	O
-	O
evoked	O
cAMP	O
accumulation	O
by	O
Tat	B-Gene_or_gene_product
,	O
suggesting	O
a	O
possible	O
role	O
for	O
this	O
nuclear	O
transcriptional	O
factor	O
in	O
the	O
regulation	O
of	O
adenylyl	B-Gene_or_gene_product
cyclase	I-Gene_or_gene_product
by	O
Tat	B-Gene_or_gene_product
in	O
microglia	O
.	O
<EOS>	B-X
We	B-X
have	B-X
studied	B-X
the	B-X
modulation	B-X
of	B-X
cyclic	B-X
AMP	B-X
(	B-X
cAMP	B-X
)	B-X
accumulation	B-X
by	B-X
the	B-X
human	B-X
immunodeficiency	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HIV	B-X
1	B-X
)	B-X
protein	B-X
Tat	B-X
in	B-X
microglia	B-X
and	B-X
astrocyte	B-X
cultures	B-X
obtained	B-X
from	B-X
neonatal	B-X
rat	B-X
brain	B-X
.	B-X
Pretreatment	B-X
of	B-X
microglia	B-X
with	B-X
recombinant	B-X
Tat	B-X
resulted	B-X
in	B-X
a	B-X
dose-	B-X
and	B-X
time-dependent	B-X
decrease	B-X
of	B-X
cAMP	B-X
accumulation	B-X
induced	B-X
by	B-X
subsequent	B-X
exposure	B-X
to	B-X
isoproterenol	B-X
(	B-X
1	B-X
microM	B-X
)	B-X
.	B-X
The	B-X
inhibitory	B-X
action	B-X
of	B-X
100	B-X
ng/mL	B-X
Tat	B-X
approached	B-X
50	B-X
%	B-X
after	B-X
4	B-X
h	B-X
of	B-X
preincubation	B-X
and	B-X
reached	B-X
a	B-X
maximum	B-X
of	B-X
70	B-X
%	B-X
after	B-X
24	B-X
h.	B-X
The	B-X
Tat-induced	B-X
time-	B-X
and	B-X
dose-dependent	B-X
decrease	B-X
of	B-X
cAMP	B-X
accumulation	B-X
was	B-X
observed	B-X
also	B-X
when	B-X
microglial	B-X
cultures	B-X
were	B-X
stimulated	B-X
with	B-X
the	B-X
adenylyl	B-X
cyclase	B-X
activator	B-X
forskolin	B-X
(	B-X
100	B-X
microM	B-X
)	B-X
.	B-X
In	B-X
both	B-X
cases	B-X
,	B-X
Tat	B-X
inhibitory	B-X
action	B-X
was	B-X
70	B-X
%	B-X
reverted	B-X
by	B-X
a	B-X
specific	B-X
monoclonal	B-X
anti-Tat	B-X
antibody	B-X
,	B-X
but	B-X
was	B-X
not	B-X
prevented	B-X
either	B-X
by	B-X
the	B-X
phosphodiesterase	B-X
inhibitor	B-X
3-isobutyl-1-methyl-xantine	B-X
(	B-X
100	B-X
microM	B-X
)	B-X
or	B-X
by	B-X
a	B-X
16-h	B-X
pretreatment	B-X
of	B-X
microglial	B-X
cultures	B-X
with	B-X
the	B-X
Gi	B-X
protein	B-X
inhibitor	B-X
pertussis	B-X
toxin	B-X
(	B-X
10	B-X
ng/mL	B-X
)	B-X
.	B-X
All	B-X
these	B-X
results	B-X
suggested	B-X
that	B-X
the	B-X
viral	B-X
protein	B-X
acts	B-X
at	B-X
a	B-X
step	B-X
of	B-X
the	B-X
cAMP	B-X
transduction	B-X
pathway	B-X
other	B-X
than	B-X
receptors	B-X
,	B-X
G	B-X
proteins	B-X
and	B-X
phosphodiesterases	B-X
.	B-X
The	B-X
target	B-X
of	B-X
Tat	B-X
appeared	B-X
to	B-X
be	B-X
adenylyl	B-X
cyclase	B-X
,	B-X
whose	B-X
activity	B-X
was	B-X
markedly	B-X
reduced	B-X
(	B-X
up	B-X
to	B-X
60	B-X
%	B-X
)	B-X
in	B-X
membranes	B-X
prepared	B-X
from	B-X
Tat-treated	B-X
microglial	B-X
cells	B-X
,	B-X
both	B-X
in	B-X
basal	B-X
conditions	B-X
and	B-X
after	B-X
stimulation	B-X
with	B-X
isoproterenol	B-X
and	B-X
forskolin	B-X
.	B-X
The	B-X
inability	B-X
of	B-X
the	B-X
competitive	B-X
inhibitor	B-X
of	B-X
nitric	B-X
oxide	B-X
synthase	B-X
N	B-X
(	B-X
G	B-X
)	B-X
-monometyl-	B-X
L-arginine	B-X
(	B-X
20	B-X
and	B-X
200	B-X
microM	B-X
)	B-X
to	B-X
revert	B-X
Tat	B-X
action	B-X
on	B-X
forskolin-induced	B-X
cAMP	B-X
accumulation	B-X
,	B-X
and	B-X
of	B-X
two	B-X
potent	B-X
nitric	B-X
oxide	B-X
donors	B-X
,	B-X
PAPA	B-X
and	B-X
DETA	B-X
(	B-X
0.1-2	B-X
m	B-X
M	B-X
)	B-X
,	B-X
to	B-X
alter	B-X
forskolin-induced	B-X
cAMP	B-X
accumulation	B-X
,	B-X
excluded	B-X
an	B-X
involvement	B-X
of	B-X
nitric	B-X
oxide	B-X
in	B-X
Tat-induced	B-X
adenylyl	B-X
cyclase	B-X
inhibition	B-X
.	B-X
On	B-X
the	B-X
contrary	B-X
,	B-X
two	B-X
inhibitors	B-X
of	B-X
nuclear	B-X
factor	B-X
kappaB	B-X
activation	B-X
,	B-X
N-tosyl-	B-X
(	B-X
L	B-X
)	B-X
-phenylalanine	B-X
chloromethyl	B-X
ketone	B-X
(	B-X
10	B-X
microM	B-X
)	B-X
and	B-X
SN50	B-X
(	B-X
25	B-X
microM	B-X
)	B-X
,	B-X
markedly	B-X
prevented	B-X
the	B-X
reduction	B-X
of	B-X
forskolin-evoked	B-X
cAMP	B-X
accumulation	B-X
by	B-X
Tat	B-X
,	B-X
suggesting	B-X
a	B-X
possible	B-X
role	B-X
for	B-X
this	B-X
nuclear	B-X
transcriptional	B-X
factor	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
by	B-X
Tat	B-X
in	B-X
microglia	B-X
.	B-X
This	B-X
assumption	B-X
was	B-X
strengthened	B-X
by	B-X
the	B-X
ability	B-X
of	B-X
lipopolysaccharide	B-X
(	B-X
100	B-X
ng/mL	B-X
,	B-X
4	B-X
h	B-X
)	B-X
to	B-X
mimic	B-X
the	B-X
inhibitory	B-X
effect	B-X
of	B-X
the	B-X
viral	B-X
protein	B-X
.	B-X
Conversely	B-X
,	B-X
astrocyte	B-X
cAMP	B-X
accumulation	B-X
was	B-X
unaffected	B-X
by	B-X
the	B-X
viral	B-X
protein	B-X
,	B-X
as	B-X
tested	B-X
at	B-X
various	B-X
concentrations	B-X
and	B-X
time	B-X
points	B-X
.	B-X
Finally	B-X
,	B-X
Tat	B-X
inhibition	B-X
of	B-X
microglial	B-X
adenylyl	B-X
cyclase	B-X
was	B-X
not	B-X
due	B-X
to	B-X
non-specific	B-X
cytotoxicity	B-X
.	B-X
As	B-X
cAMP	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
exert	B-X
a	B-X
neuroprotective	B-X
role	B-X
in	B-X
several	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
models	B-X
of	B-X
brain	B-X
pathologies	B-X
,	B-X
and	B-X
microglia	B-X
is	B-X
believed	B-X
to	B-X
mediate	B-X
Tat-induced	B-X
neurotoxicity	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
Tat	B-X
to	B-X
inhibit	B-X
cAMP	B-X
synthesis	B-X
in	B-X
microglia	B-X
may	B-X
contribute	B-X
to	B-X
neuronal	B-X
degeneration	B-X
and	B-X
cell	B-X
death	B-X
associated	B-X
with	B-X
HIV	B-X
infection	B-X
.	B-X

This	O
assumption	O
was	O
strengthened	O
by	O
the	O
ability	O
of	O
lipopolysaccharide	O
(	O
100	O
ng	O
/	O
mL	O
,	O
4	O
h	O
)	O
to	O
mimic	O
the	O
inhibitory	O
effect	O
of	O
the	O
viral	O
protein	O
.	O

Conversely	O
,	O
astrocyte	O
cAMP	O
accumulation	O
was	O
unaffected	O
by	O
the	O
viral	O
protein	O
,	O
as	O
tested	O
at	O
various	O
concentrations	O
and	O
time	O
points	O
.	O
<EOS>	B-X
We	B-X
have	B-X
studied	B-X
the	B-X
modulation	B-X
of	B-X
cyclic	B-X
AMP	B-X
(	B-X
cAMP	B-X
)	B-X
accumulation	B-X
by	B-X
the	B-X
human	B-X
immunodeficiency	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HIV	B-X
1	B-X
)	B-X
protein	B-X
Tat	B-X
in	B-X
microglia	B-X
and	B-X
astrocyte	B-X
cultures	B-X
obtained	B-X
from	B-X
neonatal	B-X
rat	B-X
brain	B-X
.	B-X
Pretreatment	B-X
of	B-X
microglia	B-X
with	B-X
recombinant	B-X
Tat	B-X
resulted	B-X
in	B-X
a	B-X
dose-	B-X
and	B-X
time-dependent	B-X
decrease	B-X
of	B-X
cAMP	B-X
accumulation	B-X
induced	B-X
by	B-X
subsequent	B-X
exposure	B-X
to	B-X
isoproterenol	B-X
(	B-X
1	B-X
microM	B-X
)	B-X
.	B-X
The	B-X
inhibitory	B-X
action	B-X
of	B-X
100	B-X
ng/mL	B-X
Tat	B-X
approached	B-X
50	B-X
%	B-X
after	B-X
4	B-X
h	B-X
of	B-X
preincubation	B-X
and	B-X
reached	B-X
a	B-X
maximum	B-X
of	B-X
70	B-X
%	B-X
after	B-X
24	B-X
h.	B-X
The	B-X
Tat-induced	B-X
time-	B-X
and	B-X
dose-dependent	B-X
decrease	B-X
of	B-X
cAMP	B-X
accumulation	B-X
was	B-X
observed	B-X
also	B-X
when	B-X
microglial	B-X
cultures	B-X
were	B-X
stimulated	B-X
with	B-X
the	B-X
adenylyl	B-X
cyclase	B-X
activator	B-X
forskolin	B-X
(	B-X
100	B-X
microM	B-X
)	B-X
.	B-X
In	B-X
both	B-X
cases	B-X
,	B-X
Tat	B-X
inhibitory	B-X
action	B-X
was	B-X
70	B-X
%	B-X
reverted	B-X
by	B-X
a	B-X
specific	B-X
monoclonal	B-X
anti-Tat	B-X
antibody	B-X
,	B-X
but	B-X
was	B-X
not	B-X
prevented	B-X
either	B-X
by	B-X
the	B-X
phosphodiesterase	B-X
inhibitor	B-X
3-isobutyl-1-methyl-xantine	B-X
(	B-X
100	B-X
microM	B-X
)	B-X
or	B-X
by	B-X
a	B-X
16-h	B-X
pretreatment	B-X
of	B-X
microglial	B-X
cultures	B-X
with	B-X
the	B-X
Gi	B-X
protein	B-X
inhibitor	B-X
pertussis	B-X
toxin	B-X
(	B-X
10	B-X
ng/mL	B-X
)	B-X
.	B-X
All	B-X
these	B-X
results	B-X
suggested	B-X
that	B-X
the	B-X
viral	B-X
protein	B-X
acts	B-X
at	B-X
a	B-X
step	B-X
of	B-X
the	B-X
cAMP	B-X
transduction	B-X
pathway	B-X
other	B-X
than	B-X
receptors	B-X
,	B-X
G	B-X
proteins	B-X
and	B-X
phosphodiesterases	B-X
.	B-X
The	B-X
inability	B-X
of	B-X
the	B-X
competitive	B-X
inhibitor	B-X
of	B-X
nitric	B-X
oxide	B-X
synthase	B-X
N	B-X
(	B-X
G	B-X
)	B-X
-monometyl-	B-X
L-arginine	B-X
(	B-X
20	B-X
and	B-X
200	B-X
microM	B-X
)	B-X
to	B-X
revert	B-X
Tat	B-X
action	B-X
on	B-X
forskolin-induced	B-X
cAMP	B-X
accumulation	B-X
,	B-X
and	B-X
of	B-X
two	B-X
potent	B-X
nitric	B-X
oxide	B-X
donors	B-X
,	B-X
PAPA	B-X
and	B-X
DETA	B-X
(	B-X
0.1-2	B-X
m	B-X
M	B-X
)	B-X
,	B-X
to	B-X
alter	B-X
forskolin-induced	B-X
cAMP	B-X
accumulation	B-X
,	B-X
excluded	B-X
an	B-X
involvement	B-X
of	B-X
nitric	B-X
oxide	B-X
in	B-X
Tat-induced	B-X
adenylyl	B-X
cyclase	B-X
inhibition	B-X
.	B-X
On	B-X
the	B-X
contrary	B-X
,	B-X
two	B-X
inhibitors	B-X
of	B-X
nuclear	B-X
factor	B-X
kappaB	B-X
activation	B-X
,	B-X
N-tosyl-	B-X
(	B-X
L	B-X
)	B-X
-phenylalanine	B-X
chloromethyl	B-X
ketone	B-X
(	B-X
10	B-X
microM	B-X
)	B-X
and	B-X
SN50	B-X
(	B-X
25	B-X
microM	B-X
)	B-X
,	B-X
markedly	B-X
prevented	B-X
the	B-X
reduction	B-X
of	B-X
forskolin-evoked	B-X
cAMP	B-X
accumulation	B-X
by	B-X
Tat	B-X
,	B-X
suggesting	B-X
a	B-X
possible	B-X
role	B-X
for	B-X
this	B-X
nuclear	B-X
transcriptional	B-X
factor	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
by	B-X
Tat	B-X
in	B-X
microglia	B-X
.	B-X
This	B-X
assumption	B-X
was	B-X
strengthened	B-X
by	B-X
the	B-X
ability	B-X
of	B-X
lipopolysaccharide	B-X
(	B-X
100	B-X
ng/mL	B-X
,	B-X
4	B-X
h	B-X
)	B-X
to	B-X
mimic	B-X
the	B-X
inhibitory	B-X
effect	B-X
of	B-X
the	B-X
viral	B-X
protein	B-X
.	B-X
Conversely	B-X
,	B-X
astrocyte	B-X
cAMP	B-X
accumulation	B-X
was	B-X
unaffected	B-X
by	B-X
the	B-X
viral	B-X
protein	B-X
,	B-X
as	B-X
tested	B-X
at	B-X
various	B-X
concentrations	B-X
and	B-X
time	B-X
points	B-X
.	B-X
As	B-X
cAMP	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
exert	B-X
a	B-X
neuroprotective	B-X
role	B-X
in	B-X
several	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
models	B-X
of	B-X
brain	B-X
pathologies	B-X
,	B-X
and	B-X
microglia	B-X
is	B-X
believed	B-X
to	B-X
mediate	B-X
Tat-induced	B-X
neurotoxicity	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
Tat	B-X
to	B-X
inhibit	B-X
cAMP	B-X
synthesis	B-X
in	B-X
microglia	B-X
may	B-X
contribute	B-X
to	B-X
neuronal	B-X
degeneration	B-X
and	B-X
cell	B-X
death	B-X
associated	B-X
with	B-X
HIV	B-X
infection	B-X
.	B-X

Finally	O
,	O
Tat	B-Gene_or_gene_product
inhibition	O
of	O
microglial	O
adenylyl	B-Gene_or_gene_product
cyclase	I-Gene_or_gene_product
was	O
not	O
due	O
to	O
non	O
-	O
specific	O
cytotoxicity	O
.	O

As	O
cAMP	O
has	O
been	O
reported	O
to	O
exert	O
a	O
neuroprotective	O
role	O
in	O
several	O
in	O
vivo	O
and	O
in	O
vitro	O
models	O
of	O
brain	O
pathologies	O
,	O
and	O
microglia	O
is	O
believed	O
to	O
mediate	O
Tat	B-Gene_or_gene_product
-	O
induced	O
neurotoxicity	O
,	O
these	O
results	O
suggest	O
that	O
the	O
ability	O
of	O
Tat	B-Gene_or_gene_product
to	O
inhibit	O
cAMP	O
synthesis	O
in	O
microglia	O
may	O
contribute	O
to	O
neuronal	O
degeneration	O
and	O
cell	O
death	O
associated	O
with	O
HIV	O
infection	O
.	O
<EOS>	B-X
We	B-X
have	B-X
studied	B-X
the	B-X
modulation	B-X
of	B-X
cyclic	B-X
AMP	B-X
(	B-X
cAMP	B-X
)	B-X
accumulation	B-X
by	B-X
the	B-X
human	B-X
immunodeficiency	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HIV	B-X
1	B-X
)	B-X
protein	B-X
Tat	B-X
in	B-X
microglia	B-X
and	B-X
astrocyte	B-X
cultures	B-X
obtained	B-X
from	B-X
neonatal	B-X
rat	B-X
brain	B-X
.	B-X
Pretreatment	B-X
of	B-X
microglia	B-X
with	B-X
recombinant	B-X
Tat	B-X
resulted	B-X
in	B-X
a	B-X
dose-	B-X
and	B-X
time-dependent	B-X
decrease	B-X
of	B-X
cAMP	B-X
accumulation	B-X
induced	B-X
by	B-X
subsequent	B-X
exposure	B-X
to	B-X
isoproterenol	B-X
(	B-X
1	B-X
microM	B-X
)	B-X
.	B-X
The	B-X
inhibitory	B-X
action	B-X
of	B-X
100	B-X
ng/mL	B-X
Tat	B-X
approached	B-X
50	B-X
%	B-X
after	B-X
4	B-X
h	B-X
of	B-X
preincubation	B-X
and	B-X
reached	B-X
a	B-X
maximum	B-X
of	B-X
70	B-X
%	B-X
after	B-X
24	B-X
h.	B-X
The	B-X
Tat-induced	B-X
time-	B-X
and	B-X
dose-dependent	B-X
decrease	B-X
of	B-X
cAMP	B-X
accumulation	B-X
was	B-X
observed	B-X
also	B-X
when	B-X
microglial	B-X
cultures	B-X
were	B-X
stimulated	B-X
with	B-X
the	B-X
adenylyl	B-X
cyclase	B-X
activator	B-X
forskolin	B-X
(	B-X
100	B-X
microM	B-X
)	B-X
.	B-X
In	B-X
both	B-X
cases	B-X
,	B-X
Tat	B-X
inhibitory	B-X
action	B-X
was	B-X
70	B-X
%	B-X
reverted	B-X
by	B-X
a	B-X
specific	B-X
monoclonal	B-X
anti-Tat	B-X
antibody	B-X
,	B-X
but	B-X
was	B-X
not	B-X
prevented	B-X
either	B-X
by	B-X
the	B-X
phosphodiesterase	B-X
inhibitor	B-X
3-isobutyl-1-methyl-xantine	B-X
(	B-X
100	B-X
microM	B-X
)	B-X
or	B-X
by	B-X
a	B-X
16-h	B-X
pretreatment	B-X
of	B-X
microglial	B-X
cultures	B-X
with	B-X
the	B-X
Gi	B-X
protein	B-X
inhibitor	B-X
pertussis	B-X
toxin	B-X
(	B-X
10	B-X
ng/mL	B-X
)	B-X
.	B-X
All	B-X
these	B-X
results	B-X
suggested	B-X
that	B-X
the	B-X
viral	B-X
protein	B-X
acts	B-X
at	B-X
a	B-X
step	B-X
of	B-X
the	B-X
cAMP	B-X
transduction	B-X
pathway	B-X
other	B-X
than	B-X
receptors	B-X
,	B-X
G	B-X
proteins	B-X
and	B-X
phosphodiesterases	B-X
.	B-X
The	B-X
target	B-X
of	B-X
Tat	B-X
appeared	B-X
to	B-X
be	B-X
adenylyl	B-X
cyclase	B-X
,	B-X
whose	B-X
activity	B-X
was	B-X
markedly	B-X
reduced	B-X
(	B-X
up	B-X
to	B-X
60	B-X
%	B-X
)	B-X
in	B-X
membranes	B-X
prepared	B-X
from	B-X
Tat-treated	B-X
microglial	B-X
cells	B-X
,	B-X
both	B-X
in	B-X
basal	B-X
conditions	B-X
and	B-X
after	B-X
stimulation	B-X
with	B-X
isoproterenol	B-X
and	B-X
forskolin	B-X
.	B-X
The	B-X
inability	B-X
of	B-X
the	B-X
competitive	B-X
inhibitor	B-X
of	B-X
nitric	B-X
oxide	B-X
synthase	B-X
N	B-X
(	B-X
G	B-X
)	B-X
-monometyl-	B-X
L-arginine	B-X
(	B-X
20	B-X
and	B-X
200	B-X
microM	B-X
)	B-X
to	B-X
revert	B-X
Tat	B-X
action	B-X
on	B-X
forskolin-induced	B-X
cAMP	B-X
accumulation	B-X
,	B-X
and	B-X
of	B-X
two	B-X
potent	B-X
nitric	B-X
oxide	B-X
donors	B-X
,	B-X
PAPA	B-X
and	B-X
DETA	B-X
(	B-X
0.1-2	B-X
m	B-X
M	B-X
)	B-X
,	B-X
to	B-X
alter	B-X
forskolin-induced	B-X
cAMP	B-X
accumulation	B-X
,	B-X
excluded	B-X
an	B-X
involvement	B-X
of	B-X
nitric	B-X
oxide	B-X
in	B-X
Tat-induced	B-X
adenylyl	B-X
cyclase	B-X
inhibition	B-X
.	B-X
On	B-X
the	B-X
contrary	B-X
,	B-X
two	B-X
inhibitors	B-X
of	B-X
nuclear	B-X
factor	B-X
kappaB	B-X
activation	B-X
,	B-X
N-tosyl-	B-X
(	B-X
L	B-X
)	B-X
-phenylalanine	B-X
chloromethyl	B-X
ketone	B-X
(	B-X
10	B-X
microM	B-X
)	B-X
and	B-X
SN50	B-X
(	B-X
25	B-X
microM	B-X
)	B-X
,	B-X
markedly	B-X
prevented	B-X
the	B-X
reduction	B-X
of	B-X
forskolin-evoked	B-X
cAMP	B-X
accumulation	B-X
by	B-X
Tat	B-X
,	B-X
suggesting	B-X
a	B-X
possible	B-X
role	B-X
for	B-X
this	B-X
nuclear	B-X
transcriptional	B-X
factor	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
by	B-X
Tat	B-X
in	B-X
microglia	B-X
.	B-X
This	B-X
assumption	B-X
was	B-X
strengthened	B-X
by	B-X
the	B-X
ability	B-X
of	B-X
lipopolysaccharide	B-X
(	B-X
100	B-X
ng/mL	B-X
,	B-X
4	B-X
h	B-X
)	B-X
to	B-X
mimic	B-X
the	B-X
inhibitory	B-X
effect	B-X
of	B-X
the	B-X
viral	B-X
protein	B-X
.	B-X
Conversely	B-X
,	B-X
astrocyte	B-X
cAMP	B-X
accumulation	B-X
was	B-X
unaffected	B-X
by	B-X
the	B-X
viral	B-X
protein	B-X
,	B-X
as	B-X
tested	B-X
at	B-X
various	B-X
concentrations	B-X
and	B-X
time	B-X
points	B-X
.	B-X
Finally	B-X
,	B-X
Tat	B-X
inhibition	B-X
of	B-X
microglial	B-X
adenylyl	B-X
cyclase	B-X
was	B-X
not	B-X
due	B-X
to	B-X
non-specific	B-X
cytotoxicity	B-X
.	B-X
As	B-X
cAMP	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
exert	B-X
a	B-X
neuroprotective	B-X
role	B-X
in	B-X
several	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
models	B-X
of	B-X
brain	B-X
pathologies	B-X
,	B-X
and	B-X
microglia	B-X
is	B-X
believed	B-X
to	B-X
mediate	B-X
Tat-induced	B-X
neurotoxicity	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
Tat	B-X
to	B-X
inhibit	B-X
cAMP	B-X
synthesis	B-X
in	B-X
microglia	B-X
may	B-X
contribute	B-X
to	B-X
neuronal	B-X
degeneration	B-X
and	B-X
cell	B-X
death	B-X
associated	B-X
with	B-X
HIV	B-X
infection	B-X
.	B-X

Biosynthesis	O
of	O
N	O
-	O
acetylneuraminic	O
acid	O
in	O
cells	O
lacking	O
UDP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylglucosamine	I-Gene_or_gene_product
2	I-Gene_or_gene_product
-	I-Gene_or_gene_product
epimerase	I-Gene_or_gene_product
/	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylmannosamine	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
.	O

The	O
first	O
two	O
steps	O
in	O
mammalian	O
biosynthesis	O
of	O
N	O
-	O
acetylneuraminic	O
acid	O
,	O
an	O
important	O
carbohydrate	O
moiety	O
in	O
biological	O
recognition	O
systems	O
,	O
are	O
performed	O
by	O
the	O
bifunctional	O
enzyme	O
UDP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylglucosamine	I-Gene_or_gene_product
2	I-Gene_or_gene_product
-	I-Gene_or_gene_product
epimerase	I-Gene_or_gene_product
/	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylmannosamine	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
.	O

A	O
subclone	O
of	O
the	O
human	O
B	O
lymphoma	O
cell	O
line	O
BJA	O
-	O
B	O
K20	O
,	O
lacking	O
UDP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylglucosamine	I-Gene_or_gene_product
2	I-Gene_or_gene_product
-	I-Gene_or_gene_product
epimerase	I-Gene_or_gene_product
/	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylmannosamine	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
mRNA	O
as	O
well	O
as	O
epimerase	O
activity	O
,	O
displayed	O
hyposialylated	O
,	O
functionally	O
impaired	O
cell	O
surface	O
glycoconjugates	O
.	O

Here	O
we	O
show	O
that	O
this	O
cell	O
line	O
surprisingly	O
still	O
retains	O
N	B-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylmannosamine	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
activity	O
.	O
<EOS>	B-X
The	B-X
first	B-X
two	B-X
steps	B-X
in	B-X
mammalian	B-X
biosynthesis	B-X
of	B-X
N-acetylneuraminic	B-X
acid	B-X
,	B-X
an	B-X
important	B-X
carbohydrate	B-X
moiety	B-X
in	B-X
biological	B-X
recognition	B-X
systems	B-X
,	B-X
are	B-X
performed	B-X
by	B-X
the	B-X
bifunctional	B-X
enzyme	B-X
UDP-N-acetylglucosamine	B-X
2-epimerase/N-acetylmannosamine	B-X
kinase	B-X
.	B-X
A	B-X
subclone	B-X
of	B-X
the	B-X
human	B-X
B	B-X
lymphoma	B-X
cell	B-X
line	B-X
BJA-B	B-X
K20	B-X
,	B-X
lacking	B-X
UDP-N-acetylglucosamine	B-X
2-epimerase/N-acetylmannosamine	B-X
kinase	B-X
mRNA	B-X
as	B-X
well	B-X
as	B-X
epimerase	B-X
activity	B-X
,	B-X
displayed	B-X
hyposialylated	B-X
,	B-X
functionally	B-X
impaired	B-X
cell	B-X
surface	B-X
glycoconjugates	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
this	B-X
cell	B-X
line	B-X
surprisingly	B-X
still	B-X
retains	B-X
N-acetylmannosamine	B-X
kinase	B-X
activity	B-X
.	B-X
A	B-X
gel	B-X
filtration	B-X
analysis	B-X
of	B-X
BJA-B	B-X
K88	B-X
control	B-X
cells	B-X
,	B-X
which	B-X
express	B-X
UDP-N-acetylglucosamine	B-X
2-epimerase/N-acetylmannosamine	B-X
kinase	B-X
,	B-X
revealed	B-X
two	B-X
N-acetylmannosamine	B-X
kinase	B-X
activity	B-X
peaks	B-X
,	B-X
one	B-X
co-eluting	B-X
with	B-X
UDP-N-acetylglucosamine	B-X
2-epimerase	B-X
activity	B-X
and	B-X
one	B-X
co-eluting	B-X
with	B-X
N-acetylglucosamine	B-X
kinase	B-X
.	B-X
For	B-X
this	B-X
enzyme	B-X
previous	B-X
studies	B-X
already	B-X
showed	B-X
a	B-X
ManNAc	B-X
kinase	B-X
activity	B-X
in	B-X
vitro	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
hyposialylated	B-X
BJA-B	B-X
K20	B-X
subclone	B-X
displayed	B-X
only	B-X
the	B-X
N-acetylmannosamine	B-X
kinase	B-X
peak	B-X
,	B-X
co-migrating	B-X
with	B-X
N-acetylglucosamine	B-X
kinase	B-X
.	B-X
The	B-X
CMP-N-acetylneuraminic	B-X
acid	B-X
content	B-X
of	B-X
both	B-X
K88	B-X
and	B-X
K20	B-X
cells	B-X
and	B-X
the	B-X
sialylation	B-X
of	B-X
cell	B-X
surface	B-X
glycoconjugates	B-X
of	B-X
K20	B-X
cells	B-X
could	B-X
be	B-X
significantly	B-X
increased	B-X
by	B-X
supplementing	B-X
the	B-X
medium	B-X
with	B-X
N-acetylmannosamine	B-X
.	B-X
This	B-X
N-acetylmannosamine-induced	B-X
increase	B-X
was	B-X
drastically	B-X
reduced	B-X
by	B-X
co-supplementation	B-X
with	B-X
N-acetylglucosamine	B-X
only	B-X
in	B-X
K20	B-X
cells	B-X
.	B-X
We	B-X
therefore	B-X
propose	B-X
the	B-X
phosphorylation	B-X
of	B-X
N-acetylmannosamine	B-X
as	B-X
a	B-X
hitherto	B-X
unrecognized	B-X
role	B-X
of	B-X
N-acetylglucosamine	B-X
kinase	B-X
in	B-X
living	B-X
cells	B-X
.	B-X

A	O
gel	O
filtration	O
analysis	O
of	O
BJA	O
-	O
B	O
K88	O
control	O
cells	O
,	O
which	O
express	O
UDP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylglucosamine	I-Gene_or_gene_product
2	I-Gene_or_gene_product
-	I-Gene_or_gene_product
epimerase	I-Gene_or_gene_product
/	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylmannosamine	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
,	O
revealed	O
two	O
N	B-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylmannosamine	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
activity	O
peaks	O
,	O
one	O
co	O
-	O
eluting	O
with	O
UDP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylglucosamine	I-Gene_or_gene_product
2	I-Gene_or_gene_product
-	I-Gene_or_gene_product
epimerase	I-Gene_or_gene_product
activity	O
and	O
one	O
co	O
-	O
eluting	O
with	O
N	B-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylglucosamine	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
.	O

For	O
this	O
enzyme	O
previous	O
studies	O
already	O
showed	O
a	O
ManNAc	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
activity	O
in	O
vitro	O
.	O
<EOS>	B-X
The	B-X
first	B-X
two	B-X
steps	B-X
in	B-X
mammalian	B-X
biosynthesis	B-X
of	B-X
N-acetylneuraminic	B-X
acid	B-X
,	B-X
an	B-X
important	B-X
carbohydrate	B-X
moiety	B-X
in	B-X
biological	B-X
recognition	B-X
systems	B-X
,	B-X
are	B-X
performed	B-X
by	B-X
the	B-X
bifunctional	B-X
enzyme	B-X
UDP-N-acetylglucosamine	B-X
2-epimerase/N-acetylmannosamine	B-X
kinase	B-X
.	B-X
A	B-X
subclone	B-X
of	B-X
the	B-X
human	B-X
B	B-X
lymphoma	B-X
cell	B-X
line	B-X
BJA-B	B-X
K20	B-X
,	B-X
lacking	B-X
UDP-N-acetylglucosamine	B-X
2-epimerase/N-acetylmannosamine	B-X
kinase	B-X
mRNA	B-X
as	B-X
well	B-X
as	B-X
epimerase	B-X
activity	B-X
,	B-X
displayed	B-X
hyposialylated	B-X
,	B-X
functionally	B-X
impaired	B-X
cell	B-X
surface	B-X
glycoconjugates	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
this	B-X
cell	B-X
line	B-X
surprisingly	B-X
still	B-X
retains	B-X
N-acetylmannosamine	B-X
kinase	B-X
activity	B-X
.	B-X
A	B-X
gel	B-X
filtration	B-X
analysis	B-X
of	B-X
BJA-B	B-X
K88	B-X
control	B-X
cells	B-X
,	B-X
which	B-X
express	B-X
UDP-N-acetylglucosamine	B-X
2-epimerase/N-acetylmannosamine	B-X
kinase	B-X
,	B-X
revealed	B-X
two	B-X
N-acetylmannosamine	B-X
kinase	B-X
activity	B-X
peaks	B-X
,	B-X
one	B-X
co-eluting	B-X
with	B-X
UDP-N-acetylglucosamine	B-X
2-epimerase	B-X
activity	B-X
and	B-X
one	B-X
co-eluting	B-X
with	B-X
N-acetylglucosamine	B-X
kinase	B-X
.	B-X
For	B-X
this	B-X
enzyme	B-X
previous	B-X
studies	B-X
already	B-X
showed	B-X
a	B-X
ManNAc	B-X
kinase	B-X
activity	B-X
in	B-X
vitro	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
hyposialylated	B-X
BJA-B	B-X
K20	B-X
subclone	B-X
displayed	B-X
only	B-X
the	B-X
N-acetylmannosamine	B-X
kinase	B-X
peak	B-X
,	B-X
co-migrating	B-X
with	B-X
N-acetylglucosamine	B-X
kinase	B-X
.	B-X
We	B-X
therefore	B-X
propose	B-X
the	B-X
phosphorylation	B-X
of	B-X
N-acetylmannosamine	B-X
as	B-X
a	B-X
hitherto	B-X
unrecognized	B-X
role	B-X
of	B-X
N-acetylglucosamine	B-X
kinase	B-X
in	B-X
living	B-X
cells	B-X
.	B-X

In	O
contrast	O
,	O
the	O
hyposialylated	O
BJA	O
-	O
B	O
K20	O
subclone	O
displayed	O
only	O
the	O
N	B-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylmannosamine	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
peak	O
,	O
co	O
-	O
migrating	O
with	O
N	B-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylglucosamine	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
.	O

The	O
CMP	O
-	O
N	O
-	O
acetylneuraminic	O
acid	O
content	O
of	O
both	O
K88	O
and	O
K20	O
cells	O
and	O
the	O
sialylation	O
of	O
cell	O
surface	O
glycoconjugates	O
of	O
K20	O
cells	O
could	O
be	O
significantly	O
increased	O
by	O
supplementing	O
the	O
medium	O
with	O
N	O
-	O
acetylmannosamine	O
.	O

This	O
N	O
-	O
acetylmannosamine	O
-	O
induced	O
increase	O
was	O
drastically	O
reduced	O
by	O
co	O
-	O
supplementation	O
with	O
N	O
-	O
acetylglucosamine	O
only	O
in	O
K20	O
cells	O
.	O

We	O
therefore	O
propose	O
the	O
phosphorylation	O
of	O
N	O
-	O
acetylmannosamine	O
as	O
a	O
hitherto	O
unrecognized	O
role	O
of	O
N	B-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylglucosamine	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
in	O
living	O
cells	O
.	O

Overlapping	O
and	O
distinct	O
roles	O
of	O
the	O
duplicated	O
yeast	O
transcription	O
factors	O
Ace2p	B-Gene_or_gene_product
and	O
Swi5p	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
yeast	B-X
transcription	B-X
factors	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
target	B-X
genes	B-X
involved	B-X
in	B-X
mating	B-X
type	B-X
switching	B-X
,	B-X
exit	B-X
from	B-X
mitosis	B-X
and	B-X
cell	B-X
wall	B-X
function	B-X
.	B-X
We	B-X
describe	B-X
the	B-X
analysis	B-X
of	B-X
12	B-X
novel	B-X
targets	B-X
,	B-X
some	B-X
regulated	B-X
by	B-X
Ace2p	B-X
or	B-X
Swi5p	B-X
alone	B-X
and	B-X
some	B-X
by	B-X
both	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Ace2p	B-X
is	B-X
the	B-X
major	B-X
regulator	B-X
of	B-X
four	B-X
genes	B-X
(	B-X
CTS1	B-X
,	B-X
YHR143W	B-X
,	B-X
SCW11	B-X
and	B-X
YER124C	B-X
)	B-X
.	B-X
Expression	B-X
of	B-X
all	B-X
four	B-X
is	B-X
inhibited	B-X
by	B-X
Swi5p	B-X
.	B-X
Like	B-X
Cts1p	B-X
and	B-X
Scw11p	B-X
,	B-X
the	B-X
two	B-X
new	B-X
Ace2p	B-X
targets	B-X
are	B-X
associated	B-X
with	B-X
cell	B-X
wall	B-X
metabolism	B-X
.	B-X
Expression	B-X
of	B-X
PIR1	B-X
,	B-X
YPL158C	B-X
and	B-X
YNL046W	B-X
is	B-X
dependent	B-X
on	B-X
Swi5p	B-X
alone	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
,	B-X
although	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
co-operate	B-X
to	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
,	B-X
some	B-X
functional	B-X
divergence	B-X
has	B-X
occurred	B-X
.	B-X
This	B-X
results	B-X
in	B-X
a	B-X
delay	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
those	B-X
genes	B-X
predominantly	B-X
regulated	B-X
by	B-X
Ace2p	B-X
,	B-X
compared	B-X
with	B-X
those	B-X
predominantly	B-X
regulated	B-X
by	B-X
Swi5p	B-X
.	B-X

The	O
yeast	O
transcription	O
factors	O
Ace2p	B-Gene_or_gene_product
and	O
Swi5p	B-Gene_or_gene_product
regulate	O
the	O
expression	O
of	O
several	O
target	O
genes	O
involved	O
in	O
mating	O
type	O
switching	O
,	O
exit	O
from	O
mitosis	O
and	O
cell	O
wall	O
function	O
.	O
<EOS>	B-X
The	B-X
yeast	B-X
transcription	B-X
factors	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
target	B-X
genes	B-X
involved	B-X
in	B-X
mating	B-X
type	B-X
switching	B-X
,	B-X
exit	B-X
from	B-X
mitosis	B-X
and	B-X
cell	B-X
wall	B-X
function	B-X
.	B-X
We	B-X
describe	B-X
the	B-X
analysis	B-X
of	B-X
12	B-X
novel	B-X
targets	B-X
,	B-X
some	B-X
regulated	B-X
by	B-X
Ace2p	B-X
or	B-X
Swi5p	B-X
alone	B-X
and	B-X
some	B-X
by	B-X
both	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Ace2p	B-X
is	B-X
the	B-X
major	B-X
regulator	B-X
of	B-X
four	B-X
genes	B-X
(	B-X
CTS1	B-X
,	B-X
YHR143W	B-X
,	B-X
SCW11	B-X
and	B-X
YER124C	B-X
)	B-X
.	B-X
Expression	B-X
of	B-X
all	B-X
four	B-X
is	B-X
inhibited	B-X
by	B-X
Swi5p	B-X
.	B-X
Like	B-X
Cts1p	B-X
and	B-X
Scw11p	B-X
,	B-X
the	B-X
two	B-X
new	B-X
Ace2p	B-X
targets	B-X
are	B-X
associated	B-X
with	B-X
cell	B-X
wall	B-X
metabolism	B-X
.	B-X
Yhr143p	B-X
is	B-X
localized	B-X
to	B-X
the	B-X
cell	B-X
wall	B-X
,	B-X
and	B-X
deletion	B-X
affects	B-X
cell	B-X
separation	B-X
and	B-X
enhances	B-X
pseudohyphal	B-X
growth	B-X
.	B-X
Deleting	B-X
YER124C	B-X
also	B-X
affects	B-X
cell	B-X
separation	B-X
and	B-X
sensitivity	B-X
to	B-X
drugs	B-X
targeted	B-X
against	B-X
the	B-X
cell	B-X
wall	B-X
.	B-X
Expression	B-X
of	B-X
PIR1	B-X
,	B-X
YPL158C	B-X
and	B-X
YNL046W	B-X
is	B-X
dependent	B-X
on	B-X
Swi5p	B-X
alone	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
expression	B-X
of	B-X
YBR158W	B-X
,	B-X
YNL078W	B-X
and	B-X
YOR264W	B-X
is	B-X
minimized	B-X
when	B-X
both	B-X
ace2	B-X
and	B-X
swi5	B-X
are	B-X
disrupted	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
,	B-X
although	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
co-operate	B-X
to	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
,	B-X
some	B-X
functional	B-X
divergence	B-X
has	B-X
occurred	B-X
.	B-X
This	B-X
results	B-X
in	B-X
a	B-X
delay	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
those	B-X
genes	B-X
predominantly	B-X
regulated	B-X
by	B-X
Ace2p	B-X
,	B-X
compared	B-X
with	B-X
those	B-X
predominantly	B-X
regulated	B-X
by	B-X
Swi5p	B-X
.	B-X

We	O
describe	O
the	O
analysis	O
of	O
12	O
novel	O
targets	O
,	O
some	O
regulated	O
by	O
Ace2p	B-Gene_or_gene_product
or	O
Swi5p	B-Gene_or_gene_product
alone	O
and	O
some	O
by	O
both	O
.	O
<EOS>	B-X
The	B-X
yeast	B-X
transcription	B-X
factors	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
target	B-X
genes	B-X
involved	B-X
in	B-X
mating	B-X
type	B-X
switching	B-X
,	B-X
exit	B-X
from	B-X
mitosis	B-X
and	B-X
cell	B-X
wall	B-X
function	B-X
.	B-X
We	B-X
describe	B-X
the	B-X
analysis	B-X
of	B-X
12	B-X
novel	B-X
targets	B-X
,	B-X
some	B-X
regulated	B-X
by	B-X
Ace2p	B-X
or	B-X
Swi5p	B-X
alone	B-X
and	B-X
some	B-X
by	B-X
both	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Ace2p	B-X
is	B-X
the	B-X
major	B-X
regulator	B-X
of	B-X
four	B-X
genes	B-X
(	B-X
CTS1	B-X
,	B-X
YHR143W	B-X
,	B-X
SCW11	B-X
and	B-X
YER124C	B-X
)	B-X
.	B-X
Expression	B-X
of	B-X
all	B-X
four	B-X
is	B-X
inhibited	B-X
by	B-X
Swi5p	B-X
.	B-X
Like	B-X
Cts1p	B-X
and	B-X
Scw11p	B-X
,	B-X
the	B-X
two	B-X
new	B-X
Ace2p	B-X
targets	B-X
are	B-X
associated	B-X
with	B-X
cell	B-X
wall	B-X
metabolism	B-X
.	B-X
Deleting	B-X
YER124C	B-X
also	B-X
affects	B-X
cell	B-X
separation	B-X
and	B-X
sensitivity	B-X
to	B-X
drugs	B-X
targeted	B-X
against	B-X
the	B-X
cell	B-X
wall	B-X
.	B-X
Expression	B-X
of	B-X
PIR1	B-X
,	B-X
YPL158C	B-X
and	B-X
YNL046W	B-X
is	B-X
dependent	B-X
on	B-X
Swi5p	B-X
alone	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
,	B-X
although	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
co-operate	B-X
to	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
,	B-X
some	B-X
functional	B-X
divergence	B-X
has	B-X
occurred	B-X
.	B-X
This	B-X
results	B-X
in	B-X
a	B-X
delay	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
those	B-X
genes	B-X
predominantly	B-X
regulated	B-X
by	B-X
Ace2p	B-X
,	B-X
compared	B-X
with	B-X
those	B-X
predominantly	B-X
regulated	B-X
by	B-X
Swi5p	B-X
.	B-X

We	O
show	O
that	O
Ace2p	B-Gene_or_gene_product
is	O
the	O
major	O
regulator	O
of	O
four	O
genes	O
(	O
CTS1	B-Gene_or_gene_product
,	O
YHR143W	B-Gene_or_gene_product
,	O
SCW11	B-Gene_or_gene_product
and	O
YER124C	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
The	B-X
yeast	B-X
transcription	B-X
factors	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
target	B-X
genes	B-X
involved	B-X
in	B-X
mating	B-X
type	B-X
switching	B-X
,	B-X
exit	B-X
from	B-X
mitosis	B-X
and	B-X
cell	B-X
wall	B-X
function	B-X
.	B-X
We	B-X
describe	B-X
the	B-X
analysis	B-X
of	B-X
12	B-X
novel	B-X
targets	B-X
,	B-X
some	B-X
regulated	B-X
by	B-X
Ace2p	B-X
or	B-X
Swi5p	B-X
alone	B-X
and	B-X
some	B-X
by	B-X
both	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Ace2p	B-X
is	B-X
the	B-X
major	B-X
regulator	B-X
of	B-X
four	B-X
genes	B-X
(	B-X
CTS1	B-X
,	B-X
YHR143W	B-X
,	B-X
SCW11	B-X
and	B-X
YER124C	B-X
)	B-X
.	B-X
Expression	B-X
of	B-X
all	B-X
four	B-X
is	B-X
inhibited	B-X
by	B-X
Swi5p	B-X
.	B-X
Like	B-X
Cts1p	B-X
and	B-X
Scw11p	B-X
,	B-X
the	B-X
two	B-X
new	B-X
Ace2p	B-X
targets	B-X
are	B-X
associated	B-X
with	B-X
cell	B-X
wall	B-X
metabolism	B-X
.	B-X
Deleting	B-X
YER124C	B-X
also	B-X
affects	B-X
cell	B-X
separation	B-X
and	B-X
sensitivity	B-X
to	B-X
drugs	B-X
targeted	B-X
against	B-X
the	B-X
cell	B-X
wall	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
,	B-X
although	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
co-operate	B-X
to	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
,	B-X
some	B-X
functional	B-X
divergence	B-X
has	B-X
occurred	B-X
.	B-X
This	B-X
results	B-X
in	B-X
a	B-X
delay	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
those	B-X
genes	B-X
predominantly	B-X
regulated	B-X
by	B-X
Ace2p	B-X
,	B-X
compared	B-X
with	B-X
those	B-X
predominantly	B-X
regulated	B-X
by	B-X
Swi5p	B-X
.	B-X

Expression	O
of	O
all	O
four	O
is	O
inhibited	O
by	O
Swi5p	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
yeast	B-X
transcription	B-X
factors	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
target	B-X
genes	B-X
involved	B-X
in	B-X
mating	B-X
type	B-X
switching	B-X
,	B-X
exit	B-X
from	B-X
mitosis	B-X
and	B-X
cell	B-X
wall	B-X
function	B-X
.	B-X
We	B-X
describe	B-X
the	B-X
analysis	B-X
of	B-X
12	B-X
novel	B-X
targets	B-X
,	B-X
some	B-X
regulated	B-X
by	B-X
Ace2p	B-X
or	B-X
Swi5p	B-X
alone	B-X
and	B-X
some	B-X
by	B-X
both	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Ace2p	B-X
is	B-X
the	B-X
major	B-X
regulator	B-X
of	B-X
four	B-X
genes	B-X
(	B-X
CTS1	B-X
,	B-X
YHR143W	B-X
,	B-X
SCW11	B-X
and	B-X
YER124C	B-X
)	B-X
.	B-X
Expression	B-X
of	B-X
all	B-X
four	B-X
is	B-X
inhibited	B-X
by	B-X
Swi5p	B-X
.	B-X
Expression	B-X
of	B-X
PIR1	B-X
,	B-X
YPL158C	B-X
and	B-X
YNL046W	B-X
is	B-X
dependent	B-X
on	B-X
Swi5p	B-X
alone	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
,	B-X
although	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
co-operate	B-X
to	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
,	B-X
some	B-X
functional	B-X
divergence	B-X
has	B-X
occurred	B-X
.	B-X
This	B-X
results	B-X
in	B-X
a	B-X
delay	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
those	B-X
genes	B-X
predominantly	B-X
regulated	B-X
by	B-X
Ace2p	B-X
,	B-X
compared	B-X
with	B-X
those	B-X
predominantly	B-X
regulated	B-X
by	B-X
Swi5p	B-X
.	B-X

Like	O
Cts1p	B-Gene_or_gene_product
and	O
Scw11p	B-Gene_or_gene_product
,	O
the	O
two	O
new	O
Ace2p	B-Gene_or_gene_product
targets	O
are	O
associated	O
with	O
cell	O
wall	O
metabolism	O
.	O
<EOS>	B-X
The	B-X
yeast	B-X
transcription	B-X
factors	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
target	B-X
genes	B-X
involved	B-X
in	B-X
mating	B-X
type	B-X
switching	B-X
,	B-X
exit	B-X
from	B-X
mitosis	B-X
and	B-X
cell	B-X
wall	B-X
function	B-X
.	B-X
We	B-X
describe	B-X
the	B-X
analysis	B-X
of	B-X
12	B-X
novel	B-X
targets	B-X
,	B-X
some	B-X
regulated	B-X
by	B-X
Ace2p	B-X
or	B-X
Swi5p	B-X
alone	B-X
and	B-X
some	B-X
by	B-X
both	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Ace2p	B-X
is	B-X
the	B-X
major	B-X
regulator	B-X
of	B-X
four	B-X
genes	B-X
(	B-X
CTS1	B-X
,	B-X
YHR143W	B-X
,	B-X
SCW11	B-X
and	B-X
YER124C	B-X
)	B-X
.	B-X
Like	B-X
Cts1p	B-X
and	B-X
Scw11p	B-X
,	B-X
the	B-X
two	B-X
new	B-X
Ace2p	B-X
targets	B-X
are	B-X
associated	B-X
with	B-X
cell	B-X
wall	B-X
metabolism	B-X
.	B-X
Yhr143p	B-X
is	B-X
localized	B-X
to	B-X
the	B-X
cell	B-X
wall	B-X
,	B-X
and	B-X
deletion	B-X
affects	B-X
cell	B-X
separation	B-X
and	B-X
enhances	B-X
pseudohyphal	B-X
growth	B-X
.	B-X
Deleting	B-X
YER124C	B-X
also	B-X
affects	B-X
cell	B-X
separation	B-X
and	B-X
sensitivity	B-X
to	B-X
drugs	B-X
targeted	B-X
against	B-X
the	B-X
cell	B-X
wall	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
,	B-X
although	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
co-operate	B-X
to	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
,	B-X
some	B-X
functional	B-X
divergence	B-X
has	B-X
occurred	B-X
.	B-X
This	B-X
results	B-X
in	B-X
a	B-X
delay	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
those	B-X
genes	B-X
predominantly	B-X
regulated	B-X
by	B-X
Ace2p	B-X
,	B-X
compared	B-X
with	B-X
those	B-X
predominantly	B-X
regulated	B-X
by	B-X
Swi5p	B-X
.	B-X

Yhr143p	B-Gene_or_gene_product
is	O
localized	O
to	O
the	O
cell	O
wall	O
,	O
and	O
deletion	O
affects	O
cell	O
separation	O
and	O
enhances	O
pseudohyphal	O
growth	O
.	O

Deleting	O
YER124C	B-Gene_or_gene_product
also	O
affects	O
cell	O
separation	O
and	O
sensitivity	O
to	O
drugs	O
targeted	O
against	O
the	O
cell	O
wall	O
.	O
<EOS>	B-X
The	B-X
yeast	B-X
transcription	B-X
factors	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
target	B-X
genes	B-X
involved	B-X
in	B-X
mating	B-X
type	B-X
switching	B-X
,	B-X
exit	B-X
from	B-X
mitosis	B-X
and	B-X
cell	B-X
wall	B-X
function	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Ace2p	B-X
is	B-X
the	B-X
major	B-X
regulator	B-X
of	B-X
four	B-X
genes	B-X
(	B-X
CTS1	B-X
,	B-X
YHR143W	B-X
,	B-X
SCW11	B-X
and	B-X
YER124C	B-X
)	B-X
.	B-X
Like	B-X
Cts1p	B-X
and	B-X
Scw11p	B-X
,	B-X
the	B-X
two	B-X
new	B-X
Ace2p	B-X
targets	B-X
are	B-X
associated	B-X
with	B-X
cell	B-X
wall	B-X
metabolism	B-X
.	B-X
Yhr143p	B-X
is	B-X
localized	B-X
to	B-X
the	B-X
cell	B-X
wall	B-X
,	B-X
and	B-X
deletion	B-X
affects	B-X
cell	B-X
separation	B-X
and	B-X
enhances	B-X
pseudohyphal	B-X
growth	B-X
.	B-X
Deleting	B-X
YER124C	B-X
also	B-X
affects	B-X
cell	B-X
separation	B-X
and	B-X
sensitivity	B-X
to	B-X
drugs	B-X
targeted	B-X
against	B-X
the	B-X
cell	B-X
wall	B-X
.	B-X

Expression	O
of	O
PIR1	B-Gene_or_gene_product
,	O
YPL158C	B-Gene_or_gene_product
and	O
YNL046W	B-Gene_or_gene_product
is	O
dependent	O
on	O
Swi5p	B-Gene_or_gene_product
alone	O
.	O
<EOS>	B-X
The	B-X
yeast	B-X
transcription	B-X
factors	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
target	B-X
genes	B-X
involved	B-X
in	B-X
mating	B-X
type	B-X
switching	B-X
,	B-X
exit	B-X
from	B-X
mitosis	B-X
and	B-X
cell	B-X
wall	B-X
function	B-X
.	B-X
We	B-X
describe	B-X
the	B-X
analysis	B-X
of	B-X
12	B-X
novel	B-X
targets	B-X
,	B-X
some	B-X
regulated	B-X
by	B-X
Ace2p	B-X
or	B-X
Swi5p	B-X
alone	B-X
and	B-X
some	B-X
by	B-X
both	B-X
.	B-X
Expression	B-X
of	B-X
all	B-X
four	B-X
is	B-X
inhibited	B-X
by	B-X
Swi5p	B-X
.	B-X
Expression	B-X
of	B-X
PIR1	B-X
,	B-X
YPL158C	B-X
and	B-X
YNL046W	B-X
is	B-X
dependent	B-X
on	B-X
Swi5p	B-X
alone	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
,	B-X
although	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
co-operate	B-X
to	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
,	B-X
some	B-X
functional	B-X
divergence	B-X
has	B-X
occurred	B-X
.	B-X
This	B-X
results	B-X
in	B-X
a	B-X
delay	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
those	B-X
genes	B-X
predominantly	B-X
regulated	B-X
by	B-X
Ace2p	B-X
,	B-X
compared	B-X
with	B-X
those	B-X
predominantly	B-X
regulated	B-X
by	B-X
Swi5p	B-X
.	B-X

In	O
contrast	O
,	O
expression	O
of	O
YBR158W	B-Gene_or_gene_product
,	O
YNL078W	B-Gene_or_gene_product
and	O
YOR264W	B-Gene_or_gene_product
is	O
minimized	O
when	O
both	O
ace2	B-Gene_or_gene_product
and	O
swi5	B-Gene_or_gene_product
are	O
disrupted	O
.	O
<EOS>	B-X
The	B-X
yeast	B-X
transcription	B-X
factors	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
target	B-X
genes	B-X
involved	B-X
in	B-X
mating	B-X
type	B-X
switching	B-X
,	B-X
exit	B-X
from	B-X
mitosis	B-X
and	B-X
cell	B-X
wall	B-X
function	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
expression	B-X
of	B-X
YBR158W	B-X
,	B-X
YNL078W	B-X
and	B-X
YOR264W	B-X
is	B-X
minimized	B-X
when	B-X
both	B-X
ace2	B-X
and	B-X
swi5	B-X
are	B-X
disrupted	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
,	B-X
although	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
co-operate	B-X
to	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
,	B-X
some	B-X
functional	B-X
divergence	B-X
has	B-X
occurred	B-X
.	B-X
This	B-X
results	B-X
in	B-X
a	B-X
delay	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
those	B-X
genes	B-X
predominantly	B-X
regulated	B-X
by	B-X
Ace2p	B-X
,	B-X
compared	B-X
with	B-X
those	B-X
predominantly	B-X
regulated	B-X
by	B-X
Swi5p	B-X
.	B-X

We	O
propose	O
that	O
,	O
although	O
Ace2p	B-Gene_or_gene_product
and	O
Swi5p	B-Gene_or_gene_product
co	O
-	O
operate	O
to	O
induce	O
the	O
expression	O
of	O
a	O
subset	O
of	O
genes	O
,	O
some	O
functional	O
divergence	O
has	O
occurred	O
.	O
<EOS>	B-X
The	B-X
yeast	B-X
transcription	B-X
factors	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
target	B-X
genes	B-X
involved	B-X
in	B-X
mating	B-X
type	B-X
switching	B-X
,	B-X
exit	B-X
from	B-X
mitosis	B-X
and	B-X
cell	B-X
wall	B-X
function	B-X
.	B-X
We	B-X
describe	B-X
the	B-X
analysis	B-X
of	B-X
12	B-X
novel	B-X
targets	B-X
,	B-X
some	B-X
regulated	B-X
by	B-X
Ace2p	B-X
or	B-X
Swi5p	B-X
alone	B-X
and	B-X
some	B-X
by	B-X
both	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Ace2p	B-X
is	B-X
the	B-X
major	B-X
regulator	B-X
of	B-X
four	B-X
genes	B-X
(	B-X
CTS1	B-X
,	B-X
YHR143W	B-X
,	B-X
SCW11	B-X
and	B-X
YER124C	B-X
)	B-X
.	B-X
Expression	B-X
of	B-X
all	B-X
four	B-X
is	B-X
inhibited	B-X
by	B-X
Swi5p	B-X
.	B-X
Like	B-X
Cts1p	B-X
and	B-X
Scw11p	B-X
,	B-X
the	B-X
two	B-X
new	B-X
Ace2p	B-X
targets	B-X
are	B-X
associated	B-X
with	B-X
cell	B-X
wall	B-X
metabolism	B-X
.	B-X
Expression	B-X
of	B-X
PIR1	B-X
,	B-X
YPL158C	B-X
and	B-X
YNL046W	B-X
is	B-X
dependent	B-X
on	B-X
Swi5p	B-X
alone	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
expression	B-X
of	B-X
YBR158W	B-X
,	B-X
YNL078W	B-X
and	B-X
YOR264W	B-X
is	B-X
minimized	B-X
when	B-X
both	B-X
ace2	B-X
and	B-X
swi5	B-X
are	B-X
disrupted	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
,	B-X
although	B-X
Ace2p	B-X
and	B-X
Swi5p	B-X
co-operate	B-X
to	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
,	B-X
some	B-X
functional	B-X
divergence	B-X
has	B-X
occurred	B-X
.	B-X
This	B-X
results	B-X
in	B-X
a	B-X
delay	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
those	B-X
genes	B-X
predominantly	B-X
regulated	B-X
by	B-X
Ace2p	B-X
,	B-X
compared	B-X
with	B-X
those	B-X
predominantly	B-X
regulated	B-X
by	B-X
Swi5p	B-X
.	B-X

This	O
results	O
in	O
a	O
delay	O
in	O
the	O
expression	O
of	O
those	O
genes	O
predominantly	O
regulated	O
by	O
Ace2p	B-Gene_or_gene_product
,	O
compared	O
with	O
those	O
predominantly	O
regulated	O
by	O
Swi5p	B-Gene_or_gene_product
.	O

Binding	O
of	O
double	O
-	O
stranded	O
RNA	O
to	O
protein	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
PKR	I-Gene_or_gene_product
is	O
required	O
for	O
dimerization	O
and	O
promotes	O
critical	O
autophosphorylation	O
events	O
in	O
the	O
activation	O
loop	O
.	O
<EOS>	B-X
Protein	B-X
kinase	B-X
PKR	B-X
is	B-X
activated	B-X
by	B-X
double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
and	B-X
phosphorylates	B-X
translation	B-X
initiation	B-X
factor	B-X
2alpha	B-X
to	B-X
inhibit	B-X
protein	B-X
synthesis	B-X
in	B-X
virus-infected	B-X
mammalian	B-X
cells	B-X
.	B-X
PKR	B-X
contains	B-X
two	B-X
dsRNA	B-X
binding	B-X
motifs	B-X
(	B-X
DRBMs	B-X
I	B-X
and	B-X
II	B-X
)	B-X
required	B-X
for	B-X
activation	B-X
by	B-X
dsRNA	B-X
.	B-X
There	B-X
is	B-X
strong	B-X
evidence	B-X
that	B-X
PKR	B-X
activation	B-X
requires	B-X
dimerization	B-X
,	B-X
but	B-X
the	B-X
role	B-X
of	B-X
dsRNA	B-X
in	B-X
dimer	B-X
formation	B-X
is	B-X
controversial	B-X
.	B-X
By	B-X
making	B-X
alanine	B-X
substitutions	B-X
predicted	B-X
to	B-X
remove	B-X
increasing	B-X
numbers	B-X
of	B-X
side	B-X
chain	B-X
contacts	B-X
between	B-X
the	B-X
DRBMs	B-X
and	B-X
dsRNA	B-X
,	B-X
we	B-X
found	B-X
that	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
in	B-X
yeast	B-X
was	B-X
impaired	B-X
by	B-X
the	B-X
minimal	B-X
combinations	B-X
of	B-X
mutations	B-X
required	B-X
to	B-X
impair	B-X
dsRNA	B-X
binding	B-X
in	B-X
vitro	B-X
.	B-X
Mutation	B-X
of	B-X
Ala-67	B-X
to	B-X
Glu	B-X
in	B-X
DRBM-I	B-X
,	B-X
reported	B-X
to	B-X
abolish	B-X
dimerization	B-X
without	B-X
affecting	B-X
dsRNA	B-X
binding	B-X
,	B-X
destroyed	B-X
both	B-X
activities	B-X
in	B-X
our	B-X
assays	B-X
.	B-X
By	B-X
contrast	B-X
,	B-X
deletion	B-X
of	B-X
a	B-X
second	B-X
dimerization	B-X
region	B-X
that	B-X
overlaps	B-X
the	B-X
kinase	B-X
domain	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
PKR	B-X
dimerization	B-X
in	B-X
yeast	B-X
.	B-X
Human	B-X
PKR	B-X
contains	B-X
at	B-X
least	B-X
15	B-X
autophosphorylation	B-X
sites	B-X
,	B-X
but	B-X
only	B-X
Thr-446	B-X
and	B-X
Thr-451	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
were	B-X
found	B-X
here	B-X
to	B-X
be	B-X
critical	B-X
for	B-X
kinase	B-X
activity	B-X
in	B-X
yeast	B-X
.	B-X
Using	B-X
an	B-X
antibody	B-X
specific	B-X
for	B-X
phosphorylated	B-X
Thr-451	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
Thr-451	B-X
phosphorylation	B-X
is	B-X
stimulated	B-X
by	B-X
dsRNA	B-X
binding	B-X
.	B-X
Our	B-X
results	B-X
provide	B-X
strong	B-X
evidence	B-X
that	B-X
dsRNA	B-X
binding	B-X
is	B-X
required	B-X
for	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
molecules	B-X
in	B-X
vivo	B-X
,	B-X
leading	B-X
to	B-X
autophosphorylation	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
and	B-X
stimulation	B-X
of	B-X
the	B-X
eIF2alpha	B-X
kinase	B-X
function	B-X
of	B-X
PKR	B-X
.	B-X

Protein	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
PKR	I-Gene_or_gene_product
is	O
activated	O
by	O
double	O
-	O
stranded	O
RNA	O
(	O
dsRNA	O
)	O
and	O
phosphorylates	O
translation	B-Gene_or_gene_product
initiation	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
2alpha	I-Gene_or_gene_product
to	O
inhibit	O
protein	O
synthesis	O
in	O
virus	O
-	O
infected	O
mammalian	O
cells	O
.	O
<EOS>	B-X
Japanese	B-X
encephalitis	B-X
virus	B-X
(	B-X
JEV	B-X
)	B-X
is	B-X
an	B-X
enveloped	B-X
flavivirus	B-X
with	B-X
a	B-X
single-stranded	B-X
,	B-X
positive-sense	B-X
RNA	B-X
genome	B-X
encoding	B-X
three	B-X
structural	B-X
and	B-X
seven	B-X
nonstructural	B-X
proteins	B-X
.	B-X
To	B-X
date	B-X
,	B-X
the	B-X
role	B-X
of	B-X
JEV	B-X
nonstructural	B-X
protein	B-X
2A	B-X
(	B-X
NS2A	B-X
)	B-X
in	B-X
the	B-X
viral	B-X
life	B-X
cycle	B-X
is	B-X
largely	B-X
unknown	B-X
.	B-X
The	B-X
interferon	B-X
(	B-X
IFN	B-X
)	B-X
-induced	B-X
double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
-activated	B-X
protein	B-X
kinase	B-X
(	B-X
PKR	B-X
)	B-X
phosphorylates	B-X
the	B-X
eukaryotic	B-X
translation	B-X
initiation	B-X
factor	B-X
2α	B-X
subunit	B-X
(	B-X
eIF2α	B-X
)	B-X
after	B-X
sensing	B-X
viral	B-X
RNA	B-X
and	B-X
results	B-X
in	B-X
global	B-X
translation	B-X
arrest	B-X
as	B-X
an	B-X
important	B-X
host	B-X
antiviral	B-X
defense	B-X
response	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
JEV	B-X
NS2A	B-X
could	B-X
antagonize	B-X
PKR-mediated	B-X
growth	B-X
inhibition	B-X
in	B-X
a	B-X
galactose-inducible	B-X
PKR-expressing	B-X
yeast	B-X
system	B-X
.	B-X
In	B-X
human	B-X
cells	B-X
,	B-X
PKR	B-X
activation	B-X
,	B-X
eIF2α	B-X
phosphorylation	B-X
,	B-X
and	B-X
the	B-X
subsequent	B-X
translational	B-X
inhibition	B-X
and	B-X
cell	B-X
death	B-X
triggered	B-X
by	B-X
dsRNA	B-X
and	B-X
IFN-α	B-X
were	B-X
also	B-X
repressed	B-X
by	B-X
JEV	B-X
NS2A	B-X
.	B-X
Moreover	B-X
,	B-X
among	B-X
the	B-X
four	B-X
eIF2α	B-X
kinases	B-X
,	B-X
NS2A	B-X
specifically	B-X
blocked	B-X
the	B-X
eIF2α	B-X
phosphorylation	B-X
mediated	B-X
by	B-X
PKR	B-X
and	B-X
attenuated	B-X
the	B-X
PKR-promoted	B-X
cell	B-X
death	B-X
induced	B-X
by	B-X
the	B-X
chemotherapeutic	B-X
drug	B-X
doxorubicin	B-X
.	B-X
A	B-X
single	B-X
point	B-X
mutation	B-X
of	B-X
NS2A	B-X
residue	B-X
33	B-X
from	B-X
Thr	B-X
to	B-X
Ile	B-X
(	B-X
T33I	B-X
)	B-X
abolished	B-X
the	B-X
anti-PKR	B-X
potential	B-X
of	B-X
JEV	B-X
NS2A	B-X
.	B-X
Thus	B-X
,	B-X
JEV	B-X
NS2A	B-X
has	B-X
a	B-X
novel	B-X
function	B-X
in	B-X
blocking	B-X
the	B-X
host	B-X
antiviral	B-X
response	B-X
of	B-X
PKR	B-X
during	B-X
JEV	B-X
infection	B-X
.	B-X

PKR	B-Gene_or_gene_product
contains	O
two	O
dsRNA	O
binding	O
motifs	O
(	O
DRBMs	O
I	O
and	O
II	O
)	O
required	O
for	O
activation	O
by	O
dsRNA	O
.	O
<EOS>	B-X
Protein	B-X
kinase	B-X
PKR	B-X
is	B-X
activated	B-X
by	B-X
double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
and	B-X
phosphorylates	B-X
translation	B-X
initiation	B-X
factor	B-X
2alpha	B-X
to	B-X
inhibit	B-X
protein	B-X
synthesis	B-X
in	B-X
virus-infected	B-X
mammalian	B-X
cells	B-X
.	B-X
PKR	B-X
contains	B-X
two	B-X
dsRNA	B-X
binding	B-X
motifs	B-X
(	B-X
DRBMs	B-X
I	B-X
and	B-X
II	B-X
)	B-X
required	B-X
for	B-X
activation	B-X
by	B-X
dsRNA	B-X
.	B-X
There	B-X
is	B-X
strong	B-X
evidence	B-X
that	B-X
PKR	B-X
activation	B-X
requires	B-X
dimerization	B-X
,	B-X
but	B-X
the	B-X
role	B-X
of	B-X
dsRNA	B-X
in	B-X
dimer	B-X
formation	B-X
is	B-X
controversial	B-X
.	B-X
By	B-X
making	B-X
alanine	B-X
substitutions	B-X
predicted	B-X
to	B-X
remove	B-X
increasing	B-X
numbers	B-X
of	B-X
side	B-X
chain	B-X
contacts	B-X
between	B-X
the	B-X
DRBMs	B-X
and	B-X
dsRNA	B-X
,	B-X
we	B-X
found	B-X
that	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
in	B-X
yeast	B-X
was	B-X
impaired	B-X
by	B-X
the	B-X
minimal	B-X
combinations	B-X
of	B-X
mutations	B-X
required	B-X
to	B-X
impair	B-X
dsRNA	B-X
binding	B-X
in	B-X
vitro	B-X
.	B-X
Mutation	B-X
of	B-X
Ala-67	B-X
to	B-X
Glu	B-X
in	B-X
DRBM-I	B-X
,	B-X
reported	B-X
to	B-X
abolish	B-X
dimerization	B-X
without	B-X
affecting	B-X
dsRNA	B-X
binding	B-X
,	B-X
destroyed	B-X
both	B-X
activities	B-X
in	B-X
our	B-X
assays	B-X
.	B-X
By	B-X
contrast	B-X
,	B-X
deletion	B-X
of	B-X
a	B-X
second	B-X
dimerization	B-X
region	B-X
that	B-X
overlaps	B-X
the	B-X
kinase	B-X
domain	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
PKR	B-X
dimerization	B-X
in	B-X
yeast	B-X
.	B-X
Human	B-X
PKR	B-X
contains	B-X
at	B-X
least	B-X
15	B-X
autophosphorylation	B-X
sites	B-X
,	B-X
but	B-X
only	B-X
Thr-446	B-X
and	B-X
Thr-451	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
were	B-X
found	B-X
here	B-X
to	B-X
be	B-X
critical	B-X
for	B-X
kinase	B-X
activity	B-X
in	B-X
yeast	B-X
.	B-X
Using	B-X
an	B-X
antibody	B-X
specific	B-X
for	B-X
phosphorylated	B-X
Thr-451	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
Thr-451	B-X
phosphorylation	B-X
is	B-X
stimulated	B-X
by	B-X
dsRNA	B-X
binding	B-X
.	B-X
Our	B-X
results	B-X
provide	B-X
strong	B-X
evidence	B-X
that	B-X
dsRNA	B-X
binding	B-X
is	B-X
required	B-X
for	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
molecules	B-X
in	B-X
vivo	B-X
,	B-X
leading	B-X
to	B-X
autophosphorylation	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
and	B-X
stimulation	B-X
of	B-X
the	B-X
eIF2alpha	B-X
kinase	B-X
function	B-X
of	B-X
PKR	B-X
.	B-X

There	O
is	O
strong	O
evidence	O
that	O
PKR	B-Gene_or_gene_product
activation	O
requires	O
dimerization	O
,	O
but	O
the	O
role	O
of	O
dsRNA	O
in	O
dimer	O
formation	O
is	O
controversial	O
.	O
<EOS>	B-X
Protein	B-X
kinase	B-X
PKR	B-X
is	B-X
activated	B-X
by	B-X
double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
and	B-X
phosphorylates	B-X
translation	B-X
initiation	B-X
factor	B-X
2alpha	B-X
to	B-X
inhibit	B-X
protein	B-X
synthesis	B-X
in	B-X
virus-infected	B-X
mammalian	B-X
cells	B-X
.	B-X
PKR	B-X
contains	B-X
two	B-X
dsRNA	B-X
binding	B-X
motifs	B-X
(	B-X
DRBMs	B-X
I	B-X
and	B-X
II	B-X
)	B-X
required	B-X
for	B-X
activation	B-X
by	B-X
dsRNA	B-X
.	B-X
There	B-X
is	B-X
strong	B-X
evidence	B-X
that	B-X
PKR	B-X
activation	B-X
requires	B-X
dimerization	B-X
,	B-X
but	B-X
the	B-X
role	B-X
of	B-X
dsRNA	B-X
in	B-X
dimer	B-X
formation	B-X
is	B-X
controversial	B-X
.	B-X
By	B-X
making	B-X
alanine	B-X
substitutions	B-X
predicted	B-X
to	B-X
remove	B-X
increasing	B-X
numbers	B-X
of	B-X
side	B-X
chain	B-X
contacts	B-X
between	B-X
the	B-X
DRBMs	B-X
and	B-X
dsRNA	B-X
,	B-X
we	B-X
found	B-X
that	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
in	B-X
yeast	B-X
was	B-X
impaired	B-X
by	B-X
the	B-X
minimal	B-X
combinations	B-X
of	B-X
mutations	B-X
required	B-X
to	B-X
impair	B-X
dsRNA	B-X
binding	B-X
in	B-X
vitro	B-X
.	B-X
Mutation	B-X
of	B-X
Ala-67	B-X
to	B-X
Glu	B-X
in	B-X
DRBM-I	B-X
,	B-X
reported	B-X
to	B-X
abolish	B-X
dimerization	B-X
without	B-X
affecting	B-X
dsRNA	B-X
binding	B-X
,	B-X
destroyed	B-X
both	B-X
activities	B-X
in	B-X
our	B-X
assays	B-X
.	B-X
By	B-X
contrast	B-X
,	B-X
deletion	B-X
of	B-X
a	B-X
second	B-X
dimerization	B-X
region	B-X
that	B-X
overlaps	B-X
the	B-X
kinase	B-X
domain	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
PKR	B-X
dimerization	B-X
in	B-X
yeast	B-X
.	B-X
Human	B-X
PKR	B-X
contains	B-X
at	B-X
least	B-X
15	B-X
autophosphorylation	B-X
sites	B-X
,	B-X
but	B-X
only	B-X
Thr-446	B-X
and	B-X
Thr-451	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
were	B-X
found	B-X
here	B-X
to	B-X
be	B-X
critical	B-X
for	B-X
kinase	B-X
activity	B-X
in	B-X
yeast	B-X
.	B-X
Using	B-X
an	B-X
antibody	B-X
specific	B-X
for	B-X
phosphorylated	B-X
Thr-451	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
Thr-451	B-X
phosphorylation	B-X
is	B-X
stimulated	B-X
by	B-X
dsRNA	B-X
binding	B-X
.	B-X
Our	B-X
results	B-X
provide	B-X
strong	B-X
evidence	B-X
that	B-X
dsRNA	B-X
binding	B-X
is	B-X
required	B-X
for	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
molecules	B-X
in	B-X
vivo	B-X
,	B-X
leading	B-X
to	B-X
autophosphorylation	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
and	B-X
stimulation	B-X
of	B-X
the	B-X
eIF2alpha	B-X
kinase	B-X
function	B-X
of	B-X
PKR	B-X
.	B-X

By	O
making	O
alanine	O
substitutions	O
predicted	O
to	O
remove	O
increasing	O
numbers	O
of	O
side	O
chain	O
contacts	O
between	O
the	O
DRBMs	O
and	O
dsRNA	O
,	O
we	O
found	O
that	O
dimerization	O
of	O
full	O
-	O
length	O
PKR	B-Gene_or_gene_product
in	O
yeast	O
was	O
impaired	O
by	O
the	O
minimal	O
combinations	O
of	O
mutations	O
required	O
to	O
impair	O
dsRNA	O
binding	O
in	O
vitro	O
.	O
<EOS>	B-X
Protein	B-X
kinase	B-X
PKR	B-X
is	B-X
activated	B-X
by	B-X
double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
and	B-X
phosphorylates	B-X
translation	B-X
initiation	B-X
factor	B-X
2alpha	B-X
to	B-X
inhibit	B-X
protein	B-X
synthesis	B-X
in	B-X
virus-infected	B-X
mammalian	B-X
cells	B-X
.	B-X
PKR	B-X
contains	B-X
two	B-X
dsRNA	B-X
binding	B-X
motifs	B-X
(	B-X
DRBMs	B-X
I	B-X
and	B-X
II	B-X
)	B-X
required	B-X
for	B-X
activation	B-X
by	B-X
dsRNA	B-X
.	B-X
There	B-X
is	B-X
strong	B-X
evidence	B-X
that	B-X
PKR	B-X
activation	B-X
requires	B-X
dimerization	B-X
,	B-X
but	B-X
the	B-X
role	B-X
of	B-X
dsRNA	B-X
in	B-X
dimer	B-X
formation	B-X
is	B-X
controversial	B-X
.	B-X
By	B-X
making	B-X
alanine	B-X
substitutions	B-X
predicted	B-X
to	B-X
remove	B-X
increasing	B-X
numbers	B-X
of	B-X
side	B-X
chain	B-X
contacts	B-X
between	B-X
the	B-X
DRBMs	B-X
and	B-X
dsRNA	B-X
,	B-X
we	B-X
found	B-X
that	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
in	B-X
yeast	B-X
was	B-X
impaired	B-X
by	B-X
the	B-X
minimal	B-X
combinations	B-X
of	B-X
mutations	B-X
required	B-X
to	B-X
impair	B-X
dsRNA	B-X
binding	B-X
in	B-X
vitro	B-X
.	B-X
Mutation	B-X
of	B-X
Ala-67	B-X
to	B-X
Glu	B-X
in	B-X
DRBM-I	B-X
,	B-X
reported	B-X
to	B-X
abolish	B-X
dimerization	B-X
without	B-X
affecting	B-X
dsRNA	B-X
binding	B-X
,	B-X
destroyed	B-X
both	B-X
activities	B-X
in	B-X
our	B-X
assays	B-X
.	B-X
By	B-X
contrast	B-X
,	B-X
deletion	B-X
of	B-X
a	B-X
second	B-X
dimerization	B-X
region	B-X
that	B-X
overlaps	B-X
the	B-X
kinase	B-X
domain	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
PKR	B-X
dimerization	B-X
in	B-X
yeast	B-X
.	B-X
Human	B-X
PKR	B-X
contains	B-X
at	B-X
least	B-X
15	B-X
autophosphorylation	B-X
sites	B-X
,	B-X
but	B-X
only	B-X
Thr-446	B-X
and	B-X
Thr-451	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
were	B-X
found	B-X
here	B-X
to	B-X
be	B-X
critical	B-X
for	B-X
kinase	B-X
activity	B-X
in	B-X
yeast	B-X
.	B-X
Using	B-X
an	B-X
antibody	B-X
specific	B-X
for	B-X
phosphorylated	B-X
Thr-451	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
Thr-451	B-X
phosphorylation	B-X
is	B-X
stimulated	B-X
by	B-X
dsRNA	B-X
binding	B-X
.	B-X
Our	B-X
results	B-X
provide	B-X
strong	B-X
evidence	B-X
that	B-X
dsRNA	B-X
binding	B-X
is	B-X
required	B-X
for	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
molecules	B-X
in	B-X
vivo	B-X
,	B-X
leading	B-X
to	B-X
autophosphorylation	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
and	B-X
stimulation	B-X
of	B-X
the	B-X
eIF2alpha	B-X
kinase	B-X
function	B-X
of	B-X
PKR	B-X
.	B-X

Mutation	O
of	O
Ala	O
-	O
67	O
to	O
Glu	O
in	O
DRBM	O
-	O
I	O
,	O
reported	O
to	O
abolish	O
dimerization	O
without	O
affecting	O
dsRNA	O
binding	O
,	O
destroyed	O
both	O
activities	O
in	O
our	O
assays	O
.	O
<EOS>	B-X
Protein	B-X
kinase	B-X
PKR	B-X
is	B-X
activated	B-X
by	B-X
double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
and	B-X
phosphorylates	B-X
translation	B-X
initiation	B-X
factor	B-X
2alpha	B-X
to	B-X
inhibit	B-X
protein	B-X
synthesis	B-X
in	B-X
virus-infected	B-X
mammalian	B-X
cells	B-X
.	B-X
PKR	B-X
contains	B-X
two	B-X
dsRNA	B-X
binding	B-X
motifs	B-X
(	B-X
DRBMs	B-X
I	B-X
and	B-X
II	B-X
)	B-X
required	B-X
for	B-X
activation	B-X
by	B-X
dsRNA	B-X
.	B-X
There	B-X
is	B-X
strong	B-X
evidence	B-X
that	B-X
PKR	B-X
activation	B-X
requires	B-X
dimerization	B-X
,	B-X
but	B-X
the	B-X
role	B-X
of	B-X
dsRNA	B-X
in	B-X
dimer	B-X
formation	B-X
is	B-X
controversial	B-X
.	B-X
By	B-X
making	B-X
alanine	B-X
substitutions	B-X
predicted	B-X
to	B-X
remove	B-X
increasing	B-X
numbers	B-X
of	B-X
side	B-X
chain	B-X
contacts	B-X
between	B-X
the	B-X
DRBMs	B-X
and	B-X
dsRNA	B-X
,	B-X
we	B-X
found	B-X
that	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
in	B-X
yeast	B-X
was	B-X
impaired	B-X
by	B-X
the	B-X
minimal	B-X
combinations	B-X
of	B-X
mutations	B-X
required	B-X
to	B-X
impair	B-X
dsRNA	B-X
binding	B-X
in	B-X
vitro	B-X
.	B-X
Mutation	B-X
of	B-X
Ala-67	B-X
to	B-X
Glu	B-X
in	B-X
DRBM-I	B-X
,	B-X
reported	B-X
to	B-X
abolish	B-X
dimerization	B-X
without	B-X
affecting	B-X
dsRNA	B-X
binding	B-X
,	B-X
destroyed	B-X
both	B-X
activities	B-X
in	B-X
our	B-X
assays	B-X
.	B-X
By	B-X
contrast	B-X
,	B-X
deletion	B-X
of	B-X
a	B-X
second	B-X
dimerization	B-X
region	B-X
that	B-X
overlaps	B-X
the	B-X
kinase	B-X
domain	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
PKR	B-X
dimerization	B-X
in	B-X
yeast	B-X
.	B-X
Using	B-X
an	B-X
antibody	B-X
specific	B-X
for	B-X
phosphorylated	B-X
Thr-451	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
Thr-451	B-X
phosphorylation	B-X
is	B-X
stimulated	B-X
by	B-X
dsRNA	B-X
binding	B-X
.	B-X
Our	B-X
results	B-X
provide	B-X
strong	B-X
evidence	B-X
that	B-X
dsRNA	B-X
binding	B-X
is	B-X
required	B-X
for	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
molecules	B-X
in	B-X
vivo	B-X
,	B-X
leading	B-X
to	B-X
autophosphorylation	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
and	B-X
stimulation	B-X
of	B-X
the	B-X
eIF2alpha	B-X
kinase	B-X
function	B-X
of	B-X
PKR	B-X
.	B-X

By	O
contrast	O
,	O
deletion	O
of	O
a	O
second	O
dimerization	O
region	O
that	O
overlaps	O
the	O
kinase	O
domain	O
had	O
no	O
effect	O
on	O
PKR	B-Gene_or_gene_product
dimerization	O
in	O
yeast	O
.	O
<EOS>	B-X
Protein	B-X
kinase	B-X
PKR	B-X
is	B-X
activated	B-X
by	B-X
double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
and	B-X
phosphorylates	B-X
translation	B-X
initiation	B-X
factor	B-X
2alpha	B-X
to	B-X
inhibit	B-X
protein	B-X
synthesis	B-X
in	B-X
virus-infected	B-X
mammalian	B-X
cells	B-X
.	B-X
PKR	B-X
contains	B-X
two	B-X
dsRNA	B-X
binding	B-X
motifs	B-X
(	B-X
DRBMs	B-X
I	B-X
and	B-X
II	B-X
)	B-X
required	B-X
for	B-X
activation	B-X
by	B-X
dsRNA	B-X
.	B-X
There	B-X
is	B-X
strong	B-X
evidence	B-X
that	B-X
PKR	B-X
activation	B-X
requires	B-X
dimerization	B-X
,	B-X
but	B-X
the	B-X
role	B-X
of	B-X
dsRNA	B-X
in	B-X
dimer	B-X
formation	B-X
is	B-X
controversial	B-X
.	B-X
By	B-X
making	B-X
alanine	B-X
substitutions	B-X
predicted	B-X
to	B-X
remove	B-X
increasing	B-X
numbers	B-X
of	B-X
side	B-X
chain	B-X
contacts	B-X
between	B-X
the	B-X
DRBMs	B-X
and	B-X
dsRNA	B-X
,	B-X
we	B-X
found	B-X
that	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
in	B-X
yeast	B-X
was	B-X
impaired	B-X
by	B-X
the	B-X
minimal	B-X
combinations	B-X
of	B-X
mutations	B-X
required	B-X
to	B-X
impair	B-X
dsRNA	B-X
binding	B-X
in	B-X
vitro	B-X
.	B-X
Mutation	B-X
of	B-X
Ala-67	B-X
to	B-X
Glu	B-X
in	B-X
DRBM-I	B-X
,	B-X
reported	B-X
to	B-X
abolish	B-X
dimerization	B-X
without	B-X
affecting	B-X
dsRNA	B-X
binding	B-X
,	B-X
destroyed	B-X
both	B-X
activities	B-X
in	B-X
our	B-X
assays	B-X
.	B-X
By	B-X
contrast	B-X
,	B-X
deletion	B-X
of	B-X
a	B-X
second	B-X
dimerization	B-X
region	B-X
that	B-X
overlaps	B-X
the	B-X
kinase	B-X
domain	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
PKR	B-X
dimerization	B-X
in	B-X
yeast	B-X
.	B-X
Human	B-X
PKR	B-X
contains	B-X
at	B-X
least	B-X
15	B-X
autophosphorylation	B-X
sites	B-X
,	B-X
but	B-X
only	B-X
Thr-446	B-X
and	B-X
Thr-451	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
were	B-X
found	B-X
here	B-X
to	B-X
be	B-X
critical	B-X
for	B-X
kinase	B-X
activity	B-X
in	B-X
yeast	B-X
.	B-X
Our	B-X
results	B-X
provide	B-X
strong	B-X
evidence	B-X
that	B-X
dsRNA	B-X
binding	B-X
is	B-X
required	B-X
for	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
molecules	B-X
in	B-X
vivo	B-X
,	B-X
leading	B-X
to	B-X
autophosphorylation	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
and	B-X
stimulation	B-X
of	B-X
the	B-X
eIF2alpha	B-X
kinase	B-X
function	B-X
of	B-X
PKR	B-X
.	B-X

Human	O
PKR	B-Gene_or_gene_product
contains	O
at	O
least	O
15	O
autophosphorylation	O
sites	O
,	O
but	O
only	O
Thr	O
-	O
446	O
and	O
Thr	O
-	O
451	O
in	O
the	O
activation	O
loop	O
were	O
found	O
here	O
to	O
be	O
critical	O
for	O
kinase	O
activity	O
in	O
yeast	O
.	O
<EOS>	B-X
Protein	B-X
kinase	B-X
PKR	B-X
is	B-X
activated	B-X
by	B-X
double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
and	B-X
phosphorylates	B-X
translation	B-X
initiation	B-X
factor	B-X
2alpha	B-X
to	B-X
inhibit	B-X
protein	B-X
synthesis	B-X
in	B-X
virus-infected	B-X
mammalian	B-X
cells	B-X
.	B-X
PKR	B-X
contains	B-X
two	B-X
dsRNA	B-X
binding	B-X
motifs	B-X
(	B-X
DRBMs	B-X
I	B-X
and	B-X
II	B-X
)	B-X
required	B-X
for	B-X
activation	B-X
by	B-X
dsRNA	B-X
.	B-X
There	B-X
is	B-X
strong	B-X
evidence	B-X
that	B-X
PKR	B-X
activation	B-X
requires	B-X
dimerization	B-X
,	B-X
but	B-X
the	B-X
role	B-X
of	B-X
dsRNA	B-X
in	B-X
dimer	B-X
formation	B-X
is	B-X
controversial	B-X
.	B-X
By	B-X
making	B-X
alanine	B-X
substitutions	B-X
predicted	B-X
to	B-X
remove	B-X
increasing	B-X
numbers	B-X
of	B-X
side	B-X
chain	B-X
contacts	B-X
between	B-X
the	B-X
DRBMs	B-X
and	B-X
dsRNA	B-X
,	B-X
we	B-X
found	B-X
that	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
in	B-X
yeast	B-X
was	B-X
impaired	B-X
by	B-X
the	B-X
minimal	B-X
combinations	B-X
of	B-X
mutations	B-X
required	B-X
to	B-X
impair	B-X
dsRNA	B-X
binding	B-X
in	B-X
vitro	B-X
.	B-X
By	B-X
contrast	B-X
,	B-X
deletion	B-X
of	B-X
a	B-X
second	B-X
dimerization	B-X
region	B-X
that	B-X
overlaps	B-X
the	B-X
kinase	B-X
domain	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
PKR	B-X
dimerization	B-X
in	B-X
yeast	B-X
.	B-X
Human	B-X
PKR	B-X
contains	B-X
at	B-X
least	B-X
15	B-X
autophosphorylation	B-X
sites	B-X
,	B-X
but	B-X
only	B-X
Thr-446	B-X
and	B-X
Thr-451	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
were	B-X
found	B-X
here	B-X
to	B-X
be	B-X
critical	B-X
for	B-X
kinase	B-X
activity	B-X
in	B-X
yeast	B-X
.	B-X
Using	B-X
an	B-X
antibody	B-X
specific	B-X
for	B-X
phosphorylated	B-X
Thr-451	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
Thr-451	B-X
phosphorylation	B-X
is	B-X
stimulated	B-X
by	B-X
dsRNA	B-X
binding	B-X
.	B-X
Our	B-X
results	B-X
provide	B-X
strong	B-X
evidence	B-X
that	B-X
dsRNA	B-X
binding	B-X
is	B-X
required	B-X
for	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
molecules	B-X
in	B-X
vivo	B-X
,	B-X
leading	B-X
to	B-X
autophosphorylation	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
and	B-X
stimulation	B-X
of	B-X
the	B-X
eIF2alpha	B-X
kinase	B-X
function	B-X
of	B-X
PKR	B-X
.	B-X

Using	O
an	O
antibody	O
specific	O
for	O
phosphorylated	O
Thr	O
-	O
451	O
,	O
we	O
showed	O
that	O
Thr	O
-	O
451	O
phosphorylation	O
is	O
stimulated	O
by	O
dsRNA	O
binding	O
.	O
<EOS>	B-X
Protein	B-X
kinase	B-X
PKR	B-X
is	B-X
activated	B-X
by	B-X
double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
and	B-X
phosphorylates	B-X
translation	B-X
initiation	B-X
factor	B-X
2alpha	B-X
to	B-X
inhibit	B-X
protein	B-X
synthesis	B-X
in	B-X
virus-infected	B-X
mammalian	B-X
cells	B-X
.	B-X
PKR	B-X
contains	B-X
two	B-X
dsRNA	B-X
binding	B-X
motifs	B-X
(	B-X
DRBMs	B-X
I	B-X
and	B-X
II	B-X
)	B-X
required	B-X
for	B-X
activation	B-X
by	B-X
dsRNA	B-X
.	B-X
There	B-X
is	B-X
strong	B-X
evidence	B-X
that	B-X
PKR	B-X
activation	B-X
requires	B-X
dimerization	B-X
,	B-X
but	B-X
the	B-X
role	B-X
of	B-X
dsRNA	B-X
in	B-X
dimer	B-X
formation	B-X
is	B-X
controversial	B-X
.	B-X
By	B-X
making	B-X
alanine	B-X
substitutions	B-X
predicted	B-X
to	B-X
remove	B-X
increasing	B-X
numbers	B-X
of	B-X
side	B-X
chain	B-X
contacts	B-X
between	B-X
the	B-X
DRBMs	B-X
and	B-X
dsRNA	B-X
,	B-X
we	B-X
found	B-X
that	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
in	B-X
yeast	B-X
was	B-X
impaired	B-X
by	B-X
the	B-X
minimal	B-X
combinations	B-X
of	B-X
mutations	B-X
required	B-X
to	B-X
impair	B-X
dsRNA	B-X
binding	B-X
in	B-X
vitro	B-X
.	B-X
Mutation	B-X
of	B-X
Ala-67	B-X
to	B-X
Glu	B-X
in	B-X
DRBM-I	B-X
,	B-X
reported	B-X
to	B-X
abolish	B-X
dimerization	B-X
without	B-X
affecting	B-X
dsRNA	B-X
binding	B-X
,	B-X
destroyed	B-X
both	B-X
activities	B-X
in	B-X
our	B-X
assays	B-X
.	B-X
Human	B-X
PKR	B-X
contains	B-X
at	B-X
least	B-X
15	B-X
autophosphorylation	B-X
sites	B-X
,	B-X
but	B-X
only	B-X
Thr-446	B-X
and	B-X
Thr-451	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
were	B-X
found	B-X
here	B-X
to	B-X
be	B-X
critical	B-X
for	B-X
kinase	B-X
activity	B-X
in	B-X
yeast	B-X
.	B-X
Using	B-X
an	B-X
antibody	B-X
specific	B-X
for	B-X
phosphorylated	B-X
Thr-451	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
Thr-451	B-X
phosphorylation	B-X
is	B-X
stimulated	B-X
by	B-X
dsRNA	B-X
binding	B-X
.	B-X
Our	B-X
results	B-X
provide	B-X
strong	B-X
evidence	B-X
that	B-X
dsRNA	B-X
binding	B-X
is	B-X
required	B-X
for	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
molecules	B-X
in	B-X
vivo	B-X
,	B-X
leading	B-X
to	B-X
autophosphorylation	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
and	B-X
stimulation	B-X
of	B-X
the	B-X
eIF2alpha	B-X
kinase	B-X
function	B-X
of	B-X
PKR	B-X
.	B-X

Our	O
results	O
provide	O
strong	O
evidence	O
that	O
dsRNA	O
binding	O
is	O
required	O
for	O
dimerization	O
of	O
full	O
-	O
length	O
PKR	B-Gene_or_gene_product
molecules	O
in	O
vivo	O
,	O
leading	O
to	O
autophosphorylation	O
in	O
the	O
activation	O
loop	O
and	O
stimulation	O
of	O
the	O
eIF2alpha	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
function	O
of	O
PKR	B-Gene_or_gene_product
.	O
<EOS>	B-X
Protein	B-X
kinase	B-X
PKR	B-X
is	B-X
activated	B-X
by	B-X
double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
and	B-X
phosphorylates	B-X
translation	B-X
initiation	B-X
factor	B-X
2alpha	B-X
to	B-X
inhibit	B-X
protein	B-X
synthesis	B-X
in	B-X
virus-infected	B-X
mammalian	B-X
cells	B-X
.	B-X
PKR	B-X
contains	B-X
two	B-X
dsRNA	B-X
binding	B-X
motifs	B-X
(	B-X
DRBMs	B-X
I	B-X
and	B-X
II	B-X
)	B-X
required	B-X
for	B-X
activation	B-X
by	B-X
dsRNA	B-X
.	B-X
There	B-X
is	B-X
strong	B-X
evidence	B-X
that	B-X
PKR	B-X
activation	B-X
requires	B-X
dimerization	B-X
,	B-X
but	B-X
the	B-X
role	B-X
of	B-X
dsRNA	B-X
in	B-X
dimer	B-X
formation	B-X
is	B-X
controversial	B-X
.	B-X
By	B-X
making	B-X
alanine	B-X
substitutions	B-X
predicted	B-X
to	B-X
remove	B-X
increasing	B-X
numbers	B-X
of	B-X
side	B-X
chain	B-X
contacts	B-X
between	B-X
the	B-X
DRBMs	B-X
and	B-X
dsRNA	B-X
,	B-X
we	B-X
found	B-X
that	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
in	B-X
yeast	B-X
was	B-X
impaired	B-X
by	B-X
the	B-X
minimal	B-X
combinations	B-X
of	B-X
mutations	B-X
required	B-X
to	B-X
impair	B-X
dsRNA	B-X
binding	B-X
in	B-X
vitro	B-X
.	B-X
Mutation	B-X
of	B-X
Ala-67	B-X
to	B-X
Glu	B-X
in	B-X
DRBM-I	B-X
,	B-X
reported	B-X
to	B-X
abolish	B-X
dimerization	B-X
without	B-X
affecting	B-X
dsRNA	B-X
binding	B-X
,	B-X
destroyed	B-X
both	B-X
activities	B-X
in	B-X
our	B-X
assays	B-X
.	B-X
By	B-X
contrast	B-X
,	B-X
deletion	B-X
of	B-X
a	B-X
second	B-X
dimerization	B-X
region	B-X
that	B-X
overlaps	B-X
the	B-X
kinase	B-X
domain	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
PKR	B-X
dimerization	B-X
in	B-X
yeast	B-X
.	B-X
Human	B-X
PKR	B-X
contains	B-X
at	B-X
least	B-X
15	B-X
autophosphorylation	B-X
sites	B-X
,	B-X
but	B-X
only	B-X
Thr-446	B-X
and	B-X
Thr-451	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
were	B-X
found	B-X
here	B-X
to	B-X
be	B-X
critical	B-X
for	B-X
kinase	B-X
activity	B-X
in	B-X
yeast	B-X
.	B-X
Using	B-X
an	B-X
antibody	B-X
specific	B-X
for	B-X
phosphorylated	B-X
Thr-451	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
Thr-451	B-X
phosphorylation	B-X
is	B-X
stimulated	B-X
by	B-X
dsRNA	B-X
binding	B-X
.	B-X
Our	B-X
results	B-X
provide	B-X
strong	B-X
evidence	B-X
that	B-X
dsRNA	B-X
binding	B-X
is	B-X
required	B-X
for	B-X
dimerization	B-X
of	B-X
full-length	B-X
PKR	B-X
molecules	B-X
in	B-X
vivo	B-X
,	B-X
leading	B-X
to	B-X
autophosphorylation	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
and	B-X
stimulation	B-X
of	B-X
the	B-X
eIF2alpha	B-X
kinase	B-X
function	B-X
of	B-X
PKR	B-X
.	B-X

IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
induced	O
chemokine	O
production	O
through	O
the	O
association	O
of	O
Syk	B-Gene_or_gene_product
with	O
TNF	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
in	O
nasal	O
fibroblast	O
lines	O
.	O
<EOS>	B-X
The	B-X
fibroblasts	B-X
stimulated	B-X
by	B-X
cytokines	B-X
released	B-X
the	B-X
chemokine	B-X
and	B-X
recruited	B-X
the	B-X
infiltrating	B-X
cells	B-X
,	B-X
including	B-X
eosinophils	B-X
,	B-X
that	B-X
play	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
airway	B-X
disease	B-X
.	B-X
We	B-X
established	B-X
the	B-X
human	B-X
fibroblast	B-X
lines	B-X
showing	B-X
high	B-X
Syk	B-X
expression	B-X
and	B-X
the	B-X
lines	B-X
showing	B-X
low	B-X
Syk	B-X
expression	B-X
from	B-X
pieces	B-X
of	B-X
nasal	B-X
polyp	B-X
.	B-X
IL-1	B-X
induces	B-X
the	B-X
interaction	B-X
of	B-X
TNFR-associated	B-X
factor	B-X
(	B-X
TRAF	B-X
)	B-X
6	B-X
with	B-X
IL-1R-associated	B-X
kinase	B-X
,	B-X
which	B-X
is	B-X
rapidly	B-X
recruited	B-X
to	B-X
the	B-X
IL-1R	B-X
after	B-X
IL-1	B-X
induction	B-X
,	B-X
whereas	B-X
TRAF2	B-X
participates	B-X
in	B-X
TNF-alpha-signaling	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Syk	B-X
played	B-X
a	B-X
different	B-X
role	B-X
in	B-X
IL-1-	B-X
and	B-X
TNF-alpha-induced	B-X
chemokine	B-X
production	B-X
through	B-X
a	B-X
signaling	B-X
complex	B-X
involving	B-X
Syk	B-X
and	B-X
TRAF6	B-X
.	B-X
Overexpression	B-X
of	B-X
wild-type	B-X
Syk	B-X
by	B-X
gene	B-X
transfer	B-X
enhanced	B-X
RANTES	B-X
production	B-X
from	B-X
nasal	B-X
fibroblasts	B-X
stimulated	B-X
with	B-X
IL-1	B-X
.	B-X
The	B-X
decrease	B-X
of	B-X
Syk	B-X
expression	B-X
by	B-X
the	B-X
administration	B-X
of	B-X
Syk	B-X
antisense	B-X
inhibited	B-X
RANTES	B-X
production	B-X
in	B-X
response	B-X
to	B-X
IL-1	B-X
.	B-X
However	B-X
,	B-X
the	B-X
change	B-X
of	B-X
Syk	B-X
expression	B-X
did	B-X
not	B-X
affect	B-X
RANTES	B-X
production	B-X
by	B-X
TNF-alpha	B-X
stimulation	B-X
.	B-X
We	B-X
concluded	B-X
that	B-X
Syk	B-X
is	B-X
required	B-X
for	B-X
the	B-X
IL-1-induced	B-X
chemokine	B-X
production	B-X
through	B-X
the	B-X
association	B-X
with	B-X
TRAF-6	B-X
in	B-X
fibroblasts	B-X
of	B-X
nasal	B-X
polyps	B-X
.	B-X

The	O
fibroblasts	O
stimulated	O
by	O
cytokines	O
released	O
the	O
chemokine	O
and	O
recruited	O
the	O
infiltrating	O
cells	O
,	O
including	O
eosinophils	O
,	O
that	O
play	O
a	O
key	O
role	O
in	O
the	O
pathogenesis	O
of	O
airway	O
disease	O
.	O
<EOS>	B-X
The	B-X
fibroblasts	B-X
stimulated	B-X
by	B-X
cytokines	B-X
released	B-X
the	B-X
chemokine	B-X
and	B-X
recruited	B-X
the	B-X
infiltrating	B-X
cells	B-X
,	B-X
including	B-X
eosinophils	B-X
,	B-X
that	B-X
play	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
airway	B-X
disease	B-X
.	B-X
IL-1	B-X
induces	B-X
the	B-X
interaction	B-X
of	B-X
TNFR-associated	B-X
factor	B-X
(	B-X
TRAF	B-X
)	B-X
6	B-X
with	B-X
IL-1R-associated	B-X
kinase	B-X
,	B-X
which	B-X
is	B-X
rapidly	B-X
recruited	B-X
to	B-X
the	B-X
IL-1R	B-X
after	B-X
IL-1	B-X
induction	B-X
,	B-X
whereas	B-X
TRAF2	B-X
participates	B-X
in	B-X
TNF-alpha-signaling	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Syk	B-X
played	B-X
a	B-X
different	B-X
role	B-X
in	B-X
IL-1-	B-X
and	B-X
TNF-alpha-induced	B-X
chemokine	B-X
production	B-X
through	B-X
a	B-X
signaling	B-X
complex	B-X
involving	B-X
Syk	B-X
and	B-X
TRAF6	B-X
.	B-X
Overexpression	B-X
of	B-X
wild-type	B-X
Syk	B-X
by	B-X
gene	B-X
transfer	B-X
enhanced	B-X
RANTES	B-X
production	B-X
from	B-X
nasal	B-X
fibroblasts	B-X
stimulated	B-X
with	B-X
IL-1	B-X
.	B-X
We	B-X
concluded	B-X
that	B-X
Syk	B-X
is	B-X
required	B-X
for	B-X
the	B-X
IL-1-induced	B-X
chemokine	B-X
production	B-X
through	B-X
the	B-X
association	B-X
with	B-X
TRAF-6	B-X
in	B-X
fibroblasts	B-X
of	B-X
nasal	B-X
polyps	B-X
.	B-X

We	O
established	O
the	O
human	O
fibroblast	O
lines	O
showing	O
high	O
Syk	B-Gene_or_gene_product
expression	O
and	O
the	O
lines	O
showing	O
low	O
Syk	B-Gene_or_gene_product
expression	O
from	O
pieces	O
of	O
nasal	O
polyp	O
.	O
<EOS>	B-X
The	B-X
fibroblasts	B-X
stimulated	B-X
by	B-X
cytokines	B-X
released	B-X
the	B-X
chemokine	B-X
and	B-X
recruited	B-X
the	B-X
infiltrating	B-X
cells	B-X
,	B-X
including	B-X
eosinophils	B-X
,	B-X
that	B-X
play	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
airway	B-X
disease	B-X
.	B-X
We	B-X
established	B-X
the	B-X
human	B-X
fibroblast	B-X
lines	B-X
showing	B-X
high	B-X
Syk	B-X
expression	B-X
and	B-X
the	B-X
lines	B-X
showing	B-X
low	B-X
Syk	B-X
expression	B-X
from	B-X
pieces	B-X
of	B-X
nasal	B-X
polyp	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Syk	B-X
played	B-X
a	B-X
different	B-X
role	B-X
in	B-X
IL-1-	B-X
and	B-X
TNF-alpha-induced	B-X
chemokine	B-X
production	B-X
through	B-X
a	B-X
signaling	B-X
complex	B-X
involving	B-X
Syk	B-X
and	B-X
TRAF6	B-X
.	B-X
Overexpression	B-X
of	B-X
wild-type	B-X
Syk	B-X
by	B-X
gene	B-X
transfer	B-X
enhanced	B-X
RANTES	B-X
production	B-X
from	B-X
nasal	B-X
fibroblasts	B-X
stimulated	B-X
with	B-X
IL-1	B-X
.	B-X
The	B-X
decrease	B-X
of	B-X
Syk	B-X
expression	B-X
by	B-X
the	B-X
administration	B-X
of	B-X
Syk	B-X
antisense	B-X
inhibited	B-X
RANTES	B-X
production	B-X
in	B-X
response	B-X
to	B-X
IL-1	B-X
.	B-X
However	B-X
,	B-X
the	B-X
change	B-X
of	B-X
Syk	B-X
expression	B-X
did	B-X
not	B-X
affect	B-X
RANTES	B-X
production	B-X
by	B-X
TNF-alpha	B-X
stimulation	B-X
.	B-X
We	B-X
concluded	B-X
that	B-X
Syk	B-X
is	B-X
required	B-X
for	B-X
the	B-X
IL-1-induced	B-X
chemokine	B-X
production	B-X
through	B-X
the	B-X
association	B-X
with	B-X
TRAF-6	B-X
in	B-X
fibroblasts	B-X
of	B-X
nasal	B-X
polyps	B-X
.	B-X

IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
induces	O
the	O
interaction	O
of	O
TNFR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	I-Gene_or_gene_product
TRAF	I-Gene_or_gene_product
)	I-Gene_or_gene_product
6	I-Gene_or_gene_product
with	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1R	I-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
,	O
which	O
is	O
rapidly	O
recruited	O
to	O
the	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1R	I-Gene_or_gene_product
after	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
induction	O
,	O
whereas	O
TRAF2	B-Gene_or_gene_product
participates	O
in	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
-	O
signaling	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
found	O
that	O
Syk	B-Gene_or_gene_product
played	O
a	O
different	O
role	O
in	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
-	O
and	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
-	O
induced	O
chemokine	O
production	O
through	O
a	O
signaling	O
complex	O
involving	O
Syk	B-Gene_or_gene_product
and	O
TRAF6	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
fibroblasts	B-X
stimulated	B-X
by	B-X
cytokines	B-X
released	B-X
the	B-X
chemokine	B-X
and	B-X
recruited	B-X
the	B-X
infiltrating	B-X
cells	B-X
,	B-X
including	B-X
eosinophils	B-X
,	B-X
that	B-X
play	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
airway	B-X
disease	B-X
.	B-X
We	B-X
established	B-X
the	B-X
human	B-X
fibroblast	B-X
lines	B-X
showing	B-X
high	B-X
Syk	B-X
expression	B-X
and	B-X
the	B-X
lines	B-X
showing	B-X
low	B-X
Syk	B-X
expression	B-X
from	B-X
pieces	B-X
of	B-X
nasal	B-X
polyp	B-X
.	B-X
IL-1	B-X
induces	B-X
the	B-X
interaction	B-X
of	B-X
TNFR-associated	B-X
factor	B-X
(	B-X
TRAF	B-X
)	B-X
6	B-X
with	B-X
IL-1R-associated	B-X
kinase	B-X
,	B-X
which	B-X
is	B-X
rapidly	B-X
recruited	B-X
to	B-X
the	B-X
IL-1R	B-X
after	B-X
IL-1	B-X
induction	B-X
,	B-X
whereas	B-X
TRAF2	B-X
participates	B-X
in	B-X
TNF-alpha-signaling	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Syk	B-X
played	B-X
a	B-X
different	B-X
role	B-X
in	B-X
IL-1-	B-X
and	B-X
TNF-alpha-induced	B-X
chemokine	B-X
production	B-X
through	B-X
a	B-X
signaling	B-X
complex	B-X
involving	B-X
Syk	B-X
and	B-X
TRAF6	B-X
.	B-X
Overexpression	B-X
of	B-X
wild-type	B-X
Syk	B-X
by	B-X
gene	B-X
transfer	B-X
enhanced	B-X
RANTES	B-X
production	B-X
from	B-X
nasal	B-X
fibroblasts	B-X
stimulated	B-X
with	B-X
IL-1	B-X
.	B-X
The	B-X
decrease	B-X
of	B-X
Syk	B-X
expression	B-X
by	B-X
the	B-X
administration	B-X
of	B-X
Syk	B-X
antisense	B-X
inhibited	B-X
RANTES	B-X
production	B-X
in	B-X
response	B-X
to	B-X
IL-1	B-X
.	B-X
However	B-X
,	B-X
the	B-X
change	B-X
of	B-X
Syk	B-X
expression	B-X
did	B-X
not	B-X
affect	B-X
RANTES	B-X
production	B-X
by	B-X
TNF-alpha	B-X
stimulation	B-X
.	B-X
We	B-X
concluded	B-X
that	B-X
Syk	B-X
is	B-X
required	B-X
for	B-X
the	B-X
IL-1-induced	B-X
chemokine	B-X
production	B-X
through	B-X
the	B-X
association	B-X
with	B-X
TRAF-6	B-X
in	B-X
fibroblasts	B-X
of	B-X
nasal	B-X
polyps	B-X
.	B-X

Overexpression	O
of	O
wild	O
-	O
type	O
Syk	B-Gene_or_gene_product
by	O
gene	O
transfer	O
enhanced	O
RANTES	B-Gene_or_gene_product
production	O
from	O
nasal	O
fibroblasts	O
stimulated	O
with	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
fibroblasts	B-X
stimulated	B-X
by	B-X
cytokines	B-X
released	B-X
the	B-X
chemokine	B-X
and	B-X
recruited	B-X
the	B-X
infiltrating	B-X
cells	B-X
,	B-X
including	B-X
eosinophils	B-X
,	B-X
that	B-X
play	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
airway	B-X
disease	B-X
.	B-X
We	B-X
established	B-X
the	B-X
human	B-X
fibroblast	B-X
lines	B-X
showing	B-X
high	B-X
Syk	B-X
expression	B-X
and	B-X
the	B-X
lines	B-X
showing	B-X
low	B-X
Syk	B-X
expression	B-X
from	B-X
pieces	B-X
of	B-X
nasal	B-X
polyp	B-X
.	B-X
IL-1	B-X
induces	B-X
the	B-X
interaction	B-X
of	B-X
TNFR-associated	B-X
factor	B-X
(	B-X
TRAF	B-X
)	B-X
6	B-X
with	B-X
IL-1R-associated	B-X
kinase	B-X
,	B-X
which	B-X
is	B-X
rapidly	B-X
recruited	B-X
to	B-X
the	B-X
IL-1R	B-X
after	B-X
IL-1	B-X
induction	B-X
,	B-X
whereas	B-X
TRAF2	B-X
participates	B-X
in	B-X
TNF-alpha-signaling	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Syk	B-X
played	B-X
a	B-X
different	B-X
role	B-X
in	B-X
IL-1-	B-X
and	B-X
TNF-alpha-induced	B-X
chemokine	B-X
production	B-X
through	B-X
a	B-X
signaling	B-X
complex	B-X
involving	B-X
Syk	B-X
and	B-X
TRAF6	B-X
.	B-X
Overexpression	B-X
of	B-X
wild-type	B-X
Syk	B-X
by	B-X
gene	B-X
transfer	B-X
enhanced	B-X
RANTES	B-X
production	B-X
from	B-X
nasal	B-X
fibroblasts	B-X
stimulated	B-X
with	B-X
IL-1	B-X
.	B-X
The	B-X
decrease	B-X
of	B-X
Syk	B-X
expression	B-X
by	B-X
the	B-X
administration	B-X
of	B-X
Syk	B-X
antisense	B-X
inhibited	B-X
RANTES	B-X
production	B-X
in	B-X
response	B-X
to	B-X
IL-1	B-X
.	B-X
However	B-X
,	B-X
the	B-X
change	B-X
of	B-X
Syk	B-X
expression	B-X
did	B-X
not	B-X
affect	B-X
RANTES	B-X
production	B-X
by	B-X
TNF-alpha	B-X
stimulation	B-X
.	B-X
We	B-X
concluded	B-X
that	B-X
Syk	B-X
is	B-X
required	B-X
for	B-X
the	B-X
IL-1-induced	B-X
chemokine	B-X
production	B-X
through	B-X
the	B-X
association	B-X
with	B-X
TRAF-6	B-X
in	B-X
fibroblasts	B-X
of	B-X
nasal	B-X
polyps	B-X
.	B-X

The	O
decrease	O
of	O
Syk	B-Gene_or_gene_product
expression	O
by	O
the	O
administration	O
of	O
Syk	B-Gene_or_gene_product
antisense	O
inhibited	O
RANTES	B-Gene_or_gene_product
production	O
in	O
response	O
to	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O
<EOS>	B-X
We	B-X
established	B-X
the	B-X
human	B-X
fibroblast	B-X
lines	B-X
showing	B-X
high	B-X
Syk	B-X
expression	B-X
and	B-X
the	B-X
lines	B-X
showing	B-X
low	B-X
Syk	B-X
expression	B-X
from	B-X
pieces	B-X
of	B-X
nasal	B-X
polyp	B-X
.	B-X
IL-1	B-X
induces	B-X
the	B-X
interaction	B-X
of	B-X
TNFR-associated	B-X
factor	B-X
(	B-X
TRAF	B-X
)	B-X
6	B-X
with	B-X
IL-1R-associated	B-X
kinase	B-X
,	B-X
which	B-X
is	B-X
rapidly	B-X
recruited	B-X
to	B-X
the	B-X
IL-1R	B-X
after	B-X
IL-1	B-X
induction	B-X
,	B-X
whereas	B-X
TRAF2	B-X
participates	B-X
in	B-X
TNF-alpha-signaling	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Syk	B-X
played	B-X
a	B-X
different	B-X
role	B-X
in	B-X
IL-1-	B-X
and	B-X
TNF-alpha-induced	B-X
chemokine	B-X
production	B-X
through	B-X
a	B-X
signaling	B-X
complex	B-X
involving	B-X
Syk	B-X
and	B-X
TRAF6	B-X
.	B-X
Overexpression	B-X
of	B-X
wild-type	B-X
Syk	B-X
by	B-X
gene	B-X
transfer	B-X
enhanced	B-X
RANTES	B-X
production	B-X
from	B-X
nasal	B-X
fibroblasts	B-X
stimulated	B-X
with	B-X
IL-1	B-X
.	B-X
The	B-X
decrease	B-X
of	B-X
Syk	B-X
expression	B-X
by	B-X
the	B-X
administration	B-X
of	B-X
Syk	B-X
antisense	B-X
inhibited	B-X
RANTES	B-X
production	B-X
in	B-X
response	B-X
to	B-X
IL-1	B-X
.	B-X
However	B-X
,	B-X
the	B-X
change	B-X
of	B-X
Syk	B-X
expression	B-X
did	B-X
not	B-X
affect	B-X
RANTES	B-X
production	B-X
by	B-X
TNF-alpha	B-X
stimulation	B-X
.	B-X
We	B-X
concluded	B-X
that	B-X
Syk	B-X
is	B-X
required	B-X
for	B-X
the	B-X
IL-1-induced	B-X
chemokine	B-X
production	B-X
through	B-X
the	B-X
association	B-X
with	B-X
TRAF-6	B-X
in	B-X
fibroblasts	B-X
of	B-X
nasal	B-X
polyps	B-X
.	B-X

However	O
,	O
the	O
change	O
of	O
Syk	B-Gene_or_gene_product
expression	O
did	O
not	O
affect	O
RANTES	B-Gene_or_gene_product
production	O
by	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
stimulation	O
.	O
<EOS>	B-X
The	B-X
catalytic	B-X
activity	B-X
of	B-X
Syk-family	B-X
tyrosine	B-X
kinases	B-X
is	B-X
regulated	B-X
by	B-X
a	B-X
tandem	B-X
Src	B-X
homology	B-X
2	B-X
module	B-X
(	B-X
tSH2	B-X
module	B-X
)	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
the	B-X
tSH2	B-X
module	B-X
to	B-X
phosphorylated	B-X
immunoreceptor	B-X
tyrosine-based	B-X
activation	B-X
motifs	B-X
necessitates	B-X
a	B-X
conformational	B-X
change	B-X
,	B-X
thereby	B-X
relieving	B-X
kinase	B-X
inhibition	B-X
and	B-X
promoting	B-X
activation	B-X
.	B-X
We	B-X
determined	B-X
the	B-X
crystal	B-X
structure	B-X
of	B-X
the	B-X
isolated	B-X
tSH2	B-X
module	B-X
of	B-X
Syk	B-X
and	B-X
find	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
ZAP-70	B-X
,	B-X
that	B-X
its	B-X
conformation	B-X
more	B-X
closely	B-X
resembles	B-X
that	B-X
of	B-X
the	B-X
peptide-bound	B-X
state	B-X
,	B-X
rather	B-X
than	B-X
the	B-X
autoinhibited	B-X
state	B-X
.	B-X
Hydrogen-deuterium	B-X
exchange	B-X
by	B-X
mass	B-X
spectrometry	B-X
,	B-X
as	B-X
well	B-X
as	B-X
molecular	B-X
dynamics	B-X
simulations	B-X
,	B-X
reveal	B-X
that	B-X
the	B-X
dynamics	B-X
of	B-X
the	B-X
tSH2	B-X
modules	B-X
of	B-X
Syk	B-X
and	B-X
ZAP-70	B-X
differ	B-X
,	B-X
with	B-X
most	B-X
of	B-X
these	B-X
differences	B-X
occurring	B-X
in	B-X
the	B-X
C-terminal	B-X
SH2	B-X
domain	B-X
.	B-X
Our	B-X
data	B-X
suggest	B-X
that	B-X
the	B-X
conformational	B-X
landscapes	B-X
of	B-X
the	B-X
tSH2	B-X
modules	B-X
in	B-X
Syk	B-X
and	B-X
ZAP-70	B-X
have	B-X
been	B-X
tuned	B-X
differently	B-X
,	B-X
such	B-X
that	B-X
the	B-X
autoinhibited	B-X
conformation	B-X
of	B-X
the	B-X
Syk	B-X
tSH2	B-X
module	B-X
is	B-X
less	B-X
stable	B-X
.	B-X
This	B-X
feature	B-X
of	B-X
Syk	B-X
likely	B-X
contributes	B-X
to	B-X
its	B-X
ability	B-X
to	B-X
more	B-X
readily	B-X
escape	B-X
autoinhibition	B-X
when	B-X
compared	B-X
to	B-X
ZAP-70	B-X
,	B-X
consistent	B-X
with	B-X
tighter	B-X
control	B-X
of	B-X
downstream	B-X
signaling	B-X
pathways	B-X
in	B-X
T	B-X
cells	B-X
.	B-X

We	O
concluded	O
that	O
Syk	B-Gene_or_gene_product
is	O
required	O
for	O
the	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
-	O
induced	O
chemokine	O
production	O
through	O
the	O
association	O
with	O
TRAF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
in	O
fibroblasts	O
of	O
nasal	O
polyps	O
.	O
<EOS>	B-X
The	B-X
fibroblasts	B-X
stimulated	B-X
by	B-X
cytokines	B-X
released	B-X
the	B-X
chemokine	B-X
and	B-X
recruited	B-X
the	B-X
infiltrating	B-X
cells	B-X
,	B-X
including	B-X
eosinophils	B-X
,	B-X
that	B-X
play	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
airway	B-X
disease	B-X
.	B-X
We	B-X
established	B-X
the	B-X
human	B-X
fibroblast	B-X
lines	B-X
showing	B-X
high	B-X
Syk	B-X
expression	B-X
and	B-X
the	B-X
lines	B-X
showing	B-X
low	B-X
Syk	B-X
expression	B-X
from	B-X
pieces	B-X
of	B-X
nasal	B-X
polyp	B-X
.	B-X
IL-1	B-X
induces	B-X
the	B-X
interaction	B-X
of	B-X
TNFR-associated	B-X
factor	B-X
(	B-X
TRAF	B-X
)	B-X
6	B-X
with	B-X
IL-1R-associated	B-X
kinase	B-X
,	B-X
which	B-X
is	B-X
rapidly	B-X
recruited	B-X
to	B-X
the	B-X
IL-1R	B-X
after	B-X
IL-1	B-X
induction	B-X
,	B-X
whereas	B-X
TRAF2	B-X
participates	B-X
in	B-X
TNF-alpha-signaling	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Syk	B-X
played	B-X
a	B-X
different	B-X
role	B-X
in	B-X
IL-1-	B-X
and	B-X
TNF-alpha-induced	B-X
chemokine	B-X
production	B-X
through	B-X
a	B-X
signaling	B-X
complex	B-X
involving	B-X
Syk	B-X
and	B-X
TRAF6	B-X
.	B-X
Overexpression	B-X
of	B-X
wild-type	B-X
Syk	B-X
by	B-X
gene	B-X
transfer	B-X
enhanced	B-X
RANTES	B-X
production	B-X
from	B-X
nasal	B-X
fibroblasts	B-X
stimulated	B-X
with	B-X
IL-1	B-X
.	B-X
The	B-X
decrease	B-X
of	B-X
Syk	B-X
expression	B-X
by	B-X
the	B-X
administration	B-X
of	B-X
Syk	B-X
antisense	B-X
inhibited	B-X
RANTES	B-X
production	B-X
in	B-X
response	B-X
to	B-X
IL-1	B-X
.	B-X
However	B-X
,	B-X
the	B-X
change	B-X
of	B-X
Syk	B-X
expression	B-X
did	B-X
not	B-X
affect	B-X
RANTES	B-X
production	B-X
by	B-X
TNF-alpha	B-X
stimulation	B-X
.	B-X
We	B-X
concluded	B-X
that	B-X
Syk	B-X
is	B-X
required	B-X
for	B-X
the	B-X
IL-1-induced	B-X
chemokine	B-X
production	B-X
through	B-X
the	B-X
association	B-X
with	B-X
TRAF-6	B-X
in	B-X
fibroblasts	B-X
of	B-X
nasal	B-X
polyps	B-X
.	B-X

Identification	O
and	O
functional	O
analysis	O
of	O
splice	O
variants	O
of	O
the	O
germ	O
cell	O
soluble	O
adenylyl	B-Gene_or_gene_product
cyclase	I-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
mammalian	B-X
germ	B-X
cells	B-X
,	B-X
cAMP	B-X
signaling	B-X
is	B-X
dependent	B-X
on	B-X
two	B-X
forms	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
,	B-X
the	B-X
conventional	B-X
membrane-bound	B-X
ACIII	B-X
and	B-X
a	B-X
soluble	B-X
form	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
(	B-X
sAC	B-X
)	B-X
.	B-X
Two	B-X
different	B-X
transcripts	B-X
encoding	B-X
a	B-X
full-length	B-X
and	B-X
truncated	B-X
sAC	B-X
were	B-X
identified	B-X
by	B-X
reverse	B-X
transcriptase-polymerase	B-X
chain	B-X
reaction	B-X
and	B-X
RNase	B-X
protection	B-X
analysis	B-X
.	B-X
The	B-X
presence	B-X
of	B-X
corresponding	B-X
proteins	B-X
in	B-X
testis	B-X
,	B-X
germ	B-X
cells	B-X
,	B-X
and	B-X
spermatozoa	B-X
was	B-X
demonstrated	B-X
by	B-X
fast	B-X
protein	B-X
liquid	B-X
chromatography	B-X
and	B-X
differential	B-X
immunoprecipitation	B-X
with	B-X
full-length	B-X
sAC-specific	B-X
antibodies	B-X
.	B-X
Bicarbonate	B-X
ions	B-X
activated	B-X
both	B-X
sAC	B-X
forms	B-X
and	B-X
increased	B-X
cAMP	B-X
levels	B-X
in	B-X
germ	B-X
cells	B-X
isolated	B-X
from	B-X
25-	B-X
and	B-X
50-day-old	B-X
rats	B-X
and	B-X
adult	B-X
rats	B-X
in	B-X
a	B-X
concentration-dependent	B-X
manner	B-X
.	B-X
Both	B-X
forms	B-X
are	B-X
active	B-X
in	B-X
spermatids	B-X
,	B-X
and	B-X
the	B-X
bicarbonate	B-X
present	B-X
in	B-X
the	B-X
seminiferous	B-X
tubule	B-X
may	B-X
be	B-X
a	B-X
signal	B-X
that	B-X
regulates	B-X
cAMP	B-X
levels	B-X
in	B-X
these	B-X
cells	B-X
.	B-X

In	O
mammalian	O
germ	O
cells	O
,	O
cAMP	O
signaling	O
is	O
dependent	O
on	O
two	O
forms	O
of	O
adenylyl	B-Gene_or_gene_product
cyclase	I-Gene_or_gene_product
,	O
the	O
conventional	O
membrane	O
-	O
bound	O
ACIII	B-Gene_or_gene_product
and	O
a	O
soluble	O
form	O
of	O
adenylyl	B-Gene_or_gene_product
cyclase	I-Gene_or_gene_product
(	O
sAC	B-Gene_or_gene_product
)	O
.	O

Recent	O
elucidation	O
of	O
the	O
sAC	B-Gene_or_gene_product
sequence	O
indicates	O
that	O
this	O
enzyme	O
is	O
phylogenetically	O
distinct	O
from	O
the	O
membrane	O
-	O
bound	O
AC	B-Gene_or_gene_product
,	O
does	O
not	O
interact	O
with	O
G	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
,	O
and	O
its	O
activity	O
is	O
regulated	O
by	O
bicarbonate	O
ions	O
.	O
<EOS>	B-X
In	B-X
mammalian	B-X
germ	B-X
cells	B-X
,	B-X
cAMP	B-X
signaling	B-X
is	B-X
dependent	B-X
on	B-X
two	B-X
forms	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
,	B-X
the	B-X
conventional	B-X
membrane-bound	B-X
ACIII	B-X
and	B-X
a	B-X
soluble	B-X
form	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
(	B-X
sAC	B-X
)	B-X
.	B-X
Recent	B-X
elucidation	B-X
of	B-X
the	B-X
sAC	B-X
sequence	B-X
indicates	B-X
that	B-X
this	B-X
enzyme	B-X
is	B-X
phylogenetically	B-X
distinct	B-X
from	B-X
the	B-X
membrane-bound	B-X
AC	B-X
,	B-X
does	B-X
not	B-X
interact	B-X
with	B-X
G	B-X
proteins	B-X
,	B-X
and	B-X
its	B-X
activity	B-X
is	B-X
regulated	B-X
by	B-X
bicarbonate	B-X
ions	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
investigated	B-X
the	B-X
properties	B-X
and	B-X
regulation	B-X
of	B-X
this	B-X
enzyme	B-X
during	B-X
spermatogenesis	B-X
.	B-X
Two	B-X
different	B-X
transcripts	B-X
encoding	B-X
a	B-X
full-length	B-X
and	B-X
truncated	B-X
sAC	B-X
were	B-X
identified	B-X
by	B-X
reverse	B-X
transcriptase-polymerase	B-X
chain	B-X
reaction	B-X
and	B-X
RNase	B-X
protection	B-X
analysis	B-X
.	B-X
The	B-X
truncated	B-X
sAC	B-X
transcript	B-X
lacks	B-X
exon	B-X
11	B-X
with	B-X
a	B-X
premature	B-X
termination	B-X
of	B-X
the	B-X
open	B-X
reading	B-X
frame	B-X
after	B-X
the	B-X
catalytic	B-X
domain	B-X
.	B-X
The	B-X
presence	B-X
of	B-X
corresponding	B-X
proteins	B-X
in	B-X
testis	B-X
,	B-X
germ	B-X
cells	B-X
,	B-X
and	B-X
spermatozoa	B-X
was	B-X
demonstrated	B-X
by	B-X
fast	B-X
protein	B-X
liquid	B-X
chromatography	B-X
and	B-X
differential	B-X
immunoprecipitation	B-X
with	B-X
full-length	B-X
sAC-specific	B-X
antibodies	B-X
.	B-X
Bicarbonate	B-X
ions	B-X
activated	B-X
both	B-X
sAC	B-X
forms	B-X
and	B-X
increased	B-X
cAMP	B-X
levels	B-X
in	B-X
germ	B-X
cells	B-X
isolated	B-X
from	B-X
25-	B-X
and	B-X
50-day-old	B-X
rats	B-X
and	B-X
adult	B-X
rats	B-X
in	B-X
a	B-X
concentration-dependent	B-X
manner	B-X
.	B-X
These	B-X
findings	B-X
provide	B-X
evidence	B-X
that	B-X
full-length	B-X
and	B-X
truncated	B-X
sAC	B-X
are	B-X
generated	B-X
by	B-X
alternate	B-X
splicing	B-X
.	B-X
Both	B-X
forms	B-X
are	B-X
active	B-X
in	B-X
spermatids	B-X
,	B-X
and	B-X
the	B-X
bicarbonate	B-X
present	B-X
in	B-X
the	B-X
seminiferous	B-X
tubule	B-X
may	B-X
be	B-X
a	B-X
signal	B-X
that	B-X
regulates	B-X
cAMP	B-X
levels	B-X
in	B-X
these	B-X
cells	B-X
.	B-X

Here	O
we	O
have	O
investigated	O
the	O
properties	O
and	O
regulation	O
of	O
this	O
enzyme	O
during	O
spermatogenesis	O
.	O
<EOS>	B-X
Resveratrol	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
investigated	B-X
natural	B-X
polyphenolic	B-X
compounds	B-X
and	B-X
is	B-X
contained	B-X
in	B-X
more	B-X
than	B-X
70	B-X
types	B-X
of	B-X
plants	B-X
and	B-X
in	B-X
red	B-X
wine	B-X
.	B-X
The	B-X
widespread	B-X
interest	B-X
in	B-X
this	B-X
polyphenol	B-X
derives	B-X
from	B-X
its	B-X
antioxidant	B-X
,	B-X
anti-inflammatory	B-X
and	B-X
anti-aging	B-X
properties	B-X
.	B-X
In	B-X
males	B-X
,	B-X
resveratrol	B-X
enhances	B-X
testes	B-X
function	B-X
and	B-X
spermatogenesis	B-X
through	B-X
activation	B-X
of	B-X
the	B-X
AMPK	B-X
pathway	B-X
.	B-X
O1	B-X
Regulation	B-X
of	B-X
genes	B-X
by	B-X
telomere	B-X
length	B-X
over	B-X
long	B-X
distances	B-X
Jerry	B-X
W.	B-X
Shay	B-X
O2	B-X
The	B-X
microtubule	B-X
destabilizer	B-X
KIF2A	B-X
regulates	B-X
the	B-X
postnatal	B-X
establishment	B-X
of	B-X
neuronal	B-X
circuits	B-X
in	B-X
addition	B-X
to	B-X
prenatal	B-X
cell	B-X
survival	B-X
,	B-X
cell	B-X
migration	B-X
,	B-X
and	B-X
axon	B-X
elongation	B-X
,	B-X
and	B-X
its	B-X
loss	B-X
leading	B-X
to	B-X
malformation	B-X
of	B-X
cortical	B-X
development	B-X
and	B-X
severe	B-X
epilepsy	B-X
Noriko	B-X
Homma	B-X
,	B-X
Ruyun	B-X
Zhou	B-X
,	B-X
Muhammad	B-X
Imran	B-X
Naseer	B-X
,	B-X
Adeel	B-X
G.	B-X
Chaudhary	B-X
,	B-X
Mohammed	B-X
Al-Qahtani	B-X
,	B-X
Nobutaka	B-X
Hirokawa	B-X
O3	B-X
Integration	B-X
of	B-X
metagenomics	B-X
and	B-X
metabolomics	B-X
in	B-X
gut	B-X
microbiome	B-X
research	B-X
Maryam	B-X
Goudarzi	B-X
,	B-X
Albert	B-X
J.	B-X
Fornace	B-X
Jr.	B-X
O4	B-X
A	B-X
unique	B-X
integrated	B-X
system	B-X
to	B-X
discern	B-X
pathogenesis	B-X
of	B-X
central	B-X
nervous	B-X
system	B-X
tumors	B-X
Saleh	B-X
Baeesa	B-X
,	B-X
Deema	B-X
Hussain	B-X
,	B-X
Mohammed	B-X
Bangash	B-X
,	B-X
Fahad	B-X
Alghamdi	B-X
,	B-X
Hans-Juergen	B-X
Schulten	B-X
,	B-X
Angel	B-X
Carracedo	B-X
,	B-X
Ishaq	B-X
Khan	B-X
,	B-X
Hanadi	B-X
Qashqari	B-X
,	B-X
Nawal	B-X
Madkhali	B-X
,	B-X
Mohamad	B-X
Saka	B-X
,	B-X
Kulvinder	B-X
S.	B-X
Saini	B-X
,	B-X
Awatif	B-X
Jamal	B-X
,	B-X
Jaudah	B-X
Al-Maghrabi	B-X
,	B-X
Adel	B-X
Abuzenadah	B-X
,	B-X
Adeel	B-X
Chaudhary	B-X
,	B-X
Mohammed	B-X
Al	B-X
Qahtani	B-X
,	B-X
Ghazi	B-X
Damanhouri	B-X
O5	B-X
RPL27A	B-X
is	B-X
a	B-X
target	B-X
of	B-X
miR-595	B-X
and	B-X
deficiency	B-X
contributes	B-X
to	B-X
ribosomal	B-X
dysgenesis	B-X
Heba	B-X
Alkhatabi	B-X
O6	B-X
Next	B-X
generation	B-X
DNA	B-X
sequencing	B-X
panels	B-X
for	B-X
haemostatic	B-X
and	B-X
platelet	B-X
disorders	B-X
and	B-X
for	B-X
Fanconi	B-X
anaemia	B-X
in	B-X
routine	B-X
diagnostic	B-X
service	B-X
Anne	B-X
Goodeve	B-X
,	B-X
Laura	B-X
Crookes	B-X
,	B-X
Nikolas	B-X
Niksic	B-X
,	B-X
Nicholas	B-X
Beauchamp	B-X
O7	B-X
Targeted	B-X
sequencing	B-X
panels	B-X
and	B-X
their	B-X
utilization	B-X
in	B-X
personalized	B-X
medicine	B-X
Adel	B-X
M.	B-X
Abuzenadah	B-X
O8	B-X
International	B-X
biobanking	B-X
in	B-X
the	B-X
era	B-X
of	B-X
precision	B-X
medicine	B-X
Jim	B-X
Vaught	B-X
O9	B-X
Biobank	B-X
and	B-X
biodata	B-X
for	B-X
clinical	B-X
and	B-X
forensic	B-X
applications	B-X
Bruce	B-X
Budowle	B-X
,	B-X
Mourad	B-X
Assidi	B-X
,	B-X
Abdelbaset	B-X
Buhmeida	B-X
O10	B-X
Tissue	B-X
microarray	B-X
technique	B-X
:	B-X
a	B-X
powerful	B-X
adjunct	B-X
tool	B-X
for	B-X
molecular	B-X
profiling	B-X
of	B-X
solid	B-X
tumors	B-X
Jaudah	B-X
Al-Maghrabi	B-X
O11	B-X
The	B-X
CEGMR	B-X
biobanking	B-X
unit	B-X
:	B-X
achievements	B-X
,	B-X
challenges	B-X
and	B-X
future	B-X
plans	B-X
Abdelbaset	B-X
Buhmeida	B-X
,	B-X
Mourad	B-X
Assidi	B-X
,	B-X
Leena	B-X
Merdad	B-X
O12	B-X
Phylomedicine	B-X
of	B-X
tumors	B-X
Sudhir	B-X
Kumar	B-X
,	B-X
Sayaka	B-X
Miura	B-X
,	B-X
Karen	B-X
Gomez	B-X
O13	B-X
Clinical	B-X
implementation	B-X
of	B-X
pharmacogenomics	B-X
for	B-X
colorectal	B-X
cancer	B-X
treatment	B-X
Angel	B-X
Carracedo	B-X
,	B-X
Mahmood	B-X
Rasool	B-X
O14	B-X
From	B-X
association	B-X
to	B-X
causality	B-X
:	B-X
translation	B-X
of	B-X
GWAS	B-X
findings	B-X
for	B-X
genomic	B-X
medicine	B-X
Ahmed	B-X
Rebai	B-X
O15	B-X
E-GRASP	B-X
:	B-X
an	B-X
interactive	B-X
database	B-X
and	B-X
web	B-X
application	B-X
for	B-X
efficient	B-X
analysis	B-X
of	B-X
disease-associated	B-X
genetic	B-X
information	B-X
Sajjad	B-X
Karim	B-X
,	B-X
Hend	B-X
F	B-X
Nour	B-X
Eldin	B-X
,	B-X
Heba	B-X
Abusamra	B-X
,	B-X
Elham	B-X
M	B-X
Alhathli	B-X
,	B-X
Nada	B-X
Salem	B-X
,	B-X
Mohammed	B-X
H	B-X
Al-Qahtani	B-X
,	B-X
Sudhir	B-X
Kumar	B-X
O16	B-X
The	B-X
supercomputer	B-X
facility	B-X
“	B-X
AZIZ	B-X
”	B-X
at	B-X
KAU	B-X
:	B-X
utility	B-X
and	B-X
future	B-X
prospects	B-X
Hossam	B-X
Faheem	B-X
O17	B-X
New	B-X
research	B-X
into	B-X
the	B-X
causes	B-X
of	B-X
male	B-X
infertility	B-X
Ashok	B-X
Agarwa	B-X
O18	B-X
The	B-X
Klinefelter	B-X
syndrome	B-X
:	B-X
recent	B-X
progress	B-X
in	B-X
pathophysiology	B-X
and	B-X
management	B-X
Eberhard	B-X
Nieschlag	B-X
,	B-X
Joachim	B-X
Wistuba	B-X
,	B-X
Oliver	B-X
S.	B-X
Damm	B-X
,	B-X
Mohd	B-X
A.	B-X
Beg	B-X
,	B-X
Taha	B-X
A.	B-X
Abdel-Meguid	B-X
,	B-X
Hisham	B-X
A.	B-X
Mosli	B-X
,	B-X
Osama	B-X
S.	B-X
Bajouh	B-X
,	B-X
Adel	B-X
M.	B-X
Abuzenadah	B-X
,	B-X
Mohammed	B-X
H.	B-X
Al-Qahtani	B-X
O19	B-X
A	B-X
new	B-X
look	B-X
to	B-X
reproductive	B-X
medicine	B-X
in	B-X
the	B-X
era	B-X
of	B-X
genomics	B-X
Serdar	B-X
Coskun	B-X
P1	B-X
Wnt	B-X
signalling	B-X
receptors	B-X
expression	B-X
in	B-X
Saudi	B-X
breast	B-X
cancer	B-X
patients	B-X
Muhammad	B-X
Abu-Elmagd	B-X
,	B-X
Abdelbaset	B-X
Buhmeida	B-X
,	B-X
Ashraf	B-X
Dallol	B-X
,	B-X
Jaudah	B-X
Al-Maghrabi	B-X
,	B-X
Sahar	B-X
Hakamy	B-X
,	B-X
Wejdan	B-X
Al-Qahtani	B-X
,	B-X
Asia	B-X
Al-Harbi	B-X
,	B-X
Shireen	B-X
Hussain	B-X
,	B-X
Mourad	B-X
Assidi	B-X
,	B-X
Mohammed	B-X
Al-Qahtani	B-X
,	B-X
Adel	B-X
Abuzenadah	B-X
P2	B-X
Analysis	B-X
of	B-X
oxidative	B-X
stress	B-X
interactome	B-X
during	B-X
spermatogenesis	B-X
:	B-X
a	B-X
systems	B-X
biology	B-X
approach	B-X
to	B-X
reproduction	B-X
Burak	B-X
Ozkosem	B-X
,	B-X
Rick	B-X
DuBois	B-X
P3	B-X
Interleukin-18	B-X
gene	B-X
variants	B-X
are	B-X
strongly	B-X
associated	B-X
with	B-X
idiopathic	B-X
recurrent	B-X
pregnancy	B-X
loss	B-X
.	B-X

Two	O
different	O
transcripts	O
encoding	O
a	O
full	O
-	O
length	O
and	O
truncated	O
sAC	B-Gene_or_gene_product
were	O
identified	O
by	O
reverse	B-Gene_or_gene_product
transcriptase	I-Gene_or_gene_product
-	O
polymerase	O
chain	O
reaction	O
and	O
RNase	B-Gene_or_gene_product
protection	O
analysis	O
.	O
<EOS>	B-X
In	B-X
mammalian	B-X
germ	B-X
cells	B-X
,	B-X
cAMP	B-X
signaling	B-X
is	B-X
dependent	B-X
on	B-X
two	B-X
forms	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
,	B-X
the	B-X
conventional	B-X
membrane-bound	B-X
ACIII	B-X
and	B-X
a	B-X
soluble	B-X
form	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
(	B-X
sAC	B-X
)	B-X
.	B-X
Recent	B-X
elucidation	B-X
of	B-X
the	B-X
sAC	B-X
sequence	B-X
indicates	B-X
that	B-X
this	B-X
enzyme	B-X
is	B-X
phylogenetically	B-X
distinct	B-X
from	B-X
the	B-X
membrane-bound	B-X
AC	B-X
,	B-X
does	B-X
not	B-X
interact	B-X
with	B-X
G	B-X
proteins	B-X
,	B-X
and	B-X
its	B-X
activity	B-X
is	B-X
regulated	B-X
by	B-X
bicarbonate	B-X
ions	B-X
.	B-X
Two	B-X
different	B-X
transcripts	B-X
encoding	B-X
a	B-X
full-length	B-X
and	B-X
truncated	B-X
sAC	B-X
were	B-X
identified	B-X
by	B-X
reverse	B-X
transcriptase-polymerase	B-X
chain	B-X
reaction	B-X
and	B-X
RNase	B-X
protection	B-X
analysis	B-X
.	B-X
The	B-X
truncated	B-X
sAC	B-X
transcript	B-X
lacks	B-X
exon	B-X
11	B-X
with	B-X
a	B-X
premature	B-X
termination	B-X
of	B-X
the	B-X
open	B-X
reading	B-X
frame	B-X
after	B-X
the	B-X
catalytic	B-X
domain	B-X
.	B-X
Reverse	B-X
transcriptase-polymerase	B-X
chain	B-X
reaction	B-X
with	B-X
testis	B-X
RNA	B-X
from	B-X
adult	B-X
mouse	B-X
and	B-X
rat	B-X
of	B-X
different	B-X
ages	B-X
,	B-X
as	B-X
well	B-X
as	B-X
RNase	B-X
protection	B-X
,	B-X
showed	B-X
that	B-X
both	B-X
transcripts	B-X
are	B-X
absent	B-X
at	B-X
11	B-X
days	B-X
of	B-X
age	B-X
,	B-X
appear	B-X
between	B-X
20	B-X
and	B-X
30	B-X
days	B-X
of	B-X
age	B-X
,	B-X
and	B-X
are	B-X
retained	B-X
in	B-X
the	B-X
adult	B-X
testis	B-X
.	B-X
The	B-X
presence	B-X
of	B-X
corresponding	B-X
proteins	B-X
in	B-X
testis	B-X
,	B-X
germ	B-X
cells	B-X
,	B-X
and	B-X
spermatozoa	B-X
was	B-X
demonstrated	B-X
by	B-X
fast	B-X
protein	B-X
liquid	B-X
chromatography	B-X
and	B-X
differential	B-X
immunoprecipitation	B-X
with	B-X
full-length	B-X
sAC-specific	B-X
antibodies	B-X
.	B-X
Bicarbonate	B-X
ions	B-X
activated	B-X
both	B-X
sAC	B-X
forms	B-X
and	B-X
increased	B-X
cAMP	B-X
levels	B-X
in	B-X
germ	B-X
cells	B-X
isolated	B-X
from	B-X
25-	B-X
and	B-X
50-day-old	B-X
rats	B-X
and	B-X
adult	B-X
rats	B-X
in	B-X
a	B-X
concentration-dependent	B-X
manner	B-X
.	B-X
These	B-X
findings	B-X
provide	B-X
evidence	B-X
that	B-X
full-length	B-X
and	B-X
truncated	B-X
sAC	B-X
are	B-X
generated	B-X
by	B-X
alternate	B-X
splicing	B-X
.	B-X

The	O
truncated	O
sAC	B-Gene_or_gene_product
transcript	O
lacks	O
exon	O
11	O
with	O
a	O
premature	O
termination	O
of	O
the	O
open	O
reading	O
frame	O
after	O
the	O
catalytic	O
domain	O
.	O
<EOS>	B-X
In	B-X
mammalian	B-X
germ	B-X
cells	B-X
,	B-X
cAMP	B-X
signaling	B-X
is	B-X
dependent	B-X
on	B-X
two	B-X
forms	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
,	B-X
the	B-X
conventional	B-X
membrane-bound	B-X
ACIII	B-X
and	B-X
a	B-X
soluble	B-X
form	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
(	B-X
sAC	B-X
)	B-X
.	B-X
Recent	B-X
elucidation	B-X
of	B-X
the	B-X
sAC	B-X
sequence	B-X
indicates	B-X
that	B-X
this	B-X
enzyme	B-X
is	B-X
phylogenetically	B-X
distinct	B-X
from	B-X
the	B-X
membrane-bound	B-X
AC	B-X
,	B-X
does	B-X
not	B-X
interact	B-X
with	B-X
G	B-X
proteins	B-X
,	B-X
and	B-X
its	B-X
activity	B-X
is	B-X
regulated	B-X
by	B-X
bicarbonate	B-X
ions	B-X
.	B-X
Two	B-X
different	B-X
transcripts	B-X
encoding	B-X
a	B-X
full-length	B-X
and	B-X
truncated	B-X
sAC	B-X
were	B-X
identified	B-X
by	B-X
reverse	B-X
transcriptase-polymerase	B-X
chain	B-X
reaction	B-X
and	B-X
RNase	B-X
protection	B-X
analysis	B-X
.	B-X
The	B-X
truncated	B-X
sAC	B-X
transcript	B-X
lacks	B-X
exon	B-X
11	B-X
with	B-X
a	B-X
premature	B-X
termination	B-X
of	B-X
the	B-X
open	B-X
reading	B-X
frame	B-X
after	B-X
the	B-X
catalytic	B-X
domain	B-X
.	B-X
Reverse	B-X
transcriptase-polymerase	B-X
chain	B-X
reaction	B-X
with	B-X
testis	B-X
RNA	B-X
from	B-X
adult	B-X
mouse	B-X
and	B-X
rat	B-X
of	B-X
different	B-X
ages	B-X
,	B-X
as	B-X
well	B-X
as	B-X
RNase	B-X
protection	B-X
,	B-X
showed	B-X
that	B-X
both	B-X
transcripts	B-X
are	B-X
absent	B-X
at	B-X
11	B-X
days	B-X
of	B-X
age	B-X
,	B-X
appear	B-X
between	B-X
20	B-X
and	B-X
30	B-X
days	B-X
of	B-X
age	B-X
,	B-X
and	B-X
are	B-X
retained	B-X
in	B-X
the	B-X
adult	B-X
testis	B-X
.	B-X
The	B-X
presence	B-X
of	B-X
corresponding	B-X
proteins	B-X
in	B-X
testis	B-X
,	B-X
germ	B-X
cells	B-X
,	B-X
and	B-X
spermatozoa	B-X
was	B-X
demonstrated	B-X
by	B-X
fast	B-X
protein	B-X
liquid	B-X
chromatography	B-X
and	B-X
differential	B-X
immunoprecipitation	B-X
with	B-X
full-length	B-X
sAC-specific	B-X
antibodies	B-X
.	B-X
Bicarbonate	B-X
ions	B-X
activated	B-X
both	B-X
sAC	B-X
forms	B-X
and	B-X
increased	B-X
cAMP	B-X
levels	B-X
in	B-X
germ	B-X
cells	B-X
isolated	B-X
from	B-X
25-	B-X
and	B-X
50-day-old	B-X
rats	B-X
and	B-X
adult	B-X
rats	B-X
in	B-X
a	B-X
concentration-dependent	B-X
manner	B-X
.	B-X
These	B-X
findings	B-X
provide	B-X
evidence	B-X
that	B-X
full-length	B-X
and	B-X
truncated	B-X
sAC	B-X
are	B-X
generated	B-X
by	B-X
alternate	B-X
splicing	B-X
.	B-X

Reverse	B-Gene_or_gene_product
transcriptase	I-Gene_or_gene_product
-	O
polymerase	O
chain	O
reaction	O
with	O
testis	O
RNA	O
from	O
adult	O
mouse	O
and	O
rat	O
of	O
different	O
ages	O
,	O
as	O
well	O
as	O
RNase	B-Gene_or_gene_product
protection	O
,	O
showed	O
that	O
both	O
transcripts	O
are	O
absent	O
at	O
11	O
days	O
of	O
age	O
,	O
appear	O
between	O
20	O
and	O
30	O
days	O
of	O
age	O
,	O
and	O
are	O
retained	O
in	O
the	O
adult	O
testis	O
.	O
<EOS>	B-X
Two	B-X
different	B-X
transcripts	B-X
encoding	B-X
a	B-X
full-length	B-X
and	B-X
truncated	B-X
sAC	B-X
were	B-X
identified	B-X
by	B-X
reverse	B-X
transcriptase-polymerase	B-X
chain	B-X
reaction	B-X
and	B-X
RNase	B-X
protection	B-X
analysis	B-X
.	B-X
The	B-X
truncated	B-X
sAC	B-X
transcript	B-X
lacks	B-X
exon	B-X
11	B-X
with	B-X
a	B-X
premature	B-X
termination	B-X
of	B-X
the	B-X
open	B-X
reading	B-X
frame	B-X
after	B-X
the	B-X
catalytic	B-X
domain	B-X
.	B-X
Reverse	B-X
transcriptase-polymerase	B-X
chain	B-X
reaction	B-X
with	B-X
testis	B-X
RNA	B-X
from	B-X
adult	B-X
mouse	B-X
and	B-X
rat	B-X
of	B-X
different	B-X
ages	B-X
,	B-X
as	B-X
well	B-X
as	B-X
RNase	B-X
protection	B-X
,	B-X
showed	B-X
that	B-X
both	B-X
transcripts	B-X
are	B-X
absent	B-X
at	B-X
11	B-X
days	B-X
of	B-X
age	B-X
,	B-X
appear	B-X
between	B-X
20	B-X
and	B-X
30	B-X
days	B-X
of	B-X
age	B-X
,	B-X
and	B-X
are	B-X
retained	B-X
in	B-X
the	B-X
adult	B-X
testis	B-X
.	B-X
The	B-X
presence	B-X
of	B-X
corresponding	B-X
proteins	B-X
in	B-X
testis	B-X
,	B-X
germ	B-X
cells	B-X
,	B-X
and	B-X
spermatozoa	B-X
was	B-X
demonstrated	B-X
by	B-X
fast	B-X
protein	B-X
liquid	B-X
chromatography	B-X
and	B-X
differential	B-X
immunoprecipitation	B-X
with	B-X
full-length	B-X
sAC-specific	B-X
antibodies	B-X
.	B-X
Bicarbonate	B-X
ions	B-X
activated	B-X
both	B-X
sAC	B-X
forms	B-X
and	B-X
increased	B-X
cAMP	B-X
levels	B-X
in	B-X
germ	B-X
cells	B-X
isolated	B-X
from	B-X
25-	B-X
and	B-X
50-day-old	B-X
rats	B-X
and	B-X
adult	B-X
rats	B-X
in	B-X
a	B-X
concentration-dependent	B-X
manner	B-X
.	B-X
These	B-X
findings	B-X
provide	B-X
evidence	B-X
that	B-X
full-length	B-X
and	B-X
truncated	B-X
sAC	B-X
are	B-X
generated	B-X
by	B-X
alternate	B-X
splicing	B-X
.	B-X

The	O
presence	O
of	O
corresponding	O
proteins	O
in	O
testis	O
,	O
germ	O
cells	O
,	O
and	O
spermatozoa	O
was	O
demonstrated	O
by	O
fast	O
protein	O
liquid	O
chromatography	O
and	O
differential	O
immunoprecipitation	O
with	O
full	O
-	O
length	O
sAC	B-Gene_or_gene_product
-	O
specific	O
antibodies	O
.	O
<EOS>	B-X
In	B-X
mammalian	B-X
germ	B-X
cells	B-X
,	B-X
cAMP	B-X
signaling	B-X
is	B-X
dependent	B-X
on	B-X
two	B-X
forms	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
,	B-X
the	B-X
conventional	B-X
membrane-bound	B-X
ACIII	B-X
and	B-X
a	B-X
soluble	B-X
form	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
(	B-X
sAC	B-X
)	B-X
.	B-X
Recent	B-X
elucidation	B-X
of	B-X
the	B-X
sAC	B-X
sequence	B-X
indicates	B-X
that	B-X
this	B-X
enzyme	B-X
is	B-X
phylogenetically	B-X
distinct	B-X
from	B-X
the	B-X
membrane-bound	B-X
AC	B-X
,	B-X
does	B-X
not	B-X
interact	B-X
with	B-X
G	B-X
proteins	B-X
,	B-X
and	B-X
its	B-X
activity	B-X
is	B-X
regulated	B-X
by	B-X
bicarbonate	B-X
ions	B-X
.	B-X
Two	B-X
different	B-X
transcripts	B-X
encoding	B-X
a	B-X
full-length	B-X
and	B-X
truncated	B-X
sAC	B-X
were	B-X
identified	B-X
by	B-X
reverse	B-X
transcriptase-polymerase	B-X
chain	B-X
reaction	B-X
and	B-X
RNase	B-X
protection	B-X
analysis	B-X
.	B-X
The	B-X
truncated	B-X
sAC	B-X
transcript	B-X
lacks	B-X
exon	B-X
11	B-X
with	B-X
a	B-X
premature	B-X
termination	B-X
of	B-X
the	B-X
open	B-X
reading	B-X
frame	B-X
after	B-X
the	B-X
catalytic	B-X
domain	B-X
.	B-X
Reverse	B-X
transcriptase-polymerase	B-X
chain	B-X
reaction	B-X
with	B-X
testis	B-X
RNA	B-X
from	B-X
adult	B-X
mouse	B-X
and	B-X
rat	B-X
of	B-X
different	B-X
ages	B-X
,	B-X
as	B-X
well	B-X
as	B-X
RNase	B-X
protection	B-X
,	B-X
showed	B-X
that	B-X
both	B-X
transcripts	B-X
are	B-X
absent	B-X
at	B-X
11	B-X
days	B-X
of	B-X
age	B-X
,	B-X
appear	B-X
between	B-X
20	B-X
and	B-X
30	B-X
days	B-X
of	B-X
age	B-X
,	B-X
and	B-X
are	B-X
retained	B-X
in	B-X
the	B-X
adult	B-X
testis	B-X
.	B-X
The	B-X
presence	B-X
of	B-X
corresponding	B-X
proteins	B-X
in	B-X
testis	B-X
,	B-X
germ	B-X
cells	B-X
,	B-X
and	B-X
spermatozoa	B-X
was	B-X
demonstrated	B-X
by	B-X
fast	B-X
protein	B-X
liquid	B-X
chromatography	B-X
and	B-X
differential	B-X
immunoprecipitation	B-X
with	B-X
full-length	B-X
sAC-specific	B-X
antibodies	B-X
.	B-X
Bicarbonate	B-X
ions	B-X
activated	B-X
both	B-X
sAC	B-X
forms	B-X
and	B-X
increased	B-X
cAMP	B-X
levels	B-X
in	B-X
germ	B-X
cells	B-X
isolated	B-X
from	B-X
25-	B-X
and	B-X
50-day-old	B-X
rats	B-X
and	B-X
adult	B-X
rats	B-X
in	B-X
a	B-X
concentration-dependent	B-X
manner	B-X
.	B-X
These	B-X
findings	B-X
provide	B-X
evidence	B-X
that	B-X
full-length	B-X
and	B-X
truncated	B-X
sAC	B-X
are	B-X
generated	B-X
by	B-X
alternate	B-X
splicing	B-X
.	B-X
Both	B-X
forms	B-X
are	B-X
active	B-X
in	B-X
spermatids	B-X
,	B-X
and	B-X
the	B-X
bicarbonate	B-X
present	B-X
in	B-X
the	B-X
seminiferous	B-X
tubule	B-X
may	B-X
be	B-X
a	B-X
signal	B-X
that	B-X
regulates	B-X
cAMP	B-X
levels	B-X
in	B-X
these	B-X
cells	B-X
.	B-X

Bicarbonate	O
ions	O
activated	O
both	O
sAC	B-Gene_or_gene_product
forms	O
and	O
increased	O
cAMP	O
levels	O
in	O
germ	O
cells	O
isolated	O
from	O
25	O
-	O
and	O
50	O
-	O
day	O
-	O
old	O
rats	O
and	O
adult	O
rats	O
in	O
a	O
concentration	O
-	O
dependent	O
manner	O
.	O

These	O
findings	O
provide	O
evidence	O
that	O
full	O
-	O
length	O
and	O
truncated	O
sAC	B-Gene_or_gene_product
are	O
generated	O
by	O
alternate	O
splicing	O
.	O
<EOS>	B-X
In	B-X
mammalian	B-X
germ	B-X
cells	B-X
,	B-X
cAMP	B-X
signaling	B-X
is	B-X
dependent	B-X
on	B-X
two	B-X
forms	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
,	B-X
the	B-X
conventional	B-X
membrane-bound	B-X
ACIII	B-X
and	B-X
a	B-X
soluble	B-X
form	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
(	B-X
sAC	B-X
)	B-X
.	B-X
Recent	B-X
elucidation	B-X
of	B-X
the	B-X
sAC	B-X
sequence	B-X
indicates	B-X
that	B-X
this	B-X
enzyme	B-X
is	B-X
phylogenetically	B-X
distinct	B-X
from	B-X
the	B-X
membrane-bound	B-X
AC	B-X
,	B-X
does	B-X
not	B-X
interact	B-X
with	B-X
G	B-X
proteins	B-X
,	B-X
and	B-X
its	B-X
activity	B-X
is	B-X
regulated	B-X
by	B-X
bicarbonate	B-X
ions	B-X
.	B-X
Two	B-X
different	B-X
transcripts	B-X
encoding	B-X
a	B-X
full-length	B-X
and	B-X
truncated	B-X
sAC	B-X
were	B-X
identified	B-X
by	B-X
reverse	B-X
transcriptase-polymerase	B-X
chain	B-X
reaction	B-X
and	B-X
RNase	B-X
protection	B-X
analysis	B-X
.	B-X
The	B-X
truncated	B-X
sAC	B-X
transcript	B-X
lacks	B-X
exon	B-X
11	B-X
with	B-X
a	B-X
premature	B-X
termination	B-X
of	B-X
the	B-X
open	B-X
reading	B-X
frame	B-X
after	B-X
the	B-X
catalytic	B-X
domain	B-X
.	B-X
The	B-X
presence	B-X
of	B-X
corresponding	B-X
proteins	B-X
in	B-X
testis	B-X
,	B-X
germ	B-X
cells	B-X
,	B-X
and	B-X
spermatozoa	B-X
was	B-X
demonstrated	B-X
by	B-X
fast	B-X
protein	B-X
liquid	B-X
chromatography	B-X
and	B-X
differential	B-X
immunoprecipitation	B-X
with	B-X
full-length	B-X
sAC-specific	B-X
antibodies	B-X
.	B-X
Bicarbonate	B-X
ions	B-X
activated	B-X
both	B-X
sAC	B-X
forms	B-X
and	B-X
increased	B-X
cAMP	B-X
levels	B-X
in	B-X
germ	B-X
cells	B-X
isolated	B-X
from	B-X
25-	B-X
and	B-X
50-day-old	B-X
rats	B-X
and	B-X
adult	B-X
rats	B-X
in	B-X
a	B-X
concentration-dependent	B-X
manner	B-X
.	B-X
These	B-X
findings	B-X
provide	B-X
evidence	B-X
that	B-X
full-length	B-X
and	B-X
truncated	B-X
sAC	B-X
are	B-X
generated	B-X
by	B-X
alternate	B-X
splicing	B-X
.	B-X

Both	O
forms	O
are	O
active	O
in	O
spermatids	O
,	O
and	O
the	O
bicarbonate	O
present	O
in	O
the	O
seminiferous	O
tubule	O
may	O
be	O
a	O
signal	O
that	O
regulates	O
cAMP	O
levels	O
in	O
these	O
cells	O
.	O
<EOS>	B-X
In	B-X
mammalian	B-X
germ	B-X
cells	B-X
,	B-X
cAMP	B-X
signaling	B-X
is	B-X
dependent	B-X
on	B-X
two	B-X
forms	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
,	B-X
the	B-X
conventional	B-X
membrane-bound	B-X
ACIII	B-X
and	B-X
a	B-X
soluble	B-X
form	B-X
of	B-X
adenylyl	B-X
cyclase	B-X
(	B-X
sAC	B-X
)	B-X
.	B-X
Recent	B-X
elucidation	B-X
of	B-X
the	B-X
sAC	B-X
sequence	B-X
indicates	B-X
that	B-X
this	B-X
enzyme	B-X
is	B-X
phylogenetically	B-X
distinct	B-X
from	B-X
the	B-X
membrane-bound	B-X
AC	B-X
,	B-X
does	B-X
not	B-X
interact	B-X
with	B-X
G	B-X
proteins	B-X
,	B-X
and	B-X
its	B-X
activity	B-X
is	B-X
regulated	B-X
by	B-X
bicarbonate	B-X
ions	B-X
.	B-X
The	B-X
presence	B-X
of	B-X
corresponding	B-X
proteins	B-X
in	B-X
testis	B-X
,	B-X
germ	B-X
cells	B-X
,	B-X
and	B-X
spermatozoa	B-X
was	B-X
demonstrated	B-X
by	B-X
fast	B-X
protein	B-X
liquid	B-X
chromatography	B-X
and	B-X
differential	B-X
immunoprecipitation	B-X
with	B-X
full-length	B-X
sAC-specific	B-X
antibodies	B-X
.	B-X
Bicarbonate	B-X
ions	B-X
activated	B-X
both	B-X
sAC	B-X
forms	B-X
and	B-X
increased	B-X
cAMP	B-X
levels	B-X
in	B-X
germ	B-X
cells	B-X
isolated	B-X
from	B-X
25-	B-X
and	B-X
50-day-old	B-X
rats	B-X
and	B-X
adult	B-X
rats	B-X
in	B-X
a	B-X
concentration-dependent	B-X
manner	B-X
.	B-X
Both	B-X
forms	B-X
are	B-X
active	B-X
in	B-X
spermatids	B-X
,	B-X
and	B-X
the	B-X
bicarbonate	B-X
present	B-X
in	B-X
the	B-X
seminiferous	B-X
tubule	B-X
may	B-X
be	B-X
a	B-X
signal	B-X
that	B-X
regulates	B-X
cAMP	B-X
levels	B-X
in	B-X
these	B-X
cells	B-X
.	B-X

Functional	O
analysis	O
of	O
the	O
hydrophobic	O
patch	O
on	O
nuclear	B-Gene_or_gene_product
transport	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
2	I-Gene_or_gene_product
involved	O
in	O
interactions	O
with	O
the	O
nuclear	O
pore	O
in	O
vivo	O
.	O
<EOS>	B-X
Nuclear	B-X
transport	B-X
factor	B-X
2	B-X
(	B-X
NTF2	B-X
)	B-X
is	B-X
a	B-X
small	B-X
homodimeric	B-X
protein	B-X
that	B-X
interacts	B-X
simultaneously	B-X
with	B-X
both	B-X
RanGDP	B-X
and	B-X
FxFG	B-X
nucleoporins	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
Ran	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
import	B-X
of	B-X
Ran	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
Here	B-X
we	B-X
use	B-X
mutational	B-X
analysis	B-X
to	B-X
dissect	B-X
the	B-X
in	B-X
vivo	B-X
role	B-X
of	B-X
the	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
nucleoporins	B-X
.	B-X
We	B-X
identify	B-X
a	B-X
series	B-X
of	B-X
surface	B-X
residues	B-X
that	B-X
form	B-X
a	B-X
hydrophobic	B-X
patch	B-X
on	B-X
NTF2	B-X
,	B-X
which	B-X
when	B-X
mutated	B-X
disrupt	B-X
the	B-X
NTF2-nucleoporin	B-X
interaction	B-X
.	B-X
Analysis	B-X
of	B-X
these	B-X
mutants	B-X
in	B-X
vivo	B-X
demonstrates	B-X
that	B-X
the	B-X
strength	B-X
of	B-X
this	B-X
interaction	B-X
can	B-X
be	B-X
significantly	B-X
reduced	B-X
without	B-X
affecting	B-X
cell	B-X
viability	B-X
.	B-X
However	B-X
,	B-X
cells	B-X
cease	B-X
to	B-X
be	B-X
viable	B-X
if	B-X
the	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
nucleoporins	B-X
is	B-X
abolished	B-X
completely	B-X
,	B-X
indicating	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
function	B-X
of	B-X
NTF2	B-X
in	B-X
vivo	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
have	B-X
isolated	B-X
a	B-X
dominant	B-X
negative	B-X
mutant	B-X
of	B-X
NTF2	B-X
,	B-X
N77Y	B-X
,	B-X
which	B-X
has	B-X
increased	B-X
affinity	B-X
for	B-X
nucleoporins	B-X
.	B-X
Overexpression	B-X
of	B-X
the	B-X
N77Y	B-X
protein	B-X
blocks	B-X
nuclear	B-X
protein	B-X
import	B-X
and	B-X
concentrates	B-X
Ran	B-X
at	B-X
the	B-X
nuclear	B-X
rim	B-X
.	B-X
These	B-X
data	B-X
support	B-X
a	B-X
mechanism	B-X
in	B-X
which	B-X
NTF2	B-X
interacts	B-X
transiently	B-X
with	B-X
FxFG	B-X
nucleoporins	B-X
to	B-X
translocate	B-X
through	B-X
the	B-X
pore	B-X
and	B-X
import	B-X
RanGDP	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X

Nuclear	B-Gene_or_gene_product
transport	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
2	I-Gene_or_gene_product
(	O
NTF2	B-Gene_or_gene_product
)	O
is	O
a	O
small	O
homodimeric	O
protein	O
that	O
interacts	O
simultaneously	O
with	O
both	O
RanGDP	B-Gene_or_gene_product
and	O
FxFG	B-Gene_or_gene_product
nucleoporins	I-Gene_or_gene_product
.	O
<EOS>	B-X
Nuclear	B-X
transport	B-X
factor	B-X
2	B-X
(	B-X
NTF2	B-X
)	B-X
is	B-X
a	B-X
small	B-X
homodimeric	B-X
protein	B-X
that	B-X
interacts	B-X
simultaneously	B-X
with	B-X
both	B-X
RanGDP	B-X
and	B-X
FxFG	B-X
nucleoporins	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
Ran	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
import	B-X
of	B-X
Ran	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
Here	B-X
we	B-X
use	B-X
mutational	B-X
analysis	B-X
to	B-X
dissect	B-X
the	B-X
in	B-X
vivo	B-X
role	B-X
of	B-X
the	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
nucleoporins	B-X
.	B-X
We	B-X
identify	B-X
a	B-X
series	B-X
of	B-X
surface	B-X
residues	B-X
that	B-X
form	B-X
a	B-X
hydrophobic	B-X
patch	B-X
on	B-X
NTF2	B-X
,	B-X
which	B-X
when	B-X
mutated	B-X
disrupt	B-X
the	B-X
NTF2-nucleoporin	B-X
interaction	B-X
.	B-X
However	B-X
,	B-X
cells	B-X
cease	B-X
to	B-X
be	B-X
viable	B-X
if	B-X
the	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
nucleoporins	B-X
is	B-X
abolished	B-X
completely	B-X
,	B-X
indicating	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
function	B-X
of	B-X
NTF2	B-X
in	B-X
vivo	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
have	B-X
isolated	B-X
a	B-X
dominant	B-X
negative	B-X
mutant	B-X
of	B-X
NTF2	B-X
,	B-X
N77Y	B-X
,	B-X
which	B-X
has	B-X
increased	B-X
affinity	B-X
for	B-X
nucleoporins	B-X
.	B-X
Overexpression	B-X
of	B-X
the	B-X
N77Y	B-X
protein	B-X
blocks	B-X
nuclear	B-X
protein	B-X
import	B-X
and	B-X
concentrates	B-X
Ran	B-X
at	B-X
the	B-X
nuclear	B-X
rim	B-X
.	B-X
These	B-X
data	B-X
support	B-X
a	B-X
mechanism	B-X
in	B-X
which	B-X
NTF2	B-X
interacts	B-X
transiently	B-X
with	B-X
FxFG	B-X
nucleoporins	B-X
to	B-X
translocate	B-X
through	B-X
the	B-X
pore	B-X
and	B-X
import	B-X
RanGDP	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X

The	O
interaction	O
between	O
NTF2	B-Gene_or_gene_product
and	O
Ran	B-Gene_or_gene_product
is	O
essential	O
for	O
the	O
import	O
of	O
Ran	B-Gene_or_gene_product
into	O
the	O
nucleus	O
.	O
<EOS>	B-X
The	B-X
active	B-X
transport	B-X
of	B-X
proteins	B-X
into	B-X
and	B-X
out	B-X
of	B-X
the	B-X
nucleus	B-X
is	B-X
mediated	B-X
by	B-X
specific	B-X
signals	B-X
,	B-X
the	B-X
nuclear	B-X
localization	B-X
signal	B-X
(	B-X
NLS	B-X
)	B-X
and	B-X
nuclear	B-X
export	B-X
signal	B-X
(	B-X
NES	B-X
)	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
SV40	B-X
T-NLS	B-X
containing	B-X
transport	B-X
substrates	B-X
are	B-X
carried	B-X
into	B-X
the	B-X
nucleus	B-X
by	B-X
an	B-X
importin	B-X
alpha/beta	B-X
heterodimer	B-X
.	B-X
Importin	B-X
alpha	B-X
recognizes	B-X
the	B-X
NLS	B-X
and	B-X
acts	B-X
as	B-X
an	B-X
adapter	B-X
between	B-X
the	B-X
NLS	B-X
and	B-X
importin	B-X
beta	B-X
,	B-X
whereas	B-X
importin	B-X
beta	B-X
interacts	B-X
with	B-X
importin	B-X
alpha	B-X
bound	B-X
to	B-X
the	B-X
NLS	B-X
,	B-X
and	B-X
acts	B-X
as	B-X
a	B-X
carrier	B-X
of	B-X
the	B-X
NLS/importin	B-X
alpha/beta	B-X
trimer	B-X
.	B-X
It	B-X
is	B-X
generally	B-X
thought	B-X
that	B-X
importin	B-X
alpha	B-X
and	B-X
beta	B-X
are	B-X
part	B-X
of	B-X
a	B-X
large	B-X
protein	B-X
family	B-X
.	B-X
The	B-X
leucine	B-X
rich	B-X
NES-containing	B-X
proteins	B-X
are	B-X
exported	B-X
from	B-X
the	B-X
nucleus	B-X
by	B-X
one	B-X
of	B-X
the	B-X
importin	B-X
beta	B-X
family	B-X
molecules	B-X
,	B-X
CRM1/exportin	B-X
1	B-X
.	B-X
A	B-X
Ras-like	B-X
small	B-X
GTPase	B-X
Ran	B-X
plays	B-X
a	B-X
crucial	B-X
role	B-X
in	B-X
both	B-X
import/export	B-X
pathways	B-X
and	B-X
determines	B-X
the	B-X
directionality	B-X
of	B-X
nuclear	B-X
transport	B-X
.	B-X
It	B-X
has	B-X
recently	B-X
been	B-X
demonstrated	B-X
in	B-X
living	B-X
cells	B-X
that	B-X
Ran	B-X
actually	B-X
shuttles	B-X
between	B-X
the	B-X
nucleus	B-X
and	B-X
the	B-X
cytoplasm	B-X
and	B-X
that	B-X
the	B-X
recycling	B-X
of	B-X
Ran	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
nuclear	B-X
transport	B-X
.	B-X
Furthermore	B-X
,	B-X
it	B-X
has	B-X
been	B-X
shown	B-X
that	B-X
nuclear	B-X
transport	B-X
factor	B-X
2	B-X
(	B-X
NTF2	B-X
)	B-X
mediates	B-X
the	B-X
nuclear	B-X
import	B-X
of	B-X
RanGDP	B-X
.	B-X
This	B-X
review	B-X
largely	B-X
focuses	B-X
on	B-X
the	B-X
issue	B-X
concerning	B-X
the	B-X
functional	B-X
divergence	B-X
of	B-X
importin	B-X
alpha	B-X
family	B-X
molecules	B-X
and	B-X
the	B-X
role	B-X
of	B-X
Ran	B-X
in	B-X
nucleocytoplasmic	B-X
protein	B-X
transport	B-X
.	B-X

Here	O
we	O
use	O
mutational	O
analysis	O
to	O
dissect	O
the	O
in	O
vivo	O
role	O
of	O
the	O
interaction	O
between	O
NTF2	B-Gene_or_gene_product
and	O
nucleoporins	B-Gene_or_gene_product
.	O
<EOS>	B-X
Nuclear	B-X
transport	B-X
factor	B-X
2	B-X
(	B-X
NTF2	B-X
)	B-X
is	B-X
a	B-X
small	B-X
homodimeric	B-X
protein	B-X
that	B-X
interacts	B-X
simultaneously	B-X
with	B-X
both	B-X
RanGDP	B-X
and	B-X
FxFG	B-X
nucleoporins	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
Ran	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
import	B-X
of	B-X
Ran	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
Here	B-X
we	B-X
use	B-X
mutational	B-X
analysis	B-X
to	B-X
dissect	B-X
the	B-X
in	B-X
vivo	B-X
role	B-X
of	B-X
the	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
nucleoporins	B-X
.	B-X
We	B-X
identify	B-X
a	B-X
series	B-X
of	B-X
surface	B-X
residues	B-X
that	B-X
form	B-X
a	B-X
hydrophobic	B-X
patch	B-X
on	B-X
NTF2	B-X
,	B-X
which	B-X
when	B-X
mutated	B-X
disrupt	B-X
the	B-X
NTF2-nucleoporin	B-X
interaction	B-X
.	B-X
Analysis	B-X
of	B-X
these	B-X
mutants	B-X
in	B-X
vivo	B-X
demonstrates	B-X
that	B-X
the	B-X
strength	B-X
of	B-X
this	B-X
interaction	B-X
can	B-X
be	B-X
significantly	B-X
reduced	B-X
without	B-X
affecting	B-X
cell	B-X
viability	B-X
.	B-X
However	B-X
,	B-X
cells	B-X
cease	B-X
to	B-X
be	B-X
viable	B-X
if	B-X
the	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
nucleoporins	B-X
is	B-X
abolished	B-X
completely	B-X
,	B-X
indicating	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
function	B-X
of	B-X
NTF2	B-X
in	B-X
vivo	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
have	B-X
isolated	B-X
a	B-X
dominant	B-X
negative	B-X
mutant	B-X
of	B-X
NTF2	B-X
,	B-X
N77Y	B-X
,	B-X
which	B-X
has	B-X
increased	B-X
affinity	B-X
for	B-X
nucleoporins	B-X
.	B-X
These	B-X
data	B-X
support	B-X
a	B-X
mechanism	B-X
in	B-X
which	B-X
NTF2	B-X
interacts	B-X
transiently	B-X
with	B-X
FxFG	B-X
nucleoporins	B-X
to	B-X
translocate	B-X
through	B-X
the	B-X
pore	B-X
and	B-X
import	B-X
RanGDP	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X

We	O
identify	O
a	O
series	O
of	O
surface	O
residues	O
that	O
form	O
a	O
hydrophobic	O
patch	O
on	O
NTF2	B-Gene_or_gene_product
,	O
which	O
when	O
mutated	O
disrupt	O
the	O
NTF2	B-Gene_or_gene_product
-	O
nucleoporin	B-Gene_or_gene_product
interaction	O
.	O

Analysis	O
of	O
these	O
mutants	O
in	O
vivo	O
demonstrates	O
that	O
the	O
strength	O
of	O
this	O
interaction	O
can	O
be	O
significantly	O
reduced	O
without	O
affecting	O
cell	O
viability	O
.	O
<EOS>	B-X
The	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
Ran	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
import	B-X
of	B-X
Ran	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
Here	B-X
we	B-X
use	B-X
mutational	B-X
analysis	B-X
to	B-X
dissect	B-X
the	B-X
in	B-X
vivo	B-X
role	B-X
of	B-X
the	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
nucleoporins	B-X
.	B-X
We	B-X
identify	B-X
a	B-X
series	B-X
of	B-X
surface	B-X
residues	B-X
that	B-X
form	B-X
a	B-X
hydrophobic	B-X
patch	B-X
on	B-X
NTF2	B-X
,	B-X
which	B-X
when	B-X
mutated	B-X
disrupt	B-X
the	B-X
NTF2-nucleoporin	B-X
interaction	B-X
.	B-X
Analysis	B-X
of	B-X
these	B-X
mutants	B-X
in	B-X
vivo	B-X
demonstrates	B-X
that	B-X
the	B-X
strength	B-X
of	B-X
this	B-X
interaction	B-X
can	B-X
be	B-X
significantly	B-X
reduced	B-X
without	B-X
affecting	B-X
cell	B-X
viability	B-X
.	B-X
However	B-X
,	B-X
cells	B-X
cease	B-X
to	B-X
be	B-X
viable	B-X
if	B-X
the	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
nucleoporins	B-X
is	B-X
abolished	B-X
completely	B-X
,	B-X
indicating	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
function	B-X
of	B-X
NTF2	B-X
in	B-X
vivo	B-X
.	B-X

However	O
,	O
cells	O
cease	O
to	O
be	O
viable	O
if	O
the	O
interaction	O
between	O
NTF2	B-Gene_or_gene_product
and	O
nucleoporins	B-Gene_or_gene_product
is	O
abolished	O
completely	O
,	O
indicating	O
that	O
this	O
interaction	O
is	O
essential	O
for	O
the	O
function	O
of	O
NTF2	B-Gene_or_gene_product
in	O
vivo	O
.	O
<EOS>	B-X
Nuclear	B-X
transport	B-X
factor	B-X
2	B-X
(	B-X
NTF2	B-X
)	B-X
is	B-X
a	B-X
small	B-X
homodimeric	B-X
protein	B-X
that	B-X
interacts	B-X
simultaneously	B-X
with	B-X
both	B-X
RanGDP	B-X
and	B-X
FxFG	B-X
nucleoporins	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
Ran	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
import	B-X
of	B-X
Ran	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
Here	B-X
we	B-X
use	B-X
mutational	B-X
analysis	B-X
to	B-X
dissect	B-X
the	B-X
in	B-X
vivo	B-X
role	B-X
of	B-X
the	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
nucleoporins	B-X
.	B-X
We	B-X
identify	B-X
a	B-X
series	B-X
of	B-X
surface	B-X
residues	B-X
that	B-X
form	B-X
a	B-X
hydrophobic	B-X
patch	B-X
on	B-X
NTF2	B-X
,	B-X
which	B-X
when	B-X
mutated	B-X
disrupt	B-X
the	B-X
NTF2-nucleoporin	B-X
interaction	B-X
.	B-X
Analysis	B-X
of	B-X
these	B-X
mutants	B-X
in	B-X
vivo	B-X
demonstrates	B-X
that	B-X
the	B-X
strength	B-X
of	B-X
this	B-X
interaction	B-X
can	B-X
be	B-X
significantly	B-X
reduced	B-X
without	B-X
affecting	B-X
cell	B-X
viability	B-X
.	B-X
However	B-X
,	B-X
cells	B-X
cease	B-X
to	B-X
be	B-X
viable	B-X
if	B-X
the	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
nucleoporins	B-X
is	B-X
abolished	B-X
completely	B-X
,	B-X
indicating	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
function	B-X
of	B-X
NTF2	B-X
in	B-X
vivo	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
have	B-X
isolated	B-X
a	B-X
dominant	B-X
negative	B-X
mutant	B-X
of	B-X
NTF2	B-X
,	B-X
N77Y	B-X
,	B-X
which	B-X
has	B-X
increased	B-X
affinity	B-X
for	B-X
nucleoporins	B-X
.	B-X
These	B-X
data	B-X
support	B-X
a	B-X
mechanism	B-X
in	B-X
which	B-X
NTF2	B-X
interacts	B-X
transiently	B-X
with	B-X
FxFG	B-X
nucleoporins	B-X
to	B-X
translocate	B-X
through	B-X
the	B-X
pore	B-X
and	B-X
import	B-X
RanGDP	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X

In	O
addition	O
,	O
we	O
have	O
isolated	O
a	O
dominant	O
negative	O
mutant	O
of	O
NTF2	B-Gene_or_gene_product
,	O
N77Y	B-Gene_or_gene_product
,	O
which	O
has	O
increased	O
affinity	O
for	O
nucleoporins	B-Gene_or_gene_product
.	O
<EOS>	B-X
Nuclear	B-X
transport	B-X
factor	B-X
2	B-X
(	B-X
NTF2	B-X
)	B-X
is	B-X
a	B-X
small	B-X
homodimeric	B-X
protein	B-X
that	B-X
interacts	B-X
simultaneously	B-X
with	B-X
both	B-X
RanGDP	B-X
and	B-X
FxFG	B-X
nucleoporins	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
Ran	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
import	B-X
of	B-X
Ran	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
Here	B-X
we	B-X
use	B-X
mutational	B-X
analysis	B-X
to	B-X
dissect	B-X
the	B-X
in	B-X
vivo	B-X
role	B-X
of	B-X
the	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
nucleoporins	B-X
.	B-X
We	B-X
identify	B-X
a	B-X
series	B-X
of	B-X
surface	B-X
residues	B-X
that	B-X
form	B-X
a	B-X
hydrophobic	B-X
patch	B-X
on	B-X
NTF2	B-X
,	B-X
which	B-X
when	B-X
mutated	B-X
disrupt	B-X
the	B-X
NTF2-nucleoporin	B-X
interaction	B-X
.	B-X
Analysis	B-X
of	B-X
these	B-X
mutants	B-X
in	B-X
vivo	B-X
demonstrates	B-X
that	B-X
the	B-X
strength	B-X
of	B-X
this	B-X
interaction	B-X
can	B-X
be	B-X
significantly	B-X
reduced	B-X
without	B-X
affecting	B-X
cell	B-X
viability	B-X
.	B-X
However	B-X
,	B-X
cells	B-X
cease	B-X
to	B-X
be	B-X
viable	B-X
if	B-X
the	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
nucleoporins	B-X
is	B-X
abolished	B-X
completely	B-X
,	B-X
indicating	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
function	B-X
of	B-X
NTF2	B-X
in	B-X
vivo	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
have	B-X
isolated	B-X
a	B-X
dominant	B-X
negative	B-X
mutant	B-X
of	B-X
NTF2	B-X
,	B-X
N77Y	B-X
,	B-X
which	B-X
has	B-X
increased	B-X
affinity	B-X
for	B-X
nucleoporins	B-X
.	B-X
Overexpression	B-X
of	B-X
the	B-X
N77Y	B-X
protein	B-X
blocks	B-X
nuclear	B-X
protein	B-X
import	B-X
and	B-X
concentrates	B-X
Ran	B-X
at	B-X
the	B-X
nuclear	B-X
rim	B-X
.	B-X
These	B-X
data	B-X
support	B-X
a	B-X
mechanism	B-X
in	B-X
which	B-X
NTF2	B-X
interacts	B-X
transiently	B-X
with	B-X
FxFG	B-X
nucleoporins	B-X
to	B-X
translocate	B-X
through	B-X
the	B-X
pore	B-X
and	B-X
import	B-X
RanGDP	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X

Overexpression	O
of	O
the	O
N77Y	B-Gene_or_gene_product
protein	O
blocks	O
nuclear	O
protein	O
import	O
and	O
concentrates	O
Ran	B-Gene_or_gene_product
at	O
the	O
nuclear	O
rim	O
.	O
<EOS>	B-X
Nuclear	B-X
transport	B-X
factor	B-X
2	B-X
(	B-X
NTF2	B-X
)	B-X
is	B-X
a	B-X
small	B-X
homodimeric	B-X
protein	B-X
that	B-X
interacts	B-X
simultaneously	B-X
with	B-X
both	B-X
RanGDP	B-X
and	B-X
FxFG	B-X
nucleoporins	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
Ran	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
import	B-X
of	B-X
Ran	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
have	B-X
isolated	B-X
a	B-X
dominant	B-X
negative	B-X
mutant	B-X
of	B-X
NTF2	B-X
,	B-X
N77Y	B-X
,	B-X
which	B-X
has	B-X
increased	B-X
affinity	B-X
for	B-X
nucleoporins	B-X
.	B-X
Overexpression	B-X
of	B-X
the	B-X
N77Y	B-X
protein	B-X
blocks	B-X
nuclear	B-X
protein	B-X
import	B-X
and	B-X
concentrates	B-X
Ran	B-X
at	B-X
the	B-X
nuclear	B-X
rim	B-X
.	B-X
These	B-X
data	B-X
support	B-X
a	B-X
mechanism	B-X
in	B-X
which	B-X
NTF2	B-X
interacts	B-X
transiently	B-X
with	B-X
FxFG	B-X
nucleoporins	B-X
to	B-X
translocate	B-X
through	B-X
the	B-X
pore	B-X
and	B-X
import	B-X
RanGDP	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X

These	O
data	O
support	O
a	O
mechanism	O
in	O
which	O
NTF2	B-Gene_or_gene_product
interacts	O
transiently	O
with	O
FxFG	B-Gene_or_gene_product
nucleoporins	I-Gene_or_gene_product
to	O
translocate	O
through	O
the	O
pore	O
and	O
import	O
RanGDP	B-Gene_or_gene_product
into	O
the	O
nucleus	O
.	O
<EOS>	B-X
Nuclear	B-X
transport	B-X
factor	B-X
2	B-X
(	B-X
NTF2	B-X
)	B-X
is	B-X
a	B-X
small	B-X
homodimeric	B-X
protein	B-X
that	B-X
interacts	B-X
simultaneously	B-X
with	B-X
both	B-X
RanGDP	B-X
and	B-X
FxFG	B-X
nucleoporins	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
Ran	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
import	B-X
of	B-X
Ran	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
Here	B-X
we	B-X
use	B-X
mutational	B-X
analysis	B-X
to	B-X
dissect	B-X
the	B-X
in	B-X
vivo	B-X
role	B-X
of	B-X
the	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
nucleoporins	B-X
.	B-X
We	B-X
identify	B-X
a	B-X
series	B-X
of	B-X
surface	B-X
residues	B-X
that	B-X
form	B-X
a	B-X
hydrophobic	B-X
patch	B-X
on	B-X
NTF2	B-X
,	B-X
which	B-X
when	B-X
mutated	B-X
disrupt	B-X
the	B-X
NTF2-nucleoporin	B-X
interaction	B-X
.	B-X
However	B-X
,	B-X
cells	B-X
cease	B-X
to	B-X
be	B-X
viable	B-X
if	B-X
the	B-X
interaction	B-X
between	B-X
NTF2	B-X
and	B-X
nucleoporins	B-X
is	B-X
abolished	B-X
completely	B-X
,	B-X
indicating	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
function	B-X
of	B-X
NTF2	B-X
in	B-X
vivo	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
have	B-X
isolated	B-X
a	B-X
dominant	B-X
negative	B-X
mutant	B-X
of	B-X
NTF2	B-X
,	B-X
N77Y	B-X
,	B-X
which	B-X
has	B-X
increased	B-X
affinity	B-X
for	B-X
nucleoporins	B-X
.	B-X
Overexpression	B-X
of	B-X
the	B-X
N77Y	B-X
protein	B-X
blocks	B-X
nuclear	B-X
protein	B-X
import	B-X
and	B-X
concentrates	B-X
Ran	B-X
at	B-X
the	B-X
nuclear	B-X
rim	B-X
.	B-X
These	B-X
data	B-X
support	B-X
a	B-X
mechanism	B-X
in	B-X
which	B-X
NTF2	B-X
interacts	B-X
transiently	B-X
with	B-X
FxFG	B-X
nucleoporins	B-X
to	B-X
translocate	B-X
through	B-X
the	B-X
pore	B-X
and	B-X
import	B-X
RanGDP	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X

Expression	O
and	O
properties	O
of	O
human	O
liver	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
ureidopropionase	I-Gene_or_gene_product
.	O
<EOS>	B-X
A	B-X
cDNA	B-X
encoding	B-X
beta-ureidopropionase	B-X
(	B-X
BUP	B-X
)	B-X
was	B-X
isolated	B-X
from	B-X
a	B-X
human	B-X
liver	B-X
cDNA	B-X
library	B-X
,	B-X
expressed	B-X
in	B-X
E.	B-X
coli	B-X
,	B-X
and	B-X
purified	B-X
from	B-X
the	B-X
culture	B-X
extract	B-X
.	B-X
The	B-X
enzyme	B-X
was	B-X
inhibited	B-X
by	B-X
1	B-X
mM	B-X
propionate	B-X
,	B-X
but	B-X
not	B-X
by	B-X
10	B-X
mM	B-X
beta-alanine	B-X
.	B-X
Chemical	B-X
analysis	B-X
of	B-X
the	B-X
purified	B-X
human	B-X
BUP	B-X
showed	B-X
0.54	B-X
zinc	B-X
atoms	B-X
per	B-X
subunit	B-X
,	B-X
and	B-X
the	B-X
sequence	B-X
of	B-X
BUP	B-X
cDNA	B-X
contained	B-X
one	B-X
putative	B-X
zinc-binding	B-X
site	B-X
motif	B-X
.	B-X
The	B-X
purified	B-X
enzyme	B-X
had	B-X
a	B-X
pI	B-X
of	B-X
5.65	B-X
,	B-X
and	B-X
exhibited	B-X
positive	B-X
cooperativity	B-X
with	B-X
N-carbamoyl-beta-alanine	B-X
as	B-X
the	B-X
substrate	B-X
with	B-X
a	B-X
Hill	B-X
coefficient	B-X
2.0	B-X
.	B-X
These	B-X
properties	B-X
of	B-X
human	B-X
BUP	B-X
,	B-X
except	B-X
the	B-X
inhibition	B-X
by	B-X
beta-alanine	B-X
,	B-X
were	B-X
similar	B-X
to	B-X
the	B-X
rat	B-X
liver	B-X
purified	B-X
enzyme	B-X
.	B-X
The	B-X
complex	B-X
regulatory	B-X
function	B-X
and	B-X
the	B-X
negative	B-X
cooperative	B-X
mechanism	B-X
of	B-X
BUP	B-X
by	B-X
beta-alanine	B-X
have	B-X
been	B-X
observed	B-X
in	B-X
rats	B-X
.	B-X
This	B-X
kind	B-X
of	B-X
mechanism	B-X
may	B-X
not	B-X
exist	B-X
in	B-X
humans	B-X
,	B-X
because	B-X
beta-alanine	B-X
did	B-X
not	B-X
inhibit	B-X
human	B-X
BUP	B-X
.	B-X

A	O
cDNA	O
encoding	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
ureidopropionase	I-Gene_or_gene_product
(	O
BUP	B-Gene_or_gene_product
)	O
was	O
isolated	O
from	O
a	O
human	O
liver	O
cDNA	O
library	O
,	O
expressed	O
in	O
E	O
.	O
coli	O
,	O
and	O
purified	O
from	O
the	O
culture	O
extract	O
.	O

The	O
2	O
,	O
006	O
bp	O
cDNA	O
contained	O
a	O
1	O
,	O
152	O
bp	O
open	O
reading	O
frame	O
encoding	O
a	O
protein	O
of	O
384	O
amino	O
acids	O
with	O
a	O
molecular	O
weight	O
of	O
43	O
,	O
165	O
Da	O
.	O
<EOS>	B-X
A	B-X
cDNA	B-X
encoding	B-X
beta-ureidopropionase	B-X
(	B-X
BUP	B-X
)	B-X
was	B-X
isolated	B-X
from	B-X
a	B-X
human	B-X
liver	B-X
cDNA	B-X
library	B-X
,	B-X
expressed	B-X
in	B-X
E.	B-X
coli	B-X
,	B-X
and	B-X
purified	B-X
from	B-X
the	B-X
culture	B-X
extract	B-X
.	B-X
The	B-X
2,006	B-X
bp	B-X
cDNA	B-X
contained	B-X
a	B-X
1,152	B-X
bp	B-X
open	B-X
reading	B-X
frame	B-X
encoding	B-X
a	B-X
protein	B-X
of	B-X
384	B-X
amino	B-X
acids	B-X
with	B-X
a	B-X
molecular	B-X
weight	B-X
of	B-X
43,165	B-X
Da	B-X
.	B-X
The	B-X
subunit	B-X
molecular	B-X
weight	B-X
of	B-X
the	B-X
enzyme	B-X
expressed	B-X
was	B-X
about	B-X
43,000	B-X
Da	B-X
.	B-X
The	B-X
enzyme	B-X
was	B-X
inhibited	B-X
by	B-X
1	B-X
mM	B-X
propionate	B-X
,	B-X
but	B-X
not	B-X
by	B-X
10	B-X
mM	B-X
beta-alanine	B-X
.	B-X
Chemical	B-X
analysis	B-X
of	B-X
the	B-X
purified	B-X
human	B-X
BUP	B-X
showed	B-X
0.54	B-X
zinc	B-X
atoms	B-X
per	B-X
subunit	B-X
,	B-X
and	B-X
the	B-X
sequence	B-X
of	B-X
BUP	B-X
cDNA	B-X
contained	B-X
one	B-X
putative	B-X
zinc-binding	B-X
site	B-X
motif	B-X
.	B-X
The	B-X
purified	B-X
enzyme	B-X
had	B-X
a	B-X
pI	B-X
of	B-X
5.65	B-X
,	B-X
and	B-X
exhibited	B-X
positive	B-X
cooperativity	B-X
with	B-X
N-carbamoyl-beta-alanine	B-X
as	B-X
the	B-X
substrate	B-X
with	B-X
a	B-X
Hill	B-X
coefficient	B-X
2.0	B-X
.	B-X

The	O
subunit	O
molecular	O
weight	O
of	O
the	O
enzyme	O
expressed	O
was	O
about	O
43	O
,	O
000	O
Da	O
.	O
<EOS>	B-X
Amino	B-X
acid	B-X
sequences	B-X
of	B-X
five	B-X
tryptic	B-X
peptides	B-X
from	B-X
rat	B-X
deoxyhypusine	B-X
synthase	B-X
were	B-X
found	B-X
to	B-X
match	B-X
partially	B-X
the	B-X
deduced	B-X
amino	B-X
acid	B-X
sequence	B-X
of	B-X
the	B-X
open	B-X
reading	B-X
frame	B-X
of	B-X
gene	B-X
YHR068w	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
chromosome	B-X
VIII	B-X
(	B-X
AC	B-X
:	B-X
U00061	B-X
)	B-X
.	B-X
In	B-X
order	B-X
to	B-X
determine	B-X
whether	B-X
the	B-X
product	B-X
of	B-X
this	B-X
gene	B-X
corresponds	B-X
to	B-X
yeast	B-X
deoxyhypusine	B-X
synthase	B-X
,	B-X
a	B-X
1.17-kilobase	B-X
pair	B-X
cDNA	B-X
with	B-X
an	B-X
identical	B-X
nucleotide	B-X
sequence	B-X
to	B-X
that	B-X
of	B-X
the	B-X
YHR068w	B-X
coding	B-X
region	B-X
was	B-X
obtained	B-X
from	B-X
S.	B-X
cerevisiae	B-X
cDNA	B-X
by	B-X
polymerase	B-X
chain	B-X
reaction	B-X
and	B-X
was	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
B	B-X
strain	B-X
BL21	B-X
(	B-X
DE3	B-X
)	B-X
.	B-X
The	B-X
purified	B-X
form	B-X
of	B-X
the	B-X
expressed	B-X
protein	B-X
effectively	B-X
catalyzed	B-X
the	B-X
formation	B-X
of	B-X
deoxyhypusine	B-X
in	B-X
yeast	B-X
eIF-5A	B-X
precursors	B-X
as	B-X
well	B-X
as	B-X
in	B-X
human	B-X
precursor	B-X
and	B-X
in	B-X
those	B-X
from	B-X
Chinese	B-X
hamster	B-X
ovary	B-X
cells	B-X
.	B-X
The	B-X
molecular	B-X
mass	B-X
of	B-X
the	B-X
enzyme	B-X
was	B-X
estimated	B-X
to	B-X
be	B-X
172,000	B-X
+/-	B-X
4,300	B-X
Da	B-X
by	B-X
equilibrium	B-X
centrifugation	B-X
.	B-X
The	B-X
mass	B-X
of	B-X
its	B-X
polypeptide	B-X
subunit	B-X
was	B-X
determined	B-X
to	B-X
be	B-X
approximately	B-X
43,000	B-X
Da	B-X
,	B-X
in	B-X
close	B-X
agreement	B-X
with	B-X
that	B-X
calculated	B-X
for	B-X
the	B-X
coding	B-X
region	B-X
of	B-X
the	B-X
YHRO68w	B-X
gene	B-X
.	B-X

The	O
enzyme	O
was	O
inhibited	O
by	O
1	O
mM	O
propionate	O
,	O
but	O
not	O
by	O
10	O
mM	O
beta	O
-	O
alanine	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
that	B-X
in	B-X
Caenorhabditis	B-X
elegans	B-X
,	B-X
loss	B-X
of	B-X
the	B-X
D-2HG	B-X
dehydrogenase	B-X
DHGD-1	B-X
causes	B-X
D-2HG	B-X
accumulation	B-X
and	B-X
mitochondrial	B-X
damage	B-X
.	B-X
The	B-X
excess	B-X
D-2HG	B-X
leads	B-X
to	B-X
a	B-X
build-up	B-X
of	B-X
3-hydroxypropionate	B-X
(	B-X
3-HP	B-X
)	B-X
,	B-X
a	B-X
toxic	B-X
metabolite	B-X
in	B-X
mitochondrial	B-X
propionate	B-X
oxidation	B-X
,	B-X
by	B-X
inhibiting	B-X
the	B-X
3-HP	B-X
dehydrogenase	B-X
HPHD-1	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
3-HP	B-X
binds	B-X
the	B-X
MICOS	B-X
subunit	B-X
MIC60	B-X
(	B-X
encoded	B-X
by	B-X
immt-1	B-X
)	B-X
and	B-X
inhibits	B-X
its	B-X
membrane-binding	B-X
and	B-X
membrane-shaping	B-X
activities	B-X
.	B-X
Furthermore	B-X
,	B-X
Ang	B-X
II	B-X
treatment	B-X
enhanced	B-X
mice	B-X
myocardial	B-X
I/R	B-X
injury	B-X
,	B-X
which	B-X
was	B-X
reversed	B-X
by	B-X
caveolin-1	B-X
(	B-X
CAV-1	B-X
)	B-X
-shRNA	B-X
or	B-X
strengthened	B-X
by	B-X
angiotensin-converting	B-X
enzyme	B-X
2	B-X
(	B-X
ACE2	B-X
)	B-X
-shRNA	B-X
.	B-X
The	B-X
results	B-X
showed	B-X
that	B-X
CAV-1	B-X
and	B-X
ACE2	B-X
have	B-X
protein	B-X
interactions	B-X
and	B-X
inhibit	B-X
each	B-X
other	B-X
's	B-X
expression	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
propionate	B-X
,	B-X
a	B-X
bacterial	B-X
metabolite	B-X
,	B-X
inhibited	B-X
the	B-X
elevation	B-X
of	B-X
Ang	B-X
II	B-X
and	B-X
myocardial	B-X
injury	B-X
,	B-X
while	B-X
GPR41-shRNA	B-X
abolished	B-X
the	B-X
protective	B-X
effects	B-X
of	B-X
propionate	B-X
on	B-X
myocardial	B-X
I/R	B-X
injury	B-X
.	B-X
Clinically	B-X
,	B-X
the	B-X
propionate	B-X
content	B-X
in	B-X
the	B-X
patient	B-X
's	B-X
preoperative	B-X
stool	B-X
was	B-X
related	B-X
to	B-X
Ang	B-X
II	B-X
levels	B-X
and	B-X
myocardial	B-X
I/R	B-X
injury	B-X
levels	B-X
during	B-X
myocardial	B-X
reperfusion	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
propionate	B-X
alleviates	B-X
myocardial	B-X
I/R	B-X
injury	B-X
aggravated	B-X
by	B-X
Ang	B-X
II	B-X
dependent	B-X
on	B-X
CAV-1/ACE2	B-X
axis	B-X
through	B-X
GPR41	B-X
,	B-X
which	B-X
provides	B-X
a	B-X
new	B-X
direction	B-X
that	B-X
diet	B-X
to	B-X
regulate	B-X
the	B-X
intestinal	B-X
flora	B-X
for	B-X
treatment	B-X
of	B-X
myocardial	B-X
I/R	B-X
injury	B-X
.	B-X

Chemical	O
analysis	O
of	O
the	O
purified	O
human	O
BUP	B-Gene_or_gene_product
showed	O
0	O
.	O
54	O
zinc	O
atoms	O
per	O
subunit	O
,	O
and	O
the	O
sequence	O
of	O
BUP	B-Gene_or_gene_product
cDNA	O
contained	O
one	O
putative	O
zinc	O
-	O
binding	O
site	O
motif	O
.	O

The	O
purified	O
enzyme	O
had	O
a	O
pI	O
of	O
5	O
.	O
65	O
,	O
and	O
exhibited	O
positive	O
cooperativity	O
with	O
N	O
-	O
carbamoyl	O
-	O
beta	O
-	O
alanine	O
as	O
the	O
substrate	O
with	O
a	O
Hill	O
coefficient	O
2	O
.	O
0	O
.	O

These	O
properties	O
of	O
human	O
BUP	B-Gene_or_gene_product
,	O
except	O
the	O
inhibition	O
by	O
beta	O
-	O
alanine	O
,	O
were	O
similar	O
to	O
the	O
rat	O
liver	O
purified	O
enzyme	O
.	O

Beta	O
-	O
alanine	O
inhibits	O
rats	O
BUP	B-Gene_or_gene_product
activity	O
.	O
<EOS>	B-X
A	B-X
cDNA	B-X
encoding	B-X
beta-ureidopropionase	B-X
(	B-X
BUP	B-X
)	B-X
was	B-X
isolated	B-X
from	B-X
a	B-X
human	B-X
liver	B-X
cDNA	B-X
library	B-X
,	B-X
expressed	B-X
in	B-X
E.	B-X
coli	B-X
,	B-X
and	B-X
purified	B-X
from	B-X
the	B-X
culture	B-X
extract	B-X
.	B-X
The	B-X
enzyme	B-X
was	B-X
inhibited	B-X
by	B-X
1	B-X
mM	B-X
propionate	B-X
,	B-X
but	B-X
not	B-X
by	B-X
10	B-X
mM	B-X
beta-alanine	B-X
.	B-X
Chemical	B-X
analysis	B-X
of	B-X
the	B-X
purified	B-X
human	B-X
BUP	B-X
showed	B-X
0.54	B-X
zinc	B-X
atoms	B-X
per	B-X
subunit	B-X
,	B-X
and	B-X
the	B-X
sequence	B-X
of	B-X
BUP	B-X
cDNA	B-X
contained	B-X
one	B-X
putative	B-X
zinc-binding	B-X
site	B-X
motif	B-X
.	B-X
The	B-X
purified	B-X
enzyme	B-X
had	B-X
a	B-X
pI	B-X
of	B-X
5.65	B-X
,	B-X
and	B-X
exhibited	B-X
positive	B-X
cooperativity	B-X
with	B-X
N-carbamoyl-beta-alanine	B-X
as	B-X
the	B-X
substrate	B-X
with	B-X
a	B-X
Hill	B-X
coefficient	B-X
2.0	B-X
.	B-X
These	B-X
properties	B-X
of	B-X
human	B-X
BUP	B-X
,	B-X
except	B-X
the	B-X
inhibition	B-X
by	B-X
beta-alanine	B-X
,	B-X
were	B-X
similar	B-X
to	B-X
the	B-X
rat	B-X
liver	B-X
purified	B-X
enzyme	B-X
.	B-X
Beta-alanine	B-X
inhibits	B-X
rats	B-X
BUP	B-X
activity	B-X
.	B-X
The	B-X
complex	B-X
regulatory	B-X
function	B-X
and	B-X
the	B-X
negative	B-X
cooperative	B-X
mechanism	B-X
of	B-X
BUP	B-X
by	B-X
beta-alanine	B-X
have	B-X
been	B-X
observed	B-X
in	B-X
rats	B-X
.	B-X
This	B-X
kind	B-X
of	B-X
mechanism	B-X
may	B-X
not	B-X
exist	B-X
in	B-X
humans	B-X
,	B-X
because	B-X
beta-alanine	B-X
did	B-X
not	B-X
inhibit	B-X
human	B-X
BUP	B-X
.	B-X

The	O
complex	O
regulatory	O
function	O
and	O
the	O
negative	O
cooperative	O
mechanism	O
of	O
BUP	B-Gene_or_gene_product
by	O
beta	O
-	O
alanine	O
have	O
been	O
observed	O
in	O
rats	O
.	O
<EOS>	B-X
A	B-X
cDNA	B-X
encoding	B-X
beta-ureidopropionase	B-X
(	B-X
BUP	B-X
)	B-X
was	B-X
isolated	B-X
from	B-X
a	B-X
human	B-X
liver	B-X
cDNA	B-X
library	B-X
,	B-X
expressed	B-X
in	B-X
E.	B-X
coli	B-X
,	B-X
and	B-X
purified	B-X
from	B-X
the	B-X
culture	B-X
extract	B-X
.	B-X
The	B-X
enzyme	B-X
was	B-X
inhibited	B-X
by	B-X
1	B-X
mM	B-X
propionate	B-X
,	B-X
but	B-X
not	B-X
by	B-X
10	B-X
mM	B-X
beta-alanine	B-X
.	B-X
Chemical	B-X
analysis	B-X
of	B-X
the	B-X
purified	B-X
human	B-X
BUP	B-X
showed	B-X
0.54	B-X
zinc	B-X
atoms	B-X
per	B-X
subunit	B-X
,	B-X
and	B-X
the	B-X
sequence	B-X
of	B-X
BUP	B-X
cDNA	B-X
contained	B-X
one	B-X
putative	B-X
zinc-binding	B-X
site	B-X
motif	B-X
.	B-X
The	B-X
purified	B-X
enzyme	B-X
had	B-X
a	B-X
pI	B-X
of	B-X
5.65	B-X
,	B-X
and	B-X
exhibited	B-X
positive	B-X
cooperativity	B-X
with	B-X
N-carbamoyl-beta-alanine	B-X
as	B-X
the	B-X
substrate	B-X
with	B-X
a	B-X
Hill	B-X
coefficient	B-X
2.0	B-X
.	B-X
These	B-X
properties	B-X
of	B-X
human	B-X
BUP	B-X
,	B-X
except	B-X
the	B-X
inhibition	B-X
by	B-X
beta-alanine	B-X
,	B-X
were	B-X
similar	B-X
to	B-X
the	B-X
rat	B-X
liver	B-X
purified	B-X
enzyme	B-X
.	B-X
Beta-alanine	B-X
inhibits	B-X
rats	B-X
BUP	B-X
activity	B-X
.	B-X
The	B-X
complex	B-X
regulatory	B-X
function	B-X
and	B-X
the	B-X
negative	B-X
cooperative	B-X
mechanism	B-X
of	B-X
BUP	B-X
by	B-X
beta-alanine	B-X
have	B-X
been	B-X
observed	B-X
in	B-X
rats	B-X
.	B-X
This	B-X
kind	B-X
of	B-X
mechanism	B-X
may	B-X
not	B-X
exist	B-X
in	B-X
humans	B-X
,	B-X
because	B-X
beta-alanine	B-X
did	B-X
not	B-X
inhibit	B-X
human	B-X
BUP	B-X
.	B-X

This	O
kind	O
of	O
mechanism	O
may	O
not	O
exist	O
in	O
humans	O
,	O
because	O
beta	O
-	O
alanine	O
did	O
not	O
inhibit	O
human	O
BUP	B-Gene_or_gene_product
.	O
<EOS>	B-X
They	B-X
are	B-X
a	B-X
kind	B-X
of	B-X
biological	B-X
macromolecules	B-X
with	B-X
immune	B-X
regulation	B-X
,	B-X
anti-tumor	B-X
,	B-X
anti-radiation	B-X
,	B-X
anti-inflammation	B-X
,	B-X
anti-fatigue	B-X
and	B-X
anti-aging	B-X
effects	B-X
.	B-X
Ferroptosis	B-X
is	B-X
a	B-X
kind	B-X
of	B-X
regulated	B-X
cell	B-X
death	B-X
(	B-X
RCD	B-X
)	B-X
caused	B-X
by	B-X
the	B-X
redox	B-X
state	B-X
disorder	B-X
of	B-X
intracellular	B-X
microenvironment	B-X
controlled	B-X
by	B-X
glutathione	B-X
(	B-X
GSH	B-X
)	B-X
peroxidase	B-X
4	B-X
(	B-X
GPX4	B-X
)	B-X
,	B-X
which	B-X
is	B-X
inhibited	B-X
by	B-X
iron	B-X
chelators	B-X
and	B-X
lipophilic	B-X
antioxidants	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
classical	B-X
regulatory	B-X
mechanisms	B-X
,	B-X
new	B-X
regulatory	B-X
factors	B-X
for	B-X
ferroptosis	B-X
have	B-X
been	B-X
discovered	B-X
in	B-X
recent	B-X
years	B-X
,	B-X
such	B-X
as	B-X
the	B-X
P53	B-X
pathway	B-X
,	B-X
the	B-X
activating	B-X
transcription	B-X
factor	B-X
(	B-X
ATF	B-X
)	B-X
3/4	B-X
pathway	B-X
,	B-X
Beclin	B-X
1	B-X
(	B-X
BECN1	B-X
)	B-X
pathway	B-X
,	B-X
and	B-X
some	B-X
non-coding	B-X
RNA	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
will	B-X
provide	B-X
a	B-X
brief	B-X
overview	B-X
of	B-X
ferroptosis	B-X
regulatory	B-X
mechanisms	B-X
,	B-X
as	B-X
well	B-X
as	B-X
an	B-X
emphasis	B-X
on	B-X
the	B-X
mechanism	B-X
of	B-X
Nrf2	B-X
regulating	B-X
ferroptosis	B-X
.	B-X

Cell	O
cycle	O
-	O
dependent	O
recruitment	O
of	O
HDAC	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
correlates	O
with	O
deacetylation	O
of	O
histone	B-Gene_or_gene_product
H4	I-Gene_or_gene_product
on	O
an	O
Rb	B-Gene_or_gene_product
-	O
E2F	B-Gene_or_gene_product
target	O
promoter	O
.	O

The	O
transcription	O
factor	O
E2F	B-Gene_or_gene_product
,	O
which	O
is	O
a	O
key	O
element	O
in	O
the	O
control	O
of	O
cell	O
proliferation	O
,	O
is	O
repressed	O
by	O
Rb	B-Gene_or_gene_product
and	O
other	O
pocket	O
proteins	O
in	O
growth	O
-	O
arrested	O
differentiating	O
cells	O
,	O
as	O
well	O
as	O
in	O
proliferating	O
cells	O
when	O
they	O
progress	O
through	O
early	O
G1	O
.	O
<EOS>	B-X
The	B-X
transcription	B-X
factor	B-X
E2F	B-X
,	B-X
which	B-X
is	B-X
a	B-X
key	B-X
element	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
proliferation	B-X
,	B-X
is	B-X
repressed	B-X
by	B-X
Rb	B-X
and	B-X
other	B-X
pocket	B-X
proteins	B-X
in	B-X
growth-arrested	B-X
differentiating	B-X
cells	B-X
,	B-X
as	B-X
well	B-X
as	B-X
in	B-X
proliferating	B-X
cells	B-X
when	B-X
they	B-X
progress	B-X
through	B-X
early	B-X
G1	B-X
.	B-X
A	B-X
body	B-X
of	B-X
data	B-X
suggests	B-X
that	B-X
E2F	B-X
repression	B-X
by	B-X
pocket	B-X
proteins	B-X
involves	B-X
class	B-X
I	B-X
histone	B-X
deacetylases	B-X
(	B-X
HDACs	B-X
)	B-X
.	B-X
It	B-X
has	B-X
been	B-X
hypothesized	B-X
that	B-X
these	B-X
enzymes	B-X
are	B-X
recruited	B-X
to	B-X
E2F	B-X
target	B-X
promoters	B-X
where	B-X
they	B-X
deacetylate	B-X
histones	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
tested	B-X
this	B-X
hypothesis	B-X
directly	B-X
by	B-X
using	B-X
formaldehyde	B-X
cross-linked	B-X
chromatin	B-X
immunoprecipitation	B-X
(	B-X
XChIP	B-X
)	B-X
assays	B-X
to	B-X
evaluate	B-X
HDAC	B-X
association	B-X
in	B-X
living	B-X
cells	B-X
.	B-X
Our	B-X
data	B-X
show	B-X
that	B-X
a	B-X
histone	B-X
deacetylase	B-X
,	B-X
HDAC-1	B-X
,	B-X
is	B-X
stably	B-X
bound	B-X
to	B-X
an	B-X
E2F	B-X
target	B-X
promoter	B-X
during	B-X
early	B-X
G1	B-X
in	B-X
proliferating	B-X
cells	B-X
and	B-X
released	B-X
at	B-X
the	B-X
G1-S	B-X
transition	B-X
.	B-X

It	O
is	O
not	O
known	O
whether	O
similar	O
mechanisms	O
are	O
operative	O
in	O
the	O
two	O
situations	O
.	O

A	O
body	O
of	O
data	O
suggests	O
that	O
E2F	B-Gene_or_gene_product
repression	O
by	O
pocket	O
proteins	O
involves	O
class	B-Gene_or_gene_product
I	I-Gene_or_gene_product
histone	I-Gene_or_gene_product
deacetylases	I-Gene_or_gene_product
(	O
HDACs	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
The	B-X
transcription	B-X
factor	B-X
E2F	B-X
,	B-X
which	B-X
is	B-X
a	B-X
key	B-X
element	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
proliferation	B-X
,	B-X
is	B-X
repressed	B-X
by	B-X
Rb	B-X
and	B-X
other	B-X
pocket	B-X
proteins	B-X
in	B-X
growth-arrested	B-X
differentiating	B-X
cells	B-X
,	B-X
as	B-X
well	B-X
as	B-X
in	B-X
proliferating	B-X
cells	B-X
when	B-X
they	B-X
progress	B-X
through	B-X
early	B-X
G1	B-X
.	B-X
A	B-X
body	B-X
of	B-X
data	B-X
suggests	B-X
that	B-X
E2F	B-X
repression	B-X
by	B-X
pocket	B-X
proteins	B-X
involves	B-X
class	B-X
I	B-X
histone	B-X
deacetylases	B-X
(	B-X
HDACs	B-X
)	B-X
.	B-X
It	B-X
has	B-X
been	B-X
hypothesized	B-X
that	B-X
these	B-X
enzymes	B-X
are	B-X
recruited	B-X
to	B-X
E2F	B-X
target	B-X
promoters	B-X
where	B-X
they	B-X
deacetylate	B-X
histones	B-X
.	B-X
Our	B-X
data	B-X
show	B-X
that	B-X
a	B-X
histone	B-X
deacetylase	B-X
,	B-X
HDAC-1	B-X
,	B-X
is	B-X
stably	B-X
bound	B-X
to	B-X
an	B-X
E2F	B-X
target	B-X
promoter	B-X
during	B-X
early	B-X
G1	B-X
in	B-X
proliferating	B-X
cells	B-X
and	B-X
released	B-X
at	B-X
the	B-X
G1-S	B-X
transition	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
our	B-X
results	B-X
reveal	B-X
an	B-X
inverse	B-X
correlation	B-X
between	B-X
HDAC-1	B-X
recruitment	B-X
and	B-X
histone	B-X
H4	B-X
acetylation	B-X
on	B-X
specific	B-X
lysines	B-X
.	B-X

It	O
has	O
been	O
hypothesized	O
that	O
these	O
enzymes	O
are	O
recruited	O
to	O
E2F	B-Gene_or_gene_product
target	O
promoters	O
where	O
they	O
deacetylate	O
histones	O
.	O
<EOS>	B-X
The	B-X
transcription	B-X
factor	B-X
E2F	B-X
,	B-X
which	B-X
is	B-X
a	B-X
key	B-X
element	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
proliferation	B-X
,	B-X
is	B-X
repressed	B-X
by	B-X
Rb	B-X
and	B-X
other	B-X
pocket	B-X
proteins	B-X
in	B-X
growth-arrested	B-X
differentiating	B-X
cells	B-X
,	B-X
as	B-X
well	B-X
as	B-X
in	B-X
proliferating	B-X
cells	B-X
when	B-X
they	B-X
progress	B-X
through	B-X
early	B-X
G1	B-X
.	B-X
A	B-X
body	B-X
of	B-X
data	B-X
suggests	B-X
that	B-X
E2F	B-X
repression	B-X
by	B-X
pocket	B-X
proteins	B-X
involves	B-X
class	B-X
I	B-X
histone	B-X
deacetylases	B-X
(	B-X
HDACs	B-X
)	B-X
.	B-X
It	B-X
has	B-X
been	B-X
hypothesized	B-X
that	B-X
these	B-X
enzymes	B-X
are	B-X
recruited	B-X
to	B-X
E2F	B-X
target	B-X
promoters	B-X
where	B-X
they	B-X
deacetylate	B-X
histones	B-X
.	B-X
Our	B-X
data	B-X
show	B-X
that	B-X
a	B-X
histone	B-X
deacetylase	B-X
,	B-X
HDAC-1	B-X
,	B-X
is	B-X
stably	B-X
bound	B-X
to	B-X
an	B-X
E2F	B-X
target	B-X
promoter	B-X
during	B-X
early	B-X
G1	B-X
in	B-X
proliferating	B-X
cells	B-X
and	B-X
released	B-X
at	B-X
the	B-X
G1-S	B-X
transition	B-X
.	B-X

Here	O
we	O
have	O
tested	O
this	O
hypothesis	O
directly	O
by	O
using	O
formaldehyde	O
cross	O
-	O
linked	O
chromatin	O
immunoprecipitation	O
(	O
XChIP	O
)	O
assays	O
to	O
evaluate	O
HDAC	B-Gene_or_gene_product
association	O
in	O
living	O
cells	O
.	O
<EOS>	B-X
The	B-X
transcription	B-X
factor	B-X
E2F	B-X
,	B-X
which	B-X
is	B-X
a	B-X
key	B-X
element	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
proliferation	B-X
,	B-X
is	B-X
repressed	B-X
by	B-X
Rb	B-X
and	B-X
other	B-X
pocket	B-X
proteins	B-X
in	B-X
growth-arrested	B-X
differentiating	B-X
cells	B-X
,	B-X
as	B-X
well	B-X
as	B-X
in	B-X
proliferating	B-X
cells	B-X
when	B-X
they	B-X
progress	B-X
through	B-X
early	B-X
G1	B-X
.	B-X
A	B-X
body	B-X
of	B-X
data	B-X
suggests	B-X
that	B-X
E2F	B-X
repression	B-X
by	B-X
pocket	B-X
proteins	B-X
involves	B-X
class	B-X
I	B-X
histone	B-X
deacetylases	B-X
(	B-X
HDACs	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
tested	B-X
this	B-X
hypothesis	B-X
directly	B-X
by	B-X
using	B-X
formaldehyde	B-X
cross-linked	B-X
chromatin	B-X
immunoprecipitation	B-X
(	B-X
XChIP	B-X
)	B-X
assays	B-X
to	B-X
evaluate	B-X
HDAC	B-X
association	B-X
in	B-X
living	B-X
cells	B-X
.	B-X
Our	B-X
data	B-X
show	B-X
that	B-X
a	B-X
histone	B-X
deacetylase	B-X
,	B-X
HDAC-1	B-X
,	B-X
is	B-X
stably	B-X
bound	B-X
to	B-X
an	B-X
E2F	B-X
target	B-X
promoter	B-X
during	B-X
early	B-X
G1	B-X
in	B-X
proliferating	B-X
cells	B-X
and	B-X
released	B-X
at	B-X
the	B-X
G1-S	B-X
transition	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
our	B-X
results	B-X
reveal	B-X
an	B-X
inverse	B-X
correlation	B-X
between	B-X
HDAC-1	B-X
recruitment	B-X
and	B-X
histone	B-X
H4	B-X
acetylation	B-X
on	B-X
specific	B-X
lysines	B-X
.	B-X

Our	O
data	O
show	O
that	O
a	O
histone	B-Gene_or_gene_product
deacetylase	I-Gene_or_gene_product
,	O
HDAC	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
is	O
stably	O
bound	O
to	O
an	O
E2F	B-Gene_or_gene_product
target	O
promoter	O
during	O
early	O
G1	O
in	O
proliferating	O
cells	O
and	O
released	O
at	O
the	O
G1	O
-	O
S	O
transition	O
.	O

In	O
addition	O
,	O
our	O
results	O
reveal	O
an	O
inverse	O
correlation	O
between	O
HDAC	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
recruitment	O
and	O
histone	B-Gene_or_gene_product
H4	I-Gene_or_gene_product
acetylation	O
on	O
specific	O
lysines	O
.	O
<EOS>	B-X
The	B-X
transcription	B-X
factor	B-X
E2F	B-X
,	B-X
which	B-X
is	B-X
a	B-X
key	B-X
element	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
proliferation	B-X
,	B-X
is	B-X
repressed	B-X
by	B-X
Rb	B-X
and	B-X
other	B-X
pocket	B-X
proteins	B-X
in	B-X
growth-arrested	B-X
differentiating	B-X
cells	B-X
,	B-X
as	B-X
well	B-X
as	B-X
in	B-X
proliferating	B-X
cells	B-X
when	B-X
they	B-X
progress	B-X
through	B-X
early	B-X
G1	B-X
.	B-X
A	B-X
body	B-X
of	B-X
data	B-X
suggests	B-X
that	B-X
E2F	B-X
repression	B-X
by	B-X
pocket	B-X
proteins	B-X
involves	B-X
class	B-X
I	B-X
histone	B-X
deacetylases	B-X
(	B-X
HDACs	B-X
)	B-X
.	B-X
It	B-X
has	B-X
been	B-X
hypothesized	B-X
that	B-X
these	B-X
enzymes	B-X
are	B-X
recruited	B-X
to	B-X
E2F	B-X
target	B-X
promoters	B-X
where	B-X
they	B-X
deacetylate	B-X
histones	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
tested	B-X
this	B-X
hypothesis	B-X
directly	B-X
by	B-X
using	B-X
formaldehyde	B-X
cross-linked	B-X
chromatin	B-X
immunoprecipitation	B-X
(	B-X
XChIP	B-X
)	B-X
assays	B-X
to	B-X
evaluate	B-X
HDAC	B-X
association	B-X
in	B-X
living	B-X
cells	B-X
.	B-X
Our	B-X
data	B-X
show	B-X
that	B-X
a	B-X
histone	B-X
deacetylase	B-X
,	B-X
HDAC-1	B-X
,	B-X
is	B-X
stably	B-X
bound	B-X
to	B-X
an	B-X
E2F	B-X
target	B-X
promoter	B-X
during	B-X
early	B-X
G1	B-X
in	B-X
proliferating	B-X
cells	B-X
and	B-X
released	B-X
at	B-X
the	B-X
G1-S	B-X
transition	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
our	B-X
results	B-X
reveal	B-X
an	B-X
inverse	B-X
correlation	B-X
between	B-X
HDAC-1	B-X
recruitment	B-X
and	B-X
histone	B-X
H4	B-X
acetylation	B-X
on	B-X
specific	B-X
lysines	B-X
.	B-X

Transcriptional	O
coregulation	O
by	O
the	O
cell	O
integrity	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
Slt2	B-Gene_or_gene_product
and	O
the	O
cell	O
cycle	O
regulator	O
Swi4	B-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
heterodimeric	B-X
transcription	B-X
factor	B-X
SBF	B-X
(	B-X
for	B-X
SCB	B-X
binding	B-X
factor	B-X
)	B-X
is	B-X
composed	B-X
of	B-X
Swi4	B-X
and	B-X
Swi6	B-X
and	B-X
activates	B-X
gene	B-X
expression	B-X
at	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S-phase	B-X
transition	B-X
of	B-X
the	B-X
mitotic	B-X
cell	B-X
cycle	B-X
.	B-X
Cell	B-X
cycle	B-X
commitment	B-X
is	B-X
associated	B-X
not	B-X
only	B-X
with	B-X
major	B-X
alterations	B-X
in	B-X
gene	B-X
expression	B-X
but	B-X
also	B-X
with	B-X
highly	B-X
polarized	B-X
cell	B-X
growth	B-X
;	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
Slt2	B-X
is	B-X
required	B-X
to	B-X
maintain	B-X
cell	B-X
wall	B-X
integrity	B-X
during	B-X
periods	B-X
of	B-X
polarized	B-X
growth	B-X
and	B-X
cell	B-X
wall	B-X
stress	B-X
.	B-X
We	B-X
describe	B-X
experiments	B-X
aimed	B-X
at	B-X
defining	B-X
the	B-X
regulatory	B-X
pathway	B-X
involving	B-X
the	B-X
cell	B-X
cycle	B-X
transcription	B-X
factor	B-X
SBF	B-X
and	B-X
Slt2-MAPK	B-X
.	B-X
Gene	B-X
expression	B-X
assays	B-X
and	B-X
chromatin	B-X
immunoprecipitation	B-X
experiments	B-X
revealed	B-X
Slt2-dependent	B-X
recruitment	B-X
of	B-X
SBF	B-X
to	B-X
the	B-X
promoters	B-X
of	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
cyclins	B-X
PCL1	B-X
and	B-X
PCL2	B-X
after	B-X
activation	B-X
of	B-X
the	B-X
Slt2-MAPK	B-X
pathway	B-X
.	B-X
Genes	B-X
that	B-X
are	B-X
sensitive	B-X
to	B-X
both	B-X
Slt2	B-X
and	B-X
Swi4	B-X
appear	B-X
to	B-X
be	B-X
uniquely	B-X
regulated	B-X
and	B-X
reveal	B-X
a	B-X
role	B-X
for	B-X
Swi4	B-X
,	B-X
the	B-X
DNA-binding	B-X
component	B-X
of	B-X
SBF	B-X
,	B-X
which	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
regulatory	B-X
subunit	B-X
Swi6	B-X
.	B-X
Some	B-X
of	B-X
the	B-X
Swi4-	B-X
and	B-X
Slt2-dependent	B-X
genes	B-X
do	B-X
not	B-X
require	B-X
Swi6	B-X
for	B-X
either	B-X
their	B-X
expression	B-X
or	B-X
for	B-X
Swi4	B-X
localization	B-X
to	B-X
their	B-X
promoters	B-X
.	B-X
Consistent	B-X
with	B-X
these	B-X
results	B-X
,	B-X
we	B-X
found	B-X
a	B-X
direct	B-X
interaction	B-X
between	B-X
Swi4	B-X
and	B-X
Slt2	B-X
.	B-X
Our	B-X
results	B-X
establish	B-X
a	B-X
new	B-X
Slt2-dependent	B-X
mode	B-X
of	B-X
Swi4	B-X
regulation	B-X
and	B-X
suggest	B-X
roles	B-X
for	B-X
Swi4	B-X
beyond	B-X
its	B-X
prominent	B-X
role	B-X
in	B-X
controlling	B-X
cell	B-X
cycle	B-X
transcription	B-X
.	B-X

In	O
Saccharomyces	O
cerevisiae	O
,	O
the	O
heterodimeric	O
transcription	O
factor	O
SBF	O
(	O
for	O
SCB	O
binding	O
factor	O
)	O
is	O
composed	O
of	O
Swi4	B-Gene_or_gene_product
and	O
Swi6	B-Gene_or_gene_product
and	O
activates	O
gene	O
expression	O
at	O
the	O
G	O
(	O
1	O
)	O
/	O
S	O
-	O
phase	O
transition	O
of	O
the	O
mitotic	O
cell	O
cycle	O
.	O

Cell	O
cycle	O
commitment	O
is	O
associated	O
not	O
only	O
with	O
major	O
alterations	O
in	O
gene	O
expression	O
but	O
also	O
with	O
highly	O
polarized	O
cell	O
growth	O
;	O
the	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
MAPK	B-Gene_or_gene_product
)	O
Slt2	B-Gene_or_gene_product
is	O
required	O
to	O
maintain	O
cell	O
wall	O
integrity	O
during	O
periods	O
of	O
polarized	O
growth	O
and	O
cell	O
wall	O
stress	O
.	O
<EOS>	B-X
Cohesin	B-X
is	B-X
a	B-X
multisubunit	B-X
protein	B-X
complex	B-X
that	B-X
forms	B-X
a	B-X
ring-like	B-X
structure	B-X
around	B-X
DNA	B-X
.	B-X
It	B-X
is	B-X
essential	B-X
for	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
,	B-X
chromatin	B-X
organization	B-X
,	B-X
transcriptional	B-X
regulation	B-X
,	B-X
and	B-X
DNA	B-X
damage	B-X
repair	B-X
and	B-X
plays	B-X
a	B-X
major	B-X
role	B-X
in	B-X
dynamically	B-X
shaping	B-X
the	B-X
genome	B-X
architecture	B-X
and	B-X
maintaining	B-X
DNA	B-X
integrity	B-X
.	B-X
These	B-X
mutations	B-X
are	B-X
found	B-X
across	B-X
the	B-X
full	B-X
spectrum	B-X
of	B-X
myeloid	B-X
neoplasia	B-X
,	B-X
including	B-X
pediatric	B-X
Down	B-X
syndrome-associated	B-X
acute	B-X
megakaryoblastic	B-X
leukemia	B-X
,	B-X
myelodysplastic	B-X
syndromes	B-X
,	B-X
chronic	B-X
myelomonocytic	B-X
leukemia	B-X
,	B-X
and	B-X
de	B-X
novo	B-X
and	B-X
secondary	B-X
acute	B-X
myeloid	B-X
leukemias	B-X
.	B-X
Recent	B-X
studies	B-X
have	B-X
described	B-X
the	B-X
impact	B-X
of	B-X
cohesin	B-X
alterations	B-X
on	B-X
self-renewal	B-X
and	B-X
differentiation	B-X
of	B-X
hematopoietic	B-X
stem	B-X
and	B-X
progenitor	B-X
cells	B-X
,	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
changes	B-X
in	B-X
chromatin	B-X
and	B-X
epigenetic	B-X
state	B-X
directing	B-X
lineage	B-X
commitment	B-X
,	B-X
as	B-X
well	B-X
as	B-X
genomic	B-X
integrity	B-X
.	B-X

We	O
describe	O
experiments	O
aimed	O
at	O
defining	O
the	O
regulatory	O
pathway	O
involving	O
the	O
cell	O
cycle	O
transcription	O
factor	O
SBF	O
and	O
Slt2	B-Gene_or_gene_product
-	I-Gene_or_gene_product
MAPK	I-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
heterodimeric	B-X
transcription	B-X
factor	B-X
SBF	B-X
(	B-X
for	B-X
SCB	B-X
binding	B-X
factor	B-X
)	B-X
is	B-X
composed	B-X
of	B-X
Swi4	B-X
and	B-X
Swi6	B-X
and	B-X
activates	B-X
gene	B-X
expression	B-X
at	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S-phase	B-X
transition	B-X
of	B-X
the	B-X
mitotic	B-X
cell	B-X
cycle	B-X
.	B-X
Cell	B-X
cycle	B-X
commitment	B-X
is	B-X
associated	B-X
not	B-X
only	B-X
with	B-X
major	B-X
alterations	B-X
in	B-X
gene	B-X
expression	B-X
but	B-X
also	B-X
with	B-X
highly	B-X
polarized	B-X
cell	B-X
growth	B-X
;	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
Slt2	B-X
is	B-X
required	B-X
to	B-X
maintain	B-X
cell	B-X
wall	B-X
integrity	B-X
during	B-X
periods	B-X
of	B-X
polarized	B-X
growth	B-X
and	B-X
cell	B-X
wall	B-X
stress	B-X
.	B-X
We	B-X
describe	B-X
experiments	B-X
aimed	B-X
at	B-X
defining	B-X
the	B-X
regulatory	B-X
pathway	B-X
involving	B-X
the	B-X
cell	B-X
cycle	B-X
transcription	B-X
factor	B-X
SBF	B-X
and	B-X
Slt2-MAPK	B-X
.	B-X
Gene	B-X
expression	B-X
assays	B-X
and	B-X
chromatin	B-X
immunoprecipitation	B-X
experiments	B-X
revealed	B-X
Slt2-dependent	B-X
recruitment	B-X
of	B-X
SBF	B-X
to	B-X
the	B-X
promoters	B-X
of	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
cyclins	B-X
PCL1	B-X
and	B-X
PCL2	B-X
after	B-X
activation	B-X
of	B-X
the	B-X
Slt2-MAPK	B-X
pathway	B-X
.	B-X
Genes	B-X
that	B-X
are	B-X
sensitive	B-X
to	B-X
both	B-X
Slt2	B-X
and	B-X
Swi4	B-X
appear	B-X
to	B-X
be	B-X
uniquely	B-X
regulated	B-X
and	B-X
reveal	B-X
a	B-X
role	B-X
for	B-X
Swi4	B-X
,	B-X
the	B-X
DNA-binding	B-X
component	B-X
of	B-X
SBF	B-X
,	B-X
which	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
regulatory	B-X
subunit	B-X
Swi6	B-X
.	B-X
Some	B-X
of	B-X
the	B-X
Swi4-	B-X
and	B-X
Slt2-dependent	B-X
genes	B-X
do	B-X
not	B-X
require	B-X
Swi6	B-X
for	B-X
either	B-X
their	B-X
expression	B-X
or	B-X
for	B-X
Swi4	B-X
localization	B-X
to	B-X
their	B-X
promoters	B-X
.	B-X
Consistent	B-X
with	B-X
these	B-X
results	B-X
,	B-X
we	B-X
found	B-X
a	B-X
direct	B-X
interaction	B-X
between	B-X
Swi4	B-X
and	B-X
Slt2	B-X
.	B-X
Our	B-X
results	B-X
establish	B-X
a	B-X
new	B-X
Slt2-dependent	B-X
mode	B-X
of	B-X
Swi4	B-X
regulation	B-X
and	B-X
suggest	B-X
roles	B-X
for	B-X
Swi4	B-X
beyond	B-X
its	B-X
prominent	B-X
role	B-X
in	B-X
controlling	B-X
cell	B-X
cycle	B-X
transcription	B-X
.	B-X

Gene	O
expression	O
assays	O
and	O
chromatin	O
immunoprecipitation	O
experiments	O
revealed	O
Slt2	B-Gene_or_gene_product
-	O
dependent	O
recruitment	O
of	O
SBF	O
to	O
the	O
promoters	O
of	O
the	O
G	O
(	O
1	O
)	O
cyclins	B-Gene_or_gene_product
PCL1	B-Gene_or_gene_product
and	O
PCL2	B-Gene_or_gene_product
after	O
activation	O
of	O
the	O
Slt2	B-Gene_or_gene_product
-	I-Gene_or_gene_product
MAPK	I-Gene_or_gene_product
pathway	O
.	O

We	O
performed	O
DNA	O
microarray	O
analysis	O
and	O
identified	O
other	O
genes	O
whose	O
expression	O
was	O
reduced	O
in	O
both	O
SLT2	B-Gene_or_gene_product
and	O
SWI4	B-Gene_or_gene_product
deletion	O
strains	O
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
heterodimeric	B-X
transcription	B-X
factor	B-X
SBF	B-X
(	B-X
for	B-X
SCB	B-X
binding	B-X
factor	B-X
)	B-X
is	B-X
composed	B-X
of	B-X
Swi4	B-X
and	B-X
Swi6	B-X
and	B-X
activates	B-X
gene	B-X
expression	B-X
at	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S-phase	B-X
transition	B-X
of	B-X
the	B-X
mitotic	B-X
cell	B-X
cycle	B-X
.	B-X
Cell	B-X
cycle	B-X
commitment	B-X
is	B-X
associated	B-X
not	B-X
only	B-X
with	B-X
major	B-X
alterations	B-X
in	B-X
gene	B-X
expression	B-X
but	B-X
also	B-X
with	B-X
highly	B-X
polarized	B-X
cell	B-X
growth	B-X
;	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
Slt2	B-X
is	B-X
required	B-X
to	B-X
maintain	B-X
cell	B-X
wall	B-X
integrity	B-X
during	B-X
periods	B-X
of	B-X
polarized	B-X
growth	B-X
and	B-X
cell	B-X
wall	B-X
stress	B-X
.	B-X
Gene	B-X
expression	B-X
assays	B-X
and	B-X
chromatin	B-X
immunoprecipitation	B-X
experiments	B-X
revealed	B-X
Slt2-dependent	B-X
recruitment	B-X
of	B-X
SBF	B-X
to	B-X
the	B-X
promoters	B-X
of	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
cyclins	B-X
PCL1	B-X
and	B-X
PCL2	B-X
after	B-X
activation	B-X
of	B-X
the	B-X
Slt2-MAPK	B-X
pathway	B-X
.	B-X
We	B-X
performed	B-X
DNA	B-X
microarray	B-X
analysis	B-X
and	B-X
identified	B-X
other	B-X
genes	B-X
whose	B-X
expression	B-X
was	B-X
reduced	B-X
in	B-X
both	B-X
SLT2	B-X
and	B-X
SWI4	B-X
deletion	B-X
strains	B-X
.	B-X
Genes	B-X
that	B-X
are	B-X
sensitive	B-X
to	B-X
both	B-X
Slt2	B-X
and	B-X
Swi4	B-X
appear	B-X
to	B-X
be	B-X
uniquely	B-X
regulated	B-X
and	B-X
reveal	B-X
a	B-X
role	B-X
for	B-X
Swi4	B-X
,	B-X
the	B-X
DNA-binding	B-X
component	B-X
of	B-X
SBF	B-X
,	B-X
which	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
regulatory	B-X
subunit	B-X
Swi6	B-X
.	B-X
Some	B-X
of	B-X
the	B-X
Swi4-	B-X
and	B-X
Slt2-dependent	B-X
genes	B-X
do	B-X
not	B-X
require	B-X
Swi6	B-X
for	B-X
either	B-X
their	B-X
expression	B-X
or	B-X
for	B-X
Swi4	B-X
localization	B-X
to	B-X
their	B-X
promoters	B-X
.	B-X

Genes	O
that	O
are	O
sensitive	O
to	O
both	O
Slt2	B-Gene_or_gene_product
and	O
Swi4	B-Gene_or_gene_product
appear	O
to	O
be	O
uniquely	O
regulated	O
and	O
reveal	O
a	O
role	O
for	O
Swi4	B-Gene_or_gene_product
,	O
the	O
DNA	O
-	O
binding	O
component	O
of	O
SBF	O
,	O
which	O
is	O
independent	O
of	O
the	O
regulatory	O
subunit	O
Swi6	B-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
heterodimeric	B-X
transcription	B-X
factor	B-X
SBF	B-X
(	B-X
for	B-X
SCB	B-X
binding	B-X
factor	B-X
)	B-X
is	B-X
composed	B-X
of	B-X
Swi4	B-X
and	B-X
Swi6	B-X
and	B-X
activates	B-X
gene	B-X
expression	B-X
at	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S-phase	B-X
transition	B-X
of	B-X
the	B-X
mitotic	B-X
cell	B-X
cycle	B-X
.	B-X
Cell	B-X
cycle	B-X
commitment	B-X
is	B-X
associated	B-X
not	B-X
only	B-X
with	B-X
major	B-X
alterations	B-X
in	B-X
gene	B-X
expression	B-X
but	B-X
also	B-X
with	B-X
highly	B-X
polarized	B-X
cell	B-X
growth	B-X
;	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
Slt2	B-X
is	B-X
required	B-X
to	B-X
maintain	B-X
cell	B-X
wall	B-X
integrity	B-X
during	B-X
periods	B-X
of	B-X
polarized	B-X
growth	B-X
and	B-X
cell	B-X
wall	B-X
stress	B-X
.	B-X
We	B-X
describe	B-X
experiments	B-X
aimed	B-X
at	B-X
defining	B-X
the	B-X
regulatory	B-X
pathway	B-X
involving	B-X
the	B-X
cell	B-X
cycle	B-X
transcription	B-X
factor	B-X
SBF	B-X
and	B-X
Slt2-MAPK	B-X
.	B-X
Gene	B-X
expression	B-X
assays	B-X
and	B-X
chromatin	B-X
immunoprecipitation	B-X
experiments	B-X
revealed	B-X
Slt2-dependent	B-X
recruitment	B-X
of	B-X
SBF	B-X
to	B-X
the	B-X
promoters	B-X
of	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
cyclins	B-X
PCL1	B-X
and	B-X
PCL2	B-X
after	B-X
activation	B-X
of	B-X
the	B-X
Slt2-MAPK	B-X
pathway	B-X
.	B-X
We	B-X
performed	B-X
DNA	B-X
microarray	B-X
analysis	B-X
and	B-X
identified	B-X
other	B-X
genes	B-X
whose	B-X
expression	B-X
was	B-X
reduced	B-X
in	B-X
both	B-X
SLT2	B-X
and	B-X
SWI4	B-X
deletion	B-X
strains	B-X
.	B-X
Genes	B-X
that	B-X
are	B-X
sensitive	B-X
to	B-X
both	B-X
Slt2	B-X
and	B-X
Swi4	B-X
appear	B-X
to	B-X
be	B-X
uniquely	B-X
regulated	B-X
and	B-X
reveal	B-X
a	B-X
role	B-X
for	B-X
Swi4	B-X
,	B-X
the	B-X
DNA-binding	B-X
component	B-X
of	B-X
SBF	B-X
,	B-X
which	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
regulatory	B-X
subunit	B-X
Swi6	B-X
.	B-X
Some	B-X
of	B-X
the	B-X
Swi4-	B-X
and	B-X
Slt2-dependent	B-X
genes	B-X
do	B-X
not	B-X
require	B-X
Swi6	B-X
for	B-X
either	B-X
their	B-X
expression	B-X
or	B-X
for	B-X
Swi4	B-X
localization	B-X
to	B-X
their	B-X
promoters	B-X
.	B-X
Consistent	B-X
with	B-X
these	B-X
results	B-X
,	B-X
we	B-X
found	B-X
a	B-X
direct	B-X
interaction	B-X
between	B-X
Swi4	B-X
and	B-X
Slt2	B-X
.	B-X
Our	B-X
results	B-X
establish	B-X
a	B-X
new	B-X
Slt2-dependent	B-X
mode	B-X
of	B-X
Swi4	B-X
regulation	B-X
and	B-X
suggest	B-X
roles	B-X
for	B-X
Swi4	B-X
beyond	B-X
its	B-X
prominent	B-X
role	B-X
in	B-X
controlling	B-X
cell	B-X
cycle	B-X
transcription	B-X
.	B-X

Some	O
of	O
the	O
Swi4	B-Gene_or_gene_product
-	O
and	O
Slt2	B-Gene_or_gene_product
-	O
dependent	O
genes	O
do	O
not	O
require	O
Swi6	B-Gene_or_gene_product
for	O
either	O
their	O
expression	O
or	O
for	O
Swi4	B-Gene_or_gene_product
localization	O
to	O
their	O
promoters	O
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
heterodimeric	B-X
transcription	B-X
factor	B-X
SBF	B-X
(	B-X
for	B-X
SCB	B-X
binding	B-X
factor	B-X
)	B-X
is	B-X
composed	B-X
of	B-X
Swi4	B-X
and	B-X
Swi6	B-X
and	B-X
activates	B-X
gene	B-X
expression	B-X
at	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S-phase	B-X
transition	B-X
of	B-X
the	B-X
mitotic	B-X
cell	B-X
cycle	B-X
.	B-X
Cell	B-X
cycle	B-X
commitment	B-X
is	B-X
associated	B-X
not	B-X
only	B-X
with	B-X
major	B-X
alterations	B-X
in	B-X
gene	B-X
expression	B-X
but	B-X
also	B-X
with	B-X
highly	B-X
polarized	B-X
cell	B-X
growth	B-X
;	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
Slt2	B-X
is	B-X
required	B-X
to	B-X
maintain	B-X
cell	B-X
wall	B-X
integrity	B-X
during	B-X
periods	B-X
of	B-X
polarized	B-X
growth	B-X
and	B-X
cell	B-X
wall	B-X
stress	B-X
.	B-X
We	B-X
describe	B-X
experiments	B-X
aimed	B-X
at	B-X
defining	B-X
the	B-X
regulatory	B-X
pathway	B-X
involving	B-X
the	B-X
cell	B-X
cycle	B-X
transcription	B-X
factor	B-X
SBF	B-X
and	B-X
Slt2-MAPK	B-X
.	B-X
Gene	B-X
expression	B-X
assays	B-X
and	B-X
chromatin	B-X
immunoprecipitation	B-X
experiments	B-X
revealed	B-X
Slt2-dependent	B-X
recruitment	B-X
of	B-X
SBF	B-X
to	B-X
the	B-X
promoters	B-X
of	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
cyclins	B-X
PCL1	B-X
and	B-X
PCL2	B-X
after	B-X
activation	B-X
of	B-X
the	B-X
Slt2-MAPK	B-X
pathway	B-X
.	B-X
We	B-X
performed	B-X
DNA	B-X
microarray	B-X
analysis	B-X
and	B-X
identified	B-X
other	B-X
genes	B-X
whose	B-X
expression	B-X
was	B-X
reduced	B-X
in	B-X
both	B-X
SLT2	B-X
and	B-X
SWI4	B-X
deletion	B-X
strains	B-X
.	B-X
Genes	B-X
that	B-X
are	B-X
sensitive	B-X
to	B-X
both	B-X
Slt2	B-X
and	B-X
Swi4	B-X
appear	B-X
to	B-X
be	B-X
uniquely	B-X
regulated	B-X
and	B-X
reveal	B-X
a	B-X
role	B-X
for	B-X
Swi4	B-X
,	B-X
the	B-X
DNA-binding	B-X
component	B-X
of	B-X
SBF	B-X
,	B-X
which	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
regulatory	B-X
subunit	B-X
Swi6	B-X
.	B-X
Some	B-X
of	B-X
the	B-X
Swi4-	B-X
and	B-X
Slt2-dependent	B-X
genes	B-X
do	B-X
not	B-X
require	B-X
Swi6	B-X
for	B-X
either	B-X
their	B-X
expression	B-X
or	B-X
for	B-X
Swi4	B-X
localization	B-X
to	B-X
their	B-X
promoters	B-X
.	B-X
Consistent	B-X
with	B-X
these	B-X
results	B-X
,	B-X
we	B-X
found	B-X
a	B-X
direct	B-X
interaction	B-X
between	B-X
Swi4	B-X
and	B-X
Slt2	B-X
.	B-X
Our	B-X
results	B-X
establish	B-X
a	B-X
new	B-X
Slt2-dependent	B-X
mode	B-X
of	B-X
Swi4	B-X
regulation	B-X
and	B-X
suggest	B-X
roles	B-X
for	B-X
Swi4	B-X
beyond	B-X
its	B-X
prominent	B-X
role	B-X
in	B-X
controlling	B-X
cell	B-X
cycle	B-X
transcription	B-X
.	B-X

Consistent	O
with	O
these	O
results	O
,	O
we	O
found	O
a	O
direct	O
interaction	O
between	O
Swi4	B-Gene_or_gene_product
and	O
Slt2	B-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
heterodimeric	B-X
transcription	B-X
factor	B-X
SBF	B-X
(	B-X
for	B-X
SCB	B-X
binding	B-X
factor	B-X
)	B-X
is	B-X
composed	B-X
of	B-X
Swi4	B-X
and	B-X
Swi6	B-X
and	B-X
activates	B-X
gene	B-X
expression	B-X
at	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S-phase	B-X
transition	B-X
of	B-X
the	B-X
mitotic	B-X
cell	B-X
cycle	B-X
.	B-X
Cell	B-X
cycle	B-X
commitment	B-X
is	B-X
associated	B-X
not	B-X
only	B-X
with	B-X
major	B-X
alterations	B-X
in	B-X
gene	B-X
expression	B-X
but	B-X
also	B-X
with	B-X
highly	B-X
polarized	B-X
cell	B-X
growth	B-X
;	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
Slt2	B-X
is	B-X
required	B-X
to	B-X
maintain	B-X
cell	B-X
wall	B-X
integrity	B-X
during	B-X
periods	B-X
of	B-X
polarized	B-X
growth	B-X
and	B-X
cell	B-X
wall	B-X
stress	B-X
.	B-X
We	B-X
describe	B-X
experiments	B-X
aimed	B-X
at	B-X
defining	B-X
the	B-X
regulatory	B-X
pathway	B-X
involving	B-X
the	B-X
cell	B-X
cycle	B-X
transcription	B-X
factor	B-X
SBF	B-X
and	B-X
Slt2-MAPK	B-X
.	B-X
Gene	B-X
expression	B-X
assays	B-X
and	B-X
chromatin	B-X
immunoprecipitation	B-X
experiments	B-X
revealed	B-X
Slt2-dependent	B-X
recruitment	B-X
of	B-X
SBF	B-X
to	B-X
the	B-X
promoters	B-X
of	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
cyclins	B-X
PCL1	B-X
and	B-X
PCL2	B-X
after	B-X
activation	B-X
of	B-X
the	B-X
Slt2-MAPK	B-X
pathway	B-X
.	B-X
Genes	B-X
that	B-X
are	B-X
sensitive	B-X
to	B-X
both	B-X
Slt2	B-X
and	B-X
Swi4	B-X
appear	B-X
to	B-X
be	B-X
uniquely	B-X
regulated	B-X
and	B-X
reveal	B-X
a	B-X
role	B-X
for	B-X
Swi4	B-X
,	B-X
the	B-X
DNA-binding	B-X
component	B-X
of	B-X
SBF	B-X
,	B-X
which	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
regulatory	B-X
subunit	B-X
Swi6	B-X
.	B-X
Some	B-X
of	B-X
the	B-X
Swi4-	B-X
and	B-X
Slt2-dependent	B-X
genes	B-X
do	B-X
not	B-X
require	B-X
Swi6	B-X
for	B-X
either	B-X
their	B-X
expression	B-X
or	B-X
for	B-X
Swi4	B-X
localization	B-X
to	B-X
their	B-X
promoters	B-X
.	B-X
Consistent	B-X
with	B-X
these	B-X
results	B-X
,	B-X
we	B-X
found	B-X
a	B-X
direct	B-X
interaction	B-X
between	B-X
Swi4	B-X
and	B-X
Slt2	B-X
.	B-X
Our	B-X
results	B-X
establish	B-X
a	B-X
new	B-X
Slt2-dependent	B-X
mode	B-X
of	B-X
Swi4	B-X
regulation	B-X
and	B-X
suggest	B-X
roles	B-X
for	B-X
Swi4	B-X
beyond	B-X
its	B-X
prominent	B-X
role	B-X
in	B-X
controlling	B-X
cell	B-X
cycle	B-X
transcription	B-X
.	B-X

Our	O
results	O
establish	O
a	O
new	O
Slt2	B-Gene_or_gene_product
-	O
dependent	O
mode	O
of	O
Swi4	B-Gene_or_gene_product
regulation	O
and	O
suggest	O
roles	O
for	O
Swi4	B-Gene_or_gene_product
beyond	O
its	O
prominent	O
role	O
in	O
controlling	O
cell	O
cycle	O
transcription	O
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
heterodimeric	B-X
transcription	B-X
factor	B-X
SBF	B-X
(	B-X
for	B-X
SCB	B-X
binding	B-X
factor	B-X
)	B-X
is	B-X
composed	B-X
of	B-X
Swi4	B-X
and	B-X
Swi6	B-X
and	B-X
activates	B-X
gene	B-X
expression	B-X
at	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S-phase	B-X
transition	B-X
of	B-X
the	B-X
mitotic	B-X
cell	B-X
cycle	B-X
.	B-X
Cell	B-X
cycle	B-X
commitment	B-X
is	B-X
associated	B-X
not	B-X
only	B-X
with	B-X
major	B-X
alterations	B-X
in	B-X
gene	B-X
expression	B-X
but	B-X
also	B-X
with	B-X
highly	B-X
polarized	B-X
cell	B-X
growth	B-X
;	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
Slt2	B-X
is	B-X
required	B-X
to	B-X
maintain	B-X
cell	B-X
wall	B-X
integrity	B-X
during	B-X
periods	B-X
of	B-X
polarized	B-X
growth	B-X
and	B-X
cell	B-X
wall	B-X
stress	B-X
.	B-X
We	B-X
describe	B-X
experiments	B-X
aimed	B-X
at	B-X
defining	B-X
the	B-X
regulatory	B-X
pathway	B-X
involving	B-X
the	B-X
cell	B-X
cycle	B-X
transcription	B-X
factor	B-X
SBF	B-X
and	B-X
Slt2-MAPK	B-X
.	B-X
Gene	B-X
expression	B-X
assays	B-X
and	B-X
chromatin	B-X
immunoprecipitation	B-X
experiments	B-X
revealed	B-X
Slt2-dependent	B-X
recruitment	B-X
of	B-X
SBF	B-X
to	B-X
the	B-X
promoters	B-X
of	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
cyclins	B-X
PCL1	B-X
and	B-X
PCL2	B-X
after	B-X
activation	B-X
of	B-X
the	B-X
Slt2-MAPK	B-X
pathway	B-X
.	B-X
Genes	B-X
that	B-X
are	B-X
sensitive	B-X
to	B-X
both	B-X
Slt2	B-X
and	B-X
Swi4	B-X
appear	B-X
to	B-X
be	B-X
uniquely	B-X
regulated	B-X
and	B-X
reveal	B-X
a	B-X
role	B-X
for	B-X
Swi4	B-X
,	B-X
the	B-X
DNA-binding	B-X
component	B-X
of	B-X
SBF	B-X
,	B-X
which	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
regulatory	B-X
subunit	B-X
Swi6	B-X
.	B-X
Some	B-X
of	B-X
the	B-X
Swi4-	B-X
and	B-X
Slt2-dependent	B-X
genes	B-X
do	B-X
not	B-X
require	B-X
Swi6	B-X
for	B-X
either	B-X
their	B-X
expression	B-X
or	B-X
for	B-X
Swi4	B-X
localization	B-X
to	B-X
their	B-X
promoters	B-X
.	B-X
Consistent	B-X
with	B-X
these	B-X
results	B-X
,	B-X
we	B-X
found	B-X
a	B-X
direct	B-X
interaction	B-X
between	B-X
Swi4	B-X
and	B-X
Slt2	B-X
.	B-X
Our	B-X
results	B-X
establish	B-X
a	B-X
new	B-X
Slt2-dependent	B-X
mode	B-X
of	B-X
Swi4	B-X
regulation	B-X
and	B-X
suggest	B-X
roles	B-X
for	B-X
Swi4	B-X
beyond	B-X
its	B-X
prominent	B-X
role	B-X
in	B-X
controlling	B-X
cell	B-X
cycle	B-X
transcription	B-X
.	B-X

Regulation	O
of	O
the	O
anaphase	O
-	O
promoting	O
complex	O
by	O
the	O
dual	O
specificity	O
phosphatase	O
human	O
Cdc14a	B-Gene_or_gene_product
.	O
<EOS>	B-X
Two	B-X
forms	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex	B-X
(	B-X
APC	B-X
)	B-X
mediate	B-X
the	B-X
degradation	B-X
of	B-X
critical	B-X
cell	B-X
cycle	B-X
regulators	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
phosphorylation	B-X
of	B-X
human	B-X
Cdh1	B-X
(	B-X
hCdh1	B-X
)	B-X
by	B-X
cyclin	B-X
B-Cdc2	B-X
alters	B-X
the	B-X
conformation	B-X
of	B-X
hCdh1	B-X
and	B-X
prevents	B-X
it	B-X
from	B-X
activating	B-X
APC	B-X
.	B-X
A	B-X
human	B-X
homologue	B-X
of	B-X
yeast	B-X
Cdc14	B-X
,	B-X
human	B-X
Cdc14a	B-X
(	B-X
hCdc14a	B-X
)	B-X
,	B-X
dephosphorylates	B-X
hCdh1	B-X
and	B-X
activates	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
hCdc14a	B-X
does	B-X
not	B-X
affect	B-X
the	B-X
activity	B-X
of	B-X
APC	B-X
(	B-X
Cdc20	B-X
)	B-X
.	B-X
hCdc14a	B-X
is	B-X
a	B-X
major	B-X
phosphatase	B-X
for	B-X
hCdh1	B-X
and	B-X
localizes	B-X
to	B-X
centrosomes	B-X
in	B-X
HeLa	B-X
cells	B-X
.	B-X
Therefore	B-X
,	B-X
hCdc14a	B-X
may	B-X
promote	B-X
the	B-X
activation	B-X
of	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
and	B-X
exit	B-X
from	B-X
mitosis	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

Two	O
forms	O
of	O
the	O
anaphase	O
-	O
promoting	O
complex	O
(	O
APC	O
)	O
mediate	O
the	O
degradation	O
of	O
critical	O
cell	O
cycle	O
regulators	O
.	O
<EOS>	B-X
Two	B-X
forms	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex	B-X
(	B-X
APC	B-X
)	B-X
mediate	B-X
the	B-X
degradation	B-X
of	B-X
critical	B-X
cell	B-X
cycle	B-X
regulators	B-X
.	B-X
APC	B-X
(	B-X
Cdc20	B-X
)	B-X
promotes	B-X
sister-chromatid	B-X
separation	B-X
by	B-X
ubiquitinating	B-X
securin	B-X
,	B-X
whereas	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
ubiquitinates	B-X
mitotic	B-X
cyclins	B-X
,	B-X
allowing	B-X
the	B-X
exit	B-X
from	B-X
mitosis	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
phosphorylation	B-X
of	B-X
human	B-X
Cdh1	B-X
(	B-X
hCdh1	B-X
)	B-X
by	B-X
cyclin	B-X
B-Cdc2	B-X
alters	B-X
the	B-X
conformation	B-X
of	B-X
hCdh1	B-X
and	B-X
prevents	B-X
it	B-X
from	B-X
activating	B-X
APC	B-X
.	B-X
A	B-X
human	B-X
homologue	B-X
of	B-X
yeast	B-X
Cdc14	B-X
,	B-X
human	B-X
Cdc14a	B-X
(	B-X
hCdc14a	B-X
)	B-X
,	B-X
dephosphorylates	B-X
hCdh1	B-X
and	B-X
activates	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
hCdc14a	B-X
does	B-X
not	B-X
affect	B-X
the	B-X
activity	B-X
of	B-X
APC	B-X
(	B-X
Cdc20	B-X
)	B-X
.	B-X
hCdc14a	B-X
is	B-X
a	B-X
major	B-X
phosphatase	B-X
for	B-X
hCdh1	B-X
and	B-X
localizes	B-X
to	B-X
centrosomes	B-X
in	B-X
HeLa	B-X
cells	B-X
.	B-X
Therefore	B-X
,	B-X
hCdc14a	B-X
may	B-X
promote	B-X
the	B-X
activation	B-X
of	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
and	B-X
exit	B-X
from	B-X
mitosis	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

APC	O
(	O
Cdc20	O
)	O
promotes	O
sister	O
-	O
chromatid	O
separation	O
by	O
ubiquitinating	O
securin	B-Gene_or_gene_product
,	O
whereas	O
APC	O
(	O
Cdh1	O
)	O
ubiquitinates	O
mitotic	O
cyclins	B-Gene_or_gene_product
,	O
allowing	O
the	O
exit	O
from	O
mitosis	O
.	O
<EOS>	B-X
Two	B-X
forms	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex	B-X
(	B-X
APC	B-X
)	B-X
mediate	B-X
the	B-X
degradation	B-X
of	B-X
critical	B-X
cell	B-X
cycle	B-X
regulators	B-X
.	B-X
APC	B-X
(	B-X
Cdc20	B-X
)	B-X
promotes	B-X
sister-chromatid	B-X
separation	B-X
by	B-X
ubiquitinating	B-X
securin	B-X
,	B-X
whereas	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
ubiquitinates	B-X
mitotic	B-X
cyclins	B-X
,	B-X
allowing	B-X
the	B-X
exit	B-X
from	B-X
mitosis	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
phosphorylation	B-X
of	B-X
human	B-X
Cdh1	B-X
(	B-X
hCdh1	B-X
)	B-X
by	B-X
cyclin	B-X
B-Cdc2	B-X
alters	B-X
the	B-X
conformation	B-X
of	B-X
hCdh1	B-X
and	B-X
prevents	B-X
it	B-X
from	B-X
activating	B-X
APC	B-X
.	B-X
A	B-X
human	B-X
homologue	B-X
of	B-X
yeast	B-X
Cdc14	B-X
,	B-X
human	B-X
Cdc14a	B-X
(	B-X
hCdc14a	B-X
)	B-X
,	B-X
dephosphorylates	B-X
hCdh1	B-X
and	B-X
activates	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
hCdc14a	B-X
does	B-X
not	B-X
affect	B-X
the	B-X
activity	B-X
of	B-X
APC	B-X
(	B-X
Cdc20	B-X
)	B-X
.	B-X
hCdc14a	B-X
is	B-X
a	B-X
major	B-X
phosphatase	B-X
for	B-X
hCdh1	B-X
and	B-X
localizes	B-X
to	B-X
centrosomes	B-X
in	B-X
HeLa	B-X
cells	B-X
.	B-X
Therefore	B-X
,	B-X
hCdc14a	B-X
may	B-X
promote	B-X
the	B-X
activation	B-X
of	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
and	B-X
exit	B-X
from	B-X
mitosis	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

Here	O
we	O
show	O
that	O
phosphorylation	O
of	O
human	O
Cdh1	B-Gene_or_gene_product
(	O
hCdh1	B-Gene_or_gene_product
)	O
by	O
cyclin	O
B	O
-	O
Cdc2	O
alters	O
the	O
conformation	O
of	O
hCdh1	B-Gene_or_gene_product
and	O
prevents	O
it	O
from	O
activating	O
APC	O
.	O
<EOS>	B-X
Two	B-X
forms	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex	B-X
(	B-X
APC	B-X
)	B-X
mediate	B-X
the	B-X
degradation	B-X
of	B-X
critical	B-X
cell	B-X
cycle	B-X
regulators	B-X
.	B-X
APC	B-X
(	B-X
Cdc20	B-X
)	B-X
promotes	B-X
sister-chromatid	B-X
separation	B-X
by	B-X
ubiquitinating	B-X
securin	B-X
,	B-X
whereas	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
ubiquitinates	B-X
mitotic	B-X
cyclins	B-X
,	B-X
allowing	B-X
the	B-X
exit	B-X
from	B-X
mitosis	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
phosphorylation	B-X
of	B-X
human	B-X
Cdh1	B-X
(	B-X
hCdh1	B-X
)	B-X
by	B-X
cyclin	B-X
B-Cdc2	B-X
alters	B-X
the	B-X
conformation	B-X
of	B-X
hCdh1	B-X
and	B-X
prevents	B-X
it	B-X
from	B-X
activating	B-X
APC	B-X
.	B-X
A	B-X
human	B-X
homologue	B-X
of	B-X
yeast	B-X
Cdc14	B-X
,	B-X
human	B-X
Cdc14a	B-X
(	B-X
hCdc14a	B-X
)	B-X
,	B-X
dephosphorylates	B-X
hCdh1	B-X
and	B-X
activates	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
hCdc14a	B-X
does	B-X
not	B-X
affect	B-X
the	B-X
activity	B-X
of	B-X
APC	B-X
(	B-X
Cdc20	B-X
)	B-X
.	B-X
hCdc14a	B-X
is	B-X
a	B-X
major	B-X
phosphatase	B-X
for	B-X
hCdh1	B-X
and	B-X
localizes	B-X
to	B-X
centrosomes	B-X
in	B-X
HeLa	B-X
cells	B-X
.	B-X
Therefore	B-X
,	B-X
hCdc14a	B-X
may	B-X
promote	B-X
the	B-X
activation	B-X
of	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
and	B-X
exit	B-X
from	B-X
mitosis	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

A	O
human	O
homologue	O
of	O
yeast	O
Cdc14	B-Gene_or_gene_product
,	O
human	O
Cdc14a	B-Gene_or_gene_product
(	O
hCdc14a	B-Gene_or_gene_product
)	O
,	O
dephosphorylates	O
hCdh1	B-Gene_or_gene_product
and	O
activates	O
APC	O
(	O
Cdh1	O
)	O
.	O
<EOS>	B-X
Two	B-X
forms	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex	B-X
(	B-X
APC	B-X
)	B-X
mediate	B-X
the	B-X
degradation	B-X
of	B-X
critical	B-X
cell	B-X
cycle	B-X
regulators	B-X
.	B-X
APC	B-X
(	B-X
Cdc20	B-X
)	B-X
promotes	B-X
sister-chromatid	B-X
separation	B-X
by	B-X
ubiquitinating	B-X
securin	B-X
,	B-X
whereas	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
ubiquitinates	B-X
mitotic	B-X
cyclins	B-X
,	B-X
allowing	B-X
the	B-X
exit	B-X
from	B-X
mitosis	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
phosphorylation	B-X
of	B-X
human	B-X
Cdh1	B-X
(	B-X
hCdh1	B-X
)	B-X
by	B-X
cyclin	B-X
B-Cdc2	B-X
alters	B-X
the	B-X
conformation	B-X
of	B-X
hCdh1	B-X
and	B-X
prevents	B-X
it	B-X
from	B-X
activating	B-X
APC	B-X
.	B-X
A	B-X
human	B-X
homologue	B-X
of	B-X
yeast	B-X
Cdc14	B-X
,	B-X
human	B-X
Cdc14a	B-X
(	B-X
hCdc14a	B-X
)	B-X
,	B-X
dephosphorylates	B-X
hCdh1	B-X
and	B-X
activates	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
hCdc14a	B-X
does	B-X
not	B-X
affect	B-X
the	B-X
activity	B-X
of	B-X
APC	B-X
(	B-X
Cdc20	B-X
)	B-X
.	B-X
hCdc14a	B-X
is	B-X
a	B-X
major	B-X
phosphatase	B-X
for	B-X
hCdh1	B-X
and	B-X
localizes	B-X
to	B-X
centrosomes	B-X
in	B-X
HeLa	B-X
cells	B-X
.	B-X
Therefore	B-X
,	B-X
hCdc14a	B-X
may	B-X
promote	B-X
the	B-X
activation	B-X
of	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
and	B-X
exit	B-X
from	B-X
mitosis	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

In	O
contrast	O
,	O
hCdc14a	B-Gene_or_gene_product
does	O
not	O
affect	O
the	O
activity	O
of	O
APC	O
(	O
Cdc20	O
)	O
.	O

hCdc14a	B-Gene_or_gene_product
is	O
a	O
major	O
phosphatase	O
for	O
hCdh1	B-Gene_or_gene_product
and	O
localizes	O
to	O
centrosomes	O
in	O
HeLa	O
cells	O
.	O

Therefore	O
,	O
hCdc14a	B-Gene_or_gene_product
may	O
promote	O
the	O
activation	O
of	O
APC	O
(	O
Cdh1	O
)	O
and	O
exit	O
from	O
mitosis	O
in	O
mammalian	O
cells	O
.	O
<EOS>	B-X
Two	B-X
forms	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex	B-X
(	B-X
APC	B-X
)	B-X
mediate	B-X
the	B-X
degradation	B-X
of	B-X
critical	B-X
cell	B-X
cycle	B-X
regulators	B-X
.	B-X
APC	B-X
(	B-X
Cdc20	B-X
)	B-X
promotes	B-X
sister-chromatid	B-X
separation	B-X
by	B-X
ubiquitinating	B-X
securin	B-X
,	B-X
whereas	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
ubiquitinates	B-X
mitotic	B-X
cyclins	B-X
,	B-X
allowing	B-X
the	B-X
exit	B-X
from	B-X
mitosis	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
phosphorylation	B-X
of	B-X
human	B-X
Cdh1	B-X
(	B-X
hCdh1	B-X
)	B-X
by	B-X
cyclin	B-X
B-Cdc2	B-X
alters	B-X
the	B-X
conformation	B-X
of	B-X
hCdh1	B-X
and	B-X
prevents	B-X
it	B-X
from	B-X
activating	B-X
APC	B-X
.	B-X
A	B-X
human	B-X
homologue	B-X
of	B-X
yeast	B-X
Cdc14	B-X
,	B-X
human	B-X
Cdc14a	B-X
(	B-X
hCdc14a	B-X
)	B-X
,	B-X
dephosphorylates	B-X
hCdh1	B-X
and	B-X
activates	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
hCdc14a	B-X
does	B-X
not	B-X
affect	B-X
the	B-X
activity	B-X
of	B-X
APC	B-X
(	B-X
Cdc20	B-X
)	B-X
.	B-X
hCdc14a	B-X
is	B-X
a	B-X
major	B-X
phosphatase	B-X
for	B-X
hCdh1	B-X
and	B-X
localizes	B-X
to	B-X
centrosomes	B-X
in	B-X
HeLa	B-X
cells	B-X
.	B-X
Therefore	B-X
,	B-X
hCdc14a	B-X
may	B-X
promote	B-X
the	B-X
activation	B-X
of	B-X
APC	B-X
(	B-X
Cdh1	B-X
)	B-X
and	B-X
exit	B-X
from	B-X
mitosis	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

Physiological	O
substrates	O
for	O
human	O
lysosomal	O
beta	O
-	O
hexosaminidase	O
S	O
.	O
<EOS>	B-X
Human	B-X
lysosomal	B-X
beta-hexosaminidases	B-X
remove	B-X
terminal	B-X
beta-glycosidically	B-X
bound	B-X
N-acetylhexosamine	B-X
residues	B-X
from	B-X
a	B-X
number	B-X
of	B-X
glycoconjugates	B-X
.	B-X
Three	B-X
different	B-X
isozymes	B-X
composed	B-X
of	B-X
two	B-X
noncovalently	B-X
linked	B-X
subunits	B-X
alpha	B-X
and	B-X
beta	B-X
exist	B-X
:	B-X
Hex	B-X
A	B-X
(	B-X
alphabeta	B-X
)	B-X
,	B-X
Hex	B-X
B	B-X
(	B-X
betabeta	B-X
)	B-X
,	B-X
and	B-X
Hex	B-X
S	B-X
(	B-X
alphaalpha	B-X
)	B-X
.	B-X
However	B-X
,	B-X
the	B-X
striking	B-X
accumulation	B-X
of	B-X
anionic	B-X
oligosaccharides	B-X
in	B-X
double	B-X
knockout	B-X
mice	B-X
totally	B-X
deficient	B-X
in	B-X
hexosaminidase	B-X
activity	B-X
but	B-X
not	B-X
in	B-X
mice	B-X
expressing	B-X
Hex	B-X
S	B-X
(	B-X
Sango	B-X
,	B-X
K.	B-X
,	B-X
McDonald	B-X
,	B-X
M.	B-X
P.	B-X
,	B-X
Crawley	B-X
,	B-X
J.	B-X
N.	B-X
,	B-X
Mack	B-X
,	B-X
M.	B-X
L.	B-X
,	B-X
Tifft	B-X
,	B-X
C.J.	B-X
,	B-X
Skop	B-X
,	B-X
E.	B-X
,	B-X
Starr	B-X
,	B-X
C.	B-X
M.	B-X
,	B-X
Hoffmann	B-X
,	B-X
A.	B-X
,	B-X
Sandhoff	B-X
,	B-X
K.	B-X
,	B-X
Suzuki	B-X
,	B-X
K.	B-X
,	B-X
and	B-X
Proia	B-X
,	B-X
R.	B-X
L.	B-X
,	B-X
(	B-X
1996	B-X
)	B-X
Nat	B-X
.	B-X
14	B-X
,	B-X
348-352	B-X
)	B-X
prompted	B-X
us	B-X
to	B-X
reinvestigate	B-X
the	B-X
substrate	B-X
specificity	B-X
of	B-X
Hex	B-X
S.	B-X
To	B-X
identify	B-X
physiological	B-X
substrates	B-X
of	B-X
Hex	B-X
S	B-X
,	B-X
anionic	B-X
and	B-X
neutral	B-X
oligosaccharides	B-X
excreted	B-X
in	B-X
the	B-X
urine	B-X
of	B-X
the	B-X
double	B-X
knockout	B-X
mice	B-X
were	B-X
isolated	B-X
and	B-X
analyzed	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
recombinant	B-X
Hex	B-X
S	B-X
was	B-X
highly	B-X
active	B-X
on	B-X
water-soluble	B-X
and	B-X
amphiphilic	B-X
glycoconjugates	B-X
including	B-X
artificial	B-X
substrates	B-X
,	B-X
sulfated	B-X
GAG	B-X
fragments	B-X
,	B-X
and	B-X
the	B-X
sulfated	B-X
glycosphingolipid	B-X
SM2	B-X
.	B-X
Hydrolysis	B-X
of	B-X
membrane-bound	B-X
SM2	B-X
by	B-X
the	B-X
recombinant	B-X
Hex	B-X
S	B-X
was	B-X
synergistically	B-X
stimulated	B-X
by	B-X
the	B-X
GM2	B-X
activator	B-X
protein	B-X
and	B-X
the	B-X
lysosomal	B-X
anionic	B-X
phospholipid	B-X
bis	B-X
(	B-X
monoacylglycero	B-X
)	B-X
phosphate	B-X
.	B-X

Human	O
lysosomal	O
beta	O
-	O
hexosaminidases	O
remove	O
terminal	O
beta	O
-	O
glycosidically	O
bound	O
N	O
-	O
acetylhexosamine	O
residues	O
from	O
a	O
number	O
of	O
glycoconjugates	O
.	O

Three	O
different	O
isozymes	O
composed	O
of	O
two	O
noncovalently	O
linked	O
subunits	O
alpha	O
and	O
beta	O
exist	O
:	O
Hex	O
A	O
(	O
alphabeta	O
)	O
,	O
Hex	O
B	O
(	O
betabeta	O
)	O
,	O
and	O
Hex	O
S	O
(	O
alphaalpha	O
)	O
.	O

While	O
the	O
role	O
of	O
Hex	O
A	O
and	O
B	O
for	O
the	O
degradation	O
of	O
several	O
anionic	O
and	O
neutral	O
glycoconjugates	O
has	O
been	O
well	O
established	O
,	O
the	O
physiological	O
significance	O
of	O
labile	O
Hex	O
S	O
has	O
remained	O
unclear	O
.	O

However	O
,	O
the	O
striking	O
accumulation	O
of	O
anionic	O
oligosaccharides	O
in	O
double	O
knockout	O
mice	O
totally	O
deficient	O
in	O
hexosaminidase	O
activity	O
but	O
not	O
in	O
mice	O
expressing	O
Hex	O
S	O
(	O
Sango	O
,	O
K	O
.	O
,	O
McDonald	O
,	O
M	O
.	O
P	O
.	O
,	O
Crawley	O
,	O
J	O
.	O
N	O
.	O
,	O
Mack	O
,	O
M	O
.	O
L	O
.	O
,	O
Tifft	O
,	O
C	O
.	O
J	O
.	O
,	O
Skop	O
,	O
E	O
.	O
,	O
Starr	O
,	O
C	O
.	O
M	O
.	O
,	O
Hoffmann	O
,	O
A	O
.	O
,	O
Sandhoff	O
,	O
K	O
.	O
,	O
Suzuki	O
,	O
K	O
.	O
,	O
and	O
Proia	O
,	O
R	O
.	O
L	O
.	O
,	O
(	O
1996	O
)	O
Nat	O
.	O
Genet	O
.	O
14	O
,	O
348	O
-	O
352	O
)	O
prompted	O
us	O
to	O
reinvestigate	O
the	O
substrate	O
specificity	O
of	O
Hex	O
S	O
.	O

To	O
identify	O
physiological	O
substrates	O
of	O
Hex	O
S	O
,	O
anionic	O
and	O
neutral	O
oligosaccharides	O
excreted	O
in	O
the	O
urine	O
of	O
the	O
double	O
knockout	O
mice	O
were	O
isolated	O
and	O
analyzed	O
.	O

Using	O
ESI	O
-	O
MS	O
/	O
MS	O
and	O
glycosidase	B-Gene_or_gene_product
digestion	O
the	O
anionic	O
glycans	O
were	O
identified	O
as	O
products	O
of	O
incomplete	O
dermatan	O
sulfate	O
degradation	O
whereas	O
the	O
neutral	O
storage	O
oligosaccharides	O
were	O
found	O
to	O
be	O
fragments	O
of	O
N	O
-	O
glycan	O
degradation	O
.	O

In	O
vitro	O
,	O
recombinant	O
Hex	O
S	O
was	O
highly	O
active	O
on	O
water	O
-	O
soluble	O
and	O
amphiphilic	O
glycoconjugates	O
including	O
artificial	O
substrates	O
,	O
sulfated	O
GAG	O
fragments	O
,	O
and	O
the	O
sulfated	O
glycosphingolipid	O
SM2	O
.	O

Hydrolysis	O
of	O
membrane	O
-	O
bound	O
SM2	O
by	O
the	O
recombinant	O
Hex	O
S	O
was	O
synergistically	O
stimulated	O
by	O
the	O
GM2	B-Gene_or_gene_product
activator	O
protein	O
and	O
the	O
lysosomal	O
anionic	O
phospholipid	O
bis	O
(	O
monoacylglycero	O
)	O
phosphate	O
.	O

C	B-Gene_or_gene_product
-	I-Gene_or_gene_product
TAK1	I-Gene_or_gene_product
regulates	O
Ras	B-Gene_or_gene_product
signaling	O
by	O
phosphorylating	O
the	O
MAPK	B-Gene_or_gene_product
scaffold	O
,	O
KSR1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Kinase	B-X
suppressor	B-X
of	B-X
Ras	B-X
(	B-X
KSR	B-X
)	B-X
is	B-X
a	B-X
conserved	B-X
component	B-X
of	B-X
the	B-X
Ras	B-X
pathway	B-X
that	B-X
interacts	B-X
directly	B-X
with	B-X
MEK	B-X
and	B-X
MAPK	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
KSR1	B-X
translocates	B-X
from	B-X
the	B-X
cytoplasm	B-X
to	B-X
the	B-X
cell	B-X
surface	B-X
in	B-X
response	B-X
to	B-X
growth	B-X
factor	B-X
treatment	B-X
and	B-X
that	B-X
this	B-X
process	B-X
is	B-X
regulated	B-X
by	B-X
Cdc25C-associated	B-X
kinase	B-X
1	B-X
(	B-X
C-TAK1	B-X
)	B-X
.	B-X
C-TAK1	B-X
constitutively	B-X
associates	B-X
with	B-X
mammalian	B-X
KSR1	B-X
and	B-X
phosphorylates	B-X
serine	B-X
392	B-X
to	B-X
confer	B-X
14-3-3	B-X
binding	B-X
and	B-X
cytoplasmic	B-X
sequestration	B-X
of	B-X
KSR1	B-X
in	B-X
unstimulated	B-X
cells	B-X
.	B-X
In	B-X
response	B-X
to	B-X
signal	B-X
activation	B-X
,	B-X
the	B-X
phosphorylation	B-X
state	B-X
of	B-X
S392	B-X
is	B-X
reduced	B-X
,	B-X
allowing	B-X
the	B-X
KSR1	B-X
complex	B-X
to	B-X
colocalize	B-X
with	B-X
activated	B-X
Ras	B-X
and	B-X
Raf-1	B-X
at	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
thereby	B-X
facilitating	B-X
the	B-X
phosphorylation	B-X
reactions	B-X
required	B-X
for	B-X
the	B-X
activation	B-X
of	B-X
MEK	B-X
and	B-X
MAPK	B-X
.	B-X

Kinase	B-Gene_or_gene_product
suppressor	I-Gene_or_gene_product
of	I-Gene_or_gene_product
Ras	I-Gene_or_gene_product
(	O
KSR	B-Gene_or_gene_product
)	O
is	O
a	O
conserved	O
component	O
of	O
the	O
Ras	B-Gene_or_gene_product
pathway	O
that	O
interacts	O
directly	O
with	O
MEK	B-Gene_or_gene_product
and	O
MAPK	B-Gene_or_gene_product
.	O
<EOS>	B-X
Kinase	B-X
suppressor	B-X
of	B-X
Ras	B-X
(	B-X
KSR	B-X
)	B-X
is	B-X
a	B-X
conserved	B-X
component	B-X
of	B-X
the	B-X
Ras	B-X
pathway	B-X
that	B-X
acts	B-X
as	B-X
a	B-X
molecular	B-X
scaffold	B-X
to	B-X
promote	B-X
signal	B-X
transmission	B-X
from	B-X
Raf-1	B-X
to	B-X
MEK	B-X
and	B-X
MAPK	B-X
.	B-X
All	B-X
KSR	B-X
proteins	B-X
contain	B-X
a	B-X
conserved	B-X
cysteine-rich	B-X
C1	B-X
domain	B-X
,	B-X
and	B-X
studies	B-X
have	B-X
implicated	B-X
this	B-X
domain	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
KSR1	B-X
subcellular	B-X
localization	B-X
and	B-X
function	B-X
.	B-X
To	B-X
further	B-X
elucidate	B-X
the	B-X
biological	B-X
role	B-X
of	B-X
the	B-X
KSR1	B-X
C1	B-X
domain	B-X
,	B-X
we	B-X
have	B-X
determined	B-X
its	B-X
three-dimensional	B-X
solution	B-X
structure	B-X
using	B-X
nuclear	B-X
magnetic	B-X
resonance	B-X
(	B-X
NMR	B-X
)	B-X
.	B-X
We	B-X
find	B-X
that	B-X
while	B-X
the	B-X
overall	B-X
topology	B-X
of	B-X
the	B-X
KSR1	B-X
C1	B-X
domain	B-X
is	B-X
similar	B-X
to	B-X
the	B-X
C1	B-X
domains	B-X
of	B-X
Raf-1	B-X
and	B-X
PKCgamma	B-X
,	B-X
the	B-X
predicted	B-X
ligand-binding	B-X
region	B-X
and	B-X
the	B-X
surface	B-X
charge	B-X
distribution	B-X
are	B-X
unique	B-X
.	B-X
Moreover	B-X
,	B-X
by	B-X
generating	B-X
chimeric	B-X
proteins	B-X
in	B-X
which	B-X
these	B-X
domains	B-X
have	B-X
been	B-X
swapped	B-X
,	B-X
we	B-X
find	B-X
that	B-X
the	B-X
C1	B-X
domains	B-X
of	B-X
Raf-1	B-X
,	B-X
PKCgamma	B-X
,	B-X
and	B-X
KSR1	B-X
are	B-X
not	B-X
functionally	B-X
interchangeable	B-X
.	B-X
The	B-X
KSR1	B-X
C1	B-X
domain	B-X
does	B-X
not	B-X
bind	B-X
with	B-X
high	B-X
affinity	B-X
or	B-X
respond	B-X
biologically	B-X
to	B-X
phorbol	B-X
esters	B-X
or	B-X
ceramide	B-X
,	B-X
and	B-X
it	B-X
does	B-X
not	B-X
interact	B-X
directly	B-X
with	B-X
Ras	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
putative	B-X
ligand	B-X
(	B-X
s	B-X
)	B-X
for	B-X
the	B-X
KSR1	B-X
C1	B-X
domain	B-X
are	B-X
distinct	B-X
from	B-X
those	B-X
that	B-X
interact	B-X
with	B-X
PKCgamma	B-X
and	B-X
Raf-1	B-X
.	B-X
Finally	B-X
,	B-X
our	B-X
findings	B-X
demonstrate	B-X
an	B-X
absolute	B-X
requirement	B-X
of	B-X
the	B-X
KSR1	B-X
C1	B-X
domain	B-X
in	B-X
mediating	B-X
the	B-X
membrane	B-X
localization	B-X
of	B-X
KSR1	B-X
,	B-X
a	B-X
crucial	B-X
feature	B-X
of	B-X
its	B-X
scaffolding	B-X
activity	B-X
.	B-X

Here	O
we	O
show	O
that	O
KSR1	B-Gene_or_gene_product
translocates	O
from	O
the	O
cytoplasm	O
to	O
the	O
cell	O
surface	O
in	O
response	O
to	O
growth	O
factor	O
treatment	O
and	O
that	O
this	O
process	O
is	O
regulated	O
by	O
Cdc25C	B-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
C	B-Gene_or_gene_product
-	I-Gene_or_gene_product
TAK1	I-Gene_or_gene_product
)	O
.	O

C	B-Gene_or_gene_product
-	I-Gene_or_gene_product
TAK1	I-Gene_or_gene_product
constitutively	O
associates	O
with	O
mammalian	O
KSR1	B-Gene_or_gene_product
and	O
phosphorylates	O
serine	O
392	O
to	O
confer	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
binding	O
and	O
cytoplasmic	O
sequestration	O
of	O
KSR1	B-Gene_or_gene_product
in	O
unstimulated	O
cells	O
.	O
<EOS>	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
KSR1	B-X
translocates	B-X
from	B-X
the	B-X
cytoplasm	B-X
to	B-X
the	B-X
cell	B-X
surface	B-X
in	B-X
response	B-X
to	B-X
growth	B-X
factor	B-X
treatment	B-X
and	B-X
that	B-X
this	B-X
process	B-X
is	B-X
regulated	B-X
by	B-X
Cdc25C-associated	B-X
kinase	B-X
1	B-X
(	B-X
C-TAK1	B-X
)	B-X
.	B-X
C-TAK1	B-X
constitutively	B-X
associates	B-X
with	B-X
mammalian	B-X
KSR1	B-X
and	B-X
phosphorylates	B-X
serine	B-X
392	B-X
to	B-X
confer	B-X
14-3-3	B-X
binding	B-X
and	B-X
cytoplasmic	B-X
sequestration	B-X
of	B-X
KSR1	B-X
in	B-X
unstimulated	B-X
cells	B-X
.	B-X
In	B-X
response	B-X
to	B-X
signal	B-X
activation	B-X
,	B-X
the	B-X
phosphorylation	B-X
state	B-X
of	B-X
S392	B-X
is	B-X
reduced	B-X
,	B-X
allowing	B-X
the	B-X
KSR1	B-X
complex	B-X
to	B-X
colocalize	B-X
with	B-X
activated	B-X
Ras	B-X
and	B-X
Raf-1	B-X
at	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
thereby	B-X
facilitating	B-X
the	B-X
phosphorylation	B-X
reactions	B-X
required	B-X
for	B-X
the	B-X
activation	B-X
of	B-X
MEK	B-X
and	B-X
MAPK	B-X
.	B-X

In	O
response	O
to	O
signal	O
activation	O
,	O
the	O
phosphorylation	O
state	O
of	O
S392	O
is	O
reduced	O
,	O
allowing	O
the	O
KSR1	B-Gene_or_gene_product
complex	O
to	O
colocalize	O
with	O
activated	O
Ras	B-Gene_or_gene_product
and	O
Raf	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
at	O
the	O
plasma	O
membrane	O
,	O
thereby	O
facilitating	O
the	O
phosphorylation	O
reactions	O
required	O
for	O
the	O
activation	O
of	O
MEK	B-Gene_or_gene_product
and	O
MAPK	B-Gene_or_gene_product
.	O
<EOS>	B-X
Kinase	B-X
suppressor	B-X
of	B-X
Ras	B-X
(	B-X
KSR	B-X
)	B-X
is	B-X
a	B-X
conserved	B-X
component	B-X
of	B-X
the	B-X
Ras	B-X
pathway	B-X
that	B-X
interacts	B-X
directly	B-X
with	B-X
MEK	B-X
and	B-X
MAPK	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
KSR1	B-X
translocates	B-X
from	B-X
the	B-X
cytoplasm	B-X
to	B-X
the	B-X
cell	B-X
surface	B-X
in	B-X
response	B-X
to	B-X
growth	B-X
factor	B-X
treatment	B-X
and	B-X
that	B-X
this	B-X
process	B-X
is	B-X
regulated	B-X
by	B-X
Cdc25C-associated	B-X
kinase	B-X
1	B-X
(	B-X
C-TAK1	B-X
)	B-X
.	B-X
C-TAK1	B-X
constitutively	B-X
associates	B-X
with	B-X
mammalian	B-X
KSR1	B-X
and	B-X
phosphorylates	B-X
serine	B-X
392	B-X
to	B-X
confer	B-X
14-3-3	B-X
binding	B-X
and	B-X
cytoplasmic	B-X
sequestration	B-X
of	B-X
KSR1	B-X
in	B-X
unstimulated	B-X
cells	B-X
.	B-X
In	B-X
response	B-X
to	B-X
signal	B-X
activation	B-X
,	B-X
the	B-X
phosphorylation	B-X
state	B-X
of	B-X
S392	B-X
is	B-X
reduced	B-X
,	B-X
allowing	B-X
the	B-X
KSR1	B-X
complex	B-X
to	B-X
colocalize	B-X
with	B-X
activated	B-X
Ras	B-X
and	B-X
Raf-1	B-X
at	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
thereby	B-X
facilitating	B-X
the	B-X
phosphorylation	B-X
reactions	B-X
required	B-X
for	B-X
the	B-X
activation	B-X
of	B-X
MEK	B-X
and	B-X
MAPK	B-X
.	B-X

TIP41	B-Gene_or_gene_product
interacts	O
with	O
TAP42	B-Gene_or_gene_product
and	O
negatively	O
regulates	O
the	O
TOR	B-Gene_or_gene_product
signaling	O
pathway	O
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
rapamycin-sensitive	B-X
TOR	B-X
kinases	B-X
negatively	B-X
regulate	B-X
the	B-X
type	B-X
2A-related	B-X
phosphatase	B-X
SIT4	B-X
by	B-X
promoting	B-X
the	B-X
association	B-X
of	B-X
this	B-X
phosphatase	B-X
with	B-X
the	B-X
inhibitor	B-X
TAP42	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
TIP41	B-X
,	B-X
a	B-X
conserved	B-X
TAP42-interacting	B-X
protein	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
SIT4	B-X
.	B-X
Deletion	B-X
of	B-X
the	B-X
TIP41	B-X
gene	B-X
confers	B-X
rapamycin	B-X
resistance	B-X
,	B-X
suppresses	B-X
a	B-X
tap42	B-X
mutation	B-X
,	B-X
and	B-X
prevents	B-X
dissociation	B-X
of	B-X
SIT4	B-X
from	B-X
TAP42	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
TIP41	B-X
deletion	B-X
prevents	B-X
SIT4-dependent	B-X
events	B-X
such	B-X
as	B-X
dephosphorylation	B-X
of	B-X
the	B-X
kinase	B-X
NPR1	B-X
and	B-X
nuclear	B-X
translocation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
GLN3	B-X
.	B-X
Thus	B-X
,	B-X
TIP41	B-X
negatively	B-X
regulates	B-X
the	B-X
TOR	B-X
pathway	B-X
by	B-X
binding	B-X
and	B-X
inhibiting	B-X
TAP42	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
TIP41	B-X
to	B-X
TAP42	B-X
is	B-X
stimulated	B-X
upon	B-X
rapamycin	B-X
treatment	B-X
via	B-X
SIT4-dependent	B-X
dephosphorylation	B-X
of	B-X
TIP41	B-X
,	B-X
suggesting	B-X
that	B-X
TIP41	B-X
is	B-X
part	B-X
of	B-X
a	B-X
feedback	B-X
loop	B-X
that	B-X
rapidly	B-X
amplifies	B-X
SIT4	B-X
phosphatase	B-X
activity	B-X
under	B-X
TOR-inactivating	B-X
conditions	B-X
.	B-X

In	O
Saccharomyces	O
cerevisiae	O
,	O
the	O
rapamycin	O
-	O
sensitive	O
TOR	B-Gene_or_gene_product
kinases	O
negatively	O
regulate	O
the	O
type	O
2A	O
-	O
related	O
phosphatase	O
SIT4	B-Gene_or_gene_product
by	O
promoting	O
the	O
association	O
of	O
this	O
phosphatase	O
with	O
the	O
inhibitor	O
TAP42	B-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
rapamycin-sensitive	B-X
TOR	B-X
kinases	B-X
negatively	B-X
regulate	B-X
the	B-X
type	B-X
2A-related	B-X
phosphatase	B-X
SIT4	B-X
by	B-X
promoting	B-X
the	B-X
association	B-X
of	B-X
this	B-X
phosphatase	B-X
with	B-X
the	B-X
inhibitor	B-X
TAP42	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
TIP41	B-X
,	B-X
a	B-X
conserved	B-X
TAP42-interacting	B-X
protein	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
SIT4	B-X
.	B-X
Deletion	B-X
of	B-X
the	B-X
TIP41	B-X
gene	B-X
confers	B-X
rapamycin	B-X
resistance	B-X
,	B-X
suppresses	B-X
a	B-X
tap42	B-X
mutation	B-X
,	B-X
and	B-X
prevents	B-X
dissociation	B-X
of	B-X
SIT4	B-X
from	B-X
TAP42	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
TIP41	B-X
deletion	B-X
prevents	B-X
SIT4-dependent	B-X
events	B-X
such	B-X
as	B-X
dephosphorylation	B-X
of	B-X
the	B-X
kinase	B-X
NPR1	B-X
and	B-X
nuclear	B-X
translocation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
GLN3	B-X
.	B-X
Thus	B-X
,	B-X
TIP41	B-X
negatively	B-X
regulates	B-X
the	B-X
TOR	B-X
pathway	B-X
by	B-X
binding	B-X
and	B-X
inhibiting	B-X
TAP42	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
TIP41	B-X
to	B-X
TAP42	B-X
is	B-X
stimulated	B-X
upon	B-X
rapamycin	B-X
treatment	B-X
via	B-X
SIT4-dependent	B-X
dephosphorylation	B-X
of	B-X
TIP41	B-X
,	B-X
suggesting	B-X
that	B-X
TIP41	B-X
is	B-X
part	B-X
of	B-X
a	B-X
feedback	B-X
loop	B-X
that	B-X
rapidly	B-X
amplifies	B-X
SIT4	B-X
phosphatase	B-X
activity	B-X
under	B-X
TOR-inactivating	B-X
conditions	B-X
.	B-X

Here	O
,	O
we	O
describe	O
TIP41	B-Gene_or_gene_product
,	O
a	O
conserved	O
TAP42	B-Gene_or_gene_product
-	O
interacting	O
protein	O
involved	O
in	O
the	O
regulation	O
of	O
SIT4	B-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
rapamycin-sensitive	B-X
TOR	B-X
kinases	B-X
negatively	B-X
regulate	B-X
the	B-X
type	B-X
2A-related	B-X
phosphatase	B-X
SIT4	B-X
by	B-X
promoting	B-X
the	B-X
association	B-X
of	B-X
this	B-X
phosphatase	B-X
with	B-X
the	B-X
inhibitor	B-X
TAP42	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
TIP41	B-X
,	B-X
a	B-X
conserved	B-X
TAP42-interacting	B-X
protein	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
SIT4	B-X
.	B-X
Deletion	B-X
of	B-X
the	B-X
TIP41	B-X
gene	B-X
confers	B-X
rapamycin	B-X
resistance	B-X
,	B-X
suppresses	B-X
a	B-X
tap42	B-X
mutation	B-X
,	B-X
and	B-X
prevents	B-X
dissociation	B-X
of	B-X
SIT4	B-X
from	B-X
TAP42	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
TIP41	B-X
deletion	B-X
prevents	B-X
SIT4-dependent	B-X
events	B-X
such	B-X
as	B-X
dephosphorylation	B-X
of	B-X
the	B-X
kinase	B-X
NPR1	B-X
and	B-X
nuclear	B-X
translocation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
GLN3	B-X
.	B-X
Thus	B-X
,	B-X
TIP41	B-X
negatively	B-X
regulates	B-X
the	B-X
TOR	B-X
pathway	B-X
by	B-X
binding	B-X
and	B-X
inhibiting	B-X
TAP42	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
TIP41	B-X
to	B-X
TAP42	B-X
is	B-X
stimulated	B-X
upon	B-X
rapamycin	B-X
treatment	B-X
via	B-X
SIT4-dependent	B-X
dephosphorylation	B-X
of	B-X
TIP41	B-X
,	B-X
suggesting	B-X
that	B-X
TIP41	B-X
is	B-X
part	B-X
of	B-X
a	B-X
feedback	B-X
loop	B-X
that	B-X
rapidly	B-X
amplifies	B-X
SIT4	B-X
phosphatase	B-X
activity	B-X
under	B-X
TOR-inactivating	B-X
conditions	B-X
.	B-X

Deletion	O
of	O
the	O
TIP41	B-Gene_or_gene_product
gene	O
confers	O
rapamycin	O
resistance	O
,	O
suppresses	O
a	O
tap42	B-Gene_or_gene_product
mutation	O
,	O
and	O
prevents	O
dissociation	O
of	O
SIT4	B-Gene_or_gene_product
from	O
TAP42	B-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
rapamycin-sensitive	B-X
TOR	B-X
kinases	B-X
negatively	B-X
regulate	B-X
the	B-X
type	B-X
2A-related	B-X
phosphatase	B-X
SIT4	B-X
by	B-X
promoting	B-X
the	B-X
association	B-X
of	B-X
this	B-X
phosphatase	B-X
with	B-X
the	B-X
inhibitor	B-X
TAP42	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
TIP41	B-X
,	B-X
a	B-X
conserved	B-X
TAP42-interacting	B-X
protein	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
SIT4	B-X
.	B-X
Deletion	B-X
of	B-X
the	B-X
TIP41	B-X
gene	B-X
confers	B-X
rapamycin	B-X
resistance	B-X
,	B-X
suppresses	B-X
a	B-X
tap42	B-X
mutation	B-X
,	B-X
and	B-X
prevents	B-X
dissociation	B-X
of	B-X
SIT4	B-X
from	B-X
TAP42	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
TIP41	B-X
deletion	B-X
prevents	B-X
SIT4-dependent	B-X
events	B-X
such	B-X
as	B-X
dephosphorylation	B-X
of	B-X
the	B-X
kinase	B-X
NPR1	B-X
and	B-X
nuclear	B-X
translocation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
GLN3	B-X
.	B-X
Thus	B-X
,	B-X
TIP41	B-X
negatively	B-X
regulates	B-X
the	B-X
TOR	B-X
pathway	B-X
by	B-X
binding	B-X
and	B-X
inhibiting	B-X
TAP42	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
TIP41	B-X
to	B-X
TAP42	B-X
is	B-X
stimulated	B-X
upon	B-X
rapamycin	B-X
treatment	B-X
via	B-X
SIT4-dependent	B-X
dephosphorylation	B-X
of	B-X
TIP41	B-X
,	B-X
suggesting	B-X
that	B-X
TIP41	B-X
is	B-X
part	B-X
of	B-X
a	B-X
feedback	B-X
loop	B-X
that	B-X
rapidly	B-X
amplifies	B-X
SIT4	B-X
phosphatase	B-X
activity	B-X
under	B-X
TOR-inactivating	B-X
conditions	B-X
.	B-X

Furthermore	O
,	O
a	O
TIP41	B-Gene_or_gene_product
deletion	O
prevents	O
SIT4	B-Gene_or_gene_product
-	O
dependent	O
events	O
such	O
as	O
dephosphorylation	O
of	O
the	O
kinase	O
NPR1	B-Gene_or_gene_product
and	O
nuclear	O
translocation	O
of	O
the	O
transcription	O
factor	O
GLN3	B-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
rapamycin-sensitive	B-X
TOR	B-X
kinases	B-X
negatively	B-X
regulate	B-X
the	B-X
type	B-X
2A-related	B-X
phosphatase	B-X
SIT4	B-X
by	B-X
promoting	B-X
the	B-X
association	B-X
of	B-X
this	B-X
phosphatase	B-X
with	B-X
the	B-X
inhibitor	B-X
TAP42	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
TIP41	B-X
,	B-X
a	B-X
conserved	B-X
TAP42-interacting	B-X
protein	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
SIT4	B-X
.	B-X
Deletion	B-X
of	B-X
the	B-X
TIP41	B-X
gene	B-X
confers	B-X
rapamycin	B-X
resistance	B-X
,	B-X
suppresses	B-X
a	B-X
tap42	B-X
mutation	B-X
,	B-X
and	B-X
prevents	B-X
dissociation	B-X
of	B-X
SIT4	B-X
from	B-X
TAP42	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
TIP41	B-X
deletion	B-X
prevents	B-X
SIT4-dependent	B-X
events	B-X
such	B-X
as	B-X
dephosphorylation	B-X
of	B-X
the	B-X
kinase	B-X
NPR1	B-X
and	B-X
nuclear	B-X
translocation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
GLN3	B-X
.	B-X
Thus	B-X
,	B-X
TIP41	B-X
negatively	B-X
regulates	B-X
the	B-X
TOR	B-X
pathway	B-X
by	B-X
binding	B-X
and	B-X
inhibiting	B-X
TAP42	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
TIP41	B-X
to	B-X
TAP42	B-X
is	B-X
stimulated	B-X
upon	B-X
rapamycin	B-X
treatment	B-X
via	B-X
SIT4-dependent	B-X
dephosphorylation	B-X
of	B-X
TIP41	B-X
,	B-X
suggesting	B-X
that	B-X
TIP41	B-X
is	B-X
part	B-X
of	B-X
a	B-X
feedback	B-X
loop	B-X
that	B-X
rapidly	B-X
amplifies	B-X
SIT4	B-X
phosphatase	B-X
activity	B-X
under	B-X
TOR-inactivating	B-X
conditions	B-X
.	B-X

Thus	O
,	O
TIP41	B-Gene_or_gene_product
negatively	O
regulates	O
the	O
TOR	B-Gene_or_gene_product
pathway	O
by	O
binding	O
and	O
inhibiting	O
TAP42	B-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
rapamycin-sensitive	B-X
TOR	B-X
kinases	B-X
negatively	B-X
regulate	B-X
the	B-X
type	B-X
2A-related	B-X
phosphatase	B-X
SIT4	B-X
by	B-X
promoting	B-X
the	B-X
association	B-X
of	B-X
this	B-X
phosphatase	B-X
with	B-X
the	B-X
inhibitor	B-X
TAP42	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
TIP41	B-X
,	B-X
a	B-X
conserved	B-X
TAP42-interacting	B-X
protein	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
SIT4	B-X
.	B-X
Deletion	B-X
of	B-X
the	B-X
TIP41	B-X
gene	B-X
confers	B-X
rapamycin	B-X
resistance	B-X
,	B-X
suppresses	B-X
a	B-X
tap42	B-X
mutation	B-X
,	B-X
and	B-X
prevents	B-X
dissociation	B-X
of	B-X
SIT4	B-X
from	B-X
TAP42	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
TIP41	B-X
deletion	B-X
prevents	B-X
SIT4-dependent	B-X
events	B-X
such	B-X
as	B-X
dephosphorylation	B-X
of	B-X
the	B-X
kinase	B-X
NPR1	B-X
and	B-X
nuclear	B-X
translocation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
GLN3	B-X
.	B-X
Thus	B-X
,	B-X
TIP41	B-X
negatively	B-X
regulates	B-X
the	B-X
TOR	B-X
pathway	B-X
by	B-X
binding	B-X
and	B-X
inhibiting	B-X
TAP42	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
TIP41	B-X
to	B-X
TAP42	B-X
is	B-X
stimulated	B-X
upon	B-X
rapamycin	B-X
treatment	B-X
via	B-X
SIT4-dependent	B-X
dephosphorylation	B-X
of	B-X
TIP41	B-X
,	B-X
suggesting	B-X
that	B-X
TIP41	B-X
is	B-X
part	B-X
of	B-X
a	B-X
feedback	B-X
loop	B-X
that	B-X
rapidly	B-X
amplifies	B-X
SIT4	B-X
phosphatase	B-X
activity	B-X
under	B-X
TOR-inactivating	B-X
conditions	B-X
.	B-X

The	O
binding	O
of	O
TIP41	B-Gene_or_gene_product
to	O
TAP42	B-Gene_or_gene_product
is	O
stimulated	O
upon	O
rapamycin	O
treatment	O
via	O
SIT4	B-Gene_or_gene_product
-	O
dependent	O
dephosphorylation	O
of	O
TIP41	B-Gene_or_gene_product
,	O
suggesting	O
that	O
TIP41	B-Gene_or_gene_product
is	O
part	O
of	O
a	O
feedback	O
loop	O
that	O
rapidly	O
amplifies	O
SIT4	B-Gene_or_gene_product
phosphatase	O
activity	O
under	O
TOR	B-Gene_or_gene_product
-	O
inactivating	O
conditions	O
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
rapamycin-sensitive	B-X
TOR	B-X
kinases	B-X
negatively	B-X
regulate	B-X
the	B-X
type	B-X
2A-related	B-X
phosphatase	B-X
SIT4	B-X
by	B-X
promoting	B-X
the	B-X
association	B-X
of	B-X
this	B-X
phosphatase	B-X
with	B-X
the	B-X
inhibitor	B-X
TAP42	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
TIP41	B-X
,	B-X
a	B-X
conserved	B-X
TAP42-interacting	B-X
protein	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
SIT4	B-X
.	B-X
Deletion	B-X
of	B-X
the	B-X
TIP41	B-X
gene	B-X
confers	B-X
rapamycin	B-X
resistance	B-X
,	B-X
suppresses	B-X
a	B-X
tap42	B-X
mutation	B-X
,	B-X
and	B-X
prevents	B-X
dissociation	B-X
of	B-X
SIT4	B-X
from	B-X
TAP42	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
TIP41	B-X
deletion	B-X
prevents	B-X
SIT4-dependent	B-X
events	B-X
such	B-X
as	B-X
dephosphorylation	B-X
of	B-X
the	B-X
kinase	B-X
NPR1	B-X
and	B-X
nuclear	B-X
translocation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
GLN3	B-X
.	B-X
Thus	B-X
,	B-X
TIP41	B-X
negatively	B-X
regulates	B-X
the	B-X
TOR	B-X
pathway	B-X
by	B-X
binding	B-X
and	B-X
inhibiting	B-X
TAP42	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
TIP41	B-X
to	B-X
TAP42	B-X
is	B-X
stimulated	B-X
upon	B-X
rapamycin	B-X
treatment	B-X
via	B-X
SIT4-dependent	B-X
dephosphorylation	B-X
of	B-X
TIP41	B-X
,	B-X
suggesting	B-X
that	B-X
TIP41	B-X
is	B-X
part	B-X
of	B-X
a	B-X
feedback	B-X
loop	B-X
that	B-X
rapidly	B-X
amplifies	B-X
SIT4	B-X
phosphatase	B-X
activity	B-X
under	B-X
TOR-inactivating	B-X
conditions	B-X
.	B-X

Pseudosubstrate	O
regulation	O
of	O
the	O
SCF	O
(	O
beta	O
-	O
TrCP	O
)	O
ubiquitin	B-Gene_or_gene_product
ligase	O
by	O
hnRNP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
U	I-Gene_or_gene_product
.	O
<EOS>	B-X
beta-TrCP/E3RS	B-X
(	B-X
E3RS	B-X
)	B-X
is	B-X
the	B-X
F-box	B-X
protein	B-X
that	B-X
functions	B-X
as	B-X
the	B-X
receptor	B-X
subunit	B-X
of	B-X
the	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
(	B-X
E3	B-X
)	B-X
.	B-X
Surprisingly	B-X
,	B-X
although	B-X
its	B-X
two	B-X
recognized	B-X
substrates	B-X
,	B-X
IkappaB	B-X
(	B-X
alpha	B-X
)	B-X
and	B-X
beta-catenin	B-X
,	B-X
are	B-X
present	B-X
in	B-X
the	B-X
cytoplasm	B-X
,	B-X
we	B-X
have	B-X
found	B-X
that	B-X
E3RS	B-X
is	B-X
located	B-X
predominantly	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
isolation	B-X
of	B-X
the	B-X
major	B-X
E3RS-associated	B-X
protein	B-X
,	B-X
hnRNP-U	B-X
,	B-X
an	B-X
abundant	B-X
nuclear	B-X
phosphoprotein	B-X
.	B-X
hnRNP-U	B-X
binding	B-X
was	B-X
abolished	B-X
by	B-X
competition	B-X
with	B-X
a	B-X
pIkappaB	B-X
(	B-X
alpha	B-X
)	B-X
peptide	B-X
,	B-X
or	B-X
by	B-X
a	B-X
specific	B-X
point	B-X
mutation	B-X
in	B-X
the	B-X
E3RS	B-X
WD	B-X
region	B-X
,	B-X
indicating	B-X
an	B-X
E3-substrate-type	B-X
interaction	B-X
.	B-X
However	B-X
,	B-X
unlike	B-X
pI	B-X
(	B-X
kappa	B-X
)	B-X
Balpha	B-X
,	B-X
which	B-X
is	B-X
targeted	B-X
by	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
for	B-X
degradation	B-X
,	B-X
the	B-X
E3-bound	B-X
hnRNP-U	B-X
is	B-X
stable	B-X
and	B-X
is	B-X
,	B-X
therefore	B-X
,	B-X
a	B-X
pseudosubstrate	B-X
.	B-X
Consequently	B-X
,	B-X
hnRNP-U	B-X
engages	B-X
a	B-X
highly	B-X
neddylated	B-X
active	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
,	B-X
which	B-X
dissociates	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
high-affinity	B-X
substrate	B-X
,	B-X
resulting	B-X
in	B-X
ubiquitination	B-X
of	B-X
the	B-X
latter	B-X
.	B-X
Our	B-X
study	B-X
points	B-X
to	B-X
a	B-X
novel	B-X
regulatory	B-X
mechanism	B-X
,	B-X
which	B-X
secures	B-X
the	B-X
localization	B-X
,	B-X
stability	B-X
,	B-X
substrate	B-X
binding	B-X
threshold	B-X
,	B-X
and	B-X
efficacy	B-X
of	B-X
a	B-X
specific	B-X
protein-ubiquitin	B-X
ligase	B-X
.	B-X

beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
TrCP	I-Gene_or_gene_product
/	O
E3RS	B-Gene_or_gene_product
(	O
E3RS	B-Gene_or_gene_product
)	O
is	O
the	O
F	O
-	O
box	O
protein	O
that	O
functions	O
as	O
the	O
receptor	O
subunit	O
of	O
the	O
SCF	O
(	O
beta	O
-	O
TrCP	O
)	O
ubiquitin	B-Gene_or_gene_product
ligase	O
(	O
E3	O
)	O
.	O

Surprisingly	O
,	O
although	O
its	O
two	O
recognized	O
substrates	O
,	O
IkappaB	B-Gene_or_gene_product
(	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
)	I-Gene_or_gene_product
and	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
,	O
are	O
present	O
in	O
the	O
cytoplasm	O
,	O
we	O
have	O
found	O
that	O
E3RS	B-Gene_or_gene_product
is	O
located	O
predominantly	O
in	O
the	O
nucleus	O
.	O
<EOS>	B-X
beta-TrCP/E3RS	B-X
(	B-X
E3RS	B-X
)	B-X
is	B-X
the	B-X
F-box	B-X
protein	B-X
that	B-X
functions	B-X
as	B-X
the	B-X
receptor	B-X
subunit	B-X
of	B-X
the	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
(	B-X
E3	B-X
)	B-X
.	B-X
Surprisingly	B-X
,	B-X
although	B-X
its	B-X
two	B-X
recognized	B-X
substrates	B-X
,	B-X
IkappaB	B-X
(	B-X
alpha	B-X
)	B-X
and	B-X
beta-catenin	B-X
,	B-X
are	B-X
present	B-X
in	B-X
the	B-X
cytoplasm	B-X
,	B-X
we	B-X
have	B-X
found	B-X
that	B-X
E3RS	B-X
is	B-X
located	B-X
predominantly	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
isolation	B-X
of	B-X
the	B-X
major	B-X
E3RS-associated	B-X
protein	B-X
,	B-X
hnRNP-U	B-X
,	B-X
an	B-X
abundant	B-X
nuclear	B-X
phosphoprotein	B-X
.	B-X
This	B-X
protein	B-X
occupies	B-X
E3RS	B-X
in	B-X
a	B-X
specific	B-X
and	B-X
stoichiometric	B-X
manner	B-X
,	B-X
stabilizes	B-X
the	B-X
E3	B-X
component	B-X
,	B-X
and	B-X
is	B-X
likely	B-X
responsible	B-X
for	B-X
its	B-X
nuclear	B-X
localization	B-X
.	B-X
hnRNP-U	B-X
binding	B-X
was	B-X
abolished	B-X
by	B-X
competition	B-X
with	B-X
a	B-X
pIkappaB	B-X
(	B-X
alpha	B-X
)	B-X
peptide	B-X
,	B-X
or	B-X
by	B-X
a	B-X
specific	B-X
point	B-X
mutation	B-X
in	B-X
the	B-X
E3RS	B-X
WD	B-X
region	B-X
,	B-X
indicating	B-X
an	B-X
E3-substrate-type	B-X
interaction	B-X
.	B-X
However	B-X
,	B-X
unlike	B-X
pI	B-X
(	B-X
kappa	B-X
)	B-X
Balpha	B-X
,	B-X
which	B-X
is	B-X
targeted	B-X
by	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
for	B-X
degradation	B-X
,	B-X
the	B-X
E3-bound	B-X
hnRNP-U	B-X
is	B-X
stable	B-X
and	B-X
is	B-X
,	B-X
therefore	B-X
,	B-X
a	B-X
pseudosubstrate	B-X
.	B-X
Consequently	B-X
,	B-X
hnRNP-U	B-X
engages	B-X
a	B-X
highly	B-X
neddylated	B-X
active	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
,	B-X
which	B-X
dissociates	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
high-affinity	B-X
substrate	B-X
,	B-X
resulting	B-X
in	B-X
ubiquitination	B-X
of	B-X
the	B-X
latter	B-X
.	B-X

Here	O
we	O
report	O
the	O
isolation	O
of	O
the	O
major	O
E3RS	B-Gene_or_gene_product
-	O
associated	O
protein	O
,	O
hnRNP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
U	I-Gene_or_gene_product
,	O
an	O
abundant	O
nuclear	O
phosphoprotein	O
.	O
<EOS>	B-X
beta-TrCP/E3RS	B-X
(	B-X
E3RS	B-X
)	B-X
is	B-X
the	B-X
F-box	B-X
protein	B-X
that	B-X
functions	B-X
as	B-X
the	B-X
receptor	B-X
subunit	B-X
of	B-X
the	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
(	B-X
E3	B-X
)	B-X
.	B-X
Surprisingly	B-X
,	B-X
although	B-X
its	B-X
two	B-X
recognized	B-X
substrates	B-X
,	B-X
IkappaB	B-X
(	B-X
alpha	B-X
)	B-X
and	B-X
beta-catenin	B-X
,	B-X
are	B-X
present	B-X
in	B-X
the	B-X
cytoplasm	B-X
,	B-X
we	B-X
have	B-X
found	B-X
that	B-X
E3RS	B-X
is	B-X
located	B-X
predominantly	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
isolation	B-X
of	B-X
the	B-X
major	B-X
E3RS-associated	B-X
protein	B-X
,	B-X
hnRNP-U	B-X
,	B-X
an	B-X
abundant	B-X
nuclear	B-X
phosphoprotein	B-X
.	B-X
This	B-X
protein	B-X
occupies	B-X
E3RS	B-X
in	B-X
a	B-X
specific	B-X
and	B-X
stoichiometric	B-X
manner	B-X
,	B-X
stabilizes	B-X
the	B-X
E3	B-X
component	B-X
,	B-X
and	B-X
is	B-X
likely	B-X
responsible	B-X
for	B-X
its	B-X
nuclear	B-X
localization	B-X
.	B-X
hnRNP-U	B-X
binding	B-X
was	B-X
abolished	B-X
by	B-X
competition	B-X
with	B-X
a	B-X
pIkappaB	B-X
(	B-X
alpha	B-X
)	B-X
peptide	B-X
,	B-X
or	B-X
by	B-X
a	B-X
specific	B-X
point	B-X
mutation	B-X
in	B-X
the	B-X
E3RS	B-X
WD	B-X
region	B-X
,	B-X
indicating	B-X
an	B-X
E3-substrate-type	B-X
interaction	B-X
.	B-X
However	B-X
,	B-X
unlike	B-X
pI	B-X
(	B-X
kappa	B-X
)	B-X
Balpha	B-X
,	B-X
which	B-X
is	B-X
targeted	B-X
by	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
for	B-X
degradation	B-X
,	B-X
the	B-X
E3-bound	B-X
hnRNP-U	B-X
is	B-X
stable	B-X
and	B-X
is	B-X
,	B-X
therefore	B-X
,	B-X
a	B-X
pseudosubstrate	B-X
.	B-X
Consequently	B-X
,	B-X
hnRNP-U	B-X
engages	B-X
a	B-X
highly	B-X
neddylated	B-X
active	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
,	B-X
which	B-X
dissociates	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
high-affinity	B-X
substrate	B-X
,	B-X
resulting	B-X
in	B-X
ubiquitination	B-X
of	B-X
the	B-X
latter	B-X
.	B-X
Our	B-X
study	B-X
points	B-X
to	B-X
a	B-X
novel	B-X
regulatory	B-X
mechanism	B-X
,	B-X
which	B-X
secures	B-X
the	B-X
localization	B-X
,	B-X
stability	B-X
,	B-X
substrate	B-X
binding	B-X
threshold	B-X
,	B-X
and	B-X
efficacy	B-X
of	B-X
a	B-X
specific	B-X
protein-ubiquitin	B-X
ligase	B-X
.	B-X

This	O
protein	O
occupies	O
E3RS	B-Gene_or_gene_product
in	O
a	O
specific	O
and	O
stoichiometric	O
manner	O
,	O
stabilizes	O
the	O
E3	O
component	O
,	O
and	O
is	O
likely	O
responsible	O
for	O
its	O
nuclear	O
localization	O
.	O

hnRNP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
U	I-Gene_or_gene_product
binding	O
was	O
abolished	O
by	O
competition	O
with	O
a	O
pIkappaB	B-Gene_or_gene_product
(	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
)	I-Gene_or_gene_product
peptide	O
,	O
or	O
by	O
a	O
specific	O
point	O
mutation	O
in	O
the	O
E3RS	B-Gene_or_gene_product
WD	O
region	O
,	O
indicating	O
an	O
E3	O
-	O
substrate	O
-	O
type	O
interaction	O
.	O
<EOS>	B-X
beta-TrCP/E3RS	B-X
(	B-X
E3RS	B-X
)	B-X
is	B-X
the	B-X
F-box	B-X
protein	B-X
that	B-X
functions	B-X
as	B-X
the	B-X
receptor	B-X
subunit	B-X
of	B-X
the	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
(	B-X
E3	B-X
)	B-X
.	B-X
Surprisingly	B-X
,	B-X
although	B-X
its	B-X
two	B-X
recognized	B-X
substrates	B-X
,	B-X
IkappaB	B-X
(	B-X
alpha	B-X
)	B-X
and	B-X
beta-catenin	B-X
,	B-X
are	B-X
present	B-X
in	B-X
the	B-X
cytoplasm	B-X
,	B-X
we	B-X
have	B-X
found	B-X
that	B-X
E3RS	B-X
is	B-X
located	B-X
predominantly	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
isolation	B-X
of	B-X
the	B-X
major	B-X
E3RS-associated	B-X
protein	B-X
,	B-X
hnRNP-U	B-X
,	B-X
an	B-X
abundant	B-X
nuclear	B-X
phosphoprotein	B-X
.	B-X
This	B-X
protein	B-X
occupies	B-X
E3RS	B-X
in	B-X
a	B-X
specific	B-X
and	B-X
stoichiometric	B-X
manner	B-X
,	B-X
stabilizes	B-X
the	B-X
E3	B-X
component	B-X
,	B-X
and	B-X
is	B-X
likely	B-X
responsible	B-X
for	B-X
its	B-X
nuclear	B-X
localization	B-X
.	B-X
hnRNP-U	B-X
binding	B-X
was	B-X
abolished	B-X
by	B-X
competition	B-X
with	B-X
a	B-X
pIkappaB	B-X
(	B-X
alpha	B-X
)	B-X
peptide	B-X
,	B-X
or	B-X
by	B-X
a	B-X
specific	B-X
point	B-X
mutation	B-X
in	B-X
the	B-X
E3RS	B-X
WD	B-X
region	B-X
,	B-X
indicating	B-X
an	B-X
E3-substrate-type	B-X
interaction	B-X
.	B-X
However	B-X
,	B-X
unlike	B-X
pI	B-X
(	B-X
kappa	B-X
)	B-X
Balpha	B-X
,	B-X
which	B-X
is	B-X
targeted	B-X
by	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
for	B-X
degradation	B-X
,	B-X
the	B-X
E3-bound	B-X
hnRNP-U	B-X
is	B-X
stable	B-X
and	B-X
is	B-X
,	B-X
therefore	B-X
,	B-X
a	B-X
pseudosubstrate	B-X
.	B-X
Consequently	B-X
,	B-X
hnRNP-U	B-X
engages	B-X
a	B-X
highly	B-X
neddylated	B-X
active	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
,	B-X
which	B-X
dissociates	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
high-affinity	B-X
substrate	B-X
,	B-X
resulting	B-X
in	B-X
ubiquitination	B-X
of	B-X
the	B-X
latter	B-X
.	B-X
Our	B-X
study	B-X
points	B-X
to	B-X
a	B-X
novel	B-X
regulatory	B-X
mechanism	B-X
,	B-X
which	B-X
secures	B-X
the	B-X
localization	B-X
,	B-X
stability	B-X
,	B-X
substrate	B-X
binding	B-X
threshold	B-X
,	B-X
and	B-X
efficacy	B-X
of	B-X
a	B-X
specific	B-X
protein-ubiquitin	B-X
ligase	B-X
.	B-X

However	O
,	O
unlike	O
pI	B-Gene_or_gene_product
(	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
)	I-Gene_or_gene_product
Balpha	I-Gene_or_gene_product
,	O
which	O
is	O
targeted	O
by	O
SCF	O
(	O
beta	O
-	O
TrCP	O
)	O
for	O
degradation	O
,	O
the	O
E3	O
-	O
bound	O
hnRNP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
U	I-Gene_or_gene_product
is	O
stable	O
and	O
is	O
,	O
therefore	O
,	O
a	O
pseudosubstrate	O
.	O
<EOS>	B-X
beta-TrCP/E3RS	B-X
(	B-X
E3RS	B-X
)	B-X
is	B-X
the	B-X
F-box	B-X
protein	B-X
that	B-X
functions	B-X
as	B-X
the	B-X
receptor	B-X
subunit	B-X
of	B-X
the	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
(	B-X
E3	B-X
)	B-X
.	B-X
Surprisingly	B-X
,	B-X
although	B-X
its	B-X
two	B-X
recognized	B-X
substrates	B-X
,	B-X
IkappaB	B-X
(	B-X
alpha	B-X
)	B-X
and	B-X
beta-catenin	B-X
,	B-X
are	B-X
present	B-X
in	B-X
the	B-X
cytoplasm	B-X
,	B-X
we	B-X
have	B-X
found	B-X
that	B-X
E3RS	B-X
is	B-X
located	B-X
predominantly	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
isolation	B-X
of	B-X
the	B-X
major	B-X
E3RS-associated	B-X
protein	B-X
,	B-X
hnRNP-U	B-X
,	B-X
an	B-X
abundant	B-X
nuclear	B-X
phosphoprotein	B-X
.	B-X
This	B-X
protein	B-X
occupies	B-X
E3RS	B-X
in	B-X
a	B-X
specific	B-X
and	B-X
stoichiometric	B-X
manner	B-X
,	B-X
stabilizes	B-X
the	B-X
E3	B-X
component	B-X
,	B-X
and	B-X
is	B-X
likely	B-X
responsible	B-X
for	B-X
its	B-X
nuclear	B-X
localization	B-X
.	B-X
hnRNP-U	B-X
binding	B-X
was	B-X
abolished	B-X
by	B-X
competition	B-X
with	B-X
a	B-X
pIkappaB	B-X
(	B-X
alpha	B-X
)	B-X
peptide	B-X
,	B-X
or	B-X
by	B-X
a	B-X
specific	B-X
point	B-X
mutation	B-X
in	B-X
the	B-X
E3RS	B-X
WD	B-X
region	B-X
,	B-X
indicating	B-X
an	B-X
E3-substrate-type	B-X
interaction	B-X
.	B-X
However	B-X
,	B-X
unlike	B-X
pI	B-X
(	B-X
kappa	B-X
)	B-X
Balpha	B-X
,	B-X
which	B-X
is	B-X
targeted	B-X
by	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
for	B-X
degradation	B-X
,	B-X
the	B-X
E3-bound	B-X
hnRNP-U	B-X
is	B-X
stable	B-X
and	B-X
is	B-X
,	B-X
therefore	B-X
,	B-X
a	B-X
pseudosubstrate	B-X
.	B-X
Consequently	B-X
,	B-X
hnRNP-U	B-X
engages	B-X
a	B-X
highly	B-X
neddylated	B-X
active	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
,	B-X
which	B-X
dissociates	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
high-affinity	B-X
substrate	B-X
,	B-X
resulting	B-X
in	B-X
ubiquitination	B-X
of	B-X
the	B-X
latter	B-X
.	B-X

Consequently	O
,	O
hnRNP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
U	I-Gene_or_gene_product
engages	O
a	O
highly	O
neddylated	O
active	O
SCF	O
(	O
beta	O
-	O
TrCP	O
)	O
,	O
which	O
dissociates	O
in	O
the	O
presence	O
of	O
a	O
high	O
-	O
affinity	O
substrate	O
,	O
resulting	O
in	O
ubiquitination	O
of	O
the	O
latter	O
.	O
<EOS>	B-X
beta-TrCP/E3RS	B-X
(	B-X
E3RS	B-X
)	B-X
is	B-X
the	B-X
F-box	B-X
protein	B-X
that	B-X
functions	B-X
as	B-X
the	B-X
receptor	B-X
subunit	B-X
of	B-X
the	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
(	B-X
E3	B-X
)	B-X
.	B-X
Surprisingly	B-X
,	B-X
although	B-X
its	B-X
two	B-X
recognized	B-X
substrates	B-X
,	B-X
IkappaB	B-X
(	B-X
alpha	B-X
)	B-X
and	B-X
beta-catenin	B-X
,	B-X
are	B-X
present	B-X
in	B-X
the	B-X
cytoplasm	B-X
,	B-X
we	B-X
have	B-X
found	B-X
that	B-X
E3RS	B-X
is	B-X
located	B-X
predominantly	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
isolation	B-X
of	B-X
the	B-X
major	B-X
E3RS-associated	B-X
protein	B-X
,	B-X
hnRNP-U	B-X
,	B-X
an	B-X
abundant	B-X
nuclear	B-X
phosphoprotein	B-X
.	B-X
hnRNP-U	B-X
binding	B-X
was	B-X
abolished	B-X
by	B-X
competition	B-X
with	B-X
a	B-X
pIkappaB	B-X
(	B-X
alpha	B-X
)	B-X
peptide	B-X
,	B-X
or	B-X
by	B-X
a	B-X
specific	B-X
point	B-X
mutation	B-X
in	B-X
the	B-X
E3RS	B-X
WD	B-X
region	B-X
,	B-X
indicating	B-X
an	B-X
E3-substrate-type	B-X
interaction	B-X
.	B-X
However	B-X
,	B-X
unlike	B-X
pI	B-X
(	B-X
kappa	B-X
)	B-X
Balpha	B-X
,	B-X
which	B-X
is	B-X
targeted	B-X
by	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
for	B-X
degradation	B-X
,	B-X
the	B-X
E3-bound	B-X
hnRNP-U	B-X
is	B-X
stable	B-X
and	B-X
is	B-X
,	B-X
therefore	B-X
,	B-X
a	B-X
pseudosubstrate	B-X
.	B-X
Consequently	B-X
,	B-X
hnRNP-U	B-X
engages	B-X
a	B-X
highly	B-X
neddylated	B-X
active	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
,	B-X
which	B-X
dissociates	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
high-affinity	B-X
substrate	B-X
,	B-X
resulting	B-X
in	B-X
ubiquitination	B-X
of	B-X
the	B-X
latter	B-X
.	B-X
Our	B-X
study	B-X
points	B-X
to	B-X
a	B-X
novel	B-X
regulatory	B-X
mechanism	B-X
,	B-X
which	B-X
secures	B-X
the	B-X
localization	B-X
,	B-X
stability	B-X
,	B-X
substrate	B-X
binding	B-X
threshold	B-X
,	B-X
and	B-X
efficacy	B-X
of	B-X
a	B-X
specific	B-X
protein-ubiquitin	B-X
ligase	B-X
.	B-X

Our	O
study	O
points	O
to	O
a	O
novel	O
regulatory	O
mechanism	O
,	O
which	O
secures	O
the	O
localization	O
,	O
stability	O
,	O
substrate	O
binding	O
threshold	O
,	O
and	O
efficacy	O
of	O
a	O
specific	O
protein	O
-	O
ubiquitin	B-Gene_or_gene_product
ligase	O
.	O
<EOS>	B-X
beta-TrCP/E3RS	B-X
(	B-X
E3RS	B-X
)	B-X
is	B-X
the	B-X
F-box	B-X
protein	B-X
that	B-X
functions	B-X
as	B-X
the	B-X
receptor	B-X
subunit	B-X
of	B-X
the	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
(	B-X
E3	B-X
)	B-X
.	B-X
Surprisingly	B-X
,	B-X
although	B-X
its	B-X
two	B-X
recognized	B-X
substrates	B-X
,	B-X
IkappaB	B-X
(	B-X
alpha	B-X
)	B-X
and	B-X
beta-catenin	B-X
,	B-X
are	B-X
present	B-X
in	B-X
the	B-X
cytoplasm	B-X
,	B-X
we	B-X
have	B-X
found	B-X
that	B-X
E3RS	B-X
is	B-X
located	B-X
predominantly	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
isolation	B-X
of	B-X
the	B-X
major	B-X
E3RS-associated	B-X
protein	B-X
,	B-X
hnRNP-U	B-X
,	B-X
an	B-X
abundant	B-X
nuclear	B-X
phosphoprotein	B-X
.	B-X
This	B-X
protein	B-X
occupies	B-X
E3RS	B-X
in	B-X
a	B-X
specific	B-X
and	B-X
stoichiometric	B-X
manner	B-X
,	B-X
stabilizes	B-X
the	B-X
E3	B-X
component	B-X
,	B-X
and	B-X
is	B-X
likely	B-X
responsible	B-X
for	B-X
its	B-X
nuclear	B-X
localization	B-X
.	B-X
hnRNP-U	B-X
binding	B-X
was	B-X
abolished	B-X
by	B-X
competition	B-X
with	B-X
a	B-X
pIkappaB	B-X
(	B-X
alpha	B-X
)	B-X
peptide	B-X
,	B-X
or	B-X
by	B-X
a	B-X
specific	B-X
point	B-X
mutation	B-X
in	B-X
the	B-X
E3RS	B-X
WD	B-X
region	B-X
,	B-X
indicating	B-X
an	B-X
E3-substrate-type	B-X
interaction	B-X
.	B-X
However	B-X
,	B-X
unlike	B-X
pI	B-X
(	B-X
kappa	B-X
)	B-X
Balpha	B-X
,	B-X
which	B-X
is	B-X
targeted	B-X
by	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
for	B-X
degradation	B-X
,	B-X
the	B-X
E3-bound	B-X
hnRNP-U	B-X
is	B-X
stable	B-X
and	B-X
is	B-X
,	B-X
therefore	B-X
,	B-X
a	B-X
pseudosubstrate	B-X
.	B-X
Consequently	B-X
,	B-X
hnRNP-U	B-X
engages	B-X
a	B-X
highly	B-X
neddylated	B-X
active	B-X
SCF	B-X
(	B-X
beta-TrCP	B-X
)	B-X
,	B-X
which	B-X
dissociates	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
high-affinity	B-X
substrate	B-X
,	B-X
resulting	B-X
in	B-X
ubiquitination	B-X
of	B-X
the	B-X
latter	B-X
.	B-X
Our	B-X
study	B-X
points	B-X
to	B-X
a	B-X
novel	B-X
regulatory	B-X
mechanism	B-X
,	B-X
which	B-X
secures	B-X
the	B-X
localization	B-X
,	B-X
stability	B-X
,	B-X
substrate	B-X
binding	B-X
threshold	B-X
,	B-X
and	B-X
efficacy	B-X
of	B-X
a	B-X
specific	B-X
protein-ubiquitin	B-X
ligase	B-X
.	B-X

Chromatin	O
-	O
IgG	O
complexes	O
activate	O
B	O
cells	O
by	O
dual	O
engagement	O
of	O
IgM	B-Gene_or_gene_product
and	O
Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
.	O
<EOS>	B-X
Autoreactive	B-X
B	B-X
cells	B-X
are	B-X
present	B-X
in	B-X
the	B-X
lymphoid	B-X
tissues	B-X
of	B-X
healthy	B-X
individuals	B-X
,	B-X
but	B-X
typically	B-X
remain	B-X
quiescent	B-X
.	B-X
B	B-X
cells	B-X
expressing	B-X
an	B-X
antigen	B-X
receptor	B-X
specific	B-X
for	B-X
self-immunoglobulin-gamma	B-X
(	B-X
IgG	B-X
)	B-X
make	B-X
a	B-X
class	B-X
of	B-X
autoantibodies	B-X
known	B-X
as	B-X
rheumatoid	B-X
factor	B-X
(	B-X
RF	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
effective	B-X
activation	B-X
of	B-X
RF+	B-X
B	B-X
cells	B-X
is	B-X
mediated	B-X
by	B-X
IgG2a-chromatin	B-X
immune	B-X
complexes	B-X
and	B-X
requires	B-X
the	B-X
synergistic	B-X
engagement	B-X
of	B-X
the	B-X
antigen	B-X
receptor	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
MyD88-dependent	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
family	B-X
.	B-X
The	B-X
unique	B-X
features	B-X
of	B-X
this	B-X
dual-engagement	B-X
pathway	B-X
should	B-X
facilitate	B-X
the	B-X
development	B-X
of	B-X
therapies	B-X
that	B-X
specifically	B-X
target	B-X
autoreactive	B-X
B	B-X
cells	B-X
.	B-X

Autoreactive	O
B	O
cells	O
are	O
present	O
in	O
the	O
lymphoid	O
tissues	O
of	O
healthy	O
individuals	O
,	O
but	O
typically	O
remain	O
quiescent	O
.	O
<EOS>	B-X
Autoreactive	B-X
B	B-X
cells	B-X
are	B-X
present	B-X
in	B-X
the	B-X
lymphoid	B-X
tissues	B-X
of	B-X
healthy	B-X
individuals	B-X
,	B-X
but	B-X
typically	B-X
remain	B-X
quiescent	B-X
.	B-X
B	B-X
cells	B-X
expressing	B-X
an	B-X
antigen	B-X
receptor	B-X
specific	B-X
for	B-X
self-immunoglobulin-gamma	B-X
(	B-X
IgG	B-X
)	B-X
make	B-X
a	B-X
class	B-X
of	B-X
autoantibodies	B-X
known	B-X
as	B-X
rheumatoid	B-X
factor	B-X
(	B-X
RF	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
effective	B-X
activation	B-X
of	B-X
RF+	B-X
B	B-X
cells	B-X
is	B-X
mediated	B-X
by	B-X
IgG2a-chromatin	B-X
immune	B-X
complexes	B-X
and	B-X
requires	B-X
the	B-X
synergistic	B-X
engagement	B-X
of	B-X
the	B-X
antigen	B-X
receptor	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
MyD88-dependent	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
family	B-X
.	B-X
The	B-X
unique	B-X
features	B-X
of	B-X
this	B-X
dual-engagement	B-X
pathway	B-X
should	B-X
facilitate	B-X
the	B-X
development	B-X
of	B-X
therapies	B-X
that	B-X
specifically	B-X
target	B-X
autoreactive	B-X
B	B-X
cells	B-X
.	B-X

When	O
this	O
homeostasis	O
is	O
perturbed	O
,	O
the	O
formation	O
of	O
self	O
-	O
reactive	O
antibodies	O
can	O
have	O
serious	O
pathological	O
consequences	O
.	O
<EOS>	B-X
Autoreactive	B-X
B	B-X
cells	B-X
are	B-X
present	B-X
in	B-X
the	B-X
lymphoid	B-X
tissues	B-X
of	B-X
healthy	B-X
individuals	B-X
,	B-X
but	B-X
typically	B-X
remain	B-X
quiescent	B-X
.	B-X
When	B-X
this	B-X
homeostasis	B-X
is	B-X
perturbed	B-X
,	B-X
the	B-X
formation	B-X
of	B-X
self-reactive	B-X
antibodies	B-X
can	B-X
have	B-X
serious	B-X
pathological	B-X
consequences	B-X
.	B-X
B	B-X
cells	B-X
expressing	B-X
an	B-X
antigen	B-X
receptor	B-X
specific	B-X
for	B-X
self-immunoglobulin-gamma	B-X
(	B-X
IgG	B-X
)	B-X
make	B-X
a	B-X
class	B-X
of	B-X
autoantibodies	B-X
known	B-X
as	B-X
rheumatoid	B-X
factor	B-X
(	B-X
RF	B-X
)	B-X
.	B-X
These	B-X
data	B-X
establish	B-X
a	B-X
critical	B-X
link	B-X
between	B-X
the	B-X
innate	B-X
and	B-X
adaptive	B-X
immune	B-X
systems	B-X
in	B-X
the	B-X
development	B-X
of	B-X
systemic	B-X
autoimmune	B-X
disease	B-X
and	B-X
explain	B-X
the	B-X
preponderance	B-X
of	B-X
autoantibodies	B-X
reactive	B-X
with	B-X
nucleic	B-X
acid-protein	B-X
particles	B-X
.	B-X
The	B-X
unique	B-X
features	B-X
of	B-X
this	B-X
dual-engagement	B-X
pathway	B-X
should	B-X
facilitate	B-X
the	B-X
development	B-X
of	B-X
therapies	B-X
that	B-X
specifically	B-X
target	B-X
autoreactive	B-X
B	B-X
cells	B-X
.	B-X

B	O
cells	O
expressing	O
an	O
antigen	O
receptor	O
specific	O
for	O
self	O
-	O
immunoglobulin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
gamma	I-Gene_or_gene_product
(	O
IgG	B-Gene_or_gene_product
)	O
make	O
a	O
class	O
of	O
autoantibodies	O
known	O
as	O
rheumatoid	B-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
RF	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
Autoreactive	B-X
B	B-X
cells	B-X
are	B-X
present	B-X
in	B-X
the	B-X
lymphoid	B-X
tissues	B-X
of	B-X
healthy	B-X
individuals	B-X
,	B-X
but	B-X
typically	B-X
remain	B-X
quiescent	B-X
.	B-X
When	B-X
this	B-X
homeostasis	B-X
is	B-X
perturbed	B-X
,	B-X
the	B-X
formation	B-X
of	B-X
self-reactive	B-X
antibodies	B-X
can	B-X
have	B-X
serious	B-X
pathological	B-X
consequences	B-X
.	B-X
B	B-X
cells	B-X
expressing	B-X
an	B-X
antigen	B-X
receptor	B-X
specific	B-X
for	B-X
self-immunoglobulin-gamma	B-X
(	B-X
IgG	B-X
)	B-X
make	B-X
a	B-X
class	B-X
of	B-X
autoantibodies	B-X
known	B-X
as	B-X
rheumatoid	B-X
factor	B-X
(	B-X
RF	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
effective	B-X
activation	B-X
of	B-X
RF+	B-X
B	B-X
cells	B-X
is	B-X
mediated	B-X
by	B-X
IgG2a-chromatin	B-X
immune	B-X
complexes	B-X
and	B-X
requires	B-X
the	B-X
synergistic	B-X
engagement	B-X
of	B-X
the	B-X
antigen	B-X
receptor	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
MyD88-dependent	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
family	B-X
.	B-X
These	B-X
data	B-X
establish	B-X
a	B-X
critical	B-X
link	B-X
between	B-X
the	B-X
innate	B-X
and	B-X
adaptive	B-X
immune	B-X
systems	B-X
in	B-X
the	B-X
development	B-X
of	B-X
systemic	B-X
autoimmune	B-X
disease	B-X
and	B-X
explain	B-X
the	B-X
preponderance	B-X
of	B-X
autoantibodies	B-X
reactive	B-X
with	B-X
nucleic	B-X
acid-protein	B-X
particles	B-X
.	B-X
The	B-X
unique	B-X
features	B-X
of	B-X
this	B-X
dual-engagement	B-X
pathway	B-X
should	B-X
facilitate	B-X
the	B-X
development	B-X
of	B-X
therapies	B-X
that	B-X
specifically	B-X
target	B-X
autoreactive	B-X
B	B-X
cells	B-X
.	B-X

Here	O
we	O
show	O
that	O
effective	O
activation	O
of	O
RF	B-Gene_or_gene_product
+	O
B	O
cells	O
is	O
mediated	O
by	O
IgG2a	B-Gene_or_gene_product
-	O
chromatin	O
immune	O
complexes	O
and	O
requires	O
the	O
synergistic	O
engagement	O
of	O
the	O
antigen	O
receptor	O
and	O
a	O
member	O
of	O
the	O
MyD88	B-Gene_or_gene_product
-	O
dependent	O
Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	O
TLR	B-Gene_or_gene_product
)	O
family	O
.	O

Inhibitor	O
studies	O
implicate	O
TLR9	B-Gene_or_gene_product
.	O
<EOS>	B-X
Electronic	B-X
cigarette	B-X
(	B-X
e-cig	B-X
)	B-X
use	B-X
has	B-X
recently	B-X
been	B-X
implicated	B-X
in	B-X
promoting	B-X
atherosclerosis	B-X
.	B-X
To	B-X
study	B-X
the	B-X
potential	B-X
mechanism	B-X
of	B-X
the	B-X
SGLT2	B-X
inhibition	B-X
in	B-X
heart	B-X
failure	B-X
,	B-X
we	B-X
used	B-X
the	B-X
murine	B-X
doxorubicin-induced	B-X
cardiomyopathy	B-X
model	B-X
and	B-X
identified	B-X
the	B-X
toll-like	B-X
receptor	B-X
9	B-X
(	B-X
TLR9	B-X
)	B-X
,	B-X
NAD-dependent	B-X
deacetylase	B-X
sirtuin-3	B-X
(	B-X
SIRT3	B-X
)	B-X
,	B-X
and	B-X
Beclin	B-X
1	B-X
,	B-X
acting	B-X
in	B-X
a	B-X
complex	B-X
together	B-X
in	B-X
response	B-X
to	B-X
empagliflozin	B-X
treatment	B-X
.	B-X
A	B-X
number	B-X
of	B-X
recent	B-X
studies	B-X
have	B-X
shown	B-X
a	B-X
type	B-X
I	B-X
interferon	B-X
gene	B-X
expression	B-X
induction	B-X
in	B-X
patients	B-X
with	B-X
primary	B-X
antiphospholipid	B-X
syndrome	B-X
via	B-X
the	B-X
plasmacytoid	B-X
dendritic	B-X
cell	B-X
pathway	B-X
,	B-X
toll	B-X
like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
such	B-X
as	B-X
TLR7	B-X
and	B-X
TLR9	B-X
,	B-X
anti-beta2glycoprotein	B-X
I	B-X
antibody-mediated	B-X
neutrophil	B-X
activation	B-X
and	B-X
neutrophil	B-X
extracellular	B-X
traps	B-X
(	B-X
NETs	B-X
)	B-X
release	B-X
in	B-X
a	B-X
TLR4-dependent	B-X
fashion	B-X
,	B-X
and	B-X
a	B-X
subsequent	B-X
B	B-X
cell	B-X
and	B-X
plasmablast	B-X
activation	B-X
.	B-X
Correlation	B-X
of	B-X
high	B-X
interferon	B-X
scores	B-X
to	B-X
worse	B-X
outcomes	B-X
in	B-X
prospective	B-X
studies	B-X
could	B-X
direct	B-X
the	B-X
initiation	B-X
for	B-X
a	B-X
prompt	B-X
treatment	B-X
in	B-X
high-risk	B-X
populations	B-X
.	B-X
Potential	B-X
therapeutic	B-X
approaches	B-X
targeting	B-X
type	B-X
I	B-X
interferon	B-X
production	B-X
and	B-X
signaling	B-X
pathway	B-X
components	B-X
might	B-X
include	B-X
anti-interferon	B-X
or	B-X
interferon	B-X
receptor	B-X
monoclonal	B-X
antibodies	B-X
,	B-X
or	B-X
an	B-X
interferon	B-X
based	B-X
therapeutic	B-X
vaccine	B-X
as	B-X
was	B-X
indicated	B-X
from	B-X
previous	B-X
systemic	B-X
lupus	B-X
erythematosus	B-X
studies	B-X
,	B-X
TLR	B-X
inhibitors	B-X
including	B-X
hydroxychloroquine	B-X
and	B-X
anti-TLR	B-X
antibodies	B-X
,	B-X
plasmacytoid	B-X
dendritic	B-X
cell	B-X
inhibition	B-X
,	B-X
adenosine-receptor	B-X
agonists	B-X
,	B-X
and	B-X
plasmablast	B-X
targeting	B-X
treatments	B-X
.	B-X
Well-designed	B-X
studies	B-X
are	B-X
needed	B-X
to	B-X
further	B-X
assess	B-X
the	B-X
immunomodulatory	B-X
potential	B-X
of	B-X
the	B-X
above	B-X
targets	B-X
for	B-X
therapeutic	B-X
intervention	B-X
in	B-X
patients	B-X
with	B-X
primary	B-X
antiphospholipid	B-X
syndrome	B-X
.	B-X

These	O
data	O
establish	O
a	O
critical	O
link	O
between	O
the	O
innate	O
and	O
adaptive	O
immune	O
systems	O
in	O
the	O
development	O
of	O
systemic	O
autoimmune	O
disease	O
and	O
explain	O
the	O
preponderance	O
of	O
autoantibodies	O
reactive	O
with	O
nucleic	O
acid	O
-	O
protein	O
particles	O
.	O
<EOS>	B-X
Autoreactive	B-X
B	B-X
cells	B-X
are	B-X
present	B-X
in	B-X
the	B-X
lymphoid	B-X
tissues	B-X
of	B-X
healthy	B-X
individuals	B-X
,	B-X
but	B-X
typically	B-X
remain	B-X
quiescent	B-X
.	B-X
When	B-X
this	B-X
homeostasis	B-X
is	B-X
perturbed	B-X
,	B-X
the	B-X
formation	B-X
of	B-X
self-reactive	B-X
antibodies	B-X
can	B-X
have	B-X
serious	B-X
pathological	B-X
consequences	B-X
.	B-X
B	B-X
cells	B-X
expressing	B-X
an	B-X
antigen	B-X
receptor	B-X
specific	B-X
for	B-X
self-immunoglobulin-gamma	B-X
(	B-X
IgG	B-X
)	B-X
make	B-X
a	B-X
class	B-X
of	B-X
autoantibodies	B-X
known	B-X
as	B-X
rheumatoid	B-X
factor	B-X
(	B-X
RF	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
effective	B-X
activation	B-X
of	B-X
RF+	B-X
B	B-X
cells	B-X
is	B-X
mediated	B-X
by	B-X
IgG2a-chromatin	B-X
immune	B-X
complexes	B-X
and	B-X
requires	B-X
the	B-X
synergistic	B-X
engagement	B-X
of	B-X
the	B-X
antigen	B-X
receptor	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
MyD88-dependent	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
family	B-X
.	B-X
These	B-X
data	B-X
establish	B-X
a	B-X
critical	B-X
link	B-X
between	B-X
the	B-X
innate	B-X
and	B-X
adaptive	B-X
immune	B-X
systems	B-X
in	B-X
the	B-X
development	B-X
of	B-X
systemic	B-X
autoimmune	B-X
disease	B-X
and	B-X
explain	B-X
the	B-X
preponderance	B-X
of	B-X
autoantibodies	B-X
reactive	B-X
with	B-X
nucleic	B-X
acid-protein	B-X
particles	B-X
.	B-X
The	B-X
unique	B-X
features	B-X
of	B-X
this	B-X
dual-engagement	B-X
pathway	B-X
should	B-X
facilitate	B-X
the	B-X
development	B-X
of	B-X
therapies	B-X
that	B-X
specifically	B-X
target	B-X
autoreactive	B-X
B	B-X
cells	B-X
.	B-X

The	O
unique	O
features	O
of	O
this	O
dual	O
-	O
engagement	O
pathway	O
should	O
facilitate	O
the	O
development	O
of	O
therapies	O
that	O
specifically	O
target	O
autoreactive	O
B	O
cells	O
.	O
<EOS>	B-X
Autoreactive	B-X
B	B-X
cells	B-X
are	B-X
present	B-X
in	B-X
the	B-X
lymphoid	B-X
tissues	B-X
of	B-X
healthy	B-X
individuals	B-X
,	B-X
but	B-X
typically	B-X
remain	B-X
quiescent	B-X
.	B-X
B	B-X
cells	B-X
expressing	B-X
an	B-X
antigen	B-X
receptor	B-X
specific	B-X
for	B-X
self-immunoglobulin-gamma	B-X
(	B-X
IgG	B-X
)	B-X
make	B-X
a	B-X
class	B-X
of	B-X
autoantibodies	B-X
known	B-X
as	B-X
rheumatoid	B-X
factor	B-X
(	B-X
RF	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
effective	B-X
activation	B-X
of	B-X
RF+	B-X
B	B-X
cells	B-X
is	B-X
mediated	B-X
by	B-X
IgG2a-chromatin	B-X
immune	B-X
complexes	B-X
and	B-X
requires	B-X
the	B-X
synergistic	B-X
engagement	B-X
of	B-X
the	B-X
antigen	B-X
receptor	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
MyD88-dependent	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
family	B-X
.	B-X
These	B-X
data	B-X
establish	B-X
a	B-X
critical	B-X
link	B-X
between	B-X
the	B-X
innate	B-X
and	B-X
adaptive	B-X
immune	B-X
systems	B-X
in	B-X
the	B-X
development	B-X
of	B-X
systemic	B-X
autoimmune	B-X
disease	B-X
and	B-X
explain	B-X
the	B-X
preponderance	B-X
of	B-X
autoantibodies	B-X
reactive	B-X
with	B-X
nucleic	B-X
acid-protein	B-X
particles	B-X
.	B-X
The	B-X
unique	B-X
features	B-X
of	B-X
this	B-X
dual-engagement	B-X
pathway	B-X
should	B-X
facilitate	B-X
the	B-X
development	B-X
of	B-X
therapies	B-X
that	B-X
specifically	B-X
target	B-X
autoreactive	B-X
B	B-X
cells	B-X
.	B-X

Kremen	B-Gene_or_gene_product
proteins	O
are	O
Dickkopf	B-Gene_or_gene_product
receptors	O
that	O
regulate	O
Wnt	B-Gene_or_gene_product
/	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
signalling	O
.	O
<EOS>	B-X
The	B-X
Wnt	B-X
family	B-X
of	B-X
secreted	B-X
glycoproteins	B-X
mediate	B-X
cell	B-X
cell	B-X
interactions	B-X
during	B-X
cell	B-X
growth	B-X
and	B-X
differentiation	B-X
in	B-X
both	B-X
embryos	B-X
and	B-X
adults	B-X
.	B-X
Canonical	B-X
Wnt	B-X
signalling	B-X
by	B-X
way	B-X
of	B-X
the	B-X
beta-catenin	B-X
pathway	B-X
is	B-X
transduced	B-X
by	B-X
two	B-X
receptor	B-X
families	B-X
.	B-X
Frizzled	B-X
proteins	B-X
and	B-X
lipoprotein-receptor-related	B-X
proteins	B-X
5	B-X
and	B-X
6	B-X
(	B-X
LRP5/6	B-X
)	B-X
bind	B-X
Wnts	B-X
and	B-X
transmit	B-X
their	B-X
signal	B-X
by	B-X
stabilizing	B-X
intracellular	B-X
beta-catenin	B-X
.	B-X
Wnt/beta-catenin	B-X
signalling	B-X
is	B-X
inhibited	B-X
by	B-X
the	B-X
secreted	B-X
protein	B-X
Dickkopf1	B-X
(	B-X
Dkk1	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
a	B-X
multigene	B-X
family	B-X
,	B-X
which	B-X
induces	B-X
head	B-X
formation	B-X
in	B-X
amphibian	B-X
embryos	B-X
.	B-X
Dkk1	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
inhibit	B-X
Wnt	B-X
signalling	B-X
by	B-X
binding	B-X
to	B-X
and	B-X
antagonizing	B-X
LRP5/6	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
the	B-X
transmembrane	B-X
proteins	B-X
Kremen1	B-X
and	B-X
Kremen2	B-X
are	B-X
high-affinity	B-X
Dkk1	B-X
receptors	B-X
that	B-X
functionally	B-X
cooperate	B-X
with	B-X
Dkk1	B-X
to	B-X
block	B-X
Wnt/beta-catenin	B-X
signalling	B-X
.	B-X
Kremen2	B-X
forms	B-X
a	B-X
ternary	B-X
complex	B-X
with	B-X
Dkk1	B-X
and	B-X
LRP6	B-X
,	B-X
and	B-X
induces	B-X
rapid	B-X
endocytosis	B-X
and	B-X
removal	B-X
of	B-X
the	B-X
Wnt	B-X
receptor	B-X
LRP6	B-X
from	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
Kremen1	B-X
and	B-X
Kremen2	B-X
are	B-X
components	B-X
of	B-X
a	B-X
membrane	B-X
complex	B-X
modulating	B-X
canonical	B-X
Wnt	B-X
signalling	B-X
through	B-X
LRP6	B-X
in	B-X
vertebrates	B-X
.	B-X

The	O
Wnt	B-Gene_or_gene_product
family	O
of	O
secreted	O
glycoproteins	O
mediate	O
cell	O
cell	O
interactions	O
during	O
cell	O
growth	O
and	O
differentiation	O
in	O
both	O
embryos	O
and	O
adults	O
.	O
<EOS>	B-X
The	B-X
Wnt	B-X
family	B-X
of	B-X
secreted	B-X
glycoproteins	B-X
mediate	B-X
cell	B-X
cell	B-X
interactions	B-X
during	B-X
cell	B-X
growth	B-X
and	B-X
differentiation	B-X
in	B-X
both	B-X
embryos	B-X
and	B-X
adults	B-X
.	B-X
Canonical	B-X
Wnt	B-X
signalling	B-X
by	B-X
way	B-X
of	B-X
the	B-X
beta-catenin	B-X
pathway	B-X
is	B-X
transduced	B-X
by	B-X
two	B-X
receptor	B-X
families	B-X
.	B-X
Frizzled	B-X
proteins	B-X
and	B-X
lipoprotein-receptor-related	B-X
proteins	B-X
5	B-X
and	B-X
6	B-X
(	B-X
LRP5/6	B-X
)	B-X
bind	B-X
Wnts	B-X
and	B-X
transmit	B-X
their	B-X
signal	B-X
by	B-X
stabilizing	B-X
intracellular	B-X
beta-catenin	B-X
.	B-X
Wnt/beta-catenin	B-X
signalling	B-X
is	B-X
inhibited	B-X
by	B-X
the	B-X
secreted	B-X
protein	B-X
Dickkopf1	B-X
(	B-X
Dkk1	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
a	B-X
multigene	B-X
family	B-X
,	B-X
which	B-X
induces	B-X
head	B-X
formation	B-X
in	B-X
amphibian	B-X
embryos	B-X
.	B-X
Dkk1	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
inhibit	B-X
Wnt	B-X
signalling	B-X
by	B-X
binding	B-X
to	B-X
and	B-X
antagonizing	B-X
LRP5/6	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
the	B-X
transmembrane	B-X
proteins	B-X
Kremen1	B-X
and	B-X
Kremen2	B-X
are	B-X
high-affinity	B-X
Dkk1	B-X
receptors	B-X
that	B-X
functionally	B-X
cooperate	B-X
with	B-X
Dkk1	B-X
to	B-X
block	B-X
Wnt/beta-catenin	B-X
signalling	B-X
.	B-X
Kremen2	B-X
forms	B-X
a	B-X
ternary	B-X
complex	B-X
with	B-X
Dkk1	B-X
and	B-X
LRP6	B-X
,	B-X
and	B-X
induces	B-X
rapid	B-X
endocytosis	B-X
and	B-X
removal	B-X
of	B-X
the	B-X
Wnt	B-X
receptor	B-X
LRP6	B-X
from	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
Kremen1	B-X
and	B-X
Kremen2	B-X
are	B-X
components	B-X
of	B-X
a	B-X
membrane	B-X
complex	B-X
modulating	B-X
canonical	B-X
Wnt	B-X
signalling	B-X
through	B-X
LRP6	B-X
in	B-X
vertebrates	B-X
.	B-X

Canonical	O
Wnt	B-Gene_or_gene_product
signalling	O
by	O
way	O
of	O
the	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
pathway	O
is	O
transduced	O
by	O
two	O
receptor	O
families	O
.	O
<EOS>	B-X
The	B-X
Wnt	B-X
family	B-X
of	B-X
secreted	B-X
glycoproteins	B-X
mediate	B-X
cell	B-X
cell	B-X
interactions	B-X
during	B-X
cell	B-X
growth	B-X
and	B-X
differentiation	B-X
in	B-X
both	B-X
embryos	B-X
and	B-X
adults	B-X
.	B-X
Canonical	B-X
Wnt	B-X
signalling	B-X
by	B-X
way	B-X
of	B-X
the	B-X
beta-catenin	B-X
pathway	B-X
is	B-X
transduced	B-X
by	B-X
two	B-X
receptor	B-X
families	B-X
.	B-X
Frizzled	B-X
proteins	B-X
and	B-X
lipoprotein-receptor-related	B-X
proteins	B-X
5	B-X
and	B-X
6	B-X
(	B-X
LRP5/6	B-X
)	B-X
bind	B-X
Wnts	B-X
and	B-X
transmit	B-X
their	B-X
signal	B-X
by	B-X
stabilizing	B-X
intracellular	B-X
beta-catenin	B-X
.	B-X
Wnt/beta-catenin	B-X
signalling	B-X
is	B-X
inhibited	B-X
by	B-X
the	B-X
secreted	B-X
protein	B-X
Dickkopf1	B-X
(	B-X
Dkk1	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
a	B-X
multigene	B-X
family	B-X
,	B-X
which	B-X
induces	B-X
head	B-X
formation	B-X
in	B-X
amphibian	B-X
embryos	B-X
.	B-X
Dkk1	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
inhibit	B-X
Wnt	B-X
signalling	B-X
by	B-X
binding	B-X
to	B-X
and	B-X
antagonizing	B-X
LRP5/6	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
the	B-X
transmembrane	B-X
proteins	B-X
Kremen1	B-X
and	B-X
Kremen2	B-X
are	B-X
high-affinity	B-X
Dkk1	B-X
receptors	B-X
that	B-X
functionally	B-X
cooperate	B-X
with	B-X
Dkk1	B-X
to	B-X
block	B-X
Wnt/beta-catenin	B-X
signalling	B-X
.	B-X
Kremen2	B-X
forms	B-X
a	B-X
ternary	B-X
complex	B-X
with	B-X
Dkk1	B-X
and	B-X
LRP6	B-X
,	B-X
and	B-X
induces	B-X
rapid	B-X
endocytosis	B-X
and	B-X
removal	B-X
of	B-X
the	B-X
Wnt	B-X
receptor	B-X
LRP6	B-X
from	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
Kremen1	B-X
and	B-X
Kremen2	B-X
are	B-X
components	B-X
of	B-X
a	B-X
membrane	B-X
complex	B-X
modulating	B-X
canonical	B-X
Wnt	B-X
signalling	B-X
through	B-X
LRP6	B-X
in	B-X
vertebrates	B-X
.	B-X

Frizzled	B-Gene_or_gene_product
proteins	O
and	O
lipoprotein	B-Gene_or_gene_product
-	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
related	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
5	I-Gene_or_gene_product
and	O
6	B-Gene_or_gene_product
(	O
LRP5	B-Gene_or_gene_product
/	O
6	B-Gene_or_gene_product
)	O
bind	O
Wnts	B-Gene_or_gene_product
and	O
transmit	O
their	O
signal	O
by	O
stabilizing	O
intracellular	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
Wnt	B-X
family	B-X
of	B-X
secreted	B-X
glycoproteins	B-X
mediate	B-X
cell	B-X
cell	B-X
interactions	B-X
during	B-X
cell	B-X
growth	B-X
and	B-X
differentiation	B-X
in	B-X
both	B-X
embryos	B-X
and	B-X
adults	B-X
.	B-X
Canonical	B-X
Wnt	B-X
signalling	B-X
by	B-X
way	B-X
of	B-X
the	B-X
beta-catenin	B-X
pathway	B-X
is	B-X
transduced	B-X
by	B-X
two	B-X
receptor	B-X
families	B-X
.	B-X
Frizzled	B-X
proteins	B-X
and	B-X
lipoprotein-receptor-related	B-X
proteins	B-X
5	B-X
and	B-X
6	B-X
(	B-X
LRP5/6	B-X
)	B-X
bind	B-X
Wnts	B-X
and	B-X
transmit	B-X
their	B-X
signal	B-X
by	B-X
stabilizing	B-X
intracellular	B-X
beta-catenin	B-X
.	B-X
Wnt/beta-catenin	B-X
signalling	B-X
is	B-X
inhibited	B-X
by	B-X
the	B-X
secreted	B-X
protein	B-X
Dickkopf1	B-X
(	B-X
Dkk1	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
a	B-X
multigene	B-X
family	B-X
,	B-X
which	B-X
induces	B-X
head	B-X
formation	B-X
in	B-X
amphibian	B-X
embryos	B-X
.	B-X
Dkk1	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
inhibit	B-X
Wnt	B-X
signalling	B-X
by	B-X
binding	B-X
to	B-X
and	B-X
antagonizing	B-X
LRP5/6	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
the	B-X
transmembrane	B-X
proteins	B-X
Kremen1	B-X
and	B-X
Kremen2	B-X
are	B-X
high-affinity	B-X
Dkk1	B-X
receptors	B-X
that	B-X
functionally	B-X
cooperate	B-X
with	B-X
Dkk1	B-X
to	B-X
block	B-X
Wnt/beta-catenin	B-X
signalling	B-X
.	B-X
Kremen2	B-X
forms	B-X
a	B-X
ternary	B-X
complex	B-X
with	B-X
Dkk1	B-X
and	B-X
LRP6	B-X
,	B-X
and	B-X
induces	B-X
rapid	B-X
endocytosis	B-X
and	B-X
removal	B-X
of	B-X
the	B-X
Wnt	B-X
receptor	B-X
LRP6	B-X
from	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
Kremen1	B-X
and	B-X
Kremen2	B-X
are	B-X
components	B-X
of	B-X
a	B-X
membrane	B-X
complex	B-X
modulating	B-X
canonical	B-X
Wnt	B-X
signalling	B-X
through	B-X
LRP6	B-X
in	B-X
vertebrates	B-X
.	B-X

Wnt	B-Gene_or_gene_product
/	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
signalling	O
is	O
inhibited	O
by	O
the	O
secreted	O
protein	O
Dickkopf1	B-Gene_or_gene_product
(	O
Dkk1	B-Gene_or_gene_product
)	O
,	O
a	O
member	O
of	O
a	O
multigene	O
family	O
,	O
which	O
induces	O
head	O
formation	O
in	O
amphibian	O
embryos	O
.	O
<EOS>	B-X
Wnt	B-X
glycoproteins	B-X
have	B-X
been	B-X
implicated	B-X
in	B-X
diverse	B-X
processes	B-X
during	B-X
embryonic	B-X
patterning	B-X
in	B-X
metazoa	B-X
.	B-X
They	B-X
signal	B-X
through	B-X
frizzled-type	B-X
seven-transmembrane-domain	B-X
receptors	B-X
to	B-X
stabilize	B-X
beta-catenin	B-X
.	B-X
Wnt	B-X
signalling	B-X
is	B-X
antagonized	B-X
by	B-X
the	B-X
extracellular	B-X
Wnt	B-X
inhibitor	B-X
dickkopf1	B-X
(	B-X
dkk1	B-X
)	B-X
,	B-X
which	B-X
is	B-X
a	B-X
member	B-X
of	B-X
a	B-X
multigene	B-X
family	B-X
.	B-X
dkk1	B-X
was	B-X
initially	B-X
identified	B-X
as	B-X
a	B-X
head	B-X
inducer	B-X
in	B-X
Xenopus	B-X
embryos	B-X
but	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
it	B-X
blocks	B-X
Wnt	B-X
signalling	B-X
is	B-X
unknown	B-X
.	B-X
LDL-receptor-related	B-X
protein	B-X
6	B-X
(	B-X
LRP6	B-X
)	B-X
is	B-X
required	B-X
during	B-X
Wnt/beta-catenin	B-X
signalling	B-X
in	B-X
Drosophila	B-X
,	B-X
Xenopus	B-X
and	B-X
mouse	B-X
,	B-X
possibly	B-X
acting	B-X
as	B-X
a	B-X
co-receptor	B-X
for	B-X
Wnt	B-X
.	B-X
7	B-X
)	B-X
is	B-X
a	B-X
specific	B-X
,	B-X
high-affinity	B-X
receptor	B-X
for	B-X
Dkk1	B-X
and	B-X
Dkk2	B-X
.	B-X
Dkk1	B-X
blocks	B-X
LRP6-mediated	B-X
Wnt/beta-catenin	B-X
signalling	B-X
by	B-X
interacting	B-X
with	B-X
domains	B-X
that	B-X
are	B-X
distinct	B-X
from	B-X
those	B-X
required	B-X
for	B-X
Wnt/Frizzled	B-X
interaction	B-X
.	B-X
dkk1	B-X
and	B-X
LRP6	B-X
interact	B-X
antagonistically	B-X
during	B-X
embryonic	B-X
head	B-X
induction	B-X
in	B-X
Xenopus	B-X
where	B-X
LRP6	B-X
promotes	B-X
the	B-X
posteriorizing	B-X
role	B-X
of	B-X
Wnt/beta-catenin	B-X
signalling	B-X
.	B-X
Thus	B-X
,	B-X
DKKs	B-X
inhibit	B-X
Wnt	B-X
co-receptor	B-X
function	B-X
,	B-X
exemplifying	B-X
the	B-X
modulation	B-X
of	B-X
LRP	B-X
signalling	B-X
by	B-X
antagonists	B-X
.	B-X

Dkk1	B-Gene_or_gene_product
has	O
been	O
shown	O
to	O
inhibit	O
Wnt	B-Gene_or_gene_product
signalling	O
by	O
binding	O
to	O
and	O
antagonizing	O
LRP5	B-Gene_or_gene_product
/	O
6	B-Gene_or_gene_product
.	O
<EOS>	B-X
Low-density	B-X
lipoprotein	B-X
receptor-related	B-X
protein	B-X
5	B-X
(	B-X
LRP5	B-X
)	B-X
,	B-X
a	B-X
Wnt	B-X
coreceptor	B-X
,	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
bone	B-X
metabolism	B-X
as	B-X
loss-of-function	B-X
and	B-X
gain-of-function	B-X
mutations	B-X
in	B-X
LRP5	B-X
result	B-X
in	B-X
the	B-X
autosomal	B-X
recessive	B-X
osteoporosis-pseudoglioma	B-X
syndrome	B-X
and	B-X
autosomal	B-X
dominant	B-X
high-bone	B-X
mass	B-X
(	B-X
HBM	B-X
)	B-X
phenotypes	B-X
,	B-X
respectively	B-X
.	B-X
Prior	B-X
studies	B-X
suggested	B-X
that	B-X
the	B-X
presence	B-X
of	B-X
HBM-associated	B-X
LRP5	B-X
mutations	B-X
results	B-X
in	B-X
decreased	B-X
antagonism	B-X
of	B-X
LRP5-mediated	B-X
Wnt	B-X
signaling	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
six	B-X
different	B-X
HBM-LRP5	B-X
mutations	B-X
and	B-X
confirm	B-X
that	B-X
neither	B-X
Dickkopf1	B-X
(	B-X
DKK1	B-X
)	B-X
nor	B-X
sclerostin	B-X
efficiently	B-X
inhibits	B-X
HBM-LRP5	B-X
signaling	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
when	B-X
coexpressed	B-X
,	B-X
DKK1	B-X
and	B-X
sclerostin	B-X
do	B-X
not	B-X
inhibit	B-X
HBM-LRP5	B-X
mutants	B-X
better	B-X
than	B-X
either	B-X
inhibitor	B-X
by	B-X
itself	B-X
.	B-X
Also	B-X
,	B-X
DKK1	B-X
and	B-X
sclerostin	B-X
do	B-X
not	B-X
simultaneously	B-X
bind	B-X
to	B-X
wild-type	B-X
LRP5	B-X
,	B-X
and	B-X
DKK1	B-X
is	B-X
able	B-X
to	B-X
displace	B-X
sclerostin	B-X
from	B-X
previously	B-X
formed	B-X
sclerostin-LRP5	B-X
complexes	B-X
.	B-X
In	B-X
conclusion	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
DKK1	B-X
and	B-X
sclerostin	B-X
are	B-X
independent	B-X
,	B-X
and	B-X
not	B-X
synergistic	B-X
,	B-X
regulators	B-X
of	B-X
LRP5	B-X
signaling	B-X
and	B-X
that	B-X
the	B-X
function	B-X
of	B-X
each	B-X
is	B-X
impaired	B-X
by	B-X
HBM-LRP5	B-X
mutations	B-X
.	B-X

Here	O
we	O
show	O
that	O
the	O
transmembrane	O
proteins	O
Kremen1	B-Gene_or_gene_product
and	O
Kremen2	B-Gene_or_gene_product
are	O
high	O
-	O
affinity	O
Dkk1	B-Gene_or_gene_product
receptors	O
that	O
functionally	O
cooperate	O
with	O
Dkk1	B-Gene_or_gene_product
to	O
block	O
Wnt	B-Gene_or_gene_product
/	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
signalling	O
.	O
<EOS>	B-X
The	B-X
Wnt	B-X
family	B-X
of	B-X
secreted	B-X
glycoproteins	B-X
mediate	B-X
cell	B-X
cell	B-X
interactions	B-X
during	B-X
cell	B-X
growth	B-X
and	B-X
differentiation	B-X
in	B-X
both	B-X
embryos	B-X
and	B-X
adults	B-X
.	B-X
Canonical	B-X
Wnt	B-X
signalling	B-X
by	B-X
way	B-X
of	B-X
the	B-X
beta-catenin	B-X
pathway	B-X
is	B-X
transduced	B-X
by	B-X
two	B-X
receptor	B-X
families	B-X
.	B-X
Frizzled	B-X
proteins	B-X
and	B-X
lipoprotein-receptor-related	B-X
proteins	B-X
5	B-X
and	B-X
6	B-X
(	B-X
LRP5/6	B-X
)	B-X
bind	B-X
Wnts	B-X
and	B-X
transmit	B-X
their	B-X
signal	B-X
by	B-X
stabilizing	B-X
intracellular	B-X
beta-catenin	B-X
.	B-X
Wnt/beta-catenin	B-X
signalling	B-X
is	B-X
inhibited	B-X
by	B-X
the	B-X
secreted	B-X
protein	B-X
Dickkopf1	B-X
(	B-X
Dkk1	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
a	B-X
multigene	B-X
family	B-X
,	B-X
which	B-X
induces	B-X
head	B-X
formation	B-X
in	B-X
amphibian	B-X
embryos	B-X
.	B-X
Dkk1	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
inhibit	B-X
Wnt	B-X
signalling	B-X
by	B-X
binding	B-X
to	B-X
and	B-X
antagonizing	B-X
LRP5/6	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
the	B-X
transmembrane	B-X
proteins	B-X
Kremen1	B-X
and	B-X
Kremen2	B-X
are	B-X
high-affinity	B-X
Dkk1	B-X
receptors	B-X
that	B-X
functionally	B-X
cooperate	B-X
with	B-X
Dkk1	B-X
to	B-X
block	B-X
Wnt/beta-catenin	B-X
signalling	B-X
.	B-X
Kremen2	B-X
forms	B-X
a	B-X
ternary	B-X
complex	B-X
with	B-X
Dkk1	B-X
and	B-X
LRP6	B-X
,	B-X
and	B-X
induces	B-X
rapid	B-X
endocytosis	B-X
and	B-X
removal	B-X
of	B-X
the	B-X
Wnt	B-X
receptor	B-X
LRP6	B-X
from	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
Kremen1	B-X
and	B-X
Kremen2	B-X
are	B-X
components	B-X
of	B-X
a	B-X
membrane	B-X
complex	B-X
modulating	B-X
canonical	B-X
Wnt	B-X
signalling	B-X
through	B-X
LRP6	B-X
in	B-X
vertebrates	B-X
.	B-X

Kremen2	B-Gene_or_gene_product
forms	O
a	O
ternary	O
complex	O
with	O
Dkk1	B-Gene_or_gene_product
and	O
LRP6	B-Gene_or_gene_product
,	O
and	O
induces	O
rapid	O
endocytosis	O
and	O
removal	O
of	O
the	O
Wnt	B-Gene_or_gene_product
receptor	O
LRP6	B-Gene_or_gene_product
from	O
the	O
plasma	O
membrane	O
.	O
<EOS>	B-X
The	B-X
Wnt	B-X
family	B-X
of	B-X
secreted	B-X
glycoproteins	B-X
mediate	B-X
cell	B-X
cell	B-X
interactions	B-X
during	B-X
cell	B-X
growth	B-X
and	B-X
differentiation	B-X
in	B-X
both	B-X
embryos	B-X
and	B-X
adults	B-X
.	B-X
Canonical	B-X
Wnt	B-X
signalling	B-X
by	B-X
way	B-X
of	B-X
the	B-X
beta-catenin	B-X
pathway	B-X
is	B-X
transduced	B-X
by	B-X
two	B-X
receptor	B-X
families	B-X
.	B-X
Frizzled	B-X
proteins	B-X
and	B-X
lipoprotein-receptor-related	B-X
proteins	B-X
5	B-X
and	B-X
6	B-X
(	B-X
LRP5/6	B-X
)	B-X
bind	B-X
Wnts	B-X
and	B-X
transmit	B-X
their	B-X
signal	B-X
by	B-X
stabilizing	B-X
intracellular	B-X
beta-catenin	B-X
.	B-X
Wnt/beta-catenin	B-X
signalling	B-X
is	B-X
inhibited	B-X
by	B-X
the	B-X
secreted	B-X
protein	B-X
Dickkopf1	B-X
(	B-X
Dkk1	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
a	B-X
multigene	B-X
family	B-X
,	B-X
which	B-X
induces	B-X
head	B-X
formation	B-X
in	B-X
amphibian	B-X
embryos	B-X
.	B-X
Dkk1	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
inhibit	B-X
Wnt	B-X
signalling	B-X
by	B-X
binding	B-X
to	B-X
and	B-X
antagonizing	B-X
LRP5/6	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
the	B-X
transmembrane	B-X
proteins	B-X
Kremen1	B-X
and	B-X
Kremen2	B-X
are	B-X
high-affinity	B-X
Dkk1	B-X
receptors	B-X
that	B-X
functionally	B-X
cooperate	B-X
with	B-X
Dkk1	B-X
to	B-X
block	B-X
Wnt/beta-catenin	B-X
signalling	B-X
.	B-X
Kremen2	B-X
forms	B-X
a	B-X
ternary	B-X
complex	B-X
with	B-X
Dkk1	B-X
and	B-X
LRP6	B-X
,	B-X
and	B-X
induces	B-X
rapid	B-X
endocytosis	B-X
and	B-X
removal	B-X
of	B-X
the	B-X
Wnt	B-X
receptor	B-X
LRP6	B-X
from	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
Kremen1	B-X
and	B-X
Kremen2	B-X
are	B-X
components	B-X
of	B-X
a	B-X
membrane	B-X
complex	B-X
modulating	B-X
canonical	B-X
Wnt	B-X
signalling	B-X
through	B-X
LRP6	B-X
in	B-X
vertebrates	B-X
.	B-X

The	O
results	O
indicate	O
that	O
Kremen1	B-Gene_or_gene_product
and	O
Kremen2	B-Gene_or_gene_product
are	O
components	O
of	O
a	O
membrane	O
complex	O
modulating	O
canonical	O
Wnt	B-Gene_or_gene_product
signalling	O
through	O
LRP6	B-Gene_or_gene_product
in	O
vertebrates	O
.	O
<EOS>	B-X
The	B-X
Wnt	B-X
family	B-X
of	B-X
secreted	B-X
glycoproteins	B-X
mediate	B-X
cell	B-X
cell	B-X
interactions	B-X
during	B-X
cell	B-X
growth	B-X
and	B-X
differentiation	B-X
in	B-X
both	B-X
embryos	B-X
and	B-X
adults	B-X
.	B-X
Canonical	B-X
Wnt	B-X
signalling	B-X
by	B-X
way	B-X
of	B-X
the	B-X
beta-catenin	B-X
pathway	B-X
is	B-X
transduced	B-X
by	B-X
two	B-X
receptor	B-X
families	B-X
.	B-X
Frizzled	B-X
proteins	B-X
and	B-X
lipoprotein-receptor-related	B-X
proteins	B-X
5	B-X
and	B-X
6	B-X
(	B-X
LRP5/6	B-X
)	B-X
bind	B-X
Wnts	B-X
and	B-X
transmit	B-X
their	B-X
signal	B-X
by	B-X
stabilizing	B-X
intracellular	B-X
beta-catenin	B-X
.	B-X
Wnt/beta-catenin	B-X
signalling	B-X
is	B-X
inhibited	B-X
by	B-X
the	B-X
secreted	B-X
protein	B-X
Dickkopf1	B-X
(	B-X
Dkk1	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
a	B-X
multigene	B-X
family	B-X
,	B-X
which	B-X
induces	B-X
head	B-X
formation	B-X
in	B-X
amphibian	B-X
embryos	B-X
.	B-X
Dkk1	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
inhibit	B-X
Wnt	B-X
signalling	B-X
by	B-X
binding	B-X
to	B-X
and	B-X
antagonizing	B-X
LRP5/6	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
the	B-X
transmembrane	B-X
proteins	B-X
Kremen1	B-X
and	B-X
Kremen2	B-X
are	B-X
high-affinity	B-X
Dkk1	B-X
receptors	B-X
that	B-X
functionally	B-X
cooperate	B-X
with	B-X
Dkk1	B-X
to	B-X
block	B-X
Wnt/beta-catenin	B-X
signalling	B-X
.	B-X
Kremen2	B-X
forms	B-X
a	B-X
ternary	B-X
complex	B-X
with	B-X
Dkk1	B-X
and	B-X
LRP6	B-X
,	B-X
and	B-X
induces	B-X
rapid	B-X
endocytosis	B-X
and	B-X
removal	B-X
of	B-X
the	B-X
Wnt	B-X
receptor	B-X
LRP6	B-X
from	B-X
the	B-X
plasma	B-X
membrane	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
Kremen1	B-X
and	B-X
Kremen2	B-X
are	B-X
components	B-X
of	B-X
a	B-X
membrane	B-X
complex	B-X
modulating	B-X
canonical	B-X
Wnt	B-X
signalling	B-X
through	B-X
LRP6	B-X
in	B-X
vertebrates	B-X
.	B-X

Expression	O
of	O
p73	B-Gene_or_gene_product
and	O
Reelin	B-Gene_or_gene_product
in	O
the	O
developing	O
human	O
cortex	O
.	O
<EOS>	B-X
Cajal-Retzius	B-X
(	B-X
CR	B-X
)	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
secrete	B-X
Reelin	B-X
(	B-X
Reln	B-X
)	B-X
,	B-X
a	B-X
glycoprotein	B-X
involved	B-X
in	B-X
neuronal	B-X
migration	B-X
.	B-X
CR	B-X
cells	B-X
selectively	B-X
express	B-X
p73	B-X
,	B-X
a	B-X
p53	B-X
family	B-X
member	B-X
implicated	B-X
in	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
.	B-X
Immunocytochemistry	B-X
in	B-X
prenatal	B-X
human	B-X
telencephalon	B-X
reveals	B-X
a	B-X
complex	B-X
sequence	B-X
of	B-X
migration	B-X
waves	B-X
of	B-X
p73-	B-X
and	B-X
Reln-immunoreactive	B-X
(	B-X
IR	B-X
)	B-X
neurons	B-X
into	B-X
the	B-X
cortical	B-X
marginal	B-X
zone	B-X
(	B-X
MZ	B-X
)	B-X
.	B-X
At	B-X
early	B-X
preplate	B-X
stages	B-X
,	B-X
p73/Reln-IR	B-X
cells	B-X
arise	B-X
in	B-X
distinct	B-X
sectors	B-X
of	B-X
the	B-X
telencephalon	B-X
,	B-X
including	B-X
cortical	B-X
primordium	B-X
and	B-X
ganglionic	B-X
eminences	B-X
.	B-X
After	B-X
the	B-X
appearance	B-X
of	B-X
the	B-X
cortical	B-X
plate	B-X
,	B-X
further	B-X
p73/Reln-IR	B-X
cells	B-X
originate	B-X
in	B-X
the	B-X
medial	B-X
periolfactory	B-X
forebrain	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
p73	B-X
marks	B-X
a	B-X
novel	B-X
cell	B-X
population	B-X
that	B-X
appears	B-X
at	B-X
the	B-X
choroid-cortical	B-X
junction	B-X
or	B-X
cortical	B-X
hem	B-X
before	B-X
the	B-X
emergence	B-X
of	B-X
the	B-X
dorsal	B-X
hippocampus	B-X
.	B-X
A	B-X
pronounced	B-X
mediolateral	B-X
gradient	B-X
in	B-X
the	B-X
density	B-X
of	B-X
p73/Reln-IR	B-X
neurons	B-X
in	B-X
the	B-X
neocortical	B-X
MZ	B-X
at	B-X
8	B-X
gestational	B-X
weeks	B-X
suggests	B-X
that	B-X
a	B-X
subset	B-X
of	B-X
CR	B-X
cells	B-X
migrate	B-X
tangentially	B-X
from	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
into	B-X
neocortical	B-X
territory	B-X
.	B-X
This	B-X
hypothesis	B-X
is	B-X
supported	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
p73-transcripts	B-X
in	B-X
prospective	B-X
neocortex	B-X
of	B-X
p73-/-mice	B-X
at	B-X
embryonic	B-X
day	B-X
12	B-X
(	B-X
E12	B-X
)	B-X
,	B-X
whereas	B-X
they	B-X
are	B-X
present	B-X
in	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
.	B-X
In	B-X
the	B-X
p73-/-	B-X
preplate	B-X
,	B-X
Reln	B-X
is	B-X
faintly	B-X
expressed	B-X
in	B-X
a	B-X
calretinin-positive	B-X
cell	B-X
population	B-X
,	B-X
not	B-X
present	B-X
in	B-X
this	B-X
form	B-X
in	B-X
the	B-X
E12	B-X
wild-type	B-X
cortex	B-X
.	B-X
At	B-X
P2	B-X
,	B-X
Reln-IR	B-X
CR	B-X
cells	B-X
are	B-X
undetectable	B-X
in	B-X
the	B-X
p73-/-	B-X
cortex	B-X
,	B-X
whereas	B-X
Reln-expression	B-X
in	B-X
interneurons	B-X
is	B-X
unchanged	B-X
.	B-X
Our	B-X
results	B-X
point	B-X
to	B-X
a	B-X
close	B-X
association	B-X
between	B-X
p73	B-X
and	B-X
Reln	B-X
in	B-X
CR	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
,	B-X
with	B-X
a	B-X
partial	B-X
dissociation	B-X
in	B-X
early	B-X
preplate	B-X
and	B-X
basal	B-X
telencephalon	B-X
,	B-X
and	B-X
to	B-X
a	B-X
p73-mediated	B-X
role	B-X
of	B-X
the	B-X
cortical	B-X
hem	B-X
in	B-X
neocortical	B-X
development	B-X
.	B-X

Cajal	O
-	O
Retzius	O
(	O
CR	O
)	O
cells	O
of	O
the	O
developing	O
neocortex	O
secrete	O
Reelin	B-Gene_or_gene_product
(	O
Reln	B-Gene_or_gene_product
)	O
,	O
a	O
glycoprotein	O
involved	O
in	O
neuronal	O
migration	O
.	O
<EOS>	B-X
In	B-X
the	B-X
fetal	B-X
human	B-X
hippocampus	B-X
,	B-X
Cajal-Retzius	B-X
(	B-X
CR	B-X
)	B-X
cells	B-X
coexpress	B-X
p73	B-X
,	B-X
a	B-X
p53-family	B-X
member	B-X
involved	B-X
in	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
,	B-X
and	B-X
the	B-X
glycoprotein	B-X
reelin	B-X
,	B-X
crucial	B-X
for	B-X
radial	B-X
migration	B-X
.	B-X
We	B-X
distinguish	B-X
two	B-X
populations	B-X
of	B-X
putative	B-X
CR	B-X
cells	B-X
.	B-X
p73/reelin	B-X
expressing	B-X
cells	B-X
appear	B-X
around	B-X
10	B-X
gestational	B-X
weeks	B-X
(	B-X
GW	B-X
)	B-X
at	B-X
the	B-X
cortico-choroid	B-X
border	B-X
in	B-X
the	B-X
temporal	B-X
horn	B-X
of	B-X
the	B-X
lateral	B-X
ventricle	B-X
(	B-X
the	B-X
ventral	B-X
cortical	B-X
hem	B-X
)	B-X
and	B-X
occupy	B-X
the	B-X
marginal	B-X
zone	B-X
(	B-X
MZ	B-X
)	B-X
overlying	B-X
the	B-X
ammonic	B-X
and	B-X
dentate	B-X
primordia	B-X
.	B-X
Additional	B-X
p73-positive	B-X
cells	B-X
appear	B-X
from	B-X
14	B-X
GW	B-X
onward	B-X
in	B-X
the	B-X
neuroepithelium	B-X
near	B-X
the	B-X
dentate-fimbrial	B-X
boundary	B-X
and	B-X
spread	B-X
toward	B-X
the	B-X
pial	B-X
surface	B-X
,	B-X
flanking	B-X
the	B-X
migrating	B-X
secondary	B-X
dentate	B-X
matrix	B-X
.	B-X
From	B-X
13	B-X
to	B-X
17	B-X
GW	B-X
,	B-X
large	B-X
parts	B-X
of	B-X
the	B-X
dentate	B-X
gyrus	B-X
are	B-X
almost	B-X
devoid	B-X
of	B-X
CR	B-X
cells	B-X
.	B-X
p73/Reelin-positive	B-X
CR	B-X
cells	B-X
appear	B-X
in	B-X
the	B-X
MZ	B-X
of	B-X
the	B-X
suprapyramidal	B-X
blade	B-X
at	B-X
16	B-X
GW	B-X
and	B-X
around	B-X
21	B-X
GW	B-X
in	B-X
the	B-X
infrapyramidal	B-X
blade	B-X
.	B-X
The	B-X
p73-positive	B-X
cells	B-X
of	B-X
the	B-X
dentate-fimbrial	B-X
boundary	B-X
express	B-X
reelin	B-X
when	B-X
they	B-X
are	B-X
close	B-X
to	B-X
the	B-X
pial	B-X
surface	B-X
,	B-X
suggesting	B-X
that	B-X
they	B-X
differentiate	B-X
into	B-X
CR	B-X
cells	B-X
of	B-X
the	B-X
infrapyramidal	B-X
blade	B-X
.	B-X
Reelin-positive	B-X
,	B-X
p73-negative	B-X
interneurons	B-X
are	B-X
prominent	B-X
in	B-X
the	B-X
prospective	B-X
strata	B-X
lacunosum-moleculare	B-X
and	B-X
radiatum	B-X
of	B-X
cornu	B-X
ammonis	B-X
as	B-X
early	B-X
as	B-X
14	B-X
GW	B-X
;	B-X
in	B-X
the	B-X
dentate	B-X
molecular	B-X
layer	B-X
and	B-X
hilus	B-X
they	B-X
appear	B-X
around	B-X
midgestation	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
CR	B-X
cells	B-X
of	B-X
the	B-X
human	B-X
hippocampal	B-X
formation	B-X
belong	B-X
to	B-X
two	B-X
distinct	B-X
cell	B-X
populations	B-X
:	B-X
an	B-X
early	B-X
one	B-X
derived	B-X
from	B-X
the	B-X
ventral	B-X
cortical	B-X
hem	B-X
and	B-X
mainly	B-X
related	B-X
to	B-X
migration	B-X
of	B-X
the	B-X
ammonic	B-X
and	B-X
dentate	B-X
plates	B-X
and	B-X
a	B-X
later	B-X
appearing	B-X
one	B-X
derived	B-X
from	B-X
the	B-X
dentate-fimbrial	B-X
neuroepithelium	B-X
,	B-X
which	B-X
may	B-X
be	B-X
related	B-X
to	B-X
the	B-X
protracted	B-X
neurogenesis	B-X
and	B-X
migration	B-X
of	B-X
dentate	B-X
granule	B-X
cells	B-X
,	B-X
particularly	B-X
of	B-X
the	B-X
infrapyramidal	B-X
blade	B-X
.	B-X

CR	O
cells	O
selectively	O
express	O
p73	B-Gene_or_gene_product
,	O
a	O
p53	B-Gene_or_gene_product
family	O
member	O
implicated	O
in	O
cell	O
survival	O
and	O
apoptosis	O
.	O
<EOS>	B-X
Cajal-Retzius	B-X
(	B-X
CR	B-X
)	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
secrete	B-X
Reelin	B-X
(	B-X
Reln	B-X
)	B-X
,	B-X
a	B-X
glycoprotein	B-X
involved	B-X
in	B-X
neuronal	B-X
migration	B-X
.	B-X
CR	B-X
cells	B-X
selectively	B-X
express	B-X
p73	B-X
,	B-X
a	B-X
p53	B-X
family	B-X
member	B-X
implicated	B-X
in	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
.	B-X
Immunocytochemistry	B-X
in	B-X
prenatal	B-X
human	B-X
telencephalon	B-X
reveals	B-X
a	B-X
complex	B-X
sequence	B-X
of	B-X
migration	B-X
waves	B-X
of	B-X
p73-	B-X
and	B-X
Reln-immunoreactive	B-X
(	B-X
IR	B-X
)	B-X
neurons	B-X
into	B-X
the	B-X
cortical	B-X
marginal	B-X
zone	B-X
(	B-X
MZ	B-X
)	B-X
.	B-X
At	B-X
early	B-X
preplate	B-X
stages	B-X
,	B-X
p73/Reln-IR	B-X
cells	B-X
arise	B-X
in	B-X
distinct	B-X
sectors	B-X
of	B-X
the	B-X
telencephalon	B-X
,	B-X
including	B-X
cortical	B-X
primordium	B-X
and	B-X
ganglionic	B-X
eminences	B-X
.	B-X
After	B-X
the	B-X
appearance	B-X
of	B-X
the	B-X
cortical	B-X
plate	B-X
,	B-X
further	B-X
p73/Reln-IR	B-X
cells	B-X
originate	B-X
in	B-X
the	B-X
medial	B-X
periolfactory	B-X
forebrain	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
p73	B-X
marks	B-X
a	B-X
novel	B-X
cell	B-X
population	B-X
that	B-X
appears	B-X
at	B-X
the	B-X
choroid-cortical	B-X
junction	B-X
or	B-X
cortical	B-X
hem	B-X
before	B-X
the	B-X
emergence	B-X
of	B-X
the	B-X
dorsal	B-X
hippocampus	B-X
.	B-X
A	B-X
pronounced	B-X
mediolateral	B-X
gradient	B-X
in	B-X
the	B-X
density	B-X
of	B-X
p73/Reln-IR	B-X
neurons	B-X
in	B-X
the	B-X
neocortical	B-X
MZ	B-X
at	B-X
8	B-X
gestational	B-X
weeks	B-X
suggests	B-X
that	B-X
a	B-X
subset	B-X
of	B-X
CR	B-X
cells	B-X
migrate	B-X
tangentially	B-X
from	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
into	B-X
neocortical	B-X
territory	B-X
.	B-X
This	B-X
hypothesis	B-X
is	B-X
supported	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
p73-transcripts	B-X
in	B-X
prospective	B-X
neocortex	B-X
of	B-X
p73-/-mice	B-X
at	B-X
embryonic	B-X
day	B-X
12	B-X
(	B-X
E12	B-X
)	B-X
,	B-X
whereas	B-X
they	B-X
are	B-X
present	B-X
in	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
.	B-X
In	B-X
the	B-X
p73-/-	B-X
preplate	B-X
,	B-X
Reln	B-X
is	B-X
faintly	B-X
expressed	B-X
in	B-X
a	B-X
calretinin-positive	B-X
cell	B-X
population	B-X
,	B-X
not	B-X
present	B-X
in	B-X
this	B-X
form	B-X
in	B-X
the	B-X
E12	B-X
wild-type	B-X
cortex	B-X
.	B-X
At	B-X
P2	B-X
,	B-X
Reln-IR	B-X
CR	B-X
cells	B-X
are	B-X
undetectable	B-X
in	B-X
the	B-X
p73-/-	B-X
cortex	B-X
,	B-X
whereas	B-X
Reln-expression	B-X
in	B-X
interneurons	B-X
is	B-X
unchanged	B-X
.	B-X
Our	B-X
results	B-X
point	B-X
to	B-X
a	B-X
close	B-X
association	B-X
between	B-X
p73	B-X
and	B-X
Reln	B-X
in	B-X
CR	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
,	B-X
with	B-X
a	B-X
partial	B-X
dissociation	B-X
in	B-X
early	B-X
preplate	B-X
and	B-X
basal	B-X
telencephalon	B-X
,	B-X
and	B-X
to	B-X
a	B-X
p73-mediated	B-X
role	B-X
of	B-X
the	B-X
cortical	B-X
hem	B-X
in	B-X
neocortical	B-X
development	B-X
.	B-X

Immunocytochemistry	O
in	O
prenatal	O
human	O
telencephalon	O
reveals	O
a	O
complex	O
sequence	O
of	O
migration	O
waves	O
of	O
p73	B-Gene_or_gene_product
-	O
and	O
Reln	B-Gene_or_gene_product
-	O
immunoreactive	O
(	O
IR	O
)	O
neurons	O
into	O
the	O
cortical	O
marginal	O
zone	O
(	O
MZ	O
)	O
.	O
<EOS>	B-X
Cajal-Retzius	B-X
(	B-X
CR	B-X
)	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
secrete	B-X
Reelin	B-X
(	B-X
Reln	B-X
)	B-X
,	B-X
a	B-X
glycoprotein	B-X
involved	B-X
in	B-X
neuronal	B-X
migration	B-X
.	B-X
CR	B-X
cells	B-X
selectively	B-X
express	B-X
p73	B-X
,	B-X
a	B-X
p53	B-X
family	B-X
member	B-X
implicated	B-X
in	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
.	B-X
Immunocytochemistry	B-X
in	B-X
prenatal	B-X
human	B-X
telencephalon	B-X
reveals	B-X
a	B-X
complex	B-X
sequence	B-X
of	B-X
migration	B-X
waves	B-X
of	B-X
p73-	B-X
and	B-X
Reln-immunoreactive	B-X
(	B-X
IR	B-X
)	B-X
neurons	B-X
into	B-X
the	B-X
cortical	B-X
marginal	B-X
zone	B-X
(	B-X
MZ	B-X
)	B-X
.	B-X
At	B-X
early	B-X
preplate	B-X
stages	B-X
,	B-X
p73/Reln-IR	B-X
cells	B-X
arise	B-X
in	B-X
distinct	B-X
sectors	B-X
of	B-X
the	B-X
telencephalon	B-X
,	B-X
including	B-X
cortical	B-X
primordium	B-X
and	B-X
ganglionic	B-X
eminences	B-X
.	B-X
After	B-X
the	B-X
appearance	B-X
of	B-X
the	B-X
cortical	B-X
plate	B-X
,	B-X
further	B-X
p73/Reln-IR	B-X
cells	B-X
originate	B-X
in	B-X
the	B-X
medial	B-X
periolfactory	B-X
forebrain	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
p73	B-X
marks	B-X
a	B-X
novel	B-X
cell	B-X
population	B-X
that	B-X
appears	B-X
at	B-X
the	B-X
choroid-cortical	B-X
junction	B-X
or	B-X
cortical	B-X
hem	B-X
before	B-X
the	B-X
emergence	B-X
of	B-X
the	B-X
dorsal	B-X
hippocampus	B-X
.	B-X
A	B-X
pronounced	B-X
mediolateral	B-X
gradient	B-X
in	B-X
the	B-X
density	B-X
of	B-X
p73/Reln-IR	B-X
neurons	B-X
in	B-X
the	B-X
neocortical	B-X
MZ	B-X
at	B-X
8	B-X
gestational	B-X
weeks	B-X
suggests	B-X
that	B-X
a	B-X
subset	B-X
of	B-X
CR	B-X
cells	B-X
migrate	B-X
tangentially	B-X
from	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
into	B-X
neocortical	B-X
territory	B-X
.	B-X
This	B-X
hypothesis	B-X
is	B-X
supported	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
p73-transcripts	B-X
in	B-X
prospective	B-X
neocortex	B-X
of	B-X
p73-/-mice	B-X
at	B-X
embryonic	B-X
day	B-X
12	B-X
(	B-X
E12	B-X
)	B-X
,	B-X
whereas	B-X
they	B-X
are	B-X
present	B-X
in	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
.	B-X
In	B-X
the	B-X
p73-/-	B-X
preplate	B-X
,	B-X
Reln	B-X
is	B-X
faintly	B-X
expressed	B-X
in	B-X
a	B-X
calretinin-positive	B-X
cell	B-X
population	B-X
,	B-X
not	B-X
present	B-X
in	B-X
this	B-X
form	B-X
in	B-X
the	B-X
E12	B-X
wild-type	B-X
cortex	B-X
.	B-X
At	B-X
P2	B-X
,	B-X
Reln-IR	B-X
CR	B-X
cells	B-X
are	B-X
undetectable	B-X
in	B-X
the	B-X
p73-/-	B-X
cortex	B-X
,	B-X
whereas	B-X
Reln-expression	B-X
in	B-X
interneurons	B-X
is	B-X
unchanged	B-X
.	B-X
Our	B-X
results	B-X
point	B-X
to	B-X
a	B-X
close	B-X
association	B-X
between	B-X
p73	B-X
and	B-X
Reln	B-X
in	B-X
CR	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
,	B-X
with	B-X
a	B-X
partial	B-X
dissociation	B-X
in	B-X
early	B-X
preplate	B-X
and	B-X
basal	B-X
telencephalon	B-X
,	B-X
and	B-X
to	B-X
a	B-X
p73-mediated	B-X
role	B-X
of	B-X
the	B-X
cortical	B-X
hem	B-X
in	B-X
neocortical	B-X
development	B-X
.	B-X

At	O
early	O
preplate	O
stages	O
,	O
p73	B-Gene_or_gene_product
/	O
Reln	B-Gene_or_gene_product
-	O
IR	O
cells	O
arise	O
in	O
distinct	O
sectors	O
of	O
the	O
telencephalon	O
,	O
including	O
cortical	O
primordium	O
and	O
ganglionic	O
eminences	O
.	O
<EOS>	B-X
Cajal-Retzius	B-X
(	B-X
CR	B-X
)	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
secrete	B-X
Reelin	B-X
(	B-X
Reln	B-X
)	B-X
,	B-X
a	B-X
glycoprotein	B-X
involved	B-X
in	B-X
neuronal	B-X
migration	B-X
.	B-X
CR	B-X
cells	B-X
selectively	B-X
express	B-X
p73	B-X
,	B-X
a	B-X
p53	B-X
family	B-X
member	B-X
implicated	B-X
in	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
.	B-X
Immunocytochemistry	B-X
in	B-X
prenatal	B-X
human	B-X
telencephalon	B-X
reveals	B-X
a	B-X
complex	B-X
sequence	B-X
of	B-X
migration	B-X
waves	B-X
of	B-X
p73-	B-X
and	B-X
Reln-immunoreactive	B-X
(	B-X
IR	B-X
)	B-X
neurons	B-X
into	B-X
the	B-X
cortical	B-X
marginal	B-X
zone	B-X
(	B-X
MZ	B-X
)	B-X
.	B-X
At	B-X
early	B-X
preplate	B-X
stages	B-X
,	B-X
p73/Reln-IR	B-X
cells	B-X
arise	B-X
in	B-X
distinct	B-X
sectors	B-X
of	B-X
the	B-X
telencephalon	B-X
,	B-X
including	B-X
cortical	B-X
primordium	B-X
and	B-X
ganglionic	B-X
eminences	B-X
.	B-X
After	B-X
the	B-X
appearance	B-X
of	B-X
the	B-X
cortical	B-X
plate	B-X
,	B-X
further	B-X
p73/Reln-IR	B-X
cells	B-X
originate	B-X
in	B-X
the	B-X
medial	B-X
periolfactory	B-X
forebrain	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
p73	B-X
marks	B-X
a	B-X
novel	B-X
cell	B-X
population	B-X
that	B-X
appears	B-X
at	B-X
the	B-X
choroid-cortical	B-X
junction	B-X
or	B-X
cortical	B-X
hem	B-X
before	B-X
the	B-X
emergence	B-X
of	B-X
the	B-X
dorsal	B-X
hippocampus	B-X
.	B-X
A	B-X
pronounced	B-X
mediolateral	B-X
gradient	B-X
in	B-X
the	B-X
density	B-X
of	B-X
p73/Reln-IR	B-X
neurons	B-X
in	B-X
the	B-X
neocortical	B-X
MZ	B-X
at	B-X
8	B-X
gestational	B-X
weeks	B-X
suggests	B-X
that	B-X
a	B-X
subset	B-X
of	B-X
CR	B-X
cells	B-X
migrate	B-X
tangentially	B-X
from	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
into	B-X
neocortical	B-X
territory	B-X
.	B-X
This	B-X
hypothesis	B-X
is	B-X
supported	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
p73-transcripts	B-X
in	B-X
prospective	B-X
neocortex	B-X
of	B-X
p73-/-mice	B-X
at	B-X
embryonic	B-X
day	B-X
12	B-X
(	B-X
E12	B-X
)	B-X
,	B-X
whereas	B-X
they	B-X
are	B-X
present	B-X
in	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
.	B-X
In	B-X
the	B-X
p73-/-	B-X
preplate	B-X
,	B-X
Reln	B-X
is	B-X
faintly	B-X
expressed	B-X
in	B-X
a	B-X
calretinin-positive	B-X
cell	B-X
population	B-X
,	B-X
not	B-X
present	B-X
in	B-X
this	B-X
form	B-X
in	B-X
the	B-X
E12	B-X
wild-type	B-X
cortex	B-X
.	B-X
At	B-X
P2	B-X
,	B-X
Reln-IR	B-X
CR	B-X
cells	B-X
are	B-X
undetectable	B-X
in	B-X
the	B-X
p73-/-	B-X
cortex	B-X
,	B-X
whereas	B-X
Reln-expression	B-X
in	B-X
interneurons	B-X
is	B-X
unchanged	B-X
.	B-X
Our	B-X
results	B-X
point	B-X
to	B-X
a	B-X
close	B-X
association	B-X
between	B-X
p73	B-X
and	B-X
Reln	B-X
in	B-X
CR	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
,	B-X
with	B-X
a	B-X
partial	B-X
dissociation	B-X
in	B-X
early	B-X
preplate	B-X
and	B-X
basal	B-X
telencephalon	B-X
,	B-X
and	B-X
to	B-X
a	B-X
p73-mediated	B-X
role	B-X
of	B-X
the	B-X
cortical	B-X
hem	B-X
in	B-X
neocortical	B-X
development	B-X
.	B-X

After	O
the	O
appearance	O
of	O
the	O
cortical	O
plate	O
,	O
further	O
p73	B-Gene_or_gene_product
/	O
Reln	B-Gene_or_gene_product
-	O
IR	O
cells	O
originate	O
in	O
the	O
medial	O
periolfactory	O
forebrain	O
.	O
<EOS>	B-X
Cajal-Retzius	B-X
(	B-X
CR	B-X
)	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
secrete	B-X
Reelin	B-X
(	B-X
Reln	B-X
)	B-X
,	B-X
a	B-X
glycoprotein	B-X
involved	B-X
in	B-X
neuronal	B-X
migration	B-X
.	B-X
CR	B-X
cells	B-X
selectively	B-X
express	B-X
p73	B-X
,	B-X
a	B-X
p53	B-X
family	B-X
member	B-X
implicated	B-X
in	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
.	B-X
Immunocytochemistry	B-X
in	B-X
prenatal	B-X
human	B-X
telencephalon	B-X
reveals	B-X
a	B-X
complex	B-X
sequence	B-X
of	B-X
migration	B-X
waves	B-X
of	B-X
p73-	B-X
and	B-X
Reln-immunoreactive	B-X
(	B-X
IR	B-X
)	B-X
neurons	B-X
into	B-X
the	B-X
cortical	B-X
marginal	B-X
zone	B-X
(	B-X
MZ	B-X
)	B-X
.	B-X
At	B-X
early	B-X
preplate	B-X
stages	B-X
,	B-X
p73/Reln-IR	B-X
cells	B-X
arise	B-X
in	B-X
distinct	B-X
sectors	B-X
of	B-X
the	B-X
telencephalon	B-X
,	B-X
including	B-X
cortical	B-X
primordium	B-X
and	B-X
ganglionic	B-X
eminences	B-X
.	B-X
After	B-X
the	B-X
appearance	B-X
of	B-X
the	B-X
cortical	B-X
plate	B-X
,	B-X
further	B-X
p73/Reln-IR	B-X
cells	B-X
originate	B-X
in	B-X
the	B-X
medial	B-X
periolfactory	B-X
forebrain	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
p73	B-X
marks	B-X
a	B-X
novel	B-X
cell	B-X
population	B-X
that	B-X
appears	B-X
at	B-X
the	B-X
choroid-cortical	B-X
junction	B-X
or	B-X
cortical	B-X
hem	B-X
before	B-X
the	B-X
emergence	B-X
of	B-X
the	B-X
dorsal	B-X
hippocampus	B-X
.	B-X
A	B-X
pronounced	B-X
mediolateral	B-X
gradient	B-X
in	B-X
the	B-X
density	B-X
of	B-X
p73/Reln-IR	B-X
neurons	B-X
in	B-X
the	B-X
neocortical	B-X
MZ	B-X
at	B-X
8	B-X
gestational	B-X
weeks	B-X
suggests	B-X
that	B-X
a	B-X
subset	B-X
of	B-X
CR	B-X
cells	B-X
migrate	B-X
tangentially	B-X
from	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
into	B-X
neocortical	B-X
territory	B-X
.	B-X
This	B-X
hypothesis	B-X
is	B-X
supported	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
p73-transcripts	B-X
in	B-X
prospective	B-X
neocortex	B-X
of	B-X
p73-/-mice	B-X
at	B-X
embryonic	B-X
day	B-X
12	B-X
(	B-X
E12	B-X
)	B-X
,	B-X
whereas	B-X
they	B-X
are	B-X
present	B-X
in	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
.	B-X
In	B-X
the	B-X
p73-/-	B-X
preplate	B-X
,	B-X
Reln	B-X
is	B-X
faintly	B-X
expressed	B-X
in	B-X
a	B-X
calretinin-positive	B-X
cell	B-X
population	B-X
,	B-X
not	B-X
present	B-X
in	B-X
this	B-X
form	B-X
in	B-X
the	B-X
E12	B-X
wild-type	B-X
cortex	B-X
.	B-X
At	B-X
P2	B-X
,	B-X
Reln-IR	B-X
CR	B-X
cells	B-X
are	B-X
undetectable	B-X
in	B-X
the	B-X
p73-/-	B-X
cortex	B-X
,	B-X
whereas	B-X
Reln-expression	B-X
in	B-X
interneurons	B-X
is	B-X
unchanged	B-X
.	B-X
Our	B-X
results	B-X
point	B-X
to	B-X
a	B-X
close	B-X
association	B-X
between	B-X
p73	B-X
and	B-X
Reln	B-X
in	B-X
CR	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
,	B-X
with	B-X
a	B-X
partial	B-X
dissociation	B-X
in	B-X
early	B-X
preplate	B-X
and	B-X
basal	B-X
telencephalon	B-X
,	B-X
and	B-X
to	B-X
a	B-X
p73-mediated	B-X
role	B-X
of	B-X
the	B-X
cortical	B-X
hem	B-X
in	B-X
neocortical	B-X
development	B-X
.	B-X

In	O
addition	O
,	O
p73	B-Gene_or_gene_product
marks	O
a	O
novel	O
cell	O
population	O
that	O
appears	O
at	O
the	O
choroid	O
-	O
cortical	O
junction	O
or	O
cortical	O
hem	O
before	O
the	O
emergence	O
of	O
the	O
dorsal	O
hippocampus	O
.	O
<EOS>	B-X
Cajal-Retzius	B-X
(	B-X
CR	B-X
)	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
secrete	B-X
Reelin	B-X
(	B-X
Reln	B-X
)	B-X
,	B-X
a	B-X
glycoprotein	B-X
involved	B-X
in	B-X
neuronal	B-X
migration	B-X
.	B-X
CR	B-X
cells	B-X
selectively	B-X
express	B-X
p73	B-X
,	B-X
a	B-X
p53	B-X
family	B-X
member	B-X
implicated	B-X
in	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
.	B-X
Immunocytochemistry	B-X
in	B-X
prenatal	B-X
human	B-X
telencephalon	B-X
reveals	B-X
a	B-X
complex	B-X
sequence	B-X
of	B-X
migration	B-X
waves	B-X
of	B-X
p73-	B-X
and	B-X
Reln-immunoreactive	B-X
(	B-X
IR	B-X
)	B-X
neurons	B-X
into	B-X
the	B-X
cortical	B-X
marginal	B-X
zone	B-X
(	B-X
MZ	B-X
)	B-X
.	B-X
At	B-X
early	B-X
preplate	B-X
stages	B-X
,	B-X
p73/Reln-IR	B-X
cells	B-X
arise	B-X
in	B-X
distinct	B-X
sectors	B-X
of	B-X
the	B-X
telencephalon	B-X
,	B-X
including	B-X
cortical	B-X
primordium	B-X
and	B-X
ganglionic	B-X
eminences	B-X
.	B-X
After	B-X
the	B-X
appearance	B-X
of	B-X
the	B-X
cortical	B-X
plate	B-X
,	B-X
further	B-X
p73/Reln-IR	B-X
cells	B-X
originate	B-X
in	B-X
the	B-X
medial	B-X
periolfactory	B-X
forebrain	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
p73	B-X
marks	B-X
a	B-X
novel	B-X
cell	B-X
population	B-X
that	B-X
appears	B-X
at	B-X
the	B-X
choroid-cortical	B-X
junction	B-X
or	B-X
cortical	B-X
hem	B-X
before	B-X
the	B-X
emergence	B-X
of	B-X
the	B-X
dorsal	B-X
hippocampus	B-X
.	B-X
A	B-X
pronounced	B-X
mediolateral	B-X
gradient	B-X
in	B-X
the	B-X
density	B-X
of	B-X
p73/Reln-IR	B-X
neurons	B-X
in	B-X
the	B-X
neocortical	B-X
MZ	B-X
at	B-X
8	B-X
gestational	B-X
weeks	B-X
suggests	B-X
that	B-X
a	B-X
subset	B-X
of	B-X
CR	B-X
cells	B-X
migrate	B-X
tangentially	B-X
from	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
into	B-X
neocortical	B-X
territory	B-X
.	B-X
This	B-X
hypothesis	B-X
is	B-X
supported	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
p73-transcripts	B-X
in	B-X
prospective	B-X
neocortex	B-X
of	B-X
p73-/-mice	B-X
at	B-X
embryonic	B-X
day	B-X
12	B-X
(	B-X
E12	B-X
)	B-X
,	B-X
whereas	B-X
they	B-X
are	B-X
present	B-X
in	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
.	B-X
In	B-X
the	B-X
p73-/-	B-X
preplate	B-X
,	B-X
Reln	B-X
is	B-X
faintly	B-X
expressed	B-X
in	B-X
a	B-X
calretinin-positive	B-X
cell	B-X
population	B-X
,	B-X
not	B-X
present	B-X
in	B-X
this	B-X
form	B-X
in	B-X
the	B-X
E12	B-X
wild-type	B-X
cortex	B-X
.	B-X
At	B-X
P2	B-X
,	B-X
Reln-IR	B-X
CR	B-X
cells	B-X
are	B-X
undetectable	B-X
in	B-X
the	B-X
p73-/-	B-X
cortex	B-X
,	B-X
whereas	B-X
Reln-expression	B-X
in	B-X
interneurons	B-X
is	B-X
unchanged	B-X
.	B-X
Our	B-X
results	B-X
point	B-X
to	B-X
a	B-X
close	B-X
association	B-X
between	B-X
p73	B-X
and	B-X
Reln	B-X
in	B-X
CR	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
,	B-X
with	B-X
a	B-X
partial	B-X
dissociation	B-X
in	B-X
early	B-X
preplate	B-X
and	B-X
basal	B-X
telencephalon	B-X
,	B-X
and	B-X
to	B-X
a	B-X
p73-mediated	B-X
role	B-X
of	B-X
the	B-X
cortical	B-X
hem	B-X
in	B-X
neocortical	B-X
development	B-X
.	B-X

A	O
pronounced	O
mediolateral	O
gradient	O
in	O
the	O
density	O
of	O
p73	B-Gene_or_gene_product
/	O
Reln	B-Gene_or_gene_product
-	O
IR	O
neurons	O
in	O
the	O
neocortical	O
MZ	O
at	O
8	O
gestational	O
weeks	O
suggests	O
that	O
a	O
subset	O
of	O
CR	O
cells	O
migrate	O
tangentially	O
from	O
cortical	O
hem	O
and	O
taenia	O
tecta	O
into	O
neocortical	O
territory	O
.	O
<EOS>	B-X
Cajal-Retzius	B-X
(	B-X
CR	B-X
)	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
secrete	B-X
Reelin	B-X
(	B-X
Reln	B-X
)	B-X
,	B-X
a	B-X
glycoprotein	B-X
involved	B-X
in	B-X
neuronal	B-X
migration	B-X
.	B-X
CR	B-X
cells	B-X
selectively	B-X
express	B-X
p73	B-X
,	B-X
a	B-X
p53	B-X
family	B-X
member	B-X
implicated	B-X
in	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
.	B-X
Immunocytochemistry	B-X
in	B-X
prenatal	B-X
human	B-X
telencephalon	B-X
reveals	B-X
a	B-X
complex	B-X
sequence	B-X
of	B-X
migration	B-X
waves	B-X
of	B-X
p73-	B-X
and	B-X
Reln-immunoreactive	B-X
(	B-X
IR	B-X
)	B-X
neurons	B-X
into	B-X
the	B-X
cortical	B-X
marginal	B-X
zone	B-X
(	B-X
MZ	B-X
)	B-X
.	B-X
At	B-X
early	B-X
preplate	B-X
stages	B-X
,	B-X
p73/Reln-IR	B-X
cells	B-X
arise	B-X
in	B-X
distinct	B-X
sectors	B-X
of	B-X
the	B-X
telencephalon	B-X
,	B-X
including	B-X
cortical	B-X
primordium	B-X
and	B-X
ganglionic	B-X
eminences	B-X
.	B-X
After	B-X
the	B-X
appearance	B-X
of	B-X
the	B-X
cortical	B-X
plate	B-X
,	B-X
further	B-X
p73/Reln-IR	B-X
cells	B-X
originate	B-X
in	B-X
the	B-X
medial	B-X
periolfactory	B-X
forebrain	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
p73	B-X
marks	B-X
a	B-X
novel	B-X
cell	B-X
population	B-X
that	B-X
appears	B-X
at	B-X
the	B-X
choroid-cortical	B-X
junction	B-X
or	B-X
cortical	B-X
hem	B-X
before	B-X
the	B-X
emergence	B-X
of	B-X
the	B-X
dorsal	B-X
hippocampus	B-X
.	B-X
A	B-X
pronounced	B-X
mediolateral	B-X
gradient	B-X
in	B-X
the	B-X
density	B-X
of	B-X
p73/Reln-IR	B-X
neurons	B-X
in	B-X
the	B-X
neocortical	B-X
MZ	B-X
at	B-X
8	B-X
gestational	B-X
weeks	B-X
suggests	B-X
that	B-X
a	B-X
subset	B-X
of	B-X
CR	B-X
cells	B-X
migrate	B-X
tangentially	B-X
from	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
into	B-X
neocortical	B-X
territory	B-X
.	B-X
This	B-X
hypothesis	B-X
is	B-X
supported	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
p73-transcripts	B-X
in	B-X
prospective	B-X
neocortex	B-X
of	B-X
p73-/-mice	B-X
at	B-X
embryonic	B-X
day	B-X
12	B-X
(	B-X
E12	B-X
)	B-X
,	B-X
whereas	B-X
they	B-X
are	B-X
present	B-X
in	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
.	B-X
In	B-X
the	B-X
p73-/-	B-X
preplate	B-X
,	B-X
Reln	B-X
is	B-X
faintly	B-X
expressed	B-X
in	B-X
a	B-X
calretinin-positive	B-X
cell	B-X
population	B-X
,	B-X
not	B-X
present	B-X
in	B-X
this	B-X
form	B-X
in	B-X
the	B-X
E12	B-X
wild-type	B-X
cortex	B-X
.	B-X
At	B-X
P2	B-X
,	B-X
Reln-IR	B-X
CR	B-X
cells	B-X
are	B-X
undetectable	B-X
in	B-X
the	B-X
p73-/-	B-X
cortex	B-X
,	B-X
whereas	B-X
Reln-expression	B-X
in	B-X
interneurons	B-X
is	B-X
unchanged	B-X
.	B-X
Our	B-X
results	B-X
point	B-X
to	B-X
a	B-X
close	B-X
association	B-X
between	B-X
p73	B-X
and	B-X
Reln	B-X
in	B-X
CR	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
,	B-X
with	B-X
a	B-X
partial	B-X
dissociation	B-X
in	B-X
early	B-X
preplate	B-X
and	B-X
basal	B-X
telencephalon	B-X
,	B-X
and	B-X
to	B-X
a	B-X
p73-mediated	B-X
role	B-X
of	B-X
the	B-X
cortical	B-X
hem	B-X
in	B-X
neocortical	B-X
development	B-X
.	B-X

This	O
hypothesis	O
is	O
supported	O
by	O
the	O
absence	O
of	O
p73	B-Gene_or_gene_product
-	O
transcripts	O
in	O
prospective	O
neocortex	O
of	O
p73	B-Gene_or_gene_product
-	O
/	O
-	O
mice	O
at	O
embryonic	O
day	O
12	O
(	O
E12	O
)	O
,	O
whereas	O
they	O
are	O
present	O
in	O
cortical	O
hem	O
and	O
taenia	O
tecta	O
.	O
<EOS>	B-X
Cajal-Retzius	B-X
(	B-X
CR	B-X
)	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
secrete	B-X
Reelin	B-X
(	B-X
Reln	B-X
)	B-X
,	B-X
a	B-X
glycoprotein	B-X
involved	B-X
in	B-X
neuronal	B-X
migration	B-X
.	B-X
CR	B-X
cells	B-X
selectively	B-X
express	B-X
p73	B-X
,	B-X
a	B-X
p53	B-X
family	B-X
member	B-X
implicated	B-X
in	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
.	B-X
Immunocytochemistry	B-X
in	B-X
prenatal	B-X
human	B-X
telencephalon	B-X
reveals	B-X
a	B-X
complex	B-X
sequence	B-X
of	B-X
migration	B-X
waves	B-X
of	B-X
p73-	B-X
and	B-X
Reln-immunoreactive	B-X
(	B-X
IR	B-X
)	B-X
neurons	B-X
into	B-X
the	B-X
cortical	B-X
marginal	B-X
zone	B-X
(	B-X
MZ	B-X
)	B-X
.	B-X
At	B-X
early	B-X
preplate	B-X
stages	B-X
,	B-X
p73/Reln-IR	B-X
cells	B-X
arise	B-X
in	B-X
distinct	B-X
sectors	B-X
of	B-X
the	B-X
telencephalon	B-X
,	B-X
including	B-X
cortical	B-X
primordium	B-X
and	B-X
ganglionic	B-X
eminences	B-X
.	B-X
After	B-X
the	B-X
appearance	B-X
of	B-X
the	B-X
cortical	B-X
plate	B-X
,	B-X
further	B-X
p73/Reln-IR	B-X
cells	B-X
originate	B-X
in	B-X
the	B-X
medial	B-X
periolfactory	B-X
forebrain	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
p73	B-X
marks	B-X
a	B-X
novel	B-X
cell	B-X
population	B-X
that	B-X
appears	B-X
at	B-X
the	B-X
choroid-cortical	B-X
junction	B-X
or	B-X
cortical	B-X
hem	B-X
before	B-X
the	B-X
emergence	B-X
of	B-X
the	B-X
dorsal	B-X
hippocampus	B-X
.	B-X
A	B-X
pronounced	B-X
mediolateral	B-X
gradient	B-X
in	B-X
the	B-X
density	B-X
of	B-X
p73/Reln-IR	B-X
neurons	B-X
in	B-X
the	B-X
neocortical	B-X
MZ	B-X
at	B-X
8	B-X
gestational	B-X
weeks	B-X
suggests	B-X
that	B-X
a	B-X
subset	B-X
of	B-X
CR	B-X
cells	B-X
migrate	B-X
tangentially	B-X
from	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
into	B-X
neocortical	B-X
territory	B-X
.	B-X
This	B-X
hypothesis	B-X
is	B-X
supported	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
p73-transcripts	B-X
in	B-X
prospective	B-X
neocortex	B-X
of	B-X
p73-/-mice	B-X
at	B-X
embryonic	B-X
day	B-X
12	B-X
(	B-X
E12	B-X
)	B-X
,	B-X
whereas	B-X
they	B-X
are	B-X
present	B-X
in	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
.	B-X
In	B-X
the	B-X
p73-/-	B-X
preplate	B-X
,	B-X
Reln	B-X
is	B-X
faintly	B-X
expressed	B-X
in	B-X
a	B-X
calretinin-positive	B-X
cell	B-X
population	B-X
,	B-X
not	B-X
present	B-X
in	B-X
this	B-X
form	B-X
in	B-X
the	B-X
E12	B-X
wild-type	B-X
cortex	B-X
.	B-X
At	B-X
P2	B-X
,	B-X
Reln-IR	B-X
CR	B-X
cells	B-X
are	B-X
undetectable	B-X
in	B-X
the	B-X
p73-/-	B-X
cortex	B-X
,	B-X
whereas	B-X
Reln-expression	B-X
in	B-X
interneurons	B-X
is	B-X
unchanged	B-X
.	B-X
Our	B-X
results	B-X
point	B-X
to	B-X
a	B-X
close	B-X
association	B-X
between	B-X
p73	B-X
and	B-X
Reln	B-X
in	B-X
CR	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
,	B-X
with	B-X
a	B-X
partial	B-X
dissociation	B-X
in	B-X
early	B-X
preplate	B-X
and	B-X
basal	B-X
telencephalon	B-X
,	B-X
and	B-X
to	B-X
a	B-X
p73-mediated	B-X
role	B-X
of	B-X
the	B-X
cortical	B-X
hem	B-X
in	B-X
neocortical	B-X
development	B-X
.	B-X

In	O
the	O
p73	B-Gene_or_gene_product
-	O
/	O
-	O
preplate	O
,	O
Reln	B-Gene_or_gene_product
is	O
faintly	O
expressed	O
in	O
a	O
calretinin	B-Gene_or_gene_product
-	O
positive	O
cell	O
population	O
,	O
not	O
present	O
in	O
this	O
form	O
in	O
the	O
E12	O
wild	O
-	O
type	O
cortex	O
.	O

At	O
P2	O
,	O
Reln	B-Gene_or_gene_product
-	O
IR	O
CR	O
cells	O
are	O
undetectable	O
in	O
the	O
p73	B-Gene_or_gene_product
-	O
/	O
-	O
cortex	O
,	O
whereas	O
Reln	B-Gene_or_gene_product
-	O
expression	O
in	O
interneurons	O
is	O
unchanged	O
.	O
<EOS>	B-X
Cajal-Retzius	B-X
(	B-X
CR	B-X
)	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
secrete	B-X
Reelin	B-X
(	B-X
Reln	B-X
)	B-X
,	B-X
a	B-X
glycoprotein	B-X
involved	B-X
in	B-X
neuronal	B-X
migration	B-X
.	B-X
CR	B-X
cells	B-X
selectively	B-X
express	B-X
p73	B-X
,	B-X
a	B-X
p53	B-X
family	B-X
member	B-X
implicated	B-X
in	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
.	B-X
Immunocytochemistry	B-X
in	B-X
prenatal	B-X
human	B-X
telencephalon	B-X
reveals	B-X
a	B-X
complex	B-X
sequence	B-X
of	B-X
migration	B-X
waves	B-X
of	B-X
p73-	B-X
and	B-X
Reln-immunoreactive	B-X
(	B-X
IR	B-X
)	B-X
neurons	B-X
into	B-X
the	B-X
cortical	B-X
marginal	B-X
zone	B-X
(	B-X
MZ	B-X
)	B-X
.	B-X
At	B-X
early	B-X
preplate	B-X
stages	B-X
,	B-X
p73/Reln-IR	B-X
cells	B-X
arise	B-X
in	B-X
distinct	B-X
sectors	B-X
of	B-X
the	B-X
telencephalon	B-X
,	B-X
including	B-X
cortical	B-X
primordium	B-X
and	B-X
ganglionic	B-X
eminences	B-X
.	B-X
After	B-X
the	B-X
appearance	B-X
of	B-X
the	B-X
cortical	B-X
plate	B-X
,	B-X
further	B-X
p73/Reln-IR	B-X
cells	B-X
originate	B-X
in	B-X
the	B-X
medial	B-X
periolfactory	B-X
forebrain	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
p73	B-X
marks	B-X
a	B-X
novel	B-X
cell	B-X
population	B-X
that	B-X
appears	B-X
at	B-X
the	B-X
choroid-cortical	B-X
junction	B-X
or	B-X
cortical	B-X
hem	B-X
before	B-X
the	B-X
emergence	B-X
of	B-X
the	B-X
dorsal	B-X
hippocampus	B-X
.	B-X
A	B-X
pronounced	B-X
mediolateral	B-X
gradient	B-X
in	B-X
the	B-X
density	B-X
of	B-X
p73/Reln-IR	B-X
neurons	B-X
in	B-X
the	B-X
neocortical	B-X
MZ	B-X
at	B-X
8	B-X
gestational	B-X
weeks	B-X
suggests	B-X
that	B-X
a	B-X
subset	B-X
of	B-X
CR	B-X
cells	B-X
migrate	B-X
tangentially	B-X
from	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
into	B-X
neocortical	B-X
territory	B-X
.	B-X
This	B-X
hypothesis	B-X
is	B-X
supported	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
p73-transcripts	B-X
in	B-X
prospective	B-X
neocortex	B-X
of	B-X
p73-/-mice	B-X
at	B-X
embryonic	B-X
day	B-X
12	B-X
(	B-X
E12	B-X
)	B-X
,	B-X
whereas	B-X
they	B-X
are	B-X
present	B-X
in	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
.	B-X
In	B-X
the	B-X
p73-/-	B-X
preplate	B-X
,	B-X
Reln	B-X
is	B-X
faintly	B-X
expressed	B-X
in	B-X
a	B-X
calretinin-positive	B-X
cell	B-X
population	B-X
,	B-X
not	B-X
present	B-X
in	B-X
this	B-X
form	B-X
in	B-X
the	B-X
E12	B-X
wild-type	B-X
cortex	B-X
.	B-X
At	B-X
P2	B-X
,	B-X
Reln-IR	B-X
CR	B-X
cells	B-X
are	B-X
undetectable	B-X
in	B-X
the	B-X
p73-/-	B-X
cortex	B-X
,	B-X
whereas	B-X
Reln-expression	B-X
in	B-X
interneurons	B-X
is	B-X
unchanged	B-X
.	B-X
Our	B-X
results	B-X
point	B-X
to	B-X
a	B-X
close	B-X
association	B-X
between	B-X
p73	B-X
and	B-X
Reln	B-X
in	B-X
CR	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
,	B-X
with	B-X
a	B-X
partial	B-X
dissociation	B-X
in	B-X
early	B-X
preplate	B-X
and	B-X
basal	B-X
telencephalon	B-X
,	B-X
and	B-X
to	B-X
a	B-X
p73-mediated	B-X
role	B-X
of	B-X
the	B-X
cortical	B-X
hem	B-X
in	B-X
neocortical	B-X
development	B-X
.	B-X

Our	O
results	O
point	O
to	O
a	O
close	O
association	O
between	O
p73	B-Gene_or_gene_product
and	O
Reln	B-Gene_or_gene_product
in	O
CR	O
cells	O
of	O
the	O
developing	O
neocortex	O
,	O
with	O
a	O
partial	O
dissociation	O
in	O
early	O
preplate	O
and	O
basal	O
telencephalon	O
,	O
and	O
to	O
a	O
p73	B-Gene_or_gene_product
-	O
mediated	O
role	O
of	O
the	O
cortical	O
hem	O
in	O
neocortical	O
development	O
.	O
<EOS>	B-X
Cajal-Retzius	B-X
(	B-X
CR	B-X
)	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
secrete	B-X
Reelin	B-X
(	B-X
Reln	B-X
)	B-X
,	B-X
a	B-X
glycoprotein	B-X
involved	B-X
in	B-X
neuronal	B-X
migration	B-X
.	B-X
CR	B-X
cells	B-X
selectively	B-X
express	B-X
p73	B-X
,	B-X
a	B-X
p53	B-X
family	B-X
member	B-X
implicated	B-X
in	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
.	B-X
Immunocytochemistry	B-X
in	B-X
prenatal	B-X
human	B-X
telencephalon	B-X
reveals	B-X
a	B-X
complex	B-X
sequence	B-X
of	B-X
migration	B-X
waves	B-X
of	B-X
p73-	B-X
and	B-X
Reln-immunoreactive	B-X
(	B-X
IR	B-X
)	B-X
neurons	B-X
into	B-X
the	B-X
cortical	B-X
marginal	B-X
zone	B-X
(	B-X
MZ	B-X
)	B-X
.	B-X
At	B-X
early	B-X
preplate	B-X
stages	B-X
,	B-X
p73/Reln-IR	B-X
cells	B-X
arise	B-X
in	B-X
distinct	B-X
sectors	B-X
of	B-X
the	B-X
telencephalon	B-X
,	B-X
including	B-X
cortical	B-X
primordium	B-X
and	B-X
ganglionic	B-X
eminences	B-X
.	B-X
After	B-X
the	B-X
appearance	B-X
of	B-X
the	B-X
cortical	B-X
plate	B-X
,	B-X
further	B-X
p73/Reln-IR	B-X
cells	B-X
originate	B-X
in	B-X
the	B-X
medial	B-X
periolfactory	B-X
forebrain	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
p73	B-X
marks	B-X
a	B-X
novel	B-X
cell	B-X
population	B-X
that	B-X
appears	B-X
at	B-X
the	B-X
choroid-cortical	B-X
junction	B-X
or	B-X
cortical	B-X
hem	B-X
before	B-X
the	B-X
emergence	B-X
of	B-X
the	B-X
dorsal	B-X
hippocampus	B-X
.	B-X
A	B-X
pronounced	B-X
mediolateral	B-X
gradient	B-X
in	B-X
the	B-X
density	B-X
of	B-X
p73/Reln-IR	B-X
neurons	B-X
in	B-X
the	B-X
neocortical	B-X
MZ	B-X
at	B-X
8	B-X
gestational	B-X
weeks	B-X
suggests	B-X
that	B-X
a	B-X
subset	B-X
of	B-X
CR	B-X
cells	B-X
migrate	B-X
tangentially	B-X
from	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
into	B-X
neocortical	B-X
territory	B-X
.	B-X
This	B-X
hypothesis	B-X
is	B-X
supported	B-X
by	B-X
the	B-X
absence	B-X
of	B-X
p73-transcripts	B-X
in	B-X
prospective	B-X
neocortex	B-X
of	B-X
p73-/-mice	B-X
at	B-X
embryonic	B-X
day	B-X
12	B-X
(	B-X
E12	B-X
)	B-X
,	B-X
whereas	B-X
they	B-X
are	B-X
present	B-X
in	B-X
cortical	B-X
hem	B-X
and	B-X
taenia	B-X
tecta	B-X
.	B-X
In	B-X
the	B-X
p73-/-	B-X
preplate	B-X
,	B-X
Reln	B-X
is	B-X
faintly	B-X
expressed	B-X
in	B-X
a	B-X
calretinin-positive	B-X
cell	B-X
population	B-X
,	B-X
not	B-X
present	B-X
in	B-X
this	B-X
form	B-X
in	B-X
the	B-X
E12	B-X
wild-type	B-X
cortex	B-X
.	B-X
At	B-X
P2	B-X
,	B-X
Reln-IR	B-X
CR	B-X
cells	B-X
are	B-X
undetectable	B-X
in	B-X
the	B-X
p73-/-	B-X
cortex	B-X
,	B-X
whereas	B-X
Reln-expression	B-X
in	B-X
interneurons	B-X
is	B-X
unchanged	B-X
.	B-X
Our	B-X
results	B-X
point	B-X
to	B-X
a	B-X
close	B-X
association	B-X
between	B-X
p73	B-X
and	B-X
Reln	B-X
in	B-X
CR	B-X
cells	B-X
of	B-X
the	B-X
developing	B-X
neocortex	B-X
,	B-X
with	B-X
a	B-X
partial	B-X
dissociation	B-X
in	B-X
early	B-X
preplate	B-X
and	B-X
basal	B-X
telencephalon	B-X
,	B-X
and	B-X
to	B-X
a	B-X
p73-mediated	B-X
role	B-X
of	B-X
the	B-X
cortical	B-X
hem	B-X
in	B-X
neocortical	B-X
development	B-X
.	B-X

Apaf	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
is	O
a	O
mediator	O
of	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
-	O
induced	O
apoptosis	O
.	O
<EOS>	B-X
E2F-1	B-X
is	B-X
capable	B-X
of	B-X
promoting	B-X
both	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
apoptosis	B-X
.	B-X
E2F-1-induced	B-X
apoptosis	B-X
was	B-X
accompanied	B-X
by	B-X
caspase-9	B-X
activation	B-X
and	B-X
inhibited	B-X
by	B-X
a	B-X
specific	B-X
inhibitor	B-X
of	B-X
caspase-9	B-X
in	B-X
K562	B-X
sublines	B-X
overexpressing	B-X
E2F-1	B-X
.	B-X
E2F-1	B-X
enhanced	B-X
the	B-X
expression	B-X
of	B-X
Apaf-1	B-X
without	B-X
the	B-X
cytosolic	B-X
accumulation	B-X
of	B-X
cytochrome	B-X
c.	B-X
Apaf-1-deficient	B-X
melanoma	B-X
cell	B-X
lines	B-X
were	B-X
resistant	B-X
to	B-X
E2F-1	B-X
,	B-X
indicating	B-X
that	B-X
Apaf-1	B-X
is	B-X
an	B-X
essential	B-X
element	B-X
of	B-X
E2F-1-mediated	B-X
apoptosis	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
isolated	B-X
the	B-X
promoter	B-X
region	B-X
of	B-X
the	B-X
Apaf-1	B-X
gene	B-X
and	B-X
found	B-X
a	B-X
putative	B-X
binding	B-X
site	B-X
for	B-X
E2F	B-X
.	B-X
A	B-X
chromatin	B-X
immunoprecipitation	B-X
assay	B-X
revealed	B-X
that	B-X
E2F-1	B-X
bound	B-X
to	B-X
Apaf-1	B-X
promoter	B-X
upon	B-X
E2F-1	B-X
overexpression	B-X
,	B-X
suggesting	B-X
that	B-X
Apaf-1	B-X
is	B-X
under	B-X
transcriptional	B-X
regulation	B-X
of	B-X
E2F-1	B-X
.	B-X
These	B-X
data	B-X
demonstrate	B-X
a	B-X
novel	B-X
mechanism	B-X
of	B-X
apoptosis	B-X
in	B-X
which	B-X
an	B-X
increase	B-X
in	B-X
Apaf-1	B-X
levels	B-X
results	B-X
in	B-X
direct	B-X
activation	B-X
of	B-X
caspase-9	B-X
without	B-X
mitochondrial	B-X
damage	B-X
,	B-X
leading	B-X
to	B-X
the	B-X
initiation	B-X
of	B-X
a	B-X
caspase	B-X
cascade	B-X
.	B-X

E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
is	O
capable	O
of	O
promoting	O
both	O
cell	O
cycle	O
progression	O
and	O
apoptosis	O
.	O
<EOS>	B-X
Long	B-X
non-coding	B-X
RNAs	B-X
(	B-X
lncRNAs	B-X
)	B-X
are	B-X
crucial	B-X
in	B-X
the	B-X
invasion	B-X
,	B-X
angiogenesis	B-X
,	B-X
progression	B-X
,	B-X
and	B-X
metastasis	B-X
of	B-X
hepatocellular	B-X
carcinoma	B-X
(	B-X
HCC	B-X
)	B-X
.	B-X
The	B-X
lncRNA	B-X
MYLK-AS1	B-X
promotes	B-X
the	B-X
growth	B-X
and	B-X
invasion	B-X
of	B-X
HCC	B-X
through	B-X
the	B-X
EGFR/HER2-ERK1/2	B-X
signaling	B-X
pathway	B-X
.	B-X
However	B-X
,	B-X
the	B-X
clinical	B-X
significance	B-X
of	B-X
MYLK-AS1	B-X
in	B-X
HCC	B-X
still	B-X
needs	B-X
to	B-X
be	B-X
further	B-X
determined	B-X
.	B-X
E2F-1	B-X
is	B-X
capable	B-X
of	B-X
promoting	B-X
both	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
apoptosis	B-X
.	B-X
The	B-X
latter	B-X
is	B-X
important	B-X
for	B-X
suppressing	B-X
untoward	B-X
expansion	B-X
of	B-X
proliferating	B-X
cells	B-X
.	B-X
E2F-1-induced	B-X
apoptosis	B-X
was	B-X
accompanied	B-X
by	B-X
caspase-9	B-X
activation	B-X
and	B-X
inhibited	B-X
by	B-X
a	B-X
specific	B-X
inhibitor	B-X
of	B-X
caspase-9	B-X
in	B-X
K562	B-X
sublines	B-X
overexpressing	B-X
E2F-1	B-X
.	B-X
E2F-1	B-X
enhanced	B-X
the	B-X
expression	B-X
of	B-X
Apaf-1	B-X
without	B-X
the	B-X
cytosolic	B-X
accumulation	B-X
of	B-X
cytochrome	B-X
c.	B-X
Apaf-1-deficient	B-X
melanoma	B-X
cell	B-X
lines	B-X
were	B-X
resistant	B-X
to	B-X
E2F-1	B-X
,	B-X
indicating	B-X
that	B-X
Apaf-1	B-X
is	B-X
an	B-X
essential	B-X
element	B-X
of	B-X
E2F-1-mediated	B-X
apoptosis	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
isolated	B-X
the	B-X
promoter	B-X
region	B-X
of	B-X
the	B-X
Apaf-1	B-X
gene	B-X
and	B-X
found	B-X
a	B-X
putative	B-X
binding	B-X
site	B-X
for	B-X
E2F	B-X
.	B-X
A	B-X
chromatin	B-X
immunoprecipitation	B-X
assay	B-X
revealed	B-X
that	B-X
E2F-1	B-X
bound	B-X
to	B-X
Apaf-1	B-X
promoter	B-X
upon	B-X
E2F-1	B-X
overexpression	B-X
,	B-X
suggesting	B-X
that	B-X
Apaf-1	B-X
is	B-X
under	B-X
transcriptional	B-X
regulation	B-X
of	B-X
E2F-1	B-X
.	B-X
These	B-X
data	B-X
demonstrate	B-X
a	B-X
novel	B-X
mechanism	B-X
of	B-X
apoptosis	B-X
in	B-X
which	B-X
an	B-X
increase	B-X
in	B-X
Apaf-1	B-X
levels	B-X
results	B-X
in	B-X
direct	B-X
activation	B-X
of	B-X
caspase-9	B-X
without	B-X
mitochondrial	B-X
damage	B-X
,	B-X
leading	B-X
to	B-X
the	B-X
initiation	B-X
of	B-X
a	B-X
caspase	B-X
cascade	B-X
.	B-X

The	O
latter	O
is	O
important	O
for	O
suppressing	O
untoward	O
expansion	O
of	O
proliferating	O
cells	O
.	O
<EOS>	B-X
The	B-X
latter	B-X
is	B-X
important	B-X
for	B-X
suppressing	B-X
untoward	B-X
expansion	B-X
of	B-X
proliferating	B-X
cells	B-X
.	B-X

In	O
this	O
study	O
,	O
we	O
investigated	O
its	O
underlying	O
mechanisms	O
.	O
<EOS>	B-X
Studies	B-X
determining	B-X
the	B-X
microbial	B-X
mechanisms	B-X
that	B-X
directly	B-X
contribute	B-X
to	B-X
CRC	B-X
development	B-X
or	B-X
progression	B-X
are	B-X
revealing	B-X
bacterial	B-X
factors	B-X
such	B-X
as	B-X
toxins	B-X
that	B-X
contribute	B-X
to	B-X
colorectal	B-X
carcinogenesis	B-X
.	B-X
In	B-X
doing	B-X
so	B-X
,	B-X
we	B-X
aim	B-X
to	B-X
elucidate	B-X
unique	B-X
and	B-X
shared	B-X
mechanisms	B-X
underlying	B-X
the	B-X
microbiota	B-X
's	B-X
contributions	B-X
to	B-X
CRC	B-X
and	B-X
to	B-X
accelerate	B-X
investigation	B-X
from	B-X
target	B-X
validation	B-X
to	B-X
CRC	B-X
therapeutic	B-X
discovery	B-X
.	B-X
A	B-X
thorough	B-X
understanding	B-X
of	B-X
the	B-X
mechanisms	B-X
underlying	B-X
eating	B-X
behavior	B-X
is	B-X
essential	B-X
in	B-X
the	B-X
management	B-X
of	B-X
patients	B-X
after	B-X
bariatric	B-X
surgery	B-X
.	B-X
Studies	B-X
investigating	B-X
candidate	B-X
mechanisms	B-X
have	B-X
expanded	B-X
dramatically	B-X
in	B-X
the	B-X
last	B-X
decade	B-X
.	B-X
Herein	B-X
we	B-X
review	B-X
the	B-X
proposed	B-X
mechanisms	B-X
governing	B-X
changes	B-X
in	B-X
eating	B-X
behavior	B-X
,	B-X
food	B-X
intake	B-X
,	B-X
and	B-X
body	B-X
weight	B-X
after	B-X
bariatric	B-X
surgery	B-X
.	B-X
Considered	B-X
application	B-X
of	B-X
strategies	B-X
designed	B-X
to	B-X
support	B-X
the	B-X
underlying	B-X
principles	B-X
governing	B-X
changes	B-X
in	B-X
eating	B-X
behavior	B-X
holds	B-X
promise	B-X
as	B-X
a	B-X
means	B-X
of	B-X
optimizing	B-X
responses	B-X
to	B-X
surgery	B-X
and	B-X
long-term	B-X
outcomes	B-X
.	B-X

E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
-	O
induced	O
apoptosis	O
was	O
accompanied	O
by	O
caspase	B-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
activation	O
and	O
inhibited	O
by	O
a	O
specific	O
inhibitor	O
of	O
caspase	B-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
in	O
K562	O
sublines	O
overexpressing	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O
<EOS>	B-X
E2F-1	B-X
is	B-X
capable	B-X
of	B-X
promoting	B-X
both	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
apoptosis	B-X
.	B-X
E2F-1-induced	B-X
apoptosis	B-X
was	B-X
accompanied	B-X
by	B-X
caspase-9	B-X
activation	B-X
and	B-X
inhibited	B-X
by	B-X
a	B-X
specific	B-X
inhibitor	B-X
of	B-X
caspase-9	B-X
in	B-X
K562	B-X
sublines	B-X
overexpressing	B-X
E2F-1	B-X
.	B-X
E2F-1	B-X
enhanced	B-X
the	B-X
expression	B-X
of	B-X
Apaf-1	B-X
without	B-X
the	B-X
cytosolic	B-X
accumulation	B-X
of	B-X
cytochrome	B-X
c.	B-X
Apaf-1-deficient	B-X
melanoma	B-X
cell	B-X
lines	B-X
were	B-X
resistant	B-X
to	B-X
E2F-1	B-X
,	B-X
indicating	B-X
that	B-X
Apaf-1	B-X
is	B-X
an	B-X
essential	B-X
element	B-X
of	B-X
E2F-1-mediated	B-X
apoptosis	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
isolated	B-X
the	B-X
promoter	B-X
region	B-X
of	B-X
the	B-X
Apaf-1	B-X
gene	B-X
and	B-X
found	B-X
a	B-X
putative	B-X
binding	B-X
site	B-X
for	B-X
E2F	B-X
.	B-X
A	B-X
chromatin	B-X
immunoprecipitation	B-X
assay	B-X
revealed	B-X
that	B-X
E2F-1	B-X
bound	B-X
to	B-X
Apaf-1	B-X
promoter	B-X
upon	B-X
E2F-1	B-X
overexpression	B-X
,	B-X
suggesting	B-X
that	B-X
Apaf-1	B-X
is	B-X
under	B-X
transcriptional	B-X
regulation	B-X
of	B-X
E2F-1	B-X
.	B-X
These	B-X
data	B-X
demonstrate	B-X
a	B-X
novel	B-X
mechanism	B-X
of	B-X
apoptosis	B-X
in	B-X
which	B-X
an	B-X
increase	B-X
in	B-X
Apaf-1	B-X
levels	B-X
results	B-X
in	B-X
direct	B-X
activation	B-X
of	B-X
caspase-9	B-X
without	B-X
mitochondrial	B-X
damage	B-X
,	B-X
leading	B-X
to	B-X
the	B-X
initiation	B-X
of	B-X
a	B-X
caspase	B-X
cascade	B-X
.	B-X

E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
enhanced	O
the	O
expression	O
of	O
Apaf	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
without	O
the	O
cytosolic	O
accumulation	O
of	O
cytochrome	B-Gene_or_gene_product
c	I-Gene_or_gene_product
.	O
<EOS>	B-X
E2F-1	B-X
is	B-X
capable	B-X
of	B-X
promoting	B-X
both	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
apoptosis	B-X
.	B-X
The	B-X
latter	B-X
is	B-X
important	B-X
for	B-X
suppressing	B-X
untoward	B-X
expansion	B-X
of	B-X
proliferating	B-X
cells	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
its	B-X
underlying	B-X
mechanisms	B-X
.	B-X
E2F-1-induced	B-X
apoptosis	B-X
was	B-X
accompanied	B-X
by	B-X
caspase-9	B-X
activation	B-X
and	B-X
inhibited	B-X
by	B-X
a	B-X
specific	B-X
inhibitor	B-X
of	B-X
caspase-9	B-X
in	B-X
K562	B-X
sublines	B-X
overexpressing	B-X
E2F-1	B-X
.	B-X
E2F-1	B-X
enhanced	B-X
the	B-X
expression	B-X
of	B-X
Apaf-1	B-X
without	B-X
the	B-X
cytosolic	B-X
accumulation	B-X
of	B-X
cytochrome	B-X
c.	B-X
Apaf-1-deficient	B-X
melanoma	B-X
cell	B-X
lines	B-X
were	B-X
resistant	B-X
to	B-X
E2F-1	B-X
,	B-X
indicating	B-X
that	B-X
Apaf-1	B-X
is	B-X
an	B-X
essential	B-X
element	B-X
of	B-X
E2F-1-mediated	B-X
apoptosis	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
isolated	B-X
the	B-X
promoter	B-X
region	B-X
of	B-X
the	B-X
Apaf-1	B-X
gene	B-X
and	B-X
found	B-X
a	B-X
putative	B-X
binding	B-X
site	B-X
for	B-X
E2F	B-X
.	B-X
A	B-X
chromatin	B-X
immunoprecipitation	B-X
assay	B-X
revealed	B-X
that	B-X
E2F-1	B-X
bound	B-X
to	B-X
Apaf-1	B-X
promoter	B-X
upon	B-X
E2F-1	B-X
overexpression	B-X
,	B-X
suggesting	B-X
that	B-X
Apaf-1	B-X
is	B-X
under	B-X
transcriptional	B-X
regulation	B-X
of	B-X
E2F-1	B-X
.	B-X
These	B-X
data	B-X
demonstrate	B-X
a	B-X
novel	B-X
mechanism	B-X
of	B-X
apoptosis	B-X
in	B-X
which	B-X
an	B-X
increase	B-X
in	B-X
Apaf-1	B-X
levels	B-X
results	B-X
in	B-X
direct	B-X
activation	B-X
of	B-X
caspase-9	B-X
without	B-X
mitochondrial	B-X
damage	B-X
,	B-X
leading	B-X
to	B-X
the	B-X
initiation	B-X
of	B-X
a	B-X
caspase	B-X
cascade	B-X
.	B-X

Apaf	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
-	O
deficient	O
melanoma	O
cell	O
lines	O
were	O
resistant	O
to	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
indicating	O
that	O
Apaf	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
is	O
an	O
essential	O
element	O
of	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
-	O
mediated	O
apoptosis	O
.	O
<EOS>	B-X
E2F-1	B-X
is	B-X
capable	B-X
of	B-X
promoting	B-X
both	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
apoptosis	B-X
.	B-X
The	B-X
latter	B-X
is	B-X
important	B-X
for	B-X
suppressing	B-X
untoward	B-X
expansion	B-X
of	B-X
proliferating	B-X
cells	B-X
.	B-X
E2F-1-induced	B-X
apoptosis	B-X
was	B-X
accompanied	B-X
by	B-X
caspase-9	B-X
activation	B-X
and	B-X
inhibited	B-X
by	B-X
a	B-X
specific	B-X
inhibitor	B-X
of	B-X
caspase-9	B-X
in	B-X
K562	B-X
sublines	B-X
overexpressing	B-X
E2F-1	B-X
.	B-X
E2F-1	B-X
enhanced	B-X
the	B-X
expression	B-X
of	B-X
Apaf-1	B-X
without	B-X
the	B-X
cytosolic	B-X
accumulation	B-X
of	B-X
cytochrome	B-X
c.	B-X
Apaf-1-deficient	B-X
melanoma	B-X
cell	B-X
lines	B-X
were	B-X
resistant	B-X
to	B-X
E2F-1	B-X
,	B-X
indicating	B-X
that	B-X
Apaf-1	B-X
is	B-X
an	B-X
essential	B-X
element	B-X
of	B-X
E2F-1-mediated	B-X
apoptosis	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
isolated	B-X
the	B-X
promoter	B-X
region	B-X
of	B-X
the	B-X
Apaf-1	B-X
gene	B-X
and	B-X
found	B-X
a	B-X
putative	B-X
binding	B-X
site	B-X
for	B-X
E2F	B-X
.	B-X
A	B-X
chromatin	B-X
immunoprecipitation	B-X
assay	B-X
revealed	B-X
that	B-X
E2F-1	B-X
bound	B-X
to	B-X
Apaf-1	B-X
promoter	B-X
upon	B-X
E2F-1	B-X
overexpression	B-X
,	B-X
suggesting	B-X
that	B-X
Apaf-1	B-X
is	B-X
under	B-X
transcriptional	B-X
regulation	B-X
of	B-X
E2F-1	B-X
.	B-X
These	B-X
data	B-X
demonstrate	B-X
a	B-X
novel	B-X
mechanism	B-X
of	B-X
apoptosis	B-X
in	B-X
which	B-X
an	B-X
increase	B-X
in	B-X
Apaf-1	B-X
levels	B-X
results	B-X
in	B-X
direct	B-X
activation	B-X
of	B-X
caspase-9	B-X
without	B-X
mitochondrial	B-X
damage	B-X
,	B-X
leading	B-X
to	B-X
the	B-X
initiation	B-X
of	B-X
a	B-X
caspase	B-X
cascade	B-X
.	B-X

Finally	O
,	O
we	O
isolated	O
the	O
promoter	O
region	O
of	O
the	O
Apaf	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
gene	O
and	O
found	O
a	O
putative	O
binding	O
site	O
for	O
E2F	B-Gene_or_gene_product
.	O
<EOS>	B-X
E2F-1	B-X
is	B-X
capable	B-X
of	B-X
promoting	B-X
both	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
apoptosis	B-X
.	B-X
E2F-1-induced	B-X
apoptosis	B-X
was	B-X
accompanied	B-X
by	B-X
caspase-9	B-X
activation	B-X
and	B-X
inhibited	B-X
by	B-X
a	B-X
specific	B-X
inhibitor	B-X
of	B-X
caspase-9	B-X
in	B-X
K562	B-X
sublines	B-X
overexpressing	B-X
E2F-1	B-X
.	B-X
E2F-1	B-X
enhanced	B-X
the	B-X
expression	B-X
of	B-X
Apaf-1	B-X
without	B-X
the	B-X
cytosolic	B-X
accumulation	B-X
of	B-X
cytochrome	B-X
c.	B-X
Apaf-1-deficient	B-X
melanoma	B-X
cell	B-X
lines	B-X
were	B-X
resistant	B-X
to	B-X
E2F-1	B-X
,	B-X
indicating	B-X
that	B-X
Apaf-1	B-X
is	B-X
an	B-X
essential	B-X
element	B-X
of	B-X
E2F-1-mediated	B-X
apoptosis	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
isolated	B-X
the	B-X
promoter	B-X
region	B-X
of	B-X
the	B-X
Apaf-1	B-X
gene	B-X
and	B-X
found	B-X
a	B-X
putative	B-X
binding	B-X
site	B-X
for	B-X
E2F	B-X
.	B-X
A	B-X
chromatin	B-X
immunoprecipitation	B-X
assay	B-X
revealed	B-X
that	B-X
E2F-1	B-X
bound	B-X
to	B-X
Apaf-1	B-X
promoter	B-X
upon	B-X
E2F-1	B-X
overexpression	B-X
,	B-X
suggesting	B-X
that	B-X
Apaf-1	B-X
is	B-X
under	B-X
transcriptional	B-X
regulation	B-X
of	B-X
E2F-1	B-X
.	B-X
These	B-X
data	B-X
demonstrate	B-X
a	B-X
novel	B-X
mechanism	B-X
of	B-X
apoptosis	B-X
in	B-X
which	B-X
an	B-X
increase	B-X
in	B-X
Apaf-1	B-X
levels	B-X
results	B-X
in	B-X
direct	B-X
activation	B-X
of	B-X
caspase-9	B-X
without	B-X
mitochondrial	B-X
damage	B-X
,	B-X
leading	B-X
to	B-X
the	B-X
initiation	B-X
of	B-X
a	B-X
caspase	B-X
cascade	B-X
.	B-X

A	O
chromatin	O
immunoprecipitation	O
assay	O
revealed	O
that	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
bound	O
to	O
Apaf	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
promoter	O
upon	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
overexpression	O
,	O
suggesting	O
that	O
Apaf	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
is	O
under	O
transcriptional	O
regulation	O
of	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O
<EOS>	B-X
E2F-1	B-X
is	B-X
capable	B-X
of	B-X
promoting	B-X
both	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
apoptosis	B-X
.	B-X
E2F-1-induced	B-X
apoptosis	B-X
was	B-X
accompanied	B-X
by	B-X
caspase-9	B-X
activation	B-X
and	B-X
inhibited	B-X
by	B-X
a	B-X
specific	B-X
inhibitor	B-X
of	B-X
caspase-9	B-X
in	B-X
K562	B-X
sublines	B-X
overexpressing	B-X
E2F-1	B-X
.	B-X
E2F-1	B-X
enhanced	B-X
the	B-X
expression	B-X
of	B-X
Apaf-1	B-X
without	B-X
the	B-X
cytosolic	B-X
accumulation	B-X
of	B-X
cytochrome	B-X
c.	B-X
Apaf-1-deficient	B-X
melanoma	B-X
cell	B-X
lines	B-X
were	B-X
resistant	B-X
to	B-X
E2F-1	B-X
,	B-X
indicating	B-X
that	B-X
Apaf-1	B-X
is	B-X
an	B-X
essential	B-X
element	B-X
of	B-X
E2F-1-mediated	B-X
apoptosis	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
isolated	B-X
the	B-X
promoter	B-X
region	B-X
of	B-X
the	B-X
Apaf-1	B-X
gene	B-X
and	B-X
found	B-X
a	B-X
putative	B-X
binding	B-X
site	B-X
for	B-X
E2F	B-X
.	B-X
A	B-X
chromatin	B-X
immunoprecipitation	B-X
assay	B-X
revealed	B-X
that	B-X
E2F-1	B-X
bound	B-X
to	B-X
Apaf-1	B-X
promoter	B-X
upon	B-X
E2F-1	B-X
overexpression	B-X
,	B-X
suggesting	B-X
that	B-X
Apaf-1	B-X
is	B-X
under	B-X
transcriptional	B-X
regulation	B-X
of	B-X
E2F-1	B-X
.	B-X
These	B-X
data	B-X
demonstrate	B-X
a	B-X
novel	B-X
mechanism	B-X
of	B-X
apoptosis	B-X
in	B-X
which	B-X
an	B-X
increase	B-X
in	B-X
Apaf-1	B-X
levels	B-X
results	B-X
in	B-X
direct	B-X
activation	B-X
of	B-X
caspase-9	B-X
without	B-X
mitochondrial	B-X
damage	B-X
,	B-X
leading	B-X
to	B-X
the	B-X
initiation	B-X
of	B-X
a	B-X
caspase	B-X
cascade	B-X
.	B-X

These	O
data	O
demonstrate	O
a	O
novel	O
mechanism	O
of	O
apoptosis	O
in	O
which	O
an	O
increase	O
in	O
Apaf	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
levels	O
results	O
in	O
direct	O
activation	O
of	O
caspase	B-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
without	O
mitochondrial	O
damage	O
,	O
leading	O
to	O
the	O
initiation	O
of	O
a	O
caspase	B-Gene_or_gene_product
cascade	O
.	O

Dual	O
regulation	O
of	O
the	O
met4	B-Gene_or_gene_product
transcription	O
factor	O
by	O
ubiquitin	B-Gene_or_gene_product
-	O
dependent	O
degradation	O
and	O
inhibition	O
of	O
promoter	O
recruitment	O
.	O
<EOS>	B-X
The	B-X
ubiquitin	B-X
system	B-X
has	B-X
been	B-X
recently	B-X
implicated	B-X
in	B-X
various	B-X
aspects	B-X
of	B-X
transcriptional	B-X
regulation	B-X
,	B-X
including	B-X
proteasome-dependent	B-X
degradation	B-X
of	B-X
transcriptional	B-X
activators	B-X
.	B-X
In	B-X
yeast	B-X
,	B-X
the	B-X
activator	B-X
Met4	B-X
is	B-X
inhibited	B-X
by	B-X
the	B-X
SCF	B-X
(	B-X
Met30	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
,	B-X
which	B-X
recognizes	B-X
and	B-X
oligo-ubiquitylates	B-X
Met4	B-X
.	B-X
In	B-X
the	B-X
latter	B-X
growth	B-X
condition	B-X
,	B-X
oligo-ubiquitylated	B-X
Met4	B-X
is	B-X
not	B-X
recruited	B-X
to	B-X
MET	B-X
gene	B-X
promoters	B-X
,	B-X
but	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
SAM	B-X
genes	B-X
,	B-X
which	B-X
are	B-X
required	B-X
for	B-X
production	B-X
of	B-X
S-adenosylmethionine	B-X
,	B-X
an	B-X
unstable	B-X
metabolite	B-X
that	B-X
is	B-X
not	B-X
present	B-X
in	B-X
rich	B-X
medium	B-X
.	B-X
Thus	B-X
,	B-X
ubiquitylation	B-X
not	B-X
only	B-X
regulates	B-X
Met4	B-X
by	B-X
distinct	B-X
degradation-dependent	B-X
and	B-X
-independent	B-X
mechanisms	B-X
,	B-X
but	B-X
also	B-X
controls	B-X
differential	B-X
recruitment	B-X
of	B-X
a	B-X
single	B-X
transcription	B-X
factor	B-X
to	B-X
distinct	B-X
promoters	B-X
,	B-X
thereby	B-X
diversifying	B-X
transcriptional	B-X
activator	B-X
specificity	B-X
.	B-X

The	O
ubiquitin	B-Gene_or_gene_product
system	O
has	O
been	O
recently	O
implicated	O
in	O
various	O
aspects	O
of	O
transcriptional	O
regulation	O
,	O
including	O
proteasome	O
-	O
dependent	O
degradation	O
of	O
transcriptional	O
activators	O
.	O
<EOS>	B-X
The	B-X
ubiquitin	B-X
system	B-X
has	B-X
been	B-X
recently	B-X
implicated	B-X
in	B-X
various	B-X
aspects	B-X
of	B-X
transcriptional	B-X
regulation	B-X
,	B-X
including	B-X
proteasome-dependent	B-X
degradation	B-X
of	B-X
transcriptional	B-X
activators	B-X
.	B-X
In	B-X
yeast	B-X
,	B-X
the	B-X
activator	B-X
Met4	B-X
is	B-X
inhibited	B-X
by	B-X
the	B-X
SCF	B-X
(	B-X
Met30	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
,	B-X
which	B-X
recognizes	B-X
and	B-X
oligo-ubiquitylates	B-X
Met4	B-X
.	B-X
Thus	B-X
,	B-X
ubiquitylation	B-X
not	B-X
only	B-X
regulates	B-X
Met4	B-X
by	B-X
distinct	B-X
degradation-dependent	B-X
and	B-X
-independent	B-X
mechanisms	B-X
,	B-X
but	B-X
also	B-X
controls	B-X
differential	B-X
recruitment	B-X
of	B-X
a	B-X
single	B-X
transcription	B-X
factor	B-X
to	B-X
distinct	B-X
promoters	B-X
,	B-X
thereby	B-X
diversifying	B-X
transcriptional	B-X
activator	B-X
specificity	B-X
.	B-X

In	O
yeast	O
,	O
the	O
activator	O
Met4	B-Gene_or_gene_product
is	O
inhibited	O
by	O
the	O
SCF	O
(	O
Met30	O
)	O
ubiquitin	B-Gene_or_gene_product
ligase	O
,	O
which	O
recognizes	O
and	O
oligo	O
-	O
ubiquitylates	O
Met4	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
ubiquitin	B-X
system	B-X
has	B-X
been	B-X
recently	B-X
implicated	B-X
in	B-X
various	B-X
aspects	B-X
of	B-X
transcriptional	B-X
regulation	B-X
,	B-X
including	B-X
proteasome-dependent	B-X
degradation	B-X
of	B-X
transcriptional	B-X
activators	B-X
.	B-X
In	B-X
yeast	B-X
,	B-X
the	B-X
activator	B-X
Met4	B-X
is	B-X
inhibited	B-X
by	B-X
the	B-X
SCF	B-X
(	B-X
Met30	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
,	B-X
which	B-X
recognizes	B-X
and	B-X
oligo-ubiquitylates	B-X
Met4	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
in	B-X
minimal	B-X
media	B-X
,	B-X
Met4	B-X
is	B-X
ubiquitylated	B-X
and	B-X
rapidly	B-X
degraded	B-X
in	B-X
response	B-X
to	B-X
methionine	B-X
excess	B-X
,	B-X
whereas	B-X
in	B-X
rich	B-X
media	B-X
,	B-X
Met4	B-X
is	B-X
oligo-ubiquitylated	B-X
but	B-X
remains	B-X
stable	B-X
.	B-X
In	B-X
the	B-X
latter	B-X
growth	B-X
condition	B-X
,	B-X
oligo-ubiquitylated	B-X
Met4	B-X
is	B-X
not	B-X
recruited	B-X
to	B-X
MET	B-X
gene	B-X
promoters	B-X
,	B-X
but	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
SAM	B-X
genes	B-X
,	B-X
which	B-X
are	B-X
required	B-X
for	B-X
production	B-X
of	B-X
S-adenosylmethionine	B-X
,	B-X
an	B-X
unstable	B-X
metabolite	B-X
that	B-X
is	B-X
not	B-X
present	B-X
in	B-X
rich	B-X
medium	B-X
.	B-X
Thus	B-X
,	B-X
ubiquitylation	B-X
not	B-X
only	B-X
regulates	B-X
Met4	B-X
by	B-X
distinct	B-X
degradation-dependent	B-X
and	B-X
-independent	B-X
mechanisms	B-X
,	B-X
but	B-X
also	B-X
controls	B-X
differential	B-X
recruitment	B-X
of	B-X
a	B-X
single	B-X
transcription	B-X
factor	B-X
to	B-X
distinct	B-X
promoters	B-X
,	B-X
thereby	B-X
diversifying	B-X
transcriptional	B-X
activator	B-X
specificity	B-X
.	B-X

Here	O
,	O
we	O
demonstrate	O
that	O
in	O
minimal	O
media	O
,	O
Met4	B-Gene_or_gene_product
is	O
ubiquitylated	O
and	O
rapidly	O
degraded	O
in	O
response	O
to	O
methionine	O
excess	O
,	O
whereas	O
in	O
rich	O
media	O
,	O
Met4	B-Gene_or_gene_product
is	O
oligo	O
-	O
ubiquitylated	O
but	O
remains	O
stable	O
.	O
<EOS>	B-X
In	B-X
yeast	B-X
,	B-X
the	B-X
activator	B-X
Met4	B-X
is	B-X
inhibited	B-X
by	B-X
the	B-X
SCF	B-X
(	B-X
Met30	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
,	B-X
which	B-X
recognizes	B-X
and	B-X
oligo-ubiquitylates	B-X
Met4	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
in	B-X
minimal	B-X
media	B-X
,	B-X
Met4	B-X
is	B-X
ubiquitylated	B-X
and	B-X
rapidly	B-X
degraded	B-X
in	B-X
response	B-X
to	B-X
methionine	B-X
excess	B-X
,	B-X
whereas	B-X
in	B-X
rich	B-X
media	B-X
,	B-X
Met4	B-X
is	B-X
oligo-ubiquitylated	B-X
but	B-X
remains	B-X
stable	B-X
.	B-X
In	B-X
the	B-X
latter	B-X
growth	B-X
condition	B-X
,	B-X
oligo-ubiquitylated	B-X
Met4	B-X
is	B-X
not	B-X
recruited	B-X
to	B-X
MET	B-X
gene	B-X
promoters	B-X
,	B-X
but	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
SAM	B-X
genes	B-X
,	B-X
which	B-X
are	B-X
required	B-X
for	B-X
production	B-X
of	B-X
S-adenosylmethionine	B-X
,	B-X
an	B-X
unstable	B-X
metabolite	B-X
that	B-X
is	B-X
not	B-X
present	B-X
in	B-X
rich	B-X
medium	B-X
.	B-X
Thus	B-X
,	B-X
ubiquitylation	B-X
not	B-X
only	B-X
regulates	B-X
Met4	B-X
by	B-X
distinct	B-X
degradation-dependent	B-X
and	B-X
-independent	B-X
mechanisms	B-X
,	B-X
but	B-X
also	B-X
controls	B-X
differential	B-X
recruitment	B-X
of	B-X
a	B-X
single	B-X
transcription	B-X
factor	B-X
to	B-X
distinct	B-X
promoters	B-X
,	B-X
thereby	B-X
diversifying	B-X
transcriptional	B-X
activator	B-X
specificity	B-X
.	B-X

In	O
the	O
latter	O
growth	O
condition	O
,	O
oligo	O
-	O
ubiquitylated	O
Met4	B-Gene_or_gene_product
is	O
not	O
recruited	O
to	O
MET	O
gene	O
promoters	O
,	O
but	O
is	O
recruited	O
to	O
the	O
SAM	O
genes	O
,	O
which	O
are	O
required	O
for	O
production	O
of	O
S	O
-	O
adenosylmethionine	O
,	O
an	O
unstable	O
metabolite	O
that	O
is	O
not	O
present	O
in	O
rich	O
medium	O
.	O

Thus	O
,	O
ubiquitylation	O
not	O
only	O
regulates	O
Met4	B-Gene_or_gene_product
by	O
distinct	O
degradation	O
-	O
dependent	O
and	O
-	O
independent	O
mechanisms	O
,	O
but	O
also	O
controls	O
differential	O
recruitment	O
of	O
a	O
single	O
transcription	O
factor	O
to	O
distinct	O
promoters	O
,	O
thereby	O
diversifying	O
transcriptional	O
activator	O
specificity	O
.	O
<EOS>	B-X
In	B-X
recent	B-X
years	B-X
,	B-X
considerable	B-X
progress	B-X
has	B-X
been	B-X
made	B-X
in	B-X
the	B-X
understanding	B-X
of	B-X
the	B-X
molecular	B-X
action	B-X
of	B-X
ubiquitin	B-X
in	B-X
signaling	B-X
pathways	B-X
and	B-X
how	B-X
alterations	B-X
in	B-X
the	B-X
ubiquitin	B-X
system	B-X
lead	B-X
to	B-X
the	B-X
development	B-X
of	B-X
distinct	B-X
human	B-X
diseases	B-X
.	B-X
Ubiquitination	B-X
has	B-X
long	B-X
been	B-X
recognised	B-X
as	B-X
a	B-X
key	B-X
determinator	B-X
of	B-X
protein	B-X
fate	B-X
by	B-X
tagging	B-X
proteins	B-X
for	B-X
proteasomal	B-X
degradation	B-X
.	B-X
Although	B-X
autophagy	B-X
was	B-X
first	B-X
believed	B-X
to	B-X
be	B-X
a	B-X
bulk	B-X
,	B-X
non-selective	B-X
'self-eating	B-X
'	B-X
degradative	B-X
process	B-X
,	B-X
the	B-X
molecular	B-X
mechanisms	B-X
of	B-X
selectivity	B-X
are	B-X
now	B-X
starting	B-X
to	B-X
emerge	B-X
.	B-X
Deubiquitinases	B-X
(	B-X
DUBs	B-X
)	B-X
are	B-X
specialized	B-X
proteases	B-X
that	B-X
remove	B-X
ubiquitin	B-X
from	B-X
substrates	B-X
or	B-X
cleave	B-X
within	B-X
ubiquitin	B-X
chains	B-X
to	B-X
regulate	B-X
ubiquitylation	B-X
and	B-X
therefore	B-X
play	B-X
important	B-X
roles	B-X
in	B-X
eukaryotic	B-X
biology	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
summarize	B-X
the	B-X
multiple	B-X
layers	B-X
of	B-X
regulation	B-X
that	B-X
control	B-X
autoinhibition	B-X
,	B-X
activation	B-X
,	B-X
and	B-X
substrate	B-X
specificity	B-X
of	B-X
DUBs	B-X
.	B-X

Genetic	O
and	O
epigenetic	O
alterations	O
of	O
the	O
INK4a	B-Gene_or_gene_product
-	O
ARF	B-Gene_or_gene_product
pathway	O
in	O
cholangiocarcinoma	O
.	O
<EOS>	B-X
The	B-X
INK4a-ARF	B-X
locus	B-X
,	B-X
located	B-X
on	B-X
chromosome	B-X
9p21	B-X
,	B-X
encodes	B-X
two	B-X
cell-cycle	B-X
regulatory	B-X
proteins	B-X
,	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
and	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
,	B-X
acting	B-X
through	B-X
the	B-X
Rb-CDK4	B-X
and	B-X
p53	B-X
pathways	B-X
.	B-X
To	B-X
study	B-X
the	B-X
contribution	B-X
of	B-X
each	B-X
pathway	B-X
in	B-X
the	B-X
tumourigenesis	B-X
of	B-X
cholangiocarcinoma	B-X
,	B-X
the	B-X
alterations	B-X
of	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
,	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
,	B-X
p53	B-X
,	B-X
and	B-X
pRb	B-X
were	B-X
analysed	B-X
.	B-X
After	B-X
microdissection	B-X
,	B-X
DNAs	B-X
from	B-X
51	B-X
cholangiocarcinomas	B-X
were	B-X
analysed	B-X
by	B-X
methylation-specific	B-X
PCR	B-X
(	B-X
MSP	B-X
)	B-X
,	B-X
restriction-enzyme	B-X
related	B-X
polymerase	B-X
chain	B-X
reaction	B-X
(	B-X
RE-PCR	B-X
)	B-X
,	B-X
microsatellite	B-X
analysis	B-X
,	B-X
mRNA	B-X
expression	B-X
,	B-X
and	B-X
DNA	B-X
sequencing	B-X
.	B-X
Immunohistochemistry	B-X
of	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
,	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
,	B-X
p53	B-X
,	B-X
and	B-X
pRb	B-X
was	B-X
also	B-X
performed	B-X
.	B-X
Promoter	B-X
methylation	B-X
of	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
was	B-X
found	B-X
in	B-X
13/51	B-X
cases	B-X
(	B-X
25	B-X
%	B-X
)	B-X
and	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
showed	B-X
aberrant	B-X
promoter	B-X
methylation	B-X
in	B-X
39/51	B-X
cases	B-X
(	B-X
76	B-X
%	B-X
)	B-X
which	B-X
correlated	B-X
with	B-X
loss	B-X
of	B-X
mRNA	B-X
transcription	B-X
.	B-X
Two	B-X
tumours	B-X
(	B-X
4	B-X
%	B-X
)	B-X
had	B-X
homozygous	B-X
deletion	B-X
of	B-X
the	B-X
INK4a-ARF	B-X
locus	B-X
.	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
inactivation	B-X
appeared	B-X
in	B-X
the	B-X
context	B-X
of	B-X
an	B-X
unmethylated	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
promoter	B-X
in	B-X
eight	B-X
of	B-X
13	B-X
cases	B-X
(	B-X
61	B-X
%	B-X
)	B-X
of	B-X
the	B-X
carcinomas	B-X
methylated	B-X
at	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
.	B-X
Mutations	B-X
of	B-X
p53	B-X
were	B-X
found	B-X
in	B-X
19	B-X
of	B-X
51	B-X
tumours	B-X
(	B-X
37	B-X
%	B-X
)	B-X
,	B-X
and	B-X
four	B-X
of	B-X
them	B-X
(	B-X
21	B-X
%	B-X
)	B-X
harboured	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
inactivation	B-X
.	B-X
Alterations	B-X
of	B-X
the	B-X
INK4a-ARF	B-X
locus	B-X
,	B-X
pRB	B-X
or	B-X
p53	B-X
status	B-X
could	B-X
not	B-X
be	B-X
established	B-X
as	B-X
independent	B-X
prognostic	B-X
factors	B-X
in	B-X
these	B-X
tumours	B-X
.	B-X
These	B-X
findings	B-X
indicate	B-X
that	B-X
the	B-X
INK4a-ARF	B-X
locus	B-X
is	B-X
frequently	B-X
inactivated	B-X
in	B-X
cholangiocarcinoma	B-X
of	B-X
the	B-X
liver	B-X
and	B-X
occurs	B-X
independently	B-X
of	B-X
the	B-X
status	B-X
of	B-X
p53	B-X
or	B-X
pRb	B-X
.	B-X

The	O
INK4a	B-Gene_or_gene_product
-	O
ARF	B-Gene_or_gene_product
locus	O
,	O
located	O
on	O
chromosome	O
9p21	O
,	O
encodes	O
two	O
cell	O
-	O
cycle	O
regulatory	O
proteins	O
,	O
p16	B-Gene_or_gene_product
(	O
INK4a	B-Gene_or_gene_product
)	O
and	O
p14	B-Gene_or_gene_product
(	O
ARF	B-Gene_or_gene_product
)	O
,	O
acting	O
through	O
the	O
Rb	B-Gene_or_gene_product
-	O
CDK4	B-Gene_or_gene_product
and	O
p53	B-Gene_or_gene_product
pathways	O
.	O
<EOS>	B-X
The	B-X
INK4a-ARF	B-X
locus	B-X
,	B-X
located	B-X
on	B-X
chromosome	B-X
9p21	B-X
,	B-X
encodes	B-X
two	B-X
cell-cycle	B-X
regulatory	B-X
proteins	B-X
,	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
and	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
,	B-X
acting	B-X
through	B-X
the	B-X
Rb-CDK4	B-X
and	B-X
p53	B-X
pathways	B-X
.	B-X
To	B-X
study	B-X
the	B-X
contribution	B-X
of	B-X
each	B-X
pathway	B-X
in	B-X
the	B-X
tumourigenesis	B-X
of	B-X
cholangiocarcinoma	B-X
,	B-X
the	B-X
alterations	B-X
of	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
,	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
,	B-X
p53	B-X
,	B-X
and	B-X
pRb	B-X
were	B-X
analysed	B-X
.	B-X
Immunohistochemistry	B-X
of	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
,	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
,	B-X
p53	B-X
,	B-X
and	B-X
pRb	B-X
was	B-X
also	B-X
performed	B-X
.	B-X
Promoter	B-X
methylation	B-X
of	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
was	B-X
found	B-X
in	B-X
13/51	B-X
cases	B-X
(	B-X
25	B-X
%	B-X
)	B-X
and	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
showed	B-X
aberrant	B-X
promoter	B-X
methylation	B-X
in	B-X
39/51	B-X
cases	B-X
(	B-X
76	B-X
%	B-X
)	B-X
which	B-X
correlated	B-X
with	B-X
loss	B-X
of	B-X
mRNA	B-X
transcription	B-X
.	B-X
Two	B-X
tumours	B-X
(	B-X
4	B-X
%	B-X
)	B-X
had	B-X
homozygous	B-X
deletion	B-X
of	B-X
the	B-X
INK4a-ARF	B-X
locus	B-X
.	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
inactivation	B-X
appeared	B-X
in	B-X
the	B-X
context	B-X
of	B-X
an	B-X
unmethylated	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
promoter	B-X
in	B-X
eight	B-X
of	B-X
13	B-X
cases	B-X
(	B-X
61	B-X
%	B-X
)	B-X
of	B-X
the	B-X
carcinomas	B-X
methylated	B-X
at	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
.	B-X
Mutations	B-X
of	B-X
p53	B-X
were	B-X
found	B-X
in	B-X
19	B-X
of	B-X
51	B-X
tumours	B-X
(	B-X
37	B-X
%	B-X
)	B-X
,	B-X
and	B-X
four	B-X
of	B-X
them	B-X
(	B-X
21	B-X
%	B-X
)	B-X
harboured	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
inactivation	B-X
.	B-X
The	B-X
pRb	B-X
protein	B-X
was	B-X
detected	B-X
in	B-X
30/51	B-X
(	B-X
59	B-X
%	B-X
)	B-X
tumours	B-X
examined	B-X
.	B-X
Alterations	B-X
of	B-X
the	B-X
INK4a-ARF	B-X
locus	B-X
,	B-X
pRB	B-X
or	B-X
p53	B-X
status	B-X
could	B-X
not	B-X
be	B-X
established	B-X
as	B-X
independent	B-X
prognostic	B-X
factors	B-X
in	B-X
these	B-X
tumours	B-X
.	B-X
These	B-X
findings	B-X
indicate	B-X
that	B-X
the	B-X
INK4a-ARF	B-X
locus	B-X
is	B-X
frequently	B-X
inactivated	B-X
in	B-X
cholangiocarcinoma	B-X
of	B-X
the	B-X
liver	B-X
and	B-X
occurs	B-X
independently	B-X
of	B-X
the	B-X
status	B-X
of	B-X
p53	B-X
or	B-X
pRb	B-X
.	B-X

To	O
study	O
the	O
contribution	O
of	O
each	O
pathway	O
in	O
the	O
tumourigenesis	O
of	O
cholangiocarcinoma	O
,	O
the	O
alterations	O
of	O
p14	B-Gene_or_gene_product
(	O
ARF	B-Gene_or_gene_product
)	O
,	O
p16	B-Gene_or_gene_product
(	O
INK4a	B-Gene_or_gene_product
)	O
,	O
p53	B-Gene_or_gene_product
,	O
and	O
pRb	B-Gene_or_gene_product
were	O
analysed	O
.	O

After	O
microdissection	O
,	O
DNAs	O
from	O
51	O
cholangiocarcinomas	O
were	O
analysed	O
by	O
methylation	O
-	O
specific	O
PCR	O
(	O
MSP	O
)	O
,	O
restriction	O
-	O
enzyme	O
related	O
polymerase	O
chain	O
reaction	O
(	O
RE	O
-	O
PCR	O
)	O
,	O
microsatellite	O
analysis	O
,	O
mRNA	O
expression	O
,	O
and	O
DNA	O
sequencing	O
.	O
<EOS>	B-X
To	B-X
study	B-X
the	B-X
contribution	B-X
of	B-X
each	B-X
pathway	B-X
in	B-X
the	B-X
tumourigenesis	B-X
of	B-X
cholangiocarcinoma	B-X
,	B-X
the	B-X
alterations	B-X
of	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
,	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
,	B-X
p53	B-X
,	B-X
and	B-X
pRb	B-X
were	B-X
analysed	B-X
.	B-X
After	B-X
microdissection	B-X
,	B-X
DNAs	B-X
from	B-X
51	B-X
cholangiocarcinomas	B-X
were	B-X
analysed	B-X
by	B-X
methylation-specific	B-X
PCR	B-X
(	B-X
MSP	B-X
)	B-X
,	B-X
restriction-enzyme	B-X
related	B-X
polymerase	B-X
chain	B-X
reaction	B-X
(	B-X
RE-PCR	B-X
)	B-X
,	B-X
microsatellite	B-X
analysis	B-X
,	B-X
mRNA	B-X
expression	B-X
,	B-X
and	B-X
DNA	B-X
sequencing	B-X
.	B-X
Promoter	B-X
methylation	B-X
of	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
was	B-X
found	B-X
in	B-X
13/51	B-X
cases	B-X
(	B-X
25	B-X
%	B-X
)	B-X
and	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
showed	B-X
aberrant	B-X
promoter	B-X
methylation	B-X
in	B-X
39/51	B-X
cases	B-X
(	B-X
76	B-X
%	B-X
)	B-X
which	B-X
correlated	B-X
with	B-X
loss	B-X
of	B-X
mRNA	B-X
transcription	B-X
.	B-X
Mutations	B-X
of	B-X
p53	B-X
were	B-X
found	B-X
in	B-X
19	B-X
of	B-X
51	B-X
tumours	B-X
(	B-X
37	B-X
%	B-X
)	B-X
,	B-X
and	B-X
four	B-X
of	B-X
them	B-X
(	B-X
21	B-X
%	B-X
)	B-X
harboured	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
inactivation	B-X
.	B-X
The	B-X
pRb	B-X
protein	B-X
was	B-X
detected	B-X
in	B-X
30/51	B-X
(	B-X
59	B-X
%	B-X
)	B-X
tumours	B-X
examined	B-X
.	B-X

Immunohistochemistry	O
of	O
p14	B-Gene_or_gene_product
(	O
ARF	B-Gene_or_gene_product
)	O
,	O
p16	B-Gene_or_gene_product
(	O
INK4a	B-Gene_or_gene_product
)	O
,	O
p53	B-Gene_or_gene_product
,	O
and	O
pRb	B-Gene_or_gene_product
was	O
also	O
performed	O
.	O
<EOS>	B-X
The	B-X
INK4a-ARF	B-X
locus	B-X
,	B-X
located	B-X
on	B-X
chromosome	B-X
9p21	B-X
,	B-X
encodes	B-X
two	B-X
cell-cycle	B-X
regulatory	B-X
proteins	B-X
,	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
and	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
,	B-X
acting	B-X
through	B-X
the	B-X
Rb-CDK4	B-X
and	B-X
p53	B-X
pathways	B-X
.	B-X
To	B-X
study	B-X
the	B-X
contribution	B-X
of	B-X
each	B-X
pathway	B-X
in	B-X
the	B-X
tumourigenesis	B-X
of	B-X
cholangiocarcinoma	B-X
,	B-X
the	B-X
alterations	B-X
of	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
,	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
,	B-X
p53	B-X
,	B-X
and	B-X
pRb	B-X
were	B-X
analysed	B-X
.	B-X
Immunohistochemistry	B-X
of	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
,	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
,	B-X
p53	B-X
,	B-X
and	B-X
pRb	B-X
was	B-X
also	B-X
performed	B-X
.	B-X
Promoter	B-X
methylation	B-X
of	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
was	B-X
found	B-X
in	B-X
13/51	B-X
cases	B-X
(	B-X
25	B-X
%	B-X
)	B-X
and	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
showed	B-X
aberrant	B-X
promoter	B-X
methylation	B-X
in	B-X
39/51	B-X
cases	B-X
(	B-X
76	B-X
%	B-X
)	B-X
which	B-X
correlated	B-X
with	B-X
loss	B-X
of	B-X
mRNA	B-X
transcription	B-X
.	B-X
Two	B-X
tumours	B-X
(	B-X
4	B-X
%	B-X
)	B-X
had	B-X
homozygous	B-X
deletion	B-X
of	B-X
the	B-X
INK4a-ARF	B-X
locus	B-X
.	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
inactivation	B-X
appeared	B-X
in	B-X
the	B-X
context	B-X
of	B-X
an	B-X
unmethylated	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
promoter	B-X
in	B-X
eight	B-X
of	B-X
13	B-X
cases	B-X
(	B-X
61	B-X
%	B-X
)	B-X
of	B-X
the	B-X
carcinomas	B-X
methylated	B-X
at	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
.	B-X
Mutations	B-X
of	B-X
p53	B-X
were	B-X
found	B-X
in	B-X
19	B-X
of	B-X
51	B-X
tumours	B-X
(	B-X
37	B-X
%	B-X
)	B-X
,	B-X
and	B-X
four	B-X
of	B-X
them	B-X
(	B-X
21	B-X
%	B-X
)	B-X
harboured	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
inactivation	B-X
.	B-X
The	B-X
pRb	B-X
protein	B-X
was	B-X
detected	B-X
in	B-X
30/51	B-X
(	B-X
59	B-X
%	B-X
)	B-X
tumours	B-X
examined	B-X
.	B-X
Alterations	B-X
of	B-X
the	B-X
INK4a-ARF	B-X
locus	B-X
,	B-X
pRB	B-X
or	B-X
p53	B-X
status	B-X
could	B-X
not	B-X
be	B-X
established	B-X
as	B-X
independent	B-X
prognostic	B-X
factors	B-X
in	B-X
these	B-X
tumours	B-X
.	B-X
These	B-X
findings	B-X
indicate	B-X
that	B-X
the	B-X
INK4a-ARF	B-X
locus	B-X
is	B-X
frequently	B-X
inactivated	B-X
in	B-X
cholangiocarcinoma	B-X
of	B-X
the	B-X
liver	B-X
and	B-X
occurs	B-X
independently	B-X
of	B-X
the	B-X
status	B-X
of	B-X
p53	B-X
or	B-X
pRb	B-X
.	B-X

Promoter	O
methylation	O
of	O
p14	B-Gene_or_gene_product
(	O
ARF	B-Gene_or_gene_product
)	O
was	O
found	O
in	O
13	O
/	O
51	O
cases	O
(	O
25	O
%	O
)	O
and	O
p16	B-Gene_or_gene_product
(	O
INK4a	B-Gene_or_gene_product
)	O
showed	O
aberrant	O
promoter	O
methylation	O
in	O
39	O
/	O
51	O
cases	O
(	O
76	O
%	O
)	O
which	O
correlated	O
with	O
loss	O
of	O
mRNA	O
transcription	O
.	O

Two	O
tumours	O
(	O
4	O
%	O
)	O
had	O
homozygous	O
deletion	O
of	O
the	O
INK4a	B-Gene_or_gene_product
-	O
ARF	B-Gene_or_gene_product
locus	O
.	O
<EOS>	B-X
To	B-X
elucidate	B-X
the	B-X
role	B-X
of	B-X
p53/p16	B-X
(	B-X
INK4a	B-X
)	B-X
/RB1	B-X
pathways	B-X
in	B-X
prostate	B-X
carcinogenesis	B-X
,	B-X
we	B-X
analyzed	B-X
the	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
,	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
,	B-X
RB1	B-X
,	B-X
p21	B-X
(	B-X
Waf1	B-X
)	B-X
,	B-X
p27	B-X
(	B-X
Kip1	B-X
)	B-X
,	B-X
PTEN	B-X
,	B-X
p73	B-X
,	B-X
p53	B-X
,	B-X
and	B-X
MDM2	B-X
gene	B-X
status	B-X
of	B-X
multiple	B-X
areas	B-X
within	B-X
16	B-X
histologically	B-X
heterogeneous	B-X
prostate	B-X
carcinomas	B-X
using	B-X
methylation-specific	B-X
polymerase	B-X
chain	B-X
reaction	B-X
,	B-X
differential	B-X
polymerase	B-X
chain	B-X
reaction	B-X
,	B-X
and	B-X
immunohistochemistry	B-X
.	B-X
Methylation	B-X
of	B-X
either	B-X
PTEN	B-X
or	B-X
p73	B-X
was	B-X
undetected	B-X
in	B-X
any	B-X
sample	B-X
,	B-X
whereas	B-X
expression	B-X
of	B-X
MDM2	B-X
seemed	B-X
to	B-X
be	B-X
an	B-X
independent	B-X
event	B-X
within	B-X
small	B-X
foci	B-X
of	B-X
4	B-X
of	B-X
16	B-X
tumors	B-X
.	B-X
Loss	B-X
of	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
,	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
,	B-X
RB1	B-X
,	B-X
and	B-X
p27	B-X
(	B-X
Kip1	B-X
)	B-X
expression	B-X
correlated	B-X
with	B-X
homozygous	B-X
deletion	B-X
or	B-X
promoter	B-X
hypermethylation	B-X
.	B-X
One	B-X
carcinoma	B-X
showed	B-X
co-deletion	B-X
of	B-X
both	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
and	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
in	B-X
two	B-X
of	B-X
five	B-X
areas	B-X
examined	B-X
;	B-X
two	B-X
areas	B-X
within	B-X
another	B-X
tumor	B-X
demonstrated	B-X
concurrent	B-X
hypermethylation	B-X
of	B-X
the	B-X
promoter	B-X
regions	B-X
of	B-X
the	B-X
same	B-X
genes	B-X
.	B-X

Specific	O
mutations	O
of	O
both	O
exons	O
were	O
not	O
detected	O
.	O
<EOS>	B-X
Gsα-coding	B-X
GNAS	B-X
mutations	B-X
that	B-X
lead	B-X
to	B-X
diminished	B-X
Gsα	B-X
expression	B-X
and/or	B-X
function	B-X
result	B-X
in	B-X
Albright	B-X
's	B-X
hereditary	B-X
osteodystrophy	B-X
(	B-X
AHO	B-X
)	B-X
with	B-X
or	B-X
without	B-X
hormone	B-X
resistance	B-X
,	B-X
i.e.	B-X
,	B-X
pseudohypoparathyroidism	B-X
type-Ia/Ic	B-X
and	B-X
pseudo-pseudohypoparathyroidism	B-X
,	B-X
respectively	B-X
.	B-X
Notably	B-X
,	B-X
we	B-X
observed	B-X
a	B-X
mutually	B-X
exclusive	B-X
pattern	B-X
between	B-X
EIS	B-X
and	B-X
somatic	B-X
mutations	B-X
in	B-X
their	B-X
affected	B-X
genes	B-X
.	B-X
To	B-X
identify	B-X
further	B-X
genetic	B-X
risk	B-X
factors	B-X
,	B-X
here	B-X
we	B-X
assess	B-X
the	B-X
role	B-X
of	B-X
de	B-X
novo	B-X
mutations	B-X
in	B-X
ASD	B-X
by	B-X
sequencing	B-X
the	B-X
exomes	B-X
of	B-X
ASD	B-X
cases	B-X
and	B-X
their	B-X
parents	B-X
(	B-X
n	B-X
=	B-X
175	B-X
trios	B-X
)	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
proteins	B-X
encoded	B-X
by	B-X
genes	B-X
that	B-X
harboured	B-X
de	B-X
novo	B-X
missense	B-X
or	B-X
nonsense	B-X
mutations	B-X
showed	B-X
a	B-X
higher	B-X
degree	B-X
of	B-X
connectivity	B-X
among	B-X
themselves	B-X
and	B-X
to	B-X
previous	B-X
ASD	B-X
genes	B-X
as	B-X
indexed	B-X
by	B-X
protein-protein	B-X
interaction	B-X
screens	B-X
.	B-X
The	B-X
small	B-X
increase	B-X
in	B-X
the	B-X
rate	B-X
of	B-X
de	B-X
novo	B-X
events	B-X
,	B-X
when	B-X
taken	B-X
together	B-X
with	B-X
the	B-X
protein	B-X
interaction	B-X
results	B-X
,	B-X
are	B-X
consistent	B-X
with	B-X
an	B-X
important	B-X
but	B-X
limited	B-X
role	B-X
for	B-X
de	B-X
novo	B-X
point	B-X
mutations	B-X
in	B-X
ASD	B-X
,	B-X
similar	B-X
to	B-X
that	B-X
documented	B-X
for	B-X
de	B-X
novo	B-X
copy	B-X
number	B-X
variants	B-X
.	B-X
Our	B-X
results	B-X
support	B-X
polygenic	B-X
models	B-X
in	B-X
which	B-X
spontaneous	B-X
coding	B-X
mutations	B-X
in	B-X
any	B-X
of	B-X
a	B-X
large	B-X
number	B-X
of	B-X
genes	B-X
increases	B-X
risk	B-X
by	B-X
5-	B-X
to	B-X
20-fold	B-X
.	B-X

p14	B-Gene_or_gene_product
(	O
ARF	B-Gene_or_gene_product
)	O
inactivation	O
appeared	O
in	O
the	O
context	O
of	O
an	O
unmethylated	O
p16	B-Gene_or_gene_product
(	O
INK4a	B-Gene_or_gene_product
)	O
promoter	O
in	O
eight	O
of	O
13	O
cases	O
(	O
61	O
%	O
)	O
of	O
the	O
carcinomas	O
methylated	O
at	O
p14	B-Gene_or_gene_product
(	O
ARF	B-Gene_or_gene_product
)	O
.	O

Mutations	O
of	O
p53	B-Gene_or_gene_product
were	O
found	O
in	O
19	O
of	O
51	O
tumours	O
(	O
37	O
%	O
)	O
,	O
and	O
four	O
of	O
them	O
(	O
21	O
%	O
)	O
harboured	O
p14	B-Gene_or_gene_product
(	O
ARF	B-Gene_or_gene_product
)	O
inactivation	O
.	O

The	O
pRb	B-Gene_or_gene_product
protein	O
was	O
detected	O
in	O
30	O
/	O
51	O
(	O
59	O
%	O
)	O
tumours	O
examined	O
.	O
<EOS>	B-X
The	B-X
INK4a-ARF	B-X
locus	B-X
,	B-X
located	B-X
on	B-X
chromosome	B-X
9p21	B-X
,	B-X
encodes	B-X
two	B-X
cell-cycle	B-X
regulatory	B-X
proteins	B-X
,	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
and	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
,	B-X
acting	B-X
through	B-X
the	B-X
Rb-CDK4	B-X
and	B-X
p53	B-X
pathways	B-X
.	B-X
To	B-X
study	B-X
the	B-X
contribution	B-X
of	B-X
each	B-X
pathway	B-X
in	B-X
the	B-X
tumourigenesis	B-X
of	B-X
cholangiocarcinoma	B-X
,	B-X
the	B-X
alterations	B-X
of	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
,	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
,	B-X
p53	B-X
,	B-X
and	B-X
pRb	B-X
were	B-X
analysed	B-X
.	B-X
After	B-X
microdissection	B-X
,	B-X
DNAs	B-X
from	B-X
51	B-X
cholangiocarcinomas	B-X
were	B-X
analysed	B-X
by	B-X
methylation-specific	B-X
PCR	B-X
(	B-X
MSP	B-X
)	B-X
,	B-X
restriction-enzyme	B-X
related	B-X
polymerase	B-X
chain	B-X
reaction	B-X
(	B-X
RE-PCR	B-X
)	B-X
,	B-X
microsatellite	B-X
analysis	B-X
,	B-X
mRNA	B-X
expression	B-X
,	B-X
and	B-X
DNA	B-X
sequencing	B-X
.	B-X
Immunohistochemistry	B-X
of	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
,	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
,	B-X
p53	B-X
,	B-X
and	B-X
pRb	B-X
was	B-X
also	B-X
performed	B-X
.	B-X
Promoter	B-X
methylation	B-X
of	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
was	B-X
found	B-X
in	B-X
13/51	B-X
cases	B-X
(	B-X
25	B-X
%	B-X
)	B-X
and	B-X
p16	B-X
(	B-X
INK4a	B-X
)	B-X
showed	B-X
aberrant	B-X
promoter	B-X
methylation	B-X
in	B-X
39/51	B-X
cases	B-X
(	B-X
76	B-X
%	B-X
)	B-X
which	B-X
correlated	B-X
with	B-X
loss	B-X
of	B-X
mRNA	B-X
transcription	B-X
.	B-X
Two	B-X
tumours	B-X
(	B-X
4	B-X
%	B-X
)	B-X
had	B-X
homozygous	B-X
deletion	B-X
of	B-X
the	B-X
INK4a-ARF	B-X
locus	B-X
.	B-X
Specific	B-X
mutations	B-X
of	B-X
both	B-X
exons	B-X
were	B-X
not	B-X
detected	B-X
.	B-X
Mutations	B-X
of	B-X
p53	B-X
were	B-X
found	B-X
in	B-X
19	B-X
of	B-X
51	B-X
tumours	B-X
(	B-X
37	B-X
%	B-X
)	B-X
,	B-X
and	B-X
four	B-X
of	B-X
them	B-X
(	B-X
21	B-X
%	B-X
)	B-X
harboured	B-X
p14	B-X
(	B-X
ARF	B-X
)	B-X
inactivation	B-X
.	B-X
The	B-X
pRb	B-X
protein	B-X
was	B-X
detected	B-X
in	B-X
30/51	B-X
(	B-X
59	B-X
%	B-X
)	B-X
tumours	B-X
examined	B-X
.	B-X
The	B-X
absence	B-X
of	B-X
pRB	B-X
protein	B-X
did	B-X
not	B-X
correlate	B-X
with	B-X
any	B-X
of	B-X
the	B-X
examined	B-X
parameters	B-X
.	B-X
Alterations	B-X
of	B-X
the	B-X
INK4a-ARF	B-X
locus	B-X
,	B-X
pRB	B-X
or	B-X
p53	B-X
status	B-X
could	B-X
not	B-X
be	B-X
established	B-X
as	B-X
independent	B-X
prognostic	B-X
factors	B-X
in	B-X
these	B-X
tumours	B-X
.	B-X
These	B-X
findings	B-X
indicate	B-X
that	B-X
the	B-X
INK4a-ARF	B-X
locus	B-X
is	B-X
frequently	B-X
inactivated	B-X
in	B-X
cholangiocarcinoma	B-X
of	B-X
the	B-X
liver	B-X
and	B-X
occurs	B-X
independently	B-X
of	B-X
the	B-X
status	B-X
of	B-X
p53	B-X
or	B-X
pRb	B-X
.	B-X

The	O
absence	O
of	O
pRB	B-Gene_or_gene_product
protein	O
did	O
not	O
correlate	O
with	O
any	O
of	O
the	O
examined	O
parameters	O
.	O
<EOS>	B-X
PEST-containing	B-X
nuclear	B-X
protein	B-X
(	B-X
PCNP	B-X
)	B-X
,	B-X
a	B-X
novel	B-X
nuclear	B-X
protein	B-X
,	B-X
is	B-X
involved	B-X
in	B-X
vital	B-X
cellular	B-X
processes	B-X
like	B-X
cell	B-X
proliferation	B-X
and	B-X
mediates	B-X
tumorigenesis	B-X
.	B-X
PCNP	B-X
is	B-X
a	B-X
short-living	B-X
,	B-X
small	B-X
nuclear	B-X
protein	B-X
of	B-X
only	B-X
178	B-X
amino	B-X
acids	B-X
with	B-X
two	B-X
remarkable	B-X
PEST	B-X
sequences	B-X
that	B-X
are	B-X
rich	B-X
in	B-X
proline	B-X
(	B-X
P	B-X
)	B-X
,	B-X
glutamic	B-X
acid	B-X
(	B-X
E	B-X
)	B-X
,	B-X
serine	B-X
(	B-X
S	B-X
)	B-X
,	B-X
and	B-X
threonine	B-X
(	B-X
T	B-X
)	B-X
.	B-X
The	B-X
current	B-X
understanding	B-X
of	B-X
PCNP	B-X
reveals	B-X
that	B-X
PCNP	B-X
has	B-X
the	B-X
ability	B-X
to	B-X
interact	B-X
with	B-X
cell	B-X
cycle	B-X
regulatory	B-X
proteins	B-X
;	B-X
tumor	B-X
suppressors	B-X
(	B-X
p53	B-X
and	B-X
pRB	B-X
)	B-X
,	B-X
and	B-X
promoters	B-X
(	B-X
cyclin	B-X
E	B-X
and	B-X
cyclin	B-X
D	B-X
)	B-X
to	B-X
determine	B-X
the	B-X
fate	B-X
of	B-X
tissues	B-X
to	B-X
facilitate	B-X
the	B-X
process	B-X
of	B-X
either	B-X
apoptosis	B-X
or	B-X
cell	B-X
proliferation	B-X
.	B-X
When	B-X
activated	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
normal	B-X
terminal	B-X
differentiation	B-X
cues	B-X
,	B-X
these	B-X
mechanisms	B-X
can	B-X
result	B-X
in	B-X
a	B-X
state	B-X
of	B-X
persistent	B-X
cytostasis	B-X
.	B-X
Despite	B-X
differences	B-X
in	B-X
upstream	B-X
signaling	B-X
,	B-X
senescence	B-X
often	B-X
involves	B-X
convergent	B-X
interdependent	B-X
activation	B-X
of	B-X
tumor	B-X
suppressors	B-X
p53	B-X
and	B-X
p16/pRB	B-X
,	B-X
but	B-X
can	B-X
be	B-X
induced	B-X
,	B-X
albeit	B-X
with	B-X
reduced	B-X
sensitivity	B-X
,	B-X
when	B-X
these	B-X
suppressors	B-X
are	B-X
compromised	B-X
.	B-X

Alterations	O
of	O
the	O
INK4a	B-Gene_or_gene_product
-	O
ARF	B-Gene_or_gene_product
locus	O
,	O
pRB	B-Gene_or_gene_product
or	O
p53	B-Gene_or_gene_product
status	O
could	O
not	O
be	O
established	O
as	O
independent	O
prognostic	O
factors	O
in	O
these	O
tumours	O
.	O
<EOS>	B-X
The	B-X
importance	B-X
of	B-X
cancer-cell-autonomous	B-X
functions	B-X
of	B-X
the	B-X
tumour	B-X
suppressor	B-X
p53	B-X
(	B-X
encoded	B-X
by	B-X
In	B-X
this	B-X
study	B-X
we	B-X
reveal	B-X
a	B-X
dual	B-X
role	B-X
of	B-X
p62	B-X
in	B-X
ferroptosis	B-X
of	B-X
glioblastoma	B-X
(	B-X
GBM	B-X
)	B-X
according	B-X
to	B-X
p53	B-X
status	B-X
.	B-X
p53	B-X
is	B-X
an	B-X
important	B-X
tumor	B-X
suppressor	B-X
,	B-X
and	B-X
the	B-X
complexities	B-X
of	B-X
p53	B-X
function	B-X
in	B-X
regulating	B-X
cancer	B-X
cell	B-X
behaviour	B-X
are	B-X
well	B-X
established	B-X
.	B-X
Many	B-X
cancers	B-X
lose	B-X
or	B-X
express	B-X
mutant	B-X
forms	B-X
of	B-X
p53	B-X
,	B-X
with	B-X
evidence	B-X
that	B-X
the	B-X
type	B-X
of	B-X
alteration	B-X
affecting	B-X
p53	B-X
may	B-X
differentially	B-X
impact	B-X
cancer	B-X
development	B-X
and	B-X
progression	B-X
.	B-X
It	B-X
is	B-X
also	B-X
clear	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
cell-autonomous	B-X
functions	B-X
,	B-X
p53	B-X
status	B-X
also	B-X
affects	B-X
the	B-X
way	B-X
cancer	B-X
cells	B-X
interact	B-X
with	B-X
each	B-X
other	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
briefly	B-X
examine	B-X
the	B-X
impact	B-X
of	B-X
different	B-X
p53	B-X
mutations	B-X
and	B-X
focus	B-X
on	B-X
how	B-X
heterogeneity	B-X
of	B-X
p53	B-X
status	B-X
can	B-X
affect	B-X
relationships	B-X
between	B-X
cells	B-X
within	B-X
a	B-X
tumor	B-X
.	B-X

These	O
findings	O
indicate	O
that	O
the	O
INK4a	B-Gene_or_gene_product
-	O
ARF	B-Gene_or_gene_product
locus	O
is	O
frequently	O
inactivated	O
in	O
cholangiocarcinoma	O
of	O
the	O
liver	O
and	O
occurs	O
independently	O
of	O
the	O
status	O
of	O
p53	B-Gene_or_gene_product
or	O
pRb	B-Gene_or_gene_product
.	O
<EOS>	B-X
It	B-X
has	B-X
been	B-X
shown	B-X
that	B-X
Rb	B-X
protein	B-X
(	B-X
pRb	B-X
)	B-X
is	B-X
responsible	B-X
for	B-X
a	B-X
major	B-X
G1	B-X
checkpoint	B-X
,	B-X
blocking	B-X
S-phase	B-X
entry	B-X
and	B-X
cell	B-X
growth	B-X
.	B-X
The	B-X
pRb	B-X
protein	B-X
represses	B-X
gene	B-X
transcription	B-X
,	B-X
required	B-X
for	B-X
transition	B-X
from	B-X
G1	B-X
to	B-X
S	B-X
phase	B-X
,	B-X
by	B-X
directly	B-X
binding	B-X
to	B-X
the	B-X
transactivation	B-X
domain	B-X
of	B-X
E2F	B-X
and	B-X
by	B-X
binding	B-X
to	B-X
the	B-X
promoter	B-X
of	B-X
these	B-X
genes	B-X
as	B-X
a	B-X
complex	B-X
with	B-X
E2F	B-X
.	B-X
pRb	B-X
represses	B-X
transcription	B-X
also	B-X
by	B-X
remodeling	B-X
chromatin	B-X
structure	B-X
through	B-X
interaction	B-X
with	B-X
proteins	B-X
such	B-X
as	B-X
hBRM	B-X
,	B-X
BRG1	B-X
,	B-X
HDAC1	B-X
and	B-X
SUV39H1	B-X
,	B-X
which	B-X
are	B-X
involved	B-X
in	B-X
nucleosome	B-X
remodeling	B-X
,	B-X
histone	B-X
acetylation/deacetylation	B-X
and	B-X
methylation	B-X
,	B-X
respectively	B-X
.	B-X
Loss	B-X
of	B-X
pRb	B-X
functions	B-X
may	B-X
induce	B-X
cell	B-X
cycle	B-X
deregulation	B-X
and	B-X
so	B-X
lead	B-X
to	B-X
a	B-X
malignant	B-X
phenotype	B-X
.	B-X
Functional	B-X
inactivation	B-X
of	B-X
pRb	B-X
by	B-X
viral	B-X
oncoprotein	B-X
binding	B-X
is	B-X
also	B-X
shown	B-X
in	B-X
many	B-X
neoplasias	B-X
such	B-X
as	B-X
cervical	B-X
cancer	B-X
,	B-X
mesothelioma	B-X
and	B-X
AIDS-related	B-X
Burkitt	B-X
's	B-X
lymphoma	B-X
.	B-X

The	O
human	O
L	B-Gene_or_gene_product
-	I-Gene_or_gene_product
threonine	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
dehydrogenase	I-Gene_or_gene_product
gene	O
is	O
an	O
expressed	O
pseudogene	O
.	O

BACKGROUND	O
:	O
L	O
-	O
threonine	O
is	O
an	O
indispensable	O
amino	O
acid	O
.	O
<EOS>	B-X
L-threonine	B-X
is	B-X
an	B-X
indispensable	B-X
amino	B-X
acid	B-X
.	B-X
One	B-X
of	B-X
the	B-X
major	B-X
L-threonine	B-X
degradation	B-X
pathways	B-X
is	B-X
the	B-X
conversion	B-X
of	B-X
L-threonine	B-X
via	B-X
2-amino-3-ketobutyrate	B-X
to	B-X
glycine	B-X
.	B-X
L-threonine	B-X
dehydrogenase	B-X
(	B-X
EC	B-X
1.1.1.103	B-X
)	B-X
is	B-X
the	B-X
first	B-X
enzyme	B-X
in	B-X
the	B-X
pathway	B-X
and	B-X
catalyses	B-X
the	B-X
reaction	B-X
:	B-X
L-threonine	B-X
+	B-X
NAD+	B-X
=	B-X
2-amino-3-ketobutyrate	B-X
+	B-X
NADH	B-X
.	B-X
The	B-X
murine	B-X
and	B-X
porcine	B-X
L-threonine	B-X
dehydrogenase	B-X
genes	B-X
(	B-X
TDH	B-X
)	B-X
have	B-X
been	B-X
identified	B-X
previously	B-X
,	B-X
but	B-X
the	B-X
human	B-X
gene	B-X
has	B-X
not	B-X
been	B-X
identified	B-X
.	B-X

One	O
of	O
the	O
major	O
L	O
-	O
threonine	O
degradation	O
pathways	O
is	O
the	O
conversion	O
of	O
L	O
-	O
threonine	O
via	O
2	O
-	O
amino	O
-	O
3	O
-	O
ketobutyrate	O
to	O
glycine	O
.	O

L	B-Gene_or_gene_product
-	I-Gene_or_gene_product
threonine	I-Gene_or_gene_product
dehydrogenase	I-Gene_or_gene_product
(	O
EC	B-Gene_or_gene_product
1	I-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	I-Gene_or_gene_product
103	I-Gene_or_gene_product
)	O
is	O
the	O
first	O
enzyme	O
in	O
the	O
pathway	O
and	O
catalyses	O
the	O
reaction	O
:	O
L	O
-	O
threonine	O
+	O
NAD	O
+	O
=	O
2	O
-	O
amino	O
-	O
3	O
-	O
ketobutyrate	O
+	O
NADH	O
.	O
<EOS>	B-X
L-threonine	B-X
is	B-X
an	B-X
indispensable	B-X
amino	B-X
acid	B-X
.	B-X
One	B-X
of	B-X
the	B-X
major	B-X
L-threonine	B-X
degradation	B-X
pathways	B-X
is	B-X
the	B-X
conversion	B-X
of	B-X
L-threonine	B-X
via	B-X
2-amino-3-ketobutyrate	B-X
to	B-X
glycine	B-X
.	B-X
L-threonine	B-X
dehydrogenase	B-X
(	B-X
EC	B-X
1.1.1.103	B-X
)	B-X
is	B-X
the	B-X
first	B-X
enzyme	B-X
in	B-X
the	B-X
pathway	B-X
and	B-X
catalyses	B-X
the	B-X
reaction	B-X
:	B-X
L-threonine	B-X
+	B-X
NAD+	B-X
=	B-X
2-amino-3-ketobutyrate	B-X
+	B-X
NADH	B-X
.	B-X
The	B-X
murine	B-X
and	B-X
porcine	B-X
L-threonine	B-X
dehydrogenase	B-X
genes	B-X
(	B-X
TDH	B-X
)	B-X
have	B-X
been	B-X
identified	B-X
previously	B-X
,	B-X
but	B-X
the	B-X
human	B-X
gene	B-X
has	B-X
not	B-X
been	B-X
identified	B-X
.	B-X

The	O
murine	O
and	O
porcine	O
L	B-Gene_or_gene_product
-	I-Gene_or_gene_product
threonine	I-Gene_or_gene_product
dehydrogenase	I-Gene_or_gene_product
genes	O
(	O
TDH	B-Gene_or_gene_product
)	O
have	O
been	O
identified	O
previously	O
,	O
but	O
the	O
human	O
gene	O
has	O
not	O
been	O
identified	O
.	O

RESULTS	O
:	O
The	O
human	O
TDH	B-Gene_or_gene_product
gene	O
is	O
located	O
at	O
8p23	O
-	O
22	O
and	O
has	O
8	O
exons	O
spanning	O
10	O
kb	O
that	O
would	O
have	O
been	O
expected	O
to	O
encode	O
a	O
369	O
residue	O
ORF	O
.	O
<EOS>	B-X
L-threonine	B-X
dehydrogenase	B-X
(	B-X
EC	B-X
1.1.1.103	B-X
)	B-X
is	B-X
the	B-X
first	B-X
enzyme	B-X
in	B-X
the	B-X
pathway	B-X
and	B-X
catalyses	B-X
the	B-X
reaction	B-X
:	B-X
L-threonine	B-X
+	B-X
NAD+	B-X
=	B-X
2-amino-3-ketobutyrate	B-X
+	B-X
NADH	B-X
.	B-X
The	B-X
murine	B-X
and	B-X
porcine	B-X
L-threonine	B-X
dehydrogenase	B-X
genes	B-X
(	B-X
TDH	B-X
)	B-X
have	B-X
been	B-X
identified	B-X
previously	B-X
,	B-X
but	B-X
the	B-X
human	B-X
gene	B-X
has	B-X
not	B-X
been	B-X
identified	B-X
.	B-X

However	O
,	O
2	O
cDNA	O
TDH	B-Gene_or_gene_product
transcripts	O
encode	O
truncated	O
proteins	O
of	O
157	O
and	O
230	O
residues	O
.	O
<EOS>	B-X
One	B-X
of	B-X
the	B-X
major	B-X
L-threonine	B-X
degradation	B-X
pathways	B-X
is	B-X
the	B-X
conversion	B-X
of	B-X
L-threonine	B-X
via	B-X
2-amino-3-ketobutyrate	B-X
to	B-X
glycine	B-X
.	B-X
L-threonine	B-X
dehydrogenase	B-X
(	B-X
EC	B-X
1.1.1.103	B-X
)	B-X
is	B-X
the	B-X
first	B-X
enzyme	B-X
in	B-X
the	B-X
pathway	B-X
and	B-X
catalyses	B-X
the	B-X
reaction	B-X
:	B-X
L-threonine	B-X
+	B-X
NAD+	B-X
=	B-X
2-amino-3-ketobutyrate	B-X
+	B-X
NADH	B-X
.	B-X
The	B-X
murine	B-X
and	B-X
porcine	B-X
L-threonine	B-X
dehydrogenase	B-X
genes	B-X
(	B-X
TDH	B-X
)	B-X
have	B-X
been	B-X
identified	B-X
previously	B-X
,	B-X
but	B-X
the	B-X
human	B-X
gene	B-X
has	B-X
not	B-X
been	B-X
identified	B-X
.	B-X

These	O
truncated	O
proteins	O
are	O
the	O
result	O
of	O
3	O
mutations	O
within	O
the	O
gene	O
.	O
<EOS>	B-X
Chronic	B-X
lymphocytic	B-X
leukemia	B-X
(	B-X
CLL	B-X
)	B-X
is	B-X
the	B-X
most	B-X
frequent	B-X
leukemia	B-X
type	B-X
in	B-X
which	B-X
the	B-X
genetic	B-X
alterations	B-X
influencing	B-X
the	B-X
clinico-biological	B-X
course	B-X
are	B-X
not	B-X
entirely	B-X
understood	B-X
.	B-X
CLL	B-X
has	B-X
a	B-X
heterogeneous	B-X
course	B-X
,	B-X
with	B-X
some	B-X
patients	B-X
showing	B-X
an	B-X
indolent	B-X
course	B-X
and	B-X
others	B-X
experiencing	B-X
an	B-X
aggressive	B-X
course	B-X
.	B-X
Whole-genome	B-X
sequencing	B-X
and	B-X
whole-exome	B-X
sequencing	B-X
studies	B-X
identified	B-X
recurrently	B-X
mutated	B-X
genes	B-X
in	B-X
CLL	B-X
and	B-X
profiled	B-X
its	B-X
clonal	B-X
evolution	B-X
patterns	B-X
.	B-X
Here	B-X
we	B-X
describe	B-X
the	B-X
most	B-X
representative	B-X
non-coding	B-X
lesion	B-X
of	B-X
the	B-X
CLL	B-X
genome	B-X
,	B-X
including	B-X
lesions	B-X
in	B-X
the	B-X
3'-UTR	B-X
region	B-X
of	B-X
NOTCH1	B-X
which	B-X
result	B-X
in	B-X
the	B-X
truncation	B-X
of	B-X
the	B-X
NOTCH1	B-X
protein	B-X
PEST	B-X
domain	B-X
,	B-X
and	B-X
non-coding	B-X
mutations	B-X
in	B-X
an	B-X
enhancer	B-X
region	B-X
on	B-X
chromosome	B-X
9p13	B-X
which	B-X
result	B-X
in	B-X
reduced	B-X
expression	B-X
of	B-X
the	B-X
PAX5	B-X
transcription	B-X
factor	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
describe	B-X
the	B-X
role	B-X
of	B-X
microRNA	B-X
in	B-X
CLL	B-X
,	B-X
in	B-X
particular	B-X
the	B-X
miR15a/miR16-1	B-X
microRNA	B-X
recurrently	B-X
affected	B-X
by	B-X
deletions	B-X
of	B-X
chromosome	B-X
13q14	B-X
.	B-X
Together	B-X
,	B-X
new	B-X
findings	B-X
in	B-X
non-coding	B-X
genome	B-X
genetic	B-X
lesions	B-X
provide	B-X
a	B-X
more	B-X
complete	B-X
portrait	B-X
of	B-X
the	B-X
genomic	B-X
landscape	B-X
of	B-X
CLL	B-X
with	B-X
clinical	B-X
implications	B-X
.	B-X

There	O
is	O
a	O
SNP	O
,	O
A	O
to	O
G	O
,	O
present	O
in	O
the	O
genomic	O
DNA	O
sequence	O
of	O
some	O
individuals	O
which	O
results	O
in	O
the	O
loss	O
of	O
the	O
acceptor	O
splice	O
site	O
preceding	O
exon	O
4	O
.	O

The	O
acceptor	O
splice	O
site	O
preceding	O
exon	O
6	O
was	O
lost	O
in	O
all	O
23	O
individuals	O
genotyped	O
and	O
there	O
is	O
an	O
in	O
-	O
frame	O
stop	O
codon	O
in	O
exon	O
6	O
(	O
CGA	O
to	O
TGA	O
)	O
resulting	O
in	O
arginine	O
-	O
214	O
being	O
replaced	O
by	O
a	O
stop	O
codon	O
.	O

These	O
truncated	O
proteins	O
would	O
be	O
non	O
-	O
functional	O
since	O
they	O
have	O
lost	O
part	O
of	O
the	O
NAD	O
+	O
binding	O
motif	O
and	O
the	O
COOH	O
terminal	O
domain	O
that	O
is	O
thought	O
to	O
be	O
involved	O
in	O
binding	O
L	O
-	O
threonine	O
.	O

TDH	B-Gene_or_gene_product
mRNA	O
was	O
present	O
in	O
all	O
tissues	O
examined	O
.	O
<EOS>	B-X
The	B-X
murine	B-X
and	B-X
porcine	B-X
L-threonine	B-X
dehydrogenase	B-X
genes	B-X
(	B-X
TDH	B-X
)	B-X
have	B-X
been	B-X
identified	B-X
previously	B-X
,	B-X
but	B-X
the	B-X
human	B-X
gene	B-X
has	B-X
not	B-X
been	B-X
identified	B-X
.	B-X

CONCLUSIONS	O
:	O
The	O
human	O
L	B-Gene_or_gene_product
-	I-Gene_or_gene_product
threonine	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
dehydrogenase	I-Gene_or_gene_product
gene	O
is	O
an	O
expressed	O
pseudogene	O
having	O
lost	O
the	O
splice	O
acceptor	O
site	O
preceding	O
exon	O
6	O
and	O
codon	O
arginine	O
-	O
214	O
(	O
CGA	O
)	O
is	O
mutated	O
to	O
a	O
stop	O
codon	O
(	O
TGA	O
)	O
.	O

Human	O
T	O
-	O
lymphotropic	O
virus	O
type	O
I	O
tax	B-Gene_or_gene_product
activates	O
I	O
-	O
kappa	O
B	O
kinase	O
by	O
inhibiting	O
I	O
-	O
kappa	O
B	O
kinase	O
-	O
associated	O
serine	B-Gene_or_gene_product
/	I-Gene_or_gene_product
threonine	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
2A	I-Gene_or_gene_product
.	O
<EOS>	B-X
I-kappa	B-X
B	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
is	B-X
a	B-X
serine/threonine	B-X
kinase	B-X
that	B-X
phosphorylates	B-X
I-kappa	B-X
B	B-X
alpha	B-X
and	B-X
I-kappa	B-X
B	B-X
beta	B-X
and	B-X
targets	B-X
them	B-X
for	B-X
polyubiquitination	B-X
and	B-X
proteasome-mediated	B-X
degradation	B-X
.	B-X
IKK	B-X
consists	B-X
of	B-X
two	B-X
highly	B-X
related	B-X
catalytic	B-X
subunits	B-X
,	B-X
alpha	B-X
and	B-X
beta	B-X
,	B-X
and	B-X
a	B-X
regulatory	B-X
gamma	B-X
subunit	B-X
,	B-X
which	B-X
becomes	B-X
activated	B-X
after	B-X
serine	B-X
phosphorylation	B-X
of	B-X
the	B-X
activation	B-X
loops	B-X
of	B-X
the	B-X
catalytic	B-X
domains	B-X
.	B-X
The	B-X
human	B-X
T-lymphotropic	B-X
retrovirus	B-X
type-I	B-X
trans-activator	B-X
,	B-X
Tax	B-X
,	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
interact	B-X
directly	B-X
with	B-X
IKK	B-X
gamma	B-X
and	B-X
activates	B-X
IKK	B-X
via	B-X
a	B-X
mechanism	B-X
not	B-X
fully	B-X
understood	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
IKK	B-X
binds	B-X
serine/threonine	B-X
protein	B-X
phosphatase	B-X
2A	B-X
(	B-X
PP2A	B-X
)	B-X
,	B-X
and	B-X
via	B-X
a	B-X
tripartite	B-X
protein-protein	B-X
interaction	B-X
,	B-X
Tax	B-X
,	B-X
IKK	B-X
gamma	B-X
,	B-X
and	B-X
PP2A	B-X
form	B-X
a	B-X
stable	B-X
ternary	B-X
complex	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
PP2A	B-X
down-regulates	B-X
active	B-X
IKK	B-X
prepared	B-X
from	B-X
Tax-producing	B-X
MT4	B-X
cells	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
however	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PP2A	B-X
to	B-X
inactivate	B-X
IKK	B-X
is	B-X
diminished	B-X
.	B-X
Despite	B-X
their	B-X
interaction	B-X
with	B-X
IKK	B-X
gamma	B-X
,	B-X
PP2A-interaction-defective	B-X
Tax	B-X
mutants	B-X
failed	B-X
to	B-X
activate	B-X
NF-kappa	B-X
B	B-X
.	B-X
Our	B-X
data	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
IKK	B-X
gamma-associated	B-X
PP2A	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
rapid	B-X
deactivation	B-X
of	B-X
IKK	B-X
,	B-X
and	B-X
inhibition	B-X
of	B-X
PP2A	B-X
by	B-X
Tax	B-X
in	B-X
the	B-X
context	B-X
of	B-X
IKK	B-X
x	B-X
PP2A	B-X
x	B-X
Tax	B-X
ternary	B-X
complex	B-X
leads	B-X
to	B-X
constitutive	B-X
IKK	B-X
and	B-X
NF-kappa	B-X
B	B-X
activation	B-X
.	B-X

I	O
-	O
kappa	O
B	O
kinase	O
(	O
IKK	O
)	O
is	O
a	O
serine	O
/	O
threonine	O
kinase	O
that	O
phosphorylates	O
I	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
I	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
and	O
targets	O
them	O
for	O
polyubiquitination	O
and	O
proteasome	O
-	O
mediated	O
degradation	O
.	O
<EOS>	B-X
Activation	B-X
of	B-X
MAP3K7	B-X
(	B-X
also	B-X
termed	B-X
TAK1	B-X
)	B-X
and	B-X
downstream	B-X
IκB	B-X
kinase	B-X
β	B-X
(	B-X
IKKβ	B-X
)	B-X
by	B-X
proinflammatory	B-X
cytokines	B-X
such	B-X
as	B-X
TNFα	B-X
stimulates	B-X
NF-κB	B-X
survival	B-X
pathways	B-X
.	B-X
TNFα	B-X
treatment	B-X
increased	B-X
AR	B-X
protein	B-X
ubiquitination	B-X
and	B-X
proteasomal	B-X
degradation	B-X
.	B-X
Mechanistically	B-X
,	B-X
activation	B-X
of	B-X
IKKβ	B-X
by	B-X
TNFα	B-X
induced	B-X
phosphorylation	B-X
and	B-X
TRCP1/2	B-X
E3	B-X
ligase-mediated	B-X
polyubiquitination	B-X
and	B-X
degradation	B-X
of	B-X
AR	B-X
protein	B-X
.	B-X
TNFα	B-X
suppressed	B-X
prostate	B-X
cancer	B-X
proliferation	B-X
,	B-X
which	B-X
could	B-X
be	B-X
rescued	B-X
by	B-X
blockade	B-X
of	B-X
AR	B-X
degradation	B-X
.	B-X
These	B-X
findings	B-X
reveal	B-X
a	B-X
previously	B-X
unrecognized	B-X
tumor	B-X
suppressive	B-X
function	B-X
of	B-X
the	B-X
inflammation-activated	B-X
MAP3K7-IKKβ	B-X
axis	B-X
in	B-X
degrading	B-X
AR	B-X
protein	B-X
.	B-X
SIGNIFICANCE	B-X
:	B-X
This	B-X
study	B-X
identifies	B-X
that	B-X
MAP3K7-IKKβ	B-X
signaling	B-X
plays	B-X
a	B-X
tumor-suppressive	B-X
role	B-X
in	B-X
prostate	B-X
cancer	B-X
by	B-X
degrading	B-X
AR	B-X
,	B-X
revealing	B-X
potential	B-X
prognostic	B-X
and	B-X
therapeutic	B-X
strategies	B-X
for	B-X
MAP3K7-deficient	B-X
tumors	B-X
.	B-X

IKK	O
consists	O
of	O
two	O
highly	O
related	O
catalytic	O
subunits	O
,	O
alpha	B-Gene_or_gene_product
and	O
beta	B-Gene_or_gene_product
,	O
and	O
a	O
regulatory	O
gamma	B-Gene_or_gene_product
subunit	O
,	O
which	O
becomes	O
activated	O
after	O
serine	O
phosphorylation	O
of	O
the	O
activation	O
loops	O
of	O
the	O
catalytic	O
domains	O
.	O

The	O
human	O
T	O
-	O
lymphotropic	O
retrovirus	O
type	O
-	O
I	O
trans	O
-	O
activator	O
,	O
Tax	B-Gene_or_gene_product
,	O
has	O
been	O
shown	O
to	O
interact	O
directly	O
with	O
IKK	B-Gene_or_gene_product
gamma	I-Gene_or_gene_product
and	O
activates	O
IKK	O
via	O
a	O
mechanism	O
not	O
fully	O
understood	O
.	O

Here	O
we	O
demonstrate	O
that	O
IKK	O
binds	O
serine	B-Gene_or_gene_product
/	I-Gene_or_gene_product
threonine	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
2A	I-Gene_or_gene_product
(	O
PP2A	B-Gene_or_gene_product
)	O
,	O
and	O
via	O
a	O
tripartite	O
protein	O
-	O
protein	O
interaction	O
,	O
Tax	B-Gene_or_gene_product
,	O
IKK	B-Gene_or_gene_product
gamma	I-Gene_or_gene_product
,	O
and	O
PP2A	B-Gene_or_gene_product
form	O
a	O
stable	O
ternary	O
complex	O
.	O

In	O
vitro	O
,	O
PP2A	B-Gene_or_gene_product
down	O
-	O
regulates	O
active	O
IKK	O
prepared	O
from	O
Tax	B-Gene_or_gene_product
-	O
producing	O
MT4	O
cells	O
.	O
<EOS>	B-X
I-kappa	B-X
B	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
is	B-X
a	B-X
serine/threonine	B-X
kinase	B-X
that	B-X
phosphorylates	B-X
I-kappa	B-X
B	B-X
alpha	B-X
and	B-X
I-kappa	B-X
B	B-X
beta	B-X
and	B-X
targets	B-X
them	B-X
for	B-X
polyubiquitination	B-X
and	B-X
proteasome-mediated	B-X
degradation	B-X
.	B-X
IKK	B-X
consists	B-X
of	B-X
two	B-X
highly	B-X
related	B-X
catalytic	B-X
subunits	B-X
,	B-X
alpha	B-X
and	B-X
beta	B-X
,	B-X
and	B-X
a	B-X
regulatory	B-X
gamma	B-X
subunit	B-X
,	B-X
which	B-X
becomes	B-X
activated	B-X
after	B-X
serine	B-X
phosphorylation	B-X
of	B-X
the	B-X
activation	B-X
loops	B-X
of	B-X
the	B-X
catalytic	B-X
domains	B-X
.	B-X
The	B-X
human	B-X
T-lymphotropic	B-X
retrovirus	B-X
type-I	B-X
trans-activator	B-X
,	B-X
Tax	B-X
,	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
interact	B-X
directly	B-X
with	B-X
IKK	B-X
gamma	B-X
and	B-X
activates	B-X
IKK	B-X
via	B-X
a	B-X
mechanism	B-X
not	B-X
fully	B-X
understood	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
IKK	B-X
binds	B-X
serine/threonine	B-X
protein	B-X
phosphatase	B-X
2A	B-X
(	B-X
PP2A	B-X
)	B-X
,	B-X
and	B-X
via	B-X
a	B-X
tripartite	B-X
protein-protein	B-X
interaction	B-X
,	B-X
Tax	B-X
,	B-X
IKK	B-X
gamma	B-X
,	B-X
and	B-X
PP2A	B-X
form	B-X
a	B-X
stable	B-X
ternary	B-X
complex	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
PP2A	B-X
down-regulates	B-X
active	B-X
IKK	B-X
prepared	B-X
from	B-X
Tax-producing	B-X
MT4	B-X
cells	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
however	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PP2A	B-X
to	B-X
inactivate	B-X
IKK	B-X
is	B-X
diminished	B-X
.	B-X
Despite	B-X
their	B-X
interaction	B-X
with	B-X
IKK	B-X
gamma	B-X
,	B-X
PP2A-interaction-defective	B-X
Tax	B-X
mutants	B-X
failed	B-X
to	B-X
activate	B-X
NF-kappa	B-X
B	B-X
.	B-X
Our	B-X
data	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
IKK	B-X
gamma-associated	B-X
PP2A	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
rapid	B-X
deactivation	B-X
of	B-X
IKK	B-X
,	B-X
and	B-X
inhibition	B-X
of	B-X
PP2A	B-X
by	B-X
Tax	B-X
in	B-X
the	B-X
context	B-X
of	B-X
IKK	B-X
x	B-X
PP2A	B-X
x	B-X
Tax	B-X
ternary	B-X
complex	B-X
leads	B-X
to	B-X
constitutive	B-X
IKK	B-X
and	B-X
NF-kappa	B-X
B	B-X
activation	B-X
.	B-X

In	O
the	O
presence	O
of	O
Tax	B-Gene_or_gene_product
,	O
however	O
,	O
the	O
ability	O
of	O
PP2A	B-Gene_or_gene_product
to	O
inactivate	O
IKK	O
is	O
diminished	O
.	O
<EOS>	B-X
I-kappa	B-X
B	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
is	B-X
a	B-X
serine/threonine	B-X
kinase	B-X
that	B-X
phosphorylates	B-X
I-kappa	B-X
B	B-X
alpha	B-X
and	B-X
I-kappa	B-X
B	B-X
beta	B-X
and	B-X
targets	B-X
them	B-X
for	B-X
polyubiquitination	B-X
and	B-X
proteasome-mediated	B-X
degradation	B-X
.	B-X
IKK	B-X
consists	B-X
of	B-X
two	B-X
highly	B-X
related	B-X
catalytic	B-X
subunits	B-X
,	B-X
alpha	B-X
and	B-X
beta	B-X
,	B-X
and	B-X
a	B-X
regulatory	B-X
gamma	B-X
subunit	B-X
,	B-X
which	B-X
becomes	B-X
activated	B-X
after	B-X
serine	B-X
phosphorylation	B-X
of	B-X
the	B-X
activation	B-X
loops	B-X
of	B-X
the	B-X
catalytic	B-X
domains	B-X
.	B-X
The	B-X
human	B-X
T-lymphotropic	B-X
retrovirus	B-X
type-I	B-X
trans-activator	B-X
,	B-X
Tax	B-X
,	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
interact	B-X
directly	B-X
with	B-X
IKK	B-X
gamma	B-X
and	B-X
activates	B-X
IKK	B-X
via	B-X
a	B-X
mechanism	B-X
not	B-X
fully	B-X
understood	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
IKK	B-X
binds	B-X
serine/threonine	B-X
protein	B-X
phosphatase	B-X
2A	B-X
(	B-X
PP2A	B-X
)	B-X
,	B-X
and	B-X
via	B-X
a	B-X
tripartite	B-X
protein-protein	B-X
interaction	B-X
,	B-X
Tax	B-X
,	B-X
IKK	B-X
gamma	B-X
,	B-X
and	B-X
PP2A	B-X
form	B-X
a	B-X
stable	B-X
ternary	B-X
complex	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
PP2A	B-X
down-regulates	B-X
active	B-X
IKK	B-X
prepared	B-X
from	B-X
Tax-producing	B-X
MT4	B-X
cells	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
however	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PP2A	B-X
to	B-X
inactivate	B-X
IKK	B-X
is	B-X
diminished	B-X
.	B-X
Despite	B-X
their	B-X
interaction	B-X
with	B-X
IKK	B-X
gamma	B-X
,	B-X
PP2A-interaction-defective	B-X
Tax	B-X
mutants	B-X
failed	B-X
to	B-X
activate	B-X
NF-kappa	B-X
B	B-X
.	B-X
Our	B-X
data	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
IKK	B-X
gamma-associated	B-X
PP2A	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
rapid	B-X
deactivation	B-X
of	B-X
IKK	B-X
,	B-X
and	B-X
inhibition	B-X
of	B-X
PP2A	B-X
by	B-X
Tax	B-X
in	B-X
the	B-X
context	B-X
of	B-X
IKK	B-X
x	B-X
PP2A	B-X
x	B-X
Tax	B-X
ternary	B-X
complex	B-X
leads	B-X
to	B-X
constitutive	B-X
IKK	B-X
and	B-X
NF-kappa	B-X
B	B-X
activation	B-X
.	B-X

Despite	O
their	O
interaction	O
with	O
IKK	B-Gene_or_gene_product
gamma	I-Gene_or_gene_product
,	O
PP2A	B-Gene_or_gene_product
-	O
interaction	O
-	O
defective	O
Tax	B-Gene_or_gene_product
mutants	O
failed	O
to	O
activate	O
NF	O
-	O
kappa	O
B	O
.	O
<EOS>	B-X
I-kappa	B-X
B	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
is	B-X
a	B-X
serine/threonine	B-X
kinase	B-X
that	B-X
phosphorylates	B-X
I-kappa	B-X
B	B-X
alpha	B-X
and	B-X
I-kappa	B-X
B	B-X
beta	B-X
and	B-X
targets	B-X
them	B-X
for	B-X
polyubiquitination	B-X
and	B-X
proteasome-mediated	B-X
degradation	B-X
.	B-X
IKK	B-X
consists	B-X
of	B-X
two	B-X
highly	B-X
related	B-X
catalytic	B-X
subunits	B-X
,	B-X
alpha	B-X
and	B-X
beta	B-X
,	B-X
and	B-X
a	B-X
regulatory	B-X
gamma	B-X
subunit	B-X
,	B-X
which	B-X
becomes	B-X
activated	B-X
after	B-X
serine	B-X
phosphorylation	B-X
of	B-X
the	B-X
activation	B-X
loops	B-X
of	B-X
the	B-X
catalytic	B-X
domains	B-X
.	B-X
The	B-X
human	B-X
T-lymphotropic	B-X
retrovirus	B-X
type-I	B-X
trans-activator	B-X
,	B-X
Tax	B-X
,	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
interact	B-X
directly	B-X
with	B-X
IKK	B-X
gamma	B-X
and	B-X
activates	B-X
IKK	B-X
via	B-X
a	B-X
mechanism	B-X
not	B-X
fully	B-X
understood	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
IKK	B-X
binds	B-X
serine/threonine	B-X
protein	B-X
phosphatase	B-X
2A	B-X
(	B-X
PP2A	B-X
)	B-X
,	B-X
and	B-X
via	B-X
a	B-X
tripartite	B-X
protein-protein	B-X
interaction	B-X
,	B-X
Tax	B-X
,	B-X
IKK	B-X
gamma	B-X
,	B-X
and	B-X
PP2A	B-X
form	B-X
a	B-X
stable	B-X
ternary	B-X
complex	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
PP2A	B-X
down-regulates	B-X
active	B-X
IKK	B-X
prepared	B-X
from	B-X
Tax-producing	B-X
MT4	B-X
cells	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
however	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PP2A	B-X
to	B-X
inactivate	B-X
IKK	B-X
is	B-X
diminished	B-X
.	B-X
Despite	B-X
their	B-X
interaction	B-X
with	B-X
IKK	B-X
gamma	B-X
,	B-X
PP2A-interaction-defective	B-X
Tax	B-X
mutants	B-X
failed	B-X
to	B-X
activate	B-X
NF-kappa	B-X
B	B-X
.	B-X
Our	B-X
data	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
IKK	B-X
gamma-associated	B-X
PP2A	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
rapid	B-X
deactivation	B-X
of	B-X
IKK	B-X
,	B-X
and	B-X
inhibition	B-X
of	B-X
PP2A	B-X
by	B-X
Tax	B-X
in	B-X
the	B-X
context	B-X
of	B-X
IKK	B-X
x	B-X
PP2A	B-X
x	B-X
Tax	B-X
ternary	B-X
complex	B-X
leads	B-X
to	B-X
constitutive	B-X
IKK	B-X
and	B-X
NF-kappa	B-X
B	B-X
activation	B-X
.	B-X

Our	O
data	O
support	O
the	O
notion	O
that	O
IKK	B-Gene_or_gene_product
gamma	I-Gene_or_gene_product
-	O
associated	O
PP2A	B-Gene_or_gene_product
is	O
responsible	O
for	O
the	O
rapid	O
deactivation	O
of	O
IKK	O
,	O
and	O
inhibition	O
of	O
PP2A	B-Gene_or_gene_product
by	O
Tax	B-Gene_or_gene_product
in	O
the	O
context	O
of	O
IKK	O
x	O
PP2A	O
x	O
Tax	O
ternary	O
complex	O
leads	O
to	O
constitutive	O
IKK	O
and	O
NF	O
-	O
kappa	O
B	O
activation	O
.	O
<EOS>	B-X
I-kappa	B-X
B	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
is	B-X
a	B-X
serine/threonine	B-X
kinase	B-X
that	B-X
phosphorylates	B-X
I-kappa	B-X
B	B-X
alpha	B-X
and	B-X
I-kappa	B-X
B	B-X
beta	B-X
and	B-X
targets	B-X
them	B-X
for	B-X
polyubiquitination	B-X
and	B-X
proteasome-mediated	B-X
degradation	B-X
.	B-X
IKK	B-X
consists	B-X
of	B-X
two	B-X
highly	B-X
related	B-X
catalytic	B-X
subunits	B-X
,	B-X
alpha	B-X
and	B-X
beta	B-X
,	B-X
and	B-X
a	B-X
regulatory	B-X
gamma	B-X
subunit	B-X
,	B-X
which	B-X
becomes	B-X
activated	B-X
after	B-X
serine	B-X
phosphorylation	B-X
of	B-X
the	B-X
activation	B-X
loops	B-X
of	B-X
the	B-X
catalytic	B-X
domains	B-X
.	B-X
The	B-X
human	B-X
T-lymphotropic	B-X
retrovirus	B-X
type-I	B-X
trans-activator	B-X
,	B-X
Tax	B-X
,	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
interact	B-X
directly	B-X
with	B-X
IKK	B-X
gamma	B-X
and	B-X
activates	B-X
IKK	B-X
via	B-X
a	B-X
mechanism	B-X
not	B-X
fully	B-X
understood	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
IKK	B-X
binds	B-X
serine/threonine	B-X
protein	B-X
phosphatase	B-X
2A	B-X
(	B-X
PP2A	B-X
)	B-X
,	B-X
and	B-X
via	B-X
a	B-X
tripartite	B-X
protein-protein	B-X
interaction	B-X
,	B-X
Tax	B-X
,	B-X
IKK	B-X
gamma	B-X
,	B-X
and	B-X
PP2A	B-X
form	B-X
a	B-X
stable	B-X
ternary	B-X
complex	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
PP2A	B-X
down-regulates	B-X
active	B-X
IKK	B-X
prepared	B-X
from	B-X
Tax-producing	B-X
MT4	B-X
cells	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
however	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PP2A	B-X
to	B-X
inactivate	B-X
IKK	B-X
is	B-X
diminished	B-X
.	B-X
Despite	B-X
their	B-X
interaction	B-X
with	B-X
IKK	B-X
gamma	B-X
,	B-X
PP2A-interaction-defective	B-X
Tax	B-X
mutants	B-X
failed	B-X
to	B-X
activate	B-X
NF-kappa	B-X
B	B-X
.	B-X
Our	B-X
data	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
IKK	B-X
gamma-associated	B-X
PP2A	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
rapid	B-X
deactivation	B-X
of	B-X
IKK	B-X
,	B-X
and	B-X
inhibition	B-X
of	B-X
PP2A	B-X
by	B-X
Tax	B-X
in	B-X
the	B-X
context	B-X
of	B-X
IKK	B-X
x	B-X
PP2A	B-X
x	B-X
Tax	B-X
ternary	B-X
complex	B-X
leads	B-X
to	B-X
constitutive	B-X
IKK	B-X
and	B-X
NF-kappa	B-X
B	B-X
activation	B-X
.	B-X

E2F	B-Gene_or_gene_product
mediates	O
sustained	O
G2	O
arrest	O
and	O
down	O
-	O
regulation	O
of	O
Stathmin	B-Gene_or_gene_product
and	O
AIM	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
expression	O
in	O
response	O
to	O
genotoxic	O
stress	O
.	O
<EOS>	B-X
Exposure	B-X
of	B-X
cells	B-X
to	B-X
genotoxic	B-X
agents	B-X
results	B-X
in	B-X
activation	B-X
of	B-X
checkpoint	B-X
pathways	B-X
leading	B-X
to	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
These	B-X
arrest	B-X
pathways	B-X
allow	B-X
repair	B-X
of	B-X
damaged	B-X
DNA	B-X
before	B-X
its	B-X
replication	B-X
and	B-X
segregation	B-X
,	B-X
thus	B-X
preventing	B-X
accumulation	B-X
of	B-X
mutations	B-X
.	B-X
The	B-X
tumor	B-X
suppressor	B-X
retinoblastoma	B-X
(	B-X
RB	B-X
)	B-X
is	B-X
required	B-X
for	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S	B-X
checkpoint	B-X
function	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
regulation	B-X
of	B-X
the	B-X
G	B-X
(	B-X
2	B-X
)	B-X
checkpoint	B-X
by	B-X
the	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
RB-dependent	B-X
.	B-X
However	B-X
,	B-X
the	B-X
molecular	B-X
mechanism	B-X
underlying	B-X
the	B-X
involvement	B-X
of	B-X
RB	B-X
and	B-X
its	B-X
related	B-X
proteins	B-X
p107	B-X
and	B-X
p130	B-X
in	B-X
the	B-X
G	B-X
(	B-X
2	B-X
)	B-X
checkpoint	B-X
is	B-X
not	B-X
fully	B-X
understood	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
sustained	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
arrest	B-X
induced	B-X
by	B-X
the	B-X
genotoxic	B-X
agent	B-X
doxorubicin	B-X
is	B-X
E2F-dependent	B-X
and	B-X
involves	B-X
a	B-X
decrease	B-X
in	B-X
expression	B-X
of	B-X
two	B-X
mitotic	B-X
regulators	B-X
,	B-X
Stathmin	B-X
and	B-X
AIM-1	B-X
.	B-X
Abrogation	B-X
of	B-X
E2F	B-X
function	B-X
by	B-X
dominant	B-X
negative	B-X
E2F	B-X
abolishes	B-X
the	B-X
doxorubicin-induced	B-X
down-regulation	B-X
of	B-X
Stathmin	B-X
and	B-X
AIM-1	B-X
and	B-X
leads	B-X
to	B-X
premature	B-X
exit	B-X
from	B-X
G	B-X
(	B-X
2	B-X
)	B-X
.	B-X
Expression	B-X
of	B-X
the	B-X
E7	B-X
papilloma	B-X
virus	B-X
protein	B-X
,	B-X
which	B-X
dissociates	B-X
complexes	B-X
containing	B-X
E2F	B-X
and	B-X
RB	B-X
family	B-X
members	B-X
,	B-X
also	B-X
prevents	B-X
the	B-X
down-regulation	B-X
of	B-X
these	B-X
mitotic	B-X
genes	B-X
and	B-X
leads	B-X
to	B-X
premature	B-X
exit	B-X
from	B-X
G	B-X
(	B-X
2	B-X
)	B-X
after	B-X
genotoxic	B-X
stress	B-X
.	B-X
Furthermore	B-X
,	B-X
genotoxic	B-X
stress	B-X
increases	B-X
the	B-X
levels	B-X
of	B-X
nuclear	B-X
E2F-4	B-X
and	B-X
p130	B-X
as	B-X
well	B-X
as	B-X
their	B-X
in	B-X
vivo	B-X
binding	B-X
to	B-X
the	B-X
Stathmin	B-X
promoter	B-X
.	B-X
Thus	B-X
,	B-X
functional	B-X
complexes	B-X
containing	B-X
E2F	B-X
and	B-X
RB	B-X
family	B-X
members	B-X
appear	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
repressing	B-X
expression	B-X
of	B-X
critical	B-X
mitotic	B-X
regulators	B-X
and	B-X
maintaining	B-X
the	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
checkpoint	B-X
.	B-X

Exposure	O
of	O
cells	O
to	O
genotoxic	O
agents	O
results	O
in	O
activation	O
of	O
checkpoint	O
pathways	O
leading	O
to	O
cell	O
cycle	O
arrest	O
.	O
<EOS>	B-X
The	B-X
ability	B-X
of	B-X
cells	B-X
to	B-X
maintain	B-X
genomic	B-X
integrity	B-X
is	B-X
vital	B-X
for	B-X
cell	B-X
survival	B-X
and	B-X
proliferation	B-X
.	B-X
Lack	B-X
of	B-X
fidelity	B-X
in	B-X
DNA	B-X
replication	B-X
and	B-X
maintenance	B-X
can	B-X
result	B-X
in	B-X
deleterious	B-X
mutations	B-X
leading	B-X
to	B-X
cell	B-X
death	B-X
or	B-X
,	B-X
in	B-X
multicellular	B-X
organisms	B-X
,	B-X
cancer	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
review	B-X
is	B-X
to	B-X
discuss	B-X
the	B-X
known	B-X
signal	B-X
transduction	B-X
pathways	B-X
that	B-X
regulate	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
the	B-X
mechanisms	B-X
cells	B-X
employ	B-X
to	B-X
insure	B-X
DNA	B-X
stability	B-X
in	B-X
the	B-X
face	B-X
of	B-X
genotoxic	B-X
stress	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
we	B-X
focus	B-X
on	B-X
mammalian	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
functions	B-X
,	B-X
their	B-X
role	B-X
in	B-X
maintaining	B-X
DNA	B-X
stability	B-X
during	B-X
the	B-X
cell	B-X
cycle	B-X
following	B-X
exposure	B-X
to	B-X
genotoxic	B-X
agents	B-X
,	B-X
and	B-X
the	B-X
gene	B-X
products	B-X
that	B-X
act	B-X
in	B-X
checkpoint	B-X
function	B-X
signal	B-X
transduction	B-X
cascades	B-X
.	B-X
Key	B-X
transitions	B-X
in	B-X
the	B-X
cell	B-X
cycle	B-X
are	B-X
regulated	B-X
by	B-X
the	B-X
activities	B-X
of	B-X
various	B-X
protein	B-X
kinase	B-X
complexes	B-X
composed	B-X
of	B-X
cyclin	B-X
and	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
molecules	B-X
.	B-X
Surveillance	B-X
control	B-X
mechanisms	B-X
that	B-X
check	B-X
to	B-X
ensure	B-X
proper	B-X
completion	B-X
of	B-X
early	B-X
events	B-X
and	B-X
cellular	B-X
integrity	B-X
before	B-X
initiation	B-X
of	B-X
subsequent	B-X
events	B-X
in	B-X
cell	B-X
cycle	B-X
progression	B-X
are	B-X
referred	B-X
to	B-X
as	B-X
cell	B-X
cycle	B-X
checkpoints	B-X
and	B-X
can	B-X
generate	B-X
a	B-X
transient	B-X
delay	B-X
that	B-X
provides	B-X
the	B-X
cell	B-X
more	B-X
time	B-X
to	B-X
repair	B-X
damage	B-X
before	B-X
progressing	B-X
to	B-X
the	B-X
next	B-X
phase	B-X
of	B-X
the	B-X
cycle	B-X
.	B-X
A	B-X
variety	B-X
of	B-X
cellular	B-X
responses	B-X
are	B-X
elicited	B-X
that	B-X
function	B-X
in	B-X
checkpoint	B-X
signaling	B-X
to	B-X
inhibit	B-X
cyclin/Cdk	B-X
activities	B-X
.	B-X
Eliciting	B-X
proper	B-X
G1	B-X
,	B-X
S	B-X
,	B-X
and	B-X
G2	B-X
checkpoint	B-X
responses	B-X
to	B-X
double-strand	B-X
DNA	B-X
breaks	B-X
requires	B-X
the	B-X
function	B-X
of	B-X
the	B-X
Ataxia	B-X
telangiectasia	B-X
mutated	B-X
gene	B-X
product	B-X
.	B-X
Several	B-X
human	B-X
heritable	B-X
cancer-prone	B-X
syndromes	B-X
known	B-X
to	B-X
alter	B-X
DNA	B-X
stability	B-X
have	B-X
been	B-X
found	B-X
to	B-X
have	B-X
defects	B-X
in	B-X
checkpoint	B-X
surveillance	B-X
pathways	B-X
.	B-X
Exposures	B-X
to	B-X
several	B-X
common	B-X
sources	B-X
of	B-X
genotoxic	B-X
stress	B-X
,	B-X
including	B-X
oxidative	B-X
stress	B-X
,	B-X
ionizing	B-X
radiation	B-X
,	B-X
UV	B-X
radiation	B-X
,	B-X
and	B-X
the	B-X
genotoxic	B-X
compound	B-X
benzo	B-X
[	B-X
a	B-X
]	B-X
pyrene	B-X
,	B-X
elicit	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
responses	B-X
that	B-X
show	B-X
both	B-X
similarities	B-X
and	B-X
differences	B-X
in	B-X
their	B-X
molecular	B-X
signaling	B-X
.	B-X

These	O
arrest	O
pathways	O
allow	O
repair	O
of	O
damaged	O
DNA	O
before	O
its	O
replication	O
and	O
segregation	O
,	O
thus	O
preventing	O
accumulation	O
of	O
mutations	O
.	O
<EOS>	B-X
Exposure	B-X
of	B-X
cells	B-X
to	B-X
genotoxic	B-X
agents	B-X
results	B-X
in	B-X
activation	B-X
of	B-X
checkpoint	B-X
pathways	B-X
leading	B-X
to	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
These	B-X
arrest	B-X
pathways	B-X
allow	B-X
repair	B-X
of	B-X
damaged	B-X
DNA	B-X
before	B-X
its	B-X
replication	B-X
and	B-X
segregation	B-X
,	B-X
thus	B-X
preventing	B-X
accumulation	B-X
of	B-X
mutations	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
sustained	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
arrest	B-X
induced	B-X
by	B-X
the	B-X
genotoxic	B-X
agent	B-X
doxorubicin	B-X
is	B-X
E2F-dependent	B-X
and	B-X
involves	B-X
a	B-X
decrease	B-X
in	B-X
expression	B-X
of	B-X
two	B-X
mitotic	B-X
regulators	B-X
,	B-X
Stathmin	B-X
and	B-X
AIM-1	B-X
.	B-X

The	O
tumor	O
suppressor	O
retinoblastoma	B-Gene_or_gene_product
(	O
RB	B-Gene_or_gene_product
)	O
is	O
required	O
for	O
the	O
G	O
(	O
1	O
)	O
/	O
S	O
checkpoint	O
function	O
.	O

In	O
addition	O
,	O
regulation	O
of	O
the	O
G	O
(	O
2	O
)	O
checkpoint	O
by	O
the	O
tumor	O
suppressor	O
p53	B-Gene_or_gene_product
is	O
RB	B-Gene_or_gene_product
-	O
dependent	O
.	O

However	O
,	O
the	O
molecular	O
mechanism	O
underlying	O
the	O
involvement	O
of	O
RB	B-Gene_or_gene_product
and	O
its	O
related	O
proteins	O
p107	B-Gene_or_gene_product
and	O
p130	B-Gene_or_gene_product
in	O
the	O
G	O
(	O
2	O
)	O
checkpoint	O
is	O
not	O
fully	O
understood	O
.	O

We	O
show	O
here	O
that	O
sustained	O
G	O
(	O
2	O
)	O
/	O
M	O
arrest	O
induced	O
by	O
the	O
genotoxic	O
agent	O
doxorubicin	O
is	O
E2F	B-Gene_or_gene_product
-	O
dependent	O
and	O
involves	O
a	O
decrease	O
in	O
expression	O
of	O
two	O
mitotic	O
regulators	O
,	O
Stathmin	B-Gene_or_gene_product
and	O
AIM	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O
<EOS>	B-X
Exposure	B-X
of	B-X
cells	B-X
to	B-X
genotoxic	B-X
agents	B-X
results	B-X
in	B-X
activation	B-X
of	B-X
checkpoint	B-X
pathways	B-X
leading	B-X
to	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
These	B-X
arrest	B-X
pathways	B-X
allow	B-X
repair	B-X
of	B-X
damaged	B-X
DNA	B-X
before	B-X
its	B-X
replication	B-X
and	B-X
segregation	B-X
,	B-X
thus	B-X
preventing	B-X
accumulation	B-X
of	B-X
mutations	B-X
.	B-X
The	B-X
tumor	B-X
suppressor	B-X
retinoblastoma	B-X
(	B-X
RB	B-X
)	B-X
is	B-X
required	B-X
for	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S	B-X
checkpoint	B-X
function	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
regulation	B-X
of	B-X
the	B-X
G	B-X
(	B-X
2	B-X
)	B-X
checkpoint	B-X
by	B-X
the	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
RB-dependent	B-X
.	B-X
However	B-X
,	B-X
the	B-X
molecular	B-X
mechanism	B-X
underlying	B-X
the	B-X
involvement	B-X
of	B-X
RB	B-X
and	B-X
its	B-X
related	B-X
proteins	B-X
p107	B-X
and	B-X
p130	B-X
in	B-X
the	B-X
G	B-X
(	B-X
2	B-X
)	B-X
checkpoint	B-X
is	B-X
not	B-X
fully	B-X
understood	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
sustained	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
arrest	B-X
induced	B-X
by	B-X
the	B-X
genotoxic	B-X
agent	B-X
doxorubicin	B-X
is	B-X
E2F-dependent	B-X
and	B-X
involves	B-X
a	B-X
decrease	B-X
in	B-X
expression	B-X
of	B-X
two	B-X
mitotic	B-X
regulators	B-X
,	B-X
Stathmin	B-X
and	B-X
AIM-1	B-X
.	B-X
Abrogation	B-X
of	B-X
E2F	B-X
function	B-X
by	B-X
dominant	B-X
negative	B-X
E2F	B-X
abolishes	B-X
the	B-X
doxorubicin-induced	B-X
down-regulation	B-X
of	B-X
Stathmin	B-X
and	B-X
AIM-1	B-X
and	B-X
leads	B-X
to	B-X
premature	B-X
exit	B-X
from	B-X
G	B-X
(	B-X
2	B-X
)	B-X
.	B-X
Expression	B-X
of	B-X
the	B-X
E7	B-X
papilloma	B-X
virus	B-X
protein	B-X
,	B-X
which	B-X
dissociates	B-X
complexes	B-X
containing	B-X
E2F	B-X
and	B-X
RB	B-X
family	B-X
members	B-X
,	B-X
also	B-X
prevents	B-X
the	B-X
down-regulation	B-X
of	B-X
these	B-X
mitotic	B-X
genes	B-X
and	B-X
leads	B-X
to	B-X
premature	B-X
exit	B-X
from	B-X
G	B-X
(	B-X
2	B-X
)	B-X
after	B-X
genotoxic	B-X
stress	B-X
.	B-X
Furthermore	B-X
,	B-X
genotoxic	B-X
stress	B-X
increases	B-X
the	B-X
levels	B-X
of	B-X
nuclear	B-X
E2F-4	B-X
and	B-X
p130	B-X
as	B-X
well	B-X
as	B-X
their	B-X
in	B-X
vivo	B-X
binding	B-X
to	B-X
the	B-X
Stathmin	B-X
promoter	B-X
.	B-X
Thus	B-X
,	B-X
functional	B-X
complexes	B-X
containing	B-X
E2F	B-X
and	B-X
RB	B-X
family	B-X
members	B-X
appear	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
repressing	B-X
expression	B-X
of	B-X
critical	B-X
mitotic	B-X
regulators	B-X
and	B-X
maintaining	B-X
the	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
checkpoint	B-X
.	B-X

Abrogation	O
of	O
E2F	B-Gene_or_gene_product
function	O
by	O
dominant	O
negative	O
E2F	B-Gene_or_gene_product
abolishes	O
the	O
doxorubicin	O
-	O
induced	O
down	O
-	O
regulation	O
of	O
Stathmin	B-Gene_or_gene_product
and	O
AIM	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
leads	O
to	O
premature	O
exit	O
from	O
G	O
(	O
2	O
)	O
.	O

Expression	O
of	O
the	O
E7	B-Gene_or_gene_product
papilloma	O
virus	O
protein	O
,	O
which	O
dissociates	O
complexes	O
containing	O
E2F	B-Gene_or_gene_product
and	O
RB	B-Gene_or_gene_product
family	O
members	O
,	O
also	O
prevents	O
the	O
down	O
-	O
regulation	O
of	O
these	O
mitotic	O
genes	O
and	O
leads	O
to	O
premature	O
exit	O
from	O
G	O
(	O
2	O
)	O
after	O
genotoxic	O
stress	O
.	O

Furthermore	O
,	O
genotoxic	O
stress	O
increases	O
the	O
levels	O
of	O
nuclear	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
and	O
p130	B-Gene_or_gene_product
as	O
well	O
as	O
their	O
in	O
vivo	O
binding	O
to	O
the	O
Stathmin	B-Gene_or_gene_product
promoter	O
.	O

Thus	O
,	O
functional	O
complexes	O
containing	O
E2F	B-Gene_or_gene_product
and	O
RB	B-Gene_or_gene_product
family	O
members	O
appear	O
to	O
be	O
essential	O
for	O
repressing	O
expression	O
of	O
critical	O
mitotic	O
regulators	O
and	O
maintaining	O
the	O
G	O
(	O
2	O
)	O
/	O
M	O
checkpoint	O
.	O

Cell	O
cycle	O
-	O
dependent	O
nuclear	O
export	O
of	O
Cdh1p	B-Gene_or_gene_product
may	O
contribute	O
to	O
the	O
inactivation	O
of	O
APC	O
/	O
C	O
(	O
Cdh1	O
)	O
.	O

Cdh1p	B-Gene_or_gene_product
is	O
a	O
substrate	O
-	O
specific	O
subunit	O
of	O
the	O
anaphase	O
-	O
promoting	O
complex	O
(	O
APC	O
/	O
C	O
)	O
,	O
which	O
functions	O
as	O
an	O
E3	O
ubiquitin	B-Gene_or_gene_product
ligase	O
to	O
degrade	O
the	O
mitotic	O
cyclin	B-Gene_or_gene_product
Clb2p	I-Gene_or_gene_product
and	O
other	O
substrates	O
during	O
the	O
G	O
(	O
1	O
)	O
phase	O
of	O
the	O
cell	O
cycle	O
.	O

Cdh1p	B-Gene_or_gene_product
is	O
phosphorylated	O
and	O
thereby	O
inactivated	O
at	O
the	O
G	O
(	O
1	O
)	O
/	O
S	O
transition	O
predominantly	O
by	O
Cdc28p	O
-	O
Clb5p	O
.	O

Here	O
we	O
show	O
that	O
Cdh1p	B-Gene_or_gene_product
is	O
nuclear	O
during	O
the	O
G	O
(	O
1	O
)	O
phase	O
of	O
the	O
cell	O
cycle	O
,	O
but	O
redistributes	O
to	O
the	O
cytoplasm	O
between	O
S	O
phase	O
and	O
the	O
end	O
of	O
mitosis	O
.	O

Nuclear	O
export	O
of	O
Cdh1p	B-Gene_or_gene_product
is	O
regulated	O
by	O
phosphorylation	O
and	O
requires	O
active	O
Cdc28p	B-Gene_or_gene_product
kinase	O
.	O
<EOS>	B-X
Cdh1p	B-X
is	B-X
a	B-X
substrate-specific	B-X
subunit	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex	B-X
(	B-X
APC/C	B-X
)	B-X
,	B-X
which	B-X
functions	B-X
as	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
to	B-X
degrade	B-X
the	B-X
mitotic	B-X
cyclin	B-X
Clb2p	B-X
and	B-X
other	B-X
substrates	B-X
during	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Cdh1p	B-X
is	B-X
phosphorylated	B-X
and	B-X
thereby	B-X
inactivated	B-X
at	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S	B-X
transition	B-X
predominantly	B-X
by	B-X
Cdc28p-Clb5p	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Cdh1p	B-X
is	B-X
nuclear	B-X
during	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
,	B-X
but	B-X
redistributes	B-X
to	B-X
the	B-X
cytoplasm	B-X
between	B-X
S	B-X
phase	B-X
and	B-X
the	B-X
end	B-X
of	B-X
mitosis	B-X
.	B-X
Nuclear	B-X
export	B-X
of	B-X
Cdh1p	B-X
is	B-X
regulated	B-X
by	B-X
phosphorylation	B-X
and	B-X
requires	B-X
active	B-X
Cdc28p	B-X
kinase	B-X
.	B-X
Cdh1p	B-X
binds	B-X
to	B-X
the	B-X
importin	B-X
Pse1p	B-X
and	B-X
the	B-X
exportin	B-X
Msn5p	B-X
,	B-X
which	B-X
is	B-X
necessary	B-X
and	B-X
sufficient	B-X
to	B-X
promote	B-X
efficient	B-X
export	B-X
of	B-X
Cdh1p	B-X
in	B-X
vivo	B-X
.	B-X
Although	B-X
msn5delta	B-X
cells	B-X
are	B-X
viable	B-X
,	B-X
they	B-X
are	B-X
sensitive	B-X
to	B-X
Cdh1p	B-X
overexpression	B-X
.	B-X
Likewise	B-X
,	B-X
a	B-X
mutant	B-X
form	B-X
of	B-X
Cdh1p	B-X
,	B-X
which	B-X
is	B-X
constitutively	B-X
nuclear	B-X
,	B-X
prevents	B-X
accumulation	B-X
of	B-X
Clb2p	B-X
and	B-X
leads	B-X
to	B-X
cell	B-X
cycle	B-X
arrest	B-X
when	B-X
overexpressed	B-X
in	B-X
wild-type	B-X
cells	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
phosphorylation-dependent	B-X
nuclear	B-X
export	B-X
of	B-X
Cdh1p	B-X
by	B-X
Msn5p	B-X
contributes	B-X
to	B-X
efficient	B-X
inactivation	B-X
of	B-X
APC/C	B-X
(	B-X
Cdh1	B-X
)	B-X
.	B-X

Cdh1p	B-Gene_or_gene_product
binds	O
to	O
the	O
importin	O
Pse1p	B-Gene_or_gene_product
and	O
the	O
exportin	O
Msn5p	B-Gene_or_gene_product
,	O
which	O
is	O
necessary	O
and	O
sufficient	O
to	O
promote	O
efficient	O
export	O
of	O
Cdh1p	B-Gene_or_gene_product
in	O
vivo	O
.	O

Although	O
msn5delta	B-Gene_or_gene_product
cells	O
are	O
viable	O
,	O
they	O
are	O
sensitive	O
to	O
Cdh1p	B-Gene_or_gene_product
overexpression	O
.	O
<EOS>	B-X
Cdh1p	B-X
is	B-X
a	B-X
substrate-specific	B-X
subunit	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex	B-X
(	B-X
APC/C	B-X
)	B-X
,	B-X
which	B-X
functions	B-X
as	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
to	B-X
degrade	B-X
the	B-X
mitotic	B-X
cyclin	B-X
Clb2p	B-X
and	B-X
other	B-X
substrates	B-X
during	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Cdh1p	B-X
is	B-X
phosphorylated	B-X
and	B-X
thereby	B-X
inactivated	B-X
at	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S	B-X
transition	B-X
predominantly	B-X
by	B-X
Cdc28p-Clb5p	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Cdh1p	B-X
is	B-X
nuclear	B-X
during	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
,	B-X
but	B-X
redistributes	B-X
to	B-X
the	B-X
cytoplasm	B-X
between	B-X
S	B-X
phase	B-X
and	B-X
the	B-X
end	B-X
of	B-X
mitosis	B-X
.	B-X
Nuclear	B-X
export	B-X
of	B-X
Cdh1p	B-X
is	B-X
regulated	B-X
by	B-X
phosphorylation	B-X
and	B-X
requires	B-X
active	B-X
Cdc28p	B-X
kinase	B-X
.	B-X
Cdh1p	B-X
binds	B-X
to	B-X
the	B-X
importin	B-X
Pse1p	B-X
and	B-X
the	B-X
exportin	B-X
Msn5p	B-X
,	B-X
which	B-X
is	B-X
necessary	B-X
and	B-X
sufficient	B-X
to	B-X
promote	B-X
efficient	B-X
export	B-X
of	B-X
Cdh1p	B-X
in	B-X
vivo	B-X
.	B-X
Although	B-X
msn5delta	B-X
cells	B-X
are	B-X
viable	B-X
,	B-X
they	B-X
are	B-X
sensitive	B-X
to	B-X
Cdh1p	B-X
overexpression	B-X
.	B-X
Likewise	B-X
,	B-X
a	B-X
mutant	B-X
form	B-X
of	B-X
Cdh1p	B-X
,	B-X
which	B-X
is	B-X
constitutively	B-X
nuclear	B-X
,	B-X
prevents	B-X
accumulation	B-X
of	B-X
Clb2p	B-X
and	B-X
leads	B-X
to	B-X
cell	B-X
cycle	B-X
arrest	B-X
when	B-X
overexpressed	B-X
in	B-X
wild-type	B-X
cells	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
phosphorylation-dependent	B-X
nuclear	B-X
export	B-X
of	B-X
Cdh1p	B-X
by	B-X
Msn5p	B-X
contributes	B-X
to	B-X
efficient	B-X
inactivation	B-X
of	B-X
APC/C	B-X
(	B-X
Cdh1	B-X
)	B-X
.	B-X

Likewise	O
,	O
a	O
mutant	O
form	O
of	O
Cdh1p	B-Gene_or_gene_product
,	O
which	O
is	O
constitutively	O
nuclear	O
,	O
prevents	O
accumulation	O
of	O
Clb2p	B-Gene_or_gene_product
and	O
leads	O
to	O
cell	O
cycle	O
arrest	O
when	O
overexpressed	O
in	O
wild	O
-	O
type	O
cells	O
.	O
<EOS>	B-X
Cdh1p	B-X
is	B-X
a	B-X
substrate-specific	B-X
subunit	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex	B-X
(	B-X
APC/C	B-X
)	B-X
,	B-X
which	B-X
functions	B-X
as	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
to	B-X
degrade	B-X
the	B-X
mitotic	B-X
cyclin	B-X
Clb2p	B-X
and	B-X
other	B-X
substrates	B-X
during	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Cdh1p	B-X
is	B-X
phosphorylated	B-X
and	B-X
thereby	B-X
inactivated	B-X
at	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S	B-X
transition	B-X
predominantly	B-X
by	B-X
Cdc28p-Clb5p	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Cdh1p	B-X
is	B-X
nuclear	B-X
during	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
,	B-X
but	B-X
redistributes	B-X
to	B-X
the	B-X
cytoplasm	B-X
between	B-X
S	B-X
phase	B-X
and	B-X
the	B-X
end	B-X
of	B-X
mitosis	B-X
.	B-X
Nuclear	B-X
export	B-X
of	B-X
Cdh1p	B-X
is	B-X
regulated	B-X
by	B-X
phosphorylation	B-X
and	B-X
requires	B-X
active	B-X
Cdc28p	B-X
kinase	B-X
.	B-X
Cdh1p	B-X
binds	B-X
to	B-X
the	B-X
importin	B-X
Pse1p	B-X
and	B-X
the	B-X
exportin	B-X
Msn5p	B-X
,	B-X
which	B-X
is	B-X
necessary	B-X
and	B-X
sufficient	B-X
to	B-X
promote	B-X
efficient	B-X
export	B-X
of	B-X
Cdh1p	B-X
in	B-X
vivo	B-X
.	B-X
Although	B-X
msn5delta	B-X
cells	B-X
are	B-X
viable	B-X
,	B-X
they	B-X
are	B-X
sensitive	B-X
to	B-X
Cdh1p	B-X
overexpression	B-X
.	B-X
Likewise	B-X
,	B-X
a	B-X
mutant	B-X
form	B-X
of	B-X
Cdh1p	B-X
,	B-X
which	B-X
is	B-X
constitutively	B-X
nuclear	B-X
,	B-X
prevents	B-X
accumulation	B-X
of	B-X
Clb2p	B-X
and	B-X
leads	B-X
to	B-X
cell	B-X
cycle	B-X
arrest	B-X
when	B-X
overexpressed	B-X
in	B-X
wild-type	B-X
cells	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
phosphorylation-dependent	B-X
nuclear	B-X
export	B-X
of	B-X
Cdh1p	B-X
by	B-X
Msn5p	B-X
contributes	B-X
to	B-X
efficient	B-X
inactivation	B-X
of	B-X
APC/C	B-X
(	B-X
Cdh1	B-X
)	B-X
.	B-X

Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
phosphorylation	O
-	O
dependent	O
nuclear	O
export	O
of	O
Cdh1p	B-Gene_or_gene_product
by	O
Msn5p	B-Gene_or_gene_product
contributes	O
to	O
efficient	O
inactivation	O
of	O
APC	O
/	O
C	O
(	O
Cdh1	O
)	O
.	O
<EOS>	B-X
Cdh1p	B-X
is	B-X
a	B-X
substrate-specific	B-X
subunit	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex	B-X
(	B-X
APC/C	B-X
)	B-X
,	B-X
which	B-X
functions	B-X
as	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
to	B-X
degrade	B-X
the	B-X
mitotic	B-X
cyclin	B-X
Clb2p	B-X
and	B-X
other	B-X
substrates	B-X
during	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Cdh1p	B-X
is	B-X
phosphorylated	B-X
and	B-X
thereby	B-X
inactivated	B-X
at	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S	B-X
transition	B-X
predominantly	B-X
by	B-X
Cdc28p-Clb5p	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Cdh1p	B-X
is	B-X
nuclear	B-X
during	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
,	B-X
but	B-X
redistributes	B-X
to	B-X
the	B-X
cytoplasm	B-X
between	B-X
S	B-X
phase	B-X
and	B-X
the	B-X
end	B-X
of	B-X
mitosis	B-X
.	B-X
Nuclear	B-X
export	B-X
of	B-X
Cdh1p	B-X
is	B-X
regulated	B-X
by	B-X
phosphorylation	B-X
and	B-X
requires	B-X
active	B-X
Cdc28p	B-X
kinase	B-X
.	B-X
Cdh1p	B-X
binds	B-X
to	B-X
the	B-X
importin	B-X
Pse1p	B-X
and	B-X
the	B-X
exportin	B-X
Msn5p	B-X
,	B-X
which	B-X
is	B-X
necessary	B-X
and	B-X
sufficient	B-X
to	B-X
promote	B-X
efficient	B-X
export	B-X
of	B-X
Cdh1p	B-X
in	B-X
vivo	B-X
.	B-X
Although	B-X
msn5delta	B-X
cells	B-X
are	B-X
viable	B-X
,	B-X
they	B-X
are	B-X
sensitive	B-X
to	B-X
Cdh1p	B-X
overexpression	B-X
.	B-X
Likewise	B-X
,	B-X
a	B-X
mutant	B-X
form	B-X
of	B-X
Cdh1p	B-X
,	B-X
which	B-X
is	B-X
constitutively	B-X
nuclear	B-X
,	B-X
prevents	B-X
accumulation	B-X
of	B-X
Clb2p	B-X
and	B-X
leads	B-X
to	B-X
cell	B-X
cycle	B-X
arrest	B-X
when	B-X
overexpressed	B-X
in	B-X
wild-type	B-X
cells	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
phosphorylation-dependent	B-X
nuclear	B-X
export	B-X
of	B-X
Cdh1p	B-X
by	B-X
Msn5p	B-X
contributes	B-X
to	B-X
efficient	B-X
inactivation	B-X
of	B-X
APC/C	B-X
(	B-X
Cdh1	B-X
)	B-X
.	B-X

Recruitment	O
of	O
NBS1	B-Gene_or_gene_product
into	O
PML	B-Gene_or_gene_product
oncogenic	O
domains	O
via	O
interaction	O
with	O
SP100	B-Gene_or_gene_product
protein	O
.	O
<EOS>	B-X
NBS1	B-X
,	B-X
the	B-X
protein	B-X
responsible	B-X
for	B-X
NBS	B-X
,	B-X
forms	B-X
a	B-X
complex	B-X
with	B-X
MRE11	B-X
and	B-X
RAD50	B-X
,	B-X
and	B-X
plays	B-X
a	B-X
vital	B-X
role	B-X
in	B-X
DNA	B-X
repair	B-X
,	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
,	B-X
and	B-X
telomere	B-X
maintenance	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
a	B-X
BRCA	B-X
carboxyl	B-X
terminus	B-X
(	B-X
BRCT	B-X
)	B-X
domain-containing	B-X
region	B-X
of	B-X
NBS1	B-X
interacts	B-X
with	B-X
a	B-X
nuclear	B-X
dots-associated	B-X
protein	B-X
,	B-X
SP100	B-X
.	B-X
The	B-X
SP100	B-X
and	B-X
NBS1	B-X
proteins	B-X
co-localized	B-X
in	B-X
PODs	B-X
and	B-X
APBs	B-X
in	B-X
normal	B-X
human	B-X
fibroblast	B-X
MRC5	B-X
and	B-X
ALT	B-X
line	B-X
VA13	B-X
at	B-X
G2	B-X
phase	B-X
,	B-X
respectively	B-X
.	B-X
Introduction	B-X
of	B-X
PML	B-X
and	B-X
SP100	B-X
into	B-X
NT2	B-X
cells	B-X
,	B-X
which	B-X
express	B-X
no	B-X
detectable	B-X
amount	B-X
of	B-X
PML	B-X
or	B-X
SP100	B-X
proteins	B-X
,	B-X
resulted	B-X
in	B-X
localization	B-X
of	B-X
NBS1	B-X
in	B-X
ectopically	B-X
expressed	B-X
PODs	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
NBS1	B-X
is	B-X
recruited	B-X
into	B-X
PODs	B-X
via	B-X
interaction	B-X
with	B-X
SP100	B-X
protein	B-X
.	B-X
Thus	B-X
,	B-X
interaction	B-X
between	B-X
the	B-X
NBS1	B-X
and	B-X
SP100	B-X
proteins	B-X
may	B-X
be	B-X
involved	B-X
in	B-X
genomic	B-X
stability	B-X
and	B-X
telomere	B-X
maintenance	B-X
.	B-X

Nijmegen	O
breakage	O
syndrome	O
(	O
NBS	O
)	O
is	O
an	O
autosomal	O
recessive	O
disorder	O
characterized	O
by	O
microcephaly	O
,	O
chromosomal	O
instability	O
,	O
radiation	O
sensitivity	O
,	O
and	O
an	O
increased	O
incidence	O
of	O
malignancies	O
.	O

NBS1	B-Gene_or_gene_product
,	O
the	O
protein	O
responsible	O
for	O
NBS	O
,	O
forms	O
a	O
complex	O
with	O
MRE11	B-Gene_or_gene_product
and	O
RAD50	B-Gene_or_gene_product
,	O
and	O
plays	O
a	O
vital	O
role	O
in	O
DNA	O
repair	O
,	O
cell	O
cycle	O
checkpoint	O
,	O
and	O
telomere	O
maintenance	O
.	O

Here	O
,	O
we	O
show	O
that	O
a	O
BRCA	B-Gene_or_gene_product
carboxyl	O
terminus	O
(	O
BRCT	O
)	O
domain	O
-	O
containing	O
region	O
of	O
NBS1	B-Gene_or_gene_product
interacts	O
with	O
a	O
nuclear	O
dots	O
-	O
associated	O
protein	O
,	O
SP100	B-Gene_or_gene_product
.	O
<EOS>	B-X
NBS1	B-X
,	B-X
the	B-X
protein	B-X
responsible	B-X
for	B-X
NBS	B-X
,	B-X
forms	B-X
a	B-X
complex	B-X
with	B-X
MRE11	B-X
and	B-X
RAD50	B-X
,	B-X
and	B-X
plays	B-X
a	B-X
vital	B-X
role	B-X
in	B-X
DNA	B-X
repair	B-X
,	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
,	B-X
and	B-X
telomere	B-X
maintenance	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
a	B-X
BRCA	B-X
carboxyl	B-X
terminus	B-X
(	B-X
BRCT	B-X
)	B-X
domain-containing	B-X
region	B-X
of	B-X
NBS1	B-X
interacts	B-X
with	B-X
a	B-X
nuclear	B-X
dots-associated	B-X
protein	B-X
,	B-X
SP100	B-X
.	B-X
The	B-X
SP100	B-X
and	B-X
NBS1	B-X
proteins	B-X
co-localized	B-X
in	B-X
PODs	B-X
and	B-X
APBs	B-X
in	B-X
normal	B-X
human	B-X
fibroblast	B-X
MRC5	B-X
and	B-X
ALT	B-X
line	B-X
VA13	B-X
at	B-X
G2	B-X
phase	B-X
,	B-X
respectively	B-X
.	B-X
Introduction	B-X
of	B-X
PML	B-X
and	B-X
SP100	B-X
into	B-X
NT2	B-X
cells	B-X
,	B-X
which	B-X
express	B-X
no	B-X
detectable	B-X
amount	B-X
of	B-X
PML	B-X
or	B-X
SP100	B-X
proteins	B-X
,	B-X
resulted	B-X
in	B-X
localization	B-X
of	B-X
NBS1	B-X
in	B-X
ectopically	B-X
expressed	B-X
PODs	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
NBS1	B-X
is	B-X
recruited	B-X
into	B-X
PODs	B-X
via	B-X
interaction	B-X
with	B-X
SP100	B-X
protein	B-X
.	B-X
Thus	B-X
,	B-X
interaction	B-X
between	B-X
the	B-X
NBS1	B-X
and	B-X
SP100	B-X
proteins	B-X
may	B-X
be	B-X
involved	B-X
in	B-X
genomic	B-X
stability	B-X
and	B-X
telomere	B-X
maintenance	B-X
.	B-X

The	O
SP100	B-Gene_or_gene_product
and	O
NBS1	B-Gene_or_gene_product
proteins	O
co	O
-	O
localized	O
in	O
PODs	O
and	O
APBs	O
in	O
normal	O
human	O
fibroblast	O
MRC5	O
and	O
ALT	O
line	O
VA13	O
at	O
G2	O
phase	O
,	O
respectively	O
.	O
<EOS>	B-X
NBS1	B-X
,	B-X
the	B-X
protein	B-X
responsible	B-X
for	B-X
NBS	B-X
,	B-X
forms	B-X
a	B-X
complex	B-X
with	B-X
MRE11	B-X
and	B-X
RAD50	B-X
,	B-X
and	B-X
plays	B-X
a	B-X
vital	B-X
role	B-X
in	B-X
DNA	B-X
repair	B-X
,	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
,	B-X
and	B-X
telomere	B-X
maintenance	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
a	B-X
BRCA	B-X
carboxyl	B-X
terminus	B-X
(	B-X
BRCT	B-X
)	B-X
domain-containing	B-X
region	B-X
of	B-X
NBS1	B-X
interacts	B-X
with	B-X
a	B-X
nuclear	B-X
dots-associated	B-X
protein	B-X
,	B-X
SP100	B-X
.	B-X
The	B-X
SP100	B-X
and	B-X
NBS1	B-X
proteins	B-X
co-localized	B-X
in	B-X
PODs	B-X
and	B-X
APBs	B-X
in	B-X
normal	B-X
human	B-X
fibroblast	B-X
MRC5	B-X
and	B-X
ALT	B-X
line	B-X
VA13	B-X
at	B-X
G2	B-X
phase	B-X
,	B-X
respectively	B-X
.	B-X
Introduction	B-X
of	B-X
PML	B-X
and	B-X
SP100	B-X
into	B-X
NT2	B-X
cells	B-X
,	B-X
which	B-X
express	B-X
no	B-X
detectable	B-X
amount	B-X
of	B-X
PML	B-X
or	B-X
SP100	B-X
proteins	B-X
,	B-X
resulted	B-X
in	B-X
localization	B-X
of	B-X
NBS1	B-X
in	B-X
ectopically	B-X
expressed	B-X
PODs	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
NBS1	B-X
is	B-X
recruited	B-X
into	B-X
PODs	B-X
via	B-X
interaction	B-X
with	B-X
SP100	B-X
protein	B-X
.	B-X
Thus	B-X
,	B-X
interaction	B-X
between	B-X
the	B-X
NBS1	B-X
and	B-X
SP100	B-X
proteins	B-X
may	B-X
be	B-X
involved	B-X
in	B-X
genomic	B-X
stability	B-X
and	B-X
telomere	B-X
maintenance	B-X
.	B-X

Introduction	O
of	O
PML	B-Gene_or_gene_product
and	O
SP100	B-Gene_or_gene_product
into	O
NT2	O
cells	O
,	O
which	O
express	O
no	O
detectable	O
amount	O
of	O
PML	B-Gene_or_gene_product
or	O
SP100	B-Gene_or_gene_product
proteins	O
,	O
resulted	O
in	O
localization	O
of	O
NBS1	B-Gene_or_gene_product
in	O
ectopically	O
expressed	O
PODs	O
.	O
<EOS>	B-X
NBS1	B-X
,	B-X
the	B-X
protein	B-X
responsible	B-X
for	B-X
NBS	B-X
,	B-X
forms	B-X
a	B-X
complex	B-X
with	B-X
MRE11	B-X
and	B-X
RAD50	B-X
,	B-X
and	B-X
plays	B-X
a	B-X
vital	B-X
role	B-X
in	B-X
DNA	B-X
repair	B-X
,	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
,	B-X
and	B-X
telomere	B-X
maintenance	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
a	B-X
BRCA	B-X
carboxyl	B-X
terminus	B-X
(	B-X
BRCT	B-X
)	B-X
domain-containing	B-X
region	B-X
of	B-X
NBS1	B-X
interacts	B-X
with	B-X
a	B-X
nuclear	B-X
dots-associated	B-X
protein	B-X
,	B-X
SP100	B-X
.	B-X
The	B-X
SP100	B-X
and	B-X
NBS1	B-X
proteins	B-X
co-localized	B-X
in	B-X
PODs	B-X
and	B-X
APBs	B-X
in	B-X
normal	B-X
human	B-X
fibroblast	B-X
MRC5	B-X
and	B-X
ALT	B-X
line	B-X
VA13	B-X
at	B-X
G2	B-X
phase	B-X
,	B-X
respectively	B-X
.	B-X
Introduction	B-X
of	B-X
PML	B-X
and	B-X
SP100	B-X
into	B-X
NT2	B-X
cells	B-X
,	B-X
which	B-X
express	B-X
no	B-X
detectable	B-X
amount	B-X
of	B-X
PML	B-X
or	B-X
SP100	B-X
proteins	B-X
,	B-X
resulted	B-X
in	B-X
localization	B-X
of	B-X
NBS1	B-X
in	B-X
ectopically	B-X
expressed	B-X
PODs	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
NBS1	B-X
is	B-X
recruited	B-X
into	B-X
PODs	B-X
via	B-X
interaction	B-X
with	B-X
SP100	B-X
protein	B-X
.	B-X
Thus	B-X
,	B-X
interaction	B-X
between	B-X
the	B-X
NBS1	B-X
and	B-X
SP100	B-X
proteins	B-X
may	B-X
be	B-X
involved	B-X
in	B-X
genomic	B-X
stability	B-X
and	B-X
telomere	B-X
maintenance	B-X
.	B-X

These	O
results	O
indicate	O
that	O
NBS1	B-Gene_or_gene_product
is	O
recruited	O
into	O
PODs	O
via	O
interaction	O
with	O
SP100	B-Gene_or_gene_product
protein	O
.	O
<EOS>	B-X
NBS1	B-X
,	B-X
the	B-X
protein	B-X
responsible	B-X
for	B-X
NBS	B-X
,	B-X
forms	B-X
a	B-X
complex	B-X
with	B-X
MRE11	B-X
and	B-X
RAD50	B-X
,	B-X
and	B-X
plays	B-X
a	B-X
vital	B-X
role	B-X
in	B-X
DNA	B-X
repair	B-X
,	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
,	B-X
and	B-X
telomere	B-X
maintenance	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
a	B-X
BRCA	B-X
carboxyl	B-X
terminus	B-X
(	B-X
BRCT	B-X
)	B-X
domain-containing	B-X
region	B-X
of	B-X
NBS1	B-X
interacts	B-X
with	B-X
a	B-X
nuclear	B-X
dots-associated	B-X
protein	B-X
,	B-X
SP100	B-X
.	B-X
The	B-X
SP100	B-X
and	B-X
NBS1	B-X
proteins	B-X
co-localized	B-X
in	B-X
PODs	B-X
and	B-X
APBs	B-X
in	B-X
normal	B-X
human	B-X
fibroblast	B-X
MRC5	B-X
and	B-X
ALT	B-X
line	B-X
VA13	B-X
at	B-X
G2	B-X
phase	B-X
,	B-X
respectively	B-X
.	B-X
Introduction	B-X
of	B-X
PML	B-X
and	B-X
SP100	B-X
into	B-X
NT2	B-X
cells	B-X
,	B-X
which	B-X
express	B-X
no	B-X
detectable	B-X
amount	B-X
of	B-X
PML	B-X
or	B-X
SP100	B-X
proteins	B-X
,	B-X
resulted	B-X
in	B-X
localization	B-X
of	B-X
NBS1	B-X
in	B-X
ectopically	B-X
expressed	B-X
PODs	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
NBS1	B-X
is	B-X
recruited	B-X
into	B-X
PODs	B-X
via	B-X
interaction	B-X
with	B-X
SP100	B-X
protein	B-X
.	B-X
Thus	B-X
,	B-X
interaction	B-X
between	B-X
the	B-X
NBS1	B-X
and	B-X
SP100	B-X
proteins	B-X
may	B-X
be	B-X
involved	B-X
in	B-X
genomic	B-X
stability	B-X
and	B-X
telomere	B-X
maintenance	B-X
.	B-X

Thus	O
,	O
interaction	O
between	O
the	O
NBS1	B-Gene_or_gene_product
and	O
SP100	B-Gene_or_gene_product
proteins	O
may	O
be	O
involved	O
in	O
genomic	O
stability	O
and	O
telomere	O
maintenance	O
.	O
<EOS>	B-X
Nijmegen	B-X
breakage	B-X
syndrome	B-X
(	B-X
NBS	B-X
)	B-X
is	B-X
an	B-X
autosomal	B-X
recessive	B-X
disorder	B-X
characterized	B-X
by	B-X
microcephaly	B-X
,	B-X
chromosomal	B-X
instability	B-X
,	B-X
radiation	B-X
sensitivity	B-X
,	B-X
and	B-X
an	B-X
increased	B-X
incidence	B-X
of	B-X
malignancies	B-X
.	B-X
NBS1	B-X
,	B-X
the	B-X
protein	B-X
responsible	B-X
for	B-X
NBS	B-X
,	B-X
forms	B-X
a	B-X
complex	B-X
with	B-X
MRE11	B-X
and	B-X
RAD50	B-X
,	B-X
and	B-X
plays	B-X
a	B-X
vital	B-X
role	B-X
in	B-X
DNA	B-X
repair	B-X
,	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
,	B-X
and	B-X
telomere	B-X
maintenance	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
a	B-X
BRCA	B-X
carboxyl	B-X
terminus	B-X
(	B-X
BRCT	B-X
)	B-X
domain-containing	B-X
region	B-X
of	B-X
NBS1	B-X
interacts	B-X
with	B-X
a	B-X
nuclear	B-X
dots-associated	B-X
protein	B-X
,	B-X
SP100	B-X
.	B-X
The	B-X
SP100	B-X
and	B-X
NBS1	B-X
proteins	B-X
co-localized	B-X
in	B-X
PODs	B-X
and	B-X
APBs	B-X
in	B-X
normal	B-X
human	B-X
fibroblast	B-X
MRC5	B-X
and	B-X
ALT	B-X
line	B-X
VA13	B-X
at	B-X
G2	B-X
phase	B-X
,	B-X
respectively	B-X
.	B-X
Introduction	B-X
of	B-X
PML	B-X
and	B-X
SP100	B-X
into	B-X
NT2	B-X
cells	B-X
,	B-X
which	B-X
express	B-X
no	B-X
detectable	B-X
amount	B-X
of	B-X
PML	B-X
or	B-X
SP100	B-X
proteins	B-X
,	B-X
resulted	B-X
in	B-X
localization	B-X
of	B-X
NBS1	B-X
in	B-X
ectopically	B-X
expressed	B-X
PODs	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
NBS1	B-X
is	B-X
recruited	B-X
into	B-X
PODs	B-X
via	B-X
interaction	B-X
with	B-X
SP100	B-X
protein	B-X
.	B-X
Thus	B-X
,	B-X
interaction	B-X
between	B-X
the	B-X
NBS1	B-X
and	B-X
SP100	B-X
proteins	B-X
may	B-X
be	B-X
involved	B-X
in	B-X
genomic	B-X
stability	B-X
and	B-X
telomere	B-X
maintenance	B-X
.	B-X

Cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
:	O
linking	O
apoptosis	O
to	O
cell	O
cycle	O
and	O
mitotic	O
catastrophe	O
.	O
<EOS>	B-X
The	B-X
cyclin-dependent	B-X
kinase	B-X
1	B-X
(	B-X
Cdk1	B-X
)	B-X
,	B-X
formerly	B-X
called	B-X
Cdc2	B-X
(	B-X
or	B-X
p34	B-X
(	B-X
Cdc2	B-X
)	B-X
)	B-X
,	B-X
interacts	B-X
with	B-X
cyclin	B-X
B1	B-X
to	B-X
form	B-X
an	B-X
active	B-X
heterodimer	B-X
.	B-X
The	B-X
activity	B-X
of	B-X
Cdk1	B-X
is	B-X
subjected	B-X
to	B-X
a	B-X
complex	B-X
spatiotemporary	B-X
regulation	B-X
,	B-X
required	B-X
to	B-X
guarantee	B-X
its	B-X
scheduled	B-X
contribution	B-X
to	B-X
the	B-X
mitotic	B-X
prophase	B-X
and	B-X
metaphase	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
Cdk1	B-X
may	B-X
be	B-X
required	B-X
for	B-X
apoptosis	B-X
induction	B-X
in	B-X
some	B-X
particular	B-X
pathways	B-X
of	B-X
cell	B-X
killing	B-X
.	B-X
This	B-X
applies	B-X
to	B-X
several	B-X
clinically	B-X
important	B-X
settings	B-X
,	B-X
for	B-X
instance	B-X
to	B-X
paclitaxel-induced	B-X
killing	B-X
of	B-X
breast	B-X
cancer	B-X
cells	B-X
,	B-X
in	B-X
which	B-X
the	B-X
ErbB2	B-X
receptor	B-X
kinase	B-X
can	B-X
mediate	B-X
apoptosis	B-X
inhibition	B-X
through	B-X
inactivation	B-X
of	B-X
Cdk1	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
Cdk1	B-X
participates	B-X
also	B-X
in	B-X
HIV-1-induced	B-X
apoptosis	B-X
,	B-X
upstream	B-X
of	B-X
the	B-X
p53-dependent	B-X
mitochondrial	B-X
permeabilization	B-X
step	B-X
.	B-X
An	B-X
unscheduled	B-X
Cdk1	B-X
activation	B-X
may	B-X
contribute	B-X
to	B-X
neuronal	B-X
apoptosis	B-X
occurring	B-X
in	B-X
neurodegenerative	B-X
diseases	B-X
.	B-X
Finally	B-X
,	B-X
the	B-X
premature	B-X
activation	B-X
of	B-X
Cdk1	B-X
can	B-X
lead	B-X
to	B-X
mitotic	B-X
catastrophe	B-X
,	B-X
for	B-X
instance	B-X
after	B-X
irradiation-induced	B-X
DNA	B-X
damage	B-X
.	B-X
Thus	B-X
,	B-X
a	B-X
cell	B-X
type-specific	B-X
modulation	B-X
of	B-X
Cdk1	B-X
might	B-X
be	B-X
taken	B-X
advantage	B-X
of	B-X
for	B-X
the	B-X
therapeutic	B-X
correction	B-X
of	B-X
pathogenic	B-X
imbalances	B-X
in	B-X
apoptosis	B-X
control	B-X
.	B-X

The	O
cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
Cdk1	B-Gene_or_gene_product
)	O
,	O
formerly	O
called	O
Cdc2	B-Gene_or_gene_product
(	O
or	O
p34	B-Gene_or_gene_product
(	I-Gene_or_gene_product
Cdc2	I-Gene_or_gene_product
)	I-Gene_or_gene_product
)	O
,	O
interacts	O
with	O
cyclin	B-Gene_or_gene_product
B1	I-Gene_or_gene_product
to	O
form	O
an	O
active	O
heterodimer	O
.	O
<EOS>	B-X
The	B-X
cyclin-dependent	B-X
kinase	B-X
1	B-X
(	B-X
Cdk1	B-X
)	B-X
,	B-X
formerly	B-X
called	B-X
Cdc2	B-X
(	B-X
or	B-X
p34	B-X
(	B-X
Cdc2	B-X
)	B-X
)	B-X
,	B-X
interacts	B-X
with	B-X
cyclin	B-X
B1	B-X
to	B-X
form	B-X
an	B-X
active	B-X
heterodimer	B-X
.	B-X
The	B-X
activity	B-X
of	B-X
Cdk1	B-X
is	B-X
subjected	B-X
to	B-X
a	B-X
complex	B-X
spatiotemporary	B-X
regulation	B-X
,	B-X
required	B-X
to	B-X
guarantee	B-X
its	B-X
scheduled	B-X
contribution	B-X
to	B-X
the	B-X
mitotic	B-X
prophase	B-X
and	B-X
metaphase	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
Cdk1	B-X
may	B-X
be	B-X
required	B-X
for	B-X
apoptosis	B-X
induction	B-X
in	B-X
some	B-X
particular	B-X
pathways	B-X
of	B-X
cell	B-X
killing	B-X
.	B-X
This	B-X
applies	B-X
to	B-X
several	B-X
clinically	B-X
important	B-X
settings	B-X
,	B-X
for	B-X
instance	B-X
to	B-X
paclitaxel-induced	B-X
killing	B-X
of	B-X
breast	B-X
cancer	B-X
cells	B-X
,	B-X
in	B-X
which	B-X
the	B-X
ErbB2	B-X
receptor	B-X
kinase	B-X
can	B-X
mediate	B-X
apoptosis	B-X
inhibition	B-X
through	B-X
inactivation	B-X
of	B-X
Cdk1	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
Cdk1	B-X
participates	B-X
also	B-X
in	B-X
HIV-1-induced	B-X
apoptosis	B-X
,	B-X
upstream	B-X
of	B-X
the	B-X
p53-dependent	B-X
mitochondrial	B-X
permeabilization	B-X
step	B-X
.	B-X
An	B-X
unscheduled	B-X
Cdk1	B-X
activation	B-X
may	B-X
contribute	B-X
to	B-X
neuronal	B-X
apoptosis	B-X
occurring	B-X
in	B-X
neurodegenerative	B-X
diseases	B-X
.	B-X
Finally	B-X
,	B-X
the	B-X
premature	B-X
activation	B-X
of	B-X
Cdk1	B-X
can	B-X
lead	B-X
to	B-X
mitotic	B-X
catastrophe	B-X
,	B-X
for	B-X
instance	B-X
after	B-X
irradiation-induced	B-X
DNA	B-X
damage	B-X
.	B-X
Thus	B-X
,	B-X
a	B-X
cell	B-X
type-specific	B-X
modulation	B-X
of	B-X
Cdk1	B-X
might	B-X
be	B-X
taken	B-X
advantage	B-X
of	B-X
for	B-X
the	B-X
therapeutic	B-X
correction	B-X
of	B-X
pathogenic	B-X
imbalances	B-X
in	B-X
apoptosis	B-X
control	B-X
.	B-X

The	O
activity	O
of	O
Cdk1	B-Gene_or_gene_product
is	O
subjected	O
to	O
a	O
complex	O
spatiotemporary	O
regulation	O
,	O
required	O
to	O
guarantee	O
its	O
scheduled	O
contribution	O
to	O
the	O
mitotic	O
prophase	O
and	O
metaphase	O
.	O

Moreover	O
,	O
the	O
activation	O
of	O
Cdk1	B-Gene_or_gene_product
may	O
be	O
required	O
for	O
apoptosis	O
induction	O
in	O
some	O
particular	O
pathways	O
of	O
cell	O
killing	O
.	O
<EOS>	B-X
The	B-X
cyclin-dependent	B-X
kinase	B-X
1	B-X
(	B-X
Cdk1	B-X
)	B-X
,	B-X
formerly	B-X
called	B-X
Cdc2	B-X
(	B-X
or	B-X
p34	B-X
(	B-X
Cdc2	B-X
)	B-X
)	B-X
,	B-X
interacts	B-X
with	B-X
cyclin	B-X
B1	B-X
to	B-X
form	B-X
an	B-X
active	B-X
heterodimer	B-X
.	B-X
The	B-X
activity	B-X
of	B-X
Cdk1	B-X
is	B-X
subjected	B-X
to	B-X
a	B-X
complex	B-X
spatiotemporary	B-X
regulation	B-X
,	B-X
required	B-X
to	B-X
guarantee	B-X
its	B-X
scheduled	B-X
contribution	B-X
to	B-X
the	B-X
mitotic	B-X
prophase	B-X
and	B-X
metaphase	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
Cdk1	B-X
may	B-X
be	B-X
required	B-X
for	B-X
apoptosis	B-X
induction	B-X
in	B-X
some	B-X
particular	B-X
pathways	B-X
of	B-X
cell	B-X
killing	B-X
.	B-X
This	B-X
applies	B-X
to	B-X
several	B-X
clinically	B-X
important	B-X
settings	B-X
,	B-X
for	B-X
instance	B-X
to	B-X
paclitaxel-induced	B-X
killing	B-X
of	B-X
breast	B-X
cancer	B-X
cells	B-X
,	B-X
in	B-X
which	B-X
the	B-X
ErbB2	B-X
receptor	B-X
kinase	B-X
can	B-X
mediate	B-X
apoptosis	B-X
inhibition	B-X
through	B-X
inactivation	B-X
of	B-X
Cdk1	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
Cdk1	B-X
participates	B-X
also	B-X
in	B-X
HIV-1-induced	B-X
apoptosis	B-X
,	B-X
upstream	B-X
of	B-X
the	B-X
p53-dependent	B-X
mitochondrial	B-X
permeabilization	B-X
step	B-X
.	B-X
An	B-X
unscheduled	B-X
Cdk1	B-X
activation	B-X
may	B-X
contribute	B-X
to	B-X
neuronal	B-X
apoptosis	B-X
occurring	B-X
in	B-X
neurodegenerative	B-X
diseases	B-X
.	B-X
Finally	B-X
,	B-X
the	B-X
premature	B-X
activation	B-X
of	B-X
Cdk1	B-X
can	B-X
lead	B-X
to	B-X
mitotic	B-X
catastrophe	B-X
,	B-X
for	B-X
instance	B-X
after	B-X
irradiation-induced	B-X
DNA	B-X
damage	B-X
.	B-X
Thus	B-X
,	B-X
a	B-X
cell	B-X
type-specific	B-X
modulation	B-X
of	B-X
Cdk1	B-X
might	B-X
be	B-X
taken	B-X
advantage	B-X
of	B-X
for	B-X
the	B-X
therapeutic	B-X
correction	B-X
of	B-X
pathogenic	B-X
imbalances	B-X
in	B-X
apoptosis	B-X
control	B-X
.	B-X

This	O
applies	O
to	O
several	O
clinically	O
important	O
settings	O
,	O
for	O
instance	O
to	O
paclitaxel	O
-	O
induced	O
killing	O
of	O
breast	O
cancer	O
cells	O
,	O
in	O
which	O
the	O
ErbB2	B-Gene_or_gene_product
receptor	O
kinase	O
can	O
mediate	O
apoptosis	O
inhibition	O
through	O
inactivation	O
of	O
Cdk1	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
cyclin-dependent	B-X
kinase	B-X
1	B-X
(	B-X
Cdk1	B-X
)	B-X
,	B-X
formerly	B-X
called	B-X
Cdc2	B-X
(	B-X
or	B-X
p34	B-X
(	B-X
Cdc2	B-X
)	B-X
)	B-X
,	B-X
interacts	B-X
with	B-X
cyclin	B-X
B1	B-X
to	B-X
form	B-X
an	B-X
active	B-X
heterodimer	B-X
.	B-X
The	B-X
activity	B-X
of	B-X
Cdk1	B-X
is	B-X
subjected	B-X
to	B-X
a	B-X
complex	B-X
spatiotemporary	B-X
regulation	B-X
,	B-X
required	B-X
to	B-X
guarantee	B-X
its	B-X
scheduled	B-X
contribution	B-X
to	B-X
the	B-X
mitotic	B-X
prophase	B-X
and	B-X
metaphase	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
Cdk1	B-X
may	B-X
be	B-X
required	B-X
for	B-X
apoptosis	B-X
induction	B-X
in	B-X
some	B-X
particular	B-X
pathways	B-X
of	B-X
cell	B-X
killing	B-X
.	B-X
This	B-X
applies	B-X
to	B-X
several	B-X
clinically	B-X
important	B-X
settings	B-X
,	B-X
for	B-X
instance	B-X
to	B-X
paclitaxel-induced	B-X
killing	B-X
of	B-X
breast	B-X
cancer	B-X
cells	B-X
,	B-X
in	B-X
which	B-X
the	B-X
ErbB2	B-X
receptor	B-X
kinase	B-X
can	B-X
mediate	B-X
apoptosis	B-X
inhibition	B-X
through	B-X
inactivation	B-X
of	B-X
Cdk1	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
Cdk1	B-X
participates	B-X
also	B-X
in	B-X
HIV-1-induced	B-X
apoptosis	B-X
,	B-X
upstream	B-X
of	B-X
the	B-X
p53-dependent	B-X
mitochondrial	B-X
permeabilization	B-X
step	B-X
.	B-X
An	B-X
unscheduled	B-X
Cdk1	B-X
activation	B-X
may	B-X
contribute	B-X
to	B-X
neuronal	B-X
apoptosis	B-X
occurring	B-X
in	B-X
neurodegenerative	B-X
diseases	B-X
.	B-X
Finally	B-X
,	B-X
the	B-X
premature	B-X
activation	B-X
of	B-X
Cdk1	B-X
can	B-X
lead	B-X
to	B-X
mitotic	B-X
catastrophe	B-X
,	B-X
for	B-X
instance	B-X
after	B-X
irradiation-induced	B-X
DNA	B-X
damage	B-X
.	B-X
Thus	B-X
,	B-X
a	B-X
cell	B-X
type-specific	B-X
modulation	B-X
of	B-X
Cdk1	B-X
might	B-X
be	B-X
taken	B-X
advantage	B-X
of	B-X
for	B-X
the	B-X
therapeutic	B-X
correction	B-X
of	B-X
pathogenic	B-X
imbalances	B-X
in	B-X
apoptosis	B-X
control	B-X
.	B-X

The	O
activation	O
of	O
Cdk1	B-Gene_or_gene_product
participates	O
also	O
in	O
HIV	O
-	O
1	O
-	O
induced	O
apoptosis	O
,	O
upstream	O
of	O
the	O
p53	B-Gene_or_gene_product
-	O
dependent	O
mitochondrial	O
permeabilization	O
step	O
.	O
<EOS>	B-X
The	B-X
cyclin-dependent	B-X
kinase	B-X
1	B-X
(	B-X
Cdk1	B-X
)	B-X
,	B-X
formerly	B-X
called	B-X
Cdc2	B-X
(	B-X
or	B-X
p34	B-X
(	B-X
Cdc2	B-X
)	B-X
)	B-X
,	B-X
interacts	B-X
with	B-X
cyclin	B-X
B1	B-X
to	B-X
form	B-X
an	B-X
active	B-X
heterodimer	B-X
.	B-X
The	B-X
activity	B-X
of	B-X
Cdk1	B-X
is	B-X
subjected	B-X
to	B-X
a	B-X
complex	B-X
spatiotemporary	B-X
regulation	B-X
,	B-X
required	B-X
to	B-X
guarantee	B-X
its	B-X
scheduled	B-X
contribution	B-X
to	B-X
the	B-X
mitotic	B-X
prophase	B-X
and	B-X
metaphase	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
Cdk1	B-X
may	B-X
be	B-X
required	B-X
for	B-X
apoptosis	B-X
induction	B-X
in	B-X
some	B-X
particular	B-X
pathways	B-X
of	B-X
cell	B-X
killing	B-X
.	B-X
This	B-X
applies	B-X
to	B-X
several	B-X
clinically	B-X
important	B-X
settings	B-X
,	B-X
for	B-X
instance	B-X
to	B-X
paclitaxel-induced	B-X
killing	B-X
of	B-X
breast	B-X
cancer	B-X
cells	B-X
,	B-X
in	B-X
which	B-X
the	B-X
ErbB2	B-X
receptor	B-X
kinase	B-X
can	B-X
mediate	B-X
apoptosis	B-X
inhibition	B-X
through	B-X
inactivation	B-X
of	B-X
Cdk1	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
Cdk1	B-X
participates	B-X
also	B-X
in	B-X
HIV-1-induced	B-X
apoptosis	B-X
,	B-X
upstream	B-X
of	B-X
the	B-X
p53-dependent	B-X
mitochondrial	B-X
permeabilization	B-X
step	B-X
.	B-X
An	B-X
unscheduled	B-X
Cdk1	B-X
activation	B-X
may	B-X
contribute	B-X
to	B-X
neuronal	B-X
apoptosis	B-X
occurring	B-X
in	B-X
neurodegenerative	B-X
diseases	B-X
.	B-X
Finally	B-X
,	B-X
the	B-X
premature	B-X
activation	B-X
of	B-X
Cdk1	B-X
can	B-X
lead	B-X
to	B-X
mitotic	B-X
catastrophe	B-X
,	B-X
for	B-X
instance	B-X
after	B-X
irradiation-induced	B-X
DNA	B-X
damage	B-X
.	B-X
Thus	B-X
,	B-X
a	B-X
cell	B-X
type-specific	B-X
modulation	B-X
of	B-X
Cdk1	B-X
might	B-X
be	B-X
taken	B-X
advantage	B-X
of	B-X
for	B-X
the	B-X
therapeutic	B-X
correction	B-X
of	B-X
pathogenic	B-X
imbalances	B-X
in	B-X
apoptosis	B-X
control	B-X
.	B-X

An	O
unscheduled	O
Cdk1	B-Gene_or_gene_product
activation	O
may	O
contribute	O
to	O
neuronal	O
apoptosis	O
occurring	O
in	O
neurodegenerative	O
diseases	O
.	O
<EOS>	B-X
The	B-X
cyclin-dependent	B-X
kinase	B-X
1	B-X
(	B-X
Cdk1	B-X
)	B-X
,	B-X
formerly	B-X
called	B-X
Cdc2	B-X
(	B-X
or	B-X
p34	B-X
(	B-X
Cdc2	B-X
)	B-X
)	B-X
,	B-X
interacts	B-X
with	B-X
cyclin	B-X
B1	B-X
to	B-X
form	B-X
an	B-X
active	B-X
heterodimer	B-X
.	B-X
The	B-X
activity	B-X
of	B-X
Cdk1	B-X
is	B-X
subjected	B-X
to	B-X
a	B-X
complex	B-X
spatiotemporary	B-X
regulation	B-X
,	B-X
required	B-X
to	B-X
guarantee	B-X
its	B-X
scheduled	B-X
contribution	B-X
to	B-X
the	B-X
mitotic	B-X
prophase	B-X
and	B-X
metaphase	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
Cdk1	B-X
may	B-X
be	B-X
required	B-X
for	B-X
apoptosis	B-X
induction	B-X
in	B-X
some	B-X
particular	B-X
pathways	B-X
of	B-X
cell	B-X
killing	B-X
.	B-X
This	B-X
applies	B-X
to	B-X
several	B-X
clinically	B-X
important	B-X
settings	B-X
,	B-X
for	B-X
instance	B-X
to	B-X
paclitaxel-induced	B-X
killing	B-X
of	B-X
breast	B-X
cancer	B-X
cells	B-X
,	B-X
in	B-X
which	B-X
the	B-X
ErbB2	B-X
receptor	B-X
kinase	B-X
can	B-X
mediate	B-X
apoptosis	B-X
inhibition	B-X
through	B-X
inactivation	B-X
of	B-X
Cdk1	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
Cdk1	B-X
participates	B-X
also	B-X
in	B-X
HIV-1-induced	B-X
apoptosis	B-X
,	B-X
upstream	B-X
of	B-X
the	B-X
p53-dependent	B-X
mitochondrial	B-X
permeabilization	B-X
step	B-X
.	B-X
An	B-X
unscheduled	B-X
Cdk1	B-X
activation	B-X
may	B-X
contribute	B-X
to	B-X
neuronal	B-X
apoptosis	B-X
occurring	B-X
in	B-X
neurodegenerative	B-X
diseases	B-X
.	B-X
Finally	B-X
,	B-X
the	B-X
premature	B-X
activation	B-X
of	B-X
Cdk1	B-X
can	B-X
lead	B-X
to	B-X
mitotic	B-X
catastrophe	B-X
,	B-X
for	B-X
instance	B-X
after	B-X
irradiation-induced	B-X
DNA	B-X
damage	B-X
.	B-X
Thus	B-X
,	B-X
a	B-X
cell	B-X
type-specific	B-X
modulation	B-X
of	B-X
Cdk1	B-X
might	B-X
be	B-X
taken	B-X
advantage	B-X
of	B-X
for	B-X
the	B-X
therapeutic	B-X
correction	B-X
of	B-X
pathogenic	B-X
imbalances	B-X
in	B-X
apoptosis	B-X
control	B-X
.	B-X

Finally	O
,	O
the	O
premature	O
activation	O
of	O
Cdk1	B-Gene_or_gene_product
can	O
lead	O
to	O
mitotic	O
catastrophe	O
,	O
for	O
instance	O
after	O
irradiation	O
-	O
induced	O
DNA	O
damage	O
.	O
<EOS>	B-X
The	B-X
cyclin-dependent	B-X
kinase	B-X
1	B-X
(	B-X
Cdk1	B-X
)	B-X
,	B-X
formerly	B-X
called	B-X
Cdc2	B-X
(	B-X
or	B-X
p34	B-X
(	B-X
Cdc2	B-X
)	B-X
)	B-X
,	B-X
interacts	B-X
with	B-X
cyclin	B-X
B1	B-X
to	B-X
form	B-X
an	B-X
active	B-X
heterodimer	B-X
.	B-X
The	B-X
activity	B-X
of	B-X
Cdk1	B-X
is	B-X
subjected	B-X
to	B-X
a	B-X
complex	B-X
spatiotemporary	B-X
regulation	B-X
,	B-X
required	B-X
to	B-X
guarantee	B-X
its	B-X
scheduled	B-X
contribution	B-X
to	B-X
the	B-X
mitotic	B-X
prophase	B-X
and	B-X
metaphase	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
Cdk1	B-X
may	B-X
be	B-X
required	B-X
for	B-X
apoptosis	B-X
induction	B-X
in	B-X
some	B-X
particular	B-X
pathways	B-X
of	B-X
cell	B-X
killing	B-X
.	B-X
This	B-X
applies	B-X
to	B-X
several	B-X
clinically	B-X
important	B-X
settings	B-X
,	B-X
for	B-X
instance	B-X
to	B-X
paclitaxel-induced	B-X
killing	B-X
of	B-X
breast	B-X
cancer	B-X
cells	B-X
,	B-X
in	B-X
which	B-X
the	B-X
ErbB2	B-X
receptor	B-X
kinase	B-X
can	B-X
mediate	B-X
apoptosis	B-X
inhibition	B-X
through	B-X
inactivation	B-X
of	B-X
Cdk1	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
Cdk1	B-X
participates	B-X
also	B-X
in	B-X
HIV-1-induced	B-X
apoptosis	B-X
,	B-X
upstream	B-X
of	B-X
the	B-X
p53-dependent	B-X
mitochondrial	B-X
permeabilization	B-X
step	B-X
.	B-X
An	B-X
unscheduled	B-X
Cdk1	B-X
activation	B-X
may	B-X
contribute	B-X
to	B-X
neuronal	B-X
apoptosis	B-X
occurring	B-X
in	B-X
neurodegenerative	B-X
diseases	B-X
.	B-X
Finally	B-X
,	B-X
the	B-X
premature	B-X
activation	B-X
of	B-X
Cdk1	B-X
can	B-X
lead	B-X
to	B-X
mitotic	B-X
catastrophe	B-X
,	B-X
for	B-X
instance	B-X
after	B-X
irradiation-induced	B-X
DNA	B-X
damage	B-X
.	B-X
Thus	B-X
,	B-X
a	B-X
cell	B-X
type-specific	B-X
modulation	B-X
of	B-X
Cdk1	B-X
might	B-X
be	B-X
taken	B-X
advantage	B-X
of	B-X
for	B-X
the	B-X
therapeutic	B-X
correction	B-X
of	B-X
pathogenic	B-X
imbalances	B-X
in	B-X
apoptosis	B-X
control	B-X
.	B-X

Thus	O
,	O
a	O
cell	O
type	O
-	O
specific	O
modulation	O
of	O
Cdk1	B-Gene_or_gene_product
might	O
be	O
taken	O
advantage	O
of	O
for	O
the	O
therapeutic	O
correction	O
of	O
pathogenic	O
imbalances	O
in	O
apoptosis	O
control	O
.	O
<EOS>	B-X
The	B-X
cyclin-dependent	B-X
kinase	B-X
1	B-X
(	B-X
Cdk1	B-X
)	B-X
,	B-X
formerly	B-X
called	B-X
Cdc2	B-X
(	B-X
or	B-X
p34	B-X
(	B-X
Cdc2	B-X
)	B-X
)	B-X
,	B-X
interacts	B-X
with	B-X
cyclin	B-X
B1	B-X
to	B-X
form	B-X
an	B-X
active	B-X
heterodimer	B-X
.	B-X
The	B-X
activity	B-X
of	B-X
Cdk1	B-X
is	B-X
subjected	B-X
to	B-X
a	B-X
complex	B-X
spatiotemporary	B-X
regulation	B-X
,	B-X
required	B-X
to	B-X
guarantee	B-X
its	B-X
scheduled	B-X
contribution	B-X
to	B-X
the	B-X
mitotic	B-X
prophase	B-X
and	B-X
metaphase	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
Cdk1	B-X
may	B-X
be	B-X
required	B-X
for	B-X
apoptosis	B-X
induction	B-X
in	B-X
some	B-X
particular	B-X
pathways	B-X
of	B-X
cell	B-X
killing	B-X
.	B-X
This	B-X
applies	B-X
to	B-X
several	B-X
clinically	B-X
important	B-X
settings	B-X
,	B-X
for	B-X
instance	B-X
to	B-X
paclitaxel-induced	B-X
killing	B-X
of	B-X
breast	B-X
cancer	B-X
cells	B-X
,	B-X
in	B-X
which	B-X
the	B-X
ErbB2	B-X
receptor	B-X
kinase	B-X
can	B-X
mediate	B-X
apoptosis	B-X
inhibition	B-X
through	B-X
inactivation	B-X
of	B-X
Cdk1	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
Cdk1	B-X
participates	B-X
also	B-X
in	B-X
HIV-1-induced	B-X
apoptosis	B-X
,	B-X
upstream	B-X
of	B-X
the	B-X
p53-dependent	B-X
mitochondrial	B-X
permeabilization	B-X
step	B-X
.	B-X
An	B-X
unscheduled	B-X
Cdk1	B-X
activation	B-X
may	B-X
contribute	B-X
to	B-X
neuronal	B-X
apoptosis	B-X
occurring	B-X
in	B-X
neurodegenerative	B-X
diseases	B-X
.	B-X
Finally	B-X
,	B-X
the	B-X
premature	B-X
activation	B-X
of	B-X
Cdk1	B-X
can	B-X
lead	B-X
to	B-X
mitotic	B-X
catastrophe	B-X
,	B-X
for	B-X
instance	B-X
after	B-X
irradiation-induced	B-X
DNA	B-X
damage	B-X
.	B-X
Thus	B-X
,	B-X
a	B-X
cell	B-X
type-specific	B-X
modulation	B-X
of	B-X
Cdk1	B-X
might	B-X
be	B-X
taken	B-X
advantage	B-X
of	B-X
for	B-X
the	B-X
therapeutic	B-X
correction	B-X
of	B-X
pathogenic	B-X
imbalances	B-X
in	B-X
apoptosis	B-X
control	B-X
.	B-X

betaTrCP	B-Gene_or_gene_product
-	O
mediated	O
proteolysis	O
of	O
NF	O
-	O
kappaB1	O
p105	B-Gene_or_gene_product
requires	O
phosphorylation	O
of	O
p105	B-Gene_or_gene_product
serines	O
927	O
and	O
932	O
.	O
<EOS>	B-X
NF-kappaB1	B-X
p105	B-X
functions	B-X
both	B-X
as	B-X
a	B-X
precursor	B-X
of	B-X
NF-kappaB1	B-X
p50	B-X
and	B-X
as	B-X
a	B-X
cytoplasmic	B-X
inhibitor	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Following	B-X
the	B-X
stimulation	B-X
of	B-X
cells	B-X
with	B-X
tumor	B-X
necrosis	B-X
factor	B-X
alpha	B-X
(	B-X
TNF-alpha	B-X
)	B-X
,	B-X
the	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
rapidly	B-X
phosphorylates	B-X
NF-kappaB1	B-X
p105	B-X
on	B-X
serine	B-X
927	B-X
in	B-X
the	B-X
PEST	B-X
region	B-X
.	B-X
This	B-X
phosphorylation	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
trigger	B-X
p105	B-X
degradation	B-X
,	B-X
which	B-X
releases	B-X
the	B-X
associated	B-X
Rel/NF-kappaB	B-X
subunits	B-X
to	B-X
translocate	B-X
into	B-X
the	B-X
nucleus	B-X
and	B-X
regulate	B-X
target	B-X
gene	B-X
transcription	B-X
.	B-X
Serine	B-X
927	B-X
resides	B-X
in	B-X
a	B-X
conserved	B-X
motif	B-X
(	B-X
Asp-Ser	B-X
(	B-X
927	B-X
)	B-X
-Gly-Val-Glu-Thr-Ser	B-X
(	B-X
932	B-X
)	B-X
)	B-X
homologous	B-X
to	B-X
the	B-X
IKK	B-X
target	B-X
sequence	B-X
in	B-X
IkappaBalpha	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
TNF-alpha-induced	B-X
p105	B-X
proteolysis	B-X
was	B-X
revealed	B-X
to	B-X
additionally	B-X
require	B-X
the	B-X
phosphorylation	B-X
of	B-X
serine	B-X
932	B-X
.	B-X
Experiments	B-X
with	B-X
IKK1	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
IKK2	B-X
(	B-X
-/-	B-X
)	B-X
double	B-X
knockout	B-X
embryonic	B-X
fibroblasts	B-X
demonstrate	B-X
that	B-X
the	B-X
IKK	B-X
complex	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
stimulate	B-X
phosphorylation	B-X
on	B-X
p105	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
.	B-X
Furthermore	B-X
,	B-X
purified	B-X
IKK1	B-X
and	B-X
IKK2	B-X
can	B-X
each	B-X
phosphorylate	B-X
a	B-X
glutathione	B-X
S-transferase-p105	B-X
(	B-X
758-967	B-X
)	B-X
fusion	B-X
protein	B-X
on	B-X
both	B-X
regulatory	B-X
serines	B-X
in	B-X
vitro	B-X
.	B-X
IKK-mediated	B-X
p105	B-X
phosphorylation	B-X
generates	B-X
a	B-X
binding	B-X
site	B-X
for	B-X
betaTrCP	B-X
,	B-X
the	B-X
receptor	B-X
subunit	B-X
of	B-X
an	B-X
SCF-type	B-X
ubiquitin	B-X
E3	B-X
ligase	B-X
,	B-X
and	B-X
depletion	B-X
of	B-X
betaTrCP	B-X
by	B-X
RNA	B-X
interference	B-X
blocks	B-X
TNF-alpha-induced	B-X
p105	B-X
ubiquitination	B-X
and	B-X
proteolysis	B-X
.	B-X
Phosphopeptide	B-X
competition	B-X
experiments	B-X
indicate	B-X
that	B-X
betaTrCP	B-X
binds	B-X
p105	B-X
more	B-X
effectively	B-X
when	B-X
both	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
are	B-X
phosphorylated	B-X
.	B-X
Interestingly	B-X
,	B-X
however	B-X
,	B-X
betaTrCP	B-X
affinity	B-X
for	B-X
the	B-X
IKK-phosphorylated	B-X
sequence	B-X
on	B-X
p105	B-X
is	B-X
substantially	B-X
lower	B-X
than	B-X
that	B-X
on	B-X
IkappaBalpha	B-X
.	B-X
Thus	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
reduced	B-X
p105	B-X
recruitment	B-X
of	B-X
betaTrCP	B-X
and	B-X
subsequent	B-X
ubiquitination	B-X
may	B-X
contribute	B-X
to	B-X
delayed	B-X
p105	B-X
proteolysis	B-X
after	B-X
TNF-alpha	B-X
stimulation	B-X
relative	B-X
to	B-X
that	B-X
for	B-X
IkappaBalpha	B-X
.	B-X

NF	O
-	O
kappaB1	O
p105	B-Gene_or_gene_product
functions	O
both	O
as	O
a	O
precursor	O
of	O
NF	O
-	O
kappaB1	O
p50	B-Gene_or_gene_product
and	O
as	O
a	O
cytoplasmic	O
inhibitor	O
of	O
NF	O
-	O
kappaB	O
.	O

Following	O
the	O
stimulation	O
of	O
cells	O
with	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
(	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
)	O
,	O
the	O
IkappaB	O
kinase	O
(	O
IKK	O
)	O
complex	O
rapidly	O
phosphorylates	O
NF	O
-	O
kappaB1	O
p105	B-Gene_or_gene_product
on	O
serine	O
927	O
in	O
the	O
PEST	O
region	O
.	O
<EOS>	B-X
NF-kappaB1	B-X
p105	B-X
functions	B-X
both	B-X
as	B-X
a	B-X
precursor	B-X
of	B-X
NF-kappaB1	B-X
p50	B-X
and	B-X
as	B-X
a	B-X
cytoplasmic	B-X
inhibitor	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Following	B-X
the	B-X
stimulation	B-X
of	B-X
cells	B-X
with	B-X
tumor	B-X
necrosis	B-X
factor	B-X
alpha	B-X
(	B-X
TNF-alpha	B-X
)	B-X
,	B-X
the	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
rapidly	B-X
phosphorylates	B-X
NF-kappaB1	B-X
p105	B-X
on	B-X
serine	B-X
927	B-X
in	B-X
the	B-X
PEST	B-X
region	B-X
.	B-X
This	B-X
phosphorylation	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
trigger	B-X
p105	B-X
degradation	B-X
,	B-X
which	B-X
releases	B-X
the	B-X
associated	B-X
Rel/NF-kappaB	B-X
subunits	B-X
to	B-X
translocate	B-X
into	B-X
the	B-X
nucleus	B-X
and	B-X
regulate	B-X
target	B-X
gene	B-X
transcription	B-X
.	B-X
Serine	B-X
927	B-X
resides	B-X
in	B-X
a	B-X
conserved	B-X
motif	B-X
(	B-X
Asp-Ser	B-X
(	B-X
927	B-X
)	B-X
-Gly-Val-Glu-Thr-Ser	B-X
(	B-X
932	B-X
)	B-X
)	B-X
homologous	B-X
to	B-X
the	B-X
IKK	B-X
target	B-X
sequence	B-X
in	B-X
IkappaBalpha	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
TNF-alpha-induced	B-X
p105	B-X
proteolysis	B-X
was	B-X
revealed	B-X
to	B-X
additionally	B-X
require	B-X
the	B-X
phosphorylation	B-X
of	B-X
serine	B-X
932	B-X
.	B-X
Experiments	B-X
with	B-X
IKK1	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
IKK2	B-X
(	B-X
-/-	B-X
)	B-X
double	B-X
knockout	B-X
embryonic	B-X
fibroblasts	B-X
demonstrate	B-X
that	B-X
the	B-X
IKK	B-X
complex	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
stimulate	B-X
phosphorylation	B-X
on	B-X
p105	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
.	B-X
Furthermore	B-X
,	B-X
purified	B-X
IKK1	B-X
and	B-X
IKK2	B-X
can	B-X
each	B-X
phosphorylate	B-X
a	B-X
glutathione	B-X
S-transferase-p105	B-X
(	B-X
758-967	B-X
)	B-X
fusion	B-X
protein	B-X
on	B-X
both	B-X
regulatory	B-X
serines	B-X
in	B-X
vitro	B-X
.	B-X
IKK-mediated	B-X
p105	B-X
phosphorylation	B-X
generates	B-X
a	B-X
binding	B-X
site	B-X
for	B-X
betaTrCP	B-X
,	B-X
the	B-X
receptor	B-X
subunit	B-X
of	B-X
an	B-X
SCF-type	B-X
ubiquitin	B-X
E3	B-X
ligase	B-X
,	B-X
and	B-X
depletion	B-X
of	B-X
betaTrCP	B-X
by	B-X
RNA	B-X
interference	B-X
blocks	B-X
TNF-alpha-induced	B-X
p105	B-X
ubiquitination	B-X
and	B-X
proteolysis	B-X
.	B-X
Phosphopeptide	B-X
competition	B-X
experiments	B-X
indicate	B-X
that	B-X
betaTrCP	B-X
binds	B-X
p105	B-X
more	B-X
effectively	B-X
when	B-X
both	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
are	B-X
phosphorylated	B-X
.	B-X
Interestingly	B-X
,	B-X
however	B-X
,	B-X
betaTrCP	B-X
affinity	B-X
for	B-X
the	B-X
IKK-phosphorylated	B-X
sequence	B-X
on	B-X
p105	B-X
is	B-X
substantially	B-X
lower	B-X
than	B-X
that	B-X
on	B-X
IkappaBalpha	B-X
.	B-X
Thus	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
reduced	B-X
p105	B-X
recruitment	B-X
of	B-X
betaTrCP	B-X
and	B-X
subsequent	B-X
ubiquitination	B-X
may	B-X
contribute	B-X
to	B-X
delayed	B-X
p105	B-X
proteolysis	B-X
after	B-X
TNF-alpha	B-X
stimulation	B-X
relative	B-X
to	B-X
that	B-X
for	B-X
IkappaBalpha	B-X
.	B-X

This	O
phosphorylation	O
is	O
essential	O
for	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
to	O
trigger	O
p105	B-Gene_or_gene_product
degradation	O
,	O
which	O
releases	O
the	O
associated	O
Rel	B-Gene_or_gene_product
/	O
NF	O
-	O
kappaB	O
subunits	O
to	O
translocate	O
into	O
the	O
nucleus	O
and	O
regulate	O
target	O
gene	O
transcription	O
.	O
<EOS>	B-X
NF-kappaB1	B-X
p105	B-X
functions	B-X
both	B-X
as	B-X
a	B-X
precursor	B-X
of	B-X
NF-kappaB1	B-X
p50	B-X
and	B-X
as	B-X
a	B-X
cytoplasmic	B-X
inhibitor	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Following	B-X
the	B-X
stimulation	B-X
of	B-X
cells	B-X
with	B-X
tumor	B-X
necrosis	B-X
factor	B-X
alpha	B-X
(	B-X
TNF-alpha	B-X
)	B-X
,	B-X
the	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
rapidly	B-X
phosphorylates	B-X
NF-kappaB1	B-X
p105	B-X
on	B-X
serine	B-X
927	B-X
in	B-X
the	B-X
PEST	B-X
region	B-X
.	B-X
This	B-X
phosphorylation	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
trigger	B-X
p105	B-X
degradation	B-X
,	B-X
which	B-X
releases	B-X
the	B-X
associated	B-X
Rel/NF-kappaB	B-X
subunits	B-X
to	B-X
translocate	B-X
into	B-X
the	B-X
nucleus	B-X
and	B-X
regulate	B-X
target	B-X
gene	B-X
transcription	B-X
.	B-X
Serine	B-X
927	B-X
resides	B-X
in	B-X
a	B-X
conserved	B-X
motif	B-X
(	B-X
Asp-Ser	B-X
(	B-X
927	B-X
)	B-X
-Gly-Val-Glu-Thr-Ser	B-X
(	B-X
932	B-X
)	B-X
)	B-X
homologous	B-X
to	B-X
the	B-X
IKK	B-X
target	B-X
sequence	B-X
in	B-X
IkappaBalpha	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
TNF-alpha-induced	B-X
p105	B-X
proteolysis	B-X
was	B-X
revealed	B-X
to	B-X
additionally	B-X
require	B-X
the	B-X
phosphorylation	B-X
of	B-X
serine	B-X
932	B-X
.	B-X
Experiments	B-X
with	B-X
IKK1	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
IKK2	B-X
(	B-X
-/-	B-X
)	B-X
double	B-X
knockout	B-X
embryonic	B-X
fibroblasts	B-X
demonstrate	B-X
that	B-X
the	B-X
IKK	B-X
complex	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
stimulate	B-X
phosphorylation	B-X
on	B-X
p105	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
.	B-X
Furthermore	B-X
,	B-X
purified	B-X
IKK1	B-X
and	B-X
IKK2	B-X
can	B-X
each	B-X
phosphorylate	B-X
a	B-X
glutathione	B-X
S-transferase-p105	B-X
(	B-X
758-967	B-X
)	B-X
fusion	B-X
protein	B-X
on	B-X
both	B-X
regulatory	B-X
serines	B-X
in	B-X
vitro	B-X
.	B-X
IKK-mediated	B-X
p105	B-X
phosphorylation	B-X
generates	B-X
a	B-X
binding	B-X
site	B-X
for	B-X
betaTrCP	B-X
,	B-X
the	B-X
receptor	B-X
subunit	B-X
of	B-X
an	B-X
SCF-type	B-X
ubiquitin	B-X
E3	B-X
ligase	B-X
,	B-X
and	B-X
depletion	B-X
of	B-X
betaTrCP	B-X
by	B-X
RNA	B-X
interference	B-X
blocks	B-X
TNF-alpha-induced	B-X
p105	B-X
ubiquitination	B-X
and	B-X
proteolysis	B-X
.	B-X
Phosphopeptide	B-X
competition	B-X
experiments	B-X
indicate	B-X
that	B-X
betaTrCP	B-X
binds	B-X
p105	B-X
more	B-X
effectively	B-X
when	B-X
both	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
are	B-X
phosphorylated	B-X
.	B-X
Interestingly	B-X
,	B-X
however	B-X
,	B-X
betaTrCP	B-X
affinity	B-X
for	B-X
the	B-X
IKK-phosphorylated	B-X
sequence	B-X
on	B-X
p105	B-X
is	B-X
substantially	B-X
lower	B-X
than	B-X
that	B-X
on	B-X
IkappaBalpha	B-X
.	B-X
Thus	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
reduced	B-X
p105	B-X
recruitment	B-X
of	B-X
betaTrCP	B-X
and	B-X
subsequent	B-X
ubiquitination	B-X
may	B-X
contribute	B-X
to	B-X
delayed	B-X
p105	B-X
proteolysis	B-X
after	B-X
TNF-alpha	B-X
stimulation	B-X
relative	B-X
to	B-X
that	B-X
for	B-X
IkappaBalpha	B-X
.	B-X

Serine	O
927	O
resides	O
in	O
a	O
conserved	O
motif	O
(	O
Asp	O
-	O
Ser	O
(	O
927	O
)	O
-	O
Gly	O
-	O
Val	O
-	O
Glu	O
-	O
Thr	O
-	O
Ser	O
(	O
932	O
)	O
)	O
homologous	O
to	O
the	O
IKK	O
target	O
sequence	O
in	O
IkappaBalpha	B-Gene_or_gene_product
.	O

In	O
this	O
study	O
,	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
-	O
induced	O
p105	B-Gene_or_gene_product
proteolysis	O
was	O
revealed	O
to	O
additionally	O
require	O
the	O
phosphorylation	O
of	O
serine	O
932	O
.	O
<EOS>	B-X
NF-kappaB1	B-X
p105	B-X
functions	B-X
both	B-X
as	B-X
a	B-X
precursor	B-X
of	B-X
NF-kappaB1	B-X
p50	B-X
and	B-X
as	B-X
a	B-X
cytoplasmic	B-X
inhibitor	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Following	B-X
the	B-X
stimulation	B-X
of	B-X
cells	B-X
with	B-X
tumor	B-X
necrosis	B-X
factor	B-X
alpha	B-X
(	B-X
TNF-alpha	B-X
)	B-X
,	B-X
the	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
rapidly	B-X
phosphorylates	B-X
NF-kappaB1	B-X
p105	B-X
on	B-X
serine	B-X
927	B-X
in	B-X
the	B-X
PEST	B-X
region	B-X
.	B-X
This	B-X
phosphorylation	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
trigger	B-X
p105	B-X
degradation	B-X
,	B-X
which	B-X
releases	B-X
the	B-X
associated	B-X
Rel/NF-kappaB	B-X
subunits	B-X
to	B-X
translocate	B-X
into	B-X
the	B-X
nucleus	B-X
and	B-X
regulate	B-X
target	B-X
gene	B-X
transcription	B-X
.	B-X
Serine	B-X
927	B-X
resides	B-X
in	B-X
a	B-X
conserved	B-X
motif	B-X
(	B-X
Asp-Ser	B-X
(	B-X
927	B-X
)	B-X
-Gly-Val-Glu-Thr-Ser	B-X
(	B-X
932	B-X
)	B-X
)	B-X
homologous	B-X
to	B-X
the	B-X
IKK	B-X
target	B-X
sequence	B-X
in	B-X
IkappaBalpha	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
TNF-alpha-induced	B-X
p105	B-X
proteolysis	B-X
was	B-X
revealed	B-X
to	B-X
additionally	B-X
require	B-X
the	B-X
phosphorylation	B-X
of	B-X
serine	B-X
932	B-X
.	B-X
Experiments	B-X
with	B-X
IKK1	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
IKK2	B-X
(	B-X
-/-	B-X
)	B-X
double	B-X
knockout	B-X
embryonic	B-X
fibroblasts	B-X
demonstrate	B-X
that	B-X
the	B-X
IKK	B-X
complex	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
stimulate	B-X
phosphorylation	B-X
on	B-X
p105	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
.	B-X
Furthermore	B-X
,	B-X
purified	B-X
IKK1	B-X
and	B-X
IKK2	B-X
can	B-X
each	B-X
phosphorylate	B-X
a	B-X
glutathione	B-X
S-transferase-p105	B-X
(	B-X
758-967	B-X
)	B-X
fusion	B-X
protein	B-X
on	B-X
both	B-X
regulatory	B-X
serines	B-X
in	B-X
vitro	B-X
.	B-X
IKK-mediated	B-X
p105	B-X
phosphorylation	B-X
generates	B-X
a	B-X
binding	B-X
site	B-X
for	B-X
betaTrCP	B-X
,	B-X
the	B-X
receptor	B-X
subunit	B-X
of	B-X
an	B-X
SCF-type	B-X
ubiquitin	B-X
E3	B-X
ligase	B-X
,	B-X
and	B-X
depletion	B-X
of	B-X
betaTrCP	B-X
by	B-X
RNA	B-X
interference	B-X
blocks	B-X
TNF-alpha-induced	B-X
p105	B-X
ubiquitination	B-X
and	B-X
proteolysis	B-X
.	B-X
Phosphopeptide	B-X
competition	B-X
experiments	B-X
indicate	B-X
that	B-X
betaTrCP	B-X
binds	B-X
p105	B-X
more	B-X
effectively	B-X
when	B-X
both	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
are	B-X
phosphorylated	B-X
.	B-X
Interestingly	B-X
,	B-X
however	B-X
,	B-X
betaTrCP	B-X
affinity	B-X
for	B-X
the	B-X
IKK-phosphorylated	B-X
sequence	B-X
on	B-X
p105	B-X
is	B-X
substantially	B-X
lower	B-X
than	B-X
that	B-X
on	B-X
IkappaBalpha	B-X
.	B-X
Thus	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
reduced	B-X
p105	B-X
recruitment	B-X
of	B-X
betaTrCP	B-X
and	B-X
subsequent	B-X
ubiquitination	B-X
may	B-X
contribute	B-X
to	B-X
delayed	B-X
p105	B-X
proteolysis	B-X
after	B-X
TNF-alpha	B-X
stimulation	B-X
relative	B-X
to	B-X
that	B-X
for	B-X
IkappaBalpha	B-X
.	B-X

Experiments	O
with	O
IKK1	B-Gene_or_gene_product
(	O
-	O
/	O
-	O
)	O
and	O
IKK2	B-Gene_or_gene_product
(	O
-	O
/	O
-	O
)	O
double	O
knockout	O
embryonic	O
fibroblasts	O
demonstrate	O
that	O
the	O
IKK	O
complex	O
is	O
essential	O
for	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
to	O
stimulate	O
phosphorylation	O
on	O
p105	B-Gene_or_gene_product
serines	O
927	O
and	O
932	O
.	O

Furthermore	O
,	O
purified	O
IKK1	B-Gene_or_gene_product
and	O
IKK2	B-Gene_or_gene_product
can	O
each	O
phosphorylate	O
a	O
glutathione	B-Gene_or_gene_product
S	I-Gene_or_gene_product
-	I-Gene_or_gene_product
transferase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
p105	I-Gene_or_gene_product
(	O
758	O
-	O
967	O
)	O
fusion	O
protein	O
on	O
both	O
regulatory	O
serines	O
in	O
vitro	O
.	O
<EOS>	B-X
NF-kappaB1	B-X
p105	B-X
functions	B-X
both	B-X
as	B-X
a	B-X
precursor	B-X
of	B-X
NF-kappaB1	B-X
p50	B-X
and	B-X
as	B-X
a	B-X
cytoplasmic	B-X
inhibitor	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Following	B-X
the	B-X
stimulation	B-X
of	B-X
cells	B-X
with	B-X
tumor	B-X
necrosis	B-X
factor	B-X
alpha	B-X
(	B-X
TNF-alpha	B-X
)	B-X
,	B-X
the	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
rapidly	B-X
phosphorylates	B-X
NF-kappaB1	B-X
p105	B-X
on	B-X
serine	B-X
927	B-X
in	B-X
the	B-X
PEST	B-X
region	B-X
.	B-X
This	B-X
phosphorylation	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
trigger	B-X
p105	B-X
degradation	B-X
,	B-X
which	B-X
releases	B-X
the	B-X
associated	B-X
Rel/NF-kappaB	B-X
subunits	B-X
to	B-X
translocate	B-X
into	B-X
the	B-X
nucleus	B-X
and	B-X
regulate	B-X
target	B-X
gene	B-X
transcription	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
TNF-alpha-induced	B-X
p105	B-X
proteolysis	B-X
was	B-X
revealed	B-X
to	B-X
additionally	B-X
require	B-X
the	B-X
phosphorylation	B-X
of	B-X
serine	B-X
932	B-X
.	B-X
Experiments	B-X
with	B-X
IKK1	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
IKK2	B-X
(	B-X
-/-	B-X
)	B-X
double	B-X
knockout	B-X
embryonic	B-X
fibroblasts	B-X
demonstrate	B-X
that	B-X
the	B-X
IKK	B-X
complex	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
stimulate	B-X
phosphorylation	B-X
on	B-X
p105	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
.	B-X
Furthermore	B-X
,	B-X
purified	B-X
IKK1	B-X
and	B-X
IKK2	B-X
can	B-X
each	B-X
phosphorylate	B-X
a	B-X
glutathione	B-X
S-transferase-p105	B-X
(	B-X
758-967	B-X
)	B-X
fusion	B-X
protein	B-X
on	B-X
both	B-X
regulatory	B-X
serines	B-X
in	B-X
vitro	B-X
.	B-X
IKK-mediated	B-X
p105	B-X
phosphorylation	B-X
generates	B-X
a	B-X
binding	B-X
site	B-X
for	B-X
betaTrCP	B-X
,	B-X
the	B-X
receptor	B-X
subunit	B-X
of	B-X
an	B-X
SCF-type	B-X
ubiquitin	B-X
E3	B-X
ligase	B-X
,	B-X
and	B-X
depletion	B-X
of	B-X
betaTrCP	B-X
by	B-X
RNA	B-X
interference	B-X
blocks	B-X
TNF-alpha-induced	B-X
p105	B-X
ubiquitination	B-X
and	B-X
proteolysis	B-X
.	B-X
Phosphopeptide	B-X
competition	B-X
experiments	B-X
indicate	B-X
that	B-X
betaTrCP	B-X
binds	B-X
p105	B-X
more	B-X
effectively	B-X
when	B-X
both	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
are	B-X
phosphorylated	B-X
.	B-X
Interestingly	B-X
,	B-X
however	B-X
,	B-X
betaTrCP	B-X
affinity	B-X
for	B-X
the	B-X
IKK-phosphorylated	B-X
sequence	B-X
on	B-X
p105	B-X
is	B-X
substantially	B-X
lower	B-X
than	B-X
that	B-X
on	B-X
IkappaBalpha	B-X
.	B-X
Thus	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
reduced	B-X
p105	B-X
recruitment	B-X
of	B-X
betaTrCP	B-X
and	B-X
subsequent	B-X
ubiquitination	B-X
may	B-X
contribute	B-X
to	B-X
delayed	B-X
p105	B-X
proteolysis	B-X
after	B-X
TNF-alpha	B-X
stimulation	B-X
relative	B-X
to	B-X
that	B-X
for	B-X
IkappaBalpha	B-X
.	B-X

IKK	O
-	O
mediated	O
p105	B-Gene_or_gene_product
phosphorylation	O
generates	O
a	O
binding	O
site	O
for	O
betaTrCP	B-Gene_or_gene_product
,	O
the	O
receptor	O
subunit	O
of	O
an	O
SCF	O
-	O
type	O
ubiquitin	B-Gene_or_gene_product
E3	O
ligase	O
,	O
and	O
depletion	O
of	O
betaTrCP	B-Gene_or_gene_product
by	O
RNA	O
interference	O
blocks	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
-	O
induced	O
p105	B-Gene_or_gene_product
ubiquitination	O
and	O
proteolysis	O
.	O
<EOS>	B-X
NF-kappaB1	B-X
p105	B-X
functions	B-X
both	B-X
as	B-X
a	B-X
precursor	B-X
of	B-X
NF-kappaB1	B-X
p50	B-X
and	B-X
as	B-X
a	B-X
cytoplasmic	B-X
inhibitor	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Following	B-X
the	B-X
stimulation	B-X
of	B-X
cells	B-X
with	B-X
tumor	B-X
necrosis	B-X
factor	B-X
alpha	B-X
(	B-X
TNF-alpha	B-X
)	B-X
,	B-X
the	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
rapidly	B-X
phosphorylates	B-X
NF-kappaB1	B-X
p105	B-X
on	B-X
serine	B-X
927	B-X
in	B-X
the	B-X
PEST	B-X
region	B-X
.	B-X
This	B-X
phosphorylation	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
trigger	B-X
p105	B-X
degradation	B-X
,	B-X
which	B-X
releases	B-X
the	B-X
associated	B-X
Rel/NF-kappaB	B-X
subunits	B-X
to	B-X
translocate	B-X
into	B-X
the	B-X
nucleus	B-X
and	B-X
regulate	B-X
target	B-X
gene	B-X
transcription	B-X
.	B-X
Serine	B-X
927	B-X
resides	B-X
in	B-X
a	B-X
conserved	B-X
motif	B-X
(	B-X
Asp-Ser	B-X
(	B-X
927	B-X
)	B-X
-Gly-Val-Glu-Thr-Ser	B-X
(	B-X
932	B-X
)	B-X
)	B-X
homologous	B-X
to	B-X
the	B-X
IKK	B-X
target	B-X
sequence	B-X
in	B-X
IkappaBalpha	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
TNF-alpha-induced	B-X
p105	B-X
proteolysis	B-X
was	B-X
revealed	B-X
to	B-X
additionally	B-X
require	B-X
the	B-X
phosphorylation	B-X
of	B-X
serine	B-X
932	B-X
.	B-X
Experiments	B-X
with	B-X
IKK1	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
IKK2	B-X
(	B-X
-/-	B-X
)	B-X
double	B-X
knockout	B-X
embryonic	B-X
fibroblasts	B-X
demonstrate	B-X
that	B-X
the	B-X
IKK	B-X
complex	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
stimulate	B-X
phosphorylation	B-X
on	B-X
p105	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
.	B-X
Furthermore	B-X
,	B-X
purified	B-X
IKK1	B-X
and	B-X
IKK2	B-X
can	B-X
each	B-X
phosphorylate	B-X
a	B-X
glutathione	B-X
S-transferase-p105	B-X
(	B-X
758-967	B-X
)	B-X
fusion	B-X
protein	B-X
on	B-X
both	B-X
regulatory	B-X
serines	B-X
in	B-X
vitro	B-X
.	B-X
IKK-mediated	B-X
p105	B-X
phosphorylation	B-X
generates	B-X
a	B-X
binding	B-X
site	B-X
for	B-X
betaTrCP	B-X
,	B-X
the	B-X
receptor	B-X
subunit	B-X
of	B-X
an	B-X
SCF-type	B-X
ubiquitin	B-X
E3	B-X
ligase	B-X
,	B-X
and	B-X
depletion	B-X
of	B-X
betaTrCP	B-X
by	B-X
RNA	B-X
interference	B-X
blocks	B-X
TNF-alpha-induced	B-X
p105	B-X
ubiquitination	B-X
and	B-X
proteolysis	B-X
.	B-X
Phosphopeptide	B-X
competition	B-X
experiments	B-X
indicate	B-X
that	B-X
betaTrCP	B-X
binds	B-X
p105	B-X
more	B-X
effectively	B-X
when	B-X
both	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
are	B-X
phosphorylated	B-X
.	B-X
Interestingly	B-X
,	B-X
however	B-X
,	B-X
betaTrCP	B-X
affinity	B-X
for	B-X
the	B-X
IKK-phosphorylated	B-X
sequence	B-X
on	B-X
p105	B-X
is	B-X
substantially	B-X
lower	B-X
than	B-X
that	B-X
on	B-X
IkappaBalpha	B-X
.	B-X
Thus	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
reduced	B-X
p105	B-X
recruitment	B-X
of	B-X
betaTrCP	B-X
and	B-X
subsequent	B-X
ubiquitination	B-X
may	B-X
contribute	B-X
to	B-X
delayed	B-X
p105	B-X
proteolysis	B-X
after	B-X
TNF-alpha	B-X
stimulation	B-X
relative	B-X
to	B-X
that	B-X
for	B-X
IkappaBalpha	B-X
.	B-X

Phosphopeptide	O
competition	O
experiments	O
indicate	O
that	O
betaTrCP	B-Gene_or_gene_product
binds	O
p105	B-Gene_or_gene_product
more	O
effectively	O
when	O
both	O
serines	O
927	O
and	O
932	O
are	O
phosphorylated	O
.	O
<EOS>	B-X
NF-kappaB1	B-X
p105	B-X
functions	B-X
both	B-X
as	B-X
a	B-X
precursor	B-X
of	B-X
NF-kappaB1	B-X
p50	B-X
and	B-X
as	B-X
a	B-X
cytoplasmic	B-X
inhibitor	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Following	B-X
the	B-X
stimulation	B-X
of	B-X
cells	B-X
with	B-X
tumor	B-X
necrosis	B-X
factor	B-X
alpha	B-X
(	B-X
TNF-alpha	B-X
)	B-X
,	B-X
the	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
rapidly	B-X
phosphorylates	B-X
NF-kappaB1	B-X
p105	B-X
on	B-X
serine	B-X
927	B-X
in	B-X
the	B-X
PEST	B-X
region	B-X
.	B-X
This	B-X
phosphorylation	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
trigger	B-X
p105	B-X
degradation	B-X
,	B-X
which	B-X
releases	B-X
the	B-X
associated	B-X
Rel/NF-kappaB	B-X
subunits	B-X
to	B-X
translocate	B-X
into	B-X
the	B-X
nucleus	B-X
and	B-X
regulate	B-X
target	B-X
gene	B-X
transcription	B-X
.	B-X
Serine	B-X
927	B-X
resides	B-X
in	B-X
a	B-X
conserved	B-X
motif	B-X
(	B-X
Asp-Ser	B-X
(	B-X
927	B-X
)	B-X
-Gly-Val-Glu-Thr-Ser	B-X
(	B-X
932	B-X
)	B-X
)	B-X
homologous	B-X
to	B-X
the	B-X
IKK	B-X
target	B-X
sequence	B-X
in	B-X
IkappaBalpha	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
TNF-alpha-induced	B-X
p105	B-X
proteolysis	B-X
was	B-X
revealed	B-X
to	B-X
additionally	B-X
require	B-X
the	B-X
phosphorylation	B-X
of	B-X
serine	B-X
932	B-X
.	B-X
Experiments	B-X
with	B-X
IKK1	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
IKK2	B-X
(	B-X
-/-	B-X
)	B-X
double	B-X
knockout	B-X
embryonic	B-X
fibroblasts	B-X
demonstrate	B-X
that	B-X
the	B-X
IKK	B-X
complex	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
stimulate	B-X
phosphorylation	B-X
on	B-X
p105	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
.	B-X
Furthermore	B-X
,	B-X
purified	B-X
IKK1	B-X
and	B-X
IKK2	B-X
can	B-X
each	B-X
phosphorylate	B-X
a	B-X
glutathione	B-X
S-transferase-p105	B-X
(	B-X
758-967	B-X
)	B-X
fusion	B-X
protein	B-X
on	B-X
both	B-X
regulatory	B-X
serines	B-X
in	B-X
vitro	B-X
.	B-X
IKK-mediated	B-X
p105	B-X
phosphorylation	B-X
generates	B-X
a	B-X
binding	B-X
site	B-X
for	B-X
betaTrCP	B-X
,	B-X
the	B-X
receptor	B-X
subunit	B-X
of	B-X
an	B-X
SCF-type	B-X
ubiquitin	B-X
E3	B-X
ligase	B-X
,	B-X
and	B-X
depletion	B-X
of	B-X
betaTrCP	B-X
by	B-X
RNA	B-X
interference	B-X
blocks	B-X
TNF-alpha-induced	B-X
p105	B-X
ubiquitination	B-X
and	B-X
proteolysis	B-X
.	B-X
Phosphopeptide	B-X
competition	B-X
experiments	B-X
indicate	B-X
that	B-X
betaTrCP	B-X
binds	B-X
p105	B-X
more	B-X
effectively	B-X
when	B-X
both	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
are	B-X
phosphorylated	B-X
.	B-X
Interestingly	B-X
,	B-X
however	B-X
,	B-X
betaTrCP	B-X
affinity	B-X
for	B-X
the	B-X
IKK-phosphorylated	B-X
sequence	B-X
on	B-X
p105	B-X
is	B-X
substantially	B-X
lower	B-X
than	B-X
that	B-X
on	B-X
IkappaBalpha	B-X
.	B-X
Thus	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
reduced	B-X
p105	B-X
recruitment	B-X
of	B-X
betaTrCP	B-X
and	B-X
subsequent	B-X
ubiquitination	B-X
may	B-X
contribute	B-X
to	B-X
delayed	B-X
p105	B-X
proteolysis	B-X
after	B-X
TNF-alpha	B-X
stimulation	B-X
relative	B-X
to	B-X
that	B-X
for	B-X
IkappaBalpha	B-X
.	B-X

Interestingly	O
,	O
however	O
,	O
betaTrCP	B-Gene_or_gene_product
affinity	O
for	O
the	O
IKK	O
-	O
phosphorylated	O
sequence	O
on	O
p105	B-Gene_or_gene_product
is	O
substantially	O
lower	O
than	O
that	O
on	O
IkappaBalpha	B-Gene_or_gene_product
.	O
<EOS>	B-X
NF-kappaB1	B-X
p105	B-X
functions	B-X
both	B-X
as	B-X
a	B-X
precursor	B-X
of	B-X
NF-kappaB1	B-X
p50	B-X
and	B-X
as	B-X
a	B-X
cytoplasmic	B-X
inhibitor	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Following	B-X
the	B-X
stimulation	B-X
of	B-X
cells	B-X
with	B-X
tumor	B-X
necrosis	B-X
factor	B-X
alpha	B-X
(	B-X
TNF-alpha	B-X
)	B-X
,	B-X
the	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
rapidly	B-X
phosphorylates	B-X
NF-kappaB1	B-X
p105	B-X
on	B-X
serine	B-X
927	B-X
in	B-X
the	B-X
PEST	B-X
region	B-X
.	B-X
This	B-X
phosphorylation	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
trigger	B-X
p105	B-X
degradation	B-X
,	B-X
which	B-X
releases	B-X
the	B-X
associated	B-X
Rel/NF-kappaB	B-X
subunits	B-X
to	B-X
translocate	B-X
into	B-X
the	B-X
nucleus	B-X
and	B-X
regulate	B-X
target	B-X
gene	B-X
transcription	B-X
.	B-X
Serine	B-X
927	B-X
resides	B-X
in	B-X
a	B-X
conserved	B-X
motif	B-X
(	B-X
Asp-Ser	B-X
(	B-X
927	B-X
)	B-X
-Gly-Val-Glu-Thr-Ser	B-X
(	B-X
932	B-X
)	B-X
)	B-X
homologous	B-X
to	B-X
the	B-X
IKK	B-X
target	B-X
sequence	B-X
in	B-X
IkappaBalpha	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
TNF-alpha-induced	B-X
p105	B-X
proteolysis	B-X
was	B-X
revealed	B-X
to	B-X
additionally	B-X
require	B-X
the	B-X
phosphorylation	B-X
of	B-X
serine	B-X
932	B-X
.	B-X
Experiments	B-X
with	B-X
IKK1	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
IKK2	B-X
(	B-X
-/-	B-X
)	B-X
double	B-X
knockout	B-X
embryonic	B-X
fibroblasts	B-X
demonstrate	B-X
that	B-X
the	B-X
IKK	B-X
complex	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
stimulate	B-X
phosphorylation	B-X
on	B-X
p105	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
.	B-X
Furthermore	B-X
,	B-X
purified	B-X
IKK1	B-X
and	B-X
IKK2	B-X
can	B-X
each	B-X
phosphorylate	B-X
a	B-X
glutathione	B-X
S-transferase-p105	B-X
(	B-X
758-967	B-X
)	B-X
fusion	B-X
protein	B-X
on	B-X
both	B-X
regulatory	B-X
serines	B-X
in	B-X
vitro	B-X
.	B-X
IKK-mediated	B-X
p105	B-X
phosphorylation	B-X
generates	B-X
a	B-X
binding	B-X
site	B-X
for	B-X
betaTrCP	B-X
,	B-X
the	B-X
receptor	B-X
subunit	B-X
of	B-X
an	B-X
SCF-type	B-X
ubiquitin	B-X
E3	B-X
ligase	B-X
,	B-X
and	B-X
depletion	B-X
of	B-X
betaTrCP	B-X
by	B-X
RNA	B-X
interference	B-X
blocks	B-X
TNF-alpha-induced	B-X
p105	B-X
ubiquitination	B-X
and	B-X
proteolysis	B-X
.	B-X
Phosphopeptide	B-X
competition	B-X
experiments	B-X
indicate	B-X
that	B-X
betaTrCP	B-X
binds	B-X
p105	B-X
more	B-X
effectively	B-X
when	B-X
both	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
are	B-X
phosphorylated	B-X
.	B-X
Interestingly	B-X
,	B-X
however	B-X
,	B-X
betaTrCP	B-X
affinity	B-X
for	B-X
the	B-X
IKK-phosphorylated	B-X
sequence	B-X
on	B-X
p105	B-X
is	B-X
substantially	B-X
lower	B-X
than	B-X
that	B-X
on	B-X
IkappaBalpha	B-X
.	B-X
Thus	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
reduced	B-X
p105	B-X
recruitment	B-X
of	B-X
betaTrCP	B-X
and	B-X
subsequent	B-X
ubiquitination	B-X
may	B-X
contribute	B-X
to	B-X
delayed	B-X
p105	B-X
proteolysis	B-X
after	B-X
TNF-alpha	B-X
stimulation	B-X
relative	B-X
to	B-X
that	B-X
for	B-X
IkappaBalpha	B-X
.	B-X

Thus	O
,	O
it	O
appears	O
that	O
reduced	O
p105	B-Gene_or_gene_product
recruitment	O
of	O
betaTrCP	B-Gene_or_gene_product
and	O
subsequent	O
ubiquitination	O
may	O
contribute	O
to	O
delayed	O
p105	B-Gene_or_gene_product
proteolysis	O
after	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
stimulation	O
relative	O
to	O
that	O
for	O
IkappaBalpha	B-Gene_or_gene_product
.	O
<EOS>	B-X
NF-kappaB1	B-X
p105	B-X
functions	B-X
both	B-X
as	B-X
a	B-X
precursor	B-X
of	B-X
NF-kappaB1	B-X
p50	B-X
and	B-X
as	B-X
a	B-X
cytoplasmic	B-X
inhibitor	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Following	B-X
the	B-X
stimulation	B-X
of	B-X
cells	B-X
with	B-X
tumor	B-X
necrosis	B-X
factor	B-X
alpha	B-X
(	B-X
TNF-alpha	B-X
)	B-X
,	B-X
the	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
rapidly	B-X
phosphorylates	B-X
NF-kappaB1	B-X
p105	B-X
on	B-X
serine	B-X
927	B-X
in	B-X
the	B-X
PEST	B-X
region	B-X
.	B-X
This	B-X
phosphorylation	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
trigger	B-X
p105	B-X
degradation	B-X
,	B-X
which	B-X
releases	B-X
the	B-X
associated	B-X
Rel/NF-kappaB	B-X
subunits	B-X
to	B-X
translocate	B-X
into	B-X
the	B-X
nucleus	B-X
and	B-X
regulate	B-X
target	B-X
gene	B-X
transcription	B-X
.	B-X
Serine	B-X
927	B-X
resides	B-X
in	B-X
a	B-X
conserved	B-X
motif	B-X
(	B-X
Asp-Ser	B-X
(	B-X
927	B-X
)	B-X
-Gly-Val-Glu-Thr-Ser	B-X
(	B-X
932	B-X
)	B-X
)	B-X
homologous	B-X
to	B-X
the	B-X
IKK	B-X
target	B-X
sequence	B-X
in	B-X
IkappaBalpha	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
TNF-alpha-induced	B-X
p105	B-X
proteolysis	B-X
was	B-X
revealed	B-X
to	B-X
additionally	B-X
require	B-X
the	B-X
phosphorylation	B-X
of	B-X
serine	B-X
932	B-X
.	B-X
Experiments	B-X
with	B-X
IKK1	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
IKK2	B-X
(	B-X
-/-	B-X
)	B-X
double	B-X
knockout	B-X
embryonic	B-X
fibroblasts	B-X
demonstrate	B-X
that	B-X
the	B-X
IKK	B-X
complex	B-X
is	B-X
essential	B-X
for	B-X
TNF-alpha	B-X
to	B-X
stimulate	B-X
phosphorylation	B-X
on	B-X
p105	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
.	B-X
Furthermore	B-X
,	B-X
purified	B-X
IKK1	B-X
and	B-X
IKK2	B-X
can	B-X
each	B-X
phosphorylate	B-X
a	B-X
glutathione	B-X
S-transferase-p105	B-X
(	B-X
758-967	B-X
)	B-X
fusion	B-X
protein	B-X
on	B-X
both	B-X
regulatory	B-X
serines	B-X
in	B-X
vitro	B-X
.	B-X
IKK-mediated	B-X
p105	B-X
phosphorylation	B-X
generates	B-X
a	B-X
binding	B-X
site	B-X
for	B-X
betaTrCP	B-X
,	B-X
the	B-X
receptor	B-X
subunit	B-X
of	B-X
an	B-X
SCF-type	B-X
ubiquitin	B-X
E3	B-X
ligase	B-X
,	B-X
and	B-X
depletion	B-X
of	B-X
betaTrCP	B-X
by	B-X
RNA	B-X
interference	B-X
blocks	B-X
TNF-alpha-induced	B-X
p105	B-X
ubiquitination	B-X
and	B-X
proteolysis	B-X
.	B-X
Phosphopeptide	B-X
competition	B-X
experiments	B-X
indicate	B-X
that	B-X
betaTrCP	B-X
binds	B-X
p105	B-X
more	B-X
effectively	B-X
when	B-X
both	B-X
serines	B-X
927	B-X
and	B-X
932	B-X
are	B-X
phosphorylated	B-X
.	B-X
Interestingly	B-X
,	B-X
however	B-X
,	B-X
betaTrCP	B-X
affinity	B-X
for	B-X
the	B-X
IKK-phosphorylated	B-X
sequence	B-X
on	B-X
p105	B-X
is	B-X
substantially	B-X
lower	B-X
than	B-X
that	B-X
on	B-X
IkappaBalpha	B-X
.	B-X
Thus	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
reduced	B-X
p105	B-X
recruitment	B-X
of	B-X
betaTrCP	B-X
and	B-X
subsequent	B-X
ubiquitination	B-X
may	B-X
contribute	B-X
to	B-X
delayed	B-X
p105	B-X
proteolysis	B-X
after	B-X
TNF-alpha	B-X
stimulation	B-X
relative	B-X
to	B-X
that	B-X
for	B-X
IkappaBalpha	B-X
.	B-X

Regulation	O
of	O
lymphoid	B-Gene_or_gene_product
enhancer	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	I-Gene_or_gene_product
T	I-Gene_or_gene_product
-	I-Gene_or_gene_product
cell	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
by	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	O
related	O
Nemo	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	O
dependent	O
phosphorylation	O
in	O
Wnt	B-Gene_or_gene_product
/	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
signaling	O
.	O
<EOS>	B-X
The	B-X
Wnt/beta-catenin	B-X
signaling	B-X
pathway	B-X
regulates	B-X
many	B-X
developmental	B-X
processes	B-X
by	B-X
modulating	B-X
gene	B-X
expression	B-X
.	B-X
Wnt	B-X
signaling	B-X
induces	B-X
the	B-X
stabilization	B-X
of	B-X
cytosolic	B-X
beta-catenin	B-X
,	B-X
which	B-X
then	B-X
associates	B-X
with	B-X
lymphoid	B-X
enhancer	B-X
factor	B-X
and	B-X
T-cell	B-X
factor	B-X
(	B-X
LEF-1/TCF	B-X
)	B-X
to	B-X
form	B-X
a	B-X
transcription	B-X
complex	B-X
that	B-X
activates	B-X
Wnt	B-X
target	B-X
genes	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
a	B-X
specific	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
pathway	B-X
involving	B-X
the	B-X
MAP	B-X
kinase	B-X
kinase	B-X
kinase	B-X
TAK1	B-X
and	B-X
MAP	B-X
kinase-related	B-X
Nemo-like	B-X
kinase	B-X
(	B-X
NLK	B-X
)	B-X
suppresses	B-X
Wnt	B-X
signaling	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relationships	B-X
among	B-X
NLK	B-X
,	B-X
beta-catenin	B-X
,	B-X
and	B-X
LEF-1/TCF	B-X
.	B-X
We	B-X
found	B-X
that	B-X
NLK	B-X
interacts	B-X
directly	B-X
with	B-X
LEF-1/TCF	B-X
and	B-X
indirectly	B-X
with	B-X
beta-catenin	B-X
via	B-X
LEF-1/TCF	B-X
to	B-X
form	B-X
a	B-X
complex	B-X
.	B-X
NLK	B-X
phosphorylates	B-X
LEF-1/TCF	B-X
on	B-X
two	B-X
serine/threonine	B-X
residues	B-X
located	B-X
in	B-X
its	B-X
central	B-X
region	B-X
.	B-X
Mutation	B-X
of	B-X
both	B-X
residues	B-X
to	B-X
alanine	B-X
enhanced	B-X
LEF-1	B-X
transcriptional	B-X
activity	B-X
and	B-X
rendered	B-X
it	B-X
resistant	B-X
to	B-X
inhibition	B-X
by	B-X
NLK	B-X
.	B-X
Phosphorylation	B-X
of	B-X
TCF-4	B-X
by	B-X
NLK	B-X
inhibited	B-X
DNA	B-X
binding	B-X
by	B-X
the	B-X
beta-catenin-TCF-4	B-X
complex	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
NLK	B-X
phosphorylation	B-X
on	B-X
these	B-X
sites	B-X
contributes	B-X
to	B-X
the	B-X
down-regulation	B-X
of	B-X
LEF-1/TCF	B-X
transcriptional	B-X
activity	B-X
.	B-X

The	O
Wnt	B-Gene_or_gene_product
/	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
signaling	O
pathway	O
regulates	O
many	O
developmental	O
processes	O
by	O
modulating	O
gene	O
expression	O
.	O
<EOS>	B-X
Genetic	B-X
analyses	B-X
in	B-X
different	B-X
systems	B-X
have	B-X
revealed	B-X
that	B-X
interactions	B-X
between	B-X
Wnt	B-X
and	B-X
Notch	B-X
signalling	B-X
play	B-X
pervasive	B-X
roles	B-X
in	B-X
these	B-X
processes	B-X
.	B-X
While	B-X
many	B-X
of	B-X
these	B-X
interactions	B-X
can	B-X
be	B-X
explained	B-X
in	B-X
terms	B-X
of	B-X
transcriptional	B-X
cross-talk	B-X
between	B-X
the	B-X
effectors	B-X
of	B-X
these	B-X
pathways	B-X
,	B-X
some	B-X
of	B-X
them	B-X
require	B-X
a	B-X
different	B-X
explanation	B-X
.	B-X
Experiments	B-X
in	B-X
Drosophila	B-X
,	B-X
Xenopus	B-X
and	B-X
mouse	B-X
have	B-X
revealed	B-X
that	B-X
Notch	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
modulation	B-X
of	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
β-catenin	B-X
(	B-X
the	B-X
main	B-X
effector	B-X
of	B-X
Wnt	B-X
signalling	B-X
pathway	B-X
,	B-X
independently	B-X
of	B-X
its	B-X
well	B-X
characterized	B-X
function	B-X
as	B-X
a	B-X
membrane	B-X
tethered	B-X
transcription	B-X
factor	B-X
.	B-X
These	B-X
studies	B-X
suggest	B-X
that	B-X
rather	B-X
than	B-X
two	B-X
separate	B-X
pathways	B-X
,	B-X
elements	B-X
of	B-X
Wnt	B-X
and	B-X
Notch	B-X
signalling	B-X
configure	B-X
a	B-X
single	B-X
functional	B-X
module	B-X
,	B-X
Wntch	B-X
,	B-X
that	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
resolution	B-X
of	B-X
cell	B-X
fate	B-X
decisions	B-X
.	B-X
Here	B-X
we	B-X
review	B-X
the	B-X
evidence	B-X
for	B-X
Wntch	B-X
and	B-X
present	B-X
a	B-X
current	B-X
circuit	B-X
view	B-X
of	B-X
the	B-X
system	B-X
,	B-X
its	B-X
control	B-X
and	B-X
its	B-X
role	B-X
in	B-X
development	B-X
with	B-X
a	B-X
special	B-X
focus	B-X
on	B-X
stem	B-X
cell	B-X
populations	B-X
.	B-X

Wnt	B-Gene_or_gene_product
signaling	O
induces	O
the	O
stabilization	O
of	O
cytosolic	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
,	O
which	O
then	O
associates	O
with	O
lymphoid	B-Gene_or_gene_product
enhancer	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
and	O
T	B-Gene_or_gene_product
-	I-Gene_or_gene_product
cell	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
LEF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	O
TCF	B-Gene_or_gene_product
)	O
to	O
form	O
a	O
transcription	O
complex	O
that	O
activates	O
Wnt	B-Gene_or_gene_product
target	O
genes	O
.	O

Previously	O
,	O
we	O
have	O
shown	O
that	O
a	O
specific	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	I-Gene_or_gene_product
MAP	I-Gene_or_gene_product
)	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
pathway	O
involving	O
the	O
MAP	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
TAK1	I-Gene_or_gene_product
and	O
MAP	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	O
related	O
Nemo	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
NLK	B-Gene_or_gene_product
)	O
suppresses	O
Wnt	B-Gene_or_gene_product
signaling	O
.	O
<EOS>	B-X
The	B-X
Wnt/beta-catenin	B-X
signaling	B-X
pathway	B-X
regulates	B-X
many	B-X
developmental	B-X
processes	B-X
by	B-X
modulating	B-X
gene	B-X
expression	B-X
.	B-X
Wnt	B-X
signaling	B-X
induces	B-X
the	B-X
stabilization	B-X
of	B-X
cytosolic	B-X
beta-catenin	B-X
,	B-X
which	B-X
then	B-X
associates	B-X
with	B-X
lymphoid	B-X
enhancer	B-X
factor	B-X
and	B-X
T-cell	B-X
factor	B-X
(	B-X
LEF-1/TCF	B-X
)	B-X
to	B-X
form	B-X
a	B-X
transcription	B-X
complex	B-X
that	B-X
activates	B-X
Wnt	B-X
target	B-X
genes	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
a	B-X
specific	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
pathway	B-X
involving	B-X
the	B-X
MAP	B-X
kinase	B-X
kinase	B-X
kinase	B-X
TAK1	B-X
and	B-X
MAP	B-X
kinase-related	B-X
Nemo-like	B-X
kinase	B-X
(	B-X
NLK	B-X
)	B-X
suppresses	B-X
Wnt	B-X
signaling	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relationships	B-X
among	B-X
NLK	B-X
,	B-X
beta-catenin	B-X
,	B-X
and	B-X
LEF-1/TCF	B-X
.	B-X
We	B-X
found	B-X
that	B-X
NLK	B-X
interacts	B-X
directly	B-X
with	B-X
LEF-1/TCF	B-X
and	B-X
indirectly	B-X
with	B-X
beta-catenin	B-X
via	B-X
LEF-1/TCF	B-X
to	B-X
form	B-X
a	B-X
complex	B-X
.	B-X
NLK	B-X
phosphorylates	B-X
LEF-1/TCF	B-X
on	B-X
two	B-X
serine/threonine	B-X
residues	B-X
located	B-X
in	B-X
its	B-X
central	B-X
region	B-X
.	B-X
Mutation	B-X
of	B-X
both	B-X
residues	B-X
to	B-X
alanine	B-X
enhanced	B-X
LEF-1	B-X
transcriptional	B-X
activity	B-X
and	B-X
rendered	B-X
it	B-X
resistant	B-X
to	B-X
inhibition	B-X
by	B-X
NLK	B-X
.	B-X
Phosphorylation	B-X
of	B-X
TCF-4	B-X
by	B-X
NLK	B-X
inhibited	B-X
DNA	B-X
binding	B-X
by	B-X
the	B-X
beta-catenin-TCF-4	B-X
complex	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
NLK	B-X
phosphorylation	B-X
on	B-X
these	B-X
sites	B-X
contributes	B-X
to	B-X
the	B-X
down-regulation	B-X
of	B-X
LEF-1/TCF	B-X
transcriptional	B-X
activity	B-X
.	B-X

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
relationships	O
among	O
NLK	B-Gene_or_gene_product
,	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
,	O
and	O
LEF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	I-Gene_or_gene_product
TCF	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
Wnt/beta-catenin	B-X
signaling	B-X
pathway	B-X
regulates	B-X
many	B-X
developmental	B-X
processes	B-X
by	B-X
modulating	B-X
gene	B-X
expression	B-X
.	B-X
Wnt	B-X
signaling	B-X
induces	B-X
the	B-X
stabilization	B-X
of	B-X
cytosolic	B-X
beta-catenin	B-X
,	B-X
which	B-X
then	B-X
associates	B-X
with	B-X
lymphoid	B-X
enhancer	B-X
factor	B-X
and	B-X
T-cell	B-X
factor	B-X
(	B-X
LEF-1/TCF	B-X
)	B-X
to	B-X
form	B-X
a	B-X
transcription	B-X
complex	B-X
that	B-X
activates	B-X
Wnt	B-X
target	B-X
genes	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
a	B-X
specific	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
pathway	B-X
involving	B-X
the	B-X
MAP	B-X
kinase	B-X
kinase	B-X
kinase	B-X
TAK1	B-X
and	B-X
MAP	B-X
kinase-related	B-X
Nemo-like	B-X
kinase	B-X
(	B-X
NLK	B-X
)	B-X
suppresses	B-X
Wnt	B-X
signaling	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relationships	B-X
among	B-X
NLK	B-X
,	B-X
beta-catenin	B-X
,	B-X
and	B-X
LEF-1/TCF	B-X
.	B-X
We	B-X
found	B-X
that	B-X
NLK	B-X
interacts	B-X
directly	B-X
with	B-X
LEF-1/TCF	B-X
and	B-X
indirectly	B-X
with	B-X
beta-catenin	B-X
via	B-X
LEF-1/TCF	B-X
to	B-X
form	B-X
a	B-X
complex	B-X
.	B-X
NLK	B-X
phosphorylates	B-X
LEF-1/TCF	B-X
on	B-X
two	B-X
serine/threonine	B-X
residues	B-X
located	B-X
in	B-X
its	B-X
central	B-X
region	B-X
.	B-X
Mutation	B-X
of	B-X
both	B-X
residues	B-X
to	B-X
alanine	B-X
enhanced	B-X
LEF-1	B-X
transcriptional	B-X
activity	B-X
and	B-X
rendered	B-X
it	B-X
resistant	B-X
to	B-X
inhibition	B-X
by	B-X
NLK	B-X
.	B-X
Phosphorylation	B-X
of	B-X
TCF-4	B-X
by	B-X
NLK	B-X
inhibited	B-X
DNA	B-X
binding	B-X
by	B-X
the	B-X
beta-catenin-TCF-4	B-X
complex	B-X
.	B-X
However	B-X
,	B-X
this	B-X
inhibition	B-X
was	B-X
abrogated	B-X
when	B-X
a	B-X
mutant	B-X
form	B-X
of	B-X
TCF-4	B-X
was	B-X
used	B-X
in	B-X
which	B-X
both	B-X
threonines	B-X
were	B-X
replaced	B-X
with	B-X
valines	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
NLK	B-X
phosphorylation	B-X
on	B-X
these	B-X
sites	B-X
contributes	B-X
to	B-X
the	B-X
down-regulation	B-X
of	B-X
LEF-1/TCF	B-X
transcriptional	B-X
activity	B-X
.	B-X

We	O
found	O
that	O
NLK	B-Gene_or_gene_product
interacts	O
directly	O
with	O
LEF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	I-Gene_or_gene_product
TCF	I-Gene_or_gene_product
and	O
indirectly	O
with	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
via	O
LEF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	I-Gene_or_gene_product
TCF	I-Gene_or_gene_product
to	O
form	O
a	O
complex	O
.	O

NLK	B-Gene_or_gene_product
phosphorylates	O
LEF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	I-Gene_or_gene_product
TCF	I-Gene_or_gene_product
on	O
two	O
serine	O
/	O
threonine	O
residues	O
located	O
in	O
its	O
central	O
region	O
.	O
<EOS>	B-X
Wnt	B-X
signaling	B-X
induces	B-X
the	B-X
stabilization	B-X
of	B-X
cytosolic	B-X
beta-catenin	B-X
,	B-X
which	B-X
then	B-X
associates	B-X
with	B-X
lymphoid	B-X
enhancer	B-X
factor	B-X
and	B-X
T-cell	B-X
factor	B-X
(	B-X
LEF-1/TCF	B-X
)	B-X
to	B-X
form	B-X
a	B-X
transcription	B-X
complex	B-X
that	B-X
activates	B-X
Wnt	B-X
target	B-X
genes	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
a	B-X
specific	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
pathway	B-X
involving	B-X
the	B-X
MAP	B-X
kinase	B-X
kinase	B-X
kinase	B-X
TAK1	B-X
and	B-X
MAP	B-X
kinase-related	B-X
Nemo-like	B-X
kinase	B-X
(	B-X
NLK	B-X
)	B-X
suppresses	B-X
Wnt	B-X
signaling	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relationships	B-X
among	B-X
NLK	B-X
,	B-X
beta-catenin	B-X
,	B-X
and	B-X
LEF-1/TCF	B-X
.	B-X
We	B-X
found	B-X
that	B-X
NLK	B-X
interacts	B-X
directly	B-X
with	B-X
LEF-1/TCF	B-X
and	B-X
indirectly	B-X
with	B-X
beta-catenin	B-X
via	B-X
LEF-1/TCF	B-X
to	B-X
form	B-X
a	B-X
complex	B-X
.	B-X
NLK	B-X
phosphorylates	B-X
LEF-1/TCF	B-X
on	B-X
two	B-X
serine/threonine	B-X
residues	B-X
located	B-X
in	B-X
its	B-X
central	B-X
region	B-X
.	B-X
Mutation	B-X
of	B-X
both	B-X
residues	B-X
to	B-X
alanine	B-X
enhanced	B-X
LEF-1	B-X
transcriptional	B-X
activity	B-X
and	B-X
rendered	B-X
it	B-X
resistant	B-X
to	B-X
inhibition	B-X
by	B-X
NLK	B-X
.	B-X
Phosphorylation	B-X
of	B-X
TCF-4	B-X
by	B-X
NLK	B-X
inhibited	B-X
DNA	B-X
binding	B-X
by	B-X
the	B-X
beta-catenin-TCF-4	B-X
complex	B-X
.	B-X
However	B-X
,	B-X
this	B-X
inhibition	B-X
was	B-X
abrogated	B-X
when	B-X
a	B-X
mutant	B-X
form	B-X
of	B-X
TCF-4	B-X
was	B-X
used	B-X
in	B-X
which	B-X
both	B-X
threonines	B-X
were	B-X
replaced	B-X
with	B-X
valines	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
NLK	B-X
phosphorylation	B-X
on	B-X
these	B-X
sites	B-X
contributes	B-X
to	B-X
the	B-X
down-regulation	B-X
of	B-X
LEF-1/TCF	B-X
transcriptional	B-X
activity	B-X
.	B-X

Mutation	O
of	O
both	O
residues	O
to	O
alanine	O
enhanced	O
LEF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
transcriptional	O
activity	O
and	O
rendered	O
it	O
resistant	O
to	O
inhibition	O
by	O
NLK	B-Gene_or_gene_product
.	O
<EOS>	B-X
Wnt	B-X
signaling	B-X
induces	B-X
the	B-X
stabilization	B-X
of	B-X
cytosolic	B-X
beta-catenin	B-X
,	B-X
which	B-X
then	B-X
associates	B-X
with	B-X
lymphoid	B-X
enhancer	B-X
factor	B-X
and	B-X
T-cell	B-X
factor	B-X
(	B-X
LEF-1/TCF	B-X
)	B-X
to	B-X
form	B-X
a	B-X
transcription	B-X
complex	B-X
that	B-X
activates	B-X
Wnt	B-X
target	B-X
genes	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
a	B-X
specific	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
pathway	B-X
involving	B-X
the	B-X
MAP	B-X
kinase	B-X
kinase	B-X
kinase	B-X
TAK1	B-X
and	B-X
MAP	B-X
kinase-related	B-X
Nemo-like	B-X
kinase	B-X
(	B-X
NLK	B-X
)	B-X
suppresses	B-X
Wnt	B-X
signaling	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relationships	B-X
among	B-X
NLK	B-X
,	B-X
beta-catenin	B-X
,	B-X
and	B-X
LEF-1/TCF	B-X
.	B-X
We	B-X
found	B-X
that	B-X
NLK	B-X
interacts	B-X
directly	B-X
with	B-X
LEF-1/TCF	B-X
and	B-X
indirectly	B-X
with	B-X
beta-catenin	B-X
via	B-X
LEF-1/TCF	B-X
to	B-X
form	B-X
a	B-X
complex	B-X
.	B-X
NLK	B-X
phosphorylates	B-X
LEF-1/TCF	B-X
on	B-X
two	B-X
serine/threonine	B-X
residues	B-X
located	B-X
in	B-X
its	B-X
central	B-X
region	B-X
.	B-X
Mutation	B-X
of	B-X
both	B-X
residues	B-X
to	B-X
alanine	B-X
enhanced	B-X
LEF-1	B-X
transcriptional	B-X
activity	B-X
and	B-X
rendered	B-X
it	B-X
resistant	B-X
to	B-X
inhibition	B-X
by	B-X
NLK	B-X
.	B-X
Phosphorylation	B-X
of	B-X
TCF-4	B-X
by	B-X
NLK	B-X
inhibited	B-X
DNA	B-X
binding	B-X
by	B-X
the	B-X
beta-catenin-TCF-4	B-X
complex	B-X
.	B-X
However	B-X
,	B-X
this	B-X
inhibition	B-X
was	B-X
abrogated	B-X
when	B-X
a	B-X
mutant	B-X
form	B-X
of	B-X
TCF-4	B-X
was	B-X
used	B-X
in	B-X
which	B-X
both	B-X
threonines	B-X
were	B-X
replaced	B-X
with	B-X
valines	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
NLK	B-X
phosphorylation	B-X
on	B-X
these	B-X
sites	B-X
contributes	B-X
to	B-X
the	B-X
down-regulation	B-X
of	B-X
LEF-1/TCF	B-X
transcriptional	B-X
activity	B-X
.	B-X

Phosphorylation	O
of	O
TCF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
by	O
NLK	B-Gene_or_gene_product
inhibited	O
DNA	O
binding	O
by	O
the	O
beta	O
-	O
catenin	O
-	O
TCF	O
-	O
4	O
complex	O
.	O
<EOS>	B-X
The	B-X
Wnt	B-X
signalling	B-X
pathway	B-X
regulates	B-X
many	B-X
developmental	B-X
processes	B-X
through	B-X
a	B-X
complex	B-X
of	B-X
beta-catenin	B-X
and	B-X
the	B-X
T-cell	B-X
factor/lymphoid	B-X
enhancer	B-X
factor	B-X
(	B-X
TCF/LEF	B-X
)	B-X
family	B-X
of	B-X
high-mobility-group	B-X
transcription	B-X
factors	B-X
.	B-X
Wnt	B-X
stabilizes	B-X
cytosolic	B-X
beta-catenin	B-X
,	B-X
which	B-X
then	B-X
binds	B-X
to	B-X
TCF	B-X
and	B-X
activates	B-X
gene	B-X
transcription	B-X
.	B-X
In	B-X
C.	B-X
elegans	B-X
,	B-X
the	B-X
proteins	B-X
MOM-4	B-X
and	B-X
LIT-1	B-X
regulate	B-X
Wnt	B-X
signalling	B-X
to	B-X
polarize	B-X
responding	B-X
cells	B-X
during	B-X
embryogenesis	B-X
.	B-X
MOM-4	B-X
and	B-X
LIT-1	B-X
are	B-X
homologous	B-X
to	B-X
TAK1	B-X
(	B-X
a	B-X
kinase	B-X
activated	B-X
by	B-X
transforming	B-X
growth	B-X
factor-beta	B-X
)	B-X
mitogen-activated	B-X
protein-kinase-kinase	B-X
kinase	B-X
(	B-X
MAP3K	B-X
)	B-X
and	B-X
MAP	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
-related	B-X
NEMO-like	B-X
kinase	B-X
(	B-X
NLK	B-X
)	B-X
,	B-X
respectively	B-X
,	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
These	B-X
results	B-X
raise	B-X
the	B-X
possibility	B-X
that	B-X
TAK1	B-X
and	B-X
NLK	B-X
are	B-X
also	B-X
involved	B-X
in	B-X
Wnt	B-X
signalling	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
TAK1	B-X
activation	B-X
stimulates	B-X
NLK	B-X
activity	B-X
and	B-X
downregulates	B-X
transcriptional	B-X
activation	B-X
mediated	B-X
by	B-X
beta-catenin	B-X
and	B-X
TCF	B-X
.	B-X
Injection	B-X
of	B-X
NLK	B-X
suppresses	B-X
the	B-X
induction	B-X
of	B-X
axis	B-X
duplication	B-X
by	B-X
microinjected	B-X
beta-catenin	B-X
in	B-X
Xenopus	B-X
embryos	B-X
.	B-X
NLK	B-X
phosphorylates	B-X
TCF/LEF	B-X
factors	B-X
and	B-X
inhibits	B-X
the	B-X
interaction	B-X
of	B-X
the	B-X
beta-catenin-TCF	B-X
complex	B-X
with	B-X
DNA	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
TAK1-NLK-MAPK-like	B-X
pathway	B-X
negatively	B-X
regulates	B-X
the	B-X
Wnt	B-X
signalling	B-X
pathway	B-X
.	B-X

However	O
,	O
this	O
inhibition	O
was	O
abrogated	O
when	O
a	O
mutant	O
form	O
of	O
TCF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
was	O
used	O
in	O
which	O
both	O
threonines	O
were	O
replaced	O
with	O
valines	O
.	O
<EOS>	B-X
Wnt	B-X
signaling	B-X
induces	B-X
the	B-X
stabilization	B-X
of	B-X
cytosolic	B-X
beta-catenin	B-X
,	B-X
which	B-X
then	B-X
associates	B-X
with	B-X
lymphoid	B-X
enhancer	B-X
factor	B-X
and	B-X
T-cell	B-X
factor	B-X
(	B-X
LEF-1/TCF	B-X
)	B-X
to	B-X
form	B-X
a	B-X
transcription	B-X
complex	B-X
that	B-X
activates	B-X
Wnt	B-X
target	B-X
genes	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relationships	B-X
among	B-X
NLK	B-X
,	B-X
beta-catenin	B-X
,	B-X
and	B-X
LEF-1/TCF	B-X
.	B-X
We	B-X
found	B-X
that	B-X
NLK	B-X
interacts	B-X
directly	B-X
with	B-X
LEF-1/TCF	B-X
and	B-X
indirectly	B-X
with	B-X
beta-catenin	B-X
via	B-X
LEF-1/TCF	B-X
to	B-X
form	B-X
a	B-X
complex	B-X
.	B-X
NLK	B-X
phosphorylates	B-X
LEF-1/TCF	B-X
on	B-X
two	B-X
serine/threonine	B-X
residues	B-X
located	B-X
in	B-X
its	B-X
central	B-X
region	B-X
.	B-X
Mutation	B-X
of	B-X
both	B-X
residues	B-X
to	B-X
alanine	B-X
enhanced	B-X
LEF-1	B-X
transcriptional	B-X
activity	B-X
and	B-X
rendered	B-X
it	B-X
resistant	B-X
to	B-X
inhibition	B-X
by	B-X
NLK	B-X
.	B-X
Phosphorylation	B-X
of	B-X
TCF-4	B-X
by	B-X
NLK	B-X
inhibited	B-X
DNA	B-X
binding	B-X
by	B-X
the	B-X
beta-catenin-TCF-4	B-X
complex	B-X
.	B-X
However	B-X
,	B-X
this	B-X
inhibition	B-X
was	B-X
abrogated	B-X
when	B-X
a	B-X
mutant	B-X
form	B-X
of	B-X
TCF-4	B-X
was	B-X
used	B-X
in	B-X
which	B-X
both	B-X
threonines	B-X
were	B-X
replaced	B-X
with	B-X
valines	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
NLK	B-X
phosphorylation	B-X
on	B-X
these	B-X
sites	B-X
contributes	B-X
to	B-X
the	B-X
down-regulation	B-X
of	B-X
LEF-1/TCF	B-X
transcriptional	B-X
activity	B-X
.	B-X

These	O
results	O
suggest	O
that	O
NLK	B-Gene_or_gene_product
phosphorylation	O
on	O
these	O
sites	O
contributes	O
to	O
the	O
down	O
-	O
regulation	O
of	O
LEF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	I-Gene_or_gene_product
TCF	I-Gene_or_gene_product
transcriptional	O
activity	O
.	O

Tetrameric	O
oligomerization	O
of	O
IkappaB	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
gamma	I-Gene_or_gene_product
(	O
IKKgamma	B-Gene_or_gene_product
)	O
is	O
obligatory	O
for	O
IKK	O
complex	O
activity	O
and	O
NF	O
-	O
kappaB	O
activation	O
.	O
<EOS>	B-X
The	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
mediates	B-X
activation	B-X
of	B-X
transcription	B-X
factor	B-X
NF-kappaB	B-X
by	B-X
phosphorylation	B-X
of	B-X
IkappaB	B-X
proteins	B-X
.	B-X
Its	B-X
catalytic	B-X
subunits	B-X
,	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
,	B-X
require	B-X
association	B-X
with	B-X
the	B-X
regulatory	B-X
IKKgamma	B-X
(	B-X
NEMO	B-X
)	B-X
component	B-X
to	B-X
gain	B-X
full	B-X
basal	B-X
and	B-X
inducible	B-X
kinase	B-X
activity	B-X
.	B-X
However	B-X
,	B-X
the	B-X
oligomeric	B-X
composition	B-X
of	B-X
the	B-X
IKK	B-X
complex	B-X
and	B-X
its	B-X
regulation	B-X
by	B-X
IKKgamma	B-X
are	B-X
poorly	B-X
understood	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
IKKgamma	B-X
predominantly	B-X
forms	B-X
tetramers	B-X
and	B-X
interacts	B-X
with	B-X
IKKalpha	B-X
or	B-X
IKKbeta	B-X
in	B-X
this	B-X
state	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
tetramerization	B-X
is	B-X
accomplished	B-X
by	B-X
a	B-X
prerequisite	B-X
dimerization	B-X
through	B-X
a	B-X
C-terminal	B-X
coiled-coil	B-X
minimal	B-X
oligomerization	B-X
domain	B-X
(	B-X
MOD	B-X
)	B-X
.	B-X
Tetrameric	B-X
IKKgamma	B-X
sequesters	B-X
four	B-X
kinase	B-X
molecules	B-X
,	B-X
yielding	B-X
a	B-X
gamma	B-X
(	B-X
4	B-X
)	B-X
(	B-X
alpha/beta	B-X
)	B-X
(	B-X
4	B-X
)	B-X
stoichiometry	B-X
.	B-X
Deletion	B-X
of	B-X
the	B-X
MOD	B-X
leads	B-X
to	B-X
loss	B-X
of	B-X
tetramerization	B-X
and	B-X
of	B-X
phosphorylation	B-X
of	B-X
IKKbeta	B-X
and	B-X
IKKgamma	B-X
,	B-X
although	B-X
the	B-X
kinase	B-X
can	B-X
still	B-X
interact	B-X
with	B-X
the	B-X
resultant	B-X
IKKgamma	B-X
monomers	B-X
and	B-X
dimers	B-X
.	B-X
Likewise	B-X
,	B-X
MOD-mediated	B-X
IKKgamma	B-X
tetramerization	B-X
is	B-X
required	B-X
to	B-X
enhance	B-X
IKKbeta	B-X
kinase	B-X
activity	B-X
when	B-X
overexpressed	B-X
in	B-X
293	B-X
cells	B-X
and	B-X
to	B-X
reconstitute	B-X
a	B-X
lipopolysaccharide-responsive	B-X
IKK	B-X
complex	B-X
in	B-X
pre-B	B-X
cells	B-X
.	B-X
These	B-X
data	B-X
thus	B-X
suggest	B-X
that	B-X
IKKgamma	B-X
tetramerization	B-X
enforces	B-X
a	B-X
spatial	B-X
positioning	B-X
of	B-X
two	B-X
kinase	B-X
dimers	B-X
to	B-X
facilitate	B-X
transautophosphorylation	B-X
and	B-X
activation	B-X
.	B-X

The	O
IkappaB	O
kinase	O
(	O
IKK	O
)	O
complex	O
mediates	O
activation	O
of	O
transcription	O
factor	O
NF	O
-	O
kappaB	O
by	O
phosphorylation	O
of	O
IkappaB	B-Gene_or_gene_product
proteins	O
.	O
<EOS>	B-X
Nuclear	B-X
factor-kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
consists	B-X
of	B-X
a	B-X
family	B-X
of	B-X
transcription	B-X
factors	B-X
that	B-X
play	B-X
critical	B-X
roles	B-X
in	B-X
inflammation	B-X
,	B-X
immunity	B-X
,	B-X
cell	B-X
proliferation	B-X
,	B-X
differentiation	B-X
,	B-X
and	B-X
survival	B-X
.	B-X
Inducible	B-X
NF-kappaB	B-X
activation	B-X
depends	B-X
on	B-X
phosphorylation-induced	B-X
proteosomal	B-X
degradation	B-X
of	B-X
the	B-X
inhibitor	B-X
of	B-X
NF-kappaB	B-X
proteins	B-X
(	B-X
IkappaBs	B-X
)	B-X
,	B-X
which	B-X
retain	B-X
inactive	B-X
NF-kappaB	B-X
dimers	B-X
in	B-X
the	B-X
cytosol	B-X
in	B-X
unstimulated	B-X
cells	B-X
.	B-X
The	B-X
majority	B-X
of	B-X
the	B-X
diverse	B-X
signaling	B-X
pathways	B-X
that	B-X
lead	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
converge	B-X
on	B-X
the	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
,	B-X
which	B-X
is	B-X
responsible	B-X
for	B-X
IkappaB	B-X
phosphorylation	B-X
and	B-X
is	B-X
essential	B-X
for	B-X
signal	B-X
transduction	B-X
to	B-X
NF-kappaB	B-X
.	B-X
Additional	B-X
regulation	B-X
of	B-X
NF-kappaB	B-X
activity	B-X
is	B-X
achieved	B-X
through	B-X
various	B-X
post-translational	B-X
modifications	B-X
of	B-X
the	B-X
core	B-X
components	B-X
of	B-X
the	B-X
NF-kappaB	B-X
signaling	B-X
pathways	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
cytosolic	B-X
modifications	B-X
of	B-X
IKK	B-X
and	B-X
IkappaB	B-X
proteins	B-X
,	B-X
as	B-X
well	B-X
as	B-X
other	B-X
pathway-specific	B-X
mediators	B-X
,	B-X
the	B-X
transcription	B-X
factors	B-X
are	B-X
themselves	B-X
extensively	B-X
modified	B-X
.	B-X
Tremendous	B-X
progress	B-X
has	B-X
been	B-X
made	B-X
over	B-X
the	B-X
last	B-X
two	B-X
decades	B-X
in	B-X
unraveling	B-X
the	B-X
elaborate	B-X
regulatory	B-X
networks	B-X
that	B-X
control	B-X
the	B-X
NF-kappaB	B-X
response	B-X
.	B-X
This	B-X
has	B-X
made	B-X
the	B-X
NF-kappaB	B-X
pathway	B-X
a	B-X
paradigm	B-X
for	B-X
understanding	B-X
general	B-X
principles	B-X
of	B-X
signal	B-X
transduction	B-X
and	B-X
gene	B-X
regulation	B-X
.	B-X

Its	O
catalytic	O
subunits	O
,	O
IKKalpha	B-Gene_or_gene_product
and	O
IKKbeta	B-Gene_or_gene_product
,	O
require	O
association	O
with	O
the	O
regulatory	O
IKKgamma	B-Gene_or_gene_product
(	O
NEMO	B-Gene_or_gene_product
)	O
component	O
to	O
gain	O
full	O
basal	O
and	O
inducible	O
kinase	O
activity	O
.	O
<EOS>	B-X
The	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
mediates	B-X
activation	B-X
of	B-X
transcription	B-X
factor	B-X
NF-kappaB	B-X
by	B-X
phosphorylation	B-X
of	B-X
IkappaB	B-X
proteins	B-X
.	B-X
Its	B-X
catalytic	B-X
subunits	B-X
,	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
,	B-X
require	B-X
association	B-X
with	B-X
the	B-X
regulatory	B-X
IKKgamma	B-X
(	B-X
NEMO	B-X
)	B-X
component	B-X
to	B-X
gain	B-X
full	B-X
basal	B-X
and	B-X
inducible	B-X
kinase	B-X
activity	B-X
.	B-X
However	B-X
,	B-X
the	B-X
oligomeric	B-X
composition	B-X
of	B-X
the	B-X
IKK	B-X
complex	B-X
and	B-X
its	B-X
regulation	B-X
by	B-X
IKKgamma	B-X
are	B-X
poorly	B-X
understood	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
IKKgamma	B-X
predominantly	B-X
forms	B-X
tetramers	B-X
and	B-X
interacts	B-X
with	B-X
IKKalpha	B-X
or	B-X
IKKbeta	B-X
in	B-X
this	B-X
state	B-X
.	B-X
Tetrameric	B-X
IKKgamma	B-X
sequesters	B-X
four	B-X
kinase	B-X
molecules	B-X
,	B-X
yielding	B-X
a	B-X
gamma	B-X
(	B-X
4	B-X
)	B-X
(	B-X
alpha/beta	B-X
)	B-X
(	B-X
4	B-X
)	B-X
stoichiometry	B-X
.	B-X
Deletion	B-X
of	B-X
the	B-X
MOD	B-X
leads	B-X
to	B-X
loss	B-X
of	B-X
tetramerization	B-X
and	B-X
of	B-X
phosphorylation	B-X
of	B-X
IKKbeta	B-X
and	B-X
IKKgamma	B-X
,	B-X
although	B-X
the	B-X
kinase	B-X
can	B-X
still	B-X
interact	B-X
with	B-X
the	B-X
resultant	B-X
IKKgamma	B-X
monomers	B-X
and	B-X
dimers	B-X
.	B-X
Likewise	B-X
,	B-X
MOD-mediated	B-X
IKKgamma	B-X
tetramerization	B-X
is	B-X
required	B-X
to	B-X
enhance	B-X
IKKbeta	B-X
kinase	B-X
activity	B-X
when	B-X
overexpressed	B-X
in	B-X
293	B-X
cells	B-X
and	B-X
to	B-X
reconstitute	B-X
a	B-X
lipopolysaccharide-responsive	B-X
IKK	B-X
complex	B-X
in	B-X
pre-B	B-X
cells	B-X
.	B-X
These	B-X
data	B-X
thus	B-X
suggest	B-X
that	B-X
IKKgamma	B-X
tetramerization	B-X
enforces	B-X
a	B-X
spatial	B-X
positioning	B-X
of	B-X
two	B-X
kinase	B-X
dimers	B-X
to	B-X
facilitate	B-X
transautophosphorylation	B-X
and	B-X
activation	B-X
.	B-X

However	O
,	O
the	O
oligomeric	O
composition	O
of	O
the	O
IKK	O
complex	O
and	O
its	O
regulation	O
by	O
IKKgamma	B-Gene_or_gene_product
are	O
poorly	O
understood	O
.	O
<EOS>	B-X
The	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
mediates	B-X
activation	B-X
of	B-X
transcription	B-X
factor	B-X
NF-kappaB	B-X
by	B-X
phosphorylation	B-X
of	B-X
IkappaB	B-X
proteins	B-X
.	B-X
Its	B-X
catalytic	B-X
subunits	B-X
,	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
,	B-X
require	B-X
association	B-X
with	B-X
the	B-X
regulatory	B-X
IKKgamma	B-X
(	B-X
NEMO	B-X
)	B-X
component	B-X
to	B-X
gain	B-X
full	B-X
basal	B-X
and	B-X
inducible	B-X
kinase	B-X
activity	B-X
.	B-X
However	B-X
,	B-X
the	B-X
oligomeric	B-X
composition	B-X
of	B-X
the	B-X
IKK	B-X
complex	B-X
and	B-X
its	B-X
regulation	B-X
by	B-X
IKKgamma	B-X
are	B-X
poorly	B-X
understood	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
IKKgamma	B-X
predominantly	B-X
forms	B-X
tetramers	B-X
and	B-X
interacts	B-X
with	B-X
IKKalpha	B-X
or	B-X
IKKbeta	B-X
in	B-X
this	B-X
state	B-X
.	B-X
Tetrameric	B-X
IKKgamma	B-X
sequesters	B-X
four	B-X
kinase	B-X
molecules	B-X
,	B-X
yielding	B-X
a	B-X
gamma	B-X
(	B-X
4	B-X
)	B-X
(	B-X
alpha/beta	B-X
)	B-X
(	B-X
4	B-X
)	B-X
stoichiometry	B-X
.	B-X
Deletion	B-X
of	B-X
the	B-X
MOD	B-X
leads	B-X
to	B-X
loss	B-X
of	B-X
tetramerization	B-X
and	B-X
of	B-X
phosphorylation	B-X
of	B-X
IKKbeta	B-X
and	B-X
IKKgamma	B-X
,	B-X
although	B-X
the	B-X
kinase	B-X
can	B-X
still	B-X
interact	B-X
with	B-X
the	B-X
resultant	B-X
IKKgamma	B-X
monomers	B-X
and	B-X
dimers	B-X
.	B-X
Likewise	B-X
,	B-X
MOD-mediated	B-X
IKKgamma	B-X
tetramerization	B-X
is	B-X
required	B-X
to	B-X
enhance	B-X
IKKbeta	B-X
kinase	B-X
activity	B-X
when	B-X
overexpressed	B-X
in	B-X
293	B-X
cells	B-X
and	B-X
to	B-X
reconstitute	B-X
a	B-X
lipopolysaccharide-responsive	B-X
IKK	B-X
complex	B-X
in	B-X
pre-B	B-X
cells	B-X
.	B-X
These	B-X
data	B-X
thus	B-X
suggest	B-X
that	B-X
IKKgamma	B-X
tetramerization	B-X
enforces	B-X
a	B-X
spatial	B-X
positioning	B-X
of	B-X
two	B-X
kinase	B-X
dimers	B-X
to	B-X
facilitate	B-X
transautophosphorylation	B-X
and	B-X
activation	B-X
.	B-X

We	O
show	O
here	O
that	O
IKKgamma	B-Gene_or_gene_product
predominantly	O
forms	O
tetramers	O
and	O
interacts	O
with	O
IKKalpha	B-Gene_or_gene_product
or	O
IKKbeta	B-Gene_or_gene_product
in	O
this	O
state	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
IKKβ	B-X
,	B-X
a	B-X
kinase	B-X
activated	B-X
during	B-X
priming	B-X
,	B-X
induces	B-X
recruitment	B-X
of	B-X
NLRP3	B-X
to	B-X
phosphatidylinositol-4-phosphate	B-X
(	B-X
PI4P	B-X
)	B-X
,	B-X
a	B-X
phospholipid	B-X
enriched	B-X
on	B-X
the	B-X
trans-Golgi	B-X
network	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
PI4P	B-X
binding	B-X
represents	B-X
a	B-X
primed	B-X
state	B-X
into	B-X
which	B-X
NLRP3	B-X
is	B-X
brought	B-X
by	B-X
IKKβ	B-X
activity	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
the	B-X
hypothalamus	B-X
is	B-X
important	B-X
for	B-X
the	B-X
development	B-X
of	B-X
whole-body	B-X
ageing	B-X
in	B-X
mice	B-X
,	B-X
and	B-X
that	B-X
the	B-X
underlying	B-X
basis	B-X
involves	B-X
hypothalamic	B-X
immunity	B-X
mediated	B-X
by	B-X
IκB	B-X
kinase-β	B-X
(	B-X
IKK-β	B-X
)	B-X
,	B-X
nuclear	B-X
factor	B-X
κB	B-X
(	B-X
NF-κB	B-X
)	B-X
and	B-X
related	B-X
microglia-neuron	B-X
immune	B-X
crosstalk	B-X
.	B-X
Several	B-X
interventional	B-X
models	B-X
were	B-X
developed	B-X
showing	B-X
that	B-X
ageing	B-X
retardation	B-X
and	B-X
lifespan	B-X
extension	B-X
are	B-X
achieved	B-X
in	B-X
mice	B-X
by	B-X
preventing	B-X
ageing-related	B-X
hypothalamic	B-X
or	B-X
brain	B-X
IKK-β	B-X
and	B-X
NF-κB	B-X
activation	B-X
.	B-X

We	O
propose	O
that	O
tetramerization	O
is	O
accomplished	O
by	O
a	O
prerequisite	O
dimerization	O
through	O
a	O
C	O
-	O
terminal	O
coiled	O
-	O
coil	O
minimal	O
oligomerization	O
domain	O
(	O
MOD	O
)	O
.	O

This	O
is	O
followed	O
by	O
dimerization	O
of	O
the	O
dimers	O
with	O
their	O
N	O
-	O
terminal	O
sequences	O
.	O
<EOS>	B-X
Estrogen	B-X
receptor	B-X
(	B-X
ER	B-X
)	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
nuclear	B-X
receptor	B-X
superfamily	B-X
whose	B-X
members	B-X
share	B-X
conserved	B-X
domain	B-X
structures	B-X
,	B-X
including	B-X
a	B-X
DNA-binding	B-X
domain	B-X
(	B-X
DBD	B-X
)	B-X
and	B-X
ligand-binding	B-X
domain	B-X
(	B-X
LBD	B-X
)	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
it	B-X
is	B-X
still	B-X
less	B-X
well	B-X
defined	B-X
as	B-X
to	B-X
the	B-X
ligand-dependent	B-X
regulation	B-X
of	B-X
N-terminal	B-X
AF-1	B-X
activity	B-X
.	B-X
(	B-X
1	B-X
)	B-X
The	B-X
F-domain	B-X
,	B-X
which	B-X
is	B-X
connected	B-X
to	B-X
helix	B-X
12	B-X
,	B-X
controls	B-X
4-hydroxytamoxifen	B-X
(	B-X
4OHT	B-X
)	B-X
mediated	B-X
AF-1	B-X
activation	B-X
associated	B-X
with	B-X
the	B-X
receptor	B-X
dimerization	B-X
activity	B-X
.	B-X
(	B-X
3	B-X
)	B-X
The	B-X
novel	B-X
estrogen	B-X
responsive	B-X
genomic	B-X
DNA	B-X
element	B-X
,	B-X
which	B-X
contains	B-X
multiple	B-X
long-spaced	B-X
direct-repeats	B-X
without	B-X
a	B-X
palindromic	B-X
ERE	B-X
sequence	B-X
,	B-X
is	B-X
differentially	B-X
recognized	B-X
by	B-X
4OHT	B-X
and	B-X
E2	B-X
ligand	B-X
bound	B-X
ERα	B-X
transactivation	B-X
complexes	B-X
.	B-X

Tetrameric	O
IKKgamma	O
sequesters	O
four	O
kinase	O
molecules	O
,	O
yielding	O
a	O
gamma	B-Gene_or_gene_product
(	O
4	O
)	O
(	O
alpha	B-Gene_or_gene_product
/	O
beta	B-Gene_or_gene_product
)	O
(	O
4	O
)	O
stoichiometry	O
.	O

Deletion	O
of	O
the	O
MOD	O
leads	O
to	O
loss	O
of	O
tetramerization	O
and	O
of	O
phosphorylation	O
of	O
IKKbeta	B-Gene_or_gene_product
and	O
IKKgamma	B-Gene_or_gene_product
,	O
although	O
the	O
kinase	O
can	O
still	O
interact	O
with	O
the	O
resultant	O
IKKgamma	B-Gene_or_gene_product
monomers	O
and	O
dimers	O
.	O
<EOS>	B-X
The	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
mediates	B-X
activation	B-X
of	B-X
transcription	B-X
factor	B-X
NF-kappaB	B-X
by	B-X
phosphorylation	B-X
of	B-X
IkappaB	B-X
proteins	B-X
.	B-X
Its	B-X
catalytic	B-X
subunits	B-X
,	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
,	B-X
require	B-X
association	B-X
with	B-X
the	B-X
regulatory	B-X
IKKgamma	B-X
(	B-X
NEMO	B-X
)	B-X
component	B-X
to	B-X
gain	B-X
full	B-X
basal	B-X
and	B-X
inducible	B-X
kinase	B-X
activity	B-X
.	B-X
However	B-X
,	B-X
the	B-X
oligomeric	B-X
composition	B-X
of	B-X
the	B-X
IKK	B-X
complex	B-X
and	B-X
its	B-X
regulation	B-X
by	B-X
IKKgamma	B-X
are	B-X
poorly	B-X
understood	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
IKKgamma	B-X
predominantly	B-X
forms	B-X
tetramers	B-X
and	B-X
interacts	B-X
with	B-X
IKKalpha	B-X
or	B-X
IKKbeta	B-X
in	B-X
this	B-X
state	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
tetramerization	B-X
is	B-X
accomplished	B-X
by	B-X
a	B-X
prerequisite	B-X
dimerization	B-X
through	B-X
a	B-X
C-terminal	B-X
coiled-coil	B-X
minimal	B-X
oligomerization	B-X
domain	B-X
(	B-X
MOD	B-X
)	B-X
.	B-X
This	B-X
is	B-X
followed	B-X
by	B-X
dimerization	B-X
of	B-X
the	B-X
dimers	B-X
with	B-X
their	B-X
N-terminal	B-X
sequences	B-X
.	B-X
Tetrameric	B-X
IKKgamma	B-X
sequesters	B-X
four	B-X
kinase	B-X
molecules	B-X
,	B-X
yielding	B-X
a	B-X
gamma	B-X
(	B-X
4	B-X
)	B-X
(	B-X
alpha/beta	B-X
)	B-X
(	B-X
4	B-X
)	B-X
stoichiometry	B-X
.	B-X
Deletion	B-X
of	B-X
the	B-X
MOD	B-X
leads	B-X
to	B-X
loss	B-X
of	B-X
tetramerization	B-X
and	B-X
of	B-X
phosphorylation	B-X
of	B-X
IKKbeta	B-X
and	B-X
IKKgamma	B-X
,	B-X
although	B-X
the	B-X
kinase	B-X
can	B-X
still	B-X
interact	B-X
with	B-X
the	B-X
resultant	B-X
IKKgamma	B-X
monomers	B-X
and	B-X
dimers	B-X
.	B-X
Likewise	B-X
,	B-X
MOD-mediated	B-X
IKKgamma	B-X
tetramerization	B-X
is	B-X
required	B-X
to	B-X
enhance	B-X
IKKbeta	B-X
kinase	B-X
activity	B-X
when	B-X
overexpressed	B-X
in	B-X
293	B-X
cells	B-X
and	B-X
to	B-X
reconstitute	B-X
a	B-X
lipopolysaccharide-responsive	B-X
IKK	B-X
complex	B-X
in	B-X
pre-B	B-X
cells	B-X
.	B-X
These	B-X
data	B-X
thus	B-X
suggest	B-X
that	B-X
IKKgamma	B-X
tetramerization	B-X
enforces	B-X
a	B-X
spatial	B-X
positioning	B-X
of	B-X
two	B-X
kinase	B-X
dimers	B-X
to	B-X
facilitate	B-X
transautophosphorylation	B-X
and	B-X
activation	B-X
.	B-X

Likewise	O
,	O
MOD	O
-	O
mediated	O
IKKgamma	B-Gene_or_gene_product
tetramerization	O
is	O
required	O
to	O
enhance	O
IKKbeta	B-Gene_or_gene_product
kinase	O
activity	O
when	O
overexpressed	O
in	O
293	O
cells	O
and	O
to	O
reconstitute	O
a	O
lipopolysaccharide	O
-	O
responsive	O
IKK	O
complex	O
in	O
pre	O
-	O
B	O
cells	O
.	O
<EOS>	B-X
The	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
mediates	B-X
activation	B-X
of	B-X
transcription	B-X
factor	B-X
NF-kappaB	B-X
by	B-X
phosphorylation	B-X
of	B-X
IkappaB	B-X
proteins	B-X
.	B-X
Its	B-X
catalytic	B-X
subunits	B-X
,	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
,	B-X
require	B-X
association	B-X
with	B-X
the	B-X
regulatory	B-X
IKKgamma	B-X
(	B-X
NEMO	B-X
)	B-X
component	B-X
to	B-X
gain	B-X
full	B-X
basal	B-X
and	B-X
inducible	B-X
kinase	B-X
activity	B-X
.	B-X
However	B-X
,	B-X
the	B-X
oligomeric	B-X
composition	B-X
of	B-X
the	B-X
IKK	B-X
complex	B-X
and	B-X
its	B-X
regulation	B-X
by	B-X
IKKgamma	B-X
are	B-X
poorly	B-X
understood	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
IKKgamma	B-X
predominantly	B-X
forms	B-X
tetramers	B-X
and	B-X
interacts	B-X
with	B-X
IKKalpha	B-X
or	B-X
IKKbeta	B-X
in	B-X
this	B-X
state	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
tetramerization	B-X
is	B-X
accomplished	B-X
by	B-X
a	B-X
prerequisite	B-X
dimerization	B-X
through	B-X
a	B-X
C-terminal	B-X
coiled-coil	B-X
minimal	B-X
oligomerization	B-X
domain	B-X
(	B-X
MOD	B-X
)	B-X
.	B-X
Tetrameric	B-X
IKKgamma	B-X
sequesters	B-X
four	B-X
kinase	B-X
molecules	B-X
,	B-X
yielding	B-X
a	B-X
gamma	B-X
(	B-X
4	B-X
)	B-X
(	B-X
alpha/beta	B-X
)	B-X
(	B-X
4	B-X
)	B-X
stoichiometry	B-X
.	B-X
Deletion	B-X
of	B-X
the	B-X
MOD	B-X
leads	B-X
to	B-X
loss	B-X
of	B-X
tetramerization	B-X
and	B-X
of	B-X
phosphorylation	B-X
of	B-X
IKKbeta	B-X
and	B-X
IKKgamma	B-X
,	B-X
although	B-X
the	B-X
kinase	B-X
can	B-X
still	B-X
interact	B-X
with	B-X
the	B-X
resultant	B-X
IKKgamma	B-X
monomers	B-X
and	B-X
dimers	B-X
.	B-X
Likewise	B-X
,	B-X
MOD-mediated	B-X
IKKgamma	B-X
tetramerization	B-X
is	B-X
required	B-X
to	B-X
enhance	B-X
IKKbeta	B-X
kinase	B-X
activity	B-X
when	B-X
overexpressed	B-X
in	B-X
293	B-X
cells	B-X
and	B-X
to	B-X
reconstitute	B-X
a	B-X
lipopolysaccharide-responsive	B-X
IKK	B-X
complex	B-X
in	B-X
pre-B	B-X
cells	B-X
.	B-X
These	B-X
data	B-X
thus	B-X
suggest	B-X
that	B-X
IKKgamma	B-X
tetramerization	B-X
enforces	B-X
a	B-X
spatial	B-X
positioning	B-X
of	B-X
two	B-X
kinase	B-X
dimers	B-X
to	B-X
facilitate	B-X
transautophosphorylation	B-X
and	B-X
activation	B-X
.	B-X

These	O
data	O
thus	O
suggest	O
that	O
IKKgamma	B-Gene_or_gene_product
tetramerization	O
enforces	O
a	O
spatial	O
positioning	O
of	O
two	O
kinase	O
dimers	O
to	O
facilitate	O
transautophosphorylation	O
and	O
activation	O
.	O
<EOS>	B-X
The	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
complex	B-X
mediates	B-X
activation	B-X
of	B-X
transcription	B-X
factor	B-X
NF-kappaB	B-X
by	B-X
phosphorylation	B-X
of	B-X
IkappaB	B-X
proteins	B-X
.	B-X
Its	B-X
catalytic	B-X
subunits	B-X
,	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
,	B-X
require	B-X
association	B-X
with	B-X
the	B-X
regulatory	B-X
IKKgamma	B-X
(	B-X
NEMO	B-X
)	B-X
component	B-X
to	B-X
gain	B-X
full	B-X
basal	B-X
and	B-X
inducible	B-X
kinase	B-X
activity	B-X
.	B-X
However	B-X
,	B-X
the	B-X
oligomeric	B-X
composition	B-X
of	B-X
the	B-X
IKK	B-X
complex	B-X
and	B-X
its	B-X
regulation	B-X
by	B-X
IKKgamma	B-X
are	B-X
poorly	B-X
understood	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
IKKgamma	B-X
predominantly	B-X
forms	B-X
tetramers	B-X
and	B-X
interacts	B-X
with	B-X
IKKalpha	B-X
or	B-X
IKKbeta	B-X
in	B-X
this	B-X
state	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
tetramerization	B-X
is	B-X
accomplished	B-X
by	B-X
a	B-X
prerequisite	B-X
dimerization	B-X
through	B-X
a	B-X
C-terminal	B-X
coiled-coil	B-X
minimal	B-X
oligomerization	B-X
domain	B-X
(	B-X
MOD	B-X
)	B-X
.	B-X
This	B-X
is	B-X
followed	B-X
by	B-X
dimerization	B-X
of	B-X
the	B-X
dimers	B-X
with	B-X
their	B-X
N-terminal	B-X
sequences	B-X
.	B-X
Tetrameric	B-X
IKKgamma	B-X
sequesters	B-X
four	B-X
kinase	B-X
molecules	B-X
,	B-X
yielding	B-X
a	B-X
gamma	B-X
(	B-X
4	B-X
)	B-X
(	B-X
alpha/beta	B-X
)	B-X
(	B-X
4	B-X
)	B-X
stoichiometry	B-X
.	B-X
Deletion	B-X
of	B-X
the	B-X
MOD	B-X
leads	B-X
to	B-X
loss	B-X
of	B-X
tetramerization	B-X
and	B-X
of	B-X
phosphorylation	B-X
of	B-X
IKKbeta	B-X
and	B-X
IKKgamma	B-X
,	B-X
although	B-X
the	B-X
kinase	B-X
can	B-X
still	B-X
interact	B-X
with	B-X
the	B-X
resultant	B-X
IKKgamma	B-X
monomers	B-X
and	B-X
dimers	B-X
.	B-X
Likewise	B-X
,	B-X
MOD-mediated	B-X
IKKgamma	B-X
tetramerization	B-X
is	B-X
required	B-X
to	B-X
enhance	B-X
IKKbeta	B-X
kinase	B-X
activity	B-X
when	B-X
overexpressed	B-X
in	B-X
293	B-X
cells	B-X
and	B-X
to	B-X
reconstitute	B-X
a	B-X
lipopolysaccharide-responsive	B-X
IKK	B-X
complex	B-X
in	B-X
pre-B	B-X
cells	B-X
.	B-X
These	B-X
data	B-X
thus	B-X
suggest	B-X
that	B-X
IKKgamma	B-X
tetramerization	B-X
enforces	B-X
a	B-X
spatial	B-X
positioning	B-X
of	B-X
two	B-X
kinase	B-X
dimers	B-X
to	B-X
facilitate	B-X
transautophosphorylation	B-X
and	B-X
activation	B-X
.	B-X

Biotin	O
uptake	O
by	O
human	O
intestinal	O
and	O
liver	O
epithelial	O
cells	O
:	O
role	O
of	O
the	O
SMVT	B-Gene_or_gene_product
system	O
.	O
<EOS>	B-X
It	B-X
has	B-X
been	B-X
well	B-X
established	B-X
that	B-X
human	B-X
intestinal	B-X
and	B-X
liver	B-X
epithelial	B-X
cells	B-X
transport	B-X
biotin	B-X
via	B-X
an	B-X
Na+-dependent	B-X
carrier-mediated	B-X
mechanism	B-X
.	B-X
The	B-X
sodium-dependent	B-X
multivitamin	B-X
transport	B-X
(	B-X
SMVT	B-X
)	B-X
,	B-X
a	B-X
biotin	B-X
transporter	B-X
,	B-X
is	B-X
expressed	B-X
in	B-X
both	B-X
cell	B-X
types	B-X
.	B-X
However	B-X
,	B-X
the	B-X
relative	B-X
contribution	B-X
of	B-X
SMVT	B-X
toward	B-X
total	B-X
carrier-mediated	B-X
uptake	B-X
of	B-X
physiological	B-X
(	B-X
nanomolar	B-X
)	B-X
concentrations	B-X
of	B-X
biotin	B-X
by	B-X
these	B-X
cells	B-X
is	B-X
not	B-X
clear	B-X
.	B-X
Addressing	B-X
this	B-X
issue	B-X
is	B-X
important	B-X
,	B-X
especially	B-X
in	B-X
light	B-X
of	B-X
the	B-X
recent	B-X
identification	B-X
of	B-X
a	B-X
second	B-X
human	B-X
high-affinity	B-X
biotin	B-X
uptake	B-X
mechanism	B-X
that	B-X
operates	B-X
at	B-X
the	B-X
nanomolar	B-X
range	B-X
.	B-X
Hence	B-X
,	B-X
we	B-X
employed	B-X
a	B-X
physiological	B-X
approach	B-X
of	B-X
characterizing	B-X
biotin	B-X
uptake	B-X
by	B-X
human-derived	B-X
intestinal	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
at	B-X
the	B-X
nanomolar	B-X
concentration	B-X
range	B-X
.	B-X
We	B-X
also	B-X
employed	B-X
a	B-X
molecular	B-X
biology	B-X
approach	B-X
of	B-X
selectively	B-X
silencing	B-X
the	B-X
endogenous	B-X
SMVT	B-X
of	B-X
these	B-X
cells	B-X
with	B-X
specific	B-X
small	B-X
interfering	B-X
RNAs	B-X
(	B-X
siRNAs	B-X
)	B-X
,	B-X
then	B-X
examining	B-X
carrier-mediated	B-X
biotin	B-X
uptake	B-X
.	B-X
The	B-X
results	B-X
showed	B-X
that	B-X
in	B-X
both	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
,	B-X
the	B-X
initial	B-X
rate	B-X
of	B-X
biotin	B-X
uptake	B-X
as	B-X
a	B-X
function	B-X
of	B-X
concentration	B-X
over	B-X
the	B-X
range	B-X
of	B-X
0.1	B-X
to	B-X
50	B-X
nM	B-X
to	B-X
be	B-X
linear	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
addition	B-X
of	B-X
100	B-X
nM	B-X
unlabeled	B-X
biotin	B-X
,	B-X
desthiobiotin	B-X
,	B-X
or	B-X
pantothenic	B-X
acid	B-X
to	B-X
the	B-X
incubation	B-X
medium	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
the	B-X
uptake	B-X
of	B-X
2.6	B-X
nM	B-X
[	B-X
3H	B-X
]	B-X
biotin	B-X
.	B-X
Pretreatment	B-X
of	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
with	B-X
SMVT	B-X
specific	B-X
siRNAs	B-X
substantially	B-X
reduced	B-X
SMVT	B-X
mRNA	B-X
and	B-X
protein	B-X
levels	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
carrier-mediated	B-X
[	B-X
3H	B-X
]	B-X
biotin	B-X
(	B-X
2.6	B-X
nM	B-X
)	B-X
uptake	B-X
by	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
was	B-X
severely	B-X
(	B-X
P	B-X
0.01	B-X
)	B-X
inhibited	B-X
by	B-X
the	B-X
siRNAs	B-X
pretreatment	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
recently	B-X
described	B-X
human	B-X
high-affinity	B-X
biotin	B-X
uptake	B-X
system	B-X
is	B-X
not	B-X
functional	B-X
in	B-X
intestinal	B-X
and	B-X
liver	B-X
epithelial	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
results	B-X
provide	B-X
strong	B-X
evidence	B-X
that	B-X
SMVT	B-X
is	B-X
the	B-X
major	B-X
(	B-X
if	B-X
not	B-X
the	B-X
only	B-X
)	B-X
biotin	B-X
uptake	B-X
system	B-X
that	B-X
operates	B-X
in	B-X
these	B-X
cells	B-X
.	B-X

It	O
has	O
been	O
well	O
established	O
that	O
human	O
intestinal	O
and	O
liver	O
epithelial	O
cells	O
transport	O
biotin	O
via	O
an	O
Na	O
+	O
-	O
dependent	O
carrier	O
-	O
mediated	O
mechanism	O
.	O

The	O
sodium	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
multivitamin	I-Gene_or_gene_product
transport	I-Gene_or_gene_product
(	O
SMVT	B-Gene_or_gene_product
)	O
,	O
a	O
biotin	O
transporter	O
,	O
is	O
expressed	O
in	O
both	O
cell	O
types	O
.	O
<EOS>	B-X
Utilizing	B-X
a	B-X
conditional	B-X
(	B-X
intestinal-specific	B-X
)	B-X
knockout	B-X
(	B-X
cKO	B-X
)	B-X
mouse	B-X
model	B-X
,	B-X
we	B-X
have	B-X
recently	B-X
shown	B-X
that	B-X
the	B-X
sodium-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
(	B-X
SLC5A6	B-X
)	B-X
is	B-X
the	B-X
only	B-X
biotin	B-X
uptake	B-X
system	B-X
that	B-X
operates	B-X
in	B-X
the	B-X
gut	B-X
and	B-X
that	B-X
its	B-X
deletion	B-X
leads	B-X
to	B-X
biotin	B-X
deficiency	B-X
.	B-X
Unexpectedly	B-X
,	B-X
we	B-X
also	B-X
observed	B-X
that	B-X
all	B-X
SMVT-cKO	B-X
mice	B-X
develop	B-X
chronic	B-X
active	B-X
inflammation	B-X
,	B-X
especially	B-X
in	B-X
the	B-X
cecum	B-X
.	B-X
Our	B-X
aim	B-X
here	B-X
was	B-X
to	B-X
examine	B-X
the	B-X
role	B-X
of	B-X
SMVT	B-X
in	B-X
the	B-X
maintenance	B-X
of	B-X
intestinal	B-X
mucosal	B-X
integrity	B-X
[	B-X
permeability	B-X
and	B-X
expression	B-X
of	B-X
tight	B-X
junction	B-X
(	B-X
TJ	B-X
)	B-X
proteins	B-X
]	B-X
.	B-X
Our	B-X
results	B-X
showed	B-X
that	B-X
knocking	B-X
out	B-X
the	B-X
mouse	B-X
intestinal	B-X
SMVT	B-X
is	B-X
associated	B-X
with	B-X
a	B-X
significant	B-X
increase	B-X
in	B-X
gut	B-X
permeability	B-X
and	B-X
with	B-X
changes	B-X
in	B-X
the	B-X
level	B-X
of	B-X
expression	B-X
of	B-X
TJ	B-X
proteins	B-X
.	B-X
To	B-X
determine	B-X
whether	B-X
these	B-X
changes	B-X
are	B-X
related	B-X
to	B-X
the	B-X
state	B-X
of	B-X
biotin	B-X
deficiency	B-X
that	B-X
develops	B-X
in	B-X
SMVT-cKO	B-X
mice	B-X
,	B-X
we	B-X
induced	B-X
(	B-X
by	B-X
dietary	B-X
means	B-X
)	B-X
biotin	B-X
deficiency	B-X
in	B-X
wild-type	B-X
mice	B-X
and	B-X
examined	B-X
its	B-X
effect	B-X
on	B-X
the	B-X
above-mentioned	B-X
parameters	B-X
.	B-X
The	B-X
results	B-X
showed	B-X
that	B-X
dietary-induced	B-X
biotin	B-X
deficiency	B-X
leads	B-X
to	B-X
a	B-X
similar	B-X
development	B-X
of	B-X
chronic	B-X
active	B-X
inflammation	B-X
in	B-X
the	B-X
cecum	B-X
with	B-X
an	B-X
increase	B-X
in	B-X
the	B-X
level	B-X
of	B-X
expression	B-X
of	B-X
proinflammatory	B-X
cytokines	B-X
,	B-X
as	B-X
well	B-X
as	B-X
an	B-X
increase	B-X
in	B-X
intestinal	B-X
permeability	B-X
and	B-X
changes	B-X
in	B-X
the	B-X
level	B-X
of	B-X
expression	B-X
of	B-X
TJ	B-X
proteins	B-X
.	B-X
We	B-X
also	B-X
examined	B-X
the	B-X
effect	B-X
of	B-X
chronic	B-X
biotin	B-X
deficiency	B-X
on	B-X
permeability	B-X
and	B-X
expression	B-X
of	B-X
TJ	B-X
proteins	B-X
in	B-X
confluent	B-X
intestinal	B-X
epithelial	B-X
Caco-2	B-X
monolayers	B-X
but	B-X
observed	B-X
no	B-X
changes	B-X
in	B-X
these	B-X
parameters	B-X
.	B-X
These	B-X
results	B-X
show	B-X
that	B-X
the	B-X
intestinal	B-X
SMVT	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
maintenance	B-X
of	B-X
normal	B-X
mucosal	B-X
integrity	B-X
,	B-X
most	B-X
likely	B-X
via	B-X
its	B-X
role	B-X
in	B-X
providing	B-X
biotin	B-X
to	B-X
different	B-X
cells	B-X
of	B-X
the	B-X
gut	B-X
mucosa	B-X
.	B-X

However	O
,	O
the	O
relative	O
contribution	O
of	O
SMVT	B-Gene_or_gene_product
toward	O
total	O
carrier	O
-	O
mediated	O
uptake	O
of	O
physiological	O
(	O
nanomolar	O
)	O
concentrations	O
of	O
biotin	O
by	O
these	O
cells	O
is	O
not	O
clear	O
.	O

Addressing	O
this	O
issue	O
is	O
important	O
,	O
especially	O
in	O
light	O
of	O
the	O
recent	O
identification	O
of	O
a	O
second	O
human	O
high	O
-	O
affinity	O
biotin	O
uptake	O
mechanism	O
that	O
operates	O
at	O
the	O
nanomolar	O
range	O
.	O
<EOS>	B-X
It	B-X
has	B-X
been	B-X
well	B-X
established	B-X
that	B-X
human	B-X
intestinal	B-X
and	B-X
liver	B-X
epithelial	B-X
cells	B-X
transport	B-X
biotin	B-X
via	B-X
an	B-X
Na+-dependent	B-X
carrier-mediated	B-X
mechanism	B-X
.	B-X
The	B-X
sodium-dependent	B-X
multivitamin	B-X
transport	B-X
(	B-X
SMVT	B-X
)	B-X
,	B-X
a	B-X
biotin	B-X
transporter	B-X
,	B-X
is	B-X
expressed	B-X
in	B-X
both	B-X
cell	B-X
types	B-X
.	B-X
However	B-X
,	B-X
the	B-X
relative	B-X
contribution	B-X
of	B-X
SMVT	B-X
toward	B-X
total	B-X
carrier-mediated	B-X
uptake	B-X
of	B-X
physiological	B-X
(	B-X
nanomolar	B-X
)	B-X
concentrations	B-X
of	B-X
biotin	B-X
by	B-X
these	B-X
cells	B-X
is	B-X
not	B-X
clear	B-X
.	B-X
Addressing	B-X
this	B-X
issue	B-X
is	B-X
important	B-X
,	B-X
especially	B-X
in	B-X
light	B-X
of	B-X
the	B-X
recent	B-X
identification	B-X
of	B-X
a	B-X
second	B-X
human	B-X
high-affinity	B-X
biotin	B-X
uptake	B-X
mechanism	B-X
that	B-X
operates	B-X
at	B-X
the	B-X
nanomolar	B-X
range	B-X
.	B-X
Hence	B-X
,	B-X
we	B-X
employed	B-X
a	B-X
physiological	B-X
approach	B-X
of	B-X
characterizing	B-X
biotin	B-X
uptake	B-X
by	B-X
human-derived	B-X
intestinal	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
at	B-X
the	B-X
nanomolar	B-X
concentration	B-X
range	B-X
.	B-X
We	B-X
also	B-X
employed	B-X
a	B-X
molecular	B-X
biology	B-X
approach	B-X
of	B-X
selectively	B-X
silencing	B-X
the	B-X
endogenous	B-X
SMVT	B-X
of	B-X
these	B-X
cells	B-X
with	B-X
specific	B-X
small	B-X
interfering	B-X
RNAs	B-X
(	B-X
siRNAs	B-X
)	B-X
,	B-X
then	B-X
examining	B-X
carrier-mediated	B-X
biotin	B-X
uptake	B-X
.	B-X
The	B-X
results	B-X
showed	B-X
that	B-X
in	B-X
both	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
,	B-X
the	B-X
initial	B-X
rate	B-X
of	B-X
biotin	B-X
uptake	B-X
as	B-X
a	B-X
function	B-X
of	B-X
concentration	B-X
over	B-X
the	B-X
range	B-X
of	B-X
0.1	B-X
to	B-X
50	B-X
nM	B-X
to	B-X
be	B-X
linear	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
addition	B-X
of	B-X
100	B-X
nM	B-X
unlabeled	B-X
biotin	B-X
,	B-X
desthiobiotin	B-X
,	B-X
or	B-X
pantothenic	B-X
acid	B-X
to	B-X
the	B-X
incubation	B-X
medium	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
the	B-X
uptake	B-X
of	B-X
2.6	B-X
nM	B-X
[	B-X
3H	B-X
]	B-X
biotin	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
carrier-mediated	B-X
[	B-X
3H	B-X
]	B-X
biotin	B-X
(	B-X
2.6	B-X
nM	B-X
)	B-X
uptake	B-X
by	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
was	B-X
severely	B-X
(	B-X
P	B-X
0.01	B-X
)	B-X
inhibited	B-X
by	B-X
the	B-X
siRNAs	B-X
pretreatment	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
recently	B-X
described	B-X
human	B-X
high-affinity	B-X
biotin	B-X
uptake	B-X
system	B-X
is	B-X
not	B-X
functional	B-X
in	B-X
intestinal	B-X
and	B-X
liver	B-X
epithelial	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
results	B-X
provide	B-X
strong	B-X
evidence	B-X
that	B-X
SMVT	B-X
is	B-X
the	B-X
major	B-X
(	B-X
if	B-X
not	B-X
the	B-X
only	B-X
)	B-X
biotin	B-X
uptake	B-X
system	B-X
that	B-X
operates	B-X
in	B-X
these	B-X
cells	B-X
.	B-X

Hence	O
,	O
we	O
employed	O
a	O
physiological	O
approach	O
of	O
characterizing	O
biotin	O
uptake	O
by	O
human	O
-	O
derived	O
intestinal	O
Caco	O
-	O
2	O
and	O
HepG2	O
cells	O
at	O
the	O
nanomolar	O
concentration	O
range	O
.	O
<EOS>	B-X
It	B-X
has	B-X
been	B-X
well	B-X
established	B-X
that	B-X
human	B-X
intestinal	B-X
and	B-X
liver	B-X
epithelial	B-X
cells	B-X
transport	B-X
biotin	B-X
via	B-X
an	B-X
Na+-dependent	B-X
carrier-mediated	B-X
mechanism	B-X
.	B-X
The	B-X
sodium-dependent	B-X
multivitamin	B-X
transport	B-X
(	B-X
SMVT	B-X
)	B-X
,	B-X
a	B-X
biotin	B-X
transporter	B-X
,	B-X
is	B-X
expressed	B-X
in	B-X
both	B-X
cell	B-X
types	B-X
.	B-X
However	B-X
,	B-X
the	B-X
relative	B-X
contribution	B-X
of	B-X
SMVT	B-X
toward	B-X
total	B-X
carrier-mediated	B-X
uptake	B-X
of	B-X
physiological	B-X
(	B-X
nanomolar	B-X
)	B-X
concentrations	B-X
of	B-X
biotin	B-X
by	B-X
these	B-X
cells	B-X
is	B-X
not	B-X
clear	B-X
.	B-X
Addressing	B-X
this	B-X
issue	B-X
is	B-X
important	B-X
,	B-X
especially	B-X
in	B-X
light	B-X
of	B-X
the	B-X
recent	B-X
identification	B-X
of	B-X
a	B-X
second	B-X
human	B-X
high-affinity	B-X
biotin	B-X
uptake	B-X
mechanism	B-X
that	B-X
operates	B-X
at	B-X
the	B-X
nanomolar	B-X
range	B-X
.	B-X
Hence	B-X
,	B-X
we	B-X
employed	B-X
a	B-X
physiological	B-X
approach	B-X
of	B-X
characterizing	B-X
biotin	B-X
uptake	B-X
by	B-X
human-derived	B-X
intestinal	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
at	B-X
the	B-X
nanomolar	B-X
concentration	B-X
range	B-X
.	B-X
We	B-X
also	B-X
employed	B-X
a	B-X
molecular	B-X
biology	B-X
approach	B-X
of	B-X
selectively	B-X
silencing	B-X
the	B-X
endogenous	B-X
SMVT	B-X
of	B-X
these	B-X
cells	B-X
with	B-X
specific	B-X
small	B-X
interfering	B-X
RNAs	B-X
(	B-X
siRNAs	B-X
)	B-X
,	B-X
then	B-X
examining	B-X
carrier-mediated	B-X
biotin	B-X
uptake	B-X
.	B-X
The	B-X
results	B-X
showed	B-X
that	B-X
in	B-X
both	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
,	B-X
the	B-X
initial	B-X
rate	B-X
of	B-X
biotin	B-X
uptake	B-X
as	B-X
a	B-X
function	B-X
of	B-X
concentration	B-X
over	B-X
the	B-X
range	B-X
of	B-X
0.1	B-X
to	B-X
50	B-X
nM	B-X
to	B-X
be	B-X
linear	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
addition	B-X
of	B-X
100	B-X
nM	B-X
unlabeled	B-X
biotin	B-X
,	B-X
desthiobiotin	B-X
,	B-X
or	B-X
pantothenic	B-X
acid	B-X
to	B-X
the	B-X
incubation	B-X
medium	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
the	B-X
uptake	B-X
of	B-X
2.6	B-X
nM	B-X
[	B-X
3H	B-X
]	B-X
biotin	B-X
.	B-X
Pretreatment	B-X
of	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
with	B-X
SMVT	B-X
specific	B-X
siRNAs	B-X
substantially	B-X
reduced	B-X
SMVT	B-X
mRNA	B-X
and	B-X
protein	B-X
levels	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
carrier-mediated	B-X
[	B-X
3H	B-X
]	B-X
biotin	B-X
(	B-X
2.6	B-X
nM	B-X
)	B-X
uptake	B-X
by	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
was	B-X
severely	B-X
(	B-X
P	B-X
0.01	B-X
)	B-X
inhibited	B-X
by	B-X
the	B-X
siRNAs	B-X
pretreatment	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
recently	B-X
described	B-X
human	B-X
high-affinity	B-X
biotin	B-X
uptake	B-X
system	B-X
is	B-X
not	B-X
functional	B-X
in	B-X
intestinal	B-X
and	B-X
liver	B-X
epithelial	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
results	B-X
provide	B-X
strong	B-X
evidence	B-X
that	B-X
SMVT	B-X
is	B-X
the	B-X
major	B-X
(	B-X
if	B-X
not	B-X
the	B-X
only	B-X
)	B-X
biotin	B-X
uptake	B-X
system	B-X
that	B-X
operates	B-X
in	B-X
these	B-X
cells	B-X
.	B-X

We	O
also	O
employed	O
a	O
molecular	O
biology	O
approach	O
of	O
selectively	O
silencing	O
the	O
endogenous	O
SMVT	B-Gene_or_gene_product
of	O
these	O
cells	O
with	O
specific	O
small	O
interfering	O
RNAs	O
(	O
siRNAs	O
)	O
,	O
then	O
examining	O
carrier	O
-	O
mediated	O
biotin	O
uptake	O
.	O
<EOS>	B-X
It	B-X
has	B-X
been	B-X
well	B-X
established	B-X
that	B-X
human	B-X
intestinal	B-X
and	B-X
liver	B-X
epithelial	B-X
cells	B-X
transport	B-X
biotin	B-X
via	B-X
an	B-X
Na+-dependent	B-X
carrier-mediated	B-X
mechanism	B-X
.	B-X
The	B-X
sodium-dependent	B-X
multivitamin	B-X
transport	B-X
(	B-X
SMVT	B-X
)	B-X
,	B-X
a	B-X
biotin	B-X
transporter	B-X
,	B-X
is	B-X
expressed	B-X
in	B-X
both	B-X
cell	B-X
types	B-X
.	B-X
However	B-X
,	B-X
the	B-X
relative	B-X
contribution	B-X
of	B-X
SMVT	B-X
toward	B-X
total	B-X
carrier-mediated	B-X
uptake	B-X
of	B-X
physiological	B-X
(	B-X
nanomolar	B-X
)	B-X
concentrations	B-X
of	B-X
biotin	B-X
by	B-X
these	B-X
cells	B-X
is	B-X
not	B-X
clear	B-X
.	B-X
Addressing	B-X
this	B-X
issue	B-X
is	B-X
important	B-X
,	B-X
especially	B-X
in	B-X
light	B-X
of	B-X
the	B-X
recent	B-X
identification	B-X
of	B-X
a	B-X
second	B-X
human	B-X
high-affinity	B-X
biotin	B-X
uptake	B-X
mechanism	B-X
that	B-X
operates	B-X
at	B-X
the	B-X
nanomolar	B-X
range	B-X
.	B-X
Hence	B-X
,	B-X
we	B-X
employed	B-X
a	B-X
physiological	B-X
approach	B-X
of	B-X
characterizing	B-X
biotin	B-X
uptake	B-X
by	B-X
human-derived	B-X
intestinal	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
at	B-X
the	B-X
nanomolar	B-X
concentration	B-X
range	B-X
.	B-X
We	B-X
also	B-X
employed	B-X
a	B-X
molecular	B-X
biology	B-X
approach	B-X
of	B-X
selectively	B-X
silencing	B-X
the	B-X
endogenous	B-X
SMVT	B-X
of	B-X
these	B-X
cells	B-X
with	B-X
specific	B-X
small	B-X
interfering	B-X
RNAs	B-X
(	B-X
siRNAs	B-X
)	B-X
,	B-X
then	B-X
examining	B-X
carrier-mediated	B-X
biotin	B-X
uptake	B-X
.	B-X
The	B-X
results	B-X
showed	B-X
that	B-X
in	B-X
both	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
,	B-X
the	B-X
initial	B-X
rate	B-X
of	B-X
biotin	B-X
uptake	B-X
as	B-X
a	B-X
function	B-X
of	B-X
concentration	B-X
over	B-X
the	B-X
range	B-X
of	B-X
0.1	B-X
to	B-X
50	B-X
nM	B-X
to	B-X
be	B-X
linear	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
addition	B-X
of	B-X
100	B-X
nM	B-X
unlabeled	B-X
biotin	B-X
,	B-X
desthiobiotin	B-X
,	B-X
or	B-X
pantothenic	B-X
acid	B-X
to	B-X
the	B-X
incubation	B-X
medium	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
the	B-X
uptake	B-X
of	B-X
2.6	B-X
nM	B-X
[	B-X
3H	B-X
]	B-X
biotin	B-X
.	B-X
Pretreatment	B-X
of	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
with	B-X
SMVT	B-X
specific	B-X
siRNAs	B-X
substantially	B-X
reduced	B-X
SMVT	B-X
mRNA	B-X
and	B-X
protein	B-X
levels	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
carrier-mediated	B-X
[	B-X
3H	B-X
]	B-X
biotin	B-X
(	B-X
2.6	B-X
nM	B-X
)	B-X
uptake	B-X
by	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
was	B-X
severely	B-X
(	B-X
P	B-X
0.01	B-X
)	B-X
inhibited	B-X
by	B-X
the	B-X
siRNAs	B-X
pretreatment	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
recently	B-X
described	B-X
human	B-X
high-affinity	B-X
biotin	B-X
uptake	B-X
system	B-X
is	B-X
not	B-X
functional	B-X
in	B-X
intestinal	B-X
and	B-X
liver	B-X
epithelial	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
results	B-X
provide	B-X
strong	B-X
evidence	B-X
that	B-X
SMVT	B-X
is	B-X
the	B-X
major	B-X
(	B-X
if	B-X
not	B-X
the	B-X
only	B-X
)	B-X
biotin	B-X
uptake	B-X
system	B-X
that	B-X
operates	B-X
in	B-X
these	B-X
cells	B-X
.	B-X

The	O
results	O
showed	O
that	O
in	O
both	O
Caco	O
-	O
2	O
and	O
HepG2	O
cells	O
,	O
the	O
initial	O
rate	O
of	O
biotin	O
uptake	O
as	O
a	O
function	O
of	O
concentration	O
over	O
the	O
range	O
of	O
0	O
.	O
1	O
to	O
50	O
nM	O
to	O
be	O
linear	O
.	O

Furthermore	O
,	O
we	O
found	O
that	O
the	O
addition	O
of	O
100	O
nM	O
unlabeled	O
biotin	O
,	O
desthiobiotin	O
,	O
or	O
pantothenic	O
acid	O
to	O
the	O
incubation	O
medium	O
had	O
no	O
effect	O
on	O
the	O
uptake	O
of	O
2	O
.	O
6	O
nM	O
[	O
3H	O
]	O
biotin	O
.	O
<EOS>	B-X
It	B-X
has	B-X
been	B-X
well	B-X
established	B-X
that	B-X
human	B-X
intestinal	B-X
and	B-X
liver	B-X
epithelial	B-X
cells	B-X
transport	B-X
biotin	B-X
via	B-X
an	B-X
Na+-dependent	B-X
carrier-mediated	B-X
mechanism	B-X
.	B-X
The	B-X
sodium-dependent	B-X
multivitamin	B-X
transport	B-X
(	B-X
SMVT	B-X
)	B-X
,	B-X
a	B-X
biotin	B-X
transporter	B-X
,	B-X
is	B-X
expressed	B-X
in	B-X
both	B-X
cell	B-X
types	B-X
.	B-X
However	B-X
,	B-X
the	B-X
relative	B-X
contribution	B-X
of	B-X
SMVT	B-X
toward	B-X
total	B-X
carrier-mediated	B-X
uptake	B-X
of	B-X
physiological	B-X
(	B-X
nanomolar	B-X
)	B-X
concentrations	B-X
of	B-X
biotin	B-X
by	B-X
these	B-X
cells	B-X
is	B-X
not	B-X
clear	B-X
.	B-X
Addressing	B-X
this	B-X
issue	B-X
is	B-X
important	B-X
,	B-X
especially	B-X
in	B-X
light	B-X
of	B-X
the	B-X
recent	B-X
identification	B-X
of	B-X
a	B-X
second	B-X
human	B-X
high-affinity	B-X
biotin	B-X
uptake	B-X
mechanism	B-X
that	B-X
operates	B-X
at	B-X
the	B-X
nanomolar	B-X
range	B-X
.	B-X
Hence	B-X
,	B-X
we	B-X
employed	B-X
a	B-X
physiological	B-X
approach	B-X
of	B-X
characterizing	B-X
biotin	B-X
uptake	B-X
by	B-X
human-derived	B-X
intestinal	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
at	B-X
the	B-X
nanomolar	B-X
concentration	B-X
range	B-X
.	B-X
We	B-X
also	B-X
employed	B-X
a	B-X
molecular	B-X
biology	B-X
approach	B-X
of	B-X
selectively	B-X
silencing	B-X
the	B-X
endogenous	B-X
SMVT	B-X
of	B-X
these	B-X
cells	B-X
with	B-X
specific	B-X
small	B-X
interfering	B-X
RNAs	B-X
(	B-X
siRNAs	B-X
)	B-X
,	B-X
then	B-X
examining	B-X
carrier-mediated	B-X
biotin	B-X
uptake	B-X
.	B-X
The	B-X
results	B-X
showed	B-X
that	B-X
in	B-X
both	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
,	B-X
the	B-X
initial	B-X
rate	B-X
of	B-X
biotin	B-X
uptake	B-X
as	B-X
a	B-X
function	B-X
of	B-X
concentration	B-X
over	B-X
the	B-X
range	B-X
of	B-X
0.1	B-X
to	B-X
50	B-X
nM	B-X
to	B-X
be	B-X
linear	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
addition	B-X
of	B-X
100	B-X
nM	B-X
unlabeled	B-X
biotin	B-X
,	B-X
desthiobiotin	B-X
,	B-X
or	B-X
pantothenic	B-X
acid	B-X
to	B-X
the	B-X
incubation	B-X
medium	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
the	B-X
uptake	B-X
of	B-X
2.6	B-X
nM	B-X
[	B-X
3H	B-X
]	B-X
biotin	B-X
.	B-X
Pretreatment	B-X
of	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
with	B-X
SMVT	B-X
specific	B-X
siRNAs	B-X
substantially	B-X
reduced	B-X
SMVT	B-X
mRNA	B-X
and	B-X
protein	B-X
levels	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
carrier-mediated	B-X
[	B-X
3H	B-X
]	B-X
biotin	B-X
(	B-X
2.6	B-X
nM	B-X
)	B-X
uptake	B-X
by	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
was	B-X
severely	B-X
(	B-X
P	B-X
0.01	B-X
)	B-X
inhibited	B-X
by	B-X
the	B-X
siRNAs	B-X
pretreatment	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
recently	B-X
described	B-X
human	B-X
high-affinity	B-X
biotin	B-X
uptake	B-X
system	B-X
is	B-X
not	B-X
functional	B-X
in	B-X
intestinal	B-X
and	B-X
liver	B-X
epithelial	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
results	B-X
provide	B-X
strong	B-X
evidence	B-X
that	B-X
SMVT	B-X
is	B-X
the	B-X
major	B-X
(	B-X
if	B-X
not	B-X
the	B-X
only	B-X
)	B-X
biotin	B-X
uptake	B-X
system	B-X
that	B-X
operates	B-X
in	B-X
these	B-X
cells	B-X
.	B-X

Pretreatment	O
of	O
Caco	O
-	O
2	O
and	O
HepG2	O
cells	O
with	O
SMVT	B-Gene_or_gene_product
specific	O
siRNAs	O
substantially	O
reduced	O
SMVT	B-Gene_or_gene_product
mRNA	O
and	O
protein	O
levels	O
.	O
<EOS>	B-X
It	B-X
has	B-X
been	B-X
well	B-X
established	B-X
that	B-X
human	B-X
intestinal	B-X
and	B-X
liver	B-X
epithelial	B-X
cells	B-X
transport	B-X
biotin	B-X
via	B-X
an	B-X
Na+-dependent	B-X
carrier-mediated	B-X
mechanism	B-X
.	B-X
The	B-X
sodium-dependent	B-X
multivitamin	B-X
transport	B-X
(	B-X
SMVT	B-X
)	B-X
,	B-X
a	B-X
biotin	B-X
transporter	B-X
,	B-X
is	B-X
expressed	B-X
in	B-X
both	B-X
cell	B-X
types	B-X
.	B-X
However	B-X
,	B-X
the	B-X
relative	B-X
contribution	B-X
of	B-X
SMVT	B-X
toward	B-X
total	B-X
carrier-mediated	B-X
uptake	B-X
of	B-X
physiological	B-X
(	B-X
nanomolar	B-X
)	B-X
concentrations	B-X
of	B-X
biotin	B-X
by	B-X
these	B-X
cells	B-X
is	B-X
not	B-X
clear	B-X
.	B-X
Hence	B-X
,	B-X
we	B-X
employed	B-X
a	B-X
physiological	B-X
approach	B-X
of	B-X
characterizing	B-X
biotin	B-X
uptake	B-X
by	B-X
human-derived	B-X
intestinal	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
at	B-X
the	B-X
nanomolar	B-X
concentration	B-X
range	B-X
.	B-X
We	B-X
also	B-X
employed	B-X
a	B-X
molecular	B-X
biology	B-X
approach	B-X
of	B-X
selectively	B-X
silencing	B-X
the	B-X
endogenous	B-X
SMVT	B-X
of	B-X
these	B-X
cells	B-X
with	B-X
specific	B-X
small	B-X
interfering	B-X
RNAs	B-X
(	B-X
siRNAs	B-X
)	B-X
,	B-X
then	B-X
examining	B-X
carrier-mediated	B-X
biotin	B-X
uptake	B-X
.	B-X
The	B-X
results	B-X
showed	B-X
that	B-X
in	B-X
both	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
,	B-X
the	B-X
initial	B-X
rate	B-X
of	B-X
biotin	B-X
uptake	B-X
as	B-X
a	B-X
function	B-X
of	B-X
concentration	B-X
over	B-X
the	B-X
range	B-X
of	B-X
0.1	B-X
to	B-X
50	B-X
nM	B-X
to	B-X
be	B-X
linear	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
addition	B-X
of	B-X
100	B-X
nM	B-X
unlabeled	B-X
biotin	B-X
,	B-X
desthiobiotin	B-X
,	B-X
or	B-X
pantothenic	B-X
acid	B-X
to	B-X
the	B-X
incubation	B-X
medium	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
the	B-X
uptake	B-X
of	B-X
2.6	B-X
nM	B-X
[	B-X
3H	B-X
]	B-X
biotin	B-X
.	B-X
Pretreatment	B-X
of	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
with	B-X
SMVT	B-X
specific	B-X
siRNAs	B-X
substantially	B-X
reduced	B-X
SMVT	B-X
mRNA	B-X
and	B-X
protein	B-X
levels	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
carrier-mediated	B-X
[	B-X
3H	B-X
]	B-X
biotin	B-X
(	B-X
2.6	B-X
nM	B-X
)	B-X
uptake	B-X
by	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
was	B-X
severely	B-X
(	B-X
P	B-X
0.01	B-X
)	B-X
inhibited	B-X
by	B-X
the	B-X
siRNAs	B-X
pretreatment	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
recently	B-X
described	B-X
human	B-X
high-affinity	B-X
biotin	B-X
uptake	B-X
system	B-X
is	B-X
not	B-X
functional	B-X
in	B-X
intestinal	B-X
and	B-X
liver	B-X
epithelial	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
results	B-X
provide	B-X
strong	B-X
evidence	B-X
that	B-X
SMVT	B-X
is	B-X
the	B-X
major	B-X
(	B-X
if	B-X
not	B-X
the	B-X
only	B-X
)	B-X
biotin	B-X
uptake	B-X
system	B-X
that	B-X
operates	B-X
in	B-X
these	B-X
cells	B-X
.	B-X

In	O
addition	O
,	O
carrier	O
-	O
mediated	O
[	O
3H	O
]	O
biotin	O
(	O
2	O
.	O
6	O
nM	O
)	O
uptake	O
by	O
Caco	O
-	O
2	O
and	O
HepG2	O
cells	O
was	O
severely	O
(	O
P	O
0	O
.	O
01	O
)	O
inhibited	O
by	O
the	O
siRNAs	O
pretreatment	O
.	O

These	O
results	O
demonstrate	O
that	O
the	O
recently	O
described	O
human	O
high	O
-	O
affinity	O
biotin	O
uptake	O
system	O
is	O
not	O
functional	O
in	O
intestinal	O
and	O
liver	O
epithelial	O
cells	O
.	O

In	O
addition	O
,	O
the	O
results	O
provide	O
strong	O
evidence	O
that	O
SMVT	B-Gene_or_gene_product
is	O
the	O
major	O
(	O
if	O
not	O
the	O
only	O
)	O
biotin	O
uptake	O
system	O
that	O
operates	O
in	O
these	O
cells	O
.	O
<EOS>	B-X
It	B-X
has	B-X
been	B-X
well	B-X
established	B-X
that	B-X
human	B-X
intestinal	B-X
and	B-X
liver	B-X
epithelial	B-X
cells	B-X
transport	B-X
biotin	B-X
via	B-X
an	B-X
Na+-dependent	B-X
carrier-mediated	B-X
mechanism	B-X
.	B-X
The	B-X
sodium-dependent	B-X
multivitamin	B-X
transport	B-X
(	B-X
SMVT	B-X
)	B-X
,	B-X
a	B-X
biotin	B-X
transporter	B-X
,	B-X
is	B-X
expressed	B-X
in	B-X
both	B-X
cell	B-X
types	B-X
.	B-X
However	B-X
,	B-X
the	B-X
relative	B-X
contribution	B-X
of	B-X
SMVT	B-X
toward	B-X
total	B-X
carrier-mediated	B-X
uptake	B-X
of	B-X
physiological	B-X
(	B-X
nanomolar	B-X
)	B-X
concentrations	B-X
of	B-X
biotin	B-X
by	B-X
these	B-X
cells	B-X
is	B-X
not	B-X
clear	B-X
.	B-X
Addressing	B-X
this	B-X
issue	B-X
is	B-X
important	B-X
,	B-X
especially	B-X
in	B-X
light	B-X
of	B-X
the	B-X
recent	B-X
identification	B-X
of	B-X
a	B-X
second	B-X
human	B-X
high-affinity	B-X
biotin	B-X
uptake	B-X
mechanism	B-X
that	B-X
operates	B-X
at	B-X
the	B-X
nanomolar	B-X
range	B-X
.	B-X
Hence	B-X
,	B-X
we	B-X
employed	B-X
a	B-X
physiological	B-X
approach	B-X
of	B-X
characterizing	B-X
biotin	B-X
uptake	B-X
by	B-X
human-derived	B-X
intestinal	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
at	B-X
the	B-X
nanomolar	B-X
concentration	B-X
range	B-X
.	B-X
We	B-X
also	B-X
employed	B-X
a	B-X
molecular	B-X
biology	B-X
approach	B-X
of	B-X
selectively	B-X
silencing	B-X
the	B-X
endogenous	B-X
SMVT	B-X
of	B-X
these	B-X
cells	B-X
with	B-X
specific	B-X
small	B-X
interfering	B-X
RNAs	B-X
(	B-X
siRNAs	B-X
)	B-X
,	B-X
then	B-X
examining	B-X
carrier-mediated	B-X
biotin	B-X
uptake	B-X
.	B-X
The	B-X
results	B-X
showed	B-X
that	B-X
in	B-X
both	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
,	B-X
the	B-X
initial	B-X
rate	B-X
of	B-X
biotin	B-X
uptake	B-X
as	B-X
a	B-X
function	B-X
of	B-X
concentration	B-X
over	B-X
the	B-X
range	B-X
of	B-X
0.1	B-X
to	B-X
50	B-X
nM	B-X
to	B-X
be	B-X
linear	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
addition	B-X
of	B-X
100	B-X
nM	B-X
unlabeled	B-X
biotin	B-X
,	B-X
desthiobiotin	B-X
,	B-X
or	B-X
pantothenic	B-X
acid	B-X
to	B-X
the	B-X
incubation	B-X
medium	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
the	B-X
uptake	B-X
of	B-X
2.6	B-X
nM	B-X
[	B-X
3H	B-X
]	B-X
biotin	B-X
.	B-X
Pretreatment	B-X
of	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
with	B-X
SMVT	B-X
specific	B-X
siRNAs	B-X
substantially	B-X
reduced	B-X
SMVT	B-X
mRNA	B-X
and	B-X
protein	B-X
levels	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
carrier-mediated	B-X
[	B-X
3H	B-X
]	B-X
biotin	B-X
(	B-X
2.6	B-X
nM	B-X
)	B-X
uptake	B-X
by	B-X
Caco-2	B-X
and	B-X
HepG2	B-X
cells	B-X
was	B-X
severely	B-X
(	B-X
P	B-X
0.01	B-X
)	B-X
inhibited	B-X
by	B-X
the	B-X
siRNAs	B-X
pretreatment	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
recently	B-X
described	B-X
human	B-X
high-affinity	B-X
biotin	B-X
uptake	B-X
system	B-X
is	B-X
not	B-X
functional	B-X
in	B-X
intestinal	B-X
and	B-X
liver	B-X
epithelial	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
results	B-X
provide	B-X
strong	B-X
evidence	B-X
that	B-X
SMVT	B-X
is	B-X
the	B-X
major	B-X
(	B-X
if	B-X
not	B-X
the	B-X
only	B-X
)	B-X
biotin	B-X
uptake	B-X
system	B-X
that	B-X
operates	B-X
in	B-X
these	B-X
cells	B-X
.	B-X

Identification	O
of	O
E	O
-	O
box	O
factor	O
TFE3	B-Gene_or_gene_product
as	O
a	O
functional	O
partner	O
for	O
the	O
E2F3	B-Gene_or_gene_product
transcription	O
factor	O
.	O
<EOS>	B-X
Various	B-X
studies	B-X
have	B-X
demonstrated	B-X
a	B-X
role	B-X
for	B-X
E2F	B-X
proteins	B-X
in	B-X
the	B-X
control	B-X
of	B-X
transcription	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
DNA	B-X
replication	B-X
,	B-X
cell	B-X
cycle	B-X
progression	B-X
,	B-X
and	B-X
cell	B-X
fate	B-X
determination	B-X
.	B-X
Although	B-X
it	B-X
is	B-X
clear	B-X
that	B-X
the	B-X
functions	B-X
of	B-X
the	B-X
E2F	B-X
proteins	B-X
overlap	B-X
,	B-X
there	B-X
is	B-X
also	B-X
evidence	B-X
for	B-X
specific	B-X
roles	B-X
for	B-X
individual	B-X
E2F	B-X
proteins	B-X
in	B-X
the	B-X
control	B-X
of	B-X
apoptosis	B-X
and	B-X
cell	B-X
proliferation	B-X
.	B-X
Investigating	B-X
protein	B-X
interactions	B-X
that	B-X
might	B-X
provide	B-X
a	B-X
mechanistic	B-X
basis	B-X
for	B-X
the	B-X
specificity	B-X
of	B-X
E2F	B-X
function	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
E-box	B-X
binding	B-X
factor	B-X
TFE3	B-X
as	B-X
an	B-X
E2F3-specific	B-X
partner	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
marked	B-X
box	B-X
domain	B-X
of	B-X
E2F3	B-X
.	B-X
We	B-X
provide	B-X
evidence	B-X
for	B-X
a	B-X
role	B-X
for	B-X
TFE3	B-X
in	B-X
the	B-X
synergistic	B-X
activation	B-X
of	B-X
the	B-X
p68	B-X
subunit	B-X
gene	B-X
of	B-X
DNA	B-X
polymerase	B-X
alpha	B-X
together	B-X
with	B-X
E2F3	B-X
,	B-X
again	B-X
dependent	B-X
on	B-X
the	B-X
E2F3	B-X
marked	B-X
box	B-X
domain	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
showed	B-X
that	B-X
TFE3	B-X
and	B-X
E2F3	B-X
were	B-X
bound	B-X
to	B-X
the	B-X
p68	B-X
promoter	B-X
in	B-X
vivo	B-X
and	B-X
that	B-X
the	B-X
interaction	B-X
of	B-X
either	B-X
E2F3	B-X
or	B-X
TFE3	B-X
with	B-X
the	B-X
promoter	B-X
was	B-X
facilitated	B-X
by	B-X
the	B-X
presence	B-X
of	B-X
both	B-X
proteins	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
neither	B-X
E2F1	B-X
nor	B-X
E2F2	B-X
interacted	B-X
with	B-X
the	B-X
p68	B-X
promoter	B-X
under	B-X
these	B-X
conditions	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
physical	B-X
interaction	B-X
of	B-X
TFE3	B-X
and	B-X
E2F3	B-X
facilitates	B-X
transcriptional	B-X
activation	B-X
of	B-X
the	B-X
p68	B-X
gene	B-X
and	B-X
provides	B-X
strong	B-X
evidence	B-X
for	B-X
the	B-X
specificity	B-X
of	B-X
E2F	B-X
function	B-X
.	B-X

Various	O
studies	O
have	O
demonstrated	O
a	O
role	O
for	O
E2F	B-Gene_or_gene_product
proteins	O
in	O
the	O
control	O
of	O
transcription	O
of	O
genes	O
involved	O
in	O
DNA	O
replication	O
,	O
cell	O
cycle	O
progression	O
,	O
and	O
cell	O
fate	O
determination	O
.	O
<EOS>	B-X
Various	B-X
studies	B-X
have	B-X
demonstrated	B-X
a	B-X
role	B-X
for	B-X
E2F	B-X
proteins	B-X
in	B-X
the	B-X
control	B-X
of	B-X
transcription	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
DNA	B-X
replication	B-X
,	B-X
cell	B-X
cycle	B-X
progression	B-X
,	B-X
and	B-X
cell	B-X
fate	B-X
determination	B-X
.	B-X
Although	B-X
it	B-X
is	B-X
clear	B-X
that	B-X
the	B-X
functions	B-X
of	B-X
the	B-X
E2F	B-X
proteins	B-X
overlap	B-X
,	B-X
there	B-X
is	B-X
also	B-X
evidence	B-X
for	B-X
specific	B-X
roles	B-X
for	B-X
individual	B-X
E2F	B-X
proteins	B-X
in	B-X
the	B-X
control	B-X
of	B-X
apoptosis	B-X
and	B-X
cell	B-X
proliferation	B-X
.	B-X
Investigating	B-X
protein	B-X
interactions	B-X
that	B-X
might	B-X
provide	B-X
a	B-X
mechanistic	B-X
basis	B-X
for	B-X
the	B-X
specificity	B-X
of	B-X
E2F	B-X
function	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
E-box	B-X
binding	B-X
factor	B-X
TFE3	B-X
as	B-X
an	B-X
E2F3-specific	B-X
partner	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
marked	B-X
box	B-X
domain	B-X
of	B-X
E2F3	B-X
.	B-X
We	B-X
provide	B-X
evidence	B-X
for	B-X
a	B-X
role	B-X
for	B-X
TFE3	B-X
in	B-X
the	B-X
synergistic	B-X
activation	B-X
of	B-X
the	B-X
p68	B-X
subunit	B-X
gene	B-X
of	B-X
DNA	B-X
polymerase	B-X
alpha	B-X
together	B-X
with	B-X
E2F3	B-X
,	B-X
again	B-X
dependent	B-X
on	B-X
the	B-X
E2F3	B-X
marked	B-X
box	B-X
domain	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
showed	B-X
that	B-X
TFE3	B-X
and	B-X
E2F3	B-X
were	B-X
bound	B-X
to	B-X
the	B-X
p68	B-X
promoter	B-X
in	B-X
vivo	B-X
and	B-X
that	B-X
the	B-X
interaction	B-X
of	B-X
either	B-X
E2F3	B-X
or	B-X
TFE3	B-X
with	B-X
the	B-X
promoter	B-X
was	B-X
facilitated	B-X
by	B-X
the	B-X
presence	B-X
of	B-X
both	B-X
proteins	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
neither	B-X
E2F1	B-X
nor	B-X
E2F2	B-X
interacted	B-X
with	B-X
the	B-X
p68	B-X
promoter	B-X
under	B-X
these	B-X
conditions	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
physical	B-X
interaction	B-X
of	B-X
TFE3	B-X
and	B-X
E2F3	B-X
facilitates	B-X
transcriptional	B-X
activation	B-X
of	B-X
the	B-X
p68	B-X
gene	B-X
and	B-X
provides	B-X
strong	B-X
evidence	B-X
for	B-X
the	B-X
specificity	B-X
of	B-X
E2F	B-X
function	B-X
.	B-X

Although	O
it	O
is	O
clear	O
that	O
the	O
functions	O
of	O
the	O
E2F	B-Gene_or_gene_product
proteins	O
overlap	O
,	O
there	O
is	O
also	O
evidence	O
for	O
specific	O
roles	O
for	O
individual	O
E2F	B-Gene_or_gene_product
proteins	O
in	O
the	O
control	O
of	O
apoptosis	O
and	O
cell	O
proliferation	O
.	O
<EOS>	B-X
Various	B-X
studies	B-X
have	B-X
demonstrated	B-X
a	B-X
role	B-X
for	B-X
E2F	B-X
proteins	B-X
in	B-X
the	B-X
control	B-X
of	B-X
transcription	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
DNA	B-X
replication	B-X
,	B-X
cell	B-X
cycle	B-X
progression	B-X
,	B-X
and	B-X
cell	B-X
fate	B-X
determination	B-X
.	B-X
Although	B-X
it	B-X
is	B-X
clear	B-X
that	B-X
the	B-X
functions	B-X
of	B-X
the	B-X
E2F	B-X
proteins	B-X
overlap	B-X
,	B-X
there	B-X
is	B-X
also	B-X
evidence	B-X
for	B-X
specific	B-X
roles	B-X
for	B-X
individual	B-X
E2F	B-X
proteins	B-X
in	B-X
the	B-X
control	B-X
of	B-X
apoptosis	B-X
and	B-X
cell	B-X
proliferation	B-X
.	B-X
Investigating	B-X
protein	B-X
interactions	B-X
that	B-X
might	B-X
provide	B-X
a	B-X
mechanistic	B-X
basis	B-X
for	B-X
the	B-X
specificity	B-X
of	B-X
E2F	B-X
function	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
E-box	B-X
binding	B-X
factor	B-X
TFE3	B-X
as	B-X
an	B-X
E2F3-specific	B-X
partner	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
marked	B-X
box	B-X
domain	B-X
of	B-X
E2F3	B-X
.	B-X
We	B-X
provide	B-X
evidence	B-X
for	B-X
a	B-X
role	B-X
for	B-X
TFE3	B-X
in	B-X
the	B-X
synergistic	B-X
activation	B-X
of	B-X
the	B-X
p68	B-X
subunit	B-X
gene	B-X
of	B-X
DNA	B-X
polymerase	B-X
alpha	B-X
together	B-X
with	B-X
E2F3	B-X
,	B-X
again	B-X
dependent	B-X
on	B-X
the	B-X
E2F3	B-X
marked	B-X
box	B-X
domain	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
showed	B-X
that	B-X
TFE3	B-X
and	B-X
E2F3	B-X
were	B-X
bound	B-X
to	B-X
the	B-X
p68	B-X
promoter	B-X
in	B-X
vivo	B-X
and	B-X
that	B-X
the	B-X
interaction	B-X
of	B-X
either	B-X
E2F3	B-X
or	B-X
TFE3	B-X
with	B-X
the	B-X
promoter	B-X
was	B-X
facilitated	B-X
by	B-X
the	B-X
presence	B-X
of	B-X
both	B-X
proteins	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
neither	B-X
E2F1	B-X
nor	B-X
E2F2	B-X
interacted	B-X
with	B-X
the	B-X
p68	B-X
promoter	B-X
under	B-X
these	B-X
conditions	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
physical	B-X
interaction	B-X
of	B-X
TFE3	B-X
and	B-X
E2F3	B-X
facilitates	B-X
transcriptional	B-X
activation	B-X
of	B-X
the	B-X
p68	B-X
gene	B-X
and	B-X
provides	B-X
strong	B-X
evidence	B-X
for	B-X
the	B-X
specificity	B-X
of	B-X
E2F	B-X
function	B-X
.	B-X

Investigating	O
protein	O
interactions	O
that	O
might	O
provide	O
a	O
mechanistic	O
basis	O
for	O
the	O
specificity	O
of	O
E2F	B-Gene_or_gene_product
function	O
,	O
we	O
identified	O
the	O
E	O
-	O
box	O
binding	O
factor	O
TFE3	B-Gene_or_gene_product
as	O
an	O
E2F3	B-Gene_or_gene_product
-	O
specific	O
partner	O
.	O

We	O
also	O
show	O
that	O
this	O
interaction	O
is	O
dependent	O
on	O
the	O
marked	O
box	O
domain	O
of	O
E2F3	B-Gene_or_gene_product
.	O
<EOS>	B-X
Although	B-X
it	B-X
is	B-X
clear	B-X
that	B-X
the	B-X
functions	B-X
of	B-X
the	B-X
E2F	B-X
proteins	B-X
overlap	B-X
,	B-X
there	B-X
is	B-X
also	B-X
evidence	B-X
for	B-X
specific	B-X
roles	B-X
for	B-X
individual	B-X
E2F	B-X
proteins	B-X
in	B-X
the	B-X
control	B-X
of	B-X
apoptosis	B-X
and	B-X
cell	B-X
proliferation	B-X
.	B-X
Investigating	B-X
protein	B-X
interactions	B-X
that	B-X
might	B-X
provide	B-X
a	B-X
mechanistic	B-X
basis	B-X
for	B-X
the	B-X
specificity	B-X
of	B-X
E2F	B-X
function	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
E-box	B-X
binding	B-X
factor	B-X
TFE3	B-X
as	B-X
an	B-X
E2F3-specific	B-X
partner	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
marked	B-X
box	B-X
domain	B-X
of	B-X
E2F3	B-X
.	B-X
We	B-X
provide	B-X
evidence	B-X
for	B-X
a	B-X
role	B-X
for	B-X
TFE3	B-X
in	B-X
the	B-X
synergistic	B-X
activation	B-X
of	B-X
the	B-X
p68	B-X
subunit	B-X
gene	B-X
of	B-X
DNA	B-X
polymerase	B-X
alpha	B-X
together	B-X
with	B-X
E2F3	B-X
,	B-X
again	B-X
dependent	B-X
on	B-X
the	B-X
E2F3	B-X
marked	B-X
box	B-X
domain	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
showed	B-X
that	B-X
TFE3	B-X
and	B-X
E2F3	B-X
were	B-X
bound	B-X
to	B-X
the	B-X
p68	B-X
promoter	B-X
in	B-X
vivo	B-X
and	B-X
that	B-X
the	B-X
interaction	B-X
of	B-X
either	B-X
E2F3	B-X
or	B-X
TFE3	B-X
with	B-X
the	B-X
promoter	B-X
was	B-X
facilitated	B-X
by	B-X
the	B-X
presence	B-X
of	B-X
both	B-X
proteins	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
physical	B-X
interaction	B-X
of	B-X
TFE3	B-X
and	B-X
E2F3	B-X
facilitates	B-X
transcriptional	B-X
activation	B-X
of	B-X
the	B-X
p68	B-X
gene	B-X
and	B-X
provides	B-X
strong	B-X
evidence	B-X
for	B-X
the	B-X
specificity	B-X
of	B-X
E2F	B-X
function	B-X
.	B-X

We	O
provide	O
evidence	O
for	O
a	O
role	O
for	O
TFE3	B-Gene_or_gene_product
in	O
the	O
synergistic	O
activation	O
of	O
the	O
p68	B-Gene_or_gene_product
subunit	O
gene	O
of	O
DNA	O
polymerase	O
alpha	O
together	O
with	O
E2F3	B-Gene_or_gene_product
,	O
again	O
dependent	O
on	O
the	O
E2F3	B-Gene_or_gene_product
marked	O
box	O
domain	O
.	O
<EOS>	B-X
Various	B-X
studies	B-X
have	B-X
demonstrated	B-X
a	B-X
role	B-X
for	B-X
E2F	B-X
proteins	B-X
in	B-X
the	B-X
control	B-X
of	B-X
transcription	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
DNA	B-X
replication	B-X
,	B-X
cell	B-X
cycle	B-X
progression	B-X
,	B-X
and	B-X
cell	B-X
fate	B-X
determination	B-X
.	B-X
Although	B-X
it	B-X
is	B-X
clear	B-X
that	B-X
the	B-X
functions	B-X
of	B-X
the	B-X
E2F	B-X
proteins	B-X
overlap	B-X
,	B-X
there	B-X
is	B-X
also	B-X
evidence	B-X
for	B-X
specific	B-X
roles	B-X
for	B-X
individual	B-X
E2F	B-X
proteins	B-X
in	B-X
the	B-X
control	B-X
of	B-X
apoptosis	B-X
and	B-X
cell	B-X
proliferation	B-X
.	B-X
Investigating	B-X
protein	B-X
interactions	B-X
that	B-X
might	B-X
provide	B-X
a	B-X
mechanistic	B-X
basis	B-X
for	B-X
the	B-X
specificity	B-X
of	B-X
E2F	B-X
function	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
E-box	B-X
binding	B-X
factor	B-X
TFE3	B-X
as	B-X
an	B-X
E2F3-specific	B-X
partner	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
marked	B-X
box	B-X
domain	B-X
of	B-X
E2F3	B-X
.	B-X
We	B-X
provide	B-X
evidence	B-X
for	B-X
a	B-X
role	B-X
for	B-X
TFE3	B-X
in	B-X
the	B-X
synergistic	B-X
activation	B-X
of	B-X
the	B-X
p68	B-X
subunit	B-X
gene	B-X
of	B-X
DNA	B-X
polymerase	B-X
alpha	B-X
together	B-X
with	B-X
E2F3	B-X
,	B-X
again	B-X
dependent	B-X
on	B-X
the	B-X
E2F3	B-X
marked	B-X
box	B-X
domain	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
showed	B-X
that	B-X
TFE3	B-X
and	B-X
E2F3	B-X
were	B-X
bound	B-X
to	B-X
the	B-X
p68	B-X
promoter	B-X
in	B-X
vivo	B-X
and	B-X
that	B-X
the	B-X
interaction	B-X
of	B-X
either	B-X
E2F3	B-X
or	B-X
TFE3	B-X
with	B-X
the	B-X
promoter	B-X
was	B-X
facilitated	B-X
by	B-X
the	B-X
presence	B-X
of	B-X
both	B-X
proteins	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
neither	B-X
E2F1	B-X
nor	B-X
E2F2	B-X
interacted	B-X
with	B-X
the	B-X
p68	B-X
promoter	B-X
under	B-X
these	B-X
conditions	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
physical	B-X
interaction	B-X
of	B-X
TFE3	B-X
and	B-X
E2F3	B-X
facilitates	B-X
transcriptional	B-X
activation	B-X
of	B-X
the	B-X
p68	B-X
gene	B-X
and	B-X
provides	B-X
strong	B-X
evidence	B-X
for	B-X
the	B-X
specificity	B-X
of	B-X
E2F	B-X
function	B-X
.	B-X

Chromatin	O
immunoprecipitation	O
assays	O
showed	O
that	O
TFE3	B-Gene_or_gene_product
and	O
E2F3	B-Gene_or_gene_product
were	O
bound	O
to	O
the	O
p68	B-Gene_or_gene_product
promoter	O
in	O
vivo	O
and	O
that	O
the	O
interaction	O
of	O
either	O
E2F3	B-Gene_or_gene_product
or	O
TFE3	B-Gene_or_gene_product
with	O
the	O
promoter	O
was	O
facilitated	O
by	O
the	O
presence	O
of	O
both	O
proteins	O
.	O
<EOS>	B-X
Various	B-X
studies	B-X
have	B-X
demonstrated	B-X
a	B-X
role	B-X
for	B-X
E2F	B-X
proteins	B-X
in	B-X
the	B-X
control	B-X
of	B-X
transcription	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
DNA	B-X
replication	B-X
,	B-X
cell	B-X
cycle	B-X
progression	B-X
,	B-X
and	B-X
cell	B-X
fate	B-X
determination	B-X
.	B-X
Although	B-X
it	B-X
is	B-X
clear	B-X
that	B-X
the	B-X
functions	B-X
of	B-X
the	B-X
E2F	B-X
proteins	B-X
overlap	B-X
,	B-X
there	B-X
is	B-X
also	B-X
evidence	B-X
for	B-X
specific	B-X
roles	B-X
for	B-X
individual	B-X
E2F	B-X
proteins	B-X
in	B-X
the	B-X
control	B-X
of	B-X
apoptosis	B-X
and	B-X
cell	B-X
proliferation	B-X
.	B-X
Investigating	B-X
protein	B-X
interactions	B-X
that	B-X
might	B-X
provide	B-X
a	B-X
mechanistic	B-X
basis	B-X
for	B-X
the	B-X
specificity	B-X
of	B-X
E2F	B-X
function	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
E-box	B-X
binding	B-X
factor	B-X
TFE3	B-X
as	B-X
an	B-X
E2F3-specific	B-X
partner	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
marked	B-X
box	B-X
domain	B-X
of	B-X
E2F3	B-X
.	B-X
We	B-X
provide	B-X
evidence	B-X
for	B-X
a	B-X
role	B-X
for	B-X
TFE3	B-X
in	B-X
the	B-X
synergistic	B-X
activation	B-X
of	B-X
the	B-X
p68	B-X
subunit	B-X
gene	B-X
of	B-X
DNA	B-X
polymerase	B-X
alpha	B-X
together	B-X
with	B-X
E2F3	B-X
,	B-X
again	B-X
dependent	B-X
on	B-X
the	B-X
E2F3	B-X
marked	B-X
box	B-X
domain	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
showed	B-X
that	B-X
TFE3	B-X
and	B-X
E2F3	B-X
were	B-X
bound	B-X
to	B-X
the	B-X
p68	B-X
promoter	B-X
in	B-X
vivo	B-X
and	B-X
that	B-X
the	B-X
interaction	B-X
of	B-X
either	B-X
E2F3	B-X
or	B-X
TFE3	B-X
with	B-X
the	B-X
promoter	B-X
was	B-X
facilitated	B-X
by	B-X
the	B-X
presence	B-X
of	B-X
both	B-X
proteins	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
neither	B-X
E2F1	B-X
nor	B-X
E2F2	B-X
interacted	B-X
with	B-X
the	B-X
p68	B-X
promoter	B-X
under	B-X
these	B-X
conditions	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
physical	B-X
interaction	B-X
of	B-X
TFE3	B-X
and	B-X
E2F3	B-X
facilitates	B-X
transcriptional	B-X
activation	B-X
of	B-X
the	B-X
p68	B-X
gene	B-X
and	B-X
provides	B-X
strong	B-X
evidence	B-X
for	B-X
the	B-X
specificity	B-X
of	B-X
E2F	B-X
function	B-X
.	B-X

In	O
contrast	O
,	O
neither	O
E2F1	B-Gene_or_gene_product
nor	O
E2F2	B-Gene_or_gene_product
interacted	O
with	O
the	O
p68	B-Gene_or_gene_product
promoter	O
under	O
these	O
conditions	O
.	O
<EOS>	B-X
We	B-X
provide	B-X
evidence	B-X
for	B-X
a	B-X
role	B-X
for	B-X
TFE3	B-X
in	B-X
the	B-X
synergistic	B-X
activation	B-X
of	B-X
the	B-X
p68	B-X
subunit	B-X
gene	B-X
of	B-X
DNA	B-X
polymerase	B-X
alpha	B-X
together	B-X
with	B-X
E2F3	B-X
,	B-X
again	B-X
dependent	B-X
on	B-X
the	B-X
E2F3	B-X
marked	B-X
box	B-X
domain	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
showed	B-X
that	B-X
TFE3	B-X
and	B-X
E2F3	B-X
were	B-X
bound	B-X
to	B-X
the	B-X
p68	B-X
promoter	B-X
in	B-X
vivo	B-X
and	B-X
that	B-X
the	B-X
interaction	B-X
of	B-X
either	B-X
E2F3	B-X
or	B-X
TFE3	B-X
with	B-X
the	B-X
promoter	B-X
was	B-X
facilitated	B-X
by	B-X
the	B-X
presence	B-X
of	B-X
both	B-X
proteins	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
neither	B-X
E2F1	B-X
nor	B-X
E2F2	B-X
interacted	B-X
with	B-X
the	B-X
p68	B-X
promoter	B-X
under	B-X
these	B-X
conditions	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
physical	B-X
interaction	B-X
of	B-X
TFE3	B-X
and	B-X
E2F3	B-X
facilitates	B-X
transcriptional	B-X
activation	B-X
of	B-X
the	B-X
p68	B-X
gene	B-X
and	B-X
provides	B-X
strong	B-X
evidence	B-X
for	B-X
the	B-X
specificity	B-X
of	B-X
E2F	B-X
function	B-X
.	B-X

We	O
propose	O
that	O
the	O
physical	O
interaction	O
of	O
TFE3	B-Gene_or_gene_product
and	O
E2F3	B-Gene_or_gene_product
facilitates	O
transcriptional	O
activation	O
of	O
the	O
p68	B-Gene_or_gene_product
gene	O
and	O
provides	O
strong	O
evidence	O
for	O
the	O
specificity	O
of	O
E2F	B-Gene_or_gene_product
function	O
.	O
<EOS>	B-X
Various	B-X
studies	B-X
have	B-X
demonstrated	B-X
a	B-X
role	B-X
for	B-X
E2F	B-X
proteins	B-X
in	B-X
the	B-X
control	B-X
of	B-X
transcription	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
DNA	B-X
replication	B-X
,	B-X
cell	B-X
cycle	B-X
progression	B-X
,	B-X
and	B-X
cell	B-X
fate	B-X
determination	B-X
.	B-X
Although	B-X
it	B-X
is	B-X
clear	B-X
that	B-X
the	B-X
functions	B-X
of	B-X
the	B-X
E2F	B-X
proteins	B-X
overlap	B-X
,	B-X
there	B-X
is	B-X
also	B-X
evidence	B-X
for	B-X
specific	B-X
roles	B-X
for	B-X
individual	B-X
E2F	B-X
proteins	B-X
in	B-X
the	B-X
control	B-X
of	B-X
apoptosis	B-X
and	B-X
cell	B-X
proliferation	B-X
.	B-X
Investigating	B-X
protein	B-X
interactions	B-X
that	B-X
might	B-X
provide	B-X
a	B-X
mechanistic	B-X
basis	B-X
for	B-X
the	B-X
specificity	B-X
of	B-X
E2F	B-X
function	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
E-box	B-X
binding	B-X
factor	B-X
TFE3	B-X
as	B-X
an	B-X
E2F3-specific	B-X
partner	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
marked	B-X
box	B-X
domain	B-X
of	B-X
E2F3	B-X
.	B-X
We	B-X
provide	B-X
evidence	B-X
for	B-X
a	B-X
role	B-X
for	B-X
TFE3	B-X
in	B-X
the	B-X
synergistic	B-X
activation	B-X
of	B-X
the	B-X
p68	B-X
subunit	B-X
gene	B-X
of	B-X
DNA	B-X
polymerase	B-X
alpha	B-X
together	B-X
with	B-X
E2F3	B-X
,	B-X
again	B-X
dependent	B-X
on	B-X
the	B-X
E2F3	B-X
marked	B-X
box	B-X
domain	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
showed	B-X
that	B-X
TFE3	B-X
and	B-X
E2F3	B-X
were	B-X
bound	B-X
to	B-X
the	B-X
p68	B-X
promoter	B-X
in	B-X
vivo	B-X
and	B-X
that	B-X
the	B-X
interaction	B-X
of	B-X
either	B-X
E2F3	B-X
or	B-X
TFE3	B-X
with	B-X
the	B-X
promoter	B-X
was	B-X
facilitated	B-X
by	B-X
the	B-X
presence	B-X
of	B-X
both	B-X
proteins	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
neither	B-X
E2F1	B-X
nor	B-X
E2F2	B-X
interacted	B-X
with	B-X
the	B-X
p68	B-X
promoter	B-X
under	B-X
these	B-X
conditions	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
physical	B-X
interaction	B-X
of	B-X
TFE3	B-X
and	B-X
E2F3	B-X
facilitates	B-X
transcriptional	B-X
activation	B-X
of	B-X
the	B-X
p68	B-X
gene	B-X
and	B-X
provides	B-X
strong	B-X
evidence	B-X
for	B-X
the	B-X
specificity	B-X
of	B-X
E2F	B-X
function	B-X
.	B-X

A	O
subset	O
of	O
ATM	B-Gene_or_gene_product
-	O
and	O
ATR	B-Gene_or_gene_product
-	O
dependent	O
phosphorylation	O
events	O
requires	O
the	O
BRCA1	B-Gene_or_gene_product
protein	O
.	O
<EOS>	B-X
BRCA1	B-X
is	B-X
a	B-X
central	B-X
component	B-X
of	B-X
the	B-X
DNA	B-X
damage	B-X
response	B-X
mechanism	B-X
and	B-X
defects	B-X
in	B-X
BRCA1	B-X
confer	B-X
sensitivity	B-X
to	B-X
a	B-X
broad	B-X
range	B-X
of	B-X
DNA	B-X
damaging	B-X
agents	B-X
.	B-X
BRCA1	B-X
is	B-X
required	B-X
for	B-X
homologous	B-X
recombination	B-X
and	B-X
DNA	B-X
damage-induced	B-X
S	B-X
and	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
phase	B-X
arrest	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
BRCA1	B-X
is	B-X
required	B-X
for	B-X
ATM-	B-X
and	B-X
ATR-dependent	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
c-Jun	B-X
,	B-X
Nbs1	B-X
and	B-X
Chk2	B-X
following	B-X
exposure	B-X
to	B-X
ionizing	B-X
or	B-X
ultraviolet	B-X
radiation	B-X
,	B-X
respectively	B-X
,	B-X
and	B-X
is	B-X
also	B-X
required	B-X
for	B-X
ATM	B-X
phosphorylation	B-X
of	B-X
CtIP	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DNA	B-X
damage-induced	B-X
phosphorylation	B-X
of	B-X
the	B-X
histone	B-X
variant	B-X
H2AX	B-X
is	B-X
independent	B-X
of	B-X
BRCA1	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
the	B-X
presence	B-X
of	B-X
BRCA1	B-X
is	B-X
dispensable	B-X
for	B-X
DNA	B-X
damage-induced	B-X
phosphorylation	B-X
of	B-X
Rad9	B-X
,	B-X
Hus1	B-X
and	B-X
Rad17	B-X
,	B-X
and	B-X
for	B-X
the	B-X
relocalization	B-X
of	B-X
Rad9	B-X
and	B-X
Hus1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
BRCA1	B-X
facilitates	B-X
the	B-X
ability	B-X
of	B-X
ATM	B-X
and	B-X
ATR	B-X
to	B-X
phosphorylate	B-X
downstream	B-X
substrates	B-X
that	B-X
directly	B-X
influence	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
arrest	B-X
and	B-X
apoptosis	B-X
,	B-X
but	B-X
that	B-X
BRCA1	B-X
is	B-X
dispensable	B-X
for	B-X
the	B-X
phosphorylation	B-X
of	B-X
DNA-associated	B-X
ATM	B-X
and	B-X
ATR	B-X
substrates	B-X
.	B-X

BRCA1	B-Gene_or_gene_product
is	O
a	O
central	O
component	O
of	O
the	O
DNA	O
damage	O
response	O
mechanism	O
and	O
defects	O
in	O
BRCA1	B-Gene_or_gene_product
confer	O
sensitivity	O
to	O
a	O
broad	O
range	O
of	O
DNA	O
damaging	O
agents	O
.	O
<EOS>	B-X
BRCA1	B-X
is	B-X
a	B-X
central	B-X
component	B-X
of	B-X
the	B-X
DNA	B-X
damage	B-X
response	B-X
mechanism	B-X
and	B-X
defects	B-X
in	B-X
BRCA1	B-X
confer	B-X
sensitivity	B-X
to	B-X
a	B-X
broad	B-X
range	B-X
of	B-X
DNA	B-X
damaging	B-X
agents	B-X
.	B-X
BRCA1	B-X
is	B-X
required	B-X
for	B-X
homologous	B-X
recombination	B-X
and	B-X
DNA	B-X
damage-induced	B-X
S	B-X
and	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
phase	B-X
arrest	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
BRCA1	B-X
is	B-X
required	B-X
for	B-X
ATM-	B-X
and	B-X
ATR-dependent	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
c-Jun	B-X
,	B-X
Nbs1	B-X
and	B-X
Chk2	B-X
following	B-X
exposure	B-X
to	B-X
ionizing	B-X
or	B-X
ultraviolet	B-X
radiation	B-X
,	B-X
respectively	B-X
,	B-X
and	B-X
is	B-X
also	B-X
required	B-X
for	B-X
ATM	B-X
phosphorylation	B-X
of	B-X
CtIP	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DNA	B-X
damage-induced	B-X
phosphorylation	B-X
of	B-X
the	B-X
histone	B-X
variant	B-X
H2AX	B-X
is	B-X
independent	B-X
of	B-X
BRCA1	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
the	B-X
presence	B-X
of	B-X
BRCA1	B-X
is	B-X
dispensable	B-X
for	B-X
DNA	B-X
damage-induced	B-X
phosphorylation	B-X
of	B-X
Rad9	B-X
,	B-X
Hus1	B-X
and	B-X
Rad17	B-X
,	B-X
and	B-X
for	B-X
the	B-X
relocalization	B-X
of	B-X
Rad9	B-X
and	B-X
Hus1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
BRCA1	B-X
facilitates	B-X
the	B-X
ability	B-X
of	B-X
ATM	B-X
and	B-X
ATR	B-X
to	B-X
phosphorylate	B-X
downstream	B-X
substrates	B-X
that	B-X
directly	B-X
influence	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
arrest	B-X
and	B-X
apoptosis	B-X
,	B-X
but	B-X
that	B-X
BRCA1	B-X
is	B-X
dispensable	B-X
for	B-X
the	B-X
phosphorylation	B-X
of	B-X
DNA-associated	B-X
ATM	B-X
and	B-X
ATR	B-X
substrates	B-X
.	B-X

BRCA1	B-Gene_or_gene_product
is	O
required	O
for	O
homologous	O
recombination	O
and	O
DNA	O
damage	O
-	O
induced	O
S	O
and	O
G	O
(	O
2	O
)	O
/	O
M	O
phase	O
arrest	O
.	O

We	O
show	O
here	O
that	O
BRCA1	B-Gene_or_gene_product
is	O
required	O
for	O
ATM	B-Gene_or_gene_product
-	O
and	O
ATR	B-Gene_or_gene_product
-	O
dependent	O
phosphorylation	O
of	O
p53	B-Gene_or_gene_product
,	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
,	O
Nbs1	B-Gene_or_gene_product
and	O
Chk2	B-Gene_or_gene_product
following	O
exposure	O
to	O
ionizing	O
or	O
ultraviolet	O
radiation	O
,	O
respectively	O
,	O
and	O
is	O
also	O
required	O
for	O
ATM	B-Gene_or_gene_product
phosphorylation	O
of	O
CtIP	B-Gene_or_gene_product
.	O
<EOS>	B-X
BRCA1	B-X
is	B-X
a	B-X
central	B-X
component	B-X
of	B-X
the	B-X
DNA	B-X
damage	B-X
response	B-X
mechanism	B-X
and	B-X
defects	B-X
in	B-X
BRCA1	B-X
confer	B-X
sensitivity	B-X
to	B-X
a	B-X
broad	B-X
range	B-X
of	B-X
DNA	B-X
damaging	B-X
agents	B-X
.	B-X
BRCA1	B-X
is	B-X
required	B-X
for	B-X
homologous	B-X
recombination	B-X
and	B-X
DNA	B-X
damage-induced	B-X
S	B-X
and	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
phase	B-X
arrest	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
BRCA1	B-X
is	B-X
required	B-X
for	B-X
ATM-	B-X
and	B-X
ATR-dependent	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
c-Jun	B-X
,	B-X
Nbs1	B-X
and	B-X
Chk2	B-X
following	B-X
exposure	B-X
to	B-X
ionizing	B-X
or	B-X
ultraviolet	B-X
radiation	B-X
,	B-X
respectively	B-X
,	B-X
and	B-X
is	B-X
also	B-X
required	B-X
for	B-X
ATM	B-X
phosphorylation	B-X
of	B-X
CtIP	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DNA	B-X
damage-induced	B-X
phosphorylation	B-X
of	B-X
the	B-X
histone	B-X
variant	B-X
H2AX	B-X
is	B-X
independent	B-X
of	B-X
BRCA1	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
the	B-X
presence	B-X
of	B-X
BRCA1	B-X
is	B-X
dispensable	B-X
for	B-X
DNA	B-X
damage-induced	B-X
phosphorylation	B-X
of	B-X
Rad9	B-X
,	B-X
Hus1	B-X
and	B-X
Rad17	B-X
,	B-X
and	B-X
for	B-X
the	B-X
relocalization	B-X
of	B-X
Rad9	B-X
and	B-X
Hus1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
BRCA1	B-X
facilitates	B-X
the	B-X
ability	B-X
of	B-X
ATM	B-X
and	B-X
ATR	B-X
to	B-X
phosphorylate	B-X
downstream	B-X
substrates	B-X
that	B-X
directly	B-X
influence	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
arrest	B-X
and	B-X
apoptosis	B-X
,	B-X
but	B-X
that	B-X
BRCA1	B-X
is	B-X
dispensable	B-X
for	B-X
the	B-X
phosphorylation	B-X
of	B-X
DNA-associated	B-X
ATM	B-X
and	B-X
ATR	B-X
substrates	B-X
.	B-X

In	O
contrast	O
,	O
DNA	O
damage	O
-	O
induced	O
phosphorylation	O
of	O
the	O
histone	B-Gene_or_gene_product
variant	O
H2AX	B-Gene_or_gene_product
is	O
independent	O
of	O
BRCA1	B-Gene_or_gene_product
.	O
<EOS>	B-X
BRCA1	B-X
is	B-X
a	B-X
central	B-X
component	B-X
of	B-X
the	B-X
DNA	B-X
damage	B-X
response	B-X
mechanism	B-X
and	B-X
defects	B-X
in	B-X
BRCA1	B-X
confer	B-X
sensitivity	B-X
to	B-X
a	B-X
broad	B-X
range	B-X
of	B-X
DNA	B-X
damaging	B-X
agents	B-X
.	B-X
BRCA1	B-X
is	B-X
required	B-X
for	B-X
homologous	B-X
recombination	B-X
and	B-X
DNA	B-X
damage-induced	B-X
S	B-X
and	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
phase	B-X
arrest	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
BRCA1	B-X
is	B-X
required	B-X
for	B-X
ATM-	B-X
and	B-X
ATR-dependent	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
c-Jun	B-X
,	B-X
Nbs1	B-X
and	B-X
Chk2	B-X
following	B-X
exposure	B-X
to	B-X
ionizing	B-X
or	B-X
ultraviolet	B-X
radiation	B-X
,	B-X
respectively	B-X
,	B-X
and	B-X
is	B-X
also	B-X
required	B-X
for	B-X
ATM	B-X
phosphorylation	B-X
of	B-X
CtIP	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DNA	B-X
damage-induced	B-X
phosphorylation	B-X
of	B-X
the	B-X
histone	B-X
variant	B-X
H2AX	B-X
is	B-X
independent	B-X
of	B-X
BRCA1	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
the	B-X
presence	B-X
of	B-X
BRCA1	B-X
is	B-X
dispensable	B-X
for	B-X
DNA	B-X
damage-induced	B-X
phosphorylation	B-X
of	B-X
Rad9	B-X
,	B-X
Hus1	B-X
and	B-X
Rad17	B-X
,	B-X
and	B-X
for	B-X
the	B-X
relocalization	B-X
of	B-X
Rad9	B-X
and	B-X
Hus1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
BRCA1	B-X
facilitates	B-X
the	B-X
ability	B-X
of	B-X
ATM	B-X
and	B-X
ATR	B-X
to	B-X
phosphorylate	B-X
downstream	B-X
substrates	B-X
that	B-X
directly	B-X
influence	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
arrest	B-X
and	B-X
apoptosis	B-X
,	B-X
but	B-X
that	B-X
BRCA1	B-X
is	B-X
dispensable	B-X
for	B-X
the	B-X
phosphorylation	B-X
of	B-X
DNA-associated	B-X
ATM	B-X
and	B-X
ATR	B-X
substrates	B-X
.	B-X

We	O
also	O
show	O
that	O
the	O
presence	O
of	O
BRCA1	B-Gene_or_gene_product
is	O
dispensable	O
for	O
DNA	O
damage	O
-	O
induced	O
phosphorylation	O
of	O
Rad9	B-Gene_or_gene_product
,	O
Hus1	B-Gene_or_gene_product
and	O
Rad17	B-Gene_or_gene_product
,	O
and	O
for	O
the	O
relocalization	O
of	O
Rad9	B-Gene_or_gene_product
and	O
Hus1	B-Gene_or_gene_product
.	O
<EOS>	B-X
BRCA1	B-X
is	B-X
a	B-X
central	B-X
component	B-X
of	B-X
the	B-X
DNA	B-X
damage	B-X
response	B-X
mechanism	B-X
and	B-X
defects	B-X
in	B-X
BRCA1	B-X
confer	B-X
sensitivity	B-X
to	B-X
a	B-X
broad	B-X
range	B-X
of	B-X
DNA	B-X
damaging	B-X
agents	B-X
.	B-X
BRCA1	B-X
is	B-X
required	B-X
for	B-X
homologous	B-X
recombination	B-X
and	B-X
DNA	B-X
damage-induced	B-X
S	B-X
and	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
phase	B-X
arrest	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
BRCA1	B-X
is	B-X
required	B-X
for	B-X
ATM-	B-X
and	B-X
ATR-dependent	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
c-Jun	B-X
,	B-X
Nbs1	B-X
and	B-X
Chk2	B-X
following	B-X
exposure	B-X
to	B-X
ionizing	B-X
or	B-X
ultraviolet	B-X
radiation	B-X
,	B-X
respectively	B-X
,	B-X
and	B-X
is	B-X
also	B-X
required	B-X
for	B-X
ATM	B-X
phosphorylation	B-X
of	B-X
CtIP	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DNA	B-X
damage-induced	B-X
phosphorylation	B-X
of	B-X
the	B-X
histone	B-X
variant	B-X
H2AX	B-X
is	B-X
independent	B-X
of	B-X
BRCA1	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
the	B-X
presence	B-X
of	B-X
BRCA1	B-X
is	B-X
dispensable	B-X
for	B-X
DNA	B-X
damage-induced	B-X
phosphorylation	B-X
of	B-X
Rad9	B-X
,	B-X
Hus1	B-X
and	B-X
Rad17	B-X
,	B-X
and	B-X
for	B-X
the	B-X
relocalization	B-X
of	B-X
Rad9	B-X
and	B-X
Hus1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
BRCA1	B-X
facilitates	B-X
the	B-X
ability	B-X
of	B-X
ATM	B-X
and	B-X
ATR	B-X
to	B-X
phosphorylate	B-X
downstream	B-X
substrates	B-X
that	B-X
directly	B-X
influence	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
arrest	B-X
and	B-X
apoptosis	B-X
,	B-X
but	B-X
that	B-X
BRCA1	B-X
is	B-X
dispensable	B-X
for	B-X
the	B-X
phosphorylation	B-X
of	B-X
DNA-associated	B-X
ATM	B-X
and	B-X
ATR	B-X
substrates	B-X
.	B-X

We	O
propose	O
that	O
BRCA1	B-Gene_or_gene_product
facilitates	O
the	O
ability	O
of	O
ATM	B-Gene_or_gene_product
and	O
ATR	B-Gene_or_gene_product
to	O
phosphorylate	O
downstream	O
substrates	O
that	O
directly	O
influence	O
cell	O
cycle	O
checkpoint	O
arrest	O
and	O
apoptosis	O
,	O
but	O
that	O
BRCA1	B-Gene_or_gene_product
is	O
dispensable	O
for	O
the	O
phosphorylation	O
of	O
DNA	O
-	O
associated	O
ATM	B-Gene_or_gene_product
and	O
ATR	B-Gene_or_gene_product
substrates	O
.	O
<EOS>	B-X
BRCA1	B-X
is	B-X
a	B-X
central	B-X
component	B-X
of	B-X
the	B-X
DNA	B-X
damage	B-X
response	B-X
mechanism	B-X
and	B-X
defects	B-X
in	B-X
BRCA1	B-X
confer	B-X
sensitivity	B-X
to	B-X
a	B-X
broad	B-X
range	B-X
of	B-X
DNA	B-X
damaging	B-X
agents	B-X
.	B-X
BRCA1	B-X
is	B-X
required	B-X
for	B-X
homologous	B-X
recombination	B-X
and	B-X
DNA	B-X
damage-induced	B-X
S	B-X
and	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
phase	B-X
arrest	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
BRCA1	B-X
is	B-X
required	B-X
for	B-X
ATM-	B-X
and	B-X
ATR-dependent	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
c-Jun	B-X
,	B-X
Nbs1	B-X
and	B-X
Chk2	B-X
following	B-X
exposure	B-X
to	B-X
ionizing	B-X
or	B-X
ultraviolet	B-X
radiation	B-X
,	B-X
respectively	B-X
,	B-X
and	B-X
is	B-X
also	B-X
required	B-X
for	B-X
ATM	B-X
phosphorylation	B-X
of	B-X
CtIP	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DNA	B-X
damage-induced	B-X
phosphorylation	B-X
of	B-X
the	B-X
histone	B-X
variant	B-X
H2AX	B-X
is	B-X
independent	B-X
of	B-X
BRCA1	B-X
.	B-X
We	B-X
also	B-X
show	B-X
that	B-X
the	B-X
presence	B-X
of	B-X
BRCA1	B-X
is	B-X
dispensable	B-X
for	B-X
DNA	B-X
damage-induced	B-X
phosphorylation	B-X
of	B-X
Rad9	B-X
,	B-X
Hus1	B-X
and	B-X
Rad17	B-X
,	B-X
and	B-X
for	B-X
the	B-X
relocalization	B-X
of	B-X
Rad9	B-X
and	B-X
Hus1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
BRCA1	B-X
facilitates	B-X
the	B-X
ability	B-X
of	B-X
ATM	B-X
and	B-X
ATR	B-X
to	B-X
phosphorylate	B-X
downstream	B-X
substrates	B-X
that	B-X
directly	B-X
influence	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
arrest	B-X
and	B-X
apoptosis	B-X
,	B-X
but	B-X
that	B-X
BRCA1	B-X
is	B-X
dispensable	B-X
for	B-X
the	B-X
phosphorylation	B-X
of	B-X
DNA-associated	B-X
ATM	B-X
and	B-X
ATR	B-X
substrates	B-X
.	B-X

Phosphorylation	O
of	O
p90	B-Gene_or_gene_product
ribosomal	I-Gene_or_gene_product
S6	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
RSK	B-Gene_or_gene_product
)	O
regulates	O
extracellular	B-Gene_or_gene_product
signal	I-Gene_or_gene_product
-	I-Gene_or_gene_product
regulated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
docking	O
and	O
RSK	B-Gene_or_gene_product
activity	O
.	O
<EOS>	B-X
Stimulation	B-X
of	B-X
the	B-X
Ras/extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
ERK	B-X
)	B-X
pathway	B-X
can	B-X
modulate	B-X
cell	B-X
growth	B-X
,	B-X
proliferation	B-X
,	B-X
survival	B-X
,	B-X
and	B-X
motility	B-X
.	B-X
The	B-X
p90	B-X
ribosomal	B-X
S6	B-X
kinases	B-X
(	B-X
RSKs	B-X
)	B-X
comprise	B-X
a	B-X
family	B-X
of	B-X
serine/threonine	B-X
kinases	B-X
that	B-X
lie	B-X
at	B-X
the	B-X
terminus	B-X
of	B-X
the	B-X
ERK	B-X
pathway	B-X
.	B-X
Efficient	B-X
RSK	B-X
activation	B-X
by	B-X
ERK	B-X
requires	B-X
its	B-X
interaction	B-X
through	B-X
a	B-X
docking	B-X
site	B-X
located	B-X
near	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
RSK	B-X
,	B-X
but	B-X
the	B-X
regulation	B-X
of	B-X
this	B-X
interaction	B-X
remains	B-X
unknown	B-X
.	B-X
In	B-X
this	B-X
report	B-X
we	B-X
show	B-X
that	B-X
RSK1	B-X
and	B-X
ERK1/2	B-X
form	B-X
a	B-X
complex	B-X
in	B-X
quiescent	B-X
HEK293	B-X
cells	B-X
that	B-X
transiently	B-X
dissociates	B-X
upon	B-X
mitogen	B-X
stimulation	B-X
.	B-X
Complex	B-X
dissociation	B-X
requires	B-X
phosphorylation	B-X
of	B-X
RSK1	B-X
serine	B-X
749	B-X
,	B-X
which	B-X
is	B-X
a	B-X
mitogen-regulated	B-X
phosphorylation	B-X
site	B-X
located	B-X
near	B-X
the	B-X
ERK	B-X
docking	B-X
site	B-X
.	B-X
Using	B-X
recombinant	B-X
RSK1	B-X
proteins	B-X
,	B-X
we	B-X
find	B-X
that	B-X
serine	B-X
749	B-X
is	B-X
phosphorylated	B-X
by	B-X
the	B-X
N-terminal	B-X
kinase	B-X
domain	B-X
of	B-X
RSK1	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
ERK1/2	B-X
dissociation	B-X
is	B-X
mediated	B-X
through	B-X
RSK1	B-X
autophosphorylation	B-X
of	B-X
this	B-X
residue	B-X
.	B-X
Consistent	B-X
with	B-X
this	B-X
hypothesis	B-X
,	B-X
we	B-X
find	B-X
that	B-X
inactivating	B-X
mutations	B-X
in	B-X
the	B-X
RSK1	B-X
kinase	B-X
domains	B-X
disrupted	B-X
the	B-X
mitogen-regulated	B-X
dissociation	B-X
of	B-X
ERK1/2	B-X
in	B-X
vivo	B-X
.	B-X
Analysis	B-X
of	B-X
different	B-X
RSK	B-X
isoforms	B-X
revealed	B-X
that	B-X
RSK1	B-X
and	B-X
RSK2	B-X
readily	B-X
dissociate	B-X
from	B-X
ERK1/2	B-X
following	B-X
mitogen	B-X
stimulation	B-X
but	B-X
that	B-X
RSK3	B-X
remains	B-X
associated	B-X
with	B-X
active	B-X
ERK1/2	B-X
.	B-X
RSK	B-X
activity	B-X
assays	B-X
revealed	B-X
that	B-X
RSK3	B-X
also	B-X
remains	B-X
active	B-X
longer	B-X
than	B-X
RSK1	B-X
and	B-X
RSK2	B-X
,	B-X
suggesting	B-X
that	B-X
prolonged	B-X
ERK	B-X
association	B-X
increased	B-X
the	B-X
duration	B-X
of	B-X
RSK3	B-X
activation	B-X
.	B-X
These	B-X
results	B-X
provide	B-X
new	B-X
evidence	B-X
for	B-X
the	B-X
regulated	B-X
nature	B-X
of	B-X
ERK	B-X
docking	B-X
interactions	B-X
and	B-X
reveal	B-X
important	B-X
differences	B-X
among	B-X
the	B-X
closely	B-X
related	B-X
RSK	B-X
family	B-X
members	B-X
.	B-X

Stimulation	O
of	O
the	O
Ras	B-Gene_or_gene_product
/	O
extracellular	B-Gene_or_gene_product
signal	I-Gene_or_gene_product
-	I-Gene_or_gene_product
regulated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
ERK	B-Gene_or_gene_product
)	O
pathway	O
can	O
modulate	O
cell	O
growth	O
,	O
proliferation	O
,	O
survival	O
,	O
and	O
motility	O
.	O
<EOS>	B-X
Thrombin	B-X
signalling	B-X
through	B-X
PAR	B-X
(	B-X
protease-activated	B-X
receptor	B-X
)	B-X
-1	B-X
is	B-X
involved	B-X
in	B-X
cellular	B-X
processes	B-X
,	B-X
such	B-X
as	B-X
proliferation	B-X
,	B-X
differentiation	B-X
and	B-X
cell	B-X
survival	B-X
.	B-X
Following	B-X
traumatic	B-X
injury	B-X
to	B-X
the	B-X
eye	B-X
,	B-X
thrombin	B-X
signalling	B-X
may	B-X
participate	B-X
in	B-X
disorders	B-X
,	B-X
such	B-X
as	B-X
PVR	B-X
(	B-X
proliferative	B-X
vitreoretinopathy	B-X
)	B-X
,	B-X
a	B-X
human	B-X
eye	B-X
disease	B-X
characterized	B-X
by	B-X
the	B-X
uncontrolled	B-X
proliferation	B-X
,	B-X
transdifferentiation	B-X
and	B-X
migration	B-X
of	B-X
otherwise	B-X
quiescent	B-X
RPE	B-X
(	B-X
retinal	B-X
pigment	B-X
epithelium	B-X
)	B-X
cells	B-X
.	B-X
PARs	B-X
activate	B-X
the	B-X
Ras/Raf/MEK/ERK	B-X
MAPK	B-X
pathway	B-X
(	B-X
where	B-X
ERK	B-X
is	B-X
extracellular-signal-regulated	B-X
kinase	B-X
,	B-X
MAPK	B-X
is	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
and	B-X
MEK	B-X
is	B-X
MAPK/ERK	B-X
kinase	B-X
)	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
G	B-X
(	B-X
alpha	B-X
)	B-X
and	B-X
G	B-X
(	B-X
betagamma	B-X
)	B-X
heterotrimeric	B-X
G-proteins	B-X
,	B-X
and	B-X
the	B-X
downstream	B-X
stimulation	B-X
of	B-X
the	B-X
PLC	B-X
(	B-X
phospholipase	B-X
C	B-X
)	B-X
-beta/PKC	B-X
(	B-X
protein	B-X
kinase	B-X
C	B-X
)	B-X
and	B-X
PI3K	B-X
(	B-X
phosphoinositide	B-X
3-kinase	B-X
)	B-X
signalling	B-X
axis	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
examined	B-X
the	B-X
molecular	B-X
signalling	B-X
involved	B-X
in	B-X
thrombin-induced	B-X
RPE	B-X
cell	B-X
proliferation	B-X
,	B-X
using	B-X
rat	B-X
RPE	B-X
cells	B-X
in	B-X
culture	B-X
as	B-X
a	B-X
model	B-X
system	B-X
for	B-X
PVR	B-X
pathogenesis	B-X
.	B-X
Our	B-X
results	B-X
showed	B-X
that	B-X
thrombin	B-X
activation	B-X
of	B-X
PAR-1	B-X
induces	B-X
RPE	B-X
cell	B-X
proliferation	B-X
through	B-X
Ras-independent	B-X
activation	B-X
of	B-X
the	B-X
Raf/MEK/ERK1/2	B-X
MAPK	B-X
signalling	B-X
cascade	B-X
.	B-X
Pharmacological	B-X
analysis	B-X
revealed	B-X
that	B-X
the	B-X
activation	B-X
of	B-X
'conventional	B-X
'	B-X
PKC	B-X
isoforms	B-X
is	B-X
essential	B-X
for	B-X
proliferation	B-X
,	B-X
although	B-X
thrombin-induced	B-X
phosphorylation	B-X
of	B-X
ERK1/2	B-X
requires	B-X
the	B-X
activation	B-X
of	B-X
atypical	B-X
PKCzeta	B-X
by	B-X
PI3K	B-X
.	B-X
Consistently	B-X
,	B-X
thrombin-induced	B-X
ERK1/2	B-X
activation	B-X
and	B-X
RPE	B-X
cell	B-X
proliferation	B-X
were	B-X
prevented	B-X
completely	B-X
by	B-X
PI3K	B-X
or	B-X
PKCzeta	B-X
inhibition	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
thrombin	B-X
induces	B-X
RPE	B-X
cell	B-X
proliferation	B-X
by	B-X
joint	B-X
activation	B-X
of	B-X
PLC-dependent	B-X
and	B-X
atypical	B-X
PKC	B-X
isoforms	B-X
and	B-X
the	B-X
Ras-independent	B-X
downstream	B-X
stimulation	B-X
of	B-X
the	B-X
Raf/MEK/ERK1/2	B-X
MAPK	B-X
cascade	B-X
.	B-X
The	B-X
present	B-X
study	B-X
is	B-X
the	B-X
first	B-X
report	B-X
demonstrating	B-X
directly	B-X
thrombin-induced	B-X
ERK	B-X
phosphorylation	B-X
in	B-X
the	B-X
RPE	B-X
,	B-X
and	B-X
the	B-X
involvement	B-X
of	B-X
atypical	B-X
PKCzeta	B-X
in	B-X
this	B-X
process	B-X
.	B-X

The	O
p90	B-Gene_or_gene_product
ribosomal	I-Gene_or_gene_product
S6	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
(	O
RSKs	B-Gene_or_gene_product
)	O
comprise	O
a	O
family	O
of	O
serine	O
/	O
threonine	O
kinases	O
that	O
lie	O
at	O
the	O
terminus	O
of	O
the	O
ERK	B-Gene_or_gene_product
pathway	O
.	O

Efficient	O
RSK	B-Gene_or_gene_product
activation	O
by	O
ERK	B-Gene_or_gene_product
requires	O
its	O
interaction	O
through	O
a	O
docking	O
site	O
located	O
near	O
the	O
C	O
terminus	O
of	O
RSK	B-Gene_or_gene_product
,	O
but	O
the	O
regulation	O
of	O
this	O
interaction	O
remains	O
unknown	O
.	O

In	O
this	O
report	O
we	O
show	O
that	O
RSK1	B-Gene_or_gene_product
and	O
ERK1	B-Gene_or_gene_product
/	I-Gene_or_gene_product
2	I-Gene_or_gene_product
form	O
a	O
complex	O
in	O
quiescent	O
HEK293	O
cells	O
that	O
transiently	O
dissociates	O
upon	O
mitogen	O
stimulation	O
.	O

Complex	O
dissociation	O
requires	O
phosphorylation	O
of	O
RSK1	B-Gene_or_gene_product
serine	O
749	O
,	O
which	O
is	O
a	O
mitogen	O
-	O
regulated	O
phosphorylation	O
site	O
located	O
near	O
the	O
ERK	B-Gene_or_gene_product
docking	O
site	O
.	O
<EOS>	B-X
Stimulation	B-X
of	B-X
the	B-X
Ras/extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
ERK	B-X
)	B-X
pathway	B-X
can	B-X
modulate	B-X
cell	B-X
growth	B-X
,	B-X
proliferation	B-X
,	B-X
survival	B-X
,	B-X
and	B-X
motility	B-X
.	B-X
The	B-X
p90	B-X
ribosomal	B-X
S6	B-X
kinases	B-X
(	B-X
RSKs	B-X
)	B-X
comprise	B-X
a	B-X
family	B-X
of	B-X
serine/threonine	B-X
kinases	B-X
that	B-X
lie	B-X
at	B-X
the	B-X
terminus	B-X
of	B-X
the	B-X
ERK	B-X
pathway	B-X
.	B-X
Efficient	B-X
RSK	B-X
activation	B-X
by	B-X
ERK	B-X
requires	B-X
its	B-X
interaction	B-X
through	B-X
a	B-X
docking	B-X
site	B-X
located	B-X
near	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
RSK	B-X
,	B-X
but	B-X
the	B-X
regulation	B-X
of	B-X
this	B-X
interaction	B-X
remains	B-X
unknown	B-X
.	B-X
In	B-X
this	B-X
report	B-X
we	B-X
show	B-X
that	B-X
RSK1	B-X
and	B-X
ERK1/2	B-X
form	B-X
a	B-X
complex	B-X
in	B-X
quiescent	B-X
HEK293	B-X
cells	B-X
that	B-X
transiently	B-X
dissociates	B-X
upon	B-X
mitogen	B-X
stimulation	B-X
.	B-X
Complex	B-X
dissociation	B-X
requires	B-X
phosphorylation	B-X
of	B-X
RSK1	B-X
serine	B-X
749	B-X
,	B-X
which	B-X
is	B-X
a	B-X
mitogen-regulated	B-X
phosphorylation	B-X
site	B-X
located	B-X
near	B-X
the	B-X
ERK	B-X
docking	B-X
site	B-X
.	B-X
Using	B-X
recombinant	B-X
RSK1	B-X
proteins	B-X
,	B-X
we	B-X
find	B-X
that	B-X
serine	B-X
749	B-X
is	B-X
phosphorylated	B-X
by	B-X
the	B-X
N-terminal	B-X
kinase	B-X
domain	B-X
of	B-X
RSK1	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
ERK1/2	B-X
dissociation	B-X
is	B-X
mediated	B-X
through	B-X
RSK1	B-X
autophosphorylation	B-X
of	B-X
this	B-X
residue	B-X
.	B-X
Consistent	B-X
with	B-X
this	B-X
hypothesis	B-X
,	B-X
we	B-X
find	B-X
that	B-X
inactivating	B-X
mutations	B-X
in	B-X
the	B-X
RSK1	B-X
kinase	B-X
domains	B-X
disrupted	B-X
the	B-X
mitogen-regulated	B-X
dissociation	B-X
of	B-X
ERK1/2	B-X
in	B-X
vivo	B-X
.	B-X
Analysis	B-X
of	B-X
different	B-X
RSK	B-X
isoforms	B-X
revealed	B-X
that	B-X
RSK1	B-X
and	B-X
RSK2	B-X
readily	B-X
dissociate	B-X
from	B-X
ERK1/2	B-X
following	B-X
mitogen	B-X
stimulation	B-X
but	B-X
that	B-X
RSK3	B-X
remains	B-X
associated	B-X
with	B-X
active	B-X
ERK1/2	B-X
.	B-X
RSK	B-X
activity	B-X
assays	B-X
revealed	B-X
that	B-X
RSK3	B-X
also	B-X
remains	B-X
active	B-X
longer	B-X
than	B-X
RSK1	B-X
and	B-X
RSK2	B-X
,	B-X
suggesting	B-X
that	B-X
prolonged	B-X
ERK	B-X
association	B-X
increased	B-X
the	B-X
duration	B-X
of	B-X
RSK3	B-X
activation	B-X
.	B-X
These	B-X
results	B-X
provide	B-X
new	B-X
evidence	B-X
for	B-X
the	B-X
regulated	B-X
nature	B-X
of	B-X
ERK	B-X
docking	B-X
interactions	B-X
and	B-X
reveal	B-X
important	B-X
differences	B-X
among	B-X
the	B-X
closely	B-X
related	B-X
RSK	B-X
family	B-X
members	B-X
.	B-X

Using	O
recombinant	O
RSK1	B-Gene_or_gene_product
proteins	O
,	O
we	O
find	O
that	O
serine	O
749	O
is	O
phosphorylated	O
by	O
the	O
N	O
-	O
terminal	O
kinase	O
domain	O
of	O
RSK1	B-Gene_or_gene_product
in	O
vitro	O
,	O
suggesting	O
that	O
ERK1	B-Gene_or_gene_product
/	I-Gene_or_gene_product
2	I-Gene_or_gene_product
dissociation	O
is	O
mediated	O
through	O
RSK1	B-Gene_or_gene_product
autophosphorylation	O
of	O
this	O
residue	O
.	O

Consistent	O
with	O
this	O
hypothesis	O
,	O
we	O
find	O
that	O
inactivating	O
mutations	O
in	O
the	O
RSK1	B-Gene_or_gene_product
kinase	O
domains	O
disrupted	O
the	O
mitogen	O
-	O
regulated	O
dissociation	O
of	O
ERK1	B-Gene_or_gene_product
/	I-Gene_or_gene_product
2	I-Gene_or_gene_product
in	O
vivo	O
.	O
<EOS>	B-X
Stimulation	B-X
of	B-X
the	B-X
Ras/extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
ERK	B-X
)	B-X
pathway	B-X
can	B-X
modulate	B-X
cell	B-X
growth	B-X
,	B-X
proliferation	B-X
,	B-X
survival	B-X
,	B-X
and	B-X
motility	B-X
.	B-X
The	B-X
p90	B-X
ribosomal	B-X
S6	B-X
kinases	B-X
(	B-X
RSKs	B-X
)	B-X
comprise	B-X
a	B-X
family	B-X
of	B-X
serine/threonine	B-X
kinases	B-X
that	B-X
lie	B-X
at	B-X
the	B-X
terminus	B-X
of	B-X
the	B-X
ERK	B-X
pathway	B-X
.	B-X
In	B-X
this	B-X
report	B-X
we	B-X
show	B-X
that	B-X
RSK1	B-X
and	B-X
ERK1/2	B-X
form	B-X
a	B-X
complex	B-X
in	B-X
quiescent	B-X
HEK293	B-X
cells	B-X
that	B-X
transiently	B-X
dissociates	B-X
upon	B-X
mitogen	B-X
stimulation	B-X
.	B-X
Complex	B-X
dissociation	B-X
requires	B-X
phosphorylation	B-X
of	B-X
RSK1	B-X
serine	B-X
749	B-X
,	B-X
which	B-X
is	B-X
a	B-X
mitogen-regulated	B-X
phosphorylation	B-X
site	B-X
located	B-X
near	B-X
the	B-X
ERK	B-X
docking	B-X
site	B-X
.	B-X
Using	B-X
recombinant	B-X
RSK1	B-X
proteins	B-X
,	B-X
we	B-X
find	B-X
that	B-X
serine	B-X
749	B-X
is	B-X
phosphorylated	B-X
by	B-X
the	B-X
N-terminal	B-X
kinase	B-X
domain	B-X
of	B-X
RSK1	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
ERK1/2	B-X
dissociation	B-X
is	B-X
mediated	B-X
through	B-X
RSK1	B-X
autophosphorylation	B-X
of	B-X
this	B-X
residue	B-X
.	B-X
Consistent	B-X
with	B-X
this	B-X
hypothesis	B-X
,	B-X
we	B-X
find	B-X
that	B-X
inactivating	B-X
mutations	B-X
in	B-X
the	B-X
RSK1	B-X
kinase	B-X
domains	B-X
disrupted	B-X
the	B-X
mitogen-regulated	B-X
dissociation	B-X
of	B-X
ERK1/2	B-X
in	B-X
vivo	B-X
.	B-X
Analysis	B-X
of	B-X
different	B-X
RSK	B-X
isoforms	B-X
revealed	B-X
that	B-X
RSK1	B-X
and	B-X
RSK2	B-X
readily	B-X
dissociate	B-X
from	B-X
ERK1/2	B-X
following	B-X
mitogen	B-X
stimulation	B-X
but	B-X
that	B-X
RSK3	B-X
remains	B-X
associated	B-X
with	B-X
active	B-X
ERK1/2	B-X
.	B-X
RSK	B-X
activity	B-X
assays	B-X
revealed	B-X
that	B-X
RSK3	B-X
also	B-X
remains	B-X
active	B-X
longer	B-X
than	B-X
RSK1	B-X
and	B-X
RSK2	B-X
,	B-X
suggesting	B-X
that	B-X
prolonged	B-X
ERK	B-X
association	B-X
increased	B-X
the	B-X
duration	B-X
of	B-X
RSK3	B-X
activation	B-X
.	B-X
These	B-X
results	B-X
provide	B-X
new	B-X
evidence	B-X
for	B-X
the	B-X
regulated	B-X
nature	B-X
of	B-X
ERK	B-X
docking	B-X
interactions	B-X
and	B-X
reveal	B-X
important	B-X
differences	B-X
among	B-X
the	B-X
closely	B-X
related	B-X
RSK	B-X
family	B-X
members	B-X
.	B-X

Analysis	O
of	O
different	O
RSK	B-Gene_or_gene_product
isoforms	O
revealed	O
that	O
RSK1	B-Gene_or_gene_product
and	O
RSK2	B-Gene_or_gene_product
readily	O
dissociate	O
from	O
ERK1	B-Gene_or_gene_product
/	I-Gene_or_gene_product
2	I-Gene_or_gene_product
following	O
mitogen	O
stimulation	O
but	O
that	O
RSK3	B-Gene_or_gene_product
remains	O
associated	O
with	O
active	O
ERK1	B-Gene_or_gene_product
/	I-Gene_or_gene_product
2	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
p90	B-X
ribosomal	B-X
S6	B-X
kinases	B-X
(	B-X
RSKs	B-X
)	B-X
comprise	B-X
a	B-X
family	B-X
of	B-X
serine/threonine	B-X
kinases	B-X
that	B-X
lie	B-X
at	B-X
the	B-X
terminus	B-X
of	B-X
the	B-X
ERK	B-X
pathway	B-X
.	B-X
Efficient	B-X
RSK	B-X
activation	B-X
by	B-X
ERK	B-X
requires	B-X
its	B-X
interaction	B-X
through	B-X
a	B-X
docking	B-X
site	B-X
located	B-X
near	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
RSK	B-X
,	B-X
but	B-X
the	B-X
regulation	B-X
of	B-X
this	B-X
interaction	B-X
remains	B-X
unknown	B-X
.	B-X
In	B-X
this	B-X
report	B-X
we	B-X
show	B-X
that	B-X
RSK1	B-X
and	B-X
ERK1/2	B-X
form	B-X
a	B-X
complex	B-X
in	B-X
quiescent	B-X
HEK293	B-X
cells	B-X
that	B-X
transiently	B-X
dissociates	B-X
upon	B-X
mitogen	B-X
stimulation	B-X
.	B-X
Complex	B-X
dissociation	B-X
requires	B-X
phosphorylation	B-X
of	B-X
RSK1	B-X
serine	B-X
749	B-X
,	B-X
which	B-X
is	B-X
a	B-X
mitogen-regulated	B-X
phosphorylation	B-X
site	B-X
located	B-X
near	B-X
the	B-X
ERK	B-X
docking	B-X
site	B-X
.	B-X
Using	B-X
recombinant	B-X
RSK1	B-X
proteins	B-X
,	B-X
we	B-X
find	B-X
that	B-X
serine	B-X
749	B-X
is	B-X
phosphorylated	B-X
by	B-X
the	B-X
N-terminal	B-X
kinase	B-X
domain	B-X
of	B-X
RSK1	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
ERK1/2	B-X
dissociation	B-X
is	B-X
mediated	B-X
through	B-X
RSK1	B-X
autophosphorylation	B-X
of	B-X
this	B-X
residue	B-X
.	B-X
Consistent	B-X
with	B-X
this	B-X
hypothesis	B-X
,	B-X
we	B-X
find	B-X
that	B-X
inactivating	B-X
mutations	B-X
in	B-X
the	B-X
RSK1	B-X
kinase	B-X
domains	B-X
disrupted	B-X
the	B-X
mitogen-regulated	B-X
dissociation	B-X
of	B-X
ERK1/2	B-X
in	B-X
vivo	B-X
.	B-X
Analysis	B-X
of	B-X
different	B-X
RSK	B-X
isoforms	B-X
revealed	B-X
that	B-X
RSK1	B-X
and	B-X
RSK2	B-X
readily	B-X
dissociate	B-X
from	B-X
ERK1/2	B-X
following	B-X
mitogen	B-X
stimulation	B-X
but	B-X
that	B-X
RSK3	B-X
remains	B-X
associated	B-X
with	B-X
active	B-X
ERK1/2	B-X
.	B-X
RSK	B-X
activity	B-X
assays	B-X
revealed	B-X
that	B-X
RSK3	B-X
also	B-X
remains	B-X
active	B-X
longer	B-X
than	B-X
RSK1	B-X
and	B-X
RSK2	B-X
,	B-X
suggesting	B-X
that	B-X
prolonged	B-X
ERK	B-X
association	B-X
increased	B-X
the	B-X
duration	B-X
of	B-X
RSK3	B-X
activation	B-X
.	B-X
These	B-X
results	B-X
provide	B-X
new	B-X
evidence	B-X
for	B-X
the	B-X
regulated	B-X
nature	B-X
of	B-X
ERK	B-X
docking	B-X
interactions	B-X
and	B-X
reveal	B-X
important	B-X
differences	B-X
among	B-X
the	B-X
closely	B-X
related	B-X
RSK	B-X
family	B-X
members	B-X
.	B-X

RSK	B-Gene_or_gene_product
activity	O
assays	O
revealed	O
that	O
RSK3	B-Gene_or_gene_product
also	O
remains	O
active	O
longer	O
than	O
RSK1	B-Gene_or_gene_product
and	O
RSK2	B-Gene_or_gene_product
,	O
suggesting	O
that	O
prolonged	O
ERK	B-Gene_or_gene_product
association	O
increased	O
the	O
duration	O
of	O
RSK3	B-Gene_or_gene_product
activation	O
.	O
<EOS>	B-X
Stimulation	B-X
of	B-X
the	B-X
Ras/extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
ERK	B-X
)	B-X
pathway	B-X
can	B-X
modulate	B-X
cell	B-X
growth	B-X
,	B-X
proliferation	B-X
,	B-X
survival	B-X
,	B-X
and	B-X
motility	B-X
.	B-X
The	B-X
p90	B-X
ribosomal	B-X
S6	B-X
kinases	B-X
(	B-X
RSKs	B-X
)	B-X
comprise	B-X
a	B-X
family	B-X
of	B-X
serine/threonine	B-X
kinases	B-X
that	B-X
lie	B-X
at	B-X
the	B-X
terminus	B-X
of	B-X
the	B-X
ERK	B-X
pathway	B-X
.	B-X
Efficient	B-X
RSK	B-X
activation	B-X
by	B-X
ERK	B-X
requires	B-X
its	B-X
interaction	B-X
through	B-X
a	B-X
docking	B-X
site	B-X
located	B-X
near	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
RSK	B-X
,	B-X
but	B-X
the	B-X
regulation	B-X
of	B-X
this	B-X
interaction	B-X
remains	B-X
unknown	B-X
.	B-X
In	B-X
this	B-X
report	B-X
we	B-X
show	B-X
that	B-X
RSK1	B-X
and	B-X
ERK1/2	B-X
form	B-X
a	B-X
complex	B-X
in	B-X
quiescent	B-X
HEK293	B-X
cells	B-X
that	B-X
transiently	B-X
dissociates	B-X
upon	B-X
mitogen	B-X
stimulation	B-X
.	B-X
Complex	B-X
dissociation	B-X
requires	B-X
phosphorylation	B-X
of	B-X
RSK1	B-X
serine	B-X
749	B-X
,	B-X
which	B-X
is	B-X
a	B-X
mitogen-regulated	B-X
phosphorylation	B-X
site	B-X
located	B-X
near	B-X
the	B-X
ERK	B-X
docking	B-X
site	B-X
.	B-X
Using	B-X
recombinant	B-X
RSK1	B-X
proteins	B-X
,	B-X
we	B-X
find	B-X
that	B-X
serine	B-X
749	B-X
is	B-X
phosphorylated	B-X
by	B-X
the	B-X
N-terminal	B-X
kinase	B-X
domain	B-X
of	B-X
RSK1	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
ERK1/2	B-X
dissociation	B-X
is	B-X
mediated	B-X
through	B-X
RSK1	B-X
autophosphorylation	B-X
of	B-X
this	B-X
residue	B-X
.	B-X
Consistent	B-X
with	B-X
this	B-X
hypothesis	B-X
,	B-X
we	B-X
find	B-X
that	B-X
inactivating	B-X
mutations	B-X
in	B-X
the	B-X
RSK1	B-X
kinase	B-X
domains	B-X
disrupted	B-X
the	B-X
mitogen-regulated	B-X
dissociation	B-X
of	B-X
ERK1/2	B-X
in	B-X
vivo	B-X
.	B-X
Analysis	B-X
of	B-X
different	B-X
RSK	B-X
isoforms	B-X
revealed	B-X
that	B-X
RSK1	B-X
and	B-X
RSK2	B-X
readily	B-X
dissociate	B-X
from	B-X
ERK1/2	B-X
following	B-X
mitogen	B-X
stimulation	B-X
but	B-X
that	B-X
RSK3	B-X
remains	B-X
associated	B-X
with	B-X
active	B-X
ERK1/2	B-X
.	B-X
RSK	B-X
activity	B-X
assays	B-X
revealed	B-X
that	B-X
RSK3	B-X
also	B-X
remains	B-X
active	B-X
longer	B-X
than	B-X
RSK1	B-X
and	B-X
RSK2	B-X
,	B-X
suggesting	B-X
that	B-X
prolonged	B-X
ERK	B-X
association	B-X
increased	B-X
the	B-X
duration	B-X
of	B-X
RSK3	B-X
activation	B-X
.	B-X
These	B-X
results	B-X
provide	B-X
new	B-X
evidence	B-X
for	B-X
the	B-X
regulated	B-X
nature	B-X
of	B-X
ERK	B-X
docking	B-X
interactions	B-X
and	B-X
reveal	B-X
important	B-X
differences	B-X
among	B-X
the	B-X
closely	B-X
related	B-X
RSK	B-X
family	B-X
members	B-X
.	B-X

These	O
results	O
provide	O
new	O
evidence	O
for	O
the	O
regulated	O
nature	O
of	O
ERK	B-Gene_or_gene_product
docking	O
interactions	O
and	O
reveal	O
important	O
differences	O
among	O
the	O
closely	O
related	O
RSK	B-Gene_or_gene_product
family	O
members	O
.	O
<EOS>	B-X
Stimulation	B-X
of	B-X
the	B-X
Ras/extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
ERK	B-X
)	B-X
pathway	B-X
can	B-X
modulate	B-X
cell	B-X
growth	B-X
,	B-X
proliferation	B-X
,	B-X
survival	B-X
,	B-X
and	B-X
motility	B-X
.	B-X
The	B-X
p90	B-X
ribosomal	B-X
S6	B-X
kinases	B-X
(	B-X
RSKs	B-X
)	B-X
comprise	B-X
a	B-X
family	B-X
of	B-X
serine/threonine	B-X
kinases	B-X
that	B-X
lie	B-X
at	B-X
the	B-X
terminus	B-X
of	B-X
the	B-X
ERK	B-X
pathway	B-X
.	B-X
Efficient	B-X
RSK	B-X
activation	B-X
by	B-X
ERK	B-X
requires	B-X
its	B-X
interaction	B-X
through	B-X
a	B-X
docking	B-X
site	B-X
located	B-X
near	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
RSK	B-X
,	B-X
but	B-X
the	B-X
regulation	B-X
of	B-X
this	B-X
interaction	B-X
remains	B-X
unknown	B-X
.	B-X
In	B-X
this	B-X
report	B-X
we	B-X
show	B-X
that	B-X
RSK1	B-X
and	B-X
ERK1/2	B-X
form	B-X
a	B-X
complex	B-X
in	B-X
quiescent	B-X
HEK293	B-X
cells	B-X
that	B-X
transiently	B-X
dissociates	B-X
upon	B-X
mitogen	B-X
stimulation	B-X
.	B-X
Complex	B-X
dissociation	B-X
requires	B-X
phosphorylation	B-X
of	B-X
RSK1	B-X
serine	B-X
749	B-X
,	B-X
which	B-X
is	B-X
a	B-X
mitogen-regulated	B-X
phosphorylation	B-X
site	B-X
located	B-X
near	B-X
the	B-X
ERK	B-X
docking	B-X
site	B-X
.	B-X
Using	B-X
recombinant	B-X
RSK1	B-X
proteins	B-X
,	B-X
we	B-X
find	B-X
that	B-X
serine	B-X
749	B-X
is	B-X
phosphorylated	B-X
by	B-X
the	B-X
N-terminal	B-X
kinase	B-X
domain	B-X
of	B-X
RSK1	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
ERK1/2	B-X
dissociation	B-X
is	B-X
mediated	B-X
through	B-X
RSK1	B-X
autophosphorylation	B-X
of	B-X
this	B-X
residue	B-X
.	B-X
Consistent	B-X
with	B-X
this	B-X
hypothesis	B-X
,	B-X
we	B-X
find	B-X
that	B-X
inactivating	B-X
mutations	B-X
in	B-X
the	B-X
RSK1	B-X
kinase	B-X
domains	B-X
disrupted	B-X
the	B-X
mitogen-regulated	B-X
dissociation	B-X
of	B-X
ERK1/2	B-X
in	B-X
vivo	B-X
.	B-X
Analysis	B-X
of	B-X
different	B-X
RSK	B-X
isoforms	B-X
revealed	B-X
that	B-X
RSK1	B-X
and	B-X
RSK2	B-X
readily	B-X
dissociate	B-X
from	B-X
ERK1/2	B-X
following	B-X
mitogen	B-X
stimulation	B-X
but	B-X
that	B-X
RSK3	B-X
remains	B-X
associated	B-X
with	B-X
active	B-X
ERK1/2	B-X
.	B-X
RSK	B-X
activity	B-X
assays	B-X
revealed	B-X
that	B-X
RSK3	B-X
also	B-X
remains	B-X
active	B-X
longer	B-X
than	B-X
RSK1	B-X
and	B-X
RSK2	B-X
,	B-X
suggesting	B-X
that	B-X
prolonged	B-X
ERK	B-X
association	B-X
increased	B-X
the	B-X
duration	B-X
of	B-X
RSK3	B-X
activation	B-X
.	B-X
These	B-X
results	B-X
provide	B-X
new	B-X
evidence	B-X
for	B-X
the	B-X
regulated	B-X
nature	B-X
of	B-X
ERK	B-X
docking	B-X
interactions	B-X
and	B-X
reveal	B-X
important	B-X
differences	B-X
among	B-X
the	B-X
closely	B-X
related	B-X
RSK	B-X
family	B-X
members	B-X
.	B-X

E2F6	B-Gene_or_gene_product
negatively	O
regulates	O
BRCA1	B-Gene_or_gene_product
in	O
human	O
cancer	O
cells	O
without	O
methylation	O
of	O
histone	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
on	O
lysine	O
9	O
.	O
<EOS>	B-X
E2F6	B-X
contains	B-X
a	B-X
DNA	B-X
binding	B-X
domain	B-X
that	B-X
is	B-X
very	B-X
similar	B-X
to	B-X
that	B-X
of	B-X
the	B-X
other	B-X
members	B-X
of	B-X
the	B-X
E2F	B-X
family	B-X
of	B-X
transcriptional	B-X
regulators	B-X
.	B-X
However	B-X
,	B-X
E2F6	B-X
can	B-X
not	B-X
bind	B-X
to	B-X
all	B-X
promoters	B-X
that	B-X
contain	B-X
consensus	B-X
E2F-binding	B-X
sites	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
used	B-X
a	B-X
combination	B-X
of	B-X
chromatin	B-X
immunoprecipitation	B-X
and	B-X
genomic	B-X
microarrays	B-X
to	B-X
identify	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Although	B-X
most	B-X
of	B-X
the	B-X
identified	B-X
promoters	B-X
were	B-X
bound	B-X
by	B-X
multiple	B-X
E2F	B-X
family	B-X
members	B-X
,	B-X
one	B-X
promoter	B-X
was	B-X
bound	B-X
only	B-X
by	B-X
E2F6	B-X
.	B-X
To	B-X
determine	B-X
which	B-X
of	B-X
the	B-X
newly	B-X
identified	B-X
promoters	B-X
were	B-X
regulated	B-X
by	B-X
E2F6	B-X
,	B-X
we	B-X
reduced	B-X
the	B-X
level	B-X
of	B-X
E2F6	B-X
by	B-X
using	B-X
RNA	B-X
interference	B-X
technology	B-X
.	B-X
We	B-X
found	B-X
that	B-X
mRNA	B-X
transcribed	B-X
from	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
was	B-X
increased	B-X
after	B-X
reduction	B-X
of	B-X
the	B-X
amount	B-X
of	B-X
E2F6	B-X
protein	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
Interestingly	B-X
,	B-X
many	B-X
of	B-X
the	B-X
E2F6-regulated	B-X
genes	B-X
encoded	B-X
functions	B-X
involved	B-X
in	B-X
tumor	B-X
suppression	B-X
and	B-X
the	B-X
maintenance	B-X
of	B-X
chromatin	B-X
structure	B-X
.	B-X
Specifically	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
E2F6	B-X
represses	B-X
transcription	B-X
of	B-X
the	B-X
brca1	B-X
,	B-X
ctip	B-X
,	B-X
art27	B-X
,	B-X
hp1alpha	B-X
,	B-X
and	B-X
the	B-X
rbap48	B-X
genes	B-X
.	B-X
E2F6	B-X
has	B-X
been	B-X
postulated	B-X
to	B-X
mediate	B-X
transcriptional	B-X
repression	B-X
by	B-X
recruiting	B-X
a	B-X
histone	B-X
H3	B-X
methyltransferase	B-X
to	B-X
the	B-X
DNA	B-X
.	B-X
However	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
E2F6-regulated	B-X
promoters	B-X
did	B-X
not	B-X
contain	B-X
histone	B-X
H3	B-X
methylated	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
E2F6	B-X
regulates	B-X
transcription	B-X
,	B-X
we	B-X
performed	B-X
chromatin	B-X
immunoprecipitation	B-X
before	B-X
and	B-X
after	B-X
the	B-X
introduction	B-X
of	B-X
small	B-X
inhibitory	B-X
ribonucleic	B-X
acids	B-X
specific	B-X
to	B-X
E2F6	B-X
.	B-X
We	B-X
found	B-X
that	B-X
depletion	B-X
of	B-X
E2F6	B-X
resulted	B-X
in	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
target	B-X
promoters	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
48	B-X
endogenous	B-X
target	B-X
genes	B-X
of	B-X
E2F6	B-X
and	B-X
have	B-X
shown	B-X
that	B-X
E2F6	B-X
can	B-X
repress	B-X
target	B-X
promoters	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
does	B-X
not	B-X
require	B-X
histone	B-X
H3	B-X
methylation	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X

E2F6	B-Gene_or_gene_product
contains	O
a	O
DNA	O
binding	O
domain	O
that	O
is	O
very	O
similar	O
to	O
that	O
of	O
the	O
other	O
members	O
of	O
the	O
E2F	B-Gene_or_gene_product
family	O
of	O
transcriptional	O
regulators	O
.	O
<EOS>	B-X
E2F6	B-X
contains	B-X
a	B-X
DNA	B-X
binding	B-X
domain	B-X
that	B-X
is	B-X
very	B-X
similar	B-X
to	B-X
that	B-X
of	B-X
the	B-X
other	B-X
members	B-X
of	B-X
the	B-X
E2F	B-X
family	B-X
of	B-X
transcriptional	B-X
regulators	B-X
.	B-X
However	B-X
,	B-X
E2F6	B-X
can	B-X
not	B-X
bind	B-X
to	B-X
all	B-X
promoters	B-X
that	B-X
contain	B-X
consensus	B-X
E2F-binding	B-X
sites	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
used	B-X
a	B-X
combination	B-X
of	B-X
chromatin	B-X
immunoprecipitation	B-X
and	B-X
genomic	B-X
microarrays	B-X
to	B-X
identify	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Although	B-X
most	B-X
of	B-X
the	B-X
identified	B-X
promoters	B-X
were	B-X
bound	B-X
by	B-X
multiple	B-X
E2F	B-X
family	B-X
members	B-X
,	B-X
one	B-X
promoter	B-X
was	B-X
bound	B-X
only	B-X
by	B-X
E2F6	B-X
.	B-X
To	B-X
determine	B-X
which	B-X
of	B-X
the	B-X
newly	B-X
identified	B-X
promoters	B-X
were	B-X
regulated	B-X
by	B-X
E2F6	B-X
,	B-X
we	B-X
reduced	B-X
the	B-X
level	B-X
of	B-X
E2F6	B-X
by	B-X
using	B-X
RNA	B-X
interference	B-X
technology	B-X
.	B-X
We	B-X
found	B-X
that	B-X
mRNA	B-X
transcribed	B-X
from	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
was	B-X
increased	B-X
after	B-X
reduction	B-X
of	B-X
the	B-X
amount	B-X
of	B-X
E2F6	B-X
protein	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
Interestingly	B-X
,	B-X
many	B-X
of	B-X
the	B-X
E2F6-regulated	B-X
genes	B-X
encoded	B-X
functions	B-X
involved	B-X
in	B-X
tumor	B-X
suppression	B-X
and	B-X
the	B-X
maintenance	B-X
of	B-X
chromatin	B-X
structure	B-X
.	B-X
Specifically	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
E2F6	B-X
represses	B-X
transcription	B-X
of	B-X
the	B-X
brca1	B-X
,	B-X
ctip	B-X
,	B-X
art27	B-X
,	B-X
hp1alpha	B-X
,	B-X
and	B-X
the	B-X
rbap48	B-X
genes	B-X
.	B-X
E2F6	B-X
has	B-X
been	B-X
postulated	B-X
to	B-X
mediate	B-X
transcriptional	B-X
repression	B-X
by	B-X
recruiting	B-X
a	B-X
histone	B-X
H3	B-X
methyltransferase	B-X
to	B-X
the	B-X
DNA	B-X
.	B-X
However	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
E2F6-regulated	B-X
promoters	B-X
did	B-X
not	B-X
contain	B-X
histone	B-X
H3	B-X
methylated	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
E2F6	B-X
regulates	B-X
transcription	B-X
,	B-X
we	B-X
performed	B-X
chromatin	B-X
immunoprecipitation	B-X
before	B-X
and	B-X
after	B-X
the	B-X
introduction	B-X
of	B-X
small	B-X
inhibitory	B-X
ribonucleic	B-X
acids	B-X
specific	B-X
to	B-X
E2F6	B-X
.	B-X
We	B-X
found	B-X
that	B-X
depletion	B-X
of	B-X
E2F6	B-X
resulted	B-X
in	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
target	B-X
promoters	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
48	B-X
endogenous	B-X
target	B-X
genes	B-X
of	B-X
E2F6	B-X
and	B-X
have	B-X
shown	B-X
that	B-X
E2F6	B-X
can	B-X
repress	B-X
target	B-X
promoters	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
does	B-X
not	B-X
require	B-X
histone	B-X
H3	B-X
methylation	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X

However	O
,	O
E2F6	B-Gene_or_gene_product
cannot	O
bind	O
to	O
all	O
promoters	O
that	O
contain	O
consensus	O
E2F	B-Gene_or_gene_product
-	O
binding	O
sites	O
.	O
<EOS>	B-X
E2F6	B-X
contains	B-X
a	B-X
DNA	B-X
binding	B-X
domain	B-X
that	B-X
is	B-X
very	B-X
similar	B-X
to	B-X
that	B-X
of	B-X
the	B-X
other	B-X
members	B-X
of	B-X
the	B-X
E2F	B-X
family	B-X
of	B-X
transcriptional	B-X
regulators	B-X
.	B-X
However	B-X
,	B-X
E2F6	B-X
can	B-X
not	B-X
bind	B-X
to	B-X
all	B-X
promoters	B-X
that	B-X
contain	B-X
consensus	B-X
E2F-binding	B-X
sites	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
used	B-X
a	B-X
combination	B-X
of	B-X
chromatin	B-X
immunoprecipitation	B-X
and	B-X
genomic	B-X
microarrays	B-X
to	B-X
identify	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Although	B-X
most	B-X
of	B-X
the	B-X
identified	B-X
promoters	B-X
were	B-X
bound	B-X
by	B-X
multiple	B-X
E2F	B-X
family	B-X
members	B-X
,	B-X
one	B-X
promoter	B-X
was	B-X
bound	B-X
only	B-X
by	B-X
E2F6	B-X
.	B-X
To	B-X
determine	B-X
which	B-X
of	B-X
the	B-X
newly	B-X
identified	B-X
promoters	B-X
were	B-X
regulated	B-X
by	B-X
E2F6	B-X
,	B-X
we	B-X
reduced	B-X
the	B-X
level	B-X
of	B-X
E2F6	B-X
by	B-X
using	B-X
RNA	B-X
interference	B-X
technology	B-X
.	B-X
We	B-X
found	B-X
that	B-X
mRNA	B-X
transcribed	B-X
from	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
was	B-X
increased	B-X
after	B-X
reduction	B-X
of	B-X
the	B-X
amount	B-X
of	B-X
E2F6	B-X
protein	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
Interestingly	B-X
,	B-X
many	B-X
of	B-X
the	B-X
E2F6-regulated	B-X
genes	B-X
encoded	B-X
functions	B-X
involved	B-X
in	B-X
tumor	B-X
suppression	B-X
and	B-X
the	B-X
maintenance	B-X
of	B-X
chromatin	B-X
structure	B-X
.	B-X
Specifically	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
E2F6	B-X
represses	B-X
transcription	B-X
of	B-X
the	B-X
brca1	B-X
,	B-X
ctip	B-X
,	B-X
art27	B-X
,	B-X
hp1alpha	B-X
,	B-X
and	B-X
the	B-X
rbap48	B-X
genes	B-X
.	B-X
E2F6	B-X
has	B-X
been	B-X
postulated	B-X
to	B-X
mediate	B-X
transcriptional	B-X
repression	B-X
by	B-X
recruiting	B-X
a	B-X
histone	B-X
H3	B-X
methyltransferase	B-X
to	B-X
the	B-X
DNA	B-X
.	B-X
However	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
E2F6-regulated	B-X
promoters	B-X
did	B-X
not	B-X
contain	B-X
histone	B-X
H3	B-X
methylated	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
E2F6	B-X
regulates	B-X
transcription	B-X
,	B-X
we	B-X
performed	B-X
chromatin	B-X
immunoprecipitation	B-X
before	B-X
and	B-X
after	B-X
the	B-X
introduction	B-X
of	B-X
small	B-X
inhibitory	B-X
ribonucleic	B-X
acids	B-X
specific	B-X
to	B-X
E2F6	B-X
.	B-X
We	B-X
found	B-X
that	B-X
depletion	B-X
of	B-X
E2F6	B-X
resulted	B-X
in	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
target	B-X
promoters	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
48	B-X
endogenous	B-X
target	B-X
genes	B-X
of	B-X
E2F6	B-X
and	B-X
have	B-X
shown	B-X
that	B-X
E2F6	B-X
can	B-X
repress	B-X
target	B-X
promoters	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
does	B-X
not	B-X
require	B-X
histone	B-X
H3	B-X
methylation	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X

Therefore	O
,	O
we	O
used	O
a	O
combination	O
of	O
chromatin	O
immunoprecipitation	O
and	O
genomic	O
microarrays	O
to	O
identify	O
promoters	O
bound	O
by	O
E2F6	B-Gene_or_gene_product
in	O
human	O
cells	O
.	O
<EOS>	B-X
E2F6	B-X
contains	B-X
a	B-X
DNA	B-X
binding	B-X
domain	B-X
that	B-X
is	B-X
very	B-X
similar	B-X
to	B-X
that	B-X
of	B-X
the	B-X
other	B-X
members	B-X
of	B-X
the	B-X
E2F	B-X
family	B-X
of	B-X
transcriptional	B-X
regulators	B-X
.	B-X
However	B-X
,	B-X
E2F6	B-X
can	B-X
not	B-X
bind	B-X
to	B-X
all	B-X
promoters	B-X
that	B-X
contain	B-X
consensus	B-X
E2F-binding	B-X
sites	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
used	B-X
a	B-X
combination	B-X
of	B-X
chromatin	B-X
immunoprecipitation	B-X
and	B-X
genomic	B-X
microarrays	B-X
to	B-X
identify	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Although	B-X
most	B-X
of	B-X
the	B-X
identified	B-X
promoters	B-X
were	B-X
bound	B-X
by	B-X
multiple	B-X
E2F	B-X
family	B-X
members	B-X
,	B-X
one	B-X
promoter	B-X
was	B-X
bound	B-X
only	B-X
by	B-X
E2F6	B-X
.	B-X
To	B-X
determine	B-X
which	B-X
of	B-X
the	B-X
newly	B-X
identified	B-X
promoters	B-X
were	B-X
regulated	B-X
by	B-X
E2F6	B-X
,	B-X
we	B-X
reduced	B-X
the	B-X
level	B-X
of	B-X
E2F6	B-X
by	B-X
using	B-X
RNA	B-X
interference	B-X
technology	B-X
.	B-X
We	B-X
found	B-X
that	B-X
mRNA	B-X
transcribed	B-X
from	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
was	B-X
increased	B-X
after	B-X
reduction	B-X
of	B-X
the	B-X
amount	B-X
of	B-X
E2F6	B-X
protein	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
Interestingly	B-X
,	B-X
many	B-X
of	B-X
the	B-X
E2F6-regulated	B-X
genes	B-X
encoded	B-X
functions	B-X
involved	B-X
in	B-X
tumor	B-X
suppression	B-X
and	B-X
the	B-X
maintenance	B-X
of	B-X
chromatin	B-X
structure	B-X
.	B-X
Specifically	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
E2F6	B-X
represses	B-X
transcription	B-X
of	B-X
the	B-X
brca1	B-X
,	B-X
ctip	B-X
,	B-X
art27	B-X
,	B-X
hp1alpha	B-X
,	B-X
and	B-X
the	B-X
rbap48	B-X
genes	B-X
.	B-X
E2F6	B-X
has	B-X
been	B-X
postulated	B-X
to	B-X
mediate	B-X
transcriptional	B-X
repression	B-X
by	B-X
recruiting	B-X
a	B-X
histone	B-X
H3	B-X
methyltransferase	B-X
to	B-X
the	B-X
DNA	B-X
.	B-X
However	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
E2F6-regulated	B-X
promoters	B-X
did	B-X
not	B-X
contain	B-X
histone	B-X
H3	B-X
methylated	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
E2F6	B-X
regulates	B-X
transcription	B-X
,	B-X
we	B-X
performed	B-X
chromatin	B-X
immunoprecipitation	B-X
before	B-X
and	B-X
after	B-X
the	B-X
introduction	B-X
of	B-X
small	B-X
inhibitory	B-X
ribonucleic	B-X
acids	B-X
specific	B-X
to	B-X
E2F6	B-X
.	B-X
We	B-X
found	B-X
that	B-X
depletion	B-X
of	B-X
E2F6	B-X
resulted	B-X
in	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
target	B-X
promoters	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
48	B-X
endogenous	B-X
target	B-X
genes	B-X
of	B-X
E2F6	B-X
and	B-X
have	B-X
shown	B-X
that	B-X
E2F6	B-X
can	B-X
repress	B-X
target	B-X
promoters	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
does	B-X
not	B-X
require	B-X
histone	B-X
H3	B-X
methylation	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X

Although	O
most	O
of	O
the	O
identified	O
promoters	O
were	O
bound	O
by	O
multiple	O
E2F	B-Gene_or_gene_product
family	O
members	O
,	O
one	O
promoter	O
was	O
bound	O
only	O
by	O
E2F6	B-Gene_or_gene_product
.	O
<EOS>	B-X
E2F6	B-X
contains	B-X
a	B-X
DNA	B-X
binding	B-X
domain	B-X
that	B-X
is	B-X
very	B-X
similar	B-X
to	B-X
that	B-X
of	B-X
the	B-X
other	B-X
members	B-X
of	B-X
the	B-X
E2F	B-X
family	B-X
of	B-X
transcriptional	B-X
regulators	B-X
.	B-X
However	B-X
,	B-X
E2F6	B-X
can	B-X
not	B-X
bind	B-X
to	B-X
all	B-X
promoters	B-X
that	B-X
contain	B-X
consensus	B-X
E2F-binding	B-X
sites	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
used	B-X
a	B-X
combination	B-X
of	B-X
chromatin	B-X
immunoprecipitation	B-X
and	B-X
genomic	B-X
microarrays	B-X
to	B-X
identify	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Although	B-X
most	B-X
of	B-X
the	B-X
identified	B-X
promoters	B-X
were	B-X
bound	B-X
by	B-X
multiple	B-X
E2F	B-X
family	B-X
members	B-X
,	B-X
one	B-X
promoter	B-X
was	B-X
bound	B-X
only	B-X
by	B-X
E2F6	B-X
.	B-X
To	B-X
determine	B-X
which	B-X
of	B-X
the	B-X
newly	B-X
identified	B-X
promoters	B-X
were	B-X
regulated	B-X
by	B-X
E2F6	B-X
,	B-X
we	B-X
reduced	B-X
the	B-X
level	B-X
of	B-X
E2F6	B-X
by	B-X
using	B-X
RNA	B-X
interference	B-X
technology	B-X
.	B-X
We	B-X
found	B-X
that	B-X
mRNA	B-X
transcribed	B-X
from	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
was	B-X
increased	B-X
after	B-X
reduction	B-X
of	B-X
the	B-X
amount	B-X
of	B-X
E2F6	B-X
protein	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
Interestingly	B-X
,	B-X
many	B-X
of	B-X
the	B-X
E2F6-regulated	B-X
genes	B-X
encoded	B-X
functions	B-X
involved	B-X
in	B-X
tumor	B-X
suppression	B-X
and	B-X
the	B-X
maintenance	B-X
of	B-X
chromatin	B-X
structure	B-X
.	B-X
Specifically	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
E2F6	B-X
represses	B-X
transcription	B-X
of	B-X
the	B-X
brca1	B-X
,	B-X
ctip	B-X
,	B-X
art27	B-X
,	B-X
hp1alpha	B-X
,	B-X
and	B-X
the	B-X
rbap48	B-X
genes	B-X
.	B-X
E2F6	B-X
has	B-X
been	B-X
postulated	B-X
to	B-X
mediate	B-X
transcriptional	B-X
repression	B-X
by	B-X
recruiting	B-X
a	B-X
histone	B-X
H3	B-X
methyltransferase	B-X
to	B-X
the	B-X
DNA	B-X
.	B-X
However	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
E2F6-regulated	B-X
promoters	B-X
did	B-X
not	B-X
contain	B-X
histone	B-X
H3	B-X
methylated	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
E2F6	B-X
regulates	B-X
transcription	B-X
,	B-X
we	B-X
performed	B-X
chromatin	B-X
immunoprecipitation	B-X
before	B-X
and	B-X
after	B-X
the	B-X
introduction	B-X
of	B-X
small	B-X
inhibitory	B-X
ribonucleic	B-X
acids	B-X
specific	B-X
to	B-X
E2F6	B-X
.	B-X
We	B-X
found	B-X
that	B-X
depletion	B-X
of	B-X
E2F6	B-X
resulted	B-X
in	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
target	B-X
promoters	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
48	B-X
endogenous	B-X
target	B-X
genes	B-X
of	B-X
E2F6	B-X
and	B-X
have	B-X
shown	B-X
that	B-X
E2F6	B-X
can	B-X
repress	B-X
target	B-X
promoters	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
does	B-X
not	B-X
require	B-X
histone	B-X
H3	B-X
methylation	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X

To	O
determine	O
which	O
of	O
the	O
newly	O
identified	O
promoters	O
were	O
regulated	O
by	O
E2F6	B-Gene_or_gene_product
,	O
we	O
reduced	O
the	O
level	O
of	O
E2F6	B-Gene_or_gene_product
by	O
using	O
RNA	O
interference	O
technology	O
.	O
<EOS>	B-X
E2F6	B-X
contains	B-X
a	B-X
DNA	B-X
binding	B-X
domain	B-X
that	B-X
is	B-X
very	B-X
similar	B-X
to	B-X
that	B-X
of	B-X
the	B-X
other	B-X
members	B-X
of	B-X
the	B-X
E2F	B-X
family	B-X
of	B-X
transcriptional	B-X
regulators	B-X
.	B-X
However	B-X
,	B-X
E2F6	B-X
can	B-X
not	B-X
bind	B-X
to	B-X
all	B-X
promoters	B-X
that	B-X
contain	B-X
consensus	B-X
E2F-binding	B-X
sites	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
used	B-X
a	B-X
combination	B-X
of	B-X
chromatin	B-X
immunoprecipitation	B-X
and	B-X
genomic	B-X
microarrays	B-X
to	B-X
identify	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Although	B-X
most	B-X
of	B-X
the	B-X
identified	B-X
promoters	B-X
were	B-X
bound	B-X
by	B-X
multiple	B-X
E2F	B-X
family	B-X
members	B-X
,	B-X
one	B-X
promoter	B-X
was	B-X
bound	B-X
only	B-X
by	B-X
E2F6	B-X
.	B-X
To	B-X
determine	B-X
which	B-X
of	B-X
the	B-X
newly	B-X
identified	B-X
promoters	B-X
were	B-X
regulated	B-X
by	B-X
E2F6	B-X
,	B-X
we	B-X
reduced	B-X
the	B-X
level	B-X
of	B-X
E2F6	B-X
by	B-X
using	B-X
RNA	B-X
interference	B-X
technology	B-X
.	B-X
We	B-X
found	B-X
that	B-X
mRNA	B-X
transcribed	B-X
from	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
was	B-X
increased	B-X
after	B-X
reduction	B-X
of	B-X
the	B-X
amount	B-X
of	B-X
E2F6	B-X
protein	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
Interestingly	B-X
,	B-X
many	B-X
of	B-X
the	B-X
E2F6-regulated	B-X
genes	B-X
encoded	B-X
functions	B-X
involved	B-X
in	B-X
tumor	B-X
suppression	B-X
and	B-X
the	B-X
maintenance	B-X
of	B-X
chromatin	B-X
structure	B-X
.	B-X
Specifically	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
E2F6	B-X
represses	B-X
transcription	B-X
of	B-X
the	B-X
brca1	B-X
,	B-X
ctip	B-X
,	B-X
art27	B-X
,	B-X
hp1alpha	B-X
,	B-X
and	B-X
the	B-X
rbap48	B-X
genes	B-X
.	B-X
E2F6	B-X
has	B-X
been	B-X
postulated	B-X
to	B-X
mediate	B-X
transcriptional	B-X
repression	B-X
by	B-X
recruiting	B-X
a	B-X
histone	B-X
H3	B-X
methyltransferase	B-X
to	B-X
the	B-X
DNA	B-X
.	B-X
However	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
E2F6-regulated	B-X
promoters	B-X
did	B-X
not	B-X
contain	B-X
histone	B-X
H3	B-X
methylated	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
E2F6	B-X
regulates	B-X
transcription	B-X
,	B-X
we	B-X
performed	B-X
chromatin	B-X
immunoprecipitation	B-X
before	B-X
and	B-X
after	B-X
the	B-X
introduction	B-X
of	B-X
small	B-X
inhibitory	B-X
ribonucleic	B-X
acids	B-X
specific	B-X
to	B-X
E2F6	B-X
.	B-X
We	B-X
found	B-X
that	B-X
depletion	B-X
of	B-X
E2F6	B-X
resulted	B-X
in	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
target	B-X
promoters	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
48	B-X
endogenous	B-X
target	B-X
genes	B-X
of	B-X
E2F6	B-X
and	B-X
have	B-X
shown	B-X
that	B-X
E2F6	B-X
can	B-X
repress	B-X
target	B-X
promoters	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
does	B-X
not	B-X
require	B-X
histone	B-X
H3	B-X
methylation	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X

We	O
found	O
that	O
mRNA	O
transcribed	O
from	O
promoters	O
bound	O
by	O
E2F6	B-Gene_or_gene_product
was	O
increased	O
after	O
reduction	O
of	O
the	O
amount	O
of	O
E2F6	B-Gene_or_gene_product
protein	O
in	O
the	O
cell	O
.	O
<EOS>	B-X
E2F6	B-X
contains	B-X
a	B-X
DNA	B-X
binding	B-X
domain	B-X
that	B-X
is	B-X
very	B-X
similar	B-X
to	B-X
that	B-X
of	B-X
the	B-X
other	B-X
members	B-X
of	B-X
the	B-X
E2F	B-X
family	B-X
of	B-X
transcriptional	B-X
regulators	B-X
.	B-X
However	B-X
,	B-X
E2F6	B-X
can	B-X
not	B-X
bind	B-X
to	B-X
all	B-X
promoters	B-X
that	B-X
contain	B-X
consensus	B-X
E2F-binding	B-X
sites	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
used	B-X
a	B-X
combination	B-X
of	B-X
chromatin	B-X
immunoprecipitation	B-X
and	B-X
genomic	B-X
microarrays	B-X
to	B-X
identify	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Although	B-X
most	B-X
of	B-X
the	B-X
identified	B-X
promoters	B-X
were	B-X
bound	B-X
by	B-X
multiple	B-X
E2F	B-X
family	B-X
members	B-X
,	B-X
one	B-X
promoter	B-X
was	B-X
bound	B-X
only	B-X
by	B-X
E2F6	B-X
.	B-X
To	B-X
determine	B-X
which	B-X
of	B-X
the	B-X
newly	B-X
identified	B-X
promoters	B-X
were	B-X
regulated	B-X
by	B-X
E2F6	B-X
,	B-X
we	B-X
reduced	B-X
the	B-X
level	B-X
of	B-X
E2F6	B-X
by	B-X
using	B-X
RNA	B-X
interference	B-X
technology	B-X
.	B-X
We	B-X
found	B-X
that	B-X
mRNA	B-X
transcribed	B-X
from	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
was	B-X
increased	B-X
after	B-X
reduction	B-X
of	B-X
the	B-X
amount	B-X
of	B-X
E2F6	B-X
protein	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
Interestingly	B-X
,	B-X
many	B-X
of	B-X
the	B-X
E2F6-regulated	B-X
genes	B-X
encoded	B-X
functions	B-X
involved	B-X
in	B-X
tumor	B-X
suppression	B-X
and	B-X
the	B-X
maintenance	B-X
of	B-X
chromatin	B-X
structure	B-X
.	B-X
Specifically	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
E2F6	B-X
represses	B-X
transcription	B-X
of	B-X
the	B-X
brca1	B-X
,	B-X
ctip	B-X
,	B-X
art27	B-X
,	B-X
hp1alpha	B-X
,	B-X
and	B-X
the	B-X
rbap48	B-X
genes	B-X
.	B-X
E2F6	B-X
has	B-X
been	B-X
postulated	B-X
to	B-X
mediate	B-X
transcriptional	B-X
repression	B-X
by	B-X
recruiting	B-X
a	B-X
histone	B-X
H3	B-X
methyltransferase	B-X
to	B-X
the	B-X
DNA	B-X
.	B-X
However	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
E2F6-regulated	B-X
promoters	B-X
did	B-X
not	B-X
contain	B-X
histone	B-X
H3	B-X
methylated	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
E2F6	B-X
regulates	B-X
transcription	B-X
,	B-X
we	B-X
performed	B-X
chromatin	B-X
immunoprecipitation	B-X
before	B-X
and	B-X
after	B-X
the	B-X
introduction	B-X
of	B-X
small	B-X
inhibitory	B-X
ribonucleic	B-X
acids	B-X
specific	B-X
to	B-X
E2F6	B-X
.	B-X
We	B-X
found	B-X
that	B-X
depletion	B-X
of	B-X
E2F6	B-X
resulted	B-X
in	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
target	B-X
promoters	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
48	B-X
endogenous	B-X
target	B-X
genes	B-X
of	B-X
E2F6	B-X
and	B-X
have	B-X
shown	B-X
that	B-X
E2F6	B-X
can	B-X
repress	B-X
target	B-X
promoters	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
does	B-X
not	B-X
require	B-X
histone	B-X
H3	B-X
methylation	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X

Interestingly	O
,	O
many	O
of	O
the	O
E2F6	B-Gene_or_gene_product
-	O
regulated	O
genes	O
encoded	O
functions	O
involved	O
in	O
tumor	O
suppression	O
and	O
the	O
maintenance	O
of	O
chromatin	O
structure	O
.	O
<EOS>	B-X
E2F6	B-X
contains	B-X
a	B-X
DNA	B-X
binding	B-X
domain	B-X
that	B-X
is	B-X
very	B-X
similar	B-X
to	B-X
that	B-X
of	B-X
the	B-X
other	B-X
members	B-X
of	B-X
the	B-X
E2F	B-X
family	B-X
of	B-X
transcriptional	B-X
regulators	B-X
.	B-X
However	B-X
,	B-X
E2F6	B-X
can	B-X
not	B-X
bind	B-X
to	B-X
all	B-X
promoters	B-X
that	B-X
contain	B-X
consensus	B-X
E2F-binding	B-X
sites	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
used	B-X
a	B-X
combination	B-X
of	B-X
chromatin	B-X
immunoprecipitation	B-X
and	B-X
genomic	B-X
microarrays	B-X
to	B-X
identify	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Although	B-X
most	B-X
of	B-X
the	B-X
identified	B-X
promoters	B-X
were	B-X
bound	B-X
by	B-X
multiple	B-X
E2F	B-X
family	B-X
members	B-X
,	B-X
one	B-X
promoter	B-X
was	B-X
bound	B-X
only	B-X
by	B-X
E2F6	B-X
.	B-X
To	B-X
determine	B-X
which	B-X
of	B-X
the	B-X
newly	B-X
identified	B-X
promoters	B-X
were	B-X
regulated	B-X
by	B-X
E2F6	B-X
,	B-X
we	B-X
reduced	B-X
the	B-X
level	B-X
of	B-X
E2F6	B-X
by	B-X
using	B-X
RNA	B-X
interference	B-X
technology	B-X
.	B-X
We	B-X
found	B-X
that	B-X
mRNA	B-X
transcribed	B-X
from	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
was	B-X
increased	B-X
after	B-X
reduction	B-X
of	B-X
the	B-X
amount	B-X
of	B-X
E2F6	B-X
protein	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
Interestingly	B-X
,	B-X
many	B-X
of	B-X
the	B-X
E2F6-regulated	B-X
genes	B-X
encoded	B-X
functions	B-X
involved	B-X
in	B-X
tumor	B-X
suppression	B-X
and	B-X
the	B-X
maintenance	B-X
of	B-X
chromatin	B-X
structure	B-X
.	B-X
Specifically	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
E2F6	B-X
represses	B-X
transcription	B-X
of	B-X
the	B-X
brca1	B-X
,	B-X
ctip	B-X
,	B-X
art27	B-X
,	B-X
hp1alpha	B-X
,	B-X
and	B-X
the	B-X
rbap48	B-X
genes	B-X
.	B-X
E2F6	B-X
has	B-X
been	B-X
postulated	B-X
to	B-X
mediate	B-X
transcriptional	B-X
repression	B-X
by	B-X
recruiting	B-X
a	B-X
histone	B-X
H3	B-X
methyltransferase	B-X
to	B-X
the	B-X
DNA	B-X
.	B-X
However	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
E2F6-regulated	B-X
promoters	B-X
did	B-X
not	B-X
contain	B-X
histone	B-X
H3	B-X
methylated	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
E2F6	B-X
regulates	B-X
transcription	B-X
,	B-X
we	B-X
performed	B-X
chromatin	B-X
immunoprecipitation	B-X
before	B-X
and	B-X
after	B-X
the	B-X
introduction	B-X
of	B-X
small	B-X
inhibitory	B-X
ribonucleic	B-X
acids	B-X
specific	B-X
to	B-X
E2F6	B-X
.	B-X
We	B-X
found	B-X
that	B-X
depletion	B-X
of	B-X
E2F6	B-X
resulted	B-X
in	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
target	B-X
promoters	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
48	B-X
endogenous	B-X
target	B-X
genes	B-X
of	B-X
E2F6	B-X
and	B-X
have	B-X
shown	B-X
that	B-X
E2F6	B-X
can	B-X
repress	B-X
target	B-X
promoters	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
does	B-X
not	B-X
require	B-X
histone	B-X
H3	B-X
methylation	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X

Specifically	O
,	O
our	O
results	O
suggest	O
that	O
E2F6	B-Gene_or_gene_product
represses	O
transcription	O
of	O
the	O
brca1	B-Gene_or_gene_product
,	O
ctip	B-Gene_or_gene_product
,	O
art27	B-Gene_or_gene_product
,	O
hp1alpha	B-Gene_or_gene_product
,	O
and	O
the	O
rbap48	B-Gene_or_gene_product
genes	O
.	O
<EOS>	B-X
E2F6	B-X
contains	B-X
a	B-X
DNA	B-X
binding	B-X
domain	B-X
that	B-X
is	B-X
very	B-X
similar	B-X
to	B-X
that	B-X
of	B-X
the	B-X
other	B-X
members	B-X
of	B-X
the	B-X
E2F	B-X
family	B-X
of	B-X
transcriptional	B-X
regulators	B-X
.	B-X
However	B-X
,	B-X
E2F6	B-X
can	B-X
not	B-X
bind	B-X
to	B-X
all	B-X
promoters	B-X
that	B-X
contain	B-X
consensus	B-X
E2F-binding	B-X
sites	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
used	B-X
a	B-X
combination	B-X
of	B-X
chromatin	B-X
immunoprecipitation	B-X
and	B-X
genomic	B-X
microarrays	B-X
to	B-X
identify	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Although	B-X
most	B-X
of	B-X
the	B-X
identified	B-X
promoters	B-X
were	B-X
bound	B-X
by	B-X
multiple	B-X
E2F	B-X
family	B-X
members	B-X
,	B-X
one	B-X
promoter	B-X
was	B-X
bound	B-X
only	B-X
by	B-X
E2F6	B-X
.	B-X
To	B-X
determine	B-X
which	B-X
of	B-X
the	B-X
newly	B-X
identified	B-X
promoters	B-X
were	B-X
regulated	B-X
by	B-X
E2F6	B-X
,	B-X
we	B-X
reduced	B-X
the	B-X
level	B-X
of	B-X
E2F6	B-X
by	B-X
using	B-X
RNA	B-X
interference	B-X
technology	B-X
.	B-X
We	B-X
found	B-X
that	B-X
mRNA	B-X
transcribed	B-X
from	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
was	B-X
increased	B-X
after	B-X
reduction	B-X
of	B-X
the	B-X
amount	B-X
of	B-X
E2F6	B-X
protein	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
Interestingly	B-X
,	B-X
many	B-X
of	B-X
the	B-X
E2F6-regulated	B-X
genes	B-X
encoded	B-X
functions	B-X
involved	B-X
in	B-X
tumor	B-X
suppression	B-X
and	B-X
the	B-X
maintenance	B-X
of	B-X
chromatin	B-X
structure	B-X
.	B-X
Specifically	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
E2F6	B-X
represses	B-X
transcription	B-X
of	B-X
the	B-X
brca1	B-X
,	B-X
ctip	B-X
,	B-X
art27	B-X
,	B-X
hp1alpha	B-X
,	B-X
and	B-X
the	B-X
rbap48	B-X
genes	B-X
.	B-X
E2F6	B-X
has	B-X
been	B-X
postulated	B-X
to	B-X
mediate	B-X
transcriptional	B-X
repression	B-X
by	B-X
recruiting	B-X
a	B-X
histone	B-X
H3	B-X
methyltransferase	B-X
to	B-X
the	B-X
DNA	B-X
.	B-X
However	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
E2F6-regulated	B-X
promoters	B-X
did	B-X
not	B-X
contain	B-X
histone	B-X
H3	B-X
methylated	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
E2F6	B-X
regulates	B-X
transcription	B-X
,	B-X
we	B-X
performed	B-X
chromatin	B-X
immunoprecipitation	B-X
before	B-X
and	B-X
after	B-X
the	B-X
introduction	B-X
of	B-X
small	B-X
inhibitory	B-X
ribonucleic	B-X
acids	B-X
specific	B-X
to	B-X
E2F6	B-X
.	B-X
We	B-X
found	B-X
that	B-X
depletion	B-X
of	B-X
E2F6	B-X
resulted	B-X
in	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
target	B-X
promoters	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
48	B-X
endogenous	B-X
target	B-X
genes	B-X
of	B-X
E2F6	B-X
and	B-X
have	B-X
shown	B-X
that	B-X
E2F6	B-X
can	B-X
repress	B-X
target	B-X
promoters	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
does	B-X
not	B-X
require	B-X
histone	B-X
H3	B-X
methylation	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X

E2F6	B-Gene_or_gene_product
has	O
been	O
postulated	O
to	O
mediate	O
transcriptional	O
repression	O
by	O
recruiting	O
a	O
histone	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
methyltransferase	I-Gene_or_gene_product
to	O
the	O
DNA	O
.	O

However	O
,	O
we	O
found	O
that	O
the	O
E2F6	B-Gene_or_gene_product
-	O
regulated	O
promoters	O
did	O
not	O
contain	O
histone	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
methylated	O
at	O
lysine	O
9	O
.	O
<EOS>	B-X
The	B-X
expression	B-X
of	B-X
COX10-AS1	B-X
,	B-X
miR-641	B-X
and	B-X
E2F6	B-X
was	B-X
measured	B-X
by	B-X
qRT-PCR	B-X
and/or	B-X
western	B-X
blot	B-X
.	B-X
Clone	B-X
formation	B-X
assays	B-X
,	B-X
EdU	B-X
assays	B-X
,	B-X
Transwell	B-X
assays	B-X
and	B-X
tumour	B-X
xenograft	B-X
experiments	B-X
were	B-X
performed	B-X
to	B-X
evaluate	B-X
the	B-X
effects	B-X
of	B-X
COX10-AS1	B-X
,	B-X
miR-641	B-X
and	B-X
E2F6	B-X
on	B-X
glioma	B-X
proliferation	B-X
,	B-X
migration	B-X
and	B-X
invasion	B-X
.	B-X
Luciferase	B-X
reporter	B-X
assays	B-X
,	B-X
RNA	B-X
pull-down	B-X
assays	B-X
and	B-X
ChIP	B-X
assays	B-X
were	B-X
conducted	B-X
to	B-X
analyse	B-X
the	B-X
relationship	B-X
among	B-X
COX10-AS1	B-X
,	B-X
miR-641	B-X
and	B-X
E2F6	B-X
.	B-X
We	B-X
demonstrated	B-X
that	B-X
COX10-AS1	B-X
was	B-X
upregulated	B-X
in	B-X
glioma	B-X
tissues	B-X
and	B-X
cell	B-X
lines	B-X
,	B-X
which	B-X
was	B-X
related	B-X
to	B-X
the	B-X
grade	B-X
of	B-X
glioma	B-X
and	B-X
patient	B-X
survival	B-X
.	B-X
Next	B-X
,	B-X
through	B-X
functional	B-X
assays	B-X
,	B-X
we	B-X
found	B-X
that	B-X
COX10-AS1	B-X
influenced	B-X
the	B-X
proliferation	B-X
,	B-X
migration	B-X
and	B-X
invasion	B-X
of	B-X
glioma	B-X
cell	B-X
lines	B-X
.	B-X
Then	B-X
,	B-X
with	B-X
the	B-X
help	B-X
of	B-X
bioinformatics	B-X
analysis	B-X
,	B-X
we	B-X
confirmed	B-X
that	B-X
COX10-AS1	B-X
regulated	B-X
glioma	B-X
progress	B-X
by	B-X
acting	B-X
as	B-X
a	B-X
sponge	B-X
of	B-X
miR-641	B-X
to	B-X
regulate	B-X
E2F6	B-X
.	B-X
Moreover	B-X
,	B-X
further	B-X
study	B-X
indicated	B-X
that	B-X
E2F6	B-X
could	B-X
promote	B-X
COX10-AS1	B-X
expression	B-X
by	B-X
binding	B-X
to	B-X
its	B-X
promoter	B-X
region	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
the	B-X
data	B-X
indicated	B-X
that	B-X
COX10-AS1	B-X
acts	B-X
as	B-X
an	B-X
oncogene	B-X
in	B-X
combination	B-X
with	B-X
COX10-AS1/miR-641/E2F6	B-X
in	B-X
glioma	B-X
,	B-X
which	B-X
may	B-X
be	B-X
beneficial	B-X
to	B-X
the	B-X
diagnosis	B-X
and	B-X
treatment	B-X
of	B-X
glioma	B-X
.	B-X

To	O
determine	O
the	O
mechanism	O
by	O
which	O
E2F6	B-Gene_or_gene_product
regulates	O
transcription	O
,	O
we	O
performed	O
chromatin	O
immunoprecipitation	O
before	O
and	O
after	O
the	O
introduction	O
of	O
small	O
inhibitory	O
ribonucleic	O
acids	O
specific	O
to	O
E2F6	B-Gene_or_gene_product
.	O
<EOS>	B-X
E2F6	B-X
contains	B-X
a	B-X
DNA	B-X
binding	B-X
domain	B-X
that	B-X
is	B-X
very	B-X
similar	B-X
to	B-X
that	B-X
of	B-X
the	B-X
other	B-X
members	B-X
of	B-X
the	B-X
E2F	B-X
family	B-X
of	B-X
transcriptional	B-X
regulators	B-X
.	B-X
However	B-X
,	B-X
E2F6	B-X
can	B-X
not	B-X
bind	B-X
to	B-X
all	B-X
promoters	B-X
that	B-X
contain	B-X
consensus	B-X
E2F-binding	B-X
sites	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
used	B-X
a	B-X
combination	B-X
of	B-X
chromatin	B-X
immunoprecipitation	B-X
and	B-X
genomic	B-X
microarrays	B-X
to	B-X
identify	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Although	B-X
most	B-X
of	B-X
the	B-X
identified	B-X
promoters	B-X
were	B-X
bound	B-X
by	B-X
multiple	B-X
E2F	B-X
family	B-X
members	B-X
,	B-X
one	B-X
promoter	B-X
was	B-X
bound	B-X
only	B-X
by	B-X
E2F6	B-X
.	B-X
To	B-X
determine	B-X
which	B-X
of	B-X
the	B-X
newly	B-X
identified	B-X
promoters	B-X
were	B-X
regulated	B-X
by	B-X
E2F6	B-X
,	B-X
we	B-X
reduced	B-X
the	B-X
level	B-X
of	B-X
E2F6	B-X
by	B-X
using	B-X
RNA	B-X
interference	B-X
technology	B-X
.	B-X
We	B-X
found	B-X
that	B-X
mRNA	B-X
transcribed	B-X
from	B-X
promoters	B-X
bound	B-X
by	B-X
E2F6	B-X
was	B-X
increased	B-X
after	B-X
reduction	B-X
of	B-X
the	B-X
amount	B-X
of	B-X
E2F6	B-X
protein	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
Interestingly	B-X
,	B-X
many	B-X
of	B-X
the	B-X
E2F6-regulated	B-X
genes	B-X
encoded	B-X
functions	B-X
involved	B-X
in	B-X
tumor	B-X
suppression	B-X
and	B-X
the	B-X
maintenance	B-X
of	B-X
chromatin	B-X
structure	B-X
.	B-X
Specifically	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
E2F6	B-X
represses	B-X
transcription	B-X
of	B-X
the	B-X
brca1	B-X
,	B-X
ctip	B-X
,	B-X
art27	B-X
,	B-X
hp1alpha	B-X
,	B-X
and	B-X
the	B-X
rbap48	B-X
genes	B-X
.	B-X
E2F6	B-X
has	B-X
been	B-X
postulated	B-X
to	B-X
mediate	B-X
transcriptional	B-X
repression	B-X
by	B-X
recruiting	B-X
a	B-X
histone	B-X
H3	B-X
methyltransferase	B-X
to	B-X
the	B-X
DNA	B-X
.	B-X
However	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
E2F6-regulated	B-X
promoters	B-X
did	B-X
not	B-X
contain	B-X
histone	B-X
H3	B-X
methylated	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X
To	B-X
determine	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
E2F6	B-X
regulates	B-X
transcription	B-X
,	B-X
we	B-X
performed	B-X
chromatin	B-X
immunoprecipitation	B-X
before	B-X
and	B-X
after	B-X
the	B-X
introduction	B-X
of	B-X
small	B-X
inhibitory	B-X
ribonucleic	B-X
acids	B-X
specific	B-X
to	B-X
E2F6	B-X
.	B-X
We	B-X
found	B-X
that	B-X
depletion	B-X
of	B-X
E2F6	B-X
resulted	B-X
in	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
target	B-X
promoters	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
we	B-X
have	B-X
identified	B-X
48	B-X
endogenous	B-X
target	B-X
genes	B-X
of	B-X
E2F6	B-X
and	B-X
have	B-X
shown	B-X
that	B-X
E2F6	B-X
can	B-X
repress	B-X
target	B-X
promoters	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
does	B-X
not	B-X
require	B-X
histone	B-X
H3	B-X
methylation	B-X
at	B-X
lysine	B-X
9	B-X
.	B-X

We	O
found	O
that	O
depletion	O
of	O
E2F6	B-Gene_or_gene_product
resulted	O
in	O
the	O
recruitment	O
of	O
E2F1	B-Gene_or_gene_product
to	O
the	O
target	O
promoters	O
.	O

In	O
summary	O
,	O
we	O
have	O
identified	O
48	O
endogenous	O
target	O
genes	O
of	O
E2F6	B-Gene_or_gene_product
and	O
have	O
shown	O
that	O
E2F6	B-Gene_or_gene_product
can	O
repress	O
target	O
promoters	O
in	O
a	O
manner	O
that	O
does	O
not	O
require	O
histone	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
methylation	O
at	O
lysine	O
9	O
.	O

SIGIRR	B-Gene_or_gene_product
,	O
a	O
negative	O
regulator	O
of	O
Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
interleukin	I-Gene_or_gene_product
1	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
signaling	O
.	O
<EOS>	B-X
The	B-X
Toll-like	B-X
receptor-interleukin	B-X
1	B-X
receptor	B-X
signaling	B-X
(	B-X
TLR-IL-1R	B-X
)	B-X
receptor	B-X
superfamily	B-X
is	B-X
important	B-X
in	B-X
differentially	B-X
recognizing	B-X
pathogen	B-X
products	B-X
and	B-X
eliciting	B-X
appropriate	B-X
immune	B-X
responses	B-X
.	B-X
These	B-X
receptors	B-X
alter	B-X
gene	B-X
expression	B-X
,	B-X
mainly	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
nuclear	B-X
factor-kappaB	B-X
and	B-X
activating	B-X
protein	B-X
1	B-X
.	B-X
SIGIRR	B-X
(	B-X
single	B-X
immunoglobulin	B-X
IL-1R-related	B-X
molecule	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
this	B-X
family	B-X
that	B-X
does	B-X
not	B-X
activate	B-X
these	B-X
factors	B-X
,	B-X
instead	B-X
negatively	B-X
modulates	B-X
immune	B-X
responses	B-X
.	B-X
Inflammation	B-X
is	B-X
enhanced	B-X
in	B-X
SIGIRR-deficient	B-X
mice	B-X
,	B-X
as	B-X
shown	B-X
by	B-X
their	B-X
enhanced	B-X
chemokine	B-X
induction	B-X
after	B-X
IL-1	B-X
injection	B-X
and	B-X
reduced	B-X
threshold	B-X
for	B-X
lethal	B-X
endotoxin	B-X
challenge	B-X
.	B-X
Cells	B-X
from	B-X
SIGIRR-deficient	B-X
mice	B-X
showed	B-X
enhanced	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
either	B-X
IL-1	B-X
or	B-X
certain	B-X
Toll	B-X
ligands	B-X
.	B-X
Finally	B-X
,	B-X
biochemical	B-X
analysis	B-X
indicated	B-X
that	B-X
SIGIRR	B-X
binds	B-X
to	B-X
the	B-X
TLR-IL-1R	B-X
signaling	B-X
components	B-X
in	B-X
a	B-X
ligand-dependent	B-X
way	B-X
.	B-X
Our	B-X
data	B-X
show	B-X
that	B-X
SIGIRR	B-X
functions	B-X
as	B-X
a	B-X
biologically	B-X
important	B-X
modulator	B-X
of	B-X
TLR-IL-1R	B-X
signaling	B-X
.	B-X

The	O
Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
interleukin	I-Gene_or_gene_product
1	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
signaling	O
(	O
TLR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IL	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1R	I-Gene_or_gene_product
)	O
receptor	O
superfamily	O
is	O
important	O
in	O
differentially	O
recognizing	O
pathogen	O
products	O
and	O
eliciting	O
appropriate	O
immune	O
responses	O
.	O
<EOS>	B-X
The	B-X
Toll-like	B-X
receptor-interleukin	B-X
1	B-X
receptor	B-X
signaling	B-X
(	B-X
TLR-IL-1R	B-X
)	B-X
receptor	B-X
superfamily	B-X
is	B-X
important	B-X
in	B-X
differentially	B-X
recognizing	B-X
pathogen	B-X
products	B-X
and	B-X
eliciting	B-X
appropriate	B-X
immune	B-X
responses	B-X
.	B-X
These	B-X
receptors	B-X
alter	B-X
gene	B-X
expression	B-X
,	B-X
mainly	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
nuclear	B-X
factor-kappaB	B-X
and	B-X
activating	B-X
protein	B-X
1	B-X
.	B-X
SIGIRR	B-X
(	B-X
single	B-X
immunoglobulin	B-X
IL-1R-related	B-X
molecule	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
this	B-X
family	B-X
that	B-X
does	B-X
not	B-X
activate	B-X
these	B-X
factors	B-X
,	B-X
instead	B-X
negatively	B-X
modulates	B-X
immune	B-X
responses	B-X
.	B-X
Inflammation	B-X
is	B-X
enhanced	B-X
in	B-X
SIGIRR-deficient	B-X
mice	B-X
,	B-X
as	B-X
shown	B-X
by	B-X
their	B-X
enhanced	B-X
chemokine	B-X
induction	B-X
after	B-X
IL-1	B-X
injection	B-X
and	B-X
reduced	B-X
threshold	B-X
for	B-X
lethal	B-X
endotoxin	B-X
challenge	B-X
.	B-X
Cells	B-X
from	B-X
SIGIRR-deficient	B-X
mice	B-X
showed	B-X
enhanced	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
either	B-X
IL-1	B-X
or	B-X
certain	B-X
Toll	B-X
ligands	B-X
.	B-X
Finally	B-X
,	B-X
biochemical	B-X
analysis	B-X
indicated	B-X
that	B-X
SIGIRR	B-X
binds	B-X
to	B-X
the	B-X
TLR-IL-1R	B-X
signaling	B-X
components	B-X
in	B-X
a	B-X
ligand-dependent	B-X
way	B-X
.	B-X
Our	B-X
data	B-X
show	B-X
that	B-X
SIGIRR	B-X
functions	B-X
as	B-X
a	B-X
biologically	B-X
important	B-X
modulator	B-X
of	B-X
TLR-IL-1R	B-X
signaling	B-X
.	B-X

These	O
receptors	O
alter	O
gene	O
expression	O
,	O
mainly	O
through	O
the	O
activation	O
of	O
nuclear	O
factor	O
-	O
kappaB	O
and	O
activating	O
protein	O
1	O
.	O
<EOS>	B-X
The	B-X
canonical	B-X
WNT/β-catenin	B-X
pathway	B-X
and	B-X
peroxisome	B-X
proliferator-activated	B-X
receptor	B-X
gamma	B-X
(	B-X
PPARγ	B-X
)	B-X
generally	B-X
work	B-X
in	B-X
opposition	B-X
.	B-X
Asthma	B-X
is	B-X
a	B-X
common	B-X
respiratory	B-X
disease	B-X
,	B-X
and	B-X
immune	B-X
system	B-X
dysregulation	B-X
has	B-X
direct	B-X
relevance	B-X
to	B-X
asthma	B-X
pathogenesis	B-X
.	B-X
Allergic	B-X
asthma	B-X
model	B-X
of	B-X
BALB/c	B-X
mice	B-X
was	B-X
produced	B-X
and	B-X
treated	B-X
with	B-X
probiotics	B-X
(	B-X
LA-5	B-X
,	B-X
GG	B-X
,	B-X
and	B-X
BB-12	B-X
)	B-X
and	B-X
prebiotics	B-X
(	B-X
FOS	B-X
and	B-X
GOS	B-X
)	B-X
.	B-X
Then	B-X
AHR	B-X
,	B-X
BALF	B-X
cells	B-X
count	B-X
,	B-X
EPO	B-X
activity	B-X
,	B-X
IL-4	B-X
,	B-X
5	B-X
,	B-X
13	B-X
,	B-X
17	B-X
,	B-X
25	B-X
,	B-X
33	B-X
,	B-X
as	B-X
well	B-X
as	B-X
IFN-γ	B-X
,	B-X
total	B-X
and	B-X
OVA-specific	B-X
IgE	B-X
,	B-X
IgG1	B-X
,	B-X
Cys-LT	B-X
,	B-X
LTB4	B-X
,	B-X
LTC4	B-X
,	B-X
and	B-X
TSLP	B-X
levels	B-X
were	B-X
measured	B-X
.	B-X
Also	B-X
,	B-X
the	B-X
GTP/GOT	B-X
assay	B-X
was	B-X
performed	B-X
and	B-X
gene	B-X
expression	B-X
of	B-X
Akt	B-X
,	B-X
NLR3	B-X
,	B-X
NF-kB	B-X
,	B-X
PI3K	B-X
,	B-X
MyD88	B-X
,	B-X
TLR4	B-X
,	B-X
CCL11	B-X
,	B-X
CCL24	B-X
,	B-X
MUC5a	B-X
,	B-X
Eotaxin	B-X
,	B-X
IL-38	B-X
,	B-X
and	B-X
IL-8	B-X
were	B-X
determined	B-X
.	B-X
Treatment	B-X
with	B-X
probiotics	B-X
could	B-X
control	B-X
AHR	B-X
,	B-X
eosinophil	B-X
infiltration	B-X
to	B-X
the	B-X
BALF	B-X
and	B-X
reduce	B-X
the	B-X
levels	B-X
of	B-X
immunoglobulins	B-X
,	B-X
IL-17	B-X
,	B-X
GTP	B-X
and	B-X
also	B-X
decrease	B-X
mucus	B-X
secretion	B-X
,	B-X
goblet	B-X
cell	B-X
hyperplasia	B-X
,	B-X
peribronchial	B-X
and	B-X
perivascular	B-X
inflammation	B-X
and	B-X
also	B-X
,	B-X
EPO	B-X
activity	B-X
.	B-X
It	B-X
could	B-X
reduce	B-X
gene	B-X
expression	B-X
of	B-X
TLR4	B-X
and	B-X
CCL11	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
IL-38	B-X
gene	B-X
expression	B-X
was	B-X
increased	B-X
by	B-X
both	B-X
probiotic	B-X
and	B-X
prebiotic	B-X
treatment	B-X
.	B-X
Treatment	B-X
with	B-X
probiotics	B-X
and	B-X
prebiotics	B-X
could	B-X
control	B-X
levels	B-X
of	B-X
IL-4	B-X
,	B-X
5	B-X
,	B-X
13	B-X
,	B-X
25	B-X
,	B-X
33	B-X
,	B-X
leukotrienes	B-X
,	B-X
the	B-X
gene	B-X
expression	B-X
of	B-X
AKT	B-X
,	B-X
NLR3	B-X
,	B-X
NF-κB	B-X
,	B-X
MyD88	B-X
,	B-X
MUC5a	B-X
.	B-X
The	B-X
prebiotic	B-X
treatment	B-X
could	B-X
control	B-X
peribronchial	B-X
inflammation	B-X
and	B-X
PI3K	B-X
gene	B-X
expression	B-X
.	B-X
Both	B-X
of	B-X
the	B-X
treatments	B-X
had	B-X
no	B-X
significant	B-X
effect	B-X
on	B-X
the	B-X
GOT	B-X
,	B-X
TSLP	B-X
and	B-X
IL-8	B-X
,	B-X
eotaxin	B-X
and	B-X
CCL24	B-X
gene	B-X
expression	B-X
.	B-X
Probiotics	B-X
and	B-X
prebiotics	B-X
could	B-X
induce	B-X
tolerance	B-X
in	B-X
allegro-inflammatory	B-X
reactions	B-X
and	B-X
alter	B-X
immune	B-X
responses	B-X
in	B-X
allergic	B-X
conditions	B-X
.	B-X

SIGIRR	B-Gene_or_gene_product
(	O
single	B-Gene_or_gene_product
immunoglobulin	I-Gene_or_gene_product
IL	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1R	I-Gene_or_gene_product
-	I-Gene_or_gene_product
related	I-Gene_or_gene_product
molecule	I-Gene_or_gene_product
)	O
,	O
a	O
member	O
of	O
this	O
family	O
that	O
does	O
not	O
activate	O
these	O
factors	O
,	O
instead	O
negatively	O
modulates	O
immune	O
responses	O
.	O
<EOS>	B-X
A	B-X
novel	B-X
member	B-X
of	B-X
the	B-X
interleukin	B-X
1	B-X
receptor	B-X
(	B-X
IL-1R	B-X
)	B-X
superfamily	B-X
,	B-X
SIGIRR	B-X
(	B-X
single	B-X
Ig	B-X
IL-1R-related	B-X
molecule	B-X
)	B-X
was	B-X
identified	B-X
in	B-X
mouse	B-X
and	B-X
human	B-X
.	B-X
Although	B-X
it	B-X
shows	B-X
the	B-X
typical	B-X
conserved	B-X
motifs	B-X
that	B-X
characterize	B-X
the	B-X
IL-1R	B-X
and	B-X
Toll	B-X
superfamily	B-X
,	B-X
it	B-X
is	B-X
structurally	B-X
and	B-X
functionally	B-X
distinct	B-X
from	B-X
both	B-X
.	B-X
SIGIRR	B-X
has	B-X
only	B-X
one	B-X
Ig	B-X
domain	B-X
in	B-X
its	B-X
extracellular	B-X
portion	B-X
whereas	B-X
the	B-X
IL-1R	B-X
family	B-X
contains	B-X
three	B-X
Ig	B-X
folds	B-X
.	B-X
An	B-X
unusually	B-X
long	B-X
cytoplasmic	B-X
domain	B-X
is	B-X
reminiscent	B-X
of	B-X
the	B-X
structure	B-X
of	B-X
drosophila	B-X
Toll	B-X
,	B-X
yet	B-X
the	B-X
SIGIRR	B-X
peptide	B-X
sequence	B-X
is	B-X
more	B-X
closely	B-X
related	B-X
to	B-X
IL-1RI	B-X
.	B-X
The	B-X
human	B-X
SIGIRR	B-X
gene	B-X
maps	B-X
to	B-X
11p15	B-X
.	B-X
5	B-X
and	B-X
thus	B-X
is	B-X
not	B-X
located	B-X
in	B-X
the	B-X
same	B-X
cluster	B-X
on	B-X
chromosome	B-X
2	B-X
that	B-X
is	B-X
known	B-X
to	B-X
contain	B-X
four	B-X
members	B-X
of	B-X
the	B-X
IL-1R	B-X
family	B-X
.	B-X
It	B-X
failed	B-X
to	B-X
bind	B-X
to	B-X
the	B-X
known	B-X
IL-1-family	B-X
members	B-X
and	B-X
,	B-X
when	B-X
co-expressed	B-X
with	B-X
the	B-X
IL-1RI	B-X
,	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
the	B-X
binding	B-X
of	B-X
IL-1	B-X
and	B-X
on	B-X
subsequent	B-X
nuclear	B-X
factor	B-X
kappaB	B-X
(	B-X
NFkappaB	B-X
)	B-X
activation	B-X
.	B-X
A	B-X
chimera	B-X
,	B-X
in	B-X
which	B-X
the	B-X
SIGIRR	B-X
intracellular	B-X
domain	B-X
was	B-X
fused	B-X
to	B-X
the	B-X
IL-1R	B-X
extracellular	B-X
domain	B-X
,	B-X
did	B-X
not	B-X
activate	B-X
NFkappaB	B-X
unlike	B-X
similar	B-X
fusion	B-X
proteins	B-X
of	B-X
other	B-X
IL-1R	B-X
related	B-X
molecules	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
the	B-X
SIGIRR	B-X
protein	B-X
represents	B-X
a	B-X
novel	B-X
subtype	B-X
of	B-X
the	B-X
IL-1R	B-X
superfamily	B-X
.	B-X

Inflammation	O
is	O
enhanced	O
in	O
SIGIRR	B-Gene_or_gene_product
-	O
deficient	O
mice	O
,	O
as	O
shown	O
by	O
their	O
enhanced	O
chemokine	O
induction	O
after	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
injection	O
and	O
reduced	O
threshold	O
for	O
lethal	O
endotoxin	O
challenge	O
.	O
<EOS>	B-X
The	B-X
Toll-like	B-X
receptor-interleukin	B-X
1	B-X
receptor	B-X
signaling	B-X
(	B-X
TLR-IL-1R	B-X
)	B-X
receptor	B-X
superfamily	B-X
is	B-X
important	B-X
in	B-X
differentially	B-X
recognizing	B-X
pathogen	B-X
products	B-X
and	B-X
eliciting	B-X
appropriate	B-X
immune	B-X
responses	B-X
.	B-X
These	B-X
receptors	B-X
alter	B-X
gene	B-X
expression	B-X
,	B-X
mainly	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
nuclear	B-X
factor-kappaB	B-X
and	B-X
activating	B-X
protein	B-X
1	B-X
.	B-X
SIGIRR	B-X
(	B-X
single	B-X
immunoglobulin	B-X
IL-1R-related	B-X
molecule	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
this	B-X
family	B-X
that	B-X
does	B-X
not	B-X
activate	B-X
these	B-X
factors	B-X
,	B-X
instead	B-X
negatively	B-X
modulates	B-X
immune	B-X
responses	B-X
.	B-X
Inflammation	B-X
is	B-X
enhanced	B-X
in	B-X
SIGIRR-deficient	B-X
mice	B-X
,	B-X
as	B-X
shown	B-X
by	B-X
their	B-X
enhanced	B-X
chemokine	B-X
induction	B-X
after	B-X
IL-1	B-X
injection	B-X
and	B-X
reduced	B-X
threshold	B-X
for	B-X
lethal	B-X
endotoxin	B-X
challenge	B-X
.	B-X
Cells	B-X
from	B-X
SIGIRR-deficient	B-X
mice	B-X
showed	B-X
enhanced	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
either	B-X
IL-1	B-X
or	B-X
certain	B-X
Toll	B-X
ligands	B-X
.	B-X
Finally	B-X
,	B-X
biochemical	B-X
analysis	B-X
indicated	B-X
that	B-X
SIGIRR	B-X
binds	B-X
to	B-X
the	B-X
TLR-IL-1R	B-X
signaling	B-X
components	B-X
in	B-X
a	B-X
ligand-dependent	B-X
way	B-X
.	B-X
Our	B-X
data	B-X
show	B-X
that	B-X
SIGIRR	B-X
functions	B-X
as	B-X
a	B-X
biologically	B-X
important	B-X
modulator	B-X
of	B-X
TLR-IL-1R	B-X
signaling	B-X
.	B-X

Cells	O
from	O
SIGIRR	B-Gene_or_gene_product
-	O
deficient	O
mice	O
showed	O
enhanced	O
activation	O
in	O
response	O
to	O
either	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
or	O
certain	O
Toll	B-Gene_or_gene_product
ligands	O
.	O
<EOS>	B-X
The	B-X
identification	B-X
of	B-X
the	B-X
Drosophila	B-X
melanogaster	B-X
Toll	B-X
pathway	B-X
cascade	B-X
and	B-X
the	B-X
subsequent	B-X
characterization	B-X
of	B-X
TLRs	B-X
have	B-X
reshaped	B-X
our	B-X
understanding	B-X
of	B-X
the	B-X
immune	B-X
system	B-X
.	B-X
In	B-X
flies	B-X
,	B-X
the	B-X
Toll	B-X
receptors	B-X
are	B-X
essential	B-X
for	B-X
embryonic	B-X
development	B-X
and	B-X
immunity	B-X
.	B-X
In	B-X
total	B-X
,	B-X
nine	B-X
Toll	B-X
receptors	B-X
are	B-X
encoded	B-X
in	B-X
the	B-X
Drosophila	B-X
genome	B-X
,	B-X
including	B-X
the	B-X
Toll	B-X
pathway	B-X
receptor	B-X
Toll	B-X
.	B-X
The	B-X
induction	B-X
of	B-X
the	B-X
Toll	B-X
pathway	B-X
by	B-X
gram-positive	B-X
bacteria	B-X
or	B-X
fungi	B-X
leads	B-X
to	B-X
the	B-X
activation	B-X
of	B-X
cellular	B-X
immunity	B-X
as	B-X
well	B-X
as	B-X
the	B-X
systemic	B-X
production	B-X
of	B-X
certain	B-X
antimicrobial	B-X
peptides	B-X
.	B-X
The	B-X
Toll	B-X
receptor	B-X
is	B-X
activated	B-X
when	B-X
the	B-X
proteolytically	B-X
cleaved	B-X
ligand	B-X
Spatzle	B-X
binds	B-X
to	B-X
the	B-X
receptor	B-X
,	B-X
eventually	B-X
leading	B-X
to	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
NF-κB	B-X
factors	B-X
Dorsal-related	B-X
immunity	B-X
factor	B-X
or	B-X
Dorsal	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
review	B-X
the	B-X
current	B-X
literature	B-X
on	B-X
the	B-X
Toll	B-X
pathway	B-X
and	B-X
compare	B-X
the	B-X
Drosophila	B-X
and	B-X
mammalian	B-X
NF-κB	B-X
pathways	B-X
.	B-X

Finally	O
,	O
biochemical	O
analysis	O
indicated	O
that	O
SIGIRR	B-Gene_or_gene_product
binds	O
to	O
the	O
TLR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IL	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1R	I-Gene_or_gene_product
signaling	O
components	O
in	O
a	O
ligand	O
-	O
dependent	O
way	O
.	O

Our	O
data	O
show	O
that	O
SIGIRR	B-Gene_or_gene_product
functions	O
as	O
a	O
biologically	O
important	O
modulator	O
of	O
TLR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IL	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1R	I-Gene_or_gene_product
signaling	O
.	O
<EOS>	B-X
The	B-X
Toll-like	B-X
receptor-interleukin	B-X
1	B-X
receptor	B-X
signaling	B-X
(	B-X
TLR-IL-1R	B-X
)	B-X
receptor	B-X
superfamily	B-X
is	B-X
important	B-X
in	B-X
differentially	B-X
recognizing	B-X
pathogen	B-X
products	B-X
and	B-X
eliciting	B-X
appropriate	B-X
immune	B-X
responses	B-X
.	B-X
SIGIRR	B-X
(	B-X
single	B-X
immunoglobulin	B-X
IL-1R-related	B-X
molecule	B-X
)	B-X
,	B-X
a	B-X
member	B-X
of	B-X
this	B-X
family	B-X
that	B-X
does	B-X
not	B-X
activate	B-X
these	B-X
factors	B-X
,	B-X
instead	B-X
negatively	B-X
modulates	B-X
immune	B-X
responses	B-X
.	B-X
Inflammation	B-X
is	B-X
enhanced	B-X
in	B-X
SIGIRR-deficient	B-X
mice	B-X
,	B-X
as	B-X
shown	B-X
by	B-X
their	B-X
enhanced	B-X
chemokine	B-X
induction	B-X
after	B-X
IL-1	B-X
injection	B-X
and	B-X
reduced	B-X
threshold	B-X
for	B-X
lethal	B-X
endotoxin	B-X
challenge	B-X
.	B-X
Cells	B-X
from	B-X
SIGIRR-deficient	B-X
mice	B-X
showed	B-X
enhanced	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
either	B-X
IL-1	B-X
or	B-X
certain	B-X
Toll	B-X
ligands	B-X
.	B-X
Finally	B-X
,	B-X
biochemical	B-X
analysis	B-X
indicated	B-X
that	B-X
SIGIRR	B-X
binds	B-X
to	B-X
the	B-X
TLR-IL-1R	B-X
signaling	B-X
components	B-X
in	B-X
a	B-X
ligand-dependent	B-X
way	B-X
.	B-X
Our	B-X
data	B-X
show	B-X
that	B-X
SIGIRR	B-X
functions	B-X
as	B-X
a	B-X
biologically	B-X
important	B-X
modulator	B-X
of	B-X
TLR-IL-1R	B-X
signaling	B-X
.	B-X

Molecular	O
cloning	O
and	O
characterization	O
of	O
a	O
novel	O
Rel	B-Gene_or_gene_product
/	I-Gene_or_gene_product
NF	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
family	O
member	O
displaying	O
structural	O
and	O
functional	O
homology	O
to	O
NF	O
-	O
kappa	O
B	O
p50	B-Gene_or_gene_product
/	O
p105	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
inducible	B-X
expression	B-X
of	B-X
many	B-X
genes	B-X
,	B-X
including	B-X
inflammatory	B-X
,	B-X
immune	B-X
,	B-X
and	B-X
acute-phase	B-X
response	B-X
genes	B-X
.	B-X
NF-kappa	B-X
B	B-X
consists	B-X
of	B-X
two	B-X
subunits	B-X
,	B-X
50K	B-X
and	B-X
65K	B-X
polypeptides	B-X
.	B-X
The	B-X
genes	B-X
encoding	B-X
p50	B-X
and	B-X
p65	B-X
have	B-X
sequence	B-X
similarities	B-X
with	B-X
the	B-X
c-rel	B-X
proto-oncogene	B-X
and	B-X
the	B-X
Drosophila	B-X
maternal	B-X
effect	B-X
gene	B-X
dorsal	B-X
.	B-X
We	B-X
describe	B-X
the	B-X
cloning	B-X
and	B-X
characterization	B-X
of	B-X
a	B-X
novel	B-X
rel-related	B-X
gene	B-X
encoding	B-X
a	B-X
98K	B-X
product	B-X
that	B-X
shares	B-X
extensive	B-X
homology	B-X
with	B-X
the	B-X
p105	B-X
precursor	B-X
of	B-X
the	B-X
NF-kappa	B-X
B	B-X
p50	B-X
protein	B-X
,	B-X
containing	B-X
both	B-X
a	B-X
Rel	B-X
homology	B-X
and	B-X
SWI6/ankyrin	B-X
repeat	B-X
domain	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
p98	B-X
is	B-X
proteolytically	B-X
processed	B-X
in	B-X
vivo	B-X
to	B-X
generate	B-X
a	B-X
55K	B-X
polypeptide	B-X
,	B-X
which	B-X
binds	B-X
to	B-X
kappa	B-X
B	B-X
sites	B-X
.	B-X
p55	B-X
is	B-X
capable	B-X
of	B-X
forming	B-X
heterocomplexes	B-X
with	B-X
other	B-X
Rel/NF-kappa	B-X
B	B-X
family	B-X
members	B-X
,	B-X
which	B-X
can	B-X
bind	B-X
to	B-X
kappa	B-X
B	B-X
motifs	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
stimulate	B-X
transcription	B-X
of	B-X
reporter	B-X
genes	B-X
containing	B-X
these	B-X
cis-elements	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
identification	B-X
of	B-X
a	B-X
homolog	B-X
for	B-X
NF-kappa	B-X
B	B-X
p50/p105	B-X
,	B-X
termed	B-X
p55/p98	B-X
,	B-X
gives	B-X
further	B-X
support	B-X
to	B-X
the	B-X
idea	B-X
that	B-X
NF-kappa	B-X
B	B-X
is	B-X
a	B-X
collection	B-X
of	B-X
structurally	B-X
related	B-X
complexes	B-X
of	B-X
which	B-X
contribute	B-X
to	B-X
the	B-X
pleiotropic	B-X
regulatory	B-X
processes	B-X
originally	B-X
assigned	B-X
to	B-X
NF-kappa	B-X
B	B-X
.	B-X

The	O
NF	O
-	O
kappa	O
B	O
transcription	O
factor	O
has	O
been	O
implicated	O
in	O
the	O
inducible	O
expression	O
of	O
many	O
genes	O
,	O
including	O
inflammatory	O
,	O
immune	O
,	O
and	O
acute	O
-	O
phase	O
response	O
genes	O
.	O
<EOS>	B-X
The	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
inducible	B-X
expression	B-X
of	B-X
many	B-X
genes	B-X
,	B-X
including	B-X
inflammatory	B-X
,	B-X
immune	B-X
,	B-X
and	B-X
acute-phase	B-X
response	B-X
genes	B-X
.	B-X
NF-kappa	B-X
B	B-X
consists	B-X
of	B-X
two	B-X
subunits	B-X
,	B-X
50K	B-X
and	B-X
65K	B-X
polypeptides	B-X
.	B-X
The	B-X
genes	B-X
encoding	B-X
p50	B-X
and	B-X
p65	B-X
have	B-X
sequence	B-X
similarities	B-X
with	B-X
the	B-X
c-rel	B-X
proto-oncogene	B-X
and	B-X
the	B-X
Drosophila	B-X
maternal	B-X
effect	B-X
gene	B-X
dorsal	B-X
.	B-X
We	B-X
describe	B-X
the	B-X
cloning	B-X
and	B-X
characterization	B-X
of	B-X
a	B-X
novel	B-X
rel-related	B-X
gene	B-X
encoding	B-X
a	B-X
98K	B-X
product	B-X
that	B-X
shares	B-X
extensive	B-X
homology	B-X
with	B-X
the	B-X
p105	B-X
precursor	B-X
of	B-X
the	B-X
NF-kappa	B-X
B	B-X
p50	B-X
protein	B-X
,	B-X
containing	B-X
both	B-X
a	B-X
Rel	B-X
homology	B-X
and	B-X
SWI6/ankyrin	B-X
repeat	B-X
domain	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
p98	B-X
is	B-X
proteolytically	B-X
processed	B-X
in	B-X
vivo	B-X
to	B-X
generate	B-X
a	B-X
55K	B-X
polypeptide	B-X
,	B-X
which	B-X
binds	B-X
to	B-X
kappa	B-X
B	B-X
sites	B-X
.	B-X
p55	B-X
is	B-X
capable	B-X
of	B-X
forming	B-X
heterocomplexes	B-X
with	B-X
other	B-X
Rel/NF-kappa	B-X
B	B-X
family	B-X
members	B-X
,	B-X
which	B-X
can	B-X
bind	B-X
to	B-X
kappa	B-X
B	B-X
motifs	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
stimulate	B-X
transcription	B-X
of	B-X
reporter	B-X
genes	B-X
containing	B-X
these	B-X
cis-elements	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
identification	B-X
of	B-X
a	B-X
homolog	B-X
for	B-X
NF-kappa	B-X
B	B-X
p50/p105	B-X
,	B-X
termed	B-X
p55/p98	B-X
,	B-X
gives	B-X
further	B-X
support	B-X
to	B-X
the	B-X
idea	B-X
that	B-X
NF-kappa	B-X
B	B-X
is	B-X
a	B-X
collection	B-X
of	B-X
structurally	B-X
related	B-X
complexes	B-X
of	B-X
which	B-X
contribute	B-X
to	B-X
the	B-X
pleiotropic	B-X
regulatory	B-X
processes	B-X
originally	B-X
assigned	B-X
to	B-X
NF-kappa	B-X
B	B-X
.	B-X

NF	O
-	O
kappa	O
B	O
consists	O
of	O
two	O
subunits	O
,	O
50K	O
and	O
65K	O
polypeptides	O
.	O
<EOS>	B-X
NF-kappa	B-X
B	B-X
,	B-X
which	B-X
consists	B-X
of	B-X
two	B-X
polypeptides	B-X
,	B-X
p50	B-X
(	B-X
M	B-X
(	B-X
r	B-X
)	B-X
50K	B-X
)	B-X
and	B-X
p65/RelA	B-X
(	B-X
M	B-X
(	B-X
r	B-X
)	B-X
65K	B-X
)	B-X
,	B-X
is	B-X
thought	B-X
to	B-X
be	B-X
a	B-X
key	B-X
regulator	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
responses	B-X
to	B-X
infection	B-X
,	B-X
inflammation	B-X
and	B-X
stress	B-X
.	B-X
Here	B-X
we	B-X
describe	B-X
the	B-X
generation	B-X
of	B-X
mice	B-X
deficient	B-X
in	B-X
the	B-X
RelA	B-X
subunit	B-X
of	B-X
NF-kappa	B-X
B.	B-X
Disruption	B-X
of	B-X
the	B-X
relA	B-X
locus	B-X
leads	B-X
to	B-X
embryonic	B-X
lethality	B-X
at	B-X
15-16	B-X
days	B-X
of	B-X
gestation	B-X
,	B-X
concomitant	B-X
with	B-X
a	B-X
massive	B-X
degeneration	B-X
of	B-X
the	B-X
liver	B-X
by	B-X
programmed	B-X
cell	B-X
death	B-X
or	B-X
apoptosis	B-X
.	B-X
Embryonic	B-X
fibroblasts	B-X
from	B-X
RelA-deficient	B-X
mice	B-X
are	B-X
defective	B-X
in	B-X
the	B-X
tumour	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-mediated	B-X
induction	B-X
of	B-X
messenger	B-X
RNAs	B-X
for	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
and	B-X
granulocyte/macrophage	B-X
colony	B-X
stimulating	B-X
factor	B-X
(	B-X
GM-CSF	B-X
)	B-X
,	B-X
although	B-X
basal	B-X
levels	B-X
of	B-X
these	B-X
transcripts	B-X
are	B-X
unaltered	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
RelA	B-X
controls	B-X
inducible	B-X
,	B-X
but	B-X
not	B-X
basal	B-X
,	B-X
transcription	B-X
in	B-X
NF-kappa	B-X
B-regulated	B-X
pathways	B-X
.	B-X

The	O
genes	O
encoding	O
p50	B-Gene_or_gene_product
and	O
p65	B-Gene_or_gene_product
have	O
sequence	O
similarities	O
with	O
the	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
rel	I-Gene_or_gene_product
proto	O
-	O
oncogene	O
and	O
the	O
Drosophila	O
maternal	O
effect	O
gene	O
dorsal	O
.	O

We	O
describe	O
the	O
cloning	O
and	O
characterization	O
of	O
a	O
novel	O
rel	B-Gene_or_gene_product
-	O
related	O
gene	O
encoding	O
a	O
98K	O
product	O
that	O
shares	O
extensive	O
homology	O
with	O
the	O
p105	B-Gene_or_gene_product
precursor	O
of	O
the	O
NF	O
-	O
kappa	O
B	O
p50	B-Gene_or_gene_product
protein	O
,	O
containing	O
both	O
a	O
Rel	B-Gene_or_gene_product
homology	O
and	O
SWI6	B-Gene_or_gene_product
/	O
ankyrin	B-Gene_or_gene_product
repeat	O
domain	O
.	O
<EOS>	B-X
The	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
inducible	B-X
expression	B-X
of	B-X
many	B-X
genes	B-X
,	B-X
including	B-X
inflammatory	B-X
,	B-X
immune	B-X
,	B-X
and	B-X
acute-phase	B-X
response	B-X
genes	B-X
.	B-X
NF-kappa	B-X
B	B-X
consists	B-X
of	B-X
two	B-X
subunits	B-X
,	B-X
50K	B-X
and	B-X
65K	B-X
polypeptides	B-X
.	B-X
The	B-X
genes	B-X
encoding	B-X
p50	B-X
and	B-X
p65	B-X
have	B-X
sequence	B-X
similarities	B-X
with	B-X
the	B-X
c-rel	B-X
proto-oncogene	B-X
and	B-X
the	B-X
Drosophila	B-X
maternal	B-X
effect	B-X
gene	B-X
dorsal	B-X
.	B-X
We	B-X
describe	B-X
the	B-X
cloning	B-X
and	B-X
characterization	B-X
of	B-X
a	B-X
novel	B-X
rel-related	B-X
gene	B-X
encoding	B-X
a	B-X
98K	B-X
product	B-X
that	B-X
shares	B-X
extensive	B-X
homology	B-X
with	B-X
the	B-X
p105	B-X
precursor	B-X
of	B-X
the	B-X
NF-kappa	B-X
B	B-X
p50	B-X
protein	B-X
,	B-X
containing	B-X
both	B-X
a	B-X
Rel	B-X
homology	B-X
and	B-X
SWI6/ankyrin	B-X
repeat	B-X
domain	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
p98	B-X
is	B-X
proteolytically	B-X
processed	B-X
in	B-X
vivo	B-X
to	B-X
generate	B-X
a	B-X
55K	B-X
polypeptide	B-X
,	B-X
which	B-X
binds	B-X
to	B-X
kappa	B-X
B	B-X
sites	B-X
.	B-X
p55	B-X
is	B-X
capable	B-X
of	B-X
forming	B-X
heterocomplexes	B-X
with	B-X
other	B-X
Rel/NF-kappa	B-X
B	B-X
family	B-X
members	B-X
,	B-X
which	B-X
can	B-X
bind	B-X
to	B-X
kappa	B-X
B	B-X
motifs	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
stimulate	B-X
transcription	B-X
of	B-X
reporter	B-X
genes	B-X
containing	B-X
these	B-X
cis-elements	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
identification	B-X
of	B-X
a	B-X
homolog	B-X
for	B-X
NF-kappa	B-X
B	B-X
p50/p105	B-X
,	B-X
termed	B-X
p55/p98	B-X
,	B-X
gives	B-X
further	B-X
support	B-X
to	B-X
the	B-X
idea	B-X
that	B-X
NF-kappa	B-X
B	B-X
is	B-X
a	B-X
collection	B-X
of	B-X
structurally	B-X
related	B-X
complexes	B-X
of	B-X
which	B-X
contribute	B-X
to	B-X
the	B-X
pleiotropic	B-X
regulatory	B-X
processes	B-X
originally	B-X
assigned	B-X
to	B-X
NF-kappa	B-X
B	B-X
.	B-X

We	O
demonstrate	O
that	O
p98	B-Gene_or_gene_product
is	O
proteolytically	O
processed	O
in	O
vivo	O
to	O
generate	O
a	O
55K	O
polypeptide	O
,	O
which	O
binds	O
to	O
kappa	O
B	O
sites	O
.	O
<EOS>	B-X
The	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
inducible	B-X
expression	B-X
of	B-X
many	B-X
genes	B-X
,	B-X
including	B-X
inflammatory	B-X
,	B-X
immune	B-X
,	B-X
and	B-X
acute-phase	B-X
response	B-X
genes	B-X
.	B-X
NF-kappa	B-X
B	B-X
consists	B-X
of	B-X
two	B-X
subunits	B-X
,	B-X
50K	B-X
and	B-X
65K	B-X
polypeptides	B-X
.	B-X
We	B-X
describe	B-X
the	B-X
cloning	B-X
and	B-X
characterization	B-X
of	B-X
a	B-X
novel	B-X
rel-related	B-X
gene	B-X
encoding	B-X
a	B-X
98K	B-X
product	B-X
that	B-X
shares	B-X
extensive	B-X
homology	B-X
with	B-X
the	B-X
p105	B-X
precursor	B-X
of	B-X
the	B-X
NF-kappa	B-X
B	B-X
p50	B-X
protein	B-X
,	B-X
containing	B-X
both	B-X
a	B-X
Rel	B-X
homology	B-X
and	B-X
SWI6/ankyrin	B-X
repeat	B-X
domain	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
p98	B-X
is	B-X
proteolytically	B-X
processed	B-X
in	B-X
vivo	B-X
to	B-X
generate	B-X
a	B-X
55K	B-X
polypeptide	B-X
,	B-X
which	B-X
binds	B-X
to	B-X
kappa	B-X
B	B-X
sites	B-X
.	B-X
p55	B-X
is	B-X
capable	B-X
of	B-X
forming	B-X
heterocomplexes	B-X
with	B-X
other	B-X
Rel/NF-kappa	B-X
B	B-X
family	B-X
members	B-X
,	B-X
which	B-X
can	B-X
bind	B-X
to	B-X
kappa	B-X
B	B-X
motifs	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
stimulate	B-X
transcription	B-X
of	B-X
reporter	B-X
genes	B-X
containing	B-X
these	B-X
cis-elements	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
identification	B-X
of	B-X
a	B-X
homolog	B-X
for	B-X
NF-kappa	B-X
B	B-X
p50/p105	B-X
,	B-X
termed	B-X
p55/p98	B-X
,	B-X
gives	B-X
further	B-X
support	B-X
to	B-X
the	B-X
idea	B-X
that	B-X
NF-kappa	B-X
B	B-X
is	B-X
a	B-X
collection	B-X
of	B-X
structurally	B-X
related	B-X
complexes	B-X
of	B-X
which	B-X
contribute	B-X
to	B-X
the	B-X
pleiotropic	B-X
regulatory	B-X
processes	B-X
originally	B-X
assigned	B-X
to	B-X
NF-kappa	B-X
B	B-X
.	B-X

p55	B-Gene_or_gene_product
is	O
capable	O
of	O
forming	O
heterocomplexes	O
with	O
other	O
Rel	B-Gene_or_gene_product
/	I-Gene_or_gene_product
NF	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
family	O
members	O
,	O
which	O
can	O
bind	O
to	O
kappa	O
B	O
motifs	O
in	O
vitro	O
,	O
and	O
stimulate	O
transcription	O
of	O
reporter	O
genes	O
containing	O
these	O
cis	O
-	O
elements	O
in	O
vivo	O
.	O
<EOS>	B-X
The	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
inducible	B-X
expression	B-X
of	B-X
many	B-X
genes	B-X
,	B-X
including	B-X
inflammatory	B-X
,	B-X
immune	B-X
,	B-X
and	B-X
acute-phase	B-X
response	B-X
genes	B-X
.	B-X
NF-kappa	B-X
B	B-X
consists	B-X
of	B-X
two	B-X
subunits	B-X
,	B-X
50K	B-X
and	B-X
65K	B-X
polypeptides	B-X
.	B-X
The	B-X
genes	B-X
encoding	B-X
p50	B-X
and	B-X
p65	B-X
have	B-X
sequence	B-X
similarities	B-X
with	B-X
the	B-X
c-rel	B-X
proto-oncogene	B-X
and	B-X
the	B-X
Drosophila	B-X
maternal	B-X
effect	B-X
gene	B-X
dorsal	B-X
.	B-X
We	B-X
describe	B-X
the	B-X
cloning	B-X
and	B-X
characterization	B-X
of	B-X
a	B-X
novel	B-X
rel-related	B-X
gene	B-X
encoding	B-X
a	B-X
98K	B-X
product	B-X
that	B-X
shares	B-X
extensive	B-X
homology	B-X
with	B-X
the	B-X
p105	B-X
precursor	B-X
of	B-X
the	B-X
NF-kappa	B-X
B	B-X
p50	B-X
protein	B-X
,	B-X
containing	B-X
both	B-X
a	B-X
Rel	B-X
homology	B-X
and	B-X
SWI6/ankyrin	B-X
repeat	B-X
domain	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
p98	B-X
is	B-X
proteolytically	B-X
processed	B-X
in	B-X
vivo	B-X
to	B-X
generate	B-X
a	B-X
55K	B-X
polypeptide	B-X
,	B-X
which	B-X
binds	B-X
to	B-X
kappa	B-X
B	B-X
sites	B-X
.	B-X
p55	B-X
is	B-X
capable	B-X
of	B-X
forming	B-X
heterocomplexes	B-X
with	B-X
other	B-X
Rel/NF-kappa	B-X
B	B-X
family	B-X
members	B-X
,	B-X
which	B-X
can	B-X
bind	B-X
to	B-X
kappa	B-X
B	B-X
motifs	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
stimulate	B-X
transcription	B-X
of	B-X
reporter	B-X
genes	B-X
containing	B-X
these	B-X
cis-elements	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
identification	B-X
of	B-X
a	B-X
homolog	B-X
for	B-X
NF-kappa	B-X
B	B-X
p50/p105	B-X
,	B-X
termed	B-X
p55/p98	B-X
,	B-X
gives	B-X
further	B-X
support	B-X
to	B-X
the	B-X
idea	B-X
that	B-X
NF-kappa	B-X
B	B-X
is	B-X
a	B-X
collection	B-X
of	B-X
structurally	B-X
related	B-X
complexes	B-X
of	B-X
which	B-X
contribute	B-X
to	B-X
the	B-X
pleiotropic	B-X
regulatory	B-X
processes	B-X
originally	B-X
assigned	B-X
to	B-X
NF-kappa	B-X
B	B-X
.	B-X

The	O
identification	O
of	O
a	O
homolog	O
for	O
NF	O
-	O
kappa	O
B	O
p50	B-Gene_or_gene_product
/	O
p105	B-Gene_or_gene_product
,	O
termed	O
p55	B-Gene_or_gene_product
/	O
p98	B-Gene_or_gene_product
,	O
gives	O
further	O
support	O
to	O
the	O
idea	O
that	O
NF	O
-	O
kappa	O
B	O
is	O
a	O
collection	O
of	O
structurally	O
related	O
complexes	O
of	O
which	O
contribute	O
to	O
the	O
pleiotropic	O
regulatory	O
processes	O
originally	O
assigned	O
to	O
NF	O
-	O
kappa	O
B	O
.	O

Ser	O
-	O
64	O
and	O
Ser	O
-	O
111	O
in	O
PHAS	B-Gene_or_gene_product
-	I-Gene_or_gene_product
I	I-Gene_or_gene_product
are	O
dispensable	O
for	O
insulin	B-Gene_or_gene_product
-	O
stimulated	O
dissociation	O
from	O
eIF4E	B-Gene_or_gene_product
.	O
<EOS>	B-X
Insulin	B-X
stimulates	B-X
phosphorylation	B-X
of	B-X
multiple	B-X
sites	B-X
in	B-X
the	B-X
eIF4E-binding	B-X
protein	B-X
,	B-X
PHAS-I	B-X
,	B-X
leading	B-X
to	B-X
dissociation	B-X
of	B-X
the	B-X
PHAS-I.eIF4E	B-X
complex	B-X
and	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
cap-dependent	B-X
translation	B-X
.	B-X
The	B-X
Ser-64	B-X
and	B-X
Ser-111	B-X
sites	B-X
have	B-X
been	B-X
proposed	B-X
to	B-X
have	B-X
key	B-X
roles	B-X
in	B-X
controlling	B-X
the	B-X
association	B-X
of	B-X
PHAS-I	B-X
and	B-X
eIF4E	B-X
.	B-X
To	B-X
determine	B-X
whether	B-X
the	B-X
effects	B-X
of	B-X
insulin	B-X
require	B-X
these	B-X
sites	B-X
,	B-X
we	B-X
assessed	B-X
the	B-X
control	B-X
of	B-X
PHAS-I	B-X
proteins	B-X
having	B-X
Ala-64	B-X
or	B-X
Ala-111	B-X
mutations	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
phosphorylation	B-X
of	B-X
neither	B-X
site	B-X
is	B-X
required	B-X
for	B-X
insulin	B-X
to	B-X
promote	B-X
release	B-X
of	B-X
PHAS-I	B-X
from	B-X
eIF4E	B-X
.	B-X
Also	B-X
,	B-X
the	B-X
mutation	B-X
of	B-X
Ser-111	B-X
,	B-X
which	B-X
has	B-X
been	B-X
proposed	B-X
to	B-X
serve	B-X
as	B-X
a	B-X
necessary	B-X
priming	B-X
site	B-X
for	B-X
the	B-X
phosphorylation	B-X
of	B-X
other	B-X
sites	B-X
in	B-X
PHAS-I	B-X
,	B-X
did	B-X
not	B-X
affect	B-X
the	B-X
phosphorylation	B-X
of	B-X
Thr-36/45	B-X
,	B-X
Ser-64	B-X
,	B-X
or	B-X
Thr-69	B-X
.	B-X
Insulin	B-X
promoted	B-X
the	B-X
release	B-X
of	B-X
eIF4E	B-X
from	B-X
PHAS-II	B-X
,	B-X
a	B-X
PHAS	B-X
isoform	B-X
that	B-X
lacks	B-X
the	B-X
Ser-111	B-X
site	B-X
,	B-X
but	B-X
it	B-X
was	B-X
without	B-X
effect	B-X
on	B-X
the	B-X
amount	B-X
of	B-X
eIF4E	B-X
bound	B-X
to	B-X
the	B-X
third	B-X
isoform	B-X
,	B-X
PHAS-III	B-X
.	B-X
The	B-X
results	B-X
demonstrate	B-X
that	B-X
contrary	B-X
to	B-X
widely	B-X
accepted	B-X
models	B-X
,	B-X
Ser-64	B-X
and	B-X
Ser-111	B-X
are	B-X
not	B-X
required	B-X
for	B-X
the	B-X
control	B-X
of	B-X
PHAS-I	B-X
binding	B-X
to	B-X
eIF4E	B-X
in	B-X
cells	B-X
,	B-X
implicating	B-X
phosphorylation	B-X
of	B-X
the	B-X
Thr	B-X
sites	B-X
in	B-X
dissociation	B-X
of	B-X
the	B-X
PHAS-I.eIF4E	B-X
complex	B-X
.	B-X
The	B-X
findings	B-X
also	B-X
indicate	B-X
that	B-X
PHAS-II	B-X
,	B-X
but	B-X
not	B-X
PHAS-III	B-X
,	B-X
contributes	B-X
to	B-X
the	B-X
control	B-X
of	B-X
protein	B-X
synthesis	B-X
by	B-X
insulin	B-X
.	B-X

Insulin	B-Gene_or_gene_product
stimulates	O
phosphorylation	O
of	O
multiple	O
sites	O
in	O
the	O
eIF4E	B-Gene_or_gene_product
-	O
binding	O
protein	O
,	O
PHAS	B-Gene_or_gene_product
-	I-Gene_or_gene_product
I	I-Gene_or_gene_product
,	O
leading	O
to	O
dissociation	O
of	O
the	O
PHAS	O
-	O
I	O
.	O
eIF4E	O
complex	O
and	O
to	O
an	O
increase	O
in	O
cap	O
-	O
dependent	O
translation	O
.	O

The	O
Ser	O
-	O
64	O
and	O
Ser	O
-	O
111	O
sites	O
have	O
been	O
proposed	O
to	O
have	O
key	O
roles	O
in	O
controlling	O
the	O
association	O
of	O
PHAS	B-Gene_or_gene_product
-	I-Gene_or_gene_product
I	I-Gene_or_gene_product
and	O
eIF4E	B-Gene_or_gene_product
.	O
<EOS>	B-X
Insulin	B-X
stimulates	B-X
phosphorylation	B-X
of	B-X
multiple	B-X
sites	B-X
in	B-X
the	B-X
eIF4E-binding	B-X
protein	B-X
,	B-X
PHAS-I	B-X
,	B-X
leading	B-X
to	B-X
dissociation	B-X
of	B-X
the	B-X
PHAS-I.eIF4E	B-X
complex	B-X
and	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
cap-dependent	B-X
translation	B-X
.	B-X
The	B-X
Ser-64	B-X
and	B-X
Ser-111	B-X
sites	B-X
have	B-X
been	B-X
proposed	B-X
to	B-X
have	B-X
key	B-X
roles	B-X
in	B-X
controlling	B-X
the	B-X
association	B-X
of	B-X
PHAS-I	B-X
and	B-X
eIF4E	B-X
.	B-X
To	B-X
determine	B-X
whether	B-X
the	B-X
effects	B-X
of	B-X
insulin	B-X
require	B-X
these	B-X
sites	B-X
,	B-X
we	B-X
assessed	B-X
the	B-X
control	B-X
of	B-X
PHAS-I	B-X
proteins	B-X
having	B-X
Ala-64	B-X
or	B-X
Ala-111	B-X
mutations	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
phosphorylation	B-X
of	B-X
neither	B-X
site	B-X
is	B-X
required	B-X
for	B-X
insulin	B-X
to	B-X
promote	B-X
release	B-X
of	B-X
PHAS-I	B-X
from	B-X
eIF4E	B-X
.	B-X
Also	B-X
,	B-X
the	B-X
mutation	B-X
of	B-X
Ser-111	B-X
,	B-X
which	B-X
has	B-X
been	B-X
proposed	B-X
to	B-X
serve	B-X
as	B-X
a	B-X
necessary	B-X
priming	B-X
site	B-X
for	B-X
the	B-X
phosphorylation	B-X
of	B-X
other	B-X
sites	B-X
in	B-X
PHAS-I	B-X
,	B-X
did	B-X
not	B-X
affect	B-X
the	B-X
phosphorylation	B-X
of	B-X
Thr-36/45	B-X
,	B-X
Ser-64	B-X
,	B-X
or	B-X
Thr-69	B-X
.	B-X
Insulin	B-X
promoted	B-X
the	B-X
release	B-X
of	B-X
eIF4E	B-X
from	B-X
PHAS-II	B-X
,	B-X
a	B-X
PHAS	B-X
isoform	B-X
that	B-X
lacks	B-X
the	B-X
Ser-111	B-X
site	B-X
,	B-X
but	B-X
it	B-X
was	B-X
without	B-X
effect	B-X
on	B-X
the	B-X
amount	B-X
of	B-X
eIF4E	B-X
bound	B-X
to	B-X
the	B-X
third	B-X
isoform	B-X
,	B-X
PHAS-III	B-X
.	B-X
The	B-X
results	B-X
demonstrate	B-X
that	B-X
contrary	B-X
to	B-X
widely	B-X
accepted	B-X
models	B-X
,	B-X
Ser-64	B-X
and	B-X
Ser-111	B-X
are	B-X
not	B-X
required	B-X
for	B-X
the	B-X
control	B-X
of	B-X
PHAS-I	B-X
binding	B-X
to	B-X
eIF4E	B-X
in	B-X
cells	B-X
,	B-X
implicating	B-X
phosphorylation	B-X
of	B-X
the	B-X
Thr	B-X
sites	B-X
in	B-X
dissociation	B-X
of	B-X
the	B-X
PHAS-I.eIF4E	B-X
complex	B-X
.	B-X
The	B-X
findings	B-X
also	B-X
indicate	B-X
that	B-X
PHAS-II	B-X
,	B-X
but	B-X
not	B-X
PHAS-III	B-X
,	B-X
contributes	B-X
to	B-X
the	B-X
control	B-X
of	B-X
protein	B-X
synthesis	B-X
by	B-X
insulin	B-X
.	B-X

To	O
determine	O
whether	O
the	O
effects	O
of	O
insulin	B-Gene_or_gene_product
require	O
these	O
sites	O
,	O
we	O
assessed	O
the	O
control	O
of	O
PHAS	B-Gene_or_gene_product
-	I-Gene_or_gene_product
I	I-Gene_or_gene_product
proteins	O
having	O
Ala	O
-	O
64	O
or	O
Ala	O
-	O
111	O
mutations	O
.	O
<EOS>	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
disruption	B-X
and/or	B-X
mutation	B-X
of	B-X
G4	B-X
binding	B-X
proteins	B-X
(	B-X
G4BPs	B-X
)	B-X
,	B-X
such	B-X
as	B-X
heterogeneous	B-X
nuclear	B-X
ribonucleoproteins	B-X
(	B-X
hnRNPs	B-X
)	B-X
and	B-X
DNA/RNA	B-X
helicases	B-X
,	B-X
is	B-X
related	B-X
to	B-X
neurological	B-X
diseases	B-X
.	B-X
For	B-X
instance	B-X
,	B-X
mutations	B-X
in	B-X
a	B-X
G4BP	B-X
called	B-X
ATRX	B-X
lead	B-X
to	B-X
a	B-X
neurodevelopmental	B-X
disorder	B-X
,	B-X
ATR-X	B-X
syndrome	B-X
,	B-X
which	B-X
is	B-X
associated	B-X
with	B-X
intellectual	B-X
disability	B-X
.	B-X
As	B-X
one	B-X
of	B-X
the	B-X
major	B-X
enamel	B-X
matrix	B-X
proteins	B-X
(	B-X
EMPs	B-X
)	B-X
,	B-X
enamelin	B-X
(	B-X
ENAM	B-X
)	B-X
has	B-X
three	B-X
serines	B-X
located	B-X
in	B-X
Ser-x-Glu	B-X
(	B-X
S-x-E	B-X
)	B-X
motifs	B-X
,	B-X
which	B-X
are	B-X
potential	B-X
phosphorylation	B-X
sites	B-X
for	B-X
the	B-X
Golgi	B-X
casein	B-X
kinase	B-X
FAM20C	B-X
.	B-X
Ribonuclease	B-X
inactivating	B-X
point	B-X
mutations	B-X
are	B-X
found	B-X
in	B-X
a	B-X
subset	B-X
of	B-X
patients	B-X
with	B-X
ALS	B-X
,	B-X
a	B-X
fatal	B-X
neurodegenerative	B-X
disease	B-X
with	B-X
no	B-X
cure	B-X
.	B-X
Selected	B-X
5'-tiRNAs	B-X
(	B-X
e.g.	B-X
,	B-X
tiRNA	B-X
(	B-X
Ala	B-X
)	B-X
,	B-X
tiRNA	B-X
(	B-X
Cys	B-X
)	B-X
)	B-X
cooperate	B-X
with	B-X
the	B-X
translational	B-X
repressor	B-X
Y-box	B-X
binding	B-X
protein	B-X
1	B-X
(	B-X
YB-1	B-X
)	B-X
to	B-X
displace	B-X
the	B-X
cap-binding	B-X
complex	B-X
eIF4F	B-X
from	B-X
capped	B-X
mRNA	B-X
,	B-X
inhibit	B-X
translation	B-X
initiation	B-X
,	B-X
and	B-X
induce	B-X
the	B-X
assembly	B-X
of	B-X
stress	B-X
granules	B-X
(	B-X
SGs	B-X
)	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
translationally	B-X
active	B-X
tiRNAs	B-X
assemble	B-X
unique	B-X
G-quadruplex	B-X
(	B-X
G4	B-X
)	B-X
structures	B-X
that	B-X
are	B-X
required	B-X
for	B-X
translation	B-X
inhibition	B-X
.	B-X
We	B-X
show	B-X
that	B-X
tiRNA	B-X
(	B-X
Ala	B-X
)	B-X
binds	B-X
the	B-X
cold	B-X
shock	B-X
domain	B-X
of	B-X
YB-1	B-X
to	B-X
activate	B-X
these	B-X
translational	B-X
reprogramming	B-X
events	B-X
.	B-X
We	B-X
discovered	B-X
that	B-X
5'-tiDNA	B-X
(	B-X
Ala	B-X
)	B-X
(	B-X
the	B-X
DNA	B-X
equivalent	B-X
of	B-X
5'-tiRNA	B-X
(	B-X
Ala	B-X
)	B-X
)	B-X
is	B-X
a	B-X
stable	B-X
tiRNA	B-X
analog	B-X
that	B-X
displaces	B-X
eIF4F	B-X
from	B-X
capped	B-X
mRNA	B-X
,	B-X
inhibits	B-X
translation	B-X
initiation	B-X
,	B-X
and	B-X
induces	B-X
the	B-X
assembly	B-X
of	B-X
SGs	B-X
.	B-X
The	B-X
5'-tiDNA	B-X
(	B-X
Ala	B-X
)	B-X
also	B-X
assembles	B-X
a	B-X
G4	B-X
structure	B-X
that	B-X
allows	B-X
it	B-X
to	B-X
enter	B-X
motor	B-X
neurons	B-X
spontaneously	B-X
and	B-X
trigger	B-X
a	B-X
neuroprotective	B-X
response	B-X
in	B-X
a	B-X
YB-1-dependent	B-X
manner	B-X
.	B-X
Remarkably	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
5'-tiRNA	B-X
(	B-X
Ala	B-X
)	B-X
to	B-X
induce	B-X
SG	B-X
assembly	B-X
is	B-X
inhibited	B-X
by	B-X
G4	B-X
structures	B-X
formed	B-X
by	B-X
pathological	B-X
GGGGCC	B-X
repeats	B-X
found	B-X
in	B-X
C9ORF72	B-X
,	B-X
the	B-X
most	B-X
common	B-X
genetic	B-X
cause	B-X
of	B-X
ALS	B-X
,	B-X
suggesting	B-X
that	B-X
functional	B-X
interactions	B-X
between	B-X
G4	B-X
RNAs	B-X
may	B-X
contribute	B-X
to	B-X
neurodegenerative	B-X
disease	B-X
.	B-X

The	O
results	O
indicate	O
that	O
phosphorylation	O
of	O
neither	O
site	O
is	O
required	O
for	O
insulin	B-Gene_or_gene_product
to	O
promote	O
release	O
of	O
PHAS	B-Gene_or_gene_product
-	I-Gene_or_gene_product
I	I-Gene_or_gene_product
from	O
eIF4E	B-Gene_or_gene_product
.	O
<EOS>	B-X
Insulin	B-X
stimulates	B-X
phosphorylation	B-X
of	B-X
multiple	B-X
sites	B-X
in	B-X
the	B-X
eIF4E-binding	B-X
protein	B-X
,	B-X
PHAS-I	B-X
,	B-X
leading	B-X
to	B-X
dissociation	B-X
of	B-X
the	B-X
PHAS-I.eIF4E	B-X
complex	B-X
and	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
cap-dependent	B-X
translation	B-X
.	B-X
The	B-X
Ser-64	B-X
and	B-X
Ser-111	B-X
sites	B-X
have	B-X
been	B-X
proposed	B-X
to	B-X
have	B-X
key	B-X
roles	B-X
in	B-X
controlling	B-X
the	B-X
association	B-X
of	B-X
PHAS-I	B-X
and	B-X
eIF4E	B-X
.	B-X
To	B-X
determine	B-X
whether	B-X
the	B-X
effects	B-X
of	B-X
insulin	B-X
require	B-X
these	B-X
sites	B-X
,	B-X
we	B-X
assessed	B-X
the	B-X
control	B-X
of	B-X
PHAS-I	B-X
proteins	B-X
having	B-X
Ala-64	B-X
or	B-X
Ala-111	B-X
mutations	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
phosphorylation	B-X
of	B-X
neither	B-X
site	B-X
is	B-X
required	B-X
for	B-X
insulin	B-X
to	B-X
promote	B-X
release	B-X
of	B-X
PHAS-I	B-X
from	B-X
eIF4E	B-X
.	B-X
Also	B-X
,	B-X
the	B-X
mutation	B-X
of	B-X
Ser-111	B-X
,	B-X
which	B-X
has	B-X
been	B-X
proposed	B-X
to	B-X
serve	B-X
as	B-X
a	B-X
necessary	B-X
priming	B-X
site	B-X
for	B-X
the	B-X
phosphorylation	B-X
of	B-X
other	B-X
sites	B-X
in	B-X
PHAS-I	B-X
,	B-X
did	B-X
not	B-X
affect	B-X
the	B-X
phosphorylation	B-X
of	B-X
Thr-36/45	B-X
,	B-X
Ser-64	B-X
,	B-X
or	B-X
Thr-69	B-X
.	B-X
Insulin	B-X
promoted	B-X
the	B-X
release	B-X
of	B-X
eIF4E	B-X
from	B-X
PHAS-II	B-X
,	B-X
a	B-X
PHAS	B-X
isoform	B-X
that	B-X
lacks	B-X
the	B-X
Ser-111	B-X
site	B-X
,	B-X
but	B-X
it	B-X
was	B-X
without	B-X
effect	B-X
on	B-X
the	B-X
amount	B-X
of	B-X
eIF4E	B-X
bound	B-X
to	B-X
the	B-X
third	B-X
isoform	B-X
,	B-X
PHAS-III	B-X
.	B-X
The	B-X
results	B-X
demonstrate	B-X
that	B-X
contrary	B-X
to	B-X
widely	B-X
accepted	B-X
models	B-X
,	B-X
Ser-64	B-X
and	B-X
Ser-111	B-X
are	B-X
not	B-X
required	B-X
for	B-X
the	B-X
control	B-X
of	B-X
PHAS-I	B-X
binding	B-X
to	B-X
eIF4E	B-X
in	B-X
cells	B-X
,	B-X
implicating	B-X
phosphorylation	B-X
of	B-X
the	B-X
Thr	B-X
sites	B-X
in	B-X
dissociation	B-X
of	B-X
the	B-X
PHAS-I.eIF4E	B-X
complex	B-X
.	B-X
The	B-X
findings	B-X
also	B-X
indicate	B-X
that	B-X
PHAS-II	B-X
,	B-X
but	B-X
not	B-X
PHAS-III	B-X
,	B-X
contributes	B-X
to	B-X
the	B-X
control	B-X
of	B-X
protein	B-X
synthesis	B-X
by	B-X
insulin	B-X
.	B-X

Also	O
,	O
the	O
mutation	O
of	O
Ser	O
-	O
111	O
,	O
which	O
has	O
been	O
proposed	O
to	O
serve	O
as	O
a	O
necessary	O
priming	O
site	O
for	O
the	O
phosphorylation	O
of	O
other	O
sites	O
in	O
PHAS	B-Gene_or_gene_product
-	I-Gene_or_gene_product
I	I-Gene_or_gene_product
,	O
did	O
not	O
affect	O
the	O
phosphorylation	O
of	O
Thr	O
-	O
36	O
/	O
45	O
,	O
Ser	O
-	O
64	O
,	O
or	O
Thr	O
-	O
69	O
.	O
<EOS>	B-X
Ser/Thr	B-X
and	B-X
Tyr	B-X
phosphatases	B-X
are	B-X
associated	B-X
with	B-X
growth	B-X
and	B-X
virulence	B-X
of	B-X
many	B-X
bacteria	B-X
.	B-X
This	B-X
review	B-X
focuses	B-X
on	B-X
the	B-X
role	B-X
of	B-X
Ser/Thr-	B-X
and	B-X
Tyr-specific	B-X
phosphatases	B-X
present	B-X
in	B-X
pathogenic	B-X
bacteria	B-X
,	B-X
with	B-X
an	B-X
emphasis	B-X
on	B-X
the	B-X
regulation	B-X
of	B-X
basic	B-X
cellular	B-X
processes	B-X
and	B-X
virulence	B-X
.	B-X
Rivaroxaban	B-X
showed	B-X
similar	B-X
efficacy	B-X
to	B-X
apixaban	B-X
in	B-X
patients	B-X
with	B-X
THR	B-X
and	B-X
TKR	B-X
(	B-X
OR	B-X
,	B-X
0.69	B-X
;	B-X
95	B-X
%	B-X
CI	B-X
,	B-X
0.38-1.25	B-X
and	B-X
OR	B-X
,	B-X
0.83	B-X
;	B-X
95	B-X
%	B-X
CI	B-X
,	B-X
0.57-1.19	B-X
,	B-X
respectively	B-X
)	B-X
.	B-X
No	B-X
significant	B-X
differences	B-X
were	B-X
observed	B-X
in	B-X
bleeding	B-X
outcomes	B-X
between	B-X
treatments	B-X
.	B-X

Insulin	B-Gene_or_gene_product
promoted	O
the	O
release	O
of	O
eIF4E	B-Gene_or_gene_product
from	O
PHAS	B-Gene_or_gene_product
-	I-Gene_or_gene_product
II	I-Gene_or_gene_product
,	O
a	O
PHAS	B-Gene_or_gene_product
isoform	O
that	O
lacks	O
the	O
Ser	O
-	O
111	O
site	O
,	O
but	O
it	O
was	O
without	O
effect	O
on	O
the	O
amount	O
of	O
eIF4E	B-Gene_or_gene_product
bound	O
to	O
the	O
third	O
isoform	O
,	O
PHAS	B-Gene_or_gene_product
-	I-Gene_or_gene_product
III	I-Gene_or_gene_product
.	O

The	O
results	O
demonstrate	O
that	O
contrary	O
to	O
widely	O
accepted	O
models	O
,	O
Ser	O
-	O
64	O
and	O
Ser	O
-	O
111	O
are	O
not	O
required	O
for	O
the	O
control	O
of	O
PHAS	B-Gene_or_gene_product
-	I-Gene_or_gene_product
I	I-Gene_or_gene_product
binding	O
to	O
eIF4E	B-Gene_or_gene_product
in	O
cells	O
,	O
implicating	O
phosphorylation	O
of	O
the	O
Thr	O
sites	O
in	O
dissociation	O
of	O
the	O
PHAS	O
-	O
I	O
.	O
eIF4E	O
complex	O
.	O

The	O
findings	O
also	O
indicate	O
that	O
PHAS	B-Gene_or_gene_product
-	I-Gene_or_gene_product
II	I-Gene_or_gene_product
,	O
but	O
not	O
PHAS	B-Gene_or_gene_product
-	I-Gene_or_gene_product
III	I-Gene_or_gene_product
,	O
contributes	O
to	O
the	O
control	O
of	O
protein	O
synthesis	O
by	O
insulin	B-Gene_or_gene_product
.	O
<EOS>	B-X
Obesity	B-X
and	B-X
obesity-related	B-X
low-grade	B-X
inflammation	B-X
are	B-X
common	B-X
findings	B-X
in	B-X
polycystic	B-X
ovary	B-X
syndrome	B-X
(	B-X
PCOS	B-X
)	B-X
,	B-X
the	B-X
most	B-X
common	B-X
endocrine-metabolic	B-X
disorder-affecting	B-X
women	B-X
in	B-X
reproductive	B-X
age	B-X
.	B-X
Diseases	B-X
are	B-X
generally	B-X
characterized	B-X
by	B-X
common	B-X
clinical	B-X
characteristics	B-X
across	B-X
subjects	B-X
,	B-X
but	B-X
there	B-X
are	B-X
also	B-X
significant	B-X
inter-subject	B-X
variations	B-X
.	B-X
A	B-X
poor	B-X
prognosis	B-X
for	B-X
patients	B-X
with	B-X
Stage	B-X
IIIA	B-X
clinical	B-X
N2	B-X
treated	B-X
by	B-X
surgery	B-X
alone	B-X
has	B-X
led	B-X
clinical	B-X
researchers	B-X
to	B-X
find	B-X
a	B-X
new	B-X
treatment	B-X
modality	B-X
to	B-X
improve	B-X
the	B-X
curative	B-X
potential	B-X
of	B-X
surgery	B-X
.	B-X
Many	B-X
Phas	B-X
II	B-X
trials	B-X
have	B-X
been	B-X
carried	B-X
out	B-X
with	B-X
induction	B-X
chemo-	B-X
or	B-X
chemo-radiotherapy	B-X
prior	B-X
to	B-X
surgery	B-X
.	B-X
From	B-X
June	B-X
1988	B-X
to	B-X
July	B-X
1991	B-X
,	B-X
46	B-X
patients	B-X
with	B-X
non-small	B-X
cell	B-X
lung	B-X
cancer	B-X
(	B-X
NSCLC	B-X
)	B-X
Stage	B-X
IIIA	B-X
clinical	B-X
N2	B-X
entered	B-X
a	B-X
Phase	B-X
II	B-X
induction-chemotherapy	B-X
trial	B-X
.	B-X
Cisplatin	B-X
with	B-X
etoposide	B-X
is	B-X
an	B-X
active	B-X
and	B-X
safe	B-X
induction	B-X
chemotherapy	B-X
regimen	B-X
for	B-X
NSCLC	B-X
Stage	B-X
IIIA	B-X
N2	B-X
with	B-X
a	B-X
high	B-X
response	B-X
rate	B-X
.	B-X

p73	B-Gene_or_gene_product
tumor	O
-	O
suppressor	O
activity	O
is	O
impaired	O
in	O
human	O
thyroid	O
cancer	O
.	O
<EOS>	B-X
The	B-X
p73	B-X
protein	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
p53	B-X
family	B-X
and	B-X
,	B-X
like	B-X
p53	B-X
,	B-X
can	B-X
induce	B-X
cell-cycle	B-X
arrest	B-X
and	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
Because	B-X
the	B-X
loss	B-X
of	B-X
p53	B-X
function	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
progression	B-X
of	B-X
well-differentiated	B-X
thyroid	B-X
cancer	B-X
to	B-X
more	B-X
aggressive	B-X
phenotypes	B-X
,	B-X
we	B-X
hypothesized	B-X
that	B-X
p73	B-X
might	B-X
also	B-X
be	B-X
involved	B-X
in	B-X
thyroid	B-X
carcinogenesis	B-X
.	B-X
We	B-X
find	B-X
that	B-X
normal	B-X
thyrocites	B-X
do	B-X
not	B-X
express	B-X
p73	B-X
,	B-X
whereas	B-X
most	B-X
thyroid	B-X
malignancies	B-X
are	B-X
positive	B-X
for	B-X
p73	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
the	B-X
p73	B-X
protein	B-X
of	B-X
thyroid	B-X
cancer	B-X
cells	B-X
is	B-X
unresponsive	B-X
to	B-X
DNA-damaging	B-X
agents	B-X
,	B-X
failing	B-X
to	B-X
elicit	B-X
a	B-X
block	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
or	B-X
an	B-X
apoptotic	B-X
response	B-X
.	B-X
Notably	B-X
,	B-X
overexpression	B-X
of	B-X
transcriptionally	B-X
active	B-X
p73	B-X
in	B-X
thyroid	B-X
cancer	B-X
lines	B-X
can	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
but	B-X
is	B-X
still	B-X
unable	B-X
to	B-X
induce	B-X
cell	B-X
death	B-X
.	B-X
The	B-X
loss	B-X
of	B-X
p73	B-X
biological	B-X
activity	B-X
in	B-X
neoplastic	B-X
thyroid	B-X
cells	B-X
is	B-X
partly	B-X
explained	B-X
by	B-X
its	B-X
interaction	B-X
with	B-X
transcriptionally	B-X
inactive	B-X
variants	B-X
of	B-X
p73	B-X
(	B-X
DeltaNp73	B-X
)	B-X
and	B-X
with	B-X
mutant	B-X
p53	B-X
.	B-X
Our	B-X
findings	B-X
suggest	B-X
that	B-X
the	B-X
functional	B-X
impairment	B-X
of	B-X
p73	B-X
could	B-X
be	B-X
involved	B-X
in	B-X
the	B-X
development	B-X
of	B-X
thyroid	B-X
malignancies	B-X
,	B-X
defining	B-X
p73	B-X
as	B-X
a	B-X
potential	B-X
therapeutic	B-X
target	B-X
for	B-X
thyroid	B-X
cancer	B-X
.	B-X

The	O
p73	B-Gene_or_gene_product
protein	O
is	O
a	O
member	O
of	O
the	O
p53	B-Gene_or_gene_product
family	O
and	O
,	O
like	O
p53	B-Gene_or_gene_product
,	O
can	O
induce	O
cell	O
-	O
cycle	O
arrest	O
and	O
apoptosis	O
in	O
response	O
to	O
DNA	O
damage	O
.	O
<EOS>	B-X
Members	B-X
of	B-X
the	B-X
P53	B-X
transcription	B-X
factor	B-X
family	B-X
,	B-X
P53	B-X
,	B-X
P63	B-X
,	B-X
and	B-X
P73	B-X
,	B-X
play	B-X
important	B-X
roles	B-X
in	B-X
normal	B-X
development	B-X
and	B-X
in	B-X
regulating	B-X
the	B-X
expression	B-X
of	B-X
genes	B-X
that	B-X
control	B-X
apoptosis	B-X
and	B-X
cell	B-X
cycle	B-X
progression	B-X
in	B-X
response	B-X
to	B-X
genotoxic	B-X
stress	B-X
.	B-X
P53	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
DNA	B-X
damage	B-X
response	B-X
pathway	B-X
that	B-X
is	B-X
activated	B-X
by	B-X
hydroxyurea	B-X
in	B-X
organogenesis-stage	B-X
murine	B-X
embryos	B-X
.	B-X
The	B-X
extent	B-X
to	B-X
which	B-X
P63	B-X
and	B-X
P73	B-X
contribute	B-X
to	B-X
this	B-X
stress	B-X
response	B-X
is	B-X
not	B-X
known	B-X
.	B-X
To	B-X
address	B-X
this	B-X
question	B-X
,	B-X
we	B-X
examined	B-X
the	B-X
roles	B-X
of	B-X
P53	B-X
,	B-X
P63	B-X
,	B-X
and	B-X
P73	B-X
in	B-X
mediating	B-X
the	B-X
response	B-X
of	B-X
Trp53-positive	B-X
and	B-X
Trp53-deficient	B-X
murine	B-X
embryos	B-X
to	B-X
a	B-X
single	B-X
dose	B-X
of	B-X
hydroxyurea	B-X
(	B-X
400	B-X
mg/kg	B-X
)	B-X
on	B-X
gestational	B-X
day	B-X
9	B-X
.	B-X
Hydroxyurea	B-X
treatment	B-X
downregulated	B-X
the	B-X
expression	B-X
of	B-X
Trp63	B-X
and	B-X
upregulated	B-X
Trp73	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
effects	B-X
on	B-X
the	B-X
levels	B-X
of	B-X
Trp53	B-X
transcripts	B-X
;	B-X
Trp73	B-X
upregulation	B-X
was	B-X
P53-dependent	B-X
.	B-X
At	B-X
the	B-X
protein	B-X
level	B-X
,	B-X
hydroxyurea	B-X
treatment	B-X
increased	B-X
the	B-X
levels	B-X
and	B-X
phosphorylation	B-X
of	B-X
P53	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
effects	B-X
on	B-X
P63	B-X
and	B-X
P73	B-X
.	B-X
Upregulation	B-X
of	B-X
the	B-X
expression	B-X
of	B-X
genes	B-X
that	B-X
regulate	B-X
cell	B-X
cycle	B-X
arrest	B-X
and	B-X
apoptosis	B-X
,	B-X
Cdkn1a	B-X
,	B-X
Rb1	B-X
,	B-X
Fas	B-X
,	B-X
Trp53inp1	B-X
,	B-X
and	B-X
Pmaip1	B-X
,	B-X
was	B-X
P53-dependent	B-X
in	B-X
hydroxyurea-treated	B-X
embryos	B-X
.	B-X
The	B-X
increase	B-X
in	B-X
cleaved	B-X
caspase-3	B-X
and	B-X
cleaved	B-X
mammalian	B-X
sterile-20-like-1	B-X
kinase	B-X
levels	B-X
induced	B-X
by	B-X
hydroxyurea	B-X
was	B-X
also	B-X
P53-dependent	B-X
;	B-X
in	B-X
contrast	B-X
,	B-X
the	B-X
increase	B-X
in	B-X
phosphorylated	B-X
H2AX	B-X
,	B-X
a	B-X
marker	B-X
of	B-X
DNA	B-X
double-strand	B-X
breaks	B-X
,	B-X
in	B-X
response	B-X
to	B-X
hydroxyurea	B-X
treatment	B-X
was	B-X
only	B-X
partially	B-X
P53-dependent	B-X
.	B-X
Together	B-X
,	B-X
our	B-X
data	B-X
show	B-X
that	B-X
P53	B-X
is	B-X
the	B-X
principal	B-X
P53	B-X
family	B-X
member	B-X
that	B-X
is	B-X
activated	B-X
in	B-X
the	B-X
embryonic	B-X
DNA	B-X
damage	B-X
response	B-X
.	B-X

Because	O
the	O
loss	O
of	O
p53	B-Gene_or_gene_product
function	O
is	O
responsible	O
for	O
the	O
progression	O
of	O
well	O
-	O
differentiated	O
thyroid	O
cancer	O
to	O
more	O
aggressive	O
phenotypes	O
,	O
we	O
hypothesized	O
that	O
p73	B-Gene_or_gene_product
might	O
also	O
be	O
involved	O
in	O
thyroid	O
carcinogenesis	O
.	O
<EOS>	B-X
The	B-X
p73	B-X
protein	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
p53	B-X
family	B-X
and	B-X
,	B-X
like	B-X
p53	B-X
,	B-X
can	B-X
induce	B-X
cell-cycle	B-X
arrest	B-X
and	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
Because	B-X
the	B-X
loss	B-X
of	B-X
p53	B-X
function	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
progression	B-X
of	B-X
well-differentiated	B-X
thyroid	B-X
cancer	B-X
to	B-X
more	B-X
aggressive	B-X
phenotypes	B-X
,	B-X
we	B-X
hypothesized	B-X
that	B-X
p73	B-X
might	B-X
also	B-X
be	B-X
involved	B-X
in	B-X
thyroid	B-X
carcinogenesis	B-X
.	B-X
We	B-X
find	B-X
that	B-X
normal	B-X
thyrocites	B-X
do	B-X
not	B-X
express	B-X
p73	B-X
,	B-X
whereas	B-X
most	B-X
thyroid	B-X
malignancies	B-X
are	B-X
positive	B-X
for	B-X
p73	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
the	B-X
p73	B-X
protein	B-X
of	B-X
thyroid	B-X
cancer	B-X
cells	B-X
is	B-X
unresponsive	B-X
to	B-X
DNA-damaging	B-X
agents	B-X
,	B-X
failing	B-X
to	B-X
elicit	B-X
a	B-X
block	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
or	B-X
an	B-X
apoptotic	B-X
response	B-X
.	B-X
Notably	B-X
,	B-X
overexpression	B-X
of	B-X
transcriptionally	B-X
active	B-X
p73	B-X
in	B-X
thyroid	B-X
cancer	B-X
lines	B-X
can	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
but	B-X
is	B-X
still	B-X
unable	B-X
to	B-X
induce	B-X
cell	B-X
death	B-X
.	B-X
The	B-X
loss	B-X
of	B-X
p73	B-X
biological	B-X
activity	B-X
in	B-X
neoplastic	B-X
thyroid	B-X
cells	B-X
is	B-X
partly	B-X
explained	B-X
by	B-X
its	B-X
interaction	B-X
with	B-X
transcriptionally	B-X
inactive	B-X
variants	B-X
of	B-X
p73	B-X
(	B-X
DeltaNp73	B-X
)	B-X
and	B-X
with	B-X
mutant	B-X
p53	B-X
.	B-X
Our	B-X
findings	B-X
suggest	B-X
that	B-X
the	B-X
functional	B-X
impairment	B-X
of	B-X
p73	B-X
could	B-X
be	B-X
involved	B-X
in	B-X
the	B-X
development	B-X
of	B-X
thyroid	B-X
malignancies	B-X
,	B-X
defining	B-X
p73	B-X
as	B-X
a	B-X
potential	B-X
therapeutic	B-X
target	B-X
for	B-X
thyroid	B-X
cancer	B-X
.	B-X

We	O
find	O
that	O
normal	O
thyrocites	O
do	O
not	O
express	O
p73	B-Gene_or_gene_product
,	O
whereas	O
most	O
thyroid	O
malignancies	O
are	O
positive	O
for	O
p73	B-Gene_or_gene_product
expression	O
.	O

However	O
,	O
the	O
p73	B-Gene_or_gene_product
protein	O
of	O
thyroid	O
cancer	O
cells	O
is	O
unresponsive	O
to	O
DNA	O
-	O
damaging	O
agents	O
,	O
failing	O
to	O
elicit	O
a	O
block	O
of	O
the	O
cell	O
cycle	O
or	O
an	O
apoptotic	O
response	O
.	O
<EOS>	B-X
Macrophages	B-X
are	B-X
dynamic	B-X
cells	B-X
that	B-X
play	B-X
critical	B-X
roles	B-X
in	B-X
the	B-X
induction	B-X
and	B-X
resolution	B-X
of	B-X
sterile	B-X
inflammation	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
will	B-X
compile	B-X
and	B-X
interpret	B-X
recent	B-X
findings	B-X
on	B-X
the	B-X
plasticity	B-X
of	B-X
macrophages	B-X
and	B-X
how	B-X
these	B-X
cells	B-X
contribute	B-X
to	B-X
the	B-X
development	B-X
of	B-X
non-infectious	B-X
inflammatory	B-X
diseases	B-X
,	B-X
with	B-X
a	B-X
particular	B-X
focus	B-X
on	B-X
allergic	B-X
and	B-X
autoimmune	B-X
disorders	B-X
.	B-X
The	B-X
critical	B-X
roles	B-X
of	B-X
macrophages	B-X
in	B-X
the	B-X
resolution	B-X
of	B-X
inflammation	B-X
will	B-X
then	B-X
be	B-X
examined	B-X
,	B-X
emphasizing	B-X
the	B-X
ability	B-X
of	B-X
macrophages	B-X
to	B-X
clear	B-X
apoptotic	B-X
immune	B-X
cells	B-X
.	B-X
Rheumatoid	B-X
arthritis	B-X
(	B-X
RA	B-X
)	B-X
is	B-X
a	B-X
chronic	B-X
autoimmune-driven	B-X
spectrum	B-X
of	B-X
diseases	B-X
where	B-X
persistent	B-X
inflammation	B-X
results	B-X
in	B-X
synovial	B-X
hyperplasia	B-X
and	B-X
excessive	B-X
immune	B-X
cell	B-X
accumulation	B-X
,	B-X
leading	B-X
to	B-X
remodeling	B-X
and	B-X
reduced	B-X
function	B-X
in	B-X
affected	B-X
joints	B-X
.	B-X
Macrophages	B-X
are	B-X
central	B-X
to	B-X
the	B-X
pathophysiology	B-X
of	B-X
RA	B-X
,	B-X
driving	B-X
episodic	B-X
cycles	B-X
of	B-X
chronic	B-X
inflammation	B-X
and	B-X
tissue	B-X
destruction	B-X
.	B-X
RA	B-X
patients	B-X
have	B-X
increased	B-X
numbers	B-X
of	B-X
active	B-X
M1	B-X
polarized	B-X
pro-inflammatory	B-X
macrophages	B-X
and	B-X
few	B-X
or	B-X
inactive	B-X
M2	B-X
type	B-X
cells	B-X
.	B-X
Macrophage	B-X
polarization	B-X
has	B-X
a	B-X
profound	B-X
impact	B-X
on	B-X
asthma	B-X
pathogenesis	B-X
,	B-X
as	B-X
the	B-X
response	B-X
to	B-X
allergen	B-X
exposure	B-X
is	B-X
regulated	B-X
by	B-X
an	B-X
intricate	B-X
interplay	B-X
between	B-X
local	B-X
immune	B-X
factors	B-X
including	B-X
cytokines	B-X
,	B-X
chemokines	B-X
and	B-X
danger	B-X
signals	B-X
from	B-X
neighboring	B-X
cells	B-X
.	B-X
In	B-X
the	B-X
Th2-polarized	B-X
environment	B-X
characteristic	B-X
of	B-X
allergic	B-X
asthma	B-X
,	B-X
high	B-X
levels	B-X
of	B-X
IL-4	B-X
produced	B-X
by	B-X
locally	B-X
infiltrating	B-X
innate	B-X
lymphoid	B-X
cells	B-X
and	B-X
helper	B-X
T	B-X
cells	B-X
promote	B-X
the	B-X
acquisition	B-X
of	B-X
an	B-X
alternatively	B-X
activated	B-X
M2a	B-X
phenotype	B-X
in	B-X
macrophages	B-X
,	B-X
with	B-X
myriad	B-X
effects	B-X
on	B-X
the	B-X
local	B-X
immune	B-X
response	B-X
and	B-X
airway	B-X
structure	B-X
.	B-X
Macrophages	B-X
promote	B-X
the	B-X
re-balancing	B-X
of	B-X
pro-inflammatory	B-X
responses	B-X
towards	B-X
pro-resolution	B-X
responses	B-X
and	B-X
are	B-X
thus	B-X
central	B-X
to	B-X
the	B-X
success	B-X
of	B-X
an	B-X
inflammatory	B-X
response	B-X
.	B-X
This	B-X
drives	B-X
resolution	B-X
responses	B-X
and	B-X
mediates	B-X
a	B-X
phenotypic	B-X
switch	B-X
in	B-X
the	B-X
polarity	B-X
of	B-X
macrophages	B-X
.	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
apoptotic	B-X
cell-derived	B-X
extracellular	B-X
vesicles	B-X
(	B-X
ACdEV	B-X
)	B-X
in	B-X
the	B-X
recruitment	B-X
and	B-X
control	B-X
of	B-X
macrophage	B-X
phenotype	B-X
has	B-X
received	B-X
remarkably	B-X
little	B-X
attention	B-X
.	B-X
ACdEV	B-X
are	B-X
powerful	B-X
mediators	B-X
of	B-X
intercellular	B-X
communication	B-X
,	B-X
carrying	B-X
a	B-X
wealth	B-X
of	B-X
lipid	B-X
and	B-X
protein	B-X
mediators	B-X
that	B-X
may	B-X
modulate	B-X
macrophage	B-X
phenotype	B-X
,	B-X
including	B-X
a	B-X
cargo	B-X
of	B-X
active	B-X
immune-modulating	B-X
enzymes	B-X
.	B-X

Notably	O
,	O
overexpression	O
of	O
transcriptionally	O
active	O
p73	B-Gene_or_gene_product
in	O
thyroid	O
cancer	O
lines	O
can	O
arrest	O
the	O
cell	O
cycle	O
but	O
is	O
still	O
unable	O
to	O
induce	O
cell	O
death	O
.	O
<EOS>	B-X
The	B-X
p73	B-X
protein	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
p53	B-X
family	B-X
and	B-X
,	B-X
like	B-X
p53	B-X
,	B-X
can	B-X
induce	B-X
cell-cycle	B-X
arrest	B-X
and	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
Because	B-X
the	B-X
loss	B-X
of	B-X
p53	B-X
function	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
progression	B-X
of	B-X
well-differentiated	B-X
thyroid	B-X
cancer	B-X
to	B-X
more	B-X
aggressive	B-X
phenotypes	B-X
,	B-X
we	B-X
hypothesized	B-X
that	B-X
p73	B-X
might	B-X
also	B-X
be	B-X
involved	B-X
in	B-X
thyroid	B-X
carcinogenesis	B-X
.	B-X
We	B-X
find	B-X
that	B-X
normal	B-X
thyrocites	B-X
do	B-X
not	B-X
express	B-X
p73	B-X
,	B-X
whereas	B-X
most	B-X
thyroid	B-X
malignancies	B-X
are	B-X
positive	B-X
for	B-X
p73	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
the	B-X
p73	B-X
protein	B-X
of	B-X
thyroid	B-X
cancer	B-X
cells	B-X
is	B-X
unresponsive	B-X
to	B-X
DNA-damaging	B-X
agents	B-X
,	B-X
failing	B-X
to	B-X
elicit	B-X
a	B-X
block	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
or	B-X
an	B-X
apoptotic	B-X
response	B-X
.	B-X
Notably	B-X
,	B-X
overexpression	B-X
of	B-X
transcriptionally	B-X
active	B-X
p73	B-X
in	B-X
thyroid	B-X
cancer	B-X
lines	B-X
can	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
but	B-X
is	B-X
still	B-X
unable	B-X
to	B-X
induce	B-X
cell	B-X
death	B-X
.	B-X
The	B-X
loss	B-X
of	B-X
p73	B-X
biological	B-X
activity	B-X
in	B-X
neoplastic	B-X
thyroid	B-X
cells	B-X
is	B-X
partly	B-X
explained	B-X
by	B-X
its	B-X
interaction	B-X
with	B-X
transcriptionally	B-X
inactive	B-X
variants	B-X
of	B-X
p73	B-X
(	B-X
DeltaNp73	B-X
)	B-X
and	B-X
with	B-X
mutant	B-X
p53	B-X
.	B-X
Our	B-X
findings	B-X
suggest	B-X
that	B-X
the	B-X
functional	B-X
impairment	B-X
of	B-X
p73	B-X
could	B-X
be	B-X
involved	B-X
in	B-X
the	B-X
development	B-X
of	B-X
thyroid	B-X
malignancies	B-X
,	B-X
defining	B-X
p73	B-X
as	B-X
a	B-X
potential	B-X
therapeutic	B-X
target	B-X
for	B-X
thyroid	B-X
cancer	B-X
.	B-X

The	O
loss	O
of	O
p73	B-Gene_or_gene_product
biological	O
activity	O
in	O
neoplastic	O
thyroid	O
cells	O
is	O
partly	O
explained	O
by	O
its	O
interaction	O
with	O
transcriptionally	O
inactive	O
variants	O
of	O
p73	B-Gene_or_gene_product
(	O
DeltaNp73	B-Gene_or_gene_product
)	O
and	O
with	O
mutant	O
p53	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
p73	B-X
protein	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
p53	B-X
family	B-X
and	B-X
,	B-X
like	B-X
p53	B-X
,	B-X
can	B-X
induce	B-X
cell-cycle	B-X
arrest	B-X
and	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
Because	B-X
the	B-X
loss	B-X
of	B-X
p53	B-X
function	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
progression	B-X
of	B-X
well-differentiated	B-X
thyroid	B-X
cancer	B-X
to	B-X
more	B-X
aggressive	B-X
phenotypes	B-X
,	B-X
we	B-X
hypothesized	B-X
that	B-X
p73	B-X
might	B-X
also	B-X
be	B-X
involved	B-X
in	B-X
thyroid	B-X
carcinogenesis	B-X
.	B-X
We	B-X
find	B-X
that	B-X
normal	B-X
thyrocites	B-X
do	B-X
not	B-X
express	B-X
p73	B-X
,	B-X
whereas	B-X
most	B-X
thyroid	B-X
malignancies	B-X
are	B-X
positive	B-X
for	B-X
p73	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
the	B-X
p73	B-X
protein	B-X
of	B-X
thyroid	B-X
cancer	B-X
cells	B-X
is	B-X
unresponsive	B-X
to	B-X
DNA-damaging	B-X
agents	B-X
,	B-X
failing	B-X
to	B-X
elicit	B-X
a	B-X
block	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
or	B-X
an	B-X
apoptotic	B-X
response	B-X
.	B-X
Notably	B-X
,	B-X
overexpression	B-X
of	B-X
transcriptionally	B-X
active	B-X
p73	B-X
in	B-X
thyroid	B-X
cancer	B-X
lines	B-X
can	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
but	B-X
is	B-X
still	B-X
unable	B-X
to	B-X
induce	B-X
cell	B-X
death	B-X
.	B-X
The	B-X
loss	B-X
of	B-X
p73	B-X
biological	B-X
activity	B-X
in	B-X
neoplastic	B-X
thyroid	B-X
cells	B-X
is	B-X
partly	B-X
explained	B-X
by	B-X
its	B-X
interaction	B-X
with	B-X
transcriptionally	B-X
inactive	B-X
variants	B-X
of	B-X
p73	B-X
(	B-X
DeltaNp73	B-X
)	B-X
and	B-X
with	B-X
mutant	B-X
p53	B-X
.	B-X
Our	B-X
findings	B-X
suggest	B-X
that	B-X
the	B-X
functional	B-X
impairment	B-X
of	B-X
p73	B-X
could	B-X
be	B-X
involved	B-X
in	B-X
the	B-X
development	B-X
of	B-X
thyroid	B-X
malignancies	B-X
,	B-X
defining	B-X
p73	B-X
as	B-X
a	B-X
potential	B-X
therapeutic	B-X
target	B-X
for	B-X
thyroid	B-X
cancer	B-X
.	B-X

Our	O
findings	O
suggest	O
that	O
the	O
functional	O
impairment	O
of	O
p73	B-Gene_or_gene_product
could	O
be	O
involved	O
in	O
the	O
development	O
of	O
thyroid	O
malignancies	O
,	O
defining	O
p73	B-Gene_or_gene_product
as	O
a	O
potential	O
therapeutic	O
target	O
for	O
thyroid	O
cancer	O
.	O
<EOS>	B-X
The	B-X
p73	B-X
protein	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
p53	B-X
family	B-X
and	B-X
,	B-X
like	B-X
p53	B-X
,	B-X
can	B-X
induce	B-X
cell-cycle	B-X
arrest	B-X
and	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
Because	B-X
the	B-X
loss	B-X
of	B-X
p53	B-X
function	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
progression	B-X
of	B-X
well-differentiated	B-X
thyroid	B-X
cancer	B-X
to	B-X
more	B-X
aggressive	B-X
phenotypes	B-X
,	B-X
we	B-X
hypothesized	B-X
that	B-X
p73	B-X
might	B-X
also	B-X
be	B-X
involved	B-X
in	B-X
thyroid	B-X
carcinogenesis	B-X
.	B-X
We	B-X
find	B-X
that	B-X
normal	B-X
thyrocites	B-X
do	B-X
not	B-X
express	B-X
p73	B-X
,	B-X
whereas	B-X
most	B-X
thyroid	B-X
malignancies	B-X
are	B-X
positive	B-X
for	B-X
p73	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
the	B-X
p73	B-X
protein	B-X
of	B-X
thyroid	B-X
cancer	B-X
cells	B-X
is	B-X
unresponsive	B-X
to	B-X
DNA-damaging	B-X
agents	B-X
,	B-X
failing	B-X
to	B-X
elicit	B-X
a	B-X
block	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
or	B-X
an	B-X
apoptotic	B-X
response	B-X
.	B-X
Notably	B-X
,	B-X
overexpression	B-X
of	B-X
transcriptionally	B-X
active	B-X
p73	B-X
in	B-X
thyroid	B-X
cancer	B-X
lines	B-X
can	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
but	B-X
is	B-X
still	B-X
unable	B-X
to	B-X
induce	B-X
cell	B-X
death	B-X
.	B-X
The	B-X
loss	B-X
of	B-X
p73	B-X
biological	B-X
activity	B-X
in	B-X
neoplastic	B-X
thyroid	B-X
cells	B-X
is	B-X
partly	B-X
explained	B-X
by	B-X
its	B-X
interaction	B-X
with	B-X
transcriptionally	B-X
inactive	B-X
variants	B-X
of	B-X
p73	B-X
(	B-X
DeltaNp73	B-X
)	B-X
and	B-X
with	B-X
mutant	B-X
p53	B-X
.	B-X
Our	B-X
findings	B-X
suggest	B-X
that	B-X
the	B-X
functional	B-X
impairment	B-X
of	B-X
p73	B-X
could	B-X
be	B-X
involved	B-X
in	B-X
the	B-X
development	B-X
of	B-X
thyroid	B-X
malignancies	B-X
,	B-X
defining	B-X
p73	B-X
as	B-X
a	B-X
potential	B-X
therapeutic	B-X
target	B-X
for	B-X
thyroid	B-X
cancer	B-X
.	B-X

Recruitment	O
of	O
Cdc28	B-Gene_or_gene_product
by	O
Whi3	B-Gene_or_gene_product
restricts	O
nuclear	O
accumulation	O
of	O
the	O
G1	O
cyclin	O
-	O
Cdk	O
complex	O
to	O
late	O
G1	O
.	O
<EOS>	B-X
The	B-X
G1	B-X
cyclin	B-X
Cln3	B-X
is	B-X
a	B-X
key	B-X
activator	B-X
of	B-X
cell-cycle	B-X
entry	B-X
in	B-X
budding	B-X
yeast	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Whi3	B-X
,	B-X
a	B-X
negative	B-X
G1	B-X
regulator	B-X
of	B-X
Cln3	B-X
,	B-X
interacts	B-X
in	B-X
vivo	B-X
with	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
Cdc28	B-X
and	B-X
regulates	B-X
its	B-X
localization	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
Efficient	B-X
interaction	B-X
with	B-X
Cdc28	B-X
depends	B-X
on	B-X
an	B-X
N-terminal	B-X
domain	B-X
of	B-X
Whi3	B-X
that	B-X
is	B-X
also	B-X
required	B-X
for	B-X
cytoplasmic	B-X
localization	B-X
of	B-X
Cdc28	B-X
,	B-X
and	B-X
for	B-X
proper	B-X
regulation	B-X
of	B-X
G1	B-X
length	B-X
and	B-X
filamentous	B-X
growth	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cdc28	B-X
requires	B-X
the	B-X
nuclear	B-X
localization	B-X
signal	B-X
of	B-X
Cln3	B-X
,	B-X
which	B-X
is	B-X
also	B-X
found	B-X
in	B-X
Whi3	B-X
complexes	B-X
.	B-X
Both	B-X
Cln3	B-X
and	B-X
Cdc28	B-X
are	B-X
mainly	B-X
cytoplasmic	B-X
during	B-X
early	B-X
G1	B-X
,	B-X
and	B-X
become	B-X
nuclear	B-X
in	B-X
late	B-X
G1	B-X
.	B-X
However	B-X
,	B-X
Whi3-deficient	B-X
cells	B-X
show	B-X
a	B-X
distinct	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cln3	B-X
and	B-X
Cdc28	B-X
already	B-X
in	B-X
early	B-X
G1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Whi3	B-X
constitutes	B-X
a	B-X
cytoplasmic	B-X
retention	B-X
device	B-X
for	B-X
Cln3-Cdc28	B-X
complexes	B-X
,	B-X
thus	B-X
defining	B-X
a	B-X
key	B-X
G1	B-X
event	B-X
in	B-X
yeast	B-X
cells	B-X
.	B-X

The	O
G1	O
cyclin	B-Gene_or_gene_product
Cln3	I-Gene_or_gene_product
is	O
a	O
key	O
activator	O
of	O
cell	O
-	O
cycle	O
entry	O
in	O
budding	O
yeast	O
.	O
<EOS>	B-X
Cells	B-X
adapt	B-X
their	B-X
size	B-X
to	B-X
both	B-X
intrinsic	B-X
and	B-X
extrinsic	B-X
demands	B-X
and	B-X
,	B-X
among	B-X
them	B-X
,	B-X
those	B-X
that	B-X
stem	B-X
from	B-X
growth	B-X
and	B-X
proliferation	B-X
rates	B-X
are	B-X
crucial	B-X
for	B-X
cell	B-X
size	B-X
homeostasis	B-X
.	B-X
Here	B-X
we	B-X
revisit	B-X
mechanisms	B-X
that	B-X
regulate	B-X
cell	B-X
cycle	B-X
and	B-X
cell	B-X
growth	B-X
in	B-X
budding	B-X
yeast	B-X
.	B-X
Cyclin	B-X
Cln3	B-X
,	B-X
the	B-X
most	B-X
upstream	B-X
activator	B-X
of	B-X
Start	B-X
,	B-X
is	B-X
retained	B-X
at	B-X
the	B-X
endoplasmic	B-X
reticulum	B-X
in	B-X
early	B-X
G	B-X
(	B-X
1	B-X
)	B-X
and	B-X
released	B-X
by	B-X
specific	B-X
chaperones	B-X
in	B-X
late	B-X
G	B-X
(	B-X
1	B-X
)	B-X
to	B-X
initiate	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
On	B-X
one	B-X
hand	B-X
,	B-X
these	B-X
chaperones	B-X
are	B-X
rate-limiting	B-X
for	B-X
release	B-X
of	B-X
Cln3	B-X
and	B-X
cell	B-X
cycle	B-X
entry	B-X
and	B-X
,	B-X
on	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
they	B-X
are	B-X
required	B-X
for	B-X
key	B-X
biosynthetic	B-X
processes	B-X
.	B-X
We	B-X
propose	B-X
a	B-X
model	B-X
whereby	B-X
the	B-X
competition	B-X
for	B-X
specialized	B-X
chaperones	B-X
between	B-X
growth	B-X
and	B-X
cycle	B-X
machineries	B-X
could	B-X
gauge	B-X
biosynthetic	B-X
rates	B-X
and	B-X
set	B-X
a	B-X
critical	B-X
size	B-X
threshold	B-X
at	B-X
Start	B-X
.	B-X

Here	O
we	O
show	O
that	O
Whi3	B-Gene_or_gene_product
,	O
a	O
negative	O
G1	O
regulator	O
of	O
Cln3	B-Gene_or_gene_product
,	O
interacts	O
in	O
vivo	O
with	O
the	O
cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
Cdc28	I-Gene_or_gene_product
and	O
regulates	O
its	O
localization	O
in	O
the	O
cell	O
.	O
<EOS>	B-X
The	B-X
G1	B-X
cyclin	B-X
Cln3	B-X
is	B-X
a	B-X
key	B-X
activator	B-X
of	B-X
cell-cycle	B-X
entry	B-X
in	B-X
budding	B-X
yeast	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Whi3	B-X
,	B-X
a	B-X
negative	B-X
G1	B-X
regulator	B-X
of	B-X
Cln3	B-X
,	B-X
interacts	B-X
in	B-X
vivo	B-X
with	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
Cdc28	B-X
and	B-X
regulates	B-X
its	B-X
localization	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
Efficient	B-X
interaction	B-X
with	B-X
Cdc28	B-X
depends	B-X
on	B-X
an	B-X
N-terminal	B-X
domain	B-X
of	B-X
Whi3	B-X
that	B-X
is	B-X
also	B-X
required	B-X
for	B-X
cytoplasmic	B-X
localization	B-X
of	B-X
Cdc28	B-X
,	B-X
and	B-X
for	B-X
proper	B-X
regulation	B-X
of	B-X
G1	B-X
length	B-X
and	B-X
filamentous	B-X
growth	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cdc28	B-X
requires	B-X
the	B-X
nuclear	B-X
localization	B-X
signal	B-X
of	B-X
Cln3	B-X
,	B-X
which	B-X
is	B-X
also	B-X
found	B-X
in	B-X
Whi3	B-X
complexes	B-X
.	B-X
Both	B-X
Cln3	B-X
and	B-X
Cdc28	B-X
are	B-X
mainly	B-X
cytoplasmic	B-X
during	B-X
early	B-X
G1	B-X
,	B-X
and	B-X
become	B-X
nuclear	B-X
in	B-X
late	B-X
G1	B-X
.	B-X
However	B-X
,	B-X
Whi3-deficient	B-X
cells	B-X
show	B-X
a	B-X
distinct	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cln3	B-X
and	B-X
Cdc28	B-X
already	B-X
in	B-X
early	B-X
G1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Whi3	B-X
constitutes	B-X
a	B-X
cytoplasmic	B-X
retention	B-X
device	B-X
for	B-X
Cln3-Cdc28	B-X
complexes	B-X
,	B-X
thus	B-X
defining	B-X
a	B-X
key	B-X
G1	B-X
event	B-X
in	B-X
yeast	B-X
cells	B-X
.	B-X

Efficient	O
interaction	O
with	O
Cdc28	B-Gene_or_gene_product
depends	O
on	O
an	O
N	O
-	O
terminal	O
domain	O
of	O
Whi3	B-Gene_or_gene_product
that	O
is	O
also	O
required	O
for	O
cytoplasmic	O
localization	O
of	O
Cdc28	B-Gene_or_gene_product
,	O
and	O
for	O
proper	O
regulation	O
of	O
G1	O
length	O
and	O
filamentous	O
growth	O
.	O

On	O
the	O
other	O
hand	O
,	O
nuclear	O
accumulation	O
of	O
Cdc28	B-Gene_or_gene_product
requires	O
the	O
nuclear	O
localization	O
signal	O
of	O
Cln3	B-Gene_or_gene_product
,	O
which	O
is	O
also	O
found	O
in	O
Whi3	O
complexes	O
.	O
<EOS>	B-X
The	B-X
G1	B-X
cyclin	B-X
Cln3	B-X
is	B-X
a	B-X
key	B-X
activator	B-X
of	B-X
cell-cycle	B-X
entry	B-X
in	B-X
budding	B-X
yeast	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Whi3	B-X
,	B-X
a	B-X
negative	B-X
G1	B-X
regulator	B-X
of	B-X
Cln3	B-X
,	B-X
interacts	B-X
in	B-X
vivo	B-X
with	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
Cdc28	B-X
and	B-X
regulates	B-X
its	B-X
localization	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
Efficient	B-X
interaction	B-X
with	B-X
Cdc28	B-X
depends	B-X
on	B-X
an	B-X
N-terminal	B-X
domain	B-X
of	B-X
Whi3	B-X
that	B-X
is	B-X
also	B-X
required	B-X
for	B-X
cytoplasmic	B-X
localization	B-X
of	B-X
Cdc28	B-X
,	B-X
and	B-X
for	B-X
proper	B-X
regulation	B-X
of	B-X
G1	B-X
length	B-X
and	B-X
filamentous	B-X
growth	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cdc28	B-X
requires	B-X
the	B-X
nuclear	B-X
localization	B-X
signal	B-X
of	B-X
Cln3	B-X
,	B-X
which	B-X
is	B-X
also	B-X
found	B-X
in	B-X
Whi3	B-X
complexes	B-X
.	B-X
Both	B-X
Cln3	B-X
and	B-X
Cdc28	B-X
are	B-X
mainly	B-X
cytoplasmic	B-X
during	B-X
early	B-X
G1	B-X
,	B-X
and	B-X
become	B-X
nuclear	B-X
in	B-X
late	B-X
G1	B-X
.	B-X
However	B-X
,	B-X
Whi3-deficient	B-X
cells	B-X
show	B-X
a	B-X
distinct	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cln3	B-X
and	B-X
Cdc28	B-X
already	B-X
in	B-X
early	B-X
G1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Whi3	B-X
constitutes	B-X
a	B-X
cytoplasmic	B-X
retention	B-X
device	B-X
for	B-X
Cln3-Cdc28	B-X
complexes	B-X
,	B-X
thus	B-X
defining	B-X
a	B-X
key	B-X
G1	B-X
event	B-X
in	B-X
yeast	B-X
cells	B-X
.	B-X

Both	O
Cln3	B-Gene_or_gene_product
and	O
Cdc28	B-Gene_or_gene_product
are	O
mainly	O
cytoplasmic	O
during	O
early	O
G1	O
,	O
and	O
become	O
nuclear	O
in	O
late	O
G1	O
.	O
<EOS>	B-X
The	B-X
G1	B-X
cyclin	B-X
Cln3	B-X
is	B-X
a	B-X
key	B-X
activator	B-X
of	B-X
cell-cycle	B-X
entry	B-X
in	B-X
budding	B-X
yeast	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Whi3	B-X
,	B-X
a	B-X
negative	B-X
G1	B-X
regulator	B-X
of	B-X
Cln3	B-X
,	B-X
interacts	B-X
in	B-X
vivo	B-X
with	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
Cdc28	B-X
and	B-X
regulates	B-X
its	B-X
localization	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
Efficient	B-X
interaction	B-X
with	B-X
Cdc28	B-X
depends	B-X
on	B-X
an	B-X
N-terminal	B-X
domain	B-X
of	B-X
Whi3	B-X
that	B-X
is	B-X
also	B-X
required	B-X
for	B-X
cytoplasmic	B-X
localization	B-X
of	B-X
Cdc28	B-X
,	B-X
and	B-X
for	B-X
proper	B-X
regulation	B-X
of	B-X
G1	B-X
length	B-X
and	B-X
filamentous	B-X
growth	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cdc28	B-X
requires	B-X
the	B-X
nuclear	B-X
localization	B-X
signal	B-X
of	B-X
Cln3	B-X
,	B-X
which	B-X
is	B-X
also	B-X
found	B-X
in	B-X
Whi3	B-X
complexes	B-X
.	B-X
Both	B-X
Cln3	B-X
and	B-X
Cdc28	B-X
are	B-X
mainly	B-X
cytoplasmic	B-X
during	B-X
early	B-X
G1	B-X
,	B-X
and	B-X
become	B-X
nuclear	B-X
in	B-X
late	B-X
G1	B-X
.	B-X
However	B-X
,	B-X
Whi3-deficient	B-X
cells	B-X
show	B-X
a	B-X
distinct	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cln3	B-X
and	B-X
Cdc28	B-X
already	B-X
in	B-X
early	B-X
G1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Whi3	B-X
constitutes	B-X
a	B-X
cytoplasmic	B-X
retention	B-X
device	B-X
for	B-X
Cln3-Cdc28	B-X
complexes	B-X
,	B-X
thus	B-X
defining	B-X
a	B-X
key	B-X
G1	B-X
event	B-X
in	B-X
yeast	B-X
cells	B-X
.	B-X

However	O
,	O
Whi3	B-Gene_or_gene_product
-	O
deficient	O
cells	O
show	O
a	O
distinct	O
nuclear	O
accumulation	O
of	O
Cln3	B-Gene_or_gene_product
and	O
Cdc28	B-Gene_or_gene_product
already	O
in	O
early	O
G1	O
.	O
<EOS>	B-X
The	B-X
G1	B-X
cyclin	B-X
Cln3	B-X
is	B-X
a	B-X
key	B-X
activator	B-X
of	B-X
cell-cycle	B-X
entry	B-X
in	B-X
budding	B-X
yeast	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Whi3	B-X
,	B-X
a	B-X
negative	B-X
G1	B-X
regulator	B-X
of	B-X
Cln3	B-X
,	B-X
interacts	B-X
in	B-X
vivo	B-X
with	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
Cdc28	B-X
and	B-X
regulates	B-X
its	B-X
localization	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
Efficient	B-X
interaction	B-X
with	B-X
Cdc28	B-X
depends	B-X
on	B-X
an	B-X
N-terminal	B-X
domain	B-X
of	B-X
Whi3	B-X
that	B-X
is	B-X
also	B-X
required	B-X
for	B-X
cytoplasmic	B-X
localization	B-X
of	B-X
Cdc28	B-X
,	B-X
and	B-X
for	B-X
proper	B-X
regulation	B-X
of	B-X
G1	B-X
length	B-X
and	B-X
filamentous	B-X
growth	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cdc28	B-X
requires	B-X
the	B-X
nuclear	B-X
localization	B-X
signal	B-X
of	B-X
Cln3	B-X
,	B-X
which	B-X
is	B-X
also	B-X
found	B-X
in	B-X
Whi3	B-X
complexes	B-X
.	B-X
Both	B-X
Cln3	B-X
and	B-X
Cdc28	B-X
are	B-X
mainly	B-X
cytoplasmic	B-X
during	B-X
early	B-X
G1	B-X
,	B-X
and	B-X
become	B-X
nuclear	B-X
in	B-X
late	B-X
G1	B-X
.	B-X
However	B-X
,	B-X
Whi3-deficient	B-X
cells	B-X
show	B-X
a	B-X
distinct	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cln3	B-X
and	B-X
Cdc28	B-X
already	B-X
in	B-X
early	B-X
G1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Whi3	B-X
constitutes	B-X
a	B-X
cytoplasmic	B-X
retention	B-X
device	B-X
for	B-X
Cln3-Cdc28	B-X
complexes	B-X
,	B-X
thus	B-X
defining	B-X
a	B-X
key	B-X
G1	B-X
event	B-X
in	B-X
yeast	B-X
cells	B-X
.	B-X

We	O
propose	O
that	O
Whi3	B-Gene_or_gene_product
constitutes	O
a	O
cytoplasmic	O
retention	O
device	O
for	O
Cln3	O
-	O
Cdc28	O
complexes	O
,	O
thus	O
defining	O
a	O
key	O
G1	O
event	O
in	O
yeast	O
cells	O
.	O
<EOS>	B-X
The	B-X
G1	B-X
cyclin	B-X
Cln3	B-X
is	B-X
a	B-X
key	B-X
activator	B-X
of	B-X
cell-cycle	B-X
entry	B-X
in	B-X
budding	B-X
yeast	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Whi3	B-X
,	B-X
a	B-X
negative	B-X
G1	B-X
regulator	B-X
of	B-X
Cln3	B-X
,	B-X
interacts	B-X
in	B-X
vivo	B-X
with	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
Cdc28	B-X
and	B-X
regulates	B-X
its	B-X
localization	B-X
in	B-X
the	B-X
cell	B-X
.	B-X
Efficient	B-X
interaction	B-X
with	B-X
Cdc28	B-X
depends	B-X
on	B-X
an	B-X
N-terminal	B-X
domain	B-X
of	B-X
Whi3	B-X
that	B-X
is	B-X
also	B-X
required	B-X
for	B-X
cytoplasmic	B-X
localization	B-X
of	B-X
Cdc28	B-X
,	B-X
and	B-X
for	B-X
proper	B-X
regulation	B-X
of	B-X
G1	B-X
length	B-X
and	B-X
filamentous	B-X
growth	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cdc28	B-X
requires	B-X
the	B-X
nuclear	B-X
localization	B-X
signal	B-X
of	B-X
Cln3	B-X
,	B-X
which	B-X
is	B-X
also	B-X
found	B-X
in	B-X
Whi3	B-X
complexes	B-X
.	B-X
Both	B-X
Cln3	B-X
and	B-X
Cdc28	B-X
are	B-X
mainly	B-X
cytoplasmic	B-X
during	B-X
early	B-X
G1	B-X
,	B-X
and	B-X
become	B-X
nuclear	B-X
in	B-X
late	B-X
G1	B-X
.	B-X
However	B-X
,	B-X
Whi3-deficient	B-X
cells	B-X
show	B-X
a	B-X
distinct	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cln3	B-X
and	B-X
Cdc28	B-X
already	B-X
in	B-X
early	B-X
G1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Whi3	B-X
constitutes	B-X
a	B-X
cytoplasmic	B-X
retention	B-X
device	B-X
for	B-X
Cln3-Cdc28	B-X
complexes	B-X
,	B-X
thus	B-X
defining	B-X
a	B-X
key	B-X
G1	B-X
event	B-X
in	B-X
yeast	B-X
cells	B-X
.	B-X

Regulation	O
of	O
NF	O
-	O
kappaB	O
signaling	O
by	O
Pin1	B-Gene_or_gene_product
-	O
dependent	O
prolyl	O
isomerization	O
and	O
ubiquitin	B-Gene_or_gene_product
-	O
mediated	O
proteolysis	O
of	O
p65	B-Gene_or_gene_product
/	O
RelA	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
transcription	B-X
factor	B-X
NF-kappaB	B-X
is	B-X
activated	B-X
by	B-X
the	B-X
degradation	B-X
of	B-X
its	B-X
inhibitor	B-X
IkappaBalpha	B-X
,	B-X
resulting	B-X
in	B-X
its	B-X
nuclear	B-X
translocation	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
nuclear	B-X
NF-kappaB	B-X
is	B-X
subsequently	B-X
regulated	B-X
is	B-X
not	B-X
clear	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
NF-kappaB	B-X
function	B-X
is	B-X
regulated	B-X
by	B-X
Pin1-mediated	B-X
prolyl	B-X
isomerization	B-X
and	B-X
ubiquitin-mediated	B-X
proteolysis	B-X
of	B-X
its	B-X
p65/RelA	B-X
subunit	B-X
.	B-X
Upon	B-X
cytokine	B-X
treatment	B-X
,	B-X
Pin1	B-X
binds	B-X
to	B-X
the	B-X
pThr254-Pro	B-X
motif	B-X
in	B-X
p65	B-X
and	B-X
inhibits	B-X
p65	B-X
binding	B-X
to	B-X
IkappaBalpha	B-X
,	B-X
resulting	B-X
in	B-X
increased	B-X
nuclear	B-X
accumulation	B-X
and	B-X
protein	B-X
stability	B-X
of	B-X
p65	B-X
and	B-X
enhanced	B-X
NF-kappaB	B-X
activity	B-X
.	B-X
Significantly	B-X
,	B-X
Pin1-deficient	B-X
mice	B-X
and	B-X
cells	B-X
are	B-X
refractory	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
cytokine	B-X
signals	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
stability	B-X
of	B-X
p65	B-X
is	B-X
controlled	B-X
by	B-X
ubiquitin-mediated	B-X
proteolysis	B-X
,	B-X
facilitated	B-X
by	B-X
a	B-X
cytokine	B-X
signal	B-X
inhibitor	B-X
,	B-X
SOCS-1	B-X
,	B-X
acting	B-X
as	B-X
a	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
These	B-X
findings	B-X
uncover	B-X
two	B-X
important	B-X
mechanisms	B-X
of	B-X
regulating	B-X
NF-kappaB	B-X
signaling	B-X
and	B-X
offer	B-X
new	B-X
insight	B-X
into	B-X
the	B-X
pathogenesis	B-X
and	B-X
treatment	B-X
of	B-X
some	B-X
human	B-X
diseases	B-X
such	B-X
as	B-X
cancers	B-X
.	B-X

The	O
transcription	O
factor	O
NF	O
-	O
kappaB	O
is	O
activated	O
by	O
the	O
degradation	O
of	O
its	O
inhibitor	O
IkappaBalpha	B-Gene_or_gene_product
,	O
resulting	O
in	O
its	O
nuclear	O
translocation	O
.	O
<EOS>	B-X
Nuclear	B-X
factor-kappa	B-X
B	B-X
(	B-X
NF-κB	B-X
)	B-X
signaling	B-X
is	B-X
closely	B-X
related	B-X
to	B-X
tumor	B-X
invasion	B-X
and	B-X
metastasis	B-X
.	B-X
However	B-X
,	B-X
it	B-X
is	B-X
unclear	B-X
whether	B-X
ROC1	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
NF-κB	B-X
signaling	B-X
associated	B-X
with	B-X
malignant	B-X
BCa	B-X
progression	B-X
.	B-X
NF-κB-mediated	B-X
inflammatory	B-X
phenotypic	B-X
switching	B-X
of	B-X
vascular	B-X
smooth	B-X
muscle	B-X
cells	B-X
(	B-X
VSMCs	B-X
)	B-X
plays	B-X
a	B-X
central	B-X
role	B-X
in	B-X
atherosclerosis	B-X
and	B-X
neointimal	B-X
formation	B-X
.	B-X
However	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
roles	B-X
of	B-X
circRNAs	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
NF-κB	B-X
signaling	B-X
.	B-X
First	B-X
,	B-X
in	B-X
the	B-X
cytoplasm	B-X
,	B-X
circ-Sirt1	B-X
directly	B-X
interacts	B-X
with	B-X
and	B-X
sequesters	B-X
NF-κB	B-X
p65	B-X
from	B-X
nuclear	B-X
translocation	B-X
induced	B-X
by	B-X
TNF-α	B-X
in	B-X
a	B-X
sequence-dependent	B-X
manner	B-X
.	B-X
The	B-X
inhibitory	B-X
complex	B-X
of	B-X
circ-Sirt1-NF-κB	B-X
p65	B-X
is	B-X
not	B-X
dependent	B-X
on	B-X
IκBα	B-X
.	B-X
Increased	B-X
SIRT1	B-X
results	B-X
in	B-X
deacetylation	B-X
and	B-X
inactivation	B-X
of	B-X
the	B-X
nuclear	B-X
NF-κB	B-X
p65	B-X
.	B-X

However	O
,	O
the	O
mechanism	O
by	O
which	O
nuclear	O
NF	O
-	O
kappaB	O
is	O
subsequently	O
regulated	O
is	O
not	O
clear	O
.	O
<EOS>	B-X
Inflammation	B-X
is	B-X
triggered	B-X
by	B-X
stimulation	B-X
of	B-X
innate	B-X
sensors	B-X
that	B-X
recognize	B-X
pathogens	B-X
,	B-X
chemical	B-X
and	B-X
physical	B-X
irritants	B-X
,	B-X
and	B-X
damaged	B-X
cells	B-X
subsequently	B-X
initiating	B-X
a	B-X
well-orchestrated	B-X
adaptive	B-X
immune	B-X
response	B-X
.	B-X
Immune	B-X
cell	B-X
activation	B-X
is	B-X
a	B-X
strictly	B-X
regulated	B-X
and	B-X
self-resolving	B-X
process	B-X
supported	B-X
by	B-X
an	B-X
array	B-X
of	B-X
negative	B-X
feedback	B-X
mechanisms	B-X
to	B-X
sustain	B-X
tissue	B-X
homeostasis	B-X
.	B-X
A20	B-X
(	B-X
tumor	B-X
necrosis	B-X
factor	B-X
α-induced	B-X
protein	B-X
3	B-X
or	B-X
TNFAIP3	B-X
)	B-X
is	B-X
a	B-X
ubiquitin-editing	B-X
enzyme	B-X
that	B-X
mainly	B-X
functions	B-X
as	B-X
an	B-X
endogenous	B-X
regulator	B-X
of	B-X
inflammation	B-X
through	B-X
termination	B-X
of	B-X
nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-κB	B-X
activation	B-X
as	B-X
part	B-X
of	B-X
a	B-X
negative	B-X
feedback	B-X
loop	B-X
.	B-X
This	B-X
review	B-X
presents	B-X
information	B-X
on	B-X
the	B-X
ubiquitin	B-X
system	B-X
and	B-X
regulation	B-X
of	B-X
NF-κB	B-X
by	B-X
ubiquitination	B-X
using	B-X
A20	B-X
as	B-X
a	B-X
representative	B-X
molecule	B-X
and	B-X
highlights	B-X
how	B-X
the	B-X
dysregulation	B-X
of	B-X
this	B-X
system	B-X
can	B-X
lead	B-X
to	B-X
several	B-X
immune	B-X
pathologies	B-X
,	B-X
including	B-X
oral	B-X
cavity-related	B-X
disorders	B-X
mainly	B-X
focusing	B-X
on	B-X
periodontitis	B-X
.	B-X

Here	O
we	O
demonstrate	O
that	O
NF	O
-	O
kappaB	O
function	O
is	O
regulated	O
by	O
Pin1	B-Gene_or_gene_product
-	O
mediated	O
prolyl	O
isomerization	O
and	O
ubiquitin	B-Gene_or_gene_product
-	O
mediated	O
proteolysis	O
of	O
its	O
p65	B-Gene_or_gene_product
/	O
RelA	B-Gene_or_gene_product
subunit	O
.	O
<EOS>	B-X
The	B-X
transcription	B-X
factor	B-X
NF-kappaB	B-X
is	B-X
activated	B-X
by	B-X
the	B-X
degradation	B-X
of	B-X
its	B-X
inhibitor	B-X
IkappaBalpha	B-X
,	B-X
resulting	B-X
in	B-X
its	B-X
nuclear	B-X
translocation	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
nuclear	B-X
NF-kappaB	B-X
is	B-X
subsequently	B-X
regulated	B-X
is	B-X
not	B-X
clear	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
NF-kappaB	B-X
function	B-X
is	B-X
regulated	B-X
by	B-X
Pin1-mediated	B-X
prolyl	B-X
isomerization	B-X
and	B-X
ubiquitin-mediated	B-X
proteolysis	B-X
of	B-X
its	B-X
p65/RelA	B-X
subunit	B-X
.	B-X
Upon	B-X
cytokine	B-X
treatment	B-X
,	B-X
Pin1	B-X
binds	B-X
to	B-X
the	B-X
pThr254-Pro	B-X
motif	B-X
in	B-X
p65	B-X
and	B-X
inhibits	B-X
p65	B-X
binding	B-X
to	B-X
IkappaBalpha	B-X
,	B-X
resulting	B-X
in	B-X
increased	B-X
nuclear	B-X
accumulation	B-X
and	B-X
protein	B-X
stability	B-X
of	B-X
p65	B-X
and	B-X
enhanced	B-X
NF-kappaB	B-X
activity	B-X
.	B-X
Significantly	B-X
,	B-X
Pin1-deficient	B-X
mice	B-X
and	B-X
cells	B-X
are	B-X
refractory	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
cytokine	B-X
signals	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
stability	B-X
of	B-X
p65	B-X
is	B-X
controlled	B-X
by	B-X
ubiquitin-mediated	B-X
proteolysis	B-X
,	B-X
facilitated	B-X
by	B-X
a	B-X
cytokine	B-X
signal	B-X
inhibitor	B-X
,	B-X
SOCS-1	B-X
,	B-X
acting	B-X
as	B-X
a	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
These	B-X
findings	B-X
uncover	B-X
two	B-X
important	B-X
mechanisms	B-X
of	B-X
regulating	B-X
NF-kappaB	B-X
signaling	B-X
and	B-X
offer	B-X
new	B-X
insight	B-X
into	B-X
the	B-X
pathogenesis	B-X
and	B-X
treatment	B-X
of	B-X
some	B-X
human	B-X
diseases	B-X
such	B-X
as	B-X
cancers	B-X
.	B-X

Upon	O
cytokine	O
treatment	O
,	O
Pin1	B-Gene_or_gene_product
binds	O
to	O
the	O
pThr254	O
-	O
Pro	O
motif	O
in	O
p65	B-Gene_or_gene_product
and	O
inhibits	O
p65	B-Gene_or_gene_product
binding	O
to	O
IkappaBalpha	B-Gene_or_gene_product
,	O
resulting	O
in	O
increased	O
nuclear	O
accumulation	O
and	O
protein	O
stability	O
of	O
p65	B-Gene_or_gene_product
and	O
enhanced	O
NF	O
-	O
kappaB	O
activity	O
.	O

Significantly	O
,	O
Pin1	B-Gene_or_gene_product
-	O
deficient	O
mice	O
and	O
cells	O
are	O
refractory	O
to	O
NF	O
-	O
kappaB	O
activation	O
by	O
cytokine	O
signals	O
.	O
<EOS>	B-X
The	B-X
transcription	B-X
factor	B-X
NF-kappaB	B-X
is	B-X
activated	B-X
by	B-X
the	B-X
degradation	B-X
of	B-X
its	B-X
inhibitor	B-X
IkappaBalpha	B-X
,	B-X
resulting	B-X
in	B-X
its	B-X
nuclear	B-X
translocation	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
nuclear	B-X
NF-kappaB	B-X
is	B-X
subsequently	B-X
regulated	B-X
is	B-X
not	B-X
clear	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
NF-kappaB	B-X
function	B-X
is	B-X
regulated	B-X
by	B-X
Pin1-mediated	B-X
prolyl	B-X
isomerization	B-X
and	B-X
ubiquitin-mediated	B-X
proteolysis	B-X
of	B-X
its	B-X
p65/RelA	B-X
subunit	B-X
.	B-X
Upon	B-X
cytokine	B-X
treatment	B-X
,	B-X
Pin1	B-X
binds	B-X
to	B-X
the	B-X
pThr254-Pro	B-X
motif	B-X
in	B-X
p65	B-X
and	B-X
inhibits	B-X
p65	B-X
binding	B-X
to	B-X
IkappaBalpha	B-X
,	B-X
resulting	B-X
in	B-X
increased	B-X
nuclear	B-X
accumulation	B-X
and	B-X
protein	B-X
stability	B-X
of	B-X
p65	B-X
and	B-X
enhanced	B-X
NF-kappaB	B-X
activity	B-X
.	B-X
Significantly	B-X
,	B-X
Pin1-deficient	B-X
mice	B-X
and	B-X
cells	B-X
are	B-X
refractory	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
cytokine	B-X
signals	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
stability	B-X
of	B-X
p65	B-X
is	B-X
controlled	B-X
by	B-X
ubiquitin-mediated	B-X
proteolysis	B-X
,	B-X
facilitated	B-X
by	B-X
a	B-X
cytokine	B-X
signal	B-X
inhibitor	B-X
,	B-X
SOCS-1	B-X
,	B-X
acting	B-X
as	B-X
a	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
These	B-X
findings	B-X
uncover	B-X
two	B-X
important	B-X
mechanisms	B-X
of	B-X
regulating	B-X
NF-kappaB	B-X
signaling	B-X
and	B-X
offer	B-X
new	B-X
insight	B-X
into	B-X
the	B-X
pathogenesis	B-X
and	B-X
treatment	B-X
of	B-X
some	B-X
human	B-X
diseases	B-X
such	B-X
as	B-X
cancers	B-X
.	B-X

Moreover	O
,	O
the	O
stability	O
of	O
p65	B-Gene_or_gene_product
is	O
controlled	O
by	O
ubiquitin	B-Gene_or_gene_product
-	O
mediated	O
proteolysis	O
,	O
facilitated	O
by	O
a	O
cytokine	O
signal	O
inhibitor	O
,	O
SOCS	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
acting	O
as	O
a	O
ubiquitin	B-Gene_or_gene_product
ligase	O
.	O
<EOS>	B-X
The	B-X
transcription	B-X
factor	B-X
NF-kappaB	B-X
is	B-X
activated	B-X
by	B-X
the	B-X
degradation	B-X
of	B-X
its	B-X
inhibitor	B-X
IkappaBalpha	B-X
,	B-X
resulting	B-X
in	B-X
its	B-X
nuclear	B-X
translocation	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
NF-kappaB	B-X
function	B-X
is	B-X
regulated	B-X
by	B-X
Pin1-mediated	B-X
prolyl	B-X
isomerization	B-X
and	B-X
ubiquitin-mediated	B-X
proteolysis	B-X
of	B-X
its	B-X
p65/RelA	B-X
subunit	B-X
.	B-X
Upon	B-X
cytokine	B-X
treatment	B-X
,	B-X
Pin1	B-X
binds	B-X
to	B-X
the	B-X
pThr254-Pro	B-X
motif	B-X
in	B-X
p65	B-X
and	B-X
inhibits	B-X
p65	B-X
binding	B-X
to	B-X
IkappaBalpha	B-X
,	B-X
resulting	B-X
in	B-X
increased	B-X
nuclear	B-X
accumulation	B-X
and	B-X
protein	B-X
stability	B-X
of	B-X
p65	B-X
and	B-X
enhanced	B-X
NF-kappaB	B-X
activity	B-X
.	B-X
Significantly	B-X
,	B-X
Pin1-deficient	B-X
mice	B-X
and	B-X
cells	B-X
are	B-X
refractory	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
cytokine	B-X
signals	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
stability	B-X
of	B-X
p65	B-X
is	B-X
controlled	B-X
by	B-X
ubiquitin-mediated	B-X
proteolysis	B-X
,	B-X
facilitated	B-X
by	B-X
a	B-X
cytokine	B-X
signal	B-X
inhibitor	B-X
,	B-X
SOCS-1	B-X
,	B-X
acting	B-X
as	B-X
a	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
These	B-X
findings	B-X
uncover	B-X
two	B-X
important	B-X
mechanisms	B-X
of	B-X
regulating	B-X
NF-kappaB	B-X
signaling	B-X
and	B-X
offer	B-X
new	B-X
insight	B-X
into	B-X
the	B-X
pathogenesis	B-X
and	B-X
treatment	B-X
of	B-X
some	B-X
human	B-X
diseases	B-X
such	B-X
as	B-X
cancers	B-X
.	B-X

These	O
findings	O
uncover	O
two	O
important	O
mechanisms	O
of	O
regulating	O
NF	O
-	O
kappaB	O
signaling	O
and	O
offer	O
new	O
insight	O
into	O
the	O
pathogenesis	O
and	O
treatment	O
of	O
some	O
human	O
diseases	O
such	O
as	O
cancers	O
.	O
<EOS>	B-X
The	B-X
transcription	B-X
factor	B-X
NF-kappaB	B-X
is	B-X
activated	B-X
by	B-X
the	B-X
degradation	B-X
of	B-X
its	B-X
inhibitor	B-X
IkappaBalpha	B-X
,	B-X
resulting	B-X
in	B-X
its	B-X
nuclear	B-X
translocation	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
nuclear	B-X
NF-kappaB	B-X
is	B-X
subsequently	B-X
regulated	B-X
is	B-X
not	B-X
clear	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
NF-kappaB	B-X
function	B-X
is	B-X
regulated	B-X
by	B-X
Pin1-mediated	B-X
prolyl	B-X
isomerization	B-X
and	B-X
ubiquitin-mediated	B-X
proteolysis	B-X
of	B-X
its	B-X
p65/RelA	B-X
subunit	B-X
.	B-X
Upon	B-X
cytokine	B-X
treatment	B-X
,	B-X
Pin1	B-X
binds	B-X
to	B-X
the	B-X
pThr254-Pro	B-X
motif	B-X
in	B-X
p65	B-X
and	B-X
inhibits	B-X
p65	B-X
binding	B-X
to	B-X
IkappaBalpha	B-X
,	B-X
resulting	B-X
in	B-X
increased	B-X
nuclear	B-X
accumulation	B-X
and	B-X
protein	B-X
stability	B-X
of	B-X
p65	B-X
and	B-X
enhanced	B-X
NF-kappaB	B-X
activity	B-X
.	B-X
Significantly	B-X
,	B-X
Pin1-deficient	B-X
mice	B-X
and	B-X
cells	B-X
are	B-X
refractory	B-X
to	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
cytokine	B-X
signals	B-X
.	B-X
These	B-X
findings	B-X
uncover	B-X
two	B-X
important	B-X
mechanisms	B-X
of	B-X
regulating	B-X
NF-kappaB	B-X
signaling	B-X
and	B-X
offer	B-X
new	B-X
insight	B-X
into	B-X
the	B-X
pathogenesis	B-X
and	B-X
treatment	B-X
of	B-X
some	B-X
human	B-X
diseases	B-X
such	B-X
as	B-X
cancers	B-X
.	B-X

Structures	O
of	O
human	O
purine	B-Gene_or_gene_product
nucleoside	I-Gene_or_gene_product
phosphorylase	I-Gene_or_gene_product
complexed	O
with	O
inosine	O
and	O
ddI	O
.	O
<EOS>	B-X
Human	B-X
purine	B-X
nucleoside	B-X
phosphorylase	B-X
(	B-X
PNP	B-X
)	B-X
is	B-X
a	B-X
ubiquitous	B-X
enzyme	B-X
which	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
purine	B-X
salvage	B-X
pathway	B-X
,	B-X
and	B-X
PNP	B-X
deficiency	B-X
in	B-X
humans	B-X
leads	B-X
to	B-X
an	B-X
impairment	B-X
of	B-X
T-cell	B-X
function	B-X
,	B-X
usually	B-X
with	B-X
no	B-X
apparent	B-X
effect	B-X
on	B-X
B-cell	B-X
function	B-X
.	B-X
PNP	B-X
is	B-X
highly	B-X
specific	B-X
for	B-X
6-oxopurine	B-X
nucleosides	B-X
and	B-X
exhibits	B-X
negligible	B-X
activity	B-X
for	B-X
6-aminopurine	B-X
nucleosides	B-X
.	B-X
The	B-X
catalytic	B-X
efficiency	B-X
for	B-X
inosine	B-X
is	B-X
350,000-fold	B-X
greater	B-X
than	B-X
for	B-X
adenosine	B-X
.	B-X
Adenine	B-X
nucleosides	B-X
and	B-X
nucleotides	B-X
are	B-X
deaminated	B-X
by	B-X
adenosine	B-X
deaminase	B-X
and	B-X
AMP	B-X
deaminase	B-X
to	B-X
their	B-X
corresponding	B-X
inosine	B-X
derivatives	B-X
which	B-X
,	B-X
in	B-X
turn	B-X
,	B-X
may	B-X
be	B-X
further	B-X
degraded	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
crystal	B-X
structures	B-X
of	B-X
human	B-X
PNP	B-X
in	B-X
complex	B-X
with	B-X
inosine	B-X
and	B-X
2	B-X
(	B-X
'	B-X
)	B-X
,3	B-X
(	B-X
'	B-X
)	B-X
-dideoxyinosine	B-X
,	B-X
refined	B-X
to	B-X
2.8A	B-X
resolution	B-X
using	B-X
synchrotron	B-X
radiation	B-X
.	B-X
The	B-X
present	B-X
structures	B-X
provide	B-X
explanation	B-X
for	B-X
ligand	B-X
binding	B-X
,	B-X
refine	B-X
the	B-X
purine-binding	B-X
site	B-X
,	B-X
and	B-X
can	B-X
be	B-X
used	B-X
for	B-X
future	B-X
inhibitor	B-X
design	B-X
.	B-X

Human	O
purine	B-Gene_or_gene_product
nucleoside	I-Gene_or_gene_product
phosphorylase	I-Gene_or_gene_product
(	O
PNP	B-Gene_or_gene_product
)	O
is	O
a	O
ubiquitous	O
enzyme	O
which	O
plays	O
a	O
key	O
role	O
in	O
the	O
purine	O
salvage	O
pathway	O
,	O
and	O
PNP	B-Gene_or_gene_product
deficiency	O
in	O
humans	O
leads	O
to	O
an	O
impairment	O
of	O
T	O
-	O
cell	O
function	O
,	O
usually	O
with	O
no	O
apparent	O
effect	O
on	O
B	O
-	O
cell	O
function	O
.	O

PNP	B-Gene_or_gene_product
is	O
highly	O
specific	O
for	O
6	O
-	O
oxopurine	O
nucleosides	O
and	O
exhibits	O
negligible	O
activity	O
for	O
6	O
-	O
aminopurine	O
nucleosides	O
.	O
<EOS>	B-X
Human	B-X
purine	B-X
nucleoside	B-X
phosphorylase	B-X
(	B-X
PNP	B-X
)	B-X
is	B-X
a	B-X
ubiquitous	B-X
enzyme	B-X
which	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
purine	B-X
salvage	B-X
pathway	B-X
,	B-X
and	B-X
PNP	B-X
deficiency	B-X
in	B-X
humans	B-X
leads	B-X
to	B-X
an	B-X
impairment	B-X
of	B-X
T-cell	B-X
function	B-X
,	B-X
usually	B-X
with	B-X
no	B-X
apparent	B-X
effect	B-X
on	B-X
B-cell	B-X
function	B-X
.	B-X
PNP	B-X
is	B-X
highly	B-X
specific	B-X
for	B-X
6-oxopurine	B-X
nucleosides	B-X
and	B-X
exhibits	B-X
negligible	B-X
activity	B-X
for	B-X
6-aminopurine	B-X
nucleosides	B-X
.	B-X
Adenine	B-X
nucleosides	B-X
and	B-X
nucleotides	B-X
are	B-X
deaminated	B-X
by	B-X
adenosine	B-X
deaminase	B-X
and	B-X
AMP	B-X
deaminase	B-X
to	B-X
their	B-X
corresponding	B-X
inosine	B-X
derivatives	B-X
which	B-X
,	B-X
in	B-X
turn	B-X
,	B-X
may	B-X
be	B-X
further	B-X
degraded	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
crystal	B-X
structures	B-X
of	B-X
human	B-X
PNP	B-X
in	B-X
complex	B-X
with	B-X
inosine	B-X
and	B-X
2	B-X
(	B-X
'	B-X
)	B-X
,3	B-X
(	B-X
'	B-X
)	B-X
-dideoxyinosine	B-X
,	B-X
refined	B-X
to	B-X
2.8A	B-X
resolution	B-X
using	B-X
synchrotron	B-X
radiation	B-X
.	B-X

The	O
catalytic	O
efficiency	O
for	O
inosine	O
is	O
350	O
,	O
000	O
-	O
fold	O
greater	O
than	O
for	O
adenosine	O
.	O
<EOS>	B-X
The	B-X
catalytic	B-X
efficiency	B-X
for	B-X
inosine	B-X
is	B-X
350,000-fold	B-X
greater	B-X
than	B-X
for	B-X
adenosine	B-X
.	B-X
Adenine	B-X
nucleosides	B-X
and	B-X
nucleotides	B-X
are	B-X
deaminated	B-X
by	B-X
adenosine	B-X
deaminase	B-X
and	B-X
AMP	B-X
deaminase	B-X
to	B-X
their	B-X
corresponding	B-X
inosine	B-X
derivatives	B-X
which	B-X
,	B-X
in	B-X
turn	B-X
,	B-X
may	B-X
be	B-X
further	B-X
degraded	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
crystal	B-X
structures	B-X
of	B-X
human	B-X
PNP	B-X
in	B-X
complex	B-X
with	B-X
inosine	B-X
and	B-X
2	B-X
(	B-X
'	B-X
)	B-X
,3	B-X
(	B-X
'	B-X
)	B-X
-dideoxyinosine	B-X
,	B-X
refined	B-X
to	B-X
2.8A	B-X
resolution	B-X
using	B-X
synchrotron	B-X
radiation	B-X
.	B-X

Adenine	O
nucleosides	O
and	O
nucleotides	O
are	O
deaminated	O
by	O
adenosine	B-Gene_or_gene_product
deaminase	I-Gene_or_gene_product
and	O
AMP	B-Gene_or_gene_product
deaminase	I-Gene_or_gene_product
to	O
their	O
corresponding	O
inosine	O
derivatives	O
which	O
,	O
in	O
turn	O
,	O
may	O
be	O
further	O
degraded	O
.	O
<EOS>	B-X
PNP	B-X
is	B-X
highly	B-X
specific	B-X
for	B-X
6-oxopurine	B-X
nucleosides	B-X
and	B-X
exhibits	B-X
negligible	B-X
activity	B-X
for	B-X
6-aminopurine	B-X
nucleosides	B-X
.	B-X
The	B-X
catalytic	B-X
efficiency	B-X
for	B-X
inosine	B-X
is	B-X
350,000-fold	B-X
greater	B-X
than	B-X
for	B-X
adenosine	B-X
.	B-X
Adenine	B-X
nucleosides	B-X
and	B-X
nucleotides	B-X
are	B-X
deaminated	B-X
by	B-X
adenosine	B-X
deaminase	B-X
and	B-X
AMP	B-X
deaminase	B-X
to	B-X
their	B-X
corresponding	B-X
inosine	B-X
derivatives	B-X
which	B-X
,	B-X
in	B-X
turn	B-X
,	B-X
may	B-X
be	B-X
further	B-X
degraded	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
crystal	B-X
structures	B-X
of	B-X
human	B-X
PNP	B-X
in	B-X
complex	B-X
with	B-X
inosine	B-X
and	B-X
2	B-X
(	B-X
'	B-X
)	B-X
,3	B-X
(	B-X
'	B-X
)	B-X
-dideoxyinosine	B-X
,	B-X
refined	B-X
to	B-X
2.8A	B-X
resolution	B-X
using	B-X
synchrotron	B-X
radiation	B-X
.	B-X

Here	O
we	O
report	O
the	O
crystal	O
structures	O
of	O
human	O
PNP	B-Gene_or_gene_product
in	O
complex	O
with	O
inosine	O
and	O
2	O
(	O
'	O
)	O
,	O
3	O
(	O
'	O
)	O
-	O
dideoxyinosine	O
,	O
refined	O
to	O
2	O
.	O
8A	O
resolution	O
using	O
synchrotron	O
radiation	O
.	O

The	O
present	O
structures	O
provide	O
explanation	O
for	O
ligand	O
binding	O
,	O
refine	O
the	O
purine	O
-	O
binding	O
site	O
,	O
and	O
can	O
be	O
used	O
for	O
future	O
inhibitor	O
design	O
.	O
<EOS>	B-X
Human	B-X
purine	B-X
nucleoside	B-X
phosphorylase	B-X
(	B-X
PNP	B-X
)	B-X
is	B-X
a	B-X
ubiquitous	B-X
enzyme	B-X
which	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
the	B-X
purine	B-X
salvage	B-X
pathway	B-X
,	B-X
and	B-X
PNP	B-X
deficiency	B-X
in	B-X
humans	B-X
leads	B-X
to	B-X
an	B-X
impairment	B-X
of	B-X
T-cell	B-X
function	B-X
,	B-X
usually	B-X
with	B-X
no	B-X
apparent	B-X
effect	B-X
on	B-X
B-cell	B-X
function	B-X
.	B-X
PNP	B-X
is	B-X
highly	B-X
specific	B-X
for	B-X
6-oxopurine	B-X
nucleosides	B-X
and	B-X
exhibits	B-X
negligible	B-X
activity	B-X
for	B-X
6-aminopurine	B-X
nucleosides	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
crystal	B-X
structures	B-X
of	B-X
human	B-X
PNP	B-X
in	B-X
complex	B-X
with	B-X
inosine	B-X
and	B-X
2	B-X
(	B-X
'	B-X
)	B-X
,3	B-X
(	B-X
'	B-X
)	B-X
-dideoxyinosine	B-X
,	B-X
refined	B-X
to	B-X
2.8A	B-X
resolution	B-X
using	B-X
synchrotron	B-X
radiation	B-X
.	B-X
The	B-X
present	B-X
structures	B-X
provide	B-X
explanation	B-X
for	B-X
ligand	B-X
binding	B-X
,	B-X
refine	B-X
the	B-X
purine-binding	B-X
site	B-X
,	B-X
and	B-X
can	B-X
be	B-X
used	B-X
for	B-X
future	B-X
inhibitor	B-X
design	B-X
.	B-X

Loss	O
of	O
the	O
tumor	O
suppressor	O
PML	B-Gene_or_gene_product
in	O
human	O
cancers	O
of	O
multiple	O
histologic	O
origins	O
.	O
<EOS>	B-X
The	B-X
PML	B-X
gene	B-X
is	B-X
fused	B-X
to	B-X
the	B-X
RARalpha	B-X
gene	B-X
in	B-X
the	B-X
vast	B-X
majority	B-X
of	B-X
acute	B-X
promyelocytic	B-X
leukemias	B-X
(	B-X
APL	B-X
)	B-X
and	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
key	B-X
tumor-suppressive	B-X
pathways	B-X
.	B-X
However	B-X
,	B-X
its	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
human	B-X
cancers	B-X
other	B-X
than	B-X
APL	B-X
is	B-X
still	B-X
unclear	B-X
.	B-X
We	B-X
therefore	B-X
assessed	B-X
the	B-X
status	B-X
and	B-X
expression	B-X
of	B-X
the	B-X
PML	B-X
gene	B-X
in	B-X
solid	B-X
tumors	B-X
of	B-X
multiple	B-X
histologic	B-X
origins	B-X
.	B-X
The	B-X
promyelocytic	B-X
leukaemia	B-X
protein	B-X
PML	B-X
is	B-X
a	B-X
growth	B-X
and	B-X
tumour	B-X
suppressor	B-X
inactivated	B-X
in	B-X
acute	B-X
promyelocytic	B-X
leukaemia	B-X
(	B-X
APL	B-X
)	B-X
.	B-X
Recent	B-X
evidence	B-X
indicates	B-X
that	B-X
PML	B-X
plays	B-X
a	B-X
tumour-suppressive	B-X
role	B-X
in	B-X
cancer	B-X
of	B-X
multiple	B-X
histological	B-X
origins	B-X
.	B-X
However	B-X
,	B-X
it	B-X
is	B-X
only	B-X
very	B-X
recently	B-X
that	B-X
PML	B-X
growth-suppressive	B-X
functions	B-X
have	B-X
been	B-X
implicated	B-X
in	B-X
regulating	B-X
physiological	B-X
processes	B-X
and	B-X
tissue	B-X
homoeostasis	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
it	B-X
has	B-X
been	B-X
shown	B-X
that	B-X
PML	B-X
is	B-X
one	B-X
of	B-X
the	B-X
key	B-X
cell-cycle	B-X
regulators	B-X
controlling	B-X
stem	B-X
cell	B-X
function	B-X
in	B-X
multiple	B-X
tissues	B-X
,	B-X
from	B-X
the	B-X
blood	B-X
to	B-X
the	B-X
brain	B-X
.	B-X
As	B-X
a	B-X
consequence	B-X
,	B-X
PML	B-X
loss	B-X
has	B-X
an	B-X
impact	B-X
on	B-X
tissue	B-X
development	B-X
and	B-X
maintenance	B-X
of	B-X
stem	B-X
cell	B-X
pools	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
new	B-X
data	B-X
suggest	B-X
that	B-X
PML	B-X
regulates	B-X
self-renewal	B-X
in	B-X
cancer	B-X
stem	B-X
cells	B-X
.	B-X
Finally	B-X
,	B-X
the	B-X
oncogenic	B-X
fusion	B-X
protein	B-X
PML/RARalpha	B-X
,	B-X
contrary	B-X
to	B-X
the	B-X
conventional	B-X
view	B-X
,	B-X
appears	B-X
to	B-X
hijack	B-X
growth-suppressive	B-X
pathways	B-X
to	B-X
promote	B-X
transformation	B-X
of	B-X
haematopoietic	B-X
stem	B-X
cells	B-X
and	B-X
to	B-X
maintain	B-X
the	B-X
APL	B-X
stem	B-X
cell	B-X
niche	B-X
.	B-X
Overall	B-X
,	B-X
these	B-X
findings	B-X
not	B-X
only	B-X
represent	B-X
a	B-X
change	B-X
in	B-X
paradigm	B-X
in	B-X
the	B-X
field	B-X
of	B-X
PML/APL	B-X
research	B-X
,	B-X
but	B-X
also	B-X
contribute	B-X
to	B-X
the	B-X
understanding	B-X
of	B-X
fundamental	B-X
mechanisms	B-X
underlying	B-X
stem	B-X
cell	B-X
function	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
main	B-X
objective	B-X
of	B-X
this	B-X
review	B-X
is	B-X
to	B-X
critically	B-X
discuss	B-X
the	B-X
very	B-X
recent	B-X
literature	B-X
on	B-X
the	B-X
role	B-X
of	B-X
PML	B-X
in	B-X
stem	B-X
cells	B-X
and	B-X
tumour-initiating	B-X
cells	B-X
.	B-X

BACKGROUND	O
:	O
The	O
PML	B-Gene_or_gene_product
gene	O
is	O
fused	O
to	O
the	O
RARalpha	B-Gene_or_gene_product
gene	O
in	O
the	O
vast	O
majority	O
of	O
acute	O
promyelocytic	O
leukemias	O
(	O
APL	O
)	O
and	O
has	O
been	O
implicated	O
in	O
the	O
control	O
of	O
key	O
tumor	O
-	O
suppressive	O
pathways	O
.	O

However	O
,	O
its	O
role	O
in	O
the	O
pathogenesis	O
of	O
human	O
cancers	O
other	O
than	O
APL	O
is	O
still	O
unclear	O
.	O
<EOS>	B-X
All‑trans	B-X
retinoic	B-X
acid	B-X
(	B-X
ATRA	B-X
)	B-X
and	B-X
arsenic	B-X
trioxide	B-X
(	B-X
As2O3	B-X
)	B-X
are	B-X
currently	B-X
first‑line	B-X
treatments	B-X
for	B-X
acute	B-X
promyelocytic	B-X
leukemia	B-X
(	B-X
APL	B-X
)	B-X
.	B-X
However	B-X
,	B-X
a	B-X
number	B-X
of	B-X
patients	B-X
with	B-X
APL	B-X
are	B-X
resistant	B-X
to	B-X
ATRA	B-X
but	B-X
still	B-X
sensitive	B-X
to	B-X
As2O3	B-X
,	B-X
and	B-X
the	B-X
underlying	B-X
mechanisms	B-X
of	B-X
this	B-X
remain	B-X
unclear	B-X
.	B-X
However	B-X
,	B-X
the	B-X
opposite	B-X
effects	B-X
of	B-X
As2O3	B-X
on	B-X
the	B-X
cytochrome	B-X
C	B-X
distribution	B-X
were	B-X
found	B-X
in	B-X
NB4‑R1	B-X
cells	B-X
.	B-X
In	B-X
conclusion	B-X
,	B-X
cofilin‑1	B-X
played	B-X
a	B-X
role	B-X
in	B-X
As2O3‑induced	B-X
NB4‑R1	B-X
cell	B-X
apoptosis	B-X
and	B-X
it	B-X
might	B-X
be	B-X
a	B-X
novel	B-X
target	B-X
for	B-X
APL	B-X
treatment	B-X
.	B-X

We	O
therefore	O
assessed	O
the	O
status	O
and	O
expression	O
of	O
the	O
PML	B-Gene_or_gene_product
gene	O
in	O
solid	O
tumors	O
of	O
multiple	O
histologic	O
origins	O
.	O
<EOS>	B-X
The	B-X
PML	B-X
gene	B-X
is	B-X
fused	B-X
to	B-X
the	B-X
RARalpha	B-X
gene	B-X
in	B-X
the	B-X
vast	B-X
majority	B-X
of	B-X
acute	B-X
promyelocytic	B-X
leukemias	B-X
(	B-X
APL	B-X
)	B-X
and	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
key	B-X
tumor-suppressive	B-X
pathways	B-X
.	B-X
However	B-X
,	B-X
its	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
human	B-X
cancers	B-X
other	B-X
than	B-X
APL	B-X
is	B-X
still	B-X
unclear	B-X
.	B-X
We	B-X
therefore	B-X
assessed	B-X
the	B-X
status	B-X
and	B-X
expression	B-X
of	B-X
the	B-X
PML	B-X
gene	B-X
in	B-X
solid	B-X
tumors	B-X
of	B-X
multiple	B-X
histologic	B-X
origins	B-X
.	B-X

METHODS	O
:	O
We	O
created	O
tumor	O
tissue	O
microarrays	O
(	O
TTMs	O
)	O
with	O
samples	O
from	O
patients	O
with	O
colon	O
adenocarcinoma	O
(	O
n	O
=	O
109	O
)	O
,	O
lung	O
carcinoma	O
(	O
n	O
=	O
19	O
)	O
,	O
prostate	O
adenocarcinoma	O
(	O
n	O
=	O
36	O
)	O
,	O
breast	O
carcinoma	O
(	O
n	O
=	O
38	O
)	O
,	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
tumors	O
(	O
n	O
=	O
51	O
)	O
,	O
germ	O
cell	O
tumors	O
(	O
n	O
=	O
60	O
)	O
,	O
thyroid	O
carcinoma	O
(	O
n	O
=	O
32	O
)	O
,	O
adrenal	O
cortical	O
carcinoma	O
(	O
n	O
=	O
12	O
)	O
,	O
and	O
non	O
-	O
Hodgkin	O
'	O
s	O
lymphoma	O
(	O
n	O
=	O
251	O
)	O
and	O
from	O
normal	O
tissue	O
corresponding	O
to	O
each	O
histotype	O
and	O
analyzed	O
PML	B-Gene_or_gene_product
protein	O
and	O
mRNA	O
expression	O
by	O
immunohistochemistry	O
and	O
in	O
situ	O
hybridization	O
,	O
respectively	O
.	O

Tumor	O
cell	O
lines	O
(	O
n	O
=	O
64	O
)	O
of	O
various	O
histologic	O
origins	O
were	O
analyzed	O
for	O
PML	B-Gene_or_gene_product
protein	O
and	O
mRNA	O
expression	O
by	O
immunofluorescence	O
and	O
northern	O
blotting	O
,	O
respectively	O
.	O
<EOS>	B-X
The	B-X
PML	B-X
gene	B-X
is	B-X
fused	B-X
to	B-X
the	B-X
RARalpha	B-X
gene	B-X
in	B-X
the	B-X
vast	B-X
majority	B-X
of	B-X
acute	B-X
promyelocytic	B-X
leukemias	B-X
(	B-X
APL	B-X
)	B-X
and	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
key	B-X
tumor-suppressive	B-X
pathways	B-X
.	B-X
However	B-X
,	B-X
its	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
human	B-X
cancers	B-X
other	B-X
than	B-X
APL	B-X
is	B-X
still	B-X
unclear	B-X
.	B-X
We	B-X
therefore	B-X
assessed	B-X
the	B-X
status	B-X
and	B-X
expression	B-X
of	B-X
the	B-X
PML	B-X
gene	B-X
in	B-X
solid	B-X
tumors	B-X
of	B-X
multiple	B-X
histologic	B-X
origins	B-X
.	B-X

DNA	O
from	O
microdissected	O
tumor	O
samples	O
and	O
cell	O
lines	O
was	O
analyzed	O
for	O
PML	B-Gene_or_gene_product
mutations	O
and	O
loss	O
of	O
heterozygosity	O
(	O
LOH	O
)	O
.	O
<EOS>	B-X
The	B-X
PML	B-X
gene	B-X
is	B-X
fused	B-X
to	B-X
the	B-X
RARalpha	B-X
gene	B-X
in	B-X
the	B-X
vast	B-X
majority	B-X
of	B-X
acute	B-X
promyelocytic	B-X
leukemias	B-X
(	B-X
APL	B-X
)	B-X
and	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
key	B-X
tumor-suppressive	B-X
pathways	B-X
.	B-X
We	B-X
therefore	B-X
assessed	B-X
the	B-X
status	B-X
and	B-X
expression	B-X
of	B-X
the	B-X
PML	B-X
gene	B-X
in	B-X
solid	B-X
tumors	B-X
of	B-X
multiple	B-X
histologic	B-X
origins	B-X
.	B-X

For	O
some	O
tumor	O
types	O
,	O
the	O
association	O
between	O
PML	B-Gene_or_gene_product
expression	O
and	O
tumor	O
stage	O
and	O
grade	O
was	O
analyzed	O
.	O
<EOS>	B-X
The	B-X
PML	B-X
gene	B-X
is	B-X
fused	B-X
to	B-X
the	B-X
RARalpha	B-X
gene	B-X
in	B-X
the	B-X
vast	B-X
majority	B-X
of	B-X
acute	B-X
promyelocytic	B-X
leukemias	B-X
(	B-X
APL	B-X
)	B-X
and	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
key	B-X
tumor-suppressive	B-X
pathways	B-X
.	B-X
We	B-X
therefore	B-X
assessed	B-X
the	B-X
status	B-X
and	B-X
expression	B-X
of	B-X
the	B-X
PML	B-X
gene	B-X
in	B-X
solid	B-X
tumors	B-X
of	B-X
multiple	B-X
histologic	B-X
origins	B-X
.	B-X

Statistical	O
tests	O
were	O
two	O
-	O
sided	O
.	O
<EOS>	B-X
One-	B-X
versus	B-X
two-sided	B-X
statistical	B-X
tests	B-X
:	B-X
A	B-X
never-ending	B-X
debate	B-X
.	B-X
There	B-X
is	B-X
a	B-X
tendency	B-X
to	B-X
automatically	B-X
use	B-X
two-sided	B-X
tests	B-X
to	B-X
assess	B-X
the	B-X
statistical	B-X
significance	B-X
of	B-X
experimental	B-X
results	B-X
.	B-X
Yet	B-X
if	B-X
a	B-X
theory	B-X
predicts	B-X
the	B-X
direction	B-X
of	B-X
an	B-X
experimental	B-X
outcome	B-X
,	B-X
or	B-X
if	B-X
for	B-X
some	B-X
practical	B-X
(	B-X
eg	B-X
clinical	B-X
)	B-X
reason	B-X
an	B-X
outcome	B-X
in	B-X
that	B-X
direction	B-X
is	B-X
the	B-X
only	B-X
one	B-X
of	B-X
interest	B-X
,	B-X
then	B-X
it	B-X
makes	B-X
sense	B-X
to	B-X
use	B-X
a	B-X
one-sided	B-X
test	B-X
.	B-X
The	B-X
use	B-X
of	B-X
a	B-X
two-sided	B-X
test	B-X
in	B-X
these	B-X
situations	B-X
will	B-X
lead	B-X
to	B-X
too	B-X
many	B-X
false	B-X
negatives	B-X
.	B-X
Following	B-X
a	B-X
nonsignificant	B-X
one-sided	B-X
test	B-X
,	B-X
the	B-X
possibility	B-X
of	B-X
an	B-X
effect	B-X
in	B-X
the	B-X
direction	B-X
opposite	B-X
to	B-X
that	B-X
predicted	B-X
or	B-X
required	B-X
can	B-X
be	B-X
assessed	B-X
in	B-X
an	B-X
exploratory	B-X
fashion	B-X
by	B-X
computing	B-X
the	B-X
odds	B-X
in	B-X
favour	B-X
of	B-X
such	B-X
an	B-X
effect	B-X
.	B-X
The	B-X
question	B-X
of	B-X
whether	B-X
to	B-X
use	B-X
a	B-X
one-sided	B-X
or	B-X
two-sided	B-X
statistical	B-X
test	B-X
should	B-X
always	B-X
be	B-X
decided	B-X
on	B-X
logical	B-X
grounds	B-X
not	B-X
statistical	B-X
ones	B-X
,	B-X
and	B-X
suspicions	B-X
regarding	B-X
the	B-X
motives	B-X
of	B-X
the	B-X
investigator	B-X
(	B-X
s	B-X
)	B-X
should	B-X
be	B-X
disregarded	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
this	B-X
choice	B-X
can	B-X
be	B-X
avoided	B-X
altogether	B-X
by	B-X
assuming	B-X
that	B-X
a	B-X
treatment	B-X
always	B-X
has	B-X
some	B-X
effect	B-X
(	B-X
however	B-X
small	B-X
)	B-X
and	B-X
then	B-X
computing	B-X
the	B-X
strength	B-X
of	B-X
the	B-X
evidence	B-X
in	B-X
favour	B-X
of	B-X
the	B-X
observed	B-X
or	B-X
predicted/required	B-X
effect	B-X
(	B-X
ie	B-X
1-P	B-X
,	B-X
where	B-X
P	B-X
is	B-X
the	B-X
one-sided	B-X
significance	B-X
level	B-X
of	B-X
the	B-X
test	B-X
)	B-X
.	B-X
With	B-X
this	B-X
approach	B-X
one-sided	B-X
and	B-X
two-sided	B-X
tests	B-X
yield	B-X
identical	B-X
results	B-X
,	B-X
and	B-X
so	B-X
there	B-X
is	B-X
effectively	B-X
only	B-X
one	B-X
type	B-X
of	B-X
test	B-X
.	B-X

RESULTS	O
:	O
All	O
normal	O
tissues	O
expressed	O
PML	B-Gene_or_gene_product
protein	O
.	O
<EOS>	B-X
The	B-X
PML	B-X
gene	B-X
is	B-X
fused	B-X
to	B-X
the	B-X
retinoic	B-X
acid	B-X
receptor	B-X
alpha	B-X
gene	B-X
(	B-X
RAR	B-X
alpha	B-X
)	B-X
in	B-X
the	B-X
acute	B-X
promyelocytic	B-X
leukemia	B-X
(	B-X
APL	B-X
)	B-X
15	B-X
;	B-X
17	B-X
translocation	B-X
.	B-X
PML	B-X
is	B-X
expressed	B-X
in	B-X
diverse	B-X
tissues	B-X
and	B-X
cell	B-X
lines	B-X
and	B-X
localized	B-X
in	B-X
the	B-X
nucleus	B-X
with	B-X
a	B-X
typical	B-X
speckled	B-X
pattern	B-X
.	B-X
In	B-X
the	B-X
bone	B-X
marrow	B-X
,	B-X
it	B-X
is	B-X
preferentially	B-X
expressed	B-X
in	B-X
myeloid	B-X
cells	B-X
.	B-X
PML	B-X
appears	B-X
to	B-X
be	B-X
transcriptionally	B-X
regulated	B-X
by	B-X
class	B-X
I	B-X
and	B-X
II	B-X
interferons	B-X
,	B-X
which	B-X
raises	B-X
the	B-X
possibility	B-X
that	B-X
interferons	B-X
modulate	B-X
the	B-X
function	B-X
and	B-X
growth	B-X
and	B-X
differentiation	B-X
potential	B-X
of	B-X
normal	B-X
myeloid	B-X
cells	B-X
and	B-X
precursors	B-X
by	B-X
activating	B-X
PML-dependent	B-X
pathways	B-X
.	B-X
Similarly	B-X
,	B-X
interferons	B-X
could	B-X
act	B-X
on	B-X
APL	B-X
cells	B-X
,	B-X
alone	B-X
or	B-X
in	B-X
combination	B-X
with	B-X
all-trans	B-X
retinoic	B-X
acid	B-X
(	B-X
RA	B-X
)	B-X
,	B-X
especially	B-X
if	B-X
the	B-X
PML/RAR	B-X
alpha	B-X
fusion	B-X
transcript	B-X
that	B-X
results	B-X
from	B-X
the	B-X
t	B-X
(	B-X
15	B-X
;	B-X
17	B-X
)	B-X
is	B-X
induced	B-X
by	B-X
interferon	B-X
.	B-X
We	B-X
report	B-X
here	B-X
that	B-X
PML	B-X
is	B-X
expressed	B-X
at	B-X
low	B-X
levels	B-X
or	B-X
not	B-X
expressed	B-X
in	B-X
normal	B-X
circulating	B-X
human	B-X
monocytes	B-X
,	B-X
lymphocytes	B-X
,	B-X
and	B-X
polymorphonucleate	B-X
cells	B-X
,	B-X
but	B-X
is	B-X
markedly	B-X
induced	B-X
by	B-X
interferon	B-X
;	B-X
that	B-X
PML	B-X
and	B-X
PML/RAR	B-X
alpha	B-X
expression	B-X
is	B-X
augmented	B-X
by	B-X
interferon	B-X
in	B-X
the	B-X
NB4	B-X
APL	B-X
cell	B-X
line	B-X
,	B-X
which	B-X
carries	B-X
the	B-X
t	B-X
(	B-X
15	B-X
;	B-X
17	B-X
)	B-X
,	B-X
and	B-X
in	B-X
APL	B-X
blasts	B-X
from	B-X
patients	B-X
;	B-X
that	B-X
interferon	B-X
inhibits	B-X
growth	B-X
and	B-X
survival	B-X
of	B-X
NB4	B-X
APL	B-X
cells	B-X
in	B-X
cooperation	B-X
with	B-X
RA	B-X
;	B-X
that	B-X
interferons	B-X
alone	B-X
have	B-X
minimal	B-X
maturation	B-X
effect	B-X
on	B-X
NB4	B-X
cells	B-X
;	B-X
and	B-X
,	B-X
finally	B-X
,	B-X
that	B-X
interferon	B-X
gamma	B-X
,	B-X
but	B-X
not	B-X
alpha	B-X
or	B-X
beta	B-X
,	B-X
induces	B-X
maturation	B-X
and	B-X
growth	B-X
suppression	B-X
of	B-X
NB4	B-X
cells	B-X
with	B-X
de	B-X
novo	B-X
retinoid	B-X
resistance	B-X
,	B-X
and	B-X
partially	B-X
restores	B-X
RA	B-X
response	B-X
.	B-X

PML	B-Gene_or_gene_product
protein	O
expression	O
was	O
reduced	O
or	O
abolished	O
in	O
prostate	O
adenocarcinomas	O
(	O
63	O
%	O
[	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
=	O
48	O
%	O
to	O
78	O
%	O
]	O
and	O
28	O
%	O
[	O
95	O
%	O
CI	O
=	O
13	O
%	O
to	O
43	O
%	O
]	O
,	O
respectively	O
)	O
,	O
colon	O
adenocarcinomas	O
(	O
31	O
%	O
[	O
95	O
%	O
CI	O
=	O
22	O
%	O
to	O
40	O
%	O
]	O
and	O
17	O
%	O
[	O
95	O
%	O
CI	O
=	O
10	O
%	O
to	O
24	O
%	O
]	O
)	O
,	O
breast	O
carcinomas	O
(	O
21	O
%	O
[	O
95	O
%	O
CI	O
=	O
8	O
%	O
to	O
34	O
%	O
]	O
and	O
31	O
%	O
[	O
95	O
%	O
CI	O
=	O
16	O
%	O
to	O
46	O
%	O
]	O
)	O
,	O
lung	O
carcinomas	O
(	O
36	O
%	O
[	O
95	O
%	O
CI	O
=	O
15	O
%	O
to	O
57	O
%	O
]	O
and	O
21	O
%	O
[	O
95	O
%	O
=	O
3	O
%	O
to	O
39	O
%	O
]	O
)	O
,	O
lymphomas	O
(	O
14	O
%	O
[	O
95	O
%	O
CI	O
=	O
10	O
%	O
to	O
18	O
%	O
]	O
and	O
69	O
%	O
[	O
95	O
%	O
CI	O
=	O
63	O
%	O
to	O
75	O
%	O
]	O
)	O
,	O
CNS	O
tumors	O
(	O
24	O
%	O
[	O
95	O
%	O
CI	O
=	O
13	O
%	O
to	O
35	O
%	O
]	O
and	O
49	O
%	O
[	O
95	O
%	O
CI	O
=	O
36	O
%	O
to	O
62	O
%	O
]	O
)	O
,	O
and	O
germ	O
cell	O
tumors	O
(	O
36	O
%	O
[	O
95	O
%	O
CI	O
=	O
24	O
%	O
to	O
48	O
%	O
]	O
and	O
48	O
%	O
[	O
95	O
%	O
CI	O
=	O
36	O
%	O
to	O
60	O
%	O
]	O
)	O
but	O
not	O
in	O
thyroid	O
or	O
adrenal	O
carcinomas	O
.	O
<EOS>	B-X
Adrenocortical	B-X
tumors	B-X
range	B-X
from	B-X
primary	B-X
bilateral	B-X
micronodular	B-X
or	B-X
macronodular	B-X
forms	B-X
of	B-X
adrenocortical	B-X
disease	B-X
to	B-X
conventional	B-X
adrenocortical	B-X
adenomas	B-X
and	B-X
carcinomas	B-X
.	B-X
This	B-X
article	B-X
focuses	B-X
on	B-X
a	B-X
practical	B-X
approach	B-X
to	B-X
the	B-X
evaluation	B-X
of	B-X
adrenocortical	B-X
tumors	B-X
with	B-X
an	B-X
emphasis	B-X
on	B-X
clinical	B-X
and	B-X
imaging	B-X
findings	B-X
,	B-X
morphologic	B-X
characteristics	B-X
,	B-X
and	B-X
multifactorial	B-X
diagnostic	B-X
schemes	B-X
and	B-X
algorithms	B-X
.	B-X
Adrenocortical	B-X
carcinoma	B-X
(	B-X
ACC	B-X
)	B-X
is	B-X
a	B-X
rare	B-X
endocrine	B-X
malignancy	B-X
of	B-X
the	B-X
adrenal	B-X
gland	B-X
with	B-X
an	B-X
unfavorable	B-X
prognosis	B-X
.	B-X
It	B-X
is	B-X
rare	B-X
in	B-X
the	B-X
pediatric	B-X
population	B-X
,	B-X
with	B-X
an	B-X
incidence	B-X
of	B-X
0.2-0.3	B-X
patients	B-X
per	B-X
million	B-X
in	B-X
patients	B-X
under	B-X
20	B-X
years	B-X
old	B-X
.	B-X
The	B-X
incidence	B-X
of	B-X
pediatric	B-X
ACC	B-X
is	B-X
10-15fold	B-X
higher	B-X
in	B-X
southern	B-X
Brazil	B-X
due	B-X
to	B-X
a	B-X
higher	B-X
prevalence	B-X
of	B-X

Loss	O
of	O
PML	B-Gene_or_gene_product
protein	O
expression	O
was	O
associated	O
with	O
tumor	O
progression	O
in	O
prostate	O
cancer	O
(	O
the	O
progression	O
from	O
prostatic	O
intraepithelial	O
neoplasia	O
to	O
invasive	O
carcinoma	O
was	O
associated	O
with	O
complete	O
PML	B-Gene_or_gene_product
loss	O
;	O
P	O
<	O
.	O
001	O
)	O
,	O
breast	O
cancer	O
(	O
complete	O
PML	B-Gene_or_gene_product
loss	O
was	O
associated	O
with	O
lymph	O
node	O
metastasis	O
;	O
P	O
=	O
.	O
01	O
)	O
,	O
and	O
CNS	O
tumors	O
(	O
complete	O
PML	B-Gene_or_gene_product
loss	O
was	O
associated	O
with	O
high	O
-	O
grade	O
tumors	O
;	O
P	O
=	O
.	O
003	O
)	O
.	O
<EOS>	B-X
The	B-X
PML	B-X
gene	B-X
is	B-X
fused	B-X
to	B-X
the	B-X
RARalpha	B-X
gene	B-X
in	B-X
the	B-X
vast	B-X
majority	B-X
of	B-X
acute	B-X
promyelocytic	B-X
leukemias	B-X
(	B-X
APL	B-X
)	B-X
and	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
key	B-X
tumor-suppressive	B-X
pathways	B-X
.	B-X
However	B-X
,	B-X
its	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
human	B-X
cancers	B-X
other	B-X
than	B-X
APL	B-X
is	B-X
still	B-X
unclear	B-X
.	B-X
We	B-X
therefore	B-X
assessed	B-X
the	B-X
status	B-X
and	B-X
expression	B-X
of	B-X
the	B-X
PML	B-X
gene	B-X
in	B-X
solid	B-X
tumors	B-X
of	B-X
multiple	B-X
histologic	B-X
origins	B-X
.	B-X

PML	B-Gene_or_gene_product
mRNA	O
was	O
expressed	O
in	O
all	O
tumor	O
and	O
cell	O
line	O
samples	O
.	O
<EOS>	B-X
Dysregulation	B-X
of	B-X
PML	B-X
,	B-X
a	B-X
significant	B-X
tumor	B-X
suppressor	B-X
is	B-X
linked	B-X
with	B-X
cancers	B-X
of	B-X
different	B-X
histological	B-X
origins	B-X
,	B-X
with	B-X
a	B-X
decreased	B-X
expression	B-X
observed	B-X
with	B-X
a	B-X
higher	B-X
tumor	B-X
grade	B-X
.	B-X
This	B-X
necessitates	B-X
studying	B-X
the	B-X
mechanisms	B-X
to	B-X
maintain	B-X
a	B-X
stable	B-X
expression	B-X
of	B-X
PML	B-X
.	B-X
However	B-X
much	B-X
less	B-X
is	B-X
known	B-X
about	B-X
the	B-X
transcriptional	B-X
regulation	B-X
of	B-X
PML	B-X
,	B-X
more	B-X
so	B-X
in	B-X
the	B-X
context	B-X
of	B-X
breast	B-X
carcinoma	B-X
.	B-X
The	B-X
PML	B-X
gene	B-X
is	B-X
fused	B-X
to	B-X
the	B-X
RARalpha	B-X
gene	B-X
in	B-X
the	B-X
vast	B-X
majority	B-X
of	B-X
acute	B-X
promyelocytic	B-X
leukemias	B-X
(	B-X
APL	B-X
)	B-X
and	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
key	B-X
tumor-suppressive	B-X
pathways	B-X
.	B-X
We	B-X
therefore	B-X
assessed	B-X
the	B-X
status	B-X
and	B-X
expression	B-X
of	B-X
the	B-X
PML	B-X
gene	B-X
in	B-X
solid	B-X
tumors	B-X
of	B-X
multiple	B-X
histologic	B-X
origins	B-X
.	B-X

The	O
PML	B-Gene_or_gene_product
gene	O
was	O
rarely	O
mutated	O
and	O
was	O
not	O
subject	O
to	O
LOH	O
.	O
<EOS>	B-X
p73	B-X
,	B-X
a	B-X
homologue	B-X
to	B-X
the	B-X
tumor	B-X
suppressor	B-X
gene	B-X
p53	B-X
,	B-X
is	B-X
involved	B-X
in	B-X
tumorigenesis	B-X
,	B-X
though	B-X
its	B-X
specific	B-X
role	B-X
remains	B-X
unclear	B-X
.	B-X
The	B-X
gene	B-X
has	B-X
two	B-X
distinct	B-X
promoters	B-X
which	B-X
allow	B-X
the	B-X
formation	B-X
of	B-X
two	B-X
protein	B-X
isoforms	B-X
with	B-X
opposite	B-X
effects	B-X
:	B-X
full-length	B-X
transactivating	B-X
(	B-X
TA	B-X
)	B-X
p73	B-X
shows	B-X
pro-apoptotic	B-X
effects	B-X
,	B-X
while	B-X
the	B-X
shorter	B-X
DeltaNp73	B-X
,	B-X
which	B-X
lacks	B-X
the	B-X
N-terminal	B-X
transactivating	B-X
domain	B-X
,	B-X
has	B-X
an	B-X
evident	B-X
anti-apoptotic	B-X
function	B-X
.	B-X
Unlike	B-X
p53	B-X
,	B-X
the	B-X
p73	B-X
gene	B-X
is	B-X
rarely	B-X
mutated	B-X
in	B-X
human	B-X
cancers	B-X
.	B-X
Much	B-X
effort	B-X
is	B-X
currently	B-X
focused	B-X
on	B-X
the	B-X
elucidation	B-X
of	B-X
the	B-X
mechanisms	B-X
that	B-X
differentially	B-X
control	B-X
TA	B-X
and	B-X
DeltaNp73	B-X
activity	B-X
and	B-X
protein	B-X
stability	B-X
,	B-X
a	B-X
process	B-X
complicated	B-X
by	B-X
the	B-X
finding	B-X
that	B-X
both	B-X
proteins	B-X
are	B-X
regulated	B-X
by	B-X
a	B-X
similar	B-X
suite	B-X
of	B-X
complex	B-X
post-translational	B-X
modifications	B-X
that	B-X
include	B-X
ubiquitination	B-X
,	B-X
sequential	B-X
phosphorylation	B-X
,	B-X
prolyl-isomerization	B-X
,	B-X
recruitment	B-X
into	B-X
the	B-X
PML-nuclear	B-X
body	B-X
(	B-X
PML-NB	B-X
)	B-X
,	B-X
and	B-X
acetylation	B-X
.	B-X
Here	B-X
we	B-X
shall	B-X
consider	B-X
the	B-X
main	B-X
regulatory	B-X
partners	B-X
of	B-X
p73	B-X
,	B-X
with	B-X
particular	B-X
attention	B-X
to	B-X
the	B-X
recently	B-X
discovered	B-X
Itch-	B-X
and	B-X
Nedd8-mediated	B-X
degradation	B-X
pathways	B-X
,	B-X
along	B-X
with	B-X
the	B-X
emerging	B-X
roles	B-X
of	B-X
PML	B-X
,	B-X
p38	B-X
MAP	B-X
kinase	B-X
,	B-X
Pin1	B-X
,	B-X
and	B-X
p300	B-X
in	B-X
p73	B-X
transcriptional	B-X
activation	B-X
,	B-X
and	B-X
possible	B-X
mechanisms	B-X
for	B-X
the	B-X
differential	B-X
regulation	B-X
of	B-X
the	B-X
TAp73	B-X
and	B-X
DeltaNp73	B-X
isoforms	B-X
.	B-X

CONCLUSIONS	O
:	O
PML	B-Gene_or_gene_product
protein	O
expression	O
is	O
frequently	O
lost	O
in	O
human	O
cancers	O
of	O
various	O
histologic	O
origins	O
,	O
and	O
its	O
loss	O
associates	O
with	O
tumor	O
grade	O
and	O
progression	O
in	O
some	O
tumor	O
histotypes	O
.	O
<EOS>	B-X
The	B-X
PML	B-X
gene	B-X
is	B-X
fused	B-X
to	B-X
the	B-X
RARalpha	B-X
gene	B-X
in	B-X
the	B-X
vast	B-X
majority	B-X
of	B-X
acute	B-X
promyelocytic	B-X
leukemias	B-X
(	B-X
APL	B-X
)	B-X
and	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
key	B-X
tumor-suppressive	B-X
pathways	B-X
.	B-X
However	B-X
,	B-X
its	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
human	B-X
cancers	B-X
other	B-X
than	B-X
APL	B-X
is	B-X
still	B-X
unclear	B-X
.	B-X
We	B-X
therefore	B-X
assessed	B-X
the	B-X
status	B-X
and	B-X
expression	B-X
of	B-X
the	B-X
PML	B-X
gene	B-X
in	B-X
solid	B-X
tumors	B-X
of	B-X
multiple	B-X
histologic	B-X
origins	B-X
.	B-X

mTOR	B-Gene_or_gene_product
-	O
dependent	O
activation	O
of	O
the	O
transcription	O
factor	O
TIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IA	I-Gene_or_gene_product
links	O
rRNA	O
synthesis	O
to	O
nutrient	O
availability	O
.	O
<EOS>	B-X
In	B-X
cycling	B-X
cells	B-X
,	B-X
transcription	B-X
of	B-X
ribosomal	B-X
RNA	B-X
genes	B-X
by	B-X
RNA	B-X
polymerase	B-X
I	B-X
(	B-X
Pol	B-X
I	B-X
)	B-X
is	B-X
tightly	B-X
coordinated	B-X
with	B-X
cell	B-X
growth	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
regulates	B-X
Pol	B-X
I	B-X
transcription	B-X
by	B-X
modulating	B-X
the	B-X
activity	B-X
of	B-X
TIF-IA	B-X
,	B-X
a	B-X
regulatory	B-X
factor	B-X
that	B-X
senses	B-X
nutrient	B-X
and	B-X
growth-factor	B-X
availability	B-X
.	B-X
Inhibition	B-X
of	B-X
mTOR	B-X
signaling	B-X
by	B-X
rapamycin	B-X
inactivates	B-X
TIF-IA	B-X
and	B-X
impairs	B-X
transcription-initiation	B-X
complex	B-X
formation	B-X
.	B-X
Moreover	B-X
,	B-X
rapamycin	B-X
treatment	B-X
leads	B-X
to	B-X
translocation	B-X
of	B-X
TIF-IA	B-X
into	B-X
the	B-X
cytoplasm	B-X
.	B-X
Rapamycin-mediated	B-X
inactivation	B-X
of	B-X
TIF-IA	B-X
is	B-X
caused	B-X
by	B-X
hypophosphorylation	B-X
of	B-X
Se	B-X
44	B-X
(	B-X
S44	B-X
)	B-X
and	B-X
hyperphosphorylation	B-X
of	B-X
Se	B-X
199	B-X
(	B-X
S199	B-X
)	B-X
.	B-X
Phosphorylation	B-X
at	B-X
these	B-X
sites	B-X
affects	B-X
TIF-IA	B-X
activity	B-X
in	B-X
opposite	B-X
ways	B-X
,	B-X
for	B-X
example	B-X
,	B-X
phosphorylation	B-X
of	B-X
S44	B-X
activates	B-X
and	B-X
S199	B-X
inactivates	B-X
TIF-IA	B-X
.	B-X
The	B-X
results	B-X
identify	B-X
a	B-X
new	B-X
target	B-X
formTOR-signaling	B-X
pathways	B-X
and	B-X
elucidate	B-X
the	B-X
molecular	B-X
mechanism	B-X
underlying	B-X
mTOR-dependent	B-X
regulation	B-X
of	B-X
RNA	B-X
synthesis	B-X
.	B-X

In	O
cycling	O
cells	O
,	O
transcription	O
of	O
ribosomal	O
RNA	O
genes	O
by	O
RNA	B-Gene_or_gene_product
polymerase	I-Gene_or_gene_product
I	I-Gene_or_gene_product
(	O
Pol	B-Gene_or_gene_product
I	I-Gene_or_gene_product
)	O
is	O
tightly	O
coordinated	O
with	O
cell	O
growth	O
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
mammalian	B-Gene_or_gene_product
target	I-Gene_or_gene_product
of	I-Gene_or_gene_product
rapamycin	I-Gene_or_gene_product
(	O
mTOR	B-Gene_or_gene_product
)	O
regulates	O
Pol	B-Gene_or_gene_product
I	I-Gene_or_gene_product
transcription	O
by	O
modulating	O
the	O
activity	O
of	O
TIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IA	I-Gene_or_gene_product
,	O
a	O
regulatory	O
factor	O
that	O
senses	O
nutrient	O
and	O
growth	O
-	O
factor	O
availability	O
.	O

Inhibition	O
of	O
mTOR	B-Gene_or_gene_product
signaling	O
by	O
rapamycin	O
inactivates	O
TIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IA	I-Gene_or_gene_product
and	O
impairs	O
transcription	O
-	O
initiation	O
complex	O
formation	O
.	O
<EOS>	B-X
In	B-X
cycling	B-X
cells	B-X
,	B-X
transcription	B-X
of	B-X
ribosomal	B-X
RNA	B-X
genes	B-X
by	B-X
RNA	B-X
polymerase	B-X
I	B-X
(	B-X
Pol	B-X
I	B-X
)	B-X
is	B-X
tightly	B-X
coordinated	B-X
with	B-X
cell	B-X
growth	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
regulates	B-X
Pol	B-X
I	B-X
transcription	B-X
by	B-X
modulating	B-X
the	B-X
activity	B-X
of	B-X
TIF-IA	B-X
,	B-X
a	B-X
regulatory	B-X
factor	B-X
that	B-X
senses	B-X
nutrient	B-X
and	B-X
growth-factor	B-X
availability	B-X
.	B-X
Inhibition	B-X
of	B-X
mTOR	B-X
signaling	B-X
by	B-X
rapamycin	B-X
inactivates	B-X
TIF-IA	B-X
and	B-X
impairs	B-X
transcription-initiation	B-X
complex	B-X
formation	B-X
.	B-X
Moreover	B-X
,	B-X
rapamycin	B-X
treatment	B-X
leads	B-X
to	B-X
translocation	B-X
of	B-X
TIF-IA	B-X
into	B-X
the	B-X
cytoplasm	B-X
.	B-X
Rapamycin-mediated	B-X
inactivation	B-X
of	B-X
TIF-IA	B-X
is	B-X
caused	B-X
by	B-X
hypophosphorylation	B-X
of	B-X
Se	B-X
44	B-X
(	B-X
S44	B-X
)	B-X
and	B-X
hyperphosphorylation	B-X
of	B-X
Se	B-X
199	B-X
(	B-X
S199	B-X
)	B-X
.	B-X
Phosphorylation	B-X
at	B-X
these	B-X
sites	B-X
affects	B-X
TIF-IA	B-X
activity	B-X
in	B-X
opposite	B-X
ways	B-X
,	B-X
for	B-X
example	B-X
,	B-X
phosphorylation	B-X
of	B-X
S44	B-X
activates	B-X
and	B-X
S199	B-X
inactivates	B-X
TIF-IA	B-X
.	B-X
The	B-X
results	B-X
identify	B-X
a	B-X
new	B-X
target	B-X
formTOR-signaling	B-X
pathways	B-X
and	B-X
elucidate	B-X
the	B-X
molecular	B-X
mechanism	B-X
underlying	B-X
mTOR-dependent	B-X
regulation	B-X
of	B-X
RNA	B-X
synthesis	B-X
.	B-X

Moreover	O
,	O
rapamycin	O
treatment	O
leads	O
to	O
translocation	O
of	O
TIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IA	I-Gene_or_gene_product
into	O
the	O
cytoplasm	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
regulates	B-X
Pol	B-X
I	B-X
transcription	B-X
by	B-X
modulating	B-X
the	B-X
activity	B-X
of	B-X
TIF-IA	B-X
,	B-X
a	B-X
regulatory	B-X
factor	B-X
that	B-X
senses	B-X
nutrient	B-X
and	B-X
growth-factor	B-X
availability	B-X
.	B-X
Inhibition	B-X
of	B-X
mTOR	B-X
signaling	B-X
by	B-X
rapamycin	B-X
inactivates	B-X
TIF-IA	B-X
and	B-X
impairs	B-X
transcription-initiation	B-X
complex	B-X
formation	B-X
.	B-X
Moreover	B-X
,	B-X
rapamycin	B-X
treatment	B-X
leads	B-X
to	B-X
translocation	B-X
of	B-X
TIF-IA	B-X
into	B-X
the	B-X
cytoplasm	B-X
.	B-X
Rapamycin-mediated	B-X
inactivation	B-X
of	B-X
TIF-IA	B-X
is	B-X
caused	B-X
by	B-X
hypophosphorylation	B-X
of	B-X
Se	B-X
44	B-X
(	B-X
S44	B-X
)	B-X
and	B-X
hyperphosphorylation	B-X
of	B-X
Se	B-X
199	B-X
(	B-X
S199	B-X
)	B-X
.	B-X
Phosphorylation	B-X
at	B-X
these	B-X
sites	B-X
affects	B-X
TIF-IA	B-X
activity	B-X
in	B-X
opposite	B-X
ways	B-X
,	B-X
for	B-X
example	B-X
,	B-X
phosphorylation	B-X
of	B-X
S44	B-X
activates	B-X
and	B-X
S199	B-X
inactivates	B-X
TIF-IA	B-X
.	B-X

Rapamycin	O
-	O
mediated	O
inactivation	O
of	O
TIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IA	I-Gene_or_gene_product
is	O
caused	O
by	O
hypophosphorylation	O
of	O
Se	O
44	O
(	O
S44	O
)	O
and	O
hyperphosphorylation	O
of	O
Se	O
199	O
(	O
S199	O
)	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
regulates	B-X
Pol	B-X
I	B-X
transcription	B-X
by	B-X
modulating	B-X
the	B-X
activity	B-X
of	B-X
TIF-IA	B-X
,	B-X
a	B-X
regulatory	B-X
factor	B-X
that	B-X
senses	B-X
nutrient	B-X
and	B-X
growth-factor	B-X
availability	B-X
.	B-X
Inhibition	B-X
of	B-X
mTOR	B-X
signaling	B-X
by	B-X
rapamycin	B-X
inactivates	B-X
TIF-IA	B-X
and	B-X
impairs	B-X
transcription-initiation	B-X
complex	B-X
formation	B-X
.	B-X
Moreover	B-X
,	B-X
rapamycin	B-X
treatment	B-X
leads	B-X
to	B-X
translocation	B-X
of	B-X
TIF-IA	B-X
into	B-X
the	B-X
cytoplasm	B-X
.	B-X
Rapamycin-mediated	B-X
inactivation	B-X
of	B-X
TIF-IA	B-X
is	B-X
caused	B-X
by	B-X
hypophosphorylation	B-X
of	B-X
Se	B-X
44	B-X
(	B-X
S44	B-X
)	B-X
and	B-X
hyperphosphorylation	B-X
of	B-X
Se	B-X
199	B-X
(	B-X
S199	B-X
)	B-X
.	B-X
Phosphorylation	B-X
at	B-X
these	B-X
sites	B-X
affects	B-X
TIF-IA	B-X
activity	B-X
in	B-X
opposite	B-X
ways	B-X
,	B-X
for	B-X
example	B-X
,	B-X
phosphorylation	B-X
of	B-X
S44	B-X
activates	B-X
and	B-X
S199	B-X
inactivates	B-X
TIF-IA	B-X
.	B-X

Phosphorylation	O
at	O
these	O
sites	O
affects	O
TIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IA	I-Gene_or_gene_product
activity	O
in	O
opposite	O
ways	O
,	O
for	O
example	O
,	O
phosphorylation	O
of	O
S44	O
activates	O
and	O
S199	O
inactivates	O
TIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IA	I-Gene_or_gene_product
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
regulates	B-X
Pol	B-X
I	B-X
transcription	B-X
by	B-X
modulating	B-X
the	B-X
activity	B-X
of	B-X
TIF-IA	B-X
,	B-X
a	B-X
regulatory	B-X
factor	B-X
that	B-X
senses	B-X
nutrient	B-X
and	B-X
growth-factor	B-X
availability	B-X
.	B-X
Inhibition	B-X
of	B-X
mTOR	B-X
signaling	B-X
by	B-X
rapamycin	B-X
inactivates	B-X
TIF-IA	B-X
and	B-X
impairs	B-X
transcription-initiation	B-X
complex	B-X
formation	B-X
.	B-X
Moreover	B-X
,	B-X
rapamycin	B-X
treatment	B-X
leads	B-X
to	B-X
translocation	B-X
of	B-X
TIF-IA	B-X
into	B-X
the	B-X
cytoplasm	B-X
.	B-X
Rapamycin-mediated	B-X
inactivation	B-X
of	B-X
TIF-IA	B-X
is	B-X
caused	B-X
by	B-X
hypophosphorylation	B-X
of	B-X
Se	B-X
44	B-X
(	B-X
S44	B-X
)	B-X
and	B-X
hyperphosphorylation	B-X
of	B-X
Se	B-X
199	B-X
(	B-X
S199	B-X
)	B-X
.	B-X
Phosphorylation	B-X
at	B-X
these	B-X
sites	B-X
affects	B-X
TIF-IA	B-X
activity	B-X
in	B-X
opposite	B-X
ways	B-X
,	B-X
for	B-X
example	B-X
,	B-X
phosphorylation	B-X
of	B-X
S44	B-X
activates	B-X
and	B-X
S199	B-X
inactivates	B-X
TIF-IA	B-X
.	B-X
The	B-X
results	B-X
identify	B-X
a	B-X
new	B-X
target	B-X
formTOR-signaling	B-X
pathways	B-X
and	B-X
elucidate	B-X
the	B-X
molecular	B-X
mechanism	B-X
underlying	B-X
mTOR-dependent	B-X
regulation	B-X
of	B-X
RNA	B-X
synthesis	B-X
.	B-X

The	O
results	O
identify	O
a	O
new	O
target	O
formTOR	B-Gene_or_gene_product
-	O
signaling	O
pathways	O
and	O
elucidate	O
the	O
molecular	O
mechanism	O
underlying	O
mTOR	B-Gene_or_gene_product
-	O
dependent	O
regulation	O
of	O
RNA	O
synthesis	O
.	O
<EOS>	B-X
In	B-X
cycling	B-X
cells	B-X
,	B-X
transcription	B-X
of	B-X
ribosomal	B-X
RNA	B-X
genes	B-X
by	B-X
RNA	B-X
polymerase	B-X
I	B-X
(	B-X
Pol	B-X
I	B-X
)	B-X
is	B-X
tightly	B-X
coordinated	B-X
with	B-X
cell	B-X
growth	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
regulates	B-X
Pol	B-X
I	B-X
transcription	B-X
by	B-X
modulating	B-X
the	B-X
activity	B-X
of	B-X
TIF-IA	B-X
,	B-X
a	B-X
regulatory	B-X
factor	B-X
that	B-X
senses	B-X
nutrient	B-X
and	B-X
growth-factor	B-X
availability	B-X
.	B-X
Inhibition	B-X
of	B-X
mTOR	B-X
signaling	B-X
by	B-X
rapamycin	B-X
inactivates	B-X
TIF-IA	B-X
and	B-X
impairs	B-X
transcription-initiation	B-X
complex	B-X
formation	B-X
.	B-X
The	B-X
results	B-X
identify	B-X
a	B-X
new	B-X
target	B-X
formTOR-signaling	B-X
pathways	B-X
and	B-X
elucidate	B-X
the	B-X
molecular	B-X
mechanism	B-X
underlying	B-X
mTOR-dependent	B-X
regulation	B-X
of	B-X
RNA	B-X
synthesis	B-X
.	B-X

Coupling	O
morphogenesis	O
to	O
mitotic	O
entry	O
.	O
<EOS>	B-X
In	B-X
eukaryotes	B-X
,	B-X
cyclin	B-X
B-bound	B-X
cyclin-dependent	B-X
protein	B-X
kinase	B-X
1	B-X
promotes	B-X
mitotic	B-X
entry	B-X
but	B-X
is	B-X
held	B-X
in	B-X
check	B-X
,	B-X
in	B-X
part	B-X
,	B-X
by	B-X
Wee1	B-X
protein	B-X
kinase	B-X
.	B-X
Timely	B-X
mitotic	B-X
entry	B-X
in	B-X
budding	B-X
yeast	B-X
requires	B-X
inactivation	B-X
of	B-X
Swe1	B-X
(	B-X
Wee1	B-X
ortholog	B-X
)	B-X
.	B-X
Failures	B-X
to	B-X
properly	B-X
regulate	B-X
mitotic	B-X
progression	B-X
result	B-X
in	B-X
aneuploidy	B-X
,	B-X
a	B-X
hallmark	B-X
of	B-X
cancer	B-X
.	B-X
The	B-X
correct	B-X
timing	B-X
of	B-X
CDK-based	B-X
mitotic	B-X
regulation	B-X
is	B-X
coordinated	B-X
with	B-X
the	B-X
structure	B-X
and	B-X
function	B-X
of	B-X
microtubules	B-X
.	B-X
To	B-X
determine	B-X
whether	B-X
mitotic	B-X
gene	B-X
expression	B-X
is	B-X
also	B-X
regulated	B-X
by	B-X
the	B-X
integrity	B-X
of	B-X
microtubules	B-X
,	B-X
we	B-X
performed	B-X
ribosome	B-X
profiling	B-X
and	B-X
mRNA-sequencing	B-X
in	B-X
the	B-X
presence	B-X
and	B-X
absence	B-X
of	B-X
microtubules	B-X
in	B-X
the	B-X
budding	B-X
yeast	B-X

In	O
eukaryotes	O
,	O
cyclin	B-Gene_or_gene_product
B	I-Gene_or_gene_product
-	O
bound	O
cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
promotes	O
mitotic	O
entry	O
but	O
is	O
held	O
in	O
check	O
,	O
in	O
part	O
,	O
by	O
Wee1	B-Gene_or_gene_product
protein	O
kinase	O
.	O
<EOS>	B-X
In	B-X
eukaryotes	B-X
,	B-X
cyclin	B-X
B-bound	B-X
cyclin-dependent	B-X
protein	B-X
kinase	B-X
1	B-X
promotes	B-X
mitotic	B-X
entry	B-X
but	B-X
is	B-X
held	B-X
in	B-X
check	B-X
,	B-X
in	B-X
part	B-X
,	B-X
by	B-X
Wee1	B-X
protein	B-X
kinase	B-X
.	B-X
Timely	B-X
mitotic	B-X
entry	B-X
in	B-X
budding	B-X
yeast	B-X
requires	B-X
inactivation	B-X
of	B-X
Swe1	B-X
(	B-X
Wee1	B-X
ortholog	B-X
)	B-X
.	B-X
Perturbations	B-X
of	B-X
the	B-X
septin	B-X
collar	B-X
at	B-X
the	B-X
bud	B-X
neck	B-X
lead	B-X
to	B-X
Swe1	B-X
stabilization	B-X
,	B-X
delaying	B-X
the	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
transition	B-X
.	B-X
Swe1	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
neck	B-X
and	B-X
hyperphosphorylated	B-X
before	B-X
ubiquitin-mediated	B-X
degradation	B-X
.	B-X
Hsl1	B-X
kinase	B-X
(	B-X
Nim1	B-X
ortholog	B-X
)	B-X
,	B-X
a	B-X
negative	B-X
regulator	B-X
of	B-X
Wee1	B-X
,	B-X
is	B-X
required	B-X
for	B-X
efficient	B-X
Swe1	B-X
localization	B-X
at	B-X
the	B-X
neck	B-X
but	B-X
seems	B-X
not	B-X
to	B-X
phosphorylate	B-X
Swe1	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
two	B-X
other	B-X
kinases	B-X
targeted	B-X
sequentially	B-X
to	B-X
the	B-X
neck	B-X
,	B-X
Cla4/PAK	B-X
and	B-X
Cdc5/Polo	B-X
,	B-X
are	B-X
responsible	B-X
for	B-X
stepwise	B-X
phosphorylation	B-X
and	B-X
down-regulation	B-X
of	B-X
Swe1	B-X
.	B-X

Timely	O
mitotic	O
entry	O
in	O
budding	O
yeast	O
requires	O
inactivation	O
of	O
Swe1	B-Gene_or_gene_product
(	O
Wee1	B-Gene_or_gene_product
ortholog	O
)	O
.	O
<EOS>	B-X
In	B-X
eukaryotes	B-X
,	B-X
cyclin	B-X
B-bound	B-X
cyclin-dependent	B-X
protein	B-X
kinase	B-X
1	B-X
promotes	B-X
mitotic	B-X
entry	B-X
but	B-X
is	B-X
held	B-X
in	B-X
check	B-X
,	B-X
in	B-X
part	B-X
,	B-X
by	B-X
Wee1	B-X
protein	B-X
kinase	B-X
.	B-X
Timely	B-X
mitotic	B-X
entry	B-X
in	B-X
budding	B-X
yeast	B-X
requires	B-X
inactivation	B-X
of	B-X
Swe1	B-X
(	B-X
Wee1	B-X
ortholog	B-X
)	B-X
.	B-X
Perturbations	B-X
of	B-X
the	B-X
septin	B-X
collar	B-X
at	B-X
the	B-X
bud	B-X
neck	B-X
lead	B-X
to	B-X
Swe1	B-X
stabilization	B-X
,	B-X
delaying	B-X
the	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
transition	B-X
.	B-X
Swe1	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
neck	B-X
and	B-X
hyperphosphorylated	B-X
before	B-X
ubiquitin-mediated	B-X
degradation	B-X
.	B-X
Hsl1	B-X
kinase	B-X
(	B-X
Nim1	B-X
ortholog	B-X
)	B-X
,	B-X
a	B-X
negative	B-X
regulator	B-X
of	B-X
Wee1	B-X
,	B-X
is	B-X
required	B-X
for	B-X
efficient	B-X
Swe1	B-X
localization	B-X
at	B-X
the	B-X
neck	B-X
but	B-X
seems	B-X
not	B-X
to	B-X
phosphorylate	B-X
Swe1	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
two	B-X
other	B-X
kinases	B-X
targeted	B-X
sequentially	B-X
to	B-X
the	B-X
neck	B-X
,	B-X
Cla4/PAK	B-X
and	B-X
Cdc5/Polo	B-X
,	B-X
are	B-X
responsible	B-X
for	B-X
stepwise	B-X
phosphorylation	B-X
and	B-X
down-regulation	B-X
of	B-X
Swe1	B-X
.	B-X

Perturbations	O
of	O
the	O
septin	B-Gene_or_gene_product
collar	O
at	O
the	O
bud	O
neck	O
lead	O
to	O
Swe1	B-Gene_or_gene_product
stabilization	O
,	O
delaying	O
the	O
G	O
(	O
2	O
)	O
/	O
M	O
transition	O
.	O

Swe1	B-Gene_or_gene_product
is	O
recruited	O
to	O
the	O
neck	O
and	O
hyperphosphorylated	O
before	O
ubiquitin	B-Gene_or_gene_product
-	O
mediated	O
degradation	O
.	O

Hsl1	B-Gene_or_gene_product
kinase	O
(	O
Nim1	B-Gene_or_gene_product
ortholog	O
)	O
,	O
a	O
negative	O
regulator	O
of	O
Wee1	B-Gene_or_gene_product
,	O
is	O
required	O
for	O
efficient	O
Swe1	B-Gene_or_gene_product
localization	O
at	O
the	O
neck	O
but	O
seems	O
not	O
to	O
phosphorylate	O
Swe1	B-Gene_or_gene_product
.	O

Here	O
,	O
we	O
show	O
that	O
two	O
other	O
kinases	O
targeted	O
sequentially	O
to	O
the	O
neck	O
,	O
Cla4	B-Gene_or_gene_product
/	I-Gene_or_gene_product
PAK	I-Gene_or_gene_product
and	O
Cdc5	B-Gene_or_gene_product
/	I-Gene_or_gene_product
Polo	I-Gene_or_gene_product
,	O
are	O
responsible	O
for	O
stepwise	O
phosphorylation	O
and	O
down	O
-	O
regulation	O
of	O
Swe1	B-Gene_or_gene_product
.	O

This	O
mechanism	O
links	O
assembly	O
of	O
a	O
cellular	O
structure	O
to	O
passage	O
into	O
mitosis	O
.	O
<EOS>	B-X
Local	B-X
chromatin	B-X
structure	B-X
must	B-X
also	B-X
be	B-X
re-assembled	B-X
each	B-X
S	B-X
phase	B-X
to	B-X
incorporate	B-X
newly	B-X
replicated	B-X
sister	B-X
chromatids	B-X
.	B-X
The	B-X
replication	B-X
fork	B-X
is	B-X
the	B-X
one	B-X
complex	B-X
that	B-X
potentially	B-X
interacts	B-X
with	B-X
every	B-X
nucleotide	B-X
of	B-X
the	B-X
genome	B-X
,	B-X
providing	B-X
a	B-X
mechanism	B-X
to	B-X
couple	B-X
chromatin	B-X
assembly	B-X
to	B-X
S	B-X
phase	B-X
passage	B-X
.	B-X
Intriguingly	B-X
,	B-X
recent	B-X
studies	B-X
indicate	B-X
that	B-X
these	B-X
processes	B-X
are	B-X
linked	B-X
to	B-X
S	B-X
phase	B-X
by	B-X
temporal	B-X
mechanisms	B-X
as	B-X
well	B-X
as	B-X
by	B-X
replication-dependent	B-X
activities	B-X
.	B-X
This	B-X
mechanism	B-X
links	B-X
assembly	B-X
of	B-X
a	B-X
cellular	B-X
structure	B-X
to	B-X
passage	B-X
into	B-X
mitosis	B-X
.	B-X

Bruton	B-Gene_or_gene_product
'	I-Gene_or_gene_product
s	I-Gene_or_gene_product
tyrosine	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
Btk	B-Gene_or_gene_product
)	O
-	O
the	O
critical	O
tyrosine	O
kinase	O
in	O
LPS	O
signalling	O
?	O
<EOS>	B-X
One	B-X
unresolved	B-X
question	B-X
regarding	B-X
LPS	B-X
signalling	B-X
is	B-X
whether	B-X
there	B-X
is	B-X
a	B-X
role	B-X
for	B-X
tyrosine	B-X
kinases	B-X
downstream	B-X
of	B-X
the	B-X
LPS	B-X
receptor	B-X
.	B-X
Studies	B-X
in	B-X
mice	B-X
deficient	B-X
in	B-X
Bruton	B-X
's	B-X
tyrosine	B-X
kinase	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
they	B-X
are	B-X
defective	B-X
in	B-X
their	B-X
responses	B-X
to	B-X
LPS	B-X
.	B-X
Further	B-X
investigation	B-X
into	B-X
the	B-X
role	B-X
of	B-X
Btk	B-X
in	B-X
LPS	B-X
signalling	B-X
has	B-X
directly	B-X
implicated	B-X
Btk	B-X
downstream	B-X
of	B-X
TLR4	B-X
,	B-X
both	B-X
with	B-X
respect	B-X
to	B-X
p38	B-X
MAPK	B-X
activation	B-X
and	B-X
activation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
NFkappaB	B-X
.	B-X
In	B-X
fact	B-X
Btk	B-X
is	B-X
activated	B-X
by	B-X
LPS	B-X
and	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
directly	B-X
bind	B-X
TLR4	B-X
and	B-X
the	B-X
key	B-X
proximal	B-X
signalling	B-X
proteins	B-X
involved	B-X
in	B-X
LPS-induced	B-X
NFkappaB	B-X
activation	B-X
,	B-X
MyD88	B-X
,	B-X
Mal	B-X
and	B-X
IRAK-1	B-X
.	B-X
These	B-X
recent	B-X
findings	B-X
point	B-X
to	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
Btk	B-X
in	B-X
LPS	B-X
signal	B-X
transduction	B-X
and	B-X
raise	B-X
interesting	B-X
questions	B-X
regarding	B-X
the	B-X
mode	B-X
of	B-X
activation	B-X
of	B-X
Btk	B-X
following	B-X
LPS	B-X
stimulation	B-X
and	B-X
the	B-X
precise	B-X
nature	B-X
of	B-X
the	B-X
pathways	B-X
activated	B-X
downstream	B-X
of	B-X
Btk	B-X
.	B-X
A	B-X
better	B-X
understanding	B-X
of	B-X
how	B-X
Btk	B-X
functions	B-X
in	B-X
LPS	B-X
signalling	B-X
will	B-X
have	B-X
important	B-X
implications	B-X
for	B-X
inflammatory	B-X
and	B-X
autoimmune	B-X
disorders	B-X
and	B-X
therapies	B-X
thereof	B-X
.	B-X

The	O
discovery	O
of	O
the	O
Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
(	O
TLRs	B-Gene_or_gene_product
)	O
has	O
revolutionised	O
the	O
field	O
of	O
innate	O
immunity	O
.	O
<EOS>	B-X
The	B-X
discovery	B-X
of	B-X
the	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
has	B-X
revolutionised	B-X
the	B-X
field	B-X
of	B-X
innate	B-X
immunity	B-X
.	B-X

One	O
unresolved	O
question	O
regarding	O
LPS	O
signalling	O
is	O
whether	O
there	O
is	O
a	O
role	O
for	O
tyrosine	O
kinases	O
downstream	O
of	O
the	O
LPS	O
receptor	O
.	O
<EOS>	B-X
The	B-X
discovery	B-X
of	B-X
the	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
has	B-X
revolutionised	B-X
the	B-X
field	B-X
of	B-X
innate	B-X
immunity	B-X
.	B-X
One	B-X
unresolved	B-X
question	B-X
regarding	B-X
LPS	B-X
signalling	B-X
is	B-X
whether	B-X
there	B-X
is	B-X
a	B-X
role	B-X
for	B-X
tyrosine	B-X
kinases	B-X
downstream	B-X
of	B-X
the	B-X
LPS	B-X
receptor	B-X
.	B-X
Studies	B-X
in	B-X
mice	B-X
deficient	B-X
in	B-X
Bruton	B-X
's	B-X
tyrosine	B-X
kinase	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
they	B-X
are	B-X
defective	B-X
in	B-X
their	B-X
responses	B-X
to	B-X
LPS	B-X
.	B-X
Further	B-X
investigation	B-X
into	B-X
the	B-X
role	B-X
of	B-X
Btk	B-X
in	B-X
LPS	B-X
signalling	B-X
has	B-X
directly	B-X
implicated	B-X
Btk	B-X
downstream	B-X
of	B-X
TLR4	B-X
,	B-X
both	B-X
with	B-X
respect	B-X
to	B-X
p38	B-X
MAPK	B-X
activation	B-X
and	B-X
activation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
NFkappaB	B-X
.	B-X
In	B-X
fact	B-X
Btk	B-X
is	B-X
activated	B-X
by	B-X
LPS	B-X
and	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
directly	B-X
bind	B-X
TLR4	B-X
and	B-X
the	B-X
key	B-X
proximal	B-X
signalling	B-X
proteins	B-X
involved	B-X
in	B-X
LPS-induced	B-X
NFkappaB	B-X
activation	B-X
,	B-X
MyD88	B-X
,	B-X
Mal	B-X
and	B-X
IRAK-1	B-X
.	B-X
These	B-X
recent	B-X
findings	B-X
point	B-X
to	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
Btk	B-X
in	B-X
LPS	B-X
signal	B-X
transduction	B-X
and	B-X
raise	B-X
interesting	B-X
questions	B-X
regarding	B-X
the	B-X
mode	B-X
of	B-X
activation	B-X
of	B-X
Btk	B-X
following	B-X
LPS	B-X
stimulation	B-X
and	B-X
the	B-X
precise	B-X
nature	B-X
of	B-X
the	B-X
pathways	B-X
activated	B-X
downstream	B-X
of	B-X
Btk	B-X
.	B-X
A	B-X
better	B-X
understanding	B-X
of	B-X
how	B-X
Btk	B-X
functions	B-X
in	B-X
LPS	B-X
signalling	B-X
will	B-X
have	B-X
important	B-X
implications	B-X
for	B-X
inflammatory	B-X
and	B-X
autoimmune	B-X
disorders	B-X
and	B-X
therapies	B-X
thereof	B-X
.	B-X

Studies	O
in	O
mice	O
deficient	O
in	O
Bruton	B-Gene_or_gene_product
'	I-Gene_or_gene_product
s	I-Gene_or_gene_product
tyrosine	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
have	O
previously	O
shown	O
that	O
they	O
are	O
defective	O
in	O
their	O
responses	O
to	O
LPS	O
.	O
<EOS>	B-X
One	B-X
unresolved	B-X
question	B-X
regarding	B-X
LPS	B-X
signalling	B-X
is	B-X
whether	B-X
there	B-X
is	B-X
a	B-X
role	B-X
for	B-X
tyrosine	B-X
kinases	B-X
downstream	B-X
of	B-X
the	B-X
LPS	B-X
receptor	B-X
.	B-X
Studies	B-X
in	B-X
mice	B-X
deficient	B-X
in	B-X
Bruton	B-X
's	B-X
tyrosine	B-X
kinase	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
they	B-X
are	B-X
defective	B-X
in	B-X
their	B-X
responses	B-X
to	B-X
LPS	B-X
.	B-X
Further	B-X
investigation	B-X
into	B-X
the	B-X
role	B-X
of	B-X
Btk	B-X
in	B-X
LPS	B-X
signalling	B-X
has	B-X
directly	B-X
implicated	B-X
Btk	B-X
downstream	B-X
of	B-X
TLR4	B-X
,	B-X
both	B-X
with	B-X
respect	B-X
to	B-X
p38	B-X
MAPK	B-X
activation	B-X
and	B-X
activation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
NFkappaB	B-X
.	B-X
In	B-X
fact	B-X
Btk	B-X
is	B-X
activated	B-X
by	B-X
LPS	B-X
and	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
directly	B-X
bind	B-X
TLR4	B-X
and	B-X
the	B-X
key	B-X
proximal	B-X
signalling	B-X
proteins	B-X
involved	B-X
in	B-X
LPS-induced	B-X
NFkappaB	B-X
activation	B-X
,	B-X
MyD88	B-X
,	B-X
Mal	B-X
and	B-X
IRAK-1	B-X
.	B-X
These	B-X
recent	B-X
findings	B-X
point	B-X
to	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
Btk	B-X
in	B-X
LPS	B-X
signal	B-X
transduction	B-X
and	B-X
raise	B-X
interesting	B-X
questions	B-X
regarding	B-X
the	B-X
mode	B-X
of	B-X
activation	B-X
of	B-X
Btk	B-X
following	B-X
LPS	B-X
stimulation	B-X
and	B-X
the	B-X
precise	B-X
nature	B-X
of	B-X
the	B-X
pathways	B-X
activated	B-X
downstream	B-X
of	B-X
Btk	B-X
.	B-X
A	B-X
better	B-X
understanding	B-X
of	B-X
how	B-X
Btk	B-X
functions	B-X
in	B-X
LPS	B-X
signalling	B-X
will	B-X
have	B-X
important	B-X
implications	B-X
for	B-X
inflammatory	B-X
and	B-X
autoimmune	B-X
disorders	B-X
and	B-X
therapies	B-X
thereof	B-X
.	B-X

Further	O
investigation	O
into	O
the	O
role	O
of	O
Btk	B-Gene_or_gene_product
in	O
LPS	O
signalling	O
has	O
directly	O
implicated	O
Btk	B-Gene_or_gene_product
downstream	O
of	O
TLR4	B-Gene_or_gene_product
,	O
both	O
with	O
respect	O
to	O
p38	B-Gene_or_gene_product
MAPK	I-Gene_or_gene_product
activation	O
and	O
activation	O
of	O
the	O
transcription	O
factor	O
NFkappaB	O
.	O
<EOS>	B-X
One	B-X
unresolved	B-X
question	B-X
regarding	B-X
LPS	B-X
signalling	B-X
is	B-X
whether	B-X
there	B-X
is	B-X
a	B-X
role	B-X
for	B-X
tyrosine	B-X
kinases	B-X
downstream	B-X
of	B-X
the	B-X
LPS	B-X
receptor	B-X
.	B-X
Studies	B-X
in	B-X
mice	B-X
deficient	B-X
in	B-X
Bruton	B-X
's	B-X
tyrosine	B-X
kinase	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
they	B-X
are	B-X
defective	B-X
in	B-X
their	B-X
responses	B-X
to	B-X
LPS	B-X
.	B-X
Further	B-X
investigation	B-X
into	B-X
the	B-X
role	B-X
of	B-X
Btk	B-X
in	B-X
LPS	B-X
signalling	B-X
has	B-X
directly	B-X
implicated	B-X
Btk	B-X
downstream	B-X
of	B-X
TLR4	B-X
,	B-X
both	B-X
with	B-X
respect	B-X
to	B-X
p38	B-X
MAPK	B-X
activation	B-X
and	B-X
activation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
NFkappaB	B-X
.	B-X
In	B-X
fact	B-X
Btk	B-X
is	B-X
activated	B-X
by	B-X
LPS	B-X
and	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
directly	B-X
bind	B-X
TLR4	B-X
and	B-X
the	B-X
key	B-X
proximal	B-X
signalling	B-X
proteins	B-X
involved	B-X
in	B-X
LPS-induced	B-X
NFkappaB	B-X
activation	B-X
,	B-X
MyD88	B-X
,	B-X
Mal	B-X
and	B-X
IRAK-1	B-X
.	B-X
These	B-X
recent	B-X
findings	B-X
point	B-X
to	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
Btk	B-X
in	B-X
LPS	B-X
signal	B-X
transduction	B-X
and	B-X
raise	B-X
interesting	B-X
questions	B-X
regarding	B-X
the	B-X
mode	B-X
of	B-X
activation	B-X
of	B-X
Btk	B-X
following	B-X
LPS	B-X
stimulation	B-X
and	B-X
the	B-X
precise	B-X
nature	B-X
of	B-X
the	B-X
pathways	B-X
activated	B-X
downstream	B-X
of	B-X
Btk	B-X
.	B-X
A	B-X
better	B-X
understanding	B-X
of	B-X
how	B-X
Btk	B-X
functions	B-X
in	B-X
LPS	B-X
signalling	B-X
will	B-X
have	B-X
important	B-X
implications	B-X
for	B-X
inflammatory	B-X
and	B-X
autoimmune	B-X
disorders	B-X
and	B-X
therapies	B-X
thereof	B-X
.	B-X

In	O
fact	O
Btk	B-Gene_or_gene_product
is	O
activated	O
by	O
LPS	O
and	O
has	O
been	O
shown	O
to	O
directly	O
bind	O
TLR4	B-Gene_or_gene_product
and	O
the	O
key	O
proximal	O
signalling	O
proteins	O
involved	O
in	O
LPS	O
-	O
induced	O
NFkappaB	O
activation	O
,	O
MyD88	B-Gene_or_gene_product
,	O
Mal	B-Gene_or_gene_product
and	O
IRAK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O

These	O
recent	O
findings	O
point	O
to	O
a	O
direct	O
role	O
for	O
Btk	B-Gene_or_gene_product
in	O
LPS	O
signal	O
transduction	O
and	O
raise	O
interesting	O
questions	O
regarding	O
the	O
mode	O
of	O
activation	O
of	O
Btk	B-Gene_or_gene_product
following	O
LPS	O
stimulation	O
and	O
the	O
precise	O
nature	O
of	O
the	O
pathways	O
activated	O
downstream	O
of	O
Btk	B-Gene_or_gene_product
.	O
<EOS>	B-X
One	B-X
unresolved	B-X
question	B-X
regarding	B-X
LPS	B-X
signalling	B-X
is	B-X
whether	B-X
there	B-X
is	B-X
a	B-X
role	B-X
for	B-X
tyrosine	B-X
kinases	B-X
downstream	B-X
of	B-X
the	B-X
LPS	B-X
receptor	B-X
.	B-X
Studies	B-X
in	B-X
mice	B-X
deficient	B-X
in	B-X
Bruton	B-X
's	B-X
tyrosine	B-X
kinase	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
they	B-X
are	B-X
defective	B-X
in	B-X
their	B-X
responses	B-X
to	B-X
LPS	B-X
.	B-X
Further	B-X
investigation	B-X
into	B-X
the	B-X
role	B-X
of	B-X
Btk	B-X
in	B-X
LPS	B-X
signalling	B-X
has	B-X
directly	B-X
implicated	B-X
Btk	B-X
downstream	B-X
of	B-X
TLR4	B-X
,	B-X
both	B-X
with	B-X
respect	B-X
to	B-X
p38	B-X
MAPK	B-X
activation	B-X
and	B-X
activation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
NFkappaB	B-X
.	B-X
In	B-X
fact	B-X
Btk	B-X
is	B-X
activated	B-X
by	B-X
LPS	B-X
and	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
directly	B-X
bind	B-X
TLR4	B-X
and	B-X
the	B-X
key	B-X
proximal	B-X
signalling	B-X
proteins	B-X
involved	B-X
in	B-X
LPS-induced	B-X
NFkappaB	B-X
activation	B-X
,	B-X
MyD88	B-X
,	B-X
Mal	B-X
and	B-X
IRAK-1	B-X
.	B-X
These	B-X
recent	B-X
findings	B-X
point	B-X
to	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
Btk	B-X
in	B-X
LPS	B-X
signal	B-X
transduction	B-X
and	B-X
raise	B-X
interesting	B-X
questions	B-X
regarding	B-X
the	B-X
mode	B-X
of	B-X
activation	B-X
of	B-X
Btk	B-X
following	B-X
LPS	B-X
stimulation	B-X
and	B-X
the	B-X
precise	B-X
nature	B-X
of	B-X
the	B-X
pathways	B-X
activated	B-X
downstream	B-X
of	B-X
Btk	B-X
.	B-X
A	B-X
better	B-X
understanding	B-X
of	B-X
how	B-X
Btk	B-X
functions	B-X
in	B-X
LPS	B-X
signalling	B-X
will	B-X
have	B-X
important	B-X
implications	B-X
for	B-X
inflammatory	B-X
and	B-X
autoimmune	B-X
disorders	B-X
and	B-X
therapies	B-X
thereof	B-X
.	B-X

A	O
better	O
understanding	O
of	O
how	O
Btk	B-Gene_or_gene_product
functions	O
in	O
LPS	O
signalling	O
will	O
have	O
important	O
implications	O
for	O
inflammatory	O
and	O
autoimmune	O
disorders	O
and	O
therapies	O
thereof	O
.	O
<EOS>	B-X
One	B-X
unresolved	B-X
question	B-X
regarding	B-X
LPS	B-X
signalling	B-X
is	B-X
whether	B-X
there	B-X
is	B-X
a	B-X
role	B-X
for	B-X
tyrosine	B-X
kinases	B-X
downstream	B-X
of	B-X
the	B-X
LPS	B-X
receptor	B-X
.	B-X
Studies	B-X
in	B-X
mice	B-X
deficient	B-X
in	B-X
Bruton	B-X
's	B-X
tyrosine	B-X
kinase	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
they	B-X
are	B-X
defective	B-X
in	B-X
their	B-X
responses	B-X
to	B-X
LPS	B-X
.	B-X
Further	B-X
investigation	B-X
into	B-X
the	B-X
role	B-X
of	B-X
Btk	B-X
in	B-X
LPS	B-X
signalling	B-X
has	B-X
directly	B-X
implicated	B-X
Btk	B-X
downstream	B-X
of	B-X
TLR4	B-X
,	B-X
both	B-X
with	B-X
respect	B-X
to	B-X
p38	B-X
MAPK	B-X
activation	B-X
and	B-X
activation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
NFkappaB	B-X
.	B-X
In	B-X
fact	B-X
Btk	B-X
is	B-X
activated	B-X
by	B-X
LPS	B-X
and	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
directly	B-X
bind	B-X
TLR4	B-X
and	B-X
the	B-X
key	B-X
proximal	B-X
signalling	B-X
proteins	B-X
involved	B-X
in	B-X
LPS-induced	B-X
NFkappaB	B-X
activation	B-X
,	B-X
MyD88	B-X
,	B-X
Mal	B-X
and	B-X
IRAK-1	B-X
.	B-X
These	B-X
recent	B-X
findings	B-X
point	B-X
to	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
Btk	B-X
in	B-X
LPS	B-X
signal	B-X
transduction	B-X
and	B-X
raise	B-X
interesting	B-X
questions	B-X
regarding	B-X
the	B-X
mode	B-X
of	B-X
activation	B-X
of	B-X
Btk	B-X
following	B-X
LPS	B-X
stimulation	B-X
and	B-X
the	B-X
precise	B-X
nature	B-X
of	B-X
the	B-X
pathways	B-X
activated	B-X
downstream	B-X
of	B-X
Btk	B-X
.	B-X
A	B-X
better	B-X
understanding	B-X
of	B-X
how	B-X
Btk	B-X
functions	B-X
in	B-X
LPS	B-X
signalling	B-X
will	B-X
have	B-X
important	B-X
implications	B-X
for	B-X
inflammatory	B-X
and	B-X
autoimmune	B-X
disorders	B-X
and	B-X
therapies	B-X
thereof	B-X
.	B-X

Molecular	O
cloning	O
and	O
characterization	O
of	O
a	O
human	O
multisubstrate	O
specific	O
nucleotide	O
-	O
sugar	O
transporter	O
homologous	O
to	O
Drosophila	O
fringe	B-Gene_or_gene_product
connection	I-Gene_or_gene_product
.	O
<EOS>	B-X
Nucleotide-sugar	B-X
transporters	B-X
are	B-X
crucial	B-X
components	B-X
in	B-X
the	B-X
synthesis	B-X
of	B-X
glycoconjugates	B-X
.	B-X
We	B-X
identified	B-X
a	B-X
novel	B-X
human	B-X
nucleotide-sugar	B-X
transporter	B-X
gene	B-X
,	B-X
hfrc1	B-X
,	B-X
which	B-X
is	B-X
homologous	B-X
to	B-X
Drosophila	B-X
melanogaster	B-X
fringe	B-X
connection	B-X
,	B-X
Caenorhabditis	B-X
elegans	B-X
sqv-7	B-X
,	B-X
and	B-X
human	B-X
UGTrel7	B-X
.	B-X
In	B-X
human	B-X
tissues	B-X
,	B-X
hfrc1	B-X
and	B-X
UGTrel7	B-X
exhibited	B-X
similar	B-X
tissue	B-X
distributions	B-X
,	B-X
although	B-X
hfrc1	B-X
transcripts	B-X
showed	B-X
a	B-X
10	B-X
times	B-X
greater	B-X
abundance	B-X
than	B-X
those	B-X
of	B-X
UGTrel7	B-X
.	B-X
The	B-X
heterologous	B-X
expression	B-X
of	B-X
HFRC1	B-X
in	B-X
the	B-X
yeast	B-X
revealed	B-X
the	B-X
multisubstrate	B-X
specific	B-X
transport	B-X
activity	B-X
of	B-X
HFRC1	B-X
(	B-X
for	B-X
UDP-N-acetylglucosamine	B-X
(	B-X
UDP-GlcNAc	B-X
)	B-X
,	B-X
UDP-glucose	B-X
(	B-X
UDP-Glc	B-X
)	B-X
,	B-X
and	B-X
GDP-mannose	B-X
(	B-X
GDP-Man	B-X
)	B-X
,	B-X
with	B-X
apparent	B-X
K	B-X
(	B-X
m	B-X
)	B-X
values	B-X
of	B-X
8.0	B-X
,	B-X
2.1	B-X
,	B-X
and	B-X
0.14	B-X
microm	B-X
,	B-X
respectively	B-X
)	B-X
.	B-X

Nucleotide	O
-	O
sugar	O
transporters	O
are	O
crucial	O
components	O
in	O
the	O
synthesis	O
of	O
glycoconjugates	O
.	O
<EOS>	B-X
The	B-X
phenolics	B-X
suppressed	B-X
the	B-X
expression	B-X
of	B-X
genes	B-X
crucial	B-X
for	B-X
carbohydrate	B-X
utilization	B-X
,	B-X
transmembrane	B-X
glucose	B-X
transport	B-X
,	B-X
tricarboxylic	B-X
acid	B-X
(	B-X
TCA	B-X
)	B-X
,	B-X
and	B-X
ATP	B-X
synthesis	B-X
.	B-X
The	B-X
phenolic-induced	B-X
stress	B-X
also	B-X
downregulated	B-X
the	B-X
expression	B-X
of	B-X
quorum	B-X
sensing	B-X
and	B-X
virulence-related	B-X
genes	B-X
,	B-X
peptidoglycan	B-X
and	B-X
phospholipid	B-X
synthases	B-X
,	B-X
and	B-X
ABC	B-X
transporters	B-X
.	B-X
Nucleotide-sugar	B-X
transporters	B-X
are	B-X
crucial	B-X
components	B-X
in	B-X
the	B-X
synthesis	B-X
of	B-X
glycoconjugates	B-X
.	B-X
We	B-X
identified	B-X
a	B-X
novel	B-X
human	B-X
nucleotide-sugar	B-X
transporter	B-X
gene	B-X
,	B-X
hfrc1	B-X
,	B-X
which	B-X
is	B-X
homologous	B-X
to	B-X
Drosophila	B-X
melanogaster	B-X
fringe	B-X
connection	B-X
,	B-X
Caenorhabditis	B-X
elegans	B-X
sqv-7	B-X
,	B-X
and	B-X
human	B-X
UGTrel7	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
HFRC1	B-X
takes	B-X
part	B-X
in	B-X
the	B-X
synthesis	B-X
of	B-X
heparan	B-X
sulfate	B-X
by	B-X
regulating	B-X
the	B-X
level	B-X
of	B-X
UDP-GlcNAc	B-X
,	B-X
a	B-X
donor	B-X
substrate	B-X
for	B-X
the	B-X
heparan	B-X
sulfate	B-X
synthases	B-X
.	B-X

We	O
identified	O
a	O
novel	O
human	O
nucleotide	O
-	O
sugar	O
transporter	O
gene	O
,	O
hfrc1	B-Gene_or_gene_product
,	O
which	O
is	O
homologous	O
to	O
Drosophila	O
melanogaster	O
fringe	B-Gene_or_gene_product
connection	I-Gene_or_gene_product
,	O
Caenorhabditis	O
elegans	O
sqv	B-Gene_or_gene_product
-	I-Gene_or_gene_product
7	I-Gene_or_gene_product
,	O
and	O
human	O
UGTrel7	B-Gene_or_gene_product
.	O
<EOS>	B-X
Nucleotide-sugar	B-X
transporters	B-X
are	B-X
crucial	B-X
components	B-X
in	B-X
the	B-X
synthesis	B-X
of	B-X
glycoconjugates	B-X
.	B-X
We	B-X
identified	B-X
a	B-X
novel	B-X
human	B-X
nucleotide-sugar	B-X
transporter	B-X
gene	B-X
,	B-X
hfrc1	B-X
,	B-X
which	B-X
is	B-X
homologous	B-X
to	B-X
Drosophila	B-X
melanogaster	B-X
fringe	B-X
connection	B-X
,	B-X
Caenorhabditis	B-X
elegans	B-X
sqv-7	B-X
,	B-X
and	B-X
human	B-X
UGTrel7	B-X
.	B-X
In	B-X
human	B-X
tissues	B-X
,	B-X
hfrc1	B-X
and	B-X
UGTrel7	B-X
exhibited	B-X
similar	B-X
tissue	B-X
distributions	B-X
,	B-X
although	B-X
hfrc1	B-X
transcripts	B-X
showed	B-X
a	B-X
10	B-X
times	B-X
greater	B-X
abundance	B-X
than	B-X
those	B-X
of	B-X
UGTrel7	B-X
.	B-X
Overexpression	B-X
of	B-X
the	B-X
hfrc1	B-X
gene	B-X
in	B-X
HCT116	B-X
cells	B-X
modulated	B-X
the	B-X
cell	B-X
surface	B-X
heparan	B-X
sulfate	B-X
expression	B-X
status	B-X
.	B-X

HFRC1	B-Gene_or_gene_product
was	O
localized	O
within	O
the	O
Golgi	O
apparatus	O
following	O
its	O
transient	O
expression	O
in	O
HCT116	O
cells	O
.	O
<EOS>	B-X
HFRC1	B-X
was	B-X
localized	B-X
within	B-X
the	B-X
Golgi	B-X
apparatus	B-X
following	B-X
its	B-X
transient	B-X
expression	B-X
in	B-X
HCT116	B-X
cells	B-X
.	B-X
The	B-X
heterologous	B-X
expression	B-X
of	B-X
HFRC1	B-X
in	B-X
the	B-X
yeast	B-X
revealed	B-X
the	B-X
multisubstrate	B-X
specific	B-X
transport	B-X
activity	B-X
of	B-X
HFRC1	B-X
(	B-X
for	B-X
UDP-N-acetylglucosamine	B-X
(	B-X
UDP-GlcNAc	B-X
)	B-X
,	B-X
UDP-glucose	B-X
(	B-X
UDP-Glc	B-X
)	B-X
,	B-X
and	B-X
GDP-mannose	B-X
(	B-X
GDP-Man	B-X
)	B-X
,	B-X
with	B-X
apparent	B-X
K	B-X
(	B-X
m	B-X
)	B-X
values	B-X
of	B-X
8.0	B-X
,	B-X
2.1	B-X
,	B-X
and	B-X
0.14	B-X
microm	B-X
,	B-X
respectively	B-X
)	B-X
.	B-X
In	B-X
the	B-X
mammalian	B-X
cells	B-X
,	B-X
HFRC1	B-X
transported	B-X
UDP-GlcNAc	B-X
and	B-X
UDP-Glc	B-X
,	B-X
but	B-X
not	B-X
GDP-Man	B-X
.	B-X
Overexpression	B-X
of	B-X
the	B-X
hfrc1	B-X
gene	B-X
in	B-X
HCT116	B-X
cells	B-X
modulated	B-X
the	B-X
cell	B-X
surface	B-X
heparan	B-X
sulfate	B-X
expression	B-X
status	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
HFRC1	B-X
takes	B-X
part	B-X
in	B-X
the	B-X
synthesis	B-X
of	B-X
heparan	B-X
sulfate	B-X
by	B-X
regulating	B-X
the	B-X
level	B-X
of	B-X
UDP-GlcNAc	B-X
,	B-X
a	B-X
donor	B-X
substrate	B-X
for	B-X
the	B-X
heparan	B-X
sulfate	B-X
synthases	B-X
.	B-X

In	O
human	O
tissues	O
,	O
hfrc1	B-Gene_or_gene_product
and	O
UGTrel7	B-Gene_or_gene_product
exhibited	O
similar	O
tissue	O
distributions	O
,	O
although	O
hfrc1	B-Gene_or_gene_product
transcripts	O
showed	O
a	O
10	O
times	O
greater	O
abundance	O
than	O
those	O
of	O
UGTrel7	B-Gene_or_gene_product
.	O
<EOS>	B-X
We	B-X
identified	B-X
a	B-X
novel	B-X
human	B-X
nucleotide-sugar	B-X
transporter	B-X
gene	B-X
,	B-X
hfrc1	B-X
,	B-X
which	B-X
is	B-X
homologous	B-X
to	B-X
Drosophila	B-X
melanogaster	B-X
fringe	B-X
connection	B-X
,	B-X
Caenorhabditis	B-X
elegans	B-X
sqv-7	B-X
,	B-X
and	B-X
human	B-X
UGTrel7	B-X
.	B-X
In	B-X
human	B-X
tissues	B-X
,	B-X
hfrc1	B-X
and	B-X
UGTrel7	B-X
exhibited	B-X
similar	B-X
tissue	B-X
distributions	B-X
,	B-X
although	B-X
hfrc1	B-X
transcripts	B-X
showed	B-X
a	B-X
10	B-X
times	B-X
greater	B-X
abundance	B-X
than	B-X
those	B-X
of	B-X
UGTrel7	B-X
.	B-X
Overexpression	B-X
of	B-X
the	B-X
hfrc1	B-X
gene	B-X
in	B-X
HCT116	B-X
cells	B-X
modulated	B-X
the	B-X
cell	B-X
surface	B-X
heparan	B-X
sulfate	B-X
expression	B-X
status	B-X
.	B-X

The	O
heterologous	O
expression	O
of	O
HFRC1	B-Gene_or_gene_product
in	O
the	O
yeast	O
revealed	O
the	O
multisubstrate	O
specific	O
transport	O
activity	O
of	O
HFRC1	B-Gene_or_gene_product
(	O
for	O
UDP	O
-	O
N	O
-	O
acetylglucosamine	O
(	O
UDP	O
-	O
GlcNAc	O
)	O
,	O
UDP	O
-	O
glucose	O
(	O
UDP	O
-	O
Glc	O
)	O
,	O
and	O
GDP	O
-	O
mannose	O
(	O
GDP	O
-	O
Man	O
)	O
,	O
with	O
apparent	O
K	O
(	O
m	O
)	O
values	O
of	O
8	O
.	O
0	O
,	O
2	O
.	O
1	O
,	O
and	O
0	O
.	O
14	O
microm	O
,	O
respectively	O
)	O
.	O

In	O
the	O
mammalian	O
cells	O
,	O
HFRC1	B-Gene_or_gene_product
transported	O
UDP	O
-	O
GlcNAc	O
and	O
UDP	O
-	O
Glc	O
,	O
but	O
not	O
GDP	O
-	O
Man	O
.	O

Overexpression	O
of	O
the	O
hfrc1	B-Gene_or_gene_product
gene	O
in	O
HCT116	O
cells	O
modulated	O
the	O
cell	O
surface	O
heparan	O
sulfate	O
expression	O
status	O
.	O
<EOS>	B-X
We	B-X
identified	B-X
a	B-X
novel	B-X
human	B-X
nucleotide-sugar	B-X
transporter	B-X
gene	B-X
,	B-X
hfrc1	B-X
,	B-X
which	B-X
is	B-X
homologous	B-X
to	B-X
Drosophila	B-X
melanogaster	B-X
fringe	B-X
connection	B-X
,	B-X
Caenorhabditis	B-X
elegans	B-X
sqv-7	B-X
,	B-X
and	B-X
human	B-X
UGTrel7	B-X
.	B-X
HFRC1	B-X
was	B-X
localized	B-X
within	B-X
the	B-X
Golgi	B-X
apparatus	B-X
following	B-X
its	B-X
transient	B-X
expression	B-X
in	B-X
HCT116	B-X
cells	B-X
.	B-X
In	B-X
human	B-X
tissues	B-X
,	B-X
hfrc1	B-X
and	B-X
UGTrel7	B-X
exhibited	B-X
similar	B-X
tissue	B-X
distributions	B-X
,	B-X
although	B-X
hfrc1	B-X
transcripts	B-X
showed	B-X
a	B-X
10	B-X
times	B-X
greater	B-X
abundance	B-X
than	B-X
those	B-X
of	B-X
UGTrel7	B-X
.	B-X
The	B-X
heterologous	B-X
expression	B-X
of	B-X
HFRC1	B-X
in	B-X
the	B-X
yeast	B-X
revealed	B-X
the	B-X
multisubstrate	B-X
specific	B-X
transport	B-X
activity	B-X
of	B-X
HFRC1	B-X
(	B-X
for	B-X
UDP-N-acetylglucosamine	B-X
(	B-X
UDP-GlcNAc	B-X
)	B-X
,	B-X
UDP-glucose	B-X
(	B-X
UDP-Glc	B-X
)	B-X
,	B-X
and	B-X
GDP-mannose	B-X
(	B-X
GDP-Man	B-X
)	B-X
,	B-X
with	B-X
apparent	B-X
K	B-X
(	B-X
m	B-X
)	B-X
values	B-X
of	B-X
8.0	B-X
,	B-X
2.1	B-X
,	B-X
and	B-X
0.14	B-X
microm	B-X
,	B-X
respectively	B-X
)	B-X
.	B-X
In	B-X
the	B-X
mammalian	B-X
cells	B-X
,	B-X
HFRC1	B-X
transported	B-X
UDP-GlcNAc	B-X
and	B-X
UDP-Glc	B-X
,	B-X
but	B-X
not	B-X
GDP-Man	B-X
.	B-X
Overexpression	B-X
of	B-X
the	B-X
hfrc1	B-X
gene	B-X
in	B-X
HCT116	B-X
cells	B-X
modulated	B-X
the	B-X
cell	B-X
surface	B-X
heparan	B-X
sulfate	B-X
expression	B-X
status	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
HFRC1	B-X
takes	B-X
part	B-X
in	B-X
the	B-X
synthesis	B-X
of	B-X
heparan	B-X
sulfate	B-X
by	B-X
regulating	B-X
the	B-X
level	B-X
of	B-X
UDP-GlcNAc	B-X
,	B-X
a	B-X
donor	B-X
substrate	B-X
for	B-X
the	B-X
heparan	B-X
sulfate	B-X
synthases	B-X
.	B-X

These	O
results	O
suggest	O
that	O
HFRC1	B-Gene_or_gene_product
takes	O
part	O
in	O
the	O
synthesis	O
of	O
heparan	O
sulfate	O
by	O
regulating	O
the	O
level	O
of	O
UDP	O
-	O
GlcNAc	O
,	O
a	O
donor	O
substrate	O
for	O
the	O
heparan	O
sulfate	O
synthases	O
.	O
<EOS>	B-X
Nucleotide-sugar	B-X
transporters	B-X
are	B-X
crucial	B-X
components	B-X
in	B-X
the	B-X
synthesis	B-X
of	B-X
glycoconjugates	B-X
.	B-X
HFRC1	B-X
was	B-X
localized	B-X
within	B-X
the	B-X
Golgi	B-X
apparatus	B-X
following	B-X
its	B-X
transient	B-X
expression	B-X
in	B-X
HCT116	B-X
cells	B-X
.	B-X
The	B-X
heterologous	B-X
expression	B-X
of	B-X
HFRC1	B-X
in	B-X
the	B-X
yeast	B-X
revealed	B-X
the	B-X
multisubstrate	B-X
specific	B-X
transport	B-X
activity	B-X
of	B-X
HFRC1	B-X
(	B-X
for	B-X
UDP-N-acetylglucosamine	B-X
(	B-X
UDP-GlcNAc	B-X
)	B-X
,	B-X
UDP-glucose	B-X
(	B-X
UDP-Glc	B-X
)	B-X
,	B-X
and	B-X
GDP-mannose	B-X
(	B-X
GDP-Man	B-X
)	B-X
,	B-X
with	B-X
apparent	B-X
K	B-X
(	B-X
m	B-X
)	B-X
values	B-X
of	B-X
8.0	B-X
,	B-X
2.1	B-X
,	B-X
and	B-X
0.14	B-X
microm	B-X
,	B-X
respectively	B-X
)	B-X
.	B-X
In	B-X
the	B-X
mammalian	B-X
cells	B-X
,	B-X
HFRC1	B-X
transported	B-X
UDP-GlcNAc	B-X
and	B-X
UDP-Glc	B-X
,	B-X
but	B-X
not	B-X
GDP-Man	B-X
.	B-X
Overexpression	B-X
of	B-X
the	B-X
hfrc1	B-X
gene	B-X
in	B-X
HCT116	B-X
cells	B-X
modulated	B-X
the	B-X
cell	B-X
surface	B-X
heparan	B-X
sulfate	B-X
expression	B-X
status	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
HFRC1	B-X
takes	B-X
part	B-X
in	B-X
the	B-X
synthesis	B-X
of	B-X
heparan	B-X
sulfate	B-X
by	B-X
regulating	B-X
the	B-X
level	B-X
of	B-X
UDP-GlcNAc	B-X
,	B-X
a	B-X
donor	B-X
substrate	B-X
for	B-X
the	B-X
heparan	B-X
sulfate	B-X
synthases	B-X
.	B-X

Hierarchical	O
requirement	O
of	O
SWI	O
/	O
SNF	O
in	O
retinoblastoma	B-Gene_or_gene_product
tumor	O
suppressor	O
-	O
mediated	O
repression	O
of	O
Plk1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Plk1	B-X
(	B-X
Polo-like	B-X
kinase	B-X
1	B-X
)	B-X
is	B-X
a	B-X
critical	B-X
regulator	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
that	B-X
harbors	B-X
oncogenic	B-X
activity	B-X
and	B-X
exhibits	B-X
aberrant	B-X
expression	B-X
in	B-X
multiple	B-X
tumors	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
Plk1	B-X
expression	B-X
is	B-X
regulated	B-X
has	B-X
not	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
(	B-X
RB	B-X
)	B-X
pathway	B-X
.	B-X
Activation	B-X
of	B-X
RB	B-X
and	B-X
related	B-X
pocket	B-X
proteins	B-X
p107/p130	B-X
mediate	B-X
attenuation	B-X
of	B-X
Plk1	B-X
.	B-X
Conversely	B-X
,	B-X
RB	B-X
loss	B-X
deregulates	B-X
the	B-X
control	B-X
of	B-X
Plk1	B-X
expression	B-X
.	B-X
RB	B-X
pathway	B-X
activation	B-X
resulted	B-X
in	B-X
the	B-X
repression	B-X
of	B-X
Plk1	B-X
promoter	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
action	B-X
was	B-X
dependent	B-X
on	B-X
the	B-X
SWI/SNF	B-X
chromatin	B-X
remodeling	B-X
complex	B-X
.	B-X
Although	B-X
SWI/SNF	B-X
subunits	B-X
are	B-X
lost	B-X
during	B-X
tumorigenesis	B-X
and	B-X
cooperate	B-X
with	B-X
RB	B-X
for	B-X
transcriptional	B-X
repression	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
SWI/SNF	B-X
impinges	B-X
on	B-X
RB	B-X
action	B-X
is	B-X
unresolved	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
delineated	B-X
the	B-X
requirement	B-X
of	B-X
SWI/SNF	B-X
for	B-X
three	B-X
critical	B-X
facets	B-X
of	B-X
Plk1	B-X
promoter	B-X
regulation	B-X
:	B-X
transcription	B-X
factor	B-X
binding	B-X
,	B-X
corepressor	B-X
binding	B-X
,	B-X
and	B-X
histone	B-X
modification	B-X
.	B-X
We	B-X
find	B-X
that	B-X
E2F4	B-X
and	B-X
pocket	B-X
protein	B-X
association	B-X
with	B-X
the	B-X
Plk1	B-X
promoter	B-X
is	B-X
independent	B-X
of	B-X
SWI/SNF	B-X
.	B-X
However	B-X
,	B-X
these	B-X
analyses	B-X
revealed	B-X
that	B-X
SWI/SNF	B-X
is	B-X
required	B-X
for	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
.	B-X
The	B-X
importance	B-X
of	B-X
SWI/SNF-dependent	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
was	B-X
evident	B-X
,	B-X
because	B-X
blockade	B-X
of	B-X
this	B-X
event	B-X
restored	B-X
Plk1	B-X
expression	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
active	B-X
RB	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
data	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
RB	B-X
pathway	B-X
.	B-X
Moreover	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
hierarchical	B-X
role	B-X
for	B-X
SWI/SNF	B-X
in	B-X
the	B-X
control	B-X
of	B-X
promoter	B-X
activity	B-X
through	B-X
histone	B-X
modification	B-X
.	B-X

Plk1	B-Gene_or_gene_product
(	O
Polo	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
is	O
a	O
critical	O
regulator	O
of	O
cell	O
cycle	O
progression	O
that	O
harbors	O
oncogenic	O
activity	O
and	O
exhibits	O
aberrant	O
expression	O
in	O
multiple	O
tumors	O
.	O
<EOS>	B-X
Plk1	B-X
(	B-X
Polo-like	B-X
kinase	B-X
1	B-X
)	B-X
is	B-X
a	B-X
critical	B-X
regulator	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
that	B-X
harbors	B-X
oncogenic	B-X
activity	B-X
and	B-X
exhibits	B-X
aberrant	B-X
expression	B-X
in	B-X
multiple	B-X
tumors	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
Plk1	B-X
expression	B-X
is	B-X
regulated	B-X
has	B-X
not	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
(	B-X
RB	B-X
)	B-X
pathway	B-X
.	B-X
Activation	B-X
of	B-X
RB	B-X
and	B-X
related	B-X
pocket	B-X
proteins	B-X
p107/p130	B-X
mediate	B-X
attenuation	B-X
of	B-X
Plk1	B-X
.	B-X
Conversely	B-X
,	B-X
RB	B-X
loss	B-X
deregulates	B-X
the	B-X
control	B-X
of	B-X
Plk1	B-X
expression	B-X
.	B-X
RB	B-X
pathway	B-X
activation	B-X
resulted	B-X
in	B-X
the	B-X
repression	B-X
of	B-X
Plk1	B-X
promoter	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
action	B-X
was	B-X
dependent	B-X
on	B-X
the	B-X
SWI/SNF	B-X
chromatin	B-X
remodeling	B-X
complex	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
delineated	B-X
the	B-X
requirement	B-X
of	B-X
SWI/SNF	B-X
for	B-X
three	B-X
critical	B-X
facets	B-X
of	B-X
Plk1	B-X
promoter	B-X
regulation	B-X
:	B-X
transcription	B-X
factor	B-X
binding	B-X
,	B-X
corepressor	B-X
binding	B-X
,	B-X
and	B-X
histone	B-X
modification	B-X
.	B-X
We	B-X
find	B-X
that	B-X
E2F4	B-X
and	B-X
pocket	B-X
protein	B-X
association	B-X
with	B-X
the	B-X
Plk1	B-X
promoter	B-X
is	B-X
independent	B-X
of	B-X
SWI/SNF	B-X
.	B-X
However	B-X
,	B-X
these	B-X
analyses	B-X
revealed	B-X
that	B-X
SWI/SNF	B-X
is	B-X
required	B-X
for	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
.	B-X
The	B-X
importance	B-X
of	B-X
SWI/SNF-dependent	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
was	B-X
evident	B-X
,	B-X
because	B-X
blockade	B-X
of	B-X
this	B-X
event	B-X
restored	B-X
Plk1	B-X
expression	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
active	B-X
RB	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
data	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
RB	B-X
pathway	B-X
.	B-X
Moreover	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
hierarchical	B-X
role	B-X
for	B-X
SWI/SNF	B-X
in	B-X
the	B-X
control	B-X
of	B-X
promoter	B-X
activity	B-X
through	B-X
histone	B-X
modification	B-X
.	B-X

However	O
,	O
the	O
mechanism	O
through	O
which	O
Plk1	B-Gene_or_gene_product
expression	O
is	O
regulated	O
has	O
not	O
been	O
extensively	O
studied	O
.	O
<EOS>	B-X
Polo-like	B-X
kinase	B-X
1	B-X
(	B-X
Plk1	B-X
)	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
cell-cycle	B-X
regulation	B-X
.	B-X
Recent	B-X
work	B-X
has	B-X
suggested	B-X
that	B-X
Plk1	B-X
could	B-X
be	B-X
a	B-X
biomarker	B-X
of	B-X
gemcitabine	B-X
response	B-X
in	B-X
pancreatic	B-X
ductal	B-X
adenocarcinoma	B-X
(	B-X
PDAC	B-X
)	B-X
.	B-X
Although	B-X
targeting	B-X
Plk1	B-X
to	B-X
treat	B-X
PDAC	B-X
has	B-X
been	B-X
attempted	B-X
in	B-X
clinical	B-X
trials	B-X
,	B-X
the	B-X
results	B-X
were	B-X
not	B-X
promising	B-X
,	B-X
and	B-X
the	B-X
mechanisms	B-X
of	B-X
resistance	B-X
to	B-X
Plk1	B-X
inhibition	B-X
is	B-X
poorly	B-X
understood	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
role	B-X
of	B-X
Plk1	B-X
in	B-X
PDAC	B-X
progression	B-X
requires	B-X
further	B-X
elucidation	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
Plk1	B-X
was	B-X
associated	B-X
with	B-X
poor	B-X
outcomes	B-X
in	B-X
patients	B-X
with	B-X
PDAC	B-X
.	B-X
In	B-X
an	B-X
inducible	B-X
transgenic	B-X
mouse	B-X
line	B-X
with	B-X
specific	B-X
expression	B-X
of	B-X
Plk1	B-X
in	B-X
the	B-X
pancreas	B-X
,	B-X
Plk1	B-X
overexpression	B-X
significantly	B-X
inhibited	B-X
caerulein-induced	B-X
acute	B-X
pancreatitis	B-X
and	B-X
delayed	B-X
development	B-X
of	B-X
acinar-to-ductal	B-X
metaplasia	B-X
and	B-X
pancreatic	B-X
intraepithelial	B-X
neoplasia	B-X
.	B-X
Bioinformatics	B-X
analyses	B-X
identified	B-X
the	B-X
regulatory	B-X
networks	B-X
in	B-X
which	B-X
Plk1	B-X
is	B-X
involved	B-X
in	B-X
PDAC	B-X
disease	B-X
progression	B-X
,	B-X
including	B-X
multiple	B-X
inflammation-related	B-X
pathways	B-X
.	B-X
Unexpectedly	B-X
,	B-X
inhibition	B-X
or	B-X
depletion	B-X
of	B-X
Plk1	B-X
resulted	B-X
in	B-X
upregulation	B-X
of	B-X
PD-L1	B-X
via	B-X
activation	B-X
of	B-X
the	B-X
NF-κB	B-X
pathway	B-X
.	B-X
Mechanistically	B-X
,	B-X
Plk1-mediated	B-X
phosphorylation	B-X
of	B-X
RB	B-X
at	B-X
S758	B-X
inhibited	B-X
the	B-X
translocation	B-X
of	B-X
NF-κB	B-X
to	B-X
nucleus	B-X
,	B-X
inactivating	B-X
the	B-X
pathway	B-X
.	B-X
Inhibition	B-X
of	B-X
Plk1	B-X
sensitized	B-X
PDAC	B-X
to	B-X
immune	B-X
checkpoint	B-X
blockade	B-X
therapy	B-X
through	B-X
activation	B-X
of	B-X
an	B-X
antitumor	B-X
immune	B-X
response	B-X
.	B-X
Together	B-X
,	B-X
Plk1	B-X
suppresses	B-X
PDAC	B-X
progression	B-X
and	B-X
inhibits	B-X
NF-κB	B-X
activity	B-X
,	B-X
and	B-X
targeting	B-X
Plk1	B-X
can	B-X
potentiate	B-X
the	B-X
efficacy	B-X
of	B-X
immunotherapy	B-X
in	B-X
PDAC	B-X
.	B-X

Here	O
we	O
demonstrate	O
that	O
Plk1	B-Gene_or_gene_product
is	O
a	O
target	O
of	O
the	O
retinoblastoma	B-Gene_or_gene_product
tumor	O
suppressor	O
(	O
RB	B-Gene_or_gene_product
)	O
pathway	O
.	O
<EOS>	B-X
Plk1	B-X
(	B-X
Polo-like	B-X
kinase	B-X
1	B-X
)	B-X
is	B-X
a	B-X
critical	B-X
regulator	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
that	B-X
harbors	B-X
oncogenic	B-X
activity	B-X
and	B-X
exhibits	B-X
aberrant	B-X
expression	B-X
in	B-X
multiple	B-X
tumors	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
Plk1	B-X
expression	B-X
is	B-X
regulated	B-X
has	B-X
not	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
(	B-X
RB	B-X
)	B-X
pathway	B-X
.	B-X
Activation	B-X
of	B-X
RB	B-X
and	B-X
related	B-X
pocket	B-X
proteins	B-X
p107/p130	B-X
mediate	B-X
attenuation	B-X
of	B-X
Plk1	B-X
.	B-X
Conversely	B-X
,	B-X
RB	B-X
loss	B-X
deregulates	B-X
the	B-X
control	B-X
of	B-X
Plk1	B-X
expression	B-X
.	B-X
RB	B-X
pathway	B-X
activation	B-X
resulted	B-X
in	B-X
the	B-X
repression	B-X
of	B-X
Plk1	B-X
promoter	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
action	B-X
was	B-X
dependent	B-X
on	B-X
the	B-X
SWI/SNF	B-X
chromatin	B-X
remodeling	B-X
complex	B-X
.	B-X
Although	B-X
SWI/SNF	B-X
subunits	B-X
are	B-X
lost	B-X
during	B-X
tumorigenesis	B-X
and	B-X
cooperate	B-X
with	B-X
RB	B-X
for	B-X
transcriptional	B-X
repression	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
SWI/SNF	B-X
impinges	B-X
on	B-X
RB	B-X
action	B-X
is	B-X
unresolved	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
delineated	B-X
the	B-X
requirement	B-X
of	B-X
SWI/SNF	B-X
for	B-X
three	B-X
critical	B-X
facets	B-X
of	B-X
Plk1	B-X
promoter	B-X
regulation	B-X
:	B-X
transcription	B-X
factor	B-X
binding	B-X
,	B-X
corepressor	B-X
binding	B-X
,	B-X
and	B-X
histone	B-X
modification	B-X
.	B-X
We	B-X
find	B-X
that	B-X
E2F4	B-X
and	B-X
pocket	B-X
protein	B-X
association	B-X
with	B-X
the	B-X
Plk1	B-X
promoter	B-X
is	B-X
independent	B-X
of	B-X
SWI/SNF	B-X
.	B-X
However	B-X
,	B-X
these	B-X
analyses	B-X
revealed	B-X
that	B-X
SWI/SNF	B-X
is	B-X
required	B-X
for	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
.	B-X
The	B-X
importance	B-X
of	B-X
SWI/SNF-dependent	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
was	B-X
evident	B-X
,	B-X
because	B-X
blockade	B-X
of	B-X
this	B-X
event	B-X
restored	B-X
Plk1	B-X
expression	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
active	B-X
RB	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
data	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
RB	B-X
pathway	B-X
.	B-X
Moreover	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
hierarchical	B-X
role	B-X
for	B-X
SWI/SNF	B-X
in	B-X
the	B-X
control	B-X
of	B-X
promoter	B-X
activity	B-X
through	B-X
histone	B-X
modification	B-X
.	B-X

Activation	O
of	O
RB	B-Gene_or_gene_product
and	O
related	O
pocket	O
proteins	O
p107	B-Gene_or_gene_product
/	O
p130	B-Gene_or_gene_product
mediate	O
attenuation	O
of	O
Plk1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Plk1	B-X
(	B-X
Polo-like	B-X
kinase	B-X
1	B-X
)	B-X
is	B-X
a	B-X
critical	B-X
regulator	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
that	B-X
harbors	B-X
oncogenic	B-X
activity	B-X
and	B-X
exhibits	B-X
aberrant	B-X
expression	B-X
in	B-X
multiple	B-X
tumors	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
Plk1	B-X
expression	B-X
is	B-X
regulated	B-X
has	B-X
not	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
(	B-X
RB	B-X
)	B-X
pathway	B-X
.	B-X
Activation	B-X
of	B-X
RB	B-X
and	B-X
related	B-X
pocket	B-X
proteins	B-X
p107/p130	B-X
mediate	B-X
attenuation	B-X
of	B-X
Plk1	B-X
.	B-X
Conversely	B-X
,	B-X
RB	B-X
loss	B-X
deregulates	B-X
the	B-X
control	B-X
of	B-X
Plk1	B-X
expression	B-X
.	B-X
RB	B-X
pathway	B-X
activation	B-X
resulted	B-X
in	B-X
the	B-X
repression	B-X
of	B-X
Plk1	B-X
promoter	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
action	B-X
was	B-X
dependent	B-X
on	B-X
the	B-X
SWI/SNF	B-X
chromatin	B-X
remodeling	B-X
complex	B-X
.	B-X
Although	B-X
SWI/SNF	B-X
subunits	B-X
are	B-X
lost	B-X
during	B-X
tumorigenesis	B-X
and	B-X
cooperate	B-X
with	B-X
RB	B-X
for	B-X
transcriptional	B-X
repression	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
SWI/SNF	B-X
impinges	B-X
on	B-X
RB	B-X
action	B-X
is	B-X
unresolved	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
delineated	B-X
the	B-X
requirement	B-X
of	B-X
SWI/SNF	B-X
for	B-X
three	B-X
critical	B-X
facets	B-X
of	B-X
Plk1	B-X
promoter	B-X
regulation	B-X
:	B-X
transcription	B-X
factor	B-X
binding	B-X
,	B-X
corepressor	B-X
binding	B-X
,	B-X
and	B-X
histone	B-X
modification	B-X
.	B-X
We	B-X
find	B-X
that	B-X
E2F4	B-X
and	B-X
pocket	B-X
protein	B-X
association	B-X
with	B-X
the	B-X
Plk1	B-X
promoter	B-X
is	B-X
independent	B-X
of	B-X
SWI/SNF	B-X
.	B-X
However	B-X
,	B-X
these	B-X
analyses	B-X
revealed	B-X
that	B-X
SWI/SNF	B-X
is	B-X
required	B-X
for	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
.	B-X
The	B-X
importance	B-X
of	B-X
SWI/SNF-dependent	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
was	B-X
evident	B-X
,	B-X
because	B-X
blockade	B-X
of	B-X
this	B-X
event	B-X
restored	B-X
Plk1	B-X
expression	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
active	B-X
RB	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
data	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
RB	B-X
pathway	B-X
.	B-X

Conversely	O
,	O
RB	B-Gene_or_gene_product
loss	O
deregulates	O
the	O
control	O
of	O
Plk1	B-Gene_or_gene_product
expression	O
.	O
<EOS>	B-X
Plk1	B-X
(	B-X
Polo-like	B-X
kinase	B-X
1	B-X
)	B-X
is	B-X
a	B-X
critical	B-X
regulator	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
that	B-X
harbors	B-X
oncogenic	B-X
activity	B-X
and	B-X
exhibits	B-X
aberrant	B-X
expression	B-X
in	B-X
multiple	B-X
tumors	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
Plk1	B-X
expression	B-X
is	B-X
regulated	B-X
has	B-X
not	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
(	B-X
RB	B-X
)	B-X
pathway	B-X
.	B-X
Activation	B-X
of	B-X
RB	B-X
and	B-X
related	B-X
pocket	B-X
proteins	B-X
p107/p130	B-X
mediate	B-X
attenuation	B-X
of	B-X
Plk1	B-X
.	B-X
Conversely	B-X
,	B-X
RB	B-X
loss	B-X
deregulates	B-X
the	B-X
control	B-X
of	B-X
Plk1	B-X
expression	B-X
.	B-X
RB	B-X
pathway	B-X
activation	B-X
resulted	B-X
in	B-X
the	B-X
repression	B-X
of	B-X
Plk1	B-X
promoter	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
action	B-X
was	B-X
dependent	B-X
on	B-X
the	B-X
SWI/SNF	B-X
chromatin	B-X
remodeling	B-X
complex	B-X
.	B-X
Although	B-X
SWI/SNF	B-X
subunits	B-X
are	B-X
lost	B-X
during	B-X
tumorigenesis	B-X
and	B-X
cooperate	B-X
with	B-X
RB	B-X
for	B-X
transcriptional	B-X
repression	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
SWI/SNF	B-X
impinges	B-X
on	B-X
RB	B-X
action	B-X
is	B-X
unresolved	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
delineated	B-X
the	B-X
requirement	B-X
of	B-X
SWI/SNF	B-X
for	B-X
three	B-X
critical	B-X
facets	B-X
of	B-X
Plk1	B-X
promoter	B-X
regulation	B-X
:	B-X
transcription	B-X
factor	B-X
binding	B-X
,	B-X
corepressor	B-X
binding	B-X
,	B-X
and	B-X
histone	B-X
modification	B-X
.	B-X
We	B-X
find	B-X
that	B-X
E2F4	B-X
and	B-X
pocket	B-X
protein	B-X
association	B-X
with	B-X
the	B-X
Plk1	B-X
promoter	B-X
is	B-X
independent	B-X
of	B-X
SWI/SNF	B-X
.	B-X
However	B-X
,	B-X
these	B-X
analyses	B-X
revealed	B-X
that	B-X
SWI/SNF	B-X
is	B-X
required	B-X
for	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
.	B-X
The	B-X
importance	B-X
of	B-X
SWI/SNF-dependent	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
was	B-X
evident	B-X
,	B-X
because	B-X
blockade	B-X
of	B-X
this	B-X
event	B-X
restored	B-X
Plk1	B-X
expression	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
active	B-X
RB	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
data	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
RB	B-X
pathway	B-X
.	B-X
Moreover	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
hierarchical	B-X
role	B-X
for	B-X
SWI/SNF	B-X
in	B-X
the	B-X
control	B-X
of	B-X
promoter	B-X
activity	B-X
through	B-X
histone	B-X
modification	B-X
.	B-X

RB	B-Gene_or_gene_product
pathway	O
activation	O
resulted	O
in	O
the	O
repression	O
of	O
Plk1	B-Gene_or_gene_product
promoter	O
activity	O
,	O
and	O
this	O
action	O
was	O
dependent	O
on	O
the	O
SWI	O
/	O
SNF	O
chromatin	O
remodeling	O
complex	O
.	O
<EOS>	B-X
Plk1	B-X
(	B-X
Polo-like	B-X
kinase	B-X
1	B-X
)	B-X
is	B-X
a	B-X
critical	B-X
regulator	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
that	B-X
harbors	B-X
oncogenic	B-X
activity	B-X
and	B-X
exhibits	B-X
aberrant	B-X
expression	B-X
in	B-X
multiple	B-X
tumors	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
Plk1	B-X
expression	B-X
is	B-X
regulated	B-X
has	B-X
not	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
(	B-X
RB	B-X
)	B-X
pathway	B-X
.	B-X
Activation	B-X
of	B-X
RB	B-X
and	B-X
related	B-X
pocket	B-X
proteins	B-X
p107/p130	B-X
mediate	B-X
attenuation	B-X
of	B-X
Plk1	B-X
.	B-X
Conversely	B-X
,	B-X
RB	B-X
loss	B-X
deregulates	B-X
the	B-X
control	B-X
of	B-X
Plk1	B-X
expression	B-X
.	B-X
RB	B-X
pathway	B-X
activation	B-X
resulted	B-X
in	B-X
the	B-X
repression	B-X
of	B-X
Plk1	B-X
promoter	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
action	B-X
was	B-X
dependent	B-X
on	B-X
the	B-X
SWI/SNF	B-X
chromatin	B-X
remodeling	B-X
complex	B-X
.	B-X
Although	B-X
SWI/SNF	B-X
subunits	B-X
are	B-X
lost	B-X
during	B-X
tumorigenesis	B-X
and	B-X
cooperate	B-X
with	B-X
RB	B-X
for	B-X
transcriptional	B-X
repression	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
SWI/SNF	B-X
impinges	B-X
on	B-X
RB	B-X
action	B-X
is	B-X
unresolved	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
delineated	B-X
the	B-X
requirement	B-X
of	B-X
SWI/SNF	B-X
for	B-X
three	B-X
critical	B-X
facets	B-X
of	B-X
Plk1	B-X
promoter	B-X
regulation	B-X
:	B-X
transcription	B-X
factor	B-X
binding	B-X
,	B-X
corepressor	B-X
binding	B-X
,	B-X
and	B-X
histone	B-X
modification	B-X
.	B-X
We	B-X
find	B-X
that	B-X
E2F4	B-X
and	B-X
pocket	B-X
protein	B-X
association	B-X
with	B-X
the	B-X
Plk1	B-X
promoter	B-X
is	B-X
independent	B-X
of	B-X
SWI/SNF	B-X
.	B-X
However	B-X
,	B-X
these	B-X
analyses	B-X
revealed	B-X
that	B-X
SWI/SNF	B-X
is	B-X
required	B-X
for	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
.	B-X
The	B-X
importance	B-X
of	B-X
SWI/SNF-dependent	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
was	B-X
evident	B-X
,	B-X
because	B-X
blockade	B-X
of	B-X
this	B-X
event	B-X
restored	B-X
Plk1	B-X
expression	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
active	B-X
RB	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
data	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
RB	B-X
pathway	B-X
.	B-X
Moreover	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
hierarchical	B-X
role	B-X
for	B-X
SWI/SNF	B-X
in	B-X
the	B-X
control	B-X
of	B-X
promoter	B-X
activity	B-X
through	B-X
histone	B-X
modification	B-X
.	B-X

Although	O
SWI	O
/	O
SNF	O
subunits	O
are	O
lost	O
during	O
tumorigenesis	O
and	O
cooperate	O
with	O
RB	B-Gene_or_gene_product
for	O
transcriptional	O
repression	O
,	O
the	O
mechanism	O
through	O
which	O
SWI	O
/	O
SNF	O
impinges	O
on	O
RB	B-Gene_or_gene_product
action	O
is	O
unresolved	O
.	O
<EOS>	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
Plk1	B-X
expression	B-X
is	B-X
regulated	B-X
has	B-X
not	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
(	B-X
RB	B-X
)	B-X
pathway	B-X
.	B-X
Activation	B-X
of	B-X
RB	B-X
and	B-X
related	B-X
pocket	B-X
proteins	B-X
p107/p130	B-X
mediate	B-X
attenuation	B-X
of	B-X
Plk1	B-X
.	B-X
Conversely	B-X
,	B-X
RB	B-X
loss	B-X
deregulates	B-X
the	B-X
control	B-X
of	B-X
Plk1	B-X
expression	B-X
.	B-X
RB	B-X
pathway	B-X
activation	B-X
resulted	B-X
in	B-X
the	B-X
repression	B-X
of	B-X
Plk1	B-X
promoter	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
action	B-X
was	B-X
dependent	B-X
on	B-X
the	B-X
SWI/SNF	B-X
chromatin	B-X
remodeling	B-X
complex	B-X
.	B-X
Although	B-X
SWI/SNF	B-X
subunits	B-X
are	B-X
lost	B-X
during	B-X
tumorigenesis	B-X
and	B-X
cooperate	B-X
with	B-X
RB	B-X
for	B-X
transcriptional	B-X
repression	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
SWI/SNF	B-X
impinges	B-X
on	B-X
RB	B-X
action	B-X
is	B-X
unresolved	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
delineated	B-X
the	B-X
requirement	B-X
of	B-X
SWI/SNF	B-X
for	B-X
three	B-X
critical	B-X
facets	B-X
of	B-X
Plk1	B-X
promoter	B-X
regulation	B-X
:	B-X
transcription	B-X
factor	B-X
binding	B-X
,	B-X
corepressor	B-X
binding	B-X
,	B-X
and	B-X
histone	B-X
modification	B-X
.	B-X
We	B-X
find	B-X
that	B-X
E2F4	B-X
and	B-X
pocket	B-X
protein	B-X
association	B-X
with	B-X
the	B-X
Plk1	B-X
promoter	B-X
is	B-X
independent	B-X
of	B-X
SWI/SNF	B-X
.	B-X
However	B-X
,	B-X
these	B-X
analyses	B-X
revealed	B-X
that	B-X
SWI/SNF	B-X
is	B-X
required	B-X
for	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
.	B-X
The	B-X
importance	B-X
of	B-X
SWI/SNF-dependent	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
was	B-X
evident	B-X
,	B-X
because	B-X
blockade	B-X
of	B-X
this	B-X
event	B-X
restored	B-X
Plk1	B-X
expression	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
active	B-X
RB	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
data	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
RB	B-X
pathway	B-X
.	B-X
Moreover	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
hierarchical	B-X
role	B-X
for	B-X
SWI/SNF	B-X
in	B-X
the	B-X
control	B-X
of	B-X
promoter	B-X
activity	B-X
through	B-X
histone	B-X
modification	B-X
.	B-X

Therefore	O
,	O
we	O
delineated	O
the	O
requirement	O
of	O
SWI	O
/	O
SNF	O
for	O
three	O
critical	O
facets	O
of	O
Plk1	B-Gene_or_gene_product
promoter	O
regulation	O
:	O
transcription	O
factor	O
binding	O
,	O
corepressor	O
binding	O
,	O
and	O
histone	B-Gene_or_gene_product
modification	O
.	O
<EOS>	B-X
Plk1	B-X
(	B-X
Polo-like	B-X
kinase	B-X
1	B-X
)	B-X
is	B-X
a	B-X
critical	B-X
regulator	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
that	B-X
harbors	B-X
oncogenic	B-X
activity	B-X
and	B-X
exhibits	B-X
aberrant	B-X
expression	B-X
in	B-X
multiple	B-X
tumors	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
Plk1	B-X
expression	B-X
is	B-X
regulated	B-X
has	B-X
not	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
(	B-X
RB	B-X
)	B-X
pathway	B-X
.	B-X
Activation	B-X
of	B-X
RB	B-X
and	B-X
related	B-X
pocket	B-X
proteins	B-X
p107/p130	B-X
mediate	B-X
attenuation	B-X
of	B-X
Plk1	B-X
.	B-X
Conversely	B-X
,	B-X
RB	B-X
loss	B-X
deregulates	B-X
the	B-X
control	B-X
of	B-X
Plk1	B-X
expression	B-X
.	B-X
RB	B-X
pathway	B-X
activation	B-X
resulted	B-X
in	B-X
the	B-X
repression	B-X
of	B-X
Plk1	B-X
promoter	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
action	B-X
was	B-X
dependent	B-X
on	B-X
the	B-X
SWI/SNF	B-X
chromatin	B-X
remodeling	B-X
complex	B-X
.	B-X
Although	B-X
SWI/SNF	B-X
subunits	B-X
are	B-X
lost	B-X
during	B-X
tumorigenesis	B-X
and	B-X
cooperate	B-X
with	B-X
RB	B-X
for	B-X
transcriptional	B-X
repression	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
SWI/SNF	B-X
impinges	B-X
on	B-X
RB	B-X
action	B-X
is	B-X
unresolved	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
delineated	B-X
the	B-X
requirement	B-X
of	B-X
SWI/SNF	B-X
for	B-X
three	B-X
critical	B-X
facets	B-X
of	B-X
Plk1	B-X
promoter	B-X
regulation	B-X
:	B-X
transcription	B-X
factor	B-X
binding	B-X
,	B-X
corepressor	B-X
binding	B-X
,	B-X
and	B-X
histone	B-X
modification	B-X
.	B-X
We	B-X
find	B-X
that	B-X
E2F4	B-X
and	B-X
pocket	B-X
protein	B-X
association	B-X
with	B-X
the	B-X
Plk1	B-X
promoter	B-X
is	B-X
independent	B-X
of	B-X
SWI/SNF	B-X
.	B-X
However	B-X
,	B-X
these	B-X
analyses	B-X
revealed	B-X
that	B-X
SWI/SNF	B-X
is	B-X
required	B-X
for	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
.	B-X
The	B-X
importance	B-X
of	B-X
SWI/SNF-dependent	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
was	B-X
evident	B-X
,	B-X
because	B-X
blockade	B-X
of	B-X
this	B-X
event	B-X
restored	B-X
Plk1	B-X
expression	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
active	B-X
RB	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
data	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
RB	B-X
pathway	B-X
.	B-X
Moreover	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
hierarchical	B-X
role	B-X
for	B-X
SWI/SNF	B-X
in	B-X
the	B-X
control	B-X
of	B-X
promoter	B-X
activity	B-X
through	B-X
histone	B-X
modification	B-X
.	B-X

We	O
find	O
that	O
E2F4	B-Gene_or_gene_product
and	O
pocket	O
protein	O
association	O
with	O
the	O
Plk1	B-Gene_or_gene_product
promoter	O
is	O
independent	O
of	O
SWI	O
/	O
SNF	O
.	O
<EOS>	B-X
Plk1	B-X
(	B-X
Polo-like	B-X
kinase	B-X
1	B-X
)	B-X
is	B-X
a	B-X
critical	B-X
regulator	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
that	B-X
harbors	B-X
oncogenic	B-X
activity	B-X
and	B-X
exhibits	B-X
aberrant	B-X
expression	B-X
in	B-X
multiple	B-X
tumors	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
Plk1	B-X
expression	B-X
is	B-X
regulated	B-X
has	B-X
not	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
(	B-X
RB	B-X
)	B-X
pathway	B-X
.	B-X
Activation	B-X
of	B-X
RB	B-X
and	B-X
related	B-X
pocket	B-X
proteins	B-X
p107/p130	B-X
mediate	B-X
attenuation	B-X
of	B-X
Plk1	B-X
.	B-X
Conversely	B-X
,	B-X
RB	B-X
loss	B-X
deregulates	B-X
the	B-X
control	B-X
of	B-X
Plk1	B-X
expression	B-X
.	B-X
RB	B-X
pathway	B-X
activation	B-X
resulted	B-X
in	B-X
the	B-X
repression	B-X
of	B-X
Plk1	B-X
promoter	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
action	B-X
was	B-X
dependent	B-X
on	B-X
the	B-X
SWI/SNF	B-X
chromatin	B-X
remodeling	B-X
complex	B-X
.	B-X
Although	B-X
SWI/SNF	B-X
subunits	B-X
are	B-X
lost	B-X
during	B-X
tumorigenesis	B-X
and	B-X
cooperate	B-X
with	B-X
RB	B-X
for	B-X
transcriptional	B-X
repression	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
SWI/SNF	B-X
impinges	B-X
on	B-X
RB	B-X
action	B-X
is	B-X
unresolved	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
delineated	B-X
the	B-X
requirement	B-X
of	B-X
SWI/SNF	B-X
for	B-X
three	B-X
critical	B-X
facets	B-X
of	B-X
Plk1	B-X
promoter	B-X
regulation	B-X
:	B-X
transcription	B-X
factor	B-X
binding	B-X
,	B-X
corepressor	B-X
binding	B-X
,	B-X
and	B-X
histone	B-X
modification	B-X
.	B-X
We	B-X
find	B-X
that	B-X
E2F4	B-X
and	B-X
pocket	B-X
protein	B-X
association	B-X
with	B-X
the	B-X
Plk1	B-X
promoter	B-X
is	B-X
independent	B-X
of	B-X
SWI/SNF	B-X
.	B-X
However	B-X
,	B-X
these	B-X
analyses	B-X
revealed	B-X
that	B-X
SWI/SNF	B-X
is	B-X
required	B-X
for	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
.	B-X
The	B-X
importance	B-X
of	B-X
SWI/SNF-dependent	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
was	B-X
evident	B-X
,	B-X
because	B-X
blockade	B-X
of	B-X
this	B-X
event	B-X
restored	B-X
Plk1	B-X
expression	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
active	B-X
RB	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
data	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
RB	B-X
pathway	B-X
.	B-X
Moreover	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
hierarchical	B-X
role	B-X
for	B-X
SWI/SNF	B-X
in	B-X
the	B-X
control	B-X
of	B-X
promoter	B-X
activity	B-X
through	B-X
histone	B-X
modification	B-X
.	B-X

However	O
,	O
these	O
analyses	O
revealed	O
that	O
SWI	O
/	O
SNF	O
is	O
required	O
for	O
histone	B-Gene_or_gene_product
deacetylation	O
of	O
the	O
Plk1	B-Gene_or_gene_product
promoter	O
.	O
<EOS>	B-X
Plk1	B-X
(	B-X
Polo-like	B-X
kinase	B-X
1	B-X
)	B-X
is	B-X
a	B-X
critical	B-X
regulator	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
that	B-X
harbors	B-X
oncogenic	B-X
activity	B-X
and	B-X
exhibits	B-X
aberrant	B-X
expression	B-X
in	B-X
multiple	B-X
tumors	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
Plk1	B-X
expression	B-X
is	B-X
regulated	B-X
has	B-X
not	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
(	B-X
RB	B-X
)	B-X
pathway	B-X
.	B-X
Activation	B-X
of	B-X
RB	B-X
and	B-X
related	B-X
pocket	B-X
proteins	B-X
p107/p130	B-X
mediate	B-X
attenuation	B-X
of	B-X
Plk1	B-X
.	B-X
Conversely	B-X
,	B-X
RB	B-X
loss	B-X
deregulates	B-X
the	B-X
control	B-X
of	B-X
Plk1	B-X
expression	B-X
.	B-X
RB	B-X
pathway	B-X
activation	B-X
resulted	B-X
in	B-X
the	B-X
repression	B-X
of	B-X
Plk1	B-X
promoter	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
action	B-X
was	B-X
dependent	B-X
on	B-X
the	B-X
SWI/SNF	B-X
chromatin	B-X
remodeling	B-X
complex	B-X
.	B-X
Although	B-X
SWI/SNF	B-X
subunits	B-X
are	B-X
lost	B-X
during	B-X
tumorigenesis	B-X
and	B-X
cooperate	B-X
with	B-X
RB	B-X
for	B-X
transcriptional	B-X
repression	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
SWI/SNF	B-X
impinges	B-X
on	B-X
RB	B-X
action	B-X
is	B-X
unresolved	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
delineated	B-X
the	B-X
requirement	B-X
of	B-X
SWI/SNF	B-X
for	B-X
three	B-X
critical	B-X
facets	B-X
of	B-X
Plk1	B-X
promoter	B-X
regulation	B-X
:	B-X
transcription	B-X
factor	B-X
binding	B-X
,	B-X
corepressor	B-X
binding	B-X
,	B-X
and	B-X
histone	B-X
modification	B-X
.	B-X
We	B-X
find	B-X
that	B-X
E2F4	B-X
and	B-X
pocket	B-X
protein	B-X
association	B-X
with	B-X
the	B-X
Plk1	B-X
promoter	B-X
is	B-X
independent	B-X
of	B-X
SWI/SNF	B-X
.	B-X
However	B-X
,	B-X
these	B-X
analyses	B-X
revealed	B-X
that	B-X
SWI/SNF	B-X
is	B-X
required	B-X
for	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
.	B-X
The	B-X
importance	B-X
of	B-X
SWI/SNF-dependent	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
was	B-X
evident	B-X
,	B-X
because	B-X
blockade	B-X
of	B-X
this	B-X
event	B-X
restored	B-X
Plk1	B-X
expression	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
active	B-X
RB	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
data	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
RB	B-X
pathway	B-X
.	B-X
Moreover	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
hierarchical	B-X
role	B-X
for	B-X
SWI/SNF	B-X
in	B-X
the	B-X
control	B-X
of	B-X
promoter	B-X
activity	B-X
through	B-X
histone	B-X
modification	B-X
.	B-X

The	O
importance	O
of	O
SWI	O
/	O
SNF	O
-	O
dependent	O
histone	B-Gene_or_gene_product
deacetylation	O
of	O
the	O
Plk1	B-Gene_or_gene_product
promoter	O
was	O
evident	O
,	O
because	O
blockade	O
of	O
this	O
event	O
restored	O
Plk1	B-Gene_or_gene_product
expression	O
in	O
the	O
presence	O
of	O
active	O
RB	B-Gene_or_gene_product
.	O
<EOS>	B-X
Plk1	B-X
(	B-X
Polo-like	B-X
kinase	B-X
1	B-X
)	B-X
is	B-X
a	B-X
critical	B-X
regulator	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
that	B-X
harbors	B-X
oncogenic	B-X
activity	B-X
and	B-X
exhibits	B-X
aberrant	B-X
expression	B-X
in	B-X
multiple	B-X
tumors	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
Plk1	B-X
expression	B-X
is	B-X
regulated	B-X
has	B-X
not	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
(	B-X
RB	B-X
)	B-X
pathway	B-X
.	B-X
Activation	B-X
of	B-X
RB	B-X
and	B-X
related	B-X
pocket	B-X
proteins	B-X
p107/p130	B-X
mediate	B-X
attenuation	B-X
of	B-X
Plk1	B-X
.	B-X
Conversely	B-X
,	B-X
RB	B-X
loss	B-X
deregulates	B-X
the	B-X
control	B-X
of	B-X
Plk1	B-X
expression	B-X
.	B-X
RB	B-X
pathway	B-X
activation	B-X
resulted	B-X
in	B-X
the	B-X
repression	B-X
of	B-X
Plk1	B-X
promoter	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
action	B-X
was	B-X
dependent	B-X
on	B-X
the	B-X
SWI/SNF	B-X
chromatin	B-X
remodeling	B-X
complex	B-X
.	B-X
Although	B-X
SWI/SNF	B-X
subunits	B-X
are	B-X
lost	B-X
during	B-X
tumorigenesis	B-X
and	B-X
cooperate	B-X
with	B-X
RB	B-X
for	B-X
transcriptional	B-X
repression	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
SWI/SNF	B-X
impinges	B-X
on	B-X
RB	B-X
action	B-X
is	B-X
unresolved	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
delineated	B-X
the	B-X
requirement	B-X
of	B-X
SWI/SNF	B-X
for	B-X
three	B-X
critical	B-X
facets	B-X
of	B-X
Plk1	B-X
promoter	B-X
regulation	B-X
:	B-X
transcription	B-X
factor	B-X
binding	B-X
,	B-X
corepressor	B-X
binding	B-X
,	B-X
and	B-X
histone	B-X
modification	B-X
.	B-X
We	B-X
find	B-X
that	B-X
E2F4	B-X
and	B-X
pocket	B-X
protein	B-X
association	B-X
with	B-X
the	B-X
Plk1	B-X
promoter	B-X
is	B-X
independent	B-X
of	B-X
SWI/SNF	B-X
.	B-X
However	B-X
,	B-X
these	B-X
analyses	B-X
revealed	B-X
that	B-X
SWI/SNF	B-X
is	B-X
required	B-X
for	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
.	B-X
The	B-X
importance	B-X
of	B-X
SWI/SNF-dependent	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
was	B-X
evident	B-X
,	B-X
because	B-X
blockade	B-X
of	B-X
this	B-X
event	B-X
restored	B-X
Plk1	B-X
expression	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
active	B-X
RB	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
data	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
RB	B-X
pathway	B-X
.	B-X
Moreover	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
hierarchical	B-X
role	B-X
for	B-X
SWI/SNF	B-X
in	B-X
the	B-X
control	B-X
of	B-X
promoter	B-X
activity	B-X
through	B-X
histone	B-X
modification	B-X
.	B-X

In	O
summary	O
,	O
these	O
data	O
demonstrate	O
that	O
Plk1	B-Gene_or_gene_product
is	O
a	O
target	O
of	O
the	O
RB	B-Gene_or_gene_product
pathway	O
.	O
<EOS>	B-X
Plk1	B-X
(	B-X
Polo-like	B-X
kinase	B-X
1	B-X
)	B-X
is	B-X
a	B-X
critical	B-X
regulator	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
that	B-X
harbors	B-X
oncogenic	B-X
activity	B-X
and	B-X
exhibits	B-X
aberrant	B-X
expression	B-X
in	B-X
multiple	B-X
tumors	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
Plk1	B-X
expression	B-X
is	B-X
regulated	B-X
has	B-X
not	B-X
been	B-X
extensively	B-X
studied	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
(	B-X
RB	B-X
)	B-X
pathway	B-X
.	B-X
Activation	B-X
of	B-X
RB	B-X
and	B-X
related	B-X
pocket	B-X
proteins	B-X
p107/p130	B-X
mediate	B-X
attenuation	B-X
of	B-X
Plk1	B-X
.	B-X
Conversely	B-X
,	B-X
RB	B-X
loss	B-X
deregulates	B-X
the	B-X
control	B-X
of	B-X
Plk1	B-X
expression	B-X
.	B-X
RB	B-X
pathway	B-X
activation	B-X
resulted	B-X
in	B-X
the	B-X
repression	B-X
of	B-X
Plk1	B-X
promoter	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
action	B-X
was	B-X
dependent	B-X
on	B-X
the	B-X
SWI/SNF	B-X
chromatin	B-X
remodeling	B-X
complex	B-X
.	B-X
Although	B-X
SWI/SNF	B-X
subunits	B-X
are	B-X
lost	B-X
during	B-X
tumorigenesis	B-X
and	B-X
cooperate	B-X
with	B-X
RB	B-X
for	B-X
transcriptional	B-X
repression	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
SWI/SNF	B-X
impinges	B-X
on	B-X
RB	B-X
action	B-X
is	B-X
unresolved	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
delineated	B-X
the	B-X
requirement	B-X
of	B-X
SWI/SNF	B-X
for	B-X
three	B-X
critical	B-X
facets	B-X
of	B-X
Plk1	B-X
promoter	B-X
regulation	B-X
:	B-X
transcription	B-X
factor	B-X
binding	B-X
,	B-X
corepressor	B-X
binding	B-X
,	B-X
and	B-X
histone	B-X
modification	B-X
.	B-X
We	B-X
find	B-X
that	B-X
E2F4	B-X
and	B-X
pocket	B-X
protein	B-X
association	B-X
with	B-X
the	B-X
Plk1	B-X
promoter	B-X
is	B-X
independent	B-X
of	B-X
SWI/SNF	B-X
.	B-X
However	B-X
,	B-X
these	B-X
analyses	B-X
revealed	B-X
that	B-X
SWI/SNF	B-X
is	B-X
required	B-X
for	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
.	B-X
The	B-X
importance	B-X
of	B-X
SWI/SNF-dependent	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
was	B-X
evident	B-X
,	B-X
because	B-X
blockade	B-X
of	B-X
this	B-X
event	B-X
restored	B-X
Plk1	B-X
expression	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
active	B-X
RB	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
data	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
RB	B-X
pathway	B-X
.	B-X
Moreover	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
hierarchical	B-X
role	B-X
for	B-X
SWI/SNF	B-X
in	B-X
the	B-X
control	B-X
of	B-X
promoter	B-X
activity	B-X
through	B-X
histone	B-X
modification	B-X
.	B-X

Moreover	O
,	O
these	O
findings	O
demonstrate	O
a	O
hierarchical	O
role	O
for	O
SWI	O
/	O
SNF	O
in	O
the	O
control	O
of	O
promoter	O
activity	O
through	O
histone	B-Gene_or_gene_product
modification	O
.	O
<EOS>	B-X
Plk1	B-X
(	B-X
Polo-like	B-X
kinase	B-X
1	B-X
)	B-X
is	B-X
a	B-X
critical	B-X
regulator	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
that	B-X
harbors	B-X
oncogenic	B-X
activity	B-X
and	B-X
exhibits	B-X
aberrant	B-X
expression	B-X
in	B-X
multiple	B-X
tumors	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
(	B-X
RB	B-X
)	B-X
pathway	B-X
.	B-X
Conversely	B-X
,	B-X
RB	B-X
loss	B-X
deregulates	B-X
the	B-X
control	B-X
of	B-X
Plk1	B-X
expression	B-X
.	B-X
RB	B-X
pathway	B-X
activation	B-X
resulted	B-X
in	B-X
the	B-X
repression	B-X
of	B-X
Plk1	B-X
promoter	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
action	B-X
was	B-X
dependent	B-X
on	B-X
the	B-X
SWI/SNF	B-X
chromatin	B-X
remodeling	B-X
complex	B-X
.	B-X
Although	B-X
SWI/SNF	B-X
subunits	B-X
are	B-X
lost	B-X
during	B-X
tumorigenesis	B-X
and	B-X
cooperate	B-X
with	B-X
RB	B-X
for	B-X
transcriptional	B-X
repression	B-X
,	B-X
the	B-X
mechanism	B-X
through	B-X
which	B-X
SWI/SNF	B-X
impinges	B-X
on	B-X
RB	B-X
action	B-X
is	B-X
unresolved	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
delineated	B-X
the	B-X
requirement	B-X
of	B-X
SWI/SNF	B-X
for	B-X
three	B-X
critical	B-X
facets	B-X
of	B-X
Plk1	B-X
promoter	B-X
regulation	B-X
:	B-X
transcription	B-X
factor	B-X
binding	B-X
,	B-X
corepressor	B-X
binding	B-X
,	B-X
and	B-X
histone	B-X
modification	B-X
.	B-X
We	B-X
find	B-X
that	B-X
E2F4	B-X
and	B-X
pocket	B-X
protein	B-X
association	B-X
with	B-X
the	B-X
Plk1	B-X
promoter	B-X
is	B-X
independent	B-X
of	B-X
SWI/SNF	B-X
.	B-X
However	B-X
,	B-X
these	B-X
analyses	B-X
revealed	B-X
that	B-X
SWI/SNF	B-X
is	B-X
required	B-X
for	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
.	B-X
The	B-X
importance	B-X
of	B-X
SWI/SNF-dependent	B-X
histone	B-X
deacetylation	B-X
of	B-X
the	B-X
Plk1	B-X
promoter	B-X
was	B-X
evident	B-X
,	B-X
because	B-X
blockade	B-X
of	B-X
this	B-X
event	B-X
restored	B-X
Plk1	B-X
expression	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
active	B-X
RB	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
data	B-X
demonstrate	B-X
that	B-X
Plk1	B-X
is	B-X
a	B-X
target	B-X
of	B-X
the	B-X
RB	B-X
pathway	B-X
.	B-X
Moreover	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
hierarchical	B-X
role	B-X
for	B-X
SWI/SNF	B-X
in	B-X
the	B-X
control	B-X
of	B-X
promoter	B-X
activity	B-X
through	B-X
histone	B-X
modification	B-X
.	B-X

Human	O
recombinant	O
thiamine	B-Gene_or_gene_product
triphosphatase	I-Gene_or_gene_product
:	O
purification	O
,	O
secondary	O
structure	O
and	O
catalytic	O
properties	O
.	O
<EOS>	B-X
We	B-X
have	B-X
recently	B-X
cloned	B-X
the	B-X
cDNA	B-X
coding	B-X
for	B-X
a	B-X
highly	B-X
specific	B-X
mammalian	B-X
25	B-X
kDa	B-X
thiamine	B-X
triphosphatase	B-X
(	B-X
ThTPase	B-X
;	B-X
EC	B-X
3.6.1.28	B-X
)	B-X
.	B-X
As	B-X
the	B-X
enzyme	B-X
has	B-X
a	B-X
high	B-X
catalytic	B-X
efficiency	B-X
and	B-X
no	B-X
sequence	B-X
homology	B-X
with	B-X
known	B-X
phosphohydrolases	B-X
,	B-X
it	B-X
was	B-X
worth	B-X
investigating	B-X
its	B-X
structure	B-X
and	B-X
catalytic	B-X
properties	B-X
.	B-X
For	B-X
this	B-X
purpose	B-X
,	B-X
we	B-X
expressed	B-X
the	B-X
untagged	B-X
recombinant	B-X
human	B-X
ThTPase	B-X
(	B-X
hThTPase	B-X
)	B-X
in	B-X
E.	B-X
coli	B-X
,	B-X
produced	B-X
the	B-X
protein	B-X
on	B-X
a	B-X
large	B-X
scale	B-X
and	B-X
purified	B-X
it	B-X
to	B-X
homogeneity	B-X
.	B-X
Its	B-X
kinetic	B-X
properties	B-X
were	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
the	B-X
genuine	B-X
human	B-X
enzyme	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
recombinant	B-X
hThTPase	B-X
is	B-X
completely	B-X
functional	B-X
.	B-X
With	B-X
ATP	B-X
as	B-X
substrate	B-X
,	B-X
the	B-X
catalytic	B-X
efficiency	B-X
was	B-X
10	B-X
(	B-X
-4	B-X
)	B-X
-fold	B-X
lower	B-X
than	B-X
with	B-X
ThTP	B-X
,	B-X
confirming	B-X
the	B-X
nearly	B-X
absolute	B-X
specificity	B-X
of	B-X
the	B-X
25	B-X
kDa	B-X
ThTPase	B-X
for	B-X
ThTP	B-X
.	B-X
The	B-X
secondary	B-X
structure	B-X
of	B-X
the	B-X
enzyme	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
Fourier-transform	B-X
infrared	B-X
spectroscopy	B-X
,	B-X
was	B-X
predominantly	B-X
beta-sheet	B-X
and	B-X
alpha-helix	B-X
.	B-X

Thiamine	O
triphosphate	O
(	O
ThTP	O
)	O
is	O
found	O
in	O
most	O
living	O
organisms	O
and	O
it	O
may	O
act	O
as	O
a	O
phosphate	O
donor	O
for	O
protein	O
phosphorylation	O
.	O
<EOS>	B-X
Thiamine	B-X
triphosphate	B-X
(	B-X
ThTP	B-X
)	B-X
is	B-X
found	B-X
in	B-X
most	B-X
living	B-X
organisms	B-X
and	B-X
it	B-X
may	B-X
act	B-X
as	B-X
a	B-X
phosphate	B-X
donor	B-X
for	B-X
protein	B-X
phosphorylation	B-X
.	B-X
We	B-X
have	B-X
recently	B-X
cloned	B-X
the	B-X
cDNA	B-X
coding	B-X
for	B-X
a	B-X
highly	B-X
specific	B-X
mammalian	B-X
25	B-X
kDa	B-X
thiamine	B-X
triphosphatase	B-X
(	B-X
ThTPase	B-X
;	B-X
EC	B-X
3.6.1.28	B-X
)	B-X
.	B-X
For	B-X
this	B-X
purpose	B-X
,	B-X
we	B-X
expressed	B-X
the	B-X
untagged	B-X
recombinant	B-X
human	B-X
ThTPase	B-X
(	B-X
hThTPase	B-X
)	B-X
in	B-X
E.	B-X
coli	B-X
,	B-X
produced	B-X
the	B-X
protein	B-X
on	B-X
a	B-X
large	B-X
scale	B-X
and	B-X
purified	B-X
it	B-X
to	B-X
homogeneity	B-X
.	B-X
Its	B-X
kinetic	B-X
properties	B-X
were	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
the	B-X
genuine	B-X
human	B-X
enzyme	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
recombinant	B-X
hThTPase	B-X
is	B-X
completely	B-X
functional	B-X
.	B-X
Mg2+	B-X
ions	B-X
were	B-X
required	B-X
for	B-X
activity	B-X
and	B-X
Ca2+	B-X
inhibited	B-X
the	B-X
enzyme	B-X
by	B-X
competition	B-X
with	B-X
Mg2+	B-X
.	B-X
With	B-X
ATP	B-X
as	B-X
substrate	B-X
,	B-X
the	B-X
catalytic	B-X
efficiency	B-X
was	B-X
10	B-X
(	B-X
-4	B-X
)	B-X
-fold	B-X
lower	B-X
than	B-X
with	B-X
ThTP	B-X
,	B-X
confirming	B-X
the	B-X
nearly	B-X
absolute	B-X
specificity	B-X
of	B-X
the	B-X
25	B-X
kDa	B-X
ThTPase	B-X
for	B-X
ThTP	B-X
.	B-X
The	B-X
activity	B-X
was	B-X
maximum	B-X
at	B-X
pH	B-X
8.5	B-X
and	B-X
very	B-X
low	B-X
at	B-X
pH	B-X
6.0	B-X
.	B-X
Zn2+	B-X
ions	B-X
were	B-X
inhibitory	B-X
at	B-X
micromolar	B-X
concentrations	B-X
at	B-X
pH	B-X
8.0	B-X
but	B-X
activated	B-X
at	B-X
pH	B-X
6.0	B-X
.	B-X
Kinetic	B-X
analysis	B-X
suggests	B-X
an	B-X
activator	B-X
site	B-X
for	B-X
Mg2+	B-X
and	B-X
a	B-X
separate	B-X
regulatory	B-X
site	B-X
for	B-X
Zn2+	B-X
.	B-X
The	B-X
effects	B-X
of	B-X
group-specific	B-X
reagents	B-X
such	B-X
as	B-X
Woodward	B-X
's	B-X
reagent	B-X
K	B-X
and	B-X
diethylpyrocarbonate	B-X
suggest	B-X
that	B-X
at	B-X
least	B-X
one	B-X
carboxyl	B-X
group	B-X
in	B-X
the	B-X
active	B-X
site	B-X
is	B-X
essential	B-X
for	B-X
catalysis	B-X
,	B-X
while	B-X
a	B-X
positively	B-X
charged	B-X
amino	B-X
group	B-X
may	B-X
be	B-X
involved	B-X
in	B-X
substrate	B-X
binding	B-X
.	B-X

We	O
have	O
recently	O
cloned	O
the	O
cDNA	O
coding	O
for	O
a	O
highly	O
specific	O
mammalian	O
25	O
kDa	O
thiamine	B-Gene_or_gene_product
triphosphatase	I-Gene_or_gene_product
(	O
ThTPase	B-Gene_or_gene_product
;	O
EC	B-Gene_or_gene_product
3	I-Gene_or_gene_product
.	I-Gene_or_gene_product
6	I-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	I-Gene_or_gene_product
28	I-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
We	B-X
have	B-X
recently	B-X
cloned	B-X
the	B-X
cDNA	B-X
coding	B-X
for	B-X
a	B-X
highly	B-X
specific	B-X
mammalian	B-X
25	B-X
kDa	B-X
thiamine	B-X
triphosphatase	B-X
(	B-X
ThTPase	B-X
;	B-X
EC	B-X
3.6.1.28	B-X
)	B-X
.	B-X
For	B-X
this	B-X
purpose	B-X
,	B-X
we	B-X
expressed	B-X
the	B-X
untagged	B-X
recombinant	B-X
human	B-X
ThTPase	B-X
(	B-X
hThTPase	B-X
)	B-X
in	B-X
E.	B-X
coli	B-X
,	B-X
produced	B-X
the	B-X
protein	B-X
on	B-X
a	B-X
large	B-X
scale	B-X
and	B-X
purified	B-X
it	B-X
to	B-X
homogeneity	B-X
.	B-X
Its	B-X
kinetic	B-X
properties	B-X
were	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
the	B-X
genuine	B-X
human	B-X
enzyme	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
recombinant	B-X
hThTPase	B-X
is	B-X
completely	B-X
functional	B-X
.	B-X
With	B-X
ATP	B-X
as	B-X
substrate	B-X
,	B-X
the	B-X
catalytic	B-X
efficiency	B-X
was	B-X
10	B-X
(	B-X
-4	B-X
)	B-X
-fold	B-X
lower	B-X
than	B-X
with	B-X
ThTP	B-X
,	B-X
confirming	B-X
the	B-X
nearly	B-X
absolute	B-X
specificity	B-X
of	B-X
the	B-X
25	B-X
kDa	B-X
ThTPase	B-X
for	B-X
ThTP	B-X
.	B-X
The	B-X
activity	B-X
was	B-X
maximum	B-X
at	B-X
pH	B-X
8.5	B-X
and	B-X
very	B-X
low	B-X
at	B-X
pH	B-X
6.0	B-X
.	B-X
Zn2+	B-X
ions	B-X
were	B-X
inhibitory	B-X
at	B-X
micromolar	B-X
concentrations	B-X
at	B-X
pH	B-X
8.0	B-X
but	B-X
activated	B-X
at	B-X
pH	B-X
6.0	B-X
.	B-X
The	B-X
effects	B-X
of	B-X
group-specific	B-X
reagents	B-X
such	B-X
as	B-X
Woodward	B-X
's	B-X
reagent	B-X
K	B-X
and	B-X
diethylpyrocarbonate	B-X
suggest	B-X
that	B-X
at	B-X
least	B-X
one	B-X
carboxyl	B-X
group	B-X
in	B-X
the	B-X
active	B-X
site	B-X
is	B-X
essential	B-X
for	B-X
catalysis	B-X
,	B-X
while	B-X
a	B-X
positively	B-X
charged	B-X
amino	B-X
group	B-X
may	B-X
be	B-X
involved	B-X
in	B-X
substrate	B-X
binding	B-X
.	B-X

As	O
the	O
enzyme	O
has	O
a	O
high	O
catalytic	O
efficiency	O
and	O
no	O
sequence	O
homology	O
with	O
known	O
phosphohydrolases	O
,	O
it	O
was	O
worth	O
investigating	O
its	O
structure	O
and	O
catalytic	O
properties	O
.	O

For	O
this	O
purpose	O
,	O
we	O
expressed	O
the	O
untagged	O
recombinant	O
human	O
ThTPase	B-Gene_or_gene_product
(	O
hThTPase	B-Gene_or_gene_product
)	O
in	O
E	O
.	O
coli	O
,	O
produced	O
the	O
protein	O
on	O
a	O
large	O
scale	O
and	O
purified	O
it	O
to	O
homogeneity	O
.	O

Its	O
kinetic	O
properties	O
were	O
similar	O
to	O
those	O
of	O
the	O
genuine	O
human	O
enzyme	O
,	O
indicating	O
that	O
the	O
recombinant	O
hThTPase	B-Gene_or_gene_product
is	O
completely	O
functional	O
.	O
<EOS>	B-X
As	B-X
the	B-X
enzyme	B-X
has	B-X
a	B-X
high	B-X
catalytic	B-X
efficiency	B-X
and	B-X
no	B-X
sequence	B-X
homology	B-X
with	B-X
known	B-X
phosphohydrolases	B-X
,	B-X
it	B-X
was	B-X
worth	B-X
investigating	B-X
its	B-X
structure	B-X
and	B-X
catalytic	B-X
properties	B-X
.	B-X
For	B-X
this	B-X
purpose	B-X
,	B-X
we	B-X
expressed	B-X
the	B-X
untagged	B-X
recombinant	B-X
human	B-X
ThTPase	B-X
(	B-X
hThTPase	B-X
)	B-X
in	B-X
E.	B-X
coli	B-X
,	B-X
produced	B-X
the	B-X
protein	B-X
on	B-X
a	B-X
large	B-X
scale	B-X
and	B-X
purified	B-X
it	B-X
to	B-X
homogeneity	B-X
.	B-X
Its	B-X
kinetic	B-X
properties	B-X
were	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
the	B-X
genuine	B-X
human	B-X
enzyme	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
recombinant	B-X
hThTPase	B-X
is	B-X
completely	B-X
functional	B-X
.	B-X
Mg2+	B-X
ions	B-X
were	B-X
required	B-X
for	B-X
activity	B-X
and	B-X
Ca2+	B-X
inhibited	B-X
the	B-X
enzyme	B-X
by	B-X
competition	B-X
with	B-X
Mg2+	B-X
.	B-X
The	B-X
secondary	B-X
structure	B-X
of	B-X
the	B-X
enzyme	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
Fourier-transform	B-X
infrared	B-X
spectroscopy	B-X
,	B-X
was	B-X
predominantly	B-X
beta-sheet	B-X
and	B-X
alpha-helix	B-X
.	B-X

Mg2	O
+	O
ions	O
were	O
required	O
for	O
activity	O
and	O
Ca2	O
+	O
inhibited	O
the	O
enzyme	O
by	O
competition	O
with	O
Mg2	O
+	O
.	O
<EOS>	B-X
Saturation	B-X
curves	B-X
for	B-X
substrate	B-X
(	B-X
fructose	B-X
1,6-diphosphate	B-X
)	B-X
and	B-X
a	B-X
cofactor	B-X
(	B-X
Mg	B-X
(	B-X
2+	B-X
)	B-X
)	B-X
are	B-X
sigmoidal	B-X
,	B-X
and	B-X
Hill	B-X
plots	B-X
of	B-X
the	B-X
results	B-X
suggest	B-X
a	B-X
minimum	B-X
of	B-X
two	B-X
interacting	B-X
fructose	B-X
1,6-diphosphate	B-X
sites	B-X
and	B-X
two	B-X
interacting	B-X
Mg	B-X
(	B-X
2+	B-X
)	B-X
sites	B-X
per	B-X
molecule	B-X
of	B-X
enzyme	B-X
.	B-X
Mn	B-X
(	B-X
2+	B-X
)	B-X
-saturation	B-X
curves	B-X
are	B-X
hyperbolic	B-X
,	B-X
and	B-X
the	B-X
K	B-X
(	B-X
a	B-X
)	B-X
for	B-X
Mn	B-X
(	B-X
2+	B-X
)	B-X
,	B-X
which	B-X
inhibits	B-X
the	B-X
enzyme	B-X
at	B-X
high	B-X
concentrations	B-X
,	B-X
is	B-X
50-100-fold	B-X
lower	B-X
than	B-X
the	B-X
K	B-X
(	B-X
a	B-X
)	B-X
for	B-X
Mg	B-X
(	B-X
2+	B-X
)	B-X
.	B-X
Fructose	B-X
diphosphatase	B-X
is	B-X
inhibited	B-X
by	B-X
low	B-X
concentrations	B-X
of	B-X
AMP	B-X
;	B-X
this	B-X
inhibition	B-X
appears	B-X
to	B-X
be	B-X
decreased	B-X
and	B-X
reversed	B-X
by	B-X
increasing	B-X
the	B-X
concentrations	B-X
of	B-X
Mg	B-X
(	B-X
2+	B-X
)	B-X
and	B-X
Mn	B-X
(	B-X
2+	B-X
)	B-X
.	B-X
Higher	B-X
concentrations	B-X
of	B-X
AMP	B-X
are	B-X
required	B-X
to	B-X
inhibit	B-X
the	B-X
trout	B-X
fructose	B-X
diphosphatase	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
Mn	B-X
(	B-X
2+	B-X
)	B-X
.	B-X
The	B-X
pH	B-X
optimum	B-X
of	B-X
the	B-X
enzyme	B-X
depends	B-X
on	B-X
the	B-X
concentrations	B-X
of	B-X
Mg	B-X
(	B-X
2+	B-X
)	B-X
and	B-X
Mn	B-X
(	B-X
2+	B-X
)	B-X
.	B-X
The	B-X
enzyme	B-X
is	B-X
inhibited	B-X
by	B-X
Ca	B-X
(	B-X
2+	B-X
)	B-X
and	B-X
Zn	B-X
(	B-X
2+	B-X
)	B-X
,	B-X
and	B-X
the	B-X
inhibition	B-X
is	B-X
competitive	B-X
with	B-X
respect	B-X
to	B-X
both	B-X
cations	B-X
.	B-X
The	B-X
possible	B-X
roles	B-X
of	B-X
these	B-X
ions	B-X
and	B-X
AMP	B-X
in	B-X
the	B-X
modulation	B-X
of	B-X
fructose	B-X
diphosphatase	B-X
and	B-X
gluconeogenic	B-X
activity	B-X
are	B-X
discussed	B-X
in	B-X
relation	B-X
to	B-X
temperature	B-X
adaptation	B-X
.	B-X

With	O
ATP	O
as	O
substrate	O
,	O
the	O
catalytic	O
efficiency	O
was	O
10	O
(	O
-	O
4	O
)	O
-	O
fold	O
lower	O
than	O
with	O
ThTP	O
,	O
confirming	O
the	O
nearly	O
absolute	O
specificity	O
of	O
the	O
25	O
kDa	O
ThTPase	B-Gene_or_gene_product
for	O
ThTP	O
.	O
<EOS>	B-X
Thiamine	B-X
triphosphate	B-X
(	B-X
ThTP	B-X
)	B-X
is	B-X
found	B-X
in	B-X
most	B-X
living	B-X
organisms	B-X
and	B-X
it	B-X
may	B-X
act	B-X
as	B-X
a	B-X
phosphate	B-X
donor	B-X
for	B-X
protein	B-X
phosphorylation	B-X
.	B-X
We	B-X
have	B-X
recently	B-X
cloned	B-X
the	B-X
cDNA	B-X
coding	B-X
for	B-X
a	B-X
highly	B-X
specific	B-X
mammalian	B-X
25	B-X
kDa	B-X
thiamine	B-X
triphosphatase	B-X
(	B-X
ThTPase	B-X
;	B-X
EC	B-X
3.6.1.28	B-X
)	B-X
.	B-X
As	B-X
the	B-X
enzyme	B-X
has	B-X
a	B-X
high	B-X
catalytic	B-X
efficiency	B-X
and	B-X
no	B-X
sequence	B-X
homology	B-X
with	B-X
known	B-X
phosphohydrolases	B-X
,	B-X
it	B-X
was	B-X
worth	B-X
investigating	B-X
its	B-X
structure	B-X
and	B-X
catalytic	B-X
properties	B-X
.	B-X
For	B-X
this	B-X
purpose	B-X
,	B-X
we	B-X
expressed	B-X
the	B-X
untagged	B-X
recombinant	B-X
human	B-X
ThTPase	B-X
(	B-X
hThTPase	B-X
)	B-X
in	B-X
E.	B-X
coli	B-X
,	B-X
produced	B-X
the	B-X
protein	B-X
on	B-X
a	B-X
large	B-X
scale	B-X
and	B-X
purified	B-X
it	B-X
to	B-X
homogeneity	B-X
.	B-X
Its	B-X
kinetic	B-X
properties	B-X
were	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
the	B-X
genuine	B-X
human	B-X
enzyme	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
recombinant	B-X
hThTPase	B-X
is	B-X
completely	B-X
functional	B-X
.	B-X
With	B-X
ATP	B-X
as	B-X
substrate	B-X
,	B-X
the	B-X
catalytic	B-X
efficiency	B-X
was	B-X
10	B-X
(	B-X
-4	B-X
)	B-X
-fold	B-X
lower	B-X
than	B-X
with	B-X
ThTP	B-X
,	B-X
confirming	B-X
the	B-X
nearly	B-X
absolute	B-X
specificity	B-X
of	B-X
the	B-X
25	B-X
kDa	B-X
ThTPase	B-X
for	B-X
ThTP	B-X
.	B-X
The	B-X
effects	B-X
of	B-X
group-specific	B-X
reagents	B-X
such	B-X
as	B-X
Woodward	B-X
's	B-X
reagent	B-X
K	B-X
and	B-X
diethylpyrocarbonate	B-X
suggest	B-X
that	B-X
at	B-X
least	B-X
one	B-X
carboxyl	B-X
group	B-X
in	B-X
the	B-X
active	B-X
site	B-X
is	B-X
essential	B-X
for	B-X
catalysis	B-X
,	B-X
while	B-X
a	B-X
positively	B-X
charged	B-X
amino	B-X
group	B-X
may	B-X
be	B-X
involved	B-X
in	B-X
substrate	B-X
binding	B-X
.	B-X

The	O
activity	O
was	O
maximum	O
at	O
pH	O
8	O
.	O
5	O
and	O
very	O
low	O
at	O
pH	O
6	O
.	O
0	O
.	O

Zn2	O
+	O
ions	O
were	O
inhibitory	O
at	O
micromolar	O
concentrations	O
at	O
pH	O
8	O
.	O
0	O
but	O
activated	O
at	O
pH	O
6	O
.	O
0	O
.	O

Kinetic	O
analysis	O
suggests	O
an	O
activator	O
site	O
for	O
Mg2	O
+	O
and	O
a	O
separate	O
regulatory	O
site	O
for	O
Zn2	O
+	O
.	O

The	O
effects	O
of	O
group	O
-	O
specific	O
reagents	O
such	O
as	O
Woodward	O
'	O
s	O
reagent	O
K	O
and	O
diethylpyrocarbonate	O
suggest	O
that	O
at	O
least	O
one	O
carboxyl	O
group	O
in	O
the	O
active	O
site	O
is	O
essential	O
for	O
catalysis	O
,	O
while	O
a	O
positively	O
charged	O
amino	O
group	O
may	O
be	O
involved	O
in	O
substrate	O
binding	O
.	O
<EOS>	B-X
Thiamine	B-X
triphosphate	B-X
(	B-X
ThTP	B-X
)	B-X
is	B-X
found	B-X
in	B-X
most	B-X
living	B-X
organisms	B-X
and	B-X
it	B-X
may	B-X
act	B-X
as	B-X
a	B-X
phosphate	B-X
donor	B-X
for	B-X
protein	B-X
phosphorylation	B-X
.	B-X
We	B-X
have	B-X
recently	B-X
cloned	B-X
the	B-X
cDNA	B-X
coding	B-X
for	B-X
a	B-X
highly	B-X
specific	B-X
mammalian	B-X
25	B-X
kDa	B-X
thiamine	B-X
triphosphatase	B-X
(	B-X
ThTPase	B-X
;	B-X
EC	B-X
3.6.1.28	B-X
)	B-X
.	B-X
With	B-X
ATP	B-X
as	B-X
substrate	B-X
,	B-X
the	B-X
catalytic	B-X
efficiency	B-X
was	B-X
10	B-X
(	B-X
-4	B-X
)	B-X
-fold	B-X
lower	B-X
than	B-X
with	B-X
ThTP	B-X
,	B-X
confirming	B-X
the	B-X
nearly	B-X
absolute	B-X
specificity	B-X
of	B-X
the	B-X
25	B-X
kDa	B-X
ThTPase	B-X
for	B-X
ThTP	B-X
.	B-X
Kinetic	B-X
analysis	B-X
suggests	B-X
an	B-X
activator	B-X
site	B-X
for	B-X
Mg2+	B-X
and	B-X
a	B-X
separate	B-X
regulatory	B-X
site	B-X
for	B-X
Zn2+	B-X
.	B-X
The	B-X
effects	B-X
of	B-X
group-specific	B-X
reagents	B-X
such	B-X
as	B-X
Woodward	B-X
's	B-X
reagent	B-X
K	B-X
and	B-X
diethylpyrocarbonate	B-X
suggest	B-X
that	B-X
at	B-X
least	B-X
one	B-X
carboxyl	B-X
group	B-X
in	B-X
the	B-X
active	B-X
site	B-X
is	B-X
essential	B-X
for	B-X
catalysis	B-X
,	B-X
while	B-X
a	B-X
positively	B-X
charged	B-X
amino	B-X
group	B-X
may	B-X
be	B-X
involved	B-X
in	B-X
substrate	B-X
binding	B-X
.	B-X

The	O
secondary	O
structure	O
of	O
the	O
enzyme	O
,	O
as	O
determined	O
by	O
Fourier	O
-	O
transform	O
infrared	O
spectroscopy	O
,	O
was	O
predominantly	O
beta	O
-	O
sheet	O
and	O
alpha	O
-	O
helix	O
.	O
<EOS>	B-X
As	B-X
the	B-X
enzyme	B-X
has	B-X
a	B-X
high	B-X
catalytic	B-X
efficiency	B-X
and	B-X
no	B-X
sequence	B-X
homology	B-X
with	B-X
known	B-X
phosphohydrolases	B-X
,	B-X
it	B-X
was	B-X
worth	B-X
investigating	B-X
its	B-X
structure	B-X
and	B-X
catalytic	B-X
properties	B-X
.	B-X
Its	B-X
kinetic	B-X
properties	B-X
were	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
the	B-X
genuine	B-X
human	B-X
enzyme	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
recombinant	B-X
hThTPase	B-X
is	B-X
completely	B-X
functional	B-X
.	B-X
Mg2+	B-X
ions	B-X
were	B-X
required	B-X
for	B-X
activity	B-X
and	B-X
Ca2+	B-X
inhibited	B-X
the	B-X
enzyme	B-X
by	B-X
competition	B-X
with	B-X
Mg2+	B-X
.	B-X
The	B-X
secondary	B-X
structure	B-X
of	B-X
the	B-X
enzyme	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
Fourier-transform	B-X
infrared	B-X
spectroscopy	B-X
,	B-X
was	B-X
predominantly	B-X
beta-sheet	B-X
and	B-X
alpha-helix	B-X
.	B-X

beta	O
-	O
D	O
-	O
Glucoside	O
suppresses	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	O
induced	O
activation	O
of	O
nuclear	O
transcription	O
factor	O
kappaB	O
but	O
potentiates	O
apoptosis	O
.	O
<EOS>	B-X
Because	B-X
NF-kappaB	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
these	B-X
processes	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
mangiferin	B-X
modulates	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Our	B-X
results	B-X
show	B-X
that	B-X
mangiferin	B-X
blocks	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-induced	B-X
NF-kappaB	B-X
activation	B-X
and	B-X
NF-kappaB-dependent	B-X
genes	B-X
like	B-X
ICAM1	B-X
and	B-X
COX2	B-X
.	B-X
The	B-X
effect	B-X
was	B-X
mediated	B-X
through	B-X
inhibition	B-X
of	B-X
IKK	B-X
activation	B-X
and	B-X
subsequent	B-X
blocking	B-X
of	B-X
phosphorylation	B-X
and	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
mangiferin	B-X
inhibits	B-X
TNF-induced	B-X
p65	B-X
phosphorylation	B-X
as	B-X
well	B-X
as	B-X
translocation	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
also	B-X
inhibits	B-X
NF-kappaB	B-X
activation	B-X
induced	B-X
by	B-X
other	B-X
inflammatory	B-X
agents	B-X
like	B-X
PMA	B-X
,	B-X
ceramide	B-X
,	B-X
and	B-X
SA-LPS	B-X
.	B-X
Mangiferin	B-X
,	B-X
similar	B-X
to	B-X
the	B-X
other	B-X
known	B-X
antioxidants	B-X
,	B-X
NAC	B-X
and	B-X
PDTC	B-X
,	B-X
inhibits	B-X
TNF-induced	B-X
reactive	B-X
oxygen	B-X
intermediate	B-X
(	B-X
ROI	B-X
)	B-X
generation	B-X
.	B-X
Since	B-X
intracellular	B-X
glutathione	B-X
(	B-X
GSH	B-X
)	B-X
levels	B-X
are	B-X
known	B-X
to	B-X
modulate	B-X
NF-kappaB	B-X
levels	B-X
,	B-X
we	B-X
measured	B-X
the	B-X
levels	B-X
of	B-X
GSH	B-X
.	B-X
Hence	B-X
mangiferin	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
inhibit	B-X
NF-kappaB	B-X
and	B-X
increase	B-X
the	B-X
intracellular	B-X
GSH	B-X
levels	B-X
may	B-X
prove	B-X
to	B-X
be	B-X
a	B-X
potent	B-X
drug	B-X
for	B-X
anti-inflammatory	B-X
and	B-X
antioxidant	B-X
therapy	B-X
.	B-X
Mangiferin-mediated	B-X
down-regulation	B-X
of	B-X
NF-kappaB	B-X
also	B-X
potentiates	B-X
chemotherapeutic	B-X
agent-mediated	B-X
cell	B-X
death	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
in	B-X
combination	B-X
therapy	B-X
for	B-X
cancer	B-X
.	B-X

Mangiferin	O
,	O
a	O
natural	O
polyphenol	O
is	O
known	O
to	O
exhibit	O
anti	O
-	O
inflammatory	O
,	O
antioxidant	O
,	O
and	O
antiviral	O
effects	O
.	O
<EOS>	B-X
Mangiferin	B-X
,	B-X
a	B-X
natural	B-X
polyphenol	B-X
is	B-X
known	B-X
to	B-X
exhibit	B-X
anti-inflammatory	B-X
,	B-X
antioxidant	B-X
,	B-X
and	B-X
antiviral	B-X
effects	B-X
.	B-X
However	B-X
the	B-X
molecular	B-X
mechanism	B-X
underlying	B-X
these	B-X
effects	B-X
has	B-X
not	B-X
been	B-X
well	B-X
characterized	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
mangiferin	B-X
inhibits	B-X
TNF-induced	B-X
p65	B-X
phosphorylation	B-X
as	B-X
well	B-X
as	B-X
translocation	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
also	B-X
inhibits	B-X
NF-kappaB	B-X
activation	B-X
induced	B-X
by	B-X
other	B-X
inflammatory	B-X
agents	B-X
like	B-X
PMA	B-X
,	B-X
ceramide	B-X
,	B-X
and	B-X
SA-LPS	B-X
.	B-X
Mangiferin	B-X
,	B-X
similar	B-X
to	B-X
the	B-X
other	B-X
known	B-X
antioxidants	B-X
,	B-X
NAC	B-X
and	B-X
PDTC	B-X
,	B-X
inhibits	B-X
TNF-induced	B-X
reactive	B-X
oxygen	B-X
intermediate	B-X
(	B-X
ROI	B-X
)	B-X
generation	B-X
.	B-X
Since	B-X
intracellular	B-X
glutathione	B-X
(	B-X
GSH	B-X
)	B-X
levels	B-X
are	B-X
known	B-X
to	B-X
modulate	B-X
NF-kappaB	B-X
levels	B-X
,	B-X
we	B-X
measured	B-X
the	B-X
levels	B-X
of	B-X
GSH	B-X
.	B-X
Mangiferin	B-X
enhances	B-X
glutathione	B-X
level	B-X
by	B-X
almost	B-X
2-fold	B-X
more	B-X
than	B-X
other	B-X
anti-oxidants	B-X
,	B-X
and	B-X
at	B-X
the	B-X
same	B-X
time	B-X
it	B-X
decreases	B-X
the	B-X
levels	B-X
of	B-X
GSSG	B-X
and	B-X
increases	B-X
the	B-X
activity	B-X
of	B-X
catalase	B-X
.	B-X
Hence	B-X
mangiferin	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
inhibit	B-X
NF-kappaB	B-X
and	B-X
increase	B-X
the	B-X
intracellular	B-X
GSH	B-X
levels	B-X
may	B-X
prove	B-X
to	B-X
be	B-X
a	B-X
potent	B-X
drug	B-X
for	B-X
anti-inflammatory	B-X
and	B-X
antioxidant	B-X
therapy	B-X
.	B-X
Mangiferin-mediated	B-X
down-regulation	B-X
of	B-X
NF-kappaB	B-X
also	B-X
potentiates	B-X
chemotherapeutic	B-X
agent-mediated	B-X
cell	B-X
death	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
in	B-X
combination	B-X
therapy	B-X
for	B-X
cancer	B-X
.	B-X

However	O
the	O
molecular	O
mechanism	O
underlying	O
these	O
effects	O
has	O
not	O
been	O
well	O
characterized	O
.	O
<EOS>	B-X
However	B-X
,	B-X
resistance	B-X
to	B-X
cisplatin	B-X
may	B-X
develop	B-X
,	B-X
thus	B-X
substantially	B-X
compromising	B-X
the	B-X
efficacy	B-X
of	B-X
cisplatin	B-X
to	B-X
treat	B-X
advanced	B-X
or	B-X
recurrent	B-X
cervical	B-X
cancer	B-X
.	B-X
In	B-X
this	B-X
article	B-X
,	B-X
we	B-X
systematically	B-X
review	B-X
the	B-X
recent	B-X
literature	B-X
and	B-X
summarize	B-X
the	B-X
recent	B-X
advances	B-X
in	B-X
our	B-X
understanding	B-X
of	B-X
the	B-X
molecular	B-X
mechanisms	B-X
underlying	B-X
cisplatin	B-X
resistance	B-X
in	B-X
cervical	B-X
cancer	B-X
.	B-X
Despite	B-X
the	B-X
considerable	B-X
progress	B-X
in	B-X
pain	B-X
management	B-X
methods	B-X
made	B-X
to	B-X
date	B-X
,	B-X
peripheral	B-X
neuropathic	B-X
pain	B-X
significantly	B-X
impacts	B-X
patients	B-X
'	B-X
quality	B-X
of	B-X
life	B-X
,	B-X
as	B-X
pharmacological	B-X
and	B-X
non-pharmacological	B-X
methods	B-X
often	B-X
fail	B-X
or	B-X
induce	B-X
side	B-X
effects	B-X
.	B-X
Moreover	B-X
,	B-X
topical	B-X
treatments	B-X
applied	B-X
locally	B-X
may	B-X
target	B-X
the	B-X
underlying	B-X
mechanisms	B-X
of	B-X
peripheral	B-X
sensitization	B-X
and	B-X
pain	B-X
.	B-X
Recent	B-X
studies	B-X
showed	B-X
that	B-X
peripheral	B-X
sensitization	B-X
results	B-X
from	B-X
interactions	B-X
between	B-X
neuronal	B-X
and	B-X
non-neuronal	B-X
cells	B-X
,	B-X
with	B-X
numerous	B-X
signaling	B-X
molecules	B-X
and	B-X
molecular/cellular	B-X
targets	B-X
involved	B-X
.	B-X
This	B-X
narrative	B-X
review	B-X
discusses	B-X
the	B-X
molecular/cellular	B-X
mechanisms	B-X
of	B-X
drugs	B-X
available	B-X
in	B-X
topical	B-X
formulations	B-X
utilized	B-X
in	B-X
clinical	B-X
practice	B-X
and	B-X
their	B-X
effectiveness	B-X
in	B-X
clinical	B-X
studies	B-X
in	B-X
patients	B-X
with	B-X
peripheral	B-X
neuropathic	B-X
pain	B-X
.	B-X
The	B-X
key	B-X
search	B-X
phrases	B-X
for	B-X
identifying	B-X
potentially	B-X
relevant	B-X
articles	B-X
were	B-X
``	B-X
topical	B-X
AND	B-X
pain	B-X
''	B-X
,	B-X
``	B-X
topical	B-X
AND	B-X
neuropathic	B-X
''	B-X
,	B-X
``	B-X
topical	B-X
AND	B-X
treatment	B-X
''	B-X
,	B-X
``	B-X
topical	B-X
AND	B-X
mechanism	B-X
''	B-X
,	B-X
``	B-X
peripheral	B-X
neuropathic	B-X
''	B-X
,	B-X
and	B-X
``	B-X
mechanism	B-X
''	B-X
.	B-X
The	B-X
data	B-X
from	B-X
preclinical	B-X
studies	B-X
revealed	B-X
that	B-X
active	B-X
compounds	B-X
of	B-X
topical	B-X
treatments	B-X
exert	B-X
multiple	B-X
mechanisms	B-X
of	B-X
action	B-X
,	B-X
directly	B-X
or	B-X
indirectly	B-X
modulating	B-X
ion	B-X
channels	B-X
,	B-X
receptors	B-X
,	B-X
proteins	B-X
,	B-X
and	B-X
enzymes	B-X
expressed	B-X
by	B-X
neuronal	B-X
and	B-X
non-neuronal	B-X
cells	B-X
,	B-X
and	B-X
thus	B-X
contributing	B-X
to	B-X
antinociception	B-X
.	B-X
However	B-X
,	B-X
which	B-X
mechanisms	B-X
and	B-X
the	B-X
extent	B-X
to	B-X
which	B-X
the	B-X
mechanisms	B-X
contribute	B-X
to	B-X
pain	B-X
relief	B-X
observed	B-X
in	B-X
humans	B-X
remain	B-X
unclear	B-X
.	B-X

Because	O
NF	O
-	O
kappaB	O
plays	O
an	O
important	O
role	O
in	O
these	O
processes	O
,	O
it	O
is	O
possible	O
that	O
mangiferin	O
modulates	O
NF	O
-	O
kappaB	O
activation	O
.	O
<EOS>	B-X
Because	B-X
NF-kappaB	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
these	B-X
processes	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
mangiferin	B-X
modulates	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Our	B-X
results	B-X
show	B-X
that	B-X
mangiferin	B-X
blocks	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-induced	B-X
NF-kappaB	B-X
activation	B-X
and	B-X
NF-kappaB-dependent	B-X
genes	B-X
like	B-X
ICAM1	B-X
and	B-X
COX2	B-X
.	B-X
The	B-X
effect	B-X
was	B-X
mediated	B-X
through	B-X
inhibition	B-X
of	B-X
IKK	B-X
activation	B-X
and	B-X
subsequent	B-X
blocking	B-X
of	B-X
phosphorylation	B-X
and	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
mangiferin	B-X
inhibits	B-X
TNF-induced	B-X
p65	B-X
phosphorylation	B-X
as	B-X
well	B-X
as	B-X
translocation	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
also	B-X
inhibits	B-X
NF-kappaB	B-X
activation	B-X
induced	B-X
by	B-X
other	B-X
inflammatory	B-X
agents	B-X
like	B-X
PMA	B-X
,	B-X
ceramide	B-X
,	B-X
and	B-X
SA-LPS	B-X
.	B-X
Mangiferin	B-X
,	B-X
similar	B-X
to	B-X
the	B-X
other	B-X
known	B-X
antioxidants	B-X
,	B-X
NAC	B-X
and	B-X
PDTC	B-X
,	B-X
inhibits	B-X
TNF-induced	B-X
reactive	B-X
oxygen	B-X
intermediate	B-X
(	B-X
ROI	B-X
)	B-X
generation	B-X
.	B-X
Since	B-X
intracellular	B-X
glutathione	B-X
(	B-X
GSH	B-X
)	B-X
levels	B-X
are	B-X
known	B-X
to	B-X
modulate	B-X
NF-kappaB	B-X
levels	B-X
,	B-X
we	B-X
measured	B-X
the	B-X
levels	B-X
of	B-X
GSH	B-X
.	B-X
Depletion	B-X
of	B-X
GSH	B-X
by	B-X
buthionine	B-X
sulfoximine	B-X
led	B-X
to	B-X
a	B-X
significant	B-X
reversal	B-X
of	B-X
mangiferin	B-X
effect	B-X
.	B-X
Hence	B-X
mangiferin	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
inhibit	B-X
NF-kappaB	B-X
and	B-X
increase	B-X
the	B-X
intracellular	B-X
GSH	B-X
levels	B-X
may	B-X
prove	B-X
to	B-X
be	B-X
a	B-X
potent	B-X
drug	B-X
for	B-X
anti-inflammatory	B-X
and	B-X
antioxidant	B-X
therapy	B-X
.	B-X
Mangiferin-mediated	B-X
down-regulation	B-X
of	B-X
NF-kappaB	B-X
also	B-X
potentiates	B-X
chemotherapeutic	B-X
agent-mediated	B-X
cell	B-X
death	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
in	B-X
combination	B-X
therapy	B-X
for	B-X
cancer	B-X
.	B-X

Our	O
results	O
show	O
that	O
mangiferin	O
blocks	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
TNF	B-Gene_or_gene_product
)	O
-	O
induced	O
NF	O
-	O
kappaB	O
activation	O
and	O
NF	O
-	O
kappaB	O
-	O
dependent	O
genes	O
like	O
ICAM1	B-Gene_or_gene_product
and	O
COX2	B-Gene_or_gene_product
.	O
<EOS>	B-X
Because	B-X
NF-kappaB	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
these	B-X
processes	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
mangiferin	B-X
modulates	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Our	B-X
results	B-X
show	B-X
that	B-X
mangiferin	B-X
blocks	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-induced	B-X
NF-kappaB	B-X
activation	B-X
and	B-X
NF-kappaB-dependent	B-X
genes	B-X
like	B-X
ICAM1	B-X
and	B-X
COX2	B-X
.	B-X
The	B-X
effect	B-X
was	B-X
mediated	B-X
through	B-X
inhibition	B-X
of	B-X
IKK	B-X
activation	B-X
and	B-X
subsequent	B-X
blocking	B-X
of	B-X
phosphorylation	B-X
and	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
mangiferin	B-X
inhibits	B-X
TNF-induced	B-X
p65	B-X
phosphorylation	B-X
as	B-X
well	B-X
as	B-X
translocation	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
also	B-X
inhibits	B-X
NF-kappaB	B-X
activation	B-X
induced	B-X
by	B-X
other	B-X
inflammatory	B-X
agents	B-X
like	B-X
PMA	B-X
,	B-X
ceramide	B-X
,	B-X
and	B-X
SA-LPS	B-X
.	B-X
Mangiferin	B-X
,	B-X
similar	B-X
to	B-X
the	B-X
other	B-X
known	B-X
antioxidants	B-X
,	B-X
NAC	B-X
and	B-X
PDTC	B-X
,	B-X
inhibits	B-X
TNF-induced	B-X
reactive	B-X
oxygen	B-X
intermediate	B-X
(	B-X
ROI	B-X
)	B-X
generation	B-X
.	B-X
Since	B-X
intracellular	B-X
glutathione	B-X
(	B-X
GSH	B-X
)	B-X
levels	B-X
are	B-X
known	B-X
to	B-X
modulate	B-X
NF-kappaB	B-X
levels	B-X
,	B-X
we	B-X
measured	B-X
the	B-X
levels	B-X
of	B-X
GSH	B-X
.	B-X
Depletion	B-X
of	B-X
GSH	B-X
by	B-X
buthionine	B-X
sulfoximine	B-X
led	B-X
to	B-X
a	B-X
significant	B-X
reversal	B-X
of	B-X
mangiferin	B-X
effect	B-X
.	B-X
Hence	B-X
mangiferin	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
inhibit	B-X
NF-kappaB	B-X
and	B-X
increase	B-X
the	B-X
intracellular	B-X
GSH	B-X
levels	B-X
may	B-X
prove	B-X
to	B-X
be	B-X
a	B-X
potent	B-X
drug	B-X
for	B-X
anti-inflammatory	B-X
and	B-X
antioxidant	B-X
therapy	B-X
.	B-X
Mangiferin-mediated	B-X
down-regulation	B-X
of	B-X
NF-kappaB	B-X
also	B-X
potentiates	B-X
chemotherapeutic	B-X
agent-mediated	B-X
cell	B-X
death	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
in	B-X
combination	B-X
therapy	B-X
for	B-X
cancer	B-X
.	B-X

The	O
effect	O
was	O
mediated	O
through	O
inhibition	O
of	O
IKK	O
activation	O
and	O
subsequent	O
blocking	O
of	O
phosphorylation	O
and	O
degradation	O
of	O
IkappaBalpha	B-Gene_or_gene_product
.	O
<EOS>	B-X
Resolving	B-X
chronic	B-X
inflammation	B-X
or	B-X
blocking	B-X
inflammatory	B-X
signal	B-X
transduction	B-X
may	B-X
prevent	B-X
cancer	B-X
development	B-X
.	B-X
Subsequent	B-X
studies	B-X
reveal	B-X
that	B-X
such	B-X
treatment	B-X
has	B-X
little	B-X
effect	B-X
on	B-X
resolving	B-X
chronic	B-X
inflammatory	B-X
conditions	B-X
in	B-X
the	B-X
lung	B-X
,	B-X
but	B-X
it	B-X
significantly	B-X
blocks	B-X
the	B-X
NF-κB-mediated	B-X
expression	B-X
of	B-X
proliferation	B-X
and	B-X
survival	B-X
genes	B-X
in	B-X
cancer	B-X
cells	B-X
.	B-X
While	B-X
aspirin	B-X
directly	B-X
inhibits	B-X
IκB	B-X
kinases	B-X
(	B-X
IKKs	B-X
)	B-X
to	B-X
phosphorylate	B-X
IκBα	B-X
for	B-X
NF-κB	B-X
activation	B-X
,	B-X
triptolide	B-X
does	B-X
not	B-X
directly	B-X
target	B-X
IKKs	B-X
or	B-X
other	B-X
factors	B-X
that	B-X
mediate	B-X
IKK	B-X
activation	B-X
.	B-X
Instead	B-X
,	B-X
it	B-X
requires	B-X
p53	B-X
to	B-X
inhibit	B-X
IκBα	B-X
phosphorylation	B-X
and	B-X
degradation	B-X
.	B-X
Subsequently	B-X
,	B-X
p53	B-X
competes	B-X
with	B-X
IκBα	B-X
for	B-X
substrate	B-X
binding	B-X
to	B-X
IKKβ	B-X
and	B-X
thereby	B-X
blocks	B-X
IκBα	B-X
phosphorylation	B-X
and	B-X
NF-κB	B-X
nuclear	B-X
translocation	B-X
.	B-X
Inhibition	B-X
of	B-X
p38α	B-X
and	B-X
ERK1/2	B-X
or	B-X
p53	B-X
mutations	B-X
could	B-X
abolish	B-X
the	B-X
inhibitory	B-X
effects	B-X
of	B-X
triptolide	B-X
on	B-X
NF-κB	B-X
.	B-X
Our	B-X
study	B-X
defines	B-X
a	B-X
new	B-X
p53-dependent	B-X
mechanism	B-X
for	B-X
blocking	B-X
NF-κB	B-X
survival	B-X
pathways	B-X
in	B-X
cancer	B-X
cells	B-X
.	B-X

In	O
addition	O
,	O
mangiferin	O
inhibits	O
TNF	B-Gene_or_gene_product
-	O
induced	O
p65	B-Gene_or_gene_product
phosphorylation	O
as	O
well	O
as	O
translocation	O
to	O
the	O
nucleus	O
and	O
also	O
inhibits	O
NF	O
-	O
kappaB	O
activation	O
induced	O
by	O
other	O
inflammatory	O
agents	O
like	O
PMA	O
,	O
ceramide	O
,	O
and	O
SA	O
-	O
LPS	O
.	O

Mangiferin	O
,	O
similar	O
to	O
the	O
other	O
known	O
antioxidants	O
,	O
NAC	O
and	O
PDTC	O
,	O
inhibits	O
TNF	B-Gene_or_gene_product
-	O
induced	O
reactive	O
oxygen	O
intermediate	O
(	O
ROI	O
)	O
generation	O
.	O

Since	O
intracellular	O
glutathione	O
(	O
GSH	O
)	O
levels	O
are	O
known	O
to	O
modulate	O
NF	O
-	O
kappaB	O
levels	O
,	O
we	O
measured	O
the	O
levels	O
of	O
GSH	O
.	O
<EOS>	B-X
Mangiferin	B-X
,	B-X
a	B-X
natural	B-X
polyphenol	B-X
is	B-X
known	B-X
to	B-X
exhibit	B-X
anti-inflammatory	B-X
,	B-X
antioxidant	B-X
,	B-X
and	B-X
antiviral	B-X
effects	B-X
.	B-X
Because	B-X
NF-kappaB	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
these	B-X
processes	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
mangiferin	B-X
modulates	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Our	B-X
results	B-X
show	B-X
that	B-X
mangiferin	B-X
blocks	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-induced	B-X
NF-kappaB	B-X
activation	B-X
and	B-X
NF-kappaB-dependent	B-X
genes	B-X
like	B-X
ICAM1	B-X
and	B-X
COX2	B-X
.	B-X
The	B-X
effect	B-X
was	B-X
mediated	B-X
through	B-X
inhibition	B-X
of	B-X
IKK	B-X
activation	B-X
and	B-X
subsequent	B-X
blocking	B-X
of	B-X
phosphorylation	B-X
and	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
mangiferin	B-X
inhibits	B-X
TNF-induced	B-X
p65	B-X
phosphorylation	B-X
as	B-X
well	B-X
as	B-X
translocation	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
also	B-X
inhibits	B-X
NF-kappaB	B-X
activation	B-X
induced	B-X
by	B-X
other	B-X
inflammatory	B-X
agents	B-X
like	B-X
PMA	B-X
,	B-X
ceramide	B-X
,	B-X
and	B-X
SA-LPS	B-X
.	B-X
Mangiferin	B-X
,	B-X
similar	B-X
to	B-X
the	B-X
other	B-X
known	B-X
antioxidants	B-X
,	B-X
NAC	B-X
and	B-X
PDTC	B-X
,	B-X
inhibits	B-X
TNF-induced	B-X
reactive	B-X
oxygen	B-X
intermediate	B-X
(	B-X
ROI	B-X
)	B-X
generation	B-X
.	B-X
Since	B-X
intracellular	B-X
glutathione	B-X
(	B-X
GSH	B-X
)	B-X
levels	B-X
are	B-X
known	B-X
to	B-X
modulate	B-X
NF-kappaB	B-X
levels	B-X
,	B-X
we	B-X
measured	B-X
the	B-X
levels	B-X
of	B-X
GSH	B-X
.	B-X
Mangiferin	B-X
enhances	B-X
glutathione	B-X
level	B-X
by	B-X
almost	B-X
2-fold	B-X
more	B-X
than	B-X
other	B-X
anti-oxidants	B-X
,	B-X
and	B-X
at	B-X
the	B-X
same	B-X
time	B-X
it	B-X
decreases	B-X
the	B-X
levels	B-X
of	B-X
GSSG	B-X
and	B-X
increases	B-X
the	B-X
activity	B-X
of	B-X
catalase	B-X
.	B-X
Depletion	B-X
of	B-X
GSH	B-X
by	B-X
buthionine	B-X
sulfoximine	B-X
led	B-X
to	B-X
a	B-X
significant	B-X
reversal	B-X
of	B-X
mangiferin	B-X
effect	B-X
.	B-X
Hence	B-X
mangiferin	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
inhibit	B-X
NF-kappaB	B-X
and	B-X
increase	B-X
the	B-X
intracellular	B-X
GSH	B-X
levels	B-X
may	B-X
prove	B-X
to	B-X
be	B-X
a	B-X
potent	B-X
drug	B-X
for	B-X
anti-inflammatory	B-X
and	B-X
antioxidant	B-X
therapy	B-X
.	B-X
Mangiferin-mediated	B-X
down-regulation	B-X
of	B-X
NF-kappaB	B-X
also	B-X
potentiates	B-X
chemotherapeutic	B-X
agent-mediated	B-X
cell	B-X
death	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
in	B-X
combination	B-X
therapy	B-X
for	B-X
cancer	B-X
.	B-X

Mangiferin	O
enhances	O
glutathione	O
level	O
by	O
almost	O
2	O
-	O
fold	O
more	O
than	O
other	O
anti	O
-	O
oxidants	O
,	O
and	O
at	O
the	O
same	O
time	O
it	O
decreases	O
the	O
levels	O
of	O
GSSG	O
and	O
increases	O
the	O
activity	O
of	O
catalase	B-Gene_or_gene_product
.	O
<EOS>	B-X
Mangiferin	B-X
,	B-X
a	B-X
natural	B-X
polyphenol	B-X
is	B-X
known	B-X
to	B-X
exhibit	B-X
anti-inflammatory	B-X
,	B-X
antioxidant	B-X
,	B-X
and	B-X
antiviral	B-X
effects	B-X
.	B-X
Our	B-X
results	B-X
show	B-X
that	B-X
mangiferin	B-X
blocks	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-induced	B-X
NF-kappaB	B-X
activation	B-X
and	B-X
NF-kappaB-dependent	B-X
genes	B-X
like	B-X
ICAM1	B-X
and	B-X
COX2	B-X
.	B-X
Mangiferin	B-X
,	B-X
similar	B-X
to	B-X
the	B-X
other	B-X
known	B-X
antioxidants	B-X
,	B-X
NAC	B-X
and	B-X
PDTC	B-X
,	B-X
inhibits	B-X
TNF-induced	B-X
reactive	B-X
oxygen	B-X
intermediate	B-X
(	B-X
ROI	B-X
)	B-X
generation	B-X
.	B-X
Since	B-X
intracellular	B-X
glutathione	B-X
(	B-X
GSH	B-X
)	B-X
levels	B-X
are	B-X
known	B-X
to	B-X
modulate	B-X
NF-kappaB	B-X
levels	B-X
,	B-X
we	B-X
measured	B-X
the	B-X
levels	B-X
of	B-X
GSH	B-X
.	B-X
Mangiferin	B-X
enhances	B-X
glutathione	B-X
level	B-X
by	B-X
almost	B-X
2-fold	B-X
more	B-X
than	B-X
other	B-X
anti-oxidants	B-X
,	B-X
and	B-X
at	B-X
the	B-X
same	B-X
time	B-X
it	B-X
decreases	B-X
the	B-X
levels	B-X
of	B-X
GSSG	B-X
and	B-X
increases	B-X
the	B-X
activity	B-X
of	B-X
catalase	B-X
.	B-X
Hence	B-X
mangiferin	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
inhibit	B-X
NF-kappaB	B-X
and	B-X
increase	B-X
the	B-X
intracellular	B-X
GSH	B-X
levels	B-X
may	B-X
prove	B-X
to	B-X
be	B-X
a	B-X
potent	B-X
drug	B-X
for	B-X
anti-inflammatory	B-X
and	B-X
antioxidant	B-X
therapy	B-X
.	B-X
Mangiferin-mediated	B-X
down-regulation	B-X
of	B-X
NF-kappaB	B-X
also	B-X
potentiates	B-X
chemotherapeutic	B-X
agent-mediated	B-X
cell	B-X
death	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
in	B-X
combination	B-X
therapy	B-X
for	B-X
cancer	B-X
.	B-X

Depletion	O
of	O
GSH	O
by	O
buthionine	O
sulfoximine	O
led	O
to	O
a	O
significant	O
reversal	O
of	O
mangiferin	O
effect	O
.	O
<EOS>	B-X
Mangiferin	B-X
,	B-X
a	B-X
natural	B-X
polyphenol	B-X
is	B-X
known	B-X
to	B-X
exhibit	B-X
anti-inflammatory	B-X
,	B-X
antioxidant	B-X
,	B-X
and	B-X
antiviral	B-X
effects	B-X
.	B-X
However	B-X
the	B-X
molecular	B-X
mechanism	B-X
underlying	B-X
these	B-X
effects	B-X
has	B-X
not	B-X
been	B-X
well	B-X
characterized	B-X
.	B-X
Because	B-X
NF-kappaB	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
these	B-X
processes	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
mangiferin	B-X
modulates	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Our	B-X
results	B-X
show	B-X
that	B-X
mangiferin	B-X
blocks	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-induced	B-X
NF-kappaB	B-X
activation	B-X
and	B-X
NF-kappaB-dependent	B-X
genes	B-X
like	B-X
ICAM1	B-X
and	B-X
COX2	B-X
.	B-X
The	B-X
effect	B-X
was	B-X
mediated	B-X
through	B-X
inhibition	B-X
of	B-X
IKK	B-X
activation	B-X
and	B-X
subsequent	B-X
blocking	B-X
of	B-X
phosphorylation	B-X
and	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
mangiferin	B-X
inhibits	B-X
TNF-induced	B-X
p65	B-X
phosphorylation	B-X
as	B-X
well	B-X
as	B-X
translocation	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
also	B-X
inhibits	B-X
NF-kappaB	B-X
activation	B-X
induced	B-X
by	B-X
other	B-X
inflammatory	B-X
agents	B-X
like	B-X
PMA	B-X
,	B-X
ceramide	B-X
,	B-X
and	B-X
SA-LPS	B-X
.	B-X
Since	B-X
intracellular	B-X
glutathione	B-X
(	B-X
GSH	B-X
)	B-X
levels	B-X
are	B-X
known	B-X
to	B-X
modulate	B-X
NF-kappaB	B-X
levels	B-X
,	B-X
we	B-X
measured	B-X
the	B-X
levels	B-X
of	B-X
GSH	B-X
.	B-X
Depletion	B-X
of	B-X
GSH	B-X
by	B-X
buthionine	B-X
sulfoximine	B-X
led	B-X
to	B-X
a	B-X
significant	B-X
reversal	B-X
of	B-X
mangiferin	B-X
effect	B-X
.	B-X
Hence	B-X
mangiferin	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
inhibit	B-X
NF-kappaB	B-X
and	B-X
increase	B-X
the	B-X
intracellular	B-X
GSH	B-X
levels	B-X
may	B-X
prove	B-X
to	B-X
be	B-X
a	B-X
potent	B-X
drug	B-X
for	B-X
anti-inflammatory	B-X
and	B-X
antioxidant	B-X
therapy	B-X
.	B-X

Hence	O
mangiferin	O
with	O
its	O
ability	O
to	O
inhibit	O
NF	O
-	O
kappaB	O
and	O
increase	O
the	O
intracellular	O
GSH	O
levels	O
may	O
prove	O
to	O
be	O
a	O
potent	O
drug	O
for	O
anti	O
-	O
inflammatory	O
and	O
antioxidant	O
therapy	O
.	O
<EOS>	B-X
Mangiferin	B-X
,	B-X
a	B-X
natural	B-X
polyphenol	B-X
is	B-X
known	B-X
to	B-X
exhibit	B-X
anti-inflammatory	B-X
,	B-X
antioxidant	B-X
,	B-X
and	B-X
antiviral	B-X
effects	B-X
.	B-X
Because	B-X
NF-kappaB	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
these	B-X
processes	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
mangiferin	B-X
modulates	B-X
NF-kappaB	B-X
activation	B-X
.	B-X
Our	B-X
results	B-X
show	B-X
that	B-X
mangiferin	B-X
blocks	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-induced	B-X
NF-kappaB	B-X
activation	B-X
and	B-X
NF-kappaB-dependent	B-X
genes	B-X
like	B-X
ICAM1	B-X
and	B-X
COX2	B-X
.	B-X
The	B-X
effect	B-X
was	B-X
mediated	B-X
through	B-X
inhibition	B-X
of	B-X
IKK	B-X
activation	B-X
and	B-X
subsequent	B-X
blocking	B-X
of	B-X
phosphorylation	B-X
and	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
mangiferin	B-X
inhibits	B-X
TNF-induced	B-X
p65	B-X
phosphorylation	B-X
as	B-X
well	B-X
as	B-X
translocation	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
also	B-X
inhibits	B-X
NF-kappaB	B-X
activation	B-X
induced	B-X
by	B-X
other	B-X
inflammatory	B-X
agents	B-X
like	B-X
PMA	B-X
,	B-X
ceramide	B-X
,	B-X
and	B-X
SA-LPS	B-X
.	B-X
Mangiferin	B-X
,	B-X
similar	B-X
to	B-X
the	B-X
other	B-X
known	B-X
antioxidants	B-X
,	B-X
NAC	B-X
and	B-X
PDTC	B-X
,	B-X
inhibits	B-X
TNF-induced	B-X
reactive	B-X
oxygen	B-X
intermediate	B-X
(	B-X
ROI	B-X
)	B-X
generation	B-X
.	B-X
Since	B-X
intracellular	B-X
glutathione	B-X
(	B-X
GSH	B-X
)	B-X
levels	B-X
are	B-X
known	B-X
to	B-X
modulate	B-X
NF-kappaB	B-X
levels	B-X
,	B-X
we	B-X
measured	B-X
the	B-X
levels	B-X
of	B-X
GSH	B-X
.	B-X
Mangiferin	B-X
enhances	B-X
glutathione	B-X
level	B-X
by	B-X
almost	B-X
2-fold	B-X
more	B-X
than	B-X
other	B-X
anti-oxidants	B-X
,	B-X
and	B-X
at	B-X
the	B-X
same	B-X
time	B-X
it	B-X
decreases	B-X
the	B-X
levels	B-X
of	B-X
GSSG	B-X
and	B-X
increases	B-X
the	B-X
activity	B-X
of	B-X
catalase	B-X
.	B-X
Depletion	B-X
of	B-X
GSH	B-X
by	B-X
buthionine	B-X
sulfoximine	B-X
led	B-X
to	B-X
a	B-X
significant	B-X
reversal	B-X
of	B-X
mangiferin	B-X
effect	B-X
.	B-X
Hence	B-X
mangiferin	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
inhibit	B-X
NF-kappaB	B-X
and	B-X
increase	B-X
the	B-X
intracellular	B-X
GSH	B-X
levels	B-X
may	B-X
prove	B-X
to	B-X
be	B-X
a	B-X
potent	B-X
drug	B-X
for	B-X
anti-inflammatory	B-X
and	B-X
antioxidant	B-X
therapy	B-X
.	B-X
Mangiferin-mediated	B-X
down-regulation	B-X
of	B-X
NF-kappaB	B-X
also	B-X
potentiates	B-X
chemotherapeutic	B-X
agent-mediated	B-X
cell	B-X
death	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
in	B-X
combination	B-X
therapy	B-X
for	B-X
cancer	B-X
.	B-X

Mangiferin	O
-	O
mediated	O
down	O
-	O
regulation	O
of	O
NF	O
-	O
kappaB	O
also	O
potentiates	O
chemotherapeutic	O
agent	O
-	O
mediated	O
cell	O
death	O
,	O
suggesting	O
a	O
role	O
in	O
combination	O
therapy	O
for	O
cancer	O
.	O
<EOS>	B-X
Mangiferin-mediated	B-X
down-regulation	B-X
of	B-X
NFκB	B-X
showed	B-X
potential	B-X
for	B-X
chemotherapeutic	B-X
agent-mediated	B-X
cell	B-X
death	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
in	B-X
combination	B-X
therapy	B-X
for	B-X
cancer	B-X
.	B-X
In	B-X
this	B-X
study	B-X
the	B-X
combined	B-X
mechanism	B-X
of	B-X
the	B-X
anticancer	B-X
action	B-X
of	B-X
oxaliplatin	B-X
and	B-X
mangiferin	B-X
was	B-X
investigated	B-X
.	B-X
MTT	B-X
dose	B-X
response	B-X
curves	B-X
,	B-X
trypan	B-X
blue	B-X
staining	B-X
,	B-X
caspase	B-X
3	B-X
assays	B-X
as	B-X
well	B-X
as	B-X
DNA	B-X
cell	B-X
cycle	B-X
analyses	B-X
were	B-X
performed	B-X
on	B-X
HeLa	B-X
,	B-X
HT29	B-X
and	B-X
MCF7	B-X
cancer	B-X
cell	B-X
lines	B-X
,	B-X
with	B-X
and	B-X
without	B-X
the	B-X
addition	B-X
of	B-X
10	B-X
µg/ml	B-X
mangiferin	B-X
.	B-X
Mitochondrial	B-X
membrane	B-X
potential	B-X
,	B-X
DNA	B-X
fragmentation	B-X
,	B-X
resistance	B-X
induction	B-X
studies	B-X
and	B-X
NFκB	B-X
assays	B-X
were	B-X
performed	B-X
on	B-X
HT29	B-X
cells	B-X
only	B-X
.	B-X
Addition	B-X
of	B-X
10	B-X
µg/ml	B-X
mangiferin	B-X
reduced	B-X
oxaliplatin	B-X
IC	B-X
(	B-X
50	B-X
)	B-X
values	B-X
in	B-X
HT29	B-X
(	B-X
3.4	B-X
fold	B-X
)	B-X
and	B-X
HeLa	B-X
(	B-X
1.7	B-X
fold	B-X
)	B-X
cells	B-X
in	B-X
the	B-X
MTT	B-X
assay	B-X
while	B-X
reducing	B-X
trypan	B-X
blue	B-X
staining	B-X
.	B-X
This	B-X
was	B-X
accompanied	B-X
by	B-X
increased	B-X
caspase	B-X
3	B-X
activation	B-X
and	B-X
DNA	B-X
fragmentation	B-X
and	B-X
a	B-X
delay	B-X
in	B-X
the	B-X
S-phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Mitochondrial	B-X
membrane	B-X
permeabilization	B-X
was	B-X
not	B-X
enhanced	B-X
in	B-X
the	B-X
combination	B-X
treatment	B-X
.	B-X
Mangiferin	B-X
was	B-X
shown	B-X
to	B-X
cause	B-X
a	B-X
reduction	B-X
of	B-X
NF-κB	B-X
activation	B-X
in	B-X
HT29	B-X
cells	B-X
rendered	B-X
resistant	B-X
to	B-X
oxaliplatin	B-X
.	B-X
The	B-X
present	B-X
study	B-X
indicates	B-X
that	B-X
mangiferin	B-X
in	B-X
combination	B-X
with	B-X
oxaliplatin	B-X
favours	B-X
apoptotic	B-X
cell	B-X
death	B-X
and	B-X
thereby	B-X
improves	B-X
the	B-X
efficacy	B-X
of	B-X
oxaliplatin	B-X
in	B-X
vitro	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
combination	B-X
therapy	B-X
with	B-X
mangiferin	B-X
may	B-X
also	B-X
counteract	B-X
the	B-X
development	B-X
of	B-X
resistance	B-X
in	B-X
cancer	B-X
cell	B-X
lines	B-X
.	B-X

Endogenous	O
ligands	O
of	O
Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
.	O
<EOS>	B-X
Pattern	B-X
recognition	B-X
receptors	B-X
(	B-X
PRRs	B-X
)	B-X
,	B-X
expressed	B-X
by	B-X
astrocytes	B-X
and	B-X
microglia	B-X
,	B-X
sense	B-X
pathogen-derived	B-X
or	B-X
endogenous	B-X
ligands	B-X
released	B-X
by	B-X
damaged	B-X
cells	B-X
and	B-X
initiate	B-X
the	B-X
innate	B-X
immune	B-X
response	B-X
.	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
are	B-X
a	B-X
well-characterized	B-X
family	B-X
of	B-X
PRRs	B-X
.	B-X
The	B-X
innate	B-X
immune	B-X
system	B-X
has	B-X
the	B-X
capacity	B-X
to	B-X
detect	B-X
'non-self	B-X
'	B-X
molecules	B-X
derived	B-X
from	B-X
pathogens	B-X
,	B-X
known	B-X
as	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
,	B-X
via	B-X
pattern	B-X
recognition	B-X
receptors	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
an	B-X
increasing	B-X
number	B-X
of	B-X
endogenous	B-X
host-derived	B-X
molecules	B-X
,	B-X
termed	B-X
damage-associated	B-X
molecular	B-X
patterns	B-X
(	B-X
DAMPs	B-X
)	B-X
,	B-X
have	B-X
been	B-X
found	B-X
to	B-X
be	B-X
sensed	B-X
by	B-X
various	B-X
innate	B-X
immune	B-X
receptors	B-X
.	B-X
Here	B-X
we	B-X
examine	B-X
recent	B-X
discoveries	B-X
concerning	B-X
the	B-X
roles	B-X
of	B-X
DAMP-sensing	B-X
receptors	B-X
in	B-X
sterile	B-X
inflammation	B-X
and	B-X
in	B-X
diseases	B-X
resulting	B-X
from	B-X
dysregulated	B-X
sterile	B-X
inflammation	B-X
,	B-X
and	B-X
then	B-X
discuss	B-X
insights	B-X
into	B-X
the	B-X
cross-regulation	B-X
of	B-X
these	B-X
receptors	B-X
and	B-X
their	B-X
ligands	B-X
.	B-X

Extensive	O
work	O
has	O
suggested	O
that	O
a	O
number	O
of	O
endogenous	O
molecules	O
such	O
as	O
heat	B-Gene_or_gene_product
shock	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
(	O
hsp	B-Gene_or_gene_product
)	O
may	O
be	O
potent	O
activators	O
of	O
the	O
innate	O
immune	O
system	O
capable	O
of	O
inducing	O
proinflammatory	O
cytokine	O
production	O
by	O
the	O
monocyte	O
-	O
macrophage	O
system	O
and	O
the	O
activation	O
and	O
maturation	O
of	O
dendritic	O
cells	O
.	O
<EOS>	B-X
Extensive	B-X
work	B-X
has	B-X
suggested	B-X
that	B-X
a	B-X
number	B-X
of	B-X
endogenous	B-X
molecules	B-X
such	B-X
as	B-X
heat	B-X
shock	B-X
proteins	B-X
(	B-X
hsp	B-X
)	B-X
may	B-X
be	B-X
potent	B-X
activators	B-X
of	B-X
the	B-X
innate	B-X
immune	B-X
system	B-X
capable	B-X
of	B-X
inducing	B-X
proinflammatory	B-X
cytokine	B-X
production	B-X
by	B-X
the	B-X
monocyte-macrophage	B-X
system	B-X
and	B-X
the	B-X
activation	B-X
and	B-X
maturation	B-X
of	B-X
dendritic	B-X
cells	B-X
.	B-X
The	B-X
cytokine-like	B-X
effects	B-X
of	B-X
these	B-X
endogenous	B-X
molecules	B-X
are	B-X
mediated	B-X
via	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
signal-transduction	B-X
pathways	B-X
in	B-X
a	B-X
manner	B-X
similar	B-X
to	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
;	B-X
via	B-X
TLR4	B-X
)	B-X
and	B-X
bacterial	B-X
lipoproteins	B-X
(	B-X
via	B-X
TLR2	B-X
)	B-X
.	B-X
However	B-X
,	B-X
recent	B-X
evidence	B-X
suggests	B-X
that	B-X
the	B-X
reported	B-X
cytokine	B-X
effects	B-X
of	B-X
hsp	B-X
may	B-X
be	B-X
a	B-X
result	B-X
of	B-X
the	B-X
contaminating	B-X
LPS	B-X
and	B-X
LPS-associated	B-X
molecules	B-X
.	B-X
The	B-X
reasons	B-X
for	B-X
previous	B-X
failure	B-X
to	B-X
recognize	B-X
the	B-X
contaminant	B-X
(	B-X
s	B-X
)	B-X
being	B-X
responsible	B-X
for	B-X
the	B-X
putative	B-X
TLR	B-X
ligands	B-X
of	B-X
hsp	B-X
include	B-X
failure	B-X
to	B-X
use	B-X
highly	B-X
purified	B-X
hsp	B-X
free	B-X
of	B-X
LPS	B-X
contamination	B-X
;	B-X
failure	B-X
to	B-X
recognize	B-X
the	B-X
heat	B-X
sensitivity	B-X
of	B-X
LPS	B-X
;	B-X
and	B-X
failure	B-X
to	B-X
consider	B-X
contaminant	B-X
(	B-X
s	B-X
)	B-X
other	B-X
than	B-X
LPS	B-X
.	B-X
Whether	B-X
other	B-X
reported	B-X
putative	B-X
endogenous	B-X
ligands	B-X
of	B-X
TLR2	B-X
and	B-X
TLR4	B-X
are	B-X
a	B-X
result	B-X
of	B-X
contamination	B-X
of	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
is	B-X
not	B-X
clear	B-X
.	B-X
It	B-X
is	B-X
essential	B-X
that	B-X
efforts	B-X
should	B-X
be	B-X
directed	B-X
to	B-X
conclusively	B-X
determine	B-X
whether	B-X
the	B-X
reported	B-X
putative	B-X
endogenous	B-X
ligands	B-X
of	B-X
TLRs	B-X
are	B-X
a	B-X
result	B-X
of	B-X
the	B-X
endogenous	B-X
molecules	B-X
or	B-X
of	B-X
contaminant	B-X
(	B-X
s	B-X
)	B-X
,	B-X
before	B-X
exploring	B-X
further	B-X
the	B-X
implication	B-X
and	B-X
therapeutic	B-X
potential	B-X
of	B-X
these	B-X
putative	B-X
TLR	B-X
ligands	B-X
.	B-X

The	O
cytokine	O
-	O
like	O
effects	O
of	O
these	O
endogenous	O
molecules	O
are	O
mediated	O
via	O
the	O
Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	O
TLR	B-Gene_or_gene_product
)	O
signal	O
-	O
transduction	O
pathways	O
in	O
a	O
manner	O
similar	O
to	O
lipopolysaccharide	O
(	O
LPS	O
;	O
via	O
TLR4	B-Gene_or_gene_product
)	O
and	O
bacterial	O
lipoproteins	O
(	O
via	O
TLR2	B-Gene_or_gene_product
)	O
.	O

However	O
,	O
recent	O
evidence	O
suggests	O
that	O
the	O
reported	O
cytokine	O
effects	O
of	O
hsp	B-Gene_or_gene_product
may	O
be	O
a	O
result	O
of	O
the	O
contaminating	O
LPS	O
and	O
LPS	O
-	O
associated	O
molecules	O
.	O
<EOS>	B-X
Extensive	B-X
work	B-X
has	B-X
suggested	B-X
that	B-X
a	B-X
number	B-X
of	B-X
endogenous	B-X
molecules	B-X
such	B-X
as	B-X
heat	B-X
shock	B-X
proteins	B-X
(	B-X
hsp	B-X
)	B-X
may	B-X
be	B-X
potent	B-X
activators	B-X
of	B-X
the	B-X
innate	B-X
immune	B-X
system	B-X
capable	B-X
of	B-X
inducing	B-X
proinflammatory	B-X
cytokine	B-X
production	B-X
by	B-X
the	B-X
monocyte-macrophage	B-X
system	B-X
and	B-X
the	B-X
activation	B-X
and	B-X
maturation	B-X
of	B-X
dendritic	B-X
cells	B-X
.	B-X
The	B-X
cytokine-like	B-X
effects	B-X
of	B-X
these	B-X
endogenous	B-X
molecules	B-X
are	B-X
mediated	B-X
via	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
signal-transduction	B-X
pathways	B-X
in	B-X
a	B-X
manner	B-X
similar	B-X
to	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
;	B-X
via	B-X
TLR4	B-X
)	B-X
and	B-X
bacterial	B-X
lipoproteins	B-X
(	B-X
via	B-X
TLR2	B-X
)	B-X
.	B-X
However	B-X
,	B-X
recent	B-X
evidence	B-X
suggests	B-X
that	B-X
the	B-X
reported	B-X
cytokine	B-X
effects	B-X
of	B-X
hsp	B-X
may	B-X
be	B-X
a	B-X
result	B-X
of	B-X
the	B-X
contaminating	B-X
LPS	B-X
and	B-X
LPS-associated	B-X
molecules	B-X
.	B-X
The	B-X
reasons	B-X
for	B-X
previous	B-X
failure	B-X
to	B-X
recognize	B-X
the	B-X
contaminant	B-X
(	B-X
s	B-X
)	B-X
being	B-X
responsible	B-X
for	B-X
the	B-X
putative	B-X
TLR	B-X
ligands	B-X
of	B-X
hsp	B-X
include	B-X
failure	B-X
to	B-X
use	B-X
highly	B-X
purified	B-X
hsp	B-X
free	B-X
of	B-X
LPS	B-X
contamination	B-X
;	B-X
failure	B-X
to	B-X
recognize	B-X
the	B-X
heat	B-X
sensitivity	B-X
of	B-X
LPS	B-X
;	B-X
and	B-X
failure	B-X
to	B-X
consider	B-X
contaminant	B-X
(	B-X
s	B-X
)	B-X
other	B-X
than	B-X
LPS	B-X
.	B-X
Whether	B-X
other	B-X
reported	B-X
putative	B-X
endogenous	B-X
ligands	B-X
of	B-X
TLR2	B-X
and	B-X
TLR4	B-X
are	B-X
a	B-X
result	B-X
of	B-X
contamination	B-X
of	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
is	B-X
not	B-X
clear	B-X
.	B-X
It	B-X
is	B-X
essential	B-X
that	B-X
efforts	B-X
should	B-X
be	B-X
directed	B-X
to	B-X
conclusively	B-X
determine	B-X
whether	B-X
the	B-X
reported	B-X
putative	B-X
endogenous	B-X
ligands	B-X
of	B-X
TLRs	B-X
are	B-X
a	B-X
result	B-X
of	B-X
the	B-X
endogenous	B-X
molecules	B-X
or	B-X
of	B-X
contaminant	B-X
(	B-X
s	B-X
)	B-X
,	B-X
before	B-X
exploring	B-X
further	B-X
the	B-X
implication	B-X
and	B-X
therapeutic	B-X
potential	B-X
of	B-X
these	B-X
putative	B-X
TLR	B-X
ligands	B-X
.	B-X

The	O
reasons	O
for	O
previous	O
failure	O
to	O
recognize	O
the	O
contaminant	O
(	O
s	O
)	O
being	O
responsible	O
for	O
the	O
putative	O
TLR	B-Gene_or_gene_product
ligands	O
of	O
hsp	B-Gene_or_gene_product
include	O
failure	O
to	O
use	O
highly	O
purified	O
hsp	B-Gene_or_gene_product
free	O
of	O
LPS	O
contamination	O
;	O
failure	O
to	O
recognize	O
the	O
heat	O
sensitivity	O
of	O
LPS	O
;	O
and	O
failure	O
to	O
consider	O
contaminant	O
(	O
s	O
)	O
other	O
than	O
LPS	O
.	O
<EOS>	B-X
Extensive	B-X
work	B-X
has	B-X
suggested	B-X
that	B-X
a	B-X
number	B-X
of	B-X
endogenous	B-X
molecules	B-X
such	B-X
as	B-X
heat	B-X
shock	B-X
proteins	B-X
(	B-X
hsp	B-X
)	B-X
may	B-X
be	B-X
potent	B-X
activators	B-X
of	B-X
the	B-X
innate	B-X
immune	B-X
system	B-X
capable	B-X
of	B-X
inducing	B-X
proinflammatory	B-X
cytokine	B-X
production	B-X
by	B-X
the	B-X
monocyte-macrophage	B-X
system	B-X
and	B-X
the	B-X
activation	B-X
and	B-X
maturation	B-X
of	B-X
dendritic	B-X
cells	B-X
.	B-X
The	B-X
cytokine-like	B-X
effects	B-X
of	B-X
these	B-X
endogenous	B-X
molecules	B-X
are	B-X
mediated	B-X
via	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
signal-transduction	B-X
pathways	B-X
in	B-X
a	B-X
manner	B-X
similar	B-X
to	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
;	B-X
via	B-X
TLR4	B-X
)	B-X
and	B-X
bacterial	B-X
lipoproteins	B-X
(	B-X
via	B-X
TLR2	B-X
)	B-X
.	B-X
However	B-X
,	B-X
recent	B-X
evidence	B-X
suggests	B-X
that	B-X
the	B-X
reported	B-X
cytokine	B-X
effects	B-X
of	B-X
hsp	B-X
may	B-X
be	B-X
a	B-X
result	B-X
of	B-X
the	B-X
contaminating	B-X
LPS	B-X
and	B-X
LPS-associated	B-X
molecules	B-X
.	B-X
The	B-X
reasons	B-X
for	B-X
previous	B-X
failure	B-X
to	B-X
recognize	B-X
the	B-X
contaminant	B-X
(	B-X
s	B-X
)	B-X
being	B-X
responsible	B-X
for	B-X
the	B-X
putative	B-X
TLR	B-X
ligands	B-X
of	B-X
hsp	B-X
include	B-X
failure	B-X
to	B-X
use	B-X
highly	B-X
purified	B-X
hsp	B-X
free	B-X
of	B-X
LPS	B-X
contamination	B-X
;	B-X
failure	B-X
to	B-X
recognize	B-X
the	B-X
heat	B-X
sensitivity	B-X
of	B-X
LPS	B-X
;	B-X
and	B-X
failure	B-X
to	B-X
consider	B-X
contaminant	B-X
(	B-X
s	B-X
)	B-X
other	B-X
than	B-X
LPS	B-X
.	B-X
Whether	B-X
other	B-X
reported	B-X
putative	B-X
endogenous	B-X
ligands	B-X
of	B-X
TLR2	B-X
and	B-X
TLR4	B-X
are	B-X
a	B-X
result	B-X
of	B-X
contamination	B-X
of	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
is	B-X
not	B-X
clear	B-X
.	B-X
It	B-X
is	B-X
essential	B-X
that	B-X
efforts	B-X
should	B-X
be	B-X
directed	B-X
to	B-X
conclusively	B-X
determine	B-X
whether	B-X
the	B-X
reported	B-X
putative	B-X
endogenous	B-X
ligands	B-X
of	B-X
TLRs	B-X
are	B-X
a	B-X
result	B-X
of	B-X
the	B-X
endogenous	B-X
molecules	B-X
or	B-X
of	B-X
contaminant	B-X
(	B-X
s	B-X
)	B-X
,	B-X
before	B-X
exploring	B-X
further	B-X
the	B-X
implication	B-X
and	B-X
therapeutic	B-X
potential	B-X
of	B-X
these	B-X
putative	B-X
TLR	B-X
ligands	B-X
.	B-X

Whether	O
other	O
reported	O
putative	O
endogenous	O
ligands	O
of	O
TLR2	B-Gene_or_gene_product
and	O
TLR4	B-Gene_or_gene_product
are	O
a	O
result	O
of	O
contamination	O
of	O
pathogen	O
-	O
associated	O
molecular	O
patterns	O
is	O
not	O
clear	O
.	O

It	O
is	O
essential	O
that	O
efforts	O
should	O
be	O
directed	O
to	O
conclusively	O
determine	O
whether	O
the	O
reported	O
putative	O
endogenous	O
ligands	O
of	O
TLRs	B-Gene_or_gene_product
are	O
a	O
result	O
of	O
the	O
endogenous	O
molecules	O
or	O
of	O
contaminant	O
(	O
s	O
)	O
,	O
before	O
exploring	O
further	O
the	O
implication	O
and	O
therapeutic	O
potential	O
of	O
these	O
putative	O
TLR	B-Gene_or_gene_product
ligands	O
.	O
<EOS>	B-X
Extensive	B-X
work	B-X
has	B-X
suggested	B-X
that	B-X
a	B-X
number	B-X
of	B-X
endogenous	B-X
molecules	B-X
such	B-X
as	B-X
heat	B-X
shock	B-X
proteins	B-X
(	B-X
hsp	B-X
)	B-X
may	B-X
be	B-X
potent	B-X
activators	B-X
of	B-X
the	B-X
innate	B-X
immune	B-X
system	B-X
capable	B-X
of	B-X
inducing	B-X
proinflammatory	B-X
cytokine	B-X
production	B-X
by	B-X
the	B-X
monocyte-macrophage	B-X
system	B-X
and	B-X
the	B-X
activation	B-X
and	B-X
maturation	B-X
of	B-X
dendritic	B-X
cells	B-X
.	B-X
The	B-X
cytokine-like	B-X
effects	B-X
of	B-X
these	B-X
endogenous	B-X
molecules	B-X
are	B-X
mediated	B-X
via	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
signal-transduction	B-X
pathways	B-X
in	B-X
a	B-X
manner	B-X
similar	B-X
to	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
;	B-X
via	B-X
TLR4	B-X
)	B-X
and	B-X
bacterial	B-X
lipoproteins	B-X
(	B-X
via	B-X
TLR2	B-X
)	B-X
.	B-X
However	B-X
,	B-X
recent	B-X
evidence	B-X
suggests	B-X
that	B-X
the	B-X
reported	B-X
cytokine	B-X
effects	B-X
of	B-X
hsp	B-X
may	B-X
be	B-X
a	B-X
result	B-X
of	B-X
the	B-X
contaminating	B-X
LPS	B-X
and	B-X
LPS-associated	B-X
molecules	B-X
.	B-X
The	B-X
reasons	B-X
for	B-X
previous	B-X
failure	B-X
to	B-X
recognize	B-X
the	B-X
contaminant	B-X
(	B-X
s	B-X
)	B-X
being	B-X
responsible	B-X
for	B-X
the	B-X
putative	B-X
TLR	B-X
ligands	B-X
of	B-X
hsp	B-X
include	B-X
failure	B-X
to	B-X
use	B-X
highly	B-X
purified	B-X
hsp	B-X
free	B-X
of	B-X
LPS	B-X
contamination	B-X
;	B-X
failure	B-X
to	B-X
recognize	B-X
the	B-X
heat	B-X
sensitivity	B-X
of	B-X
LPS	B-X
;	B-X
and	B-X
failure	B-X
to	B-X
consider	B-X
contaminant	B-X
(	B-X
s	B-X
)	B-X
other	B-X
than	B-X
LPS	B-X
.	B-X
Whether	B-X
other	B-X
reported	B-X
putative	B-X
endogenous	B-X
ligands	B-X
of	B-X
TLR2	B-X
and	B-X
TLR4	B-X
are	B-X
a	B-X
result	B-X
of	B-X
contamination	B-X
of	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
is	B-X
not	B-X
clear	B-X
.	B-X
It	B-X
is	B-X
essential	B-X
that	B-X
efforts	B-X
should	B-X
be	B-X
directed	B-X
to	B-X
conclusively	B-X
determine	B-X
whether	B-X
the	B-X
reported	B-X
putative	B-X
endogenous	B-X
ligands	B-X
of	B-X
TLRs	B-X
are	B-X
a	B-X
result	B-X
of	B-X
the	B-X
endogenous	B-X
molecules	B-X
or	B-X
of	B-X
contaminant	B-X
(	B-X
s	B-X
)	B-X
,	B-X
before	B-X
exploring	B-X
further	B-X
the	B-X
implication	B-X
and	B-X
therapeutic	B-X
potential	B-X
of	B-X
these	B-X
putative	B-X
TLR	B-X
ligands	B-X
.	B-X

Targeted	O
proteomic	O
study	O
of	O
the	O
cyclin	O
-	O
Cdk	O
module	O
.	O
<EOS>	B-X
The	B-X
cell	B-X
division	B-X
cycle	B-X
of	B-X
the	B-X
yeast	B-X
S.	B-X
cerevisiae	B-X
is	B-X
driven	B-X
by	B-X
one	B-X
Cdk	B-X
(	B-X
cyclin-dependent	B-X
kinase	B-X
)	B-X
,	B-X
which	B-X
becomes	B-X
active	B-X
when	B-X
bound	B-X
to	B-X
one	B-X
of	B-X
nine	B-X
cyclin	B-X
subunits	B-X
.	B-X
Elucidation	B-X
of	B-X
Cdk	B-X
substrates	B-X
and	B-X
other	B-X
Cdk-associated	B-X
proteins	B-X
is	B-X
essential	B-X
for	B-X
a	B-X
full	B-X
understanding	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
the	B-X
results	B-X
of	B-X
a	B-X
targeted	B-X
proteomics	B-X
study	B-X
using	B-X
affinity	B-X
purification	B-X
coupled	B-X
to	B-X
mass	B-X
spectrometry	B-X
.	B-X
Our	B-X
study	B-X
identified	B-X
numerous	B-X
proteins	B-X
in	B-X
association	B-X
with	B-X
particular	B-X
cyclin-Cdk	B-X
complexes	B-X
.	B-X
Using	B-X
a	B-X
hypothesis-driven	B-X
mass	B-X
spectrometric	B-X
approach	B-X
,	B-X
we	B-X
also	B-X
mapped	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
at	B-X
Cdk	B-X
consensus	B-X
motif-containing	B-X
peptides	B-X
within	B-X
several	B-X
cyclin-associated	B-X
candidate	B-X
Cdk	B-X
substrates	B-X
.	B-X
Our	B-X
results	B-X
demonstrate	B-X
that	B-X
this	B-X
approach	B-X
can	B-X
be	B-X
used	B-X
to	B-X
detect	B-X
a	B-X
host	B-X
of	B-X
transient	B-X
and	B-X
dynamic	B-X
protein	B-X
associations	B-X
within	B-X
a	B-X
biological	B-X
module	B-X
.	B-X

The	O
cell	O
division	O
cycle	O
of	O
the	O
yeast	O
S	O
.	O
cerevisiae	O
is	O
driven	O
by	O
one	O
Cdk	B-Gene_or_gene_product
(	O
cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
)	O
,	O
which	O
becomes	O
active	O
when	O
bound	O
to	O
one	O
of	O
nine	O
cyclin	O
subunits	O
.	O

Elucidation	O
of	O
Cdk	B-Gene_or_gene_product
substrates	O
and	O
other	O
Cdk	B-Gene_or_gene_product
-	O
associated	O
proteins	O
is	O
essential	O
for	O
a	O
full	O
understanding	O
of	O
the	O
cell	O
cycle	O
.	O
<EOS>	B-X
The	B-X
cell	B-X
division	B-X
cycle	B-X
of	B-X
the	B-X
yeast	B-X
S.	B-X
cerevisiae	B-X
is	B-X
driven	B-X
by	B-X
one	B-X
Cdk	B-X
(	B-X
cyclin-dependent	B-X
kinase	B-X
)	B-X
,	B-X
which	B-X
becomes	B-X
active	B-X
when	B-X
bound	B-X
to	B-X
one	B-X
of	B-X
nine	B-X
cyclin	B-X
subunits	B-X
.	B-X
Elucidation	B-X
of	B-X
Cdk	B-X
substrates	B-X
and	B-X
other	B-X
Cdk-associated	B-X
proteins	B-X
is	B-X
essential	B-X
for	B-X
a	B-X
full	B-X
understanding	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Our	B-X
study	B-X
identified	B-X
numerous	B-X
proteins	B-X
in	B-X
association	B-X
with	B-X
particular	B-X
cyclin-Cdk	B-X
complexes	B-X
.	B-X
These	B-X
included	B-X
phosphorylation	B-X
substrates	B-X
,	B-X
ubiquitination-degradation	B-X
proteins	B-X
,	B-X
adaptors	B-X
,	B-X
and	B-X
inhibitors	B-X
.	B-X
Using	B-X
a	B-X
hypothesis-driven	B-X
mass	B-X
spectrometric	B-X
approach	B-X
,	B-X
we	B-X
also	B-X
mapped	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
at	B-X
Cdk	B-X
consensus	B-X
motif-containing	B-X
peptides	B-X
within	B-X
several	B-X
cyclin-associated	B-X
candidate	B-X
Cdk	B-X
substrates	B-X
.	B-X

Here	O
,	O
we	O
report	O
the	O
results	O
of	O
a	O
targeted	O
proteomics	O
study	O
using	O
affinity	O
purification	O
coupled	O
to	O
mass	O
spectrometry	O
.	O
<EOS>	B-X
Previous	B-X
studies	B-X
have	B-X
reported	B-X
that	B-X
malonylation	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
inflammation	B-X
,	B-X
angiogenesis	B-X
,	B-X
and	B-X
diabetes	B-X
.	B-X
We	B-X
also	B-X
detected	B-X
a	B-X
decreased	B-X
lysine	B-X
malonylation	B-X
in	B-X
hypertrophic	B-X
H9C2	B-X
cardiomyocytes	B-X
induced	B-X
by	B-X
angiotensin	B-X
II	B-X
for	B-X
48	B-X
h.	B-X
Using	B-X
a	B-X
proteomic	B-X
method	B-X
based	B-X
on	B-X
affinity	B-X
purification	B-X
and	B-X
LC-MS/MS	B-X
,	B-X
we	B-X
identified	B-X
total	B-X
679	B-X
malonylated	B-X
sites	B-X
in	B-X
330	B-X
proteins	B-X
in	B-X
the	B-X
hearts	B-X
of	B-X
sham	B-X
mice	B-X
and	B-X
TAC	B-X
mice	B-X
.	B-X
Specifically	B-X
,	B-X
we	B-X
detected	B-X
a	B-X
decreased	B-X
lysine	B-X
malonylation	B-X
in	B-X
myocardial	B-X
isocitrate	B-X
dehydrogenase	B-X
2	B-X
(	B-X
IDH2	B-X
)	B-X
by	B-X
immunoprecipitation	B-X
coupled	B-X
with	B-X
Western	B-X
blotting	B-X
both	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
.	B-X
Cardiac	B-X
hypertrophy	B-X
can	B-X
be	B-X
regulated	B-X
at	B-X
post-translational	B-X
modifications	B-X
(	B-X
PTMs	B-X
)	B-X
,	B-X
and	B-X
several	B-X
PTMs	B-X
have	B-X
been	B-X
reported	B-X
in	B-X
cardiac	B-X
hypertrrophy	B-X
and	B-X
heart	B-X
failure	B-X
.	B-X
In	B-X
our	B-X
study	B-X
,	B-X
we	B-X
first	B-X
reported	B-X
a	B-X
novel	B-X
PTMs	B-X
,	B-X
lysine	B-X
malonylation	B-X
,	B-X
in	B-X
cardiac	B-X
hypertophy	B-X
.	B-X
Using	B-X
affinity	B-X
purification	B-X
and	B-X
LC-MS/MS	B-X
,	B-X
we	B-X
identified	B-X
679	B-X
malonylated	B-X
sites	B-X
in	B-X
330	B-X
proteins	B-X
in	B-X
the	B-X
hearts	B-X
of	B-X
sham	B-X
and	B-X
TAC	B-X
mice	B-X
.	B-X
Compared	B-X
to	B-X
the	B-X
sham	B-X
group	B-X
,	B-X
5	B-X
sites	B-X
in	B-X
2	B-X
proteins	B-X
were	B-X
quantified	B-X
as	B-X
downregulated	B-X
targets	B-X
using	B-X
a	B-X
2-fold	B-X
threshold	B-X
(	B-X
downregulation	B-X
<	B-X
0.5-fold	B-X
,	B-X
P	B-X
<	B-X
0.05	B-X
)	B-X
.	B-X
Notably	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
decreased	B-X
Kmal	B-X
level	B-X
in	B-X
isocitrate	B-X
dehydrogenase	B-X
2	B-X
(	B-X
IDH2	B-X
)	B-X
,	B-X
but	B-X
the	B-X
protein	B-X
level	B-X
of	B-X
IDH2	B-X
has	B-X
no	B-X
changed	B-X
in	B-X
cardiac	B-X
hypertrophy	B-X
,	B-X
These	B-X
results	B-X
highlight	B-X
that	B-X
lysine	B-X
malonylation	B-X
is	B-X
associated	B-X
with	B-X
cardiac	B-X
hypertrophy	B-X
,	B-X
and	B-X
may	B-X
be	B-X
a	B-X
new	B-X
therapeutic	B-X
target	B-X
of	B-X
the	B-X
disease	B-X
.	B-X

Our	O
study	O
identified	O
numerous	O
proteins	O
in	O
association	O
with	O
particular	O
cyclin	O
-	O
Cdk	O
complexes	O
.	O
<EOS>	B-X
The	B-X
cell	B-X
division	B-X
cycle	B-X
of	B-X
the	B-X
yeast	B-X
S.	B-X
cerevisiae	B-X
is	B-X
driven	B-X
by	B-X
one	B-X
Cdk	B-X
(	B-X
cyclin-dependent	B-X
kinase	B-X
)	B-X
,	B-X
which	B-X
becomes	B-X
active	B-X
when	B-X
bound	B-X
to	B-X
one	B-X
of	B-X
nine	B-X
cyclin	B-X
subunits	B-X
.	B-X
Elucidation	B-X
of	B-X
Cdk	B-X
substrates	B-X
and	B-X
other	B-X
Cdk-associated	B-X
proteins	B-X
is	B-X
essential	B-X
for	B-X
a	B-X
full	B-X
understanding	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
the	B-X
results	B-X
of	B-X
a	B-X
targeted	B-X
proteomics	B-X
study	B-X
using	B-X
affinity	B-X
purification	B-X
coupled	B-X
to	B-X
mass	B-X
spectrometry	B-X
.	B-X
Our	B-X
study	B-X
identified	B-X
numerous	B-X
proteins	B-X
in	B-X
association	B-X
with	B-X
particular	B-X
cyclin-Cdk	B-X
complexes	B-X
.	B-X
These	B-X
included	B-X
phosphorylation	B-X
substrates	B-X
,	B-X
ubiquitination-degradation	B-X
proteins	B-X
,	B-X
adaptors	B-X
,	B-X
and	B-X
inhibitors	B-X
.	B-X
Some	B-X
associations	B-X
were	B-X
previously	B-X
known	B-X
,	B-X
and	B-X
for	B-X
others	B-X
,	B-X
we	B-X
confirmed	B-X
their	B-X
specificity	B-X
and	B-X
biological	B-X
relevance	B-X
.	B-X
Using	B-X
a	B-X
hypothesis-driven	B-X
mass	B-X
spectrometric	B-X
approach	B-X
,	B-X
we	B-X
also	B-X
mapped	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
at	B-X
Cdk	B-X
consensus	B-X
motif-containing	B-X
peptides	B-X
within	B-X
several	B-X
cyclin-associated	B-X
candidate	B-X
Cdk	B-X
substrates	B-X
.	B-X
Our	B-X
results	B-X
demonstrate	B-X
that	B-X
this	B-X
approach	B-X
can	B-X
be	B-X
used	B-X
to	B-X
detect	B-X
a	B-X
host	B-X
of	B-X
transient	B-X
and	B-X
dynamic	B-X
protein	B-X
associations	B-X
within	B-X
a	B-X
biological	B-X
module	B-X
.	B-X

These	O
included	O
phosphorylation	O
substrates	O
,	O
ubiquitination	O
-	O
degradation	O
proteins	O
,	O
adaptors	O
,	O
and	O
inhibitors	O
.	O
<EOS>	B-X
The	B-X
adaptor	B-X
proteins	B-X
,	B-X
β-arrestins	B-X
1	B-X
and	B-X
2	B-X
,	B-X
were	B-X
originally	B-X
identified	B-X
as	B-X
inhibitors	B-X
of	B-X
G	B-X
protein	B-X
signaling	B-X
at	B-X
the	B-X
seven-transmembrane	B-X
receptors	B-X
(	B-X
7TMRs	B-X
,	B-X
also	B-X
called	B-X
G	B-X
protein-coupled	B-X
receptors	B-X
or	B-X
GPCRs	B-X
)	B-X
.	B-X
Subsequent	B-X
studies	B-X
have	B-X
established	B-X
β-arrestins	B-X
as	B-X
critical	B-X
multifunctional	B-X
7TMR	B-X
adaptors	B-X
that	B-X
mediate	B-X
receptor	B-X
trafficking	B-X
and	B-X
activate	B-X
G	B-X
protein-independent	B-X
signaling	B-X
pathways	B-X
.	B-X
7TMR	B-X
activation	B-X
leads	B-X
not	B-X
only	B-X
to	B-X
the	B-X
recruitment	B-X
of	B-X
arrestin	B-X
proteins	B-X
upon	B-X
phosphorylation	B-X
by	B-X
GPCR	B-X
kinases	B-X
but	B-X
also	B-X
to	B-X
β-arrestin	B-X
ubiquitination	B-X
.	B-X
β-Arrestin	B-X
ubiquitination	B-X
allows	B-X
it	B-X
to	B-X
form	B-X
protein	B-X
complexes	B-X
with	B-X
activated	B-X
7TMRs	B-X
,	B-X
endocytic	B-X
proteins	B-X
such	B-X
as	B-X
clathrin	B-X
,	B-X
and	B-X
phosphorylated	B-X
ERK1/2	B-X
.	B-X
β-Arrestin	B-X
ubiquitination	B-X
is	B-X
dependent	B-X
on	B-X
its	B-X
activated	B-X
conformation	B-X
and	B-X
likely	B-X
regulates	B-X
timing	B-X
and	B-X
subcellular	B-X
localization	B-X
of	B-X
various	B-X
protein	B-X
interactions	B-X
during	B-X
receptor	B-X
trafficking	B-X
and	B-X
signaling	B-X
.	B-X
β-Arrestins	B-X
also	B-X
serve	B-X
as	B-X
adaptors	B-X
that	B-X
escort	B-X
E3	B-X
ubiquitin	B-X
ligases	B-X
to	B-X
mediate	B-X
ubiquitination	B-X
of	B-X
a	B-X
wide	B-X
list	B-X
of	B-X
substrate	B-X
proteins	B-X
including	B-X
7TMRs	B-X
and	B-X
provide	B-X
an	B-X
added	B-X
layer	B-X
of	B-X
regulation	B-X
for	B-X
defining	B-X
substrate	B-X
specificity	B-X
in	B-X
the	B-X
cellular	B-X
ubiquitination	B-X
pathway	B-X
.	B-X

Some	O
associations	O
were	O
previously	O
known	O
,	O
and	O
for	O
others	O
,	O
we	O
confirmed	O
their	O
specificity	O
and	O
biological	O
relevance	O
.	O
<EOS>	B-X
In	B-X
2013	B-X
,	B-X
a	B-X
precursor	B-X
study	B-X
in	B-X
humans	B-X
was	B-X
published	B-X
in	B-X
the	B-X
European	B-X
Journal	B-X
of	B-X
Translation	B-X
Myology	B-X
(	B-X
formerly	B-X
known	B-X
as	B-X
Basic	B-X
and	B-X
Applied	B-X
Myology	B-X
)	B-X
,	B-X
highlighting	B-X
the	B-X
occurrence	B-X
of	B-X
reinnervation	B-X
in	B-X
the	B-X
musculature	B-X
of	B-X
aged	B-X
,	B-X
exercise-trained	B-X
individuals	B-X
as	B-X
compared	B-X
to	B-X
the	B-X
matching	B-X
control	B-X
.	B-X
Some	B-X
associations	B-X
were	B-X
previously	B-X
known	B-X
,	B-X
and	B-X
for	B-X
others	B-X
,	B-X
we	B-X
confirmed	B-X
their	B-X
specificity	B-X
and	B-X
biological	B-X
relevance	B-X
.	B-X
Our	B-X
results	B-X
demonstrate	B-X
that	B-X
this	B-X
approach	B-X
can	B-X
be	B-X
used	B-X
to	B-X
detect	B-X
a	B-X
host	B-X
of	B-X
transient	B-X
and	B-X
dynamic	B-X
protein	B-X
associations	B-X
within	B-X
a	B-X
biological	B-X
module	B-X
.	B-X
However	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
how	B-X
genetic	B-X
variations	B-X
result	B-X
in	B-X
phenotypic	B-X
changes	B-X
.	B-X
Quantitative	B-X
trait	B-X
loci	B-X
that	B-X
affect	B-X
levels	B-X
of	B-X
gene	B-X
expression	B-X
are	B-X
called	B-X
expression	B-X
quantitative	B-X
trait	B-X
loci	B-X
(	B-X
eQTL	B-X
)	B-X
,	B-X
which	B-X
can	B-X
provide	B-X
insight	B-X
into	B-X
the	B-X
biological	B-X
relevance	B-X
of	B-X
data	B-X
from	B-X
genome-wide	B-X
association	B-X
studies	B-X
.	B-X

Using	O
a	O
hypothesis	O
-	O
driven	O
mass	O
spectrometric	O
approach	O
,	O
we	O
also	O
mapped	O
in	O
vivo	O
phosphorylation	O
at	O
Cdk	B-Gene_or_gene_product
consensus	O
motif	O
-	O
containing	O
peptides	O
within	O
several	O
cyclin	O
-	O
associated	O
candidate	O
Cdk	B-Gene_or_gene_product
substrates	O
.	O
<EOS>	B-X
The	B-X
cell	B-X
division	B-X
cycle	B-X
of	B-X
the	B-X
yeast	B-X
S.	B-X
cerevisiae	B-X
is	B-X
driven	B-X
by	B-X
one	B-X
Cdk	B-X
(	B-X
cyclin-dependent	B-X
kinase	B-X
)	B-X
,	B-X
which	B-X
becomes	B-X
active	B-X
when	B-X
bound	B-X
to	B-X
one	B-X
of	B-X
nine	B-X
cyclin	B-X
subunits	B-X
.	B-X
Elucidation	B-X
of	B-X
Cdk	B-X
substrates	B-X
and	B-X
other	B-X
Cdk-associated	B-X
proteins	B-X
is	B-X
essential	B-X
for	B-X
a	B-X
full	B-X
understanding	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
the	B-X
results	B-X
of	B-X
a	B-X
targeted	B-X
proteomics	B-X
study	B-X
using	B-X
affinity	B-X
purification	B-X
coupled	B-X
to	B-X
mass	B-X
spectrometry	B-X
.	B-X
Our	B-X
study	B-X
identified	B-X
numerous	B-X
proteins	B-X
in	B-X
association	B-X
with	B-X
particular	B-X
cyclin-Cdk	B-X
complexes	B-X
.	B-X
These	B-X
included	B-X
phosphorylation	B-X
substrates	B-X
,	B-X
ubiquitination-degradation	B-X
proteins	B-X
,	B-X
adaptors	B-X
,	B-X
and	B-X
inhibitors	B-X
.	B-X
Using	B-X
a	B-X
hypothesis-driven	B-X
mass	B-X
spectrometric	B-X
approach	B-X
,	B-X
we	B-X
also	B-X
mapped	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
at	B-X
Cdk	B-X
consensus	B-X
motif-containing	B-X
peptides	B-X
within	B-X
several	B-X
cyclin-associated	B-X
candidate	B-X
Cdk	B-X
substrates	B-X
.	B-X
Our	B-X
results	B-X
demonstrate	B-X
that	B-X
this	B-X
approach	B-X
can	B-X
be	B-X
used	B-X
to	B-X
detect	B-X
a	B-X
host	B-X
of	B-X
transient	B-X
and	B-X
dynamic	B-X
protein	B-X
associations	B-X
within	B-X
a	B-X
biological	B-X
module	B-X
.	B-X

Our	O
results	O
demonstrate	O
that	O
this	O
approach	O
can	O
be	O
used	O
to	O
detect	O
a	O
host	O
of	O
transient	O
and	O
dynamic	O
protein	O
associations	O
within	O
a	O
biological	O
module	O
.	O
<EOS>	B-X
Elucidation	B-X
of	B-X
Cdk	B-X
substrates	B-X
and	B-X
other	B-X
Cdk-associated	B-X
proteins	B-X
is	B-X
essential	B-X
for	B-X
a	B-X
full	B-X
understanding	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
the	B-X
results	B-X
of	B-X
a	B-X
targeted	B-X
proteomics	B-X
study	B-X
using	B-X
affinity	B-X
purification	B-X
coupled	B-X
to	B-X
mass	B-X
spectrometry	B-X
.	B-X
Our	B-X
study	B-X
identified	B-X
numerous	B-X
proteins	B-X
in	B-X
association	B-X
with	B-X
particular	B-X
cyclin-Cdk	B-X
complexes	B-X
.	B-X
These	B-X
included	B-X
phosphorylation	B-X
substrates	B-X
,	B-X
ubiquitination-degradation	B-X
proteins	B-X
,	B-X
adaptors	B-X
,	B-X
and	B-X
inhibitors	B-X
.	B-X
Some	B-X
associations	B-X
were	B-X
previously	B-X
known	B-X
,	B-X
and	B-X
for	B-X
others	B-X
,	B-X
we	B-X
confirmed	B-X
their	B-X
specificity	B-X
and	B-X
biological	B-X
relevance	B-X
.	B-X
Using	B-X
a	B-X
hypothesis-driven	B-X
mass	B-X
spectrometric	B-X
approach	B-X
,	B-X
we	B-X
also	B-X
mapped	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
at	B-X
Cdk	B-X
consensus	B-X
motif-containing	B-X
peptides	B-X
within	B-X
several	B-X
cyclin-associated	B-X
candidate	B-X
Cdk	B-X
substrates	B-X
.	B-X
Our	B-X
results	B-X
demonstrate	B-X
that	B-X
this	B-X
approach	B-X
can	B-X
be	B-X
used	B-X
to	B-X
detect	B-X
a	B-X
host	B-X
of	B-X
transient	B-X
and	B-X
dynamic	B-X
protein	B-X
associations	B-X
within	B-X
a	B-X
biological	B-X
module	B-X
.	B-X

Genotoxic	O
stress	O
induces	O
expression	O
of	O
E2F4	B-Gene_or_gene_product
,	O
leading	O
to	O
its	O
association	O
with	O
p130	B-Gene_or_gene_product
in	O
prostate	O
carcinoma	O
cells	O
.	O
<EOS>	B-X
The	B-X
retinoblastoma	B-X
(	B-X
pRb	B-X
)	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
pocket	B-X
proteins	B-X
bind	B-X
to	B-X
the	B-X
E2F	B-X
transcription	B-X
factors	B-X
to	B-X
control	B-X
gene	B-X
expression	B-X
.	B-X
E2F4	B-X
protein	B-X
levels	B-X
increased	B-X
and	B-X
accumulated	B-X
in	B-X
the	B-X
nuclei	B-X
of	B-X
prostate	B-X
carcinoma	B-X
cells	B-X
subjected	B-X
to	B-X
ionizing	B-X
radiation	B-X
(	B-X
IR	B-X
)	B-X
.	B-X
The	B-X
IR-induced	B-X
increase	B-X
of	B-X
E2F4	B-X
levels	B-X
led	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
E2F4	B-X
binding	B-X
to	B-X
p130	B-X
but	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
E2F4/p107	B-X
or	B-X
E2F5/p130	B-X
complexes	B-X
.	B-X
The	B-X
increase	B-X
in	B-X
E2F4/p130	B-X
association	B-X
after	B-X
IR	B-X
was	B-X
observed	B-X
in	B-X
prostate	B-X
carcinoma	B-X
cells	B-X
regardless	B-X
of	B-X
their	B-X
sensitivity	B-X
to	B-X
androgens	B-X
,	B-X
but	B-X
not	B-X
in	B-X
breast	B-X
carcinoma	B-X
cells	B-X
.	B-X
E2F4/p130	B-X
complex	B-X
formation	B-X
was	B-X
dependent	B-X
on	B-X
dissociation	B-X
of	B-X
p130	B-X
from	B-X
cyclin-dependent	B-X
kinase	B-X
2	B-X
and	B-X
p130	B-X
dephosphorylation	B-X
.	B-X
Disruption	B-X
of	B-X
E2F4	B-X
through	B-X
small	B-X
interfering	B-X
RNA	B-X
prevented	B-X
p130/E2F4	B-X
complex	B-X
formation	B-X
and	B-X
sensitized	B-X
cells	B-X
to	B-X
IR-induced	B-X
apoptosis	B-X
,	B-X
leading	B-X
to	B-X
caspase-3	B-X
activation	B-X
,	B-X
cleavage	B-X
of	B-X
its	B-X
substrate	B-X
,	B-X
poly	B-X
(	B-X
ADP-ribose	B-X
)	B-X
polymerase	B-X
,	B-X
and	B-X
nuclear	B-X
condensation	B-X
.	B-X
The	B-X
E2F4/p130	B-X
pocket	B-X
protein	B-X
complex	B-X
emerges	B-X
as	B-X
a	B-X
new	B-X
target	B-X
of	B-X
radiation	B-X
in	B-X
prostate	B-X
carcinoma	B-X
cells	B-X
.	B-X

The	O
retinoblastoma	B-Gene_or_gene_product
(	O
pRb	B-Gene_or_gene_product
)	O
,	O
p107	B-Gene_or_gene_product
,	O
and	O
p130	B-Gene_or_gene_product
pocket	O
proteins	O
bind	O
to	O
the	O
E2F	B-Gene_or_gene_product
transcription	O
factors	O
to	O
control	O
gene	O
expression	O
.	O

E2F4	B-Gene_or_gene_product
protein	O
levels	O
increased	O
and	O
accumulated	O
in	O
the	O
nuclei	O
of	O
prostate	O
carcinoma	O
cells	O
subjected	O
to	O
ionizing	O
radiation	O
(	O
IR	O
)	O
.	O
<EOS>	B-X
The	B-X
retinoblastoma	B-X
(	B-X
pRb	B-X
)	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
pocket	B-X
proteins	B-X
bind	B-X
to	B-X
the	B-X
E2F	B-X
transcription	B-X
factors	B-X
to	B-X
control	B-X
gene	B-X
expression	B-X
.	B-X
E2F4	B-X
protein	B-X
levels	B-X
increased	B-X
and	B-X
accumulated	B-X
in	B-X
the	B-X
nuclei	B-X
of	B-X
prostate	B-X
carcinoma	B-X
cells	B-X
subjected	B-X
to	B-X
ionizing	B-X
radiation	B-X
(	B-X
IR	B-X
)	B-X
.	B-X
The	B-X
IR-induced	B-X
increase	B-X
of	B-X
E2F4	B-X
levels	B-X
led	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
E2F4	B-X
binding	B-X
to	B-X
p130	B-X
but	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
E2F4/p107	B-X
or	B-X
E2F5/p130	B-X
complexes	B-X
.	B-X
The	B-X
increase	B-X
in	B-X
E2F4/p130	B-X
association	B-X
after	B-X
IR	B-X
was	B-X
observed	B-X
in	B-X
prostate	B-X
carcinoma	B-X
cells	B-X
regardless	B-X
of	B-X
their	B-X
sensitivity	B-X
to	B-X
androgens	B-X
,	B-X
but	B-X
not	B-X
in	B-X
breast	B-X
carcinoma	B-X
cells	B-X
.	B-X
E2F4/p130	B-X
complex	B-X
formation	B-X
was	B-X
dependent	B-X
on	B-X
dissociation	B-X
of	B-X
p130	B-X
from	B-X
cyclin-dependent	B-X
kinase	B-X
2	B-X
and	B-X
p130	B-X
dephosphorylation	B-X
.	B-X
Disruption	B-X
of	B-X
E2F4	B-X
through	B-X
small	B-X
interfering	B-X
RNA	B-X
prevented	B-X
p130/E2F4	B-X
complex	B-X
formation	B-X
and	B-X
sensitized	B-X
cells	B-X
to	B-X
IR-induced	B-X
apoptosis	B-X
,	B-X
leading	B-X
to	B-X
caspase-3	B-X
activation	B-X
,	B-X
cleavage	B-X
of	B-X
its	B-X
substrate	B-X
,	B-X
poly	B-X
(	B-X
ADP-ribose	B-X
)	B-X
polymerase	B-X
,	B-X
and	B-X
nuclear	B-X
condensation	B-X
.	B-X
The	B-X
E2F4/p130	B-X
pocket	B-X
protein	B-X
complex	B-X
emerges	B-X
as	B-X
a	B-X
new	B-X
target	B-X
of	B-X
radiation	B-X
in	B-X
prostate	B-X
carcinoma	B-X
cells	B-X
.	B-X

The	O
IR	O
-	O
induced	O
increase	O
of	O
E2F4	B-Gene_or_gene_product
levels	O
led	O
to	O
an	O
increase	O
in	O
E2F4	B-Gene_or_gene_product
binding	O
to	O
p130	B-Gene_or_gene_product
but	O
had	O
no	O
effect	O
on	O
E2F4	O
/	O
p107	O
or	O
E2F5	O
/	O
p130	O
complexes	O
.	O
<EOS>	B-X
The	B-X
retinoblastoma	B-X
(	B-X
Rb	B-X
)	B-X
gene	B-X
family	B-X
member	B-X
p130	B-X
binds	B-X
preferentially	B-X
to	B-X
the	B-X
E2F5	B-X
transcription	B-X
factor	B-X
and	B-X
forms	B-X
a	B-X
repressive	B-X
E2F5/p130	B-X
complex	B-X
that	B-X
inhibits	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
tumor	B-X
growth	B-X
.	B-X
It	B-X
is	B-X
unclear	B-X
whether	B-X
E2F5	B-X
,	B-X
either	B-X
alone	B-X
or	B-X
in	B-X
combination	B-X
with	B-X
p130	B-X
,	B-X
can	B-X
interfere	B-X
with	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
other	B-X
E2F	B-X
family	B-X
members	B-X
,	B-X
such	B-X
as	B-X
E2F1	B-X
and	B-X
E2F3a	B-X
,	B-X
in	B-X
vivo	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
used	B-X
transgenic	B-X
mice	B-X
to	B-X
test	B-X
whether	B-X
overexpression	B-X
of	B-X
E2F5	B-X
with/without	B-X
p130	B-X
would	B-X
be	B-X
sufficient	B-X
to	B-X
inhibit	B-X
E2F1	B-X
or	B-X
E2F3a	B-X
induced	B-X
cell	B-X
cycle	B-X
reentry	B-X
.	B-X
E2F4	B-X
and	B-X
E2F5	B-X
in	B-X
complexes	B-X
with	B-X
pocket	B-X
proteins	B-X
p107	B-X
or	B-X
p130	B-X
stop	B-X
cells	B-X
in	B-X
G1	B-X
,	B-X
repressing	B-X
transcription	B-X
of	B-X
genes	B-X
important	B-X
for	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X
p107	B-X
and	B-X
p130	B-X
inhibits	B-X
activity	B-X
of	B-X
cyclin/cdk2	B-X
complexes	B-X
.	B-X

The	O
increase	O
in	O
E2F4	O
/	O
p130	O
association	O
after	O
IR	O
was	O
observed	O
in	O
prostate	O
carcinoma	O
cells	O
regardless	O
of	O
their	O
sensitivity	O
to	O
androgens	O
,	O
but	O
not	O
in	O
breast	O
carcinoma	O
cells	O
.	O

E2F4	O
/	O
p130	O
complex	O
formation	O
was	O
dependent	O
on	O
dissociation	O
of	O
p130	B-Gene_or_gene_product
from	O
cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
2	I-Gene_or_gene_product
and	O
p130	B-Gene_or_gene_product
dephosphorylation	O
.	O
<EOS>	B-X
During	B-X
G0	B-X
phase	B-X
the	B-X
p130	B-X
,	B-X
member	B-X
of	B-X
the	B-X
pRb	B-X
tumor	B-X
suppressor	B-X
protein	B-X
family	B-X
,	B-X
forms	B-X
a	B-X
repressor	B-X
complex	B-X
with	B-X
E2F4	B-X
which	B-X
is	B-X
inactivated	B-X
in	B-X
G1/S	B-X
by	B-X
hyperphosphorylation	B-X
of	B-X
the	B-X
p130	B-X
.	B-X
The	B-X
role	B-X
of	B-X
p130	B-X
after	B-X
G1/S	B-X
remains	B-X
poorly	B-X
investigated	B-X
.	B-X
We	B-X
found	B-X
that	B-X
in	B-X
nuclear	B-X
extracts	B-X
of	B-X
T98G	B-X
cells	B-X
,	B-X
the	B-X
p130-E2F4-DNA	B-X
(	B-X
pp-E2F4	B-X
)	B-X
complex	B-X
does	B-X
not	B-X
dissociate	B-X
at	B-X
G1/S	B-X
transition	B-X
,	B-X
but	B-X
instead	B-X
reverts	B-X
to	B-X
the	B-X
p130-E2F4-cyclin	B-X
E/A-cdk2	B-X
(	B-X
cyc/cdk-pp-E2F4	B-X
)	B-X
complex	B-X
,	B-X
which	B-X
is	B-X
detected	B-X
in	B-X
S	B-X
and	B-X
G2/M	B-X
phases	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Hyperphosphorylation	B-X
of	B-X
the	B-X
p130	B-X
at	B-X
G1/S	B-X
transition	B-X
is	B-X
associated	B-X
with	B-X
a	B-X
decrease	B-X
of	B-X
its	B-X
total	B-X
amount	B-X
;	B-X
however	B-X
,	B-X
this	B-X
protein	B-X
is	B-X
still	B-X
detected	B-X
during	B-X
the	B-X
rest	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
,	B-X
and	B-X
it	B-X
is	B-X
increasingly	B-X
hyperphosphorylated	B-X
in	B-X
the	B-X
cytosol	B-X
,	B-X
but	B-X
continuously	B-X
dephosphorylated	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X
Both	B-X
nuclear	B-X
and	B-X
cytosol	B-X
cell	B-X
fractions	B-X
in	B-X
T98G	B-X
cells	B-X
contain	B-X
a	B-X
hyperphosphorylated	B-X
form	B-X
of	B-X
p130	B-X
in	B-X
complex	B-X
with	B-X
E2F4	B-X
at	B-X
S	B-X
and	B-X
G2/M	B-X
cell	B-X
cycle	B-X
phases	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
T98G	B-X
cells	B-X
,	B-X
transformation	B-X
of	B-X
the	B-X
p130	B-X
containing	B-X
cyc/cdk-pp-E2F4	B-X
complex	B-X
into	B-X
the	B-X
p130-pp-E2F4	B-X
repressor	B-X
does	B-X
not	B-X
occur	B-X
in	B-X
HeLa	B-X
cells	B-X
under	B-X
growth	B-X
restriction	B-X
conditions	B-X
.	B-X

Disruption	O
of	O
E2F4	B-Gene_or_gene_product
through	O
small	O
interfering	O
RNA	O
prevented	O
p130	B-Gene_or_gene_product
/	O
E2F4	B-Gene_or_gene_product
complex	O
formation	O
and	O
sensitized	O
cells	O
to	O
IR	O
-	O
induced	O
apoptosis	O
,	O
leading	O
to	O
caspase	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
activation	O
,	O
cleavage	O
of	O
its	O
substrate	O
,	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
polymerase	O
,	O
and	O
nuclear	O
condensation	O
.	O
<EOS>	B-X
The	B-X
retinoblastoma	B-X
(	B-X
pRb	B-X
)	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
pocket	B-X
proteins	B-X
bind	B-X
to	B-X
the	B-X
E2F	B-X
transcription	B-X
factors	B-X
to	B-X
control	B-X
gene	B-X
expression	B-X
.	B-X
E2F4	B-X
protein	B-X
levels	B-X
increased	B-X
and	B-X
accumulated	B-X
in	B-X
the	B-X
nuclei	B-X
of	B-X
prostate	B-X
carcinoma	B-X
cells	B-X
subjected	B-X
to	B-X
ionizing	B-X
radiation	B-X
(	B-X
IR	B-X
)	B-X
.	B-X
The	B-X
IR-induced	B-X
increase	B-X
of	B-X
E2F4	B-X
levels	B-X
led	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
E2F4	B-X
binding	B-X
to	B-X
p130	B-X
but	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
E2F4/p107	B-X
or	B-X
E2F5/p130	B-X
complexes	B-X
.	B-X
The	B-X
increase	B-X
in	B-X
E2F4/p130	B-X
association	B-X
after	B-X
IR	B-X
was	B-X
observed	B-X
in	B-X
prostate	B-X
carcinoma	B-X
cells	B-X
regardless	B-X
of	B-X
their	B-X
sensitivity	B-X
to	B-X
androgens	B-X
,	B-X
but	B-X
not	B-X
in	B-X
breast	B-X
carcinoma	B-X
cells	B-X
.	B-X
E2F4/p130	B-X
complex	B-X
formation	B-X
was	B-X
dependent	B-X
on	B-X
dissociation	B-X
of	B-X
p130	B-X
from	B-X
cyclin-dependent	B-X
kinase	B-X
2	B-X
and	B-X
p130	B-X
dephosphorylation	B-X
.	B-X
Disruption	B-X
of	B-X
E2F4	B-X
through	B-X
small	B-X
interfering	B-X
RNA	B-X
prevented	B-X
p130/E2F4	B-X
complex	B-X
formation	B-X
and	B-X
sensitized	B-X
cells	B-X
to	B-X
IR-induced	B-X
apoptosis	B-X
,	B-X
leading	B-X
to	B-X
caspase-3	B-X
activation	B-X
,	B-X
cleavage	B-X
of	B-X
its	B-X
substrate	B-X
,	B-X
poly	B-X
(	B-X
ADP-ribose	B-X
)	B-X
polymerase	B-X
,	B-X
and	B-X
nuclear	B-X
condensation	B-X
.	B-X
The	B-X
E2F4/p130	B-X
pocket	B-X
protein	B-X
complex	B-X
emerges	B-X
as	B-X
a	B-X
new	B-X
target	B-X
of	B-X
radiation	B-X
in	B-X
prostate	B-X
carcinoma	B-X
cells	B-X
.	B-X

The	O
E2F4	O
/	O
p130	O
pocket	O
protein	O
complex	O
emerges	O
as	O
a	O
new	O
target	O
of	O
radiation	O
in	O
prostate	O
carcinoma	O
cells	O
.	O
<EOS>	B-X
The	B-X
retinoblastoma	B-X
(	B-X
pRb	B-X
)	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
pocket	B-X
proteins	B-X
bind	B-X
to	B-X
the	B-X
E2F	B-X
transcription	B-X
factors	B-X
to	B-X
control	B-X
gene	B-X
expression	B-X
.	B-X
E2F4	B-X
protein	B-X
levels	B-X
increased	B-X
and	B-X
accumulated	B-X
in	B-X
the	B-X
nuclei	B-X
of	B-X
prostate	B-X
carcinoma	B-X
cells	B-X
subjected	B-X
to	B-X
ionizing	B-X
radiation	B-X
(	B-X
IR	B-X
)	B-X
.	B-X
The	B-X
IR-induced	B-X
increase	B-X
of	B-X
E2F4	B-X
levels	B-X
led	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
E2F4	B-X
binding	B-X
to	B-X
p130	B-X
but	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
E2F4/p107	B-X
or	B-X
E2F5/p130	B-X
complexes	B-X
.	B-X
The	B-X
increase	B-X
in	B-X
E2F4/p130	B-X
association	B-X
after	B-X
IR	B-X
was	B-X
observed	B-X
in	B-X
prostate	B-X
carcinoma	B-X
cells	B-X
regardless	B-X
of	B-X
their	B-X
sensitivity	B-X
to	B-X
androgens	B-X
,	B-X
but	B-X
not	B-X
in	B-X
breast	B-X
carcinoma	B-X
cells	B-X
.	B-X
E2F4/p130	B-X
complex	B-X
formation	B-X
was	B-X
dependent	B-X
on	B-X
dissociation	B-X
of	B-X
p130	B-X
from	B-X
cyclin-dependent	B-X
kinase	B-X
2	B-X
and	B-X
p130	B-X
dephosphorylation	B-X
.	B-X
Disruption	B-X
of	B-X
E2F4	B-X
through	B-X
small	B-X
interfering	B-X
RNA	B-X
prevented	B-X
p130/E2F4	B-X
complex	B-X
formation	B-X
and	B-X
sensitized	B-X
cells	B-X
to	B-X
IR-induced	B-X
apoptosis	B-X
,	B-X
leading	B-X
to	B-X
caspase-3	B-X
activation	B-X
,	B-X
cleavage	B-X
of	B-X
its	B-X
substrate	B-X
,	B-X
poly	B-X
(	B-X
ADP-ribose	B-X
)	B-X
polymerase	B-X
,	B-X
and	B-X
nuclear	B-X
condensation	B-X
.	B-X
The	B-X
E2F4/p130	B-X
pocket	B-X
protein	B-X
complex	B-X
emerges	B-X
as	B-X
a	B-X
new	B-X
target	B-X
of	B-X
radiation	B-X
in	B-X
prostate	B-X
carcinoma	B-X
cells	B-X
.	B-X

Regulation	O
of	O
Toll	B-Gene_or_gene_product
/	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
-	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	O
mediated	O
gene	O
expression	O
by	O
the	O
inducible	O
nuclear	O
protein	O
IkappaBzeta	B-Gene_or_gene_product
.	O
<EOS>	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
recognize	B-X
microbial	B-X
components	B-X
and	B-X
trigger	B-X
the	B-X
inflammatory	B-X
and	B-X
immune	B-X
responses	B-X
against	B-X
pathogens	B-X
.	B-X
IkappaBzeta	B-X
(	B-X
also	B-X
known	B-X
as	B-X
MAIL	B-X
and	B-X
INAP	B-X
)	B-X
is	B-X
an	B-X
ankyrin-repeat-containing	B-X
nuclear	B-X
protein	B-X
that	B-X
is	B-X
highly	B-X
homologous	B-X
to	B-X
the	B-X
IkappaB	B-X
family	B-X
member	B-X
Bcl-3	B-X
(	B-X
refs	B-X
1-6	B-X
)	B-X
.	B-X
Transcription	B-X
of	B-X
IkappaBzeta	B-X
is	B-X
rapidly	B-X
induced	B-X
by	B-X
stimulation	B-X
with	B-X
TLR	B-X
ligands	B-X
and	B-X
interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
IkappaBzeta	B-X
is	B-X
indispensable	B-X
for	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
activated	B-X
in	B-X
TLR/IL-1R	B-X
signalling	B-X
pathways	B-X
.	B-X
IkappaBzeta-deficient	B-X
cells	B-X
show	B-X
severe	B-X
impairment	B-X
of	B-X
IL-6	B-X
production	B-X
in	B-X
response	B-X
to	B-X
a	B-X
variety	B-X
of	B-X
TLR	B-X
ligands	B-X
as	B-X
well	B-X
as	B-X
IL-1	B-X
,	B-X
but	B-X
not	B-X
in	B-X
response	B-X
to	B-X
tumour-necrosis	B-X
factor-alpha	B-X
.	B-X
Endogenous	B-X
IkappaBzeta	B-X
specifically	B-X
associates	B-X
with	B-X
the	B-X
p50	B-X
subunit	B-X
of	B-X
NF-kappaB	B-X
,	B-X
and	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
NF-kappaB	B-X
binding	B-X
site	B-X
of	B-X
the	B-X
IL-6	B-X
promoter	B-X
on	B-X
stimulation	B-X
.	B-X
Moreover	B-X
,	B-X
NF-kappaB1/p50-deficient	B-X
mice	B-X
show	B-X
responses	B-X
to	B-X
TLR/IL-1R	B-X
ligands	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
IkappaBzeta-deficient	B-X
mice	B-X
.	B-X
Endotoxin-induced	B-X
expression	B-X
of	B-X
other	B-X
genes	B-X
such	B-X
as	B-X
Il12b	B-X
and	B-X
Csf2	B-X
is	B-X
also	B-X
abrogated	B-X
in	B-X
IkappaBzeta-deficient	B-X
macrophages	B-X
.	B-X
Given	B-X
that	B-X
the	B-X
lipopolysaccharide-induced	B-X
transcription	B-X
of	B-X
IkappaBzeta	B-X
occurs	B-X
earlier	B-X
than	B-X
transcription	B-X
of	B-X
these	B-X
genes	B-X
,	B-X
some	B-X
TLR/IL-1R-mediated	B-X
responses	B-X
may	B-X
be	B-X
regulated	B-X
in	B-X
a	B-X
gene	B-X
expression	B-X
process	B-X
of	B-X
at	B-X
least	B-X
two	B-X
steps	B-X
that	B-X
requires	B-X
inducible	B-X
IkappaBzeta	B-X
.	B-X

Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
(	O
TLRs	B-Gene_or_gene_product
)	O
recognize	O
microbial	O
components	O
and	O
trigger	O
the	O
inflammatory	O
and	O
immune	O
responses	O
against	O
pathogens	O
.	O
<EOS>	B-X
The	B-X
innate	B-X
immune	B-X
system	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
first	B-X
line	B-X
of	B-X
host	B-X
defense	B-X
against	B-X
infections	B-X
and	B-X
is	B-X
equipped	B-X
with	B-X
patterns	B-X
recognition	B-X
receptors	B-X
(	B-X
PRRs	B-X
)	B-X
that	B-X
recognize	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
(	B-X
PAMPs	B-X
)	B-X
and	B-X
damage-associated	B-X
molecular	B-X
patterns	B-X
(	B-X
DAMPs	B-X
)	B-X
.	B-X
Several	B-X
classes	B-X
of	B-X
PRRS	B-X
,	B-X
including	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
,	B-X
NOD-like	B-X
receptors	B-X
(	B-X
NLRs	B-X
)	B-X
,	B-X
and	B-X
RIG-I-like	B-X
receptors	B-X
(	B-X
RLRs	B-X
)	B-X
recognize	B-X
distinct	B-X
microbial	B-X
components	B-X
and	B-X
directly	B-X
activate	B-X
immune	B-X
cells	B-X
.	B-X
TLRs	B-X
are	B-X
transmembrane	B-X
receptors	B-X
,	B-X
while	B-X
NLRs	B-X
and	B-X
RLRs	B-X
are	B-X
intracellular	B-X
molecules	B-X
.	B-X
Exposure	B-X
of	B-X
immune	B-X
cells	B-X
to	B-X
the	B-X
ligands	B-X
of	B-X
these	B-X
receptors	B-X
activates	B-X
intracellular	B-X
signaling	B-X
cascades	B-X
that	B-X
rapidly	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
variety	B-X
of	B-X
overlapping	B-X
and	B-X
unique	B-X
genes	B-X
involved	B-X
in	B-X
the	B-X
inflammatory	B-X
and	B-X
immune	B-X
responses	B-X
.	B-X
The	B-X
innate	B-X
immune	B-X
system	B-X
also	B-X
influences	B-X
pathways	B-X
involved	B-X
in	B-X
cancer	B-X
immunosurveillance	B-X
.	B-X
Natural	B-X
and	B-X
synthetic	B-X
agonists	B-X
of	B-X
TLRs	B-X
,	B-X
NLRs	B-X
,	B-X
or	B-X
RLRs	B-X
can	B-X
trigger	B-X
cell	B-X
death	B-X
in	B-X
malignant	B-X
cells	B-X
,	B-X
recruit	B-X
immune	B-X
cells	B-X
,	B-X
such	B-X
as	B-X
DCs	B-X
,	B-X
CD8+	B-X
T	B-X
cells	B-X
,	B-X
and	B-X
NK	B-X
cells	B-X
,	B-X
into	B-X
the	B-X
tumor	B-X
microenvironment	B-X
,	B-X
and	B-X
are	B-X
being	B-X
explored	B-X
as	B-X
promising	B-X
adjuvants	B-X
in	B-X
cancer	B-X
immunotherapies	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
provide	B-X
a	B-X
concise	B-X
overview	B-X
of	B-X
TLRs	B-X
,	B-X
NLRs	B-X
,	B-X
and	B-X
RLRs	B-X
:	B-X
their	B-X
structure	B-X
,	B-X
functions	B-X
,	B-X
signaling	B-X
pathways	B-X
,	B-X
and	B-X
regulation	B-X
.	B-X
We	B-X
also	B-X
describe	B-X
various	B-X
ligands	B-X
for	B-X
these	B-X
receptors	B-X
and	B-X
their	B-X
possible	B-X
application	B-X
in	B-X
treatment	B-X
of	B-X
hematopoietic	B-X
diseases	B-X
.	B-X

IkappaBzeta	B-Gene_or_gene_product
(	O
also	O
known	O
as	O
MAIL	B-Gene_or_gene_product
and	O
INAP	B-Gene_or_gene_product
)	O
is	O
an	O
ankyrin	O
-	O
repeat	O
-	O
containing	O
nuclear	O
protein	O
that	O
is	O
highly	O
homologous	O
to	O
the	O
IkappaB	B-Gene_or_gene_product
family	O
member	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
(	O
refs	O
1	O
-	O
6	O
)	O
.	O

Transcription	O
of	O
IkappaBzeta	B-Gene_or_gene_product
is	O
rapidly	O
induced	O
by	O
stimulation	O
with	O
TLR	B-Gene_or_gene_product
ligands	O
and	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
recognize	B-X
microbial	B-X
components	B-X
and	B-X
trigger	B-X
the	B-X
inflammatory	B-X
and	B-X
immune	B-X
responses	B-X
against	B-X
pathogens	B-X
.	B-X
IkappaBzeta	B-X
(	B-X
also	B-X
known	B-X
as	B-X
MAIL	B-X
and	B-X
INAP	B-X
)	B-X
is	B-X
an	B-X
ankyrin-repeat-containing	B-X
nuclear	B-X
protein	B-X
that	B-X
is	B-X
highly	B-X
homologous	B-X
to	B-X
the	B-X
IkappaB	B-X
family	B-X
member	B-X
Bcl-3	B-X
(	B-X
refs	B-X
1-6	B-X
)	B-X
.	B-X
Transcription	B-X
of	B-X
IkappaBzeta	B-X
is	B-X
rapidly	B-X
induced	B-X
by	B-X
stimulation	B-X
with	B-X
TLR	B-X
ligands	B-X
and	B-X
interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
IkappaBzeta	B-X
is	B-X
indispensable	B-X
for	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
activated	B-X
in	B-X
TLR/IL-1R	B-X
signalling	B-X
pathways	B-X
.	B-X
IkappaBzeta-deficient	B-X
cells	B-X
show	B-X
severe	B-X
impairment	B-X
of	B-X
IL-6	B-X
production	B-X
in	B-X
response	B-X
to	B-X
a	B-X
variety	B-X
of	B-X
TLR	B-X
ligands	B-X
as	B-X
well	B-X
as	B-X
IL-1	B-X
,	B-X
but	B-X
not	B-X
in	B-X
response	B-X
to	B-X
tumour-necrosis	B-X
factor-alpha	B-X
.	B-X
Endogenous	B-X
IkappaBzeta	B-X
specifically	B-X
associates	B-X
with	B-X
the	B-X
p50	B-X
subunit	B-X
of	B-X
NF-kappaB	B-X
,	B-X
and	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
NF-kappaB	B-X
binding	B-X
site	B-X
of	B-X
the	B-X
IL-6	B-X
promoter	B-X
on	B-X
stimulation	B-X
.	B-X
Moreover	B-X
,	B-X
NF-kappaB1/p50-deficient	B-X
mice	B-X
show	B-X
responses	B-X
to	B-X
TLR/IL-1R	B-X
ligands	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
IkappaBzeta-deficient	B-X
mice	B-X
.	B-X
Endotoxin-induced	B-X
expression	B-X
of	B-X
other	B-X
genes	B-X
such	B-X
as	B-X
Il12b	B-X
and	B-X
Csf2	B-X
is	B-X
also	B-X
abrogated	B-X
in	B-X
IkappaBzeta-deficient	B-X
macrophages	B-X
.	B-X
Given	B-X
that	B-X
the	B-X
lipopolysaccharide-induced	B-X
transcription	B-X
of	B-X
IkappaBzeta	B-X
occurs	B-X
earlier	B-X
than	B-X
transcription	B-X
of	B-X
these	B-X
genes	B-X
,	B-X
some	B-X
TLR/IL-1R-mediated	B-X
responses	B-X
may	B-X
be	B-X
regulated	B-X
in	B-X
a	B-X
gene	B-X
expression	B-X
process	B-X
of	B-X
at	B-X
least	B-X
two	B-X
steps	B-X
that	B-X
requires	B-X
inducible	B-X
IkappaBzeta	B-X
.	B-X

Here	O
we	O
show	O
that	O
IkappaBzeta	B-Gene_or_gene_product
is	O
indispensable	O
for	O
the	O
expression	O
of	O
a	O
subset	O
of	O
genes	O
activated	O
in	O
TLR	B-Gene_or_gene_product
/	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1R	I-Gene_or_gene_product
signalling	O
pathways	O
.	O
<EOS>	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
recognize	B-X
microbial	B-X
components	B-X
and	B-X
trigger	B-X
the	B-X
inflammatory	B-X
and	B-X
immune	B-X
responses	B-X
against	B-X
pathogens	B-X
.	B-X
IkappaBzeta	B-X
(	B-X
also	B-X
known	B-X
as	B-X
MAIL	B-X
and	B-X
INAP	B-X
)	B-X
is	B-X
an	B-X
ankyrin-repeat-containing	B-X
nuclear	B-X
protein	B-X
that	B-X
is	B-X
highly	B-X
homologous	B-X
to	B-X
the	B-X
IkappaB	B-X
family	B-X
member	B-X
Bcl-3	B-X
(	B-X
refs	B-X
1-6	B-X
)	B-X
.	B-X
Transcription	B-X
of	B-X
IkappaBzeta	B-X
is	B-X
rapidly	B-X
induced	B-X
by	B-X
stimulation	B-X
with	B-X
TLR	B-X
ligands	B-X
and	B-X
interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
IkappaBzeta	B-X
is	B-X
indispensable	B-X
for	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
activated	B-X
in	B-X
TLR/IL-1R	B-X
signalling	B-X
pathways	B-X
.	B-X
IkappaBzeta-deficient	B-X
cells	B-X
show	B-X
severe	B-X
impairment	B-X
of	B-X
IL-6	B-X
production	B-X
in	B-X
response	B-X
to	B-X
a	B-X
variety	B-X
of	B-X
TLR	B-X
ligands	B-X
as	B-X
well	B-X
as	B-X
IL-1	B-X
,	B-X
but	B-X
not	B-X
in	B-X
response	B-X
to	B-X
tumour-necrosis	B-X
factor-alpha	B-X
.	B-X
Endogenous	B-X
IkappaBzeta	B-X
specifically	B-X
associates	B-X
with	B-X
the	B-X
p50	B-X
subunit	B-X
of	B-X
NF-kappaB	B-X
,	B-X
and	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
NF-kappaB	B-X
binding	B-X
site	B-X
of	B-X
the	B-X
IL-6	B-X
promoter	B-X
on	B-X
stimulation	B-X
.	B-X
Moreover	B-X
,	B-X
NF-kappaB1/p50-deficient	B-X
mice	B-X
show	B-X
responses	B-X
to	B-X
TLR/IL-1R	B-X
ligands	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
IkappaBzeta-deficient	B-X
mice	B-X
.	B-X
Endotoxin-induced	B-X
expression	B-X
of	B-X
other	B-X
genes	B-X
such	B-X
as	B-X
Il12b	B-X
and	B-X
Csf2	B-X
is	B-X
also	B-X
abrogated	B-X
in	B-X
IkappaBzeta-deficient	B-X
macrophages	B-X
.	B-X
Given	B-X
that	B-X
the	B-X
lipopolysaccharide-induced	B-X
transcription	B-X
of	B-X
IkappaBzeta	B-X
occurs	B-X
earlier	B-X
than	B-X
transcription	B-X
of	B-X
these	B-X
genes	B-X
,	B-X
some	B-X
TLR/IL-1R-mediated	B-X
responses	B-X
may	B-X
be	B-X
regulated	B-X
in	B-X
a	B-X
gene	B-X
expression	B-X
process	B-X
of	B-X
at	B-X
least	B-X
two	B-X
steps	B-X
that	B-X
requires	B-X
inducible	B-X
IkappaBzeta	B-X
.	B-X

IkappaBzeta	B-Gene_or_gene_product
-	O
deficient	O
cells	O
show	O
severe	O
impairment	O
of	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
production	O
in	O
response	O
to	O
a	O
variety	O
of	O
TLR	B-Gene_or_gene_product
ligands	O
as	O
well	O
as	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
but	O
not	O
in	O
response	O
to	O
tumour	B-Gene_or_gene_product
-	I-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
.	O

Endogenous	O
IkappaBzeta	B-Gene_or_gene_product
specifically	O
associates	O
with	O
the	O
p50	B-Gene_or_gene_product
subunit	O
of	O
NF	O
-	O
kappaB	O
,	O
and	O
is	O
recruited	O
to	O
the	O
NF	O
-	O
kappaB	O
binding	O
site	O
of	O
the	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
promoter	O
on	O
stimulation	O
.	O

Moreover	O
,	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB1	I-Gene_or_gene_product
/	O
p50	B-Gene_or_gene_product
-	O
deficient	O
mice	O
show	O
responses	O
to	O
TLR	B-Gene_or_gene_product
/	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1R	I-Gene_or_gene_product
ligands	O
similar	O
to	O
those	O
of	O
IkappaBzeta	B-Gene_or_gene_product
-	O
deficient	O
mice	O
.	O
<EOS>	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
recognize	B-X
microbial	B-X
components	B-X
and	B-X
trigger	B-X
the	B-X
inflammatory	B-X
and	B-X
immune	B-X
responses	B-X
against	B-X
pathogens	B-X
.	B-X
IkappaBzeta	B-X
(	B-X
also	B-X
known	B-X
as	B-X
MAIL	B-X
and	B-X
INAP	B-X
)	B-X
is	B-X
an	B-X
ankyrin-repeat-containing	B-X
nuclear	B-X
protein	B-X
that	B-X
is	B-X
highly	B-X
homologous	B-X
to	B-X
the	B-X
IkappaB	B-X
family	B-X
member	B-X
Bcl-3	B-X
(	B-X
refs	B-X
1-6	B-X
)	B-X
.	B-X
Transcription	B-X
of	B-X
IkappaBzeta	B-X
is	B-X
rapidly	B-X
induced	B-X
by	B-X
stimulation	B-X
with	B-X
TLR	B-X
ligands	B-X
and	B-X
interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
IkappaBzeta	B-X
is	B-X
indispensable	B-X
for	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
activated	B-X
in	B-X
TLR/IL-1R	B-X
signalling	B-X
pathways	B-X
.	B-X
IkappaBzeta-deficient	B-X
cells	B-X
show	B-X
severe	B-X
impairment	B-X
of	B-X
IL-6	B-X
production	B-X
in	B-X
response	B-X
to	B-X
a	B-X
variety	B-X
of	B-X
TLR	B-X
ligands	B-X
as	B-X
well	B-X
as	B-X
IL-1	B-X
,	B-X
but	B-X
not	B-X
in	B-X
response	B-X
to	B-X
tumour-necrosis	B-X
factor-alpha	B-X
.	B-X
Endogenous	B-X
IkappaBzeta	B-X
specifically	B-X
associates	B-X
with	B-X
the	B-X
p50	B-X
subunit	B-X
of	B-X
NF-kappaB	B-X
,	B-X
and	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
NF-kappaB	B-X
binding	B-X
site	B-X
of	B-X
the	B-X
IL-6	B-X
promoter	B-X
on	B-X
stimulation	B-X
.	B-X
Moreover	B-X
,	B-X
NF-kappaB1/p50-deficient	B-X
mice	B-X
show	B-X
responses	B-X
to	B-X
TLR/IL-1R	B-X
ligands	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
IkappaBzeta-deficient	B-X
mice	B-X
.	B-X
Endotoxin-induced	B-X
expression	B-X
of	B-X
other	B-X
genes	B-X
such	B-X
as	B-X
Il12b	B-X
and	B-X
Csf2	B-X
is	B-X
also	B-X
abrogated	B-X
in	B-X
IkappaBzeta-deficient	B-X
macrophages	B-X
.	B-X
Given	B-X
that	B-X
the	B-X
lipopolysaccharide-induced	B-X
transcription	B-X
of	B-X
IkappaBzeta	B-X
occurs	B-X
earlier	B-X
than	B-X
transcription	B-X
of	B-X
these	B-X
genes	B-X
,	B-X
some	B-X
TLR/IL-1R-mediated	B-X
responses	B-X
may	B-X
be	B-X
regulated	B-X
in	B-X
a	B-X
gene	B-X
expression	B-X
process	B-X
of	B-X
at	B-X
least	B-X
two	B-X
steps	B-X
that	B-X
requires	B-X
inducible	B-X
IkappaBzeta	B-X
.	B-X

Endotoxin	O
-	O
induced	O
expression	O
of	O
other	O
genes	O
such	O
as	O
Il12b	B-Gene_or_gene_product
and	O
Csf2	B-Gene_or_gene_product
is	O
also	O
abrogated	O
in	O
IkappaBzeta	B-Gene_or_gene_product
-	O
deficient	O
macrophages	O
.	O
<EOS>	B-X
IkappaBzeta	B-X
(	B-X
also	B-X
known	B-X
as	B-X
MAIL	B-X
and	B-X
INAP	B-X
)	B-X
is	B-X
an	B-X
ankyrin-repeat-containing	B-X
nuclear	B-X
protein	B-X
that	B-X
is	B-X
highly	B-X
homologous	B-X
to	B-X
the	B-X
IkappaB	B-X
family	B-X
member	B-X
Bcl-3	B-X
(	B-X
refs	B-X
1-6	B-X
)	B-X
.	B-X
Transcription	B-X
of	B-X
IkappaBzeta	B-X
is	B-X
rapidly	B-X
induced	B-X
by	B-X
stimulation	B-X
with	B-X
TLR	B-X
ligands	B-X
and	B-X
interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
IkappaBzeta	B-X
is	B-X
indispensable	B-X
for	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
activated	B-X
in	B-X
TLR/IL-1R	B-X
signalling	B-X
pathways	B-X
.	B-X
IkappaBzeta-deficient	B-X
cells	B-X
show	B-X
severe	B-X
impairment	B-X
of	B-X
IL-6	B-X
production	B-X
in	B-X
response	B-X
to	B-X
a	B-X
variety	B-X
of	B-X
TLR	B-X
ligands	B-X
as	B-X
well	B-X
as	B-X
IL-1	B-X
,	B-X
but	B-X
not	B-X
in	B-X
response	B-X
to	B-X
tumour-necrosis	B-X
factor-alpha	B-X
.	B-X
Endogenous	B-X
IkappaBzeta	B-X
specifically	B-X
associates	B-X
with	B-X
the	B-X
p50	B-X
subunit	B-X
of	B-X
NF-kappaB	B-X
,	B-X
and	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
NF-kappaB	B-X
binding	B-X
site	B-X
of	B-X
the	B-X
IL-6	B-X
promoter	B-X
on	B-X
stimulation	B-X
.	B-X
Moreover	B-X
,	B-X
NF-kappaB1/p50-deficient	B-X
mice	B-X
show	B-X
responses	B-X
to	B-X
TLR/IL-1R	B-X
ligands	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
IkappaBzeta-deficient	B-X
mice	B-X
.	B-X
Endotoxin-induced	B-X
expression	B-X
of	B-X
other	B-X
genes	B-X
such	B-X
as	B-X
Il12b	B-X
and	B-X
Csf2	B-X
is	B-X
also	B-X
abrogated	B-X
in	B-X
IkappaBzeta-deficient	B-X
macrophages	B-X
.	B-X
Given	B-X
that	B-X
the	B-X
lipopolysaccharide-induced	B-X
transcription	B-X
of	B-X
IkappaBzeta	B-X
occurs	B-X
earlier	B-X
than	B-X
transcription	B-X
of	B-X
these	B-X
genes	B-X
,	B-X
some	B-X
TLR/IL-1R-mediated	B-X
responses	B-X
may	B-X
be	B-X
regulated	B-X
in	B-X
a	B-X
gene	B-X
expression	B-X
process	B-X
of	B-X
at	B-X
least	B-X
two	B-X
steps	B-X
that	B-X
requires	B-X
inducible	B-X
IkappaBzeta	B-X
.	B-X

Given	O
that	O
the	O
lipopolysaccharide	O
-	O
induced	O
transcription	O
of	O
IkappaBzeta	B-Gene_or_gene_product
occurs	O
earlier	O
than	O
transcription	O
of	O
these	O
genes	O
,	O
some	O
TLR	B-Gene_or_gene_product
/	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1R	I-Gene_or_gene_product
-	O
mediated	O
responses	O
may	O
be	O
regulated	O
in	O
a	O
gene	O
expression	O
process	O
of	O
at	O
least	O
two	O
steps	O
that	O
requires	O
inducible	O
IkappaBzeta	B-Gene_or_gene_product
.	O

Phosphorylation	O
by	O
cyclin	O
B	O
-	O
Cdk	O
underlies	O
release	O
of	O
mitotic	O
exit	O
activator	O
Cdc14	B-Gene_or_gene_product
from	O
the	O
nucleolus	O
.	O
<EOS>	B-X
Budding	B-X
yeast	B-X
protein	B-X
phosphatase	B-X
Cdc14	B-X
is	B-X
sequestered	B-X
in	B-X
the	B-X
nucleolus	B-X
in	B-X
an	B-X
inactive	B-X
state	B-X
during	B-X
interphase	B-X
by	B-X
the	B-X
anchor	B-X
protein	B-X
Net1	B-X
.	B-X
Upon	B-X
entry	B-X
into	B-X
anaphase	B-X
,	B-X
the	B-X
Cdc14	B-X
early	B-X
anaphase	B-X
release	B-X
(	B-X
FEAR	B-X
)	B-X
network	B-X
initiates	B-X
dispersal	B-X
of	B-X
active	B-X
Cdc14	B-X
throughout	B-X
the	B-X
cell	B-X
.	B-X
We	B-X
report	B-X
that	B-X
the	B-X
FEARnetwork	B-X
promotes	B-X
phosphorylation	B-X
of	B-X
Net1	B-X
by	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
complexed	B-X
with	B-X
cyclin	B-X
B1	B-X
or	B-X
cyclin	B-X
B2	B-X
.	B-X
These	B-X
phosphorylations	B-X
appear	B-X
to	B-X
be	B-X
required	B-X
for	B-X
FEAR	B-X
and	B-X
sustain	B-X
the	B-X
proper	B-X
timing	B-X
of	B-X
late	B-X
mitotic	B-X
events	B-X
.	B-X
Thus	B-X
,	B-X
a	B-X
regulatory	B-X
circuit	B-X
exists	B-X
to	B-X
ensure	B-X
that	B-X
the	B-X
arbiter	B-X
of	B-X
the	B-X
mitotic	B-X
state	B-X
,	B-X
Cdk	B-X
,	B-X
sets	B-X
in	B-X
motion	B-X
events	B-X
that	B-X
culminate	B-X
in	B-X
exit	B-X
from	B-X
mitosis	B-X
.	B-X

Budding	O
yeast	O
protein	O
phosphatase	O
Cdc14	B-Gene_or_gene_product
is	O
sequestered	O
in	O
the	O
nucleolus	O
in	O
an	O
inactive	O
state	O
during	O
interphase	O
by	O
the	O
anchor	O
protein	O
Net1	B-Gene_or_gene_product
.	O

Upon	O
entry	O
into	O
anaphase	O
,	O
the	O
Cdc14	B-Gene_or_gene_product
early	O
anaphase	O
release	O
(	O
FEAR	O
)	O
network	O
initiates	O
dispersal	O
of	O
active	O
Cdc14	B-Gene_or_gene_product
throughout	O
the	O
cell	O
.	O
<EOS>	B-X
Budding	B-X
yeast	B-X
protein	B-X
phosphatase	B-X
Cdc14	B-X
is	B-X
sequestered	B-X
in	B-X
the	B-X
nucleolus	B-X
in	B-X
an	B-X
inactive	B-X
state	B-X
during	B-X
interphase	B-X
by	B-X
the	B-X
anchor	B-X
protein	B-X
Net1	B-X
.	B-X
Upon	B-X
entry	B-X
into	B-X
anaphase	B-X
,	B-X
the	B-X
Cdc14	B-X
early	B-X
anaphase	B-X
release	B-X
(	B-X
FEAR	B-X
)	B-X
network	B-X
initiates	B-X
dispersal	B-X
of	B-X
active	B-X
Cdc14	B-X
throughout	B-X
the	B-X
cell	B-X
.	B-X
We	B-X
report	B-X
that	B-X
the	B-X
FEARnetwork	B-X
promotes	B-X
phosphorylation	B-X
of	B-X
Net1	B-X
by	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
complexed	B-X
with	B-X
cyclin	B-X
B1	B-X
or	B-X
cyclin	B-X
B2	B-X
.	B-X
These	B-X
phosphorylations	B-X
appear	B-X
to	B-X
be	B-X
required	B-X
for	B-X
FEAR	B-X
and	B-X
sustain	B-X
the	B-X
proper	B-X
timing	B-X
of	B-X
late	B-X
mitotic	B-X
events	B-X
.	B-X

We	O
report	O
that	O
the	O
FEARnetwork	O
promotes	O
phosphorylation	O
of	O
Net1	B-Gene_or_gene_product
by	O
cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
Cdk	B-Gene_or_gene_product
)	O
complexed	O
with	O
cyclin	B-Gene_or_gene_product
B1	I-Gene_or_gene_product
or	O
cyclin	B-Gene_or_gene_product
B2	I-Gene_or_gene_product
.	O
<EOS>	B-X
Among	B-X
these	B-X
DEGs	B-X
,	B-X
10	B-X
hub	B-X
genes	B-X
with	B-X
high	B-X
connectivity	B-X
degree	B-X
were	B-X
identified	B-X
,	B-X
including	B-X
cyclin	B-X
B1	B-X
,	B-X
cyclin	B-X
A2	B-X
,	B-X
cyclin	B-X
B2	B-X
,	B-X
condensin	B-X
complex	B-X
subunit	B-X
3	B-X
,	B-X
PDZ	B-X
binding	B-X
kinase	B-X
,	B-X
nucleolar	B-X
and	B-X
spindle‑associated	B-X
protein	B-X
1	B-X
,	B-X
aurora	B-X
kinase	B-X
A	B-X
,	B-X
ZW10	B-X
interacting	B-X
kinetochore	B-X
protein	B-X
,	B-X
protein	B-X
regulator	B-X
of	B-X
cytokinesis	B-X
1	B-X
and	B-X
kinesin	B-X
family	B-X
member	B-X
4A	B-X
.	B-X
Lamin	B-X
B2	B-X
(	B-X
LMNB2	B-X
)	B-X
is	B-X
involved	B-X
in	B-X
chromatin	B-X
remodeling	B-X
and	B-X
the	B-X
rupture	B-X
and	B-X
reorganization	B-X
of	B-X
nuclear	B-X
membrane	B-X
during	B-X
mitosis	B-X
,	B-X
which	B-X
is	B-X
necessary	B-X
for	B-X
eukaryotic	B-X
cell	B-X
proliferation	B-X
.	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
LMNB2	B-X
in	B-X
colorectal	B-X
cancer	B-X
(	B-X
CRC	B-X
)	B-X
is	B-X
poorly	B-X
understood	B-X
.	B-X
This	B-X
study	B-X
explored	B-X
the	B-X
biological	B-X
functions	B-X
of	B-X
LMNB2	B-X
in	B-X
the	B-X
progression	B-X
of	B-X
colorectal	B-X
cancer	B-X
and	B-X
explored	B-X
the	B-X
possible	B-X
molecular	B-X
mechanisms	B-X
.	B-X
We	B-X
found	B-X
that	B-X
LMNB2	B-X
was	B-X
significantly	B-X
upregulated	B-X
in	B-X
primary	B-X
colorectal	B-X
cancer	B-X
tissues	B-X
and	B-X
cell	B-X
lines	B-X
,	B-X
compared	B-X
with	B-X
paired	B-X
non-cancerous	B-X
tissues	B-X
and	B-X
normal	B-X
colorectal	B-X
epithelium	B-X
.	B-X
The	B-X
high	B-X
expression	B-X
of	B-X
LMNB2	B-X
in	B-X
colorectal	B-X
cancer	B-X
tissues	B-X
is	B-X
significantly	B-X
related	B-X
to	B-X
the	B-X
clinicopathological	B-X
characteristics	B-X
of	B-X
the	B-X
patients	B-X
and	B-X
the	B-X
shorter	B-X
overall	B-X
and	B-X
disease-free	B-X
cumulative	B-X
survival	B-X
.	B-X
Functional	B-X
analysis	B-X
,	B-X
including	B-X
CCK8	B-X
cell	B-X
proliferation	B-X
test	B-X
,	B-X
EdU	B-X
proliferation	B-X
test	B-X
,	B-X
colony	B-X
formation	B-X
analysis	B-X
,	B-X
nude	B-X
mouse	B-X
xenograft	B-X
,	B-X
cell	B-X
cycle	B-X
,	B-X
and	B-X
apoptosis	B-X
analysis	B-X
showed	B-X
that	B-X
LMNB2	B-X
significantly	B-X
promotes	B-X
cell	B-X
proliferation	B-X
by	B-X
promoting	B-X
cell	B-X
cycle	B-X
progression	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
gene	B-X
set	B-X
enrichment	B-X
analysis	B-X
,	B-X
luciferase	B-X
report	B-X
analysis	B-X
,	B-X
and	B-X
CHIP	B-X
analysis	B-X
showed	B-X
that	B-X
LMNB2	B-X
promotes	B-X
cell	B-X
proliferation	B-X
by	B-X
regulating	B-X
the	B-X
p21	B-X
promoter	B-X
,	B-X
whereas	B-X
LMNB2	B-X
has	B-X
no	B-X
effect	B-X
on	B-X
cell	B-X
apoptosis	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
findings	B-X
not	B-X
only	B-X
indicate	B-X
that	B-X
LMNB2	B-X
promotes	B-X
the	B-X
proliferation	B-X
of	B-X
colorectal	B-X
cancer	B-X
by	B-X
regulating	B-X
p21-mediated	B-X
cell	B-X
cycle	B-X
progression	B-X
,	B-X
but	B-X
also	B-X
suggest	B-X
the	B-X
potential	B-X
value	B-X
of	B-X
LMNB2	B-X
as	B-X
a	B-X
clinical	B-X
prognostic	B-X
marker	B-X
and	B-X
molecular	B-X
therapy	B-X
target	B-X
.	B-X

These	O
phosphorylations	O
appear	O
to	O
be	O
required	O
for	O
FEAR	O
and	O
sustain	O
the	O
proper	O
timing	O
of	O
late	O
mitotic	O
events	O
.	O
<EOS>	B-X
Upon	B-X
entry	B-X
into	B-X
anaphase	B-X
,	B-X
the	B-X
Cdc14	B-X
early	B-X
anaphase	B-X
release	B-X
(	B-X
FEAR	B-X
)	B-X
network	B-X
initiates	B-X
dispersal	B-X
of	B-X
active	B-X
Cdc14	B-X
throughout	B-X
the	B-X
cell	B-X
.	B-X
We	B-X
report	B-X
that	B-X
the	B-X
FEARnetwork	B-X
promotes	B-X
phosphorylation	B-X
of	B-X
Net1	B-X
by	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
complexed	B-X
with	B-X
cyclin	B-X
B1	B-X
or	B-X
cyclin	B-X
B2	B-X
.	B-X
These	B-X
phosphorylations	B-X
appear	B-X
to	B-X
be	B-X
required	B-X
for	B-X
FEAR	B-X
and	B-X
sustain	B-X
the	B-X
proper	B-X
timing	B-X
of	B-X
late	B-X
mitotic	B-X
events	B-X
.	B-X
Thus	B-X
,	B-X
a	B-X
regulatory	B-X
circuit	B-X
exists	B-X
to	B-X
ensure	B-X
that	B-X
the	B-X
arbiter	B-X
of	B-X
the	B-X
mitotic	B-X
state	B-X
,	B-X
Cdk	B-X
,	B-X
sets	B-X
in	B-X
motion	B-X
events	B-X
that	B-X
culminate	B-X
in	B-X
exit	B-X
from	B-X
mitosis	B-X
.	B-X

Thus	O
,	O
a	O
regulatory	O
circuit	O
exists	O
to	O
ensure	O
that	O
the	O
arbiter	O
of	O
the	O
mitotic	O
state	O
,	O
Cdk	B-Gene_or_gene_product
,	O
sets	O
in	O
motion	O
events	O
that	O
culminate	O
in	O
exit	O
from	O
mitosis	O
.	O
<EOS>	B-X
Budding	B-X
yeast	B-X
protein	B-X
phosphatase	B-X
Cdc14	B-X
is	B-X
sequestered	B-X
in	B-X
the	B-X
nucleolus	B-X
in	B-X
an	B-X
inactive	B-X
state	B-X
during	B-X
interphase	B-X
by	B-X
the	B-X
anchor	B-X
protein	B-X
Net1	B-X
.	B-X
We	B-X
report	B-X
that	B-X
the	B-X
FEARnetwork	B-X
promotes	B-X
phosphorylation	B-X
of	B-X
Net1	B-X
by	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
complexed	B-X
with	B-X
cyclin	B-X
B1	B-X
or	B-X
cyclin	B-X
B2	B-X
.	B-X
These	B-X
phosphorylations	B-X
appear	B-X
to	B-X
be	B-X
required	B-X
for	B-X
FEAR	B-X
and	B-X
sustain	B-X
the	B-X
proper	B-X
timing	B-X
of	B-X
late	B-X
mitotic	B-X
events	B-X
.	B-X
Thus	B-X
,	B-X
a	B-X
regulatory	B-X
circuit	B-X
exists	B-X
to	B-X
ensure	B-X
that	B-X
the	B-X
arbiter	B-X
of	B-X
the	B-X
mitotic	B-X
state	B-X
,	B-X
Cdk	B-X
,	B-X
sets	B-X
in	B-X
motion	B-X
events	B-X
that	B-X
culminate	B-X
in	B-X
exit	B-X
from	B-X
mitosis	B-X
.	B-X

Transcription	O
of	O
dbpA	B-Gene_or_gene_product
,	O
a	O
Y	O
box	O
binding	O
protein	O
,	O
is	O
positively	O
regulated	O
by	O
E2F1	B-Gene_or_gene_product
:	O
implications	O
in	O
hepatocarcinogenesis	O
.	O

Human	O
hepatocellular	O
carcinoma	O
is	O
one	O
of	O
the	O
most	O
common	O
cancers	O
in	O
the	O
world	O
.	O
<EOS>	B-X
Hepatocellular	B-X
carcinoma	B-X
(	B-X
HCC	B-X
)	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
common	B-X
cancers	B-X
in	B-X
the	B-X
world	B-X
,	B-X
and	B-X
cirrhosis	B-X
is	B-X
a	B-X
risk	B-X
factor	B-X
for	B-X
HCC	B-X
.	B-X
Identification	B-X
of	B-X
Prognostic	B-X
Genes	B-X
in	B-X
the	B-X
Tumor	B-X
Microenvironment	B-X
of	B-X
Hepatocellular	B-X
Carcinoma	B-X
.	B-X
Non-alcoholic	B-X
fatty	B-X
liver	B-X
disease	B-X
(	B-X
NAFLD	B-X
)	B-X
,	B-X
the	B-X
most	B-X
frequent	B-X
liver	B-X
disease	B-X
in	B-X
the	B-X
Western	B-X
world	B-X
,	B-X
is	B-X
a	B-X
common	B-X
hepatic	B-X
manifestation	B-X
of	B-X
metabolic	B-X
syndrome	B-X
(	B-X
MetS	B-X
)	B-X
.	B-X
The	B-X
main	B-X
goal	B-X
is	B-X
to	B-X
identify	B-X
the	B-X
factors	B-X
contributing	B-X
to	B-X
this	B-X
evolution	B-X
because	B-X
,	B-X
once	B-X
established	B-X
,	B-X
untreated	B-X
NASH	B-X
can	B-X
progress	B-X
through	B-X
fibrosis	B-X
to	B-X
cirrhosis	B-X
and	B-X
,	B-X
ultimately	B-X
,	B-X
be	B-X
complicated	B-X
by	B-X
hepatocellular	B-X
carcinoma	B-X
(	B-X
HCC	B-X
)	B-X
.	B-X
Several	B-X
drugs	B-X
have	B-X
been	B-X
tested	B-X
in	B-X
clinical	B-X
trials	B-X
for	B-X
use	B-X
as	B-X
specific	B-X
therapy	B-X
for	B-X
NAFLD	B-X
;	B-X
most	B-X
of	B-X
them	B-X
are	B-X
molecules	B-X
used	B-X
to	B-X
cure	B-X
type	B-X
2	B-X
diabetes	B-X
mellitus	B-X
(	B-X
T2DM	B-X
)	B-X
,	B-X
which	B-X
is	B-X
one	B-X
of	B-X
the	B-X
main	B-X
risk	B-X
factors	B-X
for	B-X
NAFLD	B-X
.	B-X
Among	B-X
the	B-X
most	B-X
studied	B-X
is	B-X
pioglitazone	B-X
,	B-X
either	B-X
alone	B-X
or	B-X
in	B-X
combination	B-X
with	B-X
vitamin	B-X
E	B-X
,	B-X
glucagon-like	B-X
peptide-1	B-X
(	B-X
GLP-1	B-X
)	B-X
receptor	B-X
agonists	B-X
,	B-X
dipeptidyl	B-X
peptidase-4	B-X
(	B-X
DPP-4	B-X
)	B-X
inhibitors	B-X
.	B-X

We	O
previously	O
showed	O
that	O
dbpA	B-Gene_or_gene_product
,	O
a	O
member	O
of	O
the	O
Y	O
box	O
family	O
of	O
proteins	O
,	O
could	O
accelerate	O
the	O
process	O
of	O
inflammation	O
-	O
induced	O
hepatocarcinogenesis	O
,	O
and	O
that	O
dbpA	B-Gene_or_gene_product
is	O
more	O
abundantly	O
expressed	O
in	O
hepatocellular	O
carcinoma	O
than	O
in	O
non	O
-	O
tumorous	O
tissue	O
.	O

In	O
this	O
study	O
,	O
to	O
clarify	O
the	O
mechanism	O
by	O
which	O
expression	O
of	O
dbpA	B-Gene_or_gene_product
is	O
enhanced	O
in	O
the	O
proliferative	O
state	O
,	O
we	O
examined	O
the	O
transcriptional	O
activity	O
of	O
the	O
dbpA	B-Gene_or_gene_product
promoter	O
region	O
.	O
<EOS>	B-X
We	B-X
previously	B-X
showed	B-X
that	B-X
dbpA	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
Y	B-X
box	B-X
family	B-X
of	B-X
proteins	B-X
,	B-X
could	B-X
accelerate	B-X
the	B-X
process	B-X
of	B-X
inflammation-induced	B-X
hepatocarcinogenesis	B-X
,	B-X
and	B-X
that	B-X
dbpA	B-X
is	B-X
more	B-X
abundantly	B-X
expressed	B-X
in	B-X
hepatocellular	B-X
carcinoma	B-X
than	B-X
in	B-X
non-tumorous	B-X
tissue	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
to	B-X
clarify	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
expression	B-X
of	B-X
dbpA	B-X
is	B-X
enhanced	B-X
in	B-X
the	B-X
proliferative	B-X
state	B-X
,	B-X
we	B-X
examined	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
the	B-X
dbpA	B-X
promoter	B-X
region	B-X
.	B-X
We	B-X
focused	B-X
on	B-X
the	B-X
sequence	B-X
5'-TTTGGGGC-3	B-X
'	B-X
(	B-X
-8	B-X
to	B-X
-1	B-X
in	B-X
the	B-X
promoter	B-X
region	B-X
)	B-X
resembling	B-X
the	B-X
E2F	B-X
binding	B-X
site	B-X
(	B-X
one	B-X
base	B-X
mismatch	B-X
,	B-X
TFSEARCH	B-X
score	B-X
86.2	B-X
)	B-X
.	B-X
By	B-X
overexpressing	B-X
E2F1	B-X
in	B-X
Huh-7	B-X
cells	B-X
,	B-X
transcriptional	B-X
activity	B-X
of	B-X
dbpA	B-X
was	B-X
significantly	B-X
increased	B-X
,	B-X
and	B-X
this	B-X
increase	B-X
was	B-X
abolished	B-X
by	B-X
mutating	B-X
or	B-X
deleting	B-X
this	B-X
sequence	B-X
.	B-X
Thus	B-X
,	B-X
expression	B-X
of	B-X
dbpA	B-X
was	B-X
positively	B-X
regulated	B-X
by	B-X
E2F1	B-X
,	B-X
suggesting	B-X
that	B-X
one	B-X
of	B-X
the	B-X
effects	B-X
of	B-X
E2F1	B-X
on	B-X
cell	B-X
proliferation	B-X
might	B-X
be	B-X
mediated	B-X
by	B-X
dbpA	B-X
at	B-X
the	B-X
carcinogenesis	B-X
step	B-X
.	B-X

We	O
focused	O
on	O
the	O
sequence	O
5	O
'	O
-	O
TTTGGGGC	O
-	O
3	O
'	O
(	O
-	O
8	O
to	O
-	O
1	O
in	O
the	O
promoter	O
region	O
)	O
resembling	O
the	O
E2F	B-Gene_or_gene_product
binding	O
site	O
(	O
one	O
base	O
mismatch	O
,	O
TFSEARCH	O
score	O
86	O
.	O
2	O
)	O
.	O
<EOS>	B-X
Human	B-X
hepatocellular	B-X
carcinoma	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
common	B-X
cancers	B-X
in	B-X
the	B-X
world	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
to	B-X
clarify	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
expression	B-X
of	B-X
dbpA	B-X
is	B-X
enhanced	B-X
in	B-X
the	B-X
proliferative	B-X
state	B-X
,	B-X
we	B-X
examined	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
the	B-X
dbpA	B-X
promoter	B-X
region	B-X
.	B-X
We	B-X
focused	B-X
on	B-X
the	B-X
sequence	B-X
5'-TTTGGGGC-3	B-X
'	B-X
(	B-X
-8	B-X
to	B-X
-1	B-X
in	B-X
the	B-X
promoter	B-X
region	B-X
)	B-X
resembling	B-X
the	B-X
E2F	B-X
binding	B-X
site	B-X
(	B-X
one	B-X
base	B-X
mismatch	B-X
,	B-X
TFSEARCH	B-X
score	B-X
86.2	B-X
)	B-X
.	B-X
By	B-X
overexpressing	B-X
E2F1	B-X
in	B-X
Huh-7	B-X
cells	B-X
,	B-X
transcriptional	B-X
activity	B-X
of	B-X
dbpA	B-X
was	B-X
significantly	B-X
increased	B-X
,	B-X
and	B-X
this	B-X
increase	B-X
was	B-X
abolished	B-X
by	B-X
mutating	B-X
or	B-X
deleting	B-X
this	B-X
sequence	B-X
.	B-X
Thus	B-X
,	B-X
expression	B-X
of	B-X
dbpA	B-X
was	B-X
positively	B-X
regulated	B-X
by	B-X
E2F1	B-X
,	B-X
suggesting	B-X
that	B-X
one	B-X
of	B-X
the	B-X
effects	B-X
of	B-X
E2F1	B-X
on	B-X
cell	B-X
proliferation	B-X
might	B-X
be	B-X
mediated	B-X
by	B-X
dbpA	B-X
at	B-X
the	B-X
carcinogenesis	B-X
step	B-X
.	B-X

By	O
overexpressing	O
E2F1	B-Gene_or_gene_product
in	O
Huh	O
-	O
7	O
cells	O
,	O
transcriptional	O
activity	O
of	O
dbpA	B-Gene_or_gene_product
was	O
significantly	O
increased	O
,	O
and	O
this	O
increase	O
was	O
abolished	O
by	O
mutating	O
or	O
deleting	O
this	O
sequence	O
.	O
<EOS>	B-X
Depending	B-X
on	B-X
the	B-X
level	B-X
of	B-X
stringency	B-X
of	B-X
the	B-X
map	B-X
,	B-X
we	B-X
estimated	B-X
that	B-X
4.8-9.5	B-X
%	B-X
of	B-X
the	B-X
genome	B-X
contributes	B-X
to	B-X
CNV	B-X
and	B-X
found	B-X
approximately	B-X
100	B-X
genes	B-X
that	B-X
can	B-X
be	B-X
completely	B-X
deleted	B-X
without	B-X
producing	B-X
apparent	B-X
phenotypic	B-X
consequences	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
budding	B-X
yeast	B-X
to	B-X
undergo	B-X
efficient	B-X
homologous	B-X
recombination	B-X
with	B-X
short	B-X
stretches	B-X
of	B-X
sequence	B-X
homology	B-X
has	B-X
led	B-X
to	B-X
an	B-X
explosion	B-X
of	B-X
PCR-based	B-X
methods	B-X
to	B-X
delete	B-X
and	B-X
mutate	B-X
yeast	B-X
genes	B-X
and	B-X
to	B-X
create	B-X
fusions	B-X
to	B-X
epitope	B-X
tags	B-X
and	B-X
fluorescent	B-X
proteins	B-X
.	B-X
However	B-X
,	B-X
compiling	B-X
sequence-specific	B-X
mutation	B-X
spectra	B-X
is	B-X
laborious	B-X
;	B-X
even	B-X
with	B-X
modern	B-X
sequencing	B-X
technology	B-X
,	B-X
it	B-X
is	B-X
rare	B-X
to	B-X
obtain	B-X
spectra	B-X
with	B-X
more	B-X
than	B-X
several	B-X
hundred	B-X
data	B-X
points	B-X
.	B-X
The	B-X
assay	B-X
for	B-X
insertion/deletion	B-X
mutations	B-X
uses	B-X
a	B-X
variety	B-X
of	B-X
different	B-X
simple	B-X
repeats	B-X
placed	B-X
in	B-X
frame	B-X
with	B-X
URA3	B-X
such	B-X
that	B-X
insertions	B-X
or	B-X
deletions	B-X
lead	B-X
to	B-X
a	B-X
selectable	B-X
Ura	B-X
(	B-X
-	B-X
)	B-X
phenotype	B-X
;	B-X
essentially	B-X
all	B-X
such	B-X
mutations	B-X
are	B-X
in	B-X
the	B-X
simple	B-X
repeat	B-X
sequence	B-X
.	B-X

Thus	O
,	O
expression	O
of	O
dbpA	B-Gene_or_gene_product
was	O
positively	O
regulated	O
by	O
E2F1	B-Gene_or_gene_product
,	O
suggesting	O
that	O
one	O
of	O
the	O
effects	O
of	O
E2F1	B-Gene_or_gene_product
on	O
cell	O
proliferation	O
might	O
be	O
mediated	O
by	O
dbpA	B-Gene_or_gene_product
at	O
the	O
carcinogenesis	O
step	O
.	O
<EOS>	B-X
Human	B-X
hepatocellular	B-X
carcinoma	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
common	B-X
cancers	B-X
in	B-X
the	B-X
world	B-X
.	B-X
We	B-X
previously	B-X
showed	B-X
that	B-X
dbpA	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
Y	B-X
box	B-X
family	B-X
of	B-X
proteins	B-X
,	B-X
could	B-X
accelerate	B-X
the	B-X
process	B-X
of	B-X
inflammation-induced	B-X
hepatocarcinogenesis	B-X
,	B-X
and	B-X
that	B-X
dbpA	B-X
is	B-X
more	B-X
abundantly	B-X
expressed	B-X
in	B-X
hepatocellular	B-X
carcinoma	B-X
than	B-X
in	B-X
non-tumorous	B-X
tissue	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
to	B-X
clarify	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
expression	B-X
of	B-X
dbpA	B-X
is	B-X
enhanced	B-X
in	B-X
the	B-X
proliferative	B-X
state	B-X
,	B-X
we	B-X
examined	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
the	B-X
dbpA	B-X
promoter	B-X
region	B-X
.	B-X
We	B-X
focused	B-X
on	B-X
the	B-X
sequence	B-X
5'-TTTGGGGC-3	B-X
'	B-X
(	B-X
-8	B-X
to	B-X
-1	B-X
in	B-X
the	B-X
promoter	B-X
region	B-X
)	B-X
resembling	B-X
the	B-X
E2F	B-X
binding	B-X
site	B-X
(	B-X
one	B-X
base	B-X
mismatch	B-X
,	B-X
TFSEARCH	B-X
score	B-X
86.2	B-X
)	B-X
.	B-X
By	B-X
overexpressing	B-X
E2F1	B-X
in	B-X
Huh-7	B-X
cells	B-X
,	B-X
transcriptional	B-X
activity	B-X
of	B-X
dbpA	B-X
was	B-X
significantly	B-X
increased	B-X
,	B-X
and	B-X
this	B-X
increase	B-X
was	B-X
abolished	B-X
by	B-X
mutating	B-X
or	B-X
deleting	B-X
this	B-X
sequence	B-X
.	B-X
Thus	B-X
,	B-X
expression	B-X
of	B-X
dbpA	B-X
was	B-X
positively	B-X
regulated	B-X
by	B-X
E2F1	B-X
,	B-X
suggesting	B-X
that	B-X
one	B-X
of	B-X
the	B-X
effects	B-X
of	B-X
E2F1	B-X
on	B-X
cell	B-X
proliferation	B-X
might	B-X
be	B-X
mediated	B-X
by	B-X
dbpA	B-X
at	B-X
the	B-X
carcinogenesis	B-X
step	B-X
.	B-X

Upstream	O
and	O
downstream	O
of	O
mTOR	B-Gene_or_gene_product
.	O
<EOS>	B-X
However	B-X
,	B-X
the	B-X
precise	B-X
role	B-X
of	B-X
mechanistic	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
-dependent	B-X
autophagy	B-X
and	B-X
its	B-X
underlying	B-X
regulatory	B-X
mechanisms	B-X
in	B-X
the	B-X
intestinal	B-X
epithelium	B-X
in	B-X
response	B-X
to	B-X
inflammation	B-X
and	B-X
oxidative	B-X
stress	B-X
remain	B-X
poorly	B-X
understood	B-X
.	B-X
Work	B-X
in	B-X
the	B-X
last	B-X
decade	B-X
clearly	B-X
demonstrates	B-X
that	B-X
TOR	B-X
controls	B-X
protein	B-X
synthesis	B-X
through	B-X
a	B-X
stunning	B-X
number	B-X
of	B-X
downstream	B-X
targets	B-X
.	B-X
We	B-X
describe	B-X
both	B-X
the	B-X
upstream	B-X
components	B-X
of	B-X
the	B-X
signaling	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
that	B-X
activates	B-X
mammalian	B-X
TOR	B-X
(	B-X
mTOR	B-X
)	B-X
and	B-X
the	B-X
downstream	B-X
targets	B-X
that	B-X
affect	B-X
protein	B-X
synthesis	B-X
.	B-X
We	B-X
also	B-X
summarize	B-X
the	B-X
roles	B-X
of	B-X
mTOR	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
growth	B-X
and	B-X
proliferation	B-X
,	B-X
as	B-X
well	B-X
as	B-X
its	B-X
relevance	B-X
to	B-X
cancer	B-X
and	B-X
synaptic	B-X
plasticity	B-X
.	B-X

The	O
evolutionarily	O
conserved	O
checkpoint	O
protein	O
kinase	O
,	O
TOR	B-Gene_or_gene_product
(	O
target	B-Gene_or_gene_product
of	I-Gene_or_gene_product
rapamycin	I-Gene_or_gene_product
)	O
,	O
has	O
emerged	O
as	O
a	O
major	O
effector	O
of	O
cell	O
growth	O
and	O
proliferation	O
via	O
the	O
regulation	O
of	O
protein	O
synthesis	O
.	O

Work	O
in	O
the	O
last	O
decade	O
clearly	O
demonstrates	O
that	O
TOR	B-Gene_or_gene_product
controls	O
protein	O
synthesis	O
through	O
a	O
stunning	O
number	O
of	O
downstream	O
targets	O
.	O
<EOS>	B-X
The	B-X
evolutionarily	B-X
conserved	B-X
checkpoint	B-X
protein	B-X
kinase	B-X
,	B-X
TOR	B-X
(	B-X
target	B-X
of	B-X
rapamycin	B-X
)	B-X
,	B-X
has	B-X
emerged	B-X
as	B-X
a	B-X
major	B-X
effector	B-X
of	B-X
cell	B-X
growth	B-X
and	B-X
proliferation	B-X
via	B-X
the	B-X
regulation	B-X
of	B-X
protein	B-X
synthesis	B-X
.	B-X
Work	B-X
in	B-X
the	B-X
last	B-X
decade	B-X
clearly	B-X
demonstrates	B-X
that	B-X
TOR	B-X
controls	B-X
protein	B-X
synthesis	B-X
through	B-X
a	B-X
stunning	B-X
number	B-X
of	B-X
downstream	B-X
targets	B-X
.	B-X
Some	B-X
of	B-X
the	B-X
targets	B-X
are	B-X
phosphorylated	B-X
directly	B-X
by	B-X
TOR	B-X
,	B-X
but	B-X
many	B-X
are	B-X
phosphorylated	B-X
indirectly	B-X
.	B-X
We	B-X
describe	B-X
both	B-X
the	B-X
upstream	B-X
components	B-X
of	B-X
the	B-X
signaling	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
that	B-X
activates	B-X
mammalian	B-X
TOR	B-X
(	B-X
mTOR	B-X
)	B-X
and	B-X
the	B-X
downstream	B-X
targets	B-X
that	B-X
affect	B-X
protein	B-X
synthesis	B-X
.	B-X
We	B-X
also	B-X
summarize	B-X
the	B-X
roles	B-X
of	B-X
mTOR	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
growth	B-X
and	B-X
proliferation	B-X
,	B-X
as	B-X
well	B-X
as	B-X
its	B-X
relevance	B-X
to	B-X
cancer	B-X
and	B-X
synaptic	B-X
plasticity	B-X
.	B-X

Some	O
of	O
the	O
targets	O
are	O
phosphorylated	O
directly	O
by	O
TOR	B-Gene_or_gene_product
,	O
but	O
many	O
are	O
phosphorylated	O
indirectly	O
.	O
<EOS>	B-X
The	B-X
evolutionarily	B-X
conserved	B-X
checkpoint	B-X
protein	B-X
kinase	B-X
,	B-X
TOR	B-X
(	B-X
target	B-X
of	B-X
rapamycin	B-X
)	B-X
,	B-X
has	B-X
emerged	B-X
as	B-X
a	B-X
major	B-X
effector	B-X
of	B-X
cell	B-X
growth	B-X
and	B-X
proliferation	B-X
via	B-X
the	B-X
regulation	B-X
of	B-X
protein	B-X
synthesis	B-X
.	B-X
Work	B-X
in	B-X
the	B-X
last	B-X
decade	B-X
clearly	B-X
demonstrates	B-X
that	B-X
TOR	B-X
controls	B-X
protein	B-X
synthesis	B-X
through	B-X
a	B-X
stunning	B-X
number	B-X
of	B-X
downstream	B-X
targets	B-X
.	B-X
Some	B-X
of	B-X
the	B-X
targets	B-X
are	B-X
phosphorylated	B-X
directly	B-X
by	B-X
TOR	B-X
,	B-X
but	B-X
many	B-X
are	B-X
phosphorylated	B-X
indirectly	B-X
.	B-X
We	B-X
describe	B-X
both	B-X
the	B-X
upstream	B-X
components	B-X
of	B-X
the	B-X
signaling	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
that	B-X
activates	B-X
mammalian	B-X
TOR	B-X
(	B-X
mTOR	B-X
)	B-X
and	B-X
the	B-X
downstream	B-X
targets	B-X
that	B-X
affect	B-X
protein	B-X
synthesis	B-X
.	B-X
We	B-X
also	B-X
summarize	B-X
the	B-X
roles	B-X
of	B-X
mTOR	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
growth	B-X
and	B-X
proliferation	B-X
,	B-X
as	B-X
well	B-X
as	B-X
its	B-X
relevance	B-X
to	B-X
cancer	B-X
and	B-X
synaptic	B-X
plasticity	B-X
.	B-X

In	O
this	O
review	O
,	O
we	O
summarize	O
some	O
recent	O
developments	O
in	O
this	O
fast	O
-	O
evolving	O
field	O
.	O
<EOS>	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
summarize	B-X
some	B-X
recent	B-X
developments	B-X
in	B-X
this	B-X
fast-evolving	B-X
field	B-X
.	B-X
We	B-X
also	B-X
summarize	B-X
the	B-X
roles	B-X
of	B-X
mTOR	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
growth	B-X
and	B-X
proliferation	B-X
,	B-X
as	B-X
well	B-X
as	B-X
its	B-X
relevance	B-X
to	B-X
cancer	B-X
and	B-X
synaptic	B-X
plasticity	B-X
.	B-X
However	B-X
,	B-X
the	B-X
therapeutic	B-X
effect	B-X
of	B-X
catalytic	B-X
therapy	B-X
is	B-X
seriously	B-X
restricted	B-X
by	B-X
the	B-X
fast	B-X
charge	B-X
recombination	B-X
and	B-X
the	B-X
limited	B-X
utilization	B-X
of	B-X
exogenous	B-X
stimulation	B-X
by	B-X
catalysts	B-X
.	B-X
This	B-X
review	B-X
attempts	B-X
to	B-X
summarize	B-X
the	B-X
recent	B-X
progress	B-X
in	B-X
the	B-X
rational	B-X
design	B-X
and	B-X
fabrication	B-X
of	B-X
heterojunction	B-X
nanomedicine	B-X
,	B-X
such	B-X
as	B-X
semiconductor-semiconductor	B-X
heterojunctions	B-X
(	B-X
including	B-X
type	B-X
I	B-X
,	B-X
type	B-X
II	B-X
,	B-X
type	B-X
III	B-X
,	B-X
PN	B-X
,	B-X
and	B-X
Z-scheme	B-X
junctions	B-X
)	B-X
and	B-X
semiconductor-metal	B-X
heterojunctions	B-X
(	B-X
including	B-X
Schottky	B-X
,	B-X
Ohmic	B-X
,	B-X
and	B-X
localized	B-X
surface	B-X
plasmon	B-X
resonance-mediated	B-X
junctions	B-X
)	B-X
.	B-X
This	B-X
review	B-X
concludes	B-X
with	B-X
a	B-X
summary	B-X
of	B-X
the	B-X
challenges	B-X
and	B-X
some	B-X
perspectives	B-X
on	B-X
future	B-X
directions	B-X
in	B-X
this	B-X
exciting	B-X
and	B-X
still	B-X
evolving	B-X
field	B-X
of	B-X
research	B-X
.	B-X

We	O
describe	O
both	O
the	O
upstream	O
components	O
of	O
the	O
signaling	O
pathway	O
(	O
s	O
)	O
that	O
activates	O
mammalian	B-Gene_or_gene_product
TOR	I-Gene_or_gene_product
(	O
mTOR	B-Gene_or_gene_product
)	O
and	O
the	O
downstream	O
targets	O
that	O
affect	O
protein	O
synthesis	O
.	O
<EOS>	B-X
The	B-X
evolutionarily	B-X
conserved	B-X
checkpoint	B-X
protein	B-X
kinase	B-X
,	B-X
TOR	B-X
(	B-X
target	B-X
of	B-X
rapamycin	B-X
)	B-X
,	B-X
has	B-X
emerged	B-X
as	B-X
a	B-X
major	B-X
effector	B-X
of	B-X
cell	B-X
growth	B-X
and	B-X
proliferation	B-X
via	B-X
the	B-X
regulation	B-X
of	B-X
protein	B-X
synthesis	B-X
.	B-X
Work	B-X
in	B-X
the	B-X
last	B-X
decade	B-X
clearly	B-X
demonstrates	B-X
that	B-X
TOR	B-X
controls	B-X
protein	B-X
synthesis	B-X
through	B-X
a	B-X
stunning	B-X
number	B-X
of	B-X
downstream	B-X
targets	B-X
.	B-X
Some	B-X
of	B-X
the	B-X
targets	B-X
are	B-X
phosphorylated	B-X
directly	B-X
by	B-X
TOR	B-X
,	B-X
but	B-X
many	B-X
are	B-X
phosphorylated	B-X
indirectly	B-X
.	B-X
We	B-X
describe	B-X
both	B-X
the	B-X
upstream	B-X
components	B-X
of	B-X
the	B-X
signaling	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
that	B-X
activates	B-X
mammalian	B-X
TOR	B-X
(	B-X
mTOR	B-X
)	B-X
and	B-X
the	B-X
downstream	B-X
targets	B-X
that	B-X
affect	B-X
protein	B-X
synthesis	B-X
.	B-X
We	B-X
also	B-X
summarize	B-X
the	B-X
roles	B-X
of	B-X
mTOR	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
growth	B-X
and	B-X
proliferation	B-X
,	B-X
as	B-X
well	B-X
as	B-X
its	B-X
relevance	B-X
to	B-X
cancer	B-X
and	B-X
synaptic	B-X
plasticity	B-X
.	B-X

We	O
also	O
summarize	O
the	O
roles	O
of	O
mTOR	B-Gene_or_gene_product
in	O
the	O
control	O
of	O
cell	O
growth	O
and	O
proliferation	O
,	O
as	O
well	O
as	O
its	O
relevance	O
to	O
cancer	O
and	O
synaptic	O
plasticity	O
.	O
<EOS>	B-X
The	B-X
evolutionarily	B-X
conserved	B-X
checkpoint	B-X
protein	B-X
kinase	B-X
,	B-X
TOR	B-X
(	B-X
target	B-X
of	B-X
rapamycin	B-X
)	B-X
,	B-X
has	B-X
emerged	B-X
as	B-X
a	B-X
major	B-X
effector	B-X
of	B-X
cell	B-X
growth	B-X
and	B-X
proliferation	B-X
via	B-X
the	B-X
regulation	B-X
of	B-X
protein	B-X
synthesis	B-X
.	B-X
Work	B-X
in	B-X
the	B-X
last	B-X
decade	B-X
clearly	B-X
demonstrates	B-X
that	B-X
TOR	B-X
controls	B-X
protein	B-X
synthesis	B-X
through	B-X
a	B-X
stunning	B-X
number	B-X
of	B-X
downstream	B-X
targets	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
summarize	B-X
some	B-X
recent	B-X
developments	B-X
in	B-X
this	B-X
fast-evolving	B-X
field	B-X
.	B-X
We	B-X
describe	B-X
both	B-X
the	B-X
upstream	B-X
components	B-X
of	B-X
the	B-X
signaling	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
that	B-X
activates	B-X
mammalian	B-X
TOR	B-X
(	B-X
mTOR	B-X
)	B-X
and	B-X
the	B-X
downstream	B-X
targets	B-X
that	B-X
affect	B-X
protein	B-X
synthesis	B-X
.	B-X
We	B-X
also	B-X
summarize	B-X
the	B-X
roles	B-X
of	B-X
mTOR	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
growth	B-X
and	B-X
proliferation	B-X
,	B-X
as	B-X
well	B-X
as	B-X
its	B-X
relevance	B-X
to	B-X
cancer	B-X
and	B-X
synaptic	B-X
plasticity	B-X
.	B-X

Phosphorylation	O
-	O
dependent	O
binding	O
of	O
mitotic	O
cyclins	O
to	O
Cdc6	B-Gene_or_gene_product
contributes	O
to	O
DNA	O
replication	O
control	O
.	O
<EOS>	B-X
Cyclin-dependent	B-X
kinases	B-X
(	B-X
CDKs	B-X
)	B-X
limit	B-X
the	B-X
activation	B-X
of	B-X
DNA	B-X
replication	B-X
origins	B-X
to	B-X
once	B-X
per	B-X
cell	B-X
cycle	B-X
by	B-X
preventing	B-X
the	B-X
assembly	B-X
of	B-X
pre-replicative	B-X
complexes	B-X
(	B-X
pre-RCs	B-X
)	B-X
during	B-X
S	B-X
,	B-X
G2	B-X
and	B-X
M	B-X
phases	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
in	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
.	B-X
CDKs	B-X
inhibit	B-X
each	B-X
pre-RC	B-X
component	B-X
(	B-X
ORC	B-X
,	B-X
Cdc6	B-X
,	B-X
Cdt1/Mcm2-7	B-X
)	B-X
by	B-X
different	B-X
mechanisms	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
the	B-X
mitotic	B-X
CDK	B-X
,	B-X
Clb2/Cdc28	B-X
,	B-X
binds	B-X
tightly	B-X
to	B-X
an	B-X
amino-terminal	B-X
domain	B-X
(	B-X
NTD	B-X
)	B-X
of	B-X
Cdc6	B-X
,	B-X
and	B-X
that	B-X
Cdc6	B-X
in	B-X
this	B-X
complex	B-X
is	B-X
unable	B-X
to	B-X
assemble	B-X
pre-RCs	B-X
.	B-X
We	B-X
present	B-X
evidence	B-X
indicating	B-X
that	B-X
this	B-X
Clb2-dependent	B-X
mechanism	B-X
contributes	B-X
to	B-X
preventing	B-X
re-replication	B-X
in	B-X
vivo	B-X
.	B-X
CDK	B-X
interaction	B-X
with	B-X
the	B-X
NTD	B-X
of	B-X
Cdc6	B-X
is	B-X
mediated	B-X
by	B-X
the	B-X
cyclin	B-X
subunit	B-X
Clb2	B-X
,	B-X
and	B-X
could	B-X
be	B-X
reconstituted	B-X
with	B-X
recombinant	B-X
Clb2	B-X
protein	B-X
and	B-X
synthetic	B-X
NTD	B-X
peptides	B-X
.	B-X
Tight	B-X
Clb2	B-X
binding	B-X
occurred	B-X
only	B-X
when	B-X
the	B-X
NTD	B-X
was	B-X
phosphorylated	B-X
on	B-X
CDK	B-X
consensus	B-X
sites	B-X
.	B-X
Human	B-X
CDKs	B-X
containing	B-X
cyclins	B-X
A	B-X
,	B-X
B	B-X
and	B-X
E	B-X
also	B-X
bound	B-X
specifically	B-X
to	B-X
phospho-NTD	B-X
peptides	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
direct	B-X
binding	B-X
of	B-X
cyclins	B-X
to	B-X
phosphopeptide	B-X
motifs	B-X
may	B-X
be	B-X
a	B-X
widespread	B-X
phenomenon	B-X
contributing	B-X
to	B-X
the	B-X
targeting	B-X
of	B-X
CDKs	B-X
to	B-X
substrates	B-X
.	B-X

Cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
(	O
CDKs	B-Gene_or_gene_product
)	O
limit	O
the	O
activation	O
of	O
DNA	O
replication	O
origins	O
to	O
once	O
per	O
cell	O
cycle	O
by	O
preventing	O
the	O
assembly	O
of	O
pre	O
-	O
replicative	O
complexes	O
(	O
pre	O
-	O
RCs	O
)	O
during	O
S	O
,	O
G2	O
and	O
M	O
phases	O
of	O
the	O
cell	O
cycle	O
in	O
the	O
budding	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

CDKs	B-Gene_or_gene_product
inhibit	O
each	O
pre	O
-	O
RC	O
component	O
(	O
ORC	B-Gene_or_gene_product
,	O
Cdc6	B-Gene_or_gene_product
,	O
Cdt1	O
/	O
Mcm2	O
-	O
7	O
)	O
by	O
different	O
mechanisms	O
.	O
<EOS>	B-X
Cyclin-dependent	B-X
kinases	B-X
(	B-X
CDKs	B-X
)	B-X
limit	B-X
the	B-X
activation	B-X
of	B-X
DNA	B-X
replication	B-X
origins	B-X
to	B-X
once	B-X
per	B-X
cell	B-X
cycle	B-X
by	B-X
preventing	B-X
the	B-X
assembly	B-X
of	B-X
pre-replicative	B-X
complexes	B-X
(	B-X
pre-RCs	B-X
)	B-X
during	B-X
S	B-X
,	B-X
G2	B-X
and	B-X
M	B-X
phases	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
in	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
.	B-X
CDKs	B-X
inhibit	B-X
each	B-X
pre-RC	B-X
component	B-X
(	B-X
ORC	B-X
,	B-X
Cdc6	B-X
,	B-X
Cdt1/Mcm2-7	B-X
)	B-X
by	B-X
different	B-X
mechanisms	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
the	B-X
mitotic	B-X
CDK	B-X
,	B-X
Clb2/Cdc28	B-X
,	B-X
binds	B-X
tightly	B-X
to	B-X
an	B-X
amino-terminal	B-X
domain	B-X
(	B-X
NTD	B-X
)	B-X
of	B-X
Cdc6	B-X
,	B-X
and	B-X
that	B-X
Cdc6	B-X
in	B-X
this	B-X
complex	B-X
is	B-X
unable	B-X
to	B-X
assemble	B-X
pre-RCs	B-X
.	B-X
We	B-X
present	B-X
evidence	B-X
indicating	B-X
that	B-X
this	B-X
Clb2-dependent	B-X
mechanism	B-X
contributes	B-X
to	B-X
preventing	B-X
re-replication	B-X
in	B-X
vivo	B-X
.	B-X
CDK	B-X
interaction	B-X
with	B-X
the	B-X
NTD	B-X
of	B-X
Cdc6	B-X
is	B-X
mediated	B-X
by	B-X
the	B-X
cyclin	B-X
subunit	B-X
Clb2	B-X
,	B-X
and	B-X
could	B-X
be	B-X
reconstituted	B-X
with	B-X
recombinant	B-X
Clb2	B-X
protein	B-X
and	B-X
synthetic	B-X
NTD	B-X
peptides	B-X
.	B-X
Human	B-X
CDKs	B-X
containing	B-X
cyclins	B-X
A	B-X
,	B-X
B	B-X
and	B-X
E	B-X
also	B-X
bound	B-X
specifically	B-X
to	B-X
phospho-NTD	B-X
peptides	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
direct	B-X
binding	B-X
of	B-X
cyclins	B-X
to	B-X
phosphopeptide	B-X
motifs	B-X
may	B-X
be	B-X
a	B-X
widespread	B-X
phenomenon	B-X
contributing	B-X
to	B-X
the	B-X
targeting	B-X
of	B-X
CDKs	B-X
to	B-X
substrates	B-X
.	B-X

We	O
show	O
here	O
that	O
the	O
mitotic	O
CDK	B-Gene_or_gene_product
,	O
Clb2	O
/	O
Cdc28	O
,	O
binds	O
tightly	O
to	O
an	O
amino	O
-	O
terminal	O
domain	O
(	O
NTD	O
)	O
of	O
Cdc6	B-Gene_or_gene_product
,	O
and	O
that	O
Cdc6	B-Gene_or_gene_product
in	O
this	O
complex	O
is	O
unable	O
to	O
assemble	O
pre	O
-	O
RCs	O
.	O

We	O
present	O
evidence	O
indicating	O
that	O
this	O
Clb2	B-Gene_or_gene_product
-	O
dependent	O
mechanism	O
contributes	O
to	O
preventing	O
re	O
-	O
replication	O
in	O
vivo	O
.	O
<EOS>	B-X
Cyclin-dependent	B-X
kinases	B-X
(	B-X
CDKs	B-X
)	B-X
limit	B-X
the	B-X
activation	B-X
of	B-X
DNA	B-X
replication	B-X
origins	B-X
to	B-X
once	B-X
per	B-X
cell	B-X
cycle	B-X
by	B-X
preventing	B-X
the	B-X
assembly	B-X
of	B-X
pre-replicative	B-X
complexes	B-X
(	B-X
pre-RCs	B-X
)	B-X
during	B-X
S	B-X
,	B-X
G2	B-X
and	B-X
M	B-X
phases	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
in	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
.	B-X
CDKs	B-X
inhibit	B-X
each	B-X
pre-RC	B-X
component	B-X
(	B-X
ORC	B-X
,	B-X
Cdc6	B-X
,	B-X
Cdt1/Mcm2-7	B-X
)	B-X
by	B-X
different	B-X
mechanisms	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
the	B-X
mitotic	B-X
CDK	B-X
,	B-X
Clb2/Cdc28	B-X
,	B-X
binds	B-X
tightly	B-X
to	B-X
an	B-X
amino-terminal	B-X
domain	B-X
(	B-X
NTD	B-X
)	B-X
of	B-X
Cdc6	B-X
,	B-X
and	B-X
that	B-X
Cdc6	B-X
in	B-X
this	B-X
complex	B-X
is	B-X
unable	B-X
to	B-X
assemble	B-X
pre-RCs	B-X
.	B-X
We	B-X
present	B-X
evidence	B-X
indicating	B-X
that	B-X
this	B-X
Clb2-dependent	B-X
mechanism	B-X
contributes	B-X
to	B-X
preventing	B-X
re-replication	B-X
in	B-X
vivo	B-X
.	B-X
CDK	B-X
interaction	B-X
with	B-X
the	B-X
NTD	B-X
of	B-X
Cdc6	B-X
is	B-X
mediated	B-X
by	B-X
the	B-X
cyclin	B-X
subunit	B-X
Clb2	B-X
,	B-X
and	B-X
could	B-X
be	B-X
reconstituted	B-X
with	B-X
recombinant	B-X
Clb2	B-X
protein	B-X
and	B-X
synthetic	B-X
NTD	B-X
peptides	B-X
.	B-X
Tight	B-X
Clb2	B-X
binding	B-X
occurred	B-X
only	B-X
when	B-X
the	B-X
NTD	B-X
was	B-X
phosphorylated	B-X
on	B-X
CDK	B-X
consensus	B-X
sites	B-X
.	B-X

CDK	B-Gene_or_gene_product
interaction	O
with	O
the	O
NTD	O
of	O
Cdc6	B-Gene_or_gene_product
is	O
mediated	O
by	O
the	O
cyclin	O
subunit	O
Clb2	B-Gene_or_gene_product
,	O
and	O
could	O
be	O
reconstituted	O
with	O
recombinant	O
Clb2	B-Gene_or_gene_product
protein	O
and	O
synthetic	O
NTD	O
peptides	O
.	O
<EOS>	B-X
Cyclin-dependent	B-X
kinases	B-X
(	B-X
CDKs	B-X
)	B-X
limit	B-X
the	B-X
activation	B-X
of	B-X
DNA	B-X
replication	B-X
origins	B-X
to	B-X
once	B-X
per	B-X
cell	B-X
cycle	B-X
by	B-X
preventing	B-X
the	B-X
assembly	B-X
of	B-X
pre-replicative	B-X
complexes	B-X
(	B-X
pre-RCs	B-X
)	B-X
during	B-X
S	B-X
,	B-X
G2	B-X
and	B-X
M	B-X
phases	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
in	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
.	B-X
CDKs	B-X
inhibit	B-X
each	B-X
pre-RC	B-X
component	B-X
(	B-X
ORC	B-X
,	B-X
Cdc6	B-X
,	B-X
Cdt1/Mcm2-7	B-X
)	B-X
by	B-X
different	B-X
mechanisms	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
the	B-X
mitotic	B-X
CDK	B-X
,	B-X
Clb2/Cdc28	B-X
,	B-X
binds	B-X
tightly	B-X
to	B-X
an	B-X
amino-terminal	B-X
domain	B-X
(	B-X
NTD	B-X
)	B-X
of	B-X
Cdc6	B-X
,	B-X
and	B-X
that	B-X
Cdc6	B-X
in	B-X
this	B-X
complex	B-X
is	B-X
unable	B-X
to	B-X
assemble	B-X
pre-RCs	B-X
.	B-X
We	B-X
present	B-X
evidence	B-X
indicating	B-X
that	B-X
this	B-X
Clb2-dependent	B-X
mechanism	B-X
contributes	B-X
to	B-X
preventing	B-X
re-replication	B-X
in	B-X
vivo	B-X
.	B-X
CDK	B-X
interaction	B-X
with	B-X
the	B-X
NTD	B-X
of	B-X
Cdc6	B-X
is	B-X
mediated	B-X
by	B-X
the	B-X
cyclin	B-X
subunit	B-X
Clb2	B-X
,	B-X
and	B-X
could	B-X
be	B-X
reconstituted	B-X
with	B-X
recombinant	B-X
Clb2	B-X
protein	B-X
and	B-X
synthetic	B-X
NTD	B-X
peptides	B-X
.	B-X
Tight	B-X
Clb2	B-X
binding	B-X
occurred	B-X
only	B-X
when	B-X
the	B-X
NTD	B-X
was	B-X
phosphorylated	B-X
on	B-X
CDK	B-X
consensus	B-X
sites	B-X
.	B-X
Human	B-X
CDKs	B-X
containing	B-X
cyclins	B-X
A	B-X
,	B-X
B	B-X
and	B-X
E	B-X
also	B-X
bound	B-X
specifically	B-X
to	B-X
phospho-NTD	B-X
peptides	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
direct	B-X
binding	B-X
of	B-X
cyclins	B-X
to	B-X
phosphopeptide	B-X
motifs	B-X
may	B-X
be	B-X
a	B-X
widespread	B-X
phenomenon	B-X
contributing	B-X
to	B-X
the	B-X
targeting	B-X
of	B-X
CDKs	B-X
to	B-X
substrates	B-X
.	B-X

Tight	O
Clb2	B-Gene_or_gene_product
binding	O
occurred	O
only	O
when	O
the	O
NTD	O
was	O
phosphorylated	O
on	O
CDK	B-Gene_or_gene_product
consensus	O
sites	O
.	O
<EOS>	B-X
Cyclin-dependent	B-X
kinases	B-X
(	B-X
CDKs	B-X
)	B-X
limit	B-X
the	B-X
activation	B-X
of	B-X
DNA	B-X
replication	B-X
origins	B-X
to	B-X
once	B-X
per	B-X
cell	B-X
cycle	B-X
by	B-X
preventing	B-X
the	B-X
assembly	B-X
of	B-X
pre-replicative	B-X
complexes	B-X
(	B-X
pre-RCs	B-X
)	B-X
during	B-X
S	B-X
,	B-X
G2	B-X
and	B-X
M	B-X
phases	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
in	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
.	B-X
CDKs	B-X
inhibit	B-X
each	B-X
pre-RC	B-X
component	B-X
(	B-X
ORC	B-X
,	B-X
Cdc6	B-X
,	B-X
Cdt1/Mcm2-7	B-X
)	B-X
by	B-X
different	B-X
mechanisms	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
the	B-X
mitotic	B-X
CDK	B-X
,	B-X
Clb2/Cdc28	B-X
,	B-X
binds	B-X
tightly	B-X
to	B-X
an	B-X
amino-terminal	B-X
domain	B-X
(	B-X
NTD	B-X
)	B-X
of	B-X
Cdc6	B-X
,	B-X
and	B-X
that	B-X
Cdc6	B-X
in	B-X
this	B-X
complex	B-X
is	B-X
unable	B-X
to	B-X
assemble	B-X
pre-RCs	B-X
.	B-X
We	B-X
present	B-X
evidence	B-X
indicating	B-X
that	B-X
this	B-X
Clb2-dependent	B-X
mechanism	B-X
contributes	B-X
to	B-X
preventing	B-X
re-replication	B-X
in	B-X
vivo	B-X
.	B-X
CDK	B-X
interaction	B-X
with	B-X
the	B-X
NTD	B-X
of	B-X
Cdc6	B-X
is	B-X
mediated	B-X
by	B-X
the	B-X
cyclin	B-X
subunit	B-X
Clb2	B-X
,	B-X
and	B-X
could	B-X
be	B-X
reconstituted	B-X
with	B-X
recombinant	B-X
Clb2	B-X
protein	B-X
and	B-X
synthetic	B-X
NTD	B-X
peptides	B-X
.	B-X
Tight	B-X
Clb2	B-X
binding	B-X
occurred	B-X
only	B-X
when	B-X
the	B-X
NTD	B-X
was	B-X
phosphorylated	B-X
on	B-X
CDK	B-X
consensus	B-X
sites	B-X
.	B-X
Human	B-X
CDKs	B-X
containing	B-X
cyclins	B-X
A	B-X
,	B-X
B	B-X
and	B-X
E	B-X
also	B-X
bound	B-X
specifically	B-X
to	B-X
phospho-NTD	B-X
peptides	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
direct	B-X
binding	B-X
of	B-X
cyclins	B-X
to	B-X
phosphopeptide	B-X
motifs	B-X
may	B-X
be	B-X
a	B-X
widespread	B-X
phenomenon	B-X
contributing	B-X
to	B-X
the	B-X
targeting	B-X
of	B-X
CDKs	B-X
to	B-X
substrates	B-X
.	B-X

Human	O
CDKs	B-Gene_or_gene_product
containing	O
cyclins	B-Gene_or_gene_product
A	I-Gene_or_gene_product
,	O
B	B-Gene_or_gene_product
and	O
E	B-Gene_or_gene_product
also	O
bound	O
specifically	O
to	O
phospho	O
-	O
NTD	O
peptides	O
.	O

We	O
propose	O
that	O
direct	O
binding	O
of	O
cyclins	O
to	O
phosphopeptide	O
motifs	O
may	O
be	O
a	O
widespread	O
phenomenon	O
contributing	O
to	O
the	O
targeting	O
of	O
CDKs	B-Gene_or_gene_product
to	O
substrates	O
.	O

Piceatannol	O
prevents	O
lipopolysaccharide	O
(	O
LPS	O
)	O
-	O
induced	O
nitric	O
oxide	O
(	O
NO	O
)	O
production	O
and	O
nuclear	O
factor	O
(	O
NF	O
)	O
-	O
kappaB	O
activation	O
by	O
inhibiting	O
IkappaB	O
kinase	O
(	O
IKK	O
)	O
.	O

The	O
effect	O
of	O
piceatannol	O
on	O
lipopolysaccharide	O
(	O
LPS	O
)	O
-	O
induced	O
nitric	O
oxide	O
(	O
NO	O
)	O
production	O
was	O
examined	O
.	O

Piceatannol	O
significantly	O
inhibited	O
NO	O
production	O
in	O
LPS	O
-	O
stimulated	O
RAW	O
264	O
.	O
7	O
cells	O
.	O
<EOS>	B-X
The	B-X
effect	B-X
of	B-X
piceatannol	B-X
on	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-induced	B-X
nitric	B-X
oxide	B-X
(	B-X
NO	B-X
)	B-X
production	B-X
was	B-X
examined	B-X
.	B-X
Piceatannol	B-X
significantly	B-X
inhibited	B-X
NO	B-X
production	B-X
in	B-X
LPS-stimulated	B-X
RAW	B-X
264.7	B-X
cells	B-X
.	B-X
The	B-X
inhibitory	B-X
effect	B-X
of	B-X
piceatannol	B-X
was	B-X
mediated	B-X
by	B-X
down-regulation	B-X
of	B-X
LPS-induced	B-X
nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-kappaB	B-X
activation	B-X
,	B-X
but	B-X
not	B-X
by	B-X
its	B-X
cytotoxic	B-X
action	B-X
.	B-X
Piceatannol	B-X
inhibited	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
-alpha	B-X
and	B-X
beta	B-X
phosphorylation	B-X
,	B-X
and	B-X
subsequently	B-X
IkappaB-alpha	B-X
phosphorylation	B-X
in	B-X
LPS-stimulated	B-X
RAW	B-X
264.7	B-X
cells	B-X
.	B-X
Piceatannol	B-X
inhibited	B-X
the	B-X
phosphorylation	B-X
of	B-X
Akt	B-X
and	B-X
Raf-1	B-X
molecules	B-X
,	B-X
which	B-X
regulated	B-X
the	B-X
activation	B-X
of	B-X
IKK-alpha	B-X
and	B-X
beta	B-X
phosphorylation	B-X
.	B-X
The	B-X
detailed	B-X
mechanism	B-X
of	B-X
the	B-X
inhibition	B-X
of	B-X
LPS-induced	B-X
NO	B-X
production	B-X
by	B-X
piceatannol	B-X
is	B-X
discussed	B-X
.	B-X

The	O
inhibition	O
was	O
due	O
to	O
the	O
reduced	O
expression	O
of	O
an	O
inducible	O
isoform	O
of	O
NO	B-Gene_or_gene_product
synthase	I-Gene_or_gene_product
(	O
iNOS	B-Gene_or_gene_product
)	O
.	O

The	O
inhibitory	O
effect	O
of	O
piceatannol	O
was	O
mediated	O
by	O
down	O
-	O
regulation	O
of	O
LPS	O
-	O
induced	O
nuclear	O
factor	O
(	O
NF	O
)	O
-	O
kappaB	O
activation	O
,	O
but	O
not	O
by	O
its	O
cytotoxic	O
action	O
.	O

Piceatannol	O
inhibited	O
IkappaB	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	I-Gene_or_gene_product
IKK	I-Gene_or_gene_product
)	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
beta	B-Gene_or_gene_product
phosphorylation	O
,	O
and	O
subsequently	O
IkappaB	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
phosphorylation	O
in	O
LPS	O
-	O
stimulated	O
RAW	O
264	O
.	O
7	O
cells	O
.	O
<EOS>	B-X
The	B-X
effect	B-X
of	B-X
piceatannol	B-X
on	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-induced	B-X
nitric	B-X
oxide	B-X
(	B-X
NO	B-X
)	B-X
production	B-X
was	B-X
examined	B-X
.	B-X
Piceatannol	B-X
significantly	B-X
inhibited	B-X
NO	B-X
production	B-X
in	B-X
LPS-stimulated	B-X
RAW	B-X
264.7	B-X
cells	B-X
.	B-X
The	B-X
inhibitory	B-X
effect	B-X
of	B-X
piceatannol	B-X
was	B-X
mediated	B-X
by	B-X
down-regulation	B-X
of	B-X
LPS-induced	B-X
nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-kappaB	B-X
activation	B-X
,	B-X
but	B-X
not	B-X
by	B-X
its	B-X
cytotoxic	B-X
action	B-X
.	B-X
Piceatannol	B-X
inhibited	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
-alpha	B-X
and	B-X
beta	B-X
phosphorylation	B-X
,	B-X
and	B-X
subsequently	B-X
IkappaB-alpha	B-X
phosphorylation	B-X
in	B-X
LPS-stimulated	B-X
RAW	B-X
264.7	B-X
cells	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
piceatannol	B-X
did	B-X
not	B-X
affect	B-X
activation	B-X
of	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinases	B-X
including	B-X
extracellular	B-X
signal	B-X
regulated	B-X
kinase	B-X
1/2	B-X
(	B-X
Erk1/2	B-X
)	B-X
,	B-X
p38	B-X
and	B-X
stress-activated	B-X
protein	B-X
kinase/c-Jun	B-X
NH2-terminal	B-X
kinase	B-X
(	B-X
SAPK/JNK	B-X
)	B-X
.	B-X
Piceatannol	B-X
inhibited	B-X
the	B-X
phosphorylation	B-X
of	B-X
Akt	B-X
and	B-X
Raf-1	B-X
molecules	B-X
,	B-X
which	B-X
regulated	B-X
the	B-X
activation	B-X
of	B-X
IKK-alpha	B-X
and	B-X
beta	B-X
phosphorylation	B-X
.	B-X
The	B-X
detailed	B-X
mechanism	B-X
of	B-X
the	B-X
inhibition	B-X
of	B-X
LPS-induced	B-X
NO	B-X
production	B-X
by	B-X
piceatannol	B-X
is	B-X
discussed	B-X
.	B-X

On	O
the	O
other	O
hand	O
,	O
piceatannol	O
did	O
not	O
affect	O
activation	O
of	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	I-Gene_or_gene_product
MAP	I-Gene_or_gene_product
)	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
including	O
extracellular	B-Gene_or_gene_product
signal	I-Gene_or_gene_product
regulated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	I-Gene_or_gene_product
2	I-Gene_or_gene_product
(	O
Erk1	B-Gene_or_gene_product
/	I-Gene_or_gene_product
2	I-Gene_or_gene_product
)	O
,	O
p38	B-Gene_or_gene_product
and	O
stress	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
/	I-Gene_or_gene_product
c	I-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
NH2	I-Gene_or_gene_product
-	I-Gene_or_gene_product
terminal	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
SAPK	B-Gene_or_gene_product
/	I-Gene_or_gene_product
JNK	I-Gene_or_gene_product
)	O
.	O

Piceatannol	O
inhibited	O
the	O
phosphorylation	O
of	O
Akt	B-Gene_or_gene_product
and	O
Raf	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
molecules	O
,	O
which	O
regulated	O
the	O
activation	O
of	O
IKK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
beta	B-Gene_or_gene_product
phosphorylation	O
.	O
<EOS>	B-X
Piceatannol	B-X
significantly	B-X
inhibited	B-X
NO	B-X
production	B-X
in	B-X
LPS-stimulated	B-X
RAW	B-X
264.7	B-X
cells	B-X
.	B-X
The	B-X
inhibitory	B-X
effect	B-X
of	B-X
piceatannol	B-X
was	B-X
mediated	B-X
by	B-X
down-regulation	B-X
of	B-X
LPS-induced	B-X
nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-kappaB	B-X
activation	B-X
,	B-X
but	B-X
not	B-X
by	B-X
its	B-X
cytotoxic	B-X
action	B-X
.	B-X
Piceatannol	B-X
inhibited	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
-alpha	B-X
and	B-X
beta	B-X
phosphorylation	B-X
,	B-X
and	B-X
subsequently	B-X
IkappaB-alpha	B-X
phosphorylation	B-X
in	B-X
LPS-stimulated	B-X
RAW	B-X
264.7	B-X
cells	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
piceatannol	B-X
did	B-X
not	B-X
affect	B-X
activation	B-X
of	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinases	B-X
including	B-X
extracellular	B-X
signal	B-X
regulated	B-X
kinase	B-X
1/2	B-X
(	B-X
Erk1/2	B-X
)	B-X
,	B-X
p38	B-X
and	B-X
stress-activated	B-X
protein	B-X
kinase/c-Jun	B-X
NH2-terminal	B-X
kinase	B-X
(	B-X
SAPK/JNK	B-X
)	B-X
.	B-X
Piceatannol	B-X
inhibited	B-X
the	B-X
phosphorylation	B-X
of	B-X
Akt	B-X
and	B-X
Raf-1	B-X
molecules	B-X
,	B-X
which	B-X
regulated	B-X
the	B-X
activation	B-X
of	B-X
IKK-alpha	B-X
and	B-X
beta	B-X
phosphorylation	B-X
.	B-X

The	O
detailed	O
mechanism	O
of	O
the	O
inhibition	O
of	O
LPS	O
-	O
induced	O
NO	O
production	O
by	O
piceatannol	O
is	O
discussed	O
.	O
<EOS>	B-X
The	B-X
effect	B-X
of	B-X
piceatannol	B-X
on	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-induced	B-X
nitric	B-X
oxide	B-X
(	B-X
NO	B-X
)	B-X
production	B-X
was	B-X
examined	B-X
.	B-X
Piceatannol	B-X
significantly	B-X
inhibited	B-X
NO	B-X
production	B-X
in	B-X
LPS-stimulated	B-X
RAW	B-X
264.7	B-X
cells	B-X
.	B-X
The	B-X
inhibition	B-X
was	B-X
due	B-X
to	B-X
the	B-X
reduced	B-X
expression	B-X
of	B-X
an	B-X
inducible	B-X
isoform	B-X
of	B-X
NO	B-X
synthase	B-X
(	B-X
iNOS	B-X
)	B-X
.	B-X
The	B-X
inhibitory	B-X
effect	B-X
of	B-X
piceatannol	B-X
was	B-X
mediated	B-X
by	B-X
down-regulation	B-X
of	B-X
LPS-induced	B-X
nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-kappaB	B-X
activation	B-X
,	B-X
but	B-X
not	B-X
by	B-X
its	B-X
cytotoxic	B-X
action	B-X
.	B-X
Piceatannol	B-X
inhibited	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
-alpha	B-X
and	B-X
beta	B-X
phosphorylation	B-X
,	B-X
and	B-X
subsequently	B-X
IkappaB-alpha	B-X
phosphorylation	B-X
in	B-X
LPS-stimulated	B-X
RAW	B-X
264.7	B-X
cells	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
piceatannol	B-X
did	B-X
not	B-X
affect	B-X
activation	B-X
of	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinases	B-X
including	B-X
extracellular	B-X
signal	B-X
regulated	B-X
kinase	B-X
1/2	B-X
(	B-X
Erk1/2	B-X
)	B-X
,	B-X
p38	B-X
and	B-X
stress-activated	B-X
protein	B-X
kinase/c-Jun	B-X
NH2-terminal	B-X
kinase	B-X
(	B-X
SAPK/JNK	B-X
)	B-X
.	B-X
The	B-X
detailed	B-X
mechanism	B-X
of	B-X
the	B-X
inhibition	B-X
of	B-X
LPS-induced	B-X
NO	B-X
production	B-X
by	B-X
piceatannol	B-X
is	B-X
discussed	B-X
.	B-X

Novel	O
roles	O
of	O
TLR3	B-Gene_or_gene_product
tyrosine	O
phosphorylation	O
and	O
PI3	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
in	O
double	O
-	O
stranded	O
RNA	O
signaling	O
.	O
<EOS>	B-X
Double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
,	B-X
a	B-X
frequent	B-X
byproduct	B-X
of	B-X
virus	B-X
infection	B-X
,	B-X
is	B-X
recognized	B-X
by	B-X
Toll-like	B-X
receptor	B-X
3	B-X
(	B-X
TLR3	B-X
)	B-X
to	B-X
mediate	B-X
innate	B-X
immune	B-X
response	B-X
to	B-X
virus	B-X
infection	B-X
.	B-X
TLR3	B-X
signaling	B-X
activates	B-X
the	B-X
transcription	B-X
factor	B-X
IRF-3	B-X
by	B-X
its	B-X
Ser/Thr	B-X
phosphorylation	B-X
,	B-X
accompanied	B-X
by	B-X
its	B-X
dimerization	B-X
and	B-X
nuclear	B-X
translocation	B-X
.	B-X
It	B-X
has	B-X
been	B-X
reported	B-X
that	B-X
the	B-X
Ser/Thr	B-X
kinase	B-X
TBK-1	B-X
is	B-X
essential	B-X
for	B-X
TLR3-mediated	B-X
activation	B-X
and	B-X
phosphorylation	B-X
of	B-X
IRF-3	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
dsRNA-activated	B-X
phosphorylation	B-X
of	B-X
two	B-X
specific	B-X
tyrosine	B-X
residues	B-X
of	B-X
TLR3	B-X
is	B-X
essential	B-X
for	B-X
initiating	B-X
two	B-X
distinct	B-X
signaling	B-X
pathways	B-X
.	B-X
One	B-X
involves	B-X
activation	B-X
of	B-X
TBK-1	B-X
and	B-X
the	B-X
other	B-X
recruits	B-X
and	B-X
activates	B-X
PI3	B-X
kinase	B-X
and	B-X
the	B-X
downstream	B-X
kinase	B-X
,	B-X
Akt	B-X
,	B-X
leading	B-X
to	B-X
full	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
IRF-3	B-X
.	B-X
When	B-X
PI3	B-X
kinase	B-X
is	B-X
not	B-X
recruited	B-X
to	B-X
TLR3	B-X
or	B-X
its	B-X
activity	B-X
is	B-X
blocked	B-X
,	B-X
IRF-3	B-X
is	B-X
only	B-X
partially	B-X
phosphorylated	B-X
and	B-X
fails	B-X
to	B-X
bind	B-X
the	B-X
promoter	B-X
of	B-X
the	B-X
target	B-X
gene	B-X
in	B-X
dsRNA-treated	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
PI3K-Akt	B-X
pathway	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
TLR3-mediated	B-X
gene	B-X
induction	B-X
.	B-X

Double	O
-	O
stranded	O
RNA	O
(	O
dsRNA	O
)	O
,	O
a	O
frequent	O
byproduct	O
of	O
virus	O
infection	O
,	O
is	O
recognized	O
by	O
Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
3	I-Gene_or_gene_product
(	O
TLR3	B-Gene_or_gene_product
)	O
to	O
mediate	O
innate	O
immune	O
response	O
to	O
virus	O
infection	O
.	O
<EOS>	B-X
Double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
,	B-X
a	B-X
frequent	B-X
byproduct	B-X
of	B-X
virus	B-X
infection	B-X
,	B-X
is	B-X
recognized	B-X
by	B-X
Toll-like	B-X
receptor	B-X
3	B-X
(	B-X
TLR3	B-X
)	B-X
to	B-X
mediate	B-X
innate	B-X
immune	B-X
response	B-X
to	B-X
virus	B-X
infection	B-X
.	B-X
TLR3	B-X
signaling	B-X
activates	B-X
the	B-X
transcription	B-X
factor	B-X
IRF-3	B-X
by	B-X
its	B-X
Ser/Thr	B-X
phosphorylation	B-X
,	B-X
accompanied	B-X
by	B-X
its	B-X
dimerization	B-X
and	B-X
nuclear	B-X
translocation	B-X
.	B-X
It	B-X
has	B-X
been	B-X
reported	B-X
that	B-X
the	B-X
Ser/Thr	B-X
kinase	B-X
TBK-1	B-X
is	B-X
essential	B-X
for	B-X
TLR3-mediated	B-X
activation	B-X
and	B-X
phosphorylation	B-X
of	B-X
IRF-3	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
dsRNA-activated	B-X
phosphorylation	B-X
of	B-X
two	B-X
specific	B-X
tyrosine	B-X
residues	B-X
of	B-X
TLR3	B-X
is	B-X
essential	B-X
for	B-X
initiating	B-X
two	B-X
distinct	B-X
signaling	B-X
pathways	B-X
.	B-X
One	B-X
involves	B-X
activation	B-X
of	B-X
TBK-1	B-X
and	B-X
the	B-X
other	B-X
recruits	B-X
and	B-X
activates	B-X
PI3	B-X
kinase	B-X
and	B-X
the	B-X
downstream	B-X
kinase	B-X
,	B-X
Akt	B-X
,	B-X
leading	B-X
to	B-X
full	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
IRF-3	B-X
.	B-X
When	B-X
PI3	B-X
kinase	B-X
is	B-X
not	B-X
recruited	B-X
to	B-X
TLR3	B-X
or	B-X
its	B-X
activity	B-X
is	B-X
blocked	B-X
,	B-X
IRF-3	B-X
is	B-X
only	B-X
partially	B-X
phosphorylated	B-X
and	B-X
fails	B-X
to	B-X
bind	B-X
the	B-X
promoter	B-X
of	B-X
the	B-X
target	B-X
gene	B-X
in	B-X
dsRNA-treated	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
PI3K-Akt	B-X
pathway	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
TLR3-mediated	B-X
gene	B-X
induction	B-X
.	B-X

TLR3	B-Gene_or_gene_product
signaling	O
activates	O
the	O
transcription	O
factor	O
IRF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
by	O
its	O
Ser	O
/	O
Thr	O
phosphorylation	O
,	O
accompanied	O
by	O
its	O
dimerization	O
and	O
nuclear	O
translocation	O
.	O
<EOS>	B-X
Double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
,	B-X
a	B-X
frequent	B-X
byproduct	B-X
of	B-X
virus	B-X
infection	B-X
,	B-X
is	B-X
recognized	B-X
by	B-X
Toll-like	B-X
receptor	B-X
3	B-X
(	B-X
TLR3	B-X
)	B-X
to	B-X
mediate	B-X
innate	B-X
immune	B-X
response	B-X
to	B-X
virus	B-X
infection	B-X
.	B-X
TLR3	B-X
signaling	B-X
activates	B-X
the	B-X
transcription	B-X
factor	B-X
IRF-3	B-X
by	B-X
its	B-X
Ser/Thr	B-X
phosphorylation	B-X
,	B-X
accompanied	B-X
by	B-X
its	B-X
dimerization	B-X
and	B-X
nuclear	B-X
translocation	B-X
.	B-X
It	B-X
has	B-X
been	B-X
reported	B-X
that	B-X
the	B-X
Ser/Thr	B-X
kinase	B-X
TBK-1	B-X
is	B-X
essential	B-X
for	B-X
TLR3-mediated	B-X
activation	B-X
and	B-X
phosphorylation	B-X
of	B-X
IRF-3	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
dsRNA-activated	B-X
phosphorylation	B-X
of	B-X
two	B-X
specific	B-X
tyrosine	B-X
residues	B-X
of	B-X
TLR3	B-X
is	B-X
essential	B-X
for	B-X
initiating	B-X
two	B-X
distinct	B-X
signaling	B-X
pathways	B-X
.	B-X
One	B-X
involves	B-X
activation	B-X
of	B-X
TBK-1	B-X
and	B-X
the	B-X
other	B-X
recruits	B-X
and	B-X
activates	B-X
PI3	B-X
kinase	B-X
and	B-X
the	B-X
downstream	B-X
kinase	B-X
,	B-X
Akt	B-X
,	B-X
leading	B-X
to	B-X
full	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
IRF-3	B-X
.	B-X
When	B-X
PI3	B-X
kinase	B-X
is	B-X
not	B-X
recruited	B-X
to	B-X
TLR3	B-X
or	B-X
its	B-X
activity	B-X
is	B-X
blocked	B-X
,	B-X
IRF-3	B-X
is	B-X
only	B-X
partially	B-X
phosphorylated	B-X
and	B-X
fails	B-X
to	B-X
bind	B-X
the	B-X
promoter	B-X
of	B-X
the	B-X
target	B-X
gene	B-X
in	B-X
dsRNA-treated	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
PI3K-Akt	B-X
pathway	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
TLR3-mediated	B-X
gene	B-X
induction	B-X
.	B-X

It	O
has	O
been	O
reported	O
that	O
the	O
Ser	O
/	O
Thr	O
kinase	O
TBK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
is	O
essential	O
for	O
TLR3	B-Gene_or_gene_product
-	O
mediated	O
activation	O
and	O
phosphorylation	O
of	O
IRF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
.	O
<EOS>	B-X
Double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
,	B-X
a	B-X
frequent	B-X
byproduct	B-X
of	B-X
virus	B-X
infection	B-X
,	B-X
is	B-X
recognized	B-X
by	B-X
Toll-like	B-X
receptor	B-X
3	B-X
(	B-X
TLR3	B-X
)	B-X
to	B-X
mediate	B-X
innate	B-X
immune	B-X
response	B-X
to	B-X
virus	B-X
infection	B-X
.	B-X
TLR3	B-X
signaling	B-X
activates	B-X
the	B-X
transcription	B-X
factor	B-X
IRF-3	B-X
by	B-X
its	B-X
Ser/Thr	B-X
phosphorylation	B-X
,	B-X
accompanied	B-X
by	B-X
its	B-X
dimerization	B-X
and	B-X
nuclear	B-X
translocation	B-X
.	B-X
It	B-X
has	B-X
been	B-X
reported	B-X
that	B-X
the	B-X
Ser/Thr	B-X
kinase	B-X
TBK-1	B-X
is	B-X
essential	B-X
for	B-X
TLR3-mediated	B-X
activation	B-X
and	B-X
phosphorylation	B-X
of	B-X
IRF-3	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
dsRNA-activated	B-X
phosphorylation	B-X
of	B-X
two	B-X
specific	B-X
tyrosine	B-X
residues	B-X
of	B-X
TLR3	B-X
is	B-X
essential	B-X
for	B-X
initiating	B-X
two	B-X
distinct	B-X
signaling	B-X
pathways	B-X
.	B-X
One	B-X
involves	B-X
activation	B-X
of	B-X
TBK-1	B-X
and	B-X
the	B-X
other	B-X
recruits	B-X
and	B-X
activates	B-X
PI3	B-X
kinase	B-X
and	B-X
the	B-X
downstream	B-X
kinase	B-X
,	B-X
Akt	B-X
,	B-X
leading	B-X
to	B-X
full	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
IRF-3	B-X
.	B-X
When	B-X
PI3	B-X
kinase	B-X
is	B-X
not	B-X
recruited	B-X
to	B-X
TLR3	B-X
or	B-X
its	B-X
activity	B-X
is	B-X
blocked	B-X
,	B-X
IRF-3	B-X
is	B-X
only	B-X
partially	B-X
phosphorylated	B-X
and	B-X
fails	B-X
to	B-X
bind	B-X
the	B-X
promoter	B-X
of	B-X
the	B-X
target	B-X
gene	B-X
in	B-X
dsRNA-treated	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
PI3K-Akt	B-X
pathway	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
TLR3-mediated	B-X
gene	B-X
induction	B-X
.	B-X

Here	O
we	O
report	O
that	O
dsRNA	O
-	O
activated	O
phosphorylation	O
of	O
two	O
specific	O
tyrosine	O
residues	O
of	O
TLR3	B-Gene_or_gene_product
is	O
essential	O
for	O
initiating	O
two	O
distinct	O
signaling	O
pathways	O
.	O
<EOS>	B-X
Double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
,	B-X
a	B-X
frequent	B-X
byproduct	B-X
of	B-X
virus	B-X
infection	B-X
,	B-X
is	B-X
recognized	B-X
by	B-X
Toll-like	B-X
receptor	B-X
3	B-X
(	B-X
TLR3	B-X
)	B-X
to	B-X
mediate	B-X
innate	B-X
immune	B-X
response	B-X
to	B-X
virus	B-X
infection	B-X
.	B-X
TLR3	B-X
signaling	B-X
activates	B-X
the	B-X
transcription	B-X
factor	B-X
IRF-3	B-X
by	B-X
its	B-X
Ser/Thr	B-X
phosphorylation	B-X
,	B-X
accompanied	B-X
by	B-X
its	B-X
dimerization	B-X
and	B-X
nuclear	B-X
translocation	B-X
.	B-X
It	B-X
has	B-X
been	B-X
reported	B-X
that	B-X
the	B-X
Ser/Thr	B-X
kinase	B-X
TBK-1	B-X
is	B-X
essential	B-X
for	B-X
TLR3-mediated	B-X
activation	B-X
and	B-X
phosphorylation	B-X
of	B-X
IRF-3	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
dsRNA-activated	B-X
phosphorylation	B-X
of	B-X
two	B-X
specific	B-X
tyrosine	B-X
residues	B-X
of	B-X
TLR3	B-X
is	B-X
essential	B-X
for	B-X
initiating	B-X
two	B-X
distinct	B-X
signaling	B-X
pathways	B-X
.	B-X
One	B-X
involves	B-X
activation	B-X
of	B-X
TBK-1	B-X
and	B-X
the	B-X
other	B-X
recruits	B-X
and	B-X
activates	B-X
PI3	B-X
kinase	B-X
and	B-X
the	B-X
downstream	B-X
kinase	B-X
,	B-X
Akt	B-X
,	B-X
leading	B-X
to	B-X
full	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
IRF-3	B-X
.	B-X
When	B-X
PI3	B-X
kinase	B-X
is	B-X
not	B-X
recruited	B-X
to	B-X
TLR3	B-X
or	B-X
its	B-X
activity	B-X
is	B-X
blocked	B-X
,	B-X
IRF-3	B-X
is	B-X
only	B-X
partially	B-X
phosphorylated	B-X
and	B-X
fails	B-X
to	B-X
bind	B-X
the	B-X
promoter	B-X
of	B-X
the	B-X
target	B-X
gene	B-X
in	B-X
dsRNA-treated	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
PI3K-Akt	B-X
pathway	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
TLR3-mediated	B-X
gene	B-X
induction	B-X
.	B-X

One	O
involves	O
activation	O
of	O
TBK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
the	O
other	O
recruits	O
and	O
activates	O
PI3	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
and	O
the	O
downstream	O
kinase	O
,	O
Akt	B-Gene_or_gene_product
,	O
leading	O
to	O
full	O
phosphorylation	O
and	O
activation	O
of	O
IRF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
.	O
<EOS>	B-X
Double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
,	B-X
a	B-X
frequent	B-X
byproduct	B-X
of	B-X
virus	B-X
infection	B-X
,	B-X
is	B-X
recognized	B-X
by	B-X
Toll-like	B-X
receptor	B-X
3	B-X
(	B-X
TLR3	B-X
)	B-X
to	B-X
mediate	B-X
innate	B-X
immune	B-X
response	B-X
to	B-X
virus	B-X
infection	B-X
.	B-X
TLR3	B-X
signaling	B-X
activates	B-X
the	B-X
transcription	B-X
factor	B-X
IRF-3	B-X
by	B-X
its	B-X
Ser/Thr	B-X
phosphorylation	B-X
,	B-X
accompanied	B-X
by	B-X
its	B-X
dimerization	B-X
and	B-X
nuclear	B-X
translocation	B-X
.	B-X
It	B-X
has	B-X
been	B-X
reported	B-X
that	B-X
the	B-X
Ser/Thr	B-X
kinase	B-X
TBK-1	B-X
is	B-X
essential	B-X
for	B-X
TLR3-mediated	B-X
activation	B-X
and	B-X
phosphorylation	B-X
of	B-X
IRF-3	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
dsRNA-activated	B-X
phosphorylation	B-X
of	B-X
two	B-X
specific	B-X
tyrosine	B-X
residues	B-X
of	B-X
TLR3	B-X
is	B-X
essential	B-X
for	B-X
initiating	B-X
two	B-X
distinct	B-X
signaling	B-X
pathways	B-X
.	B-X
One	B-X
involves	B-X
activation	B-X
of	B-X
TBK-1	B-X
and	B-X
the	B-X
other	B-X
recruits	B-X
and	B-X
activates	B-X
PI3	B-X
kinase	B-X
and	B-X
the	B-X
downstream	B-X
kinase	B-X
,	B-X
Akt	B-X
,	B-X
leading	B-X
to	B-X
full	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
IRF-3	B-X
.	B-X
When	B-X
PI3	B-X
kinase	B-X
is	B-X
not	B-X
recruited	B-X
to	B-X
TLR3	B-X
or	B-X
its	B-X
activity	B-X
is	B-X
blocked	B-X
,	B-X
IRF-3	B-X
is	B-X
only	B-X
partially	B-X
phosphorylated	B-X
and	B-X
fails	B-X
to	B-X
bind	B-X
the	B-X
promoter	B-X
of	B-X
the	B-X
target	B-X
gene	B-X
in	B-X
dsRNA-treated	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
PI3K-Akt	B-X
pathway	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
TLR3-mediated	B-X
gene	B-X
induction	B-X
.	B-X

When	O
PI3	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
is	O
not	O
recruited	O
to	O
TLR3	B-Gene_or_gene_product
or	O
its	O
activity	O
is	O
blocked	O
,	O
IRF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
is	O
only	O
partially	O
phosphorylated	O
and	O
fails	O
to	O
bind	O
the	O
promoter	O
of	O
the	O
target	O
gene	O
in	O
dsRNA	O
-	O
treated	O
cells	O
.	O
<EOS>	B-X
Triple-negative	B-X
breast	B-X
cancer	B-X
(	B-X
TNBC	B-X
)	B-X
is	B-X
characterised	B-X
by	B-X
poor	B-X
outcomes	B-X
and	B-X
a	B-X
historical	B-X
lack	B-X
of	B-X
targeted	B-X
therapies	B-X
.	B-X
Dysregulation	B-X
of	B-X
signalling	B-X
through	B-X
the	B-X
phosphoinositide	B-X
3	B-X
(	B-X
PI3	B-X
)	B-X
-kinase	B-X
and	B-X
AKT	B-X
signalling	B-X
pathway	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
frequent	B-X
oncogenic	B-X
aberrations	B-X
of	B-X
TNBC	B-X
.	B-X
Although	B-X
mutations	B-X
in	B-X
individual	B-X
genes	B-X
occur	B-X
relatively	B-X
rarely	B-X
,	B-X
combined	B-X
activating	B-X
mutations	B-X
in	B-X
PIK3CA	B-X
and	B-X
AKT1	B-X
,	B-X
with	B-X
inactivating	B-X
mutations	B-X
in	B-X
phosphatase	B-X
and	B-X
tensin	B-X
homologue	B-X
,	B-X
occur	B-X
in	B-X
∼25	B-X
%	B-X
‒30	B-X
%	B-X
of	B-X
advanced	B-X
TNBC	B-X
.	B-X
Recent	B-X
randomised	B-X
trials	B-X
suggest	B-X
improved	B-X
progression-free	B-X
survival	B-X
(	B-X
PFS	B-X
)	B-X
with	B-X
AKT-inhibitors	B-X
in	B-X
combination	B-X
with	B-X
first-line	B-X
chemotherapy	B-X
for	B-X
patients	B-X
with	B-X
TNBC	B-X
and	B-X
pathway	B-X
genetic	B-X
aberrations	B-X
.	B-X
We	B-X
review	B-X
the	B-X
evidence	B-X
for	B-X
PI3K	B-X
pathway	B-X
activation	B-X
in	B-X
TNBC	B-X
,	B-X
and	B-X
clinical	B-X
trial	B-X
data	B-X
for	B-X
PI3K	B-X
,	B-X
AKT	B-X
and	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
inhibitors	B-X
in	B-X
TNBC	B-X
.	B-X
We	B-X
discuss	B-X
uncertainty	B-X
over	B-X
defining	B-X
which	B-X
cancers	B-X
have	B-X
pathway	B-X
activation	B-X
and	B-X
the	B-X
future	B-X
overlap	B-X
between	B-X
immunotherapy	B-X
and	B-X
pathway	B-X
targeting	B-X
.	B-X

Thus	O
,	O
the	O
PI3K	B-Gene_or_gene_product
-	O
Akt	B-Gene_or_gene_product
pathway	O
plays	O
an	O
essential	O
role	O
in	O
TLR3	B-Gene_or_gene_product
-	O
mediated	O
gene	O
induction	O
.	O
<EOS>	B-X
Double-stranded	B-X
RNA	B-X
(	B-X
dsRNA	B-X
)	B-X
,	B-X
a	B-X
frequent	B-X
byproduct	B-X
of	B-X
virus	B-X
infection	B-X
,	B-X
is	B-X
recognized	B-X
by	B-X
Toll-like	B-X
receptor	B-X
3	B-X
(	B-X
TLR3	B-X
)	B-X
to	B-X
mediate	B-X
innate	B-X
immune	B-X
response	B-X
to	B-X
virus	B-X
infection	B-X
.	B-X
TLR3	B-X
signaling	B-X
activates	B-X
the	B-X
transcription	B-X
factor	B-X
IRF-3	B-X
by	B-X
its	B-X
Ser/Thr	B-X
phosphorylation	B-X
,	B-X
accompanied	B-X
by	B-X
its	B-X
dimerization	B-X
and	B-X
nuclear	B-X
translocation	B-X
.	B-X
It	B-X
has	B-X
been	B-X
reported	B-X
that	B-X
the	B-X
Ser/Thr	B-X
kinase	B-X
TBK-1	B-X
is	B-X
essential	B-X
for	B-X
TLR3-mediated	B-X
activation	B-X
and	B-X
phosphorylation	B-X
of	B-X
IRF-3	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
dsRNA-activated	B-X
phosphorylation	B-X
of	B-X
two	B-X
specific	B-X
tyrosine	B-X
residues	B-X
of	B-X
TLR3	B-X
is	B-X
essential	B-X
for	B-X
initiating	B-X
two	B-X
distinct	B-X
signaling	B-X
pathways	B-X
.	B-X
One	B-X
involves	B-X
activation	B-X
of	B-X
TBK-1	B-X
and	B-X
the	B-X
other	B-X
recruits	B-X
and	B-X
activates	B-X
PI3	B-X
kinase	B-X
and	B-X
the	B-X
downstream	B-X
kinase	B-X
,	B-X
Akt	B-X
,	B-X
leading	B-X
to	B-X
full	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
IRF-3	B-X
.	B-X
When	B-X
PI3	B-X
kinase	B-X
is	B-X
not	B-X
recruited	B-X
to	B-X
TLR3	B-X
or	B-X
its	B-X
activity	B-X
is	B-X
blocked	B-X
,	B-X
IRF-3	B-X
is	B-X
only	B-X
partially	B-X
phosphorylated	B-X
and	B-X
fails	B-X
to	B-X
bind	B-X
the	B-X
promoter	B-X
of	B-X
the	B-X
target	B-X
gene	B-X
in	B-X
dsRNA-treated	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
PI3K-Akt	B-X
pathway	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
TLR3-mediated	B-X
gene	B-X
induction	B-X
.	B-X

Cross	O
-	O
talk	O
between	O
pRb	B-Gene_or_gene_product
/	O
E2F	B-Gene_or_gene_product
and	O
Wnt	B-Gene_or_gene_product
/	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
pathways	O
:	O
E2F1	B-Gene_or_gene_product
induces	O
axin2	B-Gene_or_gene_product
leading	O
to	O
repression	O
of	O
Wnt	B-Gene_or_gene_product
signalling	O
and	O
to	O
increased	O
cell	O
death	O
.	O
<EOS>	B-X
The	B-X
pRb/E2F	B-X
and	B-X
Wnt/beta-catenin	B-X
pathways	B-X
are	B-X
two	B-X
of	B-X
the	B-X
most	B-X
frequently	B-X
deregulated	B-X
pathways	B-X
in	B-X
human	B-X
cancers	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
show	B-X
that	B-X
E2F1	B-X
up-regulates	B-X
the	B-X
expression	B-X
of	B-X
axin2	B-X
.	B-X
Further	B-X
,	B-X
we	B-X
show	B-X
that	B-X
axin2	B-X
can	B-X
repress	B-X
Wnt	B-X
signalling	B-X
leading	B-X
to	B-X
reduced	B-X
cell	B-X
growth	B-X
and	B-X
increased	B-X
cell	B-X
death	B-X
.	B-X
This	B-X
represents	B-X
cross-talk	B-X
between	B-X
major	B-X
pathways	B-X
involved	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
tumours	B-X
.	B-X

The	O
pRb	B-Gene_or_gene_product
/	O
E2F	B-Gene_or_gene_product
and	O
Wnt	B-Gene_or_gene_product
/	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
pathways	O
are	O
two	O
of	O
the	O
most	O
frequently	O
deregulated	O
pathways	O
in	O
human	O
cancers	O
.	O
<EOS>	B-X
Deregulation	B-X
of	B-X
the	B-X
pRb/E2F	B-X
or	B-X
Wnt/β-catenin	B-X
pathway	B-X
occurs	B-X
frequently	B-X
in	B-X
human	B-X
cancers	B-X
,	B-X
which	B-X
is	B-X
often	B-X
associated	B-X
with	B-X
inappropriate	B-X
cell	B-X
proliferation	B-X
.	B-X
Although	B-X
the	B-X
oncogenic	B-X
roles	B-X
of	B-X
pRb/E2F1	B-X
and	B-X
Wnt/β-catenin	B-X
pathways	B-X
have	B-X
been	B-X
well	B-X
studied	B-X
,	B-X
the	B-X
functional	B-X
interaction	B-X
between	B-X
the	B-X
two	B-X
pathways	B-X
has	B-X
only	B-X
recently	B-X
been	B-X
characterized	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
E2F1	B-X
has	B-X
been	B-X
recently	B-X
reported	B-X
to	B-X
negatively	B-X
regulate	B-X
Wnt/β-catenin	B-X
activity	B-X
in	B-X
human	B-X
colorectal	B-X
cancers	B-X
,	B-X
though	B-X
the	B-X
mechanism	B-X
underlying	B-X
this	B-X
regulation	B-X
is	B-X
not	B-X
fully	B-X
understood	B-X
.	B-X
Here	B-X
we	B-X
provide	B-X
evidence	B-X
that	B-X
β-catenin	B-X
interacting	B-X
protein	B-X
1	B-X
(	B-X
CTNNBIP1	B-X
)	B-X
,	B-X
also	B-X
known	B-X
as	B-X
ICAT	B-X
(	B-X
inhibitor	B-X
of	B-X
β-catenin	B-X
and	B-X
TCF4	B-X
)	B-X
,	B-X
functions	B-X
as	B-X
a	B-X
crucial	B-X
node	B-X
to	B-X
mediate	B-X
the	B-X
cross	B-X
talk	B-X
between	B-X
E2F1	B-X
and	B-X
β-catenin	B-X
signaling	B-X
.	B-X
We	B-X
show	B-X
that	B-X
ICAT	B-X
is	B-X
a	B-X
direct	B-X
transcriptional	B-X
target	B-X
of	B-X
E2F1	B-X
,	B-X
and	B-X
that	B-X
activation	B-X
of	B-X
ICAT	B-X
by	B-X
E2F1	B-X
is	B-X
required	B-X
for	B-X
E2F1	B-X
to	B-X
inhibit	B-X
β-catenin	B-X
activity	B-X
.	B-X
This	B-X
study	B-X
provides	B-X
a	B-X
mechanistic	B-X
insight	B-X
into	B-X
the	B-X
antagonistic	B-X
interaction	B-X
between	B-X
E2F1	B-X
and	B-X
β-catenin	B-X
signaling	B-X
.	B-X

In	O
this	O
study	O
,	O
we	O
show	O
that	O
E2F1	B-Gene_or_gene_product
up	O
-	O
regulates	O
the	O
expression	O
of	O
axin2	B-Gene_or_gene_product
.	O
<EOS>	B-X
Axin2	B-X
is	B-X
induced	B-X
by	B-X
E2F1	B-X
and	B-X
therefore	B-X
acts	B-X
as	B-X
a	B-X
point	B-X
of	B-X
cross-talk	B-X
between	B-X
the	B-X
pRb/E2F	B-X
and	B-X
Wnt/beta-catenin	B-X
pathways	B-X
:	B-X
two	B-X
of	B-X
the	B-X
most	B-X
frequently	B-X
deregulated	B-X
pathways	B-X
in	B-X
human	B-X
cancers	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
show	B-X
that	B-X
E2F1	B-X
up-regulates	B-X
axin2	B-X
by	B-X
two	B-X
independent	B-X
mechanisms	B-X
.	B-X
The	B-X
human	B-X
axin2	B-X
gene	B-X
allows	B-X
transcription	B-X
of	B-X
messages	B-X
with	B-X
three	B-X
different	B-X
5	B-X
'	B-X
untranslated	B-X
regions	B-X
and	B-X
in	B-X
the	B-X
first	B-X
mechanism	B-X
E2F1	B-X
directly	B-X
activates	B-X
the	B-X
transcription	B-X
of	B-X
only	B-X
one	B-X
of	B-X
these	B-X
species	B-X
by	B-X
acting	B-X
at	B-X
canonical	B-X
E2F	B-X
binding	B-X
sites	B-X
.	B-X
Second	B-X
,	B-X
E2F1	B-X
induces	B-X
stabilisation	B-X
of	B-X
axin2	B-X
mRNAs	B-X
.	B-X

Further	O
,	O
we	O
show	O
that	O
axin2	B-Gene_or_gene_product
can	O
repress	O
Wnt	B-Gene_or_gene_product
signalling	O
leading	O
to	O
reduced	O
cell	O
growth	O
and	O
increased	O
cell	O
death	O
.	O
<EOS>	B-X
The	B-X
pRb/E2F	B-X
and	B-X
Wnt/beta-catenin	B-X
pathways	B-X
are	B-X
two	B-X
of	B-X
the	B-X
most	B-X
frequently	B-X
deregulated	B-X
pathways	B-X
in	B-X
human	B-X
cancers	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
show	B-X
that	B-X
E2F1	B-X
up-regulates	B-X
the	B-X
expression	B-X
of	B-X
axin2	B-X
.	B-X
Further	B-X
,	B-X
we	B-X
show	B-X
that	B-X
axin2	B-X
can	B-X
repress	B-X
Wnt	B-X
signalling	B-X
leading	B-X
to	B-X
reduced	B-X
cell	B-X
growth	B-X
and	B-X
increased	B-X
cell	B-X
death	B-X
.	B-X
The	B-X
aberrant	B-X
activation	B-X
of	B-X
Wnt/β-catenin	B-X
signaling	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
development	B-X
of	B-X
multiple	B-X
myeloma	B-X
;	B-X
thus	B-X
,	B-X
this	B-X
signaling	B-X
pathway	B-X
is	B-X
a	B-X
potential	B-X
target	B-X
for	B-X
the	B-X
development	B-X
of	B-X
therapeutics	B-X
for	B-X
this	B-X
malignancy	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
performed	B-X
cell-based	B-X
chemical	B-X
screening	B-X
and	B-X
found	B-X
that	B-X
CGK012	B-X
,	B-X
a	B-X
pyranocoumarin	B-X
compound	B-X
,	B-X
suppressed	B-X
the	B-X
Wnt3a-CM-mediated	B-X
activation	B-X
of	B-X
β-catenin	B-X
response	B-X
transcription	B-X
.	B-X
CGK012	B-X
induced	B-X
β-catenin	B-X
phosphorylation	B-X
at	B-X
Ser33/Ser37/Thr41	B-X
,	B-X
leading	B-X
to	B-X
proteasomal	B-X
degradation	B-X
and	B-X
reducing	B-X
the	B-X
level	B-X
of	B-X
intracellular	B-X
β-catenin	B-X
.	B-X
Furthermore	B-X
,	B-X
CGK012	B-X
consistently	B-X
decreased	B-X
the	B-X
amount	B-X
of	B-X
β-catenin	B-X
and	B-X
repressed	B-X
the	B-X
expression	B-X
of	B-X
cyclin	B-X
D1	B-X
,	B-X
c-myc	B-X
,	B-X
and	B-X
axin-2	B-X
(	B-X
downstream	B-X
target	B-X
genes	B-X
of	B-X
β-catenin	B-X
)	B-X
in	B-X
RPMI-8226	B-X
multiple	B-X
myeloma	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
CGK012	B-X
inhibited	B-X
the	B-X
proliferation	B-X
of	B-X
RPMI-8226	B-X
cells	B-X
and	B-X
promoted	B-X
apoptosis	B-X
,	B-X
as	B-X
indicated	B-X
by	B-X
the	B-X
increase	B-X
in	B-X
the	B-X
population	B-X
of	B-X
Annexin	B-X
V-FITC-stained	B-X
cells	B-X
and	B-X
caspase-3/7	B-X
activity	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
that	B-X
CGK012	B-X
could	B-X
exert	B-X
antiproliferative	B-X
activity	B-X
against	B-X
multiple	B-X
myeloma	B-X
cells	B-X
by	B-X
attenuating	B-X
the	B-X
Wnt/β-catenin	B-X
pathway	B-X
;	B-X
thus	B-X
,	B-X
it	B-X
may	B-X
have	B-X
potential	B-X
as	B-X
a	B-X
therapeutic	B-X
agent	B-X
for	B-X
multiple	B-X
myeloma	B-X
treatment	B-X
.	B-X

This	O
represents	O
cross	O
-	O
talk	O
between	O
major	O
pathways	O
involved	O
in	O
the	O
formation	O
of	O
tumours	O
.	O
<EOS>	B-X
The	B-X
formidable	B-X
advances	B-X
in	B-X
cancer	B-X
treatment	B-X
have	B-X
led	B-X
to	B-X
remarkable	B-X
improvements	B-X
in	B-X
patient	B-X
's	B-X
survival	B-X
,	B-X
so	B-X
that	B-X
the	B-X
major	B-X
concern	B-X
shifted	B-X
from	B-X
primary	B-X
tumors	B-X
to	B-X
metastatic	B-X
disease	B-X
.	B-X
Moreover	B-X
,	B-X
brain	B-X
metastases	B-X
have	B-X
been	B-X
scarcely	B-X
investigated	B-X
,	B-X
which	B-X
precludes	B-X
a	B-X
comprehensive	B-X
understanding	B-X
of	B-X
the	B-X
determinants	B-X
and	B-X
players	B-X
,	B-X
as	B-X
well	B-X
as	B-X
of	B-X
the	B-X
complex	B-X
cross-talk	B-X
and	B-X
signaling	B-X
pathways	B-X
involved	B-X
.	B-X
It	B-X
also	B-X
gathers	B-X
together	B-X
the	B-X
relevant	B-X
concepts	B-X
about	B-X
the	B-X
metastatic	B-X
cascade	B-X
,	B-X
focusing	B-X
in	B-X
the	B-X
extravasation	B-X
step	B-X
across	B-X
the	B-X
microvascular	B-X
endothelium	B-X
that	B-X
leads	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
brain	B-X
metastases	B-X
.	B-X
BATF	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
activated	B-X
by	B-X
NOTCH2	B-X
,	B-X
the	B-X
major	B-X
NOTCH	B-X
family	B-X
member	B-X
in	B-X
B	B-X
cells	B-X
,	B-X
negatively	B-X
affects	B-X
the	B-X
expression	B-X
of	B-X
BZLF1	B-X
,	B-X
the	B-X
master	B-X
regulator	B-X
of	B-X
viral	B-X
lytic	B-X
cycle	B-X
.	B-X
We	B-X
also	B-X
found	B-X
that	B-X
NF-κB	B-X
pathway	B-X
is	B-X
involved	B-X
in	B-X
TERT-induced	B-X
NOTCH2	B-X
activation	B-X
.	B-X

We	O
use	O
our	O
data	O
to	O
suggest	O
a	O
novel	O
mechanism	O
for	O
tumour	O
suppression	O
.	O
<EOS>	B-X
Cisplatin	B-X
(	B-X
DDP	B-X
)	B-X
was	B-X
reported	B-X
to	B-X
improve	B-X
pathological	B-X
complete	B-X
response	B-X
(	B-X
pCR	B-X
)	B-X
rates	B-X
in	B-X
triple-negative	B-X
breast	B-X
cancer	B-X
(	B-X
TNBC	B-X
)	B-X
patients	B-X
,	B-X
however	B-X
,	B-X
the	B-X
molecular	B-X
mechanism	B-X
still	B-X
remains	B-X
largely	B-X
unknown	B-X
.	B-X
Emerging	B-X
evidence	B-X
suggested	B-X
that	B-X
some	B-X
chemotherapeutic	B-X
drugs	B-X
played	B-X
anti-tumor	B-X
effects	B-X
by	B-X
inducing	B-X
cell	B-X
pyroptosis	B-X
.	B-X
Using	B-X
a	B-X
genome-scale	B-X
T-cell	B-X
activity	B-X
array	B-X
in	B-X
combination	B-X
with	B-X
bioinformatic	B-X
analysis	B-X
of	B-X
human	B-X
cancer	B-X
databases	B-X
,	B-X
we	B-X
identified	B-X
Siglec-15	B-X
as	B-X
a	B-X
critical	B-X
immune	B-X
suppressor	B-X
with	B-X
broad	B-X
upregulation	B-X
on	B-X
various	B-X
cancer	B-X
types	B-X
and	B-X
a	B-X
potential	B-X
target	B-X
for	B-X
cancer	B-X
immunotherapy	B-X
.	B-X
It	B-X
shows	B-X
prominent	B-X
expression	B-X
on	B-X
macrophages	B-X
and	B-X
cancer	B-X
cells	B-X
and	B-X
a	B-X
mutually	B-X
exclusive	B-X
expression	B-X
with	B-X
PD-L1	B-X
,	B-X
suggesting	B-X
that	B-X
it	B-X
may	B-X
be	B-X
a	B-X
critical	B-X
immune	B-X
evasion	B-X
mechanism	B-X
in	B-X
PD-L1-negative	B-X
patients	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
provide	B-X
an	B-X
overview	B-X
of	B-X
Siglec-15	B-X
biology	B-X
,	B-X
its	B-X
role	B-X
in	B-X
cancer	B-X
immune	B-X
regulation	B-X
,	B-X
the	B-X
preliminary	B-X
and	B-X
encouraging	B-X
clinical	B-X
data	B-X
related	B-X
to	B-X
the	B-X
first-in-class	B-X
Siglec-15	B-X
targeting	B-X
mAb	B-X
,	B-X
as	B-X
well	B-X
as	B-X
many	B-X
unsolved	B-X
questions	B-X
in	B-X
this	B-X
pathway	B-X
.	B-X
As	B-X
a	B-X
new	B-X
player	B-X
in	B-X
the	B-X
cancer	B-X
immunotherapeutic	B-X
arena	B-X
,	B-X
Siglec-15	B-X
may	B-X
represent	B-X
a	B-X
novel	B-X
class	B-X
of	B-X
immune	B-X
inhibitors	B-X
with	B-X
tumor-associated	B-X
expression	B-X
and	B-X
divergent	B-X
mechanisms	B-X
of	B-X
action	B-X
to	B-X
PD-L1	B-X
,	B-X
with	B-X
potential	B-X
implications	B-X
in	B-X
anti-PD-1/PD-L1-resistant	B-X
patients	B-X
.	B-X

PIG	B-Gene_or_gene_product
-	I-Gene_or_gene_product
V	I-Gene_or_gene_product
involved	O
in	O
transferring	O
the	O
second	O
mannose	O
in	O
glycosylphosphatidylinositol	O
.	O
<EOS>	B-X
Four	B-X
mannoses	B-X
in	B-X
the	B-X
GPI	B-X
are	B-X
transferred	B-X
from	B-X
dolichol-phosphate-mannose	B-X
(	B-X
Dol-P-Man	B-X
)	B-X
and	B-X
are	B-X
linked	B-X
through	B-X
different	B-X
glycosidic	B-X
linkages	B-X
.	B-X
Therefore	B-X
,	B-X
four	B-X
Dol-P-Man-dependent	B-X
mannosyltransferases	B-X
,	B-X
GPI-MT-I	B-X
,	B-X
-MT-II	B-X
,	B-X
-MT-III	B-X
,	B-X
and	B-X
-MT-IV	B-X
for	B-X
the	B-X
first	B-X
,	B-X
second	B-X
,	B-X
third	B-X
,	B-X
and	B-X
fourth	B-X
mannoses	B-X
,	B-X
respectively	B-X
,	B-X
are	B-X
required	B-X
for	B-X
generation	B-X
of	B-X
GPI	B-X
.	B-X
GPI-MT-I	B-X
(	B-X
PIG-M	B-X
)	B-X
,	B-X
GPI-MT-III	B-X
(	B-X
PIG-B	B-X
)	B-X
,	B-X
and	B-X
GPI-MT-IV	B-X
(	B-X
SMP3	B-X
)	B-X
were	B-X
previously	B-X
reported	B-X
,	B-X
but	B-X
GPI-MT-II	B-X
remains	B-X
to	B-X
be	B-X
identified	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
cloning	B-X
of	B-X
PIG-V	B-X
involved	B-X
in	B-X
transferring	B-X
the	B-X
second	B-X
mannose	B-X
in	B-X
the	B-X
GPI	B-X
anchor	B-X
.	B-X
Human	B-X
PIG-V	B-X
encodes	B-X
a	B-X
493-amino	B-X
acid	B-X
,	B-X
endoplasmic	B-X
reticulum	B-X
(	B-X
ER	B-X
)	B-X
resident	B-X
protein	B-X
with	B-X
eight	B-X
putative	B-X
transmembrane	B-X
regions	B-X
.	B-X
Saccharomyces	B-X
cerevisiae	B-X
protein	B-X
encoded	B-X
in	B-X
open	B-X
reading	B-X
frame	B-X
YBR004c	B-X
,	B-X
which	B-X
we	B-X
termed	B-X
GPI18	B-X
,	B-X
has	B-X
25	B-X
%	B-X
amino	B-X
acid	B-X
identity	B-X
to	B-X
human	B-X
PIG-V	B-X
.	B-X
Viability	B-X
of	B-X
the	B-X
yeast	B-X
gpi18	B-X
deletion	B-X
mutant	B-X
was	B-X
restored	B-X
by	B-X
human	B-X
PIG-V	B-X
cDNA	B-X
.	B-X
PIG-V	B-X
has	B-X
two	B-X
functionally	B-X
important	B-X
conserved	B-X
regions	B-X
facing	B-X
the	B-X
ER	B-X
lumen	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
we	B-X
suggest	B-X
that	B-X
PIG-V	B-X
is	B-X
the	B-X
second	B-X
mannosyltransferase	B-X
in	B-X
GPI	B-X
anchor	B-X
biosynthesis	B-X
.	B-X

Glycosylphosphatidylinositol	O
(	O
GPI	O
)	O
is	O
a	O
glycolipid	O
that	O
anchors	O
many	O
proteins	O
to	O
the	O
eukaryotic	O
cell	O
surface	O
.	O

The	O
biosynthetic	O
pathway	O
of	O
GPI	O
is	O
mediated	O
by	O
sequential	O
additions	O
of	O
sugars	O
and	O
other	O
components	O
to	O
phosphatidylinositol	O
.	O
<EOS>	B-X
Glycosylphosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
is	B-X
a	B-X
glycolipid	B-X
that	B-X
anchors	B-X
many	B-X
proteins	B-X
to	B-X
the	B-X
eukaryotic	B-X
cell	B-X
surface	B-X
.	B-X
The	B-X
biosynthetic	B-X
pathway	B-X
of	B-X
GPI	B-X
is	B-X
mediated	B-X
by	B-X
sequential	B-X
additions	B-X
of	B-X
sugars	B-X
and	B-X
other	B-X
components	B-X
to	B-X
phosphatidylinositol	B-X
.	B-X
Four	B-X
mannoses	B-X
in	B-X
the	B-X
GPI	B-X
are	B-X
transferred	B-X
from	B-X
dolichol-phosphate-mannose	B-X
(	B-X
Dol-P-Man	B-X
)	B-X
and	B-X
are	B-X
linked	B-X
through	B-X
different	B-X
glycosidic	B-X
linkages	B-X
.	B-X
Therefore	B-X
,	B-X
four	B-X
Dol-P-Man-dependent	B-X
mannosyltransferases	B-X
,	B-X
GPI-MT-I	B-X
,	B-X
-MT-II	B-X
,	B-X
-MT-III	B-X
,	B-X
and	B-X
-MT-IV	B-X
for	B-X
the	B-X
first	B-X
,	B-X
second	B-X
,	B-X
third	B-X
,	B-X
and	B-X
fourth	B-X
mannoses	B-X
,	B-X
respectively	B-X
,	B-X
are	B-X
required	B-X
for	B-X
generation	B-X
of	B-X
GPI	B-X
.	B-X
GPI-MT-I	B-X
(	B-X
PIG-M	B-X
)	B-X
,	B-X
GPI-MT-III	B-X
(	B-X
PIG-B	B-X
)	B-X
,	B-X
and	B-X
GPI-MT-IV	B-X
(	B-X
SMP3	B-X
)	B-X
were	B-X
previously	B-X
reported	B-X
,	B-X
but	B-X
GPI-MT-II	B-X
remains	B-X
to	B-X
be	B-X
identified	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
cloning	B-X
of	B-X
PIG-V	B-X
involved	B-X
in	B-X
transferring	B-X
the	B-X
second	B-X
mannose	B-X
in	B-X
the	B-X
GPI	B-X
anchor	B-X
.	B-X
Saccharomyces	B-X
cerevisiae	B-X
protein	B-X
encoded	B-X
in	B-X
open	B-X
reading	B-X
frame	B-X
YBR004c	B-X
,	B-X
which	B-X
we	B-X
termed	B-X
GPI18	B-X
,	B-X
has	B-X
25	B-X
%	B-X
amino	B-X
acid	B-X
identity	B-X
to	B-X
human	B-X
PIG-V.	B-X
Taken	B-X
together	B-X
,	B-X
we	B-X
suggest	B-X
that	B-X
PIG-V	B-X
is	B-X
the	B-X
second	B-X
mannosyltransferase	B-X
in	B-X
GPI	B-X
anchor	B-X
biosynthesis	B-X
.	B-X

Four	O
mannoses	O
in	O
the	O
GPI	O
are	O
transferred	O
from	O
dolichol	O
-	O
phosphate	O
-	O
mannose	O
(	O
Dol	O
-	O
P	O
-	O
Man	O
)	O
and	O
are	O
linked	O
through	O
different	O
glycosidic	O
linkages	O
.	O

Therefore	O
,	O
four	O
Dol	O
-	O
P	O
-	O
Man	O
-	O
dependent	O
mannosyltransferases	B-Gene_or_gene_product
,	O
GPI	B-Gene_or_gene_product
-	I-Gene_or_gene_product
MT	I-Gene_or_gene_product
-	I-Gene_or_gene_product
I	I-Gene_or_gene_product
,	O
-	B-Gene_or_gene_product
MT	I-Gene_or_gene_product
-	I-Gene_or_gene_product
II	I-Gene_or_gene_product
,	O
-	B-Gene_or_gene_product
MT	I-Gene_or_gene_product
-	I-Gene_or_gene_product
III	I-Gene_or_gene_product
,	O
and	O
-	B-Gene_or_gene_product
MT	I-Gene_or_gene_product
-	I-Gene_or_gene_product
IV	I-Gene_or_gene_product
for	O
the	O
first	O
,	O
second	O
,	O
third	O
,	O
and	O
fourth	O
mannoses	O
,	O
respectively	O
,	O
are	O
required	O
for	O
generation	O
of	O
GPI	O
.	O

GPI	B-Gene_or_gene_product
-	I-Gene_or_gene_product
MT	I-Gene_or_gene_product
-	I-Gene_or_gene_product
I	I-Gene_or_gene_product
(	O
PIG	B-Gene_or_gene_product
-	I-Gene_or_gene_product
M	I-Gene_or_gene_product
)	O
,	O
GPI	B-Gene_or_gene_product
-	I-Gene_or_gene_product
MT	I-Gene_or_gene_product
-	I-Gene_or_gene_product
III	I-Gene_or_gene_product
(	O
PIG	B-Gene_or_gene_product
-	I-Gene_or_gene_product
B	I-Gene_or_gene_product
)	O
,	O
and	O
GPI	B-Gene_or_gene_product
-	I-Gene_or_gene_product
MT	I-Gene_or_gene_product
-	I-Gene_or_gene_product
IV	I-Gene_or_gene_product
(	O
SMP3	B-Gene_or_gene_product
)	O
were	O
previously	O
reported	O
,	O
but	O
GPI	B-Gene_or_gene_product
-	I-Gene_or_gene_product
MT	I-Gene_or_gene_product
-	I-Gene_or_gene_product
II	I-Gene_or_gene_product
remains	O
to	O
be	O
identified	O
.	O
<EOS>	B-X
Glycosylphosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
is	B-X
a	B-X
glycolipid	B-X
that	B-X
anchors	B-X
many	B-X
proteins	B-X
to	B-X
the	B-X
eukaryotic	B-X
cell	B-X
surface	B-X
.	B-X
The	B-X
biosynthetic	B-X
pathway	B-X
of	B-X
GPI	B-X
is	B-X
mediated	B-X
by	B-X
sequential	B-X
additions	B-X
of	B-X
sugars	B-X
and	B-X
other	B-X
components	B-X
to	B-X
phosphatidylinositol	B-X
.	B-X
Four	B-X
mannoses	B-X
in	B-X
the	B-X
GPI	B-X
are	B-X
transferred	B-X
from	B-X
dolichol-phosphate-mannose	B-X
(	B-X
Dol-P-Man	B-X
)	B-X
and	B-X
are	B-X
linked	B-X
through	B-X
different	B-X
glycosidic	B-X
linkages	B-X
.	B-X
Therefore	B-X
,	B-X
four	B-X
Dol-P-Man-dependent	B-X
mannosyltransferases	B-X
,	B-X
GPI-MT-I	B-X
,	B-X
-MT-II	B-X
,	B-X
-MT-III	B-X
,	B-X
and	B-X
-MT-IV	B-X
for	B-X
the	B-X
first	B-X
,	B-X
second	B-X
,	B-X
third	B-X
,	B-X
and	B-X
fourth	B-X
mannoses	B-X
,	B-X
respectively	B-X
,	B-X
are	B-X
required	B-X
for	B-X
generation	B-X
of	B-X
GPI	B-X
.	B-X
GPI-MT-I	B-X
(	B-X
PIG-M	B-X
)	B-X
,	B-X
GPI-MT-III	B-X
(	B-X
PIG-B	B-X
)	B-X
,	B-X
and	B-X
GPI-MT-IV	B-X
(	B-X
SMP3	B-X
)	B-X
were	B-X
previously	B-X
reported	B-X
,	B-X
but	B-X
GPI-MT-II	B-X
remains	B-X
to	B-X
be	B-X
identified	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
cloning	B-X
of	B-X
PIG-V	B-X
involved	B-X
in	B-X
transferring	B-X
the	B-X
second	B-X
mannose	B-X
in	B-X
the	B-X
GPI	B-X
anchor	B-X
.	B-X
Human	B-X
PIG-V	B-X
encodes	B-X
a	B-X
493-amino	B-X
acid	B-X
,	B-X
endoplasmic	B-X
reticulum	B-X
(	B-X
ER	B-X
)	B-X
resident	B-X
protein	B-X
with	B-X
eight	B-X
putative	B-X
transmembrane	B-X
regions	B-X
.	B-X
Saccharomyces	B-X
cerevisiae	B-X
protein	B-X
encoded	B-X
in	B-X
open	B-X
reading	B-X
frame	B-X
YBR004c	B-X
,	B-X
which	B-X
we	B-X
termed	B-X
GPI18	B-X
,	B-X
has	B-X
25	B-X
%	B-X
amino	B-X
acid	B-X
identity	B-X
to	B-X
human	B-X
PIG-V	B-X
.	B-X
Viability	B-X
of	B-X
the	B-X
yeast	B-X
gpi18	B-X
deletion	B-X
mutant	B-X
was	B-X
restored	B-X
by	B-X
human	B-X
PIG-V	B-X
cDNA	B-X
.	B-X
PIG-V	B-X
has	B-X
two	B-X
functionally	B-X
important	B-X
conserved	B-X
regions	B-X
facing	B-X
the	B-X
ER	B-X
lumen	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
we	B-X
suggest	B-X
that	B-X
PIG-V	B-X
is	B-X
the	B-X
second	B-X
mannosyltransferase	B-X
in	B-X
GPI	B-X
anchor	B-X
biosynthesis	B-X
.	B-X

Here	O
we	O
report	O
the	O
cloning	O
of	O
PIG	B-Gene_or_gene_product
-	I-Gene_or_gene_product
V	I-Gene_or_gene_product
involved	O
in	O
transferring	O
the	O
second	O
mannose	O
in	O
the	O
GPI	O
anchor	O
.	O
<EOS>	B-X
Glycosylphosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
is	B-X
a	B-X
glycolipid	B-X
that	B-X
anchors	B-X
many	B-X
proteins	B-X
to	B-X
the	B-X
eukaryotic	B-X
cell	B-X
surface	B-X
.	B-X
The	B-X
biosynthetic	B-X
pathway	B-X
of	B-X
GPI	B-X
is	B-X
mediated	B-X
by	B-X
sequential	B-X
additions	B-X
of	B-X
sugars	B-X
and	B-X
other	B-X
components	B-X
to	B-X
phosphatidylinositol	B-X
.	B-X
Four	B-X
mannoses	B-X
in	B-X
the	B-X
GPI	B-X
are	B-X
transferred	B-X
from	B-X
dolichol-phosphate-mannose	B-X
(	B-X
Dol-P-Man	B-X
)	B-X
and	B-X
are	B-X
linked	B-X
through	B-X
different	B-X
glycosidic	B-X
linkages	B-X
.	B-X
Therefore	B-X
,	B-X
four	B-X
Dol-P-Man-dependent	B-X
mannosyltransferases	B-X
,	B-X
GPI-MT-I	B-X
,	B-X
-MT-II	B-X
,	B-X
-MT-III	B-X
,	B-X
and	B-X
-MT-IV	B-X
for	B-X
the	B-X
first	B-X
,	B-X
second	B-X
,	B-X
third	B-X
,	B-X
and	B-X
fourth	B-X
mannoses	B-X
,	B-X
respectively	B-X
,	B-X
are	B-X
required	B-X
for	B-X
generation	B-X
of	B-X
GPI	B-X
.	B-X
GPI-MT-I	B-X
(	B-X
PIG-M	B-X
)	B-X
,	B-X
GPI-MT-III	B-X
(	B-X
PIG-B	B-X
)	B-X
,	B-X
and	B-X
GPI-MT-IV	B-X
(	B-X
SMP3	B-X
)	B-X
were	B-X
previously	B-X
reported	B-X
,	B-X
but	B-X
GPI-MT-II	B-X
remains	B-X
to	B-X
be	B-X
identified	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
cloning	B-X
of	B-X
PIG-V	B-X
involved	B-X
in	B-X
transferring	B-X
the	B-X
second	B-X
mannose	B-X
in	B-X
the	B-X
GPI	B-X
anchor	B-X
.	B-X
Human	B-X
PIG-V	B-X
encodes	B-X
a	B-X
493-amino	B-X
acid	B-X
,	B-X
endoplasmic	B-X
reticulum	B-X
(	B-X
ER	B-X
)	B-X
resident	B-X
protein	B-X
with	B-X
eight	B-X
putative	B-X
transmembrane	B-X
regions	B-X
.	B-X
Saccharomyces	B-X
cerevisiae	B-X
protein	B-X
encoded	B-X
in	B-X
open	B-X
reading	B-X
frame	B-X
YBR004c	B-X
,	B-X
which	B-X
we	B-X
termed	B-X
GPI18	B-X
,	B-X
has	B-X
25	B-X
%	B-X
amino	B-X
acid	B-X
identity	B-X
to	B-X
human	B-X
PIG-V	B-X
.	B-X
Viability	B-X
of	B-X
the	B-X
yeast	B-X
gpi18	B-X
deletion	B-X
mutant	B-X
was	B-X
restored	B-X
by	B-X
human	B-X
PIG-V	B-X
cDNA	B-X
.	B-X
PIG-V	B-X
has	B-X
two	B-X
functionally	B-X
important	B-X
conserved	B-X
regions	B-X
facing	B-X
the	B-X
ER	B-X
lumen	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
we	B-X
suggest	B-X
that	B-X
PIG-V	B-X
is	B-X
the	B-X
second	B-X
mannosyltransferase	B-X
in	B-X
GPI	B-X
anchor	B-X
biosynthesis	B-X
.	B-X

Human	O
PIG	B-Gene_or_gene_product
-	I-Gene_or_gene_product
V	I-Gene_or_gene_product
encodes	O
a	O
493	O
-	O
amino	O
acid	O
,	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
resident	O
protein	O
with	O
eight	O
putative	O
transmembrane	O
regions	O
.	O
<EOS>	B-X
Glycosylphosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
is	B-X
a	B-X
glycolipid	B-X
that	B-X
anchors	B-X
many	B-X
proteins	B-X
to	B-X
the	B-X
eukaryotic	B-X
cell	B-X
surface	B-X
.	B-X
Therefore	B-X
,	B-X
four	B-X
Dol-P-Man-dependent	B-X
mannosyltransferases	B-X
,	B-X
GPI-MT-I	B-X
,	B-X
-MT-II	B-X
,	B-X
-MT-III	B-X
,	B-X
and	B-X
-MT-IV	B-X
for	B-X
the	B-X
first	B-X
,	B-X
second	B-X
,	B-X
third	B-X
,	B-X
and	B-X
fourth	B-X
mannoses	B-X
,	B-X
respectively	B-X
,	B-X
are	B-X
required	B-X
for	B-X
generation	B-X
of	B-X
GPI	B-X
.	B-X
GPI-MT-I	B-X
(	B-X
PIG-M	B-X
)	B-X
,	B-X
GPI-MT-III	B-X
(	B-X
PIG-B	B-X
)	B-X
,	B-X
and	B-X
GPI-MT-IV	B-X
(	B-X
SMP3	B-X
)	B-X
were	B-X
previously	B-X
reported	B-X
,	B-X
but	B-X
GPI-MT-II	B-X
remains	B-X
to	B-X
be	B-X
identified	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
cloning	B-X
of	B-X
PIG-V	B-X
involved	B-X
in	B-X
transferring	B-X
the	B-X
second	B-X
mannose	B-X
in	B-X
the	B-X
GPI	B-X
anchor	B-X
.	B-X
Human	B-X
PIG-V	B-X
encodes	B-X
a	B-X
493-amino	B-X
acid	B-X
,	B-X
endoplasmic	B-X
reticulum	B-X
(	B-X
ER	B-X
)	B-X
resident	B-X
protein	B-X
with	B-X
eight	B-X
putative	B-X
transmembrane	B-X
regions	B-X
.	B-X
Saccharomyces	B-X
cerevisiae	B-X
protein	B-X
encoded	B-X
in	B-X
open	B-X
reading	B-X
frame	B-X
YBR004c	B-X
,	B-X
which	B-X
we	B-X
termed	B-X
GPI18	B-X
,	B-X
has	B-X
25	B-X
%	B-X
amino	B-X
acid	B-X
identity	B-X
to	B-X
human	B-X
PIG-V	B-X
.	B-X
Viability	B-X
of	B-X
the	B-X
yeast	B-X
gpi18	B-X
deletion	B-X
mutant	B-X
was	B-X
restored	B-X
by	B-X
human	B-X
PIG-V	B-X
cDNA	B-X
.	B-X
PIG-V	B-X
has	B-X
two	B-X
functionally	B-X
important	B-X
conserved	B-X
regions	B-X
facing	B-X
the	B-X
ER	B-X
lumen	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
we	B-X
suggest	B-X
that	B-X
PIG-V	B-X
is	B-X
the	B-X
second	B-X
mannosyltransferase	B-X
in	B-X
GPI	B-X
anchor	B-X
biosynthesis	B-X
.	B-X

Saccharomyces	O
cerevisiae	O
protein	O
encoded	O
in	O
open	O
reading	O
frame	O
YBR004c	O
,	O
which	O
we	O
termed	O
GPI18	B-Gene_or_gene_product
,	O
has	O
25	O
%	O
amino	O
acid	O
identity	O
to	O
human	O
PIG	B-Gene_or_gene_product
-	I-Gene_or_gene_product
V	I-Gene_or_gene_product
.	O
<EOS>	B-X
Glycosylphosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
is	B-X
a	B-X
glycolipid	B-X
that	B-X
anchors	B-X
many	B-X
proteins	B-X
to	B-X
the	B-X
eukaryotic	B-X
cell	B-X
surface	B-X
.	B-X
Therefore	B-X
,	B-X
four	B-X
Dol-P-Man-dependent	B-X
mannosyltransferases	B-X
,	B-X
GPI-MT-I	B-X
,	B-X
-MT-II	B-X
,	B-X
-MT-III	B-X
,	B-X
and	B-X
-MT-IV	B-X
for	B-X
the	B-X
first	B-X
,	B-X
second	B-X
,	B-X
third	B-X
,	B-X
and	B-X
fourth	B-X
mannoses	B-X
,	B-X
respectively	B-X
,	B-X
are	B-X
required	B-X
for	B-X
generation	B-X
of	B-X
GPI	B-X
.	B-X
GPI-MT-I	B-X
(	B-X
PIG-M	B-X
)	B-X
,	B-X
GPI-MT-III	B-X
(	B-X
PIG-B	B-X
)	B-X
,	B-X
and	B-X
GPI-MT-IV	B-X
(	B-X
SMP3	B-X
)	B-X
were	B-X
previously	B-X
reported	B-X
,	B-X
but	B-X
GPI-MT-II	B-X
remains	B-X
to	B-X
be	B-X
identified	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
cloning	B-X
of	B-X
PIG-V	B-X
involved	B-X
in	B-X
transferring	B-X
the	B-X
second	B-X
mannose	B-X
in	B-X
the	B-X
GPI	B-X
anchor	B-X
.	B-X
Human	B-X
PIG-V	B-X
encodes	B-X
a	B-X
493-amino	B-X
acid	B-X
,	B-X
endoplasmic	B-X
reticulum	B-X
(	B-X
ER	B-X
)	B-X
resident	B-X
protein	B-X
with	B-X
eight	B-X
putative	B-X
transmembrane	B-X
regions	B-X
.	B-X
Saccharomyces	B-X
cerevisiae	B-X
protein	B-X
encoded	B-X
in	B-X
open	B-X
reading	B-X
frame	B-X
YBR004c	B-X
,	B-X
which	B-X
we	B-X
termed	B-X
GPI18	B-X
,	B-X
has	B-X
25	B-X
%	B-X
amino	B-X
acid	B-X
identity	B-X
to	B-X
human	B-X
PIG-V	B-X
.	B-X
Viability	B-X
of	B-X
the	B-X
yeast	B-X
gpi18	B-X
deletion	B-X
mutant	B-X
was	B-X
restored	B-X
by	B-X
human	B-X
PIG-V	B-X
cDNA	B-X
.	B-X
PIG-V	B-X
has	B-X
two	B-X
functionally	B-X
important	B-X
conserved	B-X
regions	B-X
facing	B-X
the	B-X
ER	B-X
lumen	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
we	B-X
suggest	B-X
that	B-X
PIG-V	B-X
is	B-X
the	B-X
second	B-X
mannosyltransferase	B-X
in	B-X
GPI	B-X
anchor	B-X
biosynthesis	B-X
.	B-X

Viability	O
of	O
the	O
yeast	O
gpi18	O
deletion	O
mutant	O
was	O
restored	O
by	O
human	O
PIG	B-Gene_or_gene_product
-	I-Gene_or_gene_product
V	I-Gene_or_gene_product
cDNA	O
.	O
<EOS>	B-X
Therefore	B-X
,	B-X
four	B-X
Dol-P-Man-dependent	B-X
mannosyltransferases	B-X
,	B-X
GPI-MT-I	B-X
,	B-X
-MT-II	B-X
,	B-X
-MT-III	B-X
,	B-X
and	B-X
-MT-IV	B-X
for	B-X
the	B-X
first	B-X
,	B-X
second	B-X
,	B-X
third	B-X
,	B-X
and	B-X
fourth	B-X
mannoses	B-X
,	B-X
respectively	B-X
,	B-X
are	B-X
required	B-X
for	B-X
generation	B-X
of	B-X
GPI	B-X
.	B-X
GPI-MT-I	B-X
(	B-X
PIG-M	B-X
)	B-X
,	B-X
GPI-MT-III	B-X
(	B-X
PIG-B	B-X
)	B-X
,	B-X
and	B-X
GPI-MT-IV	B-X
(	B-X
SMP3	B-X
)	B-X
were	B-X
previously	B-X
reported	B-X
,	B-X
but	B-X
GPI-MT-II	B-X
remains	B-X
to	B-X
be	B-X
identified	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
cloning	B-X
of	B-X
PIG-V	B-X
involved	B-X
in	B-X
transferring	B-X
the	B-X
second	B-X
mannose	B-X
in	B-X
the	B-X
GPI	B-X
anchor	B-X
.	B-X
Human	B-X
PIG-V	B-X
encodes	B-X
a	B-X
493-amino	B-X
acid	B-X
,	B-X
endoplasmic	B-X
reticulum	B-X
(	B-X
ER	B-X
)	B-X
resident	B-X
protein	B-X
with	B-X
eight	B-X
putative	B-X
transmembrane	B-X
regions	B-X
.	B-X
Saccharomyces	B-X
cerevisiae	B-X
protein	B-X
encoded	B-X
in	B-X
open	B-X
reading	B-X
frame	B-X
YBR004c	B-X
,	B-X
which	B-X
we	B-X
termed	B-X
GPI18	B-X
,	B-X
has	B-X
25	B-X
%	B-X
amino	B-X
acid	B-X
identity	B-X
to	B-X
human	B-X
PIG-V	B-X
.	B-X
Viability	B-X
of	B-X
the	B-X
yeast	B-X
gpi18	B-X
deletion	B-X
mutant	B-X
was	B-X
restored	B-X
by	B-X
human	B-X
PIG-V	B-X
cDNA	B-X
.	B-X
PIG-V	B-X
has	B-X
two	B-X
functionally	B-X
important	B-X
conserved	B-X
regions	B-X
facing	B-X
the	B-X
ER	B-X
lumen	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
we	B-X
suggest	B-X
that	B-X
PIG-V	B-X
is	B-X
the	B-X
second	B-X
mannosyltransferase	B-X
in	B-X
GPI	B-X
anchor	B-X
biosynthesis	B-X
.	B-X

PIG	B-Gene_or_gene_product
-	I-Gene_or_gene_product
V	I-Gene_or_gene_product
has	O
two	O
functionally	O
important	O
conserved	O
regions	O
facing	O
the	O
ER	O
lumen	O
.	O
<EOS>	B-X
Therefore	B-X
,	B-X
four	B-X
Dol-P-Man-dependent	B-X
mannosyltransferases	B-X
,	B-X
GPI-MT-I	B-X
,	B-X
-MT-II	B-X
,	B-X
-MT-III	B-X
,	B-X
and	B-X
-MT-IV	B-X
for	B-X
the	B-X
first	B-X
,	B-X
second	B-X
,	B-X
third	B-X
,	B-X
and	B-X
fourth	B-X
mannoses	B-X
,	B-X
respectively	B-X
,	B-X
are	B-X
required	B-X
for	B-X
generation	B-X
of	B-X
GPI	B-X
.	B-X
GPI-MT-I	B-X
(	B-X
PIG-M	B-X
)	B-X
,	B-X
GPI-MT-III	B-X
(	B-X
PIG-B	B-X
)	B-X
,	B-X
and	B-X
GPI-MT-IV	B-X
(	B-X
SMP3	B-X
)	B-X
were	B-X
previously	B-X
reported	B-X
,	B-X
but	B-X
GPI-MT-II	B-X
remains	B-X
to	B-X
be	B-X
identified	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
cloning	B-X
of	B-X
PIG-V	B-X
involved	B-X
in	B-X
transferring	B-X
the	B-X
second	B-X
mannose	B-X
in	B-X
the	B-X
GPI	B-X
anchor	B-X
.	B-X
Human	B-X
PIG-V	B-X
encodes	B-X
a	B-X
493-amino	B-X
acid	B-X
,	B-X
endoplasmic	B-X
reticulum	B-X
(	B-X
ER	B-X
)	B-X
resident	B-X
protein	B-X
with	B-X
eight	B-X
putative	B-X
transmembrane	B-X
regions	B-X
.	B-X
Saccharomyces	B-X
cerevisiae	B-X
protein	B-X
encoded	B-X
in	B-X
open	B-X
reading	B-X
frame	B-X
YBR004c	B-X
,	B-X
which	B-X
we	B-X
termed	B-X
GPI18	B-X
,	B-X
has	B-X
25	B-X
%	B-X
amino	B-X
acid	B-X
identity	B-X
to	B-X
human	B-X
PIG-V	B-X
.	B-X
Viability	B-X
of	B-X
the	B-X
yeast	B-X
gpi18	B-X
deletion	B-X
mutant	B-X
was	B-X
restored	B-X
by	B-X
human	B-X
PIG-V	B-X
cDNA	B-X
.	B-X
PIG-V	B-X
has	B-X
two	B-X
functionally	B-X
important	B-X
conserved	B-X
regions	B-X
facing	B-X
the	B-X
ER	B-X
lumen	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
we	B-X
suggest	B-X
that	B-X
PIG-V	B-X
is	B-X
the	B-X
second	B-X
mannosyltransferase	B-X
in	B-X
GPI	B-X
anchor	B-X
biosynthesis	B-X
.	B-X

Taken	O
together	O
,	O
we	O
suggest	O
that	O
PIG	B-Gene_or_gene_product
-	I-Gene_or_gene_product
V	I-Gene_or_gene_product
is	O
the	O
second	O
mannosyltransferase	B-Gene_or_gene_product
in	O
GPI	O
anchor	O
biosynthesis	O
.	O
<EOS>	B-X
Glycosylphosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
is	B-X
a	B-X
glycolipid	B-X
that	B-X
anchors	B-X
many	B-X
proteins	B-X
to	B-X
the	B-X
eukaryotic	B-X
cell	B-X
surface	B-X
.	B-X
The	B-X
biosynthetic	B-X
pathway	B-X
of	B-X
GPI	B-X
is	B-X
mediated	B-X
by	B-X
sequential	B-X
additions	B-X
of	B-X
sugars	B-X
and	B-X
other	B-X
components	B-X
to	B-X
phosphatidylinositol	B-X
.	B-X
Four	B-X
mannoses	B-X
in	B-X
the	B-X
GPI	B-X
are	B-X
transferred	B-X
from	B-X
dolichol-phosphate-mannose	B-X
(	B-X
Dol-P-Man	B-X
)	B-X
and	B-X
are	B-X
linked	B-X
through	B-X
different	B-X
glycosidic	B-X
linkages	B-X
.	B-X
Therefore	B-X
,	B-X
four	B-X
Dol-P-Man-dependent	B-X
mannosyltransferases	B-X
,	B-X
GPI-MT-I	B-X
,	B-X
-MT-II	B-X
,	B-X
-MT-III	B-X
,	B-X
and	B-X
-MT-IV	B-X
for	B-X
the	B-X
first	B-X
,	B-X
second	B-X
,	B-X
third	B-X
,	B-X
and	B-X
fourth	B-X
mannoses	B-X
,	B-X
respectively	B-X
,	B-X
are	B-X
required	B-X
for	B-X
generation	B-X
of	B-X
GPI	B-X
.	B-X
GPI-MT-I	B-X
(	B-X
PIG-M	B-X
)	B-X
,	B-X
GPI-MT-III	B-X
(	B-X
PIG-B	B-X
)	B-X
,	B-X
and	B-X
GPI-MT-IV	B-X
(	B-X
SMP3	B-X
)	B-X
were	B-X
previously	B-X
reported	B-X
,	B-X
but	B-X
GPI-MT-II	B-X
remains	B-X
to	B-X
be	B-X
identified	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
cloning	B-X
of	B-X
PIG-V	B-X
involved	B-X
in	B-X
transferring	B-X
the	B-X
second	B-X
mannose	B-X
in	B-X
the	B-X
GPI	B-X
anchor	B-X
.	B-X
Human	B-X
PIG-V	B-X
encodes	B-X
a	B-X
493-amino	B-X
acid	B-X
,	B-X
endoplasmic	B-X
reticulum	B-X
(	B-X
ER	B-X
)	B-X
resident	B-X
protein	B-X
with	B-X
eight	B-X
putative	B-X
transmembrane	B-X
regions	B-X
.	B-X
Saccharomyces	B-X
cerevisiae	B-X
protein	B-X
encoded	B-X
in	B-X
open	B-X
reading	B-X
frame	B-X
YBR004c	B-X
,	B-X
which	B-X
we	B-X
termed	B-X
GPI18	B-X
,	B-X
has	B-X
25	B-X
%	B-X
amino	B-X
acid	B-X
identity	B-X
to	B-X
human	B-X
PIG-V	B-X
.	B-X
Viability	B-X
of	B-X
the	B-X
yeast	B-X
gpi18	B-X
deletion	B-X
mutant	B-X
was	B-X
restored	B-X
by	B-X
human	B-X
PIG-V	B-X
cDNA	B-X
.	B-X
PIG-V	B-X
has	B-X
two	B-X
functionally	B-X
important	B-X
conserved	B-X
regions	B-X
facing	B-X
the	B-X
ER	B-X
lumen	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
we	B-X
suggest	B-X
that	B-X
PIG-V	B-X
is	B-X
the	B-X
second	B-X
mannosyltransferase	B-X
in	B-X
GPI	B-X
anchor	B-X
biosynthesis	B-X
.	B-X

Identification	O
of	O
a	O
novel	O
class	O
of	O
target	O
genes	O
and	O
a	O
novel	O
type	O
of	O
binding	O
sequence	O
of	O
heat	B-Gene_or_gene_product
shock	I-Gene_or_gene_product
transcription	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
in	O
Saccharomyces	O
cerevisiae	O
.	O

In	O
response	O
to	O
hyperthermia	O
,	O
heat	B-Gene_or_gene_product
shock	I-Gene_or_gene_product
transcription	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
HSF	B-Gene_or_gene_product
)	O
activates	O
transcription	O
of	O
a	O
set	O
of	O
genes	O
encoding	O
heat	B-Gene_or_gene_product
shock	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
(	O
HSPs	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
In	B-X
response	B-X
to	B-X
hyperthermia	B-X
,	B-X
heat	B-X
shock	B-X
transcription	B-X
factor	B-X
(	B-X
HSF	B-X
)	B-X
activates	B-X
transcription	B-X
of	B-X
a	B-X
set	B-X
of	B-X
genes	B-X
encoding	B-X
heat	B-X
shock	B-X
proteins	B-X
(	B-X
HSPs	B-X
)	B-X
.	B-X
The	B-X
promoter	B-X
regions	B-X
of	B-X
HSP	B-X
genes	B-X
contain	B-X
the	B-X
HSF	B-X
binding	B-X
sequence	B-X
called	B-X
the	B-X
heat	B-X
shock	B-X
element	B-X
(	B-X
HSE	B-X
)	B-X
,	B-X
which	B-X
consists	B-X
of	B-X
contiguous	B-X
inverted	B-X
repeats	B-X
of	B-X
the	B-X
sequence	B-X
5'-nGAAn-3	B-X
'	B-X
(	B-X
where	B-X
n	B-X
is	B-X
any	B-X
nucleotide	B-X
)	B-X
.	B-X
We	B-X
have	B-X
constructed	B-X
an	B-X
hsf1	B-X
mutant	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
and	B-X
analyzed	B-X
genome-wide	B-X
changes	B-X
in	B-X
heat	B-X
shock	B-X
response	B-X
in	B-X
the	B-X
mutant	B-X
cells	B-X
.	B-X
The	B-X
results	B-X
have	B-X
revealed	B-X
that	B-X
Hsf1	B-X
is	B-X
necessary	B-X
for	B-X
heat-induced	B-X
transcription	B-X
of	B-X
not	B-X
only	B-X
HSP	B-X
but	B-X
also	B-X
genes	B-X
encoding	B-X
proteins	B-X
involved	B-X
in	B-X
diverse	B-X
cellular	B-X
processes	B-X
such	B-X
as	B-X
protein	B-X
degradation	B-X
,	B-X
detoxification	B-X
,	B-X
energy	B-X
generation	B-X
,	B-X
carbohydrate	B-X
metabolism	B-X
,	B-X
and	B-X
maintenance	B-X
of	B-X
cell	B-X
wall	B-X
integrity	B-X
.	B-X
Approximately	B-X
half	B-X
of	B-X
the	B-X
Hsf1-regulated	B-X
genes	B-X
lacked	B-X
the	B-X
typical	B-X
HSE	B-X
in	B-X
their	B-X
promoter	B-X
regions	B-X
.	B-X
Instead	B-X
,	B-X
several	B-X
of	B-X
these	B-X
genes	B-X
have	B-X
a	B-X
novel	B-X
Hsf1	B-X
binding	B-X
sequence	B-X
that	B-X
contains	B-X
three	B-X
direct	B-X
repeats	B-X
of	B-X
nTTCn	B-X
(	B-X
or	B-X
nGAAn	B-X
)	B-X
interrupted	B-X
by	B-X
5	B-X
bp	B-X
.	B-X
The	B-X
number	B-X
and	B-X
spacing	B-X
of	B-X
the	B-X
repeating	B-X
units	B-X
are	B-X
critical	B-X
determinants	B-X
for	B-X
heat-induced	B-X
transcription	B-X
as	B-X
well	B-X
as	B-X
for	B-X
recognition	B-X
by	B-X
Hsf1	B-X
.	B-X
In	B-X
the	B-X
yeast	B-X
genome	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
the	B-X
sequence	B-X
is	B-X
enriched	B-X
in	B-X
Hsf1-regulated	B-X
genes	B-X
,	B-X
suggesting	B-X
that	B-X
it	B-X
is	B-X
generally	B-X
used	B-X
as	B-X
an	B-X
HSE	B-X
in	B-X
the	B-X
Hsf1	B-X
regulon	B-X
.	B-X

The	O
promoter	O
regions	O
of	O
HSP	B-Gene_or_gene_product
genes	O
contain	O
the	O
HSF	B-Gene_or_gene_product
binding	O
sequence	O
called	O
the	O
heat	O
shock	O
element	O
(	O
HSE	O
)	O
,	O
which	O
consists	O
of	O
contiguous	O
inverted	O
repeats	O
of	O
the	O
sequence	O
5	O
'	O
-	O
nGAAn	O
-	O
3	O
'	O
(	O
where	O
n	O
is	O
any	O
nucleotide	O
)	O
.	O
<EOS>	B-X
In	B-X
response	B-X
to	B-X
hyperthermia	B-X
,	B-X
heat	B-X
shock	B-X
transcription	B-X
factor	B-X
(	B-X
HSF	B-X
)	B-X
activates	B-X
transcription	B-X
of	B-X
a	B-X
set	B-X
of	B-X
genes	B-X
encoding	B-X
heat	B-X
shock	B-X
proteins	B-X
(	B-X
HSPs	B-X
)	B-X
.	B-X
The	B-X
promoter	B-X
regions	B-X
of	B-X
HSP	B-X
genes	B-X
contain	B-X
the	B-X
HSF	B-X
binding	B-X
sequence	B-X
called	B-X
the	B-X
heat	B-X
shock	B-X
element	B-X
(	B-X
HSE	B-X
)	B-X
,	B-X
which	B-X
consists	B-X
of	B-X
contiguous	B-X
inverted	B-X
repeats	B-X
of	B-X
the	B-X
sequence	B-X
5'-nGAAn-3	B-X
'	B-X
(	B-X
where	B-X
n	B-X
is	B-X
any	B-X
nucleotide	B-X
)	B-X
.	B-X
We	B-X
have	B-X
constructed	B-X
an	B-X
hsf1	B-X
mutant	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
and	B-X
analyzed	B-X
genome-wide	B-X
changes	B-X
in	B-X
heat	B-X
shock	B-X
response	B-X
in	B-X
the	B-X
mutant	B-X
cells	B-X
.	B-X
The	B-X
results	B-X
have	B-X
revealed	B-X
that	B-X
Hsf1	B-X
is	B-X
necessary	B-X
for	B-X
heat-induced	B-X
transcription	B-X
of	B-X
not	B-X
only	B-X
HSP	B-X
but	B-X
also	B-X
genes	B-X
encoding	B-X
proteins	B-X
involved	B-X
in	B-X
diverse	B-X
cellular	B-X
processes	B-X
such	B-X
as	B-X
protein	B-X
degradation	B-X
,	B-X
detoxification	B-X
,	B-X
energy	B-X
generation	B-X
,	B-X
carbohydrate	B-X
metabolism	B-X
,	B-X
and	B-X
maintenance	B-X
of	B-X
cell	B-X
wall	B-X
integrity	B-X
.	B-X
Approximately	B-X
half	B-X
of	B-X
the	B-X
Hsf1-regulated	B-X
genes	B-X
lacked	B-X
the	B-X
typical	B-X
HSE	B-X
in	B-X
their	B-X
promoter	B-X
regions	B-X
.	B-X
Instead	B-X
,	B-X
several	B-X
of	B-X
these	B-X
genes	B-X
have	B-X
a	B-X
novel	B-X
Hsf1	B-X
binding	B-X
sequence	B-X
that	B-X
contains	B-X
three	B-X
direct	B-X
repeats	B-X
of	B-X
nTTCn	B-X
(	B-X
or	B-X
nGAAn	B-X
)	B-X
interrupted	B-X
by	B-X
5	B-X
bp	B-X
.	B-X
The	B-X
number	B-X
and	B-X
spacing	B-X
of	B-X
the	B-X
repeating	B-X
units	B-X
are	B-X
critical	B-X
determinants	B-X
for	B-X
heat-induced	B-X
transcription	B-X
as	B-X
well	B-X
as	B-X
for	B-X
recognition	B-X
by	B-X
Hsf1	B-X
.	B-X
In	B-X
the	B-X
yeast	B-X
genome	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
the	B-X
sequence	B-X
is	B-X
enriched	B-X
in	B-X
Hsf1-regulated	B-X
genes	B-X
,	B-X
suggesting	B-X
that	B-X
it	B-X
is	B-X
generally	B-X
used	B-X
as	B-X
an	B-X
HSE	B-X
in	B-X
the	B-X
Hsf1	B-X
regulon	B-X
.	B-X

We	O
have	O
constructed	O
an	O
hsf1	B-Gene_or_gene_product
mutant	O
of	O
Saccharomyces	O
cerevisiae	O
and	O
analyzed	O
genome	O
-	O
wide	O
changes	O
in	O
heat	O
shock	O
response	O
in	O
the	O
mutant	O
cells	O
.	O
<EOS>	B-X
In	B-X
response	B-X
to	B-X
hyperthermia	B-X
,	B-X
heat	B-X
shock	B-X
transcription	B-X
factor	B-X
(	B-X
HSF	B-X
)	B-X
activates	B-X
transcription	B-X
of	B-X
a	B-X
set	B-X
of	B-X
genes	B-X
encoding	B-X
heat	B-X
shock	B-X
proteins	B-X
(	B-X
HSPs	B-X
)	B-X
.	B-X
The	B-X
promoter	B-X
regions	B-X
of	B-X
HSP	B-X
genes	B-X
contain	B-X
the	B-X
HSF	B-X
binding	B-X
sequence	B-X
called	B-X
the	B-X
heat	B-X
shock	B-X
element	B-X
(	B-X
HSE	B-X
)	B-X
,	B-X
which	B-X
consists	B-X
of	B-X
contiguous	B-X
inverted	B-X
repeats	B-X
of	B-X
the	B-X
sequence	B-X
5'-nGAAn-3	B-X
'	B-X
(	B-X
where	B-X
n	B-X
is	B-X
any	B-X
nucleotide	B-X
)	B-X
.	B-X
We	B-X
have	B-X
constructed	B-X
an	B-X
hsf1	B-X
mutant	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
and	B-X
analyzed	B-X
genome-wide	B-X
changes	B-X
in	B-X
heat	B-X
shock	B-X
response	B-X
in	B-X
the	B-X
mutant	B-X
cells	B-X
.	B-X
The	B-X
results	B-X
have	B-X
revealed	B-X
that	B-X
Hsf1	B-X
is	B-X
necessary	B-X
for	B-X
heat-induced	B-X
transcription	B-X
of	B-X
not	B-X
only	B-X
HSP	B-X
but	B-X
also	B-X
genes	B-X
encoding	B-X
proteins	B-X
involved	B-X
in	B-X
diverse	B-X
cellular	B-X
processes	B-X
such	B-X
as	B-X
protein	B-X
degradation	B-X
,	B-X
detoxification	B-X
,	B-X
energy	B-X
generation	B-X
,	B-X
carbohydrate	B-X
metabolism	B-X
,	B-X
and	B-X
maintenance	B-X
of	B-X
cell	B-X
wall	B-X
integrity	B-X
.	B-X
The	B-X
number	B-X
and	B-X
spacing	B-X
of	B-X
the	B-X
repeating	B-X
units	B-X
are	B-X
critical	B-X
determinants	B-X
for	B-X
heat-induced	B-X
transcription	B-X
as	B-X
well	B-X
as	B-X
for	B-X
recognition	B-X
by	B-X
Hsf1	B-X
.	B-X
In	B-X
the	B-X
yeast	B-X
genome	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
the	B-X
sequence	B-X
is	B-X
enriched	B-X
in	B-X
Hsf1-regulated	B-X
genes	B-X
,	B-X
suggesting	B-X
that	B-X
it	B-X
is	B-X
generally	B-X
used	B-X
as	B-X
an	B-X
HSE	B-X
in	B-X
the	B-X
Hsf1	B-X
regulon	B-X
.	B-X

The	O
results	O
have	O
revealed	O
that	O
Hsf1	B-Gene_or_gene_product
is	O
necessary	O
for	O
heat	O
-	O
induced	O
transcription	O
of	O
not	O
only	O
HSP	B-Gene_or_gene_product
but	O
also	O
genes	O
encoding	O
proteins	O
involved	O
in	O
diverse	O
cellular	O
processes	O
such	O
as	O
protein	O
degradation	O
,	O
detoxification	O
,	O
energy	O
generation	O
,	O
carbohydrate	O
metabolism	O
,	O
and	O
maintenance	O
of	O
cell	O
wall	O
integrity	O
.	O
<EOS>	B-X
The	B-X
heat-shock	B-X
response	B-X
is	B-X
a	B-X
crucial	B-X
system	B-X
for	B-X
survival	B-X
of	B-X
organisms	B-X
under	B-X
heat	B-X
stress	B-X
.	B-X
During	B-X
heat-shock	B-X
stress	B-X
,	B-X
gene	B-X
expression	B-X
is	B-X
globally	B-X
suppressed	B-X
,	B-X
but	B-X
expression	B-X
of	B-X
some	B-X
genes	B-X
,	B-X
such	B-X
as	B-X
chaperone	B-X
genes	B-X
,	B-X
is	B-X
selectively	B-X
promoted	B-X
.	B-X
These	B-X
selectively	B-X
activated	B-X
genes	B-X
have	B-X
critical	B-X
roles	B-X
in	B-X
the	B-X
heat-shock	B-X
response	B-X
,	B-X
so	B-X
it	B-X
is	B-X
necessary	B-X
to	B-X
discover	B-X
heat-inducible	B-X
genes	B-X
to	B-X
reveal	B-X
the	B-X
overall	B-X
heat-shock	B-X
response	B-X
picture	B-X
.	B-X
The	B-X
expression	B-X
profiling	B-X
of	B-X
heat-inducible	B-X
protein-coding	B-X
genes	B-X
has	B-X
been	B-X
well-studied	B-X
,	B-X
but	B-X
that	B-X
of	B-X
non-coding	B-X
genes	B-X
remains	B-X
unclear	B-X
in	B-X
mammalian	B-X
systems	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
used	B-X
RNA-seq	B-X
analysis	B-X
of	B-X
heat	B-X
shock-treated	B-X
A549	B-X
cells	B-X
to	B-X
identify	B-X
seven	B-X
novel	B-X
long	B-X
non-coding	B-X
RNAs	B-X
that	B-X
responded	B-X
to	B-X
heat	B-X
shock	B-X
.	B-X
We	B-X
focussed	B-X
on	B-X
CTD-2377D24.6	B-X
RNA	B-X
,	B-X
which	B-X
is	B-X
most	B-X
significantly	B-X
induced	B-X
by	B-X
heat	B-X
shock	B-X
,	B-X
and	B-X
found	B-X
that	B-X
the	B-X
promoter	B-X
region	B-X
of	B-X
CTD-2377D24.6	B-X
contains	B-X
the	B-X
binding	B-X
site	B-X
for	B-X
transcription	B-X
factor	B-X
HSF1	B-X
(	B-X
heat	B-X
shock	B-X
factor	B-X
1	B-X
)	B-X
,	B-X
which	B-X
plays	B-X
a	B-X
central	B-X
role	B-X
in	B-X
the	B-X
heat-shock	B-X
response	B-X
.	B-X
We	B-X
confirmed	B-X
that	B-X
HSF1	B-X
knockdown	B-X
cancelled	B-X
the	B-X
induction	B-X
of	B-X
CTD-2377D24.6	B-X
RNA	B-X
upon	B-X
heat	B-X
shock	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
CTD-2377D24.6	B-X
RNA	B-X
is	B-X
a	B-X
novel	B-X
heat	B-X
shock-inducible	B-X
transcript	B-X
that	B-X
is	B-X
transcribed	B-X
by	B-X
HSF1	B-X
.	B-X

Approximately	O
half	O
of	O
the	O
Hsf1	B-Gene_or_gene_product
-	O
regulated	O
genes	O
lacked	O
the	O
typical	O
HSE	O
in	O
their	O
promoter	O
regions	O
.	O
<EOS>	B-X
In	B-X
response	B-X
to	B-X
hyperthermia	B-X
,	B-X
heat	B-X
shock	B-X
transcription	B-X
factor	B-X
(	B-X
HSF	B-X
)	B-X
activates	B-X
transcription	B-X
of	B-X
a	B-X
set	B-X
of	B-X
genes	B-X
encoding	B-X
heat	B-X
shock	B-X
proteins	B-X
(	B-X
HSPs	B-X
)	B-X
.	B-X
The	B-X
promoter	B-X
regions	B-X
of	B-X
HSP	B-X
genes	B-X
contain	B-X
the	B-X
HSF	B-X
binding	B-X
sequence	B-X
called	B-X
the	B-X
heat	B-X
shock	B-X
element	B-X
(	B-X
HSE	B-X
)	B-X
,	B-X
which	B-X
consists	B-X
of	B-X
contiguous	B-X
inverted	B-X
repeats	B-X
of	B-X
the	B-X
sequence	B-X
5'-nGAAn-3	B-X
'	B-X
(	B-X
where	B-X
n	B-X
is	B-X
any	B-X
nucleotide	B-X
)	B-X
.	B-X
The	B-X
results	B-X
have	B-X
revealed	B-X
that	B-X
Hsf1	B-X
is	B-X
necessary	B-X
for	B-X
heat-induced	B-X
transcription	B-X
of	B-X
not	B-X
only	B-X
HSP	B-X
but	B-X
also	B-X
genes	B-X
encoding	B-X
proteins	B-X
involved	B-X
in	B-X
diverse	B-X
cellular	B-X
processes	B-X
such	B-X
as	B-X
protein	B-X
degradation	B-X
,	B-X
detoxification	B-X
,	B-X
energy	B-X
generation	B-X
,	B-X
carbohydrate	B-X
metabolism	B-X
,	B-X
and	B-X
maintenance	B-X
of	B-X
cell	B-X
wall	B-X
integrity	B-X
.	B-X
Approximately	B-X
half	B-X
of	B-X
the	B-X
Hsf1-regulated	B-X
genes	B-X
lacked	B-X
the	B-X
typical	B-X
HSE	B-X
in	B-X
their	B-X
promoter	B-X
regions	B-X
.	B-X
Instead	B-X
,	B-X
several	B-X
of	B-X
these	B-X
genes	B-X
have	B-X
a	B-X
novel	B-X
Hsf1	B-X
binding	B-X
sequence	B-X
that	B-X
contains	B-X
three	B-X
direct	B-X
repeats	B-X
of	B-X
nTTCn	B-X
(	B-X
or	B-X
nGAAn	B-X
)	B-X
interrupted	B-X
by	B-X
5	B-X
bp	B-X
.	B-X
The	B-X
number	B-X
and	B-X
spacing	B-X
of	B-X
the	B-X
repeating	B-X
units	B-X
are	B-X
critical	B-X
determinants	B-X
for	B-X
heat-induced	B-X
transcription	B-X
as	B-X
well	B-X
as	B-X
for	B-X
recognition	B-X
by	B-X
Hsf1	B-X
.	B-X
In	B-X
the	B-X
yeast	B-X
genome	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
the	B-X
sequence	B-X
is	B-X
enriched	B-X
in	B-X
Hsf1-regulated	B-X
genes	B-X
,	B-X
suggesting	B-X
that	B-X
it	B-X
is	B-X
generally	B-X
used	B-X
as	B-X
an	B-X
HSE	B-X
in	B-X
the	B-X
Hsf1	B-X
regulon	B-X
.	B-X

Instead	O
,	O
several	O
of	O
these	O
genes	O
have	O
a	O
novel	O
Hsf1	B-Gene_or_gene_product
binding	O
sequence	O
that	O
contains	O
three	O
direct	O
repeats	O
of	O
nTTCn	O
(	O
or	O
nGAAn	O
)	O
interrupted	O
by	O
5	O
bp	O
.	O
<EOS>	B-X
In	B-X
response	B-X
to	B-X
hyperthermia	B-X
,	B-X
heat	B-X
shock	B-X
transcription	B-X
factor	B-X
(	B-X
HSF	B-X
)	B-X
activates	B-X
transcription	B-X
of	B-X
a	B-X
set	B-X
of	B-X
genes	B-X
encoding	B-X
heat	B-X
shock	B-X
proteins	B-X
(	B-X
HSPs	B-X
)	B-X
.	B-X
The	B-X
promoter	B-X
regions	B-X
of	B-X
HSP	B-X
genes	B-X
contain	B-X
the	B-X
HSF	B-X
binding	B-X
sequence	B-X
called	B-X
the	B-X
heat	B-X
shock	B-X
element	B-X
(	B-X
HSE	B-X
)	B-X
,	B-X
which	B-X
consists	B-X
of	B-X
contiguous	B-X
inverted	B-X
repeats	B-X
of	B-X
the	B-X
sequence	B-X
5'-nGAAn-3	B-X
'	B-X
(	B-X
where	B-X
n	B-X
is	B-X
any	B-X
nucleotide	B-X
)	B-X
.	B-X
The	B-X
results	B-X
have	B-X
revealed	B-X
that	B-X
Hsf1	B-X
is	B-X
necessary	B-X
for	B-X
heat-induced	B-X
transcription	B-X
of	B-X
not	B-X
only	B-X
HSP	B-X
but	B-X
also	B-X
genes	B-X
encoding	B-X
proteins	B-X
involved	B-X
in	B-X
diverse	B-X
cellular	B-X
processes	B-X
such	B-X
as	B-X
protein	B-X
degradation	B-X
,	B-X
detoxification	B-X
,	B-X
energy	B-X
generation	B-X
,	B-X
carbohydrate	B-X
metabolism	B-X
,	B-X
and	B-X
maintenance	B-X
of	B-X
cell	B-X
wall	B-X
integrity	B-X
.	B-X
Approximately	B-X
half	B-X
of	B-X
the	B-X
Hsf1-regulated	B-X
genes	B-X
lacked	B-X
the	B-X
typical	B-X
HSE	B-X
in	B-X
their	B-X
promoter	B-X
regions	B-X
.	B-X
Instead	B-X
,	B-X
several	B-X
of	B-X
these	B-X
genes	B-X
have	B-X
a	B-X
novel	B-X
Hsf1	B-X
binding	B-X
sequence	B-X
that	B-X
contains	B-X
three	B-X
direct	B-X
repeats	B-X
of	B-X
nTTCn	B-X
(	B-X
or	B-X
nGAAn	B-X
)	B-X
interrupted	B-X
by	B-X
5	B-X
bp	B-X
.	B-X
The	B-X
number	B-X
and	B-X
spacing	B-X
of	B-X
the	B-X
repeating	B-X
units	B-X
are	B-X
critical	B-X
determinants	B-X
for	B-X
heat-induced	B-X
transcription	B-X
as	B-X
well	B-X
as	B-X
for	B-X
recognition	B-X
by	B-X
Hsf1	B-X
.	B-X
In	B-X
the	B-X
yeast	B-X
genome	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
the	B-X
sequence	B-X
is	B-X
enriched	B-X
in	B-X
Hsf1-regulated	B-X
genes	B-X
,	B-X
suggesting	B-X
that	B-X
it	B-X
is	B-X
generally	B-X
used	B-X
as	B-X
an	B-X
HSE	B-X
in	B-X
the	B-X
Hsf1	B-X
regulon	B-X
.	B-X

The	O
number	O
and	O
spacing	O
of	O
the	O
repeating	O
units	O
are	O
critical	O
determinants	O
for	O
heat	O
-	O
induced	O
transcription	O
as	O
well	O
as	O
for	O
recognition	O
by	O
Hsf1	B-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
response	B-X
to	B-X
hyperthermia	B-X
,	B-X
heat	B-X
shock	B-X
transcription	B-X
factor	B-X
(	B-X
HSF	B-X
)	B-X
activates	B-X
transcription	B-X
of	B-X
a	B-X
set	B-X
of	B-X
genes	B-X
encoding	B-X
heat	B-X
shock	B-X
proteins	B-X
(	B-X
HSPs	B-X
)	B-X
.	B-X
The	B-X
promoter	B-X
regions	B-X
of	B-X
HSP	B-X
genes	B-X
contain	B-X
the	B-X
HSF	B-X
binding	B-X
sequence	B-X
called	B-X
the	B-X
heat	B-X
shock	B-X
element	B-X
(	B-X
HSE	B-X
)	B-X
,	B-X
which	B-X
consists	B-X
of	B-X
contiguous	B-X
inverted	B-X
repeats	B-X
of	B-X
the	B-X
sequence	B-X
5'-nGAAn-3	B-X
'	B-X
(	B-X
where	B-X
n	B-X
is	B-X
any	B-X
nucleotide	B-X
)	B-X
.	B-X
We	B-X
have	B-X
constructed	B-X
an	B-X
hsf1	B-X
mutant	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
and	B-X
analyzed	B-X
genome-wide	B-X
changes	B-X
in	B-X
heat	B-X
shock	B-X
response	B-X
in	B-X
the	B-X
mutant	B-X
cells	B-X
.	B-X
The	B-X
results	B-X
have	B-X
revealed	B-X
that	B-X
Hsf1	B-X
is	B-X
necessary	B-X
for	B-X
heat-induced	B-X
transcription	B-X
of	B-X
not	B-X
only	B-X
HSP	B-X
but	B-X
also	B-X
genes	B-X
encoding	B-X
proteins	B-X
involved	B-X
in	B-X
diverse	B-X
cellular	B-X
processes	B-X
such	B-X
as	B-X
protein	B-X
degradation	B-X
,	B-X
detoxification	B-X
,	B-X
energy	B-X
generation	B-X
,	B-X
carbohydrate	B-X
metabolism	B-X
,	B-X
and	B-X
maintenance	B-X
of	B-X
cell	B-X
wall	B-X
integrity	B-X
.	B-X
Approximately	B-X
half	B-X
of	B-X
the	B-X
Hsf1-regulated	B-X
genes	B-X
lacked	B-X
the	B-X
typical	B-X
HSE	B-X
in	B-X
their	B-X
promoter	B-X
regions	B-X
.	B-X
Instead	B-X
,	B-X
several	B-X
of	B-X
these	B-X
genes	B-X
have	B-X
a	B-X
novel	B-X
Hsf1	B-X
binding	B-X
sequence	B-X
that	B-X
contains	B-X
three	B-X
direct	B-X
repeats	B-X
of	B-X
nTTCn	B-X
(	B-X
or	B-X
nGAAn	B-X
)	B-X
interrupted	B-X
by	B-X
5	B-X
bp	B-X
.	B-X
The	B-X
number	B-X
and	B-X
spacing	B-X
of	B-X
the	B-X
repeating	B-X
units	B-X
are	B-X
critical	B-X
determinants	B-X
for	B-X
heat-induced	B-X
transcription	B-X
as	B-X
well	B-X
as	B-X
for	B-X
recognition	B-X
by	B-X
Hsf1	B-X
.	B-X
In	B-X
the	B-X
yeast	B-X
genome	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
the	B-X
sequence	B-X
is	B-X
enriched	B-X
in	B-X
Hsf1-regulated	B-X
genes	B-X
,	B-X
suggesting	B-X
that	B-X
it	B-X
is	B-X
generally	B-X
used	B-X
as	B-X
an	B-X
HSE	B-X
in	B-X
the	B-X
Hsf1	B-X
regulon	B-X
.	B-X

In	O
the	O
yeast	O
genome	O
,	O
the	O
presence	O
of	O
the	O
sequence	O
is	O
enriched	O
in	O
Hsf1	B-Gene_or_gene_product
-	O
regulated	O
genes	O
,	O
suggesting	O
that	O
it	O
is	O
generally	O
used	O
as	O
an	O
HSE	O
in	O
the	O
Hsf1	B-Gene_or_gene_product
regulon	O
.	O
<EOS>	B-X
In	B-X
response	B-X
to	B-X
hyperthermia	B-X
,	B-X
heat	B-X
shock	B-X
transcription	B-X
factor	B-X
(	B-X
HSF	B-X
)	B-X
activates	B-X
transcription	B-X
of	B-X
a	B-X
set	B-X
of	B-X
genes	B-X
encoding	B-X
heat	B-X
shock	B-X
proteins	B-X
(	B-X
HSPs	B-X
)	B-X
.	B-X
The	B-X
promoter	B-X
regions	B-X
of	B-X
HSP	B-X
genes	B-X
contain	B-X
the	B-X
HSF	B-X
binding	B-X
sequence	B-X
called	B-X
the	B-X
heat	B-X
shock	B-X
element	B-X
(	B-X
HSE	B-X
)	B-X
,	B-X
which	B-X
consists	B-X
of	B-X
contiguous	B-X
inverted	B-X
repeats	B-X
of	B-X
the	B-X
sequence	B-X
5'-nGAAn-3	B-X
'	B-X
(	B-X
where	B-X
n	B-X
is	B-X
any	B-X
nucleotide	B-X
)	B-X
.	B-X
We	B-X
have	B-X
constructed	B-X
an	B-X
hsf1	B-X
mutant	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
and	B-X
analyzed	B-X
genome-wide	B-X
changes	B-X
in	B-X
heat	B-X
shock	B-X
response	B-X
in	B-X
the	B-X
mutant	B-X
cells	B-X
.	B-X
The	B-X
results	B-X
have	B-X
revealed	B-X
that	B-X
Hsf1	B-X
is	B-X
necessary	B-X
for	B-X
heat-induced	B-X
transcription	B-X
of	B-X
not	B-X
only	B-X
HSP	B-X
but	B-X
also	B-X
genes	B-X
encoding	B-X
proteins	B-X
involved	B-X
in	B-X
diverse	B-X
cellular	B-X
processes	B-X
such	B-X
as	B-X
protein	B-X
degradation	B-X
,	B-X
detoxification	B-X
,	B-X
energy	B-X
generation	B-X
,	B-X
carbohydrate	B-X
metabolism	B-X
,	B-X
and	B-X
maintenance	B-X
of	B-X
cell	B-X
wall	B-X
integrity	B-X
.	B-X
Approximately	B-X
half	B-X
of	B-X
the	B-X
Hsf1-regulated	B-X
genes	B-X
lacked	B-X
the	B-X
typical	B-X
HSE	B-X
in	B-X
their	B-X
promoter	B-X
regions	B-X
.	B-X
Instead	B-X
,	B-X
several	B-X
of	B-X
these	B-X
genes	B-X
have	B-X
a	B-X
novel	B-X
Hsf1	B-X
binding	B-X
sequence	B-X
that	B-X
contains	B-X
three	B-X
direct	B-X
repeats	B-X
of	B-X
nTTCn	B-X
(	B-X
or	B-X
nGAAn	B-X
)	B-X
interrupted	B-X
by	B-X
5	B-X
bp	B-X
.	B-X
The	B-X
number	B-X
and	B-X
spacing	B-X
of	B-X
the	B-X
repeating	B-X
units	B-X
are	B-X
critical	B-X
determinants	B-X
for	B-X
heat-induced	B-X
transcription	B-X
as	B-X
well	B-X
as	B-X
for	B-X
recognition	B-X
by	B-X
Hsf1	B-X
.	B-X
In	B-X
the	B-X
yeast	B-X
genome	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
the	B-X
sequence	B-X
is	B-X
enriched	B-X
in	B-X
Hsf1-regulated	B-X
genes	B-X
,	B-X
suggesting	B-X
that	B-X
it	B-X
is	B-X
generally	B-X
used	B-X
as	B-X
an	B-X
HSE	B-X
in	B-X
the	B-X
Hsf1	B-X
regulon	B-X
.	B-X

NF	O
-	O
{	O
kappa	O
}	O
B	O
is	O
transported	O
into	O
the	O
nucleus	O
by	O
importin	B-Gene_or_gene_product
{	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
}	I-Gene_or_gene_product
3	I-Gene_or_gene_product
and	O
importin	B-Gene_or_gene_product
{	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
}	I-Gene_or_gene_product
4	I-Gene_or_gene_product
.	O
<EOS>	B-X
NF-kappaB	B-X
transcription	B-X
factors	B-X
are	B-X
retained	B-X
in	B-X
the	B-X
cytoplasm	B-X
in	B-X
an	B-X
inactive	B-X
form	B-X
until	B-X
they	B-X
are	B-X
activated	B-X
and	B-X
rapidly	B-X
imported	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
We	B-X
identified	B-X
importin	B-X
alpha3	B-X
and	B-X
importin	B-X
alpha4	B-X
as	B-X
the	B-X
main	B-X
importin	B-X
alpha	B-X
isoforms	B-X
mediating	B-X
TNF-alpha-stimulated	B-X
NF-kappaB	B-X
p50/p65	B-X
heterodimer	B-X
translocation	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
Importin	B-X
alpha3	B-X
and	B-X
alpha4	B-X
are	B-X
close	B-X
relatives	B-X
in	B-X
the	B-X
human	B-X
importin	B-X
alpha	B-X
family	B-X
.	B-X
We	B-X
show	B-X
that	B-X
importin	B-X
alpha3	B-X
isoform	B-X
also	B-X
mediates	B-X
nuclear	B-X
import	B-X
of	B-X
NF-kappaB	B-X
p50	B-X
homodimer	B-X
in	B-X
nonstimulated	B-X
cells	B-X
.	B-X
Importin	B-X
alpha3	B-X
is	B-X
shown	B-X
to	B-X
directly	B-X
bind	B-X
to	B-X
previously	B-X
characterized	B-X
nuclear	B-X
localization	B-X
signals	B-X
(	B-X
NLSs	B-X
)	B-X
of	B-X
NF-kappaB	B-X
p50	B-X
and	B-X
p65	B-X
proteins	B-X
.	B-X
Importin	B-X
alpha	B-X
molecules	B-X
are	B-X
known	B-X
to	B-X
have	B-X
armadillo	B-X
repeats	B-X
that	B-X
constitute	B-X
the	B-X
N-terminal	B-X
and	B-X
C-terminal	B-X
NLS	B-X
binding	B-X
sites	B-X
.	B-X
We	B-X
demonstrate	B-X
by	B-X
site-directed	B-X
mutagenesis	B-X
that	B-X
NF-kappaB	B-X
p50	B-X
binds	B-X
to	B-X
the	B-X
N-terminal	B-X
and	B-X
p65	B-X
to	B-X
the	B-X
C-terminal	B-X
NLS	B-X
binding	B-X
site	B-X
of	B-X
importin	B-X
alpha3	B-X
.	B-X
In	B-X
vitro	B-X
competition	B-X
experiments	B-X
and	B-X
analysis	B-X
of	B-X
cellular	B-X
NF-kappaB	B-X
suggest	B-X
that	B-X
NF-kappaB	B-X
binds	B-X
to	B-X
importin	B-X
alpha	B-X
only	B-X
when	B-X
it	B-X
is	B-X
free	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
The	B-X
present	B-X
study	B-X
demonstrates	B-X
that	B-X
the	B-X
nuclear	B-X
import	B-X
of	B-X
NF-kappaB	B-X
is	B-X
a	B-X
highly	B-X
regulated	B-X
process	B-X
mediated	B-X
by	B-X
a	B-X
subset	B-X
of	B-X
importin	B-X
alpha	B-X
molecules	B-X
.	B-X

NF	O
-	O
kappaB	O
transcription	O
factors	O
are	O
retained	O
in	O
the	O
cytoplasm	O
in	O
an	O
inactive	O
form	O
until	O
they	O
are	O
activated	O
and	O
rapidly	O
imported	O
into	O
the	O
nucleus	O
.	O

We	O
identified	O
importin	B-Gene_or_gene_product
alpha3	I-Gene_or_gene_product
and	O
importin	B-Gene_or_gene_product
alpha4	I-Gene_or_gene_product
as	O
the	O
main	O
importin	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
isoforms	O
mediating	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
-	O
stimulated	O
NF	O
-	O
kappaB	O
p50	O
/	O
p65	O
heterodimer	O
translocation	O
into	O
the	O
nucleus	O
.	O
<EOS>	B-X
NF-kappaB	B-X
transcription	B-X
factors	B-X
are	B-X
retained	B-X
in	B-X
the	B-X
cytoplasm	B-X
in	B-X
an	B-X
inactive	B-X
form	B-X
until	B-X
they	B-X
are	B-X
activated	B-X
and	B-X
rapidly	B-X
imported	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
We	B-X
identified	B-X
importin	B-X
alpha3	B-X
and	B-X
importin	B-X
alpha4	B-X
as	B-X
the	B-X
main	B-X
importin	B-X
alpha	B-X
isoforms	B-X
mediating	B-X
TNF-alpha-stimulated	B-X
NF-kappaB	B-X
p50/p65	B-X
heterodimer	B-X
translocation	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
Importin	B-X
alpha3	B-X
and	B-X
alpha4	B-X
are	B-X
close	B-X
relatives	B-X
in	B-X
the	B-X
human	B-X
importin	B-X
alpha	B-X
family	B-X
.	B-X
We	B-X
show	B-X
that	B-X
importin	B-X
alpha3	B-X
isoform	B-X
also	B-X
mediates	B-X
nuclear	B-X
import	B-X
of	B-X
NF-kappaB	B-X
p50	B-X
homodimer	B-X
in	B-X
nonstimulated	B-X
cells	B-X
.	B-X
Importin	B-X
alpha3	B-X
is	B-X
shown	B-X
to	B-X
directly	B-X
bind	B-X
to	B-X
previously	B-X
characterized	B-X
nuclear	B-X
localization	B-X
signals	B-X
(	B-X
NLSs	B-X
)	B-X
of	B-X
NF-kappaB	B-X
p50	B-X
and	B-X
p65	B-X
proteins	B-X
.	B-X
Importin	B-X
alpha	B-X
molecules	B-X
are	B-X
known	B-X
to	B-X
have	B-X
armadillo	B-X
repeats	B-X
that	B-X
constitute	B-X
the	B-X
N-terminal	B-X
and	B-X
C-terminal	B-X
NLS	B-X
binding	B-X
sites	B-X
.	B-X
We	B-X
demonstrate	B-X
by	B-X
site-directed	B-X
mutagenesis	B-X
that	B-X
NF-kappaB	B-X
p50	B-X
binds	B-X
to	B-X
the	B-X
N-terminal	B-X
and	B-X
p65	B-X
to	B-X
the	B-X
C-terminal	B-X
NLS	B-X
binding	B-X
site	B-X
of	B-X
importin	B-X
alpha3	B-X
.	B-X
In	B-X
vitro	B-X
competition	B-X
experiments	B-X
and	B-X
analysis	B-X
of	B-X
cellular	B-X
NF-kappaB	B-X
suggest	B-X
that	B-X
NF-kappaB	B-X
binds	B-X
to	B-X
importin	B-X
alpha	B-X
only	B-X
when	B-X
it	B-X
is	B-X
free	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
The	B-X
present	B-X
study	B-X
demonstrates	B-X
that	B-X
the	B-X
nuclear	B-X
import	B-X
of	B-X
NF-kappaB	B-X
is	B-X
a	B-X
highly	B-X
regulated	B-X
process	B-X
mediated	B-X
by	B-X
a	B-X
subset	B-X
of	B-X
importin	B-X
alpha	B-X
molecules	B-X
.	B-X

Importin	B-Gene_or_gene_product
alpha3	I-Gene_or_gene_product
and	O
alpha4	B-Gene_or_gene_product
are	O
close	O
relatives	O
in	O
the	O
human	O
importin	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
family	O
.	O
<EOS>	B-X
We	B-X
identified	B-X
importin	B-X
alpha3	B-X
and	B-X
importin	B-X
alpha4	B-X
as	B-X
the	B-X
main	B-X
importin	B-X
alpha	B-X
isoforms	B-X
mediating	B-X
TNF-alpha-stimulated	B-X
NF-kappaB	B-X
p50/p65	B-X
heterodimer	B-X
translocation	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
Importin	B-X
alpha3	B-X
and	B-X
alpha4	B-X
are	B-X
close	B-X
relatives	B-X
in	B-X
the	B-X
human	B-X
importin	B-X
alpha	B-X
family	B-X
.	B-X
We	B-X
show	B-X
that	B-X
importin	B-X
alpha3	B-X
isoform	B-X
also	B-X
mediates	B-X
nuclear	B-X
import	B-X
of	B-X
NF-kappaB	B-X
p50	B-X
homodimer	B-X
in	B-X
nonstimulated	B-X
cells	B-X
.	B-X
Importin	B-X
alpha3	B-X
is	B-X
shown	B-X
to	B-X
directly	B-X
bind	B-X
to	B-X
previously	B-X
characterized	B-X
nuclear	B-X
localization	B-X
signals	B-X
(	B-X
NLSs	B-X
)	B-X
of	B-X
NF-kappaB	B-X
p50	B-X
and	B-X
p65	B-X
proteins	B-X
.	B-X
Importin	B-X
alpha	B-X
molecules	B-X
are	B-X
known	B-X
to	B-X
have	B-X
armadillo	B-X
repeats	B-X
that	B-X
constitute	B-X
the	B-X
N-terminal	B-X
and	B-X
C-terminal	B-X
NLS	B-X
binding	B-X
sites	B-X
.	B-X
We	B-X
demonstrate	B-X
by	B-X
site-directed	B-X
mutagenesis	B-X
that	B-X
NF-kappaB	B-X
p50	B-X
binds	B-X
to	B-X
the	B-X
N-terminal	B-X
and	B-X
p65	B-X
to	B-X
the	B-X
C-terminal	B-X
NLS	B-X
binding	B-X
site	B-X
of	B-X
importin	B-X
alpha3	B-X
.	B-X
In	B-X
vitro	B-X
competition	B-X
experiments	B-X
and	B-X
analysis	B-X
of	B-X
cellular	B-X
NF-kappaB	B-X
suggest	B-X
that	B-X
NF-kappaB	B-X
binds	B-X
to	B-X
importin	B-X
alpha	B-X
only	B-X
when	B-X
it	B-X
is	B-X
free	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
The	B-X
present	B-X
study	B-X
demonstrates	B-X
that	B-X
the	B-X
nuclear	B-X
import	B-X
of	B-X
NF-kappaB	B-X
is	B-X
a	B-X
highly	B-X
regulated	B-X
process	B-X
mediated	B-X
by	B-X
a	B-X
subset	B-X
of	B-X
importin	B-X
alpha	B-X
molecules	B-X
.	B-X

We	O
show	O
that	O
importin	B-Gene_or_gene_product
alpha3	I-Gene_or_gene_product
isoform	O
also	O
mediates	O
nuclear	O
import	O
of	O
NF	O
-	O
kappaB	O
p50	O
homodimer	O
in	O
nonstimulated	O
cells	O
.	O
<EOS>	B-X
NF-kappaB	B-X
transcription	B-X
factors	B-X
are	B-X
retained	B-X
in	B-X
the	B-X
cytoplasm	B-X
in	B-X
an	B-X
inactive	B-X
form	B-X
until	B-X
they	B-X
are	B-X
activated	B-X
and	B-X
rapidly	B-X
imported	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
We	B-X
identified	B-X
importin	B-X
alpha3	B-X
and	B-X
importin	B-X
alpha4	B-X
as	B-X
the	B-X
main	B-X
importin	B-X
alpha	B-X
isoforms	B-X
mediating	B-X
TNF-alpha-stimulated	B-X
NF-kappaB	B-X
p50/p65	B-X
heterodimer	B-X
translocation	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
Importin	B-X
alpha3	B-X
and	B-X
alpha4	B-X
are	B-X
close	B-X
relatives	B-X
in	B-X
the	B-X
human	B-X
importin	B-X
alpha	B-X
family	B-X
.	B-X
We	B-X
show	B-X
that	B-X
importin	B-X
alpha3	B-X
isoform	B-X
also	B-X
mediates	B-X
nuclear	B-X
import	B-X
of	B-X
NF-kappaB	B-X
p50	B-X
homodimer	B-X
in	B-X
nonstimulated	B-X
cells	B-X
.	B-X
Importin	B-X
alpha3	B-X
is	B-X
shown	B-X
to	B-X
directly	B-X
bind	B-X
to	B-X
previously	B-X
characterized	B-X
nuclear	B-X
localization	B-X
signals	B-X
(	B-X
NLSs	B-X
)	B-X
of	B-X
NF-kappaB	B-X
p50	B-X
and	B-X
p65	B-X
proteins	B-X
.	B-X
We	B-X
demonstrate	B-X
by	B-X
site-directed	B-X
mutagenesis	B-X
that	B-X
NF-kappaB	B-X
p50	B-X
binds	B-X
to	B-X
the	B-X
N-terminal	B-X
and	B-X
p65	B-X
to	B-X
the	B-X
C-terminal	B-X
NLS	B-X
binding	B-X
site	B-X
of	B-X
importin	B-X
alpha3	B-X
.	B-X
In	B-X
vitro	B-X
competition	B-X
experiments	B-X
and	B-X
analysis	B-X
of	B-X
cellular	B-X
NF-kappaB	B-X
suggest	B-X
that	B-X
NF-kappaB	B-X
binds	B-X
to	B-X
importin	B-X
alpha	B-X
only	B-X
when	B-X
it	B-X
is	B-X
free	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
The	B-X
present	B-X
study	B-X
demonstrates	B-X
that	B-X
the	B-X
nuclear	B-X
import	B-X
of	B-X
NF-kappaB	B-X
is	B-X
a	B-X
highly	B-X
regulated	B-X
process	B-X
mediated	B-X
by	B-X
a	B-X
subset	B-X
of	B-X
importin	B-X
alpha	B-X
molecules	B-X
.	B-X

Importin	B-Gene_or_gene_product
alpha3	I-Gene_or_gene_product
is	O
shown	O
to	O
directly	O
bind	O
to	O
previously	O
characterized	O
nuclear	O
localization	O
signals	O
(	O
NLSs	O
)	O
of	O
NF	O
-	O
kappaB	O
p50	B-Gene_or_gene_product
and	O
p65	B-Gene_or_gene_product
proteins	O
.	O
<EOS>	B-X
NF-kappaB	B-X
transcription	B-X
factors	B-X
are	B-X
retained	B-X
in	B-X
the	B-X
cytoplasm	B-X
in	B-X
an	B-X
inactive	B-X
form	B-X
until	B-X
they	B-X
are	B-X
activated	B-X
and	B-X
rapidly	B-X
imported	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
We	B-X
identified	B-X
importin	B-X
alpha3	B-X
and	B-X
importin	B-X
alpha4	B-X
as	B-X
the	B-X
main	B-X
importin	B-X
alpha	B-X
isoforms	B-X
mediating	B-X
TNF-alpha-stimulated	B-X
NF-kappaB	B-X
p50/p65	B-X
heterodimer	B-X
translocation	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
Importin	B-X
alpha3	B-X
and	B-X
alpha4	B-X
are	B-X
close	B-X
relatives	B-X
in	B-X
the	B-X
human	B-X
importin	B-X
alpha	B-X
family	B-X
.	B-X
We	B-X
show	B-X
that	B-X
importin	B-X
alpha3	B-X
isoform	B-X
also	B-X
mediates	B-X
nuclear	B-X
import	B-X
of	B-X
NF-kappaB	B-X
p50	B-X
homodimer	B-X
in	B-X
nonstimulated	B-X
cells	B-X
.	B-X
Importin	B-X
alpha3	B-X
is	B-X
shown	B-X
to	B-X
directly	B-X
bind	B-X
to	B-X
previously	B-X
characterized	B-X
nuclear	B-X
localization	B-X
signals	B-X
(	B-X
NLSs	B-X
)	B-X
of	B-X
NF-kappaB	B-X
p50	B-X
and	B-X
p65	B-X
proteins	B-X
.	B-X
Importin	B-X
alpha	B-X
molecules	B-X
are	B-X
known	B-X
to	B-X
have	B-X
armadillo	B-X
repeats	B-X
that	B-X
constitute	B-X
the	B-X
N-terminal	B-X
and	B-X
C-terminal	B-X
NLS	B-X
binding	B-X
sites	B-X
.	B-X
We	B-X
demonstrate	B-X
by	B-X
site-directed	B-X
mutagenesis	B-X
that	B-X
NF-kappaB	B-X
p50	B-X
binds	B-X
to	B-X
the	B-X
N-terminal	B-X
and	B-X
p65	B-X
to	B-X
the	B-X
C-terminal	B-X
NLS	B-X
binding	B-X
site	B-X
of	B-X
importin	B-X
alpha3	B-X
.	B-X
In	B-X
vitro	B-X
competition	B-X
experiments	B-X
and	B-X
analysis	B-X
of	B-X
cellular	B-X
NF-kappaB	B-X
suggest	B-X
that	B-X
NF-kappaB	B-X
binds	B-X
to	B-X
importin	B-X
alpha	B-X
only	B-X
when	B-X
it	B-X
is	B-X
free	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
The	B-X
present	B-X
study	B-X
demonstrates	B-X
that	B-X
the	B-X
nuclear	B-X
import	B-X
of	B-X
NF-kappaB	B-X
is	B-X
a	B-X
highly	B-X
regulated	B-X
process	B-X
mediated	B-X
by	B-X
a	B-X
subset	B-X
of	B-X
importin	B-X
alpha	B-X
molecules	B-X
.	B-X

Importin	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
molecules	O
are	O
known	O
to	O
have	O
armadillo	O
repeats	O
that	O
constitute	O
the	O
N	O
-	O
terminal	O
and	O
C	O
-	O
terminal	O
NLS	O
binding	O
sites	O
.	O

We	O
demonstrate	O
by	O
site	O
-	O
directed	O
mutagenesis	O
that	O
NF	O
-	O
kappaB	O
p50	B-Gene_or_gene_product
binds	O
to	O
the	O
N	O
-	O
terminal	O
and	O
p65	B-Gene_or_gene_product
to	O
the	O
C	O
-	O
terminal	O
NLS	O
binding	O
site	O
of	O
importin	B-Gene_or_gene_product
alpha3	I-Gene_or_gene_product
.	O

In	O
vitro	O
competition	O
experiments	O
and	O
analysis	O
of	O
cellular	O
NF	O
-	O
kappaB	O
suggest	O
that	O
NF	O
-	O
kappaB	O
binds	O
to	O
importin	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
only	O
when	O
it	O
is	O
free	O
of	O
IkappaBalpha	B-Gene_or_gene_product
.	O
<EOS>	B-X
NF-kappaB	B-X
transcription	B-X
factors	B-X
are	B-X
retained	B-X
in	B-X
the	B-X
cytoplasm	B-X
in	B-X
an	B-X
inactive	B-X
form	B-X
until	B-X
they	B-X
are	B-X
activated	B-X
and	B-X
rapidly	B-X
imported	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
We	B-X
identified	B-X
importin	B-X
alpha3	B-X
and	B-X
importin	B-X
alpha4	B-X
as	B-X
the	B-X
main	B-X
importin	B-X
alpha	B-X
isoforms	B-X
mediating	B-X
TNF-alpha-stimulated	B-X
NF-kappaB	B-X
p50/p65	B-X
heterodimer	B-X
translocation	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
Importin	B-X
alpha3	B-X
and	B-X
alpha4	B-X
are	B-X
close	B-X
relatives	B-X
in	B-X
the	B-X
human	B-X
importin	B-X
alpha	B-X
family	B-X
.	B-X
We	B-X
show	B-X
that	B-X
importin	B-X
alpha3	B-X
isoform	B-X
also	B-X
mediates	B-X
nuclear	B-X
import	B-X
of	B-X
NF-kappaB	B-X
p50	B-X
homodimer	B-X
in	B-X
nonstimulated	B-X
cells	B-X
.	B-X
Importin	B-X
alpha3	B-X
is	B-X
shown	B-X
to	B-X
directly	B-X
bind	B-X
to	B-X
previously	B-X
characterized	B-X
nuclear	B-X
localization	B-X
signals	B-X
(	B-X
NLSs	B-X
)	B-X
of	B-X
NF-kappaB	B-X
p50	B-X
and	B-X
p65	B-X
proteins	B-X
.	B-X
Importin	B-X
alpha	B-X
molecules	B-X
are	B-X
known	B-X
to	B-X
have	B-X
armadillo	B-X
repeats	B-X
that	B-X
constitute	B-X
the	B-X
N-terminal	B-X
and	B-X
C-terminal	B-X
NLS	B-X
binding	B-X
sites	B-X
.	B-X
We	B-X
demonstrate	B-X
by	B-X
site-directed	B-X
mutagenesis	B-X
that	B-X
NF-kappaB	B-X
p50	B-X
binds	B-X
to	B-X
the	B-X
N-terminal	B-X
and	B-X
p65	B-X
to	B-X
the	B-X
C-terminal	B-X
NLS	B-X
binding	B-X
site	B-X
of	B-X
importin	B-X
alpha3	B-X
.	B-X
In	B-X
vitro	B-X
competition	B-X
experiments	B-X
and	B-X
analysis	B-X
of	B-X
cellular	B-X
NF-kappaB	B-X
suggest	B-X
that	B-X
NF-kappaB	B-X
binds	B-X
to	B-X
importin	B-X
alpha	B-X
only	B-X
when	B-X
it	B-X
is	B-X
free	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
The	B-X
present	B-X
study	B-X
demonstrates	B-X
that	B-X
the	B-X
nuclear	B-X
import	B-X
of	B-X
NF-kappaB	B-X
is	B-X
a	B-X
highly	B-X
regulated	B-X
process	B-X
mediated	B-X
by	B-X
a	B-X
subset	B-X
of	B-X
importin	B-X
alpha	B-X
molecules	B-X
.	B-X

The	O
present	O
study	O
demonstrates	O
that	O
the	O
nuclear	O
import	O
of	O
NF	O
-	O
kappaB	O
is	O
a	O
highly	O
regulated	O
process	O
mediated	O
by	O
a	O
subset	O
of	O
importin	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
molecules	O
.	O
<EOS>	B-X
NF-kappaB	B-X
transcription	B-X
factors	B-X
are	B-X
retained	B-X
in	B-X
the	B-X
cytoplasm	B-X
in	B-X
an	B-X
inactive	B-X
form	B-X
until	B-X
they	B-X
are	B-X
activated	B-X
and	B-X
rapidly	B-X
imported	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
We	B-X
identified	B-X
importin	B-X
alpha3	B-X
and	B-X
importin	B-X
alpha4	B-X
as	B-X
the	B-X
main	B-X
importin	B-X
alpha	B-X
isoforms	B-X
mediating	B-X
TNF-alpha-stimulated	B-X
NF-kappaB	B-X
p50/p65	B-X
heterodimer	B-X
translocation	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
Importin	B-X
alpha3	B-X
and	B-X
alpha4	B-X
are	B-X
close	B-X
relatives	B-X
in	B-X
the	B-X
human	B-X
importin	B-X
alpha	B-X
family	B-X
.	B-X
We	B-X
show	B-X
that	B-X
importin	B-X
alpha3	B-X
isoform	B-X
also	B-X
mediates	B-X
nuclear	B-X
import	B-X
of	B-X
NF-kappaB	B-X
p50	B-X
homodimer	B-X
in	B-X
nonstimulated	B-X
cells	B-X
.	B-X
Importin	B-X
alpha3	B-X
is	B-X
shown	B-X
to	B-X
directly	B-X
bind	B-X
to	B-X
previously	B-X
characterized	B-X
nuclear	B-X
localization	B-X
signals	B-X
(	B-X
NLSs	B-X
)	B-X
of	B-X
NF-kappaB	B-X
p50	B-X
and	B-X
p65	B-X
proteins	B-X
.	B-X
Importin	B-X
alpha	B-X
molecules	B-X
are	B-X
known	B-X
to	B-X
have	B-X
armadillo	B-X
repeats	B-X
that	B-X
constitute	B-X
the	B-X
N-terminal	B-X
and	B-X
C-terminal	B-X
NLS	B-X
binding	B-X
sites	B-X
.	B-X
We	B-X
demonstrate	B-X
by	B-X
site-directed	B-X
mutagenesis	B-X
that	B-X
NF-kappaB	B-X
p50	B-X
binds	B-X
to	B-X
the	B-X
N-terminal	B-X
and	B-X
p65	B-X
to	B-X
the	B-X
C-terminal	B-X
NLS	B-X
binding	B-X
site	B-X
of	B-X
importin	B-X
alpha3	B-X
.	B-X
In	B-X
vitro	B-X
competition	B-X
experiments	B-X
and	B-X
analysis	B-X
of	B-X
cellular	B-X
NF-kappaB	B-X
suggest	B-X
that	B-X
NF-kappaB	B-X
binds	B-X
to	B-X
importin	B-X
alpha	B-X
only	B-X
when	B-X
it	B-X
is	B-X
free	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
The	B-X
present	B-X
study	B-X
demonstrates	B-X
that	B-X
the	B-X
nuclear	B-X
import	B-X
of	B-X
NF-kappaB	B-X
is	B-X
a	B-X
highly	B-X
regulated	B-X
process	B-X
mediated	B-X
by	B-X
a	B-X
subset	B-X
of	B-X
importin	B-X
alpha	B-X
molecules	B-X
.	B-X

Regulation	O
of	O
neuron	O
survival	O
and	O
death	O
by	O
p130	B-Gene_or_gene_product
and	O
associated	O
chromatin	O
modifiers	O
.	O
<EOS>	B-X
E2F-mediated	B-X
gene	B-X
repression	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
regulation	B-X
of	B-X
neuron	B-X
survival	B-X
and	B-X
death	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
p130	B-X
is	B-X
the	B-X
predominant	B-X
Rb	B-X
family	B-X
member	B-X
associated	B-X
with	B-X
E2F	B-X
in	B-X
neurons	B-X
,	B-X
that	B-X
its	B-X
major	B-X
partner	B-X
for	B-X
repression	B-X
of	B-X
pro-apoptotic	B-X
genes	B-X
is	B-X
E2F4	B-X
,	B-X
and	B-X
that	B-X
the	B-X
p130-E2F4	B-X
complex	B-X
recruits	B-X
the	B-X
chromatin	B-X
modifiers	B-X
HDAC1	B-X
and	B-X
Suv39H1	B-X
to	B-X
promote	B-X
gene	B-X
silencing	B-X
and	B-X
neuron	B-X
survival	B-X
.	B-X
Apoptotic	B-X
stimuli	B-X
induce	B-X
neuron	B-X
death	B-X
by	B-X
sequentially	B-X
causing	B-X
p130	B-X
hyperphosphorylation	B-X
,	B-X
dissociation	B-X
of	B-X
p130-E2F4-Suv39H1-HDAC	B-X
complexes	B-X
,	B-X
altered	B-X
modification	B-X
of	B-X
H3	B-X
histone	B-X
and	B-X
gene	B-X
derepression	B-X
.	B-X
Experimental	B-X
suppression	B-X
of	B-X
such	B-X
events	B-X
blocks	B-X
neuron	B-X
death	B-X
while	B-X
interference	B-X
with	B-X
the	B-X
synthesis	B-X
of	B-X
E2F4	B-X
or	B-X
p130	B-X
,	B-X
or	B-X
with	B-X
the	B-X
interaction	B-X
of	B-X
E2F4-p130	B-X
with	B-X
chromatin	B-X
modifiers	B-X
,	B-X
induces	B-X
neuron	B-X
death	B-X
.	B-X
Thus	B-X
,	B-X
neuron	B-X
survival	B-X
and	B-X
death	B-X
are	B-X
dependent	B-X
on	B-X
the	B-X
integrity	B-X
of	B-X
E2F4-p130-HDAC/Suv39H1	B-X
complexes	B-X
.	B-X

E2F	B-Gene_or_gene_product
-	O
mediated	O
gene	O
repression	O
plays	O
a	O
key	O
role	O
in	O
regulation	O
of	O
neuron	O
survival	O
and	O
death	O
.	O

However	O
,	O
the	O
key	O
molecules	O
involved	O
in	O
such	O
regulation	O
and	O
the	O
mechanisms	O
by	O
which	O
they	O
respond	O
to	O
apoptotic	O
stimuli	O
are	O
largely	O
unknown	O
.	O
<EOS>	B-X
E2F-mediated	B-X
gene	B-X
repression	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
regulation	B-X
of	B-X
neuron	B-X
survival	B-X
and	B-X
death	B-X
.	B-X
However	B-X
,	B-X
the	B-X
key	B-X
molecules	B-X
involved	B-X
in	B-X
such	B-X
regulation	B-X
and	B-X
the	B-X
mechanisms	B-X
by	B-X
which	B-X
they	B-X
respond	B-X
to	B-X
apoptotic	B-X
stimuli	B-X
are	B-X
largely	B-X
unknown	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
p130	B-X
is	B-X
the	B-X
predominant	B-X
Rb	B-X
family	B-X
member	B-X
associated	B-X
with	B-X
E2F	B-X
in	B-X
neurons	B-X
,	B-X
that	B-X
its	B-X
major	B-X
partner	B-X
for	B-X
repression	B-X
of	B-X
pro-apoptotic	B-X
genes	B-X
is	B-X
E2F4	B-X
,	B-X
and	B-X
that	B-X
the	B-X
p130-E2F4	B-X
complex	B-X
recruits	B-X
the	B-X
chromatin	B-X
modifiers	B-X
HDAC1	B-X
and	B-X
Suv39H1	B-X
to	B-X
promote	B-X
gene	B-X
silencing	B-X
and	B-X
neuron	B-X
survival	B-X
.	B-X
Apoptotic	B-X
stimuli	B-X
induce	B-X
neuron	B-X
death	B-X
by	B-X
sequentially	B-X
causing	B-X
p130	B-X
hyperphosphorylation	B-X
,	B-X
dissociation	B-X
of	B-X
p130-E2F4-Suv39H1-HDAC	B-X
complexes	B-X
,	B-X
altered	B-X
modification	B-X
of	B-X
H3	B-X
histone	B-X
and	B-X
gene	B-X
derepression	B-X
.	B-X

Here	O
we	O
show	O
that	O
p130	B-Gene_or_gene_product
is	O
the	O
predominant	O
Rb	B-Gene_or_gene_product
family	O
member	O
associated	O
with	O
E2F	B-Gene_or_gene_product
in	O
neurons	O
,	O
that	O
its	O
major	O
partner	O
for	O
repression	O
of	O
pro	O
-	O
apoptotic	O
genes	O
is	O
E2F4	B-Gene_or_gene_product
,	O
and	O
that	O
the	O
p130	O
-	O
E2F4	O
complex	O
recruits	O
the	O
chromatin	O
modifiers	O
HDAC1	B-Gene_or_gene_product
and	O
Suv39H1	B-Gene_or_gene_product
to	O
promote	O
gene	O
silencing	O
and	O
neuron	O
survival	O
.	O

Apoptotic	O
stimuli	O
induce	O
neuron	O
death	O
by	O
sequentially	O
causing	O
p130	B-Gene_or_gene_product
hyperphosphorylation	O
,	O
dissociation	O
of	O
p130	O
-	O
E2F4	O
-	O
Suv39H1	O
-	O
HDAC	O
complexes	O
,	O
altered	O
modification	O
of	O
H3	B-Gene_or_gene_product
histone	I-Gene_or_gene_product
and	O
gene	O
derepression	O
.	O
<EOS>	B-X
E2F-mediated	B-X
gene	B-X
repression	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
regulation	B-X
of	B-X
neuron	B-X
survival	B-X
and	B-X
death	B-X
.	B-X
However	B-X
,	B-X
the	B-X
key	B-X
molecules	B-X
involved	B-X
in	B-X
such	B-X
regulation	B-X
and	B-X
the	B-X
mechanisms	B-X
by	B-X
which	B-X
they	B-X
respond	B-X
to	B-X
apoptotic	B-X
stimuli	B-X
are	B-X
largely	B-X
unknown	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
p130	B-X
is	B-X
the	B-X
predominant	B-X
Rb	B-X
family	B-X
member	B-X
associated	B-X
with	B-X
E2F	B-X
in	B-X
neurons	B-X
,	B-X
that	B-X
its	B-X
major	B-X
partner	B-X
for	B-X
repression	B-X
of	B-X
pro-apoptotic	B-X
genes	B-X
is	B-X
E2F4	B-X
,	B-X
and	B-X
that	B-X
the	B-X
p130-E2F4	B-X
complex	B-X
recruits	B-X
the	B-X
chromatin	B-X
modifiers	B-X
HDAC1	B-X
and	B-X
Suv39H1	B-X
to	B-X
promote	B-X
gene	B-X
silencing	B-X
and	B-X
neuron	B-X
survival	B-X
.	B-X
Apoptotic	B-X
stimuli	B-X
induce	B-X
neuron	B-X
death	B-X
by	B-X
sequentially	B-X
causing	B-X
p130	B-X
hyperphosphorylation	B-X
,	B-X
dissociation	B-X
of	B-X
p130-E2F4-Suv39H1-HDAC	B-X
complexes	B-X
,	B-X
altered	B-X
modification	B-X
of	B-X
H3	B-X
histone	B-X
and	B-X
gene	B-X
derepression	B-X
.	B-X
Experimental	B-X
suppression	B-X
of	B-X
such	B-X
events	B-X
blocks	B-X
neuron	B-X
death	B-X
while	B-X
interference	B-X
with	B-X
the	B-X
synthesis	B-X
of	B-X
E2F4	B-X
or	B-X
p130	B-X
,	B-X
or	B-X
with	B-X
the	B-X
interaction	B-X
of	B-X
E2F4-p130	B-X
with	B-X
chromatin	B-X
modifiers	B-X
,	B-X
induces	B-X
neuron	B-X
death	B-X
.	B-X
Thus	B-X
,	B-X
neuron	B-X
survival	B-X
and	B-X
death	B-X
are	B-X
dependent	B-X
on	B-X
the	B-X
integrity	B-X
of	B-X
E2F4-p130-HDAC/Suv39H1	B-X
complexes	B-X
.	B-X

Experimental	O
suppression	O
of	O
such	O
events	O
blocks	O
neuron	O
death	O
while	O
interference	O
with	O
the	O
synthesis	O
of	O
E2F4	B-Gene_or_gene_product
or	O
p130	B-Gene_or_gene_product
,	O
or	O
with	O
the	O
interaction	O
of	O
E2F4	O
-	O
p130	O
with	O
chromatin	O
modifiers	O
,	O
induces	O
neuron	O
death	O
.	O
<EOS>	B-X
The	B-X
modulation	B-X
of	B-X
protein-protein	B-X
interactions	B-X
(	B-X
PPIs	B-X
)	B-X
has	B-X
developed	B-X
into	B-X
a	B-X
well-established	B-X
field	B-X
of	B-X
drug	B-X
discovery	B-X
.	B-X
The	B-X
existence	B-X
of	B-X
a	B-X
retinoblastoma	B-X
family	B-X
of	B-X
proteins	B-X
pRb	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
and	B-X
their	B-X
potential	B-X
unique	B-X
and	B-X
overlapping	B-X
functions	B-X
as	B-X
master	B-X
regulators	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
transcriptional	B-X
modulation	B-X
by	B-X
similar	B-X
processes	B-X
,	B-X
may	B-X
provide	B-X
potential	B-X
clues	B-X
to	B-X
explain	B-X
such	B-X
conundrum	B-X
.	B-X
The	B-X
composition	B-X
of	B-X
DREAM	B-X
is	B-X
temporally	B-X
regulated	B-X
during	B-X
cell	B-X
cycle	B-X
;	B-X
being	B-X
associated	B-X
with	B-X
E2F-4	B-X
and	B-X
either	B-X
p107	B-X
or	B-X
p130	B-X
in	B-X
G0/G1	B-X
(	B-X
repressive	B-X
DREAM	B-X
complexes	B-X
)	B-X
and	B-X
with	B-X
B-myb	B-X
transcription	B-X
factor	B-X
in	B-X
S/G2	B-X
(	B-X
activator	B-X
DREAM	B-X
complex	B-X
)	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
the	B-X
E7	B-X
of	B-X
high	B-X
risk	B-X
HPV	B-X
binds	B-X
to	B-X
pRB	B-X
family	B-X
members	B-X
(	B-X
pRB	B-X
,	B-X
p107	B-X
and	B-X
p130	B-X
)	B-X
for	B-X
degradation	B-X
.	B-X
It	B-X
has	B-X
recently	B-X
been	B-X
discovered	B-X
that	B-X
the	B-X
p107	B-X
and	B-X
p130	B-X
'pocket	B-X
proteins	B-X
'	B-X
are	B-X
members	B-X
of	B-X
mammalian	B-X
DREAM	B-X
complexes	B-X
.	B-X

Thus	O
,	O
neuron	O
survival	O
and	O
death	O
are	O
dependent	O
on	O
the	O
integrity	O
of	O
E2F4	O
-	O
p130	O
-	O
HDAC	O
/	O
Suv39H1	O
complexes	O
.	O
<EOS>	B-X
E2F-mediated	B-X
gene	B-X
repression	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
regulation	B-X
of	B-X
neuron	B-X
survival	B-X
and	B-X
death	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
p130	B-X
is	B-X
the	B-X
predominant	B-X
Rb	B-X
family	B-X
member	B-X
associated	B-X
with	B-X
E2F	B-X
in	B-X
neurons	B-X
,	B-X
that	B-X
its	B-X
major	B-X
partner	B-X
for	B-X
repression	B-X
of	B-X
pro-apoptotic	B-X
genes	B-X
is	B-X
E2F4	B-X
,	B-X
and	B-X
that	B-X
the	B-X
p130-E2F4	B-X
complex	B-X
recruits	B-X
the	B-X
chromatin	B-X
modifiers	B-X
HDAC1	B-X
and	B-X
Suv39H1	B-X
to	B-X
promote	B-X
gene	B-X
silencing	B-X
and	B-X
neuron	B-X
survival	B-X
.	B-X
Apoptotic	B-X
stimuli	B-X
induce	B-X
neuron	B-X
death	B-X
by	B-X
sequentially	B-X
causing	B-X
p130	B-X
hyperphosphorylation	B-X
,	B-X
dissociation	B-X
of	B-X
p130-E2F4-Suv39H1-HDAC	B-X
complexes	B-X
,	B-X
altered	B-X
modification	B-X
of	B-X
H3	B-X
histone	B-X
and	B-X
gene	B-X
derepression	B-X
.	B-X
Experimental	B-X
suppression	B-X
of	B-X
such	B-X
events	B-X
blocks	B-X
neuron	B-X
death	B-X
while	B-X
interference	B-X
with	B-X
the	B-X
synthesis	B-X
of	B-X
E2F4	B-X
or	B-X
p130	B-X
,	B-X
or	B-X
with	B-X
the	B-X
interaction	B-X
of	B-X
E2F4-p130	B-X
with	B-X
chromatin	B-X
modifiers	B-X
,	B-X
induces	B-X
neuron	B-X
death	B-X
.	B-X
Thus	B-X
,	B-X
neuron	B-X
survival	B-X
and	B-X
death	B-X
are	B-X
dependent	B-X
on	B-X
the	B-X
integrity	B-X
of	B-X
E2F4-p130-HDAC/Suv39H1	B-X
complexes	B-X
.	B-X

Production	O
of	O
matrix	B-Gene_or_gene_product
metalloproteinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
by	O
activated	O
human	O
monocytes	O
involves	O
a	O
phosphatidylinositol	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
/	O
Akt	B-Gene_or_gene_product
/	O
IKKalpha	B-Gene_or_gene_product
/	O
NF	O
-	O
kappaB	O
pathway	O
.	O
<EOS>	B-X
Matrix	B-X
metalloproteinase-9	B-X
(	B-X
MMP-9	B-X
)	B-X
is	B-X
considered	B-X
to	B-X
be	B-X
an	B-X
important	B-X
component	B-X
in	B-X
the	B-X
progression	B-X
of	B-X
inflammation	B-X
.	B-X
Monocytes/macrophages	B-X
are	B-X
prominent	B-X
at	B-X
inflammation	B-X
sites	B-X
,	B-X
and	B-X
activation	B-X
of	B-X
these	B-X
cells	B-X
by	B-X
stimulants	B-X
,	B-X
such	B-X
as	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
or	B-X
tumor	B-X
necrosis	B-X
factor	B-X
alpha	B-X
and	B-X
granulocyte	B-X
macrophage-colony	B-X
stimulating	B-X
factor	B-X
,	B-X
leads	B-X
to	B-X
the	B-X
production	B-X
of	B-X
significant	B-X
amounts	B-X
of	B-X
MMP-9	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
LPS	B-X
stimulation	B-X
of	B-X
monocytes	B-X
results	B-X
in	B-X
MMP-9	B-X
production	B-X
through	B-X
a	B-X
phosphatidylinositol-3	B-X
kinase	B-X
(	B-X
PI-3K	B-X
)	B-X
/Akt/inhibitor	B-X
of	B-X
kappaB	B-X
(	B-X
IkappaB	B-X
)	B-X
kinase-alpha	B-X
(	B-X
IKKalpha	B-X
)	B-X
/nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-kappaB	B-X
pathway	B-X
.	B-X
This	B-X
new	B-X
role	B-X
for	B-X
Akt	B-X
in	B-X
signaling	B-X
leading	B-X
to	B-X
MMP-9	B-X
production	B-X
was	B-X
demonstrated	B-X
by	B-X
inhibitor	B-X
and	B-X
immunoprecipitation	B-X
studies	B-X
.	B-X
LY294002	B-X
or	B-X
wortmannin	B-X
,	B-X
inhibitors	B-X
of	B-X
PI-3K	B-X
,	B-X
suppressed	B-X
LPS-induced	B-X
Akt	B-X
activity	B-X
and	B-X
MMP-9	B-X
production	B-X
.	B-X
Evidence	B-X
for	B-X
the	B-X
participation	B-X
of	B-X
Akt	B-X
in	B-X
monocyte	B-X
MMP-9	B-X
synthesis	B-X
was	B-X
demonstrated	B-X
by	B-X
the	B-X
inhibition	B-X
of	B-X
MMP-9	B-X
by	B-X
SH-5	B-X
,	B-X
a	B-X
specific	B-X
inhibitor	B-X
of	B-X
Akt	B-X
.	B-X
The	B-X
mechanism	B-X
by	B-X
which	B-X
Akt	B-X
regulates	B-X
MMP-9	B-X
is	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
,	B-X
as	B-X
shown	B-X
by	B-X
coimmunoprecipitation	B-X
of	B-X
the	B-X
phosphorylated	B-X
form	B-X
of	B-X
IKKalpha	B-X
and	B-X
Akt	B-X
as	B-X
well	B-X
as	B-X
the	B-X
SH-5	B-X
suppression	B-X
of	B-X
the	B-X
dissociation	B-X
of	B-X
IkappaB	B-X
from	B-X
NF-kappaB	B-X
and	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
p65	B-X
.	B-X
The	B-X
role	B-X
of	B-X
NF-kappaB	B-X
in	B-X
regulation	B-X
of	B-X
MMP-9	B-X
was	B-X
demonstrated	B-X
further	B-X
by	B-X
the	B-X
inhibition	B-X
of	B-X
MMP-9	B-X
production	B-X
by	B-X
proteasome	B-X
inhibitors	B-X
,	B-X
lactacystin	B-X
and	B-X
MG-132	B-X
,	B-X
which	B-X
prevented	B-X
the	B-X
ubiquitination	B-X
and	B-X
dissociation	B-X
of	B-X
IkappaB	B-X
from	B-X
NF-kappaB	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
demonstration	B-X
that	B-X
Akt	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
signaling	B-X
pathway	B-X
leading	B-X
to	B-X
the	B-X
production	B-X
of	B-X
monocyte	B-X
MMP-9	B-X
and	B-X
provides	B-X
an	B-X
additional	B-X
approach	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
this	B-X
enzyme	B-X
in	B-X
human	B-X
primary	B-X
monocytes	B-X
.	B-X

Matrix	B-Gene_or_gene_product
metalloproteinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
(	O
MMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
)	O
is	O
considered	O
to	O
be	O
an	O
important	O
component	O
in	O
the	O
progression	O
of	O
inflammation	O
.	O

Monocytes	O
/	O
macrophages	O
are	O
prominent	O
at	O
inflammation	O
sites	O
,	O
and	O
activation	O
of	O
these	O
cells	O
by	O
stimulants	O
,	O
such	O
as	O
lipopolysaccharide	O
(	O
LPS	O
)	O
or	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
granulocyte	B-Gene_or_gene_product
macrophage	I-Gene_or_gene_product
-	I-Gene_or_gene_product
colony	I-Gene_or_gene_product
stimulating	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
,	O
leads	O
to	O
the	O
production	O
of	O
significant	O
amounts	O
of	O
MMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
.	O
<EOS>	B-X
Matrix	B-X
metalloproteinase-9	B-X
(	B-X
MMP-9	B-X
)	B-X
is	B-X
considered	B-X
to	B-X
be	B-X
an	B-X
important	B-X
component	B-X
in	B-X
the	B-X
progression	B-X
of	B-X
inflammation	B-X
.	B-X
Monocytes/macrophages	B-X
are	B-X
prominent	B-X
at	B-X
inflammation	B-X
sites	B-X
,	B-X
and	B-X
activation	B-X
of	B-X
these	B-X
cells	B-X
by	B-X
stimulants	B-X
,	B-X
such	B-X
as	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
or	B-X
tumor	B-X
necrosis	B-X
factor	B-X
alpha	B-X
and	B-X
granulocyte	B-X
macrophage-colony	B-X
stimulating	B-X
factor	B-X
,	B-X
leads	B-X
to	B-X
the	B-X
production	B-X
of	B-X
significant	B-X
amounts	B-X
of	B-X
MMP-9	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
LPS	B-X
stimulation	B-X
of	B-X
monocytes	B-X
results	B-X
in	B-X
MMP-9	B-X
production	B-X
through	B-X
a	B-X
phosphatidylinositol-3	B-X
kinase	B-X
(	B-X
PI-3K	B-X
)	B-X
/Akt/inhibitor	B-X
of	B-X
kappaB	B-X
(	B-X
IkappaB	B-X
)	B-X
kinase-alpha	B-X
(	B-X
IKKalpha	B-X
)	B-X
/nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-kappaB	B-X
pathway	B-X
.	B-X
This	B-X
new	B-X
role	B-X
for	B-X
Akt	B-X
in	B-X
signaling	B-X
leading	B-X
to	B-X
MMP-9	B-X
production	B-X
was	B-X
demonstrated	B-X
by	B-X
inhibitor	B-X
and	B-X
immunoprecipitation	B-X
studies	B-X
.	B-X
LY294002	B-X
or	B-X
wortmannin	B-X
,	B-X
inhibitors	B-X
of	B-X
PI-3K	B-X
,	B-X
suppressed	B-X
LPS-induced	B-X
Akt	B-X
activity	B-X
and	B-X
MMP-9	B-X
production	B-X
.	B-X
Evidence	B-X
for	B-X
the	B-X
participation	B-X
of	B-X
Akt	B-X
in	B-X
monocyte	B-X
MMP-9	B-X
synthesis	B-X
was	B-X
demonstrated	B-X
by	B-X
the	B-X
inhibition	B-X
of	B-X
MMP-9	B-X
by	B-X
SH-5	B-X
,	B-X
a	B-X
specific	B-X
inhibitor	B-X
of	B-X
Akt	B-X
.	B-X
The	B-X
mechanism	B-X
by	B-X
which	B-X
Akt	B-X
regulates	B-X
MMP-9	B-X
is	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
,	B-X
as	B-X
shown	B-X
by	B-X
coimmunoprecipitation	B-X
of	B-X
the	B-X
phosphorylated	B-X
form	B-X
of	B-X
IKKalpha	B-X
and	B-X
Akt	B-X
as	B-X
well	B-X
as	B-X
the	B-X
SH-5	B-X
suppression	B-X
of	B-X
the	B-X
dissociation	B-X
of	B-X
IkappaB	B-X
from	B-X
NF-kappaB	B-X
and	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
p65	B-X
.	B-X
The	B-X
role	B-X
of	B-X
NF-kappaB	B-X
in	B-X
regulation	B-X
of	B-X
MMP-9	B-X
was	B-X
demonstrated	B-X
further	B-X
by	B-X
the	B-X
inhibition	B-X
of	B-X
MMP-9	B-X
production	B-X
by	B-X
proteasome	B-X
inhibitors	B-X
,	B-X
lactacystin	B-X
and	B-X
MG-132	B-X
,	B-X
which	B-X
prevented	B-X
the	B-X
ubiquitination	B-X
and	B-X
dissociation	B-X
of	B-X
IkappaB	B-X
from	B-X
NF-kappaB	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
demonstration	B-X
that	B-X
Akt	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
signaling	B-X
pathway	B-X
leading	B-X
to	B-X
the	B-X
production	B-X
of	B-X
monocyte	B-X
MMP-9	B-X
and	B-X
provides	B-X
an	B-X
additional	B-X
approach	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
this	B-X
enzyme	B-X
in	B-X
human	B-X
primary	B-X
monocytes	B-X
.	B-X

Here	O
,	O
we	O
show	O
that	O
LPS	O
stimulation	O
of	O
monocytes	O
results	O
in	O
MMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
production	O
through	O
a	O
phosphatidylinositol	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
PI	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3K	I-Gene_or_gene_product
)	O
/	O
Akt	B-Gene_or_gene_product
/	O
inhibitor	B-Gene_or_gene_product
of	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
(	I-Gene_or_gene_product
IkappaB	I-Gene_or_gene_product
)	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
(	O
IKKalpha	B-Gene_or_gene_product
)	O
/	O
nuclear	O
factor	O
(	O
NF	O
)	O
-	O
kappaB	O
pathway	O
.	O
<EOS>	B-X
Matrix	B-X
metalloproteinase-9	B-X
(	B-X
MMP-9	B-X
)	B-X
is	B-X
considered	B-X
to	B-X
be	B-X
an	B-X
important	B-X
component	B-X
in	B-X
the	B-X
progression	B-X
of	B-X
inflammation	B-X
.	B-X
Monocytes/macrophages	B-X
are	B-X
prominent	B-X
at	B-X
inflammation	B-X
sites	B-X
,	B-X
and	B-X
activation	B-X
of	B-X
these	B-X
cells	B-X
by	B-X
stimulants	B-X
,	B-X
such	B-X
as	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
or	B-X
tumor	B-X
necrosis	B-X
factor	B-X
alpha	B-X
and	B-X
granulocyte	B-X
macrophage-colony	B-X
stimulating	B-X
factor	B-X
,	B-X
leads	B-X
to	B-X
the	B-X
production	B-X
of	B-X
significant	B-X
amounts	B-X
of	B-X
MMP-9	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
LPS	B-X
stimulation	B-X
of	B-X
monocytes	B-X
results	B-X
in	B-X
MMP-9	B-X
production	B-X
through	B-X
a	B-X
phosphatidylinositol-3	B-X
kinase	B-X
(	B-X
PI-3K	B-X
)	B-X
/Akt/inhibitor	B-X
of	B-X
kappaB	B-X
(	B-X
IkappaB	B-X
)	B-X
kinase-alpha	B-X
(	B-X
IKKalpha	B-X
)	B-X
/nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-kappaB	B-X
pathway	B-X
.	B-X
This	B-X
new	B-X
role	B-X
for	B-X
Akt	B-X
in	B-X
signaling	B-X
leading	B-X
to	B-X
MMP-9	B-X
production	B-X
was	B-X
demonstrated	B-X
by	B-X
inhibitor	B-X
and	B-X
immunoprecipitation	B-X
studies	B-X
.	B-X
LY294002	B-X
or	B-X
wortmannin	B-X
,	B-X
inhibitors	B-X
of	B-X
PI-3K	B-X
,	B-X
suppressed	B-X
LPS-induced	B-X
Akt	B-X
activity	B-X
and	B-X
MMP-9	B-X
production	B-X
.	B-X
Evidence	B-X
for	B-X
the	B-X
participation	B-X
of	B-X
Akt	B-X
in	B-X
monocyte	B-X
MMP-9	B-X
synthesis	B-X
was	B-X
demonstrated	B-X
by	B-X
the	B-X
inhibition	B-X
of	B-X
MMP-9	B-X
by	B-X
SH-5	B-X
,	B-X
a	B-X
specific	B-X
inhibitor	B-X
of	B-X
Akt	B-X
.	B-X
The	B-X
mechanism	B-X
by	B-X
which	B-X
Akt	B-X
regulates	B-X
MMP-9	B-X
is	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
,	B-X
as	B-X
shown	B-X
by	B-X
coimmunoprecipitation	B-X
of	B-X
the	B-X
phosphorylated	B-X
form	B-X
of	B-X
IKKalpha	B-X
and	B-X
Akt	B-X
as	B-X
well	B-X
as	B-X
the	B-X
SH-5	B-X
suppression	B-X
of	B-X
the	B-X
dissociation	B-X
of	B-X
IkappaB	B-X
from	B-X
NF-kappaB	B-X
and	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
p65	B-X
.	B-X
The	B-X
role	B-X
of	B-X
NF-kappaB	B-X
in	B-X
regulation	B-X
of	B-X
MMP-9	B-X
was	B-X
demonstrated	B-X
further	B-X
by	B-X
the	B-X
inhibition	B-X
of	B-X
MMP-9	B-X
production	B-X
by	B-X
proteasome	B-X
inhibitors	B-X
,	B-X
lactacystin	B-X
and	B-X
MG-132	B-X
,	B-X
which	B-X
prevented	B-X
the	B-X
ubiquitination	B-X
and	B-X
dissociation	B-X
of	B-X
IkappaB	B-X
from	B-X
NF-kappaB	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
demonstration	B-X
that	B-X
Akt	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
signaling	B-X
pathway	B-X
leading	B-X
to	B-X
the	B-X
production	B-X
of	B-X
monocyte	B-X
MMP-9	B-X
and	B-X
provides	B-X
an	B-X
additional	B-X
approach	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
this	B-X
enzyme	B-X
in	B-X
human	B-X
primary	B-X
monocytes	B-X
.	B-X

This	O
new	O
role	O
for	O
Akt	B-Gene_or_gene_product
in	O
signaling	O
leading	O
to	O
MMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
production	O
was	O
demonstrated	O
by	O
inhibitor	O
and	O
immunoprecipitation	O
studies	O
.	O
<EOS>	B-X
Matrix	B-X
metalloproteinase-9	B-X
(	B-X
MMP-9	B-X
)	B-X
is	B-X
considered	B-X
to	B-X
be	B-X
an	B-X
important	B-X
component	B-X
in	B-X
the	B-X
progression	B-X
of	B-X
inflammation	B-X
.	B-X
Monocytes/macrophages	B-X
are	B-X
prominent	B-X
at	B-X
inflammation	B-X
sites	B-X
,	B-X
and	B-X
activation	B-X
of	B-X
these	B-X
cells	B-X
by	B-X
stimulants	B-X
,	B-X
such	B-X
as	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
or	B-X
tumor	B-X
necrosis	B-X
factor	B-X
alpha	B-X
and	B-X
granulocyte	B-X
macrophage-colony	B-X
stimulating	B-X
factor	B-X
,	B-X
leads	B-X
to	B-X
the	B-X
production	B-X
of	B-X
significant	B-X
amounts	B-X
of	B-X
MMP-9	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
LPS	B-X
stimulation	B-X
of	B-X
monocytes	B-X
results	B-X
in	B-X
MMP-9	B-X
production	B-X
through	B-X
a	B-X
phosphatidylinositol-3	B-X
kinase	B-X
(	B-X
PI-3K	B-X
)	B-X
/Akt/inhibitor	B-X
of	B-X
kappaB	B-X
(	B-X
IkappaB	B-X
)	B-X
kinase-alpha	B-X
(	B-X
IKKalpha	B-X
)	B-X
/nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-kappaB	B-X
pathway	B-X
.	B-X
This	B-X
new	B-X
role	B-X
for	B-X
Akt	B-X
in	B-X
signaling	B-X
leading	B-X
to	B-X
MMP-9	B-X
production	B-X
was	B-X
demonstrated	B-X
by	B-X
inhibitor	B-X
and	B-X
immunoprecipitation	B-X
studies	B-X
.	B-X
LY294002	B-X
or	B-X
wortmannin	B-X
,	B-X
inhibitors	B-X
of	B-X
PI-3K	B-X
,	B-X
suppressed	B-X
LPS-induced	B-X
Akt	B-X
activity	B-X
and	B-X
MMP-9	B-X
production	B-X
.	B-X
Evidence	B-X
for	B-X
the	B-X
participation	B-X
of	B-X
Akt	B-X
in	B-X
monocyte	B-X
MMP-9	B-X
synthesis	B-X
was	B-X
demonstrated	B-X
by	B-X
the	B-X
inhibition	B-X
of	B-X
MMP-9	B-X
by	B-X
SH-5	B-X
,	B-X
a	B-X
specific	B-X
inhibitor	B-X
of	B-X
Akt	B-X
.	B-X
The	B-X
mechanism	B-X
by	B-X
which	B-X
Akt	B-X
regulates	B-X
MMP-9	B-X
is	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
,	B-X
as	B-X
shown	B-X
by	B-X
coimmunoprecipitation	B-X
of	B-X
the	B-X
phosphorylated	B-X
form	B-X
of	B-X
IKKalpha	B-X
and	B-X
Akt	B-X
as	B-X
well	B-X
as	B-X
the	B-X
SH-5	B-X
suppression	B-X
of	B-X
the	B-X
dissociation	B-X
of	B-X
IkappaB	B-X
from	B-X
NF-kappaB	B-X
and	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
p65	B-X
.	B-X
The	B-X
role	B-X
of	B-X
NF-kappaB	B-X
in	B-X
regulation	B-X
of	B-X
MMP-9	B-X
was	B-X
demonstrated	B-X
further	B-X
by	B-X
the	B-X
inhibition	B-X
of	B-X
MMP-9	B-X
production	B-X
by	B-X
proteasome	B-X
inhibitors	B-X
,	B-X
lactacystin	B-X
and	B-X
MG-132	B-X
,	B-X
which	B-X
prevented	B-X
the	B-X
ubiquitination	B-X
and	B-X
dissociation	B-X
of	B-X
IkappaB	B-X
from	B-X
NF-kappaB	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
demonstration	B-X
that	B-X
Akt	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
signaling	B-X
pathway	B-X
leading	B-X
to	B-X
the	B-X
production	B-X
of	B-X
monocyte	B-X
MMP-9	B-X
and	B-X
provides	B-X
an	B-X
additional	B-X
approach	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
this	B-X
enzyme	B-X
in	B-X
human	B-X
primary	B-X
monocytes	B-X
.	B-X

LY294002	O
or	O
wortmannin	O
,	O
inhibitors	O
of	O
PI	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3K	I-Gene_or_gene_product
,	O
suppressed	O
LPS	O
-	O
induced	O
Akt	B-Gene_or_gene_product
activity	O
and	O
MMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
production	O
.	O
<EOS>	B-X
Aseptic	B-X
loosening	B-X
caused	B-X
by	B-X
peri-implant	B-X
osteolysis	B-X
(	B-X
PIO	B-X
)	B-X
is	B-X
a	B-X
common	B-X
complication	B-X
after	B-X
joint	B-X
replacement	B-X
,	B-X
and	B-X
there	B-X
is	B-X
still	B-X
no	B-X
better	B-X
treatment	B-X
than	B-X
revision	B-X
surgery	B-X
.	B-X
The	B-X
wear	B-X
particle-induced	B-X
inflammation	B-X
response	B-X
,	B-X
especially	B-X
subsequent	B-X
osteoclastic	B-X
bone	B-X
resorption	B-X
,	B-X
is	B-X
responsible	B-X
for	B-X
PIO	B-X
.	B-X
As	B-X
the	B-X
importance	B-X
of	B-X
wear	B-X
particles	B-X
in	B-X
inducing	B-X
autophagy	B-X
in	B-X
cells	B-X
around	B-X
the	B-X
prosthesis	B-X
in	B-X
PIO	B-X
has	B-X
been	B-X
discovered	B-X
,	B-X
this	B-X
might	B-X
be	B-X
a	B-X
central	B-X
process	B-X
underlying	B-X
aseptic	B-X
loosening	B-X
.	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
autophagy	B-X
induced	B-X
by	B-X
wear	B-X
particles	B-X
in	B-X
osteoclastogenesis	B-X
during	B-X
PIO	B-X
remains	B-X
unclear	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
knocking	B-X
down	B-X
the	B-X
Atg5	B-X
gene	B-X
or	B-X
using	B-X
autophagy	B-X
inhibitors	B-X
(	B-X
3-MA	B-X
,	B-X
LY294002	B-X
)	B-X
to	B-X
inhibit	B-X
autophagy	B-X
was	B-X
found	B-X
to	B-X
repress	B-X
osteoclastogenesis	B-X
and	B-X
decrease	B-X
expression	B-X
of	B-X
the	B-X
osteoclast-related	B-X
genes	B-X
TRAP	B-X
,	B-X
cathepsin	B-X
K	B-X
,	B-X
and	B-X
matrix	B-X
metalloprotein	B-X
9	B-X
(	B-X
MMP-9	B-X
)	B-X
with	B-X
or	B-X
without	B-X
titanium	B-X
(	B-X
Ti	B-X
)	B-X
particles	B-X
.	B-X
In	B-X
vivo	B-X
,	B-X
3-MA	B-X
and	B-X
LY294002	B-X
repressed	B-X
Ti	B-X
particle-stimulated	B-X
osteolysis	B-X
and	B-X
osteoclastogenesis	B-X
and	B-X
reduced	B-X
expression	B-X
of	B-X
the	B-X
pro-inflammatory	B-X
factors	B-X
TNF-α	B-X
,	B-X
IL-1β	B-X
,	B-X
and	B-X
IL-6	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
3-MA	B-X
and	B-X
LY294002	B-X
might	B-X
be	B-X
the	B-X
potential	B-X
medicines	B-X
to	B-X
prevent	B-X
and	B-X
treat	B-X
PIO	B-X
and	B-X
aseptic	B-X
loosening	B-X
.	B-X

Evidence	O
for	O
the	O
participation	O
of	O
Akt	B-Gene_or_gene_product
in	O
monocyte	O
MMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
synthesis	O
was	O
demonstrated	O
by	O
the	O
inhibition	O
of	O
MMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
by	O
SH	O
-	O
5	O
,	O
a	O
specific	O
inhibitor	O
of	O
Akt	B-Gene_or_gene_product
.	O

The	O
mechanism	O
by	O
which	O
Akt	B-Gene_or_gene_product
regulates	O
MMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
is	O
through	O
the	O
activation	O
of	O
NF	O
-	O
kappaB	O
,	O
as	O
shown	O
by	O
coimmunoprecipitation	O
of	O
the	O
phosphorylated	O
form	O
of	O
IKKalpha	B-Gene_or_gene_product
and	O
Akt	B-Gene_or_gene_product
as	O
well	O
as	O
the	O
SH	O
-	O
5	O
suppression	O
of	O
the	O
dissociation	O
of	O
IkappaB	B-Gene_or_gene_product
from	O
NF	O
-	O
kappaB	O
and	O
the	O
activation	O
of	O
NF	O
-	O
kappaB	O
p65	B-Gene_or_gene_product
.	O

The	O
role	O
of	O
NF	O
-	O
kappaB	O
in	O
regulation	O
of	O
MMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
was	O
demonstrated	O
further	O
by	O
the	O
inhibition	O
of	O
MMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
production	O
by	O
proteasome	O
inhibitors	O
,	O
lactacystin	O
and	O
MG	O
-	O
132	O
,	O
which	O
prevented	O
the	O
ubiquitination	O
and	O
dissociation	O
of	O
IkappaB	B-Gene_or_gene_product
from	O
NF	O
-	O
kappaB	O
.	O
<EOS>	B-X
Matrix	B-X
metalloproteinase-9	B-X
(	B-X
MMP-9	B-X
)	B-X
is	B-X
considered	B-X
to	B-X
be	B-X
an	B-X
important	B-X
component	B-X
in	B-X
the	B-X
progression	B-X
of	B-X
inflammation	B-X
.	B-X
Monocytes/macrophages	B-X
are	B-X
prominent	B-X
at	B-X
inflammation	B-X
sites	B-X
,	B-X
and	B-X
activation	B-X
of	B-X
these	B-X
cells	B-X
by	B-X
stimulants	B-X
,	B-X
such	B-X
as	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
or	B-X
tumor	B-X
necrosis	B-X
factor	B-X
alpha	B-X
and	B-X
granulocyte	B-X
macrophage-colony	B-X
stimulating	B-X
factor	B-X
,	B-X
leads	B-X
to	B-X
the	B-X
production	B-X
of	B-X
significant	B-X
amounts	B-X
of	B-X
MMP-9	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
LPS	B-X
stimulation	B-X
of	B-X
monocytes	B-X
results	B-X
in	B-X
MMP-9	B-X
production	B-X
through	B-X
a	B-X
phosphatidylinositol-3	B-X
kinase	B-X
(	B-X
PI-3K	B-X
)	B-X
/Akt/inhibitor	B-X
of	B-X
kappaB	B-X
(	B-X
IkappaB	B-X
)	B-X
kinase-alpha	B-X
(	B-X
IKKalpha	B-X
)	B-X
/nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-kappaB	B-X
pathway	B-X
.	B-X
This	B-X
new	B-X
role	B-X
for	B-X
Akt	B-X
in	B-X
signaling	B-X
leading	B-X
to	B-X
MMP-9	B-X
production	B-X
was	B-X
demonstrated	B-X
by	B-X
inhibitor	B-X
and	B-X
immunoprecipitation	B-X
studies	B-X
.	B-X
LY294002	B-X
or	B-X
wortmannin	B-X
,	B-X
inhibitors	B-X
of	B-X
PI-3K	B-X
,	B-X
suppressed	B-X
LPS-induced	B-X
Akt	B-X
activity	B-X
and	B-X
MMP-9	B-X
production	B-X
.	B-X
Evidence	B-X
for	B-X
the	B-X
participation	B-X
of	B-X
Akt	B-X
in	B-X
monocyte	B-X
MMP-9	B-X
synthesis	B-X
was	B-X
demonstrated	B-X
by	B-X
the	B-X
inhibition	B-X
of	B-X
MMP-9	B-X
by	B-X
SH-5	B-X
,	B-X
a	B-X
specific	B-X
inhibitor	B-X
of	B-X
Akt	B-X
.	B-X
The	B-X
mechanism	B-X
by	B-X
which	B-X
Akt	B-X
regulates	B-X
MMP-9	B-X
is	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
,	B-X
as	B-X
shown	B-X
by	B-X
coimmunoprecipitation	B-X
of	B-X
the	B-X
phosphorylated	B-X
form	B-X
of	B-X
IKKalpha	B-X
and	B-X
Akt	B-X
as	B-X
well	B-X
as	B-X
the	B-X
SH-5	B-X
suppression	B-X
of	B-X
the	B-X
dissociation	B-X
of	B-X
IkappaB	B-X
from	B-X
NF-kappaB	B-X
and	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
p65	B-X
.	B-X
The	B-X
role	B-X
of	B-X
NF-kappaB	B-X
in	B-X
regulation	B-X
of	B-X
MMP-9	B-X
was	B-X
demonstrated	B-X
further	B-X
by	B-X
the	B-X
inhibition	B-X
of	B-X
MMP-9	B-X
production	B-X
by	B-X
proteasome	B-X
inhibitors	B-X
,	B-X
lactacystin	B-X
and	B-X
MG-132	B-X
,	B-X
which	B-X
prevented	B-X
the	B-X
ubiquitination	B-X
and	B-X
dissociation	B-X
of	B-X
IkappaB	B-X
from	B-X
NF-kappaB	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
demonstration	B-X
that	B-X
Akt	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
signaling	B-X
pathway	B-X
leading	B-X
to	B-X
the	B-X
production	B-X
of	B-X
monocyte	B-X
MMP-9	B-X
and	B-X
provides	B-X
an	B-X
additional	B-X
approach	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
this	B-X
enzyme	B-X
in	B-X
human	B-X
primary	B-X
monocytes	B-X
.	B-X

This	O
is	O
the	O
first	O
demonstration	O
that	O
Akt	B-Gene_or_gene_product
is	O
involved	O
in	O
the	O
signaling	O
pathway	O
leading	O
to	O
the	O
production	O
of	O
monocyte	O
MMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
and	O
provides	O
an	O
additional	O
approach	O
in	O
the	O
regulation	O
of	O
this	O
enzyme	O
in	O
human	O
primary	O
monocytes	O
.	O

Phosphorylation	O
and	O
functional	O
inactivation	O
of	O
TSC2	B-Gene_or_gene_product
by	O
Erk	B-Gene_or_gene_product
implications	O
for	O
tuberous	O
sclerosis	O
and	O
cancer	O
pathogenesis	O
.	O
<EOS>	B-X
Tuberous	B-X
sclerosis	B-X
(	B-X
TSC	B-X
)	B-X
is	B-X
a	B-X
tumor	B-X
syndrome	B-X
caused	B-X
by	B-X
mutation	B-X
in	B-X
TSC1	B-X
or	B-X
TSC2	B-X
genes	B-X
.	B-X
Recently	B-X
,	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
Erk	B-X
)	B-X
has	B-X
been	B-X
found	B-X
activated	B-X
in	B-X
TSC	B-X
lesions	B-X
lacking	B-X
TSC1	B-X
or	B-X
TSC2	B-X
LOH	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Erk	B-X
may	B-X
play	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
TSC	B-X
progression	B-X
through	B-X
posttranslational	B-X
inactivation	B-X
of	B-X
TSC2	B-X
.	B-X
Erk-dependent	B-X
phosphorylation	B-X
leads	B-X
to	B-X
TSC1-TSC2	B-X
dissociation	B-X
and	B-X
markedly	B-X
impairs	B-X
TSC2	B-X
ability	B-X
to	B-X
inhibit	B-X
mTOR	B-X
signaling	B-X
,	B-X
cell	B-X
proliferation	B-X
,	B-X
and	B-X
oncogenic	B-X
transformation	B-X
.	B-X
Importantly	B-X
,	B-X
expression	B-X
of	B-X
an	B-X
Erk	B-X
nonphosphorylatable	B-X
TSC2	B-X
mutant	B-X
in	B-X
TSC2+/-	B-X
tumor	B-X
cells	B-X
where	B-X
Erk	B-X
is	B-X
constitutively	B-X
activated	B-X
blocks	B-X
tumorigenecity	B-X
in	B-X
vivo	B-X
,	B-X
while	B-X
wild-type	B-X
TSC2	B-X
is	B-X
ineffective	B-X
.	B-X
Our	B-X
findings	B-X
position	B-X
the	B-X
Ras/MAPK	B-X
pathway	B-X
upstream	B-X
of	B-X
the	B-X
TSC	B-X
complex	B-X
and	B-X
suggest	B-X
that	B-X
Erk	B-X
may	B-X
modulate	B-X
mTOR	B-X
signaling	B-X
and	B-X
contribute	B-X
to	B-X
disease	B-X
progression	B-X
through	B-X
phosphorylation	B-X
and	B-X
inactivation	B-X
of	B-X
TSC2	B-X
.	B-X

Tuberous	O
sclerosis	O
(	O
TSC	O
)	O
is	O
a	O
tumor	O
syndrome	O
caused	O
by	O
mutation	O
in	O
TSC1	B-Gene_or_gene_product
or	O
TSC2	B-Gene_or_gene_product
genes	O
.	O
<EOS>	B-X
Tuberous	B-X
sclerosis	B-X
complex	B-X
(	B-X
TSC	B-X
)	B-X
is	B-X
a	B-X
neurocutaneous	B-X
syndrome	B-X
that	B-X
can	B-X
present	B-X
at	B-X
any	B-X
age	B-X
and	B-X
can	B-X
affect	B-X
multiple	B-X
organ	B-X
systems	B-X
.	B-X
Tuberous	B-X
sclerosis	B-X
complex	B-X
is	B-X
a	B-X
genetic	B-X
disorder	B-X
caused	B-X
by	B-X
a	B-X
mutation	B-X
in	B-X
either	B-X
the	B-X
TSC1	B-X
or	B-X
TSC2	B-X
gene	B-X
leading	B-X
to	B-X
dysfunction	B-X
of	B-X
hamartin	B-X
or	B-X
tuberin	B-X
,	B-X
respectively	B-X
.	B-X
Specific	B-X
guidelines	B-X
for	B-X
diagnosis	B-X
,	B-X
surveillance	B-X
,	B-X
and	B-X
management	B-X
have	B-X
been	B-X
proposed	B-X
by	B-X
the	B-X
International	B-X
Tuberous	B-X
Sclerosis	B-X
Complex	B-X
Consensus	B-X
Group	B-X
.	B-X
Treatment	B-X
of	B-X
tuberous	B-X
sclerosis	B-X
complex	B-X
is	B-X
in	B-X
part	B-X
symptomatic	B-X
;	B-X
however	B-X
,	B-X
for	B-X
certain	B-X
clinical	B-X
manifestations	B-X
,	B-X
specific	B-X
treatments	B-X
may	B-X
be	B-X
indicated	B-X
.	B-X

TSC	O
tumorigenesis	O
is	O
not	O
always	O
accompanied	O
by	O
loss	O
of	O
heterozygosity	O
(	O
LOH	O
)	O
.	O
<EOS>	B-X
We	B-X
generated	B-X
a	B-X
human	B-X
cerebral	B-X
organoid	B-X
model	B-X
for	B-X
tuberous	B-X
sclerosis	B-X
complex	B-X
(	B-X
TSC	B-X
)	B-X
and	B-X
identified	B-X
a	B-X
specific	B-X
neural	B-X
stem	B-X
cell	B-X
type	B-X
,	B-X
caudal	B-X
late	B-X
interneuron	B-X
progenitor	B-X
(	B-X
CLIP	B-X
)	B-X
cells	B-X
.	B-X
In	B-X
TSC	B-X
,	B-X
CLIP	B-X
cells	B-X
over-proliferate	B-X
,	B-X
generating	B-X
excessive	B-X
interneurons	B-X
,	B-X
brain	B-X
tumors	B-X
,	B-X
and	B-X
cortical	B-X
malformations	B-X
.	B-X
Epidermal	B-X
growth	B-X
factor	B-X
receptor	B-X
inhibition	B-X
reduces	B-X
tumor	B-X
burden	B-X
,	B-X
identifying	B-X
potential	B-X
treatment	B-X
options	B-X
for	B-X
TSC	B-X
and	B-X
related	B-X
disorders	B-X
.	B-X
Tumor-initiating	B-X
stem	B-X
cells	B-X
(	B-X
TSCs	B-X
)	B-X
are	B-X
critical	B-X
for	B-X
drug	B-X
resistance	B-X
and	B-X
immune	B-X
escape	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mutual	B-X
regulations	B-X
between	B-X
TSC	B-X
and	B-X
tumor	B-X
microenvironment	B-X
(	B-X
TME	B-X
)	B-X
remain	B-X
unclear	B-X
.	B-X
Using	B-X
DNA-label	B-X
retaining	B-X
,	B-X
single-cell	B-X
RNA	B-X
sequencing	B-X
(	B-X
scRNA-seq	B-X
)	B-X
,	B-X
and	B-X
other	B-X
approaches	B-X
,	B-X
we	B-X
investigated	B-X
intestinal	B-X
adenoma	B-X
in	B-X
response	B-X
to	B-X
chemoradiotherapy	B-X
(	B-X
CRT	B-X
)	B-X
,	B-X
thus	B-X
identifying	B-X
therapy-resistant	B-X
TSCs	B-X
(	B-X
TrTSCs	B-X
)	B-X
.	B-X
We	B-X
find	B-X
bidirectional	B-X
crosstalk	B-X
between	B-X
TSCs	B-X
and	B-X
TME	B-X
using	B-X
CellPhoneDB	B-X
analysis	B-X
.	B-X
An	B-X
intriguing	B-X
finding	B-X
is	B-X
that	B-X
TSCs	B-X
shape	B-X
TME	B-X
into	B-X
a	B-X
landscape	B-X
that	B-X
favors	B-X
TSCs	B-X
for	B-X
immunosuppression	B-X
and	B-X
propagation	B-X
.	B-X
Using	B-X
adenoma-organoid	B-X
co-cultures	B-X
,	B-X
niche-cell	B-X
depletion	B-X
,	B-X
and	B-X
lineaging	B-X
tracing	B-X
,	B-X
we	B-X
characterize	B-X
a	B-X
functional	B-X
role	B-X
of	B-X
cyclooxygenase-2	B-X
(	B-X
Cox-2	B-X
)	B-X
-dependent	B-X
signaling	B-X
,	B-X
predominantly	B-X
occurring	B-X
between	B-X
tumor-associated	B-X
monocytes	B-X
and	B-X
macrophages	B-X
(	B-X
TAMMs	B-X
)	B-X
and	B-X
TrTSCs	B-X
.	B-X
We	B-X
show	B-X
that	B-X
TAMMs	B-X
promote	B-X
TrTSC	B-X
proliferation	B-X
through	B-X
prostaglandin	B-X
E2	B-X
(	B-X
PGE2	B-X
)	B-X
-PTGER4	B-X
(	B-X
EP4	B-X
)	B-X
signaling	B-X
,	B-X
which	B-X
enhances	B-X
β-catenin	B-X
activity	B-X
via	B-X
AKT	B-X
phosphorylation	B-X
.	B-X
Thus	B-X
,	B-X
our	B-X
study	B-X
shows	B-X
that	B-X
the	B-X
bidirectional	B-X
crosstalk	B-X
between	B-X
TrTSC	B-X
and	B-X
TME	B-X
results	B-X
in	B-X
a	B-X
pro-tumorigenic	B-X
and	B-X
immunosuppressive	B-X
contexture	B-X
.	B-X

Recently	O
,	O
extracellular	B-Gene_or_gene_product
signal	I-Gene_or_gene_product
-	I-Gene_or_gene_product
regulated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
Erk	B-Gene_or_gene_product
)	O
has	O
been	O
found	O
activated	O
in	O
TSC	O
lesions	O
lacking	O
TSC1	B-Gene_or_gene_product
or	O
TSC2	B-Gene_or_gene_product
LOH	O
.	O
<EOS>	B-X
Tuberous	B-X
sclerosis	B-X
complex	B-X
(	B-X
TSC	B-X
)	B-X
is	B-X
an	B-X
autosomal	B-X
dominant	B-X
monogenetic	B-X
disorder	B-X
that	B-X
is	B-X
characterized	B-X
by	B-X
the	B-X
formation	B-X
of	B-X
benign	B-X
tumors	B-X
in	B-X
several	B-X
organs	B-X
as	B-X
well	B-X
as	B-X
brain	B-X
malformations	B-X
and	B-X
neuronal	B-X
defects	B-X
.	B-X
TSC	B-X
is	B-X
caused	B-X
by	B-X
inactivating	B-X
mutations	B-X
in	B-X
one	B-X
of	B-X
two	B-X
genes	B-X
,	B-X
TSC1	B-X
and	B-X
TSC2	B-X
,	B-X
resulting	B-X
in	B-X
increased	B-X
activity	B-X
of	B-X
the	B-X
mammalian	B-X
Target	B-X
of	B-X
Rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
explore	B-X
the	B-X
cytoarchitectural	B-X
and	B-X
functional	B-X
CNS	B-X
aberrations	B-X
that	B-X
may	B-X
account	B-X
for	B-X
the	B-X
neurological	B-X
presentations	B-X
of	B-X
TSC	B-X
,	B-X
notably	B-X
seizures	B-X
,	B-X
hydrocephalus	B-X
,	B-X
and	B-X
cognitive	B-X
and	B-X
psychological	B-X
impairments	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
recent	B-X
mouse	B-X
models	B-X
of	B-X
brain	B-X
lesions	B-X
are	B-X
presented	B-X
with	B-X
an	B-X
emphasis	B-X
on	B-X
using	B-X
electroporation	B-X
to	B-X
allow	B-X
the	B-X
generation	B-X
of	B-X
discrete	B-X
lesions	B-X
resulting	B-X
from	B-X
loss	B-X
of	B-X
heterozygosity	B-X
during	B-X
perinatal	B-X
development	B-X
.	B-X
Cortical	B-X
lesions	B-X
are	B-X
thought	B-X
to	B-X
contribute	B-X
to	B-X
epileptogenesis	B-X
and	B-X
worsening	B-X
of	B-X
cognitive	B-X
defects	B-X
.	B-X
However	B-X
,	B-X
it	B-X
has	B-X
recently	B-X
been	B-X
suggested	B-X
that	B-X
being	B-X
born	B-X
with	B-X
a	B-X
mutant	B-X
allele	B-X
without	B-X
loss	B-X
of	B-X
heterozygosity	B-X
and	B-X
associated	B-X
cortical	B-X
lesions	B-X
is	B-X
sufficient	B-X
to	B-X
generate	B-X
cognitive	B-X
and	B-X
neuropsychiatric	B-X
problems	B-X
.	B-X
Ultimately	B-X
,	B-X
a	B-X
major	B-X
goal	B-X
of	B-X
TSC	B-X
research	B-X
is	B-X
to	B-X
identify	B-X
the	B-X
cellular	B-X
and	B-X
molecular	B-X
mechanisms	B-X
downstream	B-X
of	B-X
mTOR	B-X
underlying	B-X
the	B-X
neurological	B-X
manifestations	B-X
observed	B-X
in	B-X
TSC	B-X
patients	B-X
and	B-X
identify	B-X
novel	B-X
therapeutic	B-X
targets	B-X
to	B-X
prevent	B-X
the	B-X
formation	B-X
of	B-X
brain	B-X
lesions	B-X
and	B-X
restore	B-X
neuronal	B-X
function	B-X
.	B-X

Here	O
,	O
we	O
show	O
that	O
Erk	B-Gene_or_gene_product
may	O
play	O
a	O
critical	O
role	O
in	O
TSC	O
progression	O
through	O
posttranslational	O
inactivation	O
of	O
TSC2	B-Gene_or_gene_product
.	O
<EOS>	B-X
Tuberous	B-X
sclerosis	B-X
(	B-X
TSC	B-X
)	B-X
is	B-X
a	B-X
tumor	B-X
syndrome	B-X
caused	B-X
by	B-X
mutation	B-X
in	B-X
TSC1	B-X
or	B-X
TSC2	B-X
genes	B-X
.	B-X
TSC	B-X
tumorigenesis	B-X
is	B-X
not	B-X
always	B-X
accompanied	B-X
by	B-X
loss	B-X
of	B-X
heterozygosity	B-X
(	B-X
LOH	B-X
)	B-X
.	B-X
Recently	B-X
,	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
Erk	B-X
)	B-X
has	B-X
been	B-X
found	B-X
activated	B-X
in	B-X
TSC	B-X
lesions	B-X
lacking	B-X
TSC1	B-X
or	B-X
TSC2	B-X
LOH	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Erk	B-X
may	B-X
play	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
TSC	B-X
progression	B-X
through	B-X
posttranslational	B-X
inactivation	B-X
of	B-X
TSC2	B-X
.	B-X
Erk-dependent	B-X
phosphorylation	B-X
leads	B-X
to	B-X
TSC1-TSC2	B-X
dissociation	B-X
and	B-X
markedly	B-X
impairs	B-X
TSC2	B-X
ability	B-X
to	B-X
inhibit	B-X
mTOR	B-X
signaling	B-X
,	B-X
cell	B-X
proliferation	B-X
,	B-X
and	B-X
oncogenic	B-X
transformation	B-X
.	B-X
Importantly	B-X
,	B-X
expression	B-X
of	B-X
an	B-X
Erk	B-X
nonphosphorylatable	B-X
TSC2	B-X
mutant	B-X
in	B-X
TSC2+/-	B-X
tumor	B-X
cells	B-X
where	B-X
Erk	B-X
is	B-X
constitutively	B-X
activated	B-X
blocks	B-X
tumorigenecity	B-X
in	B-X
vivo	B-X
,	B-X
while	B-X
wild-type	B-X
TSC2	B-X
is	B-X
ineffective	B-X
.	B-X
Our	B-X
findings	B-X
position	B-X
the	B-X
Ras/MAPK	B-X
pathway	B-X
upstream	B-X
of	B-X
the	B-X
TSC	B-X
complex	B-X
and	B-X
suggest	B-X
that	B-X
Erk	B-X
may	B-X
modulate	B-X
mTOR	B-X
signaling	B-X
and	B-X
contribute	B-X
to	B-X
disease	B-X
progression	B-X
through	B-X
phosphorylation	B-X
and	B-X
inactivation	B-X
of	B-X
TSC2	B-X
.	B-X

Erk	B-Gene_or_gene_product
-	O
dependent	O
phosphorylation	O
leads	O
to	O
TSC1	O
-	O
TSC2	O
dissociation	O
and	O
markedly	O
impairs	O
TSC2	B-Gene_or_gene_product
ability	O
to	O
inhibit	O
mTOR	B-Gene_or_gene_product
signaling	O
,	O
cell	O
proliferation	O
,	O
and	O
oncogenic	O
transformation	O
.	O
<EOS>	B-X
Tuberous	B-X
sclerosis	B-X
(	B-X
TSC	B-X
)	B-X
is	B-X
a	B-X
tumor	B-X
syndrome	B-X
caused	B-X
by	B-X
mutation	B-X
in	B-X
TSC1	B-X
or	B-X
TSC2	B-X
genes	B-X
.	B-X
Recently	B-X
,	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
Erk	B-X
)	B-X
has	B-X
been	B-X
found	B-X
activated	B-X
in	B-X
TSC	B-X
lesions	B-X
lacking	B-X
TSC1	B-X
or	B-X
TSC2	B-X
LOH	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Erk	B-X
may	B-X
play	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
TSC	B-X
progression	B-X
through	B-X
posttranslational	B-X
inactivation	B-X
of	B-X
TSC2	B-X
.	B-X
Erk-dependent	B-X
phosphorylation	B-X
leads	B-X
to	B-X
TSC1-TSC2	B-X
dissociation	B-X
and	B-X
markedly	B-X
impairs	B-X
TSC2	B-X
ability	B-X
to	B-X
inhibit	B-X
mTOR	B-X
signaling	B-X
,	B-X
cell	B-X
proliferation	B-X
,	B-X
and	B-X
oncogenic	B-X
transformation	B-X
.	B-X
Importantly	B-X
,	B-X
expression	B-X
of	B-X
an	B-X
Erk	B-X
nonphosphorylatable	B-X
TSC2	B-X
mutant	B-X
in	B-X
TSC2+/-	B-X
tumor	B-X
cells	B-X
where	B-X
Erk	B-X
is	B-X
constitutively	B-X
activated	B-X
blocks	B-X
tumorigenecity	B-X
in	B-X
vivo	B-X
,	B-X
while	B-X
wild-type	B-X
TSC2	B-X
is	B-X
ineffective	B-X
.	B-X
Our	B-X
findings	B-X
position	B-X
the	B-X
Ras/MAPK	B-X
pathway	B-X
upstream	B-X
of	B-X
the	B-X
TSC	B-X
complex	B-X
and	B-X
suggest	B-X
that	B-X
Erk	B-X
may	B-X
modulate	B-X
mTOR	B-X
signaling	B-X
and	B-X
contribute	B-X
to	B-X
disease	B-X
progression	B-X
through	B-X
phosphorylation	B-X
and	B-X
inactivation	B-X
of	B-X
TSC2	B-X
.	B-X

Importantly	O
,	O
expression	O
of	O
an	O
Erk	B-Gene_or_gene_product
nonphosphorylatable	O
TSC2	B-Gene_or_gene_product
mutant	O
in	O
TSC2	B-Gene_or_gene_product
+	O
/	O
-	O
tumor	O
cells	O
where	O
Erk	B-Gene_or_gene_product
is	O
constitutively	O
activated	O
blocks	O
tumorigenecity	O
in	O
vivo	O
,	O
while	O
wild	O
-	O
type	O
TSC2	B-Gene_or_gene_product
is	O
ineffective	O
.	O
<EOS>	B-X
Tuberous	B-X
sclerosis	B-X
(	B-X
TSC	B-X
)	B-X
is	B-X
a	B-X
tumor	B-X
syndrome	B-X
caused	B-X
by	B-X
mutation	B-X
in	B-X
TSC1	B-X
or	B-X
TSC2	B-X
genes	B-X
.	B-X
TSC	B-X
tumorigenesis	B-X
is	B-X
not	B-X
always	B-X
accompanied	B-X
by	B-X
loss	B-X
of	B-X
heterozygosity	B-X
(	B-X
LOH	B-X
)	B-X
.	B-X
Recently	B-X
,	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
Erk	B-X
)	B-X
has	B-X
been	B-X
found	B-X
activated	B-X
in	B-X
TSC	B-X
lesions	B-X
lacking	B-X
TSC1	B-X
or	B-X
TSC2	B-X
LOH	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Erk	B-X
may	B-X
play	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
TSC	B-X
progression	B-X
through	B-X
posttranslational	B-X
inactivation	B-X
of	B-X
TSC2	B-X
.	B-X
Erk-dependent	B-X
phosphorylation	B-X
leads	B-X
to	B-X
TSC1-TSC2	B-X
dissociation	B-X
and	B-X
markedly	B-X
impairs	B-X
TSC2	B-X
ability	B-X
to	B-X
inhibit	B-X
mTOR	B-X
signaling	B-X
,	B-X
cell	B-X
proliferation	B-X
,	B-X
and	B-X
oncogenic	B-X
transformation	B-X
.	B-X
Importantly	B-X
,	B-X
expression	B-X
of	B-X
an	B-X
Erk	B-X
nonphosphorylatable	B-X
TSC2	B-X
mutant	B-X
in	B-X
TSC2+/-	B-X
tumor	B-X
cells	B-X
where	B-X
Erk	B-X
is	B-X
constitutively	B-X
activated	B-X
blocks	B-X
tumorigenecity	B-X
in	B-X
vivo	B-X
,	B-X
while	B-X
wild-type	B-X
TSC2	B-X
is	B-X
ineffective	B-X
.	B-X
Our	B-X
findings	B-X
position	B-X
the	B-X
Ras/MAPK	B-X
pathway	B-X
upstream	B-X
of	B-X
the	B-X
TSC	B-X
complex	B-X
and	B-X
suggest	B-X
that	B-X
Erk	B-X
may	B-X
modulate	B-X
mTOR	B-X
signaling	B-X
and	B-X
contribute	B-X
to	B-X
disease	B-X
progression	B-X
through	B-X
phosphorylation	B-X
and	B-X
inactivation	B-X
of	B-X
TSC2	B-X
.	B-X

Our	O
findings	O
position	O
the	O
Ras	B-Gene_or_gene_product
/	O
MAPK	B-Gene_or_gene_product
pathway	O
upstream	O
of	O
the	O
TSC	O
complex	O
and	O
suggest	O
that	O
Erk	B-Gene_or_gene_product
may	O
modulate	O
mTOR	B-Gene_or_gene_product
signaling	O
and	O
contribute	O
to	O
disease	O
progression	O
through	O
phosphorylation	O
and	O
inactivation	O
of	O
TSC2	B-Gene_or_gene_product
.	O
<EOS>	B-X
Tuberous	B-X
sclerosis	B-X
(	B-X
TSC	B-X
)	B-X
is	B-X
a	B-X
tumor	B-X
syndrome	B-X
caused	B-X
by	B-X
mutation	B-X
in	B-X
TSC1	B-X
or	B-X
TSC2	B-X
genes	B-X
.	B-X
TSC	B-X
tumorigenesis	B-X
is	B-X
not	B-X
always	B-X
accompanied	B-X
by	B-X
loss	B-X
of	B-X
heterozygosity	B-X
(	B-X
LOH	B-X
)	B-X
.	B-X
Recently	B-X
,	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
Erk	B-X
)	B-X
has	B-X
been	B-X
found	B-X
activated	B-X
in	B-X
TSC	B-X
lesions	B-X
lacking	B-X
TSC1	B-X
or	B-X
TSC2	B-X
LOH	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Erk	B-X
may	B-X
play	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
TSC	B-X
progression	B-X
through	B-X
posttranslational	B-X
inactivation	B-X
of	B-X
TSC2	B-X
.	B-X
Erk-dependent	B-X
phosphorylation	B-X
leads	B-X
to	B-X
TSC1-TSC2	B-X
dissociation	B-X
and	B-X
markedly	B-X
impairs	B-X
TSC2	B-X
ability	B-X
to	B-X
inhibit	B-X
mTOR	B-X
signaling	B-X
,	B-X
cell	B-X
proliferation	B-X
,	B-X
and	B-X
oncogenic	B-X
transformation	B-X
.	B-X
Importantly	B-X
,	B-X
expression	B-X
of	B-X
an	B-X
Erk	B-X
nonphosphorylatable	B-X
TSC2	B-X
mutant	B-X
in	B-X
TSC2+/-	B-X
tumor	B-X
cells	B-X
where	B-X
Erk	B-X
is	B-X
constitutively	B-X
activated	B-X
blocks	B-X
tumorigenecity	B-X
in	B-X
vivo	B-X
,	B-X
while	B-X
wild-type	B-X
TSC2	B-X
is	B-X
ineffective	B-X
.	B-X
Our	B-X
findings	B-X
position	B-X
the	B-X
Ras/MAPK	B-X
pathway	B-X
upstream	B-X
of	B-X
the	B-X
TSC	B-X
complex	B-X
and	B-X
suggest	B-X
that	B-X
Erk	B-X
may	B-X
modulate	B-X
mTOR	B-X
signaling	B-X
and	B-X
contribute	B-X
to	B-X
disease	B-X
progression	B-X
through	B-X
phosphorylation	B-X
and	B-X
inactivation	B-X
of	B-X
TSC2	B-X
.	B-X

H19	B-Gene_or_gene_product
mRNA	O
-	O
like	O
noncoding	O
RNA	O
promotes	O
breast	O
cancer	O
cell	O
proliferation	O
through	O
positive	O
control	O
by	O
E2F1	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
imprinted	B-X
H19	B-X
gene	B-X
has	B-X
riboregulatory	B-X
functions	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
H19	B-X
transcription	B-X
is	B-X
up-regulated	B-X
during	B-X
the	B-X
S-phase	B-X
of	B-X
growth-stimulated	B-X
cells	B-X
and	B-X
that	B-X
the	B-X
H19	B-X
promoter	B-X
is	B-X
activated	B-X
by	B-X
E2F1	B-X
in	B-X
breast	B-X
cancer	B-X
cells	B-X
.	B-X
H19	B-X
repression	B-X
by	B-X
pRb	B-X
and	B-X
E2F6	B-X
confirms	B-X
the	B-X
E2F1-dependent	B-X
control	B-X
of	B-X
the	B-X
H19	B-X
promoter	B-X
.	B-X
Consistently	B-X
,	B-X
we	B-X
demonstrate	B-X
by	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
that	B-X
endogenous	B-X
E2F1	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
H19	B-X
promoter	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
functionality	B-X
of	B-X
E2F	B-X
promoter	B-X
sites	B-X
was	B-X
further	B-X
confirmed	B-X
by	B-X
gel	B-X
shift	B-X
and	B-X
mutagenesis	B-X
experiments	B-X
,	B-X
revealing	B-X
that	B-X
these	B-X
sites	B-X
are	B-X
required	B-X
for	B-X
binding	B-X
and	B-X
promoter	B-X
response	B-X
to	B-X
E2F1	B-X
exogenous	B-X
expression	B-X
and	B-X
serum	B-X
stimulation	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
H19	B-X
overexpression	B-X
confers	B-X
a	B-X
growth	B-X
advantage	B-X
on	B-X
breast	B-X
cancer	B-X
cells	B-X
released	B-X
from	B-X
growth	B-X
arrest	B-X
as	B-X
well	B-X
as	B-X
in	B-X
asynchronously	B-X
growing	B-X
cells	B-X
.	B-X
The	B-X
H19	B-X
knockdown	B-X
by	B-X
small	B-X
interfering	B-X
RNA	B-X
duplexes	B-X
impedes	B-X
S-phase	B-X
entry	B-X
in	B-X
both	B-X
wild-type	B-X
and	B-X
stably	B-X
H19-transfected	B-X
cells	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
conclude	B-X
that	B-X
the	B-X
H19	B-X
RNA	B-X
is	B-X
actively	B-X
linked	B-X
to	B-X
E2F1	B-X
to	B-X
promote	B-X
cell	B-X
cycle	B-X
progression	B-X
of	B-X
breast	B-X
cancer	B-X
cells	B-X
.	B-X
This	B-X
clearly	B-X
supports	B-X
the	B-X
H19	B-X
oncogenic	B-X
function	B-X
in	B-X
breast	B-X
tumor	B-X
genesis	B-X
.	B-X

The	O
imprinted	O
H19	B-Gene_or_gene_product
gene	O
has	O
riboregulatory	O
functions	O
.	O
<EOS>	B-X
The	B-X
imprinted	B-X
H19	B-X
gene	B-X
has	B-X
riboregulatory	B-X
functions	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
H19	B-X
transcription	B-X
is	B-X
up-regulated	B-X
during	B-X
the	B-X
S-phase	B-X
of	B-X
growth-stimulated	B-X
cells	B-X
and	B-X
that	B-X
the	B-X
H19	B-X
promoter	B-X
is	B-X
activated	B-X
by	B-X
E2F1	B-X
in	B-X
breast	B-X
cancer	B-X
cells	B-X
.	B-X
H19	B-X
repression	B-X
by	B-X
pRb	B-X
and	B-X
E2F6	B-X
confirms	B-X
the	B-X
E2F1-dependent	B-X
control	B-X
of	B-X
the	B-X
H19	B-X
promoter	B-X
.	B-X
Consistently	B-X
,	B-X
we	B-X
demonstrate	B-X
by	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
that	B-X
endogenous	B-X
E2F1	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
H19	B-X
promoter	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
functionality	B-X
of	B-X
E2F	B-X
promoter	B-X
sites	B-X
was	B-X
further	B-X
confirmed	B-X
by	B-X
gel	B-X
shift	B-X
and	B-X
mutagenesis	B-X
experiments	B-X
,	B-X
revealing	B-X
that	B-X
these	B-X
sites	B-X
are	B-X
required	B-X
for	B-X
binding	B-X
and	B-X
promoter	B-X
response	B-X
to	B-X
E2F1	B-X
exogenous	B-X
expression	B-X
and	B-X
serum	B-X
stimulation	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
H19	B-X
overexpression	B-X
confers	B-X
a	B-X
growth	B-X
advantage	B-X
on	B-X
breast	B-X
cancer	B-X
cells	B-X
released	B-X
from	B-X
growth	B-X
arrest	B-X
as	B-X
well	B-X
as	B-X
in	B-X
asynchronously	B-X
growing	B-X
cells	B-X
.	B-X
The	B-X
H19	B-X
knockdown	B-X
by	B-X
small	B-X
interfering	B-X
RNA	B-X
duplexes	B-X
impedes	B-X
S-phase	B-X
entry	B-X
in	B-X
both	B-X
wild-type	B-X
and	B-X
stably	B-X
H19-transfected	B-X
cells	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
conclude	B-X
that	B-X
the	B-X
H19	B-X
RNA	B-X
is	B-X
actively	B-X
linked	B-X
to	B-X
E2F1	B-X
to	B-X
promote	B-X
cell	B-X
cycle	B-X
progression	B-X
of	B-X
breast	B-X
cancer	B-X
cells	B-X
.	B-X
This	B-X
clearly	B-X
supports	B-X
the	B-X
H19	B-X
oncogenic	B-X
function	B-X
in	B-X
breast	B-X
tumor	B-X
genesis	B-X
.	B-X

We	O
show	O
here	O
that	O
H19	B-Gene_or_gene_product
transcription	O
is	O
up	O
-	O
regulated	O
during	O
the	O
S	O
-	O
phase	O
of	O
growth	O
-	O
stimulated	O
cells	O
and	O
that	O
the	O
H19	B-Gene_or_gene_product
promoter	O
is	O
activated	O
by	O
E2F1	B-Gene_or_gene_product
in	O
breast	O
cancer	O
cells	O
.	O

H19	B-Gene_or_gene_product
repression	O
by	O
pRb	B-Gene_or_gene_product
and	O
E2F6	B-Gene_or_gene_product
confirms	O
the	O
E2F1	B-Gene_or_gene_product
-	O
dependent	O
control	O
of	O
the	O
H19	B-Gene_or_gene_product
promoter	O
.	O
<EOS>	B-X
The	B-X
imprinted	B-X
H19	B-X
gene	B-X
has	B-X
riboregulatory	B-X
functions	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
H19	B-X
transcription	B-X
is	B-X
up-regulated	B-X
during	B-X
the	B-X
S-phase	B-X
of	B-X
growth-stimulated	B-X
cells	B-X
and	B-X
that	B-X
the	B-X
H19	B-X
promoter	B-X
is	B-X
activated	B-X
by	B-X
E2F1	B-X
in	B-X
breast	B-X
cancer	B-X
cells	B-X
.	B-X
H19	B-X
repression	B-X
by	B-X
pRb	B-X
and	B-X
E2F6	B-X
confirms	B-X
the	B-X
E2F1-dependent	B-X
control	B-X
of	B-X
the	B-X
H19	B-X
promoter	B-X
.	B-X
Consistently	B-X
,	B-X
we	B-X
demonstrate	B-X
by	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
that	B-X
endogenous	B-X
E2F1	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
H19	B-X
promoter	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
functionality	B-X
of	B-X
E2F	B-X
promoter	B-X
sites	B-X
was	B-X
further	B-X
confirmed	B-X
by	B-X
gel	B-X
shift	B-X
and	B-X
mutagenesis	B-X
experiments	B-X
,	B-X
revealing	B-X
that	B-X
these	B-X
sites	B-X
are	B-X
required	B-X
for	B-X
binding	B-X
and	B-X
promoter	B-X
response	B-X
to	B-X
E2F1	B-X
exogenous	B-X
expression	B-X
and	B-X
serum	B-X
stimulation	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
H19	B-X
overexpression	B-X
confers	B-X
a	B-X
growth	B-X
advantage	B-X
on	B-X
breast	B-X
cancer	B-X
cells	B-X
released	B-X
from	B-X
growth	B-X
arrest	B-X
as	B-X
well	B-X
as	B-X
in	B-X
asynchronously	B-X
growing	B-X
cells	B-X
.	B-X
The	B-X
H19	B-X
knockdown	B-X
by	B-X
small	B-X
interfering	B-X
RNA	B-X
duplexes	B-X
impedes	B-X
S-phase	B-X
entry	B-X
in	B-X
both	B-X
wild-type	B-X
and	B-X
stably	B-X
H19-transfected	B-X
cells	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
conclude	B-X
that	B-X
the	B-X
H19	B-X
RNA	B-X
is	B-X
actively	B-X
linked	B-X
to	B-X
E2F1	B-X
to	B-X
promote	B-X
cell	B-X
cycle	B-X
progression	B-X
of	B-X
breast	B-X
cancer	B-X
cells	B-X
.	B-X
This	B-X
clearly	B-X
supports	B-X
the	B-X
H19	B-X
oncogenic	B-X
function	B-X
in	B-X
breast	B-X
tumor	B-X
genesis	B-X
.	B-X

Consistently	O
,	O
we	O
demonstrate	O
by	O
chromatin	O
immunoprecipitation	O
assays	O
that	O
endogenous	O
E2F1	B-Gene_or_gene_product
is	O
recruited	O
to	O
the	O
H19	B-Gene_or_gene_product
promoter	O
in	O
vivo	O
.	O

The	O
functionality	O
of	O
E2F	B-Gene_or_gene_product
promoter	O
sites	O
was	O
further	O
confirmed	O
by	O
gel	O
shift	O
and	O
mutagenesis	O
experiments	O
,	O
revealing	O
that	O
these	O
sites	O
are	O
required	O
for	O
binding	O
and	O
promoter	O
response	O
to	O
E2F1	B-Gene_or_gene_product
exogenous	O
expression	O
and	O
serum	O
stimulation	O
.	O
<EOS>	B-X
We	B-X
show	B-X
here	B-X
that	B-X
H19	B-X
transcription	B-X
is	B-X
up-regulated	B-X
during	B-X
the	B-X
S-phase	B-X
of	B-X
growth-stimulated	B-X
cells	B-X
and	B-X
that	B-X
the	B-X
H19	B-X
promoter	B-X
is	B-X
activated	B-X
by	B-X
E2F1	B-X
in	B-X
breast	B-X
cancer	B-X
cells	B-X
.	B-X
H19	B-X
repression	B-X
by	B-X
pRb	B-X
and	B-X
E2F6	B-X
confirms	B-X
the	B-X
E2F1-dependent	B-X
control	B-X
of	B-X
the	B-X
H19	B-X
promoter	B-X
.	B-X
Consistently	B-X
,	B-X
we	B-X
demonstrate	B-X
by	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
that	B-X
endogenous	B-X
E2F1	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
H19	B-X
promoter	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
functionality	B-X
of	B-X
E2F	B-X
promoter	B-X
sites	B-X
was	B-X
further	B-X
confirmed	B-X
by	B-X
gel	B-X
shift	B-X
and	B-X
mutagenesis	B-X
experiments	B-X
,	B-X
revealing	B-X
that	B-X
these	B-X
sites	B-X
are	B-X
required	B-X
for	B-X
binding	B-X
and	B-X
promoter	B-X
response	B-X
to	B-X
E2F1	B-X
exogenous	B-X
expression	B-X
and	B-X
serum	B-X
stimulation	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
H19	B-X
overexpression	B-X
confers	B-X
a	B-X
growth	B-X
advantage	B-X
on	B-X
breast	B-X
cancer	B-X
cells	B-X
released	B-X
from	B-X
growth	B-X
arrest	B-X
as	B-X
well	B-X
as	B-X
in	B-X
asynchronously	B-X
growing	B-X
cells	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
conclude	B-X
that	B-X
the	B-X
H19	B-X
RNA	B-X
is	B-X
actively	B-X
linked	B-X
to	B-X
E2F1	B-X
to	B-X
promote	B-X
cell	B-X
cycle	B-X
progression	B-X
of	B-X
breast	B-X
cancer	B-X
cells	B-X
.	B-X

Furthermore	O
,	O
we	O
show	O
that	O
H19	B-Gene_or_gene_product
overexpression	O
confers	O
a	O
growth	O
advantage	O
on	O
breast	O
cancer	O
cells	O
released	O
from	O
growth	O
arrest	O
as	O
well	O
as	O
in	O
asynchronously	O
growing	O
cells	O
.	O
<EOS>	B-X
The	B-X
imprinted	B-X
H19	B-X
gene	B-X
has	B-X
riboregulatory	B-X
functions	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
H19	B-X
transcription	B-X
is	B-X
up-regulated	B-X
during	B-X
the	B-X
S-phase	B-X
of	B-X
growth-stimulated	B-X
cells	B-X
and	B-X
that	B-X
the	B-X
H19	B-X
promoter	B-X
is	B-X
activated	B-X
by	B-X
E2F1	B-X
in	B-X
breast	B-X
cancer	B-X
cells	B-X
.	B-X
H19	B-X
repression	B-X
by	B-X
pRb	B-X
and	B-X
E2F6	B-X
confirms	B-X
the	B-X
E2F1-dependent	B-X
control	B-X
of	B-X
the	B-X
H19	B-X
promoter	B-X
.	B-X
Consistently	B-X
,	B-X
we	B-X
demonstrate	B-X
by	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
that	B-X
endogenous	B-X
E2F1	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
H19	B-X
promoter	B-X
in	B-X
vivo	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
H19	B-X
overexpression	B-X
confers	B-X
a	B-X
growth	B-X
advantage	B-X
on	B-X
breast	B-X
cancer	B-X
cells	B-X
released	B-X
from	B-X
growth	B-X
arrest	B-X
as	B-X
well	B-X
as	B-X
in	B-X
asynchronously	B-X
growing	B-X
cells	B-X
.	B-X
The	B-X
H19	B-X
knockdown	B-X
by	B-X
small	B-X
interfering	B-X
RNA	B-X
duplexes	B-X
impedes	B-X
S-phase	B-X
entry	B-X
in	B-X
both	B-X
wild-type	B-X
and	B-X
stably	B-X
H19-transfected	B-X
cells	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
conclude	B-X
that	B-X
the	B-X
H19	B-X
RNA	B-X
is	B-X
actively	B-X
linked	B-X
to	B-X
E2F1	B-X
to	B-X
promote	B-X
cell	B-X
cycle	B-X
progression	B-X
of	B-X
breast	B-X
cancer	B-X
cells	B-X
.	B-X
This	B-X
clearly	B-X
supports	B-X
the	B-X
H19	B-X
oncogenic	B-X
function	B-X
in	B-X
breast	B-X
tumor	B-X
genesis	B-X
.	B-X

The	O
H19	B-Gene_or_gene_product
knockdown	O
by	O
small	O
interfering	O
RNA	O
duplexes	O
impedes	O
S	O
-	O
phase	O
entry	O
in	O
both	O
wild	O
-	O
type	O
and	O
stably	O
H19	O
-	O
transfected	O
cells	O
.	O
<EOS>	B-X
The	B-X
imprinted	B-X
H19	B-X
gene	B-X
has	B-X
riboregulatory	B-X
functions	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
H19	B-X
transcription	B-X
is	B-X
up-regulated	B-X
during	B-X
the	B-X
S-phase	B-X
of	B-X
growth-stimulated	B-X
cells	B-X
and	B-X
that	B-X
the	B-X
H19	B-X
promoter	B-X
is	B-X
activated	B-X
by	B-X
E2F1	B-X
in	B-X
breast	B-X
cancer	B-X
cells	B-X
.	B-X
H19	B-X
repression	B-X
by	B-X
pRb	B-X
and	B-X
E2F6	B-X
confirms	B-X
the	B-X
E2F1-dependent	B-X
control	B-X
of	B-X
the	B-X
H19	B-X
promoter	B-X
.	B-X
Consistently	B-X
,	B-X
we	B-X
demonstrate	B-X
by	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
that	B-X
endogenous	B-X
E2F1	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
H19	B-X
promoter	B-X
in	B-X
vivo	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
H19	B-X
overexpression	B-X
confers	B-X
a	B-X
growth	B-X
advantage	B-X
on	B-X
breast	B-X
cancer	B-X
cells	B-X
released	B-X
from	B-X
growth	B-X
arrest	B-X
as	B-X
well	B-X
as	B-X
in	B-X
asynchronously	B-X
growing	B-X
cells	B-X
.	B-X
The	B-X
H19	B-X
knockdown	B-X
by	B-X
small	B-X
interfering	B-X
RNA	B-X
duplexes	B-X
impedes	B-X
S-phase	B-X
entry	B-X
in	B-X
both	B-X
wild-type	B-X
and	B-X
stably	B-X
H19-transfected	B-X
cells	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
conclude	B-X
that	B-X
the	B-X
H19	B-X
RNA	B-X
is	B-X
actively	B-X
linked	B-X
to	B-X
E2F1	B-X
to	B-X
promote	B-X
cell	B-X
cycle	B-X
progression	B-X
of	B-X
breast	B-X
cancer	B-X
cells	B-X
.	B-X
This	B-X
clearly	B-X
supports	B-X
the	B-X
H19	B-X
oncogenic	B-X
function	B-X
in	B-X
breast	B-X
tumor	B-X
genesis	B-X
.	B-X

Based	O
on	O
these	O
findings	O
,	O
we	O
conclude	O
that	O
the	O
H19	B-Gene_or_gene_product
RNA	O
is	O
actively	O
linked	O
to	O
E2F1	B-Gene_or_gene_product
to	O
promote	O
cell	O
cycle	O
progression	O
of	O
breast	O
cancer	O
cells	O
.	O
<EOS>	B-X
The	B-X
imprinted	B-X
H19	B-X
gene	B-X
has	B-X
riboregulatory	B-X
functions	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
H19	B-X
transcription	B-X
is	B-X
up-regulated	B-X
during	B-X
the	B-X
S-phase	B-X
of	B-X
growth-stimulated	B-X
cells	B-X
and	B-X
that	B-X
the	B-X
H19	B-X
promoter	B-X
is	B-X
activated	B-X
by	B-X
E2F1	B-X
in	B-X
breast	B-X
cancer	B-X
cells	B-X
.	B-X
H19	B-X
repression	B-X
by	B-X
pRb	B-X
and	B-X
E2F6	B-X
confirms	B-X
the	B-X
E2F1-dependent	B-X
control	B-X
of	B-X
the	B-X
H19	B-X
promoter	B-X
.	B-X
Consistently	B-X
,	B-X
we	B-X
demonstrate	B-X
by	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
that	B-X
endogenous	B-X
E2F1	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
H19	B-X
promoter	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
functionality	B-X
of	B-X
E2F	B-X
promoter	B-X
sites	B-X
was	B-X
further	B-X
confirmed	B-X
by	B-X
gel	B-X
shift	B-X
and	B-X
mutagenesis	B-X
experiments	B-X
,	B-X
revealing	B-X
that	B-X
these	B-X
sites	B-X
are	B-X
required	B-X
for	B-X
binding	B-X
and	B-X
promoter	B-X
response	B-X
to	B-X
E2F1	B-X
exogenous	B-X
expression	B-X
and	B-X
serum	B-X
stimulation	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
H19	B-X
overexpression	B-X
confers	B-X
a	B-X
growth	B-X
advantage	B-X
on	B-X
breast	B-X
cancer	B-X
cells	B-X
released	B-X
from	B-X
growth	B-X
arrest	B-X
as	B-X
well	B-X
as	B-X
in	B-X
asynchronously	B-X
growing	B-X
cells	B-X
.	B-X
The	B-X
H19	B-X
knockdown	B-X
by	B-X
small	B-X
interfering	B-X
RNA	B-X
duplexes	B-X
impedes	B-X
S-phase	B-X
entry	B-X
in	B-X
both	B-X
wild-type	B-X
and	B-X
stably	B-X
H19-transfected	B-X
cells	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
conclude	B-X
that	B-X
the	B-X
H19	B-X
RNA	B-X
is	B-X
actively	B-X
linked	B-X
to	B-X
E2F1	B-X
to	B-X
promote	B-X
cell	B-X
cycle	B-X
progression	B-X
of	B-X
breast	B-X
cancer	B-X
cells	B-X
.	B-X
This	B-X
clearly	B-X
supports	B-X
the	B-X
H19	B-X
oncogenic	B-X
function	B-X
in	B-X
breast	B-X
tumor	B-X
genesis	B-X
.	B-X

This	O
clearly	O
supports	O
the	O
H19	B-Gene_or_gene_product
oncogenic	O
function	O
in	O
breast	O
tumor	O
genesis	O
.	O
<EOS>	B-X
The	B-X
imprinted	B-X
H19	B-X
gene	B-X
has	B-X
riboregulatory	B-X
functions	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
H19	B-X
transcription	B-X
is	B-X
up-regulated	B-X
during	B-X
the	B-X
S-phase	B-X
of	B-X
growth-stimulated	B-X
cells	B-X
and	B-X
that	B-X
the	B-X
H19	B-X
promoter	B-X
is	B-X
activated	B-X
by	B-X
E2F1	B-X
in	B-X
breast	B-X
cancer	B-X
cells	B-X
.	B-X
H19	B-X
repression	B-X
by	B-X
pRb	B-X
and	B-X
E2F6	B-X
confirms	B-X
the	B-X
E2F1-dependent	B-X
control	B-X
of	B-X
the	B-X
H19	B-X
promoter	B-X
.	B-X
Consistently	B-X
,	B-X
we	B-X
demonstrate	B-X
by	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
that	B-X
endogenous	B-X
E2F1	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
H19	B-X
promoter	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
functionality	B-X
of	B-X
E2F	B-X
promoter	B-X
sites	B-X
was	B-X
further	B-X
confirmed	B-X
by	B-X
gel	B-X
shift	B-X
and	B-X
mutagenesis	B-X
experiments	B-X
,	B-X
revealing	B-X
that	B-X
these	B-X
sites	B-X
are	B-X
required	B-X
for	B-X
binding	B-X
and	B-X
promoter	B-X
response	B-X
to	B-X
E2F1	B-X
exogenous	B-X
expression	B-X
and	B-X
serum	B-X
stimulation	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
H19	B-X
overexpression	B-X
confers	B-X
a	B-X
growth	B-X
advantage	B-X
on	B-X
breast	B-X
cancer	B-X
cells	B-X
released	B-X
from	B-X
growth	B-X
arrest	B-X
as	B-X
well	B-X
as	B-X
in	B-X
asynchronously	B-X
growing	B-X
cells	B-X
.	B-X
The	B-X
H19	B-X
knockdown	B-X
by	B-X
small	B-X
interfering	B-X
RNA	B-X
duplexes	B-X
impedes	B-X
S-phase	B-X
entry	B-X
in	B-X
both	B-X
wild-type	B-X
and	B-X
stably	B-X
H19-transfected	B-X
cells	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
conclude	B-X
that	B-X
the	B-X
H19	B-X
RNA	B-X
is	B-X
actively	B-X
linked	B-X
to	B-X
E2F1	B-X
to	B-X
promote	B-X
cell	B-X
cycle	B-X
progression	B-X
of	B-X
breast	B-X
cancer	B-X
cells	B-X
.	B-X
This	B-X
clearly	B-X
supports	B-X
the	B-X
H19	B-X
oncogenic	B-X
function	B-X
in	B-X
breast	B-X
tumor	B-X
genesis	B-X
.	B-X

Mip1	B-Gene_or_gene_product
,	O
an	O
MEKK2	B-Gene_or_gene_product
-	O
interacting	O
protein	O
,	O
controls	O
MEKK2	B-Gene_or_gene_product
dimerization	O
and	O
activation	O
.	O
<EOS>	B-X
Mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
cascades	B-X
are	B-X
central	B-X
components	B-X
of	B-X
the	B-X
intracellular	B-X
signaling	B-X
networks	B-X
used	B-X
by	B-X
eukaryotic	B-X
cells	B-X
to	B-X
respond	B-X
to	B-X
a	B-X
wide	B-X
spectrum	B-X
of	B-X
extracellular	B-X
stimuli	B-X
.	B-X
However	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
molecular	B-X
aspects	B-X
of	B-X
the	B-X
regulation	B-X
and	B-X
activation	B-X
of	B-X
large	B-X
numbers	B-X
of	B-X
MAP3Ks	B-X
that	B-X
are	B-X
crucial	B-X
in	B-X
relaying	B-X
upstream	B-X
receptor-mediated	B-X
signals	B-X
through	B-X
the	B-X
MAPK	B-X
cascades	B-X
to	B-X
induce	B-X
various	B-X
physiological	B-X
responses	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
novel	B-X
MEKK2-interacting	B-X
protein	B-X
,	B-X
Mip1	B-X
,	B-X
that	B-X
regulates	B-X
MEKK2	B-X
dimerization	B-X
and	B-X
activation	B-X
by	B-X
forming	B-X
a	B-X
complex	B-X
with	B-X
inactive	B-X
and	B-X
nonphosphorylated	B-X
MEKK2	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
Mip1	B-X
prevented	B-X
MEKK2	B-X
activation	B-X
by	B-X
blocking	B-X
MEKK2	B-X
dimer	B-X
formation	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
blocked	B-X
JNKK2	B-X
,	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
1	B-X
(	B-X
JNK1	B-X
)	B-X
,	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
5	B-X
,	B-X
and	B-X
AP-1	B-X
reporter	B-X
gene	B-X
activation	B-X
by	B-X
MEKK2	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
endogenous	B-X
Mip1-MEKK2	B-X
complex	B-X
was	B-X
dissociated	B-X
transiently	B-X
following	B-X
epidermal	B-X
growth	B-X
factor	B-X
stimulation	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
knockdown	B-X
of	B-X
Mip1	B-X
expression	B-X
by	B-X
siRNA	B-X
augmented	B-X
the	B-X
MEKK2-mediated	B-X
JNK	B-X
and	B-X
AP-1	B-X
reporter	B-X
activation	B-X
.	B-X
Together	B-X
,	B-X
our	B-X
data	B-X
suggest	B-X
a	B-X
novel	B-X
model	B-X
for	B-X
MEKK2	B-X
regulation	B-X
and	B-X
activation	B-X
.	B-X

Mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
MAPK	B-Gene_or_gene_product
)	O
cascades	O
are	O
central	O
components	O
of	O
the	O
intracellular	O
signaling	O
networks	O
used	O
by	O
eukaryotic	O
cells	O
to	O
respond	O
to	O
a	O
wide	O
spectrum	O
of	O
extracellular	O
stimuli	O
.	O
<EOS>	B-X
Mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
cascades	B-X
are	B-X
central	B-X
components	B-X
of	B-X
the	B-X
intracellular	B-X
signaling	B-X
networks	B-X
used	B-X
by	B-X
eukaryotic	B-X
cells	B-X
to	B-X
respond	B-X
to	B-X
a	B-X
wide	B-X
spectrum	B-X
of	B-X
extracellular	B-X
stimuli	B-X
.	B-X
An	B-X
MAPK	B-X
is	B-X
activated	B-X
by	B-X
an	B-X
MAPK	B-X
kinase	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
is	B-X
activated	B-X
by	B-X
an	B-X
MAPK	B-X
kinase	B-X
kinase	B-X
(	B-X
MAP3K	B-X
)	B-X
.	B-X
However	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
molecular	B-X
aspects	B-X
of	B-X
the	B-X
regulation	B-X
and	B-X
activation	B-X
of	B-X
large	B-X
numbers	B-X
of	B-X
MAP3Ks	B-X
that	B-X
are	B-X
crucial	B-X
in	B-X
relaying	B-X
upstream	B-X
receptor-mediated	B-X
signals	B-X
through	B-X
the	B-X
MAPK	B-X
cascades	B-X
to	B-X
induce	B-X
various	B-X
physiological	B-X
responses	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
novel	B-X
MEKK2-interacting	B-X
protein	B-X
,	B-X
Mip1	B-X
,	B-X
that	B-X
regulates	B-X
MEKK2	B-X
dimerization	B-X
and	B-X
activation	B-X
by	B-X
forming	B-X
a	B-X
complex	B-X
with	B-X
inactive	B-X
and	B-X
nonphosphorylated	B-X
MEKK2	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
Mip1	B-X
prevented	B-X
MEKK2	B-X
activation	B-X
by	B-X
blocking	B-X
MEKK2	B-X
dimer	B-X
formation	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
blocked	B-X
JNKK2	B-X
,	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
1	B-X
(	B-X
JNK1	B-X
)	B-X
,	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
5	B-X
,	B-X
and	B-X
AP-1	B-X
reporter	B-X
gene	B-X
activation	B-X
by	B-X
MEKK2	B-X
.	B-X

An	O
MAPK	B-Gene_or_gene_product
is	O
activated	O
by	O
an	O
MAPK	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
,	O
which	O
in	O
turn	O
is	O
activated	O
by	O
an	O
MAPK	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
MAP3K	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
Mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
signal	B-X
transduction	B-X
pathways	B-X
are	B-X
ubiquitous	B-X
in	B-X
eukaryotic	B-X
cells	B-X
,	B-X
which	B-X
transfer	B-X
signals	B-X
from	B-X
the	B-X
cell	B-X
surface	B-X
to	B-X
the	B-X
nucleus	B-X
,	B-X
controlling	B-X
multiple	B-X
cellular	B-X
programs	B-X
.	B-X
MAPKs	B-X
are	B-X
activated	B-X
by	B-X
MAPK	B-X
kinases	B-X
[	B-X
MAP2Ks	B-X
or	B-X
MAP/extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
ERK	B-X
)	B-X
kinases	B-X
(	B-X
MEK	B-X
)	B-X
]	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
are	B-X
activated	B-X
by	B-X
MAPK	B-X
kinase	B-X
kinases	B-X
(	B-X
MAP3Ks	B-X
)	B-X
.	B-X
TAO2	B-X
is	B-X
a	B-X
MAP3K	B-X
level	B-X
kinase	B-X
that	B-X
activates	B-X
the	B-X
MAP2Ks	B-X
MEK3	B-X
and	B-X
MEK6	B-X
to	B-X
activate	B-X
p38	B-X
MAPKs	B-X
.	B-X
Because	B-X
p38	B-X
MAPKs	B-X
are	B-X
key	B-X
regulators	B-X
of	B-X
expression	B-X
of	B-X
inflammatory	B-X
cytokines	B-X
,	B-X
they	B-X
appear	B-X
to	B-X
be	B-X
involved	B-X
in	B-X
human	B-X
diseases	B-X
such	B-X
as	B-X
asthma	B-X
and	B-X
autoimmunity	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
crystal	B-X
structure	B-X
of	B-X
active	B-X
TAO2	B-X
kinase	B-X
domain	B-X
in	B-X
complex	B-X
with	B-X
staurosporine	B-X
,	B-X
a	B-X
broad-range	B-X
protein	B-X
kinase	B-X
inhibitor	B-X
that	B-X
inhibits	B-X
TAO2	B-X
with	B-X
an	B-X
IC50	B-X
of	B-X
3	B-X
mM	B-X
.	B-X
Staurosporine	B-X
induces	B-X
conformational	B-X
changes	B-X
in	B-X
TAO2	B-X
residues	B-X
that	B-X
surround	B-X
the	B-X
inhibitor	B-X
molecule	B-X
,	B-X
but	B-X
causes	B-X
very	B-X
limited	B-X
global	B-X
changes	B-X
in	B-X
the	B-X
kinase	B-X
.	B-X
The	B-X
structure	B-X
presented	B-X
here	B-X
should	B-X
aid	B-X
in	B-X
the	B-X
design	B-X
of	B-X
inhibitors	B-X
specific	B-X
to	B-X
TAO2	B-X
and	B-X
related	B-X
kinases	B-X
.	B-X

However	O
,	O
little	O
is	O
known	O
about	O
the	O
molecular	O
aspects	O
of	O
the	O
regulation	O
and	O
activation	O
of	O
large	O
numbers	O
of	O
MAP3Ks	B-Gene_or_gene_product
that	O
are	O
crucial	O
in	O
relaying	O
upstream	O
receptor	O
-	O
mediated	O
signals	O
through	O
the	O
MAPK	B-Gene_or_gene_product
cascades	O
to	O
induce	O
various	O
physiological	O
responses	O
.	O
<EOS>	B-X
Mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
cascades	B-X
are	B-X
central	B-X
components	B-X
of	B-X
the	B-X
intracellular	B-X
signaling	B-X
networks	B-X
used	B-X
by	B-X
eukaryotic	B-X
cells	B-X
to	B-X
respond	B-X
to	B-X
a	B-X
wide	B-X
spectrum	B-X
of	B-X
extracellular	B-X
stimuli	B-X
.	B-X
An	B-X
MAPK	B-X
is	B-X
activated	B-X
by	B-X
an	B-X
MAPK	B-X
kinase	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
is	B-X
activated	B-X
by	B-X
an	B-X
MAPK	B-X
kinase	B-X
kinase	B-X
(	B-X
MAP3K	B-X
)	B-X
.	B-X
However	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
molecular	B-X
aspects	B-X
of	B-X
the	B-X
regulation	B-X
and	B-X
activation	B-X
of	B-X
large	B-X
numbers	B-X
of	B-X
MAP3Ks	B-X
that	B-X
are	B-X
crucial	B-X
in	B-X
relaying	B-X
upstream	B-X
receptor-mediated	B-X
signals	B-X
through	B-X
the	B-X
MAPK	B-X
cascades	B-X
to	B-X
induce	B-X
various	B-X
physiological	B-X
responses	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
novel	B-X
MEKK2-interacting	B-X
protein	B-X
,	B-X
Mip1	B-X
,	B-X
that	B-X
regulates	B-X
MEKK2	B-X
dimerization	B-X
and	B-X
activation	B-X
by	B-X
forming	B-X
a	B-X
complex	B-X
with	B-X
inactive	B-X
and	B-X
nonphosphorylated	B-X
MEKK2	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
Mip1	B-X
prevented	B-X
MEKK2	B-X
activation	B-X
by	B-X
blocking	B-X
MEKK2	B-X
dimer	B-X
formation	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
blocked	B-X
JNKK2	B-X
,	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
1	B-X
(	B-X
JNK1	B-X
)	B-X
,	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
5	B-X
,	B-X
and	B-X
AP-1	B-X
reporter	B-X
gene	B-X
activation	B-X
by	B-X
MEKK2	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
knockdown	B-X
of	B-X
Mip1	B-X
expression	B-X
by	B-X
siRNA	B-X
augmented	B-X
the	B-X
MEKK2-mediated	B-X
JNK	B-X
and	B-X
AP-1	B-X
reporter	B-X
activation	B-X
.	B-X
Together	B-X
,	B-X
our	B-X
data	B-X
suggest	B-X
a	B-X
novel	B-X
model	B-X
for	B-X
MEKK2	B-X
regulation	B-X
and	B-X
activation	B-X
.	B-X

In	O
this	O
study	O
,	O
we	O
identified	O
a	O
novel	O
MEKK2	B-Gene_or_gene_product
-	O
interacting	O
protein	O
,	O
Mip1	B-Gene_or_gene_product
,	O
that	O
regulates	O
MEKK2	B-Gene_or_gene_product
dimerization	O
and	O
activation	O
by	O
forming	O
a	O
complex	O
with	O
inactive	O
and	O
nonphosphorylated	O
MEKK2	B-Gene_or_gene_product
.	O
<EOS>	B-X
Mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
cascades	B-X
are	B-X
central	B-X
components	B-X
of	B-X
the	B-X
intracellular	B-X
signaling	B-X
networks	B-X
used	B-X
by	B-X
eukaryotic	B-X
cells	B-X
to	B-X
respond	B-X
to	B-X
a	B-X
wide	B-X
spectrum	B-X
of	B-X
extracellular	B-X
stimuli	B-X
.	B-X
However	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
molecular	B-X
aspects	B-X
of	B-X
the	B-X
regulation	B-X
and	B-X
activation	B-X
of	B-X
large	B-X
numbers	B-X
of	B-X
MAP3Ks	B-X
that	B-X
are	B-X
crucial	B-X
in	B-X
relaying	B-X
upstream	B-X
receptor-mediated	B-X
signals	B-X
through	B-X
the	B-X
MAPK	B-X
cascades	B-X
to	B-X
induce	B-X
various	B-X
physiological	B-X
responses	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
novel	B-X
MEKK2-interacting	B-X
protein	B-X
,	B-X
Mip1	B-X
,	B-X
that	B-X
regulates	B-X
MEKK2	B-X
dimerization	B-X
and	B-X
activation	B-X
by	B-X
forming	B-X
a	B-X
complex	B-X
with	B-X
inactive	B-X
and	B-X
nonphosphorylated	B-X
MEKK2	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
Mip1	B-X
prevented	B-X
MEKK2	B-X
activation	B-X
by	B-X
blocking	B-X
MEKK2	B-X
dimer	B-X
formation	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
blocked	B-X
JNKK2	B-X
,	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
1	B-X
(	B-X
JNK1	B-X
)	B-X
,	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
5	B-X
,	B-X
and	B-X
AP-1	B-X
reporter	B-X
gene	B-X
activation	B-X
by	B-X
MEKK2	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
endogenous	B-X
Mip1-MEKK2	B-X
complex	B-X
was	B-X
dissociated	B-X
transiently	B-X
following	B-X
epidermal	B-X
growth	B-X
factor	B-X
stimulation	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
knockdown	B-X
of	B-X
Mip1	B-X
expression	B-X
by	B-X
siRNA	B-X
augmented	B-X
the	B-X
MEKK2-mediated	B-X
JNK	B-X
and	B-X
AP-1	B-X
reporter	B-X
activation	B-X
.	B-X
Together	B-X
,	B-X
our	B-X
data	B-X
suggest	B-X
a	B-X
novel	B-X
model	B-X
for	B-X
MEKK2	B-X
regulation	B-X
and	B-X
activation	B-X
.	B-X

In	O
particular	O
,	O
Mip1	B-Gene_or_gene_product
prevented	O
MEKK2	B-Gene_or_gene_product
activation	O
by	O
blocking	O
MEKK2	B-Gene_or_gene_product
dimer	O
formation	O
,	O
which	O
in	O
turn	O
blocked	O
JNKK2	B-Gene_or_gene_product
,	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
terminal	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
JNK1	B-Gene_or_gene_product
)	O
,	O
extracellular	B-Gene_or_gene_product
signal	I-Gene_or_gene_product
-	I-Gene_or_gene_product
regulated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
5	I-Gene_or_gene_product
,	O
and	O
AP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
reporter	O
gene	O
activation	O
by	O
MEKK2	B-Gene_or_gene_product
.	O
<EOS>	B-X
Mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
cascades	B-X
are	B-X
central	B-X
components	B-X
of	B-X
the	B-X
intracellular	B-X
signaling	B-X
networks	B-X
used	B-X
by	B-X
eukaryotic	B-X
cells	B-X
to	B-X
respond	B-X
to	B-X
a	B-X
wide	B-X
spectrum	B-X
of	B-X
extracellular	B-X
stimuli	B-X
.	B-X
An	B-X
MAPK	B-X
is	B-X
activated	B-X
by	B-X
an	B-X
MAPK	B-X
kinase	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
is	B-X
activated	B-X
by	B-X
an	B-X
MAPK	B-X
kinase	B-X
kinase	B-X
(	B-X
MAP3K	B-X
)	B-X
.	B-X
However	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
molecular	B-X
aspects	B-X
of	B-X
the	B-X
regulation	B-X
and	B-X
activation	B-X
of	B-X
large	B-X
numbers	B-X
of	B-X
MAP3Ks	B-X
that	B-X
are	B-X
crucial	B-X
in	B-X
relaying	B-X
upstream	B-X
receptor-mediated	B-X
signals	B-X
through	B-X
the	B-X
MAPK	B-X
cascades	B-X
to	B-X
induce	B-X
various	B-X
physiological	B-X
responses	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
novel	B-X
MEKK2-interacting	B-X
protein	B-X
,	B-X
Mip1	B-X
,	B-X
that	B-X
regulates	B-X
MEKK2	B-X
dimerization	B-X
and	B-X
activation	B-X
by	B-X
forming	B-X
a	B-X
complex	B-X
with	B-X
inactive	B-X
and	B-X
nonphosphorylated	B-X
MEKK2	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
Mip1	B-X
prevented	B-X
MEKK2	B-X
activation	B-X
by	B-X
blocking	B-X
MEKK2	B-X
dimer	B-X
formation	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
blocked	B-X
JNKK2	B-X
,	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
1	B-X
(	B-X
JNK1	B-X
)	B-X
,	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
5	B-X
,	B-X
and	B-X
AP-1	B-X
reporter	B-X
gene	B-X
activation	B-X
by	B-X
MEKK2	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
endogenous	B-X
Mip1-MEKK2	B-X
complex	B-X
was	B-X
dissociated	B-X
transiently	B-X
following	B-X
epidermal	B-X
growth	B-X
factor	B-X
stimulation	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
knockdown	B-X
of	B-X
Mip1	B-X
expression	B-X
by	B-X
siRNA	B-X
augmented	B-X
the	B-X
MEKK2-mediated	B-X
JNK	B-X
and	B-X
AP-1	B-X
reporter	B-X
activation	B-X
.	B-X
Together	B-X
,	B-X
our	B-X
data	B-X
suggest	B-X
a	B-X
novel	B-X
model	B-X
for	B-X
MEKK2	B-X
regulation	B-X
and	B-X
activation	B-X
.	B-X

Furthermore	O
,	O
we	O
found	O
that	O
the	O
endogenous	O
Mip1	O
-	O
MEKK2	O
complex	O
was	O
dissociated	O
transiently	O
following	O
epidermal	O
growth	O
factor	O
stimulation	O
.	O
<EOS>	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
novel	B-X
MEKK2-interacting	B-X
protein	B-X
,	B-X
Mip1	B-X
,	B-X
that	B-X
regulates	B-X
MEKK2	B-X
dimerization	B-X
and	B-X
activation	B-X
by	B-X
forming	B-X
a	B-X
complex	B-X
with	B-X
inactive	B-X
and	B-X
nonphosphorylated	B-X
MEKK2	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
Mip1	B-X
prevented	B-X
MEKK2	B-X
activation	B-X
by	B-X
blocking	B-X
MEKK2	B-X
dimer	B-X
formation	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
blocked	B-X
JNKK2	B-X
,	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
1	B-X
(	B-X
JNK1	B-X
)	B-X
,	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
5	B-X
,	B-X
and	B-X
AP-1	B-X
reporter	B-X
gene	B-X
activation	B-X
by	B-X
MEKK2	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
endogenous	B-X
Mip1-MEKK2	B-X
complex	B-X
was	B-X
dissociated	B-X
transiently	B-X
following	B-X
epidermal	B-X
growth	B-X
factor	B-X
stimulation	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
knockdown	B-X
of	B-X
Mip1	B-X
expression	B-X
by	B-X
siRNA	B-X
augmented	B-X
the	B-X
MEKK2-mediated	B-X
JNK	B-X
and	B-X
AP-1	B-X
reporter	B-X
activation	B-X
.	B-X
Together	B-X
,	B-X
our	B-X
data	B-X
suggest	B-X
a	B-X
novel	B-X
model	B-X
for	B-X
MEKK2	B-X
regulation	B-X
and	B-X
activation	B-X
.	B-X

In	O
contrast	O
,	O
the	O
knockdown	O
of	O
Mip1	B-Gene_or_gene_product
expression	O
by	O
siRNA	O
augmented	O
the	O
MEKK2	B-Gene_or_gene_product
-	O
mediated	O
JNK	B-Gene_or_gene_product
and	O
AP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
reporter	O
activation	O
.	O
<EOS>	B-X
Mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
cascades	B-X
are	B-X
central	B-X
components	B-X
of	B-X
the	B-X
intracellular	B-X
signaling	B-X
networks	B-X
used	B-X
by	B-X
eukaryotic	B-X
cells	B-X
to	B-X
respond	B-X
to	B-X
a	B-X
wide	B-X
spectrum	B-X
of	B-X
extracellular	B-X
stimuli	B-X
.	B-X
An	B-X
MAPK	B-X
is	B-X
activated	B-X
by	B-X
an	B-X
MAPK	B-X
kinase	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
is	B-X
activated	B-X
by	B-X
an	B-X
MAPK	B-X
kinase	B-X
kinase	B-X
(	B-X
MAP3K	B-X
)	B-X
.	B-X
However	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
molecular	B-X
aspects	B-X
of	B-X
the	B-X
regulation	B-X
and	B-X
activation	B-X
of	B-X
large	B-X
numbers	B-X
of	B-X
MAP3Ks	B-X
that	B-X
are	B-X
crucial	B-X
in	B-X
relaying	B-X
upstream	B-X
receptor-mediated	B-X
signals	B-X
through	B-X
the	B-X
MAPK	B-X
cascades	B-X
to	B-X
induce	B-X
various	B-X
physiological	B-X
responses	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
novel	B-X
MEKK2-interacting	B-X
protein	B-X
,	B-X
Mip1	B-X
,	B-X
that	B-X
regulates	B-X
MEKK2	B-X
dimerization	B-X
and	B-X
activation	B-X
by	B-X
forming	B-X
a	B-X
complex	B-X
with	B-X
inactive	B-X
and	B-X
nonphosphorylated	B-X
MEKK2	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
Mip1	B-X
prevented	B-X
MEKK2	B-X
activation	B-X
by	B-X
blocking	B-X
MEKK2	B-X
dimer	B-X
formation	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
blocked	B-X
JNKK2	B-X
,	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
1	B-X
(	B-X
JNK1	B-X
)	B-X
,	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
5	B-X
,	B-X
and	B-X
AP-1	B-X
reporter	B-X
gene	B-X
activation	B-X
by	B-X
MEKK2	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
endogenous	B-X
Mip1-MEKK2	B-X
complex	B-X
was	B-X
dissociated	B-X
transiently	B-X
following	B-X
epidermal	B-X
growth	B-X
factor	B-X
stimulation	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
knockdown	B-X
of	B-X
Mip1	B-X
expression	B-X
by	B-X
siRNA	B-X
augmented	B-X
the	B-X
MEKK2-mediated	B-X
JNK	B-X
and	B-X
AP-1	B-X
reporter	B-X
activation	B-X
.	B-X
Together	B-X
,	B-X
our	B-X
data	B-X
suggest	B-X
a	B-X
novel	B-X
model	B-X
for	B-X
MEKK2	B-X
regulation	B-X
and	B-X
activation	B-X
.	B-X

Together	O
,	O
our	O
data	O
suggest	O
a	O
novel	O
model	O
for	O
MEKK2	B-Gene_or_gene_product
regulation	O
and	O
activation	O
.	O
<EOS>	B-X
However	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
the	B-X
molecular	B-X
aspects	B-X
of	B-X
the	B-X
regulation	B-X
and	B-X
activation	B-X
of	B-X
large	B-X
numbers	B-X
of	B-X
MAP3Ks	B-X
that	B-X
are	B-X
crucial	B-X
in	B-X
relaying	B-X
upstream	B-X
receptor-mediated	B-X
signals	B-X
through	B-X
the	B-X
MAPK	B-X
cascades	B-X
to	B-X
induce	B-X
various	B-X
physiological	B-X
responses	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
novel	B-X
MEKK2-interacting	B-X
protein	B-X
,	B-X
Mip1	B-X
,	B-X
that	B-X
regulates	B-X
MEKK2	B-X
dimerization	B-X
and	B-X
activation	B-X
by	B-X
forming	B-X
a	B-X
complex	B-X
with	B-X
inactive	B-X
and	B-X
nonphosphorylated	B-X
MEKK2	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
Mip1	B-X
prevented	B-X
MEKK2	B-X
activation	B-X
by	B-X
blocking	B-X
MEKK2	B-X
dimer	B-X
formation	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
blocked	B-X
JNKK2	B-X
,	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
1	B-X
(	B-X
JNK1	B-X
)	B-X
,	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
5	B-X
,	B-X
and	B-X
AP-1	B-X
reporter	B-X
gene	B-X
activation	B-X
by	B-X
MEKK2	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
endogenous	B-X
Mip1-MEKK2	B-X
complex	B-X
was	B-X
dissociated	B-X
transiently	B-X
following	B-X
epidermal	B-X
growth	B-X
factor	B-X
stimulation	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
knockdown	B-X
of	B-X
Mip1	B-X
expression	B-X
by	B-X
siRNA	B-X
augmented	B-X
the	B-X
MEKK2-mediated	B-X
JNK	B-X
and	B-X
AP-1	B-X
reporter	B-X
activation	B-X
.	B-X
Together	B-X
,	B-X
our	B-X
data	B-X
suggest	B-X
a	B-X
novel	B-X
model	B-X
for	B-X
MEKK2	B-X
regulation	B-X
and	B-X
activation	B-X
.	B-X

PTEN	B-Gene_or_gene_product
represses	O
RNA	B-Gene_or_gene_product
Polymerase	I-Gene_or_gene_product
I	I-Gene_or_gene_product
transcription	O
by	O
disrupting	O
the	O
SL1	O
complex	O
.	O
<EOS>	B-X
PTEN	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
whose	B-X
function	B-X
is	B-X
frequently	B-X
lost	B-X
in	B-X
human	B-X
cancer	B-X
.	B-X
It	B-X
possesses	B-X
a	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
that	B-X
represses	B-X
the	B-X
activation	B-X
of	B-X
PI3	B-X
kinase/Akt	B-X
signaling	B-X
,	B-X
leading	B-X
to	B-X
decreased	B-X
cell	B-X
growth	B-X
,	B-X
proliferation	B-X
,	B-X
and	B-X
survival	B-X
.	B-X
The	B-X
potential	B-X
for	B-X
PTEN	B-X
to	B-X
regulate	B-X
transcription	B-X
of	B-X
the	B-X
large	B-X
rRNAs	B-X
by	B-X
RNA	B-X
polymerase	B-X
I	B-X
(	B-X
RNA	B-X
Pol	B-X
I	B-X
)	B-X
was	B-X
investigated	B-X
.	B-X
As	B-X
increased	B-X
synthesis	B-X
of	B-X
rRNAs	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
neoplastic	B-X
transformation	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PTEN	B-X
to	B-X
control	B-X
the	B-X
transcription	B-X
of	B-X
rRNAs	B-X
might	B-X
be	B-X
crucial	B-X
for	B-X
its	B-X
tumor	B-X
suppressor	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
PTEN	B-X
in	B-X
PTEN-deficient	B-X
cells	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
,	B-X
while	B-X
decreasing	B-X
PTEN	B-X
expression	B-X
enhances	B-X
transcription	B-X
.	B-X
PTEN-mediated	B-X
repression	B-X
requires	B-X
its	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
and	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
p53	B-X
status	B-X
of	B-X
the	B-X
cell	B-X
.	B-X
This	B-X
event	B-X
can	B-X
be	B-X
uncoupled	B-X
from	B-X
PTEN	B-X
's	B-X
ability	B-X
to	B-X
regulate	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
RNA	B-X
Pol	B-X
I	B-X
is	B-X
regulated	B-X
through	B-X
PI3	B-X
kinase/Akt/mammalian	B-X
target	B-X
of	B-X
rapamycin/S6	B-X
kinase	B-X
,	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
constitutively	B-X
activated	B-X
S6	B-X
kinase	B-X
is	B-X
able	B-X
to	B-X
abrogate	B-X
transcription	B-X
repression	B-X
by	B-X
PTEN	B-X
.	B-X
No	B-X
change	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
components	B-X
,	B-X
upstream	B-X
binding	B-X
factor	B-X
or	B-X
SL1	B-X
,	B-X
was	B-X
observed	B-X
upon	B-X
PTEN	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
differentially	B-X
reduces	B-X
the	B-X
occupancy	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
on	B-X
the	B-X
rRNA	B-X
gene	B-X
promoter	B-X
.	B-X
Furthermore	B-X
,	B-X
PTEN	B-X
induces	B-X
dissociation	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
through	B-X
a	B-X
novel	B-X
mechanism	B-X
that	B-X
involves	B-X
disruption	B-X
of	B-X
the	B-X
SL1	B-X
complex	B-X
.	B-X

PTEN	B-Gene_or_gene_product
is	O
a	O
tumor	O
suppressor	O
whose	O
function	O
is	O
frequently	O
lost	O
in	O
human	O
cancer	O
.	O
<EOS>	B-X
PTEN	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
whose	B-X
function	B-X
is	B-X
frequently	B-X
lost	B-X
in	B-X
human	B-X
cancer	B-X
.	B-X
The	B-X
potential	B-X
for	B-X
PTEN	B-X
to	B-X
regulate	B-X
transcription	B-X
of	B-X
the	B-X
large	B-X
rRNAs	B-X
by	B-X
RNA	B-X
polymerase	B-X
I	B-X
(	B-X
RNA	B-X
Pol	B-X
I	B-X
)	B-X
was	B-X
investigated	B-X
.	B-X
As	B-X
increased	B-X
synthesis	B-X
of	B-X
rRNAs	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
neoplastic	B-X
transformation	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PTEN	B-X
to	B-X
control	B-X
the	B-X
transcription	B-X
of	B-X
rRNAs	B-X
might	B-X
be	B-X
crucial	B-X
for	B-X
its	B-X
tumor	B-X
suppressor	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
PTEN	B-X
in	B-X
PTEN-deficient	B-X
cells	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
,	B-X
while	B-X
decreasing	B-X
PTEN	B-X
expression	B-X
enhances	B-X
transcription	B-X
.	B-X
PTEN-mediated	B-X
repression	B-X
requires	B-X
its	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
and	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
p53	B-X
status	B-X
of	B-X
the	B-X
cell	B-X
.	B-X
This	B-X
event	B-X
can	B-X
be	B-X
uncoupled	B-X
from	B-X
PTEN	B-X
's	B-X
ability	B-X
to	B-X
regulate	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
RNA	B-X
Pol	B-X
I	B-X
is	B-X
regulated	B-X
through	B-X
PI3	B-X
kinase/Akt/mammalian	B-X
target	B-X
of	B-X
rapamycin/S6	B-X
kinase	B-X
,	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
constitutively	B-X
activated	B-X
S6	B-X
kinase	B-X
is	B-X
able	B-X
to	B-X
abrogate	B-X
transcription	B-X
repression	B-X
by	B-X
PTEN	B-X
.	B-X
No	B-X
change	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
components	B-X
,	B-X
upstream	B-X
binding	B-X
factor	B-X
or	B-X
SL1	B-X
,	B-X
was	B-X
observed	B-X
upon	B-X
PTEN	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
differentially	B-X
reduces	B-X
the	B-X
occupancy	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
on	B-X
the	B-X
rRNA	B-X
gene	B-X
promoter	B-X
.	B-X
Furthermore	B-X
,	B-X
PTEN	B-X
induces	B-X
dissociation	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
through	B-X
a	B-X
novel	B-X
mechanism	B-X
that	B-X
involves	B-X
disruption	B-X
of	B-X
the	B-X
SL1	B-X
complex	B-X
.	B-X

It	O
possesses	O
a	O
lipid	O
phosphatase	O
activity	O
that	O
represses	O
the	O
activation	O
of	O
PI3	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
/	O
Akt	B-Gene_or_gene_product
signaling	O
,	O
leading	O
to	O
decreased	O
cell	O
growth	O
,	O
proliferation	O
,	O
and	O
survival	O
.	O
<EOS>	B-X
It	B-X
possesses	B-X
a	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
that	B-X
represses	B-X
the	B-X
activation	B-X
of	B-X
PI3	B-X
kinase/Akt	B-X
signaling	B-X
,	B-X
leading	B-X
to	B-X
decreased	B-X
cell	B-X
growth	B-X
,	B-X
proliferation	B-X
,	B-X
and	B-X
survival	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
PTEN	B-X
in	B-X
PTEN-deficient	B-X
cells	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
,	B-X
while	B-X
decreasing	B-X
PTEN	B-X
expression	B-X
enhances	B-X
transcription	B-X
.	B-X
PTEN-mediated	B-X
repression	B-X
requires	B-X
its	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
and	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
p53	B-X
status	B-X
of	B-X
the	B-X
cell	B-X
.	B-X
This	B-X
event	B-X
can	B-X
be	B-X
uncoupled	B-X
from	B-X
PTEN	B-X
's	B-X
ability	B-X
to	B-X
regulate	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
RNA	B-X
Pol	B-X
I	B-X
is	B-X
regulated	B-X
through	B-X
PI3	B-X
kinase/Akt/mammalian	B-X
target	B-X
of	B-X
rapamycin/S6	B-X
kinase	B-X
,	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
constitutively	B-X
activated	B-X
S6	B-X
kinase	B-X
is	B-X
able	B-X
to	B-X
abrogate	B-X
transcription	B-X
repression	B-X
by	B-X
PTEN	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
through	B-X
a	B-X
novel	B-X
mechanism	B-X
that	B-X
involves	B-X
disruption	B-X
of	B-X
the	B-X
SL1	B-X
complex	B-X
.	B-X

The	O
potential	O
for	O
PTEN	B-Gene_or_gene_product
to	O
regulate	O
transcription	O
of	O
the	O
large	O
rRNAs	O
by	O
RNA	B-Gene_or_gene_product
polymerase	I-Gene_or_gene_product
I	I-Gene_or_gene_product
(	O
RNA	B-Gene_or_gene_product
Pol	I-Gene_or_gene_product
I	I-Gene_or_gene_product
)	O
was	O
investigated	O
.	O
<EOS>	B-X
PTEN	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
whose	B-X
function	B-X
is	B-X
frequently	B-X
lost	B-X
in	B-X
human	B-X
cancer	B-X
.	B-X
The	B-X
potential	B-X
for	B-X
PTEN	B-X
to	B-X
regulate	B-X
transcription	B-X
of	B-X
the	B-X
large	B-X
rRNAs	B-X
by	B-X
RNA	B-X
polymerase	B-X
I	B-X
(	B-X
RNA	B-X
Pol	B-X
I	B-X
)	B-X
was	B-X
investigated	B-X
.	B-X
As	B-X
increased	B-X
synthesis	B-X
of	B-X
rRNAs	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
neoplastic	B-X
transformation	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PTEN	B-X
to	B-X
control	B-X
the	B-X
transcription	B-X
of	B-X
rRNAs	B-X
might	B-X
be	B-X
crucial	B-X
for	B-X
its	B-X
tumor	B-X
suppressor	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
PTEN	B-X
in	B-X
PTEN-deficient	B-X
cells	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
,	B-X
while	B-X
decreasing	B-X
PTEN	B-X
expression	B-X
enhances	B-X
transcription	B-X
.	B-X
PTEN-mediated	B-X
repression	B-X
requires	B-X
its	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
and	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
p53	B-X
status	B-X
of	B-X
the	B-X
cell	B-X
.	B-X
This	B-X
event	B-X
can	B-X
be	B-X
uncoupled	B-X
from	B-X
PTEN	B-X
's	B-X
ability	B-X
to	B-X
regulate	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
RNA	B-X
Pol	B-X
I	B-X
is	B-X
regulated	B-X
through	B-X
PI3	B-X
kinase/Akt/mammalian	B-X
target	B-X
of	B-X
rapamycin/S6	B-X
kinase	B-X
,	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
constitutively	B-X
activated	B-X
S6	B-X
kinase	B-X
is	B-X
able	B-X
to	B-X
abrogate	B-X
transcription	B-X
repression	B-X
by	B-X
PTEN	B-X
.	B-X
No	B-X
change	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
components	B-X
,	B-X
upstream	B-X
binding	B-X
factor	B-X
or	B-X
SL1	B-X
,	B-X
was	B-X
observed	B-X
upon	B-X
PTEN	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
differentially	B-X
reduces	B-X
the	B-X
occupancy	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
on	B-X
the	B-X
rRNA	B-X
gene	B-X
promoter	B-X
.	B-X
Furthermore	B-X
,	B-X
PTEN	B-X
induces	B-X
dissociation	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
through	B-X
a	B-X
novel	B-X
mechanism	B-X
that	B-X
involves	B-X
disruption	B-X
of	B-X
the	B-X
SL1	B-X
complex	B-X
.	B-X

As	O
increased	O
synthesis	O
of	O
rRNAs	O
is	O
a	O
hallmark	O
of	O
neoplastic	O
transformation	O
,	O
the	O
ability	O
of	O
PTEN	B-Gene_or_gene_product
to	O
control	O
the	O
transcription	O
of	O
rRNAs	O
might	O
be	O
crucial	O
for	O
its	O
tumor	O
suppressor	O
function	O
.	O
<EOS>	B-X
PTEN	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
whose	B-X
function	B-X
is	B-X
frequently	B-X
lost	B-X
in	B-X
human	B-X
cancer	B-X
.	B-X
The	B-X
potential	B-X
for	B-X
PTEN	B-X
to	B-X
regulate	B-X
transcription	B-X
of	B-X
the	B-X
large	B-X
rRNAs	B-X
by	B-X
RNA	B-X
polymerase	B-X
I	B-X
(	B-X
RNA	B-X
Pol	B-X
I	B-X
)	B-X
was	B-X
investigated	B-X
.	B-X
As	B-X
increased	B-X
synthesis	B-X
of	B-X
rRNAs	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
neoplastic	B-X
transformation	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PTEN	B-X
to	B-X
control	B-X
the	B-X
transcription	B-X
of	B-X
rRNAs	B-X
might	B-X
be	B-X
crucial	B-X
for	B-X
its	B-X
tumor	B-X
suppressor	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
PTEN	B-X
in	B-X
PTEN-deficient	B-X
cells	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
,	B-X
while	B-X
decreasing	B-X
PTEN	B-X
expression	B-X
enhances	B-X
transcription	B-X
.	B-X
PTEN-mediated	B-X
repression	B-X
requires	B-X
its	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
and	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
p53	B-X
status	B-X
of	B-X
the	B-X
cell	B-X
.	B-X
This	B-X
event	B-X
can	B-X
be	B-X
uncoupled	B-X
from	B-X
PTEN	B-X
's	B-X
ability	B-X
to	B-X
regulate	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
RNA	B-X
Pol	B-X
I	B-X
is	B-X
regulated	B-X
through	B-X
PI3	B-X
kinase/Akt/mammalian	B-X
target	B-X
of	B-X
rapamycin/S6	B-X
kinase	B-X
,	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
constitutively	B-X
activated	B-X
S6	B-X
kinase	B-X
is	B-X
able	B-X
to	B-X
abrogate	B-X
transcription	B-X
repression	B-X
by	B-X
PTEN	B-X
.	B-X
No	B-X
change	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
components	B-X
,	B-X
upstream	B-X
binding	B-X
factor	B-X
or	B-X
SL1	B-X
,	B-X
was	B-X
observed	B-X
upon	B-X
PTEN	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
differentially	B-X
reduces	B-X
the	B-X
occupancy	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
on	B-X
the	B-X
rRNA	B-X
gene	B-X
promoter	B-X
.	B-X
Furthermore	B-X
,	B-X
PTEN	B-X
induces	B-X
dissociation	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
through	B-X
a	B-X
novel	B-X
mechanism	B-X
that	B-X
involves	B-X
disruption	B-X
of	B-X
the	B-X
SL1	B-X
complex	B-X
.	B-X

The	O
expression	O
of	O
PTEN	B-Gene_or_gene_product
in	O
PTEN	B-Gene_or_gene_product
-	O
deficient	O
cells	O
represses	O
RNA	B-Gene_or_gene_product
Pol	I-Gene_or_gene_product
I	I-Gene_or_gene_product
transcription	O
,	O
while	O
decreasing	O
PTEN	B-Gene_or_gene_product
expression	O
enhances	O
transcription	O
.	O
<EOS>	B-X
PTEN	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
whose	B-X
function	B-X
is	B-X
frequently	B-X
lost	B-X
in	B-X
human	B-X
cancer	B-X
.	B-X
It	B-X
possesses	B-X
a	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
that	B-X
represses	B-X
the	B-X
activation	B-X
of	B-X
PI3	B-X
kinase/Akt	B-X
signaling	B-X
,	B-X
leading	B-X
to	B-X
decreased	B-X
cell	B-X
growth	B-X
,	B-X
proliferation	B-X
,	B-X
and	B-X
survival	B-X
.	B-X
The	B-X
potential	B-X
for	B-X
PTEN	B-X
to	B-X
regulate	B-X
transcription	B-X
of	B-X
the	B-X
large	B-X
rRNAs	B-X
by	B-X
RNA	B-X
polymerase	B-X
I	B-X
(	B-X
RNA	B-X
Pol	B-X
I	B-X
)	B-X
was	B-X
investigated	B-X
.	B-X
As	B-X
increased	B-X
synthesis	B-X
of	B-X
rRNAs	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
neoplastic	B-X
transformation	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PTEN	B-X
to	B-X
control	B-X
the	B-X
transcription	B-X
of	B-X
rRNAs	B-X
might	B-X
be	B-X
crucial	B-X
for	B-X
its	B-X
tumor	B-X
suppressor	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
PTEN	B-X
in	B-X
PTEN-deficient	B-X
cells	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
,	B-X
while	B-X
decreasing	B-X
PTEN	B-X
expression	B-X
enhances	B-X
transcription	B-X
.	B-X
PTEN-mediated	B-X
repression	B-X
requires	B-X
its	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
and	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
p53	B-X
status	B-X
of	B-X
the	B-X
cell	B-X
.	B-X
This	B-X
event	B-X
can	B-X
be	B-X
uncoupled	B-X
from	B-X
PTEN	B-X
's	B-X
ability	B-X
to	B-X
regulate	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
RNA	B-X
Pol	B-X
I	B-X
is	B-X
regulated	B-X
through	B-X
PI3	B-X
kinase/Akt/mammalian	B-X
target	B-X
of	B-X
rapamycin/S6	B-X
kinase	B-X
,	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
constitutively	B-X
activated	B-X
S6	B-X
kinase	B-X
is	B-X
able	B-X
to	B-X
abrogate	B-X
transcription	B-X
repression	B-X
by	B-X
PTEN	B-X
.	B-X
No	B-X
change	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
components	B-X
,	B-X
upstream	B-X
binding	B-X
factor	B-X
or	B-X
SL1	B-X
,	B-X
was	B-X
observed	B-X
upon	B-X
PTEN	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
differentially	B-X
reduces	B-X
the	B-X
occupancy	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
on	B-X
the	B-X
rRNA	B-X
gene	B-X
promoter	B-X
.	B-X
Furthermore	B-X
,	B-X
PTEN	B-X
induces	B-X
dissociation	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
through	B-X
a	B-X
novel	B-X
mechanism	B-X
that	B-X
involves	B-X
disruption	B-X
of	B-X
the	B-X
SL1	B-X
complex	B-X
.	B-X

PTEN	B-Gene_or_gene_product
-	O
mediated	O
repression	O
requires	O
its	O
lipid	O
phosphatase	O
activity	O
and	O
is	O
independent	O
of	O
the	O
p53	B-Gene_or_gene_product
status	O
of	O
the	O
cell	O
.	O
<EOS>	B-X
PTEN	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
whose	B-X
function	B-X
is	B-X
frequently	B-X
lost	B-X
in	B-X
human	B-X
cancer	B-X
.	B-X
It	B-X
possesses	B-X
a	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
that	B-X
represses	B-X
the	B-X
activation	B-X
of	B-X
PI3	B-X
kinase/Akt	B-X
signaling	B-X
,	B-X
leading	B-X
to	B-X
decreased	B-X
cell	B-X
growth	B-X
,	B-X
proliferation	B-X
,	B-X
and	B-X
survival	B-X
.	B-X
The	B-X
potential	B-X
for	B-X
PTEN	B-X
to	B-X
regulate	B-X
transcription	B-X
of	B-X
the	B-X
large	B-X
rRNAs	B-X
by	B-X
RNA	B-X
polymerase	B-X
I	B-X
(	B-X
RNA	B-X
Pol	B-X
I	B-X
)	B-X
was	B-X
investigated	B-X
.	B-X
As	B-X
increased	B-X
synthesis	B-X
of	B-X
rRNAs	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
neoplastic	B-X
transformation	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PTEN	B-X
to	B-X
control	B-X
the	B-X
transcription	B-X
of	B-X
rRNAs	B-X
might	B-X
be	B-X
crucial	B-X
for	B-X
its	B-X
tumor	B-X
suppressor	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
PTEN	B-X
in	B-X
PTEN-deficient	B-X
cells	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
,	B-X
while	B-X
decreasing	B-X
PTEN	B-X
expression	B-X
enhances	B-X
transcription	B-X
.	B-X
PTEN-mediated	B-X
repression	B-X
requires	B-X
its	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
and	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
p53	B-X
status	B-X
of	B-X
the	B-X
cell	B-X
.	B-X
This	B-X
event	B-X
can	B-X
be	B-X
uncoupled	B-X
from	B-X
PTEN	B-X
's	B-X
ability	B-X
to	B-X
regulate	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
RNA	B-X
Pol	B-X
I	B-X
is	B-X
regulated	B-X
through	B-X
PI3	B-X
kinase/Akt/mammalian	B-X
target	B-X
of	B-X
rapamycin/S6	B-X
kinase	B-X
,	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
constitutively	B-X
activated	B-X
S6	B-X
kinase	B-X
is	B-X
able	B-X
to	B-X
abrogate	B-X
transcription	B-X
repression	B-X
by	B-X
PTEN	B-X
.	B-X
No	B-X
change	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
components	B-X
,	B-X
upstream	B-X
binding	B-X
factor	B-X
or	B-X
SL1	B-X
,	B-X
was	B-X
observed	B-X
upon	B-X
PTEN	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
differentially	B-X
reduces	B-X
the	B-X
occupancy	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
on	B-X
the	B-X
rRNA	B-X
gene	B-X
promoter	B-X
.	B-X
Furthermore	B-X
,	B-X
PTEN	B-X
induces	B-X
dissociation	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
through	B-X
a	B-X
novel	B-X
mechanism	B-X
that	B-X
involves	B-X
disruption	B-X
of	B-X
the	B-X
SL1	B-X
complex	B-X
.	B-X

This	O
event	O
can	O
be	O
uncoupled	O
from	O
PTEN	B-Gene_or_gene_product
'	O
s	O
ability	O
to	O
regulate	O
the	O
cell	O
cycle	O
.	O
<EOS>	B-X
PTEN	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
whose	B-X
function	B-X
is	B-X
frequently	B-X
lost	B-X
in	B-X
human	B-X
cancer	B-X
.	B-X
It	B-X
possesses	B-X
a	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
that	B-X
represses	B-X
the	B-X
activation	B-X
of	B-X
PI3	B-X
kinase/Akt	B-X
signaling	B-X
,	B-X
leading	B-X
to	B-X
decreased	B-X
cell	B-X
growth	B-X
,	B-X
proliferation	B-X
,	B-X
and	B-X
survival	B-X
.	B-X
The	B-X
potential	B-X
for	B-X
PTEN	B-X
to	B-X
regulate	B-X
transcription	B-X
of	B-X
the	B-X
large	B-X
rRNAs	B-X
by	B-X
RNA	B-X
polymerase	B-X
I	B-X
(	B-X
RNA	B-X
Pol	B-X
I	B-X
)	B-X
was	B-X
investigated	B-X
.	B-X
As	B-X
increased	B-X
synthesis	B-X
of	B-X
rRNAs	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
neoplastic	B-X
transformation	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PTEN	B-X
to	B-X
control	B-X
the	B-X
transcription	B-X
of	B-X
rRNAs	B-X
might	B-X
be	B-X
crucial	B-X
for	B-X
its	B-X
tumor	B-X
suppressor	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
PTEN	B-X
in	B-X
PTEN-deficient	B-X
cells	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
,	B-X
while	B-X
decreasing	B-X
PTEN	B-X
expression	B-X
enhances	B-X
transcription	B-X
.	B-X
PTEN-mediated	B-X
repression	B-X
requires	B-X
its	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
and	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
p53	B-X
status	B-X
of	B-X
the	B-X
cell	B-X
.	B-X
This	B-X
event	B-X
can	B-X
be	B-X
uncoupled	B-X
from	B-X
PTEN	B-X
's	B-X
ability	B-X
to	B-X
regulate	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
RNA	B-X
Pol	B-X
I	B-X
is	B-X
regulated	B-X
through	B-X
PI3	B-X
kinase/Akt/mammalian	B-X
target	B-X
of	B-X
rapamycin/S6	B-X
kinase	B-X
,	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
constitutively	B-X
activated	B-X
S6	B-X
kinase	B-X
is	B-X
able	B-X
to	B-X
abrogate	B-X
transcription	B-X
repression	B-X
by	B-X
PTEN	B-X
.	B-X
No	B-X
change	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
components	B-X
,	B-X
upstream	B-X
binding	B-X
factor	B-X
or	B-X
SL1	B-X
,	B-X
was	B-X
observed	B-X
upon	B-X
PTEN	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
differentially	B-X
reduces	B-X
the	B-X
occupancy	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
on	B-X
the	B-X
rRNA	B-X
gene	B-X
promoter	B-X
.	B-X
Furthermore	B-X
,	B-X
PTEN	B-X
induces	B-X
dissociation	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
through	B-X
a	B-X
novel	B-X
mechanism	B-X
that	B-X
involves	B-X
disruption	B-X
of	B-X
the	B-X
SL1	B-X
complex	B-X
.	B-X

RNA	B-Gene_or_gene_product
Pol	I-Gene_or_gene_product
I	I-Gene_or_gene_product
is	O
regulated	O
through	O
PI3	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
/	O
Akt	B-Gene_or_gene_product
/	O
mammalian	B-Gene_or_gene_product
target	I-Gene_or_gene_product
of	I-Gene_or_gene_product
rapamycin	I-Gene_or_gene_product
/	O
S6	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
,	O
and	O
the	O
expression	O
of	O
constitutively	O
activated	O
S6	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
is	O
able	O
to	O
abrogate	O
transcription	O
repression	O
by	O
PTEN	B-Gene_or_gene_product
.	O
<EOS>	B-X
PTEN	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
whose	B-X
function	B-X
is	B-X
frequently	B-X
lost	B-X
in	B-X
human	B-X
cancer	B-X
.	B-X
It	B-X
possesses	B-X
a	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
that	B-X
represses	B-X
the	B-X
activation	B-X
of	B-X
PI3	B-X
kinase/Akt	B-X
signaling	B-X
,	B-X
leading	B-X
to	B-X
decreased	B-X
cell	B-X
growth	B-X
,	B-X
proliferation	B-X
,	B-X
and	B-X
survival	B-X
.	B-X
The	B-X
potential	B-X
for	B-X
PTEN	B-X
to	B-X
regulate	B-X
transcription	B-X
of	B-X
the	B-X
large	B-X
rRNAs	B-X
by	B-X
RNA	B-X
polymerase	B-X
I	B-X
(	B-X
RNA	B-X
Pol	B-X
I	B-X
)	B-X
was	B-X
investigated	B-X
.	B-X
As	B-X
increased	B-X
synthesis	B-X
of	B-X
rRNAs	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
neoplastic	B-X
transformation	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PTEN	B-X
to	B-X
control	B-X
the	B-X
transcription	B-X
of	B-X
rRNAs	B-X
might	B-X
be	B-X
crucial	B-X
for	B-X
its	B-X
tumor	B-X
suppressor	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
PTEN	B-X
in	B-X
PTEN-deficient	B-X
cells	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
,	B-X
while	B-X
decreasing	B-X
PTEN	B-X
expression	B-X
enhances	B-X
transcription	B-X
.	B-X
PTEN-mediated	B-X
repression	B-X
requires	B-X
its	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
and	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
p53	B-X
status	B-X
of	B-X
the	B-X
cell	B-X
.	B-X
This	B-X
event	B-X
can	B-X
be	B-X
uncoupled	B-X
from	B-X
PTEN	B-X
's	B-X
ability	B-X
to	B-X
regulate	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
RNA	B-X
Pol	B-X
I	B-X
is	B-X
regulated	B-X
through	B-X
PI3	B-X
kinase/Akt/mammalian	B-X
target	B-X
of	B-X
rapamycin/S6	B-X
kinase	B-X
,	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
constitutively	B-X
activated	B-X
S6	B-X
kinase	B-X
is	B-X
able	B-X
to	B-X
abrogate	B-X
transcription	B-X
repression	B-X
by	B-X
PTEN	B-X
.	B-X
No	B-X
change	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
components	B-X
,	B-X
upstream	B-X
binding	B-X
factor	B-X
or	B-X
SL1	B-X
,	B-X
was	B-X
observed	B-X
upon	B-X
PTEN	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
differentially	B-X
reduces	B-X
the	B-X
occupancy	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
on	B-X
the	B-X
rRNA	B-X
gene	B-X
promoter	B-X
.	B-X
Furthermore	B-X
,	B-X
PTEN	B-X
induces	B-X
dissociation	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
through	B-X
a	B-X
novel	B-X
mechanism	B-X
that	B-X
involves	B-X
disruption	B-X
of	B-X
the	B-X
SL1	B-X
complex	B-X
.	B-X

No	O
change	O
in	O
the	O
expression	O
of	O
the	O
RNA	B-Gene_or_gene_product
Pol	I-Gene_or_gene_product
I	I-Gene_or_gene_product
transcription	O
components	O
,	O
upstream	B-Gene_or_gene_product
binding	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
or	O
SL1	B-Gene_or_gene_product
,	O
was	O
observed	O
upon	O
PTEN	B-Gene_or_gene_product
expression	O
.	O
<EOS>	B-X
PTEN	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
whose	B-X
function	B-X
is	B-X
frequently	B-X
lost	B-X
in	B-X
human	B-X
cancer	B-X
.	B-X
The	B-X
potential	B-X
for	B-X
PTEN	B-X
to	B-X
regulate	B-X
transcription	B-X
of	B-X
the	B-X
large	B-X
rRNAs	B-X
by	B-X
RNA	B-X
polymerase	B-X
I	B-X
(	B-X
RNA	B-X
Pol	B-X
I	B-X
)	B-X
was	B-X
investigated	B-X
.	B-X
As	B-X
increased	B-X
synthesis	B-X
of	B-X
rRNAs	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
neoplastic	B-X
transformation	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PTEN	B-X
to	B-X
control	B-X
the	B-X
transcription	B-X
of	B-X
rRNAs	B-X
might	B-X
be	B-X
crucial	B-X
for	B-X
its	B-X
tumor	B-X
suppressor	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
PTEN	B-X
in	B-X
PTEN-deficient	B-X
cells	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
,	B-X
while	B-X
decreasing	B-X
PTEN	B-X
expression	B-X
enhances	B-X
transcription	B-X
.	B-X
PTEN-mediated	B-X
repression	B-X
requires	B-X
its	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
and	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
p53	B-X
status	B-X
of	B-X
the	B-X
cell	B-X
.	B-X
This	B-X
event	B-X
can	B-X
be	B-X
uncoupled	B-X
from	B-X
PTEN	B-X
's	B-X
ability	B-X
to	B-X
regulate	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
RNA	B-X
Pol	B-X
I	B-X
is	B-X
regulated	B-X
through	B-X
PI3	B-X
kinase/Akt/mammalian	B-X
target	B-X
of	B-X
rapamycin/S6	B-X
kinase	B-X
,	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
constitutively	B-X
activated	B-X
S6	B-X
kinase	B-X
is	B-X
able	B-X
to	B-X
abrogate	B-X
transcription	B-X
repression	B-X
by	B-X
PTEN	B-X
.	B-X
No	B-X
change	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
components	B-X
,	B-X
upstream	B-X
binding	B-X
factor	B-X
or	B-X
SL1	B-X
,	B-X
was	B-X
observed	B-X
upon	B-X
PTEN	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
differentially	B-X
reduces	B-X
the	B-X
occupancy	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
on	B-X
the	B-X
rRNA	B-X
gene	B-X
promoter	B-X
.	B-X
Furthermore	B-X
,	B-X
PTEN	B-X
induces	B-X
dissociation	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
through	B-X
a	B-X
novel	B-X
mechanism	B-X
that	B-X
involves	B-X
disruption	B-X
of	B-X
the	B-X
SL1	B-X
complex	B-X
.	B-X

However	O
,	O
chromatin	O
immunoprecipitation	O
assays	O
demonstrate	O
that	O
PTEN	B-Gene_or_gene_product
differentially	O
reduces	O
the	O
occupancy	O
of	O
the	O
SL1	B-Gene_or_gene_product
subunits	O
on	O
the	O
rRNA	O
gene	O
promoter	O
.	O
<EOS>	B-X
PTEN	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
whose	B-X
function	B-X
is	B-X
frequently	B-X
lost	B-X
in	B-X
human	B-X
cancer	B-X
.	B-X
The	B-X
potential	B-X
for	B-X
PTEN	B-X
to	B-X
regulate	B-X
transcription	B-X
of	B-X
the	B-X
large	B-X
rRNAs	B-X
by	B-X
RNA	B-X
polymerase	B-X
I	B-X
(	B-X
RNA	B-X
Pol	B-X
I	B-X
)	B-X
was	B-X
investigated	B-X
.	B-X
As	B-X
increased	B-X
synthesis	B-X
of	B-X
rRNAs	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
neoplastic	B-X
transformation	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PTEN	B-X
to	B-X
control	B-X
the	B-X
transcription	B-X
of	B-X
rRNAs	B-X
might	B-X
be	B-X
crucial	B-X
for	B-X
its	B-X
tumor	B-X
suppressor	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
PTEN	B-X
in	B-X
PTEN-deficient	B-X
cells	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
,	B-X
while	B-X
decreasing	B-X
PTEN	B-X
expression	B-X
enhances	B-X
transcription	B-X
.	B-X
PTEN-mediated	B-X
repression	B-X
requires	B-X
its	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
and	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
p53	B-X
status	B-X
of	B-X
the	B-X
cell	B-X
.	B-X
This	B-X
event	B-X
can	B-X
be	B-X
uncoupled	B-X
from	B-X
PTEN	B-X
's	B-X
ability	B-X
to	B-X
regulate	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
RNA	B-X
Pol	B-X
I	B-X
is	B-X
regulated	B-X
through	B-X
PI3	B-X
kinase/Akt/mammalian	B-X
target	B-X
of	B-X
rapamycin/S6	B-X
kinase	B-X
,	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
constitutively	B-X
activated	B-X
S6	B-X
kinase	B-X
is	B-X
able	B-X
to	B-X
abrogate	B-X
transcription	B-X
repression	B-X
by	B-X
PTEN	B-X
.	B-X
No	B-X
change	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
components	B-X
,	B-X
upstream	B-X
binding	B-X
factor	B-X
or	B-X
SL1	B-X
,	B-X
was	B-X
observed	B-X
upon	B-X
PTEN	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
differentially	B-X
reduces	B-X
the	B-X
occupancy	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
on	B-X
the	B-X
rRNA	B-X
gene	B-X
promoter	B-X
.	B-X
Furthermore	B-X
,	B-X
PTEN	B-X
induces	B-X
dissociation	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
through	B-X
a	B-X
novel	B-X
mechanism	B-X
that	B-X
involves	B-X
disruption	B-X
of	B-X
the	B-X
SL1	B-X
complex	B-X
.	B-X

Furthermore	O
,	O
PTEN	B-Gene_or_gene_product
induces	O
dissociation	O
of	O
the	O
SL1	B-Gene_or_gene_product
subunits	O
.	O
<EOS>	B-X
PTEN	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
whose	B-X
function	B-X
is	B-X
frequently	B-X
lost	B-X
in	B-X
human	B-X
cancer	B-X
.	B-X
The	B-X
potential	B-X
for	B-X
PTEN	B-X
to	B-X
regulate	B-X
transcription	B-X
of	B-X
the	B-X
large	B-X
rRNAs	B-X
by	B-X
RNA	B-X
polymerase	B-X
I	B-X
(	B-X
RNA	B-X
Pol	B-X
I	B-X
)	B-X
was	B-X
investigated	B-X
.	B-X
As	B-X
increased	B-X
synthesis	B-X
of	B-X
rRNAs	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
neoplastic	B-X
transformation	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PTEN	B-X
to	B-X
control	B-X
the	B-X
transcription	B-X
of	B-X
rRNAs	B-X
might	B-X
be	B-X
crucial	B-X
for	B-X
its	B-X
tumor	B-X
suppressor	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
PTEN	B-X
in	B-X
PTEN-deficient	B-X
cells	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
,	B-X
while	B-X
decreasing	B-X
PTEN	B-X
expression	B-X
enhances	B-X
transcription	B-X
.	B-X
PTEN-mediated	B-X
repression	B-X
requires	B-X
its	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
and	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
p53	B-X
status	B-X
of	B-X
the	B-X
cell	B-X
.	B-X
This	B-X
event	B-X
can	B-X
be	B-X
uncoupled	B-X
from	B-X
PTEN	B-X
's	B-X
ability	B-X
to	B-X
regulate	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
RNA	B-X
Pol	B-X
I	B-X
is	B-X
regulated	B-X
through	B-X
PI3	B-X
kinase/Akt/mammalian	B-X
target	B-X
of	B-X
rapamycin/S6	B-X
kinase	B-X
,	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
constitutively	B-X
activated	B-X
S6	B-X
kinase	B-X
is	B-X
able	B-X
to	B-X
abrogate	B-X
transcription	B-X
repression	B-X
by	B-X
PTEN	B-X
.	B-X
No	B-X
change	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
components	B-X
,	B-X
upstream	B-X
binding	B-X
factor	B-X
or	B-X
SL1	B-X
,	B-X
was	B-X
observed	B-X
upon	B-X
PTEN	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
differentially	B-X
reduces	B-X
the	B-X
occupancy	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
on	B-X
the	B-X
rRNA	B-X
gene	B-X
promoter	B-X
.	B-X
Furthermore	B-X
,	B-X
PTEN	B-X
induces	B-X
dissociation	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
through	B-X
a	B-X
novel	B-X
mechanism	B-X
that	B-X
involves	B-X
disruption	B-X
of	B-X
the	B-X
SL1	B-X
complex	B-X
.	B-X

Together	O
,	O
these	O
results	O
demonstrate	O
that	O
PTEN	B-Gene_or_gene_product
represses	O
RNA	B-Gene_or_gene_product
Pol	I-Gene_or_gene_product
I	I-Gene_or_gene_product
transcription	O
through	O
a	O
novel	O
mechanism	O
that	O
involves	O
disruption	O
of	O
the	O
SL1	O
complex	O
.	O
<EOS>	B-X
PTEN	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
whose	B-X
function	B-X
is	B-X
frequently	B-X
lost	B-X
in	B-X
human	B-X
cancer	B-X
.	B-X
It	B-X
possesses	B-X
a	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
that	B-X
represses	B-X
the	B-X
activation	B-X
of	B-X
PI3	B-X
kinase/Akt	B-X
signaling	B-X
,	B-X
leading	B-X
to	B-X
decreased	B-X
cell	B-X
growth	B-X
,	B-X
proliferation	B-X
,	B-X
and	B-X
survival	B-X
.	B-X
The	B-X
potential	B-X
for	B-X
PTEN	B-X
to	B-X
regulate	B-X
transcription	B-X
of	B-X
the	B-X
large	B-X
rRNAs	B-X
by	B-X
RNA	B-X
polymerase	B-X
I	B-X
(	B-X
RNA	B-X
Pol	B-X
I	B-X
)	B-X
was	B-X
investigated	B-X
.	B-X
As	B-X
increased	B-X
synthesis	B-X
of	B-X
rRNAs	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
neoplastic	B-X
transformation	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
PTEN	B-X
to	B-X
control	B-X
the	B-X
transcription	B-X
of	B-X
rRNAs	B-X
might	B-X
be	B-X
crucial	B-X
for	B-X
its	B-X
tumor	B-X
suppressor	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
PTEN	B-X
in	B-X
PTEN-deficient	B-X
cells	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
,	B-X
while	B-X
decreasing	B-X
PTEN	B-X
expression	B-X
enhances	B-X
transcription	B-X
.	B-X
PTEN-mediated	B-X
repression	B-X
requires	B-X
its	B-X
lipid	B-X
phosphatase	B-X
activity	B-X
and	B-X
is	B-X
independent	B-X
of	B-X
the	B-X
p53	B-X
status	B-X
of	B-X
the	B-X
cell	B-X
.	B-X
This	B-X
event	B-X
can	B-X
be	B-X
uncoupled	B-X
from	B-X
PTEN	B-X
's	B-X
ability	B-X
to	B-X
regulate	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
RNA	B-X
Pol	B-X
I	B-X
is	B-X
regulated	B-X
through	B-X
PI3	B-X
kinase/Akt/mammalian	B-X
target	B-X
of	B-X
rapamycin/S6	B-X
kinase	B-X
,	B-X
and	B-X
the	B-X
expression	B-X
of	B-X
constitutively	B-X
activated	B-X
S6	B-X
kinase	B-X
is	B-X
able	B-X
to	B-X
abrogate	B-X
transcription	B-X
repression	B-X
by	B-X
PTEN	B-X
.	B-X
No	B-X
change	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
components	B-X
,	B-X
upstream	B-X
binding	B-X
factor	B-X
or	B-X
SL1	B-X
,	B-X
was	B-X
observed	B-X
upon	B-X
PTEN	B-X
expression	B-X
.	B-X
However	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
differentially	B-X
reduces	B-X
the	B-X
occupancy	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
on	B-X
the	B-X
rRNA	B-X
gene	B-X
promoter	B-X
.	B-X
Furthermore	B-X
,	B-X
PTEN	B-X
induces	B-X
dissociation	B-X
of	B-X
the	B-X
SL1	B-X
subunits	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
demonstrate	B-X
that	B-X
PTEN	B-X
represses	B-X
RNA	B-X
Pol	B-X
I	B-X
transcription	B-X
through	B-X
a	B-X
novel	B-X
mechanism	B-X
that	B-X
involves	B-X
disruption	B-X
of	B-X
the	B-X
SL1	B-X
complex	B-X
.	B-X

Pocket	O
protein	O
complexes	O
are	O
recruited	O
to	O
distinct	O
targets	O
in	O
quiescent	O
and	O
proliferating	O
cells	O
.	O
<EOS>	B-X
Biochemical	B-X
and	B-X
genetic	B-X
studies	B-X
have	B-X
determined	B-X
that	B-X
retinoblastoma	B-X
protein	B-X
(	B-X
pRB	B-X
)	B-X
tumor	B-X
suppressor	B-X
family	B-X
members	B-X
have	B-X
overlapping	B-X
functions	B-X
.	B-X
However	B-X
,	B-X
these	B-X
studies	B-X
have	B-X
largely	B-X
failed	B-X
to	B-X
distinguish	B-X
functional	B-X
differences	B-X
between	B-X
the	B-X
highly	B-X
related	B-X
p107	B-X
and	B-X
p130	B-X
proteins	B-X
.	B-X
Moreover	B-X
,	B-X
most	B-X
studies	B-X
pertaining	B-X
to	B-X
the	B-X
pRB	B-X
family	B-X
and	B-X
its	B-X
principal	B-X
target	B-X
,	B-X
the	B-X
E2F	B-X
transcription	B-X
factor	B-X
,	B-X
have	B-X
focused	B-X
on	B-X
cells	B-X
that	B-X
have	B-X
reinitiated	B-X
a	B-X
cell	B-X
cycle	B-X
from	B-X
quiescence	B-X
,	B-X
although	B-X
recent	B-X
studies	B-X
suggest	B-X
that	B-X
cycling	B-X
cells	B-X
exhibit	B-X
layers	B-X
of	B-X
regulation	B-X
distinct	B-X
from	B-X
mitogenically	B-X
stimulated	B-X
cells	B-X
.	B-X
Using	B-X
genome-wide	B-X
chromatin	B-X
immunoprecipitation	B-X
,	B-X
we	B-X
show	B-X
that	B-X
there	B-X
are	B-X
distinct	B-X
classes	B-X
of	B-X
genes	B-X
directly	B-X
regulated	B-X
by	B-X
unique	B-X
combinations	B-X
of	B-X
E2F4	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
,	B-X
including	B-X
a	B-X
group	B-X
of	B-X
genes	B-X
specifically	B-X
regulated	B-X
in	B-X
cycling	B-X
cells	B-X
.	B-X
These	B-X
groups	B-X
exhibit	B-X
both	B-X
distinct	B-X
histone	B-X
acetylation	B-X
signatures	B-X
and	B-X
patterns	B-X
of	B-X
mammalian	B-X
Sin3B	B-X
corepressor	B-X
recruitment	B-X
.	B-X
Our	B-X
findings	B-X
suggest	B-X
that	B-X
cell	B-X
cycle-dependent	B-X
repression	B-X
results	B-X
from	B-X
recruitment	B-X
of	B-X
an	B-X
unexpected	B-X
array	B-X
of	B-X
diverse	B-X
complexes	B-X
and	B-X
reveals	B-X
specific	B-X
differences	B-X
between	B-X
transcriptional	B-X
regulation	B-X
in	B-X
cycling	B-X
and	B-X
quiescent	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
factor	B-X
location	B-X
analyses	B-X
have	B-X
,	B-X
for	B-X
the	B-X
first	B-X
time	B-X
,	B-X
allowed	B-X
the	B-X
identification	B-X
of	B-X
novel	B-X
and	B-X
specific	B-X
targets	B-X
of	B-X
the	B-X
highly	B-X
related	B-X
transcriptional	B-X
regulators	B-X
p107	B-X
and	B-X
p130	B-X
,	B-X
suggesting	B-X
new	B-X
and	B-X
distinct	B-X
regulatory	B-X
networks	B-X
engaged	B-X
by	B-X
each	B-X
protein	B-X
in	B-X
continuously	B-X
cycling	B-X
cells	B-X
.	B-X

Biochemical	O
and	O
genetic	O
studies	O
have	O
determined	O
that	O
retinoblastoma	B-Gene_or_gene_product
protein	O
(	O
pRB	B-Gene_or_gene_product
)	O
tumor	O
suppressor	O
family	O
members	O
have	O
overlapping	O
functions	O
.	O
<EOS>	B-X
Biochemical	B-X
and	B-X
genetic	B-X
studies	B-X
have	B-X
determined	B-X
that	B-X
retinoblastoma	B-X
protein	B-X
(	B-X
pRB	B-X
)	B-X
tumor	B-X
suppressor	B-X
family	B-X
members	B-X
have	B-X
overlapping	B-X
functions	B-X
.	B-X
However	B-X
,	B-X
these	B-X
studies	B-X
have	B-X
largely	B-X
failed	B-X
to	B-X
distinguish	B-X
functional	B-X
differences	B-X
between	B-X
the	B-X
highly	B-X
related	B-X
p107	B-X
and	B-X
p130	B-X
proteins	B-X
.	B-X
Moreover	B-X
,	B-X
most	B-X
studies	B-X
pertaining	B-X
to	B-X
the	B-X
pRB	B-X
family	B-X
and	B-X
its	B-X
principal	B-X
target	B-X
,	B-X
the	B-X
E2F	B-X
transcription	B-X
factor	B-X
,	B-X
have	B-X
focused	B-X
on	B-X
cells	B-X
that	B-X
have	B-X
reinitiated	B-X
a	B-X
cell	B-X
cycle	B-X
from	B-X
quiescence	B-X
,	B-X
although	B-X
recent	B-X
studies	B-X
suggest	B-X
that	B-X
cycling	B-X
cells	B-X
exhibit	B-X
layers	B-X
of	B-X
regulation	B-X
distinct	B-X
from	B-X
mitogenically	B-X
stimulated	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
factor	B-X
location	B-X
analyses	B-X
have	B-X
,	B-X
for	B-X
the	B-X
first	B-X
time	B-X
,	B-X
allowed	B-X
the	B-X
identification	B-X
of	B-X
novel	B-X
and	B-X
specific	B-X
targets	B-X
of	B-X
the	B-X
highly	B-X
related	B-X
transcriptional	B-X
regulators	B-X
p107	B-X
and	B-X
p130	B-X
,	B-X
suggesting	B-X
new	B-X
and	B-X
distinct	B-X
regulatory	B-X
networks	B-X
engaged	B-X
by	B-X
each	B-X
protein	B-X
in	B-X
continuously	B-X
cycling	B-X
cells	B-X
.	B-X

However	O
,	O
these	O
studies	O
have	O
largely	O
failed	O
to	O
distinguish	O
functional	O
differences	O
between	O
the	O
highly	O
related	O
p107	B-Gene_or_gene_product
and	O
p130	B-Gene_or_gene_product
proteins	O
.	O
<EOS>	B-X
Biochemical	B-X
and	B-X
genetic	B-X
studies	B-X
have	B-X
determined	B-X
that	B-X
retinoblastoma	B-X
protein	B-X
(	B-X
pRB	B-X
)	B-X
tumor	B-X
suppressor	B-X
family	B-X
members	B-X
have	B-X
overlapping	B-X
functions	B-X
.	B-X
However	B-X
,	B-X
these	B-X
studies	B-X
have	B-X
largely	B-X
failed	B-X
to	B-X
distinguish	B-X
functional	B-X
differences	B-X
between	B-X
the	B-X
highly	B-X
related	B-X
p107	B-X
and	B-X
p130	B-X
proteins	B-X
.	B-X
Moreover	B-X
,	B-X
most	B-X
studies	B-X
pertaining	B-X
to	B-X
the	B-X
pRB	B-X
family	B-X
and	B-X
its	B-X
principal	B-X
target	B-X
,	B-X
the	B-X
E2F	B-X
transcription	B-X
factor	B-X
,	B-X
have	B-X
focused	B-X
on	B-X
cells	B-X
that	B-X
have	B-X
reinitiated	B-X
a	B-X
cell	B-X
cycle	B-X
from	B-X
quiescence	B-X
,	B-X
although	B-X
recent	B-X
studies	B-X
suggest	B-X
that	B-X
cycling	B-X
cells	B-X
exhibit	B-X
layers	B-X
of	B-X
regulation	B-X
distinct	B-X
from	B-X
mitogenically	B-X
stimulated	B-X
cells	B-X
.	B-X
Using	B-X
genome-wide	B-X
chromatin	B-X
immunoprecipitation	B-X
,	B-X
we	B-X
show	B-X
that	B-X
there	B-X
are	B-X
distinct	B-X
classes	B-X
of	B-X
genes	B-X
directly	B-X
regulated	B-X
by	B-X
unique	B-X
combinations	B-X
of	B-X
E2F4	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
,	B-X
including	B-X
a	B-X
group	B-X
of	B-X
genes	B-X
specifically	B-X
regulated	B-X
in	B-X
cycling	B-X
cells	B-X
.	B-X
Our	B-X
findings	B-X
suggest	B-X
that	B-X
cell	B-X
cycle-dependent	B-X
repression	B-X
results	B-X
from	B-X
recruitment	B-X
of	B-X
an	B-X
unexpected	B-X
array	B-X
of	B-X
diverse	B-X
complexes	B-X
and	B-X
reveals	B-X
specific	B-X
differences	B-X
between	B-X
transcriptional	B-X
regulation	B-X
in	B-X
cycling	B-X
and	B-X
quiescent	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
factor	B-X
location	B-X
analyses	B-X
have	B-X
,	B-X
for	B-X
the	B-X
first	B-X
time	B-X
,	B-X
allowed	B-X
the	B-X
identification	B-X
of	B-X
novel	B-X
and	B-X
specific	B-X
targets	B-X
of	B-X
the	B-X
highly	B-X
related	B-X
transcriptional	B-X
regulators	B-X
p107	B-X
and	B-X
p130	B-X
,	B-X
suggesting	B-X
new	B-X
and	B-X
distinct	B-X
regulatory	B-X
networks	B-X
engaged	B-X
by	B-X
each	B-X
protein	B-X
in	B-X
continuously	B-X
cycling	B-X
cells	B-X
.	B-X

Moreover	O
,	O
most	O
studies	O
pertaining	O
to	O
the	O
pRB	B-Gene_or_gene_product
family	O
and	O
its	O
principal	O
target	O
,	O
the	O
E2F	B-Gene_or_gene_product
transcription	O
factor	O
,	O
have	O
focused	O
on	O
cells	O
that	O
have	O
reinitiated	O
a	O
cell	O
cycle	O
from	O
quiescence	O
,	O
although	O
recent	O
studies	O
suggest	O
that	O
cycling	O
cells	O
exhibit	O
layers	O
of	O
regulation	O
distinct	O
from	O
mitogenically	O
stimulated	O
cells	O
.	O

Using	O
genome	O
-	O
wide	O
chromatin	O
immunoprecipitation	O
,	O
we	O
show	O
that	O
there	O
are	O
distinct	O
classes	O
of	O
genes	O
directly	O
regulated	O
by	O
unique	O
combinations	O
of	O
E2F4	B-Gene_or_gene_product
,	O
p107	B-Gene_or_gene_product
,	O
and	O
p130	B-Gene_or_gene_product
,	O
including	O
a	O
group	O
of	O
genes	O
specifically	O
regulated	O
in	O
cycling	O
cells	O
.	O
<EOS>	B-X
However	B-X
,	B-X
these	B-X
studies	B-X
have	B-X
largely	B-X
failed	B-X
to	B-X
distinguish	B-X
functional	B-X
differences	B-X
between	B-X
the	B-X
highly	B-X
related	B-X
p107	B-X
and	B-X
p130	B-X
proteins	B-X
.	B-X
Moreover	B-X
,	B-X
most	B-X
studies	B-X
pertaining	B-X
to	B-X
the	B-X
pRB	B-X
family	B-X
and	B-X
its	B-X
principal	B-X
target	B-X
,	B-X
the	B-X
E2F	B-X
transcription	B-X
factor	B-X
,	B-X
have	B-X
focused	B-X
on	B-X
cells	B-X
that	B-X
have	B-X
reinitiated	B-X
a	B-X
cell	B-X
cycle	B-X
from	B-X
quiescence	B-X
,	B-X
although	B-X
recent	B-X
studies	B-X
suggest	B-X
that	B-X
cycling	B-X
cells	B-X
exhibit	B-X
layers	B-X
of	B-X
regulation	B-X
distinct	B-X
from	B-X
mitogenically	B-X
stimulated	B-X
cells	B-X
.	B-X
Using	B-X
genome-wide	B-X
chromatin	B-X
immunoprecipitation	B-X
,	B-X
we	B-X
show	B-X
that	B-X
there	B-X
are	B-X
distinct	B-X
classes	B-X
of	B-X
genes	B-X
directly	B-X
regulated	B-X
by	B-X
unique	B-X
combinations	B-X
of	B-X
E2F4	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
,	B-X
including	B-X
a	B-X
group	B-X
of	B-X
genes	B-X
specifically	B-X
regulated	B-X
in	B-X
cycling	B-X
cells	B-X
.	B-X
These	B-X
groups	B-X
exhibit	B-X
both	B-X
distinct	B-X
histone	B-X
acetylation	B-X
signatures	B-X
and	B-X
patterns	B-X
of	B-X
mammalian	B-X
Sin3B	B-X
corepressor	B-X
recruitment	B-X
.	B-X
Our	B-X
findings	B-X
suggest	B-X
that	B-X
cell	B-X
cycle-dependent	B-X
repression	B-X
results	B-X
from	B-X
recruitment	B-X
of	B-X
an	B-X
unexpected	B-X
array	B-X
of	B-X
diverse	B-X
complexes	B-X
and	B-X
reveals	B-X
specific	B-X
differences	B-X
between	B-X
transcriptional	B-X
regulation	B-X
in	B-X
cycling	B-X
and	B-X
quiescent	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
factor	B-X
location	B-X
analyses	B-X
have	B-X
,	B-X
for	B-X
the	B-X
first	B-X
time	B-X
,	B-X
allowed	B-X
the	B-X
identification	B-X
of	B-X
novel	B-X
and	B-X
specific	B-X
targets	B-X
of	B-X
the	B-X
highly	B-X
related	B-X
transcriptional	B-X
regulators	B-X
p107	B-X
and	B-X
p130	B-X
,	B-X
suggesting	B-X
new	B-X
and	B-X
distinct	B-X
regulatory	B-X
networks	B-X
engaged	B-X
by	B-X
each	B-X
protein	B-X
in	B-X
continuously	B-X
cycling	B-X
cells	B-X
.	B-X

These	O
groups	O
exhibit	O
both	O
distinct	O
histone	B-Gene_or_gene_product
acetylation	O
signatures	O
and	O
patterns	O
of	O
mammalian	O
Sin3B	B-Gene_or_gene_product
corepressor	O
recruitment	O
.	O
<EOS>	B-X
Moreover	B-X
,	B-X
most	B-X
studies	B-X
pertaining	B-X
to	B-X
the	B-X
pRB	B-X
family	B-X
and	B-X
its	B-X
principal	B-X
target	B-X
,	B-X
the	B-X
E2F	B-X
transcription	B-X
factor	B-X
,	B-X
have	B-X
focused	B-X
on	B-X
cells	B-X
that	B-X
have	B-X
reinitiated	B-X
a	B-X
cell	B-X
cycle	B-X
from	B-X
quiescence	B-X
,	B-X
although	B-X
recent	B-X
studies	B-X
suggest	B-X
that	B-X
cycling	B-X
cells	B-X
exhibit	B-X
layers	B-X
of	B-X
regulation	B-X
distinct	B-X
from	B-X
mitogenically	B-X
stimulated	B-X
cells	B-X
.	B-X
Using	B-X
genome-wide	B-X
chromatin	B-X
immunoprecipitation	B-X
,	B-X
we	B-X
show	B-X
that	B-X
there	B-X
are	B-X
distinct	B-X
classes	B-X
of	B-X
genes	B-X
directly	B-X
regulated	B-X
by	B-X
unique	B-X
combinations	B-X
of	B-X
E2F4	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
,	B-X
including	B-X
a	B-X
group	B-X
of	B-X
genes	B-X
specifically	B-X
regulated	B-X
in	B-X
cycling	B-X
cells	B-X
.	B-X
These	B-X
groups	B-X
exhibit	B-X
both	B-X
distinct	B-X
histone	B-X
acetylation	B-X
signatures	B-X
and	B-X
patterns	B-X
of	B-X
mammalian	B-X
Sin3B	B-X
corepressor	B-X
recruitment	B-X
.	B-X
Our	B-X
findings	B-X
suggest	B-X
that	B-X
cell	B-X
cycle-dependent	B-X
repression	B-X
results	B-X
from	B-X
recruitment	B-X
of	B-X
an	B-X
unexpected	B-X
array	B-X
of	B-X
diverse	B-X
complexes	B-X
and	B-X
reveals	B-X
specific	B-X
differences	B-X
between	B-X
transcriptional	B-X
regulation	B-X
in	B-X
cycling	B-X
and	B-X
quiescent	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
factor	B-X
location	B-X
analyses	B-X
have	B-X
,	B-X
for	B-X
the	B-X
first	B-X
time	B-X
,	B-X
allowed	B-X
the	B-X
identification	B-X
of	B-X
novel	B-X
and	B-X
specific	B-X
targets	B-X
of	B-X
the	B-X
highly	B-X
related	B-X
transcriptional	B-X
regulators	B-X
p107	B-X
and	B-X
p130	B-X
,	B-X
suggesting	B-X
new	B-X
and	B-X
distinct	B-X
regulatory	B-X
networks	B-X
engaged	B-X
by	B-X
each	B-X
protein	B-X
in	B-X
continuously	B-X
cycling	B-X
cells	B-X
.	B-X

Our	O
findings	O
suggest	O
that	O
cell	O
cycle	O
-	O
dependent	O
repression	O
results	O
from	O
recruitment	O
of	O
an	O
unexpected	O
array	O
of	O
diverse	O
complexes	O
and	O
reveals	O
specific	O
differences	O
between	O
transcriptional	O
regulation	O
in	O
cycling	O
and	O
quiescent	O
cells	O
.	O
<EOS>	B-X
However	B-X
,	B-X
these	B-X
studies	B-X
have	B-X
largely	B-X
failed	B-X
to	B-X
distinguish	B-X
functional	B-X
differences	B-X
between	B-X
the	B-X
highly	B-X
related	B-X
p107	B-X
and	B-X
p130	B-X
proteins	B-X
.	B-X
Moreover	B-X
,	B-X
most	B-X
studies	B-X
pertaining	B-X
to	B-X
the	B-X
pRB	B-X
family	B-X
and	B-X
its	B-X
principal	B-X
target	B-X
,	B-X
the	B-X
E2F	B-X
transcription	B-X
factor	B-X
,	B-X
have	B-X
focused	B-X
on	B-X
cells	B-X
that	B-X
have	B-X
reinitiated	B-X
a	B-X
cell	B-X
cycle	B-X
from	B-X
quiescence	B-X
,	B-X
although	B-X
recent	B-X
studies	B-X
suggest	B-X
that	B-X
cycling	B-X
cells	B-X
exhibit	B-X
layers	B-X
of	B-X
regulation	B-X
distinct	B-X
from	B-X
mitogenically	B-X
stimulated	B-X
cells	B-X
.	B-X
Using	B-X
genome-wide	B-X
chromatin	B-X
immunoprecipitation	B-X
,	B-X
we	B-X
show	B-X
that	B-X
there	B-X
are	B-X
distinct	B-X
classes	B-X
of	B-X
genes	B-X
directly	B-X
regulated	B-X
by	B-X
unique	B-X
combinations	B-X
of	B-X
E2F4	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
,	B-X
including	B-X
a	B-X
group	B-X
of	B-X
genes	B-X
specifically	B-X
regulated	B-X
in	B-X
cycling	B-X
cells	B-X
.	B-X
These	B-X
groups	B-X
exhibit	B-X
both	B-X
distinct	B-X
histone	B-X
acetylation	B-X
signatures	B-X
and	B-X
patterns	B-X
of	B-X
mammalian	B-X
Sin3B	B-X
corepressor	B-X
recruitment	B-X
.	B-X
Our	B-X
findings	B-X
suggest	B-X
that	B-X
cell	B-X
cycle-dependent	B-X
repression	B-X
results	B-X
from	B-X
recruitment	B-X
of	B-X
an	B-X
unexpected	B-X
array	B-X
of	B-X
diverse	B-X
complexes	B-X
and	B-X
reveals	B-X
specific	B-X
differences	B-X
between	B-X
transcriptional	B-X
regulation	B-X
in	B-X
cycling	B-X
and	B-X
quiescent	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
factor	B-X
location	B-X
analyses	B-X
have	B-X
,	B-X
for	B-X
the	B-X
first	B-X
time	B-X
,	B-X
allowed	B-X
the	B-X
identification	B-X
of	B-X
novel	B-X
and	B-X
specific	B-X
targets	B-X
of	B-X
the	B-X
highly	B-X
related	B-X
transcriptional	B-X
regulators	B-X
p107	B-X
and	B-X
p130	B-X
,	B-X
suggesting	B-X
new	B-X
and	B-X
distinct	B-X
regulatory	B-X
networks	B-X
engaged	B-X
by	B-X
each	B-X
protein	B-X
in	B-X
continuously	B-X
cycling	B-X
cells	B-X
.	B-X

In	O
addition	O
,	O
factor	O
location	O
analyses	O
have	O
,	O
for	O
the	O
first	O
time	O
,	O
allowed	O
the	O
identification	O
of	O
novel	O
and	O
specific	O
targets	O
of	O
the	O
highly	O
related	O
transcriptional	O
regulators	O
p107	B-Gene_or_gene_product
and	O
p130	B-Gene_or_gene_product
,	O
suggesting	O
new	O
and	O
distinct	O
regulatory	O
networks	O
engaged	O
by	O
each	O
protein	O
in	O
continuously	O
cycling	O
cells	O
.	O
<EOS>	B-X
Biochemical	B-X
and	B-X
genetic	B-X
studies	B-X
have	B-X
determined	B-X
that	B-X
retinoblastoma	B-X
protein	B-X
(	B-X
pRB	B-X
)	B-X
tumor	B-X
suppressor	B-X
family	B-X
members	B-X
have	B-X
overlapping	B-X
functions	B-X
.	B-X
However	B-X
,	B-X
these	B-X
studies	B-X
have	B-X
largely	B-X
failed	B-X
to	B-X
distinguish	B-X
functional	B-X
differences	B-X
between	B-X
the	B-X
highly	B-X
related	B-X
p107	B-X
and	B-X
p130	B-X
proteins	B-X
.	B-X
Moreover	B-X
,	B-X
most	B-X
studies	B-X
pertaining	B-X
to	B-X
the	B-X
pRB	B-X
family	B-X
and	B-X
its	B-X
principal	B-X
target	B-X
,	B-X
the	B-X
E2F	B-X
transcription	B-X
factor	B-X
,	B-X
have	B-X
focused	B-X
on	B-X
cells	B-X
that	B-X
have	B-X
reinitiated	B-X
a	B-X
cell	B-X
cycle	B-X
from	B-X
quiescence	B-X
,	B-X
although	B-X
recent	B-X
studies	B-X
suggest	B-X
that	B-X
cycling	B-X
cells	B-X
exhibit	B-X
layers	B-X
of	B-X
regulation	B-X
distinct	B-X
from	B-X
mitogenically	B-X
stimulated	B-X
cells	B-X
.	B-X
Using	B-X
genome-wide	B-X
chromatin	B-X
immunoprecipitation	B-X
,	B-X
we	B-X
show	B-X
that	B-X
there	B-X
are	B-X
distinct	B-X
classes	B-X
of	B-X
genes	B-X
directly	B-X
regulated	B-X
by	B-X
unique	B-X
combinations	B-X
of	B-X
E2F4	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
,	B-X
including	B-X
a	B-X
group	B-X
of	B-X
genes	B-X
specifically	B-X
regulated	B-X
in	B-X
cycling	B-X
cells	B-X
.	B-X
These	B-X
groups	B-X
exhibit	B-X
both	B-X
distinct	B-X
histone	B-X
acetylation	B-X
signatures	B-X
and	B-X
patterns	B-X
of	B-X
mammalian	B-X
Sin3B	B-X
corepressor	B-X
recruitment	B-X
.	B-X
Our	B-X
findings	B-X
suggest	B-X
that	B-X
cell	B-X
cycle-dependent	B-X
repression	B-X
results	B-X
from	B-X
recruitment	B-X
of	B-X
an	B-X
unexpected	B-X
array	B-X
of	B-X
diverse	B-X
complexes	B-X
and	B-X
reveals	B-X
specific	B-X
differences	B-X
between	B-X
transcriptional	B-X
regulation	B-X
in	B-X
cycling	B-X
and	B-X
quiescent	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
factor	B-X
location	B-X
analyses	B-X
have	B-X
,	B-X
for	B-X
the	B-X
first	B-X
time	B-X
,	B-X
allowed	B-X
the	B-X
identification	B-X
of	B-X
novel	B-X
and	B-X
specific	B-X
targets	B-X
of	B-X
the	B-X
highly	B-X
related	B-X
transcriptional	B-X
regulators	B-X
p107	B-X
and	B-X
p130	B-X
,	B-X
suggesting	B-X
new	B-X
and	B-X
distinct	B-X
regulatory	B-X
networks	B-X
engaged	B-X
by	B-X
each	B-X
protein	B-X
in	B-X
continuously	B-X
cycling	B-X
cells	B-X
.	B-X

CsgA	B-Gene_or_gene_product
is	O
a	O
pathogen	O
-	O
associated	O
molecular	O
pattern	O
of	O
Salmonella	O
enterica	O
serotype	O
Typhimurium	O
that	O
is	O
recognized	O
by	O
Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
2	I-Gene_or_gene_product
.	O
<EOS>	B-X
Knowledge	B-X
about	B-X
the	B-X
origin	B-X
and	B-X
identity	B-X
of	B-X
the	B-X
microbial	B-X
products	B-X
recognized	B-X
by	B-X
the	B-X
innate	B-X
immune	B-X
system	B-X
is	B-X
important	B-X
for	B-X
understanding	B-X
the	B-X
pathogenesis	B-X
of	B-X
inflammatory	B-X
diseases	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
potential	B-X
role	B-X
of	B-X
Salmonella	B-X
enterica	B-X
serotype	B-X
Typhimurium	B-X
fimbriae	B-X
as	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
(	B-X
PAMPs	B-X
)	B-X
that	B-X
may	B-X
stimulate	B-X
innate	B-X
pathways	B-X
of	B-X
inflammation	B-X
.	B-X
We	B-X
screened	B-X
a	B-X
panel	B-X
of	B-X
11	B-X
mutants	B-X
,	B-X
each	B-X
carrying	B-X
a	B-X
deletion	B-X
of	B-X
a	B-X
different	B-X
fimbrial	B-X
operon	B-X
,	B-X
for	B-X
their	B-X
enteropathogenicity	B-X
using	B-X
the	B-X
calf	B-X
model	B-X
of	B-X
human	B-X
gastroenteritis	B-X
.	B-X
The	B-X
S.	B-X
Typhimurium	B-X
csgBA	B-X
mutant	B-X
induced	B-X
significantly	B-X
less	B-X
IL-8	B-X
production	B-X
than	B-X
the	B-X
wild	B-X
type	B-X
in	B-X
human	B-X
macrophage-like	B-X
cells	B-X
.	B-X
Purified	B-X
thin	B-X
curled	B-X
fimbriae	B-X
induced	B-X
IL-8	B-X
expression	B-X
in	B-X
human	B-X
embryonic	B-X
kidney	B-X
(	B-X
HEK293	B-X
)	B-X
cells	B-X
transfected	B-X
with	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
2/CD14	B-X
but	B-X
not	B-X
in	B-X
cells	B-X
transfected	B-X
with	B-X
TLR5	B-X
,	B-X
TLR4/MD2/CD14	B-X
or	B-X
TLR11	B-X
.	B-X
Fusion	B-X
proteins	B-X
between	B-X
the	B-X
major	B-X
fimbrial	B-X
subunit	B-X
of	B-X
thin	B-X
curled	B-X
fimbriae	B-X
(	B-X
CsgA	B-X
)	B-X
and	B-X
glutathione-S-transferase	B-X
(	B-X
GST	B-X
)	B-X
elicited	B-X
IL-8	B-X
production	B-X
in	B-X
HEK293	B-X
cells	B-X
transfected	B-X
with	B-X
TLR2/CD14	B-X
.	B-X
Proteinase	B-X
K	B-X
treatment	B-X
abrogated	B-X
IL-8	B-X
production	B-X
elicited	B-X
in	B-X
these	B-X
cells	B-X
by	B-X
GST-CsgA	B-X
,	B-X
but	B-X
not	B-X
by	B-X
synthetic	B-X
lipoprotein	B-X
.	B-X
GST-CsgA	B-X
elicited	B-X
more	B-X
IL-6	B-X
production	B-X
than	B-X
GST	B-X
in	B-X
bone	B-X
marrow-derived	B-X
macrophages	B-X
from	B-X
TLR2+/+	B-X
mice	B-X
,	B-X
while	B-X
there	B-X
was	B-X
no	B-X
difference	B-X
in	B-X
IL-6	B-X
secretion	B-X
between	B-X
GST-CsgA	B-X
and	B-X
GST	B-X
in	B-X
macrophages	B-X
from	B-X
TLR2-/-	B-X
mice	B-X
.	B-X
These	B-X
data	B-X
suggested	B-X
that	B-X
CsgA	B-X
is	B-X
a	B-X
PAMP	B-X
that	B-X
is	B-X
recognized	B-X
by	B-X
TLR2	B-X
.	B-X

Knowledge	O
about	O
the	O
origin	O
and	O
identity	O
of	O
the	O
microbial	O
products	O
recognized	O
by	O
the	O
innate	O
immune	O
system	O
is	O
important	O
for	O
understanding	O
the	O
pathogenesis	O
of	O
inflammatory	O
diseases	O
.	O
<EOS>	B-X
Knowledge	B-X
about	B-X
the	B-X
origin	B-X
and	B-X
identity	B-X
of	B-X
the	B-X
microbial	B-X
products	B-X
recognized	B-X
by	B-X
the	B-X
innate	B-X
immune	B-X
system	B-X
is	B-X
important	B-X
for	B-X
understanding	B-X
the	B-X
pathogenesis	B-X
of	B-X
inflammatory	B-X
diseases	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
potential	B-X
role	B-X
of	B-X
Salmonella	B-X
enterica	B-X
serotype	B-X
Typhimurium	B-X
fimbriae	B-X
as	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
(	B-X
PAMPs	B-X
)	B-X
that	B-X
may	B-X
stimulate	B-X
innate	B-X
pathways	B-X
of	B-X
inflammation	B-X
.	B-X
These	B-X
data	B-X
suggested	B-X
that	B-X
CsgA	B-X
is	B-X
a	B-X
PAMP	B-X
that	B-X
is	B-X
recognized	B-X
by	B-X
TLR2	B-X
.	B-X

We	O
investigated	O
the	O
potential	O
role	O
of	O
Salmonella	O
enterica	O
serotype	O
Typhimurium	O
fimbriae	O
as	O
pathogen	O
-	O
associated	O
molecular	O
patterns	O
(	O
PAMPs	O
)	O
that	O
may	O
stimulate	O
innate	O
pathways	O
of	O
inflammation	O
.	O

We	O
screened	O
a	O
panel	O
of	O
11	O
mutants	O
,	O
each	O
carrying	O
a	O
deletion	O
of	O
a	O
different	O
fimbrial	O
operon	O
,	O
for	O
their	O
enteropathogenicity	O
using	O
the	O
calf	O
model	O
of	O
human	O
gastroenteritis	O
.	O
<EOS>	B-X
We	B-X
screened	B-X
a	B-X
panel	B-X
of	B-X
11	B-X
mutants	B-X
,	B-X
each	B-X
carrying	B-X
a	B-X
deletion	B-X
of	B-X
a	B-X
different	B-X
fimbrial	B-X
operon	B-X
,	B-X
for	B-X
their	B-X
enteropathogenicity	B-X
using	B-X
the	B-X
calf	B-X
model	B-X
of	B-X
human	B-X
gastroenteritis	B-X
.	B-X
The	B-X
mechanism	B-X
by	B-X
which	B-X
thin	B-X
curled	B-X
fimbriae	B-X
encoded	B-X
by	B-X
the	B-X
csg	B-X
genes	B-X
contribute	B-X
to	B-X
inflammation	B-X
was	B-X
further	B-X
investigated	B-X
using	B-X
tissue	B-X
culture	B-X
.	B-X
The	B-X
S.	B-X
Typhimurium	B-X
csgBA	B-X
mutant	B-X
induced	B-X
significantly	B-X
less	B-X
IL-8	B-X
production	B-X
than	B-X
the	B-X
wild	B-X
type	B-X
in	B-X
human	B-X
macrophage-like	B-X
cells	B-X
.	B-X
Purified	B-X
thin	B-X
curled	B-X
fimbriae	B-X
induced	B-X
IL-8	B-X
expression	B-X
in	B-X
human	B-X
embryonic	B-X
kidney	B-X
(	B-X
HEK293	B-X
)	B-X
cells	B-X
transfected	B-X
with	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
2/CD14	B-X
but	B-X
not	B-X
in	B-X
cells	B-X
transfected	B-X
with	B-X
TLR5	B-X
,	B-X
TLR4/MD2/CD14	B-X
or	B-X
TLR11	B-X
.	B-X
Fusion	B-X
proteins	B-X
between	B-X
the	B-X
major	B-X
fimbrial	B-X
subunit	B-X
of	B-X
thin	B-X
curled	B-X
fimbriae	B-X
(	B-X
CsgA	B-X
)	B-X
and	B-X
glutathione-S-transferase	B-X
(	B-X
GST	B-X
)	B-X
elicited	B-X
IL-8	B-X
production	B-X
in	B-X
HEK293	B-X
cells	B-X
transfected	B-X
with	B-X
TLR2/CD14	B-X
.	B-X

One	O
mutant	O
(	O
csgBA	O
)	O
was	O
attenuated	O
in	O
its	O
ability	O
to	O
elicit	O
fluid	O
accumulation	O
and	O
GROalpha	B-Gene_or_gene_product
mRNA	O
expression	O
in	O
bovine	O
ligated	O
ileal	O
loops	O
.	O
<EOS>	B-X
We	B-X
screened	B-X
a	B-X
panel	B-X
of	B-X
11	B-X
mutants	B-X
,	B-X
each	B-X
carrying	B-X
a	B-X
deletion	B-X
of	B-X
a	B-X
different	B-X
fimbrial	B-X
operon	B-X
,	B-X
for	B-X
their	B-X
enteropathogenicity	B-X
using	B-X
the	B-X
calf	B-X
model	B-X
of	B-X
human	B-X
gastroenteritis	B-X
.	B-X
One	B-X
mutant	B-X
(	B-X
csgBA	B-X
)	B-X
was	B-X
attenuated	B-X
in	B-X
its	B-X
ability	B-X
to	B-X
elicit	B-X
fluid	B-X
accumulation	B-X
and	B-X
GROalpha	B-X
mRNA	B-X
expression	B-X
in	B-X
bovine	B-X
ligated	B-X
ileal	B-X
loops	B-X
.	B-X
The	B-X
S.	B-X
Typhimurium	B-X
csgBA	B-X
mutant	B-X
induced	B-X
significantly	B-X
less	B-X
IL-8	B-X
production	B-X
than	B-X
the	B-X
wild	B-X
type	B-X
in	B-X
human	B-X
macrophage-like	B-X
cells	B-X
.	B-X
Purified	B-X
thin	B-X
curled	B-X
fimbriae	B-X
induced	B-X
IL-8	B-X
expression	B-X
in	B-X
human	B-X
embryonic	B-X
kidney	B-X
(	B-X
HEK293	B-X
)	B-X
cells	B-X
transfected	B-X
with	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
2/CD14	B-X
but	B-X
not	B-X
in	B-X
cells	B-X
transfected	B-X
with	B-X
TLR5	B-X
,	B-X
TLR4/MD2/CD14	B-X
or	B-X
TLR11	B-X
.	B-X
Fusion	B-X
proteins	B-X
between	B-X
the	B-X
major	B-X
fimbrial	B-X
subunit	B-X
of	B-X
thin	B-X
curled	B-X
fimbriae	B-X
(	B-X
CsgA	B-X
)	B-X
and	B-X
glutathione-S-transferase	B-X
(	B-X
GST	B-X
)	B-X
elicited	B-X
IL-8	B-X
production	B-X
in	B-X
HEK293	B-X
cells	B-X
transfected	B-X
with	B-X
TLR2/CD14	B-X
.	B-X
Proteinase	B-X
K	B-X
treatment	B-X
abrogated	B-X
IL-8	B-X
production	B-X
elicited	B-X
in	B-X
these	B-X
cells	B-X
by	B-X
GST-CsgA	B-X
,	B-X
but	B-X
not	B-X
by	B-X
synthetic	B-X
lipoprotein	B-X
.	B-X
GST-CsgA	B-X
elicited	B-X
more	B-X
IL-6	B-X
production	B-X
than	B-X
GST	B-X
in	B-X
bone	B-X
marrow-derived	B-X
macrophages	B-X
from	B-X
TLR2+/+	B-X
mice	B-X
,	B-X
while	B-X
there	B-X
was	B-X
no	B-X
difference	B-X
in	B-X
IL-6	B-X
secretion	B-X
between	B-X
GST-CsgA	B-X
and	B-X
GST	B-X
in	B-X
macrophages	B-X
from	B-X
TLR2-/-	B-X
mice	B-X
.	B-X

The	O
mechanism	O
by	O
which	O
thin	O
curled	O
fimbriae	O
encoded	O
by	O
the	O
csg	B-Gene_or_gene_product
genes	O
contribute	O
to	O
inflammation	O
was	O
further	O
investigated	O
using	O
tissue	O
culture	O
.	O
<EOS>	B-X
Knowledge	B-X
about	B-X
the	B-X
origin	B-X
and	B-X
identity	B-X
of	B-X
the	B-X
microbial	B-X
products	B-X
recognized	B-X
by	B-X
the	B-X
innate	B-X
immune	B-X
system	B-X
is	B-X
important	B-X
for	B-X
understanding	B-X
the	B-X
pathogenesis	B-X
of	B-X
inflammatory	B-X
diseases	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
potential	B-X
role	B-X
of	B-X
Salmonella	B-X
enterica	B-X
serotype	B-X
Typhimurium	B-X
fimbriae	B-X
as	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
(	B-X
PAMPs	B-X
)	B-X
that	B-X
may	B-X
stimulate	B-X
innate	B-X
pathways	B-X
of	B-X
inflammation	B-X
.	B-X
We	B-X
screened	B-X
a	B-X
panel	B-X
of	B-X
11	B-X
mutants	B-X
,	B-X
each	B-X
carrying	B-X
a	B-X
deletion	B-X
of	B-X
a	B-X
different	B-X
fimbrial	B-X
operon	B-X
,	B-X
for	B-X
their	B-X
enteropathogenicity	B-X
using	B-X
the	B-X
calf	B-X
model	B-X
of	B-X
human	B-X
gastroenteritis	B-X
.	B-X
One	B-X
mutant	B-X
(	B-X
csgBA	B-X
)	B-X
was	B-X
attenuated	B-X
in	B-X
its	B-X
ability	B-X
to	B-X
elicit	B-X
fluid	B-X
accumulation	B-X
and	B-X
GROalpha	B-X
mRNA	B-X
expression	B-X
in	B-X
bovine	B-X
ligated	B-X
ileal	B-X
loops	B-X
.	B-X
The	B-X
mechanism	B-X
by	B-X
which	B-X
thin	B-X
curled	B-X
fimbriae	B-X
encoded	B-X
by	B-X
the	B-X
csg	B-X
genes	B-X
contribute	B-X
to	B-X
inflammation	B-X
was	B-X
further	B-X
investigated	B-X
using	B-X
tissue	B-X
culture	B-X
.	B-X
The	B-X
S.	B-X
Typhimurium	B-X
csgBA	B-X
mutant	B-X
induced	B-X
significantly	B-X
less	B-X
IL-8	B-X
production	B-X
than	B-X
the	B-X
wild	B-X
type	B-X
in	B-X
human	B-X
macrophage-like	B-X
cells	B-X
.	B-X
Purified	B-X
thin	B-X
curled	B-X
fimbriae	B-X
induced	B-X
IL-8	B-X
expression	B-X
in	B-X
human	B-X
embryonic	B-X
kidney	B-X
(	B-X
HEK293	B-X
)	B-X
cells	B-X
transfected	B-X
with	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
2/CD14	B-X
but	B-X
not	B-X
in	B-X
cells	B-X
transfected	B-X
with	B-X
TLR5	B-X
,	B-X
TLR4/MD2/CD14	B-X
or	B-X
TLR11	B-X
.	B-X
Fusion	B-X
proteins	B-X
between	B-X
the	B-X
major	B-X
fimbrial	B-X
subunit	B-X
of	B-X
thin	B-X
curled	B-X
fimbriae	B-X
(	B-X
CsgA	B-X
)	B-X
and	B-X
glutathione-S-transferase	B-X
(	B-X
GST	B-X
)	B-X
elicited	B-X
IL-8	B-X
production	B-X
in	B-X
HEK293	B-X
cells	B-X
transfected	B-X
with	B-X
TLR2/CD14	B-X
.	B-X

The	O
S	O
.	O

Typhimurium	O
csgBA	O
mutant	O
induced	O
significantly	O
less	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
8	I-Gene_or_gene_product
production	O
than	O
the	O
wild	O
type	O
in	O
human	O
macrophage	O
-	O
like	O
cells	O
.	O

Purified	O
thin	O
curled	O
fimbriae	O
induced	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
8	I-Gene_or_gene_product
expression	O
in	O
human	O
embryonic	O
kidney	O
(	O
HEK293	O
)	O
cells	O
transfected	O
with	O
Toll	O
-	O
like	O
receptor	O
(	O
TLR	O
)	O
2	O
/	O
CD14	O
but	O
not	O
in	O
cells	O
transfected	O
with	O
TLR5	B-Gene_or_gene_product
,	O
TLR4	O
/	O
MD2	O
/	O
CD14	O
or	O
TLR11	B-Gene_or_gene_product
.	O
<EOS>	B-X
Dendritic	B-X
cells	B-X
(	B-X
DCs	B-X
)	B-X
are	B-X
indispensable	B-X
for	B-X
defense	B-X
against	B-X
pathogens	B-X
but	B-X
may	B-X
also	B-X
contribute	B-X
to	B-X
immunopathology	B-X
.	B-X
Activation	B-X
of	B-X
DCs	B-X
upon	B-X
the	B-X
sensing	B-X
of	B-X
pathogens	B-X
by	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
is	B-X
largely	B-X
mediated	B-X
by	B-X
pattern	B-X
recognition	B-X
receptor/nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
signaling	B-X
and	B-X
depends	B-X
on	B-X
the	B-X
appropriate	B-X
ubiquitination	B-X
of	B-X
the	B-X
respective	B-X
signaling	B-X
molecules	B-X
.	B-X
Stimulation	B-X
of	B-X
DCs	B-X
with	B-X
the	B-X
TLR11/12	B-X
ligand	B-X
T.	B-X
gondii	B-X
profilin	B-X
and	B-X
the	B-X
TLR4	B-X
ligand	B-X
lipopolysaccharide	B-X
induced	B-X
an	B-X
increase	B-X
in	B-X
NF-κB	B-X
activation	B-X
in	B-X
OTUB1-competent	B-X
cells	B-X
,	B-X
resulting	B-X
in	B-X
elevated	B-X
interleukin-6	B-X
(	B-X
IL-6	B-X
)	B-X
,	B-X
IL-12	B-X
,	B-X
and	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
production	B-X
,	B-X
which	B-X
was	B-X
also	B-X
observed	B-X
upon	B-X
the	B-X
specific	B-X
stimulation	B-X
of	B-X
TLR2	B-X
,	B-X
TLR3	B-X
,	B-X
TLR7	B-X
,	B-X
and	B-X
TLR9	B-X
.	B-X
Mechanistically	B-X
,	B-X
OTUB1	B-X
promoted	B-X
NF-κB	B-X
activity	B-X
in	B-X
DCs	B-X
by	B-X
K48-linked	B-X
deubiquitination	B-X
and	B-X
stabilization	B-X
of	B-X
the	B-X
E2-conjugating	B-X
enzyme	B-X
UBC13	B-X
,	B-X
resulting	B-X
in	B-X
increased	B-X
K63-linked	B-X
ubiquitination	B-X
of	B-X
IRAK1	B-X
(	B-X
IL-1	B-X
receptor-associated	B-X
kinase	B-X
1	B-X
)	B-X
and	B-X
TRAF6	B-X
(	B-X
TNF	B-X
receptor-associated	B-X
factor	B-X
6	B-X
)	B-X
.	B-X
Consequently	B-X
,	B-X
DC-specific	B-X
deletion	B-X
of	B-X
OTUB1	B-X
impaired	B-X
the	B-X
production	B-X
of	B-X
cytokines	B-X
,	B-X
in	B-X
particular	B-X
IL-12	B-X
,	B-X
by	B-X
DCs	B-X
over	B-X
the	B-X
first	B-X
2	B-X
days	B-X
of	B-X
T.	B-X
gondii	B-X
infection	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
diminished	B-X
production	B-X
of	B-X
protective	B-X
interferon-γ	B-X
(	B-X
IFN-γ	B-X
)	B-X
by	B-X
natural	B-X
killer	B-X
cells	B-X
,	B-X
impaired	B-X
control	B-X
of	B-X
parasite	B-X
replication	B-X
,	B-X
and	B-X
,	B-X
finally	B-X
,	B-X
death	B-X
from	B-X
chronic	B-X
T.	B-X
encephalitis	B-X
,	B-X
all	B-X
of	B-X
which	B-X
could	B-X
be	B-X
prevented	B-X
by	B-X
low-dose	B-X
IL-12	B-X
treatment	B-X
in	B-X
the	B-X
first	B-X
3	B-X
days	B-X
of	B-X
infection	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
impaired	B-X
OTUB1-deficient	B-X
DC	B-X
activation	B-X
and	B-X
cytokine	B-X
production	B-X
by	B-X
OTUB1-deficient	B-X
DCs	B-X
protected	B-X
mice	B-X
from	B-X
lipopolysaccharide-induced	B-X
immunopathology	B-X
.	B-X

Fusion	O
proteins	O
between	O
the	O
major	O
fimbrial	O
subunit	O
of	O
thin	O
curled	O
fimbriae	O
(	O
CsgA	B-Gene_or_gene_product
)	O
and	O
glutathione	B-Gene_or_gene_product
-	I-Gene_or_gene_product
S	I-Gene_or_gene_product
-	I-Gene_or_gene_product
transferase	I-Gene_or_gene_product
(	O
GST	B-Gene_or_gene_product
)	O
elicited	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
8	I-Gene_or_gene_product
production	O
in	O
HEK293	O
cells	O
transfected	O
with	O
TLR2	O
/	O
CD14	O
.	O
<EOS>	B-X
We	B-X
investigated	B-X
the	B-X
potential	B-X
role	B-X
of	B-X
Salmonella	B-X
enterica	B-X
serotype	B-X
Typhimurium	B-X
fimbriae	B-X
as	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
(	B-X
PAMPs	B-X
)	B-X
that	B-X
may	B-X
stimulate	B-X
innate	B-X
pathways	B-X
of	B-X
inflammation	B-X
.	B-X
We	B-X
screened	B-X
a	B-X
panel	B-X
of	B-X
11	B-X
mutants	B-X
,	B-X
each	B-X
carrying	B-X
a	B-X
deletion	B-X
of	B-X
a	B-X
different	B-X
fimbrial	B-X
operon	B-X
,	B-X
for	B-X
their	B-X
enteropathogenicity	B-X
using	B-X
the	B-X
calf	B-X
model	B-X
of	B-X
human	B-X
gastroenteritis	B-X
.	B-X
The	B-X
mechanism	B-X
by	B-X
which	B-X
thin	B-X
curled	B-X
fimbriae	B-X
encoded	B-X
by	B-X
the	B-X
csg	B-X
genes	B-X
contribute	B-X
to	B-X
inflammation	B-X
was	B-X
further	B-X
investigated	B-X
using	B-X
tissue	B-X
culture	B-X
.	B-X
The	B-X
S.	B-X
Typhimurium	B-X
csgBA	B-X
mutant	B-X
induced	B-X
significantly	B-X
less	B-X
IL-8	B-X
production	B-X
than	B-X
the	B-X
wild	B-X
type	B-X
in	B-X
human	B-X
macrophage-like	B-X
cells	B-X
.	B-X
Purified	B-X
thin	B-X
curled	B-X
fimbriae	B-X
induced	B-X
IL-8	B-X
expression	B-X
in	B-X
human	B-X
embryonic	B-X
kidney	B-X
(	B-X
HEK293	B-X
)	B-X
cells	B-X
transfected	B-X
with	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
2/CD14	B-X
but	B-X
not	B-X
in	B-X
cells	B-X
transfected	B-X
with	B-X
TLR5	B-X
,	B-X
TLR4/MD2/CD14	B-X
or	B-X
TLR11	B-X
.	B-X
Fusion	B-X
proteins	B-X
between	B-X
the	B-X
major	B-X
fimbrial	B-X
subunit	B-X
of	B-X
thin	B-X
curled	B-X
fimbriae	B-X
(	B-X
CsgA	B-X
)	B-X
and	B-X
glutathione-S-transferase	B-X
(	B-X
GST	B-X
)	B-X
elicited	B-X
IL-8	B-X
production	B-X
in	B-X
HEK293	B-X
cells	B-X
transfected	B-X
with	B-X
TLR2/CD14	B-X
.	B-X
Proteinase	B-X
K	B-X
treatment	B-X
abrogated	B-X
IL-8	B-X
production	B-X
elicited	B-X
in	B-X
these	B-X
cells	B-X
by	B-X
GST-CsgA	B-X
,	B-X
but	B-X
not	B-X
by	B-X
synthetic	B-X
lipoprotein	B-X
.	B-X
GST-CsgA	B-X
elicited	B-X
more	B-X
IL-6	B-X
production	B-X
than	B-X
GST	B-X
in	B-X
bone	B-X
marrow-derived	B-X
macrophages	B-X
from	B-X
TLR2+/+	B-X
mice	B-X
,	B-X
while	B-X
there	B-X
was	B-X
no	B-X
difference	B-X
in	B-X
IL-6	B-X
secretion	B-X
between	B-X
GST-CsgA	B-X
and	B-X
GST	B-X
in	B-X
macrophages	B-X
from	B-X
TLR2-/-	B-X
mice	B-X
.	B-X
These	B-X
data	B-X
suggested	B-X
that	B-X
CsgA	B-X
is	B-X
a	B-X
PAMP	B-X
that	B-X
is	B-X
recognized	B-X
by	B-X
TLR2	B-X
.	B-X

Proteinase	B-Gene_or_gene_product
K	I-Gene_or_gene_product
treatment	O
abrogated	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
8	I-Gene_or_gene_product
production	O
elicited	O
in	O
these	O
cells	O
by	O
GST	B-Gene_or_gene_product
-	I-Gene_or_gene_product
CsgA	I-Gene_or_gene_product
,	O
but	O
not	O
by	O
synthetic	O
lipoprotein	O
.	O

GST	B-Gene_or_gene_product
-	I-Gene_or_gene_product
CsgA	I-Gene_or_gene_product
elicited	O
more	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
production	O
than	O
GST	B-Gene_or_gene_product
in	O
bone	O
marrow	O
-	O
derived	O
macrophages	O
from	O
TLR2	B-Gene_or_gene_product
+	O
/	O
+	O
mice	O
,	O
while	O
there	O
was	O
no	O
difference	O
in	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
secretion	O
between	O
GST	B-Gene_or_gene_product
-	I-Gene_or_gene_product
CsgA	I-Gene_or_gene_product
and	O
GST	B-Gene_or_gene_product
in	O
macrophages	O
from	O
TLR2	B-Gene_or_gene_product
-	O
/	O
-	O
mice	O
.	O
<EOS>	B-X
The	B-X
S.	B-X
Typhimurium	B-X
csgBA	B-X
mutant	B-X
induced	B-X
significantly	B-X
less	B-X
IL-8	B-X
production	B-X
than	B-X
the	B-X
wild	B-X
type	B-X
in	B-X
human	B-X
macrophage-like	B-X
cells	B-X
.	B-X
Purified	B-X
thin	B-X
curled	B-X
fimbriae	B-X
induced	B-X
IL-8	B-X
expression	B-X
in	B-X
human	B-X
embryonic	B-X
kidney	B-X
(	B-X
HEK293	B-X
)	B-X
cells	B-X
transfected	B-X
with	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
2/CD14	B-X
but	B-X
not	B-X
in	B-X
cells	B-X
transfected	B-X
with	B-X
TLR5	B-X
,	B-X
TLR4/MD2/CD14	B-X
or	B-X
TLR11	B-X
.	B-X
Fusion	B-X
proteins	B-X
between	B-X
the	B-X
major	B-X
fimbrial	B-X
subunit	B-X
of	B-X
thin	B-X
curled	B-X
fimbriae	B-X
(	B-X
CsgA	B-X
)	B-X
and	B-X
glutathione-S-transferase	B-X
(	B-X
GST	B-X
)	B-X
elicited	B-X
IL-8	B-X
production	B-X
in	B-X
HEK293	B-X
cells	B-X
transfected	B-X
with	B-X
TLR2/CD14	B-X
.	B-X
Proteinase	B-X
K	B-X
treatment	B-X
abrogated	B-X
IL-8	B-X
production	B-X
elicited	B-X
in	B-X
these	B-X
cells	B-X
by	B-X
GST-CsgA	B-X
,	B-X
but	B-X
not	B-X
by	B-X
synthetic	B-X
lipoprotein	B-X
.	B-X
GST-CsgA	B-X
elicited	B-X
more	B-X
IL-6	B-X
production	B-X
than	B-X
GST	B-X
in	B-X
bone	B-X
marrow-derived	B-X
macrophages	B-X
from	B-X
TLR2+/+	B-X
mice	B-X
,	B-X
while	B-X
there	B-X
was	B-X
no	B-X
difference	B-X
in	B-X
IL-6	B-X
secretion	B-X
between	B-X
GST-CsgA	B-X
and	B-X
GST	B-X
in	B-X
macrophages	B-X
from	B-X
TLR2-/-	B-X
mice	B-X
.	B-X
These	B-X
data	B-X
suggested	B-X
that	B-X
CsgA	B-X
is	B-X
a	B-X
PAMP	B-X
that	B-X
is	B-X
recognized	B-X
by	B-X
TLR2	B-X
.	B-X

These	O
data	O
suggested	O
that	O
CsgA	B-Gene_or_gene_product
is	O
a	O
PAMP	O
that	O
is	O
recognized	O
by	O
TLR2	B-Gene_or_gene_product
.	O
<EOS>	B-X
Knowledge	B-X
about	B-X
the	B-X
origin	B-X
and	B-X
identity	B-X
of	B-X
the	B-X
microbial	B-X
products	B-X
recognized	B-X
by	B-X
the	B-X
innate	B-X
immune	B-X
system	B-X
is	B-X
important	B-X
for	B-X
understanding	B-X
the	B-X
pathogenesis	B-X
of	B-X
inflammatory	B-X
diseases	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
potential	B-X
role	B-X
of	B-X
Salmonella	B-X
enterica	B-X
serotype	B-X
Typhimurium	B-X
fimbriae	B-X
as	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
(	B-X
PAMPs	B-X
)	B-X
that	B-X
may	B-X
stimulate	B-X
innate	B-X
pathways	B-X
of	B-X
inflammation	B-X
.	B-X
Fusion	B-X
proteins	B-X
between	B-X
the	B-X
major	B-X
fimbrial	B-X
subunit	B-X
of	B-X
thin	B-X
curled	B-X
fimbriae	B-X
(	B-X
CsgA	B-X
)	B-X
and	B-X
glutathione-S-transferase	B-X
(	B-X
GST	B-X
)	B-X
elicited	B-X
IL-8	B-X
production	B-X
in	B-X
HEK293	B-X
cells	B-X
transfected	B-X
with	B-X
TLR2/CD14	B-X
.	B-X
Proteinase	B-X
K	B-X
treatment	B-X
abrogated	B-X
IL-8	B-X
production	B-X
elicited	B-X
in	B-X
these	B-X
cells	B-X
by	B-X
GST-CsgA	B-X
,	B-X
but	B-X
not	B-X
by	B-X
synthetic	B-X
lipoprotein	B-X
.	B-X
GST-CsgA	B-X
elicited	B-X
more	B-X
IL-6	B-X
production	B-X
than	B-X
GST	B-X
in	B-X
bone	B-X
marrow-derived	B-X
macrophages	B-X
from	B-X
TLR2+/+	B-X
mice	B-X
,	B-X
while	B-X
there	B-X
was	B-X
no	B-X
difference	B-X
in	B-X
IL-6	B-X
secretion	B-X
between	B-X
GST-CsgA	B-X
and	B-X
GST	B-X
in	B-X
macrophages	B-X
from	B-X
TLR2-/-	B-X
mice	B-X
.	B-X
These	B-X
data	B-X
suggested	B-X
that	B-X
CsgA	B-X
is	B-X
a	B-X
PAMP	B-X
that	B-X
is	B-X
recognized	B-X
by	B-X
TLR2	B-X
.	B-X

Cdc28	B-Gene_or_gene_product
-	O
dependent	O
regulation	O
of	O
the	O
Cdc5	B-Gene_or_gene_product
/	O
Polo	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
.	O
<EOS>	B-X
Polo	B-X
kinase	B-X
is	B-X
activated	B-X
as	B-X
cells	B-X
enter	B-X
mitosis	B-X
and	B-X
plays	B-X
a	B-X
central	B-X
role	B-X
in	B-X
coordinating	B-X
diverse	B-X
mitotic	B-X
events	B-X
,	B-X
yet	B-X
the	B-X
mechanisms	B-X
leading	B-X
to	B-X
activation	B-X
of	B-X
Polo	B-X
kinase	B-X
are	B-X
poorly	B-X
understood	B-X
.	B-X
Work	B-X
in	B-X
Xenopus	B-X
meiotic	B-X
cell	B-X
cycles	B-X
has	B-X
suggested	B-X
that	B-X
Polo	B-X
kinase	B-X
functions	B-X
in	B-X
a	B-X
pathway	B-X
that	B-X
helps	B-X
trigger	B-X
activation	B-X
of	B-X
Cdk1	B-X
.	B-X
However	B-X
,	B-X
studies	B-X
in	B-X
other	B-X
organisms	B-X
have	B-X
suggested	B-X
that	B-X
activation	B-X
of	B-X
Polo	B-X
kinase	B-X
is	B-X
dependent	B-X
upon	B-X
Cdk1	B-X
and	B-X
therefore	B-X
occurs	B-X
downstream	B-X
of	B-X
Cdk1	B-X
activation	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
have	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
Cdk1	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
budding	B-X
yeast	B-X
Polo	B-X
kinase	B-X
.	B-X
The	B-X
budding	B-X
yeast	B-X
homologs	B-X
of	B-X
Cdk1	B-X
and	B-X
Polo	B-X
kinase	B-X
are	B-X
referred	B-X
to	B-X
as	B-X
Cdc28	B-X
and	B-X
Cdc5	B-X
.	B-X
We	B-X
show	B-X
that	B-X
signaling	B-X
from	B-X
Cdc28	B-X
is	B-X
required	B-X
to	B-X
maintain	B-X
Cdc5	B-X
activity	B-X
in	B-X
vivo	B-X
.	B-X
Furthermore	B-X
,	B-X
purified	B-X
Cdc28	B-X
associated	B-X
with	B-X
the	B-X
mitotic	B-X
cyclin	B-X
Clb2	B-X
is	B-X
sufficient	B-X
to	B-X
activate	B-X
purified	B-X
Cdc5	B-X
in	B-X
vitro	B-X
.	B-X
A	B-X
single	B-X
Cdc28	B-X
consensus	B-X
phosphorylation	B-X
site	B-X
found	B-X
at	B-X
threonine	B-X
242	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
segment	B-X
of	B-X
Cdc5	B-X
is	B-X
required	B-X
for	B-X
Cdc5	B-X
function	B-X
in	B-X
vivo	B-X
and	B-X
for	B-X
kinase	B-X
activity	B-X
in	B-X
vitro	B-X
,	B-X
whereas	B-X
four	B-X
other	B-X
Cdc28	B-X
consensus	B-X
sites	B-X
are	B-X
dispensable	B-X
.	B-X
Analysis	B-X
of	B-X
Cdc5	B-X
phosphorylation	B-X
by	B-X
mass	B-X
spectrometry	B-X
indicates	B-X
that	B-X
threonine	B-X
242	B-X
is	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
Cdc28	B-X
activates	B-X
Cdc5	B-X
via	B-X
phosphorylation	B-X
of	B-X
threonine	B-X
242	B-X
.	B-X

Polo	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
is	O
activated	O
as	O
cells	O
enter	O
mitosis	O
and	O
plays	O
a	O
central	O
role	O
in	O
coordinating	O
diverse	O
mitotic	O
events	O
,	O
yet	O
the	O
mechanisms	O
leading	O
to	O
activation	O
of	O
Polo	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
are	O
poorly	O
understood	O
.	O

Work	O
in	O
Xenopus	O
meiotic	O
cell	O
cycles	O
has	O
suggested	O
that	O
Polo	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
functions	O
in	O
a	O
pathway	O
that	O
helps	O
trigger	O
activation	O
of	O
Cdk1	B-Gene_or_gene_product
.	O

However	O
,	O
studies	O
in	O
other	O
organisms	O
have	O
suggested	O
that	O
activation	O
of	O
Polo	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
is	O
dependent	O
upon	O
Cdk1	B-Gene_or_gene_product
and	O
therefore	O
occurs	O
downstream	O
of	O
Cdk1	B-Gene_or_gene_product
activation	O
.	O
<EOS>	B-X
Polo	B-X
kinase	B-X
is	B-X
activated	B-X
as	B-X
cells	B-X
enter	B-X
mitosis	B-X
and	B-X
plays	B-X
a	B-X
central	B-X
role	B-X
in	B-X
coordinating	B-X
diverse	B-X
mitotic	B-X
events	B-X
,	B-X
yet	B-X
the	B-X
mechanisms	B-X
leading	B-X
to	B-X
activation	B-X
of	B-X
Polo	B-X
kinase	B-X
are	B-X
poorly	B-X
understood	B-X
.	B-X
Work	B-X
in	B-X
Xenopus	B-X
meiotic	B-X
cell	B-X
cycles	B-X
has	B-X
suggested	B-X
that	B-X
Polo	B-X
kinase	B-X
functions	B-X
in	B-X
a	B-X
pathway	B-X
that	B-X
helps	B-X
trigger	B-X
activation	B-X
of	B-X
Cdk1	B-X
.	B-X
However	B-X
,	B-X
studies	B-X
in	B-X
other	B-X
organisms	B-X
have	B-X
suggested	B-X
that	B-X
activation	B-X
of	B-X
Polo	B-X
kinase	B-X
is	B-X
dependent	B-X
upon	B-X
Cdk1	B-X
and	B-X
therefore	B-X
occurs	B-X
downstream	B-X
of	B-X
Cdk1	B-X
activation	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
have	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
Cdk1	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
budding	B-X
yeast	B-X
Polo	B-X
kinase	B-X
.	B-X
The	B-X
budding	B-X
yeast	B-X
homologs	B-X
of	B-X
Cdk1	B-X
and	B-X
Polo	B-X
kinase	B-X
are	B-X
referred	B-X
to	B-X
as	B-X
Cdc28	B-X
and	B-X
Cdc5	B-X
.	B-X
A	B-X
single	B-X
Cdc28	B-X
consensus	B-X
phosphorylation	B-X
site	B-X
found	B-X
at	B-X
threonine	B-X
242	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
segment	B-X
of	B-X
Cdc5	B-X
is	B-X
required	B-X
for	B-X
Cdc5	B-X
function	B-X
in	B-X
vivo	B-X
and	B-X
for	B-X
kinase	B-X
activity	B-X
in	B-X
vitro	B-X
,	B-X
whereas	B-X
four	B-X
other	B-X
Cdc28	B-X
consensus	B-X
sites	B-X
are	B-X
dispensable	B-X
.	B-X

In	O
this	O
study	O
,	O
we	O
have	O
investigated	O
the	O
role	O
of	O
Cdk1	B-Gene_or_gene_product
in	O
the	O
activation	O
of	O
budding	O
yeast	O
Polo	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
.	O
<EOS>	B-X
Polo	B-X
kinase	B-X
is	B-X
activated	B-X
as	B-X
cells	B-X
enter	B-X
mitosis	B-X
and	B-X
plays	B-X
a	B-X
central	B-X
role	B-X
in	B-X
coordinating	B-X
diverse	B-X
mitotic	B-X
events	B-X
,	B-X
yet	B-X
the	B-X
mechanisms	B-X
leading	B-X
to	B-X
activation	B-X
of	B-X
Polo	B-X
kinase	B-X
are	B-X
poorly	B-X
understood	B-X
.	B-X
Work	B-X
in	B-X
Xenopus	B-X
meiotic	B-X
cell	B-X
cycles	B-X
has	B-X
suggested	B-X
that	B-X
Polo	B-X
kinase	B-X
functions	B-X
in	B-X
a	B-X
pathway	B-X
that	B-X
helps	B-X
trigger	B-X
activation	B-X
of	B-X
Cdk1	B-X
.	B-X
However	B-X
,	B-X
studies	B-X
in	B-X
other	B-X
organisms	B-X
have	B-X
suggested	B-X
that	B-X
activation	B-X
of	B-X
Polo	B-X
kinase	B-X
is	B-X
dependent	B-X
upon	B-X
Cdk1	B-X
and	B-X
therefore	B-X
occurs	B-X
downstream	B-X
of	B-X
Cdk1	B-X
activation	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
have	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
Cdk1	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
budding	B-X
yeast	B-X
Polo	B-X
kinase	B-X
.	B-X
The	B-X
budding	B-X
yeast	B-X
homologs	B-X
of	B-X
Cdk1	B-X
and	B-X
Polo	B-X
kinase	B-X
are	B-X
referred	B-X
to	B-X
as	B-X
Cdc28	B-X
and	B-X
Cdc5	B-X
.	B-X
A	B-X
single	B-X
Cdc28	B-X
consensus	B-X
phosphorylation	B-X
site	B-X
found	B-X
at	B-X
threonine	B-X
242	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
segment	B-X
of	B-X
Cdc5	B-X
is	B-X
required	B-X
for	B-X
Cdc5	B-X
function	B-X
in	B-X
vivo	B-X
and	B-X
for	B-X
kinase	B-X
activity	B-X
in	B-X
vitro	B-X
,	B-X
whereas	B-X
four	B-X
other	B-X
Cdc28	B-X
consensus	B-X
sites	B-X
are	B-X
dispensable	B-X
.	B-X

The	O
budding	O
yeast	O
homologs	O
of	O
Cdk1	B-Gene_or_gene_product
and	O
Polo	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
are	O
referred	O
to	O
as	O
Cdc28	B-Gene_or_gene_product
and	O
Cdc5	B-Gene_or_gene_product
.	O

We	O
show	O
that	O
signaling	O
from	O
Cdc28	B-Gene_or_gene_product
is	O
required	O
to	O
maintain	O
Cdc5	B-Gene_or_gene_product
activity	O
in	O
vivo	O
.	O
<EOS>	B-X
The	B-X
budding	B-X
yeast	B-X
homologs	B-X
of	B-X
Cdk1	B-X
and	B-X
Polo	B-X
kinase	B-X
are	B-X
referred	B-X
to	B-X
as	B-X
Cdc28	B-X
and	B-X
Cdc5	B-X
.	B-X
We	B-X
show	B-X
that	B-X
signaling	B-X
from	B-X
Cdc28	B-X
is	B-X
required	B-X
to	B-X
maintain	B-X
Cdc5	B-X
activity	B-X
in	B-X
vivo	B-X
.	B-X
Furthermore	B-X
,	B-X
purified	B-X
Cdc28	B-X
associated	B-X
with	B-X
the	B-X
mitotic	B-X
cyclin	B-X
Clb2	B-X
is	B-X
sufficient	B-X
to	B-X
activate	B-X
purified	B-X
Cdc5	B-X
in	B-X
vitro	B-X
.	B-X
A	B-X
single	B-X
Cdc28	B-X
consensus	B-X
phosphorylation	B-X
site	B-X
found	B-X
at	B-X
threonine	B-X
242	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
segment	B-X
of	B-X
Cdc5	B-X
is	B-X
required	B-X
for	B-X
Cdc5	B-X
function	B-X
in	B-X
vivo	B-X
and	B-X
for	B-X
kinase	B-X
activity	B-X
in	B-X
vitro	B-X
,	B-X
whereas	B-X
four	B-X
other	B-X
Cdc28	B-X
consensus	B-X
sites	B-X
are	B-X
dispensable	B-X
.	B-X
Analysis	B-X
of	B-X
Cdc5	B-X
phosphorylation	B-X
by	B-X
mass	B-X
spectrometry	B-X
indicates	B-X
that	B-X
threonine	B-X
242	B-X
is	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
Cdc28	B-X
activates	B-X
Cdc5	B-X
via	B-X
phosphorylation	B-X
of	B-X
threonine	B-X
242	B-X
.	B-X

Furthermore	O
,	O
purified	O
Cdc28	B-Gene_or_gene_product
associated	O
with	O
the	O
mitotic	O
cyclin	B-Gene_or_gene_product
Clb2	I-Gene_or_gene_product
is	O
sufficient	O
to	O
activate	O
purified	O
Cdc5	B-Gene_or_gene_product
in	O
vitro	O
.	O
<EOS>	B-X
Polo	B-X
kinase	B-X
is	B-X
activated	B-X
as	B-X
cells	B-X
enter	B-X
mitosis	B-X
and	B-X
plays	B-X
a	B-X
central	B-X
role	B-X
in	B-X
coordinating	B-X
diverse	B-X
mitotic	B-X
events	B-X
,	B-X
yet	B-X
the	B-X
mechanisms	B-X
leading	B-X
to	B-X
activation	B-X
of	B-X
Polo	B-X
kinase	B-X
are	B-X
poorly	B-X
understood	B-X
.	B-X
The	B-X
budding	B-X
yeast	B-X
homologs	B-X
of	B-X
Cdk1	B-X
and	B-X
Polo	B-X
kinase	B-X
are	B-X
referred	B-X
to	B-X
as	B-X
Cdc28	B-X
and	B-X
Cdc5	B-X
.	B-X
We	B-X
show	B-X
that	B-X
signaling	B-X
from	B-X
Cdc28	B-X
is	B-X
required	B-X
to	B-X
maintain	B-X
Cdc5	B-X
activity	B-X
in	B-X
vivo	B-X
.	B-X
Furthermore	B-X
,	B-X
purified	B-X
Cdc28	B-X
associated	B-X
with	B-X
the	B-X
mitotic	B-X
cyclin	B-X
Clb2	B-X
is	B-X
sufficient	B-X
to	B-X
activate	B-X
purified	B-X
Cdc5	B-X
in	B-X
vitro	B-X
.	B-X
A	B-X
single	B-X
Cdc28	B-X
consensus	B-X
phosphorylation	B-X
site	B-X
found	B-X
at	B-X
threonine	B-X
242	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
segment	B-X
of	B-X
Cdc5	B-X
is	B-X
required	B-X
for	B-X
Cdc5	B-X
function	B-X
in	B-X
vivo	B-X
and	B-X
for	B-X
kinase	B-X
activity	B-X
in	B-X
vitro	B-X
,	B-X
whereas	B-X
four	B-X
other	B-X
Cdc28	B-X
consensus	B-X
sites	B-X
are	B-X
dispensable	B-X
.	B-X
Analysis	B-X
of	B-X
Cdc5	B-X
phosphorylation	B-X
by	B-X
mass	B-X
spectrometry	B-X
indicates	B-X
that	B-X
threonine	B-X
242	B-X
is	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
Cdc28	B-X
activates	B-X
Cdc5	B-X
via	B-X
phosphorylation	B-X
of	B-X
threonine	B-X
242	B-X
.	B-X

A	O
single	O
Cdc28	B-Gene_or_gene_product
consensus	O
phosphorylation	O
site	O
found	O
at	O
threonine	O
242	O
in	O
the	O
activation	O
loop	O
segment	O
of	O
Cdc5	B-Gene_or_gene_product
is	O
required	O
for	O
Cdc5	B-Gene_or_gene_product
function	O
in	O
vivo	O
and	O
for	O
kinase	O
activity	O
in	O
vitro	O
,	O
whereas	O
four	O
other	O
Cdc28	B-Gene_or_gene_product
consensus	O
sites	O
are	O
dispensable	O
.	O
<EOS>	B-X
Polo	B-X
kinase	B-X
is	B-X
activated	B-X
as	B-X
cells	B-X
enter	B-X
mitosis	B-X
and	B-X
plays	B-X
a	B-X
central	B-X
role	B-X
in	B-X
coordinating	B-X
diverse	B-X
mitotic	B-X
events	B-X
,	B-X
yet	B-X
the	B-X
mechanisms	B-X
leading	B-X
to	B-X
activation	B-X
of	B-X
Polo	B-X
kinase	B-X
are	B-X
poorly	B-X
understood	B-X
.	B-X
Work	B-X
in	B-X
Xenopus	B-X
meiotic	B-X
cell	B-X
cycles	B-X
has	B-X
suggested	B-X
that	B-X
Polo	B-X
kinase	B-X
functions	B-X
in	B-X
a	B-X
pathway	B-X
that	B-X
helps	B-X
trigger	B-X
activation	B-X
of	B-X
Cdk1	B-X
.	B-X
However	B-X
,	B-X
studies	B-X
in	B-X
other	B-X
organisms	B-X
have	B-X
suggested	B-X
that	B-X
activation	B-X
of	B-X
Polo	B-X
kinase	B-X
is	B-X
dependent	B-X
upon	B-X
Cdk1	B-X
and	B-X
therefore	B-X
occurs	B-X
downstream	B-X
of	B-X
Cdk1	B-X
activation	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
have	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
Cdk1	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
budding	B-X
yeast	B-X
Polo	B-X
kinase	B-X
.	B-X
The	B-X
budding	B-X
yeast	B-X
homologs	B-X
of	B-X
Cdk1	B-X
and	B-X
Polo	B-X
kinase	B-X
are	B-X
referred	B-X
to	B-X
as	B-X
Cdc28	B-X
and	B-X
Cdc5	B-X
.	B-X
We	B-X
show	B-X
that	B-X
signaling	B-X
from	B-X
Cdc28	B-X
is	B-X
required	B-X
to	B-X
maintain	B-X
Cdc5	B-X
activity	B-X
in	B-X
vivo	B-X
.	B-X
Furthermore	B-X
,	B-X
purified	B-X
Cdc28	B-X
associated	B-X
with	B-X
the	B-X
mitotic	B-X
cyclin	B-X
Clb2	B-X
is	B-X
sufficient	B-X
to	B-X
activate	B-X
purified	B-X
Cdc5	B-X
in	B-X
vitro	B-X
.	B-X
A	B-X
single	B-X
Cdc28	B-X
consensus	B-X
phosphorylation	B-X
site	B-X
found	B-X
at	B-X
threonine	B-X
242	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
segment	B-X
of	B-X
Cdc5	B-X
is	B-X
required	B-X
for	B-X
Cdc5	B-X
function	B-X
in	B-X
vivo	B-X
and	B-X
for	B-X
kinase	B-X
activity	B-X
in	B-X
vitro	B-X
,	B-X
whereas	B-X
four	B-X
other	B-X
Cdc28	B-X
consensus	B-X
sites	B-X
are	B-X
dispensable	B-X
.	B-X
Analysis	B-X
of	B-X
Cdc5	B-X
phosphorylation	B-X
by	B-X
mass	B-X
spectrometry	B-X
indicates	B-X
that	B-X
threonine	B-X
242	B-X
is	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
Cdc28	B-X
activates	B-X
Cdc5	B-X
via	B-X
phosphorylation	B-X
of	B-X
threonine	B-X
242	B-X
.	B-X

Analysis	O
of	O
Cdc5	B-Gene_or_gene_product
phosphorylation	O
by	O
mass	O
spectrometry	O
indicates	O
that	O
threonine	O
242	O
is	O
phosphorylated	O
in	O
vivo	O
.	O
<EOS>	B-X
The	B-X
budding	B-X
yeast	B-X
homologs	B-X
of	B-X
Cdk1	B-X
and	B-X
Polo	B-X
kinase	B-X
are	B-X
referred	B-X
to	B-X
as	B-X
Cdc28	B-X
and	B-X
Cdc5	B-X
.	B-X
We	B-X
show	B-X
that	B-X
signaling	B-X
from	B-X
Cdc28	B-X
is	B-X
required	B-X
to	B-X
maintain	B-X
Cdc5	B-X
activity	B-X
in	B-X
vivo	B-X
.	B-X
Furthermore	B-X
,	B-X
purified	B-X
Cdc28	B-X
associated	B-X
with	B-X
the	B-X
mitotic	B-X
cyclin	B-X
Clb2	B-X
is	B-X
sufficient	B-X
to	B-X
activate	B-X
purified	B-X
Cdc5	B-X
in	B-X
vitro	B-X
.	B-X
A	B-X
single	B-X
Cdc28	B-X
consensus	B-X
phosphorylation	B-X
site	B-X
found	B-X
at	B-X
threonine	B-X
242	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
segment	B-X
of	B-X
Cdc5	B-X
is	B-X
required	B-X
for	B-X
Cdc5	B-X
function	B-X
in	B-X
vivo	B-X
and	B-X
for	B-X
kinase	B-X
activity	B-X
in	B-X
vitro	B-X
,	B-X
whereas	B-X
four	B-X
other	B-X
Cdc28	B-X
consensus	B-X
sites	B-X
are	B-X
dispensable	B-X
.	B-X
Analysis	B-X
of	B-X
Cdc5	B-X
phosphorylation	B-X
by	B-X
mass	B-X
spectrometry	B-X
indicates	B-X
that	B-X
threonine	B-X
242	B-X
is	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
Cdc28	B-X
activates	B-X
Cdc5	B-X
via	B-X
phosphorylation	B-X
of	B-X
threonine	B-X
242	B-X
.	B-X

These	O
results	O
suggest	O
that	O
Cdc28	B-Gene_or_gene_product
activates	O
Cdc5	B-Gene_or_gene_product
via	O
phosphorylation	O
of	O
threonine	O
242	O
.	O
<EOS>	B-X
Work	B-X
in	B-X
Xenopus	B-X
meiotic	B-X
cell	B-X
cycles	B-X
has	B-X
suggested	B-X
that	B-X
Polo	B-X
kinase	B-X
functions	B-X
in	B-X
a	B-X
pathway	B-X
that	B-X
helps	B-X
trigger	B-X
activation	B-X
of	B-X
Cdk1	B-X
.	B-X
However	B-X
,	B-X
studies	B-X
in	B-X
other	B-X
organisms	B-X
have	B-X
suggested	B-X
that	B-X
activation	B-X
of	B-X
Polo	B-X
kinase	B-X
is	B-X
dependent	B-X
upon	B-X
Cdk1	B-X
and	B-X
therefore	B-X
occurs	B-X
downstream	B-X
of	B-X
Cdk1	B-X
activation	B-X
.	B-X
The	B-X
budding	B-X
yeast	B-X
homologs	B-X
of	B-X
Cdk1	B-X
and	B-X
Polo	B-X
kinase	B-X
are	B-X
referred	B-X
to	B-X
as	B-X
Cdc28	B-X
and	B-X
Cdc5	B-X
.	B-X
We	B-X
show	B-X
that	B-X
signaling	B-X
from	B-X
Cdc28	B-X
is	B-X
required	B-X
to	B-X
maintain	B-X
Cdc5	B-X
activity	B-X
in	B-X
vivo	B-X
.	B-X
Furthermore	B-X
,	B-X
purified	B-X
Cdc28	B-X
associated	B-X
with	B-X
the	B-X
mitotic	B-X
cyclin	B-X
Clb2	B-X
is	B-X
sufficient	B-X
to	B-X
activate	B-X
purified	B-X
Cdc5	B-X
in	B-X
vitro	B-X
.	B-X
A	B-X
single	B-X
Cdc28	B-X
consensus	B-X
phosphorylation	B-X
site	B-X
found	B-X
at	B-X
threonine	B-X
242	B-X
in	B-X
the	B-X
activation	B-X
loop	B-X
segment	B-X
of	B-X
Cdc5	B-X
is	B-X
required	B-X
for	B-X
Cdc5	B-X
function	B-X
in	B-X
vivo	B-X
and	B-X
for	B-X
kinase	B-X
activity	B-X
in	B-X
vitro	B-X
,	B-X
whereas	B-X
four	B-X
other	B-X
Cdc28	B-X
consensus	B-X
sites	B-X
are	B-X
dispensable	B-X
.	B-X
Analysis	B-X
of	B-X
Cdc5	B-X
phosphorylation	B-X
by	B-X
mass	B-X
spectrometry	B-X
indicates	B-X
that	B-X
threonine	B-X
242	B-X
is	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
Cdc28	B-X
activates	B-X
Cdc5	B-X
via	B-X
phosphorylation	B-X
of	B-X
threonine	B-X
242	B-X
.	B-X

GC	O
-	O
selective	O
DNA	O
-	O
binding	O
antibiotic	O
,	O
mithramycin	O
A	O
,	O
reveals	O
multiple	O
points	O
of	O
control	O
in	O
the	O
regulation	O
of	O
Hdm2	B-Gene_or_gene_product
protein	O
synthesis	O
.	O
<EOS>	B-X
The	B-X
primary	B-X
role	B-X
of	B-X
the	B-X
Hdm2/Mdm2	B-X
oncoprotein	B-X
is	B-X
to	B-X
regulate	B-X
the	B-X
levels	B-X
and	B-X
activity	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
p53	B-X
.	B-X
Hdm2	B-X
synthesis	B-X
is	B-X
itself	B-X
tightly	B-X
controlled	B-X
and	B-X
,	B-X
as	B-X
demonstrated	B-X
by	B-X
a	B-X
recently	B-X
described	B-X
SNP	B-X
(	B-X
SNP309	B-X
)	B-X
in	B-X
the	B-X
hdm2-P2	B-X
promoter	B-X
,	B-X
minor	B-X
variations	B-X
in	B-X
Hdm2	B-X
expression	B-X
have	B-X
phenotypic	B-X
consequences	B-X
on	B-X
radiation	B-X
sensitivity	B-X
and	B-X
cancer	B-X
predisposition	B-X
.	B-X
To	B-X
further	B-X
define	B-X
mechanisms	B-X
regulating	B-X
Hdm2	B-X
expression	B-X
,	B-X
we	B-X
have	B-X
investigated	B-X
the	B-X
effects	B-X
of	B-X
the	B-X
GC-selective	B-X
DNA-binding	B-X
drug	B-X
,	B-X
Mithramycin	B-X
A	B-X
(	B-X
MA	B-X
)	B-X
on	B-X
hdm2	B-X
mRNA	B-X
transcription	B-X
,	B-X
trafficking	B-X
,	B-X
and	B-X
translation	B-X
.	B-X
Thirdly	B-X
,	B-X
and	B-X
critically	B-X
,	B-X
MA	B-X
also	B-X
inhibits	B-X
Hdm2	B-X
synthesis	B-X
at	B-X
the	B-X
post-transcriptional	B-X
level	B-X
,	B-X
with	B-X
negative	B-X
effects	B-X
on	B-X
hdm2	B-X
mRNA	B-X
nuclear	B-X
export	B-X
and	B-X
translation	B-X
.	B-X
This	B-X
study	B-X
highlights	B-X
the	B-X
complex	B-X
interplay	B-X
between	B-X
the	B-X
pathways	B-X
that	B-X
regulate	B-X
Hdm2	B-X
protein	B-X
synthesis	B-X
in	B-X
cancer	B-X
cells	B-X
,	B-X
and	B-X
furthermore	B-X
emphasizes	B-X
the	B-X
export	B-X
of	B-X
hdm2	B-X
mRNA	B-X
from	B-X
the	B-X
nucleus	B-X
to	B-X
the	B-X
cytoplasm	B-X
as	B-X
a	B-X
key	B-X
point	B-X
of	B-X
control	B-X
in	B-X
this	B-X
process	B-X
.	B-X

The	O
primary	O
role	O
of	O
the	O
Hdm2	B-Gene_or_gene_product
/	O
Mdm2	B-Gene_or_gene_product
oncoprotein	O
is	O
to	O
regulate	O
the	O
levels	O
and	O
activity	O
of	O
the	O
transcription	O
factor	O
p53	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
MYCN	B-X
oncogene	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
neuroblastoma	B-X
.	B-X
MYCN	B-X
exerts	B-X
its	B-X
oncogenic	B-X
effects	B-X
through	B-X
transcriptional	B-X
regulation	B-X
of	B-X
numerous	B-X
target	B-X
genes	B-X
.	B-X
We	B-X
have	B-X
recently	B-X
characterized	B-X
the	B-X
p53	B-X
inhibitor	B-X
MDM2	B-X
(	B-X
HDM2	B-X
)	B-X
as	B-X
one	B-X
such	B-X
target	B-X
in	B-X
MYCN	B-X
amplified	B-X
neuroblastoma	B-X
cell	B-X
lines	B-X
.	B-X
MYCN	B-X
inhibition	B-X
leads	B-X
to	B-X
diminished	B-X
MDM2	B-X
,	B-X
stabilized	B-X
p53	B-X
and	B-X
apoptosis	B-X
.	B-X
As	B-X
the	B-X
primary	B-X
negative	B-X
regulator	B-X
of	B-X
p53	B-X
,	B-X
MDM2	B-X
is	B-X
critically	B-X
regulated	B-X
in	B-X
normal	B-X
cells	B-X
to	B-X
ensure	B-X
adequate	B-X
p53	B-X
activity	B-X
in	B-X
response	B-X
to	B-X
damage	B-X
or	B-X
stress	B-X
.	B-X
Additionally	B-X
,	B-X
MDM2	B-X
regulates	B-X
many	B-X
p53	B-X
independent	B-X
processes	B-X
pertinent	B-X
to	B-X
oncogenesis	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
increased	B-X
MDM2	B-X
levels	B-X
downstream	B-X
of	B-X
MYCN	B-X
are	B-X
tumorigenic	B-X
secondary	B-X
to	B-X
disruption	B-X
of	B-X
multiple	B-X
p53	B-X
dependent	B-X
and	B-X
independent	B-X
mechanisms	B-X
controlling	B-X
genomic	B-X
stability	B-X
,	B-X
apoptopsis	B-X
and	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X
Further	B-X
research	B-X
into	B-X
the	B-X
MYCN/MDM2	B-X
regulated	B-X
pathways	B-X
will	B-X
provide	B-X
insight	B-X
into	B-X
the	B-X
pathogenesis	B-X
of	B-X
MYCN-driven	B-X
tumors	B-X
and	B-X
provide	B-X
targets	B-X
for	B-X
novel	B-X
therapeutic	B-X
interventions	B-X
.	B-X

Hdm2	B-Gene_or_gene_product
synthesis	O
is	O
itself	O
tightly	O
controlled	O
and	O
,	O
as	O
demonstrated	O
by	O
a	O
recently	O
described	O
SNP	O
(	O
SNP309	O
)	O
in	O
the	O
hdm2	B-Gene_or_gene_product
-	O
P2	O
promoter	O
,	O
minor	O
variations	O
in	O
Hdm2	B-Gene_or_gene_product
expression	O
have	O
phenotypic	O
consequences	O
on	O
radiation	O
sensitivity	O
and	O
cancer	O
predisposition	O
.	O
<EOS>	B-X
The	B-X
primary	B-X
role	B-X
of	B-X
the	B-X
Hdm2/Mdm2	B-X
oncoprotein	B-X
is	B-X
to	B-X
regulate	B-X
the	B-X
levels	B-X
and	B-X
activity	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
p53	B-X
.	B-X
Hdm2	B-X
synthesis	B-X
is	B-X
itself	B-X
tightly	B-X
controlled	B-X
and	B-X
,	B-X
as	B-X
demonstrated	B-X
by	B-X
a	B-X
recently	B-X
described	B-X
SNP	B-X
(	B-X
SNP309	B-X
)	B-X
in	B-X
the	B-X
hdm2-P2	B-X
promoter	B-X
,	B-X
minor	B-X
variations	B-X
in	B-X
Hdm2	B-X
expression	B-X
have	B-X
phenotypic	B-X
consequences	B-X
on	B-X
radiation	B-X
sensitivity	B-X
and	B-X
cancer	B-X
predisposition	B-X
.	B-X
To	B-X
further	B-X
define	B-X
mechanisms	B-X
regulating	B-X
Hdm2	B-X
expression	B-X
,	B-X
we	B-X
have	B-X
investigated	B-X
the	B-X
effects	B-X
of	B-X
the	B-X
GC-selective	B-X
DNA-binding	B-X
drug	B-X
,	B-X
Mithramycin	B-X
A	B-X
(	B-X
MA	B-X
)	B-X
on	B-X
hdm2	B-X
mRNA	B-X
transcription	B-X
,	B-X
trafficking	B-X
,	B-X
and	B-X
translation	B-X
.	B-X
Firstly	B-X
we	B-X
show	B-X
that	B-X
the	B-X
constitutive	B-X
hdm2-P1	B-X
promoter	B-X
is	B-X
inhibited	B-X
by	B-X
MA	B-X
.	B-X
We	B-X
define	B-X
,	B-X
for	B-X
the	B-X
first	B-X
time	B-X
,	B-X
the	B-X
minimal	B-X
sequence	B-X
elements	B-X
that	B-X
are	B-X
required	B-X
for	B-X
P1-promoter	B-X
activity	B-X
and	B-X
identify	B-X
those	B-X
which	B-X
confer	B-X
MA	B-X
sensitivity	B-X
.	B-X
Secondly	B-X
,	B-X
MA	B-X
induces	B-X
p53-dependent	B-X
transcription	B-X
from	B-X
the	B-X
hdm2-P2	B-X
promoter	B-X
.	B-X
Thirdly	B-X
,	B-X
and	B-X
critically	B-X
,	B-X
MA	B-X
also	B-X
inhibits	B-X
Hdm2	B-X
synthesis	B-X
at	B-X
the	B-X
post-transcriptional	B-X
level	B-X
,	B-X
with	B-X
negative	B-X
effects	B-X
on	B-X
hdm2	B-X
mRNA	B-X
nuclear	B-X
export	B-X
and	B-X
translation	B-X
.	B-X
This	B-X
study	B-X
highlights	B-X
the	B-X
complex	B-X
interplay	B-X
between	B-X
the	B-X
pathways	B-X
that	B-X
regulate	B-X
Hdm2	B-X
protein	B-X
synthesis	B-X
in	B-X
cancer	B-X
cells	B-X
,	B-X
and	B-X
furthermore	B-X
emphasizes	B-X
the	B-X
export	B-X
of	B-X
hdm2	B-X
mRNA	B-X
from	B-X
the	B-X
nucleus	B-X
to	B-X
the	B-X
cytoplasm	B-X
as	B-X
a	B-X
key	B-X
point	B-X
of	B-X
control	B-X
in	B-X
this	B-X
process	B-X
.	B-X

To	O
further	O
define	O
mechanisms	O
regulating	O
Hdm2	B-Gene_or_gene_product
expression	O
,	O
we	O
have	O
investigated	O
the	O
effects	O
of	O
the	O
GC	O
-	O
selective	O
DNA	O
-	O
binding	O
drug	O
,	O
Mithramycin	O
A	O
(	O
MA	O
)	O
on	O
hdm2	B-Gene_or_gene_product
mRNA	O
transcription	O
,	O
trafficking	O
,	O
and	O
translation	O
.	O

Firstly	O
we	O
show	O
that	O
the	O
constitutive	O
hdm2	B-Gene_or_gene_product
-	O
P1	O
promoter	O
is	O
inhibited	O
by	O
MA	O
.	O

We	O
define	O
,	O
for	O
the	O
first	O
time	O
,	O
the	O
minimal	O
sequence	O
elements	O
that	O
are	O
required	O
for	O
P1	O
-	O
promoter	O
activity	O
and	O
identify	O
those	O
which	O
confer	O
MA	O
sensitivity	O
.	O
<EOS>	B-X
The	B-X
primary	B-X
role	B-X
of	B-X
the	B-X
Hdm2/Mdm2	B-X
oncoprotein	B-X
is	B-X
to	B-X
regulate	B-X
the	B-X
levels	B-X
and	B-X
activity	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
p53	B-X
.	B-X
Hdm2	B-X
synthesis	B-X
is	B-X
itself	B-X
tightly	B-X
controlled	B-X
and	B-X
,	B-X
as	B-X
demonstrated	B-X
by	B-X
a	B-X
recently	B-X
described	B-X
SNP	B-X
(	B-X
SNP309	B-X
)	B-X
in	B-X
the	B-X
hdm2-P2	B-X
promoter	B-X
,	B-X
minor	B-X
variations	B-X
in	B-X
Hdm2	B-X
expression	B-X
have	B-X
phenotypic	B-X
consequences	B-X
on	B-X
radiation	B-X
sensitivity	B-X
and	B-X
cancer	B-X
predisposition	B-X
.	B-X
To	B-X
further	B-X
define	B-X
mechanisms	B-X
regulating	B-X
Hdm2	B-X
expression	B-X
,	B-X
we	B-X
have	B-X
investigated	B-X
the	B-X
effects	B-X
of	B-X
the	B-X
GC-selective	B-X
DNA-binding	B-X
drug	B-X
,	B-X
Mithramycin	B-X
A	B-X
(	B-X
MA	B-X
)	B-X
on	B-X
hdm2	B-X
mRNA	B-X
transcription	B-X
,	B-X
trafficking	B-X
,	B-X
and	B-X
translation	B-X
.	B-X
Firstly	B-X
we	B-X
show	B-X
that	B-X
the	B-X
constitutive	B-X
hdm2-P1	B-X
promoter	B-X
is	B-X
inhibited	B-X
by	B-X
MA	B-X
.	B-X
We	B-X
define	B-X
,	B-X
for	B-X
the	B-X
first	B-X
time	B-X
,	B-X
the	B-X
minimal	B-X
sequence	B-X
elements	B-X
that	B-X
are	B-X
required	B-X
for	B-X
P1-promoter	B-X
activity	B-X
and	B-X
identify	B-X
those	B-X
which	B-X
confer	B-X
MA	B-X
sensitivity	B-X
.	B-X
Secondly	B-X
,	B-X
MA	B-X
induces	B-X
p53-dependent	B-X
transcription	B-X
from	B-X
the	B-X
hdm2-P2	B-X
promoter	B-X
.	B-X

Secondly	O
,	O
MA	O
induces	O
p53	B-Gene_or_gene_product
-	O
dependent	O
transcription	O
from	O
the	O
hdm2	B-Gene_or_gene_product
-	O
P2	O
promoter	O
.	O
<EOS>	B-X
The	B-X
primary	B-X
role	B-X
of	B-X
the	B-X
Hdm2/Mdm2	B-X
oncoprotein	B-X
is	B-X
to	B-X
regulate	B-X
the	B-X
levels	B-X
and	B-X
activity	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
p53	B-X
.	B-X
Hdm2	B-X
synthesis	B-X
is	B-X
itself	B-X
tightly	B-X
controlled	B-X
and	B-X
,	B-X
as	B-X
demonstrated	B-X
by	B-X
a	B-X
recently	B-X
described	B-X
SNP	B-X
(	B-X
SNP309	B-X
)	B-X
in	B-X
the	B-X
hdm2-P2	B-X
promoter	B-X
,	B-X
minor	B-X
variations	B-X
in	B-X
Hdm2	B-X
expression	B-X
have	B-X
phenotypic	B-X
consequences	B-X
on	B-X
radiation	B-X
sensitivity	B-X
and	B-X
cancer	B-X
predisposition	B-X
.	B-X
To	B-X
further	B-X
define	B-X
mechanisms	B-X
regulating	B-X
Hdm2	B-X
expression	B-X
,	B-X
we	B-X
have	B-X
investigated	B-X
the	B-X
effects	B-X
of	B-X
the	B-X
GC-selective	B-X
DNA-binding	B-X
drug	B-X
,	B-X
Mithramycin	B-X
A	B-X
(	B-X
MA	B-X
)	B-X
on	B-X
hdm2	B-X
mRNA	B-X
transcription	B-X
,	B-X
trafficking	B-X
,	B-X
and	B-X
translation	B-X
.	B-X
Firstly	B-X
we	B-X
show	B-X
that	B-X
the	B-X
constitutive	B-X
hdm2-P1	B-X
promoter	B-X
is	B-X
inhibited	B-X
by	B-X
MA	B-X
.	B-X
We	B-X
define	B-X
,	B-X
for	B-X
the	B-X
first	B-X
time	B-X
,	B-X
the	B-X
minimal	B-X
sequence	B-X
elements	B-X
that	B-X
are	B-X
required	B-X
for	B-X
P1-promoter	B-X
activity	B-X
and	B-X
identify	B-X
those	B-X
which	B-X
confer	B-X
MA	B-X
sensitivity	B-X
.	B-X
Secondly	B-X
,	B-X
MA	B-X
induces	B-X
p53-dependent	B-X
transcription	B-X
from	B-X
the	B-X
hdm2-P2	B-X
promoter	B-X
.	B-X
Thirdly	B-X
,	B-X
and	B-X
critically	B-X
,	B-X
MA	B-X
also	B-X
inhibits	B-X
Hdm2	B-X
synthesis	B-X
at	B-X
the	B-X
post-transcriptional	B-X
level	B-X
,	B-X
with	B-X
negative	B-X
effects	B-X
on	B-X
hdm2	B-X
mRNA	B-X
nuclear	B-X
export	B-X
and	B-X
translation	B-X
.	B-X
This	B-X
study	B-X
highlights	B-X
the	B-X
complex	B-X
interplay	B-X
between	B-X
the	B-X
pathways	B-X
that	B-X
regulate	B-X
Hdm2	B-X
protein	B-X
synthesis	B-X
in	B-X
cancer	B-X
cells	B-X
,	B-X
and	B-X
furthermore	B-X
emphasizes	B-X
the	B-X
export	B-X
of	B-X
hdm2	B-X
mRNA	B-X
from	B-X
the	B-X
nucleus	B-X
to	B-X
the	B-X
cytoplasm	B-X
as	B-X
a	B-X
key	B-X
point	B-X
of	B-X
control	B-X
in	B-X
this	B-X
process	B-X
.	B-X

Thirdly	O
,	O
and	O
critically	O
,	O
MA	O
also	O
inhibits	O
Hdm2	B-Gene_or_gene_product
synthesis	O
at	O
the	O
post	O
-	O
transcriptional	O
level	O
,	O
with	O
negative	O
effects	O
on	O
hdm2	B-Gene_or_gene_product
mRNA	O
nuclear	O
export	O
and	O
translation	O
.	O
<EOS>	B-X
The	B-X
primary	B-X
role	B-X
of	B-X
the	B-X
Hdm2/Mdm2	B-X
oncoprotein	B-X
is	B-X
to	B-X
regulate	B-X
the	B-X
levels	B-X
and	B-X
activity	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
p53	B-X
.	B-X
Hdm2	B-X
synthesis	B-X
is	B-X
itself	B-X
tightly	B-X
controlled	B-X
and	B-X
,	B-X
as	B-X
demonstrated	B-X
by	B-X
a	B-X
recently	B-X
described	B-X
SNP	B-X
(	B-X
SNP309	B-X
)	B-X
in	B-X
the	B-X
hdm2-P2	B-X
promoter	B-X
,	B-X
minor	B-X
variations	B-X
in	B-X
Hdm2	B-X
expression	B-X
have	B-X
phenotypic	B-X
consequences	B-X
on	B-X
radiation	B-X
sensitivity	B-X
and	B-X
cancer	B-X
predisposition	B-X
.	B-X
To	B-X
further	B-X
define	B-X
mechanisms	B-X
regulating	B-X
Hdm2	B-X
expression	B-X
,	B-X
we	B-X
have	B-X
investigated	B-X
the	B-X
effects	B-X
of	B-X
the	B-X
GC-selective	B-X
DNA-binding	B-X
drug	B-X
,	B-X
Mithramycin	B-X
A	B-X
(	B-X
MA	B-X
)	B-X
on	B-X
hdm2	B-X
mRNA	B-X
transcription	B-X
,	B-X
trafficking	B-X
,	B-X
and	B-X
translation	B-X
.	B-X
Firstly	B-X
we	B-X
show	B-X
that	B-X
the	B-X
constitutive	B-X
hdm2-P1	B-X
promoter	B-X
is	B-X
inhibited	B-X
by	B-X
MA	B-X
.	B-X
Secondly	B-X
,	B-X
MA	B-X
induces	B-X
p53-dependent	B-X
transcription	B-X
from	B-X
the	B-X
hdm2-P2	B-X
promoter	B-X
.	B-X
Thirdly	B-X
,	B-X
and	B-X
critically	B-X
,	B-X
MA	B-X
also	B-X
inhibits	B-X
Hdm2	B-X
synthesis	B-X
at	B-X
the	B-X
post-transcriptional	B-X
level	B-X
,	B-X
with	B-X
negative	B-X
effects	B-X
on	B-X
hdm2	B-X
mRNA	B-X
nuclear	B-X
export	B-X
and	B-X
translation	B-X
.	B-X
This	B-X
study	B-X
highlights	B-X
the	B-X
complex	B-X
interplay	B-X
between	B-X
the	B-X
pathways	B-X
that	B-X
regulate	B-X
Hdm2	B-X
protein	B-X
synthesis	B-X
in	B-X
cancer	B-X
cells	B-X
,	B-X
and	B-X
furthermore	B-X
emphasizes	B-X
the	B-X
export	B-X
of	B-X
hdm2	B-X
mRNA	B-X
from	B-X
the	B-X
nucleus	B-X
to	B-X
the	B-X
cytoplasm	B-X
as	B-X
a	B-X
key	B-X
point	B-X
of	B-X
control	B-X
in	B-X
this	B-X
process	B-X
.	B-X

This	O
study	O
highlights	O
the	O
complex	O
interplay	O
between	O
the	O
pathways	O
that	O
regulate	O
Hdm2	B-Gene_or_gene_product
protein	O
synthesis	O
in	O
cancer	O
cells	O
,	O
and	O
furthermore	O
emphasizes	O
the	O
export	O
of	O
hdm2	B-Gene_or_gene_product
mRNA	O
from	O
the	O
nucleus	O
to	O
the	O
cytoplasm	O
as	O
a	O
key	O
point	O
of	O
control	O
in	O
this	O
process	O
.	O

ASK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
apoptosis	B-Gene_or_gene_product
signal	I-Gene_or_gene_product
-	I-Gene_or_gene_product
regulating	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
is	O
a	O
direct	O
E2F	B-Gene_or_gene_product
target	O
gene	O
.	O
<EOS>	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
show	B-X
that	B-X
E2Fs	B-X
(	B-X
E2	B-X
promoter-binding	B-X
factors	B-X
)	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
ASK-1	B-X
(	B-X
apoptosis	B-X
signal-regulating	B-X
kinase	B-X
1	B-X
)	B-X
,	B-X
which	B-X
encodes	B-X
a	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinase	B-X
,	B-X
also	B-X
known	B-X
as	B-X
MAP3K5	B-X
.	B-X
Moreover	B-X
,	B-X
overexpression	B-X
and	B-X
RNA	B-X
interference	B-X
experiments	B-X
support	B-X
the	B-X
requirement	B-X
of	B-X
endogenous	B-X
E2F/DP	B-X
(	B-X
E2F	B-X
dimerization	B-X
partner	B-X
)	B-X
activity	B-X
for	B-X
ASK-1	B-X
expression	B-X
.	B-X
Characterization	B-X
of	B-X
the	B-X
human	B-X
ASK-1	B-X
promoter	B-X
demonstrates	B-X
that	B-X
the	B-X
-95/+11	B-X
region	B-X
is	B-X
critical	B-X
for	B-X
E2F-mediated	B-X
up-regulation	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
show	B-X
that	B-X
E2F1-E2F4	B-X
are	B-X
bound	B-X
in	B-X
vivo	B-X
to	B-X
the	B-X
ASK-1	B-X
promoter	B-X
in	B-X
cycling	B-X
cells	B-X
,	B-X
probably	B-X
through	B-X
a	B-X
non-consensus	B-X
E2F-binding	B-X
site	B-X
located	B-X
12	B-X
bp	B-X
upstream	B-X
of	B-X
the	B-X
transcription	B-X
start	B-X
site	B-X
.	B-X
Mutation	B-X
of	B-X
this	B-X
site	B-X
completely	B-X
abolishes	B-X
the	B-X
ASK-1	B-X
promoter	B-X
response	B-X
to	B-X
E2Fs	B-X
as	B-X
well	B-X
as	B-X
the	B-X
E2F1	B-X
binding	B-X
in	B-X
electrophoretic	B-X
mobility-shift	B-X
experiments	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
that	B-X
E2Fs	B-X
modulate	B-X
the	B-X
expression	B-X
of	B-X
ASK-1	B-X
and	B-X
suggest	B-X
that	B-X
some	B-X
of	B-X
the	B-X
cellular	B-X
functions	B-X
of	B-X
ASK-1	B-X
may	B-X
be	B-X
under	B-X
the	B-X
control	B-X
of	B-X
E2F	B-X
transcription	B-X
factors	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
up-regulation	B-X
of	B-X
ASK-1	B-X
may	B-X
also	B-X
favour	B-X
the	B-X
p53-independent	B-X
E2F1	B-X
apoptotic	B-X
activity	B-X
.	B-X

In	O
the	O
present	O
study	O
,	O
we	O
show	O
that	O
E2Fs	B-Gene_or_gene_product
(	O
E2	B-Gene_or_gene_product
promoter	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
factors	I-Gene_or_gene_product
)	O
regulate	O
the	O
expression	O
of	O
ASK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
apoptosis	B-Gene_or_gene_product
signal	I-Gene_or_gene_product
-	I-Gene_or_gene_product
regulating	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
,	O
which	O
encodes	O
a	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
,	O
also	O
known	O
as	O
MAP3K5	B-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
show	B-X
that	B-X
E2Fs	B-X
(	B-X
E2	B-X
promoter-binding	B-X
factors	B-X
)	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
ASK-1	B-X
(	B-X
apoptosis	B-X
signal-regulating	B-X
kinase	B-X
1	B-X
)	B-X
,	B-X
which	B-X
encodes	B-X
a	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinase	B-X
,	B-X
also	B-X
known	B-X
as	B-X
MAP3K5	B-X
.	B-X
Its	B-X
mRNA	B-X
expression	B-X
is	B-X
cell-cycle-regulated	B-X
in	B-X
human	B-X
T98G	B-X
cells	B-X
released	B-X
from	B-X
serum	B-X
starvation	B-X
.	B-X
Moreover	B-X
,	B-X
overexpression	B-X
and	B-X
RNA	B-X
interference	B-X
experiments	B-X
support	B-X
the	B-X
requirement	B-X
of	B-X
endogenous	B-X
E2F/DP	B-X
(	B-X
E2F	B-X
dimerization	B-X
partner	B-X
)	B-X
activity	B-X
for	B-X
ASK-1	B-X
expression	B-X
.	B-X
Characterization	B-X
of	B-X
the	B-X
human	B-X
ASK-1	B-X
promoter	B-X
demonstrates	B-X
that	B-X
the	B-X
-95/+11	B-X
region	B-X
is	B-X
critical	B-X
for	B-X
E2F-mediated	B-X
up-regulation	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
show	B-X
that	B-X
E2F1-E2F4	B-X
are	B-X
bound	B-X
in	B-X
vivo	B-X
to	B-X
the	B-X
ASK-1	B-X
promoter	B-X
in	B-X
cycling	B-X
cells	B-X
,	B-X
probably	B-X
through	B-X
a	B-X
non-consensus	B-X
E2F-binding	B-X
site	B-X
located	B-X
12	B-X
bp	B-X
upstream	B-X
of	B-X
the	B-X
transcription	B-X
start	B-X
site	B-X
.	B-X
Mutation	B-X
of	B-X
this	B-X
site	B-X
completely	B-X
abolishes	B-X
the	B-X
ASK-1	B-X
promoter	B-X
response	B-X
to	B-X
E2Fs	B-X
as	B-X
well	B-X
as	B-X
the	B-X
E2F1	B-X
binding	B-X
in	B-X
electrophoretic	B-X
mobility-shift	B-X
experiments	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
that	B-X
E2Fs	B-X
modulate	B-X
the	B-X
expression	B-X
of	B-X
ASK-1	B-X
and	B-X
suggest	B-X
that	B-X
some	B-X
of	B-X
the	B-X
cellular	B-X
functions	B-X
of	B-X
ASK-1	B-X
may	B-X
be	B-X
under	B-X
the	B-X
control	B-X
of	B-X
E2F	B-X
transcription	B-X
factors	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
up-regulation	B-X
of	B-X
ASK-1	B-X
may	B-X
also	B-X
favour	B-X
the	B-X
p53-independent	B-X
E2F1	B-X
apoptotic	B-X
activity	B-X
.	B-X

Its	O
mRNA	O
expression	O
is	O
cell	O
-	O
cycle	O
-	O
regulated	O
in	O
human	O
T98G	O
cells	O
released	O
from	O
serum	O
starvation	O
.	O
<EOS>	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
show	B-X
that	B-X
E2Fs	B-X
(	B-X
E2	B-X
promoter-binding	B-X
factors	B-X
)	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
ASK-1	B-X
(	B-X
apoptosis	B-X
signal-regulating	B-X
kinase	B-X
1	B-X
)	B-X
,	B-X
which	B-X
encodes	B-X
a	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinase	B-X
,	B-X
also	B-X
known	B-X
as	B-X
MAP3K5	B-X
.	B-X
Its	B-X
mRNA	B-X
expression	B-X
is	B-X
cell-cycle-regulated	B-X
in	B-X
human	B-X
T98G	B-X
cells	B-X
released	B-X
from	B-X
serum	B-X
starvation	B-X
.	B-X
Moreover	B-X
,	B-X
overexpression	B-X
and	B-X
RNA	B-X
interference	B-X
experiments	B-X
support	B-X
the	B-X
requirement	B-X
of	B-X
endogenous	B-X
E2F/DP	B-X
(	B-X
E2F	B-X
dimerization	B-X
partner	B-X
)	B-X
activity	B-X
for	B-X
ASK-1	B-X
expression	B-X
.	B-X
Characterization	B-X
of	B-X
the	B-X
human	B-X
ASK-1	B-X
promoter	B-X
demonstrates	B-X
that	B-X
the	B-X
-95/+11	B-X
region	B-X
is	B-X
critical	B-X
for	B-X
E2F-mediated	B-X
up-regulation	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
show	B-X
that	B-X
E2F1-E2F4	B-X
are	B-X
bound	B-X
in	B-X
vivo	B-X
to	B-X
the	B-X
ASK-1	B-X
promoter	B-X
in	B-X
cycling	B-X
cells	B-X
,	B-X
probably	B-X
through	B-X
a	B-X
non-consensus	B-X
E2F-binding	B-X
site	B-X
located	B-X
12	B-X
bp	B-X
upstream	B-X
of	B-X
the	B-X
transcription	B-X
start	B-X
site	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
that	B-X
E2Fs	B-X
modulate	B-X
the	B-X
expression	B-X
of	B-X
ASK-1	B-X
and	B-X
suggest	B-X
that	B-X
some	B-X
of	B-X
the	B-X
cellular	B-X
functions	B-X
of	B-X
ASK-1	B-X
may	B-X
be	B-X
under	B-X
the	B-X
control	B-X
of	B-X
E2F	B-X
transcription	B-X
factors	B-X
.	B-X

Moreover	O
,	O
overexpression	O
and	O
RNA	O
interference	O
experiments	O
support	O
the	O
requirement	O
of	O
endogenous	O
E2F	O
/	O
DP	O
(	O
E2F	O
dimerization	O
partner	O
)	O
activity	O
for	O
ASK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
expression	O
.	O
<EOS>	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
show	B-X
that	B-X
E2Fs	B-X
(	B-X
E2	B-X
promoter-binding	B-X
factors	B-X
)	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
ASK-1	B-X
(	B-X
apoptosis	B-X
signal-regulating	B-X
kinase	B-X
1	B-X
)	B-X
,	B-X
which	B-X
encodes	B-X
a	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinase	B-X
,	B-X
also	B-X
known	B-X
as	B-X
MAP3K5	B-X
.	B-X
Its	B-X
mRNA	B-X
expression	B-X
is	B-X
cell-cycle-regulated	B-X
in	B-X
human	B-X
T98G	B-X
cells	B-X
released	B-X
from	B-X
serum	B-X
starvation	B-X
.	B-X
Moreover	B-X
,	B-X
overexpression	B-X
and	B-X
RNA	B-X
interference	B-X
experiments	B-X
support	B-X
the	B-X
requirement	B-X
of	B-X
endogenous	B-X
E2F/DP	B-X
(	B-X
E2F	B-X
dimerization	B-X
partner	B-X
)	B-X
activity	B-X
for	B-X
ASK-1	B-X
expression	B-X
.	B-X
Characterization	B-X
of	B-X
the	B-X
human	B-X
ASK-1	B-X
promoter	B-X
demonstrates	B-X
that	B-X
the	B-X
-95/+11	B-X
region	B-X
is	B-X
critical	B-X
for	B-X
E2F-mediated	B-X
up-regulation	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
show	B-X
that	B-X
E2F1-E2F4	B-X
are	B-X
bound	B-X
in	B-X
vivo	B-X
to	B-X
the	B-X
ASK-1	B-X
promoter	B-X
in	B-X
cycling	B-X
cells	B-X
,	B-X
probably	B-X
through	B-X
a	B-X
non-consensus	B-X
E2F-binding	B-X
site	B-X
located	B-X
12	B-X
bp	B-X
upstream	B-X
of	B-X
the	B-X
transcription	B-X
start	B-X
site	B-X
.	B-X
Mutation	B-X
of	B-X
this	B-X
site	B-X
completely	B-X
abolishes	B-X
the	B-X
ASK-1	B-X
promoter	B-X
response	B-X
to	B-X
E2Fs	B-X
as	B-X
well	B-X
as	B-X
the	B-X
E2F1	B-X
binding	B-X
in	B-X
electrophoretic	B-X
mobility-shift	B-X
experiments	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
that	B-X
E2Fs	B-X
modulate	B-X
the	B-X
expression	B-X
of	B-X
ASK-1	B-X
and	B-X
suggest	B-X
that	B-X
some	B-X
of	B-X
the	B-X
cellular	B-X
functions	B-X
of	B-X
ASK-1	B-X
may	B-X
be	B-X
under	B-X
the	B-X
control	B-X
of	B-X
E2F	B-X
transcription	B-X
factors	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
up-regulation	B-X
of	B-X
ASK-1	B-X
may	B-X
also	B-X
favour	B-X
the	B-X
p53-independent	B-X
E2F1	B-X
apoptotic	B-X
activity	B-X
.	B-X

Characterization	O
of	O
the	O
human	O
ASK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
promoter	O
demonstrates	O
that	O
the	O
-	O
95	O
/	O
+	O
11	O
region	O
is	O
critical	O
for	O
E2F	B-Gene_or_gene_product
-	O
mediated	O
up	O
-	O
regulation	O
.	O
<EOS>	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
show	B-X
that	B-X
E2Fs	B-X
(	B-X
E2	B-X
promoter-binding	B-X
factors	B-X
)	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
ASK-1	B-X
(	B-X
apoptosis	B-X
signal-regulating	B-X
kinase	B-X
1	B-X
)	B-X
,	B-X
which	B-X
encodes	B-X
a	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinase	B-X
,	B-X
also	B-X
known	B-X
as	B-X
MAP3K5	B-X
.	B-X
Its	B-X
mRNA	B-X
expression	B-X
is	B-X
cell-cycle-regulated	B-X
in	B-X
human	B-X
T98G	B-X
cells	B-X
released	B-X
from	B-X
serum	B-X
starvation	B-X
.	B-X
Moreover	B-X
,	B-X
overexpression	B-X
and	B-X
RNA	B-X
interference	B-X
experiments	B-X
support	B-X
the	B-X
requirement	B-X
of	B-X
endogenous	B-X
E2F/DP	B-X
(	B-X
E2F	B-X
dimerization	B-X
partner	B-X
)	B-X
activity	B-X
for	B-X
ASK-1	B-X
expression	B-X
.	B-X
Characterization	B-X
of	B-X
the	B-X
human	B-X
ASK-1	B-X
promoter	B-X
demonstrates	B-X
that	B-X
the	B-X
-95/+11	B-X
region	B-X
is	B-X
critical	B-X
for	B-X
E2F-mediated	B-X
up-regulation	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
show	B-X
that	B-X
E2F1-E2F4	B-X
are	B-X
bound	B-X
in	B-X
vivo	B-X
to	B-X
the	B-X
ASK-1	B-X
promoter	B-X
in	B-X
cycling	B-X
cells	B-X
,	B-X
probably	B-X
through	B-X
a	B-X
non-consensus	B-X
E2F-binding	B-X
site	B-X
located	B-X
12	B-X
bp	B-X
upstream	B-X
of	B-X
the	B-X
transcription	B-X
start	B-X
site	B-X
.	B-X
Mutation	B-X
of	B-X
this	B-X
site	B-X
completely	B-X
abolishes	B-X
the	B-X
ASK-1	B-X
promoter	B-X
response	B-X
to	B-X
E2Fs	B-X
as	B-X
well	B-X
as	B-X
the	B-X
E2F1	B-X
binding	B-X
in	B-X
electrophoretic	B-X
mobility-shift	B-X
experiments	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
that	B-X
E2Fs	B-X
modulate	B-X
the	B-X
expression	B-X
of	B-X
ASK-1	B-X
and	B-X
suggest	B-X
that	B-X
some	B-X
of	B-X
the	B-X
cellular	B-X
functions	B-X
of	B-X
ASK-1	B-X
may	B-X
be	B-X
under	B-X
the	B-X
control	B-X
of	B-X
E2F	B-X
transcription	B-X
factors	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
up-regulation	B-X
of	B-X
ASK-1	B-X
may	B-X
also	B-X
favour	B-X
the	B-X
p53-independent	B-X
E2F1	B-X
apoptotic	B-X
activity	B-X
.	B-X

Chromatin	O
immunoprecipitation	O
assays	O
show	O
that	O
E2F1	B-Gene_or_gene_product
-	O
E2F4	B-Gene_or_gene_product
are	O
bound	O
in	O
vivo	O
to	O
the	O
ASK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
promoter	O
in	O
cycling	O
cells	O
,	O
probably	O
through	O
a	O
non	O
-	O
consensus	O
E2F	B-Gene_or_gene_product
-	O
binding	O
site	O
located	O
12	O
bp	O
upstream	O
of	O
the	O
transcription	O
start	O
site	O
.	O

Mutation	O
of	O
this	O
site	O
completely	O
abolishes	O
the	O
ASK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
promoter	O
response	O
to	O
E2Fs	B-Gene_or_gene_product
as	O
well	O
as	O
the	O
E2F1	B-Gene_or_gene_product
binding	O
in	O
electrophoretic	O
mobility	O
-	O
shift	O
experiments	O
.	O
<EOS>	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
show	B-X
that	B-X
E2Fs	B-X
(	B-X
E2	B-X
promoter-binding	B-X
factors	B-X
)	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
ASK-1	B-X
(	B-X
apoptosis	B-X
signal-regulating	B-X
kinase	B-X
1	B-X
)	B-X
,	B-X
which	B-X
encodes	B-X
a	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinase	B-X
,	B-X
also	B-X
known	B-X
as	B-X
MAP3K5	B-X
.	B-X
Moreover	B-X
,	B-X
overexpression	B-X
and	B-X
RNA	B-X
interference	B-X
experiments	B-X
support	B-X
the	B-X
requirement	B-X
of	B-X
endogenous	B-X
E2F/DP	B-X
(	B-X
E2F	B-X
dimerization	B-X
partner	B-X
)	B-X
activity	B-X
for	B-X
ASK-1	B-X
expression	B-X
.	B-X
Characterization	B-X
of	B-X
the	B-X
human	B-X
ASK-1	B-X
promoter	B-X
demonstrates	B-X
that	B-X
the	B-X
-95/+11	B-X
region	B-X
is	B-X
critical	B-X
for	B-X
E2F-mediated	B-X
up-regulation	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
show	B-X
that	B-X
E2F1-E2F4	B-X
are	B-X
bound	B-X
in	B-X
vivo	B-X
to	B-X
the	B-X
ASK-1	B-X
promoter	B-X
in	B-X
cycling	B-X
cells	B-X
,	B-X
probably	B-X
through	B-X
a	B-X
non-consensus	B-X
E2F-binding	B-X
site	B-X
located	B-X
12	B-X
bp	B-X
upstream	B-X
of	B-X
the	B-X
transcription	B-X
start	B-X
site	B-X
.	B-X
Mutation	B-X
of	B-X
this	B-X
site	B-X
completely	B-X
abolishes	B-X
the	B-X
ASK-1	B-X
promoter	B-X
response	B-X
to	B-X
E2Fs	B-X
as	B-X
well	B-X
as	B-X
the	B-X
E2F1	B-X
binding	B-X
in	B-X
electrophoretic	B-X
mobility-shift	B-X
experiments	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
that	B-X
E2Fs	B-X
modulate	B-X
the	B-X
expression	B-X
of	B-X
ASK-1	B-X
and	B-X
suggest	B-X
that	B-X
some	B-X
of	B-X
the	B-X
cellular	B-X
functions	B-X
of	B-X
ASK-1	B-X
may	B-X
be	B-X
under	B-X
the	B-X
control	B-X
of	B-X
E2F	B-X
transcription	B-X
factors	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
up-regulation	B-X
of	B-X
ASK-1	B-X
may	B-X
also	B-X
favour	B-X
the	B-X
p53-independent	B-X
E2F1	B-X
apoptotic	B-X
activity	B-X
.	B-X

Our	O
results	O
indicate	O
that	O
E2Fs	B-Gene_or_gene_product
modulate	O
the	O
expression	O
of	O
ASK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
suggest	O
that	O
some	O
of	O
the	O
cellular	O
functions	O
of	O
ASK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
may	O
be	O
under	O
the	O
control	O
of	O
E2F	B-Gene_or_gene_product
transcription	O
factors	O
.	O
<EOS>	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
show	B-X
that	B-X
E2Fs	B-X
(	B-X
E2	B-X
promoter-binding	B-X
factors	B-X
)	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
ASK-1	B-X
(	B-X
apoptosis	B-X
signal-regulating	B-X
kinase	B-X
1	B-X
)	B-X
,	B-X
which	B-X
encodes	B-X
a	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinase	B-X
,	B-X
also	B-X
known	B-X
as	B-X
MAP3K5	B-X
.	B-X
Its	B-X
mRNA	B-X
expression	B-X
is	B-X
cell-cycle-regulated	B-X
in	B-X
human	B-X
T98G	B-X
cells	B-X
released	B-X
from	B-X
serum	B-X
starvation	B-X
.	B-X
Moreover	B-X
,	B-X
overexpression	B-X
and	B-X
RNA	B-X
interference	B-X
experiments	B-X
support	B-X
the	B-X
requirement	B-X
of	B-X
endogenous	B-X
E2F/DP	B-X
(	B-X
E2F	B-X
dimerization	B-X
partner	B-X
)	B-X
activity	B-X
for	B-X
ASK-1	B-X
expression	B-X
.	B-X
Characterization	B-X
of	B-X
the	B-X
human	B-X
ASK-1	B-X
promoter	B-X
demonstrates	B-X
that	B-X
the	B-X
-95/+11	B-X
region	B-X
is	B-X
critical	B-X
for	B-X
E2F-mediated	B-X
up-regulation	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
show	B-X
that	B-X
E2F1-E2F4	B-X
are	B-X
bound	B-X
in	B-X
vivo	B-X
to	B-X
the	B-X
ASK-1	B-X
promoter	B-X
in	B-X
cycling	B-X
cells	B-X
,	B-X
probably	B-X
through	B-X
a	B-X
non-consensus	B-X
E2F-binding	B-X
site	B-X
located	B-X
12	B-X
bp	B-X
upstream	B-X
of	B-X
the	B-X
transcription	B-X
start	B-X
site	B-X
.	B-X
Mutation	B-X
of	B-X
this	B-X
site	B-X
completely	B-X
abolishes	B-X
the	B-X
ASK-1	B-X
promoter	B-X
response	B-X
to	B-X
E2Fs	B-X
as	B-X
well	B-X
as	B-X
the	B-X
E2F1	B-X
binding	B-X
in	B-X
electrophoretic	B-X
mobility-shift	B-X
experiments	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
that	B-X
E2Fs	B-X
modulate	B-X
the	B-X
expression	B-X
of	B-X
ASK-1	B-X
and	B-X
suggest	B-X
that	B-X
some	B-X
of	B-X
the	B-X
cellular	B-X
functions	B-X
of	B-X
ASK-1	B-X
may	B-X
be	B-X
under	B-X
the	B-X
control	B-X
of	B-X
E2F	B-X
transcription	B-X
factors	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
up-regulation	B-X
of	B-X
ASK-1	B-X
may	B-X
also	B-X
favour	B-X
the	B-X
p53-independent	B-X
E2F1	B-X
apoptotic	B-X
activity	B-X
.	B-X

Moreover	O
,	O
the	O
up	O
-	O
regulation	O
of	O
ASK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
may	O
also	O
favour	O
the	O
p53	B-Gene_or_gene_product
-	O
independent	O
E2F1	B-Gene_or_gene_product
apoptotic	O
activity	O
.	O
<EOS>	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
show	B-X
that	B-X
E2Fs	B-X
(	B-X
E2	B-X
promoter-binding	B-X
factors	B-X
)	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
ASK-1	B-X
(	B-X
apoptosis	B-X
signal-regulating	B-X
kinase	B-X
1	B-X
)	B-X
,	B-X
which	B-X
encodes	B-X
a	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
kinase	B-X
kinase	B-X
,	B-X
also	B-X
known	B-X
as	B-X
MAP3K5	B-X
.	B-X
Moreover	B-X
,	B-X
overexpression	B-X
and	B-X
RNA	B-X
interference	B-X
experiments	B-X
support	B-X
the	B-X
requirement	B-X
of	B-X
endogenous	B-X
E2F/DP	B-X
(	B-X
E2F	B-X
dimerization	B-X
partner	B-X
)	B-X
activity	B-X
for	B-X
ASK-1	B-X
expression	B-X
.	B-X
Characterization	B-X
of	B-X
the	B-X
human	B-X
ASK-1	B-X
promoter	B-X
demonstrates	B-X
that	B-X
the	B-X
-95/+11	B-X
region	B-X
is	B-X
critical	B-X
for	B-X
E2F-mediated	B-X
up-regulation	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
show	B-X
that	B-X
E2F1-E2F4	B-X
are	B-X
bound	B-X
in	B-X
vivo	B-X
to	B-X
the	B-X
ASK-1	B-X
promoter	B-X
in	B-X
cycling	B-X
cells	B-X
,	B-X
probably	B-X
through	B-X
a	B-X
non-consensus	B-X
E2F-binding	B-X
site	B-X
located	B-X
12	B-X
bp	B-X
upstream	B-X
of	B-X
the	B-X
transcription	B-X
start	B-X
site	B-X
.	B-X
Mutation	B-X
of	B-X
this	B-X
site	B-X
completely	B-X
abolishes	B-X
the	B-X
ASK-1	B-X
promoter	B-X
response	B-X
to	B-X
E2Fs	B-X
as	B-X
well	B-X
as	B-X
the	B-X
E2F1	B-X
binding	B-X
in	B-X
electrophoretic	B-X
mobility-shift	B-X
experiments	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
that	B-X
E2Fs	B-X
modulate	B-X
the	B-X
expression	B-X
of	B-X
ASK-1	B-X
and	B-X
suggest	B-X
that	B-X
some	B-X
of	B-X
the	B-X
cellular	B-X
functions	B-X
of	B-X
ASK-1	B-X
may	B-X
be	B-X
under	B-X
the	B-X
control	B-X
of	B-X
E2F	B-X
transcription	B-X
factors	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
up-regulation	B-X
of	B-X
ASK-1	B-X
may	B-X
also	B-X
favour	B-X
the	B-X
p53-independent	B-X
E2F1	B-X
apoptotic	B-X
activity	B-X
.	B-X

Glc7	B-Gene_or_gene_product
/	O
protein	B-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
regulatory	I-Gene_or_gene_product
subunits	I-Gene_or_gene_product
can	O
oppose	O
the	O
Ipl1	B-Gene_or_gene_product
/	O
aurora	B-Gene_or_gene_product
protein	O
kinase	O
by	O
redistributing	O
Glc7	B-Gene_or_gene_product
.	O
<EOS>	B-X
Faithful	B-X
chromosome	B-X
segregation	B-X
depends	B-X
on	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Glc7/PP1	B-X
protein	B-X
phosphatase	B-X
and	B-X
Ipl1/Aurora	B-X
protein	B-X
kinase	B-X
.	B-X
We	B-X
explored	B-X
the	B-X
relationship	B-X
between	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
and	B-X
found	B-X
that	B-X
the	B-X
phosphorylation	B-X
of	B-X
the	B-X
Ipl1	B-X
substrate	B-X
,	B-X
Dam1	B-X
,	B-X
was	B-X
altered	B-X
by	B-X
decreased	B-X
Glc7	B-X
activity	B-X
,	B-X
whereas	B-X
Ipl1	B-X
levels	B-X
,	B-X
localization	B-X
,	B-X
and	B-X
kinase	B-X
activity	B-X
were	B-X
not	B-X
.	B-X
These	B-X
data	B-X
strongly	B-X
suggest	B-X
that	B-X
Glc7	B-X
ensures	B-X
accurate	B-X
chromosome	B-X
segregation	B-X
by	B-X
dephosphorylating	B-X
Ipl1	B-X
targets	B-X
rather	B-X
than	B-X
regulating	B-X
the	B-X
Ipl1	B-X
kinase	B-X
.	B-X
To	B-X
identify	B-X
potential	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
substrates	B-X
,	B-X
we	B-X
isolated	B-X
ipl1-321	B-X
dosage	B-X
suppressors	B-X
.	B-X
Seven	B-X
genes	B-X
(	B-X
SDS22	B-X
,	B-X
BUD14	B-X
,	B-X
GIP3	B-X
,	B-X
GIP4	B-X
,	B-X
SOL1	B-X
,	B-X
SOL2	B-X
,	B-X
and	B-X
PEX31	B-X
)	B-X
encode	B-X
newly	B-X
identified	B-X
ipl1	B-X
dosage	B-X
suppressors	B-X
,	B-X
and	B-X
all	B-X
10	B-X
suppressors	B-X
encode	B-X
proteins	B-X
that	B-X
physically	B-X
interact	B-X
with	B-X
Glc7	B-X
.	B-X
The	B-X
overexpression	B-X
of	B-X
the	B-X
Gip3	B-X
and	B-X
Gip4	B-X
suppressors	B-X
altered	B-X
Glc7	B-X
localization	B-X
,	B-X
indicating	B-X
they	B-X
are	B-X
previously	B-X
unidentified	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
overexpression	B-X
of	B-X
Gip3	B-X
and	B-X
Gip4	B-X
from	B-X
the	B-X
galactose	B-X
promoter	B-X
restored	B-X
Dam1	B-X
phosphorylation	B-X
in	B-X
ipl1-321	B-X
mutant	B-X
cells	B-X
and	B-X
caused	B-X
wild-type	B-X
cells	B-X
to	B-X
arrest	B-X
in	B-X
metaphase	B-X
with	B-X
unsegregated	B-X
chromosomes	B-X
,	B-X
suggesting	B-X
that	B-X
Gip3	B-X
and	B-X
Gip4	B-X
overexpression	B-X
impairs	B-X
Glc7	B-X
's	B-X
mitotic	B-X
functions	B-X
.	B-X
We	B-X
therefore	B-X
propose	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
can	B-X
titrate	B-X
Glc7	B-X
away	B-X
from	B-X
relevant	B-X
Ipl1	B-X
targets	B-X
and	B-X
thereby	B-X
suppress	B-X
ipl1-321	B-X
cells	B-X
by	B-X
restoring	B-X
the	B-X
balance	B-X
of	B-X
phosphatase/kinase	B-X
activity	B-X
.	B-X

Faithful	O
chromosome	O
segregation	O
depends	O
on	O
the	O
opposing	O
activities	O
of	O
the	O
budding	O
yeast	O
Glc7	B-Gene_or_gene_product
/	O
PP1	B-Gene_or_gene_product
protein	O
phosphatase	O
and	O
Ipl1	B-Gene_or_gene_product
/	O
Aurora	B-Gene_or_gene_product
protein	O
kinase	O
.	O
<EOS>	B-X
Faithful	B-X
chromosome	B-X
segregation	B-X
depends	B-X
on	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Glc7/PP1	B-X
protein	B-X
phosphatase	B-X
and	B-X
Ipl1/Aurora	B-X
protein	B-X
kinase	B-X
.	B-X
We	B-X
explored	B-X
the	B-X
relationship	B-X
between	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
and	B-X
found	B-X
that	B-X
the	B-X
phosphorylation	B-X
of	B-X
the	B-X
Ipl1	B-X
substrate	B-X
,	B-X
Dam1	B-X
,	B-X
was	B-X
altered	B-X
by	B-X
decreased	B-X
Glc7	B-X
activity	B-X
,	B-X
whereas	B-X
Ipl1	B-X
levels	B-X
,	B-X
localization	B-X
,	B-X
and	B-X
kinase	B-X
activity	B-X
were	B-X
not	B-X
.	B-X
These	B-X
data	B-X
strongly	B-X
suggest	B-X
that	B-X
Glc7	B-X
ensures	B-X
accurate	B-X
chromosome	B-X
segregation	B-X
by	B-X
dephosphorylating	B-X
Ipl1	B-X
targets	B-X
rather	B-X
than	B-X
regulating	B-X
the	B-X
Ipl1	B-X
kinase	B-X
.	B-X
To	B-X
identify	B-X
potential	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
substrates	B-X
,	B-X
we	B-X
isolated	B-X
ipl1-321	B-X
dosage	B-X
suppressors	B-X
.	B-X
Seven	B-X
genes	B-X
(	B-X
SDS22	B-X
,	B-X
BUD14	B-X
,	B-X
GIP3	B-X
,	B-X
GIP4	B-X
,	B-X
SOL1	B-X
,	B-X
SOL2	B-X
,	B-X
and	B-X
PEX31	B-X
)	B-X
encode	B-X
newly	B-X
identified	B-X
ipl1	B-X
dosage	B-X
suppressors	B-X
,	B-X
and	B-X
all	B-X
10	B-X
suppressors	B-X
encode	B-X
proteins	B-X
that	B-X
physically	B-X
interact	B-X
with	B-X
Glc7	B-X
.	B-X
The	B-X
overexpression	B-X
of	B-X
the	B-X
Gip3	B-X
and	B-X
Gip4	B-X
suppressors	B-X
altered	B-X
Glc7	B-X
localization	B-X
,	B-X
indicating	B-X
they	B-X
are	B-X
previously	B-X
unidentified	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
overexpression	B-X
of	B-X
Gip3	B-X
and	B-X
Gip4	B-X
from	B-X
the	B-X
galactose	B-X
promoter	B-X
restored	B-X
Dam1	B-X
phosphorylation	B-X
in	B-X
ipl1-321	B-X
mutant	B-X
cells	B-X
and	B-X
caused	B-X
wild-type	B-X
cells	B-X
to	B-X
arrest	B-X
in	B-X
metaphase	B-X
with	B-X
unsegregated	B-X
chromosomes	B-X
,	B-X
suggesting	B-X
that	B-X
Gip3	B-X
and	B-X
Gip4	B-X
overexpression	B-X
impairs	B-X
Glc7	B-X
's	B-X
mitotic	B-X
functions	B-X
.	B-X
We	B-X
therefore	B-X
propose	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
can	B-X
titrate	B-X
Glc7	B-X
away	B-X
from	B-X
relevant	B-X
Ipl1	B-X
targets	B-X
and	B-X
thereby	B-X
suppress	B-X
ipl1-321	B-X
cells	B-X
by	B-X
restoring	B-X
the	B-X
balance	B-X
of	B-X
phosphatase/kinase	B-X
activity	B-X
.	B-X

We	O
explored	O
the	O
relationship	O
between	O
Glc7	B-Gene_or_gene_product
and	O
Ipl1	B-Gene_or_gene_product
and	O
found	O
that	O
the	O
phosphorylation	O
of	O
the	O
Ipl1	B-Gene_or_gene_product
substrate	O
,	O
Dam1	B-Gene_or_gene_product
,	O
was	O
altered	O
by	O
decreased	O
Glc7	B-Gene_or_gene_product
activity	O
,	O
whereas	O
Ipl1	B-Gene_or_gene_product
levels	O
,	O
localization	O
,	O
and	O
kinase	O
activity	O
were	O
not	O
.	O
<EOS>	B-X
Faithful	B-X
chromosome	B-X
segregation	B-X
depends	B-X
on	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Glc7/PP1	B-X
protein	B-X
phosphatase	B-X
and	B-X
Ipl1/Aurora	B-X
protein	B-X
kinase	B-X
.	B-X
We	B-X
explored	B-X
the	B-X
relationship	B-X
between	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
and	B-X
found	B-X
that	B-X
the	B-X
phosphorylation	B-X
of	B-X
the	B-X
Ipl1	B-X
substrate	B-X
,	B-X
Dam1	B-X
,	B-X
was	B-X
altered	B-X
by	B-X
decreased	B-X
Glc7	B-X
activity	B-X
,	B-X
whereas	B-X
Ipl1	B-X
levels	B-X
,	B-X
localization	B-X
,	B-X
and	B-X
kinase	B-X
activity	B-X
were	B-X
not	B-X
.	B-X
These	B-X
data	B-X
strongly	B-X
suggest	B-X
that	B-X
Glc7	B-X
ensures	B-X
accurate	B-X
chromosome	B-X
segregation	B-X
by	B-X
dephosphorylating	B-X
Ipl1	B-X
targets	B-X
rather	B-X
than	B-X
regulating	B-X
the	B-X
Ipl1	B-X
kinase	B-X
.	B-X
To	B-X
identify	B-X
potential	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
substrates	B-X
,	B-X
we	B-X
isolated	B-X
ipl1-321	B-X
dosage	B-X
suppressors	B-X
.	B-X
Seven	B-X
genes	B-X
(	B-X
SDS22	B-X
,	B-X
BUD14	B-X
,	B-X
GIP3	B-X
,	B-X
GIP4	B-X
,	B-X
SOL1	B-X
,	B-X
SOL2	B-X
,	B-X
and	B-X
PEX31	B-X
)	B-X
encode	B-X
newly	B-X
identified	B-X
ipl1	B-X
dosage	B-X
suppressors	B-X
,	B-X
and	B-X
all	B-X
10	B-X
suppressors	B-X
encode	B-X
proteins	B-X
that	B-X
physically	B-X
interact	B-X
with	B-X
Glc7	B-X
.	B-X
The	B-X
overexpression	B-X
of	B-X
the	B-X
Gip3	B-X
and	B-X
Gip4	B-X
suppressors	B-X
altered	B-X
Glc7	B-X
localization	B-X
,	B-X
indicating	B-X
they	B-X
are	B-X
previously	B-X
unidentified	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
overexpression	B-X
of	B-X
Gip3	B-X
and	B-X
Gip4	B-X
from	B-X
the	B-X
galactose	B-X
promoter	B-X
restored	B-X
Dam1	B-X
phosphorylation	B-X
in	B-X
ipl1-321	B-X
mutant	B-X
cells	B-X
and	B-X
caused	B-X
wild-type	B-X
cells	B-X
to	B-X
arrest	B-X
in	B-X
metaphase	B-X
with	B-X
unsegregated	B-X
chromosomes	B-X
,	B-X
suggesting	B-X
that	B-X
Gip3	B-X
and	B-X
Gip4	B-X
overexpression	B-X
impairs	B-X
Glc7	B-X
's	B-X
mitotic	B-X
functions	B-X
.	B-X
We	B-X
therefore	B-X
propose	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
can	B-X
titrate	B-X
Glc7	B-X
away	B-X
from	B-X
relevant	B-X
Ipl1	B-X
targets	B-X
and	B-X
thereby	B-X
suppress	B-X
ipl1-321	B-X
cells	B-X
by	B-X
restoring	B-X
the	B-X
balance	B-X
of	B-X
phosphatase/kinase	B-X
activity	B-X
.	B-X

These	O
data	O
strongly	O
suggest	O
that	O
Glc7	B-Gene_or_gene_product
ensures	O
accurate	O
chromosome	O
segregation	O
by	O
dephosphorylating	O
Ipl1	B-Gene_or_gene_product
targets	O
rather	O
than	O
regulating	O
the	O
Ipl1	B-Gene_or_gene_product
kinase	O
.	O
<EOS>	B-X
Faithful	B-X
chromosome	B-X
segregation	B-X
depends	B-X
on	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Glc7/PP1	B-X
protein	B-X
phosphatase	B-X
and	B-X
Ipl1/Aurora	B-X
protein	B-X
kinase	B-X
.	B-X
We	B-X
explored	B-X
the	B-X
relationship	B-X
between	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
and	B-X
found	B-X
that	B-X
the	B-X
phosphorylation	B-X
of	B-X
the	B-X
Ipl1	B-X
substrate	B-X
,	B-X
Dam1	B-X
,	B-X
was	B-X
altered	B-X
by	B-X
decreased	B-X
Glc7	B-X
activity	B-X
,	B-X
whereas	B-X
Ipl1	B-X
levels	B-X
,	B-X
localization	B-X
,	B-X
and	B-X
kinase	B-X
activity	B-X
were	B-X
not	B-X
.	B-X
These	B-X
data	B-X
strongly	B-X
suggest	B-X
that	B-X
Glc7	B-X
ensures	B-X
accurate	B-X
chromosome	B-X
segregation	B-X
by	B-X
dephosphorylating	B-X
Ipl1	B-X
targets	B-X
rather	B-X
than	B-X
regulating	B-X
the	B-X
Ipl1	B-X
kinase	B-X
.	B-X
To	B-X
identify	B-X
potential	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
substrates	B-X
,	B-X
we	B-X
isolated	B-X
ipl1-321	B-X
dosage	B-X
suppressors	B-X
.	B-X
Seven	B-X
genes	B-X
(	B-X
SDS22	B-X
,	B-X
BUD14	B-X
,	B-X
GIP3	B-X
,	B-X
GIP4	B-X
,	B-X
SOL1	B-X
,	B-X
SOL2	B-X
,	B-X
and	B-X
PEX31	B-X
)	B-X
encode	B-X
newly	B-X
identified	B-X
ipl1	B-X
dosage	B-X
suppressors	B-X
,	B-X
and	B-X
all	B-X
10	B-X
suppressors	B-X
encode	B-X
proteins	B-X
that	B-X
physically	B-X
interact	B-X
with	B-X
Glc7	B-X
.	B-X
The	B-X
overexpression	B-X
of	B-X
the	B-X
Gip3	B-X
and	B-X
Gip4	B-X
suppressors	B-X
altered	B-X
Glc7	B-X
localization	B-X
,	B-X
indicating	B-X
they	B-X
are	B-X
previously	B-X
unidentified	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
overexpression	B-X
of	B-X
Gip3	B-X
and	B-X
Gip4	B-X
from	B-X
the	B-X
galactose	B-X
promoter	B-X
restored	B-X
Dam1	B-X
phosphorylation	B-X
in	B-X
ipl1-321	B-X
mutant	B-X
cells	B-X
and	B-X
caused	B-X
wild-type	B-X
cells	B-X
to	B-X
arrest	B-X
in	B-X
metaphase	B-X
with	B-X
unsegregated	B-X
chromosomes	B-X
,	B-X
suggesting	B-X
that	B-X
Gip3	B-X
and	B-X
Gip4	B-X
overexpression	B-X
impairs	B-X
Glc7	B-X
's	B-X
mitotic	B-X
functions	B-X
.	B-X
We	B-X
therefore	B-X
propose	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
can	B-X
titrate	B-X
Glc7	B-X
away	B-X
from	B-X
relevant	B-X
Ipl1	B-X
targets	B-X
and	B-X
thereby	B-X
suppress	B-X
ipl1-321	B-X
cells	B-X
by	B-X
restoring	B-X
the	B-X
balance	B-X
of	B-X
phosphatase/kinase	B-X
activity	B-X
.	B-X

To	O
identify	O
potential	O
Glc7	B-Gene_or_gene_product
and	O
Ipl1	B-Gene_or_gene_product
substrates	O
,	O
we	O
isolated	O
ipl1	B-Gene_or_gene_product
-	I-Gene_or_gene_product
321	I-Gene_or_gene_product
dosage	O
suppressors	O
.	O
<EOS>	B-X
Faithful	B-X
chromosome	B-X
segregation	B-X
depends	B-X
on	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Glc7/PP1	B-X
protein	B-X
phosphatase	B-X
and	B-X
Ipl1/Aurora	B-X
protein	B-X
kinase	B-X
.	B-X
We	B-X
explored	B-X
the	B-X
relationship	B-X
between	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
and	B-X
found	B-X
that	B-X
the	B-X
phosphorylation	B-X
of	B-X
the	B-X
Ipl1	B-X
substrate	B-X
,	B-X
Dam1	B-X
,	B-X
was	B-X
altered	B-X
by	B-X
decreased	B-X
Glc7	B-X
activity	B-X
,	B-X
whereas	B-X
Ipl1	B-X
levels	B-X
,	B-X
localization	B-X
,	B-X
and	B-X
kinase	B-X
activity	B-X
were	B-X
not	B-X
.	B-X
These	B-X
data	B-X
strongly	B-X
suggest	B-X
that	B-X
Glc7	B-X
ensures	B-X
accurate	B-X
chromosome	B-X
segregation	B-X
by	B-X
dephosphorylating	B-X
Ipl1	B-X
targets	B-X
rather	B-X
than	B-X
regulating	B-X
the	B-X
Ipl1	B-X
kinase	B-X
.	B-X
To	B-X
identify	B-X
potential	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
substrates	B-X
,	B-X
we	B-X
isolated	B-X
ipl1-321	B-X
dosage	B-X
suppressors	B-X
.	B-X
Seven	B-X
genes	B-X
(	B-X
SDS22	B-X
,	B-X
BUD14	B-X
,	B-X
GIP3	B-X
,	B-X
GIP4	B-X
,	B-X
SOL1	B-X
,	B-X
SOL2	B-X
,	B-X
and	B-X
PEX31	B-X
)	B-X
encode	B-X
newly	B-X
identified	B-X
ipl1	B-X
dosage	B-X
suppressors	B-X
,	B-X
and	B-X
all	B-X
10	B-X
suppressors	B-X
encode	B-X
proteins	B-X
that	B-X
physically	B-X
interact	B-X
with	B-X
Glc7	B-X
.	B-X
The	B-X
overexpression	B-X
of	B-X
the	B-X
Gip3	B-X
and	B-X
Gip4	B-X
suppressors	B-X
altered	B-X
Glc7	B-X
localization	B-X
,	B-X
indicating	B-X
they	B-X
are	B-X
previously	B-X
unidentified	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
overexpression	B-X
of	B-X
Gip3	B-X
and	B-X
Gip4	B-X
from	B-X
the	B-X
galactose	B-X
promoter	B-X
restored	B-X
Dam1	B-X
phosphorylation	B-X
in	B-X
ipl1-321	B-X
mutant	B-X
cells	B-X
and	B-X
caused	B-X
wild-type	B-X
cells	B-X
to	B-X
arrest	B-X
in	B-X
metaphase	B-X
with	B-X
unsegregated	B-X
chromosomes	B-X
,	B-X
suggesting	B-X
that	B-X
Gip3	B-X
and	B-X
Gip4	B-X
overexpression	B-X
impairs	B-X
Glc7	B-X
's	B-X
mitotic	B-X
functions	B-X
.	B-X
We	B-X
therefore	B-X
propose	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
can	B-X
titrate	B-X
Glc7	B-X
away	B-X
from	B-X
relevant	B-X
Ipl1	B-X
targets	B-X
and	B-X
thereby	B-X
suppress	B-X
ipl1-321	B-X
cells	B-X
by	B-X
restoring	B-X
the	B-X
balance	B-X
of	B-X
phosphatase/kinase	B-X
activity	B-X
.	B-X

Seven	O
genes	O
(	O
SDS22	B-Gene_or_gene_product
,	O
BUD14	B-Gene_or_gene_product
,	O
GIP3	B-Gene_or_gene_product
,	O
GIP4	B-Gene_or_gene_product
,	O
SOL1	B-Gene_or_gene_product
,	O
SOL2	B-Gene_or_gene_product
,	O
and	O
PEX31	B-Gene_or_gene_product
)	O
encode	O
newly	O
identified	O
ipl1	B-Gene_or_gene_product
dosage	O
suppressors	O
,	O
and	O
all	O
10	O
suppressors	O
encode	O
proteins	O
that	O
physically	O
interact	O
with	O
Glc7	B-Gene_or_gene_product
.	O
<EOS>	B-X
Faithful	B-X
chromosome	B-X
segregation	B-X
depends	B-X
on	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Glc7/PP1	B-X
protein	B-X
phosphatase	B-X
and	B-X
Ipl1/Aurora	B-X
protein	B-X
kinase	B-X
.	B-X
We	B-X
explored	B-X
the	B-X
relationship	B-X
between	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
and	B-X
found	B-X
that	B-X
the	B-X
phosphorylation	B-X
of	B-X
the	B-X
Ipl1	B-X
substrate	B-X
,	B-X
Dam1	B-X
,	B-X
was	B-X
altered	B-X
by	B-X
decreased	B-X
Glc7	B-X
activity	B-X
,	B-X
whereas	B-X
Ipl1	B-X
levels	B-X
,	B-X
localization	B-X
,	B-X
and	B-X
kinase	B-X
activity	B-X
were	B-X
not	B-X
.	B-X
These	B-X
data	B-X
strongly	B-X
suggest	B-X
that	B-X
Glc7	B-X
ensures	B-X
accurate	B-X
chromosome	B-X
segregation	B-X
by	B-X
dephosphorylating	B-X
Ipl1	B-X
targets	B-X
rather	B-X
than	B-X
regulating	B-X
the	B-X
Ipl1	B-X
kinase	B-X
.	B-X
To	B-X
identify	B-X
potential	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
substrates	B-X
,	B-X
we	B-X
isolated	B-X
ipl1-321	B-X
dosage	B-X
suppressors	B-X
.	B-X
Seven	B-X
genes	B-X
(	B-X
SDS22	B-X
,	B-X
BUD14	B-X
,	B-X
GIP3	B-X
,	B-X
GIP4	B-X
,	B-X
SOL1	B-X
,	B-X
SOL2	B-X
,	B-X
and	B-X
PEX31	B-X
)	B-X
encode	B-X
newly	B-X
identified	B-X
ipl1	B-X
dosage	B-X
suppressors	B-X
,	B-X
and	B-X
all	B-X
10	B-X
suppressors	B-X
encode	B-X
proteins	B-X
that	B-X
physically	B-X
interact	B-X
with	B-X
Glc7	B-X
.	B-X
The	B-X
overexpression	B-X
of	B-X
the	B-X
Gip3	B-X
and	B-X
Gip4	B-X
suppressors	B-X
altered	B-X
Glc7	B-X
localization	B-X
,	B-X
indicating	B-X
they	B-X
are	B-X
previously	B-X
unidentified	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
overexpression	B-X
of	B-X
Gip3	B-X
and	B-X
Gip4	B-X
from	B-X
the	B-X
galactose	B-X
promoter	B-X
restored	B-X
Dam1	B-X
phosphorylation	B-X
in	B-X
ipl1-321	B-X
mutant	B-X
cells	B-X
and	B-X
caused	B-X
wild-type	B-X
cells	B-X
to	B-X
arrest	B-X
in	B-X
metaphase	B-X
with	B-X
unsegregated	B-X
chromosomes	B-X
,	B-X
suggesting	B-X
that	B-X
Gip3	B-X
and	B-X
Gip4	B-X
overexpression	B-X
impairs	B-X
Glc7	B-X
's	B-X
mitotic	B-X
functions	B-X
.	B-X
We	B-X
therefore	B-X
propose	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
can	B-X
titrate	B-X
Glc7	B-X
away	B-X
from	B-X
relevant	B-X
Ipl1	B-X
targets	B-X
and	B-X
thereby	B-X
suppress	B-X
ipl1-321	B-X
cells	B-X
by	B-X
restoring	B-X
the	B-X
balance	B-X
of	B-X
phosphatase/kinase	B-X
activity	B-X
.	B-X

The	O
overexpression	O
of	O
the	O
Gip3	B-Gene_or_gene_product
and	O
Gip4	B-Gene_or_gene_product
suppressors	O
altered	O
Glc7	B-Gene_or_gene_product
localization	O
,	O
indicating	O
they	O
are	O
previously	O
unidentified	O
Glc7	B-Gene_or_gene_product
regulatory	O
subunits	O
.	O
<EOS>	B-X
Faithful	B-X
chromosome	B-X
segregation	B-X
depends	B-X
on	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Glc7/PP1	B-X
protein	B-X
phosphatase	B-X
and	B-X
Ipl1/Aurora	B-X
protein	B-X
kinase	B-X
.	B-X
We	B-X
explored	B-X
the	B-X
relationship	B-X
between	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
and	B-X
found	B-X
that	B-X
the	B-X
phosphorylation	B-X
of	B-X
the	B-X
Ipl1	B-X
substrate	B-X
,	B-X
Dam1	B-X
,	B-X
was	B-X
altered	B-X
by	B-X
decreased	B-X
Glc7	B-X
activity	B-X
,	B-X
whereas	B-X
Ipl1	B-X
levels	B-X
,	B-X
localization	B-X
,	B-X
and	B-X
kinase	B-X
activity	B-X
were	B-X
not	B-X
.	B-X
These	B-X
data	B-X
strongly	B-X
suggest	B-X
that	B-X
Glc7	B-X
ensures	B-X
accurate	B-X
chromosome	B-X
segregation	B-X
by	B-X
dephosphorylating	B-X
Ipl1	B-X
targets	B-X
rather	B-X
than	B-X
regulating	B-X
the	B-X
Ipl1	B-X
kinase	B-X
.	B-X
To	B-X
identify	B-X
potential	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
substrates	B-X
,	B-X
we	B-X
isolated	B-X
ipl1-321	B-X
dosage	B-X
suppressors	B-X
.	B-X
Seven	B-X
genes	B-X
(	B-X
SDS22	B-X
,	B-X
BUD14	B-X
,	B-X
GIP3	B-X
,	B-X
GIP4	B-X
,	B-X
SOL1	B-X
,	B-X
SOL2	B-X
,	B-X
and	B-X
PEX31	B-X
)	B-X
encode	B-X
newly	B-X
identified	B-X
ipl1	B-X
dosage	B-X
suppressors	B-X
,	B-X
and	B-X
all	B-X
10	B-X
suppressors	B-X
encode	B-X
proteins	B-X
that	B-X
physically	B-X
interact	B-X
with	B-X
Glc7	B-X
.	B-X
The	B-X
overexpression	B-X
of	B-X
the	B-X
Gip3	B-X
and	B-X
Gip4	B-X
suppressors	B-X
altered	B-X
Glc7	B-X
localization	B-X
,	B-X
indicating	B-X
they	B-X
are	B-X
previously	B-X
unidentified	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
overexpression	B-X
of	B-X
Gip3	B-X
and	B-X
Gip4	B-X
from	B-X
the	B-X
galactose	B-X
promoter	B-X
restored	B-X
Dam1	B-X
phosphorylation	B-X
in	B-X
ipl1-321	B-X
mutant	B-X
cells	B-X
and	B-X
caused	B-X
wild-type	B-X
cells	B-X
to	B-X
arrest	B-X
in	B-X
metaphase	B-X
with	B-X
unsegregated	B-X
chromosomes	B-X
,	B-X
suggesting	B-X
that	B-X
Gip3	B-X
and	B-X
Gip4	B-X
overexpression	B-X
impairs	B-X
Glc7	B-X
's	B-X
mitotic	B-X
functions	B-X
.	B-X
We	B-X
therefore	B-X
propose	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
can	B-X
titrate	B-X
Glc7	B-X
away	B-X
from	B-X
relevant	B-X
Ipl1	B-X
targets	B-X
and	B-X
thereby	B-X
suppress	B-X
ipl1-321	B-X
cells	B-X
by	B-X
restoring	B-X
the	B-X
balance	B-X
of	B-X
phosphatase/kinase	B-X
activity	B-X
.	B-X

In	O
addition	O
,	O
the	O
overexpression	O
of	O
Gip3	B-Gene_or_gene_product
and	O
Gip4	B-Gene_or_gene_product
from	O
the	O
galactose	O
promoter	O
restored	O
Dam1	B-Gene_or_gene_product
phosphorylation	O
in	O
ipl1	B-Gene_or_gene_product
-	I-Gene_or_gene_product
321	I-Gene_or_gene_product
mutant	O
cells	O
and	O
caused	O
wild	O
-	O
type	O
cells	O
to	O
arrest	O
in	O
metaphase	O
with	O
unsegregated	O
chromosomes	O
,	O
suggesting	O
that	O
Gip3	B-Gene_or_gene_product
and	O
Gip4	B-Gene_or_gene_product
overexpression	O
impairs	O
Glc7	B-Gene_or_gene_product
'	O
s	O
mitotic	O
functions	O
.	O
<EOS>	B-X
Faithful	B-X
chromosome	B-X
segregation	B-X
depends	B-X
on	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Glc7/PP1	B-X
protein	B-X
phosphatase	B-X
and	B-X
Ipl1/Aurora	B-X
protein	B-X
kinase	B-X
.	B-X
We	B-X
explored	B-X
the	B-X
relationship	B-X
between	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
and	B-X
found	B-X
that	B-X
the	B-X
phosphorylation	B-X
of	B-X
the	B-X
Ipl1	B-X
substrate	B-X
,	B-X
Dam1	B-X
,	B-X
was	B-X
altered	B-X
by	B-X
decreased	B-X
Glc7	B-X
activity	B-X
,	B-X
whereas	B-X
Ipl1	B-X
levels	B-X
,	B-X
localization	B-X
,	B-X
and	B-X
kinase	B-X
activity	B-X
were	B-X
not	B-X
.	B-X
These	B-X
data	B-X
strongly	B-X
suggest	B-X
that	B-X
Glc7	B-X
ensures	B-X
accurate	B-X
chromosome	B-X
segregation	B-X
by	B-X
dephosphorylating	B-X
Ipl1	B-X
targets	B-X
rather	B-X
than	B-X
regulating	B-X
the	B-X
Ipl1	B-X
kinase	B-X
.	B-X
To	B-X
identify	B-X
potential	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
substrates	B-X
,	B-X
we	B-X
isolated	B-X
ipl1-321	B-X
dosage	B-X
suppressors	B-X
.	B-X
Seven	B-X
genes	B-X
(	B-X
SDS22	B-X
,	B-X
BUD14	B-X
,	B-X
GIP3	B-X
,	B-X
GIP4	B-X
,	B-X
SOL1	B-X
,	B-X
SOL2	B-X
,	B-X
and	B-X
PEX31	B-X
)	B-X
encode	B-X
newly	B-X
identified	B-X
ipl1	B-X
dosage	B-X
suppressors	B-X
,	B-X
and	B-X
all	B-X
10	B-X
suppressors	B-X
encode	B-X
proteins	B-X
that	B-X
physically	B-X
interact	B-X
with	B-X
Glc7	B-X
.	B-X
The	B-X
overexpression	B-X
of	B-X
the	B-X
Gip3	B-X
and	B-X
Gip4	B-X
suppressors	B-X
altered	B-X
Glc7	B-X
localization	B-X
,	B-X
indicating	B-X
they	B-X
are	B-X
previously	B-X
unidentified	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
overexpression	B-X
of	B-X
Gip3	B-X
and	B-X
Gip4	B-X
from	B-X
the	B-X
galactose	B-X
promoter	B-X
restored	B-X
Dam1	B-X
phosphorylation	B-X
in	B-X
ipl1-321	B-X
mutant	B-X
cells	B-X
and	B-X
caused	B-X
wild-type	B-X
cells	B-X
to	B-X
arrest	B-X
in	B-X
metaphase	B-X
with	B-X
unsegregated	B-X
chromosomes	B-X
,	B-X
suggesting	B-X
that	B-X
Gip3	B-X
and	B-X
Gip4	B-X
overexpression	B-X
impairs	B-X
Glc7	B-X
's	B-X
mitotic	B-X
functions	B-X
.	B-X
We	B-X
therefore	B-X
propose	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
can	B-X
titrate	B-X
Glc7	B-X
away	B-X
from	B-X
relevant	B-X
Ipl1	B-X
targets	B-X
and	B-X
thereby	B-X
suppress	B-X
ipl1-321	B-X
cells	B-X
by	B-X
restoring	B-X
the	B-X
balance	B-X
of	B-X
phosphatase/kinase	B-X
activity	B-X
.	B-X

We	O
therefore	O
propose	O
that	O
the	O
overexpression	O
of	O
Glc7	B-Gene_or_gene_product
regulatory	O
subunits	O
can	O
titrate	O
Glc7	B-Gene_or_gene_product
away	O
from	O
relevant	O
Ipl1	B-Gene_or_gene_product
targets	O
and	O
thereby	O
suppress	O
ipl1	B-Gene_or_gene_product
-	I-Gene_or_gene_product
321	I-Gene_or_gene_product
cells	O
by	O
restoring	O
the	O
balance	O
of	O
phosphatase	O
/	O
kinase	O
activity	O
.	O
<EOS>	B-X
Faithful	B-X
chromosome	B-X
segregation	B-X
depends	B-X
on	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
budding	B-X
yeast	B-X
Glc7/PP1	B-X
protein	B-X
phosphatase	B-X
and	B-X
Ipl1/Aurora	B-X
protein	B-X
kinase	B-X
.	B-X
We	B-X
explored	B-X
the	B-X
relationship	B-X
between	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
and	B-X
found	B-X
that	B-X
the	B-X
phosphorylation	B-X
of	B-X
the	B-X
Ipl1	B-X
substrate	B-X
,	B-X
Dam1	B-X
,	B-X
was	B-X
altered	B-X
by	B-X
decreased	B-X
Glc7	B-X
activity	B-X
,	B-X
whereas	B-X
Ipl1	B-X
levels	B-X
,	B-X
localization	B-X
,	B-X
and	B-X
kinase	B-X
activity	B-X
were	B-X
not	B-X
.	B-X
These	B-X
data	B-X
strongly	B-X
suggest	B-X
that	B-X
Glc7	B-X
ensures	B-X
accurate	B-X
chromosome	B-X
segregation	B-X
by	B-X
dephosphorylating	B-X
Ipl1	B-X
targets	B-X
rather	B-X
than	B-X
regulating	B-X
the	B-X
Ipl1	B-X
kinase	B-X
.	B-X
To	B-X
identify	B-X
potential	B-X
Glc7	B-X
and	B-X
Ipl1	B-X
substrates	B-X
,	B-X
we	B-X
isolated	B-X
ipl1-321	B-X
dosage	B-X
suppressors	B-X
.	B-X
Seven	B-X
genes	B-X
(	B-X
SDS22	B-X
,	B-X
BUD14	B-X
,	B-X
GIP3	B-X
,	B-X
GIP4	B-X
,	B-X
SOL1	B-X
,	B-X
SOL2	B-X
,	B-X
and	B-X
PEX31	B-X
)	B-X
encode	B-X
newly	B-X
identified	B-X
ipl1	B-X
dosage	B-X
suppressors	B-X
,	B-X
and	B-X
all	B-X
10	B-X
suppressors	B-X
encode	B-X
proteins	B-X
that	B-X
physically	B-X
interact	B-X
with	B-X
Glc7	B-X
.	B-X
The	B-X
overexpression	B-X
of	B-X
the	B-X
Gip3	B-X
and	B-X
Gip4	B-X
suppressors	B-X
altered	B-X
Glc7	B-X
localization	B-X
,	B-X
indicating	B-X
they	B-X
are	B-X
previously	B-X
unidentified	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
overexpression	B-X
of	B-X
Gip3	B-X
and	B-X
Gip4	B-X
from	B-X
the	B-X
galactose	B-X
promoter	B-X
restored	B-X
Dam1	B-X
phosphorylation	B-X
in	B-X
ipl1-321	B-X
mutant	B-X
cells	B-X
and	B-X
caused	B-X
wild-type	B-X
cells	B-X
to	B-X
arrest	B-X
in	B-X
metaphase	B-X
with	B-X
unsegregated	B-X
chromosomes	B-X
,	B-X
suggesting	B-X
that	B-X
Gip3	B-X
and	B-X
Gip4	B-X
overexpression	B-X
impairs	B-X
Glc7	B-X
's	B-X
mitotic	B-X
functions	B-X
.	B-X
We	B-X
therefore	B-X
propose	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
Glc7	B-X
regulatory	B-X
subunits	B-X
can	B-X
titrate	B-X
Glc7	B-X
away	B-X
from	B-X
relevant	B-X
Ipl1	B-X
targets	B-X
and	B-X
thereby	B-X
suppress	B-X
ipl1-321	B-X
cells	B-X
by	B-X
restoring	B-X
the	B-X
balance	B-X
of	B-X
phosphatase/kinase	B-X
activity	B-X
.	B-X

Detection	O
of	O
catalase	B-Gene_or_gene_product
in	O
rat	O
heart	O
mitochondria	O
.	O
<EOS>	B-X
The	B-X
presence	B-X
of	B-X
heme-containing	B-X
catalase	B-X
in	B-X
rat	B-X
heart	B-X
mitochondria	B-X
(	B-X
20	B-X
+/-	B-X
5	B-X
units/mg	B-X
)	B-X
was	B-X
demonstrated	B-X
by	B-X
biochemical	B-X
and	B-X
immunocytochemical	B-X
analysis	B-X
.	B-X
Intact	B-X
rat	B-X
heart	B-X
mitochondria	B-X
efficiently	B-X
consumed	B-X
exogenously	B-X
added	B-X
H2O2	B-X
.	B-X
The	B-X
rate	B-X
of	B-X
H2O2	B-X
consumption	B-X
was	B-X
not	B-X
influenced	B-X
by	B-X
succinate	B-X
,	B-X
glutamate/malate	B-X
,	B-X
or	B-X
N-ethylmaleimide	B-X
but	B-X
was	B-X
significantly	B-X
inhibited	B-X
by	B-X
cyanide	B-X
.	B-X
Hydrogen	B-X
peroxide	B-X
decomposition	B-X
by	B-X
mitochondria	B-X
yielded	B-X
molecular	B-X
oxygen	B-X
in	B-X
a	B-X
2:1	B-X
stoichiometry	B-X
,	B-X
consistent	B-X
with	B-X
a	B-X
catalytic	B-X
mechanism	B-X
.	B-X
Mitochondrial	B-X
fractionation	B-X
studies	B-X
and	B-X
quantitative	B-X
electron	B-X
microscopic	B-X
immunocytochemistry	B-X
revealed	B-X
that	B-X
most	B-X
catalase	B-X
was	B-X
matrix-associated	B-X
.	B-X
Electrophoretic	B-X
analysis	B-X
and	B-X
Western	B-X
blotting	B-X
of	B-X
the	B-X
mitochondrial	B-X
matrix	B-X
fraction	B-X
indicated	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
protein	B-X
with	B-X
similar	B-X
electrophoretic	B-X
mobility	B-X
to	B-X
bovine	B-X
and	B-X
rat	B-X
liver	B-X
catalase	B-X
and	B-X
immunoreactive	B-X
to	B-X
anti-catalase	B-X
antibody	B-X
.	B-X
Myocardial	B-X
tissue	B-X
has	B-X
a	B-X
lower	B-X
catalase-specific	B-X
activity	B-X
and	B-X
a	B-X
greater	B-X
mitochondrial	B-X
H2O2	B-X
production/g	B-X
of	B-X
tissue	B-X
than	B-X
most	B-X
organs	B-X
.	B-X
Thus	B-X
catalase	B-X
,	B-X
representing	B-X
0.025	B-X
%	B-X
of	B-X
heart	B-X
mitochondrial	B-X
protein	B-X
,	B-X
is	B-X
important	B-X
for	B-X
detoxifying	B-X
mitochondrial	B-X
derived	B-X
H2O2	B-X
and	B-X
represents	B-X
a	B-X
key	B-X
antioxidant	B-X
defense	B-X
mechanism	B-X
for	B-X
myocardial	B-X
tissue	B-X
.	B-X

The	O
presence	O
of	O
heme	O
-	O
containing	O
catalase	B-Gene_or_gene_product
in	O
rat	O
heart	O
mitochondria	O
(	O
20	O
+	O
/	O
-	O
5	O
units	O
/	O
mg	O
)	O
was	O
demonstrated	O
by	O
biochemical	O
and	O
immunocytochemical	O
analysis	O
.	O
<EOS>	B-X
The	B-X
presence	B-X
of	B-X
heme-containing	B-X
catalase	B-X
in	B-X
rat	B-X
heart	B-X
mitochondria	B-X
(	B-X
20	B-X
+/-	B-X
5	B-X
units/mg	B-X
)	B-X
was	B-X
demonstrated	B-X
by	B-X
biochemical	B-X
and	B-X
immunocytochemical	B-X
analysis	B-X
.	B-X
Intact	B-X
rat	B-X
heart	B-X
mitochondria	B-X
efficiently	B-X
consumed	B-X
exogenously	B-X
added	B-X
H2O2	B-X
.	B-X
The	B-X
rate	B-X
of	B-X
H2O2	B-X
consumption	B-X
was	B-X
not	B-X
influenced	B-X
by	B-X
succinate	B-X
,	B-X
glutamate/malate	B-X
,	B-X
or	B-X
N-ethylmaleimide	B-X
but	B-X
was	B-X
significantly	B-X
inhibited	B-X
by	B-X
cyanide	B-X
.	B-X
Hydrogen	B-X
peroxide	B-X
decomposition	B-X
by	B-X
mitochondria	B-X
yielded	B-X
molecular	B-X
oxygen	B-X
in	B-X
a	B-X
2:1	B-X
stoichiometry	B-X
,	B-X
consistent	B-X
with	B-X
a	B-X
catalytic	B-X
mechanism	B-X
.	B-X
Mitochondrial	B-X
fractionation	B-X
studies	B-X
and	B-X
quantitative	B-X
electron	B-X
microscopic	B-X
immunocytochemistry	B-X
revealed	B-X
that	B-X
most	B-X
catalase	B-X
was	B-X
matrix-associated	B-X
.	B-X
Electrophoretic	B-X
analysis	B-X
and	B-X
Western	B-X
blotting	B-X
of	B-X
the	B-X
mitochondrial	B-X
matrix	B-X
fraction	B-X
indicated	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
protein	B-X
with	B-X
similar	B-X
electrophoretic	B-X
mobility	B-X
to	B-X
bovine	B-X
and	B-X
rat	B-X
liver	B-X
catalase	B-X
and	B-X
immunoreactive	B-X
to	B-X
anti-catalase	B-X
antibody	B-X
.	B-X
Myocardial	B-X
tissue	B-X
has	B-X
a	B-X
lower	B-X
catalase-specific	B-X
activity	B-X
and	B-X
a	B-X
greater	B-X
mitochondrial	B-X
H2O2	B-X
production/g	B-X
of	B-X
tissue	B-X
than	B-X
most	B-X
organs	B-X
.	B-X
Thus	B-X
catalase	B-X
,	B-X
representing	B-X
0.025	B-X
%	B-X
of	B-X
heart	B-X
mitochondrial	B-X
protein	B-X
,	B-X
is	B-X
important	B-X
for	B-X
detoxifying	B-X
mitochondrial	B-X
derived	B-X
H2O2	B-X
and	B-X
represents	B-X
a	B-X
key	B-X
antioxidant	B-X
defense	B-X
mechanism	B-X
for	B-X
myocardial	B-X
tissue	B-X
.	B-X

Intact	O
rat	O
heart	O
mitochondria	O
efficiently	O
consumed	O
exogenously	O
added	O
H2O2	O
.	O
<EOS>	B-X
The	B-X
presence	B-X
of	B-X
heme-containing	B-X
catalase	B-X
in	B-X
rat	B-X
heart	B-X
mitochondria	B-X
(	B-X
20	B-X
+/-	B-X
5	B-X
units/mg	B-X
)	B-X
was	B-X
demonstrated	B-X
by	B-X
biochemical	B-X
and	B-X
immunocytochemical	B-X
analysis	B-X
.	B-X
Intact	B-X
rat	B-X
heart	B-X
mitochondria	B-X
efficiently	B-X
consumed	B-X
exogenously	B-X
added	B-X
H2O2	B-X
.	B-X
The	B-X
rate	B-X
of	B-X
H2O2	B-X
consumption	B-X
was	B-X
not	B-X
influenced	B-X
by	B-X
succinate	B-X
,	B-X
glutamate/malate	B-X
,	B-X
or	B-X
N-ethylmaleimide	B-X
but	B-X
was	B-X
significantly	B-X
inhibited	B-X
by	B-X
cyanide	B-X
.	B-X
Hydrogen	B-X
peroxide	B-X
decomposition	B-X
by	B-X
mitochondria	B-X
yielded	B-X
molecular	B-X
oxygen	B-X
in	B-X
a	B-X
2:1	B-X
stoichiometry	B-X
,	B-X
consistent	B-X
with	B-X
a	B-X
catalytic	B-X
mechanism	B-X
.	B-X
Electrophoretic	B-X
analysis	B-X
and	B-X
Western	B-X
blotting	B-X
of	B-X
the	B-X
mitochondrial	B-X
matrix	B-X
fraction	B-X
indicated	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
protein	B-X
with	B-X
similar	B-X
electrophoretic	B-X
mobility	B-X
to	B-X
bovine	B-X
and	B-X
rat	B-X
liver	B-X
catalase	B-X
and	B-X
immunoreactive	B-X
to	B-X
anti-catalase	B-X
antibody	B-X
.	B-X
Myocardial	B-X
tissue	B-X
has	B-X
a	B-X
lower	B-X
catalase-specific	B-X
activity	B-X
and	B-X
a	B-X
greater	B-X
mitochondrial	B-X
H2O2	B-X
production/g	B-X
of	B-X
tissue	B-X
than	B-X
most	B-X
organs	B-X
.	B-X
Thus	B-X
catalase	B-X
,	B-X
representing	B-X
0.025	B-X
%	B-X
of	B-X
heart	B-X
mitochondrial	B-X
protein	B-X
,	B-X
is	B-X
important	B-X
for	B-X
detoxifying	B-X
mitochondrial	B-X
derived	B-X
H2O2	B-X
and	B-X
represents	B-X
a	B-X
key	B-X
antioxidant	B-X
defense	B-X
mechanism	B-X
for	B-X
myocardial	B-X
tissue	B-X
.	B-X

The	O
rate	O
of	O
H2O2	O
consumption	O
was	O
not	O
influenced	O
by	O
succinate	O
,	O
glutamate	O
/	O
malate	O
,	O
or	O
N	O
-	O
ethylmaleimide	O
but	O
was	O
significantly	O
inhibited	O
by	O
cyanide	O
.	O
<EOS>	B-X
Adequate	B-X
methods	B-X
to	B-X
measure	B-X
the	B-X
rate	B-X
of	B-X
mitochondrial	B-X
oxygen	B-X
radical	B-X
generation	B-X
are	B-X
needed	B-X
since	B-X
oxygen	B-X
radicals	B-X
are	B-X
involved	B-X
in	B-X
many	B-X
pathologies	B-X
.	B-X
A	B-X
fluorometric	B-X
method	B-X
appropriate	B-X
to	B-X
measure	B-X
the	B-X
rate	B-X
of	B-X
generation	B-X
of	B-X
H2O2	B-X
in	B-X
intact	B-X
mitochondria	B-X
is	B-X
described	B-X
.	B-X
Just	B-X
after	B-X
isolation	B-X
of	B-X
functional	B-X
mitochondria	B-X
from	B-X
fresh	B-X
tissues	B-X
,	B-X
rates	B-X
of	B-X
generation	B-X
of	B-X
H2O2	B-X
are	B-X
kinetically	B-X
measured	B-X
by	B-X
fluorometry	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
homovanillic	B-X
acid	B-X
and	B-X
horseradish	B-X
peroxidase	B-X
.	B-X
The	B-X
method	B-X
is	B-X
specific	B-X
for	B-X
H2O2	B-X
and	B-X
is	B-X
sensitive	B-X
enough	B-X
to	B-X
assay	B-X
mitochondrial	B-X
H2O2	B-X
generation	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
respiratory	B-X
substrate	B-X
without	B-X
inhibitors	B-X
of	B-X
the	B-X
respiratory	B-X
chain	B-X
.	B-X
Simultaneous	B-X
measurement	B-X
of	B-X
mitochondrial	B-X
oxygen	B-X
consumption	B-X
allows	B-X
calculation	B-X
of	B-X
the	B-X
free	B-X
radical	B-X
leak	B-X
:	B-X
the	B-X
percentage	B-X
of	B-X
electrons	B-X
out	B-X
of	B-X
sequence	B-X
which	B-X
reduce	B-X
oxygen	B-X
to	B-X
oxygen	B-X
radicals	B-X
along	B-X
the	B-X
mitochondrial	B-X
respiratory	B-X
chain	B-X
instead	B-X
of	B-X
reducing	B-X
oxygen	B-X
to	B-X
water	B-X
at	B-X
the	B-X
terminal	B-X
cytochrome	B-X
oxidase	B-X
.	B-X
The	B-X
method	B-X
shows	B-X
instantaneous	B-X
response	B-X
to	B-X
H2O2	B-X
.	B-X
This	B-X
makes	B-X
it	B-X
appropriate	B-X
to	B-X
study	B-X
the	B-X
quick	B-X
effects	B-X
of	B-X
different	B-X
inhibitors	B-X
and	B-X
modulators	B-X
on	B-X
the	B-X
rate	B-X
of	B-X
mitochondrial	B-X
oxygen	B-X
radical	B-X
production	B-X
.	B-X

Hydrogen	O
peroxide	O
decomposition	O
by	O
mitochondria	O
yielded	O
molecular	O
oxygen	O
in	O
a	O
2	O
:	O
1	O
stoichiometry	O
,	O
consistent	O
with	O
a	O
catalytic	O
mechanism	O
.	O

Mitochondrial	O
fractionation	O
studies	O
and	O
quantitative	O
electron	O
microscopic	O
immunocytochemistry	O
revealed	O
that	O
most	O
catalase	B-Gene_or_gene_product
was	O
matrix	O
-	O
associated	O
.	O
<EOS>	B-X
The	B-X
presence	B-X
of	B-X
heme-containing	B-X
catalase	B-X
in	B-X
rat	B-X
heart	B-X
mitochondria	B-X
(	B-X
20	B-X
+/-	B-X
5	B-X
units/mg	B-X
)	B-X
was	B-X
demonstrated	B-X
by	B-X
biochemical	B-X
and	B-X
immunocytochemical	B-X
analysis	B-X
.	B-X
Mitochondrial	B-X
fractionation	B-X
studies	B-X
and	B-X
quantitative	B-X
electron	B-X
microscopic	B-X
immunocytochemistry	B-X
revealed	B-X
that	B-X
most	B-X
catalase	B-X
was	B-X
matrix-associated	B-X
.	B-X
Electrophoretic	B-X
analysis	B-X
and	B-X
Western	B-X
blotting	B-X
of	B-X
the	B-X
mitochondrial	B-X
matrix	B-X
fraction	B-X
indicated	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
protein	B-X
with	B-X
similar	B-X
electrophoretic	B-X
mobility	B-X
to	B-X
bovine	B-X
and	B-X
rat	B-X
liver	B-X
catalase	B-X
and	B-X
immunoreactive	B-X
to	B-X
anti-catalase	B-X
antibody	B-X
.	B-X
Myocardial	B-X
tissue	B-X
has	B-X
a	B-X
lower	B-X
catalase-specific	B-X
activity	B-X
and	B-X
a	B-X
greater	B-X
mitochondrial	B-X
H2O2	B-X
production/g	B-X
of	B-X
tissue	B-X
than	B-X
most	B-X
organs	B-X
.	B-X
Thus	B-X
catalase	B-X
,	B-X
representing	B-X
0.025	B-X
%	B-X
of	B-X
heart	B-X
mitochondrial	B-X
protein	B-X
,	B-X
is	B-X
important	B-X
for	B-X
detoxifying	B-X
mitochondrial	B-X
derived	B-X
H2O2	B-X
and	B-X
represents	B-X
a	B-X
key	B-X
antioxidant	B-X
defense	B-X
mechanism	B-X
for	B-X
myocardial	B-X
tissue	B-X
.	B-X

Electrophoretic	O
analysis	O
and	O
Western	O
blotting	O
of	O
the	O
mitochondrial	O
matrix	O
fraction	O
indicated	O
the	O
presence	O
of	O
a	O
protein	O
with	O
similar	O
electrophoretic	O
mobility	O
to	O
bovine	O
and	O
rat	O
liver	O
catalase	B-Gene_or_gene_product
and	O
immunoreactive	O
to	O
anti	O
-	O
catalase	B-Gene_or_gene_product
antibody	O
.	O
<EOS>	B-X
The	B-X
presence	B-X
of	B-X
heme-containing	B-X
catalase	B-X
in	B-X
rat	B-X
heart	B-X
mitochondria	B-X
(	B-X
20	B-X
+/-	B-X
5	B-X
units/mg	B-X
)	B-X
was	B-X
demonstrated	B-X
by	B-X
biochemical	B-X
and	B-X
immunocytochemical	B-X
analysis	B-X
.	B-X
Intact	B-X
rat	B-X
heart	B-X
mitochondria	B-X
efficiently	B-X
consumed	B-X
exogenously	B-X
added	B-X
H2O2	B-X
.	B-X
The	B-X
rate	B-X
of	B-X
H2O2	B-X
consumption	B-X
was	B-X
not	B-X
influenced	B-X
by	B-X
succinate	B-X
,	B-X
glutamate/malate	B-X
,	B-X
or	B-X
N-ethylmaleimide	B-X
but	B-X
was	B-X
significantly	B-X
inhibited	B-X
by	B-X
cyanide	B-X
.	B-X
Mitochondrial	B-X
fractionation	B-X
studies	B-X
and	B-X
quantitative	B-X
electron	B-X
microscopic	B-X
immunocytochemistry	B-X
revealed	B-X
that	B-X
most	B-X
catalase	B-X
was	B-X
matrix-associated	B-X
.	B-X
Electrophoretic	B-X
analysis	B-X
and	B-X
Western	B-X
blotting	B-X
of	B-X
the	B-X
mitochondrial	B-X
matrix	B-X
fraction	B-X
indicated	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
protein	B-X
with	B-X
similar	B-X
electrophoretic	B-X
mobility	B-X
to	B-X
bovine	B-X
and	B-X
rat	B-X
liver	B-X
catalase	B-X
and	B-X
immunoreactive	B-X
to	B-X
anti-catalase	B-X
antibody	B-X
.	B-X
Myocardial	B-X
tissue	B-X
has	B-X
a	B-X
lower	B-X
catalase-specific	B-X
activity	B-X
and	B-X
a	B-X
greater	B-X
mitochondrial	B-X
H2O2	B-X
production/g	B-X
of	B-X
tissue	B-X
than	B-X
most	B-X
organs	B-X
.	B-X
Thus	B-X
catalase	B-X
,	B-X
representing	B-X
0.025	B-X
%	B-X
of	B-X
heart	B-X
mitochondrial	B-X
protein	B-X
,	B-X
is	B-X
important	B-X
for	B-X
detoxifying	B-X
mitochondrial	B-X
derived	B-X
H2O2	B-X
and	B-X
represents	B-X
a	B-X
key	B-X
antioxidant	B-X
defense	B-X
mechanism	B-X
for	B-X
myocardial	B-X
tissue	B-X
.	B-X

Myocardial	O
tissue	O
has	O
a	O
lower	O
catalase	O
-	O
specific	O
activity	O
and	O
a	O
greater	O
mitochondrial	O
H2O2	O
production	O
/	O
g	O
of	O
tissue	O
than	O
most	O
organs	O
.	O

Thus	O
catalase	B-Gene_or_gene_product
,	O
representing	O
0	O
.	O
025	O
%	O
of	O
heart	O
mitochondrial	O
protein	O
,	O
is	O
important	O
for	O
detoxifying	O
mitochondrial	O
derived	O
H2O2	O
and	O
represents	O
a	O
key	O
antioxidant	O
defense	O
mechanism	O
for	O
myocardial	O
tissue	O
.	O

Nuclear	O
export	O
of	O
S6K1	B-Gene_or_gene_product
II	I-Gene_or_gene_product
is	O
regulated	O
by	O
protein	O
kinase	O
CK2	O
phosphorylation	O
at	O
Ser	O
-	O
17	O
.	O
<EOS>	B-X
Ribosomal	B-X
S6	B-X
kinases	B-X
(	B-X
S6Ks	B-X
)	B-X
are	B-X
principal	B-X
players	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
cell	B-X
growth	B-X
and	B-X
energy	B-X
metabolism	B-X
.	B-X
Signaling	B-X
via	B-X
phosphatidylinositol	B-X
3-kinase	B-X
and	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
pathways	B-X
mediates	B-X
the	B-X
activation	B-X
of	B-X
S6K	B-X
in	B-X
response	B-X
to	B-X
various	B-X
mitogenic	B-X
stimuli	B-X
.	B-X
The	B-X
family	B-X
of	B-X
S6Ks	B-X
consists	B-X
of	B-X
two	B-X
forms	B-X
,	B-X
S6K1	B-X
and	B-X
-2	B-X
,	B-X
that	B-X
have	B-X
cytoplasmic	B-X
and	B-X
nuclear	B-X
splicing	B-X
variants	B-X
,	B-X
S6K1	B-X
II	B-X
and	B-X
S6K1	B-X
I	B-X
,	B-X
respectively	B-X
.	B-X
Nuclear-cytoplasmic	B-X
shuttling	B-X
of	B-X
both	B-X
isoforms	B-X
induced	B-X
by	B-X
mitogenic	B-X
stimuli	B-X
has	B-X
been	B-X
reported	B-X
recently	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
the	B-X
identification	B-X
of	B-X
protein	B-X
kinase	B-X
CK2	B-X
(	B-X
CK2	B-X
)	B-X
as	B-X
a	B-X
novel	B-X
binding	B-X
and	B-X
regulatory	B-X
partner	B-X
for	B-X
S6K1	B-X
II	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2beta	B-X
regulatory	B-X
subunit	B-X
was	B-X
initially	B-X
identified	B-X
in	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
screen	B-X
and	B-X
further	B-X
confirmed	B-X
by	B-X
co-immunoprecipitation	B-X
of	B-X
transiently	B-X
expressed	B-X
and	B-X
endogenous	B-X
proteins	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
was	B-X
found	B-X
to	B-X
occur	B-X
in	B-X
serum-starved	B-X
and	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
found	B-X
that	B-X
S6K1	B-X
II	B-X
is	B-X
a	B-X
substrate	B-X
for	B-X
CK2	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
the	B-X
CK2	B-X
phosphorylation	B-X
site	B-X
was	B-X
narrowed	B-X
down	B-X
to	B-X
Ser-17	B-X
in	B-X
S6K1	B-X
II	B-X
.	B-X
Mutational	B-X
analysis	B-X
and	B-X
the	B-X
use	B-X
of	B-X
phosphospecific	B-X
antibody	B-X
indicate	B-X
that	B-X
Ser-17	B-X
is	B-X
a	B-X
major	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
site	B-X
for	B-X
CK2	B-X
.	B-X
Functional	B-X
studies	B-X
reveal	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
wild	B-X
type	B-X
kinase	B-X
,	B-X
the	B-X
phosphorylation-mimicking	B-X
mutant	B-X
of	B-X
S6K1	B-X
II	B-X
(	B-X
S17E	B-X
)	B-X
retains	B-X
its	B-X
cytoplasmic	B-X
localization	B-X
in	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
Treatment	B-X
of	B-X
cells	B-X
with	B-X
the	B-X
nuclear	B-X
export	B-X
inhibitor	B-X
leptomycin	B-X
B	B-X
revealed	B-X
that	B-X
the	B-X
S17E	B-X
mutant	B-X
accumulates	B-X
in	B-X
the	B-X
nucleus	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
S6K1	B-X
II	B-X
wild	B-X
type	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
nuclear	B-X
import	B-X
of	B-X
the	B-X
S17E	B-X
mutant	B-X
is	B-X
not	B-X
affected	B-X
,	B-X
although	B-X
the	B-X
export	B-X
is	B-X
significantly	B-X
enhanced	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
nuclear	B-X
export	B-X
of	B-X
S6K1	B-X
is	B-X
mediated	B-X
by	B-X
a	B-X
CRM1-dependent	B-X
mechanism	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
establishes	B-X
a	B-X
functional	B-X
link	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
signaling	B-X
,	B-X
which	B-X
involves	B-X
the	B-X
regulation	B-X
of	B-X
S6K1	B-X
II	B-X
nuclear	B-X
export	B-X
by	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Ser-17	B-X
.	B-X

Ribosomal	O
S6	B-Gene_or_gene_product
kinases	I-Gene_or_gene_product
(	O
S6Ks	B-Gene_or_gene_product
)	O
are	O
principal	O
players	O
in	O
the	O
regulation	O
of	O
cell	O
growth	O
and	O
energy	O
metabolism	O
.	O
<EOS>	B-X
Ribosomal	B-X
S6	B-X
kinases	B-X
(	B-X
S6Ks	B-X
)	B-X
are	B-X
principal	B-X
players	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
cell	B-X
growth	B-X
and	B-X
energy	B-X
metabolism	B-X
.	B-X
Signaling	B-X
via	B-X
phosphatidylinositol	B-X
3-kinase	B-X
and	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
pathways	B-X
mediates	B-X
the	B-X
activation	B-X
of	B-X
S6K	B-X
in	B-X
response	B-X
to	B-X
various	B-X
mitogenic	B-X
stimuli	B-X
.	B-X
The	B-X
family	B-X
of	B-X
S6Ks	B-X
consists	B-X
of	B-X
two	B-X
forms	B-X
,	B-X
S6K1	B-X
and	B-X
-2	B-X
,	B-X
that	B-X
have	B-X
cytoplasmic	B-X
and	B-X
nuclear	B-X
splicing	B-X
variants	B-X
,	B-X
S6K1	B-X
II	B-X
and	B-X
S6K1	B-X
I	B-X
,	B-X
respectively	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
the	B-X
identification	B-X
of	B-X
protein	B-X
kinase	B-X
CK2	B-X
(	B-X
CK2	B-X
)	B-X
as	B-X
a	B-X
novel	B-X
binding	B-X
and	B-X
regulatory	B-X
partner	B-X
for	B-X
S6K1	B-X
II	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2beta	B-X
regulatory	B-X
subunit	B-X
was	B-X
initially	B-X
identified	B-X
in	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
screen	B-X
and	B-X
further	B-X
confirmed	B-X
by	B-X
co-immunoprecipitation	B-X
of	B-X
transiently	B-X
expressed	B-X
and	B-X
endogenous	B-X
proteins	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
was	B-X
found	B-X
to	B-X
occur	B-X
in	B-X
serum-starved	B-X
and	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
found	B-X
that	B-X
S6K1	B-X
II	B-X
is	B-X
a	B-X
substrate	B-X
for	B-X
CK2	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
the	B-X
CK2	B-X
phosphorylation	B-X
site	B-X
was	B-X
narrowed	B-X
down	B-X
to	B-X
Ser-17	B-X
in	B-X
S6K1	B-X
II	B-X
.	B-X
Functional	B-X
studies	B-X
reveal	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
wild	B-X
type	B-X
kinase	B-X
,	B-X
the	B-X
phosphorylation-mimicking	B-X
mutant	B-X
of	B-X
S6K1	B-X
II	B-X
(	B-X
S17E	B-X
)	B-X
retains	B-X
its	B-X
cytoplasmic	B-X
localization	B-X
in	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
Treatment	B-X
of	B-X
cells	B-X
with	B-X
the	B-X
nuclear	B-X
export	B-X
inhibitor	B-X
leptomycin	B-X
B	B-X
revealed	B-X
that	B-X
the	B-X
S17E	B-X
mutant	B-X
accumulates	B-X
in	B-X
the	B-X
nucleus	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
S6K1	B-X
II	B-X
wild	B-X
type	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
nuclear	B-X
export	B-X
of	B-X
S6K1	B-X
is	B-X
mediated	B-X
by	B-X
a	B-X
CRM1-dependent	B-X
mechanism	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
establishes	B-X
a	B-X
functional	B-X
link	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
signaling	B-X
,	B-X
which	B-X
involves	B-X
the	B-X
regulation	B-X
of	B-X
S6K1	B-X
II	B-X
nuclear	B-X
export	B-X
by	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Ser-17	B-X
.	B-X

Signaling	O
via	O
phosphatidylinositol	B-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
and	O
mammalian	B-Gene_or_gene_product
target	I-Gene_or_gene_product
of	I-Gene_or_gene_product
rapamycin	I-Gene_or_gene_product
pathways	O
mediates	O
the	O
activation	O
of	O
S6K	B-Gene_or_gene_product
in	O
response	O
to	O
various	O
mitogenic	O
stimuli	O
.	O
<EOS>	B-X
Translation	B-X
of	B-X
terminal	B-X
oligopyrimidine	B-X
tract	B-X
(	B-X
TOP	B-X
)	B-X
mRNAs	B-X
,	B-X
which	B-X
encode	B-X
multiple	B-X
components	B-X
of	B-X
the	B-X
protein	B-X
synthesis	B-X
machinery	B-X
,	B-X
is	B-X
known	B-X
to	B-X
be	B-X
controlled	B-X
by	B-X
mitogenic	B-X
stimuli	B-X
.	B-X
However	B-X
,	B-X
both	B-X
growth	B-X
and	B-X
mitogenic	B-X
signals	B-X
converge	B-X
via	B-X
the	B-X
phosphatidylinositol	B-X
3-kinase	B-X
(	B-X
PI3-kinase	B-X
)	B-X
-mediated	B-X
pathway	B-X
and	B-X
are	B-X
transduced	B-X
to	B-X
efficiently	B-X
translate	B-X
TOP	B-X
mRNAs	B-X
.	B-X
Translational	B-X
activation	B-X
of	B-X
TOP	B-X
mRNAs	B-X
can	B-X
be	B-X
abolished	B-X
by	B-X
LY294002	B-X
,	B-X
a	B-X
PI3-kinase	B-X
inhibitor	B-X
,	B-X
or	B-X
by	B-X
overexpression	B-X
of	B-X
PTEN	B-X
as	B-X
well	B-X
as	B-X
by	B-X
dominant-negative	B-X
mutants	B-X
of	B-X
PI3-kinase	B-X
or	B-X
its	B-X
effectors	B-X
,	B-X
PDK1	B-X
and	B-X
protein	B-X
kinase	B-X
Balpha	B-X
(	B-X
PKBalpha	B-X
)	B-X
.	B-X
Likewise	B-X
,	B-X
overexpression	B-X
of	B-X
constitutively	B-X
active	B-X
PI3-kinase	B-X
or	B-X
PKBalpha	B-X
can	B-X
relieve	B-X
the	B-X
translational	B-X
repression	B-X
of	B-X
TOP	B-X
mRNAs	B-X
in	B-X
quiescent	B-X
cells	B-X
.	B-X
Both	B-X
mitogenic	B-X
and	B-X
growth	B-X
signals	B-X
lead	B-X
to	B-X
phosphorylation	B-X
of	B-X
ribosomal	B-X
protein	B-X
S6	B-X
(	B-X
rpS6	B-X
)	B-X
,	B-X
which	B-X
precedes	B-X
the	B-X
translational	B-X
activation	B-X
of	B-X
TOP	B-X
mRNAs	B-X
.	B-X
Nevertheless	B-X
,	B-X
neither	B-X
rpS6	B-X
phosphorylation	B-X
nor	B-X
its	B-X
kinase	B-X
,	B-X
S6K1	B-X
,	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
translational	B-X
response	B-X
of	B-X
these	B-X
mRNAs	B-X
.	B-X
Thus	B-X
,	B-X
TOP	B-X
mRNAs	B-X
can	B-X
be	B-X
translationally	B-X
activated	B-X
by	B-X
growth	B-X
or	B-X
mitogenic	B-X
stimuli	B-X
of	B-X
ES	B-X
cells	B-X
,	B-X
whose	B-X
rpS6	B-X
is	B-X
constitutively	B-X
unphosphorylated	B-X
due	B-X
to	B-X
the	B-X
disruption	B-X
of	B-X
both	B-X
alleles	B-X
of	B-X
S6K1	B-X
.	B-X
Similarly	B-X
,	B-X
complete	B-X
inhibition	B-X
of	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
and	B-X
its	B-X
effector	B-X
S6K	B-X
by	B-X
rapamycin	B-X
in	B-X
various	B-X
cell	B-X
lines	B-X
has	B-X
only	B-X
a	B-X
mild	B-X
repressive	B-X
effect	B-X
on	B-X
the	B-X
translation	B-X
of	B-X
TOP	B-X
mRNAs	B-X
.	B-X
It	B-X
therefore	B-X
appears	B-X
that	B-X
translation	B-X
of	B-X
TOP	B-X
mRNAs	B-X
is	B-X
primarily	B-X
regulated	B-X
by	B-X
growth	B-X
and	B-X
mitogenic	B-X
cues	B-X
through	B-X
the	B-X
PI3-kinase	B-X
pathway	B-X
,	B-X
with	B-X
a	B-X
minor	B-X
role	B-X
,	B-X
if	B-X
any	B-X
,	B-X
for	B-X
the	B-X
mTOR	B-X
pathway	B-X
.	B-X

The	O
family	O
of	O
S6Ks	B-Gene_or_gene_product
consists	O
of	O
two	O
forms	O
,	O
S6K1	B-Gene_or_gene_product
and	O
-	B-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
that	O
have	O
cytoplasmic	O
and	O
nuclear	O
splicing	O
variants	O
,	O
S6K1	B-Gene_or_gene_product
II	I-Gene_or_gene_product
and	O
S6K1	B-Gene_or_gene_product
I	I-Gene_or_gene_product
,	O
respectively	O
.	O
<EOS>	B-X
Ribosomal	B-X
S6	B-X
kinases	B-X
(	B-X
S6Ks	B-X
)	B-X
are	B-X
principal	B-X
players	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
cell	B-X
growth	B-X
and	B-X
energy	B-X
metabolism	B-X
.	B-X
The	B-X
family	B-X
of	B-X
S6Ks	B-X
consists	B-X
of	B-X
two	B-X
forms	B-X
,	B-X
S6K1	B-X
and	B-X
-2	B-X
,	B-X
that	B-X
have	B-X
cytoplasmic	B-X
and	B-X
nuclear	B-X
splicing	B-X
variants	B-X
,	B-X
S6K1	B-X
II	B-X
and	B-X
S6K1	B-X
I	B-X
,	B-X
respectively	B-X
.	B-X
Nuclear-cytoplasmic	B-X
shuttling	B-X
of	B-X
both	B-X
isoforms	B-X
induced	B-X
by	B-X
mitogenic	B-X
stimuli	B-X
has	B-X
been	B-X
reported	B-X
recently	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
the	B-X
identification	B-X
of	B-X
protein	B-X
kinase	B-X
CK2	B-X
(	B-X
CK2	B-X
)	B-X
as	B-X
a	B-X
novel	B-X
binding	B-X
and	B-X
regulatory	B-X
partner	B-X
for	B-X
S6K1	B-X
II	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2beta	B-X
regulatory	B-X
subunit	B-X
was	B-X
initially	B-X
identified	B-X
in	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
screen	B-X
and	B-X
further	B-X
confirmed	B-X
by	B-X
co-immunoprecipitation	B-X
of	B-X
transiently	B-X
expressed	B-X
and	B-X
endogenous	B-X
proteins	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
was	B-X
found	B-X
to	B-X
occur	B-X
in	B-X
serum-starved	B-X
and	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
found	B-X
that	B-X
S6K1	B-X
II	B-X
is	B-X
a	B-X
substrate	B-X
for	B-X
CK2	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
the	B-X
CK2	B-X
phosphorylation	B-X
site	B-X
was	B-X
narrowed	B-X
down	B-X
to	B-X
Ser-17	B-X
in	B-X
S6K1	B-X
II	B-X
.	B-X
Mutational	B-X
analysis	B-X
and	B-X
the	B-X
use	B-X
of	B-X
phosphospecific	B-X
antibody	B-X
indicate	B-X
that	B-X
Ser-17	B-X
is	B-X
a	B-X
major	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
site	B-X
for	B-X
CK2	B-X
.	B-X
Functional	B-X
studies	B-X
reveal	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
wild	B-X
type	B-X
kinase	B-X
,	B-X
the	B-X
phosphorylation-mimicking	B-X
mutant	B-X
of	B-X
S6K1	B-X
II	B-X
(	B-X
S17E	B-X
)	B-X
retains	B-X
its	B-X
cytoplasmic	B-X
localization	B-X
in	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
Treatment	B-X
of	B-X
cells	B-X
with	B-X
the	B-X
nuclear	B-X
export	B-X
inhibitor	B-X
leptomycin	B-X
B	B-X
revealed	B-X
that	B-X
the	B-X
S17E	B-X
mutant	B-X
accumulates	B-X
in	B-X
the	B-X
nucleus	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
S6K1	B-X
II	B-X
wild	B-X
type	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
nuclear	B-X
import	B-X
of	B-X
the	B-X
S17E	B-X
mutant	B-X
is	B-X
not	B-X
affected	B-X
,	B-X
although	B-X
the	B-X
export	B-X
is	B-X
significantly	B-X
enhanced	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
nuclear	B-X
export	B-X
of	B-X
S6K1	B-X
is	B-X
mediated	B-X
by	B-X
a	B-X
CRM1-dependent	B-X
mechanism	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
establishes	B-X
a	B-X
functional	B-X
link	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
signaling	B-X
,	B-X
which	B-X
involves	B-X
the	B-X
regulation	B-X
of	B-X
S6K1	B-X
II	B-X
nuclear	B-X
export	B-X
by	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Ser-17	B-X
.	B-X

Nuclear	O
-	O
cytoplasmic	O
shuttling	O
of	O
both	O
isoforms	O
induced	O
by	O
mitogenic	O
stimuli	O
has	O
been	O
reported	O
recently	O
.	O
<EOS>	B-X
Signaling	B-X
via	B-X
phosphatidylinositol	B-X
3-kinase	B-X
and	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
pathways	B-X
mediates	B-X
the	B-X
activation	B-X
of	B-X
S6K	B-X
in	B-X
response	B-X
to	B-X
various	B-X
mitogenic	B-X
stimuli	B-X
.	B-X
The	B-X
family	B-X
of	B-X
S6Ks	B-X
consists	B-X
of	B-X
two	B-X
forms	B-X
,	B-X
S6K1	B-X
and	B-X
-2	B-X
,	B-X
that	B-X
have	B-X
cytoplasmic	B-X
and	B-X
nuclear	B-X
splicing	B-X
variants	B-X
,	B-X
S6K1	B-X
II	B-X
and	B-X
S6K1	B-X
I	B-X
,	B-X
respectively	B-X
.	B-X
Nuclear-cytoplasmic	B-X
shuttling	B-X
of	B-X
both	B-X
isoforms	B-X
induced	B-X
by	B-X
mitogenic	B-X
stimuli	B-X
has	B-X
been	B-X
reported	B-X
recently	B-X
.	B-X
Functional	B-X
studies	B-X
reveal	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
wild	B-X
type	B-X
kinase	B-X
,	B-X
the	B-X
phosphorylation-mimicking	B-X
mutant	B-X
of	B-X
S6K1	B-X
II	B-X
(	B-X
S17E	B-X
)	B-X
retains	B-X
its	B-X
cytoplasmic	B-X
localization	B-X
in	B-X
serum-stimulated	B-X
cells	B-X
.	B-X

Here	O
we	O
present	O
the	O
identification	O
of	O
protein	O
kinase	O
CK2	O
(	O
CK2	O
)	O
as	O
a	O
novel	O
binding	O
and	O
regulatory	O
partner	O
for	O
S6K1	B-Gene_or_gene_product
II	I-Gene_or_gene_product
.	O
<EOS>	B-X
Ribosomal	B-X
S6	B-X
kinases	B-X
(	B-X
S6Ks	B-X
)	B-X
are	B-X
principal	B-X
players	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
cell	B-X
growth	B-X
and	B-X
energy	B-X
metabolism	B-X
.	B-X
Signaling	B-X
via	B-X
phosphatidylinositol	B-X
3-kinase	B-X
and	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
pathways	B-X
mediates	B-X
the	B-X
activation	B-X
of	B-X
S6K	B-X
in	B-X
response	B-X
to	B-X
various	B-X
mitogenic	B-X
stimuli	B-X
.	B-X
The	B-X
family	B-X
of	B-X
S6Ks	B-X
consists	B-X
of	B-X
two	B-X
forms	B-X
,	B-X
S6K1	B-X
and	B-X
-2	B-X
,	B-X
that	B-X
have	B-X
cytoplasmic	B-X
and	B-X
nuclear	B-X
splicing	B-X
variants	B-X
,	B-X
S6K1	B-X
II	B-X
and	B-X
S6K1	B-X
I	B-X
,	B-X
respectively	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
the	B-X
identification	B-X
of	B-X
protein	B-X
kinase	B-X
CK2	B-X
(	B-X
CK2	B-X
)	B-X
as	B-X
a	B-X
novel	B-X
binding	B-X
and	B-X
regulatory	B-X
partner	B-X
for	B-X
S6K1	B-X
II	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2beta	B-X
regulatory	B-X
subunit	B-X
was	B-X
initially	B-X
identified	B-X
in	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
screen	B-X
and	B-X
further	B-X
confirmed	B-X
by	B-X
co-immunoprecipitation	B-X
of	B-X
transiently	B-X
expressed	B-X
and	B-X
endogenous	B-X
proteins	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
was	B-X
found	B-X
to	B-X
occur	B-X
in	B-X
serum-starved	B-X
and	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
found	B-X
that	B-X
S6K1	B-X
II	B-X
is	B-X
a	B-X
substrate	B-X
for	B-X
CK2	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
the	B-X
CK2	B-X
phosphorylation	B-X
site	B-X
was	B-X
narrowed	B-X
down	B-X
to	B-X
Ser-17	B-X
in	B-X
S6K1	B-X
II	B-X
.	B-X
Mutational	B-X
analysis	B-X
and	B-X
the	B-X
use	B-X
of	B-X
phosphospecific	B-X
antibody	B-X
indicate	B-X
that	B-X
Ser-17	B-X
is	B-X
a	B-X
major	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
site	B-X
for	B-X
CK2	B-X
.	B-X
Functional	B-X
studies	B-X
reveal	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
wild	B-X
type	B-X
kinase	B-X
,	B-X
the	B-X
phosphorylation-mimicking	B-X
mutant	B-X
of	B-X
S6K1	B-X
II	B-X
(	B-X
S17E	B-X
)	B-X
retains	B-X
its	B-X
cytoplasmic	B-X
localization	B-X
in	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
Treatment	B-X
of	B-X
cells	B-X
with	B-X
the	B-X
nuclear	B-X
export	B-X
inhibitor	B-X
leptomycin	B-X
B	B-X
revealed	B-X
that	B-X
the	B-X
S17E	B-X
mutant	B-X
accumulates	B-X
in	B-X
the	B-X
nucleus	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
S6K1	B-X
II	B-X
wild	B-X
type	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
nuclear	B-X
export	B-X
of	B-X
S6K1	B-X
is	B-X
mediated	B-X
by	B-X
a	B-X
CRM1-dependent	B-X
mechanism	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
establishes	B-X
a	B-X
functional	B-X
link	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
signaling	B-X
,	B-X
which	B-X
involves	B-X
the	B-X
regulation	B-X
of	B-X
S6K1	B-X
II	B-X
nuclear	B-X
export	B-X
by	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Ser-17	B-X
.	B-X

The	O
interaction	O
between	O
S6K1	B-Gene_or_gene_product
II	I-Gene_or_gene_product
and	O
CK2beta	B-Gene_or_gene_product
regulatory	O
subunit	O
was	O
initially	O
identified	O
in	O
a	O
yeast	O
two	O
-	O
hybrid	O
screen	O
and	O
further	O
confirmed	O
by	O
co	O
-	O
immunoprecipitation	O
of	O
transiently	O
expressed	O
and	O
endogenous	O
proteins	O
.	O

The	O
interaction	O
between	O
S6K1	B-Gene_or_gene_product
II	I-Gene_or_gene_product
and	O
CK2	O
was	O
found	O
to	O
occur	O
in	O
serum	O
-	O
starved	O
and	O
serum	O
-	O
stimulated	O
cells	O
.	O
<EOS>	B-X
The	B-X
family	B-X
of	B-X
S6Ks	B-X
consists	B-X
of	B-X
two	B-X
forms	B-X
,	B-X
S6K1	B-X
and	B-X
-2	B-X
,	B-X
that	B-X
have	B-X
cytoplasmic	B-X
and	B-X
nuclear	B-X
splicing	B-X
variants	B-X
,	B-X
S6K1	B-X
II	B-X
and	B-X
S6K1	B-X
I	B-X
,	B-X
respectively	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
the	B-X
identification	B-X
of	B-X
protein	B-X
kinase	B-X
CK2	B-X
(	B-X
CK2	B-X
)	B-X
as	B-X
a	B-X
novel	B-X
binding	B-X
and	B-X
regulatory	B-X
partner	B-X
for	B-X
S6K1	B-X
II	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2beta	B-X
regulatory	B-X
subunit	B-X
was	B-X
initially	B-X
identified	B-X
in	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
screen	B-X
and	B-X
further	B-X
confirmed	B-X
by	B-X
co-immunoprecipitation	B-X
of	B-X
transiently	B-X
expressed	B-X
and	B-X
endogenous	B-X
proteins	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
was	B-X
found	B-X
to	B-X
occur	B-X
in	B-X
serum-starved	B-X
and	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
found	B-X
that	B-X
S6K1	B-X
II	B-X
is	B-X
a	B-X
substrate	B-X
for	B-X
CK2	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
the	B-X
CK2	B-X
phosphorylation	B-X
site	B-X
was	B-X
narrowed	B-X
down	B-X
to	B-X
Ser-17	B-X
in	B-X
S6K1	B-X
II	B-X
.	B-X
Mutational	B-X
analysis	B-X
and	B-X
the	B-X
use	B-X
of	B-X
phosphospecific	B-X
antibody	B-X
indicate	B-X
that	B-X
Ser-17	B-X
is	B-X
a	B-X
major	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
site	B-X
for	B-X
CK2	B-X
.	B-X
Functional	B-X
studies	B-X
reveal	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
wild	B-X
type	B-X
kinase	B-X
,	B-X
the	B-X
phosphorylation-mimicking	B-X
mutant	B-X
of	B-X
S6K1	B-X
II	B-X
(	B-X
S17E	B-X
)	B-X
retains	B-X
its	B-X
cytoplasmic	B-X
localization	B-X
in	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
Treatment	B-X
of	B-X
cells	B-X
with	B-X
the	B-X
nuclear	B-X
export	B-X
inhibitor	B-X
leptomycin	B-X
B	B-X
revealed	B-X
that	B-X
the	B-X
S17E	B-X
mutant	B-X
accumulates	B-X
in	B-X
the	B-X
nucleus	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
S6K1	B-X
II	B-X
wild	B-X
type	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
nuclear	B-X
export	B-X
of	B-X
S6K1	B-X
is	B-X
mediated	B-X
by	B-X
a	B-X
CRM1-dependent	B-X
mechanism	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
establishes	B-X
a	B-X
functional	B-X
link	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
signaling	B-X
,	B-X
which	B-X
involves	B-X
the	B-X
regulation	B-X
of	B-X
S6K1	B-X
II	B-X
nuclear	B-X
export	B-X
by	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Ser-17	B-X
.	B-X

In	O
addition	O
,	O
we	O
found	O
that	O
S6K1	B-Gene_or_gene_product
II	I-Gene_or_gene_product
is	O
a	O
substrate	O
for	O
CK2	O
.	O
<EOS>	B-X
The	B-X
family	B-X
of	B-X
S6Ks	B-X
consists	B-X
of	B-X
two	B-X
forms	B-X
,	B-X
S6K1	B-X
and	B-X
-2	B-X
,	B-X
that	B-X
have	B-X
cytoplasmic	B-X
and	B-X
nuclear	B-X
splicing	B-X
variants	B-X
,	B-X
S6K1	B-X
II	B-X
and	B-X
S6K1	B-X
I	B-X
,	B-X
respectively	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
the	B-X
identification	B-X
of	B-X
protein	B-X
kinase	B-X
CK2	B-X
(	B-X
CK2	B-X
)	B-X
as	B-X
a	B-X
novel	B-X
binding	B-X
and	B-X
regulatory	B-X
partner	B-X
for	B-X
S6K1	B-X
II	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2beta	B-X
regulatory	B-X
subunit	B-X
was	B-X
initially	B-X
identified	B-X
in	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
screen	B-X
and	B-X
further	B-X
confirmed	B-X
by	B-X
co-immunoprecipitation	B-X
of	B-X
transiently	B-X
expressed	B-X
and	B-X
endogenous	B-X
proteins	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
was	B-X
found	B-X
to	B-X
occur	B-X
in	B-X
serum-starved	B-X
and	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
found	B-X
that	B-X
S6K1	B-X
II	B-X
is	B-X
a	B-X
substrate	B-X
for	B-X
CK2	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
the	B-X
CK2	B-X
phosphorylation	B-X
site	B-X
was	B-X
narrowed	B-X
down	B-X
to	B-X
Ser-17	B-X
in	B-X
S6K1	B-X
II	B-X
.	B-X
Mutational	B-X
analysis	B-X
and	B-X
the	B-X
use	B-X
of	B-X
phosphospecific	B-X
antibody	B-X
indicate	B-X
that	B-X
Ser-17	B-X
is	B-X
a	B-X
major	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
site	B-X
for	B-X
CK2	B-X
.	B-X
Functional	B-X
studies	B-X
reveal	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
wild	B-X
type	B-X
kinase	B-X
,	B-X
the	B-X
phosphorylation-mimicking	B-X
mutant	B-X
of	B-X
S6K1	B-X
II	B-X
(	B-X
S17E	B-X
)	B-X
retains	B-X
its	B-X
cytoplasmic	B-X
localization	B-X
in	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
Treatment	B-X
of	B-X
cells	B-X
with	B-X
the	B-X
nuclear	B-X
export	B-X
inhibitor	B-X
leptomycin	B-X
B	B-X
revealed	B-X
that	B-X
the	B-X
S17E	B-X
mutant	B-X
accumulates	B-X
in	B-X
the	B-X
nucleus	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
S6K1	B-X
II	B-X
wild	B-X
type	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
nuclear	B-X
export	B-X
of	B-X
S6K1	B-X
is	B-X
mediated	B-X
by	B-X
a	B-X
CRM1-dependent	B-X
mechanism	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
establishes	B-X
a	B-X
functional	B-X
link	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
signaling	B-X
,	B-X
which	B-X
involves	B-X
the	B-X
regulation	B-X
of	B-X
S6K1	B-X
II	B-X
nuclear	B-X
export	B-X
by	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Ser-17	B-X
.	B-X

The	O
localization	O
of	O
the	O
CK2	O
phosphorylation	O
site	O
was	O
narrowed	O
down	O
to	O
Ser	O
-	O
17	O
in	O
S6K1	B-Gene_or_gene_product
II	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
family	B-X
of	B-X
S6Ks	B-X
consists	B-X
of	B-X
two	B-X
forms	B-X
,	B-X
S6K1	B-X
and	B-X
-2	B-X
,	B-X
that	B-X
have	B-X
cytoplasmic	B-X
and	B-X
nuclear	B-X
splicing	B-X
variants	B-X
,	B-X
S6K1	B-X
II	B-X
and	B-X
S6K1	B-X
I	B-X
,	B-X
respectively	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
the	B-X
identification	B-X
of	B-X
protein	B-X
kinase	B-X
CK2	B-X
(	B-X
CK2	B-X
)	B-X
as	B-X
a	B-X
novel	B-X
binding	B-X
and	B-X
regulatory	B-X
partner	B-X
for	B-X
S6K1	B-X
II	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2beta	B-X
regulatory	B-X
subunit	B-X
was	B-X
initially	B-X
identified	B-X
in	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
screen	B-X
and	B-X
further	B-X
confirmed	B-X
by	B-X
co-immunoprecipitation	B-X
of	B-X
transiently	B-X
expressed	B-X
and	B-X
endogenous	B-X
proteins	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
was	B-X
found	B-X
to	B-X
occur	B-X
in	B-X
serum-starved	B-X
and	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
found	B-X
that	B-X
S6K1	B-X
II	B-X
is	B-X
a	B-X
substrate	B-X
for	B-X
CK2	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
the	B-X
CK2	B-X
phosphorylation	B-X
site	B-X
was	B-X
narrowed	B-X
down	B-X
to	B-X
Ser-17	B-X
in	B-X
S6K1	B-X
II	B-X
.	B-X
Mutational	B-X
analysis	B-X
and	B-X
the	B-X
use	B-X
of	B-X
phosphospecific	B-X
antibody	B-X
indicate	B-X
that	B-X
Ser-17	B-X
is	B-X
a	B-X
major	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
site	B-X
for	B-X
CK2	B-X
.	B-X
Functional	B-X
studies	B-X
reveal	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
wild	B-X
type	B-X
kinase	B-X
,	B-X
the	B-X
phosphorylation-mimicking	B-X
mutant	B-X
of	B-X
S6K1	B-X
II	B-X
(	B-X
S17E	B-X
)	B-X
retains	B-X
its	B-X
cytoplasmic	B-X
localization	B-X
in	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
Treatment	B-X
of	B-X
cells	B-X
with	B-X
the	B-X
nuclear	B-X
export	B-X
inhibitor	B-X
leptomycin	B-X
B	B-X
revealed	B-X
that	B-X
the	B-X
S17E	B-X
mutant	B-X
accumulates	B-X
in	B-X
the	B-X
nucleus	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
S6K1	B-X
II	B-X
wild	B-X
type	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
nuclear	B-X
import	B-X
of	B-X
the	B-X
S17E	B-X
mutant	B-X
is	B-X
not	B-X
affected	B-X
,	B-X
although	B-X
the	B-X
export	B-X
is	B-X
significantly	B-X
enhanced	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
nuclear	B-X
export	B-X
of	B-X
S6K1	B-X
is	B-X
mediated	B-X
by	B-X
a	B-X
CRM1-dependent	B-X
mechanism	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
establishes	B-X
a	B-X
functional	B-X
link	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
signaling	B-X
,	B-X
which	B-X
involves	B-X
the	B-X
regulation	B-X
of	B-X
S6K1	B-X
II	B-X
nuclear	B-X
export	B-X
by	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Ser-17	B-X
.	B-X

Mutational	O
analysis	O
and	O
the	O
use	O
of	O
phosphospecific	O
antibody	O
indicate	O
that	O
Ser	O
-	O
17	O
is	O
a	O
major	O
in	O
vitro	O
and	O
in	O
vivo	O
phosphorylation	O
site	O
for	O
CK2	O
.	O

Functional	O
studies	O
reveal	O
that	O
,	O
in	O
contrast	O
to	O
the	O
wild	O
type	O
kinase	O
,	O
the	O
phosphorylation	O
-	O
mimicking	O
mutant	O
of	O
S6K1	B-Gene_or_gene_product
II	I-Gene_or_gene_product
(	O
S17E	B-Gene_or_gene_product
)	O
retains	O
its	O
cytoplasmic	O
localization	O
in	O
serum	O
-	O
stimulated	O
cells	O
.	O

Treatment	O
of	O
cells	O
with	O
the	O
nuclear	O
export	O
inhibitor	O
leptomycin	O
B	O
revealed	O
that	O
the	O
S17E	B-Gene_or_gene_product
mutant	O
accumulates	O
in	O
the	O
nucleus	O
to	O
the	O
same	O
extent	O
as	O
S6K1	B-Gene_or_gene_product
II	I-Gene_or_gene_product
wild	O
type	O
.	O

These	O
results	O
indicate	O
that	O
nuclear	O
import	O
of	O
the	O
S17E	B-Gene_or_gene_product
mutant	O
is	O
not	O
affected	O
,	O
although	O
the	O
export	O
is	O
significantly	O
enhanced	O
.	O

We	O
also	O
provide	O
evidence	O
that	O
nuclear	O
export	O
of	O
S6K1	B-Gene_or_gene_product
is	O
mediated	O
by	O
a	O
CRM1	B-Gene_or_gene_product
-	O
dependent	O
mechanism	O
.	O
<EOS>	B-X
The	B-X
family	B-X
of	B-X
S6Ks	B-X
consists	B-X
of	B-X
two	B-X
forms	B-X
,	B-X
S6K1	B-X
and	B-X
-2	B-X
,	B-X
that	B-X
have	B-X
cytoplasmic	B-X
and	B-X
nuclear	B-X
splicing	B-X
variants	B-X
,	B-X
S6K1	B-X
II	B-X
and	B-X
S6K1	B-X
I	B-X
,	B-X
respectively	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
the	B-X
identification	B-X
of	B-X
protein	B-X
kinase	B-X
CK2	B-X
(	B-X
CK2	B-X
)	B-X
as	B-X
a	B-X
novel	B-X
binding	B-X
and	B-X
regulatory	B-X
partner	B-X
for	B-X
S6K1	B-X
II	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2beta	B-X
regulatory	B-X
subunit	B-X
was	B-X
initially	B-X
identified	B-X
in	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
screen	B-X
and	B-X
further	B-X
confirmed	B-X
by	B-X
co-immunoprecipitation	B-X
of	B-X
transiently	B-X
expressed	B-X
and	B-X
endogenous	B-X
proteins	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
was	B-X
found	B-X
to	B-X
occur	B-X
in	B-X
serum-starved	B-X
and	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
found	B-X
that	B-X
S6K1	B-X
II	B-X
is	B-X
a	B-X
substrate	B-X
for	B-X
CK2	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
the	B-X
CK2	B-X
phosphorylation	B-X
site	B-X
was	B-X
narrowed	B-X
down	B-X
to	B-X
Ser-17	B-X
in	B-X
S6K1	B-X
II	B-X
.	B-X
Functional	B-X
studies	B-X
reveal	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
wild	B-X
type	B-X
kinase	B-X
,	B-X
the	B-X
phosphorylation-mimicking	B-X
mutant	B-X
of	B-X
S6K1	B-X
II	B-X
(	B-X
S17E	B-X
)	B-X
retains	B-X
its	B-X
cytoplasmic	B-X
localization	B-X
in	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
Treatment	B-X
of	B-X
cells	B-X
with	B-X
the	B-X
nuclear	B-X
export	B-X
inhibitor	B-X
leptomycin	B-X
B	B-X
revealed	B-X
that	B-X
the	B-X
S17E	B-X
mutant	B-X
accumulates	B-X
in	B-X
the	B-X
nucleus	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
S6K1	B-X
II	B-X
wild	B-X
type	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
nuclear	B-X
import	B-X
of	B-X
the	B-X
S17E	B-X
mutant	B-X
is	B-X
not	B-X
affected	B-X
,	B-X
although	B-X
the	B-X
export	B-X
is	B-X
significantly	B-X
enhanced	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
nuclear	B-X
export	B-X
of	B-X
S6K1	B-X
is	B-X
mediated	B-X
by	B-X
a	B-X
CRM1-dependent	B-X
mechanism	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
establishes	B-X
a	B-X
functional	B-X
link	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
signaling	B-X
,	B-X
which	B-X
involves	B-X
the	B-X
regulation	B-X
of	B-X
S6K1	B-X
II	B-X
nuclear	B-X
export	B-X
by	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Ser-17	B-X
.	B-X

Taken	O
together	O
,	O
this	O
study	O
establishes	O
a	O
functional	O
link	O
between	O
S6K1	B-Gene_or_gene_product
II	I-Gene_or_gene_product
and	O
CK2	O
signaling	O
,	O
which	O
involves	O
the	O
regulation	O
of	O
S6K1	B-Gene_or_gene_product
II	I-Gene_or_gene_product
nuclear	O
export	O
by	O
CK2	O
-	O
mediated	O
phosphorylation	O
of	O
Ser	O
-	O
17	O
.	O
<EOS>	B-X
Ribosomal	B-X
S6	B-X
kinases	B-X
(	B-X
S6Ks	B-X
)	B-X
are	B-X
principal	B-X
players	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
cell	B-X
growth	B-X
and	B-X
energy	B-X
metabolism	B-X
.	B-X
The	B-X
family	B-X
of	B-X
S6Ks	B-X
consists	B-X
of	B-X
two	B-X
forms	B-X
,	B-X
S6K1	B-X
and	B-X
-2	B-X
,	B-X
that	B-X
have	B-X
cytoplasmic	B-X
and	B-X
nuclear	B-X
splicing	B-X
variants	B-X
,	B-X
S6K1	B-X
II	B-X
and	B-X
S6K1	B-X
I	B-X
,	B-X
respectively	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
the	B-X
identification	B-X
of	B-X
protein	B-X
kinase	B-X
CK2	B-X
(	B-X
CK2	B-X
)	B-X
as	B-X
a	B-X
novel	B-X
binding	B-X
and	B-X
regulatory	B-X
partner	B-X
for	B-X
S6K1	B-X
II	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2beta	B-X
regulatory	B-X
subunit	B-X
was	B-X
initially	B-X
identified	B-X
in	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
screen	B-X
and	B-X
further	B-X
confirmed	B-X
by	B-X
co-immunoprecipitation	B-X
of	B-X
transiently	B-X
expressed	B-X
and	B-X
endogenous	B-X
proteins	B-X
.	B-X
The	B-X
interaction	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
was	B-X
found	B-X
to	B-X
occur	B-X
in	B-X
serum-starved	B-X
and	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
found	B-X
that	B-X
S6K1	B-X
II	B-X
is	B-X
a	B-X
substrate	B-X
for	B-X
CK2	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
the	B-X
CK2	B-X
phosphorylation	B-X
site	B-X
was	B-X
narrowed	B-X
down	B-X
to	B-X
Ser-17	B-X
in	B-X
S6K1	B-X
II	B-X
.	B-X
Mutational	B-X
analysis	B-X
and	B-X
the	B-X
use	B-X
of	B-X
phosphospecific	B-X
antibody	B-X
indicate	B-X
that	B-X
Ser-17	B-X
is	B-X
a	B-X
major	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
site	B-X
for	B-X
CK2	B-X
.	B-X
Functional	B-X
studies	B-X
reveal	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
wild	B-X
type	B-X
kinase	B-X
,	B-X
the	B-X
phosphorylation-mimicking	B-X
mutant	B-X
of	B-X
S6K1	B-X
II	B-X
(	B-X
S17E	B-X
)	B-X
retains	B-X
its	B-X
cytoplasmic	B-X
localization	B-X
in	B-X
serum-stimulated	B-X
cells	B-X
.	B-X
Treatment	B-X
of	B-X
cells	B-X
with	B-X
the	B-X
nuclear	B-X
export	B-X
inhibitor	B-X
leptomycin	B-X
B	B-X
revealed	B-X
that	B-X
the	B-X
S17E	B-X
mutant	B-X
accumulates	B-X
in	B-X
the	B-X
nucleus	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
S6K1	B-X
II	B-X
wild	B-X
type	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
nuclear	B-X
import	B-X
of	B-X
the	B-X
S17E	B-X
mutant	B-X
is	B-X
not	B-X
affected	B-X
,	B-X
although	B-X
the	B-X
export	B-X
is	B-X
significantly	B-X
enhanced	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
nuclear	B-X
export	B-X
of	B-X
S6K1	B-X
is	B-X
mediated	B-X
by	B-X
a	B-X
CRM1-dependent	B-X
mechanism	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
establishes	B-X
a	B-X
functional	B-X
link	B-X
between	B-X
S6K1	B-X
II	B-X
and	B-X
CK2	B-X
signaling	B-X
,	B-X
which	B-X
involves	B-X
the	B-X
regulation	B-X
of	B-X
S6K1	B-X
II	B-X
nuclear	B-X
export	B-X
by	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Ser-17	B-X
.	B-X

Invariant	O
Leu	O
preceding	O
turn	O
motif	O
phosphorylation	O
site	O
controls	O
the	O
interaction	O
of	O
protein	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
C	I-Gene_or_gene_product
with	O
Hsp70	B-Gene_or_gene_product
.	O
<EOS>	B-X
Heat	B-X
shock	B-X
proteins	B-X
play	B-X
important	B-X
roles	B-X
in	B-X
regulating	B-X
signal	B-X
transduction	B-X
in	B-X
cells	B-X
by	B-X
associating	B-X
with	B-X
,	B-X
and	B-X
stabilizing	B-X
,	B-X
diverse	B-X
signaling	B-X
molecules	B-X
,	B-X
including	B-X
protein	B-X
kinases	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
heat	B-X
shock	B-X
protein	B-X
Hsp70	B-X
associates	B-X
with	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
via	B-X
an	B-X
interaction	B-X
that	B-X
is	B-X
triggered	B-X
by	B-X
dephosphorylation	B-X
at	B-X
the	B-X
turn	B-X
phosphorylation	B-X
motif	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
identified	B-X
an	B-X
invariant	B-X
residue	B-X
in	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
PKC	B-X
that	B-X
mediates	B-X
the	B-X
binding	B-X
to	B-X
Hsp70	B-X
.	B-X
Specifically	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Hsp70	B-X
binds	B-X
to	B-X
Leu	B-X
(	B-X
Leu-640	B-X
)	B-X
immediately	B-X
preceding	B-X
the	B-X
conserved	B-X
turn	B-X
motif	B-X
autophosphorylation	B-X
site	B-X
(	B-X
Thr-641	B-X
)	B-X
in	B-X
PKC	B-X
betaII	B-X
.	B-X
Co-immunoprecipitation	B-X
experiments	B-X
reveal	B-X
that	B-X
mutation	B-X
of	B-X
Leu-640	B-X
to	B-X
Gly	B-X
decreases	B-X
the	B-X
interaction	B-X
of	B-X
Hsp70	B-X
with	B-X
PKC	B-X
betaII	B-X
.	B-X
This	B-X
weakened	B-X
interaction	B-X
between	B-X
Hsp70	B-X
and	B-X
the	B-X
mutant	B-X
PKCs	B-X
results	B-X
in	B-X
accumulation	B-X
of	B-X
dephosphorylated	B-X
PKC	B-X
in	B-X
the	B-X
detergent-insoluble	B-X
fraction	B-X
of	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
Hsp70-binding	B-X
mutant	B-X
is	B-X
considerably	B-X
more	B-X
sensitive	B-X
to	B-X
down-regulation	B-X
compared	B-X
with	B-X
WT	B-X
PKC	B-X
:	B-X
disruption	B-X
of	B-X
Hsp70	B-X
binding	B-X
leads	B-X
to	B-X
accelerated	B-X
dephosphorylation	B-X
and	B-X
enhanced	B-X
ubiquitination	B-X
of	B-X
mutant	B-X
PKC	B-X
upon	B-X
phorbol	B-X
ester	B-X
treatment	B-X
.	B-X
Last	B-X
,	B-X
pulse-chase	B-X
experiments	B-X
demonstrate	B-X
that	B-X
Hsp70	B-X
preferentially	B-X
binds	B-X
the	B-X
species	B-X
of	B-X
mature	B-X
PKC	B-X
that	B-X
has	B-X
become	B-X
dephosphorylated	B-X
compared	B-X
with	B-X
the	B-X
newly	B-X
synthesized	B-X
protein	B-X
that	B-X
has	B-X
yet	B-X
to	B-X
be	B-X
phosphorylated	B-X
.	B-X
Thus	B-X
,	B-X
Hsp70	B-X
binds	B-X
a	B-X
hydrophobic	B-X
residue	B-X
preceding	B-X
the	B-X
turn	B-X
motif	B-X
,	B-X
protecting	B-X
PKC	B-X
from	B-X
down-regulation	B-X
and	B-X
sustaining	B-X
the	B-X
signaling	B-X
lifetime	B-X
of	B-X
the	B-X
kinase	B-X
.	B-X

Heat	O
shock	O
proteins	O
play	O
important	O
roles	O
in	O
regulating	O
signal	O
transduction	O
in	O
cells	O
by	O
associating	O
with	O
,	O
and	O
stabilizing	O
,	O
diverse	O
signaling	O
molecules	O
,	O
including	O
protein	O
kinases	O
.	O
<EOS>	B-X
Heat	B-X
shock	B-X
proteins	B-X
play	B-X
important	B-X
roles	B-X
in	B-X
regulating	B-X
signal	B-X
transduction	B-X
in	B-X
cells	B-X
by	B-X
associating	B-X
with	B-X
,	B-X
and	B-X
stabilizing	B-X
,	B-X
diverse	B-X
signaling	B-X
molecules	B-X
,	B-X
including	B-X
protein	B-X
kinases	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
heat	B-X
shock	B-X
protein	B-X
Hsp70	B-X
associates	B-X
with	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
via	B-X
an	B-X
interaction	B-X
that	B-X
is	B-X
triggered	B-X
by	B-X
dephosphorylation	B-X
at	B-X
the	B-X
turn	B-X
phosphorylation	B-X
motif	B-X
.	B-X
This	B-X
weakened	B-X
interaction	B-X
between	B-X
Hsp70	B-X
and	B-X
the	B-X
mutant	B-X
PKCs	B-X
results	B-X
in	B-X
accumulation	B-X
of	B-X
dephosphorylated	B-X
PKC	B-X
in	B-X
the	B-X
detergent-insoluble	B-X
fraction	B-X
of	B-X
cells	B-X
.	B-X
Last	B-X
,	B-X
pulse-chase	B-X
experiments	B-X
demonstrate	B-X
that	B-X
Hsp70	B-X
preferentially	B-X
binds	B-X
the	B-X
species	B-X
of	B-X
mature	B-X
PKC	B-X
that	B-X
has	B-X
become	B-X
dephosphorylated	B-X
compared	B-X
with	B-X
the	B-X
newly	B-X
synthesized	B-X
protein	B-X
that	B-X
has	B-X
yet	B-X
to	B-X
be	B-X
phosphorylated	B-X
.	B-X
Thus	B-X
,	B-X
Hsp70	B-X
binds	B-X
a	B-X
hydrophobic	B-X
residue	B-X
preceding	B-X
the	B-X
turn	B-X
motif	B-X
,	B-X
protecting	B-X
PKC	B-X
from	B-X
down-regulation	B-X
and	B-X
sustaining	B-X
the	B-X
signaling	B-X
lifetime	B-X
of	B-X
the	B-X
kinase	B-X
.	B-X

Previously	O
,	O
we	O
have	O
shown	O
that	O
heat	O
shock	O
protein	O
Hsp70	B-Gene_or_gene_product
associates	O
with	O
protein	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
C	I-Gene_or_gene_product
(	O
PKC	B-Gene_or_gene_product
)	O
via	O
an	O
interaction	O
that	O
is	O
triggered	O
by	O
dephosphorylation	O
at	O
the	O
turn	O
phosphorylation	O
motif	O
.	O
<EOS>	B-X
Heat	B-X
shock	B-X
proteins	B-X
play	B-X
important	B-X
roles	B-X
in	B-X
regulating	B-X
signal	B-X
transduction	B-X
in	B-X
cells	B-X
by	B-X
associating	B-X
with	B-X
,	B-X
and	B-X
stabilizing	B-X
,	B-X
diverse	B-X
signaling	B-X
molecules	B-X
,	B-X
including	B-X
protein	B-X
kinases	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
heat	B-X
shock	B-X
protein	B-X
Hsp70	B-X
associates	B-X
with	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
via	B-X
an	B-X
interaction	B-X
that	B-X
is	B-X
triggered	B-X
by	B-X
dephosphorylation	B-X
at	B-X
the	B-X
turn	B-X
phosphorylation	B-X
motif	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
identified	B-X
an	B-X
invariant	B-X
residue	B-X
in	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
PKC	B-X
that	B-X
mediates	B-X
the	B-X
binding	B-X
to	B-X
Hsp70	B-X
.	B-X
Specifically	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Hsp70	B-X
binds	B-X
to	B-X
Leu	B-X
(	B-X
Leu-640	B-X
)	B-X
immediately	B-X
preceding	B-X
the	B-X
conserved	B-X
turn	B-X
motif	B-X
autophosphorylation	B-X
site	B-X
(	B-X
Thr-641	B-X
)	B-X
in	B-X
PKC	B-X
betaII	B-X
.	B-X
Co-immunoprecipitation	B-X
experiments	B-X
reveal	B-X
that	B-X
mutation	B-X
of	B-X
Leu-640	B-X
to	B-X
Gly	B-X
decreases	B-X
the	B-X
interaction	B-X
of	B-X
Hsp70	B-X
with	B-X
PKC	B-X
betaII	B-X
.	B-X
This	B-X
weakened	B-X
interaction	B-X
between	B-X
Hsp70	B-X
and	B-X
the	B-X
mutant	B-X
PKCs	B-X
results	B-X
in	B-X
accumulation	B-X
of	B-X
dephosphorylated	B-X
PKC	B-X
in	B-X
the	B-X
detergent-insoluble	B-X
fraction	B-X
of	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
Hsp70-binding	B-X
mutant	B-X
is	B-X
considerably	B-X
more	B-X
sensitive	B-X
to	B-X
down-regulation	B-X
compared	B-X
with	B-X
WT	B-X
PKC	B-X
:	B-X
disruption	B-X
of	B-X
Hsp70	B-X
binding	B-X
leads	B-X
to	B-X
accelerated	B-X
dephosphorylation	B-X
and	B-X
enhanced	B-X
ubiquitination	B-X
of	B-X
mutant	B-X
PKC	B-X
upon	B-X
phorbol	B-X
ester	B-X
treatment	B-X
.	B-X
Last	B-X
,	B-X
pulse-chase	B-X
experiments	B-X
demonstrate	B-X
that	B-X
Hsp70	B-X
preferentially	B-X
binds	B-X
the	B-X
species	B-X
of	B-X
mature	B-X
PKC	B-X
that	B-X
has	B-X
become	B-X
dephosphorylated	B-X
compared	B-X
with	B-X
the	B-X
newly	B-X
synthesized	B-X
protein	B-X
that	B-X
has	B-X
yet	B-X
to	B-X
be	B-X
phosphorylated	B-X
.	B-X
Thus	B-X
,	B-X
Hsp70	B-X
binds	B-X
a	B-X
hydrophobic	B-X
residue	B-X
preceding	B-X
the	B-X
turn	B-X
motif	B-X
,	B-X
protecting	B-X
PKC	B-X
from	B-X
down-regulation	B-X
and	B-X
sustaining	B-X
the	B-X
signaling	B-X
lifetime	B-X
of	B-X
the	B-X
kinase	B-X
.	B-X

Here	O
we	O
have	O
identified	O
an	O
invariant	O
residue	O
in	O
the	O
carboxyl	O
terminus	O
of	O
PKC	B-Gene_or_gene_product
that	O
mediates	O
the	O
binding	O
to	O
Hsp70	B-Gene_or_gene_product
.	O
<EOS>	B-X
Previously	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
heat	B-X
shock	B-X
protein	B-X
Hsp70	B-X
associates	B-X
with	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
via	B-X
an	B-X
interaction	B-X
that	B-X
is	B-X
triggered	B-X
by	B-X
dephosphorylation	B-X
at	B-X
the	B-X
turn	B-X
phosphorylation	B-X
motif	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
identified	B-X
an	B-X
invariant	B-X
residue	B-X
in	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
PKC	B-X
that	B-X
mediates	B-X
the	B-X
binding	B-X
to	B-X
Hsp70	B-X
.	B-X
Specifically	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Hsp70	B-X
binds	B-X
to	B-X
Leu	B-X
(	B-X
Leu-640	B-X
)	B-X
immediately	B-X
preceding	B-X
the	B-X
conserved	B-X
turn	B-X
motif	B-X
autophosphorylation	B-X
site	B-X
(	B-X
Thr-641	B-X
)	B-X
in	B-X
PKC	B-X
betaII	B-X
.	B-X
Co-immunoprecipitation	B-X
experiments	B-X
reveal	B-X
that	B-X
mutation	B-X
of	B-X
Leu-640	B-X
to	B-X
Gly	B-X
decreases	B-X
the	B-X
interaction	B-X
of	B-X
Hsp70	B-X
with	B-X
PKC	B-X
betaII	B-X
.	B-X
This	B-X
weakened	B-X
interaction	B-X
between	B-X
Hsp70	B-X
and	B-X
the	B-X
mutant	B-X
PKCs	B-X
results	B-X
in	B-X
accumulation	B-X
of	B-X
dephosphorylated	B-X
PKC	B-X
in	B-X
the	B-X
detergent-insoluble	B-X
fraction	B-X
of	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
Hsp70-binding	B-X
mutant	B-X
is	B-X
considerably	B-X
more	B-X
sensitive	B-X
to	B-X
down-regulation	B-X
compared	B-X
with	B-X
WT	B-X
PKC	B-X
:	B-X
disruption	B-X
of	B-X
Hsp70	B-X
binding	B-X
leads	B-X
to	B-X
accelerated	B-X
dephosphorylation	B-X
and	B-X
enhanced	B-X
ubiquitination	B-X
of	B-X
mutant	B-X
PKC	B-X
upon	B-X
phorbol	B-X
ester	B-X
treatment	B-X
.	B-X
Last	B-X
,	B-X
pulse-chase	B-X
experiments	B-X
demonstrate	B-X
that	B-X
Hsp70	B-X
preferentially	B-X
binds	B-X
the	B-X
species	B-X
of	B-X
mature	B-X
PKC	B-X
that	B-X
has	B-X
become	B-X
dephosphorylated	B-X
compared	B-X
with	B-X
the	B-X
newly	B-X
synthesized	B-X
protein	B-X
that	B-X
has	B-X
yet	B-X
to	B-X
be	B-X
phosphorylated	B-X
.	B-X
Thus	B-X
,	B-X
Hsp70	B-X
binds	B-X
a	B-X
hydrophobic	B-X
residue	B-X
preceding	B-X
the	B-X
turn	B-X
motif	B-X
,	B-X
protecting	B-X
PKC	B-X
from	B-X
down-regulation	B-X
and	B-X
sustaining	B-X
the	B-X
signaling	B-X
lifetime	B-X
of	B-X
the	B-X
kinase	B-X
.	B-X

Specifically	O
,	O
we	O
show	O
that	O
Hsp70	B-Gene_or_gene_product
binds	O
to	O
Leu	O
(	O
Leu	O
-	O
640	O
)	O
immediately	O
preceding	O
the	O
conserved	O
turn	O
motif	O
autophosphorylation	O
site	O
(	O
Thr	O
-	O
641	O
)	O
in	O
PKC	B-Gene_or_gene_product
betaII	I-Gene_or_gene_product
.	O
<EOS>	B-X
Previously	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
heat	B-X
shock	B-X
protein	B-X
Hsp70	B-X
associates	B-X
with	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
via	B-X
an	B-X
interaction	B-X
that	B-X
is	B-X
triggered	B-X
by	B-X
dephosphorylation	B-X
at	B-X
the	B-X
turn	B-X
phosphorylation	B-X
motif	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
identified	B-X
an	B-X
invariant	B-X
residue	B-X
in	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
PKC	B-X
that	B-X
mediates	B-X
the	B-X
binding	B-X
to	B-X
Hsp70	B-X
.	B-X
Specifically	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Hsp70	B-X
binds	B-X
to	B-X
Leu	B-X
(	B-X
Leu-640	B-X
)	B-X
immediately	B-X
preceding	B-X
the	B-X
conserved	B-X
turn	B-X
motif	B-X
autophosphorylation	B-X
site	B-X
(	B-X
Thr-641	B-X
)	B-X
in	B-X
PKC	B-X
betaII	B-X
.	B-X
Co-immunoprecipitation	B-X
experiments	B-X
reveal	B-X
that	B-X
mutation	B-X
of	B-X
Leu-640	B-X
to	B-X
Gly	B-X
decreases	B-X
the	B-X
interaction	B-X
of	B-X
Hsp70	B-X
with	B-X
PKC	B-X
betaII	B-X
.	B-X
This	B-X
weakened	B-X
interaction	B-X
between	B-X
Hsp70	B-X
and	B-X
the	B-X
mutant	B-X
PKCs	B-X
results	B-X
in	B-X
accumulation	B-X
of	B-X
dephosphorylated	B-X
PKC	B-X
in	B-X
the	B-X
detergent-insoluble	B-X
fraction	B-X
of	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
Hsp70-binding	B-X
mutant	B-X
is	B-X
considerably	B-X
more	B-X
sensitive	B-X
to	B-X
down-regulation	B-X
compared	B-X
with	B-X
WT	B-X
PKC	B-X
:	B-X
disruption	B-X
of	B-X
Hsp70	B-X
binding	B-X
leads	B-X
to	B-X
accelerated	B-X
dephosphorylation	B-X
and	B-X
enhanced	B-X
ubiquitination	B-X
of	B-X
mutant	B-X
PKC	B-X
upon	B-X
phorbol	B-X
ester	B-X
treatment	B-X
.	B-X
Last	B-X
,	B-X
pulse-chase	B-X
experiments	B-X
demonstrate	B-X
that	B-X
Hsp70	B-X
preferentially	B-X
binds	B-X
the	B-X
species	B-X
of	B-X
mature	B-X
PKC	B-X
that	B-X
has	B-X
become	B-X
dephosphorylated	B-X
compared	B-X
with	B-X
the	B-X
newly	B-X
synthesized	B-X
protein	B-X
that	B-X
has	B-X
yet	B-X
to	B-X
be	B-X
phosphorylated	B-X
.	B-X
Thus	B-X
,	B-X
Hsp70	B-X
binds	B-X
a	B-X
hydrophobic	B-X
residue	B-X
preceding	B-X
the	B-X
turn	B-X
motif	B-X
,	B-X
protecting	B-X
PKC	B-X
from	B-X
down-regulation	B-X
and	B-X
sustaining	B-X
the	B-X
signaling	B-X
lifetime	B-X
of	B-X
the	B-X
kinase	B-X
.	B-X

Co	O
-	O
immunoprecipitation	O
experiments	O
reveal	O
that	O
mutation	O
of	O
Leu	O
-	O
640	O
to	O
Gly	O
decreases	O
the	O
interaction	O
of	O
Hsp70	B-Gene_or_gene_product
with	O
PKC	B-Gene_or_gene_product
betaII	I-Gene_or_gene_product
.	O
<EOS>	B-X
Previously	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
heat	B-X
shock	B-X
protein	B-X
Hsp70	B-X
associates	B-X
with	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
via	B-X
an	B-X
interaction	B-X
that	B-X
is	B-X
triggered	B-X
by	B-X
dephosphorylation	B-X
at	B-X
the	B-X
turn	B-X
phosphorylation	B-X
motif	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
identified	B-X
an	B-X
invariant	B-X
residue	B-X
in	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
PKC	B-X
that	B-X
mediates	B-X
the	B-X
binding	B-X
to	B-X
Hsp70	B-X
.	B-X
Specifically	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Hsp70	B-X
binds	B-X
to	B-X
Leu	B-X
(	B-X
Leu-640	B-X
)	B-X
immediately	B-X
preceding	B-X
the	B-X
conserved	B-X
turn	B-X
motif	B-X
autophosphorylation	B-X
site	B-X
(	B-X
Thr-641	B-X
)	B-X
in	B-X
PKC	B-X
betaII	B-X
.	B-X
Co-immunoprecipitation	B-X
experiments	B-X
reveal	B-X
that	B-X
mutation	B-X
of	B-X
Leu-640	B-X
to	B-X
Gly	B-X
decreases	B-X
the	B-X
interaction	B-X
of	B-X
Hsp70	B-X
with	B-X
PKC	B-X
betaII	B-X
.	B-X
This	B-X
weakened	B-X
interaction	B-X
between	B-X
Hsp70	B-X
and	B-X
the	B-X
mutant	B-X
PKCs	B-X
results	B-X
in	B-X
accumulation	B-X
of	B-X
dephosphorylated	B-X
PKC	B-X
in	B-X
the	B-X
detergent-insoluble	B-X
fraction	B-X
of	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
Hsp70-binding	B-X
mutant	B-X
is	B-X
considerably	B-X
more	B-X
sensitive	B-X
to	B-X
down-regulation	B-X
compared	B-X
with	B-X
WT	B-X
PKC	B-X
:	B-X
disruption	B-X
of	B-X
Hsp70	B-X
binding	B-X
leads	B-X
to	B-X
accelerated	B-X
dephosphorylation	B-X
and	B-X
enhanced	B-X
ubiquitination	B-X
of	B-X
mutant	B-X
PKC	B-X
upon	B-X
phorbol	B-X
ester	B-X
treatment	B-X
.	B-X
Last	B-X
,	B-X
pulse-chase	B-X
experiments	B-X
demonstrate	B-X
that	B-X
Hsp70	B-X
preferentially	B-X
binds	B-X
the	B-X
species	B-X
of	B-X
mature	B-X
PKC	B-X
that	B-X
has	B-X
become	B-X
dephosphorylated	B-X
compared	B-X
with	B-X
the	B-X
newly	B-X
synthesized	B-X
protein	B-X
that	B-X
has	B-X
yet	B-X
to	B-X
be	B-X
phosphorylated	B-X
.	B-X
Thus	B-X
,	B-X
Hsp70	B-X
binds	B-X
a	B-X
hydrophobic	B-X
residue	B-X
preceding	B-X
the	B-X
turn	B-X
motif	B-X
,	B-X
protecting	B-X
PKC	B-X
from	B-X
down-regulation	B-X
and	B-X
sustaining	B-X
the	B-X
signaling	B-X
lifetime	B-X
of	B-X
the	B-X
kinase	B-X
.	B-X

This	O
weakened	O
interaction	O
between	O
Hsp70	B-Gene_or_gene_product
and	O
the	O
mutant	O
PKCs	B-Gene_or_gene_product
results	O
in	O
accumulation	O
of	O
dephosphorylated	O
PKC	B-Gene_or_gene_product
in	O
the	O
detergent	O
-	O
insoluble	O
fraction	O
of	O
cells	O
.	O
<EOS>	B-X
Heat	B-X
shock	B-X
proteins	B-X
play	B-X
important	B-X
roles	B-X
in	B-X
regulating	B-X
signal	B-X
transduction	B-X
in	B-X
cells	B-X
by	B-X
associating	B-X
with	B-X
,	B-X
and	B-X
stabilizing	B-X
,	B-X
diverse	B-X
signaling	B-X
molecules	B-X
,	B-X
including	B-X
protein	B-X
kinases	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
heat	B-X
shock	B-X
protein	B-X
Hsp70	B-X
associates	B-X
with	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
via	B-X
an	B-X
interaction	B-X
that	B-X
is	B-X
triggered	B-X
by	B-X
dephosphorylation	B-X
at	B-X
the	B-X
turn	B-X
phosphorylation	B-X
motif	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
identified	B-X
an	B-X
invariant	B-X
residue	B-X
in	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
PKC	B-X
that	B-X
mediates	B-X
the	B-X
binding	B-X
to	B-X
Hsp70	B-X
.	B-X
Specifically	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Hsp70	B-X
binds	B-X
to	B-X
Leu	B-X
(	B-X
Leu-640	B-X
)	B-X
immediately	B-X
preceding	B-X
the	B-X
conserved	B-X
turn	B-X
motif	B-X
autophosphorylation	B-X
site	B-X
(	B-X
Thr-641	B-X
)	B-X
in	B-X
PKC	B-X
betaII	B-X
.	B-X
Co-immunoprecipitation	B-X
experiments	B-X
reveal	B-X
that	B-X
mutation	B-X
of	B-X
Leu-640	B-X
to	B-X
Gly	B-X
decreases	B-X
the	B-X
interaction	B-X
of	B-X
Hsp70	B-X
with	B-X
PKC	B-X
betaII	B-X
.	B-X
This	B-X
weakened	B-X
interaction	B-X
between	B-X
Hsp70	B-X
and	B-X
the	B-X
mutant	B-X
PKCs	B-X
results	B-X
in	B-X
accumulation	B-X
of	B-X
dephosphorylated	B-X
PKC	B-X
in	B-X
the	B-X
detergent-insoluble	B-X
fraction	B-X
of	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
Hsp70-binding	B-X
mutant	B-X
is	B-X
considerably	B-X
more	B-X
sensitive	B-X
to	B-X
down-regulation	B-X
compared	B-X
with	B-X
WT	B-X
PKC	B-X
:	B-X
disruption	B-X
of	B-X
Hsp70	B-X
binding	B-X
leads	B-X
to	B-X
accelerated	B-X
dephosphorylation	B-X
and	B-X
enhanced	B-X
ubiquitination	B-X
of	B-X
mutant	B-X
PKC	B-X
upon	B-X
phorbol	B-X
ester	B-X
treatment	B-X
.	B-X
Last	B-X
,	B-X
pulse-chase	B-X
experiments	B-X
demonstrate	B-X
that	B-X
Hsp70	B-X
preferentially	B-X
binds	B-X
the	B-X
species	B-X
of	B-X
mature	B-X
PKC	B-X
that	B-X
has	B-X
become	B-X
dephosphorylated	B-X
compared	B-X
with	B-X
the	B-X
newly	B-X
synthesized	B-X
protein	B-X
that	B-X
has	B-X
yet	B-X
to	B-X
be	B-X
phosphorylated	B-X
.	B-X
Thus	B-X
,	B-X
Hsp70	B-X
binds	B-X
a	B-X
hydrophobic	B-X
residue	B-X
preceding	B-X
the	B-X
turn	B-X
motif	B-X
,	B-X
protecting	B-X
PKC	B-X
from	B-X
down-regulation	B-X
and	B-X
sustaining	B-X
the	B-X
signaling	B-X
lifetime	B-X
of	B-X
the	B-X
kinase	B-X
.	B-X

In	O
addition	O
,	O
the	O
Hsp70	B-Gene_or_gene_product
-	O
binding	O
mutant	O
is	O
considerably	O
more	O
sensitive	O
to	O
down	O
-	O
regulation	O
compared	O
with	O
WT	O
PKC	B-Gene_or_gene_product
:	O
disruption	O
of	O
Hsp70	B-Gene_or_gene_product
binding	O
leads	O
to	O
accelerated	O
dephosphorylation	O
and	O
enhanced	O
ubiquitination	O
of	O
mutant	O
PKC	B-Gene_or_gene_product
upon	O
phorbol	O
ester	O
treatment	O
.	O
<EOS>	B-X
Previously	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
heat	B-X
shock	B-X
protein	B-X
Hsp70	B-X
associates	B-X
with	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
via	B-X
an	B-X
interaction	B-X
that	B-X
is	B-X
triggered	B-X
by	B-X
dephosphorylation	B-X
at	B-X
the	B-X
turn	B-X
phosphorylation	B-X
motif	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
identified	B-X
an	B-X
invariant	B-X
residue	B-X
in	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
PKC	B-X
that	B-X
mediates	B-X
the	B-X
binding	B-X
to	B-X
Hsp70	B-X
.	B-X
Specifically	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Hsp70	B-X
binds	B-X
to	B-X
Leu	B-X
(	B-X
Leu-640	B-X
)	B-X
immediately	B-X
preceding	B-X
the	B-X
conserved	B-X
turn	B-X
motif	B-X
autophosphorylation	B-X
site	B-X
(	B-X
Thr-641	B-X
)	B-X
in	B-X
PKC	B-X
betaII	B-X
.	B-X
Co-immunoprecipitation	B-X
experiments	B-X
reveal	B-X
that	B-X
mutation	B-X
of	B-X
Leu-640	B-X
to	B-X
Gly	B-X
decreases	B-X
the	B-X
interaction	B-X
of	B-X
Hsp70	B-X
with	B-X
PKC	B-X
betaII	B-X
.	B-X
This	B-X
weakened	B-X
interaction	B-X
between	B-X
Hsp70	B-X
and	B-X
the	B-X
mutant	B-X
PKCs	B-X
results	B-X
in	B-X
accumulation	B-X
of	B-X
dephosphorylated	B-X
PKC	B-X
in	B-X
the	B-X
detergent-insoluble	B-X
fraction	B-X
of	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
Hsp70-binding	B-X
mutant	B-X
is	B-X
considerably	B-X
more	B-X
sensitive	B-X
to	B-X
down-regulation	B-X
compared	B-X
with	B-X
WT	B-X
PKC	B-X
:	B-X
disruption	B-X
of	B-X
Hsp70	B-X
binding	B-X
leads	B-X
to	B-X
accelerated	B-X
dephosphorylation	B-X
and	B-X
enhanced	B-X
ubiquitination	B-X
of	B-X
mutant	B-X
PKC	B-X
upon	B-X
phorbol	B-X
ester	B-X
treatment	B-X
.	B-X
Last	B-X
,	B-X
pulse-chase	B-X
experiments	B-X
demonstrate	B-X
that	B-X
Hsp70	B-X
preferentially	B-X
binds	B-X
the	B-X
species	B-X
of	B-X
mature	B-X
PKC	B-X
that	B-X
has	B-X
become	B-X
dephosphorylated	B-X
compared	B-X
with	B-X
the	B-X
newly	B-X
synthesized	B-X
protein	B-X
that	B-X
has	B-X
yet	B-X
to	B-X
be	B-X
phosphorylated	B-X
.	B-X
Thus	B-X
,	B-X
Hsp70	B-X
binds	B-X
a	B-X
hydrophobic	B-X
residue	B-X
preceding	B-X
the	B-X
turn	B-X
motif	B-X
,	B-X
protecting	B-X
PKC	B-X
from	B-X
down-regulation	B-X
and	B-X
sustaining	B-X
the	B-X
signaling	B-X
lifetime	B-X
of	B-X
the	B-X
kinase	B-X
.	B-X

Last	O
,	O
pulse	O
-	O
chase	O
experiments	O
demonstrate	O
that	O
Hsp70	B-Gene_or_gene_product
preferentially	O
binds	O
the	O
species	O
of	O
mature	O
PKC	B-Gene_or_gene_product
that	O
has	O
become	O
dephosphorylated	O
compared	O
with	O
the	O
newly	O
synthesized	O
protein	O
that	O
has	O
yet	O
to	O
be	O
phosphorylated	O
.	O
<EOS>	B-X
Heat	B-X
shock	B-X
proteins	B-X
play	B-X
important	B-X
roles	B-X
in	B-X
regulating	B-X
signal	B-X
transduction	B-X
in	B-X
cells	B-X
by	B-X
associating	B-X
with	B-X
,	B-X
and	B-X
stabilizing	B-X
,	B-X
diverse	B-X
signaling	B-X
molecules	B-X
,	B-X
including	B-X
protein	B-X
kinases	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
heat	B-X
shock	B-X
protein	B-X
Hsp70	B-X
associates	B-X
with	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
via	B-X
an	B-X
interaction	B-X
that	B-X
is	B-X
triggered	B-X
by	B-X
dephosphorylation	B-X
at	B-X
the	B-X
turn	B-X
phosphorylation	B-X
motif	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
identified	B-X
an	B-X
invariant	B-X
residue	B-X
in	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
PKC	B-X
that	B-X
mediates	B-X
the	B-X
binding	B-X
to	B-X
Hsp70	B-X
.	B-X
Specifically	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Hsp70	B-X
binds	B-X
to	B-X
Leu	B-X
(	B-X
Leu-640	B-X
)	B-X
immediately	B-X
preceding	B-X
the	B-X
conserved	B-X
turn	B-X
motif	B-X
autophosphorylation	B-X
site	B-X
(	B-X
Thr-641	B-X
)	B-X
in	B-X
PKC	B-X
betaII	B-X
.	B-X
Co-immunoprecipitation	B-X
experiments	B-X
reveal	B-X
that	B-X
mutation	B-X
of	B-X
Leu-640	B-X
to	B-X
Gly	B-X
decreases	B-X
the	B-X
interaction	B-X
of	B-X
Hsp70	B-X
with	B-X
PKC	B-X
betaII	B-X
.	B-X
This	B-X
weakened	B-X
interaction	B-X
between	B-X
Hsp70	B-X
and	B-X
the	B-X
mutant	B-X
PKCs	B-X
results	B-X
in	B-X
accumulation	B-X
of	B-X
dephosphorylated	B-X
PKC	B-X
in	B-X
the	B-X
detergent-insoluble	B-X
fraction	B-X
of	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
Hsp70-binding	B-X
mutant	B-X
is	B-X
considerably	B-X
more	B-X
sensitive	B-X
to	B-X
down-regulation	B-X
compared	B-X
with	B-X
WT	B-X
PKC	B-X
:	B-X
disruption	B-X
of	B-X
Hsp70	B-X
binding	B-X
leads	B-X
to	B-X
accelerated	B-X
dephosphorylation	B-X
and	B-X
enhanced	B-X
ubiquitination	B-X
of	B-X
mutant	B-X
PKC	B-X
upon	B-X
phorbol	B-X
ester	B-X
treatment	B-X
.	B-X
Last	B-X
,	B-X
pulse-chase	B-X
experiments	B-X
demonstrate	B-X
that	B-X
Hsp70	B-X
preferentially	B-X
binds	B-X
the	B-X
species	B-X
of	B-X
mature	B-X
PKC	B-X
that	B-X
has	B-X
become	B-X
dephosphorylated	B-X
compared	B-X
with	B-X
the	B-X
newly	B-X
synthesized	B-X
protein	B-X
that	B-X
has	B-X
yet	B-X
to	B-X
be	B-X
phosphorylated	B-X
.	B-X
Thus	B-X
,	B-X
Hsp70	B-X
binds	B-X
a	B-X
hydrophobic	B-X
residue	B-X
preceding	B-X
the	B-X
turn	B-X
motif	B-X
,	B-X
protecting	B-X
PKC	B-X
from	B-X
down-regulation	B-X
and	B-X
sustaining	B-X
the	B-X
signaling	B-X
lifetime	B-X
of	B-X
the	B-X
kinase	B-X
.	B-X

Thus	O
,	O
Hsp70	B-Gene_or_gene_product
binds	O
a	O
hydrophobic	O
residue	O
preceding	O
the	O
turn	O
motif	O
,	O
protecting	O
PKC	B-Gene_or_gene_product
from	O
down	O
-	O
regulation	O
and	O
sustaining	O
the	O
signaling	O
lifetime	O
of	O
the	O
kinase	O
.	O
<EOS>	B-X
Heat	B-X
shock	B-X
proteins	B-X
play	B-X
important	B-X
roles	B-X
in	B-X
regulating	B-X
signal	B-X
transduction	B-X
in	B-X
cells	B-X
by	B-X
associating	B-X
with	B-X
,	B-X
and	B-X
stabilizing	B-X
,	B-X
diverse	B-X
signaling	B-X
molecules	B-X
,	B-X
including	B-X
protein	B-X
kinases	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
heat	B-X
shock	B-X
protein	B-X
Hsp70	B-X
associates	B-X
with	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
via	B-X
an	B-X
interaction	B-X
that	B-X
is	B-X
triggered	B-X
by	B-X
dephosphorylation	B-X
at	B-X
the	B-X
turn	B-X
phosphorylation	B-X
motif	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
identified	B-X
an	B-X
invariant	B-X
residue	B-X
in	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
PKC	B-X
that	B-X
mediates	B-X
the	B-X
binding	B-X
to	B-X
Hsp70	B-X
.	B-X
Specifically	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Hsp70	B-X
binds	B-X
to	B-X
Leu	B-X
(	B-X
Leu-640	B-X
)	B-X
immediately	B-X
preceding	B-X
the	B-X
conserved	B-X
turn	B-X
motif	B-X
autophosphorylation	B-X
site	B-X
(	B-X
Thr-641	B-X
)	B-X
in	B-X
PKC	B-X
betaII	B-X
.	B-X
Co-immunoprecipitation	B-X
experiments	B-X
reveal	B-X
that	B-X
mutation	B-X
of	B-X
Leu-640	B-X
to	B-X
Gly	B-X
decreases	B-X
the	B-X
interaction	B-X
of	B-X
Hsp70	B-X
with	B-X
PKC	B-X
betaII	B-X
.	B-X
This	B-X
weakened	B-X
interaction	B-X
between	B-X
Hsp70	B-X
and	B-X
the	B-X
mutant	B-X
PKCs	B-X
results	B-X
in	B-X
accumulation	B-X
of	B-X
dephosphorylated	B-X
PKC	B-X
in	B-X
the	B-X
detergent-insoluble	B-X
fraction	B-X
of	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
Hsp70-binding	B-X
mutant	B-X
is	B-X
considerably	B-X
more	B-X
sensitive	B-X
to	B-X
down-regulation	B-X
compared	B-X
with	B-X
WT	B-X
PKC	B-X
:	B-X
disruption	B-X
of	B-X
Hsp70	B-X
binding	B-X
leads	B-X
to	B-X
accelerated	B-X
dephosphorylation	B-X
and	B-X
enhanced	B-X
ubiquitination	B-X
of	B-X
mutant	B-X
PKC	B-X
upon	B-X
phorbol	B-X
ester	B-X
treatment	B-X
.	B-X
Last	B-X
,	B-X
pulse-chase	B-X
experiments	B-X
demonstrate	B-X
that	B-X
Hsp70	B-X
preferentially	B-X
binds	B-X
the	B-X
species	B-X
of	B-X
mature	B-X
PKC	B-X
that	B-X
has	B-X
become	B-X
dephosphorylated	B-X
compared	B-X
with	B-X
the	B-X
newly	B-X
synthesized	B-X
protein	B-X
that	B-X
has	B-X
yet	B-X
to	B-X
be	B-X
phosphorylated	B-X
.	B-X
Thus	B-X
,	B-X
Hsp70	B-X
binds	B-X
a	B-X
hydrophobic	B-X
residue	B-X
preceding	B-X
the	B-X
turn	B-X
motif	B-X
,	B-X
protecting	B-X
PKC	B-X
from	B-X
down-regulation	B-X
and	B-X
sustaining	B-X
the	B-X
signaling	B-X
lifetime	B-X
of	B-X
the	B-X
kinase	B-X
.	B-X

Acm1	B-Gene_or_gene_product
is	O
a	O
negative	O
regulator	O
of	O
the	O
CDH1	B-Gene_or_gene_product
-	O
dependent	O
anaphase	O
-	O
promoting	O
complex	O
/	O
cyclosome	O
in	O
budding	O
yeast	O
.	O
<EOS>	B-X
Cdh1	B-X
is	B-X
a	B-X
coactivator	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex/cyclosome	B-X
(	B-X
APC/C	B-X
)	B-X
and	B-X
contributes	B-X
to	B-X
mitotic	B-X
exit	B-X
and	B-X
G1	B-X
maintenance	B-X
by	B-X
facilitating	B-X
the	B-X
polyubiquitination	B-X
and	B-X
subsequent	B-X
proteolysis	B-X
of	B-X
specific	B-X
substrates	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
that	B-X
budding	B-X
yeast	B-X
Cdh1	B-X
is	B-X
a	B-X
component	B-X
of	B-X
a	B-X
cell	B-X
cycle-regulated	B-X
complex	B-X
that	B-X
includes	B-X
the	B-X
14-3-3	B-X
homologs	B-X
Bmh1	B-X
and	B-X
Bmh2	B-X
and	B-X
a	B-X
previously	B-X
uncharacterized	B-X
protein	B-X
,	B-X
which	B-X
we	B-X
name	B-X
Acm1	B-X
(	B-X
APC/CCdh1	B-X
modulator	B-X
1	B-X
)	B-X
.	B-X
Association	B-X
of	B-X
Cdh1	B-X
with	B-X
Bmh1	B-X
and	B-X
Bmh2	B-X
requires	B-X
Acm1	B-X
,	B-X
and	B-X
the	B-X
Acm1	B-X
protein	B-X
is	B-X
cell	B-X
cycle	B-X
regulated	B-X
,	B-X
appearing	B-X
late	B-X
in	B-X
G1	B-X
and	B-X
disappearing	B-X
in	B-X
late	B-X
M.	B-X
In	B-X
acm1Delta	B-X
strains	B-X
,	B-X
Cdh1	B-X
localization	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
and	B-X
association	B-X
with	B-X
two	B-X
substrates	B-X
,	B-X
Clb2	B-X
and	B-X
Hsl1	B-X
,	B-X
were	B-X
strongly	B-X
enhanced	B-X
.	B-X
Several	B-X
lines	B-X
of	B-X
evidence	B-X
suggest	B-X
that	B-X
Acm1	B-X
can	B-X
suppress	B-X
APC/CCdh1-mediated	B-X
proteolysis	B-X
of	B-X
mitotic	B-X
cyclins	B-X
.	B-X
First	B-X
,	B-X
overexpression	B-X
of	B-X
Acm1	B-X
fully	B-X
restored	B-X
viability	B-X
to	B-X
cells	B-X
expressing	B-X
toxic	B-X
levels	B-X
of	B-X
Cdh1	B-X
or	B-X
a	B-X
constitutively	B-X
active	B-X
Cdh1	B-X
mutant	B-X
lacking	B-X
inhibitory	B-X
phosphorylation	B-X
sites	B-X
.	B-X
Second	B-X
,	B-X
overexpression	B-X
of	B-X
Acm1	B-X
was	B-X
toxic	B-X
in	B-X
sic1Delta	B-X
cells	B-X
.	B-X
This	B-X
bud	B-X
elongation	B-X
was	B-X
independent	B-X
of	B-X
the	B-X
morphogenesis	B-X
checkpoint	B-X
,	B-X
and	B-X
the	B-X
combination	B-X
of	B-X
acm1Delta	B-X
and	B-X
hsl1Delta	B-X
resulted	B-X
in	B-X
a	B-X
dramatic	B-X
enhancement	B-X
of	B-X
bud	B-X
elongation	B-X
and	B-X
G2/M	B-X
delay	B-X
.	B-X
Effects	B-X
on	B-X
bud	B-X
elongation	B-X
were	B-X
attenuated	B-X
when	B-X
Cdh1	B-X
was	B-X
replaced	B-X
with	B-X
a	B-X
mutant	B-X
lacking	B-X
the	B-X
C-terminal	B-X
IR	B-X
dipeptide	B-X
,	B-X
suggesting	B-X
that	B-X
APC/C-dependent	B-X
proteolysis	B-X
is	B-X
required	B-X
for	B-X
this	B-X
phenotype	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Acm1	B-X
and	B-X
Bmh1/Bmh2	B-X
constitute	B-X
a	B-X
specialized	B-X
inhibitor	B-X
of	B-X
APC/CCdh1	B-X
.	B-X

Cdh1	B-Gene_or_gene_product
is	O
a	O
coactivator	O
of	O
the	O
anaphase	O
-	O
promoting	O
complex	O
/	O
cyclosome	O
(	O
APC	O
/	O
C	O
)	O
and	O
contributes	O
to	O
mitotic	O
exit	O
and	O
G1	O
maintenance	O
by	O
facilitating	O
the	O
polyubiquitination	O
and	O
subsequent	O
proteolysis	O
of	O
specific	O
substrates	O
.	O

Here	O
,	O
we	O
report	O
that	O
budding	O
yeast	O
Cdh1	B-Gene_or_gene_product
is	O
a	O
component	O
of	O
a	O
cell	O
cycle	O
-	O
regulated	O
complex	O
that	O
includes	O
the	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
homologs	O
Bmh1	B-Gene_or_gene_product
and	O
Bmh2	B-Gene_or_gene_product
and	O
a	O
previously	O
uncharacterized	O
protein	O
,	O
which	O
we	O
name	O
Acm1	B-Gene_or_gene_product
(	O
APC	B-Gene_or_gene_product
/	I-Gene_or_gene_product
CCdh1	I-Gene_or_gene_product
modulator	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
.	O

Association	O
of	O
Cdh1	B-Gene_or_gene_product
with	O
Bmh1	B-Gene_or_gene_product
and	O
Bmh2	B-Gene_or_gene_product
requires	O
Acm1	B-Gene_or_gene_product
,	O
and	O
the	O
Acm1	B-Gene_or_gene_product
protein	O
is	O
cell	O
cycle	O
regulated	O
,	O
appearing	O
late	O
in	O
G1	O
and	O
disappearing	O
in	O
late	O
M	O
.	O

In	O
acm1Delta	B-Gene_or_gene_product
strains	O
,	O
Cdh1	B-Gene_or_gene_product
localization	O
to	O
the	O
bud	O
neck	O
and	O
association	O
with	O
two	O
substrates	O
,	O
Clb2	B-Gene_or_gene_product
and	O
Hsl1	B-Gene_or_gene_product
,	O
were	O
strongly	O
enhanced	O
.	O

Several	O
lines	O
of	O
evidence	O
suggest	O
that	O
Acm1	B-Gene_or_gene_product
can	O
suppress	O
APC	O
/	O
CCdh1	O
-	O
mediated	O
proteolysis	O
of	O
mitotic	O
cyclins	B-Gene_or_gene_product
.	O
<EOS>	B-X
Cdh1	B-X
is	B-X
a	B-X
coactivator	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex/cyclosome	B-X
(	B-X
APC/C	B-X
)	B-X
and	B-X
contributes	B-X
to	B-X
mitotic	B-X
exit	B-X
and	B-X
G1	B-X
maintenance	B-X
by	B-X
facilitating	B-X
the	B-X
polyubiquitination	B-X
and	B-X
subsequent	B-X
proteolysis	B-X
of	B-X
specific	B-X
substrates	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
that	B-X
budding	B-X
yeast	B-X
Cdh1	B-X
is	B-X
a	B-X
component	B-X
of	B-X
a	B-X
cell	B-X
cycle-regulated	B-X
complex	B-X
that	B-X
includes	B-X
the	B-X
14-3-3	B-X
homologs	B-X
Bmh1	B-X
and	B-X
Bmh2	B-X
and	B-X
a	B-X
previously	B-X
uncharacterized	B-X
protein	B-X
,	B-X
which	B-X
we	B-X
name	B-X
Acm1	B-X
(	B-X
APC/CCdh1	B-X
modulator	B-X
1	B-X
)	B-X
.	B-X
Association	B-X
of	B-X
Cdh1	B-X
with	B-X
Bmh1	B-X
and	B-X
Bmh2	B-X
requires	B-X
Acm1	B-X
,	B-X
and	B-X
the	B-X
Acm1	B-X
protein	B-X
is	B-X
cell	B-X
cycle	B-X
regulated	B-X
,	B-X
appearing	B-X
late	B-X
in	B-X
G1	B-X
and	B-X
disappearing	B-X
in	B-X
late	B-X
M.	B-X
In	B-X
acm1Delta	B-X
strains	B-X
,	B-X
Cdh1	B-X
localization	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
and	B-X
association	B-X
with	B-X
two	B-X
substrates	B-X
,	B-X
Clb2	B-X
and	B-X
Hsl1	B-X
,	B-X
were	B-X
strongly	B-X
enhanced	B-X
.	B-X
Several	B-X
lines	B-X
of	B-X
evidence	B-X
suggest	B-X
that	B-X
Acm1	B-X
can	B-X
suppress	B-X
APC/CCdh1-mediated	B-X
proteolysis	B-X
of	B-X
mitotic	B-X
cyclins	B-X
.	B-X
First	B-X
,	B-X
overexpression	B-X
of	B-X
Acm1	B-X
fully	B-X
restored	B-X
viability	B-X
to	B-X
cells	B-X
expressing	B-X
toxic	B-X
levels	B-X
of	B-X
Cdh1	B-X
or	B-X
a	B-X
constitutively	B-X
active	B-X
Cdh1	B-X
mutant	B-X
lacking	B-X
inhibitory	B-X
phosphorylation	B-X
sites	B-X
.	B-X
Second	B-X
,	B-X
overexpression	B-X
of	B-X
Acm1	B-X
was	B-X
toxic	B-X
in	B-X
sic1Delta	B-X
cells	B-X
.	B-X
Effects	B-X
on	B-X
bud	B-X
elongation	B-X
were	B-X
attenuated	B-X
when	B-X
Cdh1	B-X
was	B-X
replaced	B-X
with	B-X
a	B-X
mutant	B-X
lacking	B-X
the	B-X
C-terminal	B-X
IR	B-X
dipeptide	B-X
,	B-X
suggesting	B-X
that	B-X
APC/C-dependent	B-X
proteolysis	B-X
is	B-X
required	B-X
for	B-X
this	B-X
phenotype	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Acm1	B-X
and	B-X
Bmh1/Bmh2	B-X
constitute	B-X
a	B-X
specialized	B-X
inhibitor	B-X
of	B-X
APC/CCdh1	B-X
.	B-X

First	O
,	O
overexpression	O
of	O
Acm1	B-Gene_or_gene_product
fully	O
restored	O
viability	O
to	O
cells	O
expressing	O
toxic	O
levels	O
of	O
Cdh1	B-Gene_or_gene_product
or	O
a	O
constitutively	O
active	O
Cdh1	B-Gene_or_gene_product
mutant	O
lacking	O
inhibitory	O
phosphorylation	O
sites	O
.	O
<EOS>	B-X
Cdh1	B-X
is	B-X
a	B-X
coactivator	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex/cyclosome	B-X
(	B-X
APC/C	B-X
)	B-X
and	B-X
contributes	B-X
to	B-X
mitotic	B-X
exit	B-X
and	B-X
G1	B-X
maintenance	B-X
by	B-X
facilitating	B-X
the	B-X
polyubiquitination	B-X
and	B-X
subsequent	B-X
proteolysis	B-X
of	B-X
specific	B-X
substrates	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
that	B-X
budding	B-X
yeast	B-X
Cdh1	B-X
is	B-X
a	B-X
component	B-X
of	B-X
a	B-X
cell	B-X
cycle-regulated	B-X
complex	B-X
that	B-X
includes	B-X
the	B-X
14-3-3	B-X
homologs	B-X
Bmh1	B-X
and	B-X
Bmh2	B-X
and	B-X
a	B-X
previously	B-X
uncharacterized	B-X
protein	B-X
,	B-X
which	B-X
we	B-X
name	B-X
Acm1	B-X
(	B-X
APC/CCdh1	B-X
modulator	B-X
1	B-X
)	B-X
.	B-X
Association	B-X
of	B-X
Cdh1	B-X
with	B-X
Bmh1	B-X
and	B-X
Bmh2	B-X
requires	B-X
Acm1	B-X
,	B-X
and	B-X
the	B-X
Acm1	B-X
protein	B-X
is	B-X
cell	B-X
cycle	B-X
regulated	B-X
,	B-X
appearing	B-X
late	B-X
in	B-X
G1	B-X
and	B-X
disappearing	B-X
in	B-X
late	B-X
M.	B-X
In	B-X
acm1Delta	B-X
strains	B-X
,	B-X
Cdh1	B-X
localization	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
and	B-X
association	B-X
with	B-X
two	B-X
substrates	B-X
,	B-X
Clb2	B-X
and	B-X
Hsl1	B-X
,	B-X
were	B-X
strongly	B-X
enhanced	B-X
.	B-X
Several	B-X
lines	B-X
of	B-X
evidence	B-X
suggest	B-X
that	B-X
Acm1	B-X
can	B-X
suppress	B-X
APC/CCdh1-mediated	B-X
proteolysis	B-X
of	B-X
mitotic	B-X
cyclins	B-X
.	B-X
First	B-X
,	B-X
overexpression	B-X
of	B-X
Acm1	B-X
fully	B-X
restored	B-X
viability	B-X
to	B-X
cells	B-X
expressing	B-X
toxic	B-X
levels	B-X
of	B-X
Cdh1	B-X
or	B-X
a	B-X
constitutively	B-X
active	B-X
Cdh1	B-X
mutant	B-X
lacking	B-X
inhibitory	B-X
phosphorylation	B-X
sites	B-X
.	B-X
Second	B-X
,	B-X
overexpression	B-X
of	B-X
Acm1	B-X
was	B-X
toxic	B-X
in	B-X
sic1Delta	B-X
cells	B-X
.	B-X
Third	B-X
,	B-X
ACM1	B-X
deletion	B-X
exacerbated	B-X
a	B-X
low-penetrance	B-X
elongated-bud	B-X
phenotype	B-X
caused	B-X
by	B-X
modest	B-X
overexpression	B-X
of	B-X
Cdh1	B-X
.	B-X
Effects	B-X
on	B-X
bud	B-X
elongation	B-X
were	B-X
attenuated	B-X
when	B-X
Cdh1	B-X
was	B-X
replaced	B-X
with	B-X
a	B-X
mutant	B-X
lacking	B-X
the	B-X
C-terminal	B-X
IR	B-X
dipeptide	B-X
,	B-X
suggesting	B-X
that	B-X
APC/C-dependent	B-X
proteolysis	B-X
is	B-X
required	B-X
for	B-X
this	B-X
phenotype	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Acm1	B-X
and	B-X
Bmh1/Bmh2	B-X
constitute	B-X
a	B-X
specialized	B-X
inhibitor	B-X
of	B-X
APC/CCdh1	B-X
.	B-X

Second	O
,	O
overexpression	O
of	O
Acm1	B-Gene_or_gene_product
was	O
toxic	O
in	O
sic1Delta	B-Gene_or_gene_product
cells	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
that	B-X
budding	B-X
yeast	B-X
Cdh1	B-X
is	B-X
a	B-X
component	B-X
of	B-X
a	B-X
cell	B-X
cycle-regulated	B-X
complex	B-X
that	B-X
includes	B-X
the	B-X
14-3-3	B-X
homologs	B-X
Bmh1	B-X
and	B-X
Bmh2	B-X
and	B-X
a	B-X
previously	B-X
uncharacterized	B-X
protein	B-X
,	B-X
which	B-X
we	B-X
name	B-X
Acm1	B-X
(	B-X
APC/CCdh1	B-X
modulator	B-X
1	B-X
)	B-X
.	B-X
Association	B-X
of	B-X
Cdh1	B-X
with	B-X
Bmh1	B-X
and	B-X
Bmh2	B-X
requires	B-X
Acm1	B-X
,	B-X
and	B-X
the	B-X
Acm1	B-X
protein	B-X
is	B-X
cell	B-X
cycle	B-X
regulated	B-X
,	B-X
appearing	B-X
late	B-X
in	B-X
G1	B-X
and	B-X
disappearing	B-X
in	B-X
late	B-X
M.	B-X
In	B-X
acm1Delta	B-X
strains	B-X
,	B-X
Cdh1	B-X
localization	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
and	B-X
association	B-X
with	B-X
two	B-X
substrates	B-X
,	B-X
Clb2	B-X
and	B-X
Hsl1	B-X
,	B-X
were	B-X
strongly	B-X
enhanced	B-X
.	B-X
Several	B-X
lines	B-X
of	B-X
evidence	B-X
suggest	B-X
that	B-X
Acm1	B-X
can	B-X
suppress	B-X
APC/CCdh1-mediated	B-X
proteolysis	B-X
of	B-X
mitotic	B-X
cyclins	B-X
.	B-X
First	B-X
,	B-X
overexpression	B-X
of	B-X
Acm1	B-X
fully	B-X
restored	B-X
viability	B-X
to	B-X
cells	B-X
expressing	B-X
toxic	B-X
levels	B-X
of	B-X
Cdh1	B-X
or	B-X
a	B-X
constitutively	B-X
active	B-X
Cdh1	B-X
mutant	B-X
lacking	B-X
inhibitory	B-X
phosphorylation	B-X
sites	B-X
.	B-X
Second	B-X
,	B-X
overexpression	B-X
of	B-X
Acm1	B-X
was	B-X
toxic	B-X
in	B-X
sic1Delta	B-X
cells	B-X
.	B-X
Third	B-X
,	B-X
ACM1	B-X
deletion	B-X
exacerbated	B-X
a	B-X
low-penetrance	B-X
elongated-bud	B-X
phenotype	B-X
caused	B-X
by	B-X
modest	B-X
overexpression	B-X
of	B-X
Cdh1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Acm1	B-X
and	B-X
Bmh1/Bmh2	B-X
constitute	B-X
a	B-X
specialized	B-X
inhibitor	B-X
of	B-X
APC/CCdh1	B-X
.	B-X

Third	O
,	O
ACM1	B-Gene_or_gene_product
deletion	O
exacerbated	O
a	O
low	O
-	O
penetrance	O
elongated	O
-	O
bud	O
phenotype	O
caused	O
by	O
modest	O
overexpression	O
of	O
Cdh1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Cdh1	B-X
is	B-X
a	B-X
coactivator	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex/cyclosome	B-X
(	B-X
APC/C	B-X
)	B-X
and	B-X
contributes	B-X
to	B-X
mitotic	B-X
exit	B-X
and	B-X
G1	B-X
maintenance	B-X
by	B-X
facilitating	B-X
the	B-X
polyubiquitination	B-X
and	B-X
subsequent	B-X
proteolysis	B-X
of	B-X
specific	B-X
substrates	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
that	B-X
budding	B-X
yeast	B-X
Cdh1	B-X
is	B-X
a	B-X
component	B-X
of	B-X
a	B-X
cell	B-X
cycle-regulated	B-X
complex	B-X
that	B-X
includes	B-X
the	B-X
14-3-3	B-X
homologs	B-X
Bmh1	B-X
and	B-X
Bmh2	B-X
and	B-X
a	B-X
previously	B-X
uncharacterized	B-X
protein	B-X
,	B-X
which	B-X
we	B-X
name	B-X
Acm1	B-X
(	B-X
APC/CCdh1	B-X
modulator	B-X
1	B-X
)	B-X
.	B-X
Association	B-X
of	B-X
Cdh1	B-X
with	B-X
Bmh1	B-X
and	B-X
Bmh2	B-X
requires	B-X
Acm1	B-X
,	B-X
and	B-X
the	B-X
Acm1	B-X
protein	B-X
is	B-X
cell	B-X
cycle	B-X
regulated	B-X
,	B-X
appearing	B-X
late	B-X
in	B-X
G1	B-X
and	B-X
disappearing	B-X
in	B-X
late	B-X
M.	B-X
In	B-X
acm1Delta	B-X
strains	B-X
,	B-X
Cdh1	B-X
localization	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
and	B-X
association	B-X
with	B-X
two	B-X
substrates	B-X
,	B-X
Clb2	B-X
and	B-X
Hsl1	B-X
,	B-X
were	B-X
strongly	B-X
enhanced	B-X
.	B-X
Several	B-X
lines	B-X
of	B-X
evidence	B-X
suggest	B-X
that	B-X
Acm1	B-X
can	B-X
suppress	B-X
APC/CCdh1-mediated	B-X
proteolysis	B-X
of	B-X
mitotic	B-X
cyclins	B-X
.	B-X
First	B-X
,	B-X
overexpression	B-X
of	B-X
Acm1	B-X
fully	B-X
restored	B-X
viability	B-X
to	B-X
cells	B-X
expressing	B-X
toxic	B-X
levels	B-X
of	B-X
Cdh1	B-X
or	B-X
a	B-X
constitutively	B-X
active	B-X
Cdh1	B-X
mutant	B-X
lacking	B-X
inhibitory	B-X
phosphorylation	B-X
sites	B-X
.	B-X
Second	B-X
,	B-X
overexpression	B-X
of	B-X
Acm1	B-X
was	B-X
toxic	B-X
in	B-X
sic1Delta	B-X
cells	B-X
.	B-X
Third	B-X
,	B-X
ACM1	B-X
deletion	B-X
exacerbated	B-X
a	B-X
low-penetrance	B-X
elongated-bud	B-X
phenotype	B-X
caused	B-X
by	B-X
modest	B-X
overexpression	B-X
of	B-X
Cdh1	B-X
.	B-X
This	B-X
bud	B-X
elongation	B-X
was	B-X
independent	B-X
of	B-X
the	B-X
morphogenesis	B-X
checkpoint	B-X
,	B-X
and	B-X
the	B-X
combination	B-X
of	B-X
acm1Delta	B-X
and	B-X
hsl1Delta	B-X
resulted	B-X
in	B-X
a	B-X
dramatic	B-X
enhancement	B-X
of	B-X
bud	B-X
elongation	B-X
and	B-X
G2/M	B-X
delay	B-X
.	B-X
Effects	B-X
on	B-X
bud	B-X
elongation	B-X
were	B-X
attenuated	B-X
when	B-X
Cdh1	B-X
was	B-X
replaced	B-X
with	B-X
a	B-X
mutant	B-X
lacking	B-X
the	B-X
C-terminal	B-X
IR	B-X
dipeptide	B-X
,	B-X
suggesting	B-X
that	B-X
APC/C-dependent	B-X
proteolysis	B-X
is	B-X
required	B-X
for	B-X
this	B-X
phenotype	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Acm1	B-X
and	B-X
Bmh1/Bmh2	B-X
constitute	B-X
a	B-X
specialized	B-X
inhibitor	B-X
of	B-X
APC/CCdh1	B-X
.	B-X

This	O
bud	O
elongation	O
was	O
independent	O
of	O
the	O
morphogenesis	O
checkpoint	O
,	O
and	O
the	O
combination	O
of	O
acm1Delta	B-Gene_or_gene_product
and	O
hsl1Delta	B-Gene_or_gene_product
resulted	O
in	O
a	O
dramatic	O
enhancement	O
of	O
bud	O
elongation	O
and	O
G2	O
/	O
M	O
delay	O
.	O

Effects	O
on	O
bud	O
elongation	O
were	O
attenuated	O
when	O
Cdh1	B-Gene_or_gene_product
was	O
replaced	O
with	O
a	O
mutant	O
lacking	O
the	O
C	O
-	O
terminal	O
IR	O
dipeptide	O
,	O
suggesting	O
that	O
APC	O
/	O
C	O
-	O
dependent	O
proteolysis	O
is	O
required	O
for	O
this	O
phenotype	O
.	O

We	O
propose	O
that	O
Acm1	B-Gene_or_gene_product
and	O
Bmh1	B-Gene_or_gene_product
/	O
Bmh2	B-Gene_or_gene_product
constitute	O
a	O
specialized	O
inhibitor	O
of	O
APC	O
/	O
CCdh1	O
.	O
<EOS>	B-X
Cdh1	B-X
is	B-X
a	B-X
coactivator	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex/cyclosome	B-X
(	B-X
APC/C	B-X
)	B-X
and	B-X
contributes	B-X
to	B-X
mitotic	B-X
exit	B-X
and	B-X
G1	B-X
maintenance	B-X
by	B-X
facilitating	B-X
the	B-X
polyubiquitination	B-X
and	B-X
subsequent	B-X
proteolysis	B-X
of	B-X
specific	B-X
substrates	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
that	B-X
budding	B-X
yeast	B-X
Cdh1	B-X
is	B-X
a	B-X
component	B-X
of	B-X
a	B-X
cell	B-X
cycle-regulated	B-X
complex	B-X
that	B-X
includes	B-X
the	B-X
14-3-3	B-X
homologs	B-X
Bmh1	B-X
and	B-X
Bmh2	B-X
and	B-X
a	B-X
previously	B-X
uncharacterized	B-X
protein	B-X
,	B-X
which	B-X
we	B-X
name	B-X
Acm1	B-X
(	B-X
APC/CCdh1	B-X
modulator	B-X
1	B-X
)	B-X
.	B-X
Association	B-X
of	B-X
Cdh1	B-X
with	B-X
Bmh1	B-X
and	B-X
Bmh2	B-X
requires	B-X
Acm1	B-X
,	B-X
and	B-X
the	B-X
Acm1	B-X
protein	B-X
is	B-X
cell	B-X
cycle	B-X
regulated	B-X
,	B-X
appearing	B-X
late	B-X
in	B-X
G1	B-X
and	B-X
disappearing	B-X
in	B-X
late	B-X
M.	B-X
In	B-X
acm1Delta	B-X
strains	B-X
,	B-X
Cdh1	B-X
localization	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
and	B-X
association	B-X
with	B-X
two	B-X
substrates	B-X
,	B-X
Clb2	B-X
and	B-X
Hsl1	B-X
,	B-X
were	B-X
strongly	B-X
enhanced	B-X
.	B-X
Several	B-X
lines	B-X
of	B-X
evidence	B-X
suggest	B-X
that	B-X
Acm1	B-X
can	B-X
suppress	B-X
APC/CCdh1-mediated	B-X
proteolysis	B-X
of	B-X
mitotic	B-X
cyclins	B-X
.	B-X
First	B-X
,	B-X
overexpression	B-X
of	B-X
Acm1	B-X
fully	B-X
restored	B-X
viability	B-X
to	B-X
cells	B-X
expressing	B-X
toxic	B-X
levels	B-X
of	B-X
Cdh1	B-X
or	B-X
a	B-X
constitutively	B-X
active	B-X
Cdh1	B-X
mutant	B-X
lacking	B-X
inhibitory	B-X
phosphorylation	B-X
sites	B-X
.	B-X
Second	B-X
,	B-X
overexpression	B-X
of	B-X
Acm1	B-X
was	B-X
toxic	B-X
in	B-X
sic1Delta	B-X
cells	B-X
.	B-X
Effects	B-X
on	B-X
bud	B-X
elongation	B-X
were	B-X
attenuated	B-X
when	B-X
Cdh1	B-X
was	B-X
replaced	B-X
with	B-X
a	B-X
mutant	B-X
lacking	B-X
the	B-X
C-terminal	B-X
IR	B-X
dipeptide	B-X
,	B-X
suggesting	B-X
that	B-X
APC/C-dependent	B-X
proteolysis	B-X
is	B-X
required	B-X
for	B-X
this	B-X
phenotype	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Acm1	B-X
and	B-X
Bmh1/Bmh2	B-X
constitute	B-X
a	B-X
specialized	B-X
inhibitor	B-X
of	B-X
APC/CCdh1	B-X
.	B-X

Teratogen	O
-	O
induced	O
activation	O
of	O
p53	B-Gene_or_gene_product
in	O
early	O
postimplantation	O
mouse	O
embryos	O
.	O
<EOS>	B-X
Hyperthermia	B-X
(	B-X
HS	B-X
)	B-X
and	B-X
4-hydroperoxycyclophosphamide	B-X
(	B-X
4CP	B-X
)	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
.	B-X
Previous	B-X
microarray	B-X
analyses	B-X
Microarray	B-X
analyses	B-X
revealed	B-X
that	B-X
several	B-X
p53	B-X
target	B-X
genes	B-X
are	B-X
upregulated	B-X
after	B-X
exposure	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
.	B-X
To	B-X
explore	B-X
the	B-X
role	B-X
of	B-X
p53	B-X
,	B-X
we	B-X
assessed	B-X
the	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
in	B-X
vitro	B-X
.	B-X
Both	B-X
teratogens	B-X
induced	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
and	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
ser-15	B-X
,	B-X
two	B-X
hallmarks	B-X
of	B-X
p53	B-X
activation	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
an	B-X
increase	B-X
in	B-X
Noxa	B-X
and	B-X
Puma	B-X
mRNAs	B-X
,	B-X
transcripts	B-X
of	B-X
two	B-X
known	B-X
proapoptotic	B-X
p53	B-X
target	B-X
genes	B-X
;	B-X
however	B-X
,	B-X
these	B-X
two	B-X
teratogens	B-X
did	B-X
not	B-X
induce	B-X
significant	B-X
increases	B-X
in	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
,	B-X
suggesting	B-X
that	B-X
p53	B-X
does	B-X
not	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
by	B-X
transcriptionally	B-X
upregulating	B-X
the	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
mRNA	B-X
and	B-X
protein	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
We	B-X
now	B-X
show	B-X
that	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
a	B-X
robust	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
the	B-X
embryo	B-X
proper	B-X
but	B-X
an	B-X
attenuated	B-X
induction	B-X
in	B-X
the	B-X
heart	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
protein	B-X
in	B-X
majority	B-X
of	B-X
the	B-X
cells	B-X
in	B-X
the	B-X
embryo	B-X
;	B-X
however	B-X
,	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
were	B-X
not	B-X
significantly	B-X
induced	B-X
in	B-X
heads	B-X
,	B-X
hearts	B-X
,	B-X
or	B-X
trunks	B-X
of	B-X
day	B-X
9	B-X
embryos	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
p53	B-X
may	B-X
play	B-X
a	B-X
transcription-dependent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
but	B-X
a	B-X
transcription-independent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
.	B-X

Hyperthermia	O
(	O
HS	O
)	O
and	O
4	O
-	O
hydroperoxycyclophosphamide	O
(	O
4CP	O
)	O
activate	O
the	O
mitochondrial	O
apoptotic	O
pathway	O
in	O
day	O
9	O
mouse	O
embryos	O
.	O
<EOS>	B-X
Using	B-X
vital	B-X
dyes	B-X
,	B-X
we	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
while	B-X
hyperthermia	B-X
(	B-X
HS	B-X
)	B-X
,	B-X
4-hydroperoxycyclophosphamide	B-X
(	B-X
4CP	B-X
)	B-X
,	B-X
and	B-X
staurosporine	B-X
(	B-X
ST	B-X
)	B-X
induce	B-X
cell	B-X
death	B-X
within	B-X
specific	B-X
tissues	B-X
(	B-X
e.g.	B-X
,	B-X
neuroepithelium	B-X
)	B-X
of	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
,	B-X
cells	B-X
of	B-X
the	B-X
heart	B-X
are	B-X
resistant	B-X
to	B-X
the	B-X
cell	B-X
death-inducing	B-X
potential	B-X
of	B-X
these	B-X
teratogens	B-X
.	B-X
Subsequent	B-X
work	B-X
has	B-X
shown	B-X
that	B-X
teratogen-induced	B-X
cell	B-X
death	B-X
is	B-X
associated	B-X
with	B-X
activation	B-X
of	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
,	B-X
i.e.	B-X
,	B-X
release	B-X
of	B-X
cytochrome	B-X
c	B-X
from	B-X
mitochondria	B-X
,	B-X
activation/cleavage	B-X
of	B-X
procaspase-9	B-X
,	B-X
-3	B-X
,	B-X
and	B-X
-2	B-X
,	B-X
inactivation	B-X
of	B-X
poly	B-X
(	B-X
ADP-ribose	B-X
)	B-X
polymerase	B-X
,	B-X
and	B-X
internucleosomal	B-X
fragmentation	B-X
of	B-X
DNA	B-X
,	B-X
whereas	B-X
resistance	B-X
to	B-X
teratogen-induced	B-X
cell	B-X
death	B-X
in	B-X
the	B-X
heart	B-X
is	B-X
associated	B-X
with	B-X
a	B-X
failure	B-X
to	B-X
activate	B-X
this	B-X
pathway	B-X
.	B-X
Teratogen-induced	B-X
activation	B-X
of	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
is	B-X
initiated	B-X
between	B-X
2.5	B-X
and	B-X
5	B-X
hr	B-X
after	B-X
teratogens	B-X
are	B-X
added	B-X
to	B-X
the	B-X
culture	B-X
medium	B-X
.	B-X
Because	B-X
both	B-X
the	B-X
heart	B-X
and	B-X
the	B-X
surrounding	B-X
yolk	B-X
sac	B-X
are	B-X
essential	B-X
to	B-X
successful	B-X
development	B-X
of	B-X
mouse	B-X
embryos	B-X
during	B-X
early	B-X
postimplantation	B-X
mouse	B-X
development	B-X
,	B-X
we	B-X
hypothesized	B-X
that	B-X
cells	B-X
of	B-X
the	B-X
yolk	B-X
sac	B-X
are	B-X
also	B-X
resistant	B-X
to	B-X
teratogen-induced	B-X
cell	B-X
death	B-X
.	B-X

Previous	O
microarray	O
analyses	O
Microarray	O
analyses	O
revealed	O
that	O
several	O
p53	B-Gene_or_gene_product
target	O
genes	O
are	O
upregulated	O
after	O
exposure	O
to	O
HS	O
or	O
4CP	O
,	O
suggesting	O
a	O
role	O
for	O
p53	B-Gene_or_gene_product
in	O
teratogen	O
-	O
induced	O
apoptosis	O
.	O
<EOS>	B-X
Hyperthermia	B-X
(	B-X
HS	B-X
)	B-X
and	B-X
4-hydroperoxycyclophosphamide	B-X
(	B-X
4CP	B-X
)	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
.	B-X
Previous	B-X
microarray	B-X
analyses	B-X
Microarray	B-X
analyses	B-X
revealed	B-X
that	B-X
several	B-X
p53	B-X
target	B-X
genes	B-X
are	B-X
upregulated	B-X
after	B-X
exposure	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
.	B-X
To	B-X
explore	B-X
the	B-X
role	B-X
of	B-X
p53	B-X
,	B-X
we	B-X
assessed	B-X
the	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
in	B-X
vitro	B-X
.	B-X
Both	B-X
teratogens	B-X
induced	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
and	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
ser-15	B-X
,	B-X
two	B-X
hallmarks	B-X
of	B-X
p53	B-X
activation	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
an	B-X
increase	B-X
in	B-X
Noxa	B-X
and	B-X
Puma	B-X
mRNAs	B-X
,	B-X
transcripts	B-X
of	B-X
two	B-X
known	B-X
proapoptotic	B-X
p53	B-X
target	B-X
genes	B-X
;	B-X
however	B-X
,	B-X
these	B-X
two	B-X
teratogens	B-X
did	B-X
not	B-X
induce	B-X
significant	B-X
increases	B-X
in	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
,	B-X
suggesting	B-X
that	B-X
p53	B-X
does	B-X
not	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
by	B-X
transcriptionally	B-X
upregulating	B-X
the	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
mRNA	B-X
and	B-X
protein	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
also	B-X
showed	B-X
that	B-X
HS	B-X
and	B-X
4CP	B-X
activate	B-X
the	B-X
apoptotic	B-X
pathway	B-X
in	B-X
the	B-X
embryo	B-X
proper	B-X
(	B-X
head	B-X
and	B-X
trunk	B-X
)	B-X
but	B-X
not	B-X
in	B-X
the	B-X
heart	B-X
.	B-X
We	B-X
now	B-X
show	B-X
that	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
a	B-X
robust	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
the	B-X
embryo	B-X
proper	B-X
but	B-X
an	B-X
attenuated	B-X
induction	B-X
in	B-X
the	B-X
heart	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
protein	B-X
in	B-X
majority	B-X
of	B-X
the	B-X
cells	B-X
in	B-X
the	B-X
embryo	B-X
;	B-X
however	B-X
,	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
were	B-X
not	B-X
significantly	B-X
induced	B-X
in	B-X
heads	B-X
,	B-X
hearts	B-X
,	B-X
or	B-X
trunks	B-X
of	B-X
day	B-X
9	B-X
embryos	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
p53	B-X
may	B-X
play	B-X
a	B-X
transcription-dependent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
but	B-X
a	B-X
transcription-independent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
.	B-X

To	O
explore	O
the	O
role	O
of	O
p53	B-Gene_or_gene_product
,	O
we	O
assessed	O
the	O
activation	O
of	O
p53	B-Gene_or_gene_product
in	O
day	O
9	O
mouse	O
embryos	O
exposed	O
to	O
HS	O
or	O
4CP	O
in	O
vitro	O
.	O
<EOS>	B-X
Hyperthermia	B-X
(	B-X
HS	B-X
)	B-X
and	B-X
4-hydroperoxycyclophosphamide	B-X
(	B-X
4CP	B-X
)	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
.	B-X
Previous	B-X
microarray	B-X
analyses	B-X
Microarray	B-X
analyses	B-X
revealed	B-X
that	B-X
several	B-X
p53	B-X
target	B-X
genes	B-X
are	B-X
upregulated	B-X
after	B-X
exposure	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
.	B-X
To	B-X
explore	B-X
the	B-X
role	B-X
of	B-X
p53	B-X
,	B-X
we	B-X
assessed	B-X
the	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
in	B-X
vitro	B-X
.	B-X
Both	B-X
teratogens	B-X
induced	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
and	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
ser-15	B-X
,	B-X
two	B-X
hallmarks	B-X
of	B-X
p53	B-X
activation	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
an	B-X
increase	B-X
in	B-X
Noxa	B-X
and	B-X
Puma	B-X
mRNAs	B-X
,	B-X
transcripts	B-X
of	B-X
two	B-X
known	B-X
proapoptotic	B-X
p53	B-X
target	B-X
genes	B-X
;	B-X
however	B-X
,	B-X
these	B-X
two	B-X
teratogens	B-X
did	B-X
not	B-X
induce	B-X
significant	B-X
increases	B-X
in	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
,	B-X
suggesting	B-X
that	B-X
p53	B-X
does	B-X
not	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
by	B-X
transcriptionally	B-X
upregulating	B-X
the	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
mRNA	B-X
and	B-X
protein	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
also	B-X
showed	B-X
that	B-X
HS	B-X
and	B-X
4CP	B-X
activate	B-X
the	B-X
apoptotic	B-X
pathway	B-X
in	B-X
the	B-X
embryo	B-X
proper	B-X
(	B-X
head	B-X
and	B-X
trunk	B-X
)	B-X
but	B-X
not	B-X
in	B-X
the	B-X
heart	B-X
.	B-X
We	B-X
now	B-X
show	B-X
that	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
a	B-X
robust	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
the	B-X
embryo	B-X
proper	B-X
but	B-X
an	B-X
attenuated	B-X
induction	B-X
in	B-X
the	B-X
heart	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
protein	B-X
in	B-X
majority	B-X
of	B-X
the	B-X
cells	B-X
in	B-X
the	B-X
embryo	B-X
;	B-X
however	B-X
,	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
were	B-X
not	B-X
significantly	B-X
induced	B-X
in	B-X
heads	B-X
,	B-X
hearts	B-X
,	B-X
or	B-X
trunks	B-X
of	B-X
day	B-X
9	B-X
embryos	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
p53	B-X
may	B-X
play	B-X
a	B-X
transcription-dependent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
but	B-X
a	B-X
transcription-independent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
.	B-X

Both	O
teratogens	O
induced	O
the	O
accumulation	O
of	O
p53	B-Gene_or_gene_product
and	O
phosphorylation	O
of	O
p53	B-Gene_or_gene_product
at	O
ser	O
-	O
15	O
,	O
two	O
hallmarks	O
of	O
p53	B-Gene_or_gene_product
activation	O
.	O
<EOS>	B-X
Previous	B-X
microarray	B-X
analyses	B-X
Microarray	B-X
analyses	B-X
revealed	B-X
that	B-X
several	B-X
p53	B-X
target	B-X
genes	B-X
are	B-X
upregulated	B-X
after	B-X
exposure	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
.	B-X
To	B-X
explore	B-X
the	B-X
role	B-X
of	B-X
p53	B-X
,	B-X
we	B-X
assessed	B-X
the	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
in	B-X
vitro	B-X
.	B-X
Both	B-X
teratogens	B-X
induced	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
and	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
ser-15	B-X
,	B-X
two	B-X
hallmarks	B-X
of	B-X
p53	B-X
activation	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
an	B-X
increase	B-X
in	B-X
Noxa	B-X
and	B-X
Puma	B-X
mRNAs	B-X
,	B-X
transcripts	B-X
of	B-X
two	B-X
known	B-X
proapoptotic	B-X
p53	B-X
target	B-X
genes	B-X
;	B-X
however	B-X
,	B-X
these	B-X
two	B-X
teratogens	B-X
did	B-X
not	B-X
induce	B-X
significant	B-X
increases	B-X
in	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
,	B-X
suggesting	B-X
that	B-X
p53	B-X
does	B-X
not	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
by	B-X
transcriptionally	B-X
upregulating	B-X
the	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
mRNA	B-X
and	B-X
protein	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
We	B-X
now	B-X
show	B-X
that	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
a	B-X
robust	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
the	B-X
embryo	B-X
proper	B-X
but	B-X
an	B-X
attenuated	B-X
induction	B-X
in	B-X
the	B-X
heart	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
protein	B-X
in	B-X
majority	B-X
of	B-X
the	B-X
cells	B-X
in	B-X
the	B-X
embryo	B-X
;	B-X
however	B-X
,	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
were	B-X
not	B-X
significantly	B-X
induced	B-X
in	B-X
heads	B-X
,	B-X
hearts	B-X
,	B-X
or	B-X
trunks	B-X
of	B-X
day	B-X
9	B-X
embryos	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
p53	B-X
may	B-X
play	B-X
a	B-X
transcription-dependent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
but	B-X
a	B-X
transcription-independent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
.	B-X

HS	O
and	O
4CP	O
also	O
induced	O
an	O
increase	O
in	O
Noxa	B-Gene_or_gene_product
and	O
Puma	B-Gene_or_gene_product
mRNAs	O
,	O
transcripts	O
of	O
two	O
known	O
proapoptotic	O
p53	B-Gene_or_gene_product
target	O
genes	O
;	O
however	O
,	O
these	O
two	O
teratogens	O
did	O
not	O
induce	O
significant	O
increases	O
in	O
NOXA	B-Gene_or_gene_product
and	O
PUMA	B-Gene_or_gene_product
proteins	O
,	O
suggesting	O
that	O
p53	B-Gene_or_gene_product
does	O
not	O
activate	O
the	O
mitochondrial	O
apoptotic	O
pathway	O
by	O
transcriptionally	O
upregulating	O
the	O
expression	O
of	O
NOXA	B-Gene_or_gene_product
and	O
PUMA	B-Gene_or_gene_product
proteins	O
.	O
<EOS>	B-X
Hyperthermia	B-X
(	B-X
HS	B-X
)	B-X
and	B-X
4-hydroperoxycyclophosphamide	B-X
(	B-X
4CP	B-X
)	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
.	B-X
Previous	B-X
microarray	B-X
analyses	B-X
Microarray	B-X
analyses	B-X
revealed	B-X
that	B-X
several	B-X
p53	B-X
target	B-X
genes	B-X
are	B-X
upregulated	B-X
after	B-X
exposure	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
.	B-X
To	B-X
explore	B-X
the	B-X
role	B-X
of	B-X
p53	B-X
,	B-X
we	B-X
assessed	B-X
the	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
in	B-X
vitro	B-X
.	B-X
Both	B-X
teratogens	B-X
induced	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
and	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
ser-15	B-X
,	B-X
two	B-X
hallmarks	B-X
of	B-X
p53	B-X
activation	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
an	B-X
increase	B-X
in	B-X
Noxa	B-X
and	B-X
Puma	B-X
mRNAs	B-X
,	B-X
transcripts	B-X
of	B-X
two	B-X
known	B-X
proapoptotic	B-X
p53	B-X
target	B-X
genes	B-X
;	B-X
however	B-X
,	B-X
these	B-X
two	B-X
teratogens	B-X
did	B-X
not	B-X
induce	B-X
significant	B-X
increases	B-X
in	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
,	B-X
suggesting	B-X
that	B-X
p53	B-X
does	B-X
not	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
by	B-X
transcriptionally	B-X
upregulating	B-X
the	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
mRNA	B-X
and	B-X
protein	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
also	B-X
showed	B-X
that	B-X
HS	B-X
and	B-X
4CP	B-X
activate	B-X
the	B-X
apoptotic	B-X
pathway	B-X
in	B-X
the	B-X
embryo	B-X
proper	B-X
(	B-X
head	B-X
and	B-X
trunk	B-X
)	B-X
but	B-X
not	B-X
in	B-X
the	B-X
heart	B-X
.	B-X
We	B-X
now	B-X
show	B-X
that	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
a	B-X
robust	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
the	B-X
embryo	B-X
proper	B-X
but	B-X
an	B-X
attenuated	B-X
induction	B-X
in	B-X
the	B-X
heart	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
protein	B-X
in	B-X
majority	B-X
of	B-X
the	B-X
cells	B-X
in	B-X
the	B-X
embryo	B-X
;	B-X
however	B-X
,	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
were	B-X
not	B-X
significantly	B-X
induced	B-X
in	B-X
heads	B-X
,	B-X
hearts	B-X
,	B-X
or	B-X
trunks	B-X
of	B-X
day	B-X
9	B-X
embryos	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
p53	B-X
may	B-X
play	B-X
a	B-X
transcription-dependent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
but	B-X
a	B-X
transcription-independent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
.	B-X

HS	O
and	O
4CP	O
also	O
induced	O
the	O
expression	O
of	O
p21	B-Gene_or_gene_product
mRNA	O
and	O
protein	O
,	O
suggesting	O
a	O
role	O
for	O
p53	B-Gene_or_gene_product
in	O
teratogen	O
-	O
induced	O
cell	O
cycle	O
arrest	O
.	O
<EOS>	B-X
Hyperthermia	B-X
(	B-X
HS	B-X
)	B-X
and	B-X
4-hydroperoxycyclophosphamide	B-X
(	B-X
4CP	B-X
)	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
.	B-X
Previous	B-X
microarray	B-X
analyses	B-X
Microarray	B-X
analyses	B-X
revealed	B-X
that	B-X
several	B-X
p53	B-X
target	B-X
genes	B-X
are	B-X
upregulated	B-X
after	B-X
exposure	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
.	B-X
To	B-X
explore	B-X
the	B-X
role	B-X
of	B-X
p53	B-X
,	B-X
we	B-X
assessed	B-X
the	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
in	B-X
vitro	B-X
.	B-X
Both	B-X
teratogens	B-X
induced	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
and	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
ser-15	B-X
,	B-X
two	B-X
hallmarks	B-X
of	B-X
p53	B-X
activation	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
an	B-X
increase	B-X
in	B-X
Noxa	B-X
and	B-X
Puma	B-X
mRNAs	B-X
,	B-X
transcripts	B-X
of	B-X
two	B-X
known	B-X
proapoptotic	B-X
p53	B-X
target	B-X
genes	B-X
;	B-X
however	B-X
,	B-X
these	B-X
two	B-X
teratogens	B-X
did	B-X
not	B-X
induce	B-X
significant	B-X
increases	B-X
in	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
,	B-X
suggesting	B-X
that	B-X
p53	B-X
does	B-X
not	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
by	B-X
transcriptionally	B-X
upregulating	B-X
the	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
mRNA	B-X
and	B-X
protein	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
also	B-X
showed	B-X
that	B-X
HS	B-X
and	B-X
4CP	B-X
activate	B-X
the	B-X
apoptotic	B-X
pathway	B-X
in	B-X
the	B-X
embryo	B-X
proper	B-X
(	B-X
head	B-X
and	B-X
trunk	B-X
)	B-X
but	B-X
not	B-X
in	B-X
the	B-X
heart	B-X
.	B-X
We	B-X
now	B-X
show	B-X
that	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
a	B-X
robust	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
the	B-X
embryo	B-X
proper	B-X
but	B-X
an	B-X
attenuated	B-X
induction	B-X
in	B-X
the	B-X
heart	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
protein	B-X
in	B-X
majority	B-X
of	B-X
the	B-X
cells	B-X
in	B-X
the	B-X
embryo	B-X
;	B-X
however	B-X
,	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
were	B-X
not	B-X
significantly	B-X
induced	B-X
in	B-X
heads	B-X
,	B-X
hearts	B-X
,	B-X
or	B-X
trunks	B-X
of	B-X
day	B-X
9	B-X
embryos	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
p53	B-X
may	B-X
play	B-X
a	B-X
transcription-dependent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
but	B-X
a	B-X
transcription-independent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
.	B-X

Previously	O
,	O
we	O
also	O
showed	O
that	O
HS	O
and	O
4CP	O
activate	O
the	O
apoptotic	O
pathway	O
in	O
the	O
embryo	O
proper	O
(	O
head	O
and	O
trunk	O
)	O
but	O
not	O
in	O
the	O
heart	O
.	O

We	O
now	O
show	O
that	O
HS	O
and	O
4CP	O
induce	O
a	O
robust	O
activation	O
of	O
p53	B-Gene_or_gene_product
in	O
the	O
embryo	O
proper	O
but	O
an	O
attenuated	O
induction	O
in	O
the	O
heart	O
.	O
<EOS>	B-X
Hyperthermia	B-X
(	B-X
HS	B-X
)	B-X
and	B-X
4-hydroperoxycyclophosphamide	B-X
(	B-X
4CP	B-X
)	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
.	B-X
Previous	B-X
microarray	B-X
analyses	B-X
Microarray	B-X
analyses	B-X
revealed	B-X
that	B-X
several	B-X
p53	B-X
target	B-X
genes	B-X
are	B-X
upregulated	B-X
after	B-X
exposure	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
.	B-X
To	B-X
explore	B-X
the	B-X
role	B-X
of	B-X
p53	B-X
,	B-X
we	B-X
assessed	B-X
the	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
in	B-X
vitro	B-X
.	B-X
Both	B-X
teratogens	B-X
induced	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
and	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
ser-15	B-X
,	B-X
two	B-X
hallmarks	B-X
of	B-X
p53	B-X
activation	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
an	B-X
increase	B-X
in	B-X
Noxa	B-X
and	B-X
Puma	B-X
mRNAs	B-X
,	B-X
transcripts	B-X
of	B-X
two	B-X
known	B-X
proapoptotic	B-X
p53	B-X
target	B-X
genes	B-X
;	B-X
however	B-X
,	B-X
these	B-X
two	B-X
teratogens	B-X
did	B-X
not	B-X
induce	B-X
significant	B-X
increases	B-X
in	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
,	B-X
suggesting	B-X
that	B-X
p53	B-X
does	B-X
not	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
by	B-X
transcriptionally	B-X
upregulating	B-X
the	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
mRNA	B-X
and	B-X
protein	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
also	B-X
showed	B-X
that	B-X
HS	B-X
and	B-X
4CP	B-X
activate	B-X
the	B-X
apoptotic	B-X
pathway	B-X
in	B-X
the	B-X
embryo	B-X
proper	B-X
(	B-X
head	B-X
and	B-X
trunk	B-X
)	B-X
but	B-X
not	B-X
in	B-X
the	B-X
heart	B-X
.	B-X
We	B-X
now	B-X
show	B-X
that	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
a	B-X
robust	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
the	B-X
embryo	B-X
proper	B-X
but	B-X
an	B-X
attenuated	B-X
induction	B-X
in	B-X
the	B-X
heart	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
protein	B-X
in	B-X
majority	B-X
of	B-X
the	B-X
cells	B-X
in	B-X
the	B-X
embryo	B-X
;	B-X
however	B-X
,	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
were	B-X
not	B-X
significantly	B-X
induced	B-X
in	B-X
heads	B-X
,	B-X
hearts	B-X
,	B-X
or	B-X
trunks	B-X
of	B-X
day	B-X
9	B-X
embryos	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
p53	B-X
may	B-X
play	B-X
a	B-X
transcription-dependent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
but	B-X
a	B-X
transcription-independent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
.	B-X

HS	O
and	O
4CP	O
induce	O
the	O
expression	O
of	O
p21	B-Gene_or_gene_product
protein	O
in	O
majority	O
of	O
the	O
cells	O
in	O
the	O
embryo	O
;	O
however	O
,	O
expression	O
of	O
NOXA	B-Gene_or_gene_product
and	O
PUMA	B-Gene_or_gene_product
proteins	O
were	O
not	O
significantly	O
induced	O
in	O
heads	O
,	O
hearts	O
,	O
or	O
trunks	O
of	O
day	O
9	O
embryos	O
.	O
<EOS>	B-X
Hyperthermia	B-X
(	B-X
HS	B-X
)	B-X
and	B-X
4-hydroperoxycyclophosphamide	B-X
(	B-X
4CP	B-X
)	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
.	B-X
Previous	B-X
microarray	B-X
analyses	B-X
Microarray	B-X
analyses	B-X
revealed	B-X
that	B-X
several	B-X
p53	B-X
target	B-X
genes	B-X
are	B-X
upregulated	B-X
after	B-X
exposure	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
.	B-X
To	B-X
explore	B-X
the	B-X
role	B-X
of	B-X
p53	B-X
,	B-X
we	B-X
assessed	B-X
the	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
in	B-X
vitro	B-X
.	B-X
Both	B-X
teratogens	B-X
induced	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
and	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
ser-15	B-X
,	B-X
two	B-X
hallmarks	B-X
of	B-X
p53	B-X
activation	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
an	B-X
increase	B-X
in	B-X
Noxa	B-X
and	B-X
Puma	B-X
mRNAs	B-X
,	B-X
transcripts	B-X
of	B-X
two	B-X
known	B-X
proapoptotic	B-X
p53	B-X
target	B-X
genes	B-X
;	B-X
however	B-X
,	B-X
these	B-X
two	B-X
teratogens	B-X
did	B-X
not	B-X
induce	B-X
significant	B-X
increases	B-X
in	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
,	B-X
suggesting	B-X
that	B-X
p53	B-X
does	B-X
not	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
by	B-X
transcriptionally	B-X
upregulating	B-X
the	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
mRNA	B-X
and	B-X
protein	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
also	B-X
showed	B-X
that	B-X
HS	B-X
and	B-X
4CP	B-X
activate	B-X
the	B-X
apoptotic	B-X
pathway	B-X
in	B-X
the	B-X
embryo	B-X
proper	B-X
(	B-X
head	B-X
and	B-X
trunk	B-X
)	B-X
but	B-X
not	B-X
in	B-X
the	B-X
heart	B-X
.	B-X
We	B-X
now	B-X
show	B-X
that	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
a	B-X
robust	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
the	B-X
embryo	B-X
proper	B-X
but	B-X
an	B-X
attenuated	B-X
induction	B-X
in	B-X
the	B-X
heart	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
protein	B-X
in	B-X
majority	B-X
of	B-X
the	B-X
cells	B-X
in	B-X
the	B-X
embryo	B-X
;	B-X
however	B-X
,	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
were	B-X
not	B-X
significantly	B-X
induced	B-X
in	B-X
heads	B-X
,	B-X
hearts	B-X
,	B-X
or	B-X
trunks	B-X
of	B-X
day	B-X
9	B-X
embryos	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
p53	B-X
may	B-X
play	B-X
a	B-X
transcription-dependent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
but	B-X
a	B-X
transcription-independent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
.	B-X

Overall	O
,	O
our	O
results	O
suggest	O
that	O
p53	B-Gene_or_gene_product
may	O
play	O
a	O
transcription	O
-	O
dependent	O
role	O
in	O
teratogen	O
-	O
induced	O
cell	O
cycle	O
arrest	O
but	O
a	O
transcription	O
-	O
independent	O
role	O
in	O
teratogen	O
-	O
induced	O
apoptosis	O
in	O
day	O
9	O
mouse	O
embryos	O
exposed	O
to	O
HS	O
or	O
4CP	O
.	O
<EOS>	B-X
Hyperthermia	B-X
(	B-X
HS	B-X
)	B-X
and	B-X
4-hydroperoxycyclophosphamide	B-X
(	B-X
4CP	B-X
)	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
.	B-X
Previous	B-X
microarray	B-X
analyses	B-X
Microarray	B-X
analyses	B-X
revealed	B-X
that	B-X
several	B-X
p53	B-X
target	B-X
genes	B-X
are	B-X
upregulated	B-X
after	B-X
exposure	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
.	B-X
To	B-X
explore	B-X
the	B-X
role	B-X
of	B-X
p53	B-X
,	B-X
we	B-X
assessed	B-X
the	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
in	B-X
vitro	B-X
.	B-X
Both	B-X
teratogens	B-X
induced	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
and	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
ser-15	B-X
,	B-X
two	B-X
hallmarks	B-X
of	B-X
p53	B-X
activation	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
an	B-X
increase	B-X
in	B-X
Noxa	B-X
and	B-X
Puma	B-X
mRNAs	B-X
,	B-X
transcripts	B-X
of	B-X
two	B-X
known	B-X
proapoptotic	B-X
p53	B-X
target	B-X
genes	B-X
;	B-X
however	B-X
,	B-X
these	B-X
two	B-X
teratogens	B-X
did	B-X
not	B-X
induce	B-X
significant	B-X
increases	B-X
in	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
,	B-X
suggesting	B-X
that	B-X
p53	B-X
does	B-X
not	B-X
activate	B-X
the	B-X
mitochondrial	B-X
apoptotic	B-X
pathway	B-X
by	B-X
transcriptionally	B-X
upregulating	B-X
the	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
also	B-X
induced	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
mRNA	B-X
and	B-X
protein	B-X
,	B-X
suggesting	B-X
a	B-X
role	B-X
for	B-X
p53	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
also	B-X
showed	B-X
that	B-X
HS	B-X
and	B-X
4CP	B-X
activate	B-X
the	B-X
apoptotic	B-X
pathway	B-X
in	B-X
the	B-X
embryo	B-X
proper	B-X
(	B-X
head	B-X
and	B-X
trunk	B-X
)	B-X
but	B-X
not	B-X
in	B-X
the	B-X
heart	B-X
.	B-X
We	B-X
now	B-X
show	B-X
that	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
a	B-X
robust	B-X
activation	B-X
of	B-X
p53	B-X
in	B-X
the	B-X
embryo	B-X
proper	B-X
but	B-X
an	B-X
attenuated	B-X
induction	B-X
in	B-X
the	B-X
heart	B-X
.	B-X
HS	B-X
and	B-X
4CP	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
p21	B-X
protein	B-X
in	B-X
majority	B-X
of	B-X
the	B-X
cells	B-X
in	B-X
the	B-X
embryo	B-X
;	B-X
however	B-X
,	B-X
expression	B-X
of	B-X
NOXA	B-X
and	B-X
PUMA	B-X
proteins	B-X
were	B-X
not	B-X
significantly	B-X
induced	B-X
in	B-X
heads	B-X
,	B-X
hearts	B-X
,	B-X
or	B-X
trunks	B-X
of	B-X
day	B-X
9	B-X
embryos	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
p53	B-X
may	B-X
play	B-X
a	B-X
transcription-dependent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
cell	B-X
cycle	B-X
arrest	B-X
but	B-X
a	B-X
transcription-independent	B-X
role	B-X
in	B-X
teratogen-induced	B-X
apoptosis	B-X
in	B-X
day	B-X
9	B-X
mouse	B-X
embryos	B-X
exposed	B-X
to	B-X
HS	B-X
or	B-X
4CP	B-X
.	B-X

Identification	O
of	O
novel	O
phosphorylation	O
sites	O
in	O
MSK1	B-Gene_or_gene_product
by	O
precursor	O
ion	O
scanning	O
MS	O
.	O
<EOS>	B-X
MSK1	B-X
(	B-X
mitogen-	B-X
and	B-X
stress-activated	B-X
kinase	B-X
1	B-X
)	B-X
is	B-X
a	B-X
dual	B-X
kinase	B-X
domain	B-X
protein	B-X
that	B-X
acts	B-X
downstream	B-X
of	B-X
the	B-X
ERK1/2	B-X
(	B-X
extracellular-signal-regulated	B-X
kinase	B-X
1/2	B-X
)	B-X
and	B-X
p38	B-X
MAPK	B-X
(	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
)	B-X
signalling	B-X
pathways	B-X
in	B-X
cells	B-X
.	B-X
MSK1	B-X
,	B-X
and	B-X
its	B-X
related	B-X
isoform	B-X
MSK2	B-X
,	B-X
phosphorylate	B-X
the	B-X
transcription	B-X
factors	B-X
CREB	B-X
(	B-X
cAMP-response-element-binding	B-X
protein	B-X
)	B-X
and	B-X
ATF1	B-X
(	B-X
activating	B-X
transcription	B-X
factor	B-X
1	B-X
)	B-X
,	B-X
and	B-X
the	B-X
chromatin	B-X
proteins	B-X
histone	B-X
H3	B-X
and	B-X
HMGN1	B-X
(	B-X
high-mobility-group	B-X
nucleosomal-binding	B-X
protein	B-X
1	B-X
)	B-X
in	B-X
response	B-X
to	B-X
either	B-X
mitogenic	B-X
stimulation	B-X
or	B-X
cellular	B-X
stress	B-X
.	B-X
MSK1	B-X
activity	B-X
is	B-X
tightly	B-X
regulated	B-X
in	B-X
cells	B-X
,	B-X
and	B-X
activation	B-X
requires	B-X
the	B-X
phosphorylation	B-X
of	B-X
MSK1	B-X
by	B-X
either	B-X
ERK1/2	B-X
or	B-X
p38a	B-X
.	B-X
This	B-X
results	B-X
in	B-X
activation	B-X
of	B-X
the	B-X
C-terminal	B-X
kinase	B-X
domain	B-X
,	B-X
which	B-X
then	B-X
phosphorylates	B-X
further	B-X
sites	B-X
in	B-X
MSK1	B-X
,	B-X
leading	B-X
to	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
N-terminal	B-X
kinase	B-X
domain	B-X
and	B-X
phosphorylation	B-X
of	B-X
substrates	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
use	B-X
precursor	B-X
ion	B-X
scanning	B-X
MS	B-X
to	B-X
identify	B-X
five	B-X
previously	B-X
unknown	B-X
sites	B-X
in	B-X
MSK1	B-X
:	B-X
Thr630	B-X
,	B-X
Ser647	B-X
,	B-X
Ser657	B-X
,	B-X
Ser695	B-X
and	B-X
Thr700	B-X
.	B-X
One	B-X
of	B-X
these	B-X
sites	B-X
,	B-X
Thr700	B-X
,	B-X
was	B-X
found	B-X
to	B-X
be	B-X
a	B-X
third	B-X
site	B-X
in	B-X
MSK1	B-X
phosphorylated	B-X
by	B-X
the	B-X
upstream	B-X
kinases	B-X
ERK1/2	B-X
and	B-X
p38a	B-X
.	B-X
Mutation	B-X
of	B-X
Thr700	B-X
resulted	B-X
in	B-X
an	B-X
increased	B-X
basal	B-X
activity	B-X
of	B-X
MSK1	B-X
,	B-X
but	B-X
this	B-X
could	B-X
be	B-X
further	B-X
increased	B-X
by	B-X
stimulation	B-X
with	B-X
PMA	B-X
or	B-X
UV-C	B-X
radiation	B-X
.	B-X
Surprisingly	B-X
,	B-X
however	B-X
,	B-X
mutation	B-X
of	B-X
Thr700	B-X
resulted	B-X
in	B-X
a	B-X
dramatic	B-X
loss	B-X
of	B-X
Thr581	B-X
phosphorylation	B-X
,	B-X
a	B-X
site	B-X
essential	B-X
for	B-X
activity	B-X
.	B-X
Mutation	B-X
of	B-X
Thr700	B-X
and	B-X
Thr581	B-X
to	B-X
an	B-X
alanine	B-X
residue	B-X
resulted	B-X
in	B-X
an	B-X
inactive	B-X
kinase	B-X
,	B-X
while	B-X
mutation	B-X
of	B-X
both	B-X
sites	B-X
to	B-X
an	B-X
aspartic	B-X
acid	B-X
residue	B-X
resulted	B-X
in	B-X
a	B-X
kinase	B-X
with	B-X
a	B-X
significant	B-X
basal	B-X
activity	B-X
that	B-X
could	B-X
not	B-X
be	B-X
further	B-X
stimulated	B-X
.	B-X
Together	B-X
these	B-X
results	B-X
are	B-X
consistent	B-X
with	B-X
a	B-X
mechanism	B-X
by	B-X
which	B-X
Thr700	B-X
phosphorylation	B-X
relieves	B-X
the	B-X
inhibition	B-X
of	B-X
MSK1	B-X
by	B-X
a	B-X
C-terminal	B-X
autoinhibitory	B-X
helix	B-X
and	B-X
helps	B-X
induce	B-X
a	B-X
conformational	B-X
shift	B-X
that	B-X
protects	B-X
Thr581	B-X
from	B-X
dephosphorylation	B-X
.	B-X

MSK1	B-Gene_or_gene_product
(	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
and	I-Gene_or_gene_product
stress	I-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
is	O
a	O
dual	O
kinase	O
domain	O
protein	O
that	O
acts	O
downstream	O
of	O
the	O
ERK1	B-Gene_or_gene_product
/	I-Gene_or_gene_product
2	I-Gene_or_gene_product
(	O
extracellular	B-Gene_or_gene_product
-	I-Gene_or_gene_product
signal	I-Gene_or_gene_product
-	I-Gene_or_gene_product
regulated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	I-Gene_or_gene_product
2	I-Gene_or_gene_product
)	O
and	O
p38	B-Gene_or_gene_product
MAPK	I-Gene_or_gene_product
(	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
)	O
signalling	O
pathways	O
in	O
cells	O
.	O
<EOS>	B-X
MSK1	B-X
(	B-X
mitogen-	B-X
and	B-X
stress-activated	B-X
kinase	B-X
1	B-X
)	B-X
is	B-X
a	B-X
dual	B-X
kinase	B-X
domain	B-X
protein	B-X
that	B-X
acts	B-X
downstream	B-X
of	B-X
the	B-X
ERK1/2	B-X
(	B-X
extracellular-signal-regulated	B-X
kinase	B-X
1/2	B-X
)	B-X
and	B-X
p38	B-X
MAPK	B-X
(	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
)	B-X
signalling	B-X
pathways	B-X
in	B-X
cells	B-X
.	B-X
MSK1	B-X
,	B-X
and	B-X
its	B-X
related	B-X
isoform	B-X
MSK2	B-X
,	B-X
phosphorylate	B-X
the	B-X
transcription	B-X
factors	B-X
CREB	B-X
(	B-X
cAMP-response-element-binding	B-X
protein	B-X
)	B-X
and	B-X
ATF1	B-X
(	B-X
activating	B-X
transcription	B-X
factor	B-X
1	B-X
)	B-X
,	B-X
and	B-X
the	B-X
chromatin	B-X
proteins	B-X
histone	B-X
H3	B-X
and	B-X
HMGN1	B-X
(	B-X
high-mobility-group	B-X
nucleosomal-binding	B-X
protein	B-X
1	B-X
)	B-X
in	B-X
response	B-X
to	B-X
either	B-X
mitogenic	B-X
stimulation	B-X
or	B-X
cellular	B-X
stress	B-X
.	B-X
MSK1	B-X
activity	B-X
is	B-X
tightly	B-X
regulated	B-X
in	B-X
cells	B-X
,	B-X
and	B-X
activation	B-X
requires	B-X
the	B-X
phosphorylation	B-X
of	B-X
MSK1	B-X
by	B-X
either	B-X
ERK1/2	B-X
or	B-X
p38a	B-X
.	B-X
This	B-X
results	B-X
in	B-X
activation	B-X
of	B-X
the	B-X
C-terminal	B-X
kinase	B-X
domain	B-X
,	B-X
which	B-X
then	B-X
phosphorylates	B-X
further	B-X
sites	B-X
in	B-X
MSK1	B-X
,	B-X
leading	B-X
to	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
N-terminal	B-X
kinase	B-X
domain	B-X
and	B-X
phosphorylation	B-X
of	B-X
substrates	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
use	B-X
precursor	B-X
ion	B-X
scanning	B-X
MS	B-X
to	B-X
identify	B-X
five	B-X
previously	B-X
unknown	B-X
sites	B-X
in	B-X
MSK1	B-X
:	B-X
Thr630	B-X
,	B-X
Ser647	B-X
,	B-X
Ser657	B-X
,	B-X
Ser695	B-X
and	B-X
Thr700	B-X
.	B-X
One	B-X
of	B-X
these	B-X
sites	B-X
,	B-X
Thr700	B-X
,	B-X
was	B-X
found	B-X
to	B-X
be	B-X
a	B-X
third	B-X
site	B-X
in	B-X
MSK1	B-X
phosphorylated	B-X
by	B-X
the	B-X
upstream	B-X
kinases	B-X
ERK1/2	B-X
and	B-X
p38a	B-X
.	B-X
Mutation	B-X
of	B-X
Thr700	B-X
resulted	B-X
in	B-X
an	B-X
increased	B-X
basal	B-X
activity	B-X
of	B-X
MSK1	B-X
,	B-X
but	B-X
this	B-X
could	B-X
be	B-X
further	B-X
increased	B-X
by	B-X
stimulation	B-X
with	B-X
PMA	B-X
or	B-X
UV-C	B-X
radiation	B-X
.	B-X
Surprisingly	B-X
,	B-X
however	B-X
,	B-X
mutation	B-X
of	B-X
Thr700	B-X
resulted	B-X
in	B-X
a	B-X
dramatic	B-X
loss	B-X
of	B-X
Thr581	B-X
phosphorylation	B-X
,	B-X
a	B-X
site	B-X
essential	B-X
for	B-X
activity	B-X
.	B-X
Mutation	B-X
of	B-X
Thr700	B-X
and	B-X
Thr581	B-X
to	B-X
an	B-X
alanine	B-X
residue	B-X
resulted	B-X
in	B-X
an	B-X
inactive	B-X
kinase	B-X
,	B-X
while	B-X
mutation	B-X
of	B-X
both	B-X
sites	B-X
to	B-X
an	B-X
aspartic	B-X
acid	B-X
residue	B-X
resulted	B-X
in	B-X
a	B-X
kinase	B-X
with	B-X
a	B-X
significant	B-X
basal	B-X
activity	B-X
that	B-X
could	B-X
not	B-X
be	B-X
further	B-X
stimulated	B-X
.	B-X
Together	B-X
these	B-X
results	B-X
are	B-X
consistent	B-X
with	B-X
a	B-X
mechanism	B-X
by	B-X
which	B-X
Thr700	B-X
phosphorylation	B-X
relieves	B-X
the	B-X
inhibition	B-X
of	B-X
MSK1	B-X
by	B-X
a	B-X
C-terminal	B-X
autoinhibitory	B-X
helix	B-X
and	B-X
helps	B-X
induce	B-X
a	B-X
conformational	B-X
shift	B-X
that	B-X
protects	B-X
Thr581	B-X
from	B-X
dephosphorylation	B-X
.	B-X

MSK1	B-Gene_or_gene_product
,	O
and	O
its	O
related	O
isoform	O
MSK2	B-Gene_or_gene_product
,	O
phosphorylate	O
the	O
transcription	O
factors	O
CREB	B-Gene_or_gene_product
(	O
cAMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
response	I-Gene_or_gene_product
-	I-Gene_or_gene_product
element	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
)	O
and	O
ATF1	B-Gene_or_gene_product
(	O
activating	B-Gene_or_gene_product
transcription	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
,	O
and	O
the	O
chromatin	O
proteins	O
histone	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
and	O
HMGN1	B-Gene_or_gene_product
(	O
high	B-Gene_or_gene_product
-	I-Gene_or_gene_product
mobility	I-Gene_or_gene_product
-	I-Gene_or_gene_product
group	I-Gene_or_gene_product
nucleosomal	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
in	O
response	O
to	O
either	O
mitogenic	O
stimulation	O
or	O
cellular	O
stress	O
.	O
<EOS>	B-X
Acute	B-X
stress	B-X
increases	B-X
resistance	B-X
to	B-X
infection	B-X
.	B-X
The	B-X
alteration	B-X
of	B-X
this	B-X
mechanism	B-X
in	B-X
chronically	B-X
stressed	B-X
people	B-X
impairs	B-X
the	B-X
organism	B-X
's	B-X
ability	B-X
to	B-X
mount	B-X
a	B-X
strong	B-X
immune	B-X
response	B-X
with	B-X
a	B-X
resultant	B-X
increase	B-X
in	B-X
morbidity	B-X
.	B-X
Acute	B-X
stress	B-X
induces	B-X
a	B-X
probable	B-X
sympatho-adrenergically	B-X
mediated	B-X
increase	B-X
in	B-X
chemotaxis	B-X
and	B-X
adhesion	B-X
molecules	B-X
expression	B-X
,	B-X
thus	B-X
promoting	B-X
immune	B-X
cells	B-X
migration	B-X
to	B-X
sites	B-X
of	B-X
infection	B-X
and/or	B-X
inflammation	B-X
,	B-X
while	B-X
chronic	B-X
stress	B-X
impairs	B-X
this	B-X
mechanism	B-X
.	B-X
Protracted	B-X
stressful	B-X
conditions	B-X
decrease	B-X
NK	B-X
cytotoxic	B-X
capacity	B-X
.	B-X
There	B-X
is	B-X
a	B-X
substance	B-X
P	B-X
,	B-X
which	B-X
under	B-X
stressful	B-X
circumstances	B-X
mediates	B-X
the	B-X
increase	B-X
in	B-X
macrophage	B-X
cytokine	B-X
production	B-X
.	B-X
Acute	B-X
stress	B-X
increases	B-X
T	B-X
cell	B-X
mobilization	B-X
through	B-X
a	B-X
beta2-adrenergically	B-X
mediated	B-X
process	B-X
,	B-X
which	B-X
is	B-X
blunted	B-X
during	B-X
chronic	B-X
stress	B-X
.	B-X
Psychological	B-X
stress	B-X
impairs	B-X
the	B-X
immune	B-X
system	B-X
's	B-X
ability	B-X
to	B-X
produce	B-X
antibodies	B-X
in	B-X
response	B-X
to	B-X
a	B-X
vaccine	B-X
,	B-X
thereby	B-X
making	B-X
the	B-X
organism	B-X
more	B-X
vulnerable	B-X
to	B-X
infections	B-X
.	B-X

MSK1	B-Gene_or_gene_product
activity	O
is	O
tightly	O
regulated	O
in	O
cells	O
,	O
and	O
activation	O
requires	O
the	O
phosphorylation	O
of	O
MSK1	B-Gene_or_gene_product
by	O
either	O
ERK1	B-Gene_or_gene_product
/	I-Gene_or_gene_product
2	I-Gene_or_gene_product
or	O
p38a	B-Gene_or_gene_product
.	O
<EOS>	B-X
Hirschsprung	B-X
's	B-X
disease	B-X
(	B-X
HSCR	B-X
)	B-X
is	B-X
a	B-X
functional	B-X
obstruction	B-X
of	B-X
the	B-X
gastrointestinal	B-X
tract	B-X
due	B-X
to	B-X
the	B-X
congenital	B-X
absence	B-X
of	B-X
enteric	B-X
ganglion	B-X
cells	B-X
.	B-X
In	B-X
2009	B-X
,	B-X
Fedorov	B-X
et	B-X
al	B-X
.	B-X
Since	B-X
2009	B-X
,	B-X
there	B-X
has	B-X
been	B-X
a	B-X
doubling	B-X
in	B-X
the	B-X
number	B-X
of	B-X
publications	B-X
,	B-X
patents	B-X
,	B-X
and	B-X
drugs	B-X
targeting	B-X
the	B-X
kinome	B-X
.	B-X
To	B-X
investigate	B-X
whether	B-X
the	B-X
p38α	B-X
mitogen-activated	B-X
protein	B-X
kinases	B-X
(	B-X
MAPK	B-X
)	B-X
is	B-X
involved	B-X
in	B-X
bone	B-X
morphogenetic	B-X
protein	B-X
(	B-X
BMP	B-X
)	B-X
-2-induced	B-X
odontoblastic	B-X
differentiation	B-X
of	B-X
human	B-X
dental	B-X
pulp	B-X
cells	B-X
(	B-X
HDPCs	B-X
)	B-X
.	B-X

This	O
results	O
in	O
activation	O
of	O
the	O
C	O
-	O
terminal	O
kinase	O
domain	O
,	O
which	O
then	O
phosphorylates	O
further	O
sites	O
in	O
MSK1	B-Gene_or_gene_product
,	O
leading	O
to	O
the	O
activation	O
of	O
the	O
N	O
-	O
terminal	O
kinase	O
domain	O
and	O
phosphorylation	O
of	O
substrates	O
.	O

Here	O
,	O
we	O
use	O
precursor	O
ion	O
scanning	O
MS	O
to	O
identify	O
five	O
previously	O
unknown	O
sites	O
in	O
MSK1	B-Gene_or_gene_product
:	O
Thr630	O
,	O
Ser647	O
,	O
Ser657	O
,	O
Ser695	O
and	O
Thr700	O
.	O
<EOS>	B-X
MSK1	B-X
(	B-X
mitogen-	B-X
and	B-X
stress-activated	B-X
kinase	B-X
1	B-X
)	B-X
is	B-X
a	B-X
dual	B-X
kinase	B-X
domain	B-X
protein	B-X
that	B-X
acts	B-X
downstream	B-X
of	B-X
the	B-X
ERK1/2	B-X
(	B-X
extracellular-signal-regulated	B-X
kinase	B-X
1/2	B-X
)	B-X
and	B-X
p38	B-X
MAPK	B-X
(	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
)	B-X
signalling	B-X
pathways	B-X
in	B-X
cells	B-X
.	B-X
MSK1	B-X
,	B-X
and	B-X
its	B-X
related	B-X
isoform	B-X
MSK2	B-X
,	B-X
phosphorylate	B-X
the	B-X
transcription	B-X
factors	B-X
CREB	B-X
(	B-X
cAMP-response-element-binding	B-X
protein	B-X
)	B-X
and	B-X
ATF1	B-X
(	B-X
activating	B-X
transcription	B-X
factor	B-X
1	B-X
)	B-X
,	B-X
and	B-X
the	B-X
chromatin	B-X
proteins	B-X
histone	B-X
H3	B-X
and	B-X
HMGN1	B-X
(	B-X
high-mobility-group	B-X
nucleosomal-binding	B-X
protein	B-X
1	B-X
)	B-X
in	B-X
response	B-X
to	B-X
either	B-X
mitogenic	B-X
stimulation	B-X
or	B-X
cellular	B-X
stress	B-X
.	B-X
MSK1	B-X
activity	B-X
is	B-X
tightly	B-X
regulated	B-X
in	B-X
cells	B-X
,	B-X
and	B-X
activation	B-X
requires	B-X
the	B-X
phosphorylation	B-X
of	B-X
MSK1	B-X
by	B-X
either	B-X
ERK1/2	B-X
or	B-X
p38a	B-X
.	B-X
This	B-X
results	B-X
in	B-X
activation	B-X
of	B-X
the	B-X
C-terminal	B-X
kinase	B-X
domain	B-X
,	B-X
which	B-X
then	B-X
phosphorylates	B-X
further	B-X
sites	B-X
in	B-X
MSK1	B-X
,	B-X
leading	B-X
to	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
N-terminal	B-X
kinase	B-X
domain	B-X
and	B-X
phosphorylation	B-X
of	B-X
substrates	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
use	B-X
precursor	B-X
ion	B-X
scanning	B-X
MS	B-X
to	B-X
identify	B-X
five	B-X
previously	B-X
unknown	B-X
sites	B-X
in	B-X
MSK1	B-X
:	B-X
Thr630	B-X
,	B-X
Ser647	B-X
,	B-X
Ser657	B-X
,	B-X
Ser695	B-X
and	B-X
Thr700	B-X
.	B-X
One	B-X
of	B-X
these	B-X
sites	B-X
,	B-X
Thr700	B-X
,	B-X
was	B-X
found	B-X
to	B-X
be	B-X
a	B-X
third	B-X
site	B-X
in	B-X
MSK1	B-X
phosphorylated	B-X
by	B-X
the	B-X
upstream	B-X
kinases	B-X
ERK1/2	B-X
and	B-X
p38a	B-X
.	B-X
Mutation	B-X
of	B-X
Thr700	B-X
resulted	B-X
in	B-X
an	B-X
increased	B-X
basal	B-X
activity	B-X
of	B-X
MSK1	B-X
,	B-X
but	B-X
this	B-X
could	B-X
be	B-X
further	B-X
increased	B-X
by	B-X
stimulation	B-X
with	B-X
PMA	B-X
or	B-X
UV-C	B-X
radiation	B-X
.	B-X
Surprisingly	B-X
,	B-X
however	B-X
,	B-X
mutation	B-X
of	B-X
Thr700	B-X
resulted	B-X
in	B-X
a	B-X
dramatic	B-X
loss	B-X
of	B-X
Thr581	B-X
phosphorylation	B-X
,	B-X
a	B-X
site	B-X
essential	B-X
for	B-X
activity	B-X
.	B-X
Mutation	B-X
of	B-X
Thr700	B-X
and	B-X
Thr581	B-X
to	B-X
an	B-X
alanine	B-X
residue	B-X
resulted	B-X
in	B-X
an	B-X
inactive	B-X
kinase	B-X
,	B-X
while	B-X
mutation	B-X
of	B-X
both	B-X
sites	B-X
to	B-X
an	B-X
aspartic	B-X
acid	B-X
residue	B-X
resulted	B-X
in	B-X
a	B-X
kinase	B-X
with	B-X
a	B-X
significant	B-X
basal	B-X
activity	B-X
that	B-X
could	B-X
not	B-X
be	B-X
further	B-X
stimulated	B-X
.	B-X
Together	B-X
these	B-X
results	B-X
are	B-X
consistent	B-X
with	B-X
a	B-X
mechanism	B-X
by	B-X
which	B-X
Thr700	B-X
phosphorylation	B-X
relieves	B-X
the	B-X
inhibition	B-X
of	B-X
MSK1	B-X
by	B-X
a	B-X
C-terminal	B-X
autoinhibitory	B-X
helix	B-X
and	B-X
helps	B-X
induce	B-X
a	B-X
conformational	B-X
shift	B-X
that	B-X
protects	B-X
Thr581	B-X
from	B-X
dephosphorylation	B-X
.	B-X

One	O
of	O
these	O
sites	O
,	O
Thr700	O
,	O
was	O
found	O
to	O
be	O
a	O
third	O
site	O
in	O
MSK1	B-Gene_or_gene_product
phosphorylated	O
by	O
the	O
upstream	O
kinases	O
ERK1	B-Gene_or_gene_product
/	I-Gene_or_gene_product
2	I-Gene_or_gene_product
and	O
p38a	B-Gene_or_gene_product
.	O
<EOS>	B-X
MSK1	B-X
(	B-X
mitogen-	B-X
and	B-X
stress-activated	B-X
kinase	B-X
1	B-X
)	B-X
is	B-X
a	B-X
dual	B-X
kinase	B-X
domain	B-X
protein	B-X
that	B-X
acts	B-X
downstream	B-X
of	B-X
the	B-X
ERK1/2	B-X
(	B-X
extracellular-signal-regulated	B-X
kinase	B-X
1/2	B-X
)	B-X
and	B-X
p38	B-X
MAPK	B-X
(	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
)	B-X
signalling	B-X
pathways	B-X
in	B-X
cells	B-X
.	B-X
MSK1	B-X
,	B-X
and	B-X
its	B-X
related	B-X
isoform	B-X
MSK2	B-X
,	B-X
phosphorylate	B-X
the	B-X
transcription	B-X
factors	B-X
CREB	B-X
(	B-X
cAMP-response-element-binding	B-X
protein	B-X
)	B-X
and	B-X
ATF1	B-X
(	B-X
activating	B-X
transcription	B-X
factor	B-X
1	B-X
)	B-X
,	B-X
and	B-X
the	B-X
chromatin	B-X
proteins	B-X
histone	B-X
H3	B-X
and	B-X
HMGN1	B-X
(	B-X
high-mobility-group	B-X
nucleosomal-binding	B-X
protein	B-X
1	B-X
)	B-X
in	B-X
response	B-X
to	B-X
either	B-X
mitogenic	B-X
stimulation	B-X
or	B-X
cellular	B-X
stress	B-X
.	B-X
MSK1	B-X
activity	B-X
is	B-X
tightly	B-X
regulated	B-X
in	B-X
cells	B-X
,	B-X
and	B-X
activation	B-X
requires	B-X
the	B-X
phosphorylation	B-X
of	B-X
MSK1	B-X
by	B-X
either	B-X
ERK1/2	B-X
or	B-X
p38a	B-X
.	B-X
This	B-X
results	B-X
in	B-X
activation	B-X
of	B-X
the	B-X
C-terminal	B-X
kinase	B-X
domain	B-X
,	B-X
which	B-X
then	B-X
phosphorylates	B-X
further	B-X
sites	B-X
in	B-X
MSK1	B-X
,	B-X
leading	B-X
to	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
N-terminal	B-X
kinase	B-X
domain	B-X
and	B-X
phosphorylation	B-X
of	B-X
substrates	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
use	B-X
precursor	B-X
ion	B-X
scanning	B-X
MS	B-X
to	B-X
identify	B-X
five	B-X
previously	B-X
unknown	B-X
sites	B-X
in	B-X
MSK1	B-X
:	B-X
Thr630	B-X
,	B-X
Ser647	B-X
,	B-X
Ser657	B-X
,	B-X
Ser695	B-X
and	B-X
Thr700	B-X
.	B-X
One	B-X
of	B-X
these	B-X
sites	B-X
,	B-X
Thr700	B-X
,	B-X
was	B-X
found	B-X
to	B-X
be	B-X
a	B-X
third	B-X
site	B-X
in	B-X
MSK1	B-X
phosphorylated	B-X
by	B-X
the	B-X
upstream	B-X
kinases	B-X
ERK1/2	B-X
and	B-X
p38a	B-X
.	B-X
Mutation	B-X
of	B-X
Thr700	B-X
resulted	B-X
in	B-X
an	B-X
increased	B-X
basal	B-X
activity	B-X
of	B-X
MSK1	B-X
,	B-X
but	B-X
this	B-X
could	B-X
be	B-X
further	B-X
increased	B-X
by	B-X
stimulation	B-X
with	B-X
PMA	B-X
or	B-X
UV-C	B-X
radiation	B-X
.	B-X
Surprisingly	B-X
,	B-X
however	B-X
,	B-X
mutation	B-X
of	B-X
Thr700	B-X
resulted	B-X
in	B-X
a	B-X
dramatic	B-X
loss	B-X
of	B-X
Thr581	B-X
phosphorylation	B-X
,	B-X
a	B-X
site	B-X
essential	B-X
for	B-X
activity	B-X
.	B-X
Mutation	B-X
of	B-X
Thr700	B-X
and	B-X
Thr581	B-X
to	B-X
an	B-X
alanine	B-X
residue	B-X
resulted	B-X
in	B-X
an	B-X
inactive	B-X
kinase	B-X
,	B-X
while	B-X
mutation	B-X
of	B-X
both	B-X
sites	B-X
to	B-X
an	B-X
aspartic	B-X
acid	B-X
residue	B-X
resulted	B-X
in	B-X
a	B-X
kinase	B-X
with	B-X
a	B-X
significant	B-X
basal	B-X
activity	B-X
that	B-X
could	B-X
not	B-X
be	B-X
further	B-X
stimulated	B-X
.	B-X
Together	B-X
these	B-X
results	B-X
are	B-X
consistent	B-X
with	B-X
a	B-X
mechanism	B-X
by	B-X
which	B-X
Thr700	B-X
phosphorylation	B-X
relieves	B-X
the	B-X
inhibition	B-X
of	B-X
MSK1	B-X
by	B-X
a	B-X
C-terminal	B-X
autoinhibitory	B-X
helix	B-X
and	B-X
helps	B-X
induce	B-X
a	B-X
conformational	B-X
shift	B-X
that	B-X
protects	B-X
Thr581	B-X
from	B-X
dephosphorylation	B-X
.	B-X

Mutation	O
of	O
Thr700	O
resulted	O
in	O
an	O
increased	O
basal	O
activity	O
of	O
MSK1	B-Gene_or_gene_product
,	O
but	O
this	O
could	O
be	O
further	O
increased	O
by	O
stimulation	O
with	O
PMA	O
or	O
UV	O
-	O
C	O
radiation	O
.	O
<EOS>	B-X
Demand	B-X
for	B-X
healthy	B-X
,	B-X
safe	B-X
,	B-X
and	B-X
high-quality	B-X
foods	B-X
and	B-X
disadvantages	B-X
of	B-X
thermal	B-X
processing	B-X
methods	B-X
such	B-X
as	B-X
quality	B-X
losses	B-X
supported	B-X
the	B-X
improvement	B-X
of	B-X
the	B-X
novel	B-X
,	B-X
affordable	B-X
,	B-X
and	B-X
quick	B-X
nonthermal	B-X
food	B-X
preservation	B-X
techniques	B-X
such	B-X
as	B-X
UV	B-X
light	B-X
.	B-X
UV-C	B-X
light	B-X
(	B-X
200-280	B-X
nm	B-X
)	B-X
radiation	B-X
is	B-X
an	B-X
emerging	B-X
technology	B-X
for	B-X
the	B-X
disinfection	B-X
of	B-X
pathogen	B-X
microorganisms	B-X
,	B-X
increasing	B-X
the	B-X
shelf	B-X
life	B-X
of	B-X
foods	B-X
,	B-X
and	B-X
used	B-X
for	B-X
pasteurization	B-X
,	B-X
surface	B-X
sterilization	B-X
,	B-X
cleaning	B-X
of	B-X
equipment	B-X
and	B-X
water	B-X
,	B-X
and	B-X
so	B-X
on	B-X
.	B-X
Rheological	B-X
and	B-X
textural	B-X
changes	B-X
generally	B-X
occur	B-X
in	B-X
the	B-X
surface	B-X
of	B-X
UV-C-irradiated	B-X
samples	B-X
due	B-X
to	B-X
the	B-X
low	B-X
penetration	B-X
of	B-X
UV-C	B-X
light	B-X
.	B-X
The	B-X
UV	B-X
light	B-X
treatment	B-X
may	B-X
cause	B-X
internal	B-X
disruption	B-X
of	B-X
cell	B-X
membranes	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
cause	B-X
loss	B-X
of	B-X
turgidity	B-X
,	B-X
weaken	B-X
the	B-X
cell	B-X
walls	B-X
,	B-X
and	B-X
contraction	B-X
of	B-X
tissues	B-X
,	B-X
which	B-X
are	B-X
related	B-X
to	B-X
the	B-X
changes	B-X
in	B-X
the	B-X
textural	B-X
and	B-X
rheological	B-X
properties	B-X
of	B-X
foods	B-X
.	B-X
The	B-X
present	B-X
review	B-X
focuses	B-X
on	B-X
the	B-X
effect	B-X
of	B-X
UV-C	B-X
radiation	B-X
on	B-X
the	B-X
rheology	B-X
and	B-X
textural	B-X
properties	B-X
of	B-X
food	B-X
products	B-X
.	B-X

Surprisingly	O
,	O
however	O
,	O
mutation	O
of	O
Thr700	O
resulted	O
in	O
a	O
dramatic	O
loss	O
of	O
Thr581	O
phosphorylation	O
,	O
a	O
site	O
essential	O
for	O
activity	O
.	O

Mutation	O
of	O
Thr700	O
and	O
Thr581	O
to	O
an	O
alanine	O
residue	O
resulted	O
in	O
an	O
inactive	O
kinase	O
,	O
while	O
mutation	O
of	O
both	O
sites	O
to	O
an	O
aspartic	O
acid	O
residue	O
resulted	O
in	O
a	O
kinase	O
with	O
a	O
significant	O
basal	O
activity	O
that	O
could	O
not	O
be	O
further	O
stimulated	O
.	O

Together	O
these	O
results	O
are	O
consistent	O
with	O
a	O
mechanism	O
by	O
which	O
Thr700	O
phosphorylation	O
relieves	O
the	O
inhibition	O
of	O
MSK1	B-Gene_or_gene_product
by	O
a	O
C	O
-	O
terminal	O
autoinhibitory	O
helix	O
and	O
helps	O
induce	O
a	O
conformational	O
shift	O
that	O
protects	O
Thr581	O
from	O
dephosphorylation	O
.	O

The	O
Rtt109	O
-	O
Vps75	O
histone	B-Gene_or_gene_product
acetyltransferase	I-Gene_or_gene_product
complex	O
acetylates	O
non	O
-	O
nucleosomal	O
histone	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
.	O
<EOS>	B-X
Acetylation	B-X
of	B-X
lysine	B-X
56	B-X
of	B-X
histone	B-X
H3	B-X
(	B-X
H3-Lys-56	B-X
)	B-X
occurs	B-X
in	B-X
S	B-X
phase	B-X
and	B-X
disappears	B-X
during	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
We	B-X
and	B-X
others	B-X
have	B-X
shown	B-X
that	B-X
the	B-X
histone	B-X
acetyltransferase	B-X
(	B-X
HAT	B-X
)	B-X
Rtt109	B-X
is	B-X
the	B-X
primary	B-X
HAT	B-X
responsible	B-X
for	B-X
acetylating	B-X
H3-Lys-56	B-X
in	B-X
budding	B-X
yeast	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Rtt109	B-X
forms	B-X
a	B-X
complex	B-X
with	B-X
Vps75	B-X
and	B-X
that	B-X
both	B-X
recombinant	B-X
Rtt109-Vps75	B-X
complexes	B-X
and	B-X
native	B-X
complexes	B-X
purified	B-X
from	B-X
yeast	B-X
cells	B-X
acetylate	B-X
H3	B-X
present	B-X
in	B-X
H3/H4/H2A/H2B	B-X
core	B-X
histones	B-X
but	B-X
not	B-X
other	B-X
histones	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
both	B-X
recombinant	B-X
and	B-X
native	B-X
Rtt109-Vps75	B-X
HAT	B-X
complexes	B-X
exhibited	B-X
no	B-X
detectable	B-X
activity	B-X
toward	B-X
nucleosomal	B-X
H3	B-X
,	B-X
suggesting	B-X
that	B-X
H3-Lys-56	B-X
acetylation	B-X
is	B-X
at	B-X
least	B-X
in	B-X
part	B-X
regulated	B-X
by	B-X
the	B-X
inability	B-X
of	B-X
Rtt109-Vps75	B-X
complexes	B-X
to	B-X
acetylate	B-X
nucleosomal	B-X
H3	B-X
during	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Further	B-X
,	B-X
Rtt109	B-X
bound	B-X
mutant	B-X
H3/H4	B-X
tetramers	B-X
composed	B-X
of	B-X
histones	B-X
lacking	B-X
their	B-X
N-terminal	B-X
tail	B-X
domains	B-X
less	B-X
efficiently	B-X
than	B-X
wild-type	B-X
H3/H4	B-X
tetramers	B-X
,	B-X
and	B-X
Rtt109-Vps75	B-X
complexes	B-X
displayed	B-X
reduced	B-X
HAT	B-X
activity	B-X
toward	B-X
these	B-X
mutant	B-X
H3/H4	B-X
tetramers	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
N	B-X
termini	B-X
of	B-X
H3/H4	B-X
tetramers	B-X
are	B-X
required	B-X
for	B-X
efficient	B-X
acetylation	B-X
of	B-X
H3	B-X
by	B-X
the	B-X
Rtt109-Vps75	B-X
complex	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
studies	B-X
provide	B-X
insights	B-X
into	B-X
how	B-X
H3-Lys-56	B-X
acetylation	B-X
is	B-X
regulated	B-X
during	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X

Acetylation	O
of	O
lysine	O
56	O
of	O
histone	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
(	O
H3	B-Gene_or_gene_product
-	O
Lys	O
-	O
56	O
)	O
occurs	O
in	O
S	O
phase	O
and	O
disappears	O
during	O
G	O
(	O
2	O
)	O
/	O
M	O
phase	O
of	O
the	O
cell	O
cycle	O
.	O

However	O
,	O
it	O
is	O
not	O
clear	O
how	O
this	O
modification	O
is	O
regulated	O
during	O
the	O
progression	O
of	O
the	O
cell	O
cycle	O
.	O

We	O
and	O
others	O
have	O
shown	O
that	O
the	O
histone	B-Gene_or_gene_product
acetyltransferase	I-Gene_or_gene_product
(	O
HAT	B-Gene_or_gene_product
)	O
Rtt109	B-Gene_or_gene_product
is	O
the	O
primary	O
HAT	B-Gene_or_gene_product
responsible	O
for	O
acetylating	O
H3	B-Gene_or_gene_product
-	O
Lys	O
-	O
56	O
in	O
budding	O
yeast	O
.	O
<EOS>	B-X
Acetylation	B-X
of	B-X
lysine	B-X
56	B-X
of	B-X
histone	B-X
H3	B-X
(	B-X
H3-Lys-56	B-X
)	B-X
occurs	B-X
in	B-X
S	B-X
phase	B-X
and	B-X
disappears	B-X
during	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
We	B-X
and	B-X
others	B-X
have	B-X
shown	B-X
that	B-X
the	B-X
histone	B-X
acetyltransferase	B-X
(	B-X
HAT	B-X
)	B-X
Rtt109	B-X
is	B-X
the	B-X
primary	B-X
HAT	B-X
responsible	B-X
for	B-X
acetylating	B-X
H3-Lys-56	B-X
in	B-X
budding	B-X
yeast	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Rtt109	B-X
forms	B-X
a	B-X
complex	B-X
with	B-X
Vps75	B-X
and	B-X
that	B-X
both	B-X
recombinant	B-X
Rtt109-Vps75	B-X
complexes	B-X
and	B-X
native	B-X
complexes	B-X
purified	B-X
from	B-X
yeast	B-X
cells	B-X
acetylate	B-X
H3	B-X
present	B-X
in	B-X
H3/H4/H2A/H2B	B-X
core	B-X
histones	B-X
but	B-X
not	B-X
other	B-X
histones	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
both	B-X
recombinant	B-X
and	B-X
native	B-X
Rtt109-Vps75	B-X
HAT	B-X
complexes	B-X
exhibited	B-X
no	B-X
detectable	B-X
activity	B-X
toward	B-X
nucleosomal	B-X
H3	B-X
,	B-X
suggesting	B-X
that	B-X
H3-Lys-56	B-X
acetylation	B-X
is	B-X
at	B-X
least	B-X
in	B-X
part	B-X
regulated	B-X
by	B-X
the	B-X
inability	B-X
of	B-X
Rtt109-Vps75	B-X
complexes	B-X
to	B-X
acetylate	B-X
nucleosomal	B-X
H3	B-X
during	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Further	B-X
,	B-X
Rtt109	B-X
bound	B-X
mutant	B-X
H3/H4	B-X
tetramers	B-X
composed	B-X
of	B-X
histones	B-X
lacking	B-X
their	B-X
N-terminal	B-X
tail	B-X
domains	B-X
less	B-X
efficiently	B-X
than	B-X
wild-type	B-X
H3/H4	B-X
tetramers	B-X
,	B-X
and	B-X
Rtt109-Vps75	B-X
complexes	B-X
displayed	B-X
reduced	B-X
HAT	B-X
activity	B-X
toward	B-X
these	B-X
mutant	B-X
H3/H4	B-X
tetramers	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
N	B-X
termini	B-X
of	B-X
H3/H4	B-X
tetramers	B-X
are	B-X
required	B-X
for	B-X
efficient	B-X
acetylation	B-X
of	B-X
H3	B-X
by	B-X
the	B-X
Rtt109-Vps75	B-X
complex	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
studies	B-X
provide	B-X
insights	B-X
into	B-X
how	B-X
H3-Lys-56	B-X
acetylation	B-X
is	B-X
regulated	B-X
during	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X

Here	O
we	O
show	O
that	O
Rtt109	B-Gene_or_gene_product
forms	O
a	O
complex	O
with	O
Vps75	B-Gene_or_gene_product
and	O
that	O
both	O
recombinant	O
Rtt109	O
-	O
Vps75	O
complexes	O
and	O
native	O
complexes	O
purified	O
from	O
yeast	O
cells	O
acetylate	O
H3	B-Gene_or_gene_product
present	O
in	O
H3	B-Gene_or_gene_product
/	O
H4	B-Gene_or_gene_product
/	O
H2A	B-Gene_or_gene_product
/	O
H2B	B-Gene_or_gene_product
core	O
histones	B-Gene_or_gene_product
but	O
not	O
other	O
histones	B-Gene_or_gene_product
.	O

In	O
addition	O
,	O
both	O
recombinant	O
and	O
native	O
Rtt109	O
-	O
Vps75	O
HAT	B-Gene_or_gene_product
complexes	O
exhibited	O
no	O
detectable	O
activity	O
toward	O
nucleosomal	O
H3	B-Gene_or_gene_product
,	O
suggesting	O
that	O
H3	B-Gene_or_gene_product
-	O
Lys	O
-	O
56	O
acetylation	O
is	O
at	O
least	O
in	O
part	O
regulated	O
by	O
the	O
inability	O
of	O
Rtt109	O
-	O
Vps75	O
complexes	O
to	O
acetylate	O
nucleosomal	O
H3	B-Gene_or_gene_product
during	O
G	O
(	O
2	O
)	O
/	O
M	O
phase	O
of	O
the	O
cell	O
cycle	O
.	O

Further	O
,	O
Rtt109	B-Gene_or_gene_product
bound	O
mutant	O
H3	O
/	O
H4	O
tetramers	O
composed	O
of	O
histones	B-Gene_or_gene_product
lacking	O
their	O
N	O
-	O
terminal	O
tail	O
domains	O
less	O
efficiently	O
than	O
wild	O
-	O
type	O
H3	O
/	O
H4	O
tetramers	O
,	O
and	O
Rtt109	O
-	O
Vps75	O
complexes	O
displayed	O
reduced	O
HAT	B-Gene_or_gene_product
activity	O
toward	O
these	O
mutant	O
H3	O
/	O
H4	O
tetramers	O
.	O
<EOS>	B-X
Acetylation	B-X
of	B-X
lysine	B-X
56	B-X
of	B-X
histone	B-X
H3	B-X
(	B-X
H3-Lys-56	B-X
)	B-X
occurs	B-X
in	B-X
S	B-X
phase	B-X
and	B-X
disappears	B-X
during	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
We	B-X
and	B-X
others	B-X
have	B-X
shown	B-X
that	B-X
the	B-X
histone	B-X
acetyltransferase	B-X
(	B-X
HAT	B-X
)	B-X
Rtt109	B-X
is	B-X
the	B-X
primary	B-X
HAT	B-X
responsible	B-X
for	B-X
acetylating	B-X
H3-Lys-56	B-X
in	B-X
budding	B-X
yeast	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Rtt109	B-X
forms	B-X
a	B-X
complex	B-X
with	B-X
Vps75	B-X
and	B-X
that	B-X
both	B-X
recombinant	B-X
Rtt109-Vps75	B-X
complexes	B-X
and	B-X
native	B-X
complexes	B-X
purified	B-X
from	B-X
yeast	B-X
cells	B-X
acetylate	B-X
H3	B-X
present	B-X
in	B-X
H3/H4/H2A/H2B	B-X
core	B-X
histones	B-X
but	B-X
not	B-X
other	B-X
histones	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
both	B-X
recombinant	B-X
and	B-X
native	B-X
Rtt109-Vps75	B-X
HAT	B-X
complexes	B-X
exhibited	B-X
no	B-X
detectable	B-X
activity	B-X
toward	B-X
nucleosomal	B-X
H3	B-X
,	B-X
suggesting	B-X
that	B-X
H3-Lys-56	B-X
acetylation	B-X
is	B-X
at	B-X
least	B-X
in	B-X
part	B-X
regulated	B-X
by	B-X
the	B-X
inability	B-X
of	B-X
Rtt109-Vps75	B-X
complexes	B-X
to	B-X
acetylate	B-X
nucleosomal	B-X
H3	B-X
during	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Further	B-X
,	B-X
Rtt109	B-X
bound	B-X
mutant	B-X
H3/H4	B-X
tetramers	B-X
composed	B-X
of	B-X
histones	B-X
lacking	B-X
their	B-X
N-terminal	B-X
tail	B-X
domains	B-X
less	B-X
efficiently	B-X
than	B-X
wild-type	B-X
H3/H4	B-X
tetramers	B-X
,	B-X
and	B-X
Rtt109-Vps75	B-X
complexes	B-X
displayed	B-X
reduced	B-X
HAT	B-X
activity	B-X
toward	B-X
these	B-X
mutant	B-X
H3/H4	B-X
tetramers	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
N	B-X
termini	B-X
of	B-X
H3/H4	B-X
tetramers	B-X
are	B-X
required	B-X
for	B-X
efficient	B-X
acetylation	B-X
of	B-X
H3	B-X
by	B-X
the	B-X
Rtt109-Vps75	B-X
complex	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
studies	B-X
provide	B-X
insights	B-X
into	B-X
how	B-X
H3-Lys-56	B-X
acetylation	B-X
is	B-X
regulated	B-X
during	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X

Thus	O
,	O
the	O
N	O
termini	O
of	O
H3	O
/	O
H4	O
tetramers	O
are	O
required	O
for	O
efficient	O
acetylation	O
of	O
H3	B-Gene_or_gene_product
by	O
the	O
Rtt109	O
-	O
Vps75	O
complex	O
.	O

Taken	O
together	O
,	O
these	O
studies	O
provide	O
insights	O
into	O
how	O
H3	B-Gene_or_gene_product
-	O
Lys	O
-	O
56	O
acetylation	O
is	O
regulated	O
during	O
the	O
cell	O
cycle	O
.	O
<EOS>	B-X
Acetylation	B-X
of	B-X
lysine	B-X
56	B-X
of	B-X
histone	B-X
H3	B-X
(	B-X
H3-Lys-56	B-X
)	B-X
occurs	B-X
in	B-X
S	B-X
phase	B-X
and	B-X
disappears	B-X
during	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
However	B-X
,	B-X
it	B-X
is	B-X
not	B-X
clear	B-X
how	B-X
this	B-X
modification	B-X
is	B-X
regulated	B-X
during	B-X
the	B-X
progression	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
We	B-X
and	B-X
others	B-X
have	B-X
shown	B-X
that	B-X
the	B-X
histone	B-X
acetyltransferase	B-X
(	B-X
HAT	B-X
)	B-X
Rtt109	B-X
is	B-X
the	B-X
primary	B-X
HAT	B-X
responsible	B-X
for	B-X
acetylating	B-X
H3-Lys-56	B-X
in	B-X
budding	B-X
yeast	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Rtt109	B-X
forms	B-X
a	B-X
complex	B-X
with	B-X
Vps75	B-X
and	B-X
that	B-X
both	B-X
recombinant	B-X
Rtt109-Vps75	B-X
complexes	B-X
and	B-X
native	B-X
complexes	B-X
purified	B-X
from	B-X
yeast	B-X
cells	B-X
acetylate	B-X
H3	B-X
present	B-X
in	B-X
H3/H4/H2A/H2B	B-X
core	B-X
histones	B-X
but	B-X
not	B-X
other	B-X
histones	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
both	B-X
recombinant	B-X
and	B-X
native	B-X
Rtt109-Vps75	B-X
HAT	B-X
complexes	B-X
exhibited	B-X
no	B-X
detectable	B-X
activity	B-X
toward	B-X
nucleosomal	B-X
H3	B-X
,	B-X
suggesting	B-X
that	B-X
H3-Lys-56	B-X
acetylation	B-X
is	B-X
at	B-X
least	B-X
in	B-X
part	B-X
regulated	B-X
by	B-X
the	B-X
inability	B-X
of	B-X
Rtt109-Vps75	B-X
complexes	B-X
to	B-X
acetylate	B-X
nucleosomal	B-X
H3	B-X
during	B-X
G	B-X
(	B-X
2	B-X
)	B-X
/M	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Further	B-X
,	B-X
Rtt109	B-X
bound	B-X
mutant	B-X
H3/H4	B-X
tetramers	B-X
composed	B-X
of	B-X
histones	B-X
lacking	B-X
their	B-X
N-terminal	B-X
tail	B-X
domains	B-X
less	B-X
efficiently	B-X
than	B-X
wild-type	B-X
H3/H4	B-X
tetramers	B-X
,	B-X
and	B-X
Rtt109-Vps75	B-X
complexes	B-X
displayed	B-X
reduced	B-X
HAT	B-X
activity	B-X
toward	B-X
these	B-X
mutant	B-X
H3/H4	B-X
tetramers	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
N	B-X
termini	B-X
of	B-X
H3/H4	B-X
tetramers	B-X
are	B-X
required	B-X
for	B-X
efficient	B-X
acetylation	B-X
of	B-X
H3	B-X
by	B-X
the	B-X
Rtt109-Vps75	B-X
complex	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
studies	B-X
provide	B-X
insights	B-X
into	B-X
how	B-X
H3-Lys-56	B-X
acetylation	B-X
is	B-X
regulated	B-X
during	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X

The	O
Aurora	B-Gene_or_gene_product
kinase	O
Ipl1	B-Gene_or_gene_product
maintains	O
the	O
centromeric	O
localization	O
of	O
PP2A	O
to	O
protect	O
cohesin	O
during	O
meiosis	O
.	O
<EOS>	B-X
Homologue	B-X
segregation	B-X
during	B-X
the	B-X
first	B-X
meiotic	B-X
division	B-X
requires	B-X
the	B-X
proper	B-X
spatial	B-X
regulation	B-X
of	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
and	B-X
its	B-X
dissolution	B-X
along	B-X
chromosome	B-X
arms	B-X
,	B-X
but	B-X
its	B-X
protection	B-X
at	B-X
centromeric	B-X
regions	B-X
.	B-X
This	B-X
protection	B-X
requires	B-X
the	B-X
conserved	B-X
MEI-S332/Sgo1	B-X
proteins	B-X
that	B-X
localize	B-X
to	B-X
centromeric	B-X
regions	B-X
and	B-X
also	B-X
recruit	B-X
the	B-X
PP2A	B-X
phosphatase	B-X
by	B-X
binding	B-X
its	B-X
regulatory	B-X
subunit	B-X
,	B-X
Rts1	B-X
.	B-X
Centromeric	B-X
Rts1/PP2A	B-X
then	B-X
locally	B-X
prevents	B-X
cohesion	B-X
dissolution	B-X
possibly	B-X
by	B-X
dephosphorylating	B-X
the	B-X
protein	B-X
complex	B-X
cohesin	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Aurora	B-X
B	B-X
kinase	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
(	B-X
Ipl1	B-X
)	B-X
is	B-X
also	B-X
essential	B-X
for	B-X
the	B-X
protection	B-X
of	B-X
meiotic	B-X
centromeric	B-X
cohesion	B-X
.	B-X
Coupled	B-X
with	B-X
a	B-X
previous	B-X
study	B-X
in	B-X
Drosophila	B-X
melanogaster	B-X
,	B-X
this	B-X
meiotic	B-X
function	B-X
of	B-X
Aurora	B-X
B	B-X
kinase	B-X
appears	B-X
to	B-X
be	B-X
conserved	B-X
among	B-X
eukaryotes	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Sgo1	B-X
recruits	B-X
Ipl1	B-X
to	B-X
centromeric	B-X
regions	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
Ipl1	B-X
,	B-X
Rts1	B-X
can	B-X
initially	B-X
bind	B-X
to	B-X
centromeric	B-X
regions	B-X
but	B-X
disappears	B-X
from	B-X
these	B-X
regions	B-X
after	B-X
anaphase	B-X
I	B-X
onset	B-X
.	B-X
We	B-X
suggest	B-X
that	B-X
centromeric	B-X
Ipl1	B-X
ensures	B-X
the	B-X
continued	B-X
centromeric	B-X
presence	B-X
of	B-X
active	B-X
Rts1/PP2A	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
locally	B-X
protects	B-X
cohesin	B-X
and	B-X
cohesion	B-X
.	B-X

Homologue	O
segregation	O
during	O
the	O
first	O
meiotic	O
division	O
requires	O
the	O
proper	O
spatial	O
regulation	O
of	O
sister	O
chromatid	O
cohesion	O
and	O
its	O
dissolution	O
along	O
chromosome	O
arms	O
,	O
but	O
its	O
protection	O
at	O
centromeric	O
regions	O
.	O
<EOS>	B-X
Homologue	B-X
segregation	B-X
during	B-X
the	B-X
first	B-X
meiotic	B-X
division	B-X
requires	B-X
the	B-X
proper	B-X
spatial	B-X
regulation	B-X
of	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
and	B-X
its	B-X
dissolution	B-X
along	B-X
chromosome	B-X
arms	B-X
,	B-X
but	B-X
its	B-X
protection	B-X
at	B-X
centromeric	B-X
regions	B-X
.	B-X
This	B-X
protection	B-X
requires	B-X
the	B-X
conserved	B-X
MEI-S332/Sgo1	B-X
proteins	B-X
that	B-X
localize	B-X
to	B-X
centromeric	B-X
regions	B-X
and	B-X
also	B-X
recruit	B-X
the	B-X
PP2A	B-X
phosphatase	B-X
by	B-X
binding	B-X
its	B-X
regulatory	B-X
subunit	B-X
,	B-X
Rts1	B-X
.	B-X
Centromeric	B-X
Rts1/PP2A	B-X
then	B-X
locally	B-X
prevents	B-X
cohesion	B-X
dissolution	B-X
possibly	B-X
by	B-X
dephosphorylating	B-X
the	B-X
protein	B-X
complex	B-X
cohesin	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Aurora	B-X
B	B-X
kinase	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
(	B-X
Ipl1	B-X
)	B-X
is	B-X
also	B-X
essential	B-X
for	B-X
the	B-X
protection	B-X
of	B-X
meiotic	B-X
centromeric	B-X
cohesion	B-X
.	B-X
Coupled	B-X
with	B-X
a	B-X
previous	B-X
study	B-X
in	B-X
Drosophila	B-X
melanogaster	B-X
,	B-X
this	B-X
meiotic	B-X
function	B-X
of	B-X
Aurora	B-X
B	B-X
kinase	B-X
appears	B-X
to	B-X
be	B-X
conserved	B-X
among	B-X
eukaryotes	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Sgo1	B-X
recruits	B-X
Ipl1	B-X
to	B-X
centromeric	B-X
regions	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
Ipl1	B-X
,	B-X
Rts1	B-X
can	B-X
initially	B-X
bind	B-X
to	B-X
centromeric	B-X
regions	B-X
but	B-X
disappears	B-X
from	B-X
these	B-X
regions	B-X
after	B-X
anaphase	B-X
I	B-X
onset	B-X
.	B-X
We	B-X
suggest	B-X
that	B-X
centromeric	B-X
Ipl1	B-X
ensures	B-X
the	B-X
continued	B-X
centromeric	B-X
presence	B-X
of	B-X
active	B-X
Rts1/PP2A	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
locally	B-X
protects	B-X
cohesin	B-X
and	B-X
cohesion	B-X
.	B-X

This	O
protection	O
requires	O
the	O
conserved	O
MEI	B-Gene_or_gene_product
-	I-Gene_or_gene_product
S332	I-Gene_or_gene_product
/	O
Sgo1	B-Gene_or_gene_product
proteins	O
that	O
localize	O
to	O
centromeric	O
regions	O
and	O
also	O
recruit	O
the	O
PP2A	O
phosphatase	O
by	O
binding	O
its	O
regulatory	O
subunit	O
,	O
Rts1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Homologue	B-X
segregation	B-X
during	B-X
the	B-X
first	B-X
meiotic	B-X
division	B-X
requires	B-X
the	B-X
proper	B-X
spatial	B-X
regulation	B-X
of	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
and	B-X
its	B-X
dissolution	B-X
along	B-X
chromosome	B-X
arms	B-X
,	B-X
but	B-X
its	B-X
protection	B-X
at	B-X
centromeric	B-X
regions	B-X
.	B-X
This	B-X
protection	B-X
requires	B-X
the	B-X
conserved	B-X
MEI-S332/Sgo1	B-X
proteins	B-X
that	B-X
localize	B-X
to	B-X
centromeric	B-X
regions	B-X
and	B-X
also	B-X
recruit	B-X
the	B-X
PP2A	B-X
phosphatase	B-X
by	B-X
binding	B-X
its	B-X
regulatory	B-X
subunit	B-X
,	B-X
Rts1	B-X
.	B-X
Centromeric	B-X
Rts1/PP2A	B-X
then	B-X
locally	B-X
prevents	B-X
cohesion	B-X
dissolution	B-X
possibly	B-X
by	B-X
dephosphorylating	B-X
the	B-X
protein	B-X
complex	B-X
cohesin	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Aurora	B-X
B	B-X
kinase	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
(	B-X
Ipl1	B-X
)	B-X
is	B-X
also	B-X
essential	B-X
for	B-X
the	B-X
protection	B-X
of	B-X
meiotic	B-X
centromeric	B-X
cohesion	B-X
.	B-X
Coupled	B-X
with	B-X
a	B-X
previous	B-X
study	B-X
in	B-X
Drosophila	B-X
melanogaster	B-X
,	B-X
this	B-X
meiotic	B-X
function	B-X
of	B-X
Aurora	B-X
B	B-X
kinase	B-X
appears	B-X
to	B-X
be	B-X
conserved	B-X
among	B-X
eukaryotes	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Sgo1	B-X
recruits	B-X
Ipl1	B-X
to	B-X
centromeric	B-X
regions	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
Ipl1	B-X
,	B-X
Rts1	B-X
can	B-X
initially	B-X
bind	B-X
to	B-X
centromeric	B-X
regions	B-X
but	B-X
disappears	B-X
from	B-X
these	B-X
regions	B-X
after	B-X
anaphase	B-X
I	B-X
onset	B-X
.	B-X
We	B-X
suggest	B-X
that	B-X
centromeric	B-X
Ipl1	B-X
ensures	B-X
the	B-X
continued	B-X
centromeric	B-X
presence	B-X
of	B-X
active	B-X
Rts1/PP2A	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
locally	B-X
protects	B-X
cohesin	B-X
and	B-X
cohesion	B-X
.	B-X

Centromeric	O
Rts1	B-Gene_or_gene_product
/	O
PP2A	O
then	O
locally	O
prevents	O
cohesion	O
dissolution	O
possibly	O
by	O
dephosphorylating	O
the	O
protein	O
complex	O
cohesin	O
.	O
<EOS>	B-X
Homologue	B-X
segregation	B-X
during	B-X
the	B-X
first	B-X
meiotic	B-X
division	B-X
requires	B-X
the	B-X
proper	B-X
spatial	B-X
regulation	B-X
of	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
and	B-X
its	B-X
dissolution	B-X
along	B-X
chromosome	B-X
arms	B-X
,	B-X
but	B-X
its	B-X
protection	B-X
at	B-X
centromeric	B-X
regions	B-X
.	B-X
This	B-X
protection	B-X
requires	B-X
the	B-X
conserved	B-X
MEI-S332/Sgo1	B-X
proteins	B-X
that	B-X
localize	B-X
to	B-X
centromeric	B-X
regions	B-X
and	B-X
also	B-X
recruit	B-X
the	B-X
PP2A	B-X
phosphatase	B-X
by	B-X
binding	B-X
its	B-X
regulatory	B-X
subunit	B-X
,	B-X
Rts1	B-X
.	B-X
Centromeric	B-X
Rts1/PP2A	B-X
then	B-X
locally	B-X
prevents	B-X
cohesion	B-X
dissolution	B-X
possibly	B-X
by	B-X
dephosphorylating	B-X
the	B-X
protein	B-X
complex	B-X
cohesin	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Aurora	B-X
B	B-X
kinase	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
(	B-X
Ipl1	B-X
)	B-X
is	B-X
also	B-X
essential	B-X
for	B-X
the	B-X
protection	B-X
of	B-X
meiotic	B-X
centromeric	B-X
cohesion	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
Ipl1	B-X
,	B-X
Rts1	B-X
can	B-X
initially	B-X
bind	B-X
to	B-X
centromeric	B-X
regions	B-X
but	B-X
disappears	B-X
from	B-X
these	B-X
regions	B-X
after	B-X
anaphase	B-X
I	B-X
onset	B-X
.	B-X
We	B-X
suggest	B-X
that	B-X
centromeric	B-X
Ipl1	B-X
ensures	B-X
the	B-X
continued	B-X
centromeric	B-X
presence	B-X
of	B-X
active	B-X
Rts1/PP2A	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
locally	B-X
protects	B-X
cohesin	B-X
and	B-X
cohesion	B-X
.	B-X

We	O
show	O
that	O
Aurora	B-Gene_or_gene_product
B	I-Gene_or_gene_product
kinase	O
in	O
Saccharomyces	O
cerevisiae	O
(	O
Ipl1	B-Gene_or_gene_product
)	O
is	O
also	O
essential	O
for	O
the	O
protection	O
of	O
meiotic	O
centromeric	O
cohesion	O
.	O
<EOS>	B-X
Homologue	B-X
segregation	B-X
during	B-X
the	B-X
first	B-X
meiotic	B-X
division	B-X
requires	B-X
the	B-X
proper	B-X
spatial	B-X
regulation	B-X
of	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
and	B-X
its	B-X
dissolution	B-X
along	B-X
chromosome	B-X
arms	B-X
,	B-X
but	B-X
its	B-X
protection	B-X
at	B-X
centromeric	B-X
regions	B-X
.	B-X
This	B-X
protection	B-X
requires	B-X
the	B-X
conserved	B-X
MEI-S332/Sgo1	B-X
proteins	B-X
that	B-X
localize	B-X
to	B-X
centromeric	B-X
regions	B-X
and	B-X
also	B-X
recruit	B-X
the	B-X
PP2A	B-X
phosphatase	B-X
by	B-X
binding	B-X
its	B-X
regulatory	B-X
subunit	B-X
,	B-X
Rts1	B-X
.	B-X
Centromeric	B-X
Rts1/PP2A	B-X
then	B-X
locally	B-X
prevents	B-X
cohesion	B-X
dissolution	B-X
possibly	B-X
by	B-X
dephosphorylating	B-X
the	B-X
protein	B-X
complex	B-X
cohesin	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Aurora	B-X
B	B-X
kinase	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
(	B-X
Ipl1	B-X
)	B-X
is	B-X
also	B-X
essential	B-X
for	B-X
the	B-X
protection	B-X
of	B-X
meiotic	B-X
centromeric	B-X
cohesion	B-X
.	B-X
Coupled	B-X
with	B-X
a	B-X
previous	B-X
study	B-X
in	B-X
Drosophila	B-X
melanogaster	B-X
,	B-X
this	B-X
meiotic	B-X
function	B-X
of	B-X
Aurora	B-X
B	B-X
kinase	B-X
appears	B-X
to	B-X
be	B-X
conserved	B-X
among	B-X
eukaryotes	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Sgo1	B-X
recruits	B-X
Ipl1	B-X
to	B-X
centromeric	B-X
regions	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
Ipl1	B-X
,	B-X
Rts1	B-X
can	B-X
initially	B-X
bind	B-X
to	B-X
centromeric	B-X
regions	B-X
but	B-X
disappears	B-X
from	B-X
these	B-X
regions	B-X
after	B-X
anaphase	B-X
I	B-X
onset	B-X
.	B-X
We	B-X
suggest	B-X
that	B-X
centromeric	B-X
Ipl1	B-X
ensures	B-X
the	B-X
continued	B-X
centromeric	B-X
presence	B-X
of	B-X
active	B-X
Rts1/PP2A	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
locally	B-X
protects	B-X
cohesin	B-X
and	B-X
cohesion	B-X
.	B-X

Coupled	O
with	O
a	O
previous	O
study	O
in	O
Drosophila	O
melanogaster	O
,	O
this	O
meiotic	O
function	O
of	O
Aurora	B-Gene_or_gene_product
B	I-Gene_or_gene_product
kinase	O
appears	O
to	O
be	O
conserved	O
among	O
eukaryotes	O
.	O
<EOS>	B-X
Homologue	B-X
segregation	B-X
during	B-X
the	B-X
first	B-X
meiotic	B-X
division	B-X
requires	B-X
the	B-X
proper	B-X
spatial	B-X
regulation	B-X
of	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
and	B-X
its	B-X
dissolution	B-X
along	B-X
chromosome	B-X
arms	B-X
,	B-X
but	B-X
its	B-X
protection	B-X
at	B-X
centromeric	B-X
regions	B-X
.	B-X
This	B-X
protection	B-X
requires	B-X
the	B-X
conserved	B-X
MEI-S332/Sgo1	B-X
proteins	B-X
that	B-X
localize	B-X
to	B-X
centromeric	B-X
regions	B-X
and	B-X
also	B-X
recruit	B-X
the	B-X
PP2A	B-X
phosphatase	B-X
by	B-X
binding	B-X
its	B-X
regulatory	B-X
subunit	B-X
,	B-X
Rts1	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Aurora	B-X
B	B-X
kinase	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
(	B-X
Ipl1	B-X
)	B-X
is	B-X
also	B-X
essential	B-X
for	B-X
the	B-X
protection	B-X
of	B-X
meiotic	B-X
centromeric	B-X
cohesion	B-X
.	B-X
Coupled	B-X
with	B-X
a	B-X
previous	B-X
study	B-X
in	B-X
Drosophila	B-X
melanogaster	B-X
,	B-X
this	B-X
meiotic	B-X
function	B-X
of	B-X
Aurora	B-X
B	B-X
kinase	B-X
appears	B-X
to	B-X
be	B-X
conserved	B-X
among	B-X
eukaryotes	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
Ipl1	B-X
,	B-X
Rts1	B-X
can	B-X
initially	B-X
bind	B-X
to	B-X
centromeric	B-X
regions	B-X
but	B-X
disappears	B-X
from	B-X
these	B-X
regions	B-X
after	B-X
anaphase	B-X
I	B-X
onset	B-X
.	B-X

Furthermore	O
,	O
we	O
show	O
that	O
Sgo1	B-Gene_or_gene_product
recruits	O
Ipl1	B-Gene_or_gene_product
to	O
centromeric	O
regions	O
.	O
<EOS>	B-X
Homologue	B-X
segregation	B-X
during	B-X
the	B-X
first	B-X
meiotic	B-X
division	B-X
requires	B-X
the	B-X
proper	B-X
spatial	B-X
regulation	B-X
of	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
and	B-X
its	B-X
dissolution	B-X
along	B-X
chromosome	B-X
arms	B-X
,	B-X
but	B-X
its	B-X
protection	B-X
at	B-X
centromeric	B-X
regions	B-X
.	B-X
This	B-X
protection	B-X
requires	B-X
the	B-X
conserved	B-X
MEI-S332/Sgo1	B-X
proteins	B-X
that	B-X
localize	B-X
to	B-X
centromeric	B-X
regions	B-X
and	B-X
also	B-X
recruit	B-X
the	B-X
PP2A	B-X
phosphatase	B-X
by	B-X
binding	B-X
its	B-X
regulatory	B-X
subunit	B-X
,	B-X
Rts1	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Aurora	B-X
B	B-X
kinase	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
(	B-X
Ipl1	B-X
)	B-X
is	B-X
also	B-X
essential	B-X
for	B-X
the	B-X
protection	B-X
of	B-X
meiotic	B-X
centromeric	B-X
cohesion	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Sgo1	B-X
recruits	B-X
Ipl1	B-X
to	B-X
centromeric	B-X
regions	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
Ipl1	B-X
,	B-X
Rts1	B-X
can	B-X
initially	B-X
bind	B-X
to	B-X
centromeric	B-X
regions	B-X
but	B-X
disappears	B-X
from	B-X
these	B-X
regions	B-X
after	B-X
anaphase	B-X
I	B-X
onset	B-X
.	B-X
We	B-X
suggest	B-X
that	B-X
centromeric	B-X
Ipl1	B-X
ensures	B-X
the	B-X
continued	B-X
centromeric	B-X
presence	B-X
of	B-X
active	B-X
Rts1/PP2A	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
locally	B-X
protects	B-X
cohesin	B-X
and	B-X
cohesion	B-X
.	B-X

In	O
the	O
absence	O
of	O
Ipl1	B-Gene_or_gene_product
,	O
Rts1	B-Gene_or_gene_product
can	O
initially	O
bind	O
to	O
centromeric	O
regions	O
but	O
disappears	O
from	O
these	O
regions	O
after	O
anaphase	O
I	O
onset	O
.	O
<EOS>	B-X
Homologue	B-X
segregation	B-X
during	B-X
the	B-X
first	B-X
meiotic	B-X
division	B-X
requires	B-X
the	B-X
proper	B-X
spatial	B-X
regulation	B-X
of	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
and	B-X
its	B-X
dissolution	B-X
along	B-X
chromosome	B-X
arms	B-X
,	B-X
but	B-X
its	B-X
protection	B-X
at	B-X
centromeric	B-X
regions	B-X
.	B-X
This	B-X
protection	B-X
requires	B-X
the	B-X
conserved	B-X
MEI-S332/Sgo1	B-X
proteins	B-X
that	B-X
localize	B-X
to	B-X
centromeric	B-X
regions	B-X
and	B-X
also	B-X
recruit	B-X
the	B-X
PP2A	B-X
phosphatase	B-X
by	B-X
binding	B-X
its	B-X
regulatory	B-X
subunit	B-X
,	B-X
Rts1	B-X
.	B-X
Centromeric	B-X
Rts1/PP2A	B-X
then	B-X
locally	B-X
prevents	B-X
cohesion	B-X
dissolution	B-X
possibly	B-X
by	B-X
dephosphorylating	B-X
the	B-X
protein	B-X
complex	B-X
cohesin	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Aurora	B-X
B	B-X
kinase	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
(	B-X
Ipl1	B-X
)	B-X
is	B-X
also	B-X
essential	B-X
for	B-X
the	B-X
protection	B-X
of	B-X
meiotic	B-X
centromeric	B-X
cohesion	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Sgo1	B-X
recruits	B-X
Ipl1	B-X
to	B-X
centromeric	B-X
regions	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
Ipl1	B-X
,	B-X
Rts1	B-X
can	B-X
initially	B-X
bind	B-X
to	B-X
centromeric	B-X
regions	B-X
but	B-X
disappears	B-X
from	B-X
these	B-X
regions	B-X
after	B-X
anaphase	B-X
I	B-X
onset	B-X
.	B-X
We	B-X
suggest	B-X
that	B-X
centromeric	B-X
Ipl1	B-X
ensures	B-X
the	B-X
continued	B-X
centromeric	B-X
presence	B-X
of	B-X
active	B-X
Rts1/PP2A	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
locally	B-X
protects	B-X
cohesin	B-X
and	B-X
cohesion	B-X
.	B-X

We	O
suggest	O
that	O
centromeric	O
Ipl1	B-Gene_or_gene_product
ensures	O
the	O
continued	O
centromeric	O
presence	O
of	O
active	O
Rts1	B-Gene_or_gene_product
/	O
PP2A	O
,	O
which	O
in	O
turn	O
locally	O
protects	O
cohesin	O
and	O
cohesion	O
.	O
<EOS>	B-X
Homologue	B-X
segregation	B-X
during	B-X
the	B-X
first	B-X
meiotic	B-X
division	B-X
requires	B-X
the	B-X
proper	B-X
spatial	B-X
regulation	B-X
of	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
and	B-X
its	B-X
dissolution	B-X
along	B-X
chromosome	B-X
arms	B-X
,	B-X
but	B-X
its	B-X
protection	B-X
at	B-X
centromeric	B-X
regions	B-X
.	B-X
This	B-X
protection	B-X
requires	B-X
the	B-X
conserved	B-X
MEI-S332/Sgo1	B-X
proteins	B-X
that	B-X
localize	B-X
to	B-X
centromeric	B-X
regions	B-X
and	B-X
also	B-X
recruit	B-X
the	B-X
PP2A	B-X
phosphatase	B-X
by	B-X
binding	B-X
its	B-X
regulatory	B-X
subunit	B-X
,	B-X
Rts1	B-X
.	B-X
Centromeric	B-X
Rts1/PP2A	B-X
then	B-X
locally	B-X
prevents	B-X
cohesion	B-X
dissolution	B-X
possibly	B-X
by	B-X
dephosphorylating	B-X
the	B-X
protein	B-X
complex	B-X
cohesin	B-X
.	B-X
We	B-X
show	B-X
that	B-X
Aurora	B-X
B	B-X
kinase	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
(	B-X
Ipl1	B-X
)	B-X
is	B-X
also	B-X
essential	B-X
for	B-X
the	B-X
protection	B-X
of	B-X
meiotic	B-X
centromeric	B-X
cohesion	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
Sgo1	B-X
recruits	B-X
Ipl1	B-X
to	B-X
centromeric	B-X
regions	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
Ipl1	B-X
,	B-X
Rts1	B-X
can	B-X
initially	B-X
bind	B-X
to	B-X
centromeric	B-X
regions	B-X
but	B-X
disappears	B-X
from	B-X
these	B-X
regions	B-X
after	B-X
anaphase	B-X
I	B-X
onset	B-X
.	B-X
We	B-X
suggest	B-X
that	B-X
centromeric	B-X
Ipl1	B-X
ensures	B-X
the	B-X
continued	B-X
centromeric	B-X
presence	B-X
of	B-X
active	B-X
Rts1/PP2A	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
locally	B-X
protects	B-X
cohesin	B-X
and	B-X
cohesion	B-X
.	B-X

PRAS40	B-Gene_or_gene_product
is	O
an	O
insulin	B-Gene_or_gene_product
-	O
regulated	O
inhibitor	O
of	O
the	O
mTORC1	O
protein	O
kinase	O
.	O
<EOS>	B-X
The	B-X
heterotrimeric	B-X
mTORC1	B-X
protein	B-X
kinase	B-X
nucleates	B-X
a	B-X
signaling	B-X
network	B-X
that	B-X
promotes	B-X
cell	B-X
growth	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
and	B-X
becomes	B-X
constitutively	B-X
active	B-X
in	B-X
cells	B-X
missing	B-X
the	B-X
TSC1	B-X
or	B-X
TSC2	B-X
tumor	B-X
suppressors	B-X
.	B-X
Insulin	B-X
stimulates	B-X
the	B-X
phosphorylation	B-X
of	B-X
S6K1	B-X
,	B-X
an	B-X
mTORC1	B-X
substrate	B-X
,	B-X
but	B-X
it	B-X
is	B-X
not	B-X
known	B-X
how	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
is	B-X
regulated	B-X
.	B-X
We	B-X
identify	B-X
PRAS40	B-X
as	B-X
a	B-X
raptor-interacting	B-X
protein	B-X
that	B-X
binds	B-X
to	B-X
mTORC1	B-X
in	B-X
insulin-deprived	B-X
cells	B-X
and	B-X
whose	B-X
in	B-X
vitro	B-X
interaction	B-X
with	B-X
mTORC1	B-X
is	B-X
disrupted	B-X
by	B-X
high	B-X
salt	B-X
concentrations	B-X
.	B-X
PRAS40	B-X
inhibits	B-X
cell	B-X
growth	B-X
,	B-X
S6K1	B-X
phosphorylation	B-X
,	B-X
and	B-X
rheb-induced	B-X
activation	B-X
of	B-X
the	B-X
mTORC1	B-X
pathway	B-X
,	B-X
and	B-X
in	B-X
vitro	B-X
it	B-X
prevents	B-X
the	B-X
great	B-X
increase	B-X
in	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
induced	B-X
by	B-X
rheb1-GTP	B-X
.	B-X
Insulin	B-X
stimulates	B-X
Akt/PKB-mediated	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
,	B-X
which	B-X
prevents	B-X
its	B-X
inhibition	B-X
of	B-X
mTORC1	B-X
in	B-X
cells	B-X
and	B-X
in	B-X
vitro	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
relative	B-X
strengths	B-X
of	B-X
the	B-X
rheb-	B-X
and	B-X
PRAS40-mediated	B-X
inputs	B-X
to	B-X
mTORC1	B-X
set	B-X
overall	B-X
pathway	B-X
activity	B-X
and	B-X
that	B-X
insulin	B-X
activates	B-X
mTORC1	B-X
through	B-X
the	B-X
coordinated	B-X
regulation	B-X
of	B-X
both	B-X
.	B-X

The	O
heterotrimeric	O
mTORC1	O
protein	O
kinase	O
nucleates	O
a	O
signaling	O
network	O
that	O
promotes	O
cell	O
growth	O
in	O
response	O
to	O
insulin	B-Gene_or_gene_product
and	O
becomes	O
constitutively	O
active	O
in	O
cells	O
missing	O
the	O
TSC1	B-Gene_or_gene_product
or	O
TSC2	B-Gene_or_gene_product
tumor	O
suppressors	O
.	O
<EOS>	B-X
The	B-X
diagnosis	B-X
is	B-X
based	B-X
on	B-X
genetic	B-X
criteria	B-X
,	B-X
by	B-X
the	B-X
identification	B-X
of	B-X
inactivating	B-X
pathogenic	B-X
mutation	B-X
of	B-X
tumor	B-X
suppressor	B-X
genes	B-X
TSC1	B-X
and	B-X
TSC2	B-X
,	B-X
and	B-X
clinical	B-X
criteria	B-X
,	B-X
including	B-X
cutaneous	B-X
,	B-X
renal	B-X
,	B-X
pulmonary	B-X
,	B-X
cardiac	B-X
and	B-X
neurological	B-X
manifestations	B-X
.	B-X
The	B-X
affected	B-X
genes	B-X
are	B-X
TSC1	B-X
and	B-X
TSC2	B-X
,	B-X
encoding	B-X
hamartin	B-X
and	B-X
tuberin	B-X
respectively	B-X
.	B-X
The	B-X
hamartin-tuberin	B-X
complex	B-X
inhibits	B-X
the	B-X
mammalian-target-of-rapamycin	B-X
pathway	B-X
,	B-X
which	B-X
controls	B-X
cell	B-X
growth	B-X
and	B-X
proliferation	B-X
.	B-X
Mutation	B-X
in	B-X
either	B-X
the	B-X
TSC1	B-X
or	B-X
TSC2	B-X
tumour	B-X
suppressor	B-X
gene	B-X
is	B-X
responsible	B-X
for	B-X
both	B-X
the	B-X
familial	B-X
and	B-X
sporadic	B-X
forms	B-X
of	B-X
this	B-X
disease	B-X
.	B-X
TSC1	B-X
and	B-X
TSC2	B-X
proteins	B-X
form	B-X
a	B-X
physical	B-X
and	B-X
functional	B-X
complex	B-X
in	B-X
vivo	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
TSC1-TSC2	B-X
inhibits	B-X
the	B-X
p70	B-X
ribosomal	B-X
protein	B-X
S6	B-X
kinase	B-X
1	B-X
(	B-X
an	B-X
activator	B-X
of	B-X
translation	B-X
)	B-X
and	B-X
activates	B-X
the	B-X
eukaryotic	B-X
initiation	B-X
factor	B-X
4E	B-X
binding	B-X
protein	B-X
1	B-X
(	B-X
4E-BP1	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
translational	B-X
initiation	B-X
)	B-X
.	B-X
These	B-X
functions	B-X
of	B-X
TSC1-TSC2	B-X
are	B-X
mediated	B-X
by	B-X
inhibition	B-X
of	B-X
the	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
TSC2	B-X
is	B-X
directly	B-X
phosphorylated	B-X
by	B-X
Akt	B-X
,	B-X
which	B-X
is	B-X
involved	B-X
in	B-X
stimulating	B-X
cell	B-X
growth	B-X
and	B-X
is	B-X
activated	B-X
by	B-X
growth	B-X
stimulating	B-X
signals	B-X
,	B-X
such	B-X
as	B-X
insulin	B-X
.	B-X
TSC2	B-X
is	B-X
inactivated	B-X
by	B-X
Akt-dependent	B-X
phosphorylation	B-X
,	B-X
which	B-X
destabilizes	B-X
TSC2	B-X
and	B-X
disrupts	B-X
its	B-X
interaction	B-X
with	B-X
TSC1	B-X
.	B-X
Our	B-X
data	B-X
indicate	B-X
a	B-X
molecular	B-X
mechanism	B-X
for	B-X
TSC2	B-X
in	B-X
insulin	B-X
signalling	B-X
,	B-X
tumour	B-X
suppressor	B-X
functions	B-X
and	B-X
in	B-X
the	B-X
inhibition	B-X
of	B-X
cell	B-X
growth	B-X
.	B-X

Insulin	B-Gene_or_gene_product
stimulates	O
the	O
phosphorylation	O
of	O
S6K1	B-Gene_or_gene_product
,	O
an	O
mTORC1	O
substrate	O
,	O
but	O
it	O
is	O
not	O
known	O
how	O
mTORC1	O
kinase	O
activity	O
is	O
regulated	O
.	O
<EOS>	B-X
Activation	B-X
of	B-X
the	B-X
protein	B-X
kinase	B-X
mechanistic	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
in	B-X
both	B-X
complexes	B-X
1	B-X
and	B-X
2	B-X
(	B-X
mTORC1/2	B-X
)	B-X
in	B-X
the	B-X
liver	B-X
is	B-X
repressed	B-X
during	B-X
fasting	B-X
and	B-X
rapidly	B-X
stimulated	B-X
in	B-X
response	B-X
to	B-X
a	B-X
meal	B-X
.	B-X
The	B-X
effect	B-X
of	B-X
feeding	B-X
on	B-X
hepatic	B-X
mTORC1/2	B-X
is	B-X
attributed	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
plasma	B-X
levels	B-X
of	B-X
nutrients	B-X
,	B-X
such	B-X
as	B-X
amino	B-X
acids	B-X
,	B-X
and	B-X
insulin	B-X
.	B-X
Herein	B-X
we	B-X
investigated	B-X
the	B-X
impact	B-X
of	B-X
insulin	B-X
and	B-X
glucagon	B-X
on	B-X
mTORC1/2	B-X
activation	B-X
.	B-X
In	B-X
H4IIE	B-X
and	B-X
HepG2	B-X
cultures	B-X
,	B-X
insulin	B-X
enhanced	B-X
phosphorylation	B-X
of	B-X
the	B-X
mTORC1	B-X
substrates	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
.	B-X
Surprisingly	B-X
,	B-X
the	B-X
effect	B-X
of	B-X
glucagon	B-X
on	B-X
mTORC1	B-X
was	B-X
biphasic	B-X
,	B-X
wherein	B-X
there	B-X
was	B-X
an	B-X
acute	B-X
increase	B-X
in	B-X
phosphorylation	B-X
of	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
over	B-X
the	B-X
first	B-X
hour	B-X
of	B-X
exposure	B-X
,	B-X
followed	B-X
by	B-X
latent	B-X
suppression	B-X
.	B-X
The	B-X
transient	B-X
stimulatory	B-X
effect	B-X
of	B-X
glucagon	B-X
on	B-X
mTORC1	B-X
was	B-X
not	B-X
additive	B-X
with	B-X
insulin	B-X
,	B-X
suggesting	B-X
convergent	B-X
signaling	B-X
.	B-X
Glucagon	B-X
enhanced	B-X
cAMP	B-X
levels	B-X
and	B-X
mTORC1	B-X
stimulation	B-X
required	B-X
activation	B-X
of	B-X
the	B-X
glucagon	B-X
receptor	B-X
,	B-X
PI3K/Akt	B-X
,	B-X
and	B-X
exchange	B-X
protein	B-X
activated	B-X
by	B-X
cAMP	B-X
(	B-X
EPAC	B-X
)	B-X
.	B-X
Rap1	B-X
expression	B-X
enhanced	B-X
S6K1	B-X
phosphorylation	B-X
and	B-X
glucagon	B-X
addition	B-X
to	B-X
culture	B-X
medium	B-X
promoted	B-X
Rap1-GTP	B-X
loading	B-X
.	B-X
Signaling	B-X
through	B-X
mTORC1	B-X
acts	B-X
to	B-X
regulate	B-X
protein	B-X
synthesis	B-X
and	B-X
we	B-X
found	B-X
that	B-X
glucagon	B-X
promoted	B-X
an	B-X
EPAC-dependent	B-X
increase	B-X
in	B-X
protein	B-X
synthesis	B-X
.	B-X
Overall	B-X
,	B-X
the	B-X
findings	B-X
support	B-X
that	B-X
glucagon	B-X
elicits	B-X
acute	B-X
activation	B-X
of	B-X
mTORC1/2	B-X
by	B-X
an	B-X
EPAC-dependent	B-X
increase	B-X
in	B-X
Rap1-GTP	B-X
.	B-X

We	O
identify	O
PRAS40	B-Gene_or_gene_product
as	O
a	O
raptor	B-Gene_or_gene_product
-	O
interacting	O
protein	O
that	O
binds	O
to	O
mTORC1	O
in	O
insulin	B-Gene_or_gene_product
-	O
deprived	O
cells	O
and	O
whose	O
in	O
vitro	O
interaction	O
with	O
mTORC1	O
is	O
disrupted	O
by	O
high	O
salt	O
concentrations	O
.	O
<EOS>	B-X
The	B-X
heterotrimeric	B-X
mTORC1	B-X
protein	B-X
kinase	B-X
nucleates	B-X
a	B-X
signaling	B-X
network	B-X
that	B-X
promotes	B-X
cell	B-X
growth	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
and	B-X
becomes	B-X
constitutively	B-X
active	B-X
in	B-X
cells	B-X
missing	B-X
the	B-X
TSC1	B-X
or	B-X
TSC2	B-X
tumor	B-X
suppressors	B-X
.	B-X
Insulin	B-X
stimulates	B-X
the	B-X
phosphorylation	B-X
of	B-X
S6K1	B-X
,	B-X
an	B-X
mTORC1	B-X
substrate	B-X
,	B-X
but	B-X
it	B-X
is	B-X
not	B-X
known	B-X
how	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
is	B-X
regulated	B-X
.	B-X
We	B-X
identify	B-X
PRAS40	B-X
as	B-X
a	B-X
raptor-interacting	B-X
protein	B-X
that	B-X
binds	B-X
to	B-X
mTORC1	B-X
in	B-X
insulin-deprived	B-X
cells	B-X
and	B-X
whose	B-X
in	B-X
vitro	B-X
interaction	B-X
with	B-X
mTORC1	B-X
is	B-X
disrupted	B-X
by	B-X
high	B-X
salt	B-X
concentrations	B-X
.	B-X
PRAS40	B-X
inhibits	B-X
cell	B-X
growth	B-X
,	B-X
S6K1	B-X
phosphorylation	B-X
,	B-X
and	B-X
rheb-induced	B-X
activation	B-X
of	B-X
the	B-X
mTORC1	B-X
pathway	B-X
,	B-X
and	B-X
in	B-X
vitro	B-X
it	B-X
prevents	B-X
the	B-X
great	B-X
increase	B-X
in	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
induced	B-X
by	B-X
rheb1-GTP	B-X
.	B-X
Insulin	B-X
stimulates	B-X
Akt/PKB-mediated	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
,	B-X
which	B-X
prevents	B-X
its	B-X
inhibition	B-X
of	B-X
mTORC1	B-X
in	B-X
cells	B-X
and	B-X
in	B-X
vitro	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
relative	B-X
strengths	B-X
of	B-X
the	B-X
rheb-	B-X
and	B-X
PRAS40-mediated	B-X
inputs	B-X
to	B-X
mTORC1	B-X
set	B-X
overall	B-X
pathway	B-X
activity	B-X
and	B-X
that	B-X
insulin	B-X
activates	B-X
mTORC1	B-X
through	B-X
the	B-X
coordinated	B-X
regulation	B-X
of	B-X
both	B-X
.	B-X

PRAS40	B-Gene_or_gene_product
inhibits	O
cell	O
growth	O
,	O
S6K1	B-Gene_or_gene_product
phosphorylation	O
,	O
and	O
rheb	B-Gene_or_gene_product
-	O
induced	O
activation	O
of	O
the	O
mTORC1	O
pathway	O
,	O
and	O
in	O
vitro	O
it	O
prevents	O
the	O
great	O
increase	O
in	O
mTORC1	O
kinase	O
activity	O
induced	O
by	O
rheb1	O
-	O
GTP	O
.	O
<EOS>	B-X
The	B-X
heterotrimeric	B-X
mTORC1	B-X
protein	B-X
kinase	B-X
nucleates	B-X
a	B-X
signaling	B-X
network	B-X
that	B-X
promotes	B-X
cell	B-X
growth	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
and	B-X
becomes	B-X
constitutively	B-X
active	B-X
in	B-X
cells	B-X
missing	B-X
the	B-X
TSC1	B-X
or	B-X
TSC2	B-X
tumor	B-X
suppressors	B-X
.	B-X
Insulin	B-X
stimulates	B-X
the	B-X
phosphorylation	B-X
of	B-X
S6K1	B-X
,	B-X
an	B-X
mTORC1	B-X
substrate	B-X
,	B-X
but	B-X
it	B-X
is	B-X
not	B-X
known	B-X
how	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
is	B-X
regulated	B-X
.	B-X
We	B-X
identify	B-X
PRAS40	B-X
as	B-X
a	B-X
raptor-interacting	B-X
protein	B-X
that	B-X
binds	B-X
to	B-X
mTORC1	B-X
in	B-X
insulin-deprived	B-X
cells	B-X
and	B-X
whose	B-X
in	B-X
vitro	B-X
interaction	B-X
with	B-X
mTORC1	B-X
is	B-X
disrupted	B-X
by	B-X
high	B-X
salt	B-X
concentrations	B-X
.	B-X
PRAS40	B-X
inhibits	B-X
cell	B-X
growth	B-X
,	B-X
S6K1	B-X
phosphorylation	B-X
,	B-X
and	B-X
rheb-induced	B-X
activation	B-X
of	B-X
the	B-X
mTORC1	B-X
pathway	B-X
,	B-X
and	B-X
in	B-X
vitro	B-X
it	B-X
prevents	B-X
the	B-X
great	B-X
increase	B-X
in	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
induced	B-X
by	B-X
rheb1-GTP	B-X
.	B-X
Insulin	B-X
stimulates	B-X
Akt/PKB-mediated	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
,	B-X
which	B-X
prevents	B-X
its	B-X
inhibition	B-X
of	B-X
mTORC1	B-X
in	B-X
cells	B-X
and	B-X
in	B-X
vitro	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
relative	B-X
strengths	B-X
of	B-X
the	B-X
rheb-	B-X
and	B-X
PRAS40-mediated	B-X
inputs	B-X
to	B-X
mTORC1	B-X
set	B-X
overall	B-X
pathway	B-X
activity	B-X
and	B-X
that	B-X
insulin	B-X
activates	B-X
mTORC1	B-X
through	B-X
the	B-X
coordinated	B-X
regulation	B-X
of	B-X
both	B-X
.	B-X

Insulin	B-Gene_or_gene_product
stimulates	O
Akt	B-Gene_or_gene_product
/	O
PKB	B-Gene_or_gene_product
-	O
mediated	O
phosphorylation	O
of	O
PRAS40	B-Gene_or_gene_product
,	O
which	O
prevents	O
its	O
inhibition	O
of	O
mTORC1	O
in	O
cells	O
and	O
in	O
vitro	O
.	O
<EOS>	B-X
The	B-X
heterotrimeric	B-X
mTORC1	B-X
protein	B-X
kinase	B-X
nucleates	B-X
a	B-X
signaling	B-X
network	B-X
that	B-X
promotes	B-X
cell	B-X
growth	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
and	B-X
becomes	B-X
constitutively	B-X
active	B-X
in	B-X
cells	B-X
missing	B-X
the	B-X
TSC1	B-X
or	B-X
TSC2	B-X
tumor	B-X
suppressors	B-X
.	B-X
Insulin	B-X
stimulates	B-X
the	B-X
phosphorylation	B-X
of	B-X
S6K1	B-X
,	B-X
an	B-X
mTORC1	B-X
substrate	B-X
,	B-X
but	B-X
it	B-X
is	B-X
not	B-X
known	B-X
how	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
is	B-X
regulated	B-X
.	B-X
We	B-X
identify	B-X
PRAS40	B-X
as	B-X
a	B-X
raptor-interacting	B-X
protein	B-X
that	B-X
binds	B-X
to	B-X
mTORC1	B-X
in	B-X
insulin-deprived	B-X
cells	B-X
and	B-X
whose	B-X
in	B-X
vitro	B-X
interaction	B-X
with	B-X
mTORC1	B-X
is	B-X
disrupted	B-X
by	B-X
high	B-X
salt	B-X
concentrations	B-X
.	B-X
PRAS40	B-X
inhibits	B-X
cell	B-X
growth	B-X
,	B-X
S6K1	B-X
phosphorylation	B-X
,	B-X
and	B-X
rheb-induced	B-X
activation	B-X
of	B-X
the	B-X
mTORC1	B-X
pathway	B-X
,	B-X
and	B-X
in	B-X
vitro	B-X
it	B-X
prevents	B-X
the	B-X
great	B-X
increase	B-X
in	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
induced	B-X
by	B-X
rheb1-GTP	B-X
.	B-X
Insulin	B-X
stimulates	B-X
Akt/PKB-mediated	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
,	B-X
which	B-X
prevents	B-X
its	B-X
inhibition	B-X
of	B-X
mTORC1	B-X
in	B-X
cells	B-X
and	B-X
in	B-X
vitro	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
relative	B-X
strengths	B-X
of	B-X
the	B-X
rheb-	B-X
and	B-X
PRAS40-mediated	B-X
inputs	B-X
to	B-X
mTORC1	B-X
set	B-X
overall	B-X
pathway	B-X
activity	B-X
and	B-X
that	B-X
insulin	B-X
activates	B-X
mTORC1	B-X
through	B-X
the	B-X
coordinated	B-X
regulation	B-X
of	B-X
both	B-X
.	B-X

We	O
propose	O
that	O
the	O
relative	O
strengths	O
of	O
the	O
rheb	B-Gene_or_gene_product
-	O
and	O
PRAS40	B-Gene_or_gene_product
-	O
mediated	O
inputs	O
to	O
mTORC1	O
set	O
overall	O
pathway	O
activity	O
and	O
that	O
insulin	B-Gene_or_gene_product
activates	O
mTORC1	O
through	O
the	O
coordinated	O
regulation	O
of	O
both	O
.	O
<EOS>	B-X
The	B-X
heterotrimeric	B-X
mTORC1	B-X
protein	B-X
kinase	B-X
nucleates	B-X
a	B-X
signaling	B-X
network	B-X
that	B-X
promotes	B-X
cell	B-X
growth	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
and	B-X
becomes	B-X
constitutively	B-X
active	B-X
in	B-X
cells	B-X
missing	B-X
the	B-X
TSC1	B-X
or	B-X
TSC2	B-X
tumor	B-X
suppressors	B-X
.	B-X
Insulin	B-X
stimulates	B-X
the	B-X
phosphorylation	B-X
of	B-X
S6K1	B-X
,	B-X
an	B-X
mTORC1	B-X
substrate	B-X
,	B-X
but	B-X
it	B-X
is	B-X
not	B-X
known	B-X
how	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
is	B-X
regulated	B-X
.	B-X
We	B-X
identify	B-X
PRAS40	B-X
as	B-X
a	B-X
raptor-interacting	B-X
protein	B-X
that	B-X
binds	B-X
to	B-X
mTORC1	B-X
in	B-X
insulin-deprived	B-X
cells	B-X
and	B-X
whose	B-X
in	B-X
vitro	B-X
interaction	B-X
with	B-X
mTORC1	B-X
is	B-X
disrupted	B-X
by	B-X
high	B-X
salt	B-X
concentrations	B-X
.	B-X
PRAS40	B-X
inhibits	B-X
cell	B-X
growth	B-X
,	B-X
S6K1	B-X
phosphorylation	B-X
,	B-X
and	B-X
rheb-induced	B-X
activation	B-X
of	B-X
the	B-X
mTORC1	B-X
pathway	B-X
,	B-X
and	B-X
in	B-X
vitro	B-X
it	B-X
prevents	B-X
the	B-X
great	B-X
increase	B-X
in	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
induced	B-X
by	B-X
rheb1-GTP	B-X
.	B-X
Insulin	B-X
stimulates	B-X
Akt/PKB-mediated	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
,	B-X
which	B-X
prevents	B-X
its	B-X
inhibition	B-X
of	B-X
mTORC1	B-X
in	B-X
cells	B-X
and	B-X
in	B-X
vitro	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
relative	B-X
strengths	B-X
of	B-X
the	B-X
rheb-	B-X
and	B-X
PRAS40-mediated	B-X
inputs	B-X
to	B-X
mTORC1	B-X
set	B-X
overall	B-X
pathway	B-X
activity	B-X
and	B-X
that	B-X
insulin	B-X
activates	B-X
mTORC1	B-X
through	B-X
the	B-X
coordinated	B-X
regulation	B-X
of	B-X
both	B-X
.	B-X

Beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
arrestin	I-Gene_or_gene_product
is	O
a	O
necessary	O
component	O
of	O
Wnt	B-Gene_or_gene_product
/	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
signaling	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O
<EOS>	B-X
The	B-X
Wnt/beta-catenin	B-X
signaling	B-X
pathway	B-X
is	B-X
crucial	B-X
for	B-X
proper	B-X
embryonic	B-X
development	B-X
and	B-X
tissue	B-X
homeostasis	B-X
.	B-X
The	B-X
phosphoprotein	B-X
dishevelled	B-X
(	B-X
Dvl	B-X
)	B-X
is	B-X
an	B-X
integral	B-X
part	B-X
of	B-X
Wnt	B-X
signaling	B-X
and	B-X
has	B-X
recently	B-X
been	B-X
shown	B-X
to	B-X
interact	B-X
with	B-X
the	B-X
multifunctional	B-X
scaffolding	B-X
protein	B-X
beta-arrestin	B-X
.	B-X
Using	B-X
Dvl	B-X
deletion	B-X
constructs	B-X
,	B-X
we	B-X
found	B-X
that	B-X
beta-arrestin	B-X
binds	B-X
a	B-X
region	B-X
N-terminal	B-X
of	B-X
the	B-X
PDZ	B-X
domain	B-X
of	B-X
Dvl	B-X
,	B-X
which	B-X
contains	B-X
casein	B-X
kinase	B-X
1	B-X
(	B-X
CK1	B-X
)	B-X
phosphorylation	B-X
sites	B-X
.	B-X
Inhibition	B-X
of	B-X
Wnt	B-X
signaling	B-X
by	B-X
CK1	B-X
inhibitors	B-X
reduced	B-X
the	B-X
binding	B-X
of	B-X
beta-arrestin	B-X
to	B-X
Dvl	B-X
.	B-X
Moreover	B-X
,	B-X
mouse	B-X
embryonic	B-X
fibroblasts	B-X
lacking	B-X
beta-arrestins	B-X
were	B-X
able	B-X
to	B-X
phosphorylate	B-X
LRP6	B-X
in	B-X
response	B-X
to	B-X
Wnt-3a	B-X
but	B-X
decreased	B-X
the	B-X
activation	B-X
of	B-X
Dvl	B-X
and	B-X
blocked	B-X
beta-catenin	B-X
signaling	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
found	B-X
that	B-X
beta-arrestin	B-X
can	B-X
bind	B-X
axin	B-X
and	B-X
forms	B-X
a	B-X
trimeric	B-X
complex	B-X
with	B-X
axin	B-X
and	B-X
Dvl	B-X
.	B-X
Furthermore	B-X
,	B-X
treatment	B-X
of	B-X
Xenopus	B-X
laevis	B-X
embryos	B-X
with	B-X
beta-arrestin	B-X
morpholinos	B-X
reduced	B-X
the	B-X
activation	B-X
of	B-X
endogenous	B-X
beta-catenin	B-X
,	B-X
decreased	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
beta-catenin	B-X
target	B-X
gene	B-X
,	B-X
Xnr3	B-X
,	B-X
and	B-X
blocked	B-X
axis	B-X
duplication	B-X
induced	B-X
by	B-X
X-Wnt-8	B-X
,	B-X
CK1epsilon	B-X
,	B-X
or	B-X
DshDeltaDEP	B-X
,	B-X
but	B-X
not	B-X
by	B-X
beta-catenin	B-X
.	B-X
Thus	B-X
,	B-X
our	B-X
results	B-X
identify	B-X
beta-arrestin	B-X
as	B-X
a	B-X
necessary	B-X
component	B-X
for	B-X
Wnt/beta-catenin	B-X
signaling	B-X
,	B-X
linking	B-X
Dvl	B-X
and	B-X
axin	B-X
,	B-X
and	B-X
open	B-X
a	B-X
vast	B-X
array	B-X
of	B-X
signaling	B-X
avenues	B-X
and	B-X
possibilities	B-X
for	B-X
cross-talk	B-X
with	B-X
other	B-X
beta-arrestin-dependent	B-X
signaling	B-X
pathways	B-X
.	B-X

The	O
Wnt	B-Gene_or_gene_product
/	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
signaling	O
pathway	O
is	O
crucial	O
for	O
proper	O
embryonic	O
development	O
and	O
tissue	O
homeostasis	O
.	O
<EOS>	B-X
The	B-X
blood-brain	B-X
barrier	B-X
(	B-X
BBB	B-X
)	B-X
is	B-X
essential	B-X
for	B-X
maintaining	B-X
homeostasis	B-X
within	B-X
the	B-X
central	B-X
nervous	B-X
system	B-X
(	B-X
CNS	B-X
)	B-X
and	B-X
is	B-X
a	B-X
prerequisite	B-X
for	B-X
proper	B-X
neuronal	B-X
function	B-X
.	B-X
During	B-X
embryonic	B-X
development	B-X
,	B-X
the	B-X
CNS	B-X
is	B-X
vascularized	B-X
by	B-X
angiogenic	B-X
sprouting	B-X
from	B-X
vascular	B-X
networks	B-X
originating	B-X
outside	B-X
of	B-X
the	B-X
CNS	B-X
in	B-X
a	B-X
precise	B-X
spatio-temporal	B-X
manner	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
summarize	B-X
the	B-X
currently	B-X
known	B-X
cellular	B-X
and	B-X
molecular	B-X
mechanisms	B-X
mediating	B-X
brain	B-X
angiogenesis	B-X
and	B-X
introduce	B-X
more	B-X
recently	B-X
discovered	B-X
CNS-specific	B-X
pathways	B-X
(	B-X
Wnt/β-catenin	B-X
,	B-X
Norrin/Frizzled4	B-X
and	B-X
hedgehog	B-X
)	B-X
and	B-X
molecules	B-X
(	B-X
GPR124	B-X
)	B-X
that	B-X
are	B-X
crucial	B-X
in	B-X
BBB	B-X
differentiation	B-X
and	B-X
maturation	B-X
.	B-X
Wnt	B-X
signalling	B-X
is	B-X
involved	B-X
in	B-X
multiple	B-X
aspects	B-X
of	B-X
embryonic	B-X
development	B-X
and	B-X
adult	B-X
tissue	B-X
homeostasis	B-X
,	B-X
notably	B-X
via	B-X
controlling	B-X
cellular	B-X
proliferation	B-X
and	B-X
differentiation	B-X
.	B-X
Wnt	B-X
signalling	B-X
is	B-X
subject	B-X
to	B-X
stringent	B-X
positive	B-X
and	B-X
negative	B-X
regulation	B-X
to	B-X
promote	B-X
proper	B-X
development	B-X
and	B-X
homeostasis	B-X
yet	B-X
avoid	B-X
aberrant	B-X
growth	B-X
.	B-X
Such	B-X
multi-layer	B-X
regulation	B-X
includes	B-X
post-translational	B-X
modification	B-X
and	B-X
processing	B-X
of	B-X
Wnt	B-X
proteins	B-X
themselves	B-X
,	B-X
R-spondin	B-X
(	B-X
Rspo	B-X
)	B-X
amplification	B-X
of	B-X
Wnt	B-X
signalling	B-X
,	B-X
diverse	B-X
receptor	B-X
families	B-X
,	B-X
and	B-X
intracellular	B-X
and	B-X
extracellular	B-X
antagonists	B-X
and	B-X
destruction	B-X
and	B-X
transcription	B-X
complexes	B-X
.	B-X
In	B-X
the	B-X
gastrointestinal	B-X
tract	B-X
,	B-X
Wnt	B-X
signalling	B-X
is	B-X
crucial	B-X
for	B-X
development	B-X
and	B-X
renewal	B-X
of	B-X
the	B-X
intestinal	B-X
epithelium	B-X
.	B-X
Sources	B-X
of	B-X
Wnts	B-X
and	B-X
Wnt	B-X
amplifers	B-X
such	B-X
as	B-X
R-spondins	B-X
are	B-X
beginning	B-X
to	B-X
be	B-X
elucidated	B-X
as	B-X
well	B-X
as	B-X
their	B-X
functional	B-X
contribution	B-X
to	B-X
intestinal	B-X
homeostasis	B-X
.	B-X
In	B-X
this	B-X
review	B-X
we	B-X
focus	B-X
on	B-X
regulation	B-X
of	B-X
ISCs	B-X
and	B-X
intestinal	B-X
homeostasis	B-X
by	B-X
the	B-X
Wnt/Rspo	B-X
pathway	B-X
,	B-X
the	B-X
potential	B-X
cellular	B-X
sources	B-X
of	B-X
Wnt	B-X
signalling	B-X
regulators	B-X
and	B-X
highlight	B-X
potential	B-X
future	B-X
areas	B-X
of	B-X
study	B-X
.	B-X

The	O
phosphoprotein	O
dishevelled	B-Gene_or_gene_product
(	O
Dvl	B-Gene_or_gene_product
)	O
is	O
an	O
integral	O
part	O
of	O
Wnt	B-Gene_or_gene_product
signaling	O
and	O
has	O
recently	O
been	O
shown	O
to	O
interact	O
with	O
the	O
multifunctional	O
scaffolding	O
protein	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
arrestin	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
Wnt/beta-catenin	B-X
signaling	B-X
pathway	B-X
is	B-X
crucial	B-X
for	B-X
proper	B-X
embryonic	B-X
development	B-X
and	B-X
tissue	B-X
homeostasis	B-X
.	B-X
The	B-X
phosphoprotein	B-X
dishevelled	B-X
(	B-X
Dvl	B-X
)	B-X
is	B-X
an	B-X
integral	B-X
part	B-X
of	B-X
Wnt	B-X
signaling	B-X
and	B-X
has	B-X
recently	B-X
been	B-X
shown	B-X
to	B-X
interact	B-X
with	B-X
the	B-X
multifunctional	B-X
scaffolding	B-X
protein	B-X
beta-arrestin	B-X
.	B-X
Using	B-X
Dvl	B-X
deletion	B-X
constructs	B-X
,	B-X
we	B-X
found	B-X
that	B-X
beta-arrestin	B-X
binds	B-X
a	B-X
region	B-X
N-terminal	B-X
of	B-X
the	B-X
PDZ	B-X
domain	B-X
of	B-X
Dvl	B-X
,	B-X
which	B-X
contains	B-X
casein	B-X
kinase	B-X
1	B-X
(	B-X
CK1	B-X
)	B-X
phosphorylation	B-X
sites	B-X
.	B-X
Inhibition	B-X
of	B-X
Wnt	B-X
signaling	B-X
by	B-X
CK1	B-X
inhibitors	B-X
reduced	B-X
the	B-X
binding	B-X
of	B-X
beta-arrestin	B-X
to	B-X
Dvl	B-X
.	B-X
Moreover	B-X
,	B-X
mouse	B-X
embryonic	B-X
fibroblasts	B-X
lacking	B-X
beta-arrestins	B-X
were	B-X
able	B-X
to	B-X
phosphorylate	B-X
LRP6	B-X
in	B-X
response	B-X
to	B-X
Wnt-3a	B-X
but	B-X
decreased	B-X
the	B-X
activation	B-X
of	B-X
Dvl	B-X
and	B-X
blocked	B-X
beta-catenin	B-X
signaling	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
found	B-X
that	B-X
beta-arrestin	B-X
can	B-X
bind	B-X
axin	B-X
and	B-X
forms	B-X
a	B-X
trimeric	B-X
complex	B-X
with	B-X
axin	B-X
and	B-X
Dvl	B-X
.	B-X
Furthermore	B-X
,	B-X
treatment	B-X
of	B-X
Xenopus	B-X
laevis	B-X
embryos	B-X
with	B-X
beta-arrestin	B-X
morpholinos	B-X
reduced	B-X
the	B-X
activation	B-X
of	B-X
endogenous	B-X
beta-catenin	B-X
,	B-X
decreased	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
beta-catenin	B-X
target	B-X
gene	B-X
,	B-X
Xnr3	B-X
,	B-X
and	B-X
blocked	B-X
axis	B-X
duplication	B-X
induced	B-X
by	B-X
X-Wnt-8	B-X
,	B-X
CK1epsilon	B-X
,	B-X
or	B-X
DshDeltaDEP	B-X
,	B-X
but	B-X
not	B-X
by	B-X
beta-catenin	B-X
.	B-X
Thus	B-X
,	B-X
our	B-X
results	B-X
identify	B-X
beta-arrestin	B-X
as	B-X
a	B-X
necessary	B-X
component	B-X
for	B-X
Wnt/beta-catenin	B-X
signaling	B-X
,	B-X
linking	B-X
Dvl	B-X
and	B-X
axin	B-X
,	B-X
and	B-X
open	B-X
a	B-X
vast	B-X
array	B-X
of	B-X
signaling	B-X
avenues	B-X
and	B-X
possibilities	B-X
for	B-X
cross-talk	B-X
with	B-X
other	B-X
beta-arrestin-dependent	B-X
signaling	B-X
pathways	B-X
.	B-X

Using	O
Dvl	B-Gene_or_gene_product
deletion	O
constructs	O
,	O
we	O
found	O
that	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
arrestin	I-Gene_or_gene_product
binds	O
a	O
region	O
N	O
-	O
terminal	O
of	O
the	O
PDZ	O
domain	O
of	O
Dvl	B-Gene_or_gene_product
,	O
which	O
contains	O
casein	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
CK1	B-Gene_or_gene_product
)	O
phosphorylation	O
sites	O
.	O
<EOS>	B-X
The	B-X
Wnt/beta-catenin	B-X
signaling	B-X
pathway	B-X
is	B-X
crucial	B-X
for	B-X
proper	B-X
embryonic	B-X
development	B-X
and	B-X
tissue	B-X
homeostasis	B-X
.	B-X
The	B-X
phosphoprotein	B-X
dishevelled	B-X
(	B-X
Dvl	B-X
)	B-X
is	B-X
an	B-X
integral	B-X
part	B-X
of	B-X
Wnt	B-X
signaling	B-X
and	B-X
has	B-X
recently	B-X
been	B-X
shown	B-X
to	B-X
interact	B-X
with	B-X
the	B-X
multifunctional	B-X
scaffolding	B-X
protein	B-X
beta-arrestin	B-X
.	B-X
Using	B-X
Dvl	B-X
deletion	B-X
constructs	B-X
,	B-X
we	B-X
found	B-X
that	B-X
beta-arrestin	B-X
binds	B-X
a	B-X
region	B-X
N-terminal	B-X
of	B-X
the	B-X
PDZ	B-X
domain	B-X
of	B-X
Dvl	B-X
,	B-X
which	B-X
contains	B-X
casein	B-X
kinase	B-X
1	B-X
(	B-X
CK1	B-X
)	B-X
phosphorylation	B-X
sites	B-X
.	B-X
Inhibition	B-X
of	B-X
Wnt	B-X
signaling	B-X
by	B-X
CK1	B-X
inhibitors	B-X
reduced	B-X
the	B-X
binding	B-X
of	B-X
beta-arrestin	B-X
to	B-X
Dvl	B-X
.	B-X
Moreover	B-X
,	B-X
mouse	B-X
embryonic	B-X
fibroblasts	B-X
lacking	B-X
beta-arrestins	B-X
were	B-X
able	B-X
to	B-X
phosphorylate	B-X
LRP6	B-X
in	B-X
response	B-X
to	B-X
Wnt-3a	B-X
but	B-X
decreased	B-X
the	B-X
activation	B-X
of	B-X
Dvl	B-X
and	B-X
blocked	B-X
beta-catenin	B-X
signaling	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
found	B-X
that	B-X
beta-arrestin	B-X
can	B-X
bind	B-X
axin	B-X
and	B-X
forms	B-X
a	B-X
trimeric	B-X
complex	B-X
with	B-X
axin	B-X
and	B-X
Dvl	B-X
.	B-X
Furthermore	B-X
,	B-X
treatment	B-X
of	B-X
Xenopus	B-X
laevis	B-X
embryos	B-X
with	B-X
beta-arrestin	B-X
morpholinos	B-X
reduced	B-X
the	B-X
activation	B-X
of	B-X
endogenous	B-X
beta-catenin	B-X
,	B-X
decreased	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
beta-catenin	B-X
target	B-X
gene	B-X
,	B-X
Xnr3	B-X
,	B-X
and	B-X
blocked	B-X
axis	B-X
duplication	B-X
induced	B-X
by	B-X
X-Wnt-8	B-X
,	B-X
CK1epsilon	B-X
,	B-X
or	B-X
DshDeltaDEP	B-X
,	B-X
but	B-X
not	B-X
by	B-X
beta-catenin	B-X
.	B-X
Thus	B-X
,	B-X
our	B-X
results	B-X
identify	B-X
beta-arrestin	B-X
as	B-X
a	B-X
necessary	B-X
component	B-X
for	B-X
Wnt/beta-catenin	B-X
signaling	B-X
,	B-X
linking	B-X
Dvl	B-X
and	B-X
axin	B-X
,	B-X
and	B-X
open	B-X
a	B-X
vast	B-X
array	B-X
of	B-X
signaling	B-X
avenues	B-X
and	B-X
possibilities	B-X
for	B-X
cross-talk	B-X
with	B-X
other	B-X
beta-arrestin-dependent	B-X
signaling	B-X
pathways	B-X
.	B-X

Inhibition	O
of	O
Wnt	B-Gene_or_gene_product
signaling	O
by	O
CK1	B-Gene_or_gene_product
inhibitors	O
reduced	O
the	O
binding	O
of	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
arrestin	I-Gene_or_gene_product
to	O
Dvl	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
Wnt/beta-catenin	B-X
signaling	B-X
pathway	B-X
is	B-X
crucial	B-X
for	B-X
proper	B-X
embryonic	B-X
development	B-X
and	B-X
tissue	B-X
homeostasis	B-X
.	B-X
The	B-X
phosphoprotein	B-X
dishevelled	B-X
(	B-X
Dvl	B-X
)	B-X
is	B-X
an	B-X
integral	B-X
part	B-X
of	B-X
Wnt	B-X
signaling	B-X
and	B-X
has	B-X
recently	B-X
been	B-X
shown	B-X
to	B-X
interact	B-X
with	B-X
the	B-X
multifunctional	B-X
scaffolding	B-X
protein	B-X
beta-arrestin	B-X
.	B-X
Using	B-X
Dvl	B-X
deletion	B-X
constructs	B-X
,	B-X
we	B-X
found	B-X
that	B-X
beta-arrestin	B-X
binds	B-X
a	B-X
region	B-X
N-terminal	B-X
of	B-X
the	B-X
PDZ	B-X
domain	B-X
of	B-X
Dvl	B-X
,	B-X
which	B-X
contains	B-X
casein	B-X
kinase	B-X
1	B-X
(	B-X
CK1	B-X
)	B-X
phosphorylation	B-X
sites	B-X
.	B-X
Inhibition	B-X
of	B-X
Wnt	B-X
signaling	B-X
by	B-X
CK1	B-X
inhibitors	B-X
reduced	B-X
the	B-X
binding	B-X
of	B-X
beta-arrestin	B-X
to	B-X
Dvl	B-X
.	B-X
Moreover	B-X
,	B-X
mouse	B-X
embryonic	B-X
fibroblasts	B-X
lacking	B-X
beta-arrestins	B-X
were	B-X
able	B-X
to	B-X
phosphorylate	B-X
LRP6	B-X
in	B-X
response	B-X
to	B-X
Wnt-3a	B-X
but	B-X
decreased	B-X
the	B-X
activation	B-X
of	B-X
Dvl	B-X
and	B-X
blocked	B-X
beta-catenin	B-X
signaling	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
found	B-X
that	B-X
beta-arrestin	B-X
can	B-X
bind	B-X
axin	B-X
and	B-X
forms	B-X
a	B-X
trimeric	B-X
complex	B-X
with	B-X
axin	B-X
and	B-X
Dvl	B-X
.	B-X
Furthermore	B-X
,	B-X
treatment	B-X
of	B-X
Xenopus	B-X
laevis	B-X
embryos	B-X
with	B-X
beta-arrestin	B-X
morpholinos	B-X
reduced	B-X
the	B-X
activation	B-X
of	B-X
endogenous	B-X
beta-catenin	B-X
,	B-X
decreased	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
beta-catenin	B-X
target	B-X
gene	B-X
,	B-X
Xnr3	B-X
,	B-X
and	B-X
blocked	B-X
axis	B-X
duplication	B-X
induced	B-X
by	B-X
X-Wnt-8	B-X
,	B-X
CK1epsilon	B-X
,	B-X
or	B-X
DshDeltaDEP	B-X
,	B-X
but	B-X
not	B-X
by	B-X
beta-catenin	B-X
.	B-X
Thus	B-X
,	B-X
our	B-X
results	B-X
identify	B-X
beta-arrestin	B-X
as	B-X
a	B-X
necessary	B-X
component	B-X
for	B-X
Wnt/beta-catenin	B-X
signaling	B-X
,	B-X
linking	B-X
Dvl	B-X
and	B-X
axin	B-X
,	B-X
and	B-X
open	B-X
a	B-X
vast	B-X
array	B-X
of	B-X
signaling	B-X
avenues	B-X
and	B-X
possibilities	B-X
for	B-X
cross-talk	B-X
with	B-X
other	B-X
beta-arrestin-dependent	B-X
signaling	B-X
pathways	B-X
.	B-X

Moreover	O
,	O
mouse	O
embryonic	O
fibroblasts	O
lacking	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
arrestins	I-Gene_or_gene_product
were	O
able	O
to	O
phosphorylate	O
LRP6	B-Gene_or_gene_product
in	O
response	O
to	O
Wnt	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3a	I-Gene_or_gene_product
but	O
decreased	O
the	O
activation	O
of	O
Dvl	B-Gene_or_gene_product
and	O
blocked	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
signaling	O
.	O
<EOS>	B-X
The	B-X
Wnt/beta-catenin	B-X
signaling	B-X
pathway	B-X
is	B-X
crucial	B-X
for	B-X
proper	B-X
embryonic	B-X
development	B-X
and	B-X
tissue	B-X
homeostasis	B-X
.	B-X
The	B-X
phosphoprotein	B-X
dishevelled	B-X
(	B-X
Dvl	B-X
)	B-X
is	B-X
an	B-X
integral	B-X
part	B-X
of	B-X
Wnt	B-X
signaling	B-X
and	B-X
has	B-X
recently	B-X
been	B-X
shown	B-X
to	B-X
interact	B-X
with	B-X
the	B-X
multifunctional	B-X
scaffolding	B-X
protein	B-X
beta-arrestin	B-X
.	B-X
Using	B-X
Dvl	B-X
deletion	B-X
constructs	B-X
,	B-X
we	B-X
found	B-X
that	B-X
beta-arrestin	B-X
binds	B-X
a	B-X
region	B-X
N-terminal	B-X
of	B-X
the	B-X
PDZ	B-X
domain	B-X
of	B-X
Dvl	B-X
,	B-X
which	B-X
contains	B-X
casein	B-X
kinase	B-X
1	B-X
(	B-X
CK1	B-X
)	B-X
phosphorylation	B-X
sites	B-X
.	B-X
Inhibition	B-X
of	B-X
Wnt	B-X
signaling	B-X
by	B-X
CK1	B-X
inhibitors	B-X
reduced	B-X
the	B-X
binding	B-X
of	B-X
beta-arrestin	B-X
to	B-X
Dvl	B-X
.	B-X
Moreover	B-X
,	B-X
mouse	B-X
embryonic	B-X
fibroblasts	B-X
lacking	B-X
beta-arrestins	B-X
were	B-X
able	B-X
to	B-X
phosphorylate	B-X
LRP6	B-X
in	B-X
response	B-X
to	B-X
Wnt-3a	B-X
but	B-X
decreased	B-X
the	B-X
activation	B-X
of	B-X
Dvl	B-X
and	B-X
blocked	B-X
beta-catenin	B-X
signaling	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
found	B-X
that	B-X
beta-arrestin	B-X
can	B-X
bind	B-X
axin	B-X
and	B-X
forms	B-X
a	B-X
trimeric	B-X
complex	B-X
with	B-X
axin	B-X
and	B-X
Dvl	B-X
.	B-X
Furthermore	B-X
,	B-X
treatment	B-X
of	B-X
Xenopus	B-X
laevis	B-X
embryos	B-X
with	B-X
beta-arrestin	B-X
morpholinos	B-X
reduced	B-X
the	B-X
activation	B-X
of	B-X
endogenous	B-X
beta-catenin	B-X
,	B-X
decreased	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
beta-catenin	B-X
target	B-X
gene	B-X
,	B-X
Xnr3	B-X
,	B-X
and	B-X
blocked	B-X
axis	B-X
duplication	B-X
induced	B-X
by	B-X
X-Wnt-8	B-X
,	B-X
CK1epsilon	B-X
,	B-X
or	B-X
DshDeltaDEP	B-X
,	B-X
but	B-X
not	B-X
by	B-X
beta-catenin	B-X
.	B-X
Thus	B-X
,	B-X
our	B-X
results	B-X
identify	B-X
beta-arrestin	B-X
as	B-X
a	B-X
necessary	B-X
component	B-X
for	B-X
Wnt/beta-catenin	B-X
signaling	B-X
,	B-X
linking	B-X
Dvl	B-X
and	B-X
axin	B-X
,	B-X
and	B-X
open	B-X
a	B-X
vast	B-X
array	B-X
of	B-X
signaling	B-X
avenues	B-X
and	B-X
possibilities	B-X
for	B-X
cross-talk	B-X
with	B-X
other	B-X
beta-arrestin-dependent	B-X
signaling	B-X
pathways	B-X
.	B-X

In	O
addition	O
,	O
we	O
found	O
that	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
arrestin	I-Gene_or_gene_product
can	O
bind	O
axin	B-Gene_or_gene_product
and	O
forms	O
a	O
trimeric	O
complex	O
with	O
axin	B-Gene_or_gene_product
and	O
Dvl	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
Wnt/beta-catenin	B-X
signaling	B-X
pathway	B-X
is	B-X
crucial	B-X
for	B-X
proper	B-X
embryonic	B-X
development	B-X
and	B-X
tissue	B-X
homeostasis	B-X
.	B-X
The	B-X
phosphoprotein	B-X
dishevelled	B-X
(	B-X
Dvl	B-X
)	B-X
is	B-X
an	B-X
integral	B-X
part	B-X
of	B-X
Wnt	B-X
signaling	B-X
and	B-X
has	B-X
recently	B-X
been	B-X
shown	B-X
to	B-X
interact	B-X
with	B-X
the	B-X
multifunctional	B-X
scaffolding	B-X
protein	B-X
beta-arrestin	B-X
.	B-X
Using	B-X
Dvl	B-X
deletion	B-X
constructs	B-X
,	B-X
we	B-X
found	B-X
that	B-X
beta-arrestin	B-X
binds	B-X
a	B-X
region	B-X
N-terminal	B-X
of	B-X
the	B-X
PDZ	B-X
domain	B-X
of	B-X
Dvl	B-X
,	B-X
which	B-X
contains	B-X
casein	B-X
kinase	B-X
1	B-X
(	B-X
CK1	B-X
)	B-X
phosphorylation	B-X
sites	B-X
.	B-X
Inhibition	B-X
of	B-X
Wnt	B-X
signaling	B-X
by	B-X
CK1	B-X
inhibitors	B-X
reduced	B-X
the	B-X
binding	B-X
of	B-X
beta-arrestin	B-X
to	B-X
Dvl	B-X
.	B-X
Moreover	B-X
,	B-X
mouse	B-X
embryonic	B-X
fibroblasts	B-X
lacking	B-X
beta-arrestins	B-X
were	B-X
able	B-X
to	B-X
phosphorylate	B-X
LRP6	B-X
in	B-X
response	B-X
to	B-X
Wnt-3a	B-X
but	B-X
decreased	B-X
the	B-X
activation	B-X
of	B-X
Dvl	B-X
and	B-X
blocked	B-X
beta-catenin	B-X
signaling	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
found	B-X
that	B-X
beta-arrestin	B-X
can	B-X
bind	B-X
axin	B-X
and	B-X
forms	B-X
a	B-X
trimeric	B-X
complex	B-X
with	B-X
axin	B-X
and	B-X
Dvl	B-X
.	B-X
Furthermore	B-X
,	B-X
treatment	B-X
of	B-X
Xenopus	B-X
laevis	B-X
embryos	B-X
with	B-X
beta-arrestin	B-X
morpholinos	B-X
reduced	B-X
the	B-X
activation	B-X
of	B-X
endogenous	B-X
beta-catenin	B-X
,	B-X
decreased	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
beta-catenin	B-X
target	B-X
gene	B-X
,	B-X
Xnr3	B-X
,	B-X
and	B-X
blocked	B-X
axis	B-X
duplication	B-X
induced	B-X
by	B-X
X-Wnt-8	B-X
,	B-X
CK1epsilon	B-X
,	B-X
or	B-X
DshDeltaDEP	B-X
,	B-X
but	B-X
not	B-X
by	B-X
beta-catenin	B-X
.	B-X
Thus	B-X
,	B-X
our	B-X
results	B-X
identify	B-X
beta-arrestin	B-X
as	B-X
a	B-X
necessary	B-X
component	B-X
for	B-X
Wnt/beta-catenin	B-X
signaling	B-X
,	B-X
linking	B-X
Dvl	B-X
and	B-X
axin	B-X
,	B-X
and	B-X
open	B-X
a	B-X
vast	B-X
array	B-X
of	B-X
signaling	B-X
avenues	B-X
and	B-X
possibilities	B-X
for	B-X
cross-talk	B-X
with	B-X
other	B-X
beta-arrestin-dependent	B-X
signaling	B-X
pathways	B-X
.	B-X

Furthermore	O
,	O
treatment	O
of	O
Xenopus	O
laevis	O
embryos	O
with	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
arrestin	I-Gene_or_gene_product
morpholinos	O
reduced	O
the	O
activation	O
of	O
endogenous	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
,	O
decreased	O
the	O
expression	O
of	O
the	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
target	O
gene	O
,	O
Xnr3	B-Gene_or_gene_product
,	O
and	O
blocked	O
axis	O
duplication	O
induced	O
by	O
X	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Wnt	I-Gene_or_gene_product
-	I-Gene_or_gene_product
8	I-Gene_or_gene_product
,	O
CK1epsilon	B-Gene_or_gene_product
,	O
or	O
DshDeltaDEP	B-Gene_or_gene_product
,	O
but	O
not	O
by	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
.	O

Thus	O
,	O
our	O
results	O
identify	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
arrestin	I-Gene_or_gene_product
as	O
a	O
necessary	O
component	O
for	O
Wnt	B-Gene_or_gene_product
/	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
signaling	O
,	O
linking	O
Dvl	B-Gene_or_gene_product
and	O
axin	B-Gene_or_gene_product
,	O
and	O
open	O
a	O
vast	O
array	O
of	O
signaling	O
avenues	O
and	O
possibilities	O
for	O
cross	O
-	O
talk	O
with	O
other	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
arrestin	I-Gene_or_gene_product
-	O
dependent	O
signaling	O
pathways	O
.	O

Mammalian	O
DET1	B-Gene_or_gene_product
regulates	O
Cul4A	B-Gene_or_gene_product
activity	O
and	O
forms	O
stable	O
complexes	O
with	O
E2	O
ubiquitin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
conjugating	I-Gene_or_gene_product
enzymes	I-Gene_or_gene_product
.	O
<EOS>	B-X
DET1	B-X
(	B-X
de-etiolated	B-X
1	B-X
)	B-X
is	B-X
an	B-X
essential	B-X
negative	B-X
regulator	B-X
of	B-X
plant	B-X
light	B-X
responses	B-X
,	B-X
and	B-X
it	B-X
is	B-X
a	B-X
component	B-X
of	B-X
the	B-X
Arabidopsis	B-X
thaliana	B-X
CDD	B-X
complex	B-X
containing	B-X
DDB1	B-X
and	B-X
COP10	B-X
ubiquitin	B-X
E2	B-X
variant	B-X
.	B-X
Human	B-X
DET1	B-X
has	B-X
recently	B-X
been	B-X
isolated	B-X
as	B-X
one	B-X
of	B-X
the	B-X
DDB1-	B-X
and	B-X
Cul4A-associated	B-X
factors	B-X
,	B-X
along	B-X
with	B-X
an	B-X
array	B-X
of	B-X
WD40-containing	B-X
substrate	B-X
receptors	B-X
of	B-X
the	B-X
Cul4A-DDB1	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
However	B-X
,	B-X
DET1	B-X
differs	B-X
from	B-X
conventional	B-X
substrate	B-X
receptors	B-X
of	B-X
cullin	B-X
E3	B-X
ligases	B-X
in	B-X
both	B-X
biochemical	B-X
behavior	B-X
and	B-X
activity	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
mammalian	B-X
DET1	B-X
forms	B-X
stable	B-X
DDD-E2	B-X
complexes	B-X
,	B-X
consisting	B-X
of	B-X
DDB1	B-X
,	B-X
DDA1	B-X
(	B-X
DET1	B-X
,	B-X
DDB1	B-X
associated	B-X
1	B-X
)	B-X
,	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
UBE2E	B-X
group	B-X
of	B-X
canonical	B-X
ubiquitin-conjugating	B-X
enzymes	B-X
.	B-X
DDD-E2	B-X
complexes	B-X
interact	B-X
with	B-X
multiple	B-X
ubiquitin	B-X
E3	B-X
ligases	B-X
.	B-X
We	B-X
show	B-X
that	B-X
the	B-X
E2	B-X
component	B-X
can	B-X
not	B-X
maintain	B-X
the	B-X
ubiquitin	B-X
thioester	B-X
linkage	B-X
once	B-X
bound	B-X
to	B-X
the	B-X
DDD	B-X
core	B-X
,	B-X
rendering	B-X
mammalian	B-X
DDD-E2	B-X
equivalent	B-X
to	B-X
the	B-X
Arabidopsis	B-X
CDD	B-X
complex	B-X
.	B-X
While	B-X
free	B-X
UBE2E-3	B-X
is	B-X
active	B-X
and	B-X
able	B-X
to	B-X
enhance	B-X
UbcH5/Cul4A	B-X
activity	B-X
,	B-X
the	B-X
DDD	B-X
core	B-X
specifically	B-X
inhibits	B-X
Cul4A-dependent	B-X
polyubiquitin	B-X
chain	B-X
assembly	B-X
in	B-X
vitro	B-X
.	B-X
Overexpression	B-X
of	B-X
DET1	B-X
inhibits	B-X
UV-induced	B-X
CDT1	B-X
degradation	B-X
in	B-X
cultured	B-X
cells	B-X
.	B-X
These	B-X
findings	B-X
demonstrate	B-X
that	B-X
the	B-X
conserved	B-X
DET1	B-X
complex	B-X
modulates	B-X
Cul4A	B-X
functions	B-X
by	B-X
a	B-X
novel	B-X
mechanism	B-X
.	B-X

DET1	B-Gene_or_gene_product
(	O
de	B-Gene_or_gene_product
-	I-Gene_or_gene_product
etiolated	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
is	O
an	O
essential	O
negative	O
regulator	O
of	O
plant	O
light	O
responses	O
,	O
and	O
it	O
is	O
a	O
component	O
of	O
the	O
Arabidopsis	O
thaliana	O
CDD	O
complex	O
containing	O
DDB1	B-Gene_or_gene_product
and	O
COP10	B-Gene_or_gene_product
ubiquitin	I-Gene_or_gene_product
E2	I-Gene_or_gene_product
variant	I-Gene_or_gene_product
.	O
<EOS>	B-X
DET1	B-X
(	B-X
de-etiolated	B-X
1	B-X
)	B-X
is	B-X
an	B-X
essential	B-X
negative	B-X
regulator	B-X
of	B-X
plant	B-X
light	B-X
responses	B-X
,	B-X
and	B-X
it	B-X
is	B-X
a	B-X
component	B-X
of	B-X
the	B-X
Arabidopsis	B-X
thaliana	B-X
CDD	B-X
complex	B-X
containing	B-X
DDB1	B-X
and	B-X
COP10	B-X
ubiquitin	B-X
E2	B-X
variant	B-X
.	B-X
Human	B-X
DET1	B-X
has	B-X
recently	B-X
been	B-X
isolated	B-X
as	B-X
one	B-X
of	B-X
the	B-X
DDB1-	B-X
and	B-X
Cul4A-associated	B-X
factors	B-X
,	B-X
along	B-X
with	B-X
an	B-X
array	B-X
of	B-X
WD40-containing	B-X
substrate	B-X
receptors	B-X
of	B-X
the	B-X
Cul4A-DDB1	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
However	B-X
,	B-X
DET1	B-X
differs	B-X
from	B-X
conventional	B-X
substrate	B-X
receptors	B-X
of	B-X
cullin	B-X
E3	B-X
ligases	B-X
in	B-X
both	B-X
biochemical	B-X
behavior	B-X
and	B-X
activity	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
mammalian	B-X
DET1	B-X
forms	B-X
stable	B-X
DDD-E2	B-X
complexes	B-X
,	B-X
consisting	B-X
of	B-X
DDB1	B-X
,	B-X
DDA1	B-X
(	B-X
DET1	B-X
,	B-X
DDB1	B-X
associated	B-X
1	B-X
)	B-X
,	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
UBE2E	B-X
group	B-X
of	B-X
canonical	B-X
ubiquitin-conjugating	B-X
enzymes	B-X
.	B-X
DDD-E2	B-X
complexes	B-X
interact	B-X
with	B-X
multiple	B-X
ubiquitin	B-X
E3	B-X
ligases	B-X
.	B-X
We	B-X
show	B-X
that	B-X
the	B-X
E2	B-X
component	B-X
can	B-X
not	B-X
maintain	B-X
the	B-X
ubiquitin	B-X
thioester	B-X
linkage	B-X
once	B-X
bound	B-X
to	B-X
the	B-X
DDD	B-X
core	B-X
,	B-X
rendering	B-X
mammalian	B-X
DDD-E2	B-X
equivalent	B-X
to	B-X
the	B-X
Arabidopsis	B-X
CDD	B-X
complex	B-X
.	B-X
While	B-X
free	B-X
UBE2E-3	B-X
is	B-X
active	B-X
and	B-X
able	B-X
to	B-X
enhance	B-X
UbcH5/Cul4A	B-X
activity	B-X
,	B-X
the	B-X
DDD	B-X
core	B-X
specifically	B-X
inhibits	B-X
Cul4A-dependent	B-X
polyubiquitin	B-X
chain	B-X
assembly	B-X
in	B-X
vitro	B-X
.	B-X
Overexpression	B-X
of	B-X
DET1	B-X
inhibits	B-X
UV-induced	B-X
CDT1	B-X
degradation	B-X
in	B-X
cultured	B-X
cells	B-X
.	B-X
These	B-X
findings	B-X
demonstrate	B-X
that	B-X
the	B-X
conserved	B-X
DET1	B-X
complex	B-X
modulates	B-X
Cul4A	B-X
functions	B-X
by	B-X
a	B-X
novel	B-X
mechanism	B-X
.	B-X

Human	O
DET1	B-Gene_or_gene_product
has	O
recently	O
been	O
isolated	O
as	O
one	O
of	O
the	O
DDB1	B-Gene_or_gene_product
-	O
and	O
Cul4A	B-Gene_or_gene_product
-	O
associated	O
factors	O
,	O
along	O
with	O
an	O
array	O
of	O
WD40	O
-	O
containing	O
substrate	O
receptors	O
of	O
the	O
Cul4A	O
-	O
DDB1	O
ubiquitin	B-Gene_or_gene_product
ligase	O
.	O
<EOS>	B-X
DET1	B-X
(	B-X
de-etiolated	B-X
1	B-X
)	B-X
is	B-X
an	B-X
essential	B-X
negative	B-X
regulator	B-X
of	B-X
plant	B-X
light	B-X
responses	B-X
,	B-X
and	B-X
it	B-X
is	B-X
a	B-X
component	B-X
of	B-X
the	B-X
Arabidopsis	B-X
thaliana	B-X
CDD	B-X
complex	B-X
containing	B-X
DDB1	B-X
and	B-X
COP10	B-X
ubiquitin	B-X
E2	B-X
variant	B-X
.	B-X
Human	B-X
DET1	B-X
has	B-X
recently	B-X
been	B-X
isolated	B-X
as	B-X
one	B-X
of	B-X
the	B-X
DDB1-	B-X
and	B-X
Cul4A-associated	B-X
factors	B-X
,	B-X
along	B-X
with	B-X
an	B-X
array	B-X
of	B-X
WD40-containing	B-X
substrate	B-X
receptors	B-X
of	B-X
the	B-X
Cul4A-DDB1	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
However	B-X
,	B-X
DET1	B-X
differs	B-X
from	B-X
conventional	B-X
substrate	B-X
receptors	B-X
of	B-X
cullin	B-X
E3	B-X
ligases	B-X
in	B-X
both	B-X
biochemical	B-X
behavior	B-X
and	B-X
activity	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
mammalian	B-X
DET1	B-X
forms	B-X
stable	B-X
DDD-E2	B-X
complexes	B-X
,	B-X
consisting	B-X
of	B-X
DDB1	B-X
,	B-X
DDA1	B-X
(	B-X
DET1	B-X
,	B-X
DDB1	B-X
associated	B-X
1	B-X
)	B-X
,	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
UBE2E	B-X
group	B-X
of	B-X
canonical	B-X
ubiquitin-conjugating	B-X
enzymes	B-X
.	B-X
DDD-E2	B-X
complexes	B-X
interact	B-X
with	B-X
multiple	B-X
ubiquitin	B-X
E3	B-X
ligases	B-X
.	B-X
We	B-X
show	B-X
that	B-X
the	B-X
E2	B-X
component	B-X
can	B-X
not	B-X
maintain	B-X
the	B-X
ubiquitin	B-X
thioester	B-X
linkage	B-X
once	B-X
bound	B-X
to	B-X
the	B-X
DDD	B-X
core	B-X
,	B-X
rendering	B-X
mammalian	B-X
DDD-E2	B-X
equivalent	B-X
to	B-X
the	B-X
Arabidopsis	B-X
CDD	B-X
complex	B-X
.	B-X
While	B-X
free	B-X
UBE2E-3	B-X
is	B-X
active	B-X
and	B-X
able	B-X
to	B-X
enhance	B-X
UbcH5/Cul4A	B-X
activity	B-X
,	B-X
the	B-X
DDD	B-X
core	B-X
specifically	B-X
inhibits	B-X
Cul4A-dependent	B-X
polyubiquitin	B-X
chain	B-X
assembly	B-X
in	B-X
vitro	B-X
.	B-X
Overexpression	B-X
of	B-X
DET1	B-X
inhibits	B-X
UV-induced	B-X
CDT1	B-X
degradation	B-X
in	B-X
cultured	B-X
cells	B-X
.	B-X
These	B-X
findings	B-X
demonstrate	B-X
that	B-X
the	B-X
conserved	B-X
DET1	B-X
complex	B-X
modulates	B-X
Cul4A	B-X
functions	B-X
by	B-X
a	B-X
novel	B-X
mechanism	B-X
.	B-X

However	O
,	O
DET1	B-Gene_or_gene_product
differs	O
from	O
conventional	O
substrate	O
receptors	O
of	O
cullin	B-Gene_or_gene_product
E3	O
ligases	O
in	O
both	O
biochemical	O
behavior	O
and	O
activity	O
.	O
<EOS>	B-X
DET1	B-X
(	B-X
de-etiolated	B-X
1	B-X
)	B-X
is	B-X
an	B-X
essential	B-X
negative	B-X
regulator	B-X
of	B-X
plant	B-X
light	B-X
responses	B-X
,	B-X
and	B-X
it	B-X
is	B-X
a	B-X
component	B-X
of	B-X
the	B-X
Arabidopsis	B-X
thaliana	B-X
CDD	B-X
complex	B-X
containing	B-X
DDB1	B-X
and	B-X
COP10	B-X
ubiquitin	B-X
E2	B-X
variant	B-X
.	B-X
Human	B-X
DET1	B-X
has	B-X
recently	B-X
been	B-X
isolated	B-X
as	B-X
one	B-X
of	B-X
the	B-X
DDB1-	B-X
and	B-X
Cul4A-associated	B-X
factors	B-X
,	B-X
along	B-X
with	B-X
an	B-X
array	B-X
of	B-X
WD40-containing	B-X
substrate	B-X
receptors	B-X
of	B-X
the	B-X
Cul4A-DDB1	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
However	B-X
,	B-X
DET1	B-X
differs	B-X
from	B-X
conventional	B-X
substrate	B-X
receptors	B-X
of	B-X
cullin	B-X
E3	B-X
ligases	B-X
in	B-X
both	B-X
biochemical	B-X
behavior	B-X
and	B-X
activity	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
mammalian	B-X
DET1	B-X
forms	B-X
stable	B-X
DDD-E2	B-X
complexes	B-X
,	B-X
consisting	B-X
of	B-X
DDB1	B-X
,	B-X
DDA1	B-X
(	B-X
DET1	B-X
,	B-X
DDB1	B-X
associated	B-X
1	B-X
)	B-X
,	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
UBE2E	B-X
group	B-X
of	B-X
canonical	B-X
ubiquitin-conjugating	B-X
enzymes	B-X
.	B-X
DDD-E2	B-X
complexes	B-X
interact	B-X
with	B-X
multiple	B-X
ubiquitin	B-X
E3	B-X
ligases	B-X
.	B-X
While	B-X
free	B-X
UBE2E-3	B-X
is	B-X
active	B-X
and	B-X
able	B-X
to	B-X
enhance	B-X
UbcH5/Cul4A	B-X
activity	B-X
,	B-X
the	B-X
DDD	B-X
core	B-X
specifically	B-X
inhibits	B-X
Cul4A-dependent	B-X
polyubiquitin	B-X
chain	B-X
assembly	B-X
in	B-X
vitro	B-X
.	B-X
Overexpression	B-X
of	B-X
DET1	B-X
inhibits	B-X
UV-induced	B-X
CDT1	B-X
degradation	B-X
in	B-X
cultured	B-X
cells	B-X
.	B-X
These	B-X
findings	B-X
demonstrate	B-X
that	B-X
the	B-X
conserved	B-X
DET1	B-X
complex	B-X
modulates	B-X
Cul4A	B-X
functions	B-X
by	B-X
a	B-X
novel	B-X
mechanism	B-X
.	B-X

Here	O
we	O
report	O
that	O
mammalian	O
DET1	B-Gene_or_gene_product
forms	O
stable	O
DDD	O
-	O
E2	O
complexes	O
,	O
consisting	O
of	O
DDB1	B-Gene_or_gene_product
,	O
DDA1	B-Gene_or_gene_product
(	O
DET1	B-Gene_or_gene_product
,	I-Gene_or_gene_product
DDB1	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
,	O
and	O
a	O
member	O
of	O
the	O
UBE2E	B-Gene_or_gene_product
group	O
of	O
canonical	O
ubiquitin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
conjugating	I-Gene_or_gene_product
enzymes	I-Gene_or_gene_product
.	O

DDD	O
-	O
E2	O
complexes	O
interact	O
with	O
multiple	O
ubiquitin	B-Gene_or_gene_product
E3	I-Gene_or_gene_product
ligases	I-Gene_or_gene_product
.	O
<EOS>	B-X
DET1	B-X
(	B-X
de-etiolated	B-X
1	B-X
)	B-X
is	B-X
an	B-X
essential	B-X
negative	B-X
regulator	B-X
of	B-X
plant	B-X
light	B-X
responses	B-X
,	B-X
and	B-X
it	B-X
is	B-X
a	B-X
component	B-X
of	B-X
the	B-X
Arabidopsis	B-X
thaliana	B-X
CDD	B-X
complex	B-X
containing	B-X
DDB1	B-X
and	B-X
COP10	B-X
ubiquitin	B-X
E2	B-X
variant	B-X
.	B-X
Human	B-X
DET1	B-X
has	B-X
recently	B-X
been	B-X
isolated	B-X
as	B-X
one	B-X
of	B-X
the	B-X
DDB1-	B-X
and	B-X
Cul4A-associated	B-X
factors	B-X
,	B-X
along	B-X
with	B-X
an	B-X
array	B-X
of	B-X
WD40-containing	B-X
substrate	B-X
receptors	B-X
of	B-X
the	B-X
Cul4A-DDB1	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
However	B-X
,	B-X
DET1	B-X
differs	B-X
from	B-X
conventional	B-X
substrate	B-X
receptors	B-X
of	B-X
cullin	B-X
E3	B-X
ligases	B-X
in	B-X
both	B-X
biochemical	B-X
behavior	B-X
and	B-X
activity	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
mammalian	B-X
DET1	B-X
forms	B-X
stable	B-X
DDD-E2	B-X
complexes	B-X
,	B-X
consisting	B-X
of	B-X
DDB1	B-X
,	B-X
DDA1	B-X
(	B-X
DET1	B-X
,	B-X
DDB1	B-X
associated	B-X
1	B-X
)	B-X
,	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
UBE2E	B-X
group	B-X
of	B-X
canonical	B-X
ubiquitin-conjugating	B-X
enzymes	B-X
.	B-X
DDD-E2	B-X
complexes	B-X
interact	B-X
with	B-X
multiple	B-X
ubiquitin	B-X
E3	B-X
ligases	B-X
.	B-X
We	B-X
show	B-X
that	B-X
the	B-X
E2	B-X
component	B-X
can	B-X
not	B-X
maintain	B-X
the	B-X
ubiquitin	B-X
thioester	B-X
linkage	B-X
once	B-X
bound	B-X
to	B-X
the	B-X
DDD	B-X
core	B-X
,	B-X
rendering	B-X
mammalian	B-X
DDD-E2	B-X
equivalent	B-X
to	B-X
the	B-X
Arabidopsis	B-X
CDD	B-X
complex	B-X
.	B-X
While	B-X
free	B-X
UBE2E-3	B-X
is	B-X
active	B-X
and	B-X
able	B-X
to	B-X
enhance	B-X
UbcH5/Cul4A	B-X
activity	B-X
,	B-X
the	B-X
DDD	B-X
core	B-X
specifically	B-X
inhibits	B-X
Cul4A-dependent	B-X
polyubiquitin	B-X
chain	B-X
assembly	B-X
in	B-X
vitro	B-X
.	B-X

We	O
show	O
that	O
the	O
E2	B-Gene_or_gene_product
component	I-Gene_or_gene_product
cannot	O
maintain	O
the	O
ubiquitin	B-Gene_or_gene_product
thioester	O
linkage	O
once	O
bound	O
to	O
the	O
DDD	O
core	O
,	O
rendering	O
mammalian	O
DDD	O
-	O
E2	O
equivalent	O
to	O
the	O
Arabidopsis	O
CDD	O
complex	O
.	O

While	O
free	O
UBE2E	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
is	O
active	O
and	O
able	O
to	O
enhance	O
UbcH5	B-Gene_or_gene_product
/	O
Cul4A	B-Gene_or_gene_product
activity	O
,	O
the	O
DDD	O
core	O
specifically	O
inhibits	O
Cul4A	B-Gene_or_gene_product
-	O
dependent	O
polyubiquitin	B-Gene_or_gene_product
chain	O
assembly	O
in	O
vitro	O
.	O
<EOS>	B-X
Human	B-X
DET1	B-X
has	B-X
recently	B-X
been	B-X
isolated	B-X
as	B-X
one	B-X
of	B-X
the	B-X
DDB1-	B-X
and	B-X
Cul4A-associated	B-X
factors	B-X
,	B-X
along	B-X
with	B-X
an	B-X
array	B-X
of	B-X
WD40-containing	B-X
substrate	B-X
receptors	B-X
of	B-X
the	B-X
Cul4A-DDB1	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
However	B-X
,	B-X
DET1	B-X
differs	B-X
from	B-X
conventional	B-X
substrate	B-X
receptors	B-X
of	B-X
cullin	B-X
E3	B-X
ligases	B-X
in	B-X
both	B-X
biochemical	B-X
behavior	B-X
and	B-X
activity	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
mammalian	B-X
DET1	B-X
forms	B-X
stable	B-X
DDD-E2	B-X
complexes	B-X
,	B-X
consisting	B-X
of	B-X
DDB1	B-X
,	B-X
DDA1	B-X
(	B-X
DET1	B-X
,	B-X
DDB1	B-X
associated	B-X
1	B-X
)	B-X
,	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
UBE2E	B-X
group	B-X
of	B-X
canonical	B-X
ubiquitin-conjugating	B-X
enzymes	B-X
.	B-X
DDD-E2	B-X
complexes	B-X
interact	B-X
with	B-X
multiple	B-X
ubiquitin	B-X
E3	B-X
ligases	B-X
.	B-X
We	B-X
show	B-X
that	B-X
the	B-X
E2	B-X
component	B-X
can	B-X
not	B-X
maintain	B-X
the	B-X
ubiquitin	B-X
thioester	B-X
linkage	B-X
once	B-X
bound	B-X
to	B-X
the	B-X
DDD	B-X
core	B-X
,	B-X
rendering	B-X
mammalian	B-X
DDD-E2	B-X
equivalent	B-X
to	B-X
the	B-X
Arabidopsis	B-X
CDD	B-X
complex	B-X
.	B-X
While	B-X
free	B-X
UBE2E-3	B-X
is	B-X
active	B-X
and	B-X
able	B-X
to	B-X
enhance	B-X
UbcH5/Cul4A	B-X
activity	B-X
,	B-X
the	B-X
DDD	B-X
core	B-X
specifically	B-X
inhibits	B-X
Cul4A-dependent	B-X
polyubiquitin	B-X
chain	B-X
assembly	B-X
in	B-X
vitro	B-X
.	B-X
Overexpression	B-X
of	B-X
DET1	B-X
inhibits	B-X
UV-induced	B-X
CDT1	B-X
degradation	B-X
in	B-X
cultured	B-X
cells	B-X
.	B-X
These	B-X
findings	B-X
demonstrate	B-X
that	B-X
the	B-X
conserved	B-X
DET1	B-X
complex	B-X
modulates	B-X
Cul4A	B-X
functions	B-X
by	B-X
a	B-X
novel	B-X
mechanism	B-X
.	B-X

Overexpression	O
of	O
DET1	B-Gene_or_gene_product
inhibits	O
UV	O
-	O
induced	O
CDT1	B-Gene_or_gene_product
degradation	O
in	O
cultured	O
cells	O
.	O
<EOS>	B-X
DET1	B-X
(	B-X
de-etiolated	B-X
1	B-X
)	B-X
is	B-X
an	B-X
essential	B-X
negative	B-X
regulator	B-X
of	B-X
plant	B-X
light	B-X
responses	B-X
,	B-X
and	B-X
it	B-X
is	B-X
a	B-X
component	B-X
of	B-X
the	B-X
Arabidopsis	B-X
thaliana	B-X
CDD	B-X
complex	B-X
containing	B-X
DDB1	B-X
and	B-X
COP10	B-X
ubiquitin	B-X
E2	B-X
variant	B-X
.	B-X
Human	B-X
DET1	B-X
has	B-X
recently	B-X
been	B-X
isolated	B-X
as	B-X
one	B-X
of	B-X
the	B-X
DDB1-	B-X
and	B-X
Cul4A-associated	B-X
factors	B-X
,	B-X
along	B-X
with	B-X
an	B-X
array	B-X
of	B-X
WD40-containing	B-X
substrate	B-X
receptors	B-X
of	B-X
the	B-X
Cul4A-DDB1	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
However	B-X
,	B-X
DET1	B-X
differs	B-X
from	B-X
conventional	B-X
substrate	B-X
receptors	B-X
of	B-X
cullin	B-X
E3	B-X
ligases	B-X
in	B-X
both	B-X
biochemical	B-X
behavior	B-X
and	B-X
activity	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
mammalian	B-X
DET1	B-X
forms	B-X
stable	B-X
DDD-E2	B-X
complexes	B-X
,	B-X
consisting	B-X
of	B-X
DDB1	B-X
,	B-X
DDA1	B-X
(	B-X
DET1	B-X
,	B-X
DDB1	B-X
associated	B-X
1	B-X
)	B-X
,	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
UBE2E	B-X
group	B-X
of	B-X
canonical	B-X
ubiquitin-conjugating	B-X
enzymes	B-X
.	B-X
While	B-X
free	B-X
UBE2E-3	B-X
is	B-X
active	B-X
and	B-X
able	B-X
to	B-X
enhance	B-X
UbcH5/Cul4A	B-X
activity	B-X
,	B-X
the	B-X
DDD	B-X
core	B-X
specifically	B-X
inhibits	B-X
Cul4A-dependent	B-X
polyubiquitin	B-X
chain	B-X
assembly	B-X
in	B-X
vitro	B-X
.	B-X
Overexpression	B-X
of	B-X
DET1	B-X
inhibits	B-X
UV-induced	B-X
CDT1	B-X
degradation	B-X
in	B-X
cultured	B-X
cells	B-X
.	B-X
These	B-X
findings	B-X
demonstrate	B-X
that	B-X
the	B-X
conserved	B-X
DET1	B-X
complex	B-X
modulates	B-X
Cul4A	B-X
functions	B-X
by	B-X
a	B-X
novel	B-X
mechanism	B-X
.	B-X

These	O
findings	O
demonstrate	O
that	O
the	O
conserved	O
DET1	O
complex	O
modulates	O
Cul4A	B-Gene_or_gene_product
functions	O
by	O
a	O
novel	O
mechanism	O
.	O
<EOS>	B-X
DET1	B-X
(	B-X
de-etiolated	B-X
1	B-X
)	B-X
is	B-X
an	B-X
essential	B-X
negative	B-X
regulator	B-X
of	B-X
plant	B-X
light	B-X
responses	B-X
,	B-X
and	B-X
it	B-X
is	B-X
a	B-X
component	B-X
of	B-X
the	B-X
Arabidopsis	B-X
thaliana	B-X
CDD	B-X
complex	B-X
containing	B-X
DDB1	B-X
and	B-X
COP10	B-X
ubiquitin	B-X
E2	B-X
variant	B-X
.	B-X
Human	B-X
DET1	B-X
has	B-X
recently	B-X
been	B-X
isolated	B-X
as	B-X
one	B-X
of	B-X
the	B-X
DDB1-	B-X
and	B-X
Cul4A-associated	B-X
factors	B-X
,	B-X
along	B-X
with	B-X
an	B-X
array	B-X
of	B-X
WD40-containing	B-X
substrate	B-X
receptors	B-X
of	B-X
the	B-X
Cul4A-DDB1	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
However	B-X
,	B-X
DET1	B-X
differs	B-X
from	B-X
conventional	B-X
substrate	B-X
receptors	B-X
of	B-X
cullin	B-X
E3	B-X
ligases	B-X
in	B-X
both	B-X
biochemical	B-X
behavior	B-X
and	B-X
activity	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
mammalian	B-X
DET1	B-X
forms	B-X
stable	B-X
DDD-E2	B-X
complexes	B-X
,	B-X
consisting	B-X
of	B-X
DDB1	B-X
,	B-X
DDA1	B-X
(	B-X
DET1	B-X
,	B-X
DDB1	B-X
associated	B-X
1	B-X
)	B-X
,	B-X
and	B-X
a	B-X
member	B-X
of	B-X
the	B-X
UBE2E	B-X
group	B-X
of	B-X
canonical	B-X
ubiquitin-conjugating	B-X
enzymes	B-X
.	B-X
DDD-E2	B-X
complexes	B-X
interact	B-X
with	B-X
multiple	B-X
ubiquitin	B-X
E3	B-X
ligases	B-X
.	B-X
We	B-X
show	B-X
that	B-X
the	B-X
E2	B-X
component	B-X
can	B-X
not	B-X
maintain	B-X
the	B-X
ubiquitin	B-X
thioester	B-X
linkage	B-X
once	B-X
bound	B-X
to	B-X
the	B-X
DDD	B-X
core	B-X
,	B-X
rendering	B-X
mammalian	B-X
DDD-E2	B-X
equivalent	B-X
to	B-X
the	B-X
Arabidopsis	B-X
CDD	B-X
complex	B-X
.	B-X
While	B-X
free	B-X
UBE2E-3	B-X
is	B-X
active	B-X
and	B-X
able	B-X
to	B-X
enhance	B-X
UbcH5/Cul4A	B-X
activity	B-X
,	B-X
the	B-X
DDD	B-X
core	B-X
specifically	B-X
inhibits	B-X
Cul4A-dependent	B-X
polyubiquitin	B-X
chain	B-X
assembly	B-X
in	B-X
vitro	B-X
.	B-X
Overexpression	B-X
of	B-X
DET1	B-X
inhibits	B-X
UV-induced	B-X
CDT1	B-X
degradation	B-X
in	B-X
cultured	B-X
cells	B-X
.	B-X
These	B-X
findings	B-X
demonstrate	B-X
that	B-X
the	B-X
conserved	B-X
DET1	B-X
complex	B-X
modulates	B-X
Cul4A	B-X
functions	B-X
by	B-X
a	B-X
novel	B-X
mechanism	B-X
.	B-X

Cdc34	B-Gene_or_gene_product
C	O
-	O
terminal	O
tail	O
phosphorylation	O
regulates	O
Skp1	O
/	O
cullin	O
/	O
F	O
-	O
box	O
(	O
SCF	O
)	O
-	O
mediated	O
ubiquitination	O
and	O
cell	O
cycle	O
progression	O
.	O

The	O
ubiquitin	B-Gene_or_gene_product
-	O
conjugating	O
enzyme	O
Cdc34	B-Gene_or_gene_product
(	O
cell	B-Gene_or_gene_product
division	I-Gene_or_gene_product
cycle	I-Gene_or_gene_product
34	I-Gene_or_gene_product
)	O
plays	O
an	O
essential	O
role	O
in	O
promoting	O
the	O
G1	O
-	O
S	O
-	O
phase	O
transition	O
of	O
the	O
eukaryotic	O
cell	O
cycle	O
and	O
is	O
phosphorylated	O
in	O
vivo	O
.	O
<EOS>	B-X
The	B-X
ubiquitin-conjugating	B-X
enzyme	B-X
Cdc34	B-X
(	B-X
cell	B-X
division	B-X
cycle	B-X
34	B-X
)	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
promoting	B-X
the	B-X
G1-S-phase	B-X
transition	B-X
of	B-X
the	B-X
eukaryotic	B-X
cell	B-X
cycle	B-X
and	B-X
is	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
if	B-X
phosphorylation	B-X
regulates	B-X
Cdc34	B-X
function	B-X
.	B-X
We	B-X
mapped	B-X
the	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
sites	B-X
on	B-X
budding	B-X
yeast	B-X
Cdc34	B-X
(	B-X
yCdc34	B-X
;	B-X
Ser207	B-X
and	B-X
Ser216	B-X
)	B-X
and	B-X
human	B-X
Cdc34	B-X
(	B-X
hCdc34	B-X
Ser203	B-X
,	B-X
Ser222	B-X
and	B-X
Ser231	B-X
)	B-X
to	B-X
serine	B-X
residues	B-X
in	B-X
the	B-X
acidic	B-X
tail	B-X
domain	B-X
,	B-X
a	B-X
region	B-X
that	B-X
is	B-X
critical	B-X
for	B-X
Cdc34	B-X
's	B-X
cell	B-X
cycle	B-X
function	B-X
.	B-X
CK2	B-X
(	B-X
protein	B-X
kinase	B-X
CK2	B-X
)	B-X
phosphorylates	B-X
both	B-X
yCdc34	B-X
and	B-X
hCdc34	B-X
on	B-X
these	B-X
sites	B-X
in	B-X
vitro	B-X
.	B-X
CK2-mediated	B-X
phosphorylation	B-X
increased	B-X
yCdc34	B-X
ubiquitination	B-X
activity	B-X
towards	B-X
the	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
Sic1	B-X
in	B-X
vitro	B-X
,	B-X
when	B-X
assayed	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
its	B-X
cognate	B-X
SCFCdc4	B-X
E3	B-X
ligase	B-X
[	B-X
where	B-X
SCF	B-X
is	B-X
Skp1	B-X
(	B-X
S-phase	B-X
kinase-associated	B-X
protein	B-X
1	B-X
)	B-X
/cullin/F-box	B-X
]	B-X
.	B-X
Similarly	B-X
,	B-X
mutation	B-X
of	B-X
the	B-X
yCdc34	B-X
phosphorylation	B-X
sites	B-X
to	B-X
alanine	B-X
,	B-X
aspartate	B-X
or	B-X
glutamate	B-X
residues	B-X
altered	B-X
Cdc34-SCFCdc4-mediated	B-X
Sic1	B-X
ubiquitination	B-X
activity	B-X
.	B-X
Similar	B-X
results	B-X
were	B-X
obtained	B-X
when	B-X
yCdc34	B-X
's	B-X
ubiquitination	B-X
activity	B-X
was	B-X
assayed	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
SCFCdc4	B-X
,	B-X
indicating	B-X
that	B-X
phosphorylation	B-X
regulates	B-X
the	B-X
intrinsic	B-X
catalytic	B-X
activity	B-X
of	B-X
Cdc34	B-X
.	B-X
To	B-X
evaluate	B-X
the	B-X
in	B-X
vivo	B-X
consequences	B-X
of	B-X
altered	B-X
Cdc34	B-X
activity	B-X
,	B-X
wild-type	B-X
yCdc34	B-X
and	B-X
the	B-X
phosphosite	B-X
mutants	B-X
were	B-X
introduced	B-X
into	B-X
an	B-X
S.	B-X
cerevisiae	B-X
cdc34	B-X
deletion	B-X
strain	B-X
and	B-X
,	B-X
following	B-X
synchronization	B-X
in	B-X
G1-phase	B-X
,	B-X
progression	B-X
through	B-X
the	B-X
cell	B-X
cycle	B-X
was	B-X
monitored	B-X
.	B-X
Consistent	B-X
with	B-X
the	B-X
increased	B-X
ubiquitination	B-X
activity	B-X
in	B-X
vitro	B-X
,	B-X
cells	B-X
expressing	B-X
the	B-X
phosphosite	B-X
mutants	B-X
with	B-X
higher	B-X
catalytic	B-X
activity	B-X
exhibited	B-X
accelerated	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
Sic1	B-X
degradation	B-X
.	B-X
These	B-X
studies	B-X
demonstrate	B-X
that	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Cdc34	B-X
on	B-X
the	B-X
acidic	B-X
tail	B-X
domain	B-X
stimulates	B-X
Cdc34-SCFCdc4	B-X
ubiquitination	B-X
activity	B-X
and	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
if	O
phosphorylation	O
regulates	O
Cdc34	B-Gene_or_gene_product
function	O
.	O
<EOS>	B-X
The	B-X
ubiquitin-conjugating	B-X
enzyme	B-X
Cdc34	B-X
(	B-X
cell	B-X
division	B-X
cycle	B-X
34	B-X
)	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
promoting	B-X
the	B-X
G1-S-phase	B-X
transition	B-X
of	B-X
the	B-X
eukaryotic	B-X
cell	B-X
cycle	B-X
and	B-X
is	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
if	B-X
phosphorylation	B-X
regulates	B-X
Cdc34	B-X
function	B-X
.	B-X
We	B-X
mapped	B-X
the	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
sites	B-X
on	B-X
budding	B-X
yeast	B-X
Cdc34	B-X
(	B-X
yCdc34	B-X
;	B-X
Ser207	B-X
and	B-X
Ser216	B-X
)	B-X
and	B-X
human	B-X
Cdc34	B-X
(	B-X
hCdc34	B-X
Ser203	B-X
,	B-X
Ser222	B-X
and	B-X
Ser231	B-X
)	B-X
to	B-X
serine	B-X
residues	B-X
in	B-X
the	B-X
acidic	B-X
tail	B-X
domain	B-X
,	B-X
a	B-X
region	B-X
that	B-X
is	B-X
critical	B-X
for	B-X
Cdc34	B-X
's	B-X
cell	B-X
cycle	B-X
function	B-X
.	B-X
CK2	B-X
(	B-X
protein	B-X
kinase	B-X
CK2	B-X
)	B-X
phosphorylates	B-X
both	B-X
yCdc34	B-X
and	B-X
hCdc34	B-X
on	B-X
these	B-X
sites	B-X
in	B-X
vitro	B-X
.	B-X
CK2-mediated	B-X
phosphorylation	B-X
increased	B-X
yCdc34	B-X
ubiquitination	B-X
activity	B-X
towards	B-X
the	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
Sic1	B-X
in	B-X
vitro	B-X
,	B-X
when	B-X
assayed	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
its	B-X
cognate	B-X
SCFCdc4	B-X
E3	B-X
ligase	B-X
[	B-X
where	B-X
SCF	B-X
is	B-X
Skp1	B-X
(	B-X
S-phase	B-X
kinase-associated	B-X
protein	B-X
1	B-X
)	B-X
/cullin/F-box	B-X
]	B-X
.	B-X
Similarly	B-X
,	B-X
mutation	B-X
of	B-X
the	B-X
yCdc34	B-X
phosphorylation	B-X
sites	B-X
to	B-X
alanine	B-X
,	B-X
aspartate	B-X
or	B-X
glutamate	B-X
residues	B-X
altered	B-X
Cdc34-SCFCdc4-mediated	B-X
Sic1	B-X
ubiquitination	B-X
activity	B-X
.	B-X
Similar	B-X
results	B-X
were	B-X
obtained	B-X
when	B-X
yCdc34	B-X
's	B-X
ubiquitination	B-X
activity	B-X
was	B-X
assayed	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
SCFCdc4	B-X
,	B-X
indicating	B-X
that	B-X
phosphorylation	B-X
regulates	B-X
the	B-X
intrinsic	B-X
catalytic	B-X
activity	B-X
of	B-X
Cdc34	B-X
.	B-X
To	B-X
evaluate	B-X
the	B-X
in	B-X
vivo	B-X
consequences	B-X
of	B-X
altered	B-X
Cdc34	B-X
activity	B-X
,	B-X
wild-type	B-X
yCdc34	B-X
and	B-X
the	B-X
phosphosite	B-X
mutants	B-X
were	B-X
introduced	B-X
into	B-X
an	B-X
S.	B-X
cerevisiae	B-X
cdc34	B-X
deletion	B-X
strain	B-X
and	B-X
,	B-X
following	B-X
synchronization	B-X
in	B-X
G1-phase	B-X
,	B-X
progression	B-X
through	B-X
the	B-X
cell	B-X
cycle	B-X
was	B-X
monitored	B-X
.	B-X
These	B-X
studies	B-X
demonstrate	B-X
that	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Cdc34	B-X
on	B-X
the	B-X
acidic	B-X
tail	B-X
domain	B-X
stimulates	B-X
Cdc34-SCFCdc4	B-X
ubiquitination	B-X
activity	B-X
and	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X

We	O
mapped	O
the	O
in	O
vivo	O
phosphorylation	O
sites	O
on	O
budding	O
yeast	O
Cdc34	B-Gene_or_gene_product
(	O
yCdc34	B-Gene_or_gene_product
;	O
Ser207	O
and	O
Ser216	O
)	O
and	O
human	O
Cdc34	B-Gene_or_gene_product
(	O
hCdc34	B-Gene_or_gene_product
Ser203	O
,	O
Ser222	O
and	O
Ser231	O
)	O
to	O
serine	O
residues	O
in	O
the	O
acidic	O
tail	O
domain	O
,	O
a	O
region	O
that	O
is	O
critical	O
for	O
Cdc34	B-Gene_or_gene_product
'	O
s	O
cell	O
cycle	O
function	O
.	O
<EOS>	B-X
The	B-X
ubiquitin-conjugating	B-X
enzyme	B-X
Cdc34	B-X
(	B-X
cell	B-X
division	B-X
cycle	B-X
34	B-X
)	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
promoting	B-X
the	B-X
G1-S-phase	B-X
transition	B-X
of	B-X
the	B-X
eukaryotic	B-X
cell	B-X
cycle	B-X
and	B-X
is	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
if	B-X
phosphorylation	B-X
regulates	B-X
Cdc34	B-X
function	B-X
.	B-X
We	B-X
mapped	B-X
the	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
sites	B-X
on	B-X
budding	B-X
yeast	B-X
Cdc34	B-X
(	B-X
yCdc34	B-X
;	B-X
Ser207	B-X
and	B-X
Ser216	B-X
)	B-X
and	B-X
human	B-X
Cdc34	B-X
(	B-X
hCdc34	B-X
Ser203	B-X
,	B-X
Ser222	B-X
and	B-X
Ser231	B-X
)	B-X
to	B-X
serine	B-X
residues	B-X
in	B-X
the	B-X
acidic	B-X
tail	B-X
domain	B-X
,	B-X
a	B-X
region	B-X
that	B-X
is	B-X
critical	B-X
for	B-X
Cdc34	B-X
's	B-X
cell	B-X
cycle	B-X
function	B-X
.	B-X
CK2	B-X
(	B-X
protein	B-X
kinase	B-X
CK2	B-X
)	B-X
phosphorylates	B-X
both	B-X
yCdc34	B-X
and	B-X
hCdc34	B-X
on	B-X
these	B-X
sites	B-X
in	B-X
vitro	B-X
.	B-X
CK2-mediated	B-X
phosphorylation	B-X
increased	B-X
yCdc34	B-X
ubiquitination	B-X
activity	B-X
towards	B-X
the	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
Sic1	B-X
in	B-X
vitro	B-X
,	B-X
when	B-X
assayed	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
its	B-X
cognate	B-X
SCFCdc4	B-X
E3	B-X
ligase	B-X
[	B-X
where	B-X
SCF	B-X
is	B-X
Skp1	B-X
(	B-X
S-phase	B-X
kinase-associated	B-X
protein	B-X
1	B-X
)	B-X
/cullin/F-box	B-X
]	B-X
.	B-X
Similarly	B-X
,	B-X
mutation	B-X
of	B-X
the	B-X
yCdc34	B-X
phosphorylation	B-X
sites	B-X
to	B-X
alanine	B-X
,	B-X
aspartate	B-X
or	B-X
glutamate	B-X
residues	B-X
altered	B-X
Cdc34-SCFCdc4-mediated	B-X
Sic1	B-X
ubiquitination	B-X
activity	B-X
.	B-X
Similar	B-X
results	B-X
were	B-X
obtained	B-X
when	B-X
yCdc34	B-X
's	B-X
ubiquitination	B-X
activity	B-X
was	B-X
assayed	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
SCFCdc4	B-X
,	B-X
indicating	B-X
that	B-X
phosphorylation	B-X
regulates	B-X
the	B-X
intrinsic	B-X
catalytic	B-X
activity	B-X
of	B-X
Cdc34	B-X
.	B-X
To	B-X
evaluate	B-X
the	B-X
in	B-X
vivo	B-X
consequences	B-X
of	B-X
altered	B-X
Cdc34	B-X
activity	B-X
,	B-X
wild-type	B-X
yCdc34	B-X
and	B-X
the	B-X
phosphosite	B-X
mutants	B-X
were	B-X
introduced	B-X
into	B-X
an	B-X
S.	B-X
cerevisiae	B-X
cdc34	B-X
deletion	B-X
strain	B-X
and	B-X
,	B-X
following	B-X
synchronization	B-X
in	B-X
G1-phase	B-X
,	B-X
progression	B-X
through	B-X
the	B-X
cell	B-X
cycle	B-X
was	B-X
monitored	B-X
.	B-X
Consistent	B-X
with	B-X
the	B-X
increased	B-X
ubiquitination	B-X
activity	B-X
in	B-X
vitro	B-X
,	B-X
cells	B-X
expressing	B-X
the	B-X
phosphosite	B-X
mutants	B-X
with	B-X
higher	B-X
catalytic	B-X
activity	B-X
exhibited	B-X
accelerated	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
Sic1	B-X
degradation	B-X
.	B-X
These	B-X
studies	B-X
demonstrate	B-X
that	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Cdc34	B-X
on	B-X
the	B-X
acidic	B-X
tail	B-X
domain	B-X
stimulates	B-X
Cdc34-SCFCdc4	B-X
ubiquitination	B-X
activity	B-X
and	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X

CK2	B-Gene_or_gene_product
(	O
protein	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
CK2	I-Gene_or_gene_product
)	O
phosphorylates	O
both	O
yCdc34	B-Gene_or_gene_product
and	O
hCdc34	B-Gene_or_gene_product
on	O
these	O
sites	O
in	O
vitro	O
.	O
<EOS>	B-X
We	B-X
mapped	B-X
the	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
sites	B-X
on	B-X
budding	B-X
yeast	B-X
Cdc34	B-X
(	B-X
yCdc34	B-X
;	B-X
Ser207	B-X
and	B-X
Ser216	B-X
)	B-X
and	B-X
human	B-X
Cdc34	B-X
(	B-X
hCdc34	B-X
Ser203	B-X
,	B-X
Ser222	B-X
and	B-X
Ser231	B-X
)	B-X
to	B-X
serine	B-X
residues	B-X
in	B-X
the	B-X
acidic	B-X
tail	B-X
domain	B-X
,	B-X
a	B-X
region	B-X
that	B-X
is	B-X
critical	B-X
for	B-X
Cdc34	B-X
's	B-X
cell	B-X
cycle	B-X
function	B-X
.	B-X
CK2	B-X
(	B-X
protein	B-X
kinase	B-X
CK2	B-X
)	B-X
phosphorylates	B-X
both	B-X
yCdc34	B-X
and	B-X
hCdc34	B-X
on	B-X
these	B-X
sites	B-X
in	B-X
vitro	B-X
.	B-X
CK2-mediated	B-X
phosphorylation	B-X
increased	B-X
yCdc34	B-X
ubiquitination	B-X
activity	B-X
towards	B-X
the	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
Sic1	B-X
in	B-X
vitro	B-X
,	B-X
when	B-X
assayed	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
its	B-X
cognate	B-X
SCFCdc4	B-X
E3	B-X
ligase	B-X
[	B-X
where	B-X
SCF	B-X
is	B-X
Skp1	B-X
(	B-X
S-phase	B-X
kinase-associated	B-X
protein	B-X
1	B-X
)	B-X
/cullin/F-box	B-X
]	B-X
.	B-X
Similarly	B-X
,	B-X
mutation	B-X
of	B-X
the	B-X
yCdc34	B-X
phosphorylation	B-X
sites	B-X
to	B-X
alanine	B-X
,	B-X
aspartate	B-X
or	B-X
glutamate	B-X
residues	B-X
altered	B-X
Cdc34-SCFCdc4-mediated	B-X
Sic1	B-X
ubiquitination	B-X
activity	B-X
.	B-X
Similar	B-X
results	B-X
were	B-X
obtained	B-X
when	B-X
yCdc34	B-X
's	B-X
ubiquitination	B-X
activity	B-X
was	B-X
assayed	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
SCFCdc4	B-X
,	B-X
indicating	B-X
that	B-X
phosphorylation	B-X
regulates	B-X
the	B-X
intrinsic	B-X
catalytic	B-X
activity	B-X
of	B-X
Cdc34	B-X
.	B-X
To	B-X
evaluate	B-X
the	B-X
in	B-X
vivo	B-X
consequences	B-X
of	B-X
altered	B-X
Cdc34	B-X
activity	B-X
,	B-X
wild-type	B-X
yCdc34	B-X
and	B-X
the	B-X
phosphosite	B-X
mutants	B-X
were	B-X
introduced	B-X
into	B-X
an	B-X
S.	B-X
cerevisiae	B-X
cdc34	B-X
deletion	B-X
strain	B-X
and	B-X
,	B-X
following	B-X
synchronization	B-X
in	B-X
G1-phase	B-X
,	B-X
progression	B-X
through	B-X
the	B-X
cell	B-X
cycle	B-X
was	B-X
monitored	B-X
.	B-X
Consistent	B-X
with	B-X
the	B-X
increased	B-X
ubiquitination	B-X
activity	B-X
in	B-X
vitro	B-X
,	B-X
cells	B-X
expressing	B-X
the	B-X
phosphosite	B-X
mutants	B-X
with	B-X
higher	B-X
catalytic	B-X
activity	B-X
exhibited	B-X
accelerated	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
Sic1	B-X
degradation	B-X
.	B-X
These	B-X
studies	B-X
demonstrate	B-X
that	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Cdc34	B-X
on	B-X
the	B-X
acidic	B-X
tail	B-X
domain	B-X
stimulates	B-X
Cdc34-SCFCdc4	B-X
ubiquitination	B-X
activity	B-X
and	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X

CK2	B-Gene_or_gene_product
-	O
mediated	O
phosphorylation	O
increased	O
yCdc34	B-Gene_or_gene_product
ubiquitination	O
activity	O
towards	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
Sic1	B-Gene_or_gene_product
in	O
vitro	O
,	O
when	O
assayed	O
in	O
the	O
presence	O
of	O
its	O
cognate	O
SCFCdc4	O
E3	O
ligase	O
[	O
where	O
SCF	O
is	O
Skp1	O
(	O
S	O
-	O
phase	O
kinase	O
-	O
associated	O
protein	O
1	O
)	O
/	O
cullin	O
/	O
F	O
-	O
box	O
]	O
.	O

Similarly	O
,	O
mutation	O
of	O
the	O
yCdc34	B-Gene_or_gene_product
phosphorylation	O
sites	O
to	O
alanine	O
,	O
aspartate	O
or	O
glutamate	O
residues	O
altered	O
Cdc34	B-Gene_or_gene_product
-	O
SCFCdc4	O
-	O
mediated	O
Sic1	B-Gene_or_gene_product
ubiquitination	O
activity	O
.	O
<EOS>	B-X
The	B-X
ubiquitin-conjugating	B-X
enzyme	B-X
Cdc34	B-X
(	B-X
cell	B-X
division	B-X
cycle	B-X
34	B-X
)	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
promoting	B-X
the	B-X
G1-S-phase	B-X
transition	B-X
of	B-X
the	B-X
eukaryotic	B-X
cell	B-X
cycle	B-X
and	B-X
is	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
if	B-X
phosphorylation	B-X
regulates	B-X
Cdc34	B-X
function	B-X
.	B-X
We	B-X
mapped	B-X
the	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
sites	B-X
on	B-X
budding	B-X
yeast	B-X
Cdc34	B-X
(	B-X
yCdc34	B-X
;	B-X
Ser207	B-X
and	B-X
Ser216	B-X
)	B-X
and	B-X
human	B-X
Cdc34	B-X
(	B-X
hCdc34	B-X
Ser203	B-X
,	B-X
Ser222	B-X
and	B-X
Ser231	B-X
)	B-X
to	B-X
serine	B-X
residues	B-X
in	B-X
the	B-X
acidic	B-X
tail	B-X
domain	B-X
,	B-X
a	B-X
region	B-X
that	B-X
is	B-X
critical	B-X
for	B-X
Cdc34	B-X
's	B-X
cell	B-X
cycle	B-X
function	B-X
.	B-X
CK2	B-X
(	B-X
protein	B-X
kinase	B-X
CK2	B-X
)	B-X
phosphorylates	B-X
both	B-X
yCdc34	B-X
and	B-X
hCdc34	B-X
on	B-X
these	B-X
sites	B-X
in	B-X
vitro	B-X
.	B-X
CK2-mediated	B-X
phosphorylation	B-X
increased	B-X
yCdc34	B-X
ubiquitination	B-X
activity	B-X
towards	B-X
the	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
Sic1	B-X
in	B-X
vitro	B-X
,	B-X
when	B-X
assayed	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
its	B-X
cognate	B-X
SCFCdc4	B-X
E3	B-X
ligase	B-X
[	B-X
where	B-X
SCF	B-X
is	B-X
Skp1	B-X
(	B-X
S-phase	B-X
kinase-associated	B-X
protein	B-X
1	B-X
)	B-X
/cullin/F-box	B-X
]	B-X
.	B-X
Similarly	B-X
,	B-X
mutation	B-X
of	B-X
the	B-X
yCdc34	B-X
phosphorylation	B-X
sites	B-X
to	B-X
alanine	B-X
,	B-X
aspartate	B-X
or	B-X
glutamate	B-X
residues	B-X
altered	B-X
Cdc34-SCFCdc4-mediated	B-X
Sic1	B-X
ubiquitination	B-X
activity	B-X
.	B-X
Similar	B-X
results	B-X
were	B-X
obtained	B-X
when	B-X
yCdc34	B-X
's	B-X
ubiquitination	B-X
activity	B-X
was	B-X
assayed	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
SCFCdc4	B-X
,	B-X
indicating	B-X
that	B-X
phosphorylation	B-X
regulates	B-X
the	B-X
intrinsic	B-X
catalytic	B-X
activity	B-X
of	B-X
Cdc34	B-X
.	B-X
To	B-X
evaluate	B-X
the	B-X
in	B-X
vivo	B-X
consequences	B-X
of	B-X
altered	B-X
Cdc34	B-X
activity	B-X
,	B-X
wild-type	B-X
yCdc34	B-X
and	B-X
the	B-X
phosphosite	B-X
mutants	B-X
were	B-X
introduced	B-X
into	B-X
an	B-X
S.	B-X
cerevisiae	B-X
cdc34	B-X
deletion	B-X
strain	B-X
and	B-X
,	B-X
following	B-X
synchronization	B-X
in	B-X
G1-phase	B-X
,	B-X
progression	B-X
through	B-X
the	B-X
cell	B-X
cycle	B-X
was	B-X
monitored	B-X
.	B-X
Consistent	B-X
with	B-X
the	B-X
increased	B-X
ubiquitination	B-X
activity	B-X
in	B-X
vitro	B-X
,	B-X
cells	B-X
expressing	B-X
the	B-X
phosphosite	B-X
mutants	B-X
with	B-X
higher	B-X
catalytic	B-X
activity	B-X
exhibited	B-X
accelerated	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
Sic1	B-X
degradation	B-X
.	B-X
These	B-X
studies	B-X
demonstrate	B-X
that	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Cdc34	B-X
on	B-X
the	B-X
acidic	B-X
tail	B-X
domain	B-X
stimulates	B-X
Cdc34-SCFCdc4	B-X
ubiquitination	B-X
activity	B-X
and	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X

Similar	O
results	O
were	O
obtained	O
when	O
yCdc34	B-Gene_or_gene_product
'	I-Gene_or_gene_product
s	I-Gene_or_gene_product
ubiquitination	O
activity	O
was	O
assayed	O
in	O
the	O
absence	O
of	O
SCFCdc4	O
,	O
indicating	O
that	O
phosphorylation	O
regulates	O
the	O
intrinsic	O
catalytic	O
activity	O
of	O
Cdc34	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
ubiquitin-conjugating	B-X
enzyme	B-X
Cdc34	B-X
(	B-X
cell	B-X
division	B-X
cycle	B-X
34	B-X
)	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
promoting	B-X
the	B-X
G1-S-phase	B-X
transition	B-X
of	B-X
the	B-X
eukaryotic	B-X
cell	B-X
cycle	B-X
and	B-X
is	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
if	B-X
phosphorylation	B-X
regulates	B-X
Cdc34	B-X
function	B-X
.	B-X
We	B-X
mapped	B-X
the	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
sites	B-X
on	B-X
budding	B-X
yeast	B-X
Cdc34	B-X
(	B-X
yCdc34	B-X
;	B-X
Ser207	B-X
and	B-X
Ser216	B-X
)	B-X
and	B-X
human	B-X
Cdc34	B-X
(	B-X
hCdc34	B-X
Ser203	B-X
,	B-X
Ser222	B-X
and	B-X
Ser231	B-X
)	B-X
to	B-X
serine	B-X
residues	B-X
in	B-X
the	B-X
acidic	B-X
tail	B-X
domain	B-X
,	B-X
a	B-X
region	B-X
that	B-X
is	B-X
critical	B-X
for	B-X
Cdc34	B-X
's	B-X
cell	B-X
cycle	B-X
function	B-X
.	B-X
CK2	B-X
(	B-X
protein	B-X
kinase	B-X
CK2	B-X
)	B-X
phosphorylates	B-X
both	B-X
yCdc34	B-X
and	B-X
hCdc34	B-X
on	B-X
these	B-X
sites	B-X
in	B-X
vitro	B-X
.	B-X
CK2-mediated	B-X
phosphorylation	B-X
increased	B-X
yCdc34	B-X
ubiquitination	B-X
activity	B-X
towards	B-X
the	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
Sic1	B-X
in	B-X
vitro	B-X
,	B-X
when	B-X
assayed	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
its	B-X
cognate	B-X
SCFCdc4	B-X
E3	B-X
ligase	B-X
[	B-X
where	B-X
SCF	B-X
is	B-X
Skp1	B-X
(	B-X
S-phase	B-X
kinase-associated	B-X
protein	B-X
1	B-X
)	B-X
/cullin/F-box	B-X
]	B-X
.	B-X
Similarly	B-X
,	B-X
mutation	B-X
of	B-X
the	B-X
yCdc34	B-X
phosphorylation	B-X
sites	B-X
to	B-X
alanine	B-X
,	B-X
aspartate	B-X
or	B-X
glutamate	B-X
residues	B-X
altered	B-X
Cdc34-SCFCdc4-mediated	B-X
Sic1	B-X
ubiquitination	B-X
activity	B-X
.	B-X
Similar	B-X
results	B-X
were	B-X
obtained	B-X
when	B-X
yCdc34	B-X
's	B-X
ubiquitination	B-X
activity	B-X
was	B-X
assayed	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
SCFCdc4	B-X
,	B-X
indicating	B-X
that	B-X
phosphorylation	B-X
regulates	B-X
the	B-X
intrinsic	B-X
catalytic	B-X
activity	B-X
of	B-X
Cdc34	B-X
.	B-X
To	B-X
evaluate	B-X
the	B-X
in	B-X
vivo	B-X
consequences	B-X
of	B-X
altered	B-X
Cdc34	B-X
activity	B-X
,	B-X
wild-type	B-X
yCdc34	B-X
and	B-X
the	B-X
phosphosite	B-X
mutants	B-X
were	B-X
introduced	B-X
into	B-X
an	B-X
S.	B-X
cerevisiae	B-X
cdc34	B-X
deletion	B-X
strain	B-X
and	B-X
,	B-X
following	B-X
synchronization	B-X
in	B-X
G1-phase	B-X
,	B-X
progression	B-X
through	B-X
the	B-X
cell	B-X
cycle	B-X
was	B-X
monitored	B-X
.	B-X
Consistent	B-X
with	B-X
the	B-X
increased	B-X
ubiquitination	B-X
activity	B-X
in	B-X
vitro	B-X
,	B-X
cells	B-X
expressing	B-X
the	B-X
phosphosite	B-X
mutants	B-X
with	B-X
higher	B-X
catalytic	B-X
activity	B-X
exhibited	B-X
accelerated	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
Sic1	B-X
degradation	B-X
.	B-X
These	B-X
studies	B-X
demonstrate	B-X
that	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Cdc34	B-X
on	B-X
the	B-X
acidic	B-X
tail	B-X
domain	B-X
stimulates	B-X
Cdc34-SCFCdc4	B-X
ubiquitination	B-X
activity	B-X
and	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X

To	O
evaluate	O
the	O
in	O
vivo	O
consequences	O
of	O
altered	O
Cdc34	B-Gene_or_gene_product
activity	O
,	O
wild	O
-	O
type	O
yCdc34	B-Gene_or_gene_product
and	O
the	O
phosphosite	O
mutants	O
were	O
introduced	O
into	O
an	O
S	O
.	O
cerevisiae	O
cdc34	B-Gene_or_gene_product
deletion	O
strain	O
and	O
,	O
following	O
synchronization	O
in	O
G1	O
-	O
phase	O
,	O
progression	O
through	O
the	O
cell	O
cycle	O
was	O
monitored	O
.	O

Consistent	O
with	O
the	O
increased	O
ubiquitination	O
activity	O
in	O
vitro	O
,	O
cells	O
expressing	O
the	O
phosphosite	O
mutants	O
with	O
higher	O
catalytic	O
activity	O
exhibited	O
accelerated	O
cell	O
cycle	O
progression	O
and	O
Sic1	B-Gene_or_gene_product
degradation	O
.	O
<EOS>	B-X
The	B-X
ubiquitin-conjugating	B-X
enzyme	B-X
Cdc34	B-X
(	B-X
cell	B-X
division	B-X
cycle	B-X
34	B-X
)	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
promoting	B-X
the	B-X
G1-S-phase	B-X
transition	B-X
of	B-X
the	B-X
eukaryotic	B-X
cell	B-X
cycle	B-X
and	B-X
is	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
.	B-X
We	B-X
mapped	B-X
the	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
sites	B-X
on	B-X
budding	B-X
yeast	B-X
Cdc34	B-X
(	B-X
yCdc34	B-X
;	B-X
Ser207	B-X
and	B-X
Ser216	B-X
)	B-X
and	B-X
human	B-X
Cdc34	B-X
(	B-X
hCdc34	B-X
Ser203	B-X
,	B-X
Ser222	B-X
and	B-X
Ser231	B-X
)	B-X
to	B-X
serine	B-X
residues	B-X
in	B-X
the	B-X
acidic	B-X
tail	B-X
domain	B-X
,	B-X
a	B-X
region	B-X
that	B-X
is	B-X
critical	B-X
for	B-X
Cdc34	B-X
's	B-X
cell	B-X
cycle	B-X
function	B-X
.	B-X
CK2	B-X
(	B-X
protein	B-X
kinase	B-X
CK2	B-X
)	B-X
phosphorylates	B-X
both	B-X
yCdc34	B-X
and	B-X
hCdc34	B-X
on	B-X
these	B-X
sites	B-X
in	B-X
vitro	B-X
.	B-X
CK2-mediated	B-X
phosphorylation	B-X
increased	B-X
yCdc34	B-X
ubiquitination	B-X
activity	B-X
towards	B-X
the	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
Sic1	B-X
in	B-X
vitro	B-X
,	B-X
when	B-X
assayed	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
its	B-X
cognate	B-X
SCFCdc4	B-X
E3	B-X
ligase	B-X
[	B-X
where	B-X
SCF	B-X
is	B-X
Skp1	B-X
(	B-X
S-phase	B-X
kinase-associated	B-X
protein	B-X
1	B-X
)	B-X
/cullin/F-box	B-X
]	B-X
.	B-X
Similarly	B-X
,	B-X
mutation	B-X
of	B-X
the	B-X
yCdc34	B-X
phosphorylation	B-X
sites	B-X
to	B-X
alanine	B-X
,	B-X
aspartate	B-X
or	B-X
glutamate	B-X
residues	B-X
altered	B-X
Cdc34-SCFCdc4-mediated	B-X
Sic1	B-X
ubiquitination	B-X
activity	B-X
.	B-X
Similar	B-X
results	B-X
were	B-X
obtained	B-X
when	B-X
yCdc34	B-X
's	B-X
ubiquitination	B-X
activity	B-X
was	B-X
assayed	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
SCFCdc4	B-X
,	B-X
indicating	B-X
that	B-X
phosphorylation	B-X
regulates	B-X
the	B-X
intrinsic	B-X
catalytic	B-X
activity	B-X
of	B-X
Cdc34	B-X
.	B-X
To	B-X
evaluate	B-X
the	B-X
in	B-X
vivo	B-X
consequences	B-X
of	B-X
altered	B-X
Cdc34	B-X
activity	B-X
,	B-X
wild-type	B-X
yCdc34	B-X
and	B-X
the	B-X
phosphosite	B-X
mutants	B-X
were	B-X
introduced	B-X
into	B-X
an	B-X
S.	B-X
cerevisiae	B-X
cdc34	B-X
deletion	B-X
strain	B-X
and	B-X
,	B-X
following	B-X
synchronization	B-X
in	B-X
G1-phase	B-X
,	B-X
progression	B-X
through	B-X
the	B-X
cell	B-X
cycle	B-X
was	B-X
monitored	B-X
.	B-X
Consistent	B-X
with	B-X
the	B-X
increased	B-X
ubiquitination	B-X
activity	B-X
in	B-X
vitro	B-X
,	B-X
cells	B-X
expressing	B-X
the	B-X
phosphosite	B-X
mutants	B-X
with	B-X
higher	B-X
catalytic	B-X
activity	B-X
exhibited	B-X
accelerated	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
Sic1	B-X
degradation	B-X
.	B-X
These	B-X
studies	B-X
demonstrate	B-X
that	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Cdc34	B-X
on	B-X
the	B-X
acidic	B-X
tail	B-X
domain	B-X
stimulates	B-X
Cdc34-SCFCdc4	B-X
ubiquitination	B-X
activity	B-X
and	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X

These	O
studies	O
demonstrate	O
that	O
CK2	B-Gene_or_gene_product
-	O
mediated	O
phosphorylation	O
of	O
Cdc34	B-Gene_or_gene_product
on	O
the	O
acidic	O
tail	O
domain	O
stimulates	O
Cdc34	B-Gene_or_gene_product
-	O
SCFCdc4	O
ubiquitination	O
activity	O
and	O
cell	O
cycle	O
progression	O
.	O
<EOS>	B-X
The	B-X
ubiquitin-conjugating	B-X
enzyme	B-X
Cdc34	B-X
(	B-X
cell	B-X
division	B-X
cycle	B-X
34	B-X
)	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
promoting	B-X
the	B-X
G1-S-phase	B-X
transition	B-X
of	B-X
the	B-X
eukaryotic	B-X
cell	B-X
cycle	B-X
and	B-X
is	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
if	B-X
phosphorylation	B-X
regulates	B-X
Cdc34	B-X
function	B-X
.	B-X
We	B-X
mapped	B-X
the	B-X
in	B-X
vivo	B-X
phosphorylation	B-X
sites	B-X
on	B-X
budding	B-X
yeast	B-X
Cdc34	B-X
(	B-X
yCdc34	B-X
;	B-X
Ser207	B-X
and	B-X
Ser216	B-X
)	B-X
and	B-X
human	B-X
Cdc34	B-X
(	B-X
hCdc34	B-X
Ser203	B-X
,	B-X
Ser222	B-X
and	B-X
Ser231	B-X
)	B-X
to	B-X
serine	B-X
residues	B-X
in	B-X
the	B-X
acidic	B-X
tail	B-X
domain	B-X
,	B-X
a	B-X
region	B-X
that	B-X
is	B-X
critical	B-X
for	B-X
Cdc34	B-X
's	B-X
cell	B-X
cycle	B-X
function	B-X
.	B-X
CK2	B-X
(	B-X
protein	B-X
kinase	B-X
CK2	B-X
)	B-X
phosphorylates	B-X
both	B-X
yCdc34	B-X
and	B-X
hCdc34	B-X
on	B-X
these	B-X
sites	B-X
in	B-X
vitro	B-X
.	B-X
CK2-mediated	B-X
phosphorylation	B-X
increased	B-X
yCdc34	B-X
ubiquitination	B-X
activity	B-X
towards	B-X
the	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
Sic1	B-X
in	B-X
vitro	B-X
,	B-X
when	B-X
assayed	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
its	B-X
cognate	B-X
SCFCdc4	B-X
E3	B-X
ligase	B-X
[	B-X
where	B-X
SCF	B-X
is	B-X
Skp1	B-X
(	B-X
S-phase	B-X
kinase-associated	B-X
protein	B-X
1	B-X
)	B-X
/cullin/F-box	B-X
]	B-X
.	B-X
Similarly	B-X
,	B-X
mutation	B-X
of	B-X
the	B-X
yCdc34	B-X
phosphorylation	B-X
sites	B-X
to	B-X
alanine	B-X
,	B-X
aspartate	B-X
or	B-X
glutamate	B-X
residues	B-X
altered	B-X
Cdc34-SCFCdc4-mediated	B-X
Sic1	B-X
ubiquitination	B-X
activity	B-X
.	B-X
Similar	B-X
results	B-X
were	B-X
obtained	B-X
when	B-X
yCdc34	B-X
's	B-X
ubiquitination	B-X
activity	B-X
was	B-X
assayed	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
SCFCdc4	B-X
,	B-X
indicating	B-X
that	B-X
phosphorylation	B-X
regulates	B-X
the	B-X
intrinsic	B-X
catalytic	B-X
activity	B-X
of	B-X
Cdc34	B-X
.	B-X
To	B-X
evaluate	B-X
the	B-X
in	B-X
vivo	B-X
consequences	B-X
of	B-X
altered	B-X
Cdc34	B-X
activity	B-X
,	B-X
wild-type	B-X
yCdc34	B-X
and	B-X
the	B-X
phosphosite	B-X
mutants	B-X
were	B-X
introduced	B-X
into	B-X
an	B-X
S.	B-X
cerevisiae	B-X
cdc34	B-X
deletion	B-X
strain	B-X
and	B-X
,	B-X
following	B-X
synchronization	B-X
in	B-X
G1-phase	B-X
,	B-X
progression	B-X
through	B-X
the	B-X
cell	B-X
cycle	B-X
was	B-X
monitored	B-X
.	B-X
Consistent	B-X
with	B-X
the	B-X
increased	B-X
ubiquitination	B-X
activity	B-X
in	B-X
vitro	B-X
,	B-X
cells	B-X
expressing	B-X
the	B-X
phosphosite	B-X
mutants	B-X
with	B-X
higher	B-X
catalytic	B-X
activity	B-X
exhibited	B-X
accelerated	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
Sic1	B-X
degradation	B-X
.	B-X
These	B-X
studies	B-X
demonstrate	B-X
that	B-X
CK2-mediated	B-X
phosphorylation	B-X
of	B-X
Cdc34	B-X
on	B-X
the	B-X
acidic	B-X
tail	B-X
domain	B-X
stimulates	B-X
Cdc34-SCFCdc4	B-X
ubiquitination	B-X
activity	B-X
and	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X

PRAS40	B-Gene_or_gene_product
regulates	O
mTORC1	O
kinase	O
activity	O
by	O
functioning	O
as	O
a	O
direct	O
inhibitor	O
of	O
substrate	O
binding	O
.	O
<EOS>	B-X
Mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
functions	B-X
in	B-X
two	B-X
distinct	B-X
signaling	B-X
complexes	B-X
,	B-X
mTORC1	B-X
and	B-X
mTORC2	B-X
.	B-X
In	B-X
response	B-X
to	B-X
insulin	B-X
and	B-X
nutrients	B-X
,	B-X
mTORC1	B-X
,	B-X
consisting	B-X
of	B-X
mTOR	B-X
,	B-X
raptor	B-X
(	B-X
regulatory-associated	B-X
protein	B-X
of	B-X
mTOR	B-X
)	B-X
,	B-X
and	B-X
mLST8	B-X
,	B-X
is	B-X
activated	B-X
and	B-X
phosphorylates	B-X
eukaryotic	B-X
initiation	B-X
factor	B-X
4E-binding	B-X
protein	B-X
(	B-X
4EBP	B-X
)	B-X
and	B-X
p70	B-X
S6	B-X
kinase	B-X
to	B-X
promote	B-X
protein	B-X
synthesis	B-X
and	B-X
cell	B-X
size	B-X
.	B-X
Previously	B-X
we	B-X
found	B-X
that	B-X
activation	B-X
of	B-X
mTOR	B-X
kinase	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
was	B-X
associated	B-X
with	B-X
increased	B-X
4EBP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
prolinerich	B-X
Akt	B-X
substrate	B-X
40	B-X
(	B-X
PRAS40	B-X
)	B-X
as	B-X
a	B-X
binding	B-X
partner	B-X
for	B-X
mTORC1	B-X
.	B-X
A	B-X
putative	B-X
TOR	B-X
signaling	B-X
motif	B-X
,	B-X
FVMDE	B-X
,	B-X
is	B-X
identified	B-X
in	B-X
PRAS40	B-X
and	B-X
shown	B-X
to	B-X
be	B-X
required	B-X
for	B-X
interaction	B-X
with	B-X
raptor	B-X
.	B-X
Insulin	B-X
stimulation	B-X
markedly	B-X
decreases	B-X
the	B-X
level	B-X
of	B-X
PRAS40	B-X
bound	B-X
by	B-X
mTORC1	B-X
.	B-X
Recombinant	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
this	B-X
inhibition	B-X
depends	B-X
on	B-X
PRAS40	B-X
association	B-X
with	B-X
raptor	B-X
.	B-X
Furthermore	B-X
,	B-X
decreasing	B-X
PRAS40	B-X
expression	B-X
by	B-X
short	B-X
hairpin	B-X
RNA	B-X
enhances	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
,	B-X
and	B-X
recombinant	B-X
PRAS40	B-X
competes	B-X
with	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
We	B-X
,	B-X
therefore	B-X
,	B-X
propose	B-X
that	B-X
PRAS40	B-X
regulates	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
by	B-X
functioning	B-X
as	B-X
a	B-X
direct	B-X
inhibitor	B-X
of	B-X
substrate	B-X
binding	B-X
.	B-X

Mammalian	B-Gene_or_gene_product
target	I-Gene_or_gene_product
of	I-Gene_or_gene_product
rapamycin	I-Gene_or_gene_product
(	O
mTOR	B-Gene_or_gene_product
)	O
functions	O
in	O
two	O
distinct	O
signaling	O
complexes	O
,	O
mTORC1	O
and	O
mTORC2	O
.	O
<EOS>	B-X
The	B-X
uptake	B-X
of	B-X
nutrients	B-X
from	B-X
the	B-X
environment	B-X
and	B-X
their	B-X
intracellular	B-X
metabolism	B-X
is	B-X
a	B-X
highly	B-X
controlled	B-X
process	B-X
that	B-X
involves	B-X
cross	B-X
talk	B-X
between	B-X
growth	B-X
signaling	B-X
and	B-X
metabolic	B-X
pathways	B-X
.	B-X
Despite	B-X
constant	B-X
fluctuations	B-X
in	B-X
nutrient	B-X
availability	B-X
and	B-X
environmental	B-X
signals	B-X
,	B-X
normal	B-X
cells	B-X
restore	B-X
metabolic	B-X
homeostasis	B-X
to	B-X
maintain	B-X
cellular	B-X
functions	B-X
and	B-X
prevent	B-X
disease	B-X
.	B-X
A	B-X
central	B-X
signaling	B-X
molecule	B-X
that	B-X
integrates	B-X
growth	B-X
with	B-X
metabolism	B-X
is	B-X
the	B-X
mechanistic	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
.	B-X
mTOR	B-X
is	B-X
a	B-X
protein	B-X
kinase	B-X
that	B-X
responds	B-X
to	B-X
levels	B-X
of	B-X
nutrients	B-X
and	B-X
growth	B-X
signals	B-X
.	B-X
mTOR	B-X
forms	B-X
two	B-X
protein	B-X
complexes	B-X
,	B-X
mTORC1	B-X
,	B-X
which	B-X
is	B-X
sensitive	B-X
to	B-X
rapamycin	B-X
,	B-X
and	B-X
mTORC2	B-X
,	B-X
which	B-X
is	B-X
not	B-X
directly	B-X
inhibited	B-X
by	B-X
this	B-X
drug	B-X
.	B-X
Rapamycin	B-X
has	B-X
facilitated	B-X
the	B-X
discovery	B-X
of	B-X
the	B-X
various	B-X
functions	B-X
of	B-X
mTORC1	B-X
in	B-X
metabolism	B-X
.	B-X
Genetic	B-X
models	B-X
that	B-X
disrupt	B-X
either	B-X
mTORC1	B-X
or	B-X
mTORC2	B-X
have	B-X
expanded	B-X
our	B-X
knowledge	B-X
of	B-X
their	B-X
cellular	B-X
,	B-X
tissue	B-X
,	B-X
as	B-X
well	B-X
as	B-X
systemic	B-X
functions	B-X
in	B-X
metabolism	B-X
.	B-X
Nevertheless	B-X
,	B-X
our	B-X
knowledge	B-X
of	B-X
the	B-X
regulation	B-X
and	B-X
functions	B-X
of	B-X
mTORC2	B-X
,	B-X
particularly	B-X
in	B-X
metabolism	B-X
,	B-X
has	B-X
lagged	B-X
behind	B-X
.	B-X
Since	B-X
mTOR	B-X
is	B-X
an	B-X
important	B-X
target	B-X
for	B-X
cancer	B-X
,	B-X
aging	B-X
,	B-X
and	B-X
other	B-X
metabolism-related	B-X
pathologies	B-X
,	B-X
understanding	B-X
the	B-X
distinct	B-X
and	B-X
overlapping	B-X
regulation	B-X
and	B-X
functions	B-X
of	B-X
the	B-X
two	B-X
mTOR	B-X
complexes	B-X
is	B-X
vital	B-X
for	B-X
the	B-X
development	B-X
of	B-X
more	B-X
effective	B-X
therapeutic	B-X
strategies	B-X
.	B-X
This	B-X
review	B-X
discusses	B-X
the	B-X
key	B-X
discoveries	B-X
and	B-X
recent	B-X
findings	B-X
on	B-X
the	B-X
regulation	B-X
and	B-X
metabolic	B-X
functions	B-X
of	B-X
the	B-X
mTOR	B-X
complexes	B-X
.	B-X
We	B-X
highlight	B-X
findings	B-X
from	B-X
cancer	B-X
models	B-X
but	B-X
also	B-X
discuss	B-X
other	B-X
examples	B-X
of	B-X
the	B-X
mTOR-mediated	B-X
metabolic	B-X
reprogramming	B-X
occurring	B-X
in	B-X
stem	B-X
and	B-X
immune	B-X
cells	B-X
,	B-X
type	B-X
2	B-X
diabetes/obesity	B-X
,	B-X
neurodegenerative	B-X
disorders	B-X
,	B-X
and	B-X
aging	B-X
.	B-X

In	O
response	O
to	O
insulin	B-Gene_or_gene_product
and	O
nutrients	O
,	O
mTORC1	O
,	O
consisting	O
of	O
mTOR	B-Gene_or_gene_product
,	O
raptor	B-Gene_or_gene_product
(	O
regulatory	B-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
of	I-Gene_or_gene_product
mTOR	I-Gene_or_gene_product
)	O
,	O
and	O
mLST8	B-Gene_or_gene_product
,	O
is	O
activated	O
and	O
phosphorylates	O
eukaryotic	B-Gene_or_gene_product
initiation	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
4E	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
4EBP	B-Gene_or_gene_product
)	O
and	O
p70	B-Gene_or_gene_product
S6	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
to	O
promote	O
protein	O
synthesis	O
and	O
cell	O
size	O
.	O
<EOS>	B-X
Mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
functions	B-X
in	B-X
two	B-X
distinct	B-X
signaling	B-X
complexes	B-X
,	B-X
mTORC1	B-X
and	B-X
mTORC2	B-X
.	B-X
In	B-X
response	B-X
to	B-X
insulin	B-X
and	B-X
nutrients	B-X
,	B-X
mTORC1	B-X
,	B-X
consisting	B-X
of	B-X
mTOR	B-X
,	B-X
raptor	B-X
(	B-X
regulatory-associated	B-X
protein	B-X
of	B-X
mTOR	B-X
)	B-X
,	B-X
and	B-X
mLST8	B-X
,	B-X
is	B-X
activated	B-X
and	B-X
phosphorylates	B-X
eukaryotic	B-X
initiation	B-X
factor	B-X
4E-binding	B-X
protein	B-X
(	B-X
4EBP	B-X
)	B-X
and	B-X
p70	B-X
S6	B-X
kinase	B-X
to	B-X
promote	B-X
protein	B-X
synthesis	B-X
and	B-X
cell	B-X
size	B-X
.	B-X
Previously	B-X
we	B-X
found	B-X
that	B-X
activation	B-X
of	B-X
mTOR	B-X
kinase	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
was	B-X
associated	B-X
with	B-X
increased	B-X
4EBP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
prolinerich	B-X
Akt	B-X
substrate	B-X
40	B-X
(	B-X
PRAS40	B-X
)	B-X
as	B-X
a	B-X
binding	B-X
partner	B-X
for	B-X
mTORC1	B-X
.	B-X
A	B-X
putative	B-X
TOR	B-X
signaling	B-X
motif	B-X
,	B-X
FVMDE	B-X
,	B-X
is	B-X
identified	B-X
in	B-X
PRAS40	B-X
and	B-X
shown	B-X
to	B-X
be	B-X
required	B-X
for	B-X
interaction	B-X
with	B-X
raptor	B-X
.	B-X
Insulin	B-X
stimulation	B-X
markedly	B-X
decreases	B-X
the	B-X
level	B-X
of	B-X
PRAS40	B-X
bound	B-X
by	B-X
mTORC1	B-X
.	B-X
Recombinant	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
this	B-X
inhibition	B-X
depends	B-X
on	B-X
PRAS40	B-X
association	B-X
with	B-X
raptor	B-X
.	B-X
Furthermore	B-X
,	B-X
decreasing	B-X
PRAS40	B-X
expression	B-X
by	B-X
short	B-X
hairpin	B-X
RNA	B-X
enhances	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
,	B-X
and	B-X
recombinant	B-X
PRAS40	B-X
competes	B-X
with	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
We	B-X
,	B-X
therefore	B-X
,	B-X
propose	B-X
that	B-X
PRAS40	B-X
regulates	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
by	B-X
functioning	B-X
as	B-X
a	B-X
direct	B-X
inhibitor	B-X
of	B-X
substrate	B-X
binding	B-X
.	B-X

Previously	O
we	O
found	O
that	O
activation	O
of	O
mTOR	B-Gene_or_gene_product
kinase	O
in	O
response	O
to	O
insulin	B-Gene_or_gene_product
was	O
associated	O
with	O
increased	O
4EBP1	B-Gene_or_gene_product
binding	O
to	O
raptor	B-Gene_or_gene_product
.	O
<EOS>	B-X
Mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
functions	B-X
in	B-X
two	B-X
distinct	B-X
signaling	B-X
complexes	B-X
,	B-X
mTORC1	B-X
and	B-X
mTORC2	B-X
.	B-X
In	B-X
response	B-X
to	B-X
insulin	B-X
and	B-X
nutrients	B-X
,	B-X
mTORC1	B-X
,	B-X
consisting	B-X
of	B-X
mTOR	B-X
,	B-X
raptor	B-X
(	B-X
regulatory-associated	B-X
protein	B-X
of	B-X
mTOR	B-X
)	B-X
,	B-X
and	B-X
mLST8	B-X
,	B-X
is	B-X
activated	B-X
and	B-X
phosphorylates	B-X
eukaryotic	B-X
initiation	B-X
factor	B-X
4E-binding	B-X
protein	B-X
(	B-X
4EBP	B-X
)	B-X
and	B-X
p70	B-X
S6	B-X
kinase	B-X
to	B-X
promote	B-X
protein	B-X
synthesis	B-X
and	B-X
cell	B-X
size	B-X
.	B-X
Previously	B-X
we	B-X
found	B-X
that	B-X
activation	B-X
of	B-X
mTOR	B-X
kinase	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
was	B-X
associated	B-X
with	B-X
increased	B-X
4EBP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
prolinerich	B-X
Akt	B-X
substrate	B-X
40	B-X
(	B-X
PRAS40	B-X
)	B-X
as	B-X
a	B-X
binding	B-X
partner	B-X
for	B-X
mTORC1	B-X
.	B-X
A	B-X
putative	B-X
TOR	B-X
signaling	B-X
motif	B-X
,	B-X
FVMDE	B-X
,	B-X
is	B-X
identified	B-X
in	B-X
PRAS40	B-X
and	B-X
shown	B-X
to	B-X
be	B-X
required	B-X
for	B-X
interaction	B-X
with	B-X
raptor	B-X
.	B-X
Insulin	B-X
stimulation	B-X
markedly	B-X
decreases	B-X
the	B-X
level	B-X
of	B-X
PRAS40	B-X
bound	B-X
by	B-X
mTORC1	B-X
.	B-X
Recombinant	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
this	B-X
inhibition	B-X
depends	B-X
on	B-X
PRAS40	B-X
association	B-X
with	B-X
raptor	B-X
.	B-X
Furthermore	B-X
,	B-X
decreasing	B-X
PRAS40	B-X
expression	B-X
by	B-X
short	B-X
hairpin	B-X
RNA	B-X
enhances	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
,	B-X
and	B-X
recombinant	B-X
PRAS40	B-X
competes	B-X
with	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
We	B-X
,	B-X
therefore	B-X
,	B-X
propose	B-X
that	B-X
PRAS40	B-X
regulates	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
by	B-X
functioning	B-X
as	B-X
a	B-X
direct	B-X
inhibitor	B-X
of	B-X
substrate	B-X
binding	B-X
.	B-X

Here	O
we	O
identify	O
prolinerich	B-Gene_or_gene_product
Akt	I-Gene_or_gene_product
substrate	I-Gene_or_gene_product
40	I-Gene_or_gene_product
(	O
PRAS40	B-Gene_or_gene_product
)	O
as	O
a	O
binding	O
partner	O
for	O
mTORC1	O
.	O
<EOS>	B-X
Mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
functions	B-X
in	B-X
two	B-X
distinct	B-X
signaling	B-X
complexes	B-X
,	B-X
mTORC1	B-X
and	B-X
mTORC2	B-X
.	B-X
In	B-X
response	B-X
to	B-X
insulin	B-X
and	B-X
nutrients	B-X
,	B-X
mTORC1	B-X
,	B-X
consisting	B-X
of	B-X
mTOR	B-X
,	B-X
raptor	B-X
(	B-X
regulatory-associated	B-X
protein	B-X
of	B-X
mTOR	B-X
)	B-X
,	B-X
and	B-X
mLST8	B-X
,	B-X
is	B-X
activated	B-X
and	B-X
phosphorylates	B-X
eukaryotic	B-X
initiation	B-X
factor	B-X
4E-binding	B-X
protein	B-X
(	B-X
4EBP	B-X
)	B-X
and	B-X
p70	B-X
S6	B-X
kinase	B-X
to	B-X
promote	B-X
protein	B-X
synthesis	B-X
and	B-X
cell	B-X
size	B-X
.	B-X
Previously	B-X
we	B-X
found	B-X
that	B-X
activation	B-X
of	B-X
mTOR	B-X
kinase	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
was	B-X
associated	B-X
with	B-X
increased	B-X
4EBP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
prolinerich	B-X
Akt	B-X
substrate	B-X
40	B-X
(	B-X
PRAS40	B-X
)	B-X
as	B-X
a	B-X
binding	B-X
partner	B-X
for	B-X
mTORC1	B-X
.	B-X
A	B-X
putative	B-X
TOR	B-X
signaling	B-X
motif	B-X
,	B-X
FVMDE	B-X
,	B-X
is	B-X
identified	B-X
in	B-X
PRAS40	B-X
and	B-X
shown	B-X
to	B-X
be	B-X
required	B-X
for	B-X
interaction	B-X
with	B-X
raptor	B-X
.	B-X
Insulin	B-X
stimulation	B-X
markedly	B-X
decreases	B-X
the	B-X
level	B-X
of	B-X
PRAS40	B-X
bound	B-X
by	B-X
mTORC1	B-X
.	B-X
Recombinant	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
this	B-X
inhibition	B-X
depends	B-X
on	B-X
PRAS40	B-X
association	B-X
with	B-X
raptor	B-X
.	B-X
Furthermore	B-X
,	B-X
decreasing	B-X
PRAS40	B-X
expression	B-X
by	B-X
short	B-X
hairpin	B-X
RNA	B-X
enhances	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
,	B-X
and	B-X
recombinant	B-X
PRAS40	B-X
competes	B-X
with	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
We	B-X
,	B-X
therefore	B-X
,	B-X
propose	B-X
that	B-X
PRAS40	B-X
regulates	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
by	B-X
functioning	B-X
as	B-X
a	B-X
direct	B-X
inhibitor	B-X
of	B-X
substrate	B-X
binding	B-X
.	B-X

A	O
putative	O
TOR	B-Gene_or_gene_product
signaling	O
motif	O
,	O
FVMDE	O
,	O
is	O
identified	O
in	O
PRAS40	B-Gene_or_gene_product
and	O
shown	O
to	O
be	O
required	O
for	O
interaction	O
with	O
raptor	B-Gene_or_gene_product
.	O
<EOS>	B-X
Mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
functions	B-X
in	B-X
two	B-X
distinct	B-X
signaling	B-X
complexes	B-X
,	B-X
mTORC1	B-X
and	B-X
mTORC2	B-X
.	B-X
In	B-X
response	B-X
to	B-X
insulin	B-X
and	B-X
nutrients	B-X
,	B-X
mTORC1	B-X
,	B-X
consisting	B-X
of	B-X
mTOR	B-X
,	B-X
raptor	B-X
(	B-X
regulatory-associated	B-X
protein	B-X
of	B-X
mTOR	B-X
)	B-X
,	B-X
and	B-X
mLST8	B-X
,	B-X
is	B-X
activated	B-X
and	B-X
phosphorylates	B-X
eukaryotic	B-X
initiation	B-X
factor	B-X
4E-binding	B-X
protein	B-X
(	B-X
4EBP	B-X
)	B-X
and	B-X
p70	B-X
S6	B-X
kinase	B-X
to	B-X
promote	B-X
protein	B-X
synthesis	B-X
and	B-X
cell	B-X
size	B-X
.	B-X
Previously	B-X
we	B-X
found	B-X
that	B-X
activation	B-X
of	B-X
mTOR	B-X
kinase	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
was	B-X
associated	B-X
with	B-X
increased	B-X
4EBP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
prolinerich	B-X
Akt	B-X
substrate	B-X
40	B-X
(	B-X
PRAS40	B-X
)	B-X
as	B-X
a	B-X
binding	B-X
partner	B-X
for	B-X
mTORC1	B-X
.	B-X
A	B-X
putative	B-X
TOR	B-X
signaling	B-X
motif	B-X
,	B-X
FVMDE	B-X
,	B-X
is	B-X
identified	B-X
in	B-X
PRAS40	B-X
and	B-X
shown	B-X
to	B-X
be	B-X
required	B-X
for	B-X
interaction	B-X
with	B-X
raptor	B-X
.	B-X
Insulin	B-X
stimulation	B-X
markedly	B-X
decreases	B-X
the	B-X
level	B-X
of	B-X
PRAS40	B-X
bound	B-X
by	B-X
mTORC1	B-X
.	B-X
Recombinant	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
this	B-X
inhibition	B-X
depends	B-X
on	B-X
PRAS40	B-X
association	B-X
with	B-X
raptor	B-X
.	B-X
Furthermore	B-X
,	B-X
decreasing	B-X
PRAS40	B-X
expression	B-X
by	B-X
short	B-X
hairpin	B-X
RNA	B-X
enhances	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
,	B-X
and	B-X
recombinant	B-X
PRAS40	B-X
competes	B-X
with	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
We	B-X
,	B-X
therefore	B-X
,	B-X
propose	B-X
that	B-X
PRAS40	B-X
regulates	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
by	B-X
functioning	B-X
as	B-X
a	B-X
direct	B-X
inhibitor	B-X
of	B-X
substrate	B-X
binding	B-X
.	B-X

Insulin	B-Gene_or_gene_product
stimulation	O
markedly	O
decreases	O
the	O
level	O
of	O
PRAS40	B-Gene_or_gene_product
bound	O
by	O
mTORC1	O
.	O
<EOS>	B-X
Mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
functions	B-X
in	B-X
two	B-X
distinct	B-X
signaling	B-X
complexes	B-X
,	B-X
mTORC1	B-X
and	B-X
mTORC2	B-X
.	B-X
In	B-X
response	B-X
to	B-X
insulin	B-X
and	B-X
nutrients	B-X
,	B-X
mTORC1	B-X
,	B-X
consisting	B-X
of	B-X
mTOR	B-X
,	B-X
raptor	B-X
(	B-X
regulatory-associated	B-X
protein	B-X
of	B-X
mTOR	B-X
)	B-X
,	B-X
and	B-X
mLST8	B-X
,	B-X
is	B-X
activated	B-X
and	B-X
phosphorylates	B-X
eukaryotic	B-X
initiation	B-X
factor	B-X
4E-binding	B-X
protein	B-X
(	B-X
4EBP	B-X
)	B-X
and	B-X
p70	B-X
S6	B-X
kinase	B-X
to	B-X
promote	B-X
protein	B-X
synthesis	B-X
and	B-X
cell	B-X
size	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
prolinerich	B-X
Akt	B-X
substrate	B-X
40	B-X
(	B-X
PRAS40	B-X
)	B-X
as	B-X
a	B-X
binding	B-X
partner	B-X
for	B-X
mTORC1	B-X
.	B-X
A	B-X
putative	B-X
TOR	B-X
signaling	B-X
motif	B-X
,	B-X
FVMDE	B-X
,	B-X
is	B-X
identified	B-X
in	B-X
PRAS40	B-X
and	B-X
shown	B-X
to	B-X
be	B-X
required	B-X
for	B-X
interaction	B-X
with	B-X
raptor	B-X
.	B-X
Insulin	B-X
stimulation	B-X
markedly	B-X
decreases	B-X
the	B-X
level	B-X
of	B-X
PRAS40	B-X
bound	B-X
by	B-X
mTORC1	B-X
.	B-X
Recombinant	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
this	B-X
inhibition	B-X
depends	B-X
on	B-X
PRAS40	B-X
association	B-X
with	B-X
raptor	B-X
.	B-X
Furthermore	B-X
,	B-X
decreasing	B-X
PRAS40	B-X
expression	B-X
by	B-X
short	B-X
hairpin	B-X
RNA	B-X
enhances	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
,	B-X
and	B-X
recombinant	B-X
PRAS40	B-X
competes	B-X
with	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
We	B-X
,	B-X
therefore	B-X
,	B-X
propose	B-X
that	B-X
PRAS40	B-X
regulates	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
by	B-X
functioning	B-X
as	B-X
a	B-X
direct	B-X
inhibitor	B-X
of	B-X
substrate	B-X
binding	B-X
.	B-X

Recombinant	O
PRAS40	B-Gene_or_gene_product
inhibits	O
mTORC1	O
kinase	O
activity	O
in	O
vivo	O
and	O
in	O
vitro	O
,	O
and	O
this	O
inhibition	O
depends	O
on	O
PRAS40	B-Gene_or_gene_product
association	O
with	O
raptor	B-Gene_or_gene_product
.	O
<EOS>	B-X
Mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
functions	B-X
in	B-X
two	B-X
distinct	B-X
signaling	B-X
complexes	B-X
,	B-X
mTORC1	B-X
and	B-X
mTORC2	B-X
.	B-X
In	B-X
response	B-X
to	B-X
insulin	B-X
and	B-X
nutrients	B-X
,	B-X
mTORC1	B-X
,	B-X
consisting	B-X
of	B-X
mTOR	B-X
,	B-X
raptor	B-X
(	B-X
regulatory-associated	B-X
protein	B-X
of	B-X
mTOR	B-X
)	B-X
,	B-X
and	B-X
mLST8	B-X
,	B-X
is	B-X
activated	B-X
and	B-X
phosphorylates	B-X
eukaryotic	B-X
initiation	B-X
factor	B-X
4E-binding	B-X
protein	B-X
(	B-X
4EBP	B-X
)	B-X
and	B-X
p70	B-X
S6	B-X
kinase	B-X
to	B-X
promote	B-X
protein	B-X
synthesis	B-X
and	B-X
cell	B-X
size	B-X
.	B-X
Previously	B-X
we	B-X
found	B-X
that	B-X
activation	B-X
of	B-X
mTOR	B-X
kinase	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
was	B-X
associated	B-X
with	B-X
increased	B-X
4EBP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
prolinerich	B-X
Akt	B-X
substrate	B-X
40	B-X
(	B-X
PRAS40	B-X
)	B-X
as	B-X
a	B-X
binding	B-X
partner	B-X
for	B-X
mTORC1	B-X
.	B-X
A	B-X
putative	B-X
TOR	B-X
signaling	B-X
motif	B-X
,	B-X
FVMDE	B-X
,	B-X
is	B-X
identified	B-X
in	B-X
PRAS40	B-X
and	B-X
shown	B-X
to	B-X
be	B-X
required	B-X
for	B-X
interaction	B-X
with	B-X
raptor	B-X
.	B-X
Insulin	B-X
stimulation	B-X
markedly	B-X
decreases	B-X
the	B-X
level	B-X
of	B-X
PRAS40	B-X
bound	B-X
by	B-X
mTORC1	B-X
.	B-X
Recombinant	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
this	B-X
inhibition	B-X
depends	B-X
on	B-X
PRAS40	B-X
association	B-X
with	B-X
raptor	B-X
.	B-X
Furthermore	B-X
,	B-X
decreasing	B-X
PRAS40	B-X
expression	B-X
by	B-X
short	B-X
hairpin	B-X
RNA	B-X
enhances	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
,	B-X
and	B-X
recombinant	B-X
PRAS40	B-X
competes	B-X
with	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
We	B-X
,	B-X
therefore	B-X
,	B-X
propose	B-X
that	B-X
PRAS40	B-X
regulates	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
by	B-X
functioning	B-X
as	B-X
a	B-X
direct	B-X
inhibitor	B-X
of	B-X
substrate	B-X
binding	B-X
.	B-X

Furthermore	O
,	O
decreasing	O
PRAS40	B-Gene_or_gene_product
expression	O
by	O
short	O
hairpin	O
RNA	O
enhances	O
4E	B-Gene_or_gene_product
-	I-Gene_or_gene_product
BP1	I-Gene_or_gene_product
binding	O
to	O
raptor	B-Gene_or_gene_product
,	O
and	O
recombinant	O
PRAS40	B-Gene_or_gene_product
competes	O
with	O
4E	B-Gene_or_gene_product
-	I-Gene_or_gene_product
BP1	I-Gene_or_gene_product
binding	O
to	O
raptor	B-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
response	B-X
to	B-X
insulin	B-X
and	B-X
nutrients	B-X
,	B-X
mTORC1	B-X
,	B-X
consisting	B-X
of	B-X
mTOR	B-X
,	B-X
raptor	B-X
(	B-X
regulatory-associated	B-X
protein	B-X
of	B-X
mTOR	B-X
)	B-X
,	B-X
and	B-X
mLST8	B-X
,	B-X
is	B-X
activated	B-X
and	B-X
phosphorylates	B-X
eukaryotic	B-X
initiation	B-X
factor	B-X
4E-binding	B-X
protein	B-X
(	B-X
4EBP	B-X
)	B-X
and	B-X
p70	B-X
S6	B-X
kinase	B-X
to	B-X
promote	B-X
protein	B-X
synthesis	B-X
and	B-X
cell	B-X
size	B-X
.	B-X
Previously	B-X
we	B-X
found	B-X
that	B-X
activation	B-X
of	B-X
mTOR	B-X
kinase	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
was	B-X
associated	B-X
with	B-X
increased	B-X
4EBP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
prolinerich	B-X
Akt	B-X
substrate	B-X
40	B-X
(	B-X
PRAS40	B-X
)	B-X
as	B-X
a	B-X
binding	B-X
partner	B-X
for	B-X
mTORC1	B-X
.	B-X
A	B-X
putative	B-X
TOR	B-X
signaling	B-X
motif	B-X
,	B-X
FVMDE	B-X
,	B-X
is	B-X
identified	B-X
in	B-X
PRAS40	B-X
and	B-X
shown	B-X
to	B-X
be	B-X
required	B-X
for	B-X
interaction	B-X
with	B-X
raptor	B-X
.	B-X
Insulin	B-X
stimulation	B-X
markedly	B-X
decreases	B-X
the	B-X
level	B-X
of	B-X
PRAS40	B-X
bound	B-X
by	B-X
mTORC1	B-X
.	B-X
Recombinant	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
this	B-X
inhibition	B-X
depends	B-X
on	B-X
PRAS40	B-X
association	B-X
with	B-X
raptor	B-X
.	B-X
Furthermore	B-X
,	B-X
decreasing	B-X
PRAS40	B-X
expression	B-X
by	B-X
short	B-X
hairpin	B-X
RNA	B-X
enhances	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
,	B-X
and	B-X
recombinant	B-X
PRAS40	B-X
competes	B-X
with	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
We	B-X
,	B-X
therefore	B-X
,	B-X
propose	B-X
that	B-X
PRAS40	B-X
regulates	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
by	B-X
functioning	B-X
as	B-X
a	B-X
direct	B-X
inhibitor	B-X
of	B-X
substrate	B-X
binding	B-X
.	B-X

We	O
,	O
therefore	O
,	O
propose	O
that	O
PRAS40	B-Gene_or_gene_product
regulates	O
mTORC1	O
kinase	O
activity	O
by	O
functioning	O
as	O
a	O
direct	O
inhibitor	O
of	O
substrate	O
binding	O
.	O
<EOS>	B-X
Mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
functions	B-X
in	B-X
two	B-X
distinct	B-X
signaling	B-X
complexes	B-X
,	B-X
mTORC1	B-X
and	B-X
mTORC2	B-X
.	B-X
In	B-X
response	B-X
to	B-X
insulin	B-X
and	B-X
nutrients	B-X
,	B-X
mTORC1	B-X
,	B-X
consisting	B-X
of	B-X
mTOR	B-X
,	B-X
raptor	B-X
(	B-X
regulatory-associated	B-X
protein	B-X
of	B-X
mTOR	B-X
)	B-X
,	B-X
and	B-X
mLST8	B-X
,	B-X
is	B-X
activated	B-X
and	B-X
phosphorylates	B-X
eukaryotic	B-X
initiation	B-X
factor	B-X
4E-binding	B-X
protein	B-X
(	B-X
4EBP	B-X
)	B-X
and	B-X
p70	B-X
S6	B-X
kinase	B-X
to	B-X
promote	B-X
protein	B-X
synthesis	B-X
and	B-X
cell	B-X
size	B-X
.	B-X
Previously	B-X
we	B-X
found	B-X
that	B-X
activation	B-X
of	B-X
mTOR	B-X
kinase	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
was	B-X
associated	B-X
with	B-X
increased	B-X
4EBP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
Here	B-X
we	B-X
identify	B-X
prolinerich	B-X
Akt	B-X
substrate	B-X
40	B-X
(	B-X
PRAS40	B-X
)	B-X
as	B-X
a	B-X
binding	B-X
partner	B-X
for	B-X
mTORC1	B-X
.	B-X
A	B-X
putative	B-X
TOR	B-X
signaling	B-X
motif	B-X
,	B-X
FVMDE	B-X
,	B-X
is	B-X
identified	B-X
in	B-X
PRAS40	B-X
and	B-X
shown	B-X
to	B-X
be	B-X
required	B-X
for	B-X
interaction	B-X
with	B-X
raptor	B-X
.	B-X
Insulin	B-X
stimulation	B-X
markedly	B-X
decreases	B-X
the	B-X
level	B-X
of	B-X
PRAS40	B-X
bound	B-X
by	B-X
mTORC1	B-X
.	B-X
Recombinant	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
this	B-X
inhibition	B-X
depends	B-X
on	B-X
PRAS40	B-X
association	B-X
with	B-X
raptor	B-X
.	B-X
Furthermore	B-X
,	B-X
decreasing	B-X
PRAS40	B-X
expression	B-X
by	B-X
short	B-X
hairpin	B-X
RNA	B-X
enhances	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
,	B-X
and	B-X
recombinant	B-X
PRAS40	B-X
competes	B-X
with	B-X
4E-BP1	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
We	B-X
,	B-X
therefore	B-X
,	B-X
propose	B-X
that	B-X
PRAS40	B-X
regulates	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
by	B-X
functioning	B-X
as	B-X
a	B-X
direct	B-X
inhibitor	B-X
of	B-X
substrate	B-X
binding	B-X
.	B-X

Acute	O
alcohol	O
exposure	O
exerts	O
anti	O
-	O
inflammatory	O
effects	O
by	O
inhibiting	O
IkappaB	O
kinase	O
activity	O
and	O
p65	B-Gene_or_gene_product
phosphorylation	O
in	O
human	O
monocytes	O
.	O
<EOS>	B-X
Acute	B-X
alcohol	B-X
use	B-X
is	B-X
associated	B-X
with	B-X
impaired	B-X
immune	B-X
responses	B-X
and	B-X
decreased	B-X
proinflammatory	B-X
cytokine	B-X
production	B-X
.	B-X
Our	B-X
earlier	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
acute	B-X
alcohol	B-X
intake	B-X
inhibits	B-X
NF-kappaB	B-X
DNA	B-X
binding	B-X
in	B-X
an	B-X
IkappaBalpha-independent	B-X
manner	B-X
.	B-X
We	B-X
report	B-X
using	B-X
human	B-X
peripheral	B-X
blood	B-X
monocytes	B-X
and	B-X
Chinese	B-X
hamster	B-X
ovary	B-X
cells	B-X
transfected	B-X
with	B-X
CD14	B-X
cells	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
in	B-X
vitro	B-X
exerts	B-X
NF-kappaB	B-X
inhibition	B-X
by	B-X
disrupting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X
Immunoprecipitation	B-X
of	B-X
p65	B-X
and	B-X
IkappaBalpha	B-X
revealed	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
for	B-X
1	B-X
h	B-X
decreased	B-X
NF-kappaB-IkappaBalpha	B-X
complexes	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
Phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
is	B-X
mediated	B-X
by	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
beta	B-X
and	B-X
is	B-X
required	B-X
for	B-X
NF-kappaB-dependent	B-X
cellular	B-X
responses	B-X
.	B-X
We	B-X
show	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
decreased	B-X
LPS-induced	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
activity	B-X
resulting	B-X
in	B-X
decreased	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
nuclear	B-X
expression	B-X
of	B-X
IKKalpha	B-X
increased	B-X
after	B-X
alcohol	B-X
treatment	B-X
,	B-X
which	B-X
may	B-X
contribute	B-X
to	B-X
inhibition	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Decreased	B-X
phosphorylation	B-X
of	B-X
nuclear	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
276	B-X
)	B-X
was	B-X
likely	B-X
not	B-X
due	B-X
to	B-X
alcohol-induced	B-X
inhibition	B-X
of	B-X
protein	B-X
kinase	B-X
A	B-X
and	B-X
mitogen-	B-X
and	B-X
stress-activated	B-X
protein	B-X
kinase-1	B-X
activity	B-X
.	B-X
Although	B-X
decreased	B-X
IkappaBalpha	B-X
phosphorylation	B-X
after	B-X
acute	B-X
alcohol	B-X
treatment	B-X
was	B-X
attributable	B-X
to	B-X
reduced	B-X
IKKbeta	B-X
activity	B-X
,	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
during	B-X
alcohol	B-X
exposure	B-X
was	B-X
IKKbeta-independent	B-X
.	B-X
Alcohol-induced	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
26S	B-X
proteasome	B-X
inhibitor	B-X
suggested	B-X
proteasome-independent	B-X
IkappaBalpha	B-X
degradation	B-X
.	B-X
Collectively	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
modulates	B-X
IkappaBalpha-independent	B-X
NF-kappaB	B-X
activity	B-X
primarily	B-X
by	B-X
affecting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X
These	B-X
findings	B-X
further	B-X
implicate	B-X
an	B-X
important	B-X
role	B-X
for	B-X
IKKbeta	B-X
in	B-X
the	B-X
acute	B-X
effects	B-X
of	B-X
alcohol	B-X
in	B-X
immune	B-X
cells	B-X
.	B-X

Acute	O
alcohol	O
use	O
is	O
associated	O
with	O
impaired	O
immune	O
responses	O
and	O
decreased	O
proinflammatory	O
cytokine	O
production	O
.	O
<EOS>	B-X
Acute	B-X
alcohol	B-X
use	B-X
is	B-X
associated	B-X
with	B-X
impaired	B-X
immune	B-X
responses	B-X
and	B-X
decreased	B-X
proinflammatory	B-X
cytokine	B-X
production	B-X
.	B-X
Our	B-X
earlier	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
acute	B-X
alcohol	B-X
intake	B-X
inhibits	B-X
NF-kappaB	B-X
DNA	B-X
binding	B-X
in	B-X
an	B-X
IkappaBalpha-independent	B-X
manner	B-X
.	B-X
We	B-X
report	B-X
using	B-X
human	B-X
peripheral	B-X
blood	B-X
monocytes	B-X
and	B-X
Chinese	B-X
hamster	B-X
ovary	B-X
cells	B-X
transfected	B-X
with	B-X
CD14	B-X
cells	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
in	B-X
vitro	B-X
exerts	B-X
NF-kappaB	B-X
inhibition	B-X
by	B-X
disrupting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X
Immunoprecipitation	B-X
of	B-X
p65	B-X
and	B-X
IkappaBalpha	B-X
revealed	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
for	B-X
1	B-X
h	B-X
decreased	B-X
NF-kappaB-IkappaBalpha	B-X
complexes	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
Phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
is	B-X
mediated	B-X
by	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
beta	B-X
and	B-X
is	B-X
required	B-X
for	B-X
NF-kappaB-dependent	B-X
cellular	B-X
responses	B-X
.	B-X
We	B-X
show	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
decreased	B-X
LPS-induced	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
activity	B-X
resulting	B-X
in	B-X
decreased	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
nuclear	B-X
expression	B-X
of	B-X
IKKalpha	B-X
increased	B-X
after	B-X
alcohol	B-X
treatment	B-X
,	B-X
which	B-X
may	B-X
contribute	B-X
to	B-X
inhibition	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Decreased	B-X
phosphorylation	B-X
of	B-X
nuclear	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
276	B-X
)	B-X
was	B-X
likely	B-X
not	B-X
due	B-X
to	B-X
alcohol-induced	B-X
inhibition	B-X
of	B-X
protein	B-X
kinase	B-X
A	B-X
and	B-X
mitogen-	B-X
and	B-X
stress-activated	B-X
protein	B-X
kinase-1	B-X
activity	B-X
.	B-X
Although	B-X
decreased	B-X
IkappaBalpha	B-X
phosphorylation	B-X
after	B-X
acute	B-X
alcohol	B-X
treatment	B-X
was	B-X
attributable	B-X
to	B-X
reduced	B-X
IKKbeta	B-X
activity	B-X
,	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
during	B-X
alcohol	B-X
exposure	B-X
was	B-X
IKKbeta-independent	B-X
.	B-X
Collectively	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
modulates	B-X
IkappaBalpha-independent	B-X
NF-kappaB	B-X
activity	B-X
primarily	B-X
by	B-X
affecting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X
These	B-X
findings	B-X
further	B-X
implicate	B-X
an	B-X
important	B-X
role	B-X
for	B-X
IKKbeta	B-X
in	B-X
the	B-X
acute	B-X
effects	B-X
of	B-X
alcohol	B-X
in	B-X
immune	B-X
cells	B-X
.	B-X

Our	O
earlier	O
studies	O
have	O
shown	O
that	O
acute	O
alcohol	O
intake	O
inhibits	O
NF	O
-	O
kappaB	O
DNA	O
binding	O
in	O
an	O
IkappaBalpha	B-Gene_or_gene_product
-	O
independent	O
manner	O
.	O

We	O
report	O
using	O
human	O
peripheral	O
blood	O
monocytes	O
and	O
Chinese	O
hamster	O
ovary	O
cells	O
transfected	O
with	O
CD14	B-Gene_or_gene_product
cells	O
that	O
acute	O
alcohol	O
treatment	O
in	O
vitro	O
exerts	O
NF	O
-	O
kappaB	O
inhibition	O
by	O
disrupting	O
phosphorylation	O
of	O
p65	B-Gene_or_gene_product
.	O
<EOS>	B-X
Acute	B-X
alcohol	B-X
use	B-X
is	B-X
associated	B-X
with	B-X
impaired	B-X
immune	B-X
responses	B-X
and	B-X
decreased	B-X
proinflammatory	B-X
cytokine	B-X
production	B-X
.	B-X
Our	B-X
earlier	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
acute	B-X
alcohol	B-X
intake	B-X
inhibits	B-X
NF-kappaB	B-X
DNA	B-X
binding	B-X
in	B-X
an	B-X
IkappaBalpha-independent	B-X
manner	B-X
.	B-X
We	B-X
report	B-X
using	B-X
human	B-X
peripheral	B-X
blood	B-X
monocytes	B-X
and	B-X
Chinese	B-X
hamster	B-X
ovary	B-X
cells	B-X
transfected	B-X
with	B-X
CD14	B-X
cells	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
in	B-X
vitro	B-X
exerts	B-X
NF-kappaB	B-X
inhibition	B-X
by	B-X
disrupting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X
Immunoprecipitation	B-X
of	B-X
p65	B-X
and	B-X
IkappaBalpha	B-X
revealed	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
for	B-X
1	B-X
h	B-X
decreased	B-X
NF-kappaB-IkappaBalpha	B-X
complexes	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
Phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
is	B-X
mediated	B-X
by	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
beta	B-X
and	B-X
is	B-X
required	B-X
for	B-X
NF-kappaB-dependent	B-X
cellular	B-X
responses	B-X
.	B-X
We	B-X
show	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
decreased	B-X
LPS-induced	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
activity	B-X
resulting	B-X
in	B-X
decreased	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
nuclear	B-X
expression	B-X
of	B-X
IKKalpha	B-X
increased	B-X
after	B-X
alcohol	B-X
treatment	B-X
,	B-X
which	B-X
may	B-X
contribute	B-X
to	B-X
inhibition	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Decreased	B-X
phosphorylation	B-X
of	B-X
nuclear	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
276	B-X
)	B-X
was	B-X
likely	B-X
not	B-X
due	B-X
to	B-X
alcohol-induced	B-X
inhibition	B-X
of	B-X
protein	B-X
kinase	B-X
A	B-X
and	B-X
mitogen-	B-X
and	B-X
stress-activated	B-X
protein	B-X
kinase-1	B-X
activity	B-X
.	B-X
Although	B-X
decreased	B-X
IkappaBalpha	B-X
phosphorylation	B-X
after	B-X
acute	B-X
alcohol	B-X
treatment	B-X
was	B-X
attributable	B-X
to	B-X
reduced	B-X
IKKbeta	B-X
activity	B-X
,	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
during	B-X
alcohol	B-X
exposure	B-X
was	B-X
IKKbeta-independent	B-X
.	B-X
Alcohol-induced	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
26S	B-X
proteasome	B-X
inhibitor	B-X
suggested	B-X
proteasome-independent	B-X
IkappaBalpha	B-X
degradation	B-X
.	B-X
Collectively	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
modulates	B-X
IkappaBalpha-independent	B-X
NF-kappaB	B-X
activity	B-X
primarily	B-X
by	B-X
affecting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X
These	B-X
findings	B-X
further	B-X
implicate	B-X
an	B-X
important	B-X
role	B-X
for	B-X
IKKbeta	B-X
in	B-X
the	B-X
acute	B-X
effects	B-X
of	B-X
alcohol	B-X
in	B-X
immune	B-X
cells	B-X
.	B-X

Immunoprecipitation	O
of	O
p65	B-Gene_or_gene_product
and	O
IkappaBalpha	B-Gene_or_gene_product
revealed	O
that	O
acute	O
alcohol	O
exposure	O
for	O
1	O
h	O
decreased	O
NF	O
-	O
kappaB	O
-	O
IkappaBalpha	O
complexes	O
in	O
the	O
cytoplasm	O
.	O
<EOS>	B-X
Acute	B-X
alcohol	B-X
use	B-X
is	B-X
associated	B-X
with	B-X
impaired	B-X
immune	B-X
responses	B-X
and	B-X
decreased	B-X
proinflammatory	B-X
cytokine	B-X
production	B-X
.	B-X
Our	B-X
earlier	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
acute	B-X
alcohol	B-X
intake	B-X
inhibits	B-X
NF-kappaB	B-X
DNA	B-X
binding	B-X
in	B-X
an	B-X
IkappaBalpha-independent	B-X
manner	B-X
.	B-X
We	B-X
report	B-X
using	B-X
human	B-X
peripheral	B-X
blood	B-X
monocytes	B-X
and	B-X
Chinese	B-X
hamster	B-X
ovary	B-X
cells	B-X
transfected	B-X
with	B-X
CD14	B-X
cells	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
in	B-X
vitro	B-X
exerts	B-X
NF-kappaB	B-X
inhibition	B-X
by	B-X
disrupting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X
Immunoprecipitation	B-X
of	B-X
p65	B-X
and	B-X
IkappaBalpha	B-X
revealed	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
for	B-X
1	B-X
h	B-X
decreased	B-X
NF-kappaB-IkappaBalpha	B-X
complexes	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
Phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
is	B-X
mediated	B-X
by	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
beta	B-X
and	B-X
is	B-X
required	B-X
for	B-X
NF-kappaB-dependent	B-X
cellular	B-X
responses	B-X
.	B-X
We	B-X
show	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
decreased	B-X
LPS-induced	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
activity	B-X
resulting	B-X
in	B-X
decreased	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
nuclear	B-X
expression	B-X
of	B-X
IKKalpha	B-X
increased	B-X
after	B-X
alcohol	B-X
treatment	B-X
,	B-X
which	B-X
may	B-X
contribute	B-X
to	B-X
inhibition	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Decreased	B-X
phosphorylation	B-X
of	B-X
nuclear	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
276	B-X
)	B-X
was	B-X
likely	B-X
not	B-X
due	B-X
to	B-X
alcohol-induced	B-X
inhibition	B-X
of	B-X
protein	B-X
kinase	B-X
A	B-X
and	B-X
mitogen-	B-X
and	B-X
stress-activated	B-X
protein	B-X
kinase-1	B-X
activity	B-X
.	B-X
Although	B-X
decreased	B-X
IkappaBalpha	B-X
phosphorylation	B-X
after	B-X
acute	B-X
alcohol	B-X
treatment	B-X
was	B-X
attributable	B-X
to	B-X
reduced	B-X
IKKbeta	B-X
activity	B-X
,	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
during	B-X
alcohol	B-X
exposure	B-X
was	B-X
IKKbeta-independent	B-X
.	B-X
Alcohol-induced	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
26S	B-X
proteasome	B-X
inhibitor	B-X
suggested	B-X
proteasome-independent	B-X
IkappaBalpha	B-X
degradation	B-X
.	B-X
Collectively	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
modulates	B-X
IkappaBalpha-independent	B-X
NF-kappaB	B-X
activity	B-X
primarily	B-X
by	B-X
affecting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X
These	B-X
findings	B-X
further	B-X
implicate	B-X
an	B-X
important	B-X
role	B-X
for	B-X
IKKbeta	B-X
in	B-X
the	B-X
acute	B-X
effects	B-X
of	B-X
alcohol	B-X
in	B-X
immune	B-X
cells	B-X
.	B-X

Phosphorylation	O
of	O
p65	B-Gene_or_gene_product
at	O
Ser	O
(	O
536	O
)	O
is	O
mediated	O
by	O
IkappaB	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	I-Gene_or_gene_product
IKK	I-Gene_or_gene_product
)	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
and	O
is	O
required	O
for	O
NF	O
-	O
kappaB	O
-	O
dependent	O
cellular	O
responses	O
.	O

We	O
show	O
that	O
acute	O
alcohol	O
treatment	O
decreased	O
LPS	O
-	O
induced	O
IKKalpha	B-Gene_or_gene_product
and	O
IKKbeta	B-Gene_or_gene_product
activity	O
resulting	O
in	O
decreased	O
phosphorylation	O
of	O
p65	B-Gene_or_gene_product
at	O
Ser	O
(	O
536	O
)	O
.	O
<EOS>	B-X
Acute	B-X
alcohol	B-X
use	B-X
is	B-X
associated	B-X
with	B-X
impaired	B-X
immune	B-X
responses	B-X
and	B-X
decreased	B-X
proinflammatory	B-X
cytokine	B-X
production	B-X
.	B-X
Our	B-X
earlier	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
acute	B-X
alcohol	B-X
intake	B-X
inhibits	B-X
NF-kappaB	B-X
DNA	B-X
binding	B-X
in	B-X
an	B-X
IkappaBalpha-independent	B-X
manner	B-X
.	B-X
We	B-X
report	B-X
using	B-X
human	B-X
peripheral	B-X
blood	B-X
monocytes	B-X
and	B-X
Chinese	B-X
hamster	B-X
ovary	B-X
cells	B-X
transfected	B-X
with	B-X
CD14	B-X
cells	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
in	B-X
vitro	B-X
exerts	B-X
NF-kappaB	B-X
inhibition	B-X
by	B-X
disrupting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X
Immunoprecipitation	B-X
of	B-X
p65	B-X
and	B-X
IkappaBalpha	B-X
revealed	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
for	B-X
1	B-X
h	B-X
decreased	B-X
NF-kappaB-IkappaBalpha	B-X
complexes	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
Phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
is	B-X
mediated	B-X
by	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
beta	B-X
and	B-X
is	B-X
required	B-X
for	B-X
NF-kappaB-dependent	B-X
cellular	B-X
responses	B-X
.	B-X
We	B-X
show	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
decreased	B-X
LPS-induced	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
activity	B-X
resulting	B-X
in	B-X
decreased	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
nuclear	B-X
expression	B-X
of	B-X
IKKalpha	B-X
increased	B-X
after	B-X
alcohol	B-X
treatment	B-X
,	B-X
which	B-X
may	B-X
contribute	B-X
to	B-X
inhibition	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Decreased	B-X
phosphorylation	B-X
of	B-X
nuclear	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
276	B-X
)	B-X
was	B-X
likely	B-X
not	B-X
due	B-X
to	B-X
alcohol-induced	B-X
inhibition	B-X
of	B-X
protein	B-X
kinase	B-X
A	B-X
and	B-X
mitogen-	B-X
and	B-X
stress-activated	B-X
protein	B-X
kinase-1	B-X
activity	B-X
.	B-X
Although	B-X
decreased	B-X
IkappaBalpha	B-X
phosphorylation	B-X
after	B-X
acute	B-X
alcohol	B-X
treatment	B-X
was	B-X
attributable	B-X
to	B-X
reduced	B-X
IKKbeta	B-X
activity	B-X
,	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
during	B-X
alcohol	B-X
exposure	B-X
was	B-X
IKKbeta-independent	B-X
.	B-X
Alcohol-induced	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
26S	B-X
proteasome	B-X
inhibitor	B-X
suggested	B-X
proteasome-independent	B-X
IkappaBalpha	B-X
degradation	B-X
.	B-X
Collectively	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
modulates	B-X
IkappaBalpha-independent	B-X
NF-kappaB	B-X
activity	B-X
primarily	B-X
by	B-X
affecting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X
These	B-X
findings	B-X
further	B-X
implicate	B-X
an	B-X
important	B-X
role	B-X
for	B-X
IKKbeta	B-X
in	B-X
the	B-X
acute	B-X
effects	B-X
of	B-X
alcohol	B-X
in	B-X
immune	B-X
cells	B-X
.	B-X

Furthermore	O
,	O
nuclear	O
expression	O
of	O
IKKalpha	B-Gene_or_gene_product
increased	O
after	O
alcohol	O
treatment	O
,	O
which	O
may	O
contribute	O
to	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
.	O
<EOS>	B-X
Acute	B-X
alcohol	B-X
use	B-X
is	B-X
associated	B-X
with	B-X
impaired	B-X
immune	B-X
responses	B-X
and	B-X
decreased	B-X
proinflammatory	B-X
cytokine	B-X
production	B-X
.	B-X
Our	B-X
earlier	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
acute	B-X
alcohol	B-X
intake	B-X
inhibits	B-X
NF-kappaB	B-X
DNA	B-X
binding	B-X
in	B-X
an	B-X
IkappaBalpha-independent	B-X
manner	B-X
.	B-X
We	B-X
report	B-X
using	B-X
human	B-X
peripheral	B-X
blood	B-X
monocytes	B-X
and	B-X
Chinese	B-X
hamster	B-X
ovary	B-X
cells	B-X
transfected	B-X
with	B-X
CD14	B-X
cells	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
in	B-X
vitro	B-X
exerts	B-X
NF-kappaB	B-X
inhibition	B-X
by	B-X
disrupting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X
Immunoprecipitation	B-X
of	B-X
p65	B-X
and	B-X
IkappaBalpha	B-X
revealed	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
for	B-X
1	B-X
h	B-X
decreased	B-X
NF-kappaB-IkappaBalpha	B-X
complexes	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
Phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
is	B-X
mediated	B-X
by	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
beta	B-X
and	B-X
is	B-X
required	B-X
for	B-X
NF-kappaB-dependent	B-X
cellular	B-X
responses	B-X
.	B-X
We	B-X
show	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
decreased	B-X
LPS-induced	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
activity	B-X
resulting	B-X
in	B-X
decreased	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
nuclear	B-X
expression	B-X
of	B-X
IKKalpha	B-X
increased	B-X
after	B-X
alcohol	B-X
treatment	B-X
,	B-X
which	B-X
may	B-X
contribute	B-X
to	B-X
inhibition	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Decreased	B-X
phosphorylation	B-X
of	B-X
nuclear	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
276	B-X
)	B-X
was	B-X
likely	B-X
not	B-X
due	B-X
to	B-X
alcohol-induced	B-X
inhibition	B-X
of	B-X
protein	B-X
kinase	B-X
A	B-X
and	B-X
mitogen-	B-X
and	B-X
stress-activated	B-X
protein	B-X
kinase-1	B-X
activity	B-X
.	B-X
Although	B-X
decreased	B-X
IkappaBalpha	B-X
phosphorylation	B-X
after	B-X
acute	B-X
alcohol	B-X
treatment	B-X
was	B-X
attributable	B-X
to	B-X
reduced	B-X
IKKbeta	B-X
activity	B-X
,	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
during	B-X
alcohol	B-X
exposure	B-X
was	B-X
IKKbeta-independent	B-X
.	B-X
Alcohol-induced	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
26S	B-X
proteasome	B-X
inhibitor	B-X
suggested	B-X
proteasome-independent	B-X
IkappaBalpha	B-X
degradation	B-X
.	B-X
Collectively	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
modulates	B-X
IkappaBalpha-independent	B-X
NF-kappaB	B-X
activity	B-X
primarily	B-X
by	B-X
affecting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X
These	B-X
findings	B-X
further	B-X
implicate	B-X
an	B-X
important	B-X
role	B-X
for	B-X
IKKbeta	B-X
in	B-X
the	B-X
acute	B-X
effects	B-X
of	B-X
alcohol	B-X
in	B-X
immune	B-X
cells	B-X
.	B-X

Decreased	O
phosphorylation	O
of	O
nuclear	O
p65	B-Gene_or_gene_product
at	O
Ser	O
(	O
276	O
)	O
was	O
likely	O
not	O
due	O
to	O
alcohol	O
-	O
induced	O
inhibition	O
of	O
protein	O
kinase	O
A	O
and	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
and	I-Gene_or_gene_product
stress	I-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
activity	O
.	O

Although	O
decreased	O
IkappaBalpha	B-Gene_or_gene_product
phosphorylation	O
after	O
acute	O
alcohol	O
treatment	O
was	O
attributable	O
to	O
reduced	O
IKKbeta	B-Gene_or_gene_product
activity	O
,	O
degradation	O
of	O
IkappaBalpha	B-Gene_or_gene_product
during	O
alcohol	O
exposure	O
was	O
IKKbeta	B-Gene_or_gene_product
-	O
independent	O
.	O
<EOS>	B-X
Acute	B-X
alcohol	B-X
use	B-X
is	B-X
associated	B-X
with	B-X
impaired	B-X
immune	B-X
responses	B-X
and	B-X
decreased	B-X
proinflammatory	B-X
cytokine	B-X
production	B-X
.	B-X
Our	B-X
earlier	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
acute	B-X
alcohol	B-X
intake	B-X
inhibits	B-X
NF-kappaB	B-X
DNA	B-X
binding	B-X
in	B-X
an	B-X
IkappaBalpha-independent	B-X
manner	B-X
.	B-X
We	B-X
report	B-X
using	B-X
human	B-X
peripheral	B-X
blood	B-X
monocytes	B-X
and	B-X
Chinese	B-X
hamster	B-X
ovary	B-X
cells	B-X
transfected	B-X
with	B-X
CD14	B-X
cells	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
in	B-X
vitro	B-X
exerts	B-X
NF-kappaB	B-X
inhibition	B-X
by	B-X
disrupting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X
Immunoprecipitation	B-X
of	B-X
p65	B-X
and	B-X
IkappaBalpha	B-X
revealed	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
for	B-X
1	B-X
h	B-X
decreased	B-X
NF-kappaB-IkappaBalpha	B-X
complexes	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
We	B-X
show	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
decreased	B-X
LPS-induced	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
activity	B-X
resulting	B-X
in	B-X
decreased	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
nuclear	B-X
expression	B-X
of	B-X
IKKalpha	B-X
increased	B-X
after	B-X
alcohol	B-X
treatment	B-X
,	B-X
which	B-X
may	B-X
contribute	B-X
to	B-X
inhibition	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Decreased	B-X
phosphorylation	B-X
of	B-X
nuclear	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
276	B-X
)	B-X
was	B-X
likely	B-X
not	B-X
due	B-X
to	B-X
alcohol-induced	B-X
inhibition	B-X
of	B-X
protein	B-X
kinase	B-X
A	B-X
and	B-X
mitogen-	B-X
and	B-X
stress-activated	B-X
protein	B-X
kinase-1	B-X
activity	B-X
.	B-X
Although	B-X
decreased	B-X
IkappaBalpha	B-X
phosphorylation	B-X
after	B-X
acute	B-X
alcohol	B-X
treatment	B-X
was	B-X
attributable	B-X
to	B-X
reduced	B-X
IKKbeta	B-X
activity	B-X
,	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
during	B-X
alcohol	B-X
exposure	B-X
was	B-X
IKKbeta-independent	B-X
.	B-X
Alcohol-induced	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
26S	B-X
proteasome	B-X
inhibitor	B-X
suggested	B-X
proteasome-independent	B-X
IkappaBalpha	B-X
degradation	B-X
.	B-X
Collectively	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
modulates	B-X
IkappaBalpha-independent	B-X
NF-kappaB	B-X
activity	B-X
primarily	B-X
by	B-X
affecting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X
These	B-X
findings	B-X
further	B-X
implicate	B-X
an	B-X
important	B-X
role	B-X
for	B-X
IKKbeta	B-X
in	B-X
the	B-X
acute	B-X
effects	B-X
of	B-X
alcohol	B-X
in	B-X
immune	B-X
cells	B-X
.	B-X

Alcohol	O
-	O
induced	O
degradation	O
of	O
IkappaBalpha	B-Gene_or_gene_product
in	O
the	O
presence	O
of	O
a	O
26S	O
proteasome	O
inhibitor	O
suggested	O
proteasome	O
-	O
independent	O
IkappaBalpha	B-Gene_or_gene_product
degradation	O
.	O
<EOS>	B-X
Our	B-X
earlier	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
acute	B-X
alcohol	B-X
intake	B-X
inhibits	B-X
NF-kappaB	B-X
DNA	B-X
binding	B-X
in	B-X
an	B-X
IkappaBalpha-independent	B-X
manner	B-X
.	B-X
Immunoprecipitation	B-X
of	B-X
p65	B-X
and	B-X
IkappaBalpha	B-X
revealed	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
for	B-X
1	B-X
h	B-X
decreased	B-X
NF-kappaB-IkappaBalpha	B-X
complexes	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
We	B-X
show	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
decreased	B-X
LPS-induced	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
activity	B-X
resulting	B-X
in	B-X
decreased	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
.	B-X
Decreased	B-X
phosphorylation	B-X
of	B-X
nuclear	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
276	B-X
)	B-X
was	B-X
likely	B-X
not	B-X
due	B-X
to	B-X
alcohol-induced	B-X
inhibition	B-X
of	B-X
protein	B-X
kinase	B-X
A	B-X
and	B-X
mitogen-	B-X
and	B-X
stress-activated	B-X
protein	B-X
kinase-1	B-X
activity	B-X
.	B-X
Although	B-X
decreased	B-X
IkappaBalpha	B-X
phosphorylation	B-X
after	B-X
acute	B-X
alcohol	B-X
treatment	B-X
was	B-X
attributable	B-X
to	B-X
reduced	B-X
IKKbeta	B-X
activity	B-X
,	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
during	B-X
alcohol	B-X
exposure	B-X
was	B-X
IKKbeta-independent	B-X
.	B-X
Alcohol-induced	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
26S	B-X
proteasome	B-X
inhibitor	B-X
suggested	B-X
proteasome-independent	B-X
IkappaBalpha	B-X
degradation	B-X
.	B-X
Collectively	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
modulates	B-X
IkappaBalpha-independent	B-X
NF-kappaB	B-X
activity	B-X
primarily	B-X
by	B-X
affecting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X

Collectively	O
,	O
our	O
studies	O
suggest	O
that	O
acute	O
alcohol	O
exposure	O
modulates	O
IkappaBalpha	B-Gene_or_gene_product
-	O
independent	O
NF	O
-	O
kappaB	O
activity	O
primarily	O
by	O
affecting	O
phosphorylation	O
of	O
p65	B-Gene_or_gene_product
.	O
<EOS>	B-X
Acute	B-X
alcohol	B-X
use	B-X
is	B-X
associated	B-X
with	B-X
impaired	B-X
immune	B-X
responses	B-X
and	B-X
decreased	B-X
proinflammatory	B-X
cytokine	B-X
production	B-X
.	B-X
Our	B-X
earlier	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
acute	B-X
alcohol	B-X
intake	B-X
inhibits	B-X
NF-kappaB	B-X
DNA	B-X
binding	B-X
in	B-X
an	B-X
IkappaBalpha-independent	B-X
manner	B-X
.	B-X
We	B-X
report	B-X
using	B-X
human	B-X
peripheral	B-X
blood	B-X
monocytes	B-X
and	B-X
Chinese	B-X
hamster	B-X
ovary	B-X
cells	B-X
transfected	B-X
with	B-X
CD14	B-X
cells	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
in	B-X
vitro	B-X
exerts	B-X
NF-kappaB	B-X
inhibition	B-X
by	B-X
disrupting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X
Immunoprecipitation	B-X
of	B-X
p65	B-X
and	B-X
IkappaBalpha	B-X
revealed	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
for	B-X
1	B-X
h	B-X
decreased	B-X
NF-kappaB-IkappaBalpha	B-X
complexes	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
Phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
is	B-X
mediated	B-X
by	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
beta	B-X
and	B-X
is	B-X
required	B-X
for	B-X
NF-kappaB-dependent	B-X
cellular	B-X
responses	B-X
.	B-X
We	B-X
show	B-X
that	B-X
acute	B-X
alcohol	B-X
treatment	B-X
decreased	B-X
LPS-induced	B-X
IKKalpha	B-X
and	B-X
IKKbeta	B-X
activity	B-X
resulting	B-X
in	B-X
decreased	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
nuclear	B-X
expression	B-X
of	B-X
IKKalpha	B-X
increased	B-X
after	B-X
alcohol	B-X
treatment	B-X
,	B-X
which	B-X
may	B-X
contribute	B-X
to	B-X
inhibition	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Decreased	B-X
phosphorylation	B-X
of	B-X
nuclear	B-X
p65	B-X
at	B-X
Ser	B-X
(	B-X
276	B-X
)	B-X
was	B-X
likely	B-X
not	B-X
due	B-X
to	B-X
alcohol-induced	B-X
inhibition	B-X
of	B-X
protein	B-X
kinase	B-X
A	B-X
and	B-X
mitogen-	B-X
and	B-X
stress-activated	B-X
protein	B-X
kinase-1	B-X
activity	B-X
.	B-X
Although	B-X
decreased	B-X
IkappaBalpha	B-X
phosphorylation	B-X
after	B-X
acute	B-X
alcohol	B-X
treatment	B-X
was	B-X
attributable	B-X
to	B-X
reduced	B-X
IKKbeta	B-X
activity	B-X
,	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
during	B-X
alcohol	B-X
exposure	B-X
was	B-X
IKKbeta-independent	B-X
.	B-X
Alcohol-induced	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
26S	B-X
proteasome	B-X
inhibitor	B-X
suggested	B-X
proteasome-independent	B-X
IkappaBalpha	B-X
degradation	B-X
.	B-X
Collectively	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
acute	B-X
alcohol	B-X
exposure	B-X
modulates	B-X
IkappaBalpha-independent	B-X
NF-kappaB	B-X
activity	B-X
primarily	B-X
by	B-X
affecting	B-X
phosphorylation	B-X
of	B-X
p65	B-X
.	B-X
These	B-X
findings	B-X
further	B-X
implicate	B-X
an	B-X
important	B-X
role	B-X
for	B-X
IKKbeta	B-X
in	B-X
the	B-X
acute	B-X
effects	B-X
of	B-X
alcohol	B-X
in	B-X
immune	B-X
cells	B-X
.	B-X

These	O
findings	O
further	O
implicate	O
an	O
important	O
role	O
for	O
IKKbeta	B-Gene_or_gene_product
in	O
the	O
acute	O
effects	O
of	O
alcohol	O
in	O
immune	O
cells	O
.	O
<EOS>	B-X
Proinflammatory	B-X
pathways	B-X
in	B-X
neuronal	B-X
and	B-X
non-neuronal	B-X
cells	B-X
are	B-X
implicated	B-X
in	B-X
the	B-X
acute	B-X
and	B-X
chronic	B-X
effects	B-X
of	B-X
alcohol	B-X
exposure	B-X
in	B-X
animal	B-X
models	B-X
and	B-X
humans	B-X
.	B-X
The	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
family	B-X
of	B-X
DNA	B-X
transcription	B-X
factors	B-X
plays	B-X
important	B-X
roles	B-X
in	B-X
inflammatory	B-X
diseases	B-X
.	B-X
The	B-X
role	B-X
of	B-X
IKKβ	B-X
as	B-X
a	B-X
potential	B-X
regulator	B-X
of	B-X
excessive	B-X
alcohol	B-X
drinking	B-X
had	B-X
not	B-X
previously	B-X
been	B-X
investigated	B-X
.	B-X
Based	B-X
on	B-X
previous	B-X
findings	B-X
that	B-X
the	B-X
overactivation	B-X
of	B-X
innate	B-X
immune/inflammatory	B-X
signaling	B-X
promotes	B-X
ethanol	B-X
consumption	B-X
,	B-X
we	B-X
hypothesized	B-X
that	B-X
inhibiting	B-X
IKKβ	B-X
would	B-X
limit/decrease	B-X
drinking	B-X
by	B-X
preventing	B-X
the	B-X
activation	B-X
of	B-X
NF-κB	B-X
.	B-X
We	B-X
studied	B-X
the	B-X
systemic	B-X
effects	B-X
of	B-X
two	B-X
pharmacological	B-X
inhibitors	B-X
of	B-X
IKKβ	B-X
,	B-X
TPCA-1	B-X
and	B-X
sulfasalazine	B-X
,	B-X
on	B-X
ethanol	B-X
intake	B-X
using	B-X
continuous-	B-X
and	B-X
limited-access	B-X
,	B-X
two-bottle	B-X
choice	B-X
drinking	B-X
tests	B-X
in	B-X
C57BL/6J	B-X
mice	B-X
.	B-X

Differential	O
susceptibility	O
of	O
yeast	O
S	O
and	O
M	O
phase	O
CDK	B-Gene_or_gene_product
complexes	O
to	O
inhibitory	O
tyrosine	O
phosphorylation	O
.	O

BACKGROUND	O
:	O
Several	O
checkpoint	O
pathways	O
employ	O
Wee1	B-Gene_or_gene_product
-	O
mediated	O
inhibitory	O
tyrosine	O
phosphorylation	O
of	O
cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
(	O
CDKs	B-Gene_or_gene_product
)	O
to	O
restrain	O
cell	O
-	O
cycle	O
progression	O
.	O
<EOS>	B-X
Several	B-X
checkpoint	B-X
pathways	B-X
employ	B-X
Wee1-mediated	B-X
inhibitory	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
cyclin-dependent	B-X
kinases	B-X
(	B-X
CDKs	B-X
)	B-X
to	B-X
restrain	B-X
cell-cycle	B-X
progression	B-X
.	B-X
Whereas	B-X
in	B-X
vertebrates	B-X
this	B-X
strategy	B-X
can	B-X
delay	B-X
both	B-X
DNA	B-X
replication	B-X
and	B-X
mitosis	B-X
,	B-X
in	B-X
yeast	B-X
cells	B-X
only	B-X
mitosis	B-X
is	B-X
delayed	B-X
.	B-X
This	B-X
is	B-X
particularly	B-X
surprising	B-X
because	B-X
yeasts	B-X
,	B-X
unlike	B-X
vertebrates	B-X
,	B-X
employ	B-X
a	B-X
single	B-X
family	B-X
of	B-X
cyclins	B-X
(	B-X
B	B-X
type	B-X
)	B-X
and	B-X
the	B-X
same	B-X
CDK	B-X
to	B-X
promote	B-X
both	B-X
S	B-X
phase	B-X
and	B-X
mitosis	B-X
.	B-X
The	B-X
G2-specific	B-X
arrest	B-X
could	B-X
be	B-X
explained	B-X
in	B-X
two	B-X
fundamentally	B-X
different	B-X
ways	B-X
:	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
cyclin/CDK	B-X
complexes	B-X
could	B-X
leave	B-X
sufficient	B-X
residual	B-X
activity	B-X
to	B-X
promote	B-X
S	B-X
phase	B-X
,	B-X
or	B-X
S	B-X
phase-promoting	B-X
cyclin/CDK	B-X
complexes	B-X
could	B-X
somehow	B-X
be	B-X
protected	B-X
from	B-X
checkpoint-induced	B-X
tyrosine	B-X
phosphorylation	B-X
.	B-X

Whereas	O
in	O
vertebrates	O
this	O
strategy	O
can	O
delay	O
both	O
DNA	O
replication	O
and	O
mitosis	O
,	O
in	O
yeast	O
cells	O
only	O
mitosis	O
is	O
delayed	O
.	O
<EOS>	B-X
Whereas	B-X
in	B-X
vertebrates	B-X
this	B-X
strategy	B-X
can	B-X
delay	B-X
both	B-X
DNA	B-X
replication	B-X
and	B-X
mitosis	B-X
,	B-X
in	B-X
yeast	B-X
cells	B-X
only	B-X
mitosis	B-X
is	B-X
delayed	B-X
.	B-X
This	B-X
is	B-X
particularly	B-X
surprising	B-X
because	B-X
yeasts	B-X
,	B-X
unlike	B-X
vertebrates	B-X
,	B-X
employ	B-X
a	B-X
single	B-X
family	B-X
of	B-X
cyclins	B-X
(	B-X
B	B-X
type	B-X
)	B-X
and	B-X
the	B-X
same	B-X
CDK	B-X
to	B-X
promote	B-X
both	B-X
S	B-X
phase	B-X
and	B-X
mitosis	B-X
.	B-X

This	O
is	O
particularly	O
surprising	O
because	O
yeasts	O
,	O
unlike	O
vertebrates	O
,	O
employ	O
a	O
single	O
family	O
of	O
cyclins	B-Gene_or_gene_product
(	I-Gene_or_gene_product
B	I-Gene_or_gene_product
type	I-Gene_or_gene_product
)	I-Gene_or_gene_product
and	O
the	O
same	O
CDK	B-Gene_or_gene_product
to	O
promote	O
both	O
S	O
phase	O
and	O
mitosis	O
.	O

The	O
G2	O
-	O
specific	O
arrest	O
could	O
be	O
explained	O
in	O
two	O
fundamentally	O
different	O
ways	O
:	O
tyrosine	O
phosphorylation	O
of	O
cyclin	O
/	O
CDK	O
complexes	O
could	O
leave	O
sufficient	O
residual	O
activity	O
to	O
promote	O
S	O
phase	O
,	O
or	O
S	O
phase	O
-	O
promoting	O
cyclin	O
/	O
CDK	O
complexes	O
could	O
somehow	O
be	O
protected	O
from	O
checkpoint	O
-	O
induced	O
tyrosine	O
phosphorylation	O
.	O
<EOS>	B-X
Several	B-X
checkpoint	B-X
pathways	B-X
employ	B-X
Wee1-mediated	B-X
inhibitory	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
cyclin-dependent	B-X
kinases	B-X
(	B-X
CDKs	B-X
)	B-X
to	B-X
restrain	B-X
cell-cycle	B-X
progression	B-X
.	B-X
This	B-X
is	B-X
particularly	B-X
surprising	B-X
because	B-X
yeasts	B-X
,	B-X
unlike	B-X
vertebrates	B-X
,	B-X
employ	B-X
a	B-X
single	B-X
family	B-X
of	B-X
cyclins	B-X
(	B-X
B	B-X
type	B-X
)	B-X
and	B-X
the	B-X
same	B-X
CDK	B-X
to	B-X
promote	B-X
both	B-X
S	B-X
phase	B-X
and	B-X
mitosis	B-X
.	B-X
The	B-X
G2-specific	B-X
arrest	B-X
could	B-X
be	B-X
explained	B-X
in	B-X
two	B-X
fundamentally	B-X
different	B-X
ways	B-X
:	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
cyclin/CDK	B-X
complexes	B-X
could	B-X
leave	B-X
sufficient	B-X
residual	B-X
activity	B-X
to	B-X
promote	B-X
S	B-X
phase	B-X
,	B-X
or	B-X
S	B-X
phase-promoting	B-X
cyclin/CDK	B-X
complexes	B-X
could	B-X
somehow	B-X
be	B-X
protected	B-X
from	B-X
checkpoint-induced	B-X
tyrosine	B-X
phosphorylation	B-X
.	B-X

RESULTS	O
:	O
We	O
demonstrate	O
that	O
in	O
Saccharomyces	O
cerevisiae	O
,	O
several	O
cyclin	O
/	O
CDK	O
complexes	O
are	O
protected	O
from	O
inhibitory	O
tyrosine	O
phosphorylation	O
,	O
allowing	O
Clb5	B-Gene_or_gene_product
,	I-Gene_or_gene_product
6p	I-Gene_or_gene_product
to	O
promote	O
DNA	O
replication	O
and	O
Clb3	B-Gene_or_gene_product
,	I-Gene_or_gene_product
4p	I-Gene_or_gene_product
to	O
promote	O
spindle	O
assembly	O
,	O
even	O
under	O
checkpoint	O
-	O
inducing	O
conditions	O
that	O
block	O
nuclear	O
division	O
.	O
<EOS>	B-X
Several	B-X
checkpoint	B-X
pathways	B-X
employ	B-X
Wee1-mediated	B-X
inhibitory	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
cyclin-dependent	B-X
kinases	B-X
(	B-X
CDKs	B-X
)	B-X
to	B-X
restrain	B-X
cell-cycle	B-X
progression	B-X
.	B-X
Whereas	B-X
in	B-X
vertebrates	B-X
this	B-X
strategy	B-X
can	B-X
delay	B-X
both	B-X
DNA	B-X
replication	B-X
and	B-X
mitosis	B-X
,	B-X
in	B-X
yeast	B-X
cells	B-X
only	B-X
mitosis	B-X
is	B-X
delayed	B-X
.	B-X
This	B-X
is	B-X
particularly	B-X
surprising	B-X
because	B-X
yeasts	B-X
,	B-X
unlike	B-X
vertebrates	B-X
,	B-X
employ	B-X
a	B-X
single	B-X
family	B-X
of	B-X
cyclins	B-X
(	B-X
B	B-X
type	B-X
)	B-X
and	B-X
the	B-X
same	B-X
CDK	B-X
to	B-X
promote	B-X
both	B-X
S	B-X
phase	B-X
and	B-X
mitosis	B-X
.	B-X
The	B-X
G2-specific	B-X
arrest	B-X
could	B-X
be	B-X
explained	B-X
in	B-X
two	B-X
fundamentally	B-X
different	B-X
ways	B-X
:	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
cyclin/CDK	B-X
complexes	B-X
could	B-X
leave	B-X
sufficient	B-X
residual	B-X
activity	B-X
to	B-X
promote	B-X
S	B-X
phase	B-X
,	B-X
or	B-X
S	B-X
phase-promoting	B-X
cyclin/CDK	B-X
complexes	B-X
could	B-X
somehow	B-X
be	B-X
protected	B-X
from	B-X
checkpoint-induced	B-X
tyrosine	B-X
phosphorylation	B-X
.	B-X

In	O
vivo	O
,	O
S	O
phase	O
-	O
promoting	O
Clb5p	O
/	O
Cdc28p	O
complexes	O
were	O
phosphorylated	O
more	O
slowly	O
and	O
dephosphorylated	O
more	O
effectively	O
than	O
were	O
mitosis	O
-	O
promoting	O
Clb2p	O
/	O
Cdc28p	O
complexes	O
.	O
<EOS>	B-X
Whereas	B-X
in	B-X
vertebrates	B-X
this	B-X
strategy	B-X
can	B-X
delay	B-X
both	B-X
DNA	B-X
replication	B-X
and	B-X
mitosis	B-X
,	B-X
in	B-X
yeast	B-X
cells	B-X
only	B-X
mitosis	B-X
is	B-X
delayed	B-X
.	B-X
This	B-X
is	B-X
particularly	B-X
surprising	B-X
because	B-X
yeasts	B-X
,	B-X
unlike	B-X
vertebrates	B-X
,	B-X
employ	B-X
a	B-X
single	B-X
family	B-X
of	B-X
cyclins	B-X
(	B-X
B	B-X
type	B-X
)	B-X
and	B-X
the	B-X
same	B-X
CDK	B-X
to	B-X
promote	B-X
both	B-X
S	B-X
phase	B-X
and	B-X
mitosis	B-X
.	B-X
The	B-X
G2-specific	B-X
arrest	B-X
could	B-X
be	B-X
explained	B-X
in	B-X
two	B-X
fundamentally	B-X
different	B-X
ways	B-X
:	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
cyclin/CDK	B-X
complexes	B-X
could	B-X
leave	B-X
sufficient	B-X
residual	B-X
activity	B-X
to	B-X
promote	B-X
S	B-X
phase	B-X
,	B-X
or	B-X
S	B-X
phase-promoting	B-X
cyclin/CDK	B-X
complexes	B-X
could	B-X
somehow	B-X
be	B-X
protected	B-X
from	B-X
checkpoint-induced	B-X
tyrosine	B-X
phosphorylation	B-X
.	B-X

Moreover	O
,	O
we	O
show	O
that	O
the	O
CDK	B-Gene_or_gene_product
inhibitor	I-Gene_or_gene_product
(	O
CKI	B-Gene_or_gene_product
)	O
Sic1p	B-Gene_or_gene_product
protects	O
bound	O
Clb5p	O
/	O
Cdc28p	O
complexes	O
from	O
tyrosine	O
phosphorylation	O
,	O
allowing	O
the	O
accumulation	O
of	O
unphosphorylated	O
complexes	O
that	O
are	O
unleashed	O
when	O
Sic1p	B-Gene_or_gene_product
is	O
degraded	O
to	O
promote	O
S	O
phase	O
.	O
<EOS>	B-X
Several	B-X
checkpoint	B-X
pathways	B-X
employ	B-X
Wee1-mediated	B-X
inhibitory	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
cyclin-dependent	B-X
kinases	B-X
(	B-X
CDKs	B-X
)	B-X
to	B-X
restrain	B-X
cell-cycle	B-X
progression	B-X
.	B-X
This	B-X
is	B-X
particularly	B-X
surprising	B-X
because	B-X
yeasts	B-X
,	B-X
unlike	B-X
vertebrates	B-X
,	B-X
employ	B-X
a	B-X
single	B-X
family	B-X
of	B-X
cyclins	B-X
(	B-X
B	B-X
type	B-X
)	B-X
and	B-X
the	B-X
same	B-X
CDK	B-X
to	B-X
promote	B-X
both	B-X
S	B-X
phase	B-X
and	B-X
mitosis	B-X
.	B-X
The	B-X
G2-specific	B-X
arrest	B-X
could	B-X
be	B-X
explained	B-X
in	B-X
two	B-X
fundamentally	B-X
different	B-X
ways	B-X
:	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
cyclin/CDK	B-X
complexes	B-X
could	B-X
leave	B-X
sufficient	B-X
residual	B-X
activity	B-X
to	B-X
promote	B-X
S	B-X
phase	B-X
,	B-X
or	B-X
S	B-X
phase-promoting	B-X
cyclin/CDK	B-X
complexes	B-X
could	B-X
somehow	B-X
be	B-X
protected	B-X
from	B-X
checkpoint-induced	B-X
tyrosine	B-X
phosphorylation	B-X
.	B-X

The	O
vertebrate	O
CKI	B-Gene_or_gene_product
p27	B-Gene_or_gene_product
(	O
Kip1	B-Gene_or_gene_product
)	O
similarly	O
protects	O
Cyclin	O
A	O
/	O
Cdk2	O
complexes	O
from	O
Wee1	B-Gene_or_gene_product
,	O
suggesting	O
that	O
the	O
antagonism	O
between	O
CKIs	B-Gene_or_gene_product
and	O
Wee1	B-Gene_or_gene_product
is	O
evolutionarily	O
conserved	O
.	O
<EOS>	B-X
Several	B-X
checkpoint	B-X
pathways	B-X
employ	B-X
Wee1-mediated	B-X
inhibitory	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
cyclin-dependent	B-X
kinases	B-X
(	B-X
CDKs	B-X
)	B-X
to	B-X
restrain	B-X
cell-cycle	B-X
progression	B-X
.	B-X
Whereas	B-X
in	B-X
vertebrates	B-X
this	B-X
strategy	B-X
can	B-X
delay	B-X
both	B-X
DNA	B-X
replication	B-X
and	B-X
mitosis	B-X
,	B-X
in	B-X
yeast	B-X
cells	B-X
only	B-X
mitosis	B-X
is	B-X
delayed	B-X
.	B-X
This	B-X
is	B-X
particularly	B-X
surprising	B-X
because	B-X
yeasts	B-X
,	B-X
unlike	B-X
vertebrates	B-X
,	B-X
employ	B-X
a	B-X
single	B-X
family	B-X
of	B-X
cyclins	B-X
(	B-X
B	B-X
type	B-X
)	B-X
and	B-X
the	B-X
same	B-X
CDK	B-X
to	B-X
promote	B-X
both	B-X
S	B-X
phase	B-X
and	B-X
mitosis	B-X
.	B-X
The	B-X
G2-specific	B-X
arrest	B-X
could	B-X
be	B-X
explained	B-X
in	B-X
two	B-X
fundamentally	B-X
different	B-X
ways	B-X
:	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
cyclin/CDK	B-X
complexes	B-X
could	B-X
leave	B-X
sufficient	B-X
residual	B-X
activity	B-X
to	B-X
promote	B-X
S	B-X
phase	B-X
,	B-X
or	B-X
S	B-X
phase-promoting	B-X
cyclin/CDK	B-X
complexes	B-X
could	B-X
somehow	B-X
be	B-X
protected	B-X
from	B-X
checkpoint-induced	B-X
tyrosine	B-X
phosphorylation	B-X
.	B-X

CONCLUSIONS	O
:	O
In	O
yeast	O
cells	O
,	O
the	O
combination	O
of	O
CKI	B-Gene_or_gene_product
binding	O
and	O
preferential	O
phosphorylation	O
/	O
dephosphorylation	O
of	O
different	O
B	O
cyclin	O
/	O
CDK	O
complexes	O
renders	O
S	O
phase	O
progression	O
immune	O
from	O
checkpoints	O
acting	O
via	O
CDK	B-Gene_or_gene_product
tyrosine	O
phosphorylation	O
.	O

Adiponectin	B-Gene_or_gene_product
enhances	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
production	O
in	O
human	O
synovial	O
fibroblast	O
via	O
an	O
AdipoR1	B-Gene_or_gene_product
receptor	O
,	O
AMPK	O
,	O
p38	B-Gene_or_gene_product
,	O
and	O
NF	O
-	O
kappa	O
B	O
pathway	O
.	O
<EOS>	B-X
Articular	B-X
adipose	B-X
tissue	B-X
is	B-X
a	B-X
ubiquitous	B-X
component	B-X
of	B-X
human	B-X
joints	B-X
,	B-X
and	B-X
adiponectin	B-X
is	B-X
a	B-X
protein	B-X
hormone	B-X
secreted	B-X
predominantly	B-X
by	B-X
differentiated	B-X
adipocytes	B-X
and	B-X
involved	B-X
in	B-X
energy	B-X
homeostasis	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
signaling	B-X
pathway	B-X
involved	B-X
in	B-X
IL-6	B-X
production	B-X
caused	B-X
by	B-X
adiponectin	B-X
in	B-X
both	B-X
rheumatoid	B-X
arthritis	B-X
synovial	B-X
fibroblasts	B-X
and	B-X
osteoarthritis	B-X
synovial	B-X
fibroblasts	B-X
.	B-X
Rheumatoid	B-X
arthritis	B-X
synovial	B-X
fibroblasts	B-X
and	B-X
osteoarthritis	B-X
synovial	B-X
fibroblasts	B-X
expressed	B-X
the	B-X
AdipoR1	B-X
and	B-X
AdipoR2	B-X
isoforms	B-X
of	B-X
the	B-X
adiponectin	B-X
receptor	B-X
.	B-X
Adiponectin	B-X
caused	B-X
concentration-	B-X
and	B-X
time-dependent	B-X
increases	B-X
in	B-X
IL-6	B-X
production	B-X
.	B-X
Adiponectin-mediated	B-X
IL-6	B-X
production	B-X
was	B-X
attenuated	B-X
by	B-X
AdipoR1	B-X
and	B-X
5'-AMP-activated	B-X
protein	B-X
kinase	B-X
(	B-X
AMPK	B-X
)	B-X
alpha1	B-X
small	B-X
interference	B-X
RNA	B-X
.	B-X
Pretreatment	B-X
with	B-X
AMPK	B-X
inhibitor	B-X
(	B-X
araA	B-X
and	B-X
compound	B-X
C	B-X
)	B-X
,	B-X
p38	B-X
inhibitor	B-X
(	B-X
SB203580	B-X
)	B-X
,	B-X
NF-kappaB	B-X
inhibitor	B-X
,	B-X
IkappaB	B-X
protease	B-X
inhibitor	B-X
,	B-X
and	B-X
NF-kappaB	B-X
inhibitor	B-X
peptide	B-X
also	B-X
inhibited	B-X
the	B-X
potentiating	B-X
action	B-X
of	B-X
adiponectin	B-X
.	B-X
Adiponectin	B-X
increased	B-X
the	B-X
kinase	B-X
activity	B-X
and	B-X
phosphorylation	B-X
of	B-X
AMPK	B-X
and	B-X
p38	B-X
.	B-X
Stimulation	B-X
of	B-X
synovial	B-X
fibroblasts	B-X
with	B-X
adiponectin	B-X
activated	B-X
IkappaB	B-X
kinase	B-X
alpha/beta	B-X
(	B-X
IKK	B-X
alpha/beta	B-X
)	B-X
,	B-X
IkappaBalpha	B-X
phosphorylation	B-X
,	B-X
IkappaBalpha	B-X
degradation	B-X
,	B-X
p65	B-X
phosphorylation	B-X
at	B-X
Ser	B-X
(	B-X
276	B-X
)	B-X
,	B-X
p65	B-X
and	B-X
p50	B-X
translocation	B-X
from	B-X
the	B-X
cytosol	B-X
to	B-X
the	B-X
nucleus	B-X
,	B-X
and	B-X
kappaB-luciferase	B-X
activity	B-X
.	B-X
Adiponectin-mediated	B-X
an	B-X
increase	B-X
of	B-X
IKK	B-X
alpha/beta	B-X
activity	B-X
,	B-X
kappaB-luciferase	B-X
activity	B-X
,	B-X
and	B-X
p65	B-X
and	B-X
p50	B-X
binding	B-X
to	B-X
the	B-X
NF-kappaB	B-X
element	B-X
and	B-X
was	B-X
inhibited	B-X
by	B-X
compound	B-X
C	B-X
,	B-X
SB203580	B-X
and	B-X
AdipoR1	B-X
small	B-X
interference	B-X
RNA	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
adiponectin	B-X
increased	B-X
IL-6	B-X
production	B-X
in	B-X
synovial	B-X
fibroblasts	B-X
via	B-X
the	B-X
AdipoR1	B-X
receptor/AMPK/p38/IKKalphabeta	B-X
and	B-X
NF-kappaB	B-X
signaling	B-X
pathway	B-X
.	B-X

Articular	O
adipose	O
tissue	O
is	O
a	O
ubiquitous	O
component	O
of	O
human	O
joints	O
,	O
and	O
adiponectin	B-Gene_or_gene_product
is	O
a	O
protein	O
hormone	O
secreted	O
predominantly	O
by	O
differentiated	O
adipocytes	O
and	O
involved	O
in	O
energy	O
homeostasis	O
.	O
<EOS>	B-X
Articular	B-X
adipose	B-X
tissue	B-X
is	B-X
a	B-X
ubiquitous	B-X
component	B-X
of	B-X
human	B-X
joints	B-X
,	B-X
and	B-X
adiponectin	B-X
is	B-X
a	B-X
protein	B-X
hormone	B-X
secreted	B-X
predominantly	B-X
by	B-X
differentiated	B-X
adipocytes	B-X
and	B-X
involved	B-X
in	B-X
energy	B-X
homeostasis	B-X
.	B-X
The	B-X
adiponectin	B-X
is	B-X
significantly	B-X
higher	B-X
in	B-X
synovial	B-X
fluid	B-X
of	B-X
patients	B-X
with	B-X
osteoarthritis	B-X
and	B-X
rheumatoid	B-X
arthritis	B-X
.	B-X
Matrix	B-X
metalloproteinases	B-X
(	B-X
MMP	B-X
)	B-X
-3	B-X
may	B-X
contribute	B-X
to	B-X
the	B-X
breakdown	B-X
of	B-X
articular	B-X
cartilage	B-X
during	B-X
arthritis	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
signaling	B-X
pathway	B-X
involved	B-X
in	B-X
MMP-3	B-X
caused	B-X
by	B-X
adiponectin	B-X
in	B-X
human	B-X
chondrocytes	B-X
.	B-X
Adiponectin	B-X
increased	B-X
the	B-X
secretion	B-X
of	B-X
MMP-3	B-X
in	B-X
cultured	B-X
human	B-X
chondrocytes	B-X
,	B-X
as	B-X
shown	B-X
by	B-X
qPCR	B-X
,	B-X
Western	B-X
blot	B-X
,	B-X
and	B-X
ELISA	B-X
analysis	B-X
.	B-X
Pretreatment	B-X
with	B-X
5'-AMP-activated	B-X
protein	B-X
kinase	B-X
(	B-X
AMPK	B-X
)	B-X
inhibitor	B-X
(	B-X
araA	B-X
and	B-X
compound	B-X
C	B-X
)	B-X
,	B-X
p38	B-X
inhibitor	B-X
(	B-X
SB203580	B-X
)	B-X
,	B-X
and	B-X
NF-κB	B-X
inhibitor	B-X
(	B-X
PDTC	B-X
and	B-X
TPCK	B-X
)	B-X
also	B-X
inhibited	B-X
the	B-X
potentiating	B-X
action	B-X
of	B-X
adiponectin	B-X
.	B-X
Activations	B-X
of	B-X
p38	B-X
,	B-X
AMPK	B-X
,	B-X
and	B-X
NF-κB	B-X
pathways	B-X
after	B-X
adiponectin	B-X
treatment	B-X
were	B-X
demonstrated	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
our	B-X
results	B-X
provide	B-X
evidence	B-X
that	B-X
adiponectin	B-X
acts	B-X
through	B-X
AdipoR1	B-X
to	B-X
activate	B-X
p38	B-X
and	B-X
AMPK	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
activations	B-X
of	B-X
NF-κB	B-X
on	B-X
the	B-X
MMP-3	B-X
promoter	B-X
and	B-X
contribute	B-X
cartilage	B-X
destruction	B-X
during	B-X
arthritis	B-X
.	B-X

We	O
investigated	O
the	O
signaling	O
pathway	O
involved	O
in	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
production	O
caused	O
by	O
adiponectin	B-Gene_or_gene_product
in	O
both	O
rheumatoid	O
arthritis	O
synovial	O
fibroblasts	O
and	O
osteoarthritis	O
synovial	O
fibroblasts	O
.	O
<EOS>	B-X
Articular	B-X
adipose	B-X
tissue	B-X
is	B-X
a	B-X
ubiquitous	B-X
component	B-X
of	B-X
human	B-X
joints	B-X
,	B-X
and	B-X
adiponectin	B-X
is	B-X
a	B-X
protein	B-X
hormone	B-X
secreted	B-X
predominantly	B-X
by	B-X
differentiated	B-X
adipocytes	B-X
and	B-X
involved	B-X
in	B-X
energy	B-X
homeostasis	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
signaling	B-X
pathway	B-X
involved	B-X
in	B-X
IL-6	B-X
production	B-X
caused	B-X
by	B-X
adiponectin	B-X
in	B-X
both	B-X
rheumatoid	B-X
arthritis	B-X
synovial	B-X
fibroblasts	B-X
and	B-X
osteoarthritis	B-X
synovial	B-X
fibroblasts	B-X
.	B-X
Rheumatoid	B-X
arthritis	B-X
synovial	B-X
fibroblasts	B-X
and	B-X
osteoarthritis	B-X
synovial	B-X
fibroblasts	B-X
expressed	B-X
the	B-X
AdipoR1	B-X
and	B-X
AdipoR2	B-X
isoforms	B-X
of	B-X
the	B-X
adiponectin	B-X
receptor	B-X
.	B-X
Adiponectin	B-X
caused	B-X
concentration-	B-X
and	B-X
time-dependent	B-X
increases	B-X
in	B-X
IL-6	B-X
production	B-X
.	B-X
Adiponectin-mediated	B-X
IL-6	B-X
production	B-X
was	B-X
attenuated	B-X
by	B-X
AdipoR1	B-X
and	B-X
5'-AMP-activated	B-X
protein	B-X
kinase	B-X
(	B-X
AMPK	B-X
)	B-X
alpha1	B-X
small	B-X
interference	B-X
RNA	B-X
.	B-X
Pretreatment	B-X
with	B-X
AMPK	B-X
inhibitor	B-X
(	B-X
araA	B-X
and	B-X
compound	B-X
C	B-X
)	B-X
,	B-X
p38	B-X
inhibitor	B-X
(	B-X
SB203580	B-X
)	B-X
,	B-X
NF-kappaB	B-X
inhibitor	B-X
,	B-X
IkappaB	B-X
protease	B-X
inhibitor	B-X
,	B-X
and	B-X
NF-kappaB	B-X
inhibitor	B-X
peptide	B-X
also	B-X
inhibited	B-X
the	B-X
potentiating	B-X
action	B-X
of	B-X
adiponectin	B-X
.	B-X
Stimulation	B-X
of	B-X
synovial	B-X
fibroblasts	B-X
with	B-X
adiponectin	B-X
activated	B-X
IkappaB	B-X
kinase	B-X
alpha/beta	B-X
(	B-X
IKK	B-X
alpha/beta	B-X
)	B-X
,	B-X
IkappaBalpha	B-X
phosphorylation	B-X
,	B-X
IkappaBalpha	B-X
degradation	B-X
,	B-X
p65	B-X
phosphorylation	B-X
at	B-X
Ser	B-X
(	B-X
276	B-X
)	B-X
,	B-X
p65	B-X
and	B-X
p50	B-X
translocation	B-X
from	B-X
the	B-X
cytosol	B-X
to	B-X
the	B-X
nucleus	B-X
,	B-X
and	B-X
kappaB-luciferase	B-X
activity	B-X
.	B-X
Adiponectin-mediated	B-X
an	B-X
increase	B-X
of	B-X
IKK	B-X
alpha/beta	B-X
activity	B-X
,	B-X
kappaB-luciferase	B-X
activity	B-X
,	B-X
and	B-X
p65	B-X
and	B-X
p50	B-X
binding	B-X
to	B-X
the	B-X
NF-kappaB	B-X
element	B-X
and	B-X
was	B-X
inhibited	B-X
by	B-X
compound	B-X
C	B-X
,	B-X
SB203580	B-X
and	B-X
AdipoR1	B-X
small	B-X
interference	B-X
RNA	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
adiponectin	B-X
increased	B-X
IL-6	B-X
production	B-X
in	B-X
synovial	B-X
fibroblasts	B-X
via	B-X
the	B-X
AdipoR1	B-X
receptor/AMPK/p38/IKKalphabeta	B-X
and	B-X
NF-kappaB	B-X
signaling	B-X
pathway	B-X
.	B-X

Rheumatoid	O
arthritis	O
synovial	O
fibroblasts	O
and	O
osteoarthritis	O
synovial	O
fibroblasts	O
expressed	O
the	O
AdipoR1	B-Gene_or_gene_product
and	O
AdipoR2	B-Gene_or_gene_product
isoforms	O
of	O
the	O
adiponectin	B-Gene_or_gene_product
receptor	O
.	O
<EOS>	B-X
Articular	B-X
adipose	B-X
tissue	B-X
is	B-X
a	B-X
ubiquitous	B-X
component	B-X
of	B-X
human	B-X
joints	B-X
,	B-X
and	B-X
adiponectin	B-X
is	B-X
a	B-X
protein	B-X
hormone	B-X
secreted	B-X
predominantly	B-X
by	B-X
differentiated	B-X
adipocytes	B-X
and	B-X
involved	B-X
in	B-X
energy	B-X
homeostasis	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
signaling	B-X
pathway	B-X
involved	B-X
in	B-X
IL-6	B-X
production	B-X
caused	B-X
by	B-X
adiponectin	B-X
in	B-X
both	B-X
rheumatoid	B-X
arthritis	B-X
synovial	B-X
fibroblasts	B-X
and	B-X
osteoarthritis	B-X
synovial	B-X
fibroblasts	B-X
.	B-X
Rheumatoid	B-X
arthritis	B-X
synovial	B-X
fibroblasts	B-X
and	B-X
osteoarthritis	B-X
synovial	B-X
fibroblasts	B-X
expressed	B-X
the	B-X
AdipoR1	B-X
and	B-X
AdipoR2	B-X
isoforms	B-X
of	B-X
the	B-X
adiponectin	B-X
receptor	B-X
.	B-X
Adiponectin-mediated	B-X
IL-6	B-X
production	B-X
was	B-X
attenuated	B-X
by	B-X
AdipoR1	B-X
and	B-X
5'-AMP-activated	B-X
protein	B-X
kinase	B-X
(	B-X
AMPK	B-X
)	B-X
alpha1	B-X
small	B-X
interference	B-X
RNA	B-X
.	B-X
Pretreatment	B-X
with	B-X
AMPK	B-X
inhibitor	B-X
(	B-X
araA	B-X
and	B-X
compound	B-X
C	B-X
)	B-X
,	B-X
p38	B-X
inhibitor	B-X
(	B-X
SB203580	B-X
)	B-X
,	B-X
NF-kappaB	B-X
inhibitor	B-X
,	B-X
IkappaB	B-X
protease	B-X
inhibitor	B-X
,	B-X
and	B-X
NF-kappaB	B-X
inhibitor	B-X
peptide	B-X
also	B-X
inhibited	B-X
the	B-X
potentiating	B-X
action	B-X
of	B-X
adiponectin	B-X
.	B-X
Stimulation	B-X
of	B-X
synovial	B-X
fibroblasts	B-X
with	B-X
adiponectin	B-X
activated	B-X
IkappaB	B-X
kinase	B-X
alpha/beta	B-X
(	B-X
IKK	B-X
alpha/beta	B-X
)	B-X
,	B-X
IkappaBalpha	B-X
phosphorylation	B-X
,	B-X
IkappaBalpha	B-X
degradation	B-X
,	B-X
p65	B-X
phosphorylation	B-X
at	B-X
Ser	B-X
(	B-X
276	B-X
)	B-X
,	B-X
p65	B-X
and	B-X
p50	B-X
translocation	B-X
from	B-X
the	B-X
cytosol	B-X
to	B-X
the	B-X
nucleus	B-X
,	B-X
and	B-X
kappaB-luciferase	B-X
activity	B-X
.	B-X
Adiponectin-mediated	B-X
an	B-X
increase	B-X
of	B-X
IKK	B-X
alpha/beta	B-X
activity	B-X
,	B-X
kappaB-luciferase	B-X
activity	B-X
,	B-X
and	B-X
p65	B-X
and	B-X
p50	B-X
binding	B-X
to	B-X
the	B-X
NF-kappaB	B-X
element	B-X
and	B-X
was	B-X
inhibited	B-X
by	B-X
compound	B-X
C	B-X
,	B-X
SB203580	B-X
and	B-X
AdipoR1	B-X
small	B-X
interference	B-X
RNA	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
adiponectin	B-X
increased	B-X
IL-6	B-X
production	B-X
in	B-X
synovial	B-X
fibroblasts	B-X
via	B-X
the	B-X
AdipoR1	B-X
receptor/AMPK/p38/IKKalphabeta	B-X
and	B-X
NF-kappaB	B-X
signaling	B-X
pathway	B-X
.	B-X

Adiponectin	B-Gene_or_gene_product
caused	O
concentration	O
-	O
and	O
time	O
-	O
dependent	O
increases	O
in	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
production	O
.	O
<EOS>	B-X
We	B-X
investigated	B-X
the	B-X
signaling	B-X
pathway	B-X
involved	B-X
in	B-X
IL-6	B-X
production	B-X
caused	B-X
by	B-X
adiponectin	B-X
in	B-X
both	B-X
rheumatoid	B-X
arthritis	B-X
synovial	B-X
fibroblasts	B-X
and	B-X
osteoarthritis	B-X
synovial	B-X
fibroblasts	B-X
.	B-X
Adiponectin	B-X
caused	B-X
concentration-	B-X
and	B-X
time-dependent	B-X
increases	B-X
in	B-X
IL-6	B-X
production	B-X
.	B-X
Adiponectin-mediated	B-X
IL-6	B-X
production	B-X
was	B-X
attenuated	B-X
by	B-X
AdipoR1	B-X
and	B-X
5'-AMP-activated	B-X
protein	B-X
kinase	B-X
(	B-X
AMPK	B-X
)	B-X
alpha1	B-X
small	B-X
interference	B-X
RNA	B-X
.	B-X
Adiponectin	B-X
increased	B-X
the	B-X
kinase	B-X
activity	B-X
and	B-X
phosphorylation	B-X
of	B-X
AMPK	B-X
and	B-X
p38	B-X
.	B-X
Stimulation	B-X
of	B-X
synovial	B-X
fibroblasts	B-X
with	B-X
adiponectin	B-X
activated	B-X
IkappaB	B-X
kinase	B-X
alpha/beta	B-X
(	B-X
IKK	B-X
alpha/beta	B-X
)	B-X
,	B-X
IkappaBalpha	B-X
phosphorylation	B-X
,	B-X
IkappaBalpha	B-X
degradation	B-X
,	B-X
p65	B-X
phosphorylation	B-X
at	B-X
Ser	B-X
(	B-X
276	B-X
)	B-X
,	B-X
p65	B-X
and	B-X
p50	B-X
translocation	B-X
from	B-X
the	B-X
cytosol	B-X
to	B-X
the	B-X
nucleus	B-X
,	B-X
and	B-X
kappaB-luciferase	B-X
activity	B-X
.	B-X
Adiponectin-mediated	B-X
an	B-X
increase	B-X
of	B-X
IKK	B-X
alpha/beta	B-X
activity	B-X
,	B-X
kappaB-luciferase	B-X
activity	B-X
,	B-X
and	B-X
p65	B-X
and	B-X
p50	B-X
binding	B-X
to	B-X
the	B-X
NF-kappaB	B-X
element	B-X
and	B-X
was	B-X
inhibited	B-X
by	B-X
compound	B-X
C	B-X
,	B-X
SB203580	B-X
and	B-X
AdipoR1	B-X
small	B-X
interference	B-X
RNA	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
adiponectin	B-X
increased	B-X
IL-6	B-X
production	B-X
in	B-X
synovial	B-X
fibroblasts	B-X
via	B-X
the	B-X
AdipoR1	B-X
receptor/AMPK/p38/IKKalphabeta	B-X
and	B-X
NF-kappaB	B-X
signaling	B-X
pathway	B-X
.	B-X

Adiponectin	B-Gene_or_gene_product
-	O
mediated	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
production	O
was	O
attenuated	O
by	O
AdipoR1	B-Gene_or_gene_product
and	O
5	B-Gene_or_gene_product
'	I-Gene_or_gene_product
-	I-Gene_or_gene_product
AMP	I-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	I-Gene_or_gene_product
AMPK	I-Gene_or_gene_product
)	I-Gene_or_gene_product
alpha1	I-Gene_or_gene_product
small	O
interference	O
RNA	O
.	O
<EOS>	B-X
Articular	B-X
adipose	B-X
tissue	B-X
is	B-X
a	B-X
ubiquitous	B-X
component	B-X
of	B-X
human	B-X
joints	B-X
,	B-X
and	B-X
adiponectin	B-X
is	B-X
a	B-X
protein	B-X
hormone	B-X
secreted	B-X
predominantly	B-X
by	B-X
differentiated	B-X
adipocytes	B-X
and	B-X
involved	B-X
in	B-X
energy	B-X
homeostasis	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
signaling	B-X
pathway	B-X
involved	B-X
in	B-X
IL-6	B-X
production	B-X
caused	B-X
by	B-X
adiponectin	B-X
in	B-X
both	B-X
rheumatoid	B-X
arthritis	B-X
synovial	B-X
fibroblasts	B-X
and	B-X
osteoarthritis	B-X
synovial	B-X
fibroblasts	B-X
.	B-X
Rheumatoid	B-X
arthritis	B-X
synovial	B-X
fibroblasts	B-X
and	B-X
osteoarthritis	B-X
synovial	B-X
fibroblasts	B-X
expressed	B-X
the	B-X
AdipoR1	B-X
and	B-X
AdipoR2	B-X
isoforms	B-X
of	B-X
the	B-X
adiponectin	B-X
receptor	B-X
.	B-X
Adiponectin	B-X
caused	B-X
concentration-	B-X
and	B-X
time-dependent	B-X
increases	B-X
in	B-X
IL-6	B-X
production	B-X
.	B-X
Adiponectin-mediated	B-X
IL-6	B-X
production	B-X
was	B-X
attenuated	B-X
by	B-X
AdipoR1	B-X
and	B-X
5'-AMP-activated	B-X
protein	B-X
kinase	B-X
(	B-X
AMPK	B-X
)	B-X
alpha1	B-X
small	B-X
interference	B-X
RNA	B-X
.	B-X
Pretreatment	B-X
with	B-X
AMPK	B-X
inhibitor	B-X
(	B-X
araA	B-X
and	B-X
compound	B-X
C	B-X
)	B-X
,	B-X
p38	B-X
inhibitor	B-X
(	B-X
SB203580	B-X
)	B-X
,	B-X
NF-kappaB	B-X
inhibitor	B-X
,	B-X
IkappaB	B-X
protease	B-X
inhibitor	B-X
,	B-X
and	B-X
NF-kappaB	B-X
inhibitor	B-X
peptide	B-X
also	B-X
inhibited	B-X
the	B-X
potentiating	B-X
action	B-X
of	B-X
adiponectin	B-X
.	B-X
Adiponectin	B-X
increased	B-X
the	B-X
kinase	B-X
activity	B-X
and	B-X
phosphorylation	B-X
of	B-X
AMPK	B-X
and	B-X
p38	B-X
.	B-X
Stimulation	B-X
of	B-X
synovial	B-X
fibroblasts	B-X
with	B-X
adiponectin	B-X
activated	B-X
IkappaB	B-X
kinase	B-X
alpha/beta	B-X
(	B-X
IKK	B-X
alpha/beta	B-X
)	B-X
,	B-X
IkappaBalpha	B-X
phosphorylation	B-X
,	B-X
IkappaBalpha	B-X
degradation	B-X
,	B-X
p65	B-X
phosphorylation	B-X
at	B-X
Ser	B-X
(	B-X
276	B-X
)	B-X
,	B-X
p65	B-X
and	B-X
p50	B-X
translocation	B-X
from	B-X
the	B-X
cytosol	B-X
to	B-X
the	B-X
nucleus	B-X
,	B-X
and	B-X
kappaB-luciferase	B-X
activity	B-X
.	B-X
Adiponectin-mediated	B-X
an	B-X
increase	B-X
of	B-X
IKK	B-X
alpha/beta	B-X
activity	B-X
,	B-X
kappaB-luciferase	B-X
activity	B-X
,	B-X
and	B-X
p65	B-X
and	B-X
p50	B-X
binding	B-X
to	B-X
the	B-X
NF-kappaB	B-X
element	B-X
and	B-X
was	B-X
inhibited	B-X
by	B-X
compound	B-X
C	B-X
,	B-X
SB203580	B-X
and	B-X
AdipoR1	B-X
small	B-X
interference	B-X
RNA	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
adiponectin	B-X
increased	B-X
IL-6	B-X
production	B-X
in	B-X
synovial	B-X
fibroblasts	B-X
via	B-X
the	B-X
AdipoR1	B-X
receptor/AMPK/p38/IKKalphabeta	B-X
and	B-X
NF-kappaB	B-X
signaling	B-X
pathway	B-X
.	B-X

Pretreatment	O
with	O
AMPK	O
inhibitor	O
(	O
araA	B-Gene_or_gene_product
and	O
compound	O
C	O
)	O
,	O
p38	B-Gene_or_gene_product
inhibitor	O
(	O
SB203580	O
)	O
,	O
NF	O
-	O
kappaB	O
inhibitor	O
,	O
IkappaB	B-Gene_or_gene_product
protease	O
inhibitor	O
,	O
and	O
NF	O
-	O
kappaB	O
inhibitor	O
peptide	O
also	O
inhibited	O
the	O
potentiating	O
action	O
of	O
adiponectin	B-Gene_or_gene_product
.	O
<EOS>	B-X
Articular	B-X
adipose	B-X
tissue	B-X
is	B-X
a	B-X
ubiquitous	B-X
component	B-X
of	B-X
human	B-X
joints	B-X
,	B-X
and	B-X
adiponectin	B-X
is	B-X
a	B-X
protein	B-X
hormone	B-X
secreted	B-X
predominantly	B-X
by	B-X
differentiated	B-X
adipocytes	B-X
and	B-X
involved	B-X
in	B-X
energy	B-X
homeostasis	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
signaling	B-X
pathway	B-X
involved	B-X
in	B-X
IL-6	B-X
production	B-X
caused	B-X
by	B-X
adiponectin	B-X
in	B-X
both	B-X
rheumatoid	B-X
arthritis	B-X
synovial	B-X
fibroblasts	B-X
and	B-X
osteoarthritis	B-X
synovial	B-X
fibroblasts	B-X
.	B-X
Rheumatoid	B-X
arthritis	B-X
synovial	B-X
fibroblasts	B-X
and	B-X
osteoarthritis	B-X
synovial	B-X
fibroblasts	B-X
expressed	B-X
the	B-X
AdipoR1	B-X
and	B-X
AdipoR2	B-X
isoforms	B-X
of	B-X
the	B-X
adiponectin	B-X
receptor	B-X
.	B-X
Adiponectin-mediated	B-X
IL-6	B-X
production	B-X
was	B-X
attenuated	B-X
by	B-X
AdipoR1	B-X
and	B-X
5'-AMP-activated	B-X
protein	B-X
kinase	B-X
(	B-X
AMPK	B-X
)	B-X
alpha1	B-X
small	B-X
interference	B-X
RNA	B-X
.	B-X
Pretreatment	B-X
with	B-X
AMPK	B-X
inhibitor	B-X
(	B-X
araA	B-X
and	B-X
compound	B-X
C	B-X
)	B-X
,	B-X
p38	B-X
inhibitor	B-X
(	B-X
SB203580	B-X
)	B-X
,	B-X
NF-kappaB	B-X
inhibitor	B-X
,	B-X
IkappaB	B-X
protease	B-X
inhibitor	B-X
,	B-X
and	B-X
NF-kappaB	B-X
inhibitor	B-X
peptide	B-X
also	B-X
inhibited	B-X
the	B-X
potentiating	B-X
action	B-X
of	B-X
adiponectin	B-X
.	B-X
Adiponectin	B-X
increased	B-X
the	B-X
kinase	B-X
activity	B-X
and	B-X
phosphorylation	B-X
of	B-X
AMPK	B-X
and	B-X
p38	B-X
.	B-X
Stimulation	B-X
of	B-X
synovial	B-X
fibroblasts	B-X
with	B-X
adiponectin	B-X
activated	B-X
IkappaB	B-X
kinase	B-X
alpha/beta	B-X
(	B-X
IKK	B-X
alpha/beta	B-X
)	B-X
,	B-X
IkappaBalpha	B-X
phosphorylation	B-X
,	B-X
IkappaBalpha	B-X
degradation	B-X
,	B-X
p65	B-X
phosphorylation	B-X
at	B-X
Ser	B-X
(	B-X
276	B-X
)	B-X
,	B-X
p65	B-X
and	B-X
p50	B-X
translocation	B-X
from	B-X
the	B-X
cytosol	B-X
to	B-X
the	B-X
nucleus	B-X
,	B-X
and	B-X
kappaB-luciferase	B-X
activity	B-X
.	B-X
Adiponectin-mediated	B-X
an	B-X
increase	B-X
of	B-X
IKK	B-X
alpha/beta	B-X
activity	B-X
,	B-X
kappaB-luciferase	B-X
activity	B-X
,	B-X
and	B-X
p65	B-X
and	B-X
p50	B-X
binding	B-X
to	B-X
the	B-X
NF-kappaB	B-X
element	B-X
and	B-X
was	B-X
inhibited	B-X
by	B-X
compound	B-X
C	B-X
,	B-X
SB203580	B-X
and	B-X
AdipoR1	B-X
small	B-X
interference	B-X
RNA	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
adiponectin	B-X
increased	B-X
IL-6	B-X
production	B-X
in	B-X
synovial	B-X
fibroblasts	B-X
via	B-X
the	B-X
AdipoR1	B-X
receptor/AMPK/p38/IKKalphabeta	B-X
and	B-X
NF-kappaB	B-X
signaling	B-X
pathway	B-X
.	B-X

Adiponectin	B-Gene_or_gene_product
increased	O
the	O
kinase	O
activity	O
and	O
phosphorylation	O
of	O
AMPK	O
and	O
p38	B-Gene_or_gene_product
.	O
<EOS>	B-X
Adiponectin	B-X
is	B-X
one	B-X
such	B-X
factor	B-X
,	B-X
secreted	B-X
in	B-X
large	B-X
quantities	B-X
primarily	B-X
from	B-X
adipose	B-X
tissue	B-X
.	B-X
Adiponectin	B-X
is	B-X
posttranslationally	B-X
modified	B-X
from	B-X
a	B-X
30-kDa	B-X
monomeric	B-X
protein	B-X
into	B-X
different	B-X
multimers	B-X
(	B-X
low	B-X
molecular	B-X
weight	B-X
or	B-X
trimer	B-X
,	B-X
middle	B-X
molecular	B-X
weight	B-X
or	B-X
hexamer	B-X
,	B-X
and	B-X
high	B-X
molecular	B-X
weight	B-X
)	B-X
and	B-X
secreted	B-X
into	B-X
the	B-X
circulation	B-X
.	B-X
Upon	B-X
binding	B-X
to	B-X
its	B-X
receptors	B-X
,	B-X
AdipoR1	B-X
and	B-X
R2	B-X
,	B-X
adiponectin	B-X
initiates	B-X
a	B-X
series	B-X
of	B-X
tissue-dependent	B-X
signal	B-X
transduction	B-X
events	B-X
,	B-X
including	B-X
phosphorylation	B-X
of	B-X
adenosine	B-X
monophosphate	B-X
(	B-X
AMPK	B-X
)	B-X
and	B-X
p38	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
p38	B-X
MAPK	B-X
)	B-X
,	B-X
and	B-X
increased	B-X
peroxisome	B-X
proliferator-activated	B-X
receptor	B-X
alpha	B-X
(	B-X
PPARα	B-X
)	B-X
ligand	B-X
activity	B-X
.	B-X
AdipoR1	B-X
and	B-X
R2	B-X
also	B-X
possesses	B-X
inherent	B-X
ceramidase	B-X
activity	B-X
,	B-X
resulting	B-X
in	B-X
a	B-X
decrease	B-X
in	B-X
intracellular	B-X
ceramide	B-X
,	B-X
a	B-X
sphingolipid	B-X
that	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
insulin	B-X
resistance	B-X
,	B-X
cell	B-X
death	B-X
,	B-X
inflammation	B-X
,	B-X
and	B-X
atherosclerosis	B-X
.	B-X
Adiponectin	B-X
stimulates	B-X
fatty	B-X
acid	B-X
oxidation	B-X
in	B-X
skeletal	B-X
muscle	B-X
and	B-X
inhibits	B-X
glucose	B-X
production	B-X
in	B-X
the	B-X
liver	B-X
,	B-X
resulting	B-X
in	B-X
an	B-X
improvement	B-X
in	B-X
whole-body	B-X
energy	B-X
homeostasis	B-X
.	B-X
Adiponectin	B-X
is	B-X
also	B-X
a	B-X
classic	B-X
anti-inflammatory	B-X
agent	B-X
,	B-X
reducing	B-X
inflammation	B-X
in	B-X
various	B-X
cell	B-X
types	B-X
through	B-X
AdipoR1	B-X
and	B-X
R2	B-X
signaling	B-X
mechanisms	B-X
.	B-X
Adiponectin	B-X
's	B-X
anti-inflammatory	B-X
and	B-X
anti-apoptotic	B-X
properties	B-X
results	B-X
in	B-X
protection	B-X
of	B-X
the	B-X
vasculature	B-X
,	B-X
heart	B-X
,	B-X
lung	B-X
,	B-X
and	B-X
colon	B-X
.	B-X

Stimulation	O
of	O
synovial	O
fibroblasts	O
with	O
adiponectin	B-Gene_or_gene_product
activated	O
IkappaB	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
/	O
beta	B-Gene_or_gene_product
(	O
IKK	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
/	O
beta	B-Gene_or_gene_product
)	O
,	O
IkappaBalpha	B-Gene_or_gene_product
phosphorylation	O
,	O
IkappaBalpha	B-Gene_or_gene_product
degradation	O
,	O
p65	B-Gene_or_gene_product
phosphorylation	O
at	O
Ser	O
(	O
276	O
)	O
,	O
p65	B-Gene_or_gene_product
and	O
p50	B-Gene_or_gene_product
translocation	O
from	O
the	O
cytosol	O
to	O
the	O
nucleus	O
,	O
and	O
kappaB	O
-	O
luciferase	O
activity	O
.	O

Adiponectin	B-Gene_or_gene_product
-	O
mediated	O
an	O
increase	O
of	O
IKK	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
/	O
beta	B-Gene_or_gene_product
activity	O
,	O
kappaB	O
-	O
luciferase	O
activity	O
,	O
and	O
p65	B-Gene_or_gene_product
and	O
p50	B-Gene_or_gene_product
binding	O
to	O
the	O
NF	O
-	O
kappaB	O
element	O
and	O
was	O
inhibited	O
by	O
compound	O
C	O
,	O
SB203580	O
and	O
AdipoR1	B-Gene_or_gene_product
small	O
interference	O
RNA	O
.	O

Our	O
results	O
suggest	O
that	O
adiponectin	B-Gene_or_gene_product
increased	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
production	O
in	O
synovial	O
fibroblasts	O
via	O
the	O
AdipoR1	B-Gene_or_gene_product
receptor	O
/	O
AMPK	O
/	O
p38	B-Gene_or_gene_product
/	O
IKKalphabeta	B-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
signaling	O
pathway	O
.	O
<EOS>	B-X
Articular	B-X
adipose	B-X
tissue	B-X
is	B-X
a	B-X
ubiquitous	B-X
component	B-X
of	B-X
human	B-X
joints	B-X
,	B-X
and	B-X
adiponectin	B-X
is	B-X
a	B-X
protein	B-X
hormone	B-X
secreted	B-X
predominantly	B-X
by	B-X
differentiated	B-X
adipocytes	B-X
and	B-X
involved	B-X
in	B-X
energy	B-X
homeostasis	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
signaling	B-X
pathway	B-X
involved	B-X
in	B-X
IL-6	B-X
production	B-X
caused	B-X
by	B-X
adiponectin	B-X
in	B-X
both	B-X
rheumatoid	B-X
arthritis	B-X
synovial	B-X
fibroblasts	B-X
and	B-X
osteoarthritis	B-X
synovial	B-X
fibroblasts	B-X
.	B-X
Rheumatoid	B-X
arthritis	B-X
synovial	B-X
fibroblasts	B-X
and	B-X
osteoarthritis	B-X
synovial	B-X
fibroblasts	B-X
expressed	B-X
the	B-X
AdipoR1	B-X
and	B-X
AdipoR2	B-X
isoforms	B-X
of	B-X
the	B-X
adiponectin	B-X
receptor	B-X
.	B-X
Adiponectin	B-X
caused	B-X
concentration-	B-X
and	B-X
time-dependent	B-X
increases	B-X
in	B-X
IL-6	B-X
production	B-X
.	B-X
Adiponectin-mediated	B-X
IL-6	B-X
production	B-X
was	B-X
attenuated	B-X
by	B-X
AdipoR1	B-X
and	B-X
5'-AMP-activated	B-X
protein	B-X
kinase	B-X
(	B-X
AMPK	B-X
)	B-X
alpha1	B-X
small	B-X
interference	B-X
RNA	B-X
.	B-X
Pretreatment	B-X
with	B-X
AMPK	B-X
inhibitor	B-X
(	B-X
araA	B-X
and	B-X
compound	B-X
C	B-X
)	B-X
,	B-X
p38	B-X
inhibitor	B-X
(	B-X
SB203580	B-X
)	B-X
,	B-X
NF-kappaB	B-X
inhibitor	B-X
,	B-X
IkappaB	B-X
protease	B-X
inhibitor	B-X
,	B-X
and	B-X
NF-kappaB	B-X
inhibitor	B-X
peptide	B-X
also	B-X
inhibited	B-X
the	B-X
potentiating	B-X
action	B-X
of	B-X
adiponectin	B-X
.	B-X
Adiponectin	B-X
increased	B-X
the	B-X
kinase	B-X
activity	B-X
and	B-X
phosphorylation	B-X
of	B-X
AMPK	B-X
and	B-X
p38	B-X
.	B-X
Stimulation	B-X
of	B-X
synovial	B-X
fibroblasts	B-X
with	B-X
adiponectin	B-X
activated	B-X
IkappaB	B-X
kinase	B-X
alpha/beta	B-X
(	B-X
IKK	B-X
alpha/beta	B-X
)	B-X
,	B-X
IkappaBalpha	B-X
phosphorylation	B-X
,	B-X
IkappaBalpha	B-X
degradation	B-X
,	B-X
p65	B-X
phosphorylation	B-X
at	B-X
Ser	B-X
(	B-X
276	B-X
)	B-X
,	B-X
p65	B-X
and	B-X
p50	B-X
translocation	B-X
from	B-X
the	B-X
cytosol	B-X
to	B-X
the	B-X
nucleus	B-X
,	B-X
and	B-X
kappaB-luciferase	B-X
activity	B-X
.	B-X
Adiponectin-mediated	B-X
an	B-X
increase	B-X
of	B-X
IKK	B-X
alpha/beta	B-X
activity	B-X
,	B-X
kappaB-luciferase	B-X
activity	B-X
,	B-X
and	B-X
p65	B-X
and	B-X
p50	B-X
binding	B-X
to	B-X
the	B-X
NF-kappaB	B-X
element	B-X
and	B-X
was	B-X
inhibited	B-X
by	B-X
compound	B-X
C	B-X
,	B-X
SB203580	B-X
and	B-X
AdipoR1	B-X
small	B-X
interference	B-X
RNA	B-X
.	B-X
Our	B-X
results	B-X
suggest	B-X
that	B-X
adiponectin	B-X
increased	B-X
IL-6	B-X
production	B-X
in	B-X
synovial	B-X
fibroblasts	B-X
via	B-X
the	B-X
AdipoR1	B-X
receptor/AMPK/p38/IKKalphabeta	B-X
and	B-X
NF-kappaB	B-X
signaling	B-X
pathway	B-X
.	B-X

S6K1	B-Gene_or_gene_product
-	O
mediated	O
disassembly	O
of	O
mitochondrial	O
URI	O
/	O
PP1gamma	O
complexes	O
activates	O
a	O
negative	O
feedback	O
program	O
that	O
counters	O
S6K1	B-Gene_or_gene_product
survival	O
signaling	O
.	O
<EOS>	B-X
S6	B-X
kinase	B-X
1	B-X
(	B-X
S6K1	B-X
)	B-X
acts	B-X
to	B-X
integrate	B-X
nutrient	B-X
and	B-X
growth	B-X
factor	B-X
signals	B-X
to	B-X
promote	B-X
cell	B-X
growth	B-X
but	B-X
also	B-X
cell	B-X
survival	B-X
as	B-X
a	B-X
mitochondria-tethered	B-X
protein	B-X
kinase	B-X
that	B-X
phosphorylates	B-X
and	B-X
inactivates	B-X
the	B-X
proapoptotic	B-X
molecule	B-X
BAD	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
the	B-X
prefoldin	B-X
chaperone	B-X
URI	B-X
represents	B-X
a	B-X
mitochondrial	B-X
substrate	B-X
of	B-X
S6K1	B-X
.	B-X
In	B-X
growth	B-X
factor-deprived	B-X
or	B-X
rapamycin-treated	B-X
cells	B-X
,	B-X
URI	B-X
forms	B-X
stable	B-X
complexes	B-X
with	B-X
protein	B-X
phosphatase	B-X
(	B-X
PP	B-X
)	B-X
1gamma	B-X
at	B-X
mitochondria	B-X
,	B-X
thereby	B-X
inhibiting	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
bound	B-X
enzyme	B-X
.	B-X
Growth	B-X
factor	B-X
stimulation	B-X
induces	B-X
disassembly	B-X
of	B-X
URI/PP1gamma	B-X
complexes	B-X
through	B-X
S6K1-mediated	B-X
phosphorylation	B-X
of	B-X
URI	B-X
at	B-X
serine	B-X
371	B-X
.	B-X
This	B-X
activates	B-X
a	B-X
PP1gamma-dependent	B-X
negative	B-X
feedback	B-X
program	B-X
that	B-X
decreases	B-X
S6K1	B-X
activity	B-X
and	B-X
BAD	B-X
phosphorylation	B-X
,	B-X
thereby	B-X
altering	B-X
the	B-X
threshold	B-X
for	B-X
apoptosis	B-X
.	B-X
These	B-X
findings	B-X
establish	B-X
URI	B-X
and	B-X
PP1gamma	B-X
as	B-X
integral	B-X
components	B-X
of	B-X
an	B-X
S6K1-regulated	B-X
mitochondrial	B-X
pathway	B-X
dedicated	B-X
,	B-X
in	B-X
part	B-X
,	B-X
to	B-X
oppose	B-X
sustained	B-X
S6K1	B-X
survival	B-X
signaling	B-X
and	B-X
to	B-X
ensure	B-X
that	B-X
the	B-X
mitochondrial	B-X
threshold	B-X
for	B-X
apoptosis	B-X
is	B-X
set	B-X
in	B-X
accord	B-X
with	B-X
nutrient	B-X
and	B-X
growth	B-X
factor	B-X
availability	B-X
.	B-X

S6	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
S6K1	B-Gene_or_gene_product
)	O
acts	O
to	O
integrate	O
nutrient	O
and	O
growth	O
factor	O
signals	O
to	O
promote	O
cell	O
growth	O
but	O
also	O
cell	O
survival	O
as	O
a	O
mitochondria	O
-	O
tethered	O
protein	O
kinase	O
that	O
phosphorylates	O
and	O
inactivates	O
the	O
proapoptotic	O
molecule	O
BAD	B-Gene_or_gene_product
.	O
<EOS>	B-X
S6	B-X
kinase	B-X
1	B-X
(	B-X
S6K1	B-X
)	B-X
acts	B-X
to	B-X
integrate	B-X
nutrient	B-X
and	B-X
growth	B-X
factor	B-X
signals	B-X
to	B-X
promote	B-X
cell	B-X
growth	B-X
but	B-X
also	B-X
cell	B-X
survival	B-X
as	B-X
a	B-X
mitochondria-tethered	B-X
protein	B-X
kinase	B-X
that	B-X
phosphorylates	B-X
and	B-X
inactivates	B-X
the	B-X
proapoptotic	B-X
molecule	B-X
BAD	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
the	B-X
prefoldin	B-X
chaperone	B-X
URI	B-X
represents	B-X
a	B-X
mitochondrial	B-X
substrate	B-X
of	B-X
S6K1	B-X
.	B-X
In	B-X
growth	B-X
factor-deprived	B-X
or	B-X
rapamycin-treated	B-X
cells	B-X
,	B-X
URI	B-X
forms	B-X
stable	B-X
complexes	B-X
with	B-X
protein	B-X
phosphatase	B-X
(	B-X
PP	B-X
)	B-X
1gamma	B-X
at	B-X
mitochondria	B-X
,	B-X
thereby	B-X
inhibiting	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
bound	B-X
enzyme	B-X
.	B-X
Growth	B-X
factor	B-X
stimulation	B-X
induces	B-X
disassembly	B-X
of	B-X
URI/PP1gamma	B-X
complexes	B-X
through	B-X
S6K1-mediated	B-X
phosphorylation	B-X
of	B-X
URI	B-X
at	B-X
serine	B-X
371	B-X
.	B-X
This	B-X
activates	B-X
a	B-X
PP1gamma-dependent	B-X
negative	B-X
feedback	B-X
program	B-X
that	B-X
decreases	B-X
S6K1	B-X
activity	B-X
and	B-X
BAD	B-X
phosphorylation	B-X
,	B-X
thereby	B-X
altering	B-X
the	B-X
threshold	B-X
for	B-X
apoptosis	B-X
.	B-X
These	B-X
findings	B-X
establish	B-X
URI	B-X
and	B-X
PP1gamma	B-X
as	B-X
integral	B-X
components	B-X
of	B-X
an	B-X
S6K1-regulated	B-X
mitochondrial	B-X
pathway	B-X
dedicated	B-X
,	B-X
in	B-X
part	B-X
,	B-X
to	B-X
oppose	B-X
sustained	B-X
S6K1	B-X
survival	B-X
signaling	B-X
and	B-X
to	B-X
ensure	B-X
that	B-X
the	B-X
mitochondrial	B-X
threshold	B-X
for	B-X
apoptosis	B-X
is	B-X
set	B-X
in	B-X
accord	B-X
with	B-X
nutrient	B-X
and	B-X
growth	B-X
factor	B-X
availability	B-X
.	B-X

Here	O
we	O
report	O
that	O
the	O
prefoldin	O
chaperone	O
URI	B-Gene_or_gene_product
represents	O
a	O
mitochondrial	O
substrate	O
of	O
S6K1	B-Gene_or_gene_product
.	O
<EOS>	B-X
S6	B-X
kinase	B-X
1	B-X
(	B-X
S6K1	B-X
)	B-X
acts	B-X
to	B-X
integrate	B-X
nutrient	B-X
and	B-X
growth	B-X
factor	B-X
signals	B-X
to	B-X
promote	B-X
cell	B-X
growth	B-X
but	B-X
also	B-X
cell	B-X
survival	B-X
as	B-X
a	B-X
mitochondria-tethered	B-X
protein	B-X
kinase	B-X
that	B-X
phosphorylates	B-X
and	B-X
inactivates	B-X
the	B-X
proapoptotic	B-X
molecule	B-X
BAD	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
the	B-X
prefoldin	B-X
chaperone	B-X
URI	B-X
represents	B-X
a	B-X
mitochondrial	B-X
substrate	B-X
of	B-X
S6K1	B-X
.	B-X
In	B-X
growth	B-X
factor-deprived	B-X
or	B-X
rapamycin-treated	B-X
cells	B-X
,	B-X
URI	B-X
forms	B-X
stable	B-X
complexes	B-X
with	B-X
protein	B-X
phosphatase	B-X
(	B-X
PP	B-X
)	B-X
1gamma	B-X
at	B-X
mitochondria	B-X
,	B-X
thereby	B-X
inhibiting	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
bound	B-X
enzyme	B-X
.	B-X
Growth	B-X
factor	B-X
stimulation	B-X
induces	B-X
disassembly	B-X
of	B-X
URI/PP1gamma	B-X
complexes	B-X
through	B-X
S6K1-mediated	B-X
phosphorylation	B-X
of	B-X
URI	B-X
at	B-X
serine	B-X
371	B-X
.	B-X
This	B-X
activates	B-X
a	B-X
PP1gamma-dependent	B-X
negative	B-X
feedback	B-X
program	B-X
that	B-X
decreases	B-X
S6K1	B-X
activity	B-X
and	B-X
BAD	B-X
phosphorylation	B-X
,	B-X
thereby	B-X
altering	B-X
the	B-X
threshold	B-X
for	B-X
apoptosis	B-X
.	B-X
These	B-X
findings	B-X
establish	B-X
URI	B-X
and	B-X
PP1gamma	B-X
as	B-X
integral	B-X
components	B-X
of	B-X
an	B-X
S6K1-regulated	B-X
mitochondrial	B-X
pathway	B-X
dedicated	B-X
,	B-X
in	B-X
part	B-X
,	B-X
to	B-X
oppose	B-X
sustained	B-X
S6K1	B-X
survival	B-X
signaling	B-X
and	B-X
to	B-X
ensure	B-X
that	B-X
the	B-X
mitochondrial	B-X
threshold	B-X
for	B-X
apoptosis	B-X
is	B-X
set	B-X
in	B-X
accord	B-X
with	B-X
nutrient	B-X
and	B-X
growth	B-X
factor	B-X
availability	B-X
.	B-X

In	O
growth	O
factor	O
-	O
deprived	O
or	O
rapamycin	O
-	O
treated	O
cells	O
,	O
URI	B-Gene_or_gene_product
forms	O
stable	O
complexes	O
with	O
protein	B-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
(	I-Gene_or_gene_product
PP	I-Gene_or_gene_product
)	I-Gene_or_gene_product
1gamma	I-Gene_or_gene_product
at	O
mitochondria	O
,	O
thereby	O
inhibiting	O
the	O
activity	O
of	O
the	O
bound	O
enzyme	O
.	O
<EOS>	B-X
Most	B-X
investigators	B-X
agree	B-X
that	B-X
the	B-X
bone	B-X
marrow	B-X
is	B-X
an	B-X
important	B-X
site	B-X
for	B-X
dormant	B-X
tumor	B-X
cells	B-X
,	B-X
given	B-X
the	B-X
frequency	B-X
of	B-X
bone	B-X
metastases	B-X
and	B-X
that	B-X
multiple	B-X
studies	B-X
have	B-X
reported	B-X
disseminated	B-X
tumor	B-X
cells	B-X
in	B-X
patients	B-X
with	B-X
localized	B-X
disease	B-X
.	B-X
Dormant	B-X
tumor	B-X
cells	B-X
may	B-X
be	B-X
truly	B-X
quiescent	B-X
and	B-X
in	B-X
the	B-X
G0	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
,	B-X
which	B-X
is	B-X
commonly	B-X
called	B-X
cellular	B-X
dormancy	B-X
.	B-X
However	B-X
,	B-X
tumor	B-X
growth	B-X
may	B-X
also	B-X
be	B-X
held	B-X
in	B-X
check	B-X
through	B-X
a	B-X
balance	B-X
of	B-X
proliferation	B-X
and	B-X
cell	B-X
death	B-X
(	B-X
tumor	B-X
mass	B-X
dormancy	B-X
)	B-X
.	B-X
For	B-X
induction	B-X
of	B-X
cellular	B-X
dormancy	B-X
,	B-X
prostate	B-X
cancer	B-X
cells	B-X
respond	B-X
to	B-X
signals	B-X
from	B-X
their	B-X
microenvironment	B-X
,	B-X
including	B-X
TGF-β2	B-X
,	B-X
BMP-7	B-X
,	B-X
GAS6	B-X
,	B-X
and	B-X
Wnt-5a	B-X
,	B-X
which	B-X
result	B-X
in	B-X
signals	B-X
transduced	B-X
in	B-X
part	B-X
through	B-X
p38	B-X
MAPK	B-X
and	B-X
pluripotency	B-X
associated	B-X
transcription	B-X
factors	B-X
including	B-X
SOX2	B-X
and	B-X
NANOG	B-X
,	B-X
which	B-X
likely	B-X
affect	B-X
the	B-X
epi-genome	B-X
through	B-X
histone	B-X
modification	B-X
.	B-X

Growth	O
factor	O
stimulation	O
induces	O
disassembly	O
of	O
URI	O
/	O
PP1gamma	O
complexes	O
through	O
S6K1	B-Gene_or_gene_product
-	O
mediated	O
phosphorylation	O
of	O
URI	B-Gene_or_gene_product
at	O
serine	O
371	O
.	O
<EOS>	B-X
S6	B-X
kinase	B-X
1	B-X
(	B-X
S6K1	B-X
)	B-X
acts	B-X
to	B-X
integrate	B-X
nutrient	B-X
and	B-X
growth	B-X
factor	B-X
signals	B-X
to	B-X
promote	B-X
cell	B-X
growth	B-X
but	B-X
also	B-X
cell	B-X
survival	B-X
as	B-X
a	B-X
mitochondria-tethered	B-X
protein	B-X
kinase	B-X
that	B-X
phosphorylates	B-X
and	B-X
inactivates	B-X
the	B-X
proapoptotic	B-X
molecule	B-X
BAD	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
the	B-X
prefoldin	B-X
chaperone	B-X
URI	B-X
represents	B-X
a	B-X
mitochondrial	B-X
substrate	B-X
of	B-X
S6K1	B-X
.	B-X
In	B-X
growth	B-X
factor-deprived	B-X
or	B-X
rapamycin-treated	B-X
cells	B-X
,	B-X
URI	B-X
forms	B-X
stable	B-X
complexes	B-X
with	B-X
protein	B-X
phosphatase	B-X
(	B-X
PP	B-X
)	B-X
1gamma	B-X
at	B-X
mitochondria	B-X
,	B-X
thereby	B-X
inhibiting	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
bound	B-X
enzyme	B-X
.	B-X
Growth	B-X
factor	B-X
stimulation	B-X
induces	B-X
disassembly	B-X
of	B-X
URI/PP1gamma	B-X
complexes	B-X
through	B-X
S6K1-mediated	B-X
phosphorylation	B-X
of	B-X
URI	B-X
at	B-X
serine	B-X
371	B-X
.	B-X
This	B-X
activates	B-X
a	B-X
PP1gamma-dependent	B-X
negative	B-X
feedback	B-X
program	B-X
that	B-X
decreases	B-X
S6K1	B-X
activity	B-X
and	B-X
BAD	B-X
phosphorylation	B-X
,	B-X
thereby	B-X
altering	B-X
the	B-X
threshold	B-X
for	B-X
apoptosis	B-X
.	B-X
These	B-X
findings	B-X
establish	B-X
URI	B-X
and	B-X
PP1gamma	B-X
as	B-X
integral	B-X
components	B-X
of	B-X
an	B-X
S6K1-regulated	B-X
mitochondrial	B-X
pathway	B-X
dedicated	B-X
,	B-X
in	B-X
part	B-X
,	B-X
to	B-X
oppose	B-X
sustained	B-X
S6K1	B-X
survival	B-X
signaling	B-X
and	B-X
to	B-X
ensure	B-X
that	B-X
the	B-X
mitochondrial	B-X
threshold	B-X
for	B-X
apoptosis	B-X
is	B-X
set	B-X
in	B-X
accord	B-X
with	B-X
nutrient	B-X
and	B-X
growth	B-X
factor	B-X
availability	B-X
.	B-X

This	O
activates	O
a	O
PP1gamma	B-Gene_or_gene_product
-	O
dependent	O
negative	O
feedback	O
program	O
that	O
decreases	O
S6K1	B-Gene_or_gene_product
activity	O
and	O
BAD	B-Gene_or_gene_product
phosphorylation	O
,	O
thereby	O
altering	O
the	O
threshold	O
for	O
apoptosis	O
.	O
<EOS>	B-X
S6	B-X
kinase	B-X
1	B-X
(	B-X
S6K1	B-X
)	B-X
acts	B-X
to	B-X
integrate	B-X
nutrient	B-X
and	B-X
growth	B-X
factor	B-X
signals	B-X
to	B-X
promote	B-X
cell	B-X
growth	B-X
but	B-X
also	B-X
cell	B-X
survival	B-X
as	B-X
a	B-X
mitochondria-tethered	B-X
protein	B-X
kinase	B-X
that	B-X
phosphorylates	B-X
and	B-X
inactivates	B-X
the	B-X
proapoptotic	B-X
molecule	B-X
BAD	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
the	B-X
prefoldin	B-X
chaperone	B-X
URI	B-X
represents	B-X
a	B-X
mitochondrial	B-X
substrate	B-X
of	B-X
S6K1	B-X
.	B-X
In	B-X
growth	B-X
factor-deprived	B-X
or	B-X
rapamycin-treated	B-X
cells	B-X
,	B-X
URI	B-X
forms	B-X
stable	B-X
complexes	B-X
with	B-X
protein	B-X
phosphatase	B-X
(	B-X
PP	B-X
)	B-X
1gamma	B-X
at	B-X
mitochondria	B-X
,	B-X
thereby	B-X
inhibiting	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
bound	B-X
enzyme	B-X
.	B-X
Growth	B-X
factor	B-X
stimulation	B-X
induces	B-X
disassembly	B-X
of	B-X
URI/PP1gamma	B-X
complexes	B-X
through	B-X
S6K1-mediated	B-X
phosphorylation	B-X
of	B-X
URI	B-X
at	B-X
serine	B-X
371	B-X
.	B-X
This	B-X
activates	B-X
a	B-X
PP1gamma-dependent	B-X
negative	B-X
feedback	B-X
program	B-X
that	B-X
decreases	B-X
S6K1	B-X
activity	B-X
and	B-X
BAD	B-X
phosphorylation	B-X
,	B-X
thereby	B-X
altering	B-X
the	B-X
threshold	B-X
for	B-X
apoptosis	B-X
.	B-X
These	B-X
findings	B-X
establish	B-X
URI	B-X
and	B-X
PP1gamma	B-X
as	B-X
integral	B-X
components	B-X
of	B-X
an	B-X
S6K1-regulated	B-X
mitochondrial	B-X
pathway	B-X
dedicated	B-X
,	B-X
in	B-X
part	B-X
,	B-X
to	B-X
oppose	B-X
sustained	B-X
S6K1	B-X
survival	B-X
signaling	B-X
and	B-X
to	B-X
ensure	B-X
that	B-X
the	B-X
mitochondrial	B-X
threshold	B-X
for	B-X
apoptosis	B-X
is	B-X
set	B-X
in	B-X
accord	B-X
with	B-X
nutrient	B-X
and	B-X
growth	B-X
factor	B-X
availability	B-X
.	B-X

These	O
findings	O
establish	O
URI	B-Gene_or_gene_product
and	O
PP1gamma	B-Gene_or_gene_product
as	O
integral	O
components	O
of	O
an	O
S6K1	B-Gene_or_gene_product
-	O
regulated	O
mitochondrial	O
pathway	O
dedicated	O
,	O
in	O
part	O
,	O
to	O
oppose	O
sustained	O
S6K1	B-Gene_or_gene_product
survival	O
signaling	O
and	O
to	O
ensure	O
that	O
the	O
mitochondrial	O
threshold	O
for	O
apoptosis	O
is	O
set	O
in	O
accord	O
with	O
nutrient	O
and	O
growth	O
factor	O
availability	O
.	O
<EOS>	B-X
S6	B-X
kinase	B-X
1	B-X
(	B-X
S6K1	B-X
)	B-X
acts	B-X
to	B-X
integrate	B-X
nutrient	B-X
and	B-X
growth	B-X
factor	B-X
signals	B-X
to	B-X
promote	B-X
cell	B-X
growth	B-X
but	B-X
also	B-X
cell	B-X
survival	B-X
as	B-X
a	B-X
mitochondria-tethered	B-X
protein	B-X
kinase	B-X
that	B-X
phosphorylates	B-X
and	B-X
inactivates	B-X
the	B-X
proapoptotic	B-X
molecule	B-X
BAD	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
the	B-X
prefoldin	B-X
chaperone	B-X
URI	B-X
represents	B-X
a	B-X
mitochondrial	B-X
substrate	B-X
of	B-X
S6K1	B-X
.	B-X
In	B-X
growth	B-X
factor-deprived	B-X
or	B-X
rapamycin-treated	B-X
cells	B-X
,	B-X
URI	B-X
forms	B-X
stable	B-X
complexes	B-X
with	B-X
protein	B-X
phosphatase	B-X
(	B-X
PP	B-X
)	B-X
1gamma	B-X
at	B-X
mitochondria	B-X
,	B-X
thereby	B-X
inhibiting	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
bound	B-X
enzyme	B-X
.	B-X
Growth	B-X
factor	B-X
stimulation	B-X
induces	B-X
disassembly	B-X
of	B-X
URI/PP1gamma	B-X
complexes	B-X
through	B-X
S6K1-mediated	B-X
phosphorylation	B-X
of	B-X
URI	B-X
at	B-X
serine	B-X
371	B-X
.	B-X
This	B-X
activates	B-X
a	B-X
PP1gamma-dependent	B-X
negative	B-X
feedback	B-X
program	B-X
that	B-X
decreases	B-X
S6K1	B-X
activity	B-X
and	B-X
BAD	B-X
phosphorylation	B-X
,	B-X
thereby	B-X
altering	B-X
the	B-X
threshold	B-X
for	B-X
apoptosis	B-X
.	B-X
These	B-X
findings	B-X
establish	B-X
URI	B-X
and	B-X
PP1gamma	B-X
as	B-X
integral	B-X
components	B-X
of	B-X
an	B-X
S6K1-regulated	B-X
mitochondrial	B-X
pathway	B-X
dedicated	B-X
,	B-X
in	B-X
part	B-X
,	B-X
to	B-X
oppose	B-X
sustained	B-X
S6K1	B-X
survival	B-X
signaling	B-X
and	B-X
to	B-X
ensure	B-X
that	B-X
the	B-X
mitochondrial	B-X
threshold	B-X
for	B-X
apoptosis	B-X
is	B-X
set	B-X
in	B-X
accord	B-X
with	B-X
nutrient	B-X
and	B-X
growth	B-X
factor	B-X
availability	B-X
.	B-X

PRAS40	B-Gene_or_gene_product
and	O
PRR5	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
protein	O
are	O
new	O
mTOR	B-Gene_or_gene_product
interactors	O
that	O
regulate	O
apoptosis	O
.	O
<EOS>	B-X
TOR	B-X
(	B-X
Target	B-X
of	B-X
Rapamycin	B-X
)	B-X
is	B-X
a	B-X
highly	B-X
conserved	B-X
protein	B-X
kinase	B-X
and	B-X
a	B-X
central	B-X
controller	B-X
of	B-X
cell	B-X
growth	B-X
.	B-X
TOR	B-X
is	B-X
found	B-X
in	B-X
two	B-X
functionally	B-X
and	B-X
structurally	B-X
distinct	B-X
multiprotein	B-X
complexes	B-X
termed	B-X
TOR	B-X
complex	B-X
1	B-X
(	B-X
TORC1	B-X
)	B-X
and	B-X
TOR	B-X
complex	B-X
2	B-X
(	B-X
TORC2	B-X
)	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
two-dimensional	B-X
liquid	B-X
chromatography	B-X
tandem	B-X
mass	B-X
spectrometry	B-X
(	B-X
2D	B-X
LC-MS/MS	B-X
)	B-X
based	B-X
proteomic	B-X
strategy	B-X
to	B-X
identify	B-X
new	B-X
mammalian	B-X
TOR	B-X
(	B-X
mTOR	B-X
)	B-X
binding	B-X
proteins	B-X
.	B-X
We	B-X
report	B-X
the	B-X
identification	B-X
of	B-X
Proline-rich	B-X
Akt	B-X
substrate	B-X
(	B-X
PRAS40	B-X
)	B-X
and	B-X
the	B-X
hypothetical	B-X
protein	B-X
Q6MZQ0/FLJ14213/CAE45978	B-X
as	B-X
new	B-X
mTOR	B-X
binding	B-X
proteins	B-X
.	B-X
PRAS40	B-X
binds	B-X
mTORC1	B-X
via	B-X
Raptor	B-X
,	B-X
and	B-X
is	B-X
an	B-X
mTOR	B-X
phosphorylation	B-X
substrate	B-X
.	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
autophosphorylation	B-X
and	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
toward	B-X
eIF-4E	B-X
binding	B-X
protein	B-X
(	B-X
4E-BP	B-X
)	B-X
and	B-X
PRAS40	B-X
itself	B-X
.	B-X
HeLa	B-X
cells	B-X
in	B-X
which	B-X
PRAS40	B-X
was	B-X
knocked	B-X
down	B-X
were	B-X
protected	B-X
against	B-X
induction	B-X
of	B-X
apoptosis	B-X
by	B-X
TNFalpha	B-X
and	B-X
cycloheximide	B-X
.	B-X
Rapamycin	B-X
failed	B-X
to	B-X
mimic	B-X
the	B-X
pro-apoptotic	B-X
effect	B-X
of	B-X
PRAS40	B-X
,	B-X
suggesting	B-X
that	B-X
PRAS40	B-X
mediates	B-X
apoptosis	B-X
independently	B-X
of	B-X
its	B-X
inhibitory	B-X
effect	B-X
on	B-X
mTORC1	B-X
.	B-X
Q6MZQ0	B-X
is	B-X
structurally	B-X
similar	B-X
to	B-X
proline	B-X
rich	B-X
protein	B-X
5	B-X
(	B-X
PRR5	B-X
)	B-X
and	B-X
was	B-X
therefore	B-X
named	B-X
PRR5-Like	B-X
(	B-X
PRR5L	B-X
)	B-X
.	B-X
PRR5L	B-X
binds	B-X
specifically	B-X
to	B-X
mTORC2	B-X
,	B-X
via	B-X
Rictor	B-X
and/or	B-X
SIN1	B-X
.	B-X
Unlike	B-X
other	B-X
mTORC2	B-X
members	B-X
,	B-X
PRR5L	B-X
is	B-X
not	B-X
required	B-X
for	B-X
mTORC2	B-X
integrity	B-X
or	B-X
kinase	B-X
activity	B-X
,	B-X
but	B-X
dissociates	B-X
from	B-X
mTORC2	B-X
upon	B-X
knock	B-X
down	B-X
of	B-X
tuberous	B-X
sclerosis	B-X
complex	B-X
1	B-X
(	B-X
TSC1	B-X
)	B-X
and	B-X
TSC2	B-X
.	B-X
Hyperactivation	B-X
of	B-X
mTOR	B-X
by	B-X
TSC1/2	B-X
knock	B-X
down	B-X
enhanced	B-X
apoptosis	B-X
whereas	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
.	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
also	B-X
in	B-X
mTORC2	B-X
deficient	B-X
cells	B-X
.	B-X
The	B-X
above	B-X
suggests	B-X
that	B-X
mTORC2-dissociated	B-X
PRR5L	B-X
may	B-X
promote	B-X
apoptosis	B-X
when	B-X
mTOR	B-X
is	B-X
hyperactive	B-X
.	B-X
Thus	B-X
,	B-X
PRAS40	B-X
and	B-X
PRR5L	B-X
are	B-X
novel	B-X
mTOR-associated	B-X
proteins	B-X
that	B-X
control	B-X
the	B-X
balance	B-X
between	B-X
cell	B-X
growth	B-X
and	B-X
cell	B-X
death	B-X
.	B-X

TOR	B-Gene_or_gene_product
(	O
Target	B-Gene_or_gene_product
of	I-Gene_or_gene_product
Rapamycin	I-Gene_or_gene_product
)	O
is	O
a	O
highly	O
conserved	O
protein	O
kinase	O
and	O
a	O
central	O
controller	O
of	O
cell	O
growth	O
.	O

TOR	B-Gene_or_gene_product
is	O
found	O
in	O
two	O
functionally	O
and	O
structurally	O
distinct	O
multiprotein	O
complexes	O
termed	O
TOR	O
complex	O
1	O
(	O
TORC1	O
)	O
and	O
TOR	O
complex	O
2	O
(	O
TORC2	O
)	O
.	O
<EOS>	B-X
Target	B-X
of	B-X
rapamycin	B-X
(	B-X
TOR	B-X
)	B-X
forms	B-X
two	B-X
conserved	B-X
,	B-X
structurally	B-X
distinct	B-X
kinase	B-X
complexes	B-X
termed	B-X
TOR	B-X
complex	B-X
1	B-X
(	B-X
TORC1	B-X
)	B-X
and	B-X
TORC2	B-X
.	B-X
Each	B-X
complex	B-X
phosphorylates	B-X
a	B-X
different	B-X
set	B-X
of	B-X
substrates	B-X
to	B-X
regulate	B-X
cell	B-X
growth	B-X
.	B-X
In	B-X
mammals	B-X
,	B-X
mTOR	B-X
is	B-X
stimulated	B-X
by	B-X
nutrients	B-X
and	B-X
growth	B-X
factors	B-X
and	B-X
inhibited	B-X
by	B-X
stress	B-X
to	B-X
ensure	B-X
that	B-X
cells	B-X
grow	B-X
only	B-X
during	B-X
favorable	B-X
conditions	B-X
.	B-X
Studies	B-X
in	B-X
different	B-X
organisms	B-X
have	B-X
reported	B-X
localization	B-X
of	B-X
TOR	B-X
to	B-X
several	B-X
distinct	B-X
subcellular	B-X
compartments	B-X
.	B-X
Notably	B-X
,	B-X
the	B-X
finding	B-X
that	B-X
mTORC1	B-X
is	B-X
localized	B-X
to	B-X
the	B-X
lysosome	B-X
has	B-X
significantly	B-X
enhanced	B-X
our	B-X
understanding	B-X
of	B-X
mTORC1	B-X
regulation	B-X
.	B-X
Subcellular	B-X
localization	B-X
may	B-X
be	B-X
a	B-X
general	B-X
principle	B-X
used	B-X
by	B-X
TOR	B-X
to	B-X
enact	B-X
precise	B-X
spatial	B-X
and	B-X
temporal	B-X
control	B-X
of	B-X
cell	B-X
growth	B-X
.	B-X

In	O
the	O
present	O
study	O
,	O
we	O
developed	O
a	O
two	O
-	O
dimensional	O
liquid	O
chromatography	O
tandem	O
mass	O
spectrometry	O
(	O
2D	O
LC	O
-	O
MS	O
/	O
MS	O
)	O
based	O
proteomic	O
strategy	O
to	O
identify	O
new	O
mammalian	B-Gene_or_gene_product
TOR	I-Gene_or_gene_product
(	O
mTOR	B-Gene_or_gene_product
)	O
binding	O
proteins	O
.	O

We	O
report	O
the	O
identification	O
of	O
Proline	B-Gene_or_gene_product
-	I-Gene_or_gene_product
rich	I-Gene_or_gene_product
Akt	I-Gene_or_gene_product
substrate	I-Gene_or_gene_product
(	O
PRAS40	B-Gene_or_gene_product
)	O
and	O
the	O
hypothetical	O
protein	O
Q6MZQ0	B-Gene_or_gene_product
/	O
FLJ14213	B-Gene_or_gene_product
/	O
CAE45978	B-Gene_or_gene_product
as	O
new	O
mTOR	B-Gene_or_gene_product
binding	O
proteins	O
.	O
<EOS>	B-X
TOR	B-X
(	B-X
Target	B-X
of	B-X
Rapamycin	B-X
)	B-X
is	B-X
a	B-X
highly	B-X
conserved	B-X
protein	B-X
kinase	B-X
and	B-X
a	B-X
central	B-X
controller	B-X
of	B-X
cell	B-X
growth	B-X
.	B-X
TOR	B-X
is	B-X
found	B-X
in	B-X
two	B-X
functionally	B-X
and	B-X
structurally	B-X
distinct	B-X
multiprotein	B-X
complexes	B-X
termed	B-X
TOR	B-X
complex	B-X
1	B-X
(	B-X
TORC1	B-X
)	B-X
and	B-X
TOR	B-X
complex	B-X
2	B-X
(	B-X
TORC2	B-X
)	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
two-dimensional	B-X
liquid	B-X
chromatography	B-X
tandem	B-X
mass	B-X
spectrometry	B-X
(	B-X
2D	B-X
LC-MS/MS	B-X
)	B-X
based	B-X
proteomic	B-X
strategy	B-X
to	B-X
identify	B-X
new	B-X
mammalian	B-X
TOR	B-X
(	B-X
mTOR	B-X
)	B-X
binding	B-X
proteins	B-X
.	B-X
We	B-X
report	B-X
the	B-X
identification	B-X
of	B-X
Proline-rich	B-X
Akt	B-X
substrate	B-X
(	B-X
PRAS40	B-X
)	B-X
and	B-X
the	B-X
hypothetical	B-X
protein	B-X
Q6MZQ0/FLJ14213/CAE45978	B-X
as	B-X
new	B-X
mTOR	B-X
binding	B-X
proteins	B-X
.	B-X
PRAS40	B-X
binds	B-X
mTORC1	B-X
via	B-X
Raptor	B-X
,	B-X
and	B-X
is	B-X
an	B-X
mTOR	B-X
phosphorylation	B-X
substrate	B-X
.	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
autophosphorylation	B-X
and	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
toward	B-X
eIF-4E	B-X
binding	B-X
protein	B-X
(	B-X
4E-BP	B-X
)	B-X
and	B-X
PRAS40	B-X
itself	B-X
.	B-X
HeLa	B-X
cells	B-X
in	B-X
which	B-X
PRAS40	B-X
was	B-X
knocked	B-X
down	B-X
were	B-X
protected	B-X
against	B-X
induction	B-X
of	B-X
apoptosis	B-X
by	B-X
TNFalpha	B-X
and	B-X
cycloheximide	B-X
.	B-X
Rapamycin	B-X
failed	B-X
to	B-X
mimic	B-X
the	B-X
pro-apoptotic	B-X
effect	B-X
of	B-X
PRAS40	B-X
,	B-X
suggesting	B-X
that	B-X
PRAS40	B-X
mediates	B-X
apoptosis	B-X
independently	B-X
of	B-X
its	B-X
inhibitory	B-X
effect	B-X
on	B-X
mTORC1	B-X
.	B-X
Q6MZQ0	B-X
is	B-X
structurally	B-X
similar	B-X
to	B-X
proline	B-X
rich	B-X
protein	B-X
5	B-X
(	B-X
PRR5	B-X
)	B-X
and	B-X
was	B-X
therefore	B-X
named	B-X
PRR5-Like	B-X
(	B-X
PRR5L	B-X
)	B-X
.	B-X
PRR5L	B-X
binds	B-X
specifically	B-X
to	B-X
mTORC2	B-X
,	B-X
via	B-X
Rictor	B-X
and/or	B-X
SIN1	B-X
.	B-X
Unlike	B-X
other	B-X
mTORC2	B-X
members	B-X
,	B-X
PRR5L	B-X
is	B-X
not	B-X
required	B-X
for	B-X
mTORC2	B-X
integrity	B-X
or	B-X
kinase	B-X
activity	B-X
,	B-X
but	B-X
dissociates	B-X
from	B-X
mTORC2	B-X
upon	B-X
knock	B-X
down	B-X
of	B-X
tuberous	B-X
sclerosis	B-X
complex	B-X
1	B-X
(	B-X
TSC1	B-X
)	B-X
and	B-X
TSC2	B-X
.	B-X
Hyperactivation	B-X
of	B-X
mTOR	B-X
by	B-X
TSC1/2	B-X
knock	B-X
down	B-X
enhanced	B-X
apoptosis	B-X
whereas	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
.	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
also	B-X
in	B-X
mTORC2	B-X
deficient	B-X
cells	B-X
.	B-X
The	B-X
above	B-X
suggests	B-X
that	B-X
mTORC2-dissociated	B-X
PRR5L	B-X
may	B-X
promote	B-X
apoptosis	B-X
when	B-X
mTOR	B-X
is	B-X
hyperactive	B-X
.	B-X
Thus	B-X
,	B-X
PRAS40	B-X
and	B-X
PRR5L	B-X
are	B-X
novel	B-X
mTOR-associated	B-X
proteins	B-X
that	B-X
control	B-X
the	B-X
balance	B-X
between	B-X
cell	B-X
growth	B-X
and	B-X
cell	B-X
death	B-X
.	B-X

PRAS40	B-Gene_or_gene_product
binds	O
mTORC1	O
via	O
Raptor	B-Gene_or_gene_product
,	O
and	O
is	O
an	O
mTOR	B-Gene_or_gene_product
phosphorylation	O
substrate	O
.	O
<EOS>	B-X
The	B-X
mTORC1	B-X
protein	B-X
kinase	B-X
complex	B-X
consists	B-X
of	B-X
mTOR	B-X
,	B-X
raptor	B-X
,	B-X
mLST8/GbetaL	B-X
and	B-X
PRAS40	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
reported	B-X
that	B-X
mTOR	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
regulating	B-X
protein	B-X
synthesis	B-X
in	B-X
response	B-X
to	B-X
alcohol	B-X
(	B-X
EtOH	B-X
)	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanisms	B-X
by	B-X
which	B-X
EtOH	B-X
regulates	B-X
mTORC1	B-X
activity	B-X
have	B-X
not	B-X
been	B-X
established	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
effect	B-X
of	B-X
EtOH	B-X
on	B-X
the	B-X
phosphorylation	B-X
and	B-X
interaction	B-X
of	B-X
components	B-X
of	B-X
mTORC1	B-X
in	B-X
C2C12	B-X
myocytes	B-X
.	B-X
We	B-X
also	B-X
examined	B-X
the	B-X
specific	B-X
role	B-X
that	B-X
PRAS40	B-X
plays	B-X
in	B-X
this	B-X
process	B-X
.	B-X
Incubation	B-X
of	B-X
myocytes	B-X
with	B-X
EtOH	B-X
(	B-X
100	B-X
mM	B-X
,	B-X
24	B-X
h	B-X
)	B-X
increased	B-X
raptor	B-X
and	B-X
PRAS40	B-X
phosphorylation	B-X
.	B-X
Likewise	B-X
,	B-X
there	B-X
were	B-X
increased	B-X
levels	B-X
of	B-X
the	B-X
PRAS40	B-X
upstream	B-X
regulators	B-X
Akt	B-X
and	B-X
IRS-1	B-X
.	B-X
EtOH	B-X
also	B-X
caused	B-X
changes	B-X
in	B-X
mTORC1	B-X
protein-protein	B-X
interactions	B-X
.	B-X
EtOH	B-X
enhanced	B-X
the	B-X
binding	B-X
of	B-X
raptor	B-X
and	B-X
PRAS40	B-X
with	B-X
mTOR	B-X
.	B-X
These	B-X
alterations	B-X
occurred	B-X
in	B-X
concert	B-X
with	B-X
increased	B-X
binding	B-X
of	B-X
14-3-3	B-X
to	B-X
raptor	B-X
,	B-X
while	B-X
the	B-X
PRAS40	B-X
and	B-X
14-3-3	B-X
interaction	B-X
was	B-X
not	B-X
affected	B-X
.	B-X
The	B-X
shRNA	B-X
knockdown	B-X
(	B-X
KD	B-X
)	B-X
of	B-X
PRAS40	B-X
decreased	B-X
protein	B-X
synthesis	B-X
similarly	B-X
to	B-X
EtOH	B-X
.	B-X
PRAS40	B-X
KD	B-X
increased	B-X
raptor	B-X
phosphorylation	B-X
and	B-X
its	B-X
association	B-X
with	B-X
14-3-3	B-X
,	B-X
whereas	B-X
decreased	B-X
GbetaL-mTOR	B-X
binding	B-X
.	B-X
The	B-X
effects	B-X
of	B-X
EtOH	B-X
and	B-X
PRAS40	B-X
KD	B-X
were	B-X
mediated	B-X
by	B-X
AMPK	B-X
.	B-X
Both	B-X
factors	B-X
increased	B-X
in	B-X
vitro	B-X
AMPK	B-X
activity	B-X
towards	B-X
the	B-X
substrate	B-X
raptor	B-X
.	B-X
Collectively	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
EtOH	B-X
stabilizes	B-X
the	B-X
association	B-X
of	B-X
raptor	B-X
,	B-X
PRAS40	B-X
,	B-X
and	B-X
GbetaL	B-X
with	B-X
mTOR	B-X
,	B-X
while	B-X
likewise	B-X
increasing	B-X
the	B-X
interaction	B-X
of	B-X
raptor	B-X
with	B-X
14-3-3	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
a	B-X
possible	B-X
mechanism	B-X
for	B-X
the	B-X
inhibitory	B-X
effects	B-X
of	B-X
EtOH	B-X
on	B-X
mTOR	B-X
kinase	B-X
activity	B-X
and	B-X
protein	B-X
synthesis	B-X
in	B-X
myocytes	B-X
.	B-X

PRAS40	B-Gene_or_gene_product
inhibits	O
mTORC1	O
autophosphorylation	O
and	O
mTORC1	O
kinase	O
activity	O
toward	O
eIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4E	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
4E	B-Gene_or_gene_product
-	I-Gene_or_gene_product
BP	I-Gene_or_gene_product
)	O
and	O
PRAS40	B-Gene_or_gene_product
itself	O
.	O
<EOS>	B-X
TOR	B-X
(	B-X
Target	B-X
of	B-X
Rapamycin	B-X
)	B-X
is	B-X
a	B-X
highly	B-X
conserved	B-X
protein	B-X
kinase	B-X
and	B-X
a	B-X
central	B-X
controller	B-X
of	B-X
cell	B-X
growth	B-X
.	B-X
TOR	B-X
is	B-X
found	B-X
in	B-X
two	B-X
functionally	B-X
and	B-X
structurally	B-X
distinct	B-X
multiprotein	B-X
complexes	B-X
termed	B-X
TOR	B-X
complex	B-X
1	B-X
(	B-X
TORC1	B-X
)	B-X
and	B-X
TOR	B-X
complex	B-X
2	B-X
(	B-X
TORC2	B-X
)	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
two-dimensional	B-X
liquid	B-X
chromatography	B-X
tandem	B-X
mass	B-X
spectrometry	B-X
(	B-X
2D	B-X
LC-MS/MS	B-X
)	B-X
based	B-X
proteomic	B-X
strategy	B-X
to	B-X
identify	B-X
new	B-X
mammalian	B-X
TOR	B-X
(	B-X
mTOR	B-X
)	B-X
binding	B-X
proteins	B-X
.	B-X
We	B-X
report	B-X
the	B-X
identification	B-X
of	B-X
Proline-rich	B-X
Akt	B-X
substrate	B-X
(	B-X
PRAS40	B-X
)	B-X
and	B-X
the	B-X
hypothetical	B-X
protein	B-X
Q6MZQ0/FLJ14213/CAE45978	B-X
as	B-X
new	B-X
mTOR	B-X
binding	B-X
proteins	B-X
.	B-X
PRAS40	B-X
binds	B-X
mTORC1	B-X
via	B-X
Raptor	B-X
,	B-X
and	B-X
is	B-X
an	B-X
mTOR	B-X
phosphorylation	B-X
substrate	B-X
.	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
autophosphorylation	B-X
and	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
toward	B-X
eIF-4E	B-X
binding	B-X
protein	B-X
(	B-X
4E-BP	B-X
)	B-X
and	B-X
PRAS40	B-X
itself	B-X
.	B-X
HeLa	B-X
cells	B-X
in	B-X
which	B-X
PRAS40	B-X
was	B-X
knocked	B-X
down	B-X
were	B-X
protected	B-X
against	B-X
induction	B-X
of	B-X
apoptosis	B-X
by	B-X
TNFalpha	B-X
and	B-X
cycloheximide	B-X
.	B-X
Rapamycin	B-X
failed	B-X
to	B-X
mimic	B-X
the	B-X
pro-apoptotic	B-X
effect	B-X
of	B-X
PRAS40	B-X
,	B-X
suggesting	B-X
that	B-X
PRAS40	B-X
mediates	B-X
apoptosis	B-X
independently	B-X
of	B-X
its	B-X
inhibitory	B-X
effect	B-X
on	B-X
mTORC1	B-X
.	B-X
Q6MZQ0	B-X
is	B-X
structurally	B-X
similar	B-X
to	B-X
proline	B-X
rich	B-X
protein	B-X
5	B-X
(	B-X
PRR5	B-X
)	B-X
and	B-X
was	B-X
therefore	B-X
named	B-X
PRR5-Like	B-X
(	B-X
PRR5L	B-X
)	B-X
.	B-X
Unlike	B-X
other	B-X
mTORC2	B-X
members	B-X
,	B-X
PRR5L	B-X
is	B-X
not	B-X
required	B-X
for	B-X
mTORC2	B-X
integrity	B-X
or	B-X
kinase	B-X
activity	B-X
,	B-X
but	B-X
dissociates	B-X
from	B-X
mTORC2	B-X
upon	B-X
knock	B-X
down	B-X
of	B-X
tuberous	B-X
sclerosis	B-X
complex	B-X
1	B-X
(	B-X
TSC1	B-X
)	B-X
and	B-X
TSC2	B-X
.	B-X
Thus	B-X
,	B-X
PRAS40	B-X
and	B-X
PRR5L	B-X
are	B-X
novel	B-X
mTOR-associated	B-X
proteins	B-X
that	B-X
control	B-X
the	B-X
balance	B-X
between	B-X
cell	B-X
growth	B-X
and	B-X
cell	B-X
death	B-X
.	B-X

HeLa	O
cells	O
in	O
which	O
PRAS40	B-Gene_or_gene_product
was	O
knocked	O
down	O
were	O
protected	O
against	O
induction	O
of	O
apoptosis	O
by	O
TNFalpha	B-Gene_or_gene_product
and	O
cycloheximide	O
.	O
<EOS>	B-X
We	B-X
report	B-X
the	B-X
identification	B-X
of	B-X
Proline-rich	B-X
Akt	B-X
substrate	B-X
(	B-X
PRAS40	B-X
)	B-X
and	B-X
the	B-X
hypothetical	B-X
protein	B-X
Q6MZQ0/FLJ14213/CAE45978	B-X
as	B-X
new	B-X
mTOR	B-X
binding	B-X
proteins	B-X
.	B-X
PRAS40	B-X
binds	B-X
mTORC1	B-X
via	B-X
Raptor	B-X
,	B-X
and	B-X
is	B-X
an	B-X
mTOR	B-X
phosphorylation	B-X
substrate	B-X
.	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
autophosphorylation	B-X
and	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
toward	B-X
eIF-4E	B-X
binding	B-X
protein	B-X
(	B-X
4E-BP	B-X
)	B-X
and	B-X
PRAS40	B-X
itself	B-X
.	B-X
HeLa	B-X
cells	B-X
in	B-X
which	B-X
PRAS40	B-X
was	B-X
knocked	B-X
down	B-X
were	B-X
protected	B-X
against	B-X
induction	B-X
of	B-X
apoptosis	B-X
by	B-X
TNFalpha	B-X
and	B-X
cycloheximide	B-X
.	B-X
Rapamycin	B-X
failed	B-X
to	B-X
mimic	B-X
the	B-X
pro-apoptotic	B-X
effect	B-X
of	B-X
PRAS40	B-X
,	B-X
suggesting	B-X
that	B-X
PRAS40	B-X
mediates	B-X
apoptosis	B-X
independently	B-X
of	B-X
its	B-X
inhibitory	B-X
effect	B-X
on	B-X
mTORC1	B-X
.	B-X
Hyperactivation	B-X
of	B-X
mTOR	B-X
by	B-X
TSC1/2	B-X
knock	B-X
down	B-X
enhanced	B-X
apoptosis	B-X
whereas	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
.	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
also	B-X
in	B-X
mTORC2	B-X
deficient	B-X
cells	B-X
.	B-X
The	B-X
above	B-X
suggests	B-X
that	B-X
mTORC2-dissociated	B-X
PRR5L	B-X
may	B-X
promote	B-X
apoptosis	B-X
when	B-X
mTOR	B-X
is	B-X
hyperactive	B-X
.	B-X
Thus	B-X
,	B-X
PRAS40	B-X
and	B-X
PRR5L	B-X
are	B-X
novel	B-X
mTOR-associated	B-X
proteins	B-X
that	B-X
control	B-X
the	B-X
balance	B-X
between	B-X
cell	B-X
growth	B-X
and	B-X
cell	B-X
death	B-X
.	B-X

Rapamycin	O
failed	O
to	O
mimic	O
the	O
pro	O
-	O
apoptotic	O
effect	O
of	O
PRAS40	B-Gene_or_gene_product
,	O
suggesting	O
that	O
PRAS40	B-Gene_or_gene_product
mediates	O
apoptosis	O
independently	O
of	O
its	O
inhibitory	O
effect	O
on	O
mTORC1	O
.	O
<EOS>	B-X
TOR	B-X
(	B-X
Target	B-X
of	B-X
Rapamycin	B-X
)	B-X
is	B-X
a	B-X
highly	B-X
conserved	B-X
protein	B-X
kinase	B-X
and	B-X
a	B-X
central	B-X
controller	B-X
of	B-X
cell	B-X
growth	B-X
.	B-X
TOR	B-X
is	B-X
found	B-X
in	B-X
two	B-X
functionally	B-X
and	B-X
structurally	B-X
distinct	B-X
multiprotein	B-X
complexes	B-X
termed	B-X
TOR	B-X
complex	B-X
1	B-X
(	B-X
TORC1	B-X
)	B-X
and	B-X
TOR	B-X
complex	B-X
2	B-X
(	B-X
TORC2	B-X
)	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
two-dimensional	B-X
liquid	B-X
chromatography	B-X
tandem	B-X
mass	B-X
spectrometry	B-X
(	B-X
2D	B-X
LC-MS/MS	B-X
)	B-X
based	B-X
proteomic	B-X
strategy	B-X
to	B-X
identify	B-X
new	B-X
mammalian	B-X
TOR	B-X
(	B-X
mTOR	B-X
)	B-X
binding	B-X
proteins	B-X
.	B-X
We	B-X
report	B-X
the	B-X
identification	B-X
of	B-X
Proline-rich	B-X
Akt	B-X
substrate	B-X
(	B-X
PRAS40	B-X
)	B-X
and	B-X
the	B-X
hypothetical	B-X
protein	B-X
Q6MZQ0/FLJ14213/CAE45978	B-X
as	B-X
new	B-X
mTOR	B-X
binding	B-X
proteins	B-X
.	B-X
PRAS40	B-X
binds	B-X
mTORC1	B-X
via	B-X
Raptor	B-X
,	B-X
and	B-X
is	B-X
an	B-X
mTOR	B-X
phosphorylation	B-X
substrate	B-X
.	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
autophosphorylation	B-X
and	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
toward	B-X
eIF-4E	B-X
binding	B-X
protein	B-X
(	B-X
4E-BP	B-X
)	B-X
and	B-X
PRAS40	B-X
itself	B-X
.	B-X
HeLa	B-X
cells	B-X
in	B-X
which	B-X
PRAS40	B-X
was	B-X
knocked	B-X
down	B-X
were	B-X
protected	B-X
against	B-X
induction	B-X
of	B-X
apoptosis	B-X
by	B-X
TNFalpha	B-X
and	B-X
cycloheximide	B-X
.	B-X
Rapamycin	B-X
failed	B-X
to	B-X
mimic	B-X
the	B-X
pro-apoptotic	B-X
effect	B-X
of	B-X
PRAS40	B-X
,	B-X
suggesting	B-X
that	B-X
PRAS40	B-X
mediates	B-X
apoptosis	B-X
independently	B-X
of	B-X
its	B-X
inhibitory	B-X
effect	B-X
on	B-X
mTORC1	B-X
.	B-X
Q6MZQ0	B-X
is	B-X
structurally	B-X
similar	B-X
to	B-X
proline	B-X
rich	B-X
protein	B-X
5	B-X
(	B-X
PRR5	B-X
)	B-X
and	B-X
was	B-X
therefore	B-X
named	B-X
PRR5-Like	B-X
(	B-X
PRR5L	B-X
)	B-X
.	B-X
Hyperactivation	B-X
of	B-X
mTOR	B-X
by	B-X
TSC1/2	B-X
knock	B-X
down	B-X
enhanced	B-X
apoptosis	B-X
whereas	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
.	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
also	B-X
in	B-X
mTORC2	B-X
deficient	B-X
cells	B-X
.	B-X
The	B-X
above	B-X
suggests	B-X
that	B-X
mTORC2-dissociated	B-X
PRR5L	B-X
may	B-X
promote	B-X
apoptosis	B-X
when	B-X
mTOR	B-X
is	B-X
hyperactive	B-X
.	B-X
Thus	B-X
,	B-X
PRAS40	B-X
and	B-X
PRR5L	B-X
are	B-X
novel	B-X
mTOR-associated	B-X
proteins	B-X
that	B-X
control	B-X
the	B-X
balance	B-X
between	B-X
cell	B-X
growth	B-X
and	B-X
cell	B-X
death	B-X
.	B-X

Q6MZQ0	B-Gene_or_gene_product
is	O
structurally	O
similar	O
to	O
proline	B-Gene_or_gene_product
rich	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
5	I-Gene_or_gene_product
(	O
PRR5	B-Gene_or_gene_product
)	O
and	O
was	O
therefore	O
named	O
PRR5	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Like	I-Gene_or_gene_product
(	O
PRR5L	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
TOR	B-X
(	B-X
Target	B-X
of	B-X
Rapamycin	B-X
)	B-X
is	B-X
a	B-X
highly	B-X
conserved	B-X
protein	B-X
kinase	B-X
and	B-X
a	B-X
central	B-X
controller	B-X
of	B-X
cell	B-X
growth	B-X
.	B-X
TOR	B-X
is	B-X
found	B-X
in	B-X
two	B-X
functionally	B-X
and	B-X
structurally	B-X
distinct	B-X
multiprotein	B-X
complexes	B-X
termed	B-X
TOR	B-X
complex	B-X
1	B-X
(	B-X
TORC1	B-X
)	B-X
and	B-X
TOR	B-X
complex	B-X
2	B-X
(	B-X
TORC2	B-X
)	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
two-dimensional	B-X
liquid	B-X
chromatography	B-X
tandem	B-X
mass	B-X
spectrometry	B-X
(	B-X
2D	B-X
LC-MS/MS	B-X
)	B-X
based	B-X
proteomic	B-X
strategy	B-X
to	B-X
identify	B-X
new	B-X
mammalian	B-X
TOR	B-X
(	B-X
mTOR	B-X
)	B-X
binding	B-X
proteins	B-X
.	B-X
We	B-X
report	B-X
the	B-X
identification	B-X
of	B-X
Proline-rich	B-X
Akt	B-X
substrate	B-X
(	B-X
PRAS40	B-X
)	B-X
and	B-X
the	B-X
hypothetical	B-X
protein	B-X
Q6MZQ0/FLJ14213/CAE45978	B-X
as	B-X
new	B-X
mTOR	B-X
binding	B-X
proteins	B-X
.	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
autophosphorylation	B-X
and	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
toward	B-X
eIF-4E	B-X
binding	B-X
protein	B-X
(	B-X
4E-BP	B-X
)	B-X
and	B-X
PRAS40	B-X
itself	B-X
.	B-X
Q6MZQ0	B-X
is	B-X
structurally	B-X
similar	B-X
to	B-X
proline	B-X
rich	B-X
protein	B-X
5	B-X
(	B-X
PRR5	B-X
)	B-X
and	B-X
was	B-X
therefore	B-X
named	B-X
PRR5-Like	B-X
(	B-X
PRR5L	B-X
)	B-X
.	B-X
PRR5L	B-X
binds	B-X
specifically	B-X
to	B-X
mTORC2	B-X
,	B-X
via	B-X
Rictor	B-X
and/or	B-X
SIN1	B-X
.	B-X
Unlike	B-X
other	B-X
mTORC2	B-X
members	B-X
,	B-X
PRR5L	B-X
is	B-X
not	B-X
required	B-X
for	B-X
mTORC2	B-X
integrity	B-X
or	B-X
kinase	B-X
activity	B-X
,	B-X
but	B-X
dissociates	B-X
from	B-X
mTORC2	B-X
upon	B-X
knock	B-X
down	B-X
of	B-X
tuberous	B-X
sclerosis	B-X
complex	B-X
1	B-X
(	B-X
TSC1	B-X
)	B-X
and	B-X
TSC2	B-X
.	B-X
Hyperactivation	B-X
of	B-X
mTOR	B-X
by	B-X
TSC1/2	B-X
knock	B-X
down	B-X
enhanced	B-X
apoptosis	B-X
whereas	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
.	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
also	B-X
in	B-X
mTORC2	B-X
deficient	B-X
cells	B-X
.	B-X
The	B-X
above	B-X
suggests	B-X
that	B-X
mTORC2-dissociated	B-X
PRR5L	B-X
may	B-X
promote	B-X
apoptosis	B-X
when	B-X
mTOR	B-X
is	B-X
hyperactive	B-X
.	B-X
Thus	B-X
,	B-X
PRAS40	B-X
and	B-X
PRR5L	B-X
are	B-X
novel	B-X
mTOR-associated	B-X
proteins	B-X
that	B-X
control	B-X
the	B-X
balance	B-X
between	B-X
cell	B-X
growth	B-X
and	B-X
cell	B-X
death	B-X
.	B-X

PRR5L	B-Gene_or_gene_product
binds	O
specifically	O
to	O
mTORC2	O
,	O
via	O
Rictor	B-Gene_or_gene_product
and	O
/	O
or	O
SIN1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Over	B-X
the	B-X
years	B-X
it	B-X
has	B-X
been	B-X
established	B-X
that	B-X
SIN1	B-X
,	B-X
a	B-X
key	B-X
component	B-X
of	B-X
mTORC2	B-X
,	B-X
could	B-X
interact	B-X
with	B-X
Ras	B-X
family	B-X
small	B-X
GTPases	B-X
through	B-X
its	B-X
Ras-binding	B-X
domain	B-X
(	B-X
RBD	B-X
)	B-X
.	B-X
The	B-X
physical	B-X
association	B-X
of	B-X
Ras	B-X
and	B-X
SIN1/mTORC2	B-X
could	B-X
potentially	B-X
affect	B-X
both	B-X
mTORC2	B-X
and	B-X
Ras-ERK	B-X
pathways	B-X
.	B-X
To	B-X
decipher	B-X
the	B-X
precise	B-X
molecular	B-X
mechanism	B-X
of	B-X
this	B-X
interaction	B-X
,	B-X
we	B-X
determined	B-X
the	B-X
high-resolution	B-X
structures	B-X
of	B-X
HRas/KRas-SIN1	B-X
RBD	B-X
complexes	B-X
,	B-X
showing	B-X
the	B-X
detailed	B-X
interaction	B-X
interface	B-X
.	B-X
Mutation	B-X
of	B-X
critical	B-X
interface	B-X
residues	B-X
abolished	B-X
Ras-SIN1	B-X
interaction	B-X
and	B-X
in	B-X
SIN1	B-X
knockout	B-X
cells	B-X
we	B-X
demonstrated	B-X
that	B-X
Ras-SIN1	B-X
association	B-X
promotes	B-X
SGK1	B-X
activity	B-X
but	B-X
inhibits	B-X
insulin-induced	B-X
ERK	B-X
activation	B-X
.	B-X
With	B-X
structural	B-X
comparison	B-X
and	B-X
competition	B-X
fluorescence	B-X
resonance	B-X
energy	B-X
transfer	B-X
(	B-X
FRET	B-X
)	B-X
assays	B-X
we	B-X
showed	B-X
that	B-X
HRas-SIN1	B-X
RBD	B-X
association	B-X
is	B-X
much	B-X
weaker	B-X
than	B-X
HRas-Raf1	B-X
RBD	B-X
but	B-X
is	B-X
slightly	B-X
stronger	B-X
than	B-X
HRas-PI3K	B-X
RBD	B-X
interaction	B-X
,	B-X
providing	B-X
a	B-X
possible	B-X
explanation	B-X
for	B-X
the	B-X
different	B-X
outcome	B-X
of	B-X
insulin	B-X
or	B-X
EGF	B-X
stimulation	B-X
.	B-X
We	B-X
also	B-X
found	B-X
that	B-X
SIN1	B-X
isoform	B-X
lacking	B-X
the	B-X
PH	B-X
domain	B-X
binds	B-X
stronger	B-X
to	B-X
Ras	B-X
than	B-X
other	B-X
longer	B-X
isoforms	B-X
and	B-X
the	B-X
PH	B-X
domain	B-X
appears	B-X
to	B-X
have	B-X
an	B-X
inhibitory	B-X
effect	B-X
on	B-X
Ras-SIN1	B-X
binding	B-X
.	B-X
Our	B-X
results	B-X
advance	B-X
our	B-X
understanding	B-X
of	B-X
Ras-SIN1	B-X
association	B-X
and	B-X
crosstalk	B-X
between	B-X
growth	B-X
factor-stimulated	B-X
pathways	B-X
.	B-X

Unlike	O
other	O
mTORC2	O
members	O
,	O
PRR5L	B-Gene_or_gene_product
is	O
not	O
required	O
for	O
mTORC2	O
integrity	O
or	O
kinase	O
activity	O
,	O
but	O
dissociates	O
from	O
mTORC2	O
upon	O
knock	O
down	O
of	O
tuberous	B-Gene_or_gene_product
sclerosis	I-Gene_or_gene_product
complex	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
TSC1	B-Gene_or_gene_product
)	O
and	O
TSC2	B-Gene_or_gene_product
.	O
<EOS>	B-X
TOR	B-X
(	B-X
Target	B-X
of	B-X
Rapamycin	B-X
)	B-X
is	B-X
a	B-X
highly	B-X
conserved	B-X
protein	B-X
kinase	B-X
and	B-X
a	B-X
central	B-X
controller	B-X
of	B-X
cell	B-X
growth	B-X
.	B-X
TOR	B-X
is	B-X
found	B-X
in	B-X
two	B-X
functionally	B-X
and	B-X
structurally	B-X
distinct	B-X
multiprotein	B-X
complexes	B-X
termed	B-X
TOR	B-X
complex	B-X
1	B-X
(	B-X
TORC1	B-X
)	B-X
and	B-X
TOR	B-X
complex	B-X
2	B-X
(	B-X
TORC2	B-X
)	B-X
.	B-X
We	B-X
report	B-X
the	B-X
identification	B-X
of	B-X
Proline-rich	B-X
Akt	B-X
substrate	B-X
(	B-X
PRAS40	B-X
)	B-X
and	B-X
the	B-X
hypothetical	B-X
protein	B-X
Q6MZQ0/FLJ14213/CAE45978	B-X
as	B-X
new	B-X
mTOR	B-X
binding	B-X
proteins	B-X
.	B-X
PRAS40	B-X
binds	B-X
mTORC1	B-X
via	B-X
Raptor	B-X
,	B-X
and	B-X
is	B-X
an	B-X
mTOR	B-X
phosphorylation	B-X
substrate	B-X
.	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
autophosphorylation	B-X
and	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
toward	B-X
eIF-4E	B-X
binding	B-X
protein	B-X
(	B-X
4E-BP	B-X
)	B-X
and	B-X
PRAS40	B-X
itself	B-X
.	B-X
HeLa	B-X
cells	B-X
in	B-X
which	B-X
PRAS40	B-X
was	B-X
knocked	B-X
down	B-X
were	B-X
protected	B-X
against	B-X
induction	B-X
of	B-X
apoptosis	B-X
by	B-X
TNFalpha	B-X
and	B-X
cycloheximide	B-X
.	B-X
Rapamycin	B-X
failed	B-X
to	B-X
mimic	B-X
the	B-X
pro-apoptotic	B-X
effect	B-X
of	B-X
PRAS40	B-X
,	B-X
suggesting	B-X
that	B-X
PRAS40	B-X
mediates	B-X
apoptosis	B-X
independently	B-X
of	B-X
its	B-X
inhibitory	B-X
effect	B-X
on	B-X
mTORC1	B-X
.	B-X
Q6MZQ0	B-X
is	B-X
structurally	B-X
similar	B-X
to	B-X
proline	B-X
rich	B-X
protein	B-X
5	B-X
(	B-X
PRR5	B-X
)	B-X
and	B-X
was	B-X
therefore	B-X
named	B-X
PRR5-Like	B-X
(	B-X
PRR5L	B-X
)	B-X
.	B-X
PRR5L	B-X
binds	B-X
specifically	B-X
to	B-X
mTORC2	B-X
,	B-X
via	B-X
Rictor	B-X
and/or	B-X
SIN1	B-X
.	B-X
Unlike	B-X
other	B-X
mTORC2	B-X
members	B-X
,	B-X
PRR5L	B-X
is	B-X
not	B-X
required	B-X
for	B-X
mTORC2	B-X
integrity	B-X
or	B-X
kinase	B-X
activity	B-X
,	B-X
but	B-X
dissociates	B-X
from	B-X
mTORC2	B-X
upon	B-X
knock	B-X
down	B-X
of	B-X
tuberous	B-X
sclerosis	B-X
complex	B-X
1	B-X
(	B-X
TSC1	B-X
)	B-X
and	B-X
TSC2	B-X
.	B-X
Hyperactivation	B-X
of	B-X
mTOR	B-X
by	B-X
TSC1/2	B-X
knock	B-X
down	B-X
enhanced	B-X
apoptosis	B-X
whereas	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
.	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
also	B-X
in	B-X
mTORC2	B-X
deficient	B-X
cells	B-X
.	B-X
The	B-X
above	B-X
suggests	B-X
that	B-X
mTORC2-dissociated	B-X
PRR5L	B-X
may	B-X
promote	B-X
apoptosis	B-X
when	B-X
mTOR	B-X
is	B-X
hyperactive	B-X
.	B-X
Thus	B-X
,	B-X
PRAS40	B-X
and	B-X
PRR5L	B-X
are	B-X
novel	B-X
mTOR-associated	B-X
proteins	B-X
that	B-X
control	B-X
the	B-X
balance	B-X
between	B-X
cell	B-X
growth	B-X
and	B-X
cell	B-X
death	B-X
.	B-X

Hyperactivation	O
of	O
mTOR	B-Gene_or_gene_product
by	O
TSC1	B-Gene_or_gene_product
/	O
2	B-Gene_or_gene_product
knock	O
down	O
enhanced	O
apoptosis	O
whereas	O
PRR5L	B-Gene_or_gene_product
knock	O
down	O
reduced	O
apoptosis	O
.	O
<EOS>	B-X
TOR	B-X
is	B-X
found	B-X
in	B-X
two	B-X
functionally	B-X
and	B-X
structurally	B-X
distinct	B-X
multiprotein	B-X
complexes	B-X
termed	B-X
TOR	B-X
complex	B-X
1	B-X
(	B-X
TORC1	B-X
)	B-X
and	B-X
TOR	B-X
complex	B-X
2	B-X
(	B-X
TORC2	B-X
)	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
two-dimensional	B-X
liquid	B-X
chromatography	B-X
tandem	B-X
mass	B-X
spectrometry	B-X
(	B-X
2D	B-X
LC-MS/MS	B-X
)	B-X
based	B-X
proteomic	B-X
strategy	B-X
to	B-X
identify	B-X
new	B-X
mammalian	B-X
TOR	B-X
(	B-X
mTOR	B-X
)	B-X
binding	B-X
proteins	B-X
.	B-X
We	B-X
report	B-X
the	B-X
identification	B-X
of	B-X
Proline-rich	B-X
Akt	B-X
substrate	B-X
(	B-X
PRAS40	B-X
)	B-X
and	B-X
the	B-X
hypothetical	B-X
protein	B-X
Q6MZQ0/FLJ14213/CAE45978	B-X
as	B-X
new	B-X
mTOR	B-X
binding	B-X
proteins	B-X
.	B-X
PRAS40	B-X
binds	B-X
mTORC1	B-X
via	B-X
Raptor	B-X
,	B-X
and	B-X
is	B-X
an	B-X
mTOR	B-X
phosphorylation	B-X
substrate	B-X
.	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
autophosphorylation	B-X
and	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
toward	B-X
eIF-4E	B-X
binding	B-X
protein	B-X
(	B-X
4E-BP	B-X
)	B-X
and	B-X
PRAS40	B-X
itself	B-X
.	B-X
HeLa	B-X
cells	B-X
in	B-X
which	B-X
PRAS40	B-X
was	B-X
knocked	B-X
down	B-X
were	B-X
protected	B-X
against	B-X
induction	B-X
of	B-X
apoptosis	B-X
by	B-X
TNFalpha	B-X
and	B-X
cycloheximide	B-X
.	B-X
Rapamycin	B-X
failed	B-X
to	B-X
mimic	B-X
the	B-X
pro-apoptotic	B-X
effect	B-X
of	B-X
PRAS40	B-X
,	B-X
suggesting	B-X
that	B-X
PRAS40	B-X
mediates	B-X
apoptosis	B-X
independently	B-X
of	B-X
its	B-X
inhibitory	B-X
effect	B-X
on	B-X
mTORC1	B-X
.	B-X
Q6MZQ0	B-X
is	B-X
structurally	B-X
similar	B-X
to	B-X
proline	B-X
rich	B-X
protein	B-X
5	B-X
(	B-X
PRR5	B-X
)	B-X
and	B-X
was	B-X
therefore	B-X
named	B-X
PRR5-Like	B-X
(	B-X
PRR5L	B-X
)	B-X
.	B-X
PRR5L	B-X
binds	B-X
specifically	B-X
to	B-X
mTORC2	B-X
,	B-X
via	B-X
Rictor	B-X
and/or	B-X
SIN1	B-X
.	B-X
Unlike	B-X
other	B-X
mTORC2	B-X
members	B-X
,	B-X
PRR5L	B-X
is	B-X
not	B-X
required	B-X
for	B-X
mTORC2	B-X
integrity	B-X
or	B-X
kinase	B-X
activity	B-X
,	B-X
but	B-X
dissociates	B-X
from	B-X
mTORC2	B-X
upon	B-X
knock	B-X
down	B-X
of	B-X
tuberous	B-X
sclerosis	B-X
complex	B-X
1	B-X
(	B-X
TSC1	B-X
)	B-X
and	B-X
TSC2	B-X
.	B-X
Hyperactivation	B-X
of	B-X
mTOR	B-X
by	B-X
TSC1/2	B-X
knock	B-X
down	B-X
enhanced	B-X
apoptosis	B-X
whereas	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
.	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
also	B-X
in	B-X
mTORC2	B-X
deficient	B-X
cells	B-X
.	B-X
The	B-X
above	B-X
suggests	B-X
that	B-X
mTORC2-dissociated	B-X
PRR5L	B-X
may	B-X
promote	B-X
apoptosis	B-X
when	B-X
mTOR	B-X
is	B-X
hyperactive	B-X
.	B-X
Thus	B-X
,	B-X
PRAS40	B-X
and	B-X
PRR5L	B-X
are	B-X
novel	B-X
mTOR-associated	B-X
proteins	B-X
that	B-X
control	B-X
the	B-X
balance	B-X
between	B-X
cell	B-X
growth	B-X
and	B-X
cell	B-X
death	B-X
.	B-X

PRR5L	B-Gene_or_gene_product
knock	O
down	O
reduced	O
apoptosis	O
also	O
in	O
mTORC2	O
deficient	O
cells	O
.	O
<EOS>	B-X
HeLa	B-X
cells	B-X
in	B-X
which	B-X
PRAS40	B-X
was	B-X
knocked	B-X
down	B-X
were	B-X
protected	B-X
against	B-X
induction	B-X
of	B-X
apoptosis	B-X
by	B-X
TNFalpha	B-X
and	B-X
cycloheximide	B-X
.	B-X
Rapamycin	B-X
failed	B-X
to	B-X
mimic	B-X
the	B-X
pro-apoptotic	B-X
effect	B-X
of	B-X
PRAS40	B-X
,	B-X
suggesting	B-X
that	B-X
PRAS40	B-X
mediates	B-X
apoptosis	B-X
independently	B-X
of	B-X
its	B-X
inhibitory	B-X
effect	B-X
on	B-X
mTORC1	B-X
.	B-X
Q6MZQ0	B-X
is	B-X
structurally	B-X
similar	B-X
to	B-X
proline	B-X
rich	B-X
protein	B-X
5	B-X
(	B-X
PRR5	B-X
)	B-X
and	B-X
was	B-X
therefore	B-X
named	B-X
PRR5-Like	B-X
(	B-X
PRR5L	B-X
)	B-X
.	B-X
PRR5L	B-X
binds	B-X
specifically	B-X
to	B-X
mTORC2	B-X
,	B-X
via	B-X
Rictor	B-X
and/or	B-X
SIN1	B-X
.	B-X
Unlike	B-X
other	B-X
mTORC2	B-X
members	B-X
,	B-X
PRR5L	B-X
is	B-X
not	B-X
required	B-X
for	B-X
mTORC2	B-X
integrity	B-X
or	B-X
kinase	B-X
activity	B-X
,	B-X
but	B-X
dissociates	B-X
from	B-X
mTORC2	B-X
upon	B-X
knock	B-X
down	B-X
of	B-X
tuberous	B-X
sclerosis	B-X
complex	B-X
1	B-X
(	B-X
TSC1	B-X
)	B-X
and	B-X
TSC2	B-X
.	B-X
Hyperactivation	B-X
of	B-X
mTOR	B-X
by	B-X
TSC1/2	B-X
knock	B-X
down	B-X
enhanced	B-X
apoptosis	B-X
whereas	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
.	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
also	B-X
in	B-X
mTORC2	B-X
deficient	B-X
cells	B-X
.	B-X
The	B-X
above	B-X
suggests	B-X
that	B-X
mTORC2-dissociated	B-X
PRR5L	B-X
may	B-X
promote	B-X
apoptosis	B-X
when	B-X
mTOR	B-X
is	B-X
hyperactive	B-X
.	B-X
Thus	B-X
,	B-X
PRAS40	B-X
and	B-X
PRR5L	B-X
are	B-X
novel	B-X
mTOR-associated	B-X
proteins	B-X
that	B-X
control	B-X
the	B-X
balance	B-X
between	B-X
cell	B-X
growth	B-X
and	B-X
cell	B-X
death	B-X
.	B-X

The	O
above	O
suggests	O
that	O
mTORC2	O
-	O
dissociated	O
PRR5L	B-Gene_or_gene_product
may	O
promote	O
apoptosis	O
when	O
mTOR	B-Gene_or_gene_product
is	O
hyperactive	O
.	O
<EOS>	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
two-dimensional	B-X
liquid	B-X
chromatography	B-X
tandem	B-X
mass	B-X
spectrometry	B-X
(	B-X
2D	B-X
LC-MS/MS	B-X
)	B-X
based	B-X
proteomic	B-X
strategy	B-X
to	B-X
identify	B-X
new	B-X
mammalian	B-X
TOR	B-X
(	B-X
mTOR	B-X
)	B-X
binding	B-X
proteins	B-X
.	B-X
We	B-X
report	B-X
the	B-X
identification	B-X
of	B-X
Proline-rich	B-X
Akt	B-X
substrate	B-X
(	B-X
PRAS40	B-X
)	B-X
and	B-X
the	B-X
hypothetical	B-X
protein	B-X
Q6MZQ0/FLJ14213/CAE45978	B-X
as	B-X
new	B-X
mTOR	B-X
binding	B-X
proteins	B-X
.	B-X
PRAS40	B-X
binds	B-X
mTORC1	B-X
via	B-X
Raptor	B-X
,	B-X
and	B-X
is	B-X
an	B-X
mTOR	B-X
phosphorylation	B-X
substrate	B-X
.	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
autophosphorylation	B-X
and	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
toward	B-X
eIF-4E	B-X
binding	B-X
protein	B-X
(	B-X
4E-BP	B-X
)	B-X
and	B-X
PRAS40	B-X
itself	B-X
.	B-X
HeLa	B-X
cells	B-X
in	B-X
which	B-X
PRAS40	B-X
was	B-X
knocked	B-X
down	B-X
were	B-X
protected	B-X
against	B-X
induction	B-X
of	B-X
apoptosis	B-X
by	B-X
TNFalpha	B-X
and	B-X
cycloheximide	B-X
.	B-X
Rapamycin	B-X
failed	B-X
to	B-X
mimic	B-X
the	B-X
pro-apoptotic	B-X
effect	B-X
of	B-X
PRAS40	B-X
,	B-X
suggesting	B-X
that	B-X
PRAS40	B-X
mediates	B-X
apoptosis	B-X
independently	B-X
of	B-X
its	B-X
inhibitory	B-X
effect	B-X
on	B-X
mTORC1	B-X
.	B-X
Q6MZQ0	B-X
is	B-X
structurally	B-X
similar	B-X
to	B-X
proline	B-X
rich	B-X
protein	B-X
5	B-X
(	B-X
PRR5	B-X
)	B-X
and	B-X
was	B-X
therefore	B-X
named	B-X
PRR5-Like	B-X
(	B-X
PRR5L	B-X
)	B-X
.	B-X
PRR5L	B-X
binds	B-X
specifically	B-X
to	B-X
mTORC2	B-X
,	B-X
via	B-X
Rictor	B-X
and/or	B-X
SIN1	B-X
.	B-X
Unlike	B-X
other	B-X
mTORC2	B-X
members	B-X
,	B-X
PRR5L	B-X
is	B-X
not	B-X
required	B-X
for	B-X
mTORC2	B-X
integrity	B-X
or	B-X
kinase	B-X
activity	B-X
,	B-X
but	B-X
dissociates	B-X
from	B-X
mTORC2	B-X
upon	B-X
knock	B-X
down	B-X
of	B-X
tuberous	B-X
sclerosis	B-X
complex	B-X
1	B-X
(	B-X
TSC1	B-X
)	B-X
and	B-X
TSC2	B-X
.	B-X
Hyperactivation	B-X
of	B-X
mTOR	B-X
by	B-X
TSC1/2	B-X
knock	B-X
down	B-X
enhanced	B-X
apoptosis	B-X
whereas	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
.	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
also	B-X
in	B-X
mTORC2	B-X
deficient	B-X
cells	B-X
.	B-X
The	B-X
above	B-X
suggests	B-X
that	B-X
mTORC2-dissociated	B-X
PRR5L	B-X
may	B-X
promote	B-X
apoptosis	B-X
when	B-X
mTOR	B-X
is	B-X
hyperactive	B-X
.	B-X
Thus	B-X
,	B-X
PRAS40	B-X
and	B-X
PRR5L	B-X
are	B-X
novel	B-X
mTOR-associated	B-X
proteins	B-X
that	B-X
control	B-X
the	B-X
balance	B-X
between	B-X
cell	B-X
growth	B-X
and	B-X
cell	B-X
death	B-X
.	B-X

Thus	O
,	O
PRAS40	B-Gene_or_gene_product
and	O
PRR5L	B-Gene_or_gene_product
are	O
novel	O
mTOR	B-Gene_or_gene_product
-	O
associated	O
proteins	O
that	O
control	O
the	O
balance	O
between	O
cell	O
growth	O
and	O
cell	O
death	O
.	O
<EOS>	B-X
TOR	B-X
(	B-X
Target	B-X
of	B-X
Rapamycin	B-X
)	B-X
is	B-X
a	B-X
highly	B-X
conserved	B-X
protein	B-X
kinase	B-X
and	B-X
a	B-X
central	B-X
controller	B-X
of	B-X
cell	B-X
growth	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
two-dimensional	B-X
liquid	B-X
chromatography	B-X
tandem	B-X
mass	B-X
spectrometry	B-X
(	B-X
2D	B-X
LC-MS/MS	B-X
)	B-X
based	B-X
proteomic	B-X
strategy	B-X
to	B-X
identify	B-X
new	B-X
mammalian	B-X
TOR	B-X
(	B-X
mTOR	B-X
)	B-X
binding	B-X
proteins	B-X
.	B-X
We	B-X
report	B-X
the	B-X
identification	B-X
of	B-X
Proline-rich	B-X
Akt	B-X
substrate	B-X
(	B-X
PRAS40	B-X
)	B-X
and	B-X
the	B-X
hypothetical	B-X
protein	B-X
Q6MZQ0/FLJ14213/CAE45978	B-X
as	B-X
new	B-X
mTOR	B-X
binding	B-X
proteins	B-X
.	B-X
PRAS40	B-X
binds	B-X
mTORC1	B-X
via	B-X
Raptor	B-X
,	B-X
and	B-X
is	B-X
an	B-X
mTOR	B-X
phosphorylation	B-X
substrate	B-X
.	B-X
PRAS40	B-X
inhibits	B-X
mTORC1	B-X
autophosphorylation	B-X
and	B-X
mTORC1	B-X
kinase	B-X
activity	B-X
toward	B-X
eIF-4E	B-X
binding	B-X
protein	B-X
(	B-X
4E-BP	B-X
)	B-X
and	B-X
PRAS40	B-X
itself	B-X
.	B-X
HeLa	B-X
cells	B-X
in	B-X
which	B-X
PRAS40	B-X
was	B-X
knocked	B-X
down	B-X
were	B-X
protected	B-X
against	B-X
induction	B-X
of	B-X
apoptosis	B-X
by	B-X
TNFalpha	B-X
and	B-X
cycloheximide	B-X
.	B-X
Rapamycin	B-X
failed	B-X
to	B-X
mimic	B-X
the	B-X
pro-apoptotic	B-X
effect	B-X
of	B-X
PRAS40	B-X
,	B-X
suggesting	B-X
that	B-X
PRAS40	B-X
mediates	B-X
apoptosis	B-X
independently	B-X
of	B-X
its	B-X
inhibitory	B-X
effect	B-X
on	B-X
mTORC1	B-X
.	B-X
Q6MZQ0	B-X
is	B-X
structurally	B-X
similar	B-X
to	B-X
proline	B-X
rich	B-X
protein	B-X
5	B-X
(	B-X
PRR5	B-X
)	B-X
and	B-X
was	B-X
therefore	B-X
named	B-X
PRR5-Like	B-X
(	B-X
PRR5L	B-X
)	B-X
.	B-X
PRR5L	B-X
binds	B-X
specifically	B-X
to	B-X
mTORC2	B-X
,	B-X
via	B-X
Rictor	B-X
and/or	B-X
SIN1	B-X
.	B-X
Unlike	B-X
other	B-X
mTORC2	B-X
members	B-X
,	B-X
PRR5L	B-X
is	B-X
not	B-X
required	B-X
for	B-X
mTORC2	B-X
integrity	B-X
or	B-X
kinase	B-X
activity	B-X
,	B-X
but	B-X
dissociates	B-X
from	B-X
mTORC2	B-X
upon	B-X
knock	B-X
down	B-X
of	B-X
tuberous	B-X
sclerosis	B-X
complex	B-X
1	B-X
(	B-X
TSC1	B-X
)	B-X
and	B-X
TSC2	B-X
.	B-X
Hyperactivation	B-X
of	B-X
mTOR	B-X
by	B-X
TSC1/2	B-X
knock	B-X
down	B-X
enhanced	B-X
apoptosis	B-X
whereas	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
.	B-X
PRR5L	B-X
knock	B-X
down	B-X
reduced	B-X
apoptosis	B-X
also	B-X
in	B-X
mTORC2	B-X
deficient	B-X
cells	B-X
.	B-X
The	B-X
above	B-X
suggests	B-X
that	B-X
mTORC2-dissociated	B-X
PRR5L	B-X
may	B-X
promote	B-X
apoptosis	B-X
when	B-X
mTOR	B-X
is	B-X
hyperactive	B-X
.	B-X
Thus	B-X
,	B-X
PRAS40	B-X
and	B-X
PRR5L	B-X
are	B-X
novel	B-X
mTOR-associated	B-X
proteins	B-X
that	B-X
control	B-X
the	B-X
balance	B-X
between	B-X
cell	B-X
growth	B-X
and	B-X
cell	B-X
death	B-X
.	B-X

Bub1	B-Gene_or_gene_product
kinase	O
targets	O
Sgo1	B-Gene_or_gene_product
to	O
ensure	O
efficient	O
chromosome	O
biorientation	O
in	O
budding	O
yeast	O
mitosis	O
.	O
<EOS>	B-X
During	B-X
cell	B-X
division	B-X
all	B-X
chromosomes	B-X
must	B-X
be	B-X
segregated	B-X
accurately	B-X
to	B-X
each	B-X
daughter	B-X
cell	B-X
.	B-X
The	B-X
spindle	B-X
checkpoint	B-X
is	B-X
a	B-X
surveillance	B-X
mechanism	B-X
that	B-X
ensures	B-X
high	B-X
fidelity	B-X
of	B-X
chromosome	B-X
segregation	B-X
by	B-X
inhibiting	B-X
anaphase	B-X
until	B-X
all	B-X
kinetochores	B-X
have	B-X
established	B-X
bipolar	B-X
attachments	B-X
to	B-X
spindle	B-X
microtubules	B-X
.	B-X
Bub1	B-X
kinase	B-X
is	B-X
a	B-X
core	B-X
component	B-X
of	B-X
the	B-X
spindle	B-X
checkpoint	B-X
,	B-X
and	B-X
cells	B-X
lacking	B-X
Bub1	B-X
fail	B-X
to	B-X
arrest	B-X
in	B-X
response	B-X
to	B-X
microtubule	B-X
drugs	B-X
and	B-X
precociously	B-X
segregate	B-X
their	B-X
DNA	B-X
.	B-X
The	B-X
mitotic	B-X
role	B-X
(	B-X
s	B-X
)	B-X
of	B-X
Bub1	B-X
kinase	B-X
activity	B-X
remain	B-X
elusive	B-X
,	B-X
and	B-X
it	B-X
is	B-X
controversial	B-X
whether	B-X
this	B-X
C-terminal	B-X
domain	B-X
of	B-X
Bub1p	B-X
is	B-X
required	B-X
for	B-X
spindle	B-X
checkpoint	B-X
arrest	B-X
.	B-X
Here	B-X
we	B-X
make	B-X
a	B-X
detailed	B-X
analysis	B-X
of	B-X
budding	B-X
yeast	B-X
cells	B-X
lacking	B-X
the	B-X
kinase	B-X
domain	B-X
(	B-X
bub1DeltaK	B-X
)	B-X
.	B-X
This	B-X
is	B-X
because	B-X
bub1DeltaK	B-X
cells	B-X
display	B-X
significant	B-X
chromosome	B-X
mis-segregation	B-X
upon	B-X
release	B-X
from	B-X
nocodazole	B-X
arrest	B-X
.	B-X
bub1DeltaK	B-X
cells	B-X
mislocalise	B-X
Sgo1p	B-X
,	B-X
and	B-X
we	B-X
demonstrate	B-X
that	B-X
both	B-X
the	B-X
Bub1	B-X
kinase	B-X
domain	B-X
and	B-X
Sgo1p	B-X
are	B-X
required	B-X
for	B-X
accurate	B-X
chromosome	B-X
biorientation	B-X
after	B-X
nocodazole	B-X
treatment	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Bub1	B-X
kinase	B-X
and	B-X
Sgo1p	B-X
act	B-X
together	B-X
to	B-X
ensure	B-X
efficient	B-X
biorientation	B-X
of	B-X
sister	B-X
chromatids	B-X
during	B-X
mitosis	B-X
.	B-X

During	O
cell	O
division	O
all	O
chromosomes	O
must	O
be	O
segregated	O
accurately	O
to	O
each	O
daughter	O
cell	O
.	O
<EOS>	B-X
The	B-X
correct	B-X
duplication	B-X
and	B-X
transfer	B-X
of	B-X
genetic	B-X
material	B-X
to	B-X
daughter	B-X
cells	B-X
is	B-X
the	B-X
major	B-X
event	B-X
of	B-X
cell	B-X
division	B-X
.	B-X
However	B-X
,	B-X
how	B-X
cytosolic	B-X
DNA	B-X
sensor	B-X
cGAS	B-X
participates	B-X
in	B-X
guaranteeing	B-X
accurate	B-X
cell	B-X
division	B-X
and	B-X
preventing	B-X
tumorigenesis	B-X
is	B-X
still	B-X
unclear	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
review	B-X
the	B-X
interactions	B-X
between	B-X
cell	B-X
cycle	B-X
regulation	B-X
and	B-X
cGAS/STING	B-X
signaling	B-X
,	B-X
thus	B-X
enabling	B-X
us	B-X
to	B-X
understand	B-X
the	B-X
role	B-X
of	B-X
cGAS/STING	B-X
in	B-X
cancer	B-X
initiation	B-X
,	B-X
development	B-X
,	B-X
and	B-X
treatment	B-X
.	B-X
Cell	B-X
division	B-X
,	B-X
the	B-X
purpose	B-X
of	B-X
which	B-X
is	B-X
to	B-X
enable	B-X
cell	B-X
replication	B-X
,	B-X
and	B-X
in	B-X
particular	B-X
to	B-X
distribute	B-X
complete	B-X
,	B-X
accurate	B-X
copies	B-X
of	B-X
genetic	B-X
material	B-X
to	B-X
daughter	B-X
cells	B-X
,	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
propagation	B-X
of	B-X
life	B-X
.	B-X
At	B-X
a	B-X
morphological	B-X
level	B-X
,	B-X
division	B-X
not	B-X
only	B-X
necessitates	B-X
duplication	B-X
of	B-X
cellular	B-X
structures	B-X
,	B-X
but	B-X
it	B-X
also	B-X
relies	B-X
on	B-X
polar	B-X
segregation	B-X
of	B-X
this	B-X
material	B-X
followed	B-X
by	B-X
physical	B-X
scission	B-X
of	B-X
the	B-X
parent	B-X
cell	B-X
.	B-X
For	B-X
these	B-X
fundamental	B-X
changes	B-X
in	B-X
cell	B-X
shape	B-X
and	B-X
positioning	B-X
to	B-X
be	B-X
achieved	B-X
,	B-X
mechanisms	B-X
are	B-X
required	B-X
to	B-X
link	B-X
the	B-X
cell	B-X
cycle	B-X
to	B-X
the	B-X
modulation	B-X
of	B-X
cytoarchitecture	B-X
.	B-X
Outside	B-X
of	B-X
mitosis	B-X
,	B-X
the	B-X
three	B-X
main	B-X
cytoskeletal	B-X
networks	B-X
not	B-X
only	B-X
endow	B-X
cells	B-X
with	B-X
a	B-X
physical	B-X
cytoplasmic	B-X
skeleton	B-X
,	B-X
but	B-X
they	B-X
also	B-X
provide	B-X
a	B-X
mechanism	B-X
for	B-X
spatio-temporal	B-X
sensing	B-X
via	B-X
integrin-associated	B-X
adhesion	B-X
complexes	B-X
and	B-X
site-directed	B-X
delivery	B-X
of	B-X
cargoes	B-X
.	B-X
An	B-X
economical	B-X
solution	B-X
is	B-X
to	B-X
re-use	B-X
existing	B-X
cytoskeletal	B-X
molecules	B-X
:	B-X
transcellular	B-X
actin	B-X
stress	B-X
fibres	B-X
remodel	B-X
to	B-X
create	B-X
a	B-X
rigid	B-X
cortex	B-X
and	B-X
a	B-X
cytokinetic	B-X
furrow	B-X
,	B-X
while	B-X
unipolar	B-X
radial	B-X
microtubules	B-X
become	B-X
the	B-X
primary	B-X
components	B-X
of	B-X
the	B-X
bipolar	B-X
spindle	B-X
.	B-X
This	B-X
remodelling	B-X
implies	B-X
the	B-X
existence	B-X
of	B-X
specific	B-X
mechanisms	B-X
that	B-X
link	B-X
the	B-X
cell-cycle	B-X
machinery	B-X
to	B-X
the	B-X
control	B-X
of	B-X
adhesion	B-X
and	B-X
the	B-X
cytoskeleton	B-X
.	B-X
In	B-X
this	B-X
article	B-X
,	B-X
we	B-X
review	B-X
the	B-X
intimate	B-X
three-way	B-X
connection	B-X
between	B-X
microenvironmental	B-X
sensing	B-X
,	B-X
adhesion	B-X
signalling	B-X
and	B-X
cell	B-X
proliferation	B-X
,	B-X
particularly	B-X
in	B-X
the	B-X
contexts	B-X
of	B-X
normal	B-X
growth	B-X
control	B-X
and	B-X
aberrant	B-X
tumour	B-X
progression	B-X
.	B-X
As	B-X
the	B-X
morphological	B-X
changes	B-X
that	B-X
occur	B-X
during	B-X
mitosis	B-X
are	B-X
ancient	B-X
,	B-X
the	B-X
mechanisms	B-X
linking	B-X
the	B-X
cell	B-X
cycle	B-X
to	B-X
the	B-X
cytoskeleton/adhesion	B-X
signalling	B-X
network	B-X
are	B-X
likely	B-X
to	B-X
be	B-X
primordial	B-X
in	B-X
nature	B-X
and	B-X
we	B-X
discuss	B-X
recent	B-X
advances	B-X
that	B-X
have	B-X
elucidated	B-X
elements	B-X
of	B-X
this	B-X
link	B-X
.	B-X
A	B-X
particular	B-X
focus	B-X
is	B-X
the	B-X
connection	B-X
between	B-X
CDK1	B-X
and	B-X
cell	B-X
adhesion	B-X
.	B-X

Errors	O
in	O
this	O
process	O
give	O
rise	O
to	O
aneuploidy	O
,	O
which	O
leads	O
to	O
birth	O
defects	O
and	O
is	O
implicated	O
in	O
cancer	O
progression	O
.	O
<EOS>	B-X
Errors	B-X
in	B-X
this	B-X
process	B-X
give	B-X
rise	B-X
to	B-X
aneuploidy	B-X
,	B-X
which	B-X
leads	B-X
to	B-X
birth	B-X
defects	B-X
and	B-X
is	B-X
implicated	B-X
in	B-X
cancer	B-X
progression	B-X
.	B-X
We	B-X
show	B-X
that	B-X
despite	B-X
being	B-X
able	B-X
to	B-X
arrest	B-X
in	B-X
response	B-X
to	B-X
microtubule	B-X
depolymerisation	B-X
and	B-X
kinetochore-microtubule	B-X
attachment	B-X
defects	B-X
,	B-X
bub1DeltaK	B-X
cells	B-X
are	B-X
sensitive	B-X
to	B-X
microtubule	B-X
drugs	B-X
.	B-X

The	O
spindle	O
checkpoint	O
is	O
a	O
surveillance	O
mechanism	O
that	O
ensures	O
high	O
fidelity	O
of	O
chromosome	O
segregation	O
by	O
inhibiting	O
anaphase	O
until	O
all	O
kinetochores	O
have	O
established	O
bipolar	O
attachments	O
to	O
spindle	O
microtubules	O
.	O
<EOS>	B-X
During	B-X
cell	B-X
division	B-X
all	B-X
chromosomes	B-X
must	B-X
be	B-X
segregated	B-X
accurately	B-X
to	B-X
each	B-X
daughter	B-X
cell	B-X
.	B-X
The	B-X
spindle	B-X
checkpoint	B-X
is	B-X
a	B-X
surveillance	B-X
mechanism	B-X
that	B-X
ensures	B-X
high	B-X
fidelity	B-X
of	B-X
chromosome	B-X
segregation	B-X
by	B-X
inhibiting	B-X
anaphase	B-X
until	B-X
all	B-X
kinetochores	B-X
have	B-X
established	B-X
bipolar	B-X
attachments	B-X
to	B-X
spindle	B-X
microtubules	B-X
.	B-X
Bub1	B-X
kinase	B-X
is	B-X
a	B-X
core	B-X
component	B-X
of	B-X
the	B-X
spindle	B-X
checkpoint	B-X
,	B-X
and	B-X
cells	B-X
lacking	B-X
Bub1	B-X
fail	B-X
to	B-X
arrest	B-X
in	B-X
response	B-X
to	B-X
microtubule	B-X
drugs	B-X
and	B-X
precociously	B-X
segregate	B-X
their	B-X
DNA	B-X
.	B-X
The	B-X
mitotic	B-X
role	B-X
(	B-X
s	B-X
)	B-X
of	B-X
Bub1	B-X
kinase	B-X
activity	B-X
remain	B-X
elusive	B-X
,	B-X
and	B-X
it	B-X
is	B-X
controversial	B-X
whether	B-X
this	B-X
C-terminal	B-X
domain	B-X
of	B-X
Bub1p	B-X
is	B-X
required	B-X
for	B-X
spindle	B-X
checkpoint	B-X
arrest	B-X
.	B-X
This	B-X
is	B-X
because	B-X
bub1DeltaK	B-X
cells	B-X
display	B-X
significant	B-X
chromosome	B-X
mis-segregation	B-X
upon	B-X
release	B-X
from	B-X
nocodazole	B-X
arrest	B-X
.	B-X
bub1DeltaK	B-X
cells	B-X
mislocalise	B-X
Sgo1p	B-X
,	B-X
and	B-X
we	B-X
demonstrate	B-X
that	B-X
both	B-X
the	B-X
Bub1	B-X
kinase	B-X
domain	B-X
and	B-X
Sgo1p	B-X
are	B-X
required	B-X
for	B-X
accurate	B-X
chromosome	B-X
biorientation	B-X
after	B-X
nocodazole	B-X
treatment	B-X
.	B-X

Bub1	B-Gene_or_gene_product
kinase	O
is	O
a	O
core	O
component	O
of	O
the	O
spindle	O
checkpoint	O
,	O
and	O
cells	O
lacking	O
Bub1	B-Gene_or_gene_product
fail	O
to	O
arrest	O
in	O
response	O
to	O
microtubule	O
drugs	O
and	O
precociously	O
segregate	O
their	O
DNA	O
.	O
<EOS>	B-X
During	B-X
cell	B-X
division	B-X
all	B-X
chromosomes	B-X
must	B-X
be	B-X
segregated	B-X
accurately	B-X
to	B-X
each	B-X
daughter	B-X
cell	B-X
.	B-X
The	B-X
spindle	B-X
checkpoint	B-X
is	B-X
a	B-X
surveillance	B-X
mechanism	B-X
that	B-X
ensures	B-X
high	B-X
fidelity	B-X
of	B-X
chromosome	B-X
segregation	B-X
by	B-X
inhibiting	B-X
anaphase	B-X
until	B-X
all	B-X
kinetochores	B-X
have	B-X
established	B-X
bipolar	B-X
attachments	B-X
to	B-X
spindle	B-X
microtubules	B-X
.	B-X
Bub1	B-X
kinase	B-X
is	B-X
a	B-X
core	B-X
component	B-X
of	B-X
the	B-X
spindle	B-X
checkpoint	B-X
,	B-X
and	B-X
cells	B-X
lacking	B-X
Bub1	B-X
fail	B-X
to	B-X
arrest	B-X
in	B-X
response	B-X
to	B-X
microtubule	B-X
drugs	B-X
and	B-X
precociously	B-X
segregate	B-X
their	B-X
DNA	B-X
.	B-X
The	B-X
mitotic	B-X
role	B-X
(	B-X
s	B-X
)	B-X
of	B-X
Bub1	B-X
kinase	B-X
activity	B-X
remain	B-X
elusive	B-X
,	B-X
and	B-X
it	B-X
is	B-X
controversial	B-X
whether	B-X
this	B-X
C-terminal	B-X
domain	B-X
of	B-X
Bub1p	B-X
is	B-X
required	B-X
for	B-X
spindle	B-X
checkpoint	B-X
arrest	B-X
.	B-X
Here	B-X
we	B-X
make	B-X
a	B-X
detailed	B-X
analysis	B-X
of	B-X
budding	B-X
yeast	B-X
cells	B-X
lacking	B-X
the	B-X
kinase	B-X
domain	B-X
(	B-X
bub1DeltaK	B-X
)	B-X
.	B-X
We	B-X
show	B-X
that	B-X
despite	B-X
being	B-X
able	B-X
to	B-X
arrest	B-X
in	B-X
response	B-X
to	B-X
microtubule	B-X
depolymerisation	B-X
and	B-X
kinetochore-microtubule	B-X
attachment	B-X
defects	B-X
,	B-X
bub1DeltaK	B-X
cells	B-X
are	B-X
sensitive	B-X
to	B-X
microtubule	B-X
drugs	B-X
.	B-X
This	B-X
is	B-X
because	B-X
bub1DeltaK	B-X
cells	B-X
display	B-X
significant	B-X
chromosome	B-X
mis-segregation	B-X
upon	B-X
release	B-X
from	B-X
nocodazole	B-X
arrest	B-X
.	B-X
bub1DeltaK	B-X
cells	B-X
mislocalise	B-X
Sgo1p	B-X
,	B-X
and	B-X
we	B-X
demonstrate	B-X
that	B-X
both	B-X
the	B-X
Bub1	B-X
kinase	B-X
domain	B-X
and	B-X
Sgo1p	B-X
are	B-X
required	B-X
for	B-X
accurate	B-X
chromosome	B-X
biorientation	B-X
after	B-X
nocodazole	B-X
treatment	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Bub1	B-X
kinase	B-X
and	B-X
Sgo1p	B-X
act	B-X
together	B-X
to	B-X
ensure	B-X
efficient	B-X
biorientation	B-X
of	B-X
sister	B-X
chromatids	B-X
during	B-X
mitosis	B-X
.	B-X

The	O
mitotic	O
role	O
(	O
s	O
)	O
of	O
Bub1	B-Gene_or_gene_product
kinase	O
activity	O
remain	O
elusive	O
,	O
and	O
it	O
is	O
controversial	O
whether	O
this	O
C	O
-	O
terminal	O
domain	O
of	O
Bub1p	B-Gene_or_gene_product
is	O
required	O
for	O
spindle	O
checkpoint	O
arrest	O
.	O

Here	O
we	O
make	O
a	O
detailed	O
analysis	O
of	O
budding	O
yeast	O
cells	O
lacking	O
the	O
kinase	O
domain	O
(	O
bub1DeltaK	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
Bub1	B-X
kinase	B-X
is	B-X
a	B-X
core	B-X
component	B-X
of	B-X
the	B-X
spindle	B-X
checkpoint	B-X
,	B-X
and	B-X
cells	B-X
lacking	B-X
Bub1	B-X
fail	B-X
to	B-X
arrest	B-X
in	B-X
response	B-X
to	B-X
microtubule	B-X
drugs	B-X
and	B-X
precociously	B-X
segregate	B-X
their	B-X
DNA	B-X
.	B-X
The	B-X
mitotic	B-X
role	B-X
(	B-X
s	B-X
)	B-X
of	B-X
Bub1	B-X
kinase	B-X
activity	B-X
remain	B-X
elusive	B-X
,	B-X
and	B-X
it	B-X
is	B-X
controversial	B-X
whether	B-X
this	B-X
C-terminal	B-X
domain	B-X
of	B-X
Bub1p	B-X
is	B-X
required	B-X
for	B-X
spindle	B-X
checkpoint	B-X
arrest	B-X
.	B-X
Here	B-X
we	B-X
make	B-X
a	B-X
detailed	B-X
analysis	B-X
of	B-X
budding	B-X
yeast	B-X
cells	B-X
lacking	B-X
the	B-X
kinase	B-X
domain	B-X
(	B-X
bub1DeltaK	B-X
)	B-X
.	B-X
We	B-X
show	B-X
that	B-X
despite	B-X
being	B-X
able	B-X
to	B-X
arrest	B-X
in	B-X
response	B-X
to	B-X
microtubule	B-X
depolymerisation	B-X
and	B-X
kinetochore-microtubule	B-X
attachment	B-X
defects	B-X
,	B-X
bub1DeltaK	B-X
cells	B-X
are	B-X
sensitive	B-X
to	B-X
microtubule	B-X
drugs	B-X
.	B-X
This	B-X
is	B-X
because	B-X
bub1DeltaK	B-X
cells	B-X
display	B-X
significant	B-X
chromosome	B-X
mis-segregation	B-X
upon	B-X
release	B-X
from	B-X
nocodazole	B-X
arrest	B-X
.	B-X
bub1DeltaK	B-X
cells	B-X
mislocalise	B-X
Sgo1p	B-X
,	B-X
and	B-X
we	B-X
demonstrate	B-X
that	B-X
both	B-X
the	B-X
Bub1	B-X
kinase	B-X
domain	B-X
and	B-X
Sgo1p	B-X
are	B-X
required	B-X
for	B-X
accurate	B-X
chromosome	B-X
biorientation	B-X
after	B-X
nocodazole	B-X
treatment	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Bub1	B-X
kinase	B-X
and	B-X
Sgo1p	B-X
act	B-X
together	B-X
to	B-X
ensure	B-X
efficient	B-X
biorientation	B-X
of	B-X
sister	B-X
chromatids	B-X
during	B-X
mitosis	B-X
.	B-X

We	O
show	O
that	O
despite	O
being	O
able	O
to	O
arrest	O
in	O
response	O
to	O
microtubule	O
depolymerisation	O
and	O
kinetochore	O
-	O
microtubule	O
attachment	O
defects	O
,	O
bub1DeltaK	B-Gene_or_gene_product
cells	O
are	O
sensitive	O
to	O
microtubule	O
drugs	O
.	O
<EOS>	B-X
Errors	B-X
in	B-X
this	B-X
process	B-X
give	B-X
rise	B-X
to	B-X
aneuploidy	B-X
,	B-X
which	B-X
leads	B-X
to	B-X
birth	B-X
defects	B-X
and	B-X
is	B-X
implicated	B-X
in	B-X
cancer	B-X
progression	B-X
.	B-X
The	B-X
spindle	B-X
checkpoint	B-X
is	B-X
a	B-X
surveillance	B-X
mechanism	B-X
that	B-X
ensures	B-X
high	B-X
fidelity	B-X
of	B-X
chromosome	B-X
segregation	B-X
by	B-X
inhibiting	B-X
anaphase	B-X
until	B-X
all	B-X
kinetochores	B-X
have	B-X
established	B-X
bipolar	B-X
attachments	B-X
to	B-X
spindle	B-X
microtubules	B-X
.	B-X
Bub1	B-X
kinase	B-X
is	B-X
a	B-X
core	B-X
component	B-X
of	B-X
the	B-X
spindle	B-X
checkpoint	B-X
,	B-X
and	B-X
cells	B-X
lacking	B-X
Bub1	B-X
fail	B-X
to	B-X
arrest	B-X
in	B-X
response	B-X
to	B-X
microtubule	B-X
drugs	B-X
and	B-X
precociously	B-X
segregate	B-X
their	B-X
DNA	B-X
.	B-X
The	B-X
mitotic	B-X
role	B-X
(	B-X
s	B-X
)	B-X
of	B-X
Bub1	B-X
kinase	B-X
activity	B-X
remain	B-X
elusive	B-X
,	B-X
and	B-X
it	B-X
is	B-X
controversial	B-X
whether	B-X
this	B-X
C-terminal	B-X
domain	B-X
of	B-X
Bub1p	B-X
is	B-X
required	B-X
for	B-X
spindle	B-X
checkpoint	B-X
arrest	B-X
.	B-X
Here	B-X
we	B-X
make	B-X
a	B-X
detailed	B-X
analysis	B-X
of	B-X
budding	B-X
yeast	B-X
cells	B-X
lacking	B-X
the	B-X
kinase	B-X
domain	B-X
(	B-X
bub1DeltaK	B-X
)	B-X
.	B-X
We	B-X
show	B-X
that	B-X
despite	B-X
being	B-X
able	B-X
to	B-X
arrest	B-X
in	B-X
response	B-X
to	B-X
microtubule	B-X
depolymerisation	B-X
and	B-X
kinetochore-microtubule	B-X
attachment	B-X
defects	B-X
,	B-X
bub1DeltaK	B-X
cells	B-X
are	B-X
sensitive	B-X
to	B-X
microtubule	B-X
drugs	B-X
.	B-X
This	B-X
is	B-X
because	B-X
bub1DeltaK	B-X
cells	B-X
display	B-X
significant	B-X
chromosome	B-X
mis-segregation	B-X
upon	B-X
release	B-X
from	B-X
nocodazole	B-X
arrest	B-X
.	B-X
bub1DeltaK	B-X
cells	B-X
mislocalise	B-X
Sgo1p	B-X
,	B-X
and	B-X
we	B-X
demonstrate	B-X
that	B-X
both	B-X
the	B-X
Bub1	B-X
kinase	B-X
domain	B-X
and	B-X
Sgo1p	B-X
are	B-X
required	B-X
for	B-X
accurate	B-X
chromosome	B-X
biorientation	B-X
after	B-X
nocodazole	B-X
treatment	B-X
.	B-X

This	O
is	O
because	O
bub1DeltaK	B-Gene_or_gene_product
cells	O
display	O
significant	O
chromosome	O
mis	O
-	O
segregation	O
upon	O
release	O
from	O
nocodazole	O
arrest	O
.	O
<EOS>	B-X
During	B-X
cell	B-X
division	B-X
all	B-X
chromosomes	B-X
must	B-X
be	B-X
segregated	B-X
accurately	B-X
to	B-X
each	B-X
daughter	B-X
cell	B-X
.	B-X
The	B-X
spindle	B-X
checkpoint	B-X
is	B-X
a	B-X
surveillance	B-X
mechanism	B-X
that	B-X
ensures	B-X
high	B-X
fidelity	B-X
of	B-X
chromosome	B-X
segregation	B-X
by	B-X
inhibiting	B-X
anaphase	B-X
until	B-X
all	B-X
kinetochores	B-X
have	B-X
established	B-X
bipolar	B-X
attachments	B-X
to	B-X
spindle	B-X
microtubules	B-X
.	B-X
Bub1	B-X
kinase	B-X
is	B-X
a	B-X
core	B-X
component	B-X
of	B-X
the	B-X
spindle	B-X
checkpoint	B-X
,	B-X
and	B-X
cells	B-X
lacking	B-X
Bub1	B-X
fail	B-X
to	B-X
arrest	B-X
in	B-X
response	B-X
to	B-X
microtubule	B-X
drugs	B-X
and	B-X
precociously	B-X
segregate	B-X
their	B-X
DNA	B-X
.	B-X
The	B-X
mitotic	B-X
role	B-X
(	B-X
s	B-X
)	B-X
of	B-X
Bub1	B-X
kinase	B-X
activity	B-X
remain	B-X
elusive	B-X
,	B-X
and	B-X
it	B-X
is	B-X
controversial	B-X
whether	B-X
this	B-X
C-terminal	B-X
domain	B-X
of	B-X
Bub1p	B-X
is	B-X
required	B-X
for	B-X
spindle	B-X
checkpoint	B-X
arrest	B-X
.	B-X
Here	B-X
we	B-X
make	B-X
a	B-X
detailed	B-X
analysis	B-X
of	B-X
budding	B-X
yeast	B-X
cells	B-X
lacking	B-X
the	B-X
kinase	B-X
domain	B-X
(	B-X
bub1DeltaK	B-X
)	B-X
.	B-X
We	B-X
show	B-X
that	B-X
despite	B-X
being	B-X
able	B-X
to	B-X
arrest	B-X
in	B-X
response	B-X
to	B-X
microtubule	B-X
depolymerisation	B-X
and	B-X
kinetochore-microtubule	B-X
attachment	B-X
defects	B-X
,	B-X
bub1DeltaK	B-X
cells	B-X
are	B-X
sensitive	B-X
to	B-X
microtubule	B-X
drugs	B-X
.	B-X
This	B-X
is	B-X
because	B-X
bub1DeltaK	B-X
cells	B-X
display	B-X
significant	B-X
chromosome	B-X
mis-segregation	B-X
upon	B-X
release	B-X
from	B-X
nocodazole	B-X
arrest	B-X
.	B-X
bub1DeltaK	B-X
cells	B-X
mislocalise	B-X
Sgo1p	B-X
,	B-X
and	B-X
we	B-X
demonstrate	B-X
that	B-X
both	B-X
the	B-X
Bub1	B-X
kinase	B-X
domain	B-X
and	B-X
Sgo1p	B-X
are	B-X
required	B-X
for	B-X
accurate	B-X
chromosome	B-X
biorientation	B-X
after	B-X
nocodazole	B-X
treatment	B-X
.	B-X

bub1DeltaK	B-Gene_or_gene_product
cells	O
mislocalise	O
Sgo1p	B-Gene_or_gene_product
,	O
and	O
we	O
demonstrate	O
that	O
both	O
the	O
Bub1	B-Gene_or_gene_product
kinase	O
domain	O
and	O
Sgo1p	B-Gene_or_gene_product
are	O
required	O
for	O
accurate	O
chromosome	O
biorientation	O
after	O
nocodazole	O
treatment	O
.	O
<EOS>	B-X
During	B-X
cell	B-X
division	B-X
all	B-X
chromosomes	B-X
must	B-X
be	B-X
segregated	B-X
accurately	B-X
to	B-X
each	B-X
daughter	B-X
cell	B-X
.	B-X
The	B-X
spindle	B-X
checkpoint	B-X
is	B-X
a	B-X
surveillance	B-X
mechanism	B-X
that	B-X
ensures	B-X
high	B-X
fidelity	B-X
of	B-X
chromosome	B-X
segregation	B-X
by	B-X
inhibiting	B-X
anaphase	B-X
until	B-X
all	B-X
kinetochores	B-X
have	B-X
established	B-X
bipolar	B-X
attachments	B-X
to	B-X
spindle	B-X
microtubules	B-X
.	B-X
Bub1	B-X
kinase	B-X
is	B-X
a	B-X
core	B-X
component	B-X
of	B-X
the	B-X
spindle	B-X
checkpoint	B-X
,	B-X
and	B-X
cells	B-X
lacking	B-X
Bub1	B-X
fail	B-X
to	B-X
arrest	B-X
in	B-X
response	B-X
to	B-X
microtubule	B-X
drugs	B-X
and	B-X
precociously	B-X
segregate	B-X
their	B-X
DNA	B-X
.	B-X
The	B-X
mitotic	B-X
role	B-X
(	B-X
s	B-X
)	B-X
of	B-X
Bub1	B-X
kinase	B-X
activity	B-X
remain	B-X
elusive	B-X
,	B-X
and	B-X
it	B-X
is	B-X
controversial	B-X
whether	B-X
this	B-X
C-terminal	B-X
domain	B-X
of	B-X
Bub1p	B-X
is	B-X
required	B-X
for	B-X
spindle	B-X
checkpoint	B-X
arrest	B-X
.	B-X
Here	B-X
we	B-X
make	B-X
a	B-X
detailed	B-X
analysis	B-X
of	B-X
budding	B-X
yeast	B-X
cells	B-X
lacking	B-X
the	B-X
kinase	B-X
domain	B-X
(	B-X
bub1DeltaK	B-X
)	B-X
.	B-X
We	B-X
show	B-X
that	B-X
despite	B-X
being	B-X
able	B-X
to	B-X
arrest	B-X
in	B-X
response	B-X
to	B-X
microtubule	B-X
depolymerisation	B-X
and	B-X
kinetochore-microtubule	B-X
attachment	B-X
defects	B-X
,	B-X
bub1DeltaK	B-X
cells	B-X
are	B-X
sensitive	B-X
to	B-X
microtubule	B-X
drugs	B-X
.	B-X
This	B-X
is	B-X
because	B-X
bub1DeltaK	B-X
cells	B-X
display	B-X
significant	B-X
chromosome	B-X
mis-segregation	B-X
upon	B-X
release	B-X
from	B-X
nocodazole	B-X
arrest	B-X
.	B-X
bub1DeltaK	B-X
cells	B-X
mislocalise	B-X
Sgo1p	B-X
,	B-X
and	B-X
we	B-X
demonstrate	B-X
that	B-X
both	B-X
the	B-X
Bub1	B-X
kinase	B-X
domain	B-X
and	B-X
Sgo1p	B-X
are	B-X
required	B-X
for	B-X
accurate	B-X
chromosome	B-X
biorientation	B-X
after	B-X
nocodazole	B-X
treatment	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Bub1	B-X
kinase	B-X
and	B-X
Sgo1p	B-X
act	B-X
together	B-X
to	B-X
ensure	B-X
efficient	B-X
biorientation	B-X
of	B-X
sister	B-X
chromatids	B-X
during	B-X
mitosis	B-X
.	B-X

We	O
propose	O
that	O
Bub1	B-Gene_or_gene_product
kinase	O
and	O
Sgo1p	B-Gene_or_gene_product
act	O
together	O
to	O
ensure	O
efficient	O
biorientation	O
of	O
sister	O
chromatids	O
during	O
mitosis	O
.	O
<EOS>	B-X
The	B-X
spindle	B-X
checkpoint	B-X
is	B-X
a	B-X
surveillance	B-X
mechanism	B-X
that	B-X
ensures	B-X
high	B-X
fidelity	B-X
of	B-X
chromosome	B-X
segregation	B-X
by	B-X
inhibiting	B-X
anaphase	B-X
until	B-X
all	B-X
kinetochores	B-X
have	B-X
established	B-X
bipolar	B-X
attachments	B-X
to	B-X
spindle	B-X
microtubules	B-X
.	B-X
Bub1	B-X
kinase	B-X
is	B-X
a	B-X
core	B-X
component	B-X
of	B-X
the	B-X
spindle	B-X
checkpoint	B-X
,	B-X
and	B-X
cells	B-X
lacking	B-X
Bub1	B-X
fail	B-X
to	B-X
arrest	B-X
in	B-X
response	B-X
to	B-X
microtubule	B-X
drugs	B-X
and	B-X
precociously	B-X
segregate	B-X
their	B-X
DNA	B-X
.	B-X
The	B-X
mitotic	B-X
role	B-X
(	B-X
s	B-X
)	B-X
of	B-X
Bub1	B-X
kinase	B-X
activity	B-X
remain	B-X
elusive	B-X
,	B-X
and	B-X
it	B-X
is	B-X
controversial	B-X
whether	B-X
this	B-X
C-terminal	B-X
domain	B-X
of	B-X
Bub1p	B-X
is	B-X
required	B-X
for	B-X
spindle	B-X
checkpoint	B-X
arrest	B-X
.	B-X
Here	B-X
we	B-X
make	B-X
a	B-X
detailed	B-X
analysis	B-X
of	B-X
budding	B-X
yeast	B-X
cells	B-X
lacking	B-X
the	B-X
kinase	B-X
domain	B-X
(	B-X
bub1DeltaK	B-X
)	B-X
.	B-X
bub1DeltaK	B-X
cells	B-X
mislocalise	B-X
Sgo1p	B-X
,	B-X
and	B-X
we	B-X
demonstrate	B-X
that	B-X
both	B-X
the	B-X
Bub1	B-X
kinase	B-X
domain	B-X
and	B-X
Sgo1p	B-X
are	B-X
required	B-X
for	B-X
accurate	B-X
chromosome	B-X
biorientation	B-X
after	B-X
nocodazole	B-X
treatment	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
Bub1	B-X
kinase	B-X
and	B-X
Sgo1p	B-X
act	B-X
together	B-X
to	B-X
ensure	B-X
efficient	B-X
biorientation	B-X
of	B-X
sister	B-X
chromatids	B-X
during	B-X
mitosis	B-X
.	B-X

Shugoshin	B-Gene_or_gene_product
promotes	O
sister	O
kinetochore	O
biorientation	O
in	O
Saccharomyces	O
cerevisiae	O
.	O
<EOS>	B-X
During	B-X
meiosis	B-X
this	B-X
protein	B-X
regulates	B-X
the	B-X
removal	B-X
of	B-X
cohesins	B-X
,	B-X
the	B-X
proteins	B-X
that	B-X
hold	B-X
sister	B-X
chromatids	B-X
together	B-X
,	B-X
from	B-X
chromosomes	B-X
.	B-X
During	B-X
mitosis	B-X
,	B-X
Sgo1	B-X
is	B-X
required	B-X
for	B-X
sensing	B-X
the	B-X
absence	B-X
of	B-X
tension	B-X
caused	B-X
by	B-X
sister	B-X
kinetochores	B-X
not	B-X
being	B-X
attached	B-X
to	B-X
microtubules	B-X
emanating	B-X
from	B-X
opposite	B-X
poles	B-X
.	B-X
Here	B-X
we	B-X
describe	B-X
a	B-X
differential	B-X
requirement	B-X
for	B-X
Sgo1	B-X
in	B-X
the	B-X
segregation	B-X
of	B-X
homologous	B-X
chromosomes	B-X
and	B-X
sister	B-X
chromatids	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
Sgo1	B-X
is	B-X
important	B-X
to	B-X
bias	B-X
sister	B-X
kinetochores	B-X
toward	B-X
biorientation	B-X
.	B-X
We	B-X
suggest	B-X
that	B-X
Sgo1	B-X
acts	B-X
at	B-X
sister	B-X
kinetochores	B-X
to	B-X
promote	B-X
their	B-X
biorientation	B-X
.	B-X

Chromosome	O
segregation	O
must	O
be	O
executed	O
accurately	O
during	O
both	O
mitotic	O
and	O
meiotic	O
cell	O
divisions	O
.	O
<EOS>	B-X
The	B-X
execution	B-X
of	B-X
recombinational	B-X
pathways	B-X
during	B-X
the	B-X
repair	B-X
of	B-X
certain	B-X
DNA	B-X
lesions	B-X
or	B-X
in	B-X
the	B-X
meiotic	B-X
program	B-X
is	B-X
associated	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
joint	B-X
molecules	B-X
that	B-X
physically	B-X
hold	B-X
chromosomes	B-X
together	B-X
.	B-X
These	B-X
structures	B-X
must	B-X
be	B-X
disengaged	B-X
prior	B-X
to	B-X
the	B-X
onset	B-X
of	B-X
chromosome	B-X
segregation	B-X
.	B-X
To	B-X
avoid	B-X
this	B-X
situation	B-X
,	B-X
cells	B-X
have	B-X
developed	B-X
an	B-X
arsenal	B-X
of	B-X
molecular	B-X
complexes	B-X
involving	B-X
helicases	B-X
,	B-X
resolvases	B-X
,	B-X
and	B-X
dissolvases	B-X
that	B-X
recognize	B-X
and	B-X
eliminate	B-X
chromosome	B-X
links	B-X
.	B-X
The	B-X
correct	B-X
orchestration	B-X
of	B-X
these	B-X
enzymes	B-X
promotes	B-X
the	B-X
timely	B-X
removal	B-X
of	B-X
chromosomal	B-X
connections	B-X
ensuring	B-X
the	B-X
efficient	B-X
segregation	B-X
of	B-X
the	B-X
genome	B-X
during	B-X
cell	B-X
division	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
focus	B-X
on	B-X
the	B-X
role	B-X
of	B-X
different	B-X
DNA	B-X
processing	B-X
enzymes	B-X
that	B-X
collaborate	B-X
in	B-X
removing	B-X
the	B-X
linkages	B-X
generated	B-X
during	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
homologous	B-X
recombination	B-X
machinery	B-X
as	B-X
a	B-X
consequence	B-X
of	B-X
the	B-X
appearance	B-X
of	B-X
DNA	B-X
breaks	B-X
during	B-X
the	B-X
mitotic	B-X
and	B-X
meiotic	B-X
programs	B-X
.	B-X
We	B-X
will	B-X
also	B-X
discuss	B-X
about	B-X
the	B-X
temporal	B-X
regulation	B-X
of	B-X
these	B-X
factors	B-X
along	B-X
the	B-X
cell	B-X
cycle	B-X
,	B-X
the	B-X
consequences	B-X
of	B-X
their	B-X
loss	B-X
of	B-X
function	B-X
,	B-X
and	B-X
their	B-X
specific	B-X
role	B-X
in	B-X
the	B-X
removal	B-X
of	B-X
chromosomal	B-X
links	B-X
to	B-X
ensure	B-X
the	B-X
accurate	B-X
segregation	B-X
of	B-X
the	B-X
genomic	B-X
material	B-X
during	B-X
cell	B-X
division	B-X
.	B-X

Sgo1	B-Gene_or_gene_product
plays	O
a	O
key	O
role	O
in	O
ensuring	O
faithful	O
chromosome	O
segregation	O
in	O
at	O
least	O
two	O
ways	O
.	O

During	O
meiosis	O
this	O
protein	O
regulates	O
the	O
removal	O
of	O
cohesins	O
,	O
the	O
proteins	O
that	O
hold	O
sister	O
chromatids	O
together	O
,	O
from	O
chromosomes	O
.	O
<EOS>	B-X
During	B-X
meiosis	B-X
,	B-X
cohesins	B-X
--	B-X
protein	B-X
complexes	B-X
that	B-X
hold	B-X
sister	B-X
chromatids	B-X
together	B-X
--	B-X
are	B-X
lost	B-X
from	B-X
chromosomes	B-X
in	B-X
a	B-X
step-wise	B-X
manner	B-X
.	B-X
Loss	B-X
of	B-X
cohesins	B-X
from	B-X
chromosome	B-X
arms	B-X
is	B-X
necessary	B-X
for	B-X
homologous	B-X
chromosomes	B-X
to	B-X
segregate	B-X
during	B-X
meiosis	B-X
I	B-X
.	B-X
Retention	B-X
of	B-X
cohesins	B-X
around	B-X
centromeres	B-X
until	B-X
meiosis	B-X
II	B-X
is	B-X
required	B-X
for	B-X
the	B-X
accurate	B-X
segregation	B-X
of	B-X
sister	B-X
chromatids	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
phosphorylation	B-X
of	B-X
the	B-X
cohesin	B-X
subunit	B-X
Rec8	B-X
contributes	B-X
to	B-X
step-wise	B-X
cohesin	B-X
removal	B-X
.	B-X
Our	B-X
data	B-X
further	B-X
implicate	B-X
two	B-X
other	B-X
key	B-X
regulators	B-X
of	B-X
meiotic	B-X
chromosome	B-X
segregation	B-X
,	B-X
the	B-X
cohesin	B-X
protector	B-X
Sgo1	B-X
and	B-X
meiotic	B-X
recombination	B-X
in	B-X
bringing	B-X
about	B-X
the	B-X
step-wise	B-X
loss	B-X
of	B-X
cohesins	B-X
and	B-X
thus	B-X
the	B-X
establishment	B-X
of	B-X
the	B-X
meiotic	B-X
chromosome	B-X
segregation	B-X
pattern	B-X
.	B-X

During	O
mitosis	O
,	O
Sgo1	B-Gene_or_gene_product
is	O
required	O
for	O
sensing	O
the	O
absence	O
of	O
tension	O
caused	O
by	O
sister	O
kinetochores	O
not	O
being	O
attached	O
to	O
microtubules	O
emanating	O
from	O
opposite	O
poles	O
.	O

Here	O
we	O
describe	O
a	O
differential	O
requirement	O
for	O
Sgo1	B-Gene_or_gene_product
in	O
the	O
segregation	O
of	O
homologous	O
chromosomes	O
and	O
sister	O
chromatids	O
.	O
<EOS>	B-X
Chromosome	B-X
segregation	B-X
must	B-X
be	B-X
executed	B-X
accurately	B-X
during	B-X
both	B-X
mitotic	B-X
and	B-X
meiotic	B-X
cell	B-X
divisions	B-X
.	B-X
Sgo1	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
ensuring	B-X
faithful	B-X
chromosome	B-X
segregation	B-X
in	B-X
at	B-X
least	B-X
two	B-X
ways	B-X
.	B-X
During	B-X
meiosis	B-X
this	B-X
protein	B-X
regulates	B-X
the	B-X
removal	B-X
of	B-X
cohesins	B-X
,	B-X
the	B-X
proteins	B-X
that	B-X
hold	B-X
sister	B-X
chromatids	B-X
together	B-X
,	B-X
from	B-X
chromosomes	B-X
.	B-X
During	B-X
mitosis	B-X
,	B-X
Sgo1	B-X
is	B-X
required	B-X
for	B-X
sensing	B-X
the	B-X
absence	B-X
of	B-X
tension	B-X
caused	B-X
by	B-X
sister	B-X
kinetochores	B-X
not	B-X
being	B-X
attached	B-X
to	B-X
microtubules	B-X
emanating	B-X
from	B-X
opposite	B-X
poles	B-X
.	B-X
Here	B-X
we	B-X
describe	B-X
a	B-X
differential	B-X
requirement	B-X
for	B-X
Sgo1	B-X
in	B-X
the	B-X
segregation	B-X
of	B-X
homologous	B-X
chromosomes	B-X
and	B-X
sister	B-X
chromatids	B-X
.	B-X
Sgo1	B-X
plays	B-X
only	B-X
a	B-X
minor	B-X
role	B-X
in	B-X
segregating	B-X
homologous	B-X
chromosomes	B-X
at	B-X
meiosis	B-X
I	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
Sgo1	B-X
is	B-X
important	B-X
to	B-X
bias	B-X
sister	B-X
kinetochores	B-X
toward	B-X
biorientation	B-X
.	B-X
We	B-X
suggest	B-X
that	B-X
Sgo1	B-X
acts	B-X
at	B-X
sister	B-X
kinetochores	B-X
to	B-X
promote	B-X
their	B-X
biorientation	B-X
.	B-X

Sgo1	B-Gene_or_gene_product
plays	O
only	O
a	O
minor	O
role	O
in	O
segregating	O
homologous	O
chromosomes	O
at	O
meiosis	O
I	O
.	O

In	O
contrast	O
,	O
Sgo1	B-Gene_or_gene_product
is	O
important	O
to	O
bias	O
sister	O
kinetochores	O
toward	O
biorientation	O
.	O
<EOS>	B-X
Sgo1	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
ensuring	B-X
faithful	B-X
chromosome	B-X
segregation	B-X
in	B-X
at	B-X
least	B-X
two	B-X
ways	B-X
.	B-X
During	B-X
meiosis	B-X
this	B-X
protein	B-X
regulates	B-X
the	B-X
removal	B-X
of	B-X
cohesins	B-X
,	B-X
the	B-X
proteins	B-X
that	B-X
hold	B-X
sister	B-X
chromatids	B-X
together	B-X
,	B-X
from	B-X
chromosomes	B-X
.	B-X
During	B-X
mitosis	B-X
,	B-X
Sgo1	B-X
is	B-X
required	B-X
for	B-X
sensing	B-X
the	B-X
absence	B-X
of	B-X
tension	B-X
caused	B-X
by	B-X
sister	B-X
kinetochores	B-X
not	B-X
being	B-X
attached	B-X
to	B-X
microtubules	B-X
emanating	B-X
from	B-X
opposite	B-X
poles	B-X
.	B-X
Here	B-X
we	B-X
describe	B-X
a	B-X
differential	B-X
requirement	B-X
for	B-X
Sgo1	B-X
in	B-X
the	B-X
segregation	B-X
of	B-X
homologous	B-X
chromosomes	B-X
and	B-X
sister	B-X
chromatids	B-X
.	B-X
Sgo1	B-X
plays	B-X
only	B-X
a	B-X
minor	B-X
role	B-X
in	B-X
segregating	B-X
homologous	B-X
chromosomes	B-X
at	B-X
meiosis	B-X
I	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
Sgo1	B-X
is	B-X
important	B-X
to	B-X
bias	B-X
sister	B-X
kinetochores	B-X
toward	B-X
biorientation	B-X
.	B-X
We	B-X
suggest	B-X
that	B-X
Sgo1	B-X
acts	B-X
at	B-X
sister	B-X
kinetochores	B-X
to	B-X
promote	B-X
their	B-X
biorientation	B-X
.	B-X

We	O
suggest	O
that	O
Sgo1	B-Gene_or_gene_product
acts	O
at	O
sister	O
kinetochores	O
to	O
promote	O
their	O
biorientation	O
.	O
<EOS>	B-X
Sgo1	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
ensuring	B-X
faithful	B-X
chromosome	B-X
segregation	B-X
in	B-X
at	B-X
least	B-X
two	B-X
ways	B-X
.	B-X
During	B-X
meiosis	B-X
this	B-X
protein	B-X
regulates	B-X
the	B-X
removal	B-X
of	B-X
cohesins	B-X
,	B-X
the	B-X
proteins	B-X
that	B-X
hold	B-X
sister	B-X
chromatids	B-X
together	B-X
,	B-X
from	B-X
chromosomes	B-X
.	B-X
During	B-X
mitosis	B-X
,	B-X
Sgo1	B-X
is	B-X
required	B-X
for	B-X
sensing	B-X
the	B-X
absence	B-X
of	B-X
tension	B-X
caused	B-X
by	B-X
sister	B-X
kinetochores	B-X
not	B-X
being	B-X
attached	B-X
to	B-X
microtubules	B-X
emanating	B-X
from	B-X
opposite	B-X
poles	B-X
.	B-X
Here	B-X
we	B-X
describe	B-X
a	B-X
differential	B-X
requirement	B-X
for	B-X
Sgo1	B-X
in	B-X
the	B-X
segregation	B-X
of	B-X
homologous	B-X
chromosomes	B-X
and	B-X
sister	B-X
chromatids	B-X
.	B-X
Sgo1	B-X
plays	B-X
only	B-X
a	B-X
minor	B-X
role	B-X
in	B-X
segregating	B-X
homologous	B-X
chromosomes	B-X
at	B-X
meiosis	B-X
I	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
Sgo1	B-X
is	B-X
important	B-X
to	B-X
bias	B-X
sister	B-X
kinetochores	B-X
toward	B-X
biorientation	B-X
.	B-X
We	B-X
suggest	B-X
that	B-X
Sgo1	B-X
acts	B-X
at	B-X
sister	B-X
kinetochores	B-X
to	B-X
promote	B-X
their	B-X
biorientation	B-X
.	B-X

Suppressive	O
effects	O
of	O
flavonoid	O
fisetin	O
on	O
lipopolysaccharide	O
-	O
induced	O
microglial	O
activation	O
and	O
neurotoxicity	O
.	O
<EOS>	B-X
Activated	B-X
microglia	B-X
can	B-X
produce	B-X
various	B-X
proinflammatory	B-X
cytokines	B-X
and	B-X
nitric	B-X
oxide	B-X
(	B-X
NO	B-X
)	B-X
,	B-X
which	B-X
may	B-X
exert	B-X
neurotoxic	B-X
effects	B-X
.	B-X
Inhibition	B-X
of	B-X
microglia	B-X
activation	B-X
may	B-X
alleviate	B-X
neurodegeneration	B-X
under	B-X
these	B-X
conditions	B-X
.	B-X
To	B-X
search	B-X
for	B-X
the	B-X
novel	B-X
therapeutic	B-X
agents	B-X
against	B-X
neuroinflammatory	B-X
diseases	B-X
,	B-X
we	B-X
have	B-X
screened	B-X
a	B-X
series	B-X
of	B-X
flavonoid	B-X
compounds	B-X
using	B-X
a	B-X
cell-based	B-X
assay	B-X
.	B-X
Our	B-X
studies	B-X
showed	B-X
that	B-X
fisetin	B-X
markedly	B-X
suppressed	B-X
the	B-X
production	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-alpha	B-X
,	B-X
NO	B-X
,	B-X
and	B-X
prostaglandin	B-X
(	B-X
PG	B-X
)	B-X
E2	B-X
in	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-stimulated	B-X
BV-2	B-X
microglia	B-X
cells	B-X
or	B-X
primary	B-X
microglia	B-X
cultures	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
fisetin	B-X
reduced	B-X
cytotoxicity	B-X
of	B-X
LPS-stimulated	B-X
microglia	B-X
toward	B-X
B35	B-X
neuroblastoma	B-X
cells	B-X
in	B-X
a	B-X
co-culture	B-X
system	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
fisetin	B-X
has	B-X
a	B-X
strong	B-X
anti-inflammatory	B-X
activity	B-X
in	B-X
brain	B-X
microglia	B-X
,	B-X
and	B-X
could	B-X
be	B-X
a	B-X
potential	B-X
therapeutic	B-X
agent	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
neuroinflammatory	B-X
diseases	B-X
.	B-X

Microglia	O
are	O
innate	O
immune	O
cells	O
in	O
the	O
central	O
nervous	O
system	O
.	O
<EOS>	B-X
The	B-X
post-stroke	B-X
immune	B-X
response	B-X
has	B-X
recently	B-X
emerged	B-X
as	B-X
a	B-X
new	B-X
breakthrough	B-X
target	B-X
in	B-X
the	B-X
treatment	B-X
strategy	B-X
for	B-X
ischemic	B-X
stroke	B-X
.	B-X
Glial	B-X
cells	B-X
,	B-X
including	B-X
microglia	B-X
,	B-X
astrocytes	B-X
,	B-X
and	B-X
oligodendrocytes	B-X
,	B-X
are	B-X
the	B-X
primary	B-X
components	B-X
of	B-X
the	B-X
peri-infarct	B-X
environment	B-X
in	B-X
the	B-X
central	B-X
nervous	B-X
system	B-X
(	B-X
CNS	B-X
)	B-X
and	B-X
have	B-X
been	B-X
implicated	B-X
in	B-X
post-stroke	B-X
immune	B-X
regulation	B-X
.	B-X
However	B-X
,	B-X
increasing	B-X
evidence	B-X
suggests	B-X
that	B-X
glial	B-X
cells	B-X
exert	B-X
beneficial	B-X
and	B-X
detrimental	B-X
effects	B-X
during	B-X
ischemic	B-X
stroke	B-X
.	B-X
Microglia	B-X
,	B-X
which	B-X
survey	B-X
CNS	B-X
homeostasis	B-X
and	B-X
regulate	B-X
innate	B-X
immune	B-X
responses	B-X
,	B-X
are	B-X
rapidly	B-X
activated	B-X
after	B-X
ischemic	B-X
stroke	B-X
.	B-X
Myelin-associated	B-X
antigens	B-X
released	B-X
from	B-X
oligodendrocytes	B-X
activate	B-X
peripheral	B-X
T	B-X
cells	B-X
,	B-X
thereby	B-X
resulting	B-X
in	B-X
the	B-X
autoimmune	B-X
response	B-X
.	B-X
Oligodendrocyte	B-X
precursor	B-X
cells	B-X
,	B-X
which	B-X
can	B-X
differentiate	B-X
into	B-X
oligodendrocytes	B-X
,	B-X
follow	B-X
an	B-X
ischemic	B-X
stroke	B-X
and	B-X
may	B-X
result	B-X
in	B-X
functional	B-X
recovery	B-X
.	B-X
Herein	B-X
,	B-X
we	B-X
discuss	B-X
the	B-X
mechanisms	B-X
of	B-X
post-stroke	B-X
immune	B-X
regulation	B-X
mediated	B-X
by	B-X
glial	B-X
cells	B-X
and	B-X
the	B-X
interaction	B-X
between	B-X
glial	B-X
cells	B-X
and	B-X
neurons	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
describe	B-X
the	B-X
potential	B-X
roles	B-X
of	B-X
various	B-X
glial	B-X
cells	B-X
at	B-X
different	B-X
stages	B-X
of	B-X
ischemic	B-X
stroke	B-X
and	B-X
discuss	B-X
future	B-X
intervention	B-X
targets	B-X
.	B-X

Activation	O
of	O
microglia	O
plays	O
an	O
important	O
role	O
in	O
the	O
processes	O
of	O
several	O
neurodegenerative	O
diseases	O
including	O
Alzheimer	O
'	O
s	O
disease	O
,	O
Parkinson	O
'	O
s	O
disease	O
,	O
and	O
HIV	O
dementia	O
.	O
<EOS>	B-X
Activation	B-X
of	B-X
microglia	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
processes	B-X
of	B-X
several	B-X
neurodegenerative	B-X
diseases	B-X
including	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
,	B-X
and	B-X
HIV	B-X
dementia	B-X
.	B-X
Activated	B-X
microglia	B-X
can	B-X
produce	B-X
various	B-X
proinflammatory	B-X
cytokines	B-X
and	B-X
nitric	B-X
oxide	B-X
(	B-X
NO	B-X
)	B-X
,	B-X
which	B-X
may	B-X
exert	B-X
neurotoxic	B-X
effects	B-X
.	B-X
Inhibition	B-X
of	B-X
microglia	B-X
activation	B-X
may	B-X
alleviate	B-X
neurodegeneration	B-X
under	B-X
these	B-X
conditions	B-X
.	B-X
To	B-X
search	B-X
for	B-X
the	B-X
novel	B-X
therapeutic	B-X
agents	B-X
against	B-X
neuroinflammatory	B-X
diseases	B-X
,	B-X
we	B-X
have	B-X
screened	B-X
a	B-X
series	B-X
of	B-X
flavonoid	B-X
compounds	B-X
using	B-X
a	B-X
cell-based	B-X
assay	B-X
.	B-X
Our	B-X
studies	B-X
showed	B-X
that	B-X
fisetin	B-X
markedly	B-X
suppressed	B-X
the	B-X
production	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-alpha	B-X
,	B-X
NO	B-X
,	B-X
and	B-X
prostaglandin	B-X
(	B-X
PG	B-X
)	B-X
E2	B-X
in	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-stimulated	B-X
BV-2	B-X
microglia	B-X
cells	B-X
or	B-X
primary	B-X
microglia	B-X
cultures	B-X
.	B-X
Fisetin	B-X
significantly	B-X
suppressed	B-X
I	B-X
kappa	B-X
B	B-X
degradation	B-X
,	B-X
nuclear	B-X
translocation	B-X
of	B-X
NF-kappa	B-X
B	B-X
,	B-X
and	B-X
phosphorylation	B-X
of	B-X
p38	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPKs	B-X
)	B-X
in	B-X
the	B-X
LPS-stimulated	B-X
BV-2	B-X
microglia	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
fisetin	B-X
reduced	B-X
cytotoxicity	B-X
of	B-X
LPS-stimulated	B-X
microglia	B-X
toward	B-X
B35	B-X
neuroblastoma	B-X
cells	B-X
in	B-X
a	B-X
co-culture	B-X
system	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
fisetin	B-X
has	B-X
a	B-X
strong	B-X
anti-inflammatory	B-X
activity	B-X
in	B-X
brain	B-X
microglia	B-X
,	B-X
and	B-X
could	B-X
be	B-X
a	B-X
potential	B-X
therapeutic	B-X
agent	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
neuroinflammatory	B-X
diseases	B-X
.	B-X

Activated	O
microglia	O
can	O
produce	O
various	O
proinflammatory	O
cytokines	O
and	O
nitric	O
oxide	O
(	O
NO	O
)	O
,	O
which	O
may	O
exert	O
neurotoxic	O
effects	O
.	O
<EOS>	B-X
The	B-X
blood-brain	B-X
barrier	B-X
acts	B-X
as	B-X
a	B-X
highly	B-X
regulated	B-X
interface	B-X
;	B-X
its	B-X
dysfunction	B-X
may	B-X
exacerbate	B-X
,	B-X
and	B-X
perhaps	B-X
initiate	B-X
,	B-X
neurological	B-X
and	B-X
neuropsychiatric	B-X
disorders	B-X
.	B-X
Depending	B-X
on	B-X
the	B-X
magnitude	B-X
of	B-X
microglial	B-X
reaction	B-X
,	B-X
on	B-X
the	B-X
type	B-X
of	B-X
stimulus	B-X
and	B-X
on	B-X
the	B-X
concurrence	B-X
of	B-X
other	B-X
local	B-X
factors	B-X
,	B-X
microglia	B-X
can	B-X
contribute	B-X
to	B-X
host	B-X
defence	B-X
and	B-X
repair	B-X
,	B-X
or	B-X
to	B-X
the	B-X
establishment	B-X
and	B-X
maintenance	B-X
of	B-X
brain	B-X
damage	B-X
.	B-X
Many	B-X
of	B-X
the	B-X
effects	B-X
of	B-X
microglial	B-X
cells	B-X
can	B-X
be	B-X
ascribed	B-X
to	B-X
the	B-X
numerous	B-X
substances	B-X
that	B-X
these	B-X
cells	B-X
can	B-X
synthesize	B-X
and	B-X
release	B-X
in	B-X
response	B-X
to	B-X
a	B-X
variety	B-X
of	B-X
stimuli	B-X
(	B-X
cytokines	B-X
,	B-X
pro-inflammatory	B-X
substances	B-X
,	B-X
neurotransmitters	B-X
,	B-X
toxins	B-X
,	B-X
etc.	B-X
)	B-X
.	B-X
The	B-X
present	B-X
article	B-X
deals	B-X
with	B-X
two	B-X
classes	B-X
of	B-X
compounds	B-X
that	B-X
activated	B-X
microglial	B-X
cells	B-X
can	B-X
produce	B-X
in	B-X
large	B-X
amounts	B-X
:	B-X
prostanoids	B-X
(	B-X
that	B-X
derive	B-X
from	B-X
arachidonic	B-X
acid	B-X
through	B-X
the	B-X
cyclooxygenase	B-X
pathway	B-X
)	B-X
,	B-X
and	B-X
nitric	B-X
oxide	B-X
(	B-X
that	B-X
is	B-X
synthesized	B-X
from	B-X
arginine	B-X
by	B-X
nitric	B-X
oxide	B-X
synthase	B-X
)	B-X
.	B-X
Prostanoids	B-X
and	B-X
nitric	B-X
oxide	B-X
have	B-X
a	B-X
number	B-X
of	B-X
common	B-X
targets	B-X
,	B-X
on	B-X
which	B-X
they	B-X
may	B-X
exert	B-X
similar	B-X
or	B-X
opposite	B-X
actions	B-X
,	B-X
and	B-X
have	B-X
a	B-X
crucial	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
inflammation	B-X
,	B-X
immune	B-X
responses	B-X
and	B-X
cell	B-X
viability	B-X
.	B-X
Their	B-X
synthesis	B-X
can	B-X
massively	B-X
increase	B-X
when	B-X
the	B-X
inducible	B-X
isoforms	B-X
of	B-X
cyclooxygenase	B-X
and	B-X
nitric	B-X
oxide	B-X
synthase	B-X
are	B-X
expressed	B-X
.	B-X
The	B-X
metabolic	B-X
pathways	B-X
of	B-X
prostanoids	B-X
and	B-X
nitric	B-X
oxide	B-X
are	B-X
finely	B-X
tuned	B-X
by	B-X
the	B-X
respective	B-X
end-products	B-X
,	B-X
by	B-X
cyclic	B-X
AMP	B-X
and	B-X
by	B-X
a	B-X
number	B-X
of	B-X
exogenous	B-X
factors	B-X
,	B-X
such	B-X
as	B-X
cytokines	B-X
,	B-X
glucocorticoids	B-X
,	B-X
lipocortin-1	B-X
and	B-X
others	B-X
.	B-X
transforming	B-X
growth	B-X
factor-beta	B-X
1	B-X
,	B-X
interleukin-10	B-X
,	B-X
lipocortin-1	B-X
)	B-X
may	B-X
be	B-X
secreted	B-X
by	B-X
microglial	B-X
cells	B-X
themselves	B-X
,	B-X
and	B-X
act	B-X
in	B-X
an	B-X
autocrine-paracrine	B-X
way	B-X
.	B-X
In	B-X
view	B-X
of	B-X
the	B-X
neuroprotective	B-X
role	B-X
attributed	B-X
to	B-X
some	B-X
prostaglandins	B-X
and	B-X
to	B-X
the	B-X
cytotoxicity	B-X
of	B-X
excessive	B-X
levels	B-X
of	B-X
nitric	B-X
oxide	B-X
or	B-X
its	B-X
derivatives	B-X
,	B-X
the	B-X
balance	B-X
between	B-X
prostanoid	B-X
and	B-X
nitric	B-X
oxide	B-X
levels	B-X
may	B-X
be	B-X
crucial	B-X
for	B-X
orienting	B-X
microglial	B-X
reactions	B-X
towards	B-X
neuroprotection	B-X
or	B-X
neurotoxicity	B-X
.	B-X

Inhibition	O
of	O
microglia	O
activation	O
may	O
alleviate	O
neurodegeneration	O
under	O
these	O
conditions	O
.	O
<EOS>	B-X
Glial	B-X
activation	B-X
and	B-X
neuroinflammatory	B-X
processes	B-X
play	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
neurodegenerative	B-X
diseases	B-X
such	B-X
as	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
,	B-X
and	B-X
HIV	B-X
dementia	B-X
.	B-X
Activated	B-X
glial	B-X
cells	B-X
can	B-X
secrete	B-X
various	B-X
proinflammatory	B-X
cytokines	B-X
and	B-X
neurotoxic	B-X
mediators	B-X
,	B-X
which	B-X
may	B-X
contribute	B-X
to	B-X
neuronal	B-X
cell	B-X
death	B-X
.	B-X
Inhibition	B-X
of	B-X
glial	B-X
activation	B-X
may	B-X
alleviate	B-X
neurodegeneration	B-X
under	B-X
these	B-X
conditions	B-X
.	B-X
The	B-X
results	B-X
showed	B-X
that	B-X
clomipramine	B-X
and	B-X
imipramine	B-X
significantly	B-X
decreased	B-X
the	B-X
production	B-X
of	B-X
nitric	B-X
oxide	B-X
or	B-X
tumor	B-X
necrosis	B-X
factor-alpha	B-X
(	B-X
TNF-alpha	B-X
)	B-X
in	B-X
microglia	B-X
and	B-X
astrocyte	B-X
cultures	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
clomipramine	B-X
and	B-X
imipramine	B-X
inhibited	B-X
IkappaB	B-X
degradation	B-X
,	B-X
nuclear	B-X
translocation	B-X
of	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-kappaB	B-X
,	B-X
and	B-X
phosphorylation	B-X
of	B-X
p38	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
in	B-X
the	B-X
lipopolysaccharide-stimulated	B-X
microglia	B-X
cells	B-X
.	B-X
Moreover	B-X
,	B-X
clomipramine	B-X
and	B-X
imipramine	B-X
were	B-X
neuroprotective	B-X
as	B-X
the	B-X
drugs	B-X
reduced	B-X
microglia-mediated	B-X
neuroblastoma	B-X
cell	B-X
death	B-X
in	B-X
a	B-X
microglia/neuron	B-X
co-culture	B-X
.	B-X
Therefore	B-X
,	B-X
these	B-X
results	B-X
imply	B-X
that	B-X
clomipramine	B-X
and	B-X
imipramine	B-X
have	B-X
antiinflammatory	B-X
and	B-X
neuroprotective	B-X
effects	B-X
in	B-X
the	B-X
central	B-X
nervous	B-X
system	B-X
by	B-X
modulating	B-X
glial	B-X
activation	B-X
.	B-X

To	O
search	O
for	O
the	O
novel	O
therapeutic	O
agents	O
against	O
neuroinflammatory	O
diseases	O
,	O
we	O
have	O
screened	O
a	O
series	O
of	O
flavonoid	O
compounds	O
using	O
a	O
cell	O
-	O
based	O
assay	O
.	O
<EOS>	B-X
Microglia	B-X
are	B-X
innate	B-X
immune	B-X
cells	B-X
in	B-X
the	B-X
central	B-X
nervous	B-X
system	B-X
.	B-X
Activation	B-X
of	B-X
microglia	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
processes	B-X
of	B-X
several	B-X
neurodegenerative	B-X
diseases	B-X
including	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
,	B-X
and	B-X
HIV	B-X
dementia	B-X
.	B-X
To	B-X
search	B-X
for	B-X
the	B-X
novel	B-X
therapeutic	B-X
agents	B-X
against	B-X
neuroinflammatory	B-X
diseases	B-X
,	B-X
we	B-X
have	B-X
screened	B-X
a	B-X
series	B-X
of	B-X
flavonoid	B-X
compounds	B-X
using	B-X
a	B-X
cell-based	B-X
assay	B-X
.	B-X
Our	B-X
studies	B-X
showed	B-X
that	B-X
fisetin	B-X
markedly	B-X
suppressed	B-X
the	B-X
production	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-alpha	B-X
,	B-X
NO	B-X
,	B-X
and	B-X
prostaglandin	B-X
(	B-X
PG	B-X
)	B-X
E2	B-X
in	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-stimulated	B-X
BV-2	B-X
microglia	B-X
cells	B-X
or	B-X
primary	B-X
microglia	B-X
cultures	B-X
.	B-X
Fisetin	B-X
significantly	B-X
suppressed	B-X
I	B-X
kappa	B-X
B	B-X
degradation	B-X
,	B-X
nuclear	B-X
translocation	B-X
of	B-X
NF-kappa	B-X
B	B-X
,	B-X
and	B-X
phosphorylation	B-X
of	B-X
p38	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPKs	B-X
)	B-X
in	B-X
the	B-X
LPS-stimulated	B-X
BV-2	B-X
microglia	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
fisetin	B-X
reduced	B-X
cytotoxicity	B-X
of	B-X
LPS-stimulated	B-X
microglia	B-X
toward	B-X
B35	B-X
neuroblastoma	B-X
cells	B-X
in	B-X
a	B-X
co-culture	B-X
system	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
fisetin	B-X
has	B-X
a	B-X
strong	B-X
anti-inflammatory	B-X
activity	B-X
in	B-X
brain	B-X
microglia	B-X
,	B-X
and	B-X
could	B-X
be	B-X
a	B-X
potential	B-X
therapeutic	B-X
agent	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
neuroinflammatory	B-X
diseases	B-X
.	B-X

Our	O
studies	O
showed	O
that	O
fisetin	O
markedly	O
suppressed	O
the	O
production	O
of	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	I-Gene_or_gene_product
TNF	I-Gene_or_gene_product
)	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
,	O
NO	O
,	O
and	O
prostaglandin	O
(	O
PG	O
)	O
E2	O
in	O
lipopolysaccharide	O
(	O
LPS	O
)	O
-	O
stimulated	O
BV	O
-	O
2	O
microglia	O
cells	O
or	O
primary	O
microglia	O
cultures	O
.	O
<EOS>	B-X
Interactions	B-X
between	B-X
neurons	B-X
,	B-X
astrocytes	B-X
,	B-X
and	B-X
microglia	B-X
critically	B-X
influence	B-X
neuroinflammatory	B-X
responses	B-X
to	B-X
insult	B-X
in	B-X
the	B-X
central	B-X
nervous	B-X
system	B-X
.	B-X
In	B-X
vitro	B-X
astrocyte	B-X
and	B-X
microglia	B-X
cultures	B-X
are	B-X
powerful	B-X
tools	B-X
to	B-X
study	B-X
specific	B-X
molecular	B-X
pathways	B-X
involved	B-X
in	B-X
neuroinflammation	B-X
;	B-X
however	B-X
,	B-X
in	B-X
order	B-X
to	B-X
better	B-X
understand	B-X
the	B-X
influence	B-X
of	B-X
cellular	B-X
crosstalk	B-X
on	B-X
neuroinflammation	B-X
,	B-X
new	B-X
multicellular	B-X
culture	B-X
models	B-X
are	B-X
required	B-X
.	B-X
Microglia	B-X
represent	B-X
5-10	B-X
%	B-X
of	B-X
cells	B-X
in	B-X
the	B-X
central	B-X
nervous	B-X
system	B-X
and	B-X
contribute	B-X
to	B-X
the	B-X
development	B-X
,	B-X
homeostasis	B-X
,	B-X
injury	B-X
,	B-X
and	B-X
repair	B-X
of	B-X
neural	B-X
tissues	B-X
.	B-X
As	B-X
the	B-X
tissue-resident	B-X
macrophages	B-X
of	B-X
the	B-X
central	B-X
nervous	B-X
system	B-X
,	B-X
microglia	B-X
execute	B-X
core	B-X
innate	B-X
immune	B-X
functions	B-X
such	B-X
as	B-X
detection	B-X
of	B-X
pathogens/damage	B-X
,	B-X
cytokine	B-X
secretion	B-X
,	B-X
and	B-X
phagocytosis	B-X
.	B-X
However	B-X
,	B-X
additional	B-X
properties	B-X
that	B-X
are	B-X
specific	B-X
to	B-X
microglia	B-X
and	B-X
their	B-X
neural	B-X
environment	B-X
are	B-X
beginning	B-X
to	B-X
be	B-X
appreciated	B-X
.	B-X
This	B-X
article	B-X
describes	B-X
approaches	B-X
for	B-X
purification	B-X
of	B-X
microglia	B-X
by	B-X
fluorescence-activated	B-X
cell	B-X
sorting	B-X
using	B-X
microglia-specific	B-X
surface	B-X
markers	B-X
and	B-X
for	B-X
enrichment	B-X
of	B-X
microglia	B-X
by	B-X
magnetic	B-X
sorting	B-X
and	B-X
immunopanning	B-X
.	B-X
Detailed	B-X
information	B-X
about	B-X
culturing	B-X
primary	B-X
microglia	B-X
at	B-X
various	B-X
developmental	B-X
stages	B-X
is	B-X
also	B-X
provided	B-X
.	B-X
Throughout	B-X
,	B-X
we	B-X
focus	B-X
on	B-X
special	B-X
considerations	B-X
for	B-X
handling	B-X
microglia	B-X
and	B-X
compare	B-X
the	B-X
relative	B-X
strengths	B-X
or	B-X
disadvantages	B-X
of	B-X
different	B-X
protocols	B-X
.	B-X
©	B-X
2018	B-X
by	B-X
John	B-X
Wiley	B-X
&	B-X
Sons	B-X
,	B-X
Inc	B-X
.	B-X

Fisetin	O
also	O
inhibited	O
the	O
gene	O
expression	O
of	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
,	O
interleukin	B-Gene_or_gene_product
(	I-Gene_or_gene_product
IL	I-Gene_or_gene_product
)	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
,	O
cyclooxygenase	B-Gene_or_gene_product
(	O
COX	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
)	O
and	O
inducible	O
nitric	B-Gene_or_gene_product
oxide	I-Gene_or_gene_product
synthase	I-Gene_or_gene_product
(	O
iNOS	B-Gene_or_gene_product
)	O
at	O
both	O
mRNA	O
and	O
protein	O
levels	O
.	O
<EOS>	B-X
Activation	B-X
of	B-X
microglia	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
processes	B-X
of	B-X
several	B-X
neurodegenerative	B-X
diseases	B-X
including	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
,	B-X
and	B-X
HIV	B-X
dementia	B-X
.	B-X
Activated	B-X
microglia	B-X
can	B-X
produce	B-X
various	B-X
proinflammatory	B-X
cytokines	B-X
and	B-X
nitric	B-X
oxide	B-X
(	B-X
NO	B-X
)	B-X
,	B-X
which	B-X
may	B-X
exert	B-X
neurotoxic	B-X
effects	B-X
.	B-X
Inhibition	B-X
of	B-X
microglia	B-X
activation	B-X
may	B-X
alleviate	B-X
neurodegeneration	B-X
under	B-X
these	B-X
conditions	B-X
.	B-X
Our	B-X
studies	B-X
showed	B-X
that	B-X
fisetin	B-X
markedly	B-X
suppressed	B-X
the	B-X
production	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-alpha	B-X
,	B-X
NO	B-X
,	B-X
and	B-X
prostaglandin	B-X
(	B-X
PG	B-X
)	B-X
E2	B-X
in	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-stimulated	B-X
BV-2	B-X
microglia	B-X
cells	B-X
or	B-X
primary	B-X
microglia	B-X
cultures	B-X
.	B-X
Fisetin	B-X
also	B-X
inhibited	B-X
the	B-X
gene	B-X
expression	B-X
of	B-X
TNF-alpha	B-X
,	B-X
interleukin	B-X
(	B-X
IL	B-X
)	B-X
-1	B-X
beta	B-X
,	B-X
cyclooxygenase	B-X
(	B-X
COX-2	B-X
)	B-X
and	B-X
inducible	B-X
nitric	B-X
oxide	B-X
synthase	B-X
(	B-X
iNOS	B-X
)	B-X
at	B-X
both	B-X
mRNA	B-X
and	B-X
protein	B-X
levels	B-X
.	B-X
Fisetin	B-X
significantly	B-X
suppressed	B-X
I	B-X
kappa	B-X
B	B-X
degradation	B-X
,	B-X
nuclear	B-X
translocation	B-X
of	B-X
NF-kappa	B-X
B	B-X
,	B-X
and	B-X
phosphorylation	B-X
of	B-X
p38	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPKs	B-X
)	B-X
in	B-X
the	B-X
LPS-stimulated	B-X
BV-2	B-X
microglia	B-X
cells	B-X
.	B-X

Fisetin	O
significantly	O
suppressed	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
degradation	O
,	O
nuclear	O
translocation	O
of	O
NF	O
-	O
kappa	O
B	O
,	O
and	O
phosphorylation	O
of	O
p38	B-Gene_or_gene_product
mitogen	I-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
MAPKs	B-Gene_or_gene_product
)	O
in	O
the	O
LPS	O
-	O
stimulated	O
BV	O
-	O
2	O
microglia	O
cells	O
.	O
<EOS>	B-X
Microglia	B-X
are	B-X
innate	B-X
immune	B-X
cells	B-X
in	B-X
the	B-X
central	B-X
nervous	B-X
system	B-X
.	B-X
Activation	B-X
of	B-X
microglia	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
processes	B-X
of	B-X
several	B-X
neurodegenerative	B-X
diseases	B-X
including	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
,	B-X
and	B-X
HIV	B-X
dementia	B-X
.	B-X
Activated	B-X
microglia	B-X
can	B-X
produce	B-X
various	B-X
proinflammatory	B-X
cytokines	B-X
and	B-X
nitric	B-X
oxide	B-X
(	B-X
NO	B-X
)	B-X
,	B-X
which	B-X
may	B-X
exert	B-X
neurotoxic	B-X
effects	B-X
.	B-X
Inhibition	B-X
of	B-X
microglia	B-X
activation	B-X
may	B-X
alleviate	B-X
neurodegeneration	B-X
under	B-X
these	B-X
conditions	B-X
.	B-X
Our	B-X
studies	B-X
showed	B-X
that	B-X
fisetin	B-X
markedly	B-X
suppressed	B-X
the	B-X
production	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-alpha	B-X
,	B-X
NO	B-X
,	B-X
and	B-X
prostaglandin	B-X
(	B-X
PG	B-X
)	B-X
E2	B-X
in	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-stimulated	B-X
BV-2	B-X
microglia	B-X
cells	B-X
or	B-X
primary	B-X
microglia	B-X
cultures	B-X
.	B-X
Fisetin	B-X
also	B-X
inhibited	B-X
the	B-X
gene	B-X
expression	B-X
of	B-X
TNF-alpha	B-X
,	B-X
interleukin	B-X
(	B-X
IL	B-X
)	B-X
-1	B-X
beta	B-X
,	B-X
cyclooxygenase	B-X
(	B-X
COX-2	B-X
)	B-X
and	B-X
inducible	B-X
nitric	B-X
oxide	B-X
synthase	B-X
(	B-X
iNOS	B-X
)	B-X
at	B-X
both	B-X
mRNA	B-X
and	B-X
protein	B-X
levels	B-X
.	B-X
Fisetin	B-X
significantly	B-X
suppressed	B-X
I	B-X
kappa	B-X
B	B-X
degradation	B-X
,	B-X
nuclear	B-X
translocation	B-X
of	B-X
NF-kappa	B-X
B	B-X
,	B-X
and	B-X
phosphorylation	B-X
of	B-X
p38	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPKs	B-X
)	B-X
in	B-X
the	B-X
LPS-stimulated	B-X
BV-2	B-X
microglia	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
fisetin	B-X
reduced	B-X
cytotoxicity	B-X
of	B-X
LPS-stimulated	B-X
microglia	B-X
toward	B-X
B35	B-X
neuroblastoma	B-X
cells	B-X
in	B-X
a	B-X
co-culture	B-X
system	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
fisetin	B-X
has	B-X
a	B-X
strong	B-X
anti-inflammatory	B-X
activity	B-X
in	B-X
brain	B-X
microglia	B-X
,	B-X
and	B-X
could	B-X
be	B-X
a	B-X
potential	B-X
therapeutic	B-X
agent	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
neuroinflammatory	B-X
diseases	B-X
.	B-X

In	O
addition	O
,	O
fisetin	O
reduced	O
cytotoxicity	O
of	O
LPS	O
-	O
stimulated	O
microglia	O
toward	O
B35	O
neuroblastoma	O
cells	O
in	O
a	O
co	O
-	O
culture	O
system	O
.	O

These	O
results	O
indicate	O
that	O
fisetin	O
has	O
a	O
strong	O
anti	O
-	O
inflammatory	O
activity	O
in	O
brain	O
microglia	O
,	O
and	O
could	O
be	O
a	O
potential	O
therapeutic	O
agent	O
for	O
the	O
treatment	O
of	O
neuroinflammatory	O
diseases	O
.	O

Dephosphorylation	O
and	O
activation	O
of	O
a	O
p34cdc2	O
/	O
cyclin	O
B	O
complex	O
in	O
vitro	O
by	O
human	O
CDC25	B-Gene_or_gene_product
protein	O
.	O
<EOS>	B-X
Oocytes	B-X
arrested	B-X
in	B-X
the	B-X
G2	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
contain	B-X
a	B-X
p34cdc2/cyclin	B-X
B	B-X
complex	B-X
which	B-X
is	B-X
kept	B-X
in	B-X
an	B-X
inactive	B-X
form	B-X
by	B-X
phosphorylation	B-X
of	B-X
its	B-X
p34cdc2	B-X
subunit	B-X
on	B-X
tyrosine	B-X
,	B-X
threonine	B-X
and	B-X
perhaps	B-X
serine	B-X
residues	B-X
.	B-X
The	B-X
phosphatase	B-X
(	B-X
s	B-X
)	B-X
involved	B-X
in	B-X
p34cdc2	B-X
dephosphorylation	B-X
is	B-X
unknown	B-X
,	B-X
but	B-X
the	B-X
product	B-X
of	B-X
the	B-X
fission	B-X
yeast	B-X
cdc25+	B-X
gene	B-X
,	B-X
and	B-X
its	B-X
homologues	B-X
in	B-X
budding	B-X
yeast	B-X
and	B-X
Drosophila	B-X
are	B-X
probably	B-X
positive	B-X
regulators	B-X
of	B-X
the	B-X
transition	B-X
from	B-X
G2	B-X
to	B-X
M	B-X
phase	B-X
.	B-X
We	B-X
have	B-X
purified	B-X
the	B-X
inactive	B-X
p34cdc2/cyclin	B-X
B	B-X
complex	B-X
from	B-X
G2-arrested	B-X
starfish	B-X
oocytes	B-X
.	B-X
Addition	B-X
of	B-X
the	B-X
purified	B-X
bacterially	B-X
expressed	B-X
product	B-X
of	B-X
the	B-X
human	B-X
homologue	B-X
of	B-X
the	B-X
fission	B-X
yeast	B-X
cdc25+	B-X
gene	B-X
(	B-X
p54CDC25H	B-X
)	B-X
triggers	B-X
p34cdc2	B-X
dephosphorylation	B-X
and	B-X
activates	B-X
H1	B-X
histone	B-X
kinase	B-X
activity	B-X
in	B-X
this	B-X
preparation	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
cdc25+	B-X
gene	B-X
product	B-X
directly	B-X
activates	B-X
the	B-X
p34cdc2-cyclin	B-X
B	B-X
complex	B-X
.	B-X

Oocytes	O
arrested	O
in	O
the	O
G2	O
phase	O
of	O
the	O
cell	O
cycle	O
contain	O
a	O
p34cdc2	O
/	O
cyclin	O
B	O
complex	O
which	O
is	O
kept	O
in	O
an	O
inactive	O
form	O
by	O
phosphorylation	O
of	O
its	O
p34cdc2	B-Gene_or_gene_product
subunit	O
on	O
tyrosine	O
,	O
threonine	O
and	O
perhaps	O
serine	O
residues	O
.	O

The	O
phosphatase	O
(	O
s	O
)	O
involved	O
in	O
p34cdc2	B-Gene_or_gene_product
dephosphorylation	O
is	O
unknown	O
,	O
but	O
the	O
product	O
of	O
the	O
fission	O
yeast	O
cdc25	B-Gene_or_gene_product
+	O
gene	O
,	O
and	O
its	O
homologues	O
in	O
budding	O
yeast	O
and	O
Drosophila	O
are	O
probably	O
positive	O
regulators	O
of	O
the	O
transition	O
from	O
G2	O
to	O
M	O
phase	O
.	O

We	O
have	O
purified	O
the	O
inactive	O
p34cdc2	O
/	O
cyclin	O
B	O
complex	O
from	O
G2	O
-	O
arrested	O
starfish	O
oocytes	O
.	O
<EOS>	B-X
Oocytes	B-X
arrested	B-X
in	B-X
the	B-X
G2	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
contain	B-X
a	B-X
p34cdc2/cyclin	B-X
B	B-X
complex	B-X
which	B-X
is	B-X
kept	B-X
in	B-X
an	B-X
inactive	B-X
form	B-X
by	B-X
phosphorylation	B-X
of	B-X
its	B-X
p34cdc2	B-X
subunit	B-X
on	B-X
tyrosine	B-X
,	B-X
threonine	B-X
and	B-X
perhaps	B-X
serine	B-X
residues	B-X
.	B-X
The	B-X
phosphatase	B-X
(	B-X
s	B-X
)	B-X
involved	B-X
in	B-X
p34cdc2	B-X
dephosphorylation	B-X
is	B-X
unknown	B-X
,	B-X
but	B-X
the	B-X
product	B-X
of	B-X
the	B-X
fission	B-X
yeast	B-X
cdc25+	B-X
gene	B-X
,	B-X
and	B-X
its	B-X
homologues	B-X
in	B-X
budding	B-X
yeast	B-X
and	B-X
Drosophila	B-X
are	B-X
probably	B-X
positive	B-X
regulators	B-X
of	B-X
the	B-X
transition	B-X
from	B-X
G2	B-X
to	B-X
M	B-X
phase	B-X
.	B-X
We	B-X
have	B-X
purified	B-X
the	B-X
inactive	B-X
p34cdc2/cyclin	B-X
B	B-X
complex	B-X
from	B-X
G2-arrested	B-X
starfish	B-X
oocytes	B-X
.	B-X
Addition	B-X
of	B-X
the	B-X
purified	B-X
bacterially	B-X
expressed	B-X
product	B-X
of	B-X
the	B-X
human	B-X
homologue	B-X
of	B-X
the	B-X
fission	B-X
yeast	B-X
cdc25+	B-X
gene	B-X
(	B-X
p54CDC25H	B-X
)	B-X
triggers	B-X
p34cdc2	B-X
dephosphorylation	B-X
and	B-X
activates	B-X
H1	B-X
histone	B-X
kinase	B-X
activity	B-X
in	B-X
this	B-X
preparation	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
cdc25+	B-X
gene	B-X
product	B-X
directly	B-X
activates	B-X
the	B-X
p34cdc2-cyclin	B-X
B	B-X
complex	B-X
.	B-X

Addition	O
of	O
the	O
purified	O
bacterially	O
expressed	O
product	O
of	O
the	O
human	O
homologue	O
of	O
the	O
fission	O
yeast	O
cdc25	B-Gene_or_gene_product
+	O
gene	O
(	O
p54CDC25H	B-Gene_or_gene_product
)	O
triggers	O
p34cdc2	B-Gene_or_gene_product
dephosphorylation	O
and	O
activates	O
H1	B-Gene_or_gene_product
histone	I-Gene_or_gene_product
kinase	O
activity	O
in	O
this	O
preparation	O
.	O
<EOS>	B-X
Oocytes	B-X
arrested	B-X
in	B-X
the	B-X
G2	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
contain	B-X
a	B-X
p34cdc2/cyclin	B-X
B	B-X
complex	B-X
which	B-X
is	B-X
kept	B-X
in	B-X
an	B-X
inactive	B-X
form	B-X
by	B-X
phosphorylation	B-X
of	B-X
its	B-X
p34cdc2	B-X
subunit	B-X
on	B-X
tyrosine	B-X
,	B-X
threonine	B-X
and	B-X
perhaps	B-X
serine	B-X
residues	B-X
.	B-X
The	B-X
phosphatase	B-X
(	B-X
s	B-X
)	B-X
involved	B-X
in	B-X
p34cdc2	B-X
dephosphorylation	B-X
is	B-X
unknown	B-X
,	B-X
but	B-X
the	B-X
product	B-X
of	B-X
the	B-X
fission	B-X
yeast	B-X
cdc25+	B-X
gene	B-X
,	B-X
and	B-X
its	B-X
homologues	B-X
in	B-X
budding	B-X
yeast	B-X
and	B-X
Drosophila	B-X
are	B-X
probably	B-X
positive	B-X
regulators	B-X
of	B-X
the	B-X
transition	B-X
from	B-X
G2	B-X
to	B-X
M	B-X
phase	B-X
.	B-X
We	B-X
have	B-X
purified	B-X
the	B-X
inactive	B-X
p34cdc2/cyclin	B-X
B	B-X
complex	B-X
from	B-X
G2-arrested	B-X
starfish	B-X
oocytes	B-X
.	B-X
Addition	B-X
of	B-X
the	B-X
purified	B-X
bacterially	B-X
expressed	B-X
product	B-X
of	B-X
the	B-X
human	B-X
homologue	B-X
of	B-X
the	B-X
fission	B-X
yeast	B-X
cdc25+	B-X
gene	B-X
(	B-X
p54CDC25H	B-X
)	B-X
triggers	B-X
p34cdc2	B-X
dephosphorylation	B-X
and	B-X
activates	B-X
H1	B-X
histone	B-X
kinase	B-X
activity	B-X
in	B-X
this	B-X
preparation	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
cdc25+	B-X
gene	B-X
product	B-X
directly	B-X
activates	B-X
the	B-X
p34cdc2-cyclin	B-X
B	B-X
complex	B-X
.	B-X

We	O
propose	O
that	O
the	O
cdc25	B-Gene_or_gene_product
+	O
gene	O
product	O
directly	O
activates	O
the	O
p34cdc2	O
-	O
cyclin	O
B	O
complex	O
.	O
<EOS>	B-X
Oocytes	B-X
arrested	B-X
in	B-X
the	B-X
G2	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
contain	B-X
a	B-X
p34cdc2/cyclin	B-X
B	B-X
complex	B-X
which	B-X
is	B-X
kept	B-X
in	B-X
an	B-X
inactive	B-X
form	B-X
by	B-X
phosphorylation	B-X
of	B-X
its	B-X
p34cdc2	B-X
subunit	B-X
on	B-X
tyrosine	B-X
,	B-X
threonine	B-X
and	B-X
perhaps	B-X
serine	B-X
residues	B-X
.	B-X
The	B-X
phosphatase	B-X
(	B-X
s	B-X
)	B-X
involved	B-X
in	B-X
p34cdc2	B-X
dephosphorylation	B-X
is	B-X
unknown	B-X
,	B-X
but	B-X
the	B-X
product	B-X
of	B-X
the	B-X
fission	B-X
yeast	B-X
cdc25+	B-X
gene	B-X
,	B-X
and	B-X
its	B-X
homologues	B-X
in	B-X
budding	B-X
yeast	B-X
and	B-X
Drosophila	B-X
are	B-X
probably	B-X
positive	B-X
regulators	B-X
of	B-X
the	B-X
transition	B-X
from	B-X
G2	B-X
to	B-X
M	B-X
phase	B-X
.	B-X
We	B-X
have	B-X
purified	B-X
the	B-X
inactive	B-X
p34cdc2/cyclin	B-X
B	B-X
complex	B-X
from	B-X
G2-arrested	B-X
starfish	B-X
oocytes	B-X
.	B-X
Addition	B-X
of	B-X
the	B-X
purified	B-X
bacterially	B-X
expressed	B-X
product	B-X
of	B-X
the	B-X
human	B-X
homologue	B-X
of	B-X
the	B-X
fission	B-X
yeast	B-X
cdc25+	B-X
gene	B-X
(	B-X
p54CDC25H	B-X
)	B-X
triggers	B-X
p34cdc2	B-X
dephosphorylation	B-X
and	B-X
activates	B-X
H1	B-X
histone	B-X
kinase	B-X
activity	B-X
in	B-X
this	B-X
preparation	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
cdc25+	B-X
gene	B-X
product	B-X
directly	B-X
activates	B-X
the	B-X
p34cdc2-cyclin	B-X
B	B-X
complex	B-X
.	B-X

Transcriptional	O
activation	O
of	O
CLN1	B-Gene_or_gene_product
,	O
CLN2	B-Gene_or_gene_product
,	O
and	O
a	O
putative	O
new	O
G1	O
cyclin	B-Gene_or_gene_product
(	O
HCS26	B-Gene_or_gene_product
)	O
by	O
SWI4	B-Gene_or_gene_product
,	O
a	O
positive	O
regulator	O
of	O
G1	O
-	O
specific	O
transcription	O
.	O

SWI4	B-Gene_or_gene_product
of	O
budding	O
yeast	O
codes	O
for	O
a	O
component	O
of	O
a	O
transcription	O
factor	O
(	O
cell	B-Gene_or_gene_product
cycle	I-Gene_or_gene_product
box	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
,	O
or	O
CCBF	B-Gene_or_gene_product
)	O
necessary	O
for	O
G1	O
-	O
specific	O
expression	O
of	O
HO	B-Gene_or_gene_product
.	O
<EOS>	B-X
SWI4	B-X
of	B-X
budding	B-X
yeast	B-X
codes	B-X
for	B-X
a	B-X
component	B-X
of	B-X
a	B-X
transcription	B-X
factor	B-X
(	B-X
cell	B-X
cycle	B-X
box	B-X
factor	B-X
,	B-X
or	B-X
CCBF	B-X
)	B-X
necessary	B-X
for	B-X
G1-specific	B-X
expression	B-X
of	B-X
HO	B-X
.	B-X
We	B-X
show	B-X
that	B-X
SWI4	B-X
is	B-X
essential	B-X
for	B-X
haploid	B-X
cell	B-X
viability	B-X
at	B-X
high	B-X
temperature	B-X
and	B-X
in	B-X
a/alpha	B-X
cells	B-X
at	B-X
all	B-X
temperatures	B-X
:	B-X
SWI4-deficient	B-X
cells	B-X
arrest	B-X
as	B-X
large	B-X
unbudded	B-X
cells	B-X
.	B-X
Two	B-X
carry	B-X
G1	B-X
cyclin	B-X
genes	B-X
,	B-X
CLN1	B-X
and	B-X
CLN2	B-X
;	B-X
another	B-X
carries	B-X
HCS26	B-X
,	B-X
coding	B-X
for	B-X
a	B-X
putative	B-X
cyclin	B-X
,	B-X
a/alpha	B-X
swi4-	B-X
mutants	B-X
exhibit	B-X
3-	B-X
to	B-X
20-fold	B-X
reductions	B-X
in	B-X
the	B-X
levels	B-X
of	B-X
CLN1	B-X
,	B-X
CLN2	B-X
,	B-X
and	B-X
HCS26	B-X
transcripts	B-X
.	B-X
The	B-X
requirement	B-X
of	B-X
SWI4	B-X
for	B-X
transcription	B-X
appears	B-X
to	B-X
be	B-X
direct	B-X
:	B-X
each	B-X
gene	B-X
contains	B-X
sites	B-X
similar	B-X
to	B-X
the	B-X
CCBF-binding	B-X
site	B-X
;	B-X
CCBF	B-X
binds	B-X
to	B-X
the	B-X
upstream	B-X
region	B-X
of	B-X
HCS26	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
SWI4	B-X
participates	B-X
in	B-X
a	B-X
positive	B-X
feedback	B-X
loop	B-X
by	B-X
which	B-X
CLN1	B-X
,	B-X
CLN2	B-X
,	B-X
and	B-X
possibly	B-X
HCS26	B-X
promote	B-X
their	B-X
own	B-X
transcription	B-X
in	B-X
G1	B-X
.	B-X

We	O
show	O
that	O
SWI4	B-Gene_or_gene_product
is	O
essential	O
for	O
haploid	O
cell	O
viability	O
at	O
high	O
temperature	O
and	O
in	O
a	O
/	O
alpha	O
cells	O
at	O
all	O
temperatures	O
:	O
SWI4	B-Gene_or_gene_product
-	O
deficient	O
cells	O
arrest	O
as	O
large	O
unbudded	O
cells	O
.	O

Eight	O
high	O
copy	O
number	O
plasmids	O
were	O
identified	O
that	O
allow	O
swi4	B-Gene_or_gene_product
-	O
strains	O
to	O
grow	O
under	O
nonpermissive	O
conditions	O
.	O
<EOS>	B-X
We	B-X
show	B-X
that	B-X
SWI4	B-X
is	B-X
essential	B-X
for	B-X
haploid	B-X
cell	B-X
viability	B-X
at	B-X
high	B-X
temperature	B-X
and	B-X
in	B-X
a/alpha	B-X
cells	B-X
at	B-X
all	B-X
temperatures	B-X
:	B-X
SWI4-deficient	B-X
cells	B-X
arrest	B-X
as	B-X
large	B-X
unbudded	B-X
cells	B-X
.	B-X
Eight	B-X
high	B-X
copy	B-X
number	B-X
plasmids	B-X
were	B-X
identified	B-X
that	B-X
allow	B-X
swi4-	B-X
strains	B-X
to	B-X
grow	B-X
under	B-X
nonpermissive	B-X
conditions	B-X
.	B-X
Two	B-X
carry	B-X
G1	B-X
cyclin	B-X
genes	B-X
,	B-X
CLN1	B-X
and	B-X
CLN2	B-X
;	B-X
another	B-X
carries	B-X
HCS26	B-X
,	B-X
coding	B-X
for	B-X
a	B-X
putative	B-X
cyclin	B-X
,	B-X
a/alpha	B-X
swi4-	B-X
mutants	B-X
exhibit	B-X
3-	B-X
to	B-X
20-fold	B-X
reductions	B-X
in	B-X
the	B-X
levels	B-X
of	B-X
CLN1	B-X
,	B-X
CLN2	B-X
,	B-X
and	B-X
HCS26	B-X
transcripts	B-X
.	B-X

Two	O
carry	O
G1	O
cyclin	B-Gene_or_gene_product
genes	O
,	O
CLN1	B-Gene_or_gene_product
and	O
CLN2	B-Gene_or_gene_product
;	O
another	O
carries	O
HCS26	B-Gene_or_gene_product
,	O
coding	O
for	O
a	O
putative	O
cyclin	B-Gene_or_gene_product
,	O
a	O
/	O
alpha	O
swi4	B-Gene_or_gene_product
-	O
mutants	O
exhibit	O
3	O
-	O
to	O
20	O
-	O
fold	O
reductions	O
in	O
the	O
levels	O
of	O
CLN1	B-Gene_or_gene_product
,	O
CLN2	B-Gene_or_gene_product
,	O
and	O
HCS26	B-Gene_or_gene_product
transcripts	O
.	O
<EOS>	B-X
SWI4	B-X
of	B-X
budding	B-X
yeast	B-X
codes	B-X
for	B-X
a	B-X
component	B-X
of	B-X
a	B-X
transcription	B-X
factor	B-X
(	B-X
cell	B-X
cycle	B-X
box	B-X
factor	B-X
,	B-X
or	B-X
CCBF	B-X
)	B-X
necessary	B-X
for	B-X
G1-specific	B-X
expression	B-X
of	B-X
HO	B-X
.	B-X
We	B-X
show	B-X
that	B-X
SWI4	B-X
is	B-X
essential	B-X
for	B-X
haploid	B-X
cell	B-X
viability	B-X
at	B-X
high	B-X
temperature	B-X
and	B-X
in	B-X
a/alpha	B-X
cells	B-X
at	B-X
all	B-X
temperatures	B-X
:	B-X
SWI4-deficient	B-X
cells	B-X
arrest	B-X
as	B-X
large	B-X
unbudded	B-X
cells	B-X
.	B-X
Eight	B-X
high	B-X
copy	B-X
number	B-X
plasmids	B-X
were	B-X
identified	B-X
that	B-X
allow	B-X
swi4-	B-X
strains	B-X
to	B-X
grow	B-X
under	B-X
nonpermissive	B-X
conditions	B-X
.	B-X
Two	B-X
carry	B-X
G1	B-X
cyclin	B-X
genes	B-X
,	B-X
CLN1	B-X
and	B-X
CLN2	B-X
;	B-X
another	B-X
carries	B-X
HCS26	B-X
,	B-X
coding	B-X
for	B-X
a	B-X
putative	B-X
cyclin	B-X
,	B-X
a/alpha	B-X
swi4-	B-X
mutants	B-X
exhibit	B-X
3-	B-X
to	B-X
20-fold	B-X
reductions	B-X
in	B-X
the	B-X
levels	B-X
of	B-X
CLN1	B-X
,	B-X
CLN2	B-X
,	B-X
and	B-X
HCS26	B-X
transcripts	B-X
.	B-X
The	B-X
requirement	B-X
of	B-X
SWI4	B-X
for	B-X
transcription	B-X
appears	B-X
to	B-X
be	B-X
direct	B-X
:	B-X
each	B-X
gene	B-X
contains	B-X
sites	B-X
similar	B-X
to	B-X
the	B-X
CCBF-binding	B-X
site	B-X
;	B-X
CCBF	B-X
binds	B-X
to	B-X
the	B-X
upstream	B-X
region	B-X
of	B-X
HCS26	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
SWI4	B-X
participates	B-X
in	B-X
a	B-X
positive	B-X
feedback	B-X
loop	B-X
by	B-X
which	B-X
CLN1	B-X
,	B-X
CLN2	B-X
,	B-X
and	B-X
possibly	B-X
HCS26	B-X
promote	B-X
their	B-X
own	B-X
transcription	B-X
in	B-X
G1	B-X
.	B-X

The	O
requirement	O
of	O
SWI4	B-Gene_or_gene_product
for	O
transcription	O
appears	O
to	O
be	O
direct	O
:	O
each	O
gene	O
contains	O
sites	O
similar	O
to	O
the	O
CCBF	B-Gene_or_gene_product
-	O
binding	O
site	O
;	O
CCBF	B-Gene_or_gene_product
binds	O
to	O
the	O
upstream	O
region	O
of	O
HCS26	B-Gene_or_gene_product
.	O

We	O
propose	O
that	O
SWI4	B-Gene_or_gene_product
participates	O
in	O
a	O
positive	O
feedback	O
loop	O
by	O
which	O
CLN1	B-Gene_or_gene_product
,	O
CLN2	B-Gene_or_gene_product
,	O
and	O
possibly	O
HCS26	B-Gene_or_gene_product
promote	O
their	O
own	O
transcription	O
in	O
G1	O
.	O

The	O
Cdk	B-Gene_or_gene_product
inhibitor	O
p27	B-Gene_or_gene_product
in	O
human	O
cancer	O
:	O
prognostic	O
potential	O
and	O
relevance	O
to	O
anticancer	O
therapy	O
.	O
<EOS>	B-X
The	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
inhibitor	B-X
p27	B-X
(	B-X
also	B-X
known	B-X
as	B-X
KIP1	B-X
)	B-X
regulates	B-X
cell	B-X
proliferation	B-X
,	B-X
cell	B-X
motility	B-X
and	B-X
apoptosis	B-X
.	B-X
Diverse	B-X
post-translational	B-X
modifications	B-X
determine	B-X
the	B-X
physiological	B-X
role	B-X
of	B-X
p27	B-X
.	B-X
Phosphorylation	B-X
regulates	B-X
p27	B-X
binding	B-X
to	B-X
and	B-X
inhibition	B-X
of	B-X
cyclin-Cdk	B-X
complexes	B-X
,	B-X
its	B-X
localization	B-X
and	B-X
its	B-X
ubiquitin-mediated	B-X
proteolysis	B-X
.	B-X
In	B-X
cancers	B-X
,	B-X
p27	B-X
is	B-X
inactivated	B-X
through	B-X
impaired	B-X
synthesis	B-X
,	B-X
accelerated	B-X
degradation	B-X
and	B-X
by	B-X
mislocalization	B-X
.	B-X
Moreover	B-X
,	B-X
studies	B-X
in	B-X
several	B-X
tumour	B-X
types	B-X
indicate	B-X
that	B-X
p27	B-X
expression	B-X
levels	B-X
have	B-X
both	B-X
prognostic	B-X
and	B-X
therapeutic	B-X
implications	B-X
.	B-X

The	O
cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
Cdk	B-Gene_or_gene_product
)	O
inhibitor	O
p27	B-Gene_or_gene_product
(	O
also	O
known	O
as	O
KIP1	B-Gene_or_gene_product
)	O
regulates	O
cell	O
proliferation	O
,	O
cell	O
motility	O
and	O
apoptosis	O
.	O
<EOS>	B-X
The	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
inhibitor	B-X
p27	B-X
(	B-X
also	B-X
known	B-X
as	B-X
KIP1	B-X
)	B-X
regulates	B-X
cell	B-X
proliferation	B-X
,	B-X
cell	B-X
motility	B-X
and	B-X
apoptosis	B-X
.	B-X
Diverse	B-X
post-translational	B-X
modifications	B-X
determine	B-X
the	B-X
physiological	B-X
role	B-X
of	B-X
p27	B-X
.	B-X
Phosphorylation	B-X
regulates	B-X
p27	B-X
binding	B-X
to	B-X
and	B-X
inhibition	B-X
of	B-X
cyclin-Cdk	B-X
complexes	B-X
,	B-X
its	B-X
localization	B-X
and	B-X
its	B-X
ubiquitin-mediated	B-X
proteolysis	B-X
.	B-X
In	B-X
cancers	B-X
,	B-X
p27	B-X
is	B-X
inactivated	B-X
through	B-X
impaired	B-X
synthesis	B-X
,	B-X
accelerated	B-X
degradation	B-X
and	B-X
by	B-X
mislocalization	B-X
.	B-X
Moreover	B-X
,	B-X
studies	B-X
in	B-X
several	B-X
tumour	B-X
types	B-X
indicate	B-X
that	B-X
p27	B-X
expression	B-X
levels	B-X
have	B-X
both	B-X
prognostic	B-X
and	B-X
therapeutic	B-X
implications	B-X
.	B-X

Interestingly	O
,	O
the	O
protein	O
can	O
exert	O
both	O
positive	O
and	O
negative	O
functions	O
on	O
these	O
processes	O
.	O
<EOS>	B-X
PTEN	B-X
controls	B-X
an	B-X
array	B-X
of	B-X
physiopathological	B-X
processes	B-X
related	B-X
to	B-X
cell	B-X
proliferation	B-X
,	B-X
differentiation	B-X
,	B-X
DNA/chromosome	B-X
integrity	B-X
,	B-X
apoptosis	B-X
and	B-X
invasiveness	B-X
.	B-X
PTEN	B-X
dephosphorylates	B-X
not	B-X
only	B-X
proteins	B-X
,	B-X
but	B-X
also	B-X
phosphoinositides	B-X
generated	B-X
by	B-X
phosphatidylinositol	B-X
3-kinase	B-X
,	B-X
thus	B-X
counteracting	B-X
the	B-X
Akt	B-X
signalling	B-X
pathway	B-X
.	B-X
Interestingly	B-X
,	B-X
PTEN	B-X
can	B-X
also	B-X
exert	B-X
some	B-X
biological	B-X
functions	B-X
independently	B-X
of	B-X
its	B-X
catalytic	B-X
activity.A	B-X
feature	B-X
of	B-X
colorectal	B-X
cancers	B-X
is	B-X
the	B-X
relatively	B-X
low	B-X
incidence	B-X
of	B-X
PTEN	B-X
mutation	B-X
or	B-X
deletion	B-X
,	B-X
whereas	B-X
PTEN	B-X
downregulation	B-X
occurs	B-X
in	B-X
approximately	B-X
one	B-X
third	B-X
of	B-X
tumours	B-X
.	B-X
It	B-X
also	B-X
focuses	B-X
on	B-X
the	B-X
use	B-X
of	B-X
small	B-X
molecules	B-X
targeting	B-X
positive	B-X
or	B-X
negative	B-X
PTEN	B-X
regulators	B-X
and	B-X
summarizes	B-X
alternative	B-X
strategies	B-X
that	B-X
could	B-X
be	B-X
used	B-X
to	B-X
alter	B-X
PTEN	B-X
conformation/activity	B-X
.	B-X

Diverse	O
post	O
-	O
translational	O
modifications	O
determine	O
the	O
physiological	O
role	O
of	O
p27	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
inhibitor	B-X
p27	B-X
(	B-X
also	B-X
known	B-X
as	B-X
KIP1	B-X
)	B-X
regulates	B-X
cell	B-X
proliferation	B-X
,	B-X
cell	B-X
motility	B-X
and	B-X
apoptosis	B-X
.	B-X
Diverse	B-X
post-translational	B-X
modifications	B-X
determine	B-X
the	B-X
physiological	B-X
role	B-X
of	B-X
p27	B-X
.	B-X
Phosphorylation	B-X
regulates	B-X
p27	B-X
binding	B-X
to	B-X
and	B-X
inhibition	B-X
of	B-X
cyclin-Cdk	B-X
complexes	B-X
,	B-X
its	B-X
localization	B-X
and	B-X
its	B-X
ubiquitin-mediated	B-X
proteolysis	B-X
.	B-X
In	B-X
cancers	B-X
,	B-X
p27	B-X
is	B-X
inactivated	B-X
through	B-X
impaired	B-X
synthesis	B-X
,	B-X
accelerated	B-X
degradation	B-X
and	B-X
by	B-X
mislocalization	B-X
.	B-X
Moreover	B-X
,	B-X
studies	B-X
in	B-X
several	B-X
tumour	B-X
types	B-X
indicate	B-X
that	B-X
p27	B-X
expression	B-X
levels	B-X
have	B-X
both	B-X
prognostic	B-X
and	B-X
therapeutic	B-X
implications	B-X
.	B-X

Phosphorylation	O
regulates	O
p27	B-Gene_or_gene_product
binding	O
to	O
and	O
inhibition	O
of	O
cyclin	O
-	O
Cdk	O
complexes	O
,	O
its	O
localization	O
and	O
its	O
ubiquitin	B-Gene_or_gene_product
-	O
mediated	O
proteolysis	O
.	O
<EOS>	B-X
The	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
inhibitor	B-X
p27	B-X
(	B-X
also	B-X
known	B-X
as	B-X
KIP1	B-X
)	B-X
regulates	B-X
cell	B-X
proliferation	B-X
,	B-X
cell	B-X
motility	B-X
and	B-X
apoptosis	B-X
.	B-X
Diverse	B-X
post-translational	B-X
modifications	B-X
determine	B-X
the	B-X
physiological	B-X
role	B-X
of	B-X
p27	B-X
.	B-X
Phosphorylation	B-X
regulates	B-X
p27	B-X
binding	B-X
to	B-X
and	B-X
inhibition	B-X
of	B-X
cyclin-Cdk	B-X
complexes	B-X
,	B-X
its	B-X
localization	B-X
and	B-X
its	B-X
ubiquitin-mediated	B-X
proteolysis	B-X
.	B-X
In	B-X
cancers	B-X
,	B-X
p27	B-X
is	B-X
inactivated	B-X
through	B-X
impaired	B-X
synthesis	B-X
,	B-X
accelerated	B-X
degradation	B-X
and	B-X
by	B-X
mislocalization	B-X
.	B-X
Moreover	B-X
,	B-X
studies	B-X
in	B-X
several	B-X
tumour	B-X
types	B-X
indicate	B-X
that	B-X
p27	B-X
expression	B-X
levels	B-X
have	B-X
both	B-X
prognostic	B-X
and	B-X
therapeutic	B-X
implications	B-X
.	B-X

In	O
cancers	O
,	O
p27	B-Gene_or_gene_product
is	O
inactivated	O
through	O
impaired	O
synthesis	O
,	O
accelerated	O
degradation	O
and	O
by	O
mislocalization	O
.	O
<EOS>	B-X
The	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
inhibitor	B-X
p27	B-X
(	B-X
also	B-X
known	B-X
as	B-X
KIP1	B-X
)	B-X
regulates	B-X
cell	B-X
proliferation	B-X
,	B-X
cell	B-X
motility	B-X
and	B-X
apoptosis	B-X
.	B-X
Diverse	B-X
post-translational	B-X
modifications	B-X
determine	B-X
the	B-X
physiological	B-X
role	B-X
of	B-X
p27	B-X
.	B-X
Phosphorylation	B-X
regulates	B-X
p27	B-X
binding	B-X
to	B-X
and	B-X
inhibition	B-X
of	B-X
cyclin-Cdk	B-X
complexes	B-X
,	B-X
its	B-X
localization	B-X
and	B-X
its	B-X
ubiquitin-mediated	B-X
proteolysis	B-X
.	B-X
In	B-X
cancers	B-X
,	B-X
p27	B-X
is	B-X
inactivated	B-X
through	B-X
impaired	B-X
synthesis	B-X
,	B-X
accelerated	B-X
degradation	B-X
and	B-X
by	B-X
mislocalization	B-X
.	B-X
Moreover	B-X
,	B-X
studies	B-X
in	B-X
several	B-X
tumour	B-X
types	B-X
indicate	B-X
that	B-X
p27	B-X
expression	B-X
levels	B-X
have	B-X
both	B-X
prognostic	B-X
and	B-X
therapeutic	B-X
implications	B-X
.	B-X

Moreover	O
,	O
studies	O
in	O
several	O
tumour	O
types	O
indicate	O
that	O
p27	B-Gene_or_gene_product
expression	O
levels	O
have	O
both	O
prognostic	O
and	O
therapeutic	O
implications	O
.	O
<EOS>	B-X
The	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
inhibitor	B-X
p27	B-X
(	B-X
also	B-X
known	B-X
as	B-X
KIP1	B-X
)	B-X
regulates	B-X
cell	B-X
proliferation	B-X
,	B-X
cell	B-X
motility	B-X
and	B-X
apoptosis	B-X
.	B-X
Diverse	B-X
post-translational	B-X
modifications	B-X
determine	B-X
the	B-X
physiological	B-X
role	B-X
of	B-X
p27	B-X
.	B-X
Phosphorylation	B-X
regulates	B-X
p27	B-X
binding	B-X
to	B-X
and	B-X
inhibition	B-X
of	B-X
cyclin-Cdk	B-X
complexes	B-X
,	B-X
its	B-X
localization	B-X
and	B-X
its	B-X
ubiquitin-mediated	B-X
proteolysis	B-X
.	B-X
In	B-X
cancers	B-X
,	B-X
p27	B-X
is	B-X
inactivated	B-X
through	B-X
impaired	B-X
synthesis	B-X
,	B-X
accelerated	B-X
degradation	B-X
and	B-X
by	B-X
mislocalization	B-X
.	B-X
Moreover	B-X
,	B-X
studies	B-X
in	B-X
several	B-X
tumour	B-X
types	B-X
indicate	B-X
that	B-X
p27	B-X
expression	B-X
levels	B-X
have	B-X
both	B-X
prognostic	B-X
and	B-X
therapeutic	B-X
implications	B-X
.	B-X

Regulation	O
of	O
proline	B-Gene_or_gene_product
-	I-Gene_or_gene_product
rich	I-Gene_or_gene_product
Akt	I-Gene_or_gene_product
substrate	I-Gene_or_gene_product
of	I-Gene_or_gene_product
40	I-Gene_or_gene_product
kDa	I-Gene_or_gene_product
(	O
PRAS40	B-Gene_or_gene_product
)	O
function	O
by	O
mammalian	O
target	O
of	O
rapamycin	O
complex	O
1	O
(	O
mTORC1	O
)	O
-	O
mediated	O
phosphorylation	O
.	O
<EOS>	B-X
The	B-X
rapamycin-sensitive	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
complex	B-X
1	B-X
(	B-X
mTORC1	B-X
)	B-X
contains	B-X
mTOR	B-X
,	B-X
raptor	B-X
,	B-X
mLST8	B-X
,	B-X
and	B-X
PRAS40	B-X
(	B-X
proline-rich	B-X
Akt	B-X
substrate	B-X
of	B-X
40	B-X
kDa	B-X
)	B-X
.	B-X
PRAS40	B-X
functions	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
when	B-X
bound	B-X
to	B-X
mTORC1	B-X
,	B-X
and	B-X
it	B-X
dissociates	B-X
from	B-X
mTORC1	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
.	B-X
PRAS40	B-X
has	B-X
been	B-X
demonstrated	B-X
to	B-X
be	B-X
a	B-X
substrate	B-X
of	B-X
mTORC1	B-X
,	B-X
and	B-X
one	B-X
phosphorylation	B-X
site	B-X
,	B-X
Ser-183	B-X
,	B-X
has	B-X
been	B-X
identified	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
used	B-X
two-dimensional	B-X
phosphopeptide	B-X
mapping	B-X
in	B-X
conjunction	B-X
with	B-X
mutational	B-X
analysis	B-X
to	B-X
show	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
Ser-183	B-X
,	B-X
mTORC1	B-X
also	B-X
phosphorylates	B-X
Ser-212	B-X
and	B-X
Ser-221	B-X
in	B-X
PRAS40	B-X
when	B-X
assayed	B-X
in	B-X
vitro	B-X
.	B-X
Mutation	B-X
of	B-X
all	B-X
three	B-X
residues	B-X
to	B-X
Ala	B-X
markedly	B-X
reduces	B-X
mTORC1-mediated	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
in	B-X
vitro	B-X
.	B-X
Phosphorylation	B-X
of	B-X
Ser-221	B-X
and	B-X
Ser-183	B-X
but	B-X
not	B-X
Ser-212	B-X
is	B-X
sensitive	B-X
to	B-X
rapamycin	B-X
treatment	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
mutation	B-X
of	B-X
Ser-221	B-X
to	B-X
Ala	B-X
reduces	B-X
the	B-X
interaction	B-X
with	B-X
14-3-3	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
mutation	B-X
of	B-X
Thr-246	B-X
,	B-X
the	B-X
Akt/protein	B-X
kinase	B-X
B-phosphorylated	B-X
site	B-X
.	B-X
We	B-X
also	B-X
find	B-X
that	B-X
mutation	B-X
of	B-X
Ser-221	B-X
to	B-X
Ala	B-X
increases	B-X
the	B-X
inhibitory	B-X
activity	B-X
of	B-X
PRAS40	B-X
toward	B-X
mTORC1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
after	B-X
mTORC1	B-X
kinase	B-X
activation	B-X
by	B-X
upstream	B-X
regulators	B-X
,	B-X
PRAS40	B-X
is	B-X
phosphorylated	B-X
directly	B-X
by	B-X
mTOR	B-X
,	B-X
thus	B-X
contributing	B-X
to	B-X
the	B-X
relief	B-X
of	B-X
PRAS40-mediated	B-X
substrate	B-X
competition	B-X
.	B-X

The	O
rapamycin	O
-	O
sensitive	O
mammalian	O
target	O
of	O
rapamycin	O
(	O
mTOR	O
)	O
complex	O
1	O
(	O
mTORC1	O
)	O
contains	O
mTOR	B-Gene_or_gene_product
,	O
raptor	B-Gene_or_gene_product
,	O
mLST8	B-Gene_or_gene_product
,	O
and	O
PRAS40	B-Gene_or_gene_product
(	O
proline	B-Gene_or_gene_product
-	I-Gene_or_gene_product
rich	I-Gene_or_gene_product
Akt	I-Gene_or_gene_product
substrate	I-Gene_or_gene_product
of	I-Gene_or_gene_product
40	I-Gene_or_gene_product
kDa	I-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
The	B-X
rapamycin-sensitive	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
complex	B-X
1	B-X
(	B-X
mTORC1	B-X
)	B-X
contains	B-X
mTOR	B-X
,	B-X
raptor	B-X
,	B-X
mLST8	B-X
,	B-X
and	B-X
PRAS40	B-X
(	B-X
proline-rich	B-X
Akt	B-X
substrate	B-X
of	B-X
40	B-X
kDa	B-X
)	B-X
.	B-X
PRAS40	B-X
functions	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
when	B-X
bound	B-X
to	B-X
mTORC1	B-X
,	B-X
and	B-X
it	B-X
dissociates	B-X
from	B-X
mTORC1	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
.	B-X
PRAS40	B-X
has	B-X
been	B-X
demonstrated	B-X
to	B-X
be	B-X
a	B-X
substrate	B-X
of	B-X
mTORC1	B-X
,	B-X
and	B-X
one	B-X
phosphorylation	B-X
site	B-X
,	B-X
Ser-183	B-X
,	B-X
has	B-X
been	B-X
identified	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
used	B-X
two-dimensional	B-X
phosphopeptide	B-X
mapping	B-X
in	B-X
conjunction	B-X
with	B-X
mutational	B-X
analysis	B-X
to	B-X
show	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
Ser-183	B-X
,	B-X
mTORC1	B-X
also	B-X
phosphorylates	B-X
Ser-212	B-X
and	B-X
Ser-221	B-X
in	B-X
PRAS40	B-X
when	B-X
assayed	B-X
in	B-X
vitro	B-X
.	B-X
Mutation	B-X
of	B-X
all	B-X
three	B-X
residues	B-X
to	B-X
Ala	B-X
markedly	B-X
reduces	B-X
mTORC1-mediated	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
in	B-X
vitro	B-X
.	B-X
Phosphorylation	B-X
of	B-X
Ser-221	B-X
and	B-X
Ser-183	B-X
but	B-X
not	B-X
Ser-212	B-X
is	B-X
sensitive	B-X
to	B-X
rapamycin	B-X
treatment	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
mutation	B-X
of	B-X
Ser-221	B-X
to	B-X
Ala	B-X
reduces	B-X
the	B-X
interaction	B-X
with	B-X
14-3-3	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
mutation	B-X
of	B-X
Thr-246	B-X
,	B-X
the	B-X
Akt/protein	B-X
kinase	B-X
B-phosphorylated	B-X
site	B-X
.	B-X
We	B-X
also	B-X
find	B-X
that	B-X
mutation	B-X
of	B-X
Ser-221	B-X
to	B-X
Ala	B-X
increases	B-X
the	B-X
inhibitory	B-X
activity	B-X
of	B-X
PRAS40	B-X
toward	B-X
mTORC1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
after	B-X
mTORC1	B-X
kinase	B-X
activation	B-X
by	B-X
upstream	B-X
regulators	B-X
,	B-X
PRAS40	B-X
is	B-X
phosphorylated	B-X
directly	B-X
by	B-X
mTOR	B-X
,	B-X
thus	B-X
contributing	B-X
to	B-X
the	B-X
relief	B-X
of	B-X
PRAS40-mediated	B-X
substrate	B-X
competition	B-X
.	B-X

PRAS40	B-Gene_or_gene_product
functions	O
as	O
a	O
negative	O
regulator	O
when	O
bound	O
to	O
mTORC1	O
,	O
and	O
it	O
dissociates	O
from	O
mTORC1	O
in	O
response	O
to	O
insulin	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
rapamycin-sensitive	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
complex	B-X
1	B-X
(	B-X
mTORC1	B-X
)	B-X
contains	B-X
mTOR	B-X
,	B-X
raptor	B-X
,	B-X
mLST8	B-X
,	B-X
and	B-X
PRAS40	B-X
(	B-X
proline-rich	B-X
Akt	B-X
substrate	B-X
of	B-X
40	B-X
kDa	B-X
)	B-X
.	B-X
PRAS40	B-X
functions	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
when	B-X
bound	B-X
to	B-X
mTORC1	B-X
,	B-X
and	B-X
it	B-X
dissociates	B-X
from	B-X
mTORC1	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
.	B-X
PRAS40	B-X
has	B-X
been	B-X
demonstrated	B-X
to	B-X
be	B-X
a	B-X
substrate	B-X
of	B-X
mTORC1	B-X
,	B-X
and	B-X
one	B-X
phosphorylation	B-X
site	B-X
,	B-X
Ser-183	B-X
,	B-X
has	B-X
been	B-X
identified	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
used	B-X
two-dimensional	B-X
phosphopeptide	B-X
mapping	B-X
in	B-X
conjunction	B-X
with	B-X
mutational	B-X
analysis	B-X
to	B-X
show	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
Ser-183	B-X
,	B-X
mTORC1	B-X
also	B-X
phosphorylates	B-X
Ser-212	B-X
and	B-X
Ser-221	B-X
in	B-X
PRAS40	B-X
when	B-X
assayed	B-X
in	B-X
vitro	B-X
.	B-X
Mutation	B-X
of	B-X
all	B-X
three	B-X
residues	B-X
to	B-X
Ala	B-X
markedly	B-X
reduces	B-X
mTORC1-mediated	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
in	B-X
vitro	B-X
.	B-X
We	B-X
also	B-X
find	B-X
that	B-X
mutation	B-X
of	B-X
Ser-221	B-X
to	B-X
Ala	B-X
increases	B-X
the	B-X
inhibitory	B-X
activity	B-X
of	B-X
PRAS40	B-X
toward	B-X
mTORC1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
after	B-X
mTORC1	B-X
kinase	B-X
activation	B-X
by	B-X
upstream	B-X
regulators	B-X
,	B-X
PRAS40	B-X
is	B-X
phosphorylated	B-X
directly	B-X
by	B-X
mTOR	B-X
,	B-X
thus	B-X
contributing	B-X
to	B-X
the	B-X
relief	B-X
of	B-X
PRAS40-mediated	B-X
substrate	B-X
competition	B-X
.	B-X

PRAS40	B-Gene_or_gene_product
has	O
been	O
demonstrated	O
to	O
be	O
a	O
substrate	O
of	O
mTORC1	O
,	O
and	O
one	O
phosphorylation	O
site	O
,	O
Ser	O
-	O
183	O
,	O
has	O
been	O
identified	O
.	O
<EOS>	B-X
The	B-X
rapamycin-sensitive	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
complex	B-X
1	B-X
(	B-X
mTORC1	B-X
)	B-X
contains	B-X
mTOR	B-X
,	B-X
raptor	B-X
,	B-X
mLST8	B-X
,	B-X
and	B-X
PRAS40	B-X
(	B-X
proline-rich	B-X
Akt	B-X
substrate	B-X
of	B-X
40	B-X
kDa	B-X
)	B-X
.	B-X
PRAS40	B-X
functions	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
when	B-X
bound	B-X
to	B-X
mTORC1	B-X
,	B-X
and	B-X
it	B-X
dissociates	B-X
from	B-X
mTORC1	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
.	B-X
PRAS40	B-X
has	B-X
been	B-X
demonstrated	B-X
to	B-X
be	B-X
a	B-X
substrate	B-X
of	B-X
mTORC1	B-X
,	B-X
and	B-X
one	B-X
phosphorylation	B-X
site	B-X
,	B-X
Ser-183	B-X
,	B-X
has	B-X
been	B-X
identified	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
used	B-X
two-dimensional	B-X
phosphopeptide	B-X
mapping	B-X
in	B-X
conjunction	B-X
with	B-X
mutational	B-X
analysis	B-X
to	B-X
show	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
Ser-183	B-X
,	B-X
mTORC1	B-X
also	B-X
phosphorylates	B-X
Ser-212	B-X
and	B-X
Ser-221	B-X
in	B-X
PRAS40	B-X
when	B-X
assayed	B-X
in	B-X
vitro	B-X
.	B-X
Mutation	B-X
of	B-X
all	B-X
three	B-X
residues	B-X
to	B-X
Ala	B-X
markedly	B-X
reduces	B-X
mTORC1-mediated	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
in	B-X
vitro	B-X
.	B-X
All	B-X
three	B-X
sites	B-X
were	B-X
confirmed	B-X
to	B-X
be	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
by	B-X
[	B-X
(	B-X
32	B-X
)	B-X
P	B-X
]	B-X
orthophosphate	B-X
labeling	B-X
and	B-X
peptide	B-X
mapping	B-X
.	B-X
Phosphorylation	B-X
of	B-X
Ser-221	B-X
and	B-X
Ser-183	B-X
but	B-X
not	B-X
Ser-212	B-X
is	B-X
sensitive	B-X
to	B-X
rapamycin	B-X
treatment	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
mutation	B-X
of	B-X
Ser-221	B-X
to	B-X
Ala	B-X
reduces	B-X
the	B-X
interaction	B-X
with	B-X
14-3-3	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
mutation	B-X
of	B-X
Thr-246	B-X
,	B-X
the	B-X
Akt/protein	B-X
kinase	B-X
B-phosphorylated	B-X
site	B-X
.	B-X
We	B-X
also	B-X
find	B-X
that	B-X
mutation	B-X
of	B-X
Ser-221	B-X
to	B-X
Ala	B-X
increases	B-X
the	B-X
inhibitory	B-X
activity	B-X
of	B-X
PRAS40	B-X
toward	B-X
mTORC1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
after	B-X
mTORC1	B-X
kinase	B-X
activation	B-X
by	B-X
upstream	B-X
regulators	B-X
,	B-X
PRAS40	B-X
is	B-X
phosphorylated	B-X
directly	B-X
by	B-X
mTOR	B-X
,	B-X
thus	B-X
contributing	B-X
to	B-X
the	B-X
relief	B-X
of	B-X
PRAS40-mediated	B-X
substrate	B-X
competition	B-X
.	B-X

In	O
this	O
study	O
,	O
we	O
used	O
two	O
-	O
dimensional	O
phosphopeptide	O
mapping	O
in	O
conjunction	O
with	O
mutational	O
analysis	O
to	O
show	O
that	O
in	O
addition	O
to	O
Ser	O
-	O
183	O
,	O
mTORC1	O
also	O
phosphorylates	O
Ser	O
-	O
212	O
and	O
Ser	O
-	O
221	O
in	O
PRAS40	B-Gene_or_gene_product
when	O
assayed	O
in	O
vitro	O
.	O
<EOS>	B-X
The	B-X
rapamycin-sensitive	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
complex	B-X
1	B-X
(	B-X
mTORC1	B-X
)	B-X
contains	B-X
mTOR	B-X
,	B-X
raptor	B-X
,	B-X
mLST8	B-X
,	B-X
and	B-X
PRAS40	B-X
(	B-X
proline-rich	B-X
Akt	B-X
substrate	B-X
of	B-X
40	B-X
kDa	B-X
)	B-X
.	B-X
PRAS40	B-X
functions	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
when	B-X
bound	B-X
to	B-X
mTORC1	B-X
,	B-X
and	B-X
it	B-X
dissociates	B-X
from	B-X
mTORC1	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
.	B-X
PRAS40	B-X
has	B-X
been	B-X
demonstrated	B-X
to	B-X
be	B-X
a	B-X
substrate	B-X
of	B-X
mTORC1	B-X
,	B-X
and	B-X
one	B-X
phosphorylation	B-X
site	B-X
,	B-X
Ser-183	B-X
,	B-X
has	B-X
been	B-X
identified	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
used	B-X
two-dimensional	B-X
phosphopeptide	B-X
mapping	B-X
in	B-X
conjunction	B-X
with	B-X
mutational	B-X
analysis	B-X
to	B-X
show	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
Ser-183	B-X
,	B-X
mTORC1	B-X
also	B-X
phosphorylates	B-X
Ser-212	B-X
and	B-X
Ser-221	B-X
in	B-X
PRAS40	B-X
when	B-X
assayed	B-X
in	B-X
vitro	B-X
.	B-X
Mutation	B-X
of	B-X
all	B-X
three	B-X
residues	B-X
to	B-X
Ala	B-X
markedly	B-X
reduces	B-X
mTORC1-mediated	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
in	B-X
vitro	B-X
.	B-X
All	B-X
three	B-X
sites	B-X
were	B-X
confirmed	B-X
to	B-X
be	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
by	B-X
[	B-X
(	B-X
32	B-X
)	B-X
P	B-X
]	B-X
orthophosphate	B-X
labeling	B-X
and	B-X
peptide	B-X
mapping	B-X
.	B-X
Phosphorylation	B-X
of	B-X
Ser-221	B-X
and	B-X
Ser-183	B-X
but	B-X
not	B-X
Ser-212	B-X
is	B-X
sensitive	B-X
to	B-X
rapamycin	B-X
treatment	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
mutation	B-X
of	B-X
Ser-221	B-X
to	B-X
Ala	B-X
reduces	B-X
the	B-X
interaction	B-X
with	B-X
14-3-3	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
mutation	B-X
of	B-X
Thr-246	B-X
,	B-X
the	B-X
Akt/protein	B-X
kinase	B-X
B-phosphorylated	B-X
site	B-X
.	B-X
We	B-X
also	B-X
find	B-X
that	B-X
mutation	B-X
of	B-X
Ser-221	B-X
to	B-X
Ala	B-X
increases	B-X
the	B-X
inhibitory	B-X
activity	B-X
of	B-X
PRAS40	B-X
toward	B-X
mTORC1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
after	B-X
mTORC1	B-X
kinase	B-X
activation	B-X
by	B-X
upstream	B-X
regulators	B-X
,	B-X
PRAS40	B-X
is	B-X
phosphorylated	B-X
directly	B-X
by	B-X
mTOR	B-X
,	B-X
thus	B-X
contributing	B-X
to	B-X
the	B-X
relief	B-X
of	B-X
PRAS40-mediated	B-X
substrate	B-X
competition	B-X
.	B-X

Mutation	O
of	O
all	O
three	O
residues	O
to	O
Ala	O
markedly	O
reduces	O
mTORC1	O
-	O
mediated	O
phosphorylation	O
of	O
PRAS40	B-Gene_or_gene_product
in	O
vitro	O
.	O
<EOS>	B-X
The	B-X
rapamycin-sensitive	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
complex	B-X
1	B-X
(	B-X
mTORC1	B-X
)	B-X
contains	B-X
mTOR	B-X
,	B-X
raptor	B-X
,	B-X
mLST8	B-X
,	B-X
and	B-X
PRAS40	B-X
(	B-X
proline-rich	B-X
Akt	B-X
substrate	B-X
of	B-X
40	B-X
kDa	B-X
)	B-X
.	B-X
PRAS40	B-X
functions	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
when	B-X
bound	B-X
to	B-X
mTORC1	B-X
,	B-X
and	B-X
it	B-X
dissociates	B-X
from	B-X
mTORC1	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
.	B-X
PRAS40	B-X
has	B-X
been	B-X
demonstrated	B-X
to	B-X
be	B-X
a	B-X
substrate	B-X
of	B-X
mTORC1	B-X
,	B-X
and	B-X
one	B-X
phosphorylation	B-X
site	B-X
,	B-X
Ser-183	B-X
,	B-X
has	B-X
been	B-X
identified	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
used	B-X
two-dimensional	B-X
phosphopeptide	B-X
mapping	B-X
in	B-X
conjunction	B-X
with	B-X
mutational	B-X
analysis	B-X
to	B-X
show	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
Ser-183	B-X
,	B-X
mTORC1	B-X
also	B-X
phosphorylates	B-X
Ser-212	B-X
and	B-X
Ser-221	B-X
in	B-X
PRAS40	B-X
when	B-X
assayed	B-X
in	B-X
vitro	B-X
.	B-X
Mutation	B-X
of	B-X
all	B-X
three	B-X
residues	B-X
to	B-X
Ala	B-X
markedly	B-X
reduces	B-X
mTORC1-mediated	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
in	B-X
vitro	B-X
.	B-X
All	B-X
three	B-X
sites	B-X
were	B-X
confirmed	B-X
to	B-X
be	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
by	B-X
[	B-X
(	B-X
32	B-X
)	B-X
P	B-X
]	B-X
orthophosphate	B-X
labeling	B-X
and	B-X
peptide	B-X
mapping	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
mutation	B-X
of	B-X
Ser-221	B-X
to	B-X
Ala	B-X
reduces	B-X
the	B-X
interaction	B-X
with	B-X
14-3-3	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
mutation	B-X
of	B-X
Thr-246	B-X
,	B-X
the	B-X
Akt/protein	B-X
kinase	B-X
B-phosphorylated	B-X
site	B-X
.	B-X
We	B-X
also	B-X
find	B-X
that	B-X
mutation	B-X
of	B-X
Ser-221	B-X
to	B-X
Ala	B-X
increases	B-X
the	B-X
inhibitory	B-X
activity	B-X
of	B-X
PRAS40	B-X
toward	B-X
mTORC1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
after	B-X
mTORC1	B-X
kinase	B-X
activation	B-X
by	B-X
upstream	B-X
regulators	B-X
,	B-X
PRAS40	B-X
is	B-X
phosphorylated	B-X
directly	B-X
by	B-X
mTOR	B-X
,	B-X
thus	B-X
contributing	B-X
to	B-X
the	B-X
relief	B-X
of	B-X
PRAS40-mediated	B-X
substrate	B-X
competition	B-X
.	B-X

All	O
three	O
sites	O
were	O
confirmed	O
to	O
be	O
phosphorylated	O
in	O
vivo	O
by	O
[	O
(	O
32	O
)	O
P	O
]	O
orthophosphate	O
labeling	O
and	O
peptide	O
mapping	O
.	O
<EOS>	B-X
The	B-X
rapamycin-sensitive	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
complex	B-X
1	B-X
(	B-X
mTORC1	B-X
)	B-X
contains	B-X
mTOR	B-X
,	B-X
raptor	B-X
,	B-X
mLST8	B-X
,	B-X
and	B-X
PRAS40	B-X
(	B-X
proline-rich	B-X
Akt	B-X
substrate	B-X
of	B-X
40	B-X
kDa	B-X
)	B-X
.	B-X
PRAS40	B-X
functions	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
when	B-X
bound	B-X
to	B-X
mTORC1	B-X
,	B-X
and	B-X
it	B-X
dissociates	B-X
from	B-X
mTORC1	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
.	B-X
PRAS40	B-X
has	B-X
been	B-X
demonstrated	B-X
to	B-X
be	B-X
a	B-X
substrate	B-X
of	B-X
mTORC1	B-X
,	B-X
and	B-X
one	B-X
phosphorylation	B-X
site	B-X
,	B-X
Ser-183	B-X
,	B-X
has	B-X
been	B-X
identified	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
used	B-X
two-dimensional	B-X
phosphopeptide	B-X
mapping	B-X
in	B-X
conjunction	B-X
with	B-X
mutational	B-X
analysis	B-X
to	B-X
show	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
Ser-183	B-X
,	B-X
mTORC1	B-X
also	B-X
phosphorylates	B-X
Ser-212	B-X
and	B-X
Ser-221	B-X
in	B-X
PRAS40	B-X
when	B-X
assayed	B-X
in	B-X
vitro	B-X
.	B-X
Mutation	B-X
of	B-X
all	B-X
three	B-X
residues	B-X
to	B-X
Ala	B-X
markedly	B-X
reduces	B-X
mTORC1-mediated	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
in	B-X
vitro	B-X
.	B-X
All	B-X
three	B-X
sites	B-X
were	B-X
confirmed	B-X
to	B-X
be	B-X
phosphorylated	B-X
in	B-X
vivo	B-X
by	B-X
[	B-X
(	B-X
32	B-X
)	B-X
P	B-X
]	B-X
orthophosphate	B-X
labeling	B-X
and	B-X
peptide	B-X
mapping	B-X
.	B-X
Phosphorylation	B-X
of	B-X
Ser-221	B-X
and	B-X
Ser-183	B-X
but	B-X
not	B-X
Ser-212	B-X
is	B-X
sensitive	B-X
to	B-X
rapamycin	B-X
treatment	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
mutation	B-X
of	B-X
Ser-221	B-X
to	B-X
Ala	B-X
reduces	B-X
the	B-X
interaction	B-X
with	B-X
14-3-3	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
mutation	B-X
of	B-X
Thr-246	B-X
,	B-X
the	B-X
Akt/protein	B-X
kinase	B-X
B-phosphorylated	B-X
site	B-X
.	B-X
We	B-X
also	B-X
find	B-X
that	B-X
mutation	B-X
of	B-X
Ser-221	B-X
to	B-X
Ala	B-X
increases	B-X
the	B-X
inhibitory	B-X
activity	B-X
of	B-X
PRAS40	B-X
toward	B-X
mTORC1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
after	B-X
mTORC1	B-X
kinase	B-X
activation	B-X
by	B-X
upstream	B-X
regulators	B-X
,	B-X
PRAS40	B-X
is	B-X
phosphorylated	B-X
directly	B-X
by	B-X
mTOR	B-X
,	B-X
thus	B-X
contributing	B-X
to	B-X
the	B-X
relief	B-X
of	B-X
PRAS40-mediated	B-X
substrate	B-X
competition	B-X
.	B-X

Phosphorylation	O
of	O
Ser	O
-	O
221	O
and	O
Ser	O
-	O
183	O
but	O
not	O
Ser	O
-	O
212	O
is	O
sensitive	O
to	O
rapamycin	O
treatment	O
.	O
<EOS>	B-X
Tianeptine	B-X
,	B-X
but	B-X
not	B-X
imipramine	B-X
,	B-X
increased	B-X
AMPA	B-X
receptor-mediated	B-X
neuronal	B-X
responses	B-X
both	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
,	B-X
in	B-X
a	B-X
staurosporine-sensitive	B-X
manner	B-X
.	B-X
Tianeptine	B-X
rapidly	B-X
increased	B-X
the	B-X
phosphorylation	B-X
level	B-X
of	B-X
Ser	B-X
(	B-X
831	B-X
)	B-X
-GluA1	B-X
and	B-X
Ser	B-X
(	B-X
845	B-X
)	B-X
-GluA1	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
phosphorylation	B-X
states	B-X
of	B-X
Ser	B-X
(	B-X
217/221	B-X
)	B-X
-MEK	B-X
and	B-X
Thr	B-X
(	B-X
183	B-X
)	B-X
/Tyr	B-X
(	B-X
185	B-X
)	B-X
-p42MAPK	B-X
were	B-X
increased	B-X
by	B-X
Tianeptine	B-X
and	B-X
specific	B-X
kinase	B-X
blockers	B-X
of	B-X
the	B-X
MAPK	B-X
pathways	B-X
(	B-X
PD	B-X
98095	B-X
,	B-X
SB	B-X
203580	B-X
and	B-X
SP600125	B-X
)	B-X
prevented	B-X
the	B-X
effects	B-X
of	B-X
Tianeptine	B-X
.	B-X

Furthermore	O
,	O
we	O
demonstrate	O
that	O
mutation	O
of	O
Ser	O
-	O
221	O
to	O
Ala	O
reduces	O
the	O
interaction	O
with	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
to	O
the	O
same	O
extent	O
as	O
mutation	O
of	O
Thr	O
-	O
246	O
,	O
the	O
Akt	B-Gene_or_gene_product
/	O
protein	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
B	I-Gene_or_gene_product
-	O
phosphorylated	O
site	O
.	O

We	O
also	O
find	O
that	O
mutation	O
of	O
Ser	O
-	O
221	O
to	O
Ala	O
increases	O
the	O
inhibitory	O
activity	O
of	O
PRAS40	B-Gene_or_gene_product
toward	O
mTORC1	O
.	O
<EOS>	B-X
The	B-X
rapamycin-sensitive	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
complex	B-X
1	B-X
(	B-X
mTORC1	B-X
)	B-X
contains	B-X
mTOR	B-X
,	B-X
raptor	B-X
,	B-X
mLST8	B-X
,	B-X
and	B-X
PRAS40	B-X
(	B-X
proline-rich	B-X
Akt	B-X
substrate	B-X
of	B-X
40	B-X
kDa	B-X
)	B-X
.	B-X
PRAS40	B-X
functions	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
when	B-X
bound	B-X
to	B-X
mTORC1	B-X
,	B-X
and	B-X
it	B-X
dissociates	B-X
from	B-X
mTORC1	B-X
in	B-X
response	B-X
to	B-X
insulin	B-X
.	B-X
PRAS40	B-X
has	B-X
been	B-X
demonstrated	B-X
to	B-X
be	B-X
a	B-X
substrate	B-X
of	B-X
mTORC1	B-X
,	B-X
and	B-X
one	B-X
phosphorylation	B-X
site	B-X
,	B-X
Ser-183	B-X
,	B-X
has	B-X
been	B-X
identified	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
used	B-X
two-dimensional	B-X
phosphopeptide	B-X
mapping	B-X
in	B-X
conjunction	B-X
with	B-X
mutational	B-X
analysis	B-X
to	B-X
show	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
Ser-183	B-X
,	B-X
mTORC1	B-X
also	B-X
phosphorylates	B-X
Ser-212	B-X
and	B-X
Ser-221	B-X
in	B-X
PRAS40	B-X
when	B-X
assayed	B-X
in	B-X
vitro	B-X
.	B-X
Mutation	B-X
of	B-X
all	B-X
three	B-X
residues	B-X
to	B-X
Ala	B-X
markedly	B-X
reduces	B-X
mTORC1-mediated	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
in	B-X
vitro	B-X
.	B-X
Phosphorylation	B-X
of	B-X
Ser-221	B-X
and	B-X
Ser-183	B-X
but	B-X
not	B-X
Ser-212	B-X
is	B-X
sensitive	B-X
to	B-X
rapamycin	B-X
treatment	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
mutation	B-X
of	B-X
Ser-221	B-X
to	B-X
Ala	B-X
reduces	B-X
the	B-X
interaction	B-X
with	B-X
14-3-3	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
mutation	B-X
of	B-X
Thr-246	B-X
,	B-X
the	B-X
Akt/protein	B-X
kinase	B-X
B-phosphorylated	B-X
site	B-X
.	B-X
We	B-X
also	B-X
find	B-X
that	B-X
mutation	B-X
of	B-X
Ser-221	B-X
to	B-X
Ala	B-X
increases	B-X
the	B-X
inhibitory	B-X
activity	B-X
of	B-X
PRAS40	B-X
toward	B-X
mTORC1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
after	B-X
mTORC1	B-X
kinase	B-X
activation	B-X
by	B-X
upstream	B-X
regulators	B-X
,	B-X
PRAS40	B-X
is	B-X
phosphorylated	B-X
directly	B-X
by	B-X
mTOR	B-X
,	B-X
thus	B-X
contributing	B-X
to	B-X
the	B-X
relief	B-X
of	B-X
PRAS40-mediated	B-X
substrate	B-X
competition	B-X
.	B-X

We	O
propose	O
that	O
after	O
mTORC1	O
kinase	O
activation	O
by	O
upstream	O
regulators	O
,	O
PRAS40	B-Gene_or_gene_product
is	O
phosphorylated	O
directly	O
by	O
mTOR	B-Gene_or_gene_product
,	O
thus	O
contributing	O
to	O
the	O
relief	O
of	O
PRAS40	B-Gene_or_gene_product
-	O
mediated	O
substrate	O
competition	O
.	O

WD40	O
protein	O
FBW5	B-Gene_or_gene_product
promotes	O
ubiquitination	O
of	O
tumor	O
suppressor	O
TSC2	B-Gene_or_gene_product
by	O
DDB1	O
-	O
CUL4	O
-	O
ROC1	O
ligase	O
.	O
<EOS>	B-X
Tuberous	B-X
sclerosis	B-X
(	B-X
TSC	B-X
)	B-X
is	B-X
an	B-X
autosomal	B-X
dominant	B-X
disease	B-X
characterized	B-X
by	B-X
hamartoma	B-X
formation	B-X
in	B-X
various	B-X
organs	B-X
and	B-X
is	B-X
caused	B-X
by	B-X
mutations	B-X
targeting	B-X
either	B-X
the	B-X
TSC1	B-X
or	B-X
TSC2	B-X
genes	B-X
.	B-X
TSC1	B-X
and	B-X
TSC2	B-X
proteins	B-X
form	B-X
a	B-X
functionally	B-X
interdependent	B-X
dimeric	B-X
complex	B-X
.	B-X
The	B-X
majority	B-X
of	B-X
disease-associated	B-X
mutations	B-X
targeting	B-X
either	B-X
TSC1	B-X
or	B-X
TSC2	B-X
results	B-X
in	B-X
a	B-X
substantial	B-X
decrease	B-X
in	B-X
protein	B-X
level	B-X
,	B-X
suggesting	B-X
that	B-X
protein	B-X
turnover	B-X
also	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
TSC	B-X
regulation	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
TSC2	B-X
protein	B-X
binds	B-X
to	B-X
FBW5	B-X
,	B-X
a	B-X
DDB1-binding	B-X
WD40	B-X
(	B-X
DWD	B-X
)	B-X
protein	B-X
,	B-X
and	B-X
is	B-X
recruited	B-X
by	B-X
FBW5	B-X
to	B-X
the	B-X
DDB1-CUL4-ROC1	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
Overexpression	B-X
of	B-X
FBW5	B-X
or	B-X
CUL4A	B-X
promotes	B-X
TSC2	B-X
protein	B-X
degradation	B-X
,	B-X
and	B-X
this	B-X
is	B-X
abrogated	B-X
by	B-X
the	B-X
coexpression	B-X
of	B-X
TSC1	B-X
.	B-X
Conversely	B-X
,	B-X
depletion	B-X
of	B-X
FBW5	B-X
,	B-X
DDB1	B-X
,	B-X
or	B-X
CUL4A/B	B-X
stabilizes	B-X
TSC2	B-X
.	B-X
Ddb1	B-X
or	B-X
Cul4	B-X
mutations	B-X
in	B-X
Drosophila	B-X
result	B-X
in	B-X
Gigas/TSC2	B-X
protein	B-X
accumulation	B-X
and	B-X
cause	B-X
growth	B-X
defects	B-X
that	B-X
can	B-X
be	B-X
partially	B-X
rescued	B-X
by	B-X
Gigas/Tsc2	B-X
reduction	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
FBW5-DDB1-CUL4-ROC1	B-X
is	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
regulating	B-X
TSC2	B-X
protein	B-X
stability	B-X
and	B-X
TSC	B-X
complex	B-X
turnover	B-X
.	B-X

Tuberous	O
sclerosis	O
(	O
TSC	O
)	O
is	O
an	O
autosomal	O
dominant	O
disease	O
characterized	O
by	O
hamartoma	O
formation	O
in	O
various	O
organs	O
and	O
is	O
caused	O
by	O
mutations	O
targeting	O
either	O
the	O
TSC1	B-Gene_or_gene_product
or	O
TSC2	B-Gene_or_gene_product
genes	O
.	O
<EOS>	B-X
The	B-X
most	B-X
frequent	B-X
mutations	B-X
affect	B-X
TERT	B-X
promoter	B-X
(	B-X
60	B-X
%	B-X
)	B-X
,	B-X
associated	B-X
with	B-X
an	B-X
increased	B-X
telomerase	B-X
expression	B-X
.	B-X
TP53	B-X
and	B-X
CTNNB1	B-X
are	B-X
the	B-X
next	B-X
most	B-X
prevalent	B-X
mutations	B-X
,	B-X
affecting	B-X
25	B-X
%	B-X
-30	B-X
%	B-X
of	B-X
HCC	B-X
patients	B-X
,	B-X
that	B-X
,	B-X
in	B-X
addition	B-X
to	B-X
low-frequency	B-X
mutated	B-X
genes	B-X
(	B-X
eg	B-X
,	B-X
AXIN1	B-X
,	B-X
ARID2	B-X
,	B-X
ARID1A	B-X
,	B-X
TSC1/TSC2	B-X
,	B-X
RPS6KA3	B-X
,	B-X
KEAP1	B-X
,	B-X
MLL2	B-X
)	B-X
,	B-X
help	B-X
define	B-X
some	B-X
of	B-X
the	B-X
core	B-X
deregulated	B-X
pathways	B-X
in	B-X
HCC	B-X
.	B-X
We	B-X
incorporate	B-X
gene	B-X
perturbation	B-X
(	B-X
iTracer-perturb	B-X
)	B-X
and	B-X
assess	B-X
the	B-X
effect	B-X
of	B-X
mosaic	B-X
TSC2	B-X
mutations	B-X
on	B-X
cerebral	B-X
organoid	B-X
development	B-X
.	B-X
Our	B-X
data	B-X
shed	B-X
light	B-X
on	B-X
how	B-X
lineages	B-X
and	B-X
fates	B-X
are	B-X
established	B-X
during	B-X
cerebral	B-X
organoid	B-X
formation	B-X
.	B-X

TSC1	B-Gene_or_gene_product
and	O
TSC2	B-Gene_or_gene_product
proteins	O
form	O
a	O
functionally	O
interdependent	O
dimeric	O
complex	O
.	O

Phosphorylation	O
of	O
either	O
TSC	O
subunit	O
by	O
different	O
kinases	O
regulates	O
the	O
function	O
of	O
TSC	O
and	O
represents	O
a	O
major	O
mechanism	O
to	O
integrate	O
various	O
signals	O
into	O
a	O
centralized	O
cell	O
growth	O
pathway	O
.	O

The	O
majority	O
of	O
disease	O
-	O
associated	O
mutations	O
targeting	O
either	O
TSC1	B-Gene_or_gene_product
or	O
TSC2	B-Gene_or_gene_product
results	O
in	O
a	O
substantial	O
decrease	O
in	O
protein	O
level	O
,	O
suggesting	O
that	O
protein	O
turnover	O
also	O
plays	O
a	O
critical	O
role	O
in	O
TSC	O
regulation	O
.	O
<EOS>	B-X
Tuberous	B-X
sclerosis	B-X
complex	B-X
(	B-X
TSC	B-X
)	B-X
is	B-X
an	B-X
autosomal	B-X
dominant	B-X
disorder	B-X
that	B-X
affects	B-X
multiple	B-X
organ	B-X
systems	B-X
and	B-X
is	B-X
caused	B-X
by	B-X
loss-of-function	B-X
mutations	B-X
in	B-X
one	B-X
of	B-X
two	B-X
genes	B-X
:	B-X
TSC1	B-X
or	B-X
TSC2	B-X
.	B-X
First	B-X
described	B-X
in	B-X
depth	B-X
by	B-X
Bourneville	B-X
in	B-X
1880	B-X
,	B-X
it	B-X
is	B-X
now	B-X
estimated	B-X
that	B-X
nearly	B-X
2	B-X
million	B-X
people	B-X
are	B-X
affected	B-X
by	B-X
the	B-X
disease	B-X
worldwide	B-X
.	B-X
The	B-X
clinical	B-X
features	B-X
of	B-X
TSC	B-X
are	B-X
distinctive	B-X
and	B-X
can	B-X
vary	B-X
widely	B-X
between	B-X
individuals	B-X
,	B-X
even	B-X
within	B-X
one	B-X
family	B-X
.	B-X
Major	B-X
features	B-X
of	B-X
the	B-X
disease	B-X
include	B-X
tumours	B-X
of	B-X
the	B-X
brain	B-X
,	B-X
skin	B-X
,	B-X
heart	B-X
,	B-X
lungs	B-X
and	B-X
kidneys	B-X
,	B-X
seizures	B-X
and	B-X
TSC-associated	B-X
neuropsychiatric	B-X
disorders	B-X
,	B-X
which	B-X
can	B-X
include	B-X
autism	B-X
spectrum	B-X
disorder	B-X
and	B-X
cognitive	B-X
disability	B-X
.	B-X
TSC1	B-X
(	B-X
also	B-X
known	B-X
as	B-X
hamartin	B-X
)	B-X
and	B-X
TSC2	B-X
(	B-X
also	B-X
known	B-X
as	B-X
tuberin	B-X
)	B-X
form	B-X
the	B-X
TSC	B-X
protein	B-X
complex	B-X
that	B-X
acts	B-X
as	B-X
an	B-X
inhibitor	B-X
of	B-X
the	B-X
mechanistic	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
signalling	B-X
pathway	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
plays	B-X
a	B-X
pivotal	B-X
part	B-X
in	B-X
regulating	B-X
cell	B-X
growth	B-X
,	B-X
proliferation	B-X
,	B-X
autophagy	B-X
and	B-X
protein	B-X
and	B-X
lipid	B-X
synthesis	B-X
.	B-X
In	B-X
this	B-X
Primer	B-X
,	B-X
we	B-X
review	B-X
the	B-X
state-of-the-art	B-X
knowledge	B-X
in	B-X
the	B-X
TSC	B-X
field	B-X
,	B-X
including	B-X
the	B-X
molecular	B-X
and	B-X
cellular	B-X
basis	B-X
of	B-X
the	B-X
disease	B-X
,	B-X
medical	B-X
management	B-X
,	B-X
major	B-X
knowledge	B-X
gaps	B-X
and	B-X
ongoing	B-X
research	B-X
towards	B-X
a	B-X
cure	B-X
.	B-X

Here	O
we	O
report	O
that	O
TSC2	B-Gene_or_gene_product
protein	O
binds	O
to	O
FBW5	B-Gene_or_gene_product
,	O
a	O
DDB1	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
WD40	I-Gene_or_gene_product
(	O
DWD	B-Gene_or_gene_product
)	O
protein	O
,	O
and	O
is	O
recruited	O
by	O
FBW5	B-Gene_or_gene_product
to	O
the	O
DDB1	O
-	O
CUL4	O
-	O
ROC1	O
E3	O
ubiquitin	B-Gene_or_gene_product
ligase	O
.	O

Overexpression	O
of	O
FBW5	B-Gene_or_gene_product
or	O
CUL4A	B-Gene_or_gene_product
promotes	O
TSC2	B-Gene_or_gene_product
protein	O
degradation	O
,	O
and	O
this	O
is	O
abrogated	O
by	O
the	O
coexpression	O
of	O
TSC1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Tuberous	B-X
sclerosis	B-X
(	B-X
TSC	B-X
)	B-X
is	B-X
an	B-X
autosomal	B-X
dominant	B-X
disease	B-X
characterized	B-X
by	B-X
hamartoma	B-X
formation	B-X
in	B-X
various	B-X
organs	B-X
and	B-X
is	B-X
caused	B-X
by	B-X
mutations	B-X
targeting	B-X
either	B-X
the	B-X
TSC1	B-X
or	B-X
TSC2	B-X
genes	B-X
.	B-X
TSC1	B-X
and	B-X
TSC2	B-X
proteins	B-X
form	B-X
a	B-X
functionally	B-X
interdependent	B-X
dimeric	B-X
complex	B-X
.	B-X
The	B-X
majority	B-X
of	B-X
disease-associated	B-X
mutations	B-X
targeting	B-X
either	B-X
TSC1	B-X
or	B-X
TSC2	B-X
results	B-X
in	B-X
a	B-X
substantial	B-X
decrease	B-X
in	B-X
protein	B-X
level	B-X
,	B-X
suggesting	B-X
that	B-X
protein	B-X
turnover	B-X
also	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
TSC	B-X
regulation	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
TSC2	B-X
protein	B-X
binds	B-X
to	B-X
FBW5	B-X
,	B-X
a	B-X
DDB1-binding	B-X
WD40	B-X
(	B-X
DWD	B-X
)	B-X
protein	B-X
,	B-X
and	B-X
is	B-X
recruited	B-X
by	B-X
FBW5	B-X
to	B-X
the	B-X
DDB1-CUL4-ROC1	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
Overexpression	B-X
of	B-X
FBW5	B-X
or	B-X
CUL4A	B-X
promotes	B-X
TSC2	B-X
protein	B-X
degradation	B-X
,	B-X
and	B-X
this	B-X
is	B-X
abrogated	B-X
by	B-X
the	B-X
coexpression	B-X
of	B-X
TSC1	B-X
.	B-X
Conversely	B-X
,	B-X
depletion	B-X
of	B-X
FBW5	B-X
,	B-X
DDB1	B-X
,	B-X
or	B-X
CUL4A/B	B-X
stabilizes	B-X
TSC2	B-X
.	B-X
Ddb1	B-X
or	B-X
Cul4	B-X
mutations	B-X
in	B-X
Drosophila	B-X
result	B-X
in	B-X
Gigas/TSC2	B-X
protein	B-X
accumulation	B-X
and	B-X
cause	B-X
growth	B-X
defects	B-X
that	B-X
can	B-X
be	B-X
partially	B-X
rescued	B-X
by	B-X
Gigas/Tsc2	B-X
reduction	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
FBW5-DDB1-CUL4-ROC1	B-X
is	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
regulating	B-X
TSC2	B-X
protein	B-X
stability	B-X
and	B-X
TSC	B-X
complex	B-X
turnover	B-X
.	B-X

Conversely	O
,	O
depletion	O
of	O
FBW5	B-Gene_or_gene_product
,	O
DDB1	B-Gene_or_gene_product
,	O
or	O
CUL4A	B-Gene_or_gene_product
/	O
B	B-Gene_or_gene_product
stabilizes	O
TSC2	B-Gene_or_gene_product
.	O
<EOS>	B-X
Tuberous	B-X
sclerosis	B-X
(	B-X
TSC	B-X
)	B-X
is	B-X
an	B-X
autosomal	B-X
dominant	B-X
disease	B-X
characterized	B-X
by	B-X
hamartoma	B-X
formation	B-X
in	B-X
various	B-X
organs	B-X
and	B-X
is	B-X
caused	B-X
by	B-X
mutations	B-X
targeting	B-X
either	B-X
the	B-X
TSC1	B-X
or	B-X
TSC2	B-X
genes	B-X
.	B-X
TSC1	B-X
and	B-X
TSC2	B-X
proteins	B-X
form	B-X
a	B-X
functionally	B-X
interdependent	B-X
dimeric	B-X
complex	B-X
.	B-X
The	B-X
majority	B-X
of	B-X
disease-associated	B-X
mutations	B-X
targeting	B-X
either	B-X
TSC1	B-X
or	B-X
TSC2	B-X
results	B-X
in	B-X
a	B-X
substantial	B-X
decrease	B-X
in	B-X
protein	B-X
level	B-X
,	B-X
suggesting	B-X
that	B-X
protein	B-X
turnover	B-X
also	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
TSC	B-X
regulation	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
TSC2	B-X
protein	B-X
binds	B-X
to	B-X
FBW5	B-X
,	B-X
a	B-X
DDB1-binding	B-X
WD40	B-X
(	B-X
DWD	B-X
)	B-X
protein	B-X
,	B-X
and	B-X
is	B-X
recruited	B-X
by	B-X
FBW5	B-X
to	B-X
the	B-X
DDB1-CUL4-ROC1	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
Overexpression	B-X
of	B-X
FBW5	B-X
or	B-X
CUL4A	B-X
promotes	B-X
TSC2	B-X
protein	B-X
degradation	B-X
,	B-X
and	B-X
this	B-X
is	B-X
abrogated	B-X
by	B-X
the	B-X
coexpression	B-X
of	B-X
TSC1	B-X
.	B-X
Conversely	B-X
,	B-X
depletion	B-X
of	B-X
FBW5	B-X
,	B-X
DDB1	B-X
,	B-X
or	B-X
CUL4A/B	B-X
stabilizes	B-X
TSC2	B-X
.	B-X
Ddb1	B-X
or	B-X
Cul4	B-X
mutations	B-X
in	B-X
Drosophila	B-X
result	B-X
in	B-X
Gigas/TSC2	B-X
protein	B-X
accumulation	B-X
and	B-X
cause	B-X
growth	B-X
defects	B-X
that	B-X
can	B-X
be	B-X
partially	B-X
rescued	B-X
by	B-X
Gigas/Tsc2	B-X
reduction	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
FBW5-DDB1-CUL4-ROC1	B-X
is	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
regulating	B-X
TSC2	B-X
protein	B-X
stability	B-X
and	B-X
TSC	B-X
complex	B-X
turnover	B-X
.	B-X

Ddb1	B-Gene_or_gene_product
or	O
Cul4	B-Gene_or_gene_product
mutations	O
in	O
Drosophila	O
result	O
in	O
Gigas	B-Gene_or_gene_product
/	O
TSC2	B-Gene_or_gene_product
protein	O
accumulation	O
and	O
cause	O
growth	O
defects	O
that	O
can	O
be	O
partially	O
rescued	O
by	O
Gigas	B-Gene_or_gene_product
/	O
Tsc2	B-Gene_or_gene_product
reduction	O
.	O
<EOS>	B-X
Light	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
essential	B-X
environmental	B-X
factors	B-X
affecting	B-X
many	B-X
aspects	B-X
of	B-X
growth	B-X
and	B-X
developmental	B-X
processes	B-X
in	B-X
plants	B-X
.	B-X
Half	B-X
a	B-X
century	B-X
ago	B-X
,	B-X
thalidomide	B-X
was	B-X
widely	B-X
prescribed	B-X
to	B-X
pregnant	B-X
women	B-X
as	B-X
a	B-X
sedative	B-X
but	B-X
was	B-X
found	B-X
to	B-X
be	B-X
teratogenic	B-X
,	B-X
causing	B-X
multiple	B-X
birth	B-X
defects	B-X
.	B-X
Today	B-X
,	B-X
thalidomide	B-X
is	B-X
still	B-X
used	B-X
in	B-X
the	B-X
treatment	B-X
of	B-X
leprosy	B-X
and	B-X
multiple	B-X
myeloma	B-X
,	B-X
although	B-X
how	B-X
it	B-X
causes	B-X
limb	B-X
malformation	B-X
and	B-X
other	B-X
developmental	B-X
defects	B-X
is	B-X
unknown	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
identified	B-X
cereblon	B-X
(	B-X
CRBN	B-X
)	B-X
as	B-X
a	B-X
thalidomide-binding	B-X
protein	B-X
.	B-X
CRBN	B-X
forms	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
with	B-X
damaged	B-X
DNA	B-X
binding	B-X
protein	B-X
1	B-X
(	B-X
DDB1	B-X
)	B-X
and	B-X
Cul4A	B-X
that	B-X
is	B-X
important	B-X
for	B-X
limb	B-X
outgrowth	B-X
and	B-X
expression	B-X
of	B-X
the	B-X
fibroblast	B-X
growth	B-X
factor	B-X
Fgf8	B-X
in	B-X
zebrafish	B-X
and	B-X
chicks	B-X
.	B-X

These	O
results	O
indicate	O
that	O
FBW5	O
-	O
DDB1	O
-	O
CUL4	O
-	O
ROC1	O
is	O
an	O
E3	O
ubiquitin	B-Gene_or_gene_product
ligase	O
regulating	O
TSC2	B-Gene_or_gene_product
protein	O
stability	O
and	O
TSC	O
complex	O
turnover	O
.	O
<EOS>	B-X
Tuberous	B-X
sclerosis	B-X
(	B-X
TSC	B-X
)	B-X
is	B-X
an	B-X
autosomal	B-X
dominant	B-X
disease	B-X
characterized	B-X
by	B-X
hamartoma	B-X
formation	B-X
in	B-X
various	B-X
organs	B-X
and	B-X
is	B-X
caused	B-X
by	B-X
mutations	B-X
targeting	B-X
either	B-X
the	B-X
TSC1	B-X
or	B-X
TSC2	B-X
genes	B-X
.	B-X
TSC1	B-X
and	B-X
TSC2	B-X
proteins	B-X
form	B-X
a	B-X
functionally	B-X
interdependent	B-X
dimeric	B-X
complex	B-X
.	B-X
Phosphorylation	B-X
of	B-X
either	B-X
TSC	B-X
subunit	B-X
by	B-X
different	B-X
kinases	B-X
regulates	B-X
the	B-X
function	B-X
of	B-X
TSC	B-X
and	B-X
represents	B-X
a	B-X
major	B-X
mechanism	B-X
to	B-X
integrate	B-X
various	B-X
signals	B-X
into	B-X
a	B-X
centralized	B-X
cell	B-X
growth	B-X
pathway	B-X
.	B-X
The	B-X
majority	B-X
of	B-X
disease-associated	B-X
mutations	B-X
targeting	B-X
either	B-X
TSC1	B-X
or	B-X
TSC2	B-X
results	B-X
in	B-X
a	B-X
substantial	B-X
decrease	B-X
in	B-X
protein	B-X
level	B-X
,	B-X
suggesting	B-X
that	B-X
protein	B-X
turnover	B-X
also	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
TSC	B-X
regulation	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
TSC2	B-X
protein	B-X
binds	B-X
to	B-X
FBW5	B-X
,	B-X
a	B-X
DDB1-binding	B-X
WD40	B-X
(	B-X
DWD	B-X
)	B-X
protein	B-X
,	B-X
and	B-X
is	B-X
recruited	B-X
by	B-X
FBW5	B-X
to	B-X
the	B-X
DDB1-CUL4-ROC1	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
.	B-X
Overexpression	B-X
of	B-X
FBW5	B-X
or	B-X
CUL4A	B-X
promotes	B-X
TSC2	B-X
protein	B-X
degradation	B-X
,	B-X
and	B-X
this	B-X
is	B-X
abrogated	B-X
by	B-X
the	B-X
coexpression	B-X
of	B-X
TSC1	B-X
.	B-X
Conversely	B-X
,	B-X
depletion	B-X
of	B-X
FBW5	B-X
,	B-X
DDB1	B-X
,	B-X
or	B-X
CUL4A/B	B-X
stabilizes	B-X
TSC2	B-X
.	B-X
Ddb1	B-X
or	B-X
Cul4	B-X
mutations	B-X
in	B-X
Drosophila	B-X
result	B-X
in	B-X
Gigas/TSC2	B-X
protein	B-X
accumulation	B-X
and	B-X
cause	B-X
growth	B-X
defects	B-X
that	B-X
can	B-X
be	B-X
partially	B-X
rescued	B-X
by	B-X
Gigas/Tsc2	B-X
reduction	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
FBW5-DDB1-CUL4-ROC1	B-X
is	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
regulating	B-X
TSC2	B-X
protein	B-X
stability	B-X
and	B-X
TSC	B-X
complex	B-X
turnover	B-X
.	B-X

Activation	O
of	O
TLR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
and	O
liver	O
injury	O
via	O
NF	O
-	O
kappa	O
B	O
in	O
rat	O
with	O
acute	O
cholangitis	O
.	O
<EOS>	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
are	B-X
a	B-X
family	B-X
of	B-X
type	B-X
1	B-X
transmembrane	B-X
receptors	B-X
,	B-X
which	B-X
can	B-X
recognize	B-X
different	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
.	B-X
Among	B-X
them	B-X
,	B-X
TLR-4	B-X
is	B-X
specific	B-X
to	B-X
lipopolysaccharide	B-X
.	B-X
It	B-X
transfers	B-X
the	B-X
infection	B-X
signal	B-X
into	B-X
the	B-X
cell	B-X
and	B-X
promotes	B-X
the	B-X
translocation	B-X
of	B-X
nuclear	B-X
factor	B-X
kappa	B-X
B	B-X
(	B-X
NF-kappaB	B-X
)	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
the	B-X
subsequent	B-X
transcriptional	B-X
activation	B-X
of	B-X
genes	B-X
encoding	B-X
pro-	B-X
and	B-X
anti-inflammatory	B-X
cytokines	B-X
and	B-X
chemokines	B-X
.	B-X
Acute	B-X
cholangitis	B-X
(	B-X
AC	B-X
)	B-X
is	B-X
a	B-X
common	B-X
biliary	B-X
tract	B-X
infection	B-X
in	B-X
oriental	B-X
countries	B-X
,	B-X
and	B-X
often	B-X
leads	B-X
to	B-X
liver	B-X
injury	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
TLR-4	B-X
and	B-X
its	B-X
significance	B-X
in	B-X
liver	B-X
injury	B-X
in	B-X
rats	B-X
with	B-X
AC	B-X
remain	B-X
unclear	B-X
.	B-X

BACKGROUND	O
:	O
Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
(	O
TLRs	B-Gene_or_gene_product
)	O
are	O
a	O
family	O
of	O
type	O
1	O
transmembrane	O
receptors	O
,	O
which	O
can	O
recognize	O
different	O
pathogen	O
-	O
associated	O
molecular	O
patterns	O
.	O
<EOS>	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
are	B-X
a	B-X
family	B-X
of	B-X
type	B-X
1	B-X
transmembrane	B-X
receptors	B-X
,	B-X
which	B-X
can	B-X
recognize	B-X
different	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
.	B-X

Among	O
them	O
,	O
TLR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
is	O
specific	O
to	O
lipopolysaccharide	O
.	O
<EOS>	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-induced	B-X
cognitive	B-X
impairment	B-X
and	B-X
neuroinflammation	B-X
in	B-X
C57BL/6J	B-X
mice	B-X
by	B-X
using	B-X
behavioral	B-X
tests	B-X
,	B-X
immunofluorescence	B-X
,	B-X
enzyme-linked	B-X
immunosorbent	B-X
assay	B-X
(	B-X
ELISA	B-X
)	B-X
and	B-X
Western	B-X
blot	B-X
.	B-X
The	B-X
levels	B-X
of	B-X
interleukin-4	B-X
(	B-X
IL-4	B-X
)	B-X
and	B-X
interleukin-10	B-X
(	B-X
IL-10	B-X
)	B-X
in	B-X
the	B-X
serum	B-X
and	B-X
brain	B-X
homogenates	B-X
were	B-X
reduced	B-X
by	B-X
the	B-X
LPS	B-X
treatment	B-X
,	B-X
while	B-X
the	B-X
levels	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor-α	B-X
(	B-X
TNF-α	B-X
)	B-X
,	B-X
interleukin-1β	B-X
(	B-X
IL-1β	B-X
)	B-X
,	B-X
prostaglandin	B-X
E2	B-X
(	B-X
PGE	B-X
Inflammation	B-X
,	B-X
particularly	B-X
that	B-X
mediated	B-X
by	B-X
bacterial	B-X
components	B-X
translocating	B-X
from	B-X
the	B-X
gut	B-X
to	B-X
the	B-X
liver	B-X
and	B-X
binding	B-X
to	B-X
toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
,	B-X
is	B-X
central	B-X
to	B-X
cholestatic	B-X
liver	B-X
injury	B-X
.	B-X
The	B-X
triggering	B-X
receptor	B-X
expressed	B-X
on	B-X
myeloid	B-X
cells-2	B-X
(	B-X
TREM-2	B-X
)	B-X
inhibits	B-X
TLR-mediated	B-X
signaling	B-X
and	B-X
exerts	B-X
a	B-X
protective	B-X
role	B-X
in	B-X
hepatocellular	B-X
injury	B-X
and	B-X
carcinogenesis	B-X
.	B-X

It	O
transfers	O
the	O
infection	O
signal	O
into	O
the	O
cell	O
and	O
promotes	O
the	O
translocation	O
of	O
nuclear	O
factor	O
kappa	O
B	O
(	O
NF	O
-	O
kappaB	O
)	O
to	O
the	O
nucleus	O
and	O
the	O
subsequent	O
transcriptional	O
activation	O
of	O
genes	O
encoding	O
pro	O
-	O
and	O
anti	O
-	O
inflammatory	O
cytokines	O
and	O
chemokines	O
.	O

Acute	O
cholangitis	O
(	O
AC	O
)	O
is	O
a	O
common	O
biliary	O
tract	O
infection	O
in	O
oriental	O
countries	O
,	O
and	O
often	O
leads	O
to	O
liver	O
injury	O
.	O
<EOS>	B-X
It	B-X
transfers	B-X
the	B-X
infection	B-X
signal	B-X
into	B-X
the	B-X
cell	B-X
and	B-X
promotes	B-X
the	B-X
translocation	B-X
of	B-X
nuclear	B-X
factor	B-X
kappa	B-X
B	B-X
(	B-X
NF-kappaB	B-X
)	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
the	B-X
subsequent	B-X
transcriptional	B-X
activation	B-X
of	B-X
genes	B-X
encoding	B-X
pro-	B-X
and	B-X
anti-inflammatory	B-X
cytokines	B-X
and	B-X
chemokines	B-X
.	B-X
Acute	B-X
cholangitis	B-X
(	B-X
AC	B-X
)	B-X
is	B-X
a	B-X
common	B-X
biliary	B-X
tract	B-X
infection	B-X
in	B-X
oriental	B-X
countries	B-X
,	B-X
and	B-X
often	B-X
leads	B-X
to	B-X
liver	B-X
injury	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
TLR-4	B-X
and	B-X
its	B-X
significance	B-X
in	B-X
liver	B-X
injury	B-X
in	B-X
rats	B-X
with	B-X
AC	B-X
remain	B-X
unclear	B-X
.	B-X

The	O
activation	O
of	O
TLR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
and	O
its	O
significance	O
in	O
liver	O
injury	O
in	O
rats	O
with	O
AC	O
remain	O
unclear	O
.	O
<EOS>	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
are	B-X
a	B-X
family	B-X
of	B-X
type	B-X
1	B-X
transmembrane	B-X
receptors	B-X
,	B-X
which	B-X
can	B-X
recognize	B-X
different	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
.	B-X
Among	B-X
them	B-X
,	B-X
TLR-4	B-X
is	B-X
specific	B-X
to	B-X
lipopolysaccharide	B-X
.	B-X
It	B-X
transfers	B-X
the	B-X
infection	B-X
signal	B-X
into	B-X
the	B-X
cell	B-X
and	B-X
promotes	B-X
the	B-X
translocation	B-X
of	B-X
nuclear	B-X
factor	B-X
kappa	B-X
B	B-X
(	B-X
NF-kappaB	B-X
)	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
the	B-X
subsequent	B-X
transcriptional	B-X
activation	B-X
of	B-X
genes	B-X
encoding	B-X
pro-	B-X
and	B-X
anti-inflammatory	B-X
cytokines	B-X
and	B-X
chemokines	B-X
.	B-X
Acute	B-X
cholangitis	B-X
(	B-X
AC	B-X
)	B-X
is	B-X
a	B-X
common	B-X
biliary	B-X
tract	B-X
infection	B-X
in	B-X
oriental	B-X
countries	B-X
,	B-X
and	B-X
often	B-X
leads	B-X
to	B-X
liver	B-X
injury	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
TLR-4	B-X
and	B-X
its	B-X
significance	B-X
in	B-X
liver	B-X
injury	B-X
in	B-X
rats	B-X
with	B-X
AC	B-X
remain	B-X
unclear	B-X
.	B-X

METHODS	O
:	O
Rat	O
models	O
of	O
AC	O
(	O
biliary	O
tract	O
obstruction	O
+	O
E	O
.	O
coli	O
injection	O
,	O
n	O
=	O
36	O
)	O
and	O
control	O
models	O
(	O
biliary	O
tract	O
obstruction	O
+	O
saline	O
,	O
n	O
=	O
18	O
)	O
were	O
made	O
.	O

Liver	O
tissue	O
injury	O
was	O
investigated	O
by	O
pathological	O
examination	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
hypothesis	B-X
regarding	B-X
whether	B-X
fecal	B-X
microbiota	B-X
transplantation	B-X
(	B-X
FMT	B-X
)	B-X
is	B-X
effective	B-X
in	B-X
attenuating	B-X
high-fat	B-X
diet	B-X
(	B-X
HFD	B-X
)	B-X
-induced	B-X
steatohepatitis	B-X
in	B-X
mice	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
underlying	B-X
pathological	B-X
alterations	B-X
in	B-X
liver	B-X
injury	B-X
following	B-X
heart	B-X
failure	B-X
.	B-X
Sham	B-X
operated	B-X
and	B-X
ACF	B-X
rats	B-X
were	B-X
compared	B-X
for	B-X
their	B-X
morphometric	B-X
and	B-X
hemodynamic	B-X
data	B-X
,	B-X
for	B-X
histopathological	B-X
and	B-X
ultrastructural	B-X
changes	B-X
in	B-X
the	B-X
liver	B-X
as	B-X
well	B-X
as	B-X
differences	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
apoptotic	B-X
factors	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
the	B-X
results	B-X
demonstrate	B-X
that	B-X
ACF-induced	B-X
congestive	B-X
heart	B-X
failure	B-X
causes	B-X
liver	B-X
injury	B-X
which	B-X
results	B-X
in	B-X
hepatocellular	B-X
apoptotic	B-X
cell	B-X
death	B-X
mediated	B-X
by	B-X
the	B-X
intrinsic	B-X
pathway	B-X
of	B-X
mitochondrial	B-X
cytochrome	B-X
C	B-X
leakage	B-X
and	B-X
subsequent	B-X
transfer	B-X
of	B-X
activated	B-X
caspase	B-X
3	B-X
into	B-X
to	B-X
the	B-X
nucleus	B-X
to	B-X
initiate	B-X
overt	B-X
DNA	B-X
fragmentation	B-X
and	B-X
cell	B-X
death	B-X
.	B-X

The	O
levels	O
of	O
serum	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
10	I-Gene_or_gene_product
were	O
measured	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
,	O
and	O
the	O
expressions	O
of	O
TLR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
,	O
NF	O
-	O
kappaB	O
mRNAs	O
and	O
proteins	O
in	O
the	O
liver	O
were	O
detected	O
by	O
RT	O
-	O
PCR	O
,	O
immunohistochemical	O
staining	O
and	O
Western	O
blotting	O
,	O
respectively	O
.	O

RESULTS	O
:	O
Severe	O
liver	O
tissue	O
injury	O
in	O
rats	O
with	O
AC	O
was	O
evident	O
as	O
shown	O
by	O
pathological	O
examination	O
.	O
<EOS>	B-X
Acute	B-X
cholangitis	B-X
(	B-X
AC	B-X
)	B-X
is	B-X
a	B-X
common	B-X
biliary	B-X
tract	B-X
infection	B-X
in	B-X
oriental	B-X
countries	B-X
,	B-X
and	B-X
often	B-X
leads	B-X
to	B-X
liver	B-X
injury	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
TLR-4	B-X
and	B-X
its	B-X
significance	B-X
in	B-X
liver	B-X
injury	B-X
in	B-X
rats	B-X
with	B-X
AC	B-X
remain	B-X
unclear	B-X
.	B-X

TLR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
were	O
strongly	O
expressed	O
in	O
the	O
cytoplasm	O
of	O
hepatocytes	O
in	O
the	O
AC	O
group	O
.	O

They	O
were	O
negative	O
or	O
slightly	O
positive	O
in	O
the	O
control	O
group	O
.	O
<EOS>	B-X
There	B-X
is	B-X
mixed	B-X
evidence	B-X
about	B-X
emotional	B-X
processing	B-X
abnormalities	B-X
in	B-X
schizophrenia	B-X
and	B-X
schizoaffective	B-X
disorder	B-X
,	B-X
with	B-X
self-reports	B-X
and	B-X
clinician	B-X
ratings	B-X
indicating	B-X
significant	B-X
differences	B-X
between	B-X
patients	B-X
and	B-X
controls	B-X
,	B-X
but	B-X
studies	B-X
of	B-X
in-the-moment	B-X
,	B-X
self-reported	B-X
emotional	B-X
experience	B-X
finding	B-X
only	B-X
small	B-X
differences	B-X
between	B-X
these	B-X
groups	B-X
.	B-X
Control	B-X
groups	B-X
are	B-X
expected	B-X
to	B-X
show	B-X
what	B-X
happens	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
the	B-X
intervention	B-X
of	B-X
interest	B-X
(	B-X
negative	B-X
control	B-X
)	B-X
or	B-X
the	B-X
effect	B-X
of	B-X
an	B-X
intervention	B-X
expected	B-X
to	B-X
have	B-X
an	B-X
effect	B-X
(	B-X
positive	B-X
control	B-X
)	B-X
.	B-X
Because	B-X
of	B-X
this	B-X
it	B-X
is	B-X
essential	B-X
that	B-X
they	B-X
are	B-X
treated	B-X
as	B-X
any	B-X
other	B-X
experimental	B-X
group	B-X
in	B-X
terms	B-X
of	B-X
subjects	B-X
,	B-X
randomisation	B-X
,	B-X
blinding	B-X
,	B-X
etc	B-X
.	B-X
It	B-X
also	B-X
means	B-X
that	B-X
in	B-X
almost	B-X
all	B-X
cases	B-X
,	B-X
contemporaneous	B-X
control	B-X
groups	B-X
are	B-X
required	B-X
.	B-X
Historical	B-X
and	B-X
baseline	B-X
control	B-X
groups	B-X
serve	B-X
a	B-X
slightly	B-X
different	B-X
role	B-X
and	B-X
can	B-X
not	B-X
fully	B-X
replace	B-X
control	B-X
groups	B-X
run	B-X
as	B-X
an	B-X
integral	B-X
part	B-X
of	B-X
the	B-X
experiment	B-X
.	B-X
When	B-X
used	B-X
correctly	B-X
,	B-X
a	B-X
good	B-X
control	B-X
group	B-X
not	B-X
only	B-X
validates	B-X
your	B-X
experiment	B-X
;	B-X
it	B-X
provides	B-X
the	B-X
basis	B-X
for	B-X
evaluating	B-X
the	B-X
effect	B-X
of	B-X
your	B-X
treatments	B-X
.	B-X

TLR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
mRNA	O
and	O
protein	O
in	O
the	O
liver	O
of	O
rats	O
with	O
AC	O
increased	O
1	O
hour	O
after	O
biliary	O
tract	O
ligation	O
and	O
E	O
.	O
coli	O
injection	O
,	O
and	O
peaked	O
at	O
6	O
hours	O
after	O
surgery	O
.	O

Twenty	O
-	O
four	O
hours	O
later	O
,	O
they	O
began	O
to	O
decrease	O
.	O
<EOS>	B-X
Twenty-four	B-X
hours	B-X
after	B-X
implantation	B-X
,	B-X
the	B-X
catheters	B-X
were	B-X
filled	B-X
with	B-X
distinctin	B-X
.	B-X
Thirty	B-X
minutes	B-X
later	B-X
,	B-X
rats	B-X
were	B-X
challenged	B-X
via	B-X
the	B-X
CVC	B-X
with	B-X
S.	B-X
aureus	B-X
.	B-X
Administration	B-X
of	B-X
antibiotics	B-X
into	B-X
the	B-X
CVC	B-X
at	B-X
a	B-X
concentration	B-X
equal	B-X
to	B-X
the	B-X
MBC	B-X
for	B-X
adherent	B-X
cells	B-X
,	B-X
or	B-X
at	B-X
1024	B-X
microg/mL	B-X
began	B-X
24	B-X
h	B-X
later	B-X
.	B-X
The	B-X
killing	B-X
activities	B-X
of	B-X
all	B-X
antibiotics	B-X
against	B-X
adherent	B-X
bacteria	B-X
were	B-X
at	B-X
least	B-X
four-	B-X
to	B-X
eightfold	B-X
lower	B-X
than	B-X
against	B-X
freely	B-X
growing	B-X
cells	B-X
.	B-X
The	B-X
in	B-X
vivo	B-X
studies	B-X
showed	B-X
that	B-X
when	B-X
CVCs	B-X
were	B-X
pretreated	B-X
with	B-X
distinctin	B-X
biofilm	B-X
bacterial	B-X
load	B-X
was	B-X
further	B-X
decreased	B-X
to	B-X
10	B-X
(	B-X
1	B-X
)	B-X
CFU/mL	B-X
and	B-X
bacteremia	B-X
was	B-X
not	B-X
detected	B-X
.	B-X

The	O
expression	O
of	O
TLR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
was	O
paralleled	O
by	O
that	O
of	O
NF	O
-	O
kappaB	O
in	O
the	O
liver	O
and	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
in	O
serum	O
.	O
<EOS>	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
are	B-X
a	B-X
family	B-X
of	B-X
type	B-X
1	B-X
transmembrane	B-X
receptors	B-X
,	B-X
which	B-X
can	B-X
recognize	B-X
different	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
.	B-X
Among	B-X
them	B-X
,	B-X
TLR-4	B-X
is	B-X
specific	B-X
to	B-X
lipopolysaccharide	B-X
.	B-X
It	B-X
transfers	B-X
the	B-X
infection	B-X
signal	B-X
into	B-X
the	B-X
cell	B-X
and	B-X
promotes	B-X
the	B-X
translocation	B-X
of	B-X
nuclear	B-X
factor	B-X
kappa	B-X
B	B-X
(	B-X
NF-kappaB	B-X
)	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
the	B-X
subsequent	B-X
transcriptional	B-X
activation	B-X
of	B-X
genes	B-X
encoding	B-X
pro-	B-X
and	B-X
anti-inflammatory	B-X
cytokines	B-X
and	B-X
chemokines	B-X
.	B-X
Acute	B-X
cholangitis	B-X
(	B-X
AC	B-X
)	B-X
is	B-X
a	B-X
common	B-X
biliary	B-X
tract	B-X
infection	B-X
in	B-X
oriental	B-X
countries	B-X
,	B-X
and	B-X
often	B-X
leads	B-X
to	B-X
liver	B-X
injury	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
TLR-4	B-X
and	B-X
its	B-X
significance	B-X
in	B-X
liver	B-X
injury	B-X
in	B-X
rats	B-X
with	B-X
AC	B-X
remain	B-X
unclear	B-X
.	B-X

CONCLUSION	O
:	O
The	O
higher	O
expression	O
of	O
TLR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
in	O
the	O
liver	O
of	O
rats	O
with	O
AC	O
may	O
be	O
involved	O
in	O
liver	O
injury	O
through	O
the	O
activation	O
of	O
NF	O
-	O
kappaB	O
and	O
release	O
of	O
cytokines	O
such	O
as	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
.	O
<EOS>	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLRs	B-X
)	B-X
are	B-X
a	B-X
family	B-X
of	B-X
type	B-X
1	B-X
transmembrane	B-X
receptors	B-X
,	B-X
which	B-X
can	B-X
recognize	B-X
different	B-X
pathogen-associated	B-X
molecular	B-X
patterns	B-X
.	B-X
Among	B-X
them	B-X
,	B-X
TLR-4	B-X
is	B-X
specific	B-X
to	B-X
lipopolysaccharide	B-X
.	B-X
It	B-X
transfers	B-X
the	B-X
infection	B-X
signal	B-X
into	B-X
the	B-X
cell	B-X
and	B-X
promotes	B-X
the	B-X
translocation	B-X
of	B-X
nuclear	B-X
factor	B-X
kappa	B-X
B	B-X
(	B-X
NF-kappaB	B-X
)	B-X
to	B-X
the	B-X
nucleus	B-X
and	B-X
the	B-X
subsequent	B-X
transcriptional	B-X
activation	B-X
of	B-X
genes	B-X
encoding	B-X
pro-	B-X
and	B-X
anti-inflammatory	B-X
cytokines	B-X
and	B-X
chemokines	B-X
.	B-X
Acute	B-X
cholangitis	B-X
(	B-X
AC	B-X
)	B-X
is	B-X
a	B-X
common	B-X
biliary	B-X
tract	B-X
infection	B-X
in	B-X
oriental	B-X
countries	B-X
,	B-X
and	B-X
often	B-X
leads	B-X
to	B-X
liver	B-X
injury	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
TLR-4	B-X
and	B-X
its	B-X
significance	B-X
in	B-X
liver	B-X
injury	B-X
in	B-X
rats	B-X
with	B-X
AC	B-X
remain	B-X
unclear	B-X
.	B-X

5	O
-	O
Aza	O
-	O
2	O
'	O
-	O
deoxycytidine	O
restores	O
proapoptotic	O
function	O
of	O
p53	B-Gene_or_gene_product
in	O
cancer	O
cells	O
resistant	O
to	O
p53	B-Gene_or_gene_product
-	O
induced	O
apoptosis	O
.	O
<EOS>	B-X
The	B-X
expression	B-X
of	B-X
p53-target	B-X
genes	B-X
encoding	B-X
the	B-X
proapoptotic	B-X
factor	B-X
Noxa	B-X
,	B-X
but	B-X
not	B-X
PUMA	B-X
,	B-X
was	B-X
not	B-X
induced	B-X
by	B-X
p53	B-X
in	B-X
HCT116	B-X
and	B-X
SW480	B-X
cells	B-X
,	B-X
which	B-X
show	B-X
resistance	B-X
to	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
p53	B-X
overexpression	B-X
.	B-X
The	B-X
lack	B-X
of	B-X
p53	B-X
inducibility	B-X
of	B-X
Noxa	B-X
was	B-X
restored	B-X
by	B-X
treatment	B-X
with	B-X
the	B-X
DNA	B-X
methyltransferase	B-X
inhibitor	B-X
5-Aza-2'-deoxycytidine	B-X
(	B-X
5-aza-CdR	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
p53	B-X
induced	B-X
apoptosis	B-X
in	B-X
HCT116	B-X
and	B-X
SW480	B-X
cells	B-X
treated	B-X
with	B-X
5-aza-CdR	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
inhibition	B-X
of	B-X
Noxa	B-X
expression	B-X
by	B-X
RNAi	B-X
in	B-X
5-aza-CdR-treated	B-X
HCT116	B-X
cells	B-X
resulted	B-X
in	B-X
the	B-X
partial	B-X
inhibition	B-X
of	B-X
p53-induced	B-X
apoptosis	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
epigenetic	B-X
cancer	B-X
therapy	B-X
is	B-X
possible	B-X
for	B-X
some	B-X
cancers	B-X
in	B-X
combination	B-X
with	B-X
forced	B-X
p53	B-X
activation	B-X
.	B-X

The	O
expression	O
of	O
p53	B-Gene_or_gene_product
-	O
target	O
genes	O
encoding	O
the	O
proapoptotic	O
factor	O
Noxa	B-Gene_or_gene_product
,	O
but	O
not	O
PUMA	B-Gene_or_gene_product
,	O
was	O
not	O
induced	O
by	O
p53	B-Gene_or_gene_product
in	O
HCT116	O
and	O
SW480	O
cells	O
,	O
which	O
show	O
resistance	O
to	O
apoptosis	O
in	O
response	O
to	O
p53	B-Gene_or_gene_product
overexpression	O
.	O
<EOS>	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
identified	B-X
miR-3189	B-X
as	B-X
a	B-X
novel	B-X
,	B-X
p53-regulated	B-X
,	B-X
primate-specific	B-X
miRNA	B-X
embedded	B-X
in	B-X
the	B-X
intron	B-X
of	B-X
the	B-X
p53-target	B-X
gene	B-X
GDF15	B-X
.	B-X
Antagonizing	B-X
miR-3189	B-X
increased	B-X
proliferation	B-X
and	B-X
sensitized	B-X
cells	B-X
to	B-X
DNA	B-X
damage-induced	B-X
apoptosis	B-X
,	B-X
suggesting	B-X
a	B-X
tumor	B-X
suppressor	B-X
function	B-X
for	B-X
endogenous	B-X
miR-3189	B-X
.	B-X
Identification	B-X
of	B-X
genome-wide	B-X
miR-3189	B-X
targets	B-X
revealed	B-X
that	B-X
miR-3189	B-X
directly	B-X
inhibits	B-X
the	B-X
expression	B-X
of	B-X
a	B-X
large	B-X
number	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
cell	B-X
cycle	B-X
control	B-X
and	B-X
cell	B-X
survival	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
miR-3189	B-X
downregulated	B-X
the	B-X
expression	B-X
of	B-X
multiple	B-X
p53	B-X
inhibitors	B-X
resulting	B-X
in	B-X
elevated	B-X
p53	B-X
levels	B-X
and	B-X
upregulation	B-X
of	B-X
several	B-X
p53	B-X
targets	B-X
including	B-X
p21	B-X
(	B-X
CDKN1A	B-X
)	B-X
,	B-X
GADD45A	B-X
and	B-X
the	B-X
miR-3189	B-X
host	B-X
gene	B-X
GDF15	B-X
,	B-X
suggesting	B-X
miR-3189	B-X
auto-regulation	B-X
.	B-X
Surprisingly	B-X
,	B-X
miR-3189	B-X
overexpression	B-X
in	B-X
p53-/-	B-X
cells	B-X
upregulated	B-X
a	B-X
subset	B-X
of	B-X
p53-targets	B-X
including	B-X
GDF15	B-X
,	B-X
GADD45A	B-X
,	B-X
and	B-X
NOXA	B-X
,	B-X
but	B-X
not	B-X
CDKN1A	B-X
.	B-X
Consistent	B-X
with	B-X
these	B-X
results	B-X
,	B-X
overexpression	B-X
of	B-X
miR-3189	B-X
potently	B-X
induced	B-X
apoptosis	B-X
and	B-X
inhibited	B-X
tumorigenicity	B-X
in	B-X
vivo	B-X
in	B-X
a	B-X
p53-independent	B-X
manner	B-X
.	B-X
Collectively	B-X
,	B-X
our	B-X
study	B-X
identified	B-X
miR-3189	B-X
as	B-X
a	B-X
novel	B-X
,	B-X
primate-specific	B-X
miRNA	B-X
whose	B-X
effects	B-X
are	B-X
mediated	B-X
by	B-X
both	B-X
p53-dependent	B-X
and	B-X
p53-independent	B-X
mechanisms	B-X
.	B-X
miR-3189	B-X
may	B-X
,	B-X
therefore	B-X
,	B-X
represent	B-X
a	B-X
novel	B-X
tool	B-X
that	B-X
can	B-X
be	B-X
utilized	B-X
therapeutically	B-X
to	B-X
induce	B-X
a	B-X
potent	B-X
proapoptotic	B-X
effect	B-X
even	B-X
in	B-X
p53-deficient	B-X
tumors	B-X
.	B-X

The	O
lack	O
of	O
p53	B-Gene_or_gene_product
inducibility	O
of	O
Noxa	B-Gene_or_gene_product
was	O
restored	O
by	O
treatment	O
with	O
the	O
DNA	B-Gene_or_gene_product
methyltransferase	I-Gene_or_gene_product
inhibitor	O
5	O
-	O
Aza	O
-	O
2	O
'	O
-	O
deoxycytidine	O
(	O
5	O
-	O
aza	O
-	O
CdR	O
)	O
.	O
<EOS>	B-X
The	B-X
expression	B-X
of	B-X
p53-target	B-X
genes	B-X
encoding	B-X
the	B-X
proapoptotic	B-X
factor	B-X
Noxa	B-X
,	B-X
but	B-X
not	B-X
PUMA	B-X
,	B-X
was	B-X
not	B-X
induced	B-X
by	B-X
p53	B-X
in	B-X
HCT116	B-X
and	B-X
SW480	B-X
cells	B-X
,	B-X
which	B-X
show	B-X
resistance	B-X
to	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
p53	B-X
overexpression	B-X
.	B-X
The	B-X
lack	B-X
of	B-X
p53	B-X
inducibility	B-X
of	B-X
Noxa	B-X
was	B-X
restored	B-X
by	B-X
treatment	B-X
with	B-X
the	B-X
DNA	B-X
methyltransferase	B-X
inhibitor	B-X
5-Aza-2'-deoxycytidine	B-X
(	B-X
5-aza-CdR	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
p53	B-X
induced	B-X
apoptosis	B-X
in	B-X
HCT116	B-X
and	B-X
SW480	B-X
cells	B-X
treated	B-X
with	B-X
5-aza-CdR	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
inhibition	B-X
of	B-X
Noxa	B-X
expression	B-X
by	B-X
RNAi	B-X
in	B-X
5-aza-CdR-treated	B-X
HCT116	B-X
cells	B-X
resulted	B-X
in	B-X
the	B-X
partial	B-X
inhibition	B-X
of	B-X
p53-induced	B-X
apoptosis	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
epigenetic	B-X
cancer	B-X
therapy	B-X
is	B-X
possible	B-X
for	B-X
some	B-X
cancers	B-X
in	B-X
combination	B-X
with	B-X
forced	B-X
p53	B-X
activation	B-X
.	B-X

Furthermore	O
,	O
p53	B-Gene_or_gene_product
induced	O
apoptosis	O
in	O
HCT116	O
and	O
SW480	O
cells	O
treated	O
with	O
5	O
-	O
aza	O
-	O
CdR	O
.	O
<EOS>	B-X
The	B-X
expression	B-X
of	B-X
p53-target	B-X
genes	B-X
encoding	B-X
the	B-X
proapoptotic	B-X
factor	B-X
Noxa	B-X
,	B-X
but	B-X
not	B-X
PUMA	B-X
,	B-X
was	B-X
not	B-X
induced	B-X
by	B-X
p53	B-X
in	B-X
HCT116	B-X
and	B-X
SW480	B-X
cells	B-X
,	B-X
which	B-X
show	B-X
resistance	B-X
to	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
p53	B-X
overexpression	B-X
.	B-X
The	B-X
lack	B-X
of	B-X
p53	B-X
inducibility	B-X
of	B-X
Noxa	B-X
was	B-X
restored	B-X
by	B-X
treatment	B-X
with	B-X
the	B-X
DNA	B-X
methyltransferase	B-X
inhibitor	B-X
5-Aza-2'-deoxycytidine	B-X
(	B-X
5-aza-CdR	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
p53	B-X
induced	B-X
apoptosis	B-X
in	B-X
HCT116	B-X
and	B-X
SW480	B-X
cells	B-X
treated	B-X
with	B-X
5-aza-CdR	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
inhibition	B-X
of	B-X
Noxa	B-X
expression	B-X
by	B-X
RNAi	B-X
in	B-X
5-aza-CdR-treated	B-X
HCT116	B-X
cells	B-X
resulted	B-X
in	B-X
the	B-X
partial	B-X
inhibition	B-X
of	B-X
p53-induced	B-X
apoptosis	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
epigenetic	B-X
cancer	B-X
therapy	B-X
is	B-X
possible	B-X
for	B-X
some	B-X
cancers	B-X
in	B-X
combination	B-X
with	B-X
forced	B-X
p53	B-X
activation	B-X
.	B-X

Moreover	O
,	O
the	O
inhibition	O
of	O
Noxa	B-Gene_or_gene_product
expression	O
by	O
RNAi	O
in	O
5	O
-	O
aza	O
-	O
CdR	O
-	O
treated	O
HCT116	O
cells	O
resulted	O
in	O
the	O
partial	O
inhibition	O
of	O
p53	B-Gene_or_gene_product
-	O
induced	O
apoptosis	O
.	O
<EOS>	B-X
The	B-X
expression	B-X
of	B-X
p53-target	B-X
genes	B-X
encoding	B-X
the	B-X
proapoptotic	B-X
factor	B-X
Noxa	B-X
,	B-X
but	B-X
not	B-X
PUMA	B-X
,	B-X
was	B-X
not	B-X
induced	B-X
by	B-X
p53	B-X
in	B-X
HCT116	B-X
and	B-X
SW480	B-X
cells	B-X
,	B-X
which	B-X
show	B-X
resistance	B-X
to	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
p53	B-X
overexpression	B-X
.	B-X
The	B-X
lack	B-X
of	B-X
p53	B-X
inducibility	B-X
of	B-X
Noxa	B-X
was	B-X
restored	B-X
by	B-X
treatment	B-X
with	B-X
the	B-X
DNA	B-X
methyltransferase	B-X
inhibitor	B-X
5-Aza-2'-deoxycytidine	B-X
(	B-X
5-aza-CdR	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
p53	B-X
induced	B-X
apoptosis	B-X
in	B-X
HCT116	B-X
and	B-X
SW480	B-X
cells	B-X
treated	B-X
with	B-X
5-aza-CdR	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
inhibition	B-X
of	B-X
Noxa	B-X
expression	B-X
by	B-X
RNAi	B-X
in	B-X
5-aza-CdR-treated	B-X
HCT116	B-X
cells	B-X
resulted	B-X
in	B-X
the	B-X
partial	B-X
inhibition	B-X
of	B-X
p53-induced	B-X
apoptosis	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
epigenetic	B-X
cancer	B-X
therapy	B-X
is	B-X
possible	B-X
for	B-X
some	B-X
cancers	B-X
in	B-X
combination	B-X
with	B-X
forced	B-X
p53	B-X
activation	B-X
.	B-X

These	O
results	O
suggest	O
that	O
epigenetic	O
cancer	O
therapy	O
is	O
possible	O
for	O
some	O
cancers	O
in	O
combination	O
with	O
forced	O
p53	B-Gene_or_gene_product
activation	O
.	O
<EOS>	B-X
The	B-X
expression	B-X
of	B-X
p53-target	B-X
genes	B-X
encoding	B-X
the	B-X
proapoptotic	B-X
factor	B-X
Noxa	B-X
,	B-X
but	B-X
not	B-X
PUMA	B-X
,	B-X
was	B-X
not	B-X
induced	B-X
by	B-X
p53	B-X
in	B-X
HCT116	B-X
and	B-X
SW480	B-X
cells	B-X
,	B-X
which	B-X
show	B-X
resistance	B-X
to	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
p53	B-X
overexpression	B-X
.	B-X
The	B-X
lack	B-X
of	B-X
p53	B-X
inducibility	B-X
of	B-X
Noxa	B-X
was	B-X
restored	B-X
by	B-X
treatment	B-X
with	B-X
the	B-X
DNA	B-X
methyltransferase	B-X
inhibitor	B-X
5-Aza-2'-deoxycytidine	B-X
(	B-X
5-aza-CdR	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
p53	B-X
induced	B-X
apoptosis	B-X
in	B-X
HCT116	B-X
and	B-X
SW480	B-X
cells	B-X
treated	B-X
with	B-X
5-aza-CdR	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
inhibition	B-X
of	B-X
Noxa	B-X
expression	B-X
by	B-X
RNAi	B-X
in	B-X
5-aza-CdR-treated	B-X
HCT116	B-X
cells	B-X
resulted	B-X
in	B-X
the	B-X
partial	B-X
inhibition	B-X
of	B-X
p53-induced	B-X
apoptosis	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
epigenetic	B-X
cancer	B-X
therapy	B-X
is	B-X
possible	B-X
for	B-X
some	B-X
cancers	B-X
in	B-X
combination	B-X
with	B-X
forced	B-X
p53	B-X
activation	B-X
.	B-X

Regulation	O
of	O
Bax	B-Gene_or_gene_product
activation	O
and	O
apoptotic	O
response	O
to	O
UV	O
irradiation	O
by	O
p53	B-Gene_or_gene_product
transcription	O
-	O
dependent	O
and	O
-	O
independent	O
pathways	O
.	O
<EOS>	B-X
The	B-X
Trp53	B-X
tumor	B-X
suppressor	B-X
gene	B-X
product	B-X
(	B-X
p53	B-X
)	B-X
functions	B-X
in	B-X
the	B-X
nucleus	B-X
to	B-X
regulate	B-X
proapoptotic	B-X
genes	B-X
,	B-X
whereas	B-X
cytoplasmic	B-X
p53	B-X
directly	B-X
activates	B-X
proapoptotic	B-X
Bcl-2	B-X
proteins	B-X
to	B-X
permeabilize	B-X
mitochondria	B-X
and	B-X
initiate	B-X
apoptosis	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
both	B-X
p53	B-X
transcription-dependent	B-X
and	B-X
-independent	B-X
pathways	B-X
contribute	B-X
to	B-X
UV-induced	B-X
apoptosis	B-X
.	B-X
First	B-X
we	B-X
show	B-X
that	B-X
Pifithrin-alpha	B-X
,	B-X
a	B-X
small	B-X
molecule	B-X
inhibitor	B-X
of	B-X
p53	B-X
transcriptional	B-X
activity	B-X
,	B-X
delays	B-X
Bax	B-X
translocation	B-X
and	B-X
cell	B-X
death	B-X
by	B-X
UV	B-X
irradiation	B-X
.	B-X
Then	B-X
using	B-X
CHX	B-X
(	B-X
cycloheximide	B-X
)	B-X
to	B-X
prevent	B-X
new	B-X
protein	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
p53	B-X
,	B-X
we	B-X
also	B-X
find	B-X
that	B-X
Bax	B-X
translocation	B-X
and	B-X
cell	B-X
death	B-X
by	B-X
UV	B-X
irradiation	B-X
are	B-X
delayed	B-X
.	B-X
Furthermore	B-X
we	B-X
find	B-X
that	B-X
overexpression	B-X
of	B-X
Bcl-x	B-X
(	B-X
L	B-X
)	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
cytoplasmic	B-X
p53	B-X
after	B-X
UV	B-X
irradiation	B-X
,	B-X
prevents	B-X
cell	B-X
death	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
observe	B-X
that	B-X
Pifithrin-alpha	B-X
and	B-X
CHX	B-X
effectively	B-X
inhibit	B-X
PUMA	B-X
expression	B-X
by	B-X
UV	B-X
irradiation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
indicate	B-X
that	B-X
the	B-X
nuclear	B-X
p53	B-X
promotes	B-X
PUMA	B-X
expression	B-X
,	B-X
which	B-X
then	B-X
displaces	B-X
cytoplasmic	B-X
p53	B-X
from	B-X
Bcl-x	B-X
(	B-X
L	B-X
)	B-X
,	B-X
allowing	B-X
p53	B-X
to	B-X
induce	B-X
mitochondrial	B-X
permeabilization	B-X
,	B-X
thereby	B-X
triggering	B-X
apoptosis	B-X
.	B-X

The	O
Trp53	B-Gene_or_gene_product
tumor	O
suppressor	O
gene	O
product	O
(	O
p53	B-Gene_or_gene_product
)	O
functions	O
in	O
the	O
nucleus	O
to	O
regulate	O
proapoptotic	O
genes	O
,	O
whereas	O
cytoplasmic	O
p53	B-Gene_or_gene_product
directly	O
activates	O
proapoptotic	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
proteins	O
to	O
permeabilize	O
mitochondria	O
and	O
initiate	O
apoptosis	O
.	O
<EOS>	B-X
The	B-X
Trp53	B-X
tumor	B-X
suppressor	B-X
gene	B-X
product	B-X
(	B-X
p53	B-X
)	B-X
functions	B-X
in	B-X
the	B-X
nucleus	B-X
to	B-X
regulate	B-X
proapoptotic	B-X
genes	B-X
,	B-X
whereas	B-X
cytoplasmic	B-X
p53	B-X
directly	B-X
activates	B-X
proapoptotic	B-X
Bcl-2	B-X
proteins	B-X
to	B-X
permeabilize	B-X
mitochondria	B-X
and	B-X
initiate	B-X
apoptosis	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
a	B-X
tripartite	B-X
nexus	B-X
between	B-X
Bcl-xL	B-X
,	B-X
cytoplasmic	B-X
p53	B-X
,	B-X
and	B-X
PUMA	B-X
coordinates	B-X
these	B-X
distinct	B-X
p53	B-X
functions	B-X
.	B-X
After	B-X
genotoxic	B-X
stress	B-X
,	B-X
Bcl-xL	B-X
sequestered	B-X
cytoplasmic	B-X
p53	B-X
.	B-X
Nuclear	B-X
p53	B-X
caused	B-X
expression	B-X
of	B-X
PUMA	B-X
,	B-X
which	B-X
then	B-X
displaced	B-X
p53	B-X
from	B-X
Bcl-xL	B-X
,	B-X
allowing	B-X
p53	B-X
to	B-X
induce	B-X
mitochondrial	B-X
permeabilization	B-X
.	B-X
Mutant	B-X
Bcl-xL	B-X
that	B-X
bound	B-X
p53	B-X
,	B-X
but	B-X
not	B-X
PUMA	B-X
,	B-X
rendered	B-X
cells	B-X
resistant	B-X
to	B-X
p53-induced	B-X
apoptosis	B-X
irrespective	B-X
of	B-X
PUMA	B-X
expression	B-X
.	B-X
Thus	B-X
,	B-X
PUMA	B-X
couples	B-X
the	B-X
nuclear	B-X
and	B-X
cytoplasmic	B-X
proapoptotic	B-X
functions	B-X
of	B-X
p53	B-X
.	B-X

Here	O
,	O
we	O
demonstrate	O
that	O
both	O
p53	B-Gene_or_gene_product
transcription	O
-	O
dependent	O
and	O
-	O
independent	O
pathways	O
contribute	O
to	O
UV	O
-	O
induced	O
apoptosis	O
.	O
<EOS>	B-X
The	B-X
Trp53	B-X
tumor	B-X
suppressor	B-X
gene	B-X
product	B-X
(	B-X
p53	B-X
)	B-X
functions	B-X
in	B-X
the	B-X
nucleus	B-X
to	B-X
regulate	B-X
proapoptotic	B-X
genes	B-X
,	B-X
whereas	B-X
cytoplasmic	B-X
p53	B-X
directly	B-X
activates	B-X
proapoptotic	B-X
Bcl-2	B-X
proteins	B-X
to	B-X
permeabilize	B-X
mitochondria	B-X
and	B-X
initiate	B-X
apoptosis	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
both	B-X
p53	B-X
transcription-dependent	B-X
and	B-X
-independent	B-X
pathways	B-X
contribute	B-X
to	B-X
UV-induced	B-X
apoptosis	B-X
.	B-X
First	B-X
we	B-X
show	B-X
that	B-X
Pifithrin-alpha	B-X
,	B-X
a	B-X
small	B-X
molecule	B-X
inhibitor	B-X
of	B-X
p53	B-X
transcriptional	B-X
activity	B-X
,	B-X
delays	B-X
Bax	B-X
translocation	B-X
and	B-X
cell	B-X
death	B-X
by	B-X
UV	B-X
irradiation	B-X
.	B-X
Then	B-X
using	B-X
CHX	B-X
(	B-X
cycloheximide	B-X
)	B-X
to	B-X
prevent	B-X
new	B-X
protein	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
p53	B-X
,	B-X
we	B-X
also	B-X
find	B-X
that	B-X
Bax	B-X
translocation	B-X
and	B-X
cell	B-X
death	B-X
by	B-X
UV	B-X
irradiation	B-X
are	B-X
delayed	B-X
.	B-X
Furthermore	B-X
we	B-X
find	B-X
that	B-X
overexpression	B-X
of	B-X
Bcl-x	B-X
(	B-X
L	B-X
)	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
cytoplasmic	B-X
p53	B-X
after	B-X
UV	B-X
irradiation	B-X
,	B-X
prevents	B-X
cell	B-X
death	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
observe	B-X
that	B-X
Pifithrin-alpha	B-X
and	B-X
CHX	B-X
effectively	B-X
inhibit	B-X
PUMA	B-X
expression	B-X
by	B-X
UV	B-X
irradiation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
indicate	B-X
that	B-X
the	B-X
nuclear	B-X
p53	B-X
promotes	B-X
PUMA	B-X
expression	B-X
,	B-X
which	B-X
then	B-X
displaces	B-X
cytoplasmic	B-X
p53	B-X
from	B-X
Bcl-x	B-X
(	B-X
L	B-X
)	B-X
,	B-X
allowing	B-X
p53	B-X
to	B-X
induce	B-X
mitochondrial	B-X
permeabilization	B-X
,	B-X
thereby	B-X
triggering	B-X
apoptosis	B-X
.	B-X

First	O
we	O
show	O
that	O
Pifithrin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
,	O
a	O
small	O
molecule	O
inhibitor	O
of	O
p53	B-Gene_or_gene_product
transcriptional	O
activity	O
,	O
delays	O
Bax	B-Gene_or_gene_product
translocation	O
and	O
cell	O
death	O
by	O
UV	O
irradiation	O
.	O
<EOS>	B-X
The	B-X
Trp53	B-X
tumor	B-X
suppressor	B-X
gene	B-X
product	B-X
(	B-X
p53	B-X
)	B-X
functions	B-X
in	B-X
the	B-X
nucleus	B-X
to	B-X
regulate	B-X
proapoptotic	B-X
genes	B-X
,	B-X
whereas	B-X
cytoplasmic	B-X
p53	B-X
directly	B-X
activates	B-X
proapoptotic	B-X
Bcl-2	B-X
proteins	B-X
to	B-X
permeabilize	B-X
mitochondria	B-X
and	B-X
initiate	B-X
apoptosis	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
both	B-X
p53	B-X
transcription-dependent	B-X
and	B-X
-independent	B-X
pathways	B-X
contribute	B-X
to	B-X
UV-induced	B-X
apoptosis	B-X
.	B-X
First	B-X
we	B-X
show	B-X
that	B-X
Pifithrin-alpha	B-X
,	B-X
a	B-X
small	B-X
molecule	B-X
inhibitor	B-X
of	B-X
p53	B-X
transcriptional	B-X
activity	B-X
,	B-X
delays	B-X
Bax	B-X
translocation	B-X
and	B-X
cell	B-X
death	B-X
by	B-X
UV	B-X
irradiation	B-X
.	B-X
Then	B-X
using	B-X
CHX	B-X
(	B-X
cycloheximide	B-X
)	B-X
to	B-X
prevent	B-X
new	B-X
protein	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
p53	B-X
,	B-X
we	B-X
also	B-X
find	B-X
that	B-X
Bax	B-X
translocation	B-X
and	B-X
cell	B-X
death	B-X
by	B-X
UV	B-X
irradiation	B-X
are	B-X
delayed	B-X
.	B-X
Furthermore	B-X
we	B-X
find	B-X
that	B-X
overexpression	B-X
of	B-X
Bcl-x	B-X
(	B-X
L	B-X
)	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
cytoplasmic	B-X
p53	B-X
after	B-X
UV	B-X
irradiation	B-X
,	B-X
prevents	B-X
cell	B-X
death	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
observe	B-X
that	B-X
Pifithrin-alpha	B-X
and	B-X
CHX	B-X
effectively	B-X
inhibit	B-X
PUMA	B-X
expression	B-X
by	B-X
UV	B-X
irradiation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
indicate	B-X
that	B-X
the	B-X
nuclear	B-X
p53	B-X
promotes	B-X
PUMA	B-X
expression	B-X
,	B-X
which	B-X
then	B-X
displaces	B-X
cytoplasmic	B-X
p53	B-X
from	B-X
Bcl-x	B-X
(	B-X
L	B-X
)	B-X
,	B-X
allowing	B-X
p53	B-X
to	B-X
induce	B-X
mitochondrial	B-X
permeabilization	B-X
,	B-X
thereby	B-X
triggering	B-X
apoptosis	B-X
.	B-X

Then	O
using	O
CHX	O
(	O
cycloheximide	O
)	O
to	O
prevent	O
new	O
protein	O
expression	O
in	O
response	O
to	O
p53	B-Gene_or_gene_product
,	O
we	O
also	O
find	O
that	O
Bax	B-Gene_or_gene_product
translocation	O
and	O
cell	O
death	O
by	O
UV	O
irradiation	O
are	O
delayed	O
.	O
<EOS>	B-X
The	B-X
Trp53	B-X
tumor	B-X
suppressor	B-X
gene	B-X
product	B-X
(	B-X
p53	B-X
)	B-X
functions	B-X
in	B-X
the	B-X
nucleus	B-X
to	B-X
regulate	B-X
proapoptotic	B-X
genes	B-X
,	B-X
whereas	B-X
cytoplasmic	B-X
p53	B-X
directly	B-X
activates	B-X
proapoptotic	B-X
Bcl-2	B-X
proteins	B-X
to	B-X
permeabilize	B-X
mitochondria	B-X
and	B-X
initiate	B-X
apoptosis	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
both	B-X
p53	B-X
transcription-dependent	B-X
and	B-X
-independent	B-X
pathways	B-X
contribute	B-X
to	B-X
UV-induced	B-X
apoptosis	B-X
.	B-X
First	B-X
we	B-X
show	B-X
that	B-X
Pifithrin-alpha	B-X
,	B-X
a	B-X
small	B-X
molecule	B-X
inhibitor	B-X
of	B-X
p53	B-X
transcriptional	B-X
activity	B-X
,	B-X
delays	B-X
Bax	B-X
translocation	B-X
and	B-X
cell	B-X
death	B-X
by	B-X
UV	B-X
irradiation	B-X
.	B-X
Then	B-X
using	B-X
CHX	B-X
(	B-X
cycloheximide	B-X
)	B-X
to	B-X
prevent	B-X
new	B-X
protein	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
p53	B-X
,	B-X
we	B-X
also	B-X
find	B-X
that	B-X
Bax	B-X
translocation	B-X
and	B-X
cell	B-X
death	B-X
by	B-X
UV	B-X
irradiation	B-X
are	B-X
delayed	B-X
.	B-X
Furthermore	B-X
we	B-X
find	B-X
that	B-X
overexpression	B-X
of	B-X
Bcl-x	B-X
(	B-X
L	B-X
)	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
cytoplasmic	B-X
p53	B-X
after	B-X
UV	B-X
irradiation	B-X
,	B-X
prevents	B-X
cell	B-X
death	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
observe	B-X
that	B-X
Pifithrin-alpha	B-X
and	B-X
CHX	B-X
effectively	B-X
inhibit	B-X
PUMA	B-X
expression	B-X
by	B-X
UV	B-X
irradiation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
indicate	B-X
that	B-X
the	B-X
nuclear	B-X
p53	B-X
promotes	B-X
PUMA	B-X
expression	B-X
,	B-X
which	B-X
then	B-X
displaces	B-X
cytoplasmic	B-X
p53	B-X
from	B-X
Bcl-x	B-X
(	B-X
L	B-X
)	B-X
,	B-X
allowing	B-X
p53	B-X
to	B-X
induce	B-X
mitochondrial	B-X
permeabilization	B-X
,	B-X
thereby	B-X
triggering	B-X
apoptosis	B-X
.	B-X

Furthermore	O
we	O
find	O
that	O
overexpression	O
of	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
x	I-Gene_or_gene_product
(	I-Gene_or_gene_product
L	I-Gene_or_gene_product
)	I-Gene_or_gene_product
,	O
an	O
inhibitor	O
of	O
cytoplasmic	O
p53	B-Gene_or_gene_product
after	O
UV	O
irradiation	O
,	O
prevents	O
cell	O
death	O
.	O
<EOS>	B-X
The	B-X
Trp53	B-X
tumor	B-X
suppressor	B-X
gene	B-X
product	B-X
(	B-X
p53	B-X
)	B-X
functions	B-X
in	B-X
the	B-X
nucleus	B-X
to	B-X
regulate	B-X
proapoptotic	B-X
genes	B-X
,	B-X
whereas	B-X
cytoplasmic	B-X
p53	B-X
directly	B-X
activates	B-X
proapoptotic	B-X
Bcl-2	B-X
proteins	B-X
to	B-X
permeabilize	B-X
mitochondria	B-X
and	B-X
initiate	B-X
apoptosis	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
both	B-X
p53	B-X
transcription-dependent	B-X
and	B-X
-independent	B-X
pathways	B-X
contribute	B-X
to	B-X
UV-induced	B-X
apoptosis	B-X
.	B-X
First	B-X
we	B-X
show	B-X
that	B-X
Pifithrin-alpha	B-X
,	B-X
a	B-X
small	B-X
molecule	B-X
inhibitor	B-X
of	B-X
p53	B-X
transcriptional	B-X
activity	B-X
,	B-X
delays	B-X
Bax	B-X
translocation	B-X
and	B-X
cell	B-X
death	B-X
by	B-X
UV	B-X
irradiation	B-X
.	B-X
Then	B-X
using	B-X
CHX	B-X
(	B-X
cycloheximide	B-X
)	B-X
to	B-X
prevent	B-X
new	B-X
protein	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
p53	B-X
,	B-X
we	B-X
also	B-X
find	B-X
that	B-X
Bax	B-X
translocation	B-X
and	B-X
cell	B-X
death	B-X
by	B-X
UV	B-X
irradiation	B-X
are	B-X
delayed	B-X
.	B-X
Furthermore	B-X
we	B-X
find	B-X
that	B-X
overexpression	B-X
of	B-X
Bcl-x	B-X
(	B-X
L	B-X
)	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
cytoplasmic	B-X
p53	B-X
after	B-X
UV	B-X
irradiation	B-X
,	B-X
prevents	B-X
cell	B-X
death	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
observe	B-X
that	B-X
Pifithrin-alpha	B-X
and	B-X
CHX	B-X
effectively	B-X
inhibit	B-X
PUMA	B-X
expression	B-X
by	B-X
UV	B-X
irradiation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
indicate	B-X
that	B-X
the	B-X
nuclear	B-X
p53	B-X
promotes	B-X
PUMA	B-X
expression	B-X
,	B-X
which	B-X
then	B-X
displaces	B-X
cytoplasmic	B-X
p53	B-X
from	B-X
Bcl-x	B-X
(	B-X
L	B-X
)	B-X
,	B-X
allowing	B-X
p53	B-X
to	B-X
induce	B-X
mitochondrial	B-X
permeabilization	B-X
,	B-X
thereby	B-X
triggering	B-X
apoptosis	B-X
.	B-X

Finally	O
,	O
we	O
observe	O
that	O
Pifithrin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
CHX	O
effectively	O
inhibit	O
PUMA	B-Gene_or_gene_product
expression	O
by	O
UV	O
irradiation	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
both	B-X
p53	B-X
transcription-dependent	B-X
and	B-X
-independent	B-X
pathways	B-X
contribute	B-X
to	B-X
UV-induced	B-X
apoptosis	B-X
.	B-X
First	B-X
we	B-X
show	B-X
that	B-X
Pifithrin-alpha	B-X
,	B-X
a	B-X
small	B-X
molecule	B-X
inhibitor	B-X
of	B-X
p53	B-X
transcriptional	B-X
activity	B-X
,	B-X
delays	B-X
Bax	B-X
translocation	B-X
and	B-X
cell	B-X
death	B-X
by	B-X
UV	B-X
irradiation	B-X
.	B-X
Then	B-X
using	B-X
CHX	B-X
(	B-X
cycloheximide	B-X
)	B-X
to	B-X
prevent	B-X
new	B-X
protein	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
p53	B-X
,	B-X
we	B-X
also	B-X
find	B-X
that	B-X
Bax	B-X
translocation	B-X
and	B-X
cell	B-X
death	B-X
by	B-X
UV	B-X
irradiation	B-X
are	B-X
delayed	B-X
.	B-X
Furthermore	B-X
we	B-X
find	B-X
that	B-X
overexpression	B-X
of	B-X
Bcl-x	B-X
(	B-X
L	B-X
)	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
cytoplasmic	B-X
p53	B-X
after	B-X
UV	B-X
irradiation	B-X
,	B-X
prevents	B-X
cell	B-X
death	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
observe	B-X
that	B-X
Pifithrin-alpha	B-X
and	B-X
CHX	B-X
effectively	B-X
inhibit	B-X
PUMA	B-X
expression	B-X
by	B-X
UV	B-X
irradiation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
indicate	B-X
that	B-X
the	B-X
nuclear	B-X
p53	B-X
promotes	B-X
PUMA	B-X
expression	B-X
,	B-X
which	B-X
then	B-X
displaces	B-X
cytoplasmic	B-X
p53	B-X
from	B-X
Bcl-x	B-X
(	B-X
L	B-X
)	B-X
,	B-X
allowing	B-X
p53	B-X
to	B-X
induce	B-X
mitochondrial	B-X
permeabilization	B-X
,	B-X
thereby	B-X
triggering	B-X
apoptosis	B-X
.	B-X

Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
the	O
nuclear	O
p53	B-Gene_or_gene_product
promotes	O
PUMA	B-Gene_or_gene_product
expression	O
,	O
which	O
then	O
displaces	O
cytoplasmic	O
p53	B-Gene_or_gene_product
from	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
x	I-Gene_or_gene_product
(	I-Gene_or_gene_product
L	I-Gene_or_gene_product
)	I-Gene_or_gene_product
,	O
allowing	O
p53	B-Gene_or_gene_product
to	O
induce	O
mitochondrial	O
permeabilization	O
,	O
thereby	O
triggering	O
apoptosis	O
.	O
<EOS>	B-X
The	B-X
Trp53	B-X
tumor	B-X
suppressor	B-X
gene	B-X
product	B-X
(	B-X
p53	B-X
)	B-X
functions	B-X
in	B-X
the	B-X
nucleus	B-X
to	B-X
regulate	B-X
proapoptotic	B-X
genes	B-X
,	B-X
whereas	B-X
cytoplasmic	B-X
p53	B-X
directly	B-X
activates	B-X
proapoptotic	B-X
Bcl-2	B-X
proteins	B-X
to	B-X
permeabilize	B-X
mitochondria	B-X
and	B-X
initiate	B-X
apoptosis	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
both	B-X
p53	B-X
transcription-dependent	B-X
and	B-X
-independent	B-X
pathways	B-X
contribute	B-X
to	B-X
UV-induced	B-X
apoptosis	B-X
.	B-X
First	B-X
we	B-X
show	B-X
that	B-X
Pifithrin-alpha	B-X
,	B-X
a	B-X
small	B-X
molecule	B-X
inhibitor	B-X
of	B-X
p53	B-X
transcriptional	B-X
activity	B-X
,	B-X
delays	B-X
Bax	B-X
translocation	B-X
and	B-X
cell	B-X
death	B-X
by	B-X
UV	B-X
irradiation	B-X
.	B-X
Then	B-X
using	B-X
CHX	B-X
(	B-X
cycloheximide	B-X
)	B-X
to	B-X
prevent	B-X
new	B-X
protein	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
p53	B-X
,	B-X
we	B-X
also	B-X
find	B-X
that	B-X
Bax	B-X
translocation	B-X
and	B-X
cell	B-X
death	B-X
by	B-X
UV	B-X
irradiation	B-X
are	B-X
delayed	B-X
.	B-X
Furthermore	B-X
we	B-X
find	B-X
that	B-X
overexpression	B-X
of	B-X
Bcl-x	B-X
(	B-X
L	B-X
)	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
cytoplasmic	B-X
p53	B-X
after	B-X
UV	B-X
irradiation	B-X
,	B-X
prevents	B-X
cell	B-X
death	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
observe	B-X
that	B-X
Pifithrin-alpha	B-X
and	B-X
CHX	B-X
effectively	B-X
inhibit	B-X
PUMA	B-X
expression	B-X
by	B-X
UV	B-X
irradiation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
indicate	B-X
that	B-X
the	B-X
nuclear	B-X
p53	B-X
promotes	B-X
PUMA	B-X
expression	B-X
,	B-X
which	B-X
then	B-X
displaces	B-X
cytoplasmic	B-X
p53	B-X
from	B-X
Bcl-x	B-X
(	B-X
L	B-X
)	B-X
,	B-X
allowing	B-X
p53	B-X
to	B-X
induce	B-X
mitochondrial	B-X
permeabilization	B-X
,	B-X
thereby	B-X
triggering	B-X
apoptosis	B-X
.	B-X

Identification	O
of	O
genes	O
,	O
including	O
the	O
gene	O
encoding	O
p27Kip1	B-Gene_or_gene_product
,	O
regulated	O
by	O
serine	O
276	O
phosphorylation	O
of	O
the	O
p65	B-Gene_or_gene_product
subunit	O
of	O
NF	O
-	O
kappaB	O
.	O
<EOS>	B-X
Phosphorylation	B-X
of	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-kappaB	B-X
is	B-X
required	B-X
for	B-X
its	B-X
transcriptional	B-X
activity	B-X
.	B-X
Recent	B-X
reports	B-X
show	B-X
that	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
serine	B-X
276	B-X
regulates	B-X
only	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
,	B-X
such	B-X
as	B-X
those	B-X
encoding	B-X
IL-6	B-X
,	B-X
IL-8	B-X
,	B-X
Gro-beta	B-X
,	B-X
and	B-X
ICAM-1	B-X
.	B-X
In	B-X
order	B-X
to	B-X
identify	B-X
additional	B-X
genes	B-X
regulated	B-X
by	B-X
serine	B-X
276	B-X
phosphorylation	B-X
,	B-X
HepG2	B-X
hepatoma	B-X
cells	B-X
were	B-X
infected	B-X
with	B-X
adenoviruses	B-X
encoding	B-X
either	B-X
wild-type	B-X
p65	B-X
or	B-X
the	B-X
S276A	B-X
mutant	B-X
of	B-X
p65	B-X
,	B-X
followed	B-X
by	B-X
DNA	B-X
microarray	B-X
analysis	B-X
.	B-X
The	B-X
results	B-X
show	B-X
that	B-X
mutation	B-X
of	B-X
serine	B-X
276	B-X
affected	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
genes	B-X
that	B-X
encode	B-X
proteins	B-X
involved	B-X
in	B-X
cell	B-X
cycle	B-X
regulation	B-X
,	B-X
signal	B-X
transduction	B-X
,	B-X
transcription	B-X
,	B-X
and	B-X
metabolism	B-X
.	B-X
Notably	B-X
,	B-X
expression	B-X
of	B-X
S276A	B-X
increased	B-X
the	B-X
mRNA	B-X
and	B-X
protein	B-X
level	B-X
of	B-X
p27	B-X
,	B-X
a	B-X
cell	B-X
cycle	B-X
inhibitory	B-X
protein	B-X
,	B-X
which	B-X
led	B-X
to	B-X
an	B-X
increased	B-X
association	B-X
of	B-X
p27	B-X
with	B-X
cdk2	B-X
,	B-X
and	B-X
inhibition	B-X
of	B-X
cdk2	B-X
activity	B-X
.	B-X
Furthermore	B-X
,	B-X
while	B-X
wild-type	B-X
NF-kappaB	B-X
is	B-X
known	B-X
to	B-X
increase	B-X
cell	B-X
proliferation	B-X
in	B-X
a	B-X
number	B-X
of	B-X
different	B-X
cancer	B-X
cell	B-X
lines	B-X
,	B-X
our	B-X
data	B-X
shows	B-X
that	B-X
S276A	B-X
inhibited	B-X
cell	B-X
proliferation	B-X
.	B-X
Evidence	B-X
is	B-X
mounting	B-X
that	B-X
NF-kappaB	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
oncogenesis	B-X
.	B-X
Therapeutic	B-X
agents	B-X
that	B-X
regulate	B-X
the	B-X
phosphorylation	B-X
of	B-X
serine	B-X
276	B-X
and	B-X
p27	B-X
gene	B-X
expression	B-X
,	B-X
therefore	B-X
,	B-X
may	B-X
be	B-X
useful	B-X
as	B-X
anti-cancer	B-X
agents	B-X
in	B-X
the	B-X
future	B-X
.	B-X

Phosphorylation	O
of	O
the	O
p65	B-Gene_or_gene_product
subunit	O
of	O
NF	O
-	O
kappaB	O
is	O
required	O
for	O
its	O
transcriptional	O
activity	O
.	O
<EOS>	B-X
Nuclear	B-X
factor	B-X
κB	B-X
(	B-X
NF-κB	B-X
)	B-X
is	B-X
a	B-X
master	B-X
regulator	B-X
of	B-X
inflammation	B-X
and	B-X
cell	B-X
death	B-X
.	B-X
Whereas	B-X
most	B-X
of	B-X
the	B-X
activity	B-X
of	B-X
NF-κB	B-X
is	B-X
regulated	B-X
through	B-X
the	B-X
inhibitor	B-X
of	B-X
κB	B-X
(	B-X
IκB	B-X
)	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
-dependent	B-X
degradation	B-X
of	B-X
IκB	B-X
,	B-X
IKK	B-X
also	B-X
phosphorylates	B-X
subunits	B-X
of	B-X
NF-κB	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
contribution	B-X
of	B-X
the	B-X
phosphorylation	B-X
of	B-X
the	B-X
NF-κB	B-X
subunit	B-X
p65	B-X
at	B-X
the	B-X
IKK	B-X
phosphorylation	B-X
site	B-X
serine	B-X
536	B-X
(	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
)	B-X
in	B-X
humans	B-X
,	B-X
which	B-X
is	B-X
thought	B-X
to	B-X
be	B-X
required	B-X
for	B-X
the	B-X
activation	B-X
and	B-X
nuclear	B-X
translocation	B-X
of	B-X
NF-κB	B-X
.	B-X
Through	B-X
experiments	B-X
with	B-X
knock-in	B-X
mice	B-X
(	B-X
S534A	B-X
mice	B-X
)	B-X
expressing	B-X
a	B-X
mutant	B-X
p65	B-X
with	B-X
an	B-X
alanine-to-serine	B-X
substitution	B-X
at	B-X
position	B-X
534	B-X
(	B-X
the	B-X
murine	B-X
homolog	B-X
of	B-X
human	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
)	B-X
,	B-X
we	B-X
observed	B-X
increased	B-X
expression	B-X
of	B-X
NF-κB-dependent	B-X
genes	B-X
after	B-X
injection	B-X
of	B-X
mice	B-X
with	B-X
the	B-X
inflammatory	B-X
stimulus	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
or	B-X
exposure	B-X
to	B-X
gamma	B-X
irradiation	B-X
,	B-X
and	B-X
the	B-X
enhanced	B-X
gene	B-X
expression	B-X
was	B-X
most	B-X
pronounced	B-X
at	B-X
late	B-X
time	B-X
points	B-X
.	B-X
Increased	B-X
NF-κB	B-X
signaling	B-X
in	B-X
the	B-X
S534A	B-X
mice	B-X
was	B-X
at	B-X
least	B-X
in	B-X
part	B-X
explained	B-X
by	B-X
the	B-X
increased	B-X
stability	B-X
of	B-X
the	B-X
S534A	B-X
p65	B-X
protein	B-X
compared	B-X
to	B-X
that	B-X
of	B-X
the	B-X
Ser	B-X
(	B-X
534	B-X
)	B-X
-phosphorylated	B-X
wild-type	B-X
protein	B-X
.	B-X
Together	B-X
,	B-X
our	B-X
results	B-X
suggest	B-X
that	B-X
Ser	B-X
(	B-X
534	B-X
)	B-X
phosphorylation	B-X
of	B-X
p65	B-X
in	B-X
mice	B-X
(	B-X
and	B-X
,	B-X
by	B-X
extension	B-X
,	B-X
Ser	B-X
(	B-X
536	B-X
)	B-X
phosphorylation	B-X
of	B-X
human	B-X
p65	B-X
)	B-X
is	B-X
not	B-X
required	B-X
for	B-X
its	B-X
nuclear	B-X
translocation	B-X
,	B-X
but	B-X
instead	B-X
inhibits	B-X
NF-κB	B-X
signaling	B-X
to	B-X
prevent	B-X
deleterious	B-X
inflammation	B-X
.	B-X

Recent	O
reports	O
show	O
that	O
phosphorylation	O
of	O
p65	B-Gene_or_gene_product
at	O
serine	O
276	O
regulates	O
only	O
a	O
subset	O
of	O
genes	O
,	O
such	O
as	O
those	O
encoding	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
,	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
8	I-Gene_or_gene_product
,	O
Gro	B-Gene_or_gene_product
-	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
,	O
and	O
ICAM	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O

In	O
order	O
to	O
identify	O
additional	O
genes	O
regulated	O
by	O
serine	O
276	O
phosphorylation	O
,	O
HepG2	O
hepatoma	O
cells	O
were	O
infected	O
with	O
adenoviruses	O
encoding	O
either	O
wild	O
-	O
type	O
p65	B-Gene_or_gene_product
or	O
the	O
S276A	B-Gene_or_gene_product
mutant	O
of	O
p65	B-Gene_or_gene_product
,	O
followed	O
by	O
DNA	O
microarray	O
analysis	O
.	O
<EOS>	B-X
Phosphorylation	B-X
of	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-kappaB	B-X
is	B-X
required	B-X
for	B-X
its	B-X
transcriptional	B-X
activity	B-X
.	B-X
Recent	B-X
reports	B-X
show	B-X
that	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
serine	B-X
276	B-X
regulates	B-X
only	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
,	B-X
such	B-X
as	B-X
those	B-X
encoding	B-X
IL-6	B-X
,	B-X
IL-8	B-X
,	B-X
Gro-beta	B-X
,	B-X
and	B-X
ICAM-1	B-X
.	B-X
In	B-X
order	B-X
to	B-X
identify	B-X
additional	B-X
genes	B-X
regulated	B-X
by	B-X
serine	B-X
276	B-X
phosphorylation	B-X
,	B-X
HepG2	B-X
hepatoma	B-X
cells	B-X
were	B-X
infected	B-X
with	B-X
adenoviruses	B-X
encoding	B-X
either	B-X
wild-type	B-X
p65	B-X
or	B-X
the	B-X
S276A	B-X
mutant	B-X
of	B-X
p65	B-X
,	B-X
followed	B-X
by	B-X
DNA	B-X
microarray	B-X
analysis	B-X
.	B-X
The	B-X
results	B-X
show	B-X
that	B-X
mutation	B-X
of	B-X
serine	B-X
276	B-X
affected	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
genes	B-X
that	B-X
encode	B-X
proteins	B-X
involved	B-X
in	B-X
cell	B-X
cycle	B-X
regulation	B-X
,	B-X
signal	B-X
transduction	B-X
,	B-X
transcription	B-X
,	B-X
and	B-X
metabolism	B-X
.	B-X
Notably	B-X
,	B-X
expression	B-X
of	B-X
S276A	B-X
increased	B-X
the	B-X
mRNA	B-X
and	B-X
protein	B-X
level	B-X
of	B-X
p27	B-X
,	B-X
a	B-X
cell	B-X
cycle	B-X
inhibitory	B-X
protein	B-X
,	B-X
which	B-X
led	B-X
to	B-X
an	B-X
increased	B-X
association	B-X
of	B-X
p27	B-X
with	B-X
cdk2	B-X
,	B-X
and	B-X
inhibition	B-X
of	B-X
cdk2	B-X
activity	B-X
.	B-X
Furthermore	B-X
,	B-X
while	B-X
wild-type	B-X
NF-kappaB	B-X
is	B-X
known	B-X
to	B-X
increase	B-X
cell	B-X
proliferation	B-X
in	B-X
a	B-X
number	B-X
of	B-X
different	B-X
cancer	B-X
cell	B-X
lines	B-X
,	B-X
our	B-X
data	B-X
shows	B-X
that	B-X
S276A	B-X
inhibited	B-X
cell	B-X
proliferation	B-X
.	B-X
Evidence	B-X
is	B-X
mounting	B-X
that	B-X
NF-kappaB	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
oncogenesis	B-X
.	B-X
Therapeutic	B-X
agents	B-X
that	B-X
regulate	B-X
the	B-X
phosphorylation	B-X
of	B-X
serine	B-X
276	B-X
and	B-X
p27	B-X
gene	B-X
expression	B-X
,	B-X
therefore	B-X
,	B-X
may	B-X
be	B-X
useful	B-X
as	B-X
anti-cancer	B-X
agents	B-X
in	B-X
the	B-X
future	B-X
.	B-X

The	O
results	O
show	O
that	O
mutation	O
of	O
serine	O
276	O
affected	O
the	O
expression	O
of	O
several	O
genes	O
that	O
encode	O
proteins	O
involved	O
in	O
cell	O
cycle	O
regulation	O
,	O
signal	O
transduction	O
,	O
transcription	O
,	O
and	O
metabolism	O
.	O
<EOS>	B-X
Phosphorylation	B-X
of	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-kappaB	B-X
is	B-X
required	B-X
for	B-X
its	B-X
transcriptional	B-X
activity	B-X
.	B-X
Recent	B-X
reports	B-X
show	B-X
that	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
serine	B-X
276	B-X
regulates	B-X
only	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
,	B-X
such	B-X
as	B-X
those	B-X
encoding	B-X
IL-6	B-X
,	B-X
IL-8	B-X
,	B-X
Gro-beta	B-X
,	B-X
and	B-X
ICAM-1	B-X
.	B-X
In	B-X
order	B-X
to	B-X
identify	B-X
additional	B-X
genes	B-X
regulated	B-X
by	B-X
serine	B-X
276	B-X
phosphorylation	B-X
,	B-X
HepG2	B-X
hepatoma	B-X
cells	B-X
were	B-X
infected	B-X
with	B-X
adenoviruses	B-X
encoding	B-X
either	B-X
wild-type	B-X
p65	B-X
or	B-X
the	B-X
S276A	B-X
mutant	B-X
of	B-X
p65	B-X
,	B-X
followed	B-X
by	B-X
DNA	B-X
microarray	B-X
analysis	B-X
.	B-X
The	B-X
results	B-X
show	B-X
that	B-X
mutation	B-X
of	B-X
serine	B-X
276	B-X
affected	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
genes	B-X
that	B-X
encode	B-X
proteins	B-X
involved	B-X
in	B-X
cell	B-X
cycle	B-X
regulation	B-X
,	B-X
signal	B-X
transduction	B-X
,	B-X
transcription	B-X
,	B-X
and	B-X
metabolism	B-X
.	B-X
Notably	B-X
,	B-X
expression	B-X
of	B-X
S276A	B-X
increased	B-X
the	B-X
mRNA	B-X
and	B-X
protein	B-X
level	B-X
of	B-X
p27	B-X
,	B-X
a	B-X
cell	B-X
cycle	B-X
inhibitory	B-X
protein	B-X
,	B-X
which	B-X
led	B-X
to	B-X
an	B-X
increased	B-X
association	B-X
of	B-X
p27	B-X
with	B-X
cdk2	B-X
,	B-X
and	B-X
inhibition	B-X
of	B-X
cdk2	B-X
activity	B-X
.	B-X
Furthermore	B-X
,	B-X
while	B-X
wild-type	B-X
NF-kappaB	B-X
is	B-X
known	B-X
to	B-X
increase	B-X
cell	B-X
proliferation	B-X
in	B-X
a	B-X
number	B-X
of	B-X
different	B-X
cancer	B-X
cell	B-X
lines	B-X
,	B-X
our	B-X
data	B-X
shows	B-X
that	B-X
S276A	B-X
inhibited	B-X
cell	B-X
proliferation	B-X
.	B-X
Evidence	B-X
is	B-X
mounting	B-X
that	B-X
NF-kappaB	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
oncogenesis	B-X
.	B-X
Therapeutic	B-X
agents	B-X
that	B-X
regulate	B-X
the	B-X
phosphorylation	B-X
of	B-X
serine	B-X
276	B-X
and	B-X
p27	B-X
gene	B-X
expression	B-X
,	B-X
therefore	B-X
,	B-X
may	B-X
be	B-X
useful	B-X
as	B-X
anti-cancer	B-X
agents	B-X
in	B-X
the	B-X
future	B-X
.	B-X

Notably	O
,	O
expression	O
of	O
S276A	B-Gene_or_gene_product
increased	O
the	O
mRNA	O
and	O
protein	O
level	O
of	O
p27	B-Gene_or_gene_product
,	O
a	O
cell	O
cycle	O
inhibitory	O
protein	O
,	O
which	O
led	O
to	O
an	O
increased	O
association	O
of	O
p27	B-Gene_or_gene_product
with	O
cdk2	B-Gene_or_gene_product
,	O
and	O
inhibition	O
of	O
cdk2	B-Gene_or_gene_product
activity	O
.	O

Furthermore	O
,	O
while	O
wild	O
-	O
type	O
NF	O
-	O
kappaB	O
is	O
known	O
to	O
increase	O
cell	O
proliferation	O
in	O
a	O
number	O
of	O
different	O
cancer	O
cell	O
lines	O
,	O
our	O
data	O
shows	O
that	O
S276A	B-Gene_or_gene_product
inhibited	O
cell	O
proliferation	O
.	O

Evidence	O
is	O
mounting	O
that	O
NF	O
-	O
kappaB	O
plays	O
a	O
pivotal	O
role	O
in	O
oncogenesis	O
.	O

Therapeutic	O
agents	O
that	O
regulate	O
the	O
phosphorylation	O
of	O
serine	O
276	O
and	O
p27	B-Gene_or_gene_product
gene	O
expression	O
,	O
therefore	O
,	O
may	O
be	O
useful	O
as	O
anti	O
-	O
cancer	O
agents	O
in	O
the	O
future	O
.	O
<EOS>	B-X
Recent	B-X
reports	B-X
show	B-X
that	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
serine	B-X
276	B-X
regulates	B-X
only	B-X
a	B-X
subset	B-X
of	B-X
genes	B-X
,	B-X
such	B-X
as	B-X
those	B-X
encoding	B-X
IL-6	B-X
,	B-X
IL-8	B-X
,	B-X
Gro-beta	B-X
,	B-X
and	B-X
ICAM-1	B-X
.	B-X
In	B-X
order	B-X
to	B-X
identify	B-X
additional	B-X
genes	B-X
regulated	B-X
by	B-X
serine	B-X
276	B-X
phosphorylation	B-X
,	B-X
HepG2	B-X
hepatoma	B-X
cells	B-X
were	B-X
infected	B-X
with	B-X
adenoviruses	B-X
encoding	B-X
either	B-X
wild-type	B-X
p65	B-X
or	B-X
the	B-X
S276A	B-X
mutant	B-X
of	B-X
p65	B-X
,	B-X
followed	B-X
by	B-X
DNA	B-X
microarray	B-X
analysis	B-X
.	B-X
The	B-X
results	B-X
show	B-X
that	B-X
mutation	B-X
of	B-X
serine	B-X
276	B-X
affected	B-X
the	B-X
expression	B-X
of	B-X
several	B-X
genes	B-X
that	B-X
encode	B-X
proteins	B-X
involved	B-X
in	B-X
cell	B-X
cycle	B-X
regulation	B-X
,	B-X
signal	B-X
transduction	B-X
,	B-X
transcription	B-X
,	B-X
and	B-X
metabolism	B-X
.	B-X
Notably	B-X
,	B-X
expression	B-X
of	B-X
S276A	B-X
increased	B-X
the	B-X
mRNA	B-X
and	B-X
protein	B-X
level	B-X
of	B-X
p27	B-X
,	B-X
a	B-X
cell	B-X
cycle	B-X
inhibitory	B-X
protein	B-X
,	B-X
which	B-X
led	B-X
to	B-X
an	B-X
increased	B-X
association	B-X
of	B-X
p27	B-X
with	B-X
cdk2	B-X
,	B-X
and	B-X
inhibition	B-X
of	B-X
cdk2	B-X
activity	B-X
.	B-X
Furthermore	B-X
,	B-X
while	B-X
wild-type	B-X
NF-kappaB	B-X
is	B-X
known	B-X
to	B-X
increase	B-X
cell	B-X
proliferation	B-X
in	B-X
a	B-X
number	B-X
of	B-X
different	B-X
cancer	B-X
cell	B-X
lines	B-X
,	B-X
our	B-X
data	B-X
shows	B-X
that	B-X
S276A	B-X
inhibited	B-X
cell	B-X
proliferation	B-X
.	B-X
Evidence	B-X
is	B-X
mounting	B-X
that	B-X
NF-kappaB	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
oncogenesis	B-X
.	B-X
Therapeutic	B-X
agents	B-X
that	B-X
regulate	B-X
the	B-X
phosphorylation	B-X
of	B-X
serine	B-X
276	B-X
and	B-X
p27	B-X
gene	B-X
expression	B-X
,	B-X
therefore	B-X
,	B-X
may	B-X
be	B-X
useful	B-X
as	B-X
anti-cancer	B-X
agents	B-X
in	B-X
the	B-X
future	B-X
.	B-X

Analysis	O
of	O
nucleocytoplasmic	O
shuttling	O
of	O
NF	O
kappa	O
B	O
proteins	O
in	O
human	O
leukocytes	O
.	O
<EOS>	B-X
Controlled	B-X
nucleocytoplasmic	B-X
localization	B-X
regulates	B-X
activity	B-X
of	B-X
NF	B-X
kappa	B-X
B	B-X
as	B-X
well	B-X
as	B-X
other	B-X
transcription	B-X
factors	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
nucleocytoplasmic	B-X
protein	B-X
shuttling	B-X
has	B-X
been	B-X
greatly	B-X
facilitated	B-X
by	B-X
the	B-X
use	B-X
of	B-X
leptomycin	B-X
B	B-X
(	B-X
LMB	B-X
)	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
CRM1-dependent	B-X
nuclear	B-X
export	B-X
.	B-X
The	B-X
authors	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
LMB	B-X
inhibits	B-X
NF	B-X
kappa	B-X
B	B-X
activity	B-X
in	B-X
human	B-X
neutrophils	B-X
by	B-X
increasing	B-X
the	B-X
nuclear	B-X
accumulation	B-X
of	B-X
NF	B-X
kappa	B-X
B	B-X
inhibitor	B-X
,	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
.	B-X
In	B-X
this	B-X
chapter	B-X
,	B-X
the	B-X
authors	B-X
describe	B-X
a	B-X
protocol	B-X
that	B-X
uses	B-X
LMB	B-X
to	B-X
study	B-X
the	B-X
nucleocytoplasmic	B-X
shuttling	B-X
of	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
in	B-X
human	B-X
macrophage-like	B-X
U937	B-X
cells	B-X
,	B-X
thus	B-X
inhibiting	B-X
NF	B-X
kappa	B-X
B	B-X
activity	B-X
.	B-X
This	B-X
protocol	B-X
should	B-X
be	B-X
readily	B-X
adaptable	B-X
to	B-X
analyze	B-X
the	B-X
nucleocytoplasmic	B-X
shuttling	B-X
of	B-X
other	B-X
proteins	B-X
in	B-X
human	B-X
leukocytes	B-X
.	B-X

Controlled	O
nucleocytoplasmic	O
localization	O
regulates	O
activity	O
of	O
NF	O
kappa	O
B	O
as	O
well	O
as	O
other	O
transcription	O
factors	O
.	O
<EOS>	B-X
Controlled	B-X
nucleocytoplasmic	B-X
localization	B-X
regulates	B-X
activity	B-X
of	B-X
NF	B-X
kappa	B-X
B	B-X
as	B-X
well	B-X
as	B-X
other	B-X
transcription	B-X
factors	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
nucleocytoplasmic	B-X
protein	B-X
shuttling	B-X
has	B-X
been	B-X
greatly	B-X
facilitated	B-X
by	B-X
the	B-X
use	B-X
of	B-X
leptomycin	B-X
B	B-X
(	B-X
LMB	B-X
)	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
CRM1-dependent	B-X
nuclear	B-X
export	B-X
.	B-X
The	B-X
authors	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
LMB	B-X
inhibits	B-X
NF	B-X
kappa	B-X
B	B-X
activity	B-X
in	B-X
human	B-X
neutrophils	B-X
by	B-X
increasing	B-X
the	B-X
nuclear	B-X
accumulation	B-X
of	B-X
NF	B-X
kappa	B-X
B	B-X
inhibitor	B-X
,	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
.	B-X
In	B-X
this	B-X
chapter	B-X
,	B-X
the	B-X
authors	B-X
describe	B-X
a	B-X
protocol	B-X
that	B-X
uses	B-X
LMB	B-X
to	B-X
study	B-X
the	B-X
nucleocytoplasmic	B-X
shuttling	B-X
of	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
in	B-X
human	B-X
macrophage-like	B-X
U937	B-X
cells	B-X
,	B-X
thus	B-X
inhibiting	B-X
NF	B-X
kappa	B-X
B	B-X
activity	B-X
.	B-X
This	B-X
protocol	B-X
should	B-X
be	B-X
readily	B-X
adaptable	B-X
to	B-X
analyze	B-X
the	B-X
nucleocytoplasmic	B-X
shuttling	B-X
of	B-X
other	B-X
proteins	B-X
in	B-X
human	B-X
leukocytes	B-X
.	B-X

Analysis	O
of	O
the	O
nucleocytoplasmic	O
protein	O
shuttling	O
has	O
been	O
greatly	O
facilitated	O
by	O
the	O
use	O
of	O
leptomycin	O
B	O
(	O
LMB	O
)	O
,	O
an	O
inhibitor	O
of	O
CRM1	B-Gene_or_gene_product
-	O
dependent	O
nuclear	O
export	O
.	O
<EOS>	B-X
Controlled	B-X
nucleocytoplasmic	B-X
localization	B-X
regulates	B-X
activity	B-X
of	B-X
NF	B-X
kappa	B-X
B	B-X
as	B-X
well	B-X
as	B-X
other	B-X
transcription	B-X
factors	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
nucleocytoplasmic	B-X
protein	B-X
shuttling	B-X
has	B-X
been	B-X
greatly	B-X
facilitated	B-X
by	B-X
the	B-X
use	B-X
of	B-X
leptomycin	B-X
B	B-X
(	B-X
LMB	B-X
)	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
CRM1-dependent	B-X
nuclear	B-X
export	B-X
.	B-X
The	B-X
authors	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
LMB	B-X
inhibits	B-X
NF	B-X
kappa	B-X
B	B-X
activity	B-X
in	B-X
human	B-X
neutrophils	B-X
by	B-X
increasing	B-X
the	B-X
nuclear	B-X
accumulation	B-X
of	B-X
NF	B-X
kappa	B-X
B	B-X
inhibitor	B-X
,	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
.	B-X
In	B-X
this	B-X
chapter	B-X
,	B-X
the	B-X
authors	B-X
describe	B-X
a	B-X
protocol	B-X
that	B-X
uses	B-X
LMB	B-X
to	B-X
study	B-X
the	B-X
nucleocytoplasmic	B-X
shuttling	B-X
of	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
in	B-X
human	B-X
macrophage-like	B-X
U937	B-X
cells	B-X
,	B-X
thus	B-X
inhibiting	B-X
NF	B-X
kappa	B-X
B	B-X
activity	B-X
.	B-X
This	B-X
protocol	B-X
should	B-X
be	B-X
readily	B-X
adaptable	B-X
to	B-X
analyze	B-X
the	B-X
nucleocytoplasmic	B-X
shuttling	B-X
of	B-X
other	B-X
proteins	B-X
in	B-X
human	B-X
leukocytes	B-X
.	B-X

The	O
authors	O
have	O
previously	O
shown	O
that	O
LMB	O
inhibits	O
NF	O
kappa	O
B	O
activity	O
in	O
human	O
neutrophils	O
by	O
increasing	O
the	O
nuclear	O
accumulation	O
of	O
NF	O
kappa	O
B	O
inhibitor	O
,	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
.	O

In	O
this	O
chapter	O
,	O
the	O
authors	O
describe	O
a	O
protocol	O
that	O
uses	O
LMB	O
to	O
study	O
the	O
nucleocytoplasmic	O
shuttling	O
of	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
in	O
human	O
macrophage	O
-	O
like	O
U937	O
cells	O
,	O
thus	O
inhibiting	O
NF	O
kappa	O
B	O
activity	O
.	O

This	O
protocol	O
should	O
be	O
readily	O
adaptable	O
to	O
analyze	O
the	O
nucleocytoplasmic	O
shuttling	O
of	O
other	O
proteins	O
in	O
human	O
leukocytes	O
.	O
<EOS>	B-X
Controlled	B-X
nucleocytoplasmic	B-X
localization	B-X
regulates	B-X
activity	B-X
of	B-X
NF	B-X
kappa	B-X
B	B-X
as	B-X
well	B-X
as	B-X
other	B-X
transcription	B-X
factors	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
nucleocytoplasmic	B-X
protein	B-X
shuttling	B-X
has	B-X
been	B-X
greatly	B-X
facilitated	B-X
by	B-X
the	B-X
use	B-X
of	B-X
leptomycin	B-X
B	B-X
(	B-X
LMB	B-X
)	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
CRM1-dependent	B-X
nuclear	B-X
export	B-X
.	B-X
The	B-X
authors	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
LMB	B-X
inhibits	B-X
NF	B-X
kappa	B-X
B	B-X
activity	B-X
in	B-X
human	B-X
neutrophils	B-X
by	B-X
increasing	B-X
the	B-X
nuclear	B-X
accumulation	B-X
of	B-X
NF	B-X
kappa	B-X
B	B-X
inhibitor	B-X
,	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
.	B-X
In	B-X
this	B-X
chapter	B-X
,	B-X
the	B-X
authors	B-X
describe	B-X
a	B-X
protocol	B-X
that	B-X
uses	B-X
LMB	B-X
to	B-X
study	B-X
the	B-X
nucleocytoplasmic	B-X
shuttling	B-X
of	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
in	B-X
human	B-X
macrophage-like	B-X
U937	B-X
cells	B-X
,	B-X
thus	B-X
inhibiting	B-X
NF	B-X
kappa	B-X
B	B-X
activity	B-X
.	B-X
This	B-X
protocol	B-X
should	B-X
be	B-X
readily	B-X
adaptable	B-X
to	B-X
analyze	B-X
the	B-X
nucleocytoplasmic	B-X
shuttling	B-X
of	B-X
other	B-X
proteins	B-X
in	B-X
human	B-X
leukocytes	B-X
.	B-X

Wnt	B-Gene_or_gene_product
pathway	O
,	O
an	O
essential	O
role	O
in	O
bone	O
regeneration	O
.	O
<EOS>	B-X
Although	B-X
histology	B-X
characteristics	B-X
at	B-X
various	B-X
phases	B-X
of	B-X
fracture	B-X
repair	B-X
are	B-X
clear	B-X
and	B-X
well	B-X
established	B-X
,	B-X
much	B-X
remains	B-X
to	B-X
be	B-X
understood	B-X
about	B-X
the	B-X
process	B-X
of	B-X
bone	B-X
healing	B-X
,	B-X
particularly	B-X
at	B-X
the	B-X
molecular	B-X
signaling	B-X
level	B-X
.	B-X
During	B-X
the	B-X
past	B-X
decade	B-X
,	B-X
secreted	B-X
signaling	B-X
molecules	B-X
of	B-X
the	B-X
Wnt	B-X
family	B-X
have	B-X
been	B-X
widely	B-X
investigated	B-X
and	B-X
found	B-X
to	B-X
play	B-X
a	B-X
central	B-X
role	B-X
in	B-X
controlling	B-X
embryonic	B-X
development	B-X
processes	B-X
.	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
also	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
bone	B-X
mass	B-X
.	B-X
Recent	B-X
published	B-X
data	B-X
reveal	B-X
that	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
is	B-X
activated	B-X
during	B-X
postnatal	B-X
bone	B-X
regenerative	B-X
events	B-X
,	B-X
such	B-X
as	B-X
ectopic	B-X
endochondral	B-X
bone	B-X
formation	B-X
and	B-X
fracture	B-X
repair	B-X
.	B-X
Dysregulation	B-X
of	B-X
this	B-X
pathway	B-X
greatly	B-X
inhibits	B-X
bone	B-X
formation	B-X
and	B-X
healing	B-X
process	B-X
.	B-X
Interestingly	B-X
,	B-X
activation	B-X
of	B-X
Wnt	B-X
pathway	B-X
has	B-X
potential	B-X
to	B-X
improve	B-X
bone	B-X
healing	B-X
,	B-X
but	B-X
only	B-X
utilized	B-X
after	B-X
mesenchymal	B-X
cells	B-X
have	B-X
become	B-X
committed	B-X
to	B-X
the	B-X
osteoblast	B-X
lineage	B-X
.	B-X
These	B-X
advances	B-X
suggest	B-X
an	B-X
essential	B-X
role	B-X
of	B-X
Wnt	B-X
pathway	B-X
in	B-X
bone	B-X
regeneration	B-X
.	B-X

Fracture	O
repair	O
is	O
a	O
complex	O
regenerative	O
process	O
initiated	O
in	O
response	O
to	O
injury	O
,	O
resulting	O
in	O
optimal	O
restoration	O
of	O
skeletal	O
function	O
.	O
<EOS>	B-X
Fracture	B-X
repair	B-X
is	B-X
a	B-X
complex	B-X
regenerative	B-X
process	B-X
initiated	B-X
in	B-X
response	B-X
to	B-X
injury	B-X
,	B-X
resulting	B-X
in	B-X
optimal	B-X
restoration	B-X
of	B-X
skeletal	B-X
function	B-X
.	B-X
Although	B-X
histology	B-X
characteristics	B-X
at	B-X
various	B-X
phases	B-X
of	B-X
fracture	B-X
repair	B-X
are	B-X
clear	B-X
and	B-X
well	B-X
established	B-X
,	B-X
much	B-X
remains	B-X
to	B-X
be	B-X
understood	B-X
about	B-X
the	B-X
process	B-X
of	B-X
bone	B-X
healing	B-X
,	B-X
particularly	B-X
at	B-X
the	B-X
molecular	B-X
signaling	B-X
level	B-X
.	B-X
During	B-X
the	B-X
past	B-X
decade	B-X
,	B-X
secreted	B-X
signaling	B-X
molecules	B-X
of	B-X
the	B-X
Wnt	B-X
family	B-X
have	B-X
been	B-X
widely	B-X
investigated	B-X
and	B-X
found	B-X
to	B-X
play	B-X
a	B-X
central	B-X
role	B-X
in	B-X
controlling	B-X
embryonic	B-X
development	B-X
processes	B-X
.	B-X
Recent	B-X
published	B-X
data	B-X
reveal	B-X
that	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
is	B-X
activated	B-X
during	B-X
postnatal	B-X
bone	B-X
regenerative	B-X
events	B-X
,	B-X
such	B-X
as	B-X
ectopic	B-X
endochondral	B-X
bone	B-X
formation	B-X
and	B-X
fracture	B-X
repair	B-X
.	B-X
Dysregulation	B-X
of	B-X
this	B-X
pathway	B-X
greatly	B-X
inhibits	B-X
bone	B-X
formation	B-X
and	B-X
healing	B-X
process	B-X
.	B-X

Although	O
histology	O
characteristics	O
at	O
various	O
phases	O
of	O
fracture	O
repair	O
are	O
clear	O
and	O
well	O
established	O
,	O
much	O
remains	O
to	O
be	O
understood	O
about	O
the	O
process	O
of	O
bone	O
healing	O
,	O
particularly	O
at	O
the	O
molecular	O
signaling	O
level	O
.	O
<EOS>	B-X
Fracture	B-X
repair	B-X
is	B-X
a	B-X
complex	B-X
regenerative	B-X
process	B-X
initiated	B-X
in	B-X
response	B-X
to	B-X
injury	B-X
,	B-X
resulting	B-X
in	B-X
optimal	B-X
restoration	B-X
of	B-X
skeletal	B-X
function	B-X
.	B-X
Although	B-X
histology	B-X
characteristics	B-X
at	B-X
various	B-X
phases	B-X
of	B-X
fracture	B-X
repair	B-X
are	B-X
clear	B-X
and	B-X
well	B-X
established	B-X
,	B-X
much	B-X
remains	B-X
to	B-X
be	B-X
understood	B-X
about	B-X
the	B-X
process	B-X
of	B-X
bone	B-X
healing	B-X
,	B-X
particularly	B-X
at	B-X
the	B-X
molecular	B-X
signaling	B-X
level	B-X
.	B-X
During	B-X
the	B-X
past	B-X
decade	B-X
,	B-X
secreted	B-X
signaling	B-X
molecules	B-X
of	B-X
the	B-X
Wnt	B-X
family	B-X
have	B-X
been	B-X
widely	B-X
investigated	B-X
and	B-X
found	B-X
to	B-X
play	B-X
a	B-X
central	B-X
role	B-X
in	B-X
controlling	B-X
embryonic	B-X
development	B-X
processes	B-X
.	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
also	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
bone	B-X
mass	B-X
.	B-X
Recent	B-X
published	B-X
data	B-X
reveal	B-X
that	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
is	B-X
activated	B-X
during	B-X
postnatal	B-X
bone	B-X
regenerative	B-X
events	B-X
,	B-X
such	B-X
as	B-X
ectopic	B-X
endochondral	B-X
bone	B-X
formation	B-X
and	B-X
fracture	B-X
repair	B-X
.	B-X
Dysregulation	B-X
of	B-X
this	B-X
pathway	B-X
greatly	B-X
inhibits	B-X
bone	B-X
formation	B-X
and	B-X
healing	B-X
process	B-X
.	B-X
Interestingly	B-X
,	B-X
activation	B-X
of	B-X
Wnt	B-X
pathway	B-X
has	B-X
potential	B-X
to	B-X
improve	B-X
bone	B-X
healing	B-X
,	B-X
but	B-X
only	B-X
utilized	B-X
after	B-X
mesenchymal	B-X
cells	B-X
have	B-X
become	B-X
committed	B-X
to	B-X
the	B-X
osteoblast	B-X
lineage	B-X
.	B-X
These	B-X
advances	B-X
suggest	B-X
an	B-X
essential	B-X
role	B-X
of	B-X
Wnt	B-X
pathway	B-X
in	B-X
bone	B-X
regeneration	B-X
.	B-X

During	O
the	O
past	O
decade	O
,	O
secreted	O
signaling	O
molecules	O
of	O
the	O
Wnt	B-Gene_or_gene_product
family	O
have	O
been	O
widely	O
investigated	O
and	O
found	O
to	O
play	O
a	O
central	O
role	O
in	O
controlling	O
embryonic	O
development	O
processes	O
.	O
<EOS>	B-X
Although	B-X
histology	B-X
characteristics	B-X
at	B-X
various	B-X
phases	B-X
of	B-X
fracture	B-X
repair	B-X
are	B-X
clear	B-X
and	B-X
well	B-X
established	B-X
,	B-X
much	B-X
remains	B-X
to	B-X
be	B-X
understood	B-X
about	B-X
the	B-X
process	B-X
of	B-X
bone	B-X
healing	B-X
,	B-X
particularly	B-X
at	B-X
the	B-X
molecular	B-X
signaling	B-X
level	B-X
.	B-X
During	B-X
the	B-X
past	B-X
decade	B-X
,	B-X
secreted	B-X
signaling	B-X
molecules	B-X
of	B-X
the	B-X
Wnt	B-X
family	B-X
have	B-X
been	B-X
widely	B-X
investigated	B-X
and	B-X
found	B-X
to	B-X
play	B-X
a	B-X
central	B-X
role	B-X
in	B-X
controlling	B-X
embryonic	B-X
development	B-X
processes	B-X
.	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
also	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
bone	B-X
mass	B-X
.	B-X
Recent	B-X
published	B-X
data	B-X
reveal	B-X
that	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
is	B-X
activated	B-X
during	B-X
postnatal	B-X
bone	B-X
regenerative	B-X
events	B-X
,	B-X
such	B-X
as	B-X
ectopic	B-X
endochondral	B-X
bone	B-X
formation	B-X
and	B-X
fracture	B-X
repair	B-X
.	B-X
Interestingly	B-X
,	B-X
activation	B-X
of	B-X
Wnt	B-X
pathway	B-X
has	B-X
potential	B-X
to	B-X
improve	B-X
bone	B-X
healing	B-X
,	B-X
but	B-X
only	B-X
utilized	B-X
after	B-X
mesenchymal	B-X
cells	B-X
have	B-X
become	B-X
committed	B-X
to	B-X
the	B-X
osteoblast	B-X
lineage	B-X
.	B-X
These	B-X
advances	B-X
suggest	B-X
an	B-X
essential	B-X
role	B-X
of	B-X
Wnt	B-X
pathway	B-X
in	B-X
bone	B-X
regeneration	B-X
.	B-X

Wnt	B-Gene_or_gene_product
signaling	O
pathway	O
also	O
plays	O
a	O
pivotal	O
role	O
in	O
the	O
regulation	O
of	O
bone	O
mass	O
.	O

Recent	O
published	O
data	O
reveal	O
that	O
Wnt	B-Gene_or_gene_product
signaling	O
pathway	O
is	O
activated	O
during	O
postnatal	O
bone	O
regenerative	O
events	O
,	O
such	O
as	O
ectopic	O
endochondral	O
bone	O
formation	O
and	O
fracture	O
repair	O
.	O
<EOS>	B-X
Fracture	B-X
repair	B-X
is	B-X
a	B-X
complex	B-X
regenerative	B-X
process	B-X
initiated	B-X
in	B-X
response	B-X
to	B-X
injury	B-X
,	B-X
resulting	B-X
in	B-X
optimal	B-X
restoration	B-X
of	B-X
skeletal	B-X
function	B-X
.	B-X
Although	B-X
histology	B-X
characteristics	B-X
at	B-X
various	B-X
phases	B-X
of	B-X
fracture	B-X
repair	B-X
are	B-X
clear	B-X
and	B-X
well	B-X
established	B-X
,	B-X
much	B-X
remains	B-X
to	B-X
be	B-X
understood	B-X
about	B-X
the	B-X
process	B-X
of	B-X
bone	B-X
healing	B-X
,	B-X
particularly	B-X
at	B-X
the	B-X
molecular	B-X
signaling	B-X
level	B-X
.	B-X
During	B-X
the	B-X
past	B-X
decade	B-X
,	B-X
secreted	B-X
signaling	B-X
molecules	B-X
of	B-X
the	B-X
Wnt	B-X
family	B-X
have	B-X
been	B-X
widely	B-X
investigated	B-X
and	B-X
found	B-X
to	B-X
play	B-X
a	B-X
central	B-X
role	B-X
in	B-X
controlling	B-X
embryonic	B-X
development	B-X
processes	B-X
.	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
also	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
bone	B-X
mass	B-X
.	B-X
Recent	B-X
published	B-X
data	B-X
reveal	B-X
that	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
is	B-X
activated	B-X
during	B-X
postnatal	B-X
bone	B-X
regenerative	B-X
events	B-X
,	B-X
such	B-X
as	B-X
ectopic	B-X
endochondral	B-X
bone	B-X
formation	B-X
and	B-X
fracture	B-X
repair	B-X
.	B-X
Dysregulation	B-X
of	B-X
this	B-X
pathway	B-X
greatly	B-X
inhibits	B-X
bone	B-X
formation	B-X
and	B-X
healing	B-X
process	B-X
.	B-X
Interestingly	B-X
,	B-X
activation	B-X
of	B-X
Wnt	B-X
pathway	B-X
has	B-X
potential	B-X
to	B-X
improve	B-X
bone	B-X
healing	B-X
,	B-X
but	B-X
only	B-X
utilized	B-X
after	B-X
mesenchymal	B-X
cells	B-X
have	B-X
become	B-X
committed	B-X
to	B-X
the	B-X
osteoblast	B-X
lineage	B-X
.	B-X
These	B-X
advances	B-X
suggest	B-X
an	B-X
essential	B-X
role	B-X
of	B-X
Wnt	B-X
pathway	B-X
in	B-X
bone	B-X
regeneration	B-X
.	B-X

Dysregulation	O
of	O
this	O
pathway	O
greatly	O
inhibits	O
bone	O
formation	O
and	O
healing	O
process	O
.	O
<EOS>	B-X
Fracture	B-X
repair	B-X
is	B-X
a	B-X
complex	B-X
regenerative	B-X
process	B-X
initiated	B-X
in	B-X
response	B-X
to	B-X
injury	B-X
,	B-X
resulting	B-X
in	B-X
optimal	B-X
restoration	B-X
of	B-X
skeletal	B-X
function	B-X
.	B-X
Although	B-X
histology	B-X
characteristics	B-X
at	B-X
various	B-X
phases	B-X
of	B-X
fracture	B-X
repair	B-X
are	B-X
clear	B-X
and	B-X
well	B-X
established	B-X
,	B-X
much	B-X
remains	B-X
to	B-X
be	B-X
understood	B-X
about	B-X
the	B-X
process	B-X
of	B-X
bone	B-X
healing	B-X
,	B-X
particularly	B-X
at	B-X
the	B-X
molecular	B-X
signaling	B-X
level	B-X
.	B-X
During	B-X
the	B-X
past	B-X
decade	B-X
,	B-X
secreted	B-X
signaling	B-X
molecules	B-X
of	B-X
the	B-X
Wnt	B-X
family	B-X
have	B-X
been	B-X
widely	B-X
investigated	B-X
and	B-X
found	B-X
to	B-X
play	B-X
a	B-X
central	B-X
role	B-X
in	B-X
controlling	B-X
embryonic	B-X
development	B-X
processes	B-X
.	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
also	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
bone	B-X
mass	B-X
.	B-X
Recent	B-X
published	B-X
data	B-X
reveal	B-X
that	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
is	B-X
activated	B-X
during	B-X
postnatal	B-X
bone	B-X
regenerative	B-X
events	B-X
,	B-X
such	B-X
as	B-X
ectopic	B-X
endochondral	B-X
bone	B-X
formation	B-X
and	B-X
fracture	B-X
repair	B-X
.	B-X
Dysregulation	B-X
of	B-X
this	B-X
pathway	B-X
greatly	B-X
inhibits	B-X
bone	B-X
formation	B-X
and	B-X
healing	B-X
process	B-X
.	B-X
Interestingly	B-X
,	B-X
activation	B-X
of	B-X
Wnt	B-X
pathway	B-X
has	B-X
potential	B-X
to	B-X
improve	B-X
bone	B-X
healing	B-X
,	B-X
but	B-X
only	B-X
utilized	B-X
after	B-X
mesenchymal	B-X
cells	B-X
have	B-X
become	B-X
committed	B-X
to	B-X
the	B-X
osteoblast	B-X
lineage	B-X
.	B-X
These	B-X
advances	B-X
suggest	B-X
an	B-X
essential	B-X
role	B-X
of	B-X
Wnt	B-X
pathway	B-X
in	B-X
bone	B-X
regeneration	B-X
.	B-X

Interestingly	O
,	O
activation	O
of	O
Wnt	B-Gene_or_gene_product
pathway	O
has	O
potential	O
to	O
improve	O
bone	O
healing	O
,	O
but	O
only	O
utilized	O
after	O
mesenchymal	O
cells	O
have	O
become	O
committed	O
to	O
the	O
osteoblast	O
lineage	O
.	O

These	O
advances	O
suggest	O
an	O
essential	O
role	O
of	O
Wnt	B-Gene_or_gene_product
pathway	O
in	O
bone	O
regeneration	O
.	O
<EOS>	B-X
Although	B-X
histology	B-X
characteristics	B-X
at	B-X
various	B-X
phases	B-X
of	B-X
fracture	B-X
repair	B-X
are	B-X
clear	B-X
and	B-X
well	B-X
established	B-X
,	B-X
much	B-X
remains	B-X
to	B-X
be	B-X
understood	B-X
about	B-X
the	B-X
process	B-X
of	B-X
bone	B-X
healing	B-X
,	B-X
particularly	B-X
at	B-X
the	B-X
molecular	B-X
signaling	B-X
level	B-X
.	B-X
During	B-X
the	B-X
past	B-X
decade	B-X
,	B-X
secreted	B-X
signaling	B-X
molecules	B-X
of	B-X
the	B-X
Wnt	B-X
family	B-X
have	B-X
been	B-X
widely	B-X
investigated	B-X
and	B-X
found	B-X
to	B-X
play	B-X
a	B-X
central	B-X
role	B-X
in	B-X
controlling	B-X
embryonic	B-X
development	B-X
processes	B-X
.	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
also	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
bone	B-X
mass	B-X
.	B-X
Recent	B-X
published	B-X
data	B-X
reveal	B-X
that	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
is	B-X
activated	B-X
during	B-X
postnatal	B-X
bone	B-X
regenerative	B-X
events	B-X
,	B-X
such	B-X
as	B-X
ectopic	B-X
endochondral	B-X
bone	B-X
formation	B-X
and	B-X
fracture	B-X
repair	B-X
.	B-X
Dysregulation	B-X
of	B-X
this	B-X
pathway	B-X
greatly	B-X
inhibits	B-X
bone	B-X
formation	B-X
and	B-X
healing	B-X
process	B-X
.	B-X
Interestingly	B-X
,	B-X
activation	B-X
of	B-X
Wnt	B-X
pathway	B-X
has	B-X
potential	B-X
to	B-X
improve	B-X
bone	B-X
healing	B-X
,	B-X
but	B-X
only	B-X
utilized	B-X
after	B-X
mesenchymal	B-X
cells	B-X
have	B-X
become	B-X
committed	B-X
to	B-X
the	B-X
osteoblast	B-X
lineage	B-X
.	B-X
These	B-X
advances	B-X
suggest	B-X
an	B-X
essential	B-X
role	B-X
of	B-X
Wnt	B-X
pathway	B-X
in	B-X
bone	B-X
regeneration	B-X
.	B-X

Biomechanical	O
thresholds	O
regulate	O
inflammation	O
through	O
the	O
NF	O
-	O
kappaB	O
pathway	O
:	O
experiments	O
and	O
modeling	O
.	O
<EOS>	B-X
However	B-X
,	B-X
at	B-X
non-physiologic	B-X
levels	B-X
these	B-X
signals	B-X
can	B-X
induce	B-X
inflammation	B-X
and	B-X
initiate	B-X
cartilage	B-X
destruction	B-X
.	B-X

BACKGROUND	O
:	O
During	O
normal	O
physical	O
activities	O
cartilage	O
experiences	O
dynamic	O
compressive	O
forces	O
that	O
are	O
essential	O
to	O
maintain	O
cartilage	O
integrity	O
.	O
<EOS>	B-X
During	B-X
normal	B-X
physical	B-X
activities	B-X
cartilage	B-X
experiences	B-X
dynamic	B-X
compressive	B-X
forces	B-X
that	B-X
are	B-X
essential	B-X
to	B-X
maintain	B-X
cartilage	B-X
integrity	B-X
.	B-X
However	B-X
,	B-X
at	B-X
non-physiologic	B-X
levels	B-X
these	B-X
signals	B-X
can	B-X
induce	B-X
inflammation	B-X
and	B-X
initiate	B-X
cartilage	B-X
destruction	B-X
.	B-X
Here	B-X
,	B-X
by	B-X
examining	B-X
the	B-X
pro-inflammatory	B-X
signaling	B-X
networks	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
mathematical	B-X
model	B-X
to	B-X
show	B-X
the	B-X
magnitude-dependent	B-X
regulation	B-X
of	B-X
chondrocytic	B-X
responses	B-X
by	B-X
compressive	B-X
forces	B-X
.	B-X

However	O
,	O
at	O
non	O
-	O
physiologic	O
levels	O
these	O
signals	O
can	O
induce	O
inflammation	O
and	O
initiate	O
cartilage	O
destruction	O
.	O
<EOS>	B-X
During	B-X
normal	B-X
physical	B-X
activities	B-X
cartilage	B-X
experiences	B-X
dynamic	B-X
compressive	B-X
forces	B-X
that	B-X
are	B-X
essential	B-X
to	B-X
maintain	B-X
cartilage	B-X
integrity	B-X
.	B-X
However	B-X
,	B-X
at	B-X
non-physiologic	B-X
levels	B-X
these	B-X
signals	B-X
can	B-X
induce	B-X
inflammation	B-X
and	B-X
initiate	B-X
cartilage	B-X
destruction	B-X
.	B-X

Here	O
,	O
by	O
examining	O
the	O
pro	O
-	O
inflammatory	O
signaling	O
networks	O
,	O
we	O
developed	O
a	O
mathematical	O
model	O
to	O
show	O
the	O
magnitude	O
-	O
dependent	O
regulation	O
of	O
chondrocytic	O
responses	O
by	O
compressive	O
forces	O
.	O
<EOS>	B-X
During	B-X
normal	B-X
physical	B-X
activities	B-X
cartilage	B-X
experiences	B-X
dynamic	B-X
compressive	B-X
forces	B-X
that	B-X
are	B-X
essential	B-X
to	B-X
maintain	B-X
cartilage	B-X
integrity	B-X
.	B-X
Here	B-X
,	B-X
by	B-X
examining	B-X
the	B-X
pro-inflammatory	B-X
signaling	B-X
networks	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
mathematical	B-X
model	B-X
to	B-X
show	B-X
the	B-X
magnitude-dependent	B-X
regulation	B-X
of	B-X
chondrocytic	B-X
responses	B-X
by	B-X
compressive	B-X
forces	B-X
.	B-X

METHODOLOGY	O
/	O
PRINCIPAL	O
FINDINGS	O
:	O
Chondrocytic	O
cells	O
grown	O
in	O
3	O
-	O
D	O
scaffolds	O
were	O
subjected	O
to	O
various	O
magnitudes	O
of	O
dynamic	O
compressive	O
strain	O
(	O
DCS	O
)	O
,	O
and	O
the	O
regulation	O
of	O
pro	O
-	O
inflammatory	O
gene	O
expression	O
via	O
activation	O
of	O
nuclear	O
factor	O
-	O
kappa	O
B	O
(	O
NF	O
-	O
kappaB	O
)	O
signaling	O
cascade	O
examined	O
.	O
<EOS>	B-X
During	B-X
normal	B-X
physical	B-X
activities	B-X
cartilage	B-X
experiences	B-X
dynamic	B-X
compressive	B-X
forces	B-X
that	B-X
are	B-X
essential	B-X
to	B-X
maintain	B-X
cartilage	B-X
integrity	B-X
.	B-X
Here	B-X
,	B-X
by	B-X
examining	B-X
the	B-X
pro-inflammatory	B-X
signaling	B-X
networks	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
mathematical	B-X
model	B-X
to	B-X
show	B-X
the	B-X
magnitude-dependent	B-X
regulation	B-X
of	B-X
chondrocytic	B-X
responses	B-X
by	B-X
compressive	B-X
forces	B-X
.	B-X

Experimental	O
evidences	O
provide	O
the	O
existence	O
of	O
a	O
threshold	O
in	O
the	O
magnitude	O
of	O
DCS	O
that	O
regulates	O
the	O
mRNA	O
expression	O
of	O
nitric	B-Gene_or_gene_product
oxide	I-Gene_or_gene_product
synthase	I-Gene_or_gene_product
(	O
NOS2	B-Gene_or_gene_product
)	O
,	O
an	O
inducible	O
pro	O
-	O
inflammatory	O
enzyme	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
by	B-X
examining	B-X
the	B-X
pro-inflammatory	B-X
signaling	B-X
networks	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
mathematical	B-X
model	B-X
to	B-X
show	B-X
the	B-X
magnitude-dependent	B-X
regulation	B-X
of	B-X
chondrocytic	B-X
responses	B-X
by	B-X
compressive	B-X
forces	B-X
.	B-X

Interestingly	O
,	O
below	O
this	O
threshold	O
,	O
DCS	O
inhibits	O
the	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1beta	I-Gene_or_gene_product
(	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1beta	I-Gene_or_gene_product
)	O
-	O
induced	O
pro	O
-	O
inflammatory	O
gene	O
expression	O
,	O
with	O
the	O
degree	O
of	O
suppression	O
depending	O
on	O
the	O
magnitude	O
of	O
DCS	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
by	B-X
examining	B-X
the	B-X
pro-inflammatory	B-X
signaling	B-X
networks	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
mathematical	B-X
model	B-X
to	B-X
show	B-X
the	B-X
magnitude-dependent	B-X
regulation	B-X
of	B-X
chondrocytic	B-X
responses	B-X
by	B-X
compressive	B-X
forces	B-X
.	B-X

This	O
suppression	O
of	O
NOS2	B-Gene_or_gene_product
by	O
DCS	O
correlates	O
with	O
the	O
attenuation	O
of	O
the	O
NF	O
-	O
kappaB	O
signaling	O
pathway	O
as	O
measured	O
by	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1beta	I-Gene_or_gene_product
-	O
induced	O
phosphorylation	O
of	O
the	O
inhibitor	O
of	O
kappa	B-Gene_or_gene_product
B	I-Gene_or_gene_product
(	I-Gene_or_gene_product
IkappaB	I-Gene_or_gene_product
)	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
,	O
degradation	O
of	O
IkappaB	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
IkappaB	B-Gene_or_gene_product
-	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
,	O
and	O
subsequent	O
nuclear	O
translocation	O
of	O
NF	O
-	O
kappaB	O
p65	B-Gene_or_gene_product
.	O
<EOS>	B-X
Here	B-X
,	B-X
by	B-X
examining	B-X
the	B-X
pro-inflammatory	B-X
signaling	B-X
networks	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
mathematical	B-X
model	B-X
to	B-X
show	B-X
the	B-X
magnitude-dependent	B-X
regulation	B-X
of	B-X
chondrocytic	B-X
responses	B-X
by	B-X
compressive	B-X
forces	B-X
.	B-X

A	O
mathematical	O
model	O
developed	O
to	O
understand	O
the	O
complex	O
dynamics	O
of	O
the	O
system	O
predicts	O
two	O
thresholds	O
in	O
the	O
magnitudes	O
of	O
DCS	O
,	O
one	O
for	O
the	O
inhibition	O
of	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1beta	I-Gene_or_gene_product
-	O
induced	O
expression	O
of	O
NOS2	B-Gene_or_gene_product
by	O
DCS	O
at	O
low	O
magnitudes	O
,	O
and	O
second	O
for	O
the	O
DCS	O
-	O
induced	O
expression	O
of	O
NOS2	B-Gene_or_gene_product
at	O
higher	O
magnitudes	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
by	B-X
examining	B-X
the	B-X
pro-inflammatory	B-X
signaling	B-X
networks	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
mathematical	B-X
model	B-X
to	B-X
show	B-X
the	B-X
magnitude-dependent	B-X
regulation	B-X
of	B-X
chondrocytic	B-X
responses	B-X
by	B-X
compressive	B-X
forces	B-X
.	B-X

CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
Experimental	O
and	O
computational	O
results	O
indicate	O
that	O
biomechanical	O
signals	O
suppress	O
and	O
induce	O
inflammation	O
at	O
critical	O
thresholds	O
through	O
activation	O
/	O
suppression	O
of	O
the	O
NF	O
-	O
kappaB	O
signaling	O
pathway	O
.	O
<EOS>	B-X
However	B-X
,	B-X
at	B-X
non-physiologic	B-X
levels	B-X
these	B-X
signals	B-X
can	B-X
induce	B-X
inflammation	B-X
and	B-X
initiate	B-X
cartilage	B-X
destruction	B-X
.	B-X
Here	B-X
,	B-X
by	B-X
examining	B-X
the	B-X
pro-inflammatory	B-X
signaling	B-X
networks	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
mathematical	B-X
model	B-X
to	B-X
show	B-X
the	B-X
magnitude-dependent	B-X
regulation	B-X
of	B-X
chondrocytic	B-X
responses	B-X
by	B-X
compressive	B-X
forces	B-X
.	B-X

These	O
thresholds	O
arise	O
due	O
to	O
the	O
bistable	O
behavior	O
of	O
the	O
networks	O
originating	O
from	O
the	O
positive	O
feedback	O
loop	O
between	O
NF	O
-	O
kappaB	O
and	O
its	O
target	O
genes	O
.	O

These	O
findings	O
lay	O
initial	O
groundwork	O
for	O
the	O
identification	O
of	O
the	O
thresholds	O
in	O
physical	O
activities	O
that	O
can	O
differentiate	O
its	O
favorable	O
actions	O
from	O
its	O
unfavorable	O
consequences	O
on	O
joints	O
.	O
<EOS>	B-X
During	B-X
normal	B-X
physical	B-X
activities	B-X
cartilage	B-X
experiences	B-X
dynamic	B-X
compressive	B-X
forces	B-X
that	B-X
are	B-X
essential	B-X
to	B-X
maintain	B-X
cartilage	B-X
integrity	B-X
.	B-X

The	O
isolation	O
,	O
total	O
synthesis	O
and	O
structure	O
elucidation	O
of	O
chlorofusin	O
,	O
a	O
natural	O
product	O
inhibitor	O
of	O
the	O
p53	B-Gene_or_gene_product
-	O
mDM2	B-Gene_or_gene_product
protein	O
-	O
protein	O
interaction	O
.	O
<EOS>	B-X
Inhibitors	B-X
of	B-X
key	B-X
protein-protein	B-X
interactions	B-X
are	B-X
emerging	B-X
as	B-X
exciting	B-X
therapeutic	B-X
targets	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
cancer	B-X
.	B-X
One	B-X
such	B-X
interaction	B-X
between	B-X
MDM2	B-X
(	B-X
HDM2	B-X
)	B-X
and	B-X
p53	B-X
,	B-X
that	B-X
silences	B-X
the	B-X
tumour	B-X
suppression	B-X
activities	B-X
of	B-X
p53	B-X
,	B-X
was	B-X
found	B-X
to	B-X
be	B-X
inhibited	B-X
by	B-X
the	B-X
recently	B-X
isolated	B-X
natural	B-X
product	B-X
chlorofusin	B-X
.	B-X
Synthetic	B-X
studies	B-X
on	B-X
this	B-X
complex	B-X
natural	B-X
product	B-X
summarized	B-X
herein	B-X
have	B-X
served	B-X
to	B-X
reassign	B-X
its	B-X
chromophore	B-X
relative	B-X
stereochemistry	B-X
,	B-X
assign	B-X
its	B-X
absolute	B-X
stereochemistry	B-X
,	B-X
and	B-X
provided	B-X
access	B-X
to	B-X
a	B-X
series	B-X
of	B-X
key	B-X
analogues	B-X
and	B-X
partial	B-X
structures	B-X
for	B-X
biological	B-X
evaluation	B-X
.	B-X

Inhibitors	O
of	O
key	O
protein	O
-	O
protein	O
interactions	O
are	O
emerging	O
as	O
exciting	O
therapeutic	O
targets	O
for	O
the	O
treatment	O
of	O
cancer	O
.	O
<EOS>	B-X
Epigenetics	B-X
has	B-X
emerged	B-X
as	B-X
an	B-X
extremely	B-X
exciting	B-X
fast-growing	B-X
area	B-X
of	B-X
biomedical	B-X
research	B-X
in	B-X
post	B-X
genome	B-X
era	B-X
.	B-X
Epigenetic	B-X
dysfunction	B-X
is	B-X
tightly	B-X
related	B-X
with	B-X
various	B-X
diseases	B-X
such	B-X
as	B-X
cancer	B-X
and	B-X
aging	B-X
related	B-X
degeneration	B-X
,	B-X
potentiating	B-X
epigenetics	B-X
modulators	B-X
as	B-X
important	B-X
therapeutics	B-X
targets	B-X
.	B-X
It	B-X
is	B-X
well	B-X
known	B-X
that	B-X
epigenetic	B-X
modifications	B-X
are	B-X
usually	B-X
carried	B-X
out	B-X
by	B-X
multi-protein	B-X
complexes	B-X
,	B-X
and	B-X
activation	B-X
of	B-X
catalytic	B-X
subunit	B-X
is	B-X
often	B-X
tightly	B-X
regulated	B-X
by	B-X
other	B-X
interactive	B-X
protein	B-X
component	B-X
,	B-X
especially	B-X
in	B-X
disease	B-X
conditions	B-X
.	B-X
Therefore	B-X
,	B-X
it	B-X
is	B-X
not	B-X
unusual	B-X
that	B-X
epigenetic	B-X
complex	B-X
machinery	B-X
may	B-X
exhibit	B-X
allosteric	B-X
regulation	B-X
site	B-X
induced	B-X
by	B-X
protein-protein	B-X
interactions	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
highlight	B-X
recent	B-X
progress	B-X
in	B-X
the	B-X
development	B-X
of	B-X
allosteric	B-X
inhibitors	B-X
for	B-X
epigenetic	B-X
complexes	B-X
through	B-X
targeting	B-X
protein-protein	B-X
interactions	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
provide	B-X
perspectives	B-X
of	B-X
future	B-X
novel	B-X
allosteric	B-X
epigenetic	B-X
machinery	B-X
modulators	B-X
emerging	B-X
from	B-X
otherwise	B-X
undruggable	B-X
single	B-X
protein	B-X
target	B-X
.	B-X

One	O
such	O
interaction	O
between	O
MDM2	B-Gene_or_gene_product
(	O
HDM2	B-Gene_or_gene_product
)	O
and	O
p53	B-Gene_or_gene_product
,	O
that	O
silences	O
the	O
tumour	O
suppression	O
activities	O
of	O
p53	B-Gene_or_gene_product
,	O
was	O
found	O
to	O
be	O
inhibited	O
by	O
the	O
recently	O
isolated	O
natural	O
product	O
chlorofusin	O
.	O
<EOS>	B-X
Inhibitors	B-X
of	B-X
key	B-X
protein-protein	B-X
interactions	B-X
are	B-X
emerging	B-X
as	B-X
exciting	B-X
therapeutic	B-X
targets	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
cancer	B-X
.	B-X
One	B-X
such	B-X
interaction	B-X
between	B-X
MDM2	B-X
(	B-X
HDM2	B-X
)	B-X
and	B-X
p53	B-X
,	B-X
that	B-X
silences	B-X
the	B-X
tumour	B-X
suppression	B-X
activities	B-X
of	B-X
p53	B-X
,	B-X
was	B-X
found	B-X
to	B-X
be	B-X
inhibited	B-X
by	B-X
the	B-X
recently	B-X
isolated	B-X
natural	B-X
product	B-X
chlorofusin	B-X
.	B-X
Synthetic	B-X
studies	B-X
on	B-X
this	B-X
complex	B-X
natural	B-X
product	B-X
summarized	B-X
herein	B-X
have	B-X
served	B-X
to	B-X
reassign	B-X
its	B-X
chromophore	B-X
relative	B-X
stereochemistry	B-X
,	B-X
assign	B-X
its	B-X
absolute	B-X
stereochemistry	B-X
,	B-X
and	B-X
provided	B-X
access	B-X
to	B-X
a	B-X
series	B-X
of	B-X
key	B-X
analogues	B-X
and	B-X
partial	B-X
structures	B-X
for	B-X
biological	B-X
evaluation	B-X
.	B-X

Synthetic	O
studies	O
on	O
this	O
complex	O
natural	O
product	O
summarized	O
herein	O
have	O
served	O
to	O
reassign	O
its	O
chromophore	O
relative	O
stereochemistry	O
,	O
assign	O
its	O
absolute	O
stereochemistry	O
,	O
and	O
provided	O
access	O
to	O
a	O
series	O
of	O
key	O
analogues	O
and	O
partial	O
structures	O
for	O
biological	O
evaluation	O
.	O
<EOS>	B-X
Inhibitors	B-X
of	B-X
key	B-X
protein-protein	B-X
interactions	B-X
are	B-X
emerging	B-X
as	B-X
exciting	B-X
therapeutic	B-X
targets	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
cancer	B-X
.	B-X
One	B-X
such	B-X
interaction	B-X
between	B-X
MDM2	B-X
(	B-X
HDM2	B-X
)	B-X
and	B-X
p53	B-X
,	B-X
that	B-X
silences	B-X
the	B-X
tumour	B-X
suppression	B-X
activities	B-X
of	B-X
p53	B-X
,	B-X
was	B-X
found	B-X
to	B-X
be	B-X
inhibited	B-X
by	B-X
the	B-X
recently	B-X
isolated	B-X
natural	B-X
product	B-X
chlorofusin	B-X
.	B-X
Synthetic	B-X
studies	B-X
on	B-X
this	B-X
complex	B-X
natural	B-X
product	B-X
summarized	B-X
herein	B-X
have	B-X
served	B-X
to	B-X
reassign	B-X
its	B-X
chromophore	B-X
relative	B-X
stereochemistry	B-X
,	B-X
assign	B-X
its	B-X
absolute	B-X
stereochemistry	B-X
,	B-X
and	B-X
provided	B-X
access	B-X
to	B-X
a	B-X
series	B-X
of	B-X
key	B-X
analogues	B-X
and	B-X
partial	B-X
structures	B-X
for	B-X
biological	B-X
evaluation	B-X
.	B-X

Degradation	O
of	O
phosphorylated	O
p53	B-Gene_or_gene_product
by	O
viral	O
protein	O
-	O
ECS	O
E3	O
ligase	O
complex	O
.	O
<EOS>	B-X
p53-signaling	B-X
is	B-X
modulated	B-X
by	B-X
viruses	B-X
to	B-X
establish	B-X
a	B-X
host	B-X
cellular	B-X
environment	B-X
advantageous	B-X
for	B-X
their	B-X
propagation	B-X
.	B-X
The	B-X
Epstein-Barr	B-X
virus	B-X
(	B-X
EBV	B-X
)	B-X
lytic	B-X
program	B-X
induces	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
which	B-X
prevents	B-X
interaction	B-X
with	B-X
MDM2	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
induction	B-X
of	B-X
EBV	B-X
lytic	B-X
program	B-X
leads	B-X
to	B-X
degradation	B-X
of	B-X
p53	B-X
via	B-X
an	B-X
ubiquitin-proteasome	B-X
pathway	B-X
independent	B-X
of	B-X
MDM2	B-X
.	B-X
The	B-X
BZLF1	B-X
protein	B-X
directly	B-X
functions	B-X
as	B-X
an	B-X
adaptor	B-X
component	B-X
of	B-X
the	B-X
ECS	B-X
(	B-X
Elongin	B-X
B/C-Cul2/5-SOCS-box	B-X
protein	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
targeting	B-X
p53	B-X
for	B-X
degradation	B-X
.	B-X
Intringuingly	B-X
,	B-X
C-terminal	B-X
phosphorylation	B-X
of	B-X
p53	B-X
resulting	B-X
from	B-X
activated	B-X
DNA	B-X
damage	B-X
response	B-X
by	B-X
viral	B-X
lytic	B-X
replication	B-X
enhances	B-X
its	B-X
binding	B-X
to	B-X
BZLF1	B-X
protein	B-X
.	B-X
Purified	B-X
BZLF1	B-X
protein-associated	B-X
ECS	B-X
could	B-X
be	B-X
shown	B-X
to	B-X
catalyze	B-X
ubiquitination	B-X
of	B-X
phospho-mimetic	B-X
p53	B-X
more	B-X
efficiently	B-X
than	B-X
the	B-X
wild-type	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
compensation	B-X
of	B-X
p53	B-X
at	B-X
middle	B-X
and	B-X
late	B-X
stages	B-X
of	B-X
the	B-X
lytic	B-X
infection	B-X
inhibits	B-X
viral	B-X
DNA	B-X
replication	B-X
and	B-X
production	B-X
during	B-X
lytic	B-X
infection	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
degradation	B-X
of	B-X
p53	B-X
is	B-X
required	B-X
for	B-X
efficient	B-X
viral	B-X
propagation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
role	B-X
for	B-X
the	B-X
BZLF1	B-X
protein-associated	B-X
ECS	B-X
ligase	B-X
complex	B-X
in	B-X
regulation	B-X
of	B-X
p53	B-X
phosphorylated	B-X
by	B-X
activated	B-X
DNA	B-X
damage	B-X
signaling	B-X
during	B-X
viral	B-X
lytic	B-X
infection	B-X
.	B-X

p53	B-Gene_or_gene_product
-	O
signaling	O
is	O
modulated	O
by	O
viruses	O
to	O
establish	O
a	O
host	O
cellular	O
environment	O
advantageous	O
for	O
their	O
propagation	O
.	O
<EOS>	B-X
p53-signaling	B-X
is	B-X
modulated	B-X
by	B-X
viruses	B-X
to	B-X
establish	B-X
a	B-X
host	B-X
cellular	B-X
environment	B-X
advantageous	B-X
for	B-X
their	B-X
propagation	B-X
.	B-X
The	B-X
Epstein-Barr	B-X
virus	B-X
(	B-X
EBV	B-X
)	B-X
lytic	B-X
program	B-X
induces	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
which	B-X
prevents	B-X
interaction	B-X
with	B-X
MDM2	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
induction	B-X
of	B-X
EBV	B-X
lytic	B-X
program	B-X
leads	B-X
to	B-X
degradation	B-X
of	B-X
p53	B-X
via	B-X
an	B-X
ubiquitin-proteasome	B-X
pathway	B-X
independent	B-X
of	B-X
MDM2	B-X
.	B-X
The	B-X
BZLF1	B-X
protein	B-X
directly	B-X
functions	B-X
as	B-X
an	B-X
adaptor	B-X
component	B-X
of	B-X
the	B-X
ECS	B-X
(	B-X
Elongin	B-X
B/C-Cul2/5-SOCS-box	B-X
protein	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
targeting	B-X
p53	B-X
for	B-X
degradation	B-X
.	B-X
Intringuingly	B-X
,	B-X
C-terminal	B-X
phosphorylation	B-X
of	B-X
p53	B-X
resulting	B-X
from	B-X
activated	B-X
DNA	B-X
damage	B-X
response	B-X
by	B-X
viral	B-X
lytic	B-X
replication	B-X
enhances	B-X
its	B-X
binding	B-X
to	B-X
BZLF1	B-X
protein	B-X
.	B-X
Purified	B-X
BZLF1	B-X
protein-associated	B-X
ECS	B-X
could	B-X
be	B-X
shown	B-X
to	B-X
catalyze	B-X
ubiquitination	B-X
of	B-X
phospho-mimetic	B-X
p53	B-X
more	B-X
efficiently	B-X
than	B-X
the	B-X
wild-type	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
compensation	B-X
of	B-X
p53	B-X
at	B-X
middle	B-X
and	B-X
late	B-X
stages	B-X
of	B-X
the	B-X
lytic	B-X
infection	B-X
inhibits	B-X
viral	B-X
DNA	B-X
replication	B-X
and	B-X
production	B-X
during	B-X
lytic	B-X
infection	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
degradation	B-X
of	B-X
p53	B-X
is	B-X
required	B-X
for	B-X
efficient	B-X
viral	B-X
propagation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
role	B-X
for	B-X
the	B-X
BZLF1	B-X
protein-associated	B-X
ECS	B-X
ligase	B-X
complex	B-X
in	B-X
regulation	B-X
of	B-X
p53	B-X
phosphorylated	B-X
by	B-X
activated	B-X
DNA	B-X
damage	B-X
signaling	B-X
during	B-X
viral	B-X
lytic	B-X
infection	B-X
.	B-X

The	O
Epstein	O
-	O
Barr	O
virus	O
(	O
EBV	O
)	O
lytic	O
program	O
induces	O
phosphorylation	O
of	O
p53	B-Gene_or_gene_product
,	O
which	O
prevents	O
interaction	O
with	O
MDM2	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
Epstein-Barr	B-X
virus	B-X
(	B-X
EBV	B-X
)	B-X
lytic	B-X
program	B-X
elicits	B-X
ATM-dependent	B-X
DNA	B-X
damage	B-X
response	B-X
,	B-X
resulting	B-X
in	B-X
phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
N-terminus	B-X
,	B-X
which	B-X
prevents	B-X
interaction	B-X
with	B-X
MDM2	B-X
.	B-X
Nevertheless	B-X
,	B-X
p53-downstream	B-X
signaling	B-X
is	B-X
blocked	B-X
.	B-X
We	B-X
found	B-X
here	B-X
that	B-X
during	B-X
the	B-X
lytic	B-X
infection	B-X
p53	B-X
was	B-X
actively	B-X
degraded	B-X
in	B-X
a	B-X
proteasome-dependent	B-X
manner	B-X
even	B-X
with	B-X
a	B-X
reduced	B-X
level	B-X
of	B-X
MDM2	B-X
.	B-X
BZLF1	B-X
protein	B-X
enhanced	B-X
the	B-X
ubiquitination	B-X
of	B-X
p53	B-X
in	B-X
SaOS-2	B-X
cells	B-X
.	B-X
The	B-X
degradation	B-X
of	B-X
p53	B-X
was	B-X
observed	B-X
even	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
Nutlin-3	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
p53-MDM2	B-X
interaction	B-X
,	B-X
and	B-X
also	B-X
in	B-X
mouse	B-X
embryo	B-X
fibroblasts	B-X
lacking	B-X
mdm2	B-X
gene	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
BZLF1	B-X
protein-induced	B-X
degradation	B-X
of	B-X
p53	B-X
was	B-X
independent	B-X
of	B-X
MDM2	B-X
.	B-X
Furthermore	B-X
,	B-X
Nutlin-3	B-X
increased	B-X
the	B-X
level	B-X
of	B-X
p53	B-X
in	B-X
the	B-X
latent	B-X
phase	B-X
of	B-X
EBV	B-X
infection	B-X
but	B-X
not	B-X
in	B-X
the	B-X
lytic	B-X
phase	B-X
.	B-X
Although	B-X
p53	B-X
level	B-X
is	B-X
regulated	B-X
by	B-X
MDM2	B-X
in	B-X
the	B-X
latent	B-X
phase	B-X
,	B-X
it	B-X
might	B-X
be	B-X
mediated	B-X
by	B-X
the	B-X
BZLF1	B-X
protein-associated	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
in	B-X
the	B-X
lytic	B-X
phase	B-X
for	B-X
efficient	B-X
viral	B-X
propagation	B-X
.	B-X

Here	O
,	O
we	O
show	O
that	O
induction	O
of	O
EBV	O
lytic	O
program	O
leads	O
to	O
degradation	O
of	O
p53	B-Gene_or_gene_product
via	O
an	O
ubiquitin	B-Gene_or_gene_product
-	O
proteasome	O
pathway	O
independent	O
of	O
MDM2	B-Gene_or_gene_product
.	O
<EOS>	B-X
p53-signaling	B-X
is	B-X
modulated	B-X
by	B-X
viruses	B-X
to	B-X
establish	B-X
a	B-X
host	B-X
cellular	B-X
environment	B-X
advantageous	B-X
for	B-X
their	B-X
propagation	B-X
.	B-X
The	B-X
Epstein-Barr	B-X
virus	B-X
(	B-X
EBV	B-X
)	B-X
lytic	B-X
program	B-X
induces	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
which	B-X
prevents	B-X
interaction	B-X
with	B-X
MDM2	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
induction	B-X
of	B-X
EBV	B-X
lytic	B-X
program	B-X
leads	B-X
to	B-X
degradation	B-X
of	B-X
p53	B-X
via	B-X
an	B-X
ubiquitin-proteasome	B-X
pathway	B-X
independent	B-X
of	B-X
MDM2	B-X
.	B-X
The	B-X
BZLF1	B-X
protein	B-X
directly	B-X
functions	B-X
as	B-X
an	B-X
adaptor	B-X
component	B-X
of	B-X
the	B-X
ECS	B-X
(	B-X
Elongin	B-X
B/C-Cul2/5-SOCS-box	B-X
protein	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
targeting	B-X
p53	B-X
for	B-X
degradation	B-X
.	B-X
Intringuingly	B-X
,	B-X
C-terminal	B-X
phosphorylation	B-X
of	B-X
p53	B-X
resulting	B-X
from	B-X
activated	B-X
DNA	B-X
damage	B-X
response	B-X
by	B-X
viral	B-X
lytic	B-X
replication	B-X
enhances	B-X
its	B-X
binding	B-X
to	B-X
BZLF1	B-X
protein	B-X
.	B-X
Purified	B-X
BZLF1	B-X
protein-associated	B-X
ECS	B-X
could	B-X
be	B-X
shown	B-X
to	B-X
catalyze	B-X
ubiquitination	B-X
of	B-X
phospho-mimetic	B-X
p53	B-X
more	B-X
efficiently	B-X
than	B-X
the	B-X
wild-type	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
compensation	B-X
of	B-X
p53	B-X
at	B-X
middle	B-X
and	B-X
late	B-X
stages	B-X
of	B-X
the	B-X
lytic	B-X
infection	B-X
inhibits	B-X
viral	B-X
DNA	B-X
replication	B-X
and	B-X
production	B-X
during	B-X
lytic	B-X
infection	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
degradation	B-X
of	B-X
p53	B-X
is	B-X
required	B-X
for	B-X
efficient	B-X
viral	B-X
propagation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
role	B-X
for	B-X
the	B-X
BZLF1	B-X
protein-associated	B-X
ECS	B-X
ligase	B-X
complex	B-X
in	B-X
regulation	B-X
of	B-X
p53	B-X
phosphorylated	B-X
by	B-X
activated	B-X
DNA	B-X
damage	B-X
signaling	B-X
during	B-X
viral	B-X
lytic	B-X
infection	B-X
.	B-X

The	O
BZLF1	B-Gene_or_gene_product
protein	O
directly	O
functions	O
as	O
an	O
adaptor	O
component	O
of	O
the	O
ECS	O
(	O
Elongin	O
B	O
/	O
C	O
-	O
Cul2	O
/	O
5	O
-	O
SOCS	O
-	O
box	O
protein	O
)	O
ubiquitin	B-Gene_or_gene_product
ligase	O
complex	O
targeting	O
p53	B-Gene_or_gene_product
for	O
degradation	O
.	O
<EOS>	B-X
p53-signaling	B-X
is	B-X
modulated	B-X
by	B-X
viruses	B-X
to	B-X
establish	B-X
a	B-X
host	B-X
cellular	B-X
environment	B-X
advantageous	B-X
for	B-X
their	B-X
propagation	B-X
.	B-X
The	B-X
Epstein-Barr	B-X
virus	B-X
(	B-X
EBV	B-X
)	B-X
lytic	B-X
program	B-X
induces	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
which	B-X
prevents	B-X
interaction	B-X
with	B-X
MDM2	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
induction	B-X
of	B-X
EBV	B-X
lytic	B-X
program	B-X
leads	B-X
to	B-X
degradation	B-X
of	B-X
p53	B-X
via	B-X
an	B-X
ubiquitin-proteasome	B-X
pathway	B-X
independent	B-X
of	B-X
MDM2	B-X
.	B-X
The	B-X
BZLF1	B-X
protein	B-X
directly	B-X
functions	B-X
as	B-X
an	B-X
adaptor	B-X
component	B-X
of	B-X
the	B-X
ECS	B-X
(	B-X
Elongin	B-X
B/C-Cul2/5-SOCS-box	B-X
protein	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
targeting	B-X
p53	B-X
for	B-X
degradation	B-X
.	B-X
Intringuingly	B-X
,	B-X
C-terminal	B-X
phosphorylation	B-X
of	B-X
p53	B-X
resulting	B-X
from	B-X
activated	B-X
DNA	B-X
damage	B-X
response	B-X
by	B-X
viral	B-X
lytic	B-X
replication	B-X
enhances	B-X
its	B-X
binding	B-X
to	B-X
BZLF1	B-X
protein	B-X
.	B-X
Purified	B-X
BZLF1	B-X
protein-associated	B-X
ECS	B-X
could	B-X
be	B-X
shown	B-X
to	B-X
catalyze	B-X
ubiquitination	B-X
of	B-X
phospho-mimetic	B-X
p53	B-X
more	B-X
efficiently	B-X
than	B-X
the	B-X
wild-type	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
compensation	B-X
of	B-X
p53	B-X
at	B-X
middle	B-X
and	B-X
late	B-X
stages	B-X
of	B-X
the	B-X
lytic	B-X
infection	B-X
inhibits	B-X
viral	B-X
DNA	B-X
replication	B-X
and	B-X
production	B-X
during	B-X
lytic	B-X
infection	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
degradation	B-X
of	B-X
p53	B-X
is	B-X
required	B-X
for	B-X
efficient	B-X
viral	B-X
propagation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
role	B-X
for	B-X
the	B-X
BZLF1	B-X
protein-associated	B-X
ECS	B-X
ligase	B-X
complex	B-X
in	B-X
regulation	B-X
of	B-X
p53	B-X
phosphorylated	B-X
by	B-X
activated	B-X
DNA	B-X
damage	B-X
signaling	B-X
during	B-X
viral	B-X
lytic	B-X
infection	B-X
.	B-X

Intringuingly	O
,	O
C	O
-	O
terminal	O
phosphorylation	O
of	O
p53	B-Gene_or_gene_product
resulting	O
from	O
activated	O
DNA	O
damage	O
response	O
by	O
viral	O
lytic	O
replication	O
enhances	O
its	O
binding	O
to	O
BZLF1	B-Gene_or_gene_product
protein	O
.	O
<EOS>	B-X
p53-signaling	B-X
is	B-X
modulated	B-X
by	B-X
viruses	B-X
to	B-X
establish	B-X
a	B-X
host	B-X
cellular	B-X
environment	B-X
advantageous	B-X
for	B-X
their	B-X
propagation	B-X
.	B-X
The	B-X
Epstein-Barr	B-X
virus	B-X
(	B-X
EBV	B-X
)	B-X
lytic	B-X
program	B-X
induces	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
which	B-X
prevents	B-X
interaction	B-X
with	B-X
MDM2	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
induction	B-X
of	B-X
EBV	B-X
lytic	B-X
program	B-X
leads	B-X
to	B-X
degradation	B-X
of	B-X
p53	B-X
via	B-X
an	B-X
ubiquitin-proteasome	B-X
pathway	B-X
independent	B-X
of	B-X
MDM2	B-X
.	B-X
The	B-X
BZLF1	B-X
protein	B-X
directly	B-X
functions	B-X
as	B-X
an	B-X
adaptor	B-X
component	B-X
of	B-X
the	B-X
ECS	B-X
(	B-X
Elongin	B-X
B/C-Cul2/5-SOCS-box	B-X
protein	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
targeting	B-X
p53	B-X
for	B-X
degradation	B-X
.	B-X
Intringuingly	B-X
,	B-X
C-terminal	B-X
phosphorylation	B-X
of	B-X
p53	B-X
resulting	B-X
from	B-X
activated	B-X
DNA	B-X
damage	B-X
response	B-X
by	B-X
viral	B-X
lytic	B-X
replication	B-X
enhances	B-X
its	B-X
binding	B-X
to	B-X
BZLF1	B-X
protein	B-X
.	B-X
Purified	B-X
BZLF1	B-X
protein-associated	B-X
ECS	B-X
could	B-X
be	B-X
shown	B-X
to	B-X
catalyze	B-X
ubiquitination	B-X
of	B-X
phospho-mimetic	B-X
p53	B-X
more	B-X
efficiently	B-X
than	B-X
the	B-X
wild-type	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
compensation	B-X
of	B-X
p53	B-X
at	B-X
middle	B-X
and	B-X
late	B-X
stages	B-X
of	B-X
the	B-X
lytic	B-X
infection	B-X
inhibits	B-X
viral	B-X
DNA	B-X
replication	B-X
and	B-X
production	B-X
during	B-X
lytic	B-X
infection	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
degradation	B-X
of	B-X
p53	B-X
is	B-X
required	B-X
for	B-X
efficient	B-X
viral	B-X
propagation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
role	B-X
for	B-X
the	B-X
BZLF1	B-X
protein-associated	B-X
ECS	B-X
ligase	B-X
complex	B-X
in	B-X
regulation	B-X
of	B-X
p53	B-X
phosphorylated	B-X
by	B-X
activated	B-X
DNA	B-X
damage	B-X
signaling	B-X
during	B-X
viral	B-X
lytic	B-X
infection	B-X
.	B-X

Purified	O
BZLF1	B-Gene_or_gene_product
protein	O
-	O
associated	O
ECS	O
could	O
be	O
shown	O
to	O
catalyze	O
ubiquitination	O
of	O
phospho	O
-	O
mimetic	O
p53	B-Gene_or_gene_product
more	O
efficiently	O
than	O
the	O
wild	O
-	O
type	O
in	O
vitro	O
.	O

The	O
compensation	O
of	O
p53	B-Gene_or_gene_product
at	O
middle	O
and	O
late	O
stages	O
of	O
the	O
lytic	O
infection	O
inhibits	O
viral	O
DNA	O
replication	O
and	O
production	O
during	O
lytic	O
infection	O
,	O
suggesting	O
that	O
the	O
degradation	O
of	O
p53	B-Gene_or_gene_product
is	O
required	O
for	O
efficient	O
viral	O
propagation	O
.	O
<EOS>	B-X
p53-signaling	B-X
is	B-X
modulated	B-X
by	B-X
viruses	B-X
to	B-X
establish	B-X
a	B-X
host	B-X
cellular	B-X
environment	B-X
advantageous	B-X
for	B-X
their	B-X
propagation	B-X
.	B-X
The	B-X
Epstein-Barr	B-X
virus	B-X
(	B-X
EBV	B-X
)	B-X
lytic	B-X
program	B-X
induces	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
which	B-X
prevents	B-X
interaction	B-X
with	B-X
MDM2	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
induction	B-X
of	B-X
EBV	B-X
lytic	B-X
program	B-X
leads	B-X
to	B-X
degradation	B-X
of	B-X
p53	B-X
via	B-X
an	B-X
ubiquitin-proteasome	B-X
pathway	B-X
independent	B-X
of	B-X
MDM2	B-X
.	B-X
The	B-X
BZLF1	B-X
protein	B-X
directly	B-X
functions	B-X
as	B-X
an	B-X
adaptor	B-X
component	B-X
of	B-X
the	B-X
ECS	B-X
(	B-X
Elongin	B-X
B/C-Cul2/5-SOCS-box	B-X
protein	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
targeting	B-X
p53	B-X
for	B-X
degradation	B-X
.	B-X
Intringuingly	B-X
,	B-X
C-terminal	B-X
phosphorylation	B-X
of	B-X
p53	B-X
resulting	B-X
from	B-X
activated	B-X
DNA	B-X
damage	B-X
response	B-X
by	B-X
viral	B-X
lytic	B-X
replication	B-X
enhances	B-X
its	B-X
binding	B-X
to	B-X
BZLF1	B-X
protein	B-X
.	B-X
Purified	B-X
BZLF1	B-X
protein-associated	B-X
ECS	B-X
could	B-X
be	B-X
shown	B-X
to	B-X
catalyze	B-X
ubiquitination	B-X
of	B-X
phospho-mimetic	B-X
p53	B-X
more	B-X
efficiently	B-X
than	B-X
the	B-X
wild-type	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
compensation	B-X
of	B-X
p53	B-X
at	B-X
middle	B-X
and	B-X
late	B-X
stages	B-X
of	B-X
the	B-X
lytic	B-X
infection	B-X
inhibits	B-X
viral	B-X
DNA	B-X
replication	B-X
and	B-X
production	B-X
during	B-X
lytic	B-X
infection	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
degradation	B-X
of	B-X
p53	B-X
is	B-X
required	B-X
for	B-X
efficient	B-X
viral	B-X
propagation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
role	B-X
for	B-X
the	B-X
BZLF1	B-X
protein-associated	B-X
ECS	B-X
ligase	B-X
complex	B-X
in	B-X
regulation	B-X
of	B-X
p53	B-X
phosphorylated	B-X
by	B-X
activated	B-X
DNA	B-X
damage	B-X
signaling	B-X
during	B-X
viral	B-X
lytic	B-X
infection	B-X
.	B-X

Taken	O
together	O
,	O
these	O
findings	O
demonstrate	O
a	O
role	O
for	O
the	O
BZLF1	B-Gene_or_gene_product
protein	O
-	O
associated	O
ECS	O
ligase	O
complex	O
in	O
regulation	O
of	O
p53	B-Gene_or_gene_product
phosphorylated	O
by	O
activated	O
DNA	O
damage	O
signaling	O
during	O
viral	O
lytic	O
infection	O
.	O
<EOS>	B-X
p53-signaling	B-X
is	B-X
modulated	B-X
by	B-X
viruses	B-X
to	B-X
establish	B-X
a	B-X
host	B-X
cellular	B-X
environment	B-X
advantageous	B-X
for	B-X
their	B-X
propagation	B-X
.	B-X
The	B-X
Epstein-Barr	B-X
virus	B-X
(	B-X
EBV	B-X
)	B-X
lytic	B-X
program	B-X
induces	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
which	B-X
prevents	B-X
interaction	B-X
with	B-X
MDM2	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
induction	B-X
of	B-X
EBV	B-X
lytic	B-X
program	B-X
leads	B-X
to	B-X
degradation	B-X
of	B-X
p53	B-X
via	B-X
an	B-X
ubiquitin-proteasome	B-X
pathway	B-X
independent	B-X
of	B-X
MDM2	B-X
.	B-X
The	B-X
BZLF1	B-X
protein	B-X
directly	B-X
functions	B-X
as	B-X
an	B-X
adaptor	B-X
component	B-X
of	B-X
the	B-X
ECS	B-X
(	B-X
Elongin	B-X
B/C-Cul2/5-SOCS-box	B-X
protein	B-X
)	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
targeting	B-X
p53	B-X
for	B-X
degradation	B-X
.	B-X
Intringuingly	B-X
,	B-X
C-terminal	B-X
phosphorylation	B-X
of	B-X
p53	B-X
resulting	B-X
from	B-X
activated	B-X
DNA	B-X
damage	B-X
response	B-X
by	B-X
viral	B-X
lytic	B-X
replication	B-X
enhances	B-X
its	B-X
binding	B-X
to	B-X
BZLF1	B-X
protein	B-X
.	B-X
Purified	B-X
BZLF1	B-X
protein-associated	B-X
ECS	B-X
could	B-X
be	B-X
shown	B-X
to	B-X
catalyze	B-X
ubiquitination	B-X
of	B-X
phospho-mimetic	B-X
p53	B-X
more	B-X
efficiently	B-X
than	B-X
the	B-X
wild-type	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
compensation	B-X
of	B-X
p53	B-X
at	B-X
middle	B-X
and	B-X
late	B-X
stages	B-X
of	B-X
the	B-X
lytic	B-X
infection	B-X
inhibits	B-X
viral	B-X
DNA	B-X
replication	B-X
and	B-X
production	B-X
during	B-X
lytic	B-X
infection	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
degradation	B-X
of	B-X
p53	B-X
is	B-X
required	B-X
for	B-X
efficient	B-X
viral	B-X
propagation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
demonstrate	B-X
a	B-X
role	B-X
for	B-X
the	B-X
BZLF1	B-X
protein-associated	B-X
ECS	B-X
ligase	B-X
complex	B-X
in	B-X
regulation	B-X
of	B-X
p53	B-X
phosphorylated	B-X
by	B-X
activated	B-X
DNA	B-X
damage	B-X
signaling	B-X
during	B-X
viral	B-X
lytic	B-X
infection	B-X
.	B-X

Interaction	O
with	O
vascular	O
endothelium	O
enhances	O
survival	O
in	O
primary	O
chronic	O
lymphocytic	O
leukemia	O
cells	O
via	O
NF	O
-	O
kappaB	O
activation	O
and	O
de	O
novo	O
gene	O
transcription	O
.	O
<EOS>	B-X
Chronic	B-X
lymphocytic	B-X
leukemia	B-X
(	B-X
CLL	B-X
)	B-X
cells	B-X
rapidly	B-X
undergo	B-X
apoptosis	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
in	B-X
vivo	B-X
microenvironment	B-X
provides	B-X
crucial	B-X
antiapoptotic	B-X
signals	B-X
.	B-X
Coculture	B-X
of	B-X
CLL	B-X
cells	B-X
with	B-X
human	B-X
vascular	B-X
endothelial	B-X
cells	B-X
significantly	B-X
enhanced	B-X
tumor	B-X
cell	B-X
survival	B-X
,	B-X
an	B-X
effect	B-X
that	B-X
was	B-X
not	B-X
observed	B-X
with	B-X
normal	B-X
B	B-X
cells	B-X
.	B-X
Because	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
and	B-X
some	B-X
Bcl-2	B-X
family	B-X
genes	B-X
are	B-X
transcriptional	B-X
targets	B-X
for	B-X
NF-κB	B-X
,	B-X
we	B-X
assessed	B-X
NF-κB	B-X
activation	B-X
following	B-X
coculture	B-X
with	B-X
endothelial	B-X
cells	B-X
.	B-X
DNA	B-X
binding	B-X
of	B-X
the	B-X
NF-κB	B-X
subunit	B-X
Rel	B-X
A	B-X
was	B-X
significantly	B-X
increased	B-X
and	B-X
strongly	B-X
correlated	B-X
with	B-X
changes	B-X
in	B-X
transcription	B-X
of	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
BCL2	B-X
,	B-X
MCL1	B-X
,	B-X
and	B-X
BCLXL	B-X
,	B-X
effects	B-X
that	B-X
were	B-X
reversed	B-X
by	B-X
a	B-X
peptide	B-X
inhibitor	B-X
of	B-X
Rel	B-X
A	B-X
.	B-X
Therefore	B-X
,	B-X
CLL	B-X
cells	B-X
receive	B-X
specific	B-X
survival	B-X
signals	B-X
following	B-X
interaction	B-X
with	B-X
endothelial	B-X
cells	B-X
mediated	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
NF-κB	B-X
and	B-X
the	B-X
induction	B-X
of	B-X
downstream	B-X
target	B-X
genes	B-X
.	B-X
This	B-X
type	B-X
of	B-X
interaction	B-X
in	B-X
the	B-X
peripheral	B-X
vasculature	B-X
may	B-X
explain	B-X
the	B-X
constitutive	B-X
NF-κB	B-X
activation	B-X
and	B-X
the	B-X
overexpression	B-X
of	B-X
Bcl-2	B-X
family	B-X
proteins	B-X
commonly	B-X
seen	B-X
in	B-X
this	B-X
disease	B-X
.	B-X

Chronic	O
lymphocytic	O
leukemia	O
(	O
CLL	O
)	O
cells	O
rapidly	O
undergo	O
apoptosis	O
in	O
vitro	O
,	O
suggesting	O
that	O
the	O
in	O
vivo	O
microenvironment	O
provides	O
crucial	O
antiapoptotic	O
signals	O
.	O
<EOS>	B-X
Chronic	B-X
lymphocytic	B-X
leukemia	B-X
(	B-X
CLL	B-X
)	B-X
cells	B-X
rapidly	B-X
undergo	B-X
apoptosis	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
in	B-X
vivo	B-X
microenvironment	B-X
provides	B-X
crucial	B-X
antiapoptotic	B-X
signals	B-X
.	B-X
Overexpression	B-X
of	B-X
the	B-X
antiapoptotic	B-X
proteins	B-X
Bcl-2	B-X
and	B-X
Mcl-1	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
CLL	B-X
,	B-X
and	B-X
their	B-X
expression	B-X
is	B-X
further	B-X
enhanced	B-X
in	B-X
the	B-X
lymphoid	B-X
tissues	B-X
.	B-X
Coculture	B-X
of	B-X
CLL	B-X
cells	B-X
with	B-X
human	B-X
vascular	B-X
endothelial	B-X
cells	B-X
significantly	B-X
enhanced	B-X
tumor	B-X
cell	B-X
survival	B-X
,	B-X
an	B-X
effect	B-X
that	B-X
was	B-X
not	B-X
observed	B-X
with	B-X
normal	B-X
B	B-X
cells	B-X
.	B-X
This	B-X
was	B-X
associated	B-X
with	B-X
elevated	B-X
levels	B-X
of	B-X
the	B-X
antiapoptotic	B-X
proteins	B-X
Bcl-2	B-X
,	B-X
Mcl-1	B-X
,	B-X
and	B-X
Bcl-X	B-X
(	B-X
L	B-X
)	B-X
and	B-X
marked	B-X
increased	B-X
expression	B-X
of	B-X
CD38	B-X
and	B-X
CD49d	B-X
,	B-X
both	B-X
of	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
clinically	B-X
aggressive	B-X
disease	B-X
.	B-X
Because	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
and	B-X
some	B-X
Bcl-2	B-X
family	B-X
genes	B-X
are	B-X
transcriptional	B-X
targets	B-X
for	B-X
NF-κB	B-X
,	B-X
we	B-X
assessed	B-X
NF-κB	B-X
activation	B-X
following	B-X
coculture	B-X
with	B-X
endothelial	B-X
cells	B-X
.	B-X
Therefore	B-X
,	B-X
CLL	B-X
cells	B-X
receive	B-X
specific	B-X
survival	B-X
signals	B-X
following	B-X
interaction	B-X
with	B-X
endothelial	B-X
cells	B-X
mediated	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
NF-κB	B-X
and	B-X
the	B-X
induction	B-X
of	B-X
downstream	B-X
target	B-X
genes	B-X
.	B-X

Overexpression	O
of	O
the	O
antiapoptotic	O
proteins	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
and	O
Mcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
is	O
a	O
hallmark	O
of	O
CLL	O
,	O
and	O
their	O
expression	O
is	O
further	O
enhanced	O
in	O
the	O
lymphoid	O
tissues	O
.	O
<EOS>	B-X
Chronic	B-X
lymphocytic	B-X
leukemia	B-X
(	B-X
CLL	B-X
)	B-X
cells	B-X
rapidly	B-X
undergo	B-X
apoptosis	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
in	B-X
vivo	B-X
microenvironment	B-X
provides	B-X
crucial	B-X
antiapoptotic	B-X
signals	B-X
.	B-X
Overexpression	B-X
of	B-X
the	B-X
antiapoptotic	B-X
proteins	B-X
Bcl-2	B-X
and	B-X
Mcl-1	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
CLL	B-X
,	B-X
and	B-X
their	B-X
expression	B-X
is	B-X
further	B-X
enhanced	B-X
in	B-X
the	B-X
lymphoid	B-X
tissues	B-X
.	B-X
However	B-X
,	B-X
the	B-X
high	B-X
levels	B-X
of	B-X
Mcl-1	B-X
found	B-X
in	B-X
peripheral	B-X
blood	B-X
samples	B-X
,	B-X
coupled	B-X
with	B-X
its	B-X
short	B-X
half-life	B-X
,	B-X
led	B-X
us	B-X
to	B-X
hypothesize	B-X
that	B-X
it	B-X
must	B-X
be	B-X
actively	B-X
maintained	B-X
in	B-X
the	B-X
peripheral	B-X
circulation	B-X
.	B-X
Coculture	B-X
of	B-X
CLL	B-X
cells	B-X
with	B-X
human	B-X
vascular	B-X
endothelial	B-X
cells	B-X
significantly	B-X
enhanced	B-X
tumor	B-X
cell	B-X
survival	B-X
,	B-X
an	B-X
effect	B-X
that	B-X
was	B-X
not	B-X
observed	B-X
with	B-X
normal	B-X
B	B-X
cells	B-X
.	B-X
This	B-X
was	B-X
associated	B-X
with	B-X
elevated	B-X
levels	B-X
of	B-X
the	B-X
antiapoptotic	B-X
proteins	B-X
Bcl-2	B-X
,	B-X
Mcl-1	B-X
,	B-X
and	B-X
Bcl-X	B-X
(	B-X
L	B-X
)	B-X
and	B-X
marked	B-X
increased	B-X
expression	B-X
of	B-X
CD38	B-X
and	B-X
CD49d	B-X
,	B-X
both	B-X
of	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
clinically	B-X
aggressive	B-X
disease	B-X
.	B-X
Because	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
and	B-X
some	B-X
Bcl-2	B-X
family	B-X
genes	B-X
are	B-X
transcriptional	B-X
targets	B-X
for	B-X
NF-κB	B-X
,	B-X
we	B-X
assessed	B-X
NF-κB	B-X
activation	B-X
following	B-X
coculture	B-X
with	B-X
endothelial	B-X
cells	B-X
.	B-X
DNA	B-X
binding	B-X
of	B-X
the	B-X
NF-κB	B-X
subunit	B-X
Rel	B-X
A	B-X
was	B-X
significantly	B-X
increased	B-X
and	B-X
strongly	B-X
correlated	B-X
with	B-X
changes	B-X
in	B-X
transcription	B-X
of	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
BCL2	B-X
,	B-X
MCL1	B-X
,	B-X
and	B-X
BCLXL	B-X
,	B-X
effects	B-X
that	B-X
were	B-X
reversed	B-X
by	B-X
a	B-X
peptide	B-X
inhibitor	B-X
of	B-X
Rel	B-X
A	B-X
.	B-X
Therefore	B-X
,	B-X
CLL	B-X
cells	B-X
receive	B-X
specific	B-X
survival	B-X
signals	B-X
following	B-X
interaction	B-X
with	B-X
endothelial	B-X
cells	B-X
mediated	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
NF-κB	B-X
and	B-X
the	B-X
induction	B-X
of	B-X
downstream	B-X
target	B-X
genes	B-X
.	B-X
This	B-X
type	B-X
of	B-X
interaction	B-X
in	B-X
the	B-X
peripheral	B-X
vasculature	B-X
may	B-X
explain	B-X
the	B-X
constitutive	B-X
NF-κB	B-X
activation	B-X
and	B-X
the	B-X
overexpression	B-X
of	B-X
Bcl-2	B-X
family	B-X
proteins	B-X
commonly	B-X
seen	B-X
in	B-X
this	B-X
disease	B-X
.	B-X

However	O
,	O
the	O
high	O
levels	O
of	O
Mcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
found	O
in	O
peripheral	O
blood	O
samples	O
,	O
coupled	O
with	O
its	O
short	O
half	O
-	O
life	O
,	O
led	O
us	O
to	O
hypothesize	O
that	O
it	O
must	O
be	O
actively	O
maintained	O
in	O
the	O
peripheral	O
circulation	O
.	O
<EOS>	B-X
Overexpression	B-X
of	B-X
the	B-X
antiapoptotic	B-X
proteins	B-X
Bcl-2	B-X
and	B-X
Mcl-1	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
CLL	B-X
,	B-X
and	B-X
their	B-X
expression	B-X
is	B-X
further	B-X
enhanced	B-X
in	B-X
the	B-X
lymphoid	B-X
tissues	B-X
.	B-X
However	B-X
,	B-X
the	B-X
high	B-X
levels	B-X
of	B-X
Mcl-1	B-X
found	B-X
in	B-X
peripheral	B-X
blood	B-X
samples	B-X
,	B-X
coupled	B-X
with	B-X
its	B-X
short	B-X
half-life	B-X
,	B-X
led	B-X
us	B-X
to	B-X
hypothesize	B-X
that	B-X
it	B-X
must	B-X
be	B-X
actively	B-X
maintained	B-X
in	B-X
the	B-X
peripheral	B-X
circulation	B-X
.	B-X
This	B-X
was	B-X
associated	B-X
with	B-X
elevated	B-X
levels	B-X
of	B-X
the	B-X
antiapoptotic	B-X
proteins	B-X
Bcl-2	B-X
,	B-X
Mcl-1	B-X
,	B-X
and	B-X
Bcl-X	B-X
(	B-X
L	B-X
)	B-X
and	B-X
marked	B-X
increased	B-X
expression	B-X
of	B-X
CD38	B-X
and	B-X
CD49d	B-X
,	B-X
both	B-X
of	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
clinically	B-X
aggressive	B-X
disease	B-X
.	B-X
Because	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
and	B-X
some	B-X
Bcl-2	B-X
family	B-X
genes	B-X
are	B-X
transcriptional	B-X
targets	B-X
for	B-X
NF-κB	B-X
,	B-X
we	B-X
assessed	B-X
NF-κB	B-X
activation	B-X
following	B-X
coculture	B-X
with	B-X
endothelial	B-X
cells	B-X
.	B-X
DNA	B-X
binding	B-X
of	B-X
the	B-X
NF-κB	B-X
subunit	B-X
Rel	B-X
A	B-X
was	B-X
significantly	B-X
increased	B-X
and	B-X
strongly	B-X
correlated	B-X
with	B-X
changes	B-X
in	B-X
transcription	B-X
of	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
BCL2	B-X
,	B-X
MCL1	B-X
,	B-X
and	B-X
BCLXL	B-X
,	B-X
effects	B-X
that	B-X
were	B-X
reversed	B-X
by	B-X
a	B-X
peptide	B-X
inhibitor	B-X
of	B-X
Rel	B-X
A	B-X
.	B-X
This	B-X
type	B-X
of	B-X
interaction	B-X
in	B-X
the	B-X
peripheral	B-X
vasculature	B-X
may	B-X
explain	B-X
the	B-X
constitutive	B-X
NF-κB	B-X
activation	B-X
and	B-X
the	B-X
overexpression	B-X
of	B-X
Bcl-2	B-X
family	B-X
proteins	B-X
commonly	B-X
seen	B-X
in	B-X
this	B-X
disease	B-X
.	B-X

Coculture	O
of	O
CLL	O
cells	O
with	O
human	O
vascular	O
endothelial	O
cells	O
significantly	O
enhanced	O
tumor	O
cell	O
survival	O
,	O
an	O
effect	O
that	O
was	O
not	O
observed	O
with	O
normal	O
B	O
cells	O
.	O
<EOS>	B-X
With	B-X
sorafenib	B-X
displaying	B-X
the	B-X
highest	B-X
affinities	B-X
for	B-X
Flt3	B-X
,	B-X
VEGFR	B-X
(	B-X
vascular	B-X
endothelial	B-X
growth	B-X
factor	B-X
receptor	B-X
)	B-X
and	B-X
Raf	B-X
and	B-X
dasatinib	B-X
for	B-X
Abl	B-X
and	B-X
Src	B-X
kinases	B-X
,	B-X
the	B-X
profiles	B-X
of	B-X
kinases	B-X
targeted	B-X
by	B-X
these	B-X
inhibitors	B-X
differ	B-X
strongly	B-X
.	B-X
Interleukin-6	B-X
(	B-X
IL-6	B-X
)	B-X
is	B-X
a	B-X
pleiotropic	B-X
cytokine	B-X
produced	B-X
by	B-X
a	B-X
variety	B-X
of	B-X
cell	B-X
types	B-X
,	B-X
including	B-X
fibroblasts	B-X
,	B-X
endothelial	B-X
cells	B-X
,	B-X
lymphocytes	B-X
,	B-X
and	B-X
bone	B-X
marrow	B-X
stromal	B-X
cells	B-X
(	B-X
BMSCs	B-X
)	B-X
.	B-X
Levels	B-X
of	B-X
IL-6	B-X
are	B-X
increased	B-X
in	B-X
serum	B-X
of	B-X
CLL	B-X
patients	B-X
and	B-X
correlated	B-X
with	B-X
adverse	B-X
clinical	B-X
features	B-X
and	B-X
short	B-X
survival	B-X
.	B-X
In	B-X
our	B-X
study	B-X
,	B-X
we	B-X
observed	B-X
that	B-X
IL-6	B-X
induced	B-X
the	B-X
resistance	B-X
of	B-X
CLL	B-X
cells	B-X
to	B-X
pan-histone	B-X
deacetylase	B-X
(	B-X
HDAC	B-X
)	B-X
inhibitors	B-X
vorinostat	B-X
(	B-X
SAHA	B-X
)	B-X
and	B-X
panobinostat	B-X
(	B-X
LBH589	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
low	B-X
concentrations	B-X
of	B-X
SAHA	B-X
and	B-X
LBH589	B-X
enhanced	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
signal	B-X
transducer	B-X
and	B-X
activator	B-X
of	B-X
transcription	B-X
3	B-X
(	B-X
STAT3	B-X
)	B-X
signaling	B-X
pathway	B-X
induced	B-X
by	B-X
IL-6	B-X
in	B-X
CLL	B-X
cells	B-X
.	B-X
All	B-X
of	B-X
these	B-X
effects	B-X
were	B-X
blocked	B-X
by	B-X
the	B-X
STAT3-selective	B-X
inhibitor	B-X
,	B-X
WP1066	B-X
.	B-X
Meanwhile	B-X
,	B-X
WP1066	B-X
decreased	B-X
the	B-X
expressions	B-X
of	B-X
Mcl-1	B-X
and	B-X
Bcl-xL	B-X
protein	B-X
induced	B-X
by	B-X
IL-6	B-X
with	B-X
or	B-X
without	B-X
low	B-X
concentrations	B-X
of	B-X
HDAC	B-X
inhibitors	B-X
.	B-X
Co-culture	B-X
of	B-X
CLL	B-X
cells	B-X
with	B-X
BMSCs	B-X
could	B-X
also	B-X
facilitate	B-X
the	B-X
activation	B-X
of	B-X
STAT3	B-X
and	B-X
protected	B-X
CLL	B-X
cells	B-X
from	B-X
apoptosis	B-X
when	B-X
treated	B-X
with	B-X
HDAC	B-X
inhibitors	B-X
,	B-X
and	B-X
this	B-X
cytoprotection	B-X
was	B-X
reversed	B-X
by	B-X
WP1066	B-X
.	B-X
The	B-X
present	B-X
study	B-X
indicated	B-X
that	B-X
IL-6	B-X
or	B-X
co-culture	B-X
with	B-X
BMSCs	B-X
prevented	B-X
HDAC	B-X
inhibitor-induced	B-X
apoptosis	B-X
of	B-X
CLL	B-X
cells	B-X
.	B-X
Moreover	B-X
,	B-X
WP1066	B-X
reversed	B-X
the	B-X
resistance	B-X
of	B-X
CLL	B-X
cells	B-X
to	B-X
SAHA	B-X
and	B-X
LBH589	B-X
induced	B-X
by	B-X
either	B-X
IL-6	B-X
or	B-X
co-culture	B-X
with	B-X
BMSCs	B-X
.	B-X
Our	B-X
findings	B-X
suggest	B-X
that	B-X
targeting	B-X
the	B-X
STAT3	B-X
pathway	B-X
may	B-X
be	B-X
a	B-X
novel	B-X
way	B-X
to	B-X
improve	B-X
the	B-X
efficacy	B-X
of	B-X
the	B-X
HDAC	B-X
inhibitor	B-X
in	B-X
CLL	B-X
patients	B-X
by	B-X
overcoming	B-X
antiapoptotic	B-X
signaling	B-X
of	B-X
the	B-X
microenvironment	B-X
.	B-X

This	O
was	O
associated	O
with	O
elevated	O
levels	O
of	O
the	O
antiapoptotic	O
proteins	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
Mcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
and	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
X	I-Gene_or_gene_product
(	I-Gene_or_gene_product
L	I-Gene_or_gene_product
)	I-Gene_or_gene_product
and	O
marked	O
increased	O
expression	O
of	O
CD38	B-Gene_or_gene_product
and	O
CD49d	B-Gene_or_gene_product
,	O
both	O
of	O
which	O
are	O
associated	O
with	O
clinically	O
aggressive	O
disease	O
.	O
<EOS>	B-X
Chronic	B-X
lymphocytic	B-X
leukemia	B-X
(	B-X
CLL	B-X
)	B-X
cells	B-X
rapidly	B-X
undergo	B-X
apoptosis	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
in	B-X
vivo	B-X
microenvironment	B-X
provides	B-X
crucial	B-X
antiapoptotic	B-X
signals	B-X
.	B-X
Overexpression	B-X
of	B-X
the	B-X
antiapoptotic	B-X
proteins	B-X
Bcl-2	B-X
and	B-X
Mcl-1	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
CLL	B-X
,	B-X
and	B-X
their	B-X
expression	B-X
is	B-X
further	B-X
enhanced	B-X
in	B-X
the	B-X
lymphoid	B-X
tissues	B-X
.	B-X
However	B-X
,	B-X
the	B-X
high	B-X
levels	B-X
of	B-X
Mcl-1	B-X
found	B-X
in	B-X
peripheral	B-X
blood	B-X
samples	B-X
,	B-X
coupled	B-X
with	B-X
its	B-X
short	B-X
half-life	B-X
,	B-X
led	B-X
us	B-X
to	B-X
hypothesize	B-X
that	B-X
it	B-X
must	B-X
be	B-X
actively	B-X
maintained	B-X
in	B-X
the	B-X
peripheral	B-X
circulation	B-X
.	B-X
Coculture	B-X
of	B-X
CLL	B-X
cells	B-X
with	B-X
human	B-X
vascular	B-X
endothelial	B-X
cells	B-X
significantly	B-X
enhanced	B-X
tumor	B-X
cell	B-X
survival	B-X
,	B-X
an	B-X
effect	B-X
that	B-X
was	B-X
not	B-X
observed	B-X
with	B-X
normal	B-X
B	B-X
cells	B-X
.	B-X
This	B-X
was	B-X
associated	B-X
with	B-X
elevated	B-X
levels	B-X
of	B-X
the	B-X
antiapoptotic	B-X
proteins	B-X
Bcl-2	B-X
,	B-X
Mcl-1	B-X
,	B-X
and	B-X
Bcl-X	B-X
(	B-X
L	B-X
)	B-X
and	B-X
marked	B-X
increased	B-X
expression	B-X
of	B-X
CD38	B-X
and	B-X
CD49d	B-X
,	B-X
both	B-X
of	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
clinically	B-X
aggressive	B-X
disease	B-X
.	B-X
Because	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
and	B-X
some	B-X
Bcl-2	B-X
family	B-X
genes	B-X
are	B-X
transcriptional	B-X
targets	B-X
for	B-X
NF-κB	B-X
,	B-X
we	B-X
assessed	B-X
NF-κB	B-X
activation	B-X
following	B-X
coculture	B-X
with	B-X
endothelial	B-X
cells	B-X
.	B-X
DNA	B-X
binding	B-X
of	B-X
the	B-X
NF-κB	B-X
subunit	B-X
Rel	B-X
A	B-X
was	B-X
significantly	B-X
increased	B-X
and	B-X
strongly	B-X
correlated	B-X
with	B-X
changes	B-X
in	B-X
transcription	B-X
of	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
BCL2	B-X
,	B-X
MCL1	B-X
,	B-X
and	B-X
BCLXL	B-X
,	B-X
effects	B-X
that	B-X
were	B-X
reversed	B-X
by	B-X
a	B-X
peptide	B-X
inhibitor	B-X
of	B-X
Rel	B-X
A	B-X
.	B-X
Therefore	B-X
,	B-X
CLL	B-X
cells	B-X
receive	B-X
specific	B-X
survival	B-X
signals	B-X
following	B-X
interaction	B-X
with	B-X
endothelial	B-X
cells	B-X
mediated	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
NF-κB	B-X
and	B-X
the	B-X
induction	B-X
of	B-X
downstream	B-X
target	B-X
genes	B-X
.	B-X
This	B-X
type	B-X
of	B-X
interaction	B-X
in	B-X
the	B-X
peripheral	B-X
vasculature	B-X
may	B-X
explain	B-X
the	B-X
constitutive	B-X
NF-κB	B-X
activation	B-X
and	B-X
the	B-X
overexpression	B-X
of	B-X
Bcl-2	B-X
family	B-X
proteins	B-X
commonly	B-X
seen	B-X
in	B-X
this	B-X
disease	B-X
.	B-X

Because	O
CD38	B-Gene_or_gene_product
,	O
CD49d	B-Gene_or_gene_product
,	O
and	O
some	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
family	O
genes	O
are	O
transcriptional	O
targets	O
for	O
NF	O
-	O
kappaB	O
,	O
we	O
assessed	O
NF	O
-	O
kappaB	O
activation	O
following	O
coculture	O
with	O
endothelial	O
cells	O
.	O
<EOS>	B-X
Chronic	B-X
lymphocytic	B-X
leukemia	B-X
(	B-X
CLL	B-X
)	B-X
cells	B-X
rapidly	B-X
undergo	B-X
apoptosis	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
in	B-X
vivo	B-X
microenvironment	B-X
provides	B-X
crucial	B-X
antiapoptotic	B-X
signals	B-X
.	B-X
Overexpression	B-X
of	B-X
the	B-X
antiapoptotic	B-X
proteins	B-X
Bcl-2	B-X
and	B-X
Mcl-1	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
CLL	B-X
,	B-X
and	B-X
their	B-X
expression	B-X
is	B-X
further	B-X
enhanced	B-X
in	B-X
the	B-X
lymphoid	B-X
tissues	B-X
.	B-X
Coculture	B-X
of	B-X
CLL	B-X
cells	B-X
with	B-X
human	B-X
vascular	B-X
endothelial	B-X
cells	B-X
significantly	B-X
enhanced	B-X
tumor	B-X
cell	B-X
survival	B-X
,	B-X
an	B-X
effect	B-X
that	B-X
was	B-X
not	B-X
observed	B-X
with	B-X
normal	B-X
B	B-X
cells	B-X
.	B-X
This	B-X
was	B-X
associated	B-X
with	B-X
elevated	B-X
levels	B-X
of	B-X
the	B-X
antiapoptotic	B-X
proteins	B-X
Bcl-2	B-X
,	B-X
Mcl-1	B-X
,	B-X
and	B-X
Bcl-X	B-X
(	B-X
L	B-X
)	B-X
and	B-X
marked	B-X
increased	B-X
expression	B-X
of	B-X
CD38	B-X
and	B-X
CD49d	B-X
,	B-X
both	B-X
of	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
clinically	B-X
aggressive	B-X
disease	B-X
.	B-X
Because	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
and	B-X
some	B-X
Bcl-2	B-X
family	B-X
genes	B-X
are	B-X
transcriptional	B-X
targets	B-X
for	B-X
NF-κB	B-X
,	B-X
we	B-X
assessed	B-X
NF-κB	B-X
activation	B-X
following	B-X
coculture	B-X
with	B-X
endothelial	B-X
cells	B-X
.	B-X
DNA	B-X
binding	B-X
of	B-X
the	B-X
NF-κB	B-X
subunit	B-X
Rel	B-X
A	B-X
was	B-X
significantly	B-X
increased	B-X
and	B-X
strongly	B-X
correlated	B-X
with	B-X
changes	B-X
in	B-X
transcription	B-X
of	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
BCL2	B-X
,	B-X
MCL1	B-X
,	B-X
and	B-X
BCLXL	B-X
,	B-X
effects	B-X
that	B-X
were	B-X
reversed	B-X
by	B-X
a	B-X
peptide	B-X
inhibitor	B-X
of	B-X
Rel	B-X
A	B-X
.	B-X
These	B-X
effects	B-X
were	B-X
not	B-X
observed	B-X
following	B-X
coculture	B-X
with	B-X
nonendothelial	B-X
cell	B-X
lines	B-X
.	B-X
Therefore	B-X
,	B-X
CLL	B-X
cells	B-X
receive	B-X
specific	B-X
survival	B-X
signals	B-X
following	B-X
interaction	B-X
with	B-X
endothelial	B-X
cells	B-X
mediated	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
NF-κB	B-X
and	B-X
the	B-X
induction	B-X
of	B-X
downstream	B-X
target	B-X
genes	B-X
.	B-X
This	B-X
type	B-X
of	B-X
interaction	B-X
in	B-X
the	B-X
peripheral	B-X
vasculature	B-X
may	B-X
explain	B-X
the	B-X
constitutive	B-X
NF-κB	B-X
activation	B-X
and	B-X
the	B-X
overexpression	B-X
of	B-X
Bcl-2	B-X
family	B-X
proteins	B-X
commonly	B-X
seen	B-X
in	B-X
this	B-X
disease	B-X
.	B-X

DNA	O
binding	O
of	O
the	O
NF	O
-	O
kappaB	O
subunit	O
Rel	B-Gene_or_gene_product
A	I-Gene_or_gene_product
was	O
significantly	O
increased	O
and	O
strongly	O
correlated	O
with	O
changes	O
in	O
transcription	O
of	O
CD38	B-Gene_or_gene_product
,	O
CD49d	B-Gene_or_gene_product
,	O
BCL2	B-Gene_or_gene_product
,	O
MCL1	B-Gene_or_gene_product
,	O
and	O
BCLXL	B-Gene_or_gene_product
,	O
effects	O
that	O
were	O
reversed	O
by	O
a	O
peptide	O
inhibitor	O
of	O
Rel	B-Gene_or_gene_product
A	I-Gene_or_gene_product
.	O
<EOS>	B-X
Coculture	B-X
of	B-X
CLL	B-X
cells	B-X
with	B-X
human	B-X
vascular	B-X
endothelial	B-X
cells	B-X
significantly	B-X
enhanced	B-X
tumor	B-X
cell	B-X
survival	B-X
,	B-X
an	B-X
effect	B-X
that	B-X
was	B-X
not	B-X
observed	B-X
with	B-X
normal	B-X
B	B-X
cells	B-X
.	B-X
This	B-X
was	B-X
associated	B-X
with	B-X
elevated	B-X
levels	B-X
of	B-X
the	B-X
antiapoptotic	B-X
proteins	B-X
Bcl-2	B-X
,	B-X
Mcl-1	B-X
,	B-X
and	B-X
Bcl-X	B-X
(	B-X
L	B-X
)	B-X
and	B-X
marked	B-X
increased	B-X
expression	B-X
of	B-X
CD38	B-X
and	B-X
CD49d	B-X
,	B-X
both	B-X
of	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
clinically	B-X
aggressive	B-X
disease	B-X
.	B-X
Because	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
and	B-X
some	B-X
Bcl-2	B-X
family	B-X
genes	B-X
are	B-X
transcriptional	B-X
targets	B-X
for	B-X
NF-κB	B-X
,	B-X
we	B-X
assessed	B-X
NF-κB	B-X
activation	B-X
following	B-X
coculture	B-X
with	B-X
endothelial	B-X
cells	B-X
.	B-X
DNA	B-X
binding	B-X
of	B-X
the	B-X
NF-κB	B-X
subunit	B-X
Rel	B-X
A	B-X
was	B-X
significantly	B-X
increased	B-X
and	B-X
strongly	B-X
correlated	B-X
with	B-X
changes	B-X
in	B-X
transcription	B-X
of	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
BCL2	B-X
,	B-X
MCL1	B-X
,	B-X
and	B-X
BCLXL	B-X
,	B-X
effects	B-X
that	B-X
were	B-X
reversed	B-X
by	B-X
a	B-X
peptide	B-X
inhibitor	B-X
of	B-X
Rel	B-X
A	B-X
.	B-X
These	B-X
effects	B-X
were	B-X
not	B-X
observed	B-X
following	B-X
coculture	B-X
with	B-X
nonendothelial	B-X
cell	B-X
lines	B-X
.	B-X
Therefore	B-X
,	B-X
CLL	B-X
cells	B-X
receive	B-X
specific	B-X
survival	B-X
signals	B-X
following	B-X
interaction	B-X
with	B-X
endothelial	B-X
cells	B-X
mediated	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
NF-κB	B-X
and	B-X
the	B-X
induction	B-X
of	B-X
downstream	B-X
target	B-X
genes	B-X
.	B-X
This	B-X
type	B-X
of	B-X
interaction	B-X
in	B-X
the	B-X
peripheral	B-X
vasculature	B-X
may	B-X
explain	B-X
the	B-X
constitutive	B-X
NF-κB	B-X
activation	B-X
and	B-X
the	B-X
overexpression	B-X
of	B-X
Bcl-2	B-X
family	B-X
proteins	B-X
commonly	B-X
seen	B-X
in	B-X
this	B-X
disease	B-X
.	B-X

These	O
effects	O
were	O
not	O
observed	O
following	O
coculture	O
with	O
nonendothelial	O
cell	O
lines	O
.	O
<EOS>	B-X
However	B-X
,	B-X
the	B-X
effects	B-X
of	B-X
ACBT	B-X
on	B-X
COPD	B-X
patients	B-X
have	B-X
shown	B-X
mixed	B-X
results	B-X
.	B-X
Additional	B-X
research	B-X
is	B-X
warranted	B-X
to	B-X
determine	B-X
comparative	B-X
effectiveness	B-X
and	B-X
long-term	B-X
effects	B-X
of	B-X
mindfulness	B-X
training	B-X
.	B-X
How	B-X
Can	B-X
Synergism	B-X
of	B-X
Traditional	B-X
Medicines	B-X
Benefit	B-X
from	B-X
Network	B-X
Pharmacology	B-X
?	B-X
Self-Rated	B-X
Effectiveness	B-X
of	B-X
Microdosing	B-X
With	B-X
Psychedelics	B-X
for	B-X
Mental	B-X
and	B-X
Physical	B-X
Health	B-X
Problems	B-X
Among	B-X
Microdosers	B-X
.	B-X

Therefore	O
,	O
CLL	O
cells	O
receive	O
specific	O
survival	O
signals	O
following	O
interaction	O
with	O
endothelial	O
cells	O
mediated	O
through	O
the	O
activation	O
of	O
NF	O
-	O
kappaB	O
and	O
the	O
induction	O
of	O
downstream	O
target	O
genes	O
.	O
<EOS>	B-X
Chronic	B-X
lymphocytic	B-X
leukemia	B-X
(	B-X
CLL	B-X
)	B-X
cells	B-X
rapidly	B-X
undergo	B-X
apoptosis	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
in	B-X
vivo	B-X
microenvironment	B-X
provides	B-X
crucial	B-X
antiapoptotic	B-X
signals	B-X
.	B-X
Overexpression	B-X
of	B-X
the	B-X
antiapoptotic	B-X
proteins	B-X
Bcl-2	B-X
and	B-X
Mcl-1	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
CLL	B-X
,	B-X
and	B-X
their	B-X
expression	B-X
is	B-X
further	B-X
enhanced	B-X
in	B-X
the	B-X
lymphoid	B-X
tissues	B-X
.	B-X
Coculture	B-X
of	B-X
CLL	B-X
cells	B-X
with	B-X
human	B-X
vascular	B-X
endothelial	B-X
cells	B-X
significantly	B-X
enhanced	B-X
tumor	B-X
cell	B-X
survival	B-X
,	B-X
an	B-X
effect	B-X
that	B-X
was	B-X
not	B-X
observed	B-X
with	B-X
normal	B-X
B	B-X
cells	B-X
.	B-X
Because	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
and	B-X
some	B-X
Bcl-2	B-X
family	B-X
genes	B-X
are	B-X
transcriptional	B-X
targets	B-X
for	B-X
NF-κB	B-X
,	B-X
we	B-X
assessed	B-X
NF-κB	B-X
activation	B-X
following	B-X
coculture	B-X
with	B-X
endothelial	B-X
cells	B-X
.	B-X
DNA	B-X
binding	B-X
of	B-X
the	B-X
NF-κB	B-X
subunit	B-X
Rel	B-X
A	B-X
was	B-X
significantly	B-X
increased	B-X
and	B-X
strongly	B-X
correlated	B-X
with	B-X
changes	B-X
in	B-X
transcription	B-X
of	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
BCL2	B-X
,	B-X
MCL1	B-X
,	B-X
and	B-X
BCLXL	B-X
,	B-X
effects	B-X
that	B-X
were	B-X
reversed	B-X
by	B-X
a	B-X
peptide	B-X
inhibitor	B-X
of	B-X
Rel	B-X
A	B-X
.	B-X
These	B-X
effects	B-X
were	B-X
not	B-X
observed	B-X
following	B-X
coculture	B-X
with	B-X
nonendothelial	B-X
cell	B-X
lines	B-X
.	B-X
Therefore	B-X
,	B-X
CLL	B-X
cells	B-X
receive	B-X
specific	B-X
survival	B-X
signals	B-X
following	B-X
interaction	B-X
with	B-X
endothelial	B-X
cells	B-X
mediated	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
NF-κB	B-X
and	B-X
the	B-X
induction	B-X
of	B-X
downstream	B-X
target	B-X
genes	B-X
.	B-X
This	B-X
type	B-X
of	B-X
interaction	B-X
in	B-X
the	B-X
peripheral	B-X
vasculature	B-X
may	B-X
explain	B-X
the	B-X
constitutive	B-X
NF-κB	B-X
activation	B-X
and	B-X
the	B-X
overexpression	B-X
of	B-X
Bcl-2	B-X
family	B-X
proteins	B-X
commonly	B-X
seen	B-X
in	B-X
this	B-X
disease	B-X
.	B-X

This	O
type	O
of	O
interaction	O
in	O
the	O
peripheral	O
vasculature	O
may	O
explain	O
the	O
constitutive	O
NF	O
-	O
kappaB	O
activation	O
and	O
the	O
overexpression	O
of	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
family	O
proteins	O
commonly	O
seen	O
in	O
this	O
disease	O
.	O
<EOS>	B-X
Overexpression	B-X
of	B-X
the	B-X
antiapoptotic	B-X
proteins	B-X
Bcl-2	B-X
and	B-X
Mcl-1	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
CLL	B-X
,	B-X
and	B-X
their	B-X
expression	B-X
is	B-X
further	B-X
enhanced	B-X
in	B-X
the	B-X
lymphoid	B-X
tissues	B-X
.	B-X
However	B-X
,	B-X
the	B-X
high	B-X
levels	B-X
of	B-X
Mcl-1	B-X
found	B-X
in	B-X
peripheral	B-X
blood	B-X
samples	B-X
,	B-X
coupled	B-X
with	B-X
its	B-X
short	B-X
half-life	B-X
,	B-X
led	B-X
us	B-X
to	B-X
hypothesize	B-X
that	B-X
it	B-X
must	B-X
be	B-X
actively	B-X
maintained	B-X
in	B-X
the	B-X
peripheral	B-X
circulation	B-X
.	B-X
This	B-X
was	B-X
associated	B-X
with	B-X
elevated	B-X
levels	B-X
of	B-X
the	B-X
antiapoptotic	B-X
proteins	B-X
Bcl-2	B-X
,	B-X
Mcl-1	B-X
,	B-X
and	B-X
Bcl-X	B-X
(	B-X
L	B-X
)	B-X
and	B-X
marked	B-X
increased	B-X
expression	B-X
of	B-X
CD38	B-X
and	B-X
CD49d	B-X
,	B-X
both	B-X
of	B-X
which	B-X
are	B-X
associated	B-X
with	B-X
clinically	B-X
aggressive	B-X
disease	B-X
.	B-X
Because	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
and	B-X
some	B-X
Bcl-2	B-X
family	B-X
genes	B-X
are	B-X
transcriptional	B-X
targets	B-X
for	B-X
NF-κB	B-X
,	B-X
we	B-X
assessed	B-X
NF-κB	B-X
activation	B-X
following	B-X
coculture	B-X
with	B-X
endothelial	B-X
cells	B-X
.	B-X
DNA	B-X
binding	B-X
of	B-X
the	B-X
NF-κB	B-X
subunit	B-X
Rel	B-X
A	B-X
was	B-X
significantly	B-X
increased	B-X
and	B-X
strongly	B-X
correlated	B-X
with	B-X
changes	B-X
in	B-X
transcription	B-X
of	B-X
CD38	B-X
,	B-X
CD49d	B-X
,	B-X
BCL2	B-X
,	B-X
MCL1	B-X
,	B-X
and	B-X
BCLXL	B-X
,	B-X
effects	B-X
that	B-X
were	B-X
reversed	B-X
by	B-X
a	B-X
peptide	B-X
inhibitor	B-X
of	B-X
Rel	B-X
A	B-X
.	B-X
Therefore	B-X
,	B-X
CLL	B-X
cells	B-X
receive	B-X
specific	B-X
survival	B-X
signals	B-X
following	B-X
interaction	B-X
with	B-X
endothelial	B-X
cells	B-X
mediated	B-X
through	B-X
the	B-X
activation	B-X
of	B-X
NF-κB	B-X
and	B-X
the	B-X
induction	B-X
of	B-X
downstream	B-X
target	B-X
genes	B-X
.	B-X
This	B-X
type	B-X
of	B-X
interaction	B-X
in	B-X
the	B-X
peripheral	B-X
vasculature	B-X
may	B-X
explain	B-X
the	B-X
constitutive	B-X
NF-κB	B-X
activation	B-X
and	B-X
the	B-X
overexpression	B-X
of	B-X
Bcl-2	B-X
family	B-X
proteins	B-X
commonly	B-X
seen	B-X
in	B-X
this	B-X
disease	B-X
.	B-X

Interaction	O
of	O
the	O
TNFR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
associated	O
factor	O
TRAF1	B-Gene_or_gene_product
with	O
I	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
and	O
TRAF2	B-Gene_or_gene_product
indicates	O
a	O
regulatory	O
function	O
for	O
NF	O
-	O
kappa	O
B	O
signaling	O
.	O
<EOS>	B-X
I-kappa	B-X
B	B-X
kinase	B-X
2	B-X
(	B-X
IKK2	B-X
or	B-X
IKK-beta	B-X
)	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
crucial	B-X
signaling	B-X
kinases	B-X
for	B-X
activation	B-X
of	B-X
NF-kappa	B-X
B	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
is	B-X
important	B-X
for	B-X
inflammation	B-X
,	B-X
cell	B-X
survival	B-X
and	B-X
differentiation	B-X
.	B-X
Since	B-X
many	B-X
NF-kappa	B-X
B	B-X
activating	B-X
pathways	B-X
converge	B-X
at	B-X
the	B-X
level	B-X
of	B-X
IKK2	B-X
,	B-X
molecular	B-X
interactions	B-X
of	B-X
this	B-X
kinase	B-X
are	B-X
pivotal	B-X
for	B-X
regulation	B-X
of	B-X
NF-kappa	B-X
B	B-X
signaling	B-X
.	B-X

BACKGROUND	O
:	O
I	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
2	I-Gene_or_gene_product
(	O
IKK2	B-Gene_or_gene_product
or	O
IKK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
)	O
is	O
one	O
of	O
the	O
most	O
crucial	O
signaling	O
kinases	O
for	O
activation	O
of	O
NF	O
-	O
kappa	O
B	O
,	O
a	O
transcription	O
factor	O
that	O
is	O
important	O
for	O
inflammation	O
,	O
cell	O
survival	O
and	O
differentiation	O
.	O
<EOS>	B-X
I-kappa	B-X
B	B-X
kinase	B-X
2	B-X
(	B-X
IKK2	B-X
or	B-X
IKK-beta	B-X
)	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
crucial	B-X
signaling	B-X
kinases	B-X
for	B-X
activation	B-X
of	B-X
NF-kappa	B-X
B	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
is	B-X
important	B-X
for	B-X
inflammation	B-X
,	B-X
cell	B-X
survival	B-X
and	B-X
differentiation	B-X
.	B-X
Since	B-X
many	B-X
NF-kappa	B-X
B	B-X
activating	B-X
pathways	B-X
converge	B-X
at	B-X
the	B-X
level	B-X
of	B-X
IKK2	B-X
,	B-X
molecular	B-X
interactions	B-X
of	B-X
this	B-X
kinase	B-X
are	B-X
pivotal	B-X
for	B-X
regulation	B-X
of	B-X
NF-kappa	B-X
B	B-X
signaling	B-X
.	B-X

Since	O
many	O
NF	O
-	O
kappa	O
B	O
activating	O
pathways	O
converge	O
at	O
the	O
level	O
of	O
IKK2	B-Gene_or_gene_product
,	O
molecular	O
interactions	O
of	O
this	O
kinase	O
are	O
pivotal	O
for	O
regulation	O
of	O
NF	O
-	O
kappa	O
B	O
signaling	O
.	O
<EOS>	B-X
I-kappa	B-X
B	B-X
kinase	B-X
2	B-X
(	B-X
IKK2	B-X
or	B-X
IKK-beta	B-X
)	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
crucial	B-X
signaling	B-X
kinases	B-X
for	B-X
activation	B-X
of	B-X
NF-kappa	B-X
B	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
is	B-X
important	B-X
for	B-X
inflammation	B-X
,	B-X
cell	B-X
survival	B-X
and	B-X
differentiation	B-X
.	B-X
Since	B-X
many	B-X
NF-kappa	B-X
B	B-X
activating	B-X
pathways	B-X
converge	B-X
at	B-X
the	B-X
level	B-X
of	B-X
IKK2	B-X
,	B-X
molecular	B-X
interactions	B-X
of	B-X
this	B-X
kinase	B-X
are	B-X
pivotal	B-X
for	B-X
regulation	B-X
of	B-X
NF-kappa	B-X
B	B-X
signaling	B-X
.	B-X

METHODOLOGY	O
/	O
PRINCIPAL	O
FINDINGS	O
:	O
We	O
searched	O
for	O
proteins	O
interacting	O
with	O
IKK2	B-Gene_or_gene_product
using	O
the	O
C	O
-	O
terminal	O
part	O
(	O
amino	O
acids	O
466	O
-	O
756	O
)	O
as	O
bait	O
in	O
a	O
yeast	O
two	O
-	O
hybrid	O
system	O
and	O
identified	O
the	O
N	O
-	O
terminal	O
part	O
(	O
amino	O
acids	O
1	O
-	O
228	O
)	O
of	O
the	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
associated	O
factor	O
TRAF1	B-Gene_or_gene_product
as	O
putative	O
interaction	O
partner	O
.	O

The	O
interaction	O
was	O
confirmed	O
in	O
human	O
cells	O
by	O
mammalian	O
two	O
-	O
hybrid	O
and	O
coimmunoprecipitation	O
experiments	O
.	O
<EOS>	B-X
Dehydrodolichyl	B-X
diphosphate	B-X
(	B-X
DedolPP	B-X
)	B-X
synthase	B-X
catalyzes	B-X
the	B-X
sequential	B-X
condensation	B-X
of	B-X
isopentenyl	B-X
diphosphate	B-X
with	B-X
farnesyl	B-X
diphosphate	B-X
to	B-X
synthesize	B-X
DedolPP	B-X
,	B-X
a	B-X
biosynthetic	B-X
precursor	B-X
for	B-X
dolichol	B-X
which	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
as	B-X
a	B-X
sugar-carrier	B-X
lipid	B-X
in	B-X
the	B-X
biosynthesis	B-X
of	B-X
glycoprotein	B-X
in	B-X
eukaryotic	B-X
cells	B-X
.	B-X
During	B-X
certain	B-X
pathological	B-X
processes	B-X
like	B-X
Alzheimer	B-X
's	B-X
disease	B-X
or	B-X
some	B-X
neurological	B-X
disorders	B-X
,	B-X
dolichol	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
accumulate	B-X
in	B-X
human	B-X
brain	B-X
.	B-X
In	B-X
order	B-X
to	B-X
understand	B-X
the	B-X
regulatory	B-X
mechanism	B-X
of	B-X
dolichol	B-X
in	B-X
eukaryotes	B-X
,	B-X
we	B-X
performed	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
screen	B-X
using	B-X
full	B-X
length	B-X
human	B-X
DedolPP	B-X
synthase	B-X
gene	B-X
[	B-X
Endo	B-X
et	B-X
al	B-X
.	B-X
We	B-X
identified	B-X
Niemann-Pick	B-X
Type	B-X
C2	B-X
protein	B-X
(	B-X
NPC2	B-X
)	B-X
to	B-X
show	B-X
a	B-X
specific	B-X
interaction	B-X
with	B-X
human	B-X
DedolPP	B-X
synthase	B-X
.	B-X
This	B-X
interaction	B-X
was	B-X
further	B-X
confirmed	B-X
by	B-X
in	B-X
vitro	B-X
co-immunoprecipitation	B-X
experiment	B-X
,	B-X
indicating	B-X
the	B-X
possible	B-X
physiological	B-X
interaction	B-X
between	B-X
NPC2	B-X
and	B-X
DedolPP	B-X
synthase	B-X
proteins	B-X
in	B-X
human	B-X
.	B-X

The	O
IKK2	B-Gene_or_gene_product
/	O
TRAF1	B-Gene_or_gene_product
interaction	O
seemed	O
weaker	O
than	O
the	O
interaction	O
between	O
TRAF1	B-Gene_or_gene_product
and	O
TRAF2	B-Gene_or_gene_product
,	O
an	O
important	O
activating	O
adapter	O
molecule	O
of	O
NF	O
-	O
kappa	O
B	O
signaling	O
.	O

Reporter	O
gene	O
and	O
kinase	O
assays	O
using	O
ectopic	O
expression	O
of	O
TRAF1	B-Gene_or_gene_product
indicated	O
that	O
it	O
can	O
both	O
activate	O
and	O
inhibit	O
IKK2	B-Gene_or_gene_product
and	O
NF	O
-	O
kappa	O
B	O
.	O
<EOS>	B-X
I-kappa	B-X
B	B-X
kinase	B-X
2	B-X
(	B-X
IKK2	B-X
or	B-X
IKK-beta	B-X
)	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
crucial	B-X
signaling	B-X
kinases	B-X
for	B-X
activation	B-X
of	B-X
NF-kappa	B-X
B	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
is	B-X
important	B-X
for	B-X
inflammation	B-X
,	B-X
cell	B-X
survival	B-X
and	B-X
differentiation	B-X
.	B-X
Since	B-X
many	B-X
NF-kappa	B-X
B	B-X
activating	B-X
pathways	B-X
converge	B-X
at	B-X
the	B-X
level	B-X
of	B-X
IKK2	B-X
,	B-X
molecular	B-X
interactions	B-X
of	B-X
this	B-X
kinase	B-X
are	B-X
pivotal	B-X
for	B-X
regulation	B-X
of	B-X
NF-kappa	B-X
B	B-X
signaling	B-X
.	B-X

Co	O
-	O
expression	O
of	O
fluorescently	O
tagged	O
TRAF1	B-Gene_or_gene_product
and	O
TRAF2	B-Gene_or_gene_product
at	O
different	O
ratios	O
implied	O
that	O
TRAF1	B-Gene_or_gene_product
can	O
affect	O
clustering	O
and	O
presumably	O
the	O
activating	O
function	O
of	O
TRAF2	B-Gene_or_gene_product
in	O
a	O
dose	O
dependent	O
manner	O
.	O

CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
The	O
observation	O
that	O
TRAF1	B-Gene_or_gene_product
can	O
either	O
activate	O
or	O
inhibit	O
the	O
NF	O
-	O
kappa	O
B	O
pathway	O
and	O
the	O
fact	O
that	O
it	O
influences	O
the	O
oligomerization	O
of	O
TRAF2	B-Gene_or_gene_product
indicates	O
that	O
relative	O
levels	O
of	O
IKK2	B-Gene_or_gene_product
,	O
TRAF1	B-Gene_or_gene_product
and	O
TRAF2	B-Gene_or_gene_product
may	O
be	O
important	O
for	O
regulation	O
of	O
NF	O
-	O
kappa	O
B	O
activity	O
.	O
<EOS>	B-X
I-kappa	B-X
B	B-X
kinase	B-X
2	B-X
(	B-X
IKK2	B-X
or	B-X
IKK-beta	B-X
)	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
crucial	B-X
signaling	B-X
kinases	B-X
for	B-X
activation	B-X
of	B-X
NF-kappa	B-X
B	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
is	B-X
important	B-X
for	B-X
inflammation	B-X
,	B-X
cell	B-X
survival	B-X
and	B-X
differentiation	B-X
.	B-X
Since	B-X
many	B-X
NF-kappa	B-X
B	B-X
activating	B-X
pathways	B-X
converge	B-X
at	B-X
the	B-X
level	B-X
of	B-X
IKK2	B-X
,	B-X
molecular	B-X
interactions	B-X
of	B-X
this	B-X
kinase	B-X
are	B-X
pivotal	B-X
for	B-X
regulation	B-X
of	B-X
NF-kappa	B-X
B	B-X
signaling	B-X
.	B-X
The	B-X
TWEAK-Fn14	B-X
pathway	B-X
represents	B-X
a	B-X
novel	B-X
anticancer	B-X
target	B-X
that	B-X
is	B-X
being	B-X
actively	B-X
investigated	B-X
.	B-X
The	B-X
destruction	B-X
of	B-X
pancreatic	B-X
beta	B-X
cells	B-X
leading	B-X
to	B-X
type	B-X
1	B-X
diabetes	B-X
in	B-X
humans	B-X
is	B-X
thought	B-X
to	B-X
occur	B-X
mainly	B-X
through	B-X
apoptosis	B-X
and	B-X
necrosis	B-X
induced	B-X
by	B-X
activated	B-X
macrophages	B-X
and	B-X
T	B-X
cells	B-X
,	B-X
and	B-X
in	B-X
which	B-X
secreted	B-X
cytokines	B-X
play	B-X
a	B-X
significant	B-X
role	B-X
.	B-X
The	B-X
transcription	B-X
factor	B-X
nuclear	B-X
factor	B-X
kappa-B	B-X
(	B-X
NF-kappaB	B-X
)	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
mediating	B-X
the	B-X
apoptotic	B-X
action	B-X
of	B-X
cytokines	B-X
in	B-X
beta	B-X
cells	B-X
.	B-X
We	B-X
therefore	B-X
sought	B-X
to	B-X
determine	B-X
the	B-X
changes	B-X
in	B-X
expression	B-X
of	B-X
genes	B-X
modulated	B-X
by	B-X
NF-kappaB	B-X
in	B-X
human	B-X
islets	B-X
exposed	B-X
to	B-X
a	B-X
combination	B-X
of	B-X
IL1beta	B-X
,	B-X
TNF-alpha	B-X
and	B-X
IFN-gamma	B-X
.	B-X

Since	O
TRAF1	B-Gene_or_gene_product
is	O
an	O
NF	O
-	O
kappa	O
B	O
induced	O
gene	O
,	O
it	O
might	O
act	O
as	O
a	O
feedback	O
effector	O
molecule	O
.	O
<EOS>	B-X
I-kappa	B-X
B	B-X
kinase	B-X
2	B-X
(	B-X
IKK2	B-X
or	B-X
IKK-beta	B-X
)	B-X
is	B-X
one	B-X
of	B-X
the	B-X
most	B-X
crucial	B-X
signaling	B-X
kinases	B-X
for	B-X
activation	B-X
of	B-X
NF-kappa	B-X
B	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
is	B-X
important	B-X
for	B-X
inflammation	B-X
,	B-X
cell	B-X
survival	B-X
and	B-X
differentiation	B-X
.	B-X
Since	B-X
many	B-X
NF-kappa	B-X
B	B-X
activating	B-X
pathways	B-X
converge	B-X
at	B-X
the	B-X
level	B-X
of	B-X
IKK2	B-X
,	B-X
molecular	B-X
interactions	B-X
of	B-X
this	B-X
kinase	B-X
are	B-X
pivotal	B-X
for	B-X
regulation	B-X
of	B-X
NF-kappa	B-X
B	B-X
signaling	B-X
.	B-X

Human	O
adipose	O
tissue	O
-	O
derived	O
mesenchymal	O
stem	O
cells	O
facilitate	O
the	O
immunosuppressive	O
effect	O
of	O
cyclosporin	O
A	O
on	O
T	O
lymphocytes	O
through	O
Jagged	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
-	O
mediated	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
signaling	O
.	O

OBJECTIVE	O
:	O
Cyclosporine	O
A	O
(	O
CsA	O
)	O
,	O
known	O
as	O
an	O
effective	O
immunosuppressive	O
agent	O
,	O
is	O
widely	O
used	O
in	O
clinical	O
fields	O
.	O
<EOS>	B-X
Topical	B-X
cyclosporine	B-X
A	B-X
(	B-X
also	B-X
known	B-X
as	B-X
ciclosporin	B-X
A	B-X
)	B-X
(	B-X
CsA	B-X
)	B-X
is	B-X
an	B-X
anti-inflammatory	B-X
that	B-X
has	B-X
been	B-X
widely	B-X
used	B-X
to	B-X
treat	B-X
inflammatory	B-X
ocular	B-X
surface	B-X
diseases	B-X
.	B-X
Two	B-X
CsA	B-X
eyedrops	B-X
have	B-X
been	B-X
approved	B-X
by	B-X
US	B-X
Food	B-X
and	B-X
Drug	B-X
Administration	B-X
for	B-X
managing	B-X
dry	B-X
eye	B-X
:	B-X
Restasis	B-X
(	B-X
CsA	B-X
0.05	B-X
%	B-X
,	B-X
Allergan	B-X
Inc	B-X
,	B-X
Irvine	B-X
,	B-X
CA	B-X
,	B-X
USA	B-X
)	B-X
,	B-X
approved	B-X
in	B-X
2002	B-X
,	B-X
and	B-X
Cequa	B-X
(	B-X
CsA	B-X
0.09	B-X
%	B-X
,	B-X
Sun	B-X
Pharma	B-X
,	B-X
Cranbury	B-X
,	B-X
NJ	B-X
,	B-X
USA	B-X
)	B-X
,	B-X
approved	B-X
in	B-X
2018	B-X
.	B-X
Numerous	B-X
clinical	B-X
trials	B-X
have	B-X
been	B-X
performed	B-X
to	B-X
assess	B-X
the	B-X
effectiveness	B-X
and	B-X
safety	B-X
of	B-X
CsA	B-X
for	B-X
dry	B-X
eye	B-X
;	B-X
however	B-X
,	B-X
there	B-X
is	B-X
no	B-X
universal	B-X
consensus	B-X
with	B-X
regard	B-X
to	B-X
its	B-X
effect	B-X
.	B-X
Cyclosporine	B-X
A	B-X
(	B-X
CsA	B-X
)	B-X
,	B-X
known	B-X
as	B-X
an	B-X
effective	B-X
immunosuppressive	B-X
agent	B-X
,	B-X
is	B-X
widely	B-X
used	B-X
in	B-X
clinical	B-X
fields	B-X
.	B-X
Here	B-X
we	B-X
investigated	B-X
whether	B-X
human	B-X
adipose	B-X
tissue-derived	B-X
mesenchymal	B-X
stem	B-X
cells	B-X
(	B-X
AMSCs	B-X
)	B-X
facilitate	B-X
in	B-X
vitro	B-X
the	B-X
immunomodulatory	B-X
effects	B-X
of	B-X
CsA	B-X
and	B-X
we	B-X
explored	B-X
the	B-X
molecule	B-X
mechanisms	B-X
that	B-X
may	B-X
be	B-X
involved	B-X
.	B-X

Mesenchymal	O
stem	O
cells	O
may	O
exert	O
immunomodulatory	O
effects	O
on	O
the	O
immune	O
system	O
,	O
but	O
the	O
exact	O
mechanisms	O
underlying	O
them	O
remain	O
controversial	O
.	O
<EOS>	B-X
Mesenchymal	B-X
stem	B-X
cells	B-X
may	B-X
exert	B-X
immunomodulatory	B-X
effects	B-X
on	B-X
the	B-X
immune	B-X
system	B-X
,	B-X
but	B-X
the	B-X
exact	B-X
mechanisms	B-X
underlying	B-X
them	B-X
remain	B-X
controversial	B-X
.	B-X
Here	B-X
we	B-X
investigated	B-X
whether	B-X
human	B-X
adipose	B-X
tissue-derived	B-X
mesenchymal	B-X
stem	B-X
cells	B-X
(	B-X
AMSCs	B-X
)	B-X
facilitate	B-X
in	B-X
vitro	B-X
the	B-X
immunomodulatory	B-X
effects	B-X
of	B-X
CsA	B-X
and	B-X
we	B-X
explored	B-X
the	B-X
molecule	B-X
mechanisms	B-X
that	B-X
may	B-X
be	B-X
involved	B-X
.	B-X

Here	O
we	O
investigated	O
whether	O
human	O
adipose	O
tissue	O
-	O
derived	O
mesenchymal	O
stem	O
cells	O
(	O
AMSCs	O
)	O
facilitate	O
in	O
vitro	O
the	O
immunomodulatory	O
effects	O
of	O
CsA	O
and	O
we	O
explored	O
the	O
molecule	O
mechanisms	O
that	O
may	O
be	O
involved	O
.	O
<EOS>	B-X
Cyclosporine	B-X
A	B-X
(	B-X
CsA	B-X
)	B-X
,	B-X
known	B-X
as	B-X
an	B-X
effective	B-X
immunosuppressive	B-X
agent	B-X
,	B-X
is	B-X
widely	B-X
used	B-X
in	B-X
clinical	B-X
fields	B-X
.	B-X
Mesenchymal	B-X
stem	B-X
cells	B-X
may	B-X
exert	B-X
immunomodulatory	B-X
effects	B-X
on	B-X
the	B-X
immune	B-X
system	B-X
,	B-X
but	B-X
the	B-X
exact	B-X
mechanisms	B-X
underlying	B-X
them	B-X
remain	B-X
controversial	B-X
.	B-X
Here	B-X
we	B-X
investigated	B-X
whether	B-X
human	B-X
adipose	B-X
tissue-derived	B-X
mesenchymal	B-X
stem	B-X
cells	B-X
(	B-X
AMSCs	B-X
)	B-X
facilitate	B-X
in	B-X
vitro	B-X
the	B-X
immunomodulatory	B-X
effects	B-X
of	B-X
CsA	B-X
and	B-X
we	B-X
explored	B-X
the	B-X
molecule	B-X
mechanisms	B-X
that	B-X
may	B-X
be	B-X
involved	B-X
.	B-X

MATERIALS	O
AND	O
METHODS	O
:	O
Proliferation	O
of	O
T	O
lymphocytes	O
was	O
measured	O
by	O
uptake	O
of	O
(	O
3	O
)	O
H	O
-	O
thymidine	O
.	O
<EOS>	B-X
Here	B-X
we	B-X
investigated	B-X
whether	B-X
human	B-X
adipose	B-X
tissue-derived	B-X
mesenchymal	B-X
stem	B-X
cells	B-X
(	B-X
AMSCs	B-X
)	B-X
facilitate	B-X
in	B-X
vitro	B-X
the	B-X
immunomodulatory	B-X
effects	B-X
of	B-X
CsA	B-X
and	B-X
we	B-X
explored	B-X
the	B-X
molecule	B-X
mechanisms	B-X
that	B-X
may	B-X
be	B-X
involved	B-X
.	B-X

Transcription	O
and	O
production	O
of	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
and	O
interferon	B-Gene_or_gene_product
-	I-Gene_or_gene_product
gamma	I-Gene_or_gene_product
were	O
evaluated	O
by	O
real	O
-	O
time	O
quantitative	O
polymerase	O
chain	O
reaction	O
,	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
,	O
and	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

Nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
was	O
assayed	O
by	O
Western	O
blotting	O
and	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O
<EOS>	B-X
Nuclear	B-X
factor-kappa	B-X
B	B-X
(	B-X
NF-κB	B-X
)	B-X
is	B-X
a	B-X
ubiquitous	B-X
transcription	B-X
factor	B-X
that	B-X
regulates	B-X
immune	B-X
and	B-X
cell-survival	B-X
signaling	B-X
pathways	B-X
.	B-X
NF-κB	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
be	B-X
present	B-X
in	B-X
neurons	B-X
wherein	B-X
it	B-X
reportedly	B-X
responds	B-X
to	B-X
immune	B-X
and	B-X
toxic	B-X
stimuli	B-X
,	B-X
glutamate	B-X
,	B-X
and	B-X
synaptic	B-X
activity	B-X
.	B-X
However	B-X
,	B-X
because	B-X
the	B-X
brain	B-X
contains	B-X
many	B-X
cell	B-X
types	B-X
,	B-X
assays	B-X
specifically	B-X
measuring	B-X
neuronal	B-X
NF-κB	B-X
activity	B-X
are	B-X
difficult	B-X
to	B-X
perform	B-X
and	B-X
interpret	B-X
.	B-X
To	B-X
address	B-X
this	B-X
,	B-X
we	B-X
compared	B-X
NF-κB	B-X
activity	B-X
in	B-X
cultures	B-X
of	B-X
primary	B-X
neocortical	B-X
neurons	B-X
,	B-X
mixed	B-X
brain	B-X
cells	B-X
,	B-X
and	B-X
liver	B-X
cells	B-X
,	B-X
employing	B-X
Western	B-X
blot	B-X
of	B-X
NF-κB	B-X
subunits	B-X
,	B-X
electrophoretic	B-X
mobility	B-X
shift	B-X
assay	B-X
(	B-X
EMSA	B-X
)	B-X
of	B-X
nuclear	B-X
κB	B-X
DNA	B-X
binding	B-X
,	B-X
reporter	B-X
assay	B-X
of	B-X
κB	B-X
DNA	B-X
binding	B-X
,	B-X
immunofluorescence	B-X
of	B-X
the	B-X
NF-κB	B-X
subunit	B-X
protein	B-X
p65	B-X
,	B-X
quantitative	B-X
real-time	B-X
polymerase	B-X
chain	B-X
reaction	B-X
(	B-X
PCR	B-X
)	B-X
of	B-X
NF-κB-regulated	B-X
gene	B-X
expression	B-X
,	B-X
and	B-X
enzyme-linked	B-X
immunosorbent	B-X
assay	B-X
(	B-X
ELISA	B-X
)	B-X
of	B-X
produced	B-X
proteins	B-X
.	B-X
EMSA	B-X
and	B-X
reporter	B-X
assays	B-X
showed	B-X
that	B-X
constitutive	B-X
NF-κB	B-X
activity	B-X
was	B-X
nearly	B-X
absent	B-X
in	B-X
neurons	B-X
.	B-X
Induced	B-X
activity	B-X
was	B-X
minimal	B-X
--	B-X
many	B-X
fold	B-X
lower	B-X
than	B-X
in	B-X
other	B-X
cell	B-X
types	B-X
,	B-X
as	B-X
measured	B-X
by	B-X
phosphorylation	B-X
and	B-X
degradation	B-X
of	B-X
the	B-X
inhibitor	B-X
IκBα	B-X
,	B-X
nuclear	B-X
accumulation	B-X
of	B-X
p65	B-X
,	B-X
binding	B-X
to	B-X
κB	B-X
DNA	B-X
consensus	B-X
sites	B-X
,	B-X
NF-κB	B-X
reporting	B-X
,	B-X
or	B-X
induction	B-X
of	B-X
NF-κB-responsive	B-X
genes	B-X
.	B-X
The	B-X
most	B-X
efficacious	B-X
activating	B-X
stimuli	B-X
for	B-X
neurons	B-X
were	B-X
the	B-X
pro-inflammatory	B-X
cytokines	B-X
tumor	B-X
necrosis	B-X
factor	B-X
α	B-X
(	B-X
TNFα	B-X
)	B-X
and	B-X
interleukin-beta	B-X
(	B-X
IL-β	B-X
)	B-X
.	B-X
Neuronal	B-X
NF-κB	B-X
was	B-X
not	B-X
responsive	B-X
to	B-X
glutamate	B-X
in	B-X
most	B-X
assays	B-X
,	B-X
and	B-X
it	B-X
was	B-X
also	B-X
unresponsive	B-X
to	B-X
hydrogen	B-X
peroxide	B-X
,	B-X
lipopolysaccharide	B-X
,	B-X
norepinephrine	B-X
,	B-X
ATP	B-X
,	B-X
phorbol	B-X
ester	B-X
,	B-X
and	B-X
nerve	B-X
growth	B-X
factor	B-X
.	B-X
The	B-X
chemokine	B-X
gene	B-X
transcripts	B-X
CCL2	B-X
,	B-X
CXCL1	B-X
,	B-X
and	B-X
CXCL10	B-X
were	B-X
strongly	B-X
induced	B-X
via	B-X
NF-κB	B-X
activation	B-X
by	B-X
TNFα	B-X
in	B-X
neurons	B-X
,	B-X
but	B-X
many	B-X
candidate	B-X
responsive	B-X
genes	B-X
were	B-X
not	B-X
,	B-X
including	B-X
the	B-X
neuroprotective	B-X
genes	B-X
SOD2	B-X
and	B-X
Bcl-xL	B-X
.	B-X
Importantly	B-X
,	B-X
the	B-X
level	B-X
of	B-X
induced	B-X
neuronal	B-X
NF-κB	B-X
activity	B-X
in	B-X
response	B-X
to	B-X
TNFα	B-X
or	B-X
any	B-X
other	B-X
stimulus	B-X
was	B-X
lower	B-X
than	B-X
the	B-X
level	B-X
of	B-X
constitutive	B-X
activity	B-X
in	B-X
non-neuronal	B-X
cells	B-X
,	B-X
calling	B-X
into	B-X
question	B-X
the	B-X
functional	B-X
significance	B-X
of	B-X
neuronal	B-X
NF-κB	B-X
activity	B-X
.	B-X

Expression	O
of	O
Jagged	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
Jagged	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
and	O
Delta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
of	O
AMSCs	O
were	O
surveyed	O
by	O
flow	O
cytometric	O
analysis	O
and	O
Western	O
blotting	O
.	O
<EOS>	B-X
Here	B-X
we	B-X
investigated	B-X
whether	B-X
human	B-X
adipose	B-X
tissue-derived	B-X
mesenchymal	B-X
stem	B-X
cells	B-X
(	B-X
AMSCs	B-X
)	B-X
facilitate	B-X
in	B-X
vitro	B-X
the	B-X
immunomodulatory	B-X
effects	B-X
of	B-X
CsA	B-X
and	B-X
we	B-X
explored	B-X
the	B-X
molecule	B-X
mechanisms	B-X
that	B-X
may	B-X
be	B-X
involved	B-X
.	B-X

RESULTS	O
:	O
The	O
combination	O
of	O
moderate	O
-	O
dose	O
AMSCs	O
and	O
low	O
-	O
dose	O
CsA	O
was	O
significantly	O
more	O
powerful	O
than	O
moderate	O
-	O
dose	O
AMSCs	O
or	O
large	O
-	O
dose	O
CsA	O
alone	O
in	O
suppressing	O
transcription	O
and	O
production	O
of	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
and	O
interferon	B-Gene_or_gene_product
-	I-Gene_or_gene_product
gamma	I-Gene_or_gene_product
,	O
activation	O
of	O
NF	O
-	O
kappaB	O
,	O
and	O
proliferation	O
of	O
T	O
lymphocytes	O
.	O
<EOS>	B-X
Cyclosporine	B-X
A	B-X
(	B-X
CsA	B-X
)	B-X
,	B-X
known	B-X
as	B-X
an	B-X
effective	B-X
immunosuppressive	B-X
agent	B-X
,	B-X
is	B-X
widely	B-X
used	B-X
in	B-X
clinical	B-X
fields	B-X
.	B-X
Here	B-X
we	B-X
investigated	B-X
whether	B-X
human	B-X
adipose	B-X
tissue-derived	B-X
mesenchymal	B-X
stem	B-X
cells	B-X
(	B-X
AMSCs	B-X
)	B-X
facilitate	B-X
in	B-X
vitro	B-X
the	B-X
immunomodulatory	B-X
effects	B-X
of	B-X
CsA	B-X
and	B-X
we	B-X
explored	B-X
the	B-X
molecule	B-X
mechanisms	B-X
that	B-X
may	B-X
be	B-X
involved	B-X
.	B-X

In	O
addition	O
,	O
AMSCs	O
expressed	O
a	O
high	O
level	O
of	O
Jagged	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
which	O
induced	O
activation	O
of	O
Notch	B-Gene_or_gene_product
signaling	O
in	O
T	O
lymphocytes	O
,	O
thus	O
reducing	O
NF	O
-	O
kappaB	O
activity	O
.	O

Anti	O
-	O
Jagged	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
neutralizing	O
antibody	O
and	O
N	O
[	O
N	O
-	O
(	O
3	O
,	O
5	O
-	O
difluorophenacetyl	O
-	O
L	O
-	O
alanyl	O
)	O
]	O
-	O
S	O
-	O
phenylglycine	O
t	O
-	O
butyl	O
ester	O
could	O
reverse	O
this	O
trend	O
.	O

CONCLUSIONS	O
:	O
Human	O
AMSCs	O
facilitate	O
the	O
immunosuppressive	O
effect	O
of	O
CsA	O
on	O
T	O
lymphocytes	O
through	O
Jagged	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
/	O
Notch	B-Gene_or_gene_product
-	O
related	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
signaling	O
.	O

The	O
combination	O
of	O
AMSCs	O
and	O
CsA	O
represents	O
a	O
rationale	O
therapeutic	O
approach	O
aimed	O
to	O
prevent	O
adverse	O
effects	O
of	O
CsA	O
while	O
maintaining	O
its	O
adequate	O
immunosuppressive	O
effect	O
.	O
<EOS>	B-X
Cyclosporine	B-X
A	B-X
(	B-X
CsA	B-X
)	B-X
,	B-X
known	B-X
as	B-X
an	B-X
effective	B-X
immunosuppressive	B-X
agent	B-X
,	B-X
is	B-X
widely	B-X
used	B-X
in	B-X
clinical	B-X
fields	B-X
.	B-X
Mesenchymal	B-X
stem	B-X
cells	B-X
may	B-X
exert	B-X
immunomodulatory	B-X
effects	B-X
on	B-X
the	B-X
immune	B-X
system	B-X
,	B-X
but	B-X
the	B-X
exact	B-X
mechanisms	B-X
underlying	B-X
them	B-X
remain	B-X
controversial	B-X
.	B-X
Here	B-X
we	B-X
investigated	B-X
whether	B-X
human	B-X
adipose	B-X
tissue-derived	B-X
mesenchymal	B-X
stem	B-X
cells	B-X
(	B-X
AMSCs	B-X
)	B-X
facilitate	B-X
in	B-X
vitro	B-X
the	B-X
immunomodulatory	B-X
effects	B-X
of	B-X
CsA	B-X
and	B-X
we	B-X
explored	B-X
the	B-X
molecule	B-X
mechanisms	B-X
that	B-X
may	B-X
be	B-X
involved	B-X
.	B-X

Expression	O
of	O
Jagged	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
on	O
AMSCs	O
may	O
provide	O
an	O
effective	O
mechanism	O
for	O
the	O
immunomodulatory	O
activity	O
of	O
AMSCs	O
via	O
direct	O
cell	O
-	O
cell	O
interaction	O
.	O
<EOS>	B-X
Cyclosporine	B-X
A	B-X
(	B-X
CsA	B-X
)	B-X
,	B-X
known	B-X
as	B-X
an	B-X
effective	B-X
immunosuppressive	B-X
agent	B-X
,	B-X
is	B-X
widely	B-X
used	B-X
in	B-X
clinical	B-X
fields	B-X
.	B-X
Mesenchymal	B-X
stem	B-X
cells	B-X
may	B-X
exert	B-X
immunomodulatory	B-X
effects	B-X
on	B-X
the	B-X
immune	B-X
system	B-X
,	B-X
but	B-X
the	B-X
exact	B-X
mechanisms	B-X
underlying	B-X
them	B-X
remain	B-X
controversial	B-X
.	B-X
Here	B-X
we	B-X
investigated	B-X
whether	B-X
human	B-X
adipose	B-X
tissue-derived	B-X
mesenchymal	B-X
stem	B-X
cells	B-X
(	B-X
AMSCs	B-X
)	B-X
facilitate	B-X
in	B-X
vitro	B-X
the	B-X
immunomodulatory	B-X
effects	B-X
of	B-X
CsA	B-X
and	B-X
we	B-X
explored	B-X
the	B-X
molecule	B-X
mechanisms	B-X
that	B-X
may	B-X
be	B-X
involved	B-X
.	B-X

Identification	O
of	O
calcium	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
neutral	I-Gene_or_gene_product
protease	I-Gene_or_gene_product
as	O
a	O
processing	O
enzyme	O
of	O
human	B-Gene_or_gene_product
interleukin	I-Gene_or_gene_product
1	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
.	O
<EOS>	B-X
We	B-X
describe	B-X
here	B-X
the	B-X
involvement	B-X
of	B-X
calcium-activated	B-X
neutral	B-X
protease	B-X
(	B-X
CANP	B-X
or	B-X
calpain	B-X
,	B-X
EC	B-X
3.4.22.17	B-X
)	B-X
in	B-X
calcium-dependent	B-X
proteolytic	B-X
processing	B-X
of	B-X
the	B-X
precursor	B-X
of	B-X
human	B-X
interleukin	B-X
1	B-X
alpha	B-X
(	B-X
IL-1	B-X
alpha	B-X
)	B-X
into	B-X
mature	B-X
IL-1	B-X
alpha	B-X
.	B-X
Calcium	B-X
ionophore	B-X
ionomycin	B-X
enhanced	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
and	B-X
the	B-X
release	B-X
of	B-X
mature	B-X
IL-1	B-X
alpha	B-X
either	B-X
from	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-activated	B-X
human	B-X
adherent	B-X
mononuclear	B-X
cells	B-X
or	B-X
from	B-X
a	B-X
human	B-X
bladder	B-X
carcinoma	B-X
cell	B-X
line	B-X
(	B-X
HTB9	B-X
5637	B-X
)	B-X
that	B-X
constitutively	B-X
produces	B-X
human	B-X
IL-1	B-X
alpha	B-X
and	B-X
-beta	B-X
.	B-X
The	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
was	B-X
completely	B-X
inhibited	B-X
by	B-X
EGTA	B-X
.	B-X
Similar	B-X
calcium-dependent	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
was	B-X
also	B-X
observed	B-X
with	B-X
lysates	B-X
of	B-X
either	B-X
LPS-activated	B-X
human	B-X
adherent	B-X
mononuclear	B-X
cells	B-X
or	B-X
HTB9	B-X
5637	B-X
cells	B-X
.	B-X
Since	B-X
the	B-X
optimal	B-X
pH	B-X
for	B-X
processing	B-X
was	B-X
between	B-X
7	B-X
and	B-X
8	B-X
,	B-X
and	B-X
E-64	B-X
(	B-X
a	B-X
cysteine	B-X
protease	B-X
inhibitor	B-X
)	B-X
and	B-X
leupeptin	B-X
(	B-X
a	B-X
serine	B-X
and	B-X
cysteine	B-X
protease	B-X
inhibitor	B-X
)	B-X
both	B-X
inhibited	B-X
this	B-X
processing	B-X
by	B-X
cell	B-X
lysates	B-X
,	B-X
we	B-X
hypothesized	B-X
that	B-X
a	B-X
calcium-activated	B-X
neutral	B-X
protease	B-X
,	B-X
CANP	B-X
,	B-X
might	B-X
be	B-X
responsible	B-X
for	B-X
this	B-X
processing	B-X
.	B-X
This	B-X
hypothesis	B-X
was	B-X
supported	B-X
by	B-X
data	B-X
showing	B-X
that	B-X
the	B-X
specific	B-X
CANP	B-X
inhibitor	B-X
peptide	B-X
inhibited	B-X
this	B-X
proteolysis	B-X
in	B-X
cell	B-X
lysates	B-X
in	B-X
a	B-X
dose-dependent	B-X
fashion	B-X
(	B-X
IC50	B-X
=	B-X
0.05	B-X
microM	B-X
)	B-X
and	B-X
that	B-X
treatment	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
with	B-X
purified	B-X
CANP	B-X
yielded	B-X
the	B-X
17-kDa	B-X
mature	B-X
form	B-X
of	B-X
IL-1	B-X
alpha	B-X
,	B-X
which	B-X
has	B-X
an	B-X
amino	B-X
terminus	B-X
identical	B-X
with	B-X
that	B-X
reported	B-X
for	B-X
mature	B-X
human	B-X
IL-1	B-X
alpha	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
indicate	B-X
that	B-X
calcium-dependent	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
is	B-X
selectively	B-X
mediated	B-X
by	B-X
CANP	B-X
.	B-X

We	O
describe	O
here	O
the	O
involvement	O
of	O
calcium	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
neutral	I-Gene_or_gene_product
protease	I-Gene_or_gene_product
(	O
CANP	B-Gene_or_gene_product
or	O
calpain	B-Gene_or_gene_product
,	O
EC	B-Gene_or_gene_product
3	I-Gene_or_gene_product
.	I-Gene_or_gene_product
4	I-Gene_or_gene_product
.	I-Gene_or_gene_product
22	I-Gene_or_gene_product
.	I-Gene_or_gene_product
17	I-Gene_or_gene_product
)	O
in	O
calcium	O
-	O
dependent	O
proteolytic	O
processing	O
of	O
the	O
precursor	O
of	O
human	B-Gene_or_gene_product
interleukin	I-Gene_or_gene_product
1	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
(	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
)	O
into	O
mature	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
.	O
<EOS>	B-X
We	B-X
describe	B-X
here	B-X
the	B-X
involvement	B-X
of	B-X
calcium-activated	B-X
neutral	B-X
protease	B-X
(	B-X
CANP	B-X
or	B-X
calpain	B-X
,	B-X
EC	B-X
3.4.22.17	B-X
)	B-X
in	B-X
calcium-dependent	B-X
proteolytic	B-X
processing	B-X
of	B-X
the	B-X
precursor	B-X
of	B-X
human	B-X
interleukin	B-X
1	B-X
alpha	B-X
(	B-X
IL-1	B-X
alpha	B-X
)	B-X
into	B-X
mature	B-X
IL-1	B-X
alpha	B-X
.	B-X
Calcium	B-X
ionophore	B-X
ionomycin	B-X
enhanced	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
and	B-X
the	B-X
release	B-X
of	B-X
mature	B-X
IL-1	B-X
alpha	B-X
either	B-X
from	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-activated	B-X
human	B-X
adherent	B-X
mononuclear	B-X
cells	B-X
or	B-X
from	B-X
a	B-X
human	B-X
bladder	B-X
carcinoma	B-X
cell	B-X
line	B-X
(	B-X
HTB9	B-X
5637	B-X
)	B-X
that	B-X
constitutively	B-X
produces	B-X
human	B-X
IL-1	B-X
alpha	B-X
and	B-X
-beta	B-X
.	B-X
The	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
was	B-X
completely	B-X
inhibited	B-X
by	B-X
EGTA	B-X
.	B-X
Similar	B-X
calcium-dependent	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
was	B-X
also	B-X
observed	B-X
with	B-X
lysates	B-X
of	B-X
either	B-X
LPS-activated	B-X
human	B-X
adherent	B-X
mononuclear	B-X
cells	B-X
or	B-X
HTB9	B-X
5637	B-X
cells	B-X
.	B-X
Since	B-X
the	B-X
optimal	B-X
pH	B-X
for	B-X
processing	B-X
was	B-X
between	B-X
7	B-X
and	B-X
8	B-X
,	B-X
and	B-X
E-64	B-X
(	B-X
a	B-X
cysteine	B-X
protease	B-X
inhibitor	B-X
)	B-X
and	B-X
leupeptin	B-X
(	B-X
a	B-X
serine	B-X
and	B-X
cysteine	B-X
protease	B-X
inhibitor	B-X
)	B-X
both	B-X
inhibited	B-X
this	B-X
processing	B-X
by	B-X
cell	B-X
lysates	B-X
,	B-X
we	B-X
hypothesized	B-X
that	B-X
a	B-X
calcium-activated	B-X
neutral	B-X
protease	B-X
,	B-X
CANP	B-X
,	B-X
might	B-X
be	B-X
responsible	B-X
for	B-X
this	B-X
processing	B-X
.	B-X
This	B-X
hypothesis	B-X
was	B-X
supported	B-X
by	B-X
data	B-X
showing	B-X
that	B-X
the	B-X
specific	B-X
CANP	B-X
inhibitor	B-X
peptide	B-X
inhibited	B-X
this	B-X
proteolysis	B-X
in	B-X
cell	B-X
lysates	B-X
in	B-X
a	B-X
dose-dependent	B-X
fashion	B-X
(	B-X
IC50	B-X
=	B-X
0.05	B-X
microM	B-X
)	B-X
and	B-X
that	B-X
treatment	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
with	B-X
purified	B-X
CANP	B-X
yielded	B-X
the	B-X
17-kDa	B-X
mature	B-X
form	B-X
of	B-X
IL-1	B-X
alpha	B-X
,	B-X
which	B-X
has	B-X
an	B-X
amino	B-X
terminus	B-X
identical	B-X
with	B-X
that	B-X
reported	B-X
for	B-X
mature	B-X
human	B-X
IL-1	B-X
alpha	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
indicate	B-X
that	B-X
calcium-dependent	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
is	B-X
selectively	B-X
mediated	B-X
by	B-X
CANP	B-X
.	B-X

Calcium	O
ionophore	O
ionomycin	O
enhanced	O
proteolytic	O
processing	O
of	O
pre	O
-	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
the	O
release	O
of	O
mature	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
either	O
from	O
lipopolysaccharide	O
(	O
LPS	O
)	O
-	O
activated	O
human	O
adherent	O
mononuclear	O
cells	O
or	O
from	O
a	O
human	O
bladder	O
carcinoma	O
cell	O
line	O
(	O
HTB9	O
5637	O
)	O
that	O
constitutively	O
produces	O
human	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
and	O
-	B-Gene_or_gene_product
beta	I-Gene_or_gene_product
.	O
<EOS>	B-X
We	B-X
describe	B-X
here	B-X
the	B-X
involvement	B-X
of	B-X
calcium-activated	B-X
neutral	B-X
protease	B-X
(	B-X
CANP	B-X
or	B-X
calpain	B-X
,	B-X
EC	B-X
3.4.22.17	B-X
)	B-X
in	B-X
calcium-dependent	B-X
proteolytic	B-X
processing	B-X
of	B-X
the	B-X
precursor	B-X
of	B-X
human	B-X
interleukin	B-X
1	B-X
alpha	B-X
(	B-X
IL-1	B-X
alpha	B-X
)	B-X
into	B-X
mature	B-X
IL-1	B-X
alpha	B-X
.	B-X
Calcium	B-X
ionophore	B-X
ionomycin	B-X
enhanced	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
and	B-X
the	B-X
release	B-X
of	B-X
mature	B-X
IL-1	B-X
alpha	B-X
either	B-X
from	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-activated	B-X
human	B-X
adherent	B-X
mononuclear	B-X
cells	B-X
or	B-X
from	B-X
a	B-X
human	B-X
bladder	B-X
carcinoma	B-X
cell	B-X
line	B-X
(	B-X
HTB9	B-X
5637	B-X
)	B-X
that	B-X
constitutively	B-X
produces	B-X
human	B-X
IL-1	B-X
alpha	B-X
and	B-X
-beta	B-X
.	B-X
The	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
was	B-X
completely	B-X
inhibited	B-X
by	B-X
EGTA	B-X
.	B-X
Similar	B-X
calcium-dependent	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
was	B-X
also	B-X
observed	B-X
with	B-X
lysates	B-X
of	B-X
either	B-X
LPS-activated	B-X
human	B-X
adherent	B-X
mononuclear	B-X
cells	B-X
or	B-X
HTB9	B-X
5637	B-X
cells	B-X
.	B-X
Since	B-X
the	B-X
optimal	B-X
pH	B-X
for	B-X
processing	B-X
was	B-X
between	B-X
7	B-X
and	B-X
8	B-X
,	B-X
and	B-X
E-64	B-X
(	B-X
a	B-X
cysteine	B-X
protease	B-X
inhibitor	B-X
)	B-X
and	B-X
leupeptin	B-X
(	B-X
a	B-X
serine	B-X
and	B-X
cysteine	B-X
protease	B-X
inhibitor	B-X
)	B-X
both	B-X
inhibited	B-X
this	B-X
processing	B-X
by	B-X
cell	B-X
lysates	B-X
,	B-X
we	B-X
hypothesized	B-X
that	B-X
a	B-X
calcium-activated	B-X
neutral	B-X
protease	B-X
,	B-X
CANP	B-X
,	B-X
might	B-X
be	B-X
responsible	B-X
for	B-X
this	B-X
processing	B-X
.	B-X
This	B-X
hypothesis	B-X
was	B-X
supported	B-X
by	B-X
data	B-X
showing	B-X
that	B-X
the	B-X
specific	B-X
CANP	B-X
inhibitor	B-X
peptide	B-X
inhibited	B-X
this	B-X
proteolysis	B-X
in	B-X
cell	B-X
lysates	B-X
in	B-X
a	B-X
dose-dependent	B-X
fashion	B-X
(	B-X
IC50	B-X
=	B-X
0.05	B-X
microM	B-X
)	B-X
and	B-X
that	B-X
treatment	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
with	B-X
purified	B-X
CANP	B-X
yielded	B-X
the	B-X
17-kDa	B-X
mature	B-X
form	B-X
of	B-X
IL-1	B-X
alpha	B-X
,	B-X
which	B-X
has	B-X
an	B-X
amino	B-X
terminus	B-X
identical	B-X
with	B-X
that	B-X
reported	B-X
for	B-X
mature	B-X
human	B-X
IL-1	B-X
alpha	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
indicate	B-X
that	B-X
calcium-dependent	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
is	B-X
selectively	B-X
mediated	B-X
by	B-X
CANP	B-X
.	B-X

The	O
proteolytic	O
processing	O
of	O
pre	O
-	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
was	O
completely	O
inhibited	O
by	O
EGTA	O
.	O
<EOS>	B-X
We	B-X
describe	B-X
here	B-X
the	B-X
involvement	B-X
of	B-X
calcium-activated	B-X
neutral	B-X
protease	B-X
(	B-X
CANP	B-X
or	B-X
calpain	B-X
,	B-X
EC	B-X
3.4.22.17	B-X
)	B-X
in	B-X
calcium-dependent	B-X
proteolytic	B-X
processing	B-X
of	B-X
the	B-X
precursor	B-X
of	B-X
human	B-X
interleukin	B-X
1	B-X
alpha	B-X
(	B-X
IL-1	B-X
alpha	B-X
)	B-X
into	B-X
mature	B-X
IL-1	B-X
alpha	B-X
.	B-X
Calcium	B-X
ionophore	B-X
ionomycin	B-X
enhanced	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
and	B-X
the	B-X
release	B-X
of	B-X
mature	B-X
IL-1	B-X
alpha	B-X
either	B-X
from	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-activated	B-X
human	B-X
adherent	B-X
mononuclear	B-X
cells	B-X
or	B-X
from	B-X
a	B-X
human	B-X
bladder	B-X
carcinoma	B-X
cell	B-X
line	B-X
(	B-X
HTB9	B-X
5637	B-X
)	B-X
that	B-X
constitutively	B-X
produces	B-X
human	B-X
IL-1	B-X
alpha	B-X
and	B-X
-beta	B-X
.	B-X
The	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
was	B-X
completely	B-X
inhibited	B-X
by	B-X
EGTA	B-X
.	B-X
Similar	B-X
calcium-dependent	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
was	B-X
also	B-X
observed	B-X
with	B-X
lysates	B-X
of	B-X
either	B-X
LPS-activated	B-X
human	B-X
adherent	B-X
mononuclear	B-X
cells	B-X
or	B-X
HTB9	B-X
5637	B-X
cells	B-X
.	B-X
Since	B-X
the	B-X
optimal	B-X
pH	B-X
for	B-X
processing	B-X
was	B-X
between	B-X
7	B-X
and	B-X
8	B-X
,	B-X
and	B-X
E-64	B-X
(	B-X
a	B-X
cysteine	B-X
protease	B-X
inhibitor	B-X
)	B-X
and	B-X
leupeptin	B-X
(	B-X
a	B-X
serine	B-X
and	B-X
cysteine	B-X
protease	B-X
inhibitor	B-X
)	B-X
both	B-X
inhibited	B-X
this	B-X
processing	B-X
by	B-X
cell	B-X
lysates	B-X
,	B-X
we	B-X
hypothesized	B-X
that	B-X
a	B-X
calcium-activated	B-X
neutral	B-X
protease	B-X
,	B-X
CANP	B-X
,	B-X
might	B-X
be	B-X
responsible	B-X
for	B-X
this	B-X
processing	B-X
.	B-X
This	B-X
hypothesis	B-X
was	B-X
supported	B-X
by	B-X
data	B-X
showing	B-X
that	B-X
the	B-X
specific	B-X
CANP	B-X
inhibitor	B-X
peptide	B-X
inhibited	B-X
this	B-X
proteolysis	B-X
in	B-X
cell	B-X
lysates	B-X
in	B-X
a	B-X
dose-dependent	B-X
fashion	B-X
(	B-X
IC50	B-X
=	B-X
0.05	B-X
microM	B-X
)	B-X
and	B-X
that	B-X
treatment	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
with	B-X
purified	B-X
CANP	B-X
yielded	B-X
the	B-X
17-kDa	B-X
mature	B-X
form	B-X
of	B-X
IL-1	B-X
alpha	B-X
,	B-X
which	B-X
has	B-X
an	B-X
amino	B-X
terminus	B-X
identical	B-X
with	B-X
that	B-X
reported	B-X
for	B-X
mature	B-X
human	B-X
IL-1	B-X
alpha	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
indicate	B-X
that	B-X
calcium-dependent	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
is	B-X
selectively	B-X
mediated	B-X
by	B-X
CANP	B-X
.	B-X

Similar	O
calcium	O
-	O
dependent	O
proteolytic	O
processing	O
of	O
pre	O
-	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
was	O
also	O
observed	O
with	O
lysates	O
of	O
either	O
LPS	O
-	O
activated	O
human	O
adherent	O
mononuclear	O
cells	O
or	O
HTB9	O
5637	O
cells	O
.	O
<EOS>	B-X
A	B-X
colony-stimulating	B-X
factor	B-X
(	B-X
CSF	B-X
)	B-X
has	B-X
been	B-X
purified	B-X
to	B-X
homogeneity	B-X
from	B-X
the	B-X
conditioned	B-X
medium	B-X
(	B-X
CM	B-X
)	B-X
of	B-X
a	B-X
subclone	B-X
,	B-X
designated	B-X
HTB9	B-X
,	B-X
of	B-X
human	B-X
bladder	B-X
carcinoma	B-X
cell	B-X
line	B-X
5637	B-X
.	B-X
HTB9	B-X
cells	B-X
were	B-X
successfully	B-X
cultured	B-X
on	B-X
micro-carrier	B-X
beads	B-X
at	B-X
low-serum	B-X
concentration	B-X
,	B-X
and	B-X
the	B-X
resulting	B-X
CM	B-X
(	B-X
HTB9-CM	B-X
)	B-X
was	B-X
concentrated	B-X
by	B-X
ultrafiltration	B-X
.	B-X
The	B-X
finally	B-X
purified	B-X
protein	B-X
possessed	B-X
a	B-X
specific	B-X
activity	B-X
more	B-X
than	B-X
10	B-X
(	B-X
8	B-X
)	B-X
U/mg	B-X
protein	B-X
for	B-X
day-7	B-X
CFU-GM	B-X
colony	B-X
formation	B-X
and	B-X
exhibited	B-X
a	B-X
single	B-X
band	B-X
representing	B-X
a	B-X
molecular	B-X
weight	B-X
of	B-X
17,000	B-X
upon	B-X
sodium	B-X
dodecyl	B-X
sulfate-polyacrylamide	B-X
gel	B-X
electrophoresis	B-X
.	B-X
Biological	B-X
activity	B-X
was	B-X
apparently	B-X
specific	B-X
for	B-X
a	B-X
neutrophilic	B-X
granulocyte	B-X
lineage	B-X
of	B-X
human	B-X
non-phagocytic	B-X
bone-marrow	B-X
cells	B-X
in	B-X
vitro	B-X
,	B-X
and	B-X
antiserum	B-X
raised	B-X
against	B-X
this	B-X
purified	B-X
protein	B-X
completely	B-X
inhibited	B-X
the	B-X
activity	B-X
of	B-X
recombinant	B-X
granulocyte	B-X
colony-stimulating	B-X
factor	B-X
.	B-X

Since	O
the	O
optimal	O
pH	O
for	O
processing	O
was	O
between	O
7	O
and	O
8	O
,	O
and	O
E	O
-	O
64	O
(	O
a	O
cysteine	O
protease	O
inhibitor	O
)	O
and	O
leupeptin	O
(	O
a	O
serine	O
and	O
cysteine	O
protease	O
inhibitor	O
)	O
both	O
inhibited	O
this	O
processing	O
by	O
cell	O
lysates	O
,	O
we	O
hypothesized	O
that	O
a	O
calcium	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
neutral	I-Gene_or_gene_product
protease	I-Gene_or_gene_product
,	O
CANP	B-Gene_or_gene_product
,	O
might	O
be	O
responsible	O
for	O
this	O
processing	O
.	O

This	O
hypothesis	O
was	O
supported	O
by	O
data	O
showing	O
that	O
the	O
specific	O
CANP	B-Gene_or_gene_product
inhibitor	O
peptide	O
inhibited	O
this	O
proteolysis	O
in	O
cell	O
lysates	O
in	O
a	O
dose	O
-	O
dependent	O
fashion	O
(	O
IC50	O
=	O
0	O
.	O
05	O
microM	O
)	O
and	O
that	O
treatment	O
of	O
pre	O
-	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
with	O
purified	O
CANP	B-Gene_or_gene_product
yielded	O
the	O
17	O
-	O
kDa	O
mature	O
form	O
of	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
,	O
which	O
has	O
an	O
amino	O
terminus	O
identical	O
with	O
that	O
reported	O
for	O
mature	O
human	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
.	O

Taken	O
together	O
,	O
these	O
findings	O
indicate	O
that	O
calcium	O
-	O
dependent	O
proteolytic	O
processing	O
of	O
pre	O
-	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
is	O
selectively	O
mediated	O
by	O
CANP	B-Gene_or_gene_product
.	O
<EOS>	B-X
We	B-X
describe	B-X
here	B-X
the	B-X
involvement	B-X
of	B-X
calcium-activated	B-X
neutral	B-X
protease	B-X
(	B-X
CANP	B-X
or	B-X
calpain	B-X
,	B-X
EC	B-X
3.4.22.17	B-X
)	B-X
in	B-X
calcium-dependent	B-X
proteolytic	B-X
processing	B-X
of	B-X
the	B-X
precursor	B-X
of	B-X
human	B-X
interleukin	B-X
1	B-X
alpha	B-X
(	B-X
IL-1	B-X
alpha	B-X
)	B-X
into	B-X
mature	B-X
IL-1	B-X
alpha	B-X
.	B-X
Calcium	B-X
ionophore	B-X
ionomycin	B-X
enhanced	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
and	B-X
the	B-X
release	B-X
of	B-X
mature	B-X
IL-1	B-X
alpha	B-X
either	B-X
from	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-activated	B-X
human	B-X
adherent	B-X
mononuclear	B-X
cells	B-X
or	B-X
from	B-X
a	B-X
human	B-X
bladder	B-X
carcinoma	B-X
cell	B-X
line	B-X
(	B-X
HTB9	B-X
5637	B-X
)	B-X
that	B-X
constitutively	B-X
produces	B-X
human	B-X
IL-1	B-X
alpha	B-X
and	B-X
-beta	B-X
.	B-X
The	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
was	B-X
completely	B-X
inhibited	B-X
by	B-X
EGTA	B-X
.	B-X
Similar	B-X
calcium-dependent	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
was	B-X
also	B-X
observed	B-X
with	B-X
lysates	B-X
of	B-X
either	B-X
LPS-activated	B-X
human	B-X
adherent	B-X
mononuclear	B-X
cells	B-X
or	B-X
HTB9	B-X
5637	B-X
cells	B-X
.	B-X
Since	B-X
the	B-X
optimal	B-X
pH	B-X
for	B-X
processing	B-X
was	B-X
between	B-X
7	B-X
and	B-X
8	B-X
,	B-X
and	B-X
E-64	B-X
(	B-X
a	B-X
cysteine	B-X
protease	B-X
inhibitor	B-X
)	B-X
and	B-X
leupeptin	B-X
(	B-X
a	B-X
serine	B-X
and	B-X
cysteine	B-X
protease	B-X
inhibitor	B-X
)	B-X
both	B-X
inhibited	B-X
this	B-X
processing	B-X
by	B-X
cell	B-X
lysates	B-X
,	B-X
we	B-X
hypothesized	B-X
that	B-X
a	B-X
calcium-activated	B-X
neutral	B-X
protease	B-X
,	B-X
CANP	B-X
,	B-X
might	B-X
be	B-X
responsible	B-X
for	B-X
this	B-X
processing	B-X
.	B-X
This	B-X
hypothesis	B-X
was	B-X
supported	B-X
by	B-X
data	B-X
showing	B-X
that	B-X
the	B-X
specific	B-X
CANP	B-X
inhibitor	B-X
peptide	B-X
inhibited	B-X
this	B-X
proteolysis	B-X
in	B-X
cell	B-X
lysates	B-X
in	B-X
a	B-X
dose-dependent	B-X
fashion	B-X
(	B-X
IC50	B-X
=	B-X
0.05	B-X
microM	B-X
)	B-X
and	B-X
that	B-X
treatment	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
with	B-X
purified	B-X
CANP	B-X
yielded	B-X
the	B-X
17-kDa	B-X
mature	B-X
form	B-X
of	B-X
IL-1	B-X
alpha	B-X
,	B-X
which	B-X
has	B-X
an	B-X
amino	B-X
terminus	B-X
identical	B-X
with	B-X
that	B-X
reported	B-X
for	B-X
mature	B-X
human	B-X
IL-1	B-X
alpha	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
indicate	B-X
that	B-X
calcium-dependent	B-X
proteolytic	B-X
processing	B-X
of	B-X
pre-IL-1	B-X
alpha	B-X
is	B-X
selectively	B-X
mediated	B-X
by	B-X
CANP	B-X
.	B-X

NF	O
-	O
kappaB	O
suppresses	O
HIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1alpha	I-Gene_or_gene_product
response	O
by	O
competing	O
for	O
P300	B-Gene_or_gene_product
binding	O
.	O
<EOS>	B-X
HIF-1α	B-X
is	B-X
the	B-X
transcription	B-X
factor	B-X
mediating	B-X
hypoxia	B-X
responses	B-X
that	B-X
include	B-X
induction	B-X
of	B-X
VEGF	B-X
and	B-X
related	B-X
bone	B-X
induction	B-X
.	B-X
Inflammatory	B-X
signals	B-X
antagonize	B-X
bone	B-X
repair	B-X
via	B-X
the	B-X
NF-κB	B-X
pathway	B-X
.	B-X
The	B-X
present	B-X
investigation	B-X
explored	B-X
the	B-X
functional	B-X
relationship	B-X
of	B-X
hypoxia	B-X
(	B-X
HIF-1α	B-X
function	B-X
)	B-X
and	B-X
inflammatory	B-X
signaling	B-X
(	B-X
NF-κB	B-X
)	B-X
in	B-X
stem	B-X
like	B-X
and	B-X
osteoprogenitor	B-X
cell	B-X
lines	B-X
.	B-X
The	B-X
potential	B-X
interaction	B-X
between	B-X
HIF-1α	B-X
and	B-X
NF-κB	B-X
signaling	B-X
was	B-X
explored	B-X
by	B-X
co-transfection	B-X
studies	B-X
in	B-X
hFOB	B-X
with	B-X
p65	B-X
,	B-X
HIF-1α	B-X
and	B-X
9x-HRE-luc	B-X
or	B-X
HIF-1α	B-X
target	B-X
genes	B-X
reporter	B-X
plasmids	B-X
.	B-X
The	B-X
results	B-X
show	B-X
that	B-X
inflammatory	B-X
stimulation	B-X
(	B-X
TNF-α	B-X
treatment	B-X
)	B-X
causes	B-X
a	B-X
marked	B-X
inhibition	B-X
of	B-X
HIF-1α	B-X
function	B-X
at	B-X
the	B-X
HRE	B-X
in	B-X
all	B-X
cell	B-X
lines	B-X
studied	B-X
.	B-X
However	B-X
,	B-X
TNF-α	B-X
treatment	B-X
had	B-X
little	B-X
effect	B-X
on	B-X
HIF-1α	B-X
mRNA	B-X
levels	B-X
.	B-X
The	B-X
functional	B-X
interaction	B-X
of	B-X
Gal4-HIF-1α	B-X
and	B-X
VP16-p300	B-X
fusion	B-X
proteins	B-X
is	B-X
effectively	B-X
blocked	B-X
by	B-X
expression	B-X
of	B-X
p65	B-X
in	B-X
a	B-X
dose	B-X
dependent	B-X
manner	B-X
.	B-X
It	B-X
was	B-X
concluded	B-X
that	B-X
NF-κB-mediated	B-X
inflammatory	B-X
signaling	B-X
is	B-X
able	B-X
to	B-X
block	B-X
HIF-1α	B-X
transactivation	B-X
at	B-X
HRE-encoding	B-X
genes	B-X
by	B-X
direct	B-X
competition	B-X
for	B-X
p300	B-X
binding	B-X
at	B-X
the	B-X
promoter	B-X
.	B-X
Inflammation	B-X
may	B-X
influence	B-X
the	B-X
stem	B-X
cell	B-X
niche	B-X
and	B-X
tissue	B-X
regeneration	B-X
by	B-X
influencing	B-X
cellular	B-X
responses	B-X
to	B-X
hypoxia	B-X
.	B-X

Hypoxia	O
has	O
emerged	O
as	O
a	O
key	O
determinant	O
of	O
osteogenesis	O
.	O
<EOS>	B-X
Hypoxia	B-X
has	B-X
emerged	B-X
as	B-X
a	B-X
key	B-X
determinant	B-X
of	B-X
osteogenesis	B-X
.	B-X

HIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1alpha	I-Gene_or_gene_product
is	O
the	O
transcription	O
factor	O
mediating	O
hypoxia	O
responses	O
that	O
include	O
induction	O
of	O
VEGF	B-Gene_or_gene_product
and	O
related	O
bone	O
induction	O
.	O
<EOS>	B-X
HIF-1α	B-X
is	B-X
the	B-X
transcription	B-X
factor	B-X
mediating	B-X
hypoxia	B-X
responses	B-X
that	B-X
include	B-X
induction	B-X
of	B-X
VEGF	B-X
and	B-X
related	B-X
bone	B-X
induction	B-X
.	B-X
Inflammatory	B-X
signals	B-X
antagonize	B-X
bone	B-X
repair	B-X
via	B-X
the	B-X
NF-κB	B-X
pathway	B-X
.	B-X
The	B-X
present	B-X
investigation	B-X
explored	B-X
the	B-X
functional	B-X
relationship	B-X
of	B-X
hypoxia	B-X
(	B-X
HIF-1α	B-X
function	B-X
)	B-X
and	B-X
inflammatory	B-X
signaling	B-X
(	B-X
NF-κB	B-X
)	B-X
in	B-X
stem	B-X
like	B-X
and	B-X
osteoprogenitor	B-X
cell	B-X
lines	B-X
.	B-X
The	B-X
potential	B-X
interaction	B-X
between	B-X
HIF-1α	B-X
and	B-X
NF-κB	B-X
signaling	B-X
was	B-X
explored	B-X
by	B-X
co-transfection	B-X
studies	B-X
in	B-X
hFOB	B-X
with	B-X
p65	B-X
,	B-X
HIF-1α	B-X
and	B-X
9x-HRE-luc	B-X
or	B-X
HIF-1α	B-X
target	B-X
genes	B-X
reporter	B-X
plasmids	B-X
.	B-X
The	B-X
results	B-X
show	B-X
that	B-X
inflammatory	B-X
stimulation	B-X
(	B-X
TNF-α	B-X
treatment	B-X
)	B-X
causes	B-X
a	B-X
marked	B-X
inhibition	B-X
of	B-X
HIF-1α	B-X
function	B-X
at	B-X
the	B-X
HRE	B-X
in	B-X
all	B-X
cell	B-X
lines	B-X
studied	B-X
.	B-X
Also	B-X
,	B-X
co-transfection	B-X
with	B-X
p65	B-X
expression	B-X
vector	B-X
leads	B-X
to	B-X
reduced	B-X
hVEGFp	B-X
transcription	B-X
after	B-X
DFO-induced	B-X
hypoxia	B-X
.	B-X
However	B-X
,	B-X
TNF-α	B-X
treatment	B-X
had	B-X
little	B-X
effect	B-X
on	B-X
HIF-1α	B-X
mRNA	B-X
levels	B-X
.	B-X
The	B-X
functional	B-X
interaction	B-X
of	B-X
Gal4-HIF-1α	B-X
and	B-X
VP16-p300	B-X
fusion	B-X
proteins	B-X
is	B-X
effectively	B-X
blocked	B-X
by	B-X
expression	B-X
of	B-X
p65	B-X
in	B-X
a	B-X
dose	B-X
dependent	B-X
manner	B-X
.	B-X
It	B-X
was	B-X
concluded	B-X
that	B-X
NF-κB-mediated	B-X
inflammatory	B-X
signaling	B-X
is	B-X
able	B-X
to	B-X
block	B-X
HIF-1α	B-X
transactivation	B-X
at	B-X
HRE-encoding	B-X
genes	B-X
by	B-X
direct	B-X
competition	B-X
for	B-X
p300	B-X
binding	B-X
at	B-X
the	B-X
promoter	B-X
.	B-X
Inflammation	B-X
may	B-X
influence	B-X
the	B-X
stem	B-X
cell	B-X
niche	B-X
and	B-X
tissue	B-X
regeneration	B-X
by	B-X
influencing	B-X
cellular	B-X
responses	B-X
to	B-X
hypoxia	B-X
.	B-X

Inflammatory	O
signals	O
antagonize	O
bone	O
repair	O
via	O
the	O
NF	O
-	O
kappaB	O
pathway	O
.	O
<EOS>	B-X
HIF-1α	B-X
is	B-X
the	B-X
transcription	B-X
factor	B-X
mediating	B-X
hypoxia	B-X
responses	B-X
that	B-X
include	B-X
induction	B-X
of	B-X
VEGF	B-X
and	B-X
related	B-X
bone	B-X
induction	B-X
.	B-X
Inflammatory	B-X
signals	B-X
antagonize	B-X
bone	B-X
repair	B-X
via	B-X
the	B-X
NF-κB	B-X
pathway	B-X
.	B-X
The	B-X
present	B-X
investigation	B-X
explored	B-X
the	B-X
functional	B-X
relationship	B-X
of	B-X
hypoxia	B-X
(	B-X
HIF-1α	B-X
function	B-X
)	B-X
and	B-X
inflammatory	B-X
signaling	B-X
(	B-X
NF-κB	B-X
)	B-X
in	B-X
stem	B-X
like	B-X
and	B-X
osteoprogenitor	B-X
cell	B-X
lines	B-X
.	B-X
The	B-X
potential	B-X
interaction	B-X
between	B-X
HIF-1α	B-X
and	B-X
NF-κB	B-X
signaling	B-X
was	B-X
explored	B-X
by	B-X
co-transfection	B-X
studies	B-X
in	B-X
hFOB	B-X
with	B-X
p65	B-X
,	B-X
HIF-1α	B-X
and	B-X
9x-HRE-luc	B-X
or	B-X
HIF-1α	B-X
target	B-X
genes	B-X
reporter	B-X
plasmids	B-X
.	B-X
The	B-X
results	B-X
show	B-X
that	B-X
inflammatory	B-X
stimulation	B-X
(	B-X
TNF-α	B-X
treatment	B-X
)	B-X
causes	B-X
a	B-X
marked	B-X
inhibition	B-X
of	B-X
HIF-1α	B-X
function	B-X
at	B-X
the	B-X
HRE	B-X
in	B-X
all	B-X
cell	B-X
lines	B-X
studied	B-X
.	B-X
However	B-X
,	B-X
TNF-α	B-X
treatment	B-X
had	B-X
little	B-X
effect	B-X
on	B-X
HIF-1α	B-X
mRNA	B-X
levels	B-X
.	B-X
It	B-X
was	B-X
concluded	B-X
that	B-X
NF-κB-mediated	B-X
inflammatory	B-X
signaling	B-X
is	B-X
able	B-X
to	B-X
block	B-X
HIF-1α	B-X
transactivation	B-X
at	B-X
HRE-encoding	B-X
genes	B-X
by	B-X
direct	B-X
competition	B-X
for	B-X
p300	B-X
binding	B-X
at	B-X
the	B-X
promoter	B-X
.	B-X

The	O
present	O
investigation	O
explored	O
the	O
functional	O
relationship	O
of	O
hypoxia	O
(	O
HIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1alpha	I-Gene_or_gene_product
function	O
)	O
and	O
inflammatory	O
signaling	O
(	O
NF	O
-	O
kappaB	O
)	O
in	O
stem	O
like	O
and	O
osteoprogenitor	O
cell	O
lines	O
.	O
<EOS>	B-X
HIF-1α	B-X
is	B-X
the	B-X
transcription	B-X
factor	B-X
mediating	B-X
hypoxia	B-X
responses	B-X
that	B-X
include	B-X
induction	B-X
of	B-X
VEGF	B-X
and	B-X
related	B-X
bone	B-X
induction	B-X
.	B-X
Inflammatory	B-X
signals	B-X
antagonize	B-X
bone	B-X
repair	B-X
via	B-X
the	B-X
NF-κB	B-X
pathway	B-X
.	B-X
The	B-X
present	B-X
investigation	B-X
explored	B-X
the	B-X
functional	B-X
relationship	B-X
of	B-X
hypoxia	B-X
(	B-X
HIF-1α	B-X
function	B-X
)	B-X
and	B-X
inflammatory	B-X
signaling	B-X
(	B-X
NF-κB	B-X
)	B-X
in	B-X
stem	B-X
like	B-X
and	B-X
osteoprogenitor	B-X
cell	B-X
lines	B-X
.	B-X
The	B-X
potential	B-X
interaction	B-X
between	B-X
HIF-1α	B-X
and	B-X
NF-κB	B-X
signaling	B-X
was	B-X
explored	B-X
by	B-X
co-transfection	B-X
studies	B-X
in	B-X
hFOB	B-X
with	B-X
p65	B-X
,	B-X
HIF-1α	B-X
and	B-X
9x-HRE-luc	B-X
or	B-X
HIF-1α	B-X
target	B-X
genes	B-X
reporter	B-X
plasmids	B-X
.	B-X
The	B-X
results	B-X
show	B-X
that	B-X
inflammatory	B-X
stimulation	B-X
(	B-X
TNF-α	B-X
treatment	B-X
)	B-X
causes	B-X
a	B-X
marked	B-X
inhibition	B-X
of	B-X
HIF-1α	B-X
function	B-X
at	B-X
the	B-X
HRE	B-X
in	B-X
all	B-X
cell	B-X
lines	B-X
studied	B-X
.	B-X
Also	B-X
,	B-X
co-transfection	B-X
with	B-X
p65	B-X
expression	B-X
vector	B-X
leads	B-X
to	B-X
reduced	B-X
hVEGFp	B-X
transcription	B-X
after	B-X
DFO-induced	B-X
hypoxia	B-X
.	B-X
However	B-X
,	B-X
TNF-α	B-X
treatment	B-X
had	B-X
little	B-X
effect	B-X
on	B-X
HIF-1α	B-X
mRNA	B-X
levels	B-X
.	B-X
The	B-X
functional	B-X
interaction	B-X
of	B-X
Gal4-HIF-1α	B-X
and	B-X
VP16-p300	B-X
fusion	B-X
proteins	B-X
is	B-X
effectively	B-X
blocked	B-X
by	B-X
expression	B-X
of	B-X
p65	B-X
in	B-X
a	B-X
dose	B-X
dependent	B-X
manner	B-X
.	B-X
It	B-X
was	B-X
concluded	B-X
that	B-X
NF-κB-mediated	B-X
inflammatory	B-X
signaling	B-X
is	B-X
able	B-X
to	B-X
block	B-X
HIF-1α	B-X
transactivation	B-X
at	B-X
HRE-encoding	B-X
genes	B-X
by	B-X
direct	B-X
competition	B-X
for	B-X
p300	B-X
binding	B-X
at	B-X
the	B-X
promoter	B-X
.	B-X
Inflammation	B-X
may	B-X
influence	B-X
the	B-X
stem	B-X
cell	B-X
niche	B-X
and	B-X
tissue	B-X
regeneration	B-X
by	B-X
influencing	B-X
cellular	B-X
responses	B-X
to	B-X
hypoxia	B-X
.	B-X

The	O
potential	O
interaction	O
between	O
HIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1alpha	I-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
signaling	O
was	O
explored	O
by	O
co	O
-	O
transfection	O
studies	O
in	O
hFOB	O
with	O
p65	B-Gene_or_gene_product
,	O
HIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1alpha	I-Gene_or_gene_product
and	O
9x	B-Gene_or_gene_product
-	I-Gene_or_gene_product
HRE	I-Gene_or_gene_product
-	I-Gene_or_gene_product
luc	I-Gene_or_gene_product
or	O
HIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1alpha	I-Gene_or_gene_product
target	O
genes	O
reporter	O
plasmids	O
.	O
<EOS>	B-X
Hypoxia	B-X
has	B-X
emerged	B-X
as	B-X
a	B-X
key	B-X
determinant	B-X
of	B-X
osteogenesis	B-X
.	B-X
HIF-1α	B-X
is	B-X
the	B-X
transcription	B-X
factor	B-X
mediating	B-X
hypoxia	B-X
responses	B-X
that	B-X
include	B-X
induction	B-X
of	B-X
VEGF	B-X
and	B-X
related	B-X
bone	B-X
induction	B-X
.	B-X
Inflammatory	B-X
signals	B-X
antagonize	B-X
bone	B-X
repair	B-X
via	B-X
the	B-X
NF-κB	B-X
pathway	B-X
.	B-X
The	B-X
present	B-X
investigation	B-X
explored	B-X
the	B-X
functional	B-X
relationship	B-X
of	B-X
hypoxia	B-X
(	B-X
HIF-1α	B-X
function	B-X
)	B-X
and	B-X
inflammatory	B-X
signaling	B-X
(	B-X
NF-κB	B-X
)	B-X
in	B-X
stem	B-X
like	B-X
and	B-X
osteoprogenitor	B-X
cell	B-X
lines	B-X
.	B-X
The	B-X
potential	B-X
interaction	B-X
between	B-X
HIF-1α	B-X
and	B-X
NF-κB	B-X
signaling	B-X
was	B-X
explored	B-X
by	B-X
co-transfection	B-X
studies	B-X
in	B-X
hFOB	B-X
with	B-X
p65	B-X
,	B-X
HIF-1α	B-X
and	B-X
9x-HRE-luc	B-X
or	B-X
HIF-1α	B-X
target	B-X
genes	B-X
reporter	B-X
plasmids	B-X
.	B-X
Nuclear	B-X
cross-talk	B-X
was	B-X
directly	B-X
tested	B-X
using	B-X
the	B-X
mammalian	B-X
Gal4/VP16	B-X
two-hybrid	B-X
,	B-X
and	B-X
confirmed	B-X
by	B-X
co-immunoprecipitation/western	B-X
blotting	B-X
assays	B-X
.	B-X
The	B-X
results	B-X
show	B-X
that	B-X
inflammatory	B-X
stimulation	B-X
(	B-X
TNF-α	B-X
treatment	B-X
)	B-X
causes	B-X
a	B-X
marked	B-X
inhibition	B-X
of	B-X
HIF-1α	B-X
function	B-X
at	B-X
the	B-X
HRE	B-X
in	B-X
all	B-X
cell	B-X
lines	B-X
studied	B-X
.	B-X
Also	B-X
,	B-X
co-transfection	B-X
with	B-X
p65	B-X
expression	B-X
vector	B-X
leads	B-X
to	B-X
reduced	B-X
hVEGFp	B-X
transcription	B-X
after	B-X
DFO-induced	B-X
hypoxia	B-X
.	B-X
However	B-X
,	B-X
TNF-α	B-X
treatment	B-X
had	B-X
little	B-X
effect	B-X
on	B-X
HIF-1α	B-X
mRNA	B-X
levels	B-X
.	B-X
The	B-X
functional	B-X
interaction	B-X
of	B-X
Gal4-HIF-1α	B-X
and	B-X
VP16-p300	B-X
fusion	B-X
proteins	B-X
is	B-X
effectively	B-X
blocked	B-X
by	B-X
expression	B-X
of	B-X
p65	B-X
in	B-X
a	B-X
dose	B-X
dependent	B-X
manner	B-X
.	B-X
It	B-X
was	B-X
concluded	B-X
that	B-X
NF-κB-mediated	B-X
inflammatory	B-X
signaling	B-X
is	B-X
able	B-X
to	B-X
block	B-X
HIF-1α	B-X
transactivation	B-X
at	B-X
HRE-encoding	B-X
genes	B-X
by	B-X
direct	B-X
competition	B-X
for	B-X
p300	B-X
binding	B-X
at	B-X
the	B-X
promoter	B-X
.	B-X

Nuclear	O
cross	O
-	O
talk	O
was	O
directly	O
tested	O
using	O
the	O
mammalian	O
Gal4	B-Gene_or_gene_product
/	I-Gene_or_gene_product
VP16	I-Gene_or_gene_product
two	O
-	O
hybrid	O
,	O
and	O
confirmed	O
by	O
co	O
-	O
immunoprecipitation	O
/	O
western	O
blotting	O
assays	O
.	O
<EOS>	B-X
The	B-X
potential	B-X
interaction	B-X
between	B-X
HIF-1α	B-X
and	B-X
NF-κB	B-X
signaling	B-X
was	B-X
explored	B-X
by	B-X
co-transfection	B-X
studies	B-X
in	B-X
hFOB	B-X
with	B-X
p65	B-X
,	B-X
HIF-1α	B-X
and	B-X
9x-HRE-luc	B-X
or	B-X
HIF-1α	B-X
target	B-X
genes	B-X
reporter	B-X
plasmids	B-X
.	B-X
Nuclear	B-X
cross-talk	B-X
was	B-X
directly	B-X
tested	B-X
using	B-X
the	B-X
mammalian	B-X
Gal4/VP16	B-X
two-hybrid	B-X
,	B-X
and	B-X
confirmed	B-X
by	B-X
co-immunoprecipitation/western	B-X
blotting	B-X
assays	B-X
.	B-X
Also	B-X
,	B-X
co-transfection	B-X
with	B-X
p65	B-X
expression	B-X
vector	B-X
leads	B-X
to	B-X
reduced	B-X
hVEGFp	B-X
transcription	B-X
after	B-X
DFO-induced	B-X
hypoxia	B-X
.	B-X
The	B-X
functional	B-X
interaction	B-X
of	B-X
Gal4-HIF-1α	B-X
and	B-X
VP16-p300	B-X
fusion	B-X
proteins	B-X
is	B-X
effectively	B-X
blocked	B-X
by	B-X
expression	B-X
of	B-X
p65	B-X
in	B-X
a	B-X
dose	B-X
dependent	B-X
manner	B-X
.	B-X
It	B-X
was	B-X
concluded	B-X
that	B-X
NF-κB-mediated	B-X
inflammatory	B-X
signaling	B-X
is	B-X
able	B-X
to	B-X
block	B-X
HIF-1α	B-X
transactivation	B-X
at	B-X
HRE-encoding	B-X
genes	B-X
by	B-X
direct	B-X
competition	B-X
for	B-X
p300	B-X
binding	B-X
at	B-X
the	B-X
promoter	B-X
.	B-X

The	O
results	O
show	O
that	O
inflammatory	O
stimulation	O
(	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
treatment	O
)	O
causes	O
a	O
marked	O
inhibition	O
of	O
HIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1alpha	I-Gene_or_gene_product
function	O
at	O
the	O
HRE	O
in	O
all	O
cell	O
lines	O
studied	O
.	O
<EOS>	B-X
HIF-1α	B-X
is	B-X
the	B-X
transcription	B-X
factor	B-X
mediating	B-X
hypoxia	B-X
responses	B-X
that	B-X
include	B-X
induction	B-X
of	B-X
VEGF	B-X
and	B-X
related	B-X
bone	B-X
induction	B-X
.	B-X
The	B-X
present	B-X
investigation	B-X
explored	B-X
the	B-X
functional	B-X
relationship	B-X
of	B-X
hypoxia	B-X
(	B-X
HIF-1α	B-X
function	B-X
)	B-X
and	B-X
inflammatory	B-X
signaling	B-X
(	B-X
NF-κB	B-X
)	B-X
in	B-X
stem	B-X
like	B-X
and	B-X
osteoprogenitor	B-X
cell	B-X
lines	B-X
.	B-X
The	B-X
potential	B-X
interaction	B-X
between	B-X
HIF-1α	B-X
and	B-X
NF-κB	B-X
signaling	B-X
was	B-X
explored	B-X
by	B-X
co-transfection	B-X
studies	B-X
in	B-X
hFOB	B-X
with	B-X
p65	B-X
,	B-X
HIF-1α	B-X
and	B-X
9x-HRE-luc	B-X
or	B-X
HIF-1α	B-X
target	B-X
genes	B-X
reporter	B-X
plasmids	B-X
.	B-X
The	B-X
results	B-X
show	B-X
that	B-X
inflammatory	B-X
stimulation	B-X
(	B-X
TNF-α	B-X
treatment	B-X
)	B-X
causes	B-X
a	B-X
marked	B-X
inhibition	B-X
of	B-X
HIF-1α	B-X
function	B-X
at	B-X
the	B-X
HRE	B-X
in	B-X
all	B-X
cell	B-X
lines	B-X
studied	B-X
.	B-X
However	B-X
,	B-X
TNF-α	B-X
treatment	B-X
had	B-X
little	B-X
effect	B-X
on	B-X
HIF-1α	B-X
mRNA	B-X
levels	B-X
.	B-X
The	B-X
functional	B-X
interaction	B-X
of	B-X
Gal4-HIF-1α	B-X
and	B-X
VP16-p300	B-X
fusion	B-X
proteins	B-X
is	B-X
effectively	B-X
blocked	B-X
by	B-X
expression	B-X
of	B-X
p65	B-X
in	B-X
a	B-X
dose	B-X
dependent	B-X
manner	B-X
.	B-X
It	B-X
was	B-X
concluded	B-X
that	B-X
NF-κB-mediated	B-X
inflammatory	B-X
signaling	B-X
is	B-X
able	B-X
to	B-X
block	B-X
HIF-1α	B-X
transactivation	B-X
at	B-X
HRE-encoding	B-X
genes	B-X
by	B-X
direct	B-X
competition	B-X
for	B-X
p300	B-X
binding	B-X
at	B-X
the	B-X
promoter	B-X
.	B-X
Inflammation	B-X
may	B-X
influence	B-X
the	B-X
stem	B-X
cell	B-X
niche	B-X
and	B-X
tissue	B-X
regeneration	B-X
by	B-X
influencing	B-X
cellular	B-X
responses	B-X
to	B-X
hypoxia	B-X
.	B-X

Also	O
,	O
co	O
-	O
transfection	O
with	O
p65	B-Gene_or_gene_product
expression	O
vector	O
leads	O
to	O
reduced	O
hVEGFp	B-Gene_or_gene_product
transcription	O
after	O
DFO	O
-	O
induced	O
hypoxia	O
.	O
<EOS>	B-X
HIF-1α	B-X
is	B-X
the	B-X
transcription	B-X
factor	B-X
mediating	B-X
hypoxia	B-X
responses	B-X
that	B-X
include	B-X
induction	B-X
of	B-X
VEGF	B-X
and	B-X
related	B-X
bone	B-X
induction	B-X
.	B-X
The	B-X
present	B-X
investigation	B-X
explored	B-X
the	B-X
functional	B-X
relationship	B-X
of	B-X
hypoxia	B-X
(	B-X
HIF-1α	B-X
function	B-X
)	B-X
and	B-X
inflammatory	B-X
signaling	B-X
(	B-X
NF-κB	B-X
)	B-X
in	B-X
stem	B-X
like	B-X
and	B-X
osteoprogenitor	B-X
cell	B-X
lines	B-X
.	B-X
The	B-X
potential	B-X
interaction	B-X
between	B-X
HIF-1α	B-X
and	B-X
NF-κB	B-X
signaling	B-X
was	B-X
explored	B-X
by	B-X
co-transfection	B-X
studies	B-X
in	B-X
hFOB	B-X
with	B-X
p65	B-X
,	B-X
HIF-1α	B-X
and	B-X
9x-HRE-luc	B-X
or	B-X
HIF-1α	B-X
target	B-X
genes	B-X
reporter	B-X
plasmids	B-X
.	B-X
Nuclear	B-X
cross-talk	B-X
was	B-X
directly	B-X
tested	B-X
using	B-X
the	B-X
mammalian	B-X
Gal4/VP16	B-X
two-hybrid	B-X
,	B-X
and	B-X
confirmed	B-X
by	B-X
co-immunoprecipitation/western	B-X
blotting	B-X
assays	B-X
.	B-X
Also	B-X
,	B-X
co-transfection	B-X
with	B-X
p65	B-X
expression	B-X
vector	B-X
leads	B-X
to	B-X
reduced	B-X
hVEGFp	B-X
transcription	B-X
after	B-X
DFO-induced	B-X
hypoxia	B-X
.	B-X
The	B-X
functional	B-X
interaction	B-X
of	B-X
Gal4-HIF-1α	B-X
and	B-X
VP16-p300	B-X
fusion	B-X
proteins	B-X
is	B-X
effectively	B-X
blocked	B-X
by	B-X
expression	B-X
of	B-X
p65	B-X
in	B-X
a	B-X
dose	B-X
dependent	B-X
manner	B-X
.	B-X
It	B-X
was	B-X
concluded	B-X
that	B-X
NF-κB-mediated	B-X
inflammatory	B-X
signaling	B-X
is	B-X
able	B-X
to	B-X
block	B-X
HIF-1α	B-X
transactivation	B-X
at	B-X
HRE-encoding	B-X
genes	B-X
by	B-X
direct	B-X
competition	B-X
for	B-X
p300	B-X
binding	B-X
at	B-X
the	B-X
promoter	B-X
.	B-X
Inflammation	B-X
may	B-X
influence	B-X
the	B-X
stem	B-X
cell	B-X
niche	B-X
and	B-X
tissue	B-X
regeneration	B-X
by	B-X
influencing	B-X
cellular	B-X
responses	B-X
to	B-X
hypoxia	B-X
.	B-X

However	O
,	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
treatment	O
had	O
little	O
effect	O
on	O
HIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1alpha	I-Gene_or_gene_product
mRNA	O
levels	O
.	O
<EOS>	B-X
HIF-1α	B-X
is	B-X
the	B-X
transcription	B-X
factor	B-X
mediating	B-X
hypoxia	B-X
responses	B-X
that	B-X
include	B-X
induction	B-X
of	B-X
VEGF	B-X
and	B-X
related	B-X
bone	B-X
induction	B-X
.	B-X
The	B-X
present	B-X
investigation	B-X
explored	B-X
the	B-X
functional	B-X
relationship	B-X
of	B-X
hypoxia	B-X
(	B-X
HIF-1α	B-X
function	B-X
)	B-X
and	B-X
inflammatory	B-X
signaling	B-X
(	B-X
NF-κB	B-X
)	B-X
in	B-X
stem	B-X
like	B-X
and	B-X
osteoprogenitor	B-X
cell	B-X
lines	B-X
.	B-X
The	B-X
potential	B-X
interaction	B-X
between	B-X
HIF-1α	B-X
and	B-X
NF-κB	B-X
signaling	B-X
was	B-X
explored	B-X
by	B-X
co-transfection	B-X
studies	B-X
in	B-X
hFOB	B-X
with	B-X
p65	B-X
,	B-X
HIF-1α	B-X
and	B-X
9x-HRE-luc	B-X
or	B-X
HIF-1α	B-X
target	B-X
genes	B-X
reporter	B-X
plasmids	B-X
.	B-X
The	B-X
results	B-X
show	B-X
that	B-X
inflammatory	B-X
stimulation	B-X
(	B-X
TNF-α	B-X
treatment	B-X
)	B-X
causes	B-X
a	B-X
marked	B-X
inhibition	B-X
of	B-X
HIF-1α	B-X
function	B-X
at	B-X
the	B-X
HRE	B-X
in	B-X
all	B-X
cell	B-X
lines	B-X
studied	B-X
.	B-X
However	B-X
,	B-X
TNF-α	B-X
treatment	B-X
had	B-X
little	B-X
effect	B-X
on	B-X
HIF-1α	B-X
mRNA	B-X
levels	B-X
.	B-X
The	B-X
functional	B-X
interaction	B-X
of	B-X
Gal4-HIF-1α	B-X
and	B-X
VP16-p300	B-X
fusion	B-X
proteins	B-X
is	B-X
effectively	B-X
blocked	B-X
by	B-X
expression	B-X
of	B-X
p65	B-X
in	B-X
a	B-X
dose	B-X
dependent	B-X
manner	B-X
.	B-X
It	B-X
was	B-X
concluded	B-X
that	B-X
NF-κB-mediated	B-X
inflammatory	B-X
signaling	B-X
is	B-X
able	B-X
to	B-X
block	B-X
HIF-1α	B-X
transactivation	B-X
at	B-X
HRE-encoding	B-X
genes	B-X
by	B-X
direct	B-X
competition	B-X
for	B-X
p300	B-X
binding	B-X
at	B-X
the	B-X
promoter	B-X
.	B-X

The	O
functional	O
interaction	O
of	O
Gal4	B-Gene_or_gene_product
-	I-Gene_or_gene_product
HIF	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1alpha	I-Gene_or_gene_product
and	O
VP16	B-Gene_or_gene_product
-	I-Gene_or_gene_product
p300	I-Gene_or_gene_product
fusion	O
proteins	O
is	O
effectively	O
blocked	O
by	O
expression	O
of	O
p65	B-Gene_or_gene_product
in	O
a	O
dose	O
dependent	O
manner	O
.	O

It	O
was	O
concluded	O
that	O
NF	O
-	O
kappaB	O
-	O
mediated	O
inflammatory	O
signaling	O
is	O
able	O
to	O
block	O
HIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1alpha	I-Gene_or_gene_product
transactivation	O
at	O
HRE	O
-	O
encoding	O
genes	O
by	O
direct	O
competition	O
for	O
p300	B-Gene_or_gene_product
binding	O
at	O
the	O
promoter	O
.	O
<EOS>	B-X
Hypoxia	B-X
has	B-X
emerged	B-X
as	B-X
a	B-X
key	B-X
determinant	B-X
of	B-X
osteogenesis	B-X
.	B-X
HIF-1α	B-X
is	B-X
the	B-X
transcription	B-X
factor	B-X
mediating	B-X
hypoxia	B-X
responses	B-X
that	B-X
include	B-X
induction	B-X
of	B-X
VEGF	B-X
and	B-X
related	B-X
bone	B-X
induction	B-X
.	B-X
Inflammatory	B-X
signals	B-X
antagonize	B-X
bone	B-X
repair	B-X
via	B-X
the	B-X
NF-κB	B-X
pathway	B-X
.	B-X
The	B-X
present	B-X
investigation	B-X
explored	B-X
the	B-X
functional	B-X
relationship	B-X
of	B-X
hypoxia	B-X
(	B-X
HIF-1α	B-X
function	B-X
)	B-X
and	B-X
inflammatory	B-X
signaling	B-X
(	B-X
NF-κB	B-X
)	B-X
in	B-X
stem	B-X
like	B-X
and	B-X
osteoprogenitor	B-X
cell	B-X
lines	B-X
.	B-X
The	B-X
potential	B-X
interaction	B-X
between	B-X
HIF-1α	B-X
and	B-X
NF-κB	B-X
signaling	B-X
was	B-X
explored	B-X
by	B-X
co-transfection	B-X
studies	B-X
in	B-X
hFOB	B-X
with	B-X
p65	B-X
,	B-X
HIF-1α	B-X
and	B-X
9x-HRE-luc	B-X
or	B-X
HIF-1α	B-X
target	B-X
genes	B-X
reporter	B-X
plasmids	B-X
.	B-X
Nuclear	B-X
cross-talk	B-X
was	B-X
directly	B-X
tested	B-X
using	B-X
the	B-X
mammalian	B-X
Gal4/VP16	B-X
two-hybrid	B-X
,	B-X
and	B-X
confirmed	B-X
by	B-X
co-immunoprecipitation/western	B-X
blotting	B-X
assays	B-X
.	B-X
The	B-X
results	B-X
show	B-X
that	B-X
inflammatory	B-X
stimulation	B-X
(	B-X
TNF-α	B-X
treatment	B-X
)	B-X
causes	B-X
a	B-X
marked	B-X
inhibition	B-X
of	B-X
HIF-1α	B-X
function	B-X
at	B-X
the	B-X
HRE	B-X
in	B-X
all	B-X
cell	B-X
lines	B-X
studied	B-X
.	B-X
However	B-X
,	B-X
TNF-α	B-X
treatment	B-X
had	B-X
little	B-X
effect	B-X
on	B-X
HIF-1α	B-X
mRNA	B-X
levels	B-X
.	B-X
The	B-X
functional	B-X
interaction	B-X
of	B-X
Gal4-HIF-1α	B-X
and	B-X
VP16-p300	B-X
fusion	B-X
proteins	B-X
is	B-X
effectively	B-X
blocked	B-X
by	B-X
expression	B-X
of	B-X
p65	B-X
in	B-X
a	B-X
dose	B-X
dependent	B-X
manner	B-X
.	B-X
It	B-X
was	B-X
concluded	B-X
that	B-X
NF-κB-mediated	B-X
inflammatory	B-X
signaling	B-X
is	B-X
able	B-X
to	B-X
block	B-X
HIF-1α	B-X
transactivation	B-X
at	B-X
HRE-encoding	B-X
genes	B-X
by	B-X
direct	B-X
competition	B-X
for	B-X
p300	B-X
binding	B-X
at	B-X
the	B-X
promoter	B-X
.	B-X

Inflammation	O
may	O
influence	O
the	O
stem	O
cell	O
niche	O
and	O
tissue	O
regeneration	O
by	O
influencing	O
cellular	O
responses	O
to	O
hypoxia	O
.	O
<EOS>	B-X
HIF-1α	B-X
is	B-X
the	B-X
transcription	B-X
factor	B-X
mediating	B-X
hypoxia	B-X
responses	B-X
that	B-X
include	B-X
induction	B-X
of	B-X
VEGF	B-X
and	B-X
related	B-X
bone	B-X
induction	B-X
.	B-X
The	B-X
present	B-X
investigation	B-X
explored	B-X
the	B-X
functional	B-X
relationship	B-X
of	B-X
hypoxia	B-X
(	B-X
HIF-1α	B-X
function	B-X
)	B-X
and	B-X
inflammatory	B-X
signaling	B-X
(	B-X
NF-κB	B-X
)	B-X
in	B-X
stem	B-X
like	B-X
and	B-X
osteoprogenitor	B-X
cell	B-X
lines	B-X
.	B-X
The	B-X
results	B-X
show	B-X
that	B-X
inflammatory	B-X
stimulation	B-X
(	B-X
TNF-α	B-X
treatment	B-X
)	B-X
causes	B-X
a	B-X
marked	B-X
inhibition	B-X
of	B-X
HIF-1α	B-X
function	B-X
at	B-X
the	B-X
HRE	B-X
in	B-X
all	B-X
cell	B-X
lines	B-X
studied	B-X
.	B-X
Also	B-X
,	B-X
co-transfection	B-X
with	B-X
p65	B-X
expression	B-X
vector	B-X
leads	B-X
to	B-X
reduced	B-X
hVEGFp	B-X
transcription	B-X
after	B-X
DFO-induced	B-X
hypoxia	B-X
.	B-X
Inflammation	B-X
may	B-X
influence	B-X
the	B-X
stem	B-X
cell	B-X
niche	B-X
and	B-X
tissue	B-X
regeneration	B-X
by	B-X
influencing	B-X
cellular	B-X
responses	B-X
to	B-X
hypoxia	B-X
.	B-X

ZAS3	B-Gene_or_gene_product
represses	O
NFkappaB	O
-	O
dependent	O
transcription	O
by	O
direct	O
competition	O
for	O
DNA	O
binding	O
.	O
<EOS>	B-X
NFκB	B-X
and	B-X
ZAS3	B-X
are	B-X
transcription	B-X
factors	B-X
that	B-X
control	B-X
important	B-X
cellular	B-X
processes	B-X
including	B-X
immunity	B-X
,	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
.	B-X
Although	B-X
both	B-X
proteins	B-X
bind	B-X
the	B-X
κB-motif	B-X
,	B-X
they	B-X
produce	B-X
opposite	B-X
physiological	B-X
consequences	B-X
;	B-X
NFκB	B-X
activates	B-X
transcription	B-X
,	B-X
promotes	B-X
cell	B-X
growth	B-X
and	B-X
is	B-X
often	B-X
found	B-X
to	B-X
be	B-X
constitutively	B-X
expressed	B-X
in	B-X
cancer	B-X
cells	B-X
,	B-X
while	B-X
ZAS3	B-X
generally	B-X
represses	B-X
transcription	B-X
,	B-X
inhibits	B-X
cell	B-X
proliferation	B-X
and	B-X
is	B-X
downregulated	B-X
in	B-X
some	B-X
cancers	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
ZAS3	B-X
inhibits	B-X
NFκB-dependent	B-X
transcription	B-X
by	B-X
competing	B-X
with	B-X
NFκB	B-X
for	B-X
the	B-X
κB-motif	B-X
.	B-X
Transient	B-X
transfection	B-X
studies	B-X
show	B-X
that	B-X
N-terminal	B-X
645	B-X
amino	B-X
acids	B-X
is	B-X
sufficient	B-X
to	B-X
repress	B-X
transcription	B-X
activated	B-X
by	B-X
NFκB	B-X
,	B-X
and	B-X
that	B-X
the	B-X
identical	B-X
region	B-X
also	B-X
possesses	B-X
intrinsic	B-X
repression	B-X
activity	B-X
to	B-X
inhibit	B-X
basal	B-X
transcription	B-X
from	B-X
a	B-X
promoter	B-X
.	B-X
Finally	B-X
,	B-X
in	B-X
vitro	B-X
DNA-protein	B-X
interaction	B-X
analysis	B-X
shows	B-X
that	B-X
ZAS3	B-X
is	B-X
able	B-X
to	B-X
displace	B-X
NFκB	B-X
by	B-X
competing	B-X
with	B-X
NFκB	B-X
for	B-X
the	B-X
κB-motif	B-X
.	B-X
It	B-X
is	B-X
conceivable	B-X
that	B-X
ZAS3	B-X
has	B-X
therapeutic	B-X
potential	B-X
for	B-X
controlling	B-X
aberrant	B-X
activation	B-X
of	B-X
NFκB	B-X
in	B-X
various	B-X
diseases	B-X
.	B-X

NFkappaB	O
and	O
ZAS3	B-Gene_or_gene_product
are	O
transcription	O
factors	O
that	O
control	O
important	O
cellular	O
processes	O
including	O
immunity	O
,	O
cell	O
survival	O
and	O
apoptosis	O
.	O
<EOS>	B-X
NFκB	B-X
and	B-X
ZAS3	B-X
are	B-X
transcription	B-X
factors	B-X
that	B-X
control	B-X
important	B-X
cellular	B-X
processes	B-X
including	B-X
immunity	B-X
,	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
.	B-X
Although	B-X
both	B-X
proteins	B-X
bind	B-X
the	B-X
κB-motif	B-X
,	B-X
they	B-X
produce	B-X
opposite	B-X
physiological	B-X
consequences	B-X
;	B-X
NFκB	B-X
activates	B-X
transcription	B-X
,	B-X
promotes	B-X
cell	B-X
growth	B-X
and	B-X
is	B-X
often	B-X
found	B-X
to	B-X
be	B-X
constitutively	B-X
expressed	B-X
in	B-X
cancer	B-X
cells	B-X
,	B-X
while	B-X
ZAS3	B-X
generally	B-X
represses	B-X
transcription	B-X
,	B-X
inhibits	B-X
cell	B-X
proliferation	B-X
and	B-X
is	B-X
downregulated	B-X
in	B-X
some	B-X
cancers	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
ZAS3	B-X
inhibits	B-X
NFκB-dependent	B-X
transcription	B-X
by	B-X
competing	B-X
with	B-X
NFκB	B-X
for	B-X
the	B-X
κB-motif	B-X
.	B-X
Transient	B-X
transfection	B-X
studies	B-X
show	B-X
that	B-X
N-terminal	B-X
645	B-X
amino	B-X
acids	B-X
is	B-X
sufficient	B-X
to	B-X
repress	B-X
transcription	B-X
activated	B-X
by	B-X
NFκB	B-X
,	B-X
and	B-X
that	B-X
the	B-X
identical	B-X
region	B-X
also	B-X
possesses	B-X
intrinsic	B-X
repression	B-X
activity	B-X
to	B-X
inhibit	B-X
basal	B-X
transcription	B-X
from	B-X
a	B-X
promoter	B-X
.	B-X
Finally	B-X
,	B-X
in	B-X
vitro	B-X
DNA-protein	B-X
interaction	B-X
analysis	B-X
shows	B-X
that	B-X
ZAS3	B-X
is	B-X
able	B-X
to	B-X
displace	B-X
NFκB	B-X
by	B-X
competing	B-X
with	B-X
NFκB	B-X
for	B-X
the	B-X
κB-motif	B-X
.	B-X
It	B-X
is	B-X
conceivable	B-X
that	B-X
ZAS3	B-X
has	B-X
therapeutic	B-X
potential	B-X
for	B-X
controlling	B-X
aberrant	B-X
activation	B-X
of	B-X
NFκB	B-X
in	B-X
various	B-X
diseases	B-X
.	B-X

Although	O
both	O
proteins	O
bind	O
the	O
kappaB	O
-	O
motif	O
,	O
they	O
produce	O
opposite	O
physiological	O
consequences	O
;	O
NFkappaB	O
activates	O
transcription	O
,	O
promotes	O
cell	O
growth	O
and	O
is	O
often	O
found	O
to	O
be	O
constitutively	O
expressed	O
in	O
cancer	O
cells	O
,	O
while	O
ZAS3	B-Gene_or_gene_product
generally	O
represses	O
transcription	O
,	O
inhibits	O
cell	O
proliferation	O
and	O
is	O
downregulated	O
in	O
some	O
cancers	O
.	O
<EOS>	B-X
NFκB	B-X
and	B-X
ZAS3	B-X
are	B-X
transcription	B-X
factors	B-X
that	B-X
control	B-X
important	B-X
cellular	B-X
processes	B-X
including	B-X
immunity	B-X
,	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
.	B-X
Although	B-X
both	B-X
proteins	B-X
bind	B-X
the	B-X
κB-motif	B-X
,	B-X
they	B-X
produce	B-X
opposite	B-X
physiological	B-X
consequences	B-X
;	B-X
NFκB	B-X
activates	B-X
transcription	B-X
,	B-X
promotes	B-X
cell	B-X
growth	B-X
and	B-X
is	B-X
often	B-X
found	B-X
to	B-X
be	B-X
constitutively	B-X
expressed	B-X
in	B-X
cancer	B-X
cells	B-X
,	B-X
while	B-X
ZAS3	B-X
generally	B-X
represses	B-X
transcription	B-X
,	B-X
inhibits	B-X
cell	B-X
proliferation	B-X
and	B-X
is	B-X
downregulated	B-X
in	B-X
some	B-X
cancers	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
ZAS3	B-X
inhibits	B-X
NFκB-dependent	B-X
transcription	B-X
by	B-X
competing	B-X
with	B-X
NFκB	B-X
for	B-X
the	B-X
κB-motif	B-X
.	B-X
Transient	B-X
transfection	B-X
studies	B-X
show	B-X
that	B-X
N-terminal	B-X
645	B-X
amino	B-X
acids	B-X
is	B-X
sufficient	B-X
to	B-X
repress	B-X
transcription	B-X
activated	B-X
by	B-X
NFκB	B-X
,	B-X
and	B-X
that	B-X
the	B-X
identical	B-X
region	B-X
also	B-X
possesses	B-X
intrinsic	B-X
repression	B-X
activity	B-X
to	B-X
inhibit	B-X
basal	B-X
transcription	B-X
from	B-X
a	B-X
promoter	B-X
.	B-X
Finally	B-X
,	B-X
in	B-X
vitro	B-X
DNA-protein	B-X
interaction	B-X
analysis	B-X
shows	B-X
that	B-X
ZAS3	B-X
is	B-X
able	B-X
to	B-X
displace	B-X
NFκB	B-X
by	B-X
competing	B-X
with	B-X
NFκB	B-X
for	B-X
the	B-X
κB-motif	B-X
.	B-X
It	B-X
is	B-X
conceivable	B-X
that	B-X
ZAS3	B-X
has	B-X
therapeutic	B-X
potential	B-X
for	B-X
controlling	B-X
aberrant	B-X
activation	B-X
of	B-X
NFκB	B-X
in	B-X
various	B-X
diseases	B-X
.	B-X

Here	O
,	O
we	O
show	O
that	O
ZAS3	B-Gene_or_gene_product
inhibits	O
NFkappaB	O
-	O
dependent	O
transcription	O
by	O
competing	O
with	O
NFkappaB	O
for	O
the	O
kappaB	O
-	O
motif	O
.	O
<EOS>	B-X
NFκB	B-X
and	B-X
ZAS3	B-X
are	B-X
transcription	B-X
factors	B-X
that	B-X
control	B-X
important	B-X
cellular	B-X
processes	B-X
including	B-X
immunity	B-X
,	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
.	B-X
Although	B-X
both	B-X
proteins	B-X
bind	B-X
the	B-X
κB-motif	B-X
,	B-X
they	B-X
produce	B-X
opposite	B-X
physiological	B-X
consequences	B-X
;	B-X
NFκB	B-X
activates	B-X
transcription	B-X
,	B-X
promotes	B-X
cell	B-X
growth	B-X
and	B-X
is	B-X
often	B-X
found	B-X
to	B-X
be	B-X
constitutively	B-X
expressed	B-X
in	B-X
cancer	B-X
cells	B-X
,	B-X
while	B-X
ZAS3	B-X
generally	B-X
represses	B-X
transcription	B-X
,	B-X
inhibits	B-X
cell	B-X
proliferation	B-X
and	B-X
is	B-X
downregulated	B-X
in	B-X
some	B-X
cancers	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
ZAS3	B-X
inhibits	B-X
NFκB-dependent	B-X
transcription	B-X
by	B-X
competing	B-X
with	B-X
NFκB	B-X
for	B-X
the	B-X
κB-motif	B-X
.	B-X
Transient	B-X
transfection	B-X
studies	B-X
show	B-X
that	B-X
N-terminal	B-X
645	B-X
amino	B-X
acids	B-X
is	B-X
sufficient	B-X
to	B-X
repress	B-X
transcription	B-X
activated	B-X
by	B-X
NFκB	B-X
,	B-X
and	B-X
that	B-X
the	B-X
identical	B-X
region	B-X
also	B-X
possesses	B-X
intrinsic	B-X
repression	B-X
activity	B-X
to	B-X
inhibit	B-X
basal	B-X
transcription	B-X
from	B-X
a	B-X
promoter	B-X
.	B-X
Finally	B-X
,	B-X
in	B-X
vitro	B-X
DNA-protein	B-X
interaction	B-X
analysis	B-X
shows	B-X
that	B-X
ZAS3	B-X
is	B-X
able	B-X
to	B-X
displace	B-X
NFκB	B-X
by	B-X
competing	B-X
with	B-X
NFκB	B-X
for	B-X
the	B-X
κB-motif	B-X
.	B-X
It	B-X
is	B-X
conceivable	B-X
that	B-X
ZAS3	B-X
has	B-X
therapeutic	B-X
potential	B-X
for	B-X
controlling	B-X
aberrant	B-X
activation	B-X
of	B-X
NFκB	B-X
in	B-X
various	B-X
diseases	B-X
.	B-X

Transient	O
transfection	O
studies	O
show	O
that	O
N	O
-	O
terminal	O
645	O
amino	O
acids	O
is	O
sufficient	O
to	O
repress	O
transcription	O
activated	O
by	O
NFkappaB	O
,	O
and	O
that	O
the	O
identical	O
region	O
also	O
possesses	O
intrinsic	O
repression	O
activity	O
to	O
inhibit	O
basal	O
transcription	O
from	O
a	O
promoter	O
.	O

Finally	O
,	O
in	O
vitro	O
DNA	O
-	O
protein	O
interaction	O
analysis	O
shows	O
that	O
ZAS3	B-Gene_or_gene_product
is	O
able	O
to	O
displace	O
NFkappaB	O
by	O
competing	O
with	O
NFkappaB	O
for	O
the	O
kappaB	O
-	O
motif	O
.	O
<EOS>	B-X
NFκB	B-X
and	B-X
ZAS3	B-X
are	B-X
transcription	B-X
factors	B-X
that	B-X
control	B-X
important	B-X
cellular	B-X
processes	B-X
including	B-X
immunity	B-X
,	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
.	B-X
Although	B-X
both	B-X
proteins	B-X
bind	B-X
the	B-X
κB-motif	B-X
,	B-X
they	B-X
produce	B-X
opposite	B-X
physiological	B-X
consequences	B-X
;	B-X
NFκB	B-X
activates	B-X
transcription	B-X
,	B-X
promotes	B-X
cell	B-X
growth	B-X
and	B-X
is	B-X
often	B-X
found	B-X
to	B-X
be	B-X
constitutively	B-X
expressed	B-X
in	B-X
cancer	B-X
cells	B-X
,	B-X
while	B-X
ZAS3	B-X
generally	B-X
represses	B-X
transcription	B-X
,	B-X
inhibits	B-X
cell	B-X
proliferation	B-X
and	B-X
is	B-X
downregulated	B-X
in	B-X
some	B-X
cancers	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
ZAS3	B-X
inhibits	B-X
NFκB-dependent	B-X
transcription	B-X
by	B-X
competing	B-X
with	B-X
NFκB	B-X
for	B-X
the	B-X
κB-motif	B-X
.	B-X
Finally	B-X
,	B-X
in	B-X
vitro	B-X
DNA-protein	B-X
interaction	B-X
analysis	B-X
shows	B-X
that	B-X
ZAS3	B-X
is	B-X
able	B-X
to	B-X
displace	B-X
NFκB	B-X
by	B-X
competing	B-X
with	B-X
NFκB	B-X
for	B-X
the	B-X
κB-motif	B-X
.	B-X
It	B-X
is	B-X
conceivable	B-X
that	B-X
ZAS3	B-X
has	B-X
therapeutic	B-X
potential	B-X
for	B-X
controlling	B-X
aberrant	B-X
activation	B-X
of	B-X
NFκB	B-X
in	B-X
various	B-X
diseases	B-X
.	B-X

It	O
is	O
conceivable	O
that	O
ZAS3	B-Gene_or_gene_product
has	O
therapeutic	O
potential	O
for	O
controlling	O
aberrant	O
activation	O
of	O
NFkappaB	O
in	O
various	O
diseases	O
.	O
<EOS>	B-X
NFκB	B-X
and	B-X
ZAS3	B-X
are	B-X
transcription	B-X
factors	B-X
that	B-X
control	B-X
important	B-X
cellular	B-X
processes	B-X
including	B-X
immunity	B-X
,	B-X
cell	B-X
survival	B-X
and	B-X
apoptosis	B-X
.	B-X
Although	B-X
both	B-X
proteins	B-X
bind	B-X
the	B-X
κB-motif	B-X
,	B-X
they	B-X
produce	B-X
opposite	B-X
physiological	B-X
consequences	B-X
;	B-X
NFκB	B-X
activates	B-X
transcription	B-X
,	B-X
promotes	B-X
cell	B-X
growth	B-X
and	B-X
is	B-X
often	B-X
found	B-X
to	B-X
be	B-X
constitutively	B-X
expressed	B-X
in	B-X
cancer	B-X
cells	B-X
,	B-X
while	B-X
ZAS3	B-X
generally	B-X
represses	B-X
transcription	B-X
,	B-X
inhibits	B-X
cell	B-X
proliferation	B-X
and	B-X
is	B-X
downregulated	B-X
in	B-X
some	B-X
cancers	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
ZAS3	B-X
inhibits	B-X
NFκB-dependent	B-X
transcription	B-X
by	B-X
competing	B-X
with	B-X
NFκB	B-X
for	B-X
the	B-X
κB-motif	B-X
.	B-X
Finally	B-X
,	B-X
in	B-X
vitro	B-X
DNA-protein	B-X
interaction	B-X
analysis	B-X
shows	B-X
that	B-X
ZAS3	B-X
is	B-X
able	B-X
to	B-X
displace	B-X
NFκB	B-X
by	B-X
competing	B-X
with	B-X
NFκB	B-X
for	B-X
the	B-X
κB-motif	B-X
.	B-X
It	B-X
is	B-X
conceivable	B-X
that	B-X
ZAS3	B-X
has	B-X
therapeutic	B-X
potential	B-X
for	B-X
controlling	B-X
aberrant	B-X
activation	B-X
of	B-X
NFκB	B-X
in	B-X
various	B-X
diseases	B-X
.	B-X

The	O
interplay	O
between	O
NF	O
-	O
kappaB	O
and	O
E2F1	B-Gene_or_gene_product
coordinately	O
regulates	O
inflammation	O
and	O
metabolism	O
in	O
human	O
cardiac	O
cells	O
.	O
<EOS>	B-X
Expression	B-X
of	B-X
Concern	B-X
:	B-X
The	B-X
Interplay	B-X
between	B-X
NF-kappaB	B-X
and	B-X
E2F1	B-X
Coordinately	B-X
Regulates	B-X
Inflammation	B-X
and	B-X
Metabolism	B-X
in	B-X
Human	B-X
Cardiac	B-X
Cells	B-X
.	B-X
Pyruvate	B-X
dehydrogenase	B-X
kinase	B-X
4	B-X
(	B-X
PDK4	B-X
)	B-X
inhibition	B-X
by	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
is	B-X
related	B-X
to	B-X
a	B-X
shift	B-X
towards	B-X
increased	B-X
glycolysis	B-X
during	B-X
cardiac	B-X
pathological	B-X
processes	B-X
such	B-X
as	B-X
cardiac	B-X
hypertrophy	B-X
and	B-X
heart	B-X
failure	B-X
.	B-X
NF-κB	B-X
activation	B-X
in	B-X
AC16	B-X
cardiac	B-X
cells	B-X
inhibit	B-X
ERRα	B-X
and	B-X
PPARβ/δ	B-X
transcriptional	B-X
activity	B-X
,	B-X
resulting	B-X
in	B-X
reduced	B-X
PGC-1α	B-X
and	B-X
PDK4	B-X
expression	B-X
,	B-X
and	B-X
an	B-X
enhanced	B-X
glucose	B-X
oxidation	B-X
rate	B-X
.	B-X
However	B-X
,	B-X
addition	B-X
of	B-X
the	B-X
NF-κB	B-X
inhibitor	B-X
parthenolide	B-X
to	B-X
these	B-X
cells	B-X
prevents	B-X
the	B-X
downregulation	B-X
of	B-X
PDK4	B-X
expression	B-X
but	B-X
not	B-X
ERRα	B-X
and	B-X
PPARβ/δ	B-X
DNA	B-X
binding	B-X
activity	B-X
,	B-X
thus	B-X
suggesting	B-X
that	B-X
additional	B-X
transcription	B-X
factors	B-X
are	B-X
regulating	B-X
PDK4	B-X
.	B-X
Interestingly	B-X
,	B-X
a	B-X
recent	B-X
study	B-X
has	B-X
demonstrated	B-X
that	B-X
the	B-X
transcription	B-X
factor	B-X
E2F1	B-X
,	B-X
which	B-X
is	B-X
crucial	B-X
for	B-X
cell	B-X
cycle	B-X
control	B-X
,	B-X
may	B-X
regulate	B-X
PDK4	B-X
expression	B-X
.	B-X
Given	B-X
that	B-X
NF-κB	B-X
may	B-X
antagonize	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
E2F1	B-X
in	B-X
cardiac	B-X
myocytes	B-X
,	B-X
we	B-X
sought	B-X
to	B-X
study	B-X
whether	B-X
inflammatory	B-X
processes	B-X
driven	B-X
by	B-X
NF-κB	B-X
can	B-X
downregulate	B-X
PDK4	B-X
expression	B-X
in	B-X
human	B-X
cardiac	B-X
AC16	B-X
cells	B-X
through	B-X
E2F1	B-X
inhibition	B-X
.	B-X
Protein	B-X
coimmunoprecipitation	B-X
indicated	B-X
that	B-X
PDK4	B-X
downregulation	B-X
entailed	B-X
enhanced	B-X
physical	B-X
interaction	B-X
between	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-κB	B-X
and	B-X
E2F1	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
analyses	B-X
demonstrated	B-X
that	B-X
p65	B-X
translocation	B-X
into	B-X
the	B-X
nucleus	B-X
prevented	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
PDK4	B-X
promoter	B-X
and	B-X
its	B-X
subsequent	B-X
E2F1-dependent	B-X
gene	B-X
transcription	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
NF-κB	B-X
inhibitor	B-X
parthenolide	B-X
prevented	B-X
the	B-X
inhibition	B-X
of	B-X
E2F1	B-X
,	B-X
while	B-X
E2F1	B-X
overexpression	B-X
reduced	B-X
interleukin	B-X
expression	B-X
in	B-X
stimulated	B-X
cardiac	B-X
cells	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
NF-κB	B-X
acts	B-X
as	B-X
a	B-X
molecular	B-X
switch	B-X
that	B-X
regulates	B-X
E2F1-dependent	B-X
PDK4	B-X
gene	B-X
transcription	B-X
.	B-X

Pyruvate	B-Gene_or_gene_product
dehydrogenase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
4	I-Gene_or_gene_product
(	O
PDK4	B-Gene_or_gene_product
)	O
inhibition	O
by	O
nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
is	O
related	O
to	O
a	O
shift	O
towards	O
increased	O
glycolysis	O
during	O
cardiac	O
pathological	O
processes	O
such	O
as	O
cardiac	O
hypertrophy	O
and	O
heart	O
failure	O
.	O
<EOS>	B-X
Pyruvate	B-X
dehydrogenase	B-X
kinase	B-X
4	B-X
(	B-X
PDK4	B-X
)	B-X
inhibition	B-X
by	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
is	B-X
related	B-X
to	B-X
a	B-X
shift	B-X
towards	B-X
increased	B-X
glycolysis	B-X
during	B-X
cardiac	B-X
pathological	B-X
processes	B-X
such	B-X
as	B-X
cardiac	B-X
hypertrophy	B-X
and	B-X
heart	B-X
failure	B-X
.	B-X
The	B-X
transcription	B-X
factors	B-X
estrogen-related	B-X
receptor-α	B-X
(	B-X
ERRα	B-X
)	B-X
and	B-X
peroxisome	B-X
proliferator-activated	B-X
receptor	B-X
(	B-X
PPAR	B-X
)	B-X
regulate	B-X
PDK4	B-X
expression	B-X
through	B-X
the	B-X
potent	B-X
transcriptional	B-X
coactivator	B-X
PPARγ	B-X
coactivator-1α	B-X
(	B-X
PGC-1α	B-X
)	B-X
.	B-X
NF-κB	B-X
activation	B-X
in	B-X
AC16	B-X
cardiac	B-X
cells	B-X
inhibit	B-X
ERRα	B-X
and	B-X
PPARβ/δ	B-X
transcriptional	B-X
activity	B-X
,	B-X
resulting	B-X
in	B-X
reduced	B-X
PGC-1α	B-X
and	B-X
PDK4	B-X
expression	B-X
,	B-X
and	B-X
an	B-X
enhanced	B-X
glucose	B-X
oxidation	B-X
rate	B-X
.	B-X
However	B-X
,	B-X
addition	B-X
of	B-X
the	B-X
NF-κB	B-X
inhibitor	B-X
parthenolide	B-X
to	B-X
these	B-X
cells	B-X
prevents	B-X
the	B-X
downregulation	B-X
of	B-X
PDK4	B-X
expression	B-X
but	B-X
not	B-X
ERRα	B-X
and	B-X
PPARβ/δ	B-X
DNA	B-X
binding	B-X
activity	B-X
,	B-X
thus	B-X
suggesting	B-X
that	B-X
additional	B-X
transcription	B-X
factors	B-X
are	B-X
regulating	B-X
PDK4	B-X
.	B-X
Interestingly	B-X
,	B-X
a	B-X
recent	B-X
study	B-X
has	B-X
demonstrated	B-X
that	B-X
the	B-X
transcription	B-X
factor	B-X
E2F1	B-X
,	B-X
which	B-X
is	B-X
crucial	B-X
for	B-X
cell	B-X
cycle	B-X
control	B-X
,	B-X
may	B-X
regulate	B-X
PDK4	B-X
expression	B-X
.	B-X
Given	B-X
that	B-X
NF-κB	B-X
may	B-X
antagonize	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
E2F1	B-X
in	B-X
cardiac	B-X
myocytes	B-X
,	B-X
we	B-X
sought	B-X
to	B-X
study	B-X
whether	B-X
inflammatory	B-X
processes	B-X
driven	B-X
by	B-X
NF-κB	B-X
can	B-X
downregulate	B-X
PDK4	B-X
expression	B-X
in	B-X
human	B-X
cardiac	B-X
AC16	B-X
cells	B-X
through	B-X
E2F1	B-X
inhibition	B-X
.	B-X
Protein	B-X
coimmunoprecipitation	B-X
indicated	B-X
that	B-X
PDK4	B-X
downregulation	B-X
entailed	B-X
enhanced	B-X
physical	B-X
interaction	B-X
between	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-κB	B-X
and	B-X
E2F1	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
analyses	B-X
demonstrated	B-X
that	B-X
p65	B-X
translocation	B-X
into	B-X
the	B-X
nucleus	B-X
prevented	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
PDK4	B-X
promoter	B-X
and	B-X
its	B-X
subsequent	B-X
E2F1-dependent	B-X
gene	B-X
transcription	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
NF-κB	B-X
inhibitor	B-X
parthenolide	B-X
prevented	B-X
the	B-X
inhibition	B-X
of	B-X
E2F1	B-X
,	B-X
while	B-X
E2F1	B-X
overexpression	B-X
reduced	B-X
interleukin	B-X
expression	B-X
in	B-X
stimulated	B-X
cardiac	B-X
cells	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
NF-κB	B-X
acts	B-X
as	B-X
a	B-X
molecular	B-X
switch	B-X
that	B-X
regulates	B-X
E2F1-dependent	B-X
PDK4	B-X
gene	B-X
transcription	B-X
.	B-X

The	O
transcription	O
factors	O
estrogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
related	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
(	O
ERRalpha	B-Gene_or_gene_product
)	O
and	O
peroxisome	B-Gene_or_gene_product
proliferator	I-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	O
PPAR	B-Gene_or_gene_product
)	O
regulate	O
PDK4	B-Gene_or_gene_product
expression	O
through	O
the	O
potent	O
transcriptional	O
coactivator	O
PPARgamma	B-Gene_or_gene_product
coactivator	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1alpha	I-Gene_or_gene_product
(	O
PGC	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1alpha	I-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
Pyruvate	B-X
dehydrogenase	B-X
kinase	B-X
4	B-X
(	B-X
PDK4	B-X
)	B-X
inhibition	B-X
by	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
is	B-X
related	B-X
to	B-X
a	B-X
shift	B-X
towards	B-X
increased	B-X
glycolysis	B-X
during	B-X
cardiac	B-X
pathological	B-X
processes	B-X
such	B-X
as	B-X
cardiac	B-X
hypertrophy	B-X
and	B-X
heart	B-X
failure	B-X
.	B-X
The	B-X
transcription	B-X
factors	B-X
estrogen-related	B-X
receptor-α	B-X
(	B-X
ERRα	B-X
)	B-X
and	B-X
peroxisome	B-X
proliferator-activated	B-X
receptor	B-X
(	B-X
PPAR	B-X
)	B-X
regulate	B-X
PDK4	B-X
expression	B-X
through	B-X
the	B-X
potent	B-X
transcriptional	B-X
coactivator	B-X
PPARγ	B-X
coactivator-1α	B-X
(	B-X
PGC-1α	B-X
)	B-X
.	B-X
NF-κB	B-X
activation	B-X
in	B-X
AC16	B-X
cardiac	B-X
cells	B-X
inhibit	B-X
ERRα	B-X
and	B-X
PPARβ/δ	B-X
transcriptional	B-X
activity	B-X
,	B-X
resulting	B-X
in	B-X
reduced	B-X
PGC-1α	B-X
and	B-X
PDK4	B-X
expression	B-X
,	B-X
and	B-X
an	B-X
enhanced	B-X
glucose	B-X
oxidation	B-X
rate	B-X
.	B-X
However	B-X
,	B-X
addition	B-X
of	B-X
the	B-X
NF-κB	B-X
inhibitor	B-X
parthenolide	B-X
to	B-X
these	B-X
cells	B-X
prevents	B-X
the	B-X
downregulation	B-X
of	B-X
PDK4	B-X
expression	B-X
but	B-X
not	B-X
ERRα	B-X
and	B-X
PPARβ/δ	B-X
DNA	B-X
binding	B-X
activity	B-X
,	B-X
thus	B-X
suggesting	B-X
that	B-X
additional	B-X
transcription	B-X
factors	B-X
are	B-X
regulating	B-X
PDK4	B-X
.	B-X
Interestingly	B-X
,	B-X
a	B-X
recent	B-X
study	B-X
has	B-X
demonstrated	B-X
that	B-X
the	B-X
transcription	B-X
factor	B-X
E2F1	B-X
,	B-X
which	B-X
is	B-X
crucial	B-X
for	B-X
cell	B-X
cycle	B-X
control	B-X
,	B-X
may	B-X
regulate	B-X
PDK4	B-X
expression	B-X
.	B-X
Given	B-X
that	B-X
NF-κB	B-X
may	B-X
antagonize	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
E2F1	B-X
in	B-X
cardiac	B-X
myocytes	B-X
,	B-X
we	B-X
sought	B-X
to	B-X
study	B-X
whether	B-X
inflammatory	B-X
processes	B-X
driven	B-X
by	B-X
NF-κB	B-X
can	B-X
downregulate	B-X
PDK4	B-X
expression	B-X
in	B-X
human	B-X
cardiac	B-X
AC16	B-X
cells	B-X
through	B-X
E2F1	B-X
inhibition	B-X
.	B-X
Protein	B-X
coimmunoprecipitation	B-X
indicated	B-X
that	B-X
PDK4	B-X
downregulation	B-X
entailed	B-X
enhanced	B-X
physical	B-X
interaction	B-X
between	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-κB	B-X
and	B-X
E2F1	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
analyses	B-X
demonstrated	B-X
that	B-X
p65	B-X
translocation	B-X
into	B-X
the	B-X
nucleus	B-X
prevented	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
PDK4	B-X
promoter	B-X
and	B-X
its	B-X
subsequent	B-X
E2F1-dependent	B-X
gene	B-X
transcription	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
NF-κB	B-X
inhibitor	B-X
parthenolide	B-X
prevented	B-X
the	B-X
inhibition	B-X
of	B-X
E2F1	B-X
,	B-X
while	B-X
E2F1	B-X
overexpression	B-X
reduced	B-X
interleukin	B-X
expression	B-X
in	B-X
stimulated	B-X
cardiac	B-X
cells	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
NF-κB	B-X
acts	B-X
as	B-X
a	B-X
molecular	B-X
switch	B-X
that	B-X
regulates	B-X
E2F1-dependent	B-X
PDK4	B-X
gene	B-X
transcription	B-X
.	B-X

NF	O
-	O
kappaB	O
activation	O
in	O
AC16	O
cardiac	O
cells	O
inhibit	O
ERRalpha	B-Gene_or_gene_product
and	O
PPARbeta	B-Gene_or_gene_product
/	O
delta	B-Gene_or_gene_product
transcriptional	O
activity	O
,	O
resulting	O
in	O
reduced	O
PGC	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1alpha	I-Gene_or_gene_product
and	O
PDK4	B-Gene_or_gene_product
expression	O
,	O
and	O
an	O
enhanced	O
glucose	O
oxidation	O
rate	O
.	O

However	O
,	O
addition	O
of	O
the	O
NF	O
-	O
kappaB	O
inhibitor	O
parthenolide	O
to	O
these	O
cells	O
prevents	O
the	O
downregulation	O
of	O
PDK4	B-Gene_or_gene_product
expression	O
but	O
not	O
ERRalpha	B-Gene_or_gene_product
and	O
PPARbeta	B-Gene_or_gene_product
/	O
delta	B-Gene_or_gene_product
DNA	O
binding	O
activity	O
,	O
thus	O
suggesting	O
that	O
additional	O
transcription	O
factors	O
are	O
regulating	O
PDK4	B-Gene_or_gene_product
.	O

Interestingly	O
,	O
a	O
recent	O
study	O
has	O
demonstrated	O
that	O
the	O
transcription	O
factor	O
E2F1	B-Gene_or_gene_product
,	O
which	O
is	O
crucial	O
for	O
cell	O
cycle	O
control	O
,	O
may	O
regulate	O
PDK4	B-Gene_or_gene_product
expression	O
.	O
<EOS>	B-X
Pyruvate	B-X
dehydrogenase	B-X
kinase	B-X
4	B-X
(	B-X
PDK4	B-X
)	B-X
inhibition	B-X
by	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
is	B-X
related	B-X
to	B-X
a	B-X
shift	B-X
towards	B-X
increased	B-X
glycolysis	B-X
during	B-X
cardiac	B-X
pathological	B-X
processes	B-X
such	B-X
as	B-X
cardiac	B-X
hypertrophy	B-X
and	B-X
heart	B-X
failure	B-X
.	B-X
The	B-X
transcription	B-X
factors	B-X
estrogen-related	B-X
receptor-α	B-X
(	B-X
ERRα	B-X
)	B-X
and	B-X
peroxisome	B-X
proliferator-activated	B-X
receptor	B-X
(	B-X
PPAR	B-X
)	B-X
regulate	B-X
PDK4	B-X
expression	B-X
through	B-X
the	B-X
potent	B-X
transcriptional	B-X
coactivator	B-X
PPARγ	B-X
coactivator-1α	B-X
(	B-X
PGC-1α	B-X
)	B-X
.	B-X
NF-κB	B-X
activation	B-X
in	B-X
AC16	B-X
cardiac	B-X
cells	B-X
inhibit	B-X
ERRα	B-X
and	B-X
PPARβ/δ	B-X
transcriptional	B-X
activity	B-X
,	B-X
resulting	B-X
in	B-X
reduced	B-X
PGC-1α	B-X
and	B-X
PDK4	B-X
expression	B-X
,	B-X
and	B-X
an	B-X
enhanced	B-X
glucose	B-X
oxidation	B-X
rate	B-X
.	B-X
However	B-X
,	B-X
addition	B-X
of	B-X
the	B-X
NF-κB	B-X
inhibitor	B-X
parthenolide	B-X
to	B-X
these	B-X
cells	B-X
prevents	B-X
the	B-X
downregulation	B-X
of	B-X
PDK4	B-X
expression	B-X
but	B-X
not	B-X
ERRα	B-X
and	B-X
PPARβ/δ	B-X
DNA	B-X
binding	B-X
activity	B-X
,	B-X
thus	B-X
suggesting	B-X
that	B-X
additional	B-X
transcription	B-X
factors	B-X
are	B-X
regulating	B-X
PDK4	B-X
.	B-X
Interestingly	B-X
,	B-X
a	B-X
recent	B-X
study	B-X
has	B-X
demonstrated	B-X
that	B-X
the	B-X
transcription	B-X
factor	B-X
E2F1	B-X
,	B-X
which	B-X
is	B-X
crucial	B-X
for	B-X
cell	B-X
cycle	B-X
control	B-X
,	B-X
may	B-X
regulate	B-X
PDK4	B-X
expression	B-X
.	B-X
Given	B-X
that	B-X
NF-κB	B-X
may	B-X
antagonize	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
E2F1	B-X
in	B-X
cardiac	B-X
myocytes	B-X
,	B-X
we	B-X
sought	B-X
to	B-X
study	B-X
whether	B-X
inflammatory	B-X
processes	B-X
driven	B-X
by	B-X
NF-κB	B-X
can	B-X
downregulate	B-X
PDK4	B-X
expression	B-X
in	B-X
human	B-X
cardiac	B-X
AC16	B-X
cells	B-X
through	B-X
E2F1	B-X
inhibition	B-X
.	B-X
Protein	B-X
coimmunoprecipitation	B-X
indicated	B-X
that	B-X
PDK4	B-X
downregulation	B-X
entailed	B-X
enhanced	B-X
physical	B-X
interaction	B-X
between	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-κB	B-X
and	B-X
E2F1	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
analyses	B-X
demonstrated	B-X
that	B-X
p65	B-X
translocation	B-X
into	B-X
the	B-X
nucleus	B-X
prevented	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
PDK4	B-X
promoter	B-X
and	B-X
its	B-X
subsequent	B-X
E2F1-dependent	B-X
gene	B-X
transcription	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
NF-κB	B-X
inhibitor	B-X
parthenolide	B-X
prevented	B-X
the	B-X
inhibition	B-X
of	B-X
E2F1	B-X
,	B-X
while	B-X
E2F1	B-X
overexpression	B-X
reduced	B-X
interleukin	B-X
expression	B-X
in	B-X
stimulated	B-X
cardiac	B-X
cells	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
NF-κB	B-X
acts	B-X
as	B-X
a	B-X
molecular	B-X
switch	B-X
that	B-X
regulates	B-X
E2F1-dependent	B-X
PDK4	B-X
gene	B-X
transcription	B-X
.	B-X

Given	O
that	O
NF	O
-	O
kappaB	O
may	O
antagonize	O
the	O
transcriptional	O
activity	O
of	O
E2F1	B-Gene_or_gene_product
in	O
cardiac	O
myocytes	O
,	O
we	O
sought	O
to	O
study	O
whether	O
inflammatory	O
processes	O
driven	O
by	O
NF	O
-	O
kappaB	O
can	O
downregulate	O
PDK4	B-Gene_or_gene_product
expression	O
in	O
human	O
cardiac	O
AC16	O
cells	O
through	O
E2F1	B-Gene_or_gene_product
inhibition	O
.	O
<EOS>	B-X
Pyruvate	B-X
dehydrogenase	B-X
kinase	B-X
4	B-X
(	B-X
PDK4	B-X
)	B-X
inhibition	B-X
by	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
is	B-X
related	B-X
to	B-X
a	B-X
shift	B-X
towards	B-X
increased	B-X
glycolysis	B-X
during	B-X
cardiac	B-X
pathological	B-X
processes	B-X
such	B-X
as	B-X
cardiac	B-X
hypertrophy	B-X
and	B-X
heart	B-X
failure	B-X
.	B-X
The	B-X
transcription	B-X
factors	B-X
estrogen-related	B-X
receptor-α	B-X
(	B-X
ERRα	B-X
)	B-X
and	B-X
peroxisome	B-X
proliferator-activated	B-X
receptor	B-X
(	B-X
PPAR	B-X
)	B-X
regulate	B-X
PDK4	B-X
expression	B-X
through	B-X
the	B-X
potent	B-X
transcriptional	B-X
coactivator	B-X
PPARγ	B-X
coactivator-1α	B-X
(	B-X
PGC-1α	B-X
)	B-X
.	B-X
NF-κB	B-X
activation	B-X
in	B-X
AC16	B-X
cardiac	B-X
cells	B-X
inhibit	B-X
ERRα	B-X
and	B-X
PPARβ/δ	B-X
transcriptional	B-X
activity	B-X
,	B-X
resulting	B-X
in	B-X
reduced	B-X
PGC-1α	B-X
and	B-X
PDK4	B-X
expression	B-X
,	B-X
and	B-X
an	B-X
enhanced	B-X
glucose	B-X
oxidation	B-X
rate	B-X
.	B-X
However	B-X
,	B-X
addition	B-X
of	B-X
the	B-X
NF-κB	B-X
inhibitor	B-X
parthenolide	B-X
to	B-X
these	B-X
cells	B-X
prevents	B-X
the	B-X
downregulation	B-X
of	B-X
PDK4	B-X
expression	B-X
but	B-X
not	B-X
ERRα	B-X
and	B-X
PPARβ/δ	B-X
DNA	B-X
binding	B-X
activity	B-X
,	B-X
thus	B-X
suggesting	B-X
that	B-X
additional	B-X
transcription	B-X
factors	B-X
are	B-X
regulating	B-X
PDK4	B-X
.	B-X
Interestingly	B-X
,	B-X
a	B-X
recent	B-X
study	B-X
has	B-X
demonstrated	B-X
that	B-X
the	B-X
transcription	B-X
factor	B-X
E2F1	B-X
,	B-X
which	B-X
is	B-X
crucial	B-X
for	B-X
cell	B-X
cycle	B-X
control	B-X
,	B-X
may	B-X
regulate	B-X
PDK4	B-X
expression	B-X
.	B-X
Given	B-X
that	B-X
NF-κB	B-X
may	B-X
antagonize	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
E2F1	B-X
in	B-X
cardiac	B-X
myocytes	B-X
,	B-X
we	B-X
sought	B-X
to	B-X
study	B-X
whether	B-X
inflammatory	B-X
processes	B-X
driven	B-X
by	B-X
NF-κB	B-X
can	B-X
downregulate	B-X
PDK4	B-X
expression	B-X
in	B-X
human	B-X
cardiac	B-X
AC16	B-X
cells	B-X
through	B-X
E2F1	B-X
inhibition	B-X
.	B-X
Protein	B-X
coimmunoprecipitation	B-X
indicated	B-X
that	B-X
PDK4	B-X
downregulation	B-X
entailed	B-X
enhanced	B-X
physical	B-X
interaction	B-X
between	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-κB	B-X
and	B-X
E2F1	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
analyses	B-X
demonstrated	B-X
that	B-X
p65	B-X
translocation	B-X
into	B-X
the	B-X
nucleus	B-X
prevented	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
PDK4	B-X
promoter	B-X
and	B-X
its	B-X
subsequent	B-X
E2F1-dependent	B-X
gene	B-X
transcription	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
NF-κB	B-X
inhibitor	B-X
parthenolide	B-X
prevented	B-X
the	B-X
inhibition	B-X
of	B-X
E2F1	B-X
,	B-X
while	B-X
E2F1	B-X
overexpression	B-X
reduced	B-X
interleukin	B-X
expression	B-X
in	B-X
stimulated	B-X
cardiac	B-X
cells	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
NF-κB	B-X
acts	B-X
as	B-X
a	B-X
molecular	B-X
switch	B-X
that	B-X
regulates	B-X
E2F1-dependent	B-X
PDK4	B-X
gene	B-X
transcription	B-X
.	B-X

Protein	O
coimmunoprecipitation	O
indicated	O
that	O
PDK4	B-Gene_or_gene_product
downregulation	O
entailed	O
enhanced	O
physical	O
interaction	O
between	O
the	O
p65	B-Gene_or_gene_product
subunit	O
of	O
NF	O
-	O
kappaB	O
and	O
E2F1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Pyruvate	B-X
dehydrogenase	B-X
kinase	B-X
4	B-X
(	B-X
PDK4	B-X
)	B-X
inhibition	B-X
by	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
is	B-X
related	B-X
to	B-X
a	B-X
shift	B-X
towards	B-X
increased	B-X
glycolysis	B-X
during	B-X
cardiac	B-X
pathological	B-X
processes	B-X
such	B-X
as	B-X
cardiac	B-X
hypertrophy	B-X
and	B-X
heart	B-X
failure	B-X
.	B-X
The	B-X
transcription	B-X
factors	B-X
estrogen-related	B-X
receptor-α	B-X
(	B-X
ERRα	B-X
)	B-X
and	B-X
peroxisome	B-X
proliferator-activated	B-X
receptor	B-X
(	B-X
PPAR	B-X
)	B-X
regulate	B-X
PDK4	B-X
expression	B-X
through	B-X
the	B-X
potent	B-X
transcriptional	B-X
coactivator	B-X
PPARγ	B-X
coactivator-1α	B-X
(	B-X
PGC-1α	B-X
)	B-X
.	B-X
NF-κB	B-X
activation	B-X
in	B-X
AC16	B-X
cardiac	B-X
cells	B-X
inhibit	B-X
ERRα	B-X
and	B-X
PPARβ/δ	B-X
transcriptional	B-X
activity	B-X
,	B-X
resulting	B-X
in	B-X
reduced	B-X
PGC-1α	B-X
and	B-X
PDK4	B-X
expression	B-X
,	B-X
and	B-X
an	B-X
enhanced	B-X
glucose	B-X
oxidation	B-X
rate	B-X
.	B-X
However	B-X
,	B-X
addition	B-X
of	B-X
the	B-X
NF-κB	B-X
inhibitor	B-X
parthenolide	B-X
to	B-X
these	B-X
cells	B-X
prevents	B-X
the	B-X
downregulation	B-X
of	B-X
PDK4	B-X
expression	B-X
but	B-X
not	B-X
ERRα	B-X
and	B-X
PPARβ/δ	B-X
DNA	B-X
binding	B-X
activity	B-X
,	B-X
thus	B-X
suggesting	B-X
that	B-X
additional	B-X
transcription	B-X
factors	B-X
are	B-X
regulating	B-X
PDK4	B-X
.	B-X
Interestingly	B-X
,	B-X
a	B-X
recent	B-X
study	B-X
has	B-X
demonstrated	B-X
that	B-X
the	B-X
transcription	B-X
factor	B-X
E2F1	B-X
,	B-X
which	B-X
is	B-X
crucial	B-X
for	B-X
cell	B-X
cycle	B-X
control	B-X
,	B-X
may	B-X
regulate	B-X
PDK4	B-X
expression	B-X
.	B-X
Given	B-X
that	B-X
NF-κB	B-X
may	B-X
antagonize	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
E2F1	B-X
in	B-X
cardiac	B-X
myocytes	B-X
,	B-X
we	B-X
sought	B-X
to	B-X
study	B-X
whether	B-X
inflammatory	B-X
processes	B-X
driven	B-X
by	B-X
NF-κB	B-X
can	B-X
downregulate	B-X
PDK4	B-X
expression	B-X
in	B-X
human	B-X
cardiac	B-X
AC16	B-X
cells	B-X
through	B-X
E2F1	B-X
inhibition	B-X
.	B-X
Protein	B-X
coimmunoprecipitation	B-X
indicated	B-X
that	B-X
PDK4	B-X
downregulation	B-X
entailed	B-X
enhanced	B-X
physical	B-X
interaction	B-X
between	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-κB	B-X
and	B-X
E2F1	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
analyses	B-X
demonstrated	B-X
that	B-X
p65	B-X
translocation	B-X
into	B-X
the	B-X
nucleus	B-X
prevented	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
PDK4	B-X
promoter	B-X
and	B-X
its	B-X
subsequent	B-X
E2F1-dependent	B-X
gene	B-X
transcription	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
NF-κB	B-X
inhibitor	B-X
parthenolide	B-X
prevented	B-X
the	B-X
inhibition	B-X
of	B-X
E2F1	B-X
,	B-X
while	B-X
E2F1	B-X
overexpression	B-X
reduced	B-X
interleukin	B-X
expression	B-X
in	B-X
stimulated	B-X
cardiac	B-X
cells	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
NF-κB	B-X
acts	B-X
as	B-X
a	B-X
molecular	B-X
switch	B-X
that	B-X
regulates	B-X
E2F1-dependent	B-X
PDK4	B-X
gene	B-X
transcription	B-X
.	B-X

Chromatin	O
immunoprecipitation	O
analyses	O
demonstrated	O
that	O
p65	B-Gene_or_gene_product
translocation	O
into	O
the	O
nucleus	O
prevented	O
the	O
recruitment	O
of	O
E2F1	B-Gene_or_gene_product
to	O
the	O
PDK4	B-Gene_or_gene_product
promoter	O
and	O
its	O
subsequent	O
E2F1	B-Gene_or_gene_product
-	O
dependent	O
gene	O
transcription	O
.	O

Interestingly	O
,	O
the	O
NF	O
-	O
kappaB	O
inhibitor	O
parthenolide	O
prevented	O
the	O
inhibition	O
of	O
E2F1	B-Gene_or_gene_product
,	O
while	O
E2F1	B-Gene_or_gene_product
overexpression	O
reduced	O
interleukin	B-Gene_or_gene_product
expression	O
in	O
stimulated	O
cardiac	O
cells	O
.	O
<EOS>	B-X
Pyruvate	B-X
dehydrogenase	B-X
kinase	B-X
4	B-X
(	B-X
PDK4	B-X
)	B-X
inhibition	B-X
by	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
is	B-X
related	B-X
to	B-X
a	B-X
shift	B-X
towards	B-X
increased	B-X
glycolysis	B-X
during	B-X
cardiac	B-X
pathological	B-X
processes	B-X
such	B-X
as	B-X
cardiac	B-X
hypertrophy	B-X
and	B-X
heart	B-X
failure	B-X
.	B-X
The	B-X
transcription	B-X
factors	B-X
estrogen-related	B-X
receptor-α	B-X
(	B-X
ERRα	B-X
)	B-X
and	B-X
peroxisome	B-X
proliferator-activated	B-X
receptor	B-X
(	B-X
PPAR	B-X
)	B-X
regulate	B-X
PDK4	B-X
expression	B-X
through	B-X
the	B-X
potent	B-X
transcriptional	B-X
coactivator	B-X
PPARγ	B-X
coactivator-1α	B-X
(	B-X
PGC-1α	B-X
)	B-X
.	B-X
NF-κB	B-X
activation	B-X
in	B-X
AC16	B-X
cardiac	B-X
cells	B-X
inhibit	B-X
ERRα	B-X
and	B-X
PPARβ/δ	B-X
transcriptional	B-X
activity	B-X
,	B-X
resulting	B-X
in	B-X
reduced	B-X
PGC-1α	B-X
and	B-X
PDK4	B-X
expression	B-X
,	B-X
and	B-X
an	B-X
enhanced	B-X
glucose	B-X
oxidation	B-X
rate	B-X
.	B-X
However	B-X
,	B-X
addition	B-X
of	B-X
the	B-X
NF-κB	B-X
inhibitor	B-X
parthenolide	B-X
to	B-X
these	B-X
cells	B-X
prevents	B-X
the	B-X
downregulation	B-X
of	B-X
PDK4	B-X
expression	B-X
but	B-X
not	B-X
ERRα	B-X
and	B-X
PPARβ/δ	B-X
DNA	B-X
binding	B-X
activity	B-X
,	B-X
thus	B-X
suggesting	B-X
that	B-X
additional	B-X
transcription	B-X
factors	B-X
are	B-X
regulating	B-X
PDK4	B-X
.	B-X
Interestingly	B-X
,	B-X
a	B-X
recent	B-X
study	B-X
has	B-X
demonstrated	B-X
that	B-X
the	B-X
transcription	B-X
factor	B-X
E2F1	B-X
,	B-X
which	B-X
is	B-X
crucial	B-X
for	B-X
cell	B-X
cycle	B-X
control	B-X
,	B-X
may	B-X
regulate	B-X
PDK4	B-X
expression	B-X
.	B-X
Given	B-X
that	B-X
NF-κB	B-X
may	B-X
antagonize	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
E2F1	B-X
in	B-X
cardiac	B-X
myocytes	B-X
,	B-X
we	B-X
sought	B-X
to	B-X
study	B-X
whether	B-X
inflammatory	B-X
processes	B-X
driven	B-X
by	B-X
NF-κB	B-X
can	B-X
downregulate	B-X
PDK4	B-X
expression	B-X
in	B-X
human	B-X
cardiac	B-X
AC16	B-X
cells	B-X
through	B-X
E2F1	B-X
inhibition	B-X
.	B-X
Protein	B-X
coimmunoprecipitation	B-X
indicated	B-X
that	B-X
PDK4	B-X
downregulation	B-X
entailed	B-X
enhanced	B-X
physical	B-X
interaction	B-X
between	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-κB	B-X
and	B-X
E2F1	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
analyses	B-X
demonstrated	B-X
that	B-X
p65	B-X
translocation	B-X
into	B-X
the	B-X
nucleus	B-X
prevented	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
PDK4	B-X
promoter	B-X
and	B-X
its	B-X
subsequent	B-X
E2F1-dependent	B-X
gene	B-X
transcription	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
NF-κB	B-X
inhibitor	B-X
parthenolide	B-X
prevented	B-X
the	B-X
inhibition	B-X
of	B-X
E2F1	B-X
,	B-X
while	B-X
E2F1	B-X
overexpression	B-X
reduced	B-X
interleukin	B-X
expression	B-X
in	B-X
stimulated	B-X
cardiac	B-X
cells	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
NF-κB	B-X
acts	B-X
as	B-X
a	B-X
molecular	B-X
switch	B-X
that	B-X
regulates	B-X
E2F1-dependent	B-X
PDK4	B-X
gene	B-X
transcription	B-X
.	B-X

Based	O
on	O
these	O
findings	O
,	O
we	O
propose	O
that	O
NF	O
-	O
kappaB	O
acts	O
as	O
a	O
molecular	O
switch	O
that	O
regulates	O
E2F1	B-Gene_or_gene_product
-	O
dependent	O
PDK4	B-Gene_or_gene_product
gene	O
transcription	O
.	O
<EOS>	B-X
Pyruvate	B-X
dehydrogenase	B-X
kinase	B-X
4	B-X
(	B-X
PDK4	B-X
)	B-X
inhibition	B-X
by	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
is	B-X
related	B-X
to	B-X
a	B-X
shift	B-X
towards	B-X
increased	B-X
glycolysis	B-X
during	B-X
cardiac	B-X
pathological	B-X
processes	B-X
such	B-X
as	B-X
cardiac	B-X
hypertrophy	B-X
and	B-X
heart	B-X
failure	B-X
.	B-X
The	B-X
transcription	B-X
factors	B-X
estrogen-related	B-X
receptor-α	B-X
(	B-X
ERRα	B-X
)	B-X
and	B-X
peroxisome	B-X
proliferator-activated	B-X
receptor	B-X
(	B-X
PPAR	B-X
)	B-X
regulate	B-X
PDK4	B-X
expression	B-X
through	B-X
the	B-X
potent	B-X
transcriptional	B-X
coactivator	B-X
PPARγ	B-X
coactivator-1α	B-X
(	B-X
PGC-1α	B-X
)	B-X
.	B-X
NF-κB	B-X
activation	B-X
in	B-X
AC16	B-X
cardiac	B-X
cells	B-X
inhibit	B-X
ERRα	B-X
and	B-X
PPARβ/δ	B-X
transcriptional	B-X
activity	B-X
,	B-X
resulting	B-X
in	B-X
reduced	B-X
PGC-1α	B-X
and	B-X
PDK4	B-X
expression	B-X
,	B-X
and	B-X
an	B-X
enhanced	B-X
glucose	B-X
oxidation	B-X
rate	B-X
.	B-X
However	B-X
,	B-X
addition	B-X
of	B-X
the	B-X
NF-κB	B-X
inhibitor	B-X
parthenolide	B-X
to	B-X
these	B-X
cells	B-X
prevents	B-X
the	B-X
downregulation	B-X
of	B-X
PDK4	B-X
expression	B-X
but	B-X
not	B-X
ERRα	B-X
and	B-X
PPARβ/δ	B-X
DNA	B-X
binding	B-X
activity	B-X
,	B-X
thus	B-X
suggesting	B-X
that	B-X
additional	B-X
transcription	B-X
factors	B-X
are	B-X
regulating	B-X
PDK4	B-X
.	B-X
Interestingly	B-X
,	B-X
a	B-X
recent	B-X
study	B-X
has	B-X
demonstrated	B-X
that	B-X
the	B-X
transcription	B-X
factor	B-X
E2F1	B-X
,	B-X
which	B-X
is	B-X
crucial	B-X
for	B-X
cell	B-X
cycle	B-X
control	B-X
,	B-X
may	B-X
regulate	B-X
PDK4	B-X
expression	B-X
.	B-X
Given	B-X
that	B-X
NF-κB	B-X
may	B-X
antagonize	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
E2F1	B-X
in	B-X
cardiac	B-X
myocytes	B-X
,	B-X
we	B-X
sought	B-X
to	B-X
study	B-X
whether	B-X
inflammatory	B-X
processes	B-X
driven	B-X
by	B-X
NF-κB	B-X
can	B-X
downregulate	B-X
PDK4	B-X
expression	B-X
in	B-X
human	B-X
cardiac	B-X
AC16	B-X
cells	B-X
through	B-X
E2F1	B-X
inhibition	B-X
.	B-X
Protein	B-X
coimmunoprecipitation	B-X
indicated	B-X
that	B-X
PDK4	B-X
downregulation	B-X
entailed	B-X
enhanced	B-X
physical	B-X
interaction	B-X
between	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-κB	B-X
and	B-X
E2F1	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
analyses	B-X
demonstrated	B-X
that	B-X
p65	B-X
translocation	B-X
into	B-X
the	B-X
nucleus	B-X
prevented	B-X
the	B-X
recruitment	B-X
of	B-X
E2F1	B-X
to	B-X
the	B-X
PDK4	B-X
promoter	B-X
and	B-X
its	B-X
subsequent	B-X
E2F1-dependent	B-X
gene	B-X
transcription	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
NF-κB	B-X
inhibitor	B-X
parthenolide	B-X
prevented	B-X
the	B-X
inhibition	B-X
of	B-X
E2F1	B-X
,	B-X
while	B-X
E2F1	B-X
overexpression	B-X
reduced	B-X
interleukin	B-X
expression	B-X
in	B-X
stimulated	B-X
cardiac	B-X
cells	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
NF-κB	B-X
acts	B-X
as	B-X
a	B-X
molecular	B-X
switch	B-X
that	B-X
regulates	B-X
E2F1-dependent	B-X
PDK4	B-X
gene	B-X
transcription	B-X
.	B-X

Heteroarylketones	O
inhibit	O
astroglial	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
expression	O
via	O
a	O
STAT3	B-Gene_or_gene_product
/	O
NF	O
-	O
kappaB	O
signaling	O
pathway	O
.	O

BACKGROUND	O
:	O
Elevated	O
brain	O
levels	O
of	O
the	O
pleiotropic	O
cytokine	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
,	O
which	O
is	O
mainly	O
secreted	O
from	O
activated	O
local	O
astrocytes	O
,	O
contribute	O
to	O
pathological	O
events	O
including	O
neuroinflammation	O
and	O
neurodegeneration	O
.	O
<EOS>	B-X
Elevated	B-X
brain	B-X
levels	B-X
of	B-X
the	B-X
pleiotropic	B-X
cytokine	B-X
interleukin-6	B-X
,	B-X
which	B-X
is	B-X
mainly	B-X
secreted	B-X
from	B-X
activated	B-X
local	B-X
astrocytes	B-X
,	B-X
contribute	B-X
to	B-X
pathological	B-X
events	B-X
including	B-X
neuroinflammation	B-X
and	B-X
neurodegeneration	B-X
.	B-X
Thus	B-X
,	B-X
inhibition	B-X
of	B-X
pathological	B-X
IL-6	B-X
expression	B-X
provides	B-X
a	B-X
rationale	B-X
strategy	B-X
for	B-X
targeting	B-X
the	B-X
onset	B-X
or	B-X
further	B-X
progression	B-X
of	B-X
neurological	B-X
disorders	B-X
including	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
multiple	B-X
sclerosis	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
and	B-X
traumatic	B-X
brain	B-X
injury	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
identify	B-X
and	B-X
to	B-X
characterize	B-X
new	B-X
potent	B-X
inhibitors	B-X
of	B-X
astrocytic	B-X
IL-6	B-X
expression	B-X
for	B-X
further	B-X
therapeutic	B-X
development	B-X
of	B-X
novel	B-X
anti-inflammatory	B-X
and	B-X
neuroprotective	B-X
drugs	B-X
.	B-X

Thus	O
,	O
inhibition	O
of	O
pathological	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
expression	O
provides	O
a	O
rationale	O
strategy	O
for	O
targeting	O
the	O
onset	O
or	O
further	O
progression	O
of	O
neurological	O
disorders	O
including	O
Alzheimer	O
'	O
s	O
disease	O
,	O
multiple	O
sclerosis	O
,	O
Parkinson	O
'	O
s	O
disease	O
and	O
traumatic	O
brain	O
injury	O
.	O
<EOS>	B-X
Brain	B-X
TSPO	B-X
expression	B-X
is	B-X
relatively	B-X
low	B-X
under	B-X
physiological	B-X
conditions	B-X
,	B-X
but	B-X
is	B-X
upregulated	B-X
in	B-X
response	B-X
to	B-X
glial	B-X
cell	B-X
activation	B-X
.	B-X
As	B-X
the	B-X
primary	B-X
index	B-X
of	B-X
neuroinflammation	B-X
,	B-X
TSPO	B-X
is	B-X
implicated	B-X
in	B-X
the	B-X
pathogenesis	B-X
and	B-X
progression	B-X
of	B-X
numerous	B-X
neuropsychiatric	B-X
disorders	B-X
and	B-X
neurodegenerative	B-X
diseases	B-X
,	B-X
including	B-X
Alzheimer	B-X
's	B-X
disease	B-X
(	B-X
AD	B-X
)	B-X
,	B-X
amyotrophic	B-X
lateral	B-X
sclerosis	B-X
(	B-X
ALS	B-X
)	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
(	B-X
PD	B-X
)	B-X
,	B-X
multiple	B-X
sclerosis	B-X
(	B-X
MS	B-X
)	B-X
,	B-X
major	B-X
depressive	B-X
disorder	B-X
(	B-X
MDD	B-X
)	B-X
and	B-X
obsessive	B-X
compulsive	B-X
disorder	B-X
(	B-X
OCD	B-X
)	B-X
.	B-X
Addressing	B-X
these	B-X
challenges	B-X
will	B-X
facilitate	B-X
the	B-X
translation	B-X
of	B-X
TSPO	B-X
in	B-X
clinical	B-X
studies	B-X
of	B-X
neuroinflammation	B-X
associated	B-X
with	B-X
central	B-X
nervous	B-X
system	B-X
diseases	B-X
.	B-X
Neuroinflammation	B-X
leads	B-X
to	B-X
neurodegeneration	B-X
,	B-X
cognitive	B-X
defects	B-X
,	B-X
and	B-X
neurodegenerative	B-X
disorders	B-X
.	B-X
Neurotrauma/traumatic	B-X
brain	B-X
injury	B-X
(	B-X
TBI	B-X
)	B-X
can	B-X
cause	B-X
activation	B-X
of	B-X
glial	B-X
cells	B-X
,	B-X
neurons	B-X
,	B-X
and	B-X
neuroimmune	B-X
cells	B-X
in	B-X
the	B-X
brain	B-X
to	B-X
release	B-X
neuroinflammatory	B-X
mediators	B-X
.	B-X
Neurotrauma	B-X
leads	B-X
to	B-X
immediate	B-X
primary	B-X
brain	B-X
damage	B-X
(	B-X
direct	B-X
damage	B-X
)	B-X
,	B-X
neuroinflammatory	B-X
responses	B-X
,	B-X
neuroinflammation	B-X
,	B-X
and	B-X
late	B-X
secondary	B-X
brain	B-X
damage	B-X
(	B-X
indirect	B-X
)	B-X
through	B-X
neuroinflammatory	B-X
mechanism	B-X
.	B-X
Secondary	B-X
brain	B-X
damage	B-X
leads	B-X
to	B-X
chronic	B-X
inflammation	B-X
and	B-X
the	B-X
onset	B-X
and	B-X
progression	B-X
of	B-X
neurodegenerative	B-X
diseases	B-X
.	B-X
Currently	B-X
,	B-X
there	B-X
are	B-X
no	B-X
effective	B-X
and	B-X
specific	B-X
therapeutic	B-X
options	B-X
to	B-X
treat	B-X
these	B-X
brain	B-X
damages	B-X
or	B-X
neurodegenerative	B-X
diseases	B-X
.	B-X
In	B-X
this	B-X
short	B-X
review	B-X
article	B-X
,	B-X
we	B-X
have	B-X
reviewed	B-X
the	B-X
neuroprotective	B-X
effects	B-X
of	B-X
luteolin	B-X
in	B-X
neurotrauma	B-X
and	B-X
neurodegenerative	B-X
disorders	B-X
and	B-X
pathways	B-X
involved	B-X
in	B-X
this	B-X
mechanism	B-X
.	B-X
We	B-X
have	B-X
collected	B-X
data	B-X
for	B-X
this	B-X
study	B-X
from	B-X
publications	B-X
in	B-X
the	B-X
PubMed	B-X
using	B-X
the	B-X
keywords	B-X
luteolin	B-X
and	B-X
mast	B-X
cells	B-X
,	B-X
neuroinflammation	B-X
,	B-X
neurodegenerative	B-X
diseases	B-X
,	B-X
and	B-X
TBI	B-X
.	B-X
Recent	B-X
reports	B-X
suggest	B-X
that	B-X
luteolin	B-X
suppresses	B-X
systemic	B-X
and	B-X
neuroinflammatory	B-X
responses	B-X
in	B-X
Coronavirus	B-X
disease	B-X
2019	B-X
(	B-X
COVID-19	B-X
)	B-X
.	B-X
Studies	B-X
have	B-X
shown	B-X
that	B-X
luteolin	B-X
exhibits	B-X
neuroprotective	B-X
effects	B-X
through	B-X
various	B-X
mechanisms	B-X
,	B-X
including	B-X
suppressing	B-X
immune	B-X
cell	B-X
activation	B-X
,	B-X
such	B-X
as	B-X
mast	B-X
cells	B-X
,	B-X
and	B-X
inflammatory	B-X
mediators	B-X
released	B-X
from	B-X
these	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
luteolin	B-X
can	B-X
suppress	B-X
neuroinflammatory	B-X
response	B-X
,	B-X
activation	B-X
of	B-X
microglia	B-X
and	B-X
astrocytes	B-X
,	B-X
oxidative	B-X
stress	B-X
,	B-X
neuroinflammation	B-X
,	B-X
and	B-X
the	B-X
severity	B-X
of	B-X
neuroinflammatory	B-X
diseases	B-X
such	B-X
as	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
,	B-X
multiple	B-X
sclerosis	B-X
,	B-X
and	B-X
TBI	B-X
pathogenesis	B-X
.	B-X
In	B-X
conclusion	B-X
,	B-X
luteolin	B-X
can	B-X
improve	B-X
cognitive	B-X
decline	B-X
and	B-X
enhance	B-X
neuroprotection	B-X
in	B-X
neurodegenerative	B-X
diseases	B-X
,	B-X
TBI	B-X
,	B-X
and	B-X
stroke	B-X
.	B-X

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
identify	O
and	O
to	O
characterize	O
new	O
potent	O
inhibitors	O
of	O
astrocytic	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
expression	O
for	O
further	O
therapeutic	O
development	O
of	O
novel	O
anti	O
-	O
inflammatory	O
and	O
neuroprotective	O
drugs	O
.	O
<EOS>	B-X
Elevated	B-X
brain	B-X
levels	B-X
of	B-X
the	B-X
pleiotropic	B-X
cytokine	B-X
interleukin-6	B-X
,	B-X
which	B-X
is	B-X
mainly	B-X
secreted	B-X
from	B-X
activated	B-X
local	B-X
astrocytes	B-X
,	B-X
contribute	B-X
to	B-X
pathological	B-X
events	B-X
including	B-X
neuroinflammation	B-X
and	B-X
neurodegeneration	B-X
.	B-X
Thus	B-X
,	B-X
inhibition	B-X
of	B-X
pathological	B-X
IL-6	B-X
expression	B-X
provides	B-X
a	B-X
rationale	B-X
strategy	B-X
for	B-X
targeting	B-X
the	B-X
onset	B-X
or	B-X
further	B-X
progression	B-X
of	B-X
neurological	B-X
disorders	B-X
including	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
multiple	B-X
sclerosis	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
and	B-X
traumatic	B-X
brain	B-X
injury	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
identify	B-X
and	B-X
to	B-X
characterize	B-X
new	B-X
potent	B-X
inhibitors	B-X
of	B-X
astrocytic	B-X
IL-6	B-X
expression	B-X
for	B-X
further	B-X
therapeutic	B-X
development	B-X
of	B-X
novel	B-X
anti-inflammatory	B-X
and	B-X
neuroprotective	B-X
drugs	B-X
.	B-X

METHODS	O
:	O
Oncostatin	B-Gene_or_gene_product
M	I-Gene_or_gene_product
(	O
OSM	B-Gene_or_gene_product
)	O
-	O
treated	O
human	O
glioma	O
U343	O
cells	O
were	O
used	O
as	O
model	O
for	O
induction	O
of	O
astrocytic	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
expression	O
.	O
<EOS>	B-X
Elevated	B-X
brain	B-X
levels	B-X
of	B-X
the	B-X
pleiotropic	B-X
cytokine	B-X
interleukin-6	B-X
,	B-X
which	B-X
is	B-X
mainly	B-X
secreted	B-X
from	B-X
activated	B-X
local	B-X
astrocytes	B-X
,	B-X
contribute	B-X
to	B-X
pathological	B-X
events	B-X
including	B-X
neuroinflammation	B-X
and	B-X
neurodegeneration	B-X
.	B-X
Thus	B-X
,	B-X
inhibition	B-X
of	B-X
pathological	B-X
IL-6	B-X
expression	B-X
provides	B-X
a	B-X
rationale	B-X
strategy	B-X
for	B-X
targeting	B-X
the	B-X
onset	B-X
or	B-X
further	B-X
progression	B-X
of	B-X
neurological	B-X
disorders	B-X
including	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
multiple	B-X
sclerosis	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
and	B-X
traumatic	B-X
brain	B-X
injury	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
identify	B-X
and	B-X
to	B-X
characterize	B-X
new	B-X
potent	B-X
inhibitors	B-X
of	B-X
astrocytic	B-X
IL-6	B-X
expression	B-X
for	B-X
further	B-X
therapeutic	B-X
development	B-X
of	B-X
novel	B-X
anti-inflammatory	B-X
and	B-X
neuroprotective	B-X
drugs	B-X
.	B-X

This	O
model	O
was	O
characterized	O
by	O
immunoblotting	O
,	O
siRNA	O
technique	O
,	O
ELISA	O
and	O
qRT	O
-	O
PCR	O
and	O
used	O
to	O
screen	O
low	O
molecular	O
weight	O
compound	O
libraries	O
for	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
-	O
lowering	O
effects	O
.	O
<EOS>	B-X
Elevated	B-X
brain	B-X
levels	B-X
of	B-X
the	B-X
pleiotropic	B-X
cytokine	B-X
interleukin-6	B-X
,	B-X
which	B-X
is	B-X
mainly	B-X
secreted	B-X
from	B-X
activated	B-X
local	B-X
astrocytes	B-X
,	B-X
contribute	B-X
to	B-X
pathological	B-X
events	B-X
including	B-X
neuroinflammation	B-X
and	B-X
neurodegeneration	B-X
.	B-X
Thus	B-X
,	B-X
inhibition	B-X
of	B-X
pathological	B-X
IL-6	B-X
expression	B-X
provides	B-X
a	B-X
rationale	B-X
strategy	B-X
for	B-X
targeting	B-X
the	B-X
onset	B-X
or	B-X
further	B-X
progression	B-X
of	B-X
neurological	B-X
disorders	B-X
including	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
multiple	B-X
sclerosis	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
and	B-X
traumatic	B-X
brain	B-X
injury	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
identify	B-X
and	B-X
to	B-X
characterize	B-X
new	B-X
potent	B-X
inhibitors	B-X
of	B-X
astrocytic	B-X
IL-6	B-X
expression	B-X
for	B-X
further	B-X
therapeutic	B-X
development	B-X
of	B-X
novel	B-X
anti-inflammatory	B-X
and	B-X
neuroprotective	B-X
drugs	B-X
.	B-X

To	O
validate	O
bioactive	O
compounds	O
identified	O
from	O
library	O
screens	O
,	O
bacterial	O
lipopolysaccharide	O
was	O
used	O
to	O
induce	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
expression	O
in	O
cultivated	O
primary	O
astrocytes	O
and	O
in	O
mice	O
in	O
vivo	O
.	O
<EOS>	B-X
Elevated	B-X
brain	B-X
levels	B-X
of	B-X
the	B-X
pleiotropic	B-X
cytokine	B-X
interleukin-6	B-X
,	B-X
which	B-X
is	B-X
mainly	B-X
secreted	B-X
from	B-X
activated	B-X
local	B-X
astrocytes	B-X
,	B-X
contribute	B-X
to	B-X
pathological	B-X
events	B-X
including	B-X
neuroinflammation	B-X
and	B-X
neurodegeneration	B-X
.	B-X
Thus	B-X
,	B-X
inhibition	B-X
of	B-X
pathological	B-X
IL-6	B-X
expression	B-X
provides	B-X
a	B-X
rationale	B-X
strategy	B-X
for	B-X
targeting	B-X
the	B-X
onset	B-X
or	B-X
further	B-X
progression	B-X
of	B-X
neurological	B-X
disorders	B-X
including	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
multiple	B-X
sclerosis	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
and	B-X
traumatic	B-X
brain	B-X
injury	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
identify	B-X
and	B-X
to	B-X
characterize	B-X
new	B-X
potent	B-X
inhibitors	B-X
of	B-X
astrocytic	B-X
IL-6	B-X
expression	B-X
for	B-X
further	B-X
therapeutic	B-X
development	B-X
of	B-X
novel	B-X
anti-inflammatory	B-X
and	B-X
neuroprotective	B-X
drugs	B-X
.	B-X

To	O
dissect	O
underlying	O
molecular	O
mechanisms	O
,	O
protein	O
extracts	O
from	O
OSM	B-Gene_or_gene_product
-	O
treated	O
U343	O
cells	O
were	O
analyzed	O
by	O
phospho	O
-	O
specific	O
immunoblotting	O
and	O
immunocytochemistry	O
as	O
well	O
as	O
by	O
co	O
-	O
immunoprecipitation	O
.	O
<EOS>	B-X
Elevated	B-X
brain	B-X
levels	B-X
of	B-X
the	B-X
pleiotropic	B-X
cytokine	B-X
interleukin-6	B-X
,	B-X
which	B-X
is	B-X
mainly	B-X
secreted	B-X
from	B-X
activated	B-X
local	B-X
astrocytes	B-X
,	B-X
contribute	B-X
to	B-X
pathological	B-X
events	B-X
including	B-X
neuroinflammation	B-X
and	B-X
neurodegeneration	B-X
.	B-X

RESULTS	O
:	O
OSM	B-Gene_or_gene_product
-	O
treatment	O
(	O
100	O
ng	O
/	O
ml	O
;	O
24	O
h	O
)	O
led	O
to	O
30	O
-	O
fold	O
increase	O
of	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
secretion	O
from	O
U343	O
cells	O
.	O

The	O
temporal	O
profile	O
of	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
mRNA	O
induction	O
displayed	O
a	O
biphasic	O
induction	O
pattern	O
with	O
peak	O
synthesis	O
at	O
1	O
h	O
(	O
6	O
.	O
5	O
-	O
fold	O
)	O
and	O
16	O
h	O
(	O
5	O
.	O
5	O
-	O
fold	O
)	O
post	O
stimulation	O
.	O
<EOS>	B-X
Elevated	B-X
brain	B-X
levels	B-X
of	B-X
the	B-X
pleiotropic	B-X
cytokine	B-X
interleukin-6	B-X
,	B-X
which	B-X
is	B-X
mainly	B-X
secreted	B-X
from	B-X
activated	B-X
local	B-X
astrocytes	B-X
,	B-X
contribute	B-X
to	B-X
pathological	B-X
events	B-X
including	B-X
neuroinflammation	B-X
and	B-X
neurodegeneration	B-X
.	B-X
Thus	B-X
,	B-X
inhibition	B-X
of	B-X
pathological	B-X
IL-6	B-X
expression	B-X
provides	B-X
a	B-X
rationale	B-X
strategy	B-X
for	B-X
targeting	B-X
the	B-X
onset	B-X
or	B-X
further	B-X
progression	B-X
of	B-X
neurological	B-X
disorders	B-X
including	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
multiple	B-X
sclerosis	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
and	B-X
traumatic	B-X
brain	B-X
injury	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
identify	B-X
and	B-X
to	B-X
characterize	B-X
new	B-X
potent	B-X
inhibitors	B-X
of	B-X
astrocytic	B-X
IL-6	B-X
expression	B-X
for	B-X
further	B-X
therapeutic	B-X
development	B-X
of	B-X
novel	B-X
anti-inflammatory	B-X
and	B-X
neuroprotective	B-X
drugs	B-X
.	B-X

IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
protein	O
release	O
did	O
not	O
show	O
that	O
biphasic	O
pattern	O
and	O
was	O
detected	O
as	O
early	O
as	O
3	O
h	O
post	O
stimulation	O
reaching	O
a	O
maximum	O
at	O
24	O
h	O
.	O
<EOS>	B-X
Skeletal	B-X
muscle	B-X
has	B-X
recently	B-X
been	B-X
identified	B-X
as	B-X
an	B-X
endocrine	B-X
organ	B-X
.	B-X
It	B-X
has	B-X
,	B-X
therefore	B-X
,	B-X
been	B-X
suggested	B-X
that	B-X
cytokines	B-X
and	B-X
other	B-X
peptides	B-X
that	B-X
are	B-X
produced	B-X
,	B-X
expressed	B-X
,	B-X
and	B-X
released	B-X
by	B-X
muscle	B-X
fibers	B-X
and	B-X
exert	B-X
paracrine	B-X
,	B-X
autocrine	B-X
,	B-X
or	B-X
endocrine	B-X
effects	B-X
should	B-X
be	B-X
classified	B-X
as	B-X
``	B-X
myokines	B-X
.	B-X
''	B-X
Recent	B-X
research	B-X
demonstrates	B-X
that	B-X
skeletal	B-X
muscles	B-X
can	B-X
produce	B-X
and	B-X
express	B-X
cytokines	B-X
belonging	B-X
to	B-X
distinctly	B-X
different	B-X
families	B-X
.	B-X
However	B-X
,	B-X
the	B-X
first	B-X
identified	B-X
and	B-X
most	B-X
studied	B-X
myokine	B-X
is	B-X
the	B-X
gp130	B-X
receptor	B-X
cytokine	B-X
interleukin-6	B-X
(	B-X
IL-6	B-X
)	B-X
.	B-X
IL-6	B-X
was	B-X
discovered	B-X
as	B-X
a	B-X
myokine	B-X
because	B-X
of	B-X
the	B-X
observation	B-X
that	B-X
it	B-X
increases	B-X
up	B-X
to	B-X
100-fold	B-X
in	B-X
the	B-X
circulation	B-X
during	B-X
physical	B-X
exercise	B-X
.	B-X
Identification	B-X
of	B-X
IL-6	B-X
production	B-X
by	B-X
skeletal	B-X
muscle	B-X
during	B-X
physical	B-X
activity	B-X
generated	B-X
renewed	B-X
interest	B-X
in	B-X
the	B-X
metabolic	B-X
role	B-X
of	B-X
IL-6	B-X
because	B-X
it	B-X
created	B-X
a	B-X
paradox	B-X
.	B-X
On	B-X
one	B-X
hand	B-X
,	B-X
IL-6	B-X
is	B-X
markedly	B-X
produced	B-X
and	B-X
released	B-X
in	B-X
the	B-X
postexercise	B-X
period	B-X
when	B-X
insulin	B-X
action	B-X
is	B-X
enhanced	B-X
but	B-X
,	B-X
on	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
IL-6	B-X
has	B-X
been	B-X
associated	B-X
with	B-X
obesity	B-X
and	B-X
reduced	B-X
insulin	B-X
action	B-X
.	B-X
This	B-X
review	B-X
focuses	B-X
on	B-X
the	B-X
myokine	B-X
IL-6	B-X
,	B-X
its	B-X
regulation	B-X
by	B-X
exercise	B-X
,	B-X
its	B-X
signaling	B-X
pathways	B-X
in	B-X
skeletal	B-X
muscle	B-X
,	B-X
and	B-X
its	B-X
role	B-X
in	B-X
metabolism	B-X
in	B-X
both	B-X
health	B-X
and	B-X
disease	B-X
.	B-X

The	O
screen	O
of	O
compound	O
libraries	O
identified	O
a	O
set	O
of	O
heteroarylketones	O
(	O
HAKs	O
)	O
as	O
potent	O
inhibitors	O
of	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
secretion	O
.	O
<EOS>	B-X
Elevated	B-X
brain	B-X
levels	B-X
of	B-X
the	B-X
pleiotropic	B-X
cytokine	B-X
interleukin-6	B-X
,	B-X
which	B-X
is	B-X
mainly	B-X
secreted	B-X
from	B-X
activated	B-X
local	B-X
astrocytes	B-X
,	B-X
contribute	B-X
to	B-X
pathological	B-X
events	B-X
including	B-X
neuroinflammation	B-X
and	B-X
neurodegeneration	B-X
.	B-X
Thus	B-X
,	B-X
inhibition	B-X
of	B-X
pathological	B-X
IL-6	B-X
expression	B-X
provides	B-X
a	B-X
rationale	B-X
strategy	B-X
for	B-X
targeting	B-X
the	B-X
onset	B-X
or	B-X
further	B-X
progression	B-X
of	B-X
neurological	B-X
disorders	B-X
including	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
multiple	B-X
sclerosis	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
and	B-X
traumatic	B-X
brain	B-X
injury	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
identify	B-X
and	B-X
to	B-X
characterize	B-X
new	B-X
potent	B-X
inhibitors	B-X
of	B-X
astrocytic	B-X
IL-6	B-X
expression	B-X
for	B-X
further	B-X
therapeutic	B-X
development	B-X
of	B-X
novel	B-X
anti-inflammatory	B-X
and	B-X
neuroprotective	B-X
drugs	B-X
.	B-X

HAK	O
compounds	O
affected	O
the	O
second	O
peak	O
in	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
mRNA	O
synthesis	O
,	O
whereas	O
the	O
first	O
peak	O
was	O
insensitive	O
to	O
HAK	O
treatment	O
.	O
<EOS>	B-X
Elevated	B-X
brain	B-X
levels	B-X
of	B-X
the	B-X
pleiotropic	B-X
cytokine	B-X
interleukin-6	B-X
,	B-X
which	B-X
is	B-X
mainly	B-X
secreted	B-X
from	B-X
activated	B-X
local	B-X
astrocytes	B-X
,	B-X
contribute	B-X
to	B-X
pathological	B-X
events	B-X
including	B-X
neuroinflammation	B-X
and	B-X
neurodegeneration	B-X
.	B-X
Thus	B-X
,	B-X
inhibition	B-X
of	B-X
pathological	B-X
IL-6	B-X
expression	B-X
provides	B-X
a	B-X
rationale	B-X
strategy	B-X
for	B-X
targeting	B-X
the	B-X
onset	B-X
or	B-X
further	B-X
progression	B-X
of	B-X
neurological	B-X
disorders	B-X
including	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
multiple	B-X
sclerosis	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
and	B-X
traumatic	B-X
brain	B-X
injury	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
identify	B-X
and	B-X
to	B-X
characterize	B-X
new	B-X
potent	B-X
inhibitors	B-X
of	B-X
astrocytic	B-X
IL-6	B-X
expression	B-X
for	B-X
further	B-X
therapeutic	B-X
development	B-X
of	B-X
novel	B-X
anti-inflammatory	B-X
and	B-X
neuroprotective	B-X
drugs	B-X
.	B-X

HAK	O
compounds	O
also	O
suppressed	O
lipopolysaccharide	O
-	O
induced	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
expression	O
in	O
primary	O
murine	O
astrocytes	O
as	O
well	O
as	O
in	O
brain	O
and	O
plasma	O
samples	O
from	O
lipopolysaccharide	O
-	O
treated	O
mice	O
.	O
<EOS>	B-X
Elevated	B-X
brain	B-X
levels	B-X
of	B-X
the	B-X
pleiotropic	B-X
cytokine	B-X
interleukin-6	B-X
,	B-X
which	B-X
is	B-X
mainly	B-X
secreted	B-X
from	B-X
activated	B-X
local	B-X
astrocytes	B-X
,	B-X
contribute	B-X
to	B-X
pathological	B-X
events	B-X
including	B-X
neuroinflammation	B-X
and	B-X
neurodegeneration	B-X
.	B-X
Thus	B-X
,	B-X
inhibition	B-X
of	B-X
pathological	B-X
IL-6	B-X
expression	B-X
provides	B-X
a	B-X
rationale	B-X
strategy	B-X
for	B-X
targeting	B-X
the	B-X
onset	B-X
or	B-X
further	B-X
progression	B-X
of	B-X
neurological	B-X
disorders	B-X
including	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
multiple	B-X
sclerosis	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
and	B-X
traumatic	B-X
brain	B-X
injury	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
identify	B-X
and	B-X
to	B-X
characterize	B-X
new	B-X
potent	B-X
inhibitors	B-X
of	B-X
astrocytic	B-X
IL-6	B-X
expression	B-X
for	B-X
further	B-X
therapeutic	B-X
development	B-X
of	B-X
novel	B-X
anti-inflammatory	B-X
and	B-X
neuroprotective	B-X
drugs	B-X
.	B-X

Finally	O
,	O
HAK	O
compounds	O
were	O
demonstrated	O
to	O
specifically	O
suppress	O
the	O
OSM	B-Gene_or_gene_product
-	O
induced	O
phosphorylation	O
of	O
STAT3	B-Gene_or_gene_product
at	O
serine	O
727	O
and	O
the	O
physical	O
interaction	O
of	O
pSTAT3S727	B-Gene_or_gene_product
with	O
p65	B-Gene_or_gene_product
.	O

CONCLUSION	O
:	O
Heteroarylketone	O
compounds	O
are	O
potent	O
inhibitors	O
of	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
expression	O
in	O
vitro	O
and	O
in	O
vivo	O
and	O
may	O
represent	O
a	O
new	O
class	O
of	O
potent	O
anti	O
-	O
inflammatory	O
and	O
neuroprotective	O
drugs	O
.	O
<EOS>	B-X
Elevated	B-X
brain	B-X
levels	B-X
of	B-X
the	B-X
pleiotropic	B-X
cytokine	B-X
interleukin-6	B-X
,	B-X
which	B-X
is	B-X
mainly	B-X
secreted	B-X
from	B-X
activated	B-X
local	B-X
astrocytes	B-X
,	B-X
contribute	B-X
to	B-X
pathological	B-X
events	B-X
including	B-X
neuroinflammation	B-X
and	B-X
neurodegeneration	B-X
.	B-X
Thus	B-X
,	B-X
inhibition	B-X
of	B-X
pathological	B-X
IL-6	B-X
expression	B-X
provides	B-X
a	B-X
rationale	B-X
strategy	B-X
for	B-X
targeting	B-X
the	B-X
onset	B-X
or	B-X
further	B-X
progression	B-X
of	B-X
neurological	B-X
disorders	B-X
including	B-X
Alzheimer	B-X
's	B-X
disease	B-X
,	B-X
multiple	B-X
sclerosis	B-X
,	B-X
Parkinson	B-X
's	B-X
disease	B-X
and	B-X
traumatic	B-X
brain	B-X
injury	B-X
.	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
identify	B-X
and	B-X
to	B-X
characterize	B-X
new	B-X
potent	B-X
inhibitors	B-X
of	B-X
astrocytic	B-X
IL-6	B-X
expression	B-X
for	B-X
further	B-X
therapeutic	B-X
development	B-X
of	B-X
novel	B-X
anti-inflammatory	B-X
and	B-X
neuroprotective	B-X
drugs	B-X
.	B-X

The	O
Ran	B-Gene_or_gene_product
-	O
binding	O
protein	O
RanBPM	B-Gene_or_gene_product
can	O
depress	O
the	O
NF	O
-	O
kappaB	O
pathway	O
by	O
interacting	O
with	O
TRAF6	B-Gene_or_gene_product
.	O
<EOS>	B-X
Ran-binding	B-X
protein	B-X
in	B-X
microtubule-organizing	B-X
center	B-X
(	B-X
RanBPM	B-X
)	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
interact	B-X
with	B-X
the	B-X
neurotrophin	B-X
receptors	B-X
p75NTR	B-X
and	B-X
TrkA	B-X
,	B-X
meanwhile	B-X
p75NTR	B-X
and	B-X
TrkA	B-X
can	B-X
also	B-X
interact	B-X
with	B-X
TRAF6	B-X
.	B-X
Whether	B-X
RanBPM	B-X
interacts	B-X
directly	B-X
with	B-X
TRAF6	B-X
has	B-X
not	B-X
yet	B-X
been	B-X
established	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
using	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
system	B-X
and	B-X
glutathione-S	B-X
:	B-X
-transferase	B-X
pull-down	B-X
assays	B-X
,	B-X
we	B-X
determined	B-X
that	B-X
RanBPM	B-X
binds	B-X
to	B-X
the	B-X
TRAF6	B-X
C-terminus	B-X
through	B-X
its	B-X
SPRY	B-X
motif	B-X
.	B-X
Complex	B-X
formation	B-X
between	B-X
overexpressed	B-X
RanBPM	B-X
and	B-X
TRAF6	B-X
was	B-X
also	B-X
confirmed	B-X
with	B-X
a	B-X
co-immunoprecipitation	B-X
assay	B-X
,	B-X
laser	B-X
scanning	B-X
confocal	B-X
and	B-X
fluorescence	B-X
resonance	B-X
energy	B-X
transfer	B-X
.	B-X
Additional	B-X
co-immunoprecipitation	B-X
experiments	B-X
verified	B-X
that	B-X
endogenous	B-X
RanBPM	B-X
and	B-X
TRAF6	B-X
interact	B-X
in	B-X
several	B-X
mammalian	B-X
cell	B-X
lines	B-X
.	B-X
A	B-X
series	B-X
of	B-X
experiments	B-X
revealed	B-X
that	B-X
RanBPM	B-X
influences	B-X
TRAF6	B-X
ubiquitination	B-X
and	B-X
the	B-X
TRAF6-triggered	B-X
NF-κB	B-X
signaling	B-X
pathway	B-X
through	B-X
RanBPM	B-X
's	B-X
interaction	B-X
with	B-X
TRAF6	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
RanBPM	B-X
participates	B-X
in	B-X
gene	B-X
transcription	B-X
by	B-X
binding	B-X
to	B-X
TRAF6	B-X
.	B-X

Ran	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
in	I-Gene_or_gene_product
microtubule	I-Gene_or_gene_product
-	I-Gene_or_gene_product
organizing	I-Gene_or_gene_product
center	I-Gene_or_gene_product
(	O
RanBPM	B-Gene_or_gene_product
)	O
has	O
been	O
reported	O
to	O
interact	O
with	O
the	O
neurotrophin	B-Gene_or_gene_product
receptors	O
p75NTR	B-Gene_or_gene_product
and	O
TrkA	B-Gene_or_gene_product
,	O
meanwhile	O
p75NTR	B-Gene_or_gene_product
and	O
TrkA	B-Gene_or_gene_product
can	O
also	O
interact	O
with	O
TRAF6	B-Gene_or_gene_product
.	O
<EOS>	B-X
Ran-binding	B-X
protein	B-X
in	B-X
microtubule-organizing	B-X
center	B-X
(	B-X
RanBPM	B-X
)	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
interact	B-X
with	B-X
the	B-X
neurotrophin	B-X
receptors	B-X
p75NTR	B-X
and	B-X
TrkA	B-X
,	B-X
meanwhile	B-X
p75NTR	B-X
and	B-X
TrkA	B-X
can	B-X
also	B-X
interact	B-X
with	B-X
TRAF6	B-X
.	B-X
Whether	B-X
RanBPM	B-X
interacts	B-X
directly	B-X
with	B-X
TRAF6	B-X
has	B-X
not	B-X
yet	B-X
been	B-X
established	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
using	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
system	B-X
and	B-X
glutathione-S	B-X
:	B-X
-transferase	B-X
pull-down	B-X
assays	B-X
,	B-X
we	B-X
determined	B-X
that	B-X
RanBPM	B-X
binds	B-X
to	B-X
the	B-X
TRAF6	B-X
C-terminus	B-X
through	B-X
its	B-X
SPRY	B-X
motif	B-X
.	B-X
Complex	B-X
formation	B-X
between	B-X
overexpressed	B-X
RanBPM	B-X
and	B-X
TRAF6	B-X
was	B-X
also	B-X
confirmed	B-X
with	B-X
a	B-X
co-immunoprecipitation	B-X
assay	B-X
,	B-X
laser	B-X
scanning	B-X
confocal	B-X
and	B-X
fluorescence	B-X
resonance	B-X
energy	B-X
transfer	B-X
.	B-X
Additional	B-X
co-immunoprecipitation	B-X
experiments	B-X
verified	B-X
that	B-X
endogenous	B-X
RanBPM	B-X
and	B-X
TRAF6	B-X
interact	B-X
in	B-X
several	B-X
mammalian	B-X
cell	B-X
lines	B-X
.	B-X
A	B-X
series	B-X
of	B-X
experiments	B-X
revealed	B-X
that	B-X
RanBPM	B-X
influences	B-X
TRAF6	B-X
ubiquitination	B-X
and	B-X
the	B-X
TRAF6-triggered	B-X
NF-κB	B-X
signaling	B-X
pathway	B-X
through	B-X
RanBPM	B-X
's	B-X
interaction	B-X
with	B-X
TRAF6	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
RanBPM	B-X
participates	B-X
in	B-X
gene	B-X
transcription	B-X
by	B-X
binding	B-X
to	B-X
TRAF6	B-X
.	B-X

Whether	O
RanBPM	B-Gene_or_gene_product
interacts	O
directly	O
with	O
TRAF6	B-Gene_or_gene_product
has	O
not	O
yet	O
been	O
established	O
.	O

In	O
this	O
study	O
,	O
using	O
a	O
yeast	O
two	O
-	O
hybrid	O
system	O
and	O
glutathione	B-Gene_or_gene_product
-	I-Gene_or_gene_product
S	I-Gene_or_gene_product
:	I-Gene_or_gene_product
-	I-Gene_or_gene_product
transferase	I-Gene_or_gene_product
pull	O
-	O
down	O
assays	O
,	O
we	O
determined	O
that	O
RanBPM	B-Gene_or_gene_product
binds	O
to	O
the	O
TRAF6	B-Gene_or_gene_product
C	O
-	O
terminus	O
through	O
its	O
SPRY	O
motif	O
.	O

Complex	O
formation	O
between	O
overexpressed	O
RanBPM	B-Gene_or_gene_product
and	O
TRAF6	B-Gene_or_gene_product
was	O
also	O
confirmed	O
with	O
a	O
co	O
-	O
immunoprecipitation	O
assay	O
,	O
laser	O
scanning	O
confocal	O
and	O
fluorescence	O
resonance	O
energy	O
transfer	O
.	O
<EOS>	B-X
Ran-binding	B-X
protein	B-X
in	B-X
microtubule-organizing	B-X
center	B-X
(	B-X
RanBPM	B-X
)	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
interact	B-X
with	B-X
the	B-X
neurotrophin	B-X
receptors	B-X
p75NTR	B-X
and	B-X
TrkA	B-X
,	B-X
meanwhile	B-X
p75NTR	B-X
and	B-X
TrkA	B-X
can	B-X
also	B-X
interact	B-X
with	B-X
TRAF6	B-X
.	B-X
Whether	B-X
RanBPM	B-X
interacts	B-X
directly	B-X
with	B-X
TRAF6	B-X
has	B-X
not	B-X
yet	B-X
been	B-X
established	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
using	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
system	B-X
and	B-X
glutathione-S	B-X
:	B-X
-transferase	B-X
pull-down	B-X
assays	B-X
,	B-X
we	B-X
determined	B-X
that	B-X
RanBPM	B-X
binds	B-X
to	B-X
the	B-X
TRAF6	B-X
C-terminus	B-X
through	B-X
its	B-X
SPRY	B-X
motif	B-X
.	B-X
Complex	B-X
formation	B-X
between	B-X
overexpressed	B-X
RanBPM	B-X
and	B-X
TRAF6	B-X
was	B-X
also	B-X
confirmed	B-X
with	B-X
a	B-X
co-immunoprecipitation	B-X
assay	B-X
,	B-X
laser	B-X
scanning	B-X
confocal	B-X
and	B-X
fluorescence	B-X
resonance	B-X
energy	B-X
transfer	B-X
.	B-X
Additional	B-X
co-immunoprecipitation	B-X
experiments	B-X
verified	B-X
that	B-X
endogenous	B-X
RanBPM	B-X
and	B-X
TRAF6	B-X
interact	B-X
in	B-X
several	B-X
mammalian	B-X
cell	B-X
lines	B-X
.	B-X
A	B-X
series	B-X
of	B-X
experiments	B-X
revealed	B-X
that	B-X
RanBPM	B-X
influences	B-X
TRAF6	B-X
ubiquitination	B-X
and	B-X
the	B-X
TRAF6-triggered	B-X
NF-κB	B-X
signaling	B-X
pathway	B-X
through	B-X
RanBPM	B-X
's	B-X
interaction	B-X
with	B-X
TRAF6	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
RanBPM	B-X
participates	B-X
in	B-X
gene	B-X
transcription	B-X
by	B-X
binding	B-X
to	B-X
TRAF6	B-X
.	B-X

Additional	O
co	O
-	O
immunoprecipitation	O
experiments	O
verified	O
that	O
endogenous	O
RanBPM	B-Gene_or_gene_product
and	O
TRAF6	B-Gene_or_gene_product
interact	O
in	O
several	O
mammalian	O
cell	O
lines	O
.	O
<EOS>	B-X
Ran-binding	B-X
protein	B-X
in	B-X
microtubule-organizing	B-X
center	B-X
(	B-X
RanBPM	B-X
)	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
interact	B-X
with	B-X
the	B-X
neurotrophin	B-X
receptors	B-X
p75NTR	B-X
and	B-X
TrkA	B-X
,	B-X
meanwhile	B-X
p75NTR	B-X
and	B-X
TrkA	B-X
can	B-X
also	B-X
interact	B-X
with	B-X
TRAF6	B-X
.	B-X
Whether	B-X
RanBPM	B-X
interacts	B-X
directly	B-X
with	B-X
TRAF6	B-X
has	B-X
not	B-X
yet	B-X
been	B-X
established	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
using	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
system	B-X
and	B-X
glutathione-S	B-X
:	B-X
-transferase	B-X
pull-down	B-X
assays	B-X
,	B-X
we	B-X
determined	B-X
that	B-X
RanBPM	B-X
binds	B-X
to	B-X
the	B-X
TRAF6	B-X
C-terminus	B-X
through	B-X
its	B-X
SPRY	B-X
motif	B-X
.	B-X
Complex	B-X
formation	B-X
between	B-X
overexpressed	B-X
RanBPM	B-X
and	B-X
TRAF6	B-X
was	B-X
also	B-X
confirmed	B-X
with	B-X
a	B-X
co-immunoprecipitation	B-X
assay	B-X
,	B-X
laser	B-X
scanning	B-X
confocal	B-X
and	B-X
fluorescence	B-X
resonance	B-X
energy	B-X
transfer	B-X
.	B-X
Additional	B-X
co-immunoprecipitation	B-X
experiments	B-X
verified	B-X
that	B-X
endogenous	B-X
RanBPM	B-X
and	B-X
TRAF6	B-X
interact	B-X
in	B-X
several	B-X
mammalian	B-X
cell	B-X
lines	B-X
.	B-X
A	B-X
series	B-X
of	B-X
experiments	B-X
revealed	B-X
that	B-X
RanBPM	B-X
influences	B-X
TRAF6	B-X
ubiquitination	B-X
and	B-X
the	B-X
TRAF6-triggered	B-X
NF-κB	B-X
signaling	B-X
pathway	B-X
through	B-X
RanBPM	B-X
's	B-X
interaction	B-X
with	B-X
TRAF6	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
RanBPM	B-X
participates	B-X
in	B-X
gene	B-X
transcription	B-X
by	B-X
binding	B-X
to	B-X
TRAF6	B-X
.	B-X

A	O
series	O
of	O
experiments	O
revealed	O
that	O
RanBPM	B-Gene_or_gene_product
influences	O
TRAF6	B-Gene_or_gene_product
ubiquitination	O
and	O
the	O
TRAF6	B-Gene_or_gene_product
-	O
triggered	O
NF	O
-	O
kappaB	O
signaling	O
pathway	O
through	O
RanBPM	B-Gene_or_gene_product
'	O
s	O
interaction	O
with	O
TRAF6	B-Gene_or_gene_product
.	O
<EOS>	B-X
Ran-binding	B-X
protein	B-X
in	B-X
microtubule-organizing	B-X
center	B-X
(	B-X
RanBPM	B-X
)	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
interact	B-X
with	B-X
the	B-X
neurotrophin	B-X
receptors	B-X
p75NTR	B-X
and	B-X
TrkA	B-X
,	B-X
meanwhile	B-X
p75NTR	B-X
and	B-X
TrkA	B-X
can	B-X
also	B-X
interact	B-X
with	B-X
TRAF6	B-X
.	B-X
Whether	B-X
RanBPM	B-X
interacts	B-X
directly	B-X
with	B-X
TRAF6	B-X
has	B-X
not	B-X
yet	B-X
been	B-X
established	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
using	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
system	B-X
and	B-X
glutathione-S	B-X
:	B-X
-transferase	B-X
pull-down	B-X
assays	B-X
,	B-X
we	B-X
determined	B-X
that	B-X
RanBPM	B-X
binds	B-X
to	B-X
the	B-X
TRAF6	B-X
C-terminus	B-X
through	B-X
its	B-X
SPRY	B-X
motif	B-X
.	B-X
Complex	B-X
formation	B-X
between	B-X
overexpressed	B-X
RanBPM	B-X
and	B-X
TRAF6	B-X
was	B-X
also	B-X
confirmed	B-X
with	B-X
a	B-X
co-immunoprecipitation	B-X
assay	B-X
,	B-X
laser	B-X
scanning	B-X
confocal	B-X
and	B-X
fluorescence	B-X
resonance	B-X
energy	B-X
transfer	B-X
.	B-X
Additional	B-X
co-immunoprecipitation	B-X
experiments	B-X
verified	B-X
that	B-X
endogenous	B-X
RanBPM	B-X
and	B-X
TRAF6	B-X
interact	B-X
in	B-X
several	B-X
mammalian	B-X
cell	B-X
lines	B-X
.	B-X
A	B-X
series	B-X
of	B-X
experiments	B-X
revealed	B-X
that	B-X
RanBPM	B-X
influences	B-X
TRAF6	B-X
ubiquitination	B-X
and	B-X
the	B-X
TRAF6-triggered	B-X
NF-κB	B-X
signaling	B-X
pathway	B-X
through	B-X
RanBPM	B-X
's	B-X
interaction	B-X
with	B-X
TRAF6	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
RanBPM	B-X
participates	B-X
in	B-X
gene	B-X
transcription	B-X
by	B-X
binding	B-X
to	B-X
TRAF6	B-X
.	B-X

These	O
data	O
suggest	O
that	O
RanBPM	B-Gene_or_gene_product
participates	O
in	O
gene	O
transcription	O
by	O
binding	O
to	O
TRAF6	B-Gene_or_gene_product
.	O
<EOS>	B-X
Ran-binding	B-X
protein	B-X
in	B-X
microtubule-organizing	B-X
center	B-X
(	B-X
RanBPM	B-X
)	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
interact	B-X
with	B-X
the	B-X
neurotrophin	B-X
receptors	B-X
p75NTR	B-X
and	B-X
TrkA	B-X
,	B-X
meanwhile	B-X
p75NTR	B-X
and	B-X
TrkA	B-X
can	B-X
also	B-X
interact	B-X
with	B-X
TRAF6	B-X
.	B-X
Whether	B-X
RanBPM	B-X
interacts	B-X
directly	B-X
with	B-X
TRAF6	B-X
has	B-X
not	B-X
yet	B-X
been	B-X
established	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
using	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
system	B-X
and	B-X
glutathione-S	B-X
:	B-X
-transferase	B-X
pull-down	B-X
assays	B-X
,	B-X
we	B-X
determined	B-X
that	B-X
RanBPM	B-X
binds	B-X
to	B-X
the	B-X
TRAF6	B-X
C-terminus	B-X
through	B-X
its	B-X
SPRY	B-X
motif	B-X
.	B-X
Complex	B-X
formation	B-X
between	B-X
overexpressed	B-X
RanBPM	B-X
and	B-X
TRAF6	B-X
was	B-X
also	B-X
confirmed	B-X
with	B-X
a	B-X
co-immunoprecipitation	B-X
assay	B-X
,	B-X
laser	B-X
scanning	B-X
confocal	B-X
and	B-X
fluorescence	B-X
resonance	B-X
energy	B-X
transfer	B-X
.	B-X
Additional	B-X
co-immunoprecipitation	B-X
experiments	B-X
verified	B-X
that	B-X
endogenous	B-X
RanBPM	B-X
and	B-X
TRAF6	B-X
interact	B-X
in	B-X
several	B-X
mammalian	B-X
cell	B-X
lines	B-X
.	B-X
A	B-X
series	B-X
of	B-X
experiments	B-X
revealed	B-X
that	B-X
RanBPM	B-X
influences	B-X
TRAF6	B-X
ubiquitination	B-X
and	B-X
the	B-X
TRAF6-triggered	B-X
NF-κB	B-X
signaling	B-X
pathway	B-X
through	B-X
RanBPM	B-X
's	B-X
interaction	B-X
with	B-X
TRAF6	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
RanBPM	B-X
participates	B-X
in	B-X
gene	B-X
transcription	B-X
by	B-X
binding	B-X
to	B-X
TRAF6	B-X
.	B-X

Involvement	O
of	O
JNK	B-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
pathways	O
in	O
lipopolysaccharide	O
(	O
LPS	O
)	O
-	O
induced	O
BAG3	B-Gene_or_gene_product
expression	O
in	O
human	O
monocytic	O
cells	O
.	O
<EOS>	B-X
Lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
is	B-X
an	B-X
outer-membrane	B-X
glycolipid	B-X
component	B-X
of	B-X
Gram-negative	B-X
bacteria	B-X
known	B-X
for	B-X
its	B-X
fervent	B-X
ability	B-X
to	B-X
activate	B-X
monocytic	B-X
cells	B-X
and	B-X
for	B-X
its	B-X
potent	B-X
proinflammatory	B-X
capabilities	B-X
.	B-X
Bcl-2-associated	B-X
athanogene	B-X
3	B-X
(	B-X
BAG3	B-X
)	B-X
is	B-X
a	B-X
survival	B-X
protein	B-X
that	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
stimulated	B-X
during	B-X
cell	B-X
response	B-X
to	B-X
stressful	B-X
conditions	B-X
,	B-X
such	B-X
as	B-X
exposure	B-X
to	B-X
high	B-X
temperature	B-X
,	B-X
heavy	B-X
metals	B-X
,	B-X
proteasome	B-X
inhibition	B-X
,	B-X
and	B-X
human	B-X
immunodeficiency	B-X
virus	B-X
1	B-X
(	B-X
HIV-1	B-X
)	B-X
infection	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
BAG3	B-X
regulates	B-X
replication	B-X
of	B-X
Varicella-Zoster	B-X
Virus	B-X
(	B-X
VZV	B-X
)	B-X
and	B-X
Herpes	B-X
Simplex	B-X
Virus	B-X
(	B-X
HSV	B-X
)	B-X
replication	B-X
,	B-X
suggesting	B-X
that	B-X
BAG3	B-X
could	B-X
participate	B-X
in	B-X
the	B-X
host	B-X
response	B-X
to	B-X
infection	B-X
.	B-X
In	B-X
the	B-X
current	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
LPS	B-X
increased	B-X
the	B-X
expression	B-X
of	B-X
BAG3	B-X
in	B-X
a	B-X
dose-	B-X
and	B-X
time-dependent	B-X
manner	B-X
.	B-X
Actinomycin	B-X
D	B-X
completely	B-X
blocked	B-X
the	B-X
LPS-induced	B-X
BAG3	B-X
accumulation	B-X
,	B-X
as	B-X
well	B-X
as	B-X
LPS	B-X
activated	B-X
the	B-X
proximal	B-X
promoter	B-X
of	B-X
BAG3	B-X
gene	B-X
,	B-X
supported	B-X
that	B-X
the	B-X
induction	B-X
by	B-X
LPS	B-X
occurred	B-X
at	B-X
the	B-X
level	B-X
of	B-X
gene	B-X
transcription	B-X
.	B-X
LPS-induced	B-X
BAG3	B-X
expression	B-X
was	B-X
blocked	B-X
by	B-X
JNK	B-X
or	B-X
NF-κB	B-X
inhibition	B-X
,	B-X
suggesting	B-X
that	B-X
JNK	B-X
and	B-X
NF-κB	B-X
pathways	B-X
participated	B-X
in	B-X
BAG3	B-X
induction	B-X
by	B-X
LPS	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
also	B-X
found	B-X
that	B-X
induction	B-X
of	B-X
BAG3	B-X
was	B-X
implicated	B-X
in	B-X
monocytic	B-X
cell	B-X
adhesion	B-X
to	B-X
extracellular	B-X
matrix	B-X
induced	B-X
by	B-X
LPS	B-X
.	B-X
Overall	B-X
,	B-X
the	B-X
data	B-X
support	B-X
that	B-X
BAG3	B-X
is	B-X
induced	B-X
by	B-X
LPS	B-X
via	B-X
JNK	B-X
and	B-X
NF-κB-dependent	B-X
signals	B-X
,	B-X
and	B-X
involved	B-X
in	B-X
monocytic	B-X
cell-extracellular	B-X
matrix	B-X
interaction	B-X
,	B-X
suggesting	B-X
that	B-X
BAG3	B-X
may	B-X
have	B-X
a	B-X
role	B-X
in	B-X
the	B-X
host	B-X
response	B-X
to	B-X
LPS	B-X
stimulation	B-X
.	B-X

Lipopolysaccharide	O
(	O
LPS	O
)	O
is	O
an	O
outer	O
-	O
membrane	O
glycolipid	O
component	O
of	O
Gram	O
-	O
negative	O
bacteria	O
known	O
for	O
its	O
fervent	O
ability	O
to	O
activate	O
monocytic	O
cells	O
and	O
for	O
its	O
potent	O
proinflammatory	O
capabilities	O
.	O
<EOS>	B-X
Lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
is	B-X
an	B-X
outer-membrane	B-X
glycolipid	B-X
component	B-X
of	B-X
Gram-negative	B-X
bacteria	B-X
known	B-X
for	B-X
its	B-X
fervent	B-X
ability	B-X
to	B-X
activate	B-X
monocytic	B-X
cells	B-X
and	B-X
for	B-X
its	B-X
potent	B-X
proinflammatory	B-X
capabilities	B-X
.	B-X
In	B-X
the	B-X
current	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
LPS	B-X
increased	B-X
the	B-X
expression	B-X
of	B-X
BAG3	B-X
in	B-X
a	B-X
dose-	B-X
and	B-X
time-dependent	B-X
manner	B-X
.	B-X
Actinomycin	B-X
D	B-X
completely	B-X
blocked	B-X
the	B-X
LPS-induced	B-X
BAG3	B-X
accumulation	B-X
,	B-X
as	B-X
well	B-X
as	B-X
LPS	B-X
activated	B-X
the	B-X
proximal	B-X
promoter	B-X
of	B-X
BAG3	B-X
gene	B-X
,	B-X
supported	B-X
that	B-X
the	B-X
induction	B-X
by	B-X
LPS	B-X
occurred	B-X
at	B-X
the	B-X
level	B-X
of	B-X
gene	B-X
transcription	B-X
.	B-X
LPS-induced	B-X
BAG3	B-X
expression	B-X
was	B-X
blocked	B-X
by	B-X
JNK	B-X
or	B-X
NF-κB	B-X
inhibition	B-X
,	B-X
suggesting	B-X
that	B-X
JNK	B-X
and	B-X
NF-κB	B-X
pathways	B-X
participated	B-X
in	B-X
BAG3	B-X
induction	B-X
by	B-X
LPS	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
also	B-X
found	B-X
that	B-X
induction	B-X
of	B-X
BAG3	B-X
was	B-X
implicated	B-X
in	B-X
monocytic	B-X
cell	B-X
adhesion	B-X
to	B-X
extracellular	B-X
matrix	B-X
induced	B-X
by	B-X
LPS	B-X
.	B-X
Overall	B-X
,	B-X
the	B-X
data	B-X
support	B-X
that	B-X
BAG3	B-X
is	B-X
induced	B-X
by	B-X
LPS	B-X
via	B-X
JNK	B-X
and	B-X
NF-κB-dependent	B-X
signals	B-X
,	B-X
and	B-X
involved	B-X
in	B-X
monocytic	B-X
cell-extracellular	B-X
matrix	B-X
interaction	B-X
,	B-X
suggesting	B-X
that	B-X
BAG3	B-X
may	B-X
have	B-X
a	B-X
role	B-X
in	B-X
the	B-X
host	B-X
response	B-X
to	B-X
LPS	B-X
stimulation	B-X
.	B-X

Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
athanogene	I-Gene_or_gene_product
3	I-Gene_or_gene_product
(	O
BAG3	B-Gene_or_gene_product
)	O
is	O
a	O
survival	O
protein	O
that	O
has	O
been	O
shown	O
to	O
be	O
stimulated	O
during	O
cell	O
response	O
to	O
stressful	O
conditions	O
,	O
such	O
as	O
exposure	O
to	O
high	O
temperature	O
,	O
heavy	O
metals	O
,	O
proteasome	O
inhibition	O
,	O
and	O
human	O
immunodeficiency	O
virus	O
1	O
(	O
HIV	O
-	O
1	O
)	O
infection	O
.	O
<EOS>	B-X
Lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
is	B-X
an	B-X
outer-membrane	B-X
glycolipid	B-X
component	B-X
of	B-X
Gram-negative	B-X
bacteria	B-X
known	B-X
for	B-X
its	B-X
fervent	B-X
ability	B-X
to	B-X
activate	B-X
monocytic	B-X
cells	B-X
and	B-X
for	B-X
its	B-X
potent	B-X
proinflammatory	B-X
capabilities	B-X
.	B-X
Bcl-2-associated	B-X
athanogene	B-X
3	B-X
(	B-X
BAG3	B-X
)	B-X
is	B-X
a	B-X
survival	B-X
protein	B-X
that	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
stimulated	B-X
during	B-X
cell	B-X
response	B-X
to	B-X
stressful	B-X
conditions	B-X
,	B-X
such	B-X
as	B-X
exposure	B-X
to	B-X
high	B-X
temperature	B-X
,	B-X
heavy	B-X
metals	B-X
,	B-X
proteasome	B-X
inhibition	B-X
,	B-X
and	B-X
human	B-X
immunodeficiency	B-X
virus	B-X
1	B-X
(	B-X
HIV-1	B-X
)	B-X
infection	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
BAG3	B-X
regulates	B-X
replication	B-X
of	B-X
Varicella-Zoster	B-X
Virus	B-X
(	B-X
VZV	B-X
)	B-X
and	B-X
Herpes	B-X
Simplex	B-X
Virus	B-X
(	B-X
HSV	B-X
)	B-X
replication	B-X
,	B-X
suggesting	B-X
that	B-X
BAG3	B-X
could	B-X
participate	B-X
in	B-X
the	B-X
host	B-X
response	B-X
to	B-X
infection	B-X
.	B-X
In	B-X
the	B-X
current	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
LPS	B-X
increased	B-X
the	B-X
expression	B-X
of	B-X
BAG3	B-X
in	B-X
a	B-X
dose-	B-X
and	B-X
time-dependent	B-X
manner	B-X
.	B-X
Actinomycin	B-X
D	B-X
completely	B-X
blocked	B-X
the	B-X
LPS-induced	B-X
BAG3	B-X
accumulation	B-X
,	B-X
as	B-X
well	B-X
as	B-X
LPS	B-X
activated	B-X
the	B-X
proximal	B-X
promoter	B-X
of	B-X
BAG3	B-X
gene	B-X
,	B-X
supported	B-X
that	B-X
the	B-X
induction	B-X
by	B-X
LPS	B-X
occurred	B-X
at	B-X
the	B-X
level	B-X
of	B-X
gene	B-X
transcription	B-X
.	B-X
LPS-induced	B-X
BAG3	B-X
expression	B-X
was	B-X
blocked	B-X
by	B-X
JNK	B-X
or	B-X
NF-κB	B-X
inhibition	B-X
,	B-X
suggesting	B-X
that	B-X
JNK	B-X
and	B-X
NF-κB	B-X
pathways	B-X
participated	B-X
in	B-X
BAG3	B-X
induction	B-X
by	B-X
LPS	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
also	B-X
found	B-X
that	B-X
induction	B-X
of	B-X
BAG3	B-X
was	B-X
implicated	B-X
in	B-X
monocytic	B-X
cell	B-X
adhesion	B-X
to	B-X
extracellular	B-X
matrix	B-X
induced	B-X
by	B-X
LPS	B-X
.	B-X
Overall	B-X
,	B-X
the	B-X
data	B-X
support	B-X
that	B-X
BAG3	B-X
is	B-X
induced	B-X
by	B-X
LPS	B-X
via	B-X
JNK	B-X
and	B-X
NF-κB-dependent	B-X
signals	B-X
,	B-X
and	B-X
involved	B-X
in	B-X
monocytic	B-X
cell-extracellular	B-X
matrix	B-X
interaction	B-X
,	B-X
suggesting	B-X
that	B-X
BAG3	B-X
may	B-X
have	B-X
a	B-X
role	B-X
in	B-X
the	B-X
host	B-X
response	B-X
to	B-X
LPS	B-X
stimulation	B-X
.	B-X

In	O
addition	O
,	O
BAG3	B-Gene_or_gene_product
regulates	O
replication	O
of	O
Varicella	O
-	O
Zoster	O
Virus	O
(	O
VZV	O
)	O
and	O
Herpes	O
Simplex	O
Virus	O
(	O
HSV	O
)	O
replication	O
,	O
suggesting	O
that	O
BAG3	B-Gene_or_gene_product
could	O
participate	O
in	O
the	O
host	O
response	O
to	O
infection	O
.	O
<EOS>	B-X
Bcl-2-associated	B-X
athanogene	B-X
3	B-X
(	B-X
BAG3	B-X
)	B-X
is	B-X
a	B-X
survival	B-X
protein	B-X
that	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
stimulated	B-X
during	B-X
cell	B-X
response	B-X
to	B-X
stressful	B-X
conditions	B-X
,	B-X
such	B-X
as	B-X
exposure	B-X
to	B-X
high	B-X
temperature	B-X
,	B-X
heavy	B-X
metals	B-X
,	B-X
proteasome	B-X
inhibition	B-X
,	B-X
and	B-X
human	B-X
immunodeficiency	B-X
virus	B-X
1	B-X
(	B-X
HIV-1	B-X
)	B-X
infection	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
BAG3	B-X
regulates	B-X
replication	B-X
of	B-X
Varicella-Zoster	B-X
Virus	B-X
(	B-X
VZV	B-X
)	B-X
and	B-X
Herpes	B-X
Simplex	B-X
Virus	B-X
(	B-X
HSV	B-X
)	B-X
replication	B-X
,	B-X
suggesting	B-X
that	B-X
BAG3	B-X
could	B-X
participate	B-X
in	B-X
the	B-X
host	B-X
response	B-X
to	B-X
infection	B-X
.	B-X
In	B-X
the	B-X
current	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
LPS	B-X
increased	B-X
the	B-X
expression	B-X
of	B-X
BAG3	B-X
in	B-X
a	B-X
dose-	B-X
and	B-X
time-dependent	B-X
manner	B-X
.	B-X
Actinomycin	B-X
D	B-X
completely	B-X
blocked	B-X
the	B-X
LPS-induced	B-X
BAG3	B-X
accumulation	B-X
,	B-X
as	B-X
well	B-X
as	B-X
LPS	B-X
activated	B-X
the	B-X
proximal	B-X
promoter	B-X
of	B-X
BAG3	B-X
gene	B-X
,	B-X
supported	B-X
that	B-X
the	B-X
induction	B-X
by	B-X
LPS	B-X
occurred	B-X
at	B-X
the	B-X
level	B-X
of	B-X
gene	B-X
transcription	B-X
.	B-X
LPS-induced	B-X
BAG3	B-X
expression	B-X
was	B-X
blocked	B-X
by	B-X
JNK	B-X
or	B-X
NF-κB	B-X
inhibition	B-X
,	B-X
suggesting	B-X
that	B-X
JNK	B-X
and	B-X
NF-κB	B-X
pathways	B-X
participated	B-X
in	B-X
BAG3	B-X
induction	B-X
by	B-X
LPS	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
also	B-X
found	B-X
that	B-X
induction	B-X
of	B-X
BAG3	B-X
was	B-X
implicated	B-X
in	B-X
monocytic	B-X
cell	B-X
adhesion	B-X
to	B-X
extracellular	B-X
matrix	B-X
induced	B-X
by	B-X
LPS	B-X
.	B-X
Overall	B-X
,	B-X
the	B-X
data	B-X
support	B-X
that	B-X
BAG3	B-X
is	B-X
induced	B-X
by	B-X
LPS	B-X
via	B-X
JNK	B-X
and	B-X
NF-κB-dependent	B-X
signals	B-X
,	B-X
and	B-X
involved	B-X
in	B-X
monocytic	B-X
cell-extracellular	B-X
matrix	B-X
interaction	B-X
,	B-X
suggesting	B-X
that	B-X
BAG3	B-X
may	B-X
have	B-X
a	B-X
role	B-X
in	B-X
the	B-X
host	B-X
response	B-X
to	B-X
LPS	B-X
stimulation	B-X
.	B-X

In	O
the	O
current	O
study	O
,	O
we	O
found	O
that	O
LPS	O
increased	O
the	O
expression	O
of	O
BAG3	B-Gene_or_gene_product
in	O
a	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manner	O
.	O

Actinomycin	O
D	O
completely	O
blocked	O
the	O
LPS	O
-	O
induced	O
BAG3	B-Gene_or_gene_product
accumulation	O
,	O
as	O
well	O
as	O
LPS	O
activated	O
the	O
proximal	O
promoter	O
of	O
BAG3	B-Gene_or_gene_product
gene	O
,	O
supported	O
that	O
the	O
induction	O
by	O
LPS	O
occurred	O
at	O
the	O
level	O
of	O
gene	O
transcription	O
.	O
<EOS>	B-X
Lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
is	B-X
an	B-X
outer-membrane	B-X
glycolipid	B-X
component	B-X
of	B-X
Gram-negative	B-X
bacteria	B-X
known	B-X
for	B-X
its	B-X
fervent	B-X
ability	B-X
to	B-X
activate	B-X
monocytic	B-X
cells	B-X
and	B-X
for	B-X
its	B-X
potent	B-X
proinflammatory	B-X
capabilities	B-X
.	B-X
Bcl-2-associated	B-X
athanogene	B-X
3	B-X
(	B-X
BAG3	B-X
)	B-X
is	B-X
a	B-X
survival	B-X
protein	B-X
that	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
stimulated	B-X
during	B-X
cell	B-X
response	B-X
to	B-X
stressful	B-X
conditions	B-X
,	B-X
such	B-X
as	B-X
exposure	B-X
to	B-X
high	B-X
temperature	B-X
,	B-X
heavy	B-X
metals	B-X
,	B-X
proteasome	B-X
inhibition	B-X
,	B-X
and	B-X
human	B-X
immunodeficiency	B-X
virus	B-X
1	B-X
(	B-X
HIV-1	B-X
)	B-X
infection	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
BAG3	B-X
regulates	B-X
replication	B-X
of	B-X
Varicella-Zoster	B-X
Virus	B-X
(	B-X
VZV	B-X
)	B-X
and	B-X
Herpes	B-X
Simplex	B-X
Virus	B-X
(	B-X
HSV	B-X
)	B-X
replication	B-X
,	B-X
suggesting	B-X
that	B-X
BAG3	B-X
could	B-X
participate	B-X
in	B-X
the	B-X
host	B-X
response	B-X
to	B-X
infection	B-X
.	B-X
In	B-X
the	B-X
current	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
LPS	B-X
increased	B-X
the	B-X
expression	B-X
of	B-X
BAG3	B-X
in	B-X
a	B-X
dose-	B-X
and	B-X
time-dependent	B-X
manner	B-X
.	B-X
Actinomycin	B-X
D	B-X
completely	B-X
blocked	B-X
the	B-X
LPS-induced	B-X
BAG3	B-X
accumulation	B-X
,	B-X
as	B-X
well	B-X
as	B-X
LPS	B-X
activated	B-X
the	B-X
proximal	B-X
promoter	B-X
of	B-X
BAG3	B-X
gene	B-X
,	B-X
supported	B-X
that	B-X
the	B-X
induction	B-X
by	B-X
LPS	B-X
occurred	B-X
at	B-X
the	B-X
level	B-X
of	B-X
gene	B-X
transcription	B-X
.	B-X
LPS-induced	B-X
BAG3	B-X
expression	B-X
was	B-X
blocked	B-X
by	B-X
JNK	B-X
or	B-X
NF-κB	B-X
inhibition	B-X
,	B-X
suggesting	B-X
that	B-X
JNK	B-X
and	B-X
NF-κB	B-X
pathways	B-X
participated	B-X
in	B-X
BAG3	B-X
induction	B-X
by	B-X
LPS	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
also	B-X
found	B-X
that	B-X
induction	B-X
of	B-X
BAG3	B-X
was	B-X
implicated	B-X
in	B-X
monocytic	B-X
cell	B-X
adhesion	B-X
to	B-X
extracellular	B-X
matrix	B-X
induced	B-X
by	B-X
LPS	B-X
.	B-X
Overall	B-X
,	B-X
the	B-X
data	B-X
support	B-X
that	B-X
BAG3	B-X
is	B-X
induced	B-X
by	B-X
LPS	B-X
via	B-X
JNK	B-X
and	B-X
NF-κB-dependent	B-X
signals	B-X
,	B-X
and	B-X
involved	B-X
in	B-X
monocytic	B-X
cell-extracellular	B-X
matrix	B-X
interaction	B-X
,	B-X
suggesting	B-X
that	B-X
BAG3	B-X
may	B-X
have	B-X
a	B-X
role	B-X
in	B-X
the	B-X
host	B-X
response	B-X
to	B-X
LPS	B-X
stimulation	B-X
.	B-X

LPS	O
-	O
induced	O
BAG3	B-Gene_or_gene_product
expression	O
was	O
blocked	O
by	O
JNK	B-Gene_or_gene_product
or	O
NF	O
-	O
kappaB	O
inhibition	O
,	O
suggesting	O
that	O
JNK	B-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
pathways	O
participated	O
in	O
BAG3	B-Gene_or_gene_product
induction	O
by	O
LPS	O
.	O
<EOS>	B-X
Lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
is	B-X
an	B-X
outer-membrane	B-X
glycolipid	B-X
component	B-X
of	B-X
Gram-negative	B-X
bacteria	B-X
known	B-X
for	B-X
its	B-X
fervent	B-X
ability	B-X
to	B-X
activate	B-X
monocytic	B-X
cells	B-X
and	B-X
for	B-X
its	B-X
potent	B-X
proinflammatory	B-X
capabilities	B-X
.	B-X
Bcl-2-associated	B-X
athanogene	B-X
3	B-X
(	B-X
BAG3	B-X
)	B-X
is	B-X
a	B-X
survival	B-X
protein	B-X
that	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
stimulated	B-X
during	B-X
cell	B-X
response	B-X
to	B-X
stressful	B-X
conditions	B-X
,	B-X
such	B-X
as	B-X
exposure	B-X
to	B-X
high	B-X
temperature	B-X
,	B-X
heavy	B-X
metals	B-X
,	B-X
proteasome	B-X
inhibition	B-X
,	B-X
and	B-X
human	B-X
immunodeficiency	B-X
virus	B-X
1	B-X
(	B-X
HIV-1	B-X
)	B-X
infection	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
BAG3	B-X
regulates	B-X
replication	B-X
of	B-X
Varicella-Zoster	B-X
Virus	B-X
(	B-X
VZV	B-X
)	B-X
and	B-X
Herpes	B-X
Simplex	B-X
Virus	B-X
(	B-X
HSV	B-X
)	B-X
replication	B-X
,	B-X
suggesting	B-X
that	B-X
BAG3	B-X
could	B-X
participate	B-X
in	B-X
the	B-X
host	B-X
response	B-X
to	B-X
infection	B-X
.	B-X
In	B-X
the	B-X
current	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
LPS	B-X
increased	B-X
the	B-X
expression	B-X
of	B-X
BAG3	B-X
in	B-X
a	B-X
dose-	B-X
and	B-X
time-dependent	B-X
manner	B-X
.	B-X
Actinomycin	B-X
D	B-X
completely	B-X
blocked	B-X
the	B-X
LPS-induced	B-X
BAG3	B-X
accumulation	B-X
,	B-X
as	B-X
well	B-X
as	B-X
LPS	B-X
activated	B-X
the	B-X
proximal	B-X
promoter	B-X
of	B-X
BAG3	B-X
gene	B-X
,	B-X
supported	B-X
that	B-X
the	B-X
induction	B-X
by	B-X
LPS	B-X
occurred	B-X
at	B-X
the	B-X
level	B-X
of	B-X
gene	B-X
transcription	B-X
.	B-X
LPS-induced	B-X
BAG3	B-X
expression	B-X
was	B-X
blocked	B-X
by	B-X
JNK	B-X
or	B-X
NF-κB	B-X
inhibition	B-X
,	B-X
suggesting	B-X
that	B-X
JNK	B-X
and	B-X
NF-κB	B-X
pathways	B-X
participated	B-X
in	B-X
BAG3	B-X
induction	B-X
by	B-X
LPS	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
also	B-X
found	B-X
that	B-X
induction	B-X
of	B-X
BAG3	B-X
was	B-X
implicated	B-X
in	B-X
monocytic	B-X
cell	B-X
adhesion	B-X
to	B-X
extracellular	B-X
matrix	B-X
induced	B-X
by	B-X
LPS	B-X
.	B-X
Overall	B-X
,	B-X
the	B-X
data	B-X
support	B-X
that	B-X
BAG3	B-X
is	B-X
induced	B-X
by	B-X
LPS	B-X
via	B-X
JNK	B-X
and	B-X
NF-κB-dependent	B-X
signals	B-X
,	B-X
and	B-X
involved	B-X
in	B-X
monocytic	B-X
cell-extracellular	B-X
matrix	B-X
interaction	B-X
,	B-X
suggesting	B-X
that	B-X
BAG3	B-X
may	B-X
have	B-X
a	B-X
role	B-X
in	B-X
the	B-X
host	B-X
response	B-X
to	B-X
LPS	B-X
stimulation	B-X
.	B-X

In	O
addition	O
,	O
we	O
also	O
found	O
that	O
induction	O
of	O
BAG3	B-Gene_or_gene_product
was	O
implicated	O
in	O
monocytic	O
cell	O
adhesion	O
to	O
extracellular	O
matrix	O
induced	O
by	O
LPS	O
.	O
<EOS>	B-X
Lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
is	B-X
an	B-X
outer-membrane	B-X
glycolipid	B-X
component	B-X
of	B-X
Gram-negative	B-X
bacteria	B-X
known	B-X
for	B-X
its	B-X
fervent	B-X
ability	B-X
to	B-X
activate	B-X
monocytic	B-X
cells	B-X
and	B-X
for	B-X
its	B-X
potent	B-X
proinflammatory	B-X
capabilities	B-X
.	B-X
Bcl-2-associated	B-X
athanogene	B-X
3	B-X
(	B-X
BAG3	B-X
)	B-X
is	B-X
a	B-X
survival	B-X
protein	B-X
that	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
stimulated	B-X
during	B-X
cell	B-X
response	B-X
to	B-X
stressful	B-X
conditions	B-X
,	B-X
such	B-X
as	B-X
exposure	B-X
to	B-X
high	B-X
temperature	B-X
,	B-X
heavy	B-X
metals	B-X
,	B-X
proteasome	B-X
inhibition	B-X
,	B-X
and	B-X
human	B-X
immunodeficiency	B-X
virus	B-X
1	B-X
(	B-X
HIV-1	B-X
)	B-X
infection	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
BAG3	B-X
regulates	B-X
replication	B-X
of	B-X
Varicella-Zoster	B-X
Virus	B-X
(	B-X
VZV	B-X
)	B-X
and	B-X
Herpes	B-X
Simplex	B-X
Virus	B-X
(	B-X
HSV	B-X
)	B-X
replication	B-X
,	B-X
suggesting	B-X
that	B-X
BAG3	B-X
could	B-X
participate	B-X
in	B-X
the	B-X
host	B-X
response	B-X
to	B-X
infection	B-X
.	B-X
In	B-X
the	B-X
current	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
LPS	B-X
increased	B-X
the	B-X
expression	B-X
of	B-X
BAG3	B-X
in	B-X
a	B-X
dose-	B-X
and	B-X
time-dependent	B-X
manner	B-X
.	B-X
Actinomycin	B-X
D	B-X
completely	B-X
blocked	B-X
the	B-X
LPS-induced	B-X
BAG3	B-X
accumulation	B-X
,	B-X
as	B-X
well	B-X
as	B-X
LPS	B-X
activated	B-X
the	B-X
proximal	B-X
promoter	B-X
of	B-X
BAG3	B-X
gene	B-X
,	B-X
supported	B-X
that	B-X
the	B-X
induction	B-X
by	B-X
LPS	B-X
occurred	B-X
at	B-X
the	B-X
level	B-X
of	B-X
gene	B-X
transcription	B-X
.	B-X
LPS-induced	B-X
BAG3	B-X
expression	B-X
was	B-X
blocked	B-X
by	B-X
JNK	B-X
or	B-X
NF-κB	B-X
inhibition	B-X
,	B-X
suggesting	B-X
that	B-X
JNK	B-X
and	B-X
NF-κB	B-X
pathways	B-X
participated	B-X
in	B-X
BAG3	B-X
induction	B-X
by	B-X
LPS	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
also	B-X
found	B-X
that	B-X
induction	B-X
of	B-X
BAG3	B-X
was	B-X
implicated	B-X
in	B-X
monocytic	B-X
cell	B-X
adhesion	B-X
to	B-X
extracellular	B-X
matrix	B-X
induced	B-X
by	B-X
LPS	B-X
.	B-X
Overall	B-X
,	B-X
the	B-X
data	B-X
support	B-X
that	B-X
BAG3	B-X
is	B-X
induced	B-X
by	B-X
LPS	B-X
via	B-X
JNK	B-X
and	B-X
NF-κB-dependent	B-X
signals	B-X
,	B-X
and	B-X
involved	B-X
in	B-X
monocytic	B-X
cell-extracellular	B-X
matrix	B-X
interaction	B-X
,	B-X
suggesting	B-X
that	B-X
BAG3	B-X
may	B-X
have	B-X
a	B-X
role	B-X
in	B-X
the	B-X
host	B-X
response	B-X
to	B-X
LPS	B-X
stimulation	B-X
.	B-X

Overall	O
,	O
the	O
data	O
support	O
that	O
BAG3	B-Gene_or_gene_product
is	O
induced	O
by	O
LPS	O
via	O
JNK	B-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
-	O
dependent	O
signals	O
,	O
and	O
involved	O
in	O
monocytic	O
cell	O
-	O
extracellular	O
matrix	O
interaction	O
,	O
suggesting	O
that	O
BAG3	B-Gene_or_gene_product
may	O
have	O
a	O
role	O
in	O
the	O
host	O
response	O
to	O
LPS	O
stimulation	O
.	O
<EOS>	B-X
Lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
is	B-X
an	B-X
outer-membrane	B-X
glycolipid	B-X
component	B-X
of	B-X
Gram-negative	B-X
bacteria	B-X
known	B-X
for	B-X
its	B-X
fervent	B-X
ability	B-X
to	B-X
activate	B-X
monocytic	B-X
cells	B-X
and	B-X
for	B-X
its	B-X
potent	B-X
proinflammatory	B-X
capabilities	B-X
.	B-X
Bcl-2-associated	B-X
athanogene	B-X
3	B-X
(	B-X
BAG3	B-X
)	B-X
is	B-X
a	B-X
survival	B-X
protein	B-X
that	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
stimulated	B-X
during	B-X
cell	B-X
response	B-X
to	B-X
stressful	B-X
conditions	B-X
,	B-X
such	B-X
as	B-X
exposure	B-X
to	B-X
high	B-X
temperature	B-X
,	B-X
heavy	B-X
metals	B-X
,	B-X
proteasome	B-X
inhibition	B-X
,	B-X
and	B-X
human	B-X
immunodeficiency	B-X
virus	B-X
1	B-X
(	B-X
HIV-1	B-X
)	B-X
infection	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
BAG3	B-X
regulates	B-X
replication	B-X
of	B-X
Varicella-Zoster	B-X
Virus	B-X
(	B-X
VZV	B-X
)	B-X
and	B-X
Herpes	B-X
Simplex	B-X
Virus	B-X
(	B-X
HSV	B-X
)	B-X
replication	B-X
,	B-X
suggesting	B-X
that	B-X
BAG3	B-X
could	B-X
participate	B-X
in	B-X
the	B-X
host	B-X
response	B-X
to	B-X
infection	B-X
.	B-X
In	B-X
the	B-X
current	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
LPS	B-X
increased	B-X
the	B-X
expression	B-X
of	B-X
BAG3	B-X
in	B-X
a	B-X
dose-	B-X
and	B-X
time-dependent	B-X
manner	B-X
.	B-X
Actinomycin	B-X
D	B-X
completely	B-X
blocked	B-X
the	B-X
LPS-induced	B-X
BAG3	B-X
accumulation	B-X
,	B-X
as	B-X
well	B-X
as	B-X
LPS	B-X
activated	B-X
the	B-X
proximal	B-X
promoter	B-X
of	B-X
BAG3	B-X
gene	B-X
,	B-X
supported	B-X
that	B-X
the	B-X
induction	B-X
by	B-X
LPS	B-X
occurred	B-X
at	B-X
the	B-X
level	B-X
of	B-X
gene	B-X
transcription	B-X
.	B-X
LPS-induced	B-X
BAG3	B-X
expression	B-X
was	B-X
blocked	B-X
by	B-X
JNK	B-X
or	B-X
NF-κB	B-X
inhibition	B-X
,	B-X
suggesting	B-X
that	B-X
JNK	B-X
and	B-X
NF-κB	B-X
pathways	B-X
participated	B-X
in	B-X
BAG3	B-X
induction	B-X
by	B-X
LPS	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
also	B-X
found	B-X
that	B-X
induction	B-X
of	B-X
BAG3	B-X
was	B-X
implicated	B-X
in	B-X
monocytic	B-X
cell	B-X
adhesion	B-X
to	B-X
extracellular	B-X
matrix	B-X
induced	B-X
by	B-X
LPS	B-X
.	B-X
Overall	B-X
,	B-X
the	B-X
data	B-X
support	B-X
that	B-X
BAG3	B-X
is	B-X
induced	B-X
by	B-X
LPS	B-X
via	B-X
JNK	B-X
and	B-X
NF-κB-dependent	B-X
signals	B-X
,	B-X
and	B-X
involved	B-X
in	B-X
monocytic	B-X
cell-extracellular	B-X
matrix	B-X
interaction	B-X
,	B-X
suggesting	B-X
that	B-X
BAG3	B-X
may	B-X
have	B-X
a	B-X
role	B-X
in	B-X
the	B-X
host	B-X
response	B-X
to	B-X
LPS	B-X
stimulation	B-X
.	B-X

p53	B-Gene_or_gene_product
mutants	O
induce	O
transcription	O
of	O
NF	O
-	O
kappaB2	O
in	O
H1299	O
cells	O
through	O
CBP	B-Gene_or_gene_product
and	O
STAT	B-Gene_or_gene_product
binding	O
on	O
the	O
NF	O
-	O
kappaB2	O
promoter	O
and	O
gain	O
of	O
function	O
activity	O
.	O
<EOS>	B-X
Cancer	B-X
cells	B-X
with	B-X
p53	B-X
mutations	B-X
,	B-X
in	B-X
general	B-X
,	B-X
grow	B-X
more	B-X
aggressively	B-X
than	B-X
those	B-X
with	B-X
wild-type	B-X
p53	B-X
and	B-X
show	B-X
``	B-X
gain	B-X
of	B-X
function	B-X
''	B-X
(	B-X
GOF	B-X
)	B-X
phenotypes	B-X
such	B-X
as	B-X
increased	B-X
growth	B-X
rate	B-X
,	B-X
enhanced	B-X
resistance	B-X
to	B-X
chemotherapeutic	B-X
drugs	B-X
,	B-X
increased	B-X
cell	B-X
motility	B-X
and	B-X
tumorigenicity	B-X
;	B-X
although	B-X
the	B-X
mechanism	B-X
for	B-X
this	B-X
function	B-X
remains	B-X
unknown	B-X
.	B-X
In	B-X
this	B-X
communication	B-X
we	B-X
report	B-X
that	B-X
p53-mediated	B-X
NF-κB2	B-X
up-regulation	B-X
significantly	B-X
contributes	B-X
to	B-X
the	B-X
aggressive	B-X
oncogenic	B-X
behavior	B-X
of	B-X
cancer	B-X
cells	B-X
.	B-X
Lowering	B-X
the	B-X
level	B-X
of	B-X
mutant	B-X
p53	B-X
in	B-X
a	B-X
number	B-X
of	B-X
cancer	B-X
cell	B-X
lines	B-X
resulted	B-X
in	B-X
a	B-X
loss	B-X
of	B-X
GOF	B-X
phenotypes	B-X
directly	B-X
implicating	B-X
p53	B-X
mutants	B-X
in	B-X
the	B-X
process	B-X
.	B-X
RNAi	B-X
against	B-X
NF-κB2	B-X
in	B-X
naturally	B-X
occurring	B-X
cancer	B-X
cell	B-X
lines	B-X
also	B-X
lowers	B-X
GOF	B-X
activities	B-X
.	B-X
In	B-X
H1299	B-X
cells	B-X
expressing	B-X
mutant	B-X
p53	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
(	B-X
ChIP	B-X
)	B-X
assays	B-X
indicate	B-X
that	B-X
mutant	B-X
p53	B-X
induces	B-X
histone	B-X
acetylation	B-X
at	B-X
specific	B-X
sites	B-X
on	B-X
the	B-X
regulatory	B-X
regions	B-X
of	B-X
its	B-X
target	B-X
genes	B-X
.	B-X
ChIP	B-X
assays	B-X
using	B-X
antibodies	B-X
against	B-X
transcription	B-X
factors	B-X
putatively	B-X
capable	B-X
of	B-X
interacting	B-X
with	B-X
the	B-X
NF-κB2	B-X
promoter	B-X
show	B-X
increased	B-X
interaction	B-X
of	B-X
CBP	B-X
and	B-X
STAT2	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
mutant	B-X
p53	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
in	B-X
H1299	B-X
cells	B-X
,	B-X
mutant	B-X
p53	B-X
elevates	B-X
expression	B-X
of	B-X
genes	B-X
capable	B-X
of	B-X
enhancing	B-X
cell	B-X
proliferation	B-X
,	B-X
motility	B-X
,	B-X
and	B-X
tumorigenicity	B-X
by	B-X
inducing	B-X
acetylation	B-X
of	B-X
histones	B-X
via	B-X
recruitment	B-X
of	B-X
CBP	B-X
and	B-X
STAT2	B-X
on	B-X
the	B-X
promoters	B-X
causing	B-X
CBP-mediated	B-X
histone	B-X
acetylation	B-X
.	B-X

Cancer	O
cells	O
with	O
p53	B-Gene_or_gene_product
mutations	O
,	O
in	O
general	O
,	O
grow	O
more	O
aggressively	O
than	O
those	O
with	O
wild	O
-	O
type	O
p53	B-Gene_or_gene_product
and	O
show	O
"	O
gain	O
of	O
function	O
"	O
(	O
GOF	O
)	O
phenotypes	O
such	O
as	O
increased	O
growth	O
rate	O
,	O
enhanced	O
resistance	O
to	O
chemotherapeutic	O
drugs	O
,	O
increased	O
cell	O
motility	O
and	O
tumorigenicity	O
;	O
although	O
the	O
mechanism	O
for	O
this	O
function	O
remains	O
unknown	O
.	O
<EOS>	B-X
Cancer	B-X
cells	B-X
with	B-X
p53	B-X
mutations	B-X
,	B-X
in	B-X
general	B-X
,	B-X
grow	B-X
more	B-X
aggressively	B-X
than	B-X
those	B-X
with	B-X
wild-type	B-X
p53	B-X
and	B-X
show	B-X
``	B-X
gain	B-X
of	B-X
function	B-X
''	B-X
(	B-X
GOF	B-X
)	B-X
phenotypes	B-X
such	B-X
as	B-X
increased	B-X
growth	B-X
rate	B-X
,	B-X
enhanced	B-X
resistance	B-X
to	B-X
chemotherapeutic	B-X
drugs	B-X
,	B-X
increased	B-X
cell	B-X
motility	B-X
and	B-X
tumorigenicity	B-X
;	B-X
although	B-X
the	B-X
mechanism	B-X
for	B-X
this	B-X
function	B-X
remains	B-X
unknown	B-X
.	B-X
In	B-X
this	B-X
communication	B-X
we	B-X
report	B-X
that	B-X
p53-mediated	B-X
NF-κB2	B-X
up-regulation	B-X
significantly	B-X
contributes	B-X
to	B-X
the	B-X
aggressive	B-X
oncogenic	B-X
behavior	B-X
of	B-X
cancer	B-X
cells	B-X
.	B-X
Lowering	B-X
the	B-X
level	B-X
of	B-X
mutant	B-X
p53	B-X
in	B-X
a	B-X
number	B-X
of	B-X
cancer	B-X
cell	B-X
lines	B-X
resulted	B-X
in	B-X
a	B-X
loss	B-X
of	B-X
GOF	B-X
phenotypes	B-X
directly	B-X
implicating	B-X
p53	B-X
mutants	B-X
in	B-X
the	B-X
process	B-X
.	B-X
RNAi	B-X
against	B-X
NF-κB2	B-X
in	B-X
naturally	B-X
occurring	B-X
cancer	B-X
cell	B-X
lines	B-X
also	B-X
lowers	B-X
GOF	B-X
activities	B-X
.	B-X
In	B-X
H1299	B-X
cells	B-X
expressing	B-X
mutant	B-X
p53	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
(	B-X
ChIP	B-X
)	B-X
assays	B-X
indicate	B-X
that	B-X
mutant	B-X
p53	B-X
induces	B-X
histone	B-X
acetylation	B-X
at	B-X
specific	B-X
sites	B-X
on	B-X
the	B-X
regulatory	B-X
regions	B-X
of	B-X
its	B-X
target	B-X
genes	B-X
.	B-X
ChIP	B-X
assays	B-X
using	B-X
antibodies	B-X
against	B-X
transcription	B-X
factors	B-X
putatively	B-X
capable	B-X
of	B-X
interacting	B-X
with	B-X
the	B-X
NF-κB2	B-X
promoter	B-X
show	B-X
increased	B-X
interaction	B-X
of	B-X
CBP	B-X
and	B-X
STAT2	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
mutant	B-X
p53	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
in	B-X
H1299	B-X
cells	B-X
,	B-X
mutant	B-X
p53	B-X
elevates	B-X
expression	B-X
of	B-X
genes	B-X
capable	B-X
of	B-X
enhancing	B-X
cell	B-X
proliferation	B-X
,	B-X
motility	B-X
,	B-X
and	B-X
tumorigenicity	B-X
by	B-X
inducing	B-X
acetylation	B-X
of	B-X
histones	B-X
via	B-X
recruitment	B-X
of	B-X
CBP	B-X
and	B-X
STAT2	B-X
on	B-X
the	B-X
promoters	B-X
causing	B-X
CBP-mediated	B-X
histone	B-X
acetylation	B-X
.	B-X

In	O
this	O
communication	O
we	O
report	O
that	O
p53	B-Gene_or_gene_product
-	O
mediated	O
NF	O
-	O
kappaB2	O
up	O
-	O
regulation	O
significantly	O
contributes	O
to	O
the	O
aggressive	O
oncogenic	O
behavior	O
of	O
cancer	O
cells	O
.	O

Lowering	O
the	O
level	O
of	O
mutant	O
p53	B-Gene_or_gene_product
in	O
a	O
number	O
of	O
cancer	O
cell	O
lines	O
resulted	O
in	O
a	O
loss	O
of	O
GOF	O
phenotypes	O
directly	O
implicating	O
p53	B-Gene_or_gene_product
mutants	O
in	O
the	O
process	O
.	O

RNAi	O
against	O
NF	O
-	O
kappaB2	O
in	O
naturally	O
occurring	O
cancer	O
cell	O
lines	O
also	O
lowers	O
GOF	O
activities	O
.	O
<EOS>	B-X
Cancer	B-X
cells	B-X
with	B-X
p53	B-X
mutations	B-X
,	B-X
in	B-X
general	B-X
,	B-X
grow	B-X
more	B-X
aggressively	B-X
than	B-X
those	B-X
with	B-X
wild-type	B-X
p53	B-X
and	B-X
show	B-X
``	B-X
gain	B-X
of	B-X
function	B-X
''	B-X
(	B-X
GOF	B-X
)	B-X
phenotypes	B-X
such	B-X
as	B-X
increased	B-X
growth	B-X
rate	B-X
,	B-X
enhanced	B-X
resistance	B-X
to	B-X
chemotherapeutic	B-X
drugs	B-X
,	B-X
increased	B-X
cell	B-X
motility	B-X
and	B-X
tumorigenicity	B-X
;	B-X
although	B-X
the	B-X
mechanism	B-X
for	B-X
this	B-X
function	B-X
remains	B-X
unknown	B-X
.	B-X
In	B-X
this	B-X
communication	B-X
we	B-X
report	B-X
that	B-X
p53-mediated	B-X
NF-κB2	B-X
up-regulation	B-X
significantly	B-X
contributes	B-X
to	B-X
the	B-X
aggressive	B-X
oncogenic	B-X
behavior	B-X
of	B-X
cancer	B-X
cells	B-X
.	B-X
Lowering	B-X
the	B-X
level	B-X
of	B-X
mutant	B-X
p53	B-X
in	B-X
a	B-X
number	B-X
of	B-X
cancer	B-X
cell	B-X
lines	B-X
resulted	B-X
in	B-X
a	B-X
loss	B-X
of	B-X
GOF	B-X
phenotypes	B-X
directly	B-X
implicating	B-X
p53	B-X
mutants	B-X
in	B-X
the	B-X
process	B-X
.	B-X
RNAi	B-X
against	B-X
NF-κB2	B-X
in	B-X
naturally	B-X
occurring	B-X
cancer	B-X
cell	B-X
lines	B-X
also	B-X
lowers	B-X
GOF	B-X
activities	B-X
.	B-X
In	B-X
H1299	B-X
cells	B-X
expressing	B-X
mutant	B-X
p53	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
(	B-X
ChIP	B-X
)	B-X
assays	B-X
indicate	B-X
that	B-X
mutant	B-X
p53	B-X
induces	B-X
histone	B-X
acetylation	B-X
at	B-X
specific	B-X
sites	B-X
on	B-X
the	B-X
regulatory	B-X
regions	B-X
of	B-X
its	B-X
target	B-X
genes	B-X
.	B-X
ChIP	B-X
assays	B-X
using	B-X
antibodies	B-X
against	B-X
transcription	B-X
factors	B-X
putatively	B-X
capable	B-X
of	B-X
interacting	B-X
with	B-X
the	B-X
NF-κB2	B-X
promoter	B-X
show	B-X
increased	B-X
interaction	B-X
of	B-X
CBP	B-X
and	B-X
STAT2	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
mutant	B-X
p53	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
in	B-X
H1299	B-X
cells	B-X
,	B-X
mutant	B-X
p53	B-X
elevates	B-X
expression	B-X
of	B-X
genes	B-X
capable	B-X
of	B-X
enhancing	B-X
cell	B-X
proliferation	B-X
,	B-X
motility	B-X
,	B-X
and	B-X
tumorigenicity	B-X
by	B-X
inducing	B-X
acetylation	B-X
of	B-X
histones	B-X
via	B-X
recruitment	B-X
of	B-X
CBP	B-X
and	B-X
STAT2	B-X
on	B-X
the	B-X
promoters	B-X
causing	B-X
CBP-mediated	B-X
histone	B-X
acetylation	B-X
.	B-X

In	O
H1299	O
cells	O
expressing	O
mutant	O
p53	B-Gene_or_gene_product
,	O
chromatin	O
immunoprecipitation	O
(	O
ChIP	O
)	O
assays	O
indicate	O
that	O
mutant	O
p53	B-Gene_or_gene_product
induces	O
histone	B-Gene_or_gene_product
acetylation	O
at	O
specific	O
sites	O
on	O
the	O
regulatory	O
regions	O
of	O
its	O
target	O
genes	O
.	O
<EOS>	B-X
Cancer	B-X
cells	B-X
with	B-X
p53	B-X
mutations	B-X
,	B-X
in	B-X
general	B-X
,	B-X
grow	B-X
more	B-X
aggressively	B-X
than	B-X
those	B-X
with	B-X
wild-type	B-X
p53	B-X
and	B-X
show	B-X
``	B-X
gain	B-X
of	B-X
function	B-X
''	B-X
(	B-X
GOF	B-X
)	B-X
phenotypes	B-X
such	B-X
as	B-X
increased	B-X
growth	B-X
rate	B-X
,	B-X
enhanced	B-X
resistance	B-X
to	B-X
chemotherapeutic	B-X
drugs	B-X
,	B-X
increased	B-X
cell	B-X
motility	B-X
and	B-X
tumorigenicity	B-X
;	B-X
although	B-X
the	B-X
mechanism	B-X
for	B-X
this	B-X
function	B-X
remains	B-X
unknown	B-X
.	B-X
In	B-X
this	B-X
communication	B-X
we	B-X
report	B-X
that	B-X
p53-mediated	B-X
NF-κB2	B-X
up-regulation	B-X
significantly	B-X
contributes	B-X
to	B-X
the	B-X
aggressive	B-X
oncogenic	B-X
behavior	B-X
of	B-X
cancer	B-X
cells	B-X
.	B-X
Lowering	B-X
the	B-X
level	B-X
of	B-X
mutant	B-X
p53	B-X
in	B-X
a	B-X
number	B-X
of	B-X
cancer	B-X
cell	B-X
lines	B-X
resulted	B-X
in	B-X
a	B-X
loss	B-X
of	B-X
GOF	B-X
phenotypes	B-X
directly	B-X
implicating	B-X
p53	B-X
mutants	B-X
in	B-X
the	B-X
process	B-X
.	B-X
In	B-X
H1299	B-X
cells	B-X
expressing	B-X
mutant	B-X
p53	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
(	B-X
ChIP	B-X
)	B-X
assays	B-X
indicate	B-X
that	B-X
mutant	B-X
p53	B-X
induces	B-X
histone	B-X
acetylation	B-X
at	B-X
specific	B-X
sites	B-X
on	B-X
the	B-X
regulatory	B-X
regions	B-X
of	B-X
its	B-X
target	B-X
genes	B-X
.	B-X
ChIP	B-X
assays	B-X
using	B-X
antibodies	B-X
against	B-X
transcription	B-X
factors	B-X
putatively	B-X
capable	B-X
of	B-X
interacting	B-X
with	B-X
the	B-X
NF-κB2	B-X
promoter	B-X
show	B-X
increased	B-X
interaction	B-X
of	B-X
CBP	B-X
and	B-X
STAT2	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
mutant	B-X
p53	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
in	B-X
H1299	B-X
cells	B-X
,	B-X
mutant	B-X
p53	B-X
elevates	B-X
expression	B-X
of	B-X
genes	B-X
capable	B-X
of	B-X
enhancing	B-X
cell	B-X
proliferation	B-X
,	B-X
motility	B-X
,	B-X
and	B-X
tumorigenicity	B-X
by	B-X
inducing	B-X
acetylation	B-X
of	B-X
histones	B-X
via	B-X
recruitment	B-X
of	B-X
CBP	B-X
and	B-X
STAT2	B-X
on	B-X
the	B-X
promoters	B-X
causing	B-X
CBP-mediated	B-X
histone	B-X
acetylation	B-X
.	B-X

ChIP	O
assays	O
using	O
antibodies	O
against	O
transcription	O
factors	O
putatively	O
capable	O
of	O
interacting	O
with	O
the	O
NF	O
-	O
kappaB2	O
promoter	O
show	O
increased	O
interaction	O
of	O
CBP	B-Gene_or_gene_product
and	O
STAT2	B-Gene_or_gene_product
in	O
the	O
presence	O
of	O
mutant	O
p53	B-Gene_or_gene_product
.	O
<EOS>	B-X
Cancer	B-X
cells	B-X
with	B-X
p53	B-X
mutations	B-X
,	B-X
in	B-X
general	B-X
,	B-X
grow	B-X
more	B-X
aggressively	B-X
than	B-X
those	B-X
with	B-X
wild-type	B-X
p53	B-X
and	B-X
show	B-X
``	B-X
gain	B-X
of	B-X
function	B-X
''	B-X
(	B-X
GOF	B-X
)	B-X
phenotypes	B-X
such	B-X
as	B-X
increased	B-X
growth	B-X
rate	B-X
,	B-X
enhanced	B-X
resistance	B-X
to	B-X
chemotherapeutic	B-X
drugs	B-X
,	B-X
increased	B-X
cell	B-X
motility	B-X
and	B-X
tumorigenicity	B-X
;	B-X
although	B-X
the	B-X
mechanism	B-X
for	B-X
this	B-X
function	B-X
remains	B-X
unknown	B-X
.	B-X
In	B-X
this	B-X
communication	B-X
we	B-X
report	B-X
that	B-X
p53-mediated	B-X
NF-κB2	B-X
up-regulation	B-X
significantly	B-X
contributes	B-X
to	B-X
the	B-X
aggressive	B-X
oncogenic	B-X
behavior	B-X
of	B-X
cancer	B-X
cells	B-X
.	B-X
Lowering	B-X
the	B-X
level	B-X
of	B-X
mutant	B-X
p53	B-X
in	B-X
a	B-X
number	B-X
of	B-X
cancer	B-X
cell	B-X
lines	B-X
resulted	B-X
in	B-X
a	B-X
loss	B-X
of	B-X
GOF	B-X
phenotypes	B-X
directly	B-X
implicating	B-X
p53	B-X
mutants	B-X
in	B-X
the	B-X
process	B-X
.	B-X
RNAi	B-X
against	B-X
NF-κB2	B-X
in	B-X
naturally	B-X
occurring	B-X
cancer	B-X
cell	B-X
lines	B-X
also	B-X
lowers	B-X
GOF	B-X
activities	B-X
.	B-X
In	B-X
H1299	B-X
cells	B-X
expressing	B-X
mutant	B-X
p53	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
(	B-X
ChIP	B-X
)	B-X
assays	B-X
indicate	B-X
that	B-X
mutant	B-X
p53	B-X
induces	B-X
histone	B-X
acetylation	B-X
at	B-X
specific	B-X
sites	B-X
on	B-X
the	B-X
regulatory	B-X
regions	B-X
of	B-X
its	B-X
target	B-X
genes	B-X
.	B-X
ChIP	B-X
assays	B-X
using	B-X
antibodies	B-X
against	B-X
transcription	B-X
factors	B-X
putatively	B-X
capable	B-X
of	B-X
interacting	B-X
with	B-X
the	B-X
NF-κB2	B-X
promoter	B-X
show	B-X
increased	B-X
interaction	B-X
of	B-X
CBP	B-X
and	B-X
STAT2	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
mutant	B-X
p53	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
in	B-X
H1299	B-X
cells	B-X
,	B-X
mutant	B-X
p53	B-X
elevates	B-X
expression	B-X
of	B-X
genes	B-X
capable	B-X
of	B-X
enhancing	B-X
cell	B-X
proliferation	B-X
,	B-X
motility	B-X
,	B-X
and	B-X
tumorigenicity	B-X
by	B-X
inducing	B-X
acetylation	B-X
of	B-X
histones	B-X
via	B-X
recruitment	B-X
of	B-X
CBP	B-X
and	B-X
STAT2	B-X
on	B-X
the	B-X
promoters	B-X
causing	B-X
CBP-mediated	B-X
histone	B-X
acetylation	B-X
.	B-X

Thus	O
,	O
we	O
propose	O
that	O
in	O
H1299	O
cells	O
,	O
mutant	O
p53	B-Gene_or_gene_product
elevates	O
expression	O
of	O
genes	O
capable	O
of	O
enhancing	O
cell	O
proliferation	O
,	O
motility	O
,	O
and	O
tumorigenicity	O
by	O
inducing	O
acetylation	O
of	O
histones	O
via	O
recruitment	O
of	O
CBP	B-Gene_or_gene_product
and	O
STAT2	B-Gene_or_gene_product
on	O
the	O
promoters	O
causing	O
CBP	B-Gene_or_gene_product
-	O
mediated	O
histone	B-Gene_or_gene_product
acetylation	O
.	O
<EOS>	B-X
Cancer	B-X
cells	B-X
with	B-X
p53	B-X
mutations	B-X
,	B-X
in	B-X
general	B-X
,	B-X
grow	B-X
more	B-X
aggressively	B-X
than	B-X
those	B-X
with	B-X
wild-type	B-X
p53	B-X
and	B-X
show	B-X
``	B-X
gain	B-X
of	B-X
function	B-X
''	B-X
(	B-X
GOF	B-X
)	B-X
phenotypes	B-X
such	B-X
as	B-X
increased	B-X
growth	B-X
rate	B-X
,	B-X
enhanced	B-X
resistance	B-X
to	B-X
chemotherapeutic	B-X
drugs	B-X
,	B-X
increased	B-X
cell	B-X
motility	B-X
and	B-X
tumorigenicity	B-X
;	B-X
although	B-X
the	B-X
mechanism	B-X
for	B-X
this	B-X
function	B-X
remains	B-X
unknown	B-X
.	B-X
In	B-X
this	B-X
communication	B-X
we	B-X
report	B-X
that	B-X
p53-mediated	B-X
NF-κB2	B-X
up-regulation	B-X
significantly	B-X
contributes	B-X
to	B-X
the	B-X
aggressive	B-X
oncogenic	B-X
behavior	B-X
of	B-X
cancer	B-X
cells	B-X
.	B-X
Lowering	B-X
the	B-X
level	B-X
of	B-X
mutant	B-X
p53	B-X
in	B-X
a	B-X
number	B-X
of	B-X
cancer	B-X
cell	B-X
lines	B-X
resulted	B-X
in	B-X
a	B-X
loss	B-X
of	B-X
GOF	B-X
phenotypes	B-X
directly	B-X
implicating	B-X
p53	B-X
mutants	B-X
in	B-X
the	B-X
process	B-X
.	B-X
RNAi	B-X
against	B-X
NF-κB2	B-X
in	B-X
naturally	B-X
occurring	B-X
cancer	B-X
cell	B-X
lines	B-X
also	B-X
lowers	B-X
GOF	B-X
activities	B-X
.	B-X
In	B-X
H1299	B-X
cells	B-X
expressing	B-X
mutant	B-X
p53	B-X
,	B-X
chromatin	B-X
immunoprecipitation	B-X
(	B-X
ChIP	B-X
)	B-X
assays	B-X
indicate	B-X
that	B-X
mutant	B-X
p53	B-X
induces	B-X
histone	B-X
acetylation	B-X
at	B-X
specific	B-X
sites	B-X
on	B-X
the	B-X
regulatory	B-X
regions	B-X
of	B-X
its	B-X
target	B-X
genes	B-X
.	B-X
ChIP	B-X
assays	B-X
using	B-X
antibodies	B-X
against	B-X
transcription	B-X
factors	B-X
putatively	B-X
capable	B-X
of	B-X
interacting	B-X
with	B-X
the	B-X
NF-κB2	B-X
promoter	B-X
show	B-X
increased	B-X
interaction	B-X
of	B-X
CBP	B-X
and	B-X
STAT2	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
mutant	B-X
p53	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
in	B-X
H1299	B-X
cells	B-X
,	B-X
mutant	B-X
p53	B-X
elevates	B-X
expression	B-X
of	B-X
genes	B-X
capable	B-X
of	B-X
enhancing	B-X
cell	B-X
proliferation	B-X
,	B-X
motility	B-X
,	B-X
and	B-X
tumorigenicity	B-X
by	B-X
inducing	B-X
acetylation	B-X
of	B-X
histones	B-X
via	B-X
recruitment	B-X
of	B-X
CBP	B-X
and	B-X
STAT2	B-X
on	B-X
the	B-X
promoters	B-X
causing	B-X
CBP-mediated	B-X
histone	B-X
acetylation	B-X
.	B-X

New	O
molecular	O
bridge	O
between	O
RelA	B-Gene_or_gene_product
/	O
p65	B-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
target	O
genes	O
via	O
histone	B-Gene_or_gene_product
acetyltransferase	I-Gene_or_gene_product
TIP60	B-Gene_or_gene_product
cofactor	O
.	O
<EOS>	B-X
The	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
family	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
expressions	B-X
of	B-X
numerous	B-X
genes	B-X
,	B-X
in	B-X
development	B-X
,	B-X
apoptosis	B-X
,	B-X
inflammatory	B-X
responses	B-X
,	B-X
and	B-X
oncogenesis	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
identified	B-X
four	B-X
NF-κB	B-X
target	B-X
genes	B-X
that	B-X
are	B-X
modulated	B-X
by	B-X
TIP60	B-X
.	B-X
We	B-X
also	B-X
found	B-X
that	B-X
TIP60	B-X
interacts	B-X
with	B-X
the	B-X
NF-κB	B-X
RelA/p65	B-X
subunit	B-X
and	B-X
increases	B-X
its	B-X
transcriptional	B-X
activity	B-X
through	B-X
protein-protein	B-X
interaction	B-X
.	B-X
Although	B-X
TIP60	B-X
binds	B-X
with	B-X
RelA/p65	B-X
using	B-X
its	B-X
histone	B-X
acetyltransferase	B-X
domain	B-X
,	B-X
TIP60	B-X
does	B-X
not	B-X
directly	B-X
acetylate	B-X
RelA/p65	B-X
.	B-X
However	B-X
,	B-X
TIP60	B-X
maintained	B-X
acetylated	B-X
Lys-310	B-X
RelA/p65	B-X
levels	B-X
in	B-X
the	B-X
TNF-α-dependent	B-X
NF-κB	B-X
signaling	B-X
pathway	B-X
.	B-X
In	B-X
chromatin	B-X
immunoprecipitation	B-X
assay	B-X
,	B-X
TIP60	B-X
was	B-X
primarily	B-X
recruited	B-X
to	B-X
the	B-X
IL-6	B-X
,	B-X
IL-8	B-X
,	B-X
C-IAP1	B-X
,	B-X
and	B-X
XIAP	B-X
promoters	B-X
in	B-X
TNF-α	B-X
stimulation	B-X
followed	B-X
by	B-X
acetylation	B-X
of	B-X
histones	B-X
H3	B-X
and	B-X
H4	B-X
.	B-X
Chromatin	B-X
remodeling	B-X
by	B-X
TIP60	B-X
involved	B-X
the	B-X
sequential	B-X
recruitment	B-X
of	B-X
acetyl-Lys-310	B-X
RelA/p65	B-X
to	B-X
its	B-X
target	B-X
gene	B-X
promoters	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
up-regulated	B-X
TIP60	B-X
expression	B-X
was	B-X
correlated	B-X
with	B-X
acetyl-Lys-310	B-X
RelA/p65	B-X
expressions	B-X
in	B-X
hepatocarcinoma	B-X
tissues	B-X
.	B-X
Taken	B-X
together	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
TIP60	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
NF-κB	B-X
pathway	B-X
through	B-X
protein	B-X
interaction	B-X
with	B-X
RelA/p65	B-X
and	B-X
that	B-X
it	B-X
modulates	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
RelA/p65	B-X
in	B-X
NF-κB-dependent	B-X
gene	B-X
expression	B-X
.	B-X

The	O
nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
family	O
is	O
involved	O
in	O
the	O
expressions	O
of	O
numerous	O
genes	O
,	O
in	O
development	O
,	O
apoptosis	O
,	O
inflammatory	O
responses	O
,	O
and	O
oncogenesis	O
.	O
<EOS>	B-X
The	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
family	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
expressions	B-X
of	B-X
numerous	B-X
genes	B-X
,	B-X
in	B-X
development	B-X
,	B-X
apoptosis	B-X
,	B-X
inflammatory	B-X
responses	B-X
,	B-X
and	B-X
oncogenesis	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
identified	B-X
four	B-X
NF-κB	B-X
target	B-X
genes	B-X
that	B-X
are	B-X
modulated	B-X
by	B-X
TIP60	B-X
.	B-X
We	B-X
also	B-X
found	B-X
that	B-X
TIP60	B-X
interacts	B-X
with	B-X
the	B-X
NF-κB	B-X
RelA/p65	B-X
subunit	B-X
and	B-X
increases	B-X
its	B-X
transcriptional	B-X
activity	B-X
through	B-X
protein-protein	B-X
interaction	B-X
.	B-X
However	B-X
,	B-X
TIP60	B-X
maintained	B-X
acetylated	B-X
Lys-310	B-X
RelA/p65	B-X
levels	B-X
in	B-X
the	B-X
TNF-α-dependent	B-X
NF-κB	B-X
signaling	B-X
pathway	B-X
.	B-X
In	B-X
chromatin	B-X
immunoprecipitation	B-X
assay	B-X
,	B-X
TIP60	B-X
was	B-X
primarily	B-X
recruited	B-X
to	B-X
the	B-X
IL-6	B-X
,	B-X
IL-8	B-X
,	B-X
C-IAP1	B-X
,	B-X
and	B-X
XIAP	B-X
promoters	B-X
in	B-X
TNF-α	B-X
stimulation	B-X
followed	B-X
by	B-X
acetylation	B-X
of	B-X
histones	B-X
H3	B-X
and	B-X
H4	B-X
.	B-X
Chromatin	B-X
remodeling	B-X
by	B-X
TIP60	B-X
involved	B-X
the	B-X
sequential	B-X
recruitment	B-X
of	B-X
acetyl-Lys-310	B-X
RelA/p65	B-X
to	B-X
its	B-X
target	B-X
gene	B-X
promoters	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
up-regulated	B-X
TIP60	B-X
expression	B-X
was	B-X
correlated	B-X
with	B-X
acetyl-Lys-310	B-X
RelA/p65	B-X
expressions	B-X
in	B-X
hepatocarcinoma	B-X
tissues	B-X
.	B-X
Taken	B-X
together	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
TIP60	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
NF-κB	B-X
pathway	B-X
through	B-X
protein	B-X
interaction	B-X
with	B-X
RelA/p65	B-X
and	B-X
that	B-X
it	B-X
modulates	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
RelA/p65	B-X
in	B-X
NF-κB-dependent	B-X
gene	B-X
expression	B-X
.	B-X

In	O
this	O
study	O
we	O
identified	O
four	O
NF	O
-	O
kappaB	O
target	O
genes	O
that	O
are	O
modulated	O
by	O
TIP60	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
family	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
expressions	B-X
of	B-X
numerous	B-X
genes	B-X
,	B-X
in	B-X
development	B-X
,	B-X
apoptosis	B-X
,	B-X
inflammatory	B-X
responses	B-X
,	B-X
and	B-X
oncogenesis	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
identified	B-X
four	B-X
NF-κB	B-X
target	B-X
genes	B-X
that	B-X
are	B-X
modulated	B-X
by	B-X
TIP60	B-X
.	B-X
We	B-X
also	B-X
found	B-X
that	B-X
TIP60	B-X
interacts	B-X
with	B-X
the	B-X
NF-κB	B-X
RelA/p65	B-X
subunit	B-X
and	B-X
increases	B-X
its	B-X
transcriptional	B-X
activity	B-X
through	B-X
protein-protein	B-X
interaction	B-X
.	B-X
Although	B-X
TIP60	B-X
binds	B-X
with	B-X
RelA/p65	B-X
using	B-X
its	B-X
histone	B-X
acetyltransferase	B-X
domain	B-X
,	B-X
TIP60	B-X
does	B-X
not	B-X
directly	B-X
acetylate	B-X
RelA/p65	B-X
.	B-X
However	B-X
,	B-X
TIP60	B-X
maintained	B-X
acetylated	B-X
Lys-310	B-X
RelA/p65	B-X
levels	B-X
in	B-X
the	B-X
TNF-α-dependent	B-X
NF-κB	B-X
signaling	B-X
pathway	B-X
.	B-X
In	B-X
chromatin	B-X
immunoprecipitation	B-X
assay	B-X
,	B-X
TIP60	B-X
was	B-X
primarily	B-X
recruited	B-X
to	B-X
the	B-X
IL-6	B-X
,	B-X
IL-8	B-X
,	B-X
C-IAP1	B-X
,	B-X
and	B-X
XIAP	B-X
promoters	B-X
in	B-X
TNF-α	B-X
stimulation	B-X
followed	B-X
by	B-X
acetylation	B-X
of	B-X
histones	B-X
H3	B-X
and	B-X
H4	B-X
.	B-X
Chromatin	B-X
remodeling	B-X
by	B-X
TIP60	B-X
involved	B-X
the	B-X
sequential	B-X
recruitment	B-X
of	B-X
acetyl-Lys-310	B-X
RelA/p65	B-X
to	B-X
its	B-X
target	B-X
gene	B-X
promoters	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
up-regulated	B-X
TIP60	B-X
expression	B-X
was	B-X
correlated	B-X
with	B-X
acetyl-Lys-310	B-X
RelA/p65	B-X
expressions	B-X
in	B-X
hepatocarcinoma	B-X
tissues	B-X
.	B-X
Taken	B-X
together	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
TIP60	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
NF-κB	B-X
pathway	B-X
through	B-X
protein	B-X
interaction	B-X
with	B-X
RelA/p65	B-X
and	B-X
that	B-X
it	B-X
modulates	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
RelA/p65	B-X
in	B-X
NF-κB-dependent	B-X
gene	B-X
expression	B-X
.	B-X

We	O
also	O
found	O
that	O
TIP60	B-Gene_or_gene_product
interacts	O
with	O
the	O
NF	O
-	O
kappaB	O
RelA	B-Gene_or_gene_product
/	O
p65	B-Gene_or_gene_product
subunit	O
and	O
increases	O
its	O
transcriptional	O
activity	O
through	O
protein	O
-	O
protein	O
interaction	O
.	O
<EOS>	B-X
The	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
family	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
expressions	B-X
of	B-X
numerous	B-X
genes	B-X
,	B-X
in	B-X
development	B-X
,	B-X
apoptosis	B-X
,	B-X
inflammatory	B-X
responses	B-X
,	B-X
and	B-X
oncogenesis	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
identified	B-X
four	B-X
NF-κB	B-X
target	B-X
genes	B-X
that	B-X
are	B-X
modulated	B-X
by	B-X
TIP60	B-X
.	B-X
We	B-X
also	B-X
found	B-X
that	B-X
TIP60	B-X
interacts	B-X
with	B-X
the	B-X
NF-κB	B-X
RelA/p65	B-X
subunit	B-X
and	B-X
increases	B-X
its	B-X
transcriptional	B-X
activity	B-X
through	B-X
protein-protein	B-X
interaction	B-X
.	B-X
Although	B-X
TIP60	B-X
binds	B-X
with	B-X
RelA/p65	B-X
using	B-X
its	B-X
histone	B-X
acetyltransferase	B-X
domain	B-X
,	B-X
TIP60	B-X
does	B-X
not	B-X
directly	B-X
acetylate	B-X
RelA/p65	B-X
.	B-X
However	B-X
,	B-X
TIP60	B-X
maintained	B-X
acetylated	B-X
Lys-310	B-X
RelA/p65	B-X
levels	B-X
in	B-X
the	B-X
TNF-α-dependent	B-X
NF-κB	B-X
signaling	B-X
pathway	B-X
.	B-X
In	B-X
chromatin	B-X
immunoprecipitation	B-X
assay	B-X
,	B-X
TIP60	B-X
was	B-X
primarily	B-X
recruited	B-X
to	B-X
the	B-X
IL-6	B-X
,	B-X
IL-8	B-X
,	B-X
C-IAP1	B-X
,	B-X
and	B-X
XIAP	B-X
promoters	B-X
in	B-X
TNF-α	B-X
stimulation	B-X
followed	B-X
by	B-X
acetylation	B-X
of	B-X
histones	B-X
H3	B-X
and	B-X
H4	B-X
.	B-X
Chromatin	B-X
remodeling	B-X
by	B-X
TIP60	B-X
involved	B-X
the	B-X
sequential	B-X
recruitment	B-X
of	B-X
acetyl-Lys-310	B-X
RelA/p65	B-X
to	B-X
its	B-X
target	B-X
gene	B-X
promoters	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
up-regulated	B-X
TIP60	B-X
expression	B-X
was	B-X
correlated	B-X
with	B-X
acetyl-Lys-310	B-X
RelA/p65	B-X
expressions	B-X
in	B-X
hepatocarcinoma	B-X
tissues	B-X
.	B-X
Taken	B-X
together	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
TIP60	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
NF-κB	B-X
pathway	B-X
through	B-X
protein	B-X
interaction	B-X
with	B-X
RelA/p65	B-X
and	B-X
that	B-X
it	B-X
modulates	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
RelA/p65	B-X
in	B-X
NF-κB-dependent	B-X
gene	B-X
expression	B-X
.	B-X

Although	O
TIP60	B-Gene_or_gene_product
binds	O
with	O
RelA	B-Gene_or_gene_product
/	O
p65	B-Gene_or_gene_product
using	O
its	O
histone	B-Gene_or_gene_product
acetyltransferase	I-Gene_or_gene_product
domain	O
,	O
TIP60	B-Gene_or_gene_product
does	O
not	O
directly	O
acetylate	O
RelA	B-Gene_or_gene_product
/	O
p65	B-Gene_or_gene_product
.	O

However	O
,	O
TIP60	B-Gene_or_gene_product
maintained	O
acetylated	O
Lys	O
-	O
310	O
RelA	B-Gene_or_gene_product
/	O
p65	B-Gene_or_gene_product
levels	O
in	O
the	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
-	O
dependent	O
NF	O
-	O
kappaB	O
signaling	O
pathway	O
.	O
<EOS>	B-X
The	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
family	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
expressions	B-X
of	B-X
numerous	B-X
genes	B-X
,	B-X
in	B-X
development	B-X
,	B-X
apoptosis	B-X
,	B-X
inflammatory	B-X
responses	B-X
,	B-X
and	B-X
oncogenesis	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
identified	B-X
four	B-X
NF-κB	B-X
target	B-X
genes	B-X
that	B-X
are	B-X
modulated	B-X
by	B-X
TIP60	B-X
.	B-X
We	B-X
also	B-X
found	B-X
that	B-X
TIP60	B-X
interacts	B-X
with	B-X
the	B-X
NF-κB	B-X
RelA/p65	B-X
subunit	B-X
and	B-X
increases	B-X
its	B-X
transcriptional	B-X
activity	B-X
through	B-X
protein-protein	B-X
interaction	B-X
.	B-X
Although	B-X
TIP60	B-X
binds	B-X
with	B-X
RelA/p65	B-X
using	B-X
its	B-X
histone	B-X
acetyltransferase	B-X
domain	B-X
,	B-X
TIP60	B-X
does	B-X
not	B-X
directly	B-X
acetylate	B-X
RelA/p65	B-X
.	B-X
However	B-X
,	B-X
TIP60	B-X
maintained	B-X
acetylated	B-X
Lys-310	B-X
RelA/p65	B-X
levels	B-X
in	B-X
the	B-X
TNF-α-dependent	B-X
NF-κB	B-X
signaling	B-X
pathway	B-X
.	B-X
In	B-X
chromatin	B-X
immunoprecipitation	B-X
assay	B-X
,	B-X
TIP60	B-X
was	B-X
primarily	B-X
recruited	B-X
to	B-X
the	B-X
IL-6	B-X
,	B-X
IL-8	B-X
,	B-X
C-IAP1	B-X
,	B-X
and	B-X
XIAP	B-X
promoters	B-X
in	B-X
TNF-α	B-X
stimulation	B-X
followed	B-X
by	B-X
acetylation	B-X
of	B-X
histones	B-X
H3	B-X
and	B-X
H4	B-X
.	B-X
Chromatin	B-X
remodeling	B-X
by	B-X
TIP60	B-X
involved	B-X
the	B-X
sequential	B-X
recruitment	B-X
of	B-X
acetyl-Lys-310	B-X
RelA/p65	B-X
to	B-X
its	B-X
target	B-X
gene	B-X
promoters	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
up-regulated	B-X
TIP60	B-X
expression	B-X
was	B-X
correlated	B-X
with	B-X
acetyl-Lys-310	B-X
RelA/p65	B-X
expressions	B-X
in	B-X
hepatocarcinoma	B-X
tissues	B-X
.	B-X
Taken	B-X
together	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
TIP60	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
NF-κB	B-X
pathway	B-X
through	B-X
protein	B-X
interaction	B-X
with	B-X
RelA/p65	B-X
and	B-X
that	B-X
it	B-X
modulates	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
RelA/p65	B-X
in	B-X
NF-κB-dependent	B-X
gene	B-X
expression	B-X
.	B-X

In	O
chromatin	O
immunoprecipitation	O
assay	O
,	O
TIP60	B-Gene_or_gene_product
was	O
primarily	O
recruited	O
to	O
the	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
,	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
8	I-Gene_or_gene_product
,	O
C	B-Gene_or_gene_product
-	I-Gene_or_gene_product
IAP1	I-Gene_or_gene_product
,	O
and	O
XIAP	B-Gene_or_gene_product
promoters	O
in	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
stimulation	O
followed	O
by	O
acetylation	O
of	O
histones	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
and	O
H4	B-Gene_or_gene_product
.	O

Chromatin	O
remodeling	O
by	O
TIP60	B-Gene_or_gene_product
involved	O
the	O
sequential	O
recruitment	O
of	O
acetyl	O
-	O
Lys	O
-	O
310	O
RelA	B-Gene_or_gene_product
/	O
p65	B-Gene_or_gene_product
to	O
its	O
target	O
gene	O
promoters	O
.	O
<EOS>	B-X
The	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
family	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
expressions	B-X
of	B-X
numerous	B-X
genes	B-X
,	B-X
in	B-X
development	B-X
,	B-X
apoptosis	B-X
,	B-X
inflammatory	B-X
responses	B-X
,	B-X
and	B-X
oncogenesis	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
identified	B-X
four	B-X
NF-κB	B-X
target	B-X
genes	B-X
that	B-X
are	B-X
modulated	B-X
by	B-X
TIP60	B-X
.	B-X
We	B-X
also	B-X
found	B-X
that	B-X
TIP60	B-X
interacts	B-X
with	B-X
the	B-X
NF-κB	B-X
RelA/p65	B-X
subunit	B-X
and	B-X
increases	B-X
its	B-X
transcriptional	B-X
activity	B-X
through	B-X
protein-protein	B-X
interaction	B-X
.	B-X
Although	B-X
TIP60	B-X
binds	B-X
with	B-X
RelA/p65	B-X
using	B-X
its	B-X
histone	B-X
acetyltransferase	B-X
domain	B-X
,	B-X
TIP60	B-X
does	B-X
not	B-X
directly	B-X
acetylate	B-X
RelA/p65	B-X
.	B-X
However	B-X
,	B-X
TIP60	B-X
maintained	B-X
acetylated	B-X
Lys-310	B-X
RelA/p65	B-X
levels	B-X
in	B-X
the	B-X
TNF-α-dependent	B-X
NF-κB	B-X
signaling	B-X
pathway	B-X
.	B-X
In	B-X
chromatin	B-X
immunoprecipitation	B-X
assay	B-X
,	B-X
TIP60	B-X
was	B-X
primarily	B-X
recruited	B-X
to	B-X
the	B-X
IL-6	B-X
,	B-X
IL-8	B-X
,	B-X
C-IAP1	B-X
,	B-X
and	B-X
XIAP	B-X
promoters	B-X
in	B-X
TNF-α	B-X
stimulation	B-X
followed	B-X
by	B-X
acetylation	B-X
of	B-X
histones	B-X
H3	B-X
and	B-X
H4	B-X
.	B-X
Chromatin	B-X
remodeling	B-X
by	B-X
TIP60	B-X
involved	B-X
the	B-X
sequential	B-X
recruitment	B-X
of	B-X
acetyl-Lys-310	B-X
RelA/p65	B-X
to	B-X
its	B-X
target	B-X
gene	B-X
promoters	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
up-regulated	B-X
TIP60	B-X
expression	B-X
was	B-X
correlated	B-X
with	B-X
acetyl-Lys-310	B-X
RelA/p65	B-X
expressions	B-X
in	B-X
hepatocarcinoma	B-X
tissues	B-X
.	B-X
Taken	B-X
together	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
TIP60	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
NF-κB	B-X
pathway	B-X
through	B-X
protein	B-X
interaction	B-X
with	B-X
RelA/p65	B-X
and	B-X
that	B-X
it	B-X
modulates	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
RelA/p65	B-X
in	B-X
NF-κB-dependent	B-X
gene	B-X
expression	B-X
.	B-X

Furthermore	O
,	O
we	O
showed	O
that	O
up	O
-	O
regulated	O
TIP60	B-Gene_or_gene_product
expression	O
was	O
correlated	O
with	O
acetyl	O
-	O
Lys	O
-	O
310	O
RelA	B-Gene_or_gene_product
/	O
p65	B-Gene_or_gene_product
expressions	O
in	O
hepatocarcinoma	O
tissues	O
.	O
<EOS>	B-X
The	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
family	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
expressions	B-X
of	B-X
numerous	B-X
genes	B-X
,	B-X
in	B-X
development	B-X
,	B-X
apoptosis	B-X
,	B-X
inflammatory	B-X
responses	B-X
,	B-X
and	B-X
oncogenesis	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
identified	B-X
four	B-X
NF-κB	B-X
target	B-X
genes	B-X
that	B-X
are	B-X
modulated	B-X
by	B-X
TIP60	B-X
.	B-X
We	B-X
also	B-X
found	B-X
that	B-X
TIP60	B-X
interacts	B-X
with	B-X
the	B-X
NF-κB	B-X
RelA/p65	B-X
subunit	B-X
and	B-X
increases	B-X
its	B-X
transcriptional	B-X
activity	B-X
through	B-X
protein-protein	B-X
interaction	B-X
.	B-X
Although	B-X
TIP60	B-X
binds	B-X
with	B-X
RelA/p65	B-X
using	B-X
its	B-X
histone	B-X
acetyltransferase	B-X
domain	B-X
,	B-X
TIP60	B-X
does	B-X
not	B-X
directly	B-X
acetylate	B-X
RelA/p65	B-X
.	B-X
However	B-X
,	B-X
TIP60	B-X
maintained	B-X
acetylated	B-X
Lys-310	B-X
RelA/p65	B-X
levels	B-X
in	B-X
the	B-X
TNF-α-dependent	B-X
NF-κB	B-X
signaling	B-X
pathway	B-X
.	B-X
In	B-X
chromatin	B-X
immunoprecipitation	B-X
assay	B-X
,	B-X
TIP60	B-X
was	B-X
primarily	B-X
recruited	B-X
to	B-X
the	B-X
IL-6	B-X
,	B-X
IL-8	B-X
,	B-X
C-IAP1	B-X
,	B-X
and	B-X
XIAP	B-X
promoters	B-X
in	B-X
TNF-α	B-X
stimulation	B-X
followed	B-X
by	B-X
acetylation	B-X
of	B-X
histones	B-X
H3	B-X
and	B-X
H4	B-X
.	B-X
Chromatin	B-X
remodeling	B-X
by	B-X
TIP60	B-X
involved	B-X
the	B-X
sequential	B-X
recruitment	B-X
of	B-X
acetyl-Lys-310	B-X
RelA/p65	B-X
to	B-X
its	B-X
target	B-X
gene	B-X
promoters	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
up-regulated	B-X
TIP60	B-X
expression	B-X
was	B-X
correlated	B-X
with	B-X
acetyl-Lys-310	B-X
RelA/p65	B-X
expressions	B-X
in	B-X
hepatocarcinoma	B-X
tissues	B-X
.	B-X
Taken	B-X
together	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
TIP60	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
NF-κB	B-X
pathway	B-X
through	B-X
protein	B-X
interaction	B-X
with	B-X
RelA/p65	B-X
and	B-X
that	B-X
it	B-X
modulates	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
RelA/p65	B-X
in	B-X
NF-κB-dependent	B-X
gene	B-X
expression	B-X
.	B-X

Taken	O
together	O
these	O
results	O
suggest	O
that	O
TIP60	B-Gene_or_gene_product
is	O
involved	O
in	O
the	O
NF	O
-	O
kappaB	O
pathway	O
through	O
protein	O
interaction	O
with	O
RelA	B-Gene_or_gene_product
/	O
p65	B-Gene_or_gene_product
and	O
that	O
it	O
modulates	O
the	O
transcriptional	O
activity	O
of	O
RelA	B-Gene_or_gene_product
/	O
p65	B-Gene_or_gene_product
in	O
NF	O
-	O
kappaB	O
-	O
dependent	O
gene	O
expression	O
.	O
<EOS>	B-X
The	B-X
nuclear	B-X
factor-κB	B-X
(	B-X
NF-κB	B-X
)	B-X
family	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
expressions	B-X
of	B-X
numerous	B-X
genes	B-X
,	B-X
in	B-X
development	B-X
,	B-X
apoptosis	B-X
,	B-X
inflammatory	B-X
responses	B-X
,	B-X
and	B-X
oncogenesis	B-X
.	B-X
In	B-X
this	B-X
study	B-X
we	B-X
identified	B-X
four	B-X
NF-κB	B-X
target	B-X
genes	B-X
that	B-X
are	B-X
modulated	B-X
by	B-X
TIP60	B-X
.	B-X
We	B-X
also	B-X
found	B-X
that	B-X
TIP60	B-X
interacts	B-X
with	B-X
the	B-X
NF-κB	B-X
RelA/p65	B-X
subunit	B-X
and	B-X
increases	B-X
its	B-X
transcriptional	B-X
activity	B-X
through	B-X
protein-protein	B-X
interaction	B-X
.	B-X
Although	B-X
TIP60	B-X
binds	B-X
with	B-X
RelA/p65	B-X
using	B-X
its	B-X
histone	B-X
acetyltransferase	B-X
domain	B-X
,	B-X
TIP60	B-X
does	B-X
not	B-X
directly	B-X
acetylate	B-X
RelA/p65	B-X
.	B-X
However	B-X
,	B-X
TIP60	B-X
maintained	B-X
acetylated	B-X
Lys-310	B-X
RelA/p65	B-X
levels	B-X
in	B-X
the	B-X
TNF-α-dependent	B-X
NF-κB	B-X
signaling	B-X
pathway	B-X
.	B-X
In	B-X
chromatin	B-X
immunoprecipitation	B-X
assay	B-X
,	B-X
TIP60	B-X
was	B-X
primarily	B-X
recruited	B-X
to	B-X
the	B-X
IL-6	B-X
,	B-X
IL-8	B-X
,	B-X
C-IAP1	B-X
,	B-X
and	B-X
XIAP	B-X
promoters	B-X
in	B-X
TNF-α	B-X
stimulation	B-X
followed	B-X
by	B-X
acetylation	B-X
of	B-X
histones	B-X
H3	B-X
and	B-X
H4	B-X
.	B-X
Chromatin	B-X
remodeling	B-X
by	B-X
TIP60	B-X
involved	B-X
the	B-X
sequential	B-X
recruitment	B-X
of	B-X
acetyl-Lys-310	B-X
RelA/p65	B-X
to	B-X
its	B-X
target	B-X
gene	B-X
promoters	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
up-regulated	B-X
TIP60	B-X
expression	B-X
was	B-X
correlated	B-X
with	B-X
acetyl-Lys-310	B-X
RelA/p65	B-X
expressions	B-X
in	B-X
hepatocarcinoma	B-X
tissues	B-X
.	B-X
Taken	B-X
together	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
TIP60	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
NF-κB	B-X
pathway	B-X
through	B-X
protein	B-X
interaction	B-X
with	B-X
RelA/p65	B-X
and	B-X
that	B-X
it	B-X
modulates	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
RelA/p65	B-X
in	B-X
NF-κB-dependent	B-X
gene	B-X
expression	B-X
.	B-X

Interaction	O
with	O
CREB	B-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
modulates	O
the	O
activities	O
of	O
Nrf2	B-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
in	O
cystic	O
fibrosis	O
airway	O
epithelial	O
cells	O
.	O
<EOS>	B-X
Cystic	B-X
fibrosis	B-X
(	B-X
CF	B-X
)	B-X
is	B-X
characterized	B-X
by	B-X
inflammatory	B-X
lung	B-X
disease	B-X
that	B-X
significantly	B-X
contributes	B-X
to	B-X
morbidity	B-X
and	B-X
mortality	B-X
.	B-X
Airway	B-X
epithelial	B-X
cells	B-X
play	B-X
a	B-X
role	B-X
in	B-X
the	B-X
inflammatory	B-X
signaling	B-X
in	B-X
CF	B-X
and	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
exhibit	B-X
a	B-X
number	B-X
of	B-X
dysfunctions	B-X
in	B-X
signaling	B-X
cascades	B-X
that	B-X
modulate	B-X
inflammation	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
reported	B-X
that	B-X
the	B-X
activity	B-X
of	B-X
nuclear	B-X
factor	B-X
erythroid-derived-like	B-X
2	B-X
(	B-X
Nrf2	B-X
)	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
regulates	B-X
antioxidant	B-X
and	B-X
cytoprotective	B-X
protein	B-X
expression	B-X
,	B-X
is	B-X
diminished	B-X
in	B-X
CF	B-X
epithelia	B-X
(	B-X
7	B-X
)	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
examined	B-X
the	B-X
mechanism	B-X
of	B-X
Nrf2	B-X
dysregulation	B-X
in	B-X
vitro	B-X
in	B-X
human	B-X
airway	B-X
epithelial	B-X
cell	B-X
lines	B-X
and	B-X
primary	B-X
cells	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
nasal	B-X
epithelia	B-X
excised	B-X
from	B-X
ΔF508	B-X
CF	B-X
mutant	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
cAMP-mediated	B-X
signaling	B-X
markedly	B-X
reduces	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
vs.	B-X
non-CF	B-X
cells	B-X
.	B-X
Rp-cAMPS	B-X
,	B-X
a	B-X
cAMP	B-X
competitor	B-X
,	B-X
significantly	B-X
corrected	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
cells	B-X
,	B-X
predominantly	B-X
by	B-X
increasing	B-X
the	B-X
nuclear	B-X
accumulation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Rp-cAMPS	B-X
significantly	B-X
decreased	B-X
NF-κB	B-X
activation	B-X
following	B-X
inflammatory	B-X
stimulation	B-X
of	B-X
CF	B-X
cells	B-X
.	B-X
Further	B-X
investigation	B-X
revealed	B-X
that	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
compete	B-X
for	B-X
the	B-X
transcriptional	B-X
coactivator	B-X
cAMP	B-X
responsive	B-X
element-binding	B-X
protein	B-X
(	B-X
CREB	B-X
)	B-X
binding	B-X
protein	B-X
(	B-X
CBP	B-X
)	B-X
and	B-X
that	B-X
Rp-cAMPS	B-X
shifts	B-X
CBP	B-X
association	B-X
in	B-X
favor	B-X
of	B-X
Nrf2	B-X
.	B-X
Thus	B-X
our	B-X
findings	B-X
provide	B-X
a	B-X
link	B-X
between	B-X
feedback	B-X
to	B-X
CF	B-X
transmembrane	B-X
regulator	B-X
dysfunction	B-X
and	B-X
dysregulation	B-X
of	B-X
an	B-X
inflammatory	B-X
signaling	B-X
pathway	B-X
that	B-X
modulates	B-X
the	B-X
coordinated	B-X
activities	B-X
of	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
strategies	B-X
that	B-X
shift	B-X
CBP	B-X
association	B-X
away	B-X
from	B-X
NF-κB	B-X
and	B-X
toward	B-X
Nrf2	B-X
could	B-X
have	B-X
potential	B-X
therapeutic	B-X
efficacy	B-X
for	B-X
reducing	B-X
inflammation	B-X
in	B-X
patients	B-X
with	B-X
CF	B-X
.	B-X

Cystic	O
fibrosis	O
(	O
CF	O
)	O
is	O
characterized	O
by	O
inflammatory	O
lung	O
disease	O
that	O
significantly	O
contributes	O
to	O
morbidity	O
and	O
mortality	O
.	O
<EOS>	B-X
Pulmonary	B-X
disease	B-X
is	B-X
the	B-X
main	B-X
cause	B-X
of	B-X
the	B-X
morbidity	B-X
and	B-X
mortality	B-X
of	B-X
patients	B-X
affected	B-X
by	B-X
cystic	B-X
fibrosis	B-X
(	B-X
CF	B-X
)	B-X
.	B-X
The	B-X
lung	B-X
pathology	B-X
is	B-X
dominated	B-X
by	B-X
excessive	B-X
recruitment	B-X
of	B-X
neutrophils	B-X
followed	B-X
by	B-X
an	B-X
exaggerated	B-X
inflammatory	B-X
process	B-X
that	B-X
has	B-X
also	B-X
been	B-X
reported	B-X
to	B-X
occur	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
apparent	B-X
pathogenic	B-X
infections	B-X
.	B-X
The	B-X
continuous	B-X
release	B-X
of	B-X
reactive	B-X
oxygen	B-X
species	B-X
and	B-X
proteases	B-X
by	B-X
neutrophils	B-X
contributes	B-X
to	B-X
tissue	B-X
damage	B-X
,	B-X
which	B-X
eventually	B-X
leads	B-X
to	B-X
respiratory	B-X
insufficiency	B-X
.	B-X
CF	B-X
has	B-X
been	B-X
considered	B-X
a	B-X
paediatric	B-X
problem	B-X
for	B-X
several	B-X
decades	B-X
.	B-X
Nevertheless	B-X
,	B-X
during	B-X
the	B-X
last	B-X
40	B-X
years	B-X
,	B-X
therapeutic	B-X
options	B-X
for	B-X
CF	B-X
have	B-X
been	B-X
greatly	B-X
improved	B-X
,	B-X
turning	B-X
CF	B-X
into	B-X
a	B-X
chronic	B-X
disease	B-X
and	B-X
extending	B-X
the	B-X
life	B-X
expectancy	B-X
of	B-X
patients	B-X
.	B-X
Unfortunately	B-X
,	B-X
chronic	B-X
inflammatory	B-X
processes	B-X
,	B-X
which	B-X
are	B-X
characterized	B-X
by	B-X
a	B-X
substantial	B-X
release	B-X
of	B-X
cytokines	B-X
and	B-X
chemokines	B-X
,	B-X
along	B-X
with	B-X
ROS	B-X
and	B-X
proteases	B-X
,	B-X
can	B-X
accelerate	B-X
cellular	B-X
senescence	B-X
,	B-X
leading	B-X
to	B-X
further	B-X
complications	B-X
in	B-X
adulthood	B-X
.	B-X
The	B-X
alterations	B-X
and	B-X
mechanisms	B-X
downstream	B-X
of	B-X
CFTR	B-X
functional	B-X
defects	B-X
that	B-X
can	B-X
stimulate	B-X
cellular	B-X
senescence	B-X
remain	B-X
unclear	B-X
.	B-X
However	B-X
,	B-X
while	B-X
there	B-X
are	B-X
correlative	B-X
data	B-X
suggesting	B-X
that	B-X
cellular	B-X
senescence	B-X
may	B-X
be	B-X
implicated	B-X
in	B-X
CF	B-X
,	B-X
a	B-X
causal	B-X
or	B-X
consequential	B-X
relationship	B-X
between	B-X
cellular	B-X
senescence	B-X
and	B-X
CF	B-X
is	B-X
still	B-X
far	B-X
from	B-X
being	B-X
established	B-X
.	B-X
However	B-X
,	B-X
it	B-X
may	B-X
also	B-X
promote	B-X
a	B-X
pro-inflammatory	B-X
environment	B-X
,	B-X
thereby	B-X
damaging	B-X
tissues	B-X
and	B-X
leading	B-X
to	B-X
chronic	B-X
age-related	B-X
diseases	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
present	B-X
the	B-X
most	B-X
current	B-X
knowledge	B-X
on	B-X
cellular	B-X
senescence	B-X
and	B-X
contextualize	B-X
its	B-X
possible	B-X
involvement	B-X
in	B-X
CF	B-X
.	B-X

Airway	O
epithelial	O
cells	O
play	O
a	O
role	O
in	O
the	O
inflammatory	O
signaling	O
in	O
CF	O
and	O
have	O
been	O
reported	O
to	O
exhibit	O
a	O
number	O
of	O
dysfunctions	O
in	O
signaling	O
cascades	O
that	O
modulate	O
inflammation	O
.	O
<EOS>	B-X
Cystic	B-X
fibrosis	B-X
(	B-X
CF	B-X
)	B-X
is	B-X
characterized	B-X
by	B-X
inflammatory	B-X
lung	B-X
disease	B-X
that	B-X
significantly	B-X
contributes	B-X
to	B-X
morbidity	B-X
and	B-X
mortality	B-X
.	B-X
Airway	B-X
epithelial	B-X
cells	B-X
play	B-X
a	B-X
role	B-X
in	B-X
the	B-X
inflammatory	B-X
signaling	B-X
in	B-X
CF	B-X
and	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
exhibit	B-X
a	B-X
number	B-X
of	B-X
dysfunctions	B-X
in	B-X
signaling	B-X
cascades	B-X
that	B-X
modulate	B-X
inflammation	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
reported	B-X
that	B-X
the	B-X
activity	B-X
of	B-X
nuclear	B-X
factor	B-X
erythroid-derived-like	B-X
2	B-X
(	B-X
Nrf2	B-X
)	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
regulates	B-X
antioxidant	B-X
and	B-X
cytoprotective	B-X
protein	B-X
expression	B-X
,	B-X
is	B-X
diminished	B-X
in	B-X
CF	B-X
epithelia	B-X
(	B-X
7	B-X
)	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
examined	B-X
the	B-X
mechanism	B-X
of	B-X
Nrf2	B-X
dysregulation	B-X
in	B-X
vitro	B-X
in	B-X
human	B-X
airway	B-X
epithelial	B-X
cell	B-X
lines	B-X
and	B-X
primary	B-X
cells	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
nasal	B-X
epithelia	B-X
excised	B-X
from	B-X
ΔF508	B-X
CF	B-X
mutant	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
cAMP-mediated	B-X
signaling	B-X
markedly	B-X
reduces	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
vs.	B-X
non-CF	B-X
cells	B-X
.	B-X
Rp-cAMPS	B-X
,	B-X
a	B-X
cAMP	B-X
competitor	B-X
,	B-X
significantly	B-X
corrected	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
cells	B-X
,	B-X
predominantly	B-X
by	B-X
increasing	B-X
the	B-X
nuclear	B-X
accumulation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Rp-cAMPS	B-X
significantly	B-X
decreased	B-X
NF-κB	B-X
activation	B-X
following	B-X
inflammatory	B-X
stimulation	B-X
of	B-X
CF	B-X
cells	B-X
.	B-X
Thus	B-X
our	B-X
findings	B-X
provide	B-X
a	B-X
link	B-X
between	B-X
feedback	B-X
to	B-X
CF	B-X
transmembrane	B-X
regulator	B-X
dysfunction	B-X
and	B-X
dysregulation	B-X
of	B-X
an	B-X
inflammatory	B-X
signaling	B-X
pathway	B-X
that	B-X
modulates	B-X
the	B-X
coordinated	B-X
activities	B-X
of	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
strategies	B-X
that	B-X
shift	B-X
CBP	B-X
association	B-X
away	B-X
from	B-X
NF-κB	B-X
and	B-X
toward	B-X
Nrf2	B-X
could	B-X
have	B-X
potential	B-X
therapeutic	B-X
efficacy	B-X
for	B-X
reducing	B-X
inflammation	B-X
in	B-X
patients	B-X
with	B-X
CF	B-X
.	B-X

Previously	O
,	O
we	O
reported	O
that	O
the	O
activity	O
of	O
nuclear	B-Gene_or_gene_product
factor	I-Gene_or_gene_product
erythroid	I-Gene_or_gene_product
-	I-Gene_or_gene_product
derived	I-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
2	I-Gene_or_gene_product
(	O
Nrf2	B-Gene_or_gene_product
)	O
,	O
a	O
transcription	O
factor	O
that	O
regulates	O
antioxidant	O
and	O
cytoprotective	O
protein	O
expression	O
,	O
is	O
diminished	O
in	O
CF	O
epithelia	O
(	O
7	O
)	O
.	O

In	O
this	O
report	O
,	O
we	O
examined	O
the	O
mechanism	O
of	O
Nrf2	B-Gene_or_gene_product
dysregulation	O
in	O
vitro	O
in	O
human	O
airway	O
epithelial	O
cell	O
lines	O
and	O
primary	O
cells	O
and	O
in	O
vivo	O
in	O
nasal	O
epithelia	O
excised	O
from	O
DeltaF508	O
CF	O
mutant	O
mice	O
.	O
<EOS>	B-X
Cystic	B-X
fibrosis	B-X
(	B-X
CF	B-X
)	B-X
is	B-X
characterized	B-X
by	B-X
inflammatory	B-X
lung	B-X
disease	B-X
that	B-X
significantly	B-X
contributes	B-X
to	B-X
morbidity	B-X
and	B-X
mortality	B-X
.	B-X
Airway	B-X
epithelial	B-X
cells	B-X
play	B-X
a	B-X
role	B-X
in	B-X
the	B-X
inflammatory	B-X
signaling	B-X
in	B-X
CF	B-X
and	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
exhibit	B-X
a	B-X
number	B-X
of	B-X
dysfunctions	B-X
in	B-X
signaling	B-X
cascades	B-X
that	B-X
modulate	B-X
inflammation	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
reported	B-X
that	B-X
the	B-X
activity	B-X
of	B-X
nuclear	B-X
factor	B-X
erythroid-derived-like	B-X
2	B-X
(	B-X
Nrf2	B-X
)	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
regulates	B-X
antioxidant	B-X
and	B-X
cytoprotective	B-X
protein	B-X
expression	B-X
,	B-X
is	B-X
diminished	B-X
in	B-X
CF	B-X
epithelia	B-X
(	B-X
7	B-X
)	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
examined	B-X
the	B-X
mechanism	B-X
of	B-X
Nrf2	B-X
dysregulation	B-X
in	B-X
vitro	B-X
in	B-X
human	B-X
airway	B-X
epithelial	B-X
cell	B-X
lines	B-X
and	B-X
primary	B-X
cells	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
nasal	B-X
epithelia	B-X
excised	B-X
from	B-X
ΔF508	B-X
CF	B-X
mutant	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
cAMP-mediated	B-X
signaling	B-X
markedly	B-X
reduces	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
vs.	B-X
non-CF	B-X
cells	B-X
.	B-X
Rp-cAMPS	B-X
,	B-X
a	B-X
cAMP	B-X
competitor	B-X
,	B-X
significantly	B-X
corrected	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
cells	B-X
,	B-X
predominantly	B-X
by	B-X
increasing	B-X
the	B-X
nuclear	B-X
accumulation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Rp-cAMPS	B-X
significantly	B-X
decreased	B-X
NF-κB	B-X
activation	B-X
following	B-X
inflammatory	B-X
stimulation	B-X
of	B-X
CF	B-X
cells	B-X
.	B-X
Further	B-X
investigation	B-X
revealed	B-X
that	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
compete	B-X
for	B-X
the	B-X
transcriptional	B-X
coactivator	B-X
cAMP	B-X
responsive	B-X
element-binding	B-X
protein	B-X
(	B-X
CREB	B-X
)	B-X
binding	B-X
protein	B-X
(	B-X
CBP	B-X
)	B-X
and	B-X
that	B-X
Rp-cAMPS	B-X
shifts	B-X
CBP	B-X
association	B-X
in	B-X
favor	B-X
of	B-X
Nrf2	B-X
.	B-X
Thus	B-X
our	B-X
findings	B-X
provide	B-X
a	B-X
link	B-X
between	B-X
feedback	B-X
to	B-X
CF	B-X
transmembrane	B-X
regulator	B-X
dysfunction	B-X
and	B-X
dysregulation	B-X
of	B-X
an	B-X
inflammatory	B-X
signaling	B-X
pathway	B-X
that	B-X
modulates	B-X
the	B-X
coordinated	B-X
activities	B-X
of	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
strategies	B-X
that	B-X
shift	B-X
CBP	B-X
association	B-X
away	B-X
from	B-X
NF-κB	B-X
and	B-X
toward	B-X
Nrf2	B-X
could	B-X
have	B-X
potential	B-X
therapeutic	B-X
efficacy	B-X
for	B-X
reducing	B-X
inflammation	B-X
in	B-X
patients	B-X
with	B-X
CF	B-X
.	B-X

We	O
found	O
that	O
cAMP	O
-	O
mediated	O
signaling	O
markedly	O
reduces	O
Nrf2	B-Gene_or_gene_product
activity	O
in	O
CF	O
vs	O
.	O
non	O
-	O
CF	O
cells	O
.	O
<EOS>	B-X
Cystic	B-X
fibrosis	B-X
(	B-X
CF	B-X
)	B-X
is	B-X
characterized	B-X
by	B-X
inflammatory	B-X
lung	B-X
disease	B-X
that	B-X
significantly	B-X
contributes	B-X
to	B-X
morbidity	B-X
and	B-X
mortality	B-X
.	B-X
Airway	B-X
epithelial	B-X
cells	B-X
play	B-X
a	B-X
role	B-X
in	B-X
the	B-X
inflammatory	B-X
signaling	B-X
in	B-X
CF	B-X
and	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
exhibit	B-X
a	B-X
number	B-X
of	B-X
dysfunctions	B-X
in	B-X
signaling	B-X
cascades	B-X
that	B-X
modulate	B-X
inflammation	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
reported	B-X
that	B-X
the	B-X
activity	B-X
of	B-X
nuclear	B-X
factor	B-X
erythroid-derived-like	B-X
2	B-X
(	B-X
Nrf2	B-X
)	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
regulates	B-X
antioxidant	B-X
and	B-X
cytoprotective	B-X
protein	B-X
expression	B-X
,	B-X
is	B-X
diminished	B-X
in	B-X
CF	B-X
epithelia	B-X
(	B-X
7	B-X
)	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
examined	B-X
the	B-X
mechanism	B-X
of	B-X
Nrf2	B-X
dysregulation	B-X
in	B-X
vitro	B-X
in	B-X
human	B-X
airway	B-X
epithelial	B-X
cell	B-X
lines	B-X
and	B-X
primary	B-X
cells	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
nasal	B-X
epithelia	B-X
excised	B-X
from	B-X
ΔF508	B-X
CF	B-X
mutant	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
cAMP-mediated	B-X
signaling	B-X
markedly	B-X
reduces	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
vs.	B-X
non-CF	B-X
cells	B-X
.	B-X
Rp-cAMPS	B-X
,	B-X
a	B-X
cAMP	B-X
competitor	B-X
,	B-X
significantly	B-X
corrected	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
cells	B-X
,	B-X
predominantly	B-X
by	B-X
increasing	B-X
the	B-X
nuclear	B-X
accumulation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Rp-cAMPS	B-X
significantly	B-X
decreased	B-X
NF-κB	B-X
activation	B-X
following	B-X
inflammatory	B-X
stimulation	B-X
of	B-X
CF	B-X
cells	B-X
.	B-X
Further	B-X
investigation	B-X
revealed	B-X
that	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
compete	B-X
for	B-X
the	B-X
transcriptional	B-X
coactivator	B-X
cAMP	B-X
responsive	B-X
element-binding	B-X
protein	B-X
(	B-X
CREB	B-X
)	B-X
binding	B-X
protein	B-X
(	B-X
CBP	B-X
)	B-X
and	B-X
that	B-X
Rp-cAMPS	B-X
shifts	B-X
CBP	B-X
association	B-X
in	B-X
favor	B-X
of	B-X
Nrf2	B-X
.	B-X
Thus	B-X
our	B-X
findings	B-X
provide	B-X
a	B-X
link	B-X
between	B-X
feedback	B-X
to	B-X
CF	B-X
transmembrane	B-X
regulator	B-X
dysfunction	B-X
and	B-X
dysregulation	B-X
of	B-X
an	B-X
inflammatory	B-X
signaling	B-X
pathway	B-X
that	B-X
modulates	B-X
the	B-X
coordinated	B-X
activities	B-X
of	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
strategies	B-X
that	B-X
shift	B-X
CBP	B-X
association	B-X
away	B-X
from	B-X
NF-κB	B-X
and	B-X
toward	B-X
Nrf2	B-X
could	B-X
have	B-X
potential	B-X
therapeutic	B-X
efficacy	B-X
for	B-X
reducing	B-X
inflammation	B-X
in	B-X
patients	B-X
with	B-X
CF	B-X
.	B-X

Rp	O
-	O
cAMPS	O
,	O
a	O
cAMP	O
competitor	O
,	O
significantly	O
corrected	O
Nrf2	B-Gene_or_gene_product
activity	O
in	O
CF	O
cells	O
,	O
predominantly	O
by	O
increasing	O
the	O
nuclear	O
accumulation	O
of	O
the	O
transcription	O
factor	O
.	O
<EOS>	B-X
Cystic	B-X
fibrosis	B-X
(	B-X
CF	B-X
)	B-X
is	B-X
characterized	B-X
by	B-X
inflammatory	B-X
lung	B-X
disease	B-X
that	B-X
significantly	B-X
contributes	B-X
to	B-X
morbidity	B-X
and	B-X
mortality	B-X
.	B-X
Airway	B-X
epithelial	B-X
cells	B-X
play	B-X
a	B-X
role	B-X
in	B-X
the	B-X
inflammatory	B-X
signaling	B-X
in	B-X
CF	B-X
and	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
exhibit	B-X
a	B-X
number	B-X
of	B-X
dysfunctions	B-X
in	B-X
signaling	B-X
cascades	B-X
that	B-X
modulate	B-X
inflammation	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
reported	B-X
that	B-X
the	B-X
activity	B-X
of	B-X
nuclear	B-X
factor	B-X
erythroid-derived-like	B-X
2	B-X
(	B-X
Nrf2	B-X
)	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
regulates	B-X
antioxidant	B-X
and	B-X
cytoprotective	B-X
protein	B-X
expression	B-X
,	B-X
is	B-X
diminished	B-X
in	B-X
CF	B-X
epithelia	B-X
(	B-X
7	B-X
)	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
examined	B-X
the	B-X
mechanism	B-X
of	B-X
Nrf2	B-X
dysregulation	B-X
in	B-X
vitro	B-X
in	B-X
human	B-X
airway	B-X
epithelial	B-X
cell	B-X
lines	B-X
and	B-X
primary	B-X
cells	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
nasal	B-X
epithelia	B-X
excised	B-X
from	B-X
ΔF508	B-X
CF	B-X
mutant	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
cAMP-mediated	B-X
signaling	B-X
markedly	B-X
reduces	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
vs.	B-X
non-CF	B-X
cells	B-X
.	B-X
Rp-cAMPS	B-X
,	B-X
a	B-X
cAMP	B-X
competitor	B-X
,	B-X
significantly	B-X
corrected	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
cells	B-X
,	B-X
predominantly	B-X
by	B-X
increasing	B-X
the	B-X
nuclear	B-X
accumulation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Rp-cAMPS	B-X
significantly	B-X
decreased	B-X
NF-κB	B-X
activation	B-X
following	B-X
inflammatory	B-X
stimulation	B-X
of	B-X
CF	B-X
cells	B-X
.	B-X
Further	B-X
investigation	B-X
revealed	B-X
that	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
compete	B-X
for	B-X
the	B-X
transcriptional	B-X
coactivator	B-X
cAMP	B-X
responsive	B-X
element-binding	B-X
protein	B-X
(	B-X
CREB	B-X
)	B-X
binding	B-X
protein	B-X
(	B-X
CBP	B-X
)	B-X
and	B-X
that	B-X
Rp-cAMPS	B-X
shifts	B-X
CBP	B-X
association	B-X
in	B-X
favor	B-X
of	B-X
Nrf2	B-X
.	B-X
Thus	B-X
our	B-X
findings	B-X
provide	B-X
a	B-X
link	B-X
between	B-X
feedback	B-X
to	B-X
CF	B-X
transmembrane	B-X
regulator	B-X
dysfunction	B-X
and	B-X
dysregulation	B-X
of	B-X
an	B-X
inflammatory	B-X
signaling	B-X
pathway	B-X
that	B-X
modulates	B-X
the	B-X
coordinated	B-X
activities	B-X
of	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
strategies	B-X
that	B-X
shift	B-X
CBP	B-X
association	B-X
away	B-X
from	B-X
NF-κB	B-X
and	B-X
toward	B-X
Nrf2	B-X
could	B-X
have	B-X
potential	B-X
therapeutic	B-X
efficacy	B-X
for	B-X
reducing	B-X
inflammation	B-X
in	B-X
patients	B-X
with	B-X
CF	B-X
.	B-X

Furthermore	O
,	O
we	O
found	O
that	O
Rp	O
-	O
cAMPS	O
significantly	O
decreased	O
NF	O
-	O
kappaB	O
activation	O
following	O
inflammatory	O
stimulation	O
of	O
CF	O
cells	O
.	O
<EOS>	B-X
Cystic	B-X
fibrosis	B-X
(	B-X
CF	B-X
)	B-X
is	B-X
characterized	B-X
by	B-X
inflammatory	B-X
lung	B-X
disease	B-X
that	B-X
significantly	B-X
contributes	B-X
to	B-X
morbidity	B-X
and	B-X
mortality	B-X
.	B-X
Airway	B-X
epithelial	B-X
cells	B-X
play	B-X
a	B-X
role	B-X
in	B-X
the	B-X
inflammatory	B-X
signaling	B-X
in	B-X
CF	B-X
and	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
exhibit	B-X
a	B-X
number	B-X
of	B-X
dysfunctions	B-X
in	B-X
signaling	B-X
cascades	B-X
that	B-X
modulate	B-X
inflammation	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
reported	B-X
that	B-X
the	B-X
activity	B-X
of	B-X
nuclear	B-X
factor	B-X
erythroid-derived-like	B-X
2	B-X
(	B-X
Nrf2	B-X
)	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
regulates	B-X
antioxidant	B-X
and	B-X
cytoprotective	B-X
protein	B-X
expression	B-X
,	B-X
is	B-X
diminished	B-X
in	B-X
CF	B-X
epithelia	B-X
(	B-X
7	B-X
)	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
examined	B-X
the	B-X
mechanism	B-X
of	B-X
Nrf2	B-X
dysregulation	B-X
in	B-X
vitro	B-X
in	B-X
human	B-X
airway	B-X
epithelial	B-X
cell	B-X
lines	B-X
and	B-X
primary	B-X
cells	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
nasal	B-X
epithelia	B-X
excised	B-X
from	B-X
ΔF508	B-X
CF	B-X
mutant	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
cAMP-mediated	B-X
signaling	B-X
markedly	B-X
reduces	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
vs.	B-X
non-CF	B-X
cells	B-X
.	B-X
Rp-cAMPS	B-X
,	B-X
a	B-X
cAMP	B-X
competitor	B-X
,	B-X
significantly	B-X
corrected	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
cells	B-X
,	B-X
predominantly	B-X
by	B-X
increasing	B-X
the	B-X
nuclear	B-X
accumulation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Rp-cAMPS	B-X
significantly	B-X
decreased	B-X
NF-κB	B-X
activation	B-X
following	B-X
inflammatory	B-X
stimulation	B-X
of	B-X
CF	B-X
cells	B-X
.	B-X
Further	B-X
investigation	B-X
revealed	B-X
that	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
compete	B-X
for	B-X
the	B-X
transcriptional	B-X
coactivator	B-X
cAMP	B-X
responsive	B-X
element-binding	B-X
protein	B-X
(	B-X
CREB	B-X
)	B-X
binding	B-X
protein	B-X
(	B-X
CBP	B-X
)	B-X
and	B-X
that	B-X
Rp-cAMPS	B-X
shifts	B-X
CBP	B-X
association	B-X
in	B-X
favor	B-X
of	B-X
Nrf2	B-X
.	B-X
Thus	B-X
our	B-X
findings	B-X
provide	B-X
a	B-X
link	B-X
between	B-X
feedback	B-X
to	B-X
CF	B-X
transmembrane	B-X
regulator	B-X
dysfunction	B-X
and	B-X
dysregulation	B-X
of	B-X
an	B-X
inflammatory	B-X
signaling	B-X
pathway	B-X
that	B-X
modulates	B-X
the	B-X
coordinated	B-X
activities	B-X
of	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
strategies	B-X
that	B-X
shift	B-X
CBP	B-X
association	B-X
away	B-X
from	B-X
NF-κB	B-X
and	B-X
toward	B-X
Nrf2	B-X
could	B-X
have	B-X
potential	B-X
therapeutic	B-X
efficacy	B-X
for	B-X
reducing	B-X
inflammation	B-X
in	B-X
patients	B-X
with	B-X
CF	B-X
.	B-X

Further	O
investigation	O
revealed	O
that	O
Nrf2	B-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
compete	O
for	O
the	O
transcriptional	O
coactivator	O
cAMP	B-Gene_or_gene_product
responsive	I-Gene_or_gene_product
element	I-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	I-Gene_or_gene_product
CREB	I-Gene_or_gene_product
)	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
CBP	B-Gene_or_gene_product
)	O
and	O
that	O
Rp	O
-	O
cAMPS	O
shifts	O
CBP	B-Gene_or_gene_product
association	O
in	O
favor	O
of	O
Nrf2	B-Gene_or_gene_product
.	O
<EOS>	B-X
Previously	B-X
,	B-X
we	B-X
reported	B-X
that	B-X
the	B-X
activity	B-X
of	B-X
nuclear	B-X
factor	B-X
erythroid-derived-like	B-X
2	B-X
(	B-X
Nrf2	B-X
)	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
regulates	B-X
antioxidant	B-X
and	B-X
cytoprotective	B-X
protein	B-X
expression	B-X
,	B-X
is	B-X
diminished	B-X
in	B-X
CF	B-X
epithelia	B-X
(	B-X
7	B-X
)	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
examined	B-X
the	B-X
mechanism	B-X
of	B-X
Nrf2	B-X
dysregulation	B-X
in	B-X
vitro	B-X
in	B-X
human	B-X
airway	B-X
epithelial	B-X
cell	B-X
lines	B-X
and	B-X
primary	B-X
cells	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
nasal	B-X
epithelia	B-X
excised	B-X
from	B-X
ΔF508	B-X
CF	B-X
mutant	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
cAMP-mediated	B-X
signaling	B-X
markedly	B-X
reduces	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
vs.	B-X
non-CF	B-X
cells	B-X
.	B-X
Rp-cAMPS	B-X
,	B-X
a	B-X
cAMP	B-X
competitor	B-X
,	B-X
significantly	B-X
corrected	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
cells	B-X
,	B-X
predominantly	B-X
by	B-X
increasing	B-X
the	B-X
nuclear	B-X
accumulation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Rp-cAMPS	B-X
significantly	B-X
decreased	B-X
NF-κB	B-X
activation	B-X
following	B-X
inflammatory	B-X
stimulation	B-X
of	B-X
CF	B-X
cells	B-X
.	B-X
Further	B-X
investigation	B-X
revealed	B-X
that	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
compete	B-X
for	B-X
the	B-X
transcriptional	B-X
coactivator	B-X
cAMP	B-X
responsive	B-X
element-binding	B-X
protein	B-X
(	B-X
CREB	B-X
)	B-X
binding	B-X
protein	B-X
(	B-X
CBP	B-X
)	B-X
and	B-X
that	B-X
Rp-cAMPS	B-X
shifts	B-X
CBP	B-X
association	B-X
in	B-X
favor	B-X
of	B-X
Nrf2	B-X
.	B-X
Thus	B-X
our	B-X
findings	B-X
provide	B-X
a	B-X
link	B-X
between	B-X
feedback	B-X
to	B-X
CF	B-X
transmembrane	B-X
regulator	B-X
dysfunction	B-X
and	B-X
dysregulation	B-X
of	B-X
an	B-X
inflammatory	B-X
signaling	B-X
pathway	B-X
that	B-X
modulates	B-X
the	B-X
coordinated	B-X
activities	B-X
of	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
strategies	B-X
that	B-X
shift	B-X
CBP	B-X
association	B-X
away	B-X
from	B-X
NF-κB	B-X
and	B-X
toward	B-X
Nrf2	B-X
could	B-X
have	B-X
potential	B-X
therapeutic	B-X
efficacy	B-X
for	B-X
reducing	B-X
inflammation	B-X
in	B-X
patients	B-X
with	B-X
CF	B-X
.	B-X

Thus	O
our	O
findings	O
provide	O
a	O
link	O
between	O
feedback	O
to	O
CF	O
transmembrane	O
regulator	O
dysfunction	O
and	O
dysregulation	O
of	O
an	O
inflammatory	O
signaling	O
pathway	O
that	O
modulates	O
the	O
coordinated	O
activities	O
of	O
Nrf2	B-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
.	O
<EOS>	B-X
Cystic	B-X
fibrosis	B-X
(	B-X
CF	B-X
)	B-X
is	B-X
characterized	B-X
by	B-X
inflammatory	B-X
lung	B-X
disease	B-X
that	B-X
significantly	B-X
contributes	B-X
to	B-X
morbidity	B-X
and	B-X
mortality	B-X
.	B-X
Airway	B-X
epithelial	B-X
cells	B-X
play	B-X
a	B-X
role	B-X
in	B-X
the	B-X
inflammatory	B-X
signaling	B-X
in	B-X
CF	B-X
and	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
exhibit	B-X
a	B-X
number	B-X
of	B-X
dysfunctions	B-X
in	B-X
signaling	B-X
cascades	B-X
that	B-X
modulate	B-X
inflammation	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
reported	B-X
that	B-X
the	B-X
activity	B-X
of	B-X
nuclear	B-X
factor	B-X
erythroid-derived-like	B-X
2	B-X
(	B-X
Nrf2	B-X
)	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
regulates	B-X
antioxidant	B-X
and	B-X
cytoprotective	B-X
protein	B-X
expression	B-X
,	B-X
is	B-X
diminished	B-X
in	B-X
CF	B-X
epithelia	B-X
(	B-X
7	B-X
)	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
examined	B-X
the	B-X
mechanism	B-X
of	B-X
Nrf2	B-X
dysregulation	B-X
in	B-X
vitro	B-X
in	B-X
human	B-X
airway	B-X
epithelial	B-X
cell	B-X
lines	B-X
and	B-X
primary	B-X
cells	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
nasal	B-X
epithelia	B-X
excised	B-X
from	B-X
ΔF508	B-X
CF	B-X
mutant	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
cAMP-mediated	B-X
signaling	B-X
markedly	B-X
reduces	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
vs.	B-X
non-CF	B-X
cells	B-X
.	B-X
Rp-cAMPS	B-X
,	B-X
a	B-X
cAMP	B-X
competitor	B-X
,	B-X
significantly	B-X
corrected	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
cells	B-X
,	B-X
predominantly	B-X
by	B-X
increasing	B-X
the	B-X
nuclear	B-X
accumulation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Rp-cAMPS	B-X
significantly	B-X
decreased	B-X
NF-κB	B-X
activation	B-X
following	B-X
inflammatory	B-X
stimulation	B-X
of	B-X
CF	B-X
cells	B-X
.	B-X
Further	B-X
investigation	B-X
revealed	B-X
that	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
compete	B-X
for	B-X
the	B-X
transcriptional	B-X
coactivator	B-X
cAMP	B-X
responsive	B-X
element-binding	B-X
protein	B-X
(	B-X
CREB	B-X
)	B-X
binding	B-X
protein	B-X
(	B-X
CBP	B-X
)	B-X
and	B-X
that	B-X
Rp-cAMPS	B-X
shifts	B-X
CBP	B-X
association	B-X
in	B-X
favor	B-X
of	B-X
Nrf2	B-X
.	B-X
Thus	B-X
our	B-X
findings	B-X
provide	B-X
a	B-X
link	B-X
between	B-X
feedback	B-X
to	B-X
CF	B-X
transmembrane	B-X
regulator	B-X
dysfunction	B-X
and	B-X
dysregulation	B-X
of	B-X
an	B-X
inflammatory	B-X
signaling	B-X
pathway	B-X
that	B-X
modulates	B-X
the	B-X
coordinated	B-X
activities	B-X
of	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
strategies	B-X
that	B-X
shift	B-X
CBP	B-X
association	B-X
away	B-X
from	B-X
NF-κB	B-X
and	B-X
toward	B-X
Nrf2	B-X
could	B-X
have	B-X
potential	B-X
therapeutic	B-X
efficacy	B-X
for	B-X
reducing	B-X
inflammation	B-X
in	B-X
patients	B-X
with	B-X
CF	B-X
.	B-X

Furthermore	O
,	O
our	O
studies	O
suggest	O
that	O
strategies	O
that	O
shift	O
CBP	B-Gene_or_gene_product
association	O
away	O
from	O
NF	O
-	O
kappaB	O
and	O
toward	O
Nrf2	B-Gene_or_gene_product
could	O
have	O
potential	O
therapeutic	O
efficacy	O
for	O
reducing	O
inflammation	O
in	O
patients	O
with	O
CF	O
.	O
<EOS>	B-X
Cystic	B-X
fibrosis	B-X
(	B-X
CF	B-X
)	B-X
is	B-X
characterized	B-X
by	B-X
inflammatory	B-X
lung	B-X
disease	B-X
that	B-X
significantly	B-X
contributes	B-X
to	B-X
morbidity	B-X
and	B-X
mortality	B-X
.	B-X
Airway	B-X
epithelial	B-X
cells	B-X
play	B-X
a	B-X
role	B-X
in	B-X
the	B-X
inflammatory	B-X
signaling	B-X
in	B-X
CF	B-X
and	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
exhibit	B-X
a	B-X
number	B-X
of	B-X
dysfunctions	B-X
in	B-X
signaling	B-X
cascades	B-X
that	B-X
modulate	B-X
inflammation	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
reported	B-X
that	B-X
the	B-X
activity	B-X
of	B-X
nuclear	B-X
factor	B-X
erythroid-derived-like	B-X
2	B-X
(	B-X
Nrf2	B-X
)	B-X
,	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
regulates	B-X
antioxidant	B-X
and	B-X
cytoprotective	B-X
protein	B-X
expression	B-X
,	B-X
is	B-X
diminished	B-X
in	B-X
CF	B-X
epithelia	B-X
(	B-X
7	B-X
)	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
examined	B-X
the	B-X
mechanism	B-X
of	B-X
Nrf2	B-X
dysregulation	B-X
in	B-X
vitro	B-X
in	B-X
human	B-X
airway	B-X
epithelial	B-X
cell	B-X
lines	B-X
and	B-X
primary	B-X
cells	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
nasal	B-X
epithelia	B-X
excised	B-X
from	B-X
ΔF508	B-X
CF	B-X
mutant	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
cAMP-mediated	B-X
signaling	B-X
markedly	B-X
reduces	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
vs.	B-X
non-CF	B-X
cells	B-X
.	B-X
Rp-cAMPS	B-X
,	B-X
a	B-X
cAMP	B-X
competitor	B-X
,	B-X
significantly	B-X
corrected	B-X
Nrf2	B-X
activity	B-X
in	B-X
CF	B-X
cells	B-X
,	B-X
predominantly	B-X
by	B-X
increasing	B-X
the	B-X
nuclear	B-X
accumulation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Rp-cAMPS	B-X
significantly	B-X
decreased	B-X
NF-κB	B-X
activation	B-X
following	B-X
inflammatory	B-X
stimulation	B-X
of	B-X
CF	B-X
cells	B-X
.	B-X
Further	B-X
investigation	B-X
revealed	B-X
that	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
compete	B-X
for	B-X
the	B-X
transcriptional	B-X
coactivator	B-X
cAMP	B-X
responsive	B-X
element-binding	B-X
protein	B-X
(	B-X
CREB	B-X
)	B-X
binding	B-X
protein	B-X
(	B-X
CBP	B-X
)	B-X
and	B-X
that	B-X
Rp-cAMPS	B-X
shifts	B-X
CBP	B-X
association	B-X
in	B-X
favor	B-X
of	B-X
Nrf2	B-X
.	B-X
Thus	B-X
our	B-X
findings	B-X
provide	B-X
a	B-X
link	B-X
between	B-X
feedback	B-X
to	B-X
CF	B-X
transmembrane	B-X
regulator	B-X
dysfunction	B-X
and	B-X
dysregulation	B-X
of	B-X
an	B-X
inflammatory	B-X
signaling	B-X
pathway	B-X
that	B-X
modulates	B-X
the	B-X
coordinated	B-X
activities	B-X
of	B-X
Nrf2	B-X
and	B-X
NF-κB	B-X
.	B-X
Furthermore	B-X
,	B-X
our	B-X
studies	B-X
suggest	B-X
that	B-X
strategies	B-X
that	B-X
shift	B-X
CBP	B-X
association	B-X
away	B-X
from	B-X
NF-κB	B-X
and	B-X
toward	B-X
Nrf2	B-X
could	B-X
have	B-X
potential	B-X
therapeutic	B-X
efficacy	B-X
for	B-X
reducing	B-X
inflammation	B-X
in	B-X
patients	B-X
with	B-X
CF	B-X
.	B-X

E3	B-Gene_or_gene_product
-	I-Gene_or_gene_product
14	I-Gene_or_gene_product
.	I-Gene_or_gene_product
7K	I-Gene_or_gene_product
is	O
recruited	O
to	O
TNF	O
-	O
receptor	O
1	O
and	O
blocks	O
TNF	B-Gene_or_gene_product
cytolysis	O
independent	O
from	O
interaction	O
with	O
optineurin	B-Gene_or_gene_product
.	O

Escape	O
from	O
the	O
host	O
immune	O
system	O
is	O
essential	O
for	O
intracellular	O
pathogens	O
.	O
<EOS>	B-X
Innate	B-X
immunity	B-X
plays	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
mediating	B-X
the	B-X
initial	B-X
host	B-X
response	B-X
against	B-X
these	B-X
intracellular	B-X
bacteria	B-X
.	B-X
Specifically	B-X
,	B-X
macrophages	B-X
phagocytose	B-X
and	B-X
eliminate	B-X
NTM	B-X
and	B-X
act	B-X
as	B-X
antigen-presenting	B-X
cells	B-X
,	B-X
which	B-X
trigger	B-X
downstream	B-X
activation	B-X
of	B-X
cellular	B-X
and	B-X
humoral	B-X
adaptive	B-X
immune	B-X
responses	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
focus	B-X
on	B-X
NTM	B-X
immunity	B-X
,	B-X
the	B-X
role	B-X
of	B-X
macrophages	B-X
,	B-X
and	B-X
host	B-X
interaction	B-X
in	B-X
NTM	B-X
infection	B-X
.	B-X
This	B-X
review	B-X
aims	B-X
to	B-X
describe	B-X
and	B-X
discuss	B-X
the	B-X
different	B-X
functions	B-X
of	B-X
the	B-X
endolysosomal	B-X
system	B-X
,	B-X
from	B-X
homeostasis	B-X
to	B-X
its	B-X
vital	B-X
role	B-X
during	B-X
viral	B-X
infections	B-X
.	B-X
We	B-X
will	B-X
initially	B-X
describe	B-X
endolysosomal	B-X
system	B-X
's	B-X
main	B-X
functions	B-X
,	B-X
presenting	B-X
recent	B-X
data	B-X
on	B-X
how	B-X
its	B-X
compartments	B-X
are	B-X
essential	B-X
for	B-X
host	B-X
defense	B-X
to	B-X
explore	B-X
later	B-X
how	B-X
SARS-CoV-2	B-X
(	B-X
Severe	B-X
Acute	B-X
Respiratory	B-X
Syndrome	B-X
Coronavirus	B-X
2	B-X
)	B-X
and	B-X
other	B-X
coronaviruses	B-X
subvert	B-X
these	B-X
organelles	B-X
for	B-X
their	B-X
benefit	B-X
.	B-X
It	B-X
is	B-X
clear	B-X
that	B-X
to	B-X
succeed	B-X
,	B-X
pathogens	B-X
'	B-X
evolution	B-X
favored	B-X
the	B-X
establishment	B-X
of	B-X
ways	B-X
to	B-X
avoid	B-X
,	B-X
escape	B-X
,	B-X
or	B-X
manipulate	B-X
lysosomal	B-X
function	B-X
.	B-X
The	B-X
unavoidable	B-X
coexistence	B-X
with	B-X
such	B-X
an	B-X
unfriendly	B-X
milieu	B-X
imposed	B-X
on	B-X
viruses	B-X
the	B-X
establishment	B-X
of	B-X
a	B-X
vast	B-X
array	B-X
of	B-X
strategies	B-X
to	B-X
make	B-X
the	B-X
most	B-X
out	B-X
of	B-X
the	B-X
invaded	B-X
cell	B-X
's	B-X
machinery	B-X
to	B-X
produce	B-X
new	B-X
viruses	B-X
and	B-X
maneuvers	B-X
to	B-X
escape	B-X
the	B-X
host	B-X
's	B-X
defense	B-X
system	B-X
.	B-X

The	O
adenoviral	O
protein	O
E3	B-Gene_or_gene_product
-	I-Gene_or_gene_product
14	I-Gene_or_gene_product
.	I-Gene_or_gene_product
7K	I-Gene_or_gene_product
(	O
14	B-Gene_or_gene_product
.	I-Gene_or_gene_product
7K	I-Gene_or_gene_product
)	O
is	O
known	O
as	O
a	O
general	O
inhibitor	O
of	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
TNF	B-Gene_or_gene_product
)	O
-	O
induced	O
apoptosis	O
.	O
<EOS>	B-X
The	B-X
adenoviral	B-X
protein	B-X
E3-14.7K	B-X
(	B-X
14.7K	B-X
)	B-X
is	B-X
known	B-X
as	B-X
a	B-X
general	B-X
inhibitor	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-induced	B-X
apoptosis	B-X
.	B-X
It	B-X
efficiently	B-X
blocks	B-X
TNF-receptor	B-X
1	B-X
(	B-X
TNFR1	B-X
)	B-X
internalization	B-X
but	B-X
the	B-X
underlying	B-X
molecular	B-X
mechanism	B-X
still	B-X
remains	B-X
elusive	B-X
.	B-X
Direct	B-X
interaction	B-X
of	B-X
14.7K	B-X
and/or	B-X
associated	B-X
proteins	B-X
with	B-X
the	B-X
TNFR1	B-X
complex	B-X
has	B-X
been	B-X
discussed	B-X
although	B-X
to	B-X
date	B-X
not	B-X
proven	B-X
.	B-X
In	B-X
our	B-X
study	B-X
,	B-X
we	B-X
provide	B-X
for	B-X
the	B-X
first	B-X
time	B-X
evidence	B-X
for	B-X
recruitment	B-X
of	B-X
14.7K	B-X
and	B-X
the	B-X
14.7K	B-X
interacting	B-X
protein	B-X
optineurin	B-X
to	B-X
TNFR1	B-X
.	B-X
Various	B-X
functions	B-X
have	B-X
been	B-X
implicated	B-X
for	B-X
optineurin	B-X
such	B-X
as	B-X
regulation	B-X
of	B-X
receptor	B-X
endocytosis	B-X
,	B-X
vesicle	B-X
trafficking	B-X
,	B-X
regulation	B-X
of	B-X
the	B-X
nuclear	B-X
factor	B-X
κB	B-X
(	B-X
NF-κB	B-X
)	B-X
pathway	B-X
and	B-X
antiviral	B-X
signaling	B-X
.	B-X
We	B-X
therefore	B-X
hypothesized	B-X
that	B-X
binding	B-X
of	B-X
optineurin	B-X
to	B-X
14.7K	B-X
and	B-X
recruitment	B-X
of	B-X
both	B-X
proteins	B-X
to	B-X
the	B-X
TNFR1	B-X
complex	B-X
is	B-X
essential	B-X
for	B-X
protection	B-X
against	B-X
TNF-induced	B-X
cytotoxic	B-X
effects	B-X
.	B-X
To	B-X
precisely	B-X
dissect	B-X
the	B-X
individual	B-X
role	B-X
of	B-X
14.7K	B-X
and	B-X
optineurin	B-X
,	B-X
we	B-X
generated	B-X
and	B-X
characterized	B-X
a	B-X
14.7K	B-X
mutant	B-X
that	B-X
does	B-X
not	B-X
confer	B-X
TNF-resistance	B-X
but	B-X
is	B-X
still	B-X
able	B-X
to	B-X
interact	B-X
with	B-X
optineurin	B-X
.	B-X
In	B-X
H1299	B-X
and	B-X
KB	B-X
cells	B-X
expressing	B-X
14.7K	B-X
wild-type	B-X
protein	B-X
,	B-X
neither	B-X
decrease	B-X
in	B-X
cell	B-X
viability	B-X
nor	B-X
cleavage	B-X
of	B-X
caspases	B-X
was	B-X
observed	B-X
upon	B-X
stimulation	B-X
with	B-X
TNF	B-X
.	B-X
In	B-X
sharp	B-X
contrast	B-X
,	B-X
cells	B-X
expressing	B-X
the	B-X
non-protective	B-X
mutant	B-X
of	B-X
14.7K	B-X
displayed	B-X
reduced	B-X
viability	B-X
and	B-X
cleavage	B-X
of	B-X
initiator	B-X
and	B-X
effector	B-X
caspases	B-X
upon	B-X
TNF	B-X
treatment	B-X
,	B-X
indicating	B-X
ongoing	B-X
apoptotic	B-X
cell	B-X
death	B-X
.	B-X
Knockdown	B-X
of	B-X
optineurin	B-X
in	B-X
14.7K	B-X
expressing	B-X
cells	B-X
did	B-X
not	B-X
alter	B-X
the	B-X
protective	B-X
effect	B-X
as	B-X
measured	B-X
by	B-X
cell	B-X
viability	B-X
and	B-X
caspase	B-X
activation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
we	B-X
conclude	B-X
that	B-X
optineurin	B-X
despite	B-X
its	B-X
substantial	B-X
role	B-X
in	B-X
vesicular	B-X
trafficking	B-X
,	B-X
endocytosis	B-X
of	B-X
cell	B-X
surface	B-X
receptors	B-X
and	B-X
recruitment	B-X
to	B-X
the	B-X
TNFR1	B-X
complex	B-X
is	B-X
dispensable	B-X
for	B-X
the	B-X
14.7K-mediated	B-X
protection	B-X
against	B-X
TNF-induced	B-X
apoptosis	B-X
.	B-X

It	O
efficiently	O
blocks	O
TNF	O
-	O
receptor	O
1	O
(	O
TNFR1	O
)	O
internalization	O
but	O
the	O
underlying	O
molecular	O
mechanism	O
still	O
remains	O
elusive	O
.	O
<EOS>	B-X
The	B-X
adenoviral	B-X
protein	B-X
E3-14.7K	B-X
(	B-X
14.7K	B-X
)	B-X
is	B-X
known	B-X
as	B-X
a	B-X
general	B-X
inhibitor	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-induced	B-X
apoptosis	B-X
.	B-X
It	B-X
efficiently	B-X
blocks	B-X
TNF-receptor	B-X
1	B-X
(	B-X
TNFR1	B-X
)	B-X
internalization	B-X
but	B-X
the	B-X
underlying	B-X
molecular	B-X
mechanism	B-X
still	B-X
remains	B-X
elusive	B-X
.	B-X
Direct	B-X
interaction	B-X
of	B-X
14.7K	B-X
and/or	B-X
associated	B-X
proteins	B-X
with	B-X
the	B-X
TNFR1	B-X
complex	B-X
has	B-X
been	B-X
discussed	B-X
although	B-X
to	B-X
date	B-X
not	B-X
proven	B-X
.	B-X
In	B-X
our	B-X
study	B-X
,	B-X
we	B-X
provide	B-X
for	B-X
the	B-X
first	B-X
time	B-X
evidence	B-X
for	B-X
recruitment	B-X
of	B-X
14.7K	B-X
and	B-X
the	B-X
14.7K	B-X
interacting	B-X
protein	B-X
optineurin	B-X
to	B-X
TNFR1	B-X
.	B-X
Various	B-X
functions	B-X
have	B-X
been	B-X
implicated	B-X
for	B-X
optineurin	B-X
such	B-X
as	B-X
regulation	B-X
of	B-X
receptor	B-X
endocytosis	B-X
,	B-X
vesicle	B-X
trafficking	B-X
,	B-X
regulation	B-X
of	B-X
the	B-X
nuclear	B-X
factor	B-X
κB	B-X
(	B-X
NF-κB	B-X
)	B-X
pathway	B-X
and	B-X
antiviral	B-X
signaling	B-X
.	B-X
We	B-X
therefore	B-X
hypothesized	B-X
that	B-X
binding	B-X
of	B-X
optineurin	B-X
to	B-X
14.7K	B-X
and	B-X
recruitment	B-X
of	B-X
both	B-X
proteins	B-X
to	B-X
the	B-X
TNFR1	B-X
complex	B-X
is	B-X
essential	B-X
for	B-X
protection	B-X
against	B-X
TNF-induced	B-X
cytotoxic	B-X
effects	B-X
.	B-X
To	B-X
precisely	B-X
dissect	B-X
the	B-X
individual	B-X
role	B-X
of	B-X
14.7K	B-X
and	B-X
optineurin	B-X
,	B-X
we	B-X
generated	B-X
and	B-X
characterized	B-X
a	B-X
14.7K	B-X
mutant	B-X
that	B-X
does	B-X
not	B-X
confer	B-X
TNF-resistance	B-X
but	B-X
is	B-X
still	B-X
able	B-X
to	B-X
interact	B-X
with	B-X
optineurin	B-X
.	B-X
In	B-X
H1299	B-X
and	B-X
KB	B-X
cells	B-X
expressing	B-X
14.7K	B-X
wild-type	B-X
protein	B-X
,	B-X
neither	B-X
decrease	B-X
in	B-X
cell	B-X
viability	B-X
nor	B-X
cleavage	B-X
of	B-X
caspases	B-X
was	B-X
observed	B-X
upon	B-X
stimulation	B-X
with	B-X
TNF	B-X
.	B-X
In	B-X
sharp	B-X
contrast	B-X
,	B-X
cells	B-X
expressing	B-X
the	B-X
non-protective	B-X
mutant	B-X
of	B-X
14.7K	B-X
displayed	B-X
reduced	B-X
viability	B-X
and	B-X
cleavage	B-X
of	B-X
initiator	B-X
and	B-X
effector	B-X
caspases	B-X
upon	B-X
TNF	B-X
treatment	B-X
,	B-X
indicating	B-X
ongoing	B-X
apoptotic	B-X
cell	B-X
death	B-X
.	B-X
Knockdown	B-X
of	B-X
optineurin	B-X
in	B-X
14.7K	B-X
expressing	B-X
cells	B-X
did	B-X
not	B-X
alter	B-X
the	B-X
protective	B-X
effect	B-X
as	B-X
measured	B-X
by	B-X
cell	B-X
viability	B-X
and	B-X
caspase	B-X
activation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
we	B-X
conclude	B-X
that	B-X
optineurin	B-X
despite	B-X
its	B-X
substantial	B-X
role	B-X
in	B-X
vesicular	B-X
trafficking	B-X
,	B-X
endocytosis	B-X
of	B-X
cell	B-X
surface	B-X
receptors	B-X
and	B-X
recruitment	B-X
to	B-X
the	B-X
TNFR1	B-X
complex	B-X
is	B-X
dispensable	B-X
for	B-X
the	B-X
14.7K-mediated	B-X
protection	B-X
against	B-X
TNF-induced	B-X
apoptosis	B-X
.	B-X

Direct	O
interaction	O
of	O
14	B-Gene_or_gene_product
.	I-Gene_or_gene_product
7K	I-Gene_or_gene_product
and	O
/	O
or	O
associated	O
proteins	O
with	O
the	O
TNFR1	O
complex	O
has	O
been	O
discussed	O
although	O
to	O
date	O
not	O
proven	O
.	O
<EOS>	B-X
Synthetic	B-X
vectors	B-X
such	B-X
as	B-X
cationic	B-X
polymers	B-X
and	B-X
cationic	B-X
lipids	B-X
remain	B-X
attractive	B-X
tools	B-X
for	B-X
non-viral	B-X
gene	B-X
transfer	B-X
which	B-X
is	B-X
a	B-X
complex	B-X
process	B-X
whose	B-X
effectiveness	B-X
relies	B-X
on	B-X
the	B-X
ability	B-X
to	B-X
deliver	B-X
a	B-X
plasmid	B-X
DNA	B-X
(	B-X
pDNA	B-X
)	B-X
into	B-X
the	B-X
nucleus	B-X
of	B-X
non-dividing	B-X
cells	B-X
.	B-X
In	B-X
the	B-X
first	B-X
part	B-X
of	B-X
this	B-X
review	B-X
,	B-X
an	B-X
overview	B-X
on	B-X
MTs	B-X
,	B-X
dynein	B-X
,	B-X
dynein/virus	B-X
interaction	B-X
feature	B-X
is	B-X
presented	B-X
followed	B-X
by	B-X
a	B-X
summary	B-X
of	B-X
the	B-X
results	B-X
obtained	B-X
by	B-X
exploitation	B-X
of	B-X
LC8	B-X
and	B-X
TCTEL1	B-X
dynein	B-X
light	B-X
chain	B-X
association	B-X
sequence	B-X
(	B-X
DLC-AS	B-X
)	B-X
for	B-X
non-viral	B-X
transfection	B-X
.	B-X
The	B-X
second	B-X
part	B-X
dedicated	B-X
to	B-X
the	B-X
adenoviral	B-X
protein	B-X
E3-14.7K	B-X
,	B-X
reports	B-X
the	B-X
transfection	B-X
efficiency	B-X
of	B-X
polyplexes	B-X
and	B-X
lipoplexes	B-X
containing	B-X
the	B-X
E3-14.7K-derived	B-X
P79-98	B-X
peptide	B-X
linked	B-X
to	B-X
pDNA	B-X
.	B-X
The	B-X
linkage	B-X
of	B-X
various	B-X
DLC-AS	B-X
to	B-X
pDNA	B-X
carriers	B-X
led	B-X
to	B-X
modest	B-X
transfection	B-X
improvements	B-X
and	B-X
their	B-X
direct	B-X
interaction	B-X
with	B-X
MTs	B-X
was	B-X
not	B-X
demonstrated	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
pDNA	B-X
linked	B-X
to	B-X
the	B-X
P79-98	B-X
peptide	B-X
interacting	B-X
with	B-X
TCTEL1	B-X
via	B-X
a	B-X
cytosolic	B-X
protein	B-X
(	B-X
fourteen	B-X
seven	B-X
K-interacting	B-X
protein-1	B-X
(	B-X
FIP-1	B-X
)	B-X
)	B-X
,	B-X
interaction	B-X
with	B-X
MTs	B-X
is	B-X
evidenced	B-X

In	O
our	O
study	O
,	O
we	O
provide	O
for	O
the	O
first	O
time	O
evidence	O
for	O
recruitment	O
of	O
14	B-Gene_or_gene_product
.	I-Gene_or_gene_product
7K	I-Gene_or_gene_product
and	O
the	O
14	B-Gene_or_gene_product
.	I-Gene_or_gene_product
7K	I-Gene_or_gene_product
interacting	O
protein	O
optineurin	B-Gene_or_gene_product
to	O
TNFR1	O
.	O
<EOS>	B-X
The	B-X
adenoviral	B-X
protein	B-X
E3-14.7K	B-X
(	B-X
14.7K	B-X
)	B-X
is	B-X
known	B-X
as	B-X
a	B-X
general	B-X
inhibitor	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-induced	B-X
apoptosis	B-X
.	B-X
It	B-X
efficiently	B-X
blocks	B-X
TNF-receptor	B-X
1	B-X
(	B-X
TNFR1	B-X
)	B-X
internalization	B-X
but	B-X
the	B-X
underlying	B-X
molecular	B-X
mechanism	B-X
still	B-X
remains	B-X
elusive	B-X
.	B-X
Direct	B-X
interaction	B-X
of	B-X
14.7K	B-X
and/or	B-X
associated	B-X
proteins	B-X
with	B-X
the	B-X
TNFR1	B-X
complex	B-X
has	B-X
been	B-X
discussed	B-X
although	B-X
to	B-X
date	B-X
not	B-X
proven	B-X
.	B-X
In	B-X
our	B-X
study	B-X
,	B-X
we	B-X
provide	B-X
for	B-X
the	B-X
first	B-X
time	B-X
evidence	B-X
for	B-X
recruitment	B-X
of	B-X
14.7K	B-X
and	B-X
the	B-X
14.7K	B-X
interacting	B-X
protein	B-X
optineurin	B-X
to	B-X
TNFR1	B-X
.	B-X
Various	B-X
functions	B-X
have	B-X
been	B-X
implicated	B-X
for	B-X
optineurin	B-X
such	B-X
as	B-X
regulation	B-X
of	B-X
receptor	B-X
endocytosis	B-X
,	B-X
vesicle	B-X
trafficking	B-X
,	B-X
regulation	B-X
of	B-X
the	B-X
nuclear	B-X
factor	B-X
κB	B-X
(	B-X
NF-κB	B-X
)	B-X
pathway	B-X
and	B-X
antiviral	B-X
signaling	B-X
.	B-X
We	B-X
therefore	B-X
hypothesized	B-X
that	B-X
binding	B-X
of	B-X
optineurin	B-X
to	B-X
14.7K	B-X
and	B-X
recruitment	B-X
of	B-X
both	B-X
proteins	B-X
to	B-X
the	B-X
TNFR1	B-X
complex	B-X
is	B-X
essential	B-X
for	B-X
protection	B-X
against	B-X
TNF-induced	B-X
cytotoxic	B-X
effects	B-X
.	B-X
To	B-X
precisely	B-X
dissect	B-X
the	B-X
individual	B-X
role	B-X
of	B-X
14.7K	B-X
and	B-X
optineurin	B-X
,	B-X
we	B-X
generated	B-X
and	B-X
characterized	B-X
a	B-X
14.7K	B-X
mutant	B-X
that	B-X
does	B-X
not	B-X
confer	B-X
TNF-resistance	B-X
but	B-X
is	B-X
still	B-X
able	B-X
to	B-X
interact	B-X
with	B-X
optineurin	B-X
.	B-X
In	B-X
H1299	B-X
and	B-X
KB	B-X
cells	B-X
expressing	B-X
14.7K	B-X
wild-type	B-X
protein	B-X
,	B-X
neither	B-X
decrease	B-X
in	B-X
cell	B-X
viability	B-X
nor	B-X
cleavage	B-X
of	B-X
caspases	B-X
was	B-X
observed	B-X
upon	B-X
stimulation	B-X
with	B-X
TNF	B-X
.	B-X
In	B-X
sharp	B-X
contrast	B-X
,	B-X
cells	B-X
expressing	B-X
the	B-X
non-protective	B-X
mutant	B-X
of	B-X
14.7K	B-X
displayed	B-X
reduced	B-X
viability	B-X
and	B-X
cleavage	B-X
of	B-X
initiator	B-X
and	B-X
effector	B-X
caspases	B-X
upon	B-X
TNF	B-X
treatment	B-X
,	B-X
indicating	B-X
ongoing	B-X
apoptotic	B-X
cell	B-X
death	B-X
.	B-X
Knockdown	B-X
of	B-X
optineurin	B-X
in	B-X
14.7K	B-X
expressing	B-X
cells	B-X
did	B-X
not	B-X
alter	B-X
the	B-X
protective	B-X
effect	B-X
as	B-X
measured	B-X
by	B-X
cell	B-X
viability	B-X
and	B-X
caspase	B-X
activation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
we	B-X
conclude	B-X
that	B-X
optineurin	B-X
despite	B-X
its	B-X
substantial	B-X
role	B-X
in	B-X
vesicular	B-X
trafficking	B-X
,	B-X
endocytosis	B-X
of	B-X
cell	B-X
surface	B-X
receptors	B-X
and	B-X
recruitment	B-X
to	B-X
the	B-X
TNFR1	B-X
complex	B-X
is	B-X
dispensable	B-X
for	B-X
the	B-X
14.7K-mediated	B-X
protection	B-X
against	B-X
TNF-induced	B-X
apoptosis	B-X
.	B-X

Various	O
functions	O
have	O
been	O
implicated	O
for	O
optineurin	B-Gene_or_gene_product
such	O
as	O
regulation	O
of	O
receptor	O
endocytosis	O
,	O
vesicle	O
trafficking	O
,	O
regulation	O
of	O
the	O
nuclear	O
factor	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
pathway	O
and	O
antiviral	O
signaling	O
.	O
<EOS>	B-X
The	B-X
adenoviral	B-X
protein	B-X
E3-14.7K	B-X
(	B-X
14.7K	B-X
)	B-X
is	B-X
known	B-X
as	B-X
a	B-X
general	B-X
inhibitor	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-induced	B-X
apoptosis	B-X
.	B-X
It	B-X
efficiently	B-X
blocks	B-X
TNF-receptor	B-X
1	B-X
(	B-X
TNFR1	B-X
)	B-X
internalization	B-X
but	B-X
the	B-X
underlying	B-X
molecular	B-X
mechanism	B-X
still	B-X
remains	B-X
elusive	B-X
.	B-X
Direct	B-X
interaction	B-X
of	B-X
14.7K	B-X
and/or	B-X
associated	B-X
proteins	B-X
with	B-X
the	B-X
TNFR1	B-X
complex	B-X
has	B-X
been	B-X
discussed	B-X
although	B-X
to	B-X
date	B-X
not	B-X
proven	B-X
.	B-X
In	B-X
our	B-X
study	B-X
,	B-X
we	B-X
provide	B-X
for	B-X
the	B-X
first	B-X
time	B-X
evidence	B-X
for	B-X
recruitment	B-X
of	B-X
14.7K	B-X
and	B-X
the	B-X
14.7K	B-X
interacting	B-X
protein	B-X
optineurin	B-X
to	B-X
TNFR1	B-X
.	B-X
Various	B-X
functions	B-X
have	B-X
been	B-X
implicated	B-X
for	B-X
optineurin	B-X
such	B-X
as	B-X
regulation	B-X
of	B-X
receptor	B-X
endocytosis	B-X
,	B-X
vesicle	B-X
trafficking	B-X
,	B-X
regulation	B-X
of	B-X
the	B-X
nuclear	B-X
factor	B-X
κB	B-X
(	B-X
NF-κB	B-X
)	B-X
pathway	B-X
and	B-X
antiviral	B-X
signaling	B-X
.	B-X
We	B-X
therefore	B-X
hypothesized	B-X
that	B-X
binding	B-X
of	B-X
optineurin	B-X
to	B-X
14.7K	B-X
and	B-X
recruitment	B-X
of	B-X
both	B-X
proteins	B-X
to	B-X
the	B-X
TNFR1	B-X
complex	B-X
is	B-X
essential	B-X
for	B-X
protection	B-X
against	B-X
TNF-induced	B-X
cytotoxic	B-X
effects	B-X
.	B-X
To	B-X
precisely	B-X
dissect	B-X
the	B-X
individual	B-X
role	B-X
of	B-X
14.7K	B-X
and	B-X
optineurin	B-X
,	B-X
we	B-X
generated	B-X
and	B-X
characterized	B-X
a	B-X
14.7K	B-X
mutant	B-X
that	B-X
does	B-X
not	B-X
confer	B-X
TNF-resistance	B-X
but	B-X
is	B-X
still	B-X
able	B-X
to	B-X
interact	B-X
with	B-X
optineurin	B-X
.	B-X
In	B-X
H1299	B-X
and	B-X
KB	B-X
cells	B-X
expressing	B-X
14.7K	B-X
wild-type	B-X
protein	B-X
,	B-X
neither	B-X
decrease	B-X
in	B-X
cell	B-X
viability	B-X
nor	B-X
cleavage	B-X
of	B-X
caspases	B-X
was	B-X
observed	B-X
upon	B-X
stimulation	B-X
with	B-X
TNF	B-X
.	B-X
In	B-X
sharp	B-X
contrast	B-X
,	B-X
cells	B-X
expressing	B-X
the	B-X
non-protective	B-X
mutant	B-X
of	B-X
14.7K	B-X
displayed	B-X
reduced	B-X
viability	B-X
and	B-X
cleavage	B-X
of	B-X
initiator	B-X
and	B-X
effector	B-X
caspases	B-X
upon	B-X
TNF	B-X
treatment	B-X
,	B-X
indicating	B-X
ongoing	B-X
apoptotic	B-X
cell	B-X
death	B-X
.	B-X
Knockdown	B-X
of	B-X
optineurin	B-X
in	B-X
14.7K	B-X
expressing	B-X
cells	B-X
did	B-X
not	B-X
alter	B-X
the	B-X
protective	B-X
effect	B-X
as	B-X
measured	B-X
by	B-X
cell	B-X
viability	B-X
and	B-X
caspase	B-X
activation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
we	B-X
conclude	B-X
that	B-X
optineurin	B-X
despite	B-X
its	B-X
substantial	B-X
role	B-X
in	B-X
vesicular	B-X
trafficking	B-X
,	B-X
endocytosis	B-X
of	B-X
cell	B-X
surface	B-X
receptors	B-X
and	B-X
recruitment	B-X
to	B-X
the	B-X
TNFR1	B-X
complex	B-X
is	B-X
dispensable	B-X
for	B-X
the	B-X
14.7K-mediated	B-X
protection	B-X
against	B-X
TNF-induced	B-X
apoptosis	B-X
.	B-X

We	O
therefore	O
hypothesized	O
that	O
binding	O
of	O
optineurin	B-Gene_or_gene_product
to	O
14	B-Gene_or_gene_product
.	I-Gene_or_gene_product
7K	I-Gene_or_gene_product
and	O
recruitment	O
of	O
both	O
proteins	O
to	O
the	O
TNFR1	O
complex	O
is	O
essential	O
for	O
protection	O
against	O
TNF	B-Gene_or_gene_product
-	O
induced	O
cytotoxic	O
effects	O
.	O

To	O
precisely	O
dissect	O
the	O
individual	O
role	O
of	O
14	B-Gene_or_gene_product
.	I-Gene_or_gene_product
7K	I-Gene_or_gene_product
and	O
optineurin	B-Gene_or_gene_product
,	O
we	O
generated	O
and	O
characterized	O
a	O
14	B-Gene_or_gene_product
.	I-Gene_or_gene_product
7K	I-Gene_or_gene_product
mutant	O
that	O
does	O
not	O
confer	O
TNF	B-Gene_or_gene_product
-	O
resistance	O
but	O
is	O
still	O
able	O
to	O
interact	O
with	O
optineurin	B-Gene_or_gene_product
.	O

In	O
H1299	O
and	O
KB	O
cells	O
expressing	O
14	B-Gene_or_gene_product
.	I-Gene_or_gene_product
7K	I-Gene_or_gene_product
wild	O
-	O
type	O
protein	O
,	O
neither	O
decrease	O
in	O
cell	O
viability	O
nor	O
cleavage	O
of	O
caspases	O
was	O
observed	O
upon	O
stimulation	O
with	O
TNF	B-Gene_or_gene_product
.	O
<EOS>	B-X
Escape	B-X
from	B-X
the	B-X
host	B-X
immune	B-X
system	B-X
is	B-X
essential	B-X
for	B-X
intracellular	B-X
pathogens	B-X
.	B-X
The	B-X
adenoviral	B-X
protein	B-X
E3-14.7K	B-X
(	B-X
14.7K	B-X
)	B-X
is	B-X
known	B-X
as	B-X
a	B-X
general	B-X
inhibitor	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-induced	B-X
apoptosis	B-X
.	B-X
It	B-X
efficiently	B-X
blocks	B-X
TNF-receptor	B-X
1	B-X
(	B-X
TNFR1	B-X
)	B-X
internalization	B-X
but	B-X
the	B-X
underlying	B-X
molecular	B-X
mechanism	B-X
still	B-X
remains	B-X
elusive	B-X
.	B-X
Direct	B-X
interaction	B-X
of	B-X
14.7K	B-X
and/or	B-X
associated	B-X
proteins	B-X
with	B-X
the	B-X
TNFR1	B-X
complex	B-X
has	B-X
been	B-X
discussed	B-X
although	B-X
to	B-X
date	B-X
not	B-X
proven	B-X
.	B-X
In	B-X
our	B-X
study	B-X
,	B-X
we	B-X
provide	B-X
for	B-X
the	B-X
first	B-X
time	B-X
evidence	B-X
for	B-X
recruitment	B-X
of	B-X
14.7K	B-X
and	B-X
the	B-X
14.7K	B-X
interacting	B-X
protein	B-X
optineurin	B-X
to	B-X
TNFR1	B-X
.	B-X
We	B-X
therefore	B-X
hypothesized	B-X
that	B-X
binding	B-X
of	B-X
optineurin	B-X
to	B-X
14.7K	B-X
and	B-X
recruitment	B-X
of	B-X
both	B-X
proteins	B-X
to	B-X
the	B-X
TNFR1	B-X
complex	B-X
is	B-X
essential	B-X
for	B-X
protection	B-X
against	B-X
TNF-induced	B-X
cytotoxic	B-X
effects	B-X
.	B-X
To	B-X
precisely	B-X
dissect	B-X
the	B-X
individual	B-X
role	B-X
of	B-X
14.7K	B-X
and	B-X
optineurin	B-X
,	B-X
we	B-X
generated	B-X
and	B-X
characterized	B-X
a	B-X
14.7K	B-X
mutant	B-X
that	B-X
does	B-X
not	B-X
confer	B-X
TNF-resistance	B-X
but	B-X
is	B-X
still	B-X
able	B-X
to	B-X
interact	B-X
with	B-X
optineurin	B-X
.	B-X
In	B-X
H1299	B-X
and	B-X
KB	B-X
cells	B-X
expressing	B-X
14.7K	B-X
wild-type	B-X
protein	B-X
,	B-X
neither	B-X
decrease	B-X
in	B-X
cell	B-X
viability	B-X
nor	B-X
cleavage	B-X
of	B-X
caspases	B-X
was	B-X
observed	B-X
upon	B-X
stimulation	B-X
with	B-X
TNF	B-X
.	B-X
In	B-X
sharp	B-X
contrast	B-X
,	B-X
cells	B-X
expressing	B-X
the	B-X
non-protective	B-X
mutant	B-X
of	B-X
14.7K	B-X
displayed	B-X
reduced	B-X
viability	B-X
and	B-X
cleavage	B-X
of	B-X
initiator	B-X
and	B-X
effector	B-X
caspases	B-X
upon	B-X
TNF	B-X
treatment	B-X
,	B-X
indicating	B-X
ongoing	B-X
apoptotic	B-X
cell	B-X
death	B-X
.	B-X
Knockdown	B-X
of	B-X
optineurin	B-X
in	B-X
14.7K	B-X
expressing	B-X
cells	B-X
did	B-X
not	B-X
alter	B-X
the	B-X
protective	B-X
effect	B-X
as	B-X
measured	B-X
by	B-X
cell	B-X
viability	B-X
and	B-X
caspase	B-X
activation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
we	B-X
conclude	B-X
that	B-X
optineurin	B-X
despite	B-X
its	B-X
substantial	B-X
role	B-X
in	B-X
vesicular	B-X
trafficking	B-X
,	B-X
endocytosis	B-X
of	B-X
cell	B-X
surface	B-X
receptors	B-X
and	B-X
recruitment	B-X
to	B-X
the	B-X
TNFR1	B-X
complex	B-X
is	B-X
dispensable	B-X
for	B-X
the	B-X
14.7K-mediated	B-X
protection	B-X
against	B-X
TNF-induced	B-X
apoptosis	B-X
.	B-X

In	O
sharp	O
contrast	O
,	O
cells	O
expressing	O
the	O
non	O
-	O
protective	O
mutant	O
of	O
14	B-Gene_or_gene_product
.	I-Gene_or_gene_product
7K	I-Gene_or_gene_product
displayed	O
reduced	O
viability	O
and	O
cleavage	O
of	O
initiator	O
and	O
effector	O
caspases	O
upon	O
TNF	B-Gene_or_gene_product
treatment	O
,	O
indicating	O
ongoing	O
apoptotic	O
cell	O
death	O
.	O
<EOS>	B-X
Escape	B-X
from	B-X
the	B-X
host	B-X
immune	B-X
system	B-X
is	B-X
essential	B-X
for	B-X
intracellular	B-X
pathogens	B-X
.	B-X
The	B-X
adenoviral	B-X
protein	B-X
E3-14.7K	B-X
(	B-X
14.7K	B-X
)	B-X
is	B-X
known	B-X
as	B-X
a	B-X
general	B-X
inhibitor	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-induced	B-X
apoptosis	B-X
.	B-X
It	B-X
efficiently	B-X
blocks	B-X
TNF-receptor	B-X
1	B-X
(	B-X
TNFR1	B-X
)	B-X
internalization	B-X
but	B-X
the	B-X
underlying	B-X
molecular	B-X
mechanism	B-X
still	B-X
remains	B-X
elusive	B-X
.	B-X
Direct	B-X
interaction	B-X
of	B-X
14.7K	B-X
and/or	B-X
associated	B-X
proteins	B-X
with	B-X
the	B-X
TNFR1	B-X
complex	B-X
has	B-X
been	B-X
discussed	B-X
although	B-X
to	B-X
date	B-X
not	B-X
proven	B-X
.	B-X
In	B-X
our	B-X
study	B-X
,	B-X
we	B-X
provide	B-X
for	B-X
the	B-X
first	B-X
time	B-X
evidence	B-X
for	B-X
recruitment	B-X
of	B-X
14.7K	B-X
and	B-X
the	B-X
14.7K	B-X
interacting	B-X
protein	B-X
optineurin	B-X
to	B-X
TNFR1	B-X
.	B-X
We	B-X
therefore	B-X
hypothesized	B-X
that	B-X
binding	B-X
of	B-X
optineurin	B-X
to	B-X
14.7K	B-X
and	B-X
recruitment	B-X
of	B-X
both	B-X
proteins	B-X
to	B-X
the	B-X
TNFR1	B-X
complex	B-X
is	B-X
essential	B-X
for	B-X
protection	B-X
against	B-X
TNF-induced	B-X
cytotoxic	B-X
effects	B-X
.	B-X
To	B-X
precisely	B-X
dissect	B-X
the	B-X
individual	B-X
role	B-X
of	B-X
14.7K	B-X
and	B-X
optineurin	B-X
,	B-X
we	B-X
generated	B-X
and	B-X
characterized	B-X
a	B-X
14.7K	B-X
mutant	B-X
that	B-X
does	B-X
not	B-X
confer	B-X
TNF-resistance	B-X
but	B-X
is	B-X
still	B-X
able	B-X
to	B-X
interact	B-X
with	B-X
optineurin	B-X
.	B-X
In	B-X
H1299	B-X
and	B-X
KB	B-X
cells	B-X
expressing	B-X
14.7K	B-X
wild-type	B-X
protein	B-X
,	B-X
neither	B-X
decrease	B-X
in	B-X
cell	B-X
viability	B-X
nor	B-X
cleavage	B-X
of	B-X
caspases	B-X
was	B-X
observed	B-X
upon	B-X
stimulation	B-X
with	B-X
TNF	B-X
.	B-X
In	B-X
sharp	B-X
contrast	B-X
,	B-X
cells	B-X
expressing	B-X
the	B-X
non-protective	B-X
mutant	B-X
of	B-X
14.7K	B-X
displayed	B-X
reduced	B-X
viability	B-X
and	B-X
cleavage	B-X
of	B-X
initiator	B-X
and	B-X
effector	B-X
caspases	B-X
upon	B-X
TNF	B-X
treatment	B-X
,	B-X
indicating	B-X
ongoing	B-X
apoptotic	B-X
cell	B-X
death	B-X
.	B-X
Knockdown	B-X
of	B-X
optineurin	B-X
in	B-X
14.7K	B-X
expressing	B-X
cells	B-X
did	B-X
not	B-X
alter	B-X
the	B-X
protective	B-X
effect	B-X
as	B-X
measured	B-X
by	B-X
cell	B-X
viability	B-X
and	B-X
caspase	B-X
activation	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
we	B-X
conclude	B-X
that	B-X
optineurin	B-X
despite	B-X
its	B-X
substantial	B-X
role	B-X
in	B-X
vesicular	B-X
trafficking	B-X
,	B-X
endocytosis	B-X
of	B-X
cell	B-X
surface	B-X
receptors	B-X
and	B-X
recruitment	B-X
to	B-X
the	B-X
TNFR1	B-X
complex	B-X
is	B-X
dispensable	B-X
for	B-X
the	B-X
14.7K-mediated	B-X
protection	B-X
against	B-X
TNF-induced	B-X
apoptosis	B-X
.	B-X

Knockdown	O
of	O
optineurin	B-Gene_or_gene_product
in	O
14	B-Gene_or_gene_product
.	I-Gene_or_gene_product
7K	I-Gene_or_gene_product
expressing	O
cells	O
did	O
not	O
alter	O
the	O
protective	O
effect	O
as	O
measured	O
by	O
cell	O
viability	O
and	O
caspase	B-Gene_or_gene_product
activation	O
.	O
<EOS>	B-X
We	B-X
previously	B-X
isolated	B-X
rat	B-X
14.7K-interacting	B-X
protein-2	B-X
(	B-X
rFIP-2	B-X
)	B-X
from	B-X
the	B-X
rat-wounded	B-X
pulp	B-X
.	B-X
The	B-X
protein	B-X
,	B-X
homologous	B-X
to	B-X
human	B-X
FIP-2	B-X
,	B-X
is	B-X
known	B-X
as	B-X
optineurin	B-X
and	B-X
was	B-X
initially	B-X
identified	B-X
as	B-X
a	B-X
novel	B-X
tumor	B-X
necrosis	B-X
factor-α	B-X
(	B-X
TNF-α	B-X
)	B-X
-inducible	B-X
protein	B-X
,	B-X
and	B-X
more	B-X
recently	B-X
,	B-X
as	B-X
an	B-X
autophagy	B-X
receptor	B-X
.	B-X
However	B-X
,	B-X
the	B-X
biological	B-X
role	B-X
of	B-X
optineurin	B-X
in	B-X
dental	B-X
pulp	B-X
remains	B-X
elusive	B-X
.	B-X
We	B-X
hypothesized	B-X
that	B-X
optineurin	B-X
has	B-X
a	B-X
crucial	B-X
role	B-X
in	B-X
regulating	B-X
molecular	B-X
processes	B-X
during	B-X
pulp	B-X
inflammatory	B-X
responses	B-X
induced	B-X
by	B-X
TNF-α	B-X
.	B-X
We	B-X
examined	B-X
the	B-X
kinetics	B-X
of	B-X
optineurin	B-X
expression	B-X
in	B-X
pulp	B-X
inflammation	B-X
.	B-X
The	B-X
cells	B-X
were	B-X
treated	B-X
with	B-X
pharmacological	B-X
inhibitors	B-X
for	B-X
TNF-α-induced	B-X
inflammatory	B-X
signals	B-X
or	B-X
with	B-X
hydrogen	B-X
peroxide	B-X
as	B-X
apoptotic	B-X
stimuli	B-X
.	B-X
Stable	B-X
optineurin-knockdown	B-X
cells	B-X
(	B-X
OPTN-KD	B-X
cells	B-X
)	B-X
were	B-X
established	B-X
by	B-X
transfecting	B-X
normal	B-X
rat	B-X
kidney	B-X
cells	B-X
with	B-X
a	B-X
vector	B-X
expressing	B-X
optineurin-specific	B-X
small	B-X
interfering	B-X
RNA	B-X
.	B-X
Cell	B-X
proliferation	B-X
and	B-X
the	B-X
profiles	B-X
of	B-X
cytokines	B-X
and	B-X
intracellular	B-X
signaling	B-X
molecules	B-X
were	B-X
examined	B-X
using	B-X
OPTN-KD	B-X
cells	B-X
stimulated	B-X
by	B-X
TNF-α	B-X
.	B-X
The	B-X
OPTN-KD	B-X
cells	B-X
secreted	B-X
smaller	B-X
amounts	B-X
of	B-X
monocyte	B-X
chemotactic	B-X
protein-1	B-X
(	B-X
MCP-1	B-X
)	B-X
and	B-X
intracellular	B-X
MCP-1	B-X
mRNA	B-X
,	B-X
and	B-X
cell	B-X
proliferation	B-X
was	B-X
significantly	B-X
increased	B-X
.	B-X
Apoptosis-related	B-X
signaling	B-X
molecules	B-X
were	B-X
downregulated	B-X
in	B-X
OPTN-KD	B-X
cells	B-X
.	B-X
These	B-X
results	B-X
demonstrated	B-X
that	B-X
optineurin	B-X
is	B-X
a	B-X
crucial	B-X
molecule	B-X
mediated	B-X
by	B-X
TNF-α	B-X
,	B-X
which	B-X
induces	B-X
the	B-X
production	B-X
of	B-X
inflammatory	B-X
factors	B-X
and	B-X
apoptosis	B-X
signaling	B-X
,	B-X
suggesting	B-X
the	B-X
presence	B-X
of	B-X
signaling	B-X
interactions	B-X
between	B-X
optineurin	B-X
and	B-X
a	B-X
transcription	B-X
factor	B-X
for	B-X
MCP-1	B-X
.	B-X

Taken	O
together	O
,	O
we	O
conclude	O
that	O
optineurin	B-Gene_or_gene_product
despite	O
its	O
substantial	O
role	O
in	O
vesicular	O
trafficking	O
,	O
endocytosis	O
of	O
cell	O
surface	O
receptors	O
and	O
recruitment	O
to	O
the	O
TNFR1	O
complex	O
is	O
dispensable	O
for	O
the	O
14	B-Gene_or_gene_product
.	I-Gene_or_gene_product
7K	I-Gene_or_gene_product
-	O
mediated	O
protection	O
against	O
TNF	B-Gene_or_gene_product
-	O
induced	O
apoptosis	O
.	O

HTLV	O
-	O
1	O
tax	B-Gene_or_gene_product
-	O
induced	O
rapid	O
senescence	O
is	O
driven	O
by	O
the	O
transcriptional	O
activity	O
of	O
NF	O
-	O
kappaB	O
and	O
depends	O
on	O
chronically	O
activated	O
IKKalpha	B-Gene_or_gene_product
and	O
p65	B-Gene_or_gene_product
/	O
RelA	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
HTLV-1	B-X
oncoprotein	B-X
Tax	B-X
is	B-X
a	B-X
potent	B-X
activator	B-X
of	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
is	B-X
thought	B-X
to	B-X
promote	B-X
cell	B-X
proliferation	B-X
and	B-X
transformation	B-X
via	B-X
NF-κB	B-X
activation	B-X
.	B-X
We	B-X
showed	B-X
recently	B-X
that	B-X
hyperactivation	B-X
of	B-X
NF-κB	B-X
by	B-X
Tax	B-X
triggers	B-X
a	B-X
cellular	B-X
senescence	B-X
response	B-X
(	B-X
H.	B-X
Zhi	B-X
et	B-X
al.	B-X
,	B-X
PLoS	B-X
Pathog	B-X
.	B-X
7	B-X
:	B-X
e1002025	B-X
,	B-X
2011	B-X
)	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
activation	B-X
by	B-X
expression	B-X
of	B-X
I-κBα	B-X
superrepressor	B-X
or	B-X
by	B-X
small	B-X
hairpin	B-X
RNA	B-X
(	B-X
shRNA	B-X
)	B-X
-mediated	B-X
knockdown	B-X
of	B-X
p65/RelA	B-X
rescues	B-X
cells	B-X
from	B-X
Tax-induced	B-X
rapid	B-X
senescence	B-X
(	B-X
Tax-IRS	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Tax-IRS	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
.	B-X
Knockdown	B-X
of	B-X
IKKγ	B-X
,	B-X
the	B-X
primary	B-X
Tax	B-X
target	B-X
,	B-X
by	B-X
shRNAs	B-X
abrogated	B-X
Tax-mediated	B-X
activation	B-X
of	B-X
both	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
rendered	B-X
knockdown	B-X
cells	B-X
resistant	B-X
to	B-X
Tax-IRS	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
critical	B-X
role	B-X
of	B-X
IKKα	B-X
in	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
IKKα	B-X
deficiency	B-X
drastically	B-X
decreased	B-X
NF-κB	B-X
trans-activation	B-X
by	B-X
Tax	B-X
,	B-X
although	B-X
it	B-X
only	B-X
modestly	B-X
reduced	B-X
Tax-mediated	B-X
I-κBα	B-X
degradation	B-X
and	B-X
NF-κB	B-X
nuclear	B-X
localization	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
although	B-X
IKKβ	B-X
knockdown	B-X
attenuated	B-X
Tax-induced	B-X
NF-κB	B-X
transcriptional	B-X
activation	B-X
,	B-X
the	B-X
residual	B-X
NF-κB	B-X
activation	B-X
in	B-X
IKKβ-deficient	B-X
cells	B-X
was	B-X
sufficient	B-X
to	B-X
trigger	B-X
Tax-IRS	B-X
.	B-X
Importantly	B-X
,	B-X
the	B-X
phenotypes	B-X
of	B-X
NIK	B-X
and	B-X
TAK1	B-X
knockdown	B-X
were	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
knockdown	B-X
,	B-X
respectively	B-X
.	B-X
Finally	B-X
,	B-X
double	B-X
knockdown	B-X
of	B-X
RelB	B-X
and	B-X
p100	B-X
had	B-X
a	B-X
minor	B-X
effect	B-X
on	B-X
senescence	B-X
induction	B-X
by	B-X
Tax	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
Tax	B-X
,	B-X
through	B-X
its	B-X
interaction	B-X
with	B-X
IKKγ	B-X
,	B-X
helps	B-X
recruit	B-X
NIK	B-X
and	B-X
TAK1	B-X
for	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
activation	B-X
,	B-X
respectively	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
the	B-X
delineation	B-X
between	B-X
the	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
becomes	B-X
obscured	B-X
.	B-X
The	B-X
senescence	B-X
checkpoint	B-X
triggered	B-X
by	B-X
Tax	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
which	B-X
depends	B-X
on	B-X
activated	B-X
IKKα	B-X
and	B-X
p65/RelA	B-X
.	B-X

The	O
HTLV	O
-	O
1	O
oncoprotein	O
Tax	B-Gene_or_gene_product
is	O
a	O
potent	O
activator	O
of	O
classical	O
and	O
alternative	O
NF	O
-	O
kappaB	O
pathways	O
and	O
is	O
thought	O
to	O
promote	O
cell	O
proliferation	O
and	O
transformation	O
via	O
NF	O
-	O
kappaB	O
activation	O
.	O
<EOS>	B-X
The	B-X
HTLV-1	B-X
oncoprotein	B-X
Tax	B-X
is	B-X
a	B-X
potent	B-X
activator	B-X
of	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
is	B-X
thought	B-X
to	B-X
promote	B-X
cell	B-X
proliferation	B-X
and	B-X
transformation	B-X
via	B-X
NF-κB	B-X
activation	B-X
.	B-X
We	B-X
showed	B-X
recently	B-X
that	B-X
hyperactivation	B-X
of	B-X
NF-κB	B-X
by	B-X
Tax	B-X
triggers	B-X
a	B-X
cellular	B-X
senescence	B-X
response	B-X
(	B-X
H.	B-X
Zhi	B-X
et	B-X
al.	B-X
,	B-X
PLoS	B-X
Pathog	B-X
.	B-X
7	B-X
:	B-X
e1002025	B-X
,	B-X
2011	B-X
)	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
activation	B-X
by	B-X
expression	B-X
of	B-X
I-κBα	B-X
superrepressor	B-X
or	B-X
by	B-X
small	B-X
hairpin	B-X
RNA	B-X
(	B-X
shRNA	B-X
)	B-X
-mediated	B-X
knockdown	B-X
of	B-X
p65/RelA	B-X
rescues	B-X
cells	B-X
from	B-X
Tax-induced	B-X
rapid	B-X
senescence	B-X
(	B-X
Tax-IRS	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Tax-IRS	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
.	B-X
Knockdown	B-X
of	B-X
IKKγ	B-X
,	B-X
the	B-X
primary	B-X
Tax	B-X
target	B-X
,	B-X
by	B-X
shRNAs	B-X
abrogated	B-X
Tax-mediated	B-X
activation	B-X
of	B-X
both	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
rendered	B-X
knockdown	B-X
cells	B-X
resistant	B-X
to	B-X
Tax-IRS	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
critical	B-X
role	B-X
of	B-X
IKKα	B-X
in	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
IKKα	B-X
deficiency	B-X
drastically	B-X
decreased	B-X
NF-κB	B-X
trans-activation	B-X
by	B-X
Tax	B-X
,	B-X
although	B-X
it	B-X
only	B-X
modestly	B-X
reduced	B-X
Tax-mediated	B-X
I-κBα	B-X
degradation	B-X
and	B-X
NF-κB	B-X
nuclear	B-X
localization	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
although	B-X
IKKβ	B-X
knockdown	B-X
attenuated	B-X
Tax-induced	B-X
NF-κB	B-X
transcriptional	B-X
activation	B-X
,	B-X
the	B-X
residual	B-X
NF-κB	B-X
activation	B-X
in	B-X
IKKβ-deficient	B-X
cells	B-X
was	B-X
sufficient	B-X
to	B-X
trigger	B-X
Tax-IRS	B-X
.	B-X
Importantly	B-X
,	B-X
the	B-X
phenotypes	B-X
of	B-X
NIK	B-X
and	B-X
TAK1	B-X
knockdown	B-X
were	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
knockdown	B-X
,	B-X
respectively	B-X
.	B-X
Finally	B-X
,	B-X
double	B-X
knockdown	B-X
of	B-X
RelB	B-X
and	B-X
p100	B-X
had	B-X
a	B-X
minor	B-X
effect	B-X
on	B-X
senescence	B-X
induction	B-X
by	B-X
Tax	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
Tax	B-X
,	B-X
through	B-X
its	B-X
interaction	B-X
with	B-X
IKKγ	B-X
,	B-X
helps	B-X
recruit	B-X
NIK	B-X
and	B-X
TAK1	B-X
for	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
activation	B-X
,	B-X
respectively	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
the	B-X
delineation	B-X
between	B-X
the	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
becomes	B-X
obscured	B-X
.	B-X
The	B-X
senescence	B-X
checkpoint	B-X
triggered	B-X
by	B-X
Tax	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
which	B-X
depends	B-X
on	B-X
activated	B-X
IKKα	B-X
and	B-X
p65/RelA	B-X
.	B-X

We	O
showed	O
recently	O
that	O
hyperactivation	O
of	O
NF	O
-	O
kappaB	O
by	O
Tax	B-Gene_or_gene_product
triggers	O
a	O
cellular	O
senescence	O
response	O
(	O
H	O
.	O
Zhi	O
et	O
al	O
.	O
,	O
PLoS	O
Pathog	O
.	O
7	O
:	O
e1002025	O
,	O
2011	O
)	O
.	O
<EOS>	B-X
The	B-X
HTLV-1	B-X
oncoprotein	B-X
Tax	B-X
is	B-X
a	B-X
potent	B-X
activator	B-X
of	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
is	B-X
thought	B-X
to	B-X
promote	B-X
cell	B-X
proliferation	B-X
and	B-X
transformation	B-X
via	B-X
NF-κB	B-X
activation	B-X
.	B-X
We	B-X
showed	B-X
recently	B-X
that	B-X
hyperactivation	B-X
of	B-X
NF-κB	B-X
by	B-X
Tax	B-X
triggers	B-X
a	B-X
cellular	B-X
senescence	B-X
response	B-X
(	B-X
H.	B-X
Zhi	B-X
et	B-X
al.	B-X
,	B-X
PLoS	B-X
Pathog	B-X
.	B-X
7	B-X
:	B-X
e1002025	B-X
,	B-X
2011	B-X
)	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
activation	B-X
by	B-X
expression	B-X
of	B-X
I-κBα	B-X
superrepressor	B-X
or	B-X
by	B-X
small	B-X
hairpin	B-X
RNA	B-X
(	B-X
shRNA	B-X
)	B-X
-mediated	B-X
knockdown	B-X
of	B-X
p65/RelA	B-X
rescues	B-X
cells	B-X
from	B-X
Tax-induced	B-X
rapid	B-X
senescence	B-X
(	B-X
Tax-IRS	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Tax-IRS	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
.	B-X
Knockdown	B-X
of	B-X
IKKγ	B-X
,	B-X
the	B-X
primary	B-X
Tax	B-X
target	B-X
,	B-X
by	B-X
shRNAs	B-X
abrogated	B-X
Tax-mediated	B-X
activation	B-X
of	B-X
both	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
rendered	B-X
knockdown	B-X
cells	B-X
resistant	B-X
to	B-X
Tax-IRS	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
critical	B-X
role	B-X
of	B-X
IKKα	B-X
in	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
IKKα	B-X
deficiency	B-X
drastically	B-X
decreased	B-X
NF-κB	B-X
trans-activation	B-X
by	B-X
Tax	B-X
,	B-X
although	B-X
it	B-X
only	B-X
modestly	B-X
reduced	B-X
Tax-mediated	B-X
I-κBα	B-X
degradation	B-X
and	B-X
NF-κB	B-X
nuclear	B-X
localization	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
although	B-X
IKKβ	B-X
knockdown	B-X
attenuated	B-X
Tax-induced	B-X
NF-κB	B-X
transcriptional	B-X
activation	B-X
,	B-X
the	B-X
residual	B-X
NF-κB	B-X
activation	B-X
in	B-X
IKKβ-deficient	B-X
cells	B-X
was	B-X
sufficient	B-X
to	B-X
trigger	B-X
Tax-IRS	B-X
.	B-X
Finally	B-X
,	B-X
double	B-X
knockdown	B-X
of	B-X
RelB	B-X
and	B-X
p100	B-X
had	B-X
a	B-X
minor	B-X
effect	B-X
on	B-X
senescence	B-X
induction	B-X
by	B-X
Tax	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
Tax	B-X
,	B-X
through	B-X
its	B-X
interaction	B-X
with	B-X
IKKγ	B-X
,	B-X
helps	B-X
recruit	B-X
NIK	B-X
and	B-X
TAK1	B-X
for	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
activation	B-X
,	B-X
respectively	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
the	B-X
delineation	B-X
between	B-X
the	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
becomes	B-X
obscured	B-X
.	B-X
The	B-X
senescence	B-X
checkpoint	B-X
triggered	B-X
by	B-X
Tax	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
which	B-X
depends	B-X
on	B-X
activated	B-X
IKKα	B-X
and	B-X
p65/RelA	B-X
.	B-X

Inhibition	O
of	O
NF	O
-	O
kappaB	O
activation	O
by	O
expression	O
of	O
I	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaBalpha	I-Gene_or_gene_product
superrepressor	O
or	O
by	O
small	O
hairpin	O
RNA	O
(	O
shRNA	O
)	O
-	O
mediated	O
knockdown	O
of	O
p65	B-Gene_or_gene_product
/	O
RelA	B-Gene_or_gene_product
rescues	O
cells	O
from	O
Tax	B-Gene_or_gene_product
-	O
induced	O
rapid	O
senescence	O
(	O
Tax	B-Gene_or_gene_product
-	O
IRS	O
)	O
.	O
<EOS>	B-X
The	B-X
HTLV-1	B-X
oncoprotein	B-X
Tax	B-X
is	B-X
a	B-X
potent	B-X
activator	B-X
of	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
is	B-X
thought	B-X
to	B-X
promote	B-X
cell	B-X
proliferation	B-X
and	B-X
transformation	B-X
via	B-X
NF-κB	B-X
activation	B-X
.	B-X
We	B-X
showed	B-X
recently	B-X
that	B-X
hyperactivation	B-X
of	B-X
NF-κB	B-X
by	B-X
Tax	B-X
triggers	B-X
a	B-X
cellular	B-X
senescence	B-X
response	B-X
(	B-X
H.	B-X
Zhi	B-X
et	B-X
al.	B-X
,	B-X
PLoS	B-X
Pathog	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
activation	B-X
by	B-X
expression	B-X
of	B-X
I-κBα	B-X
superrepressor	B-X
or	B-X
by	B-X
small	B-X
hairpin	B-X
RNA	B-X
(	B-X
shRNA	B-X
)	B-X
-mediated	B-X
knockdown	B-X
of	B-X
p65/RelA	B-X
rescues	B-X
cells	B-X
from	B-X
Tax-induced	B-X
rapid	B-X
senescence	B-X
(	B-X
Tax-IRS	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Tax-IRS	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
.	B-X
Knockdown	B-X
of	B-X
IKKγ	B-X
,	B-X
the	B-X
primary	B-X
Tax	B-X
target	B-X
,	B-X
by	B-X
shRNAs	B-X
abrogated	B-X
Tax-mediated	B-X
activation	B-X
of	B-X
both	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
rendered	B-X
knockdown	B-X
cells	B-X
resistant	B-X
to	B-X
Tax-IRS	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
critical	B-X
role	B-X
of	B-X
IKKα	B-X
in	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
IKKα	B-X
deficiency	B-X
drastically	B-X
decreased	B-X
NF-κB	B-X
trans-activation	B-X
by	B-X
Tax	B-X
,	B-X
although	B-X
it	B-X
only	B-X
modestly	B-X
reduced	B-X
Tax-mediated	B-X
I-κBα	B-X
degradation	B-X
and	B-X
NF-κB	B-X
nuclear	B-X
localization	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
although	B-X
IKKβ	B-X
knockdown	B-X
attenuated	B-X
Tax-induced	B-X
NF-κB	B-X
transcriptional	B-X
activation	B-X
,	B-X
the	B-X
residual	B-X
NF-κB	B-X
activation	B-X
in	B-X
IKKβ-deficient	B-X
cells	B-X
was	B-X
sufficient	B-X
to	B-X
trigger	B-X
Tax-IRS	B-X
.	B-X
Importantly	B-X
,	B-X
the	B-X
phenotypes	B-X
of	B-X
NIK	B-X
and	B-X
TAK1	B-X
knockdown	B-X
were	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
knockdown	B-X
,	B-X
respectively	B-X
.	B-X
Finally	B-X
,	B-X
double	B-X
knockdown	B-X
of	B-X
RelB	B-X
and	B-X
p100	B-X
had	B-X
a	B-X
minor	B-X
effect	B-X
on	B-X
senescence	B-X
induction	B-X
by	B-X
Tax	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
Tax	B-X
,	B-X
through	B-X
its	B-X
interaction	B-X
with	B-X
IKKγ	B-X
,	B-X
helps	B-X
recruit	B-X
NIK	B-X
and	B-X
TAK1	B-X
for	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
activation	B-X
,	B-X
respectively	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
the	B-X
delineation	B-X
between	B-X
the	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
becomes	B-X
obscured	B-X
.	B-X
The	B-X
senescence	B-X
checkpoint	B-X
triggered	B-X
by	B-X
Tax	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
which	B-X
depends	B-X
on	B-X
activated	B-X
IKKα	B-X
and	B-X
p65/RelA	B-X
.	B-X

Here	O
we	O
demonstrate	O
that	O
Tax	B-Gene_or_gene_product
-	O
IRS	O
is	O
driven	O
by	O
the	O
transcriptional	O
activity	O
of	O
NF	O
-	O
kappaB	O
.	O
<EOS>	B-X
The	B-X
HTLV-1	B-X
oncoprotein	B-X
Tax	B-X
is	B-X
a	B-X
potent	B-X
activator	B-X
of	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
is	B-X
thought	B-X
to	B-X
promote	B-X
cell	B-X
proliferation	B-X
and	B-X
transformation	B-X
via	B-X
NF-κB	B-X
activation	B-X
.	B-X
We	B-X
showed	B-X
recently	B-X
that	B-X
hyperactivation	B-X
of	B-X
NF-κB	B-X
by	B-X
Tax	B-X
triggers	B-X
a	B-X
cellular	B-X
senescence	B-X
response	B-X
(	B-X
H.	B-X
Zhi	B-X
et	B-X
al.	B-X
,	B-X
PLoS	B-X
Pathog	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
activation	B-X
by	B-X
expression	B-X
of	B-X
I-κBα	B-X
superrepressor	B-X
or	B-X
by	B-X
small	B-X
hairpin	B-X
RNA	B-X
(	B-X
shRNA	B-X
)	B-X
-mediated	B-X
knockdown	B-X
of	B-X
p65/RelA	B-X
rescues	B-X
cells	B-X
from	B-X
Tax-induced	B-X
rapid	B-X
senescence	B-X
(	B-X
Tax-IRS	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Tax-IRS	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
.	B-X
Knockdown	B-X
of	B-X
IKKγ	B-X
,	B-X
the	B-X
primary	B-X
Tax	B-X
target	B-X
,	B-X
by	B-X
shRNAs	B-X
abrogated	B-X
Tax-mediated	B-X
activation	B-X
of	B-X
both	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
rendered	B-X
knockdown	B-X
cells	B-X
resistant	B-X
to	B-X
Tax-IRS	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
critical	B-X
role	B-X
of	B-X
IKKα	B-X
in	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
IKKα	B-X
deficiency	B-X
drastically	B-X
decreased	B-X
NF-κB	B-X
trans-activation	B-X
by	B-X
Tax	B-X
,	B-X
although	B-X
it	B-X
only	B-X
modestly	B-X
reduced	B-X
Tax-mediated	B-X
I-κBα	B-X
degradation	B-X
and	B-X
NF-κB	B-X
nuclear	B-X
localization	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
although	B-X
IKKβ	B-X
knockdown	B-X
attenuated	B-X
Tax-induced	B-X
NF-κB	B-X
transcriptional	B-X
activation	B-X
,	B-X
the	B-X
residual	B-X
NF-κB	B-X
activation	B-X
in	B-X
IKKβ-deficient	B-X
cells	B-X
was	B-X
sufficient	B-X
to	B-X
trigger	B-X
Tax-IRS	B-X
.	B-X
Finally	B-X
,	B-X
double	B-X
knockdown	B-X
of	B-X
RelB	B-X
and	B-X
p100	B-X
had	B-X
a	B-X
minor	B-X
effect	B-X
on	B-X
senescence	B-X
induction	B-X
by	B-X
Tax	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
Tax	B-X
,	B-X
through	B-X
its	B-X
interaction	B-X
with	B-X
IKKγ	B-X
,	B-X
helps	B-X
recruit	B-X
NIK	B-X
and	B-X
TAK1	B-X
for	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
activation	B-X
,	B-X
respectively	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
the	B-X
delineation	B-X
between	B-X
the	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
becomes	B-X
obscured	B-X
.	B-X
The	B-X
senescence	B-X
checkpoint	B-X
triggered	B-X
by	B-X
Tax	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
which	B-X
depends	B-X
on	B-X
activated	B-X
IKKα	B-X
and	B-X
p65/RelA	B-X
.	B-X

Knockdown	O
of	O
IKKgamma	B-Gene_or_gene_product
,	O
the	O
primary	O
Tax	B-Gene_or_gene_product
target	O
,	O
by	O
shRNAs	O
abrogated	O
Tax	B-Gene_or_gene_product
-	O
mediated	O
activation	O
of	O
both	O
classical	O
and	O
alternative	O
NF	O
-	O
kappaB	O
pathways	O
and	O
rendered	O
knockdown	O
cells	O
resistant	O
to	O
Tax	B-Gene_or_gene_product
-	O
IRS	O
.	O
<EOS>	B-X
The	B-X
HTLV-1	B-X
oncoprotein	B-X
Tax	B-X
is	B-X
a	B-X
potent	B-X
activator	B-X
of	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
is	B-X
thought	B-X
to	B-X
promote	B-X
cell	B-X
proliferation	B-X
and	B-X
transformation	B-X
via	B-X
NF-κB	B-X
activation	B-X
.	B-X
We	B-X
showed	B-X
recently	B-X
that	B-X
hyperactivation	B-X
of	B-X
NF-κB	B-X
by	B-X
Tax	B-X
triggers	B-X
a	B-X
cellular	B-X
senescence	B-X
response	B-X
(	B-X
H.	B-X
Zhi	B-X
et	B-X
al.	B-X
,	B-X
PLoS	B-X
Pathog	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
activation	B-X
by	B-X
expression	B-X
of	B-X
I-κBα	B-X
superrepressor	B-X
or	B-X
by	B-X
small	B-X
hairpin	B-X
RNA	B-X
(	B-X
shRNA	B-X
)	B-X
-mediated	B-X
knockdown	B-X
of	B-X
p65/RelA	B-X
rescues	B-X
cells	B-X
from	B-X
Tax-induced	B-X
rapid	B-X
senescence	B-X
(	B-X
Tax-IRS	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Tax-IRS	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
.	B-X
Knockdown	B-X
of	B-X
IKKγ	B-X
,	B-X
the	B-X
primary	B-X
Tax	B-X
target	B-X
,	B-X
by	B-X
shRNAs	B-X
abrogated	B-X
Tax-mediated	B-X
activation	B-X
of	B-X
both	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
rendered	B-X
knockdown	B-X
cells	B-X
resistant	B-X
to	B-X
Tax-IRS	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
critical	B-X
role	B-X
of	B-X
IKKα	B-X
in	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
IKKα	B-X
deficiency	B-X
drastically	B-X
decreased	B-X
NF-κB	B-X
trans-activation	B-X
by	B-X
Tax	B-X
,	B-X
although	B-X
it	B-X
only	B-X
modestly	B-X
reduced	B-X
Tax-mediated	B-X
I-κBα	B-X
degradation	B-X
and	B-X
NF-κB	B-X
nuclear	B-X
localization	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
although	B-X
IKKβ	B-X
knockdown	B-X
attenuated	B-X
Tax-induced	B-X
NF-κB	B-X
transcriptional	B-X
activation	B-X
,	B-X
the	B-X
residual	B-X
NF-κB	B-X
activation	B-X
in	B-X
IKKβ-deficient	B-X
cells	B-X
was	B-X
sufficient	B-X
to	B-X
trigger	B-X
Tax-IRS	B-X
.	B-X
Importantly	B-X
,	B-X
the	B-X
phenotypes	B-X
of	B-X
NIK	B-X
and	B-X
TAK1	B-X
knockdown	B-X
were	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
knockdown	B-X
,	B-X
respectively	B-X
.	B-X
Finally	B-X
,	B-X
double	B-X
knockdown	B-X
of	B-X
RelB	B-X
and	B-X
p100	B-X
had	B-X
a	B-X
minor	B-X
effect	B-X
on	B-X
senescence	B-X
induction	B-X
by	B-X
Tax	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
Tax	B-X
,	B-X
through	B-X
its	B-X
interaction	B-X
with	B-X
IKKγ	B-X
,	B-X
helps	B-X
recruit	B-X
NIK	B-X
and	B-X
TAK1	B-X
for	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
activation	B-X
,	B-X
respectively	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
the	B-X
delineation	B-X
between	B-X
the	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
becomes	B-X
obscured	B-X
.	B-X
The	B-X
senescence	B-X
checkpoint	B-X
triggered	B-X
by	B-X
Tax	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
which	B-X
depends	B-X
on	B-X
activated	B-X
IKKα	B-X
and	B-X
p65/RelA	B-X
.	B-X

Consistent	O
with	O
a	O
critical	O
role	O
of	O
IKKalpha	B-Gene_or_gene_product
in	O
the	O
transcriptional	O
activity	O
of	O
NF	O
-	O
kappaB	O
,	O
IKKalpha	B-Gene_or_gene_product
deficiency	O
drastically	O
decreased	O
NF	O
-	O
kappaB	O
trans	O
-	O
activation	O
by	O
Tax	B-Gene_or_gene_product
,	O
although	O
it	O
only	O
modestly	O
reduced	O
Tax	B-Gene_or_gene_product
-	O
mediated	O
I	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaBalpha	I-Gene_or_gene_product
degradation	O
and	O
NF	O
-	O
kappaB	O
nuclear	O
localization	O
.	O
<EOS>	B-X
The	B-X
HTLV-1	B-X
oncoprotein	B-X
Tax	B-X
is	B-X
a	B-X
potent	B-X
activator	B-X
of	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
is	B-X
thought	B-X
to	B-X
promote	B-X
cell	B-X
proliferation	B-X
and	B-X
transformation	B-X
via	B-X
NF-κB	B-X
activation	B-X
.	B-X
We	B-X
showed	B-X
recently	B-X
that	B-X
hyperactivation	B-X
of	B-X
NF-κB	B-X
by	B-X
Tax	B-X
triggers	B-X
a	B-X
cellular	B-X
senescence	B-X
response	B-X
(	B-X
H.	B-X
Zhi	B-X
et	B-X
al.	B-X
,	B-X
PLoS	B-X
Pathog	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
activation	B-X
by	B-X
expression	B-X
of	B-X
I-κBα	B-X
superrepressor	B-X
or	B-X
by	B-X
small	B-X
hairpin	B-X
RNA	B-X
(	B-X
shRNA	B-X
)	B-X
-mediated	B-X
knockdown	B-X
of	B-X
p65/RelA	B-X
rescues	B-X
cells	B-X
from	B-X
Tax-induced	B-X
rapid	B-X
senescence	B-X
(	B-X
Tax-IRS	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Tax-IRS	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
.	B-X
Knockdown	B-X
of	B-X
IKKγ	B-X
,	B-X
the	B-X
primary	B-X
Tax	B-X
target	B-X
,	B-X
by	B-X
shRNAs	B-X
abrogated	B-X
Tax-mediated	B-X
activation	B-X
of	B-X
both	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
rendered	B-X
knockdown	B-X
cells	B-X
resistant	B-X
to	B-X
Tax-IRS	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
critical	B-X
role	B-X
of	B-X
IKKα	B-X
in	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
IKKα	B-X
deficiency	B-X
drastically	B-X
decreased	B-X
NF-κB	B-X
trans-activation	B-X
by	B-X
Tax	B-X
,	B-X
although	B-X
it	B-X
only	B-X
modestly	B-X
reduced	B-X
Tax-mediated	B-X
I-κBα	B-X
degradation	B-X
and	B-X
NF-κB	B-X
nuclear	B-X
localization	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
although	B-X
IKKβ	B-X
knockdown	B-X
attenuated	B-X
Tax-induced	B-X
NF-κB	B-X
transcriptional	B-X
activation	B-X
,	B-X
the	B-X
residual	B-X
NF-κB	B-X
activation	B-X
in	B-X
IKKβ-deficient	B-X
cells	B-X
was	B-X
sufficient	B-X
to	B-X
trigger	B-X
Tax-IRS	B-X
.	B-X
Finally	B-X
,	B-X
double	B-X
knockdown	B-X
of	B-X
RelB	B-X
and	B-X
p100	B-X
had	B-X
a	B-X
minor	B-X
effect	B-X
on	B-X
senescence	B-X
induction	B-X
by	B-X
Tax	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
Tax	B-X
,	B-X
through	B-X
its	B-X
interaction	B-X
with	B-X
IKKγ	B-X
,	B-X
helps	B-X
recruit	B-X
NIK	B-X
and	B-X
TAK1	B-X
for	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
activation	B-X
,	B-X
respectively	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
the	B-X
delineation	B-X
between	B-X
the	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
becomes	B-X
obscured	B-X
.	B-X
The	B-X
senescence	B-X
checkpoint	B-X
triggered	B-X
by	B-X
Tax	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
which	B-X
depends	B-X
on	B-X
activated	B-X
IKKα	B-X
and	B-X
p65/RelA	B-X
.	B-X

In	O
contrast	O
,	O
although	O
IKKbeta	B-Gene_or_gene_product
knockdown	O
attenuated	O
Tax	B-Gene_or_gene_product
-	O
induced	O
NF	O
-	O
kappaB	O
transcriptional	O
activation	O
,	O
the	O
residual	O
NF	O
-	O
kappaB	O
activation	O
in	O
IKKbeta	B-Gene_or_gene_product
-	O
deficient	O
cells	O
was	O
sufficient	O
to	O
trigger	O
Tax	B-Gene_or_gene_product
-	O
IRS	O
.	O
<EOS>	B-X
The	B-X
HTLV-1	B-X
oncoprotein	B-X
Tax	B-X
is	B-X
a	B-X
potent	B-X
activator	B-X
of	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
is	B-X
thought	B-X
to	B-X
promote	B-X
cell	B-X
proliferation	B-X
and	B-X
transformation	B-X
via	B-X
NF-κB	B-X
activation	B-X
.	B-X
We	B-X
showed	B-X
recently	B-X
that	B-X
hyperactivation	B-X
of	B-X
NF-κB	B-X
by	B-X
Tax	B-X
triggers	B-X
a	B-X
cellular	B-X
senescence	B-X
response	B-X
(	B-X
H.	B-X
Zhi	B-X
et	B-X
al.	B-X
,	B-X
PLoS	B-X
Pathog	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
activation	B-X
by	B-X
expression	B-X
of	B-X
I-κBα	B-X
superrepressor	B-X
or	B-X
by	B-X
small	B-X
hairpin	B-X
RNA	B-X
(	B-X
shRNA	B-X
)	B-X
-mediated	B-X
knockdown	B-X
of	B-X
p65/RelA	B-X
rescues	B-X
cells	B-X
from	B-X
Tax-induced	B-X
rapid	B-X
senescence	B-X
(	B-X
Tax-IRS	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Tax-IRS	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
.	B-X
Knockdown	B-X
of	B-X
IKKγ	B-X
,	B-X
the	B-X
primary	B-X
Tax	B-X
target	B-X
,	B-X
by	B-X
shRNAs	B-X
abrogated	B-X
Tax-mediated	B-X
activation	B-X
of	B-X
both	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
rendered	B-X
knockdown	B-X
cells	B-X
resistant	B-X
to	B-X
Tax-IRS	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
critical	B-X
role	B-X
of	B-X
IKKα	B-X
in	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
IKKα	B-X
deficiency	B-X
drastically	B-X
decreased	B-X
NF-κB	B-X
trans-activation	B-X
by	B-X
Tax	B-X
,	B-X
although	B-X
it	B-X
only	B-X
modestly	B-X
reduced	B-X
Tax-mediated	B-X
I-κBα	B-X
degradation	B-X
and	B-X
NF-κB	B-X
nuclear	B-X
localization	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
although	B-X
IKKβ	B-X
knockdown	B-X
attenuated	B-X
Tax-induced	B-X
NF-κB	B-X
transcriptional	B-X
activation	B-X
,	B-X
the	B-X
residual	B-X
NF-κB	B-X
activation	B-X
in	B-X
IKKβ-deficient	B-X
cells	B-X
was	B-X
sufficient	B-X
to	B-X
trigger	B-X
Tax-IRS	B-X
.	B-X
Importantly	B-X
,	B-X
the	B-X
phenotypes	B-X
of	B-X
NIK	B-X
and	B-X
TAK1	B-X
knockdown	B-X
were	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
knockdown	B-X
,	B-X
respectively	B-X
.	B-X
Finally	B-X
,	B-X
double	B-X
knockdown	B-X
of	B-X
RelB	B-X
and	B-X
p100	B-X
had	B-X
a	B-X
minor	B-X
effect	B-X
on	B-X
senescence	B-X
induction	B-X
by	B-X
Tax	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
Tax	B-X
,	B-X
through	B-X
its	B-X
interaction	B-X
with	B-X
IKKγ	B-X
,	B-X
helps	B-X
recruit	B-X
NIK	B-X
and	B-X
TAK1	B-X
for	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
activation	B-X
,	B-X
respectively	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
the	B-X
delineation	B-X
between	B-X
the	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
becomes	B-X
obscured	B-X
.	B-X
The	B-X
senescence	B-X
checkpoint	B-X
triggered	B-X
by	B-X
Tax	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
which	B-X
depends	B-X
on	B-X
activated	B-X
IKKα	B-X
and	B-X
p65/RelA	B-X
.	B-X

Importantly	O
,	O
the	O
phenotypes	O
of	O
NIK	B-Gene_or_gene_product
and	O
TAK1	B-Gene_or_gene_product
knockdown	O
were	O
similar	O
to	O
those	O
of	O
IKKalpha	B-Gene_or_gene_product
and	O
IKKbeta	B-Gene_or_gene_product
knockdown	O
,	O
respectively	O
.	O
<EOS>	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
activation	B-X
by	B-X
expression	B-X
of	B-X
I-κBα	B-X
superrepressor	B-X
or	B-X
by	B-X
small	B-X
hairpin	B-X
RNA	B-X
(	B-X
shRNA	B-X
)	B-X
-mediated	B-X
knockdown	B-X
of	B-X
p65/RelA	B-X
rescues	B-X
cells	B-X
from	B-X
Tax-induced	B-X
rapid	B-X
senescence	B-X
(	B-X
Tax-IRS	B-X
)	B-X
.	B-X
Knockdown	B-X
of	B-X
IKKγ	B-X
,	B-X
the	B-X
primary	B-X
Tax	B-X
target	B-X
,	B-X
by	B-X
shRNAs	B-X
abrogated	B-X
Tax-mediated	B-X
activation	B-X
of	B-X
both	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
rendered	B-X
knockdown	B-X
cells	B-X
resistant	B-X
to	B-X
Tax-IRS	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
although	B-X
IKKβ	B-X
knockdown	B-X
attenuated	B-X
Tax-induced	B-X
NF-κB	B-X
transcriptional	B-X
activation	B-X
,	B-X
the	B-X
residual	B-X
NF-κB	B-X
activation	B-X
in	B-X
IKKβ-deficient	B-X
cells	B-X
was	B-X
sufficient	B-X
to	B-X
trigger	B-X
Tax-IRS	B-X
.	B-X
Importantly	B-X
,	B-X
the	B-X
phenotypes	B-X
of	B-X
NIK	B-X
and	B-X
TAK1	B-X
knockdown	B-X
were	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
knockdown	B-X
,	B-X
respectively	B-X
.	B-X
Finally	B-X
,	B-X
double	B-X
knockdown	B-X
of	B-X
RelB	B-X
and	B-X
p100	B-X
had	B-X
a	B-X
minor	B-X
effect	B-X
on	B-X
senescence	B-X
induction	B-X
by	B-X
Tax	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
Tax	B-X
,	B-X
through	B-X
its	B-X
interaction	B-X
with	B-X
IKKγ	B-X
,	B-X
helps	B-X
recruit	B-X
NIK	B-X
and	B-X
TAK1	B-X
for	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
activation	B-X
,	B-X
respectively	B-X
.	B-X

Finally	O
,	O
double	O
knockdown	O
of	O
RelB	B-Gene_or_gene_product
and	O
p100	B-Gene_or_gene_product
had	O
a	O
minor	O
effect	O
on	O
senescence	O
induction	O
by	O
Tax	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
HTLV-1	B-X
oncoprotein	B-X
Tax	B-X
is	B-X
a	B-X
potent	B-X
activator	B-X
of	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
is	B-X
thought	B-X
to	B-X
promote	B-X
cell	B-X
proliferation	B-X
and	B-X
transformation	B-X
via	B-X
NF-κB	B-X
activation	B-X
.	B-X
We	B-X
showed	B-X
recently	B-X
that	B-X
hyperactivation	B-X
of	B-X
NF-κB	B-X
by	B-X
Tax	B-X
triggers	B-X
a	B-X
cellular	B-X
senescence	B-X
response	B-X
(	B-X
H.	B-X
Zhi	B-X
et	B-X
al.	B-X
,	B-X
PLoS	B-X
Pathog	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
activation	B-X
by	B-X
expression	B-X
of	B-X
I-κBα	B-X
superrepressor	B-X
or	B-X
by	B-X
small	B-X
hairpin	B-X
RNA	B-X
(	B-X
shRNA	B-X
)	B-X
-mediated	B-X
knockdown	B-X
of	B-X
p65/RelA	B-X
rescues	B-X
cells	B-X
from	B-X
Tax-induced	B-X
rapid	B-X
senescence	B-X
(	B-X
Tax-IRS	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Tax-IRS	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
.	B-X
Knockdown	B-X
of	B-X
IKKγ	B-X
,	B-X
the	B-X
primary	B-X
Tax	B-X
target	B-X
,	B-X
by	B-X
shRNAs	B-X
abrogated	B-X
Tax-mediated	B-X
activation	B-X
of	B-X
both	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
rendered	B-X
knockdown	B-X
cells	B-X
resistant	B-X
to	B-X
Tax-IRS	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
critical	B-X
role	B-X
of	B-X
IKKα	B-X
in	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
IKKα	B-X
deficiency	B-X
drastically	B-X
decreased	B-X
NF-κB	B-X
trans-activation	B-X
by	B-X
Tax	B-X
,	B-X
although	B-X
it	B-X
only	B-X
modestly	B-X
reduced	B-X
Tax-mediated	B-X
I-κBα	B-X
degradation	B-X
and	B-X
NF-κB	B-X
nuclear	B-X
localization	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
although	B-X
IKKβ	B-X
knockdown	B-X
attenuated	B-X
Tax-induced	B-X
NF-κB	B-X
transcriptional	B-X
activation	B-X
,	B-X
the	B-X
residual	B-X
NF-κB	B-X
activation	B-X
in	B-X
IKKβ-deficient	B-X
cells	B-X
was	B-X
sufficient	B-X
to	B-X
trigger	B-X
Tax-IRS	B-X
.	B-X
Importantly	B-X
,	B-X
the	B-X
phenotypes	B-X
of	B-X
NIK	B-X
and	B-X
TAK1	B-X
knockdown	B-X
were	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
knockdown	B-X
,	B-X
respectively	B-X
.	B-X
Finally	B-X
,	B-X
double	B-X
knockdown	B-X
of	B-X
RelB	B-X
and	B-X
p100	B-X
had	B-X
a	B-X
minor	B-X
effect	B-X
on	B-X
senescence	B-X
induction	B-X
by	B-X
Tax	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
Tax	B-X
,	B-X
through	B-X
its	B-X
interaction	B-X
with	B-X
IKKγ	B-X
,	B-X
helps	B-X
recruit	B-X
NIK	B-X
and	B-X
TAK1	B-X
for	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
activation	B-X
,	B-X
respectively	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
the	B-X
delineation	B-X
between	B-X
the	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
becomes	B-X
obscured	B-X
.	B-X
The	B-X
senescence	B-X
checkpoint	B-X
triggered	B-X
by	B-X
Tax	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
which	B-X
depends	B-X
on	B-X
activated	B-X
IKKα	B-X
and	B-X
p65/RelA	B-X
.	B-X

These	O
data	O
suggest	O
that	O
Tax	B-Gene_or_gene_product
,	O
through	O
its	O
interaction	O
with	O
IKKgamma	B-Gene_or_gene_product
,	O
helps	O
recruit	O
NIK	B-Gene_or_gene_product
and	O
TAK1	B-Gene_or_gene_product
for	O
IKKalpha	B-Gene_or_gene_product
and	O
IKKbeta	B-Gene_or_gene_product
activation	O
,	O
respectively	O
.	O
<EOS>	B-X
The	B-X
HTLV-1	B-X
oncoprotein	B-X
Tax	B-X
is	B-X
a	B-X
potent	B-X
activator	B-X
of	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
is	B-X
thought	B-X
to	B-X
promote	B-X
cell	B-X
proliferation	B-X
and	B-X
transformation	B-X
via	B-X
NF-κB	B-X
activation	B-X
.	B-X
We	B-X
showed	B-X
recently	B-X
that	B-X
hyperactivation	B-X
of	B-X
NF-κB	B-X
by	B-X
Tax	B-X
triggers	B-X
a	B-X
cellular	B-X
senescence	B-X
response	B-X
(	B-X
H.	B-X
Zhi	B-X
et	B-X
al.	B-X
,	B-X
PLoS	B-X
Pathog	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
activation	B-X
by	B-X
expression	B-X
of	B-X
I-κBα	B-X
superrepressor	B-X
or	B-X
by	B-X
small	B-X
hairpin	B-X
RNA	B-X
(	B-X
shRNA	B-X
)	B-X
-mediated	B-X
knockdown	B-X
of	B-X
p65/RelA	B-X
rescues	B-X
cells	B-X
from	B-X
Tax-induced	B-X
rapid	B-X
senescence	B-X
(	B-X
Tax-IRS	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Tax-IRS	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
.	B-X
Knockdown	B-X
of	B-X
IKKγ	B-X
,	B-X
the	B-X
primary	B-X
Tax	B-X
target	B-X
,	B-X
by	B-X
shRNAs	B-X
abrogated	B-X
Tax-mediated	B-X
activation	B-X
of	B-X
both	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
rendered	B-X
knockdown	B-X
cells	B-X
resistant	B-X
to	B-X
Tax-IRS	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
critical	B-X
role	B-X
of	B-X
IKKα	B-X
in	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
IKKα	B-X
deficiency	B-X
drastically	B-X
decreased	B-X
NF-κB	B-X
trans-activation	B-X
by	B-X
Tax	B-X
,	B-X
although	B-X
it	B-X
only	B-X
modestly	B-X
reduced	B-X
Tax-mediated	B-X
I-κBα	B-X
degradation	B-X
and	B-X
NF-κB	B-X
nuclear	B-X
localization	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
although	B-X
IKKβ	B-X
knockdown	B-X
attenuated	B-X
Tax-induced	B-X
NF-κB	B-X
transcriptional	B-X
activation	B-X
,	B-X
the	B-X
residual	B-X
NF-κB	B-X
activation	B-X
in	B-X
IKKβ-deficient	B-X
cells	B-X
was	B-X
sufficient	B-X
to	B-X
trigger	B-X
Tax-IRS	B-X
.	B-X
Importantly	B-X
,	B-X
the	B-X
phenotypes	B-X
of	B-X
NIK	B-X
and	B-X
TAK1	B-X
knockdown	B-X
were	B-X
similar	B-X
to	B-X
those	B-X
of	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
knockdown	B-X
,	B-X
respectively	B-X
.	B-X
Finally	B-X
,	B-X
double	B-X
knockdown	B-X
of	B-X
RelB	B-X
and	B-X
p100	B-X
had	B-X
a	B-X
minor	B-X
effect	B-X
on	B-X
senescence	B-X
induction	B-X
by	B-X
Tax	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
Tax	B-X
,	B-X
through	B-X
its	B-X
interaction	B-X
with	B-X
IKKγ	B-X
,	B-X
helps	B-X
recruit	B-X
NIK	B-X
and	B-X
TAK1	B-X
for	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
activation	B-X
,	B-X
respectively	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
the	B-X
delineation	B-X
between	B-X
the	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
becomes	B-X
obscured	B-X
.	B-X
The	B-X
senescence	B-X
checkpoint	B-X
triggered	B-X
by	B-X
Tax	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
which	B-X
depends	B-X
on	B-X
activated	B-X
IKKα	B-X
and	B-X
p65/RelA	B-X
.	B-X

In	O
the	O
presence	O
of	O
Tax	B-Gene_or_gene_product
,	O
the	O
delineation	O
between	O
the	O
classical	O
and	O
alternative	O
NF	O
-	O
kappaB	O
pathways	O
becomes	O
obscured	O
.	O
<EOS>	B-X
The	B-X
HTLV-1	B-X
oncoprotein	B-X
Tax	B-X
is	B-X
a	B-X
potent	B-X
activator	B-X
of	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
is	B-X
thought	B-X
to	B-X
promote	B-X
cell	B-X
proliferation	B-X
and	B-X
transformation	B-X
via	B-X
NF-κB	B-X
activation	B-X
.	B-X
We	B-X
showed	B-X
recently	B-X
that	B-X
hyperactivation	B-X
of	B-X
NF-κB	B-X
by	B-X
Tax	B-X
triggers	B-X
a	B-X
cellular	B-X
senescence	B-X
response	B-X
(	B-X
H.	B-X
Zhi	B-X
et	B-X
al.	B-X
,	B-X
PLoS	B-X
Pathog	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
activation	B-X
by	B-X
expression	B-X
of	B-X
I-κBα	B-X
superrepressor	B-X
or	B-X
by	B-X
small	B-X
hairpin	B-X
RNA	B-X
(	B-X
shRNA	B-X
)	B-X
-mediated	B-X
knockdown	B-X
of	B-X
p65/RelA	B-X
rescues	B-X
cells	B-X
from	B-X
Tax-induced	B-X
rapid	B-X
senescence	B-X
(	B-X
Tax-IRS	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Tax-IRS	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
.	B-X
Knockdown	B-X
of	B-X
IKKγ	B-X
,	B-X
the	B-X
primary	B-X
Tax	B-X
target	B-X
,	B-X
by	B-X
shRNAs	B-X
abrogated	B-X
Tax-mediated	B-X
activation	B-X
of	B-X
both	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
rendered	B-X
knockdown	B-X
cells	B-X
resistant	B-X
to	B-X
Tax-IRS	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
critical	B-X
role	B-X
of	B-X
IKKα	B-X
in	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
IKKα	B-X
deficiency	B-X
drastically	B-X
decreased	B-X
NF-κB	B-X
trans-activation	B-X
by	B-X
Tax	B-X
,	B-X
although	B-X
it	B-X
only	B-X
modestly	B-X
reduced	B-X
Tax-mediated	B-X
I-κBα	B-X
degradation	B-X
and	B-X
NF-κB	B-X
nuclear	B-X
localization	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
although	B-X
IKKβ	B-X
knockdown	B-X
attenuated	B-X
Tax-induced	B-X
NF-κB	B-X
transcriptional	B-X
activation	B-X
,	B-X
the	B-X
residual	B-X
NF-κB	B-X
activation	B-X
in	B-X
IKKβ-deficient	B-X
cells	B-X
was	B-X
sufficient	B-X
to	B-X
trigger	B-X
Tax-IRS	B-X
.	B-X
Finally	B-X
,	B-X
double	B-X
knockdown	B-X
of	B-X
RelB	B-X
and	B-X
p100	B-X
had	B-X
a	B-X
minor	B-X
effect	B-X
on	B-X
senescence	B-X
induction	B-X
by	B-X
Tax	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
Tax	B-X
,	B-X
through	B-X
its	B-X
interaction	B-X
with	B-X
IKKγ	B-X
,	B-X
helps	B-X
recruit	B-X
NIK	B-X
and	B-X
TAK1	B-X
for	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
activation	B-X
,	B-X
respectively	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
the	B-X
delineation	B-X
between	B-X
the	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
becomes	B-X
obscured	B-X
.	B-X
The	B-X
senescence	B-X
checkpoint	B-X
triggered	B-X
by	B-X
Tax	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
which	B-X
depends	B-X
on	B-X
activated	B-X
IKKα	B-X
and	B-X
p65/RelA	B-X
.	B-X

The	O
senescence	O
checkpoint	O
triggered	O
by	O
Tax	B-Gene_or_gene_product
is	O
driven	O
by	O
the	O
transcriptional	O
activity	O
of	O
NF	O
-	O
kappaB	O
,	O
which	O
depends	O
on	O
activated	O
IKKalpha	B-Gene_or_gene_product
and	O
p65	B-Gene_or_gene_product
/	O
RelA	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
HTLV-1	B-X
oncoprotein	B-X
Tax	B-X
is	B-X
a	B-X
potent	B-X
activator	B-X
of	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
is	B-X
thought	B-X
to	B-X
promote	B-X
cell	B-X
proliferation	B-X
and	B-X
transformation	B-X
via	B-X
NF-κB	B-X
activation	B-X
.	B-X
We	B-X
showed	B-X
recently	B-X
that	B-X
hyperactivation	B-X
of	B-X
NF-κB	B-X
by	B-X
Tax	B-X
triggers	B-X
a	B-X
cellular	B-X
senescence	B-X
response	B-X
(	B-X
H.	B-X
Zhi	B-X
et	B-X
al.	B-X
,	B-X
PLoS	B-X
Pathog	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
activation	B-X
by	B-X
expression	B-X
of	B-X
I-κBα	B-X
superrepressor	B-X
or	B-X
by	B-X
small	B-X
hairpin	B-X
RNA	B-X
(	B-X
shRNA	B-X
)	B-X
-mediated	B-X
knockdown	B-X
of	B-X
p65/RelA	B-X
rescues	B-X
cells	B-X
from	B-X
Tax-induced	B-X
rapid	B-X
senescence	B-X
(	B-X
Tax-IRS	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
Tax-IRS	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
.	B-X
Knockdown	B-X
of	B-X
IKKγ	B-X
,	B-X
the	B-X
primary	B-X
Tax	B-X
target	B-X
,	B-X
by	B-X
shRNAs	B-X
abrogated	B-X
Tax-mediated	B-X
activation	B-X
of	B-X
both	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
and	B-X
rendered	B-X
knockdown	B-X
cells	B-X
resistant	B-X
to	B-X
Tax-IRS	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
critical	B-X
role	B-X
of	B-X
IKKα	B-X
in	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
IKKα	B-X
deficiency	B-X
drastically	B-X
decreased	B-X
NF-κB	B-X
trans-activation	B-X
by	B-X
Tax	B-X
,	B-X
although	B-X
it	B-X
only	B-X
modestly	B-X
reduced	B-X
Tax-mediated	B-X
I-κBα	B-X
degradation	B-X
and	B-X
NF-κB	B-X
nuclear	B-X
localization	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
although	B-X
IKKβ	B-X
knockdown	B-X
attenuated	B-X
Tax-induced	B-X
NF-κB	B-X
transcriptional	B-X
activation	B-X
,	B-X
the	B-X
residual	B-X
NF-κB	B-X
activation	B-X
in	B-X
IKKβ-deficient	B-X
cells	B-X
was	B-X
sufficient	B-X
to	B-X
trigger	B-X
Tax-IRS	B-X
.	B-X
Finally	B-X
,	B-X
double	B-X
knockdown	B-X
of	B-X
RelB	B-X
and	B-X
p100	B-X
had	B-X
a	B-X
minor	B-X
effect	B-X
on	B-X
senescence	B-X
induction	B-X
by	B-X
Tax	B-X
.	B-X
These	B-X
data	B-X
suggest	B-X
that	B-X
Tax	B-X
,	B-X
through	B-X
its	B-X
interaction	B-X
with	B-X
IKKγ	B-X
,	B-X
helps	B-X
recruit	B-X
NIK	B-X
and	B-X
TAK1	B-X
for	B-X
IKKα	B-X
and	B-X
IKKβ	B-X
activation	B-X
,	B-X
respectively	B-X
.	B-X
In	B-X
the	B-X
presence	B-X
of	B-X
Tax	B-X
,	B-X
the	B-X
delineation	B-X
between	B-X
the	B-X
classical	B-X
and	B-X
alternative	B-X
NF-κB	B-X
pathways	B-X
becomes	B-X
obscured	B-X
.	B-X
The	B-X
senescence	B-X
checkpoint	B-X
triggered	B-X
by	B-X
Tax	B-X
is	B-X
driven	B-X
by	B-X
the	B-X
transcriptional	B-X
activity	B-X
of	B-X
NF-κB	B-X
,	B-X
which	B-X
depends	B-X
on	B-X
activated	B-X
IKKα	B-X
and	B-X
p65/RelA	B-X
.	B-X

Propylene	O
glycol	O
ingestion	O
causes	O
D	O
-	O
lactic	O
acidosis	O
.	O
<EOS>	B-X
Propylene	B-X
glycol	B-X
(	B-X
1,2-propanediol	B-X
)	B-X
is	B-X
a	B-X
solvent	B-X
in	B-X
numerous	B-X
pharmaceuticals	B-X
and	B-X
a	B-X
major	B-X
preservative	B-X
and	B-X
source	B-X
of	B-X
carbohydrates	B-X
in	B-X
processed	B-X
foods	B-X
.	B-X
In	B-X
mammals	B-X
,	B-X
propylene	B-X
glycol	B-X
is	B-X
metabolized	B-X
similar	B-X
to	B-X
ethanol	B-X
,	B-X
proceeding	B-X
via	B-X
hepatic	B-X
alcohol	B-X
and	B-X
aldehyde	B-X
dehydrogenases	B-X
to	B-X
lactate	B-X
,	B-X
which	B-X
can	B-X
then	B-X
enter	B-X
gluconeogenesis	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
cats	B-X
ingesting	B-X
1.6	B-X
gm	B-X
of	B-X
propylene	B-X
glycol/kg	B-X
body	B-X
weight/day	B-X
developed	B-X
increased	B-X
anion	B-X
gap	B-X
.	B-X
To	B-X
investigate	B-X
this	B-X
further	B-X
,	B-X
we	B-X
measured	B-X
D-	B-X
and	B-X
L-lactate	B-X
concentrations	B-X
in	B-X
these	B-X
cats	B-X
;	B-X
we	B-X
also	B-X
measured	B-X
D-lactate	B-X
in	B-X
cats	B-X
ingesting	B-X
high	B-X
doses	B-X
of	B-X
propylene	B-X
glycol	B-X
(	B-X
8.0	B-X
gm/kg	B-X
)	B-X
.	B-X
While	B-X
L-lactate	B-X
actually	B-X
decreased	B-X
throughout	B-X
the	B-X
35-day	B-X
course	B-X
of	B-X
propylene	B-X
glycol	B-X
feeding	B-X
,	B-X
D-lactate	B-X
levels	B-X
were	B-X
significantly	B-X
increased	B-X
on	B-X
a	B-X
dose-dependent	B-X
basis	B-X
and	B-X
correlated	B-X
positively	B-X
with	B-X
anion	B-X
gap	B-X
.	B-X
In	B-X
cats	B-X
ingesting	B-X
the	B-X
high	B-X
dose	B-X
of	B-X
propylene	B-X
glycol	B-X
,	B-X
D-lactate	B-X
concentrations	B-X
were	B-X
as	B-X
high	B-X
as	B-X
7	B-X
mmol/liter	B-X
,	B-X
levels	B-X
associated	B-X
with	B-X
encephalopathy	B-X
in	B-X
humans	B-X
.	B-X
These	B-X
findings	B-X
are	B-X
significant	B-X
not	B-X
only	B-X
for	B-X
animals	B-X
ingesting	B-X
diets	B-X
which	B-X
contain	B-X
propylene	B-X
glycol	B-X
,	B-X
but	B-X
for	B-X
humans	B-X
who	B-X
receive	B-X
propylene	B-X
glycol-containing	B-X
medications	B-X
.	B-X

Propylene	O
glycol	O
(	O
1	O
,	O
2	O
-	O
propanediol	O
)	O
is	O
a	O
solvent	O
in	O
numerous	O
pharmaceuticals	O
and	O
a	O
major	O
preservative	O
and	O
source	O
of	O
carbohydrates	O
in	O
processed	O
foods	O
.	O

In	O
mammals	O
,	O
propylene	O
glycol	O
is	O
metabolized	O
similar	O
to	O
ethanol	O
,	O
proceeding	O
via	O
hepatic	O
alcohol	B-Gene_or_gene_product
and	I-Gene_or_gene_product
aldehyde	I-Gene_or_gene_product
dehydrogenases	I-Gene_or_gene_product
to	O
lactate	O
,	O
which	O
can	O
then	O
enter	O
gluconeogenesis	O
.	O
<EOS>	B-X
Propylene	B-X
glycol	B-X
(	B-X
1,2-propanediol	B-X
)	B-X
is	B-X
a	B-X
solvent	B-X
in	B-X
numerous	B-X
pharmaceuticals	B-X
and	B-X
a	B-X
major	B-X
preservative	B-X
and	B-X
source	B-X
of	B-X
carbohydrates	B-X
in	B-X
processed	B-X
foods	B-X
.	B-X
In	B-X
mammals	B-X
,	B-X
propylene	B-X
glycol	B-X
is	B-X
metabolized	B-X
similar	B-X
to	B-X
ethanol	B-X
,	B-X
proceeding	B-X
via	B-X
hepatic	B-X
alcohol	B-X
and	B-X
aldehyde	B-X
dehydrogenases	B-X
to	B-X
lactate	B-X
,	B-X
which	B-X
can	B-X
then	B-X
enter	B-X
gluconeogenesis	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
cats	B-X
ingesting	B-X
1.6	B-X
gm	B-X
of	B-X
propylene	B-X
glycol/kg	B-X
body	B-X
weight/day	B-X
developed	B-X
increased	B-X
anion	B-X
gap	B-X
.	B-X
To	B-X
investigate	B-X
this	B-X
further	B-X
,	B-X
we	B-X
measured	B-X
D-	B-X
and	B-X
L-lactate	B-X
concentrations	B-X
in	B-X
these	B-X
cats	B-X
;	B-X
we	B-X
also	B-X
measured	B-X
D-lactate	B-X
in	B-X
cats	B-X
ingesting	B-X
high	B-X
doses	B-X
of	B-X
propylene	B-X
glycol	B-X
(	B-X
8.0	B-X
gm/kg	B-X
)	B-X
.	B-X
While	B-X
L-lactate	B-X
actually	B-X
decreased	B-X
throughout	B-X
the	B-X
35-day	B-X
course	B-X
of	B-X
propylene	B-X
glycol	B-X
feeding	B-X
,	B-X
D-lactate	B-X
levels	B-X
were	B-X
significantly	B-X
increased	B-X
on	B-X
a	B-X
dose-dependent	B-X
basis	B-X
and	B-X
correlated	B-X
positively	B-X
with	B-X
anion	B-X
gap	B-X
.	B-X
In	B-X
cats	B-X
ingesting	B-X
the	B-X
high	B-X
dose	B-X
of	B-X
propylene	B-X
glycol	B-X
,	B-X
D-lactate	B-X
concentrations	B-X
were	B-X
as	B-X
high	B-X
as	B-X
7	B-X
mmol/liter	B-X
,	B-X
levels	B-X
associated	B-X
with	B-X
encephalopathy	B-X
in	B-X
humans	B-X
.	B-X
Indeed	B-X
,	B-X
this	B-X
group	B-X
of	B-X
cats	B-X
developed	B-X
depression	B-X
and	B-X
ataxia	B-X
,	B-X
consistent	B-X
with	B-X
intoxication	B-X
by	B-X
D-lactate	B-X
.	B-X
These	B-X
findings	B-X
are	B-X
significant	B-X
not	B-X
only	B-X
for	B-X
animals	B-X
ingesting	B-X
diets	B-X
which	B-X
contain	B-X
propylene	B-X
glycol	B-X
,	B-X
but	B-X
for	B-X
humans	B-X
who	B-X
receive	B-X
propylene	B-X
glycol-containing	B-X
medications	B-X
.	B-X

We	O
observed	O
that	O
cats	O
ingesting	O
1	O
.	O
6	O
gm	O
of	O
propylene	O
glycol	O
/	O
kg	O
body	O
weight	O
/	O
day	O
developed	O
increased	O
anion	O
gap	O
.	O
<EOS>	B-X
Propylene	B-X
glycol	B-X
(	B-X
1,2-propanediol	B-X
)	B-X
is	B-X
a	B-X
solvent	B-X
in	B-X
numerous	B-X
pharmaceuticals	B-X
and	B-X
a	B-X
major	B-X
preservative	B-X
and	B-X
source	B-X
of	B-X
carbohydrates	B-X
in	B-X
processed	B-X
foods	B-X
.	B-X
In	B-X
mammals	B-X
,	B-X
propylene	B-X
glycol	B-X
is	B-X
metabolized	B-X
similar	B-X
to	B-X
ethanol	B-X
,	B-X
proceeding	B-X
via	B-X
hepatic	B-X
alcohol	B-X
and	B-X
aldehyde	B-X
dehydrogenases	B-X
to	B-X
lactate	B-X
,	B-X
which	B-X
can	B-X
then	B-X
enter	B-X
gluconeogenesis	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
cats	B-X
ingesting	B-X
1.6	B-X
gm	B-X
of	B-X
propylene	B-X
glycol/kg	B-X
body	B-X
weight/day	B-X
developed	B-X
increased	B-X
anion	B-X
gap	B-X
.	B-X
To	B-X
investigate	B-X
this	B-X
further	B-X
,	B-X
we	B-X
measured	B-X
D-	B-X
and	B-X
L-lactate	B-X
concentrations	B-X
in	B-X
these	B-X
cats	B-X
;	B-X
we	B-X
also	B-X
measured	B-X
D-lactate	B-X
in	B-X
cats	B-X
ingesting	B-X
high	B-X
doses	B-X
of	B-X
propylene	B-X
glycol	B-X
(	B-X
8.0	B-X
gm/kg	B-X
)	B-X
.	B-X
While	B-X
L-lactate	B-X
actually	B-X
decreased	B-X
throughout	B-X
the	B-X
35-day	B-X
course	B-X
of	B-X
propylene	B-X
glycol	B-X
feeding	B-X
,	B-X
D-lactate	B-X
levels	B-X
were	B-X
significantly	B-X
increased	B-X
on	B-X
a	B-X
dose-dependent	B-X
basis	B-X
and	B-X
correlated	B-X
positively	B-X
with	B-X
anion	B-X
gap	B-X
.	B-X
In	B-X
cats	B-X
ingesting	B-X
the	B-X
high	B-X
dose	B-X
of	B-X
propylene	B-X
glycol	B-X
,	B-X
D-lactate	B-X
concentrations	B-X
were	B-X
as	B-X
high	B-X
as	B-X
7	B-X
mmol/liter	B-X
,	B-X
levels	B-X
associated	B-X
with	B-X
encephalopathy	B-X
in	B-X
humans	B-X
.	B-X
Indeed	B-X
,	B-X
this	B-X
group	B-X
of	B-X
cats	B-X
developed	B-X
depression	B-X
and	B-X
ataxia	B-X
,	B-X
consistent	B-X
with	B-X
intoxication	B-X
by	B-X
D-lactate	B-X
.	B-X
These	B-X
findings	B-X
are	B-X
significant	B-X
not	B-X
only	B-X
for	B-X
animals	B-X
ingesting	B-X
diets	B-X
which	B-X
contain	B-X
propylene	B-X
glycol	B-X
,	B-X
but	B-X
for	B-X
humans	B-X
who	B-X
receive	B-X
propylene	B-X
glycol-containing	B-X
medications	B-X
.	B-X

To	O
investigate	O
this	O
further	O
,	O
we	O
measured	O
D	O
-	O
and	O
L	O
-	O
lactate	O
concentrations	O
in	O
these	O
cats	O
;	O
we	O
also	O
measured	O
D	O
-	O
lactate	O
in	O
cats	O
ingesting	O
high	O
doses	O
of	O
propylene	O
glycol	O
(	O
8	O
.	O
0	O
gm	O
/	O
kg	O
)	O
.	O
<EOS>	B-X
We	B-X
sought	B-X
to	B-X
investigate	B-X
whether	B-X
inhibiting	B-X
dipeptidyl-peptidase-4	B-X
(	B-X
DPP4	B-X
)	B-X
,	B-X
cleaving	B-X
NPY1-36	B-X
into	B-X
NPY3-36	B-X
,	B-X
leads	B-X
to	B-X
increased	B-X
NPY1-36	B-X
potentiating	B-X
effects	B-X
and	B-X
reduced	B-X
NPY3-36	B-X
inhibitory	B-X
effects	B-X
on	B-X
CATs	B-X
,	B-X
thereby	B-X
improving	B-X
endurance	B-X
performance	B-X
.	B-X
Seven	B-X
male	B-X
participants	B-X
(	B-X
age	B-X
27	B-X
±	B-X
3	B-X
years	B-X
,	B-X
BMI	B-X
23.1	B-X
±	B-X
2.4	B-X
kg/m	B-X
Propylene	B-X
glycol	B-X
(	B-X
1,2-propanediol	B-X
)	B-X
is	B-X
a	B-X
solvent	B-X
in	B-X
numerous	B-X
pharmaceuticals	B-X
and	B-X
a	B-X
major	B-X
preservative	B-X
and	B-X
source	B-X
of	B-X
carbohydrates	B-X
in	B-X
processed	B-X
foods	B-X
.	B-X
In	B-X
mammals	B-X
,	B-X
propylene	B-X
glycol	B-X
is	B-X
metabolized	B-X
similar	B-X
to	B-X
ethanol	B-X
,	B-X
proceeding	B-X
via	B-X
hepatic	B-X
alcohol	B-X
and	B-X
aldehyde	B-X
dehydrogenases	B-X
to	B-X
lactate	B-X
,	B-X
which	B-X
can	B-X
then	B-X
enter	B-X
gluconeogenesis	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
cats	B-X
ingesting	B-X
1.6	B-X
gm	B-X
of	B-X
propylene	B-X
glycol/kg	B-X
body	B-X
weight/day	B-X
developed	B-X
increased	B-X
anion	B-X
gap	B-X
.	B-X
To	B-X
investigate	B-X
this	B-X
further	B-X
,	B-X
we	B-X
measured	B-X
D-	B-X
and	B-X
L-lactate	B-X
concentrations	B-X
in	B-X
these	B-X
cats	B-X
;	B-X
we	B-X
also	B-X
measured	B-X
D-lactate	B-X
in	B-X
cats	B-X
ingesting	B-X
high	B-X
doses	B-X
of	B-X
propylene	B-X
glycol	B-X
(	B-X
8.0	B-X
gm/kg	B-X
)	B-X
.	B-X
While	B-X
L-lactate	B-X
actually	B-X
decreased	B-X
throughout	B-X
the	B-X
35-day	B-X
course	B-X
of	B-X
propylene	B-X
glycol	B-X
feeding	B-X
,	B-X
D-lactate	B-X
levels	B-X
were	B-X
significantly	B-X
increased	B-X
on	B-X
a	B-X
dose-dependent	B-X
basis	B-X
and	B-X
correlated	B-X
positively	B-X
with	B-X
anion	B-X
gap	B-X
.	B-X
In	B-X
cats	B-X
ingesting	B-X
the	B-X
high	B-X
dose	B-X
of	B-X
propylene	B-X
glycol	B-X
,	B-X
D-lactate	B-X
concentrations	B-X
were	B-X
as	B-X
high	B-X
as	B-X
7	B-X
mmol/liter	B-X
,	B-X
levels	B-X
associated	B-X
with	B-X
encephalopathy	B-X
in	B-X
humans	B-X
.	B-X
Indeed	B-X
,	B-X
this	B-X
group	B-X
of	B-X
cats	B-X
developed	B-X
depression	B-X
and	B-X
ataxia	B-X
,	B-X
consistent	B-X
with	B-X
intoxication	B-X
by	B-X
D-lactate	B-X
.	B-X
These	B-X
findings	B-X
are	B-X
significant	B-X
not	B-X
only	B-X
for	B-X
animals	B-X
ingesting	B-X
diets	B-X
which	B-X
contain	B-X
propylene	B-X
glycol	B-X
,	B-X
but	B-X
for	B-X
humans	B-X
who	B-X
receive	B-X
propylene	B-X
glycol-containing	B-X
medications	B-X
.	B-X

While	O
L	O
-	O
lactate	O
actually	O
decreased	O
throughout	O
the	O
35	O
-	O
day	O
course	O
of	O
propylene	O
glycol	O
feeding	O
,	O
D	O
-	O
lactate	O
levels	O
were	O
significantly	O
increased	O
on	O
a	O
dose	O
-	O
dependent	O
basis	O
and	O
correlated	O
positively	O
with	O
anion	O
gap	O
.	O

In	O
cats	O
ingesting	O
the	O
high	O
dose	O
of	O
propylene	O
glycol	O
,	O
D	O
-	O
lactate	O
concentrations	O
were	O
as	O
high	O
as	O
7	O
mmol	O
/	O
liter	O
,	O
levels	O
associated	O
with	O
encephalopathy	O
in	O
humans	O
.	O

Indeed	O
,	O
this	O
group	O
of	O
cats	O
developed	O
depression	O
and	O
ataxia	O
,	O
consistent	O
with	O
intoxication	O
by	O
D	O
-	O
lactate	O
.	O
<EOS>	B-X
In	B-X
mammals	B-X
,	B-X
propylene	B-X
glycol	B-X
is	B-X
metabolized	B-X
similar	B-X
to	B-X
ethanol	B-X
,	B-X
proceeding	B-X
via	B-X
hepatic	B-X
alcohol	B-X
and	B-X
aldehyde	B-X
dehydrogenases	B-X
to	B-X
lactate	B-X
,	B-X
which	B-X
can	B-X
then	B-X
enter	B-X
gluconeogenesis	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
cats	B-X
ingesting	B-X
1.6	B-X
gm	B-X
of	B-X
propylene	B-X
glycol/kg	B-X
body	B-X
weight/day	B-X
developed	B-X
increased	B-X
anion	B-X
gap	B-X
.	B-X
To	B-X
investigate	B-X
this	B-X
further	B-X
,	B-X
we	B-X
measured	B-X
D-	B-X
and	B-X
L-lactate	B-X
concentrations	B-X
in	B-X
these	B-X
cats	B-X
;	B-X
we	B-X
also	B-X
measured	B-X
D-lactate	B-X
in	B-X
cats	B-X
ingesting	B-X
high	B-X
doses	B-X
of	B-X
propylene	B-X
glycol	B-X
(	B-X
8.0	B-X
gm/kg	B-X
)	B-X
.	B-X
While	B-X
L-lactate	B-X
actually	B-X
decreased	B-X
throughout	B-X
the	B-X
35-day	B-X
course	B-X
of	B-X
propylene	B-X
glycol	B-X
feeding	B-X
,	B-X
D-lactate	B-X
levels	B-X
were	B-X
significantly	B-X
increased	B-X
on	B-X
a	B-X
dose-dependent	B-X
basis	B-X
and	B-X
correlated	B-X
positively	B-X
with	B-X
anion	B-X
gap	B-X
.	B-X
In	B-X
cats	B-X
ingesting	B-X
the	B-X
high	B-X
dose	B-X
of	B-X
propylene	B-X
glycol	B-X
,	B-X
D-lactate	B-X
concentrations	B-X
were	B-X
as	B-X
high	B-X
as	B-X
7	B-X
mmol/liter	B-X
,	B-X
levels	B-X
associated	B-X
with	B-X
encephalopathy	B-X
in	B-X
humans	B-X
.	B-X
Indeed	B-X
,	B-X
this	B-X
group	B-X
of	B-X
cats	B-X
developed	B-X
depression	B-X
and	B-X
ataxia	B-X
,	B-X
consistent	B-X
with	B-X
intoxication	B-X
by	B-X
D-lactate	B-X
.	B-X

These	O
findings	O
are	O
significant	O
not	O
only	O
for	O
animals	O
ingesting	O
diets	O
which	O
contain	O
propylene	O
glycol	O
,	O
but	O
for	O
humans	O
who	O
receive	O
propylene	O
glycol	O
-	O
containing	O
medications	O
.	O
<EOS>	B-X
Fever	B-X
of	B-X
unknown	B-X
origin	B-X
is	B-X
a	B-X
rare	B-X
clinical	B-X
syndrome	B-X
,	B-X
that	B-X
represents	B-X
a	B-X
significant	B-X
diagnostic	B-X
challenge	B-X
.	B-X
Each	B-X
of	B-X
the	B-X
disease	B-X
type	B-X
is	B-X
associated	B-X
with	B-X
rather	B-X
characteristic	B-X
symptoms	B-X
,	B-X
clinical	B-X
signs	B-X
and	B-X
laboratory	B-X
findings	B-X
,	B-X
which	B-X
are	B-X
individually	B-X
non-specific	B-X
,	B-X
but	B-X
may	B-X
provide	B-X
helpful	B-X
clues	B-X
for	B-X
a	B-X
further	B-X
focused	B-X
diagnostic	B-X
work-up	B-X
.	B-X
It	B-X
is	B-X
important	B-X
to	B-X
identify	B-X
the	B-X
clinical	B-X
symptoms	B-X
and	B-X
physical	B-X
examination	B-X
findings	B-X
associated	B-X
with	B-X
pneumonia	B-X
to	B-X
improve	B-X
timely	B-X
diagnosis	B-X
,	B-X
prevent	B-X
significant	B-X
morbidity	B-X
,	B-X
and	B-X
limit	B-X
antibiotic	B-X
overuse	B-X
.	B-X
Headaches	B-X
are	B-X
common	B-X
in	B-X
childhood	B-X
and	B-X
adolescence	B-X
and	B-X
can	B-X
cause	B-X
significant	B-X
distress	B-X
and	B-X
disability	B-X
for	B-X
a	B-X
child	B-X
and	B-X
their	B-X
family	B-X
.	B-X

Visfatin	B-Gene_or_gene_product
induces	O
stromal	B-Gene_or_gene_product
cell	I-Gene_or_gene_product
-	I-Gene_or_gene_product
derived	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
expression	O
by	O
beta1	B-Gene_or_gene_product
integrin	I-Gene_or_gene_product
signaling	O
in	O
colorectal	O
cancer	O
cells	O
.	O
<EOS>	B-X
Obesity	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
associated	B-X
with	B-X
the	B-X
risk	B-X
of	B-X
colorectal	B-X
cancer	B-X
(	B-X
CRC	B-X
)	B-X
.	B-X
Visfatin	B-X
is	B-X
an	B-X
adipokine	B-X
shown	B-X
to	B-X
be	B-X
a	B-X
biomarker	B-X
of	B-X
CRC	B-X
malignant	B-X
potential	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
stromal	B-X
cell-derived	B-X
factor-1	B-X
(	B-X
SDF-1	B-X
)	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
CRC	B-X
progression	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanism	B-X
governing	B-X
the	B-X
interaction	B-X
between	B-X
visfatin	B-X
stimulation	B-X
and	B-X
SDF-1	B-X
expression	B-X
in	B-X
human	B-X
CRC	B-X
cell	B-X
lines	B-X
.	B-X
We	B-X
found	B-X
that	B-X
visfatin	B-X
stimulation	B-X
led	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
the	B-X
expression	B-X
and	B-X
secretion	B-X
of	B-X
SDF-1	B-X
in	B-X
CRC	B-X
DLD-1	B-X
and	B-X
SW48	B-X
cells	B-X
.	B-X
Experiments	B-X
involving	B-X
specific	B-X
inhibitors	B-X
and	B-X
small	B-X
interfering	B-X
RNA	B-X
demonstrated	B-X
that	B-X
the	B-X
activation	B-X
of	B-X
ERK	B-X
and	B-X
p38	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
pathways	B-X
are	B-X
critical	B-X
for	B-X
visfatin-induced	B-X
SDF-1	B-X
expression	B-X
.	B-X
Analysis	B-X
of	B-X
transcription	B-X
factor	B-X
binding	B-X
using	B-X
ELISA	B-X
and	B-X
luciferase	B-X
reporter	B-X
assays	B-X
revealed	B-X
that	B-X
visfatin	B-X
increased	B-X
NF-κB-	B-X
and	B-X
AP-1-DNA-binding	B-X
activities	B-X
in	B-X
DLD-1	B-X
cells	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
and	B-X
AP-1	B-X
activation	B-X
blocked	B-X
the	B-X
visfatin-induced	B-X
expression	B-X
and	B-X
activity	B-X
of	B-X
the	B-X
SDF-1	B-X
promoter	B-X
.	B-X
The	B-X
effect	B-X
of	B-X
visfatin	B-X
on	B-X
DLD-1	B-X
signaling	B-X
and	B-X
SDF-1	B-X
expression	B-X
was	B-X
mediated	B-X
by	B-X
β1	B-X
integrin	B-X
.	B-X

Obesity	O
has	O
been	O
shown	O
to	O
be	O
associated	O
with	O
the	O
risk	O
of	O
colorectal	O
cancer	O
(	O
CRC	O
)	O
.	O
<EOS>	B-X
Researchers	B-X
have	B-X
discovered	B-X
associations	B-X
between	B-X
elements	B-X
of	B-X
the	B-X
intestinal	B-X
microbiome	B-X
(	B-X
including	B-X
specific	B-X
microbes	B-X
,	B-X
signaling	B-X
pathways	B-X
,	B-X
and	B-X
microbiota-related	B-X
metabolites	B-X
)	B-X
and	B-X
risk	B-X
of	B-X
colorectal	B-X
cancer	B-X
(	B-X
CRC	B-X
)	B-X
.	B-X
However	B-X
,	B-X
it	B-X
is	B-X
unclear	B-X
whether	B-X
changes	B-X
in	B-X
the	B-X
intestinal	B-X
microbiome	B-X
contribute	B-X
to	B-X
the	B-X
development	B-X
of	B-X
sporadic	B-X
CRC	B-X
or	B-X
result	B-X
from	B-X
it	B-X
.	B-X
Changes	B-X
in	B-X
the	B-X
intestinal	B-X
microbiome	B-X
can	B-X
mediate	B-X
or	B-X
modify	B-X
the	B-X
effects	B-X
of	B-X
environmental	B-X
factors	B-X
on	B-X
risk	B-X
of	B-X
CRC	B-X
.	B-X
Factors	B-X
that	B-X
affect	B-X
risk	B-X
of	B-X
CRC	B-X
also	B-X
affect	B-X
the	B-X
intestinal	B-X
microbiome	B-X
,	B-X
including	B-X
overweight	B-X
and	B-X
obesity	B-X
;	B-X
physical	B-X
activity	B-X
;	B-X
and	B-X
dietary	B-X
intake	B-X
of	B-X
fiber	B-X
,	B-X
whole	B-X
grains	B-X
,	B-X
and	B-X
red	B-X
and	B-X
processed	B-X
meat	B-X
.	B-X
These	B-X
factors	B-X
alter	B-X
microbiome	B-X
structure	B-X
and	B-X
function	B-X
,	B-X
along	B-X
with	B-X
the	B-X
metabolic	B-X
and	B-X
immune	B-X
pathways	B-X
that	B-X
mediate	B-X
CRC	B-X
development	B-X
.	B-X
We	B-X
review	B-X
epidemiologic	B-X
and	B-X
laboratory	B-X
evidence	B-X
for	B-X
the	B-X
influence	B-X
of	B-X
the	B-X
microbiome	B-X
,	B-X
diet	B-X
,	B-X
and	B-X
environmental	B-X
factors	B-X
on	B-X
CRC	B-X
incidence	B-X
and	B-X
outcomes	B-X
.	B-X
Based	B-X
on	B-X
these	B-X
data	B-X
,	B-X
features	B-X
of	B-X
the	B-X
intestinal	B-X
microbiome	B-X
might	B-X
be	B-X
used	B-X
for	B-X
CRC	B-X
screening	B-X
and	B-X
modified	B-X
for	B-X
chemoprevention	B-X
and	B-X
treatment	B-X
.	B-X

Adipokines	O
produced	O
by	O
the	O
adipose	O
tissue	O
are	O
linked	O
to	O
some	O
malignancies	O
,	O
including	O
CRC	O
.	O
<EOS>	B-X
Obesity	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
associated	B-X
with	B-X
the	B-X
risk	B-X
of	B-X
colorectal	B-X
cancer	B-X
(	B-X
CRC	B-X
)	B-X
.	B-X
Adipokines	B-X
produced	B-X
by	B-X
the	B-X
adipose	B-X
tissue	B-X
are	B-X
linked	B-X
to	B-X
some	B-X
malignancies	B-X
,	B-X
including	B-X
CRC	B-X
.	B-X
Visfatin	B-X
is	B-X
an	B-X
adipokine	B-X
shown	B-X
to	B-X
be	B-X
a	B-X
biomarker	B-X
of	B-X
CRC	B-X
malignant	B-X
potential	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
stromal	B-X
cell-derived	B-X
factor-1	B-X
(	B-X
SDF-1	B-X
)	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
CRC	B-X
progression	B-X
.	B-X
Although	B-X
the	B-X
relationship	B-X
between	B-X
visfatin	B-X
and	B-X
CRC	B-X
has	B-X
been	B-X
established	B-X
,	B-X
the	B-X
underlying	B-X
mechanism	B-X
has	B-X
not	B-X
been	B-X
clarified	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanism	B-X
governing	B-X
the	B-X
interaction	B-X
between	B-X
visfatin	B-X
stimulation	B-X
and	B-X
SDF-1	B-X
expression	B-X
in	B-X
human	B-X
CRC	B-X
cell	B-X
lines	B-X
.	B-X
We	B-X
found	B-X
that	B-X
visfatin	B-X
stimulation	B-X
led	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
the	B-X
expression	B-X
and	B-X
secretion	B-X
of	B-X
SDF-1	B-X
in	B-X
CRC	B-X
DLD-1	B-X
and	B-X
SW48	B-X
cells	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
findings	B-X
provide	B-X
novel	B-X
insights	B-X
pertaining	B-X
to	B-X
the	B-X
pathophysiological	B-X
role	B-X
of	B-X
visfatin	B-X
in	B-X
CRC	B-X
.	B-X

Visfatin	B-Gene_or_gene_product
is	O
an	O
adipokine	O
shown	O
to	O
be	O
a	O
biomarker	O
of	O
CRC	O
malignant	O
potential	O
.	O
<EOS>	B-X
The	B-X
aim	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
evaluate	B-X
the	B-X
potential	B-X
value	B-X
of	B-X
adiponectin	B-X
,	B-X
visfatin	B-X
and	B-X
resistin	B-X
as	B-X
early	B-X
biomarkers	B-X
for	B-X
colorectal	B-X
cancer	B-X
patients	B-X
.	B-X
Obesity	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
associated	B-X
with	B-X
the	B-X
risk	B-X
of	B-X
colorectal	B-X
cancer	B-X
(	B-X
CRC	B-X
)	B-X
.	B-X
Adipokines	B-X
produced	B-X
by	B-X
the	B-X
adipose	B-X
tissue	B-X
are	B-X
linked	B-X
to	B-X
some	B-X
malignancies	B-X
,	B-X
including	B-X
CRC	B-X
.	B-X
Visfatin	B-X
is	B-X
an	B-X
adipokine	B-X
shown	B-X
to	B-X
be	B-X
a	B-X
biomarker	B-X
of	B-X
CRC	B-X
malignant	B-X
potential	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
stromal	B-X
cell-derived	B-X
factor-1	B-X
(	B-X
SDF-1	B-X
)	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
CRC	B-X
progression	B-X
.	B-X
Although	B-X
the	B-X
relationship	B-X
between	B-X
visfatin	B-X
and	B-X
CRC	B-X
has	B-X
been	B-X
established	B-X
,	B-X
the	B-X
underlying	B-X
mechanism	B-X
has	B-X
not	B-X
been	B-X
clarified	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanism	B-X
governing	B-X
the	B-X
interaction	B-X
between	B-X
visfatin	B-X
stimulation	B-X
and	B-X
SDF-1	B-X
expression	B-X
in	B-X
human	B-X
CRC	B-X
cell	B-X
lines	B-X
.	B-X
We	B-X
found	B-X
that	B-X
visfatin	B-X
stimulation	B-X
led	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
the	B-X
expression	B-X
and	B-X
secretion	B-X
of	B-X
SDF-1	B-X
in	B-X
CRC	B-X
DLD-1	B-X
and	B-X
SW48	B-X
cells	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
findings	B-X
provide	B-X
novel	B-X
insights	B-X
pertaining	B-X
to	B-X
the	B-X
pathophysiological	B-X
role	B-X
of	B-X
visfatin	B-X
in	B-X
CRC	B-X
.	B-X

In	O
addition	O
,	O
the	O
stromal	B-Gene_or_gene_product
cell	I-Gene_or_gene_product
-	I-Gene_or_gene_product
derived	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
SDF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
has	O
been	O
reported	O
to	O
play	O
a	O
role	O
in	O
CRC	O
progression	O
.	O
<EOS>	B-X
Obesity	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
associated	B-X
with	B-X
the	B-X
risk	B-X
of	B-X
colorectal	B-X
cancer	B-X
(	B-X
CRC	B-X
)	B-X
.	B-X
Adipokines	B-X
produced	B-X
by	B-X
the	B-X
adipose	B-X
tissue	B-X
are	B-X
linked	B-X
to	B-X
some	B-X
malignancies	B-X
,	B-X
including	B-X
CRC	B-X
.	B-X
Visfatin	B-X
is	B-X
an	B-X
adipokine	B-X
shown	B-X
to	B-X
be	B-X
a	B-X
biomarker	B-X
of	B-X
CRC	B-X
malignant	B-X
potential	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
stromal	B-X
cell-derived	B-X
factor-1	B-X
(	B-X
SDF-1	B-X
)	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
CRC	B-X
progression	B-X
.	B-X
Although	B-X
the	B-X
relationship	B-X
between	B-X
visfatin	B-X
and	B-X
CRC	B-X
has	B-X
been	B-X
established	B-X
,	B-X
the	B-X
underlying	B-X
mechanism	B-X
has	B-X
not	B-X
been	B-X
clarified	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanism	B-X
governing	B-X
the	B-X
interaction	B-X
between	B-X
visfatin	B-X
stimulation	B-X
and	B-X
SDF-1	B-X
expression	B-X
in	B-X
human	B-X
CRC	B-X
cell	B-X
lines	B-X
.	B-X
We	B-X
found	B-X
that	B-X
visfatin	B-X
stimulation	B-X
led	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
the	B-X
expression	B-X
and	B-X
secretion	B-X
of	B-X
SDF-1	B-X
in	B-X
CRC	B-X
DLD-1	B-X
and	B-X
SW48	B-X
cells	B-X
.	B-X
Experiments	B-X
involving	B-X
specific	B-X
inhibitors	B-X
and	B-X
small	B-X
interfering	B-X
RNA	B-X
demonstrated	B-X
that	B-X
the	B-X
activation	B-X
of	B-X
ERK	B-X
and	B-X
p38	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
pathways	B-X
are	B-X
critical	B-X
for	B-X
visfatin-induced	B-X
SDF-1	B-X
expression	B-X
.	B-X
Analysis	B-X
of	B-X
transcription	B-X
factor	B-X
binding	B-X
using	B-X
ELISA	B-X
and	B-X
luciferase	B-X
reporter	B-X
assays	B-X
revealed	B-X
that	B-X
visfatin	B-X
increased	B-X
NF-κB-	B-X
and	B-X
AP-1-DNA-binding	B-X
activities	B-X
in	B-X
DLD-1	B-X
cells	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
and	B-X
AP-1	B-X
activation	B-X
blocked	B-X
the	B-X
visfatin-induced	B-X
expression	B-X
and	B-X
activity	B-X
of	B-X
the	B-X
SDF-1	B-X
promoter	B-X
.	B-X
The	B-X
effect	B-X
of	B-X
visfatin	B-X
on	B-X
DLD-1	B-X
signaling	B-X
and	B-X
SDF-1	B-X
expression	B-X
was	B-X
mediated	B-X
by	B-X
β1	B-X
integrin	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
findings	B-X
provide	B-X
novel	B-X
insights	B-X
pertaining	B-X
to	B-X
the	B-X
pathophysiological	B-X
role	B-X
of	B-X
visfatin	B-X
in	B-X
CRC	B-X
.	B-X

Although	O
the	O
relationship	O
between	O
visfatin	B-Gene_or_gene_product
and	O
CRC	O
has	O
been	O
established	O
,	O
the	O
underlying	O
mechanism	O
has	O
not	O
been	O
clarified	O
.	O

We	O
investigated	O
the	O
molecular	O
mechanism	O
governing	O
the	O
interaction	O
between	O
visfatin	B-Gene_or_gene_product
stimulation	O
and	O
SDF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
expression	O
in	O
human	O
CRC	O
cell	O
lines	O
.	O
<EOS>	B-X
Obesity	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
associated	B-X
with	B-X
the	B-X
risk	B-X
of	B-X
colorectal	B-X
cancer	B-X
(	B-X
CRC	B-X
)	B-X
.	B-X
Adipokines	B-X
produced	B-X
by	B-X
the	B-X
adipose	B-X
tissue	B-X
are	B-X
linked	B-X
to	B-X
some	B-X
malignancies	B-X
,	B-X
including	B-X
CRC	B-X
.	B-X
Visfatin	B-X
is	B-X
an	B-X
adipokine	B-X
shown	B-X
to	B-X
be	B-X
a	B-X
biomarker	B-X
of	B-X
CRC	B-X
malignant	B-X
potential	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
stromal	B-X
cell-derived	B-X
factor-1	B-X
(	B-X
SDF-1	B-X
)	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
CRC	B-X
progression	B-X
.	B-X
Although	B-X
the	B-X
relationship	B-X
between	B-X
visfatin	B-X
and	B-X
CRC	B-X
has	B-X
been	B-X
established	B-X
,	B-X
the	B-X
underlying	B-X
mechanism	B-X
has	B-X
not	B-X
been	B-X
clarified	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanism	B-X
governing	B-X
the	B-X
interaction	B-X
between	B-X
visfatin	B-X
stimulation	B-X
and	B-X
SDF-1	B-X
expression	B-X
in	B-X
human	B-X
CRC	B-X
cell	B-X
lines	B-X
.	B-X
We	B-X
found	B-X
that	B-X
visfatin	B-X
stimulation	B-X
led	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
the	B-X
expression	B-X
and	B-X
secretion	B-X
of	B-X
SDF-1	B-X
in	B-X
CRC	B-X
DLD-1	B-X
and	B-X
SW48	B-X
cells	B-X
.	B-X
Experiments	B-X
involving	B-X
specific	B-X
inhibitors	B-X
and	B-X
small	B-X
interfering	B-X
RNA	B-X
demonstrated	B-X
that	B-X
the	B-X
activation	B-X
of	B-X
ERK	B-X
and	B-X
p38	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
pathways	B-X
are	B-X
critical	B-X
for	B-X
visfatin-induced	B-X
SDF-1	B-X
expression	B-X
.	B-X
Analysis	B-X
of	B-X
transcription	B-X
factor	B-X
binding	B-X
using	B-X
ELISA	B-X
and	B-X
luciferase	B-X
reporter	B-X
assays	B-X
revealed	B-X
that	B-X
visfatin	B-X
increased	B-X
NF-κB-	B-X
and	B-X
AP-1-DNA-binding	B-X
activities	B-X
in	B-X
DLD-1	B-X
cells	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
and	B-X
AP-1	B-X
activation	B-X
blocked	B-X
the	B-X
visfatin-induced	B-X
expression	B-X
and	B-X
activity	B-X
of	B-X
the	B-X
SDF-1	B-X
promoter	B-X
.	B-X
The	B-X
effect	B-X
of	B-X
visfatin	B-X
on	B-X
DLD-1	B-X
signaling	B-X
and	B-X
SDF-1	B-X
expression	B-X
was	B-X
mediated	B-X
by	B-X
β1	B-X
integrin	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
findings	B-X
provide	B-X
novel	B-X
insights	B-X
pertaining	B-X
to	B-X
the	B-X
pathophysiological	B-X
role	B-X
of	B-X
visfatin	B-X
in	B-X
CRC	B-X
.	B-X

We	O
found	O
that	O
visfatin	B-Gene_or_gene_product
stimulation	O
led	O
to	O
an	O
increase	O
in	O
the	O
expression	O
and	O
secretion	O
of	O
SDF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
in	O
CRC	O
DLD	O
-	O
1	O
and	O
SW48	O
cells	O
.	O

Experiments	O
involving	O
specific	O
inhibitors	O
and	O
small	O
interfering	O
RNA	O
demonstrated	O
that	O
the	O
activation	O
of	O
ERK	B-Gene_or_gene_product
and	O
p38	B-Gene_or_gene_product
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
MAPK	B-Gene_or_gene_product
)	O
pathways	O
are	O
critical	O
for	O
visfatin	B-Gene_or_gene_product
-	O
induced	O
SDF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
expression	O
.	O
<EOS>	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
stromal	B-X
cell-derived	B-X
factor-1	B-X
(	B-X
SDF-1	B-X
)	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
CRC	B-X
progression	B-X
.	B-X
Although	B-X
the	B-X
relationship	B-X
between	B-X
visfatin	B-X
and	B-X
CRC	B-X
has	B-X
been	B-X
established	B-X
,	B-X
the	B-X
underlying	B-X
mechanism	B-X
has	B-X
not	B-X
been	B-X
clarified	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanism	B-X
governing	B-X
the	B-X
interaction	B-X
between	B-X
visfatin	B-X
stimulation	B-X
and	B-X
SDF-1	B-X
expression	B-X
in	B-X
human	B-X
CRC	B-X
cell	B-X
lines	B-X
.	B-X
We	B-X
found	B-X
that	B-X
visfatin	B-X
stimulation	B-X
led	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
the	B-X
expression	B-X
and	B-X
secretion	B-X
of	B-X
SDF-1	B-X
in	B-X
CRC	B-X
DLD-1	B-X
and	B-X
SW48	B-X
cells	B-X
.	B-X
Experiments	B-X
involving	B-X
specific	B-X
inhibitors	B-X
and	B-X
small	B-X
interfering	B-X
RNA	B-X
demonstrated	B-X
that	B-X
the	B-X
activation	B-X
of	B-X
ERK	B-X
and	B-X
p38	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
pathways	B-X
are	B-X
critical	B-X
for	B-X
visfatin-induced	B-X
SDF-1	B-X
expression	B-X
.	B-X
Analysis	B-X
of	B-X
transcription	B-X
factor	B-X
binding	B-X
using	B-X
ELISA	B-X
and	B-X
luciferase	B-X
reporter	B-X
assays	B-X
revealed	B-X
that	B-X
visfatin	B-X
increased	B-X
NF-κB-	B-X
and	B-X
AP-1-DNA-binding	B-X
activities	B-X
in	B-X
DLD-1	B-X
cells	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
and	B-X
AP-1	B-X
activation	B-X
blocked	B-X
the	B-X
visfatin-induced	B-X
expression	B-X
and	B-X
activity	B-X
of	B-X
the	B-X
SDF-1	B-X
promoter	B-X
.	B-X
The	B-X
effect	B-X
of	B-X
visfatin	B-X
on	B-X
DLD-1	B-X
signaling	B-X
and	B-X
SDF-1	B-X
expression	B-X
was	B-X
mediated	B-X
by	B-X
β1	B-X
integrin	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
findings	B-X
provide	B-X
novel	B-X
insights	B-X
pertaining	B-X
to	B-X
the	B-X
pathophysiological	B-X
role	B-X
of	B-X
visfatin	B-X
in	B-X
CRC	B-X
.	B-X

Analysis	O
of	O
transcription	O
factor	O
binding	O
using	O
ELISA	O
and	O
luciferase	B-Gene_or_gene_product
reporter	O
assays	O
revealed	O
that	O
visfatin	B-Gene_or_gene_product
increased	O
NF	O
-	O
kappaB	O
-	O
and	O
AP	O
-	O
1	O
-	O
DNA	O
-	O
binding	O
activities	O
in	O
DLD	O
-	O
1	O
cells	O
.	O
<EOS>	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
stromal	B-X
cell-derived	B-X
factor-1	B-X
(	B-X
SDF-1	B-X
)	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
CRC	B-X
progression	B-X
.	B-X
Although	B-X
the	B-X
relationship	B-X
between	B-X
visfatin	B-X
and	B-X
CRC	B-X
has	B-X
been	B-X
established	B-X
,	B-X
the	B-X
underlying	B-X
mechanism	B-X
has	B-X
not	B-X
been	B-X
clarified	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanism	B-X
governing	B-X
the	B-X
interaction	B-X
between	B-X
visfatin	B-X
stimulation	B-X
and	B-X
SDF-1	B-X
expression	B-X
in	B-X
human	B-X
CRC	B-X
cell	B-X
lines	B-X
.	B-X
We	B-X
found	B-X
that	B-X
visfatin	B-X
stimulation	B-X
led	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
the	B-X
expression	B-X
and	B-X
secretion	B-X
of	B-X
SDF-1	B-X
in	B-X
CRC	B-X
DLD-1	B-X
and	B-X
SW48	B-X
cells	B-X
.	B-X
Experiments	B-X
involving	B-X
specific	B-X
inhibitors	B-X
and	B-X
small	B-X
interfering	B-X
RNA	B-X
demonstrated	B-X
that	B-X
the	B-X
activation	B-X
of	B-X
ERK	B-X
and	B-X
p38	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
pathways	B-X
are	B-X
critical	B-X
for	B-X
visfatin-induced	B-X
SDF-1	B-X
expression	B-X
.	B-X
Analysis	B-X
of	B-X
transcription	B-X
factor	B-X
binding	B-X
using	B-X
ELISA	B-X
and	B-X
luciferase	B-X
reporter	B-X
assays	B-X
revealed	B-X
that	B-X
visfatin	B-X
increased	B-X
NF-κB-	B-X
and	B-X
AP-1-DNA-binding	B-X
activities	B-X
in	B-X
DLD-1	B-X
cells	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
and	B-X
AP-1	B-X
activation	B-X
blocked	B-X
the	B-X
visfatin-induced	B-X
expression	B-X
and	B-X
activity	B-X
of	B-X
the	B-X
SDF-1	B-X
promoter	B-X
.	B-X
The	B-X
effect	B-X
of	B-X
visfatin	B-X
on	B-X
DLD-1	B-X
signaling	B-X
and	B-X
SDF-1	B-X
expression	B-X
was	B-X
mediated	B-X
by	B-X
β1	B-X
integrin	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
findings	B-X
provide	B-X
novel	B-X
insights	B-X
pertaining	B-X
to	B-X
the	B-X
pathophysiological	B-X
role	B-X
of	B-X
visfatin	B-X
in	B-X
CRC	B-X
.	B-X

Inhibition	O
of	O
NF	O
-	O
kappaB	O
and	O
AP	O
-	O
1	O
activation	O
blocked	O
the	O
visfatin	B-Gene_or_gene_product
-	O
induced	O
expression	O
and	O
activity	O
of	O
the	O
SDF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
promoter	O
.	O
<EOS>	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
stromal	B-X
cell-derived	B-X
factor-1	B-X
(	B-X
SDF-1	B-X
)	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
CRC	B-X
progression	B-X
.	B-X
Although	B-X
the	B-X
relationship	B-X
between	B-X
visfatin	B-X
and	B-X
CRC	B-X
has	B-X
been	B-X
established	B-X
,	B-X
the	B-X
underlying	B-X
mechanism	B-X
has	B-X
not	B-X
been	B-X
clarified	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanism	B-X
governing	B-X
the	B-X
interaction	B-X
between	B-X
visfatin	B-X
stimulation	B-X
and	B-X
SDF-1	B-X
expression	B-X
in	B-X
human	B-X
CRC	B-X
cell	B-X
lines	B-X
.	B-X
We	B-X
found	B-X
that	B-X
visfatin	B-X
stimulation	B-X
led	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
the	B-X
expression	B-X
and	B-X
secretion	B-X
of	B-X
SDF-1	B-X
in	B-X
CRC	B-X
DLD-1	B-X
and	B-X
SW48	B-X
cells	B-X
.	B-X
Experiments	B-X
involving	B-X
specific	B-X
inhibitors	B-X
and	B-X
small	B-X
interfering	B-X
RNA	B-X
demonstrated	B-X
that	B-X
the	B-X
activation	B-X
of	B-X
ERK	B-X
and	B-X
p38	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
pathways	B-X
are	B-X
critical	B-X
for	B-X
visfatin-induced	B-X
SDF-1	B-X
expression	B-X
.	B-X
Analysis	B-X
of	B-X
transcription	B-X
factor	B-X
binding	B-X
using	B-X
ELISA	B-X
and	B-X
luciferase	B-X
reporter	B-X
assays	B-X
revealed	B-X
that	B-X
visfatin	B-X
increased	B-X
NF-κB-	B-X
and	B-X
AP-1-DNA-binding	B-X
activities	B-X
in	B-X
DLD-1	B-X
cells	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
and	B-X
AP-1	B-X
activation	B-X
blocked	B-X
the	B-X
visfatin-induced	B-X
expression	B-X
and	B-X
activity	B-X
of	B-X
the	B-X
SDF-1	B-X
promoter	B-X
.	B-X
The	B-X
effect	B-X
of	B-X
visfatin	B-X
on	B-X
DLD-1	B-X
signaling	B-X
and	B-X
SDF-1	B-X
expression	B-X
was	B-X
mediated	B-X
by	B-X
β1	B-X
integrin	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
findings	B-X
provide	B-X
novel	B-X
insights	B-X
pertaining	B-X
to	B-X
the	B-X
pathophysiological	B-X
role	B-X
of	B-X
visfatin	B-X
in	B-X
CRC	B-X
.	B-X

The	O
effect	O
of	O
visfatin	B-Gene_or_gene_product
on	O
DLD	O
-	O
1	O
signaling	O
and	O
SDF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
expression	O
was	O
mediated	O
by	O
beta1	B-Gene_or_gene_product
integrin	I-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
stromal	B-X
cell-derived	B-X
factor-1	B-X
(	B-X
SDF-1	B-X
)	B-X
has	B-X
been	B-X
reported	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
CRC	B-X
progression	B-X
.	B-X
Although	B-X
the	B-X
relationship	B-X
between	B-X
visfatin	B-X
and	B-X
CRC	B-X
has	B-X
been	B-X
established	B-X
,	B-X
the	B-X
underlying	B-X
mechanism	B-X
has	B-X
not	B-X
been	B-X
clarified	B-X
.	B-X
We	B-X
investigated	B-X
the	B-X
molecular	B-X
mechanism	B-X
governing	B-X
the	B-X
interaction	B-X
between	B-X
visfatin	B-X
stimulation	B-X
and	B-X
SDF-1	B-X
expression	B-X
in	B-X
human	B-X
CRC	B-X
cell	B-X
lines	B-X
.	B-X
We	B-X
found	B-X
that	B-X
visfatin	B-X
stimulation	B-X
led	B-X
to	B-X
an	B-X
increase	B-X
in	B-X
the	B-X
expression	B-X
and	B-X
secretion	B-X
of	B-X
SDF-1	B-X
in	B-X
CRC	B-X
DLD-1	B-X
and	B-X
SW48	B-X
cells	B-X
.	B-X
Experiments	B-X
involving	B-X
specific	B-X
inhibitors	B-X
and	B-X
small	B-X
interfering	B-X
RNA	B-X
demonstrated	B-X
that	B-X
the	B-X
activation	B-X
of	B-X
ERK	B-X
and	B-X
p38	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
pathways	B-X
are	B-X
critical	B-X
for	B-X
visfatin-induced	B-X
SDF-1	B-X
expression	B-X
.	B-X
Analysis	B-X
of	B-X
transcription	B-X
factor	B-X
binding	B-X
using	B-X
ELISA	B-X
and	B-X
luciferase	B-X
reporter	B-X
assays	B-X
revealed	B-X
that	B-X
visfatin	B-X
increased	B-X
NF-κB-	B-X
and	B-X
AP-1-DNA-binding	B-X
activities	B-X
in	B-X
DLD-1	B-X
cells	B-X
.	B-X
Inhibition	B-X
of	B-X
NF-κB	B-X
and	B-X
AP-1	B-X
activation	B-X
blocked	B-X
the	B-X
visfatin-induced	B-X
expression	B-X
and	B-X
activity	B-X
of	B-X
the	B-X
SDF-1	B-X
promoter	B-X
.	B-X
The	B-X
effect	B-X
of	B-X
visfatin	B-X
on	B-X
DLD-1	B-X
signaling	B-X
and	B-X
SDF-1	B-X
expression	B-X
was	B-X
mediated	B-X
by	B-X
β1	B-X
integrin	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
these	B-X
findings	B-X
provide	B-X
novel	B-X
insights	B-X
pertaining	B-X
to	B-X
the	B-X
pathophysiological	B-X
role	B-X
of	B-X
visfatin	B-X
in	B-X
CRC	B-X
.	B-X

In	O
summary	O
,	O
these	O
findings	O
provide	O
novel	O
insights	O
pertaining	O
to	O
the	O
pathophysiological	O
role	O
of	O
visfatin	B-Gene_or_gene_product
in	O
CRC	O
.	O

J	O
.	O
<EOS>	B-X
Heat	B-X
shock	B-X
proteins	B-X
of	B-X
40	B-X
kDa	B-X
(	B-X
Hsp40s	B-X
)	B-X
,	B-X
also	B-X
called	B-X
J	B-X
proteins	B-X
,	B-X
are	B-X
obligate	B-X
partners	B-X
of	B-X
Hsp70s	B-X
.	B-X
Via	B-X
their	B-X
highly	B-X
conserved	B-X
and	B-X
functionally	B-X
critical	B-X
J	B-X
domain	B-X
,	B-X
J	B-X
proteins	B-X
interact	B-X
and	B-X
modulate	B-X
the	B-X
activity	B-X
of	B-X
their	B-X
Hsp70	B-X
partners	B-X
.	B-X
Mutations	B-X
in	B-X
the	B-X
critical	B-X
residues	B-X
in	B-X
the	B-X
J	B-X
domain	B-X
often	B-X
result	B-X
in	B-X
the	B-X
null	B-X
phenotype	B-X
for	B-X
the	B-X
J	B-X
protein	B-X
in	B-X
question	B-X
.	B-X
However	B-X
,	B-X
as	B-X
more	B-X
J	B-X
proteins	B-X
have	B-X
been	B-X
characterized	B-X
,	B-X
it	B-X
is	B-X
becoming	B-X
increasingly	B-X
clear	B-X
that	B-X
a	B-X
significant	B-X
number	B-X
of	B-X
J	B-X
proteins	B-X
do	B-X
not	B-X
``	B-X
completely	B-X
''	B-X
rely	B-X
on	B-X
their	B-X
J	B-X
domains	B-X
to	B-X
carry	B-X
out	B-X
their	B-X
cellular	B-X
functions	B-X
,	B-X
as	B-X
previously	B-X
thought	B-X
.	B-X
In	B-X
some	B-X
cases	B-X
,	B-X
regions	B-X
outside	B-X
the	B-X
highly	B-X
conserved	B-X
J	B-X
domain	B-X
have	B-X
become	B-X
more	B-X
important	B-X
making	B-X
the	B-X
J	B-X
domain	B-X
dispensable	B-X
for	B-X
some	B-X
,	B-X
if	B-X
not	B-X
for	B-X
all	B-X
functions	B-X
of	B-X
a	B-X
J	B-X
protein	B-X
.	B-X
This	B-X
has	B-X
profound	B-X
effects	B-X
on	B-X
the	B-X
evolution	B-X
of	B-X
such	B-X
J	B-X
proteins	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
selected	B-X
examples	B-X
of	B-X
J	B-X
proteins	B-X
that	B-X
perform	B-X
J	B-X
domain	B-X
independent	B-X
functions	B-X
and	B-X
discuss	B-X
this	B-X
in	B-X
the	B-X
context	B-X
of	B-X
evolution	B-X
of	B-X
J	B-X
proteins	B-X
with	B-X
dispensable	B-X
J	B-X
domains	B-X
and	B-X
J-like	B-X
proteins	B-X
in	B-X
eukaryotes	B-X
.	B-X

Cell	O
.	O
<EOS>	B-X
Stem	B-X
Cell	B-X
Treatments	B-X
.	B-X
Cell-based	B-X
therapy	B-X
for	B-X
disease	B-X
treatment	B-X
involves	B-X
the	B-X
transplantation	B-X
of	B-X
cells	B-X
obtained	B-X
either	B-X
from	B-X
self	B-X
or	B-X
others	B-X
into	B-X
relevant	B-X
patients	B-X
.	B-X
Cell-based	B-X
assays	B-X
,	B-X
such	B-X
as	B-X
high-throughput	B-X
screening	B-X
(	B-X
HTS	B-X
)	B-X
or	B-X
cytotoxicity	B-X
testing	B-X
,	B-X
have	B-X
already	B-X
emerged	B-X
as	B-X
dependable	B-X
and	B-X
promising	B-X
approaches	B-X
to	B-X
measure	B-X
the	B-X
functionality	B-X
or	B-X
toxicity	B-X
of	B-X
a	B-X
compound	B-X
(	B-X
in	B-X
case	B-X
of	B-X
HTS	B-X
)	B-X
;	B-X
or	B-X
to	B-X
probe	B-X
the	B-X
presence	B-X
of	B-X
pathogenic	B-X
or	B-X
toxigenic	B-X
entities	B-X
in	B-X
clinical	B-X
,	B-X
environmental	B-X
,	B-X
or	B-X
food	B-X
samples	B-X
.	B-X
The	B-X
Cell	B-X
.	B-X

Physiol	O
.	O
<EOS>	B-X
Retraction	B-X
.	B-X
Retraction	B-X
.	B-X
Retraction	B-X
.	B-X
Retraction	B-X
.	B-X

(	O
c	O
)	O
2012	O
Wiley	O
Periodicals	O
,	O
Inc	O
.	O
<EOS>	B-X
This	B-X
article	B-X
has	B-X
been	B-X
retracted	B-X
at	B-X
the	B-X
request	B-X
of	B-X
:	B-X
Editor-in-Chief	B-X
and	B-X
Authors	B-X
'Cross-talk	B-X
of	B-X
alpha	B-X
tocopherol-associated	B-X
protein	B-X
and	B-X
JNK	B-X
controls	B-X
the	B-X
oxidative	B-X
stress-induced	B-X
apoptosis	B-X
in	B-X
prostate	B-X
cancer	B-X
cells	B-X
'	B-X
by	B-X
Baoyi	B-X
Zhu	B-X
,	B-X
Xiaojuan	B-X
Li	B-X
,	B-X
Yuying	B-X
Zhang	B-X
,	B-X
Chunwei	B-X
Ye	B-X
,	B-X
Yu	B-X
Wang	B-X
,	B-X
Songwang	B-X
Cai	B-X
,	B-X
Huaiqiu	B-X
Huang	B-X
,	B-X
Yi	B-X
Cai	B-X
,	B-X
Shuyuan	B-X
Yeh	B-X
,	B-X
Zhenhua	B-X
Huang	B-X
,	B-X
Ruihan	B-X
Chen	B-X
,	B-X
Yiran	B-X
Tao	B-X
and	B-X
Xingqiao	B-X
Wen	B-X
The	B-X
above	B-X
article	B-X
,	B-X
published	B-X
online	B-X
on	B-X
28	B-X
November	B-X
2012	B-X
in	B-X
Wiley	B-X
Online	B-X
Library	B-X
(	B-X
wileyonlinelibrary.com	B-X
)	B-X
,	B-X
has	B-X
been	B-X
retracted	B-X
by	B-X
agreement	B-X
between	B-X
the	B-X
authors	B-X
,	B-X
the	B-X
journal	B-X
Editor-in-Chief	B-X
,	B-X
Prof.	B-X
Peter	B-X
Lichter	B-X
,	B-X
and	B-X
Wiley	B-X
Periodicals	B-X
,	B-X
Inc	B-X
.	B-X
The	B-X
Retraction	B-X
has	B-X
been	B-X
agreed	B-X
due	B-X
to	B-X
errors	B-X
that	B-X
were	B-X
detected	B-X
in	B-X
Fig	B-X
.	B-X
Some	B-X
images	B-X
were	B-X
duplicated	B-X
and	B-X
erroneously	B-X
presented	B-X
as	B-X
unique	B-X
.	B-X
Although	B-X
the	B-X
authors	B-X
firmly	B-X
stand	B-X
by	B-X
the	B-X
major	B-X
conclusion	B-X
of	B-X
this	B-X
paper	B-X
,	B-X
they	B-X
believe	B-X
the	B-X
most	B-X
responsible	B-X
course	B-X
of	B-X
action	B-X
is	B-X
to	B-X
retract	B-X
it	B-X
.	B-X
Reference	B-X
Zhu	B-X
,	B-X
B.	B-X
,	B-X
Li	B-X
,	B-X
X.	B-X
,	B-X
Zhang	B-X
,	B-X
Y.	B-X
,	B-X
Ye	B-X
,	B-X
C.	B-X
,	B-X
Wang	B-X
,	B-X
Y.	B-X
,	B-X
Cai	B-X
,	B-X
S.	B-X
,	B-X
Huang	B-X
,	B-X
H.	B-X
,	B-X
Cai	B-X
,	B-X
Y.	B-X
,	B-X
Yeh	B-X
,	B-X
S.	B-X
,	B-X
Huang	B-X
,	B-X
Z.	B-X
,	B-X
Chen	B-X
,	B-X
R.	B-X
,	B-X
Tao	B-X
,	B-X
Y.	B-X
and	B-X
Wen	B-X
,	B-X
X	B-X
.	B-X
(	B-X
2013	B-X
)	B-X
,	B-X
Cross-talk	B-X
of	B-X
alpha	B-X
tocopherol-associated	B-X
protein	B-X
and	B-X
JNK	B-X
controls	B-X
the	B-X
oxidative	B-X
stress-induced	B-X
apoptosis	B-X
in	B-X
prostate	B-X
cancer	B-X
cells	B-X
.	B-X
Cancer	B-X
,	B-X
132	B-X
:	B-X
2270-2282.	B-X
doi	B-X
:	B-X
10.1002/ijc.27927	B-X
.	B-X

Functional	O
properties	O
of	O
phosphorylated	O
elongation	B-Gene_or_gene_product
factor	I-Gene_or_gene_product
2	I-Gene_or_gene_product
.	O
<EOS>	B-X
eEF2	B-X
(	B-X
eukaryotic	B-X
elongation	B-X
factor	B-X
2	B-X
)	B-X
occupies	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
protein	B-X
synthesis	B-X
where	B-X
it	B-X
catalyses	B-X
the	B-X
translocation	B-X
of	B-X
the	B-X
two	B-X
tRNAs	B-X
and	B-X
the	B-X
mRNA	B-X
after	B-X
peptidyl	B-X
transfer	B-X
on	B-X
the	B-X
80	B-X
S	B-X
ribosome	B-X
.	B-X
Recent	B-X
crystal	B-X
structures	B-X
of	B-X
eEF2	B-X
and	B-X
the	B-X
cryo-electron	B-X
microscopy	B-X
reconstruction	B-X
of	B-X
its	B-X
80	B-X
S	B-X
complex	B-X
now	B-X
provide	B-X
a	B-X
substantial	B-X
structural	B-X
framework	B-X
for	B-X
dissecting	B-X
the	B-X
functional	B-X
properties	B-X
of	B-X
this	B-X
factor	B-X
.	B-X
The	B-X
factor	B-X
can	B-X
be	B-X
modified	B-X
by	B-X
either	B-X
phosphorylation	B-X
or	B-X
ADP-ribosylation	B-X
,	B-X
which	B-X
results	B-X
in	B-X
cessation	B-X
of	B-X
translation	B-X
.	B-X
We	B-X
review	B-X
the	B-X
structural	B-X
and	B-X
functional	B-X
properties	B-X
of	B-X
eEF2	B-X
with	B-X
particular	B-X
emphasis	B-X
on	B-X
the	B-X
unique	B-X
diphthamide	B-X
residue	B-X
,	B-X
which	B-X
is	B-X
ADP-ribosylated	B-X
by	B-X
diphtheria	B-X
toxin	B-X
from	B-X
Corynebacterium	B-X
diphtheriae	B-X
and	B-X
exotoxin	B-X
A	B-X
from	B-X
Pseudomonas	B-X
aeruginosa	B-X
.	B-X

The	O
effect	O
of	O
phosphorylation	O
on	O
the	O
functional	O
activity	O
of	O
eukaryotic	B-Gene_or_gene_product
elongation	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
2	I-Gene_or_gene_product
(	O
eEF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
)	O
was	O
studied	O
using	O
a	O
purified	O
phosphorylated	O
factor	O
.	O
<EOS>	B-X
The	B-X
effect	B-X
of	B-X
phosphorylation	B-X
on	B-X
the	B-X
functional	B-X
activity	B-X
of	B-X
eukaryotic	B-X
elongation	B-X
factor	B-X
2	B-X
(	B-X
eEF-2	B-X
)	B-X
was	B-X
studied	B-X
using	B-X
a	B-X
purified	B-X
phosphorylated	B-X
factor	B-X
.	B-X
The	B-X
modified	B-X
factor	B-X
was	B-X
unable	B-X
to	B-X
stimulate	B-X
protein	B-X
synthesis	B-X
in	B-X
an	B-X
eEF-2-dependent	B-X
rabbit	B-X
reticulocyte	B-X
lysate	B-X
.	B-X
The	B-X
functional	B-X
alteration	B-X
was	B-X
further	B-X
analyzed	B-X
by	B-X
measuring	B-X
the	B-X
effects	B-X
of	B-X
phosphorylation	B-X
on	B-X
the	B-X
ability	B-X
of	B-X
the	B-X
factor	B-X
to	B-X
catalyse	B-X
the	B-X
ribosome-dependent	B-X
hydrolysis	B-X
of	B-X
GTP	B-X
.	B-X
Kinetic	B-X
analysis	B-X
showed	B-X
that	B-X
both	B-X
phosphorylated	B-X
and	B-X
unmodified	B-X
factor	B-X
was	B-X
able	B-X
to	B-X
hydrolyse	B-X
GTP	B-X
with	B-X
approximately	B-X
the	B-X
same	B-X
maximum	B-X
rate	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
rate	B-X
of	B-X
nucleotide	B-X
exchange	B-X
was	B-X
not	B-X
impaired	B-X
by	B-X
the	B-X
modification	B-X
.	B-X
However	B-X
,	B-X
the	B-X
phosphorylated	B-X
factor	B-X
showed	B-X
a	B-X
marked	B-X
reduction	B-X
in	B-X
the	B-X
second-order	B-X
rate	B-X
constant	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
phosphorylation	B-X
interfered	B-X
with	B-X
ribosome.eEF-2	B-X
complex	B-X
formation	B-X
by	B-X
reducing	B-X
the	B-X
affinity	B-X
of	B-X
eEF-2	B-X
for	B-X
the	B-X
ribosome	B-X
.	B-X
This	B-X
assumption	B-X
was	B-X
confirmed	B-X
by	B-X
direct	B-X
measurements	B-X
of	B-X
the	B-X
dissociation	B-X
constants	B-X
for	B-X
the	B-X
ribosomal	B-X
complexes	B-X
containing	B-X
unmodified	B-X
and	B-X
phosphorylated	B-X
eEF-2	B-X
.	B-X

The	O
modified	O
factor	O
was	O
unable	O
to	O
stimulate	O
protein	O
synthesis	O
in	O
an	O
eEF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
-	O
dependent	O
rabbit	O
reticulocyte	O
lysate	O
.	O

The	O
functional	O
alteration	O
was	O
further	O
analyzed	O
by	O
measuring	O
the	O
effects	O
of	O
phosphorylation	O
on	O
the	O
ability	O
of	O
the	O
factor	O
to	O
catalyse	O
the	O
ribosome	O
-	O
dependent	O
hydrolysis	O
of	O
GTP	O
.	O
<EOS>	B-X
The	B-X
effect	B-X
of	B-X
phosphorylation	B-X
on	B-X
the	B-X
functional	B-X
activity	B-X
of	B-X
eukaryotic	B-X
elongation	B-X
factor	B-X
2	B-X
(	B-X
eEF-2	B-X
)	B-X
was	B-X
studied	B-X
using	B-X
a	B-X
purified	B-X
phosphorylated	B-X
factor	B-X
.	B-X
The	B-X
modified	B-X
factor	B-X
was	B-X
unable	B-X
to	B-X
stimulate	B-X
protein	B-X
synthesis	B-X
in	B-X
an	B-X
eEF-2-dependent	B-X
rabbit	B-X
reticulocyte	B-X
lysate	B-X
.	B-X
The	B-X
functional	B-X
alteration	B-X
was	B-X
further	B-X
analyzed	B-X
by	B-X
measuring	B-X
the	B-X
effects	B-X
of	B-X
phosphorylation	B-X
on	B-X
the	B-X
ability	B-X
of	B-X
the	B-X
factor	B-X
to	B-X
catalyse	B-X
the	B-X
ribosome-dependent	B-X
hydrolysis	B-X
of	B-X
GTP	B-X
.	B-X
Kinetic	B-X
analysis	B-X
showed	B-X
that	B-X
both	B-X
phosphorylated	B-X
and	B-X
unmodified	B-X
factor	B-X
was	B-X
able	B-X
to	B-X
hydrolyse	B-X
GTP	B-X
with	B-X
approximately	B-X
the	B-X
same	B-X
maximum	B-X
rate	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
rate	B-X
of	B-X
nucleotide	B-X
exchange	B-X
was	B-X
not	B-X
impaired	B-X
by	B-X
the	B-X
modification	B-X
.	B-X
However	B-X
,	B-X
the	B-X
phosphorylated	B-X
factor	B-X
showed	B-X
a	B-X
marked	B-X
reduction	B-X
in	B-X
the	B-X
second-order	B-X
rate	B-X
constant	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
phosphorylation	B-X
interfered	B-X
with	B-X
ribosome.eEF-2	B-X
complex	B-X
formation	B-X
by	B-X
reducing	B-X
the	B-X
affinity	B-X
of	B-X
eEF-2	B-X
for	B-X
the	B-X
ribosome	B-X
.	B-X

Kinetic	O
analysis	O
showed	O
that	O
both	O
phosphorylated	O
and	O
unmodified	O
factor	O
was	O
able	O
to	O
hydrolyse	O
GTP	O
with	O
approximately	O
the	O
same	O
maximum	O
rate	O
,	O
indicating	O
that	O
the	O
rate	O
of	O
nucleotide	O
exchange	O
was	O
not	O
impaired	O
by	O
the	O
modification	O
.	O

However	O
,	O
the	O
phosphorylated	O
factor	O
showed	O
a	O
marked	O
reduction	O
in	O
the	O
second	O
-	O
order	O
rate	O
constant	O
,	O
suggesting	O
that	O
the	O
phosphorylation	O
interfered	O
with	O
ribosome	O
.	O
eEF	O
-	O
2	O
complex	O
formation	O
by	O
reducing	O
the	O
affinity	O
of	O
eEF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
for	O
the	O
ribosome	O
.	O
<EOS>	B-X
The	B-X
effect	B-X
of	B-X
phosphorylation	B-X
on	B-X
the	B-X
functional	B-X
activity	B-X
of	B-X
eukaryotic	B-X
elongation	B-X
factor	B-X
2	B-X
(	B-X
eEF-2	B-X
)	B-X
was	B-X
studied	B-X
using	B-X
a	B-X
purified	B-X
phosphorylated	B-X
factor	B-X
.	B-X
The	B-X
modified	B-X
factor	B-X
was	B-X
unable	B-X
to	B-X
stimulate	B-X
protein	B-X
synthesis	B-X
in	B-X
an	B-X
eEF-2-dependent	B-X
rabbit	B-X
reticulocyte	B-X
lysate	B-X
.	B-X
The	B-X
functional	B-X
alteration	B-X
was	B-X
further	B-X
analyzed	B-X
by	B-X
measuring	B-X
the	B-X
effects	B-X
of	B-X
phosphorylation	B-X
on	B-X
the	B-X
ability	B-X
of	B-X
the	B-X
factor	B-X
to	B-X
catalyse	B-X
the	B-X
ribosome-dependent	B-X
hydrolysis	B-X
of	B-X
GTP	B-X
.	B-X
Kinetic	B-X
analysis	B-X
showed	B-X
that	B-X
both	B-X
phosphorylated	B-X
and	B-X
unmodified	B-X
factor	B-X
was	B-X
able	B-X
to	B-X
hydrolyse	B-X
GTP	B-X
with	B-X
approximately	B-X
the	B-X
same	B-X
maximum	B-X
rate	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
rate	B-X
of	B-X
nucleotide	B-X
exchange	B-X
was	B-X
not	B-X
impaired	B-X
by	B-X
the	B-X
modification	B-X
.	B-X
However	B-X
,	B-X
the	B-X
phosphorylated	B-X
factor	B-X
showed	B-X
a	B-X
marked	B-X
reduction	B-X
in	B-X
the	B-X
second-order	B-X
rate	B-X
constant	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
phosphorylation	B-X
interfered	B-X
with	B-X
ribosome.eEF-2	B-X
complex	B-X
formation	B-X
by	B-X
reducing	B-X
the	B-X
affinity	B-X
of	B-X
eEF-2	B-X
for	B-X
the	B-X
ribosome	B-X
.	B-X
This	B-X
assumption	B-X
was	B-X
confirmed	B-X
by	B-X
direct	B-X
measurements	B-X
of	B-X
the	B-X
dissociation	B-X
constants	B-X
for	B-X
the	B-X
ribosomal	B-X
complexes	B-X
containing	B-X
unmodified	B-X
and	B-X
phosphorylated	B-X
eEF-2	B-X
.	B-X

This	O
assumption	O
was	O
confirmed	O
by	O
direct	O
measurements	O
of	O
the	O
dissociation	O
constants	O
for	O
the	O
ribosomal	O
complexes	O
containing	O
unmodified	O
and	O
phosphorylated	O
eEF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
effect	B-X
of	B-X
phosphorylation	B-X
on	B-X
the	B-X
functional	B-X
activity	B-X
of	B-X
eukaryotic	B-X
elongation	B-X
factor	B-X
2	B-X
(	B-X
eEF-2	B-X
)	B-X
was	B-X
studied	B-X
using	B-X
a	B-X
purified	B-X
phosphorylated	B-X
factor	B-X
.	B-X
The	B-X
modified	B-X
factor	B-X
was	B-X
unable	B-X
to	B-X
stimulate	B-X
protein	B-X
synthesis	B-X
in	B-X
an	B-X
eEF-2-dependent	B-X
rabbit	B-X
reticulocyte	B-X
lysate	B-X
.	B-X
Kinetic	B-X
analysis	B-X
showed	B-X
that	B-X
both	B-X
phosphorylated	B-X
and	B-X
unmodified	B-X
factor	B-X
was	B-X
able	B-X
to	B-X
hydrolyse	B-X
GTP	B-X
with	B-X
approximately	B-X
the	B-X
same	B-X
maximum	B-X
rate	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
rate	B-X
of	B-X
nucleotide	B-X
exchange	B-X
was	B-X
not	B-X
impaired	B-X
by	B-X
the	B-X
modification	B-X
.	B-X
However	B-X
,	B-X
the	B-X
phosphorylated	B-X
factor	B-X
showed	B-X
a	B-X
marked	B-X
reduction	B-X
in	B-X
the	B-X
second-order	B-X
rate	B-X
constant	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
phosphorylation	B-X
interfered	B-X
with	B-X
ribosome.eEF-2	B-X
complex	B-X
formation	B-X
by	B-X
reducing	B-X
the	B-X
affinity	B-X
of	B-X
eEF-2	B-X
for	B-X
the	B-X
ribosome	B-X
.	B-X
This	B-X
assumption	B-X
was	B-X
confirmed	B-X
by	B-X
direct	B-X
measurements	B-X
of	B-X
the	B-X
dissociation	B-X
constants	B-X
for	B-X
the	B-X
ribosomal	B-X
complexes	B-X
containing	B-X
unmodified	B-X
and	B-X
phosphorylated	B-X
eEF-2	B-X
.	B-X

Human	O
gastric	B-Gene_or_gene_product
lipase	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
aim	B-X
of	B-X
the	B-X
study	B-X
was	B-X
to	B-X
implement	B-X
a	B-X
gastric	B-X
digestion	B-X
step	B-X
using	B-X
recombinant	B-X
human	B-X
gastric	B-X
lipase	B-X
(	B-X
rHGL	B-X
)	B-X
in	B-X
an	B-X
in	B-X
vitro	B-X
pediatric	B-X
gastro-intestinal	B-X
digestion	B-X
model	B-X
to	B-X
achieve	B-X
a	B-X
physiologically	B-X
relevant	B-X
gastric	B-X
contribution	B-X
to	B-X
total	B-X
gastro-intestinal	B-X
lipid	B-X
digestion	B-X
.	B-X
To	B-X
achieve	B-X
a	B-X
physiologically	B-X
relevant	B-X
level	B-X
of	B-X
gastric	B-X
digestion	B-X
,	B-X
50	B-X
min	B-X
of	B-X
in	B-X
vitro	B-X
gastric	B-X
digestion	B-X
,	B-X
using	B-X
either	B-X
0	B-X
,	B-X
3.75	B-X
or	B-X
7.5	B-X
TBU	B-X
mL	B-X
Orlistat	B-X
,	B-X
an	B-X
anti-obesity	B-X
drug	B-X
,	B-X
is	B-X
a	B-X
potent	B-X
and	B-X
specific	B-X
inhibitor	B-X
of	B-X
intestinal	B-X
lipases	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
use	B-X
of	B-X
orlistat	B-X
has	B-X
been	B-X
associated	B-X
with	B-X
rare	B-X
cases	B-X
of	B-X
acute	B-X
kidney	B-X
injury	B-X
,	B-X
possibly	B-X
due	B-X
to	B-X
the	B-X
increased	B-X
fat	B-X
malabsorption	B-X
resulting	B-X
from	B-X
the	B-X
inhibition	B-X
of	B-X
pancreatic	B-X
and	B-X
gastric	B-X
lipase	B-X
by	B-X
orlistat	B-X
,	B-X
leading	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
soaps	B-X
with	B-X
calcium	B-X
and	B-X
resulting	B-X
in	B-X
increased	B-X
free	B-X
oxalate	B-X
absorption	B-X
and	B-X
enteric	B-X
hyperoxaluria	B-X
.	B-X

The	O
N	O
-	O
terminal	O
tetrapeptide	O
is	O
essential	O
for	O
lipid	O
binding	O
and	O
lipase	B-Gene_or_gene_product
activity	O
.	O

Human	O
gastric	B-Gene_or_gene_product
lipase	I-Gene_or_gene_product
subjected	O
to	O
limited	O
tryptic	O
proteolysis	O
lost	O
its	O
ability	O
to	O
hydrolyze	O
emulsified	O
long	O
-	O
chain	O
triacylglycerol	O
.	O
<EOS>	B-X
Human	B-X
gastric	B-X
lipase	B-X
subjected	B-X
to	B-X
limited	B-X
tryptic	B-X
proteolysis	B-X
lost	B-X
its	B-X
ability	B-X
to	B-X
hydrolyze	B-X
emulsified	B-X
long-chain	B-X
triacylglycerol	B-X
.	B-X
Activity	B-X
against	B-X
a	B-X
water-soluble	B-X
substrate	B-X
was	B-X
however	B-X
retained	B-X
,	B-X
indicating	B-X
that	B-X
proteolysis	B-X
did	B-X
not	B-X
affect	B-X
the	B-X
active	B-X
site	B-X
.	B-X
This	B-X
cleavage	B-X
rendered	B-X
the	B-X
enzyme	B-X
unable	B-X
to	B-X
bind	B-X
to	B-X
emulsified	B-X
triacylglycerol	B-X
particles	B-X
,	B-X
e.g	B-X
.	B-X
We	B-X
suggest	B-X
that	B-X
the	B-X
N-terminal	B-X
tetrapeptide	B-X
,	B-X
in	B-X
particular	B-X
lysine-4	B-X
,	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
binding	B-X
of	B-X
human	B-X
gastric	B-X
lipase	B-X
to	B-X
lipid/water	B-X
interfaces	B-X
,	B-X
and	B-X
hence	B-X
,	B-X
for	B-X
its	B-X
physiological	B-X
function	B-X
.	B-X

Activity	O
against	O
a	O
water	O
-	O
soluble	O
substrate	O
was	O
however	O
retained	O
,	O
indicating	O
that	O
proteolysis	O
did	O
not	O
affect	O
the	O
active	O
site	O
.	O

Sequence	O
analysis	O
revealed	O
that	O
trypsin	B-Gene_or_gene_product
specifically	O
cleaved	O
the	O
linkage	O
between	O
lysine	O
-	O
4	O
and	O
leucine	O
-	O
5	O
.	O
<EOS>	B-X
Sequence	B-X
analysis	B-X
revealed	B-X
that	B-X
trypsin	B-X
specifically	B-X
cleaved	B-X
the	B-X
linkage	B-X
between	B-X
lysine-4	B-X
and	B-X
leucine-5	B-X
.	B-X
We	B-X
suggest	B-X
that	B-X
the	B-X
N-terminal	B-X
tetrapeptide	B-X
,	B-X
in	B-X
particular	B-X
lysine-4	B-X
,	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
binding	B-X
of	B-X
human	B-X
gastric	B-X
lipase	B-X
to	B-X
lipid/water	B-X
interfaces	B-X
,	B-X
and	B-X
hence	B-X
,	B-X
for	B-X
its	B-X
physiological	B-X
function	B-X
.	B-X

This	O
cleavage	O
rendered	O
the	O
enzyme	O
unable	O
to	O
bind	O
to	O
emulsified	O
triacylglycerol	O
particles	O
,	O
e	O
.	O
g	O
.	O
human	O
milk	O
fat	O
globules	O
.	O

We	O
suggest	O
that	O
the	O
N	O
-	O
terminal	O
tetrapeptide	O
,	O
in	O
particular	O
lysine	O
-	O
4	O
,	O
is	O
essential	O
for	O
the	O
binding	O
of	O
human	O
gastric	B-Gene_or_gene_product
lipase	I-Gene_or_gene_product
to	O
lipid	O
/	O
water	O
interfaces	O
,	O
and	O
hence	O
,	O
for	O
its	O
physiological	O
function	O
.	O

Genetic	O
evidence	O
for	O
a	O
common	O
enzyme	O
catalyzing	O
the	O
second	O
step	O
in	O
the	O
degradation	O
of	O
proline	O
and	O
hydroxyproline	O
.	O
<EOS>	B-X
The	B-X
initial	B-X
step	B-X
in	B-X
the	B-X
degradation	B-X
pathways	B-X
of	B-X
proline	B-X
and	B-X
hydroxyproline	B-X
is	B-X
catalyzed	B-X
by	B-X
proline	B-X
oxidase	B-X
and	B-X
hydroxyproline	B-X
oxidase	B-X
,	B-X
yielding	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
second	B-X
step	B-X
is	B-X
the	B-X
oxidation	B-X
of	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
to	B-X
glutamate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
to	B-X
gamma-hydroxy-glutamate	B-X
.	B-X
To	B-X
determine	B-X
if	B-X
this	B-X
second	B-X
step	B-X
in	B-X
the	B-X
degradation	B-X
of	B-X
proline	B-X
and	B-X
hydroxyproline	B-X
is	B-X
catalyzed	B-X
by	B-X
a	B-X
common	B-X
or	B-X
by	B-X
separate	B-X
enzyme	B-X
(	B-X
s	B-X
)	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
radioisotopic	B-X
assay	B-X
for	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
dehydrogenase	B-X
activity	B-X
.	B-X
We	B-X
then	B-X
compared	B-X
delta1-pyrroline-3-hydroxy-5-carboxylate	B-X
dehydrogenase	B-X
activity	B-X
with	B-X
that	B-X
of	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
dehydrogenase	B-X
in	B-X
fibroblasts	B-X
and	B-X
leukocytes	B-X
from	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
patients	B-X
,	B-X
heterozygotes	B-X
,	B-X
and	B-X
controls	B-X
.	B-X
We	B-X
found	B-X
that	B-X
cells	B-X
from	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
patients	B-X
were	B-X
deficient	B-X
in	B-X
both	B-X
dehydrogenase	B-X
activities	B-X
.	B-X
We	B-X
conclude	B-X
from	B-X
these	B-X
data	B-X
that	B-X
a	B-X
common	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
dehydrogenase	B-X
catalyzes	B-X
the	B-X
oxidation	B-X
of	B-X
both	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
,	B-X
and	B-X
that	B-X
this	B-X
activity	B-X
is	B-X
deficient	B-X
in	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
.	B-X

The	O
initial	O
step	O
in	O
the	O
degradation	O
pathways	O
of	O
proline	O
and	O
hydroxyproline	O
is	O
catalyzed	O
by	O
proline	B-Gene_or_gene_product
oxidase	I-Gene_or_gene_product
and	O
hydroxyproline	B-Gene_or_gene_product
oxidase	I-Gene_or_gene_product
,	O
yielding	O
delta	O
1	O
-	O
pyrroline	O
-	O
5	O
-	O
carboxylate	O
and	O
delta	O
1	O
-	O
pyrroline	O
-	O
3	O
-	O
hydroxy	O
-	O
5	O
-	O
carboxylate	O
,	O
respectively	O
.	O
<EOS>	B-X
The	B-X
initial	B-X
step	B-X
in	B-X
the	B-X
degradation	B-X
pathways	B-X
of	B-X
proline	B-X
and	B-X
hydroxyproline	B-X
is	B-X
catalyzed	B-X
by	B-X
proline	B-X
oxidase	B-X
and	B-X
hydroxyproline	B-X
oxidase	B-X
,	B-X
yielding	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
second	B-X
step	B-X
is	B-X
the	B-X
oxidation	B-X
of	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
to	B-X
glutamate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
to	B-X
gamma-hydroxy-glutamate	B-X
.	B-X
To	B-X
determine	B-X
if	B-X
this	B-X
second	B-X
step	B-X
in	B-X
the	B-X
degradation	B-X
of	B-X
proline	B-X
and	B-X
hydroxyproline	B-X
is	B-X
catalyzed	B-X
by	B-X
a	B-X
common	B-X
or	B-X
by	B-X
separate	B-X
enzyme	B-X
(	B-X
s	B-X
)	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
radioisotopic	B-X
assay	B-X
for	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
dehydrogenase	B-X
activity	B-X
.	B-X
We	B-X
then	B-X
compared	B-X
delta1-pyrroline-3-hydroxy-5-carboxylate	B-X
dehydrogenase	B-X
activity	B-X
with	B-X
that	B-X
of	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
dehydrogenase	B-X
in	B-X
fibroblasts	B-X
and	B-X
leukocytes	B-X
from	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
patients	B-X
,	B-X
heterozygotes	B-X
,	B-X
and	B-X
controls	B-X
.	B-X
We	B-X
found	B-X
that	B-X
cells	B-X
from	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
patients	B-X
were	B-X
deficient	B-X
in	B-X
both	B-X
dehydrogenase	B-X
activities	B-X
.	B-X
We	B-X
conclude	B-X
from	B-X
these	B-X
data	B-X
that	B-X
a	B-X
common	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
dehydrogenase	B-X
catalyzes	B-X
the	B-X
oxidation	B-X
of	B-X
both	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
,	B-X
and	B-X
that	B-X
this	B-X
activity	B-X
is	B-X
deficient	B-X
in	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
.	B-X

The	O
second	O
step	O
is	O
the	O
oxidation	O
of	O
delta	O
1	O
-	O
pyrroline	O
-	O
5	O
-	O
carboxylate	O
to	O
glutamate	O
and	O
delta	O
1	O
-	O
pyrroline	O
-	O
3	O
-	O
hydroxy	O
-	O
5	O
-	O
carboxylate	O
to	O
gamma	O
-	O
hydroxy	O
-	O
glutamate	O
.	O
<EOS>	B-X
The	B-X
initial	B-X
step	B-X
in	B-X
the	B-X
degradation	B-X
pathways	B-X
of	B-X
proline	B-X
and	B-X
hydroxyproline	B-X
is	B-X
catalyzed	B-X
by	B-X
proline	B-X
oxidase	B-X
and	B-X
hydroxyproline	B-X
oxidase	B-X
,	B-X
yielding	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
second	B-X
step	B-X
is	B-X
the	B-X
oxidation	B-X
of	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
to	B-X
glutamate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
to	B-X
gamma-hydroxy-glutamate	B-X
.	B-X
To	B-X
determine	B-X
if	B-X
this	B-X
second	B-X
step	B-X
in	B-X
the	B-X
degradation	B-X
of	B-X
proline	B-X
and	B-X
hydroxyproline	B-X
is	B-X
catalyzed	B-X
by	B-X
a	B-X
common	B-X
or	B-X
by	B-X
separate	B-X
enzyme	B-X
(	B-X
s	B-X
)	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
radioisotopic	B-X
assay	B-X
for	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
dehydrogenase	B-X
activity	B-X
.	B-X
We	B-X
then	B-X
compared	B-X
delta1-pyrroline-3-hydroxy-5-carboxylate	B-X
dehydrogenase	B-X
activity	B-X
with	B-X
that	B-X
of	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
dehydrogenase	B-X
in	B-X
fibroblasts	B-X
and	B-X
leukocytes	B-X
from	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
patients	B-X
,	B-X
heterozygotes	B-X
,	B-X
and	B-X
controls	B-X
.	B-X
We	B-X
conclude	B-X
from	B-X
these	B-X
data	B-X
that	B-X
a	B-X
common	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
dehydrogenase	B-X
catalyzes	B-X
the	B-X
oxidation	B-X
of	B-X
both	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
,	B-X
and	B-X
that	B-X
this	B-X
activity	B-X
is	B-X
deficient	B-X
in	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
.	B-X

To	O
determine	O
if	O
this	O
second	O
step	O
in	O
the	O
degradation	O
of	O
proline	O
and	O
hydroxyproline	O
is	O
catalyzed	O
by	O
a	O
common	O
or	O
by	O
separate	O
enzyme	O
(	O
s	O
)	O
,	O
we	O
developed	O
a	O
radioisotopic	O
assay	O
for	O
delta	B-Gene_or_gene_product
1	I-Gene_or_gene_product
-	I-Gene_or_gene_product
pyrroline	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
hydroxy	I-Gene_or_gene_product
-	I-Gene_or_gene_product
5	I-Gene_or_gene_product
-	I-Gene_or_gene_product
carboxylate	I-Gene_or_gene_product
dehydrogenase	I-Gene_or_gene_product
activity	O
.	O
<EOS>	B-X
The	B-X
initial	B-X
step	B-X
in	B-X
the	B-X
degradation	B-X
pathways	B-X
of	B-X
proline	B-X
and	B-X
hydroxyproline	B-X
is	B-X
catalyzed	B-X
by	B-X
proline	B-X
oxidase	B-X
and	B-X
hydroxyproline	B-X
oxidase	B-X
,	B-X
yielding	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
second	B-X
step	B-X
is	B-X
the	B-X
oxidation	B-X
of	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
to	B-X
glutamate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
to	B-X
gamma-hydroxy-glutamate	B-X
.	B-X
To	B-X
determine	B-X
if	B-X
this	B-X
second	B-X
step	B-X
in	B-X
the	B-X
degradation	B-X
of	B-X
proline	B-X
and	B-X
hydroxyproline	B-X
is	B-X
catalyzed	B-X
by	B-X
a	B-X
common	B-X
or	B-X
by	B-X
separate	B-X
enzyme	B-X
(	B-X
s	B-X
)	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
radioisotopic	B-X
assay	B-X
for	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
dehydrogenase	B-X
activity	B-X
.	B-X
We	B-X
then	B-X
compared	B-X
delta1-pyrroline-3-hydroxy-5-carboxylate	B-X
dehydrogenase	B-X
activity	B-X
with	B-X
that	B-X
of	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
dehydrogenase	B-X
in	B-X
fibroblasts	B-X
and	B-X
leukocytes	B-X
from	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
patients	B-X
,	B-X
heterozygotes	B-X
,	B-X
and	B-X
controls	B-X
.	B-X
We	B-X
found	B-X
that	B-X
cells	B-X
from	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
patients	B-X
were	B-X
deficient	B-X
in	B-X
both	B-X
dehydrogenase	B-X
activities	B-X
.	B-X
We	B-X
conclude	B-X
from	B-X
these	B-X
data	B-X
that	B-X
a	B-X
common	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
dehydrogenase	B-X
catalyzes	B-X
the	B-X
oxidation	B-X
of	B-X
both	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
,	B-X
and	B-X
that	B-X
this	B-X
activity	B-X
is	B-X
deficient	B-X
in	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
.	B-X

We	O
then	O
compared	O
delta1	B-Gene_or_gene_product
-	I-Gene_or_gene_product
pyrroline	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
hydroxy	I-Gene_or_gene_product
-	I-Gene_or_gene_product
5	I-Gene_or_gene_product
-	I-Gene_or_gene_product
carboxylate	I-Gene_or_gene_product
dehydrogenase	I-Gene_or_gene_product
activity	O
with	O
that	O
of	O
delta	B-Gene_or_gene_product
1	I-Gene_or_gene_product
-	I-Gene_or_gene_product
pyrroline	I-Gene_or_gene_product
-	I-Gene_or_gene_product
5	I-Gene_or_gene_product
-	I-Gene_or_gene_product
carboxylate	I-Gene_or_gene_product
dehydrogenase	I-Gene_or_gene_product
in	O
fibroblasts	O
and	O
leukocytes	O
from	O
type	O
II	O
hyperprolinemia	O
patients	O
,	O
heterozygotes	O
,	O
and	O
controls	O
.	O
<EOS>	B-X
The	B-X
initial	B-X
step	B-X
in	B-X
the	B-X
degradation	B-X
pathways	B-X
of	B-X
proline	B-X
and	B-X
hydroxyproline	B-X
is	B-X
catalyzed	B-X
by	B-X
proline	B-X
oxidase	B-X
and	B-X
hydroxyproline	B-X
oxidase	B-X
,	B-X
yielding	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
second	B-X
step	B-X
is	B-X
the	B-X
oxidation	B-X
of	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
to	B-X
glutamate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
to	B-X
gamma-hydroxy-glutamate	B-X
.	B-X
To	B-X
determine	B-X
if	B-X
this	B-X
second	B-X
step	B-X
in	B-X
the	B-X
degradation	B-X
of	B-X
proline	B-X
and	B-X
hydroxyproline	B-X
is	B-X
catalyzed	B-X
by	B-X
a	B-X
common	B-X
or	B-X
by	B-X
separate	B-X
enzyme	B-X
(	B-X
s	B-X
)	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
radioisotopic	B-X
assay	B-X
for	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
dehydrogenase	B-X
activity	B-X
.	B-X
We	B-X
then	B-X
compared	B-X
delta1-pyrroline-3-hydroxy-5-carboxylate	B-X
dehydrogenase	B-X
activity	B-X
with	B-X
that	B-X
of	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
dehydrogenase	B-X
in	B-X
fibroblasts	B-X
and	B-X
leukocytes	B-X
from	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
patients	B-X
,	B-X
heterozygotes	B-X
,	B-X
and	B-X
controls	B-X
.	B-X
We	B-X
found	B-X
that	B-X
cells	B-X
from	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
patients	B-X
were	B-X
deficient	B-X
in	B-X
both	B-X
dehydrogenase	B-X
activities	B-X
.	B-X
Furthermore	B-X
,	B-X
these	B-X
activities	B-X
were	B-X
highly	B-X
correlated	B-X
over	B-X
the	B-X
range	B-X
found	B-X
in	B-X
the	B-X
normals	B-X
,	B-X
heterozygotes	B-X
,	B-X
and	B-X
patients	B-X
.	B-X
We	B-X
conclude	B-X
from	B-X
these	B-X
data	B-X
that	B-X
a	B-X
common	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
dehydrogenase	B-X
catalyzes	B-X
the	B-X
oxidation	B-X
of	B-X
both	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
,	B-X
and	B-X
that	B-X
this	B-X
activity	B-X
is	B-X
deficient	B-X
in	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
.	B-X

We	O
found	O
that	O
cells	O
from	O
type	O
II	O
hyperprolinemia	O
patients	O
were	O
deficient	O
in	O
both	O
dehydrogenase	O
activities	O
.	O
<EOS>	B-X
Type	B-X
II	B-X
hyperprolinemia	B-X
is	B-X
an	B-X
inherited	B-X
abnormality	B-X
in	B-X
amino	B-X
acid	B-X
metabolism	B-X
characterized	B-X
by	B-X
elevated	B-X
plasma	B-X
proline	B-X
concentrations	B-X
,	B-X
iminoglycinuria	B-X
,	B-X
and	B-X
the	B-X
urinary	B-X
excretion	B-X
of	B-X
delta1-pyrroline	B-X
compounds	B-X
.	B-X
To	B-X
define	B-X
the	B-X
enzymologic	B-X
defect	B-X
of	B-X
this	B-X
biochemical	B-X
disorder	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
specific	B-X
,	B-X
sensitive	B-X
radioisotopic	B-X
assay	B-X
for	B-X
the	B-X
proline	B-X
degradative	B-X
enzyme	B-X
delta1-pyrroline-5-carboxylic	B-X
acid	B-X
dehydrogenase	B-X
.	B-X
Using	B-X
this	B-X
assay	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
an	B-X
absence	B-X
of	B-X
delta1-pyrroline-5-carboxylic	B-X
acid	B-X
dehydrogenase	B-X
activity	B-X
in	B-X
the	B-X
cultured	B-X
fibroblasts	B-X
from	B-X
three	B-X
patients	B-X
with	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
.	B-X
We	B-X
confirmed	B-X
this	B-X
result	B-X
on	B-X
cultured	B-X
cells	B-X
by	B-X
demonstrating	B-X
a	B-X
similar	B-X
absence	B-X
of	B-X
delta1-pyrroline-5-carboxylic	B-X
acid	B-X
dehydrogenase	B-X
activity	B-X
in	B-X
extracts	B-X
prepared	B-X
from	B-X
the	B-X
peripheral	B-X
leukocytes	B-X
of	B-X
these	B-X
patients	B-X
.	B-X
Additionally	B-X
,	B-X
we	B-X
found	B-X
significantly	B-X
decreased	B-X
levels	B-X
of	B-X
delta1-pyrroline-5-carboxylic	B-X
acid	B-X
dehydrogenase	B-X
activity	B-X
in	B-X
the	B-X
leukocyte	B-X
extracts	B-X
from	B-X
five	B-X
obligate	B-X
heterozygotes	B-X
for	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
.	B-X
We	B-X
also	B-X
demonstrated	B-X
a	B-X
reduction	B-X
in	B-X
leukocyte	B-X
delta1-pyrroline-5-carboxylic	B-X
acid	B-X
dehydrogenase	B-X
activity	B-X
in	B-X
three	B-X
successive	B-X
generations	B-X
of	B-X
a	B-X
family	B-X
.	B-X
These	B-X
results	B-X
prove	B-X
that	B-X
an	B-X
absence	B-X
of	B-X
delta1-pyrroline-5-carboxylic	B-X
acid	B-X
dehydrogenase	B-X
is	B-X
the	B-X
enzymologic	B-X
defect	B-X
in	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
and	B-X
that	B-X
this	B-X
defect	B-X
is	B-X
inherited	B-X
in	B-X
an	B-X
autosomal	B-X
recessive	B-X
fashion	B-X
.	B-X

Furthermore	O
,	O
these	O
activities	O
were	O
highly	O
correlated	O
over	O
the	O
range	O
found	O
in	O
the	O
normals	O
,	O
heterozygotes	O
,	O
and	O
patients	O
.	O
<EOS>	B-X
We	B-X
then	B-X
compared	B-X
delta1-pyrroline-3-hydroxy-5-carboxylate	B-X
dehydrogenase	B-X
activity	B-X
with	B-X
that	B-X
of	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
dehydrogenase	B-X
in	B-X
fibroblasts	B-X
and	B-X
leukocytes	B-X
from	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
patients	B-X
,	B-X
heterozygotes	B-X
,	B-X
and	B-X
controls	B-X
.	B-X
We	B-X
found	B-X
that	B-X
cells	B-X
from	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
patients	B-X
were	B-X
deficient	B-X
in	B-X
both	B-X
dehydrogenase	B-X
activities	B-X
.	B-X
Furthermore	B-X
,	B-X
these	B-X
activities	B-X
were	B-X
highly	B-X
correlated	B-X
over	B-X
the	B-X
range	B-X
found	B-X
in	B-X
the	B-X
normals	B-X
,	B-X
heterozygotes	B-X
,	B-X
and	B-X
patients	B-X
.	B-X

We	O
conclude	O
from	O
these	O
data	O
that	O
a	O
common	O
delta	B-Gene_or_gene_product
1	I-Gene_or_gene_product
-	I-Gene_or_gene_product
pyrroline	I-Gene_or_gene_product
-	I-Gene_or_gene_product
5	I-Gene_or_gene_product
-	I-Gene_or_gene_product
carboxylate	I-Gene_or_gene_product
dehydrogenase	I-Gene_or_gene_product
catalyzes	O
the	O
oxidation	O
of	O
both	O
delta	O
1	O
-	O
pyrroline	O
-	O
5	O
-	O
carboxylate	O
and	O
delta	O
1	O
-	O
pyrroline	O
-	O
3	O
-	O
hydroxy	O
-	O
5	O
-	O
carboxylate	O
,	O
and	O
that	O
this	O
activity	O
is	O
deficient	O
in	O
type	O
II	O
hyperprolinemia	O
.	O
<EOS>	B-X
The	B-X
initial	B-X
step	B-X
in	B-X
the	B-X
degradation	B-X
pathways	B-X
of	B-X
proline	B-X
and	B-X
hydroxyproline	B-X
is	B-X
catalyzed	B-X
by	B-X
proline	B-X
oxidase	B-X
and	B-X
hydroxyproline	B-X
oxidase	B-X
,	B-X
yielding	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
second	B-X
step	B-X
is	B-X
the	B-X
oxidation	B-X
of	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
to	B-X
glutamate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
to	B-X
gamma-hydroxy-glutamate	B-X
.	B-X
To	B-X
determine	B-X
if	B-X
this	B-X
second	B-X
step	B-X
in	B-X
the	B-X
degradation	B-X
of	B-X
proline	B-X
and	B-X
hydroxyproline	B-X
is	B-X
catalyzed	B-X
by	B-X
a	B-X
common	B-X
or	B-X
by	B-X
separate	B-X
enzyme	B-X
(	B-X
s	B-X
)	B-X
,	B-X
we	B-X
developed	B-X
a	B-X
radioisotopic	B-X
assay	B-X
for	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
dehydrogenase	B-X
activity	B-X
.	B-X
We	B-X
then	B-X
compared	B-X
delta1-pyrroline-3-hydroxy-5-carboxylate	B-X
dehydrogenase	B-X
activity	B-X
with	B-X
that	B-X
of	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
dehydrogenase	B-X
in	B-X
fibroblasts	B-X
and	B-X
leukocytes	B-X
from	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
patients	B-X
,	B-X
heterozygotes	B-X
,	B-X
and	B-X
controls	B-X
.	B-X
We	B-X
found	B-X
that	B-X
cells	B-X
from	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
patients	B-X
were	B-X
deficient	B-X
in	B-X
both	B-X
dehydrogenase	B-X
activities	B-X
.	B-X
We	B-X
conclude	B-X
from	B-X
these	B-X
data	B-X
that	B-X
a	B-X
common	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
dehydrogenase	B-X
catalyzes	B-X
the	B-X
oxidation	B-X
of	B-X
both	B-X
delta	B-X
1-pyrroline-5-carboxylate	B-X
and	B-X
delta	B-X
1-pyrroline-3-hydroxy-5-carboxylate	B-X
,	B-X
and	B-X
that	B-X
this	B-X
activity	B-X
is	B-X
deficient	B-X
in	B-X
type	B-X
II	B-X
hyperprolinemia	B-X
.	B-X

The	O
isolation	O
and	O
characterization	O
of	O
cDNA	O
encoding	O
human	O
and	O
rat	O
brain	O
inositol	B-Gene_or_gene_product
polyphosphate	I-Gene_or_gene_product
4	I-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
.	O
<EOS>	B-X
Inositol	B-X
polyphosphate	B-X
4-phosphatase	B-X
,	B-X
an	B-X
enzyme	B-X
of	B-X
the	B-X
inositol	B-X
phosphate	B-X
signaling	B-X
pathway	B-X
,	B-X
catalyzes	B-X
the	B-X
hydrolysis	B-X
of	B-X
the	B-X
4-position	B-X
phosphate	B-X
of	B-X
inositol	B-X
3,4-bisphosphate	B-X
,	B-X
inositol	B-X
1,3,4-trisphosphate	B-X
,	B-X
and	B-X
phosphatidylinositol	B-X
3,4-bisphosphate	B-X
.	B-X
The	B-X
amino	B-X
acid	B-X
sequences	B-X
of	B-X
tryptic	B-X
and	B-X
CNBr	B-X
peptides	B-X
of	B-X
the	B-X
enzyme	B-X
isolated	B-X
from	B-X
rat	B-X
brain	B-X
were	B-X
determined	B-X
.	B-X
Degenerate	B-X
oligonucleotide	B-X
primers	B-X
based	B-X
on	B-X
this	B-X
sequence	B-X
were	B-X
used	B-X
to	B-X
amplify	B-X
a	B-X
74-base	B-X
pair	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
.	B-X
This	B-X
product	B-X
was	B-X
used	B-X
to	B-X
isolate	B-X
a	B-X
5607-base	B-X
pair	B-X
composite	B-X
cDNA	B-X
,	B-X
which	B-X
had	B-X
an	B-X
open	B-X
reading	B-X
frame	B-X
encoding	B-X
a	B-X
protein	B-X
with	B-X
939	B-X
amino	B-X
acids	B-X
with	B-X
a	B-X
predicted	B-X
molecular	B-X
mass	B-X
of	B-X
105,588	B-X
Da	B-X
.	B-X
The	B-X
rat	B-X
brain	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
was	B-X
used	B-X
as	B-X
a	B-X
probe	B-X
to	B-X
isolate	B-X
a	B-X
human	B-X
brain	B-X
cDNA	B-X
that	B-X
predicts	B-X
a	B-X
protein	B-X
with	B-X
938	B-X
amino	B-X
acids	B-X
and	B-X
a	B-X
molecular	B-X
mass	B-X
of	B-X
105,710	B-X
Da	B-X
.	B-X
Remarkably	B-X
,	B-X
the	B-X
human	B-X
and	B-X
rat	B-X
proteins	B-X
were	B-X
97	B-X
%	B-X
identical	B-X
.	B-X
Recombinant	B-X
rat	B-X
protein	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
catalyzed	B-X
the	B-X
hydrolysis	B-X
of	B-X
all	B-X
three	B-X
substrates	B-X
of	B-X
the	B-X
4-phosphatase	B-X
.	B-X
Northern	B-X
blot	B-X
hybridization	B-X
indicates	B-X
that	B-X
the	B-X
4-phosphatase	B-X
is	B-X
widely	B-X
expressed	B-X
in	B-X
rat	B-X
tissues	B-X
with	B-X
the	B-X
highest	B-X
levels	B-X
of	B-X
expression	B-X
occurring	B-X
in	B-X
brain	B-X
,	B-X
heart	B-X
,	B-X
and	B-X
skeletal	B-X
muscle	B-X
.	B-X
Polyclonal	B-X
antiserum	B-X
directed	B-X
against	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
the	B-X
4-phosphatase	B-X
immunoprecipitated	B-X
>	B-X
95	B-X
%	B-X
of	B-X
the	B-X
4-phosphatase	B-X
activity	B-X
in	B-X
crude	B-X
homogenates	B-X
of	B-X
rat	B-X
brain	B-X
,	B-X
heart	B-X
,	B-X
skeletal	B-X
muscle	B-X
,	B-X
and	B-X
spleen	B-X
,	B-X
suggesting	B-X
that	B-X
this	B-X
enzyme	B-X
accounts	B-X
for	B-X
the	B-X
4-phosphate	B-X
activity	B-X
present	B-X
in	B-X
rat	B-X
tissues	B-X
.	B-X
This	B-X
antiserum	B-X
also	B-X
immunoprecipitated	B-X
the	B-X
4-phosphatase	B-X
from	B-X
human	B-X
platelet	B-X
sonicates	B-X
.	B-X

Inositol	B-Gene_or_gene_product
polyphosphate	I-Gene_or_gene_product
4	I-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
,	O
an	O
enzyme	O
of	O
the	O
inositol	O
phosphate	O
signaling	O
pathway	O
,	O
catalyzes	O
the	O
hydrolysis	O
of	O
the	O
4	O
-	O
position	O
phosphate	O
of	O
inositol	O
3	O
,	O
4	O
-	O
bisphosphate	O
,	O
inositol	O
1	O
,	O
3	O
,	O
4	O
-	O
trisphosphate	O
,	O
and	O
phosphatidylinositol	O
3	O
,	O
4	O
-	O
bisphosphate	O
.	O
<EOS>	B-X
Inositol	B-X
polyphosphate	B-X
4-phosphatase	B-X
,	B-X
an	B-X
enzyme	B-X
of	B-X
the	B-X
inositol	B-X
phosphate	B-X
signaling	B-X
pathway	B-X
,	B-X
catalyzes	B-X
the	B-X
hydrolysis	B-X
of	B-X
the	B-X
4-position	B-X
phosphate	B-X
of	B-X
inositol	B-X
3,4-bisphosphate	B-X
,	B-X
inositol	B-X
1,3,4-trisphosphate	B-X
,	B-X
and	B-X
phosphatidylinositol	B-X
3,4-bisphosphate	B-X
.	B-X
The	B-X
amino	B-X
acid	B-X
sequences	B-X
of	B-X
tryptic	B-X
and	B-X
CNBr	B-X
peptides	B-X
of	B-X
the	B-X
enzyme	B-X
isolated	B-X
from	B-X
rat	B-X
brain	B-X
were	B-X
determined	B-X
.	B-X
Degenerate	B-X
oligonucleotide	B-X
primers	B-X
based	B-X
on	B-X
this	B-X
sequence	B-X
were	B-X
used	B-X
to	B-X
amplify	B-X
a	B-X
74-base	B-X
pair	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
.	B-X
This	B-X
product	B-X
was	B-X
used	B-X
to	B-X
isolate	B-X
a	B-X
5607-base	B-X
pair	B-X
composite	B-X
cDNA	B-X
,	B-X
which	B-X
had	B-X
an	B-X
open	B-X
reading	B-X
frame	B-X
encoding	B-X
a	B-X
protein	B-X
with	B-X
939	B-X
amino	B-X
acids	B-X
with	B-X
a	B-X
predicted	B-X
molecular	B-X
mass	B-X
of	B-X
105,588	B-X
Da	B-X
.	B-X
The	B-X
rat	B-X
brain	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
was	B-X
used	B-X
as	B-X
a	B-X
probe	B-X
to	B-X
isolate	B-X
a	B-X
human	B-X
brain	B-X
cDNA	B-X
that	B-X
predicts	B-X
a	B-X
protein	B-X
with	B-X
938	B-X
amino	B-X
acids	B-X
and	B-X
a	B-X
molecular	B-X
mass	B-X
of	B-X
105,710	B-X
Da	B-X
.	B-X
Recombinant	B-X
rat	B-X
protein	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
catalyzed	B-X
the	B-X
hydrolysis	B-X
of	B-X
all	B-X
three	B-X
substrates	B-X
of	B-X
the	B-X
4-phosphatase	B-X
.	B-X
Northern	B-X
blot	B-X
hybridization	B-X
indicates	B-X
that	B-X
the	B-X
4-phosphatase	B-X
is	B-X
widely	B-X
expressed	B-X
in	B-X
rat	B-X
tissues	B-X
with	B-X
the	B-X
highest	B-X
levels	B-X
of	B-X
expression	B-X
occurring	B-X
in	B-X
brain	B-X
,	B-X
heart	B-X
,	B-X
and	B-X
skeletal	B-X
muscle	B-X
.	B-X
Polyclonal	B-X
antiserum	B-X
directed	B-X
against	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
the	B-X
4-phosphatase	B-X
immunoprecipitated	B-X
>	B-X
95	B-X
%	B-X
of	B-X
the	B-X
4-phosphatase	B-X
activity	B-X
in	B-X
crude	B-X
homogenates	B-X
of	B-X
rat	B-X
brain	B-X
,	B-X
heart	B-X
,	B-X
skeletal	B-X
muscle	B-X
,	B-X
and	B-X
spleen	B-X
,	B-X
suggesting	B-X
that	B-X
this	B-X
enzyme	B-X
accounts	B-X
for	B-X
the	B-X
4-phosphate	B-X
activity	B-X
present	B-X
in	B-X
rat	B-X
tissues	B-X
.	B-X
This	B-X
antiserum	B-X
also	B-X
immunoprecipitated	B-X
the	B-X
4-phosphatase	B-X
from	B-X
human	B-X
platelet	B-X
sonicates	B-X
.	B-X

The	O
amino	O
acid	O
sequences	O
of	O
tryptic	O
and	O
CNBr	O
peptides	O
of	O
the	O
enzyme	O
isolated	O
from	O
rat	O
brain	O
were	O
determined	O
.	O
<EOS>	B-X
Inositol	B-X
polyphosphate	B-X
4-phosphatase	B-X
,	B-X
an	B-X
enzyme	B-X
of	B-X
the	B-X
inositol	B-X
phosphate	B-X
signaling	B-X
pathway	B-X
,	B-X
catalyzes	B-X
the	B-X
hydrolysis	B-X
of	B-X
the	B-X
4-position	B-X
phosphate	B-X
of	B-X
inositol	B-X
3,4-bisphosphate	B-X
,	B-X
inositol	B-X
1,3,4-trisphosphate	B-X
,	B-X
and	B-X
phosphatidylinositol	B-X
3,4-bisphosphate	B-X
.	B-X
The	B-X
amino	B-X
acid	B-X
sequences	B-X
of	B-X
tryptic	B-X
and	B-X
CNBr	B-X
peptides	B-X
of	B-X
the	B-X
enzyme	B-X
isolated	B-X
from	B-X
rat	B-X
brain	B-X
were	B-X
determined	B-X
.	B-X
Degenerate	B-X
oligonucleotide	B-X
primers	B-X
based	B-X
on	B-X
this	B-X
sequence	B-X
were	B-X
used	B-X
to	B-X
amplify	B-X
a	B-X
74-base	B-X
pair	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
.	B-X
This	B-X
product	B-X
was	B-X
used	B-X
to	B-X
isolate	B-X
a	B-X
5607-base	B-X
pair	B-X
composite	B-X
cDNA	B-X
,	B-X
which	B-X
had	B-X
an	B-X
open	B-X
reading	B-X
frame	B-X
encoding	B-X
a	B-X
protein	B-X
with	B-X
939	B-X
amino	B-X
acids	B-X
with	B-X
a	B-X
predicted	B-X
molecular	B-X
mass	B-X
of	B-X
105,588	B-X
Da	B-X
.	B-X
The	B-X
rat	B-X
brain	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
was	B-X
used	B-X
as	B-X
a	B-X
probe	B-X
to	B-X
isolate	B-X
a	B-X
human	B-X
brain	B-X
cDNA	B-X
that	B-X
predicts	B-X
a	B-X
protein	B-X
with	B-X
938	B-X
amino	B-X
acids	B-X
and	B-X
a	B-X
molecular	B-X
mass	B-X
of	B-X
105,710	B-X
Da	B-X
.	B-X
Remarkably	B-X
,	B-X
the	B-X
human	B-X
and	B-X
rat	B-X
proteins	B-X
were	B-X
97	B-X
%	B-X
identical	B-X
.	B-X
Recombinant	B-X
rat	B-X
protein	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
catalyzed	B-X
the	B-X
hydrolysis	B-X
of	B-X
all	B-X
three	B-X
substrates	B-X
of	B-X
the	B-X
4-phosphatase	B-X
.	B-X
Northern	B-X
blot	B-X
hybridization	B-X
indicates	B-X
that	B-X
the	B-X
4-phosphatase	B-X
is	B-X
widely	B-X
expressed	B-X
in	B-X
rat	B-X
tissues	B-X
with	B-X
the	B-X
highest	B-X
levels	B-X
of	B-X
expression	B-X
occurring	B-X
in	B-X
brain	B-X
,	B-X
heart	B-X
,	B-X
and	B-X
skeletal	B-X
muscle	B-X
.	B-X
Polyclonal	B-X
antiserum	B-X
directed	B-X
against	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
the	B-X
4-phosphatase	B-X
immunoprecipitated	B-X
>	B-X
95	B-X
%	B-X
of	B-X
the	B-X
4-phosphatase	B-X
activity	B-X
in	B-X
crude	B-X
homogenates	B-X
of	B-X
rat	B-X
brain	B-X
,	B-X
heart	B-X
,	B-X
skeletal	B-X
muscle	B-X
,	B-X
and	B-X
spleen	B-X
,	B-X
suggesting	B-X
that	B-X
this	B-X
enzyme	B-X
accounts	B-X
for	B-X
the	B-X
4-phosphate	B-X
activity	B-X
present	B-X
in	B-X
rat	B-X
tissues	B-X
.	B-X

Degenerate	O
oligonucleotide	O
primers	O
based	O
on	O
this	O
sequence	O
were	O
used	O
to	O
amplify	O
a	O
74	O
-	O
base	O
pair	O
polymerase	O
chain	O
reaction	O
product	O
.	O
<EOS>	B-X
A	B-X
reverse	B-X
transcription-polymerase	B-X
chain	B-X
reaction	B-X
(	B-X
RT-PCR	B-X
)	B-X
procedure	B-X
for	B-X
the	B-X
detection	B-X
of	B-X
avian	B-X
,	B-X
duck	B-X
,	B-X
and	B-X
goose	B-X
reovirus	B-X
(	B-X
ARV	B-X
,	B-X
DRV	B-X
,	B-X
and	B-X
GRV	B-X
)	B-X
RNA	B-X
from	B-X
cell	B-X
culture	B-X
supernatant	B-X
and	B-X
clinical	B-X
samples	B-X
was	B-X
established	B-X
.	B-X
Based	B-X
on	B-X
multiple	B-X
sequence	B-X
alignment	B-X
,	B-X
a	B-X
pair	B-X
of	B-X
degenerate	B-X
primers	B-X
was	B-X
selected	B-X
and	B-X
synthesized	B-X
.	B-X
The	B-X
amplified	B-X
,	B-X
cloned	B-X
,	B-X
and	B-X
sequenced	B-X
598-base-pair	B-X
products	B-X
from	B-X
the	B-X
sigmaA-encoding	B-X
gene	B-X
fragment	B-X
from	B-X
16	B-X
isolates	B-X
(	B-X
ranging	B-X
over	B-X
30	B-X
years	B-X
)	B-X
indicated	B-X
that	B-X
the	B-X
primer	B-X
regions	B-X
were	B-X
well	B-X
conserved	B-X
.	B-X
The	B-X
nucleotide	B-X
sequence	B-X
analysis	B-X
indicated	B-X
that	B-X
DRV	B-X
and	B-X
GRV	B-X
isolated	B-X
from	B-X
China	B-X
in	B-X
different	B-X
locales	B-X
and	B-X
years	B-X
were	B-X
closely	B-X
related	B-X
,	B-X
showing	B-X
97.4-100	B-X
%	B-X
homology	B-X
to	B-X
each	B-X
other	B-X
,	B-X
but	B-X
with	B-X
only	B-X
86.7-88.5	B-X
%	B-X
identity	B-X
to	B-X
DRV	B-X
89026	B-X
.	B-X
The	B-X
nucleotide	B-X
and	B-X
amino	B-X
acid	B-X
sequence	B-X
identities	B-X
in	B-X
the	B-X
amplified	B-X
sigmaA-encoding	B-X
gene	B-X
were	B-X
74.2-78.4	B-X
%	B-X
and	B-X
86.9-92.0	B-X
%	B-X
,	B-X
respectively	B-X
,	B-X
between	B-X
duck/goose	B-X
and	B-X
chicken	B-X
species	B-X
.	B-X

This	O
product	O
was	O
used	O
to	O
isolate	O
a	O
5607	O
-	O
base	O
pair	O
composite	O
cDNA	O
,	O
which	O
had	O
an	O
open	O
reading	O
frame	O
encoding	O
a	O
protein	O
with	O
939	O
amino	O
acids	O
with	O
a	O
predicted	O
molecular	O
mass	O
of	O
105	O
,	O
588	O
Da	O
.	O
<EOS>	B-X
The	B-X
amino	B-X
acid	B-X
sequences	B-X
of	B-X
tryptic	B-X
and	B-X
CNBr	B-X
peptides	B-X
of	B-X
the	B-X
enzyme	B-X
isolated	B-X
from	B-X
rat	B-X
brain	B-X
were	B-X
determined	B-X
.	B-X
Degenerate	B-X
oligonucleotide	B-X
primers	B-X
based	B-X
on	B-X
this	B-X
sequence	B-X
were	B-X
used	B-X
to	B-X
amplify	B-X
a	B-X
74-base	B-X
pair	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
.	B-X
This	B-X
product	B-X
was	B-X
used	B-X
to	B-X
isolate	B-X
a	B-X
5607-base	B-X
pair	B-X
composite	B-X
cDNA	B-X
,	B-X
which	B-X
had	B-X
an	B-X
open	B-X
reading	B-X
frame	B-X
encoding	B-X
a	B-X
protein	B-X
with	B-X
939	B-X
amino	B-X
acids	B-X
with	B-X
a	B-X
predicted	B-X
molecular	B-X
mass	B-X
of	B-X
105,588	B-X
Da	B-X
.	B-X
The	B-X
rat	B-X
brain	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
was	B-X
used	B-X
as	B-X
a	B-X
probe	B-X
to	B-X
isolate	B-X
a	B-X
human	B-X
brain	B-X
cDNA	B-X
that	B-X
predicts	B-X
a	B-X
protein	B-X
with	B-X
938	B-X
amino	B-X
acids	B-X
and	B-X
a	B-X
molecular	B-X
mass	B-X
of	B-X
105,710	B-X
Da	B-X
.	B-X
Remarkably	B-X
,	B-X
the	B-X
human	B-X
and	B-X
rat	B-X
proteins	B-X
were	B-X
97	B-X
%	B-X
identical	B-X
.	B-X
Recombinant	B-X
rat	B-X
protein	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
catalyzed	B-X
the	B-X
hydrolysis	B-X
of	B-X
all	B-X
three	B-X
substrates	B-X
of	B-X
the	B-X
4-phosphatase	B-X
.	B-X

The	O
rat	O
brain	O
polymerase	O
chain	O
reaction	O
product	O
was	O
used	O
as	O
a	O
probe	O
to	O
isolate	O
a	O
human	O
brain	O
cDNA	O
that	O
predicts	O
a	O
protein	O
with	O
938	O
amino	O
acids	O
and	O
a	O
molecular	O
mass	O
of	O
105	O
,	O
710	O
Da	O
.	O

Remarkably	O
,	O
the	O
human	O
and	O
rat	O
proteins	O
were	O
97	O
%	O
identical	O
.	O
<EOS>	B-X
The	B-X
amino	B-X
acid	B-X
sequences	B-X
of	B-X
tryptic	B-X
and	B-X
CNBr	B-X
peptides	B-X
of	B-X
the	B-X
enzyme	B-X
isolated	B-X
from	B-X
rat	B-X
brain	B-X
were	B-X
determined	B-X
.	B-X
Degenerate	B-X
oligonucleotide	B-X
primers	B-X
based	B-X
on	B-X
this	B-X
sequence	B-X
were	B-X
used	B-X
to	B-X
amplify	B-X
a	B-X
74-base	B-X
pair	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
.	B-X
The	B-X
rat	B-X
brain	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
was	B-X
used	B-X
as	B-X
a	B-X
probe	B-X
to	B-X
isolate	B-X
a	B-X
human	B-X
brain	B-X
cDNA	B-X
that	B-X
predicts	B-X
a	B-X
protein	B-X
with	B-X
938	B-X
amino	B-X
acids	B-X
and	B-X
a	B-X
molecular	B-X
mass	B-X
of	B-X
105,710	B-X
Da	B-X
.	B-X
Remarkably	B-X
,	B-X
the	B-X
human	B-X
and	B-X
rat	B-X
proteins	B-X
were	B-X
97	B-X
%	B-X
identical	B-X
.	B-X
Recombinant	B-X
rat	B-X
protein	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
catalyzed	B-X
the	B-X
hydrolysis	B-X
of	B-X
all	B-X
three	B-X
substrates	B-X
of	B-X
the	B-X
4-phosphatase	B-X
.	B-X
Northern	B-X
blot	B-X
hybridization	B-X
indicates	B-X
that	B-X
the	B-X
4-phosphatase	B-X
is	B-X
widely	B-X
expressed	B-X
in	B-X
rat	B-X
tissues	B-X
with	B-X
the	B-X
highest	B-X
levels	B-X
of	B-X
expression	B-X
occurring	B-X
in	B-X
brain	B-X
,	B-X
heart	B-X
,	B-X
and	B-X
skeletal	B-X
muscle	B-X
.	B-X
Polyclonal	B-X
antiserum	B-X
directed	B-X
against	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
the	B-X
4-phosphatase	B-X
immunoprecipitated	B-X
>	B-X
95	B-X
%	B-X
of	B-X
the	B-X
4-phosphatase	B-X
activity	B-X
in	B-X
crude	B-X
homogenates	B-X
of	B-X
rat	B-X
brain	B-X
,	B-X
heart	B-X
,	B-X
skeletal	B-X
muscle	B-X
,	B-X
and	B-X
spleen	B-X
,	B-X
suggesting	B-X
that	B-X
this	B-X
enzyme	B-X
accounts	B-X
for	B-X
the	B-X
4-phosphate	B-X
activity	B-X
present	B-X
in	B-X
rat	B-X
tissues	B-X
.	B-X
This	B-X
antiserum	B-X
also	B-X
immunoprecipitated	B-X
the	B-X
4-phosphatase	B-X
from	B-X
human	B-X
platelet	B-X
sonicates	B-X
.	B-X

Recombinant	O
rat	O
protein	O
expressed	O
in	O
Escherichia	O
coli	O
catalyzed	O
the	O
hydrolysis	O
of	O
all	O
three	O
substrates	O
of	O
the	O
4	B-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
.	O
<EOS>	B-X
Inositol	B-X
polyphosphate	B-X
4-phosphatase	B-X
,	B-X
an	B-X
enzyme	B-X
of	B-X
the	B-X
inositol	B-X
phosphate	B-X
signaling	B-X
pathway	B-X
,	B-X
catalyzes	B-X
the	B-X
hydrolysis	B-X
of	B-X
the	B-X
4-position	B-X
phosphate	B-X
of	B-X
inositol	B-X
3,4-bisphosphate	B-X
,	B-X
inositol	B-X
1,3,4-trisphosphate	B-X
,	B-X
and	B-X
phosphatidylinositol	B-X
3,4-bisphosphate	B-X
.	B-X
The	B-X
amino	B-X
acid	B-X
sequences	B-X
of	B-X
tryptic	B-X
and	B-X
CNBr	B-X
peptides	B-X
of	B-X
the	B-X
enzyme	B-X
isolated	B-X
from	B-X
rat	B-X
brain	B-X
were	B-X
determined	B-X
.	B-X
Degenerate	B-X
oligonucleotide	B-X
primers	B-X
based	B-X
on	B-X
this	B-X
sequence	B-X
were	B-X
used	B-X
to	B-X
amplify	B-X
a	B-X
74-base	B-X
pair	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
.	B-X
This	B-X
product	B-X
was	B-X
used	B-X
to	B-X
isolate	B-X
a	B-X
5607-base	B-X
pair	B-X
composite	B-X
cDNA	B-X
,	B-X
which	B-X
had	B-X
an	B-X
open	B-X
reading	B-X
frame	B-X
encoding	B-X
a	B-X
protein	B-X
with	B-X
939	B-X
amino	B-X
acids	B-X
with	B-X
a	B-X
predicted	B-X
molecular	B-X
mass	B-X
of	B-X
105,588	B-X
Da	B-X
.	B-X
The	B-X
rat	B-X
brain	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
was	B-X
used	B-X
as	B-X
a	B-X
probe	B-X
to	B-X
isolate	B-X
a	B-X
human	B-X
brain	B-X
cDNA	B-X
that	B-X
predicts	B-X
a	B-X
protein	B-X
with	B-X
938	B-X
amino	B-X
acids	B-X
and	B-X
a	B-X
molecular	B-X
mass	B-X
of	B-X
105,710	B-X
Da	B-X
.	B-X
Remarkably	B-X
,	B-X
the	B-X
human	B-X
and	B-X
rat	B-X
proteins	B-X
were	B-X
97	B-X
%	B-X
identical	B-X
.	B-X
Recombinant	B-X
rat	B-X
protein	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
catalyzed	B-X
the	B-X
hydrolysis	B-X
of	B-X
all	B-X
three	B-X
substrates	B-X
of	B-X
the	B-X
4-phosphatase	B-X
.	B-X
Northern	B-X
blot	B-X
hybridization	B-X
indicates	B-X
that	B-X
the	B-X
4-phosphatase	B-X
is	B-X
widely	B-X
expressed	B-X
in	B-X
rat	B-X
tissues	B-X
with	B-X
the	B-X
highest	B-X
levels	B-X
of	B-X
expression	B-X
occurring	B-X
in	B-X
brain	B-X
,	B-X
heart	B-X
,	B-X
and	B-X
skeletal	B-X
muscle	B-X
.	B-X
Polyclonal	B-X
antiserum	B-X
directed	B-X
against	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
the	B-X
4-phosphatase	B-X
immunoprecipitated	B-X
>	B-X
95	B-X
%	B-X
of	B-X
the	B-X
4-phosphatase	B-X
activity	B-X
in	B-X
crude	B-X
homogenates	B-X
of	B-X
rat	B-X
brain	B-X
,	B-X
heart	B-X
,	B-X
skeletal	B-X
muscle	B-X
,	B-X
and	B-X
spleen	B-X
,	B-X
suggesting	B-X
that	B-X
this	B-X
enzyme	B-X
accounts	B-X
for	B-X
the	B-X
4-phosphate	B-X
activity	B-X
present	B-X
in	B-X
rat	B-X
tissues	B-X
.	B-X
This	B-X
antiserum	B-X
also	B-X
immunoprecipitated	B-X
the	B-X
4-phosphatase	B-X
from	B-X
human	B-X
platelet	B-X
sonicates	B-X
.	B-X

Northern	O
blot	O
hybridization	O
indicates	O
that	O
the	O
4	B-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
is	O
widely	O
expressed	O
in	O
rat	O
tissues	O
with	O
the	O
highest	O
levels	O
of	O
expression	O
occurring	O
in	O
brain	O
,	O
heart	O
,	O
and	O
skeletal	O
muscle	O
.	O
<EOS>	B-X
Inositol	B-X
polyphosphate	B-X
4-phosphatase	B-X
,	B-X
an	B-X
enzyme	B-X
of	B-X
the	B-X
inositol	B-X
phosphate	B-X
signaling	B-X
pathway	B-X
,	B-X
catalyzes	B-X
the	B-X
hydrolysis	B-X
of	B-X
the	B-X
4-position	B-X
phosphate	B-X
of	B-X
inositol	B-X
3,4-bisphosphate	B-X
,	B-X
inositol	B-X
1,3,4-trisphosphate	B-X
,	B-X
and	B-X
phosphatidylinositol	B-X
3,4-bisphosphate	B-X
.	B-X
The	B-X
amino	B-X
acid	B-X
sequences	B-X
of	B-X
tryptic	B-X
and	B-X
CNBr	B-X
peptides	B-X
of	B-X
the	B-X
enzyme	B-X
isolated	B-X
from	B-X
rat	B-X
brain	B-X
were	B-X
determined	B-X
.	B-X
Degenerate	B-X
oligonucleotide	B-X
primers	B-X
based	B-X
on	B-X
this	B-X
sequence	B-X
were	B-X
used	B-X
to	B-X
amplify	B-X
a	B-X
74-base	B-X
pair	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
.	B-X
The	B-X
rat	B-X
brain	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
was	B-X
used	B-X
as	B-X
a	B-X
probe	B-X
to	B-X
isolate	B-X
a	B-X
human	B-X
brain	B-X
cDNA	B-X
that	B-X
predicts	B-X
a	B-X
protein	B-X
with	B-X
938	B-X
amino	B-X
acids	B-X
and	B-X
a	B-X
molecular	B-X
mass	B-X
of	B-X
105,710	B-X
Da	B-X
.	B-X
Remarkably	B-X
,	B-X
the	B-X
human	B-X
and	B-X
rat	B-X
proteins	B-X
were	B-X
97	B-X
%	B-X
identical	B-X
.	B-X
Recombinant	B-X
rat	B-X
protein	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
catalyzed	B-X
the	B-X
hydrolysis	B-X
of	B-X
all	B-X
three	B-X
substrates	B-X
of	B-X
the	B-X
4-phosphatase	B-X
.	B-X
Northern	B-X
blot	B-X
hybridization	B-X
indicates	B-X
that	B-X
the	B-X
4-phosphatase	B-X
is	B-X
widely	B-X
expressed	B-X
in	B-X
rat	B-X
tissues	B-X
with	B-X
the	B-X
highest	B-X
levels	B-X
of	B-X
expression	B-X
occurring	B-X
in	B-X
brain	B-X
,	B-X
heart	B-X
,	B-X
and	B-X
skeletal	B-X
muscle	B-X
.	B-X
Polyclonal	B-X
antiserum	B-X
directed	B-X
against	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
the	B-X
4-phosphatase	B-X
immunoprecipitated	B-X
>	B-X
95	B-X
%	B-X
of	B-X
the	B-X
4-phosphatase	B-X
activity	B-X
in	B-X
crude	B-X
homogenates	B-X
of	B-X
rat	B-X
brain	B-X
,	B-X
heart	B-X
,	B-X
skeletal	B-X
muscle	B-X
,	B-X
and	B-X
spleen	B-X
,	B-X
suggesting	B-X
that	B-X
this	B-X
enzyme	B-X
accounts	B-X
for	B-X
the	B-X
4-phosphate	B-X
activity	B-X
present	B-X
in	B-X
rat	B-X
tissues	B-X
.	B-X
This	B-X
antiserum	B-X
also	B-X
immunoprecipitated	B-X
the	B-X
4-phosphatase	B-X
from	B-X
human	B-X
platelet	B-X
sonicates	B-X
.	B-X

Polyclonal	O
antiserum	O
directed	O
against	O
the	O
carboxyl	O
terminus	O
of	O
the	O
4	B-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
immunoprecipitated	O
>	O
95	O
%	O
of	O
the	O
4	B-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
activity	O
in	O
crude	O
homogenates	O
of	O
rat	O
brain	O
,	O
heart	O
,	O
skeletal	O
muscle	O
,	O
and	O
spleen	O
,	O
suggesting	O
that	O
this	O
enzyme	O
accounts	O
for	O
the	O
4	O
-	O
phosphate	O
activity	O
present	O
in	O
rat	O
tissues	O
.	O
<EOS>	B-X
Inositol	B-X
polyphosphate	B-X
4-phosphatase	B-X
,	B-X
an	B-X
enzyme	B-X
of	B-X
the	B-X
inositol	B-X
phosphate	B-X
signaling	B-X
pathway	B-X
,	B-X
catalyzes	B-X
the	B-X
hydrolysis	B-X
of	B-X
the	B-X
4-position	B-X
phosphate	B-X
of	B-X
inositol	B-X
3,4-bisphosphate	B-X
,	B-X
inositol	B-X
1,3,4-trisphosphate	B-X
,	B-X
and	B-X
phosphatidylinositol	B-X
3,4-bisphosphate	B-X
.	B-X
The	B-X
amino	B-X
acid	B-X
sequences	B-X
of	B-X
tryptic	B-X
and	B-X
CNBr	B-X
peptides	B-X
of	B-X
the	B-X
enzyme	B-X
isolated	B-X
from	B-X
rat	B-X
brain	B-X
were	B-X
determined	B-X
.	B-X
Degenerate	B-X
oligonucleotide	B-X
primers	B-X
based	B-X
on	B-X
this	B-X
sequence	B-X
were	B-X
used	B-X
to	B-X
amplify	B-X
a	B-X
74-base	B-X
pair	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
.	B-X
The	B-X
rat	B-X
brain	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
was	B-X
used	B-X
as	B-X
a	B-X
probe	B-X
to	B-X
isolate	B-X
a	B-X
human	B-X
brain	B-X
cDNA	B-X
that	B-X
predicts	B-X
a	B-X
protein	B-X
with	B-X
938	B-X
amino	B-X
acids	B-X
and	B-X
a	B-X
molecular	B-X
mass	B-X
of	B-X
105,710	B-X
Da	B-X
.	B-X
Remarkably	B-X
,	B-X
the	B-X
human	B-X
and	B-X
rat	B-X
proteins	B-X
were	B-X
97	B-X
%	B-X
identical	B-X
.	B-X
Recombinant	B-X
rat	B-X
protein	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
catalyzed	B-X
the	B-X
hydrolysis	B-X
of	B-X
all	B-X
three	B-X
substrates	B-X
of	B-X
the	B-X
4-phosphatase	B-X
.	B-X
Northern	B-X
blot	B-X
hybridization	B-X
indicates	B-X
that	B-X
the	B-X
4-phosphatase	B-X
is	B-X
widely	B-X
expressed	B-X
in	B-X
rat	B-X
tissues	B-X
with	B-X
the	B-X
highest	B-X
levels	B-X
of	B-X
expression	B-X
occurring	B-X
in	B-X
brain	B-X
,	B-X
heart	B-X
,	B-X
and	B-X
skeletal	B-X
muscle	B-X
.	B-X
Polyclonal	B-X
antiserum	B-X
directed	B-X
against	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
the	B-X
4-phosphatase	B-X
immunoprecipitated	B-X
>	B-X
95	B-X
%	B-X
of	B-X
the	B-X
4-phosphatase	B-X
activity	B-X
in	B-X
crude	B-X
homogenates	B-X
of	B-X
rat	B-X
brain	B-X
,	B-X
heart	B-X
,	B-X
skeletal	B-X
muscle	B-X
,	B-X
and	B-X
spleen	B-X
,	B-X
suggesting	B-X
that	B-X
this	B-X
enzyme	B-X
accounts	B-X
for	B-X
the	B-X
4-phosphate	B-X
activity	B-X
present	B-X
in	B-X
rat	B-X
tissues	B-X
.	B-X
This	B-X
antiserum	B-X
also	B-X
immunoprecipitated	B-X
the	B-X
4-phosphatase	B-X
from	B-X
human	B-X
platelet	B-X
sonicates	B-X
.	B-X

This	O
antiserum	O
also	O
immunoprecipitated	O
the	O
4	B-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
from	O
human	O
platelet	O
sonicates	O
.	O
<EOS>	B-X
Inositol	B-X
polyphosphate	B-X
4-phosphatase	B-X
,	B-X
an	B-X
enzyme	B-X
of	B-X
the	B-X
inositol	B-X
phosphate	B-X
signaling	B-X
pathway	B-X
,	B-X
catalyzes	B-X
the	B-X
hydrolysis	B-X
of	B-X
the	B-X
4-position	B-X
phosphate	B-X
of	B-X
inositol	B-X
3,4-bisphosphate	B-X
,	B-X
inositol	B-X
1,3,4-trisphosphate	B-X
,	B-X
and	B-X
phosphatidylinositol	B-X
3,4-bisphosphate	B-X
.	B-X
Degenerate	B-X
oligonucleotide	B-X
primers	B-X
based	B-X
on	B-X
this	B-X
sequence	B-X
were	B-X
used	B-X
to	B-X
amplify	B-X
a	B-X
74-base	B-X
pair	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
.	B-X
The	B-X
rat	B-X
brain	B-X
polymerase	B-X
chain	B-X
reaction	B-X
product	B-X
was	B-X
used	B-X
as	B-X
a	B-X
probe	B-X
to	B-X
isolate	B-X
a	B-X
human	B-X
brain	B-X
cDNA	B-X
that	B-X
predicts	B-X
a	B-X
protein	B-X
with	B-X
938	B-X
amino	B-X
acids	B-X
and	B-X
a	B-X
molecular	B-X
mass	B-X
of	B-X
105,710	B-X
Da	B-X
.	B-X
Remarkably	B-X
,	B-X
the	B-X
human	B-X
and	B-X
rat	B-X
proteins	B-X
were	B-X
97	B-X
%	B-X
identical	B-X
.	B-X
Recombinant	B-X
rat	B-X
protein	B-X
expressed	B-X
in	B-X
Escherichia	B-X
coli	B-X
catalyzed	B-X
the	B-X
hydrolysis	B-X
of	B-X
all	B-X
three	B-X
substrates	B-X
of	B-X
the	B-X
4-phosphatase	B-X
.	B-X
Northern	B-X
blot	B-X
hybridization	B-X
indicates	B-X
that	B-X
the	B-X
4-phosphatase	B-X
is	B-X
widely	B-X
expressed	B-X
in	B-X
rat	B-X
tissues	B-X
with	B-X
the	B-X
highest	B-X
levels	B-X
of	B-X
expression	B-X
occurring	B-X
in	B-X
brain	B-X
,	B-X
heart	B-X
,	B-X
and	B-X
skeletal	B-X
muscle	B-X
.	B-X
Polyclonal	B-X
antiserum	B-X
directed	B-X
against	B-X
the	B-X
carboxyl	B-X
terminus	B-X
of	B-X
the	B-X
4-phosphatase	B-X
immunoprecipitated	B-X
>	B-X
95	B-X
%	B-X
of	B-X
the	B-X
4-phosphatase	B-X
activity	B-X
in	B-X
crude	B-X
homogenates	B-X
of	B-X
rat	B-X
brain	B-X
,	B-X
heart	B-X
,	B-X
skeletal	B-X
muscle	B-X
,	B-X
and	B-X
spleen	B-X
,	B-X
suggesting	B-X
that	B-X
this	B-X
enzyme	B-X
accounts	B-X
for	B-X
the	B-X
4-phosphate	B-X
activity	B-X
present	B-X
in	B-X
rat	B-X
tissues	B-X
.	B-X
This	B-X
antiserum	B-X
also	B-X
immunoprecipitated	B-X
the	B-X
4-phosphatase	B-X
from	B-X
human	B-X
platelet	B-X
sonicates	B-X
.	B-X

The	O
sequence	O
of	O
phosphatidylinositol	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphate	I-Gene_or_gene_product
5	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
defines	O
a	O
novel	O
family	O
of	O
lipid	O
kinases	O
.	O
<EOS>	B-X
Phosphatidylinositol	B-X
4,5-bisphosphate	B-X
(	B-X
PtdIns	B-X
(	B-X
4,5	B-X
)	B-X
P2	B-X
)	B-X
occupies	B-X
an	B-X
essential	B-X
position	B-X
in	B-X
the	B-X
phosphoinositide	B-X
signal	B-X
transduction	B-X
cascades	B-X
as	B-X
the	B-X
precursor	B-X
to	B-X
second	B-X
messengers	B-X
and	B-X
is	B-X
thought	B-X
to	B-X
regulate	B-X
many	B-X
cellular	B-X
proteins	B-X
directly	B-X
.	B-X
The	B-X
final	B-X
step	B-X
in	B-X
the	B-X
synthesis	B-X
of	B-X
PtdIns	B-X
(	B-X
4,5	B-X
)	B-X
P2	B-X
is	B-X
the	B-X
phosphorylation	B-X
of	B-X
PtdIns	B-X
(	B-X
4	B-X
)	B-X
P-	B-X
by	B-X
PtdIns	B-X
(	B-X
4	B-X
)	B-X
P	B-X
5-kinase	B-X
(	B-X
PIP5K	B-X
)	B-X
.	B-X
Using	B-X
peptide	B-X
sequences	B-X
from	B-X
a	B-X
purified	B-X
PIP5K	B-X
,	B-X
a	B-X
cDNA	B-X
for	B-X
a	B-X
human	B-X
placental	B-X
PIP5K	B-X
was	B-X
isolated	B-X
and	B-X
sequenced	B-X
.	B-X
Expression	B-X
of	B-X
this	B-X
cDNA	B-X
in	B-X
Escherichia	B-X
coli	B-X
produced	B-X
an	B-X
active	B-X
PIP5K	B-X
.	B-X
Surprisingly	B-X
,	B-X
the	B-X
sequence	B-X
of	B-X
this	B-X
PIP5K	B-X
has	B-X
no	B-X
homology	B-X
to	B-X
known	B-X
PtdIns	B-X
kinases	B-X
or	B-X
protein	B-X
kinases	B-X
.	B-X
However	B-X
,	B-X
the	B-X
PIP5K	B-X
is	B-X
homologous	B-X
to	B-X
the	B-X
Saccharomyces	B-X
cerevisiae	B-X
proteins	B-X
Fab1p	B-X
and	B-X
Mss4p	B-X
.	B-X

Phosphatidylinositol	O
4	O
,	O
5	O
-	O
bisphosphate	O
(	O
PtdIns	O
(	O
4	O
,	O
5	O
)	O
P2	O
)	O
occupies	O
an	O
essential	O
position	O
in	O
the	O
phosphoinositide	O
signal	O
transduction	O
cascades	O
as	O
the	O
precursor	O
to	O
second	O
messengers	O
and	O
is	O
thought	O
to	O
regulate	O
many	O
cellular	O
proteins	O
directly	O
.	O

The	O
final	O
step	O
in	O
the	O
synthesis	O
of	O
PtdIns	O
(	O
4	O
,	O
5	O
)	O
P2	O
is	O
the	O
phosphorylation	O
of	O
PtdIns	O
(	O
4	O
)	O
P	O
-	O
by	O
PtdIns	B-Gene_or_gene_product
(	I-Gene_or_gene_product
4	I-Gene_or_gene_product
)	I-Gene_or_gene_product
P	I-Gene_or_gene_product
5	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
PIP5K	B-Gene_or_gene_product
)	O
.	O

Using	O
peptide	O
sequences	O
from	O
a	O
purified	O
PIP5K	B-Gene_or_gene_product
,	O
a	O
cDNA	O
for	O
a	O
human	O
placental	O
PIP5K	B-Gene_or_gene_product
was	O
isolated	O
and	O
sequenced	O
.	O
<EOS>	B-X
The	B-X
final	B-X
step	B-X
in	B-X
the	B-X
synthesis	B-X
of	B-X
PtdIns	B-X
(	B-X
4,5	B-X
)	B-X
P2	B-X
is	B-X
the	B-X
phosphorylation	B-X
of	B-X
PtdIns	B-X
(	B-X
4	B-X
)	B-X
P-	B-X
by	B-X
PtdIns	B-X
(	B-X
4	B-X
)	B-X
P	B-X
5-kinase	B-X
(	B-X
PIP5K	B-X
)	B-X
.	B-X
Using	B-X
peptide	B-X
sequences	B-X
from	B-X
a	B-X
purified	B-X
PIP5K	B-X
,	B-X
a	B-X
cDNA	B-X
for	B-X
a	B-X
human	B-X
placental	B-X
PIP5K	B-X
was	B-X
isolated	B-X
and	B-X
sequenced	B-X
.	B-X
Expression	B-X
of	B-X
this	B-X
cDNA	B-X
in	B-X
Escherichia	B-X
coli	B-X
produced	B-X
an	B-X
active	B-X
PIP5K	B-X
.	B-X
Surprisingly	B-X
,	B-X
the	B-X
sequence	B-X
of	B-X
this	B-X
PIP5K	B-X
has	B-X
no	B-X
homology	B-X
to	B-X
known	B-X
PtdIns	B-X
kinases	B-X
or	B-X
protein	B-X
kinases	B-X
.	B-X
However	B-X
,	B-X
the	B-X
PIP5K	B-X
is	B-X
homologous	B-X
to	B-X
the	B-X
Saccharomyces	B-X
cerevisiae	B-X
proteins	B-X
Fab1p	B-X
and	B-X
Mss4p	B-X
.	B-X

Expression	O
of	O
this	O
cDNA	O
in	O
Escherichia	O
coli	O
produced	O
an	O
active	O
PIP5K	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
final	B-X
step	B-X
in	B-X
the	B-X
synthesis	B-X
of	B-X
PtdIns	B-X
(	B-X
4,5	B-X
)	B-X
P2	B-X
is	B-X
the	B-X
phosphorylation	B-X
of	B-X
PtdIns	B-X
(	B-X
4	B-X
)	B-X
P-	B-X
by	B-X
PtdIns	B-X
(	B-X
4	B-X
)	B-X
P	B-X
5-kinase	B-X
(	B-X
PIP5K	B-X
)	B-X
.	B-X
Using	B-X
peptide	B-X
sequences	B-X
from	B-X
a	B-X
purified	B-X
PIP5K	B-X
,	B-X
a	B-X
cDNA	B-X
for	B-X
a	B-X
human	B-X
placental	B-X
PIP5K	B-X
was	B-X
isolated	B-X
and	B-X
sequenced	B-X
.	B-X
Expression	B-X
of	B-X
this	B-X
cDNA	B-X
in	B-X
Escherichia	B-X
coli	B-X
produced	B-X
an	B-X
active	B-X
PIP5K	B-X
.	B-X
Surprisingly	B-X
,	B-X
the	B-X
sequence	B-X
of	B-X
this	B-X
PIP5K	B-X
has	B-X
no	B-X
homology	B-X
to	B-X
known	B-X
PtdIns	B-X
kinases	B-X
or	B-X
protein	B-X
kinases	B-X
.	B-X
However	B-X
,	B-X
the	B-X
PIP5K	B-X
is	B-X
homologous	B-X
to	B-X
the	B-X
Saccharomyces	B-X
cerevisiae	B-X
proteins	B-X
Fab1p	B-X
and	B-X
Mss4p	B-X
.	B-X

Surprisingly	O
,	O
the	O
sequence	O
of	O
this	O
PIP5K	B-Gene_or_gene_product
has	O
no	O
homology	O
to	O
known	O
PtdIns	B-Gene_or_gene_product
kinases	I-Gene_or_gene_product
or	O
protein	O
kinases	O
.	O
<EOS>	B-X
We	B-X
have	B-X
catalogued	B-X
the	B-X
protein	B-X
kinase	B-X
complement	B-X
of	B-X
the	B-X
human	B-X
genome	B-X
(	B-X
the	B-X
``	B-X
kinome	B-X
''	B-X
)	B-X
using	B-X
public	B-X
and	B-X
proprietary	B-X
genomic	B-X
,	B-X
complementary	B-X
DNA	B-X
,	B-X
and	B-X
expressed	B-X
sequence	B-X
tag	B-X
(	B-X
EST	B-X
)	B-X
sequences	B-X
.	B-X
This	B-X
provides	B-X
a	B-X
starting	B-X
point	B-X
for	B-X
comprehensive	B-X
analysis	B-X
of	B-X
protein	B-X
phosphorylation	B-X
in	B-X
normal	B-X
and	B-X
disease	B-X
states	B-X
,	B-X
as	B-X
well	B-X
as	B-X
a	B-X
detailed	B-X
view	B-X
of	B-X
the	B-X
current	B-X
state	B-X
of	B-X
human	B-X
genome	B-X
analysis	B-X
through	B-X
a	B-X
focus	B-X
on	B-X
one	B-X
large	B-X
gene	B-X
family	B-X
.	B-X
We	B-X
identify	B-X
518	B-X
putative	B-X
protein	B-X
kinase	B-X
genes	B-X
,	B-X
of	B-X
which	B-X
71	B-X
have	B-X
not	B-X
previously	B-X
been	B-X
reported	B-X
or	B-X
described	B-X
as	B-X
kinases	B-X
,	B-X
and	B-X
we	B-X
extend	B-X
or	B-X
correct	B-X
the	B-X
protein	B-X
sequences	B-X
of	B-X
56	B-X
more	B-X
kinases	B-X
.	B-X
We	B-X
also	B-X
identified	B-X
106	B-X
protein	B-X
kinase	B-X
pseudogenes	B-X
.	B-X
Chromosomal	B-X
mapping	B-X
revealed	B-X
several	B-X
small	B-X
clusters	B-X
of	B-X
kinase	B-X
genes	B-X
and	B-X
revealed	B-X
that	B-X
244	B-X
kinases	B-X
map	B-X
to	B-X
disease	B-X
loci	B-X
or	B-X
cancer	B-X
amplicons	B-X
.	B-X

However	O
,	O
the	O
PIP5K	B-Gene_or_gene_product
is	O
homologous	O
to	O
the	O
Saccharomyces	O
cerevisiae	O
proteins	O
Fab1p	B-Gene_or_gene_product
and	O
Mss4p	B-Gene_or_gene_product
.	O

Growth	O
suppression	O
by	O
p18	B-Gene_or_gene_product
,	O
a	O
p16INK4	B-Gene_or_gene_product
/	O
MTS1	B-Gene_or_gene_product
-	O
and	O
p14INK4B	B-Gene_or_gene_product
/	O
MTS2	B-Gene_or_gene_product
-	O
related	O
CDK6	B-Gene_or_gene_product
inhibitor	O
,	O
correlates	O
with	O
wild	O
-	O
type	O
pRb	B-Gene_or_gene_product
function	O
.	O
<EOS>	B-X
The	B-X
D-type	B-X
cyclin-dependent	B-X
kinases	B-X
CDK4	B-X
and	B-X
CDK6	B-X
are	B-X
complexed	B-X
with	B-X
many	B-X
small	B-X
cellular	B-X
proteins	B-X
(	B-X
p14	B-X
,	B-X
p15	B-X
,	B-X
p16	B-X
,	B-X
p18	B-X
,	B-X
and	B-X
p20	B-X
)	B-X
.	B-X
We	B-X
have	B-X
isolated	B-X
cDNA	B-X
sequences	B-X
corresponding	B-X
to	B-X
the	B-X
MTS2	B-X
genomic	B-X
fragment	B-X
that	B-X
encodes	B-X
the	B-X
CDK4-	B-X
and	B-X
CDK6-associated	B-X
p14	B-X
protein	B-X
.	B-X
By	B-X
use	B-X
of	B-X
a	B-X
yeast	B-X
interaction	B-X
screen	B-X
to	B-X
search	B-X
for	B-X
CDK6-interacting	B-X
proteins	B-X
,	B-X
we	B-X
have	B-X
also	B-X
identified	B-X
an	B-X
18-kD	B-X
human	B-X
protein	B-X
,	B-X
p18	B-X
,	B-X
that	B-X
is	B-X
a	B-X
homolog	B-X
of	B-X
the	B-X
cyclin	B-X
D-CDK4	B-X
inhibitors	B-X
p16	B-X
(	B-X
INK4A/MTS1	B-X
)	B-X
and	B-X
p14	B-X
(	B-X
MTS2/INK4B	B-X
)	B-X
.	B-X
Both	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
p18	B-X
interacts	B-X
strongly	B-X
with	B-X
CDK6	B-X
,	B-X
weakly	B-X
with	B-X
CDK4	B-X
,	B-X
and	B-X
exhibits	B-X
no	B-X
detectable	B-X
interaction	B-X
with	B-X
the	B-X
other	B-X
known	B-X
CDKs	B-X
.	B-X
Recombinant	B-X
p18	B-X
inhibits	B-X
the	B-X
kinase	B-X
activity	B-X
of	B-X
cyclin	B-X
D-CDK6	B-X
.	B-X
Distinct	B-X
from	B-X
the	B-X
p21/p27	B-X
family	B-X
of	B-X
CDK	B-X
inhibitors	B-X
that	B-X
form	B-X
ternary	B-X
complexes	B-X
with	B-X
cyclin-CDKs	B-X
,	B-X
only	B-X
binary	B-X
complexes	B-X
of	B-X
p14	B-X
,	B-X
p16	B-X
,	B-X
and	B-X
p18	B-X
were	B-X
found	B-X
in	B-X
association	B-X
with	B-X
CDK4	B-X
and/or	B-X
CDK6	B-X
.	B-X
Ectopic	B-X
expression	B-X
of	B-X
p18	B-X
or	B-X
p16	B-X
suppresses	B-X
cell	B-X
growth	B-X
with	B-X
a	B-X
correlated	B-X
dependence	B-X
on	B-X
endogenous	B-X
wild-type	B-X
pRb	B-X
.	B-X

The	O
D	B-Gene_or_gene_product
-	I-Gene_or_gene_product
type	I-Gene_or_gene_product
cyclin	I-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
CDK4	B-Gene_or_gene_product
and	O
CDK6	B-Gene_or_gene_product
are	O
complexed	O
with	O
many	O
small	O
cellular	O
proteins	O
(	O
p14	B-Gene_or_gene_product
,	O
p15	B-Gene_or_gene_product
,	O
p16	B-Gene_or_gene_product
,	O
p18	B-Gene_or_gene_product
,	O
and	O
p20	B-Gene_or_gene_product
)	O
.	O

We	O
have	O
isolated	O
cDNA	O
sequences	O
corresponding	O
to	O
the	O
MTS2	B-Gene_or_gene_product
genomic	O
fragment	O
that	O
encodes	O
the	O
CDK4	B-Gene_or_gene_product
-	O
and	O
CDK6	B-Gene_or_gene_product
-	O
associated	O
p14	B-Gene_or_gene_product
protein	O
.	O

By	O
use	O
of	O
a	O
yeast	O
interaction	O
screen	O
to	O
search	O
for	O
CDK6	B-Gene_or_gene_product
-	O
interacting	O
proteins	O
,	O
we	O
have	O
also	O
identified	O
an	O
18	O
-	O
kD	O
human	O
protein	O
,	O
p18	B-Gene_or_gene_product
,	O
that	O
is	O
a	O
homolog	O
of	O
the	O
cyclin	O
D	O
-	O
CDK4	O
inhibitors	O
p16	B-Gene_or_gene_product
(	O
INK4A	B-Gene_or_gene_product
/	O
MTS1	B-Gene_or_gene_product
)	O
and	O
p14	B-Gene_or_gene_product
(	O
MTS2	B-Gene_or_gene_product
/	O
INK4B	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
The	B-X
D-type	B-X
cyclin-dependent	B-X
kinases	B-X
CDK4	B-X
and	B-X
CDK6	B-X
are	B-X
complexed	B-X
with	B-X
many	B-X
small	B-X
cellular	B-X
proteins	B-X
(	B-X
p14	B-X
,	B-X
p15	B-X
,	B-X
p16	B-X
,	B-X
p18	B-X
,	B-X
and	B-X
p20	B-X
)	B-X
.	B-X
We	B-X
have	B-X
isolated	B-X
cDNA	B-X
sequences	B-X
corresponding	B-X
to	B-X
the	B-X
MTS2	B-X
genomic	B-X
fragment	B-X
that	B-X
encodes	B-X
the	B-X
CDK4-	B-X
and	B-X
CDK6-associated	B-X
p14	B-X
protein	B-X
.	B-X
By	B-X
use	B-X
of	B-X
a	B-X
yeast	B-X
interaction	B-X
screen	B-X
to	B-X
search	B-X
for	B-X
CDK6-interacting	B-X
proteins	B-X
,	B-X
we	B-X
have	B-X
also	B-X
identified	B-X
an	B-X
18-kD	B-X
human	B-X
protein	B-X
,	B-X
p18	B-X
,	B-X
that	B-X
is	B-X
a	B-X
homolog	B-X
of	B-X
the	B-X
cyclin	B-X
D-CDK4	B-X
inhibitors	B-X
p16	B-X
(	B-X
INK4A/MTS1	B-X
)	B-X
and	B-X
p14	B-X
(	B-X
MTS2/INK4B	B-X
)	B-X
.	B-X
Both	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
p18	B-X
interacts	B-X
strongly	B-X
with	B-X
CDK6	B-X
,	B-X
weakly	B-X
with	B-X
CDK4	B-X
,	B-X
and	B-X
exhibits	B-X
no	B-X
detectable	B-X
interaction	B-X
with	B-X
the	B-X
other	B-X
known	B-X
CDKs	B-X
.	B-X
Recombinant	B-X
p18	B-X
inhibits	B-X
the	B-X
kinase	B-X
activity	B-X
of	B-X
cyclin	B-X
D-CDK6	B-X
.	B-X
Distinct	B-X
from	B-X
the	B-X
p21/p27	B-X
family	B-X
of	B-X
CDK	B-X
inhibitors	B-X
that	B-X
form	B-X
ternary	B-X
complexes	B-X
with	B-X
cyclin-CDKs	B-X
,	B-X
only	B-X
binary	B-X
complexes	B-X
of	B-X
p14	B-X
,	B-X
p16	B-X
,	B-X
and	B-X
p18	B-X
were	B-X
found	B-X
in	B-X
association	B-X
with	B-X
CDK4	B-X
and/or	B-X
CDK6	B-X
.	B-X
Ectopic	B-X
expression	B-X
of	B-X
p18	B-X
or	B-X
p16	B-X
suppresses	B-X
cell	B-X
growth	B-X
with	B-X
a	B-X
correlated	B-X
dependence	B-X
on	B-X
endogenous	B-X
wild-type	B-X
pRb	B-X
.	B-X

Both	O
in	O
vivo	O
and	O
in	O
vitro	O
,	O
p18	B-Gene_or_gene_product
interacts	O
strongly	O
with	O
CDK6	B-Gene_or_gene_product
,	O
weakly	O
with	O
CDK4	B-Gene_or_gene_product
,	O
and	O
exhibits	O
no	O
detectable	O
interaction	O
with	O
the	O
other	O
known	O
CDKs	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
D-type	B-X
cyclin-dependent	B-X
kinases	B-X
CDK4	B-X
and	B-X
CDK6	B-X
are	B-X
complexed	B-X
with	B-X
many	B-X
small	B-X
cellular	B-X
proteins	B-X
(	B-X
p14	B-X
,	B-X
p15	B-X
,	B-X
p16	B-X
,	B-X
p18	B-X
,	B-X
and	B-X
p20	B-X
)	B-X
.	B-X
We	B-X
have	B-X
isolated	B-X
cDNA	B-X
sequences	B-X
corresponding	B-X
to	B-X
the	B-X
MTS2	B-X
genomic	B-X
fragment	B-X
that	B-X
encodes	B-X
the	B-X
CDK4-	B-X
and	B-X
CDK6-associated	B-X
p14	B-X
protein	B-X
.	B-X
By	B-X
use	B-X
of	B-X
a	B-X
yeast	B-X
interaction	B-X
screen	B-X
to	B-X
search	B-X
for	B-X
CDK6-interacting	B-X
proteins	B-X
,	B-X
we	B-X
have	B-X
also	B-X
identified	B-X
an	B-X
18-kD	B-X
human	B-X
protein	B-X
,	B-X
p18	B-X
,	B-X
that	B-X
is	B-X
a	B-X
homolog	B-X
of	B-X
the	B-X
cyclin	B-X
D-CDK4	B-X
inhibitors	B-X
p16	B-X
(	B-X
INK4A/MTS1	B-X
)	B-X
and	B-X
p14	B-X
(	B-X
MTS2/INK4B	B-X
)	B-X
.	B-X
Both	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
,	B-X
p18	B-X
interacts	B-X
strongly	B-X
with	B-X
CDK6	B-X
,	B-X
weakly	B-X
with	B-X
CDK4	B-X
,	B-X
and	B-X
exhibits	B-X
no	B-X
detectable	B-X
interaction	B-X
with	B-X
the	B-X
other	B-X
known	B-X
CDKs	B-X
.	B-X
Recombinant	B-X
p18	B-X
inhibits	B-X
the	B-X
kinase	B-X
activity	B-X
of	B-X
cyclin	B-X
D-CDK6	B-X
.	B-X
Distinct	B-X
from	B-X
the	B-X
p21/p27	B-X
family	B-X
of	B-X
CDK	B-X
inhibitors	B-X
that	B-X
form	B-X
ternary	B-X
complexes	B-X
with	B-X
cyclin-CDKs	B-X
,	B-X
only	B-X
binary	B-X
complexes	B-X
of	B-X
p14	B-X
,	B-X
p16	B-X
,	B-X
and	B-X
p18	B-X
were	B-X
found	B-X
in	B-X
association	B-X
with	B-X
CDK4	B-X
and/or	B-X
CDK6	B-X
.	B-X
Ectopic	B-X
expression	B-X
of	B-X
p18	B-X
or	B-X
p16	B-X
suppresses	B-X
cell	B-X
growth	B-X
with	B-X
a	B-X
correlated	B-X
dependence	B-X
on	B-X
endogenous	B-X
wild-type	B-X
pRb	B-X
.	B-X

Recombinant	O
p18	B-Gene_or_gene_product
inhibits	O
the	O
kinase	O
activity	O
of	O
cyclin	O
D	O
-	O
CDK6	O
.	O
<EOS>	B-X
The	B-X
point	B-X
in	B-X
G1	B-X
at	B-X
which	B-X
cells	B-X
irrevocably	B-X
commit	B-X
to	B-X
DNA	B-X
synthesis	B-X
is	B-X
controlled	B-X
by	B-X
protein	B-X
complexes	B-X
consisting	B-X
of	B-X
cyclin-dependent	B-X
kinases	B-X
(	B-X
CDK4	B-X
or	B-X
CDK6	B-X
)	B-X
and	B-X
cyclins	B-X
(	B-X
D1	B-X
,	B-X
D2	B-X
or	B-X
D3	B-X
)	B-X
.	B-X
3	B-X
)	B-X
and	B-X
p18	B-X
(	B-X
ref	B-X
.	B-X
Only	B-X
the	B-X
melanoma-predisposing	B-X
mutants	B-X
were	B-X
impaired	B-X
in	B-X
their	B-X
ability	B-X
to	B-X
inhibit	B-X
the	B-X
catalytic	B-X
activity	B-X
of	B-X
the	B-X
cyclin	B-X
D1/CDK4	B-X
and	B-X
cyclin	B-X
D1/CDK6	B-X
complexes	B-X
in	B-X
vitro	B-X
.	B-X
This	B-X
is	B-X
accompanied	B-X
by	B-X
decreased	B-X
G	B-X
(	B-X
1	B-X
)	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
CDK	B-X
)	B-X
activities	B-X
,	B-X
redistribution	B-X
of	B-X
the	B-X
CDK	B-X
inhibitor	B-X
p27	B-X
(	B-X
Kip1	B-X
)	B-X
among	B-X
these	B-X
CDK	B-X
complexes	B-X
,	B-X
and	B-X
alterations	B-X
in	B-X
the	B-X
elution	B-X
profile	B-X
of	B-X
cyclin	B-X
E-Cdk2	B-X
upon	B-X
gel	B-X
filtration	B-X
chromatography	B-X
,	B-X
such	B-X
that	B-X
high-molecular-weight	B-X
complexes	B-X
predominate	B-X
.	B-X
Following	B-X
progestin	B-X
treatment	B-X
,	B-X
the	B-X
majority	B-X
of	B-X
cyclin	B-X
E-	B-X
and	B-X
D-CDK	B-X
complexes	B-X
were	B-X
bound	B-X
to	B-X
p27	B-X
(	B-X
Kip1	B-X
)	B-X
and	B-X
few	B-X
were	B-X
bound	B-X
to	B-X
p21	B-X
(	B-X
Cip1	B-X
)	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
recombinant	B-X
His	B-X
(	B-X
6	B-X
)	B-X
-p27	B-X
could	B-X
quantitatively	B-X
reproduce	B-X
the	B-X
effects	B-X
on	B-X
cyclin	B-X
E-Cdk2	B-X
kinase	B-X
activity	B-X
and	B-X
the	B-X
shift	B-X
in	B-X
molecular	B-X
weight	B-X
observed	B-X
following	B-X
progestin	B-X
treatment	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
cyclin	B-X
D-Cdk4	B-X
was	B-X
not	B-X
inhibited	B-X
by	B-X
His	B-X
(	B-X
6	B-X
)	B-X
-p27	B-X
in	B-X
vitro	B-X
or	B-X
p27	B-X
(	B-X
Kip1	B-X
)	B-X
in	B-X
vivo	B-X
.	B-X
However	B-X
,	B-X
an	B-X
increase	B-X
in	B-X
the	B-X
expression	B-X
of	B-X
the	B-X
Cdk4/6	B-X
inhibitor	B-X
p18	B-X
(	B-X
INK4c	B-X
)	B-X
and	B-X
its	B-X
extensive	B-X
association	B-X
with	B-X
Cdk4	B-X
and	B-X
Cdk6	B-X
were	B-X
apparent	B-X
following	B-X
progestin	B-X
treatment	B-X
.	B-X
Recombinant	B-X
p18	B-X
(	B-X
INK4c	B-X
)	B-X
led	B-X
to	B-X
the	B-X
reassortment	B-X
of	B-X
cyclin-CDK-CDK	B-X
inhibitor	B-X
complexes	B-X
in	B-X
vitro	B-X
,	B-X
with	B-X
consequent	B-X
decrease	B-X
in	B-X
cyclin	B-X
E-Cdk2	B-X
activity	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
a	B-X
concerted	B-X
model	B-X
of	B-X
progestin	B-X
action	B-X
whereby	B-X
p27	B-X
(	B-X
Kip1	B-X
)	B-X
and	B-X
p18	B-X
(	B-X
INK4c	B-X
)	B-X
cooperate	B-X
to	B-X
inhibit	B-X
cyclin	B-X
E-Cdk2	B-X
and	B-X
Cdk4	B-X
.	B-X

Distinct	O
from	O
the	O
p21	B-Gene_or_gene_product
/	O
p27	B-Gene_or_gene_product
family	O
of	O
CDK	B-Gene_or_gene_product
inhibitors	O
that	O
form	O
ternary	O
complexes	O
with	O
cyclin	O
-	O
CDKs	O
,	O
only	O
binary	O
complexes	O
of	O
p14	B-Gene_or_gene_product
,	O
p16	B-Gene_or_gene_product
,	O
and	O
p18	B-Gene_or_gene_product
were	O
found	O
in	O
association	O
with	O
CDK4	B-Gene_or_gene_product
and	O
/	O
or	O
CDK6	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
mammalian	B-X
cell	B-X
cycle	B-X
is	B-X
driven	B-X
by	B-X
a	B-X
complex	B-X
of	B-X
cyclins	B-X
and	B-X
their	B-X
associated	B-X
cyclin-dependent	B-X
kinases	B-X
(	B-X
CDKs	B-X
)	B-X
.	B-X
Abnormal	B-X
dysregulation	B-X
of	B-X
cyclin-CDK	B-X
is	B-X
a	B-X
hallmark	B-X
of	B-X
cancer	B-X
.	B-X
D-type	B-X
cyclins	B-X
and	B-X
their	B-X
associated	B-X
CDKs	B-X
(	B-X
CDK4	B-X
and	B-X
CDK6	B-X
)	B-X
are	B-X
key	B-X
components	B-X
of	B-X
cell	B-X
cycle	B-X
machinery	B-X
in	B-X
driving	B-X
G1	B-X
to	B-X
S	B-X
phase	B-X
transition	B-X
via	B-X
phosphorylating	B-X
and	B-X
inactivating	B-X
the	B-X
retinoblastoma	B-X
protein	B-X
(	B-X
RB	B-X
)	B-X
.	B-X
A	B-X
body	B-X
of	B-X
evidence	B-X
shows	B-X
that	B-X
the	B-X
cyclin	B-X
Ds-CDKs	B-X
axis	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
cancer	B-X
through	B-X
various	B-X
aspects	B-X
,	B-X
such	B-X
as	B-X
control	B-X
of	B-X
proliferation	B-X
,	B-X
senescence	B-X
,	B-X
migration	B-X
,	B-X
apoptosis	B-X
,	B-X
and	B-X
angiogenesis	B-X
.	B-X
CDK4/6	B-X
dual-inhibitors	B-X
show	B-X
significant	B-X
efficacy	B-X
in	B-X
pre-clinical	B-X
or	B-X
clinical	B-X
cancer	B-X
therapies	B-X
either	B-X
as	B-X
single	B-X
agents	B-X
or	B-X
in	B-X
combination	B-X
with	B-X
hormone	B-X
,	B-X
chemotherapy	B-X
,	B-X
irradiation	B-X
or	B-X
immune	B-X
treatments	B-X
.	B-X
Of	B-X
note	B-X
,	B-X
as	B-X
the	B-X
associated	B-X
partner	B-X
of	B-X
D-type	B-X
cyclins	B-X
,	B-X
CDK6	B-X
shows	B-X
multiple	B-X
distinct	B-X
functions	B-X
from	B-X
CDK4	B-X
in	B-X
cancer	B-X
.	B-X
Depletion	B-X
of	B-X
the	B-X
individual	B-X
CDK	B-X
may	B-X
provide	B-X
a	B-X
therapeutic	B-X
strategy	B-X
for	B-X
patients	B-X
with	B-X
cancer	B-X
.	B-X

Ectopic	O
expression	O
of	O
p18	B-Gene_or_gene_product
or	O
p16	B-Gene_or_gene_product
suppresses	O
cell	O
growth	O
with	O
a	O
correlated	O
dependence	O
on	O
endogenous	O
wild	O
-	O
type	O
pRb	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
cyclin-dependent	B-X
kinase	B-X
inhibitors	B-X
known	B-X
as	B-X
p15	B-X
,	B-X
p16	B-X
,	B-X
p18	B-X
and	B-X
p19	B-X
have	B-X
been	B-X
suggested	B-X
as	B-X
candidates	B-X
for	B-X
tumor	B-X
suppressor	B-X
genes	B-X
.	B-X
The	B-X
main	B-X
genetic	B-X
alterations	B-X
are	B-X
deletions	B-X
(	B-X
bi-	B-X
or	B-X
monoallelic	B-X
)	B-X
or	B-X
5	B-X
'	B-X
CpG	B-X
island	B-X
methylation	B-X
of	B-X
p15	B-X
and	B-X
p16	B-X
;	B-X
very	B-X
few	B-X
cases	B-X
or	B-X
cell	B-X
lines	B-X
had	B-X
p18	B-X
or	B-X
p19	B-X
deletions	B-X
or	B-X
hypermethylation	B-X
.	B-X
Hypermethylation	B-X
and	B-X
homozygous	B-X
deletions	B-X
of	B-X
tumor	B-X
suppressor	B-X
genes	B-X
establish	B-X
a	B-X
new	B-X
paradigm	B-X
of	B-X
inactivation	B-X
by	B-X
lack	B-X
of	B-X
expression	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
previously	B-X
identified	B-X
tumor	B-X
suppressors	B-X
which	B-X
are	B-X
predominantly	B-X
inactivated	B-X
by	B-X
point	B-X
mutations	B-X
followed	B-X
by	B-X
loss	B-X
of	B-X
the	B-X
wild-type	B-X
allele	B-X
.	B-X
Here	B-X
,	B-X
the	B-X
literature	B-X
data	B-X
on	B-X
alterations	B-X
of	B-X
this	B-X
gene	B-X
family	B-X
in	B-X
more	B-X
than	B-X
4700	B-X
primary	B-X
cases	B-X
of	B-X
leukemia	B-X
or	B-X
lymphoma	B-X
and	B-X
some	B-X
320	B-X
continuous	B-X
leukemia-lymphoma	B-X
cell	B-X
lines	B-X
are	B-X
summarized	B-X
.	B-X
Among	B-X
hematopoietic	B-X
malignancies	B-X
,	B-X
the	B-X
highest	B-X
frequencies	B-X
of	B-X
p15del	B-X
and	B-X
p16del	B-X
were	B-X
seen	B-X
in	B-X
acute	B-X
lymphoblastic	B-X
leukemia	B-X
(	B-X
ALL	B-X
)	B-X
(	B-X
>	B-X
30	B-X
%	B-X
)	B-X
with	B-X
striking	B-X
rates	B-X
in	B-X
T-ALL	B-X
(	B-X
>	B-X
50	B-X
%	B-X
)	B-X
,	B-X
but	B-X
also	B-X
high	B-X
rates	B-X
in	B-X
B	B-X
cell	B-X
precursor	B-X
(	B-X
BCP	B-X
)	B-X
-ALL	B-X
(	B-X
>	B-X
20	B-X
%	B-X
)	B-X
;	B-X
the	B-X
rates	B-X
of	B-X
deletions	B-X
in	B-X
chronic	B-X
lymphoid	B-X
leukemia	B-X
(	B-X
CLL	B-X
)	B-X
,	B-X
multiple	B-X
myeloma	B-X
,	B-X
acute	B-X
and	B-X
chronic	B-X
myeloid	B-X
leukemia	B-X
(	B-X
AML	B-X
and	B-X
CML	B-X
)	B-X
,	B-X
and	B-X
myelodysplastic	B-X
syndromes	B-X
(	B-X
MDS	B-X
)	B-X
were	B-X
rather	B-X
low	B-X
,	B-X
only	B-X
some	B-X
B	B-X
cell	B-X
and	B-X
T	B-X
cell	B-X
lymphomas	B-X
showed	B-X
increased	B-X
frequencies	B-X
.	B-X
Here	B-X
,	B-X
p15	B-X
is	B-X
most	B-X
often	B-X
inactivated	B-X
,	B-X
at	B-X
particularly	B-X
high	B-X
frequencies	B-X
in	B-X
the	B-X
disorders	B-X
lacking	B-X
any	B-X
p15/p16	B-X
deletions	B-X
:	B-X
40-80	B-X
%	B-X
p15met	B-X
in	B-X
AML	B-X
,	B-X
MDS	B-X
and	B-X
multiple	B-X
myeloma	B-X
.	B-X
There	B-X
is	B-X
controversy	B-X
concerning	B-X
the	B-X
prognostic	B-X
impact	B-X
of	B-X
p15	B-X
and	B-X
p16	B-X
aberrations	B-X
with	B-X
some	B-X
studies	B-X
describing	B-X
a	B-X
significant	B-X
correlation	B-X
between	B-X
inactivation	B-X
of	B-X
these	B-X
genes	B-X
and	B-X
poor	B-X
prognosis	B-X
,	B-X
while	B-X
most	B-X
others	B-X
did	B-X
not	B-X
detect	B-X
any	B-X
prognostic	B-X
relevance	B-X
,	B-X
at	B-X
least	B-X
in	B-X
pediatric	B-X
ALL	B-X
;	B-X
there	B-X
may	B-X
be	B-X
a	B-X
worse	B-X
prognosis	B-X
for	B-X
adults	B-X
with	B-X
B	B-X
or	B-X
T	B-X
cell	B-X
lymphomas	B-X
.	B-X
Despite	B-X
the	B-X
small	B-X
number	B-X
of	B-X
cases	B-X
studied	B-X
,	B-X
paired	B-X
sequential	B-X
analyses	B-X
suggested	B-X
that	B-X
disease	B-X
progression	B-X
is	B-X
associated	B-X
with	B-X
loss	B-X
of	B-X
p15/p16	B-X
activity	B-X
in	B-X
a	B-X
certain	B-X
percentage	B-X
of	B-X
adult	B-X
patients	B-X
.	B-X
p15del/p16del	B-X
and	B-X
p15met/p16met	B-X
were	B-X
also	B-X
detected	B-X
in	B-X
the	B-X
large	B-X
panel	B-X
of	B-X
leukemia-lymphoma	B-X
cell	B-X
lines	B-X
studied	B-X
.	B-X
In	B-X
general	B-X
,	B-X
the	B-X
results	B-X
in	B-X
cell	B-X
lines	B-X
reproduce	B-X
the	B-X
data	B-X
seen	B-X
in	B-X
primary	B-X
cells	B-X
with	B-X
the	B-X
important	B-X
difference	B-X
that	B-X
the	B-X
rates	B-X
of	B-X
p15/p16	B-X
inactivation	B-X
are	B-X
clearly	B-X
higher	B-X
in	B-X
the	B-X
cultured	B-X
cells	B-X
compared	B-X
with	B-X
the	B-X
freshly	B-X
explanted	B-X
cells	B-X
.	B-X
Retrovirus-	B-X
or	B-X
electroporation-mediated	B-X
ectopic	B-X
gene	B-X
transfer	B-X
of	B-X
p16	B-X
wild-type	B-X
into	B-X
p16-deficient	B-X
cell	B-X
lines	B-X
led	B-X
to	B-X
growth	B-X
inhibition	B-X
,	B-X
arrest	B-X
in	B-X
G1	B-X
(	B-X
without	B-X
apoptosis	B-X
)	B-X
and	B-X
occasionally	B-X
to	B-X
differentiation	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
malignant	B-X
phenotype	B-X
of	B-X
p16-/-	B-X
cell	B-X
lines	B-X
can	B-X
,	B-X
at	B-X
least	B-X
partially	B-X
,	B-X
be	B-X
reversed	B-X
by	B-X
restoring	B-X
p16	B-X
gene	B-X
expression	B-X
.	B-X
A	B-X
striking	B-X
inverse	B-X
correlation	B-X
between	B-X
the	B-X
absence	B-X
of	B-X
p16	B-X
(	B-X
due	B-X
to	B-X
deletion	B-X
)	B-X
and	B-X
presence	B-X
of	B-X
wild-type	B-X
retinoblastoma	B-X
gene	B-X
was	B-X
observed	B-X
in	B-X
cell	B-X
lines	B-X
confirming	B-X
a	B-X
common	B-X
growth	B-X
suppressor	B-X
pathway	B-X
;	B-X
no	B-X
comparable	B-X
relationship	B-X
of	B-X
p16	B-X
inactivation	B-X
with	B-X
p53	B-X
was	B-X
detected	B-X
.	B-X
Paired	B-X
analysis	B-X
of	B-X
cell	B-X
lines	B-X
and	B-X
corresponding	B-X
primary	B-X
cell	B-X
material	B-X
showed	B-X
that	B-X
in	B-X
all	B-X
instances	B-X
tested	B-X
both	B-X
populations	B-X
carried	B-X
the	B-X
same	B-X
gene	B-X
configuration	B-X
of	B-X
p15	B-X
and	B-X
p16	B-X
.	B-X
Thus	B-X
,	B-X
p15del	B-X
or	B-X
p16del	B-X
did	B-X
not	B-X
occur	B-X
during	B-X
establishment	B-X
of	B-X
the	B-X
cell	B-X
lines	B-X
or	B-X
during	B-X
prolonged	B-X
culture	B-X
.	B-X
It	B-X
is	B-X
likely	B-X
that	B-X
p15	B-X
or	B-X
p16	B-X
deletions	B-X
already	B-X
acquired	B-X
in	B-X
vivo	B-X
provide	B-X
a	B-X
dramatic	B-X
growth	B-X
advantage	B-X
for	B-X
the	B-X
immortalization	B-X
process	B-X
in	B-X
vitro	B-X
,	B-X
thus	B-X
increasing	B-X
the	B-X
success	B-X
rate	B-X
for	B-X
cell	B-X
line	B-X
establishment	B-X
which	B-X
is	B-X
commonly	B-X
extremely	B-X
difficult	B-X
.	B-X
In	B-X
conclusion	B-X
,	B-X
the	B-X
present	B-X
review	B-X
suggests	B-X
an	B-X
involvement	B-X
of	B-X
the	B-X
p15	B-X
and	B-X
p16	B-X
tumor	B-X
suppressor	B-X
genes	B-X
in	B-X
leukemo-	B-X
and	B-X
lymphomagenesis	B-X
.	B-X

Reconstitution	O
of	O
a	O
yeast	O
protein	O
kinase	O
cascade	O
in	O
vitro	O
:	O
activation	O
of	O
the	O
yeast	O
MEK	B-Gene_or_gene_product
homologue	O
STE7	B-Gene_or_gene_product
by	O
STE11	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
mating-factor	B-X
response	B-X
pathway	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
employs	B-X
a	B-X
set	B-X
of	B-X
protein	B-X
kinase	B-X
similar	B-X
to	B-X
kinases	B-X
that	B-X
function	B-X
in	B-X
signal	B-X
transduction	B-X
pathways	B-X
of	B-X
metazoans	B-X
.	B-X
We	B-X
have	B-X
purified	B-X
the	B-X
yeast	B-X
protein	B-X
kinases	B-X
encoded	B-X
by	B-X
STE11	B-X
,	B-X
STE7	B-X
,	B-X
and	B-X
FUS3	B-X
as	B-X
fusions	B-X
to	B-X
glutathione	B-X
S-transferase	B-X
(	B-X
GST	B-X
)	B-X
and	B-X
reconstituted	B-X
a	B-X
kinase	B-X
cascade	B-X
in	B-X
which	B-X
STE11	B-X
phosphorylates	B-X
and	B-X
activates	B-X
STE7	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
phosphorylates	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
FUS3	B-X
.	B-X
GST-STE11	B-X
is	B-X
active	B-X
even	B-X
when	B-X
purified	B-X
from	B-X
cells	B-X
that	B-X
have	B-X
not	B-X
been	B-X
treated	B-X
with	B-X
alpha-factor	B-X
.	B-X
This	B-X
observation	B-X
raises	B-X
the	B-X
possibility	B-X
that	B-X
STE11	B-X
activity	B-X
is	B-X
governed	B-X
by	B-X
an	B-X
inhibitor	B-X
which	B-X
is	B-X
regulated	B-X
by	B-X
pheromone	B-X
.	B-X
We	B-X
also	B-X
identify	B-X
a	B-X
STE11-dependent	B-X
phosphorylation	B-X
site	B-X
in	B-X
STE7	B-X
which	B-X
is	B-X
required	B-X
for	B-X
activity	B-X
of	B-X
STE7	B-X
.	B-X
Conservation	B-X
of	B-X
this	B-X
site	B-X
in	B-X
the	B-X
mammalian	B-X
STE7	B-X
homologue	B-X
MEK	B-X
and	B-X
other	B-X
STE7	B-X
relatives	B-X
suggests	B-X
that	B-X
this	B-X
may	B-X
be	B-X
a	B-X
regulatory	B-X
phosphorylation	B-X
site	B-X
in	B-X
all	B-X
MAP	B-X
kinase	B-X
kinases	B-X
.	B-X

The	O
mating	O
-	O
factor	O
response	O
pathway	O
of	O
Saccharomyces	O
cerevisiae	O
employs	O
a	O
set	O
of	O
protein	O
kinase	O
similar	O
to	O
kinases	O
that	O
function	O
in	O
signal	O
transduction	O
pathways	O
of	O
metazoans	O
.	O
<EOS>	B-X
The	B-X
mating-factor	B-X
response	B-X
pathway	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
employs	B-X
a	B-X
set	B-X
of	B-X
protein	B-X
kinase	B-X
similar	B-X
to	B-X
kinases	B-X
that	B-X
function	B-X
in	B-X
signal	B-X
transduction	B-X
pathways	B-X
of	B-X
metazoans	B-X
.	B-X
We	B-X
have	B-X
purified	B-X
the	B-X
yeast	B-X
protein	B-X
kinases	B-X
encoded	B-X
by	B-X
STE11	B-X
,	B-X
STE7	B-X
,	B-X
and	B-X
FUS3	B-X
as	B-X
fusions	B-X
to	B-X
glutathione	B-X
S-transferase	B-X
(	B-X
GST	B-X
)	B-X
and	B-X
reconstituted	B-X
a	B-X
kinase	B-X
cascade	B-X
in	B-X
which	B-X
STE11	B-X
phosphorylates	B-X
and	B-X
activates	B-X
STE7	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
phosphorylates	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
FUS3	B-X
.	B-X
GST-STE11	B-X
is	B-X
active	B-X
even	B-X
when	B-X
purified	B-X
from	B-X
cells	B-X
that	B-X
have	B-X
not	B-X
been	B-X
treated	B-X
with	B-X
alpha-factor	B-X
.	B-X
Conservation	B-X
of	B-X
this	B-X
site	B-X
in	B-X
the	B-X
mammalian	B-X
STE7	B-X
homologue	B-X
MEK	B-X
and	B-X
other	B-X
STE7	B-X
relatives	B-X
suggests	B-X
that	B-X
this	B-X
may	B-X
be	B-X
a	B-X
regulatory	B-X
phosphorylation	B-X
site	B-X
in	B-X
all	B-X
MAP	B-X
kinase	B-X
kinases	B-X
.	B-X

We	O
have	O
purified	O
the	O
yeast	O
protein	O
kinases	O
encoded	O
by	O
STE11	B-Gene_or_gene_product
,	O
STE7	B-Gene_or_gene_product
,	O
and	O
FUS3	B-Gene_or_gene_product
as	O
fusions	O
to	O
glutathione	B-Gene_or_gene_product
S	I-Gene_or_gene_product
-	I-Gene_or_gene_product
transferase	I-Gene_or_gene_product
(	O
GST	B-Gene_or_gene_product
)	O
and	O
reconstituted	O
a	O
kinase	O
cascade	O
in	O
which	O
STE11	B-Gene_or_gene_product
phosphorylates	O
and	O
activates	O
STE7	B-Gene_or_gene_product
,	O
which	O
in	O
turn	O
phosphorylates	O
the	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
FUS3	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
mating-factor	B-X
response	B-X
pathway	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
employs	B-X
a	B-X
set	B-X
of	B-X
protein	B-X
kinase	B-X
similar	B-X
to	B-X
kinases	B-X
that	B-X
function	B-X
in	B-X
signal	B-X
transduction	B-X
pathways	B-X
of	B-X
metazoans	B-X
.	B-X
We	B-X
have	B-X
purified	B-X
the	B-X
yeast	B-X
protein	B-X
kinases	B-X
encoded	B-X
by	B-X
STE11	B-X
,	B-X
STE7	B-X
,	B-X
and	B-X
FUS3	B-X
as	B-X
fusions	B-X
to	B-X
glutathione	B-X
S-transferase	B-X
(	B-X
GST	B-X
)	B-X
and	B-X
reconstituted	B-X
a	B-X
kinase	B-X
cascade	B-X
in	B-X
which	B-X
STE11	B-X
phosphorylates	B-X
and	B-X
activates	B-X
STE7	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
phosphorylates	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
FUS3	B-X
.	B-X
GST-STE11	B-X
is	B-X
active	B-X
even	B-X
when	B-X
purified	B-X
from	B-X
cells	B-X
that	B-X
have	B-X
not	B-X
been	B-X
treated	B-X
with	B-X
alpha-factor	B-X
.	B-X
This	B-X
observation	B-X
raises	B-X
the	B-X
possibility	B-X
that	B-X
STE11	B-X
activity	B-X
is	B-X
governed	B-X
by	B-X
an	B-X
inhibitor	B-X
which	B-X
is	B-X
regulated	B-X
by	B-X
pheromone	B-X
.	B-X
We	B-X
also	B-X
identify	B-X
a	B-X
STE11-dependent	B-X
phosphorylation	B-X
site	B-X
in	B-X
STE7	B-X
which	B-X
is	B-X
required	B-X
for	B-X
activity	B-X
of	B-X
STE7	B-X
.	B-X
Conservation	B-X
of	B-X
this	B-X
site	B-X
in	B-X
the	B-X
mammalian	B-X
STE7	B-X
homologue	B-X
MEK	B-X
and	B-X
other	B-X
STE7	B-X
relatives	B-X
suggests	B-X
that	B-X
this	B-X
may	B-X
be	B-X
a	B-X
regulatory	B-X
phosphorylation	B-X
site	B-X
in	B-X
all	B-X
MAP	B-X
kinase	B-X
kinases	B-X
.	B-X

GST	B-Gene_or_gene_product
-	I-Gene_or_gene_product
STE11	I-Gene_or_gene_product
is	O
active	O
even	O
when	O
purified	O
from	O
cells	O
that	O
have	O
not	O
been	O
treated	O
with	O
alpha	O
-	O
factor	O
.	O

This	O
observation	O
raises	O
the	O
possibility	O
that	O
STE11	B-Gene_or_gene_product
activity	O
is	O
governed	O
by	O
an	O
inhibitor	O
which	O
is	O
regulated	O
by	O
pheromone	O
.	O
<EOS>	B-X
We	B-X
have	B-X
purified	B-X
the	B-X
yeast	B-X
protein	B-X
kinases	B-X
encoded	B-X
by	B-X
STE11	B-X
,	B-X
STE7	B-X
,	B-X
and	B-X
FUS3	B-X
as	B-X
fusions	B-X
to	B-X
glutathione	B-X
S-transferase	B-X
(	B-X
GST	B-X
)	B-X
and	B-X
reconstituted	B-X
a	B-X
kinase	B-X
cascade	B-X
in	B-X
which	B-X
STE11	B-X
phosphorylates	B-X
and	B-X
activates	B-X
STE7	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
phosphorylates	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
FUS3	B-X
.	B-X
GST-STE11	B-X
is	B-X
active	B-X
even	B-X
when	B-X
purified	B-X
from	B-X
cells	B-X
that	B-X
have	B-X
not	B-X
been	B-X
treated	B-X
with	B-X
alpha-factor	B-X
.	B-X
This	B-X
observation	B-X
raises	B-X
the	B-X
possibility	B-X
that	B-X
STE11	B-X
activity	B-X
is	B-X
governed	B-X
by	B-X
an	B-X
inhibitor	B-X
which	B-X
is	B-X
regulated	B-X
by	B-X
pheromone	B-X
.	B-X
We	B-X
also	B-X
identify	B-X
a	B-X
STE11-dependent	B-X
phosphorylation	B-X
site	B-X
in	B-X
STE7	B-X
which	B-X
is	B-X
required	B-X
for	B-X
activity	B-X
of	B-X
STE7	B-X
.	B-X

We	O
also	O
identify	O
a	O
STE11	B-Gene_or_gene_product
-	O
dependent	O
phosphorylation	O
site	O
in	O
STE7	B-Gene_or_gene_product
which	O
is	O
required	O
for	O
activity	O
of	O
STE7	B-Gene_or_gene_product
.	O
<EOS>	B-X
We	B-X
have	B-X
purified	B-X
the	B-X
yeast	B-X
protein	B-X
kinases	B-X
encoded	B-X
by	B-X
STE11	B-X
,	B-X
STE7	B-X
,	B-X
and	B-X
FUS3	B-X
as	B-X
fusions	B-X
to	B-X
glutathione	B-X
S-transferase	B-X
(	B-X
GST	B-X
)	B-X
and	B-X
reconstituted	B-X
a	B-X
kinase	B-X
cascade	B-X
in	B-X
which	B-X
STE11	B-X
phosphorylates	B-X
and	B-X
activates	B-X
STE7	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
phosphorylates	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
FUS3	B-X
.	B-X
GST-STE11	B-X
is	B-X
active	B-X
even	B-X
when	B-X
purified	B-X
from	B-X
cells	B-X
that	B-X
have	B-X
not	B-X
been	B-X
treated	B-X
with	B-X
alpha-factor	B-X
.	B-X
This	B-X
observation	B-X
raises	B-X
the	B-X
possibility	B-X
that	B-X
STE11	B-X
activity	B-X
is	B-X
governed	B-X
by	B-X
an	B-X
inhibitor	B-X
which	B-X
is	B-X
regulated	B-X
by	B-X
pheromone	B-X
.	B-X
We	B-X
also	B-X
identify	B-X
a	B-X
STE11-dependent	B-X
phosphorylation	B-X
site	B-X
in	B-X
STE7	B-X
which	B-X
is	B-X
required	B-X
for	B-X
activity	B-X
of	B-X
STE7	B-X
.	B-X
Conservation	B-X
of	B-X
this	B-X
site	B-X
in	B-X
the	B-X
mammalian	B-X
STE7	B-X
homologue	B-X
MEK	B-X
and	B-X
other	B-X
STE7	B-X
relatives	B-X
suggests	B-X
that	B-X
this	B-X
may	B-X
be	B-X
a	B-X
regulatory	B-X
phosphorylation	B-X
site	B-X
in	B-X
all	B-X
MAP	B-X
kinase	B-X
kinases	B-X
.	B-X

Conservation	O
of	O
this	O
site	O
in	O
the	O
mammalian	O
STE7	B-Gene_or_gene_product
homologue	O
MEK	B-Gene_or_gene_product
and	O
other	O
STE7	B-Gene_or_gene_product
relatives	O
suggests	O
that	O
this	O
may	O
be	O
a	O
regulatory	O
phosphorylation	O
site	O
in	O
all	O
MAP	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
mating-factor	B-X
response	B-X
pathway	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
employs	B-X
a	B-X
set	B-X
of	B-X
protein	B-X
kinase	B-X
similar	B-X
to	B-X
kinases	B-X
that	B-X
function	B-X
in	B-X
signal	B-X
transduction	B-X
pathways	B-X
of	B-X
metazoans	B-X
.	B-X
We	B-X
have	B-X
purified	B-X
the	B-X
yeast	B-X
protein	B-X
kinases	B-X
encoded	B-X
by	B-X
STE11	B-X
,	B-X
STE7	B-X
,	B-X
and	B-X
FUS3	B-X
as	B-X
fusions	B-X
to	B-X
glutathione	B-X
S-transferase	B-X
(	B-X
GST	B-X
)	B-X
and	B-X
reconstituted	B-X
a	B-X
kinase	B-X
cascade	B-X
in	B-X
which	B-X
STE11	B-X
phosphorylates	B-X
and	B-X
activates	B-X
STE7	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
phosphorylates	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
FUS3	B-X
.	B-X
We	B-X
also	B-X
identify	B-X
a	B-X
STE11-dependent	B-X
phosphorylation	B-X
site	B-X
in	B-X
STE7	B-X
which	B-X
is	B-X
required	B-X
for	B-X
activity	B-X
of	B-X
STE7	B-X
.	B-X
Conservation	B-X
of	B-X
this	B-X
site	B-X
in	B-X
the	B-X
mammalian	B-X
STE7	B-X
homologue	B-X
MEK	B-X
and	B-X
other	B-X
STE7	B-X
relatives	B-X
suggests	B-X
that	B-X
this	B-X
may	B-X
be	B-X
a	B-X
regulatory	B-X
phosphorylation	B-X
site	B-X
in	B-X
all	B-X
MAP	B-X
kinase	B-X
kinases	B-X
.	B-X

Cyclic	O
AMP	O
-	O
dependent	O
protein	O
kinase	O
phosphorylates	O
rabbit	O
reticulocyte	O
elongation	B-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
and	O
induces	O
calcium	O
-	O
independent	O
activity	O
.	O
<EOS>	B-X
The	B-X
catalytic	B-X
subunit	B-X
of	B-X
cyclic	B-X
AMP-dependent	B-X
protein	B-X
kinase	B-X
(	B-X
PKA	B-X
)	B-X
phosphorylated	B-X
purified	B-X
calcium/calmodulin-dependent	B-X
eukaryotic	B-X
elongation	B-X
factor-2	B-X
(	B-X
eEF-2	B-X
)	B-X
kinase	B-X
,	B-X
isolated	B-X
from	B-X
rabbit	B-X
reticulocyte	B-X
lysates	B-X
.	B-X
It	B-X
maximally	B-X
incorporated	B-X
about	B-X
1	B-X
mol	B-X
of	B-X
phosphate/mol	B-X
of	B-X
eEF-2	B-X
kinase	B-X
.	B-X
The	B-X
Km	B-X
of	B-X
eEF-2	B-X
kinase	B-X
for	B-X
PKA	B-X
was	B-X
calculated	B-X
to	B-X
be	B-X
7	B-X
microM	B-X
.	B-X
Phosphorylation	B-X
of	B-X
eEF-2	B-X
kinase	B-X
by	B-X
PKA	B-X
induced	B-X
calcium-independent	B-X
activity	B-X
which	B-X
amounted	B-X
to	B-X
40-50	B-X
%	B-X
of	B-X
the	B-X
total	B-X
activity	B-X
measured	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
calcium	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
level	B-X
of	B-X
calcium-independent	B-X
activity	B-X
induced	B-X
by	B-X
phosphorylation	B-X
by	B-X
PKA	B-X
was	B-X
similar	B-X
to	B-X
that	B-X
induced	B-X
by	B-X
the	B-X
calcium-stimulated	B-X
autophosphorylation	B-X
of	B-X
eEF-2	B-X
kinase	B-X
.	B-X
Phosphopeptide	B-X
mapping	B-X
of	B-X
eEF-2	B-X
kinase	B-X
labelled	B-X
by	B-X
autophosphorylation	B-X
and	B-X
by	B-X
PKA	B-X
revealed	B-X
a	B-X
number	B-X
of	B-X
common	B-X
phosphopeptides	B-X
.	B-X
This	B-X
suggests	B-X
that	B-X
PKA	B-X
may	B-X
phosphorylate	B-X
the	B-X
same	B-X
site	B-X
(	B-X
s	B-X
)	B-X
which	B-X
are	B-X
phosphorylated	B-X
autocatalytically	B-X
and	B-X
which	B-X
are	B-X
responsible	B-X
for	B-X
the	B-X
induction	B-X
of	B-X
calcium-independent	B-X
activity	B-X
.	B-X

The	O
catalytic	O
subunit	O
of	O
cyclic	O
AMP	O
-	O
dependent	O
protein	O
kinase	O
(	O
PKA	O
)	O
phosphorylated	O
purified	O
calcium	O
/	O
calmodulin	B-Gene_or_gene_product
-	O
dependent	O
eukaryotic	B-Gene_or_gene_product
elongation	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
(	I-Gene_or_gene_product
eEF	I-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
)	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
,	O
isolated	O
from	O
rabbit	O
reticulocyte	O
lysates	O
.	O
<EOS>	B-X
The	B-X
catalytic	B-X
subunit	B-X
of	B-X
cyclic	B-X
AMP-dependent	B-X
protein	B-X
kinase	B-X
(	B-X
PKA	B-X
)	B-X
phosphorylated	B-X
purified	B-X
calcium/calmodulin-dependent	B-X
eukaryotic	B-X
elongation	B-X
factor-2	B-X
(	B-X
eEF-2	B-X
)	B-X
kinase	B-X
,	B-X
isolated	B-X
from	B-X
rabbit	B-X
reticulocyte	B-X
lysates	B-X
.	B-X
It	B-X
maximally	B-X
incorporated	B-X
about	B-X
1	B-X
mol	B-X
of	B-X
phosphate/mol	B-X
of	B-X
eEF-2	B-X
kinase	B-X
.	B-X
The	B-X
Km	B-X
of	B-X
eEF-2	B-X
kinase	B-X
for	B-X
PKA	B-X
was	B-X
calculated	B-X
to	B-X
be	B-X
7	B-X
microM	B-X
.	B-X
Phosphorylation	B-X
of	B-X
eEF-2	B-X
kinase	B-X
by	B-X
PKA	B-X
induced	B-X
calcium-independent	B-X
activity	B-X
which	B-X
amounted	B-X
to	B-X
40-50	B-X
%	B-X
of	B-X
the	B-X
total	B-X
activity	B-X
measured	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
calcium	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
level	B-X
of	B-X
calcium-independent	B-X
activity	B-X
induced	B-X
by	B-X
phosphorylation	B-X
by	B-X
PKA	B-X
was	B-X
similar	B-X
to	B-X
that	B-X
induced	B-X
by	B-X
the	B-X
calcium-stimulated	B-X
autophosphorylation	B-X
of	B-X
eEF-2	B-X
kinase	B-X
.	B-X
Phosphopeptide	B-X
mapping	B-X
of	B-X
eEF-2	B-X
kinase	B-X
labelled	B-X
by	B-X
autophosphorylation	B-X
and	B-X
by	B-X
PKA	B-X
revealed	B-X
a	B-X
number	B-X
of	B-X
common	B-X
phosphopeptides	B-X
.	B-X
This	B-X
suggests	B-X
that	B-X
PKA	B-X
may	B-X
phosphorylate	B-X
the	B-X
same	B-X
site	B-X
(	B-X
s	B-X
)	B-X
which	B-X
are	B-X
phosphorylated	B-X
autocatalytically	B-X
and	B-X
which	B-X
are	B-X
responsible	B-X
for	B-X
the	B-X
induction	B-X
of	B-X
calcium-independent	B-X
activity	B-X
.	B-X

It	O
maximally	O
incorporated	O
about	O
1	O
mol	O
of	O
phosphate	O
/	O
mol	O
of	O
eEF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
catalytic	B-X
subunit	B-X
of	B-X
cyclic	B-X
AMP-dependent	B-X
protein	B-X
kinase	B-X
(	B-X
PKA	B-X
)	B-X
phosphorylated	B-X
purified	B-X
calcium/calmodulin-dependent	B-X
eukaryotic	B-X
elongation	B-X
factor-2	B-X
(	B-X
eEF-2	B-X
)	B-X
kinase	B-X
,	B-X
isolated	B-X
from	B-X
rabbit	B-X
reticulocyte	B-X
lysates	B-X
.	B-X
It	B-X
maximally	B-X
incorporated	B-X
about	B-X
1	B-X
mol	B-X
of	B-X
phosphate/mol	B-X
of	B-X
eEF-2	B-X
kinase	B-X
.	B-X
The	B-X
Km	B-X
of	B-X
eEF-2	B-X
kinase	B-X
for	B-X
PKA	B-X
was	B-X
calculated	B-X
to	B-X
be	B-X
7	B-X
microM	B-X
.	B-X
Phosphorylation	B-X
of	B-X
eEF-2	B-X
kinase	B-X
by	B-X
PKA	B-X
induced	B-X
calcium-independent	B-X
activity	B-X
which	B-X
amounted	B-X
to	B-X
40-50	B-X
%	B-X
of	B-X
the	B-X
total	B-X
activity	B-X
measured	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
calcium	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
level	B-X
of	B-X
calcium-independent	B-X
activity	B-X
induced	B-X
by	B-X
phosphorylation	B-X
by	B-X
PKA	B-X
was	B-X
similar	B-X
to	B-X
that	B-X
induced	B-X
by	B-X
the	B-X
calcium-stimulated	B-X
autophosphorylation	B-X
of	B-X
eEF-2	B-X
kinase	B-X
.	B-X
Phosphopeptide	B-X
mapping	B-X
of	B-X
eEF-2	B-X
kinase	B-X
labelled	B-X
by	B-X
autophosphorylation	B-X
and	B-X
by	B-X
PKA	B-X
revealed	B-X
a	B-X
number	B-X
of	B-X
common	B-X
phosphopeptides	B-X
.	B-X

The	O
Km	O
of	O
eEF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
for	O
PKA	O
was	O
calculated	O
to	O
be	O
7	O
microM	O
.	O
<EOS>	B-X
The	B-X
catalytic	B-X
subunit	B-X
of	B-X
cyclic	B-X
AMP-dependent	B-X
protein	B-X
kinase	B-X
(	B-X
PKA	B-X
)	B-X
phosphorylated	B-X
purified	B-X
calcium/calmodulin-dependent	B-X
eukaryotic	B-X
elongation	B-X
factor-2	B-X
(	B-X
eEF-2	B-X
)	B-X
kinase	B-X
,	B-X
isolated	B-X
from	B-X
rabbit	B-X
reticulocyte	B-X
lysates	B-X
.	B-X
It	B-X
maximally	B-X
incorporated	B-X
about	B-X
1	B-X
mol	B-X
of	B-X
phosphate/mol	B-X
of	B-X
eEF-2	B-X
kinase	B-X
.	B-X
The	B-X
Km	B-X
of	B-X
eEF-2	B-X
kinase	B-X
for	B-X
PKA	B-X
was	B-X
calculated	B-X
to	B-X
be	B-X
7	B-X
microM	B-X
.	B-X
Phosphorylation	B-X
of	B-X
eEF-2	B-X
kinase	B-X
by	B-X
PKA	B-X
induced	B-X
calcium-independent	B-X
activity	B-X
which	B-X
amounted	B-X
to	B-X
40-50	B-X
%	B-X
of	B-X
the	B-X
total	B-X
activity	B-X
measured	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
calcium	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
level	B-X
of	B-X
calcium-independent	B-X
activity	B-X
induced	B-X
by	B-X
phosphorylation	B-X
by	B-X
PKA	B-X
was	B-X
similar	B-X
to	B-X
that	B-X
induced	B-X
by	B-X
the	B-X
calcium-stimulated	B-X
autophosphorylation	B-X
of	B-X
eEF-2	B-X
kinase	B-X
.	B-X
Phosphopeptide	B-X
mapping	B-X
of	B-X
eEF-2	B-X
kinase	B-X
labelled	B-X
by	B-X
autophosphorylation	B-X
and	B-X
by	B-X
PKA	B-X
revealed	B-X
a	B-X
number	B-X
of	B-X
common	B-X
phosphopeptides	B-X
.	B-X
This	B-X
suggests	B-X
that	B-X
PKA	B-X
may	B-X
phosphorylate	B-X
the	B-X
same	B-X
site	B-X
(	B-X
s	B-X
)	B-X
which	B-X
are	B-X
phosphorylated	B-X
autocatalytically	B-X
and	B-X
which	B-X
are	B-X
responsible	B-X
for	B-X
the	B-X
induction	B-X
of	B-X
calcium-independent	B-X
activity	B-X
.	B-X

Phosphorylation	O
of	O
eEF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
by	O
PKA	O
induced	O
calcium	O
-	O
independent	O
activity	O
which	O
amounted	O
to	O
40	O
-	O
50	O
%	O
of	O
the	O
total	O
activity	O
measured	O
in	O
the	O
presence	O
of	O
calcium	O
.	O
<EOS>	B-X
The	B-X
catalytic	B-X
subunit	B-X
of	B-X
cyclic	B-X
AMP-dependent	B-X
protein	B-X
kinase	B-X
(	B-X
PKA	B-X
)	B-X
phosphorylated	B-X
purified	B-X
calcium/calmodulin-dependent	B-X
eukaryotic	B-X
elongation	B-X
factor-2	B-X
(	B-X
eEF-2	B-X
)	B-X
kinase	B-X
,	B-X
isolated	B-X
from	B-X
rabbit	B-X
reticulocyte	B-X
lysates	B-X
.	B-X
It	B-X
maximally	B-X
incorporated	B-X
about	B-X
1	B-X
mol	B-X
of	B-X
phosphate/mol	B-X
of	B-X
eEF-2	B-X
kinase	B-X
.	B-X
The	B-X
Km	B-X
of	B-X
eEF-2	B-X
kinase	B-X
for	B-X
PKA	B-X
was	B-X
calculated	B-X
to	B-X
be	B-X
7	B-X
microM	B-X
.	B-X
Phosphorylation	B-X
of	B-X
eEF-2	B-X
kinase	B-X
by	B-X
PKA	B-X
induced	B-X
calcium-independent	B-X
activity	B-X
which	B-X
amounted	B-X
to	B-X
40-50	B-X
%	B-X
of	B-X
the	B-X
total	B-X
activity	B-X
measured	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
calcium	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
level	B-X
of	B-X
calcium-independent	B-X
activity	B-X
induced	B-X
by	B-X
phosphorylation	B-X
by	B-X
PKA	B-X
was	B-X
similar	B-X
to	B-X
that	B-X
induced	B-X
by	B-X
the	B-X
calcium-stimulated	B-X
autophosphorylation	B-X
of	B-X
eEF-2	B-X
kinase	B-X
.	B-X
Phosphopeptide	B-X
mapping	B-X
of	B-X
eEF-2	B-X
kinase	B-X
labelled	B-X
by	B-X
autophosphorylation	B-X
and	B-X
by	B-X
PKA	B-X
revealed	B-X
a	B-X
number	B-X
of	B-X
common	B-X
phosphopeptides	B-X
.	B-X
This	B-X
suggests	B-X
that	B-X
PKA	B-X
may	B-X
phosphorylate	B-X
the	B-X
same	B-X
site	B-X
(	B-X
s	B-X
)	B-X
which	B-X
are	B-X
phosphorylated	B-X
autocatalytically	B-X
and	B-X
which	B-X
are	B-X
responsible	B-X
for	B-X
the	B-X
induction	B-X
of	B-X
calcium-independent	B-X
activity	B-X
.	B-X

Furthermore	O
,	O
the	O
level	O
of	O
calcium	O
-	O
independent	O
activity	O
induced	O
by	O
phosphorylation	O
by	O
PKA	O
was	O
similar	O
to	O
that	O
induced	O
by	O
the	O
calcium	O
-	O
stimulated	O
autophosphorylation	O
of	O
eEF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
catalytic	B-X
subunit	B-X
of	B-X
cyclic	B-X
AMP-dependent	B-X
protein	B-X
kinase	B-X
(	B-X
PKA	B-X
)	B-X
phosphorylated	B-X
purified	B-X
calcium/calmodulin-dependent	B-X
eukaryotic	B-X
elongation	B-X
factor-2	B-X
(	B-X
eEF-2	B-X
)	B-X
kinase	B-X
,	B-X
isolated	B-X
from	B-X
rabbit	B-X
reticulocyte	B-X
lysates	B-X
.	B-X
It	B-X
maximally	B-X
incorporated	B-X
about	B-X
1	B-X
mol	B-X
of	B-X
phosphate/mol	B-X
of	B-X
eEF-2	B-X
kinase	B-X
.	B-X
The	B-X
Km	B-X
of	B-X
eEF-2	B-X
kinase	B-X
for	B-X
PKA	B-X
was	B-X
calculated	B-X
to	B-X
be	B-X
7	B-X
microM	B-X
.	B-X
Phosphorylation	B-X
of	B-X
eEF-2	B-X
kinase	B-X
by	B-X
PKA	B-X
induced	B-X
calcium-independent	B-X
activity	B-X
which	B-X
amounted	B-X
to	B-X
40-50	B-X
%	B-X
of	B-X
the	B-X
total	B-X
activity	B-X
measured	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
calcium	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
level	B-X
of	B-X
calcium-independent	B-X
activity	B-X
induced	B-X
by	B-X
phosphorylation	B-X
by	B-X
PKA	B-X
was	B-X
similar	B-X
to	B-X
that	B-X
induced	B-X
by	B-X
the	B-X
calcium-stimulated	B-X
autophosphorylation	B-X
of	B-X
eEF-2	B-X
kinase	B-X
.	B-X
Phosphopeptide	B-X
mapping	B-X
of	B-X
eEF-2	B-X
kinase	B-X
labelled	B-X
by	B-X
autophosphorylation	B-X
and	B-X
by	B-X
PKA	B-X
revealed	B-X
a	B-X
number	B-X
of	B-X
common	B-X
phosphopeptides	B-X
.	B-X
This	B-X
suggests	B-X
that	B-X
PKA	B-X
may	B-X
phosphorylate	B-X
the	B-X
same	B-X
site	B-X
(	B-X
s	B-X
)	B-X
which	B-X
are	B-X
phosphorylated	B-X
autocatalytically	B-X
and	B-X
which	B-X
are	B-X
responsible	B-X
for	B-X
the	B-X
induction	B-X
of	B-X
calcium-independent	B-X
activity	B-X
.	B-X

Phosphopeptide	O
mapping	O
of	O
eEF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
labelled	O
by	O
autophosphorylation	O
and	O
by	O
PKA	O
revealed	O
a	O
number	O
of	O
common	O
phosphopeptides	O
.	O
<EOS>	B-X
The	B-X
catalytic	B-X
subunit	B-X
of	B-X
cyclic	B-X
AMP-dependent	B-X
protein	B-X
kinase	B-X
(	B-X
PKA	B-X
)	B-X
phosphorylated	B-X
purified	B-X
calcium/calmodulin-dependent	B-X
eukaryotic	B-X
elongation	B-X
factor-2	B-X
(	B-X
eEF-2	B-X
)	B-X
kinase	B-X
,	B-X
isolated	B-X
from	B-X
rabbit	B-X
reticulocyte	B-X
lysates	B-X
.	B-X
It	B-X
maximally	B-X
incorporated	B-X
about	B-X
1	B-X
mol	B-X
of	B-X
phosphate/mol	B-X
of	B-X
eEF-2	B-X
kinase	B-X
.	B-X
The	B-X
Km	B-X
of	B-X
eEF-2	B-X
kinase	B-X
for	B-X
PKA	B-X
was	B-X
calculated	B-X
to	B-X
be	B-X
7	B-X
microM	B-X
.	B-X
Phosphorylation	B-X
of	B-X
eEF-2	B-X
kinase	B-X
by	B-X
PKA	B-X
induced	B-X
calcium-independent	B-X
activity	B-X
which	B-X
amounted	B-X
to	B-X
40-50	B-X
%	B-X
of	B-X
the	B-X
total	B-X
activity	B-X
measured	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
calcium	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
level	B-X
of	B-X
calcium-independent	B-X
activity	B-X
induced	B-X
by	B-X
phosphorylation	B-X
by	B-X
PKA	B-X
was	B-X
similar	B-X
to	B-X
that	B-X
induced	B-X
by	B-X
the	B-X
calcium-stimulated	B-X
autophosphorylation	B-X
of	B-X
eEF-2	B-X
kinase	B-X
.	B-X
Phosphopeptide	B-X
mapping	B-X
of	B-X
eEF-2	B-X
kinase	B-X
labelled	B-X
by	B-X
autophosphorylation	B-X
and	B-X
by	B-X
PKA	B-X
revealed	B-X
a	B-X
number	B-X
of	B-X
common	B-X
phosphopeptides	B-X
.	B-X
This	B-X
suggests	B-X
that	B-X
PKA	B-X
may	B-X
phosphorylate	B-X
the	B-X
same	B-X
site	B-X
(	B-X
s	B-X
)	B-X
which	B-X
are	B-X
phosphorylated	B-X
autocatalytically	B-X
and	B-X
which	B-X
are	B-X
responsible	B-X
for	B-X
the	B-X
induction	B-X
of	B-X
calcium-independent	B-X
activity	B-X
.	B-X

This	O
suggests	O
that	O
PKA	O
may	O
phosphorylate	O
the	O
same	O
site	O
(	O
s	O
)	O
which	O
are	O
phosphorylated	O
autocatalytically	O
and	O
which	O
are	O
responsible	O
for	O
the	O
induction	O
of	O
calcium	O
-	O
independent	O
activity	O
.	O
<EOS>	B-X
The	B-X
catalytic	B-X
subunit	B-X
of	B-X
cyclic	B-X
AMP-dependent	B-X
protein	B-X
kinase	B-X
(	B-X
PKA	B-X
)	B-X
phosphorylated	B-X
purified	B-X
calcium/calmodulin-dependent	B-X
eukaryotic	B-X
elongation	B-X
factor-2	B-X
(	B-X
eEF-2	B-X
)	B-X
kinase	B-X
,	B-X
isolated	B-X
from	B-X
rabbit	B-X
reticulocyte	B-X
lysates	B-X
.	B-X
The	B-X
Km	B-X
of	B-X
eEF-2	B-X
kinase	B-X
for	B-X
PKA	B-X
was	B-X
calculated	B-X
to	B-X
be	B-X
7	B-X
microM	B-X
.	B-X
Phosphorylation	B-X
of	B-X
eEF-2	B-X
kinase	B-X
by	B-X
PKA	B-X
induced	B-X
calcium-independent	B-X
activity	B-X
which	B-X
amounted	B-X
to	B-X
40-50	B-X
%	B-X
of	B-X
the	B-X
total	B-X
activity	B-X
measured	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
calcium	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
level	B-X
of	B-X
calcium-independent	B-X
activity	B-X
induced	B-X
by	B-X
phosphorylation	B-X
by	B-X
PKA	B-X
was	B-X
similar	B-X
to	B-X
that	B-X
induced	B-X
by	B-X
the	B-X
calcium-stimulated	B-X
autophosphorylation	B-X
of	B-X
eEF-2	B-X
kinase	B-X
.	B-X
Phosphopeptide	B-X
mapping	B-X
of	B-X
eEF-2	B-X
kinase	B-X
labelled	B-X
by	B-X
autophosphorylation	B-X
and	B-X
by	B-X
PKA	B-X
revealed	B-X
a	B-X
number	B-X
of	B-X
common	B-X
phosphopeptides	B-X
.	B-X
This	B-X
suggests	B-X
that	B-X
PKA	B-X
may	B-X
phosphorylate	B-X
the	B-X
same	B-X
site	B-X
(	B-X
s	B-X
)	B-X
which	B-X
are	B-X
phosphorylated	B-X
autocatalytically	B-X
and	B-X
which	B-X
are	B-X
responsible	B-X
for	B-X
the	B-X
induction	B-X
of	B-X
calcium-independent	B-X
activity	B-X
.	B-X

The	O
possible	O
implications	O
these	O
findings	O
have	O
for	O
the	O
control	O
of	O
translation	O
are	O
discussed	O
.	O
<EOS>	B-X
Circular	B-X
RNAs	B-X
(	B-X
circRNAs	B-X
)	B-X
are	B-X
a	B-X
new	B-X
class	B-X
of	B-X
long	B-X
noncoding	B-X
RNA	B-X
with	B-X
a	B-X
closed	B-X
loop	B-X
structure	B-X
that	B-X
have	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
the	B-X
complex	B-X
gene	B-X
regulatory	B-X
network	B-X
that	B-X
controls	B-X
the	B-X
emergence	B-X
of	B-X
TC	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
biological	B-X
functions	B-X
of	B-X
circRNAs	B-X
also	B-X
include	B-X
interactions	B-X
with	B-X
proteins	B-X
,	B-X
regulation	B-X
of	B-X
the	B-X
transcription	B-X
of	B-X
genes	B-X
and	B-X
acting	B-X
as	B-X
translation	B-X
templates	B-X
.	B-X
In	B-X
the	B-X
present	B-X
review	B-X
,	B-X
the	B-X
function	B-X
and	B-X
significance	B-X
of	B-X
circRNAs	B-X
and	B-X
their	B-X
potential	B-X
clinical	B-X
implications	B-X
for	B-X
TC	B-X
were	B-X
summarized	B-X
.	B-X
Furthermore	B-X
,	B-X
possible	B-X
treatment	B-X
approaches	B-X
involving	B-X
the	B-X
use	B-X
of	B-X
mesenchymal	B-X
stem	B-X
cells	B-X
(	B-X
MSCs	B-X
)	B-X
and	B-X
exosomes	B-X
derived	B-X
from	B-X
MSCs	B-X
as	B-X
carriers	B-X
to	B-X
load	B-X
and	B-X
transport	B-X
circRNAs	B-X
were	B-X
discussed	B-X
.	B-X

A	O
dominant	O
negative	O
protein	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
C	I-Gene_or_gene_product
zeta	I-Gene_or_gene_product
subspecies	O
blocks	O
NF	O
-	O
kappa	O
B	O
activation	O
.	O
<EOS>	B-X
Nuclear	B-X
factor	B-X
kappa	B-X
B	B-X
(	B-X
NF-kappa	B-X
B	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
a	B-X
number	B-X
of	B-X
genes	B-X
.	B-X
NF-kappa	B-X
B	B-X
is	B-X
a	B-X
heterodimer	B-X
of	B-X
50-	B-X
and	B-X
65-kDa	B-X
subunits	B-X
sequestered	B-X
in	B-X
the	B-X
cytoplasm	B-X
complexed	B-X
to	B-X
inhibitory	B-X
protein	B-X
I	B-X
kappa	B-X
B	B-X
.	B-X
Following	B-X
stimulation	B-X
of	B-X
cells	B-X
,	B-X
I	B-X
kappa	B-X
B	B-X
dissociates	B-X
from	B-X
NF-kappa	B-X
B	B-X
,	B-X
allowing	B-X
its	B-X
translocation	B-X
to	B-X
the	B-X
nucleus	B-X
,	B-X
where	B-X
it	B-X
carries	B-X
out	B-X
the	B-X
transactivation	B-X
function	B-X
.	B-X
The	B-X
precise	B-X
mechanism	B-X
controlling	B-X
NF-kappa	B-X
B	B-X
activation	B-X
and	B-X
the	B-X
involvement	B-X
of	B-X
members	B-X
of	B-X
the	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
family	B-X
of	B-X
isotypes	B-X
have	B-X
previously	B-X
been	B-X
investigated	B-X
.	B-X
It	B-X
was	B-X
found	B-X
that	B-X
phorbol	B-X
myristate	B-X
acetate	B-X
,	B-X
(	B-X
PMA	B-X
)	B-X
which	B-X
is	B-X
a	B-X
potent	B-X
stimulant	B-X
of	B-X
phorbol	B-X
ester-sensitive	B-X
PKC	B-X
isotypes	B-X
,	B-X
activates	B-X
NF-kappa	B-X
B	B-X
.	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
PMA-sensitive	B-X
PKCs	B-X
in	B-X
vivo	B-X
is	B-X
not	B-X
as	B-X
apparent	B-X
.	B-X
It	B-X
has	B-X
recently	B-X
been	B-X
demonstrated	B-X
in	B-X
the	B-X
model	B-X
system	B-X
of	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
that	B-X
the	B-X
PMA-insensitive	B-X
PKC	B-X
isotype	B-X
,	B-X
zeta	B-X
PKC	B-X
,	B-X
is	B-X
a	B-X
required	B-X
step	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
NF-kappa	B-X
B	B-X
in	B-X
response	B-X
to	B-X
ras	B-X
p21	B-X
.	B-X
We	B-X
demonstrate	B-X
here	B-X
that	B-X
overexpression	B-X
of	B-X
zeta	B-X
PKC	B-X
is	B-X
by	B-X
itself	B-X
sufficient	B-X
to	B-X
stimulate	B-X
a	B-X
permanent	B-X
translocation	B-X
of	B-X
functionally	B-X
active	B-X
NF-kappa	B-X
B	B-X
into	B-X
the	B-X
nucleus	B-X
of	B-X
NIH	B-X
3T3	B-X
fibroblasts	B-X
and	B-X
that	B-X
transfection	B-X
of	B-X
a	B-X
kinase-defective	B-X
dominant	B-X
negative	B-X
mutant	B-X
of	B-X
zeta	B-X
PKC	B-X
dramatically	B-X
inhibits	B-X
the	B-X
kappa	B-X
B-dependent	B-X
transactivation	B-X
of	B-X
a	B-X
chloramphenicol	B-X
acetyltransferase	B-X
reporter	B-X
plasmid	B-X
in	B-X
NIH	B-X
3T3	B-X
fibroblasts	B-X
.	B-X
All	B-X
these	B-X
results	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
zeta	B-X
PKC	B-X
plays	B-X
a	B-X
decisive	B-X
role	B-X
in	B-X
NF-kappa	B-X
B	B-X
regulation	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

Nuclear	O
factor	O
kappa	O
B	O
(	O
NF	O
-	O
kappa	O
B	O
)	O
plays	O
a	O
critical	O
role	O
in	O
the	O
regulation	O
of	O
a	O
number	O
of	O
genes	O
.	O

NF	O
-	O
kappa	O
B	O
is	O
a	O
heterodimer	O
of	O
50	O
-	O
and	O
65	O
-	O
kDa	O
subunits	O
sequestered	O
in	O
the	O
cytoplasm	O
complexed	O
to	O
inhibitory	O
protein	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
.	O
<EOS>	B-X
Nuclear	B-X
factor	B-X
kappa	B-X
B	B-X
(	B-X
NF-kappa	B-X
B	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
a	B-X
number	B-X
of	B-X
genes	B-X
.	B-X
NF-kappa	B-X
B	B-X
is	B-X
a	B-X
heterodimer	B-X
of	B-X
50-	B-X
and	B-X
65-kDa	B-X
subunits	B-X
sequestered	B-X
in	B-X
the	B-X
cytoplasm	B-X
complexed	B-X
to	B-X
inhibitory	B-X
protein	B-X
I	B-X
kappa	B-X
B	B-X
.	B-X
Following	B-X
stimulation	B-X
of	B-X
cells	B-X
,	B-X
I	B-X
kappa	B-X
B	B-X
dissociates	B-X
from	B-X
NF-kappa	B-X
B	B-X
,	B-X
allowing	B-X
its	B-X
translocation	B-X
to	B-X
the	B-X
nucleus	B-X
,	B-X
where	B-X
it	B-X
carries	B-X
out	B-X
the	B-X
transactivation	B-X
function	B-X
.	B-X
The	B-X
precise	B-X
mechanism	B-X
controlling	B-X
NF-kappa	B-X
B	B-X
activation	B-X
and	B-X
the	B-X
involvement	B-X
of	B-X
members	B-X
of	B-X
the	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
family	B-X
of	B-X
isotypes	B-X
have	B-X
previously	B-X
been	B-X
investigated	B-X
.	B-X
It	B-X
was	B-X
found	B-X
that	B-X
phorbol	B-X
myristate	B-X
acetate	B-X
,	B-X
(	B-X
PMA	B-X
)	B-X
which	B-X
is	B-X
a	B-X
potent	B-X
stimulant	B-X
of	B-X
phorbol	B-X
ester-sensitive	B-X
PKC	B-X
isotypes	B-X
,	B-X
activates	B-X
NF-kappa	B-X
B	B-X
.	B-X
It	B-X
has	B-X
recently	B-X
been	B-X
demonstrated	B-X
in	B-X
the	B-X
model	B-X
system	B-X
of	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
that	B-X
the	B-X
PMA-insensitive	B-X
PKC	B-X
isotype	B-X
,	B-X
zeta	B-X
PKC	B-X
,	B-X
is	B-X
a	B-X
required	B-X
step	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
NF-kappa	B-X
B	B-X
in	B-X
response	B-X
to	B-X
ras	B-X
p21	B-X
.	B-X
We	B-X
demonstrate	B-X
here	B-X
that	B-X
overexpression	B-X
of	B-X
zeta	B-X
PKC	B-X
is	B-X
by	B-X
itself	B-X
sufficient	B-X
to	B-X
stimulate	B-X
a	B-X
permanent	B-X
translocation	B-X
of	B-X
functionally	B-X
active	B-X
NF-kappa	B-X
B	B-X
into	B-X
the	B-X
nucleus	B-X
of	B-X
NIH	B-X
3T3	B-X
fibroblasts	B-X
and	B-X
that	B-X
transfection	B-X
of	B-X
a	B-X
kinase-defective	B-X
dominant	B-X
negative	B-X
mutant	B-X
of	B-X
zeta	B-X
PKC	B-X
dramatically	B-X
inhibits	B-X
the	B-X
kappa	B-X
B-dependent	B-X
transactivation	B-X
of	B-X
a	B-X
chloramphenicol	B-X
acetyltransferase	B-X
reporter	B-X
plasmid	B-X
in	B-X
NIH	B-X
3T3	B-X
fibroblasts	B-X
.	B-X
All	B-X
these	B-X
results	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
zeta	B-X
PKC	B-X
plays	B-X
a	B-X
decisive	B-X
role	B-X
in	B-X
NF-kappa	B-X
B	B-X
regulation	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

Following	O
stimulation	O
of	O
cells	O
,	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
dissociates	O
from	O
NF	O
-	O
kappa	O
B	O
,	O
allowing	O
its	O
translocation	O
to	O
the	O
nucleus	O
,	O
where	O
it	O
carries	O
out	O
the	O
transactivation	O
function	O
.	O

The	O
precise	O
mechanism	O
controlling	O
NF	O
-	O
kappa	O
B	O
activation	O
and	O
the	O
involvement	O
of	O
members	O
of	O
the	O
protein	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
C	I-Gene_or_gene_product
(	O
PKC	B-Gene_or_gene_product
)	O
family	O
of	O
isotypes	O
have	O
previously	O
been	O
investigated	O
.	O
<EOS>	B-X
Nuclear	B-X
factor	B-X
kappa	B-X
B	B-X
(	B-X
NF-kappa	B-X
B	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
a	B-X
number	B-X
of	B-X
genes	B-X
.	B-X
NF-kappa	B-X
B	B-X
is	B-X
a	B-X
heterodimer	B-X
of	B-X
50-	B-X
and	B-X
65-kDa	B-X
subunits	B-X
sequestered	B-X
in	B-X
the	B-X
cytoplasm	B-X
complexed	B-X
to	B-X
inhibitory	B-X
protein	B-X
I	B-X
kappa	B-X
B	B-X
.	B-X
Following	B-X
stimulation	B-X
of	B-X
cells	B-X
,	B-X
I	B-X
kappa	B-X
B	B-X
dissociates	B-X
from	B-X
NF-kappa	B-X
B	B-X
,	B-X
allowing	B-X
its	B-X
translocation	B-X
to	B-X
the	B-X
nucleus	B-X
,	B-X
where	B-X
it	B-X
carries	B-X
out	B-X
the	B-X
transactivation	B-X
function	B-X
.	B-X
The	B-X
precise	B-X
mechanism	B-X
controlling	B-X
NF-kappa	B-X
B	B-X
activation	B-X
and	B-X
the	B-X
involvement	B-X
of	B-X
members	B-X
of	B-X
the	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
family	B-X
of	B-X
isotypes	B-X
have	B-X
previously	B-X
been	B-X
investigated	B-X
.	B-X
It	B-X
was	B-X
found	B-X
that	B-X
phorbol	B-X
myristate	B-X
acetate	B-X
,	B-X
(	B-X
PMA	B-X
)	B-X
which	B-X
is	B-X
a	B-X
potent	B-X
stimulant	B-X
of	B-X
phorbol	B-X
ester-sensitive	B-X
PKC	B-X
isotypes	B-X
,	B-X
activates	B-X
NF-kappa	B-X
B	B-X
.	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
PMA-sensitive	B-X
PKCs	B-X
in	B-X
vivo	B-X
is	B-X
not	B-X
as	B-X
apparent	B-X
.	B-X
It	B-X
has	B-X
recently	B-X
been	B-X
demonstrated	B-X
in	B-X
the	B-X
model	B-X
system	B-X
of	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
that	B-X
the	B-X
PMA-insensitive	B-X
PKC	B-X
isotype	B-X
,	B-X
zeta	B-X
PKC	B-X
,	B-X
is	B-X
a	B-X
required	B-X
step	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
NF-kappa	B-X
B	B-X
in	B-X
response	B-X
to	B-X
ras	B-X
p21	B-X
.	B-X
We	B-X
demonstrate	B-X
here	B-X
that	B-X
overexpression	B-X
of	B-X
zeta	B-X
PKC	B-X
is	B-X
by	B-X
itself	B-X
sufficient	B-X
to	B-X
stimulate	B-X
a	B-X
permanent	B-X
translocation	B-X
of	B-X
functionally	B-X
active	B-X
NF-kappa	B-X
B	B-X
into	B-X
the	B-X
nucleus	B-X
of	B-X
NIH	B-X
3T3	B-X
fibroblasts	B-X
and	B-X
that	B-X
transfection	B-X
of	B-X
a	B-X
kinase-defective	B-X
dominant	B-X
negative	B-X
mutant	B-X
of	B-X
zeta	B-X
PKC	B-X
dramatically	B-X
inhibits	B-X
the	B-X
kappa	B-X
B-dependent	B-X
transactivation	B-X
of	B-X
a	B-X
chloramphenicol	B-X
acetyltransferase	B-X
reporter	B-X
plasmid	B-X
in	B-X
NIH	B-X
3T3	B-X
fibroblasts	B-X
.	B-X
All	B-X
these	B-X
results	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
zeta	B-X
PKC	B-X
plays	B-X
a	B-X
decisive	B-X
role	B-X
in	B-X
NF-kappa	B-X
B	B-X
regulation	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

It	O
was	O
found	O
that	O
phorbol	O
myristate	O
acetate	O
,	O
(	O
PMA	O
)	O
which	O
is	O
a	O
potent	O
stimulant	O
of	O
phorbol	O
ester	O
-	O
sensitive	O
PKC	B-Gene_or_gene_product
isotypes	O
,	O
activates	O
NF	O
-	O
kappa	O
B	O
.	O
<EOS>	B-X
Nuclear	B-X
factor	B-X
kappa	B-X
B	B-X
(	B-X
NF-kappa	B-X
B	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
a	B-X
number	B-X
of	B-X
genes	B-X
.	B-X
NF-kappa	B-X
B	B-X
is	B-X
a	B-X
heterodimer	B-X
of	B-X
50-	B-X
and	B-X
65-kDa	B-X
subunits	B-X
sequestered	B-X
in	B-X
the	B-X
cytoplasm	B-X
complexed	B-X
to	B-X
inhibitory	B-X
protein	B-X
I	B-X
kappa	B-X
B	B-X
.	B-X
Following	B-X
stimulation	B-X
of	B-X
cells	B-X
,	B-X
I	B-X
kappa	B-X
B	B-X
dissociates	B-X
from	B-X
NF-kappa	B-X
B	B-X
,	B-X
allowing	B-X
its	B-X
translocation	B-X
to	B-X
the	B-X
nucleus	B-X
,	B-X
where	B-X
it	B-X
carries	B-X
out	B-X
the	B-X
transactivation	B-X
function	B-X
.	B-X
The	B-X
precise	B-X
mechanism	B-X
controlling	B-X
NF-kappa	B-X
B	B-X
activation	B-X
and	B-X
the	B-X
involvement	B-X
of	B-X
members	B-X
of	B-X
the	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
family	B-X
of	B-X
isotypes	B-X
have	B-X
previously	B-X
been	B-X
investigated	B-X
.	B-X
It	B-X
was	B-X
found	B-X
that	B-X
phorbol	B-X
myristate	B-X
acetate	B-X
,	B-X
(	B-X
PMA	B-X
)	B-X
which	B-X
is	B-X
a	B-X
potent	B-X
stimulant	B-X
of	B-X
phorbol	B-X
ester-sensitive	B-X
PKC	B-X
isotypes	B-X
,	B-X
activates	B-X
NF-kappa	B-X
B	B-X
.	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
PMA-sensitive	B-X
PKCs	B-X
in	B-X
vivo	B-X
is	B-X
not	B-X
as	B-X
apparent	B-X
.	B-X
It	B-X
has	B-X
recently	B-X
been	B-X
demonstrated	B-X
in	B-X
the	B-X
model	B-X
system	B-X
of	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
that	B-X
the	B-X
PMA-insensitive	B-X
PKC	B-X
isotype	B-X
,	B-X
zeta	B-X
PKC	B-X
,	B-X
is	B-X
a	B-X
required	B-X
step	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
NF-kappa	B-X
B	B-X
in	B-X
response	B-X
to	B-X
ras	B-X
p21	B-X
.	B-X
We	B-X
demonstrate	B-X
here	B-X
that	B-X
overexpression	B-X
of	B-X
zeta	B-X
PKC	B-X
is	B-X
by	B-X
itself	B-X
sufficient	B-X
to	B-X
stimulate	B-X
a	B-X
permanent	B-X
translocation	B-X
of	B-X
functionally	B-X
active	B-X
NF-kappa	B-X
B	B-X
into	B-X
the	B-X
nucleus	B-X
of	B-X
NIH	B-X
3T3	B-X
fibroblasts	B-X
and	B-X
that	B-X
transfection	B-X
of	B-X
a	B-X
kinase-defective	B-X
dominant	B-X
negative	B-X
mutant	B-X
of	B-X
zeta	B-X
PKC	B-X
dramatically	B-X
inhibits	B-X
the	B-X
kappa	B-X
B-dependent	B-X
transactivation	B-X
of	B-X
a	B-X
chloramphenicol	B-X
acetyltransferase	B-X
reporter	B-X
plasmid	B-X
in	B-X
NIH	B-X
3T3	B-X
fibroblasts	B-X
.	B-X
All	B-X
these	B-X
results	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
zeta	B-X
PKC	B-X
plays	B-X
a	B-X
decisive	B-X
role	B-X
in	B-X
NF-kappa	B-X
B	B-X
regulation	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

However	O
,	O
the	O
role	O
of	O
PMA	O
-	O
sensitive	O
PKCs	B-Gene_or_gene_product
in	O
vivo	O
is	O
not	O
as	O
apparent	O
.	O
<EOS>	B-X
However	B-X
,	B-X
studies	B-X
with	B-X
pharmacological	B-X
agonists	B-X
(	B-X
e.g	B-X
.	B-X
phorbol	B-X
12-myristate	B-X
13-acetate	B-X
(	B-X
PMA	B-X
)	B-X
)	B-X
indicate	B-X
that	B-X
prolonged	B-X
stimulation	B-X
leads	B-X
to	B-X
PKCα	B-X
desensitization	B-X
via	B-X
dephosphorylation	B-X
and/or	B-X
degradation	B-X
.	B-X
Repeated	B-X
addition	B-X
of	B-X
1,2-dioctanoyl-sn-glycerol	B-X
(	B-X
DiC8	B-X
)	B-X
resulted	B-X
in	B-X
sustained	B-X
plasma	B-X
membrane	B-X
association	B-X
of	B-X
PKCα	B-X
in	B-X
a	B-X
pattern	B-X
comparable	B-X
with	B-X
that	B-X
induced	B-X
by	B-X
PMA	B-X
.	B-X
However	B-X
,	B-X
although	B-X
PMA	B-X
potently	B-X
down-regulated	B-X
PKCα	B-X
,	B-X
prolonged	B-X
activation	B-X
by	B-X
DiC8	B-X
failed	B-X
to	B-X
engage	B-X
known	B-X
desensitization	B-X
mechanisms	B-X
,	B-X
with	B-X
the	B-X
enzyme	B-X
remaining	B-X
membrane-associated	B-X
and	B-X
able	B-X
to	B-X
support	B-X
sustained	B-X
downstream	B-X
signaling	B-X
.	B-X
Although	B-X
DiC8	B-X
efficiently	B-X
down-regulated	B-X
novel	B-X
PKCs	B-X
PKCδ	B-X
and	B-X
PKCϵ	B-X
,	B-X
differences	B-X
in	B-X
Ca	B-X
(	B-X
2+	B-X
)	B-X
sensitivity	B-X
and	B-X
diacylglycerol	B-X
affinity	B-X
were	B-X
excluded	B-X
as	B-X
mediators	B-X
of	B-X
the	B-X
selective	B-X
resistance	B-X
of	B-X
PKCα	B-X
.	B-X
PMA	B-X
,	B-X
but	B-X
not	B-X
DiC8	B-X
,	B-X
targeted	B-X
PKCα	B-X
to	B-X
detergent-resistant	B-X
membranes	B-X
,	B-X
and	B-X
disruption	B-X
of	B-X
these	B-X
domains	B-X
with	B-X
cholesterol-binding	B-X
agents	B-X
demonstrated	B-X
a	B-X
role	B-X
for	B-X
differential	B-X
membrane	B-X
compartmentalization	B-X
in	B-X
selective	B-X
agonist-induced	B-X
degradation	B-X
.	B-X
Chronic	B-X
DiC8	B-X
treatment	B-X
failed	B-X
to	B-X
desensitize	B-X
PKCα	B-X
in	B-X
several	B-X
cell	B-X
types	B-X
and	B-X
did	B-X
not	B-X
affect	B-X
PKCβI	B-X
;	B-X
thus	B-X
,	B-X
conventional	B-X
PKCs	B-X
appear	B-X
generally	B-X
insensitive	B-X
to	B-X
desensitization	B-X
by	B-X
sustained	B-X
diacylglycerol	B-X
stimulation	B-X
.	B-X
PKCα	B-X
deficiency	B-X
affects	B-X
gene	B-X
expression	B-X
,	B-X
differentiation	B-X
,	B-X
and	B-X
tumorigenesis	B-X
in	B-X
these	B-X
tissues	B-X
,	B-X
highlighting	B-X
the	B-X
importance	B-X
of	B-X
mechanisms	B-X
that	B-X
protect	B-X
PKCα	B-X
from	B-X
desensitization	B-X
in	B-X
vivo	B-X
.	B-X

It	O
has	O
recently	O
been	O
demonstrated	O
in	O
the	O
model	O
system	O
of	O
Xenopus	O
laevis	O
oocytes	O
that	O
the	O
PMA	O
-	O
insensitive	O
PKC	B-Gene_or_gene_product
isotype	O
,	O
zeta	B-Gene_or_gene_product
PKC	I-Gene_or_gene_product
,	O
is	O
a	O
required	O
step	O
in	O
the	O
activation	O
of	O
NF	O
-	O
kappa	O
B	O
in	O
response	O
to	O
ras	B-Gene_or_gene_product
p21	I-Gene_or_gene_product
.	O
<EOS>	B-X
Nuclear	B-X
factor	B-X
kappa	B-X
B	B-X
(	B-X
NF-kappa	B-X
B	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
a	B-X
number	B-X
of	B-X
genes	B-X
.	B-X
NF-kappa	B-X
B	B-X
is	B-X
a	B-X
heterodimer	B-X
of	B-X
50-	B-X
and	B-X
65-kDa	B-X
subunits	B-X
sequestered	B-X
in	B-X
the	B-X
cytoplasm	B-X
complexed	B-X
to	B-X
inhibitory	B-X
protein	B-X
I	B-X
kappa	B-X
B	B-X
.	B-X
Following	B-X
stimulation	B-X
of	B-X
cells	B-X
,	B-X
I	B-X
kappa	B-X
B	B-X
dissociates	B-X
from	B-X
NF-kappa	B-X
B	B-X
,	B-X
allowing	B-X
its	B-X
translocation	B-X
to	B-X
the	B-X
nucleus	B-X
,	B-X
where	B-X
it	B-X
carries	B-X
out	B-X
the	B-X
transactivation	B-X
function	B-X
.	B-X
The	B-X
precise	B-X
mechanism	B-X
controlling	B-X
NF-kappa	B-X
B	B-X
activation	B-X
and	B-X
the	B-X
involvement	B-X
of	B-X
members	B-X
of	B-X
the	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
family	B-X
of	B-X
isotypes	B-X
have	B-X
previously	B-X
been	B-X
investigated	B-X
.	B-X
It	B-X
was	B-X
found	B-X
that	B-X
phorbol	B-X
myristate	B-X
acetate	B-X
,	B-X
(	B-X
PMA	B-X
)	B-X
which	B-X
is	B-X
a	B-X
potent	B-X
stimulant	B-X
of	B-X
phorbol	B-X
ester-sensitive	B-X
PKC	B-X
isotypes	B-X
,	B-X
activates	B-X
NF-kappa	B-X
B	B-X
.	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
PMA-sensitive	B-X
PKCs	B-X
in	B-X
vivo	B-X
is	B-X
not	B-X
as	B-X
apparent	B-X
.	B-X
It	B-X
has	B-X
recently	B-X
been	B-X
demonstrated	B-X
in	B-X
the	B-X
model	B-X
system	B-X
of	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
that	B-X
the	B-X
PMA-insensitive	B-X
PKC	B-X
isotype	B-X
,	B-X
zeta	B-X
PKC	B-X
,	B-X
is	B-X
a	B-X
required	B-X
step	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
NF-kappa	B-X
B	B-X
in	B-X
response	B-X
to	B-X
ras	B-X
p21	B-X
.	B-X
We	B-X
demonstrate	B-X
here	B-X
that	B-X
overexpression	B-X
of	B-X
zeta	B-X
PKC	B-X
is	B-X
by	B-X
itself	B-X
sufficient	B-X
to	B-X
stimulate	B-X
a	B-X
permanent	B-X
translocation	B-X
of	B-X
functionally	B-X
active	B-X
NF-kappa	B-X
B	B-X
into	B-X
the	B-X
nucleus	B-X
of	B-X
NIH	B-X
3T3	B-X
fibroblasts	B-X
and	B-X
that	B-X
transfection	B-X
of	B-X
a	B-X
kinase-defective	B-X
dominant	B-X
negative	B-X
mutant	B-X
of	B-X
zeta	B-X
PKC	B-X
dramatically	B-X
inhibits	B-X
the	B-X
kappa	B-X
B-dependent	B-X
transactivation	B-X
of	B-X
a	B-X
chloramphenicol	B-X
acetyltransferase	B-X
reporter	B-X
plasmid	B-X
in	B-X
NIH	B-X
3T3	B-X
fibroblasts	B-X
.	B-X
All	B-X
these	B-X
results	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
zeta	B-X
PKC	B-X
plays	B-X
a	B-X
decisive	B-X
role	B-X
in	B-X
NF-kappa	B-X
B	B-X
regulation	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

We	O
demonstrate	O
here	O
that	O
overexpression	O
of	O
zeta	B-Gene_or_gene_product
PKC	I-Gene_or_gene_product
is	O
by	O
itself	O
sufficient	O
to	O
stimulate	O
a	O
permanent	O
translocation	O
of	O
functionally	O
active	O
NF	O
-	O
kappa	O
B	O
into	O
the	O
nucleus	O
of	O
NIH	O
3T3	O
fibroblasts	O
and	O
that	O
transfection	O
of	O
a	O
kinase	O
-	O
defective	O
dominant	O
negative	O
mutant	O
of	O
zeta	B-Gene_or_gene_product
PKC	I-Gene_or_gene_product
dramatically	O
inhibits	O
the	O
kappa	O
B	O
-	O
dependent	O
transactivation	O
of	O
a	O
chloramphenicol	O
acetyltransferase	O
reporter	O
plasmid	O
in	O
NIH	O
3T3	O
fibroblasts	O
.	O
<EOS>	B-X
Nuclear	B-X
factor	B-X
kappa	B-X
B	B-X
(	B-X
NF-kappa	B-X
B	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
a	B-X
number	B-X
of	B-X
genes	B-X
.	B-X
NF-kappa	B-X
B	B-X
is	B-X
a	B-X
heterodimer	B-X
of	B-X
50-	B-X
and	B-X
65-kDa	B-X
subunits	B-X
sequestered	B-X
in	B-X
the	B-X
cytoplasm	B-X
complexed	B-X
to	B-X
inhibitory	B-X
protein	B-X
I	B-X
kappa	B-X
B	B-X
.	B-X
Following	B-X
stimulation	B-X
of	B-X
cells	B-X
,	B-X
I	B-X
kappa	B-X
B	B-X
dissociates	B-X
from	B-X
NF-kappa	B-X
B	B-X
,	B-X
allowing	B-X
its	B-X
translocation	B-X
to	B-X
the	B-X
nucleus	B-X
,	B-X
where	B-X
it	B-X
carries	B-X
out	B-X
the	B-X
transactivation	B-X
function	B-X
.	B-X
The	B-X
precise	B-X
mechanism	B-X
controlling	B-X
NF-kappa	B-X
B	B-X
activation	B-X
and	B-X
the	B-X
involvement	B-X
of	B-X
members	B-X
of	B-X
the	B-X
protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
family	B-X
of	B-X
isotypes	B-X
have	B-X
previously	B-X
been	B-X
investigated	B-X
.	B-X
It	B-X
was	B-X
found	B-X
that	B-X
phorbol	B-X
myristate	B-X
acetate	B-X
,	B-X
(	B-X
PMA	B-X
)	B-X
which	B-X
is	B-X
a	B-X
potent	B-X
stimulant	B-X
of	B-X
phorbol	B-X
ester-sensitive	B-X
PKC	B-X
isotypes	B-X
,	B-X
activates	B-X
NF-kappa	B-X
B	B-X
.	B-X
However	B-X
,	B-X
the	B-X
role	B-X
of	B-X
PMA-sensitive	B-X
PKCs	B-X
in	B-X
vivo	B-X
is	B-X
not	B-X
as	B-X
apparent	B-X
.	B-X
It	B-X
has	B-X
recently	B-X
been	B-X
demonstrated	B-X
in	B-X
the	B-X
model	B-X
system	B-X
of	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
that	B-X
the	B-X
PMA-insensitive	B-X
PKC	B-X
isotype	B-X
,	B-X
zeta	B-X
PKC	B-X
,	B-X
is	B-X
a	B-X
required	B-X
step	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
NF-kappa	B-X
B	B-X
in	B-X
response	B-X
to	B-X
ras	B-X
p21	B-X
.	B-X
We	B-X
demonstrate	B-X
here	B-X
that	B-X
overexpression	B-X
of	B-X
zeta	B-X
PKC	B-X
is	B-X
by	B-X
itself	B-X
sufficient	B-X
to	B-X
stimulate	B-X
a	B-X
permanent	B-X
translocation	B-X
of	B-X
functionally	B-X
active	B-X
NF-kappa	B-X
B	B-X
into	B-X
the	B-X
nucleus	B-X
of	B-X
NIH	B-X
3T3	B-X
fibroblasts	B-X
and	B-X
that	B-X
transfection	B-X
of	B-X
a	B-X
kinase-defective	B-X
dominant	B-X
negative	B-X
mutant	B-X
of	B-X
zeta	B-X
PKC	B-X
dramatically	B-X
inhibits	B-X
the	B-X
kappa	B-X
B-dependent	B-X
transactivation	B-X
of	B-X
a	B-X
chloramphenicol	B-X
acetyltransferase	B-X
reporter	B-X
plasmid	B-X
in	B-X
NIH	B-X
3T3	B-X
fibroblasts	B-X
.	B-X
All	B-X
these	B-X
results	B-X
support	B-X
the	B-X
notion	B-X
that	B-X
zeta	B-X
PKC	B-X
plays	B-X
a	B-X
decisive	B-X
role	B-X
in	B-X
NF-kappa	B-X
B	B-X
regulation	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

All	O
these	O
results	O
support	O
the	O
notion	O
that	O
zeta	B-Gene_or_gene_product
PKC	I-Gene_or_gene_product
plays	O
a	O
decisive	O
role	O
in	O
NF	O
-	O
kappa	O
B	O
regulation	O
in	O
mammalian	O
cells	O
.	O

The	O
yeast	O
Cln3	B-Gene_or_gene_product
protein	O
is	O
an	O
unstable	O
activator	O
of	O
Cdc28	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
Cln3	B-X
cyclin	B-X
homolog	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
functions	B-X
to	B-X
promote	B-X
cell	B-X
cycle	B-X
START	B-X
for	B-X
only	B-X
a	B-X
short	B-X
time	B-X
following	B-X
its	B-X
synthesis	B-X
.	B-X
Cln3	B-X
protein	B-X
is	B-X
highly	B-X
unstable	B-X
and	B-X
is	B-X
stabilized	B-X
by	B-X
C-terminal	B-X
truncation	B-X
.	B-X
Cln3	B-X
binds	B-X
to	B-X
Cdc28	B-X
,	B-X
a	B-X
protein	B-X
kinase	B-X
catalytic	B-X
subunit	B-X
essential	B-X
for	B-X
cell	B-X
cycle	B-X
START	B-X
,	B-X
and	B-X
Cln3	B-X
instability	B-X
requires	B-X
Cdc28	B-X
activity	B-X
.	B-X
The	B-X
long	B-X
functional	B-X
lifetime	B-X
and	B-X
the	B-X
hyperactivity	B-X
of	B-X
C-terminally	B-X
truncated	B-X
Cln3	B-X
(	B-X
Cln3-2	B-X
)	B-X
relative	B-X
to	B-X
those	B-X
of	B-X
full-length	B-X
Cln3	B-X
are	B-X
affected	B-X
by	B-X
mutations	B-X
in	B-X
CDC28	B-X
:	B-X
the	B-X
functional	B-X
lifetime	B-X
of	B-X
Cln3-2	B-X
is	B-X
drastically	B-X
reduced	B-X
by	B-X
the	B-X
cdc28-13	B-X
mutation	B-X
at	B-X
the	B-X
permissive	B-X
temperature	B-X
,	B-X
and	B-X
the	B-X
cdc28-4	B-X
mutation	B-X
at	B-X
the	B-X
permissive	B-X
temperature	B-X
completely	B-X
blocks	B-X
the	B-X
function	B-X
of	B-X
Cln3-2	B-X
while	B-X
only	B-X
partially	B-X
reducing	B-X
the	B-X
function	B-X
of	B-X
full-length	B-X
Cln3	B-X
.	B-X
Thus	B-X
,	B-X
sequences	B-X
in	B-X
the	B-X
C-terminal	B-X
third	B-X
of	B-X
Cln3	B-X
might	B-X
help	B-X
stabilize	B-X
functional	B-X
Cdc28-Cln3	B-X
association	B-X
,	B-X
as	B-X
well	B-X
as	B-X
decreasing	B-X
the	B-X
lifetime	B-X
of	B-X
the	B-X
Cln3	B-X
protein	B-X
.	B-X
These	B-X
and	B-X
other	B-X
results	B-X
strongly	B-X
support	B-X
the	B-X
idea	B-X
that	B-X
Cln	B-X
proteins	B-X
function	B-X
to	B-X
activate	B-X
Cdc28	B-X
at	B-X
START	B-X
.	B-X

The	O
Cln3	B-Gene_or_gene_product
cyclin	B-Gene_or_gene_product
homolog	O
of	O
Saccharomyces	O
cerevisiae	O
functions	O
to	O
promote	O
cell	O
cycle	O
START	O
for	O
only	O
a	O
short	O
time	O
following	O
its	O
synthesis	O
.	O

Cln3	B-Gene_or_gene_product
protein	O
is	O
highly	O
unstable	O
and	O
is	O
stabilized	O
by	O
C	O
-	O
terminal	O
truncation	O
.	O

Cln3	B-Gene_or_gene_product
binds	O
to	O
Cdc28	B-Gene_or_gene_product
,	O
a	O
protein	O
kinase	O
catalytic	O
subunit	O
essential	O
for	O
cell	O
cycle	O
START	O
,	O
and	O
Cln3	B-Gene_or_gene_product
instability	O
requires	O
Cdc28	B-Gene_or_gene_product
activity	O
.	O
<EOS>	B-X
The	B-X
Cln3	B-X
cyclin	B-X
homolog	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
functions	B-X
to	B-X
promote	B-X
cell	B-X
cycle	B-X
START	B-X
for	B-X
only	B-X
a	B-X
short	B-X
time	B-X
following	B-X
its	B-X
synthesis	B-X
.	B-X
Cln3	B-X
protein	B-X
is	B-X
highly	B-X
unstable	B-X
and	B-X
is	B-X
stabilized	B-X
by	B-X
C-terminal	B-X
truncation	B-X
.	B-X
Cln3	B-X
binds	B-X
to	B-X
Cdc28	B-X
,	B-X
a	B-X
protein	B-X
kinase	B-X
catalytic	B-X
subunit	B-X
essential	B-X
for	B-X
cell	B-X
cycle	B-X
START	B-X
,	B-X
and	B-X
Cln3	B-X
instability	B-X
requires	B-X
Cdc28	B-X
activity	B-X
.	B-X
The	B-X
long	B-X
functional	B-X
lifetime	B-X
and	B-X
the	B-X
hyperactivity	B-X
of	B-X
C-terminally	B-X
truncated	B-X
Cln3	B-X
(	B-X
Cln3-2	B-X
)	B-X
relative	B-X
to	B-X
those	B-X
of	B-X
full-length	B-X
Cln3	B-X
are	B-X
affected	B-X
by	B-X
mutations	B-X
in	B-X
CDC28	B-X
:	B-X
the	B-X
functional	B-X
lifetime	B-X
of	B-X
Cln3-2	B-X
is	B-X
drastically	B-X
reduced	B-X
by	B-X
the	B-X
cdc28-13	B-X
mutation	B-X
at	B-X
the	B-X
permissive	B-X
temperature	B-X
,	B-X
and	B-X
the	B-X
cdc28-4	B-X
mutation	B-X
at	B-X
the	B-X
permissive	B-X
temperature	B-X
completely	B-X
blocks	B-X
the	B-X
function	B-X
of	B-X
Cln3-2	B-X
while	B-X
only	B-X
partially	B-X
reducing	B-X
the	B-X
function	B-X
of	B-X
full-length	B-X
Cln3	B-X
.	B-X
Thus	B-X
,	B-X
sequences	B-X
in	B-X
the	B-X
C-terminal	B-X
third	B-X
of	B-X
Cln3	B-X
might	B-X
help	B-X
stabilize	B-X
functional	B-X
Cdc28-Cln3	B-X
association	B-X
,	B-X
as	B-X
well	B-X
as	B-X
decreasing	B-X
the	B-X
lifetime	B-X
of	B-X
the	B-X
Cln3	B-X
protein	B-X
.	B-X
These	B-X
and	B-X
other	B-X
results	B-X
strongly	B-X
support	B-X
the	B-X
idea	B-X
that	B-X
Cln	B-X
proteins	B-X
function	B-X
to	B-X
activate	B-X
Cdc28	B-X
at	B-X
START	B-X
.	B-X

The	O
long	O
functional	O
lifetime	O
and	O
the	O
hyperactivity	O
of	O
C	O
-	O
terminally	O
truncated	O
Cln3	B-Gene_or_gene_product
(	O
Cln3	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
)	O
relative	O
to	O
those	O
of	O
full	O
-	O
length	O
Cln3	B-Gene_or_gene_product
are	O
affected	O
by	O
mutations	O
in	O
CDC28	B-Gene_or_gene_product
:	O
the	O
functional	O
lifetime	O
of	O
Cln3	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
is	O
drastically	O
reduced	O
by	O
the	O
cdc28	B-Gene_or_gene_product
-	O
13	O
mutation	O
at	O
the	O
permissive	O
temperature	O
,	O
and	O
the	O
cdc28	B-Gene_or_gene_product
-	O
4	O
mutation	O
at	O
the	O
permissive	O
temperature	O
completely	O
blocks	O
the	O
function	O
of	O
Cln3	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
while	O
only	O
partially	O
reducing	O
the	O
function	O
of	O
full	O
-	O
length	O
Cln3	B-Gene_or_gene_product
.	O

Thus	O
,	O
sequences	O
in	O
the	O
C	O
-	O
terminal	O
third	O
of	O
Cln3	B-Gene_or_gene_product
might	O
help	O
stabilize	O
functional	O
Cdc28	B-Gene_or_gene_product
-	O
Cln3	B-Gene_or_gene_product
association	O
,	O
as	O
well	O
as	O
decreasing	O
the	O
lifetime	O
of	O
the	O
Cln3	B-Gene_or_gene_product
protein	O
.	O

These	O
and	O
other	O
results	O
strongly	O
support	O
the	O
idea	O
that	O
Cln	B-Gene_or_gene_product
proteins	O
function	O
to	O
activate	O
Cdc28	B-Gene_or_gene_product
at	O
START	O
.	O
<EOS>	B-X
The	B-X
Cln3	B-X
cyclin	B-X
homolog	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
functions	B-X
to	B-X
promote	B-X
cell	B-X
cycle	B-X
START	B-X
for	B-X
only	B-X
a	B-X
short	B-X
time	B-X
following	B-X
its	B-X
synthesis	B-X
.	B-X
Cln3	B-X
protein	B-X
is	B-X
highly	B-X
unstable	B-X
and	B-X
is	B-X
stabilized	B-X
by	B-X
C-terminal	B-X
truncation	B-X
.	B-X
Cln3	B-X
binds	B-X
to	B-X
Cdc28	B-X
,	B-X
a	B-X
protein	B-X
kinase	B-X
catalytic	B-X
subunit	B-X
essential	B-X
for	B-X
cell	B-X
cycle	B-X
START	B-X
,	B-X
and	B-X
Cln3	B-X
instability	B-X
requires	B-X
Cdc28	B-X
activity	B-X
.	B-X
The	B-X
long	B-X
functional	B-X
lifetime	B-X
and	B-X
the	B-X
hyperactivity	B-X
of	B-X
C-terminally	B-X
truncated	B-X
Cln3	B-X
(	B-X
Cln3-2	B-X
)	B-X
relative	B-X
to	B-X
those	B-X
of	B-X
full-length	B-X
Cln3	B-X
are	B-X
affected	B-X
by	B-X
mutations	B-X
in	B-X
CDC28	B-X
:	B-X
the	B-X
functional	B-X
lifetime	B-X
of	B-X
Cln3-2	B-X
is	B-X
drastically	B-X
reduced	B-X
by	B-X
the	B-X
cdc28-13	B-X
mutation	B-X
at	B-X
the	B-X
permissive	B-X
temperature	B-X
,	B-X
and	B-X
the	B-X
cdc28-4	B-X
mutation	B-X
at	B-X
the	B-X
permissive	B-X
temperature	B-X
completely	B-X
blocks	B-X
the	B-X
function	B-X
of	B-X
Cln3-2	B-X
while	B-X
only	B-X
partially	B-X
reducing	B-X
the	B-X
function	B-X
of	B-X
full-length	B-X
Cln3	B-X
.	B-X
Thus	B-X
,	B-X
sequences	B-X
in	B-X
the	B-X
C-terminal	B-X
third	B-X
of	B-X
Cln3	B-X
might	B-X
help	B-X
stabilize	B-X
functional	B-X
Cdc28-Cln3	B-X
association	B-X
,	B-X
as	B-X
well	B-X
as	B-X
decreasing	B-X
the	B-X
lifetime	B-X
of	B-X
the	B-X
Cln3	B-X
protein	B-X
.	B-X
These	B-X
and	B-X
other	B-X
results	B-X
strongly	B-X
support	B-X
the	B-X
idea	B-X
that	B-X
Cln	B-X
proteins	B-X
function	B-X
to	B-X
activate	B-X
Cdc28	B-X
at	B-X
START	B-X
.	B-X

Rac	B-Gene_or_gene_product
GTPase	O
interacts	O
specifically	O
with	O
phosphatidylinositol	B-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
Rac	B-X
GTP-binding	B-X
proteins	B-X
are	B-X
members	B-X
of	B-X
the	B-X
Rho	B-X
family	B-X
and	B-X
regulate	B-X
growth	B-X
factor-stimulated	B-X
actin	B-X
assembly	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
cells	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
a	B-X
direct	B-X
and	B-X
specific	B-X
interaction	B-X
of	B-X
Rac	B-X
proteins	B-X
with	B-X
phosphatidylinositol	B-X
(	B-X
PI	B-X
)	B-X
3-kinase	B-X
.	B-X
This	B-X
interaction	B-X
is	B-X
dependent	B-X
upon	B-X
Rac	B-X
being	B-X
in	B-X
a	B-X
GTP-bound	B-X
state	B-X
and	B-X
requires	B-X
an	B-X
intact	B-X
Rac	B-X
effector	B-X
domain	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
direct	B-X
binding	B-X
of	B-X
RhoA	B-X
to	B-X
PI	B-X
3-kinase	B-X
could	B-X
not	B-X
be	B-X
detected	B-X
.	B-X
Rac-GTP	B-X
also	B-X
bound	B-X
to	B-X
PI	B-X
3-kinase	B-X
in	B-X
Swiss	B-X
3T3	B-X
fibroblast	B-X
and	B-X
human	B-X
neutrophil	B-X
lysates	B-X
,	B-X
and	B-X
increased	B-X
PI	B-X
3-kinase	B-X
activity	B-X
became	B-X
associated	B-X
with	B-X
Rac-GTP	B-X
in	B-X
platelet-derived	B-X
growth	B-X
factor-stimulated	B-X
cells	B-X
.	B-X
Interaction	B-X
of	B-X
Rac-GTP	B-X
with	B-X
PI	B-X
3-kinase	B-X
in	B-X
vitro	B-X
stimulated	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
enzyme	B-X
by	B-X
2-9-fold	B-X
.	B-X
A	B-X
specific	B-X
interaction	B-X
of	B-X
active	B-X
Rac	B-X
with	B-X
PI	B-X
3-kinase	B-X
might	B-X
be	B-X
important	B-X
in	B-X
regulation	B-X
of	B-X
the	B-X
actin	B-X
cytoskeleton	B-X
.	B-X

The	O
Rac	B-Gene_or_gene_product
GTP	O
-	O
binding	O
proteins	O
are	O
members	O
of	O
the	O
Rho	B-Gene_or_gene_product
family	O
and	O
regulate	O
growth	O
factor	O
-	O
stimulated	O
actin	B-Gene_or_gene_product
assembly	O
in	O
a	O
variety	O
of	O
cells	O
.	O

The	O
formation	O
of	O
phosphorylated	O
inositol	O
lipids	O
has	O
been	O
implicated	O
in	O
control	O
of	O
the	O
processes	O
initiating	O
and	O
regulating	O
such	O
actin	B-Gene_or_gene_product
polymerization	O
.	O
<EOS>	B-X
The	B-X
Rac	B-X
GTP-binding	B-X
proteins	B-X
are	B-X
members	B-X
of	B-X
the	B-X
Rho	B-X
family	B-X
and	B-X
regulate	B-X
growth	B-X
factor-stimulated	B-X
actin	B-X
assembly	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
cells	B-X
.	B-X
The	B-X
formation	B-X
of	B-X
phosphorylated	B-X
inositol	B-X
lipids	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
control	B-X
of	B-X
the	B-X
processes	B-X
initiating	B-X
and	B-X
regulating	B-X
such	B-X
actin	B-X
polymerization	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
a	B-X
direct	B-X
and	B-X
specific	B-X
interaction	B-X
of	B-X
Rac	B-X
proteins	B-X
with	B-X
phosphatidylinositol	B-X
(	B-X
PI	B-X
)	B-X
3-kinase	B-X
.	B-X
A	B-X
specific	B-X
interaction	B-X
of	B-X
active	B-X
Rac	B-X
with	B-X
PI	B-X
3-kinase	B-X
might	B-X
be	B-X
important	B-X
in	B-X
regulation	B-X
of	B-X
the	B-X
actin	B-X
cytoskeleton	B-X
.	B-X

Associations	O
of	O
Rho	B-Gene_or_gene_product
family	O
GTP	O
-	O
binding	O
proteins	O
with	O
enzymes	O
involved	O
in	O
lipid	O
metabolism	O
have	O
been	O
described	O
.	O
<EOS>	B-X
The	B-X
Rac	B-X
GTP-binding	B-X
proteins	B-X
are	B-X
members	B-X
of	B-X
the	B-X
Rho	B-X
family	B-X
and	B-X
regulate	B-X
growth	B-X
factor-stimulated	B-X
actin	B-X
assembly	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
cells	B-X
.	B-X
The	B-X
formation	B-X
of	B-X
phosphorylated	B-X
inositol	B-X
lipids	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
control	B-X
of	B-X
the	B-X
processes	B-X
initiating	B-X
and	B-X
regulating	B-X
such	B-X
actin	B-X
polymerization	B-X
.	B-X
Associations	B-X
of	B-X
Rho	B-X
family	B-X
GTP-binding	B-X
proteins	B-X
with	B-X
enzymes	B-X
involved	B-X
in	B-X
lipid	B-X
metabolism	B-X
have	B-X
been	B-X
described	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
a	B-X
direct	B-X
and	B-X
specific	B-X
interaction	B-X
of	B-X
Rac	B-X
proteins	B-X
with	B-X
phosphatidylinositol	B-X
(	B-X
PI	B-X
)	B-X
3-kinase	B-X
.	B-X
This	B-X
interaction	B-X
is	B-X
dependent	B-X
upon	B-X
Rac	B-X
being	B-X
in	B-X
a	B-X
GTP-bound	B-X
state	B-X
and	B-X
requires	B-X
an	B-X
intact	B-X
Rac	B-X
effector	B-X
domain	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
direct	B-X
binding	B-X
of	B-X
RhoA	B-X
to	B-X
PI	B-X
3-kinase	B-X
could	B-X
not	B-X
be	B-X
detected	B-X
.	B-X
Rac-GTP	B-X
also	B-X
bound	B-X
to	B-X
PI	B-X
3-kinase	B-X
in	B-X
Swiss	B-X
3T3	B-X
fibroblast	B-X
and	B-X
human	B-X
neutrophil	B-X
lysates	B-X
,	B-X
and	B-X
increased	B-X
PI	B-X
3-kinase	B-X
activity	B-X
became	B-X
associated	B-X
with	B-X
Rac-GTP	B-X
in	B-X
platelet-derived	B-X
growth	B-X
factor-stimulated	B-X
cells	B-X
.	B-X
Interaction	B-X
of	B-X
Rac-GTP	B-X
with	B-X
PI	B-X
3-kinase	B-X
in	B-X
vitro	B-X
stimulated	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
enzyme	B-X
by	B-X
2-9-fold	B-X
.	B-X

Here	O
we	O
demonstrate	O
a	O
direct	O
and	O
specific	O
interaction	O
of	O
Rac	B-Gene_or_gene_product
proteins	O
with	O
phosphatidylinositol	B-Gene_or_gene_product
(	I-Gene_or_gene_product
PI	I-Gene_or_gene_product
)	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
Rac	B-X
GTP-binding	B-X
proteins	B-X
are	B-X
members	B-X
of	B-X
the	B-X
Rho	B-X
family	B-X
and	B-X
regulate	B-X
growth	B-X
factor-stimulated	B-X
actin	B-X
assembly	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
cells	B-X
.	B-X
Associations	B-X
of	B-X
Rho	B-X
family	B-X
GTP-binding	B-X
proteins	B-X
with	B-X
enzymes	B-X
involved	B-X
in	B-X
lipid	B-X
metabolism	B-X
have	B-X
been	B-X
described	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
a	B-X
direct	B-X
and	B-X
specific	B-X
interaction	B-X
of	B-X
Rac	B-X
proteins	B-X
with	B-X
phosphatidylinositol	B-X
(	B-X
PI	B-X
)	B-X
3-kinase	B-X
.	B-X
This	B-X
interaction	B-X
is	B-X
dependent	B-X
upon	B-X
Rac	B-X
being	B-X
in	B-X
a	B-X
GTP-bound	B-X
state	B-X
and	B-X
requires	B-X
an	B-X
intact	B-X
Rac	B-X
effector	B-X
domain	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
direct	B-X
binding	B-X
of	B-X
RhoA	B-X
to	B-X
PI	B-X
3-kinase	B-X
could	B-X
not	B-X
be	B-X
detected	B-X
.	B-X
Rac-GTP	B-X
also	B-X
bound	B-X
to	B-X
PI	B-X
3-kinase	B-X
in	B-X
Swiss	B-X
3T3	B-X
fibroblast	B-X
and	B-X
human	B-X
neutrophil	B-X
lysates	B-X
,	B-X
and	B-X
increased	B-X
PI	B-X
3-kinase	B-X
activity	B-X
became	B-X
associated	B-X
with	B-X
Rac-GTP	B-X
in	B-X
platelet-derived	B-X
growth	B-X
factor-stimulated	B-X
cells	B-X
.	B-X
Interaction	B-X
of	B-X
Rac-GTP	B-X
with	B-X
PI	B-X
3-kinase	B-X
in	B-X
vitro	B-X
stimulated	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
enzyme	B-X
by	B-X
2-9-fold	B-X
.	B-X
A	B-X
specific	B-X
interaction	B-X
of	B-X
active	B-X
Rac	B-X
with	B-X
PI	B-X
3-kinase	B-X
might	B-X
be	B-X
important	B-X
in	B-X
regulation	B-X
of	B-X
the	B-X
actin	B-X
cytoskeleton	B-X
.	B-X

This	O
interaction	O
is	O
dependent	O
upon	O
Rac	B-Gene_or_gene_product
being	O
in	O
a	O
GTP	O
-	O
bound	O
state	O
and	O
requires	O
an	O
intact	O
Rac	B-Gene_or_gene_product
effector	O
domain	O
.	O

In	O
contrast	O
,	O
direct	O
binding	O
of	O
RhoA	B-Gene_or_gene_product
to	O
PI	B-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
could	O
not	O
be	O
detected	O
.	O
<EOS>	B-X
Botulinum	B-X
C3	B-X
exoenzyme	B-X
was	B-X
used	B-X
to	B-X
specifically	B-X
ADP-ribosylate	B-X
and	B-X
inactivate	B-X
rho	B-X
p21	B-X
,	B-X
and	B-X
the	B-X
effects	B-X
of	B-X
rho	B-X
p21	B-X
inactivation	B-X
on	B-X
lysophosphatidic	B-X
acid	B-X
(	B-X
LPA	B-X
)	B-X
-induced	B-X
tyrosine	B-X
phosphorylation	B-X
were	B-X
examined	B-X
in	B-X
cultured	B-X
Swiss	B-X
3T3	B-X
cells	B-X
.	B-X
Pretreatment	B-X
of	B-X
the	B-X
cells	B-X
with	B-X
the	B-X
C3	B-X
exoenzyme	B-X
caused	B-X
ADP-ribosylation	B-X
of	B-X
rho	B-X
p21	B-X
in	B-X
the	B-X
cells	B-X
and	B-X
selectively	B-X
attenuated	B-X
the	B-X
phosphorylation	B-X
of	B-X
several	B-X
proteins	B-X
,	B-X
including	B-X
p43	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
,	B-X
p125	B-X
focal	B-X
adhesion	B-X
kinase	B-X
,	B-X
and	B-X
two	B-X
proteins	B-X
of	B-X
72	B-X
and	B-X
88	B-X
kDa	B-X
.	B-X
C3	B-X
exoenzyme	B-X
pretreatment	B-X
did	B-X
not	B-X
block	B-X
the	B-X
initial	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
but	B-X
suppressed	B-X
its	B-X
subsequent	B-X
rise	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
enzyme	B-X
treatment	B-X
inhibited	B-X
the	B-X
induction	B-X
of	B-X
phosphorylation	B-X
of	B-X
the	B-X
72-	B-X
and	B-X
88-kDa	B-X
proteins	B-X
and	B-X
suppressed	B-X
the	B-X
basal	B-X
and	B-X
LPA-induced	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
p125	B-X
focal	B-X
adhesion	B-X
kinase	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
immunoprecipitation	B-X
of	B-X
cell	B-X
lysates	B-X
with	B-X
an	B-X
antibody	B-X
directed	B-X
against	B-X
the	B-X
85-kDa	B-X
subunit	B-X
of	B-X
phosphatidylinositol	B-X
3-kinase	B-X
(	B-X
PI	B-X
3-kinase	B-X
)	B-X
co-precipitated	B-X
a	B-X
tyrosine-phosphorylated	B-X
band	B-X
of	B-X
180	B-X
kDa	B-X
.	B-X
C3	B-X
exoenzyme	B-X
pretreatment	B-X
suppressed	B-X
both	B-X
the	B-X
phosphorylation	B-X
of	B-X
this	B-X
band	B-X
and	B-X
PI	B-X
3-kinase	B-X
activation	B-X
associated	B-X
with	B-X
LPA	B-X
stimulation	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
that	B-X
rho	B-X
p21	B-X
works	B-X
as	B-X
a	B-X
link	B-X
between	B-X
the	B-X
LPA	B-X
receptor	B-X
signal	B-X
and	B-X
the	B-X
subsequent	B-X
tyrosine	B-X
phosphorylation	B-X
and	B-X
PI	B-X
3-kinase	B-X
activation	B-X
in	B-X
these	B-X
cells	B-X
.	B-X

Rac	O
-	O
GTP	O
also	O
bound	O
to	O
PI	B-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
in	O
Swiss	O
3T3	O
fibroblast	O
and	O
human	O
neutrophil	O
lysates	O
,	O
and	O
increased	O
PI	B-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
activity	O
became	O
associated	O
with	O
Rac	O
-	O
GTP	O
in	O
platelet	O
-	O
derived	O
growth	O
factor	O
-	O
stimulated	O
cells	O
.	O
<EOS>	B-X
The	B-X
Rac	B-X
GTP-binding	B-X
proteins	B-X
are	B-X
members	B-X
of	B-X
the	B-X
Rho	B-X
family	B-X
and	B-X
regulate	B-X
growth	B-X
factor-stimulated	B-X
actin	B-X
assembly	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
cells	B-X
.	B-X
Associations	B-X
of	B-X
Rho	B-X
family	B-X
GTP-binding	B-X
proteins	B-X
with	B-X
enzymes	B-X
involved	B-X
in	B-X
lipid	B-X
metabolism	B-X
have	B-X
been	B-X
described	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
a	B-X
direct	B-X
and	B-X
specific	B-X
interaction	B-X
of	B-X
Rac	B-X
proteins	B-X
with	B-X
phosphatidylinositol	B-X
(	B-X
PI	B-X
)	B-X
3-kinase	B-X
.	B-X
This	B-X
interaction	B-X
is	B-X
dependent	B-X
upon	B-X
Rac	B-X
being	B-X
in	B-X
a	B-X
GTP-bound	B-X
state	B-X
and	B-X
requires	B-X
an	B-X
intact	B-X
Rac	B-X
effector	B-X
domain	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
direct	B-X
binding	B-X
of	B-X
RhoA	B-X
to	B-X
PI	B-X
3-kinase	B-X
could	B-X
not	B-X
be	B-X
detected	B-X
.	B-X
Rac-GTP	B-X
also	B-X
bound	B-X
to	B-X
PI	B-X
3-kinase	B-X
in	B-X
Swiss	B-X
3T3	B-X
fibroblast	B-X
and	B-X
human	B-X
neutrophil	B-X
lysates	B-X
,	B-X
and	B-X
increased	B-X
PI	B-X
3-kinase	B-X
activity	B-X
became	B-X
associated	B-X
with	B-X
Rac-GTP	B-X
in	B-X
platelet-derived	B-X
growth	B-X
factor-stimulated	B-X
cells	B-X
.	B-X
Interaction	B-X
of	B-X
Rac-GTP	B-X
with	B-X
PI	B-X
3-kinase	B-X
in	B-X
vitro	B-X
stimulated	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
enzyme	B-X
by	B-X
2-9-fold	B-X
.	B-X
A	B-X
specific	B-X
interaction	B-X
of	B-X
active	B-X
Rac	B-X
with	B-X
PI	B-X
3-kinase	B-X
might	B-X
be	B-X
important	B-X
in	B-X
regulation	B-X
of	B-X
the	B-X
actin	B-X
cytoskeleton	B-X
.	B-X

Interaction	O
of	O
Rac	O
-	O
GTP	O
with	O
PI	B-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
in	O
vitro	O
stimulated	O
the	O
activity	O
of	O
the	O
enzyme	O
by	O
2	O
-	O
9	O
-	O
fold	O
.	O
<EOS>	B-X
The	B-X
Rac	B-X
GTP-binding	B-X
proteins	B-X
are	B-X
members	B-X
of	B-X
the	B-X
Rho	B-X
family	B-X
and	B-X
regulate	B-X
growth	B-X
factor-stimulated	B-X
actin	B-X
assembly	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
cells	B-X
.	B-X
Associations	B-X
of	B-X
Rho	B-X
family	B-X
GTP-binding	B-X
proteins	B-X
with	B-X
enzymes	B-X
involved	B-X
in	B-X
lipid	B-X
metabolism	B-X
have	B-X
been	B-X
described	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
a	B-X
direct	B-X
and	B-X
specific	B-X
interaction	B-X
of	B-X
Rac	B-X
proteins	B-X
with	B-X
phosphatidylinositol	B-X
(	B-X
PI	B-X
)	B-X
3-kinase	B-X
.	B-X
This	B-X
interaction	B-X
is	B-X
dependent	B-X
upon	B-X
Rac	B-X
being	B-X
in	B-X
a	B-X
GTP-bound	B-X
state	B-X
and	B-X
requires	B-X
an	B-X
intact	B-X
Rac	B-X
effector	B-X
domain	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
direct	B-X
binding	B-X
of	B-X
RhoA	B-X
to	B-X
PI	B-X
3-kinase	B-X
could	B-X
not	B-X
be	B-X
detected	B-X
.	B-X
Rac-GTP	B-X
also	B-X
bound	B-X
to	B-X
PI	B-X
3-kinase	B-X
in	B-X
Swiss	B-X
3T3	B-X
fibroblast	B-X
and	B-X
human	B-X
neutrophil	B-X
lysates	B-X
,	B-X
and	B-X
increased	B-X
PI	B-X
3-kinase	B-X
activity	B-X
became	B-X
associated	B-X
with	B-X
Rac-GTP	B-X
in	B-X
platelet-derived	B-X
growth	B-X
factor-stimulated	B-X
cells	B-X
.	B-X
Interaction	B-X
of	B-X
Rac-GTP	B-X
with	B-X
PI	B-X
3-kinase	B-X
in	B-X
vitro	B-X
stimulated	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
enzyme	B-X
by	B-X
2-9-fold	B-X
.	B-X
A	B-X
specific	B-X
interaction	B-X
of	B-X
active	B-X
Rac	B-X
with	B-X
PI	B-X
3-kinase	B-X
might	B-X
be	B-X
important	B-X
in	B-X
regulation	B-X
of	B-X
the	B-X
actin	B-X
cytoskeleton	B-X
.	B-X

A	O
specific	O
interaction	O
of	O
active	O
Rac	B-Gene_or_gene_product
with	O
PI	B-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
might	O
be	O
important	O
in	O
regulation	O
of	O
the	O
actin	B-Gene_or_gene_product
cytoskeleton	O
.	O
<EOS>	B-X
The	B-X
Rac	B-X
GTP-binding	B-X
proteins	B-X
are	B-X
members	B-X
of	B-X
the	B-X
Rho	B-X
family	B-X
and	B-X
regulate	B-X
growth	B-X
factor-stimulated	B-X
actin	B-X
assembly	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
cells	B-X
.	B-X
The	B-X
formation	B-X
of	B-X
phosphorylated	B-X
inositol	B-X
lipids	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
control	B-X
of	B-X
the	B-X
processes	B-X
initiating	B-X
and	B-X
regulating	B-X
such	B-X
actin	B-X
polymerization	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
a	B-X
direct	B-X
and	B-X
specific	B-X
interaction	B-X
of	B-X
Rac	B-X
proteins	B-X
with	B-X
phosphatidylinositol	B-X
(	B-X
PI	B-X
)	B-X
3-kinase	B-X
.	B-X
This	B-X
interaction	B-X
is	B-X
dependent	B-X
upon	B-X
Rac	B-X
being	B-X
in	B-X
a	B-X
GTP-bound	B-X
state	B-X
and	B-X
requires	B-X
an	B-X
intact	B-X
Rac	B-X
effector	B-X
domain	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
direct	B-X
binding	B-X
of	B-X
RhoA	B-X
to	B-X
PI	B-X
3-kinase	B-X
could	B-X
not	B-X
be	B-X
detected	B-X
.	B-X
Rac-GTP	B-X
also	B-X
bound	B-X
to	B-X
PI	B-X
3-kinase	B-X
in	B-X
Swiss	B-X
3T3	B-X
fibroblast	B-X
and	B-X
human	B-X
neutrophil	B-X
lysates	B-X
,	B-X
and	B-X
increased	B-X
PI	B-X
3-kinase	B-X
activity	B-X
became	B-X
associated	B-X
with	B-X
Rac-GTP	B-X
in	B-X
platelet-derived	B-X
growth	B-X
factor-stimulated	B-X
cells	B-X
.	B-X
Interaction	B-X
of	B-X
Rac-GTP	B-X
with	B-X
PI	B-X
3-kinase	B-X
in	B-X
vitro	B-X
stimulated	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
enzyme	B-X
by	B-X
2-9-fold	B-X
.	B-X
A	B-X
specific	B-X
interaction	B-X
of	B-X
active	B-X
Rac	B-X
with	B-X
PI	B-X
3-kinase	B-X
might	B-X
be	B-X
important	B-X
in	B-X
regulation	B-X
of	B-X
the	B-X
actin	B-X
cytoskeleton	B-X
.	B-X

Wild	O
type	O
and	O
mutant	O
human	O
heart	O
(	B-Gene_or_gene_product
R	I-Gene_or_gene_product
)	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
hydroxybutyrate	I-Gene_or_gene_product
dehydrogenase	I-Gene_or_gene_product
expressed	O
in	O
insect	O
cells	O
.	O
<EOS>	B-X
(	B-X
R	B-X
)	B-X
-3-Hydroxybutyrate	B-X
dehydrogenase	B-X
(	B-X
BDH	B-X
)	B-X
is	B-X
a	B-X
lipid-requiring	B-X
mitochondrial	B-X
enzyme	B-X
with	B-X
a	B-X
specific	B-X
requirement	B-X
of	B-X
phosphatidylcholine	B-X
(	B-X
PC	B-X
)	B-X
for	B-X
function	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
primary	B-X
sequence	B-X
of	B-X
BDH	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
molecular	B-X
cloning	B-X
,	B-X
predicts	B-X
that	B-X
lipid	B-X
binding	B-X
and	B-X
substrate	B-X
specificity	B-X
are	B-X
contributed	B-X
by	B-X
the	B-X
C-terminal	B-X
third	B-X
of	B-X
the	B-X
protein	B-X
[	B-X
Marks	B-X
,	B-X
A.	B-X
R.	B-X
,	B-X
McIntyre	B-X
,	B-X
J.	B-X
O.	B-X
,	B-X
Duncan	B-X
,	B-X
T.	B-X
M.	B-X
,	B-X
Erdjument-Bromage	B-X
,	B-X
H.	B-X
,	B-X
Tempst	B-X
,	B-X
P.	B-X
,	B-X
&	B-X
Fleischer	B-X
,	B-X
S.	B-X
(	B-X
1992	B-X
)	B-X
J.	B-X
Biol	B-X
.	B-X
267	B-X
,	B-X
15459-15463	B-X
]	B-X
.	B-X
The	B-X
mature	B-X
form	B-X
of	B-X
human	B-X
heart	B-X
BDH	B-X
has	B-X
now	B-X
been	B-X
expressed	B-X
in	B-X
catalytically	B-X
active	B-X
form	B-X
in	B-X
insect	B-X
cells	B-X
(	B-X
Sf9	B-X
,	B-X
Spodoptera	B-X
frugiperda	B-X
)	B-X
transfected	B-X
with	B-X
BDH-cDNA	B-X
in	B-X
baculovirus	B-X
.	B-X
Endogenous	B-X
PC	B-X
in	B-X
the	B-X
insect	B-X
cells	B-X
fulfills	B-X
the	B-X
lipid	B-X
requirement	B-X
for	B-X
the	B-X
expressed	B-X
BDH	B-X
since	B-X
enzymatic	B-X
activity	B-X
is	B-X
lost	B-X
upon	B-X
digestion	B-X
with	B-X
phospholipase	B-X
A2	B-X
and	B-X
restored	B-X
selectively	B-X
by	B-X
reconstitution	B-X
with	B-X
PC	B-X
vesicles	B-X
.	B-X
The	B-X
K	B-X
(	B-X
m	B-X
)	B-X
s	B-X
for	B-X
NAD+	B-X
and	B-X
(	B-X
R	B-X
)	B-X
-3-hydroxybutyrate	B-X
(	B-X
R-HOB	B-X
)	B-X
of	B-X
expressed	B-X
BDH	B-X
are	B-X
similar	B-X
to	B-X
those	B-X
for	B-X
bovine	B-X
heart	B-X
or	B-X
rat	B-X
liver	B-X
BDH	B-X
in	B-X
mitochondria	B-X
.	B-X
Replacing	B-X
Cys242	B-X
(	B-X
the	B-X
only	B-X
cysteine	B-X
in	B-X
the	B-X
C-terminal	B-X
domain	B-X
)	B-X
with	B-X
serine	B-X
by	B-X
site-directed	B-X
mutagenesis	B-X
resulted	B-X
in	B-X
a	B-X
10-fold	B-X
increase	B-X
in	B-X
K	B-X
(	B-X
m	B-X
)	B-X
for	B-X
R-HOB	B-X
with	B-X
no	B-X
change	B-X
in	B-X
the	B-X
K	B-X
(	B-X
m	B-X
)	B-X
for	B-X
NAD+	B-X
,	B-X
indicating	B-X
a	B-X
role	B-X
for	B-X
Cys242	B-X
in	B-X
substrate	B-X
binding	B-X
.	B-X
Carboxypeptidase	B-X
cleavage	B-X
studies	B-X
had	B-X
indicated	B-X
a	B-X
requirement	B-X
of	B-X
the	B-X
C-terminal	B-X
for	B-X
catalysis	B-X
and	B-X
a	B-X
role	B-X
in	B-X
lipid	B-X
binding	B-X
[	B-X
Adami	B-X
,	B-X
P.	B-X
,	B-X
Duncan	B-X
,	B-X
T.	B-X
M.	B-X
,	B-X
McIntyre	B-X
,	B-X
J.	B-X
O.	B-X
,	B-X
Carter	B-X
,	B-X
C.	B-X
E.	B-X
,	B-X
Fu	B-X
,	B-X
C.	B-X
,	B-X
Melin	B-X
,	B-X
M.	B-X
,	B-X
Latruffe	B-X
,	B-X
N.	B-X
,	B-X
&	B-X
Fleischer	B-X
,	B-X
S.	B-X
(	B-X
1993	B-X
)	B-X
Biochem	B-X
J	B-X
.	B-X
292	B-X
,	B-X
863-872	B-X
]	B-X
.	B-X
We	B-X
now	B-X
show	B-X
that	B-X
deletion	B-X
of	B-X
twelve	B-X
C-terminal	B-X
amino	B-X
acids	B-X
to	B-X
form	B-X
a	B-X
truncated	B-X
BDH	B-X
mutant	B-X
results	B-X
in	B-X
loss	B-X
of	B-X
enzymic	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
in	B-X
Sf	B-X
9	B-X
cells	B-X
of	B-X
the	B-X
constitutively	B-X
active	B-X
full-length	B-X
mature	B-X
form	B-X
of	B-X
human	B-X
heart	B-X
BDH	B-X
and	B-X
the	B-X
first	B-X
expression	B-X
and	B-X
characterization	B-X
of	B-X
BDH	B-X
mutants	B-X
validate	B-X
this	B-X
system	B-X
for	B-X
structure-function	B-X
studies	B-X
of	B-X
BDH	B-X
.	B-X

(	B-Gene_or_gene_product
R	I-Gene_or_gene_product
)	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
Hydroxybutyrate	I-Gene_or_gene_product
dehydrogenase	I-Gene_or_gene_product
(	O
BDH	B-Gene_or_gene_product
)	O
is	O
a	O
lipid	O
-	O
requiring	O
mitochondrial	O
enzyme	O
with	O
a	O
specific	O
requirement	O
of	O
phosphatidylcholine	O
(	O
PC	O
)	O
for	O
function	O
.	O
<EOS>	B-X
Monoclonal	B-X
antibodies	B-X
(	B-X
mAbs	B-X
)	B-X
have	B-X
been	B-X
used	B-X
to	B-X
study	B-X
structure-function	B-X
relationships	B-X
of	B-X
(	B-X
R	B-X
)	B-X
-3-hydroxybutyrate	B-X
dehydrogenase	B-X
(	B-X
BDH	B-X
)	B-X
(	B-X
EC	B-X
1.1.1.30	B-X
)	B-X
,	B-X
a	B-X
lipid-requiring	B-X
mitochondrial	B-X
membrane	B-X
enzyme	B-X
with	B-X
an	B-X
absolute	B-X
and	B-X
specific	B-X
requirement	B-X
for	B-X
phosphatidylcholine	B-X
(	B-X
PC	B-X
)	B-X
for	B-X
enzymic	B-X
activity	B-X
.	B-X
The	B-X
purified	B-X
enzyme	B-X
(	B-X
apoBDH	B-X
,	B-X
devoid	B-X
of	B-X
phospholipid	B-X
and	B-X
thereby	B-X
inactive	B-X
)	B-X
can	B-X
be	B-X
re-activated	B-X
with	B-X
preformed	B-X
phospholipid	B-X
vesicles	B-X
containing	B-X
PC	B-X
or	B-X
by	B-X
short-chain	B-X
soluble	B-X
PC	B-X
.	B-X
Five	B-X
of	B-X
six	B-X
mAbs	B-X
cross-react	B-X
with	B-X
BDH	B-X
from	B-X
bovine	B-X
heart	B-X
and	B-X
rat	B-X
liver	B-X
,	B-X
including	B-X
two	B-X
mAbs	B-X
to	B-X
conformational	B-X
epitopes	B-X
.	B-X
One	B-X
mAb	B-X
was	B-X
found	B-X
to	B-X
be	B-X
specific	B-X
for	B-X
the	B-X
C-terminal	B-X
sequence	B-X
of	B-X
BDH	B-X
and	B-X
served	B-X
to	B-X
:	B-X
(	B-X
1	B-X
)	B-X
map	B-X
endopeptidase	B-X
cleavage	B-X
and	B-X
epitope	B-X
sites	B-X
on	B-X
BDH	B-X
;	B-X
and	B-X
(	B-X
2	B-X
)	B-X
demonstrate	B-X
that	B-X
the	B-X
C-terminus	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
activity	B-X
of	B-X
BDH	B-X
.	B-X
Carboxypeptidase	B-X
cleavage	B-X
of	B-X
only	B-X
a	B-X
few	B-X
(	B-X
<	B-X
or	B-X
=	B-X
14	B-X
)	B-X
C-terminal	B-X
amino	B-X
acids	B-X
from	B-X
apoBDH	B-X
(	B-X
as	B-X
detected	B-X
by	B-X
the	B-X
loss	B-X
of	B-X
C-terminal	B-X
epitope	B-X
for	B-X
mAb	B-X
3-10A	B-X
)	B-X
prevents	B-X
activation	B-X
by	B-X
either	B-X
bilayer	B-X
or	B-X
soluble	B-X
PC	B-X
.	B-X
Further	B-X
,	B-X
for	B-X
BDH	B-X
in	B-X
bilayers	B-X
containing	B-X
PC	B-X
,	B-X
the	B-X
C-terminus	B-X
is	B-X
protected	B-X
from	B-X
carboxy-peptidase	B-X
cleavage	B-X
,	B-X
whereas	B-X
in	B-X
bilayers	B-X
devoid	B-X
of	B-X
PC	B-X
the	B-X
C-terminus	B-X
is	B-X
cleaved	B-X
,	B-X
and	B-X
subsequent	B-X
activation	B-X
by	B-X
PC	B-X
is	B-X
precluded	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
:	B-X
(	B-X
1	B-X
)	B-X
the	B-X
C-terminus	B-X
of	B-X
BDH	B-X
is	B-X
essential	B-X
for	B-X
enzymic	B-X
activity	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
prediction	B-X
,	B-X
from	B-X
primary	B-X
sequence	B-X
analysis	B-X
,	B-X
that	B-X
the	B-X
PC-binding	B-X
site	B-X
is	B-X
in	B-X
the	B-X
C-terminal	B-X
domain	B-X
of	B-X
BDH	B-X
;	B-X
and	B-X
(	B-X
2	B-X
)	B-X
the	B-X
allosteric	B-X
activation	B-X
of	B-X
BDH	B-X
by	B-X
PC	B-X
in	B-X
bilayers	B-X
protects	B-X
the	B-X
C-terminus	B-X
from	B-X
carboxypeptidase	B-X
cleavage	B-X
,	B-X
indicative	B-X
of	B-X
a	B-X
PC-induced	B-X
conformational	B-X
change	B-X
in	B-X
the	B-X
enzyme	B-X
.	B-X

PC	O
is	O
an	O
allosteric	O
activator	O
that	O
enhances	O
NAD	O
(	O
H	O
)	O
binding	O
to	O
BDH	B-Gene_or_gene_product
.	O
<EOS>	B-X
(	B-X
R	B-X
)	B-X
-3-Hydroxybutyrate	B-X
dehydrogenase	B-X
(	B-X
BDH	B-X
)	B-X
is	B-X
a	B-X
lipid-requiring	B-X
mitochondrial	B-X
enzyme	B-X
with	B-X
a	B-X
specific	B-X
requirement	B-X
of	B-X
phosphatidylcholine	B-X
(	B-X
PC	B-X
)	B-X
for	B-X
function	B-X
.	B-X
PC	B-X
is	B-X
an	B-X
allosteric	B-X
activator	B-X
that	B-X
enhances	B-X
NAD	B-X
(	B-X
H	B-X
)	B-X
binding	B-X
to	B-X
BDH	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
primary	B-X
sequence	B-X
of	B-X
BDH	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
molecular	B-X
cloning	B-X
,	B-X
predicts	B-X
that	B-X
lipid	B-X
binding	B-X
and	B-X
substrate	B-X
specificity	B-X
are	B-X
contributed	B-X
by	B-X
the	B-X
C-terminal	B-X
third	B-X
of	B-X
the	B-X
protein	B-X
[	B-X
Marks	B-X
,	B-X
A.	B-X
R.	B-X
,	B-X
McIntyre	B-X
,	B-X
J.	B-X
O.	B-X
,	B-X
Duncan	B-X
,	B-X
T.	B-X
M.	B-X
,	B-X
Erdjument-Bromage	B-X
,	B-X
H.	B-X
,	B-X
Tempst	B-X
,	B-X
P.	B-X
,	B-X
&	B-X
Fleischer	B-X
,	B-X
S.	B-X
(	B-X
1992	B-X
)	B-X
J.	B-X
Biol	B-X
.	B-X
The	B-X
mature	B-X
form	B-X
of	B-X
human	B-X
heart	B-X
BDH	B-X
has	B-X
now	B-X
been	B-X
expressed	B-X
in	B-X
catalytically	B-X
active	B-X
form	B-X
in	B-X
insect	B-X
cells	B-X
(	B-X
Sf9	B-X
,	B-X
Spodoptera	B-X
frugiperda	B-X
)	B-X
transfected	B-X
with	B-X
BDH-cDNA	B-X
in	B-X
baculovirus	B-X
.	B-X
Endogenous	B-X
PC	B-X
in	B-X
the	B-X
insect	B-X
cells	B-X
fulfills	B-X
the	B-X
lipid	B-X
requirement	B-X
for	B-X
the	B-X
expressed	B-X
BDH	B-X
since	B-X
enzymatic	B-X
activity	B-X
is	B-X
lost	B-X
upon	B-X
digestion	B-X
with	B-X
phospholipase	B-X
A2	B-X
and	B-X
restored	B-X
selectively	B-X
by	B-X
reconstitution	B-X
with	B-X
PC	B-X
vesicles	B-X
.	B-X
The	B-X
K	B-X
(	B-X
m	B-X
)	B-X
s	B-X
for	B-X
NAD+	B-X
and	B-X
(	B-X
R	B-X
)	B-X
-3-hydroxybutyrate	B-X
(	B-X
R-HOB	B-X
)	B-X
of	B-X
expressed	B-X
BDH	B-X
are	B-X
similar	B-X
to	B-X
those	B-X
for	B-X
bovine	B-X
heart	B-X
or	B-X
rat	B-X
liver	B-X
BDH	B-X
in	B-X
mitochondria	B-X
.	B-X
Replacing	B-X
Cys242	B-X
(	B-X
the	B-X
only	B-X
cysteine	B-X
in	B-X
the	B-X
C-terminal	B-X
domain	B-X
)	B-X
with	B-X
serine	B-X
by	B-X
site-directed	B-X
mutagenesis	B-X
resulted	B-X
in	B-X
a	B-X
10-fold	B-X
increase	B-X
in	B-X
K	B-X
(	B-X
m	B-X
)	B-X
for	B-X
R-HOB	B-X
with	B-X
no	B-X
change	B-X
in	B-X
the	B-X
K	B-X
(	B-X
m	B-X
)	B-X
for	B-X
NAD+	B-X
,	B-X
indicating	B-X
a	B-X
role	B-X
for	B-X
Cys242	B-X
in	B-X
substrate	B-X
binding	B-X
.	B-X
Carboxypeptidase	B-X
cleavage	B-X
studies	B-X
had	B-X
indicated	B-X
a	B-X
requirement	B-X
of	B-X
the	B-X
C-terminal	B-X
for	B-X
catalysis	B-X
and	B-X
a	B-X
role	B-X
in	B-X
lipid	B-X
binding	B-X
[	B-X
Adami	B-X
,	B-X
P.	B-X
,	B-X
Duncan	B-X
,	B-X
T.	B-X
M.	B-X
,	B-X
McIntyre	B-X
,	B-X
J.	B-X
O.	B-X
,	B-X
Carter	B-X
,	B-X
C.	B-X
E.	B-X
,	B-X
Fu	B-X
,	B-X
C.	B-X
,	B-X
Melin	B-X
,	B-X
M.	B-X
,	B-X
Latruffe	B-X
,	B-X
N.	B-X
,	B-X
&	B-X
Fleischer	B-X
,	B-X
S.	B-X
(	B-X
1993	B-X
)	B-X
Biochem	B-X
J	B-X
.	B-X
We	B-X
now	B-X
show	B-X
that	B-X
deletion	B-X
of	B-X
twelve	B-X
C-terminal	B-X
amino	B-X
acids	B-X
to	B-X
form	B-X
a	B-X
truncated	B-X
BDH	B-X
mutant	B-X
results	B-X
in	B-X
loss	B-X
of	B-X
enzymic	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
in	B-X
Sf	B-X
9	B-X
cells	B-X
of	B-X
the	B-X
constitutively	B-X
active	B-X
full-length	B-X
mature	B-X
form	B-X
of	B-X
human	B-X
heart	B-X
BDH	B-X
and	B-X
the	B-X
first	B-X
expression	B-X
and	B-X
characterization	B-X
of	B-X
BDH	B-X
mutants	B-X
validate	B-X
this	B-X
system	B-X
for	B-X
structure-function	B-X
studies	B-X
of	B-X
BDH	B-X
.	B-X

The	O
enzyme	O
serves	O
as	O
a	O
paradigm	O
to	O
study	O
specific	O
lipid	O
-	O
protein	O
interactions	O
in	O
membranes	O
.	O
<EOS>	B-X
Phospholipases	B-X
C	B-X
(	B-X
PLCs	B-X
)	B-X
reversibly	B-X
associate	B-X
with	B-X
membranes	B-X
to	B-X
hydrolyze	B-X
phosphatidylinositol-4	B-X
,	B-X
5-bisphosphate	B-X
(	B-X
PI	B-X
[	B-X
4,5	B-X
]	B-X
P	B-X
(	B-X
2	B-X
)	B-X
)	B-X
and	B-X
comprise	B-X
four	B-X
main	B-X
classes	B-X
:	B-X
beta	B-X
,	B-X
gamma	B-X
,	B-X
delta	B-X
,	B-X
and	B-X
epsilon	B-X
.	B-X
The	B-X
structure	B-X
of	B-X
a	B-X
single	B-X
PLC	B-X
PH	B-X
domain	B-X
,	B-X
that	B-X
from	B-X
PLCdelta1	B-X
,	B-X
has	B-X
been	B-X
determined	B-X
;	B-X
this	B-X
PH	B-X
domain	B-X
binds	B-X
PI	B-X
(	B-X
4,5	B-X
)	B-X
P	B-X
(	B-X
2	B-X
)	B-X
with	B-X
high	B-X
affinity	B-X
and	B-X
stereospecificity	B-X
and	B-X
has	B-X
served	B-X
as	B-X
a	B-X
paradigm	B-X
for	B-X
PH	B-X
domain	B-X
functionality	B-X
.	B-X
To	B-X
elucidate	B-X
the	B-X
structural	B-X
basis	B-X
for	B-X
their	B-X
differential	B-X
membrane-binding	B-X
specificities	B-X
,	B-X
we	B-X
modeled	B-X
the	B-X
three-dimensional	B-X
structures	B-X
of	B-X
all	B-X
mammalian	B-X
PLC	B-X
PH	B-X
domains	B-X
by	B-X
using	B-X
bioinformatic	B-X
tools	B-X
and	B-X
calculated	B-X
their	B-X
biophysical	B-X
properties	B-X
by	B-X
using	B-X
continuum	B-X
electrostatic	B-X
approaches	B-X
.	B-X
Our	B-X
computational	B-X
analysis	B-X
accounts	B-X
for	B-X
a	B-X
large	B-X
body	B-X
of	B-X
experimental	B-X
data	B-X
,	B-X
provides	B-X
predictions	B-X
for	B-X
those	B-X
PH	B-X
domains	B-X
with	B-X
unknown	B-X
functions	B-X
,	B-X
and	B-X
indicates	B-X
functional	B-X
roles	B-X
for	B-X
regions	B-X
other	B-X
than	B-X
the	B-X
canonical	B-X
lipid-binding	B-X
site	B-X
identified	B-X
in	B-X
the	B-X
PLCdelta1-PH	B-X
structure	B-X
.	B-X
nonspecific	B-X
electrostatic	B-X
interactions	B-X
contribute	B-X
to	B-X
the	B-X
membrane	B-X
localization	B-X
of	B-X
PLCdelta-	B-X
,	B-X
PLCgamma-	B-X
,	B-X
and	B-X
PLCbeta-PH	B-X
domains	B-X
,	B-X
and	B-X
(	B-X
3	B-X
)	B-X
.	B-X

Analysis	O
of	O
the	O
primary	O
sequence	O
of	O
BDH	B-Gene_or_gene_product
,	O
as	O
determined	O
by	O
molecular	O
cloning	O
,	O
predicts	O
that	O
lipid	O
binding	O
and	O
substrate	O
specificity	O
are	O
contributed	O
by	O
the	O
C	O
-	O
terminal	O
third	O
of	O
the	O
protein	O
[	O
Marks	O
,	O
A	O
.	O
R	O
.	O
,	O
McIntyre	O
,	O
J	O
.	O
O	O
.	O
,	O
Duncan	O
,	O
T	O
.	O
M	O
.	O
,	O
Erdjument	O
-	O
Bromage	O
,	O
H	O
.	O
,	O
Tempst	O
,	O
P	O
.	O
,	O
&	O
Fleischer	O
,	O
S	O
.	O
(	O
1992	O
)	O
J	O
.	O
Biol	O
.	O
Chem	O
.	O
267	O
,	O
15459	O
-	O
15463	O
]	O
.	O

The	O
mature	O
form	O
of	O
human	O
heart	O
BDH	B-Gene_or_gene_product
has	O
now	O
been	O
expressed	O
in	O
catalytically	O
active	O
form	O
in	O
insect	O
cells	O
(	O
Sf9	O
,	O
Spodoptera	O
frugiperda	O
)	O
transfected	O
with	O
BDH	B-Gene_or_gene_product
-	O
cDNA	O
in	O
baculovirus	O
.	O
<EOS>	B-X
(	B-X
R	B-X
)	B-X
-3-Hydroxybutyrate	B-X
dehydrogenase	B-X
(	B-X
BDH	B-X
)	B-X
is	B-X
a	B-X
lipid-requiring	B-X
mitochondrial	B-X
enzyme	B-X
with	B-X
a	B-X
specific	B-X
requirement	B-X
of	B-X
phosphatidylcholine	B-X
(	B-X
PC	B-X
)	B-X
for	B-X
function	B-X
.	B-X
PC	B-X
is	B-X
an	B-X
allosteric	B-X
activator	B-X
that	B-X
enhances	B-X
NAD	B-X
(	B-X
H	B-X
)	B-X
binding	B-X
to	B-X
BDH	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
primary	B-X
sequence	B-X
of	B-X
BDH	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
molecular	B-X
cloning	B-X
,	B-X
predicts	B-X
that	B-X
lipid	B-X
binding	B-X
and	B-X
substrate	B-X
specificity	B-X
are	B-X
contributed	B-X
by	B-X
the	B-X
C-terminal	B-X
third	B-X
of	B-X
the	B-X
protein	B-X
[	B-X
Marks	B-X
,	B-X
A.	B-X
R.	B-X
,	B-X
McIntyre	B-X
,	B-X
J.	B-X
O.	B-X
,	B-X
Duncan	B-X
,	B-X
T.	B-X
M.	B-X
,	B-X
Erdjument-Bromage	B-X
,	B-X
H.	B-X
,	B-X
Tempst	B-X
,	B-X
P.	B-X
,	B-X
&	B-X
Fleischer	B-X
,	B-X
S.	B-X
(	B-X
1992	B-X
)	B-X
J.	B-X
Biol	B-X
.	B-X
The	B-X
mature	B-X
form	B-X
of	B-X
human	B-X
heart	B-X
BDH	B-X
has	B-X
now	B-X
been	B-X
expressed	B-X
in	B-X
catalytically	B-X
active	B-X
form	B-X
in	B-X
insect	B-X
cells	B-X
(	B-X
Sf9	B-X
,	B-X
Spodoptera	B-X
frugiperda	B-X
)	B-X
transfected	B-X
with	B-X
BDH-cDNA	B-X
in	B-X
baculovirus	B-X
.	B-X
Endogenous	B-X
PC	B-X
in	B-X
the	B-X
insect	B-X
cells	B-X
fulfills	B-X
the	B-X
lipid	B-X
requirement	B-X
for	B-X
the	B-X
expressed	B-X
BDH	B-X
since	B-X
enzymatic	B-X
activity	B-X
is	B-X
lost	B-X
upon	B-X
digestion	B-X
with	B-X
phospholipase	B-X
A2	B-X
and	B-X
restored	B-X
selectively	B-X
by	B-X
reconstitution	B-X
with	B-X
PC	B-X
vesicles	B-X
.	B-X
The	B-X
K	B-X
(	B-X
m	B-X
)	B-X
s	B-X
for	B-X
NAD+	B-X
and	B-X
(	B-X
R	B-X
)	B-X
-3-hydroxybutyrate	B-X
(	B-X
R-HOB	B-X
)	B-X
of	B-X
expressed	B-X
BDH	B-X
are	B-X
similar	B-X
to	B-X
those	B-X
for	B-X
bovine	B-X
heart	B-X
or	B-X
rat	B-X
liver	B-X
BDH	B-X
in	B-X
mitochondria	B-X
.	B-X
We	B-X
now	B-X
show	B-X
that	B-X
deletion	B-X
of	B-X
twelve	B-X
C-terminal	B-X
amino	B-X
acids	B-X
to	B-X
form	B-X
a	B-X
truncated	B-X
BDH	B-X
mutant	B-X
results	B-X
in	B-X
loss	B-X
of	B-X
enzymic	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
in	B-X
Sf	B-X
9	B-X
cells	B-X
of	B-X
the	B-X
constitutively	B-X
active	B-X
full-length	B-X
mature	B-X
form	B-X
of	B-X
human	B-X
heart	B-X
BDH	B-X
and	B-X
the	B-X
first	B-X
expression	B-X
and	B-X
characterization	B-X
of	B-X
BDH	B-X
mutants	B-X
validate	B-X
this	B-X
system	B-X
for	B-X
structure-function	B-X
studies	B-X
of	B-X
BDH	B-X
.	B-X

Endogenous	O
PC	O
in	O
the	O
insect	O
cells	O
fulfills	O
the	O
lipid	O
requirement	O
for	O
the	O
expressed	O
BDH	B-Gene_or_gene_product
since	O
enzymatic	O
activity	O
is	O
lost	O
upon	O
digestion	O
with	O
phospholipase	B-Gene_or_gene_product
A2	I-Gene_or_gene_product
and	O
restored	O
selectively	O
by	O
reconstitution	O
with	O
PC	O
vesicles	O
.	O
<EOS>	B-X
(	B-X
R	B-X
)	B-X
-3-Hydroxybutyrate	B-X
dehydrogenase	B-X
(	B-X
BDH	B-X
)	B-X
is	B-X
a	B-X
lipid-requiring	B-X
mitochondrial	B-X
enzyme	B-X
with	B-X
a	B-X
specific	B-X
requirement	B-X
of	B-X
phosphatidylcholine	B-X
(	B-X
PC	B-X
)	B-X
for	B-X
function	B-X
.	B-X
PC	B-X
is	B-X
an	B-X
allosteric	B-X
activator	B-X
that	B-X
enhances	B-X
NAD	B-X
(	B-X
H	B-X
)	B-X
binding	B-X
to	B-X
BDH	B-X
.	B-X
The	B-X
enzyme	B-X
serves	B-X
as	B-X
a	B-X
paradigm	B-X
to	B-X
study	B-X
specific	B-X
lipid-protein	B-X
interactions	B-X
in	B-X
membranes	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
primary	B-X
sequence	B-X
of	B-X
BDH	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
molecular	B-X
cloning	B-X
,	B-X
predicts	B-X
that	B-X
lipid	B-X
binding	B-X
and	B-X
substrate	B-X
specificity	B-X
are	B-X
contributed	B-X
by	B-X
the	B-X
C-terminal	B-X
third	B-X
of	B-X
the	B-X
protein	B-X
[	B-X
Marks	B-X
,	B-X
A.	B-X
R.	B-X
,	B-X
McIntyre	B-X
,	B-X
J.	B-X
O.	B-X
,	B-X
Duncan	B-X
,	B-X
T.	B-X
M.	B-X
,	B-X
Erdjument-Bromage	B-X
,	B-X
H.	B-X
,	B-X
Tempst	B-X
,	B-X
P.	B-X
,	B-X
&	B-X
Fleischer	B-X
,	B-X
S.	B-X
(	B-X
1992	B-X
)	B-X
J.	B-X
Biol	B-X
.	B-X
The	B-X
mature	B-X
form	B-X
of	B-X
human	B-X
heart	B-X
BDH	B-X
has	B-X
now	B-X
been	B-X
expressed	B-X
in	B-X
catalytically	B-X
active	B-X
form	B-X
in	B-X
insect	B-X
cells	B-X
(	B-X
Sf9	B-X
,	B-X
Spodoptera	B-X
frugiperda	B-X
)	B-X
transfected	B-X
with	B-X
BDH-cDNA	B-X
in	B-X
baculovirus	B-X
.	B-X
Endogenous	B-X
PC	B-X
in	B-X
the	B-X
insect	B-X
cells	B-X
fulfills	B-X
the	B-X
lipid	B-X
requirement	B-X
for	B-X
the	B-X
expressed	B-X
BDH	B-X
since	B-X
enzymatic	B-X
activity	B-X
is	B-X
lost	B-X
upon	B-X
digestion	B-X
with	B-X
phospholipase	B-X
A2	B-X
and	B-X
restored	B-X
selectively	B-X
by	B-X
reconstitution	B-X
with	B-X
PC	B-X
vesicles	B-X
.	B-X
The	B-X
K	B-X
(	B-X
m	B-X
)	B-X
s	B-X
for	B-X
NAD+	B-X
and	B-X
(	B-X
R	B-X
)	B-X
-3-hydroxybutyrate	B-X
(	B-X
R-HOB	B-X
)	B-X
of	B-X
expressed	B-X
BDH	B-X
are	B-X
similar	B-X
to	B-X
those	B-X
for	B-X
bovine	B-X
heart	B-X
or	B-X
rat	B-X
liver	B-X
BDH	B-X
in	B-X
mitochondria	B-X
.	B-X
Carboxypeptidase	B-X
cleavage	B-X
studies	B-X
had	B-X
indicated	B-X
a	B-X
requirement	B-X
of	B-X
the	B-X
C-terminal	B-X
for	B-X
catalysis	B-X
and	B-X
a	B-X
role	B-X
in	B-X
lipid	B-X
binding	B-X
[	B-X
Adami	B-X
,	B-X
P.	B-X
,	B-X
Duncan	B-X
,	B-X
T.	B-X
M.	B-X
,	B-X
McIntyre	B-X
,	B-X
J.	B-X
O.	B-X
,	B-X
Carter	B-X
,	B-X
C.	B-X
E.	B-X
,	B-X
Fu	B-X
,	B-X
C.	B-X
,	B-X
Melin	B-X
,	B-X
M.	B-X
,	B-X
Latruffe	B-X
,	B-X
N.	B-X
,	B-X
&	B-X
Fleischer	B-X
,	B-X
S.	B-X
(	B-X
1993	B-X
)	B-X
Biochem	B-X
J	B-X
.	B-X
We	B-X
now	B-X
show	B-X
that	B-X
deletion	B-X
of	B-X
twelve	B-X
C-terminal	B-X
amino	B-X
acids	B-X
to	B-X
form	B-X
a	B-X
truncated	B-X
BDH	B-X
mutant	B-X
results	B-X
in	B-X
loss	B-X
of	B-X
enzymic	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
in	B-X
Sf	B-X
9	B-X
cells	B-X
of	B-X
the	B-X
constitutively	B-X
active	B-X
full-length	B-X
mature	B-X
form	B-X
of	B-X
human	B-X
heart	B-X
BDH	B-X
and	B-X
the	B-X
first	B-X
expression	B-X
and	B-X
characterization	B-X
of	B-X
BDH	B-X
mutants	B-X
validate	B-X
this	B-X
system	B-X
for	B-X
structure-function	B-X
studies	B-X
of	B-X
BDH	B-X
.	B-X

The	O
K	O
(	O
m	O
)	O
s	O
for	O
NAD	O
+	O
and	O
(	O
R	O
)	O
-	O
3	O
-	O
hydroxybutyrate	O
(	O
R	O
-	O
HOB	O
)	O
of	O
expressed	O
BDH	B-Gene_or_gene_product
are	O
similar	O
to	O
those	O
for	O
bovine	O
heart	O
or	O
rat	O
liver	O
BDH	B-Gene_or_gene_product
in	O
mitochondria	O
.	O
<EOS>	B-X
(	B-X
R	B-X
)	B-X
-3-Hydroxybutyrate	B-X
dehydrogenase	B-X
(	B-X
BDH	B-X
)	B-X
is	B-X
a	B-X
lipid-requiring	B-X
mitochondrial	B-X
enzyme	B-X
with	B-X
a	B-X
specific	B-X
requirement	B-X
of	B-X
phosphatidylcholine	B-X
(	B-X
PC	B-X
)	B-X
for	B-X
function	B-X
.	B-X
PC	B-X
is	B-X
an	B-X
allosteric	B-X
activator	B-X
that	B-X
enhances	B-X
NAD	B-X
(	B-X
H	B-X
)	B-X
binding	B-X
to	B-X
BDH	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
primary	B-X
sequence	B-X
of	B-X
BDH	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
molecular	B-X
cloning	B-X
,	B-X
predicts	B-X
that	B-X
lipid	B-X
binding	B-X
and	B-X
substrate	B-X
specificity	B-X
are	B-X
contributed	B-X
by	B-X
the	B-X
C-terminal	B-X
third	B-X
of	B-X
the	B-X
protein	B-X
[	B-X
Marks	B-X
,	B-X
A.	B-X
R.	B-X
,	B-X
McIntyre	B-X
,	B-X
J.	B-X
O.	B-X
,	B-X
Duncan	B-X
,	B-X
T.	B-X
M.	B-X
,	B-X
Erdjument-Bromage	B-X
,	B-X
H.	B-X
,	B-X
Tempst	B-X
,	B-X
P.	B-X
,	B-X
&	B-X
Fleischer	B-X
,	B-X
S.	B-X
(	B-X
1992	B-X
)	B-X
J.	B-X
Biol	B-X
.	B-X
267	B-X
,	B-X
15459-15463	B-X
]	B-X
.	B-X
The	B-X
mature	B-X
form	B-X
of	B-X
human	B-X
heart	B-X
BDH	B-X
has	B-X
now	B-X
been	B-X
expressed	B-X
in	B-X
catalytically	B-X
active	B-X
form	B-X
in	B-X
insect	B-X
cells	B-X
(	B-X
Sf9	B-X
,	B-X
Spodoptera	B-X
frugiperda	B-X
)	B-X
transfected	B-X
with	B-X
BDH-cDNA	B-X
in	B-X
baculovirus	B-X
.	B-X
Endogenous	B-X
PC	B-X
in	B-X
the	B-X
insect	B-X
cells	B-X
fulfills	B-X
the	B-X
lipid	B-X
requirement	B-X
for	B-X
the	B-X
expressed	B-X
BDH	B-X
since	B-X
enzymatic	B-X
activity	B-X
is	B-X
lost	B-X
upon	B-X
digestion	B-X
with	B-X
phospholipase	B-X
A2	B-X
and	B-X
restored	B-X
selectively	B-X
by	B-X
reconstitution	B-X
with	B-X
PC	B-X
vesicles	B-X
.	B-X
The	B-X
K	B-X
(	B-X
m	B-X
)	B-X
s	B-X
for	B-X
NAD+	B-X
and	B-X
(	B-X
R	B-X
)	B-X
-3-hydroxybutyrate	B-X
(	B-X
R-HOB	B-X
)	B-X
of	B-X
expressed	B-X
BDH	B-X
are	B-X
similar	B-X
to	B-X
those	B-X
for	B-X
bovine	B-X
heart	B-X
or	B-X
rat	B-X
liver	B-X
BDH	B-X
in	B-X
mitochondria	B-X
.	B-X
Replacing	B-X
Cys242	B-X
(	B-X
the	B-X
only	B-X
cysteine	B-X
in	B-X
the	B-X
C-terminal	B-X
domain	B-X
)	B-X
with	B-X
serine	B-X
by	B-X
site-directed	B-X
mutagenesis	B-X
resulted	B-X
in	B-X
a	B-X
10-fold	B-X
increase	B-X
in	B-X
K	B-X
(	B-X
m	B-X
)	B-X
for	B-X
R-HOB	B-X
with	B-X
no	B-X
change	B-X
in	B-X
the	B-X
K	B-X
(	B-X
m	B-X
)	B-X
for	B-X
NAD+	B-X
,	B-X
indicating	B-X
a	B-X
role	B-X
for	B-X
Cys242	B-X
in	B-X
substrate	B-X
binding	B-X
.	B-X
Carboxypeptidase	B-X
cleavage	B-X
studies	B-X
had	B-X
indicated	B-X
a	B-X
requirement	B-X
of	B-X
the	B-X
C-terminal	B-X
for	B-X
catalysis	B-X
and	B-X
a	B-X
role	B-X
in	B-X
lipid	B-X
binding	B-X
[	B-X
Adami	B-X
,	B-X
P.	B-X
,	B-X
Duncan	B-X
,	B-X
T.	B-X
M.	B-X
,	B-X
McIntyre	B-X
,	B-X
J.	B-X
O.	B-X
,	B-X
Carter	B-X
,	B-X
C.	B-X
E.	B-X
,	B-X
Fu	B-X
,	B-X
C.	B-X
,	B-X
Melin	B-X
,	B-X
M.	B-X
,	B-X
Latruffe	B-X
,	B-X
N.	B-X
,	B-X
&	B-X
Fleischer	B-X
,	B-X
S.	B-X
(	B-X
1993	B-X
)	B-X
Biochem	B-X
J	B-X
.	B-X
292	B-X
,	B-X
863-872	B-X
]	B-X
.	B-X
We	B-X
now	B-X
show	B-X
that	B-X
deletion	B-X
of	B-X
twelve	B-X
C-terminal	B-X
amino	B-X
acids	B-X
to	B-X
form	B-X
a	B-X
truncated	B-X
BDH	B-X
mutant	B-X
results	B-X
in	B-X
loss	B-X
of	B-X
enzymic	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
in	B-X
Sf	B-X
9	B-X
cells	B-X
of	B-X
the	B-X
constitutively	B-X
active	B-X
full-length	B-X
mature	B-X
form	B-X
of	B-X
human	B-X
heart	B-X
BDH	B-X
and	B-X
the	B-X
first	B-X
expression	B-X
and	B-X
characterization	B-X
of	B-X
BDH	B-X
mutants	B-X
validate	B-X
this	B-X
system	B-X
for	B-X
structure-function	B-X
studies	B-X
of	B-X
BDH	B-X
.	B-X

Replacing	O
Cys242	O
(	O
the	O
only	O
cysteine	O
in	O
the	O
C	O
-	O
terminal	O
domain	O
)	O
with	O
serine	O
by	O
site	O
-	O
directed	O
mutagenesis	O
resulted	O
in	O
a	O
10	O
-	O
fold	O
increase	O
in	O
K	O
(	O
m	O
)	O
for	O
R	O
-	O
HOB	O
with	O
no	O
change	O
in	O
the	O
K	O
(	O
m	O
)	O
for	O
NAD	O
+	O
,	O
indicating	O
a	O
role	O
for	O
Cys242	O
in	O
substrate	O
binding	O
.	O

Carboxypeptidase	B-Gene_or_gene_product
cleavage	O
studies	O
had	O
indicated	O
a	O
requirement	O
of	O
the	O
C	O
-	O
terminal	O
for	O
catalysis	O
and	O
a	O
role	O
in	O
lipid	O
binding	O
[	O
Adami	O
,	O
P	O
.	O
,	O
Duncan	O
,	O
T	O
.	O
M	O
.	O
,	O
McIntyre	O
,	O
J	O
.	O
O	O
.	O
,	O
Carter	O
,	O
C	O
.	O
E	O
.	O
,	O
Fu	O
,	O
C	O
.	O
,	O
Melin	O
,	O
M	O
.	O
,	O
Latruffe	O
,	O
N	O
.	O
,	O
&	O
Fleischer	O
,	O
S	O
.	O
(	O
1993	O
)	O
Biochem	O
J	O
.	O
292	O
,	O
863	O
-	O
872	O
]	O
.	O

We	O
now	O
show	O
that	O
deletion	O
of	O
twelve	O
C	O
-	O
terminal	O
amino	O
acids	O
to	O
form	O
a	O
truncated	O
BDH	B-Gene_or_gene_product
mutant	O
results	O
in	O
loss	O
of	O
enzymic	O
function	O
.	O

The	O
expression	O
in	O
Sf	O
9	O
cells	O
of	O
the	O
constitutively	O
active	O
full	O
-	O
length	O
mature	O
form	O
of	O
human	O
heart	O
BDH	B-Gene_or_gene_product
and	O
the	O
first	O
expression	O
and	O
characterization	O
of	O
BDH	B-Gene_or_gene_product
mutants	O
validate	O
this	O
system	O
for	O
structure	O
-	O
function	O
studies	O
of	O
BDH	B-Gene_or_gene_product
.	O
<EOS>	B-X
(	B-X
R	B-X
)	B-X
-3-Hydroxybutyrate	B-X
dehydrogenase	B-X
(	B-X
BDH	B-X
)	B-X
is	B-X
a	B-X
lipid-requiring	B-X
mitochondrial	B-X
enzyme	B-X
with	B-X
a	B-X
specific	B-X
requirement	B-X
of	B-X
phosphatidylcholine	B-X
(	B-X
PC	B-X
)	B-X
for	B-X
function	B-X
.	B-X
PC	B-X
is	B-X
an	B-X
allosteric	B-X
activator	B-X
that	B-X
enhances	B-X
NAD	B-X
(	B-X
H	B-X
)	B-X
binding	B-X
to	B-X
BDH	B-X
.	B-X
Analysis	B-X
of	B-X
the	B-X
primary	B-X
sequence	B-X
of	B-X
BDH	B-X
,	B-X
as	B-X
determined	B-X
by	B-X
molecular	B-X
cloning	B-X
,	B-X
predicts	B-X
that	B-X
lipid	B-X
binding	B-X
and	B-X
substrate	B-X
specificity	B-X
are	B-X
contributed	B-X
by	B-X
the	B-X
C-terminal	B-X
third	B-X
of	B-X
the	B-X
protein	B-X
[	B-X
Marks	B-X
,	B-X
A.	B-X
R.	B-X
,	B-X
McIntyre	B-X
,	B-X
J.	B-X
O.	B-X
,	B-X
Duncan	B-X
,	B-X
T.	B-X
M.	B-X
,	B-X
Erdjument-Bromage	B-X
,	B-X
H.	B-X
,	B-X
Tempst	B-X
,	B-X
P.	B-X
,	B-X
&	B-X
Fleischer	B-X
,	B-X
S.	B-X
(	B-X
1992	B-X
)	B-X
J.	B-X
Biol	B-X
.	B-X
267	B-X
,	B-X
15459-15463	B-X
]	B-X
.	B-X
The	B-X
mature	B-X
form	B-X
of	B-X
human	B-X
heart	B-X
BDH	B-X
has	B-X
now	B-X
been	B-X
expressed	B-X
in	B-X
catalytically	B-X
active	B-X
form	B-X
in	B-X
insect	B-X
cells	B-X
(	B-X
Sf9	B-X
,	B-X
Spodoptera	B-X
frugiperda	B-X
)	B-X
transfected	B-X
with	B-X
BDH-cDNA	B-X
in	B-X
baculovirus	B-X
.	B-X
Endogenous	B-X
PC	B-X
in	B-X
the	B-X
insect	B-X
cells	B-X
fulfills	B-X
the	B-X
lipid	B-X
requirement	B-X
for	B-X
the	B-X
expressed	B-X
BDH	B-X
since	B-X
enzymatic	B-X
activity	B-X
is	B-X
lost	B-X
upon	B-X
digestion	B-X
with	B-X
phospholipase	B-X
A2	B-X
and	B-X
restored	B-X
selectively	B-X
by	B-X
reconstitution	B-X
with	B-X
PC	B-X
vesicles	B-X
.	B-X
The	B-X
K	B-X
(	B-X
m	B-X
)	B-X
s	B-X
for	B-X
NAD+	B-X
and	B-X
(	B-X
R	B-X
)	B-X
-3-hydroxybutyrate	B-X
(	B-X
R-HOB	B-X
)	B-X
of	B-X
expressed	B-X
BDH	B-X
are	B-X
similar	B-X
to	B-X
those	B-X
for	B-X
bovine	B-X
heart	B-X
or	B-X
rat	B-X
liver	B-X
BDH	B-X
in	B-X
mitochondria	B-X
.	B-X
Carboxypeptidase	B-X
cleavage	B-X
studies	B-X
had	B-X
indicated	B-X
a	B-X
requirement	B-X
of	B-X
the	B-X
C-terminal	B-X
for	B-X
catalysis	B-X
and	B-X
a	B-X
role	B-X
in	B-X
lipid	B-X
binding	B-X
[	B-X
Adami	B-X
,	B-X
P.	B-X
,	B-X
Duncan	B-X
,	B-X
T.	B-X
M.	B-X
,	B-X
McIntyre	B-X
,	B-X
J.	B-X
O.	B-X
,	B-X
Carter	B-X
,	B-X
C.	B-X
E.	B-X
,	B-X
Fu	B-X
,	B-X
C.	B-X
,	B-X
Melin	B-X
,	B-X
M.	B-X
,	B-X
Latruffe	B-X
,	B-X
N.	B-X
,	B-X
&	B-X
Fleischer	B-X
,	B-X
S.	B-X
(	B-X
1993	B-X
)	B-X
Biochem	B-X
J	B-X
.	B-X
292	B-X
,	B-X
863-872	B-X
]	B-X
.	B-X
We	B-X
now	B-X
show	B-X
that	B-X
deletion	B-X
of	B-X
twelve	B-X
C-terminal	B-X
amino	B-X
acids	B-X
to	B-X
form	B-X
a	B-X
truncated	B-X
BDH	B-X
mutant	B-X
results	B-X
in	B-X
loss	B-X
of	B-X
enzymic	B-X
function	B-X
.	B-X
The	B-X
expression	B-X
in	B-X
Sf	B-X
9	B-X
cells	B-X
of	B-X
the	B-X
constitutively	B-X
active	B-X
full-length	B-X
mature	B-X
form	B-X
of	B-X
human	B-X
heart	B-X
BDH	B-X
and	B-X
the	B-X
first	B-X
expression	B-X
and	B-X
characterization	B-X
of	B-X
BDH	B-X
mutants	B-X
validate	B-X
this	B-X
system	B-X
for	B-X
structure-function	B-X
studies	B-X
of	B-X
BDH	B-X
.	B-X

Nuclear	O
localization	O
of	O
DP	B-Gene_or_gene_product
and	O
E2F	B-Gene_or_gene_product
transcription	O
factors	O
by	O
heterodimeric	O
partners	O
and	O
retinoblastoma	B-Gene_or_gene_product
protein	O
family	O
members	O
.	O
<EOS>	B-X
E2F	B-X
is	B-X
a	B-X
family	B-X
of	B-X
transcription	B-X
factors	B-X
implicated	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
genes	B-X
required	B-X
for	B-X
progression	B-X
through	B-X
G1	B-X
and	B-X
entry	B-X
into	B-X
the	B-X
S	B-X
phase	B-X
.	B-X
The	B-X
transcriptionally	B-X
active	B-X
forms	B-X
of	B-X
E2F	B-X
are	B-X
heterodimers	B-X
composed	B-X
of	B-X
one	B-X
polypeptide	B-X
encoded	B-X
by	B-X
the	B-X
E2F	B-X
gene	B-X
family	B-X
and	B-X
one	B-X
polypeptide	B-X
encoded	B-X
by	B-X
the	B-X
DP	B-X
gene	B-X
family	B-X
.	B-X
The	B-X
transcriptional	B-X
activity	B-X
of	B-X
E2F/DP	B-X
heterodimers	B-X
is	B-X
influenced	B-X
by	B-X
association	B-X
with	B-X
the	B-X
members	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
protein	B-X
family	B-X
(	B-X
pRb	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
)	B-X
.	B-X
Here	B-X
the	B-X
intracellular	B-X
distribution	B-X
of	B-X
E2F	B-X
and	B-X
DP	B-X
proteins	B-X
was	B-X
investigated	B-X
in	B-X
transiently	B-X
transfected	B-X
Chinese	B-X
hamster	B-X
and	B-X
human	B-X
cells	B-X
.	B-X
In	B-X
transfected	B-X
cells	B-X
,	B-X
DP-1	B-X
did	B-X
not	B-X
accumulate	B-X
in	B-X
the	B-X
nucleus	B-X
unless	B-X
it	B-X
was	B-X
coexpressed	B-X
with	B-X
the	B-X
heterodimeric	B-X
partners	B-X
E2F-1	B-X
,	B-X
E2F-2	B-X
,	B-X
or	B-X
E2F-3	B-X
.	B-X
Domain	B-X
mapping	B-X
experiments	B-X
showed	B-X
that	B-X
regions	B-X
of	B-X
E2F-1	B-X
and	B-X
DP-1	B-X
that	B-X
are	B-X
required	B-X
for	B-X
stable	B-X
association	B-X
of	B-X
the	B-X
two	B-X
proteins	B-X
were	B-X
also	B-X
required	B-X
for	B-X
nuclear	B-X
localization	B-X
of	B-X
DP-1	B-X
.	B-X
Unlike	B-X
E2F-1	B-X
,	B-X
-2	B-X
,	B-X
and	B-X
-3	B-X
,	B-X
E2F-4	B-X
did	B-X
not	B-X
accumulate	B-X
in	B-X
the	B-X
nucleus	B-X
unless	B-X
it	B-X
was	B-X
coexpressed	B-X
with	B-X
DP-2	B-X
,	B-X
p107	B-X
and	B-X
p130	B-X
,	B-X
but	B-X
not	B-X
pRb	B-X
,	B-X
stimulated	B-X
nuclear	B-X
localization	B-X
of	B-X
E2F-4	B-X
,	B-X
either	B-X
alone	B-X
or	B-X
in	B-X
combination	B-X
with	B-X
DP-2	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
DP	B-X
proteins	B-X
preferentially	B-X
associate	B-X
with	B-X
specific	B-X
E2F	B-X
partners	B-X
,	B-X
and	B-X
suggest	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
specific	B-X
E2F/DP	B-X
heterodimers	B-X
to	B-X
localize	B-X
in	B-X
the	B-X
nucleus	B-X
contributes	B-X
to	B-X
the	B-X
regulation	B-X
of	B-X
E2F	B-X
activity	B-X
.	B-X

E2F	B-Gene_or_gene_product
is	O
a	O
family	O
of	O
transcription	O
factors	O
implicated	O
in	O
the	O
regulation	O
of	O
genes	O
required	O
for	O
progression	O
through	O
G1	O
and	O
entry	O
into	O
the	O
S	O
phase	O
.	O

The	O
transcriptionally	O
active	O
forms	O
of	O
E2F	B-Gene_or_gene_product
are	O
heterodimers	O
composed	O
of	O
one	O
polypeptide	O
encoded	O
by	O
the	O
E2F	B-Gene_or_gene_product
gene	O
family	O
and	O
one	O
polypeptide	O
encoded	O
by	O
the	O
DP	B-Gene_or_gene_product
gene	O
family	O
.	O
<EOS>	B-X
E2F	B-X
is	B-X
a	B-X
family	B-X
of	B-X
transcription	B-X
factors	B-X
implicated	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
genes	B-X
required	B-X
for	B-X
progression	B-X
through	B-X
G1	B-X
and	B-X
entry	B-X
into	B-X
the	B-X
S	B-X
phase	B-X
.	B-X
The	B-X
transcriptionally	B-X
active	B-X
forms	B-X
of	B-X
E2F	B-X
are	B-X
heterodimers	B-X
composed	B-X
of	B-X
one	B-X
polypeptide	B-X
encoded	B-X
by	B-X
the	B-X
E2F	B-X
gene	B-X
family	B-X
and	B-X
one	B-X
polypeptide	B-X
encoded	B-X
by	B-X
the	B-X
DP	B-X
gene	B-X
family	B-X
.	B-X
The	B-X
transcriptional	B-X
activity	B-X
of	B-X
E2F/DP	B-X
heterodimers	B-X
is	B-X
influenced	B-X
by	B-X
association	B-X
with	B-X
the	B-X
members	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
protein	B-X
family	B-X
(	B-X
pRb	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
)	B-X
.	B-X
Here	B-X
the	B-X
intracellular	B-X
distribution	B-X
of	B-X
E2F	B-X
and	B-X
DP	B-X
proteins	B-X
was	B-X
investigated	B-X
in	B-X
transiently	B-X
transfected	B-X
Chinese	B-X
hamster	B-X
and	B-X
human	B-X
cells	B-X
.	B-X
In	B-X
transfected	B-X
cells	B-X
,	B-X
DP-1	B-X
did	B-X
not	B-X
accumulate	B-X
in	B-X
the	B-X
nucleus	B-X
unless	B-X
it	B-X
was	B-X
coexpressed	B-X
with	B-X
the	B-X
heterodimeric	B-X
partners	B-X
E2F-1	B-X
,	B-X
E2F-2	B-X
,	B-X
or	B-X
E2F-3	B-X
.	B-X
Domain	B-X
mapping	B-X
experiments	B-X
showed	B-X
that	B-X
regions	B-X
of	B-X
E2F-1	B-X
and	B-X
DP-1	B-X
that	B-X
are	B-X
required	B-X
for	B-X
stable	B-X
association	B-X
of	B-X
the	B-X
two	B-X
proteins	B-X
were	B-X
also	B-X
required	B-X
for	B-X
nuclear	B-X
localization	B-X
of	B-X
DP-1	B-X
.	B-X
Unlike	B-X
E2F-1	B-X
,	B-X
-2	B-X
,	B-X
and	B-X
-3	B-X
,	B-X
E2F-4	B-X
did	B-X
not	B-X
accumulate	B-X
in	B-X
the	B-X
nucleus	B-X
unless	B-X
it	B-X
was	B-X
coexpressed	B-X
with	B-X
DP-2	B-X
,	B-X
p107	B-X
and	B-X
p130	B-X
,	B-X
but	B-X
not	B-X
pRb	B-X
,	B-X
stimulated	B-X
nuclear	B-X
localization	B-X
of	B-X
E2F-4	B-X
,	B-X
either	B-X
alone	B-X
or	B-X
in	B-X
combination	B-X
with	B-X
DP-2	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
DP	B-X
proteins	B-X
preferentially	B-X
associate	B-X
with	B-X
specific	B-X
E2F	B-X
partners	B-X
,	B-X
and	B-X
suggest	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
specific	B-X
E2F/DP	B-X
heterodimers	B-X
to	B-X
localize	B-X
in	B-X
the	B-X
nucleus	B-X
contributes	B-X
to	B-X
the	B-X
regulation	B-X
of	B-X
E2F	B-X
activity	B-X
.	B-X

The	O
transcriptional	O
activity	O
of	O
E2F	O
/	O
DP	O
heterodimers	O
is	O
influenced	O
by	O
association	O
with	O
the	O
members	O
of	O
the	O
retinoblastoma	B-Gene_or_gene_product
tumor	O
suppressor	O
protein	O
family	O
(	O
pRb	B-Gene_or_gene_product
,	O
p107	B-Gene_or_gene_product
,	O
and	O
p130	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
E2F	B-X
is	B-X
a	B-X
family	B-X
of	B-X
transcription	B-X
factors	B-X
implicated	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
genes	B-X
required	B-X
for	B-X
progression	B-X
through	B-X
G1	B-X
and	B-X
entry	B-X
into	B-X
the	B-X
S	B-X
phase	B-X
.	B-X
The	B-X
transcriptionally	B-X
active	B-X
forms	B-X
of	B-X
E2F	B-X
are	B-X
heterodimers	B-X
composed	B-X
of	B-X
one	B-X
polypeptide	B-X
encoded	B-X
by	B-X
the	B-X
E2F	B-X
gene	B-X
family	B-X
and	B-X
one	B-X
polypeptide	B-X
encoded	B-X
by	B-X
the	B-X
DP	B-X
gene	B-X
family	B-X
.	B-X
The	B-X
transcriptional	B-X
activity	B-X
of	B-X
E2F/DP	B-X
heterodimers	B-X
is	B-X
influenced	B-X
by	B-X
association	B-X
with	B-X
the	B-X
members	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
protein	B-X
family	B-X
(	B-X
pRb	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
)	B-X
.	B-X
Here	B-X
the	B-X
intracellular	B-X
distribution	B-X
of	B-X
E2F	B-X
and	B-X
DP	B-X
proteins	B-X
was	B-X
investigated	B-X
in	B-X
transiently	B-X
transfected	B-X
Chinese	B-X
hamster	B-X
and	B-X
human	B-X
cells	B-X
.	B-X
In	B-X
transfected	B-X
cells	B-X
,	B-X
DP-1	B-X
did	B-X
not	B-X
accumulate	B-X
in	B-X
the	B-X
nucleus	B-X
unless	B-X
it	B-X
was	B-X
coexpressed	B-X
with	B-X
the	B-X
heterodimeric	B-X
partners	B-X
E2F-1	B-X
,	B-X
E2F-2	B-X
,	B-X
or	B-X
E2F-3	B-X
.	B-X
Domain	B-X
mapping	B-X
experiments	B-X
showed	B-X
that	B-X
regions	B-X
of	B-X
E2F-1	B-X
and	B-X
DP-1	B-X
that	B-X
are	B-X
required	B-X
for	B-X
stable	B-X
association	B-X
of	B-X
the	B-X
two	B-X
proteins	B-X
were	B-X
also	B-X
required	B-X
for	B-X
nuclear	B-X
localization	B-X
of	B-X
DP-1	B-X
.	B-X
Unlike	B-X
E2F-1	B-X
,	B-X
-2	B-X
,	B-X
and	B-X
-3	B-X
,	B-X
E2F-4	B-X
did	B-X
not	B-X
accumulate	B-X
in	B-X
the	B-X
nucleus	B-X
unless	B-X
it	B-X
was	B-X
coexpressed	B-X
with	B-X
DP-2	B-X
,	B-X
p107	B-X
and	B-X
p130	B-X
,	B-X
but	B-X
not	B-X
pRb	B-X
,	B-X
stimulated	B-X
nuclear	B-X
localization	B-X
of	B-X
E2F-4	B-X
,	B-X
either	B-X
alone	B-X
or	B-X
in	B-X
combination	B-X
with	B-X
DP-2	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
DP	B-X
proteins	B-X
preferentially	B-X
associate	B-X
with	B-X
specific	B-X
E2F	B-X
partners	B-X
,	B-X
and	B-X
suggest	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
specific	B-X
E2F/DP	B-X
heterodimers	B-X
to	B-X
localize	B-X
in	B-X
the	B-X
nucleus	B-X
contributes	B-X
to	B-X
the	B-X
regulation	B-X
of	B-X
E2F	B-X
activity	B-X
.	B-X

Here	O
the	O
intracellular	O
distribution	O
of	O
E2F	B-Gene_or_gene_product
and	O
DP	B-Gene_or_gene_product
proteins	O
was	O
investigated	O
in	O
transiently	O
transfected	O
Chinese	O
hamster	O
and	O
human	O
cells	O
.	O
<EOS>	B-X
E2F	B-X
is	B-X
a	B-X
family	B-X
of	B-X
transcription	B-X
factors	B-X
implicated	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
genes	B-X
required	B-X
for	B-X
progression	B-X
through	B-X
G1	B-X
and	B-X
entry	B-X
into	B-X
the	B-X
S	B-X
phase	B-X
.	B-X
The	B-X
transcriptionally	B-X
active	B-X
forms	B-X
of	B-X
E2F	B-X
are	B-X
heterodimers	B-X
composed	B-X
of	B-X
one	B-X
polypeptide	B-X
encoded	B-X
by	B-X
the	B-X
E2F	B-X
gene	B-X
family	B-X
and	B-X
one	B-X
polypeptide	B-X
encoded	B-X
by	B-X
the	B-X
DP	B-X
gene	B-X
family	B-X
.	B-X
The	B-X
transcriptional	B-X
activity	B-X
of	B-X
E2F/DP	B-X
heterodimers	B-X
is	B-X
influenced	B-X
by	B-X
association	B-X
with	B-X
the	B-X
members	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
protein	B-X
family	B-X
(	B-X
pRb	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
)	B-X
.	B-X
Here	B-X
the	B-X
intracellular	B-X
distribution	B-X
of	B-X
E2F	B-X
and	B-X
DP	B-X
proteins	B-X
was	B-X
investigated	B-X
in	B-X
transiently	B-X
transfected	B-X
Chinese	B-X
hamster	B-X
and	B-X
human	B-X
cells	B-X
.	B-X
In	B-X
transfected	B-X
cells	B-X
,	B-X
DP-1	B-X
did	B-X
not	B-X
accumulate	B-X
in	B-X
the	B-X
nucleus	B-X
unless	B-X
it	B-X
was	B-X
coexpressed	B-X
with	B-X
the	B-X
heterodimeric	B-X
partners	B-X
E2F-1	B-X
,	B-X
E2F-2	B-X
,	B-X
or	B-X
E2F-3	B-X
.	B-X
Domain	B-X
mapping	B-X
experiments	B-X
showed	B-X
that	B-X
regions	B-X
of	B-X
E2F-1	B-X
and	B-X
DP-1	B-X
that	B-X
are	B-X
required	B-X
for	B-X
stable	B-X
association	B-X
of	B-X
the	B-X
two	B-X
proteins	B-X
were	B-X
also	B-X
required	B-X
for	B-X
nuclear	B-X
localization	B-X
of	B-X
DP-1	B-X
.	B-X
Unlike	B-X
E2F-1	B-X
,	B-X
-2	B-X
,	B-X
and	B-X
-3	B-X
,	B-X
E2F-4	B-X
did	B-X
not	B-X
accumulate	B-X
in	B-X
the	B-X
nucleus	B-X
unless	B-X
it	B-X
was	B-X
coexpressed	B-X
with	B-X
DP-2	B-X
,	B-X
p107	B-X
and	B-X
p130	B-X
,	B-X
but	B-X
not	B-X
pRb	B-X
,	B-X
stimulated	B-X
nuclear	B-X
localization	B-X
of	B-X
E2F-4	B-X
,	B-X
either	B-X
alone	B-X
or	B-X
in	B-X
combination	B-X
with	B-X
DP-2	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
DP	B-X
proteins	B-X
preferentially	B-X
associate	B-X
with	B-X
specific	B-X
E2F	B-X
partners	B-X
,	B-X
and	B-X
suggest	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
specific	B-X
E2F/DP	B-X
heterodimers	B-X
to	B-X
localize	B-X
in	B-X
the	B-X
nucleus	B-X
contributes	B-X
to	B-X
the	B-X
regulation	B-X
of	B-X
E2F	B-X
activity	B-X
.	B-X

In	O
transfected	O
cells	O
,	O
DP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
did	O
not	O
accumulate	O
in	O
the	O
nucleus	O
unless	O
it	O
was	O
coexpressed	O
with	O
the	O
heterodimeric	O
partners	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
or	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
RNA-guided	B-X
Cas9	B-X
nuclease	B-X
from	B-X
the	B-X
microbial	B-X
clustered	B-X
regularly	B-X
interspaced	B-X
short	B-X
palindromic	B-X
repeats	B-X
(	B-X
CRISPR	B-X
)	B-X
adaptive	B-X
immune	B-X
system	B-X
can	B-X
be	B-X
used	B-X
to	B-X
facilitate	B-X
efficient	B-X
genome	B-X
engineering	B-X
in	B-X
eukaryotic	B-X
cells	B-X
by	B-X
simply	B-X
specifying	B-X
a	B-X
20-nt	B-X
targeting	B-X
sequence	B-X
within	B-X
its	B-X
guide	B-X
RNA	B-X
.	B-X
Here	B-X
we	B-X
describe	B-X
a	B-X
set	B-X
of	B-X
tools	B-X
for	B-X
Cas9-mediated	B-X
genome	B-X
editing	B-X
via	B-X
nonhomologous	B-X
end	B-X
joining	B-X
(	B-X
NHEJ	B-X
)	B-X
or	B-X
homology-directed	B-X
repair	B-X
(	B-X
HDR	B-X
)	B-X
in	B-X
mammalian	B-X
cells	B-X
,	B-X
as	B-X
well	B-X
as	B-X
generation	B-X
of	B-X
modified	B-X
cell	B-X
lines	B-X
for	B-X
downstream	B-X
functional	B-X
studies	B-X
.	B-X
Beginning	B-X
with	B-X
target	B-X
design	B-X
,	B-X
gene	B-X
modifications	B-X
can	B-X
be	B-X
achieved	B-X
within	B-X
as	B-X
little	B-X
as	B-X
1-2	B-X
weeks	B-X
,	B-X
and	B-X
modified	B-X
clonal	B-X
cell	B-X
lines	B-X
can	B-X
be	B-X
derived	B-X
within	B-X
2-3	B-X
weeks	B-X
.	B-X
CRISPR/Cas9	B-X
technology	B-X
enables	B-X
the	B-X
rapid	B-X
generation	B-X
of	B-X
loss-of-function	B-X
mutations	B-X
in	B-X
a	B-X
targeted	B-X
gene	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
These	B-X
protocols	B-X
will	B-X
be	B-X
broadly	B-X
useful	B-X
for	B-X
researchers	B-X
seeking	B-X
to	B-X
apply	B-X
CRISPR	B-X
to	B-X
study	B-X
gene	B-X
function	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
©	B-X
2019	B-X
The	B-X
Authors	B-X
.	B-X

Domain	O
mapping	O
experiments	O
showed	O
that	O
regions	O
of	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
DP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
that	O
are	O
required	O
for	O
stable	O
association	O
of	O
the	O
two	O
proteins	O
were	O
also	O
required	O
for	O
nuclear	O
localization	O
of	O
DP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O
<EOS>	B-X
E2F	B-X
is	B-X
a	B-X
family	B-X
of	B-X
transcription	B-X
factors	B-X
implicated	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
genes	B-X
required	B-X
for	B-X
progression	B-X
through	B-X
G1	B-X
and	B-X
entry	B-X
into	B-X
the	B-X
S	B-X
phase	B-X
.	B-X
The	B-X
transcriptionally	B-X
active	B-X
forms	B-X
of	B-X
E2F	B-X
are	B-X
heterodimers	B-X
composed	B-X
of	B-X
one	B-X
polypeptide	B-X
encoded	B-X
by	B-X
the	B-X
E2F	B-X
gene	B-X
family	B-X
and	B-X
one	B-X
polypeptide	B-X
encoded	B-X
by	B-X
the	B-X
DP	B-X
gene	B-X
family	B-X
.	B-X
The	B-X
transcriptional	B-X
activity	B-X
of	B-X
E2F/DP	B-X
heterodimers	B-X
is	B-X
influenced	B-X
by	B-X
association	B-X
with	B-X
the	B-X
members	B-X
of	B-X
the	B-X
retinoblastoma	B-X
tumor	B-X
suppressor	B-X
protein	B-X
family	B-X
(	B-X
pRb	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
)	B-X
.	B-X
Here	B-X
the	B-X
intracellular	B-X
distribution	B-X
of	B-X
E2F	B-X
and	B-X
DP	B-X
proteins	B-X
was	B-X
investigated	B-X
in	B-X
transiently	B-X
transfected	B-X
Chinese	B-X
hamster	B-X
and	B-X
human	B-X
cells	B-X
.	B-X
In	B-X
transfected	B-X
cells	B-X
,	B-X
DP-1	B-X
did	B-X
not	B-X
accumulate	B-X
in	B-X
the	B-X
nucleus	B-X
unless	B-X
it	B-X
was	B-X
coexpressed	B-X
with	B-X
the	B-X
heterodimeric	B-X
partners	B-X
E2F-1	B-X
,	B-X
E2F-2	B-X
,	B-X
or	B-X
E2F-3	B-X
.	B-X
Domain	B-X
mapping	B-X
experiments	B-X
showed	B-X
that	B-X
regions	B-X
of	B-X
E2F-1	B-X
and	B-X
DP-1	B-X
that	B-X
are	B-X
required	B-X
for	B-X
stable	B-X
association	B-X
of	B-X
the	B-X
two	B-X
proteins	B-X
were	B-X
also	B-X
required	B-X
for	B-X
nuclear	B-X
localization	B-X
of	B-X
DP-1	B-X
.	B-X
Unlike	B-X
E2F-1	B-X
,	B-X
-2	B-X
,	B-X
and	B-X
-3	B-X
,	B-X
E2F-4	B-X
did	B-X
not	B-X
accumulate	B-X
in	B-X
the	B-X
nucleus	B-X
unless	B-X
it	B-X
was	B-X
coexpressed	B-X
with	B-X
DP-2	B-X
,	B-X
p107	B-X
and	B-X
p130	B-X
,	B-X
but	B-X
not	B-X
pRb	B-X
,	B-X
stimulated	B-X
nuclear	B-X
localization	B-X
of	B-X
E2F-4	B-X
,	B-X
either	B-X
alone	B-X
or	B-X
in	B-X
combination	B-X
with	B-X
DP-2	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
DP	B-X
proteins	B-X
preferentially	B-X
associate	B-X
with	B-X
specific	B-X
E2F	B-X
partners	B-X
,	B-X
and	B-X
suggest	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
specific	B-X
E2F/DP	B-X
heterodimers	B-X
to	B-X
localize	B-X
in	B-X
the	B-X
nucleus	B-X
contributes	B-X
to	B-X
the	B-X
regulation	B-X
of	B-X
E2F	B-X
activity	B-X
.	B-X

Unlike	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
-	B-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
and	O
-	B-Gene_or_gene_product
3	I-Gene_or_gene_product
,	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
did	O
not	O
accumulate	O
in	O
the	O
nucleus	O
unless	O
it	O
was	O
coexpressed	O
with	O
DP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
p107	B-Gene_or_gene_product
and	O
p130	B-Gene_or_gene_product
,	O
but	O
not	O
pRb	B-Gene_or_gene_product
,	O
stimulated	O
nuclear	O
localization	O
of	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
,	O
either	O
alone	O
or	O
in	O
combination	O
with	O
DP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
.	O
<EOS>	B-X
Diabetic	B-X
peripheral	B-X
neuropathic	B-X
pain	B-X
(	B-X
DPNP	B-X
)	B-X
is	B-X
common	B-X
and	B-X
often	B-X
distressing	B-X
.	B-X
Most	B-X
guidelines	B-X
recommend	B-X
amitriptyline	B-X
,	B-X
duloxetine	B-X
,	B-X
pregabalin	B-X
,	B-X
or	B-X
gabapentin	B-X
as	B-X
initial	B-X
analgesic	B-X
treatment	B-X
for	B-X
DPNP	B-X
,	B-X
but	B-X
there	B-X
is	B-X
little	B-X
comparative	B-X
evidence	B-X
on	B-X
which	B-X
one	B-X
is	B-X
best	B-X
or	B-X
whether	B-X
they	B-X
should	B-X
be	B-X
combined	B-X
.	B-X
We	B-X
aimed	B-X
to	B-X
assess	B-X
the	B-X
efficacy	B-X
and	B-X
tolerability	B-X
of	B-X
different	B-X
combinations	B-X
of	B-X
first-line	B-X
drugs	B-X
for	B-X
treatment	B-X
of	B-X
DPNP	B-X
.	B-X
A	B-X
multi-institutional	B-X
phase	B-X
2	B-X
trial	B-X
assessed	B-X
the	B-X
utility	B-X
of	B-X
dose-painted	B-X
intensity	B-X
modulated	B-X
radiation	B-X
therapy	B-X
(	B-X
DP-IMRT	B-X
)	B-X
in	B-X
reducing	B-X
grade	B-X
2+	B-X
combined	B-X
acute	B-X
gastrointestinal	B-X
and	B-X
genitourinary	B-X
adverse	B-X
events	B-X
(	B-X
AEs	B-X
)	B-X
of	B-X
5-fluorouracil	B-X
(	B-X
5FU	B-X
)	B-X
and	B-X
mitomycin-C	B-X
(	B-X
MMC	B-X
)	B-X
chemoradiation	B-X
for	B-X
anal	B-X
cancer	B-X
by	B-X
at	B-X
least	B-X
15	B-X
%	B-X
compared	B-X
with	B-X
the	B-X
conventional	B-X
radiation/5FU/MMC	B-X
arm	B-X
from	B-X
RTOG	B-X
9811	B-X
.	B-X

These	O
results	O
indicate	O
that	O
DP	B-Gene_or_gene_product
proteins	O
preferentially	O
associate	O
with	O
specific	O
E2F	B-Gene_or_gene_product
partners	O
,	O
and	O
suggest	O
that	O
the	O
ability	O
of	O
specific	O
E2F	O
/	O
DP	O
heterodimers	O
to	O
localize	O
in	O
the	O
nucleus	O
contributes	O
to	O
the	O
regulation	O
of	O
E2F	B-Gene_or_gene_product
activity	O
.	O

Basal	O
phosphorylation	O
of	O
the	O
PEST	O
domain	O
in	O
the	O
I	B-Gene_or_gene_product
(	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
)	I-Gene_or_gene_product
B	I-Gene_or_gene_product
(	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
)	I-Gene_or_gene_product
regulates	O
its	O
functional	O
interaction	O
with	O
the	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
rel	I-Gene_or_gene_product
proto	O
-	O
oncogene	O
product	O
.	O

The	O
product	O
of	O
the	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
rel	I-Gene_or_gene_product
proto	O
-	O
oncogene	O
(	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
)	O
belongs	O
to	O
the	O
NF	O
-	O
kappaB	O
/	O
Rel	B-Gene_or_gene_product
family	O
of	O
polypeptides	O
and	O
has	O
been	O
implicated	O
in	O
the	O
transcriptional	O
control	O
of	O
cell	O
proliferation	O
and	O
immune	O
function	O
.	O

In	O
human	O
T	O
lymphocytes	O
,	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
is	O
sequestered	O
in	O
the	O
cytoplasmic	O
compartment	O
by	O
constitutively	O
phosphorylated	O
inhibitors	O
,	O
including	O
I	B-Gene_or_gene_product
(	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
)	I-Gene_or_gene_product
B	I-Gene_or_gene_product
(	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
)	I-Gene_or_gene_product
and	O
I	B-Gene_or_gene_product
(	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
)	I-Gene_or_gene_product
B	I-Gene_or_gene_product
(	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
)	I-Gene_or_gene_product
.	O

Studies	O
with	O
bacterially	O
expressed	O
forms	O
of	O
these	O
inhibitory	O
proteins	O
revealed	O
that	O
unphosphorylated	O
I	B-Gene_or_gene_product
(	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
)	I-Gene_or_gene_product
B	I-Gene_or_gene_product
(	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
)	I-Gene_or_gene_product
but	O
not	O
I	B-Gene_or_gene_product
(	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
)	I-Gene_or_gene_product
B	I-Gene_or_gene_product
(	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
)	I-Gene_or_gene_product
assembles	O
with	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
and	O
inhibits	O
its	O
DNA	O
binding	O
activity	O
.	O

Furthermore	O
,	O
latent	O
I	O
(	O
kappa	O
)	O
B	O
(	O
beta	O
)	O
-	O
c	O
-	O
Rel	O
complexes	O
derived	O
from	O
mammalian	O
cells	O
were	O
sensitive	O
to	O
phosphatase	O
treatment	O
,	O
whereas	O
I	O
(	O
kappa	O
)	O
B	O
(	O
alpha	O
)	O
-	O
c	O
-	O
Rel	O
complexes	O
were	O
resistant	O
.	O
<EOS>	B-X
The	B-X
product	B-X
of	B-X
the	B-X
c-rel	B-X
proto-oncogene	B-X
(	B-X
c-Rel	B-X
)	B-X
belongs	B-X
to	B-X
the	B-X
NF-kappaB/Rel	B-X
family	B-X
of	B-X
polypeptides	B-X
and	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
transcriptional	B-X
control	B-X
of	B-X
cell	B-X
proliferation	B-X
and	B-X
immune	B-X
function	B-X
.	B-X
In	B-X
human	B-X
T	B-X
lymphocytes	B-X
,	B-X
c-Rel	B-X
is	B-X
sequestered	B-X
in	B-X
the	B-X
cytoplasmic	B-X
compartment	B-X
by	B-X
constitutively	B-X
phosphorylated	B-X
inhibitors	B-X
,	B-X
including	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
and	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
.	B-X
Studies	B-X
with	B-X
bacterially	B-X
expressed	B-X
forms	B-X
of	B-X
these	B-X
inhibitory	B-X
proteins	B-X
revealed	B-X
that	B-X
unphosphorylated	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
but	B-X
not	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
assembles	B-X
with	B-X
c-Rel	B-X
and	B-X
inhibits	B-X
its	B-X
DNA	B-X
binding	B-X
activity	B-X
.	B-X
Furthermore	B-X
,	B-X
latent	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
derived	B-X
from	B-X
mammalian	B-X
cells	B-X
were	B-X
sensitive	B-X
to	B-X
phosphatase	B-X
treatment	B-X
,	B-X
whereas	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
were	B-X
resistant	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
a	B-X
constitutive	B-X
protein	B-X
kinase	B-X
in	B-X
unstimulated	B-X
T	B-X
cells	B-X
that	B-X
associates	B-X
with	B-X
and	B-X
phosphorylates	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
substrate	B-X
specificity	B-X
,	B-X
electrophoretic	B-X
mobility	B-X
,	B-X
and	B-X
antigenic	B-X
properties	B-X
of	B-X
this	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-associated	B-X
kinase	B-X
(	B-X
BAK	B-X
)	B-X
suggest	B-X
identity	B-X
with	B-X
casein	B-X
kinase	B-X
II	B-X
(	B-X
CKII	B-X
)	B-X
,	B-X
an	B-X
enzyme	B-X
known	B-X
to	B-X
mediate	B-X
basal	B-X
phosphorylation	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
.	B-X
Phosphorylation	B-X
of	B-X
recombinant	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
by	B-X
either	B-X
BAK	B-X
or	B-X
CKII	B-X
restored	B-X
the	B-X
capacity	B-X
of	B-X
this	B-X
inhibitor	B-X
to	B-X
antagonize	B-X
the	B-X
DNA	B-X
binding	B-X
activity	B-X
of	B-X
c-Rel	B-X
.	B-X
Peptide	B-X
mapping	B-X
and	B-X
mutational	B-X
analyses	B-X
localized	B-X
the	B-X
bulk	B-X
of	B-X
the	B-X
basal	B-X
phosphorylation	B-X
sites	B-X
in	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
to	B-X
the	B-X
C-terminal	B-X
PEST	B-X
domain	B-X
,	B-X
which	B-X
contains	B-X
two	B-X
potential	B-X
acceptors	B-X
for	B-X
CKII-mediated	B-X
phosphoryl	B-X
group	B-X
transfer	B-X
(	B-X
Ser-313	B-X
and	B-X
Ser-315	B-X
)	B-X
.	B-X
Point	B-X
mutations	B-X
introduced	B-X
into	B-X
the	B-X
full-length	B-X
inhibitor	B-X
at	B-X
Ser-313	B-X
and	B-X
Ser-315	B-X
led	B-X
to	B-X
a	B-X
significant	B-X
reduction	B-X
in	B-X
the	B-X
phosphorylation	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
and	B-X
severely	B-X
impaired	B-X
its	B-X
c-Rel	B-X
inhibitory	B-X
function	B-X
in	B-X
vivo	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
strongly	B-X
suggest	B-X
that	B-X
basal	B-X
phosphorylation	B-X
of	B-X
the	B-X
PEST	B-X
domain	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
at	B-X
consensus	B-X
CKII	B-X
sites	B-X
is	B-X
required	B-X
for	B-X
the	B-X
efficient	B-X
formation	B-X
of	B-X
latent	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
.	B-X

We	O
have	O
identified	O
a	O
constitutive	O
protein	O
kinase	O
in	O
unstimulated	O
T	O
cells	O
that	O
associates	O
with	O
and	O
phosphorylates	O
I	B-Gene_or_gene_product
(	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
)	I-Gene_or_gene_product
B	I-Gene_or_gene_product
(	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
)	I-Gene_or_gene_product
in	O
vitro	O
.	O
<EOS>	B-X
The	B-X
product	B-X
of	B-X
the	B-X
c-rel	B-X
proto-oncogene	B-X
(	B-X
c-Rel	B-X
)	B-X
belongs	B-X
to	B-X
the	B-X
NF-kappaB/Rel	B-X
family	B-X
of	B-X
polypeptides	B-X
and	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
transcriptional	B-X
control	B-X
of	B-X
cell	B-X
proliferation	B-X
and	B-X
immune	B-X
function	B-X
.	B-X
In	B-X
human	B-X
T	B-X
lymphocytes	B-X
,	B-X
c-Rel	B-X
is	B-X
sequestered	B-X
in	B-X
the	B-X
cytoplasmic	B-X
compartment	B-X
by	B-X
constitutively	B-X
phosphorylated	B-X
inhibitors	B-X
,	B-X
including	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
and	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
.	B-X
Studies	B-X
with	B-X
bacterially	B-X
expressed	B-X
forms	B-X
of	B-X
these	B-X
inhibitory	B-X
proteins	B-X
revealed	B-X
that	B-X
unphosphorylated	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
but	B-X
not	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
assembles	B-X
with	B-X
c-Rel	B-X
and	B-X
inhibits	B-X
its	B-X
DNA	B-X
binding	B-X
activity	B-X
.	B-X
Furthermore	B-X
,	B-X
latent	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
derived	B-X
from	B-X
mammalian	B-X
cells	B-X
were	B-X
sensitive	B-X
to	B-X
phosphatase	B-X
treatment	B-X
,	B-X
whereas	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
were	B-X
resistant	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
a	B-X
constitutive	B-X
protein	B-X
kinase	B-X
in	B-X
unstimulated	B-X
T	B-X
cells	B-X
that	B-X
associates	B-X
with	B-X
and	B-X
phosphorylates	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
substrate	B-X
specificity	B-X
,	B-X
electrophoretic	B-X
mobility	B-X
,	B-X
and	B-X
antigenic	B-X
properties	B-X
of	B-X
this	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-associated	B-X
kinase	B-X
(	B-X
BAK	B-X
)	B-X
suggest	B-X
identity	B-X
with	B-X
casein	B-X
kinase	B-X
II	B-X
(	B-X
CKII	B-X
)	B-X
,	B-X
an	B-X
enzyme	B-X
known	B-X
to	B-X
mediate	B-X
basal	B-X
phosphorylation	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
.	B-X
Phosphorylation	B-X
of	B-X
recombinant	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
by	B-X
either	B-X
BAK	B-X
or	B-X
CKII	B-X
restored	B-X
the	B-X
capacity	B-X
of	B-X
this	B-X
inhibitor	B-X
to	B-X
antagonize	B-X
the	B-X
DNA	B-X
binding	B-X
activity	B-X
of	B-X
c-Rel	B-X
.	B-X
Peptide	B-X
mapping	B-X
and	B-X
mutational	B-X
analyses	B-X
localized	B-X
the	B-X
bulk	B-X
of	B-X
the	B-X
basal	B-X
phosphorylation	B-X
sites	B-X
in	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
to	B-X
the	B-X
C-terminal	B-X
PEST	B-X
domain	B-X
,	B-X
which	B-X
contains	B-X
two	B-X
potential	B-X
acceptors	B-X
for	B-X
CKII-mediated	B-X
phosphoryl	B-X
group	B-X
transfer	B-X
(	B-X
Ser-313	B-X
and	B-X
Ser-315	B-X
)	B-X
.	B-X
Point	B-X
mutations	B-X
introduced	B-X
into	B-X
the	B-X
full-length	B-X
inhibitor	B-X
at	B-X
Ser-313	B-X
and	B-X
Ser-315	B-X
led	B-X
to	B-X
a	B-X
significant	B-X
reduction	B-X
in	B-X
the	B-X
phosphorylation	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
and	B-X
severely	B-X
impaired	B-X
its	B-X
c-Rel	B-X
inhibitory	B-X
function	B-X
in	B-X
vivo	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
strongly	B-X
suggest	B-X
that	B-X
basal	B-X
phosphorylation	B-X
of	B-X
the	B-X
PEST	B-X
domain	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
at	B-X
consensus	B-X
CKII	B-X
sites	B-X
is	B-X
required	B-X
for	B-X
the	B-X
efficient	B-X
formation	B-X
of	B-X
latent	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
.	B-X

The	O
substrate	O
specificity	O
,	O
electrophoretic	O
mobility	O
,	O
and	O
antigenic	O
properties	O
of	O
this	O
I	B-Gene_or_gene_product
(	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
)	I-Gene_or_gene_product
B	I-Gene_or_gene_product
(	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
)	I-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
BAK	B-Gene_or_gene_product
)	O
suggest	O
identity	O
with	O
casein	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
II	I-Gene_or_gene_product
(	O
CKII	B-Gene_or_gene_product
)	O
,	O
an	O
enzyme	O
known	O
to	O
mediate	O
basal	O
phosphorylation	O
of	O
I	B-Gene_or_gene_product
(	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
)	I-Gene_or_gene_product
B	I-Gene_or_gene_product
(	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
)	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
product	B-X
of	B-X
the	B-X
c-rel	B-X
proto-oncogene	B-X
(	B-X
c-Rel	B-X
)	B-X
belongs	B-X
to	B-X
the	B-X
NF-kappaB/Rel	B-X
family	B-X
of	B-X
polypeptides	B-X
and	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
transcriptional	B-X
control	B-X
of	B-X
cell	B-X
proliferation	B-X
and	B-X
immune	B-X
function	B-X
.	B-X
In	B-X
human	B-X
T	B-X
lymphocytes	B-X
,	B-X
c-Rel	B-X
is	B-X
sequestered	B-X
in	B-X
the	B-X
cytoplasmic	B-X
compartment	B-X
by	B-X
constitutively	B-X
phosphorylated	B-X
inhibitors	B-X
,	B-X
including	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
and	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
.	B-X
Studies	B-X
with	B-X
bacterially	B-X
expressed	B-X
forms	B-X
of	B-X
these	B-X
inhibitory	B-X
proteins	B-X
revealed	B-X
that	B-X
unphosphorylated	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
but	B-X
not	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
assembles	B-X
with	B-X
c-Rel	B-X
and	B-X
inhibits	B-X
its	B-X
DNA	B-X
binding	B-X
activity	B-X
.	B-X
Furthermore	B-X
,	B-X
latent	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
derived	B-X
from	B-X
mammalian	B-X
cells	B-X
were	B-X
sensitive	B-X
to	B-X
phosphatase	B-X
treatment	B-X
,	B-X
whereas	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
were	B-X
resistant	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
a	B-X
constitutive	B-X
protein	B-X
kinase	B-X
in	B-X
unstimulated	B-X
T	B-X
cells	B-X
that	B-X
associates	B-X
with	B-X
and	B-X
phosphorylates	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
substrate	B-X
specificity	B-X
,	B-X
electrophoretic	B-X
mobility	B-X
,	B-X
and	B-X
antigenic	B-X
properties	B-X
of	B-X
this	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-associated	B-X
kinase	B-X
(	B-X
BAK	B-X
)	B-X
suggest	B-X
identity	B-X
with	B-X
casein	B-X
kinase	B-X
II	B-X
(	B-X
CKII	B-X
)	B-X
,	B-X
an	B-X
enzyme	B-X
known	B-X
to	B-X
mediate	B-X
basal	B-X
phosphorylation	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
.	B-X
Phosphorylation	B-X
of	B-X
recombinant	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
by	B-X
either	B-X
BAK	B-X
or	B-X
CKII	B-X
restored	B-X
the	B-X
capacity	B-X
of	B-X
this	B-X
inhibitor	B-X
to	B-X
antagonize	B-X
the	B-X
DNA	B-X
binding	B-X
activity	B-X
of	B-X
c-Rel	B-X
.	B-X
Peptide	B-X
mapping	B-X
and	B-X
mutational	B-X
analyses	B-X
localized	B-X
the	B-X
bulk	B-X
of	B-X
the	B-X
basal	B-X
phosphorylation	B-X
sites	B-X
in	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
to	B-X
the	B-X
C-terminal	B-X
PEST	B-X
domain	B-X
,	B-X
which	B-X
contains	B-X
two	B-X
potential	B-X
acceptors	B-X
for	B-X
CKII-mediated	B-X
phosphoryl	B-X
group	B-X
transfer	B-X
(	B-X
Ser-313	B-X
and	B-X
Ser-315	B-X
)	B-X
.	B-X
Point	B-X
mutations	B-X
introduced	B-X
into	B-X
the	B-X
full-length	B-X
inhibitor	B-X
at	B-X
Ser-313	B-X
and	B-X
Ser-315	B-X
led	B-X
to	B-X
a	B-X
significant	B-X
reduction	B-X
in	B-X
the	B-X
phosphorylation	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
and	B-X
severely	B-X
impaired	B-X
its	B-X
c-Rel	B-X
inhibitory	B-X
function	B-X
in	B-X
vivo	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
strongly	B-X
suggest	B-X
that	B-X
basal	B-X
phosphorylation	B-X
of	B-X
the	B-X
PEST	B-X
domain	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
at	B-X
consensus	B-X
CKII	B-X
sites	B-X
is	B-X
required	B-X
for	B-X
the	B-X
efficient	B-X
formation	B-X
of	B-X
latent	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
.	B-X

Phosphorylation	O
of	O
recombinant	O
I	B-Gene_or_gene_product
(	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
)	I-Gene_or_gene_product
B	I-Gene_or_gene_product
(	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
)	I-Gene_or_gene_product
by	O
either	O
BAK	B-Gene_or_gene_product
or	O
CKII	B-Gene_or_gene_product
restored	O
the	O
capacity	O
of	O
this	O
inhibitor	O
to	O
antagonize	O
the	O
DNA	O
binding	O
activity	O
of	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
product	B-X
of	B-X
the	B-X
c-rel	B-X
proto-oncogene	B-X
(	B-X
c-Rel	B-X
)	B-X
belongs	B-X
to	B-X
the	B-X
NF-kappaB/Rel	B-X
family	B-X
of	B-X
polypeptides	B-X
and	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
transcriptional	B-X
control	B-X
of	B-X
cell	B-X
proliferation	B-X
and	B-X
immune	B-X
function	B-X
.	B-X
In	B-X
human	B-X
T	B-X
lymphocytes	B-X
,	B-X
c-Rel	B-X
is	B-X
sequestered	B-X
in	B-X
the	B-X
cytoplasmic	B-X
compartment	B-X
by	B-X
constitutively	B-X
phosphorylated	B-X
inhibitors	B-X
,	B-X
including	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
and	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
.	B-X
Studies	B-X
with	B-X
bacterially	B-X
expressed	B-X
forms	B-X
of	B-X
these	B-X
inhibitory	B-X
proteins	B-X
revealed	B-X
that	B-X
unphosphorylated	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
but	B-X
not	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
assembles	B-X
with	B-X
c-Rel	B-X
and	B-X
inhibits	B-X
its	B-X
DNA	B-X
binding	B-X
activity	B-X
.	B-X
Furthermore	B-X
,	B-X
latent	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
derived	B-X
from	B-X
mammalian	B-X
cells	B-X
were	B-X
sensitive	B-X
to	B-X
phosphatase	B-X
treatment	B-X
,	B-X
whereas	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
were	B-X
resistant	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
a	B-X
constitutive	B-X
protein	B-X
kinase	B-X
in	B-X
unstimulated	B-X
T	B-X
cells	B-X
that	B-X
associates	B-X
with	B-X
and	B-X
phosphorylates	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
substrate	B-X
specificity	B-X
,	B-X
electrophoretic	B-X
mobility	B-X
,	B-X
and	B-X
antigenic	B-X
properties	B-X
of	B-X
this	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-associated	B-X
kinase	B-X
(	B-X
BAK	B-X
)	B-X
suggest	B-X
identity	B-X
with	B-X
casein	B-X
kinase	B-X
II	B-X
(	B-X
CKII	B-X
)	B-X
,	B-X
an	B-X
enzyme	B-X
known	B-X
to	B-X
mediate	B-X
basal	B-X
phosphorylation	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
.	B-X
Phosphorylation	B-X
of	B-X
recombinant	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
by	B-X
either	B-X
BAK	B-X
or	B-X
CKII	B-X
restored	B-X
the	B-X
capacity	B-X
of	B-X
this	B-X
inhibitor	B-X
to	B-X
antagonize	B-X
the	B-X
DNA	B-X
binding	B-X
activity	B-X
of	B-X
c-Rel	B-X
.	B-X
Peptide	B-X
mapping	B-X
and	B-X
mutational	B-X
analyses	B-X
localized	B-X
the	B-X
bulk	B-X
of	B-X
the	B-X
basal	B-X
phosphorylation	B-X
sites	B-X
in	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
to	B-X
the	B-X
C-terminal	B-X
PEST	B-X
domain	B-X
,	B-X
which	B-X
contains	B-X
two	B-X
potential	B-X
acceptors	B-X
for	B-X
CKII-mediated	B-X
phosphoryl	B-X
group	B-X
transfer	B-X
(	B-X
Ser-313	B-X
and	B-X
Ser-315	B-X
)	B-X
.	B-X
Point	B-X
mutations	B-X
introduced	B-X
into	B-X
the	B-X
full-length	B-X
inhibitor	B-X
at	B-X
Ser-313	B-X
and	B-X
Ser-315	B-X
led	B-X
to	B-X
a	B-X
significant	B-X
reduction	B-X
in	B-X
the	B-X
phosphorylation	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
and	B-X
severely	B-X
impaired	B-X
its	B-X
c-Rel	B-X
inhibitory	B-X
function	B-X
in	B-X
vivo	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
strongly	B-X
suggest	B-X
that	B-X
basal	B-X
phosphorylation	B-X
of	B-X
the	B-X
PEST	B-X
domain	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
at	B-X
consensus	B-X
CKII	B-X
sites	B-X
is	B-X
required	B-X
for	B-X
the	B-X
efficient	B-X
formation	B-X
of	B-X
latent	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
.	B-X

Peptide	O
mapping	O
and	O
mutational	O
analyses	O
localized	O
the	O
bulk	O
of	O
the	O
basal	O
phosphorylation	O
sites	O
in	O
I	B-Gene_or_gene_product
(	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
)	I-Gene_or_gene_product
B	I-Gene_or_gene_product
(	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
)	I-Gene_or_gene_product
to	O
the	O
C	O
-	O
terminal	O
PEST	O
domain	O
,	O
which	O
contains	O
two	O
potential	O
acceptors	O
for	O
CKII	B-Gene_or_gene_product
-	O
mediated	O
phosphoryl	O
group	O
transfer	O
(	O
Ser	O
-	O
313	O
and	O
Ser	O
-	O
315	O
)	O
.	O

Point	O
mutations	O
introduced	O
into	O
the	O
full	O
-	O
length	O
inhibitor	O
at	O
Ser	O
-	O
313	O
and	O
Ser	O
-	O
315	O
led	O
to	O
a	O
significant	O
reduction	O
in	O
the	O
phosphorylation	O
of	O
I	B-Gene_or_gene_product
(	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
)	I-Gene_or_gene_product
B	I-Gene_or_gene_product
(	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
)	I-Gene_or_gene_product
and	O
severely	O
impaired	O
its	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
inhibitory	O
function	O
in	O
vivo	O
.	O
<EOS>	B-X
The	B-X
product	B-X
of	B-X
the	B-X
c-rel	B-X
proto-oncogene	B-X
(	B-X
c-Rel	B-X
)	B-X
belongs	B-X
to	B-X
the	B-X
NF-kappaB/Rel	B-X
family	B-X
of	B-X
polypeptides	B-X
and	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
transcriptional	B-X
control	B-X
of	B-X
cell	B-X
proliferation	B-X
and	B-X
immune	B-X
function	B-X
.	B-X
In	B-X
human	B-X
T	B-X
lymphocytes	B-X
,	B-X
c-Rel	B-X
is	B-X
sequestered	B-X
in	B-X
the	B-X
cytoplasmic	B-X
compartment	B-X
by	B-X
constitutively	B-X
phosphorylated	B-X
inhibitors	B-X
,	B-X
including	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
and	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
.	B-X
Studies	B-X
with	B-X
bacterially	B-X
expressed	B-X
forms	B-X
of	B-X
these	B-X
inhibitory	B-X
proteins	B-X
revealed	B-X
that	B-X
unphosphorylated	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
but	B-X
not	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
assembles	B-X
with	B-X
c-Rel	B-X
and	B-X
inhibits	B-X
its	B-X
DNA	B-X
binding	B-X
activity	B-X
.	B-X
Furthermore	B-X
,	B-X
latent	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
derived	B-X
from	B-X
mammalian	B-X
cells	B-X
were	B-X
sensitive	B-X
to	B-X
phosphatase	B-X
treatment	B-X
,	B-X
whereas	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
were	B-X
resistant	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
a	B-X
constitutive	B-X
protein	B-X
kinase	B-X
in	B-X
unstimulated	B-X
T	B-X
cells	B-X
that	B-X
associates	B-X
with	B-X
and	B-X
phosphorylates	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
substrate	B-X
specificity	B-X
,	B-X
electrophoretic	B-X
mobility	B-X
,	B-X
and	B-X
antigenic	B-X
properties	B-X
of	B-X
this	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-associated	B-X
kinase	B-X
(	B-X
BAK	B-X
)	B-X
suggest	B-X
identity	B-X
with	B-X
casein	B-X
kinase	B-X
II	B-X
(	B-X
CKII	B-X
)	B-X
,	B-X
an	B-X
enzyme	B-X
known	B-X
to	B-X
mediate	B-X
basal	B-X
phosphorylation	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
.	B-X
Phosphorylation	B-X
of	B-X
recombinant	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
by	B-X
either	B-X
BAK	B-X
or	B-X
CKII	B-X
restored	B-X
the	B-X
capacity	B-X
of	B-X
this	B-X
inhibitor	B-X
to	B-X
antagonize	B-X
the	B-X
DNA	B-X
binding	B-X
activity	B-X
of	B-X
c-Rel	B-X
.	B-X
Peptide	B-X
mapping	B-X
and	B-X
mutational	B-X
analyses	B-X
localized	B-X
the	B-X
bulk	B-X
of	B-X
the	B-X
basal	B-X
phosphorylation	B-X
sites	B-X
in	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
to	B-X
the	B-X
C-terminal	B-X
PEST	B-X
domain	B-X
,	B-X
which	B-X
contains	B-X
two	B-X
potential	B-X
acceptors	B-X
for	B-X
CKII-mediated	B-X
phosphoryl	B-X
group	B-X
transfer	B-X
(	B-X
Ser-313	B-X
and	B-X
Ser-315	B-X
)	B-X
.	B-X
Point	B-X
mutations	B-X
introduced	B-X
into	B-X
the	B-X
full-length	B-X
inhibitor	B-X
at	B-X
Ser-313	B-X
and	B-X
Ser-315	B-X
led	B-X
to	B-X
a	B-X
significant	B-X
reduction	B-X
in	B-X
the	B-X
phosphorylation	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
and	B-X
severely	B-X
impaired	B-X
its	B-X
c-Rel	B-X
inhibitory	B-X
function	B-X
in	B-X
vivo	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
strongly	B-X
suggest	B-X
that	B-X
basal	B-X
phosphorylation	B-X
of	B-X
the	B-X
PEST	B-X
domain	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
at	B-X
consensus	B-X
CKII	B-X
sites	B-X
is	B-X
required	B-X
for	B-X
the	B-X
efficient	B-X
formation	B-X
of	B-X
latent	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
.	B-X

Taken	O
together	O
,	O
these	O
findings	O
strongly	O
suggest	O
that	O
basal	O
phosphorylation	O
of	O
the	O
PEST	O
domain	O
of	O
I	B-Gene_or_gene_product
(	I-Gene_or_gene_product
kappa	I-Gene_or_gene_product
)	I-Gene_or_gene_product
B	I-Gene_or_gene_product
(	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
)	I-Gene_or_gene_product
at	O
consensus	O
CKII	B-Gene_or_gene_product
sites	O
is	O
required	O
for	O
the	O
efficient	O
formation	O
of	O
latent	O
I	O
(	O
kappa	O
)	O
B	O
(	O
beta	O
)	O
-	O
c	O
-	O
Rel	O
complexes	O
.	O
<EOS>	B-X
The	B-X
product	B-X
of	B-X
the	B-X
c-rel	B-X
proto-oncogene	B-X
(	B-X
c-Rel	B-X
)	B-X
belongs	B-X
to	B-X
the	B-X
NF-kappaB/Rel	B-X
family	B-X
of	B-X
polypeptides	B-X
and	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
transcriptional	B-X
control	B-X
of	B-X
cell	B-X
proliferation	B-X
and	B-X
immune	B-X
function	B-X
.	B-X
In	B-X
human	B-X
T	B-X
lymphocytes	B-X
,	B-X
c-Rel	B-X
is	B-X
sequestered	B-X
in	B-X
the	B-X
cytoplasmic	B-X
compartment	B-X
by	B-X
constitutively	B-X
phosphorylated	B-X
inhibitors	B-X
,	B-X
including	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
and	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
.	B-X
Studies	B-X
with	B-X
bacterially	B-X
expressed	B-X
forms	B-X
of	B-X
these	B-X
inhibitory	B-X
proteins	B-X
revealed	B-X
that	B-X
unphosphorylated	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
but	B-X
not	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
assembles	B-X
with	B-X
c-Rel	B-X
and	B-X
inhibits	B-X
its	B-X
DNA	B-X
binding	B-X
activity	B-X
.	B-X
Furthermore	B-X
,	B-X
latent	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
derived	B-X
from	B-X
mammalian	B-X
cells	B-X
were	B-X
sensitive	B-X
to	B-X
phosphatase	B-X
treatment	B-X
,	B-X
whereas	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
were	B-X
resistant	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
a	B-X
constitutive	B-X
protein	B-X
kinase	B-X
in	B-X
unstimulated	B-X
T	B-X
cells	B-X
that	B-X
associates	B-X
with	B-X
and	B-X
phosphorylates	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
substrate	B-X
specificity	B-X
,	B-X
electrophoretic	B-X
mobility	B-X
,	B-X
and	B-X
antigenic	B-X
properties	B-X
of	B-X
this	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-associated	B-X
kinase	B-X
(	B-X
BAK	B-X
)	B-X
suggest	B-X
identity	B-X
with	B-X
casein	B-X
kinase	B-X
II	B-X
(	B-X
CKII	B-X
)	B-X
,	B-X
an	B-X
enzyme	B-X
known	B-X
to	B-X
mediate	B-X
basal	B-X
phosphorylation	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
alpha	B-X
)	B-X
.	B-X
Phosphorylation	B-X
of	B-X
recombinant	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
by	B-X
either	B-X
BAK	B-X
or	B-X
CKII	B-X
restored	B-X
the	B-X
capacity	B-X
of	B-X
this	B-X
inhibitor	B-X
to	B-X
antagonize	B-X
the	B-X
DNA	B-X
binding	B-X
activity	B-X
of	B-X
c-Rel	B-X
.	B-X
Peptide	B-X
mapping	B-X
and	B-X
mutational	B-X
analyses	B-X
localized	B-X
the	B-X
bulk	B-X
of	B-X
the	B-X
basal	B-X
phosphorylation	B-X
sites	B-X
in	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
to	B-X
the	B-X
C-terminal	B-X
PEST	B-X
domain	B-X
,	B-X
which	B-X
contains	B-X
two	B-X
potential	B-X
acceptors	B-X
for	B-X
CKII-mediated	B-X
phosphoryl	B-X
group	B-X
transfer	B-X
(	B-X
Ser-313	B-X
and	B-X
Ser-315	B-X
)	B-X
.	B-X
Point	B-X
mutations	B-X
introduced	B-X
into	B-X
the	B-X
full-length	B-X
inhibitor	B-X
at	B-X
Ser-313	B-X
and	B-X
Ser-315	B-X
led	B-X
to	B-X
a	B-X
significant	B-X
reduction	B-X
in	B-X
the	B-X
phosphorylation	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
and	B-X
severely	B-X
impaired	B-X
its	B-X
c-Rel	B-X
inhibitory	B-X
function	B-X
in	B-X
vivo	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
findings	B-X
strongly	B-X
suggest	B-X
that	B-X
basal	B-X
phosphorylation	B-X
of	B-X
the	B-X
PEST	B-X
domain	B-X
of	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
at	B-X
consensus	B-X
CKII	B-X
sites	B-X
is	B-X
required	B-X
for	B-X
the	B-X
efficient	B-X
formation	B-X
of	B-X
latent	B-X
I	B-X
(	B-X
kappa	B-X
)	B-X
B	B-X
(	B-X
beta	B-X
)	B-X
-c-Rel	B-X
complexes	B-X
.	B-X

Molecular	O
cloning	O
and	O
characterization	O
of	O
a	O
novel	O
protein	O
kinase	O
with	O
a	O
catalytic	O
domain	O
homologous	O
to	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
.	O
<EOS>	B-X
A	B-X
human	B-X
protein	B-X
kinase	B-X
(	B-X
termed	B-X
MST1	B-X
)	B-X
has	B-X
been	B-X
cloned	B-X
and	B-X
characterized	B-X
.	B-X
The	B-X
MST1	B-X
catalytic	B-X
domain	B-X
is	B-X
most	B-X
homologous	B-X
to	B-X
Ste20	B-X
and	B-X
other	B-X
Ste20-like	B-X
kinases	B-X
(	B-X
62-65	B-X
%	B-X
similar	B-X
)	B-X
.	B-X
MST1	B-X
is	B-X
expressed	B-X
ubiquitously	B-X
,	B-X
and	B-X
the	B-X
MST1	B-X
protein	B-X
is	B-X
present	B-X
in	B-X
all	B-X
human	B-X
cell	B-X
lines	B-X
examined	B-X
.	B-X
Biochemical	B-X
characterization	B-X
of	B-X
MST1	B-X
catalytic	B-X
activity	B-X
demonstrates	B-X
that	B-X
it	B-X
is	B-X
a	B-X
serine/threonine	B-X
kinase	B-X
,	B-X
and	B-X
that	B-X
it	B-X
can	B-X
phosphorylate	B-X
an	B-X
exogenous	B-X
substrate	B-X
as	B-X
well	B-X
as	B-X
itself	B-X
in	B-X
an	B-X
in	B-X
vitro	B-X
kinase	B-X
assay	B-X
.	B-X
Further	B-X
characterization	B-X
of	B-X
the	B-X
protein	B-X
indicates	B-X
MST1	B-X
activity	B-X
increases	B-X
approximately	B-X
3-4-fold	B-X
upon	B-X
treatment	B-X
with	B-X
PP2A	B-X
,	B-X
suggesting	B-X
that	B-X
MST1	B-X
is	B-X
negatively	B-X
regulated	B-X
by	B-X
phosphorylation	B-X
.	B-X
MST1	B-X
activity	B-X
decreases	B-X
approximately	B-X
2-fold	B-X
upon	B-X
treatment	B-X
with	B-X
epidermal	B-X
growth	B-X
factor	B-X
;	B-X
however	B-X
,	B-X
overexpression	B-X
of	B-X
MST1	B-X
does	B-X
not	B-X
affect	B-X
extracellular	B-X
signal-regulated	B-X
kinase-1	B-X
and	B-X
-2	B-X
activation	B-X
.	B-X
MST1	B-X
is	B-X
unaffected	B-X
by	B-X
heat	B-X
shock	B-X
or	B-X
high	B-X
osmolarity	B-X
,	B-X
indicating	B-X
that	B-X
it	B-X
is	B-X
not	B-X
involved	B-X
in	B-X
the	B-X
stress-activated	B-X
or	B-X
high	B-X
osmolarity	B-X
glycerol	B-X
signal	B-X
transduction	B-X
pathways	B-X
.	B-X
Thus	B-X
MST1	B-X
,	B-X
although	B-X
homologous	B-X
to	B-X
a	B-X
member	B-X
of	B-X
a	B-X
yeast	B-X
MAPK	B-X
cascade	B-X
,	B-X
is	B-X
not	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
a	B-X
known	B-X
mammalian	B-X
MAPK	B-X
pathway	B-X
and	B-X
potentially	B-X
regulates	B-X
a	B-X
novel	B-X
signaling	B-X
cascade	B-X
.	B-X

Mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
MAPK	B-Gene_or_gene_product
)	O
signaling	O
cascades	O
include	O
MAPK	B-Gene_or_gene_product
or	O
extracellular	B-Gene_or_gene_product
signal	I-Gene_or_gene_product
-	I-Gene_or_gene_product
regulated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
ERK	B-Gene_or_gene_product
)	O
,	O
MAPK	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
MKK	B-Gene_or_gene_product
or	O
MEK	B-Gene_or_gene_product
)	O
,	O
and	O
MAPK	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
MAPKKK	B-Gene_or_gene_product
or	O
MEKK	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
The	B-X
RAS/RAF/MEK/ERK	B-X
(	B-X
MAPK	B-X
)	B-X
signaling	B-X
cascade	B-X
is	B-X
essential	B-X
for	B-X
cell	B-X
inter-	B-X
and	B-X
intra-cellular	B-X
communication	B-X
,	B-X
which	B-X
regulates	B-X
fundamental	B-X
cell	B-X
functions	B-X
such	B-X
as	B-X
growth	B-X
,	B-X
survival	B-X
,	B-X
and	B-X
differentiation	B-X
.	B-X
The	B-X
MAPK	B-X
pathway	B-X
also	B-X
integrates	B-X
signals	B-X
from	B-X
complex	B-X
intracellular	B-X
networks	B-X
in	B-X
performing	B-X
cellular	B-X
functions	B-X
.	B-X
Despite	B-X
the	B-X
initial	B-X
discovery	B-X
of	B-X
the	B-X
core	B-X
elements	B-X
of	B-X
the	B-X
MAPK	B-X
pathways	B-X
nearly	B-X
four	B-X
decades	B-X
ago	B-X
,	B-X
additional	B-X
findings	B-X
continue	B-X
to	B-X
make	B-X
a	B-X
thorough	B-X
understanding	B-X
of	B-X
the	B-X
molecular	B-X
mechanisms	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
this	B-X
pathway	B-X
challenging	B-X
.	B-X
Considerable	B-X
effort	B-X
has	B-X
been	B-X
focused	B-X
on	B-X
the	B-X
regulation	B-X
of	B-X
RAF	B-X
,	B-X
especially	B-X
after	B-X
the	B-X
discovery	B-X
of	B-X
drug	B-X
resistance	B-X
and	B-X
paradoxical	B-X
activation	B-X
upon	B-X
inhibitor	B-X
binding	B-X
to	B-X
the	B-X
kinase	B-X
.	B-X
RAF	B-X
activity	B-X
is	B-X
regulated	B-X
by	B-X
phosphorylation	B-X
and	B-X
conformation-dependent	B-X
regulation	B-X
,	B-X
including	B-X
auto-inhibition	B-X
and	B-X
dimerization	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
summarize	B-X
the	B-X
recent	B-X
major	B-X
findings	B-X
in	B-X
the	B-X
study	B-X
of	B-X
the	B-X
RAS/RAF/MEK/ERK	B-X
signaling	B-X
cascade	B-X
,	B-X
particularly	B-X
with	B-X
respect	B-X
to	B-X
the	B-X
impact	B-X
on	B-X
clinical	B-X
cancer	B-X
therapy	B-X
.	B-X

MAPKK	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
/	O
MEKK	B-Gene_or_gene_product
phosphorylates	O
and	O
activates	O
its	O
downstream	O
protein	O
kinase	O
,	O
MAPK	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
/	O
MEK	B-Gene_or_gene_product
,	O
which	O
in	O
turn	O
activates	O
MAPK	B-Gene_or_gene_product
.	O
<EOS>	B-X
We	B-X
previously	B-X
showed	B-X
activation	B-X
of	B-X
the	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
ERK	B-X
)	B-X
branch	B-X
of	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
cascade	B-X
in	B-X
hearts	B-X
of	B-X
mice	B-X
with	B-X
mutations	B-X
in	B-X
these	B-X
genes	B-X
.	B-X
Mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
signaling	B-X
cascades	B-X
include	B-X
MAPK	B-X
or	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
ERK	B-X
)	B-X
,	B-X
MAPK	B-X
kinase	B-X
(	B-X
MKK	B-X
or	B-X
MEK	B-X
)	B-X
,	B-X
and	B-X
MAPK	B-X
kinase	B-X
kinase	B-X
(	B-X
MAPKKK	B-X
or	B-X
MEKK	B-X
)	B-X
.	B-X
MAPKK	B-X
kinase/MEKK	B-X
phosphorylates	B-X
and	B-X
activates	B-X
its	B-X
downstream	B-X
protein	B-X
kinase	B-X
,	B-X
MAPK	B-X
kinase/MEK	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
activates	B-X
MAPK	B-X
.	B-X
We	B-X
report	B-X
herein	B-X
the	B-X
isolation	B-X
of	B-X
a	B-X
cDNA	B-X
encoding	B-X
a	B-X
novel	B-X
protein	B-X
kinase	B-X
designated	B-X
MAPKKK5	B-X
from	B-X
a	B-X
human	B-X
macrophage	B-X
library	B-X
.	B-X
The	B-X
nucleotide	B-X
sequence	B-X
predicts	B-X
that	B-X
MAPKKK5	B-X
encodes	B-X
an	B-X
open	B-X
reading	B-X
frame	B-X
of	B-X
1374	B-X
amino	B-X
acids	B-X
with	B-X
all	B-X
11	B-X
kinase	B-X
subdomains	B-X
.	B-X
The	B-X
putative	B-X
catalytic	B-X
domain	B-X
of	B-X
MAPKKK5	B-X
shows	B-X
significant	B-X
sequence	B-X
homology	B-X
to	B-X
the	B-X
kinase	B-X
domains	B-X
of	B-X
the	B-X
MAPKKK/MEKK	B-X
level	B-X
protein	B-X
kinases	B-X
from	B-X
mouse	B-X
MEKK2	B-X
and	B-X
-3	B-X
,	B-X
Drosophila	B-X
melanogaster	B-X
PK92B	B-X
,	B-X
Saccharomyces	B-X
cerevisiae	B-X
STE11	B-X
,	B-X
and	B-X
Schizosaccharomyces	B-X
pombe	B-X
BYR2	B-X
.	B-X
Northern	B-X
blot	B-X
analysis	B-X
showed	B-X
that	B-X
MAPKKK5	B-X
transcript	B-X
is	B-X
abundantly	B-X
expressed	B-X
in	B-X
human	B-X
heart	B-X
and	B-X
pancreas	B-X
.	B-X
When	B-X
transiently	B-X
expressed	B-X
in	B-X
COS	B-X
and	B-X
293	B-X
cells	B-X
,	B-X
MAPKKK5	B-X
markedly	B-X
activated	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
or	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
,	B-X
but	B-X
not	B-X
MAPK/ERK	B-X
.	B-X
Furthermore	B-X
,	B-X
MAPKKK5	B-X
that	B-X
was	B-X
immunoprecipitated	B-X
from	B-X
transfected	B-X
293	B-X
cells	B-X
was	B-X
able	B-X
to	B-X
phosphorylate	B-X
and	B-X
activate	B-X
MKK4	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
MAPKKK5	B-X
may	B-X
be	B-X
an	B-X
upstream	B-X
activator	B-X
of	B-X
MKK4	B-X
in	B-X
the	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
pathway	B-X
.	B-X

We	O
report	O
herein	O
the	O
isolation	O
of	O
a	O
cDNA	O
encoding	O
a	O
novel	O
protein	O
kinase	O
designated	O
MAPKKK5	B-Gene_or_gene_product
from	O
a	O
human	O
macrophage	O
library	O
.	O
<EOS>	B-X
Mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
signaling	B-X
cascades	B-X
include	B-X
MAPK	B-X
or	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
ERK	B-X
)	B-X
,	B-X
MAPK	B-X
kinase	B-X
(	B-X
MKK	B-X
or	B-X
MEK	B-X
)	B-X
,	B-X
and	B-X
MAPK	B-X
kinase	B-X
kinase	B-X
(	B-X
MAPKKK	B-X
or	B-X
MEKK	B-X
)	B-X
.	B-X
MAPKK	B-X
kinase/MEKK	B-X
phosphorylates	B-X
and	B-X
activates	B-X
its	B-X
downstream	B-X
protein	B-X
kinase	B-X
,	B-X
MAPK	B-X
kinase/MEK	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
activates	B-X
MAPK	B-X
.	B-X
We	B-X
report	B-X
herein	B-X
the	B-X
isolation	B-X
of	B-X
a	B-X
cDNA	B-X
encoding	B-X
a	B-X
novel	B-X
protein	B-X
kinase	B-X
designated	B-X
MAPKKK5	B-X
from	B-X
a	B-X
human	B-X
macrophage	B-X
library	B-X
.	B-X
The	B-X
nucleotide	B-X
sequence	B-X
predicts	B-X
that	B-X
MAPKKK5	B-X
encodes	B-X
an	B-X
open	B-X
reading	B-X
frame	B-X
of	B-X
1374	B-X
amino	B-X
acids	B-X
with	B-X
all	B-X
11	B-X
kinase	B-X
subdomains	B-X
.	B-X
The	B-X
putative	B-X
catalytic	B-X
domain	B-X
of	B-X
MAPKKK5	B-X
shows	B-X
significant	B-X
sequence	B-X
homology	B-X
to	B-X
the	B-X
kinase	B-X
domains	B-X
of	B-X
the	B-X
MAPKKK/MEKK	B-X
level	B-X
protein	B-X
kinases	B-X
from	B-X
mouse	B-X
MEKK2	B-X
and	B-X
-3	B-X
,	B-X
Drosophila	B-X
melanogaster	B-X
PK92B	B-X
,	B-X
Saccharomyces	B-X
cerevisiae	B-X
STE11	B-X
,	B-X
and	B-X
Schizosaccharomyces	B-X
pombe	B-X
BYR2	B-X
.	B-X
Northern	B-X
blot	B-X
analysis	B-X
showed	B-X
that	B-X
MAPKKK5	B-X
transcript	B-X
is	B-X
abundantly	B-X
expressed	B-X
in	B-X
human	B-X
heart	B-X
and	B-X
pancreas	B-X
.	B-X
When	B-X
transiently	B-X
expressed	B-X
in	B-X
COS	B-X
and	B-X
293	B-X
cells	B-X
,	B-X
MAPKKK5	B-X
markedly	B-X
activated	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
or	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
,	B-X
but	B-X
not	B-X
MAPK/ERK	B-X
.	B-X
Furthermore	B-X
,	B-X
MAPKKK5	B-X
that	B-X
was	B-X
immunoprecipitated	B-X
from	B-X
transfected	B-X
293	B-X
cells	B-X
was	B-X
able	B-X
to	B-X
phosphorylate	B-X
and	B-X
activate	B-X
MKK4	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
MAPKKK5	B-X
may	B-X
be	B-X
an	B-X
upstream	B-X
activator	B-X
of	B-X
MKK4	B-X
in	B-X
the	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
pathway	B-X
.	B-X

The	O
nucleotide	O
sequence	O
predicts	O
that	O
MAPKKK5	B-Gene_or_gene_product
encodes	O
an	O
open	O
reading	O
frame	O
of	O
1374	O
amino	O
acids	O
with	O
all	O
11	O
kinase	O
subdomains	O
.	O
<EOS>	B-X
Mitogen-activated	B-X
protein	B-X
kinase	B-X
(	B-X
MAPK	B-X
)	B-X
signaling	B-X
cascades	B-X
include	B-X
MAPK	B-X
or	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
ERK	B-X
)	B-X
,	B-X
MAPK	B-X
kinase	B-X
(	B-X
MKK	B-X
or	B-X
MEK	B-X
)	B-X
,	B-X
and	B-X
MAPK	B-X
kinase	B-X
kinase	B-X
(	B-X
MAPKKK	B-X
or	B-X
MEKK	B-X
)	B-X
.	B-X
MAPKK	B-X
kinase/MEKK	B-X
phosphorylates	B-X
and	B-X
activates	B-X
its	B-X
downstream	B-X
protein	B-X
kinase	B-X
,	B-X
MAPK	B-X
kinase/MEK	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
activates	B-X
MAPK	B-X
.	B-X
We	B-X
report	B-X
herein	B-X
the	B-X
isolation	B-X
of	B-X
a	B-X
cDNA	B-X
encoding	B-X
a	B-X
novel	B-X
protein	B-X
kinase	B-X
designated	B-X
MAPKKK5	B-X
from	B-X
a	B-X
human	B-X
macrophage	B-X
library	B-X
.	B-X
The	B-X
nucleotide	B-X
sequence	B-X
predicts	B-X
that	B-X
MAPKKK5	B-X
encodes	B-X
an	B-X
open	B-X
reading	B-X
frame	B-X
of	B-X
1374	B-X
amino	B-X
acids	B-X
with	B-X
all	B-X
11	B-X
kinase	B-X
subdomains	B-X
.	B-X
The	B-X
putative	B-X
catalytic	B-X
domain	B-X
of	B-X
MAPKKK5	B-X
shows	B-X
significant	B-X
sequence	B-X
homology	B-X
to	B-X
the	B-X
kinase	B-X
domains	B-X
of	B-X
the	B-X
MAPKKK/MEKK	B-X
level	B-X
protein	B-X
kinases	B-X
from	B-X
mouse	B-X
MEKK2	B-X
and	B-X
-3	B-X
,	B-X
Drosophila	B-X
melanogaster	B-X
PK92B	B-X
,	B-X
Saccharomyces	B-X
cerevisiae	B-X
STE11	B-X
,	B-X
and	B-X
Schizosaccharomyces	B-X
pombe	B-X
BYR2	B-X
.	B-X
Northern	B-X
blot	B-X
analysis	B-X
showed	B-X
that	B-X
MAPKKK5	B-X
transcript	B-X
is	B-X
abundantly	B-X
expressed	B-X
in	B-X
human	B-X
heart	B-X
and	B-X
pancreas	B-X
.	B-X
When	B-X
transiently	B-X
expressed	B-X
in	B-X
COS	B-X
and	B-X
293	B-X
cells	B-X
,	B-X
MAPKKK5	B-X
markedly	B-X
activated	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
or	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
,	B-X
but	B-X
not	B-X
MAPK/ERK	B-X
.	B-X
Furthermore	B-X
,	B-X
MAPKKK5	B-X
that	B-X
was	B-X
immunoprecipitated	B-X
from	B-X
transfected	B-X
293	B-X
cells	B-X
was	B-X
able	B-X
to	B-X
phosphorylate	B-X
and	B-X
activate	B-X
MKK4	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
MAPKKK5	B-X
may	B-X
be	B-X
an	B-X
upstream	B-X
activator	B-X
of	B-X
MKK4	B-X
in	B-X
the	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
pathway	B-X
.	B-X

The	O
putative	O
catalytic	O
domain	O
of	O
MAPKKK5	B-Gene_or_gene_product
shows	O
significant	O
sequence	O
homology	O
to	O
the	O
kinase	O
domains	O
of	O
the	O
MAPKKK	B-Gene_or_gene_product
/	O
MEKK	B-Gene_or_gene_product
level	O
protein	O
kinases	O
from	O
mouse	O
MEKK2	B-Gene_or_gene_product
and	O
-	B-Gene_or_gene_product
3	I-Gene_or_gene_product
,	O
Drosophila	O
melanogaster	O
PK92B	B-Gene_or_gene_product
,	O
Saccharomyces	O
cerevisiae	O
STE11	B-Gene_or_gene_product
,	O
and	O
Schizosaccharomyces	O
pombe	O
BYR2	B-Gene_or_gene_product
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
MAPKKK5	B-Gene_or_gene_product
transcript	O
is	O
abundantly	O
expressed	O
in	O
human	O
heart	O
and	O
pancreas	O
.	O
<EOS>	B-X
We	B-X
report	B-X
herein	B-X
the	B-X
isolation	B-X
of	B-X
a	B-X
cDNA	B-X
encoding	B-X
a	B-X
novel	B-X
protein	B-X
kinase	B-X
designated	B-X
MAPKKK5	B-X
from	B-X
a	B-X
human	B-X
macrophage	B-X
library	B-X
.	B-X
The	B-X
nucleotide	B-X
sequence	B-X
predicts	B-X
that	B-X
MAPKKK5	B-X
encodes	B-X
an	B-X
open	B-X
reading	B-X
frame	B-X
of	B-X
1374	B-X
amino	B-X
acids	B-X
with	B-X
all	B-X
11	B-X
kinase	B-X
subdomains	B-X
.	B-X
The	B-X
putative	B-X
catalytic	B-X
domain	B-X
of	B-X
MAPKKK5	B-X
shows	B-X
significant	B-X
sequence	B-X
homology	B-X
to	B-X
the	B-X
kinase	B-X
domains	B-X
of	B-X
the	B-X
MAPKKK/MEKK	B-X
level	B-X
protein	B-X
kinases	B-X
from	B-X
mouse	B-X
MEKK2	B-X
and	B-X
-3	B-X
,	B-X
Drosophila	B-X
melanogaster	B-X
PK92B	B-X
,	B-X
Saccharomyces	B-X
cerevisiae	B-X
STE11	B-X
,	B-X
and	B-X
Schizosaccharomyces	B-X
pombe	B-X
BYR2	B-X
.	B-X
Northern	B-X
blot	B-X
analysis	B-X
showed	B-X
that	B-X
MAPKKK5	B-X
transcript	B-X
is	B-X
abundantly	B-X
expressed	B-X
in	B-X
human	B-X
heart	B-X
and	B-X
pancreas	B-X
.	B-X
When	B-X
transiently	B-X
expressed	B-X
in	B-X
COS	B-X
and	B-X
293	B-X
cells	B-X
,	B-X
MAPKKK5	B-X
markedly	B-X
activated	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
or	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
,	B-X
but	B-X
not	B-X
MAPK/ERK	B-X
.	B-X
Furthermore	B-X
,	B-X
MAPKKK5	B-X
that	B-X
was	B-X
immunoprecipitated	B-X
from	B-X
transfected	B-X
293	B-X
cells	B-X
was	B-X
able	B-X
to	B-X
phosphorylate	B-X
and	B-X
activate	B-X
MKK4	B-X
in	B-X
vitro	B-X
,	B-X
suggesting	B-X
that	B-X
MAPKKK5	B-X
may	B-X
be	B-X
an	B-X
upstream	B-X
activator	B-X
of	B-X
MKK4	B-X
in	B-X
the	B-X
c-Jun	B-X
N-terminal	B-X
kinase	B-X
pathway	B-X
.	B-X

When	O
transiently	O
expressed	O
in	O
COS	O
and	O
293	O
cells	O
,	O
MAPKKK5	B-Gene_or_gene_product
markedly	O
activated	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
terminal	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
or	O
stress	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
,	O
but	O
not	O
MAPK	B-Gene_or_gene_product
/	O
ERK	B-Gene_or_gene_product
.	O
<EOS>	B-X
Salt	B-X
and	B-X
drought	B-X
stress	B-X
signal	B-X
transduction	B-X
consists	B-X
of	B-X
ionic	B-X
and	B-X
osmotic	B-X
homeostasis	B-X
signaling	B-X
pathways	B-X
,	B-X
detoxification	B-X
(	B-X
i.e.	B-X
,	B-X
damage	B-X
control	B-X
and	B-X
repair	B-X
)	B-X
response	B-X
pathways	B-X
,	B-X
and	B-X
pathways	B-X
for	B-X
growth	B-X
regulation	B-X
.	B-X
The	B-X
ionic	B-X
aspect	B-X
of	B-X
salt	B-X
stress	B-X
is	B-X
signaled	B-X
via	B-X
the	B-X
SOS	B-X
pathway	B-X
where	B-X
a	B-X
calcium-responsive	B-X
SOS3-SOS2	B-X
protein	B-X
kinase	B-X
complex	B-X
controls	B-X
the	B-X
expression	B-X
and	B-X
activity	B-X
of	B-X
ion	B-X
transporters	B-X
such	B-X
as	B-X
SOS1	B-X
.	B-X
Osmotic	B-X
stress	B-X
activates	B-X
several	B-X
protein	B-X
kinases	B-X
including	B-X
mitogen-activated	B-X
kinases	B-X
,	B-X
which	B-X
may	B-X
mediate	B-X
osmotic	B-X
homeostasis	B-X
and/or	B-X
detoxification	B-X
responses	B-X
.	B-X
A	B-X
number	B-X
of	B-X
phospholipid	B-X
systems	B-X
are	B-X
activated	B-X
by	B-X
osmotic	B-X
stress	B-X
,	B-X
generating	B-X
a	B-X
diverse	B-X
array	B-X
of	B-X
messenger	B-X
molecules	B-X
,	B-X
some	B-X
of	B-X
which	B-X
may	B-X
function	B-X
upstream	B-X
of	B-X
the	B-X
osmotic	B-X
stress-activated	B-X
protein	B-X
kinases	B-X
.	B-X
Abscisic	B-X
acid	B-X
biosynthesis	B-X
is	B-X
regulated	B-X
by	B-X
osmotic	B-X
stress	B-X
at	B-X
multiple	B-X
steps	B-X
.	B-X
Both	B-X
ABA-dependent	B-X
and	B-X
-independent	B-X
osmotic	B-X
stress	B-X
signaling	B-X
first	B-X
modify	B-X
constitutively	B-X
expressed	B-X
transcription	B-X
factors	B-X
,	B-X
leading	B-X
to	B-X
the	B-X
expression	B-X
of	B-X
early	B-X
response	B-X
transcriptional	B-X
activators	B-X
,	B-X
which	B-X
then	B-X
activate	B-X
downstream	B-X
stress	B-X
tolerance	B-X
effector	B-X
genes	B-X
.	B-X

Furthermore	O
,	O
MAPKKK5	B-Gene_or_gene_product
that	O
was	O
immunoprecipitated	O
from	O
transfected	O
293	O
cells	O
was	O
able	O
to	O
phosphorylate	O
and	O
activate	O
MKK4	B-Gene_or_gene_product
in	O
vitro	O
,	O
suggesting	O
that	O
MAPKKK5	B-Gene_or_gene_product
may	O
be	O
an	O
upstream	O
activator	O
of	O
MKK4	B-Gene_or_gene_product
in	O
the	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
terminal	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
pathway	O
.	O

Thyroid	O
Na	B-Gene_or_gene_product
+	I-Gene_or_gene_product
/	I-Gene_or_gene_product
I	I-Gene_or_gene_product
-	I-Gene_or_gene_product
symporter	I-Gene_or_gene_product
.	O

Mechanism	O
,	O
stoichiometry	O
,	O
and	O
specificity	O
.	O
<EOS>	B-X
This	B-X
topic	B-X
is	B-X
directly	B-X
related	B-X
to	B-X
other	B-X
questions	B-X
,	B-X
such	B-X
as	B-X
the	B-X
stoichiometry	B-X
of	B-X
PARP1	B-X
molecules	B-X
in	B-X
auto-modification	B-X
reaction	B-X
,	B-X
direction	B-X
of	B-X
the	B-X
chain	B-X
growth	B-X
during	B-X
PAR	B-X
elongation	B-X
and	B-X
functional	B-X
coupling	B-X
of	B-X
PARP1	B-X
with	B-X
PARylation	B-X
targets	B-X
.	B-X
Besides	B-X
DNA	B-X
damage	B-X
necessary	B-X
for	B-X
the	B-X
folding	B-X
of	B-X
catalytically	B-X
active	B-X
PARP1	B-X
,	B-X
other	B-X
mechanisms	B-X
appear	B-X
to	B-X
be	B-X
required	B-X
for	B-X
the	B-X
relevant	B-X
intensity	B-X
and	B-X
specificity	B-X
of	B-X
PARylation	B-X
reaction	B-X
.	B-X
MCT1	B-X
(	B-X
SLC16A1	B-X
)	B-X
and	B-X
MCT4	B-X
(	B-X
SLC16A3	B-X
)	B-X
are	B-X
H+-coupled	B-X
and	B-X
mediate	B-X
electroneutral	B-X
transport	B-X
of	B-X
SCFA	B-X
(	B-X
H+	B-X
:	B-X
SCFA	B-X
stoichiometry	B-X
;	B-X
1:1	B-X
)	B-X
.	B-X
SMCT1	B-X
(	B-X
SLC5A8	B-X
)	B-X
and	B-X
SMCT2	B-X
(	B-X
SLC5A12	B-X
)	B-X
are	B-X
Na+-coupled	B-X
;	B-X
SMCT1-mediated	B-X
transport	B-X
is	B-X
electrogenic	B-X
(	B-X
Na+	B-X
:	B-X
SCFA	B-X
stoichiometry	B-X
;	B-X
2:1	B-X
)	B-X
whereas	B-X
SMCT2-mediated	B-X
transport	B-X
is	B-X
electroneutral	B-X
(	B-X
Na+	B-X
:	B-X
SCFA	B-X
stoichiometry	B-X
;	B-X
1:1	B-X
)	B-X
.	B-X

The	O
rat	O
thyroid	O
Na	B-Gene_or_gene_product
+	I-Gene_or_gene_product
/	I-Gene_or_gene_product
I	I-Gene_or_gene_product
-	I-Gene_or_gene_product
symporter	I-Gene_or_gene_product
(	O
NIS	B-Gene_or_gene_product
)	O
was	O
expressed	O
in	O
Xenopus	O
laevis	O
oocytes	O
and	O
characterized	O
using	O
electrophysiological	O
,	O
tracer	O
uptake	O
,	O
and	O
electron	O
microscopic	O
methods	O
.	O

NIS	B-Gene_or_gene_product
activity	O
was	O
found	O
to	O
be	O
electrogenic	O
and	O
Na	O
+	O
-	O
dependent	O
(	O
Na	O
+	O
>	O
Li	O
+	O
>	O
H	O
+	O
)	O
.	O

The	O
apparent	O
affinity	O
constants	O
for	O
Na	O
+	O
and	O
I	O
-	O
were	O
28	O
+	O
/	O
-	O
3	O
mM	O
and	O
33	O
+	O
/	O
-	O
9	O
microM	O
,	O
respectively	O
.	O
<EOS>	B-X
The	B-X
rat	B-X
thyroid	B-X
Na+/I-	B-X
symporter	B-X
(	B-X
NIS	B-X
)	B-X
was	B-X
expressed	B-X
in	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
and	B-X
characterized	B-X
using	B-X
electrophysiological	B-X
,	B-X
tracer	B-X
uptake	B-X
,	B-X
and	B-X
electron	B-X
microscopic	B-X
methods	B-X
.	B-X
NIS	B-X
activity	B-X
was	B-X
found	B-X
to	B-X
be	B-X
electrogenic	B-X
and	B-X
Na+-dependent	B-X
(	B-X
Na+	B-X
>	B-X
>	B-X
Li+	B-X
>	B-X
>	B-X
H+	B-X
)	B-X
.	B-X
The	B-X
apparent	B-X
affinity	B-X
constants	B-X
for	B-X
Na+	B-X
and	B-X
I-	B-X
were	B-X
28	B-X
+/-	B-X
3	B-X
mM	B-X
and	B-X
33	B-X
+/-	B-X
9	B-X
microM	B-X
,	B-X
respectively	B-X
.	B-X
Stoichiometry	B-X
of	B-X
Na+/anion	B-X
cotransport	B-X
was	B-X
2:1	B-X
.	B-X
NIS	B-X
was	B-X
capable	B-X
of	B-X
transporting	B-X
a	B-X
wide	B-X
variety	B-X
of	B-X
anions	B-X
(	B-X
I-	B-X
,	B-X
ClO3-	B-X
,	B-X
SCN-	B-X
,	B-X
SeCN-	B-X
,	B-X
NO3-	B-X
,	B-X
Br-	B-X
,	B-X
BF4-	B-X
,	B-X
IO4-	B-X
,	B-X
BrO3-	B-X
,	B-X
but	B-X
perchlorate	B-X
(	B-X
ClO4-	B-X
)	B-X
was	B-X
not	B-X
transported	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
anion	B-X
substrate	B-X
,	B-X
NIS	B-X
exhibited	B-X
a	B-X
Na+-dependent	B-X
leak	B-X
current	B-X
(	B-X
approximately	B-X
35	B-X
%	B-X
of	B-X
maximum	B-X
substrate-induced	B-X
current	B-X
)	B-X
with	B-X
an	B-X
apparent	B-X
Na+	B-X
affinity	B-X
of	B-X
74	B-X
+/-	B-X
14	B-X
mM	B-X
and	B-X
a	B-X
Hill	B-X
coefficient	B-X
(	B-X
n	B-X
)	B-X
of	B-X
1	B-X
.	B-X
The	B-X
voltage	B-X
for	B-X
half-maximal	B-X
charge	B-X
translocation	B-X
(	B-X
V0.5	B-X
)	B-X
was	B-X
-15	B-X
+/-	B-X
3	B-X
mV	B-X
,	B-X
and	B-X
the	B-X
apparent	B-X
valence	B-X
of	B-X
the	B-X
movable	B-X
charge	B-X
was	B-X
1	B-X
.	B-X
Total	B-X
charge	B-X
was	B-X
insensitive	B-X
to	B-X
[	B-X
Na+	B-X
]	B-X
o	B-X
,	B-X
but	B-X
V0.5	B-X
shifted	B-X
to	B-X
more	B-X
negative	B-X
potentials	B-X
as	B-X
[	B-X
Na+	B-X
]	B-X
o	B-X
was	B-X
reduced	B-X
.	B-X
The	B-X
turnover	B-X
rate	B-X
of	B-X
NIS	B-X
was	B-X
>	B-X
/=22	B-X
s-1	B-X
in	B-X
the	B-X
Na+	B-X
uniport	B-X
mode	B-X
and	B-X
>	B-X
/=36	B-X
s-1	B-X
in	B-X
the	B-X
Na+/I-	B-X
cotransport	B-X
mode	B-X
.	B-X
On	B-X
the	B-X
basis	B-X
of	B-X
the	B-X
kinetic	B-X
results	B-X
,	B-X
we	B-X
propose	B-X
an	B-X
ordered	B-X
simultaneous	B-X
transport	B-X
mechanism	B-X
in	B-X
which	B-X
the	B-X
binding	B-X
of	B-X
Na+	B-X
to	B-X
NIS	B-X
occurs	B-X
first	B-X
.	B-X

Stoichiometry	O
of	O
Na	O
+	O
/	O
anion	O
cotransport	O
was	O
2	O
:	O
1	O
.	O
<EOS>	B-X
Obligatory	B-X
,	B-X
coupled	B-X
cotransport	B-X
of	B-X
Na	B-X
(	B-X
+	B-X
)	B-X
,	B-X
K	B-X
(	B-X
+	B-X
)	B-X
,	B-X
and	B-X
Cl	B-X
(	B-X
-	B-X
)	B-X
by	B-X
cell	B-X
membranes	B-X
has	B-X
been	B-X
reported	B-X
in	B-X
nearly	B-X
every	B-X
animal	B-X
cell	B-X
type	B-X
.	B-X
Two	B-X
isoforms	B-X
of	B-X
the	B-X
Na	B-X
(	B-X
+	B-X
)	B-X
-K	B-X
(	B-X
+	B-X
)	B-X
-Cl	B-X
(	B-X
-	B-X
)	B-X
cotransporter	B-X
(	B-X
NKCC	B-X
)	B-X
protein	B-X
(	B-X
approximately	B-X
120-130	B-X
kDa	B-X
,	B-X
unglycosylated	B-X
)	B-X
are	B-X
currently	B-X
known	B-X
.	B-X
One	B-X
isoform	B-X
(	B-X
NKCC2	B-X
)	B-X
has	B-X
at	B-X
least	B-X
three	B-X
alternatively	B-X
spliced	B-X
variants	B-X
and	B-X
is	B-X
found	B-X
exclusively	B-X
in	B-X
the	B-X
kidney	B-X
.	B-X
The	B-X
other	B-X
(	B-X
NKCC1	B-X
)	B-X
is	B-X
found	B-X
in	B-X
nearly	B-X
all	B-X
cell	B-X
types	B-X
.	B-X
Evidence	B-X
that	B-X
each	B-X
cotransport	B-X
cycle	B-X
of	B-X
the	B-X
NKCC	B-X
is	B-X
electrically	B-X
silent	B-X
is	B-X
discussed	B-X
along	B-X
with	B-X
evidence	B-X
for	B-X
the	B-X
electrically	B-X
neutral	B-X
stoichiometries	B-X
of	B-X
1	B-X
Na	B-X
(	B-X
+	B-X
)	B-X
:1	B-X
K	B-X
(	B-X
+	B-X
)	B-X
:2	B-X
Cl-	B-X
(	B-X
for	B-X
most	B-X
cells	B-X
)	B-X
and	B-X
2	B-X
Na	B-X
(	B-X
+	B-X
)	B-X
:1	B-X
K	B-X
(	B-X
+	B-X
)	B-X
:3	B-X
Cl	B-X
(	B-X
-	B-X
)	B-X
(	B-X
in	B-X
squid	B-X
axon	B-X
)	B-X
.	B-X
Although	B-X
the	B-X
NKCC	B-X
has	B-X
been	B-X
studied	B-X
for	B-X
approximately	B-X
20	B-X
years	B-X
,	B-X
we	B-X
are	B-X
only	B-X
beginning	B-X
to	B-X
frame	B-X
the	B-X
broad	B-X
outlines	B-X
of	B-X
the	B-X
structure	B-X
,	B-X
function	B-X
,	B-X
and	B-X
regulation	B-X
of	B-X
this	B-X
ubiquitous	B-X
ion	B-X
transport	B-X
mechanism	B-X
.	B-X

NIS	B-Gene_or_gene_product
was	O
capable	O
of	O
transporting	O
a	O
wide	O
variety	O
of	O
anions	O
(	O
I	O
-	O
,	O
ClO3	O
-	O
,	O
SCN	O
-	O
,	O
SeCN	O
-	O
,	O
NO3	O
-	O
,	O
Br	O
-	O
,	O
BF4	O
-	O
,	O
IO4	O
-	O
,	O
BrO3	O
-	O
,	O
but	O
perchlorate	O
(	O
ClO4	O
-	O
)	O
was	O
not	O
transported	O
.	O

In	O
the	O
absence	O
of	O
anion	O
substrate	O
,	O
NIS	B-Gene_or_gene_product
exhibited	O
a	O
Na	O
+	O
-	O
dependent	O
leak	O
current	O
(	O
approximately	O
35	O
%	O
of	O
maximum	O
substrate	O
-	O
induced	O
current	O
)	O
with	O
an	O
apparent	O
Na	O
+	O
affinity	O
of	O
74	O
+	O
/	O
-	O
14	O
mM	O
and	O
a	O
Hill	O
coefficient	O
(	O
n	O
)	O
of	O
1	O
.	O

In	O
response	O
to	O
step	O
voltage	O
changes	O
,	O
NIS	B-Gene_or_gene_product
exhibited	O
current	O
transients	O
that	O
relaxed	O
with	O
a	O
time	O
constant	O
of	O
8	O
-	O
14	O
ms	O
.	O
<EOS>	B-X
The	B-X
rat	B-X
thyroid	B-X
Na+/I-	B-X
symporter	B-X
(	B-X
NIS	B-X
)	B-X
was	B-X
expressed	B-X
in	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
and	B-X
characterized	B-X
using	B-X
electrophysiological	B-X
,	B-X
tracer	B-X
uptake	B-X
,	B-X
and	B-X
electron	B-X
microscopic	B-X
methods	B-X
.	B-X
NIS	B-X
activity	B-X
was	B-X
found	B-X
to	B-X
be	B-X
electrogenic	B-X
and	B-X
Na+-dependent	B-X
(	B-X
Na+	B-X
>	B-X
>	B-X
Li+	B-X
>	B-X
>	B-X
H+	B-X
)	B-X
.	B-X
The	B-X
apparent	B-X
affinity	B-X
constants	B-X
for	B-X
Na+	B-X
and	B-X
I-	B-X
were	B-X
28	B-X
+/-	B-X
3	B-X
mM	B-X
and	B-X
33	B-X
+/-	B-X
9	B-X
microM	B-X
,	B-X
respectively	B-X
.	B-X
NIS	B-X
was	B-X
capable	B-X
of	B-X
transporting	B-X
a	B-X
wide	B-X
variety	B-X
of	B-X
anions	B-X
(	B-X
I-	B-X
,	B-X
ClO3-	B-X
,	B-X
SCN-	B-X
,	B-X
SeCN-	B-X
,	B-X
NO3-	B-X
,	B-X
Br-	B-X
,	B-X
BF4-	B-X
,	B-X
IO4-	B-X
,	B-X
BrO3-	B-X
,	B-X
but	B-X
perchlorate	B-X
(	B-X
ClO4-	B-X
)	B-X
was	B-X
not	B-X
transported	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
anion	B-X
substrate	B-X
,	B-X
NIS	B-X
exhibited	B-X
a	B-X
Na+-dependent	B-X
leak	B-X
current	B-X
(	B-X
approximately	B-X
35	B-X
%	B-X
of	B-X
maximum	B-X
substrate-induced	B-X
current	B-X
)	B-X
with	B-X
an	B-X
apparent	B-X
Na+	B-X
affinity	B-X
of	B-X
74	B-X
+/-	B-X
14	B-X
mM	B-X
and	B-X
a	B-X
Hill	B-X
coefficient	B-X
(	B-X
n	B-X
)	B-X
of	B-X
1	B-X
.	B-X
In	B-X
response	B-X
to	B-X
step	B-X
voltage	B-X
changes	B-X
,	B-X
NIS	B-X
exhibited	B-X
current	B-X
transients	B-X
that	B-X
relaxed	B-X
with	B-X
a	B-X
time	B-X
constant	B-X
of	B-X
8-14	B-X
ms.	B-X
Presteady-state	B-X
charge	B-X
movements	B-X
(	B-X
integral	B-X
of	B-X
the	B-X
current	B-X
transients	B-X
)	B-X
versus	B-X
voltage	B-X
relations	B-X
obey	B-X
a	B-X
Boltzmann	B-X
relation	B-X
.	B-X
The	B-X
voltage	B-X
for	B-X
half-maximal	B-X
charge	B-X
translocation	B-X
(	B-X
V0.5	B-X
)	B-X
was	B-X
-15	B-X
+/-	B-X
3	B-X
mV	B-X
,	B-X
and	B-X
the	B-X
apparent	B-X
valence	B-X
of	B-X
the	B-X
movable	B-X
charge	B-X
was	B-X
1	B-X
.	B-X
NIS	B-X
charge	B-X
movements	B-X
are	B-X
attributed	B-X
to	B-X
the	B-X
conformational	B-X
changes	B-X
of	B-X
the	B-X
empty	B-X
transporter	B-X
within	B-X
the	B-X
membrane	B-X
electric	B-X
field	B-X
.	B-X
The	B-X
turnover	B-X
rate	B-X
of	B-X
NIS	B-X
was	B-X
>	B-X
/=22	B-X
s-1	B-X
in	B-X
the	B-X
Na+	B-X
uniport	B-X
mode	B-X
and	B-X
>	B-X
/=36	B-X
s-1	B-X
in	B-X
the	B-X
Na+/I-	B-X
cotransport	B-X
mode	B-X
.	B-X
Expression	B-X
of	B-X
NIS	B-X
in	B-X
oocytes	B-X
led	B-X
to	B-X
a	B-X
approximately	B-X
2	B-X
.	B-X
On	B-X
the	B-X
basis	B-X
of	B-X
the	B-X
kinetic	B-X
results	B-X
,	B-X
we	B-X
propose	B-X
an	B-X
ordered	B-X
simultaneous	B-X
transport	B-X
mechanism	B-X
in	B-X
which	B-X
the	B-X
binding	B-X
of	B-X
Na+	B-X
to	B-X
NIS	B-X
occurs	B-X
first	B-X
.	B-X

Presteady	O
-	O
state	O
charge	O
movements	O
(	O
integral	O
of	O
the	O
current	O
transients	O
)	O
versus	O
voltage	O
relations	O
obey	O
a	O
Boltzmann	O
relation	O
.	O

The	O
voltage	O
for	O
half	O
-	O
maximal	O
charge	O
translocation	O
(	O
V0	O
.	O
5	O
)	O
was	O
-	O
15	O
+	O
/	O
-	O
3	O
mV	O
,	O
and	O
the	O
apparent	O
valence	O
of	O
the	O
movable	O
charge	O
was	O
1	O
.	O
<EOS>	B-X
The	B-X
apparent	B-X
affinity	B-X
constants	B-X
for	B-X
Na+	B-X
and	B-X
I-	B-X
were	B-X
28	B-X
+/-	B-X
3	B-X
mM	B-X
and	B-X
33	B-X
+/-	B-X
9	B-X
microM	B-X
,	B-X
respectively	B-X
.	B-X
Stoichiometry	B-X
of	B-X
Na+/anion	B-X
cotransport	B-X
was	B-X
2:1	B-X
.	B-X
NIS	B-X
was	B-X
capable	B-X
of	B-X
transporting	B-X
a	B-X
wide	B-X
variety	B-X
of	B-X
anions	B-X
(	B-X
I-	B-X
,	B-X
ClO3-	B-X
,	B-X
SCN-	B-X
,	B-X
SeCN-	B-X
,	B-X
NO3-	B-X
,	B-X
Br-	B-X
,	B-X
BF4-	B-X
,	B-X
IO4-	B-X
,	B-X
BrO3-	B-X
,	B-X
but	B-X
perchlorate	B-X
(	B-X
ClO4-	B-X
)	B-X
was	B-X
not	B-X
transported	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
anion	B-X
substrate	B-X
,	B-X
NIS	B-X
exhibited	B-X
a	B-X
Na+-dependent	B-X
leak	B-X
current	B-X
(	B-X
approximately	B-X
35	B-X
%	B-X
of	B-X
maximum	B-X
substrate-induced	B-X
current	B-X
)	B-X
with	B-X
an	B-X
apparent	B-X
Na+	B-X
affinity	B-X
of	B-X
74	B-X
+/-	B-X
14	B-X
mM	B-X
and	B-X
a	B-X
Hill	B-X
coefficient	B-X
(	B-X
n	B-X
)	B-X
of	B-X
1	B-X
.	B-X
In	B-X
response	B-X
to	B-X
step	B-X
voltage	B-X
changes	B-X
,	B-X
NIS	B-X
exhibited	B-X
current	B-X
transients	B-X
that	B-X
relaxed	B-X
with	B-X
a	B-X
time	B-X
constant	B-X
of	B-X
8-14	B-X
ms.	B-X
Presteady-state	B-X
charge	B-X
movements	B-X
(	B-X
integral	B-X
of	B-X
the	B-X
current	B-X
transients	B-X
)	B-X
versus	B-X
voltage	B-X
relations	B-X
obey	B-X
a	B-X
Boltzmann	B-X
relation	B-X
.	B-X
The	B-X
voltage	B-X
for	B-X
half-maximal	B-X
charge	B-X
translocation	B-X
(	B-X
V0.5	B-X
)	B-X
was	B-X
-15	B-X
+/-	B-X
3	B-X
mV	B-X
,	B-X
and	B-X
the	B-X
apparent	B-X
valence	B-X
of	B-X
the	B-X
movable	B-X
charge	B-X
was	B-X
1	B-X
.	B-X
Total	B-X
charge	B-X
was	B-X
insensitive	B-X
to	B-X
[	B-X
Na+	B-X
]	B-X
o	B-X
,	B-X
but	B-X
V0.5	B-X
shifted	B-X
to	B-X
more	B-X
negative	B-X
potentials	B-X
as	B-X
[	B-X
Na+	B-X
]	B-X
o	B-X
was	B-X
reduced	B-X
.	B-X
NIS	B-X
charge	B-X
movements	B-X
are	B-X
attributed	B-X
to	B-X
the	B-X
conformational	B-X
changes	B-X
of	B-X
the	B-X
empty	B-X
transporter	B-X
within	B-X
the	B-X
membrane	B-X
electric	B-X
field	B-X
.	B-X
The	B-X
turnover	B-X
rate	B-X
of	B-X
NIS	B-X
was	B-X
>	B-X
/=22	B-X
s-1	B-X
in	B-X
the	B-X
Na+	B-X
uniport	B-X
mode	B-X
and	B-X
>	B-X
/=36	B-X
s-1	B-X
in	B-X
the	B-X
Na+/I-	B-X
cotransport	B-X
mode	B-X
.	B-X
5-fold	B-X
increase	B-X
in	B-X
the	B-X
density	B-X
of	B-X
plasma	B-X
membrane	B-X
protoplasmic	B-X
face	B-X
intramembrane	B-X
particles	B-X
.	B-X

Total	O
charge	O
was	O
insensitive	O
to	O
[	O
Na	O
+	O
]	O
o	O
,	O
but	O
V0	O
.	O
5	O
shifted	O
to	O
more	O
negative	O
potentials	O
as	O
[	O
Na	O
+	O
]	O
o	O
was	O
reduced	O
.	O

NIS	B-Gene_or_gene_product
charge	O
movements	O
are	O
attributed	O
to	O
the	O
conformational	O
changes	O
of	O
the	O
empty	O
transporter	O
within	O
the	O
membrane	O
electric	O
field	O
.	O

The	O
turnover	O
rate	O
of	O
NIS	B-Gene_or_gene_product
was	O
>	O
/	O
=	O
22	O
s	O
-	O
1	O
in	O
the	O
Na	O
+	O
uniport	O
mode	O
and	O
>	O
/	O
=	O
36	O
s	O
-	O
1	O
in	O
the	O
Na	O
+	O
/	O
I	O
-	O
cotransport	O
mode	O
.	O

Transporter	O
density	O
in	O
the	O
plasma	O
membrane	O
was	O
determined	O
using	O
freeze	O
-	O
fracture	O
electron	O
microscopy	O
.	O
<EOS>	B-X
The	B-X
aquaporins	B-X
(	B-X
AQPs	B-X
)	B-X
are	B-X
a	B-X
family	B-X
of	B-X
small	B-X
membrane-spanning	B-X
proteins	B-X
(	B-X
monomer	B-X
size	B-X
approximately	B-X
30	B-X
kDa	B-X
)	B-X
that	B-X
are	B-X
expressed	B-X
at	B-X
plasma	B-X
membranes	B-X
in	B-X
many	B-X
cells	B-X
types	B-X
involved	B-X
in	B-X
fluid	B-X
transport	B-X
.	B-X
Basic	B-X
features	B-X
of	B-X
aquaporin	B-X
structure	B-X
have	B-X
been	B-X
defined	B-X
using	B-X
mutagenesis	B-X
,	B-X
epitope	B-X
tagging	B-X
,	B-X
and	B-X
spectroscopic	B-X
and	B-X
freeze-fracture	B-X
electron	B-X
microscopy	B-X
methods	B-X
.	B-X
Aquaporins	B-X
appear	B-X
to	B-X
assemble	B-X
in	B-X
membranes	B-X
as	B-X
homotetramers	B-X
in	B-X
which	B-X
each	B-X
monomer	B-X
,	B-X
consisting	B-X
of	B-X
six	B-X
membrane-spanning	B-X
alpha-helical	B-X
domains	B-X
with	B-X
cytoplasmically	B-X
oriented	B-X
amino	B-X
and	B-X
carboxy	B-X
termini	B-X
,	B-X
contains	B-X
a	B-X
distinct	B-X
water	B-X
pore	B-X
.	B-X
Medium-resolution	B-X
structural	B-X
analysis	B-X
by	B-X
electron	B-X
cryocrystallography	B-X
indicated	B-X
that	B-X
the	B-X
six	B-X
tilted	B-X
helical	B-X
segments	B-X
form	B-X
a	B-X
barrel	B-X
surrounding	B-X
a	B-X
central	B-X
pore-like	B-X
region	B-X
that	B-X
contains	B-X
additional	B-X
protein	B-X
density	B-X
.	B-X

Expression	O
of	O
NIS	B-Gene_or_gene_product
in	O
oocytes	O
led	O
to	O
a	O
approximately	O
2	O
.	O
<EOS>	B-X
The	B-X
rat	B-X
thyroid	B-X
Na+/I-	B-X
symporter	B-X
(	B-X
NIS	B-X
)	B-X
was	B-X
expressed	B-X
in	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
and	B-X
characterized	B-X
using	B-X
electrophysiological	B-X
,	B-X
tracer	B-X
uptake	B-X
,	B-X
and	B-X
electron	B-X
microscopic	B-X
methods	B-X
.	B-X
NIS	B-X
activity	B-X
was	B-X
found	B-X
to	B-X
be	B-X
electrogenic	B-X
and	B-X
Na+-dependent	B-X
(	B-X
Na+	B-X
>	B-X
>	B-X
Li+	B-X
>	B-X
>	B-X
H+	B-X
)	B-X
.	B-X
The	B-X
apparent	B-X
affinity	B-X
constants	B-X
for	B-X
Na+	B-X
and	B-X
I-	B-X
were	B-X
28	B-X
+/-	B-X
3	B-X
mM	B-X
and	B-X
33	B-X
+/-	B-X
9	B-X
microM	B-X
,	B-X
respectively	B-X
.	B-X
Stoichiometry	B-X
of	B-X
Na+/anion	B-X
cotransport	B-X
was	B-X
2:1	B-X
.	B-X
NIS	B-X
was	B-X
capable	B-X
of	B-X
transporting	B-X
a	B-X
wide	B-X
variety	B-X
of	B-X
anions	B-X
(	B-X
I-	B-X
,	B-X
ClO3-	B-X
,	B-X
SCN-	B-X
,	B-X
SeCN-	B-X
,	B-X
NO3-	B-X
,	B-X
Br-	B-X
,	B-X
BF4-	B-X
,	B-X
IO4-	B-X
,	B-X
BrO3-	B-X
,	B-X
but	B-X
perchlorate	B-X
(	B-X
ClO4-	B-X
)	B-X
was	B-X
not	B-X
transported	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
anion	B-X
substrate	B-X
,	B-X
NIS	B-X
exhibited	B-X
a	B-X
Na+-dependent	B-X
leak	B-X
current	B-X
(	B-X
approximately	B-X
35	B-X
%	B-X
of	B-X
maximum	B-X
substrate-induced	B-X
current	B-X
)	B-X
with	B-X
an	B-X
apparent	B-X
Na+	B-X
affinity	B-X
of	B-X
74	B-X
+/-	B-X
14	B-X
mM	B-X
and	B-X
a	B-X
Hill	B-X
coefficient	B-X
(	B-X
n	B-X
)	B-X
of	B-X
1	B-X
.	B-X
In	B-X
response	B-X
to	B-X
step	B-X
voltage	B-X
changes	B-X
,	B-X
NIS	B-X
exhibited	B-X
current	B-X
transients	B-X
that	B-X
relaxed	B-X
with	B-X
a	B-X
time	B-X
constant	B-X
of	B-X
8-14	B-X
ms.	B-X
Presteady-state	B-X
charge	B-X
movements	B-X
(	B-X
integral	B-X
of	B-X
the	B-X
current	B-X
transients	B-X
)	B-X
versus	B-X
voltage	B-X
relations	B-X
obey	B-X
a	B-X
Boltzmann	B-X
relation	B-X
.	B-X
NIS	B-X
charge	B-X
movements	B-X
are	B-X
attributed	B-X
to	B-X
the	B-X
conformational	B-X
changes	B-X
of	B-X
the	B-X
empty	B-X
transporter	B-X
within	B-X
the	B-X
membrane	B-X
electric	B-X
field	B-X
.	B-X
The	B-X
turnover	B-X
rate	B-X
of	B-X
NIS	B-X
was	B-X
>	B-X
/=22	B-X
s-1	B-X
in	B-X
the	B-X
Na+	B-X
uniport	B-X
mode	B-X
and	B-X
>	B-X
/=36	B-X
s-1	B-X
in	B-X
the	B-X
Na+/I-	B-X
cotransport	B-X
mode	B-X
.	B-X
Expression	B-X
of	B-X
NIS	B-X
in	B-X
oocytes	B-X
led	B-X
to	B-X
a	B-X
approximately	B-X
2	B-X
.	B-X
On	B-X
the	B-X
basis	B-X
of	B-X
the	B-X
kinetic	B-X
results	B-X
,	B-X
we	B-X
propose	B-X
an	B-X
ordered	B-X
simultaneous	B-X
transport	B-X
mechanism	B-X
in	B-X
which	B-X
the	B-X
binding	B-X
of	B-X
Na+	B-X
to	B-X
NIS	B-X
occurs	B-X
first	B-X
.	B-X

5	O
-	O
fold	O
increase	O
in	O
the	O
density	O
of	O
plasma	O
membrane	O
protoplasmic	O
face	O
intramembrane	O
particles	O
.	O
<EOS>	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
anion	B-X
substrate	B-X
,	B-X
NIS	B-X
exhibited	B-X
a	B-X
Na+-dependent	B-X
leak	B-X
current	B-X
(	B-X
approximately	B-X
35	B-X
%	B-X
of	B-X
maximum	B-X
substrate-induced	B-X
current	B-X
)	B-X
with	B-X
an	B-X
apparent	B-X
Na+	B-X
affinity	B-X
of	B-X
74	B-X
+/-	B-X
14	B-X
mM	B-X
and	B-X
a	B-X
Hill	B-X
coefficient	B-X
(	B-X
n	B-X
)	B-X
of	B-X
1	B-X
.	B-X
The	B-X
voltage	B-X
for	B-X
half-maximal	B-X
charge	B-X
translocation	B-X
(	B-X
V0.5	B-X
)	B-X
was	B-X
-15	B-X
+/-	B-X
3	B-X
mV	B-X
,	B-X
and	B-X
the	B-X
apparent	B-X
valence	B-X
of	B-X
the	B-X
movable	B-X
charge	B-X
was	B-X
1	B-X
.	B-X
Total	B-X
charge	B-X
was	B-X
insensitive	B-X
to	B-X
[	B-X
Na+	B-X
]	B-X
o	B-X
,	B-X
but	B-X
V0.5	B-X
shifted	B-X
to	B-X
more	B-X
negative	B-X
potentials	B-X
as	B-X
[	B-X
Na+	B-X
]	B-X
o	B-X
was	B-X
reduced	B-X
.	B-X
NIS	B-X
charge	B-X
movements	B-X
are	B-X
attributed	B-X
to	B-X
the	B-X
conformational	B-X
changes	B-X
of	B-X
the	B-X
empty	B-X
transporter	B-X
within	B-X
the	B-X
membrane	B-X
electric	B-X
field	B-X
.	B-X
Transporter	B-X
density	B-X
in	B-X
the	B-X
plasma	B-X
membrane	B-X
was	B-X
determined	B-X
using	B-X
freeze-fracture	B-X
electron	B-X
microscopy	B-X
.	B-X
5-fold	B-X
increase	B-X
in	B-X
the	B-X
density	B-X
of	B-X
plasma	B-X
membrane	B-X
protoplasmic	B-X
face	B-X
intramembrane	B-X
particles	B-X
.	B-X

On	O
the	O
basis	O
of	O
the	O
kinetic	O
results	O
,	O
we	O
propose	O
an	O
ordered	O
simultaneous	O
transport	O
mechanism	O
in	O
which	O
the	O
binding	O
of	O
Na	O
+	O
to	O
NIS	B-Gene_or_gene_product
occurs	O
first	O
.	O

MyD88	B-Gene_or_gene_product
:	O
an	O
adapter	O
that	O
recruits	O
IRAK	B-Gene_or_gene_product
to	O
the	O
IL	O
-	O
1	O
receptor	O
complex	O
.	O

IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
is	O
a	O
proinflammatory	O
cytokine	O
that	O
signals	O
through	O
a	O
receptor	O
complex	O
of	O
two	O
different	O
transmembrane	O
chains	O
to	O
generate	O
multiple	O
cellular	O
responses	O
,	O
including	O
activation	O
of	O
the	O
transcription	O
factor	O
NF	O
-	O
kappaB	O
.	O
<EOS>	B-X
IL-1	B-X
is	B-X
a	B-X
proinflammatory	B-X
cytokine	B-X
that	B-X
signals	B-X
through	B-X
a	B-X
receptor	B-X
complex	B-X
of	B-X
two	B-X
different	B-X
transmembrane	B-X
chains	B-X
to	B-X
generate	B-X
multiple	B-X
cellular	B-X
responses	B-X
,	B-X
including	B-X
activation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
NF-kappaB	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
MyD88	B-X
,	B-X
a	B-X
previously	B-X
described	B-X
protein	B-X
of	B-X
unknown	B-X
function	B-X
,	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
IL-1	B-X
receptor	B-X
complex	B-X
following	B-X
IL-1	B-X
stimulation	B-X
.	B-X
MyD88	B-X
binds	B-X
to	B-X
both	B-X
IRAK	B-X
(	B-X
IL-1	B-X
receptor-associated	B-X
kinase	B-X
)	B-X
and	B-X
the	B-X
heterocomplex	B-X
(	B-X
the	B-X
signaling	B-X
complex	B-X
)	B-X
of	B-X
the	B-X
two	B-X
receptor	B-X
chains	B-X
and	B-X
thereby	B-X
mediates	B-X
the	B-X
association	B-X
of	B-X
IRAK	B-X
with	B-X
the	B-X
receptor	B-X
.	B-X
Ectopic	B-X
expression	B-X
of	B-X
MyD88	B-X
or	B-X
its	B-X
death	B-X
domain-containing	B-X
N-terminus	B-X
activates	B-X
NF-kappaB	B-X
.	B-X
The	B-X
C-terminus	B-X
of	B-X
MyD88	B-X
interacts	B-X
with	B-X
the	B-X
IL-1	B-X
receptor	B-X
and	B-X
blocks	B-X
NF-kappaB	B-X
activation	B-X
induced	B-X
by	B-X
IL-1	B-X
,	B-X
but	B-X
not	B-X
by	B-X
TNF	B-X
.	B-X
Thus	B-X
,	B-X
MyD88	B-X
plays	B-X
the	B-X
same	B-X
role	B-X
in	B-X
IL-1	B-X
signaling	B-X
as	B-X
TRADD	B-X
and	B-X
Tube	B-X
do	B-X
in	B-X
TNF	B-X
and	B-X
Toll	B-X
pathways	B-X
,	B-X
respectively	B-X
:	B-X
it	B-X
couples	B-X
a	B-X
serine/threonine	B-X
protein	B-X
kinase	B-X
to	B-X
the	B-X
receptor	B-X
complex	B-X
.	B-X

Here	O
we	O
show	O
that	O
MyD88	B-Gene_or_gene_product
,	O
a	O
previously	O
described	O
protein	O
of	O
unknown	O
function	O
,	O
is	O
recruited	O
to	O
the	O
IL	O
-	O
1	O
receptor	O
complex	O
following	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
stimulation	O
.	O

MyD88	B-Gene_or_gene_product
binds	O
to	O
both	O
IRAK	B-Gene_or_gene_product
(	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
)	O
and	O
the	O
heterocomplex	O
(	O
the	O
signaling	O
complex	O
)	O
of	O
the	O
two	O
receptor	O
chains	O
and	O
thereby	O
mediates	O
the	O
association	O
of	O
IRAK	B-Gene_or_gene_product
with	O
the	O
receptor	O
.	O
<EOS>	B-X
IL-1	B-X
is	B-X
a	B-X
proinflammatory	B-X
cytokine	B-X
that	B-X
signals	B-X
through	B-X
a	B-X
receptor	B-X
complex	B-X
of	B-X
two	B-X
different	B-X
transmembrane	B-X
chains	B-X
to	B-X
generate	B-X
multiple	B-X
cellular	B-X
responses	B-X
,	B-X
including	B-X
activation	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
NF-kappaB	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
MyD88	B-X
,	B-X
a	B-X
previously	B-X
described	B-X
protein	B-X
of	B-X
unknown	B-X
function	B-X
,	B-X
is	B-X
recruited	B-X
to	B-X
the	B-X
IL-1	B-X
receptor	B-X
complex	B-X
following	B-X
IL-1	B-X
stimulation	B-X
.	B-X
MyD88	B-X
binds	B-X
to	B-X
both	B-X
IRAK	B-X
(	B-X
IL-1	B-X
receptor-associated	B-X
kinase	B-X
)	B-X
and	B-X
the	B-X
heterocomplex	B-X
(	B-X
the	B-X
signaling	B-X
complex	B-X
)	B-X
of	B-X
the	B-X
two	B-X
receptor	B-X
chains	B-X
and	B-X
thereby	B-X
mediates	B-X
the	B-X
association	B-X
of	B-X
IRAK	B-X
with	B-X
the	B-X
receptor	B-X
.	B-X
Ectopic	B-X
expression	B-X
of	B-X
MyD88	B-X
or	B-X
its	B-X
death	B-X
domain-containing	B-X
N-terminus	B-X
activates	B-X
NF-kappaB	B-X
.	B-X
The	B-X
C-terminus	B-X
of	B-X
MyD88	B-X
interacts	B-X
with	B-X
the	B-X
IL-1	B-X
receptor	B-X
and	B-X
blocks	B-X
NF-kappaB	B-X
activation	B-X
induced	B-X
by	B-X
IL-1	B-X
,	B-X
but	B-X
not	B-X
by	B-X
TNF	B-X
.	B-X
Thus	B-X
,	B-X
MyD88	B-X
plays	B-X
the	B-X
same	B-X
role	B-X
in	B-X
IL-1	B-X
signaling	B-X
as	B-X
TRADD	B-X
and	B-X
Tube	B-X
do	B-X
in	B-X
TNF	B-X
and	B-X
Toll	B-X
pathways	B-X
,	B-X
respectively	B-X
:	B-X
it	B-X
couples	B-X
a	B-X
serine/threonine	B-X
protein	B-X
kinase	B-X
to	B-X
the	B-X
receptor	B-X
complex	B-X
.	B-X

Ectopic	O
expression	O
of	O
MyD88	B-Gene_or_gene_product
or	O
its	O
death	O
domain	O
-	O
containing	O
N	O
-	O
terminus	O
activates	O
NF	O
-	O
kappaB	O
.	O
<EOS>	B-X
Pyroptosis	B-X
is	B-X
the	B-X
process	B-X
of	B-X
inflammatory	B-X
cell	B-X
death	B-X
.	B-X
The	B-X
last	B-X
step	B-X
of	B-X
pyroptosis	B-X
requires	B-X
the	B-X
cleavage	B-X
of	B-X
gasdermin	B-X
D	B-X
(	B-X
GsdmD	B-X
)	B-X
at	B-X
D275	B-X
(	B-X
numbering	B-X
after	B-X
human	B-X
GSDMD	B-X
)	B-X
into	B-X
N-	B-X
and	B-X
C-termini	B-X
by	B-X
caspase	B-X
1	B-X
in	B-X
the	B-X
canonical	B-X
pathway	B-X
and	B-X
caspase	B-X
4/5/11	B-X
(	B-X
caspase	B-X
4/5	B-X
in	B-X
humans	B-X
,	B-X
caspase	B-X
11	B-X
in	B-X
mice	B-X
)	B-X
in	B-X
the	B-X
noncanonical	B-X
pathway	B-X
.	B-X
Upon	B-X
cleavage	B-X
,	B-X
the	B-X
N-terminus	B-X
of	B-X
GsdmD	B-X
(	B-X
GsdmD-N	B-X
)	B-X
forms	B-X
a	B-X
transmembrane	B-X
pore	B-X
that	B-X
releases	B-X
cytokines	B-X
such	B-X
as	B-X
IL-1	B-X
TRADD	B-X
has	B-X
two	B-X
distinct	B-X
functional	B-X
domains	B-X
,	B-X
a	B-X
TRAF-binding	B-X
domain	B-X
at	B-X
the	B-X
N-terminus	B-X
and	B-X
a	B-X
death	B-X
domain	B-X
(	B-X
DD	B-X
)	B-X
at	B-X
the	B-X
C-terminus	B-X
.	B-X
The	B-X
TRAF	B-X
binding	B-X
domain	B-X
of	B-X
TRADD	B-X
folds	B-X
into	B-X
an	B-X
α-β	B-X
plait	B-X
topology	B-X
and	B-X
is	B-X
mainly	B-X
responsible	B-X
for	B-X
binding	B-X
TRAF2	B-X
,	B-X
while	B-X
the	B-X
TRADD-DD	B-X
can	B-X
interact	B-X
with	B-X
a	B-X
variety	B-X
of	B-X
DD-containing	B-X
proteins	B-X
,	B-X
including	B-X
receptors	B-X
and	B-X
intracellular	B-X
signaling	B-X
molecules	B-X
.	B-X
After	B-X
activation	B-X
of	B-X
specific	B-X
receptors	B-X
such	B-X
as	B-X
TNFR1	B-X
and	B-X
DR3	B-X
,	B-X
TRADD	B-X
can	B-X
bind	B-X
to	B-X
the	B-X
receptor	B-X
through	B-X
DD-DD	B-X
interaction	B-X
,	B-X
creating	B-X
a	B-X
membrane-proximal	B-X
platform	B-X
for	B-X
the	B-X
recruitment	B-X
of	B-X
downstream	B-X
molecules	B-X
to	B-X
propagate	B-X
cellular	B-X
signals	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
highlight	B-X
recent	B-X
advances	B-X
in	B-X
the	B-X
studies	B-X
of	B-X
the	B-X
structural	B-X
mechanism	B-X
of	B-X
TRADD	B-X
adaptor	B-X
functions	B-X
for	B-X
NF-κB	B-X
activation	B-X
and	B-X
apoptosis	B-X
induction	B-X
.	B-X

The	O
C	O
-	O
terminus	O
of	O
MyD88	B-Gene_or_gene_product
interacts	O
with	O
the	O
IL	O
-	O
1	O
receptor	O
and	O
blocks	O
NF	O
-	O
kappaB	O
activation	O
induced	O
by	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
but	O
not	O
by	O
TNF	B-Gene_or_gene_product
.	O

Thus	O
,	O
MyD88	B-Gene_or_gene_product
plays	O
the	O
same	O
role	O
in	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
signaling	O
as	O
TRADD	B-Gene_or_gene_product
and	O
Tube	B-Gene_or_gene_product
do	O
in	O
TNF	B-Gene_or_gene_product
and	O
Toll	B-Gene_or_gene_product
pathways	O
,	O
respectively	O
:	O
it	O
couples	O
a	O
serine	O
/	O
threonine	O
protein	O
kinase	O
to	O
the	O
receptor	O
complex	O
.	O

The	O
characterization	O
of	O
butyrate	O
transport	O
across	O
pig	O
and	O
human	O
colonic	O
luminal	O
membrane	O
.	O
<EOS>	B-X
Luminal	B-X
membrane	B-X
vesicles	B-X
(	B-X
LMV	B-X
)	B-X
were	B-X
isolated	B-X
from	B-X
human	B-X
and	B-X
pig	B-X
colonic	B-X
tissues	B-X
.	B-X
They	B-X
were	B-X
characterized	B-X
in	B-X
terms	B-X
of	B-X
purity	B-X
and	B-X
ability	B-X
to	B-X
transport	B-X
[	B-X
14C	B-X
]	B-X
butyrate	B-X
.	B-X
The	B-X
activity	B-X
of	B-X
cysteine-sensitive	B-X
alkaline	B-X
phosphatase	B-X
,	B-X
and	B-X
the	B-X
abundance	B-X
of	B-X
villin	B-X
,	B-X
NHE2	B-X
and	B-X
NHE3	B-X
proteins	B-X
,	B-X
markers	B-X
of	B-X
the	B-X
colonic	B-X
luminal	B-X
membrane	B-X
,	B-X
were	B-X
significantly	B-X
enriched	B-X
in	B-X
the	B-X
LMV	B-X
compared	B-X
with	B-X
the	B-X
original	B-X
cellular	B-X
homogenate	B-X
.	B-X
The	B-X
LMV	B-X
were	B-X
free	B-X
from	B-X
contamination	B-X
by	B-X
other	B-X
cellular	B-X
organelles	B-X
and	B-X
basolateral	B-X
membranes	B-X
,	B-X
as	B-X
revealed	B-X
by	B-X
the	B-X
negligible	B-X
presence	B-X
of	B-X
either	B-X
specific	B-X
marker	B-X
enzyme	B-X
activity	B-X
or	B-X
characteristic	B-X
immunogenic	B-X
protein	B-X
.	B-X
The	B-X
transport	B-X
of	B-X
butyrate	B-X
into	B-X
the	B-X
luminal	B-X
membrane	B-X
vesicles	B-X
was	B-X
enhanced	B-X
5-fold	B-X
at	B-X
pH	B-X
5.5	B-X
compared	B-X
with	B-X
pH	B-X
8.0	B-X
.	B-X
Butyrate	B-X
transport	B-X
was	B-X
temperature	B-X
dependent	B-X
,	B-X
and	B-X
was	B-X
stimulated	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
an	B-X
outward-directed	B-X
anion	B-X
gradient	B-X
in	B-X
the	B-X
order	B-X
of	B-X
butyrate	B-X
>	B-X
bicarbonate	B-X
>	B-X
propionate	B-X
>	B-X
chloride	B-X
.	B-X
Butyrate	B-X
transport	B-X
was	B-X
significantly	B-X
reduced	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
short	B-X
chain	B-X
fatty	B-X
acids	B-X
(	B-X
SCFA	B-X
)	B-X
,	B-X
acetate	B-X
,	B-X
propionate	B-X
and	B-X
other	B-X
monocarboxylates	B-X
(	B-X
pyruvate	B-X
and	B-X
L-lactate	B-X
)	B-X
.	B-X
The	B-X
described	B-X
properties	B-X
of	B-X
butyrate	B-X
transport	B-X
across	B-X
the	B-X
luminal	B-X
pole	B-X
of	B-X
the	B-X
colon	B-X
suggest	B-X
the	B-X
involvement	B-X
of	B-X
a	B-X
carrier	B-X
protein	B-X
,	B-X
in	B-X
the	B-X
form	B-X
of	B-X
a	B-X
pH-activated	B-X
anion	B-X
exchange	B-X
process	B-X
.	B-X
The	B-X
transporter	B-X
is	B-X
distinct	B-X
from	B-X
the	B-X
erythrocyte	B-X
band-3	B-X
type	B-X
anion	B-X
exchanger	B-X
and	B-X
may	B-X
belong	B-X
to	B-X
the	B-X
monocarboxylate-type	B-X
transport	B-X
proteins	B-X
(	B-X
MCT1	B-X
)	B-X
.	B-X

1	O
.	O
<EOS>	B-X
Formate	B-X
assay	B-X
in	B-X
body	B-X
fluids	B-X
:	B-X
application	B-X
in	B-X
methanol	B-X
poisoning	B-X
.	B-X

Luminal	O
membrane	O
vesicles	O
(	O
LMV	O
)	O
were	O
isolated	O
from	O
human	O
and	O
pig	O
colonic	O
tissues	O
.	O
<EOS>	B-X
Luminal	B-X
membrane	B-X
vesicles	B-X
(	B-X
LMV	B-X
)	B-X
were	B-X
isolated	B-X
from	B-X
human	B-X
and	B-X
pig	B-X
colonic	B-X
tissues	B-X
.	B-X
The	B-X
activity	B-X
of	B-X
cysteine-sensitive	B-X
alkaline	B-X
phosphatase	B-X
,	B-X
and	B-X
the	B-X
abundance	B-X
of	B-X
villin	B-X
,	B-X
NHE2	B-X
and	B-X
NHE3	B-X
proteins	B-X
,	B-X
markers	B-X
of	B-X
the	B-X
colonic	B-X
luminal	B-X
membrane	B-X
,	B-X
were	B-X
significantly	B-X
enriched	B-X
in	B-X
the	B-X
LMV	B-X
compared	B-X
with	B-X
the	B-X
original	B-X
cellular	B-X
homogenate	B-X
.	B-X
The	B-X
LMV	B-X
were	B-X
free	B-X
from	B-X
contamination	B-X
by	B-X
other	B-X
cellular	B-X
organelles	B-X
and	B-X
basolateral	B-X
membranes	B-X
,	B-X
as	B-X
revealed	B-X
by	B-X
the	B-X
negligible	B-X
presence	B-X
of	B-X
either	B-X
specific	B-X
marker	B-X
enzyme	B-X
activity	B-X
or	B-X
characteristic	B-X
immunogenic	B-X
protein	B-X
.	B-X
The	B-X
transport	B-X
of	B-X
butyrate	B-X
into	B-X
the	B-X
luminal	B-X
membrane	B-X
vesicles	B-X
was	B-X
enhanced	B-X
5-fold	B-X
at	B-X
pH	B-X
5.5	B-X
compared	B-X
with	B-X
pH	B-X
8.0	B-X
.	B-X

They	O
were	O
characterized	O
in	O
terms	O
of	O
purity	O
and	O
ability	O
to	O
transport	O
[	O
14C	O
]	O
butyrate	O
.	O
<EOS>	B-X
They	B-X
were	B-X
characterized	B-X
in	B-X
terms	B-X
of	B-X
purity	B-X
and	B-X
ability	B-X
to	B-X
transport	B-X
[	B-X
14C	B-X
]	B-X
butyrate	B-X
.	B-X
The	B-X
transport	B-X
of	B-X
butyrate	B-X
into	B-X
the	B-X
luminal	B-X
membrane	B-X
vesicles	B-X
was	B-X
enhanced	B-X
5-fold	B-X
at	B-X
pH	B-X
5.5	B-X
compared	B-X
with	B-X
pH	B-X
8.0	B-X
.	B-X
Butyrate	B-X
transport	B-X
was	B-X
temperature	B-X
dependent	B-X
,	B-X
and	B-X
was	B-X
stimulated	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
an	B-X
outward-directed	B-X
anion	B-X
gradient	B-X
in	B-X
the	B-X
order	B-X
of	B-X
butyrate	B-X
>	B-X
bicarbonate	B-X
>	B-X
propionate	B-X
>	B-X
chloride	B-X
.	B-X
Butyrate	B-X
transport	B-X
was	B-X
significantly	B-X
reduced	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
short	B-X
chain	B-X
fatty	B-X
acids	B-X
(	B-X
SCFA	B-X
)	B-X
,	B-X
acetate	B-X
,	B-X
propionate	B-X
and	B-X
other	B-X
monocarboxylates	B-X
(	B-X
pyruvate	B-X
and	B-X
L-lactate	B-X
)	B-X
.	B-X
The	B-X
described	B-X
properties	B-X
of	B-X
butyrate	B-X
transport	B-X
across	B-X
the	B-X
luminal	B-X
pole	B-X
of	B-X
the	B-X
colon	B-X
suggest	B-X
the	B-X
involvement	B-X
of	B-X
a	B-X
carrier	B-X
protein	B-X
,	B-X
in	B-X
the	B-X
form	B-X
of	B-X
a	B-X
pH-activated	B-X
anion	B-X
exchange	B-X
process	B-X
.	B-X
The	B-X
transporter	B-X
is	B-X
distinct	B-X
from	B-X
the	B-X
erythrocyte	B-X
band-3	B-X
type	B-X
anion	B-X
exchanger	B-X
and	B-X
may	B-X
belong	B-X
to	B-X
the	B-X
monocarboxylate-type	B-X
transport	B-X
proteins	B-X
(	B-X
MCT1	B-X
)	B-X
.	B-X

2	O
.	O
<EOS>	B-X
Delineation	B-X
of	B-X
the	B-X
intimate	B-X
details	B-X
of	B-X
the	B-X
backbone	B-X
conformation	B-X
of	B-X
pyridine	B-X
nucleotide	B-X
coenzymes	B-X
in	B-X
aqueous	B-X
solution	B-X
.	B-X

The	O
activity	O
of	O
cysteine	O
-	O
sensitive	O
alkaline	B-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
,	O
and	O
the	O
abundance	O
of	O
villin	B-Gene_or_gene_product
,	O
NHE2	B-Gene_or_gene_product
and	O
NHE3	B-Gene_or_gene_product
proteins	O
,	O
markers	O
of	O
the	O
colonic	O
luminal	O
membrane	O
,	O
were	O
significantly	O
enriched	O
in	O
the	O
LMV	O
compared	O
with	O
the	O
original	O
cellular	O
homogenate	O
.	O
<EOS>	B-X
Luminal	B-X
membrane	B-X
vesicles	B-X
(	B-X
LMV	B-X
)	B-X
were	B-X
isolated	B-X
from	B-X
human	B-X
and	B-X
pig	B-X
colonic	B-X
tissues	B-X
.	B-X
The	B-X
activity	B-X
of	B-X
cysteine-sensitive	B-X
alkaline	B-X
phosphatase	B-X
,	B-X
and	B-X
the	B-X
abundance	B-X
of	B-X
villin	B-X
,	B-X
NHE2	B-X
and	B-X
NHE3	B-X
proteins	B-X
,	B-X
markers	B-X
of	B-X
the	B-X
colonic	B-X
luminal	B-X
membrane	B-X
,	B-X
were	B-X
significantly	B-X
enriched	B-X
in	B-X
the	B-X
LMV	B-X
compared	B-X
with	B-X
the	B-X
original	B-X
cellular	B-X
homogenate	B-X
.	B-X
The	B-X
LMV	B-X
were	B-X
free	B-X
from	B-X
contamination	B-X
by	B-X
other	B-X
cellular	B-X
organelles	B-X
and	B-X
basolateral	B-X
membranes	B-X
,	B-X
as	B-X
revealed	B-X
by	B-X
the	B-X
negligible	B-X
presence	B-X
of	B-X
either	B-X
specific	B-X
marker	B-X
enzyme	B-X
activity	B-X
or	B-X
characteristic	B-X
immunogenic	B-X
protein	B-X
.	B-X
The	B-X
transport	B-X
of	B-X
butyrate	B-X
into	B-X
the	B-X
luminal	B-X
membrane	B-X
vesicles	B-X
was	B-X
enhanced	B-X
5-fold	B-X
at	B-X
pH	B-X
5.5	B-X
compared	B-X
with	B-X
pH	B-X
8.0	B-X
.	B-X
Butyrate	B-X
transport	B-X
was	B-X
significantly	B-X
reduced	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
short	B-X
chain	B-X
fatty	B-X
acids	B-X
(	B-X
SCFA	B-X
)	B-X
,	B-X
acetate	B-X
,	B-X
propionate	B-X
and	B-X
other	B-X
monocarboxylates	B-X
(	B-X
pyruvate	B-X
and	B-X
L-lactate	B-X
)	B-X
.	B-X
Butyrate	B-X
uptake	B-X
was	B-X
inhibited	B-X
by	B-X
several	B-X
cysteine	B-X
group	B-X
modifying	B-X
reagents	B-X
such	B-X
as	B-X
p-chloromercuribenzosulphonic	B-X
acid	B-X
(	B-X
pCMBS	B-X
)	B-X
,	B-X
p-chloromercuribenzoate	B-X
(	B-X
pCMB	B-X
)	B-X
,	B-X
mersalyl	B-X
acid	B-X
and	B-X
HgCl2	B-X
,	B-X
but	B-X
not	B-X
by	B-X
the	B-X
stilbene	B-X
anion	B-X
exchange	B-X
inhibitors	B-X
,	B-X
4,4'-diisothiocyanostilbene-2,2'-disulphonate	B-X
(	B-X
DIDS	B-X
)	B-X
and	B-X
4,4'-dinitrostilbene-2,2'-disulphonate	B-X
(	B-X
SITS	B-X
)	B-X
.	B-X
The	B-X
described	B-X
properties	B-X
of	B-X
butyrate	B-X
transport	B-X
across	B-X
the	B-X
luminal	B-X
pole	B-X
of	B-X
the	B-X
colon	B-X
suggest	B-X
the	B-X
involvement	B-X
of	B-X
a	B-X
carrier	B-X
protein	B-X
,	B-X
in	B-X
the	B-X
form	B-X
of	B-X
a	B-X
pH-activated	B-X
anion	B-X
exchange	B-X
process	B-X
.	B-X
The	B-X
transporter	B-X
is	B-X
distinct	B-X
from	B-X
the	B-X
erythrocyte	B-X
band-3	B-X
type	B-X
anion	B-X
exchanger	B-X
and	B-X
may	B-X
belong	B-X
to	B-X
the	B-X
monocarboxylate-type	B-X
transport	B-X
proteins	B-X
(	B-X
MCT1	B-X
)	B-X
.	B-X

The	O
LMV	O
were	O
free	O
from	O
contamination	O
by	O
other	O
cellular	O
organelles	O
and	O
basolateral	O
membranes	O
,	O
as	O
revealed	O
by	O
the	O
negligible	O
presence	O
of	O
either	O
specific	O
marker	O
enzyme	O
activity	O
or	O
characteristic	O
immunogenic	O
protein	O
.	O
<EOS>	B-X
They	B-X
are	B-X
assembled	B-X
from	B-X
two	B-X
major	B-X
types	B-X
of	B-X
biomolecules	B-X
,	B-X
the	B-X
nucleic	B-X
acids	B-X
and	B-X
the	B-X
proteins	B-X
,	B-X
with	B-X
the	B-X
latter	B-X
forming	B-X
a	B-X
capsid	B-X
and	B-X
the	B-X
former	B-X
being	B-X
encapsulated	B-X
.	B-X
In	B-X
recent	B-X
years	B-X
,	B-X
many	B-X
studies	B-X
have	B-X
been	B-X
explored	B-X
about	B-X
using	B-X
phages	B-X
as	B-X
nanomedicine	B-X
platforms	B-X
for	B-X
developing	B-X
vaccines	B-X
due	B-X
to	B-X
their	B-X
unique	B-X
biological	B-X
characteristics	B-X
.	B-X
Phage-displayed	B-X
vaccines	B-X
are	B-X
the	B-X
phages	B-X
with	B-X
peptide	B-X
or	B-X
protein	B-X
antigens	B-X
genetically	B-X
displayed	B-X
on	B-X
their	B-X
surfaces	B-X
as	B-X
well	B-X
as	B-X
those	B-X
with	B-X
antigens	B-X
chemically	B-X
conjugated	B-X
or	B-X
biologically	B-X
bound	B-X
on	B-X
their	B-X
surfaces	B-X
.	B-X
The	B-X
phages	B-X
can	B-X
then	B-X
deliver	B-X
the	B-X
immunogenic	B-X
peptides	B-X
or	B-X
proteins	B-X
to	B-X
the	B-X
target	B-X
cells	B-X
or	B-X
tissues	B-X
.	B-X
The	B-X
antigens	B-X
,	B-X
either	B-X
as	B-X
the	B-X
immunogenic	B-X
peptides	B-X
or	B-X
proteins	B-X
displayed	B-X
on	B-X
the	B-X
phages	B-X
,	B-X
or	B-X
as	B-X
the	B-X
products	B-X
expressed	B-X
from	B-X
the	B-X
vaccine	B-X
genes	B-X
,	B-X
can	B-X
serve	B-X
as	B-X
vaccines	B-X
to	B-X
elicit	B-X
immune	B-X
responses	B-X
for	B-X
disease	B-X
prevention	B-X
and	B-X
treatment	B-X
.	B-X

3	O
.	O
<EOS>	B-X
Metal	B-X
substitutions	B-X
incarbonic	B-X
anhydrase	B-X
:	B-X
a	B-X
halide	B-X
ion	B-X
probe	B-X
study	B-X
.	B-X

The	O
transport	O
of	O
butyrate	O
into	O
the	O
luminal	O
membrane	O
vesicles	O
was	O
enhanced	O
5	O
-	O
fold	O
at	O
pH	O
5	O
.	O
5	O
compared	O
with	O
pH	O
8	O
.	O
0	O
.	O

Butyrate	O
transport	O
was	O
temperature	O
dependent	O
,	O
and	O
was	O
stimulated	O
in	O
the	O
presence	O
of	O
an	O
outward	O
-	O
directed	O
anion	O
gradient	O
in	O
the	O
order	O
of	O
butyrate	O
>	O
bicarbonate	O
>	O
propionate	O
>	O
chloride	O
.	O
<EOS>	B-X
They	B-X
were	B-X
characterized	B-X
in	B-X
terms	B-X
of	B-X
purity	B-X
and	B-X
ability	B-X
to	B-X
transport	B-X
[	B-X
14C	B-X
]	B-X
butyrate	B-X
.	B-X
The	B-X
LMV	B-X
were	B-X
free	B-X
from	B-X
contamination	B-X
by	B-X
other	B-X
cellular	B-X
organelles	B-X
and	B-X
basolateral	B-X
membranes	B-X
,	B-X
as	B-X
revealed	B-X
by	B-X
the	B-X
negligible	B-X
presence	B-X
of	B-X
either	B-X
specific	B-X
marker	B-X
enzyme	B-X
activity	B-X
or	B-X
characteristic	B-X
immunogenic	B-X
protein	B-X
.	B-X
The	B-X
transport	B-X
of	B-X
butyrate	B-X
into	B-X
the	B-X
luminal	B-X
membrane	B-X
vesicles	B-X
was	B-X
enhanced	B-X
5-fold	B-X
at	B-X
pH	B-X
5.5	B-X
compared	B-X
with	B-X
pH	B-X
8.0	B-X
.	B-X
Butyrate	B-X
transport	B-X
was	B-X
temperature	B-X
dependent	B-X
,	B-X
and	B-X
was	B-X
stimulated	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
an	B-X
outward-directed	B-X
anion	B-X
gradient	B-X
in	B-X
the	B-X
order	B-X
of	B-X
butyrate	B-X
>	B-X
bicarbonate	B-X
>	B-X
propionate	B-X
>	B-X
chloride	B-X
.	B-X
Butyrate	B-X
transport	B-X
was	B-X
significantly	B-X
reduced	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
short	B-X
chain	B-X
fatty	B-X
acids	B-X
(	B-X
SCFA	B-X
)	B-X
,	B-X
acetate	B-X
,	B-X
propionate	B-X
and	B-X
other	B-X
monocarboxylates	B-X
(	B-X
pyruvate	B-X
and	B-X
L-lactate	B-X
)	B-X
.	B-X
Butyrate	B-X
uptake	B-X
was	B-X
inhibited	B-X
by	B-X
several	B-X
cysteine	B-X
group	B-X
modifying	B-X
reagents	B-X
such	B-X
as	B-X
p-chloromercuribenzosulphonic	B-X
acid	B-X
(	B-X
pCMBS	B-X
)	B-X
,	B-X
p-chloromercuribenzoate	B-X
(	B-X
pCMB	B-X
)	B-X
,	B-X
mersalyl	B-X
acid	B-X
and	B-X
HgCl2	B-X
,	B-X
but	B-X
not	B-X
by	B-X
the	B-X
stilbene	B-X
anion	B-X
exchange	B-X
inhibitors	B-X
,	B-X
4,4'-diisothiocyanostilbene-2,2'-disulphonate	B-X
(	B-X
DIDS	B-X
)	B-X
and	B-X
4,4'-dinitrostilbene-2,2'-disulphonate	B-X
(	B-X
SITS	B-X
)	B-X
.	B-X
The	B-X
described	B-X
properties	B-X
of	B-X
butyrate	B-X
transport	B-X
across	B-X
the	B-X
luminal	B-X
pole	B-X
of	B-X
the	B-X
colon	B-X
suggest	B-X
the	B-X
involvement	B-X
of	B-X
a	B-X
carrier	B-X
protein	B-X
,	B-X
in	B-X
the	B-X
form	B-X
of	B-X
a	B-X
pH-activated	B-X
anion	B-X
exchange	B-X
process	B-X
.	B-X
The	B-X
transporter	B-X
is	B-X
distinct	B-X
from	B-X
the	B-X
erythrocyte	B-X
band-3	B-X
type	B-X
anion	B-X
exchanger	B-X
and	B-X
may	B-X
belong	B-X
to	B-X
the	B-X
monocarboxylate-type	B-X
transport	B-X
proteins	B-X
(	B-X
MCT1	B-X
)	B-X
.	B-X

Kinetic	O
analysis	O
of	O
increasing	O
substrate	O
concentration	O
showed	O
saturation	O
kinetics	O
with	O
an	O
apparent	O
Km	O
value	O
of	O
14	O
.	O
8	O
+	O
/	O
-	O
3	O
.	O
6	O
mM	O
and	O
a	O
Vmax	O
of	O
54	O
+	O
/	O
-	O
14	O
nmol	O
min	O
-	O
1	O
(	O
mg	O
protein	O
)	O
-	O
1	O
.	O

4	O
.	O
<EOS>	B-X
Effect	B-X
of	B-X
chloroquine	B-X
on	B-X
cultured	B-X
fibroblasts	B-X
:	B-X
release	B-X
of	B-X
lysosomal	B-X
hydrolases	B-X
and	B-X
inhibition	B-X
of	B-X
their	B-X
uptake	B-X
.	B-X

Butyrate	O
transport	O
was	O
significantly	O
reduced	O
in	O
the	O
presence	O
of	O
short	O
chain	O
fatty	O
acids	O
(	O
SCFA	O
)	O
,	O
acetate	O
,	O
propionate	O
and	O
other	O
monocarboxylates	O
(	O
pyruvate	O
and	O
L	O
-	O
lactate	O
)	O
.	O
<EOS>	B-X
Luminal	B-X
membrane	B-X
vesicles	B-X
(	B-X
LMV	B-X
)	B-X
were	B-X
isolated	B-X
from	B-X
human	B-X
and	B-X
pig	B-X
colonic	B-X
tissues	B-X
.	B-X
They	B-X
were	B-X
characterized	B-X
in	B-X
terms	B-X
of	B-X
purity	B-X
and	B-X
ability	B-X
to	B-X
transport	B-X
[	B-X
14C	B-X
]	B-X
butyrate	B-X
.	B-X
The	B-X
activity	B-X
of	B-X
cysteine-sensitive	B-X
alkaline	B-X
phosphatase	B-X
,	B-X
and	B-X
the	B-X
abundance	B-X
of	B-X
villin	B-X
,	B-X
NHE2	B-X
and	B-X
NHE3	B-X
proteins	B-X
,	B-X
markers	B-X
of	B-X
the	B-X
colonic	B-X
luminal	B-X
membrane	B-X
,	B-X
were	B-X
significantly	B-X
enriched	B-X
in	B-X
the	B-X
LMV	B-X
compared	B-X
with	B-X
the	B-X
original	B-X
cellular	B-X
homogenate	B-X
.	B-X
The	B-X
LMV	B-X
were	B-X
free	B-X
from	B-X
contamination	B-X
by	B-X
other	B-X
cellular	B-X
organelles	B-X
and	B-X
basolateral	B-X
membranes	B-X
,	B-X
as	B-X
revealed	B-X
by	B-X
the	B-X
negligible	B-X
presence	B-X
of	B-X
either	B-X
specific	B-X
marker	B-X
enzyme	B-X
activity	B-X
or	B-X
characteristic	B-X
immunogenic	B-X
protein	B-X
.	B-X
The	B-X
transport	B-X
of	B-X
butyrate	B-X
into	B-X
the	B-X
luminal	B-X
membrane	B-X
vesicles	B-X
was	B-X
enhanced	B-X
5-fold	B-X
at	B-X
pH	B-X
5.5	B-X
compared	B-X
with	B-X
pH	B-X
8.0	B-X
.	B-X
Butyrate	B-X
transport	B-X
was	B-X
temperature	B-X
dependent	B-X
,	B-X
and	B-X
was	B-X
stimulated	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
an	B-X
outward-directed	B-X
anion	B-X
gradient	B-X
in	B-X
the	B-X
order	B-X
of	B-X
butyrate	B-X
>	B-X
bicarbonate	B-X
>	B-X
propionate	B-X
>	B-X
chloride	B-X
.	B-X
Butyrate	B-X
transport	B-X
was	B-X
significantly	B-X
reduced	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
short	B-X
chain	B-X
fatty	B-X
acids	B-X
(	B-X
SCFA	B-X
)	B-X
,	B-X
acetate	B-X
,	B-X
propionate	B-X
and	B-X
other	B-X
monocarboxylates	B-X
(	B-X
pyruvate	B-X
and	B-X
L-lactate	B-X
)	B-X
.	B-X
Butyrate	B-X
uptake	B-X
was	B-X
inhibited	B-X
by	B-X
several	B-X
cysteine	B-X
group	B-X
modifying	B-X
reagents	B-X
such	B-X
as	B-X
p-chloromercuribenzosulphonic	B-X
acid	B-X
(	B-X
pCMBS	B-X
)	B-X
,	B-X
p-chloromercuribenzoate	B-X
(	B-X
pCMB	B-X
)	B-X
,	B-X
mersalyl	B-X
acid	B-X
and	B-X
HgCl2	B-X
,	B-X
but	B-X
not	B-X
by	B-X
the	B-X
stilbene	B-X
anion	B-X
exchange	B-X
inhibitors	B-X
,	B-X
4,4'-diisothiocyanostilbene-2,2'-disulphonate	B-X
(	B-X
DIDS	B-X
)	B-X
and	B-X
4,4'-dinitrostilbene-2,2'-disulphonate	B-X
(	B-X
SITS	B-X
)	B-X
.	B-X
The	B-X
described	B-X
properties	B-X
of	B-X
butyrate	B-X
transport	B-X
across	B-X
the	B-X
luminal	B-X
pole	B-X
of	B-X
the	B-X
colon	B-X
suggest	B-X
the	B-X
involvement	B-X
of	B-X
a	B-X
carrier	B-X
protein	B-X
,	B-X
in	B-X
the	B-X
form	B-X
of	B-X
a	B-X
pH-activated	B-X
anion	B-X
exchange	B-X
process	B-X
.	B-X
The	B-X
transporter	B-X
is	B-X
distinct	B-X
from	B-X
the	B-X
erythrocyte	B-X
band-3	B-X
type	B-X
anion	B-X
exchanger	B-X
and	B-X
may	B-X
belong	B-X
to	B-X
the	B-X
monocarboxylate-type	B-X
transport	B-X
proteins	B-X
(	B-X
MCT1	B-X
)	B-X
.	B-X

Butyrate	O
uptake	O
was	O
inhibited	O
by	O
several	O
cysteine	O
group	O
modifying	O
reagents	O
such	O
as	O
p	O
-	O
chloromercuribenzosulphonic	O
acid	O
(	O
pCMBS	O
)	O
,	O
p	O
-	O
chloromercuribenzoate	O
(	O
pCMB	O
)	O
,	O
mersalyl	O
acid	O
and	O
HgCl2	O
,	O
but	O
not	O
by	O
the	O
stilbene	O
anion	O
exchange	O
inhibitors	O
,	O
4	O
,	O
4	O
'	O
-	O
diisothiocyanostilbene	O
-	O
2	O
,	O
2	O
'	O
-	O
disulphonate	O
(	O
DIDS	O
)	O
and	O
4	O
,	O
4	O
'	O
-	O
dinitrostilbene	O
-	O
2	O
,	O
2	O
'	O
-	O
disulphonate	O
(	O
SITS	O
)	O
.	O

5	O
.	O
<EOS>	B-X
Atomic	B-X
models	B-X
for	B-X
the	B-X
polypeptide	B-X
backbones	B-X
of	B-X
myohemerythrin	B-X
and	B-X
hemerythrin	B-X
.	B-X

The	O
described	O
properties	O
of	O
butyrate	O
transport	O
across	O
the	O
luminal	O
pole	O
of	O
the	O
colon	O
suggest	O
the	O
involvement	O
of	O
a	O
carrier	O
protein	O
,	O
in	O
the	O
form	O
of	O
a	O
pH	O
-	O
activated	O
anion	O
exchange	O
process	O
.	O

The	O
transporter	O
is	O
distinct	O
from	O
the	O
erythrocyte	O
band	O
-	O
3	O
type	O
anion	O
exchanger	O
and	O
may	O
belong	O
to	O
the	O
monocarboxylate	B-Gene_or_gene_product
-	I-Gene_or_gene_product
type	I-Gene_or_gene_product
transport	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
(	O
MCT1	B-Gene_or_gene_product
)	O
.	O

Cloning	O
and	O
functional	O
expression	O
of	O
a	O
cDNA	O
encoding	O
a	O
mammalian	O
sodium	O
-	O
dependent	O
vitamin	O
transporter	O
mediating	O
the	O
uptake	O
of	O
pantothenate	O
,	O
biotin	O
,	O
and	O
lipoate	O
.	O
<EOS>	B-X
Previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
a	B-X
Na+-dependent	B-X
transport	B-X
system	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
transplacental	B-X
transfer	B-X
of	B-X
the	B-X
vitamins	B-X
pantothenate	B-X
and	B-X
biotin	B-X
and	B-X
the	B-X
essential	B-X
metabolite	B-X
lipoate	B-X
.	B-X
We	B-X
now	B-X
report	B-X
the	B-X
isolation	B-X
of	B-X
a	B-X
rat	B-X
placental	B-X
cDNA	B-X
encoding	B-X
a	B-X
transport	B-X
protein	B-X
responsible	B-X
for	B-X
this	B-X
function	B-X
.	B-X
The	B-X
cloned	B-X
cDNA	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
HeLa	B-X
cells	B-X
,	B-X
induces	B-X
Na+-dependent	B-X
pantothenate	B-X
and	B-X
biotin	B-X
transport	B-X
activities	B-X
.	B-X
The	B-X
transporter	B-X
is	B-X
specific	B-X
for	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
.	B-X
The	B-X
Michaelis-Menten	B-X
constant	B-X
(	B-X
Kt	B-X
)	B-X
for	B-X
the	B-X
transport	B-X
of	B-X
pantothenate	B-X
and	B-X
biotin	B-X
in	B-X
cDNA-transfected	B-X
cells	B-X
is	B-X
4.9	B-X
+/-	B-X
1.1	B-X
and	B-X
15.1	B-X
+/-	B-X
1.2	B-X
microM	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
transport	B-X
of	B-X
both	B-X
vitamins	B-X
in	B-X
cDNA-transfected	B-X
cells	B-X
is	B-X
inhibited	B-X
by	B-X
lipoate	B-X
with	B-X
an	B-X
inhibition	B-X
constant	B-X
(	B-X
Ki	B-X
)	B-X
of	B-X
approximately	B-X
5	B-X
microM	B-X
.	B-X
The	B-X
nucleotide	B-X
sequence	B-X
of	B-X
the	B-X
cDNA	B-X
(	B-X
sodium-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
)	B-X
predicts	B-X
a	B-X
protein	B-X
of	B-X
68.6	B-X
kDa	B-X
with	B-X
634	B-X
amino	B-X
acids	B-X
and	B-X
12	B-X
potential	B-X
transmembrane	B-X
domains	B-X
.	B-X
Protein	B-X
data	B-X
base	B-X
search	B-X
indicates	B-X
significant	B-X
sequence	B-X
similarity	B-X
between	B-X
SMVT	B-X
and	B-X
known	B-X
members	B-X
of	B-X
the	B-X
Na+-dependent	B-X
glucose	B-X
transporter	B-X
family	B-X
.	B-X
SMVT	B-X
represents	B-X
the	B-X
first	B-X
Na+-dependent	B-X
vitamin	B-X
transporter	B-X
to	B-X
be	B-X
cloned	B-X
from	B-X
a	B-X
mammalian	B-X
tissue	B-X
.	B-X

Previous	O
studies	O
have	O
shown	O
that	O
a	O
Na	O
+	O
-	O
dependent	O
transport	O
system	O
is	O
responsible	O
for	O
the	O
transplacental	O
transfer	O
of	O
the	O
vitamins	O
pantothenate	O
and	O
biotin	O
and	O
the	O
essential	O
metabolite	O
lipoate	O
.	O
<EOS>	B-X
Previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
a	B-X
Na+-dependent	B-X
transport	B-X
system	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
transplacental	B-X
transfer	B-X
of	B-X
the	B-X
vitamins	B-X
pantothenate	B-X
and	B-X
biotin	B-X
and	B-X
the	B-X
essential	B-X
metabolite	B-X
lipoate	B-X
.	B-X
We	B-X
now	B-X
report	B-X
the	B-X
isolation	B-X
of	B-X
a	B-X
rat	B-X
placental	B-X
cDNA	B-X
encoding	B-X
a	B-X
transport	B-X
protein	B-X
responsible	B-X
for	B-X
this	B-X
function	B-X
.	B-X
The	B-X
cloned	B-X
cDNA	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
HeLa	B-X
cells	B-X
,	B-X
induces	B-X
Na+-dependent	B-X
pantothenate	B-X
and	B-X
biotin	B-X
transport	B-X
activities	B-X
.	B-X
The	B-X
transporter	B-X
is	B-X
specific	B-X
for	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
.	B-X
The	B-X
Michaelis-Menten	B-X
constant	B-X
(	B-X
Kt	B-X
)	B-X
for	B-X
the	B-X
transport	B-X
of	B-X
pantothenate	B-X
and	B-X
biotin	B-X
in	B-X
cDNA-transfected	B-X
cells	B-X
is	B-X
4.9	B-X
+/-	B-X
1.1	B-X
and	B-X
15.1	B-X
+/-	B-X
1.2	B-X
microM	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
transport	B-X
of	B-X
both	B-X
vitamins	B-X
in	B-X
cDNA-transfected	B-X
cells	B-X
is	B-X
inhibited	B-X
by	B-X
lipoate	B-X
with	B-X
an	B-X
inhibition	B-X
constant	B-X
(	B-X
Ki	B-X
)	B-X
of	B-X
approximately	B-X
5	B-X
microM	B-X
.	B-X
The	B-X
nucleotide	B-X
sequence	B-X
of	B-X
the	B-X
cDNA	B-X
(	B-X
sodium-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
)	B-X
predicts	B-X
a	B-X
protein	B-X
of	B-X
68.6	B-X
kDa	B-X
with	B-X
634	B-X
amino	B-X
acids	B-X
and	B-X
12	B-X
potential	B-X
transmembrane	B-X
domains	B-X
.	B-X
Protein	B-X
data	B-X
base	B-X
search	B-X
indicates	B-X
significant	B-X
sequence	B-X
similarity	B-X
between	B-X
SMVT	B-X
and	B-X
known	B-X
members	B-X
of	B-X
the	B-X
Na+-dependent	B-X
glucose	B-X
transporter	B-X
family	B-X
.	B-X
SMVT	B-X
represents	B-X
the	B-X
first	B-X
Na+-dependent	B-X
vitamin	B-X
transporter	B-X
to	B-X
be	B-X
cloned	B-X
from	B-X
a	B-X
mammalian	B-X
tissue	B-X
.	B-X

We	O
now	O
report	O
the	O
isolation	O
of	O
a	O
rat	O
placental	O
cDNA	O
encoding	O
a	O
transport	O
protein	O
responsible	O
for	O
this	O
function	O
.	O
<EOS>	B-X
Previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
a	B-X
Na+-dependent	B-X
transport	B-X
system	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
transplacental	B-X
transfer	B-X
of	B-X
the	B-X
vitamins	B-X
pantothenate	B-X
and	B-X
biotin	B-X
and	B-X
the	B-X
essential	B-X
metabolite	B-X
lipoate	B-X
.	B-X
We	B-X
now	B-X
report	B-X
the	B-X
isolation	B-X
of	B-X
a	B-X
rat	B-X
placental	B-X
cDNA	B-X
encoding	B-X
a	B-X
transport	B-X
protein	B-X
responsible	B-X
for	B-X
this	B-X
function	B-X
.	B-X
The	B-X
cloned	B-X
cDNA	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
HeLa	B-X
cells	B-X
,	B-X
induces	B-X
Na+-dependent	B-X
pantothenate	B-X
and	B-X
biotin	B-X
transport	B-X
activities	B-X
.	B-X
The	B-X
transporter	B-X
is	B-X
specific	B-X
for	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
.	B-X
The	B-X
Michaelis-Menten	B-X
constant	B-X
(	B-X
Kt	B-X
)	B-X
for	B-X
the	B-X
transport	B-X
of	B-X
pantothenate	B-X
and	B-X
biotin	B-X
in	B-X
cDNA-transfected	B-X
cells	B-X
is	B-X
4.9	B-X
+/-	B-X
1.1	B-X
and	B-X
15.1	B-X
+/-	B-X
1.2	B-X
microM	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
transport	B-X
of	B-X
both	B-X
vitamins	B-X
in	B-X
cDNA-transfected	B-X
cells	B-X
is	B-X
inhibited	B-X
by	B-X
lipoate	B-X
with	B-X
an	B-X
inhibition	B-X
constant	B-X
(	B-X
Ki	B-X
)	B-X
of	B-X
approximately	B-X
5	B-X
microM	B-X
.	B-X
The	B-X
nucleotide	B-X
sequence	B-X
of	B-X
the	B-X
cDNA	B-X
(	B-X
sodium-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
)	B-X
predicts	B-X
a	B-X
protein	B-X
of	B-X
68.6	B-X
kDa	B-X
with	B-X
634	B-X
amino	B-X
acids	B-X
and	B-X
12	B-X
potential	B-X
transmembrane	B-X
domains	B-X
.	B-X
Protein	B-X
data	B-X
base	B-X
search	B-X
indicates	B-X
significant	B-X
sequence	B-X
similarity	B-X
between	B-X
SMVT	B-X
and	B-X
known	B-X
members	B-X
of	B-X
the	B-X
Na+-dependent	B-X
glucose	B-X
transporter	B-X
family	B-X
.	B-X
SMVT	B-X
represents	B-X
the	B-X
first	B-X
Na+-dependent	B-X
vitamin	B-X
transporter	B-X
to	B-X
be	B-X
cloned	B-X
from	B-X
a	B-X
mammalian	B-X
tissue	B-X
.	B-X

The	O
cloned	O
cDNA	O
,	O
when	O
expressed	O
in	O
HeLa	O
cells	O
,	O
induces	O
Na	O
+	O
-	O
dependent	O
pantothenate	O
and	O
biotin	O
transport	O
activities	O
.	O
<EOS>	B-X
Previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
a	B-X
Na+-dependent	B-X
transport	B-X
system	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
transplacental	B-X
transfer	B-X
of	B-X
the	B-X
vitamins	B-X
pantothenate	B-X
and	B-X
biotin	B-X
and	B-X
the	B-X
essential	B-X
metabolite	B-X
lipoate	B-X
.	B-X
We	B-X
now	B-X
report	B-X
the	B-X
isolation	B-X
of	B-X
a	B-X
rat	B-X
placental	B-X
cDNA	B-X
encoding	B-X
a	B-X
transport	B-X
protein	B-X
responsible	B-X
for	B-X
this	B-X
function	B-X
.	B-X
The	B-X
cloned	B-X
cDNA	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
HeLa	B-X
cells	B-X
,	B-X
induces	B-X
Na+-dependent	B-X
pantothenate	B-X
and	B-X
biotin	B-X
transport	B-X
activities	B-X
.	B-X
The	B-X
transporter	B-X
is	B-X
specific	B-X
for	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
.	B-X
The	B-X
Michaelis-Menten	B-X
constant	B-X
(	B-X
Kt	B-X
)	B-X
for	B-X
the	B-X
transport	B-X
of	B-X
pantothenate	B-X
and	B-X
biotin	B-X
in	B-X
cDNA-transfected	B-X
cells	B-X
is	B-X
4.9	B-X
+/-	B-X
1.1	B-X
and	B-X
15.1	B-X
+/-	B-X
1.2	B-X
microM	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
transport	B-X
of	B-X
both	B-X
vitamins	B-X
in	B-X
cDNA-transfected	B-X
cells	B-X
is	B-X
inhibited	B-X
by	B-X
lipoate	B-X
with	B-X
an	B-X
inhibition	B-X
constant	B-X
(	B-X
Ki	B-X
)	B-X
of	B-X
approximately	B-X
5	B-X
microM	B-X
.	B-X
The	B-X
nucleotide	B-X
sequence	B-X
of	B-X
the	B-X
cDNA	B-X
(	B-X
sodium-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
)	B-X
predicts	B-X
a	B-X
protein	B-X
of	B-X
68.6	B-X
kDa	B-X
with	B-X
634	B-X
amino	B-X
acids	B-X
and	B-X
12	B-X
potential	B-X
transmembrane	B-X
domains	B-X
.	B-X
Protein	B-X
data	B-X
base	B-X
search	B-X
indicates	B-X
significant	B-X
sequence	B-X
similarity	B-X
between	B-X
SMVT	B-X
and	B-X
known	B-X
members	B-X
of	B-X
the	B-X
Na+-dependent	B-X
glucose	B-X
transporter	B-X
family	B-X
.	B-X
SMVT	B-X
represents	B-X
the	B-X
first	B-X
Na+-dependent	B-X
vitamin	B-X
transporter	B-X
to	B-X
be	B-X
cloned	B-X
from	B-X
a	B-X
mammalian	B-X
tissue	B-X
.	B-X

The	O
transporter	O
is	O
specific	O
for	O
pantothenate	O
,	O
biotin	O
,	O
and	O
lipoate	O
.	O
<EOS>	B-X
The	B-X
characteristics	B-X
of	B-X
the	B-X
uptake	B-X
of	B-X
the	B-X
vitamin	B-X
pantothenate	B-X
into	B-X
JAr	B-X
human	B-X
placental	B-X
choriocarcinoma	B-X
cells	B-X
were	B-X
investigated	B-X
and	B-X
these	B-X
cells	B-X
were	B-X
found	B-X
to	B-X
accumulate	B-X
the	B-X
vitamin	B-X
against	B-X
a	B-X
concentration	B-X
gradient	B-X
by	B-X
a	B-X
Na	B-X
(	B-X
+	B-X
)	B-X
-dependent	B-X
process	B-X
.	B-X
The	B-X
dependence	B-X
of	B-X
the	B-X
uptake	B-X
rate	B-X
of	B-X
pantothenate	B-X
on	B-X
Na+	B-X
concentration	B-X
exhibited	B-X
sigmoidal	B-X
kinetics	B-X
,	B-X
indicating	B-X
interaction	B-X
of	B-X
more	B-X
than	B-X
one	B-X
Na+	B-X
ion	B-X
with	B-X
the	B-X
transporter	B-X
.	B-X
The	B-X
Na+/pantothenate	B-X
coupling	B-X
ratio	B-X
being	B-X
greater	B-X
than	B-X
unity	B-X
suggests	B-X
that	B-X
the	B-X
transport	B-X
process	B-X
is	B-X
electrogenic	B-X
,	B-X
resulting	B-X
in	B-X
net	B-X
transfer	B-X
of	B-X
positive	B-X
charge	B-X
across	B-X
the	B-X
membrane	B-X
.	B-X
This	B-X
was	B-X
confirmed	B-X
in	B-X
plasma	B-X
membrane	B-X
vesicles	B-X
prepared	B-X
from	B-X
JAr	B-X
cells	B-X
where	B-X
the	B-X
uptake	B-X
of	B-X
pantothenate	B-X
was	B-X
found	B-X
to	B-X
be	B-X
significantly	B-X
stimulated	B-X
by	B-X
valinomycin-induced	B-X
inside-negative	B-X
K	B-X
(	B-X
+	B-X
)	B-X
-diffusion	B-X
potential	B-X
.	B-X
Substrate	B-X
specificity	B-X
studies	B-X
showed	B-X
that	B-X
,	B-X
in	B-X
addition	B-X
to	B-X
pantothenate	B-X
,	B-X
the	B-X
transporter	B-X
interacts	B-X
with	B-X
two	B-X
other	B-X
vitamins	B-X
,	B-X
namely	B-X
biotin	B-X
and	B-X
lipoate	B-X
.	B-X
The	B-X
characteristics	B-X
of	B-X
pantothenate	B-X
uptake	B-X
in	B-X
the	B-X
placental	B-X
cell	B-X
line	B-X
BeWo	B-X
was	B-X
also	B-X
investigated	B-X
.	B-X
These	B-X
cells	B-X
were	B-X
also	B-X
found	B-X
to	B-X
express	B-X
a	B-X
pantothenate	B-X
transport	B-X
system	B-X
similar	B-X
to	B-X
that	B-X
expressed	B-X
in	B-X
the	B-X
JAr	B-X
cells	B-X
.	B-X

The	O
Michaelis	O
-	O
Menten	O
constant	O
(	O
Kt	O
)	O
for	O
the	O
transport	O
of	O
pantothenate	O
and	O
biotin	O
in	O
cDNA	O
-	O
transfected	O
cells	O
is	O
4	O
.	O
9	O
+	O
/	O
-	O
1	O
.	O
1	O
and	O
15	O
.	O
1	O
+	O
/	O
-	O
1	O
.	O
2	O
microM	O
,	O
respectively	O
.	O
<EOS>	B-X
Previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
a	B-X
Na+-dependent	B-X
transport	B-X
system	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
transplacental	B-X
transfer	B-X
of	B-X
the	B-X
vitamins	B-X
pantothenate	B-X
and	B-X
biotin	B-X
and	B-X
the	B-X
essential	B-X
metabolite	B-X
lipoate	B-X
.	B-X
We	B-X
now	B-X
report	B-X
the	B-X
isolation	B-X
of	B-X
a	B-X
rat	B-X
placental	B-X
cDNA	B-X
encoding	B-X
a	B-X
transport	B-X
protein	B-X
responsible	B-X
for	B-X
this	B-X
function	B-X
.	B-X
The	B-X
cloned	B-X
cDNA	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
HeLa	B-X
cells	B-X
,	B-X
induces	B-X
Na+-dependent	B-X
pantothenate	B-X
and	B-X
biotin	B-X
transport	B-X
activities	B-X
.	B-X
The	B-X
transporter	B-X
is	B-X
specific	B-X
for	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
.	B-X
The	B-X
Michaelis-Menten	B-X
constant	B-X
(	B-X
Kt	B-X
)	B-X
for	B-X
the	B-X
transport	B-X
of	B-X
pantothenate	B-X
and	B-X
biotin	B-X
in	B-X
cDNA-transfected	B-X
cells	B-X
is	B-X
4.9	B-X
+/-	B-X
1.1	B-X
and	B-X
15.1	B-X
+/-	B-X
1.2	B-X
microM	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
transport	B-X
of	B-X
both	B-X
vitamins	B-X
in	B-X
cDNA-transfected	B-X
cells	B-X
is	B-X
inhibited	B-X
by	B-X
lipoate	B-X
with	B-X
an	B-X
inhibition	B-X
constant	B-X
(	B-X
Ki	B-X
)	B-X
of	B-X
approximately	B-X
5	B-X
microM	B-X
.	B-X
The	B-X
nucleotide	B-X
sequence	B-X
of	B-X
the	B-X
cDNA	B-X
(	B-X
sodium-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
)	B-X
predicts	B-X
a	B-X
protein	B-X
of	B-X
68.6	B-X
kDa	B-X
with	B-X
634	B-X
amino	B-X
acids	B-X
and	B-X
12	B-X
potential	B-X
transmembrane	B-X
domains	B-X
.	B-X
Protein	B-X
data	B-X
base	B-X
search	B-X
indicates	B-X
significant	B-X
sequence	B-X
similarity	B-X
between	B-X
SMVT	B-X
and	B-X
known	B-X
members	B-X
of	B-X
the	B-X
Na+-dependent	B-X
glucose	B-X
transporter	B-X
family	B-X
.	B-X
The	B-X
size	B-X
of	B-X
the	B-X
principal	B-X
transcript	B-X
is	B-X
3.2	B-X
kilobases	B-X
.	B-X
SMVT	B-X
represents	B-X
the	B-X
first	B-X
Na+-dependent	B-X
vitamin	B-X
transporter	B-X
to	B-X
be	B-X
cloned	B-X
from	B-X
a	B-X
mammalian	B-X
tissue	B-X
.	B-X

The	O
transport	O
of	O
both	O
vitamins	O
in	O
cDNA	O
-	O
transfected	O
cells	O
is	O
inhibited	O
by	O
lipoate	O
with	O
an	O
inhibition	O
constant	O
(	O
Ki	O
)	O
of	O
approximately	O
5	O
microM	O
.	O
<EOS>	B-X
Previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
a	B-X
Na+-dependent	B-X
transport	B-X
system	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
transplacental	B-X
transfer	B-X
of	B-X
the	B-X
vitamins	B-X
pantothenate	B-X
and	B-X
biotin	B-X
and	B-X
the	B-X
essential	B-X
metabolite	B-X
lipoate	B-X
.	B-X
We	B-X
now	B-X
report	B-X
the	B-X
isolation	B-X
of	B-X
a	B-X
rat	B-X
placental	B-X
cDNA	B-X
encoding	B-X
a	B-X
transport	B-X
protein	B-X
responsible	B-X
for	B-X
this	B-X
function	B-X
.	B-X
The	B-X
cloned	B-X
cDNA	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
HeLa	B-X
cells	B-X
,	B-X
induces	B-X
Na+-dependent	B-X
pantothenate	B-X
and	B-X
biotin	B-X
transport	B-X
activities	B-X
.	B-X
The	B-X
transporter	B-X
is	B-X
specific	B-X
for	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
.	B-X
The	B-X
Michaelis-Menten	B-X
constant	B-X
(	B-X
Kt	B-X
)	B-X
for	B-X
the	B-X
transport	B-X
of	B-X
pantothenate	B-X
and	B-X
biotin	B-X
in	B-X
cDNA-transfected	B-X
cells	B-X
is	B-X
4.9	B-X
+/-	B-X
1.1	B-X
and	B-X
15.1	B-X
+/-	B-X
1.2	B-X
microM	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
transport	B-X
of	B-X
both	B-X
vitamins	B-X
in	B-X
cDNA-transfected	B-X
cells	B-X
is	B-X
inhibited	B-X
by	B-X
lipoate	B-X
with	B-X
an	B-X
inhibition	B-X
constant	B-X
(	B-X
Ki	B-X
)	B-X
of	B-X
approximately	B-X
5	B-X
microM	B-X
.	B-X
The	B-X
nucleotide	B-X
sequence	B-X
of	B-X
the	B-X
cDNA	B-X
(	B-X
sodium-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
)	B-X
predicts	B-X
a	B-X
protein	B-X
of	B-X
68.6	B-X
kDa	B-X
with	B-X
634	B-X
amino	B-X
acids	B-X
and	B-X
12	B-X
potential	B-X
transmembrane	B-X
domains	B-X
.	B-X
Protein	B-X
data	B-X
base	B-X
search	B-X
indicates	B-X
significant	B-X
sequence	B-X
similarity	B-X
between	B-X
SMVT	B-X
and	B-X
known	B-X
members	B-X
of	B-X
the	B-X
Na+-dependent	B-X
glucose	B-X
transporter	B-X
family	B-X
.	B-X
SMVT	B-X
represents	B-X
the	B-X
first	B-X
Na+-dependent	B-X
vitamin	B-X
transporter	B-X
to	B-X
be	B-X
cloned	B-X
from	B-X
a	B-X
mammalian	B-X
tissue	B-X
.	B-X

The	O
nucleotide	O
sequence	O
of	O
the	O
cDNA	O
(	O
sodium	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
multivitamin	I-Gene_or_gene_product
transporter	I-Gene_or_gene_product
(	O
SMVT	B-Gene_or_gene_product
)	O
)	O
predicts	O
a	O
protein	O
of	O
68	O
.	O
6	O
kDa	O
with	O
634	O
amino	O
acids	O
and	O
12	O
potential	O
transmembrane	O
domains	O
.	O
<EOS>	B-X
Previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
a	B-X
Na+-dependent	B-X
transport	B-X
system	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
transplacental	B-X
transfer	B-X
of	B-X
the	B-X
vitamins	B-X
pantothenate	B-X
and	B-X
biotin	B-X
and	B-X
the	B-X
essential	B-X
metabolite	B-X
lipoate	B-X
.	B-X
We	B-X
now	B-X
report	B-X
the	B-X
isolation	B-X
of	B-X
a	B-X
rat	B-X
placental	B-X
cDNA	B-X
encoding	B-X
a	B-X
transport	B-X
protein	B-X
responsible	B-X
for	B-X
this	B-X
function	B-X
.	B-X
The	B-X
cloned	B-X
cDNA	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
HeLa	B-X
cells	B-X
,	B-X
induces	B-X
Na+-dependent	B-X
pantothenate	B-X
and	B-X
biotin	B-X
transport	B-X
activities	B-X
.	B-X
The	B-X
transporter	B-X
is	B-X
specific	B-X
for	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
.	B-X
The	B-X
Michaelis-Menten	B-X
constant	B-X
(	B-X
Kt	B-X
)	B-X
for	B-X
the	B-X
transport	B-X
of	B-X
pantothenate	B-X
and	B-X
biotin	B-X
in	B-X
cDNA-transfected	B-X
cells	B-X
is	B-X
4.9	B-X
+/-	B-X
1.1	B-X
and	B-X
15.1	B-X
+/-	B-X
1.2	B-X
microM	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
transport	B-X
of	B-X
both	B-X
vitamins	B-X
in	B-X
cDNA-transfected	B-X
cells	B-X
is	B-X
inhibited	B-X
by	B-X
lipoate	B-X
with	B-X
an	B-X
inhibition	B-X
constant	B-X
(	B-X
Ki	B-X
)	B-X
of	B-X
approximately	B-X
5	B-X
microM	B-X
.	B-X
The	B-X
nucleotide	B-X
sequence	B-X
of	B-X
the	B-X
cDNA	B-X
(	B-X
sodium-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
)	B-X
predicts	B-X
a	B-X
protein	B-X
of	B-X
68.6	B-X
kDa	B-X
with	B-X
634	B-X
amino	B-X
acids	B-X
and	B-X
12	B-X
potential	B-X
transmembrane	B-X
domains	B-X
.	B-X
Protein	B-X
data	B-X
base	B-X
search	B-X
indicates	B-X
significant	B-X
sequence	B-X
similarity	B-X
between	B-X
SMVT	B-X
and	B-X
known	B-X
members	B-X
of	B-X
the	B-X
Na+-dependent	B-X
glucose	B-X
transporter	B-X
family	B-X
.	B-X
Northern	B-X
blot	B-X
analysis	B-X
shows	B-X
that	B-X
SMVT	B-X
transcripts	B-X
are	B-X
present	B-X
in	B-X
all	B-X
of	B-X
the	B-X
tissues	B-X
that	B-X
were	B-X
tested	B-X
.	B-X
SMVT	B-X
represents	B-X
the	B-X
first	B-X
Na+-dependent	B-X
vitamin	B-X
transporter	B-X
to	B-X
be	B-X
cloned	B-X
from	B-X
a	B-X
mammalian	B-X
tissue	B-X
.	B-X

Protein	O
data	O
base	O
search	O
indicates	O
significant	O
sequence	O
similarity	O
between	O
SMVT	B-Gene_or_gene_product
and	O
known	O
members	O
of	O
the	O
Na	B-Gene_or_gene_product
+	I-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
glucose	I-Gene_or_gene_product
transporter	I-Gene_or_gene_product
family	O
.	O
<EOS>	B-X
Previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
a	B-X
Na+-dependent	B-X
transport	B-X
system	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
transplacental	B-X
transfer	B-X
of	B-X
the	B-X
vitamins	B-X
pantothenate	B-X
and	B-X
biotin	B-X
and	B-X
the	B-X
essential	B-X
metabolite	B-X
lipoate	B-X
.	B-X
The	B-X
cloned	B-X
cDNA	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
HeLa	B-X
cells	B-X
,	B-X
induces	B-X
Na+-dependent	B-X
pantothenate	B-X
and	B-X
biotin	B-X
transport	B-X
activities	B-X
.	B-X
The	B-X
transporter	B-X
is	B-X
specific	B-X
for	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
.	B-X
The	B-X
nucleotide	B-X
sequence	B-X
of	B-X
the	B-X
cDNA	B-X
(	B-X
sodium-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
)	B-X
predicts	B-X
a	B-X
protein	B-X
of	B-X
68.6	B-X
kDa	B-X
with	B-X
634	B-X
amino	B-X
acids	B-X
and	B-X
12	B-X
potential	B-X
transmembrane	B-X
domains	B-X
.	B-X
Protein	B-X
data	B-X
base	B-X
search	B-X
indicates	B-X
significant	B-X
sequence	B-X
similarity	B-X
between	B-X
SMVT	B-X
and	B-X
known	B-X
members	B-X
of	B-X
the	B-X
Na+-dependent	B-X
glucose	B-X
transporter	B-X
family	B-X
.	B-X
Northern	B-X
blot	B-X
analysis	B-X
shows	B-X
that	B-X
SMVT	B-X
transcripts	B-X
are	B-X
present	B-X
in	B-X
all	B-X
of	B-X
the	B-X
tissues	B-X
that	B-X
were	B-X
tested	B-X
.	B-X
The	B-X
size	B-X
of	B-X
the	B-X
principal	B-X
transcript	B-X
is	B-X
3.2	B-X
kilobases	B-X
.	B-X
SMVT	B-X
represents	B-X
the	B-X
first	B-X
Na+-dependent	B-X
vitamin	B-X
transporter	B-X
to	B-X
be	B-X
cloned	B-X
from	B-X
a	B-X
mammalian	B-X
tissue	B-X
.	B-X

Northern	O
blot	O
analysis	O
shows	O
that	O
SMVT	B-Gene_or_gene_product
transcripts	O
are	O
present	O
in	O
all	O
of	O
the	O
tissues	O
that	O
were	O
tested	O
.	O
<EOS>	B-X
The	B-X
nucleotide	B-X
sequence	B-X
of	B-X
the	B-X
cDNA	B-X
(	B-X
sodium-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
)	B-X
predicts	B-X
a	B-X
protein	B-X
of	B-X
68.6	B-X
kDa	B-X
with	B-X
634	B-X
amino	B-X
acids	B-X
and	B-X
12	B-X
potential	B-X
transmembrane	B-X
domains	B-X
.	B-X
Protein	B-X
data	B-X
base	B-X
search	B-X
indicates	B-X
significant	B-X
sequence	B-X
similarity	B-X
between	B-X
SMVT	B-X
and	B-X
known	B-X
members	B-X
of	B-X
the	B-X
Na+-dependent	B-X
glucose	B-X
transporter	B-X
family	B-X
.	B-X
Northern	B-X
blot	B-X
analysis	B-X
shows	B-X
that	B-X
SMVT	B-X
transcripts	B-X
are	B-X
present	B-X
in	B-X
all	B-X
of	B-X
the	B-X
tissues	B-X
that	B-X
were	B-X
tested	B-X
.	B-X
SMVT	B-X
represents	B-X
the	B-X
first	B-X
Na+-dependent	B-X
vitamin	B-X
transporter	B-X
to	B-X
be	B-X
cloned	B-X
from	B-X
a	B-X
mammalian	B-X
tissue	B-X
.	B-X

The	O
size	O
of	O
the	O
principal	O
transcript	O
is	O
3	O
.	O
2	O
kilobases	O
.	O
<EOS>	B-X
Making	B-X
the	B-X
correct	B-X
choice	B-X
between	B-X
transcription	B-X
elongation	B-X
and	B-X
transcription	B-X
termination	B-X
is	B-X
essential	B-X
to	B-X
the	B-X
function	B-X
of	B-X
RNA	B-X
polymerase	B-X
II	B-X
,	B-X
and	B-X
fundamental	B-X
to	B-X
gene	B-X
expression	B-X
.	B-X
This	B-X
choice	B-X
can	B-X
be	B-X
influenced	B-X
by	B-X
factors	B-X
modifying	B-X
the	B-X
transcription	B-X
complex	B-X
,	B-X
factors	B-X
modifying	B-X
chromatin	B-X
,	B-X
or	B-X
signals	B-X
mediated	B-X
by	B-X
the	B-X
template	B-X
or	B-X
transcript	B-X
.	B-X
To	B-X
aid	B-X
in	B-X
the	B-X
study	B-X
of	B-X
transcription	B-X
elongation	B-X
and	B-X
termination	B-X
we	B-X
have	B-X
developed	B-X
a	B-X
transcription	B-X
elongation	B-X
reporter	B-X
system	B-X
that	B-X
consists	B-X
of	B-X
tandem	B-X
luciferase	B-X
reporters	B-X
flanking	B-X
a	B-X
test	B-X
sequence	B-X
of	B-X
interest	B-X
.	B-X
The	B-X
Michaelis-Menten	B-X
constant	B-X
(	B-X
Kt	B-X
)	B-X
for	B-X
the	B-X
transport	B-X
of	B-X
pantothenate	B-X
and	B-X
biotin	B-X
in	B-X
cDNA-transfected	B-X
cells	B-X
is	B-X
4.9	B-X
+/-	B-X
1.1	B-X
and	B-X
15.1	B-X
+/-	B-X
1.2	B-X
microM	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
nucleotide	B-X
sequence	B-X
of	B-X
the	B-X
cDNA	B-X
(	B-X
sodium-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
)	B-X
predicts	B-X
a	B-X
protein	B-X
of	B-X
68.6	B-X
kDa	B-X
with	B-X
634	B-X
amino	B-X
acids	B-X
and	B-X
12	B-X
potential	B-X
transmembrane	B-X
domains	B-X
.	B-X
Northern	B-X
blot	B-X
analysis	B-X
shows	B-X
that	B-X
SMVT	B-X
transcripts	B-X
are	B-X
present	B-X
in	B-X
all	B-X
of	B-X
the	B-X
tissues	B-X
that	B-X
were	B-X
tested	B-X
.	B-X
The	B-X
size	B-X
of	B-X
the	B-X
principal	B-X
transcript	B-X
is	B-X
3.2	B-X
kilobases	B-X
.	B-X

SMVT	B-Gene_or_gene_product
represents	O
the	O
first	O
Na	O
+	O
-	O
dependent	O
vitamin	O
transporter	O
to	O
be	O
cloned	O
from	O
a	O
mammalian	O
tissue	O
.	O
<EOS>	B-X
Previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
a	B-X
Na+-dependent	B-X
transport	B-X
system	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
transplacental	B-X
transfer	B-X
of	B-X
the	B-X
vitamins	B-X
pantothenate	B-X
and	B-X
biotin	B-X
and	B-X
the	B-X
essential	B-X
metabolite	B-X
lipoate	B-X
.	B-X
The	B-X
cloned	B-X
cDNA	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
HeLa	B-X
cells	B-X
,	B-X
induces	B-X
Na+-dependent	B-X
pantothenate	B-X
and	B-X
biotin	B-X
transport	B-X
activities	B-X
.	B-X
The	B-X
transporter	B-X
is	B-X
specific	B-X
for	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
.	B-X
The	B-X
transport	B-X
of	B-X
both	B-X
vitamins	B-X
in	B-X
cDNA-transfected	B-X
cells	B-X
is	B-X
inhibited	B-X
by	B-X
lipoate	B-X
with	B-X
an	B-X
inhibition	B-X
constant	B-X
(	B-X
Ki	B-X
)	B-X
of	B-X
approximately	B-X
5	B-X
microM	B-X
.	B-X
The	B-X
nucleotide	B-X
sequence	B-X
of	B-X
the	B-X
cDNA	B-X
(	B-X
sodium-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
)	B-X
predicts	B-X
a	B-X
protein	B-X
of	B-X
68.6	B-X
kDa	B-X
with	B-X
634	B-X
amino	B-X
acids	B-X
and	B-X
12	B-X
potential	B-X
transmembrane	B-X
domains	B-X
.	B-X
Protein	B-X
data	B-X
base	B-X
search	B-X
indicates	B-X
significant	B-X
sequence	B-X
similarity	B-X
between	B-X
SMVT	B-X
and	B-X
known	B-X
members	B-X
of	B-X
the	B-X
Na+-dependent	B-X
glucose	B-X
transporter	B-X
family	B-X
.	B-X
Northern	B-X
blot	B-X
analysis	B-X
shows	B-X
that	B-X
SMVT	B-X
transcripts	B-X
are	B-X
present	B-X
in	B-X
all	B-X
of	B-X
the	B-X
tissues	B-X
that	B-X
were	B-X
tested	B-X
.	B-X
SMVT	B-X
represents	B-X
the	B-X
first	B-X
Na+-dependent	B-X
vitamin	B-X
transporter	B-X
to	B-X
be	B-X
cloned	B-X
from	B-X
a	B-X
mammalian	B-X
tissue	B-X
.	B-X

p53	B-Gene_or_gene_product
-	O
dependent	O
and	O
-	O
independent	O
regulation	O
of	O
the	O
death	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
KILLER	B-Gene_or_gene_product
/	O
DR5	B-Gene_or_gene_product
gene	O
expression	O
in	O
response	O
to	O
genotoxic	O
stress	O
and	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
death	B-X
receptor	B-X
(	B-X
DR	B-X
)	B-X
KILLER/DR5	B-X
gene	B-X
has	B-X
recently	B-X
been	B-X
identified	B-X
as	B-X
a	B-X
doxorubicin-regulated	B-X
transcript	B-X
that	B-X
was	B-X
also	B-X
induced	B-X
by	B-X
exogenous	B-X
wild-type	B-X
p53	B-X
in	B-X
p53-negative	B-X
cells	B-X
.	B-X
KILLER/DR5	B-X
gene	B-X
encodes	B-X
a	B-X
DR	B-X
containing	B-X
cell	B-X
surface	B-X
protein	B-X
that	B-X
is	B-X
highly	B-X
homologous	B-X
to	B-X
DR4	B-X
,	B-X
another	B-X
DR	B-X
of	B-X
the	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
receptor	B-X
family	B-X
.	B-X
Both	B-X
DR4	B-X
and	B-X
KILLER/DR5	B-X
independently	B-X
bind	B-X
to	B-X
their	B-X
specific	B-X
ligand	B-X
TRAIL	B-X
and	B-X
engage	B-X
the	B-X
caspase	B-X
cascade	B-X
to	B-X
induce	B-X
apoptosis	B-X
.	B-X
TRID	B-X
(	B-X
also	B-X
known	B-X
as	B-X
TRAIL-R3	B-X
)	B-X
is	B-X
an	B-X
antiapoptotic	B-X
decoy	B-X
receptor	B-X
that	B-X
lacks	B-X
the	B-X
cytoplasmic	B-X
death	B-X
domain	B-X
and	B-X
competes	B-X
with	B-X
KILLER/DR5	B-X
and	B-X
DR4	B-X
for	B-X
binding	B-X
to	B-X
TRAIL	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
the	B-X
DR	B-X
KILLER/DR5	B-X
gene	B-X
is	B-X
regulated	B-X
in	B-X
a	B-X
p53-dependent	B-X
and	B-X
-independent	B-X
manner	B-X
during	B-X
genotoxic	B-X
and	B-X
nongenotoxic	B-X
stress-induced	B-X
apoptosis	B-X
.	B-X
Just	B-X
like	B-X
other	B-X
p53-regulated	B-X
genes	B-X
,	B-X
ionizing	B-X
radiation	B-X
induction	B-X
of	B-X
KILLER/DR5	B-X
occurs	B-X
in	B-X
p53	B-X
wild-type	B-X
cells	B-X
,	B-X
whereas	B-X
methyl	B-X
methanesulfonate	B-X
regulation	B-X
of	B-X
KILLER/DR5	B-X
occurs	B-X
in	B-X
a	B-X
p53-dependent	B-X
and	B-X
-independent	B-X
manner	B-X
.	B-X
However	B-X
,	B-X
unlike	B-X
other	B-X
p53-regulated	B-X
genes	B-X
,	B-X
KILLER/DR5	B-X
is	B-X
not	B-X
regulated	B-X
following	B-X
UV	B-X
irradiation	B-X
.	B-X
TNF-alpha	B-X
,	B-X
a	B-X
nongenotoxic	B-X
cytokine	B-X
,	B-X
also	B-X
induced	B-X
the	B-X
expression	B-X
of	B-X
KILLER/DR5	B-X
in	B-X
a	B-X
number	B-X
of	B-X
cancer	B-X
cell	B-X
lines	B-X
,	B-X
irrespective	B-X
of	B-X
p53	B-X
status	B-X
.	B-X
TNF-alpha	B-X
did	B-X
not	B-X
alter	B-X
the	B-X
KILLER/DR5	B-X
mRNA	B-X
stability	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
TNF-alpha	B-X
regulation	B-X
of	B-X
KILLER/DRS	B-X
expression	B-X
appears	B-X
transcriptional	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
KILLER/DR5	B-X
is	B-X
regulated	B-X
in	B-X
a	B-X
trigger	B-X
and	B-X
cell	B-X
type-specific	B-X
manner	B-X
and	B-X
that	B-X
its	B-X
induction	B-X
by	B-X
TNF-alpha	B-X
,	B-X
p53	B-X
,	B-X
or	B-X
DNA	B-X
damage	B-X
is	B-X
not	B-X
the	B-X
consequence	B-X
of	B-X
apoptosis	B-X
induced	B-X
by	B-X
these	B-X
agents	B-X
.	B-X
Unlike	B-X
KILLER/DR5	B-X
,	B-X
none	B-X
of	B-X
the	B-X
other	B-X
KILLER/DR5	B-X
family	B-X
members	B-X
,	B-X
including	B-X
DR4	B-X
,	B-X
TRID	B-X
,	B-X
or	B-X
the	B-X
ligand	B-X
TRAIL	B-X
,	B-X
displayed	B-X
genotoxic	B-X
stress	B-X
or	B-X
TNF-alpha	B-X
regulation	B-X
in	B-X
a	B-X
p53	B-X
transcription-dependent	B-X
manner	B-X
.	B-X
Thus	B-X
,	B-X
KILLER/DR5	B-X
appears	B-X
a	B-X
bona	B-X
fide	B-X
downstream	B-X
target	B-X
of	B-X
p53	B-X
that	B-X
is	B-X
also	B-X
regulated	B-X
in	B-X
a	B-X
cell	B-X
type-specific	B-X
,	B-X
trigger-dependent	B-X
,	B-X
and	B-X
p53-independent	B-X
manner	B-X
.	B-X

The	O
death	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	O
DR	B-Gene_or_gene_product
)	O
KILLER	B-Gene_or_gene_product
/	O
DR5	B-Gene_or_gene_product
gene	O
has	O
recently	O
been	O
identified	O
as	O
a	O
doxorubicin	O
-	O
regulated	O
transcript	O
that	O
was	O
also	O
induced	O
by	O
exogenous	O
wild	O
-	O
type	O
p53	B-Gene_or_gene_product
in	O
p53	B-Gene_or_gene_product
-	O
negative	O
cells	O
.	O
<EOS>	B-X
The	B-X
death	B-X
receptor	B-X
(	B-X
DR	B-X
)	B-X
KILLER/DR5	B-X
gene	B-X
has	B-X
recently	B-X
been	B-X
identified	B-X
as	B-X
a	B-X
doxorubicin-regulated	B-X
transcript	B-X
that	B-X
was	B-X
also	B-X
induced	B-X
by	B-X
exogenous	B-X
wild-type	B-X
p53	B-X
in	B-X
p53-negative	B-X
cells	B-X
.	B-X
KILLER/DR5	B-X
gene	B-X
encodes	B-X
a	B-X
DR	B-X
containing	B-X
cell	B-X
surface	B-X
protein	B-X
that	B-X
is	B-X
highly	B-X
homologous	B-X
to	B-X
DR4	B-X
,	B-X
another	B-X
DR	B-X
of	B-X
the	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
receptor	B-X
family	B-X
.	B-X
Both	B-X
DR4	B-X
and	B-X
KILLER/DR5	B-X
independently	B-X
bind	B-X
to	B-X
their	B-X
specific	B-X
ligand	B-X
TRAIL	B-X
and	B-X
engage	B-X
the	B-X
caspase	B-X
cascade	B-X
to	B-X
induce	B-X
apoptosis	B-X
.	B-X
TRID	B-X
(	B-X
also	B-X
known	B-X
as	B-X
TRAIL-R3	B-X
)	B-X
is	B-X
an	B-X
antiapoptotic	B-X
decoy	B-X
receptor	B-X
that	B-X
lacks	B-X
the	B-X
cytoplasmic	B-X
death	B-X
domain	B-X
and	B-X
competes	B-X
with	B-X
KILLER/DR5	B-X
and	B-X
DR4	B-X
for	B-X
binding	B-X
to	B-X
TRAIL	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
the	B-X
DR	B-X
KILLER/DR5	B-X
gene	B-X
is	B-X
regulated	B-X
in	B-X
a	B-X
p53-dependent	B-X
and	B-X
-independent	B-X
manner	B-X
during	B-X
genotoxic	B-X
and	B-X
nongenotoxic	B-X
stress-induced	B-X
apoptosis	B-X
.	B-X
Just	B-X
like	B-X
other	B-X
p53-regulated	B-X
genes	B-X
,	B-X
ionizing	B-X
radiation	B-X
induction	B-X
of	B-X
KILLER/DR5	B-X
occurs	B-X
in	B-X
p53	B-X
wild-type	B-X
cells	B-X
,	B-X
whereas	B-X
methyl	B-X
methanesulfonate	B-X
regulation	B-X
of	B-X
KILLER/DR5	B-X
occurs	B-X
in	B-X
a	B-X
p53-dependent	B-X
and	B-X
-independent	B-X
manner	B-X
.	B-X
However	B-X
,	B-X
unlike	B-X
other	B-X
p53-regulated	B-X
genes	B-X
,	B-X
KILLER/DR5	B-X
is	B-X
not	B-X
regulated	B-X
following	B-X
UV	B-X
irradiation	B-X
.	B-X
TNF-alpha	B-X
,	B-X
a	B-X
nongenotoxic	B-X
cytokine	B-X
,	B-X
also	B-X
induced	B-X
the	B-X
expression	B-X
of	B-X
KILLER/DR5	B-X
in	B-X
a	B-X
number	B-X
of	B-X
cancer	B-X
cell	B-X
lines	B-X
,	B-X
irrespective	B-X
of	B-X
p53	B-X
status	B-X
.	B-X
TNF-alpha	B-X
did	B-X
not	B-X
alter	B-X
the	B-X
KILLER/DR5	B-X
mRNA	B-X
stability	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
TNF-alpha	B-X
regulation	B-X
of	B-X
KILLER/DRS	B-X
expression	B-X
appears	B-X
transcriptional	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
KILLER/DR5	B-X
is	B-X
regulated	B-X
in	B-X
a	B-X
trigger	B-X
and	B-X
cell	B-X
type-specific	B-X
manner	B-X
and	B-X
that	B-X
its	B-X
induction	B-X
by	B-X
TNF-alpha	B-X
,	B-X
p53	B-X
,	B-X
or	B-X
DNA	B-X
damage	B-X
is	B-X
not	B-X
the	B-X
consequence	B-X
of	B-X
apoptosis	B-X
induced	B-X
by	B-X
these	B-X
agents	B-X
.	B-X
Unlike	B-X
KILLER/DR5	B-X
,	B-X
none	B-X
of	B-X
the	B-X
other	B-X
KILLER/DR5	B-X
family	B-X
members	B-X
,	B-X
including	B-X
DR4	B-X
,	B-X
TRID	B-X
,	B-X
or	B-X
the	B-X
ligand	B-X
TRAIL	B-X
,	B-X
displayed	B-X
genotoxic	B-X
stress	B-X
or	B-X
TNF-alpha	B-X
regulation	B-X
in	B-X
a	B-X
p53	B-X
transcription-dependent	B-X
manner	B-X
.	B-X
Thus	B-X
,	B-X
KILLER/DR5	B-X
appears	B-X
a	B-X
bona	B-X
fide	B-X
downstream	B-X
target	B-X
of	B-X
p53	B-X
that	B-X
is	B-X
also	B-X
regulated	B-X
in	B-X
a	B-X
cell	B-X
type-specific	B-X
,	B-X
trigger-dependent	B-X
,	B-X
and	B-X
p53-independent	B-X
manner	B-X
.	B-X

KILLER	B-Gene_or_gene_product
/	O
DR5	B-Gene_or_gene_product
gene	O
encodes	O
a	O
DR	B-Gene_or_gene_product
containing	O
cell	O
surface	O
protein	O
that	O
is	O
highly	O
homologous	O
to	O
DR4	B-Gene_or_gene_product
,	O
another	O
DR	B-Gene_or_gene_product
of	O
the	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	I-Gene_or_gene_product
TNF	I-Gene_or_gene_product
)	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
family	O
.	O

Both	O
DR4	B-Gene_or_gene_product
and	O
KILLER	B-Gene_or_gene_product
/	O
DR5	B-Gene_or_gene_product
independently	O
bind	O
to	O
their	O
specific	O
ligand	O
TRAIL	B-Gene_or_gene_product
and	O
engage	O
the	O
caspase	B-Gene_or_gene_product
cascade	O
to	O
induce	O
apoptosis	O
.	O
<EOS>	B-X
The	B-X
death	B-X
receptor	B-X
(	B-X
DR	B-X
)	B-X
KILLER/DR5	B-X
gene	B-X
has	B-X
recently	B-X
been	B-X
identified	B-X
as	B-X
a	B-X
doxorubicin-regulated	B-X
transcript	B-X
that	B-X
was	B-X
also	B-X
induced	B-X
by	B-X
exogenous	B-X
wild-type	B-X
p53	B-X
in	B-X
p53-negative	B-X
cells	B-X
.	B-X
KILLER/DR5	B-X
gene	B-X
encodes	B-X
a	B-X
DR	B-X
containing	B-X
cell	B-X
surface	B-X
protein	B-X
that	B-X
is	B-X
highly	B-X
homologous	B-X
to	B-X
DR4	B-X
,	B-X
another	B-X
DR	B-X
of	B-X
the	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
receptor	B-X
family	B-X
.	B-X
Both	B-X
DR4	B-X
and	B-X
KILLER/DR5	B-X
independently	B-X
bind	B-X
to	B-X
their	B-X
specific	B-X
ligand	B-X
TRAIL	B-X
and	B-X
engage	B-X
the	B-X
caspase	B-X
cascade	B-X
to	B-X
induce	B-X
apoptosis	B-X
.	B-X
TRID	B-X
(	B-X
also	B-X
known	B-X
as	B-X
TRAIL-R3	B-X
)	B-X
is	B-X
an	B-X
antiapoptotic	B-X
decoy	B-X
receptor	B-X
that	B-X
lacks	B-X
the	B-X
cytoplasmic	B-X
death	B-X
domain	B-X
and	B-X
competes	B-X
with	B-X
KILLER/DR5	B-X
and	B-X
DR4	B-X
for	B-X
binding	B-X
to	B-X
TRAIL	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
the	B-X
DR	B-X
KILLER/DR5	B-X
gene	B-X
is	B-X
regulated	B-X
in	B-X
a	B-X
p53-dependent	B-X
and	B-X
-independent	B-X
manner	B-X
during	B-X
genotoxic	B-X
and	B-X
nongenotoxic	B-X
stress-induced	B-X
apoptosis	B-X
.	B-X
Just	B-X
like	B-X
other	B-X
p53-regulated	B-X
genes	B-X
,	B-X
ionizing	B-X
radiation	B-X
induction	B-X
of	B-X
KILLER/DR5	B-X
occurs	B-X
in	B-X
p53	B-X
wild-type	B-X
cells	B-X
,	B-X
whereas	B-X
methyl	B-X
methanesulfonate	B-X
regulation	B-X
of	B-X
KILLER/DR5	B-X
occurs	B-X
in	B-X
a	B-X
p53-dependent	B-X
and	B-X
-independent	B-X
manner	B-X
.	B-X
However	B-X
,	B-X
unlike	B-X
other	B-X
p53-regulated	B-X
genes	B-X
,	B-X
KILLER/DR5	B-X
is	B-X
not	B-X
regulated	B-X
following	B-X
UV	B-X
irradiation	B-X
.	B-X
TNF-alpha	B-X
,	B-X
a	B-X
nongenotoxic	B-X
cytokine	B-X
,	B-X
also	B-X
induced	B-X
the	B-X
expression	B-X
of	B-X
KILLER/DR5	B-X
in	B-X
a	B-X
number	B-X
of	B-X
cancer	B-X
cell	B-X
lines	B-X
,	B-X
irrespective	B-X
of	B-X
p53	B-X
status	B-X
.	B-X
TNF-alpha	B-X
did	B-X
not	B-X
alter	B-X
the	B-X
KILLER/DR5	B-X
mRNA	B-X
stability	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
TNF-alpha	B-X
regulation	B-X
of	B-X
KILLER/DRS	B-X
expression	B-X
appears	B-X
transcriptional	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
KILLER/DR5	B-X
is	B-X
regulated	B-X
in	B-X
a	B-X
trigger	B-X
and	B-X
cell	B-X
type-specific	B-X
manner	B-X
and	B-X
that	B-X
its	B-X
induction	B-X
by	B-X
TNF-alpha	B-X
,	B-X
p53	B-X
,	B-X
or	B-X
DNA	B-X
damage	B-X
is	B-X
not	B-X
the	B-X
consequence	B-X
of	B-X
apoptosis	B-X
induced	B-X
by	B-X
these	B-X
agents	B-X
.	B-X
Unlike	B-X
KILLER/DR5	B-X
,	B-X
none	B-X
of	B-X
the	B-X
other	B-X
KILLER/DR5	B-X
family	B-X
members	B-X
,	B-X
including	B-X
DR4	B-X
,	B-X
TRID	B-X
,	B-X
or	B-X
the	B-X
ligand	B-X
TRAIL	B-X
,	B-X
displayed	B-X
genotoxic	B-X
stress	B-X
or	B-X
TNF-alpha	B-X
regulation	B-X
in	B-X
a	B-X
p53	B-X
transcription-dependent	B-X
manner	B-X
.	B-X
Thus	B-X
,	B-X
KILLER/DR5	B-X
appears	B-X
a	B-X
bona	B-X
fide	B-X
downstream	B-X
target	B-X
of	B-X
p53	B-X
that	B-X
is	B-X
also	B-X
regulated	B-X
in	B-X
a	B-X
cell	B-X
type-specific	B-X
,	B-X
trigger-dependent	B-X
,	B-X
and	B-X
p53-independent	B-X
manner	B-X
.	B-X

TRID	B-Gene_or_gene_product
(	O
also	O
known	O
as	O
TRAIL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
R3	I-Gene_or_gene_product
)	O
is	O
an	O
antiapoptotic	O
decoy	O
receptor	O
that	O
lacks	O
the	O
cytoplasmic	O
death	O
domain	O
and	O
competes	O
with	O
KILLER	B-Gene_or_gene_product
/	O
DR5	B-Gene_or_gene_product
and	O
DR4	B-Gene_or_gene_product
for	O
binding	O
to	O
TRAIL	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
death	B-X
receptor	B-X
(	B-X
DR	B-X
)	B-X
KILLER/DR5	B-X
gene	B-X
has	B-X
recently	B-X
been	B-X
identified	B-X
as	B-X
a	B-X
doxorubicin-regulated	B-X
transcript	B-X
that	B-X
was	B-X
also	B-X
induced	B-X
by	B-X
exogenous	B-X
wild-type	B-X
p53	B-X
in	B-X
p53-negative	B-X
cells	B-X
.	B-X
KILLER/DR5	B-X
gene	B-X
encodes	B-X
a	B-X
DR	B-X
containing	B-X
cell	B-X
surface	B-X
protein	B-X
that	B-X
is	B-X
highly	B-X
homologous	B-X
to	B-X
DR4	B-X
,	B-X
another	B-X
DR	B-X
of	B-X
the	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
receptor	B-X
family	B-X
.	B-X
Both	B-X
DR4	B-X
and	B-X
KILLER/DR5	B-X
independently	B-X
bind	B-X
to	B-X
their	B-X
specific	B-X
ligand	B-X
TRAIL	B-X
and	B-X
engage	B-X
the	B-X
caspase	B-X
cascade	B-X
to	B-X
induce	B-X
apoptosis	B-X
.	B-X
TRID	B-X
(	B-X
also	B-X
known	B-X
as	B-X
TRAIL-R3	B-X
)	B-X
is	B-X
an	B-X
antiapoptotic	B-X
decoy	B-X
receptor	B-X
that	B-X
lacks	B-X
the	B-X
cytoplasmic	B-X
death	B-X
domain	B-X
and	B-X
competes	B-X
with	B-X
KILLER/DR5	B-X
and	B-X
DR4	B-X
for	B-X
binding	B-X
to	B-X
TRAIL	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
the	B-X
DR	B-X
KILLER/DR5	B-X
gene	B-X
is	B-X
regulated	B-X
in	B-X
a	B-X
p53-dependent	B-X
and	B-X
-independent	B-X
manner	B-X
during	B-X
genotoxic	B-X
and	B-X
nongenotoxic	B-X
stress-induced	B-X
apoptosis	B-X
.	B-X
Just	B-X
like	B-X
other	B-X
p53-regulated	B-X
genes	B-X
,	B-X
ionizing	B-X
radiation	B-X
induction	B-X
of	B-X
KILLER/DR5	B-X
occurs	B-X
in	B-X
p53	B-X
wild-type	B-X
cells	B-X
,	B-X
whereas	B-X
methyl	B-X
methanesulfonate	B-X
regulation	B-X
of	B-X
KILLER/DR5	B-X
occurs	B-X
in	B-X
a	B-X
p53-dependent	B-X
and	B-X
-independent	B-X
manner	B-X
.	B-X
However	B-X
,	B-X
unlike	B-X
other	B-X
p53-regulated	B-X
genes	B-X
,	B-X
KILLER/DR5	B-X
is	B-X
not	B-X
regulated	B-X
following	B-X
UV	B-X
irradiation	B-X
.	B-X
TNF-alpha	B-X
,	B-X
a	B-X
nongenotoxic	B-X
cytokine	B-X
,	B-X
also	B-X
induced	B-X
the	B-X
expression	B-X
of	B-X
KILLER/DR5	B-X
in	B-X
a	B-X
number	B-X
of	B-X
cancer	B-X
cell	B-X
lines	B-X
,	B-X
irrespective	B-X
of	B-X
p53	B-X
status	B-X
.	B-X
TNF-alpha	B-X
did	B-X
not	B-X
alter	B-X
the	B-X
KILLER/DR5	B-X
mRNA	B-X
stability	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
TNF-alpha	B-X
regulation	B-X
of	B-X
KILLER/DRS	B-X
expression	B-X
appears	B-X
transcriptional	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
KILLER/DR5	B-X
is	B-X
regulated	B-X
in	B-X
a	B-X
trigger	B-X
and	B-X
cell	B-X
type-specific	B-X
manner	B-X
and	B-X
that	B-X
its	B-X
induction	B-X
by	B-X
TNF-alpha	B-X
,	B-X
p53	B-X
,	B-X
or	B-X
DNA	B-X
damage	B-X
is	B-X
not	B-X
the	B-X
consequence	B-X
of	B-X
apoptosis	B-X
induced	B-X
by	B-X
these	B-X
agents	B-X
.	B-X
Unlike	B-X
KILLER/DR5	B-X
,	B-X
none	B-X
of	B-X
the	B-X
other	B-X
KILLER/DR5	B-X
family	B-X
members	B-X
,	B-X
including	B-X
DR4	B-X
,	B-X
TRID	B-X
,	B-X
or	B-X
the	B-X
ligand	B-X
TRAIL	B-X
,	B-X
displayed	B-X
genotoxic	B-X
stress	B-X
or	B-X
TNF-alpha	B-X
regulation	B-X
in	B-X
a	B-X
p53	B-X
transcription-dependent	B-X
manner	B-X
.	B-X
Thus	B-X
,	B-X
KILLER/DR5	B-X
appears	B-X
a	B-X
bona	B-X
fide	B-X
downstream	B-X
target	B-X
of	B-X
p53	B-X
that	B-X
is	B-X
also	B-X
regulated	B-X
in	B-X
a	B-X
cell	B-X
type-specific	B-X
,	B-X
trigger-dependent	B-X
,	B-X
and	B-X
p53-independent	B-X
manner	B-X
.	B-X

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
the	O
DR	B-Gene_or_gene_product
KILLER	I-Gene_or_gene_product
/	O
DR5	B-Gene_or_gene_product
gene	O
is	O
regulated	O
in	O
a	O
p53	B-Gene_or_gene_product
-	O
dependent	O
and	O
-	O
independent	O
manner	O
during	O
genotoxic	O
and	O
nongenotoxic	O
stress	O
-	O
induced	O
apoptosis	O
.	O

Just	O
like	O
other	O
p53	B-Gene_or_gene_product
-	O
regulated	O
genes	O
,	O
ionizing	O
radiation	O
induction	O
of	O
KILLER	B-Gene_or_gene_product
/	O
DR5	B-Gene_or_gene_product
occurs	O
in	O
p53	B-Gene_or_gene_product
wild	O
-	O
type	O
cells	O
,	O
whereas	O
methyl	O
methanesulfonate	O
regulation	O
of	O
KILLER	B-Gene_or_gene_product
/	O
DR5	B-Gene_or_gene_product
occurs	O
in	O
a	O
p53	B-Gene_or_gene_product
-	O
dependent	O
and	O
-	O
independent	O
manner	O
.	O

However	O
,	O
unlike	O
other	O
p53	B-Gene_or_gene_product
-	O
regulated	O
genes	O
,	O
KILLER	B-Gene_or_gene_product
/	O
DR5	B-Gene_or_gene_product
is	O
not	O
regulated	O
following	O
UV	O
irradiation	O
.	O

TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
,	O
a	O
nongenotoxic	O
cytokine	O
,	O
also	O
induced	O
the	O
expression	O
of	O
KILLER	B-Gene_or_gene_product
/	O
DR5	B-Gene_or_gene_product
in	O
a	O
number	O
of	O
cancer	O
cell	O
lines	O
,	O
irrespective	O
of	O
p53	B-Gene_or_gene_product
status	O
.	O

TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
did	O
not	O
alter	O
the	O
KILLER	B-Gene_or_gene_product
/	O
DR5	B-Gene_or_gene_product
mRNA	O
stability	O
,	O
suggesting	O
that	O
the	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
regulation	O
of	O
KILLER	B-Gene_or_gene_product
/	O
DRS	B-Gene_or_gene_product
expression	O
appears	O
transcriptional	O
.	O
<EOS>	B-X
Tumour	B-X
Necrosis	B-X
Factor	B-X
alpha	B-X
(	B-X
TNF	B-X
alpha	B-X
)	B-X
,	B-X
is	B-X
an	B-X
inflammatory	B-X
cytokine	B-X
produced	B-X
by	B-X
macrophages/monocytes	B-X
during	B-X
acute	B-X
inflammation	B-X
and	B-X
is	B-X
responsible	B-X
for	B-X
a	B-X
diverse	B-X
range	B-X
of	B-X
signalling	B-X
events	B-X
within	B-X
cells	B-X
,	B-X
leading	B-X
to	B-X
necrosis	B-X
or	B-X
apoptosis	B-X
.	B-X
TNF	B-X
alpha	B-X
exerts	B-X
many	B-X
of	B-X
its	B-X
effects	B-X
by	B-X
binding	B-X
,	B-X
as	B-X
a	B-X
trimer	B-X
,	B-X
to	B-X
either	B-X
a	B-X
55	B-X
kDa	B-X
cell	B-X
membrane	B-X
receptor	B-X
termed	B-X
TNFR-1	B-X
or	B-X
a	B-X
75	B-X
kDa	B-X
cell	B-X
membrane	B-X
receptor	B-X
termed	B-X
TNFR-2	B-X
.	B-X
Both	B-X
these	B-X
receptors	B-X
belong	B-X
to	B-X
the	B-X
so-called	B-X
TNF	B-X
receptor	B-X
superfamily	B-X
.	B-X
Additionally	B-X
,	B-X
a	B-X
number	B-X
of	B-X
structurally	B-X
related	B-X
``	B-X
decoy	B-X
receptors	B-X
''	B-X
exist	B-X
that	B-X
act	B-X
to	B-X
sequester	B-X
TNF	B-X
molecules	B-X
,	B-X
thereby	B-X
rescuing	B-X
cells	B-X
from	B-X
apoptosis	B-X
.	B-X
The	B-X
crystal	B-X
structures	B-X
of	B-X
TNF	B-X
alpha	B-X
,	B-X
TNF	B-X
beta	B-X
,	B-X
the	B-X
extracellular	B-X
domain	B-X
of	B-X
TNFR-1	B-X
(	B-X
denoted	B-X
sTNFR-1	B-X
)	B-X
,	B-X
and	B-X
the	B-X
TNF	B-X
beta	B-X
sTNFR-1	B-X
complex	B-X
have	B-X
been	B-X
defined	B-X
by	B-X
crystallography	B-X
.	B-X
This	B-X
article	B-X
will	B-X
review	B-X
the	B-X
structure/function	B-X
relationships	B-X
of	B-X
the	B-X
TNF	B-X
alpha	B-X
and	B-X
the	B-X
TNF	B-X
receptor	B-X
superfamily	B-X
.	B-X
It	B-X
will	B-X
also	B-X
discuss	B-X
insights	B-X
as	B-X
to	B-X
how	B-X
structural	B-X
features	B-X
play	B-X
a	B-X
role	B-X
in	B-X
the	B-X
pleiotropic	B-X
effects	B-X
of	B-X
TNF	B-X
alpha	B-X
.	B-X

We	O
also	O
provide	O
evidence	O
that	O
KILLER	B-Gene_or_gene_product
/	O
DR5	B-Gene_or_gene_product
is	O
regulated	O
in	O
a	O
trigger	O
and	O
cell	O
type	O
-	O
specific	O
manner	O
and	O
that	O
its	O
induction	O
by	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
,	O
p53	B-Gene_or_gene_product
,	O
or	O
DNA	O
damage	O
is	O
not	O
the	O
consequence	O
of	O
apoptosis	O
induced	O
by	O
these	O
agents	O
.	O
<EOS>	B-X
Living	B-X
organisms	B-X
are	B-X
continuously	B-X
exposed	B-X
to	B-X
a	B-X
myriad	B-X
of	B-X
DNA	B-X
damaging	B-X
agents	B-X
that	B-X
can	B-X
impact	B-X
health	B-X
and	B-X
modulate	B-X
disease-states	B-X
.	B-X
However	B-X
,	B-X
robust	B-X
DNA	B-X
repair	B-X
and	B-X
damage-bypass	B-X
mechanisms	B-X
faithfully	B-X
protect	B-X
the	B-X
DNA	B-X
by	B-X
either	B-X
removing	B-X
or	B-X
tolerating	B-X
the	B-X
damage	B-X
to	B-X
ensure	B-X
an	B-X
overall	B-X
survival	B-X
.	B-X
Deviations	B-X
in	B-X
this	B-X
fine-tuning	B-X
are	B-X
known	B-X
to	B-X
destabilize	B-X
cellular	B-X
metabolic	B-X
homeostasis	B-X
,	B-X
as	B-X
exemplified	B-X
in	B-X
diverse	B-X
cancers	B-X
where	B-X
disruption	B-X
or	B-X
deregulation	B-X
of	B-X
DNA	B-X
repair	B-X
pathways	B-X
results	B-X
in	B-X
genome	B-X
instability	B-X
.	B-X
Because	B-X
routinely	B-X
used	B-X
biological	B-X
,	B-X
physical	B-X
and	B-X
chemical	B-X
agents	B-X
impact	B-X
human	B-X
health	B-X
,	B-X
testing	B-X
their	B-X
genotoxicity	B-X
and	B-X
regulating	B-X
their	B-X
use	B-X
have	B-X
become	B-X
important	B-X
.	B-X
In	B-X
this	B-X
introductory	B-X
review	B-X
,	B-X
we	B-X
will	B-X
delineate	B-X
mechanisms	B-X
of	B-X
DNA	B-X
damage	B-X
and	B-X
the	B-X
counteracting	B-X
repair/tolerance	B-X
pathways	B-X
to	B-X
provide	B-X
insights	B-X
into	B-X
the	B-X
molecular	B-X
basis	B-X
of	B-X
genotoxicity	B-X
in	B-X
cells	B-X
that	B-X
lays	B-X
the	B-X
foundation	B-X
for	B-X
subsequent	B-X
articles	B-X
in	B-X
this	B-X
issue	B-X
.	B-X

Unlike	O
KILLER	B-Gene_or_gene_product
/	O
DR5	B-Gene_or_gene_product
,	O
none	O
of	O
the	O
other	O
KILLER	B-Gene_or_gene_product
/	O
DR5	B-Gene_or_gene_product
family	O
members	O
,	O
including	O
DR4	B-Gene_or_gene_product
,	O
TRID	B-Gene_or_gene_product
,	O
or	O
the	O
ligand	O
TRAIL	B-Gene_or_gene_product
,	O
displayed	O
genotoxic	O
stress	O
or	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
regulation	O
in	O
a	O
p53	B-Gene_or_gene_product
transcription	O
-	O
dependent	O
manner	O
.	O
<EOS>	B-X
The	B-X
death	B-X
receptor	B-X
(	B-X
DR	B-X
)	B-X
KILLER/DR5	B-X
gene	B-X
has	B-X
recently	B-X
been	B-X
identified	B-X
as	B-X
a	B-X
doxorubicin-regulated	B-X
transcript	B-X
that	B-X
was	B-X
also	B-X
induced	B-X
by	B-X
exogenous	B-X
wild-type	B-X
p53	B-X
in	B-X
p53-negative	B-X
cells	B-X
.	B-X
KILLER/DR5	B-X
gene	B-X
encodes	B-X
a	B-X
DR	B-X
containing	B-X
cell	B-X
surface	B-X
protein	B-X
that	B-X
is	B-X
highly	B-X
homologous	B-X
to	B-X
DR4	B-X
,	B-X
another	B-X
DR	B-X
of	B-X
the	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
receptor	B-X
family	B-X
.	B-X
Both	B-X
DR4	B-X
and	B-X
KILLER/DR5	B-X
independently	B-X
bind	B-X
to	B-X
their	B-X
specific	B-X
ligand	B-X
TRAIL	B-X
and	B-X
engage	B-X
the	B-X
caspase	B-X
cascade	B-X
to	B-X
induce	B-X
apoptosis	B-X
.	B-X
TRID	B-X
(	B-X
also	B-X
known	B-X
as	B-X
TRAIL-R3	B-X
)	B-X
is	B-X
an	B-X
antiapoptotic	B-X
decoy	B-X
receptor	B-X
that	B-X
lacks	B-X
the	B-X
cytoplasmic	B-X
death	B-X
domain	B-X
and	B-X
competes	B-X
with	B-X
KILLER/DR5	B-X
and	B-X
DR4	B-X
for	B-X
binding	B-X
to	B-X
TRAIL	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
the	B-X
DR	B-X
KILLER/DR5	B-X
gene	B-X
is	B-X
regulated	B-X
in	B-X
a	B-X
p53-dependent	B-X
and	B-X
-independent	B-X
manner	B-X
during	B-X
genotoxic	B-X
and	B-X
nongenotoxic	B-X
stress-induced	B-X
apoptosis	B-X
.	B-X
Just	B-X
like	B-X
other	B-X
p53-regulated	B-X
genes	B-X
,	B-X
ionizing	B-X
radiation	B-X
induction	B-X
of	B-X
KILLER/DR5	B-X
occurs	B-X
in	B-X
p53	B-X
wild-type	B-X
cells	B-X
,	B-X
whereas	B-X
methyl	B-X
methanesulfonate	B-X
regulation	B-X
of	B-X
KILLER/DR5	B-X
occurs	B-X
in	B-X
a	B-X
p53-dependent	B-X
and	B-X
-independent	B-X
manner	B-X
.	B-X
However	B-X
,	B-X
unlike	B-X
other	B-X
p53-regulated	B-X
genes	B-X
,	B-X
KILLER/DR5	B-X
is	B-X
not	B-X
regulated	B-X
following	B-X
UV	B-X
irradiation	B-X
.	B-X
TNF-alpha	B-X
,	B-X
a	B-X
nongenotoxic	B-X
cytokine	B-X
,	B-X
also	B-X
induced	B-X
the	B-X
expression	B-X
of	B-X
KILLER/DR5	B-X
in	B-X
a	B-X
number	B-X
of	B-X
cancer	B-X
cell	B-X
lines	B-X
,	B-X
irrespective	B-X
of	B-X
p53	B-X
status	B-X
.	B-X
TNF-alpha	B-X
did	B-X
not	B-X
alter	B-X
the	B-X
KILLER/DR5	B-X
mRNA	B-X
stability	B-X
,	B-X
suggesting	B-X
that	B-X
the	B-X
TNF-alpha	B-X
regulation	B-X
of	B-X
KILLER/DRS	B-X
expression	B-X
appears	B-X
transcriptional	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
KILLER/DR5	B-X
is	B-X
regulated	B-X
in	B-X
a	B-X
trigger	B-X
and	B-X
cell	B-X
type-specific	B-X
manner	B-X
and	B-X
that	B-X
its	B-X
induction	B-X
by	B-X
TNF-alpha	B-X
,	B-X
p53	B-X
,	B-X
or	B-X
DNA	B-X
damage	B-X
is	B-X
not	B-X
the	B-X
consequence	B-X
of	B-X
apoptosis	B-X
induced	B-X
by	B-X
these	B-X
agents	B-X
.	B-X
Unlike	B-X
KILLER/DR5	B-X
,	B-X
none	B-X
of	B-X
the	B-X
other	B-X
KILLER/DR5	B-X
family	B-X
members	B-X
,	B-X
including	B-X
DR4	B-X
,	B-X
TRID	B-X
,	B-X
or	B-X
the	B-X
ligand	B-X
TRAIL	B-X
,	B-X
displayed	B-X
genotoxic	B-X
stress	B-X
or	B-X
TNF-alpha	B-X
regulation	B-X
in	B-X
a	B-X
p53	B-X
transcription-dependent	B-X
manner	B-X
.	B-X
Thus	B-X
,	B-X
KILLER/DR5	B-X
appears	B-X
a	B-X
bona	B-X
fide	B-X
downstream	B-X
target	B-X
of	B-X
p53	B-X
that	B-X
is	B-X
also	B-X
regulated	B-X
in	B-X
a	B-X
cell	B-X
type-specific	B-X
,	B-X
trigger-dependent	B-X
,	B-X
and	B-X
p53-independent	B-X
manner	B-X
.	B-X

Thus	O
,	O
KILLER	B-Gene_or_gene_product
/	O
DR5	B-Gene_or_gene_product
appears	O
a	O
bona	O
fide	O
downstream	O
target	O
of	O
p53	B-Gene_or_gene_product
that	O
is	O
also	O
regulated	O
in	O
a	O
cell	O
type	O
-	O
specific	O
,	O
trigger	O
-	O
dependent	O
,	O
and	O
p53	B-Gene_or_gene_product
-	O
independent	O
manner	O
.	O

The	O
eukaryotic	O
UDP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylglucosamine	I-Gene_or_gene_product
pyrophosphorylases	I-Gene_or_gene_product
.	O
<EOS>	B-X
A	B-X
search	B-X
of	B-X
the	B-X
yeast	B-X
data	B-X
base	B-X
for	B-X
a	B-X
protein	B-X
homologous	B-X
to	B-X
Escherichia	B-X
coli	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
yielded	B-X
UAP1	B-X
(	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
)	B-X
,	B-X
the	B-X
Saccharomyces	B-X
cerevisiae	B-X
gene	B-X
for	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
.	B-X
The	B-X
Candida	B-X
albicans	B-X
and	B-X
human	B-X
homologs	B-X
were	B-X
also	B-X
cloned	B-X
by	B-X
screening	B-X
a	B-X
C.	B-X
albicans	B-X
genomic	B-X
library	B-X
and	B-X
a	B-X
human	B-X
testis	B-X
cDNA	B-X
library	B-X
,	B-X
respectively	B-X
.	B-X
Sequence	B-X
analysis	B-X
revealed	B-X
that	B-X
the	B-X
human	B-X
UAP1	B-X
cDNA	B-X
was	B-X
identical	B-X
to	B-X
previously	B-X
reported	B-X
AGX1	B-X
.	B-X
All	B-X
the	B-X
recombinant	B-X
ScUap1p	B-X
,	B-X
CaUap1p	B-X
,	B-X
and	B-X
HsUap1p	B-X
possessed	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
activities	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
yeast	B-X
Uap1p	B-X
utilized	B-X
N-acetylglucosamine-1-phosphate	B-X
as	B-X
the	B-X
substrate	B-X
,	B-X
and	B-X
together	B-X
with	B-X
Agm1p	B-X
,	B-X
it	B-X
produced	B-X
UDP-N-acetylglucosamine	B-X
from	B-X
N-acetylglucosamine-6-phosphate	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
UAP1	B-X
genes	B-X
indeed	B-X
specify	B-X
eukaryotic	B-X
UDP-GlcNAc	B-X
pyrophosphorylase	B-X
and	B-X
that	B-X
phosphomutase	B-X
reaction	B-X
precedes	B-X
uridyltransfer	B-X
.	B-X
Sequence	B-X
comparison	B-X
with	B-X
other	B-X
UDP-sugar	B-X
pyrophosphorylases	B-X
revealed	B-X
that	B-X
amino	B-X
acid	B-X
residues	B-X
,	B-X
Gly112	B-X
,	B-X
Gly114	B-X
,	B-X
Thr115	B-X
,	B-X
Arg116	B-X
,	B-X
Pro122	B-X
,	B-X
and	B-X
Lys123	B-X
of	B-X
ScUap1p	B-X
are	B-X
highly	B-X
conserved	B-X
in	B-X
UDP-sugar	B-X
pyrophosphorylases	B-X
reported	B-X
to	B-X
date	B-X
.	B-X

Gene	O
cloning	O
,	O
protein	O
expression	O
,	O
and	O
catalytic	O
mechanism	O
.	O
<EOS>	B-X
Long-lived	B-X
species	B-X
Homo	B-X
sapiens	B-X
have	B-X
evolved	B-X
robust	B-X
protection	B-X
mechanisms	B-X
against	B-X
cancer	B-X
by	B-X
repressing	B-X
telomerase	B-X
and	B-X
maintaining	B-X
short	B-X
telomeres	B-X
,	B-X
thereby	B-X
delaying	B-X
the	B-X
onset	B-X
of	B-X
the	B-X
majority	B-X
of	B-X
cancer	B-X
types	B-X
until	B-X
post-reproductive	B-X
age	B-X
.	B-X
Indeed	B-X
,	B-X
telomerase	B-X
is	B-X
silent	B-X
in	B-X
most	B-X
differentiated	B-X
human	B-X
cells	B-X
,	B-X
predominantly	B-X
due	B-X
to	B-X
the	B-X
transcriptional	B-X
repression	B-X
of	B-X
its	B-X
catalytic	B-X
component	B-X
telomerase	B-X
reverse	B-X
transcriptase	B-X
(	B-X
TERT	B-X
)	B-X
gene	B-X
.	B-X
The	B-X
lack	B-X
of	B-X
telomerase/TERT	B-X
expression	B-X
leads	B-X
to	B-X
progressive	B-X
telomere	B-X
erosion	B-X
in	B-X
dividing	B-X
human	B-X
cells	B-X
,	B-X
whereas	B-X
critically	B-X
shortened	B-X
telomere	B-X
length	B-X
induces	B-X
a	B-X
permanent	B-X
growth	B-X
arrest	B-X
stage	B-X
named	B-X
replicative	B-X
senescence	B-X
.	B-X
Consistently	B-X
,	B-X
TERT	B-X
expression/telomerase	B-X
activity	B-X
is	B-X
detectable	B-X
in	B-X
up	B-X
to	B-X
90	B-X
%	B-X
of	B-X
human	B-X
primary	B-X
cancers	B-X
.	B-X
Given	B-X
these	B-X
key	B-X
roles	B-X
of	B-X
telomerase	B-X
and	B-X
TERT	B-X
in	B-X
oncogenesis	B-X
,	B-X
great	B-X
efforts	B-X
have	B-X
been	B-X
made	B-X
to	B-X
decipher	B-X
mechanisms	B-X
underlying	B-X
telomerase	B-X
activation	B-X
and	B-X
TERT	B-X
induction	B-X
.	B-X
In	B-X
this	B-X
review	B-X
article	B-X
,	B-X
we	B-X
summarize	B-X
critical	B-X
mechanisms	B-X
activating	B-X
TERT	B-X
transcription	B-X
,	B-X
with	B-X
special	B-X
emphases	B-X
on	B-X
the	B-X
contribution	B-X
of	B-X
TERT	B-X
promoter	B-X
mutations	B-X
and	B-X
structural	B-X
alterations	B-X
at	B-X
the	B-X
TERT	B-X
locus	B-X
,	B-X
and	B-X
briefly	B-X
discuss	B-X
the	B-X
underlying	B-X
implications	B-X
of	B-X
these	B-X
genomic	B-X
events-driven	B-X
TERT	B-X
hyperactivity	B-X
in	B-X
cancer	B-X
initiation/progression	B-X
and	B-X
potential	B-X
clinical	B-X
applications	B-X
as	B-X
well	B-X
.	B-X

A	O
search	O
of	O
the	O
yeast	O
data	O
base	O
for	O
a	O
protein	O
homologous	O
to	O
Escherichia	O
coli	O
UDP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylglucosamine	I-Gene_or_gene_product
pyrophosphorylase	I-Gene_or_gene_product
yielded	O
UAP1	B-Gene_or_gene_product
(	O
UDP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylglucosamine	I-Gene_or_gene_product
pyrophosphorylase	I-Gene_or_gene_product
)	O
,	O
the	O
Saccharomyces	O
cerevisiae	O
gene	O
for	O
UDP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylglucosamine	I-Gene_or_gene_product
pyrophosphorylase	I-Gene_or_gene_product
.	O
<EOS>	B-X
A	B-X
search	B-X
of	B-X
the	B-X
yeast	B-X
data	B-X
base	B-X
for	B-X
a	B-X
protein	B-X
homologous	B-X
to	B-X
Escherichia	B-X
coli	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
yielded	B-X
UAP1	B-X
(	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
)	B-X
,	B-X
the	B-X
Saccharomyces	B-X
cerevisiae	B-X
gene	B-X
for	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
.	B-X
The	B-X
Candida	B-X
albicans	B-X
and	B-X
human	B-X
homologs	B-X
were	B-X
also	B-X
cloned	B-X
by	B-X
screening	B-X
a	B-X
C.	B-X
albicans	B-X
genomic	B-X
library	B-X
and	B-X
a	B-X
human	B-X
testis	B-X
cDNA	B-X
library	B-X
,	B-X
respectively	B-X
.	B-X
Sequence	B-X
analysis	B-X
revealed	B-X
that	B-X
the	B-X
human	B-X
UAP1	B-X
cDNA	B-X
was	B-X
identical	B-X
to	B-X
previously	B-X
reported	B-X
AGX1	B-X
.	B-X
A	B-X
null	B-X
mutation	B-X
of	B-X
the	B-X
S.	B-X
cerevisiae	B-X
UAP1	B-X
(	B-X
ScUAP1	B-X
)	B-X
gene	B-X
was	B-X
lethal	B-X
,	B-X
and	B-X
when	B-X
expressed	B-X
under	B-X
the	B-X
control	B-X
of	B-X
ScUAP1	B-X
promoter	B-X
,	B-X
both	B-X
C.	B-X
albicans	B-X
and	B-X
Homo	B-X
sapiens	B-X
UAP1	B-X
(	B-X
CaUAP1	B-X
and	B-X
HsUAP1	B-X
)	B-X
rescued	B-X
the	B-X
ScUAP1-deficient	B-X
S.	B-X
cerevisiae	B-X
cells	B-X
.	B-X
All	B-X
the	B-X
recombinant	B-X
ScUap1p	B-X
,	B-X
CaUap1p	B-X
,	B-X
and	B-X
HsUap1p	B-X
possessed	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
activities	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
yeast	B-X
Uap1p	B-X
utilized	B-X
N-acetylglucosamine-1-phosphate	B-X
as	B-X
the	B-X
substrate	B-X
,	B-X
and	B-X
together	B-X
with	B-X
Agm1p	B-X
,	B-X
it	B-X
produced	B-X
UDP-N-acetylglucosamine	B-X
from	B-X
N-acetylglucosamine-6-phosphate	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
UAP1	B-X
genes	B-X
indeed	B-X
specify	B-X
eukaryotic	B-X
UDP-GlcNAc	B-X
pyrophosphorylase	B-X
and	B-X
that	B-X
phosphomutase	B-X
reaction	B-X
precedes	B-X
uridyltransfer	B-X
.	B-X
Sequence	B-X
comparison	B-X
with	B-X
other	B-X
UDP-sugar	B-X
pyrophosphorylases	B-X
revealed	B-X
that	B-X
amino	B-X
acid	B-X
residues	B-X
,	B-X
Gly112	B-X
,	B-X
Gly114	B-X
,	B-X
Thr115	B-X
,	B-X
Arg116	B-X
,	B-X
Pro122	B-X
,	B-X
and	B-X
Lys123	B-X
of	B-X
ScUap1p	B-X
are	B-X
highly	B-X
conserved	B-X
in	B-X
UDP-sugar	B-X
pyrophosphorylases	B-X
reported	B-X
to	B-X
date	B-X
.	B-X

The	O
Candida	O
albicans	O
and	O
human	O
homologs	O
were	O
also	O
cloned	O
by	O
screening	O
a	O
C	O
.	O
albicans	O
genomic	O
library	O
and	O
a	O
human	O
testis	O
cDNA	O
library	O
,	O
respectively	O
.	O

Sequence	O
analysis	O
revealed	O
that	O
the	O
human	O
UAP1	B-Gene_or_gene_product
cDNA	O
was	O
identical	O
to	O
previously	O
reported	O
AGX1	B-Gene_or_gene_product
.	O
<EOS>	B-X
A	B-X
search	B-X
of	B-X
the	B-X
yeast	B-X
data	B-X
base	B-X
for	B-X
a	B-X
protein	B-X
homologous	B-X
to	B-X
Escherichia	B-X
coli	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
yielded	B-X
UAP1	B-X
(	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
)	B-X
,	B-X
the	B-X
Saccharomyces	B-X
cerevisiae	B-X
gene	B-X
for	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
.	B-X
The	B-X
Candida	B-X
albicans	B-X
and	B-X
human	B-X
homologs	B-X
were	B-X
also	B-X
cloned	B-X
by	B-X
screening	B-X
a	B-X
C.	B-X
albicans	B-X
genomic	B-X
library	B-X
and	B-X
a	B-X
human	B-X
testis	B-X
cDNA	B-X
library	B-X
,	B-X
respectively	B-X
.	B-X
Sequence	B-X
analysis	B-X
revealed	B-X
that	B-X
the	B-X
human	B-X
UAP1	B-X
cDNA	B-X
was	B-X
identical	B-X
to	B-X
previously	B-X
reported	B-X
AGX1	B-X
.	B-X
A	B-X
null	B-X
mutation	B-X
of	B-X
the	B-X
S.	B-X
cerevisiae	B-X
UAP1	B-X
(	B-X
ScUAP1	B-X
)	B-X
gene	B-X
was	B-X
lethal	B-X
,	B-X
and	B-X
when	B-X
expressed	B-X
under	B-X
the	B-X
control	B-X
of	B-X
ScUAP1	B-X
promoter	B-X
,	B-X
both	B-X
C.	B-X
albicans	B-X
and	B-X
Homo	B-X
sapiens	B-X
UAP1	B-X
(	B-X
CaUAP1	B-X
and	B-X
HsUAP1	B-X
)	B-X
rescued	B-X
the	B-X
ScUAP1-deficient	B-X
S.	B-X
cerevisiae	B-X
cells	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
UAP1	B-X
genes	B-X
indeed	B-X
specify	B-X
eukaryotic	B-X
UDP-GlcNAc	B-X
pyrophosphorylase	B-X
and	B-X
that	B-X
phosphomutase	B-X
reaction	B-X
precedes	B-X
uridyltransfer	B-X
.	B-X
Sequence	B-X
comparison	B-X
with	B-X
other	B-X
UDP-sugar	B-X
pyrophosphorylases	B-X
revealed	B-X
that	B-X
amino	B-X
acid	B-X
residues	B-X
,	B-X
Gly112	B-X
,	B-X
Gly114	B-X
,	B-X
Thr115	B-X
,	B-X
Arg116	B-X
,	B-X
Pro122	B-X
,	B-X
and	B-X
Lys123	B-X
of	B-X
ScUap1p	B-X
are	B-X
highly	B-X
conserved	B-X
in	B-X
UDP-sugar	B-X
pyrophosphorylases	B-X
reported	B-X
to	B-X
date	B-X
.	B-X

A	O
null	O
mutation	O
of	O
the	O
S	O
.	O
cerevisiae	O
UAP1	B-Gene_or_gene_product
(	O
ScUAP1	B-Gene_or_gene_product
)	O
gene	O
was	O
lethal	O
,	O
and	O
when	O
expressed	O
under	O
the	O
control	O
of	O
ScUAP1	B-Gene_or_gene_product
promoter	O
,	O
both	O
C	O
.	O
albicans	O
and	O
Homo	O
sapiens	O
UAP1	B-Gene_or_gene_product
(	O
CaUAP1	B-Gene_or_gene_product
and	O
HsUAP1	B-Gene_or_gene_product
)	O
rescued	O
the	O
ScUAP1	B-Gene_or_gene_product
-	O
deficient	O
S	O
.	O
cerevisiae	O
cells	O
.	O

All	O
the	O
recombinant	O
ScUap1p	B-Gene_or_gene_product
,	O
CaUap1p	B-Gene_or_gene_product
,	O
and	O
HsUap1p	B-Gene_or_gene_product
possessed	O
UDP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
N	I-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylglucosamine	I-Gene_or_gene_product
pyrophosphorylase	I-Gene_or_gene_product
activities	O
in	O
vitro	O
.	O
<EOS>	B-X
A	B-X
search	B-X
of	B-X
the	B-X
yeast	B-X
data	B-X
base	B-X
for	B-X
a	B-X
protein	B-X
homologous	B-X
to	B-X
Escherichia	B-X
coli	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
yielded	B-X
UAP1	B-X
(	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
)	B-X
,	B-X
the	B-X
Saccharomyces	B-X
cerevisiae	B-X
gene	B-X
for	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
.	B-X
The	B-X
Candida	B-X
albicans	B-X
and	B-X
human	B-X
homologs	B-X
were	B-X
also	B-X
cloned	B-X
by	B-X
screening	B-X
a	B-X
C.	B-X
albicans	B-X
genomic	B-X
library	B-X
and	B-X
a	B-X
human	B-X
testis	B-X
cDNA	B-X
library	B-X
,	B-X
respectively	B-X
.	B-X
Sequence	B-X
analysis	B-X
revealed	B-X
that	B-X
the	B-X
human	B-X
UAP1	B-X
cDNA	B-X
was	B-X
identical	B-X
to	B-X
previously	B-X
reported	B-X
AGX1	B-X
.	B-X
All	B-X
the	B-X
recombinant	B-X
ScUap1p	B-X
,	B-X
CaUap1p	B-X
,	B-X
and	B-X
HsUap1p	B-X
possessed	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
activities	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
yeast	B-X
Uap1p	B-X
utilized	B-X
N-acetylglucosamine-1-phosphate	B-X
as	B-X
the	B-X
substrate	B-X
,	B-X
and	B-X
together	B-X
with	B-X
Agm1p	B-X
,	B-X
it	B-X
produced	B-X
UDP-N-acetylglucosamine	B-X
from	B-X
N-acetylglucosamine-6-phosphate	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
UAP1	B-X
genes	B-X
indeed	B-X
specify	B-X
eukaryotic	B-X
UDP-GlcNAc	B-X
pyrophosphorylase	B-X
and	B-X
that	B-X
phosphomutase	B-X
reaction	B-X
precedes	B-X
uridyltransfer	B-X
.	B-X
Sequence	B-X
comparison	B-X
with	B-X
other	B-X
UDP-sugar	B-X
pyrophosphorylases	B-X
revealed	B-X
that	B-X
amino	B-X
acid	B-X
residues	B-X
,	B-X
Gly112	B-X
,	B-X
Gly114	B-X
,	B-X
Thr115	B-X
,	B-X
Arg116	B-X
,	B-X
Pro122	B-X
,	B-X
and	B-X
Lys123	B-X
of	B-X
ScUap1p	B-X
are	B-X
highly	B-X
conserved	B-X
in	B-X
UDP-sugar	B-X
pyrophosphorylases	B-X
reported	B-X
to	B-X
date	B-X
.	B-X

The	O
yeast	O
Uap1p	B-Gene_or_gene_product
utilized	O
N	O
-	O
acetylglucosamine	O
-	O
1	O
-	O
phosphate	O
as	O
the	O
substrate	O
,	O
and	O
together	O
with	O
Agm1p	B-Gene_or_gene_product
,	O
it	O
produced	O
UDP	O
-	O
N	O
-	O
acetylglucosamine	O
from	O
N	O
-	O
acetylglucosamine	O
-	O
6	O
-	O
phosphate	O
.	O

These	O
results	O
demonstrate	O
that	O
the	O
UAP1	B-Gene_or_gene_product
genes	O
indeed	O
specify	O
eukaryotic	O
UDP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
GlcNAc	I-Gene_or_gene_product
pyrophosphorylase	I-Gene_or_gene_product
and	O
that	O
phosphomutase	O
reaction	O
precedes	O
uridyltransfer	O
.	O
<EOS>	B-X
A	B-X
search	B-X
of	B-X
the	B-X
yeast	B-X
data	B-X
base	B-X
for	B-X
a	B-X
protein	B-X
homologous	B-X
to	B-X
Escherichia	B-X
coli	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
yielded	B-X
UAP1	B-X
(	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
)	B-X
,	B-X
the	B-X
Saccharomyces	B-X
cerevisiae	B-X
gene	B-X
for	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
.	B-X
Sequence	B-X
analysis	B-X
revealed	B-X
that	B-X
the	B-X
human	B-X
UAP1	B-X
cDNA	B-X
was	B-X
identical	B-X
to	B-X
previously	B-X
reported	B-X
AGX1	B-X
.	B-X
A	B-X
null	B-X
mutation	B-X
of	B-X
the	B-X
S.	B-X
cerevisiae	B-X
UAP1	B-X
(	B-X
ScUAP1	B-X
)	B-X
gene	B-X
was	B-X
lethal	B-X
,	B-X
and	B-X
when	B-X
expressed	B-X
under	B-X
the	B-X
control	B-X
of	B-X
ScUAP1	B-X
promoter	B-X
,	B-X
both	B-X
C.	B-X
albicans	B-X
and	B-X
Homo	B-X
sapiens	B-X
UAP1	B-X
(	B-X
CaUAP1	B-X
and	B-X
HsUAP1	B-X
)	B-X
rescued	B-X
the	B-X
ScUAP1-deficient	B-X
S.	B-X
cerevisiae	B-X
cells	B-X
.	B-X
All	B-X
the	B-X
recombinant	B-X
ScUap1p	B-X
,	B-X
CaUap1p	B-X
,	B-X
and	B-X
HsUap1p	B-X
possessed	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
activities	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
yeast	B-X
Uap1p	B-X
utilized	B-X
N-acetylglucosamine-1-phosphate	B-X
as	B-X
the	B-X
substrate	B-X
,	B-X
and	B-X
together	B-X
with	B-X
Agm1p	B-X
,	B-X
it	B-X
produced	B-X
UDP-N-acetylglucosamine	B-X
from	B-X
N-acetylglucosamine-6-phosphate	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
UAP1	B-X
genes	B-X
indeed	B-X
specify	B-X
eukaryotic	B-X
UDP-GlcNAc	B-X
pyrophosphorylase	B-X
and	B-X
that	B-X
phosphomutase	B-X
reaction	B-X
precedes	B-X
uridyltransfer	B-X
.	B-X
Sequence	B-X
comparison	B-X
with	B-X
other	B-X
UDP-sugar	B-X
pyrophosphorylases	B-X
revealed	B-X
that	B-X
amino	B-X
acid	B-X
residues	B-X
,	B-X
Gly112	B-X
,	B-X
Gly114	B-X
,	B-X
Thr115	B-X
,	B-X
Arg116	B-X
,	B-X
Pro122	B-X
,	B-X
and	B-X
Lys123	B-X
of	B-X
ScUap1p	B-X
are	B-X
highly	B-X
conserved	B-X
in	B-X
UDP-sugar	B-X
pyrophosphorylases	B-X
reported	B-X
to	B-X
date	B-X
.	B-X

Sequence	O
comparison	O
with	O
other	O
UDP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
sugar	I-Gene_or_gene_product
pyrophosphorylases	I-Gene_or_gene_product
revealed	O
that	O
amino	O
acid	O
residues	O
,	O
Gly112	O
,	O
Gly114	O
,	O
Thr115	O
,	O
Arg116	O
,	O
Pro122	O
,	O
and	O
Lys123	O
of	O
ScUap1p	B-Gene_or_gene_product
are	O
highly	O
conserved	O
in	O
UDP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
sugar	I-Gene_or_gene_product
pyrophosphorylases	I-Gene_or_gene_product
reported	O
to	O
date	O
.	O
<EOS>	B-X
A	B-X
search	B-X
of	B-X
the	B-X
yeast	B-X
data	B-X
base	B-X
for	B-X
a	B-X
protein	B-X
homologous	B-X
to	B-X
Escherichia	B-X
coli	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
yielded	B-X
UAP1	B-X
(	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
)	B-X
,	B-X
the	B-X
Saccharomyces	B-X
cerevisiae	B-X
gene	B-X
for	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
.	B-X
Sequence	B-X
analysis	B-X
revealed	B-X
that	B-X
the	B-X
human	B-X
UAP1	B-X
cDNA	B-X
was	B-X
identical	B-X
to	B-X
previously	B-X
reported	B-X
AGX1	B-X
.	B-X
All	B-X
the	B-X
recombinant	B-X
ScUap1p	B-X
,	B-X
CaUap1p	B-X
,	B-X
and	B-X
HsUap1p	B-X
possessed	B-X
UDP-N-acetylglucosamine	B-X
pyrophosphorylase	B-X
activities	B-X
in	B-X
vitro	B-X
.	B-X
The	B-X
yeast	B-X
Uap1p	B-X
utilized	B-X
N-acetylglucosamine-1-phosphate	B-X
as	B-X
the	B-X
substrate	B-X
,	B-X
and	B-X
together	B-X
with	B-X
Agm1p	B-X
,	B-X
it	B-X
produced	B-X
UDP-N-acetylglucosamine	B-X
from	B-X
N-acetylglucosamine-6-phosphate	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
UAP1	B-X
genes	B-X
indeed	B-X
specify	B-X
eukaryotic	B-X
UDP-GlcNAc	B-X
pyrophosphorylase	B-X
and	B-X
that	B-X
phosphomutase	B-X
reaction	B-X
precedes	B-X
uridyltransfer	B-X
.	B-X
Sequence	B-X
comparison	B-X
with	B-X
other	B-X
UDP-sugar	B-X
pyrophosphorylases	B-X
revealed	B-X
that	B-X
amino	B-X
acid	B-X
residues	B-X
,	B-X
Gly112	B-X
,	B-X
Gly114	B-X
,	B-X
Thr115	B-X
,	B-X
Arg116	B-X
,	B-X
Pro122	B-X
,	B-X
and	B-X
Lys123	B-X
of	B-X
ScUap1p	B-X
are	B-X
highly	B-X
conserved	B-X
in	B-X
UDP-sugar	B-X
pyrophosphorylases	B-X
reported	B-X
to	B-X
date	B-X
.	B-X
Among	B-X
these	B-X
amino	B-X
acids	B-X
,	B-X
alanine	B-X
substitution	B-X
for	B-X
Gly112	B-X
,	B-X
Arg116	B-X
,	B-X
or	B-X
Lys123	B-X
severely	B-X
diminished	B-X
the	B-X
activity	B-X
,	B-X
suggesting	B-X
that	B-X
Gly112	B-X
,	B-X
Arg116	B-X
,	B-X
or	B-X
Lys123	B-X
are	B-X
possible	B-X
catalytic	B-X
residues	B-X
of	B-X
the	B-X
enzyme	B-X
.	B-X

Among	O
these	O
amino	O
acids	O
,	O
alanine	O
substitution	O
for	O
Gly112	O
,	O
Arg116	O
,	O
or	O
Lys123	O
severely	O
diminished	O
the	O
activity	O
,	O
suggesting	O
that	O
Gly112	O
,	O
Arg116	O
,	O
or	O
Lys123	O
are	O
possible	O
catalytic	O
residues	O
of	O
the	O
enzyme	O
.	O
<EOS>	B-X
Sequence	B-X
comparison	B-X
with	B-X
other	B-X
UDP-sugar	B-X
pyrophosphorylases	B-X
revealed	B-X
that	B-X
amino	B-X
acid	B-X
residues	B-X
,	B-X
Gly112	B-X
,	B-X
Gly114	B-X
,	B-X
Thr115	B-X
,	B-X
Arg116	B-X
,	B-X
Pro122	B-X
,	B-X
and	B-X
Lys123	B-X
of	B-X
ScUap1p	B-X
are	B-X
highly	B-X
conserved	B-X
in	B-X
UDP-sugar	B-X
pyrophosphorylases	B-X
reported	B-X
to	B-X
date	B-X
.	B-X
Among	B-X
these	B-X
amino	B-X
acids	B-X
,	B-X
alanine	B-X
substitution	B-X
for	B-X
Gly112	B-X
,	B-X
Arg116	B-X
,	B-X
or	B-X
Lys123	B-X
severely	B-X
diminished	B-X
the	B-X
activity	B-X
,	B-X
suggesting	B-X
that	B-X
Gly112	B-X
,	B-X
Arg116	B-X
,	B-X
or	B-X
Lys123	B-X
are	B-X
possible	B-X
catalytic	B-X
residues	B-X
of	B-X
the	B-X
enzyme	B-X
.	B-X
Peptide	B-X
amidase	B-X
(	B-X
Pam	B-X
)	B-X
,	B-X
a	B-X
hydrolytic	B-X
enzyme	B-X
that	B-X
belongs	B-X
to	B-X
the	B-X
amidase	B-X
signature	B-X
(	B-X
AS	B-X
)	B-X
family	B-X
,	B-X
selectively	B-X
catalyzes	B-X
the	B-X
hydrolysis	B-X
of	B-X
the	B-X
C-terminal	B-X
amide	B-X
bond	B-X
(	B-X
CO-NH	B-X
(	B-X
2	B-X
)	B-X
)	B-X
of	B-X
peptides	B-X
.	B-X
The	B-X
recent	B-X
availability	B-X
of	B-X
the	B-X
X-ray	B-X
structures	B-X
of	B-X
Pam	B-X
,	B-X
fatty	B-X
acid	B-X
amide	B-X
hydrolase	B-X
,	B-X
and	B-X
malonamidase	B-X
E2	B-X
has	B-X
led	B-X
to	B-X
the	B-X
proposal	B-X
of	B-X
a	B-X
novel	B-X
Ser-Ser-Lys	B-X
catalytic	B-X
triad	B-X
mechanism	B-X
for	B-X
the	B-X
amide	B-X
hydrolysis	B-X
by	B-X
the	B-X
AS	B-X
enzymes	B-X
.	B-X
The	B-X
molecular	B-X
dynamics	B-X
(	B-X
MD	B-X
)	B-X
simulations	B-X
using	B-X
the	B-X
CHARMM	B-X
force	B-X
field	B-X
were	B-X
performed	B-X
to	B-X
explore	B-X
the	B-X
catalytic	B-X
mechanism	B-X
of	B-X
Pam	B-X
.	B-X
The	B-X
five	B-X
systems	B-X
that	B-X
were	B-X
investigated	B-X
are	B-X
as	B-X
follows	B-X
:	B-X
(	B-X
i	B-X
)	B-X
enzyme.substrate	B-X
with	B-X
Lys123-NH	B-X
(	B-X
2	B-X
)	B-X
,	B-X
(	B-X
ii	B-X
)	B-X
enzyme.substrate	B-X
with	B-X
Lys123-NH	B-X
(	B-X
3	B-X
)	B-X
(	B-X
+	B-X
)	B-X
,	B-X
(	B-X
iii	B-X
)	B-X
enzyme.substrate	B-X
with	B-X
Lys123-NH	B-X
(	B-X
3	B-X
)	B-X
(	B-X
+	B-X
)	B-X
and	B-X
Ser226-O	B-X
(	B-X
-	B-X
)	B-X
,	B-X
(	B-X
iv	B-X
)	B-X
enzyme.transition	B-X
state	B-X
,	B-X
and	B-X
(	B-X
v	B-X
)	B-X
enzyme.tetrahedral	B-X
intermediate	B-X
.	B-X
Our	B-X
data	B-X
support	B-X
the	B-X
presence	B-X
of	B-X
the	B-X
hydrogen	B-X
bonding	B-X
network	B-X
among	B-X
the	B-X
catalytic	B-X
triad	B-X
residues	B-X
,	B-X
Ser226	B-X
,	B-X
Ser202	B-X
,	B-X
and	B-X
Lys123	B-X
,	B-X
where	B-X
Ser226	B-X
acts	B-X
as	B-X
the	B-X
nucleophile	B-X
and	B-X
Ser202	B-X
bridges	B-X
Ser226	B-X
and	B-X
Lys123	B-X
.	B-X
The	B-X
MD	B-X
simulation	B-X
supports	B-X
the	B-X
catalytic	B-X
role	B-X
of	B-X
the	B-X
crystallographic	B-X
waters	B-X
,	B-X
Wat1	B-X
and	B-X
Wat2	B-X
.	B-X
In	B-X
a	B-X
mechanism	B-X
that	B-X
is	B-X
relevant	B-X
at	B-X
lower	B-X
pH	B-X
,	B-X
the	B-X
Lys123-NH	B-X
(	B-X
3	B-X
)	B-X
(	B-X
+	B-X
)	B-X
-Ser202	B-X
dyad	B-X
provides	B-X
structural	B-X
support	B-X
to	B-X
the	B-X
catalytic	B-X
residue	B-X
Ser226	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
carries	B-X
out	B-X
a	B-X
nucleophilic	B-X
attack	B-X
at	B-X
the	B-X
substrate	B-X
amide	B-X
carbonyl	B-X
in	B-X
concert	B-X
with	B-X
Wat1-mediated	B-X
deprotonation	B-X
and	B-X
stabilization	B-X
of	B-X
the	B-X
tetrahedral	B-X
transition	B-X
state	B-X
by	B-X
the	B-X
oxyanion	B-X
hole	B-X
.	B-X
In	B-X
the	B-X
mechanism	B-X
operating	B-X
at	B-X
higher	B-X
pH	B-X
,	B-X
the	B-X
Lys123-NH	B-X
(	B-X
2	B-X
)	B-X
-Ser202	B-X
catalytic	B-X
dyad	B-X
acts	B-X
as	B-X
a	B-X
general	B-X
base	B-X
to	B-X
assist	B-X
addition	B-X
of	B-X
Ser226	B-X
to	B-X
the	B-X
substrate	B-X
amide	B-X
carbonyl	B-X
.	B-X
The	B-X
results	B-X
from	B-X
the	B-X
MD	B-X
simulation	B-X
of	B-X
the	B-X
tetrahedral	B-X
intermediate	B-X
state	B-X
show	B-X
that	B-X
both	B-X
Ser202	B-X
and	B-X
Lys123	B-X
are	B-X
possible	B-X
candidates	B-X
for	B-X
protonation	B-X
of	B-X
the	B-X
leaving	B-X
group	B-X
,	B-X
NH	B-X
(	B-X
2	B-X
)	B-X
,	B-X
to	B-X
form	B-X
the	B-X
acyl-enzyme	B-X
intermediate	B-X
.	B-X

Control	O
of	O
cyclin	B-Gene_or_gene_product
B1	I-Gene_or_gene_product
localization	O
through	O
regulated	O
binding	O
of	O
the	O
nuclear	O
export	O
factor	O
CRM1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Cyclin	B-X
B1	B-X
localization	B-X
changes	B-X
dramatically	B-X
during	B-X
the	B-X
cell	B-X
cycle	B-X
,	B-X
precipitously	B-X
transiting	B-X
from	B-X
the	B-X
cytoplasm	B-X
to	B-X
the	B-X
nucleus	B-X
at	B-X
the	B-X
beginning	B-X
of	B-X
mitosis	B-X
.	B-X
Presumably	B-X
,	B-X
this	B-X
relocalization	B-X
promotes	B-X
the	B-X
phosphorylation	B-X
of	B-X
nuclear	B-X
targets	B-X
critical	B-X
for	B-X
chromatin	B-X
condensation	B-X
and	B-X
nuclear	B-X
envelope	B-X
breakdown	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
the	B-X
previously	B-X
characterized	B-X
cytoplasmic	B-X
retention	B-X
sequence	B-X
of	B-X
Cyclin	B-X
B1	B-X
,	B-X
responsible	B-X
for	B-X
its	B-X
interphase	B-X
cytoplasmic	B-X
localization	B-X
,	B-X
is	B-X
actually	B-X
an	B-X
autonomous	B-X
nuclear	B-X
export	B-X
sequence	B-X
,	B-X
capable	B-X
of	B-X
directing	B-X
nuclear	B-X
export	B-X
of	B-X
a	B-X
heterologous	B-X
protein	B-X
,	B-X
and	B-X
able	B-X
to	B-X
bind	B-X
specifically	B-X
to	B-X
the	B-X
recently	B-X
identified	B-X
export	B-X
mediator	B-X
,	B-X
CRM1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
observed	B-X
cytoplasmic	B-X
localization	B-X
of	B-X
Cyclin	B-X
B1	B-X
during	B-X
interphase	B-X
reflects	B-X
the	B-X
equilibrium	B-X
between	B-X
ongoing	B-X
nuclear	B-X
import	B-X
and	B-X
rapid	B-X
CRM1-mediated	B-X
export	B-X
.	B-X
In	B-X
support	B-X
of	B-X
this	B-X
hypothesis	B-X
,	B-X
we	B-X
found	B-X
that	B-X
treatment	B-X
of	B-X
cells	B-X
with	B-X
leptomycin	B-X
B	B-X
,	B-X
which	B-X
disrupted	B-X
Cyclin	B-X
B1-CRM1	B-X
interactions	B-X
,	B-X
led	B-X
to	B-X
a	B-X
marked	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cyclin	B-X
B1	B-X
.	B-X
In	B-X
mitosis	B-X
,	B-X
Cyclin	B-X
B1	B-X
undergoes	B-X
phosphorylation	B-X
at	B-X
several	B-X
sites	B-X
,	B-X
a	B-X
subset	B-X
of	B-X
which	B-X
have	B-X
been	B-X
proposed	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
Cyclin	B-X
B1	B-X
accumulation	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X
Both	B-X
CRM1	B-X
binding	B-X
and	B-X
the	B-X
ability	B-X
to	B-X
direct	B-X
nuclear	B-X
export	B-X
were	B-X
affected	B-X
by	B-X
mutation	B-X
of	B-X
these	B-X
phosphorylation	B-X
sites	B-X
;	B-X
thus	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
Cyclin	B-X
B1	B-X
phosphorylation	B-X
at	B-X
the	B-X
G2/M	B-X
transition	B-X
prevents	B-X
its	B-X
interaction	B-X
with	B-X
CRM1	B-X
,	B-X
thereby	B-X
reducing	B-X
nuclear	B-X
export	B-X
and	B-X
facilitating	B-X
nuclear	B-X
accumulation	B-X
.	B-X

Activation	O
of	O
the	O
Cyclin	O
B	O
/	O
Cdc2	O
kinase	O
complex	O
triggers	O
entry	O
into	O
mitosis	O
in	O
all	O
eukaryotic	O
cells	O
.	O
<EOS>	B-X
Fifteen	B-X
years	B-X
ago	B-X
,	B-X
it	B-X
was	B-X
proposed	B-X
that	B-X
the	B-X
cell	B-X
cycle	B-X
in	B-X
fission	B-X
yeast	B-X
can	B-X
be	B-X
driven	B-X
by	B-X
quantitative	B-X
changes	B-X
in	B-X
the	B-X
activity	B-X
of	B-X
a	B-X
single	B-X
protein	B-X
kinase	B-X
complex	B-X
comprising	B-X
a	B-X
cyclin	B-X
-	B-X
namely	B-X
cyclin	B-X
B	B-X
-	B-X
and	B-X
cyclin	B-X
dependent	B-X
kinase	B-X
1	B-X
(	B-X
Cdk1	B-X
)	B-X
.	B-X
When	B-X
its	B-X
activity	B-X
is	B-X
low	B-X
,	B-X
Cdk1	B-X
triggers	B-X
the	B-X
onset	B-X
of	B-X
S	B-X
phase	B-X
;	B-X
when	B-X
its	B-X
activity	B-X
level	B-X
exceeds	B-X
a	B-X
specific	B-X
threshold	B-X
,	B-X
it	B-X
promotes	B-X
entry	B-X
into	B-X
mitosis	B-X
.	B-X
This	B-X
model	B-X
has	B-X
redefined	B-X
our	B-X
understanding	B-X
of	B-X
the	B-X
essential	B-X
functional	B-X
inputs	B-X
that	B-X
organize	B-X
cell	B-X
cycle	B-X
progression	B-X
,	B-X
and	B-X
its	B-X
main	B-X
principles	B-X
now	B-X
appear	B-X
to	B-X
be	B-X
applicable	B-X
to	B-X
all	B-X
eukaryotic	B-X
cells	B-X
.	B-X
But	B-X
how	B-X
does	B-X
a	B-X
change	B-X
in	B-X
the	B-X
activity	B-X
of	B-X
one	B-X
kinase	B-X
generate	B-X
ordered	B-X
progression	B-X
through	B-X
the	B-X
cell	B-X
cycle	B-X
in	B-X
order	B-X
to	B-X
separate	B-X
DNA	B-X
replication	B-X
from	B-X
mitosis	B-X
?	B-X
These	B-X
considerations	B-X
lead	B-X
to	B-X
a	B-X
general	B-X
quantitative	B-X
model	B-X
of	B-X
cell	B-X
cycle	B-X
control	B-X
,	B-X
in	B-X
which	B-X
opposing	B-X
kinase	B-X
and	B-X
phosphatase	B-X
activities	B-X
have	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
ensuring	B-X
dynamic	B-X
transitions	B-X
.	B-X

Cyclin	B-Gene_or_gene_product
B1	I-Gene_or_gene_product
localization	O
changes	O
dramatically	O
during	O
the	O
cell	O
cycle	O
,	O
precipitously	O
transiting	O
from	O
the	O
cytoplasm	O
to	O
the	O
nucleus	O
at	O
the	O
beginning	O
of	O
mitosis	O
.	O

Presumably	O
,	O
this	O
relocalization	O
promotes	O
the	O
phosphorylation	O
of	O
nuclear	O
targets	O
critical	O
for	O
chromatin	O
condensation	O
and	O
nuclear	O
envelope	O
breakdown	O
.	O
<EOS>	B-X
Presumably	B-X
,	B-X
this	B-X
relocalization	B-X
promotes	B-X
the	B-X
phosphorylation	B-X
of	B-X
nuclear	B-X
targets	B-X
critical	B-X
for	B-X
chromatin	B-X
condensation	B-X
and	B-X
nuclear	B-X
envelope	B-X
breakdown	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
the	B-X
previously	B-X
characterized	B-X
cytoplasmic	B-X
retention	B-X
sequence	B-X
of	B-X
Cyclin	B-X
B1	B-X
,	B-X
responsible	B-X
for	B-X
its	B-X
interphase	B-X
cytoplasmic	B-X
localization	B-X
,	B-X
is	B-X
actually	B-X
an	B-X
autonomous	B-X
nuclear	B-X
export	B-X
sequence	B-X
,	B-X
capable	B-X
of	B-X
directing	B-X
nuclear	B-X
export	B-X
of	B-X
a	B-X
heterologous	B-X
protein	B-X
,	B-X
and	B-X
able	B-X
to	B-X
bind	B-X
specifically	B-X
to	B-X
the	B-X
recently	B-X
identified	B-X
export	B-X
mediator	B-X
,	B-X
CRM1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
observed	B-X
cytoplasmic	B-X
localization	B-X
of	B-X
Cyclin	B-X
B1	B-X
during	B-X
interphase	B-X
reflects	B-X
the	B-X
equilibrium	B-X
between	B-X
ongoing	B-X
nuclear	B-X
import	B-X
and	B-X
rapid	B-X
CRM1-mediated	B-X
export	B-X
.	B-X
In	B-X
support	B-X
of	B-X
this	B-X
hypothesis	B-X
,	B-X
we	B-X
found	B-X
that	B-X
treatment	B-X
of	B-X
cells	B-X
with	B-X
leptomycin	B-X
B	B-X
,	B-X
which	B-X
disrupted	B-X
Cyclin	B-X
B1-CRM1	B-X
interactions	B-X
,	B-X
led	B-X
to	B-X
a	B-X
marked	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cyclin	B-X
B1	B-X
.	B-X
In	B-X
mitosis	B-X
,	B-X
Cyclin	B-X
B1	B-X
undergoes	B-X
phosphorylation	B-X
at	B-X
several	B-X
sites	B-X
,	B-X
a	B-X
subset	B-X
of	B-X
which	B-X
have	B-X
been	B-X
proposed	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
Cyclin	B-X
B1	B-X
accumulation	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X
Both	B-X
CRM1	B-X
binding	B-X
and	B-X
the	B-X
ability	B-X
to	B-X
direct	B-X
nuclear	B-X
export	B-X
were	B-X
affected	B-X
by	B-X
mutation	B-X
of	B-X
these	B-X
phosphorylation	B-X
sites	B-X
;	B-X
thus	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
Cyclin	B-X
B1	B-X
phosphorylation	B-X
at	B-X
the	B-X
G2/M	B-X
transition	B-X
prevents	B-X
its	B-X
interaction	B-X
with	B-X
CRM1	B-X
,	B-X
thereby	B-X
reducing	B-X
nuclear	B-X
export	B-X
and	B-X
facilitating	B-X
nuclear	B-X
accumulation	B-X
.	B-X

We	O
show	O
here	O
that	O
the	O
previously	O
characterized	O
cytoplasmic	O
retention	O
sequence	O
of	O
Cyclin	B-Gene_or_gene_product
B1	I-Gene_or_gene_product
,	O
responsible	O
for	O
its	O
interphase	O
cytoplasmic	O
localization	O
,	O
is	O
actually	O
an	O
autonomous	O
nuclear	O
export	O
sequence	O
,	O
capable	O
of	O
directing	O
nuclear	O
export	O
of	O
a	O
heterologous	O
protein	O
,	O
and	O
able	O
to	O
bind	O
specifically	O
to	O
the	O
recently	O
identified	O
export	O
mediator	O
,	O
CRM1	B-Gene_or_gene_product
.	O

We	O
propose	O
that	O
the	O
observed	O
cytoplasmic	O
localization	O
of	O
Cyclin	B-Gene_or_gene_product
B1	I-Gene_or_gene_product
during	O
interphase	O
reflects	O
the	O
equilibrium	O
between	O
ongoing	O
nuclear	O
import	O
and	O
rapid	O
CRM1	B-Gene_or_gene_product
-	O
mediated	O
export	O
.	O
<EOS>	B-X
Activation	B-X
of	B-X
the	B-X
Cyclin	B-X
B/Cdc2	B-X
kinase	B-X
complex	B-X
triggers	B-X
entry	B-X
into	B-X
mitosis	B-X
in	B-X
all	B-X
eukaryotic	B-X
cells	B-X
.	B-X
Cyclin	B-X
B1	B-X
localization	B-X
changes	B-X
dramatically	B-X
during	B-X
the	B-X
cell	B-X
cycle	B-X
,	B-X
precipitously	B-X
transiting	B-X
from	B-X
the	B-X
cytoplasm	B-X
to	B-X
the	B-X
nucleus	B-X
at	B-X
the	B-X
beginning	B-X
of	B-X
mitosis	B-X
.	B-X
Presumably	B-X
,	B-X
this	B-X
relocalization	B-X
promotes	B-X
the	B-X
phosphorylation	B-X
of	B-X
nuclear	B-X
targets	B-X
critical	B-X
for	B-X
chromatin	B-X
condensation	B-X
and	B-X
nuclear	B-X
envelope	B-X
breakdown	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
the	B-X
previously	B-X
characterized	B-X
cytoplasmic	B-X
retention	B-X
sequence	B-X
of	B-X
Cyclin	B-X
B1	B-X
,	B-X
responsible	B-X
for	B-X
its	B-X
interphase	B-X
cytoplasmic	B-X
localization	B-X
,	B-X
is	B-X
actually	B-X
an	B-X
autonomous	B-X
nuclear	B-X
export	B-X
sequence	B-X
,	B-X
capable	B-X
of	B-X
directing	B-X
nuclear	B-X
export	B-X
of	B-X
a	B-X
heterologous	B-X
protein	B-X
,	B-X
and	B-X
able	B-X
to	B-X
bind	B-X
specifically	B-X
to	B-X
the	B-X
recently	B-X
identified	B-X
export	B-X
mediator	B-X
,	B-X
CRM1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
observed	B-X
cytoplasmic	B-X
localization	B-X
of	B-X
Cyclin	B-X
B1	B-X
during	B-X
interphase	B-X
reflects	B-X
the	B-X
equilibrium	B-X
between	B-X
ongoing	B-X
nuclear	B-X
import	B-X
and	B-X
rapid	B-X
CRM1-mediated	B-X
export	B-X
.	B-X
In	B-X
support	B-X
of	B-X
this	B-X
hypothesis	B-X
,	B-X
we	B-X
found	B-X
that	B-X
treatment	B-X
of	B-X
cells	B-X
with	B-X
leptomycin	B-X
B	B-X
,	B-X
which	B-X
disrupted	B-X
Cyclin	B-X
B1-CRM1	B-X
interactions	B-X
,	B-X
led	B-X
to	B-X
a	B-X
marked	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cyclin	B-X
B1	B-X
.	B-X
In	B-X
mitosis	B-X
,	B-X
Cyclin	B-X
B1	B-X
undergoes	B-X
phosphorylation	B-X
at	B-X
several	B-X
sites	B-X
,	B-X
a	B-X
subset	B-X
of	B-X
which	B-X
have	B-X
been	B-X
proposed	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
Cyclin	B-X
B1	B-X
accumulation	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X
Both	B-X
CRM1	B-X
binding	B-X
and	B-X
the	B-X
ability	B-X
to	B-X
direct	B-X
nuclear	B-X
export	B-X
were	B-X
affected	B-X
by	B-X
mutation	B-X
of	B-X
these	B-X
phosphorylation	B-X
sites	B-X
;	B-X
thus	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
Cyclin	B-X
B1	B-X
phosphorylation	B-X
at	B-X
the	B-X
G2/M	B-X
transition	B-X
prevents	B-X
its	B-X
interaction	B-X
with	B-X
CRM1	B-X
,	B-X
thereby	B-X
reducing	B-X
nuclear	B-X
export	B-X
and	B-X
facilitating	B-X
nuclear	B-X
accumulation	B-X
.	B-X

In	O
support	O
of	O
this	O
hypothesis	O
,	O
we	O
found	O
that	O
treatment	O
of	O
cells	O
with	O
leptomycin	O
B	O
,	O
which	O
disrupted	O
Cyclin	B-Gene_or_gene_product
B1	I-Gene_or_gene_product
-	O
CRM1	B-Gene_or_gene_product
interactions	O
,	O
led	O
to	O
a	O
marked	O
nuclear	O
accumulation	O
of	O
Cyclin	B-Gene_or_gene_product
B1	I-Gene_or_gene_product
.	O
<EOS>	B-X
Activation	B-X
of	B-X
the	B-X
Cyclin	B-X
B/Cdc2	B-X
kinase	B-X
complex	B-X
triggers	B-X
entry	B-X
into	B-X
mitosis	B-X
in	B-X
all	B-X
eukaryotic	B-X
cells	B-X
.	B-X
Cyclin	B-X
B1	B-X
localization	B-X
changes	B-X
dramatically	B-X
during	B-X
the	B-X
cell	B-X
cycle	B-X
,	B-X
precipitously	B-X
transiting	B-X
from	B-X
the	B-X
cytoplasm	B-X
to	B-X
the	B-X
nucleus	B-X
at	B-X
the	B-X
beginning	B-X
of	B-X
mitosis	B-X
.	B-X
Presumably	B-X
,	B-X
this	B-X
relocalization	B-X
promotes	B-X
the	B-X
phosphorylation	B-X
of	B-X
nuclear	B-X
targets	B-X
critical	B-X
for	B-X
chromatin	B-X
condensation	B-X
and	B-X
nuclear	B-X
envelope	B-X
breakdown	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
the	B-X
previously	B-X
characterized	B-X
cytoplasmic	B-X
retention	B-X
sequence	B-X
of	B-X
Cyclin	B-X
B1	B-X
,	B-X
responsible	B-X
for	B-X
its	B-X
interphase	B-X
cytoplasmic	B-X
localization	B-X
,	B-X
is	B-X
actually	B-X
an	B-X
autonomous	B-X
nuclear	B-X
export	B-X
sequence	B-X
,	B-X
capable	B-X
of	B-X
directing	B-X
nuclear	B-X
export	B-X
of	B-X
a	B-X
heterologous	B-X
protein	B-X
,	B-X
and	B-X
able	B-X
to	B-X
bind	B-X
specifically	B-X
to	B-X
the	B-X
recently	B-X
identified	B-X
export	B-X
mediator	B-X
,	B-X
CRM1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
observed	B-X
cytoplasmic	B-X
localization	B-X
of	B-X
Cyclin	B-X
B1	B-X
during	B-X
interphase	B-X
reflects	B-X
the	B-X
equilibrium	B-X
between	B-X
ongoing	B-X
nuclear	B-X
import	B-X
and	B-X
rapid	B-X
CRM1-mediated	B-X
export	B-X
.	B-X
In	B-X
support	B-X
of	B-X
this	B-X
hypothesis	B-X
,	B-X
we	B-X
found	B-X
that	B-X
treatment	B-X
of	B-X
cells	B-X
with	B-X
leptomycin	B-X
B	B-X
,	B-X
which	B-X
disrupted	B-X
Cyclin	B-X
B1-CRM1	B-X
interactions	B-X
,	B-X
led	B-X
to	B-X
a	B-X
marked	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cyclin	B-X
B1	B-X
.	B-X
In	B-X
mitosis	B-X
,	B-X
Cyclin	B-X
B1	B-X
undergoes	B-X
phosphorylation	B-X
at	B-X
several	B-X
sites	B-X
,	B-X
a	B-X
subset	B-X
of	B-X
which	B-X
have	B-X
been	B-X
proposed	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
Cyclin	B-X
B1	B-X
accumulation	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X
Both	B-X
CRM1	B-X
binding	B-X
and	B-X
the	B-X
ability	B-X
to	B-X
direct	B-X
nuclear	B-X
export	B-X
were	B-X
affected	B-X
by	B-X
mutation	B-X
of	B-X
these	B-X
phosphorylation	B-X
sites	B-X
;	B-X
thus	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
Cyclin	B-X
B1	B-X
phosphorylation	B-X
at	B-X
the	B-X
G2/M	B-X
transition	B-X
prevents	B-X
its	B-X
interaction	B-X
with	B-X
CRM1	B-X
,	B-X
thereby	B-X
reducing	B-X
nuclear	B-X
export	B-X
and	B-X
facilitating	B-X
nuclear	B-X
accumulation	B-X
.	B-X

In	O
mitosis	O
,	O
Cyclin	B-Gene_or_gene_product
B1	I-Gene_or_gene_product
undergoes	O
phosphorylation	O
at	O
several	O
sites	O
,	O
a	O
subset	O
of	O
which	O
have	O
been	O
proposed	O
to	O
play	O
a	O
role	O
in	O
Cyclin	B-Gene_or_gene_product
B1	I-Gene_or_gene_product
accumulation	O
in	O
the	O
nucleus	O
.	O

Both	O
CRM1	B-Gene_or_gene_product
binding	O
and	O
the	O
ability	O
to	O
direct	O
nuclear	O
export	O
were	O
affected	O
by	O
mutation	O
of	O
these	O
phosphorylation	O
sites	O
;	O
thus	O
,	O
we	O
propose	O
that	O
Cyclin	B-Gene_or_gene_product
B1	I-Gene_or_gene_product
phosphorylation	O
at	O
the	O
G2	O
/	O
M	O
transition	O
prevents	O
its	O
interaction	O
with	O
CRM1	B-Gene_or_gene_product
,	O
thereby	O
reducing	O
nuclear	O
export	O
and	O
facilitating	O
nuclear	O
accumulation	O
.	O
<EOS>	B-X
Activation	B-X
of	B-X
the	B-X
Cyclin	B-X
B/Cdc2	B-X
kinase	B-X
complex	B-X
triggers	B-X
entry	B-X
into	B-X
mitosis	B-X
in	B-X
all	B-X
eukaryotic	B-X
cells	B-X
.	B-X
Cyclin	B-X
B1	B-X
localization	B-X
changes	B-X
dramatically	B-X
during	B-X
the	B-X
cell	B-X
cycle	B-X
,	B-X
precipitously	B-X
transiting	B-X
from	B-X
the	B-X
cytoplasm	B-X
to	B-X
the	B-X
nucleus	B-X
at	B-X
the	B-X
beginning	B-X
of	B-X
mitosis	B-X
.	B-X
Presumably	B-X
,	B-X
this	B-X
relocalization	B-X
promotes	B-X
the	B-X
phosphorylation	B-X
of	B-X
nuclear	B-X
targets	B-X
critical	B-X
for	B-X
chromatin	B-X
condensation	B-X
and	B-X
nuclear	B-X
envelope	B-X
breakdown	B-X
.	B-X
We	B-X
show	B-X
here	B-X
that	B-X
the	B-X
previously	B-X
characterized	B-X
cytoplasmic	B-X
retention	B-X
sequence	B-X
of	B-X
Cyclin	B-X
B1	B-X
,	B-X
responsible	B-X
for	B-X
its	B-X
interphase	B-X
cytoplasmic	B-X
localization	B-X
,	B-X
is	B-X
actually	B-X
an	B-X
autonomous	B-X
nuclear	B-X
export	B-X
sequence	B-X
,	B-X
capable	B-X
of	B-X
directing	B-X
nuclear	B-X
export	B-X
of	B-X
a	B-X
heterologous	B-X
protein	B-X
,	B-X
and	B-X
able	B-X
to	B-X
bind	B-X
specifically	B-X
to	B-X
the	B-X
recently	B-X
identified	B-X
export	B-X
mediator	B-X
,	B-X
CRM1	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
the	B-X
observed	B-X
cytoplasmic	B-X
localization	B-X
of	B-X
Cyclin	B-X
B1	B-X
during	B-X
interphase	B-X
reflects	B-X
the	B-X
equilibrium	B-X
between	B-X
ongoing	B-X
nuclear	B-X
import	B-X
and	B-X
rapid	B-X
CRM1-mediated	B-X
export	B-X
.	B-X
In	B-X
support	B-X
of	B-X
this	B-X
hypothesis	B-X
,	B-X
we	B-X
found	B-X
that	B-X
treatment	B-X
of	B-X
cells	B-X
with	B-X
leptomycin	B-X
B	B-X
,	B-X
which	B-X
disrupted	B-X
Cyclin	B-X
B1-CRM1	B-X
interactions	B-X
,	B-X
led	B-X
to	B-X
a	B-X
marked	B-X
nuclear	B-X
accumulation	B-X
of	B-X
Cyclin	B-X
B1	B-X
.	B-X
In	B-X
mitosis	B-X
,	B-X
Cyclin	B-X
B1	B-X
undergoes	B-X
phosphorylation	B-X
at	B-X
several	B-X
sites	B-X
,	B-X
a	B-X
subset	B-X
of	B-X
which	B-X
have	B-X
been	B-X
proposed	B-X
to	B-X
play	B-X
a	B-X
role	B-X
in	B-X
Cyclin	B-X
B1	B-X
accumulation	B-X
in	B-X
the	B-X
nucleus	B-X
.	B-X
Both	B-X
CRM1	B-X
binding	B-X
and	B-X
the	B-X
ability	B-X
to	B-X
direct	B-X
nuclear	B-X
export	B-X
were	B-X
affected	B-X
by	B-X
mutation	B-X
of	B-X
these	B-X
phosphorylation	B-X
sites	B-X
;	B-X
thus	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
Cyclin	B-X
B1	B-X
phosphorylation	B-X
at	B-X
the	B-X
G2/M	B-X
transition	B-X
prevents	B-X
its	B-X
interaction	B-X
with	B-X
CRM1	B-X
,	B-X
thereby	B-X
reducing	B-X
nuclear	B-X
export	B-X
and	B-X
facilitating	B-X
nuclear	B-X
accumulation	B-X
.	B-X

Interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O
<EOS>	B-X
More	B-X
than	B-X
any	B-X
other	B-X
cytokine	B-X
family	B-X
,	B-X
the	B-X
IL-1	B-X
family	B-X
of	B-X
ligands	B-X
and	B-X
receptors	B-X
is	B-X
primarily	B-X
associated	B-X
with	B-X
acute	B-X
and	B-X
chronic	B-X
inflammation	B-X
.	B-X
The	B-X
cytosolic	B-X
segment	B-X
of	B-X
each	B-X
IL-1	B-X
receptor	B-X
family	B-X
member	B-X
contains	B-X
the	B-X
Toll-IL-1-receptor	B-X
domain	B-X
.	B-X
Since	B-X
Toll-IL-1-receptor	B-X
domains	B-X
are	B-X
functional	B-X
for	B-X
both	B-X
receptor	B-X
families	B-X
,	B-X
responses	B-X
to	B-X
the	B-X
IL-1	B-X
family	B-X
are	B-X
fundamental	B-X
to	B-X
innate	B-X
immunity	B-X
.	B-X
Of	B-X
the	B-X
11	B-X
members	B-X
of	B-X
the	B-X
IL-1	B-X
family	B-X
,	B-X
IL-1β	B-X
has	B-X
emerged	B-X
as	B-X
a	B-X
therapeutic	B-X
target	B-X
for	B-X
an	B-X
expanding	B-X
number	B-X
of	B-X
systemic	B-X
and	B-X
local	B-X
inflammatory	B-X
conditions	B-X
called	B-X
autoinflammatory	B-X
diseases	B-X
.	B-X
For	B-X
these	B-X
,	B-X
neutralization	B-X
of	B-X
IL-1β	B-X
results	B-X
in	B-X
a	B-X
rapid	B-X
and	B-X
sustained	B-X
reduction	B-X
in	B-X
disease	B-X
severity	B-X
.	B-X
Treatment	B-X
for	B-X
autoimmune	B-X
diseases	B-X
often	B-X
includes	B-X
immunosuppressive	B-X
drugs	B-X
whereas	B-X
neutralization	B-X
of	B-X
IL-1β	B-X
is	B-X
mostly	B-X
anti-inflammatory	B-X
.	B-X
Although	B-X
some	B-X
autoinflammatory	B-X
diseases	B-X
are	B-X
due	B-X
to	B-X
gain-of-function	B-X
mutations	B-X
for	B-X
caspase-1	B-X
activity	B-X
,	B-X
common	B-X
diseases	B-X
such	B-X
as	B-X
gout	B-X
,	B-X
type	B-X
2	B-X
diabetes	B-X
,	B-X
heart	B-X
failure	B-X
,	B-X
recurrent	B-X
pericarditis	B-X
,	B-X
rheumatoid	B-X
arthritis	B-X
,	B-X
and	B-X
smoldering	B-X
myeloma	B-X
also	B-X
are	B-X
responsive	B-X
to	B-X
IL-1β	B-X
neutralization	B-X
.	B-X
This	B-X
review	B-X
summarizes	B-X
acute	B-X
and	B-X
chronic	B-X
inflammatory	B-X
diseases	B-X
that	B-X
are	B-X
treated	B-X
by	B-X
reducing	B-X
IL-1β	B-X
activity	B-X
and	B-X
proposes	B-X
that	B-X
disease	B-X
severity	B-X
is	B-X
affected	B-X
by	B-X
the	B-X
anti-inflammatory	B-X
members	B-X
of	B-X
the	B-X
IL-1	B-X
family	B-X
of	B-X
ligands	B-X
and	B-X
receptors	B-X
.	B-X

Interleukin	B-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
IL1	B-Gene_or_gene_product
)	O
is	O
a	O
primary	O
regulator	O
of	O
inflammatory	O
and	O
immune	O
responses	O
.	O
<EOS>	B-X
Kaposi	B-X
's	B-X
sarcoma-associated	B-X
herpesvirus	B-X
(	B-X
KSHV	B-X
)	B-X
represents	B-X
the	B-X
etiological	B-X
agent	B-X
for	B-X
several	B-X
human	B-X
malignancies	B-X
,	B-X
including	B-X
Kaposi	B-X
's	B-X
sarcoma	B-X
(	B-X
KS	B-X
)	B-X
,	B-X
primary	B-X
effusion	B-X
lymphoma	B-X
(	B-X
PEL	B-X
)	B-X
,	B-X
and	B-X
multicentric	B-X
Castleman	B-X
's	B-X
disease	B-X
(	B-X
MCD	B-X
)	B-X
,	B-X
which	B-X
are	B-X
mostly	B-X
seen	B-X
in	B-X
immunocompromised	B-X
patients	B-X
.	B-X
In	B-X
fact	B-X
,	B-X
KSHV	B-X
has	B-X
developed	B-X
many	B-X
strategies	B-X
to	B-X
hijack	B-X
host	B-X
immune	B-X
response	B-X
,	B-X
including	B-X
the	B-X
regulation	B-X
of	B-X
inflammatory	B-X
cytokine	B-X
production	B-X
.	B-X
Interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
family	B-X
represents	B-X
a	B-X
major	B-X
mediator	B-X
for	B-X
inflammation	B-X
and	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
both	B-X
innate	B-X
and	B-X
adaptive	B-X
immunity	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
broadening	B-X
list	B-X
of	B-X
diseases	B-X
has	B-X
revealed	B-X
the	B-X
pathologic	B-X
role	B-X
of	B-X
IL-1	B-X
mediated	B-X
inflammation	B-X
.	B-X
In	B-X
the	B-X
current	B-X
mini-review	B-X
,	B-X
we	B-X
have	B-X
summarized	B-X
recent	B-X
findings	B-X
about	B-X
how	B-X
this	B-X
oncogenic	B-X
virus	B-X
is	B-X
able	B-X
to	B-X
manipulate	B-X
the	B-X
activities	B-X
of	B-X
IL-1	B-X
signaling	B-X
pathway	B-X
to	B-X
facilitate	B-X
disease	B-X
progression	B-X
.	B-X
We	B-X
also	B-X
discuss	B-X
the	B-X
therapeutic	B-X
potential	B-X
of	B-X
IL-1	B-X
blockade	B-X
against	B-X
KSHV-related	B-X
diseases	B-X
and	B-X
several	B-X
unsolved	B-X
questions	B-X
in	B-X
this	B-X
interesting	B-X
field	B-X
.	B-X

Via	O
its	O
type	B-Gene_or_gene_product
I	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
it	O
activates	O
specific	O
protein	O
kinases	O
,	O
including	O
the	O
NF	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
inducing	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
NIK	B-Gene_or_gene_product
)	O
and	O
three	O
distinct	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	I-Gene_or_gene_product
MAP	I-Gene_or_gene_product
)	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
cascades	O
.	O
<EOS>	B-X
Via	B-X
its	B-X
type	B-X
I	B-X
receptor	B-X
it	B-X
activates	B-X
specific	B-X
protein	B-X
kinases	B-X
,	B-X
including	B-X
the	B-X
NF	B-X
kappa	B-X
B	B-X
inducing	B-X
kinase	B-X
(	B-X
NIK	B-X
)	B-X
and	B-X
three	B-X
distinct	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
cascades	B-X
.	B-X
These	B-X
modulate	B-X
a	B-X
number	B-X
of	B-X
transcription	B-X
factors	B-X
including	B-X
NF	B-X
kappa	B-X
B	B-X
,	B-X
AP1	B-X
and	B-X
CREB	B-X
each	B-X
of	B-X
which	B-X
regulate	B-X
a	B-X
plethora	B-X
of	B-X
immediate	B-X
early	B-X
genes	B-X
central	B-X
to	B-X
the	B-X
inflammatory	B-X
response	B-X
.	B-X
Phase	B-X
I	B-X
clinical	B-X
trials	B-X
of	B-X
the	B-X
soluble	B-X
type	B-X
I	B-X
receptor	B-X
and	B-X
IRAP	B-X
indicate	B-X
that	B-X
these	B-X
have	B-X
potential	B-X
anti-inflammatory	B-X
effects	B-X
.	B-X

These	O
modulate	O
a	O
number	O
of	O
transcription	O
factors	O
including	O
NF	O
kappa	O
B	O
,	O
AP1	O
and	O
CREB	B-Gene_or_gene_product
each	O
of	O
which	O
regulate	O
a	O
plethora	O
of	O
immediate	O
early	O
genes	O
central	O
to	O
the	O
inflammatory	O
response	O
.	O

Phase	O
I	O
clinical	O
trials	O
of	O
the	O
soluble	O
type	B-Gene_or_gene_product
I	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
and	O
IRAP	B-Gene_or_gene_product
indicate	O
that	O
these	O
have	O
potential	O
anti	O
-	O
inflammatory	O
effects	O
.	O
<EOS>	B-X
Interleukin	B-X
1	B-X
(	B-X
IL1	B-X
)	B-X
is	B-X
a	B-X
primary	B-X
regulator	B-X
of	B-X
inflammatory	B-X
and	B-X
immune	B-X
responses	B-X
.	B-X
Via	B-X
its	B-X
type	B-X
I	B-X
receptor	B-X
it	B-X
activates	B-X
specific	B-X
protein	B-X
kinases	B-X
,	B-X
including	B-X
the	B-X
NF	B-X
kappa	B-X
B	B-X
inducing	B-X
kinase	B-X
(	B-X
NIK	B-X
)	B-X
and	B-X
three	B-X
distinct	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
cascades	B-X
.	B-X
These	B-X
modulate	B-X
a	B-X
number	B-X
of	B-X
transcription	B-X
factors	B-X
including	B-X
NF	B-X
kappa	B-X
B	B-X
,	B-X
AP1	B-X
and	B-X
CREB	B-X
each	B-X
of	B-X
which	B-X
regulate	B-X
a	B-X
plethora	B-X
of	B-X
immediate	B-X
early	B-X
genes	B-X
central	B-X
to	B-X
the	B-X
inflammatory	B-X
response	B-X
.	B-X
Phase	B-X
I	B-X
clinical	B-X
trials	B-X
of	B-X
the	B-X
soluble	B-X
type	B-X
I	B-X
receptor	B-X
and	B-X
IRAP	B-X
indicate	B-X
that	B-X
these	B-X
have	B-X
potential	B-X
anti-inflammatory	B-X
effects	B-X
.	B-X

Cell	O
cycle	O
regulation	O
of	O
the	O
Saccharomyces	O
cerevisiae	O
polo	B-Gene_or_gene_product
-	O
like	O
kinase	O
cdc5p	B-Gene_or_gene_product
.	O
<EOS>	B-X
Progression	B-X
through	B-X
and	B-X
completion	B-X
of	B-X
mitosis	B-X
require	B-X
the	B-X
actions	B-X
of	B-X
the	B-X
evolutionarily	B-X
conserved	B-X
Polo	B-X
kinase	B-X
.	B-X
We	B-X
have	B-X
determined	B-X
that	B-X
the	B-X
levels	B-X
of	B-X
Cdc5p	B-X
,	B-X
a	B-X
Saccharomyces	B-X
cerevisiae	B-X
member	B-X
of	B-X
the	B-X
Polo	B-X
family	B-X
of	B-X
mitotic	B-X
kinases	B-X
,	B-X
are	B-X
cell	B-X
cycle	B-X
regulated	B-X
.	B-X
We	B-X
have	B-X
determined	B-X
that	B-X
Cdc5p-associated	B-X
kinase	B-X
activity	B-X
is	B-X
restricted	B-X
to	B-X
G2/M	B-X
and	B-X
that	B-X
this	B-X
activity	B-X
is	B-X
posttranslationally	B-X
regulated	B-X
.	B-X
Protein	B-X
phosphorylation	B-X
has	B-X
long	B-X
been	B-X
implicated	B-X
in	B-X
controlling	B-X
spindle	B-X
function	B-X
and	B-X
chromosome	B-X
segregation	B-X
,	B-X
and	B-X
genetic	B-X
studies	B-X
have	B-X
identified	B-X
several	B-X
protein	B-X
kinases	B-X
and	B-X
phosphatases	B-X
that	B-X
are	B-X
likely	B-X
to	B-X
regulate	B-X
these	B-X
processes	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
mutations	B-X
in	B-X
the	B-X
serine/threonine-specific	B-X
Drosophila	B-X
kinase	B-X
polo	B-X
,	B-X
and	B-X
the	B-X
structurally	B-X
related	B-X
kinase	B-X
Cdc5p	B-X
of	B-X
Saccharomyces	B-X
cerevisae	B-X
,	B-X
result	B-X
in	B-X
abnormal	B-X
mitotic	B-X
and	B-X
meiotic	B-X
divisions	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
a	B-X
detailed	B-X
analysis	B-X
of	B-X
the	B-X
cell	B-X
cycle-dependent	B-X
activity	B-X
and	B-X
subcellular	B-X
localization	B-X
of	B-X
Plk1	B-X
,	B-X
a	B-X
recently	B-X
identified	B-X
human	B-X
protein	B-X
kinase	B-X
with	B-X
extensive	B-X
sequence	B-X
similarity	B-X
to	B-X
both	B-X
Drosophila	B-X
polo	B-X
and	B-X
S.	B-X
cerevisiae	B-X
Cdc5p	B-X
.	B-X
With	B-X
the	B-X
aid	B-X
of	B-X
recombinant	B-X
baculoviruses	B-X
,	B-X
we	B-X
have	B-X
established	B-X
a	B-X
reliable	B-X
in	B-X
vitro	B-X
assay	B-X
for	B-X
Plk1	B-X
kinase	B-X
activity	B-X
.	B-X
We	B-X
show	B-X
that	B-X
the	B-X
activity	B-X
of	B-X
human	B-X
Plk1	B-X
is	B-X
cell	B-X
cycle	B-X
regulated	B-X
,	B-X
Plk1	B-X
activity	B-X
being	B-X
low	B-X
during	B-X
interphase	B-X
but	B-X
high	B-X
during	B-X
mitosis	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
our	B-X
data	B-X
strengthen	B-X
the	B-X
notion	B-X
that	B-X
human	B-X
Plk1	B-X
may	B-X
represent	B-X
a	B-X
functional	B-X
homolog	B-X
of	B-X
polo	B-X
and	B-X
Cdc5p	B-X
,	B-X
and	B-X
they	B-X
suggest	B-X
that	B-X
this	B-X
kinase	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
dynamic	B-X
function	B-X
of	B-X
the	B-X
mitotic	B-X
spindle	B-X
during	B-X
chromosome	B-X
segregation	B-X
.	B-X

Progression	O
through	O
and	O
completion	O
of	O
mitosis	O
require	O
the	O
actions	O
of	O
the	O
evolutionarily	O
conserved	O
Polo	B-Gene_or_gene_product
kinase	O
.	O
<EOS>	B-X
Progression	B-X
through	B-X
and	B-X
completion	B-X
of	B-X
mitosis	B-X
require	B-X
the	B-X
actions	B-X
of	B-X
the	B-X
evolutionarily	B-X
conserved	B-X
Polo	B-X
kinase	B-X
.	B-X
We	B-X
have	B-X
determined	B-X
that	B-X
the	B-X
levels	B-X
of	B-X
Cdc5p	B-X
,	B-X
a	B-X
Saccharomyces	B-X
cerevisiae	B-X
member	B-X
of	B-X
the	B-X
Polo	B-X
family	B-X
of	B-X
mitotic	B-X
kinases	B-X
,	B-X
are	B-X
cell	B-X
cycle	B-X
regulated	B-X
.	B-X
We	B-X
have	B-X
determined	B-X
that	B-X
Cdc5p-associated	B-X
kinase	B-X
activity	B-X
is	B-X
restricted	B-X
to	B-X
G2/M	B-X
and	B-X
that	B-X
this	B-X
activity	B-X
is	B-X
posttranslationally	B-X
regulated	B-X
.	B-X
These	B-X
results	B-X
further	B-X
link	B-X
the	B-X
actions	B-X
of	B-X
the	B-X
APC	B-X
to	B-X
the	B-X
completion	B-X
of	B-X
mitosis	B-X
and	B-X
suggest	B-X
possible	B-X
roles	B-X
for	B-X
Cdc5p	B-X
during	B-X
progression	B-X
through	B-X
and	B-X
completion	B-X
of	B-X
mitosis	B-X
.	B-X

We	O
have	O
determined	O
that	O
the	O
levels	O
of	O
Cdc5p	B-Gene_or_gene_product
,	O
a	O
Saccharomyces	O
cerevisiae	O
member	O
of	O
the	O
Polo	B-Gene_or_gene_product
family	O
of	O
mitotic	O
kinases	O
,	O
are	O
cell	O
cycle	O
regulated	O
.	O
<EOS>	B-X
Progression	B-X
through	B-X
and	B-X
completion	B-X
of	B-X
mitosis	B-X
require	B-X
the	B-X
actions	B-X
of	B-X
the	B-X
evolutionarily	B-X
conserved	B-X
Polo	B-X
kinase	B-X
.	B-X
We	B-X
have	B-X
determined	B-X
that	B-X
the	B-X
levels	B-X
of	B-X
Cdc5p	B-X
,	B-X
a	B-X
Saccharomyces	B-X
cerevisiae	B-X
member	B-X
of	B-X
the	B-X
Polo	B-X
family	B-X
of	B-X
mitotic	B-X
kinases	B-X
,	B-X
are	B-X
cell	B-X
cycle	B-X
regulated	B-X
.	B-X
Cdc5p	B-X
accumulates	B-X
in	B-X
the	B-X
nuclei	B-X
of	B-X
G2/M-phase	B-X
cells	B-X
,	B-X
and	B-X
its	B-X
levels	B-X
decline	B-X
dramatically	B-X
as	B-X
cells	B-X
progress	B-X
through	B-X
anaphase	B-X
and	B-X
begin	B-X
telophase	B-X
.	B-X
We	B-X
report	B-X
that	B-X
Cdc5p	B-X
levels	B-X
are	B-X
sensitive	B-X
to	B-X
mutations	B-X
in	B-X
key	B-X
components	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex	B-X
(	B-X
APC	B-X
)	B-X
.	B-X
We	B-X
have	B-X
determined	B-X
that	B-X
Cdc5p-associated	B-X
kinase	B-X
activity	B-X
is	B-X
restricted	B-X
to	B-X
G2/M	B-X
and	B-X
that	B-X
this	B-X
activity	B-X
is	B-X
posttranslationally	B-X
regulated	B-X
.	B-X
These	B-X
results	B-X
further	B-X
link	B-X
the	B-X
actions	B-X
of	B-X
the	B-X
APC	B-X
to	B-X
the	B-X
completion	B-X
of	B-X
mitosis	B-X
and	B-X
suggest	B-X
possible	B-X
roles	B-X
for	B-X
Cdc5p	B-X
during	B-X
progression	B-X
through	B-X
and	B-X
completion	B-X
of	B-X
mitosis	B-X
.	B-X

Cdc5p	B-Gene_or_gene_product
accumulates	O
in	O
the	O
nuclei	O
of	O
G2	O
/	O
M	O
-	O
phase	O
cells	O
,	O
and	O
its	O
levels	O
decline	O
dramatically	O
as	O
cells	O
progress	O
through	O
anaphase	O
and	O
begin	O
telophase	O
.	O
<EOS>	B-X
We	B-X
have	B-X
determined	B-X
that	B-X
the	B-X
levels	B-X
of	B-X
Cdc5p	B-X
,	B-X
a	B-X
Saccharomyces	B-X
cerevisiae	B-X
member	B-X
of	B-X
the	B-X
Polo	B-X
family	B-X
of	B-X
mitotic	B-X
kinases	B-X
,	B-X
are	B-X
cell	B-X
cycle	B-X
regulated	B-X
.	B-X
Cdc5p	B-X
accumulates	B-X
in	B-X
the	B-X
nuclei	B-X
of	B-X
G2/M-phase	B-X
cells	B-X
,	B-X
and	B-X
its	B-X
levels	B-X
decline	B-X
dramatically	B-X
as	B-X
cells	B-X
progress	B-X
through	B-X
anaphase	B-X
and	B-X
begin	B-X
telophase	B-X
.	B-X
We	B-X
report	B-X
that	B-X
Cdc5p	B-X
levels	B-X
are	B-X
sensitive	B-X
to	B-X
mutations	B-X
in	B-X
key	B-X
components	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex	B-X
(	B-X
APC	B-X
)	B-X
.	B-X
We	B-X
have	B-X
determined	B-X
that	B-X
Cdc5p-associated	B-X
kinase	B-X
activity	B-X
is	B-X
restricted	B-X
to	B-X
G2/M	B-X
and	B-X
that	B-X
this	B-X
activity	B-X
is	B-X
posttranslationally	B-X
regulated	B-X
.	B-X
These	B-X
results	B-X
further	B-X
link	B-X
the	B-X
actions	B-X
of	B-X
the	B-X
APC	B-X
to	B-X
the	B-X
completion	B-X
of	B-X
mitosis	B-X
and	B-X
suggest	B-X
possible	B-X
roles	B-X
for	B-X
Cdc5p	B-X
during	B-X
progression	B-X
through	B-X
and	B-X
completion	B-X
of	B-X
mitosis	B-X
.	B-X

We	O
report	O
that	O
Cdc5p	B-Gene_or_gene_product
levels	O
are	O
sensitive	O
to	O
mutations	O
in	O
key	O
components	O
of	O
the	O
anaphase	O
-	O
promoting	O
complex	O
(	O
APC	O
)	O
.	O
<EOS>	B-X
We	B-X
have	B-X
determined	B-X
that	B-X
the	B-X
levels	B-X
of	B-X
Cdc5p	B-X
,	B-X
a	B-X
Saccharomyces	B-X
cerevisiae	B-X
member	B-X
of	B-X
the	B-X
Polo	B-X
family	B-X
of	B-X
mitotic	B-X
kinases	B-X
,	B-X
are	B-X
cell	B-X
cycle	B-X
regulated	B-X
.	B-X
Cdc5p	B-X
accumulates	B-X
in	B-X
the	B-X
nuclei	B-X
of	B-X
G2/M-phase	B-X
cells	B-X
,	B-X
and	B-X
its	B-X
levels	B-X
decline	B-X
dramatically	B-X
as	B-X
cells	B-X
progress	B-X
through	B-X
anaphase	B-X
and	B-X
begin	B-X
telophase	B-X
.	B-X
We	B-X
report	B-X
that	B-X
Cdc5p	B-X
levels	B-X
are	B-X
sensitive	B-X
to	B-X
mutations	B-X
in	B-X
key	B-X
components	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex	B-X
(	B-X
APC	B-X
)	B-X
.	B-X
We	B-X
have	B-X
determined	B-X
that	B-X
Cdc5p-associated	B-X
kinase	B-X
activity	B-X
is	B-X
restricted	B-X
to	B-X
G2/M	B-X
and	B-X
that	B-X
this	B-X
activity	B-X
is	B-X
posttranslationally	B-X
regulated	B-X
.	B-X
These	B-X
results	B-X
further	B-X
link	B-X
the	B-X
actions	B-X
of	B-X
the	B-X
APC	B-X
to	B-X
the	B-X
completion	B-X
of	B-X
mitosis	B-X
and	B-X
suggest	B-X
possible	B-X
roles	B-X
for	B-X
Cdc5p	B-X
during	B-X
progression	B-X
through	B-X
and	B-X
completion	B-X
of	B-X
mitosis	B-X
.	B-X

We	O
have	O
determined	O
that	O
Cdc5p	B-Gene_or_gene_product
-	O
associated	O
kinase	O
activity	O
is	O
restricted	O
to	O
G2	O
/	O
M	O
and	O
that	O
this	O
activity	O
is	O
posttranslationally	O
regulated	O
.	O
<EOS>	B-X
Progression	B-X
through	B-X
and	B-X
completion	B-X
of	B-X
mitosis	B-X
require	B-X
the	B-X
actions	B-X
of	B-X
the	B-X
evolutionarily	B-X
conserved	B-X
Polo	B-X
kinase	B-X
.	B-X
We	B-X
have	B-X
determined	B-X
that	B-X
the	B-X
levels	B-X
of	B-X
Cdc5p	B-X
,	B-X
a	B-X
Saccharomyces	B-X
cerevisiae	B-X
member	B-X
of	B-X
the	B-X
Polo	B-X
family	B-X
of	B-X
mitotic	B-X
kinases	B-X
,	B-X
are	B-X
cell	B-X
cycle	B-X
regulated	B-X
.	B-X
Cdc5p	B-X
accumulates	B-X
in	B-X
the	B-X
nuclei	B-X
of	B-X
G2/M-phase	B-X
cells	B-X
,	B-X
and	B-X
its	B-X
levels	B-X
decline	B-X
dramatically	B-X
as	B-X
cells	B-X
progress	B-X
through	B-X
anaphase	B-X
and	B-X
begin	B-X
telophase	B-X
.	B-X
We	B-X
report	B-X
that	B-X
Cdc5p	B-X
levels	B-X
are	B-X
sensitive	B-X
to	B-X
mutations	B-X
in	B-X
key	B-X
components	B-X
of	B-X
the	B-X
anaphase-promoting	B-X
complex	B-X
(	B-X
APC	B-X
)	B-X
.	B-X
We	B-X
have	B-X
determined	B-X
that	B-X
Cdc5p-associated	B-X
kinase	B-X
activity	B-X
is	B-X
restricted	B-X
to	B-X
G2/M	B-X
and	B-X
that	B-X
this	B-X
activity	B-X
is	B-X
posttranslationally	B-X
regulated	B-X
.	B-X
These	B-X
results	B-X
further	B-X
link	B-X
the	B-X
actions	B-X
of	B-X
the	B-X
APC	B-X
to	B-X
the	B-X
completion	B-X
of	B-X
mitosis	B-X
and	B-X
suggest	B-X
possible	B-X
roles	B-X
for	B-X
Cdc5p	B-X
during	B-X
progression	B-X
through	B-X
and	B-X
completion	B-X
of	B-X
mitosis	B-X
.	B-X

These	O
results	O
further	O
link	O
the	O
actions	O
of	O
the	O
APC	O
to	O
the	O
completion	O
of	O
mitosis	O
and	O
suggest	O
possible	O
roles	O
for	O
Cdc5p	B-Gene_or_gene_product
during	O
progression	O
through	O
and	O
completion	O
of	O
mitosis	O
.	O

The	O
potential	O
tumor	O
suppressor	O
p73	B-Gene_or_gene_product
differentially	O
regulates	O
cellular	O
p53	B-Gene_or_gene_product
target	O
genes	O
.	O
<EOS>	B-X
p73	B-X
,	B-X
a	B-X
potential	B-X
tumor	B-X
suppressor	B-X
,	B-X
is	B-X
a	B-X
p53	B-X
homologue	B-X
.	B-X
Transient	B-X
over	B-X
expression	B-X
of	B-X
p73	B-X
in	B-X
cells	B-X
can	B-X
induce	B-X
apoptosis	B-X
and	B-X
p21	B-X
,	B-X
a	B-X
cellular	B-X
p53	B-X
target	B-X
gene	B-X
primarily	B-X
responsible	B-X
for	B-X
p53-dependent	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
To	B-X
further	B-X
characterize	B-X
the	B-X
role	B-X
of	B-X
p73	B-X
in	B-X
tumor	B-X
suppression	B-X
,	B-X
we	B-X
established	B-X
several	B-X
groups	B-X
of	B-X
cell	B-X
lines	B-X
that	B-X
inducibly	B-X
express	B-X
p73	B-X
under	B-X
a	B-X
tetracycline-regulated	B-X
promoter	B-X
.	B-X
By	B-X
using	B-X
these	B-X
cell	B-X
lines	B-X
,	B-X
we	B-X
found	B-X
that	B-X
p73	B-X
can	B-X
induce	B-X
both	B-X
cell	B-X
cycle	B-X
arrest	B-X
and	B-X
apoptosis	B-X
.	B-X
We	B-X
also	B-X
found	B-X
that	B-X
p73	B-X
can	B-X
activate	B-X
some	B-X
but	B-X
not	B-X
all	B-X
of	B-X
the	B-X
previously	B-X
identified	B-X
p53	B-X
cellular	B-X
target	B-X
genes	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
transcriptional	B-X
activities	B-X
of	B-X
p53	B-X
,	B-X
p73	B-X
alpha	B-X
,	B-X
and	B-X
p73	B-X
beta	B-X
to	B-X
induce	B-X
their	B-X
common	B-X
cellular	B-X
target	B-X
genes	B-X
differ	B-X
among	B-X
one	B-X
another	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
p73	B-X
is	B-X
both	B-X
similar	B-X
to	B-X
and	B-X
different	B-X
from	B-X
p53	B-X
in	B-X
their	B-X
signaling	B-X
pathways	B-X
leading	B-X
to	B-X
tumor	B-X
suppression	B-X
.	B-X

p73	B-Gene_or_gene_product
,	O
a	O
potential	O
tumor	O
suppressor	O
,	O
is	O
a	O
p53	B-Gene_or_gene_product
homologue	O
.	O
<EOS>	B-X
p73	B-X
,	B-X
a	B-X
potential	B-X
tumor	B-X
suppressor	B-X
,	B-X
is	B-X
a	B-X
p53	B-X
homologue	B-X
.	B-X
Transient	B-X
over	B-X
expression	B-X
of	B-X
p73	B-X
in	B-X
cells	B-X
can	B-X
induce	B-X
apoptosis	B-X
and	B-X
p21	B-X
,	B-X
a	B-X
cellular	B-X
p53	B-X
target	B-X
gene	B-X
primarily	B-X
responsible	B-X
for	B-X
p53-dependent	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
To	B-X
further	B-X
characterize	B-X
the	B-X
role	B-X
of	B-X
p73	B-X
in	B-X
tumor	B-X
suppression	B-X
,	B-X
we	B-X
established	B-X
several	B-X
groups	B-X
of	B-X
cell	B-X
lines	B-X
that	B-X
inducibly	B-X
express	B-X
p73	B-X
under	B-X
a	B-X
tetracycline-regulated	B-X
promoter	B-X
.	B-X
By	B-X
using	B-X
these	B-X
cell	B-X
lines	B-X
,	B-X
we	B-X
found	B-X
that	B-X
p73	B-X
can	B-X
induce	B-X
both	B-X
cell	B-X
cycle	B-X
arrest	B-X
and	B-X
apoptosis	B-X
.	B-X
We	B-X
also	B-X
found	B-X
that	B-X
p73	B-X
can	B-X
activate	B-X
some	B-X
but	B-X
not	B-X
all	B-X
of	B-X
the	B-X
previously	B-X
identified	B-X
p53	B-X
cellular	B-X
target	B-X
genes	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
transcriptional	B-X
activities	B-X
of	B-X
p53	B-X
,	B-X
p73	B-X
alpha	B-X
,	B-X
and	B-X
p73	B-X
beta	B-X
to	B-X
induce	B-X
their	B-X
common	B-X
cellular	B-X
target	B-X
genes	B-X
differ	B-X
among	B-X
one	B-X
another	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
p73	B-X
is	B-X
both	B-X
similar	B-X
to	B-X
and	B-X
different	B-X
from	B-X
p53	B-X
in	B-X
their	B-X
signaling	B-X
pathways	B-X
leading	B-X
to	B-X
tumor	B-X
suppression	B-X
.	B-X

Transient	O
over	O
expression	O
of	O
p73	B-Gene_or_gene_product
in	O
cells	O
can	O
induce	O
apoptosis	O
and	O
p21	B-Gene_or_gene_product
,	O
a	O
cellular	O
p53	B-Gene_or_gene_product
target	O
gene	O
primarily	O
responsible	O
for	O
p53	B-Gene_or_gene_product
-	O
dependent	O
cell	O
cycle	O
arrest	O
.	O
<EOS>	B-X
p73	B-X
,	B-X
a	B-X
potential	B-X
tumor	B-X
suppressor	B-X
,	B-X
is	B-X
a	B-X
p53	B-X
homologue	B-X
.	B-X
Transient	B-X
over	B-X
expression	B-X
of	B-X
p73	B-X
in	B-X
cells	B-X
can	B-X
induce	B-X
apoptosis	B-X
and	B-X
p21	B-X
,	B-X
a	B-X
cellular	B-X
p53	B-X
target	B-X
gene	B-X
primarily	B-X
responsible	B-X
for	B-X
p53-dependent	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
To	B-X
further	B-X
characterize	B-X
the	B-X
role	B-X
of	B-X
p73	B-X
in	B-X
tumor	B-X
suppression	B-X
,	B-X
we	B-X
established	B-X
several	B-X
groups	B-X
of	B-X
cell	B-X
lines	B-X
that	B-X
inducibly	B-X
express	B-X
p73	B-X
under	B-X
a	B-X
tetracycline-regulated	B-X
promoter	B-X
.	B-X
By	B-X
using	B-X
these	B-X
cell	B-X
lines	B-X
,	B-X
we	B-X
found	B-X
that	B-X
p73	B-X
can	B-X
induce	B-X
both	B-X
cell	B-X
cycle	B-X
arrest	B-X
and	B-X
apoptosis	B-X
.	B-X
We	B-X
also	B-X
found	B-X
that	B-X
p73	B-X
can	B-X
activate	B-X
some	B-X
but	B-X
not	B-X
all	B-X
of	B-X
the	B-X
previously	B-X
identified	B-X
p53	B-X
cellular	B-X
target	B-X
genes	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
transcriptional	B-X
activities	B-X
of	B-X
p53	B-X
,	B-X
p73	B-X
alpha	B-X
,	B-X
and	B-X
p73	B-X
beta	B-X
to	B-X
induce	B-X
their	B-X
common	B-X
cellular	B-X
target	B-X
genes	B-X
differ	B-X
among	B-X
one	B-X
another	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
p73	B-X
is	B-X
both	B-X
similar	B-X
to	B-X
and	B-X
different	B-X
from	B-X
p53	B-X
in	B-X
their	B-X
signaling	B-X
pathways	B-X
leading	B-X
to	B-X
tumor	B-X
suppression	B-X
.	B-X

To	O
further	O
characterize	O
the	O
role	O
of	O
p73	B-Gene_or_gene_product
in	O
tumor	O
suppression	O
,	O
we	O
established	O
several	O
groups	O
of	O
cell	O
lines	O
that	O
inducibly	O
express	O
p73	B-Gene_or_gene_product
under	O
a	O
tetracycline	O
-	O
regulated	O
promoter	O
.	O

By	O
using	O
these	O
cell	O
lines	O
,	O
we	O
found	O
that	O
p73	B-Gene_or_gene_product
can	O
induce	O
both	O
cell	O
cycle	O
arrest	O
and	O
apoptosis	O
.	O
<EOS>	B-X
The	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
and	B-X
apoptosis	B-X
.	B-X
Recently	B-X
,	B-X
two	B-X
p53-related	B-X
proteins	B-X
,	B-X
p73	B-X
and	B-X
p63	B-X
,	B-X
were	B-X
identified	B-X
as	B-X
members	B-X
of	B-X
the	B-X
p53	B-X
gene	B-X
family	B-X
.	B-X
Multiple	B-X
isoforms	B-X
of	B-X
p73	B-X
have	B-X
been	B-X
found	B-X
,	B-X
including	B-X
DeltaN	B-X
variants	B-X
in	B-X
which	B-X
the	B-X
N-termini	B-X
are	B-X
truncated	B-X
.	B-X
The	B-X
high	B-X
degree	B-X
of	B-X
similarity	B-X
of	B-X
p73	B-X
and	B-X
p63	B-X
to	B-X
evolutionarily	B-X
conserved	B-X
regions	B-X
of	B-X
p53	B-X
suggests	B-X
that	B-X
these	B-X
proteins	B-X
play	B-X
an	B-X
important	B-X
and	B-X
potentially	B-X
redundant	B-X
role	B-X
in	B-X
regulating	B-X
cell	B-X
cycle	B-X
arrest	B-X
and	B-X
apoptosis	B-X
.	B-X
Here	B-X
we	B-X
describe	B-X
the	B-X
characterization	B-X
of	B-X
cell	B-X
lines	B-X
generated	B-X
to	B-X
inducibly	B-X
express	B-X
p63alpha	B-X
and	B-X
DeltaNp63alpha	B-X
.	B-X
We	B-X
have	B-X
found	B-X
that	B-X
p63alpha	B-X
and	B-X
DeltaNp63alpha	B-X
can	B-X
differentially	B-X
regulate	B-X
endogenous	B-X
p53	B-X
target	B-X
genes	B-X
and	B-X
induce	B-X
cell	B-X
cycle	B-X
arrest	B-X
and	B-X
apoptosis	B-X
.	B-X
Deletion	B-X
of	B-X
the	B-X
N-terminal	B-X
26	B-X
amino	B-X
acids	B-X
of	B-X
DeltaNp63alpha	B-X
abolished	B-X
its	B-X
ability	B-X
to	B-X
transactivate	B-X
p53	B-X
target	B-X
genes	B-X
and	B-X
induce	B-X
cell	B-X
cycle	B-X
arrest	B-X
and	B-X
apoptosis	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
differential	B-X
regulation	B-X
of	B-X
p53	B-X
target	B-X
genes	B-X
by	B-X
p63alpha	B-X
and	B-X
DeltaNp63alpha	B-X
suggests	B-X
that	B-X
p63	B-X
and	B-X
p53	B-X
utilize	B-X
both	B-X
similar	B-X
and	B-X
different	B-X
signaling	B-X
pathways	B-X
to	B-X
execute	B-X
their	B-X
cellular	B-X
functions	B-X
.	B-X

We	O
also	O
found	O
that	O
p73	B-Gene_or_gene_product
can	O
activate	O
some	O
but	O
not	O
all	O
of	O
the	O
previously	O
identified	O
p53	B-Gene_or_gene_product
cellular	O
target	O
genes	O
.	O
<EOS>	B-X
We	B-X
found	B-X
that	B-X
CDK4/6	B-X
bind	B-X
and	B-X
phosphorylate	B-X
the	B-X
p53	B-X
family	B-X
member	B-X
p73	B-X
at	B-X
threonine	B-X
86	B-X
,	B-X
which	B-X
sequesters	B-X
p73	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
Inhibition	B-X
of	B-X
CDK4/6	B-X
led	B-X
to	B-X
dephosphorylation	B-X
and	B-X
nuclear	B-X
translocation	B-X
of	B-X
p73	B-X
,	B-X
which	B-X
transcriptionally	B-X
activated	B-X
death	B-X
receptor	B-X
5	B-X
(	B-X
DR5	B-X
)	B-X
,	B-X
a	B-X
cytokine	B-X
receptor	B-X
and	B-X
key	B-X
component	B-X
of	B-X
the	B-X
extrinsic	B-X
apoptotic	B-X
pathway	B-X
.	B-X
p73-mediated	B-X
induction	B-X
of	B-X
DR5	B-X
by	B-X
CDK4/6	B-X
inhibitors	B-X
promoted	B-X
immunogenic	B-X
cell	B-X
death	B-X
of	B-X
cancer	B-X
cells	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
reveal	B-X
a	B-X
previously	B-X
unrecognized	B-X
consequence	B-X
of	B-X
CDK4/6	B-X
inhibition	B-X
,	B-X
which	B-X
may	B-X
be	B-X
critical	B-X
for	B-X
potentiating	B-X
the	B-X
killing	B-X
and	B-X
immunogenic	B-X
effects	B-X
on	B-X
cancer	B-X
cells	B-X
.	B-X

Furthermore	O
,	O
we	O
found	O
that	O
the	O
transcriptional	O
activities	O
of	O
p53	B-Gene_or_gene_product
,	O
p73	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
,	O
and	O
p73	B-Gene_or_gene_product
beta	I-Gene_or_gene_product
to	O
induce	O
their	O
common	O
cellular	O
target	O
genes	O
differ	O
among	O
one	O
another	O
.	O
<EOS>	B-X
p73	B-X
,	B-X
a	B-X
potential	B-X
tumor	B-X
suppressor	B-X
,	B-X
is	B-X
a	B-X
p53	B-X
homologue	B-X
.	B-X
Transient	B-X
over	B-X
expression	B-X
of	B-X
p73	B-X
in	B-X
cells	B-X
can	B-X
induce	B-X
apoptosis	B-X
and	B-X
p21	B-X
,	B-X
a	B-X
cellular	B-X
p53	B-X
target	B-X
gene	B-X
primarily	B-X
responsible	B-X
for	B-X
p53-dependent	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
To	B-X
further	B-X
characterize	B-X
the	B-X
role	B-X
of	B-X
p73	B-X
in	B-X
tumor	B-X
suppression	B-X
,	B-X
we	B-X
established	B-X
several	B-X
groups	B-X
of	B-X
cell	B-X
lines	B-X
that	B-X
inducibly	B-X
express	B-X
p73	B-X
under	B-X
a	B-X
tetracycline-regulated	B-X
promoter	B-X
.	B-X
By	B-X
using	B-X
these	B-X
cell	B-X
lines	B-X
,	B-X
we	B-X
found	B-X
that	B-X
p73	B-X
can	B-X
induce	B-X
both	B-X
cell	B-X
cycle	B-X
arrest	B-X
and	B-X
apoptosis	B-X
.	B-X
We	B-X
also	B-X
found	B-X
that	B-X
p73	B-X
can	B-X
activate	B-X
some	B-X
but	B-X
not	B-X
all	B-X
of	B-X
the	B-X
previously	B-X
identified	B-X
p53	B-X
cellular	B-X
target	B-X
genes	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
transcriptional	B-X
activities	B-X
of	B-X
p53	B-X
,	B-X
p73	B-X
alpha	B-X
,	B-X
and	B-X
p73	B-X
beta	B-X
to	B-X
induce	B-X
their	B-X
common	B-X
cellular	B-X
target	B-X
genes	B-X
differ	B-X
among	B-X
one	B-X
another	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
p73	B-X
is	B-X
both	B-X
similar	B-X
to	B-X
and	B-X
different	B-X
from	B-X
p53	B-X
in	B-X
their	B-X
signaling	B-X
pathways	B-X
leading	B-X
to	B-X
tumor	B-X
suppression	B-X
.	B-X

These	O
results	O
suggest	O
that	O
p73	B-Gene_or_gene_product
is	O
both	O
similar	O
to	O
and	O
different	O
from	O
p53	B-Gene_or_gene_product
in	O
their	O
signaling	O
pathways	O
leading	O
to	O
tumor	O
suppression	O
.	O
<EOS>	B-X
p73	B-X
,	B-X
a	B-X
potential	B-X
tumor	B-X
suppressor	B-X
,	B-X
is	B-X
a	B-X
p53	B-X
homologue	B-X
.	B-X
Transient	B-X
over	B-X
expression	B-X
of	B-X
p73	B-X
in	B-X
cells	B-X
can	B-X
induce	B-X
apoptosis	B-X
and	B-X
p21	B-X
,	B-X
a	B-X
cellular	B-X
p53	B-X
target	B-X
gene	B-X
primarily	B-X
responsible	B-X
for	B-X
p53-dependent	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
To	B-X
further	B-X
characterize	B-X
the	B-X
role	B-X
of	B-X
p73	B-X
in	B-X
tumor	B-X
suppression	B-X
,	B-X
we	B-X
established	B-X
several	B-X
groups	B-X
of	B-X
cell	B-X
lines	B-X
that	B-X
inducibly	B-X
express	B-X
p73	B-X
under	B-X
a	B-X
tetracycline-regulated	B-X
promoter	B-X
.	B-X
By	B-X
using	B-X
these	B-X
cell	B-X
lines	B-X
,	B-X
we	B-X
found	B-X
that	B-X
p73	B-X
can	B-X
induce	B-X
both	B-X
cell	B-X
cycle	B-X
arrest	B-X
and	B-X
apoptosis	B-X
.	B-X
We	B-X
also	B-X
found	B-X
that	B-X
p73	B-X
can	B-X
activate	B-X
some	B-X
but	B-X
not	B-X
all	B-X
of	B-X
the	B-X
previously	B-X
identified	B-X
p53	B-X
cellular	B-X
target	B-X
genes	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
transcriptional	B-X
activities	B-X
of	B-X
p53	B-X
,	B-X
p73	B-X
alpha	B-X
,	B-X
and	B-X
p73	B-X
beta	B-X
to	B-X
induce	B-X
their	B-X
common	B-X
cellular	B-X
target	B-X
genes	B-X
differ	B-X
among	B-X
one	B-X
another	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
p73	B-X
is	B-X
both	B-X
similar	B-X
to	B-X
and	B-X
different	B-X
from	B-X
p53	B-X
in	B-X
their	B-X
signaling	B-X
pathways	B-X
leading	B-X
to	B-X
tumor	B-X
suppression	B-X
.	B-X

Linkage	O
of	O
ATM	B-Gene_or_gene_product
to	O
cell	O
cycle	O
regulation	O
by	O
the	O
Chk2	B-Gene_or_gene_product
protein	O
kinase	O
.	O
<EOS>	B-X
In	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
and	B-X
replication	B-X
blocks	B-X
,	B-X
cells	B-X
prevent	B-X
cell	B-X
cycle	B-X
progression	B-X
through	B-X
the	B-X
control	B-X
of	B-X
critical	B-X
cell	B-X
cycle	B-X
regulators	B-X
.	B-X
We	B-X
identified	B-X
Chk2	B-X
,	B-X
the	B-X
mammalian	B-X
homolog	B-X
of	B-X
the	B-X
Saccharomyces	B-X
cerevisiae	B-X
Rad53	B-X
and	B-X
Schizosaccharomyces	B-X
pombe	B-X
Cds1	B-X
protein	B-X
kinases	B-X
required	B-X
for	B-X
the	B-X
DNA	B-X
damage	B-X
and	B-X
replication	B-X
checkpoints	B-X
.	B-X
Chk2	B-X
was	B-X
rapidly	B-X
phosphorylated	B-X
and	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
blocks	B-X
and	B-X
DNA	B-X
damage	B-X
;	B-X
the	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
occurred	B-X
in	B-X
an	B-X
ataxia	B-X
telangiectasia	B-X
mutated	B-X
(	B-X
ATM	B-X
)	B-X
-dependent	B-X
manner	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
Chk2	B-X
phosphorylated	B-X
Cdc25C	B-X
on	B-X
serine-216	B-X
,	B-X
a	B-X
site	B-X
known	B-X
to	B-X
be	B-X
involved	B-X
in	B-X
negative	B-X
regulation	B-X
of	B-X
Cdc25C	B-X
.	B-X
This	B-X
is	B-X
the	B-X
same	B-X
site	B-X
phosphorylated	B-X
by	B-X
the	B-X
protein	B-X
kinase	B-X
Chk1	B-X
,	B-X
which	B-X
suggests	B-X
that	B-X
,	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
and	B-X
DNA	B-X
replicational	B-X
stress	B-X
,	B-X
Chk1	B-X
and	B-X
Chk2	B-X
may	B-X
phosphorylate	B-X
Cdc25C	B-X
to	B-X
prevent	B-X
entry	B-X
into	B-X
mitosis	B-X
.	B-X

In	O
response	O
to	O
DNA	O
damage	O
and	O
replication	O
blocks	O
,	O
cells	O
prevent	O
cell	O
cycle	O
progression	O
through	O
the	O
control	O
of	O
critical	O
cell	O
cycle	O
regulators	O
.	O
<EOS>	B-X
In	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
and	B-X
replication	B-X
blocks	B-X
,	B-X
cells	B-X
prevent	B-X
cell	B-X
cycle	B-X
progression	B-X
through	B-X
the	B-X
control	B-X
of	B-X
critical	B-X
cell	B-X
cycle	B-X
regulators	B-X
.	B-X
We	B-X
identified	B-X
Chk2	B-X
,	B-X
the	B-X
mammalian	B-X
homolog	B-X
of	B-X
the	B-X
Saccharomyces	B-X
cerevisiae	B-X
Rad53	B-X
and	B-X
Schizosaccharomyces	B-X
pombe	B-X
Cds1	B-X
protein	B-X
kinases	B-X
required	B-X
for	B-X
the	B-X
DNA	B-X
damage	B-X
and	B-X
replication	B-X
checkpoints	B-X
.	B-X
Chk2	B-X
was	B-X
rapidly	B-X
phosphorylated	B-X
and	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
blocks	B-X
and	B-X
DNA	B-X
damage	B-X
;	B-X
the	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
occurred	B-X
in	B-X
an	B-X
ataxia	B-X
telangiectasia	B-X
mutated	B-X
(	B-X
ATM	B-X
)	B-X
-dependent	B-X
manner	B-X
.	B-X
This	B-X
is	B-X
the	B-X
same	B-X
site	B-X
phosphorylated	B-X
by	B-X
the	B-X
protein	B-X
kinase	B-X
Chk1	B-X
,	B-X
which	B-X
suggests	B-X
that	B-X
,	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
and	B-X
DNA	B-X
replicational	B-X
stress	B-X
,	B-X
Chk1	B-X
and	B-X
Chk2	B-X
may	B-X
phosphorylate	B-X
Cdc25C	B-X
to	B-X
prevent	B-X
entry	B-X
into	B-X
mitosis	B-X
.	B-X

We	O
identified	O
Chk2	B-Gene_or_gene_product
,	O
the	O
mammalian	O
homolog	O
of	O
the	O
Saccharomyces	O
cerevisiae	O
Rad53	B-Gene_or_gene_product
and	O
Schizosaccharomyces	O
pombe	O
Cds1	B-Gene_or_gene_product
protein	O
kinases	O
required	O
for	O
the	O
DNA	O
damage	O
and	O
replication	O
checkpoints	O
.	O
<EOS>	B-X
In	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
and	B-X
replication	B-X
blocks	B-X
,	B-X
cells	B-X
prevent	B-X
cell	B-X
cycle	B-X
progression	B-X
through	B-X
the	B-X
control	B-X
of	B-X
critical	B-X
cell	B-X
cycle	B-X
regulators	B-X
.	B-X
We	B-X
identified	B-X
Chk2	B-X
,	B-X
the	B-X
mammalian	B-X
homolog	B-X
of	B-X
the	B-X
Saccharomyces	B-X
cerevisiae	B-X
Rad53	B-X
and	B-X
Schizosaccharomyces	B-X
pombe	B-X
Cds1	B-X
protein	B-X
kinases	B-X
required	B-X
for	B-X
the	B-X
DNA	B-X
damage	B-X
and	B-X
replication	B-X
checkpoints	B-X
.	B-X
Chk2	B-X
was	B-X
rapidly	B-X
phosphorylated	B-X
and	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
blocks	B-X
and	B-X
DNA	B-X
damage	B-X
;	B-X
the	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
occurred	B-X
in	B-X
an	B-X
ataxia	B-X
telangiectasia	B-X
mutated	B-X
(	B-X
ATM	B-X
)	B-X
-dependent	B-X
manner	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
Chk2	B-X
phosphorylated	B-X
Cdc25C	B-X
on	B-X
serine-216	B-X
,	B-X
a	B-X
site	B-X
known	B-X
to	B-X
be	B-X
involved	B-X
in	B-X
negative	B-X
regulation	B-X
of	B-X
Cdc25C	B-X
.	B-X
This	B-X
is	B-X
the	B-X
same	B-X
site	B-X
phosphorylated	B-X
by	B-X
the	B-X
protein	B-X
kinase	B-X
Chk1	B-X
,	B-X
which	B-X
suggests	B-X
that	B-X
,	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
and	B-X
DNA	B-X
replicational	B-X
stress	B-X
,	B-X
Chk1	B-X
and	B-X
Chk2	B-X
may	B-X
phosphorylate	B-X
Cdc25C	B-X
to	B-X
prevent	B-X
entry	B-X
into	B-X
mitosis	B-X
.	B-X

Chk2	B-Gene_or_gene_product
was	O
rapidly	O
phosphorylated	O
and	O
activated	O
in	O
response	O
to	O
replication	O
blocks	O
and	O
DNA	O
damage	O
;	O
the	O
response	O
to	O
DNA	O
damage	O
occurred	O
in	O
an	O
ataxia	B-Gene_or_gene_product
telangiectasia	I-Gene_or_gene_product
mutated	I-Gene_or_gene_product
(	O
ATM	B-Gene_or_gene_product
)	O
-	O
dependent	O
manner	O
.	O
<EOS>	B-X
As	B-X
an	B-X
addictive	B-X
substance	B-X
,	B-X
nicotine	B-X
has	B-X
been	B-X
suggested	B-X
to	B-X
facilitate	B-X
pro-survival	B-X
activities	B-X
(	B-X
such	B-X
as	B-X
anchorage-independent	B-X
growth	B-X
or	B-X
angiogenesis	B-X
)	B-X
and	B-X
the	B-X
establishment	B-X
of	B-X
drug	B-X
resistance	B-X
to	B-X
anticancer	B-X
therapy	B-X
.	B-X
Tobacco	B-X
smoking	B-X
consists	B-X
of	B-X
a	B-X
variety	B-X
of	B-X
carcinogens	B-X
[	B-X
such	B-X
as	B-X
benzopyrene	B-X
(	B-X
BP	B-X
)	B-X
and	B-X
nitrosamine	B-X
derivatives	B-X
]	B-X
that	B-X
are	B-X
able	B-X
to	B-X
cause	B-X
DNA	B-X
double	B-X
strand	B-X
breaks	B-X
.	B-X
However	B-X
,	B-X
the	B-X
effect	B-X
of	B-X
nicotine	B-X
on	B-X
DNA	B-X
damage-induced	B-X
checkpoint	B-X
response	B-X
induced	B-X
by	B-X
genotoxins	B-X
remains	B-X
unknown	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
events	B-X
occurred	B-X
during	B-X
G	B-X
(	B-X
1	B-X
)	B-X
arrest	B-X
induced	B-X
by	B-X
γ-radiation	B-X
or	B-X
BP	B-X
in	B-X
nicotine-treated	B-X
murine	B-X
or	B-X
human	B-X
lung	B-X
epithelial	B-X
cells	B-X
.	B-X
DNA	B-X
synthesis	B-X
was	B-X
rapidly	B-X
inhibited	B-X
after	B-X
exposure	B-X
to	B-X
γ-radiation	B-X
or	B-X
BP	B-X
treatment	B-X
,	B-X
accompanied	B-X
with	B-X
the	B-X
activation	B-X
of	B-X
DNA	B-X
damage	B-X
checkpoint	B-X
.	B-X
When	B-X
these	B-X
cells	B-X
were	B-X
co-treated	B-X
with	B-X
nicotine	B-X
,	B-X
the	B-X
growth	B-X
restriction	B-X
was	B-X
compromised	B-X
,	B-X
manifested	B-X
by	B-X
upregulation	B-X
of	B-X
cyclin	B-X
D	B-X
and	B-X
A	B-X
,	B-X
and	B-X
attenuation	B-X
of	B-X
Chk2	B-X
phosphorylation	B-X
.	B-X
Knockdown	B-X
of	B-X
cyclin	B-X
D	B-X
or	B-X
Chk2	B-X
by	B-X
the	B-X
siRNAs	B-X
blocked	B-X
nicotine-mediated	B-X
effect	B-X
on	B-X
DNA	B-X
damage	B-X
checkpoint	B-X
activation	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
study	B-X
presented	B-X
a	B-X
novel	B-X
observation	B-X
,	B-X
in	B-X
which	B-X
nicotine	B-X
is	B-X
able	B-X
to	B-X
override	B-X
DNA	B-X
damage	B-X
checkpoint	B-X
activated	B-X
by	B-X
tobacco-related	B-X
carcinogen	B-X
BP	B-X
or	B-X
γ-irradiation	B-X
.	B-X

In	O
vitro	O
,	O
Chk2	B-Gene_or_gene_product
phosphorylated	O
Cdc25C	B-Gene_or_gene_product
on	O
serine	O
-	O
216	O
,	O
a	O
site	O
known	O
to	O
be	O
involved	O
in	O
negative	O
regulation	O
of	O
Cdc25C	B-Gene_or_gene_product
.	O
<EOS>	B-X
We	B-X
identified	B-X
Chk2	B-X
,	B-X
the	B-X
mammalian	B-X
homolog	B-X
of	B-X
the	B-X
Saccharomyces	B-X
cerevisiae	B-X
Rad53	B-X
and	B-X
Schizosaccharomyces	B-X
pombe	B-X
Cds1	B-X
protein	B-X
kinases	B-X
required	B-X
for	B-X
the	B-X
DNA	B-X
damage	B-X
and	B-X
replication	B-X
checkpoints	B-X
.	B-X
Chk2	B-X
was	B-X
rapidly	B-X
phosphorylated	B-X
and	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
blocks	B-X
and	B-X
DNA	B-X
damage	B-X
;	B-X
the	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
occurred	B-X
in	B-X
an	B-X
ataxia	B-X
telangiectasia	B-X
mutated	B-X
(	B-X
ATM	B-X
)	B-X
-dependent	B-X
manner	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
Chk2	B-X
phosphorylated	B-X
Cdc25C	B-X
on	B-X
serine-216	B-X
,	B-X
a	B-X
site	B-X
known	B-X
to	B-X
be	B-X
involved	B-X
in	B-X
negative	B-X
regulation	B-X
of	B-X
Cdc25C	B-X
.	B-X
This	B-X
is	B-X
the	B-X
same	B-X
site	B-X
phosphorylated	B-X
by	B-X
the	B-X
protein	B-X
kinase	B-X
Chk1	B-X
,	B-X
which	B-X
suggests	B-X
that	B-X
,	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
and	B-X
DNA	B-X
replicational	B-X
stress	B-X
,	B-X
Chk1	B-X
and	B-X
Chk2	B-X
may	B-X
phosphorylate	B-X
Cdc25C	B-X
to	B-X
prevent	B-X
entry	B-X
into	B-X
mitosis	B-X
.	B-X

This	O
is	O
the	O
same	O
site	O
phosphorylated	O
by	O
the	O
protein	O
kinase	O
Chk1	B-Gene_or_gene_product
,	O
which	O
suggests	O
that	O
,	O
in	O
response	O
to	O
DNA	O
damage	O
and	O
DNA	O
replicational	O
stress	O
,	O
Chk1	B-Gene_or_gene_product
and	O
Chk2	B-Gene_or_gene_product
may	O
phosphorylate	O
Cdc25C	B-Gene_or_gene_product
to	O
prevent	O
entry	O
into	O
mitosis	O
.	O
<EOS>	B-X
In	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
and	B-X
replication	B-X
blocks	B-X
,	B-X
cells	B-X
prevent	B-X
cell	B-X
cycle	B-X
progression	B-X
through	B-X
the	B-X
control	B-X
of	B-X
critical	B-X
cell	B-X
cycle	B-X
regulators	B-X
.	B-X
We	B-X
identified	B-X
Chk2	B-X
,	B-X
the	B-X
mammalian	B-X
homolog	B-X
of	B-X
the	B-X
Saccharomyces	B-X
cerevisiae	B-X
Rad53	B-X
and	B-X
Schizosaccharomyces	B-X
pombe	B-X
Cds1	B-X
protein	B-X
kinases	B-X
required	B-X
for	B-X
the	B-X
DNA	B-X
damage	B-X
and	B-X
replication	B-X
checkpoints	B-X
.	B-X
Chk2	B-X
was	B-X
rapidly	B-X
phosphorylated	B-X
and	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
blocks	B-X
and	B-X
DNA	B-X
damage	B-X
;	B-X
the	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
occurred	B-X
in	B-X
an	B-X
ataxia	B-X
telangiectasia	B-X
mutated	B-X
(	B-X
ATM	B-X
)	B-X
-dependent	B-X
manner	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
Chk2	B-X
phosphorylated	B-X
Cdc25C	B-X
on	B-X
serine-216	B-X
,	B-X
a	B-X
site	B-X
known	B-X
to	B-X
be	B-X
involved	B-X
in	B-X
negative	B-X
regulation	B-X
of	B-X
Cdc25C	B-X
.	B-X
This	B-X
is	B-X
the	B-X
same	B-X
site	B-X
phosphorylated	B-X
by	B-X
the	B-X
protein	B-X
kinase	B-X
Chk1	B-X
,	B-X
which	B-X
suggests	B-X
that	B-X
,	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
and	B-X
DNA	B-X
replicational	B-X
stress	B-X
,	B-X
Chk1	B-X
and	B-X
Chk2	B-X
may	B-X
phosphorylate	B-X
Cdc25C	B-X
to	B-X
prevent	B-X
entry	B-X
into	B-X
mitosis	B-X
.	B-X

ATM	B-Gene_or_gene_product
associates	O
with	O
and	O
phosphorylates	O
p53	B-Gene_or_gene_product
:	O
mapping	O
the	O
region	O
of	O
interaction	O
.	O
<EOS>	B-X
The	B-X
gene	B-X
mutated	B-X
in	B-X
this	B-X
syndrome	B-X
,	B-X
ATM	B-X
(	B-X
for	B-X
AT	B-X
mutated	B-X
)	B-X
,	B-X
encodes	B-X
a	B-X
protein	B-X
containing	B-X
a	B-X
phosphatidyl-inositol	B-X
3-kinase	B-X
(	B-X
PI-3	B-X
kinase	B-X
)	B-X
-like	B-X
domain	B-X
.	B-X
ATM	B-X
also	B-X
contains	B-X
a	B-X
proline-rich	B-X
region	B-X
and	B-X
a	B-X
leucine	B-X
zipper	B-X
,	B-X
both	B-X
of	B-X
which	B-X
implicate	B-X
this	B-X
protein	B-X
in	B-X
signal	B-X
transduction	B-X
.	B-X
The	B-X
proline-rich	B-X
region	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
bind	B-X
to	B-X
the	B-X
SH3	B-X
domain	B-X
of	B-X
c-Abl	B-X
,	B-X
which	B-X
facilitates	B-X
its	B-X
phosphorylation	B-X
and	B-X
activation	B-X
by	B-X
ATM	B-X
.	B-X
Previous	B-X
results	B-X
have	B-X
demonstrated	B-X
that	B-X
AT	B-X
cells	B-X
are	B-X
defective	B-X
in	B-X
the	B-X
G1/S	B-X
checkpoint	B-X
activated	B-X
after	B-X
radiation	B-X
damage	B-X
and	B-X
that	B-X
this	B-X
defect	B-X
is	B-X
attributable	B-X
to	B-X
a	B-X
defective	B-X
p53	B-X
signal	B-X
transduction	B-X
pathway	B-X
.	B-X
We	B-X
report	B-X
here	B-X
direct	B-X
interaction	B-X
between	B-X
ATM	B-X
and	B-X
p53	B-X
involving	B-X
two	B-X
regions	B-X
in	B-X
ATM	B-X
,	B-X
one	B-X
at	B-X
the	B-X
amino	B-X
terminus	B-X
and	B-X
the	B-X
other	B-X
at	B-X
the	B-X
carboxy	B-X
terminus	B-X
,	B-X
corresponding	B-X
to	B-X
the	B-X
PI-3	B-X
kinase	B-X
domain	B-X
.	B-X
Recombinant	B-X
ATM	B-X
protein	B-X
phosphorylates	B-X
p53	B-X
on	B-X
serine	B-X
15	B-X
near	B-X
the	B-X
N	B-X
terminus	B-X
.	B-X
Furthermore	B-X
,	B-X
ectopic	B-X
expression	B-X
of	B-X
ATM	B-X
in	B-X
AT	B-X
cells	B-X
restores	B-X
normal	B-X
ionizing	B-X
radiation	B-X
(	B-X
IR	B-X
)	B-X
-induced	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
whereas	B-X
expression	B-X
of	B-X
ATM	B-X
antisense	B-X
RNA	B-X
in	B-X
control	B-X
cells	B-X
abrogates	B-X
the	B-X
rapid	B-X
IR-induced	B-X
phosphorylation	B-X
of	B-X
p53	B-X
on	B-X
serine	B-X
15	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
ATM	B-X
can	B-X
bind	B-X
p53	B-X
directly	B-X
and	B-X
is	B-X
responsible	B-X
for	B-X
its	B-X
serine	B-X
15	B-X
phosphorylation	B-X
,	B-X
thereby	B-X
contributing	B-X
to	B-X
the	B-X
activation	B-X
and	B-X
stabilization	B-X
of	B-X
p53	B-X
during	B-X
the	B-X
IR-induced	B-X
DNA	B-X
damage	B-X
response	B-X
.	B-X

The	O
human	O
genetic	O
disorder	O
ataxia	O
-	O
telangiectasia	O
(	O
AT	O
)	O
is	O
characterized	O
by	O
immunodeficiency	O
,	O
progressive	O
cerebellar	O
ataxia	O
,	O
radiosensitivity	O
,	O
cell	O
cycle	O
checkpoint	O
defects	O
and	O
cancer	O
predisposition	O
.	O
<EOS>	B-X
Ataxia-telangiectasia	B-X
mutated	B-X
(	B-X
ATM	B-X
)	B-X
is	B-X
the	B-X
product	B-X
of	B-X
the	B-X
gene	B-X
mutated	B-X
in	B-X
the	B-X
human	B-X
genetic	B-X
disorder	B-X
ataxia-telangeictasia	B-X
(	B-X
A-T	B-X
)	B-X
.	B-X
A-T	B-X
cells	B-X
and	B-X
those	B-X
derived	B-X
from	B-X
Atm-/-	B-X
mice	B-X
are	B-X
characterized	B-X
by	B-X
hypersensitivity	B-X
to	B-X
ionizing	B-X
radiation	B-X
and	B-X
defective	B-X
cell	B-X
cycle	B-X
checkpoints	B-X
.	B-X
Defects	B-X
are	B-X
observed	B-X
at	B-X
all	B-X
cell	B-X
cycle	B-X
checkpoints	B-X
in	B-X
A-T	B-X
cells	B-X
post-irradiation	B-X
including	B-X
the	B-X
G1/S	B-X
interface	B-X
where	B-X
ATM	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
tumour	B-X
suppressor	B-X
gene	B-X
product	B-X
p53	B-X
.	B-X
Absence	B-X
of	B-X
ATM	B-X
gives	B-X
rise	B-X
to	B-X
a	B-X
spectrum	B-X
of	B-X
defects	B-X
including	B-X
immunodeficiency	B-X
,	B-X
neurodegeneration	B-X
,	B-X
radiosensitivity	B-X
and	B-X
cancer	B-X
predisposition	B-X
.	B-X
It	B-X
is	B-X
clear	B-X
that	B-X
a	B-X
better	B-X
definition	B-X
of	B-X
the	B-X
role	B-X
of	B-X
ATM	B-X
in	B-X
DNA	B-X
damage	B-X
recognition	B-X
,	B-X
cell	B-X
cycle	B-X
control	B-X
and	B-X
cell	B-X
signalling	B-X
may	B-X
assist	B-X
in	B-X
the	B-X
treatment	B-X
of	B-X
the	B-X
progressive	B-X
neurodegeneration	B-X
in	B-X
this	B-X
syndrome	B-X
.	B-X

The	O
gene	O
mutated	O
in	O
this	O
syndrome	O
,	O
ATM	B-Gene_or_gene_product
(	O
for	O
AT	B-Gene_or_gene_product
mutated	I-Gene_or_gene_product
)	O
,	O
encodes	O
a	O
protein	O
containing	O
a	O
phosphatidyl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
inositol	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
PI	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
)	O
-	O
like	O
domain	O
.	O
<EOS>	B-X
The	B-X
human	B-X
genetic	B-X
disorder	B-X
ataxia-telangiectasia	B-X
(	B-X
AT	B-X
)	B-X
is	B-X
characterized	B-X
by	B-X
immunodeficiency	B-X
,	B-X
progressive	B-X
cerebellar	B-X
ataxia	B-X
,	B-X
radiosensitivity	B-X
,	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
defects	B-X
and	B-X
cancer	B-X
predisposition	B-X
.	B-X
The	B-X
gene	B-X
mutated	B-X
in	B-X
this	B-X
syndrome	B-X
,	B-X
ATM	B-X
(	B-X
for	B-X
AT	B-X
mutated	B-X
)	B-X
,	B-X
encodes	B-X
a	B-X
protein	B-X
containing	B-X
a	B-X
phosphatidyl-inositol	B-X
3-kinase	B-X
(	B-X
PI-3	B-X
kinase	B-X
)	B-X
-like	B-X
domain	B-X
.	B-X
ATM	B-X
also	B-X
contains	B-X
a	B-X
proline-rich	B-X
region	B-X
and	B-X
a	B-X
leucine	B-X
zipper	B-X
,	B-X
both	B-X
of	B-X
which	B-X
implicate	B-X
this	B-X
protein	B-X
in	B-X
signal	B-X
transduction	B-X
.	B-X
The	B-X
proline-rich	B-X
region	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
bind	B-X
to	B-X
the	B-X
SH3	B-X
domain	B-X
of	B-X
c-Abl	B-X
,	B-X
which	B-X
facilitates	B-X
its	B-X
phosphorylation	B-X
and	B-X
activation	B-X
by	B-X
ATM	B-X
.	B-X
Previous	B-X
results	B-X
have	B-X
demonstrated	B-X
that	B-X
AT	B-X
cells	B-X
are	B-X
defective	B-X
in	B-X
the	B-X
G1/S	B-X
checkpoint	B-X
activated	B-X
after	B-X
radiation	B-X
damage	B-X
and	B-X
that	B-X
this	B-X
defect	B-X
is	B-X
attributable	B-X
to	B-X
a	B-X
defective	B-X
p53	B-X
signal	B-X
transduction	B-X
pathway	B-X
.	B-X
We	B-X
report	B-X
here	B-X
direct	B-X
interaction	B-X
between	B-X
ATM	B-X
and	B-X
p53	B-X
involving	B-X
two	B-X
regions	B-X
in	B-X
ATM	B-X
,	B-X
one	B-X
at	B-X
the	B-X
amino	B-X
terminus	B-X
and	B-X
the	B-X
other	B-X
at	B-X
the	B-X
carboxy	B-X
terminus	B-X
,	B-X
corresponding	B-X
to	B-X
the	B-X
PI-3	B-X
kinase	B-X
domain	B-X
.	B-X
Recombinant	B-X
ATM	B-X
protein	B-X
phosphorylates	B-X
p53	B-X
on	B-X
serine	B-X
15	B-X
near	B-X
the	B-X
N	B-X
terminus	B-X
.	B-X
Furthermore	B-X
,	B-X
ectopic	B-X
expression	B-X
of	B-X
ATM	B-X
in	B-X
AT	B-X
cells	B-X
restores	B-X
normal	B-X
ionizing	B-X
radiation	B-X
(	B-X
IR	B-X
)	B-X
-induced	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
whereas	B-X
expression	B-X
of	B-X
ATM	B-X
antisense	B-X
RNA	B-X
in	B-X
control	B-X
cells	B-X
abrogates	B-X
the	B-X
rapid	B-X
IR-induced	B-X
phosphorylation	B-X
of	B-X
p53	B-X
on	B-X
serine	B-X
15	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
ATM	B-X
can	B-X
bind	B-X
p53	B-X
directly	B-X
and	B-X
is	B-X
responsible	B-X
for	B-X
its	B-X
serine	B-X
15	B-X
phosphorylation	B-X
,	B-X
thereby	B-X
contributing	B-X
to	B-X
the	B-X
activation	B-X
and	B-X
stabilization	B-X
of	B-X
p53	B-X
during	B-X
the	B-X
IR-induced	B-X
DNA	B-X
damage	B-X
response	B-X
.	B-X

ATM	B-Gene_or_gene_product
also	O
contains	O
a	O
proline	O
-	O
rich	O
region	O
and	O
a	O
leucine	O
zipper	O
,	O
both	O
of	O
which	O
implicate	O
this	O
protein	O
in	O
signal	O
transduction	O
.	O

The	O
proline	O
-	O
rich	O
region	O
has	O
been	O
shown	O
to	O
bind	O
to	O
the	O
SH3	O
domain	O
of	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Abl	I-Gene_or_gene_product
,	O
which	O
facilitates	O
its	O
phosphorylation	O
and	O
activation	O
by	O
ATM	B-Gene_or_gene_product
.	O

Previous	O
results	O
have	O
demonstrated	O
that	O
AT	O
cells	O
are	O
defective	O
in	O
the	O
G1	O
/	O
S	O
checkpoint	O
activated	O
after	O
radiation	O
damage	O
and	O
that	O
this	O
defect	O
is	O
attributable	O
to	O
a	O
defective	O
p53	B-Gene_or_gene_product
signal	O
transduction	O
pathway	O
.	O
<EOS>	B-X
The	B-X
human	B-X
genetic	B-X
disorder	B-X
ataxia-telangiectasia	B-X
(	B-X
AT	B-X
)	B-X
is	B-X
characterized	B-X
by	B-X
immunodeficiency	B-X
,	B-X
progressive	B-X
cerebellar	B-X
ataxia	B-X
,	B-X
radiosensitivity	B-X
,	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
defects	B-X
and	B-X
cancer	B-X
predisposition	B-X
.	B-X
ATM	B-X
also	B-X
contains	B-X
a	B-X
proline-rich	B-X
region	B-X
and	B-X
a	B-X
leucine	B-X
zipper	B-X
,	B-X
both	B-X
of	B-X
which	B-X
implicate	B-X
this	B-X
protein	B-X
in	B-X
signal	B-X
transduction	B-X
.	B-X
Previous	B-X
results	B-X
have	B-X
demonstrated	B-X
that	B-X
AT	B-X
cells	B-X
are	B-X
defective	B-X
in	B-X
the	B-X
G1/S	B-X
checkpoint	B-X
activated	B-X
after	B-X
radiation	B-X
damage	B-X
and	B-X
that	B-X
this	B-X
defect	B-X
is	B-X
attributable	B-X
to	B-X
a	B-X
defective	B-X
p53	B-X
signal	B-X
transduction	B-X
pathway	B-X
.	B-X
We	B-X
report	B-X
here	B-X
direct	B-X
interaction	B-X
between	B-X
ATM	B-X
and	B-X
p53	B-X
involving	B-X
two	B-X
regions	B-X
in	B-X
ATM	B-X
,	B-X
one	B-X
at	B-X
the	B-X
amino	B-X
terminus	B-X
and	B-X
the	B-X
other	B-X
at	B-X
the	B-X
carboxy	B-X
terminus	B-X
,	B-X
corresponding	B-X
to	B-X
the	B-X
PI-3	B-X
kinase	B-X
domain	B-X
.	B-X
Recombinant	B-X
ATM	B-X
protein	B-X
phosphorylates	B-X
p53	B-X
on	B-X
serine	B-X
15	B-X
near	B-X
the	B-X
N	B-X
terminus	B-X
.	B-X
Furthermore	B-X
,	B-X
ectopic	B-X
expression	B-X
of	B-X
ATM	B-X
in	B-X
AT	B-X
cells	B-X
restores	B-X
normal	B-X
ionizing	B-X
radiation	B-X
(	B-X
IR	B-X
)	B-X
-induced	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
whereas	B-X
expression	B-X
of	B-X
ATM	B-X
antisense	B-X
RNA	B-X
in	B-X
control	B-X
cells	B-X
abrogates	B-X
the	B-X
rapid	B-X
IR-induced	B-X
phosphorylation	B-X
of	B-X
p53	B-X
on	B-X
serine	B-X
15	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
ATM	B-X
can	B-X
bind	B-X
p53	B-X
directly	B-X
and	B-X
is	B-X
responsible	B-X
for	B-X
its	B-X
serine	B-X
15	B-X
phosphorylation	B-X
,	B-X
thereby	B-X
contributing	B-X
to	B-X
the	B-X
activation	B-X
and	B-X
stabilization	B-X
of	B-X
p53	B-X
during	B-X
the	B-X
IR-induced	B-X
DNA	B-X
damage	B-X
response	B-X
.	B-X

We	O
report	O
here	O
direct	O
interaction	O
between	O
ATM	B-Gene_or_gene_product
and	O
p53	B-Gene_or_gene_product
involving	O
two	O
regions	O
in	O
ATM	B-Gene_or_gene_product
,	O
one	O
at	O
the	O
amino	O
terminus	O
and	O
the	O
other	O
at	O
the	O
carboxy	O
terminus	O
,	O
corresponding	O
to	O
the	O
PI	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
domain	O
.	O

Recombinant	O
ATM	B-Gene_or_gene_product
protein	O
phosphorylates	O
p53	B-Gene_or_gene_product
on	O
serine	O
15	O
near	O
the	O
N	O
terminus	O
.	O

Furthermore	O
,	O
ectopic	O
expression	O
of	O
ATM	B-Gene_or_gene_product
in	O
AT	O
cells	O
restores	O
normal	O
ionizing	O
radiation	O
(	O
IR	O
)	O
-	O
induced	O
phosphorylation	O
of	O
p53	B-Gene_or_gene_product
,	O
whereas	O
expression	O
of	O
ATM	B-Gene_or_gene_product
antisense	O
RNA	O
in	O
control	O
cells	O
abrogates	O
the	O
rapid	O
IR	O
-	O
induced	O
phosphorylation	O
of	O
p53	B-Gene_or_gene_product
on	O
serine	O
15	O
.	O
<EOS>	B-X
The	B-X
gene	B-X
mutated	B-X
in	B-X
this	B-X
syndrome	B-X
,	B-X
ATM	B-X
(	B-X
for	B-X
AT	B-X
mutated	B-X
)	B-X
,	B-X
encodes	B-X
a	B-X
protein	B-X
containing	B-X
a	B-X
phosphatidyl-inositol	B-X
3-kinase	B-X
(	B-X
PI-3	B-X
kinase	B-X
)	B-X
-like	B-X
domain	B-X
.	B-X
ATM	B-X
also	B-X
contains	B-X
a	B-X
proline-rich	B-X
region	B-X
and	B-X
a	B-X
leucine	B-X
zipper	B-X
,	B-X
both	B-X
of	B-X
which	B-X
implicate	B-X
this	B-X
protein	B-X
in	B-X
signal	B-X
transduction	B-X
.	B-X
The	B-X
proline-rich	B-X
region	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
bind	B-X
to	B-X
the	B-X
SH3	B-X
domain	B-X
of	B-X
c-Abl	B-X
,	B-X
which	B-X
facilitates	B-X
its	B-X
phosphorylation	B-X
and	B-X
activation	B-X
by	B-X
ATM	B-X
.	B-X
Previous	B-X
results	B-X
have	B-X
demonstrated	B-X
that	B-X
AT	B-X
cells	B-X
are	B-X
defective	B-X
in	B-X
the	B-X
G1/S	B-X
checkpoint	B-X
activated	B-X
after	B-X
radiation	B-X
damage	B-X
and	B-X
that	B-X
this	B-X
defect	B-X
is	B-X
attributable	B-X
to	B-X
a	B-X
defective	B-X
p53	B-X
signal	B-X
transduction	B-X
pathway	B-X
.	B-X
We	B-X
report	B-X
here	B-X
direct	B-X
interaction	B-X
between	B-X
ATM	B-X
and	B-X
p53	B-X
involving	B-X
two	B-X
regions	B-X
in	B-X
ATM	B-X
,	B-X
one	B-X
at	B-X
the	B-X
amino	B-X
terminus	B-X
and	B-X
the	B-X
other	B-X
at	B-X
the	B-X
carboxy	B-X
terminus	B-X
,	B-X
corresponding	B-X
to	B-X
the	B-X
PI-3	B-X
kinase	B-X
domain	B-X
.	B-X
Recombinant	B-X
ATM	B-X
protein	B-X
phosphorylates	B-X
p53	B-X
on	B-X
serine	B-X
15	B-X
near	B-X
the	B-X
N	B-X
terminus	B-X
.	B-X
Furthermore	B-X
,	B-X
ectopic	B-X
expression	B-X
of	B-X
ATM	B-X
in	B-X
AT	B-X
cells	B-X
restores	B-X
normal	B-X
ionizing	B-X
radiation	B-X
(	B-X
IR	B-X
)	B-X
-induced	B-X
phosphorylation	B-X
of	B-X
p53	B-X
,	B-X
whereas	B-X
expression	B-X
of	B-X
ATM	B-X
antisense	B-X
RNA	B-X
in	B-X
control	B-X
cells	B-X
abrogates	B-X
the	B-X
rapid	B-X
IR-induced	B-X
phosphorylation	B-X
of	B-X
p53	B-X
on	B-X
serine	B-X
15	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
ATM	B-X
can	B-X
bind	B-X
p53	B-X
directly	B-X
and	B-X
is	B-X
responsible	B-X
for	B-X
its	B-X
serine	B-X
15	B-X
phosphorylation	B-X
,	B-X
thereby	B-X
contributing	B-X
to	B-X
the	B-X
activation	B-X
and	B-X
stabilization	B-X
of	B-X
p53	B-X
during	B-X
the	B-X
IR-induced	B-X
DNA	B-X
damage	B-X
response	B-X
.	B-X

These	O
results	O
demonstrate	O
that	O
ATM	B-Gene_or_gene_product
can	O
bind	O
p53	B-Gene_or_gene_product
directly	O
and	O
is	O
responsible	O
for	O
its	O
serine	O
15	O
phosphorylation	O
,	O
thereby	O
contributing	O
to	O
the	O
activation	O
and	O
stabilization	O
of	O
p53	B-Gene_or_gene_product
during	O
the	O
IR	O
-	O
induced	O
DNA	O
damage	O
response	O
.	O

The	O
metabolism	O
of	O
6	O
-	O
deoxyhexoses	O
in	O
bacterial	O
and	O
animal	O
cells	O
.	O

L	O
-	O
fucose	O
and	O
L	O
-	O
rhamnose	O
are	O
two	O
6	O
-	O
deoxyhexoses	O
naturally	O
occurring	O
in	O
several	O
complex	O
carbohydrates	O
.	O
<EOS>	B-X
L-fucose	B-X
and	B-X
L-rhamnose	B-X
are	B-X
two	B-X
6-deoxyhexoses	B-X
naturally	B-X
occurring	B-X
in	B-X
several	B-X
complex	B-X
carbohydrates	B-X
.	B-X
In	B-X
prokaryotes	B-X
both	B-X
of	B-X
them	B-X
are	B-X
found	B-X
in	B-X
polysaccharides	B-X
of	B-X
the	B-X
cell	B-X
wall	B-X
,	B-X
while	B-X
in	B-X
animals	B-X
only	B-X
L-fucose	B-X
has	B-X
been	B-X
described	B-X
,	B-X
which	B-X
mainly	B-X
participates	B-X
to	B-X
the	B-X
structure	B-X
of	B-X
glycoconjugates	B-X
,	B-X
either	B-X
in	B-X
the	B-X
cell	B-X
membrane	B-X
or	B-X
secreted	B-X
in	B-X
biological	B-X
fluids	B-X
,	B-X
such	B-X
as	B-X
ABH	B-X
blood	B-X
groups	B-X
and	B-X
Lewis	B-X
system	B-X
antigens	B-X
.	B-X
L-fucose	B-X
and	B-X
L-rhamnose	B-X
are	B-X
synthesized	B-X
by	B-X
two	B-X
de	B-X
novo	B-X
biosynthetic	B-X
pathways	B-X
starting	B-X
from	B-X
GDP-D-mannose	B-X
and	B-X
dTDP-D-glucose	B-X
,	B-X
respectively	B-X
,	B-X
which	B-X
share	B-X
several	B-X
common	B-X
features	B-X
.	B-X
This	B-X
leads	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
unstable	B-X
4-keto-6-deoxy	B-X
intermediates	B-X
,	B-X
which	B-X
undergo	B-X
a	B-X
subsequent	B-X
epimerization	B-X
reaction	B-X
responsible	B-X
for	B-X
the	B-X
change	B-X
from	B-X
D-	B-X
to	B-X
L-conformation	B-X
,	B-X
and	B-X
then	B-X
a	B-X
NADPH-dependent	B-X
reduction	B-X
of	B-X
the	B-X
4-keto	B-X
group	B-X
,	B-X
with	B-X
the	B-X
consequent	B-X
formation	B-X
of	B-X
either	B-X
GDP-L-fucose	B-X
or	B-X
dTDP-L-rhamnose	B-X
.	B-X
These	B-X
compounds	B-X
are	B-X
then	B-X
the	B-X
substrates	B-X
of	B-X
specific	B-X
glycosyltransferases	B-X
which	B-X
are	B-X
responsible	B-X
for	B-X
insertion	B-X
of	B-X
either	B-X
L-fucose	B-X
or	B-X
L-rhamnose	B-X
in	B-X
the	B-X
corresponding	B-X
glycoconjugates	B-X
.	B-X
The	B-X
enzyme	B-X
involved	B-X
in	B-X
the	B-X
first	B-X
step	B-X
of	B-X
GDP-L-fucose	B-X
biosynthesis	B-X
in	B-X
E.	B-X
coli	B-X
,	B-X
i.e.	B-X
,	B-X
GDP-D-mannose	B-X
4,6	B-X
dehydratase	B-X
,	B-X
has	B-X
been	B-X
recently	B-X
expressed	B-X
as	B-X
recombinant	B-X
protein	B-X
and	B-X
characterized	B-X
in	B-X
our	B-X
laboratory	B-X
.	B-X
We	B-X
have	B-X
also	B-X
cloned	B-X
and	B-X
fully	B-X
characterized	B-X
a	B-X
human	B-X
protein	B-X
,	B-X
formerly	B-X
named	B-X
FX	B-X
,	B-X
and	B-X
an	B-X
E.	B-X
coli	B-X
protein	B-X
,	B-X
WcaG	B-X
,	B-X
which	B-X
display	B-X
both	B-X
the	B-X
epimerase	B-X
and	B-X
the	B-X
reductase	B-X
activities	B-X
,	B-X
thus	B-X
indicating	B-X
that	B-X
only	B-X
two	B-X
enzymes	B-X
are	B-X
required	B-X
for	B-X
GDP-L-fucose	B-X
production	B-X
.	B-X
Fucosylated	B-X
complex	B-X
glycoconjugates	B-X
at	B-X
the	B-X
cell	B-X
surface	B-X
can	B-X
then	B-X
be	B-X
recognized	B-X
by	B-X
specific	B-X
counter-receptors	B-X
in	B-X
interacting	B-X
cells	B-X
,	B-X
these	B-X
mechanisms	B-X
initiating	B-X
important	B-X
processes	B-X
including	B-X
inflammation	B-X
and	B-X
metastasis	B-X
.	B-X
The	B-X
second	B-X
pathway	B-X
starting	B-X
from	B-X
dTDP-D-glucose	B-X
leads	B-X
to	B-X
the	B-X
synthesis	B-X
of	B-X
antibiotic	B-X
glycosides	B-X
or	B-X
,	B-X
alternatively	B-X
,	B-X
to	B-X
the	B-X
production	B-X
of	B-X
dTDP-L-rhamnose	B-X
.	B-X
While	B-X
several	B-X
sets	B-X
of	B-X
data	B-X
are	B-X
available	B-X
on	B-X
the	B-X
first	B-X
enzyme	B-X
of	B-X
the	B-X
pathway	B-X
,	B-X
i.e.	B-X
,	B-X
dTDP-D-glucose	B-X
dehydratase	B-X
,	B-X
the	B-X
enzymes	B-X
involved	B-X
in	B-X
the	B-X
following	B-X
steps	B-X
still	B-X
need	B-X
to	B-X
be	B-X
identified	B-X
and	B-X
characterized	B-X
.	B-X

In	O
prokaryotes	O
both	O
of	O
them	O
are	O
found	O
in	O
polysaccharides	O
of	O
the	O
cell	O
wall	O
,	O
while	O
in	O
animals	O
only	O
L	O
-	O
fucose	O
has	O
been	O
described	O
,	O
which	O
mainly	O
participates	O
to	O
the	O
structure	O
of	O
glycoconjugates	O
,	O
either	O
in	O
the	O
cell	O
membrane	O
or	O
secreted	O
in	O
biological	O
fluids	O
,	O
such	O
as	O
ABH	O
blood	O
groups	O
and	O
Lewis	O
system	O
antigens	O
.	O
<EOS>	B-X
Associations	B-X
between	B-X
blood	B-X
type	B-X
and	B-X
disease	B-X
have	B-X
been	B-X
studied	B-X
since	B-X
the	B-X
early	B-X
1900s	B-X
when	B-X
researchers	B-X
determined	B-X
that	B-X
antibodies	B-X
and	B-X
antigens	B-X
are	B-X
inherited	B-X
.	B-X
In	B-X
the	B-X
1950s	B-X
,	B-X
the	B-X
chemical	B-X
identification	B-X
of	B-X
the	B-X
carbohydrate	B-X
structure	B-X
of	B-X
surface	B-X
antigens	B-X
led	B-X
to	B-X
the	B-X
understanding	B-X
of	B-X
biosynthetic	B-X
pathways	B-X
.	B-X
The	B-X
blood	B-X
type	B-X
is	B-X
defined	B-X
by	B-X
oligosaccharide	B-X
structures	B-X
,	B-X
which	B-X
are	B-X
specific	B-X
to	B-X
the	B-X
antigens	B-X
,	B-X
thus	B-X
,	B-X
blood	B-X
group	B-X
antigens	B-X
are	B-X
secondary	B-X
gene	B-X
products	B-X
,	B-X
while	B-X
the	B-X
primary	B-X
gene	B-X
products	B-X
are	B-X
various	B-X
glycosyltransferase	B-X
enzymes	B-X
that	B-X
attach	B-X
the	B-X
sugar	B-X
molecules	B-X
to	B-X
the	B-X
oligosaccharide	B-X
chain	B-X
.	B-X
Blood	B-X
group	B-X
antigens	B-X
are	B-X
found	B-X
on	B-X
red	B-X
blood	B-X
cells	B-X
,	B-X
platelets	B-X
,	B-X
leukocytes	B-X
,	B-X
plasma	B-X
proteins	B-X
,	B-X
certain	B-X
tissues	B-X
,	B-X
and	B-X
various	B-X
cell	B-X
surface	B-X
enzymes	B-X
,	B-X
and	B-X
also	B-X
exist	B-X
in	B-X
soluble	B-X
form	B-X
in	B-X
body	B-X
secretions	B-X
such	B-X
as	B-X
breast	B-X
milk	B-X
,	B-X
seminal	B-X
fluid	B-X
,	B-X
saliva	B-X
,	B-X
sweat	B-X
,	B-X
gastric	B-X
secretions	B-X
,	B-X
urine	B-X
,	B-X
and	B-X
amniotic	B-X
fluid	B-X
.	B-X
Recent	B-X
advances	B-X
in	B-X
technology	B-X
,	B-X
biochemistry	B-X
,	B-X
and	B-X
genetics	B-X
have	B-X
clarified	B-X
the	B-X
functional	B-X
classifications	B-X
of	B-X
human	B-X
blood	B-X
group	B-X
antigens	B-X
,	B-X
the	B-X
structure	B-X
of	B-X
the	B-X
A	B-X
,	B-X
B	B-X
,	B-X
H	B-X
,	B-X
and	B-X
Lewis	B-X
determinants	B-X
and	B-X
the	B-X
enzymes	B-X
that	B-X
produce	B-X
them	B-X
,	B-X
and	B-X
the	B-X
association	B-X
of	B-X
blood	B-X
group	B-X
antigens	B-X
with	B-X
disease	B-X
risks	B-X
.	B-X
Further	B-X
research	B-X
to	B-X
identify	B-X
differences	B-X
in	B-X
the	B-X
biochemical	B-X
composition	B-X
of	B-X
blood	B-X
group	B-X
antigens	B-X
,	B-X
and	B-X
the	B-X
relationship	B-X
to	B-X
risks	B-X
for	B-X
disease	B-X
,	B-X
can	B-X
be	B-X
important	B-X
for	B-X
the	B-X
identification	B-X
of	B-X
targets	B-X
for	B-X
the	B-X
development	B-X
of	B-X
nutritional	B-X
intervention	B-X
strategies	B-X
,	B-X
or	B-X
the	B-X
identification	B-X
of	B-X
druggable	B-X
targets	B-X
.	B-X

L	O
-	O
fucose	O
and	O
L	O
-	O
rhamnose	O
are	O
synthesized	O
by	O
two	O
de	O
novo	O
biosynthetic	O
pathways	O
starting	O
from	O
GDP	O
-	O
D	O
-	O
mannose	O
and	O
dTDP	O
-	O
D	O
-	O
glucose	O
,	O
respectively	O
,	O
which	O
share	O
several	O
common	O
features	O
.	O
<EOS>	B-X
L-fucose	B-X
and	B-X
L-rhamnose	B-X
are	B-X
two	B-X
6-deoxyhexoses	B-X
naturally	B-X
occurring	B-X
in	B-X
several	B-X
complex	B-X
carbohydrates	B-X
.	B-X
In	B-X
prokaryotes	B-X
both	B-X
of	B-X
them	B-X
are	B-X
found	B-X
in	B-X
polysaccharides	B-X
of	B-X
the	B-X
cell	B-X
wall	B-X
,	B-X
while	B-X
in	B-X
animals	B-X
only	B-X
L-fucose	B-X
has	B-X
been	B-X
described	B-X
,	B-X
which	B-X
mainly	B-X
participates	B-X
to	B-X
the	B-X
structure	B-X
of	B-X
glycoconjugates	B-X
,	B-X
either	B-X
in	B-X
the	B-X
cell	B-X
membrane	B-X
or	B-X
secreted	B-X
in	B-X
biological	B-X
fluids	B-X
,	B-X
such	B-X
as	B-X
ABH	B-X
blood	B-X
groups	B-X
and	B-X
Lewis	B-X
system	B-X
antigens	B-X
.	B-X
L-fucose	B-X
and	B-X
L-rhamnose	B-X
are	B-X
synthesized	B-X
by	B-X
two	B-X
de	B-X
novo	B-X
biosynthetic	B-X
pathways	B-X
starting	B-X
from	B-X
GDP-D-mannose	B-X
and	B-X
dTDP-D-glucose	B-X
,	B-X
respectively	B-X
,	B-X
which	B-X
share	B-X
several	B-X
common	B-X
features	B-X
.	B-X
The	B-X
first	B-X
step	B-X
for	B-X
both	B-X
pathways	B-X
is	B-X
a	B-X
dehydration	B-X
reaction	B-X
catalyzed	B-X
by	B-X
specific	B-X
nucleotide-sugar	B-X
dehydratases	B-X
.	B-X
This	B-X
leads	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
unstable	B-X
4-keto-6-deoxy	B-X
intermediates	B-X
,	B-X
which	B-X
undergo	B-X
a	B-X
subsequent	B-X
epimerization	B-X
reaction	B-X
responsible	B-X
for	B-X
the	B-X
change	B-X
from	B-X
D-	B-X
to	B-X
L-conformation	B-X
,	B-X
and	B-X
then	B-X
a	B-X
NADPH-dependent	B-X
reduction	B-X
of	B-X
the	B-X
4-keto	B-X
group	B-X
,	B-X
with	B-X
the	B-X
consequent	B-X
formation	B-X
of	B-X
either	B-X
GDP-L-fucose	B-X
or	B-X
dTDP-L-rhamnose	B-X
.	B-X
These	B-X
compounds	B-X
are	B-X
then	B-X
the	B-X
substrates	B-X
of	B-X
specific	B-X
glycosyltransferases	B-X
which	B-X
are	B-X
responsible	B-X
for	B-X
insertion	B-X
of	B-X
either	B-X
L-fucose	B-X
or	B-X
L-rhamnose	B-X
in	B-X
the	B-X
corresponding	B-X
glycoconjugates	B-X
.	B-X
The	B-X
enzyme	B-X
involved	B-X
in	B-X
the	B-X
first	B-X
step	B-X
of	B-X
GDP-L-fucose	B-X
biosynthesis	B-X
in	B-X
E.	B-X
coli	B-X
,	B-X
i.e.	B-X
,	B-X
GDP-D-mannose	B-X
4,6	B-X
dehydratase	B-X
,	B-X
has	B-X
been	B-X
recently	B-X
expressed	B-X
as	B-X
recombinant	B-X
protein	B-X
and	B-X
characterized	B-X
in	B-X
our	B-X
laboratory	B-X
.	B-X
We	B-X
have	B-X
also	B-X
cloned	B-X
and	B-X
fully	B-X
characterized	B-X
a	B-X
human	B-X
protein	B-X
,	B-X
formerly	B-X
named	B-X
FX	B-X
,	B-X
and	B-X
an	B-X
E.	B-X
coli	B-X
protein	B-X
,	B-X
WcaG	B-X
,	B-X
which	B-X
display	B-X
both	B-X
the	B-X
epimerase	B-X
and	B-X
the	B-X
reductase	B-X
activities	B-X
,	B-X
thus	B-X
indicating	B-X
that	B-X
only	B-X
two	B-X
enzymes	B-X
are	B-X
required	B-X
for	B-X
GDP-L-fucose	B-X
production	B-X
.	B-X
The	B-X
second	B-X
pathway	B-X
starting	B-X
from	B-X
dTDP-D-glucose	B-X
leads	B-X
to	B-X
the	B-X
synthesis	B-X
of	B-X
antibiotic	B-X
glycosides	B-X
or	B-X
,	B-X
alternatively	B-X
,	B-X
to	B-X
the	B-X
production	B-X
of	B-X
dTDP-L-rhamnose	B-X
.	B-X
While	B-X
several	B-X
sets	B-X
of	B-X
data	B-X
are	B-X
available	B-X
on	B-X
the	B-X
first	B-X
enzyme	B-X
of	B-X
the	B-X
pathway	B-X
,	B-X
i.e.	B-X
,	B-X
dTDP-D-glucose	B-X
dehydratase	B-X
,	B-X
the	B-X
enzymes	B-X
involved	B-X
in	B-X
the	B-X
following	B-X
steps	B-X
still	B-X
need	B-X
to	B-X
be	B-X
identified	B-X
and	B-X
characterized	B-X
.	B-X

The	O
first	O
step	O
for	O
both	O
pathways	O
is	O
a	O
dehydration	O
reaction	O
catalyzed	O
by	O
specific	O
nucleotide	B-Gene_or_gene_product
-	I-Gene_or_gene_product
sugar	I-Gene_or_gene_product
dehydratases	I-Gene_or_gene_product
.	O
<EOS>	B-X
L-fucose	B-X
and	B-X
L-rhamnose	B-X
are	B-X
synthesized	B-X
by	B-X
two	B-X
de	B-X
novo	B-X
biosynthetic	B-X
pathways	B-X
starting	B-X
from	B-X
GDP-D-mannose	B-X
and	B-X
dTDP-D-glucose	B-X
,	B-X
respectively	B-X
,	B-X
which	B-X
share	B-X
several	B-X
common	B-X
features	B-X
.	B-X
The	B-X
first	B-X
step	B-X
for	B-X
both	B-X
pathways	B-X
is	B-X
a	B-X
dehydration	B-X
reaction	B-X
catalyzed	B-X
by	B-X
specific	B-X
nucleotide-sugar	B-X
dehydratases	B-X
.	B-X
This	B-X
leads	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
unstable	B-X
4-keto-6-deoxy	B-X
intermediates	B-X
,	B-X
which	B-X
undergo	B-X
a	B-X
subsequent	B-X
epimerization	B-X
reaction	B-X
responsible	B-X
for	B-X
the	B-X
change	B-X
from	B-X
D-	B-X
to	B-X
L-conformation	B-X
,	B-X
and	B-X
then	B-X
a	B-X
NADPH-dependent	B-X
reduction	B-X
of	B-X
the	B-X
4-keto	B-X
group	B-X
,	B-X
with	B-X
the	B-X
consequent	B-X
formation	B-X
of	B-X
either	B-X
GDP-L-fucose	B-X
or	B-X
dTDP-L-rhamnose	B-X
.	B-X
These	B-X
compounds	B-X
are	B-X
then	B-X
the	B-X
substrates	B-X
of	B-X
specific	B-X
glycosyltransferases	B-X
which	B-X
are	B-X
responsible	B-X
for	B-X
insertion	B-X
of	B-X
either	B-X
L-fucose	B-X
or	B-X
L-rhamnose	B-X
in	B-X
the	B-X
corresponding	B-X
glycoconjugates	B-X
.	B-X
The	B-X
enzyme	B-X
involved	B-X
in	B-X
the	B-X
first	B-X
step	B-X
of	B-X
GDP-L-fucose	B-X
biosynthesis	B-X
in	B-X
E.	B-X
coli	B-X
,	B-X
i.e.	B-X
,	B-X
GDP-D-mannose	B-X
4,6	B-X
dehydratase	B-X
,	B-X
has	B-X
been	B-X
recently	B-X
expressed	B-X
as	B-X
recombinant	B-X
protein	B-X
and	B-X
characterized	B-X
in	B-X
our	B-X
laboratory	B-X
.	B-X
Fucosylated	B-X
complex	B-X
glycoconjugates	B-X
at	B-X
the	B-X
cell	B-X
surface	B-X
can	B-X
then	B-X
be	B-X
recognized	B-X
by	B-X
specific	B-X
counter-receptors	B-X
in	B-X
interacting	B-X
cells	B-X
,	B-X
these	B-X
mechanisms	B-X
initiating	B-X
important	B-X
processes	B-X
including	B-X
inflammation	B-X
and	B-X
metastasis	B-X
.	B-X
While	B-X
several	B-X
sets	B-X
of	B-X
data	B-X
are	B-X
available	B-X
on	B-X
the	B-X
first	B-X
enzyme	B-X
of	B-X
the	B-X
pathway	B-X
,	B-X
i.e.	B-X
,	B-X
dTDP-D-glucose	B-X
dehydratase	B-X
,	B-X
the	B-X
enzymes	B-X
involved	B-X
in	B-X
the	B-X
following	B-X
steps	B-X
still	B-X
need	B-X
to	B-X
be	B-X
identified	B-X
and	B-X
characterized	B-X
.	B-X

This	O
leads	O
to	O
the	O
formation	O
of	O
unstable	O
4	O
-	O
keto	O
-	O
6	O
-	O
deoxy	O
intermediates	O
,	O
which	O
undergo	O
a	O
subsequent	O
epimerization	O
reaction	O
responsible	O
for	O
the	O
change	O
from	O
D	O
-	O
to	O
L	O
-	O
conformation	O
,	O
and	O
then	O
a	O
NADPH	O
-	O
dependent	O
reduction	O
of	O
the	O
4	O
-	O
keto	O
group	O
,	O
with	O
the	O
consequent	O
formation	O
of	O
either	O
GDP	O
-	O
L	O
-	O
fucose	O
or	O
dTDP	O
-	O
L	O
-	O
rhamnose	O
.	O
<EOS>	B-X
B.	B-X
anthracis	B-X
is	B-X
a	B-X
Gram-positive	B-X
bacterium	B-X
that	B-X
adds	B-X
L-rhamnose	B-X
to	B-X
its	B-X
cell-wall	B-X
polysaccharides	B-X
using	B-X
the	B-X
activated	B-X
donor	B-X
dTDP-β-L-rhamnose	B-X
.	B-X
Here	B-X
,	B-X
the	B-X
2.65	B-X
Å	B-X
resolution	B-X
crystal	B-X
structure	B-X
of	B-X
the	B-X
fourth	B-X
enzyme	B-X
in	B-X
the	B-X
dTDP-β-L-rhamnose-biosynthetic	B-X
pathway	B-X
from	B-X
B.	B-X
anthracis	B-X
,	B-X
dTDP-4-dehydro-β-L-rhamnose	B-X
reductase	B-X
(	B-X
RfbD	B-X
)	B-X
,	B-X
is	B-X
presented	B-X
in	B-X
complex	B-X
with	B-X
NADP	B-X
These	B-X
conversions	B-X
often	B-X
involve	B-X
chemical	B-X
reactions	B-X
that	B-X
are	B-X
hard	B-X
to	B-X
reproduce	B-X
in	B-X
the	B-X
laboratory	B-X
.	B-X
The	B-X
results	B-X
from	B-X
the	B-X
study	B-X
of	B-X
the	B-X
biosynthetic	B-X
dTDP-L-rhamnose	B-X
pathway	B-X
are	B-X
discussed	B-X
.	B-X
dTDP-L-rhamnose	B-X
is	B-X
a	B-X
key	B-X
intermediate	B-X
in	B-X
many	B-X
pathogenic	B-X
bacteria	B-X
,	B-X
as	B-X
it	B-X
is	B-X
the	B-X
donor	B-X
for	B-X
L-rhamnose	B-X
,	B-X
which	B-X
is	B-X
found	B-X
in	B-X
the	B-X
cell	B-X
wall	B-X
of	B-X
important	B-X
human	B-X
pathogens	B-X
,	B-X
such	B-X
as	B-X
Mycobacteria	B-X
tuberculosis	B-X
and	B-X
Salmonella	B-X
typhimurium	B-X
.	B-X
The	B-X
results	B-X
shed	B-X
light	B-X
on	B-X
three	B-X
classes	B-X
of	B-X
enzyme	B-X
mechanism	B-X
:	B-X
nucleotide	B-X
condensation	B-X
,	B-X
short-chain	B-X
dehydrogenase	B-X
activity	B-X
and	B-X
epimerization	B-X
.	B-X

These	O
compounds	O
are	O
then	O
the	O
substrates	O
of	O
specific	O
glycosyltransferases	B-Gene_or_gene_product
which	O
are	O
responsible	O
for	O
insertion	O
of	O
either	O
L	O
-	O
fucose	O
or	O
L	O
-	O
rhamnose	O
in	O
the	O
corresponding	O
glycoconjugates	O
.	O
<EOS>	B-X
L-fucose	B-X
and	B-X
L-rhamnose	B-X
are	B-X
two	B-X
6-deoxyhexoses	B-X
naturally	B-X
occurring	B-X
in	B-X
several	B-X
complex	B-X
carbohydrates	B-X
.	B-X
In	B-X
prokaryotes	B-X
both	B-X
of	B-X
them	B-X
are	B-X
found	B-X
in	B-X
polysaccharides	B-X
of	B-X
the	B-X
cell	B-X
wall	B-X
,	B-X
while	B-X
in	B-X
animals	B-X
only	B-X
L-fucose	B-X
has	B-X
been	B-X
described	B-X
,	B-X
which	B-X
mainly	B-X
participates	B-X
to	B-X
the	B-X
structure	B-X
of	B-X
glycoconjugates	B-X
,	B-X
either	B-X
in	B-X
the	B-X
cell	B-X
membrane	B-X
or	B-X
secreted	B-X
in	B-X
biological	B-X
fluids	B-X
,	B-X
such	B-X
as	B-X
ABH	B-X
blood	B-X
groups	B-X
and	B-X
Lewis	B-X
system	B-X
antigens	B-X
.	B-X
L-fucose	B-X
and	B-X
L-rhamnose	B-X
are	B-X
synthesized	B-X
by	B-X
two	B-X
de	B-X
novo	B-X
biosynthetic	B-X
pathways	B-X
starting	B-X
from	B-X
GDP-D-mannose	B-X
and	B-X
dTDP-D-glucose	B-X
,	B-X
respectively	B-X
,	B-X
which	B-X
share	B-X
several	B-X
common	B-X
features	B-X
.	B-X
The	B-X
first	B-X
step	B-X
for	B-X
both	B-X
pathways	B-X
is	B-X
a	B-X
dehydration	B-X
reaction	B-X
catalyzed	B-X
by	B-X
specific	B-X
nucleotide-sugar	B-X
dehydratases	B-X
.	B-X
This	B-X
leads	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
unstable	B-X
4-keto-6-deoxy	B-X
intermediates	B-X
,	B-X
which	B-X
undergo	B-X
a	B-X
subsequent	B-X
epimerization	B-X
reaction	B-X
responsible	B-X
for	B-X
the	B-X
change	B-X
from	B-X
D-	B-X
to	B-X
L-conformation	B-X
,	B-X
and	B-X
then	B-X
a	B-X
NADPH-dependent	B-X
reduction	B-X
of	B-X
the	B-X
4-keto	B-X
group	B-X
,	B-X
with	B-X
the	B-X
consequent	B-X
formation	B-X
of	B-X
either	B-X
GDP-L-fucose	B-X
or	B-X
dTDP-L-rhamnose	B-X
.	B-X
These	B-X
compounds	B-X
are	B-X
then	B-X
the	B-X
substrates	B-X
of	B-X
specific	B-X
glycosyltransferases	B-X
which	B-X
are	B-X
responsible	B-X
for	B-X
insertion	B-X
of	B-X
either	B-X
L-fucose	B-X
or	B-X
L-rhamnose	B-X
in	B-X
the	B-X
corresponding	B-X
glycoconjugates	B-X
.	B-X
The	B-X
enzyme	B-X
involved	B-X
in	B-X
the	B-X
first	B-X
step	B-X
of	B-X
GDP-L-fucose	B-X
biosynthesis	B-X
in	B-X
E.	B-X
coli	B-X
,	B-X
i.e.	B-X
,	B-X
GDP-D-mannose	B-X
4,6	B-X
dehydratase	B-X
,	B-X
has	B-X
been	B-X
recently	B-X
expressed	B-X
as	B-X
recombinant	B-X
protein	B-X
and	B-X
characterized	B-X
in	B-X
our	B-X
laboratory	B-X
.	B-X
We	B-X
have	B-X
also	B-X
cloned	B-X
and	B-X
fully	B-X
characterized	B-X
a	B-X
human	B-X
protein	B-X
,	B-X
formerly	B-X
named	B-X
FX	B-X
,	B-X
and	B-X
an	B-X
E.	B-X
coli	B-X
protein	B-X
,	B-X
WcaG	B-X
,	B-X
which	B-X
display	B-X
both	B-X
the	B-X
epimerase	B-X
and	B-X
the	B-X
reductase	B-X
activities	B-X
,	B-X
thus	B-X
indicating	B-X
that	B-X
only	B-X
two	B-X
enzymes	B-X
are	B-X
required	B-X
for	B-X
GDP-L-fucose	B-X
production	B-X
.	B-X
Fucosylated	B-X
complex	B-X
glycoconjugates	B-X
at	B-X
the	B-X
cell	B-X
surface	B-X
can	B-X
then	B-X
be	B-X
recognized	B-X
by	B-X
specific	B-X
counter-receptors	B-X
in	B-X
interacting	B-X
cells	B-X
,	B-X
these	B-X
mechanisms	B-X
initiating	B-X
important	B-X
processes	B-X
including	B-X
inflammation	B-X
and	B-X
metastasis	B-X
.	B-X
The	B-X
second	B-X
pathway	B-X
starting	B-X
from	B-X
dTDP-D-glucose	B-X
leads	B-X
to	B-X
the	B-X
synthesis	B-X
of	B-X
antibiotic	B-X
glycosides	B-X
or	B-X
,	B-X
alternatively	B-X
,	B-X
to	B-X
the	B-X
production	B-X
of	B-X
dTDP-L-rhamnose	B-X
.	B-X

The	O
enzyme	O
involved	O
in	O
the	O
first	O
step	O
of	O
GDP	O
-	O
L	O
-	O
fucose	O
biosynthesis	O
in	O
E	O
.	O
coli	O
,	O
i	O
.	O
e	O
.	O
,	O
GDP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
D	I-Gene_or_gene_product
-	I-Gene_or_gene_product
mannose	I-Gene_or_gene_product
4	I-Gene_or_gene_product
,	I-Gene_or_gene_product
6	I-Gene_or_gene_product
dehydratase	I-Gene_or_gene_product
,	O
has	O
been	O
recently	O
expressed	O
as	O
recombinant	O
protein	O
and	O
characterized	O
in	O
our	O
laboratory	O
.	O

We	O
have	O
also	O
cloned	O
and	O
fully	O
characterized	O
a	O
human	O
protein	O
,	O
formerly	O
named	O
FX	B-Gene_or_gene_product
,	O
and	O
an	O
E	O
.	O
coli	O
protein	O
,	O
WcaG	B-Gene_or_gene_product
,	O
which	O
display	O
both	O
the	O
epimerase	O
and	O
the	O
reductase	O
activities	O
,	O
thus	O
indicating	O
that	O
only	O
two	O
enzymes	O
are	O
required	O
for	O
GDP	O
-	O
L	O
-	O
fucose	O
production	O
.	O

Fucosylated	O
complex	O
glycoconjugates	O
at	O
the	O
cell	O
surface	O
can	O
then	O
be	O
recognized	O
by	O
specific	O
counter	O
-	O
receptors	O
in	O
interacting	O
cells	O
,	O
these	O
mechanisms	O
initiating	O
important	O
processes	O
including	O
inflammation	O
and	O
metastasis	O
.	O
<EOS>	B-X
L-fucose	B-X
and	B-X
L-rhamnose	B-X
are	B-X
two	B-X
6-deoxyhexoses	B-X
naturally	B-X
occurring	B-X
in	B-X
several	B-X
complex	B-X
carbohydrates	B-X
.	B-X
In	B-X
prokaryotes	B-X
both	B-X
of	B-X
them	B-X
are	B-X
found	B-X
in	B-X
polysaccharides	B-X
of	B-X
the	B-X
cell	B-X
wall	B-X
,	B-X
while	B-X
in	B-X
animals	B-X
only	B-X
L-fucose	B-X
has	B-X
been	B-X
described	B-X
,	B-X
which	B-X
mainly	B-X
participates	B-X
to	B-X
the	B-X
structure	B-X
of	B-X
glycoconjugates	B-X
,	B-X
either	B-X
in	B-X
the	B-X
cell	B-X
membrane	B-X
or	B-X
secreted	B-X
in	B-X
biological	B-X
fluids	B-X
,	B-X
such	B-X
as	B-X
ABH	B-X
blood	B-X
groups	B-X
and	B-X
Lewis	B-X
system	B-X
antigens	B-X
.	B-X
The	B-X
first	B-X
step	B-X
for	B-X
both	B-X
pathways	B-X
is	B-X
a	B-X
dehydration	B-X
reaction	B-X
catalyzed	B-X
by	B-X
specific	B-X
nucleotide-sugar	B-X
dehydratases	B-X
.	B-X
These	B-X
compounds	B-X
are	B-X
then	B-X
the	B-X
substrates	B-X
of	B-X
specific	B-X
glycosyltransferases	B-X
which	B-X
are	B-X
responsible	B-X
for	B-X
insertion	B-X
of	B-X
either	B-X
L-fucose	B-X
or	B-X
L-rhamnose	B-X
in	B-X
the	B-X
corresponding	B-X
glycoconjugates	B-X
.	B-X
Fucosylated	B-X
complex	B-X
glycoconjugates	B-X
at	B-X
the	B-X
cell	B-X
surface	B-X
can	B-X
then	B-X
be	B-X
recognized	B-X
by	B-X
specific	B-X
counter-receptors	B-X
in	B-X
interacting	B-X
cells	B-X
,	B-X
these	B-X
mechanisms	B-X
initiating	B-X
important	B-X
processes	B-X
including	B-X
inflammation	B-X
and	B-X
metastasis	B-X
.	B-X

The	O
second	O
pathway	O
starting	O
from	O
dTDP	O
-	O
D	O
-	O
glucose	O
leads	O
to	O
the	O
synthesis	O
of	O
antibiotic	O
glycosides	O
or	O
,	O
alternatively	O
,	O
to	O
the	O
production	O
of	O
dTDP	O
-	O
L	O
-	O
rhamnose	O
.	O

While	O
several	O
sets	O
of	O
data	O
are	O
available	O
on	O
the	O
first	O
enzyme	O
of	O
the	O
pathway	O
,	O
i	O
.	O
e	O
.	O
,	O
dTDP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
D	I-Gene_or_gene_product
-	I-Gene_or_gene_product
glucose	I-Gene_or_gene_product
dehydratase	I-Gene_or_gene_product
,	O
the	O
enzymes	O
involved	O
in	O
the	O
following	O
steps	O
still	O
need	O
to	O
be	O
identified	O
and	O
characterized	O
.	O

